Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	"Biological process"	"Molecular function"	"Disease involvement"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific nTPM"	"RNA single cell type specificity"	"RNA single cell type distribution"	"RNA single cell type specificity score"	"RNA single cell type specific nTPM"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific nTPM"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific nTPM"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific nTPM"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific nTPM"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific nTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific nTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"CCD Protein"	"CCD Transcript"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Blood expression cluster"	"Tissue expression cluster"	"Cell line expression cluster"	"Single cell expression cluster"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [nTPM]"	"Tissue RNA - adrenal gland [nTPM]"	"Tissue RNA - amygdala [nTPM]"	"Tissue RNA - appendix [nTPM]"	"Tissue RNA - basal ganglia [nTPM]"	"Tissue RNA - bone marrow [nTPM]"	"Tissue RNA - breast [nTPM]"	"Tissue RNA - cerebellum [nTPM]"	"Tissue RNA - cerebral cortex [nTPM]"	"Tissue RNA - cervix [nTPM]"	"Tissue RNA - choroid plexus [nTPM]"	"Tissue RNA - colon [nTPM]"	"Tissue RNA - duodenum [nTPM]"	"Tissue RNA - endometrium 1 [nTPM]"	"Tissue RNA - epididymis [nTPM]"	"Tissue RNA - esophagus [nTPM]"	"Tissue RNA - fallopian tube [nTPM]"	"Tissue RNA - gallbladder [nTPM]"	"Tissue RNA - heart muscle [nTPM]"	"Tissue RNA - hippocampal formation [nTPM]"	"Tissue RNA - hypothalamus [nTPM]"	"Tissue RNA - kidney [nTPM]"	"Tissue RNA - liver [nTPM]"	"Tissue RNA - lung [nTPM]"	"Tissue RNA - lymph node [nTPM]"	"Tissue RNA - medulla oblongata [nTPM]"	"Tissue RNA - midbrain [nTPM]"	"Tissue RNA - ovary [nTPM]"	"Tissue RNA - pancreas [nTPM]"	"Tissue RNA - parathyroid gland [nTPM]"	"Tissue RNA - pituitary gland [nTPM]"	"Tissue RNA - placenta [nTPM]"	"Tissue RNA - pons [nTPM]"	"Tissue RNA - prostate [nTPM]"	"Tissue RNA - rectum [nTPM]"	"Tissue RNA - retina [nTPM]"	"Tissue RNA - salivary gland [nTPM]"	"Tissue RNA - seminal vesicle [nTPM]"	"Tissue RNA - skeletal muscle [nTPM]"	"Tissue RNA - skin 1 [nTPM]"	"Tissue RNA - small intestine [nTPM]"	"Tissue RNA - smooth muscle [nTPM]"	"Tissue RNA - spinal cord [nTPM]"	"Tissue RNA - spleen [nTPM]"	"Tissue RNA - stomach 1 [nTPM]"	"Tissue RNA - testis [nTPM]"	"Tissue RNA - thalamus [nTPM]"	"Tissue RNA - thymus [nTPM]"	"Tissue RNA - thyroid gland [nTPM]"	"Tissue RNA - tongue [nTPM]"	"Tissue RNA - tonsil [nTPM]"	"Tissue RNA - urinary bladder [nTPM]"	"Tissue RNA - vagina [nTPM]"	"Tissue RNA - white matter [nTPM]"	"Cell RNA - A-431 [nTPM]"	"Cell RNA - A549 [nTPM]"	"Cell RNA - AF22 [nTPM]"	"Cell RNA - AN3-CA [nTPM]"	"Cell RNA - ASC diff [nTPM]"	"Cell RNA - ASC TERT1 [nTPM]"	"Cell RNA - BEWO [nTPM]"	"Cell RNA - BJ [nTPM]"	"Cell RNA - BJ hTERT+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [nTPM]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [nTPM]"	"Cell RNA - CACO-2 [nTPM]"	"Cell RNA - CAPAN-2 [nTPM]"	"Cell RNA - Daudi [nTPM]"	"Cell RNA - EFO-21 [nTPM]"	"Cell RNA - fHDF/TERT166 [nTPM]"	"Cell RNA - GAMG [nTPM]"	"Cell RNA - HaCaT [nTPM]"	"Cell RNA - HAP1 [nTPM]"	"Cell RNA - HBEC3-KT [nTPM]"	"Cell RNA - HBF TERT88 [nTPM]"	"Cell RNA - HDLM-2 [nTPM]"	"Cell RNA - HEK 293 [nTPM]"	"Cell RNA - HEL [nTPM]"	"Cell RNA - HeLa [nTPM]"	"Cell RNA - Hep G2 [nTPM]"	"Cell RNA - HHSteC [nTPM]"	"Cell RNA - HL-60 [nTPM]"	"Cell RNA - HMC-1 [nTPM]"	"Cell RNA - HSkMC [nTPM]"	"Cell RNA - hTCEpi [nTPM]"	"Cell RNA - hTEC/SVTERT24-B [nTPM]"	"Cell RNA - hTERT-HME1 [nTPM]"	"Cell RNA - hTERT-RPE1 [nTPM]"	"Cell RNA - HUVEC TERT2 [nTPM]"	"Cell RNA - JURKAT [nTPM]"	"Cell RNA - K-562 [nTPM]"	"Cell RNA - Karpas-707 [nTPM]"	"Cell RNA - LHCN-M2 [nTPM]"	"Cell RNA - MCF7 [nTPM]"	"Cell RNA - MOLT-4 [nTPM]"	"Cell RNA - NB-4 [nTPM]"	"Cell RNA - NTERA-2 [nTPM]"	"Cell RNA - OE19 [nTPM]"	"Cell RNA - PC-3 [nTPM]"	"Cell RNA - REH [nTPM]"	"Cell RNA - RH-30 [nTPM]"	"Cell RNA - RPMI-8226 [nTPM]"	"Cell RNA - RPTEC TERT1 [nTPM]"	"Cell RNA - RT4 [nTPM]"	"Cell RNA - SCLC-21H [nTPM]"	"Cell RNA - SH-SY5Y [nTPM]"	"Cell RNA - SiHa [nTPM]"	"Cell RNA - SK-BR-3 [nTPM]"	"Cell RNA - SK-MEL-30 [nTPM]"	"Cell RNA - SuSa [nTPM]"	"Cell RNA - T-47d [nTPM]"	"Cell RNA - THP-1 [nTPM]"	"Cell RNA - TIME [nTPM]"	"Cell RNA - U-138 MG [nTPM]"	"Cell RNA - U-2 OS [nTPM]"	"Cell RNA - U-2197 [nTPM]"	"Cell RNA - U-251 MG [nTPM]"	"Cell RNA - U-266/70 [nTPM]"	"Cell RNA - U-266/84 [nTPM]"	"Cell RNA - U-698 [nTPM]"	"Cell RNA - U-87 MG [nTPM]"	"Cell RNA - U-937 [nTPM]"	"Cell RNA - WM-115 [nTPM]"	"Blood RNA - basophil [nTPM]"	"Blood RNA - classical monocyte [nTPM]"	"Blood RNA - eosinophil [nTPM]"	"Blood RNA - gdT-cell [nTPM]"	"Blood RNA - intermediate monocyte [nTPM]"	"Blood RNA - MAIT T-cell [nTPM]"	"Blood RNA - memory B-cell [nTPM]"	"Blood RNA - memory CD4 T-cell [nTPM]"	"Blood RNA - memory CD8 T-cell [nTPM]"	"Blood RNA - myeloid DC [nTPM]"	"Blood RNA - naive B-cell [nTPM]"	"Blood RNA - naive CD4 T-cell [nTPM]"	"Blood RNA - naive CD8 T-cell [nTPM]"	"Blood RNA - neutrophil [nTPM]"	"Blood RNA - NK-cell [nTPM]"	"Blood RNA - non-classical monocyte [nTPM]"	"Blood RNA - plasmacytoid DC [nTPM]"	"Blood RNA - T-reg [nTPM]"	"Blood RNA - total PBMC [nTPM]"	"Brain RNA - amygdala [nTPM]"	"Brain RNA - basal ganglia [nTPM]"	"Brain RNA - cerebellum [nTPM]"	"Brain RNA - cerebral cortex [nTPM]"	"Brain RNA - hippocampal formation [nTPM]"	"Brain RNA - hypothalamus [nTPM]"	"Brain RNA - medulla oblongata [nTPM]"	"Brain RNA - midbrain [nTPM]"	"Brain RNA - pons [nTPM]"	"Brain RNA - spinal cord [nTPM]"	"Brain RNA - thalamus [nTPM]"	"Brain RNA - white matter [nTPM]"	"Single Cell Type RNA - Adipocytes [nTPM]"	"Single Cell Type RNA - Alveolar cells type 1 [nTPM]"	"Single Cell Type RNA - Alveolar cells type 2 [nTPM]"	"Single Cell Type RNA - Astrocytes [nTPM]"	"Single Cell Type RNA - B-cells [nTPM]"	"Single Cell Type RNA - Basal keratinocytes [nTPM]"	"Single Cell Type RNA - Basal prostatic cells [nTPM]"	"Single Cell Type RNA - Basal respiratory cells [nTPM]"	"Single Cell Type RNA - Basal squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Bipolar cells [nTPM]"	"Single Cell Type RNA - Breast glandular cells [nTPM]"	"Single Cell Type RNA - Breast myoepithelial cells [nTPM]"	"Single Cell Type RNA - Cardiomyocytes [nTPM]"	"Single Cell Type RNA - Cholangiocytes [nTPM]"	"Single Cell Type RNA - Club cells [nTPM]"	"Single Cell Type RNA - Collecting duct cells [nTPM]"	"Single Cell Type RNA - Cone photoreceptor cells [nTPM]"	"Single Cell Type RNA - Cytotrophoblasts [nTPM]"	"Single Cell Type RNA - dendritic cells [nTPM]"	"Single Cell Type RNA - Distal enterocytes [nTPM]"	"Single Cell Type RNA - Distal tubular cells [nTPM]"	"Single Cell Type RNA - Ductal cells [nTPM]"	"Single Cell Type RNA - Early spermatids [nTPM]"	"Single Cell Type RNA - Endometrial ciliated cells [nTPM]"	"Single Cell Type RNA - Endometrial stromal cells [nTPM]"	"Single Cell Type RNA - Endothelial cells [nTPM]"	"Single Cell Type RNA - Enteroendocrine cells [nTPM]"	"Single Cell Type RNA - Erythroid cells [nTPM]"	"Single Cell Type RNA - Excitatory neurons [nTPM]"	"Single Cell Type RNA - Exocrine glandular cells [nTPM]"	"Single Cell Type RNA - Extravillous trophoblasts [nTPM]"	"Single Cell Type RNA - Fibroblasts [nTPM]"	"Single Cell Type RNA - Gastric mucus-secreting cells [nTPM]"	"Single Cell Type RNA - Glandular and luminal cells [nTPM]"	"Single Cell Type RNA - granulocytes [nTPM]"	"Single Cell Type RNA - Granulosa cells [nTPM]"	"Single Cell Type RNA - Hepatic stellate cells [nTPM]"	"Single Cell Type RNA - Hepatocytes [nTPM]"	"Single Cell Type RNA - Hofbauer cells [nTPM]"	"Single Cell Type RNA - Horizontal cells [nTPM]"	"Single Cell Type RNA - Inhibitory neurons [nTPM]"	"Single Cell Type RNA - Intestinal goblet cells [nTPM]"	"Single Cell Type RNA - Ionocytes [nTPM]"	"Single Cell Type RNA - Kupffer cells [nTPM]"	"Single Cell Type RNA - Langerhans cells [nTPM]"	"Single Cell Type RNA - Late spermatids [nTPM]"	"Single Cell Type RNA - Leydig cells [nTPM]"	"Single Cell Type RNA - Macrophages [nTPM]"	"Single Cell Type RNA - Melanocytes [nTPM]"	"Single Cell Type RNA - Microglial cells [nTPM]"	"Single Cell Type RNA - monocytes [nTPM]"	"Single Cell Type RNA - Muller glia cells [nTPM]"	"Single Cell Type RNA - NK-cells [nTPM]"	"Single Cell Type RNA - Oligodendrocyte precursor cells [nTPM]"	"Single Cell Type RNA - Oligodendrocytes [nTPM]"	"Single Cell Type RNA - Pancreatic endocrine cells [nTPM]"	"Single Cell Type RNA - Paneth cells [nTPM]"	"Single Cell Type RNA - Peritubular cells [nTPM]"	"Single Cell Type RNA - Plasma cells [nTPM]"	"Single Cell Type RNA - Prostatic glandular cells [nTPM]"	"Single Cell Type RNA - Proximal enterocytes [nTPM]"	"Single Cell Type RNA - Proximal tubular cells [nTPM]"	"Single Cell Type RNA - Respiratory ciliated cells [nTPM]"	"Single Cell Type RNA - Rod photoreceptor cells [nTPM]"	"Single Cell Type RNA - Sertoli cells [nTPM]"	"Single Cell Type RNA - Skeletal myocytes [nTPM]"	"Single Cell Type RNA - Smooth muscle cells [nTPM]"	"Single Cell Type RNA - Spermatocytes [nTPM]"	"Single Cell Type RNA - Spermatogonia [nTPM]"	"Single Cell Type RNA - Squamous epithelial cells [nTPM]"	"Single Cell Type RNA - Suprabasal keratinocytes [nTPM]"	"Single Cell Type RNA - Syncytiotrophoblasts [nTPM]"	"Single Cell Type RNA - T-cells [nTPM]"	"Single Cell Type RNA - Theca cells [nTPM]"	"Single Cell Type RNA - Undifferentiated cells [nTPM]"	"Single Cell Type RNA - Urothelial cells [nTPM]"
AAAS		ENSG00000094914	"Aladin WD repeat nucleoporin"	Q9NRG9	12	53307456-53324864	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040086	Approved		Approved	"Nuclear membrane,Centrosome,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 71: Testis - DNA repair"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nuclear membrane"	"Centrosome, Cytosol"	"HPA040086: AB_10805602"	"unprognostic (1.53e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.70e-1)"	"unprognostic (4.34e-1)"	"unprognostic (1.00e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.64e-2)"	"prognostic unfavorable (2.93e-4)"	"unprognostic (1.95e-1)"	"unprognostic (9.82e-2)"	"unprognostic (2.53e-1)"	"unprognostic (7.44e-2)"	17.0	36.3	12.3	13.8	15.0	19.1	17.1	15.2	15.6	20.3	15.1	19.1	12.3	19.1	7.2	19.3	19.9	9.4	22.7	12.9	13.7	21.7	24.6	14.0	17.6	14.3	14.1	19.2	23.9	18.0	24.8	17.4	14.8	18.4	15.1	12.3	18.5	11.7	22.6	17.3	17.7	16.8	13.7	22.2	21.6	27.3	14.0	25.2	19.4	18.5	21.6	17.8	17.9	17.2	26.1	77.3	63.2	38.0	28.6	32.2	38.9	29.8	31.3	72.6	42.1	54.0	56.7	62.2	47.4	37.3	41.9	37.6	106.4	78.8	42.1	41.0	68.1	49.7	29.9	40.7	26.4	45.5	37.9	28.1	39.4	48.9	44.6	40.4	56.6	56.2	67.6	70.6	30.4	72.8	71.2	46.1	40.0	27.7	53.1	72.1	39.3	69.4	38.2	17.5	32.8	41.3	20.2	46.9	21.0	40.2	61.2	38.8	25.5	34.9	51.1	27.4	32.9	32.5	43.5	54.7	25.6	39.6	40.5	1.0	17.7	10.7	18.4	20.2	20.8	20.0	15.9	16.8	18.8	21.8	21.7	21.4	1.1	10.5	22.5	22.6	17.4	15.2	12.3	15.0	15.2	15.6	12.9	13.7	14.3	14.1	14.8	13.7	14.0	17.2	11.7	12.8	7.8	17.9	15.1	7.4	19.0	26.2	10.2	11.8	13.2	13.0	8.2	17.2	15.4	14.7	16.7	58.4	13.7	9.3	13.7	20.4	12.5	11.9	12.9	11.7	8.4	41.2	7.3	18.3	49.5	14.9	13.3	8.9	8.2	13.1	11.0	12.0	28.5	1.7	6.6	13.1	18.3	12.4	9.3	26.2	17.7	10.6	10.6	5.6	11.6	18.0	15.5	6.6	11.4	8.9	11.0	12.8	20.8	8.1	11.2	18.5	12.6	15.5	19.7	11.0	39.7	34.2	40.5	13.1	7.4	36.5	11.4	14.9	17.2	13.0
AATK	"AATYK, AATYK1, KIAA0641, LMR1, LMTK1, PPP1R77"	ENSG00000181409	"Apoptosis associated tyrosine kinase"	Q6ZMQ8	17	81110487-81166221	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 184.7"	"Cell type enriched"	"Detected in many"	5	"Oligodendrocytes: 243.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 2.0"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 2.0"	"Group enriched"	"Detected in some"	6	"CACO-2: 60.1;SH-SY5Y: 17.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009073	Enhanced		Uncertain	Mitochondria		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA009073: AB_1078076"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.95e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.29e-2)"	"unprognostic (9.85e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.88e-3)"	"unprognostic (2.48e-1)"	"unprognostic (4.28e-6)"	"unprognostic (1.58e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.57e-2)"	3.3	4.2	35.4	3.1	79.2	3.7	2.3	43.4	82.0	2.8	0.0	7.7	30.9	0.9	0.5	1.8	2.8	2.7	3.9	30.6	30.8	1.0	0.9	9.5	0.9	99.2	67.9	0.9	20.6	3.0	17.3	2.0	63.4	5.2	0.5	2.1	5.9	3.3	0.6	4.5	23.7	0.8	38.8	9.7	5.8	0.7	78.4	0.1	2.9	1.0	0.2	2.8	4.2	184.7	0.3	0.5	0.7	4.9	0.0	0.0	0.7	0.1	0.0	0.0	0.0	60.1	0.2	0.0	0.3	0.0	0.0	1.2	0.6	0.0	0.0	0.0	2.0	2.2	3.2	2.8	0.1	0.0	3.9	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	1.4	0.0	6.6	0.0	0.2	0.7	0.6	0.3	2.1	4.1	0.6	0.0	0.2	4.5	17.1	0.2	0.4	2.3	0.2	1.1	2.2	2.1	0.4	0.5	0.4	0.0	0.1	0.0	0.0	0.2	1.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	35.4	79.2	43.4	82.0	30.6	30.8	99.2	67.9	63.4	38.8	78.4	184.7	6.3	32.1	20.3	17.0	0.3	0.3	1.0	1.9	0.6	43.0	1.3	5.1	2.2	2.8	0.1	0.0	4.2	0.1	0.5	6.8	0.0	0.6	0.0	0.4	0.2	1.8	1.8	0.0	34.6	1.8	0.1	0.5	7.1	0.6	6.3	2.0	1.1	0.1	2.1	21.9	36.0	4.6	0.0	2.8	0.4	0.0	1.5	8.2	5.4	2.8	1.5	9.6	4.1	21.1	243.2	1.1	4.2	2.6	0.1	0.9	34.1	0.9	0.0	4.4	0.0	4.3	0.8	0.4	0.5	0.0	0.3	2.3	1.4	0.4	7.0	0.2
ABCA1	"ABC1, HDLDT1, TGD"	ENSG00000165029	"ATP binding cassette subfamily A member 1"	O95477	9	104781006-104928155	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism, Transport"	Translocase	"Atherosclerosis, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 105.8;Hepatocytes: 175.5;Kupffer cells: 169.1;Langerhans cells: 109.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 13.1;neutrophil: 10.6"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 13.1"	"Cell line enhanced"	"Detected in many"		"HSkMC: 34.1;U-87 MG: 79.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA057283, CAB069889"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Vesicles"		"CAB069889: AB_10002789, HPA057283: AB_2683396"	"unprognostic (1.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.47e-3)"	"unprognostic (1.85e-1)"	"unprognostic (9.22e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.28e-3)"	"unprognostic (2.14e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.00e-3)"	"unprognostic (2.51e-2)"	"unprognostic (6.71e-2)"	"unprognostic (2.57e-1)"	24.7	36.5	12.0	11.0	29.1	20.7	13.3	14.4	12.5	7.4	4.1	16.3	4.5	5.6	8.2	4.9	8.0	15.0	4.6	10.4	13.7	7.2	38.7	12.3	8.9	19.5	26.2	8.9	4.0	1.8	2.5	22.7	19.0	4.1	9.9	3.7	5.7	5.0	10.9	13.4	8.1	7.6	16.4	7.1	6.7	3.6	27.3	11.0	5.1	3.4	5.4	19.7	7.6	20.7	0.0	5.6	4.6	0.0	13.1	4.9	4.1	5.9	22.6	1.9	2.1	0.8	0.8	8.2	6.4	5.9	21.7	0.0	2.5	0.3	1.7	0.0	0.0	0.9	1.9	20.3	23.5	0.0	13.8	34.1	1.5	22.7	0.4	21.6	2.2	0.7	0.0	20.2	0.5	0.8	5.2	11.1	6.5	1.2	1.7	0.1	0.0	0.4	3.7	3.9	0.7	0.2	6.2	1.0	1.2	8.7	0.1	4.1	2.1	6.0	0.4	8.0	6.5	7.9	4.0	4.8	79.0	0.0	0.1	2.4	0.8	13.1	0.1	1.0	0.2	1.2	0.3	0.0	0.2	1.5	0.6	0.0	10.6	0.1	1.7	0.1	0.1	0.2	12.0	29.1	14.4	12.5	10.4	13.7	19.5	26.2	19.0	16.4	27.3	20.7	35.8	105.8	9.3	71.5	21.1	29.7	5.9	6.3	61.5	18.4	4.6	7.0	8.9	22.8	11.7	11.0	47.9	31.1	2.4	8.4	0.0	4.5	1.9	17.1	76.0	18.7	9.1	1.3	8.1	1.5	6.9	44.0	14.3	29.4	46.9	3.6	31.4	175.5	75.0	0.0	22.5	2.2	8.2	169.1	109.5	2.5	31.1	74.8	26.6	38.4	6.4	0.5	0.0	57.8	7.7	4.9	5.0	28.2	2.2	2.6	0.1	18.0	8.4	6.7	46.0	24.3	23.4	1.0	1.8	17.1	19.5	8.9	6.5	39.5	3.2	13.3
ABCA10	EST698739	ENSG00000154263	"ATP binding cassette subfamily A member 10"	Q8WWZ4	17	69147214-69244846	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"ovary: 18.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 231.0;Excitatory neurons: 91.9;Fibroblasts: 64.3;Inhibitory neurons: 112.4;Late spermatids: 93.1;Microglial cells: 187.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 1.3;HUVEC TERT2: 1.3;RT4: 1.3;U-2197: 2.1"									HPA014535	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA014535: AB_1844426"	"unprognostic (1.45e-4)"	"unprognostic (3.17e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.51e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"unprognostic (4.91e-1)"	"unprognostic (2.70e-4)"	"unprognostic (5.23e-3)"	"unprognostic (6.98e-2)"	"unprognostic (4.37e-2)"	"unprognostic (9.86e-3)"	8.7	1.7	2.2	0.0	3.1	0.0	10.4	4.8	6.6	4.1	2.4	2.8	1.1	3.2	2.6	2.7	12.7	3.5	7.2	2.9	2.3	1.8	4.5	3.0	0.6	4.0	2.3	18.3	2.7	0.4	2.6	0.2	4.7	2.2	4.0	3.4	5.6	0.6	6.4	4.6	3.0	1.9	1.6	1.1	2.4	3.5	3.8	0.8	5.5	2.3	0.7	3.2	4.2	3.8	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	1.3	0.2	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.1	4.8	6.6	2.9	2.3	4.0	2.3	4.7	1.6	3.8	3.8	4.3	0.0	3.2	2.6	0.3	1.0	0.5	1.1	1.2	6.7	1.8	2.3	3.9	1.5	0.2	0.0	25.0	0.0	1.2	6.9	0.0	0.6	231.0	2.1	0.7	1.9	4.9	0.0	91.9	0.2	0.0	64.3	2.0	3.3	0.0	6.9	0.4	1.8	0.1	0.0	112.4	3.7	0.0	0.0	3.3	93.1	51.0	1.0	1.8	187.4	1.6	1.9	4.1	26.2	13.5	0.4	0.4	11.7	0.7	0.3	5.6	0.5	3.1	9.0	0.0	6.1	4.5	8.1	2.6	1.1	0.4	0.0	0.6	18.9	0.7	0.5
ABCA12	"DKFZP434G232, ICR2B, LI2"	ENSG00000144452	"ATP binding cassette subfamily A member 12"	Q86UK0	2	214931542-215138626	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"breast: 5.7;skin 1: 20.7"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 12.9;Suprabasal keratinocytes: 38.6"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"hTCEpi: 38.7;SK-BR-3: 18.3;T-47d: 9.7"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"cerebral cortex: 1.0;hippocampal formation: 1.1"	HPA078239			Approved	"Nucleoli,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 28: Keratinocytes - Keratinization"	"Vesicles, Plasma membrane"	"Nucleoli, Cytosol"	"HPA078239: AB_2732373"	"unprognostic (6.12e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.09e-4)"	"unprognostic (6.52e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.11e-1)"	"unprognostic (6.35e-4)"	"unprognostic (2.50e-2)"	"unprognostic (7.69e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.08e-2)"	0.0	0.0	0.0	0.1	0.1	0.0	5.7	0.0	0.1	1.3	0.0	0.3	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.3	0.2	0.2	0.0	0.0	20.7	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	2.8	0.3	3.9	0.1	0.0	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	38.7	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.2	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.5	0.1	2.7	0.0	18.3	0.0	0.2	9.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.3	0.0	12.9	0.9	6.0	0.0	0.2	1.0	0.5	0.5	0.0	5.1	0.0	0.0	1.1	0.0	3.0	0.0	0.1	2.2	2.6	0.3	0.1	0.0	0.0	1.4	0.0	2.7	0.1	1.5	3.7	0.0	0.5	0.0	0.0	0.4	1.7	2.9	0.0	0.0	0.0	0.4	1.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	0.6	1.9	0.0	0.7	0.0	1.0	0.0	0.1	3.1	0.2	0.0	0.0	0.2	0.7	0.4	2.2	38.6	3.4	0.0	0.1	0.9	2.7
ABCA2	ABC2	ENSG00000107331	"ATP binding cassette subfamily A member 2"	Q9BZC7	9	137007234-137028922	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"brain: 543.0"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 388.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 66.4"	"Low region specificity"	"Detected in all"							HPA042886	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 6: T47d - Mammary gland"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA042886: AB_2678213"	"unprognostic (1.01e-2)"	"unprognostic (9.21e-3)"	"unprognostic (9.59e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.02e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.93e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.78e-3)"	"unprognostic (3.14e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.80e-1)"	"unprognostic (1.36e-1)"	9.0	6.0	90.2	4.2	269.7	6.7	6.3	194.3	189.0	5.9	0.0	7.9	3.0	4.3	4.5	3.3	6.2	5.9	9.1	92.4	101.3	7.1	7.4	6.2	4.6	284.9	211.4	3.2	9.3	13.4	23.4	3.1	255.1	7.1	2.2	2.7	8.4	4.7	7.3	6.6	6.5	2.4	135.7	9.5	11.6	2.9	204.9	2.9	15.2	3.5	1.8	5.6	5.3	543.0	8.6	9.2	4.5	18.2	11.1	11.8	7.9	9.5	3.8	4.2	1.5	2.8	10.3	0.4	26.2	10.2	4.1	14.4	2.9	6.9	0.8	6.4	5.9	0.8	26.2	3.5	5.5	13.3	14.5	5.0	6.3	3.0	0.9	15.3	2.4	2.7	2.2	1.5	5.3	25.7	0.1	29.1	2.4	10.9	9.5	13.3	4.6	13.0	2.9	2.0	17.4	20.0	10.1	19.6	7.2	0.3	66.4	17.4	11.9	11.2	6.1	16.0	3.9	0.3	0.2	0.1	19.0	2.6	5.8	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.6	0.2	0.3	90.2	269.7	194.3	189.0	92.4	101.3	284.9	211.4	255.1	135.7	204.9	543.0	7.2	0.0	0.0	26.1	2.3	3.3	1.5	7.1	3.4	12.6	6.2	9.1	5.1	17.2	2.3	1.8	14.6	1.0	24.0	15.2	1.9	2.9	1.0	6.7	4.8	4.7	34.7	6.6	23.4	1.5	1.2	6.4	5.1	6.9	0.0	12.6	6.1	8.6	1.2	37.0	20.8	7.0	2.0	3.5	4.6	1.6	22.1	2.7	5.4	4.7	0.9	12.8	24.7	12.5	388.7	2.3	7.1	23.7	6.7	2.4	11.6	1.4	4.9	7.9	0.0	11.4	4.7	0.5	4.7	1.7	2.7	0.8	13.2	2.8	11.0	1.3
ABCA3	"ABC-C, ABC3, EST111653, LBM180"	ENSG00000167972	"ATP binding cassette subfamily A member 3"	Q99758	16	2275881-2340746	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 91.2"	"Cell type enriched"	"Detected in many"	6	"Alveolar cells type 2: 427.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 34.6;SCLC-21H: 45.9;T-47d: 76.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007884	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 6: T47d - Mammary gland"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Cytosol"		"HPA007884: AB_1078077"	"unprognostic (2.64e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.09e-3)"	"unprognostic (2.61e-3)"	"unprognostic (2.20e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.58e-3)"	"unprognostic (3.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (2.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.85e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.30e-1)"	6.8	8.7	19.1	3.0	20.8	0.7	6.7	10.2	25.5	3.0	0.0	7.9	2.0	3.7	3.5	2.9	4.4	2.7	6.1	23.4	17.1	6.5	1.1	91.2	3.7	20.1	15.8	3.4	13.1	11.2	11.1	4.3	22.2	4.9	1.2	7.4	9.1	4.3	6.2	4.3	3.9	4.6	11.1	3.4	4.9	8.9	19.1	11.3	24.6	3.8	6.5	4.5	2.2	19.7	0.7	21.6	4.1	33.1	0.8	0.0	0.3	5.8	1.4	2.3	2.4	3.0	3.4	0.2	8.4	2.7	2.1	0.6	19.2	0.3	0.8	34.6	12.9	2.2	2.5	0.5	2.9	0.4	3.6	0.3	0.5	0.3	1.1	13.4	32.4	0.2	24.0	0.0	0.1	29.3	0.1	2.4	4.4	5.2	10.4	5.4	0.7	3.8	18.7	0.7	45.9	33.0	4.1	23.4	0.6	1.6	76.5	2.0	9.3	0.2	1.1	9.0	9.8	6.1	2.9	0.1	4.7	11.7	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.4	0.1	0.0	0.0	0.1	19.1	20.8	10.2	25.5	23.4	17.1	20.1	15.8	22.2	11.1	19.1	19.7	4.3	70.5	427.4	30.0	1.1	0.6	0.5	0.2	2.2	20.7	8.4	6.7	6.7	4.3	9.5	18.4	12.5	0.0	2.1	0.3	0.0	5.7	7.7	1.3	0.3	6.3	5.4	0.0	60.3	3.8	0.0	2.7	0.0	2.9	29.7	7.7	5.3	0.7	1.0	18.5	58.6	0.8	4.1	1.2	1.8	3.8	1.8	3.1	1.8	13.1	2.2	7.1	2.1	32.2	37.2	1.9	0.4	3.4	3.6	1.5	0.4	2.0	2.4	12.5	6.6	7.2	2.9	5.1	15.0	1.2	1.6	0.0	3.9	1.3	0.4	0.2
ABCA4	"ABCR, ARMD2, CORD3, FFM, RP19, STGD, STGD1"	ENSG00000198691	"ATP binding cassette subfamily A member 4"	P78363	1	93992834-94121148	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Age-related macular degeneration, Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"choroid plexus: 144.6;retina: 461.0"	"Group enriched"	"Detected in some"	12	"Cone photoreceptor cells: 450.4;Rod photoreceptor cells: 482.9"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.1"	"Region enriched"	"Detected in some"	6	"hippocampal formation: 9.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 3.1;EFO-21: 6.8;HeLa: 2.3;SK-BR-3: 3.0;SuSa: 3.1"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA064420, HPA078826"	Enhanced		Approved	Cytosol		NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol		"HPA064420: , HPA078826: "	"unprognostic (1.25e-1)"	"unprognostic (3.93e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.17e-4)"	"unprognostic (1.28e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (2.45e-4)"	"unprognostic (3.77e-2)"	"unprognostic (5.25e-1)"	"unprognostic (3.70e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.17e-9)"	"unprognostic (1.61e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.47e-1)"	"prognostic unfavorable (2.72e-4)"	0.5	0.0	0.4	0.1	0.3	0.0	0.8	1.1	0.7	0.5	144.6	0.2	2.5	0.1	8.4	0.2	0.4	0.1	0.2	9.3	0.1	8.7	0.9	0.3	0.4	0.4	0.5	0.2	0.0	0.0	0.1	0.6	0.2	0.2	0.1	461.0	0.0	1.4	0.1	2.1	2.9	0.0	0.1	0.1	0.1	1.0	1.4	0.3	0.4	0.0	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	0.0	0.0	3.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	6.8	0.3	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.4	2.3	0.7	0.4	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.1	0.0	0.9	0.5	0.0	1.2	0.0	0.1	0.1	0.2	0.2	0.3	0.3	0.0	0.0	0.6	3.0	0.1	3.1	0.3	0.0	0.1	0.2	1.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	1.1	0.7	9.3	0.1	0.4	0.5	0.2	0.1	1.4	0.4	1.2	0.0	1.1	1.3	0.0	0.1	0.2	1.7	0.0	27.9	0.5	1.3	1.1	0.0	1.8	7.3	450.4	0.3	0.0	0.0	0.0	0.0	8.8	0.3	0.1	3.1	0.0	0.0	0.4	0.0	1.5	0.2	0.0	0.9	0.0	0.2	1.4	0.3	0.1	10.1	0.6	16.2	0.0	0.3	0.0	21.9	0.0	0.0	0.0	19.7	0.0	37.3	0.0	0.5	0.0	0.0	0.0	0.4	0.0	2.6	1.3	0.4	2.3	482.9	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.3	0.6	0.7
ABCA5	EST90625	ENSG00000154265	"ATP binding cassette subfamily A member 5"	Q8WWZ7	17	69244311-69327244	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SiHa: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022032, HPA062904"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm		"HPA022032: AB_1844427, HPA062904: AB_2732692"	"unprognostic (1.24e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.62e-3)"	"unprognostic (7.17e-2)"	"unprognostic (8.05e-4)"	"unprognostic (3.05e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.52e-1)"	"prognostic favorable (9.97e-5)"	"unprognostic (3.60e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.55e-1)"	"unprognostic (8.52e-2)"	7.6	7.7	4.0	2.9	4.2	6.4	12.2	25.9	9.8	7.9	10.2	9.4	9.5	5.4	7.0	7.0	6.1	4.2	4.7	5.4	9.9	7.0	21.4	3.9	3.4	6.6	3.8	5.7	17.9	11.4	12.5	3.4	7.3	6.0	10.0	27.3	6.7	6.3	33.4	23.6	13.6	3.1	5.3	3.9	8.6	9.1	7.0	5.8	7.4	13.8	3.9	3.5	6.9	6.8	5.1	2.3	1.8	2.8	8.7	6.3	0.6	5.1	5.6	5.3	7.8	0.7	1.8	0.0	2.7	4.5	4.2	7.3	1.2	4.3	5.9	0.1	3.4	0.0	6.0	3.4	11.6	0.0	3.1	6.2	5.2	2.2	6.0	1.1	11.7	1.8	0.0	1.9	0.5	4.3	3.2	0.0	1.8	1.9	3.4	0.4	0.1	0.4	1.0	8.3	10.0	1.5	18.6	8.4	5.0	1.6	8.7	3.2	8.6	6.0	1.7	5.6	1.1	10.3	0.3	0.4	2.4	0.0	5.5	0.3	0.3	2.1	1.3	0.0	1.8	1.1	1.7	1.5	0.2	2.3	0.9	1.4	0.9	1.5	0.0	1.8	1.2	0.6	4.0	4.2	25.9	9.8	5.4	9.9	6.6	3.8	7.3	5.3	7.0	6.8	17.7	19.2	20.3	14.4	12.5	65.4	34.9	35.1	31.3	122.3	33.9	42.8	26.4	30.0	27.8	38.6	116.7	17.3	17.7	126.7	5.9	15.6	18.9	38.6	17.4	18.3	112.7	8.4	143.1	9.8	6.0	33.1	32.6	61.8	14.0	90.3	17.2	94.4	7.4	106.0	184.6	73.7	32.6	3.7	24.4	14.4	63.6	7.0	101.4	20.6	29.9	45.6	11.3	79.9	105.3	9.3	45.6	45.9	23.4	32.1	151.1	9.4	66.0	113.4	92.1	28.7	30.3	200.8	78.1	33.8	53.6	23.7	18.2	80.7	30.4	41.8
ABCA6	EST155051	ENSG00000154262	"ATP binding cassette subfamily A member 6"	Q8N139	17	69078702-69141895	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 77.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 62.5;Fibroblasts: 117.6;Hepatocytes: 110.3;Inhibitory neurons: 77.8;Leydig cells: 51.3;Microglial cells: 93.7;Theca cells: 45.4"	"Cancer enriched"	"Detected in some"	7	"liver cancer: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 39.9;ASC TERT1: 56.0;HSkMC: 25.3;HUVEC TERT2: 54.8;RT4: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA064878, HPA067180"			Enhanced	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm		"HPA064878: AB_2685380, HPA067180: AB_2685797"	"unprognostic (7.76e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.12e-1)"	"unprognostic (8.01e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.82e-3)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.35e-1)"	"unprognostic (6.60e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.02e-1)"	"unprognostic (7.96e-4)"	"unprognostic (1.61e-4)"	"unprognostic (2.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.69e-1)"	23.3	5.5	1.3	2.6	5.5	0.0	15.9	5.1	3.2	10.5	3.1	8.0	2.2	5.9	2.8	5.9	11.3	10.1	17.5	1.1	4.1	3.6	77.9	10.9	5.0	14.3	3.0	29.8	2.3	1.3	2.1	2.1	9.4	2.9	4.4	0.8	9.0	2.0	5.4	6.6	5.5	3.7	7.1	1.5	5.7	1.8	3.4	1.4	8.6	11.7	3.2	14.2	8.9	21.3	0.0	0.0	0.0	0.0	39.9	56.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	25.3	0.1	3.2	0.9	1.5	54.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	2.5	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	5.5	5.1	3.2	1.1	4.1	14.3	3.0	9.4	7.1	3.4	21.3	12.5	0.0	0.0	2.9	2.0	3.1	1.5	0.4	4.0	11.6	1.8	2.2	6.0	4.3	0.9	3.7	6.2	0.0	1.7	1.8	0.0	0.5	3.3	0.7	5.1	3.2	2.4	2.7	62.5	0.2	0.0	117.6	2.0	2.5	0.0	4.0	3.3	110.3	1.6	0.0	77.8	0.7	0.0	2.5	42.1	2.7	51.3	20.3	5.4	93.7	0.7	3.2	0.0	4.5	33.4	0.4	1.1	12.0	1.2	0.1	0.5	0.9	0.7	13.3	0.0	20.0	14.3	2.0	0.9	1.4	2.8	0.0	1.2	45.4	0.3	0.5
ABCA7	ABCX	ENSG00000064687	"ATP binding cassette subfamily A member 7"	Q8IZY2	19	1039997-1065572	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Phagocytosis, Transport"	Translocase	"Alzheimer disease, Amyloidosis, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 27.4;pituitary gland: 28.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Bipolar cells: 70.6;Cone photoreceptor cells: 175.2;Extravillous trophoblasts: 303.3;Rod photoreceptor cells: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 20.4;HMC-1: 40.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA041564	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus, Plasma membrane"	"Cell Junctions"	"HPA041564: AB_2677550"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (7.26e-4)"	"prognostic favorable (1.12e-4)"	"unprognostic (8.88e-2)"	"unprognostic (1.13e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.68e-2)"	"unprognostic (8.99e-3)"	"unprognostic (2.08e-2)"	"unprognostic (3.66e-1)"	"unprognostic (7.88e-2)"	"unprognostic (7.85e-2)"	4.4	3.0	3.4	5.5	3.9	27.4	3.3	4.0	6.1	3.2	11.5	3.8	2.3	1.2	0.2	7.6	2.1	2.1	3.1	3.6	3.7	6.4	4.2	9.5	8.5	5.8	4.5	0.5	7.7	2.7	28.7	1.2	5.3	5.3	1.2	25.5	8.6	1.1	3.8	5.9	10.1	0.5	3.0	26.6	3.8	1.7	4.1	10.0	5.7	0.3	3.2	2.3	2.8	3.2	4.7	6.4	0.5	4.4	7.2	2.2	7.3	0.8	1.0	0.4	0.6	5.2	2.8	13.9	5.6	1.3	0.6	8.0	1.3	6.2	0.4	10.2	2.5	6.7	20.4	5.6	1.8	3.9	40.3	3.8	1.8	0.9	1.2	4.4	1.4	7.7	10.2	6.9	1.3	2.2	4.3	2.2	0.9	3.3	2.5	3.1	0.8	11.6	3.8	6.0	0.3	1.3	8.2	1.9	1.2	1.1	4.6	7.1	2.2	0.4	1.6	3.7	0.8	9.9	6.6	5.7	2.1	7.4	2.0	2.8	1.4	5.9	1.8	1.2	1.1	0.6	0.9	1.2	2.1	0.9	0.8	1.5	3.3	1.1	1.3	7.3	0.4	1.3	3.4	3.9	4.0	6.1	3.6	3.7	5.8	4.5	5.3	3.0	4.1	3.2	4.1	73.7	21.9	8.5	13.2	3.3	0.8	10.7	5.2	70.6	4.8	2.2	6.0	4.3	14.0	5.5	175.2	4.6	9.1	14.7	1.9	2.7	7.3	8.9	1.4	2.9	3.5	13.3	12.9	2.5	303.3	1.5	5.6	6.9	10.1	2.0	2.5	4.9	7.9	15.2	11.5	4.7	16.2	12.6	7.5	4.8	0.0	12.7	0.0	4.7	19.6	13.1	9.2	1.5	2.4	7.0	9.6	0.0	12.0	1.5	1.7	1.3	17.5	149.1	0.0	2.7	2.7	0.7	2.0	6.6	3.4	25.7	12.6	1.0	5.3	1.9
ABCA8	KIAA0822	ENSG00000141338	"ATP binding cassette subfamily A member 8"	O94911	17	68867289-68955392	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 231.5;Granulosa cells: 117.3;Leydig cells: 502.6;Microglial cells: 162.1;Oligodendrocytes: 406.6;Skeletal myocytes: 216.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC diff: 31.9;ASC TERT1: 69.6;HSkMC: 53.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044914	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoplasm	Cytosol	"HPA044914: AB_10964859"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.04e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.22e-2)"	"unprognostic (6.68e-2)"	"unprognostic (8.76e-2)"	"unprognostic (1.42e-3)"	"unprognostic (3.52e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.29e-1)"	"unprognostic (6.14e-3)"	39.1	30.5	12.6	2.8	28.1	0.0	21.3	21.0	18.3	10.0	9.6	16.4	6.2	11.9	15.6	7.6	23.7	16.9	42.1	13.6	16.1	9.5	33.7	18.2	1.1	28.2	19.8	51.5	5.7	3.8	11.1	9.0	29.0	9.5	16.9	9.2	14.8	8.6	12.3	6.2	11.8	6.6	20.7	12.4	14.3	19.5	18.4	4.5	17.0	26.7	3.0	16.3	14.6	58.1	0.0	0.0	3.9	0.0	31.9	69.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	12.0	0.0	0.0	53.5	0.0	0.8	0.0	0.4	6.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	28.1	21.0	18.3	13.6	16.1	28.2	19.8	29.0	20.7	18.4	58.1	22.6	51.3	1.1	0.7	0.0	6.0	1.8	0.0	2.8	5.0	0.7	1.0	18.8	0.0	4.3	0.0	2.1	0.2	0.3	0.0	0.0	0.0	4.8	0.4	14.0	6.8	0.0	0.0	0.5	0.0	0.1	231.5	3.1	0.3	1.3	117.3	5.7	48.1	1.1	5.0	0.6	0.0	0.0	1.9	9.4	19.4	502.6	2.6	1.8	162.1	0.0	100.3	0.0	0.5	406.6	0.0	0.0	70.3	1.9	0.4	0.0	0.1	0.0	3.3	39.5	216.6	44.5	5.1	1.7	2.5	4.7	0.3	2.1	60.9	0.0	0.4
ABCA9	EST640918	ENSG00000154258	"ATP binding cassette subfamily A member 9"	Q8IUA7	17	68974488-69060949	"Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 55.5;Fibroblasts: 86.6;Inhibitory neurons: 73.2;Leydig cells: 96.3;Microglial cells: 227.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"ASC diff: 21.8;ASC TERT1: 47.7;HSkMC: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052113, HPA054823"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum"		"HPA052113: AB_2732573, HPA054823: AB_2682615"	"unprognostic (3.88e-2)"	"unprognostic (9.86e-2)"	"unprognostic (2.21e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.46e-1)"	"unprognostic (5.64e-3)"	"unprognostic (4.51e-4)"	"unprognostic (1.83e-2)"	"unprognostic (1.94e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.26e-3)"	"unprognostic (3.51e-1)"	"unprognostic (7.77e-6)"	"unprognostic (5.32e-4)"	"unprognostic (7.22e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-3)"	33.7	4.1	2.8	1.4	5.1	1.8	22.3	7.7	8.0	14.7	6.3	12.4	1.8	11.2	8.9	4.8	20.6	8.2	22.6	3.0	1.4	2.7	11.9	8.8	2.3	3.1	1.2	27.4	3.5	2.3	4.9	1.2	4.5	3.3	4.0	8.4	9.0	2.8	13.1	9.2	6.6	6.6	1.2	1.6	7.8	5.2	3.5	2.5	11.1	10.6	1.1	10.9	12.7	7.7	0.2	0.4	0.8	0.8	21.8	47.7	0.6	0.4	0.4	0.0	0.4	0.5	0.5	0.6	0.2	0.8	0.3	0.5	0.4	0.7	0.2	0.3	0.4	0.6	2.4	0.6	2.3	0.9	1.3	17.0	0.5	3.6	0.3	0.9	4.8	0.6	0.8	1.3	0.1	0.3	0.3	2.1	0.3	0.2	0.4	2.2	0.1	0.3	0.3	1.9	0.7	0.6	0.5	0.3	0.3	0.4	0.4	0.8	2.0	1.3	0.5	2.3	0.5	1.0	0.5	0.4	0.4	0.5	2.4	0.5	0.1	0.2	0.2	0.1	0.2	0.2	0.1	0.0	0.1	0.2	0.2	0.2	0.4	0.2	0.0	0.1	0.0	0.0	2.8	5.1	7.7	8.0	3.0	1.4	3.1	1.2	4.5	1.2	3.5	7.7	7.4	0.0	1.5	2.6	0.5	1.8	0.3	0.1	1.2	3.9	0.7	0.8	3.9	1.5	0.1	0.0	0.0	0.0	0.6	0.9	0.0	0.1	1.3	0.4	2.1	2.6	0.0	0.0	55.5	0.0	0.0	86.6	2.0	1.4	0.0	2.2	18.5	11.4	0.3	0.0	73.2	0.1	0.0	1.3	5.1	3.6	96.3	4.9	0.0	227.7	0.0	7.9	1.0	6.0	10.9	0.2	0.0	15.4	0.2	0.1	0.3	0.0	1.7	5.6	13.1	26.3	7.1	1.3	0.8	1.3	1.6	0.0	0.5	26.3	0.1	0.3
ABCB1	"ABC20, CD243, CLCS, GP170, MDR1, P-gp, PGY1"	ENSG00000085563	"ATP binding cassette subfamily B member 1"	P08183	7	87503017-87713323	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 101.7;intestine: 70.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 95.8;Distal enterocytes: 109.9;Microglial cells: 570.6;Paneth cells: 106.2;Proximal enterocytes: 204.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 14.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"MAIT T-cell: 27.2;NK-cell: 17.9"	"Group enriched"	"Detected in many"	9	"NK-cells: 17.9;T-cells: 27.2"	"Cell line enhanced"	"Detected in some"		"CACO-2: 67.3;HEK 293: 20.4;HEL: 37.7;Hep G2: 18.5;RPTEC TERT1: 24.2;SH-SY5Y: 78.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 12.2"	"CAB001716, HPA002199, HPA074614"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Plasma membrane"	"Focal adhesion sites"	"CAB001716: , HPA002199: AB_1844428, HPA074614: "	"unprognostic (5.38e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.25e-2)"	"unprognostic (9.99e-5)"	"unprognostic (2.23e-3)"	"unprognostic (5.65e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.17e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (5.19e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (2.06e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.12e-2)"	2.6	101.7	14.1	3.9	13.6	1.9	3.6	13.7	17.6	6.4	5.3	16.6	26.4	11.0	3.6	3.1	5.0	15.5	1.9	15.3	15.6	33.7	28.0	6.4	3.2	17.6	14.4	2.2	2.0	1.4	0.5	2.3	19.7	4.2	18.2	2.2	1.2	3.1	0.2	1.5	70.7	9.8	15.1	4.2	2.1	0.9	19.3	2.7	1.9	1.4	3.5	3.6	1.7	14.3	0.0	0.0	3.7	0.0	0.0	0.0	0.1	0.1	4.3	0.0	0.0	67.3	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	20.4	37.7	4.2	18.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.2	0.0	0.1	0.0	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	24.2	0.2	0.9	78.9	0.0	0.0	0.1	0.1	0.0	0.0	0.6	0.0	4.0	0.0	0.9	7.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	11.1	0.0	27.2	0.8	2.7	6.8	0.0	2.5	1.7	6.6	0.2	17.9	0.0	0.1	0.0	2.5	14.1	13.6	13.7	17.6	15.3	15.6	17.6	14.4	19.7	15.1	19.3	14.3	17.1	0.0	3.0	3.9	9.9	0.8	0.1	0.0	1.2	1.9	0.4	3.9	3.0	95.8	0.6	49.7	0.0	5.8	24.7	109.9	5.9	13.8	27.3	0.6	0.6	52.9	0.0	7.8	16.1	1.9	0.2	3.7	0.0	0.7	3.8	0.3	2.5	38.4	0.4	0.0	11.4	15.8	0.0	0.6	1.2	3.8	0.9	1.6	0.0	570.6	0.2	0.2	32.0	6.0	3.2	8.1	106.2	0.0	4.6	0.2	204.6	57.7	0.7	1.1	0.0	0.4	1.3	0.4	0.9	0.2	0.6	9.9	24.5	0.1	19.9	0.3
ABCB10	"EST20237, M-ABC2, MTABC2"	ENSG00000135776	"ATP binding cassette subfamily B member 10"	Q9NRK6	1	229516582-229558707	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 60.1"	"Cell type enriched"	"Detected in many"	5	"Erythroid cells: 170.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"HL-60: 101.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB044063, CAB044065, HPA055175"	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB044063: AB_353262, CAB044065: AB_2220666, HPA055175: AB_2682727"	"unprognostic (1.00e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.56e-3)"	"unprognostic (5.64e-2)"	"unprognostic (2.04e-1)"	"unprognostic (8.06e-3)"	"unprognostic (9.38e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.15e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.81e-1)"	"unprognostic (3.13e-1)"	"unprognostic (8.32e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (5.29e-2)"	"unprognostic (3.37e-2)"	8.9	6.0	4.7	8.9	4.8	60.1	7.9	6.6	6.4	6.8	5.0	11.1	17.2	6.9	4.6	8.3	7.9	6.7	7.9	4.4	4.5	9.8	19.0	8.8	11.0	4.8	4.7	5.5	7.3	9.4	3.4	11.3	4.6	8.4	11.3	6.4	6.7	7.3	12.9	8.1	13.9	9.2	4.3	8.6	10.1	3.8	5.2	8.2	7.5	10.9	9.6	8.5	6.3	5.7	25.1	14.6	11.9	9.8	19.9	17.1	51.6	22.5	16.8	20.0	18.1	15.1	18.7	27.3	20.1	20.7	8.2	21.1	25.8	18.6	20.1	18.7	32.5	30.0	12.2	19.3	14.2	101.9	16.1	11.8	15.7	12.2	14.1	12.1	21.9	47.9	65.2	61.0	20.8	7.9	26.1	57.9	15.9	28.8	12.3	23.4	23.5	29.0	16.2	15.9	8.8	13.3	17.6	19.4	28.6	7.3	15.0	35.0	17.0	21.5	13.5	13.5	31.2	14.9	11.9	23.7	11.3	17.5	13.8	0.5	0.6	0.8	0.7	0.8	1.0	0.5	0.9	1.1	0.8	0.6	0.8	1.0	0.1	0.4	0.6	0.9	0.8	0.3	4.7	4.8	6.6	6.4	4.4	4.5	4.8	4.7	4.6	4.3	5.2	5.7	6.9	9.6	2.0	16.0	3.8	3.2	2.7	4.3	3.4	6.8	6.4	4.2	11.5	5.7	5.5	0.0	12.5	6.5	7.9	13.5	1.9	4.6	0.2	6.3	8.7	6.5	10.2	170.0	21.9	5.3	10.4	5.0	6.1	6.0	5.7	3.5	8.6	19.2	9.1	10.1	27.3	10.6	2.0	13.3	6.6	0.5	5.0	8.3	8.8	10.3	16.8	3.6	4.1	31.2	30.3	4.7	8.8	4.5	5.5	8.4	13.5	4.9	12.1	4.8	6.6	5.4	6.8	4.2	4.5	8.3	5.1	3.6	5.9	2.8	11.5	3.7
ABCB11	"ABC16, BSEP, PFIC-2, PFIC2, PGY4, SPGP"	ENSG00000073734	"ATP binding cassette subfamily B member 11"	O95342	2	168915498-169031324	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 80.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 41.7;Alveolar cells type 2: 44.1;Club cells: 19.3;Early spermatids: 16.5;granulocytes: 24.0;Hepatocytes: 20.4"	"Cancer enriched"	"Detected in single"	87	"liver cancer: 6.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.6;RT4: 1.6;TIME: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019035	Enhanced		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 24: NB-4 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA019035: AB_1844429"	"unprognostic (7.78e-2)"	"unprognostic (3.92e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.64e-3)"	"unprognostic (3.71e-1)"	"unprognostic (5.26e-6)"	"unprognostic (7.12e-2)"	"unprognostic (1.82e-1)"		"unprognostic (1.94e-1)"	1.5	0.0	0.3	0.1	0.3	0.0	0.6	0.3	0.5	0.0	0.2	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	80.8	0.0	0.1	1.0	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.4	0.1	0.0	0.0	1.1	0.0	0.0	0.3	0.1	0.0	6.2	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.4	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.5	0.2	0.2	1.0	0.6	0.5	0.3	0.2	0.3	0.0	41.7	44.1	1.3	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	19.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	16.5	0.1	0.0	1.8	0.0	2.7	0.8	0.0	0.0	6.6	0.0	0.0	24.0	0.0	0.0	20.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	9.1	0.0	3.8	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	2.6	0.2	0.0	0.6
ABCB4	"GBD1, MDR2, MDR3, PFIC-3, PGY3"	ENSG00000005471	"ATP binding cassette subfamily B member 4"	P21439	7	87401696-87480435	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 123.2"	"Cell type enriched"	"Detected in some"	6	"Hepatocytes: 256.1"	"Cancer enriched"	"Detected in some"	11	"liver cancer: 16.3"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	5	"memory B-cell: 4.4;naive B-cell: 8.1"	"Lineage enriched"	"Detected in many"	7	"B-cells: 8.1"	"Group enriched"	"Detected in some"	5	"SH-SY5Y: 12.9;WM-115: 25.7"	"Low region specificity"	"Detected in many"							"HPA049395, HPA053288"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 62: Liver - Hemostasis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Plasma membrane, Actin filaments"	"Focal adhesion sites"	"HPA049395: AB_2680745, HPA053288: AB_2682102"	"unprognostic (7.92e-2)"	"unprognostic (8.87e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.35e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.53e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.44e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (8.01e-3)"	"unprognostic (7.12e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.47e-1)"	0.7	7.4	0.8	2.5	0.6	0.9	0.5	0.6	0.9	0.3	0.4	1.1	0.4	0.2	0.6	0.6	0.2	0.8	6.6	0.8	0.6	0.6	123.2	0.2	5.9	0.9	0.6	0.4	0.1	0.0	0.2	0.2	1.0	0.5	1.2	0.4	0.6	0.4	7.5	1.4	2.1	0.3	0.6	5.0	0.6	1.0	0.7	0.7	0.5	4.8	5.2	1.2	0.5	0.7	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.4	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.2	12.9	0.0	0.6	2.6	0.5	0.2	0.6	0.0	0.2	1.7	0.1	0.0	0.0	0.0	3.2	0.2	0.0	25.7	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.2	8.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.8	0.6	0.6	0.9	0.8	0.6	0.9	0.6	1.0	0.6	0.7	0.7	1.3	0.0	0.5	0.3	22.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.8	0.0	1.1	0.1	0.2	0.0	0.1	0.6	0.2	0.2	1.0	0.0	0.4	0.6	0.0	0.3	2.0	0.0	0.2	0.0	0.0	3.3	256.1	0.5	38.7	1.8	0.0	0.0	5.0	1.2	0.4	0.0	1.0	10.6	3.7	0.1	0.0	0.0	0.5	0.0	0.1	0.1	0.4	0.3	0.0	0.5	0.7	0.0	0.2	0.0	0.6	1.2	1.2	0.2	0.0	0.4	0.1	0.7	0.0	0.2	0.0
ABCB5	"ABCB5alpha, ABCB5beta, EST422562"	ENSG00000004846	"ATP binding cassette subfamily B member 5"	Q2M3G0	7	20615207-20777038	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"epididymis: 26.4"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 2.8;Early spermatids: 8.1;Fibroblasts: 2.4"	"Cancer enriched"	"Detected in some"	9	"melanoma: 5.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 47.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (3.82e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.14e-2)"	"unprognostic (2.98e-1)"	"unprognostic (2.60e-3)"	"unprognostic (1.65e-2)"	"unprognostic (2.05e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.23e-2)"	"unprognostic (5.26e-3)"	"unprognostic (3.56e-3)"	"unprognostic (9.30e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.80e-2)"	"unprognostic (2.70e-2)"	2.0	0.0	0.2	0.2	0.2	0.4	2.1	0.4	0.2	1.5	0.2	1.3	0.1	0.6	26.4	0.1	0.2	2.7	0.3	0.2	0.2	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.0	0.1	0.2	0.2	0.5	0.1	0.1	0.3	0.1	0.8	0.4	0.6	0.1	0.0	0.2	0.5	0.2	0.0	0.0	0.1	0.0	0.7	0.5	0.4	0.0	0.0	0.0	0.1	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	6.6	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	47.8	0.0	0.0	0.2	0.0	0.1	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.4	0.2	0.2	0.2	0.2	0.1	0.2	0.1	0.2	0.4	0.1	0.0	0.5	0.3	0.0	0.5	2.8	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	8.1	0.3	0.2	0.4	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.1	1.3	0.0	0.0	0.0	0.3	0.0	1.7	0.0	0.0	0.0	1.5	1.0	0.6	0.4	1.8	1.9	0.0	0.2	1.0	1.0	0.6	0.0	0.0	0.4	0.0	0.9	0.0	0.1	0.0	0.3	0.0	1.7	0.6	0.6	0.4	0.0	0.6	0.0	0.6	0.0	0.0	0.8
ABCB6	"EST45597, MTABC3, umat"	ENSG00000115657	"ATP binding cassette subfamily B member 6 (Langereis blood group)"	Q9NP58	2	219209772-219218994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Dyskeratosis congenita, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 14.7;Excitatory neurons: 12.9;Gastric mucus-secreting cells: 5.1;Inhibitory neurons: 10.9;Oligodendrocyte precursor cells: 13.6;Oligodendrocytes: 5.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Hep G2: 65.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046723, HPA058011"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane,Mitochondria,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane, Mitochondria, Cytosol"	"HPA046723: AB_10960288, HPA058011: AB_2683578"	"unprognostic (8.04e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.19e-2)"	"unprognostic (2.55e-1)"	"unprognostic (9.11e-2)"	"prognostic unfavorable (9.45e-7)"	"unprognostic (2.26e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.18e-4)"	"unprognostic (3.02e-3)"	"prognostic unfavorable (1.52e-7)"	"unprognostic (1.51e-1)"	"unprognostic (9.55e-2)"	"unprognostic (7.75e-2)"	"unprognostic (2.30e-1)"	10.2	8.7	4.3	3.4	3.9	10.4	7.6	3.2	4.6	7.7	4.4	6.5	6.9	8.4	8.2	11.4	9.6	7.1	8.5	4.0	5.1	5.2	15.9	5.9	1.9	4.4	4.2	12.9	5.7	4.8	6.0	3.1	6.2	8.0	3.3	3.0	6.2	8.6	30.4	6.8	6.3	7.9	4.1	3.9	7.9	18.0	5.7	2.6	10.7	9.8	2.9	14.9	7.9	5.0	0.3	22.9	4.7	28.8	30.8	11.1	27.6	8.5	7.9	9.2	9.2	35.5	5.0	0.3	42.8	8.6	5.0	49.1	0.6	3.6	3.0	15.0	4.7	36.3	24.9	65.8	37.0	0.0	12.0	16.3	4.2	6.2	0.1	13.9	16.3	4.8	31.4	4.4	6.3	12.0	2.3	0.1	7.2	53.6	9.2	12.3	14.3	1.6	5.1	0.4	16.6	17.8	17.6	41.4	18.7	17.4	12.4	0.8	7.5	12.5	0.5	16.9	10.3	11.2	9.6	0.1	14.0	0.4	17.0	0.7	0.4	0.0	0.7	0.4	0.2	1.0	0.5	0.2	0.3	0.8	1.2	0.8	0.0	0.4	0.3	2.3	0.5	1.0	4.3	3.9	3.2	4.6	4.0	5.1	4.4	4.2	6.2	4.1	5.7	5.0	0.2	0.0	0.0	14.7	0.3	0.3	0.0	0.5	1.2	1.0	0.2	0.0	0.2	0.0	1.3	0.0	0.0	0.2	0.2	0.1	0.0	0.8	1.2	0.3	0.6	0.4	0.0	1.3	12.9	0.0	0.1	0.7	5.1	0.2	0.0	0.5	0.0	0.4	0.1	0.0	10.9	0.3	0.0	0.3	0.4	1.0	0.3	0.3	0.0	3.7	0.0	0.3	0.0	13.6	5.6	0.3	0.0	0.4	0.5	0.0	0.5	0.2	2.2	0.8	0.0	0.4	0.3	1.0	0.3	2.8	0.3	0.3	0.1	0.4	0.2	0.1
ABCB7	"ABC7, ASAT, Atm1p, EST140535"	ENSG00000131269	"ATP binding cassette subfamily B member 7"	O75027	X	75051048-75156732	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034982	Approved		Approved	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Mitochondria		"HPA034982: AB_10601010"	"unprognostic (1.05e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.83e-3)"	"unprognostic (4.44e-3)"	"unprognostic (1.33e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.17e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.55e-2)"	"prognostic favorable (5.31e-6)"	"unprognostic (1.95e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	12.6	13.5	5.0	7.7	5.9	11.1	11.8	8.2	7.6	11.4	9.8	13.8	16.0	10.9	5.0	11.6	11.2	7.4	22.0	5.5	6.1	10.1	14.8	9.8	12.0	6.4	6.0	12.3	9.6	11.0	8.6	7.5	6.2	8.5	9.6	9.8	10.0	6.9	31.4	12.9	11.8	8.8	6.1	10.9	12.3	4.1	5.4	14.0	9.5	22.2	11.1	10.5	10.9	6.8	17.0	16.2	12.2	20.9	14.1	25.5	7.0	8.9	14.6	12.3	22.4	18.5	24.5	25.8	22.8	9.2	21.2	18.8	25.6	18.5	12.0	26.0	33.2	16.8	29.2	17.3	8.2	24.7	13.7	15.9	16.3	12.8	16.7	21.3	23.1	26.2	18.9	31.1	9.8	10.5	24.4	26.1	26.8	26.3	30.5	21.4	26.9	30.5	12.7	13.2	17.7	14.1	27.4	23.5	17.8	20.0	10.2	22.9	10.3	11.3	22.9	23.2	12.4	10.1	27.5	21.2	10.1	35.8	9.4	9.6	26.9	10.0	15.7	25.6	16.6	24.7	16.7	16.7	29.0	28.2	28.7	21.1	2.4	17.5	20.4	18.2	27.2	19.2	5.0	5.9	8.2	7.6	5.5	6.1	6.4	6.0	6.2	6.1	5.4	6.8	12.0	9.6	10.4	48.0	26.6	15.8	14.5	16.0	19.9	10.9	10.9	9.9	46.8	14.3	14.2	11.0	6.2	23.0	19.0	8.2	11.7	17.5	0.4	8.4	12.8	11.9	13.8	26.9	37.9	13.5	11.6	13.9	9.7	10.1	22.2	20.6	9.3	11.8	20.1	25.2	39.0	10.5	8.2	26.1	16.7	0.8	14.6	19.2	10.6	45.0	22.9	12.4	6.2	43.7	46.6	11.6	7.9	13.2	14.3	10.6	15.9	19.9	10.7	7.9	32.9	19.6	13.8	5.5	10.9	16.1	16.1	22.3	14.5	19.2	17.9	11.9
ABCB8	"EST328128, M-ABC1, MABC1, MITOSUR"	ENSG00000197150	"ATP binding cassette subfamily B member 8"	Q9NUT2	7	151028422-151047782	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 81.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045187	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria	Nucleoplasm	"HPA045187: AB_10964281"	"unprognostic (5.29e-2)"	"unprognostic (9.17e-3)"	"unprognostic (8.28e-2)"	"unprognostic (8.32e-2)"	"unprognostic (8.63e-3)"	"prognostic favorable (5.91e-4)"	"unprognostic (4.76e-2)"	"unprognostic (3.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-2)"	"prognostic favorable (3.34e-4)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.88e-4)"	"unprognostic (7.52e-3)"	"unprognostic (1.76e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.23e-1)"	10.3	20.4	9.3	8.4	10.3	8.1	8.6	9.7	13.7	16.6	11.3	12.1	10.9	14.9	7.9	18.3	11.0	6.0	13.2	9.5	8.6	15.0	22.3	10.8	7.5	11.5	10.3	11.6	10.0	11.5	19.6	8.4	12.2	11.0	5.3	8.7	8.9	6.6	7.9	10.6	11.3	7.1	8.3	11.2	12.2	12.4	11.1	7.2	15.6	5.8	6.2	8.9	10.6	14.3	26.1	40.1	10.1	32.3	15.8	9.2	20.0	13.6	13.8	20.6	21.9	16.1	42.7	13.8	17.7	14.4	25.2	27.1	15.0	28.1	9.3	17.2	16.5	10.9	16.2	19.7	10.3	8.5	25.9	15.7	20.8	25.1	10.3	7.8	21.4	29.5	57.8	18.3	16.1	58.4	32.3	15.9	6.9	19.6	45.8	14.8	6.4	49.0	14.2	10.9	9.8	19.6	14.5	40.4	13.0	7.9	15.6	11.0	13.3	19.3	5.1	14.1	20.6	18.7	9.8	9.8	27.6	19.9	20.2	11.8	3.2	2.5	4.9	4.7	3.4	2.8	3.4	3.9	4.3	2.1	3.1	4.4	0.7	3.0	3.3	7.1	3.8	2.8	9.3	10.3	9.7	13.7	9.5	8.6	11.5	10.3	12.2	8.3	11.1	14.3	7.3	12.8	1.1	16.6	12.1	3.7	6.6	10.6	6.2	24.9	6.4	4.7	7.0	7.2	7.2	11.0	37.5	36.2	12.0	28.5	3.9	15.9	3.1	14.8	12.8	4.8	0.0	13.7	15.9	20.0	22.5	9.8	36.7	12.1	49.6	57.8	6.1	25.2	28.0	30.3	17.8	14.0	18.3	6.0	3.9	2.8	6.5	8.2	8.8	2.8	9.7	9.0	17.5	7.1	11.8	21.5	8.5	12.4	22.9	7.0	20.6	14.3	8.8	36.6	26.3	8.9	9.5	9.9	13.5	12.0	7.4	81.8	11.3	28.1	18.7	7.6
ABCB9	EST122234	ENSG00000150967	"ATP binding cassette subfamily B member 9"	Q9NP78	12	122920951-122981649	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 20.4;testis: 17.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 46.3;Inhibitory neurons: 41.7;Plasma cells: 92.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6;memory B-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"GAMG: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033052, HPA035113, HPA035114"	Approved		Supported	Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB033052: AB_2273463, HPA035113: AB_2674470, HPA035114: AB_10601329"	"unprognostic (1.47e-2)"	"unprognostic (6.46e-4)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (5.65e-4)"	"unprognostic (1.46e-1)"	"unprognostic (2.67e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.08e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.58e-3)"	"unprognostic (2.71e-2)"	3.0	3.1	11.9	1.6	10.4	3.4	3.9	19.7	20.4	3.1	0.0	2.4	2.7	3.0	4.9	2.9	2.9	2.5	4.9	8.2	7.5	3.6	1.2	1.6	1.6	7.3	9.1	4.0	3.2	2.8	11.6	1.8	6.0	3.5	2.1	7.3	5.6	2.8	1.6	3.3	3.4	2.0	2.1	3.6	3.4	17.8	16.0	1.3	3.0	1.2	1.9	1.9	3.1	10.6	4.7	8.6	4.7	4.5	2.0	3.8	2.2	3.0	4.3	5.1	3.2	3.7	5.3	5.2	3.4	2.8	25.9	4.3	3.5	7.2	2.0	1.0	7.0	22.9	7.7	5.9	2.2	1.1	9.0	5.3	2.8	7.5	2.3	12.5	5.7	5.1	4.6	3.8	2.9	10.6	1.7	2.2	1.5	5.0	8.4	6.4	1.3	5.0	2.6	3.1	5.0	1.5	1.5	10.7	10.7	1.8	12.6	1.6	2.5	3.6	12.2	11.5	8.8	12.3	7.4	1.5	6.3	2.5	20.2	2.6	0.3	0.3	0.3	0.1	0.8	2.5	0.3	0.3	0.2	0.5	0.6	0.6	0.7	0.2	0.1	0.1	0.2	0.8	11.9	10.4	19.7	20.4	8.2	7.5	7.3	9.1	6.0	2.1	16.0	10.6	9.7	6.4	4.6	13.4	15.9	3.2	2.8	1.5	8.6	10.7	3.9	5.0	2.0	0.0	2.5	3.7	14.6	5.2	3.4	1.9	0.0	3.8	8.9	2.6	2.6	4.0	1.2	2.1	46.3	1.5	1.8	2.0	4.1	5.6	2.5	3.0	2.9	1.2	1.1	6.7	41.7	1.1	0.0	1.0	2.1	23.2	2.8	1.8	5.4	7.5	0.3	20.0	2.1	4.0	18.1	2.5	0.1	2.6	92.2	2.1	4.1	0.9	0.7	5.3	6.6	2.1	3.7	9.6	3.5	3.3	3.1	1.4	3.9	2.9	2.6	1.8
ABCC1	"GS-X, MRP, MRP1"	ENSG00000103222	"ATP binding cassette subfamily C member 1"	P33527	16	15949138-16143257	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Translocase"	"Cancer-related genes, Deafness, FDA approved drug targets, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 79.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002380, HPA076011"	Uncertain		Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Cell Junctions"	"HPA002380: AB_1844432, HPA076011: "	"unprognostic (9.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.94e-1)"	"unprognostic (4.89e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (5.42e-5)"	"unprognostic (3.42e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.78e-3)"	"unprognostic (7.19e-2)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.84e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.80e-2)"	10.4	11.6	0.3	4.0	0.2	3.6	8.6	0.3	0.7	10.4	4.1	16.1	1.1	11.0	0.1	22.8	7.0	3.1	11.2	0.3	0.5	8.0	2.3	15.5	4.4	1.1	0.8	8.9	8.9	3.6	7.2	2.0	0.7	15.2	0.7	0.4	9.2	0.9	21.2	9.7	12.4	6.3	0.5	15.7	15.0	13.1	0.6	4.3	21.0	0.1	1.1	15.4	12.8	0.9	4.3	43.7	0.3	11.7	3.2	4.5	0.5	15.4	19.0	13.1	13.8	6.7	34.8	7.0	79.6	29.6	11.0	12.1	3.4	12.4	4.6	22.2	4.4	16.4	22.0	16.3	25.1	5.9	39.5	15.0	9.0	1.1	2.3	3.8	10.2	28.6	17.8	6.8	0.5	5.4	12.0	0.9	3.5	1.8	8.2	41.9	7.8	5.3	0.7	15.2	6.4	11.8	18.9	17.8	3.6	11.9	6.2	0.8	3.5	0.4	2.0	11.4	11.9	13.5	7.4	3.3	6.6	0.6	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.3	0.7	0.3	0.5	1.1	0.8	0.7	0.5	0.6	0.9	8.6	25.6	5.6	10.7	13.1	8.8	8.5	18.2	9.6	3.1	4.4	3.7	6.0	4.3	14.4	5.5	22.9	0.9	9.8	2.7	3.9	9.1	11.0	15.7	12.9	8.6	18.6	16.0	26.6	6.2	3.2	12.3	49.5	17.8	22.1	16.8	8.6	0.4	8.5	5.0	38.5	6.6	14.2	21.4	9.1	14.3	7.5	12.2	3.6	11.2	10.5	1.2	5.2	12.1	15.9	11.2	4.5	6.8	15.7	18.7	0.5	1.1	9.9	8.8	0.0	6.4	5.1	4.9	6.6	18.1	5.1	0.5	17.4	37.1	3.7	11.6
ABCC10	"EST182763, MRP7, SIMRP7"	ENSG00000124574	"ATP binding cassette subfamily C member 10"	Q5T3U5	6	43427366-43450427	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041607, HPA045464"	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"			"HPA041607: AB_2677579, HPA045464: AB_2679336"	"unprognostic (2.41e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.69e-2)"	"unprognostic (3.01e-3)"	"unprognostic (1.85e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.64e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (2.75e-1)"	"unprognostic (3.85e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.80e-2)"	9.2	17.7	18.0	8.2	17.9	7.5	8.9	19.6	24.2	14.4	16.6	12.7	9.4	13.2	8.3	16.3	11.8	6.8	12.4	17.5	17.0	15.5	10.1	10.8	8.7	17.0	17.0	17.6	19.5	5.0	19.6	7.7	17.3	17.3	7.6	4.5	12.7	7.6	7.8	11.0	13.0	8.6	15.7	15.5	13.5	9.2	17.6	8.3	12.8	3.4	7.4	16.2	13.8	17.3	13.3	6.7	8.7	19.9	18.8	12.0	9.0	13.7	9.6	10.1	8.6	14.9	5.6	2.8	15.9	16.7	7.9	16.5	5.8	10.6	7.2	17.1	11.7	9.5	8.4	29.8	11.5	13.2	13.7	20.9	13.9	13.5	7.4	10.0	13.8	8.9	11.3	14.9	12.1	13.1	7.8	20.3	5.6	32.1	8.0	3.9	2.3	9.8	11.7	21.6	12.1	9.8	8.1	11.5	10.2	7.6	11.3	12.8	14.4	12.4	4.2	11.6	16.6	13.3	6.2	6.9	5.8	9.4	5.9	5.0	1.9	2.2	2.9	0.6	1.3	1.0	2.2	2.6	1.1	0.9	1.2	1.8	0.7	1.3	1.5	0.8	2.8	1.8	18.0	17.9	19.6	24.2	17.5	17.0	17.0	17.0	17.3	15.7	17.6	17.3	4.6	3.2	5.6	15.7	5.6	1.1	5.9	6.7	10.2	9.3	3.2	3.8	2.5	4.3	3.4	0.0	10.4	7.1	6.6	5.4	1.9	4.5	1.3	4.9	5.5	5.1	7.8	1.7	16.0	3.3	6.0	4.1	15.3	4.9	6.3	11.8	6.1	2.0	6.9	11.8	14.9	3.6	4.1	4.1	3.3	0.8	7.5	5.2	3.6	9.4	3.4	2.1	13.4	13.6	11.1	4.7	6.1	6.0	7.1	2.1	5.4	3.4	9.9	5.6	0.0	3.3	3.7	2.2	4.5	4.7	1.8	4.4	7.9	14.4	5.4	2.8
ABCC11	MRP8	ENSG00000121270	"ATP binding cassette subfamily C member 11"	Q96J66	16	48165773-48247568	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"breast: 46.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.3;Breast glandular cells: 4.4;Early spermatids: 3.3;Hepatocytes: 2.5;Late spermatids: 1.9;Spermatocytes: 4.0"	"Cancer enriched"	"Detected in some"	4	"breast cancer: 8.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"T-47d: 67.1"					"Not detected"	"Not detected"									NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 5: Breast - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (1.35e-1)"	"unprognostic (3.47e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.56e-2)"	"unprognostic (8.11e-2)"	"unprognostic (2.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.05e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.21e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.13e-2)"	"unprognostic (5.54e-4)"	0.1	0.0	0.2	0.0	0.3	0.1	46.4	0.4	0.3	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.5	0.1	0.0	0.2	0.2	0.0	1.6	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	3.6	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	2.4	0.3	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.4	0.6	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	16.0	0.1	0.0	67.1	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.3	0.3	0.1	0.0	0.5	3.3	0.2	0.0	0.0	0.0	0.0	0.4	4.4	0.9	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.3	0.3	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.2	0.0	0.1	0.0	2.5	0.0	0.0	0.6	0.0	0.0	0.3	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.5	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	4.0	0.4	0.5	0.0	0.3	0.2	0.1	0.0	0.1
ABCC12	MRP9	ENSG00000140798	"ATP binding cassette subfamily C member 12"	Q96J65	16	48081006-48156018	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"testis: 2.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.4;Excitatory neurons: 5.1;Late spermatids: 2.2;Spermatocytes: 6.0;Theca cells: 3.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA043100	Uncertain					NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA043100: AB_10794922"	"unprognostic (1.53e-1)"			"unprognostic (6.87e-2)"	"unprognostic (2.37e-2)"			"unprognostic (4.62e-3)"		"unprognostic (1.88e-1)"		"unprognostic (1.59e-2)"		"unprognostic (2.65e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.23e-1)"		0.0	0.0	0.3	0.0	0.3	0.0	0.3	0.3	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.4	0.4	0.2	0.2	0.2	0.2	0.3	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	0.9	0.0	0.0	0.0	0.0	3.1	0.0	0.0
ABCC2	"CMOAT, cMRP, DJS, MRP2"	ENSG00000023839	"ATP binding cassette subfamily C member 2"	Q92887	10	99782640-99852594	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 40.2;liver: 121.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 70.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 24.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"A549: 204.4;Hep G2: 208.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071145	Enhanced					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA071145: "	"unprognostic (1.49e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.68e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.40e-3)"	"prognostic unfavorable (1.93e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.26e-2)"	1.6	0.4	0.2	0.7	0.4	0.8	3.0	0.5	0.3	0.5	0.1	0.6	39.1	0.4	0.2	0.3	0.7	24.4	0.2	0.3	0.2	18.5	121.7	0.5	0.7	0.4	0.3	0.3	1.1	0.1	0.1	0.5	0.4	0.4	0.4	3.9	0.5	0.2	1.1	1.7	40.2	0.2	0.2	1.4	0.7	0.7	0.3	0.8	0.4	0.7	0.5	1.3	0.5	0.6	0.3	204.4	3.5	10.2	15.3	12.0	3.4	0.5	1.3	0.5	0.6	44.6	0.3	0.4	0.3	0.7	0.5	1.3	0.3	0.4	0.6	0.5	0.3	0.0	1.0	208.7	0.5	0.3	0.7	1.9	13.9	1.5	1.4	0.2	0.4	0.6	0.0	0.3	0.2	1.0	0.2	1.4	0.3	39.8	0.3	0.3	0.2	0.4	1.4	0.3	0.1	0.2	0.5	3.4	25.9	0.4	0.1	0.4	0.7	0.6	0.6	0.9	0.6	0.8	0.1	0.2	16.1	1.8	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.3	0.2	0.4	0.3	0.4	0.2	0.3	0.6	0.7	0.0	0.0	2.3	0.4	0.0	0.2	0.2	0.0	0.3	0.1	0.0	0.5	1.5	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.2	2.6	2.9	0.2	0.3	0.0	0.4	1.0	0.4	0.0	1.7	0.0	0.6	1.3	0.1	1.4	70.7	0.2	0.0	1.3	0.6	0.0	1.0	0.0	1.1	0.3	0.4	5.4	1.9	0.3	0.1	0.0	1.0	2.2	0.1	0.0	0.0	0.1	0.2	15.5	10.7	2.8	1.5	0.0	0.4	0.5	1.2	0.7	0.1	0.0	1.6	0.4	0.1	0.4	0.0
ABCC3	"cMOAT2, EST90757, MLP2, MOAT-D, MRP3"	ENSG00000108846	"ATP binding cassette subfamily C member 3"	O15438	17	50634777-50692253	"Cancer-related genes, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 59.1;liver: 50.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 231.6;Distal enterocytes: 265.1;Gastric mucus-secreting cells: 271.7;Hepatocytes: 192.9;Paneth cells: 194.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.1;non-classical monocyte: 6.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 6.4"	"Cell line enhanced"	"Detected in many"		"A549: 79.4;CAPAN-2: 60.6;HeLa: 36.9;OE19: 89.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB037136, HPA048483"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB037136: AB_477165, HPA048483: AB_2680414"	"unprognostic (1.57e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.65e-2)"	"unprognostic (9.67e-3)"	"unprognostic (6.19e-3)"	"unprognostic (7.44e-3)"	"unprognostic (8.20e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (1.60e-3)"	"prognostic unfavorable (4.68e-6)"	"unprognostic (3.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.57e-3)"	3.1	59.1	0.1	3.4	1.8	0.8	4.2	0.2	0.7	2.1	0.0	18.9	12.0	1.1	1.8	7.5	1.0	11.9	0.9	0.3	0.3	8.0	50.4	4.8	1.9	5.9	0.8	0.7	22.6	0.8	0.8	1.1	3.5	5.9	8.7	0.4	7.0	5.5	0.2	7.1	11.9	1.3	1.7	3.4	17.1	1.0	2.5	0.3	5.5	0.0	1.7	6.3	3.6	2.4	5.7	79.4	0.0	0.3	4.4	6.9	0.1	10.4	13.1	0.7	0.7	4.2	60.6	0.0	8.0	20.6	14.5	14.5	0.0	1.0	1.0	0.0	0.0	1.7	36.9	24.2	17.2	0.0	0.0	7.5	5.6	2.9	6.2	8.5	1.4	0.0	0.2	0.0	8.0	18.9	0.0	0.0	0.1	89.7	10.1	0.1	0.0	0.3	33.4	34.2	0.1	0.6	19.2	3.1	0.0	0.1	2.6	0.0	17.3	0.5	3.4	0.2	8.5	0.1	0.0	0.0	8.2	0.0	0.9	0.2	2.3	0.0	0.0	5.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	1.0	0.3	6.4	0.1	0.5	5.4	0.1	1.8	0.2	0.7	0.3	0.3	5.9	0.8	3.5	1.7	2.5	2.4	0.7	19.2	5.5	0.0	1.8	9.4	122.2	47.1	42.7	1.6	1.9	6.9	3.1	231.6	19.5	14.7	0.0	0.4	0.0	265.1	5.9	100.1	82.9	5.9	8.8	2.7	23.5	0.0	4.3	106.1	3.7	3.6	271.7	30.5	0.0	3.1	3.9	192.9	26.1	1.7	0.9	96.2	12.2	33.0	11.4	118.6	9.0	31.6	3.6	2.8	8.7	2.9	1.0	0.5	0.5	105.9	194.7	3.0	2.1	104.6	57.2	10.8	2.7	0.3	0.0	1.9	5.6	0.9	0.8	12.7	10.5	1.0	2.6	0.1	111.0	118.4
ABCC4	"EST170205, MOAT-B, MOATB, MRP4"	ENSG00000125257	"ATP binding cassette subfamily C member 4"	O15439	13	95019835-95301475	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 41.1"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 51.3;granulocytes: 53.9;Microglial cells: 203.3"	"Cancer enriched"	"Detected in all"	8	"prostate cancer: 90.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"HEL: 245.7;HMC-1: 256.3;RPTEC TERT1: 69.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002476	Enhanced		Supported	"Nucleoli,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoli, Golgi apparatus"	"HPA002476: AB_1844434"	"unprognostic (8.77e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.89e-4)"	"unprognostic (2.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.40e-2)"	"unprognostic (9.96e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.55e-2)"	"prognostic favorable (2.25e-10)"	"unprognostic (7.44e-3)"	"unprognostic (1.67e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.35e-2)"	2.2	1.3	2.5	6.1	2.3	4.1	6.9	2.5	2.5	4.9	7.2	9.2	4.9	3.4	18.8	2.0	10.2	6.1	2.0	2.3	5.4	18.0	1.3	7.6	3.9	4.3	3.7	3.7	3.3	22.5	1.4	2.1	4.6	41.1	8.5	0.9	1.5	5.5	5.3	2.9	5.4	6.3	4.9	4.1	5.2	4.7	3.2	3.9	7.7	1.7	6.3	15.4	1.8	5.1	18.5	31.7	5.3	9.4	9.5	12.3	1.3	14.4	14.3	12.6	10.9	43.8	13.2	10.2	9.3	19.5	9.0	24.0	7.9	7.1	15.8	30.7	12.1	245.7	8.8	8.8	19.2	28.6	256.3	9.4	3.2	9.1	18.5	17.9	16.4	11.3	25.8	0.4	17.1	5.9	5.4	4.6	6.2	22.3	7.9	7.7	14.3	26.9	69.3	40.4	12.5	9.3	4.8	1.2	10.1	5.9	0.0	15.1	27.0	13.3	8.6	11.2	17.3	0.1	0.0	4.0	25.4	16.0	6.6	0.2	0.5	0.2	1.3	0.6	1.1	1.4	1.0	1.5	1.8	1.6	0.6	1.5	0.3	1.9	2.3	0.3	1.5	1.3	2.5	2.3	2.5	2.5	2.3	5.4	4.3	3.7	4.6	4.9	3.2	5.1	4.6	9.6	32.7	28.4	5.8	4.2	7.0	7.3	4.0	0.1	0.6	0.6	4.5	8.6	9.1	23.9	22.9	0.1	2.0	2.7	0.0	6.9	3.8	4.2	11.3	19.8	0.0	51.3	13.6	3.1	0.4	5.7	6.1	6.0	53.9	9.5	2.9	0.6	4.5	0.0	10.3	4.0	0.0	2.5	8.1	2.0	6.8	10.7	1.8	203.3	13.5	0.5	4.1	16.1	2.5	2.9	8.3	1.9	8.3	27.1	0.5	26.4	4.7	0.8	0.0	8.2	3.1	0.9	8.3	3.4	7.5	0.3	6.4	17.3	9.2	4.5
ABCC5	"EST277145, MOAT-C, MRP5, SMRP"	ENSG00000114770	"ATP binding cassette subfamily C member 5"	O15440	3	183919934-184017939	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 167.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 196.0;Inhibitory neurons: 122.8;Rod photoreceptor cells: 121.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 136.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044067, HPA052295"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 15: RT4 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA044067: AB_2678797, HPA052295: AB_2681789"	"unprognostic (9.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.10e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (4.46e-2)"	"unprognostic (6.07e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.91e-3)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (1.10e-1)"	"unprognostic (9.05e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-2)"	15.4	23.2	42.5	16.3	44.2	22.4	13.1	48.4	50.0	30.9	167.1	24.4	10.8	21.6	10.4	44.5	16.1	17.9	47.2	45.5	43.6	41.6	7.9	15.6	13.1	44.0	39.5	23.4	13.0	24.0	41.7	17.2	44.7	27.8	22.1	126.2	18.4	13.7	117.5	24.1	23.2	16.1	34.0	37.1	82.3	16.5	46.3	15.3	13.8	40.3	11.8	34.8	35.2	43.2	21.5	11.5	25.9	30.8	25.7	28.3	40.0	16.8	13.3	14.8	16.2	17.9	15.8	22.5	38.6	16.2	22.6	83.3	32.1	18.6	19.3	24.4	31.1	48.1	32.5	18.0	10.3	14.8	36.5	45.6	18.3	15.9	10.6	30.3	17.8	65.6	45.6	30.8	25.7	56.7	40.7	17.1	26.7	38.4	21.7	28.1	8.7	13.4	54.4	136.4	46.6	27.8	17.1	93.5	29.3	33.3	56.6	4.9	20.4	17.4	16.6	22.3	23.8	11.7	24.3	21.1	12.5	29.2	17.9	11.7	4.6	8.3	6.9	2.2	4.4	3.1	3.8	3.1	3.6	4.5	4.3	6.0	16.4	5.6	4.2	1.3	5.7	4.5	42.5	44.2	48.4	50.0	45.5	43.6	44.0	39.5	44.7	34.0	46.3	43.2	8.3	9.6	5.3	39.2	6.4	8.9	14.4	18.3	35.3	39.1	10.5	11.3	37.2	2.8	37.2	44.1	196.0	3.2	7.7	23.3	7.9	5.7	6.0	10.4	18.0	9.5	59.3	21.2	101.3	4.5	5.0	12.5	91.3	20.8	5.1	31.0	6.8	3.3	49.7	33.7	122.8	6.4	20.3	32.7	6.5	3.5	8.1	29.3	12.4	32.8	8.3	13.8	9.2	82.4	62.7	7.9	20.2	7.9	7.5	9.3	5.1	4.8	44.9	121.1	0.0	27.4	15.4	6.8	18.8	41.3	12.1	4.5	8.6	14.9	7.5	61.5
ABCC6	"ARA, EST349056, MLP1, MRP6, PXE, URG7"	ENSG00000091262	"ATP binding cassette subfamily C member 6"	O95255	16	16149565-16223522	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Transport, Vision"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 134.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 31.5;Distal tubular cells: 45.0;Hepatocytes: 77.9;Proximal enterocytes: 33.7;Proximal tubular cells: 151.1"	"Group enriched"	"Detected in many"	5	"liver cancer: 16.7;renal cancer: 5.0"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	6	"classical monocyte: 3.4"	"Lineage enriched"	"Detected in single"	7	"monocytes: 3.4"	"Cell line enriched"	"Detected in some"	8	"Hep G2: 68.4"	"Not detected"	"Not detected"							HPA038105			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA038105: AB_2675835"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (5.98e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.09e-1)"	"prognostic favorable (3.82e-4)"	"unprognostic (6.54e-3)"	"unprognostic (3.64e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.12e-3)"	"unprognostic (3.42e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.41e-1)"	5.6	3.6	0.7	0.3	0.7	0.7	3.8	0.7	1.1	1.0	0.8	5.7	13.2	0.3	0.6	0.3	1.5	2.9	2.6	0.7	0.7	27.4	134.2	7.4	0.0	0.8	0.9	1.0	17.2	2.1	0.9	0.2	0.8	2.9	2.8	0.3	12.7	1.0	4.6	0.4	7.9	0.3	0.7	0.7	6.4	0.4	0.8	0.0	5.6	0.1	0.0	0.4	0.7	0.7	0.0	1.5	0.7	0.0	0.0	0.8	1.8	0.0	0.4	1.0	1.6	7.1	2.3	0.0	0.8	0.0	0.2	0.0	0.7	0.1	0.6	0.0	0.7	1.8	0.2	68.4	0.4	0.0	0.0	2.7	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.5	0.2	0.6	0.0	0.0	0.0	0.0	2.3	0.0	0.1	1.0	0.0	0.8	0.1	0.3	8.4	5.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.4	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.7	1.1	0.7	0.7	0.8	0.9	0.8	0.7	0.8	0.7	0.3	28.9	31.5	2.9	1.9	0.1	0.5	3.2	0.0	1.0	4.3	3.6	3.3	18.6	8.7	9.2	0.0	0.0	0.0	13.7	45.0	2.2	0.5	4.8	1.0	0.8	3.0	2.7	1.0	7.9	0.0	1.7	13.3	1.0	1.3	1.9	1.8	77.9	1.0	0.0	1.1	10.9	0.0	3.5	0.0	0.7	1.5	1.8	1.8	3.7	3.1	1.5	0.0	1.0	0.4	2.2	8.1	5.7	0.3	2.0	33.7	151.1	25.4	0.6	0.0	0.3	1.2	0.4	0.3	0.2	0.9	0.0	1.4	1.8	11.9	0.7
ABCC8	"ABC36, HHF1, HI, HRINS, MRP8, PHHI, SUR, SUR1, TNDM2"	ENSG00000006071	"ATP binding cassette subfamily C member 8"	Q09428	11	17392498-17476879	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"pancreas: 20.1;pituitary gland: 34.4"	"Group enriched"	"Detected in some"	4	"Astrocytes: 19.6;Bipolar cells: 39.0;Endometrial stromal cells: 17.9;Enteroendocrine cells: 22.0;Excitatory neurons: 48.2;Inhibitory neurons: 39.3;Oligodendrocyte precursor cells: 39.2"	"Cancer enriched"	"Detected in some"	9	"pancreatic cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"A549: 1.8;AN3-CA: 1.4;SCLC-21H: 2.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011451, HPA042318"	Approved		Approved	"Nucleoli,Golgi apparatus,Cytosol"		No	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Nucleoli	"Golgi apparatus, Cytosol"	"CAB011451: , HPA042318: AB_2677947"	"unprognostic (4.30e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.73e-2)"	"unprognostic (9.48e-3)"	"unprognostic (2.23e-1)"	"unprognostic (4.46e-3)"	"unprognostic (2.53e-3)"	"unprognostic (6.04e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.72e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.96e-2)"	"unprognostic (6.88e-5)"	"unprognostic (2.72e-2)"	"unprognostic (1.85e-1)"	0.4	2.8	2.6	0.0	3.7	0.0	1.8	3.9	5.2	3.5	0.0	0.7	0.5	2.6	1.4	0.1	0.6	0.0	1.6	3.1	1.4	0.5	0.1	5.0	0.0	3.3	2.7	0.4	20.1	0.2	34.4	0.4	3.3	2.1	0.3	2.2	0.0	1.5	1.5	0.2	1.0	0.2	0.6	0.1	6.1	0.4	1.2	0.0	3.4	0.6	0.0	0.4	1.3	3.5	0.0	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	3.7	3.9	5.2	3.1	1.4	3.3	2.7	3.3	0.6	1.2	3.5	0.3	0.0	0.0	19.6	0.3	0.0	0.1	0.0	0.0	39.0	5.3	3.7	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.5	17.9	0.3	22.0	0.0	48.2	0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.3	0.1	0.0	39.3	0.7	0.0	0.3	0.5	0.0	0.0	0.1	0.0	3.7	0.0	1.9	0.0	39.2	7.6	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.3	0.0	0.7	2.0	0.1	0.8	0.0	0.1	0.0	0.1	2.6	0.1	0.2
ABCC9	"CMD1O, SUR2"	ENSG00000069431	"ATP binding cassette subfamily C member 9"	O60706	12	21797389-21942529	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Atrial fibrillation, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 45.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 60.3;Astrocytes: 72.1;Hepatocytes: 99.4;Sertoli cells: 131.5;Smooth muscle cells: 140.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 24.9;BJ hTERT+: 14.0;CACO-2: 20.8;HSkMC: 27.1;U-138 MG: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007279	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA007279: AB_1844435"	"unprognostic (4.82e-2)"	"unprognostic (3.62e-2)"	"unprognostic (5.51e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.30e-2)"	"unprognostic (3.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.47e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.51e-2)"	"unprognostic (3.57e-1)"	"prognostic unfavorable (1.85e-5)"	"unprognostic (2.66e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.10e-3)"	"unprognostic (8.22e-5)"	27.4	5.9	4.5	3.4	5.4	1.7	9.2	3.1	9.2	8.2	11.6	7.4	4.0	19.1	8.3	6.2	12.3	11.7	28.3	5.4	3.6	6.6	45.2	7.7	3.5	4.8	7.4	10.9	3.5	1.9	2.2	3.6	3.7	7.9	1.8	3.2	4.5	9.9	41.9	4.2	3.1	21.0	3.4	4.4	8.1	1.2	5.1	1.8	6.3	30.3	1.5	5.3	5.1	7.2	0.9	0.2	11.9	0.3	24.9	11.0	0.3	6.1	14.0	7.0	3.5	20.8	1.0	0.5	1.2	0.6	0.8	0.3	0.0	0.0	7.2	0.3	0.2	0.5	0.8	0.3	0.1	0.5	0.6	27.1	0.0	6.7	2.5	0.4	0.0	0.4	0.3	1.2	0.3	1.4	0.2	0.4	1.4	1.2	0.6	0.5	0.3	0.3	0.0	1.2	0.4	1.7	0.4	0.5	0.2	1.7	1.2	0.3	0.3	27.0	1.9	2.2	8.7	1.1	1.3	0.4	6.7	0.3	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	4.5	5.4	3.1	9.2	5.4	3.6	4.8	7.4	3.7	3.4	5.1	7.2	33.8	35.3	60.3	72.1	0.2	3.4	1.5	5.0	0.6	0.8	0.5	0.8	38.2	0.0	25.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.6	0.8	20.6	19.7	0.0	0.0	17.2	0.2	0.1	26.2	1.1	0.6	24.0	0.0	7.1	99.4	0.1	1.7	1.0	0.0	0.0	2.4	5.9	0.1	0.3	2.5	10.6	2.8	0.0	15.9	0.0	1.5	1.4	0.1	0.0	0.4	0.0	0.5	0.0	0.1	20.4	1.2	131.5	11.1	140.7	0.4	1.6	1.1	2.3	0.3	2.5	0.2	0.0	2.2
ABCD1	"adrenoleukodystrophy, ALD, ALDP, AMN"	ENSG00000101986	"ATP binding cassette subfamily D member 1"	P33897	X	153724856-153744755	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 19.5;Proximal enterocytes: 39.2;Syncytiotrophoblasts: 27.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 36.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"EFO-21: 69.7;PC-3: 50.0;SK-BR-3: 49.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035214	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 72: Non-specific - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA035214: "	"unprognostic (1.90e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.19e-3)"	"unprognostic (5.57e-3)"	"unprognostic (8.81e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.34e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.41e-1)"	"unprognostic (6.17e-2)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (4.17e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.23e-2)"	14.6	33.3	3.1	5.4	3.9	4.7	12.5	3.4	3.8	7.5	2.2	14.7	10.6	33.2	1.7	3.7	9.3	3.4	11.9	2.9	3.4	7.0	13.3	7.6	3.9	4.4	3.6	5.4	11.9	2.1	10.0	4.7	4.8	9.9	1.8	0.5	6.2	5.6	20.5	4.4	17.4	4.8	3.1	13.8	7.2	19.0	5.5	4.3	6.0	4.6	1.7	11.9	6.1	4.2	13.2	4.0	2.6	11.2	7.4	3.2	34.3	6.3	6.8	4.2	7.4	2.6	7.1	3.5	69.7	8.6	11.3	1.7	1.6	1.4	0.5	11.8	2.1	10.3	42.1	34.1	9.8	6.4	22.4	6.2	1.7	4.8	0.4	4.4	6.7	4.7	6.0	12.4	5.9	4.7	4.5	6.1	3.3	3.2	50.0	7.8	6.2	5.7	3.2	1.4	2.8	11.5	16.4	49.2	26.4	3.0	3.7	10.8	7.9	5.5	7.4	14.3	7.0	12.2	5.7	8.4	6.9	21.7	7.8	0.4	3.2	2.5	0.8	3.0	4.0	1.0	1.0	1.2	2.7	0.7	1.1	0.8	1.7	0.7	2.8	1.7	0.3	2.5	3.1	3.9	3.4	3.8	2.9	3.4	4.4	3.6	4.8	3.1	5.5	4.2	5.0	0.0	1.1	3.6	3.8	3.2	1.6	1.6	0.6	2.2	2.7	2.8	2.4	2.8	2.2	3.7	2.1	12.2	4.8	9.5	0.0	3.8	0.7	2.0	3.5	3.4	6.0	3.6	0.5	6.9	19.5	4.5	3.6	4.0	0.0	6.9	5.7	6.8	12.6	8.4	0.9	5.0	2.0	15.9	8.4	2.7	4.1	12.3	1.8	0.0	5.9	2.4	0.0	0.0	1.2	5.0	2.1	5.7	2.4	0.8	39.2	2.8	1.2	0.7	6.6	2.3	2.8	3.8	4.8	0.8	1.3	27.4	4.0	7.8	5.5	1.4
ABCD2	"ALDL1, ALDR, ALDRP"	ENSG00000173208	"ATP binding cassette subfamily D member 2"	Q9UBJ2	12	39550033-39619803	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 15.7;brain: 8.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 71.5;Bipolar cells: 57.2;Excitatory neurons: 33.2;Inhibitory neurons: 34.2"	"Cancer enriched"	"Detected in single"	7	"glioma: 1.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Lineage enriched"	"Detected in single"	4	"T-cells: 4.2"	"Group enriched"	"Detected in some"	6	"ASC diff: 11.6;HDLM-2: 16.9;Karpas-707: 29.0;SH-SY5Y: 17.3;U-266/70: 9.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (1.26e-3)"	"unprognostic (4.06e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.06e-1)"	"unprognostic (7.31e-5)"	"unprognostic (3.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.47e-4)"	"unprognostic (5.04e-2)"	"unprognostic (8.04e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.74e-2)"	15.7	1.7	1.5	1.7	2.2	0.2	2.8	8.9	5.2	5.3	0.0	0.7	0.5	2.7	0.2	0.4	2.7	0.5	4.2	2.1	2.1	0.5	0.1	0.5	2.8	2.2	3.3	0.1	0.1	0.0	0.5	0.0	2.4	0.4	0.7	5.9	2.6	0.6	0.1	0.1	0.7	2.6	1.3	1.6	0.7	0.2	3.6	1.4	0.2	0.3	1.6	0.9	0.6	1.4	0.0	0.0	0.1	0.0	11.6	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	16.9	0.0	0.1	0.0	0.0	0.6	0.2	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.1	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	9.8	1.3	0.2	0.0	0.3	0.0	0.0	0.0	0.0	1.5	0.0	1.2	0.5	2.8	3.7	0.1	0.3	3.2	4.2	0.1	0.9	0.0	0.6	3.6	1.2	1.5	2.2	8.9	5.2	2.1	2.1	2.2	3.3	2.4	1.3	3.6	1.4	0.4	0.0	0.0	71.5	2.6	0.0	0.0	0.0	0.0	57.2	0.3	0.3	10.9	0.0	0.0	0.0	6.2	0.0	3.8	0.1	0.0	0.0	0.3	0.2	0.5	0.2	0.0	0.0	33.2	0.0	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	10.1	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	6.5	1.1	2.2	0.0	13.0	1.3	0.0	0.0	0.7	5.9	0.0	0.0	0.9	2.4	2.3	0.0	0.4	2.5	0.2	0.1	0.0	0.0	0.0	7.8	0.6	0.1	0.0
ABCD3	"PMP70, PXMP1, ZWS2"	ENSG00000117528	"ATP binding cassette subfamily D member 3"	P28288	1	94418389-94518666	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 126.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032026, HPA032027, CAB032516, CAB075749"	Enhanced		Enhanced	Peroxisomes		NA	NA		12000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Peroxisomes		"CAB032516: AB_2257637, CAB075749: AB_2665755, HPA032026: AB_2674117, HPA032027: AB_10602103"	"unprognostic (1.41e-2)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.16e-5)"	"unprognostic (1.92e-1)"	"unprognostic (5.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.94e-2)"	"unprognostic (2.54e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.20e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.12e-2)"	"prognostic favorable (4.84e-5)"	"unprognostic (5.45e-2)"	"unprognostic (6.20e-2)"	"unprognostic (3.41e-1)"	"unprognostic (1.29e-1)"	16.8	18.7	19.8	16.2	23.2	25.1	32.8	22.7	24.3	22.4	22.6	44.6	44.5	14.7	21.2	26.7	16.7	26.8	26.0	18.7	21.8	59.4	126.6	23.3	13.3	22.1	21.2	10.1	28.6	29.6	13.3	14.4	22.7	21.5	40.2	26.3	17.5	27.0	23.5	35.5	46.1	17.7	23.7	11.0	43.5	16.3	21.4	47.5	27.5	29.8	21.2	22.9	16.2	27.3	81.5	37.6	37.8	36.1	28.3	31.0	55.8	41.4	32.0	46.8	51.5	117.5	25.0	49.8	52.1	52.8	50.0	58.2	43.7	53.7	64.9	40.1	36.9	56.7	52.3	102.5	27.5	51.2	17.0	26.2	29.6	54.2	20.8	30.2	29.0	47.0	25.8	29.2	48.6	11.4	86.4	26.8	43.7	61.7	50.7	48.0	78.4	19.4	45.6	122.2	28.5	46.7	71.5	75.2	55.7	28.4	27.7	41.8	28.9	34.5	49.5	61.3	55.9	16.5	16.5	48.4	27.1	25.6	16.4	0.4	3.8	2.9	4.2	4.3	4.0	1.8	3.8	4.9	5.9	1.8	4.5	4.4	0.9	5.9	3.8	1.5	4.6	3.3	19.8	23.2	22.7	24.3	18.7	21.8	22.1	21.2	22.7	23.7	21.4	27.3	16.9	35.3	48.8	64.3	10.2	23.3	16.2	32.8	14.8	27.5	43.7	21.1	39.1	58.6	43.2	42.3	22.9	25.0	12.3	72.1	23.5	22.8	9.0	37.5	16.8	16.4	39.7	8.4	32.7	44.5	12.0	18.3	37.8	30.6	27.9	19.1	18.2	108.9	11.0	33.7	47.5	37.5	26.4	21.9	7.4	8.2	13.7	15.0	16.0	40.3	15.1	78.4	11.3	67.3	96.5	37.5	33.0	24.5	15.4	20.4	75.7	72.3	49.8	26.3	19.7	19.0	17.7	14.5	23.2	21.0	34.0	15.3	15.4	16.7	39.5	32.5
ABCD4	"EST352188, P70R, PMP69, PXMP1L"	ENSG00000119688	"ATP binding cassette subfamily D member 4"	O14678	14	74285269-74303055	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003396	Approved					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"			"HPA003396: AB_1078078"	"unprognostic (3.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.86e-2)"	"unprognostic (3.69e-1)"	"unprognostic (1.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.34e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.63e-2)"	"unprognostic (2.21e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-3)"	"unprognostic (7.93e-3)"	6.6	4.7	3.0	3.9	3.4	4.6	6.4	4.0	5.4	5.8	2.9	5.4	8.8	4.9	2.1	4.8	8.5	7.7	6.0	3.0	3.3	5.4	7.7	5.8	6.6	4.2	3.4	6.9	6.0	3.8	3.9	7.4	3.7	3.6	4.0	3.3	4.0	3.5	3.9	4.1	8.7	5.2	2.8	6.2	4.5	3.4	3.6	5.5	7.2	2.0	3.8	4.5	4.3	4.5	2.6	3.1	7.9	6.2	6.4	4.3	9.8	3.9	5.6	5.8	6.0	6.5	13.7	4.3	7.4	5.9	3.2	9.2	6.0	5.4	3.0	3.9	3.8	2.3	5.1	5.2	2.1	2.9	4.4	10.4	2.4	4.1	2.8	3.0	9.9	5.4	4.3	1.9	4.5	4.3	7.1	5.6	3.0	5.0	5.9	9.7	11.4	6.3	8.6	8.5	3.7	7.3	5.4	5.3	5.5	3.7	12.3	1.7	9.7	3.6	7.0	3.2	2.5	4.4	4.5	3.3	5.1	4.3	4.5	6.0	1.3	1.8	2.6	1.2	1.7	1.9	2.2	2.9	2.1	1.8	1.2	1.8	1.1	2.6	1.0	4.0	5.2	1.4	3.0	3.4	4.0	5.4	3.0	3.3	4.2	3.4	3.7	2.8	3.6	4.5	50.0	28.9	18.6	32.3	16.7	15.6	14.8	23.0	12.0	46.5	21.4	14.2	9.7	34.3	21.2	20.2	64.6	51.6	28.9	31.4	9.8	25.3	10.3	27.9	23.5	50.2	12.0	9.9	29.6	11.3	19.9	23.0	13.7	20.1	20.3	43.2	44.6	23.3	51.1	32.0	34.7	15.7	18.3	24.8	27.1	7.7	40.4	19.5	21.4	20.6	22.8	36.4	32.0	23.6	38.1	17.9	19.4	25.2	13.3	12.6	60.1	23.9	19.5	55.5	32.9	23.3	19.1	35.8	27.2	10.6	10.7	28.5	23.4	27.9	22.9	16.7
ABCE1	"OABP, RLI, RLI1, RNASEL1, RNASELI, RNS4I"	ENSG00000164163	"ATP binding cassette subfamily E member 1"	P61221	4	145098288-145129524	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Translation regulation"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012476, HPA036846"	Approved		Enhanced	Cytosol		No	No		380000	"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB012476: , HPA036846: AB_2675346"	"unprognostic (2.22e-3)"	"unprognostic (8.11e-3)"	"prognostic favorable (8.69e-4)"	"unprognostic (2.69e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.51e-3)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (5.68e-3)"	"unprognostic (6.77e-2)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.56e-2)"	"unprognostic (1.38e-3)"	"unprognostic (2.85e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.21e-1)"	30.0	21.5	11.2	33.6	12.5	27.2	33.1	13.7	16.0	20.7	10.7	22.7	20.2	24.4	16.0	35.1	22.5	22.4	24.9	12.5	14.3	23.8	39.7	18.5	40.5	12.6	11.2	29.1	29.4	27.0	10.0	28.7	14.4	19.4	27.7	14.4	24.1	16.9	28.0	25.2	17.7	28.9	13.8	26.4	20.1	26.5	11.8	34.2	26.9	30.3	42.1	40.5	15.9	18.1	117.1	61.2	89.5	62.2	74.6	107.5	89.4	124.6	86.4	145.1	101.3	95.5	105.9	187.6	39.3	109.2	77.7	75.4	132.5	157.7	193.1	108.6	82.9	106.9	44.0	80.6	98.3	244.3	81.3	80.0	108.4	153.8	213.7	74.8	157.4	139.1	219.5	136.1	156.3	70.4	234.5	82.2	74.8	177.5	142.9	124.0	107.9	135.7	108.1	79.9	111.1	55.1	74.7	124.6	89.5	66.7	74.2	98.1	105.3	143.3	89.4	101.3	152.5	120.6	209.6	199.5	87.7	214.6	163.7	2.2	10.0	0.9	12.3	13.1	25.4	13.2	15.4	16.0	19.5	13.0	21.0	18.1	0.8	16.4	13.4	10.9	18.5	14.8	11.2	12.5	13.7	16.0	12.5	14.3	12.6	11.2	14.4	13.8	11.8	18.1	56.4	25.6	18.7	15.3	55.9	59.9	109.0	38.7	45.5	37.2	35.0	30.6	24.0	17.2	45.4	25.8	20.9	39.4	44.4	9.8	39.2	39.4	40.1	29.0	61.8	53.7	20.4	47.5	24.2	28.2	45.1	50.6	35.7	23.4	32.9	50.3	21.4	32.9	41.5	42.1	27.8	22.5	24.4	22.4	40.3	15.4	46.9	34.6	19.6	12.2	33.2	18.1	33.0	18.1	37.5	39.1	10.3	34.6	58.3	112.2	8.0	39.8	28.5	34.9	32.9	71.7	47.5	92.4	79.4	65.5	59.5	26.5	47.2	98.4	36.6	72.2
ABCF1	"ABC50, EST123147"	ENSG00000204574	"ATP binding cassette subfamily F member 1"	Q8NE71	6	30571393-30597179	"Plasma proteins, Predicted intracellular proteins, Transporters"		Activator		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 107.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017578	Approved		Enhanced	Cytosol		NA	NA		490000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA017578: AB_1844438"	"unprognostic (5.85e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.41e-3)"	"unprognostic (4.31e-2)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (5.50e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-1)"	"unprognostic (1.68e-3)"	"unprognostic (7.16e-2)"	31.6	27.5	4.5	6.7	5.0	25.5	28.3	4.4	6.4	29.6	3.5	34.0	2.0	34.3	7.4	32.4	24.6	6.8	35.0	4.3	4.9	28.1	32.6	29.9	7.4	5.1	4.8	26.2	32.7	13.5	24.7	10.5	5.0	28.3	11.4	11.1	30.4	5.4	107.0	39.9	32.3	10.2	4.5	30.7	32.4	35.0	5.3	14.7	29.3	4.1	11.3	32.4	30.0	5.6	46.2	33.5	29.4	39.7	40.0	24.5	4.2	30.1	37.6	49.0	53.6	104.8	16.4	33.8	27.1	34.3	51.9	33.3	61.7	39.5	56.2	34.2	65.2	43.0	47.6	14.5	5.5	9.4	5.6	33.6	33.7	68.6	6.4	4.0	5.6	16.9	77.2	4.5	35.3	8.5	9.3	15.5	7.5	31.2	9.4	64.5	7.5	63.3	32.2	52.4	10.2	42.9	20.1	55.3	6.6	5.0	6.1	24.4	28.2	59.0	6.9	3.8	6.2	35.7	47.5	52.8	1.3	43.3	62.2	1.7	5.5	1.5	10.1	4.7	9.3	6.2	7.2	10.2	4.7	5.1	6.3	6.3	1.8	8.0	4.9	5.4	4.1	6.1	4.5	5.0	4.4	6.4	4.3	4.9	5.1	4.8	5.0	4.5	5.3	5.6	42.5	51.3	84.4	7.2	67.9	86.2	100.3	54.2	49.5	48.9	45.5	30.1	87.3	42.9	65.2	58.8	66.7	100.3	77.5	103.3	60.7	93.9	105.0	67.0	95.4	57.2	50.7	50.9	6.8	87.6	139.4	52.6	53.5	115.2	86.9	27.0	36.0	125.4	49.5	55.5	7.4	80.6	28.5	47.4	43.0	176.4	38.8	52.1	35.6	2.8	63.2	39.3	116.4	2.0	9.2	105.9	73.8	51.9	61.8	92.1	66.2	99.0	44.0	112.9	72.3	58.7	54.3	132.5	104.2	50.2	84.8	166.1	70.5	48.2	72.3	87.1
ABCF2	"ABC28, EST133090, HUSSY-18, M-ABC1"	ENSG00000033050	"ATP binding cassette subfamily F member 2"	Q9UG63	7	151211484-151227205	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 55.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020091, CAB020682, HPA021815, HPA030388"	Approved		Enhanced	Cytosol		NA	NA		51000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol		"CAB020682: , HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"	"unprognostic (6.80e-2)"	"unprognostic (4.23e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.07e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.52e-6)"	"unprognostic (1.52e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.73e-1)"	"unprognostic (6.31e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.07e-2)"	"unprognostic (7.84e-3)"	19.0	18.8	16.1	11.1	16.2	7.6	14.8	15.1	19.5	13.8	14.2	18.8	6.0	16.6	12.1	19.2	14.4	8.9	27.9	16.0	16.7	20.2	12.3	14.6	11.6	18.0	16.5	15.0	15.0	14.3	17.0	10.3	17.3	16.1	10.8	10.8	14.2	10.2	61.2	16.3	13.4	14.1	16.2	15.6	16.6	18.7	16.5	11.5	13.8	20.2	15.2	19.5	13.9	16.9	33.0	50.3	18.8	66.0	36.6	31.1	25.1	40.6	33.0	49.9	42.1	47.9	22.1	57.4	34.3	42.8	40.9	25.2	58.9	47.8	49.5	28.1	48.8	23.1	26.3	27.4	43.3	58.0	35.7	42.3	39.6	54.6	34.4	21.2	40.7	32.5	68.4	22.9	43.2	80.1	60.4	70.3	46.8	37.6	54.5	40.3	30.1	50.5	35.4	24.0	32.9	31.0	39.5	37.5	26.8	19.5	16.2	29.0	40.7	31.7	12.8	39.6	61.7	46.9	54.5	42.7	43.5	56.4	60.3	7.9	11.3	3.8	13.8	13.3	19.5	11.9	14.2	13.7	13.1	13.1	13.3	13.8	1.6	14.5	15.1	9.8	15.8	14.7	16.1	16.2	15.1	19.5	16.0	16.7	18.0	16.5	17.3	16.2	16.5	16.9	4.7	0.0	0.5	10.1	15.9	27.1	25.9	22.5	14.2	17.4	0.3	0.6	23.5	7.2	9.5	0.0	8.4	29.5	10.0	28.4	0.0	0.0	47.0	0.1	0.1	12.8	6.7	18.3	12.6	0.0	28.8	13.8	16.3	0.0	10.2	0.0	12.5	12.9	20.7	10.1	12.6	9.1	12.2	10.4	11.5	55.9	10.5	6.7	19.6	7.5	6.2	14.1	14.4	7.1	10.4	0.0	18.9	14.7	14.0	29.8	15.7	0.0	6.6	16.9	13.1	25.7	15.1	31.0	12.4	21.5	25.1	32.3	10.9	0.1	15.1	19.6
ABCF2-H2BE1		ENSG00000285292	"ABCF2-H2BE1 readthrough"	Q9UG63	7	151207837-151227166	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA020091, HPA021815, HPA030388"	Approved		Uncertain	Cytosol		NA	NA		51000	"Cluster 16: MAIT-cells - Unknown function"		"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA020091: AB_1844439, HPA021815: AB_1844440, HPA030388: AB_10601558"																		12.0	8.1	1.1	11.1	1.6	5.5	9.0	2.1	6.2	7.4	2.9	9.5	6.7	8.4	2.9	10.1	9.0	7.6	9.8	1.5	2.0	9.7	7.4	8.6	11.4	1.5	1.6	6.0	4.6	13.9		8.3	2.3	7.2	10.3	10.0	5.4	9.5	30.7	9.0	5.7	11.9	1.9	9.5	6.0	6.8	2.1	10.2	9.5	20.9	13.8	14.4		2.8	45.0	54.8	27.0	71.0	38.7	38.6	22.4	57.1	38.5	43.7	45.1	40.5	33.8	66.4	44.1	59.7	61.1	34.7	57.9	55.3	61.0	29.9	31.8	37.1	30.6	26.6	57.8	76.5	25.8	40.8	40.8	72.5	50.5	28.6	55.4	35.8	89.1	28.4	57.6	68.1	88.9	23.1	36.5	58.4	50.1	36.5	34.6	68.3	21.9	33.8	21.9	34.8	59.5	44.0	30.3	25.1	21.2	33.9	47.5	33.4	11.4	45.2	73.6	41.6	47.5	64.7	55.4	64.7	49.0	22.5	21.3	6.0	22.5	19.1	45.7	17.5	27.9	26.3	24.8	19.9	24.8	24.3	1.6	25.5	18.5	15.4	30.2	30.3	1.1	1.6	2.1	6.2	1.5	2.0	1.5	1.6	2.3	1.9	2.1	2.8	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ABCF3	EST201864	ENSG00000161204	"ATP binding cassette subfamily F member 3"	Q9NUQ8	3	184186023-184194012	"Predicted intracellular proteins, Transporters"	"Antiviral defense"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036332	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoli	"HPA036332: AB_10603571"	"unprognostic (1.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.10e-2)"	"unprognostic (3.81e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (4.16e-5)"	"unprognostic (5.18e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.01e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.94e-2)"	"unprognostic (6.53e-2)"	16.1	56.1	10.9	13.3	10.9	16.8	15.8	11.8	13.4	18.2	9.6	15.5	15.7	15.5	12.3	20.0	17.0	12.7	28.5	10.9	12.7	19.2	22.7	14.4	17.0	13.9	12.3	20.0	23.6	43.5	21.0	16.4	12.8	16.2	13.6	14.2	26.9	19.6	46.8	19.6	16.3	12.4	9.2	17.8	17.5	16.5	12.4	14.6	17.9	41.3	16.1	17.1	17.6	11.6	49.9	30.2	16.9	32.8	48.1	26.9	33.3	35.2	39.1	46.7	36.5	52.0	19.3	29.8	69.5	38.1	54.9	46.4	26.5	37.1	24.1	38.4	25.5	25.7	26.6	30.8	40.4	29.2	25.2	39.7	33.5	33.1	32.7	27.4	33.8	25.7	24.1	34.9	33.5	60.0	28.7	18.8	25.7	51.1	41.2	28.5	28.1	50.4	25.4	29.6	29.1	16.9	36.5	69.1	33.8	18.3	93.7	25.3	33.5	24.9	27.1	39.5	53.1	39.2	40.5	38.2	38.8	28.7	31.3	8.1	29.1	22.7	32.9	30.4	34.7	23.6	29.0	27.5	25.6	23.8	36.0	29.5	14.6	24.0	32.4	15.8	27.2	37.2	10.9	10.9	11.8	13.4	10.9	12.7	13.9	12.3	12.8	9.2	12.4	11.6	10.2	9.6	2.0	6.2	17.4	14.5	10.0	29.8	9.6	16.7	10.8	6.7	11.6	17.2	19.7	14.7	14.6	36.9	16.2	19.8	29.4	22.5	9.5	11.2	12.0	11.6	11.4	8.6	7.1	22.4	25.5	12.5	13.3	12.0	9.5	16.0	16.8	20.0	21.6	20.2	9.9	13.4	30.5	9.4	6.9	10.2	12.5	12.9	16.0	3.7	22.8	14.7	17.5	6.6	7.3	20.5	9.8	11.7	19.4	9.0	28.6	37.3	14.4	22.3	6.6	11.9	9.5	12.8	17.1	14.5	10.2	43.8	16.6	18.1	14.7	11.7
ABCG1	ABC8	ENSG00000160179	"ATP binding cassette subfamily G member 1"	P45844	21	42199689-42297244	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 122.6;Syncytiotrophoblasts: 63.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"eosinophil: 35.5;neutrophil: 36.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 36.6"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 25.5;JURKAT: 38.4;MCF7: 33.2;MOLT-4: 31.5;OE19: 54.9;RPMI-8226: 25.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031470, HPA031471"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"		"HPA031470: AB_10599188, HPA031471: AB_10600201"	"unprognostic (2.89e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.96e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.09e-2)"	"unprognostic (5.74e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.66e-3)"	"unprognostic (3.66e-3)"	"unprognostic (6.37e-2)"	"prognostic favorable (7.16e-6)"	"unprognostic (1.40e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.42e-2)"	17.2	37.7	18.3	12.1	25.5	8.1	15.2	14.4	20.2	8.1	20.0	14.1	17.5	4.9	3.9	4.1	6.3	13.8	10.5	15.5	17.0	10.2	6.3	29.4	18.1	12.0	19.9	6.3	5.3	24.4	10.7	13.7	13.3	6.2	15.0	29.1	16.1	7.0	19.6	16.8	22.0	4.0	12.2	31.2	15.9	1.1	20.3	18.9	8.5	6.2	12.1	12.9	5.0	24.7	0.0	6.0	4.6	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	3.1	1.9	0.8	0.0	0.7	0.9	0.0	8.8	0.0	8.5	0.5	10.2	19.2	0.0	17.4	0.0	0.4	2.0	25.5	0.1	3.9	0.0	18.2	38.4	0.0	0.1	0.0	33.2	31.5	0.2	1.4	54.9	10.3	0.4	0.0	25.8	0.0	2.8	22.3	5.8	3.7	13.5	0.0	0.4	5.7	0.9	11.8	0.0	4.7	0.1	0.0	13.1	4.2	0.0	0.1	3.3	0.5	1.7	1.7	35.5	3.0	0.5	5.6	5.5	6.1	6.0	1.1	7.0	5.8	5.0	36.6	7.4	0.3	2.5	7.4	2.1	18.3	25.5	14.4	20.2	15.5	17.0	12.0	19.9	13.3	12.2	20.3	24.7	38.2	6.4	8.2	0.3	21.3	8.9	6.9	3.2	5.7	48.4	4.1	6.9	9.5	4.3	5.9	25.8	50.1	7.0	7.0	33.4	3.9	2.6	4.5	21.6	6.3	33.8	3.5	5.7	13.2	1.2	1.8	7.5	11.2	45.3	0.0	1.2	42.8	0.6	16.0	11.8	17.8	12.1	8.2	44.5	23.4	7.6	0.3	20.9	3.6	7.5	4.3	16.1	3.1	43.2	40.6	2.3	8.3	1.9	4.0	3.0	36.6	1.1	4.5	122.6	6.6	1.6	3.5	0.6	0.5	1.0	6.7	63.1	21.4	10.4	1.1	9.1
ABCG2	"ABCP, BCRP, CD338, EST157481, MXR"	ENSG00000118777	"ATP binding cassette subfamily G member 2 (Junior blood group)"	Q9UNQ0	4	88090150-88231628	"Cancer-related genes, CD markers, Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 88.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 106.7;Extravillous trophoblasts: 81.7;Hofbauer cells: 137.4;Microglial cells: 185.5;Proximal enterocytes: 216.6"	"Cancer enhanced"	"Detected in many"		"glioma: 9.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 43.5;BEWO: 75.8;MCF7: 26.2;OE19: 58.6;RPMI-8226: 38.9;SuSa: 26.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB037299, HPA054719"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	Nucleoplasm	"CAB037299: AB_476804, HPA054719: "	"unprognostic (5.04e-1)"	"unprognostic (3.05e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.01e-3)"	"unprognostic (9.19e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.01e-3)"	"unprognostic (4.52e-2)"	"unprognostic (1.67e-3)"	"unprognostic (8.82e-3)"	"unprognostic (7.04e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.92e-1)"	2.3	4.0	30.8	1.0	29.1	2.3	4.0	30.0	33.1	22.1	17.4	15.7	48.2	23.1	6.8	2.3	9.8	5.1	2.9	25.4	32.3	3.5	36.0	5.1	1.2	40.1	31.3	8.3	0.8	4.4	8.9	11.7	40.1	7.1	13.9	2.5	5.0	33.8	0.3	0.6	88.3	19.8	31.1	1.4	1.9	3.0	40.0	1.3	6.4	0.9	2.0	2.3	4.0	31.9	1.7	43.5	11.9	0.0	0.4	0.0	75.8	1.9	1.3	2.1	3.5	9.8	0.5	0.0	0.4	0.3	5.4	13.2	0.4	1.2	3.1	13.2	1.9	0.6	0.3	13.0	0.0	0.6	0.1	0.2	5.1	4.8	0.3	1.2	4.1	1.0	1.1	0.0	1.3	26.2	6.3	0.2	4.1	58.6	0.0	3.2	0.0	38.9	0.1	9.5	0.2	0.5	8.9	0.9	1.2	26.1	0.3	0.1	0.0	1.7	1.6	0.4	0.2	11.9	4.7	0.0	3.1	0.0	1.8	0.0	0.0	0.0	0.7	0.0	2.2	0.0	0.2	0.2	0.0	0.5	0.2	0.1	0.0	1.1	0.1	0.2	0.8	0.2	30.8	29.1	30.0	33.1	25.4	32.3	40.1	31.3	40.1	31.1	40.0	31.9	9.4	3.2	1.1	3.9	0.9	3.8	0.3	0.0	0.0	0.4	24.3	1.9	1.6	1.5	0.2	0.0	0.0	16.8	0.6	106.7	1.9	0.0	3.3	0.4	3.8	45.8	3.0	20.6	1.1	0.2	81.7	2.4	0.5	0.5	5.7	0.2	31.4	23.4	137.4	0.0	0.7	12.0	0.0	1.3	2.5	1.2	1.2	2.8	5.4	185.5	0.1	0.7	2.1	11.1	0.9	0.1	44.3	0.4	2.0	0.2	216.6	7.6	0.8	0.9	0.0	0.4	4.3	1.0	4.3	1.1	0.4	37.6	1.0	4.3	6.1	0.2
ABCG4	WHITE2	ENSG00000172350	"ATP binding cassette subfamily G member 4"	Q9H172	11	119149052-119162653	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"retina: 52.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 13.8;Cone photoreceptor cells: 58.4;Inhibitory neurons: 9.8;Rod photoreceptor cells: 46.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.9;HAP1: 1.0;U-2 OS: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057635	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA057635: "	"unprognostic (3.26e-2)"	"unprognostic (4.75e-4)"	"unprognostic (6.31e-2)"	"unprognostic (1.83e-3)"	"unprognostic (3.76e-2)"	"unprognostic (3.66e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.35e-2)"	"unprognostic (1.67e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.29e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.15e-4)"	"unprognostic (2.26e-1)"	"unprognostic (6.48e-3)"	"unprognostic (2.65e-3)"	0.3	0.4	4.0	0.1	4.4	0.0	0.1	7.5	11.3	0.4	0.0	0.3	0.2	0.5	0.3	0.9	0.2	0.3	0.8	4.2	5.8	0.4	0.1	0.1	0.0	6.9	3.9	0.1	0.3	1.8	0.3	0.1	6.8	0.3	0.1	52.0	0.2	0.6	0.1	0.3	0.2	0.4	1.5	0.1	0.2	5.8	6.2	2.9	0.8	0.2	0.5	0.1	0.6	5.6	0.1	0.4	0.4	1.9	0.2	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.2	0.0	0.8	0.1	1.0	0.1	0.2	0.1	0.3	0.3	0.0	0.0	0.6	0.0	0.5	0.1	0.0	0.3	0.0	0.2	0.4	0.9	0.0	0.0	0.3	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.1	0.1	0.0	0.1	0.1	1.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	4.4	7.5	11.3	4.2	5.8	6.9	3.9	6.8	1.5	6.2	5.6	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	0.9	0.0	0.0	0.0	58.4	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.2	0.5	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.1	6.7	9.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.0	0.0	2.2	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	0.0	0.0	0.3	2.7	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0
ABCG5	STSL	ENSG00000138075	"ATP binding cassette subfamily G member 5"	Q9H222	2	43812472-43838865	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	69	"intestine: 47.8;liver: 62.0"	"Group enriched"	"Detected in some"	6	"Hepatocytes: 60.3;Paneth cells: 23.9;Proximal enterocytes: 30.9"	"Cancer enriched"	"Detected in some"	23	"liver cancer: 11.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	54	"Hep G2: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.71e-1)"	"unprognostic (5.47e-2)"	"unprognostic (4.01e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.24e-1)"	"unprognostic (9.97e-2)"	"prognostic favorable (2.60e-5)"	"unprognostic (4.59e-2)"	"unprognostic (3.10e-1)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-4)"	"unprognostic (1.86e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.52e-3)"	"unprognostic (8.29e-2)"	"unprognostic (5.31e-2)"	"unprognostic (3.08e-2)"	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	47.8	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.2	0.0	62.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.3	0.1	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.6	5.7	0.0	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	0.1	0.6	0.1	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.7	60.3	0.0	0.0	3.2	2.5	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	1.8	0.0	23.9	0.0	0.0	0.0	30.9	0.0	0.0	0.7	0.0	0.2	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.7	0.0
ABCG8	GBD4	ENSG00000143921	"ATP binding cassette subfamily G member 8"	Q9H221	2	43831942-43882988	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	40	"intestine: 31.5;liver: 63.4"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 32.0;Proximal enterocytes: 13.8"	"Cancer enriched"	"Detected in some"	30	"liver cancer: 21.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	44	"Hep G2: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA019556	Uncertain		Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Vesicles		"HPA019556: AB_1844444"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-1)"	"unprognostic (3.22e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.99e-3)"	"unprognostic (1.27e-1)"	"unprognostic (6.28e-1)"	"unprognostic (6.14e-3)"	"unprognostic (4.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.86e-3)"	"unprognostic (5.03e-1)"		"unprognostic (1.50e-1)"	0.1	0.0	0.4	0.1	0.3	0.1	0.0	0.2	1.1	0.0	0.0	0.2	29.8	0.1	0.0	0.0	0.2	0.9	0.0	0.2	0.4	0.3	63.4	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.0	0.1	31.5	0.0	0.0	0.1	0.3	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	1.1	0.2	0.4	0.3	0.1	0.4	0.0	0.7	0.7	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	2.8	0.6	1.8	0.0	0.0	0.1	0.0	1.9	0.1	0.0	0.2	0.7	0.6	0.0	2.7	3.6	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.4	32.0	0.0	0.0	2.8	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.0	5.0	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	1.2	0.0
ABHD17A	"C19orf27, FAM108A1, MGC5244"	ENSG00000129968	"Abhydrolase domain containing 17A, depalmitoylase"	Q96GS6	19	1876810-1885496	"Enzymes, Predicted intracellular proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 338.2;NK-cells: 383.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 90.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043270, HPA047226, HPA069225"	Uncertain		Approved	"Nuclear speckles,Vesicles"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Nuclear speckles"	"HPA043270: AB_2678401, HPA047226: AB_2679991, HPA069225: "	"unprognostic (3.77e-2)"	"unprognostic (1.85e-1)"	"unprognostic (3.57e-2)"	"prognostic favorable (1.73e-4)"	"unprognostic (3.70e-2)"	"prognostic favorable (6.46e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.92e-2)"	"unprognostic (5.09e-1)"	"unprognostic (1.44e-1)"	"prognostic favorable (1.76e-5)"	"unprognostic (1.29e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.60e-2)"	49.8	51.5	61.3	8.8	50.0	13.4	44.1	53.0	104.9	43.9	16.0	50.3	13.6	46.5	2.1	63.6	42.3	4.1	79.9	70.8	36.6	47.3	42.9	52.7	10.7	66.9	54.2	41.7	42.9	7.5	45.1	11.6	60.6	52.5	2.0	1.9	40.4	8.2	56.9	73.3	41.8	3.2	56.3	69.3	45.4	33.4	61.4	8.6	43.0	10.7	3.9	45.3	45.9	56.9	43.0	14.7	6.0	16.7	7.8	9.6	32.5	28.6	8.8	8.4	7.7	7.4	7.5	21.1	11.3	8.3	1.9	26.9	3.0	11.8	1.2	48.9	61.8	15.9	6.7	19.2	10.7	16.4	50.9	10.5	8.8	4.9	3.4	5.5	16.2	20.6	27.6	23.9	6.1	24.1	28.3	31.0	31.2	8.3	32.3	32.8	14.3	32.0	5.9	9.4	19.4	43.9	14.8	16.0	29.8	2.4	16.6	28.3	31.3	9.4	21.4	38.1	28.3	90.8	58.8	18.2	20.6	21.0	15.5	1.6	1.0	4.2	5.2	0.6	3.8	3.7	2.3	3.5	1.0	1.4	2.5	2.7	1.1	3.1	0.6	1.0	2.4	0.9	61.3	50.0	53.0	104.9	70.8	36.6	66.9	54.2	60.6	56.3	61.4	56.9	125.3	3.2	5.8	13.4	35.6	32.2	21.5	10.4	12.5	41.2	43.9	35.6	4.0	24.3	12.1	14.7	39.6	77.8	338.2	61.8	9.8	31.0	6.4	28.4	43.7	67.6	30.5	22.3	12.8	37.8	43.2	29.8	29.6	37.8	10.2	31.6	65.0	21.5	66.3	55.5	12.5	34.9	12.2	36.1	28.7	6.4	30.1	42.8	26.6	19.7	35.0	66.0	383.1	5.0	63.1	42.7	31.9	36.5	58.7	25.9	38.6	19.5	7.5	35.5	13.1	31.0	44.1	16.3	20.7	21.2	45.9	65.7	117.1	66.1	34.0	32.3
ACBD5	"DKFZp434A2417, KIAA1996"	ENSG00000107897	"Acyl-CoA binding domain containing 5"	Q5T8D3	10	27168135-27243046	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Transport"		Leukodystrophy	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011861, HPA012145"	Enhanced		Enhanced	Peroxisomes		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	Peroxisomes		"HPA011861: AB_1844493, HPA012145: AB_1844494"	"prognostic unfavorable (3.33e-4)"	"unprognostic (4.93e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.98e-3)"	"unprognostic (9.87e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.46e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (7.91e-3)"	"unprognostic (1.71e-1)"	"unprognostic (3.63e-2)"	"unprognostic (3.37e-3)"	14.6	25.1	31.0	13.5	37.0	18.2	12.3	36.2	37.1	13.2	24.2	20.3	39.8	9.4	9.7	12.0	12.0	15.4	40.4	27.6	33.1	37.3	73.8	14.7	14.7	37.2	34.0	9.9	11.1	31.2	6.4	13.4	38.1	15.2	20.9	36.2	10.3	11.4	31.0	17.3	39.2	8.8	36.7	14.7	21.0	19.3	36.1	12.2	27.8	36.6	12.7	13.5	7.5	38.8	25.8	76.5	17.1	18.0	19.1	17.3	20.1	32.3	12.1	28.1	33.5	19.4	39.9	10.7	27.0	22.4	23.4	21.1	23.2	16.3	23.0	26.2	23.9	16.5	23.1	15.2	20.6	11.0	20.9	16.7	17.7	23.5	12.8	24.9	20.5	16.7	13.6	19.5	35.7	20.0	21.1	9.4	13.1	35.2	10.0	17.4	42.5	20.2	44.1	22.4	21.3	45.5	35.4	38.3	17.9	18.9	18.8	11.5	30.4	27.2	15.2	43.7	25.9	19.4	28.1	20.7	27.4	24.6	12.0	12.5	13.0	10.2	15.3	12.7	15.2	6.4	7.5	12.4	13.0	7.0	5.0	11.0	11.1	10.3	15.1	8.5	7.4	8.0	31.0	37.0	36.2	37.1	27.6	33.1	37.2	34.0	38.1	36.7	36.1	38.8	23.3	25.6	29.9	17.9	16.0	9.7	4.1	14.5	7.4	30.8	14.5	10.8	83.0	15.7	25.2	31.3	25.0	9.6	27.4	22.4	33.2	22.1	43.1	33.7	20.2	18.7	10.2	8.6	20.6	16.2	12.6	16.4	19.4	41.1	12.6	11.5	12.8	56.9	19.0	23.5	26.9	30.4	10.2	25.5	12.5	16.9	16.4	22.4	21.4	15.9	22.4	47.7	29.9	17.6	24.8	17.8	26.1	16.6	14.2	11.7	64.4	48.2	32.7	47.2	19.7	20.9	16.1	41.0	8.3	16.5	15.5	10.4	22.3	27.1	26.5	9.2
ACE2		ENSG00000130234	"Angiotensin I converting enzyme 2"	Q9BYF1	X	15494566-15607236	"Enzymes, Metabolic proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	"Carboxypeptidase, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 65.5;intestine: 242.2;kidney: 87.6"	"Cell type enriched"	"Detected in many"	5	"Proximal enterocytes: 294.8"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 13.9;renal cancer: 26.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NB-4: 1.2;NTERA-2: 1.2;SuSa: 1.9"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA000288, CAB026174, CAB026213, CAB080024, CAB080025, CAB080027, CAB080028"	Enhanced				"Secreted to blood"	NA	NA		400000		"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 45: Enterocytes - Digestion"			"CAB026174: , CAB026213: , CAB080024: AB_10864415, CAB080025: AB_2809589, CAB080027: AB_2665870, CAB080028: AB_2665871, HPA000288: AB_1078160"	"unprognostic (1.40e-1)"	"unprognostic (7.26e-2)"	"unprognostic (2.76e-2)"	"unprognostic (5.71e-2)"	"unprognostic (2.51e-1)"	"unprognostic (5.26e-2)"	"prognostic favorable (4.21e-4)"	"unprognostic (2.34e-2)"	"unprognostic (6.74e-3)"	"unprognostic (2.54e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (2.12e-5)"	"unprognostic (1.94e-1)"	"unprognostic (9.62e-2)"	"unprognostic (2.11e-1)"	"unprognostic (7.10e-2)"	8.9	0.5	0.1	1.4	0.1	0.6	4.3	0.4	0.3	0.6	1.9	9.9	183.3	0.5	0.5	1.8	1.5	65.5	42.7	0.2	0.2	87.6	5.7	0.8	0.4	0.2	0.2	1.8	2.5	1.5	0.1	1.2	0.2	0.4	5.9	0.3	1.4	4.1	0.7	0.3	242.2	0.5	0.1	0.1	2.6	49.7	0.2	0.5	4.5	0.5	0.2	0.8	1.2	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.8	0.1	0.0	0.2	0.2	0.2	0.3	0.4	0.3	0.0	0.3	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.5	1.2	1.2	0.0	0.0	0.3	0.2	0.5	0.2	0.4	0.2	0.9	0.0	0.4	0.0	1.9	0.4	0.4	0.1	0.0	0.0	0.3	0.4	0.1	0.5	0.5	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.3	0.2	0.2	0.2	0.2	0.2	0.1	0.2	0.2	0.4	0.0	0.5	1.3	1.4	0.1	0.5	5.0	0.0	0.0	1.6	0.0	11.2	55.8	2.6	0.0	0.0	4.2	0.1	22.9	3.9	1.2	0.5	1.1	0.3	1.0	7.2	0.0	0.8	0.8	0.3	4.6	0.0	0.6	0.0	3.9	0.0	0.9	0.8	0.0	0.8	8.2	0.0	0.0	0.0	1.4	8.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.9	5.1	6.0	0.0	1.0	294.8	48.8	2.0	0.0	19.7	0.0	8.9	1.1	1.0	0.0	0.1	12.7	0.3	0.1	10.6	2.2
ACIN1	"ACINUS, fSAP152, KIAA0670"	ENSG00000100813	"Apoptotic chromatin condensation inducer 1"	Q9UKV3	14	23058564-23095614	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, mRNA processing, mRNA splicing"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA000657	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		30000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA000657: AB_1078091"	"unprognostic (2.54e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.89e-3)"	"prognostic unfavorable (4.88e-5)"	"unprognostic (1.49e-3)"	"unprognostic (9.70e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.00e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.35e-3)"	"unprognostic (4.34e-2)"	"unprognostic (2.78e-2)"	"unprognostic (2.28e-2)"	"unprognostic (7.33e-2)"	41.5	57.7	58.3	35.0	60.2	66.7	36.6	64.3	64.6	46.1	62.7	42.6	28.6	41.5	30.1	50.9	39.3	24.3	44.1	57.5	63.4	51.3	47.5	33.8	45.2	60.9	60.6	48.7	45.1	41.4	48.5	37.2	59.9	45.8	33.2	39.0	39.1	27.8	53.0	39.5	46.0	38.9	55.7	66.4	45.3	47.6	61.6	52.8	47.1	36.5	47.4	41.9	41.3	64.4	77.1	77.6	120.0	97.7	73.3	58.5	120.2	83.8	58.8	98.9	80.0	103.8	87.8	141.8	48.4	69.7	65.0	82.6	167.4	95.6	100.7	100.2	74.3	124.5	82.9	144.8	41.8	136.6	106.4	69.0	58.0	101.5	84.8	81.0	87.9	103.4	117.2	55.1	75.7	96.5	156.1	134.6	135.1	84.6	73.3	139.7	93.0	75.8	82.9	133.3	79.7	58.6	111.2	71.7	69.1	86.7	59.2	109.0	90.7	67.3	67.3	64.7	78.5	57.9	70.2	144.0	59.9	101.8	74.8	5.3	4.0	5.1	4.2	3.5	3.2	3.8	2.9	3.2	3.4	5.4	3.8	3.7	10.8	7.5	3.2	5.5	3.5	2.6	58.3	60.2	64.3	64.6	57.5	63.4	60.9	60.6	59.9	55.7	61.6	64.4	49.8	70.5	123.0	44.4	61.6	37.3	30.2	52.7	64.9	38.1	43.4	40.8	67.9	32.9	67.2	35.0	27.1	58.0	65.0	64.4	17.6	53.4	42.5	70.5	97.6	55.5	58.3	76.2	41.0	49.3	66.8	60.3	85.1	90.1	130.6	79.4	35.0	28.8	47.1	15.2	43.6	50.1	42.7	38.1	40.8	10.9	46.0	52.5	26.6	44.0	53.4	26.1	54.6	45.8	65.6	59.4	49.7	38.4	65.4	43.5	37.7	21.6	82.6	43.3	6.6	52.4	66.9	42.1	39.2	58.5	46.5	69.2	65.2	86.1	55.8	38.4
ACOT12	"Cach, STARD15, THEAL"	ENSG00000172497	"Acyl-CoA thioesterase 12"	Q8WYK0	5	81329996-81394179	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Hydrolase, Serine esterase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	36	"liver: 100.7"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 36.2"	"Cancer enriched"	"Detected in single"	76	"liver cancer: 13.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA037723			Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA				"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Nucleoplasm, Cytokinetic bridge"	"HPA037723: AB_10672606"	"unprognostic (6.06e-2)"				"unprognostic (1.39e-1)"		"prognostic favorable (5.30e-4)"		"unprognostic (7.68e-2)"	"unprognostic (8.22e-2)"	"unprognostic (5.68e-3)"	"unprognostic (2.46e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.06e-1)"		0.0	0.0	0.6	0.0	0.7	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.5	2.7	100.7	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.0	0.5	0.3	0.5	0.3	0.3	0.6	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	8.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	36.2	0.5	0.0	1.2	0.0	0.0	1.4	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.4	0.0	0.0	3.4	4.2	0.0	0.0	0.0	0.4	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0
ACTN2		ENSG00000077522	"Actinin alpha 2"	P35609	1	236664141-236764631	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	53	"heart muscle: 772.7;skeletal muscle: 2134.7;tongue: 1262.2"	"Cell type enriched"	"Detected in some"	11	"Cardiomyocytes: 1762.9"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 10.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 2.0;HEK 293: 1.3;HSkMC: 5.9;hTEC/SVTERT24-B: 2.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 66.6"	"Region enhanced"	"Detected in all"		"basal ganglia: 44.5"	"HPA006035, HPA008315"	Enhanced		Uncertain	"Actin filaments"		NA	NA		25000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Actin filaments"		"HPA006035: AB_1078095, HPA008315: AB_1844543"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.91e-1)"	"unprognostic (4.32e-3)"	"unprognostic (7.85e-2)"	"unprognostic (2.97e-3)"	"unprognostic (2.17e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.97e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.71e-11)"	"unprognostic (1.30e-2)"	"unprognostic (1.10e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.22e-1)"	0.7	0.2	12.0	0.0	26.3	0.1	0.9	8.0	20.1	0.3	11.0	0.4	0.0	0.5	0.0	21.8	0.5	0.7	772.7	13.2	12.1	0.5	0.3	3.9	0.2	9.7	8.1	1.1	1.6	0.1	0.5	0.1	10.7	16.1	0.0	1.3	18.4	0.1	2134.7	1.3	0.5	1.8	8.0	0.2	3.8	4.2	8.7	0.5	0.7	1262.2	0.1	3.5	0.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.1	1.3	0.0	0.0	0.2	0.0	0.0	0.2	5.9	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	26.3	8.0	20.1	13.2	12.1	9.7	8.1	10.7	8.0	8.7	14.2	0.3	0.0	0.6	18.6	0.0	0.3	0.4	0.0	1.2	2.6	0.4	0.5	1762.9	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	8.6	0.5	1.2	10.4	0.0	0.0	40.9	0.7	0.0	43.7	3.6	1.4	0.0	0.1	1.8	0.2	0.1	0.0	11.3	0.0	0.0	0.0	0.3	24.6	0.6	1.2	0.0	11.2	0.0	0.0	0.0	24.6	156.9	0.2	0.0	0.4	0.0	0.2	0.0	1.4	0.0	1.2	0.0	66.3	12.4	3.1	2.0	1.2	0.1	0.0	0.4	0.4	0.0	0.2
ADAM10	"CD156C, HsT18717, kuz, MADM"	ENSG00000137845	"ADAM metallopeptidase domain 10"	O14672	15	58588809-58749791	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 377.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 296.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001709, HPA050670"	Approved		Supported	"Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		690000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"CAB001709: , HPA050670: "	"unprognostic (1.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.77e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.70e-3)"	"unprognostic (7.48e-2)"	"prognostic unfavorable (8.46e-5)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (1.90e-4)"	"unprognostic (6.69e-2)"	"unprognostic (2.57e-2)"	"unprognostic (2.57e-3)"	"unprognostic (9.14e-2)"	"unprognostic (2.09e-2)"	"unprognostic (1.60e-2)"	14.9	8.7	11.4	19.0	18.6	18.7	15.2	20.2	15.0	16.0	9.7	22.2	15.9	16.3	7.7	15.4	13.9	18.9	12.1	12.2	12.7	18.0	16.1	21.0	22.2	18.2	17.6	14.1	8.8	7.9	8.2	29.0	17.5	25.2	17.2	10.8	9.3	12.2	6.1	16.9	17.5	13.3	13.7	29.0	20.3	8.5	15.5	42.7	28.6	7.1	16.4	28.0	10.4	25.2	48.4	88.5	27.6	31.2	34.8	49.8	70.0	39.0	116.0	28.6	39.1	39.9	62.6	22.7	118.0	35.2	49.2	95.9	16.8	43.5	37.0	30.1	19.3	38.7	35.1	42.1	40.8	25.0	103.8	44.4	30.0	19.9	29.2	41.1	55.6	45.0	24.5	57.9	50.4	15.4	89.5	32.0	40.2	15.4	14.6	36.4	91.6	57.1	66.6	121.4	29.9	20.3	44.0	52.8	73.1	60.0	30.4	55.0	41.4	37.1	41.2	296.6	39.6	30.7	70.7	23.5	54.1	50.8	67.3	30.9	36.2	19.2	12.8	41.1	19.2	8.3	12.7	11.6	23.6	9.6	12.7	10.8	51.5	17.7	48.6	10.2	18.2	25.8	11.4	18.6	20.2	15.0	12.2	12.7	18.2	17.6	17.5	13.7	15.5	25.2	60.1	83.3	50.8	83.2	37.9	26.6	30.7	33.3	33.0	22.7	61.6	30.9	40.0	30.0	46.7	80.9	27.1	35.6	69.4	79.0	1.9	56.0	21.2	39.5	56.4	72.5	36.1	20.8	106.1	31.8	57.8	36.1	53.0	74.0	30.3	31.5	71.4	36.2	63.8	45.4	96.2	43.6	36.7	90.1	28.9	19.4	18.0	77.9	46.2	147.1	69.0	30.6	44.3	75.9	377.6	48.9	48.1	17.0	51.0	89.1	45.1	23.7	41.2	33.4	13.1	34.4	42.8	20.3	17.8	39.5	22.3	26.5	51.3	34.1	39.5	83.9
ADAM11	MDC	ENSG00000073670	"ADAM metallopeptidase domain 11"	O75078	17	44758988-44781846	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 36.6;heart muscle: 11.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.7;Bipolar cells: 11.8;Cardiomyocytes: 18.0;Excitatory neurons: 47.1;Horizontal cells: 23.5;Inhibitory neurons: 23.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HEK 293: 19.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074550	Enhanced					NA	NA		23000		"Cluster 6: Brain - Smell perception"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA074550: AB_2732259"	"unprognostic (1.79e-1)"	"unprognostic (7.78e-2)"	"unprognostic (1.73e-3)"	"unprognostic (2.59e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.50e-1)"	"unprognostic (3.14e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.37e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.46e-3)"	"unprognostic (7.16e-2)"	"unprognostic (9.99e-16)"	"unprognostic (1.39e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.00e-1)"	0.5	0.2	11.9	0.0	16.6	0.2	0.6	23.9	36.6	1.6	0.0	2.5	0.1	3.2	0.2	0.5	1.6	0.4	11.1	18.4	3.5	0.3	0.2	0.3	0.1	9.4	6.0	1.4	0.2	0.0	1.8	0.0	10.2	1.4	0.0	2.7	0.3	0.8	0.2	1.0	0.6	1.0	0.3	0.2	0.8	4.1	14.0	0.3	0.3	0.0	0.0	0.9	0.9	17.8	0.0	1.3	0.5	4.4	0.2	0.0	0.3	0.1	0.0	1.2	0.3	0.7	0.2	0.1	0.3	0.0	1.9	0.0	3.3	0.0	0.4	1.4	19.7	0.1	0.4	0.3	0.1	0.0	2.3	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.4	0.3	0.1	4.2	0.0	2.3	0.7	1.5	1.2	2.7	0.0	0.3	0.0	0.1	3.2	1.7	0.0	0.1	1.0	0.3	1.3	0.7	0.0	0.5	1.4	1.5	0.4	0.7	0.1	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.9	16.6	23.9	36.6	18.4	3.5	9.4	6.0	10.2	0.3	14.0	17.8	0.2	0.0	0.0	10.7	0.1	0.0	0.2	0.2	0.0	11.8	0.3	0.3	18.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	1.5	0.2	1.4	0.4	0.0	0.0	47.1	0.0	0.0	1.9	0.0	0.2	0.0	0.6	0.0	0.2	0.1	23.5	23.0	0.0	0.0	0.0	0.0	3.0	0.0	0.1	0.0	4.7	0.0	2.2	1.0	3.0	4.2	0.1	0.0	1.5	0.1	0.0	0.0	0.1	0.1	3.5	0.0	0.3	1.3	0.7	0.6	0.0	0.0	0.1	0.1	0.4	0.0	0.0
ADAM12	"MCMPMltna, MLTN"	ENSG00000148848	"ADAM metallopeptidase domain 12"	O43184	10	126012381-126388455	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"placenta: 166.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 102.2;Extravillous trophoblasts: 400.8;Oligodendrocyte precursor cells: 99.0;Syncytiotrophoblasts: 129.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"MAIT T-cell: 6.1"	"Lineage enriched"	"Detected in single"	62	"T-cells: 6.1"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 154.2;hTEC/SVTERT24-B: 94.3;U-2197: 93.2;U-251 MG: 86.2;U-87 MG: 70.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA030866, HPA030867, HPA030868"	Enhanced		Supported	"Plasma membrane"	"Secreted in female reproductive system"	NA	NA		14000000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 18: U-2197 - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"		"HPA030866: AB_2673636, HPA030867: AB_10602428, HPA030868: AB_2673638"	"unprognostic (3.35e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.34e-2)"	"unprognostic (2.16e-1)"	"unprognostic (2.91e-6)"	"unprognostic (2.17e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.53e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.39e-14)"	"unprognostic (3.11e-3)"	"unprognostic (9.06e-3)"	"unprognostic (4.70e-3)"	"unprognostic (3.47e-3)"	11.4	0.1	2.0	6.0	4.0	0.1	4.6	1.6	2.1	18.2	3.5	0.4	0.2	6.3	0.0	0.4	0.2	11.8	0.7	1.0	2.5	1.0	0.2	1.3	3.2	6.0	2.7	8.8	0.5	0.1	1.1	166.5	3.1	0.3	0.6	0.3	1.1	0.0	0.1	0.4	0.5	4.3	1.8	1.6	0.5	0.9	10.4	1.8	0.3	0.0	3.5	11.6	0.5	3.0	16.8	2.5	6.5	0.1	18.7	38.3	0.0	42.7	3.5	14.2	35.5	0.0	0.0	0.0	0.0	154.2	30.0	0.0	0.2	1.4	15.5	1.9	0.6	0.2	25.1	0.0	2.9	0.0	33.2	47.0	0.0	94.3	2.9	27.1	0.0	0.0	0.0	0.2	11.8	0.0	0.0	0.0	0.1	0.0	2.8	0.0	4.8	4.4	0.4	44.1	0.5	28.4	5.0	0.0	0.7	2.5	0.1	0.1	0.0	50.9	16.9	93.2	86.2	0.0	0.5	0.0	70.7	0.1	32.3	0.0	0.0	0.0	0.3	0.0	6.1	0.0	0.2	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	2.0	4.0	1.6	2.1	1.0	2.5	6.0	2.7	3.1	1.8	10.4	3.0	0.5	0.0	1.9	22.5	0.3	1.5	0.4	3.0	0.0	2.1	1.7	3.6	2.3	0.0	0.5	0.0	102.2	14.0	0.5	0.7	0.0	8.0	10.9	10.7	16.6	1.6	0.0	0.0	7.4	1.1	400.8	34.5	0.5	1.8	49.5	7.8	2.5	0.2	15.5	6.7	19.0	1.0	4.1	0.6	3.1	1.7	16.8	0.8	1.8	14.0	9.0	3.3	1.0	99.0	52.2	2.2	0.1	0.7	0.3	1.0	0.7	0.4	6.5	30.5	0.0	5.1	13.4	6.0	5.0	0.0	0.6	129.2	4.7	28.1	0.9	0.5
ADAM17	"CD156B, cSVP, TACE"	ENSG00000151694	"ADAM metallopeptidase domain 17"	P78536	2	9488486-9556732	"CD markers, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Suprabasal keratinocytes: 154.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010738, HPA051575"	Approved		Supported	Cytosol		NA	NA		300000	"Cluster 7: Monocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	Cytosol		"HPA010738: AB_1078100, HPA051575: AB_2681539"	"unprognostic (2.28e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.28e-1)"	"unprognostic (3.51e-3)"	"unprognostic (1.57e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.12e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.53e-3)"	"unprognostic (3.13e-1)"	"unprognostic (3.82e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (4.23e-5)"	10.3	5.5	8.7	9.1	8.6	5.8	10.4	7.8	10.6	8.7	9.5	5.4	4.1	7.2	11.4	10.0	6.5	9.0	6.7	8.6	9.4	4.7	4.6	14.6	8.5	9.7	8.3	8.9	4.1	7.9	4.2	20.1	9.4	4.0	6.8	4.5	6.2	6.3	6.9	11.1	6.1	8.6	8.3	9.3	5.1	9.9	9.1	9.6	6.6	6.8	12.7	10.4	7.1	10.4	10.0	18.2	23.2	25.9	45.9	34.7	45.4	8.6	25.4	16.1	24.6	19.2	31.6	33.4	18.1	18.8	42.1	21.9	16.4	29.4	22.6	8.4	12.1	15.8	14.7	13.9	68.0	20.7	17.8	41.2	32.2	25.1	47.5	26.6	46.0	8.7	30.0	12.3	17.3	8.7	8.5	23.4	19.2	13.7	4.6	14.3	21.6	20.5	25.8	18.7	11.7	28.6	14.9	16.5	30.1	27.0	6.6	19.4	29.0	25.5	12.0	19.1	22.1	15.1	17.5	29.6	20.2	11.1	31.1	5.0	3.7	2.8	1.0	3.7	1.9	1.7	0.9	1.1	2.3	0.9	0.9	1.0	5.5	1.2	2.5	0.7	1.1	0.9	8.7	8.6	7.8	10.6	8.6	9.4	9.7	8.3	9.4	8.3	9.1	10.4	53.8	48.1	66.9	19.6	34.5	130.0	48.2	37.0	19.9	25.2	40.8	26.4	3.6	27.1	38.8	31.3	54.2	29.8	37.7	20.7	5.9	23.7	72.1	30.0	32.0	45.1	19.7	16.8	66.7	19.4	45.1	44.1	13.7	51.5	30.9	31.3	41.4	13.5	34.6	10.1	46.2	13.8	12.2	80.4	84.5	16.0	19.0	76.9	40.9	42.2	40.3	12.9	16.5	26.7	41.5	20.9	18.3	16.1	23.2	57.2	12.9	7.0	37.2	41.4	39.5	79.4	27.3	35.7	35.2	33.7	154.7	56.0	30.1	17.7	15.4	104.3
ADAM28	"ADAM23, eMDCII, MDC-Lm, MDC-Ls"	ENSG00000042980	"ADAM metallopeptidase domain 28"	Q9UKQ2	8	24294069-24359014	"Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"epididymis: 357.5;stomach 1: 110.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 240.9;Club cells: 62.9;Gastric mucus-secreting cells: 141.7;Microglial cells: 233.3"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 71.6;naive B-cell: 87.0"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 27.8;OE19: 8.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA074034	Enhanced		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"	Mitochondria	"HPA074034: AB_2686654"	"unprognostic (4.23e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (3.17e-4)"	"unprognostic (2.89e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.77e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.62e-1)"	2.2	2.2	5.9	24.7	4.6	9.3	3.9	7.1	5.0	16.1	4.0	14.3	8.8	6.9	357.5	2.8	12.3	40.2	1.0	5.8	8.8	5.1	1.2	3.9	26.7	12.0	9.3	2.3	3.5	1.1	18.5	3.7	11.7	5.3	12.1	1.3	15.9	5.7	0.3	3.3	24.7	2.9	9.8	19.9	110.3	0.7	10.1	5.1	1.9	0.4	32.3	11.3	1.7	18.6	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.1	0.2	0.0	0.0	1.1	27.8	0.3	0.8	0.0	0.9	0.1	0.0	0.8	0.1	0.1	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.7	0.7	8.8	0.1	0.1	0.0	0.4	0.6	0.8	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.3	0.1	0.1	1.2	2.5	0.1	2.1	1.0	0.2	42.4	2.5	18.5	0.0	0.6	0.0	71.6	0.1	0.0	21.0	87.0	0.1	0.0	4.3	2.7	0.2	1.1	0.1	2.5	5.9	4.6	7.1	5.0	5.8	8.8	12.0	9.3	11.7	9.8	10.1	18.6	1.5	3.2	6.0	0.7	240.9	0.9	3.0	36.9	0.0	0.1	2.3	2.2	2.0	28.6	62.9	3.7	0.0	0.4	9.9	0.7	0.0	7.9	1.3	7.6	1.0	3.7	0.0	8.2	4.3	3.5	8.7	3.9	141.7	18.4	2.5	0.0	0.0	0.0	9.4	0.0	2.7	0.4	28.5	12.3	30.9	1.8	0.6	46.4	5.4	233.3	7.8	0.1	23.7	3.5	1.6	55.7	0.1	0.4	43.3	1.5	0.6	4.4	13.1	0.1	6.6	0.0	1.1	0.4	0.2	0.7	0.6	0.5	9.0	6.4	1.3	7.6
ADAMTS1	"C3-C5, KIAA1346, METH1"	ENSG00000154734	"ADAM metallopeptidase with thrombospondin type 1 motif 1"	Q9UHI8	21	26835755-26845409	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Heparin-binding, Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 314.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 365.2;Endometrial stromal cells: 235.3;Endothelial cells: 275.9;Extravillous trophoblasts: 240.8;Fibroblasts: 243.9;Sertoli cells: 210.4;Smooth muscle cells: 452.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"gdT-cell: 4.5;NK-cell: 6.6"	"Group enriched"	"Detected in many"	56	"NK-cells: 6.6;T-cells: 4.5"	"Cell line enhanced"	"Detected in many"		"ASC diff: 382.0;BJ: 451.4;hTEC/SVTERT24-B: 250.0;hTERT-HME1: 248.2;LHCN-M2: 295.3;RPTEC TERT1: 343.9"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"spinal cord: 35.6"	"CAB016394, HPA031498"	Approved		Approved	"Plasma membrane"	"Secreted to extracellular matrix"	NA	NA		4100000	"Cluster 40: NK-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"		"CAB016394: AB_626637, HPA031498: AB_2673907"	"unprognostic (6.82e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.18e-2)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.55e-2)"	"unprognostic (9.70e-3)"	"unprognostic (8.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.76e-2)"	"unprognostic (1.57e-1)"	234.6	46.4	22.2	71.3	24.9	1.4	94.1	20.8	28.9	87.4	22.3	54.6	8.7	97.1	9.0	82.6	161.2	111.8	95.9	21.5	23.5	76.0	39.0	79.7	10.1	24.8	25.5	314.4	29.4	18.5	25.5	245.1	25.2	88.2	59.3	15.6	19.2	13.9	48.9	21.9	44.6	162.6	25.3	13.9	56.0	8.2	26.4	12.2	50.1	40.3	5.4	143.1	50.6	30.5	0.1	0.0	6.8	0.1	382.0	104.9	21.8	451.4	199.6	90.4	61.1	0.0	0.0	0.0	29.5	120.1	2.0	9.2	4.6	23.6	150.0	0.4	120.3	0.0	29.7	0.1	85.6	15.5	0.0	103.0	0.3	250.0	248.2	15.1	35.4	3.7	7.3	0.0	295.3	0.0	1.7	0.3	21.9	0.0	14.5	0.0	151.6	0.6	343.9	25.1	0.2	32.7	21.4	0.0	2.2	16.0	0.2	3.8	34.9	99.6	4.3	156.0	63.1	0.5	0.0	0.0	80.8	0.5	29.7	0.0	0.0	0.0	4.5	0.0	0.5	0.0	0.2	0.4	0.0	0.0	0.1	0.7	0.0	6.6	0.0	0.0	0.0	0.8	22.2	24.9	20.8	28.9	21.5	23.5	24.8	25.5	25.2	25.3	26.4	30.5	365.2	6.4	22.4	2.9	0.5	121.2	32.5	10.4	53.5	0.6	13.9	54.9	179.5	12.8	9.6	57.0	0.0	71.1	13.1	0.2	1.9	47.4	1.4	86.5	235.3	275.9	0.0	0.4	3.2	22.3	240.8	243.9	11.7	148.2	2.5	0.3	157.8	2.2	16.5	0.0	3.3	0.2	2.0	5.0	38.5	4.4	109.0	5.8	53.4	7.5	0.6	52.2	20.6	2.0	19.9	20.6	0.0	41.8	3.6	26.3	0.0	6.3	3.3	3.3	210.4	91.0	452.4	0.4	1.0	22.8	41.6	54.9	10.1	8.8	0.0	16.8
ADAMTS4	"ADAMTS-2, ADMP-1, KIAA0688"	ENSG00000158859	"ADAM metallopeptidase with thrombospondin type 1 motif 4"	O75173	1	161184302-161199054	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 116.8;ovary: 95.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 80.3;Endothelial cells: 115.5;Fibroblasts: 88.8;Oligodendrocytes: 56.0;Sertoli cells: 52.6;Smooth muscle cells: 313.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	8	"plasmacytoid DC: 4.4"	"Lineage enriched"	"Detected in single"	8	"dendritic cells: 4.4"	"Cell line enhanced"	"Detected in some"		"hTEC/SVTERT24-B: 11.8;HUVEC TERT2: 14.4;SH-SY5Y: 7.9;TIME: 12.2;U-138 MG: 7.4;U-251 MG: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025876, HPA051296, HPA068374"	Uncertain		Supported	"Nuclear speckles"	"Secreted to extracellular matrix"	NA	NA		11000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear speckles"		"CAB025876: , HPA051296: AB_2681426, HPA068374: AB_2685978"	"unprognostic (2.70e-2)"	"unprognostic (8.10e-3)"	"unprognostic (3.00e-3)"	"unprognostic (2.75e-1)"	"unprognostic (9.95e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.20e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.48e-2)"	"unprognostic (1.59e-1)"	"prognostic unfavorable (7.27e-7)"	"unprognostic (1.10e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.44e-3)"	"unprognostic (3.13e-2)"	116.8	9.8	6.1	16.3	31.5	0.7	43.4	31.1	19.2	16.4	5.8	18.2	0.8	15.0	0.2	6.2	34.6	14.3	53.6	8.1	15.2	26.0	8.7	50.3	1.6	38.2	29.6	95.9	9.0	2.1	13.0	3.2	31.6	16.9	2.0	1.5	5.2	0.5	13.3	5.0	9.4	10.5	28.3	1.8	22.8	1.8	26.2	1.1	21.3	0.4	0.3	31.8	12.2	48.0	0.0	0.0	0.2	0.1	6.4	4.0	0.6	5.4	0.2	0.5	3.0	0.2	0.2	0.2	4.4	1.7	0.0	0.1	0.0	0.0	1.9	0.1	0.3	0.2	0.5	1.3	0.6	0.0	0.1	4.5	0.0	11.8	0.1	0.0	14.4	0.1	0.2	0.3	0.4	0.1	0.0	0.2	5.3	0.0	0.0	0.1	5.1	0.1	0.0	0.1	0.1	7.9	0.0	0.1	0.1	0.3	0.2	0.5	12.2	7.4	0.1	0.4	10.8	0.2	0.1	0.1	2.2	0.1	0.1	0.5	0.1	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.0	4.4	0.2	0.1	6.1	31.5	31.1	19.2	8.1	15.2	38.2	29.6	31.6	28.3	26.2	48.0	80.3	0.0	4.1	0.0	0.2	31.2	3.2	0.0	2.2	2.2	8.6	5.5	5.5	0.0	0.6	0.0	0.0	0.3	0.5	0.2	0.0	0.3	0.0	0.3	13.0	115.5	0.0	0.0	0.4	0.0	0.3	88.8	0.5	0.5	0.0	0.3	43.2	0.9	1.0	3.3	0.1	0.0	0.0	1.0	32.6	0.2	0.3	3.2	35.6	2.8	1.0	0.5	0.0	0.0	56.0	0.0	0.0	1.2	0.7	9.8	0.0	0.1	0.0	1.0	52.6	21.2	313.7	2.7	0.6	2.7	19.0	0.4	3.7	1.6	0.3	7.7
ADCYAP1R1	"PAC1, PAC1R, PACAPR"	ENSG00000078549	"ADCYAP receptor type I"	P41586	7	31052308-31111479	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 148.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 57.1;Inhibitory neurons: 45.7"	"Cancer enriched"	"Detected in some"	11	"glioma: 45.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 3.7;NTERA-2: 4.8;SCLC-21H: 4.1;SH-SY5Y: 7.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030739, HPA049877"	Enhanced		Enhanced	Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA030739: AB_2732461, HPA049877: AB_2680928"	"unprognostic (5.43e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.16e-2)"	"prognostic favorable (5.78e-4)"	"unprognostic (2.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (4.93e-2)"	"unprognostic (5.75e-2)"	"unprognostic (3.50e-2)"	"unprognostic (3.88e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.67e-3)"	"unprognostic (6.43e-4)"	"unprognostic (1.09e-3)"	"unprognostic (9.55e-2)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-4)"	7.4	11.4	91.8	2.3	79.8	0.0	4.0	53.4	57.6	13.1	3.5	7.1	0.8	5.3	1.5	2.9	29.5	1.3	3.8	69.7	106.5	0.1	0.2	0.8	0.1	96.0	102.7	1.8	1.6	1.6	9.8	0.0	88.9	1.8	1.3	2.7	2.2	3.2	1.3	1.1	2.2	3.7	67.9	0.5	3.5	1.6	148.0	0.8	2.1	8.0	0.8	1.8	4.3	43.7	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	7.4	0.0	0.0	0.0	1.4	0.0	0.0	0.2	0.6	0.8	0.1	0.1	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	91.8	79.8	53.4	57.6	69.7	106.5	96.0	102.7	88.9	67.9	148.0	43.7	4.2	0.0	0.0	57.1	0.0	0.5	0.0	0.0	0.0	1.7	0.2	0.4	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.2	0.7	0.0	0.0	10.8	0.0	0.0	4.6	0.0	6.3	0.0	1.2	0.0	0.0	0.0	0.0	45.7	0.0	0.0	0.0	0.7	0.9	11.5	0.0	1.8	2.8	0.0	0.0	0.0	11.6	1.5	0.0	0.0	5.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.4	5.8	0.3	1.5	0.0	0.3	0.0	0.2	0.1	0.0	0.1
ADGRB2	BAI2	ENSG00000121753	"Adhesion G protein-coupled receptor B2"	O60241	1	31727117-31764893	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 61.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 20.9;Bipolar cells: 16.0;Excitatory neurons: 55.7;Inhibitory neurons: 13.8;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 13.2"	"Cancer enriched"	"Detected in many"	4	"glioma: 20.5"	"Region enhanced"	"Detected in many"		"hippocampal formation: 61.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 37.7;SH-SY5Y: 25.1;T-47d: 29.5;U-2 OS: 27.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069175			Supported	"Plasma membrane"		NA	NA		32000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA069175: "	"prognostic favorable (6.46e-4)"	"unprognostic (1.74e-1)"	"unprognostic (7.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.90e-1)"	"unprognostic (2.40e-1)"	"unprognostic (8.17e-4)"	"prognostic unfavorable (4.02e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.80e-3)"	"unprognostic (1.63e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.75e-3)"	"unprognostic (7.98e-2)"	1.5	3.8	30.6	0.4	30.1	0.2	1.3	0.0	41.1	2.4	0.0	1.6	4.0	2.9	0.2	0.6	1.3	1.1	4.5	61.4	0.0	0.8	0.0	0.7	0.4	0.0	0.2	1.5	0.5	1.2	8.0	2.7	0.0	1.9	0.1	2.9	0.5	1.8	0.7	0.7	3.8	1.3	0.0	0.8	1.1	2.9	1.0	8.7	2.7	0.4	0.2	1.5	1.0	12.2	1.0	7.5	6.9	20.1	1.9	1.2	3.3	4.8	7.6	4.6	8.1	0.4	2.3	0.0	4.7	2.1	7.7	0.8	3.1	0.4	0.8	5.4	3.2	0.0	37.7	0.0	0.1	0.0	2.6	1.2	0.5	6.4	0.0	14.4	0.7	14.7	0.8	0.2	5.2	0.6	13.9	0.1	8.7	0.2	2.1	20.8	0.8	0.7	0.0	9.7	5.2	25.1	11.0	0.7	0.8	2.4	29.5	0.0	0.2	3.6	27.5	0.5	1.3	0.0	0.0	0.8	11.0	0.1	8.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	30.1	0.0	41.1	61.4	0.0	0.0	0.2	0.0	0.0	1.0	12.2	0.1	0.0	0.0	20.9	0.3	0.0	0.5	0.0	0.0	16.0	2.0	1.3	4.3	0.0	0.0	0.0	6.2	1.0	1.2	0.0	0.0	0.1	3.6	1.4	0.6	0.1	1.2	0.0	55.7	0.0	1.4	2.3	0.5	0.4	0.0	1.5	0.0	0.0	0.4	8.4	13.8	0.9	0.0	0.0	0.0	12.0	1.2	0.0	0.0	4.7	0.0	11.4	4.1	20.6	13.2	0.1	0.1	1.9	0.1	0.5	5.7	2.5	0.0	5.2	0.0	1.4	0.7	0.9	4.5	0.0	0.0	0.3	0.4	0.8	0.5	1.3
ADGRB3	"BAI3, KIAA0550"	ENSG00000135298	"Adhesion G protein-coupled receptor B3"	O60242	6	68635282-69389506	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 49.6;pituitary gland: 23.7"	"Group enriched"	"Detected in some"	10	"Astrocytes: 1795.3;Excitatory neurons: 3843.1;Inhibitory neurons: 2738.1;Oligodendrocyte precursor cells: 2036.3;Oligodendrocytes: 1210.5"	"Cancer enriched"	"Detected in single"	10	"glioma: 3.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 8.8;SH-SY5Y: 19.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		8600		"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.71e-1)"	"unprognostic (9.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.72e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.04e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.08e-5)"	"unprognostic (4.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.55e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.16e-3)"	0.8	3.9	21.1	0.8	25.5	0.0	0.6	49.6	29.7	1.3	0.0	4.3	0.4	2.2	0.9	0.7	0.9	0.9	1.9	31.1	12.1	1.0	0.5	1.7	0.0	0.0	0.6	1.6	0.3	0.1	23.7	0.1	1.1	1.0	1.3	7.1	1.2	1.4	0.3	0.4	1.4	3.3	0.0	0.6	1.3	1.9	18.2	0.1	0.8	1.4	0.0	2.6	1.4	19.1	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	1.0	0.0	1.2	1.0	0.0	0.0	8.8	19.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	21.1	25.5	49.6	29.7	31.1	12.1	0.0	0.6	1.1	0.0	18.2	19.1	3.1	0.0	0.0	1795.3	0.3	0.0	0.1	0.0	0.0	47.3	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.7	0.2	4.8	0.6	0.0	0.0	3843.1	0.0	0.0	2.1	0.0	0.0	0.0	0.8	3.6	0.0	0.0	0.0	2738.1	0.0	0.0	0.6	0.0	3.1	5.0	1.3	0.0	216.4	1.0	0.8	0.0	2036.3	1210.5	0.1	0.0	8.6	0.0	0.1	0.0	0.0	0.0	2.8	0.0	0.6	7.4	11.8	3.2	0.2	0.0	0.0	0.0	0.5	0.0	0.1
ADGRE1	"EMR1, TM7LN3"	ENSG00000174837	"Adhesion G protein-coupled receptor E1"	Q14246	19	6887566-6940459	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 6.8;lymphoid tissue: 14.8"	"Group enriched"	"Detected in some"	6	"Kupffer cells: 31.5;Macrophages: 13.2;monocytes: 13.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"basophil: 166.4;eosinophil: 324.9"	"Group enriched"	"Detected in many"	18	"granulocytes: 324.9;monocytes: 105.0"	"Cell line enhanced"	"Detected in some"		"A549: 7.9;BJ hTERT+: 10.5;GAMG: 10.9;HDLM-2: 26.5;HMC-1: 18.1;Karpas-707: 22.3"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA052809	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA052809: AB_2681959"	"unprognostic (2.06e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.93e-5)"	"unprognostic (6.77e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-7)"	"unprognostic (6.69e-2)"	"unprognostic (3.33e-4)"	"unprognostic (1.11e-2)"	"unprognostic (1.35e-1)"	1.9	0.1	0.3	7.3	0.3	6.8	0.2	0.2	0.7	0.1	0.4	0.9	2.9	0.2	1.1	0.1	0.2	1.0	0.2	0.2	0.7	0.3	2.6	4.6	1.5	1.3	0.9	0.0	0.1	0.2	0.1	1.3	0.7	0.2	0.7	0.0	0.2	0.1	0.1	0.0	2.9	1.9	0.5	14.8	1.0	0.9	0.3	3.4	0.1	0.1	1.5	4.0	0.0	0.9	2.8	7.9	0.0	0.0	0.0	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.2	0.2	0.0	0.0	10.9	0.0	0.0	0.0	0.0	26.5	0.0	0.1	0.0	0.0	0.0	0.6	18.1	0.0	0.0	0.0	0.0	0.4	0.0	1.0	0.0	22.3	0.0	0.2	0.7	2.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.4	0.3	0.4	0.2	1.1	4.2	0.1	5.1	5.2	0.0	166.4	21.1	324.9	0.1	58.6	0.3	0.1	7.2	0.9	12.0	0.1	8.9	0.6	7.9	0.9	105.0	0.5	2.2	10.0	0.3	0.3	0.2	0.7	0.2	0.7	1.3	0.9	0.7	0.5	0.3	0.9	0.0	3.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.8	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.3	1.8	0.0	0.6	0.0	0.0	31.5	0.0	0.4	0.0	13.2	0.0	0.0	13.2	0.0	1.0	0.5	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.4	1.3	0.0	0.0	0.1	0.8	0.1	0.0	0.1
ADGRE5	"CD97, TM7LN1"	ENSG00000123146	"Adhesion G protein-coupled receptor E5"	P48960	19	14380501-14408725	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 211.6"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 245.4;Kupffer cells: 111.1;Macrophages: 131.6;NK-cells: 160.6;Plasma cells: 141.5;T-cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013707	Enhanced		Approved	Cytosol	"Secreted to blood"	NA	Yes	10000000	2400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA013707: AB_1846345"	"unprognostic (3.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.85e-2)"	"unprognostic (7.24e-2)"	"prognostic unfavorable (3.73e-5)"	"unprognostic (7.51e-2)"	"unprognostic (6.06e-3)"	"unprognostic (3.14e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (1.87e-6)"	"unprognostic (2.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.44e-2)"	"unprognostic (6.41e-2)"	45.6	21.4	4.7	79.5	7.6	211.6	21.5	7.8	6.3	60.9	4.0	52.7	43.6	143.6	7.0	15.1	48.9	33.2	30.4	4.8	6.0	28.0	19.9	80.2	58.2	9.6	7.4	14.6	31.4	6.1	7.5	32.7	8.4	17.0	29.7	0.4	22.1	10.4	29.5	14.9	51.0	75.3	6.6	145.0	40.5	3.4	9.0	32.5	21.3	13.5	32.0	42.2	29.3	12.1	118.1	81.9	0.8	77.2	33.3	54.1	12.2	79.6	127.0	56.0	61.0	23.5	115.9	13.5	78.5	103.1	79.6	27.2	21.0	38.8	25.0	73.4	23.7	26.4	113.0	10.4	41.0	57.4	117.3	23.9	1.0	57.1	19.4	18.2	5.6	22.7	35.0	101.9	61.9	26.6	3.7	76.3	2.3	92.7	100.4	7.8	33.7	61.8	18.7	10.4	1.0	2.8	45.4	64.1	57.9	1.8	16.7	52.3	14.0	19.0	31.1	79.5	133.2	0.2	0.4	1.1	67.6	100.4	72.0	371.6	158.5	772.8	187.5	281.4	123.9	28.5	94.2	129.6	102.6	18.5	65.5	91.9	623.2	179.2	352.9	48.4	70.6	242.4	4.7	7.6	7.8	6.3	4.8	6.0	9.6	7.4	8.4	6.6	9.0	12.1	10.0	35.3	93.1	1.3	88.6	0.0	8.5	0.0	2.2	0.5	7.2	6.7	3.7	12.8	17.3	0.0	0.0	4.1	245.4	25.8	0.0	18.1	0.1	16.1	26.9	13.1	4.9	25.7	1.4	22.5	46.3	20.0	49.5	13.3	77.0	1.4	23.9	2.9	50.8	0.0	1.8	25.9	0.0	111.1	0.0	1.4	6.5	131.6	0.0	6.5	55.3	2.6	160.6	2.0	11.2	21.2	30.6	4.9	141.5	12.8	17.8	0.9	27.7	1.5	26.3	34.6	23.1	0.5	5.3	3.2	0.0	7.9	184.3	3.7	29.1	17.6
ADGRG2	"EDDM6, GPR64, HE6, TM7LN2"	ENSG00000173698	"Adhesion G protein-coupled receptor G2"	Q8IZP9	X	18989307-19122637	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"epididymis: 1227.7"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 7.2;Endometrial stromal cells: 5.4;Fibroblasts: 5.3;Gastric mucus-secreting cells: 9.2;Oligodendrocyte precursor cells: 10.1;Oligodendrocytes: 7.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 6.0;BEWO: 7.3;HeLa: 5.9;NTERA-2: 6.4;RPMI-8226: 4.5;SH-SY5Y: 6.6;U-2197: 14.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"HPA001478, HPA050029"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		22000000		"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA001478: AB_1078923, HPA050029: AB_2680996"	"unprognostic (3.33e-2)"	"unprognostic (3.20e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.43e-3)"	"unprognostic (2.63e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.27e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.54e-7)"	"unprognostic (6.37e-2)"	"unprognostic (3.19e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.35e-1)"	3.9	0.3	0.1	0.9	0.1	0.0	2.0	0.0	1.1	1.0	0.0	0.5	0.5	1.0	1227.7	0.5	16.5	1.6	1.3	0.8	0.7	0.4	0.7	1.3	5.0	0.4	1.5	0.2	1.2	163.4	1.1	0.5	0.6	2.1	0.4	0.9	8.5	3.6	0.2	0.4	1.1	0.4	0.1	2.4	9.0	1.9	0.3	6.6	1.6	1.1	3.7	0.8	1.0	0.2	0.2	6.0	0.0	0.0	0.1	0.9	7.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	2.4	0.0	5.9	0.2	0.8	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	2.2	6.4	0.0	2.0	0.0	0.0	4.5	0.0	1.2	2.2	6.6	1.5	0.1	0.0	1.1	0.1	0.1	0.1	0.2	0.4	14.6	2.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	1.1	0.8	0.7	0.4	1.5	0.6	0.1	0.3	0.2	0.6	0.0	0.0	3.6	0.1	0.0	0.1	0.0	0.0	0.6	1.2	1.1	1.0	7.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.4	0.1	1.1	5.4	0.6	0.0	0.0	4.4	0.2	0.3	5.3	9.2	3.2	0.0	0.2	1.4	0.4	0.0	3.3	5.0	0.1	0.0	0.0	0.0	0.2	1.2	0.1	0.0	4.7	0.0	4.8	0.0	10.1	7.0	3.1	0.0	1.5	0.0	3.4	0.0	0.1	2.2	0.7	0.0	1.6	0.6	0.1	1.4	0.1	0.0	0.0	0.3	0.3	0.0	0.3
ADGRL2	"KIAA0786, LEC1, LPHH1, LPHN2"	ENSG00000117114	"Adhesion G protein-coupled receptor L2"	O95490	1	81306147-81992436	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	11	"Excitatory neurons: 902.7;Inhibitory neurons: 646.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 252.8;hTEC/SVTERT24-B: 130.3;NTERA-2: 100.0;SH-SY5Y: 168.3;U-2197: 118.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043447			Approved	"Plasma membrane"		NA	NA		700000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA043447: AB_2678486"	"unprognostic (2.54e-2)"	"unprognostic (6.29e-3)"	"unprognostic (2.57e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (3.22e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.92e-4)"	"unprognostic (3.55e-2)"	"unprognostic (9.84e-2)"	"unprognostic (2.42e-1)"	"unprognostic (7.81e-2)"	"unprognostic (8.01e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (3.00e-4)"	"unprognostic (2.76e-1)"	"unprognostic (3.38e-3)"	"unprognostic (1.41e-2)"	19.8	19.9	11.0	8.2	13.4	0.0	17.8	6.5	26.3	16.4	5.0	15.3	5.8	12.4	15.0	23.6	23.1	23.1	28.5	13.9	14.6	21.4	38.5	64.9	8.9	8.6	10.7	36.3	9.7	27.5	20.5	48.8	7.6	30.0	10.9	25.2	36.7	19.4	4.4	12.9	13.4	12.7	7.0	19.9	15.5	4.2	15.5	10.4	43.2	19.7	8.7	13.2	23.4	15.0	18.2	9.9	252.8	0.0	30.3	35.3	3.4	6.4	14.8	2.5	2.9	0.0	0.0	0.1	69.6	34.6	7.1	10.1	20.3	28.0	2.3	0.5	41.5	0.0	7.0	16.6	11.8	0.0	0.4	32.5	1.8	130.3	12.9	17.8	42.9	0.0	0.0	0.0	3.4	0.2	0.0	0.1	100.0	0.0	7.1	0.0	34.9	0.0	56.9	3.8	11.7	168.3	0.0	6.3	0.0	73.5	0.4	74.7	27.5	26.0	28.9	118.9	9.3	0.0	0.0	0.2	14.9	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.0	13.4	6.5	26.3	13.9	14.6	8.6	10.7	7.6	7.0	15.5	15.0	25.3	3.2	2.2	23.8	0.2	0.0	7.0	0.0	2.2	48.5	6.6	11.2	44.1	10.0	3.1	5.5	6.2	0.4	0.1	2.1	0.0	4.7	1.4	11.7	10.3	36.9	0.0	0.0	902.7	1.6	0.4	19.6	0.5	25.4	0.0	32.3	30.0	39.3	0.9	33.7	646.8	2.0	0.0	3.1	0.0	1.4	23.3	1.1	0.0	69.3	0.0	19.0	0.0	11.1	13.0	0.8	3.6	17.7	0.0	10.4	0.0	7.8	0.0	3.9	19.7	2.5	19.8	1.5	3.5	4.1	0.0	0.4	0.5	43.1	3.5	3.0
ADGRL3	"KIAA0768, LEC3, LPHN3"	ENSG00000150471	"Adhesion G protein-coupled receptor L3"	Q9HAR2	4	61201258-62078335	"G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.3"	"Group enriched"	"Detected in many"	11	"Astrocytes: 584.1;Excitatory neurons: 696.1;Inhibitory neurons: 737.4;Oligodendrocyte precursor cells: 1300.8;Oligodendrocytes: 592.1"	"Cancer enriched"	"Detected in some"	9	"glioma: 5.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 41.8;EFO-21: 10.8;HEK 293: 6.5;SuSa: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015027, HPA015762, CAB022698"	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"CAB022698: , HPA015027: AB_1853243, HPA015762: AB_1853245"	"unprognostic (2.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.43e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.88e-1)"	"unprognostic (7.56e-2)"	"unprognostic (8.70e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.28e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.03e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.85e-3)"	"unprognostic (4.23e-3)"	7.1	6.2	25.1	1.1	25.7	0.0	2.5	14.0	30.7	5.5	0.0	4.0	2.5	3.9	1.8	1.0	2.4	1.6	2.6	30.4	25.0	1.6	0.4	2.6	0.4	15.3	24.6	1.1	0.3	6.7	0.9	1.2	15.9	1.3	3.9	10.0	0.6	4.2	0.7	3.0	3.6	3.0	12.5	0.3	3.2	4.1	32.3	0.4	0.7	0.3	0.1	1.6	3.4	15.7	0.0	0.1	41.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.1	0.0	3.1	0.0	0.0	0.0	0.0	3.4	0.0	0.0	1.0	0.0	4.0	0.5	0.1	0.1	0.0	4.8	0.2	0.0	6.3	0.3	0.0	0.0	0.0	7.6	0.1	3.2	0.0	0.2	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	25.7	14.0	30.7	30.4	25.0	15.3	24.6	15.9	12.5	32.3	15.7	0.4	0.0	0.0	584.1	0.0	0.0	0.0	0.0	0.6	12.4	4.9	1.8	3.3	0.0	0.0	0.0	4.2	1.0	0.0	0.0	9.8	0.0	46.4	1.3	17.7	1.9	0.0	0.0	696.1	0.0	1.3	3.3	0.0	0.4	0.0	0.4	2.5	0.2	0.1	1.7	737.4	0.0	0.0	0.0	0.0	33.2	0.0	0.5	0.0	70.3	0.0	31.3	0.0	1300.8	592.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	2.4	6.6	0.3	18.5	0.9	3.5	1.2	0.0	2.2	0.2	0.1	0.0	0.1
ADGRL4	"ELTD1, ETL"	ENSG00000162618	"Adhesion G protein-coupled receptor L4"	Q9HBW9	1	78889764-79282124	"G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 73.1"	"Group enriched"	"Detected in many"	5	"Adipocytes: 559.9;Endothelial cells: 276.0;Hepatic stellate cells: 287.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"hTERT-RPE1: 101.2;HUVEC TERT2: 330.0;TIME: 379.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025229	Supported					NA	NA		3800000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA025229: AB_10602493"	"unprognostic (2.67e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (5.32e-2)"	"unprognostic (8.11e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.52e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.60e-4)"	"unprognostic (5.32e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.85e-3)"	73.1	8.2	7.7	9.7	8.2	0.7	64.0	8.5	13.8	22.1	7.0	9.3	4.7	16.3	6.2	9.0	12.1	22.4	24.2	8.0	8.0	15.2	14.3	18.0	9.9	9.1	7.7	4.8	4.7	9.7	5.1	22.5	9.1	9.4	6.3	3.0	7.9	8.9	14.2	9.0	8.6	27.6	7.6	39.8	8.0	6.7	9.8	4.6	20.8	23.6	7.1	24.0	10.4	8.4	0.0	0.0	25.7	0.2	7.3	24.7	0.0	7.8	7.7	0.5	0.3	0.8	0.2	0.2	0.6	22.5	0.0	0.0	0.1	0.0	5.0	0.0	0.0	0.5	0.7	0.1	25.3	0.0	0.3	17.8	0.4	55.7	0.3	101.2	330.0	0.2	0.4	2.5	7.0	0.0	0.0	1.0	0.4	0.2	0.4	0.2	0.0	0.0	61.1	3.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	379.3	0.2	5.8	2.0	0.0	0.8	0.5	0.1	0.3	0.5	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	7.7	8.2	8.5	13.8	8.0	8.0	9.1	7.7	9.1	7.6	9.8	8.4	559.9	0.0	6.0	0.3	1.2	0.0	0.4	0.0	4.6	0.0	1.8	2.5	7.6	5.7	0.0	0.0	0.0	0.1	0.9	0.0	0.0	0.2	45.3	0.8	1.5	276.0	0.0	2.7	1.5	0.2	0.0	10.2	0.0	3.8	0.0	0.0	287.7	3.5	0.6	1.7	1.0	0.0	0.0	19.2	0.0	57.9	0.6	1.5	0.0	72.1	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.4	1.2	1.3	0.0	0.0	0.0	0.4	0.0	5.1	5.7	7.2	1.8	1.0	0.0	0.0	1.1	5.4	0.0	0.7
ADGRV1	"DKFZp761P0710, FEB4, GPR98, KIAA0686, MASS1, USH2C, VLGR1"	ENSG00000164199	"Adhesion G protein-coupled receptor V1"	Q8WXG9	5	90529344-91164437	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Hydrolase, Receptor, Transducer"	"Deafness, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"adrenal gland: 533.0"	"Cell type enriched"	"Detected in many"	8	"Astrocytes: 2207.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 15.5;HAP1: 23.0;K-562: 9.8;NTERA-2: 11.6;SCLC-21H: 11.1;SuSa: 15.0;U-266/70: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067503	Approved		Approved	"Lipid droplets"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Lipid droplets"		"HPA067503: AB_2685856"	"unprognostic (1.29e-1)"	"unprognostic (3.02e-1)"	"unprognostic (3.69e-2)"	"unprognostic (1.38e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.61e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.62e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.95e-3)"	"unprognostic (7.50e-3)"	"unprognostic (9.73e-7)"	"unprognostic (1.87e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.48e-2)"	"unprognostic (7.14e-2)"	0.0	533.0	36.9	0.0	47.8	0.6	3.6	12.7	40.3	0.9	22.4	1.0	0.3	0.1	0.7	2.4	0.2	12.3	0.2	39.1	11.6	21.5	42.3	2.1	0.0	9.4	12.8	0.2	1.5	0.8	15.1	4.1	9.4	1.3	1.0	18.2	2.3	0.2	0.2	2.1	0.5	0.0	7.3	0.3	1.1	1.4	18.3	0.8	17.5	0.0	0.4	10.4	1.9	26.1	0.5	2.1	15.5	0.0	0.0	0.1	0.2	0.3	0.1	0.0	0.0	1.7	0.2	0.3	0.4	0.0	0.4	0.2	23.0	0.2	0.0	1.0	4.3	4.1	2.0	1.4	0.0	0.3	0.1	0.0	4.8	0.0	0.1	0.1	0.0	0.1	9.8	2.6	0.0	2.1	0.1	0.2	11.6	2.9	4.2	0.0	0.4	2.1	0.0	0.5	11.1	2.7	3.4	2.2	0.2	15.0	5.9	0.0	0.8	0.4	1.9	0.5	1.1	13.4	4.1	0.6	0.7	0.2	0.0	3.2	0.9	2.8	1.0	0.7	1.7	1.5	1.1	1.4	0.5	2.9	1.7	0.9	4.6	1.1	0.5	1.2	1.6	0.2	36.9	47.8	12.7	40.3	39.1	11.6	9.4	12.8	9.4	7.3	18.3	26.1	0.4	25.6	26.5	2207.3	0.0	0.0	6.1	0.0	1.8	28.0	15.5	7.4	2.4	2.8	5.6	5.5	264.8	3.0	0.4	0.6	1.9	1.9	43.5	3.3	0.3	1.1	7.3	0.0	54.0	4.2	2.6	1.1	4.6	1.9	0.0	6.7	0.0	12.4	0.2	10.1	21.9	0.4	0.0	0.8	0.0	54.8	0.6	0.5	0.0	51.5	1.2	8.9	1.0	40.2	7.4	1.7	1.2	0.4	0.1	2.1	0.1	24.2	7.3	84.4	0.0	0.3	0.4	3.6	4.5	2.9	0.0	4.1	0.6	0.2	1.2	9.0
ADIPOQ	"ACDC, ACRP30, adiponectin, apM1, GBP28"	ENSG00000181092	"Adiponectin, C1Q and collagen domain containing"	Q15848	3	186842704-186858463	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hormone	"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	28	"adipose tissue: 898.8;breast: 248.9"	"Cell type enhanced"	"Detected in single"		"Distal tubular cells: 1.9"	"Group enriched"	"Detected in some"	8	"breast cancer: 6.5;pancreatic cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	672	"ASC diff: 312.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB046467, HPA051767"	Uncertain				"Secreted to blood"	NA	NA	8360000000	910000000	"Cluster 17: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB046467: AB_1078104, HPA051767: AB_2681598"	"unprognostic (1.76e-2)"									"unprognostic (1.53e-1)"	"unprognostic (2.20e-2)"			"unprognostic (6.99e-3)"	"unprognostic (1.87e-1)"			898.8	8.9	0.1	2.4	0.1	0.2	248.9	0.2	0.1	0.0	0.0	7.7	0.1	0.1	0.0	1.2	0.1	7.6	6.5	0.0	0.0	0.8	0.1	0.1	1.3	0.1	0.0	0.0	6.2	0.1	0.1	0.0	0.1	0.3	6.1	0.1	18.8	0.0	2.3	6.6	8.5	1.2	0.0	0.0	3.9	0.1	0.1	2.2	2.9	20.2	0.0	2.4	0.9	0.3	0.0	0.0	0.0	0.1	312.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ADIPOR1	"ACDCR1, PAQR1"	ENSG00000159346	"Adiponectin receptor 1"	Q96A54	1	202940826-202958572	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 329.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 6: Erythroid cells - Oxygen transport"				"unprognostic (1.67e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.81e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.95e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.27e-4)"	"prognostic unfavorable (5.50e-4)"	"unprognostic (1.13e-1)"	"unprognostic (1.79e-3)"	"unprognostic (5.90e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.63e-2)"	59.8	58.5	56.1	49.1	60.1	215.2	63.6	58.7	64.2	55.4	82.9	55.6	46.5	40.9	91.4	110.9	68.6	48.2	92.6	56.8	57.7	70.4	106.2	80.5	48.0	61.2	58.6	47.7	91.7	107.1	45.5	100.0	60.2	53.7	59.8	135.6	106.6	47.4	136.5	110.8	47.4	50.9	60.1	65.8	63.3	48.7	58.7	50.2	56.6	140.2	77.9	70.9	69.2	65.2	97.0	87.2	53.4	59.9	111.4	85.4	276.8	103.4	123.9	108.8	99.4	88.7	114.7	63.5	75.3	120.6	86.3	118.0	81.3	145.5	96.5	118.5	93.5	48.6	104.3	72.6	109.7	101.6	71.6	101.7	235.0	115.9	118.3	108.4	108.8	111.7	128.1	133.5	111.2	105.6	85.3	77.4	119.7	87.1	103.1	66.7	128.7	125.7	106.5	111.0	89.2	90.8	109.6	166.5	135.5	143.6	121.1	99.4	95.7	78.9	62.2	39.4	117.3	137.8	197.4	71.4	113.5	58.9	94.5	362.2	361.8	455.4	136.0	253.6	143.8	157.9	143.4	134.1	209.8	165.2	141.5	124.3	825.9	126.0	259.6	146.1	179.5	557.4	56.1	60.1	58.7	64.2	56.8	57.7	61.2	58.6	60.2	60.1	58.7	65.2	40.7	35.3	52.5	6.8	46.8	235.0	95.2	109.8	75.7	24.8	81.9	54.2	59.7	32.9	79.3	53.3	29.2	112.7	42.8	49.3	68.4	73.8	68.2	58.8	24.5	53.4	49.1	329.0	13.7	86.3	172.4	40.9	37.2	54.3	37.3	18.8	58.5	60.8	104.2	11.8	15.1	49.1	85.5	148.5	89.7	62.5	28.6	107.6	85.4	15.9	85.0	38.0	42.2	9.5	20.0	120.0	43.5	24.5	116.0	133.1	67.3	65.9	82.5	54.9	39.5	29.2	61.7	26.4	27.2	79.3	228.9	202.8	47.1	29.2	41.7	206.6
ADIPOR2	"ACDCR2, PAQR2"	ENSG00000006831	"Adiponectin receptor 2"	Q86V24	12	1688574-1788674	"Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 321.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043737	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA043737: AB_10964205"	"unprognostic (1.52e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.33e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.86e-2)"	"unprognostic (1.61e-1)"	"unprognostic (5.34e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.79e-2)"	"unprognostic (2.00e-2)"	"unprognostic (5.85e-2)"	55.1	72.3	36.6	10.6	49.8	9.6	44.2	46.4	48.7	25.8	28.3	32.2	22.2	24.4	8.1	45.2	23.3	9.7	33.3	35.3	40.6	22.4	79.6	44.6	9.8	50.9	46.9	25.1	31.1	16.9	26.1	13.0	49.5	20.7	17.7	13.1	22.2	11.9	42.9	31.9	32.7	12.0	41.6	19.9	44.7	27.7	44.5	12.8	28.0	19.9	12.6	21.4	29.3	67.0	34.3	28.0	23.1	21.4	21.4	25.6	30.9	24.6	28.4	31.5	44.5	42.1	51.6	24.1	7.8	23.0	56.7	26.1	34.7	35.8	44.9	62.7	28.7	47.3	22.7	30.3	21.2	36.1	29.3	22.6	35.5	39.8	45.6	28.7	23.1	25.8	31.7	50.9	23.7	48.8	23.6	32.8	46.3	28.4	14.8	19.5	43.7	18.3	31.4	19.9	6.9	16.4	22.7	43.8	51.5	39.7	24.6	46.5	23.2	17.8	37.5	28.6	36.2	12.3	16.5	39.5	21.7	32.3	24.7	0.7	0.7	1.8	0.9	0.7	0.7	0.5	0.5	0.8	0.5	0.5	0.6	0.7	0.9	0.6	0.6	0.9	0.7	0.3	36.6	49.8	46.4	48.7	35.3	40.6	50.9	46.9	49.5	41.6	44.5	67.0	81.5	12.8	32.4	39.2	21.8	23.7	25.0	26.6	22.8	11.3	29.9	20.3	22.3	31.5	36.6	14.7	18.8	13.9	32.4	91.4	11.7	22.6	56.3	17.8	15.4	41.1	37.5	38.1	35.7	31.4	42.2	21.1	61.7	30.2	36.3	28.8	28.9	113.4	18.2	18.5	41.3	49.0	32.6	27.3	18.9	77.0	15.8	32.6	26.6	124.6	27.0	32.5	27.8	32.2	321.0	39.6	49.4	22.6	30.2	27.8	41.5	10.8	21.7	16.0	6.6	21.3	25.7	45.0	42.2	29.7	34.4	29.3	26.1	39.6	33.5	29.8
ADORA1	RDC7	ENSG00000163485	"Adenosine A1 receptor"	P30542	1	203090654-203167405	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.8;testis: 21.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 18.1;granulocytes: 22.3;Muller glia cells: 44.4;Oligodendrocyte precursor cells: 35.2;Oligodendrocytes: 31.5"	"Cancer enhanced"	"Detected in many"		"glioma: 24.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 40.3;MCF7: 24.4;RH-30: 65.4;RPTEC TERT1: 31.7;SK-BR-3: 35.2;U-138 MG: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044383			Supported	"Plasma membrane"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA044383: AB_2678921"	"unprognostic (3.93e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.16e-2)"	"unprognostic (2.38e-3)"	"unprognostic (2.25e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.64e-2)"	"unprognostic (4.17e-2)"	"unprognostic (3.04e-1)"	"unprognostic (4.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.13e-2)"	"unprognostic (5.76e-4)"	3.7	0.2	31.9	1.6	34.6	0.0	4.6	28.6	33.8	1.0	0.0	1.0	1.0	1.2	0.6	1.1	1.2	0.9	11.4	29.6	23.0	9.3	0.4	1.7	0.6	35.7	35.0	0.3	13.2	8.0	1.9	6.8	41.8	1.0	0.6	4.8	6.4	0.4	1.7	4.6	1.2	0.4	23.6	6.3	1.0	21.4	54.8	0.4	2.2	2.5	0.5	1.6	0.7	41.5	0.3	3.0	0.6	0.2	0.2	1.6	0.2	2.0	3.0	0.7	0.4	40.3	0.7	0.0	8.9	7.3	4.8	0.1	0.7	0.0	0.2	0.0	1.1	0.0	0.4	0.0	0.6	0.0	0.1	0.9	0.0	0.9	0.0	6.4	0.0	6.4	0.0	0.1	6.2	24.4	0.1	0.0	10.2	0.0	0.0	0.0	65.4	2.3	31.7	0.0	0.8	0.7	4.4	35.2	0.5	3.6	2.0	1.0	0.0	20.9	10.6	0.0	11.7	0.0	0.2	0.0	10.5	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.9	34.6	28.6	33.8	29.6	23.0	35.7	35.0	41.8	23.6	54.8	41.5	0.0	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.0	1.1	9.4	6.9	3.1	7.2	0.0	3.7	0.0	0.1	0.1	0.1	0.0	11.7	0.1	0.0	0.4	0.3	0.0	0.0	18.1	3.3	1.3	1.1	0.0	0.1	22.3	0.8	0.0	0.0	0.9	0.0	2.9	0.0	0.0	1.0	1.0	0.5	0.0	0.6	1.8	1.9	0.2	44.4	0.0	35.2	31.5	0.5	0.0	0.7	0.0	0.0	0.0	3.0	0.0	1.6	0.0	0.0	0.6	0.1	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1
ADORA2A	"ADORA2, RDC8"	ENSG00000128271	"Adenosine A2a receptor"	P29274	22	24417879-24442357	"Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 40.6;brain: 101.4;lymphoid tissue: 54.1"	"Group enriched"	"Detected in some"	6	"B-cells: 5.8;monocytes: 10.9;Plasma cells: 11.8;T-cells: 3.0"	"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"basal ganglia: 101.4"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 39.3;Karpas-707: 52.8;RPMI-8226: 41.1;SK-BR-3: 74.0;U-266/70: 52.8;U-266/84: 74.4;U-698: 55.0"	"Region enriched"	"Detected in many"	9	"basal ganglia: 399.8"	"Region enriched"	"Detected in many"	50	"basal ganglia: 142.2"	"CAB001943, HPA065566, HPA075997"	Enhanced	Supported				NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB001943: , HPA065566: , HPA075997: AB_2732298"	"unprognostic (7.30e-2)"	"unprognostic (2.42e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.44e-2)"	"unprognostic (1.88e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.63e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.57e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.87e-3)"	"unprognostic (6.81e-4)"	"unprognostic (1.50e-1)"	"unprognostic (9.78e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.10e-3)"	3.4	5.4	12.3	13.5	101.4	40.6	2.5	10.8	19.2	4.0	8.0	4.1	6.6	2.9	1.6	2.0	3.7	3.0	13.5	11.6	10.0	17.5	14.5	14.6	20.5	10.2	10.4	3.9	2.3	0.2	6.7	1.8	10.4	5.5	1.0	2.1	3.2	1.7	2.5	1.6	7.0	0.9	9.9	15.2	4.0	3.1	19.9	54.1	4.3	1.4	10.4	5.3	3.4	9.7	0.5	0.9	1.0	0.3	0.4	0.3	1.0	0.7	23.2	1.3	2.4	4.5	0.3	39.3	2.6	0.7	2.4	1.0	2.4	0.0	0.0	4.7	6.6	0.7	0.2	5.6	0.4	0.8	18.7	0.2	0.2	7.2	0.0	0.5	8.2	5.8	0.3	52.8	0.0	0.7	14.0	4.2	1.6	5.0	0.1	0.6	1.7	41.1	0.1	0.3	3.9	21.6	1.1	74.0	0.3	1.1	0.8	3.7	0.5	2.2	3.7	0.5	0.4	52.8	74.4	55.0	11.5	13.6	0.3	9.6	2.1	11.6	20.0	6.5	46.9	21.9	37.4	39.2	2.6	38.3	51.5	42.4	32.6	6.3	23.1	2.9	54.0	27.1	12.3	101.4	10.8	19.2	11.6	10.0	10.2	10.4	10.4	9.9	19.9	9.7	0.0	0.0	0.5	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.6	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.2	0.0	0.0	0.5	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.1
ADRA2A	"ADRA2, ADRA2R, ADRAR"	ENSG00000150594	"Adrenoceptor alpha 2A"	P08913	10	111077029-111080907	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 50.5;cervix: 46.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 52.9;Paneth cells: 105.9;Smooth muscle cells: 118.7"	"Cancer enhanced"	"Detected in all"		"pancreatic cancer: 17.7"	"Region enhanced"	"Detected in all"		"pons: 26.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 10.5;ASC TERT1: 12.9;HEL: 20.3;HeLa: 10.7;HSkMC: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 36: HEL - Hemostasis"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.87e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.38e-1)"	"prognostic favorable (8.06e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.78e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.64e-3)"	"unprognostic (5.86e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.08e-6)"	"unprognostic (1.45e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.89e-3)"	50.5	1.7	3.4	4.9	3.4	0.0	32.9	1.6	4.3	46.6	7.7	7.4	10.0	6.8	1.6	2.9	4.1	19.9	2.1	3.4	7.4	6.0	1.1	4.3	11.2	5.9	5.8	18.1	30.5	1.3	2.3	3.7	26.8	6.9	3.7	0.0	7.0	6.1	1.0	10.9	4.9	2.8	1.4	14.7	3.7	5.0	3.2	1.0	9.0	0.6	13.1	15.9	23.4	6.1	0.0	0.0	0.0	0.0	10.5	12.9	0.0	0.1	0.0	1.1	2.5	0.0	0.0	0.0	0.1	6.1	0.0	0.0	0.0	0.0	1.0	0.0	0.1	20.3	10.7	0.0	0.0	0.0	0.0	30.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	3.4	1.6	4.3	3.4	7.4	5.9	5.8	26.8	1.4	3.2	6.1	8.3	0.0	1.3	1.0	0.0	10.3	0.4	0.0	1.2	0.0	17.2	12.2	1.5	52.9	1.3	0.0	0.0	0.1	0.0	11.7	0.0	5.9	3.5	6.9	9.1	4.9	12.4	0.0	2.2	3.3	0.1	7.3	10.7	25.8	7.0	19.4	0.7	0.0	0.1	0.0	5.9	3.5	0.0	0.3	17.3	1.2	22.4	7.3	28.4	1.0	0.0	0.0	0.0	0.0	0.2	0.3	105.9	4.9	0.0	0.9	3.5	0.6	0.0	0.0	6.6	3.1	118.7	5.4	0.1	0.2	6.1	0.1	1.2	8.5	8.6	1.1
ADRB1	ADRB1R	ENSG00000043591	"Adrenoceptor beta 1"	P08588	10	114043866-114046904	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 23.7;lung: 13.1;placenta: 29.1"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 85.7;Cytotrophoblasts: 84.5;Sertoli cells: 52.6;Syncytiotrophoblasts: 38.4"	"Cancer enriched"	"Detected in many"	10	"prostate cancer: 12.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.1;PC-3: 2.6;THP-1: 4.5;TIME: 5.8;U-937: 3.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067972	Enhanced					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA067972: AB_2685936"	"unprognostic (1.45e-3)"	"unprognostic (1.18e-3)"	"unprognostic (1.44e-1)"	"unprognostic (4.92e-2)"	"unprognostic (3.22e-1)"	"unprognostic (8.88e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.77e-4)"	"unprognostic (1.33e-1)"	"unprognostic (7.80e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.44e-1)"	4.0	0.2	5.5	0.3	10.3	0.5	2.3	0.7	12.0	0.1	0.2	3.1	0.9	0.1	0.1	0.9	0.1	0.1	23.7	6.8	3.3	1.1	1.4	13.1	0.2	1.8	3.1	0.0	1.3	0.8	0.8	29.1	2.4	4.4	0.6	2.1	5.4	0.1	2.3	0.4	1.9	0.1	0.9	1.5	0.7	0.5	5.0	0.1	0.6	0.0	0.3	0.7	0.1	7.8	1.4	0.8	0.1	0.8	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.3	1.0	0.2	0.2	0.0	0.4	0.3	0.1	0.1	0.1	7.1	0.4	0.3	0.1	0.1	0.0	0.2	0.4	0.0	0.7	0.0	1.3	0.1	0.1	1.0	0.0	0.1	0.1	0.8	1.1	0.9	0.3	0.2	2.6	0.2	0.2	0.1	0.0	1.1	0.1	0.2	0.0	0.5	0.0	0.3	0.2	4.5	5.8	0.2	0.1	0.1	0.1	0.0	0.0	0.3	0.0	3.4	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	10.3	0.7	12.0	6.8	3.3	1.8	3.1	2.4	0.9	5.0	7.8	1.1	19.2	7.8	15.0	0.5	1.0	3.9	0.8	1.2	21.8	1.0	0.5	85.7	2.8	9.8	0.0	0.0	84.5	3.0	0.1	1.9	0.1	0.1	0.4	0.6	11.3	0.0	0.0	12.8	0.2	5.2	5.3	0.0	0.3	0.0	0.0	0.4	0.2	4.4	13.5	2.5	3.3	2.0	2.2	1.6	0.2	0.0	2.8	1.8	7.5	0.6	0.7	3.1	1.0	0.3	0.1	1.4	0.4	1.2	6.1	0.8	0.0	12.1	1.7	52.6	0.4	8.2	0.5	0.2	0.1	0.0	38.4	4.8	0.0	0.6	3.9
ADRB2	"ADRB2R, ADRBR, B2AR, BAR"	ENSG00000169252	"Adrenoceptor beta 2"	P07550	5	148826611-148828623	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 196.1;Basal keratinocytes: 387.5;Basal respiratory cells: 146.6;Squamous epithelial cells: 276.0;Suprabasal keratinocytes: 245.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 9.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 72.4;hTERT-HME1: 74.1;PC-3: 31.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003431, HPA075322"	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol		"HPA003431: AB_1845333, HPA075322: "	"unprognostic (2.28e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.17e-1)"	"unprognostic (9.35e-3)"	"unprognostic (5.54e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.85e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (3.15e-9)"	"unprognostic (1.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.65e-2)"	19.5	1.6	4.5	3.2	4.7	12.5	18.7	5.1	4.4	13.5	1.8	2.3	1.9	2.3	1.7	15.1	4.1	3.8	6.7	5.3	4.2	1.1	14.2	19.5	4.1	6.0	5.6	0.9	1.2	2.2	0.3	9.9	6.2	9.0	2.8	0.6	4.2	1.5	11.7	21.8	2.1	3.7	6.2	7.9	7.5	0.5	7.1	2.7	1.0	8.6	6.0	6.8	7.2	7.6	23.3	0.1	0.1	0.0	0.8	0.2	0.0	4.3	13.2	6.0	6.7	0.0	9.7	0.1	6.1	1.3	21.5	20.0	0.0	27.9	6.9	0.0	0.6	0.0	5.1	0.0	0.6	0.1	11.0	0.1	72.4	2.0	74.1	5.0	2.8	0.0	0.1	8.3	16.0	0.0	0.0	12.9	0.4	0.2	31.2	6.7	4.1	13.0	3.2	5.8	0.1	0.1	5.4	0.4	2.0	2.5	0.0	7.0	12.3	0.0	5.0	7.2	3.5	1.9	0.0	0.2	0.0	15.1	2.6	16.5	21.8	67.8	151.4	37.1	112.3	21.5	34.3	93.0	24.7	15.6	5.8	53.3	35.4	37.2	53.3	28.4	2.3	53.4	4.5	4.7	5.1	4.4	5.3	4.2	6.0	5.6	6.2	6.2	7.1	7.6	196.1	112.2	31.6	1.6	16.5	387.5	36.6	146.6	127.5	0.5	23.3	15.2	18.6	0.0	67.4	0.0	0.0	0.4	59.2	3.7	0.0	2.4	0.5	3.2	0.5	40.3	3.0	1.3	0.0	0.2	0.3	6.2	35.7	3.0	118.6	0.1	6.8	14.1	17.7	0.0	0.0	3.1	16.2	20.8	54.9	0.7	0.0	21.1	30.2	15.9	4.0	4.1	90.6	0.0	0.1	8.6	0.1	0.0	23.2	23.5	0.1	0.1	27.8	5.0	0.0	19.8	9.6	0.7	0.1	276.0	245.4	0.5	40.1	0.1	3.5	61.5
AGER	"RAGE, SCARJ1"	ENSG00000204305	"Advanced glycosylation end-product specific receptor"	Q15109	6	32180968-32184322	"Cancer-related genes, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	19	"lung: 728.3"	"Cell type enriched"	"Detected in many"	22	"Alveolar cells type 1: 2394.2"	"Cancer enhanced"	"Detected in all"		"lung cancer: 27.2;thyroid cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.5;JURKAT: 3.0;RPTEC TERT1: 2.2;U-266/70: 2.4;U-266/84: 2.0"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"CAB011682, HPA064436, HPA069474"	Enhanced		Approved	"Nucleoli fibrillar center,Plasma membrane,Cell Junctions"	"Secreted in other tissues"	NA	NA	5360000	100000		"Cluster 19: Lung - Lung function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane, Cell Junctions"	"Nucleoli fibrillar center"	"CAB011682: AB_2258049, HPA064436: AB_2685264, HPA069474: "	"unprognostic (9.37e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.55e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.36e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.27e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (9.01e-7)"	"unprognostic (3.57e-1)"	"unprognostic (3.70e-2)"	"unprognostic (4.44e-2)"	"prognostic favorable (2.74e-6)"	2.2	1.7	0.1	1.1	0.1	0.5	1.6	0.1	0.4	4.4	0.2	3.9	0.6	2.5	1.9	2.1	4.5	0.1	2.7	0.2	0.1	6.4	2.7	728.3	0.6	0.2	0.1	4.8	1.7	0.0	5.0	0.4	0.2	4.9	0.8	0.4	1.6	0.0	1.0	2.0	3.2	0.1	0.1	7.0	2.0	2.2	0.2	0.8	39.2	0.1	0.5	2.9	3.2	0.3	0.1	0.0	0.0	0.3	0.1	0.9	1.5	0.0	0.1	0.0	0.1	0.0	0.2	0.1	1.0	0.2	0.0	1.0	0.1	0.3	0.2	0.2	2.5	0.7	0.0	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.1	0.2	0.1	3.0	0.0	0.3	0.1	1.3	0.1	0.9	0.0	0.1	0.0	0.0	0.1	0.1	2.2	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.5	0.0	0.1	0.0	0.6	0.8	0.1	2.4	2.0	0.9	1.1	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.2	0.3	5.4	2394.2	107.9	5.9	4.9	0.9	1.5	2.0	2.8	5.1	1.5	2.9	3.0	4.3	20.9	1.8	0.0	1.1	2.7	1.1	0.0	1.5	0.4	1.1	2.6	4.1	0.0	4.4	0.5	1.0	0.9	3.0	1.5	1.9	17.7	3.1	2.9	2.0	1.3	6.7	0.6	1.3	0.0	5.3	6.5	1.2	1.8	5.3	1.8	4.7	4.8	4.6	2.1	2.5	1.3	1.1	2.7	1.2	3.3	2.6	0.8	0.3	5.6	3.4	6.6	1.2	2.6	0.1	1.2	1.6	1.8	2.2	6.2	1.7	1.2	0.9
AGRN	AGRIN	ENSG00000188157	Agrin	O00468	1	1020120-1056118	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Differentiation	"Developmental protein"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 94.5;Collecting duct cells: 156.3;Ductal cells: 91.2;Pancreatic endocrine cells: 87.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 205.3;EFO-21: 236.9;HaCaT: 210.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040090	Approved		Approved	"Plasma membrane,Cytosol"	"Secreted to extracellular matrix"	NA	NA		20000000		"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	"Plasma membrane"	"HPA040090: AB_10805603"	"unprognostic (8.04e-2)"	"unprognostic (8.25e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.41e-2)"	"prognostic unfavorable (4.62e-4)"	"unprognostic (2.82e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.33e-2)"	"unprognostic (9.49e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.46e-2)"	"unprognostic (8.49e-2)"	"unprognostic (2.07e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.31e-2)"	11.4	2.7	8.7	4.3	5.5	2.0	14.7	0.1	13.9	14.4	8.9	10.9	7.9	13.7	1.8	15.6	14.6	7.3	9.9	5.8	0.0	44.0	13.3	19.8	1.6	16.0	1.4	5.5	28.0	3.9	8.3	5.1	6.1	14.4	1.5	0.8	24.8	8.2	4.2	16.5	9.6	2.9	2.2	6.3	13.4	9.7	7.9	2.6	34.7	2.0	1.6	16.2	11.6	9.9	124.3	75.1	11.1	42.7	2.4	3.0	122.1	61.4	19.6	39.7	24.5	60.6	205.3	2.3	236.9	9.6	19.3	210.1	4.1	75.6	4.7	4.4	28.6	0.2	102.1	54.2	17.1	1.8	23.1	10.5	32.2	12.6	27.7	55.9	7.2	1.7	25.7	0.7	3.5	93.0	0.8	17.6	28.4	39.7	54.5	20.1	27.0	18.5	70.0	51.4	2.4	25.9	124.8	129.1	121.9	12.7	114.8	7.4	107.8	47.7	169.0	6.4	50.6	1.2	0.6	3.5	30.4	10.8	13.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	5.5	0.1	13.9	5.8	0.0	16.0	1.4	6.1	2.2	7.9	9.9	27.4	25.6	8.8	15.0	2.2	15.0	9.2	94.5	19.9	1.4	32.7	39.2	3.1	61.5	42.0	156.3	8.4	1.6	0.9	29.9	1.9	91.2	0.4	37.2	14.0	29.0	6.7	1.7	23.1	16.9	4.8	8.7	17.9	62.7	2.5	7.2	21.8	13.1	4.1	5.0	7.8	11.6	36.7	2.9	10.1	1.0	5.6	4.3	24.9	12.2	15.6	10.5	0.0	15.1	29.6	87.3	17.7	2.6	0.6	22.3	18.1	16.0	33.0	5.3	6.6	3.3	23.3	0.8	11.4	11.7	6.0	1.2	2.9	2.3	18.3	21.2
AGTR1	"AG2S, AGTR1A, AGTR1B, AT1, AT1B, AT2R1, AT2R1A, AT2R1B, HAT1R"	ENSG00000144891	"Angiotensin II receptor type 1"	P30556	3	148697784-148743008	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 96.6;placenta: 141.6"	"Cell type enhanced"	"Detected in some"		"Fibroblasts: 53.1;Hepatocytes: 30.9;Leydig cells: 145.1;Sertoli cells: 144.7;Smooth muscle cells: 71.2"	"Group enriched"	"Detected in many"	8	"breast cancer: 9.6;liver cancer: 9.8;prostate cancer: 6.8;renal cancer: 2.8"	"Region enhanced"	"Detected in some"		"midbrain: 8.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 176.8;ASC TERT1: 24.4;BJ hTERT+ SV40 Large T+: 34.8;HBF TERT88: 53.9;HSkMC: 32.2"					"Low region specificity"	"Detected in all"			HPA003596	Enhanced		Uncertain	Vesicles		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"HPA003596: AB_1845163"	"unprognostic (2.19e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.48e-4)"	"unprognostic (5.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.28e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.08e-2)"	"unprognostic (9.25e-3)"	"unprognostic (4.11e-2)"	"unprognostic (4.79e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.41e-3)"	65.9	38.2	0.3	1.8	0.7	0.0	39.9	0.2	0.4	3.4	0.4	21.1	0.8	3.5	2.7	2.8	9.8	6.2	10.9	0.4	1.4	18.4	96.6	10.4	0.7	2.1	8.1	3.8	3.5	2.8	3.8	141.6	0.9	5.3	4.4	0.9	4.7	4.2	11.6	15.8	4.3	4.6	0.2	9.1	6.5	2.2	0.7	3.0	14.2	13.8	0.2	14.6	6.1	0.2	0.0	1.0	0.8	0.0	176.8	24.4	0.0	0.2	3.9	34.8	20.0	0.0	0.0	0.0	0.0	2.6	0.2	0.0	0.0	0.0	53.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	32.2	0.0	3.4	1.8	1.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.2	0.4	0.4	1.4	2.1	8.1	0.9	0.2	0.7	0.2	20.5	0.0	0.6	0.0	0.0	3.4	0.2	0.0	0.0	0.0	1.3	0.9	6.3	2.8	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.1	0.8	0.0	0.3	3.8	23.5	0.0	0.1	7.6	0.3	53.1	0.5	0.0	0.0	0.0	17.5	30.9	0.7	0.0	0.0	0.2	0.0	0.3	3.5	1.7	145.1	0.5	1.8	2.8	0.0	5.7	0.0	0.0	0.1	0.5	0.0	7.5	0.4	1.1	0.0	0.1	0.0	0.1	144.7	7.6	71.2	0.0	1.8	0.3	1.7	0.3	0.5	0.3	0.0	0.1
AHCTF1	ELYS	ENSG00000153207	"AT-hook containing transcription factor 1"	Q8WYP5	1	246839098-246931948	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, mRNA transport, Protein transport, Translocation, Transport"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 3.0"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031658	Uncertain		Supported	"Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 51: Myeloid cells - Hemostasis"	"Nuclear membrane"		"HPA031658: AB_10601968"	"unprognostic (3.10e-1)"	"unprognostic (1.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.11e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.50e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.53e-2)"	"unprognostic (7.12e-2)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (3.49e-8)"	"unprognostic (7.65e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.91e-2)"	"unprognostic (8.52e-2)"	12.6	7.5	4.4	8.4	6.4	16.9	9.7	11.4	6.2	9.1	5.7	9.1	6.5	8.8	6.6	9.2	7.0	7.4	6.6	4.7	6.2	9.8	10.9	7.2	9.1	3.3	5.6	16.2	10.0	13.1	6.4	8.8	3.7	7.6	6.9	8.1	6.8	7.9	11.0	8.0	6.6	7.9	3.8	9.2	8.5	32.5	7.0	12.2	13.7	15.7	9.0	10.3	7.1	4.8	37.9	25.9	24.6	20.7	24.3	23.6	32.4	24.2	19.3	29.1	24.2	26.5	19.4	37.6	24.6	21.6	16.4	34.1	40.3	20.9	49.7	21.0	9.0	26.4	29.0	24.2	17.4	40.8	17.8	22.8	18.5	37.9	38.4	13.9	21.9	18.5	61.2	24.4	27.8	12.5	31.5	19.2	42.4	34.1	18.4	30.4	32.6	32.1	18.3	28.0	22.1	28.6	34.9	19.5	20.3	18.3	22.1	29.2	20.1	26.3	22.5	33.2	55.7	25.8	38.9	45.4	19.5	27.0	26.2	0.3	0.2	0.7	0.5	0.1	0.5	0.7	0.7	0.6	0.2	0.4	0.8	0.6	3.0	0.4	0.4	0.4	0.8	0.3	4.4	6.4	11.4	6.2	4.7	6.2	3.3	5.6	3.7	3.8	7.0	4.8	53.7	35.3	35.0	37.2	32.9	30.0	22.4	10.3	40.5	19.8	15.9	21.7	21.1	7.2	20.7	5.5	8.4	14.1	27.4	15.7	3.9	12.5	63.7	29.1	30.9	25.9	21.6	20.8	62.2	12.4	10.8	30.5	21.9	28.8	12.0	20.3	17.2	14.3	9.3	18.5	55.7	12.9	10.2	13.2	13.8	23.7	36.1	57.4	3.6	29.0	17.7	8.9	26.8	46.8	51.3	16.2	13.0	39.1	35.8	27.7	11.9	8.8	20.4	17.1	32.9	70.9	26.1	116.7	37.6	27.3	30.7	13.5	31.3	21.4	12.4	26.2
AHCYL1	"IRBIT, PPP1R78, XPVKONA"	ENSG00000168710	"Adenosylhomocysteinase like 1"	O43865	1	109984765-110023742	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"One-carbon metabolism"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 337.1"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 328.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042589	Approved		Supported	Cytosol		NA	NA		160000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA042589: AB_10793885"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (7.00e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.01e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.01e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.38e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.89e-1)"	"unprognostic (8.87e-2)"	"unprognostic (4.84e-3)"	68.0	66.1	222.3	33.5	271.0	14.7	51.4	244.2	238.0	66.5	175.2	52.1	126.8	54.3	91.8	47.9	72.9	65.2	38.2	183.8	300.2	102.1	69.2	44.6	31.5	337.1	292.5	53.0	73.3	178.5	51.4	56.3	271.6	44.2	51.6	68.8	50.9	64.1	91.8	38.5	64.1	57.3	310.0	34.6	56.3	28.3	299.6	32.2	75.3	44.6	37.5	49.3	39.9	295.6	100.9	83.4	77.3	80.5	182.8	106.8	127.2	78.1	87.7	72.2	70.7	65.3	56.4	42.5	64.9	115.5	55.0	63.0	69.2	89.1	95.0	355.3	59.8	70.8	106.5	69.5	188.4	61.1	47.7	109.7	55.2	90.0	131.0	175.5	92.2	70.7	51.8	84.1	75.7	80.1	51.3	30.2	91.5	140.6	64.1	54.9	161.1	47.7	157.7	99.8	75.4	49.1	121.1	142.9	165.2	116.8	76.5	60.3	80.3	69.3	67.3	82.8	70.4	68.8	30.5	36.0	142.2	65.7	145.1	3.9	5.0	4.6	2.2	5.4	2.3	3.9	2.3	3.1	3.5	4.4	2.4	2.3	4.7	2.5	3.8	3.2	5.0	2.2	222.3	271.0	244.2	238.0	183.8	300.2	337.1	292.5	271.6	310.0	299.6	295.6	67.3	35.3	74.8	328.1	30.1	89.2	100.1	61.7	47.8	62.3	105.9	71.2	49.8	85.8	68.0	117.7	223.1	80.7	29.4	72.0	125.2	142.2	41.6	226.2	69.1	59.0	85.5	42.0	48.7	110.5	50.4	107.4	69.8	181.1	31.7	81.1	61.8	158.2	42.8	63.9	50.4	71.1	65.1	75.8	67.7	29.6	93.5	62.2	62.2	53.4	57.2	99.9	19.6	60.8	53.2	100.8	38.5	81.6	27.0	108.1	134.3	143.6	83.5	105.7	46.0	87.9	105.7	31.6	13.1	75.6	108.4	100.3	26.8	61.4	78.9	134.2
AHSA1	"Aha1, C14orf3, hAha1, p38"	ENSG00000100591	"Activator of HSP90 ATPase activity 1"	O95433	14	77457870-77469472	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Stress response"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 345.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000903, CAB006244"	Supported		Supported	Cytosol		NA	NA		120000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB006244: AB_425858, HPA000903: AB_1078112"	"unprognostic (3.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.69e-1)"	"unprognostic (3.48e-1)"	"unprognostic (1.49e-3)"	"prognostic unfavorable (5.04e-6)"	"unprognostic (3.63e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.44e-2)"	"unprognostic (3.01e-1)"	70.9	99.1	134.7	51.8	136.1	51.0	55.4	142.0	345.7	63.9	135.3	82.4	44.8	80.1	72.3	72.6	120.9	39.4	116.7	134.9	139.1	73.2	71.8	60.8	71.6	141.8	139.3	69.8	50.3	65.5	66.7	76.5	144.0	64.4	71.8	39.1	56.7	70.3	140.2	59.8	54.9	85.0	139.4	55.7	61.9	99.4	142.5	65.2	47.1	118.3	91.4	76.9	61.1	156.2	185.0	356.7	103.1	131.9	159.1	110.3	175.1	131.2	111.6	223.0	165.3	277.0	163.4	361.3	103.0	145.1	258.4	204.7	386.2	186.5	231.8	131.8	207.5	156.1	181.6	343.3	113.7	102.6	230.8	98.3	244.9	150.7	72.2	133.1	209.9	225.3	205.5	115.6	138.5	522.6	278.6	207.8	170.6	347.7	372.9	210.2	110.3	178.1	178.2	187.1	155.0	161.4	119.2	302.9	115.8	154.4	174.4	152.6	100.3	115.3	162.1	126.2	198.7	103.7	241.6	273.8	169.1	211.3	131.1	82.7	51.5	67.9	66.4	74.0	76.9	81.0	59.8	68.0	67.2	63.7	69.0	70.6	39.8	88.7	92.5	66.4	77.2	52.2	134.7	136.1	142.0	345.7	134.9	139.1	141.8	139.3	144.0	139.4	142.5	156.2	46.6	35.3	21.6	10.1	59.4	156.0	208.2	82.8	74.0	36.0	49.9	46.6	92.2	42.9	57.0	27.6	85.5	153.4	66.8	60.0	74.3	74.2	40.6	112.6	60.8	54.9	78.3	55.8	14.6	48.8	113.3	68.3	25.5	59.6	76.2	55.2	28.9	41.0	93.5	18.5	14.7	70.5	65.1	26.7	117.5	34.2	67.7	52.6	90.7	12.2	58.5	46.6	61.8	10.1	23.6	67.8	65.6	66.5	54.1	145.4	56.4	87.0	132.2	54.1	98.6	46.9	135.0	92.0	57.3	67.7	140.1	136.7	92.3	86.0	85.2	120.1
AIG1	"AIG-1, dJ95L4.1, FLJ10485"	ENSG00000146416	"Androgen induced 1"	Q9NVV5	6	143060496-143341058	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 235.8"	"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 245.4;Proximal tubular cells: 261.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060766	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA060766: AB_2684356"	"unprognostic (2.70e-2)"	"prognostic unfavorable (3.26e-6)"	"unprognostic (4.27e-2)"	"prognostic unfavorable (3.06e-4)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (3.25e-7)"	"unprognostic (1.91e-2)"	"unprognostic (8.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (5.53e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.43e-1)"	"unprognostic (9.11e-2)"	"unprognostic (2.75e-1)"	42.0	29.8	43.7	10.4	44.6	31.6	30.0	43.3	46.1	17.6	48.2	23.0	46.6	14.4	33.0	34.1	34.4	24.5	54.1	44.1	49.1	102.0	235.8	19.9	10.7	45.0	43.4	34.7	31.0	31.0	36.6	11.9	46.4	22.7	18.8	33.9	19.8	24.1	23.7	16.8	45.9	15.2	47.1	20.1	20.8	15.7	51.0	6.8	42.9	32.5	14.8	29.4	26.1	52.5	32.6	25.2	20.6	56.9	29.7	22.3	7.6	28.3	57.1	26.8	61.9	37.5	81.5	20.0	40.5	66.1	41.7	42.0	26.5	79.2	64.2	67.2	63.0	5.6	35.6	157.3	40.8	46.0	2.7	32.9	76.7	35.7	129.6	88.2	10.9	30.8	4.0	67.6	59.3	45.6	14.2	9.8	40.8	37.4	27.6	20.2	61.6	36.6	100.6	77.6	75.5	42.4	35.5	33.2	17.2	36.0	31.7	96.0	3.0	25.2	27.8	22.7	33.4	99.6	95.1	2.1	59.7	9.5	26.9	12.0	6.2	9.6	6.6	29.3	15.1	9.6	12.4	10.6	33.0	5.6	13.1	10.0	11.3	11.8	35.4	2.9	9.7	9.2	43.7	44.6	43.3	46.1	44.1	49.1	45.0	43.4	46.4	47.1	51.0	52.5	40.8	16.0	27.7	114.9	22.0	25.0	51.8	82.5	27.9	68.3	69.9	65.4	73.7	72.9	66.9	51.5	25.0	79.6	8.6	12.6	52.8	60.3	22.4	99.8	25.9	32.8	39.5	29.3	204.3	31.5	10.5	42.2	26.0	83.1	36.8	90.9	36.8	229.6	32.7	53.8	245.4	33.3	59.0	40.1	42.3	7.0	32.0	37.2	55.2	100.2	18.2	74.3	8.2	105.1	172.9	25.8	65.2	38.4	47.7	35.3	232.9	261.5	69.1	36.9	32.9	41.7	50.8	5.6	17.3	53.1	45.7	108.1	18.5	61.5	42.4	53.2
AKAP5	"AKAP75, AKAP79"	ENSG00000179841	"A-kinase anchoring protein 5"	P24588	14	64465499-64474503	"Plasma proteins, Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 13.5;intestine: 3.8"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 15.6;Excitatory neurons: 17.2;granulocytes: 67.6;Intestinal goblet cells: 28.7;NK-cells: 16.5"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	29	"amygdala: 5.3;basal ganglia: 13.5;cerebral cortex: 8.5;hippocampal formation: 7.7"	"Immune cell enriched"	"Detected in single"	8	"basophil: 3.0"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 3.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.9"	"Group enriched"	"Detected in all"	5	"amygdala: 27.6;basal ganglia: 79.0;cerebral cortex: 29.4;hippocampal formation: 30.8"	"Group enriched"	"Detected in all"	5	"amygdala: 24.3;basal ganglia: 79.9;cerebral cortex: 44.9;hippocampal formation: 43.7"	"CAB004308, HPA053891"	Enhanced	Supported	Approved	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 60: Granulocytes - Receptor signaling"	Nucleoplasm		"CAB004308: AB_626655, HPA053891: AB_2682294"	"unprognostic (4.29e-2)"	"unprognostic (5.89e-3)"	"unprognostic (3.44e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.57e-1)"	"unprognostic (6.92e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.23e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.49e-4)"	"unprognostic (2.11e-1)"	"unprognostic (2.42e-1)"	"unprognostic (7.45e-2)"	0.3	0.3	5.3	1.4	13.5	0.6	0.5	0.0	8.5	0.4	0.0	3.7	0.5	1.3	0.1	0.5	0.5	0.9	0.2	7.7	0.0	1.3	0.8	1.8	1.9	0.0	0.1	0.4	0.2	0.4	1.0	1.1	0.0	0.4	3.8	0.6	0.3	0.4	0.2	0.5	1.4	1.3	0.0	1.2	0.5	0.3	0.0	0.9	0.5	0.0	1.6	0.6	0.3	0.3	1.3	1.0	1.3	0.8	0.4	0.1	4.2	0.9	0.4	1.2	1.5	10.9	3.3	1.0	2.0	0.7	0.1	0.4	2.8	0.2	1.1	2.0	2.4	3.3	2.0	0.9	0.1	0.4	0.4	0.4	0.1	0.8	0.0	2.1	0.4	2.4	0.4	0.7	0.7	0.8	2.7	0.2	1.0	0.1	0.5	3.3	0.5	0.2	1.9	1.2	3.3	1.4	1.1	0.1	0.2	3.8	1.0	0.2	0.6	1.4	4.2	0.1	1.7	2.2	2.6	2.4	0.9	0.4	0.2	3.0	0.0	0.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.1	0.1	0.2	0.3	0.0	0.1	0.0	0.0	5.3	13.5	0.0	8.5	7.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.4	6.4	2.4	1.6	2.8	0.9	1.3	0.5	1.2	7.4	1.8	1.4	1.6	1.5	0.2	0.0	8.4	0.6	15.6	5.1	0.0	0.6	2.6	0.5	1.4	1.9	0.0	2.7	17.2	0.2	1.9	2.1	0.5	1.0	67.6	0.9	0.4	0.7	0.5	8.4	5.5	28.7	0.0	0.3	2.9	0.9	0.0	1.2	1.8	0.0	0.3	0.9	16.5	3.0	1.6	0.8	2.2	0.0	6.4	1.2	0.8	1.4	0.2	7.7	0.0	2.2	0.8	0.5	4.9	0.1	0.9	0.7	12.4	0.3	6.2	0.9
AKT1	"AKT, PKB, PRKBA, RAC, RAC-alpha"	ENSG00000142208	"AKT serine/threonine kinase 1"	P31749	14	104769349-104795751	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Carbohydrate metabolism, Glucose metabolism, Glycogen biosynthesis, Glycogen metabolism, Neurogenesis, Sugar transport, Translation regulation, Transport"	"Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 61.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.5"	"Cell line enhanced"	"Detected in all"		"MCF7: 558.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002891, CAB003765"	Supported		Supported	Nucleoplasm,Microtubules		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 30: Mammary glandular cells - Lactation"	Nucleoplasm	Microtubules	"CAB003765: AB_562035, HPA002891: AB_1078123"	"unprognostic (3.30e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.70e-1)"	"unprognostic (9.17e-3)"	"unprognostic (1.55e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (4.83e-4)"	"unprognostic (3.58e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (2.12e-4)"	"unprognostic (7.14e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.41e-1)"	71.5	102.7	45.9	57.7	45.5	51.2	61.2	43.7	53.2	52.0	50.4	85.0	50.8	59.5	23.2	70.7	53.7	50.0	105.9	45.2	44.3	54.3	97.3	69.2	51.9	50.5	45.7	43.7	94.3	53.0	35.9	55.4	45.0	67.2	39.6	25.1	67.7	73.0	58.1	45.0	53.3	63.4	47.4	63.7	77.8	23.9	48.0	52.4	52.3	64.9	40.3	72.6	48.4	43.3	77.3	150.5	124.6	186.9	95.2	97.7	136.9	142.3	171.5	204.6	163.6	96.8	92.8	91.2	105.5	196.6	102.8	99.4	89.5	131.9	90.1	214.3	36.2	70.6	90.4	103.2	104.6	117.5	178.0	140.0	109.1	102.9	68.1	98.2	154.4	87.5	62.1	102.2	134.1	558.3	145.3	146.8	32.6	153.5	107.2	137.5	111.9	60.5	94.8	189.5	141.2	117.2	117.3	152.2	88.9	56.8	195.7	170.2	123.5	133.2	63.2	192.3	145.1	105.4	52.6	80.7	113.7	96.7	162.0	6.4	9.9	61.5	10.0	10.3	7.2	5.5	8.7	11.4	7.0	7.2	4.6	10.1	22.6	11.0	12.4	10.0	9.0	6.3	45.9	45.5	43.7	53.2	45.2	44.3	50.5	45.7	45.0	47.4	48.0	43.3	45.8	16.0	27.4	16.6	13.7	12.4	20.0	17.3	15.9	26.3	58.0	39.9	16.1	32.9	17.7	22.0	12.5	19.4	54.2	40.9	13.7	23.6	1.9	17.9	28.1	27.5	30.0	11.3	8.2	35.2	31.8	24.0	26.0	24.8	2.5	40.4	23.2	42.9	23.2	42.1	13.0	37.3	22.4	23.3	21.4	3.3	28.6	28.0	10.6	6.5	23.1	51.2	24.7	8.0	9.6	53.3	22.1	30.9	10.3	38.8	23.5	17.9	14.2	26.6	26.3	24.9	29.1	1.8	5.3	16.2	13.9	23.4	23.3	34.0	33.7	33.4
ALCAM	"CD166, MEMD"	ENSG00000170017	"Activated leukocyte cell adhesion molecule"	Q13740	3	105366909-105576900	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Cell adhesion, Immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"parathyroid gland: 438.9"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 737.2;Oligodendrocyte precursor cells: 680.1;Oligodendrocytes: 981.1;Respiratory ciliated cells: 318.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 29.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 29.6"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 393.4;U-138 MG: 473.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002148, HPA010926"	Enhanced		Uncertain	Vesicles	"Secreted to blood"	NA	NA		1600000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"CAB002148: AB_442053, HPA010926: AB_1078449"	"unprognostic (6.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (2.13e-1)"	"unprognostic (2.19e-1)"	"unprognostic (9.48e-3)"	"unprognostic (2.08e-2)"	"unprognostic (1.63e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.07e-1)"	"prognostic favorable (3.15e-4)"	"unprognostic (3.15e-1)"	"unprognostic (4.47e-2)"	"unprognostic (9.57e-2)"	"unprognostic (7.76e-2)"	7.7	32.7	31.3	12.2	48.1	10.5	81.0	42.4	47.2	28.0	14.4	16.6	17.0	15.5	35.4	8.2	49.1	23.3	9.6	32.4	70.6	22.2	47.9	74.1	9.9	50.7	54.9	57.6	32.7	438.9	19.2	12.1	51.7	32.7	14.5	3.6	33.8	39.6	0.8	11.0	17.4	16.2	44.9	6.3	33.4	4.5	45.7	14.2	62.4	5.0	14.5	25.6	6.4	85.0	248.4	93.7	65.9	33.7	97.6	42.7	0.6	197.7	115.1	124.9	173.8	0.8	50.5	17.3	80.3	280.6	68.8	186.5	10.6	157.4	366.1	16.6	16.6	2.4	65.8	4.6	109.6	101.3	0.8	76.0	114.9	159.9	393.4	346.8	139.3	17.9	0.3	28.6	165.9	16.9	14.5	37.0	13.7	79.3	104.8	9.4	5.9	1.0	188.9	27.2	47.5	131.9	20.6	19.6	12.9	25.9	37.7	66.3	291.6	473.7	162.3	20.9	237.2	0.3	0.6	1.8	108.0	21.1	207.4	0.0	4.7	3.5	0.6	2.1	1.9	4.7	1.5	0.9	29.6	3.0	0.3	0.2	5.3	0.6	1.2	10.5	2.4	3.2	31.3	48.1	42.4	47.2	32.4	70.6	50.7	54.9	51.7	44.9	45.7	85.0	4.5	737.2	143.6	238.6	17.9	12.1	22.8	65.8	12.0	3.0	112.4	47.9	10.1	62.9	255.3	16.5	2.1	0.7	19.5	9.1	1.9	18.5	66.5	108.6	20.1	11.9	16.8	6.3	143.0	43.0	0.7	37.0	23.4	158.1	11.4	29.5	3.6	44.1	57.5	1.7	287.0	16.3	46.8	51.0	162.6	60.1	3.7	86.4	24.9	40.3	93.4	1.3	1.0	680.1	981.1	55.2	8.5	6.4	21.8	117.5	9.6	24.2	318.3	0.8	0.0	7.9	21.8	8.1	5.5	30.1	20.2	0.8	8.9	22.8	10.4	105.4
AMIGO1	"AMIGO, KIAA1163"	ENSG00000181754	"Adhesion molecule with Ig like domain 1"	Q86WK6	1	109504178-109509738	"Predicted membrane proteins, Transporters"	"Cell adhesion, Differentiation, Neurogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 33.6;Excitatory neurons: 9.6;Inhibitory neurons: 15.9;Rod photoreceptor cells: 9.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"SK-BR-3: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046152	Approved		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Nucleoplasm, Nuclear bodies"		"HPA046152: AB_2679559"	"unprognostic (1.35e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.32e-2)"	"unprognostic (4.78e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (2.44e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.55e-2)"	"unprognostic (6.16e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.97e-1)"	3.8	10.7	12.7	2.7	13.8	0.4	3.2	11.7	20.0	3.6	8.2	6.9	2.1	4.3	11.7	2.8	3.3	2.8	8.6	14.3	12.6	5.2	2.8	4.6	4.1	11.5	10.7	8.8	6.8	12.4	7.4	1.9	12.5	6.3	2.4	23.4	7.6	7.7	19.3	2.4	3.8	4.5	7.9	3.3	4.6	2.9	12.6	2.7	6.5	11.9	3.3	3.9	2.8	11.8	2.3	1.1	2.4	8.3	3.0	1.3	2.9	3.6	2.0	4.4	2.1	0.5	0.1	0.1	1.0	2.5	1.0	1.2	6.5	0.2	3.7	0.9	0.5	0.0	1.6	0.7	2.5	1.9	4.6	0.6	2.8	1.5	0.0	0.4	1.1	1.3	1.9	0.0	0.1	4.1	0.4	3.9	1.3	2.0	2.5	0.6	0.0	0.3	5.1	1.1	8.1	2.7	0.9	11.0	3.2	1.0	3.2	2.8	1.0	0.1	4.8	3.0	1.5	0.2	0.0	0.0	1.6	0.0	2.4	0.0	0.0	0.0	0.6	0.0	0.7	0.0	0.9	1.1	0.0	0.0	2.3	1.7	0.0	0.9	0.0	0.0	0.7	0.4	12.7	13.8	11.7	20.0	14.3	12.6	11.5	10.7	12.5	7.9	12.6	11.8	0.6	3.2	2.0	5.9	0.2	0.6	0.4	0.3	0.6	33.6	2.4	1.4	8.9	1.5	0.3	3.7	4.2	1.3	0.6	1.5	0.0	1.2	0.0	0.4	0.4	1.6	4.8	0.0	9.6	0.9	0.2	1.9	0.0	0.7	0.0	1.4	1.1	1.0	0.2	5.0	15.9	1.0	2.0	0.6	0.0	0.1	2.1	0.2	0.0	2.8	0.8	6.7	0.0	3.0	2.1	0.8	1.6	5.7	0.1	1.1	2.3	0.8	0.1	9.4	0.0	4.3	1.5	1.2	1.4	0.2	0.4	0.3	1.8	0.9	1.5	0.3
ANK1	"ANK, SPH1"	ENSG00000029534	"Ankyrin 1"	P16157	8	41653220-41896762	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"skeletal muscle: 993.4;tongue: 629.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 164.7;Cone photoreceptor cells: 87.6;Erythroid cells: 250.2;Inhibitory neurons: 176.8;Skeletal myocytes: 51.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.2;naive B-cell: 7.8;plasmacytoid DC: 3.4"	"Group enriched"	"Detected in many"	4	"B-cells: 9.2;dendritic cells: 3.4"	"Group enriched"	"Detected in many"	4	"HEL: 125.2;K-562: 134.3;RH-30: 160.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004842, HPA056953"	Supported	Supported			"Intracellular and membrane"	NA	NA		4200000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA004842: AB_1844827, HPA056953: AB_2683284"	"unprognostic (1.05e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.22e-3)"	"unprognostic (2.31e-3)"	"unprognostic (1.76e-7)"	"unprognostic (2.03e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.95e-1)"	"unprognostic (3.21e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.04e-1)"	1.8	1.1	0.4	1.6	2.0	95.2	1.0	34.1	17.3	0.3	0.0	0.5	1.5	0.1	0.1	8.7	0.4	0.8	98.0	0.3	12.5	0.6	0.3	0.7	4.4	26.8	32.6	0.3	0.8	62.1	1.1	2.1	27.1	4.2	0.2	6.3	8.1	0.7	993.4	0.6	0.9	0.3	10.6	2.2	4.4	0.6	8.4	0.7	0.6	629.0	4.0	1.8	0.5	5.4	0.0	16.8	0.5	0.0	0.2	2.9	0.0	4.9	32.8	1.5	0.7	0.1	0.0	7.7	1.5	3.5	0.6	2.8	0.8	0.5	0.7	3.2	0.1	125.2	0.7	0.0	0.1	0.3	0.4	4.2	0.6	0.4	0.0	0.7	0.1	0.0	134.3	2.8	2.1	0.3	0.0	1.6	1.7	0.1	0.1	0.9	160.2	0.8	0.7	0.5	2.2	1.4	0.1	2.3	0.0	5.9	2.0	3.2	0.8	0.5	0.9	27.6	0.2	0.0	0.2	4.7	2.9	0.0	0.0	1.5	0.2	0.0	0.1	0.0	0.4	9.2	0.3	0.4	0.1	7.8	0.0	0.0	0.4	0.1	0.0	3.4	1.0	0.7	0.4	2.0	34.1	17.3	0.3	12.5	26.8	32.6	27.1	10.6	8.4	5.4	5.5	0.0	0.0	1.3	8.3	0.6	1.4	2.2	0.6	15.4	0.3	0.1	164.7	0.0	1.0	0.0	87.6	1.1	0.2	0.1	1.9	0.1	7.0	0.1	0.1	4.6	1.2	250.2	12.9	0.0	0.5	2.9	5.6	0.5	0.0	2.2	0.4	0.1	19.7	3.3	176.8	0.7	2.0	0.8	3.7	6.3	0.3	2.6	0.0	3.7	0.4	1.0	0.0	7.1	2.0	1.1	1.2	0.4	5.7	1.3	0.1	0.3	0.6	5.5	0.0	51.6	5.7	0.2	1.0	0.1	0.0	0.4	1.7	0.1	0.0	1.8
ANK2	"CFAP87, FAP87, LQT4"	ENSG00000145362	"Ankyrin 2"	Q01484	4	112818032-113384221	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 165.7;retina: 191.2;skeletal muscle: 171.7;tongue: 150.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 1101.2;Bipolar cells: 376.6;Cone photoreceptor cells: 479.6;Excitatory neurons: 1282.0;Horizontal cells: 1431.8;Inhibitory neurons: 1060.7;Oligodendrocyte precursor cells: 497.1;Oligodendrocytes: 1351.0;Rod photoreceptor cells: 484.4"	"Cancer enhanced"	"Detected in many"		"glioma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 29.2;ASC TERT1: 32.2;RH-30: 49.6;SH-SY5Y: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008007, CAB015178, HPA035970"	Enhanced	Approved	Supported	"Plasma membrane"		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"CAB015178: AB_2242828, HPA008007: AB_2667965, HPA035970: AB_2674893"	"unprognostic (8.33e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.33e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.79e-3)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (2.41e-6)"	"unprognostic (1.18e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.04e-3)"	31.0	13.6	94.9	11.2	109.0	0.1	18.3	63.1	165.7	31.6	0.0	30.1	8.5	15.8	5.9	12.9	9.6	22.5	119.5	103.9	77.5	110.1	2.4	7.2	9.2	130.2	61.1	27.3	3.2	1.2	19.3	2.1	119.5	7.8	11.4	191.2	6.7	13.3	171.7	8.7	12.7	24.9	51.9	28.3	8.3	9.4	84.8	4.4	9.6	150.5	7.2	9.5	12.3	116.2	0.1	2.9	18.7	5.2	29.2	32.2	0.1	1.5	3.4	0.9	2.6	4.2	0.0	6.9	2.1	5.9	4.1	0.1	11.0	0.6	1.0	2.3	7.3	4.0	0.0	2.9	1.7	1.9	1.2	15.2	3.0	1.2	6.0	3.9	0.0	0.4	0.0	9.3	5.8	0.3	0.2	0.1	9.4	0.1	2.0	0.7	49.6	0.0	0.2	0.0	13.6	24.1	0.2	0.7	8.1	11.7	0.1	1.1	0.0	4.7	2.2	0.4	3.0	6.8	1.8	0.9	20.1	0.6	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	109.0	63.1	165.7	103.9	77.5	130.2	61.1	119.5	51.9	84.8	116.2	6.9	0.0	3.9	1101.2	1.1	10.5	0.0	0.0	1.8	376.6	0.2	0.6	188.5	0.0	1.3	20.2	479.6	0.1	0.0	0.0	15.6	0.0	111.2	36.4	6.0	6.4	66.0	0.0	1282.0	1.6	0.1	79.0	2.0	7.2	1.3	81.8	0.0	0.4	1.0	1431.8	1060.7	0.4	8.2	0.0	19.7	49.8	36.4	2.9	17.8	90.9	0.6	44.5	0.0	497.1	1351.0	0.1	5.0	30.1	0.9	0.4	0.1	127.9	0.8	484.4	6.6	24.3	26.5	2.3	1.5	0.8	9.5	0.0	1.9	2.6	0.3	0.2
ANKH	"ANK, CCAL2, CMDJ, CPPDD, HANK, SLC62A1"	ENSG00000154122	"ANKH inorganic pyrophosphate transport regulator"	Q9HCJ1	5	14704800-14871778	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Phosphate transport, Transport"		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 160.1;Hofbauer cells: 208.8;Inhibitory neurons: 214.5;Oligodendrocytes: 261.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068104			Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA068104: AB_2685954"	"unprognostic (1.15e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.55e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (6.58e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (2.38e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.76e-3)"	"unprognostic (1.71e-1)"	"unprognostic (8.66e-2)"	"unprognostic (6.46e-2)"	9.9	10.6	22.1	6.6	23.8	8.0	9.9	33.9	29.3	5.5	26.6	12.8	16.8	7.1	4.9	7.4	7.7	9.4	32.2	22.5	25.5	8.1	21.4	7.1	8.5	25.3	28.2	16.0	15.2	19.2	22.8	8.5	25.1	32.7	11.4	25.1	14.3	9.2	40.9	20.3	15.0	8.5	24.9	6.8	7.3	1.9	26.8	11.5	10.7	37.6	14.1	7.3	7.4	28.8	7.2	5.4	6.7	1.1	13.8	32.3	3.2	6.8	13.7	2.6	2.7	4.3	9.0	16.9	15.7	9.4	6.2	4.6	4.6	7.5	3.0	6.7	11.3	0.4	47.8	11.6	4.6	4.1	1.3	10.2	13.0	8.1	9.2	9.2	5.5	12.3	3.5	35.2	8.7	9.6	6.9	13.3	2.6	9.5	6.0	9.8	3.3	15.3	0.0	2.3	16.4	4.5	33.3	5.3	7.5	6.1	0.3	1.5	5.4	6.9	6.9	11.5	12.6	9.2	9.3	13.0	23.8	15.1	29.0	0.6	0.2	0.0	1.4	0.4	2.3	1.5	2.9	2.3	0.3	1.6	3.3	1.5	0.3	0.3	0.9	0.3	4.6	0.4	22.1	23.8	33.9	29.3	22.5	25.5	25.3	28.2	25.1	24.9	26.8	28.8	50.1	25.6	19.1	64.6	15.4	25.2	79.1	33.7	40.9	58.0	29.7	15.5	73.4	7.2	10.8	7.3	127.2	76.4	21.1	58.2	5.9	1.7	1.2	7.1	14.9	25.4	41.8	69.9	160.1	11.8	6.1	25.6	8.2	16.9	17.7	9.8	12.5	32.7	208.8	20.2	214.5	37.7	8.2	89.3	29.9	1.9	5.0	42.6	10.6	106.8	3.4	20.1	21.6	95.5	261.5	6.8	31.4	31.6	14.7	55.4	44.6	10.2	6.4	50.1	0.0	32.8	12.3	2.3	7.2	10.1	10.7	42.0	25.9	8.6	37.3	22.3
ANKRD50	KIAA1223	ENSG00000151458	"Ankyrin repeat domain 50"	Q9ULJ7	4	124664048-124712732	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"intermediate monocyte: 1.1"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 56.8;HUVEC TERT2: 58.2;TIME: 147.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044008	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Cytosol"		"HPA044008: AB_10961996"	"unprognostic (7.82e-2)"	"unprognostic (1.68e-2)"	"unprognostic (6.85e-3)"	"unprognostic (5.90e-1)"	"unprognostic (9.77e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.72e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (1.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (5.55e-3)"	"unprognostic (4.82e-2)"	"unprognostic (8.23e-2)"	"unprognostic (8.16e-3)"	6.0	2.6	3.2	4.2	4.5	4.5	5.7	1.3	3.1	11.4	2.6	4.7	3.1	7.6	2.5	6.4	2.8	8.5	5.0	3.7	6.2	4.4	5.8	9.6	2.3	4.3	4.2	6.5	3.3	5.7	1.0	14.8	3.8	8.9	5.6	1.8	3.9	6.2	1.4	11.0	3.9	8.9	2.1	3.1	7.4	15.1	7.2	4.6	7.4	3.6	1.9	14.2	5.6	2.0	6.3	11.6	32.0	14.9	25.0	15.8	3.2	15.9	13.4	8.1	5.2	5.0	8.1	0.0	4.8	22.8	7.3	5.7	21.3	12.3	14.1	0.0	4.6	5.3	15.3	5.0	17.8	8.8	6.6	16.0	16.4	12.8	56.8	15.2	58.2	5.7	9.6	11.0	15.5	14.3	11.1	3.2	6.7	9.2	16.9	9.0	9.9	1.4	10.2	25.7	9.2	11.5	11.0	6.9	12.9	13.3	7.4	7.4	147.7	17.1	13.3	8.5	13.8	8.0	0.1	2.1	7.8	3.7	20.0	0.0	0.5	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.8	0.3	0.0	0.1	3.2	4.5	1.3	3.1	3.7	6.2	4.3	4.2	3.8	2.1	7.2	2.0	18.3	32.1	24.6	10.7	0.9	40.4	21.7	17.9	24.5	2.8	12.2	7.1	9.0	12.8	12.5	5.5	0.0	2.9	2.7	7.3	0.0	9.3	41.0	6.6	14.2	21.5	8.4	5.0	15.1	20.1	29.0	16.5	11.7	7.7	5.1	20.4	29.6	8.8	5.3	21.9	42.2	3.7	18.3	13.4	13.0	55.6	6.8	12.6	10.6	30.9	12.8	2.7	0.0	30.7	13.4	15.1	2.8	12.0	0.6	11.7	3.7	4.7	11.0	0.9	0.0	10.9	17.5	17.2	11.2	33.0	30.7	4.1	1.2	33.7	5.3	18.0
ANO1	"DOG1, FLJ10261, ORAOV2, TAOS2, TMEM16A"	ENSG00000131620	"Anoctamin 1"	Q5XXA6	11	70078302-70189528	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Developmental protein, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 181.7;salivary gland: 180.5;seminal vesicle: 209.2"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 70.2;Early spermatids: 54.9;Hepatocytes: 141.3;Late spermatids: 75.1;Sertoli cells: 46.0;Smooth muscle cells: 52.5;Suprabasal keratinocytes: 46.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"A-431: 140.2;CAPAN-2: 207.9;HaCaT: 254.0;OE19: 182.2"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"spinal cord: 6.6"	"HPA032148, HPA057356"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Nucleoplasm	"HPA032148: AB_2674180, HPA057356: AB_2732610"	"unprognostic (2.73e-1)"	"unprognostic (7.91e-2)"	"unprognostic (3.66e-2)"	"prognostic favorable (4.58e-6)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.16e-3)"	"prognostic unfavorable (2.40e-4)"	"unprognostic (2.13e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (4.09e-6)"	"unprognostic (1.56e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.85e-3)"	"unprognostic (1.81e-1)"	16.3	2.2	0.3	3.6	1.6	0.1	86.8	0.8	1.3	46.7	0.1	14.3	3.6	40.0	181.7	12.7	59.1	54.4	21.9	0.5	0.1	6.4	108.5	16.1	3.4	1.0	0.2	2.9	9.1	48.0	4.4	5.2	1.1	17.1	11.0	0.9	180.5	209.2	12.7	97.4	4.6	30.1	0.2	1.2	48.3	10.4	0.1	1.5	35.4	33.0	4.0	6.7	12.8	0.5	140.2	5.3	0.3	4.5	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	207.9	0.0	2.5	0.0	0.3	254.0	0.0	0.7	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.0	1.0	0.5	0.3	1.1	182.2	19.6	0.3	0.0	0.7	0.0	0.2	7.3	0.2	0.1	43.1	0.8	1.4	16.2	0.5	0.5	0.3	1.1	0.0	3.5	0.1	0.3	0.2	0.2	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.6	0.8	1.3	0.5	0.1	1.0	0.2	1.1	0.2	0.1	0.5	7.2	0.0	0.0	0.7	0.4	17.7	21.5	4.2	0.0	0.0	30.5	70.2	3.5	17.2	2.0	0.0	0.0	1.3	0.2	0.4	0.0	4.1	54.9	10.0	27.5	5.6	0.0	2.7	0.7	0.0	0.6	4.2	36.7	18.5	4.5	0.0	3.3	141.3	0.2	0.0	20.4	13.3	0.0	1.6	3.0	75.1	1.8	0.7	5.4	2.8	0.0	0.8	0.0	1.5	0.7	1.0	0.5	1.5	0.3	22.6	0.0	0.7	0.3	0.4	46.0	1.1	52.5	1.4	2.3	1.4	46.7	4.1	0.7	0.1	0.4	20.9
ANO10	"FLJ10375, MGC47890, SCAR10, TMEM16K"	ENSG00000160746	"Anoctamin 10"	Q9NW15	3	43354859-43691594	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 123.3;Excitatory neurons: 77.4;Inhibitory neurons: 97.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016624, HPA051569"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Vesicles	"HPA016624: , HPA051569: AB_2681537"	"unprognostic (1.51e-3)"	"unprognostic (1.38e-2)"	"prognostic favorable (6.70e-4)"	"prognostic favorable (1.11e-4)"	"unprognostic (4.23e-1)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (3.19e-4)"	"unprognostic (7.99e-3)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.41e-6)"	"unprognostic (9.83e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (5.71e-2)"	26.6	14.1	17.6	15.1	18.6	33.0	21.8	23.9	20.9	22.3	18.4	39.4	61.1	21.6	13.6	25.3	13.9	19.4	12.7	18.1	21.1	29.9	14.1	16.9	7.6	22.7	22.9	13.9	15.2	23.7	13.9	18.1	23.2	14.2	33.7	10.1	28.6	20.2	15.5	32.0	54.7	28.0	19.6	9.1	13.5	13.0	19.8	7.1	24.5	11.6	9.7	18.1	21.5	24.1	30.6	23.6	26.1	27.4	101.1	53.5	31.2	87.7	141.1	42.0	54.4	16.2	27.5	3.1	27.4	114.8	43.1	16.3	20.6	47.0	52.6	33.6	14.2	39.4	28.7	17.7	43.9	7.2	31.1	50.5	36.3	53.6	71.8	79.4	100.3	18.7	30.8	24.9	95.2	20.8	7.8	5.2	31.3	23.7	28.6	6.3	18.7	10.2	85.5	31.4	6.4	19.4	34.4	27.0	19.8	45.3	59.5	14.5	84.7	66.2	24.4	70.2	40.7	15.7	22.9	1.1	60.2	14.6	44.2	7.4	19.0	1.4	6.7	11.1	3.8	2.7	4.6	4.5	13.1	2.5	3.9	6.0	32.8	9.7	12.7	2.3	5.4	7.0	17.6	18.6	23.9	20.9	18.1	21.1	22.7	22.9	23.2	19.6	19.8	24.1	24.3	6.4	3.2	70.2	4.1	5.6	5.8	6.9	8.0	8.0	18.2	8.4	5.2	8.6	13.2	14.7	0.0	14.4	3.7	38.5	123.3	21.6	2.9	11.8	23.6	17.8	9.6	11.8	77.4	17.8	19.5	10.6	10.2	31.2	2.5	6.8	23.6	10.7	11.6	10.1	97.9	23.8	10.2	9.6	5.3	5.2	5.6	9.1	14.2	69.3	9.2	17.1	5.2	71.4	46.4	11.7	22.1	10.1	2.6	4.4	58.4	19.0	4.0	3.6	6.6	19.1	15.7	17.1	23.6	8.7	6.1	17.1	5.8	6.2	26.9	4.8
ANO2	"C12orf3, TMEM16B"	ENSG00000047617	"Anoctamin 2"	Q9NQ90	12	5531869-5946232	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	22	"retina: 226.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 81.3;Early spermatids: 57.3;Late spermatids: 283.2;Microglial cells: 143.4;Rod photoreceptor cells: 179.9"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 9.6;HUVEC TERT2: 9.5;U-2 OS: 24.1"	"Region enriched"	"Detected in many"	4	"basal ganglia: 19.6"					"HPA036276, HPA057499"	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	Nucleoplasm	"HPA036276: AB_10670713, HPA057499: AB_2732613"	"unprognostic (6.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (4.05e-3)"	"unprognostic (2.86e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.84e-3)"	"unprognostic (3.78e-3)"	"unprognostic (1.04e-2)"	"unprognostic (1.10e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.17e-1)"	8.8	0.3	3.8	0.4	4.4	0.0	6.6	2.2	3.3	4.3	5.0	1.9	0.7	1.8	1.4	1.7	3.2	1.1	8.0	2.5	2.4	1.2	0.2	7.2	0.1	3.2	3.2	1.5	0.9	1.3	0.6	4.1	3.4	2.5	0.6	226.0	1.3	1.0	2.0	1.1	1.7	1.5	3.0	3.4	2.2	10.1	3.9	0.3	2.4	4.4	0.2	2.4	3.5	2.8	2.5	0.0	4.4	0.0	0.0	0.2	2.0	0.0	9.6	0.5	1.0	0.0	0.2	0.2	0.3	0.0	0.1	0.3	0.0	0.1	0.7	0.3	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.5	0.0	0.0	1.9	0.0	1.0	0.0	0.0	4.6	2.3	0.0	1.9	0.0	1.0	0.1	0.1	0.0	0.0	2.3	1.6	0.0	3.9	1.3	0.0	0.2	0.0	24.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	3.8	4.4	2.2	3.3	2.5	2.4	3.2	3.2	3.4	3.0	3.9	2.8	9.7	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.6	11.5	0.3	0.1	1.9	0.0	0.0	0.0	81.3	1.4	0.0	0.0	0.0	0.0	57.3	0.4	0.4	9.1	0.0	0.0	1.7	0.0	2.0	0.3	0.0	0.5	0.0	0.0	4.6	0.0	0.2	10.1	2.0	0.0	0.0	0.0	0.0	283.2	0.3	0.1	0.0	143.4	0.0	13.0	0.0	31.2	9.9	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	179.9	0.0	1.3	0.6	1.4	1.8	0.0	0.1	2.5	0.0	0.2	0.2	0.0
ANO3	"C11orf25, DYT23, GENX-3947, TMEM16C"	ENSG00000134343	"Anoctamin 3"	Q9BYT9	11	26188842-26663289	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	19	"brain: 59.2;epididymis: 57.4"	"Cell type enriched"	"Detected in some"	5	"Excitatory neurons: 201.9"	"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	5	"basal ganglia: 59.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 1.9;HDLM-2: 6.8;U-2 OS: 1.6;U-2197: 4.3"	"Region enhanced"	"Detected in all"		"basal ganglia: 158.9"	"Region enriched"	"Detected in all"	7	"basal ganglia: 180.1"	HPA041629	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA041629: AB_10793969"	"unprognostic (7.01e-3)"	"unprognostic (4.31e-1)"	"unprognostic (2.94e-1)"	"unprognostic (9.29e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.45e-2)"	"unprognostic (7.02e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.81e-4)"	"unprognostic (9.48e-3)"	"unprognostic (3.50e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.01e-1)"	3.0	0.8	4.3	0.1	59.2	0.0	0.5	0.0	11.8	0.5	0.0	0.2	0.1	0.1	57.4	0.0	0.2	1.8	0.3	7.7	0.0	1.0	1.1	0.4	0.0	1.1	0.1	0.1	0.3	0.1	0.3	0.0	1.9	0.0	0.1	0.4	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.4	0.0	1.9	0.3	0.1	1.0	0.1	0.0	0.0	0.1	1.7	0.0	0.0	0.4	0.0	1.1	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.9	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	4.3	0.0	0.4	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	59.2	0.0	11.8	7.7	0.0	1.1	0.1	1.9	0.0	0.3	1.7	1.0	0.0	2.0	3.3	0.0	0.0	0.0	0.1	0.0	1.7	0.2	0.0	0.9	0.0	0.2	0.0	14.6	0.2	0.0	0.0	0.0	0.1	12.0	0.5	0.0	0.4	0.0	0.0	201.9	0.0	0.3	0.5	0.0	0.3	0.0	0.0	1.8	0.7	0.0	8.4	4.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	8.4	0.0	0.0	0.0	38.2	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	2.3	0.0	0.0	4.7	3.8	2.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0
ANO4	"FLJ34221, FLJ34272, FLJ35277, TMEM16D"	ENSG00000151572	"Anoctamin 4"	Q32M45	12	100717526-101128641	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 12.0;brain: 11.3;cervix: 7.6;ovary: 7.7;seminal vesicle: 8.1"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 536.3;Oligodendrocyte precursor cells: 276.9;Oligodendrocytes: 814.1"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 20.0;LHCN-M2: 9.5;SK-MEL-30: 15.5;TIME: 31.8;WM-115: 11.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053412	Uncertain					NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA053412: AB_2682140"	"unprognostic (1.11e-1)"	"unprognostic (3.03e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.95e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.97e-1)"	"unprognostic (4.72e-1)"	"unprognostic (6.54e-2)"	"prognostic favorable (5.48e-5)"	"unprognostic (1.16e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.41e-1)"	0.2	12.0	5.1	0.0	10.4	0.0	0.1	2.3	6.8	7.6	0.0	0.1	0.3	4.4	0.3	0.0	0.2	0.0	0.1	5.3	5.8	0.1	0.0	0.0	0.0	6.6	7.1	7.7	0.5	0.1	0.8	0.1	5.7	4.8	0.1	0.8	2.0	8.1	0.0	0.0	0.2	0.5	2.6	0.0	0.0	1.0	9.5	0.7	0.1	0.0	0.4	0.7	0.3	11.3	0.0	0.0	2.2	0.0	1.1	1.4	0.0	7.0	6.2	5.7	2.8	0.0	0.0	0.0	0.0	20.0	0.0	0.3	7.2	5.9	5.3	0.0	0.0	0.0	2.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	9.5	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	15.5	7.6	0.0	0.0	31.8	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	10.4	2.3	6.8	5.3	5.8	6.6	7.1	5.7	2.6	9.5	11.3	0.3	0.0	0.0	31.3	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.6	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.1	5.7	0.3	7.8	0.1	4.2	0.0	124.9	0.4	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	536.3	0.0	0.0	0.0	0.0	2.3	0.6	0.1	0.0	6.5	0.0	0.0	0.0	276.9	814.1	0.0	0.0	0.4	0.0	0.3	0.1	0.1	0.0	0.3	0.0	0.2	0.6	0.6	1.8	0.0	0.0	0.0	0.0	3.6	0.0	0.0
ANO5	"GDD1, LGMD2L, TMEM16E"	ENSG00000171714	"Anoctamin 5"	Q75V66	11	21799934-22283357	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Limb-girdle muscular dystrophy, Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 24.9;parathyroid gland: 17.0;skeletal muscle: 65.5;tongue: 50.4"	"Group enriched"	"Detected in many"	7	"Astrocytes: 67.9;Cardiomyocytes: 86.2;Excitatory neurons: 166.6;Inhibitory neurons: 136.4;Oligodendrocyte precursor cells: 81.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 4.9;HAP1: 5.0;HEK 293: 6.6;NTERA-2: 3.5;RPTEC TERT1: 3.2;U-266/84: 3.7"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA058857	Uncertain					NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA058857: AB_2683835"	"unprognostic (5.25e-3)"	"unprognostic (1.36e-3)"	"unprognostic (2.43e-1)"	"unprognostic (7.67e-3)"	"unprognostic (3.50e-2)"	"unprognostic (5.85e-2)"	"unprognostic (8.17e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.89e-2)"	"unprognostic (2.54e-4)"	"unprognostic (8.55e-2)"	"prognostic favorable (2.50e-7)"	"unprognostic (3.65e-3)"	"unprognostic (2.84e-1)"	"unprognostic (2.77e-4)"	"unprognostic (7.94e-2)"	0.9	4.5	1.9	0.8	3.0	0.0	0.7	0.1	8.9	1.6	3.0	2.6	3.3	1.5	1.3	2.0	0.8	1.7	24.9	4.0	2.2	3.6	2.1	1.2	0.2	2.7	2.1	0.5	3.9	17.0	3.4	0.0	2.2	4.2	3.3	2.1	2.6	4.1	65.5	0.1	2.5	2.7	0.4	0.7	3.0	1.8	2.4	0.2	4.7	50.4	0.3	2.0	0.3	3.4	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.3	1.4	2.5	0.0	0.0	0.0	0.0	3.5	2.6	0.0	0.0	0.0	0.0	3.2	0.1	2.7	2.6	0.0	0.0	0.0	2.1	2.1	1.9	0.0	0.0	1.9	0.0	0.0	2.0	3.7	0.0	2.8	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	3.0	0.1	8.9	4.0	2.2	2.7	2.1	2.2	0.4	2.4	3.4	0.4	0.0	5.9	67.9	0.6	0.3	0.3	0.0	0.0	6.7	2.2	0.6	86.2	1.5	0.0	1.8	0.0	0.1	0.0	7.8	1.9	1.3	5.8	0.4	0.2	3.2	5.4	0.4	166.6	2.7	0.0	3.0	1.5	0.3	0.0	3.0	2.5	5.1	0.5	1.7	136.4	7.1	0.0	0.6	1.4	2.9	0.0	1.6	1.8	14.0	1.9	2.8	0.0	81.4	4.2	1.0	4.4	1.2	0.0	1.4	2.7	3.3	0.7	0.8	0.0	8.1	2.4	11.0	0.9	0.1	0.1	0.0	0.2	1.6	4.6	0.2
ANO6	"DKFZp313M0720, TMEM16F"	ENSG00000177119	"Anoctamin 6"	Q4KMQ2	12	45215987-45482280	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Lipid transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038958	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		47000	"Cluster 14: Monocytes - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 32: U-937 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane, Cytosol"		"HPA038958: AB_10672835"	"prognostic unfavorable (7.56e-5)"	"prognostic unfavorable (3.82e-4)"	"unprognostic (2.16e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.82e-3)"	"unprognostic (7.43e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.55e-2)"	"unprognostic (2.84e-3)"	"unprognostic (1.41e-3)"	"unprognostic (3.02e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.26e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.28e-1)"	86.4	25.9	7.4	16.8	8.0	9.8	27.5	7.9	8.4	28.9	13.8	29.9	36.2	38.9	25.6	25.0	27.2	31.6	27.7	7.2	10.5	36.2	56.9	40.2	13.4	10.4	8.5	56.6	25.3	58.8	6.9	50.5	10.1	29.9	15.0	3.6	25.4	37.1	56.0	12.0	51.4	48.4	9.0	16.0	13.8	11.8	9.1	24.9	13.2	46.3	12.8	35.0	16.0	9.3	41.5	44.3	25.7	35.4	119.1	61.7	97.4	57.4	72.5	38.4	36.3	71.9	61.5	21.1	52.2	92.0	34.9	54.0	24.1	32.3	45.6	31.4	16.9	25.0	17.8	62.1	37.8	39.5	19.4	51.7	31.9	33.0	48.7	95.4	52.6	44.5	19.3	34.0	42.7	11.2	41.5	13.2	28.6	0.0	18.0	23.4	33.3	24.4	36.9	63.1	11.7	39.9	59.9	36.8	27.9	67.7	43.3	62.8	70.6	41.2	26.1	41.8	29.3	18.3	21.5	25.8	37.3	122.8	33.4	3.1	5.9	1.4	2.4	6.9	2.5	1.4	2.2	2.0	5.5	1.2	2.0	1.3	0.6	2.3	7.1	2.7	3.0	4.2	7.4	8.0	7.9	8.4	7.2	10.5	10.4	8.5	10.1	9.0	9.1	9.3	65.1	60.9	11.8	54.9	10.0	30.5	20.3	27.7	23.3	1.1	23.0	18.7	23.4	30.0	21.5	18.4	0.0	34.0	14.5	2.5	3.9	38.4	1.3	13.3	32.1	37.5	8.4	8.0	49.8	37.4	28.0	44.2	21.4	26.0	12.7	20.2	52.5	88.3	19.9	0.0	49.0	11.5	12.2	56.3	22.9	3.5	51.3	46.0	17.8	68.4	29.1	8.2	15.5	110.6	3.0	73.3	10.0	40.6	12.2	29.5	70.3	23.4	16.5	0.3	39.5	45.9	52.1	3.5	4.3	25.1	22.0	24.6	17.3	6.7	14.6	30.5
ANO7	"IPCA-5, NGEP, PCANAP5, PCANAP5L, TMEM16G"	ENSG00000146205	"Anoctamin 7"	Q6IWH7	2	241188509-241225377	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 16.3;prostate: 69.6;stomach 1: 28.1"	"Group enriched"	"Detected in many"	5	"Gastric mucus-secreting cells: 80.0;Intestinal goblet cells: 53.4"	"Cancer enriched"	"Detected in many"	19	"prostate cancer: 32.7"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.2;Hep G2: 2.3;OE19: 2.5"	"Low region specificity"	"Detected in many"							HPA078464	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA078464: "	"unprognostic (1.93e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.09e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.35e-2)"	"unprognostic (8.76e-2)"	"unprognostic (3.09e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.94e-2)"	"unprognostic (4.82e-3)"	"unprognostic (6.09e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.53e-2)"	0.3	0.3	0.2	1.0	0.7	3.6	0.2	0.2	1.0	0.3	0.0	16.3	10.7	0.5	0.0	0.2	0.3	0.0	0.2	0.2	0.2	0.2	0.1	0.1	0.0	1.2	0.2	0.5	0.4	0.0	0.2	0.1	0.4	69.6	10.1	0.0	4.9	0.2	0.0	0.2	14.7	0.1	0.3	0.3	28.1	0.2	0.8	0.0	0.2	0.0	0.0	0.2	0.2	1.6	0.0	0.2	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.2	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.1	2.5	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.7	0.2	1.0	0.2	0.2	1.2	0.2	0.4	0.3	0.8	1.6	1.2	0.0	0.0	1.6	0.7	0.3	0.8	0.8	1.2	0.2	1.9	2.7	1.6	0.0	0.2	0.0	0.0	0.6	0.1	2.6	0.0	2.7	0.1	0.8	0.7	2.1	3.0	0.0	4.8	4.2	5.6	2.0	80.0	1.9	0.0	12.4	2.9	3.9	1.5	0.0	2.7	53.4	0.0	1.3	0.0	0.0	3.4	0.7	1.8	7.5	0.0	1.4	0.0	1.0	6.9	6.4	1.9	2.2	0.5	11.9	3.6	2.8	0.0	0.6	0.0	0.8	1.0	0.1	1.7	0.1	0.0	0.7	0.3	2.6	2.4	0.8
ANO9	"PIG5, TMEM16J, TP53I5"	ENSG00000185101	"Anoctamin 9"	A1A5B4	11	417933-442011	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 34.2;skin 1: 27.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.0;Intestinal goblet cells: 50.5;Paneth cells: 50.5;Proximal enterocytes: 87.7;Undifferentiated cells: 45.2"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 26.1"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	48	"B-cells: 2.1;NK-cells: 4.1;T-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"BEWO: 9.2;CAPAN-2: 29.5;HaCaT: 16.8;RPMI-8226: 20.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039948, HPA040112"	Approved		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA039948: AB_2676765, HPA040112: "	"unprognostic (3.62e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.93e-2)"	"unprognostic (6.98e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (7.94e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.08e-1)"	"unprognostic (3.92e-1)"	"prognostic favorable (8.81e-4)"	0.7	0.1	0.0	7.0	0.0	2.2	1.7	0.0	0.0	1.1	0.2	16.0	34.2	0.5	7.0	6.3	1.2	2.0	0.1	0.0	0.0	3.7	0.3	2.9	12.0	0.0	0.0	0.1	6.5	0.7	1.3	0.1	0.0	2.9	9.1	0.0	3.0	0.7	0.0	27.8	30.0	0.8	0.0	4.7	7.0	0.2	0.0	9.0	2.4	0.1	8.7	2.4	3.4	0.0	2.7	0.6	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.0	0.0	3.1	29.5	1.9	1.4	0.0	0.1	16.8	0.0	7.0	0.0	2.1	0.0	0.0	0.6	5.1	0.0	0.4	0.0	0.0	5.6	0.0	1.2	0.1	0.0	4.5	0.1	1.9	0.0	3.8	0.5	0.1	0.0	6.0	0.0	0.1	0.0	20.6	5.1	4.4	1.6	0.0	0.3	7.3	0.0	0.2	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	5.5	2.1	6.5	3.3	0.0	0.8	3.7	2.8	0.0	4.1	0.0	0.0	8.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.7	0.3	9.1	5.2	4.6	15.3	6.2	0.0	5.5	3.9	2.4	8.6	9.1	3.7	0.0	0.3	3.0	81.0	0.0	10.5	0.8	4.9	1.0	0.8	15.5	0.0	0.3	6.5	3.7	0.6	29.0	11.0	0.0	0.0	0.7	0.3	0.4	0.0	0.2	50.5	14.2	0.3	1.9	0.1	0.0	1.2	3.6	0.0	1.3	0.0	0.0	0.0	0.0	9.0	50.5	0.0	5.0	2.7	87.7	3.7	9.2	0.0	0.0	0.1	1.0	0.2	0.2	7.0	6.3	0.1	12.8	0.0	45.2	5.7
ANXA1	"ANX1, LPC1"	ENSG00000135046	"Annexin A1"	P04083	9	73151865-73170393	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Immunity, Inflammatory response, Innate immunity"	"Phospholipase A2 inhibitor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 7527.7"	"Cell type enhanced"	"Detected in many"		"Squamous epithelial cells: 3632.9;Syncytiotrophoblasts: 7071.8;Urothelial cells: 4808.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 2816.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011271, HPA011272, CAB013023, CAB035987, CAB058693"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"	"Secreted to blood"	NA	Yes		3000000000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	Nucleoplasm	"CAB013023: AB_2533983, CAB035987: , CAB058693: AB_2665585, HPA011271: AB_1844883, HPA011272: AB_1844884"	"unprognostic (2.53e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.08e-2)"	"prognostic favorable (5.71e-5)"	"unprognostic (1.53e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-3)"	"unprognostic (1.47e-1)"	"unprognostic (9.82e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.55e-2)"	"prognostic favorable (4.57e-5)"	"prognostic unfavorable (6.19e-6)"	719.8	60.3	27.5	268.3	35.1	2132.2	442.6	24.8	44.4	952.0	32.8	152.7	64.1	116.2	58.6	7527.7	264.6	329.4	145.3	28.4	53.4	67.9	54.7	470.4	67.9	55.5	46.4	109.4	61.8	28.2	98.1	559.4	36.5	165.3	103.2	6.5	1547.5	154.9	47.6	213.8	88.7	261.5	40.4	79.6	90.2	17.9	45.9	109.9	206.8	89.1	1485.5	386.3	1536.1	43.2	960.2	1485.7	65.8	68.4	905.8	855.6	4.2	1614.6	1008.5	656.3	441.9	43.5	841.0	2.2	520.1	1426.5	1441.9	1147.7	142.6	984.1	516.8	541.6	10.3	73.2	398.5	1.4	719.4	160.9	34.7	495.7	800.6	664.7	1294.6	604.0	947.8	85.4	309.3	39.5	822.6	4.3	287.0	87.7	82.6	379.7	597.6	0.9	369.1	3.2	1495.9	200.4	1.0	0.7	556.6	14.7	377.9	862.7	3.5	24.3	1176.2	761.8	478.9	1058.2	845.1	6.8	2.0	3.6	1757.9	147.8	1171.2	2816.9	1237.6	2227.6	744.1	328.7	757.0	13.7	662.7	664.5	1513.3	3.3	190.7	348.5	128.4	443.6	324.0	53.2	134.5	2021.5	27.5	35.1	24.8	44.4	28.4	53.4	55.5	46.4	36.5	40.4	45.9	43.2	447.4	583.3	415.2	1.6	39.0	846.7	2486.8	2417.6	1748.3	0.1	225.0	417.1	22.5	58.6	2214.7	62.5	0.0	1543.4	602.1	32.2	0.0	167.4	8.2	2037.4	241.6	362.2	5.3	81.2	3.7	23.1	1747.7	732.0	86.6	1993.5	2550.6	0.1	136.7	6.5	593.8	0.0	0.1	20.8	1330.6	545.0	1190.3	7.3	222.4	901.7	307.7	29.0	575.0	0.2	319.3	0.5	0.6	733.2	5.5	9.4	140.4	1552.2	0.1	5.7	1996.9	0.0	65.7	728.2	413.3	2.3	4.0	3632.9	597.7	7071.8	1348.3	3.0	12.6	4808.1
ANXA11	ANX11	ENSG00000122359	"Annexin A11"	P50995	10	80150889-80205572	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division"		"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 443.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004851, HPA027545"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA		210000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"CAB004851: AB_626682, HPA027545: AB_1844851"	"unprognostic (1.85e-2)"	"unprognostic (2.85e-2)"	"unprognostic (5.35e-3)"	"unprognostic (5.06e-2)"	"unprognostic (8.18e-3)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-3)"	"unprognostic (6.28e-2)"	"unprognostic (2.32e-2)"	"unprognostic (4.88e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.56e-2)"	"prognostic favorable (6.69e-8)"	"unprognostic (2.69e-3)"	"unprognostic (1.84e-1)"	"unprognostic (6.79e-2)"	"unprognostic (2.02e-1)"	139.9	29.5	39.0	99.4	40.6	192.9	107.6	27.5	46.8	86.6	52.8	130.3	138.0	74.3	107.5	210.2	109.0	84.8	236.2	47.3	29.0	144.7	47.7	109.5	81.2	26.4	26.6	78.2	95.4	81.8	27.2	91.1	23.9	100.3	120.7	4.8	94.1	81.8	188.9	75.6	137.2	86.0	25.4	76.2	139.3	24.5	24.6	100.2	61.4	166.2	101.7	148.1	102.8	30.4	221.7	195.7	10.4	53.9	220.2	201.1	119.6	149.5	397.3	95.7	98.8	168.7	338.2	13.1	113.6	236.7	8.1	277.7	44.6	136.2	54.2	384.3	76.0	84.4	98.9	131.5	129.4	92.0	212.3	222.9	74.6	57.8	39.4	178.9	143.9	117.9	82.1	163.7	76.8	127.3	119.8	200.9	19.6	211.5	367.7	91.7	14.9	344.0	155.1	191.8	5.1	37.9	65.0	269.9	156.4	83.4	80.6	120.6	160.0	68.7	101.4	157.6	84.4	91.7	145.6	96.0	66.6	155.4	47.4	130.8	66.8	443.8	72.9	52.4	75.0	64.9	92.5	100.5	49.4	54.2	83.7	74.4	231.8	61.3	59.1	78.5	126.5	85.4	39.0	40.6	27.5	46.8	47.3	29.0	26.4	26.6	23.9	25.4	24.6	30.4	150.5	96.1	78.4	17.3	101.4	51.2	266.4	219.4	92.8	1.6	58.8	50.4	293.3	203.0	227.1	220.7	0.0	271.7	137.1	457.7	332.6	429.2	4.5	180.6	49.7	82.7	77.5	29.9	29.5	352.5	309.8	113.1	175.8	265.7	116.1	81.4	91.4	40.8	228.1	3.3	15.5	186.9	97.6	149.7	167.4	9.6	92.9	155.0	90.7	24.4	208.2	38.9	159.6	3.0	2.3	420.6	461.0	92.6	98.2	414.9	367.7	156.8	229.0	2.8	92.1	56.4	137.9	2.8	51.5	98.4	42.1	185.5	131.9	50.8	227.8	581.4
ANXA2	"ANX2, ANX2L4, CAL1H, LIP2, LPC2D"	ENSG00000182718	"Annexin A2"	P07355	15	60347134-60402883	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Host-virus interaction"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 2185.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 5755.6;Pancreatic endocrine cells: 5217.8;Prostatic glandular cells: 4575.5;Urothelial cells: 4326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 4429.7;classical monocyte: 2762.3;intermediate monocyte: 2401.9;myeloid DC: 4018.8;non-classical monocyte: 2686.5;T-reg: 1681.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 174.7"	"CAB004311, HPA046964, HPA061798"	Enhanced		Approved	"Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		19000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	Cytosol	"CAB004311: AB_626677, HPA046964: AB_2732537, HPA061798: AB_2732671"	"unprognostic (1.61e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (6.88e-5)"	"unprognostic (4.06e-3)"	"unprognostic (5.42e-3)"	"prognostic unfavorable (2.54e-5)"	"prognostic unfavorable (7.51e-4)"	"unprognostic (2.94e-1)"	"unprognostic (4.10e-3)"	"prognostic unfavorable (8.47e-6)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (2.11e-6)"	"unprognostic (7.74e-2)"	"unprognostic (2.55e-1)"	"unprognostic (7.41e-2)"	"prognostic unfavorable (6.59e-5)"	975.6	370.5	49.0	461.9	50.5	151.7	708.5	49.6	96.9	806.3	95.6	631.2	502.0	296.2	267.2	2185.3	388.4	453.9	393.0	47.6	79.4	358.3	185.5	878.3	200.7	90.0	83.6	187.0	324.3	344.0	163.9	650.4	84.9	399.3	606.1	30.2	933.4	386.4	304.8	1140.8	487.5	425.4	73.3	301.6	379.0	116.1	120.9	188.7	351.2	205.8	541.1	842.2	1256.7	80.1	4183.3	4421.4	223.6	105.5	2962.4	4744.2	971.0	4703.6	2968.4	2868.4	2534.9	2083.5	1903.6	10.0	3907.2	5983.6	2185.1	4304.9	992.9	8695.5	3113.5	846.8	103.9	78.2	1918.7	882.7	1782.0	4.5	59.9	2324.4	2278.6	2013.2	4335.0	3477.2	5455.0	58.4	320.9	447.9	6271.8	468.4	18.5	239.1	508.2	3444.1	3283.5	48.9	1198.8	226.6	5172.4	2410.7	295.1	171.9	1774.5	424.8	1942.8	2305.1	922.7	173.6	6336.8	2534.1	3406.8	8668.0	4807.4	172.6	616.3	83.8	2449.2	47.9	5206.0	4429.7	2762.3	355.0	603.8	2401.9	668.5	657.9	686.4	701.7	4018.8	412.1	77.0	313.9	73.6	287.1	2686.5	609.4	1681.4	3754.4	49.0	50.5	49.6	96.9	47.6	79.4	90.0	83.6	84.9	73.3	120.9	80.1	673.9	2141.0	414.8	0.3	101.3	2512.2	3396.9	5755.6	246.4	2.5	395.9	337.4	28.2	773.5	3086.6	560.9	0.0	1874.5	135.9	933.6	13.7	3941.4	93.0	855.9	457.1	772.0	103.4	38.7	0.2	2411.4	2714.4	1076.7	328.7	1376.3	105.7	97.5	474.0	64.2	1537.2	0.0	1.3	689.0	1668.2	429.6	1992.1	126.6	771.1	715.1	1417.6	15.9	1284.0	19.4	138.0	1.5	0.1	5217.8	920.9	638.7	144.5	4575.5	845.8	51.8	2446.8	8.1	184.1	437.7	831.1	13.0	29.3	789.7	2325.1	1150.1	224.1	8.6	749.9	4326.1
ANXA5	"ANX5, ENX2"	ENSG00000164111	"Annexin A5"	P08758	4	121667946-121696995	"Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Blood coagulation, Hemostasis"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1156.8;Extravillous trophoblasts: 1125.1;Syncytiotrophoblasts: 1140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003677, HPA035330"	Approved		Approved	"Nuclear membrane"		NA	NA		5000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nuclear membrane"		"CAB003677: AB_425305, HPA035330: AB_2674574"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-2)"	"unprognostic (9.70e-2)"	"prognostic favorable (3.64e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (3.01e-5)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (7.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (6.04e-2)"	"unprognostic (6.49e-3)"	"unprognostic (4.54e-1)"	"prognostic unfavorable (9.29e-7)"	"prognostic unfavorable (7.19e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (1.26e-4)"	490.6	286.5	111.7	241.7	126.3	96.2	314.0	136.9	144.7	429.1	137.7	181.9	96.5	288.7	162.6	135.1	225.0	273.1	213.9	106.4	134.7	216.2	149.5	299.0	136.2	151.2	129.6	224.7	162.9	133.7	176.7	466.0	150.4	211.7	155.5	78.1	273.8	250.5	85.2	132.5	130.9	370.3	134.3	175.7	186.0	110.4	154.3	63.3	182.9	114.8	135.2	298.1	178.6	157.3	463.5	339.6	438.0	256.1	2094.3	1645.5	503.4	1582.7	1464.9	841.3	744.8	246.2	200.6	35.7	282.9	2224.8	581.7	165.4	287.3	727.6	762.2	335.1	171.2	105.0	281.6	647.4	1213.9	221.1	178.3	945.5	344.7	705.1	665.9	927.4	1120.9	25.2	106.0	271.8	2133.5	306.7	225.5	75.1	231.9	417.7	718.5	8.2	1014.5	72.6	1368.9	66.3	117.1	141.4	579.7	227.6	1515.2	872.3	201.5	261.2	830.6	1322.1	632.1	955.2	478.0	240.8	308.6	76.0	847.8	123.5	1586.2	122.2	725.8	359.9	104.8	830.5	136.0	127.3	158.8	131.9	745.6	89.5	51.3	74.6	157.9	48.4	798.0	91.2	289.9	773.3	111.7	126.3	136.9	144.7	106.4	134.7	151.2	129.6	150.4	134.3	154.3	157.3	286.5	243.6	233.9	13.7	85.0	199.3	266.4	395.9	76.2	6.8	101.6	107.4	88.3	265.9	257.2	132.4	25.0	1156.8	53.2	15.6	297.4	703.5	16.2	239.7	318.1	287.7	48.6	29.0	15.4	338.2	1125.1	564.7	91.3	312.6	148.7	177.5	186.4	54.8	753.2	13.5	7.1	110.9	187.2	446.5	705.1	41.4	379.9	544.0	352.2	45.0	412.5	161.4	13.4	23.1	26.8	501.1	31.2	366.3	203.1	473.8	15.3	194.3	268.9	30.0	295.9	443.1	377.2	15.9	28.6	101.1	140.8	1140.8	122.0	185.7	43.2	188.2
ANXA6	ANX6	ENSG00000197043	"Annexin A6"	P08133	5	151100706-151157785	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 343.8;monocytes: 445.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 861.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002462, CAB005077, HPA009650, HPA009977"	Enhanced		Approved	Cytosol		NA	NA		1800000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Cytosol		"CAB005077: AB_630873, HPA002462: AB_1078166, HPA009650: AB_1844867, HPA009977: "	"unprognostic (1.74e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.81e-2)"	"unprognostic (2.44e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.75e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.08e-3)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (1.31e-5)"	"unprognostic (6.29e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.28e-3)"	"unprognostic (1.38e-3)"	292.9	135.4	98.1	164.2	104.1	109.7	188.3	94.0	150.6	148.9	151.8	196.0	44.5	181.5	105.0	94.7	149.9	108.7	188.7	102.5	123.1	82.6	214.4	131.6	161.8	144.2	109.4	181.7	78.3	29.6	161.9	141.1	146.2	124.9	78.2	133.6	70.3	208.6	331.3	62.7	119.9	300.1	92.3	150.9	111.4	52.5	127.4	160.8	86.7	371.5	176.4	206.5	107.4	104.8	3.0	30.4	212.8	317.1	861.2	417.8	55.1	397.4	526.4	323.5	477.6	106.7	15.6	26.9	138.5	578.6	268.1	0.5	165.9	200.2	300.3	110.5	52.1	15.3	62.1	204.7	295.0	97.6	94.7	508.6	1.5	282.3	42.0	476.9	420.6	197.5	22.0	396.1	737.6	100.4	181.8	151.7	56.2	1.2	92.4	120.4	592.9	31.0	42.2	0.3	12.2	49.3	39.9	282.7	175.6	308.4	488.3	201.1	326.8	296.6	84.2	19.4	107.1	205.4	289.5	4.5	154.5	459.7	46.2	89.7	89.4	82.9	290.4	54.7	190.4	175.4	213.4	263.3	118.3	179.0	145.8	181.6	17.6	261.9	25.0	30.2	190.9	331.7	98.1	104.1	94.0	150.6	102.5	123.1	144.2	109.4	146.2	92.3	127.4	104.8	90.3	16.0	17.3	19.2	146.8	11.0	11.5	2.2	1.8	16.5	30.7	24.0	59.5	12.8	1.1	23.9	6.2	64.3	110.3	0.3	25.4	6.5	56.9	1.8	38.5	45.6	21.4	36.4	36.5	17.8	33.7	105.9	9.2	1.7	57.5	343.8	57.1	147.1	85.4	15.2	36.3	2.4	0.0	41.0	77.8	46.8	123.3	41.2	55.2	10.3	445.2	45.6	187.4	18.6	5.6	12.1	1.2	211.4	120.3	7.3	1.0	48.4	4.7	125.8	230.1	55.3	150.6	2.5	1.5	0.6	8.1	177.2	143.4	149.4	2.5	1.5
AP1B1	"ADTB1, AP105A, BAM22, CLAPB2"	ENSG00000100280	"Adaptor related protein complex 1 subunit beta 1"	Q10567	22	29327680-29388583	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 138.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065226, HPA068520"	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		660000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"HPA065226: AB_2685438, HPA068520: AB_2685998"	"unprognostic (1.78e-1)"	"prognostic favorable (4.81e-4)"	"unprognostic (2.40e-1)"	"unprognostic (2.21e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (5.55e-5)"	"unprognostic (4.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.60e-1)"	"prognostic favorable (7.24e-6)"	"unprognostic (1.85e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.76e-2)"	30.7	46.7	38.0	47.2	38.3	45.8	26.4	37.3	45.2	22.8	35.6	34.9	43.3	22.7	12.1	63.0	23.5	30.4	23.9	36.1	40.8	34.8	34.8	30.1	57.8	44.2	44.6	17.5	38.3	67.0	39.2	44.8	43.7	38.3	30.1	35.3	40.3	25.9	24.5	47.2	45.6	27.1	41.4	52.6	40.9	24.7	52.7	34.2	29.6	20.5	54.4	39.4	32.2	48.8	84.6	47.5	49.3	50.2	37.0	27.0	60.0	59.8	65.5	71.2	68.2	74.4	33.2	46.1	37.2	68.4	33.0	74.6	71.5	97.6	45.2	58.2	102.0	79.1	60.8	42.0	38.9	114.1	99.9	38.6	36.0	67.5	55.0	33.0	98.7	17.2	54.6	54.9	48.3	93.7	45.5	36.8	37.3	124.8	53.3	89.0	54.3	119.9	50.2	194.5	75.9	52.2	74.0	82.5	36.4	33.5	66.7	49.5	84.6	79.1	48.8	46.0	62.1	60.4	32.5	84.6	56.1	48.1	46.7	0.0	29.3	5.7	9.2	29.2	9.1	16.2	6.3	7.9	28.7	18.2	4.9	5.2	3.0	7.2	31.7	9.0	8.8	24.2	38.0	38.3	37.3	45.2	36.1	40.8	44.2	44.6	43.7	41.4	52.7	48.8	17.8	12.8	16.4	27.7	53.0	7.1	9.3	16.7	16.5	26.3	26.2	20.8	16.1	21.5	16.4	22.0	39.6	52.3	15.1	69.6	23.5	41.2	7.5	16.4	11.6	19.8	21.6	40.0	24.1	40.7	30.1	12.1	33.6	30.1	5.1	13.2	35.3	34.3	138.9	45.4	25.6	24.9	18.3	95.5	24.2	13.1	11.8	65.7	12.4	51.5	29.8	28.4	9.2	16.1	14.0	65.9	33.2	12.4	28.5	17.5	51.2	30.1	14.5	42.1	6.6	17.8	12.7	23.5	17.6	33.0	9.1	68.3	17.0	39.6	36.2	18.1
AP1G1	"ADTG, CLAPG1"	ENSG00000166747	"Adaptor related protein complex 1 subunit gamma 1"	O43747	16	71729000-71809201	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 268.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009049, HPA041224"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		62000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Vesicles	Cytosol	"CAB009049: AB_2058329, HPA041224: AB_2677370"	"unprognostic (4.84e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.90e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.30e-2)"	"prognostic favorable (2.96e-8)"	"unprognostic (1.27e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.68e-2)"	"unprognostic (1.75e-1)"	19.0	25.7	15.4	23.4	16.4	76.7	24.8	19.6	20.8	20.3	26.9	23.6	22.6	17.8	25.5	26.7	18.0	18.9	13.6	16.8	14.9	36.4	33.2	21.4	24.6	14.4	14.5	15.3	24.2	40.4	16.8	17.5	15.8	22.5	25.7	52.8	22.6	16.3	28.2	26.6	23.6	16.1	13.5	22.4	29.3	30.7	15.6	24.9	24.0	36.5	30.4	20.6	18.4	24.3	43.9	62.4	46.3	48.1	48.2	45.4	41.0	44.6	42.1	56.8	54.5	64.3	47.1	55.0	41.9	60.4	41.5	55.4	62.7	49.3	74.4	21.6	33.8	36.2	31.7	46.5	28.9	44.7	114.1	39.1	33.4	76.0	46.9	36.1	50.2	35.8	47.8	23.0	56.1	80.0	39.2	35.3	43.7	34.6	26.8	62.9	37.3	59.3	53.7	49.3	42.5	25.5	55.7	34.8	24.5	46.6	61.0	33.7	60.2	49.4	37.9	27.3	32.9	35.1	50.2	109.2	40.3	34.4	43.3	5.7	6.9	10.0	6.7	7.6	6.8	5.4	5.9	7.5	7.5	5.7	4.6	5.8	14.9	6.7	6.4	5.2	6.6	4.2	15.4	16.4	19.6	20.8	16.8	14.9	14.4	14.5	15.8	13.5	15.6	24.3	32.6	32.1	31.1	42.4	34.2	28.8	27.4	17.3	22.8	26.8	47.6	25.4	13.4	35.8	25.2	36.8	73.0	14.4	40.6	39.3	19.6	21.1	268.8	55.8	37.9	26.0	23.4	9.9	54.2	21.8	13.3	24.0	46.4	84.8	21.0	26.2	21.4	58.5	16.7	30.3	59.0	25.7	12.2	30.4	27.2	130.7	17.7	32.4	23.2	36.5	25.1	16.4	24.7	53.8	79.2	30.5	24.2	19.9	30.6	36.9	30.5	46.4	31.7	66.6	19.7	33.0	26.4	35.8	37.1	32.4	38.6	24.5	33.4	23.0	26.4	47.8
AP1M1	"AP47, CLAPM2"	ENSG00000072958	"Adaptor related protein complex 1 subunit mu 1"	Q9BXS5	19	16197854-16245906	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 92.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045256	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA045256: AB_10960697"	"unprognostic (5.10e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.70e-3)"	"unprognostic (2.85e-1)"	"unprognostic (5.19e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (1.02e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.96e-2)"	"unprognostic (1.56e-1)"	49.5	47.2	30.1	30.7	31.0	58.5	37.9	22.3	36.3	32.2	22.0	37.7	32.1	38.8	9.2	29.6	29.8	21.4	39.9	33.0	31.0	39.6	81.0	31.9	36.9	26.6	30.0	31.7	18.8	20.1	24.0	27.5	33.5	25.3	12.6	17.3	21.6	24.8	44.4	30.8	31.0	35.4	23.1	37.6	27.3	60.8	25.0	37.8	23.7	29.0	28.2	38.3	29.1	25.9	63.3	70.2	69.3	65.3	82.7	80.9	39.1	69.6	74.1	99.5	103.3	83.9	48.6	49.8	78.7	76.6	64.4	35.1	54.2	56.9	111.3	85.5	122.3	80.9	63.4	114.6	67.1	91.5	96.9	83.5	42.2	89.2	59.8	65.4	95.6	69.8	40.3	98.0	109.5	75.8	131.2	55.4	56.9	22.3	162.7	87.9	56.7	67.3	54.9	45.2	44.4	99.4	56.8	34.4	64.0	36.9	41.0	73.1	83.1	111.8	45.6	151.7	134.3	104.6	141.6	54.9	125.5	112.8	88.7	89.4	142.3	243.9	104.8	180.7	105.6	99.8	103.4	111.2	121.6	92.3	115.1	147.0	101.8	133.1	235.7	131.2	161.8	174.3	30.1	31.0	22.3	36.3	33.0	31.0	26.6	30.0	33.5	23.1	25.0	25.9	17.4	41.7	31.2	12.7	30.6	4.6	7.4	13.2	11.4	35.4	11.3	10.9	17.9	14.3	15.2	12.9	20.9	32.1	30.5	8.3	15.6	21.1	32.5	10.6	27.2	22.7	19.8	21.7	11.8	18.2	40.4	28.1	8.6	14.8	27.1	19.0	21.8	41.9	42.6	42.1	11.7	7.3	6.1	36.0	13.3	92.1	23.0	30.2	10.6	5.6	34.9	18.3	38.1	4.5	12.8	31.2	5.9	19.9	24.5	6.2	25.1	23.6	13.9	40.2	0.0	26.1	22.8	61.9	23.3	12.6	7.1	17.5	32.9	17.7	9.0	4.6
AP1S1	"AP19, CLAPS1, EKV3, SIGMA1A, WUGSC:H_DJ0747G18.2"	ENSG00000106367	"Adaptor related protein complex 1 subunit sigma 1"	P61966	7	101154456-101161596	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Deafness, Ichthyosis, Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 344.4;Proximal enterocytes: 241.3;Proximal tubular cells: 304.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060945	Supported		Supported	"Golgi apparatus,Vesicles"		NA	Yes			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Golgi apparatus, Vesicles"		"HPA060945: AB_2684393"	"unprognostic (1.98e-2)"	"unprognostic (5.41e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.98e-3)"	"unprognostic (8.70e-3)"	"unprognostic (7.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.76e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.75e-2)"	"unprognostic (2.81e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.75e-1)"	14.4	24.6	72.2	13.9	75.7	5.8	17.2	43.7	82.6	18.3	34.6	28.6	39.0	16.9	17.0	34.2	13.8	12.8	11.8	85.2	59.6	41.2	36.2	14.7	11.9	53.6	51.9	13.5	21.9	22.8	31.0	15.9	53.4	22.2	22.4	14.6	20.3	9.3	6.4	39.2	30.3	12.7	46.1	20.2	22.0	16.4	62.5	19.1	15.2	8.5	13.6	20.1	19.5	62.7	121.0	87.3	63.3	118.4	42.8	70.4	138.2	76.8	51.1	50.8	52.8	47.3	147.5	24.9	127.5	84.6	97.1	59.0	35.3	116.0	45.6	57.0	56.6	16.8	52.0	61.4	54.2	46.8	87.7	79.1	91.0	49.4	20.6	76.7	76.8	54.1	56.7	103.2	129.9	292.1	40.4	107.8	97.8	177.0	188.2	24.9	27.2	54.6	127.8	88.8	47.5	157.7	40.4	121.1	151.4	101.6	50.7	46.8	79.0	74.1	132.3	27.6	55.2	21.4	51.4	48.4	195.2	50.1	152.9	0.5	3.3	0.3	2.3	3.1	2.2	2.6	3.2	2.5	4.6	2.0	1.9	1.8	1.2	1.3	1.8	5.0	3.3	2.4	72.2	75.7	43.7	82.6	85.2	59.6	53.6	51.9	53.4	46.1	62.5	62.7	34.4	6.4	0.0	2.3	17.9	38.7	29.7	173.0	46.7	30.7	54.8	49.0	1.1	45.8	72.9	55.2	8.4	170.7	19.8	88.4	344.4	128.2	2.5	28.8	34.2	36.7	90.3	16.2	21.2	111.7	101.3	27.7	42.8	31.9	5.7	85.3	28.9	43.0	95.2	30.3	10.3	96.5	116.0	24.8	21.6	3.4	35.1	27.3	53.4	7.5	58.0	34.1	17.5	2.5	9.8	183.3	86.1	21.8	17.4	34.9	241.3	304.8	34.9	22.3	19.7	11.4	38.4	13.1	70.9	51.4	45.5	60.5	19.5	157.4	119.9	38.2
AP2A1	"ADTAA, CLAPA1"	ENSG00000196961	"Adaptor related protein complex 2 subunit alpha 1"	O95782	19	49767001-49807114	"Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 165.0;Syncytiotrophoblasts: 241.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 20.5"	"Lineage enriched"	"Detected in all"	4	"monocytes: 20.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB004306	Approved		Supported	Vesicles		NA	NA		61000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"CAB004306: AB_2274034"	"unprognostic (4.33e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.61e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.92e-2)"	"unprognostic (5.85e-3)"	"unprognostic (4.84e-1)"	"prognostic unfavorable (2.91e-4)"	"unprognostic (2.82e-2)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (2.83e-9)"	"unprognostic (2.63e-1)"	"unprognostic (1.45e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.72e-3)"	47.0	87.4	37.4	25.2	47.9	54.4	41.2	20.6	49.2	48.1	9.0	42.2	24.7	56.6	7.4	46.5	48.2	19.6	52.2	44.2	31.8	33.3	51.1	37.2	19.5	45.8	31.4	57.1	33.8	13.9	34.3	31.4	45.3	33.0	9.9	13.9	28.9	18.6	89.6	54.2	34.0	21.4	17.8	47.6	36.3	88.8	50.0	15.4	30.5	26.9	13.2	46.0	43.6	35.8	70.9	100.3	33.8	78.7	59.5	72.2	69.0	82.0	55.3	49.7	51.8	52.0	43.5	31.5	30.6	85.2	41.9	62.8	25.7	59.0	21.1	50.1	58.4	46.6	66.1	56.8	65.3	37.7	75.0	113.6	42.3	55.4	28.7	44.2	59.5	51.3	118.5	42.7	47.6	55.8	41.6	50.2	34.6	66.6	101.8	46.6	79.7	40.4	29.6	88.1	25.7	34.7	90.1	61.1	34.3	36.1	52.1	52.9	82.9	128.4	70.6	54.6	59.3	63.1	83.5	33.1	90.5	54.8	55.1	0.3	5.3	3.4	2.0	12.8	1.4	1.2	1.2	1.2	4.6	1.0	0.9	1.3	4.0	2.3	20.5	1.4	1.6	4.8	37.4	47.9	20.6	49.2	44.2	31.8	45.8	31.4	45.3	17.8	50.0	35.8	22.9	0.0	2.3	19.6	18.5	13.8	19.0	18.5	14.8	45.1	26.7	19.0	2.9	14.3	11.7	14.7	43.8	90.8	21.8	39.1	11.7	16.1	129.9	23.0	57.1	22.4	2.4	106.5	24.2	29.4	35.3	36.0	22.4	16.0	8.9	33.2	39.3	36.6	31.3	50.5	25.5	17.4	8.2	56.2	21.3	165.0	53.4	34.0	19.6	14.0	40.4	31.5	63.8	14.1	21.8	27.3	19.0	61.7	28.1	16.3	41.2	50.4	14.9	30.2	59.2	23.2	28.5	54.7	59.2	22.1	13.9	241.6	23.2	48.6	23.9	24.3
AP2A2	"ADTAB, CLAPA2, DKFZP564D1864, HIP9, HYPJ, KIAA0899"	ENSG00000183020	"Adaptor related protein complex 2 subunit alpha 2"	O94973	11	924894-1012245	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017514, HPA043040"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		10000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	Nucleoplasm	"CAB017514: AB_2056344, HPA043040: AB_2678283"	"unprognostic (1.90e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.28e-2)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (9.27e-5)"	"unprognostic (1.34e-2)"	"unprognostic (4.09e-1)"	"unprognostic (1.70e-1)"	"prognostic favorable (4.57e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.86e-3)"	"unprognostic (1.05e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.08e-2)"	20.1	18.0	3.5	1.3	5.1	4.5	16.6	10.8	9.9	20.3	1.4	23.0	5.4	17.9	1.5	12.7	18.1	2.0	19.1	5.5	3.5	34.4	29.9	18.9	3.2	0.9	2.1	17.5	25.3	3.7	25.6	5.2	3.0	20.3	4.9	5.8	14.6	4.0	14.1	14.5	19.6	5.6	0.0	57.6	20.6	15.5	3.3	3.8	13.9	1.6	2.5	19.0	15.7	1.4	7.5	2.9	3.7	10.7	13.8	14.2	9.1	10.2	3.3	6.0	4.9	1.3	7.3	7.4	8.7	12.3	5.7	8.9	8.9	5.6	3.9	5.5	23.2	2.1	10.4	3.9	5.3	2.8	4.9	16.8	6.1	3.1	6.1	14.8	8.5	5.0	5.9	4.7	6.3	0.4	2.6	3.2	2.0	9.1	17.9	4.2	2.6	8.1	9.2	6.2	12.3	10.0	11.4	9.2	1.7	6.3	5.4	0.8	13.3	1.9	2.3	2.8	5.2	4.3	3.9	5.3	4.0	3.7	3.1	1.5	1.7	1.5	1.1	1.7	0.5	0.5	1.1	0.6	1.4	1.0	1.1	1.2	2.1	1.1	1.4	1.3	2.1	0.6	3.5	5.1	10.8	9.9	5.5	3.5	0.9	2.1	3.0	0.0	3.3	1.4	38.1	38.5	21.8	29.4	14.3	14.3	12.4	13.3	7.4	50.9	27.2	23.0	12.9	21.5	15.9	62.5	60.5	42.1	17.3	45.3	39.2	37.5	46.7	64.0	44.6	36.6	35.2	27.1	37.2	18.0	45.2	28.7	16.3	86.7	27.3	31.0	80.3	59.8	82.8	101.0	36.4	32.3	18.3	104.7	26.9	28.3	34.5	51.8	8.8	41.2	31.2	30.4	39.1	23.1	21.9	25.8	24.2	27.8	13.6	16.9	43.5	70.4	23.5	69.2	26.3	20.7	22.6	72.7	28.0	11.2	11.4	28.5	19.7	30.5	37.0	11.5
AP2B1	"ADTB2, CLAPB1"	ENSG00000006125	"Adaptor related protein complex 2 subunit beta 1"	P63010	17	35578046-35726413	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 503.9;Late spermatids: 739.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017631, HPA056733, HPA067983"	Approved		Supported	Vesicles		NA	NA		380000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles		"CAB017631: AB_2058201, HPA056733: AB_2683219, HPA067983: AB_2732777"	"unprognostic (1.49e-2)"	"unprognostic (4.04e-3)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.64e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.73e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.50e-1)"	"prognostic favorable (2.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.25e-2)"	"unprognostic (1.57e-2)"	46.4	42.4	77.0	38.2	87.8	49.2	58.3	69.9	88.7	54.1	76.6	67.6	33.5	41.7	70.7	25.1	46.7	42.3	67.6	92.1	83.5	69.0	35.0	53.4	38.6	69.8	78.6	57.2	33.2	126.4	55.0	66.8	76.8	40.9	84.0	76.1	41.9	50.1	57.5	29.9	38.8	56.0	80.3	42.0	48.4	93.5	78.7	59.7	65.1	61.0	45.5	46.8	34.4	95.0	188.8	233.9	113.7	132.0	184.4	202.8	51.6	94.3	138.9	131.0	141.1	129.0	154.6	90.5	81.1	175.3	168.8	173.2	162.5	264.8	190.8	108.6	147.0	117.7	161.8	71.0	104.7	119.3	80.8	128.9	104.3	134.5	209.3	151.2	211.4	111.8	190.6	126.9	206.9	36.9	113.7	58.7	94.2	98.9	164.5	94.3	165.1	64.7	166.2	108.3	94.4	114.1	114.5	39.6	126.9	273.3	161.5	78.5	211.5	99.3	93.4	109.8	142.1	53.0	106.1	84.7	124.1	86.9	112.5	19.6	11.8	16.7	16.0	15.3	16.9	12.1	13.9	14.3	10.7	11.9	6.3	8.0	13.3	9.6	16.8	10.7	20.5	11.0	77.0	87.8	69.9	88.7	92.1	83.5	69.8	78.6	76.8	80.3	78.7	95.0	76.5	16.0	17.0	49.3	45.9	31.1	26.3	57.4	70.6	67.6	88.9	50.9	62.5	68.6	37.4	112.2	56.3	29.7	70.7	97.4	117.4	105.0	503.9	74.5	83.7	56.8	71.3	214.7	105.5	120.2	42.8	47.1	36.2	85.4	41.2	46.5	79.9	64.5	44.1	69.0	109.8	79.4	28.5	54.3	25.9	739.2	58.7	37.2	16.0	60.0	47.3	52.6	74.2	81.4	89.0	177.9	46.6	68.4	32.1	37.4	39.4	102.5	30.4	40.9	59.2	25.3	37.6	258.8	60.0	19.6	14.6	32.8	49.2	37.3	89.8	29.1
AP2M1	"AP50, CLAPM1, mu2"	ENSG00000161203	"Adaptor related protein complex 2 subunit mu 1"	Q96CW1	3	184174689-184184091	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036849, HPA069870"	Uncertain		Supported	"Plasma membrane"		NA	NA		7500	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"HPA036849: AB_10672101, HPA069870: AB_2686217"	"unprognostic (1.16e-1)"	"unprognostic (1.35e-2)"	"unprognostic (5.28e-3)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (9.12e-4)"	"unprognostic (3.80e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.53e-2)"	"unprognostic (4.11e-2)"	"unprognostic (9.18e-2)"	"prognostic unfavorable (7.45e-6)"	"unprognostic (2.61e-2)"	"unprognostic (4.09e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.28e-1)"	191.8	364.2	233.5	164.7	250.3	231.3	164.6	211.3	257.3	222.8	196.3	232.4	167.5	216.4	104.2	218.1	178.6	166.5	366.2	261.1	249.0	196.0	140.9	180.0	148.2	234.8	211.1	198.6	106.4	224.8	224.9	243.3	248.9	183.2	141.1	230.4	167.2	231.8	181.2	157.2	156.2	243.7	200.9	162.5	156.3	106.4	235.4	158.4	148.0	194.0	157.6	223.7	192.4	225.6	436.3	327.5	275.7	311.8	432.1	450.8	284.3	714.3	412.5	788.5	550.5	355.1	309.9	198.2	851.3	1076.1	516.1	480.0	376.3	482.9	647.1	409.8	470.4	512.2	365.8	317.9	508.9	254.8	311.5	577.0	269.4	501.1	318.5	711.0	595.3	258.3	250.0	377.1	750.1	993.6	330.1	151.2	674.1	388.1	484.7	302.7	351.5	393.7	489.7	389.3	292.0	212.6	561.3	696.4	335.1	427.5	934.4	305.7	645.0	497.1	400.1	492.4	960.2	336.9	318.7	441.6	937.1	369.9	331.7	194.4	294.8	244.9	137.5	238.8	136.2	114.3	127.6	134.0	268.7	112.7	107.7	111.8	127.7	170.2	206.8	134.1	185.4	441.0	233.5	250.3	211.3	257.3	261.1	249.0	234.8	211.1	248.9	200.9	235.4	225.6	146.8	54.5	50.7	41.4	84.8	124.9	177.2	275.1	97.9	174.2	108.0	98.2	195.9	112.9	133.5	114.0	70.9	400.9	117.3	155.9	375.6	243.7	326.6	69.3	131.2	172.2	140.8	277.8	62.0	161.3	327.1	161.5	71.4	78.5	149.1	173.6	182.4	78.0	576.9	277.6	63.4	119.0	201.4	137.1	162.9	347.8	164.7	185.1	199.3	34.7	369.4	199.4	130.7	26.2	46.1	232.1	153.1	214.8	100.2	138.8	253.8	290.7	58.3	125.9	197.2	106.9	278.0	83.3	101.7	128.5	126.6	513.6	102.6	278.1	154.1	185.1
AP2S1	"CLAPS2, FBH3, FBHOk, HHC3"	ENSG00000042753	"Adaptor related protein complex 2 subunit sigma 1"	P53680	19	46838136-46850846	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 991.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (1.34e-1)"	"unprognostic (5.93e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.60e-2)"	"unprognostic (4.86e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.54e-2)"	"unprognostic (2.19e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (5.79e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.07e-1)"	"unprognostic (6.05e-2)"	120.2	136.5	110.7	80.6	119.9	126.5	95.9	104.9	138.5	83.0	99.6	91.5	67.3	62.1	41.0	188.9	58.6	46.1	107.5	122.1	117.7	106.8	148.9	90.2	62.4	108.0	103.9	52.3	77.2	51.9	72.4	79.1	111.9	90.8	57.4	27.6	99.8	48.8	101.6	125.8	79.8	60.1	106.0	124.6	85.1	69.2	111.3	67.2	61.5	63.7	67.6	82.9	103.4	112.5	380.3	363.2	181.6	198.7	227.1	248.7	122.2	311.0	383.2	349.2	411.0	277.1	189.3	121.1	168.6	476.2	153.6	178.8	144.9	450.6	263.9	115.1	418.6	210.4	220.6	204.0	306.7	142.1	150.0	317.9	259.0	337.9	281.1	259.0	471.1	199.5	186.1	180.4	331.1	403.2	181.1	1060.2	295.7	341.8	268.8	142.8	167.0	170.8	269.2	299.9	177.2	258.8	239.1	298.4	377.0	113.9	248.6	336.4	343.2	246.0	293.8	135.3	375.7	130.8	302.0	134.8	439.0	292.3	437.6	278.6	640.3	406.6	174.3	708.8	145.2	211.5	167.3	174.5	716.8	198.4	153.1	156.3	204.6	188.5	544.6	431.5	233.8	673.1	110.7	119.9	104.9	138.5	122.1	117.7	108.0	103.9	111.9	106.0	111.3	112.5	129.0	38.5	57.2	10.4	85.9	171.6	103.9	341.6	73.4	39.5	179.0	227.8	79.4	137.2	163.9	95.6	16.7	415.2	100.9	397.7	348.3	215.6	80.7	67.8	106.7	190.6	163.7	250.7	14.6	247.2	257.4	130.2	95.8	82.5	92.7	176.1	396.9	308.4	991.6	45.4	13.3	259.6	164.8	515.0	389.5	232.8	92.6	389.5	200.9	4.7	661.1	109.4	160.6	4.5	14.8	249.8	333.9	95.5	94.8	157.6	442.9	432.4	89.0	42.5	98.6	59.1	173.9	78.9	52.5	252.2	253.3	440.5	87.9	230.6	282.1	164.3
AP4B1	"BETA-4, SPG47"	ENSG00000134262	"Adaptor related protein complex 4 subunit beta 1"	Q9Y6B7	1	113894194-113905201	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 31.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 65.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028162, HPA028652"	Approved		Approved	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA028162: AB_10610976, HPA028652: AB_10601451"	"unprognostic (8.90e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.01e-2)"	"prognostic unfavorable (8.60e-7)"	"unprognostic (3.45e-2)"	"unprognostic (1.54e-2)"	"unprognostic (8.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (3.73e-6)"	"unprognostic (5.08e-3)"	"unprognostic (7.88e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.55e-2)"	9.7	8.5	12.5	11.1	13.1	20.5	9.3	14.6	14.6	11.9	10.9	11.5	10.6	9.7	14.2	12.1	11.0	7.0	11.2	13.0	13.0	9.7	8.4	9.5	14.3	11.6	11.4	13.7	14.0	4.8	13.7	5.9	11.8	9.6	12.7	20.0	7.6	6.2	11.7	11.5	12.8	9.1	11.5	20.1	10.4	11.1	13.3	16.1	11.0	9.1	13.9	9.2	10.0	13.3	11.0	9.8	10.0	11.8	15.7	14.1	6.4	10.1	9.8	13.0	14.0	6.8	7.7	21.5	15.9	12.4	6.5	9.7	11.3	13.4	16.5	16.6	9.8	17.6	13.6	8.3	9.5	19.6	17.3	16.1	6.7	25.5	15.3	7.8	22.7	20.9	12.3	18.5	17.6	65.2	15.6	21.6	9.4	7.7	19.0	15.0	19.5	13.3	13.2	5.5	10.2	8.5	10.1	19.1	7.8	9.5	5.7	15.4	21.8	15.0	13.9	17.4	20.8	15.2	15.8	21.3	24.6	26.0	25.1	15.9	10.5	8.6	14.7	10.8	15.6	9.5	11.7	12.6	12.9	11.9	12.7	11.1	1.2	12.2	8.5	9.1	10.4	9.5	12.5	13.1	14.6	14.6	13.0	13.0	11.6	11.4	11.8	11.5	13.3	13.3	7.2	3.2	6.7	7.5	12.3	3.6	3.3	5.4	4.6	6.8	3.2	4.3	8.7	5.7	11.9	3.7	31.3	3.8	12.0	7.8	1.9	7.7	3.6	4.6	4.7	7.6	3.0	18.1	11.4	26.8	3.5	7.0	11.2	5.2	2.5	4.5	7.5	4.1	5.2	8.4	11.6	5.3	6.1	7.3	4.9	2.3	2.8	6.9	7.2	7.5	6.1	4.7	3.1	11.6	10.0	10.9	6.9	4.9	7.4	2.8	6.5	3.3	5.2	21.0	13.1	6.1	6.2	16.4	11.5	5.7	3.7	1.6	14.8	6.4	9.0	3.3
AP4E1	"AP-4-EPSILON, SPG51"	ENSG00000081014	"Adaptor related protein complex 4 subunit epsilon 1"	Q9UPM8	15	50908672-51005895	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.7"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041749, HPA041891"	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA041749: AB_10794490, HPA041891: AB_10796462"	"unprognostic (1.72e-2)"	"unprognostic (3.44e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.27e-1)"	"unprognostic (9.46e-2)"	"unprognostic (6.83e-3)"	"unprognostic (1.06e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.77e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.40e-1)"	"unprognostic (2.03e-2)"	3.7	3.0	2.5	4.4	2.9	3.1	3.0	3.3	2.7	3.7	3.2	3.6	3.0	4.3	2.1	4.7	3.2	2.6	3.9	2.4	2.6	2.8	2.9	3.1	5.5	2.9	2.8	2.9	2.2	5.1	2.4	4.7	2.9	2.7	3.4	3.8	3.3	2.6	8.2	5.4	3.2	4.5	2.6	4.6	2.9	3.9	3.0	6.5	3.8	6.3	4.7	4.0	4.1	3.5	11.5	8.7	6.0	7.1	7.9	12.0	11.7	11.1	8.9	10.7	11.1	10.7	1.8	11.2	4.3	12.5	10.8	13.7	9.0	9.6	12.4	12.3	4.6	9.8	14.5	4.3	11.1	12.1	8.2	12.2	11.6	13.4	21.0	6.6	7.2	8.8	9.1	6.3	14.7	15.4	7.1	6.9	3.9	5.2	4.4	9.7	8.5	6.9	7.9	10.4	4.1	6.7	11.8	8.4	8.7	10.7	7.6	11.7	10.0	15.7	5.8	9.5	15.9	9.6	11.7	14.1	12.3	26.1	7.3	2.7	0.6	0.3	0.8	0.9	0.5	0.5	0.6	0.7	0.6	0.3	0.4	0.9	0.1	0.5	0.5	0.4	0.3	0.4	2.5	2.9	3.3	2.7	2.4	2.6	2.9	2.8	2.9	2.6	3.0	3.5	6.6	6.4	6.1	17.6	8.7	5.7	1.5	3.8	4.0	9.8	4.9	3.7	10.4	2.8	8.4	5.5	18.8	7.3	7.7	7.9	0.0	4.9	2.0	5.9	10.0	7.8	3.0	6.9	26.7	4.8	5.7	4.7	7.1	6.2	10.2	7.2	6.8	8.1	7.2	8.4	27.0	5.3	2.0	17.0	4.1	1.4	5.9	10.2	1.8	25.3	6.5	3.9	8.2	19.1	36.0	10.6	2.4	4.1	9.6	2.2	6.2	3.6	4.8	11.2	6.6	7.1	6.6	10.2	7.7	6.6	7.0	7.3	9.6	4.8	5.5	2.4
AP4M1	"MU-4, MU-ARP2, SPG50"	ENSG00000221838	"Adaptor related protein complex 4 subunit mu 1"	O00189	7	100101549-100110345	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 95.9;Spermatocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066774	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA066774: AB_2685718"	"unprognostic (6.40e-2)"	"unprognostic (3.28e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.22e-2)"	"unprognostic (2.24e-3)"	"prognostic unfavorable (7.63e-5)"	"unprognostic (1.58e-2)"	"unprognostic (6.98e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.05e-2)"	"unprognostic (7.18e-2)"	"prognostic unfavorable (8.29e-4)"	"unprognostic (6.59e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.46e-1)"	8.4	7.3	9.9	4.7	9.9	4.9	9.6	9.6	12.1	11.4	10.0	15.2	12.5	15.7	6.1	10.3	12.4	8.5	9.8	9.9	10.0	10.3	4.7	8.8	6.3	11.2	10.5	9.3	12.3	7.7	15.4	5.6	10.7	12.3	6.2	6.4	10.1	11.0	10.7	11.7	9.9	8.0	10.0	7.2	12.8	32.6	10.9	6.1	10.9	5.5	4.6	12.4	10.3	10.1	9.3	13.0	13.9	35.4	7.8	17.8	15.8	5.5	9.6	7.1	8.9	10.6	23.7	11.1	25.2	13.4	10.2	9.9	6.1	12.0	3.9	8.9	8.6	6.2	12.7	9.4	16.2	7.2	10.9	15.1	20.5	20.7	12.5	13.7	23.5	14.3	11.9	8.4	24.6	28.7	25.9	14.1	10.9	8.4	13.3	21.8	7.0	13.9	18.0	11.9	24.2	21.1	14.0	40.9	11.9	7.9	18.6	14.0	26.0	21.2	16.9	19.8	9.4	6.2	6.8	16.8	17.7	8.3	18.8	4.3	6.3	9.1	4.5	7.9	4.1	5.3	4.0	5.1	8.7	3.4	1.8	3.2	2.1	3.2	10.8	5.3	4.5	4.3	9.9	9.9	9.6	12.1	9.9	10.0	11.2	10.5	10.7	10.0	10.9	10.1	12.6	16.0	4.6	20.5	10.4	9.4	17.3	17.7	9.1	17.7	14.2	17.8	3.2	20.0	13.3	16.5	52.1	14.7	6.8	17.7	7.9	24.4	69.3	20.3	14.6	12.5	12.1	8.2	9.5	19.0	18.1	12.4	14.8	11.2	3.8	22.8	13.2	3.3	9.9	6.7	7.0	15.6	12.2	7.3	7.7	95.9	14.6	6.9	14.2	10.3	14.5	21.0	8.2	6.0	8.1	19.6	17.7	12.8	5.9	13.7	21.9	11.1	29.5	67.9	13.1	15.3	12.4	84.7	39.5	8.8	8.4	14.0	8.2	16.0	14.2	11.2
AP4S1	"AP47B, CLA20, SPG52"	ENSG00000100478	"Adaptor related protein complex 4 subunit sigma 1"	Q9Y587	14	31025106-31130996	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 36.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039963	Approved		Supported	Vesicles		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA039963: AB_10795240"	"unprognostic (4.03e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.00e-3)"	"unprognostic (1.03e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.79e-2)"	"unprognostic (8.62e-3)"	"unprognostic (1.15e-2)"	"unprognostic (3.02e-1)"	"prognostic favorable (2.87e-6)"	"unprognostic (2.20e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.75e-2)"	"unprognostic (5.59e-2)"	4.8	6.3	9.8	6.6	10.6	6.0	5.7	14.1	12.8	6.5	5.6	8.6	3.9	7.7	7.0	4.9	7.3	5.4	8.7	9.5	10.2	7.8	6.2	5.4	8.1	6.3	6.5	10.7	7.9	6.5	8.5	6.7	6.1	6.2	4.1	11.9	5.2	6.7	12.6	4.6	4.4	7.9	5.4	8.0	4.3	18.4	9.0	6.6	8.8	7.2	7.7	6.2	4.8	10.1	9.0	12.6	11.0	3.2	4.4	7.9	8.5	6.0	10.4	9.6	9.5	12.2	14.5	10.6	5.5	7.3	7.2	9.7	7.6	9.4	15.9	9.1	4.4	16.4	5.5	19.0	9.5	14.1	9.2	6.3	5.9	9.6	12.0	6.4	11.7	8.0	8.4	7.0	10.3	12.5	9.7	7.8	13.1	10.5	10.9	10.3	9.8	1.4	10.5	12.4	6.1	6.1	10.7	5.1	16.3	7.3	10.8	6.5	8.8	7.3	6.5	5.0	5.2	8.6	17.0	15.9	4.2	4.4	5.7	3.4	1.3	2.4	2.5	3.5	3.7	3.3	3.8	3.0	1.2	3.4	3.7	4.5	2.6	5.8	2.8	3.3	6.6	1.7	9.8	10.6	14.1	12.8	9.5	10.2	6.3	6.5	6.1	5.4	9.0	10.1	7.1	9.6	7.7	10.7	8.1	3.4	6.5	6.5	1.2	12.1	4.0	4.3	16.5	4.3	3.1	5.5	31.3	9.1	7.6	3.9	5.9	7.6	21.9	5.2	8.8	6.7	6.0	3.8	29.4	4.8	5.3	6.2	7.1	5.8	7.6	7.8	10.8	4.0	7.4	6.7	24.9	3.8	4.1	5.4	4.1	17.0	6.8	6.0	3.6	12.2	7.5	9.3	5.2	25.1	16.4	2.8	6.2	8.6	4.2	4.0	5.0	7.7	8.1	24.4	6.6	8.5	8.1	36.0	8.3	3.0	2.8	11.5	7.3	8.2	4.0	5.2
APAF1	"APAF-1, CED4"	ENSG00000120868	"Apoptotic peptidase activating factor 1"	O14727	12	98645290-98735433	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 32.0"	"Cell type enhanced"	"Detected in many"		"monocytes: 54.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 71.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031373, CAB069399"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Golgi apparatus"	"CAB069399: AB_1611908, HPA031373: AB_10602230"	"unprognostic (1.32e-1)"	"unprognostic (5.12e-2)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.21e-1)"	"unprognostic (3.94e-1)"	"unprognostic (8.21e-3)"	"unprognostic (2.03e-3)"	"unprognostic (1.35e-1)"	"unprognostic (2.26e-2)"	"unprognostic (5.92e-3)"	"unprognostic (5.63e-2)"	"unprognostic (6.04e-2)"	"unprognostic (9.93e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.07e-2)"	4.5	2.8	2.4	8.9	2.8	32.0	5.0	2.5	2.7	5.5	1.2	8.5	5.1	5.5	3.5	3.2	4.0	7.3	2.6	2.8	1.3	3.7	4.7	6.7	9.4	2.3	1.2	7.7	4.0	2.8	3.1	7.6	2.2	3.9	9.6	5.8	4.6	3.4	3.4	5.7	7.1	5.0	1.9	9.7	6.6	3.1	2.2	7.7	4.7	3.1	8.8	5.8	3.9	4.3	6.8	8.7	30.3	11.6	9.4	18.2	8.3	17.3	12.1	11.7	11.6	6.3	4.8	9.8	4.5	12.7	4.4	11.3	20.2	11.4	13.9	7.3	8.0	18.5	9.6	7.7	3.5	18.6	22.7	7.5	3.5	12.1	5.5	14.1	19.6	7.3	9.1	5.2	18.7	1.8	9.4	19.0	8.1	7.5	5.8	11.9	22.8	3.1	7.1	11.5	4.1	7.4	13.5	5.3	4.6	18.6	9.2	25.7	17.7	7.5	6.6	9.0	5.4	3.5	7.1	11.5	3.3	25.4	11.5	16.8	18.1	17.0	4.0	8.0	3.1	5.5	2.8	2.3	14.3	6.2	2.9	1.9	71.1	2.9	8.5	10.4	2.1	3.9	2.4	2.8	2.5	2.7	2.8	1.3	2.3	1.2	2.2	1.9	2.2	4.3	11.7	12.8	8.2	10.4	13.8	3.8	5.7	8.7	8.6	5.8	6.4	6.5	1.5	1.5	7.8	7.3	14.6	3.8	21.4	22.3	0.0	9.4	0.7	5.9	11.6	11.1	12.0	7.6	12.8	8.0	8.0	9.1	14.8	8.7	6.3	18.6	13.2	6.7	12.3	5.0	13.8	18.9	4.1	34.7	25.3	1.3	5.9	34.1	10.6	30.9	54.6	2.7	20.6	14.1	11.2	19.7	20.3	5.3	8.9	8.7	9.2	2.7	8.9	9.8	0.0	6.9	8.1	6.9	10.0	8.7	3.3	1.9	14.6	4.3	13.3	15.0
APBA1	"D9S411E, MINT1, X11"	ENSG00000107282	"Amyloid beta precursor protein binding family A member 1"	Q02410	9	69427532-69672371	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.5"	"Group enriched"	"Detected in many"	7	"Astrocytes: 53.5;Excitatory neurons: 130.3;Horizontal cells: 69.0;Inhibitory neurons: 181.6;Microglial cells: 78.7;Oligodendrocyte precursor cells: 141.3;Oligodendrocytes: 106.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 7.2;BJ hTERT+: 6.0;HAP1: 17.2;SCLC-21H: 6.5;TIME: 7.8;U-138 MG: 6.9;U-266/70: 7.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061287			Supported	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA061287: AB_2684467"	"unprognostic (4.02e-2)"	"unprognostic (4.64e-2)"	"unprognostic (7.29e-2)"	"unprognostic (8.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-1)"	"unprognostic (4.21e-3)"	"unprognostic (8.49e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.46e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.99e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (4.66e-3)"	2.9	1.2	14.1	0.7	13.1	0.0	2.5	0.0	16.5	3.6	0.0	2.9	0.6	4.1	0.1	1.8	2.5	1.3	3.0	16.0	9.5	2.2	11.9	1.4	0.6	15.1	13.8	5.3	1.9	6.8	6.3	1.4	16.1	1.9	1.9	3.2	2.9	1.1	2.0	3.9	1.8	0.8	0.0	3.8	2.0	2.8	7.9	0.2	2.0	0.6	0.3	2.8	3.6	0.9	0.0	0.0	0.6	0.0	3.1	2.2	0.1	7.2	6.0	0.1	0.1	0.0	0.0	0.0	3.2	3.0	0.0	0.1	17.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.9	0.3	0.0	0.0	2.9	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	2.5	6.5	4.2	0.4	0.9	0.1	0.2	0.0	0.0	7.8	6.9	0.8	0.0	0.5	7.1	3.3	0.0	0.1	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	13.1	0.0	16.5	16.0	9.5	15.1	13.8	16.1	0.0	7.9	0.9	1.0	0.0	0.0	53.5	0.0	1.8	1.2	0.2	0.0	15.4	2.0	2.2	4.9	0.0	0.2	0.0	4.2	0.8	0.0	3.7	0.0	0.1	0.3	0.9	1.7	1.4	4.2	0.0	130.3	0.0	0.6	1.7	0.0	1.0	0.0	1.3	3.3	5.8	3.1	69.0	181.6	1.6	0.0	3.7	1.4	0.6	2.5	1.4	0.0	78.7	1.0	3.2	0.0	141.3	106.2	0.2	0.4	10.9	0.0	0.6	0.0	0.4	0.1	9.1	0.0	1.6	2.3	1.1	1.3	0.5	2.4	0.4	0.5	6.0	1.2	0.4
APBA2	"D15S1518E, HsT16821, LIN-10, MGC:14091, MINT2, X11L"	ENSG00000034053	"Amyloid beta precursor protein binding family A member 2"	Q99767	15	28884483-29118315	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 8.7;lymphoid tissue: 10.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.2;Excitatory neurons: 142.7;Horizontal cells: 89.2;Inhibitory neurons: 106.1;NK-cells: 63.8;Oligodendrocyte precursor cells: 97.0;Oligodendrocytes: 74.1"	"Cancer enhanced"	"Detected in many"		"glioma: 17.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 5.4;naive CD8 T-cell: 5.6"	"Lineage enriched"	"Detected in many"	4	"T-cells: 5.6"	"Cell line enhanced"	"Detected in some"		"HEL: 8.4;SH-SY5Y: 20.0;U-937: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037065, HPA058796, HPA070376"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"CAB037065: AB_477178, HPA058796: , HPA070376: "	"unprognostic (2.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.42e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.17e-1)"	"unprognostic (8.19e-2)"	"unprognostic (4.71e-2)"	"unprognostic (9.25e-2)"	"unprognostic (4.21e-5)"	"unprognostic (1.98e-2)"	"unprognostic (4.74e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.28e-1)"	1.0	1.6	4.3	0.7	4.4	0.7	0.9	8.7	8.4	2.9	0.0	1.3	0.4	1.2	0.4	1.7	1.6	0.3	0.4	8.0	2.5	0.9	0.9	3.3	0.6	3.3	2.4	1.1	5.9	0.0	7.6	0.1	2.4	2.5	0.2	1.1	0.4	0.1	0.1	1.0	4.9	0.0	2.2	10.7	1.4	5.7	3.0	1.4	2.7	0.0	0.7	1.3	1.5	4.9	0.0	1.6	0.7	3.7	0.0	0.0	0.0	0.9	1.4	0.1	0.5	0.0	0.0	0.0	3.5	0.0	2.3	0.0	0.5	0.0	0.0	0.0	3.1	8.4	0.0	0.1	3.1	0.0	0.2	0.4	2.5	0.4	0.0	0.4	4.4	1.8	5.0	0.2	0.0	0.5	0.2	2.4	1.1	0.0	3.3	0.0	0.4	0.2	0.0	0.0	5.4	20.0	0.0	0.0	0.2	0.1	0.0	1.0	4.4	0.0	4.4	0.0	0.9	0.0	0.1	0.0	0.1	14.9	1.7	0.0	0.0	0.0	0.9	0.0	0.2	0.0	1.5	3.3	0.0	0.0	5.4	5.6	0.1	1.3	0.0	0.0	0.0	2.0	4.3	4.4	8.7	8.4	8.0	2.5	3.3	2.4	2.4	2.2	3.0	4.9	0.5	0.0	0.6	53.2	1.8	0.4	0.2	0.0	0.0	21.5	1.9	2.3	1.4	0.0	0.1	0.0	0.0	0.1	36.5	0.1	1.9	1.8	18.9	2.9	6.4	1.2	0.0	2.1	142.7	5.8	0.2	2.2	0.0	2.1	0.0	1.9	3.6	0.5	1.2	89.2	106.1	0.3	0.0	1.6	0.4	10.4	1.8	0.8	3.6	33.7	1.9	1.3	63.8	97.0	74.1	3.3	0.0	3.8	12.3	0.1	0.0	0.3	0.2	4.5	0.0	0.4	2.1	1.6	14.5	0.4	0.3	0.1	30.7	10.6	0.0	0.1
APCS	"MGC88159, PTX2, SAP"	ENSG00000132703	"Amyloid P component, serum"	P02743	1	159587826-159588865	"Disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"liver: 3629.2"	"Cell type enriched"	"Detected in some"	10	"Hepatocytes: 4141.9"	"Cancer enriched"	"Detected in some"	25	"liver cancer: 826.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RH-30: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB007817, HPA053294"	Supported				"Secreted to blood"	NA	NA	27700000000	39000000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 2: Hepatocytes - Metabolism"			"CAB007817: AB_598185, HPA053294: AB_2682104"							"unprognostic (3.19e-3)"				"unprognostic (2.30e-2)"							0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	47.7	0.2	0.0	0.0	1.3	3629.2	0.1	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	388.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.8	0.0	0.0	0.0	2.7	0.0	45.5	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	4141.9	0.0	0.0	0.0	0.0	0.0	88.9	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0
APH1A	"APH-1A, CGI-78"	ENSG00000117362	"Aph-1 homolog A, gamma-secretase subunit"	Q96BI3	1	150265399-150269580	"Predicted membrane proteins, Transporters"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037272	Approved					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 37: Intestine - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 32: Non-specific - Translation"			"CAB037272: AB_476776"	"unprognostic (1.00e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.84e-2)"	"unprognostic (1.20e-3)"	"unprognostic (4.92e-2)"	"unprognostic (3.55e-2)"	"unprognostic (2.75e-3)"	"unprognostic (4.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.53e-1)"	"unprognostic (6.99e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.87e-1)"	73.5	93.9	59.3	60.5	63.4	78.7	97.8	60.8	60.7	79.6	58.3	100.6	82.2	60.5	84.0	118.6	83.2	69.0	71.0	55.3	59.1	78.6	132.2	83.6	80.7	67.2	62.3	88.6	92.2	110.3	56.5	72.4	62.2	62.0	95.4	24.4	92.7	68.1	58.8	120.6	80.4	54.8	65.7	99.2	95.7	34.8	64.7	72.9	95.7	63.2	90.7	77.8	84.0	63.4	226.4	95.6	113.7	175.8	140.3	115.0	148.3	82.8	171.4	183.7	190.9	78.2	251.5	125.3	116.9	146.2	90.9	180.2	98.8	143.6	127.2	114.0	122.8	93.2	61.3	101.7	173.6	173.1	136.4	145.0	198.7	124.5	147.6	132.7	201.8	128.3	104.1	208.4	119.0	280.7	118.8	101.5	127.5	163.7	158.0	135.9	116.0	203.8	136.1	151.9	93.2	210.7	81.9	133.8	172.0	105.6	174.5	303.8	115.5	104.8	99.4	102.8	147.1	297.0	263.0	113.0	89.4	180.6	116.7	9.7	10.6	8.2	11.1	9.4	11.8	8.6	7.6	7.4	9.9	6.8	7.0	8.4	9.7	12.1	10.5	9.3	3.8	9.9	59.3	63.4	60.8	60.7	55.3	59.1	67.2	62.3	62.2	65.7	64.7	63.4	80.6	22.4	25.5	15.3	91.9	65.8	86.2	107.1	74.6	23.3	92.9	72.6	24.0	70.1	56.1	82.8	8.4	132.8	77.4	110.9	33.2	131.6	7.1	26.3	40.6	77.4	75.6	44.2	6.8	157.2	143.9	60.3	50.0	49.7	35.5	74.9	71.7	68.2	159.8	37.0	7.9	107.4	71.2	125.1	95.0	7.7	60.3	88.7	62.2	12.2	119.2	59.6	113.3	13.0	10.7	140.4	84.7	40.6	84.6	102.8	81.7	49.7	22.1	17.5	26.3	57.1	38.8	17.2	16.4	83.7	81.8	165.4	71.4	62.4	114.0	122.0
APH1B	"APH-1B, DKFZp564D0372, PSFL"	ENSG00000138613	"Aph-1 homolog B, gamma-secretase subunit"	Q8WW43	15	63276018-63309126	"Predicted membrane proteins, Transporters"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"testis: 122.8"	"Group enriched"	"Detected in many"	15	"Early spermatids: 1363.2;Late spermatids: 359.9;Spermatocytes: 838.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 107.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (9.92e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.57e-1)"	"unprognostic (7.86e-2)"	"unprognostic (1.78e-1)"	"unprognostic (3.86e-1)"	"unprognostic (4.56e-2)"	"prognostic favorable (1.05e-4)"	"unprognostic (8.44e-2)"	"prognostic favorable (2.25e-4)"	"unprognostic (4.29e-3)"	"unprognostic (2.54e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.62e-1)"	10.1	12.1	9.4	9.7	10.9	8.1	10.6	9.8	10.8	8.4	10.9	6.0	3.8	6.9	11.6	3.8	16.2	7.5	5.7	8.2	10.0	7.7	3.4	8.8	10.1	10.6	11.8	14.6	4.5	7.4	6.9	8.1	10.7	11.7	4.4	12.2	8.2	8.0	4.0	5.4	7.7	6.4	11.6	13.6	5.1	122.8	10.3	9.7	19.5	5.6	7.8	7.7	6.7	12.7	1.3	8.8	9.3	7.5	20.7	36.2	3.3	11.2	22.6	8.3	13.9	8.1	12.3	11.1	5.2	12.4	15.4	1.2	15.8	4.4	15.5	7.6	2.5	19.6	1.9	0.3	17.1	4.3	30.9	22.8	7.0	12.3	8.3	14.1	17.6	13.9	6.7	8.0	26.1	3.9	5.9	13.2	8.8	2.8	4.6	5.7	5.1	0.2	4.3	8.9	8.1	4.4	4.5	3.7	0.1	9.8	13.6	25.1	11.8	24.5	9.4	4.0	1.6	19.6	35.3	15.2	17.8	25.1	14.6	32.0	31.8	41.4	10.7	63.1	9.0	24.1	10.8	9.7	15.3	18.0	11.8	12.0	44.1	6.2	107.5	5.5	11.7	18.6	9.4	10.9	9.8	10.8	8.2	10.0	10.6	11.8	10.7	11.6	10.3	12.7	8.4	9.6	18.8	16.3	21.7	5.2	12.4	15.5	5.7	6.8	16.2	13.7	6.1	11.5	15.9	22.0	2.1	6.3	10.4	1.0	1.9	36.9	1363.2	25.6	12.7	12.0	20.4	5.0	18.1	6.2	38.7	18.1	4.6	4.5	22.8	12.5	17.9	1.7	55.7	1.7	22.9	4.1	22.4	52.0	17.7	359.9	24.5	41.8	10.6	16.9	29.6	21.4	6.2	27.2	28.9	11.1	0.8	16.6	16.3	8.9	0.7	6.8	38.6	14.8	13.1	12.6	15.5	838.0	20.0	2.3	3.4	6.0	14.5	16.4	2.8	9.0
APLNR	"AGTRL1, APJ, APJR, FLJ90771"	ENSG00000134817	"Apelin receptor"	P35414	11	57233577-57237235	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Gastrulation, Host-virus interaction"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 268.8;lymphoid tissue: 101.0;placenta: 88.1"	"Group enriched"	"Detected in some"	7	"Adipocytes: 67.6;Endothelial cells: 98.5"	"Cancer enhanced"	"Detected in all"		"glioma: 50.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	14	"AF22: 4.9;HEL: 4.3;K-562: 1.3;NTERA-2: 1.8;SuSa: 2.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			CAB025842	Approved					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 36: HEL - Hemostasis"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB025842: "	"unprognostic (5.06e-2)"	"unprognostic (3.56e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.68e-3)"	"unprognostic (1.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.26e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.27e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.13e-3)"	17.3	3.7	47.1	9.4	46.3	0.1	10.6	52.0	45.7	2.3	22.7	5.4	4.5	3.5	0.3	4.1	1.2	13.0	23.7	48.3	130.5	5.7	18.5	8.1	9.6	268.8	97.4	0.7	2.0	2.9	2.4	88.1	92.2	1.0	6.0	0.0	3.5	1.9	15.2	7.1	4.2	9.9	99.9	101.0	3.2	1.4	92.7	4.1	9.5	10.8	4.2	6.2	1.7	122.4	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.1	46.3	52.0	45.7	48.3	130.5	268.8	97.4	92.2	99.9	92.7	122.4	67.6	0.0	0.0	6.5	0.6	2.3	0.1	0.0	0.0	0.0	0.5	0.6	3.2	1.5	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.3	0.3	98.5	0.0	0.0	0.0	0.2	0.1	2.6	0.0	0.5	0.0	0.0	10.4	0.0	0.2	0.0	0.0	0.0	0.0	0.8	2.6	0.2	0.0	0.5	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	2.7	0.0	0.0	0.3	3.1	0.1	0.2	2.7	0.0	0.1
APOL1	APOL	ENSG00000100342	"Apolipoprotein L1"	O14791	22	36253071-36267530	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 220.5"	"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 106.1;Glandular and luminal cells: 216.2;Hepatocytes: 115.6;Pancreatic endocrine cells: 105.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"EFO-21: 243.9;HDLM-2: 166.1;HHSteC: 120.3;RPTEC TERT1: 91.1;RT4: 146.8"									"HPA018885, CAB056156"	Supported				"Secreted to blood"	NA	NA	1640000000	9200000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"CAB056156: AB_2665576, HPA018885: AB_1844953"	"unprognostic (1.05e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.98e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (5.35e-4)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.07e-3)"	"unprognostic (5.15e-2)"	"prognostic unfavorable (7.43e-6)"	"unprognostic (1.93e-1)"	"unprognostic (3.15e-2)"	"unprognostic (5.05e-3)"	"prognostic favorable (2.01e-5)"	45.3	15.8	8.1	62.5	8.2	4.2	28.4	7.8	9.8	53.8	9.4	32.0	32.7	38.8	17.7	25.7	36.7	69.0	29.5	7.4	8.4	44.5	220.5	59.5	23.1	10.0	8.5	24.8	9.0	4.9	14.1	53.0	9.6	37.5	27.2	0.9	29.7	52.2	11.7	7.1	28.9	65.4	9.0	56.8	64.9	7.9	10.8	24.9	18.0	13.8	23.6	117.7	29.9	8.2	21.6	5.1	0.1	0.6	46.8	44.6	14.2	2.3	9.0	13.7	38.6	0.6	34.4	7.0	243.9	24.8	31.3	5.3	0.0	19.2	3.6	166.1	0.2	6.1	3.2	41.4	120.3	2.4	20.2	8.3	1.7	38.0	0.8	2.0	27.3	1.3	23.8	85.1	2.4	0.2	8.5	2.1	0.6	0.6	0.2	13.6	2.6	3.2	91.1	146.8	1.9	0.1	10.9	5.8	2.1	0.3	0.8	7.8	24.7	29.5	12.4	3.2	1.5	6.5	4.0	1.6	16.0	12.4	4.6	15.6	6.1	5.5	12.6	6.8	10.7	2.6	8.1	11.2	4.3	1.4	4.6	6.3	16.1	22.4	10.3	0.5	5.4	7.2	8.1	8.2	7.8	9.8	7.4	8.4	10.0	8.5	9.6	9.0	10.8	8.2	37.4	57.7	34.3	0.3	7.2	1.7	21.4	73.5	2.8	0.5	6.3	3.0	3.6	15.7	67.1	18.4	2.1	11.0	12.6	31.2	0.0	37.8	0.8	106.1	48.8	41.3	7.7	3.8	0.1	20.0	8.2	27.3	45.9	216.2	11.4	4.3	49.6	115.6	9.1	0.0	0.1	17.7	32.6	15.8	5.3	1.4	27.4	10.9	0.0	7.5	19.4	0.1	36.0	0.0	0.0	105.1	19.9	24.0	15.0	31.2	20.5	2.1	60.5	1.3	6.6	5.5	10.6	0.4	0.4	3.4	2.3	6.7	12.9	1.6	4.6	62.5
APOO	"FAM121B, MGC4825, Mic23, MIC26, MICOS26, My025"	ENSG00000184831	"Apolipoprotein O"	Q9BUR5	X	23833353-23907938	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 180.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003187	Supported		Approved	Mitochondria,Cytosol	"Secreted to blood"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 18: U-2197 - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA003187: AB_1079375"	"unprognostic (2.53e-2)"	"prognostic favorable (3.77e-4)"	"unprognostic (4.86e-2)"	"unprognostic (6.38e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.18e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.45e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.22e-1)"	"prognostic favorable (2.56e-6)"	"unprognostic (2.53e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.48e-1)"	"unprognostic (5.88e-3)"	9.0	23.7	55.8	9.0	58.0	7.9	13.3	58.1	76.3	13.1	67.8	17.3	14.4	10.6	19.6	12.6	20.8	9.3	65.1	57.9	58.4	46.5	18.2	8.6	11.7	58.8	57.0	9.4	14.2	62.0	29.2	10.9	57.3	13.7	18.8	52.8	19.7	15.0	45.9	7.7	12.0	12.0	57.0	8.4	17.7	16.8	56.8	14.0	20.3	73.2	11.6	11.2	8.1	57.1	36.5	32.7	53.9	37.8	8.8	19.9	8.3	17.9	21.9	37.4	38.8	19.3	17.0	31.5	21.9	16.5	48.5	29.3	68.5	35.7	41.2	33.4	48.7	15.9	28.6	31.1	20.8	40.9	17.1	22.2	20.7	41.2	30.4	20.1	26.6	38.8	22.9	33.2	35.1	34.6	41.2	43.0	49.2	47.5	52.7	31.5	26.6	75.6	74.1	18.4	36.4	26.5	39.0	36.7	39.7	52.4	63.6	17.9	6.5	23.9	14.6	86.6	27.9	26.3	50.5	28.7	38.5	19.8	35.8	14.8	4.8	1.4	12.6	15.9	16.6	10.8	13.7	12.5	14.0	10.2	10.9	10.7	3.0	10.3	16.0	16.6	14.0	7.7	55.8	58.0	58.1	76.3	57.9	58.4	58.8	57.0	57.3	57.0	56.8	57.1	7.4	16.0	11.5	61.7	11.8	14.0	17.0	74.3	11.4	20.4	14.3	17.0	61.8	21.5	28.3	23.9	14.6	17.2	11.3	12.8	180.0	28.4	25.9	56.0	13.0	10.1	7.2	20.8	61.4	16.0	8.9	11.7	13.3	24.4	3.8	14.2	7.9	13.9	22.7	20.2	76.5	17.0	44.7	14.6	12.0	15.7	11.5	9.9	28.4	74.0	34.2	50.0	8.2	43.7	76.5	10.2	20.0	15.8	14.8	14.1	24.0	80.6	106.9	32.4	6.6	10.8	22.3	26.1	53.2	18.9	7.0	12.4	9.5	17.0	22.3	16.8
APP	AD1	ENSG00000142192	"Amyloid beta precursor protein"	P05067	21	25880550-26171128	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Apoptosis, Cell adhesion, Endocytosis, Notch signaling pathway"	"Heparin-binding, Protease inhibitor, Serine protease inhibitor"	"Alzheimer disease, Amyloidosis, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 870.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 38.1"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 38.1"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000157, HPA001462"	Enhanced		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		26000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	Vesicles	"CAB000157: AB_323833, HPA001462: AB_1078185"	"unprognostic (3.30e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.69e-3)"	"unprognostic (2.54e-1)"	"unprognostic (8.22e-2)"	"unprognostic (1.28e-1)"	"unprognostic (9.45e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.35e-2)"	"prognostic favorable (2.79e-6)"	"unprognostic (3.77e-2)"	"unprognostic (2.46e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.08e-3)"	249.9	498.0	413.0	157.4	457.6	134.4	447.5	413.1	572.4	264.2	396.8	357.2	226.4	281.1	293.3	178.6	308.1	350.8	389.0	456.2	405.3	532.5	298.2	279.4	78.9	425.0	481.9	306.2	323.5	278.6	155.4	451.9	448.7	260.6	328.5	209.3	270.7	343.6	107.5	218.6	200.3	379.9	419.7	154.4	213.5	165.6	426.4	159.2	469.9	176.0	78.2	304.9	151.7	523.5	388.7	489.9	538.4	448.5	707.7	869.8	559.8	757.1	1029.2	386.6	449.3	286.4	941.0	0.9	848.3	614.8	505.1	255.6	326.4	921.6	324.4	14.7	253.1	0.8	275.6	204.1	688.0	372.0	19.6	790.4	990.7	456.8	823.0	1584.3	1750.7	158.6	0.8	39.0	614.5	433.1	6.5	4.0	416.2	644.9	418.6	241.2	505.2	325.3	1283.3	270.1	267.3	385.6	824.0	549.0	393.4	720.0	482.4	400.1	1837.1	850.8	350.2	310.4	371.6	232.3	3.1	4.8	690.4	1.6	836.3	1.1	7.5	0.0	0.2	2.2	0.3	0.8	2.2	0.7	5.6	2.2	2.3	0.6	1.5	0.5	1.6	38.1	0.6	3.3	413.0	457.6	413.1	572.4	456.2	405.3	425.0	481.9	448.7	419.7	426.4	523.5	330.2	109.0	39.6	70.5	47.6	181.6	215.6	449.0	306.7	45.2	280.3	199.6	143.2	296.0	214.0	502.1	29.2	472.6	180.7	395.2	56.7	398.7	46.1	78.8	162.2	416.0	162.6	29.2	481.6	180.4	141.2	309.5	164.7	110.7	8.2	100.3	539.7	125.7	76.3	84.1	525.5	303.1	256.3	61.6	79.9	61.8	242.6	69.9	161.9	189.3	89.9	329.9	4.1	423.2	870.8	205.4	223.1	296.8	24.0	187.5	95.2	165.8	164.7	24.5	118.3	336.5	198.5	38.3	86.9	85.9	106.1	552.1	27.0	111.4	283.5	133.6
AQP1	"CHIP28, CO"	ENSG00000240583	"Aquaporin 1 (Colton blood group)"	P29972	7	30911853-30925517	"Blood group antigen proteins, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 727.9;Alveolar cells type 2: 231.8;Cholangiocytes: 358.9;Endothelial cells: 606.7;Hepatic stellate cells: 325.6;Proximal tubular cells: 319.7"	"Cancer enhanced"	"Detected in all"		"glioma: 336.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 34.7;HeLa: 12.5;SH-SY5Y: 14.7;U-2 OS: 14.9;WM-115: 76.4"					"Group enriched"	"Detected in some"	6	"medulla oblongata: 5.5;spinal cord: 22.0"	"CAB001707, HPA019206"	Enhanced		Supported	"Plasma membrane"		NA	NA		49000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB001707: , HPA019206: AB_1844965"	"unprognostic (4.18e-2)"	"unprognostic (7.82e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.02e-1)"	"prognostic favorable (6.52e-4)"	"unprognostic (1.95e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.00e-2)"	"unprognostic (3.80e-2)"	"unprognostic (4.16e-1)"	"unprognostic (2.05e-2)"	"prognostic favorable (1.32e-8)"	"unprognostic (3.43e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.09e-1)"	"unprognostic (7.21e-2)"	385.9	30.5	86.5	29.3	149.4	50.7	250.3	106.2	79.1	148.9	277.7	97.7	51.0	160.8	41.7	143.5	165.8	162.3	206.8	141.0	124.4	522.9	12.9	413.9	45.5	512.3	181.1	28.1	257.6	48.2	15.2	36.9	199.5	83.8	32.6	0.7	114.0	84.4	199.0	112.6	90.8	142.4	357.3	12.6	80.4	7.8	138.8	39.0	113.2	388.6	34.2	138.5	143.2	432.4	0.1	0.5	0.3	0.6	0.3	1.3	0.7	2.4	0.5	0.0	0.0	0.2	0.8	0.1	34.7	1.9	0.1	0.4	0.0	0.0	0.0	0.3	0.3	0.5	12.5	0.0	0.3	0.3	0.1	4.9	0.1	0.3	0.0	0.1	5.1	0.1	2.3	0.1	0.0	0.0	0.0	0.9	0.7	1.0	0.0	0.0	8.9	0.3	0.9	0.0	0.3	14.7	1.9	1.2	0.0	4.6	0.3	0.1	0.0	0.0	14.9	1.1	0.5	0.8	0.6	0.6	0.0	0.1	76.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	86.5	149.4	106.2	79.1	141.0	124.4	512.3	181.1	199.5	357.3	138.8	432.4	727.9	179.5	231.8	75.7	3.6	91.5	1.2	0.3	5.2	0.7	11.5	29.0	78.0	358.9	3.9	31.3	8.4	3.4	3.7	3.7	29.4	53.3	2.3	2.5	1.2	606.7	7.3	86.9	3.5	2.5	4.8	67.6	0.0	0.9	1.3	0.5	325.6	2.0	3.7	0.0	1.0	28.6	0.0	5.1	107.7	2.1	1.2	6.0	88.9	0.0	1.6	0.4	0.0	0.5	0.2	2.4	14.5	3.4	3.7	1.2	90.6	319.7	6.2	0.4	13.1	23.1	42.3	0.3	1.5	2.6	78.7	7.3	8.1	4.7	67.8	1.0
AQP10		ENSG00000143595	"Aquaporin 10"	Q96PS8	1	154321090-154325325	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"intestine: 68.5"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.5;Erythroid cells: 1.3;granulocytes: 5.7;Hepatic stellate cells: 1.4;Macrophages: 4.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 18.0;HMC-1: 7.1;K-562: 21.0;SH-SY5Y: 4.8"					"Not detected"	"Not detected"			"HPA062621, HPA065947"	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"	Vesicles	"HPA062621: , HPA065947: AB_2685584"	"unprognostic (6.84e-2)"	"unprognostic (4.97e-2)"		"unprognostic (4.19e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-4)"	"unprognostic (1.63e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.08e-2)"	"unprognostic (3.99e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.68e-1)"		"unprognostic (7.64e-3)"	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	68.5	0.0	0.1	0.1	4.6	0.1	0.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	49.7	0.0	0.0	0.7	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	18.0	0.0	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.4	1.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.3	0.5	0.0	1.3	0.1	0.0	0.0	0.1	0.0	0.1	5.7	0.2	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.2	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.2	0.0	0.5	0.0	0.0	0.0	0.1	0.4	0.4	0.0	0.1	0.0	0.4	0.1	0.0	0.1
AQP11		ENSG00000178301	"Aquaporin 11"	Q8NBQ7	11	77589391-77610356	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 28.6;liver: 16.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 42.0;Hepatocytes: 35.9;Late spermatids: 65.0;Muller glia cells: 30.7;Proximal enterocytes: 33.2;Spermatocytes: 56.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 8.2;GAMG: 12.3;Hep G2: 13.6;OE19: 7.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042879			Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Vesicles	"HPA042879: AB_10794919"	"unprognostic (4.95e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.15e-2)"	"unprognostic (9.62e-5)"	"unprognostic (2.42e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.48e-2)"	"unprognostic (2.65e-1)"	"prognostic favorable (9.89e-4)"	"unprognostic (1.16e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.66e-3)"	1.0	13.2	3.4	0.7	3.0	0.6	1.2	4.6	3.3	0.8	1.0	2.3	28.6	0.8	1.0	0.4	0.8	1.2	0.8	2.6	3.4	6.0	16.1	0.5	0.8	3.3	3.1	6.0	4.0	0.5	1.5	0.8	3.5	4.0	2.1	5.6	0.7	0.4	0.9	0.9	25.3	0.4	2.7	0.9	2.4	8.1	3.0	0.1	1.5	0.2	0.1	0.8	0.6	3.0	1.0	3.4	1.4	2.2	3.1	0.8	1.3	1.6	0.8	1.6	0.7	8.2	1.6	1.6	0.7	0.8	12.3	0.9	0.6	0.1	0.8	4.7	1.2	1.3	1.3	13.6	1.0	2.8	1.4	0.8	0.3	0.9	0.2	1.9	0.3	0.4	0.9	1.0	1.9	1.7	0.9	2.0	1.4	7.8	3.1	1.3	3.3	0.6	0.9	1.2	1.3	0.9	2.1	0.5	0.8	1.1	1.5	0.3	0.9	1.2	3.7	2.4	1.0	1.0	0.8	1.3	0.4	0.2	1.8	0.0	0.0	0.1	0.5	0.0	0.3	0.0	0.2	0.4	0.0	0.5	0.6	0.2	0.0	0.7	0.0	0.0	0.0	0.2	3.4	3.0	4.6	3.3	2.6	3.4	3.3	3.1	3.5	2.7	3.0	3.0	0.6	0.0	0.0	3.9	0.8	0.1	0.9	0.4	1.8	7.5	2.1	1.3	0.7	7.2	0.2	1.8	0.0	7.5	0.6	10.8	0.0	1.1	42.0	1.2	0.8	0.5	4.2	0.0	13.5	4.0	11.4	1.5	3.6	0.8	4.5	17.1	0.4	35.9	1.2	0.0	14.6	2.9	0.0	0.6	0.4	65.0	15.5	0.5	1.8	1.0	0.0	30.7	0.0	9.0	9.9	2.5	5.5	11.3	0.3	1.4	33.2	19.9	0.2	5.0	0.0	0.5	1.2	56.0	6.4	0.4	0.1	15.9	0.7	21.4	6.4	0.4
AQP12A	AQP12	ENSG00000184945	"Aquaporin 12A"	Q8IXF9	2	240691851-240698483	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	332	"pancreas: 129.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 1.5;Paneth cells: 1.2;Proximal enterocytes: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA042216	Supported					NA	NA				"Cluster 25: Pancreas - Digestion"		"Cluster 45: Enterocytes - Digestion"			"HPA042216: AB_2677905"			"unprognostic (9.82e-2)"							"unprognostic (1.63e-2)"	"unprognostic (9.48e-2)"			"unprognostic (2.14e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	129.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AQP2		ENSG00000167580	"Aquaporin 2"	P41181	12	49950737-49958878	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Diabetes insipidus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	92	"kidney: 386.9;seminal vesicle: 212.4"	"Cell type enriched"	"Detected in some"	440	"Collecting duct cells: 4143.6"	"Group enriched"	"Detected in some"	6	"renal cancer: 1.7;stomach cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 3.4;HEL: 1.1;HMC-1: 2.2;OE19: 3.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046834	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA046834: AB_2679830"	"unprognostic (2.10e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.48e-3)"	"unprognostic (3.60e-2)"			"unprognostic (9.51e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.65e-2)"	"unprognostic (7.38e-3)"	"unprognostic (5.92e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.11e-1)"		0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.2	1.5	0.0	0.0	386.9	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.4	212.4	0.0	0.2	0.0	0.0	0.0	0.0	0.9	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	4143.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	9.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	0.0	0.1	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0
AQP4	MIWC	ENSG00000171885	"Aquaporin 4"	P55087	18	26852043-26865771	"Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 440.5;lung: 114.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 1102.6;Alveolar cells type 2: 342.3;Astrocytes: 487.7;Muller glia cells: 227.2"	"Cancer enriched"	"Detected in some"	22	"glioma: 223.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.4;RPTEC TERT1: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005079, HPA014784, CAB058689"	Enhanced	Supported	Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions"	"CAB005079: AB_2274338, CAB058689: AB_2665579, HPA014784: AB_1844967"	"unprognostic (7.23e-5)"	"unprognostic (1.55e-1)"		"unprognostic (3.19e-8)"	"unprognostic (3.68e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.34e-1)"	"unprognostic (5.38e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.98e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.10e-2)"		0.1	0.1	272.7	0.0	298.7	0.0	0.3	282.0	246.3	0.6	62.9	0.3	0.0	0.0	0.8	0.9	1.1	0.1	2.8	283.6	440.5	2.3	0.9	114.8	0.3	250.5	351.2	2.5	0.2	2.2	3.7	0.0	333.3	0.4	0.0	60.2	0.7	0.2	60.1	0.1	0.1	0.0	333.0	0.5	11.4	0.5	387.1	0.2	14.7	20.9	0.1	0.1	0.1	376.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	272.7	298.7	282.0	246.3	283.6	440.5	250.5	351.2	333.3	333.0	387.1	376.0	0.0	1102.6	342.3	487.7	0.0	0.0	0.8	0.6	0.0	3.1	0.8	0.9	13.9	4.3	76.6	3.7	6.2	0.0	0.0	0.1	3.9	0.3	0.0	0.7	0.1	1.8	0.0	0.0	3.0	0.0	0.0	0.8	0.0	0.0	3.8	0.0	0.0	0.5	0.0	1.7	1.1	0.0	0.0	0.0	0.3	0.0	5.0	0.8	0.0	9.4	0.0	227.2	0.0	12.1	1.6	0.0	0.0	0.0	0.0	0.7	0.0	0.0	23.1	9.1	0.0	4.3	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.0	2.0
AQP5		ENSG00000161798	"Aquaporin 5"	P55064	12	49961872-49965682	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 622.6;testis: 222.0"	"Group enriched"	"Detected in many"	7	"Early spermatids: 1542.9;Late spermatids: 4265.6"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 87.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	22	"OE19: 223.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA065008	Enhanced		Approved	"Plasma membrane"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA065008: AB_2685401"	"unprognostic (4.67e-3)"	"unprognostic (5.00e-2)"	"unprognostic (3.30e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.92e-3)"	"prognostic favorable (1.75e-5)"	"unprognostic (4.13e-3)"	"unprognostic (1.02e-2)"	"unprognostic (9.39e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.88e-3)"	"unprognostic (2.46e-3)"	"unprognostic (1.69e-4)"	"unprognostic (2.53e-1)"	"unprognostic (5.28e-2)"	"unprognostic (2.51e-3)"	"unprognostic (9.11e-3)"	2.9	0.8	2.7	0.1	3.7	0.2	17.1	3.3	2.7	12.9	1.5	0.4	15.3	2.7	0.2	16.5	0.7	2.8	4.0	2.4	2.9	1.9	0.1	7.6	0.0	3.3	3.9	0.2	2.0	3.0	1.2	0.0	3.1	1.3	0.0	1.0	622.6	1.0	0.2	112.7	0.1	0.3	2.6	0.4	52.3	222.0	3.8	0.0	1.6	0.0	0.1	0.3	0.4	2.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.7	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.7	223.2	0.0	10.1	0.0	0.0	0.3	0.0	0.2	0.1	0.8	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	3.7	3.3	2.7	2.4	2.9	3.3	3.9	3.1	2.6	3.8	2.6	0.5	57.7	3.1	0.0	0.1	1.3	0.5	18.3	0.0	0.8	53.9	48.0	0.3	0.0	56.4	7.3	0.0	0.0	0.1	0.0	0.0	0.1	1542.9	1.5	0.1	1.8	0.0	0.0	0.0	0.2	0.0	1.4	34.7	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	26.4	0.0	1.6	4265.6	28.6	1.7	295.3	0.0	0.0	53.7	0.0	3.0	0.1	7.2	0.0	19.2	0.3	1.6	0.0	0.0	9.7	1.7	19.7	0.0	1.8	403.9	15.9	1.3	0.9	0.0	0.6	18.7	0.0	0.6
AQP6	AQP2L	ENSG00000086159	"Aquaporin 6"	Q13520	12	49967194-49977139	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"kidney: 52.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.2;Cardiomyocytes: 8.3;Collecting duct cells: 5.5;Ionocytes: 2.0"	"Cancer enriched"	"Detected in many"	9	"renal cancer: 9.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"OE19: 1.4"	"Region enriched"	"Detected in some"	7	"cerebellum: 21.0"	"Not detected"	"Not detected"			HPA015278	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA015278: AB_10600982"	"unprognostic (1.23e-1)"	"unprognostic (1.32e-2)"	"unprognostic (9.53e-2)"	"unprognostic (2.02e-2)"	"unprognostic (6.46e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.45e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.68e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.77e-1)"	0.1	0.2	2.8	0.1	4.1	0.0	0.1	5.6	2.6	0.3	1.6	0.6	0.1	0.1	0.2	0.1	0.1	0.1	0.2	2.7	2.5	52.7	0.3	0.1	0.0	4.9	4.6	0.0	0.1	0.2	0.2	0.0	5.2	0.2	0.0	0.2	1.0	0.2	0.0	0.3	0.2	0.1	3.4	0.0	0.4	2.4	6.1	0.0	0.0	0.0	0.0	0.1	0.1	3.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	1.4	0.1	0.2	0.0	0.1	0.2	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	4.1	5.6	2.6	2.7	2.5	4.9	4.6	5.2	3.4	6.1	3.3	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.6	0.0	0.1	0.4	0.3	8.3	0.0	0.9	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	2.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	1.5	1.6	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.2	0.6	0.0	0.0	0.1	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
AQP7	"AQP7L, AQP9, AQPap"	ENSG00000165269	"Aquaporin 7"	O14520	9	33383179-33402682	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 252.7;breast: 104.9;heart muscle: 108.5"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 129.7;Cardiomyocytes: 86.0;Early spermatids: 128.5;Proximal enterocytes: 160.7;Proximal tubular cells: 61.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	43	"ASC diff: 196.0"	"Not detected"	"Not detected"													NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (3.25e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.25e-5)"	"unprognostic (7.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.99e-2)"	"unprognostic (4.65e-2)"	"unprognostic (8.56e-4)"	"unprognostic (1.21e-1)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.42e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.12e-3)"	252.7	5.0	0.9	1.9	1.3	0.0	104.9	4.4	1.4	1.3	0.0	6.6	17.9	1.7	2.9	2.8	5.9	3.4	108.5	0.8	0.7	24.2	23.5	1.2	0.7	4.8	0.7	1.8	3.8	18.3	0.3	0.5	5.8	1.2	4.0	0.3	6.4	2.5	33.8	6.2	26.8	2.5	0.3	1.3	2.8	30.4	1.0	1.0	4.8	51.9	0.2	4.7	2.2	1.2	0.1	1.9	0.2	0.1	196.0	4.5	0.2	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.1	0.1	0.1	0.3	0.1	1.1	0.0	0.1	0.0	0.1	0.4	2.2	0.2	0.0	0.2	3.1	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	4.5	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.9	1.3	4.4	1.4	0.8	0.7	4.8	0.7	5.8	0.3	1.0	1.2	129.7	6.4	7.3	0.3	0.2	1.5	0.3	0.3	0.0	0.0	0.8	1.5	86.0	14.3	0.9	35.0	0.0	0.0	0.6	30.7	5.9	1.9	128.5	9.1	0.2	11.2	0.0	0.0	0.1	0.2	0.3	4.1	0.0	0.7	0.0	0.2	2.9	20.1	0.1	0.0	0.1	9.2	0.0	0.3	0.3	21.4	2.1	1.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.2	22.5	1.9	0.1	0.5	160.7	61.4	7.7	0.0	6.6	1.7	9.6	4.1	0.7	1.3	2.6	0.0	0.3	0.9	4.3	2.1
AQP8		ENSG00000103375	"Aquaporin 8"	O94778	16	25215731-25228932	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	641	"intestine: 330.0;pancreas: 1280.1"	"Group enriched"	"Detected in some"	45	"Distal enterocytes: 1005.1;Paneth cells: 379.5"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 6.4;pancreatic cancer: 15.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"Hep G2: 1.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046259	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046259: AB_10960494"	"unprognostic (8.75e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.20e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.67e-2)"	"unprognostic (3.34e-3)"	"unprognostic (8.47e-2)"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.71e-2)"	0.3	0.2	0.6	0.4	0.7	0.4	0.3	0.7	0.8	0.5	0.3	330.0	0.2	0.5	0.0	0.1	0.3	0.0	0.2	0.7	0.5	0.2	0.7	0.1	0.0	0.4	0.4	0.6	1280.1	0.0	0.1	0.1	0.4	0.3	160.3	0.1	0.1	0.3	0.1	0.4	0.2	1.2	0.4	0.1	0.8	0.5	0.6	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.7	0.8	0.7	0.5	0.4	0.4	0.4	0.4	0.6	0.6	0.2	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	1005.1	0.0	0.1	1.4	0.2	1.3	0.1	13.1	0.0	0.8	11.0	0.1	0.0	0.0	0.3	8.9	0.4	0.0	0.0	0.1	1.7	0.6	15.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	379.5	0.0	0.1	0.2	0.0	0.1	0.0	0.4	0.0	0.2	0.2	0.1	0.3	0.0	0.1	0.4	1.7	0.2	12.9	0.1
AQP9	"HsT17287, SSC1"	ENSG00000103569	"Aquaporin 9"	O43315	15	58138169-58185911	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"liver: 702.7"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 313.9;Macrophages: 82.1"	"Cancer enriched"	"Detected in many"	30	"liver cancer: 132.4"	"Region enhanced"	"Detected in many"		"cerebral cortex: 14.4"	"Immune cell enriched"	"Detected in many"	20	"neutrophil: 1161.4"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 1161.4"	"Cell line enriched"	"Detected in some"	29	"U-87 MG: 29.7"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA074762, CAB075684"	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"			"CAB075684: , HPA074762: AB_2732267"	"unprognostic (1.91e-1)"	"unprognostic (1.92e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.28e-2)"	"unprognostic (3.82e-2)"	"unprognostic (2.03e-1)"	"unprognostic (4.80e-3)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (5.72e-11)"	"unprognostic (8.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.39e-2)"	18.2	0.8	0.8	72.9	0.9	67.5	2.4	0.9	14.4	1.3	0.8	0.9	0.2	1.2	43.4	1.2	7.1	5.3	1.7	3.2	0.5	0.9	702.7	22.2	0.6	0.7	1.0	0.5	1.6	5.6	0.3	6.2	4.0	0.9	0.3	0.4	1.1	0.7	0.5	22.0	0.9	6.4	0.6	42.7	1.5	0.3	6.9	1.8	0.6	7.5	0.8	32.6	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	29.7	0.1	0.0	0.2	58.4	1.2	0.1	17.5	0.1	0.5	0.1	0.0	1.8	0.1	0.1	0.0	1161.4	0.3	23.0	0.6	0.3	18.9	0.8	0.9	0.9	14.4	3.2	0.5	0.7	1.0	4.0	0.6	6.9	0.8	0.7	0.0	12.2	0.3	2.3	0.4	0.2	0.0	0.0	0.0	0.1	0.0	1.1	5.7	3.1	0.0	0.0	0.3	0.5	0.0	0.0	0.1	2.1	0.3	0.1	0.7	0.0	13.9	2.4	0.2	0.9	1.9	0.0	1.8	7.6	0.0	7.9	313.9	40.8	0.0	0.8	0.0	0.0	28.5	6.2	1.9	0.3	82.1	0.0	0.0	18.9	0.0	1.0	0.5	0.2	0.5	0.0	0.0	0.7	0.2	0.0	0.3	1.5	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.6	0.8	1.5	0.0	0.0	0.1
ARL6IP5	"DERP11, GTRAP3-18, HSPC127, JWA, PRAF3, Yip6b"	ENSG00000144746	"ADP ribosylation factor like GTPase 6 interacting protein 5"	O75915	3	69084937-69106092	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015540, CAB019321"	Supported		Approved	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 44: Non-specific - Transcription"	"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 3: Monocytes - Immune response regulation"	"Endoplasmic reticulum"		"CAB019321: , HPA015540: AB_1852061"	"unprognostic (8.01e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.51e-3)"	"unprognostic (2.65e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.72e-3)"	"unprognostic (1.31e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.05e-3)"	"unprognostic (3.60e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.42e-2)"	"unprognostic (1.31e-2)"	157.7	130.6	91.0	109.9	95.9	67.8	139.7	100.6	156.0	123.0	83.1	87.3	59.1	72.8	104.4	78.3	90.5	102.1	216.3	91.1	105.6	88.5	80.3	125.5	138.3	100.6	93.4	74.2	55.3	83.4	47.6	88.8	106.8	129.6	85.2	135.0	159.6	90.5	183.2	48.5	66.1	100.4	104.1	100.3	72.5	34.9	98.3	92.3	71.2	186.8	130.0	111.8	61.0	113.3	86.9	59.0	71.1	52.8	361.4	335.2	89.7	87.9	196.5	66.7	77.4	30.1	205.9	17.0	28.9	151.1	124.8	67.0	59.2	100.8	57.0	339.5	55.2	59.6	91.1	45.8	92.9	51.4	280.5	243.6	177.5	61.5	77.3	235.0	206.0	55.7	26.6	156.7	163.6	50.3	56.0	67.0	18.5	200.2	55.1	48.6	65.0	159.1	330.5	143.1	17.8	47.0	87.0	93.5	119.5	69.7	61.7	80.2	203.7	44.1	34.8	112.5	96.1	139.4	208.5	31.7	146.0	126.0	72.8	697.4	388.2	650.2	332.4	357.6	257.1	397.7	462.4	427.6	275.7	336.1	391.2	409.5	162.0	298.4	315.1	176.0	530.4	933.9	91.0	95.9	100.6	156.0	91.1	105.6	100.6	93.4	106.8	104.1	98.3	113.3	101.1	176.3	132.0	34.6	183.6	72.8	70.6	275.5	108.7	201.9	214.9	174.5	422.0	95.8	185.0	93.8	187.7	305.8	212.7	146.7	25.4	281.4	20.8	144.9	79.5	121.4	42.0	89.8	45.9	214.4	379.2	254.8	64.2	233.4	336.6	75.7	150.3	72.5	292.0	122.8	70.7	57.1	270.6	260.0	402.1	18.9	207.2	275.4	272.1	35.6	476.6	235.7	272.9	49.8	97.0	244.2	95.7	261.8	93.4	93.6	91.7	77.8	155.0	272.4	190.7	190.3	125.4	7.3	4.3	207.8	73.9	178.4	292.2	133.6	77.8	94.0
ARRB1	ARR1	ENSG00000137486	"Arrestin beta 1"	P49407	11	75260122-75351705	"Predicted intracellular proteins, Transporters"	"Protein transport, Transcription, Transcription regulation, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 136.8"	"Group enriched"	"Detected in many"	5	"dendritic cells: 42.5;granulocytes: 49.5;monocytes: 136.8"	"Cell line enhanced"	"Detected in many"		"HEL: 168.9;RH-30: 114.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003763, HPA049318, HPA070249"	Approved		Supported	Nucleoplasm		NA	NA		1500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"CAB003763: AB_562248, HPA049318: AB_2680711, HPA070249: AB_2732151"	"unprognostic (3.40e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.27e-3)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.73e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.29e-1)"	"unprognostic (7.10e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.26e-1)"	30.7	7.1	49.7	21.9	49.4	15.7	24.1	28.3	49.5	10.0	0.0	26.4	21.9	10.2	6.1	19.0	15.9	12.9	17.6	54.3	43.6	14.2	10.1	53.0	15.3	41.1	55.6	16.2	24.5	3.8	4.1	25.1	49.4	16.3	22.5	5.3	12.7	9.7	11.4	16.8	27.2	21.8	23.2	40.1	33.9	4.3	49.9	9.9	8.8	10.9	10.3	16.5	11.0	36.7	5.1	23.6	24.2	12.0	20.2	17.6	48.8	5.0	17.2	6.2	4.3	34.5	23.9	2.0	58.9	4.5	4.7	1.1	9.5	0.1	2.4	0.2	5.5	168.9	3.3	20.6	5.5	5.1	63.9	8.9	1.2	10.3	0.0	7.4	70.4	6.1	83.5	0.2	12.2	14.1	3.1	58.4	17.8	76.9	7.1	18.8	114.4	6.8	26.8	20.4	12.5	13.5	8.7	61.7	15.0	49.3	44.8	27.6	61.0	4.7	5.9	19.3	0.6	0.1	0.1	0.1	3.5	78.0	5.8	33.7	65.7	45.9	11.6	106.5	4.3	0.4	5.5	6.6	42.5	0.2	5.0	6.6	49.5	14.8	136.8	0.9	5.7	41.1	49.7	49.4	28.3	49.5	54.3	43.6	41.1	55.6	49.4	23.2	49.9	36.7	24.2	28.9	14.8	52.2	1.9	1.9	2.0	1.9	2.8	3.1	9.0	14.7	4.6	8.6	5.8	3.7	6.2	41.7	10.7	38.5	1.9	5.0	2.6	0.8	4.3	19.4	5.4	10.3	35.6	8.4	4.1	9.1	17.3	0.9	23.5	2.3	25.7	2.1	39.6	0.0	48.9	11.1	8.2	55.2	17.9	21.4	15.8	31.2	3.6	55.3	42.1	0.2	29.9	8.0	23.9	9.2	19.1	16.6	1.0	3.6	29.9	0.2	4.7	1.1	13.1	4.5	7.7	0.2	0.8	1.0	3.0	33.7	5.9	9.4	20.0	2.8
ARRB2	"ARR2, BARR2, DKFZp686L0365"	ENSG00000141480	"Arrestin beta 2"	P32121	17	4710596-4721499	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Signal transduction inhibitor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 263.6;lymphoid tissue: 168.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 262.0;Kupffer cells: 242.5;Langerhans cells: 164.2;Macrophages: 226.4;monocytes: 311.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 195.8;HMC-1: 315.9;NB-4: 199.2;U-937: 279.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075177			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA075177: "	"unprognostic (1.12e-1)"	"prognostic favorable (2.93e-5)"	"unprognostic (1.09e-1)"	"unprognostic (1.47e-1)"	"unprognostic (7.43e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.62e-3)"	"unprognostic (3.85e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-3)"	"prognostic unfavorable (2.61e-5)"	"unprognostic (1.32e-2)"	"unprognostic (8.61e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.88e-1)"	48.6	39.7	54.4	110.0	53.8	263.6	26.1	48.2	62.2	19.3	49.1	29.5	50.5	17.4	10.8	15.1	29.0	31.4	25.0	63.8	67.7	25.2	35.6	94.8	59.4	61.6	58.3	17.5	19.4	16.4	24.9	35.5	59.5	19.5	27.6	16.9	20.9	11.7	12.7	14.6	51.1	29.6	55.4	168.3	35.0	7.2	59.5	45.2	15.8	18.1	38.0	41.6	17.6	66.5	17.3	88.7	34.7	32.9	6.8	9.5	18.6	13.7	18.0	38.4	48.0	31.0	14.2	49.1	12.2	10.3	18.3	28.5	58.0	18.4	39.4	116.6	85.0	195.8	46.8	55.6	10.2	89.2	315.9	8.8	23.5	47.9	18.7	24.9	29.6	89.1	13.5	46.4	8.9	30.5	87.9	199.2	18.9	44.9	18.4	104.3	31.0	53.8	13.2	9.2	36.0	49.2	30.8	50.8	23.6	14.2	24.6	40.0	26.1	14.3	29.1	25.1	51.5	19.8	28.6	27.6	37.9	279.4	21.6	116.2	145.5	269.7	49.1	151.1	35.1	10.1	31.1	51.3	84.9	9.0	29.3	38.7	250.6	29.9	168.6	20.7	28.8	93.5	54.4	53.8	48.2	62.2	63.8	67.7	61.6	58.3	59.5	55.4	59.5	66.5	7.7	22.4	32.3	5.5	26.4	11.5	7.7	16.6	3.4	20.5	9.6	12.3	8.3	14.3	47.9	3.7	2.1	7.5	83.8	7.4	15.6	11.2	0.6	1.5	3.6	10.1	8.4	33.9	20.4	7.3	12.0	8.7	19.4	1.8	94.9	7.8	19.2	12.4	262.0	21.9	18.2	17.0	50.8	242.5	164.2	3.5	5.0	226.4	10.6	42.2	311.3	5.8	89.6	7.1	8.4	6.3	22.0	4.9	23.4	4.4	35.5	17.5	24.4	8.7	19.7	10.9	8.5	1.1	13.1	6.8	8.4	6.0	77.2	3.5	11.4	11.7
ARRDC3	"KIAA1376, TLIMP"	ENSG00000113369	"Arrestin domain containing 3"	Q96B67	5	91368631-91383317	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 394.2;Syncytiotrophoblasts: 339.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 115.3"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"				"unprognostic (2.28e-1)"	"unprognostic (2.24e-1)"	"unprognostic (9.42e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.07e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.91e-2)"	"unprognostic (2.44e-1)"	"prognostic unfavorable (3.30e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.25e-8)"	"prognostic unfavorable (2.26e-4)"	"unprognostic (1.34e-1)"	"unprognostic (5.74e-2)"	"unprognostic (2.15e-1)"	36.8	80.1	16.9	26.8	22.6	167.4	94.6	23.7	32.5	44.8	24.0	19.9	9.9	40.5	27.1	38.7	24.9	39.0	24.7	16.3	20.1	52.7	75.9	44.5	29.3	27.8	20.2	93.2	20.8	54.3	21.5	76.8	22.3	30.3	27.5	75.1	63.9	24.3	34.2	41.3	16.8	33.0	23.8	37.1	25.7	16.6	18.1	28.0	84.0	44.9	28.2	57.0	42.0	41.9	6.6	10.7	12.1	16.6	18.4	31.0	40.2	15.8	14.7	9.3	16.2	5.2	26.9	7.9	13.0	16.2	26.1	14.6	13.4	13.3	8.5	8.2	1.4	3.9	43.3	8.5	14.3	27.9	1.6	13.3	21.2	8.1	20.9	56.4	26.1	7.6	11.5	37.7	14.4	3.7	29.9	4.1	4.3	2.8	11.3	24.8	15.2	41.5	60.4	11.9	21.1	14.0	48.2	3.7	2.9	30.2	17.9	13.1	28.3	7.7	11.2	12.4	9.6	28.6	40.9	16.1	45.8	16.4	8.7	28.7	15.2	20.4	29.1	13.1	21.1	12.3	18.3	22.8	9.3	9.4	24.0	37.7	115.3	14.9	22.2	2.2	21.9	19.9	16.9	22.6	23.7	32.5	16.3	20.1	27.8	20.2	22.3	23.8	18.1	41.9	53.8	51.3	166.5	6.5	47.0	112.0	17.6	51.2	9.1	30.9	89.5	48.5	34.5	20.0	72.4	97.5	31.3	89.9	110.2	21.2	154.6	72.6	27.1	28.9	43.1	143.3	73.0	37.1	10.5	79.5	81.6	95.7	38.7	51.4	37.3	36.4	37.5	155.1	48.7	32.0	15.5	32.4	10.2	106.9	394.2	22.3	21.1	100.3	120.9	14.0	56.6	97.0	50.4	13.6	28.3	41.2	16.1	15.1	58.8	31.2	9.3	57.3	28.5	67.2	19.7	32.1	54.9	8.1	9.6	55.6	118.3	339.4	66.3	23.4	20.2	22.7
ARV1		ENSG00000173409	"ARV1 homolog, fatty acid homeostasis modulator"	Q9H2C2	1	230978981-231000733	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 116.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035709	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA035709: AB_2674744"	"unprognostic (2.32e-1)"	"unprognostic (4.69e-2)"	"prognostic favorable (1.33e-4)"	"unprognostic (3.29e-1)"	"unprognostic (1.42e-1)"	"unprognostic (9.95e-2)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.27e-5)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-2)"	"unprognostic (9.57e-2)"	"unprognostic (9.82e-2)"	"unprognostic (2.31e-1)"	"unprognostic (4.82e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.12e-3)"	10.6	18.4	23.4	10.2	24.5	13.9	19.0	26.2	32.8	12.2	25.7	24.6	16.4	9.7	22.9	15.7	14.3	16.4	30.1	24.5	25.6	25.2	26.2	15.0	14.8	25.2	24.1	11.2	17.5	33.3	20.1	11.7	25.0	16.2	25.9	29.0	22.0	15.2	21.7	17.8	17.3	13.1	25.7	13.5	17.1	31.3	25.2	15.0	21.9	24.8	15.3	15.2	11.2	27.7	40.8	43.6	20.8	25.1	29.6	26.4	20.1	19.0	34.0	33.5	38.3	16.3	31.4	11.4	22.7	21.3	20.5	32.3	40.6	25.5	39.2	30.4	55.7	36.8	28.9	22.1	30.5	53.6	27.9	28.0	25.8	18.1	20.9	21.9	22.5	34.7	53.7	30.7	22.2	14.3	22.3	16.4	27.1	43.0	27.1	25.2	32.1	33.1	47.1	33.0	21.2	32.6	22.6	26.6	57.9	5.3	46.6	46.6	13.9	13.4	8.7	23.6	45.9	47.4	44.6	28.9	36.8	45.9	36.7	9.1	8.1	8.5	10.0	12.2	13.9	18.1	11.2	12.4	10.1	11.2	13.7	13.0	2.0	12.7	21.2	14.9	15.4	9.0	23.4	24.5	26.2	32.8	24.5	25.6	25.2	24.1	25.0	25.7	25.2	27.7	13.6	16.0	31.7	10.7	12.6	12.9	22.0	75.8	11.4	18.9	14.8	15.6	32.2	21.5	38.9	29.5	2.1	37.9	12.7	15.8	60.7	24.1	52.6	12.7	10.9	12.7	7.7	58.1	20.2	40.8	14.5	14.5	11.7	9.7	17.1	14.4	15.0	17.3	24.9	38.7	25.6	18.5	34.6	13.3	5.5	22.9	9.3	13.5	24.9	8.4	9.8	33.6	7.2	8.5	19.3	21.5	11.5	16.6	14.7	11.6	17.9	32.5	27.3	20.0	0.0	11.4	15.6	116.7	21.0	20.3	15.2	15.6	11.4	22.0	26.4	20.9
ASIC5	"ACCN5, HINAC, INAC"	ENSG00000256394	"Acid sensing ion channel subunit family member 5"	Q9NY37	4	155829729-155866277	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"intestine: 2.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014903, HPA029444"	Approved					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 25: Spermatids - Spermatogenesis"			"HPA014903: AB_1844498, HPA029444: AB_10611671"					"unprognostic (8.52e-5)"		"unprognostic (2.52e-1)"	"unprognostic (1.25e-1)"									"unprognostic (4.05e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
ASPH	"BAH, CASQ2BP1, HAAH, JCTN"	ENSG00000198363	"Aspartate beta-hydroxylase"	Q12797	8	61500556-61714640	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Dioxygenase, Oxidoreductase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 386.9"	"Cell type enhanced"	"Detected in all"		"Muller glia cells: 468.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 34.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 890.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055161, HPA059303"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	"Endoplasmic reticulum"		"HPA055161: AB_2682721, HPA059303: AB_2683973"	"unprognostic (8.07e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (1.73e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (3.61e-4)"	"unprognostic (6.39e-2)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (1.57e-5)"	"unprognostic (8.96e-2)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (4.24e-4)"	"unprognostic (2.74e-2)"	386.9	160.3	64.7	50.6	69.2	16.9	106.9	102.3	88.9	65.6	84.4	78.8	45.6	49.3	44.7	71.4	46.9	61.0	111.3	64.5	58.4	59.5	74.9	74.1	20.3	54.0	69.2	62.2	44.7	38.7	36.3	47.9	52.2	48.3	84.9	219.5	101.9	70.2	357.6	35.2	45.5	67.5	44.8	28.6	105.0	16.5	71.8	16.7	97.0	182.7	28.5	112.2	43.8	60.4	460.3	652.3	89.9	55.1	392.1	370.1	31.2	804.0	741.3	336.3	350.1	113.1	594.2	35.3	54.3	474.6	270.3	167.5	56.2	281.1	570.0	13.6	57.0	81.1	372.5	310.3	251.2	12.5	12.9	306.5	61.9	187.6	237.4	657.2	144.8	18.0	22.2	32.1	300.2	97.4	3.3	16.6	51.7	441.6	383.4	22.3	97.0	7.3	206.2	374.0	93.1	32.1	249.9	116.1	101.7	49.0	47.7	22.2	456.7	338.0	174.3	313.0	288.0	20.2	27.1	1.5	890.1	7.5	231.4	1.9	8.3	0.3	2.5	2.9	4.7	5.5	3.5	2.4	10.0	5.0	4.9	2.5	25.4	8.7	1.8	34.0	4.0	4.1	64.7	69.2	102.3	88.9	64.5	58.4	54.0	69.2	52.2	44.8	71.8	60.4	79.1	195.5	244.0	366.6	13.8	47.0	160.7	126.0	68.9	138.3	83.7	58.4	228.6	37.1	157.5	86.5	294.0	118.1	40.3	57.0	15.6	144.2	1.6	51.4	65.8	85.9	116.5	13.0	93.1	180.4	107.1	132.0	73.9	115.4	8.2	34.5	42.8	62.6	72.2	127.9	98.9	215.1	52.9	26.6	44.1	3.1	70.8	48.1	42.7	61.8	20.0	468.8	2.1	154.8	53.5	257.7	32.3	57.6	15.9	148.2	34.3	34.6	66.6	158.8	46.0	114.4	92.7	3.4	16.8	101.7	50.3	48.0	13.6	131.2	67.3	254.2
ASTN1	ASTN	ENSG00000152092	"Astrotactin 1"	O14525	1	176857302-177164973	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 14.9;brain: 29.8;retina: 14.0"	"Group enriched"	"Detected in some"	6	"Astrocytes: 191.3;Excitatory neurons: 218.7;Inhibitory neurons: 275.6;Oligodendrocyte precursor cells: 280.0"	"Cancer enriched"	"Detected in some"	14	"glioma: 15.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 5.8;NTERA-2: 4.4;SCLC-21H: 2.7;U-2 OS: 3.4;U-266/84: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074112			Approved	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus, Vesicles"		"HPA074112: AB_2686662"	"unprognostic (4.41e-3)"	"unprognostic (1.48e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.55e-1)"	"unprognostic (7.61e-2)"	"unprognostic (2.03e-4)"	"unprognostic (3.86e-3)"	"unprognostic (1.08e-1)"	"unprognostic (4.36e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.77e-2)"	"unprognostic (4.74e-3)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.16e-1)"	0.8	14.9	22.9	0.4	27.1	0.0	0.7	3.0	29.8	0.4	0.0	0.5	0.3	0.9	3.3	0.0	1.6	0.6	0.5	28.5	23.3	0.1	0.2	0.2	0.1	6.1	10.7	5.7	0.5	0.1	9.0	0.3	7.5	1.0	0.3	14.0	0.9	1.6	0.1	0.1	0.3	0.9	11.5	2.2	0.3	0.7	22.7	0.0	0.0	0.3	0.3	0.0	0.4	11.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.8	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	21.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.9	27.1	3.0	29.8	28.5	23.3	6.1	10.7	7.5	11.5	22.7	11.5	0.0	0.0	0.0	191.3	0.0	0.1	0.0	0.0	0.0	7.9	0.2	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.8	0.3	0.2	0.0	0.0	218.7	0.0	0.1	0.7	0.0	0.2	0.0	4.0	5.0	0.0	0.5	23.5	275.6	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	25.3	0.0	0.8	0.0	280.0	35.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.7	4.4	1.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0
ATG101	"C12orf44, FLJ11773"	ENSG00000123395	"Autophagy related 101"	Q9BSB4	12	52069246-52077494	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	5	"plasmacytoid DC: 261.9"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 261.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039904	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA039904: AB_10673262"	"unprognostic (1.77e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.19e-1)"	"unprognostic (6.33e-3)"	"prognostic unfavorable (8.07e-7)"	"unprognostic (9.39e-2)"	"unprognostic (1.40e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.15e-1)"	32.7	30.1	24.3	21.4	26.5	23.9	26.3	26.0	29.8	22.6	25.7	27.4	19.6	24.4	34.6	32.1	24.4	27.6	29.7	27.0	25.7	38.1	38.0	31.1	24.2	24.4	24.3	24.1	33.9	27.9	29.0	20.2	24.5	30.4	17.5	8.5	37.7	19.2	39.5	44.1	24.2	21.5	24.5	30.5	39.7	36.4	26.0	27.6	27.0	24.6	21.8	34.4	25.2	27.1	63.0	173.0	35.8	49.0	52.3	40.3	52.7	75.6	76.0	69.8	54.7	202.3	71.2	46.7	67.8	91.3	61.3	51.0	44.6	69.4	47.2	53.2	46.8	46.0	135.0	126.1	135.2	39.6	60.0	39.0	77.8	93.8	66.3	53.6	54.7	39.3	44.0	81.8	50.9	237.9	52.0	88.4	69.7	46.6	74.4	36.5	29.8	64.9	49.9	97.4	34.7	46.7	51.6	74.9	103.3	27.3	81.1	47.1	62.0	61.3	55.2	58.1	60.0	51.8	70.8	47.5	63.2	45.7	95.6	8.9	38.2	46.4	28.4	38.0	30.8	40.6	27.9	32.7	49.7	46.3	27.3	30.6	7.1	25.9	47.7	261.9	36.4	38.2	24.3	26.5	26.0	29.8	27.0	25.7	24.4	24.3	24.5	24.5	26.0	27.1	36.0	19.2	22.4	3.9	48.3	0.0	104.6	0.0	56.9	14.8	78.7	54.7	3.1	38.6	9.9	29.5	12.5	52.1	80.9	43.5	70.5	60.8	19.6	52.6	25.2	34.4	30.5	12.8	3.9	65.4	55.7	40.4	38.7	57.8	45.1	26.6	45.3	46.7	45.1	5.0	3.0	54.4	0.0	28.6	0.0	33.1	27.1	40.6	0.0	3.7	57.1	23.0	22.6	2.5	4.4	63.1	49.4	36.5	49.8	108.9	56.5	61.0	9.5	21.3	26.3	65.0	43.9	77.0	75.1	48.1	0.0	65.8	36.2	45.7	41.3	133.5
ATG12	"APG12, APG12L"	ENSG00000145782	"Autophagy related 12"	O94817	5	115828200-115841837	"Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013272, HPA068989"	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB013272: AB_2533272, HPA068989: "	"unprognostic (2.48e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.87e-2)"	"unprognostic (5.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (1.54e-7)"	"unprognostic (1.27e-1)"	"unprognostic (1.93e-1)"	"prognostic unfavorable (4.99e-4)"	"unprognostic (5.11e-2)"	15.5	10.5	12.3	10.7	12.7	11.3	10.2	12.9	16.9	12.0	10.5	10.4	11.6	10.8	11.9	11.3	9.8	11.6	9.7	12.6	13.3	7.1	18.4	10.4	13.6	13.2	13.2	12.0	9.5	7.4	8.7	13.6	13.7	10.8	11.1	9.6	7.9	10.9	11.1	9.0	11.9	12.7	12.7	11.2	8.8	9.4	12.8	14.0	8.6	12.6	11.6	11.8	8.8	15.0	20.7	10.9	26.3	24.1	42.9	57.4	20.0	34.9	38.3	22.6	36.5	15.8	16.5	17.8	14.5	32.1	35.3	11.3	20.5	29.4	36.4	93.2	20.2	11.5	13.0	14.8	33.7	12.8	22.0	43.0	31.5	25.1	29.6	26.3	27.6	19.0	16.8	24.4	43.5	13.5	27.2	20.2	17.9	15.7	23.6	19.8	25.4	25.7	15.7	13.7	25.8	27.6	37.3	14.7	36.6	20.0	20.3	19.2	28.3	41.3	18.9	38.2	36.0	18.7	31.5	28.9	37.7	27.2	39.6	15.4	11.5	19.3	11.8	13.6	16.5	12.3	14.3	11.7	10.3	12.2	14.6	14.1	20.9	14.4	17.4	13.8	12.3	11.0	12.3	12.7	12.9	16.9	12.6	13.3	13.2	13.2	13.7	12.7	12.8	15.0	52.5	44.8	41.0	17.0	82.8	85.8	65.4	81.6	44.3	42.3	46.8	36.1	45.2	38.6	56.9	25.8	77.2	61.8	92.3	50.3	37.2	60.6	28.7	49.0	60.7	55.1	41.8	23.8	28.5	81.6	134.1	75.2	36.2	55.8	96.9	48.8	47.5	57.9	68.2	30.3	26.5	54.5	59.0	72.1	69.8	14.9	64.0	53.7	53.4	19.7	76.8	34.1	99.9	26.7	35.5	105.5	45.8	53.8	50.1	68.4	56.3	44.3	49.7	59.2	26.3	39.5	50.5	50.0	45.1	40.0	84.7	88.7	78.8	45.1	46.0	78.1
ATG13	KIAA0652	ENSG00000175224	"Autophagy related 13"	O75143	11	46617527-46674818	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Autophagy		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039350			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA039350: AB_10673142"	"unprognostic (3.66e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.14e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.47e-1)"	32.3	39.7	55.9	26.1	67.6	60.5	30.1	49.4	63.7	30.6	46.1	26.5	29.3	28.2	32.2	32.0	32.1	29.6	36.8	55.2	51.8	28.7	43.9	25.3	31.5	60.2	59.4	29.7	44.6	37.5	57.7	21.9	61.8	31.1	24.1	48.4	35.9	25.5	34.5	39.6	28.0	24.8	51.8	36.4	36.4	82.0	59.6	40.6	36.8	33.4	33.6	27.4	29.1	87.9	32.8	58.5	44.1	26.1	60.2	70.0	44.5	37.5	65.4	45.0	57.0	40.2	31.7	30.2	25.6	56.5	58.1	38.8	42.7	50.3	45.2	57.9	81.1	32.8	39.7	71.2	67.4	44.1	54.1	84.9	59.0	31.0	67.9	63.9	45.0	69.4	57.8	66.8	40.8	48.8	44.0	65.1	55.0	59.5	49.9	41.4	57.0	53.7	29.9	34.5	41.6	42.1	51.2	40.6	55.4	42.1	58.0	89.5	44.6	54.7	33.3	51.1	41.2	61.1	73.8	38.6	67.8	39.3	40.9	41.7	36.1	48.5	35.1	42.6	27.9	27.1	31.2	27.8	35.0	21.7	26.4	29.2	67.7	31.5	35.1	25.6	44.7	39.9	55.9	67.6	49.4	63.7	55.2	51.8	60.2	59.4	61.8	51.8	59.6	87.9	10.6	16.0	16.2	14.7	16.9	9.3	12.0	9.0	13.1	22.7	16.7	12.3	13.2	8.6	12.0	12.9	39.6	9.9	25.4	24.5	7.9	18.9	42.7	30.0	17.3	12.7	18.0	28.2	23.4	32.3	22.4	14.8	20.9	46.1	8.8	22.5	13.2	22.5	15.1	33.7	25.7	22.6	14.2	19.1	9.8	46.8	11.5	15.7	12.4	15.0	22.8	16.3	19.6	25.1	61.0	30.4	12.9	11.3	36.6	19.9	19.5	13.5	9.4	32.2	13.1	16.9	19.9	46.3	16.3	15.8	11.5	26.4	18.0	9.8	11.9	24.3
ATG14	"ATG14L, KIAA0831"	ENSG00000126775	"Autophagy related 14"	Q6ZNE5	14	55366391-55411830	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB037242	Uncertain					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 24: Non-specific - Transcription regulation"			"CAB037242: AB_1852353"	"unprognostic (8.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.93e-2)"	"unprognostic (5.83e-2)"	"unprognostic (3.37e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.44e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.49e-3)"	"prognostic favorable (1.95e-4)"	"unprognostic (1.70e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.30e-1)"	6.1	6.7	5.3	4.6	6.6	28.9	6.4	6.9	6.7	7.3	4.8	6.8	5.3	7.7	2.0	7.0	5.6	5.7	8.0	5.7	5.4	6.2	4.8	5.3	4.5	5.8	5.7	8.0	4.9	8.0	3.4	6.2	5.7	5.6	3.8	8.9	6.0	6.5	16.0	8.7	5.0	6.1	5.8	5.6	4.8	7.7	5.8	5.1	6.4	10.4	5.4	6.4	6.6	8.5	8.2	5.7	4.8	7.0	8.3	9.9	10.4	7.5	13.1	7.1	8.5	5.1	9.6	3.2	6.3	7.3	3.6	8.7	5.6	2.9	10.2	5.2	3.7	4.7	7.5	6.7	8.4	5.8	6.4	6.8	8.7	6.0	5.4	11.3	6.7	5.6	4.8	7.1	6.7	6.5	4.0	6.7	8.8	3.6	7.4	4.0	12.3	2.4	3.4	5.3	5.8	6.5	11.2	6.5	7.8	5.7	6.4	2.3	8.0	11.1	8.3	5.6	3.8	4.1	4.7	3.5	6.9	3.2	5.9	2.7	2.5	1.1	2.4	1.8	2.0	2.5	2.4	2.4	1.6	2.8	2.6	2.7	0.8	5.9	1.6	2.4	2.0	1.7	5.3	6.6	6.9	6.7	5.7	5.4	5.8	5.7	5.7	5.8	5.8	8.5	22.5	19.2	27.6	17.3	20.0	17.5	7.3	7.5	30.7	14.9	27.3	22.0	39.1	11.5	15.8	11.0	8.4	10.0	17.3	15.2	19.6	11.6	7.5	21.8	30.0	19.0	19.7	49.9	28.0	7.9	7.8	22.6	12.2	35.1	25.9	16.1	15.7	12.7	7.2	3.3	27.8	10.8	8.2	12.2	9.2	5.8	14.3	14.4	14.2	12.2	14.1	12.6	16.5	24.1	44.5	11.9	12.4	16.6	16.9	9.8	10.3	17.2	10.2	23.1	13.1	22.5	21.2	21.3	53.2	20.8	26.0	14.4	17.2	11.4	8.3	11.2
ATG16L1	"APG16L, ATG16A, ATG16L, FLJ10035, WDR30"	ENSG00000085978	"Autophagy related 16 like 1"	Q676U5	2	233210051-233295674	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012577, HPA063900"	Supported		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA012577: AB_1845155, HPA063900: AB_2685146"	"unprognostic (1.24e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.22e-3)"	"unprognostic (1.89e-1)"	"unprognostic (4.49e-1)"	"prognostic unfavorable (1.48e-5)"	"unprognostic (2.51e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.85e-2)"	"unprognostic (6.66e-3)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.93e-2)"	"unprognostic (1.41e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.08e-1)"	7.6	7.8	7.0	3.8	7.5	14.3	8.8	7.9	8.4	8.1	12.8	11.1	5.0	9.6	5.5	11.6	7.1	3.3	10.7	7.3	6.6	9.2	15.1	7.6	5.8	6.5	6.3	8.5	8.6	5.3	5.5	4.0	6.9	12.1	5.2	5.6	11.5	4.3	19.9	17.2	11.1	5.2	6.3	11.5	11.1	13.5	6.5	5.9	11.2	6.1	5.2	11.5	8.2	7.7	13.3	12.2	4.9	8.5	12.4	8.0	14.0	11.4	9.3	9.6	8.9	8.9	9.7	3.1	3.7	8.9	14.3	7.7	9.8	6.4	9.8	6.2	7.7	7.1	9.1	14.6	9.1	5.6	9.0	5.3	9.1	11.5	8.7	7.2	9.0	4.7	7.6	2.9	10.2	9.3	6.7	11.2	19.1	14.1	17.6	4.8	10.3	2.6	9.9	8.4	8.8	6.5	7.8	8.5	8.5	7.4	5.3	7.1	10.7	6.2	5.4	9.6	10.3	6.5	3.9	6.1	10.5	5.7	10.2	0.0	1.7	2.9	4.8	1.4	3.7	2.0	3.1	4.4	1.4	2.2	3.5	3.5	1.2	4.1	4.7	0.7	3.8	2.1	7.0	7.5	7.9	8.4	7.3	6.6	6.5	6.3	6.9	6.3	6.5	7.7	6.1	6.4	8.2	5.2	7.4	9.1	4.6	5.2	3.4	8.4	12.0	6.6	5.6	7.2	11.6	5.5	4.2	4.6	20.9	13.9	5.9	8.3	1.2	16.4	10.9	6.4	9.0	3.8	31.0	6.7	6.2	5.2	8.2	31.8	9.5	6.4	6.1	10.2	5.6	1.7	25.6	5.1	6.1	6.3	5.7	1.7	4.1	5.1	10.6	8.4	6.6	7.1	4.1	11.6	21.4	16.8	8.0	3.8	8.1	7.1	9.2	5.6	11.5	19.5	6.6	5.8	6.9	11.0	17.6	7.3	13.2	3.7	19.2	5.1	8.4	6.0
ATG16L2	"ATG16B, FLJ00012, WDR80"	ENSG00000168010	"Autophagy related 16 like 2"	Q8NAA4	11	72814406-72843674	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 136.8;lymphoid tissue: 129.0"	"Cell type enhanced"	"Detected in many"		"Paneth cells: 59.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 45.4;neutrophil: 59.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 58.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045444, HPA050312"	Approved		Enhanced	Nucleoplasm		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm		"HPA045444: AB_2679324, HPA050312: AB_2681082"	"unprognostic (7.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.26e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.61e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.89e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (7.06e-4)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (3.39e-4)"	"unprognostic (1.74e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.83e-2)"	20.2	18.1	18.1	33.0	19.2	136.8	14.9	20.2	24.1	21.6	16.2	20.4	10.8	14.6	7.5	26.1	22.1	18.9	20.8	18.0	16.0	20.1	18.5	41.2	34.3	18.9	17.7	23.4	15.1	6.3	13.7	10.2	18.0	14.4	17.0	2.9	13.6	8.2	7.7	72.9	34.0	15.0	15.3	129.0	17.7	6.5	21.1	9.7	15.9	7.4	25.2	18.9	22.2	20.9	2.7	2.5	7.5	5.9	8.7	7.2	4.6	6.1	5.9	2.9	4.4	3.1	6.4	18.3	4.0	7.7	5.3	5.2	0.9	20.1	5.0	14.2	3.0	14.5	14.4	5.1	6.4	18.8	58.2	6.9	2.7	6.6	8.0	32.2	9.0	32.7	1.9	24.1	3.4	9.1	22.5	32.0	1.1	12.0	2.9	10.6	5.5	8.6	9.7	9.2	5.5	4.4	2.6	13.2	5.8	5.9	6.6	25.5	12.6	7.9	2.9	14.4	5.0	11.0	2.9	8.1	3.5	16.4	4.5	5.9	16.3	45.4	2.7	9.3	2.7	2.6	3.9	5.4	10.9	4.6	2.2	2.6	59.6	5.2	11.8	1.7	4.0	4.0	18.1	19.2	20.2	24.1	18.0	16.0	18.9	17.7	18.0	15.3	21.1	20.9	19.5	6.4	14.4	11.4	37.6	16.7	5.1	6.1	10.2	3.6	8.7	9.0	5.0	4.3	6.2	5.5	2.1	9.6	29.0	13.0	0.0	5.0	0.8	8.9	12.0	12.7	13.1	9.9	14.0	1.0	3.7	7.1	17.9	7.9	22.9	10.6	18.9	3.8	16.2	5.0	11.1	9.1	8.2	48.5	18.1	2.1	10.2	45.7	3.6	23.4	39.2	4.4	30.9	18.1	9.7	2.7	59.1	7.9	17.3	2.5	8.3	2.5	8.1	3.5	0.0	8.8	11.4	4.9	13.4	15.7	17.3	12.3	21.3	7.2	14.0	6.0
ATG2A	KIAA0404	ENSG00000110046	"Autophagy related 2A"	Q2TAZ0	11	64894546-64917211	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 16.9"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 16.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038715	Uncertain		Supported	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	Nucleoplasm	"HPA038715: AB_10673474"	"unprognostic (3.05e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.42e-1)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.66e-2)"	"prognostic favorable (4.79e-5)"	"unprognostic (2.92e-2)"	"unprognostic (2.69e-1)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-1)"	16.4	20.1	11.4	6.5	10.9	60.2	16.9	8.6	40.1	19.9	11.4	18.9	7.5	18.2	1.8	15.7	19.2	4.2	18.4	11.5	9.8	22.0	59.2	24.2	6.1	13.9	12.3	24.9	22.7	4.9	21.6	4.9	12.7	21.6	2.6	1.9	15.2	5.7	26.7	34.9	21.4	3.3	9.0	25.7	23.2	15.3	11.4	5.4	19.3	4.4	3.3	17.7	15.6	10.4	13.2	12.6	4.4	12.0	5.7	4.0	12.3	7.1	10.3	9.4	6.8	11.0	9.9	9.3	14.7	6.0	12.0	10.8	4.5	8.3	2.5	9.1	15.7	8.7	19.1	10.0	8.4	6.5	18.2	10.9	7.1	11.8	6.3	5.4	7.9	9.5	16.1	7.3	4.1	21.3	7.8	21.9	5.1	3.5	14.3	8.6	7.1	13.5	5.0	10.9	16.5	6.7	10.6	14.6	13.3	3.3	14.3	8.1	10.1	9.0	8.6	18.3	5.3	14.7	5.5	6.5	13.0	5.2	5.6	3.0	2.0	2.2	2.5	2.1	2.1	0.8	1.7	2.2	1.4	0.9	1.3	2.4	16.9	1.8	1.7	2.4	0.9	1.2	11.4	10.9	8.6	40.1	11.5	9.8	13.9	12.3	12.7	9.0	11.4	10.4	9.8	9.6	16.2	20.2	17.0	28.9	8.7	35.7	16.5	16.6	15.8	10.3	8.1	7.2	17.6	9.2	33.3	12.7	40.1	38.8	1.9	10.2	2.5	12.4	9.2	10.2	35.9	16.2	7.6	10.3	5.3	12.6	16.8	24.4	9.5	15.4	7.9	23.2	10.9	13.5	8.4	17.6	24.4	20.1	19.9	3.6	12.8	24.2	30.2	5.6	11.9	12.3	19.6	6.6	7.1	14.9	21.7	10.1	27.3	12.2	26.8	6.6	13.3	26.0	13.1	11.6	10.6	9.0	6.2	16.3	38.4	66.9	40.2	27.2	19.0	15.9
ATG2B	"C14orf103, FLJ10242"	ENSG00000066739	"Autophagy related 2B"	Q96BY7	14	96279195-96363341	"Predicted intracellular proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 84.5;Oligodendrocyte precursor cells: 105.6;Oligodendrocytes: 84.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001427, HPA019665"	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"			"HPA001427: AB_1845551, HPA019665: AB_2274278"	"unprognostic (9.39e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (3.19e-1)"	"unprognostic (9.29e-3)"	"unprognostic (1.47e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.75e-3)"	"unprognostic (1.45e-2)"	"unprognostic (7.60e-3)"	"unprognostic (6.66e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.90e-2)"	"unprognostic (8.49e-2)"	6.4	6.2	5.8	3.9	6.8	6.7	6.5	8.6	7.9	7.2	5.8	6.3	4.4	7.4	5.5	5.2	6.9	4.2	4.9	6.2	5.4	5.6	9.8	6.0	4.7	8.1	5.4	7.2	12.1	8.2	6.8	4.0	8.2	5.9	4.3	12.1	5.4	4.0	8.6	11.4	7.3	5.0	5.0	6.4	6.4	8.6	5.9	6.9	7.3	7.2	4.9	5.7	6.3	9.0	3.8	4.8	5.8	4.5	9.9	9.1	4.6	5.5	7.8	5.9	6.7	2.6	2.6	8.5	5.1	9.1	3.9	5.1	8.0	5.4	9.5	7.9	4.0	3.7	5.2	2.3	6.5	6.9	3.9	7.6	5.4	8.0	6.3	6.3	7.6	6.3	4.3	7.5	4.8	6.2	6.2	5.9	2.8	4.5	4.8	5.6	13.0	5.7	6.7	4.6	5.6	6.4	8.4	3.4	4.0	5.9	5.3	3.9	10.2	3.3	1.5	8.1	3.5	7.4	6.5	7.7	6.7	4.7	3.2	0.1	0.2	0.4	0.3	0.1	0.5	0.2	0.3	0.3	0.2	0.2	0.3	0.3	0.4	0.5	0.2	0.3	0.5	0.1	5.8	6.8	8.6	7.9	6.2	5.4	8.1	5.4	8.2	5.0	5.9	9.0	15.8	12.8	12.3	47.3	11.0	13.8	3.7	4.4	21.6	24.8	12.2	7.7	14.2	12.8	6.3	9.2	27.1	5.8	12.3	9.5	3.9	5.8	41.0	20.8	16.9	12.9	8.3	21.8	84.5	6.1	3.2	14.0	10.7	26.9	7.0	10.9	14.6	27.2	4.2	32.0	66.3	13.3	2.0	12.6	10.7	48.9	12.8	8.9	1.8	36.5	6.4	7.9	6.2	105.6	84.2	5.3	10.7	10.5	27.2	9.0	12.5	8.9	7.0	19.4	6.6	13.8	12.6	17.7	14.9	19.6	28.1	15.7	13.0	8.7	9.4	3.7
ATG3	"APG3L, DKFZp564M1178, FLJ22125, MGC15201, PC3-96"	ENSG00000144848	"Autophagy related 3"	Q9NT62	3	112532510-112562046	"Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 657.9;Spermatocytes: 341.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037260, HPA040471"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		140000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane, Cytosol"		"CAB037260: AB_1078236, HPA040471: AB_2677000"	"unprognostic (2.77e-2)"	"prognostic favorable (6.82e-4)"	"unprognostic (4.90e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (9.35e-6)"	"unprognostic (6.79e-2)"	"unprognostic (6.67e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.56e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (7.52e-3)"	"unprognostic (4.66e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.48e-2)"	"unprognostic (5.25e-2)"	33.1	38.7	41.4	49.1	50.1	94.1	34.7	51.3	53.5	28.3	38.2	38.2	38.2	24.7	24.7	34.8	23.2	24.7	33.3	39.7	46.8	41.6	43.3	31.1	48.4	49.1	48.2	25.6	41.8	44.8	30.6	33.6	48.5	23.2	40.3	29.1	29.4	28.3	29.5	29.8	36.6	29.9	48.2	48.2	37.7	85.3	45.6	51.2	42.2	33.6	46.3	38.7	26.3	55.7	105.0	55.9	51.5	52.6	66.6	54.5	57.5	89.8	65.3	86.9	78.9	78.9	60.6	130.3	66.6	78.0	106.6	74.1	84.9	78.0	120.9	22.8	40.9	82.0	52.3	51.0	102.9	145.2	67.0	50.6	58.3	85.5	130.2	56.8	82.2	81.2	71.6	108.8	92.9	91.4	86.4	68.2	56.3	135.8	109.7	74.9	45.9	110.5	72.6	56.1	88.1	34.7	74.7	70.5	109.5	48.4	79.8	107.5	66.7	92.3	75.8	39.4	80.1	70.2	72.0	201.3	84.4	133.2	69.4	64.4	167.7	121.9	39.4	258.8	49.4	61.8	48.0	49.2	169.4	59.2	46.2	46.3	174.2	50.5	327.9	36.3	75.6	138.2	41.4	50.1	51.3	53.5	39.7	46.8	49.1	48.2	48.5	48.2	45.6	55.7	45.6	48.1	39.0	10.1	53.3	74.1	42.4	74.3	37.5	22.5	32.0	50.2	86.2	37.1	51.3	25.8	12.5	73.1	45.3	47.0	117.4	73.7	657.9	37.9	40.8	54.1	31.2	90.0	11.7	86.1	85.0	42.6	36.7	45.2	39.9	42.0	40.0	40.0	121.3	18.5	11.4	53.3	75.3	106.3	131.1	146.5	42.6	134.8	69.4	11.2	185.8	42.1	54.6	13.0	33.7	70.9	49.2	43.2	70.4	39.1	76.0	87.5	37.3	22.2	59.2	45.5	77.6	341.0	119.7	57.4	70.6	122.3	55.0	68.6	69.8	54.2
ATG4B	"APG4B, AUTL1, DKFZp586D1822, KIAA0943"	ENSG00000168397	"Autophagy related 4B cysteine peptidase"	Q9Y4P1	2	241637213-241673857	"Enzymes, Predicted intracellular proteins, Transporters"	"Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037195, HPA069803"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Cytosol"		"CAB037195: AB_1078237, HPA069803: AB_2686200"	"unprognostic (1.51e-1)"	"unprognostic (8.80e-2)"	"prognostic unfavorable (6.85e-4)"	"unprognostic (1.51e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.67e-3)"	"unprognostic (1.07e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (2.79e-4)"	"unprognostic (2.60e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.66e-1)"	"prognostic favorable (9.64e-4)"	12.0	17.5	21.4	8.1	21.7	14.7	13.2	20.9	24.7	18.0	20.1	19.7	11.4	16.8	5.3	16.2	16.8	7.6	18.4	21.6	23.0	19.7	18.0	12.4	13.2	23.0	21.4	16.5	16.4	12.1	21.5	7.2	23.6	22.6	5.4	8.5	14.4	9.6	18.7	16.7	18.3	6.7	20.7	19.9	16.1	19.7	22.4	16.1	18.7	7.6	7.8	16.3	14.6	21.5	8.8	15.6	16.9	13.5	15.8	10.5	29.5	23.8	9.8	16.5	12.4	15.0	9.8	7.4	7.2	11.8	10.5	16.5	16.0	20.3	3.8	18.8	31.8	19.6	14.1	40.2	20.1	13.6	12.0	13.8	15.0	9.0	7.1	16.8	11.0	44.3	23.4	5.1	8.6	32.6	33.4	36.9	30.9	23.8	25.9	51.3	25.1	16.2	11.4	14.9	26.2	21.3	17.5	13.9	27.8	14.1	15.5	24.6	15.4	7.1	12.0	14.8	13.3	21.1	17.0	34.6	18.8	21.4	17.6	3.9	17.9	19.2	18.5	15.6	15.9	15.8	14.2	15.6	20.4	16.5	18.0	12.8	12.8	11.8	18.9	17.0	20.4	16.8	21.4	21.7	20.9	24.7	21.6	23.0	23.0	21.4	23.6	20.7	22.4	21.5	23.2	32.1	33.8	41.1	25.6	24.3	27.2	41.3	25.0	22.2	24.4	21.8	16.2	25.8	29.9	27.6	33.3	35.8	33.5	61.8	19.6	37.5	18.1	28.6	21.9	25.3	35.9	31.8	38.5	40.2	28.5	22.6	40.8	43.3	19.0	36.5	20.3	27.9	33.4	42.1	33.8	36.4	42.7	28.5	34.5	25.9	22.1	30.7	28.4	31.9	51.2	24.5	41.2	20.1	41.0	41.5	41.5	24.8	28.6	35.6	70.5	25.1	26.7	26.8	19.7	22.7	22.8	58.3	63.3	19.9	25.4	53.9	29.4	27.6	35.6	32.5
ATG4D	"APG4-D, APG4D, AUTL4"	ENSG00000130734	"Autophagy related 4D cysteine peptidase"	Q86TL0	19	10543895-10553418	"Enzymes, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport, Ubl conjugation pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 103.9;Proximal enterocytes: 109.3;Spermatocytes: 100.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 57.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA067683	Approved		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA067683: AB_2685886"	"unprognostic (2.85e-1)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.73e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.28e-2)"	"unprognostic (7.30e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (2.39e-7)"	"prognostic favorable (5.03e-4)"	"unprognostic (3.78e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.18e-3)"	7.3	15.6	4.2	7.3	4.7	33.2	7.4	8.3	8.6	9.4	8.2	22.3	21.8	8.1	1.6	27.3	7.6	3.9	23.2	4.5	4.0	20.8	13.2	10.6	8.3	5.2	4.7	9.5	16.3	10.7	16.6	4.9	5.3	14.0	5.2	2.5	16.6	4.4	36.9	24.6	23.2	2.1	3.1	17.0	13.7	24.5	5.4	12.0	13.4	10.8	4.6	9.7	15.0	6.1	13.8	8.7	11.7	16.5	2.1	1.8	9.9	9.2	7.8	11.1	12.2	14.9	4.3	9.2	16.2	0.9	8.6	20.8	7.3	6.8	1.4	10.4	23.5	23.1	22.3	8.2	7.4	9.4	22.1	1.8	14.2	9.8	3.4	2.8	3.3	18.1	17.8	19.8	3.6	21.9	27.6	57.8	18.9	6.1	29.0	20.0	8.2	15.1	6.4	17.8	45.3	17.8	12.6	22.6	11.3	2.1	14.0	21.6	6.4	16.8	11.0	34.7	20.4	19.2	15.4	10.8	14.4	18.0	19.5	1.6	0.8	3.7	1.1	1.0	1.5	1.0	1.3	1.2	0.6	0.4	1.2	1.7	0.2	1.3	0.4	4.2	2.2	0.8	4.2	4.7	8.3	8.6	4.5	4.0	5.2	4.7	5.3	3.1	5.4	6.1	6.3	9.6	6.6	9.1	14.4	30.5	19.8	14.9	24.5	14.9	14.1	10.2	0.5	14.3	8.1	1.8	14.6	27.9	38.7	103.9	13.7	16.1	83.6	9.6	5.5	5.3	22.2	43.6	8.4	16.5	6.7	8.2	26.5	10.1	7.0	10.9	6.1	11.9	13.4	28.6	9.1	38.5	20.3	15.0	12.1	16.3	8.7	10.0	12.4	4.7	15.7	11.8	22.6	4.5	8.4	20.5	72.4	4.5	17.6	21.6	109.3	25.4	5.2	20.1	13.1	9.1	14.2	100.7	21.2	33.4	31.3	36.5	19.6	10.6	33.2	36.4
ATG5	"APG5, APG5L, ASP, hAPG5"	ENSG00000057663	"Autophagy related 5"	Q9H1Y0	6	106045423-106325791	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Host-virus interaction, Immunity"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034432, CAB037309, HPA042973"	Approved		Approved	Centrosome	"Intracellular and membrane"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"CAB034432: AB_2243288, CAB037309: AB_796188, HPA042973: AB_2678246"	"unprognostic (1.21e-3)"	"unprognostic (6.53e-3)"	"unprognostic (2.68e-3)"	"unprognostic (4.14e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (8.84e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.73e-4)"	"unprognostic (1.86e-1)"	"unprognostic (2.37e-1)"	"unprognostic (2.51e-1)"	"unprognostic (6.42e-2)"	12.5	19.2	9.9	6.7	10.2	8.1	15.4	10.5	13.2	15.3	10.7	15.8	12.8	14.9	16.6	12.3	14.7	9.5	9.7	10.3	10.7	14.4	17.7	10.8	8.5	10.0	10.3	14.3	12.1	11.8	7.9	13.2	9.9	15.3	15.2	10.5	11.8	13.1	15.7	8.0	13.1	14.2	9.5	10.6	12.0	8.3	10.2	9.4	17.5	15.2	9.8	13.4	11.9	10.5	14.6	6.0	10.3	14.0	23.2	24.0	10.7	15.4	24.6	22.2	27.2	6.2	8.6	10.2	12.0	23.7	25.0	10.2	15.2	22.2	39.2	4.6	7.3	11.8	6.8	7.8	25.0	14.6	6.0	19.3	24.8	16.1	20.0	29.7	23.9	9.4	17.6	10.0	25.7	6.4	6.0	17.5	11.9	19.4	8.3	6.0	23.7	7.9	24.0	10.3	7.1	6.9	9.4	17.8	14.6	18.6	8.5	27.5	19.8	8.6	4.8	10.1	26.7	4.1	4.2	9.3	31.7	19.6	16.1	4.7	4.8	9.6	2.9	6.1	8.4	5.1	5.6	4.6	5.3	3.3	6.0	5.0	4.1	4.8	8.8	1.9	6.9	3.3	9.9	10.2	10.5	13.2	10.3	10.7	10.0	10.3	9.9	9.5	10.2	10.5	35.8	22.4	18.9	24.2	41.3	26.3	28.5	45.2	25.6	14.8	25.5	26.5	18.1	25.8	36.7	25.8	16.7	47.3	46.5	48.3	29.4	39.6	35.7	33.0	27.4	25.9	19.2	27.0	79.2	44.9	63.8	25.8	42.3	34.5	20.3	20.4	21.8	20.7	38.1	20.2	71.5	38.4	36.7	26.9	32.3	13.7	20.5	33.6	23.2	43.1	44.6	18.3	44.3	43.7	49.1	40.5	59.8	18.0	85.9	40.8	49.2	43.2	30.0	17.9	26.3	23.6	32.1	36.5	39.6	28.5	27.1	66.5	47.3	21.9	36.6	43.0
ATG7	"APG7L, DKFZp434N0735, GSA7"	ENSG00000197548	"Autophagy related 7"	O95352	3	11272309-11557665	"Predicted intracellular proteins, Transporters"	"Autophagy, Biological rhythms, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.0;Excitatory neurons: 178.7;Inhibitory neurons: 176.4;Late spermatids: 119.1;Microglial cells: 132.1;Oligodendrocytes: 137.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 60.1;classical monocyte: 136.6;eosinophil: 88.4;intermediate monocyte: 79.4;myeloid DC: 82.4;neutrophil: 107.4;non-classical monocyte: 60.8"	"Group enriched"	"Detected in all"	5	"dendritic cells: 82.4;granulocytes: 107.4;monocytes: 136.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007639, CAB018771"	Supported		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		33000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB018771: AB_2062165, HPA007639: AB_1845162"	"unprognostic (3.97e-2)"	"unprognostic (2.83e-2)"	"prognostic favorable (9.66e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.79e-1)"	"unprognostic (5.19e-2)"	"prognostic unfavorable (1.41e-4)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (2.67e-1)"	"prognostic favorable (9.55e-4)"	"unprognostic (1.61e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.50e-1)"	16.8	13.5	11.2	25.0	13.1	47.6	18.0	7.3	21.8	14.5	17.0	17.3	13.0	14.9	16.7	16.7	18.7	16.6	10.8	12.4	9.5	13.7	13.2	20.9	23.9	15.0	15.0	12.2	10.9	21.2	7.5	21.0	13.1	11.6	19.2	10.3	12.2	11.9	13.0	18.0	13.8	20.0	12.4	16.4	14.4	22.5	15.4	13.1	13.0	13.5	25.0	20.3	12.0	21.3	48.5	37.1	16.7	9.2	28.0	36.7	80.4	44.5	56.8	43.1	49.9	16.0	42.5	22.1	26.5	39.2	45.1	14.5	18.3	62.0	73.8	19.8	23.5	16.0	33.6	19.6	36.9	46.8	50.8	38.0	28.2	83.6	52.0	45.4	60.5	14.0	24.1	17.9	60.6	31.3	13.7	21.3	13.0	22.2	47.9	17.1	19.6	19.9	32.5	34.2	14.6	14.5	31.6	26.4	17.5	20.1	28.8	44.7	42.5	36.0	25.7	23.6	63.2	11.1	31.8	38.1	57.8	43.1	49.9	60.1	136.6	88.4	15.9	79.4	12.3	13.0	12.9	15.1	82.4	12.3	11.7	13.7	107.4	21.3	60.8	14.7	12.4	56.8	11.2	13.1	7.3	21.8	12.4	9.5	15.0	15.0	13.1	12.4	15.4	21.3	6.4	0.0	9.8	160.0	11.4	11.1	7.3	21.6	9.6	18.1	7.4	3.6	4.2	4.3	12.5	7.3	18.8	16.5	7.9	8.3	7.9	12.3	44.2	10.6	9.5	14.6	11.4	9.5	178.7	12.9	16.8	11.0	10.7	13.2	14.7	12.4	19.6	9.0	57.6	20.2	176.4	7.6	22.4	25.8	12.1	119.1	10.2	28.8	3.6	132.1	30.6	8.1	13.4	99.0	137.2	17.4	7.3	9.8	10.8	6.4	8.4	6.8	16.5	12.5	6.6	11.7	10.6	22.4	11.9	9.8	7.7	19.2	10.1	9.9	7.6	7.4
ATG9A	"APG9L1, FLJ22169"	ENSG00000198925	"Autophagy related 9A"	Q7Z3C6	2	219219380-219229717	"Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 83.8;Late spermatids: 105.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059551	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"HPA059551: AB_2684060"	"unprognostic (1.53e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (8.99e-3)"	"unprognostic (2.07e-1)"	"unprognostic (3.55e-3)"	"unprognostic (4.67e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.23e-2)"	"unprognostic (4.84e-2)"	"unprognostic (3.15e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.95e-2)"	25.6	23.6	27.2	17.3	29.0	44.7	19.2	27.8	36.6	19.5	10.0	25.6	31.4	24.1	14.2	31.4	18.8	21.8	42.1	30.0	24.3	20.0	25.9	23.7	19.4	29.0	26.7	20.4	28.1	31.2	17.6	30.7	26.2	21.6	21.8	24.6	23.9	22.8	116.8	32.1	29.7	28.1	24.3	21.7	22.8	62.2	27.6	15.7	18.4	62.7	21.2	22.7	22.7	28.6	29.4	35.7	26.9	64.0	50.3	55.1	35.9	52.1	56.1	67.3	60.2	52.9	38.8	7.7	43.7	79.8	54.7	58.0	43.2	56.9	49.6	22.6	70.7	55.7	90.1	63.9	54.9	14.1	40.6	56.7	91.4	68.7	63.0	60.9	68.2	18.6	75.6	27.0	46.2	38.3	12.2	33.4	19.5	28.5	26.9	16.9	36.7	30.2	40.0	38.6	42.6	25.7	52.0	46.7	46.5	52.0	17.3	39.3	52.5	67.0	32.3	28.7	47.1	15.5	14.7	11.2	55.7	33.9	37.2	6.5	12.4	6.3	7.2	18.0	7.2	5.6	5.6	9.1	8.5	3.6	5.4	6.1	11.2	9.7	22.6	4.1	7.1	11.6	27.2	29.0	27.8	36.6	30.0	24.3	29.0	26.7	26.2	24.3	27.6	28.6	0.3	0.0	4.5	12.7	8.2	7.8	7.6	10.6	8.6	18.9	0.3	0.3	33.2	17.2	7.1	0.0	14.6	26.8	4.1	44.0	0.0	0.2	83.8	0.6	1.5	10.0	13.8	34.7	15.2	0.5	24.4	9.1	11.7	0.8	10.2	0.3	16.8	37.1	11.5	21.9	14.1	17.6	6.1	13.3	7.0	105.9	14.0	4.8	10.6	5.6	7.0	20.5	9.2	9.5	12.5	0.3	27.6	8.6	6.7	13.4	39.3	0.3	4.7	15.7	13.1	7.1	5.5	54.9	13.8	14.2	11.1	34.8	7.5	0.8	18.5	10.5
ATG9B	"APG9L2, FLJ14885, NOS3AS, SONE"	ENSG00000181652	"Autophagy related 9B"	Q674R7	7	151012209-151024499	"Metabolic proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 8.3;skin 1: 11.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 50.7;Endometrial ciliated cells: 28.6;Late spermatids: 30.3;Respiratory ciliated cells: 25.9;Syncytiotrophoblasts: 115.5"	"Cancer enhanced"	"Detected in many"		"testis cancer: 6.2"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 8.9"	"Lineage enriched"	"Detected in many"	5	"T-cells: 8.9"	"Group enriched"	"Detected in some"	5	"BEWO: 13.0;CAPAN-2: 4.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 31: Skin - Epidermis development"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"				"unprognostic (1.59e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (5.03e-2)"	"unprognostic (1.53e-3)"	"unprognostic (1.05e-3)"	"unprognostic (2.79e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.38e-3)"	"unprognostic (6.76e-2)"	"unprognostic (2.02e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.08e-6)"	"unprognostic (2.82e-2)"	"unprognostic (2.70e-2)"	"unprognostic (6.34e-2)"	"unprognostic (2.63e-1)"	0.0	0.5	1.1	0.4	1.7	0.2	0.2	0.4	1.0	1.7	0.3	0.0	0.0	0.4	1.1	8.3	1.0	0.2	0.0	0.5	2.1	0.0	0.0	0.2	0.8	2.0	1.7	0.1	0.0	0.0	1.5	4.1	1.1	0.2	0.0	0.8	0.5	0.0	0.2	11.5	0.0	0.0	1.0	0.1	0.1	2.0	2.1	0.3	0.1	0.0	0.8	0.1	1.6	0.4	0.6	0.0	0.7	0.1	0.0	0.0	13.0	0.0	0.0	0.0	0.0	0.1	4.2	0.3	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.2	0.0	0.0	0.0	0.6	0.2	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.5	0.4	0.6	0.0	1.1	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.2	1.1	0.0	1.0	0.9	5.0	1.3	0.0	1.6	8.9	3.4	0.0	0.4	0.1	0.7	5.4	1.4	1.1	1.7	0.4	1.0	0.5	2.1	2.0	1.7	1.1	1.0	2.1	0.4	0.4	0.0	0.0	0.0	2.8	0.0	0.2	1.9	0.6	4.0	0.7	0.9	1.4	1.5	1.6	0.0	0.0	10.2	1.5	0.3	0.0	0.3	50.7	28.6	3.3	1.1	0.0	0.0	2.7	0.2	2.5	0.5	0.0	15.4	14.7	7.8	2.2	0.0	1.9	0.0	7.7	0.0	4.1	0.3	0.4	30.3	0.6	0.8	0.0	0.0	0.3	0.5	1.0	0.5	0.6	3.8	0.0	0.7	0.4	0.3	0.0	0.1	25.9	0.6	0.0	0.0	0.9	19.8	12.7	0.8	0.3	115.5	4.7	0.1	0.2	1.9
ATL1	"AD-FSP, FSP1, SPG3, SPG3A"	ENSG00000198513	"Atlastin GTPase 1"	Q8WXF7	14	50532509-50634017	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 42.8"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 138.6;Inhibitory neurons: 95.5;Oligodendrocyte precursor cells: 81.4;Oligodendrocytes: 136.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 22.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 22.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 19.8;SCLC-21H: 17.1;SH-SY5Y: 15.4;SiHa: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027550	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA027550: AB_10600983"	"unprognostic (2.06e-2)"	"unprognostic (7.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.88e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.09e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.22e-2)"	"unprognostic (3.59e-2)"	"unprognostic (2.39e-1)"	"unprognostic (4.95e-2)"	"unprognostic (1.23e-2)"	4.1	5.6	29.1	3.3	33.2	0.2	11.3	18.8	42.8	5.7	2.2	8.1	3.9	9.0	2.9	5.3	6.5	4.8	2.1	37.1	30.3	4.0	0.3	4.3	1.7	25.2	21.5	10.5	3.7	1.9	7.7	0.5	29.6	8.3	5.6	9.5	13.2	8.6	1.1	9.6	4.9	15.6	24.9	1.1	4.6	8.7	25.0	1.1	2.5	2.2	1.8	6.7	5.3	30.0	1.2	1.1	4.8	4.6	0.3	0.0	3.4	5.7	9.6	6.2	7.4	0.0	4.1	3.7	2.5	0.1	4.5	1.4	8.4	1.1	2.4	19.8	1.8	1.2	0.8	0.3	0.2	0.2	3.1	3.6	1.9	8.6	1.6	0.3	0.4	4.2	0.1	0.5	8.7	0.4	1.2	0.6	4.4	1.4	1.5	0.6	12.1	0.4	1.7	2.5	17.1	15.4	18.9	1.1	0.6	0.0	0.0	2.1	1.3	6.0	4.6	0.0	2.9	0.9	4.7	1.7	3.9	0.2	0.2	22.9	0.1	4.9	2.5	0.0	0.5	3.8	0.9	2.1	1.2	1.1	2.1	4.2	0.3	0.6	0.5	2.8	0.4	2.0	29.1	33.2	18.8	42.8	37.1	30.3	25.2	21.5	29.6	24.9	25.0	30.0	3.0	6.4	2.6	31.6	3.7	5.1	6.2	10.3	6.2	27.8	18.1	16.3	1.9	5.7	6.6	5.5	0.0	0.4	6.7	9.3	0.0	10.6	31.4	4.2	5.4	4.8	7.2	0.4	138.6	13.1	1.1	14.6	5.6	2.3	6.3	1.2	5.0	0.0	1.6	11.8	95.5	1.9	2.0	0.0	3.6	5.7	13.4	5.5	8.8	20.6	1.3	23.0	2.1	81.4	136.7	7.2	6.0	17.0	5.2	3.9	13.2	3.4	14.2	8.6	19.7	4.5	10.8	31.9	5.7	4.1	5.5	0.1	3.8	0.2	3.6	3.3
ATL2	ARL6IP2	ENSG00000119787	"Atlastin GTPase 2"	Q8NHH9	2	38293954-38377285	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029108, HPA075302"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"HPA029108: AB_10670557, HPA075302: AB_2732289"	"unprognostic (5.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-3)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.64e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.10e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.81e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.27e-3)"	"unprognostic (8.22e-2)"	"unprognostic (6.86e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.84e-1)"	19.1	32.4	15.0	16.9	20.4	32.5	41.6	26.6	18.0	29.1	16.8	52.5	33.7	33.4	19.5	41.9	29.5	18.5	16.7	17.1	14.2	28.1	40.2	22.9	19.2	13.5	13.6	37.0	15.7	15.8	13.5	16.8	12.0	31.4	26.7	25.4	51.8	31.2	53.7	50.0	31.4	36.0	11.2	20.3	31.7	17.9	16.3	27.9	54.9	46.2	35.1	27.4	33.2	14.7	84.3	36.0	51.0	37.2	44.8	27.9	61.1	31.5	25.0	33.9	38.7	40.8	65.2	61.6	33.7	20.2	47.4	94.8	64.7	32.2	56.4	74.5	44.7	38.9	26.6	58.7	24.5	47.1	35.8	20.3	68.6	32.7	45.2	21.7	34.6	23.5	60.3	37.5	28.7	31.1	56.0	46.1	64.1	89.5	22.4	46.9	50.4	45.4	25.9	43.6	26.1	44.2	32.0	40.3	38.2	39.0	22.1	28.7	21.9	34.8	52.4	33.2	57.8	48.8	48.3	79.0	23.4	47.9	42.7	1.3	2.7	10.6	2.3	2.1	3.8	2.8	2.7	2.7	3.4	4.3	4.1	3.3	3.3	2.5	3.8	2.0	3.6	2.4	15.0	20.4	26.6	18.0	17.1	14.2	13.5	13.6	12.0	11.2	16.3	14.7	18.5	12.8	32.4	62.7	18.7	36.8	32.5	25.9	14.8	20.6	40.8	33.8	7.6	11.5	44.8	7.3	14.6	15.7	14.9	12.0	7.9	11.7	22.1	12.3	17.4	17.0	6.6	22.9	66.3	5.0	14.7	16.5	11.7	17.8	4.5	14.3	14.3	34.4	10.8	21.9	55.5	11.7	77.3	8.5	16.1	19.5	14.3	12.9	12.4	59.0	8.2	8.6	7.2	46.3	20.4	5.7	8.7	16.6	13.1	23.9	17.8	12.6	23.5	21.1	32.9	16.9	19.4	16.7	21.3	46.4	46.9	14.6	13.6	9.0	12.7	31.3
ATL3	DKFZP564J0863	ENSG00000184743	"Atlastin GTPase 3"	Q6DD88	11	63624087-63671921	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase	"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"Early spermatids: 264.4;Late spermatids: 728.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065702, HPA076616"			Enhanced	"Endoplasmic reticulum"		NA	NA		58000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 71: Testis - DNA repair"	"Cluster 20: HeLa - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Endoplasmic reticulum"		"HPA065702: AB_2685536, HPA076616: AB_2732318"	"unprognostic (4.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.62e-1)"	"unprognostic (6.89e-2)"	"unprognostic (6.95e-2)"	"unprognostic (1.91e-2)"	"unprognostic (6.09e-3)"	"unprognostic (3.38e-2)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (4.52e-2)"	"unprognostic (1.11e-3)"	"unprognostic (7.41e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.67e-3)"	30.6	18.1	11.6	17.9	16.6	13.2	22.1	14.9	12.6	23.0	22.0	26.0	9.9	24.3	16.5	24.5	20.1	15.9	11.5	9.8	13.9	12.6	17.7	18.8	12.6	19.8	16.4	16.9	15.4	13.3	6.6	14.9	18.9	16.7	16.6	4.0	15.4	20.4	6.3	25.2	13.7	33.2	16.8	16.9	17.4	36.9	15.5	10.8	20.9	9.6	15.4	27.1	19.4	20.6	44.2	39.4	11.7	28.4	59.2	82.5	0.2	53.2	60.0	51.9	35.0	32.9	69.7	26.3	53.8	93.6	40.0	28.3	21.8	34.8	69.8	40.4	5.8	27.9	41.8	0.2	40.7	53.2	39.2	54.0	55.6	69.1	42.8	34.7	56.3	28.5	30.6	70.2	59.6	46.6	19.2	30.7	14.9	14.1	33.7	40.7	29.3	37.8	41.2	29.7	6.3	17.0	174.3	37.6	50.5	14.5	65.7	19.1	79.1	109.0	51.9	105.3	38.3	19.0	29.6	51.4	57.7	33.6	67.1	7.1	8.3	3.7	8.9	11.4	9.8	5.3	7.4	7.3	8.6	4.2	5.9	8.2	3.5	6.9	13.4	4.3	9.3	7.8	11.6	16.6	14.9	12.6	9.8	13.9	19.8	16.4	18.9	16.8	15.5	20.6	56.7	44.8	27.2	16.6	18.8	43.7	45.7	36.4	30.1	4.8	31.9	18.4	8.5	30.0	29.9	33.1	0.0	6.7	28.5	45.2	1.9	41.2	264.4	23.8	46.4	48.2	10.7	29.5	13.5	50.2	20.1	46.2	19.4	63.8	17.1	20.3	49.6	51.3	37.6	5.0	12.1	21.0	28.5	55.3	43.0	728.4	54.3	35.7	42.7	16.9	49.5	12.6	24.7	16.6	35.6	72.7	24.7	67.4	21.0	55.3	27.7	24.7	21.5	8.5	72.3	35.9	55.2	36.0	29.0	32.9	40.6	4.0	28.2	25.6	19.8	50.9
ATP10A	"ATP10C, ATPVA, ATPVC, KIAA0566"	ENSG00000206190	"ATPase phospholipid transporting 10A (putative)"	O60312	15	25677271-25865184	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.0"	"Cell type enriched"	"Detected in many"	6	"Microglial cells: 216.4"	"Cancer enhanced"	"Detected in all"		"melanoma: 7.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 23.0;fHDF/TERT166: 22.9;HMC-1: 19.4;SK-MEL-30: 21.9;U-2197: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041496, HPA042509"	Uncertain					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA041496: AB_2677513, HPA042509: AB_2678032"	"unprognostic (3.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.18e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (2.67e-1)"	"unprognostic (4.95e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (6.60e-5)"	"unprognostic (1.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (4.89e-2)"	"unprognostic (9.42e-2)"	6.5	8.7	13.7	2.7	9.3	2.5	5.3	6.0	8.9	2.0	0.7	3.2	0.8	1.5	0.1	1.9	2.3	3.7	2.0	5.9	5.8	5.8	0.6	7.1	1.8	9.9	9.7	1.1	1.4	3.5	2.1	1.7	9.5	2.2	0.8	0.1	7.9	0.6	0.6	2.5	3.0	2.8	5.9	1.5	3.2	4.3	15.0	1.1	2.5	0.7	1.1	2.5	1.4	4.9	0.0	5.7	1.3	0.0	2.2	2.8	0.0	23.0	9.3	6.1	9.9	0.0	0.0	0.0	1.6	22.9	0.0	0.0	9.3	1.2	0.4	0.0	0.2	0.0	0.0	0.1	0.1	0.0	19.4	0.9	0.0	0.6	0.0	2.5	0.0	1.2	0.0	0.0	3.3	0.0	1.2	0.0	1.5	0.0	1.5	4.4	4.6	2.8	9.9	0.0	0.0	0.1	0.0	0.0	21.9	0.0	7.4	1.2	0.0	8.9	0.2	12.7	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.6	0.1	0.5	0.0	0.3	0.5	0.1	0.0	0.7	0.6	0.0	1.2	0.0	1.0	0.1	0.3	13.7	9.3	6.0	8.9	5.9	5.8	9.9	9.7	9.5	5.9	15.0	4.9	0.3	32.1	8.6	2.0	0.8	1.0	0.0	2.7	0.6	0.2	2.6	1.8	1.7	1.5	5.3	0.0	0.0	0.0	11.1	0.1	0.0	0.5	23.2	2.8	2.8	4.2	0.0	0.0	4.5	0.0	0.1	5.0	3.1	7.9	15.2	0.0	0.4	0.1	2.5	0.0	2.1	0.2	0.0	2.5	5.2	21.8	4.1	4.5	17.8	216.4	2.3	0.0	14.4	1.5	2.7	0.8	0.0	17.7	1.7	0.7	0.0	0.1	4.2	0.1	0.0	4.7	9.1	0.4	1.2	0.0	0.4	0.0	8.6	0.1	0.0	0.0
ATP10D	"ATPVD, KIAA1487"	ENSG00000145246	"ATPase phospholipid transporting 10D (putative)"	Q9P241	4	47485275-47593486	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 176.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	12	"basophil: 84.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 84.3"	"Cell line enhanced"	"Detected in many"		"HAP1: 41.6"					"Low region specificity"	"Detected in all"			HPA050808	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Plasma membrane"		"HPA050808: AB_2681242"	"unprognostic (1.62e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.05e-2)"	"unprognostic (3.48e-2)"	"unprognostic (3.54e-2)"	"unprognostic (3.04e-1)"	"unprognostic (2.43e-1)"	"prognostic favorable (5.00e-8)"	"unprognostic (3.97e-2)"	"unprognostic (4.47e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.37e-2)"	4.9	6.0	2.6	5.0	2.9	1.3	4.2	1.9	2.7	7.0	15.9	3.7	3.9	7.4	7.2	10.2	4.7	7.4	4.2	1.8	4.1	10.2	2.4	6.1	6.2	3.1	3.7	8.1	4.5	10.4	3.1	14.9	2.9	4.6	3.8	4.1	3.4	6.4	1.0	9.9	4.5	9.7	2.4	10.0	5.1	2.0	5.0	4.5	9.1	2.7	7.9	7.3	6.5	2.9	2.6	1.8	4.0	2.8	11.1	12.0	0.7	17.9	21.5	8.4	15.1	9.4	15.4	8.1	6.5	29.1	14.3	4.6	41.6	15.0	12.9	3.2	3.2	6.5	2.8	0.5	9.8	2.1	3.9	10.3	11.2	16.4	10.9	27.5	14.4	4.0	0.1	4.3	23.2	1.0	4.4	1.2	1.4	0.0	2.2	4.9	9.0	0.1	15.0	3.1	2.6	4.9	8.4	2.1	5.2	8.7	3.8	2.1	21.9	20.7	4.1	1.9	7.8	1.9	1.5	0.0	10.2	11.9	6.8	84.3	3.1	0.4	1.1	5.0	1.9	2.7	0.5	0.8	4.0	6.7	0.1	0.9	1.5	2.3	6.9	2.4	0.8	1.6	2.6	2.9	1.9	2.7	1.8	4.1	3.1	3.7	2.9	2.4	5.0	2.9	22.9	9.6	7.5	39.2	27.8	19.2	9.2	21.9	23.9	12.2	6.7	8.4	4.9	4.3	8.5	16.5	31.3	48.5	17.1	1.6	1.9	5.5	4.4	4.8	29.5	16.1	9.6	4.0	25.7	4.6	11.0	22.4	14.3	7.0	2.5	21.3	18.2	6.6	13.0	13.5	42.8	4.6	18.3	21.7	7.9	1.5	62.1	17.7	7.2	47.8	15.7	21.9	15.5	52.3	24.1	2.7	3.4	25.2	23.0	5.7	1.9	9.2	6.2	9.2	26.3	12.8	23.6	0.6	2.8	35.4	27.0	176.8	15.5	51.7	4.1	8.1
ATP11A	"ATPIH, ATPIS, KIAA1021"	ENSG00000068650	"ATPase phospholipid transporting 11A"	P98196	13	112690329-112887168	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 218.0;Alveolar cells type 2: 215.0;Cone photoreceptor cells: 235.6;Glandular and luminal cells: 176.3;Oligodendrocytes: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035583, HPA035584"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles	"Golgi apparatus"	"HPA035583: AB_10671106, HPA035584: AB_10672096"	"unprognostic (1.67e-1)"	"unprognostic (5.06e-3)"	"unprognostic (1.58e-1)"	"unprognostic (5.27e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.87e-3)"	"unprognostic (1.80e-2)"	"unprognostic (6.97e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.93e-2)"	"unprognostic (4.23e-1)"	"prognostic favorable (7.44e-4)"	"unprognostic (3.85e-2)"	"unprognostic (3.69e-1)"	"unprognostic (3.26e-2)"	"unprognostic (7.40e-3)"	10.2	10.4	12.3	8.9	22.0	18.2	6.1	18.3	16.8	13.0	5.7	4.4	9.9	10.1	5.8	7.0	8.7	15.0	21.4	9.7	12.5	12.7	10.1	39.5	5.8	25.3	22.2	6.5	12.4	23.1	16.2	10.1	22.9	4.3	3.2	14.9	9.0	3.9	13.1	8.9	8.3	9.1	15.7	8.9	5.3	8.9	21.9	8.2	13.9	17.3	6.1	6.5	5.9	40.2	28.0	14.0	17.5	20.5	8.7	11.7	30.9	13.0	7.6	10.9	8.8	44.5	31.5	14.1	15.5	11.0	14.0	23.2	15.8	10.8	10.5	14.2	14.9	16.3	11.9	23.3	13.6	30.8	25.5	7.9	8.2	13.2	8.0	8.8	29.0	12.6	11.4	2.3	7.7	10.5	14.1	19.4	7.5	31.8	9.9	12.2	7.1	8.1	59.3	6.4	27.8	7.7	12.7	16.3	10.7	22.4	6.2	40.4	19.2	0.0	23.3	14.1	9.9	7.4	15.5	5.9	4.8	28.3	12.2	0.0	1.1	1.7	0.4	1.6	0.3	0.6	0.2	0.2	0.6	1.8	0.3	0.2	3.1	0.0	1.5	0.5	0.0	0.3	12.3	22.0	18.3	16.8	9.7	12.5	25.3	22.2	22.9	15.7	21.9	40.2	25.6	218.0	215.0	22.2	11.3	10.8	3.4	4.9	1.2	42.0	5.2	3.7	42.3	31.5	29.4	16.5	235.6	1.7	7.0	2.4	5.9	32.7	0.9	51.2	24.2	34.2	12.0	3.8	35.0	11.4	32.2	16.5	8.6	176.3	12.0	62.2	27.1	16.5	20.7	13.5	32.5	3.5	14.2	33.6	16.9	1.9	11.1	29.3	10.6	48.7	36.9	11.0	6.2	33.7	138.3	24.3	6.1	4.9	7.7	7.7	10.5	15.7	13.3	44.8	0.0	9.5	12.8	4.0	10.1	6.3	9.7	8.6	8.4	8.7	5.9	3.9
ATP11B	"ATPIF, ATPIR, KIAA0956"	ENSG00000058063	"ATPase phospholipid transporting 11B (putative)"	Q9Y2G3	3	182793503-182921629	"Enzymes, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 132.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036237, HPA036238"	Uncertain		Approved	"Centriolar satellite,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	"Centriolar satellite, Cytosol"		"HPA036237: AB_10673123, HPA036238: AB_10670792"	"unprognostic (4.52e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.37e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.50e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.03e-3)"	"unprognostic (7.28e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (2.02e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.35e-1)"	20.6	10.7	4.7	24.9	6.9	70.6	17.4	15.9	7.6	19.1	13.8	26.3	24.3	18.7	14.6	45.4	13.7	21.1	14.1	6.0	6.3	18.0	18.3	16.5	27.9	7.5	6.1	20.5	21.0	29.4	10.3	14.5	7.3	28.3	29.0	30.8	19.4	13.4	11.4	28.2	24.0	19.5	5.6	21.8	51.1	31.6	6.6	44.6	16.8	16.8	28.4	25.7	22.5	15.8	69.7	9.7	20.5	28.7	42.6	46.1	19.3	32.8	41.6	23.2	27.1	23.7	34.0	31.3	53.5	44.0	48.2	40.4	24.6	31.3	40.2	73.9	20.9	76.7	13.1	5.2	24.8	62.3	47.3	31.5	34.7	26.1	37.4	34.1	37.0	48.7	27.7	94.3	37.8	22.9	50.3	19.1	14.5	38.1	19.2	21.2	59.8	37.8	28.1	55.8	12.5	22.0	86.2	10.7	36.9	18.3	11.9	43.7	36.6	35.0	38.7	30.5	56.2	131.0	125.5	58.1	24.1	25.3	20.9	5.5	1.0	4.3	1.7	1.0	1.7	2.1	1.4	1.7	1.1	1.3	1.2	1.8	3.8	1.8	1.0	2.4	1.2	0.8	4.7	6.9	15.9	7.6	6.0	6.3	7.5	6.1	7.3	5.6	6.6	15.8	26.8	16.0	13.2	34.6	27.8	34.3	25.7	15.9	26.2	12.2	13.8	9.7	15.6	18.6	16.5	20.2	14.6	12.8	43.0	44.6	0.0	12.5	34.1	19.0	22.9	15.7	6.7	26.1	81.6	16.5	3.8	19.5	46.4	22.1	11.4	14.0	16.1	16.4	10.4	38.7	64.3	30.5	16.2	19.4	26.4	23.8	19.3	29.3	14.2	45.9	19.9	8.4	27.8	67.8	132.6	25.2	27.0	21.1	55.5	35.8	24.3	7.8	19.8	31.4	19.7	24.1	17.7	18.7	11.4	43.8	44.6	9.6	40.9	7.0	27.3	45.4
ATP11C	"ATPIG, ATPIQ"	ENSG00000101974	"ATPase phospholipid transporting 11C"	Q8NB49	X	139726346-139945276	"Disease related genes, Enzymes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 49.8"	"Cell type enhanced"	"Detected in many"		"Spermatocytes: 67.9"	"Cancer enhanced"	"Detected in all"		"testis cancer: 15.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030830	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA030830: AB_10601336"	"unprognostic (8.94e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.42e-3)"	"unprognostic (3.08e-1)"	"unprognostic (3.46e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.65e-2)"	"unprognostic (9.75e-2)"	"unprognostic (2.73e-1)"	"unprognostic (5.18e-2)"	13.4	7.4	3.5	9.0	4.2	6.1	10.4	3.6	4.6	11.8	10.3	10.0	5.6	11.9	9.3	5.1	10.7	8.4	5.4	3.1	4.5	11.8	49.8	7.2	14.8	4.9	4.7	12.7	4.9	5.7	3.7	5.3	5.2	9.8	7.1	2.8	6.0	14.6	3.5	6.0	8.6	10.6	3.9	12.2	7.6	9.7	4.8	11.1	6.1	4.3	8.8	13.6	9.3	4.5	16.9	7.1	14.2	23.3	20.7	27.9	18.0	19.7	26.4	15.6	21.5	6.3	13.4	24.0	43.3	28.2	10.3	13.7	34.6	9.0	24.4	22.1	20.2	12.1	15.2	12.3	23.0	21.4	7.4	18.6	5.9	16.9	14.4	17.3	27.3	18.3	14.0	17.9	20.8	9.1	19.7	14.5	24.1	0.1	13.3	19.5	15.3	20.1	13.1	27.6	11.0	18.3	7.8	0.8	10.6	13.3	5.8	11.7	31.0	21.2	6.9	25.9	27.1	5.1	5.4	18.7	9.7	26.3	10.8	2.4	0.4	0.1	0.4	0.3	0.8	0.9	0.4	0.3	0.4	0.9	0.4	0.7	0.9	1.2	0.6	0.7	0.3	0.2	3.5	4.2	3.6	4.6	3.1	4.5	4.9	4.7	5.2	3.9	4.8	4.5	27.4	16.0	8.4	22.5	14.6	14.5	16.7	6.5	5.7	1.9	8.0	8.9	4.4	2.8	9.2	11.0	0.0	2.3	11.6	7.0	1.9	4.8	13.6	11.5	22.7	32.4	9.1	15.3	1.3	10.1	12.6	17.2	10.7	13.7	9.5	23.6	34.6	46.6	9.4	0.0	26.1	6.4	8.2	37.2	14.4	11.9	14.3	15.3	10.6	45.9	33.9	3.1	7.2	29.1	27.8	7.8	7.2	15.4	13.2	15.8	4.7	7.7	6.8	3.1	0.0	19.3	19.2	67.9	53.1	5.9	13.5	6.7	12.7	11.5	5.2	14.6
ATP12A	"ATP1AL1, H-K-ATPase, HK"	ENSG00000075673	"ATPase H+/K+ transporting non-gastric alpha2 subunit"	P54707	13	24680408-24712472	"Enzymes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Sodium transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"esophagus: 11.2;kidney: 5.4;lymphoid tissue: 14.8;placenta: 5.6;skin 1: 6.2"	"Group enriched"	"Detected in some"	4	"Basal respiratory cells: 75.6;Club cells: 49.2"	"Cancer enhanced"	"Detected in many"		"testis cancer: 12.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SuSa: 4.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039526	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 12: NES - Nervous system development"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane, Actin filaments"	Cytosol	"HPA039526: AB_10673534"	"unprognostic (8.33e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.21e-2)"		"unprognostic (8.03e-3)"	"unprognostic (2.64e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.67e-1)"	"unprognostic (6.80e-2)"	"unprognostic (8.22e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.1	0.0	5.4	0.0	0.6	0.0	0.0	0.1	0.0	0.1	0.6	0.0	5.6	0.0	0.2	2.0	0.0	0.1	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.0	14.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	1.7	1.0	0.0	0.0	0.0	75.6	0.0	0.0	0.2	0.3	0.4	0.0	49.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	2.2	1.3	0.0	0.0	0.0	0.0	0.0	0.7	0.2	8.2	0.0	0.0	0.1	0.3	0.1	0.0	1.0	0.0	0.0	0.0	1.0	0.6	0.1	1.2	0.0	0.0	0.2	0.0	0.1	13.6	0.0	0.0	0.0	1.8	1.0	1.1	0.0	0.0	0.0	0.1	0.0	0.1	1.3
ATP13A1	"ATP13A, CGI-152, FLJ31858, KIAA1825"	ENSG00000105726	"ATPase 13A1"	Q9HD20	19	19645198-19663676	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031798, HPA049717"	Approved		Approved	Vesicles		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA031798: AB_2674048, HPA049717: AB_2680858"	"unprognostic (2.08e-1)"	"unprognostic (4.92e-2)"	"unprognostic (4.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (3.33e-1)"	"unprognostic (4.40e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.73e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.16e-2)"	"unprognostic (9.43e-3)"	"prognostic unfavorable (6.51e-4)"	"unprognostic (2.26e-3)"	"unprognostic (3.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.57e-1)"	12.9	17.0	7.3	21.8	6.5	16.1	13.9	5.4	8.6	17.1	12.3	15.6	18.6	16.2	8.0	15.6	15.0	14.0	9.7	7.4	7.9	12.8	12.9	14.0	21.4	7.9	6.5	20.8	21.1	23.4	18.1	12.9	6.9	15.1	13.0	8.8	17.7	12.6	12.8	16.2	22.2	11.6	6.1	26.4	16.7	15.8	7.6	15.9	20.2	5.8	17.5	13.9	14.4	9.0	32.8	45.2	24.3	52.8	38.2	25.3	66.1	28.9	40.1	24.5	24.9	43.5	54.3	44.9	48.6	34.4	14.0	17.8	37.2	37.0	13.4	16.5	77.6	24.6	48.7	34.5	39.3	46.8	70.1	36.7	34.2	26.5	31.8	27.1	17.9	32.1	43.0	97.5	24.7	53.9	31.8	33.7	44.5	40.6	54.7	25.0	17.4	100.9	25.8	44.7	33.4	56.7	26.8	42.6	30.0	11.4	26.9	50.6	28.7	51.5	7.7	59.2	35.3	78.8	50.6	26.8	36.0	59.6	39.5	0.0	3.5	3.5	2.8	5.6	3.1	2.2	3.3	3.1	6.5	1.9	2.1	2.7	0.1	1.4	8.6	5.0	2.9	2.4	7.3	6.5	5.4	8.6	7.4	7.9	7.9	6.5	6.9	6.1	7.6	9.0	11.3	9.6	5.8	12.1	22.7	5.9	7.4	8.2	9.6	12.0	13.0	8.5	5.5	11.5	9.0	14.7	18.8	20.3	12.5	28.5	1.9	19.1	10.3	11.5	9.8	9.0	18.6	11.1	11.2	18.4	18.2	10.2	31.6	13.6	5.7	16.2	10.8	13.2	20.0	5.0	11.0	22.9	12.2	12.2	9.5	5.1	14.0	18.3	7.2	7.5	13.6	12.6	8.2	9.0	11.0	15.6	22.4	9.8	50.4	11.9	28.6	6.6	12.8	10.8	6.6	9.2	11.4	14.7	14.6	12.6	6.1	15.3	13.9	20.2	22.2	6.4
ATP13A2	"CLN12, HSA9947, PARK9"	ENSG00000159363	"ATPase cation transporting 13A2"	Q9NQ11	1	16985958-17011928	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Translocase	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuronal ceroid lipofuscinosis, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 112.4"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 61.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"plasmacytoid DC: 20.6"	"Lineage enriched"	"Detected in many"	6	"dendritic cells: 20.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037038, CAB037111, HPA050910, HPA054717"	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB037038: AB_1840715, CAB037111: AB_1840714, HPA050910: AB_2681269, HPA054717: AB_2682583"	"unprognostic (3.81e-2)"	"unprognostic (1.84e-2)"	"unprognostic (5.61e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.66e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (3.33e-7)"	"unprognostic (1.04e-1)"	"unprognostic (9.71e-3)"	"unprognostic (4.51e-1)"	"unprognostic (9.85e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.84e-3)"	15.3	18.6	49.7	20.2	45.8	11.6	14.3	30.3	81.2	10.6	3.3	15.9	12.7	12.1	6.6	23.6	9.5	9.3	11.6	46.7	66.0	16.6	6.2	17.9	17.7	112.4	60.8	8.7	55.7	12.9	57.0	12.6	110.8	14.3	9.8	22.8	27.4	7.9	17.2	16.5	16.7	8.6	32.0	26.0	19.3	10.3	64.1	9.5	16.7	5.3	10.3	12.9	12.1	44.3	28.3	27.4	14.7	60.8	13.8	12.2	40.8	15.8	15.4	17.1	16.6	48.9	31.4	12.5	65.9	26.9	14.6	43.1	32.1	59.5	6.2	17.2	58.5	43.7	28.0	27.2	17.5	15.6	19.6	10.0	31.6	47.1	36.6	55.0	32.3	32.2	28.2	22.6	70.2	22.2	18.4	8.8	23.2	66.3	20.0	20.0	60.1	50.7	19.0	42.8	40.9	27.4	73.8	87.7	60.2	18.8	29.9	19.6	34.4	18.0	34.5	30.8	33.1	4.8	6.1	14.0	34.6	85.2	30.3	0.0	1.6	0.3	2.6	3.7	2.9	1.3	2.1	2.2	0.4	3.1	1.0	1.5	0.5	2.7	3.6	20.6	1.8	1.4	49.7	45.8	30.3	81.2	46.7	66.0	112.4	60.8	110.8	32.0	64.1	44.3	18.9	0.0	2.2	14.4	8.3	6.5	6.9	5.7	6.2	35.9	16.9	11.3	3.6	7.2	6.8	7.3	35.5	5.8	33.4	44.6	5.9	15.1	1.4	6.7	3.8	14.4	7.7	4.2	53.1	25.1	33.6	6.0	18.8	19.0	8.9	20.5	6.1	3.7	10.4	47.1	61.8	15.0	0.0	17.3	2.8	1.7	5.3	10.1	5.4	11.2	6.1	34.0	8.2	20.1	18.1	57.0	49.0	6.4	5.4	12.3	18.2	5.3	4.3	38.4	0.0	4.6	5.7	13.6	16.4	11.6	5.3	9.3	11.1	4.8	21.7	12.8
ATP13A4	"DKFZp761I1011, FLJ37958"	ENSG00000127249	"ATPase 13A4"	Q4VNC1	3	193398967-193593111	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 64.5;parathyroid gland: 58.4;thyroid gland: 51.9"	"Group enriched"	"Detected in many"	4	"Astrocytes: 409.4;Oligodendrocyte precursor cells: 163.3"	"Cancer enriched"	"Detected in many"	5	"thyroid cancer: 23.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051932			Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA051932: "	"unprognostic (4.97e-2)"	"unprognostic (1.50e-3)"	"unprognostic (4.86e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.72e-2)"	"prognostic favorable (3.91e-4)"	"unprognostic (1.55e-1)"	"unprognostic (3.99e-3)"	"unprognostic (2.65e-1)"	"unprognostic (1.36e-1)"	"unprognostic (4.39e-2)"	"unprognostic (1.34e-1)"	"unprognostic (4.29e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.75e-3)"	"unprognostic (2.00e-1)"	0.1	0.3	19.5	0.2	20.9	0.2	22.7	18.1	20.1	2.8	28.2	2.0	0.3	0.1	64.5	20.1	2.4	4.6	0.1	18.0	17.0	0.7	0.6	27.3	0.4	18.5	21.5	0.3	5.3	58.4	4.8	0.1	17.9	0.1	3.4	2.5	7.2	2.4	0.5	16.9	0.3	0.1	15.2	0.3	9.6	0.5	21.6	0.3	51.9	0.0	4.8	0.1	6.7	15.8	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.6	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	19.5	20.9	18.1	20.1	18.0	17.0	18.5	21.5	17.9	15.2	21.6	15.8	0.2	64.1	30.5	409.4	1.1	0.1	0.0	1.7	0.0	1.6	6.1	3.6	0.4	11.5	15.3	0.0	0.0	1.2	0.5	1.6	0.0	3.3	0.4	4.0	0.7	0.1	0.0	0.0	5.8	0.2	0.1	0.2	17.3	6.4	1.3	0.3	1.4	0.1	0.2	1.7	10.9	1.9	0.0	0.3	0.5	1.0	0.0	0.5	1.8	13.1	0.0	0.5	0.0	163.3	20.6	1.3	1.7	0.4	0.2	0.0	0.0	0.4	8.5	1.0	0.0	0.1	0.2	0.7	1.5	2.2	1.6	0.7	0.9	0.1	2.2	0.1
ATP1A1		ENSG00000163399	"ATPase Na+/K+ transporting subunit alpha 1"	P05023	1	116372668-116410261	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Cancer-related genes, Charcot-Marie-Tooth disease, Epilepsy, FDA approved drug targets, Mental retardation, Neurodegeneration, Neuropathy, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 1482.3"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 1879.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 2979.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB018702, CAB069993"	Enhanced					NA	NA		420000	"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"			"CAB018702: AB_626713, CAB069993: AB_2060979"	"unprognostic (6.18e-2)"	"unprognostic (2.18e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.42e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.65e-1)"	"prognostic favorable (8.98e-8)"	"unprognostic (4.75e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.11e-2)"	"prognostic unfavorable (4.01e-4)"	150.9	206.6	115.5	144.1	135.7	104.3	220.2	176.4	264.7	137.6	209.2	580.5	785.5	92.3	304.6	255.9	143.6	361.3	233.1	176.0	133.9	1127.5	132.5	255.7	89.7	140.8	103.5	137.7	661.3	1482.3	160.6	120.0	196.3	176.4	542.6	301.2	721.9	294.1	147.3	316.6	813.9	146.1	117.4	78.1	201.5	140.0	104.1	92.8	744.4	117.7	132.4	149.7	187.4	142.2	399.8	144.8	147.2	74.5	288.8	277.5	750.8	232.9	462.9	281.6	396.6	583.9	278.5	314.2	321.3	279.0	284.4	505.1	293.8	493.7	406.2	116.1	324.2	183.5	249.2	498.4	220.1	465.2	246.1	311.6	808.0	328.4	429.0	395.5	350.8	187.4	306.9	294.2	253.0	793.7	189.6	167.7	346.0	630.5	285.6	179.7	343.4	278.6	1023.2	405.1	143.8	126.7	363.0	679.6	2979.2	358.2	179.1	265.9	311.9	159.4	221.4	415.4	479.5	140.7	118.1	238.0	488.2	263.1	956.1	19.2	36.6	17.2	59.7	56.6	62.8	26.4	66.9	64.2	59.6	15.2	76.5	55.5	4.5	30.8	86.0	30.4	57.6	53.6	115.5	135.7	176.4	264.7	176.0	133.9	140.8	103.5	196.3	117.4	104.1	142.2	199.2	275.7	295.3	26.8	84.6	276.8	336.8	220.5	390.9	101.0	189.2	145.2	74.1	579.0	238.4	770.6	398.2	83.7	89.1	789.9	373.7	625.6	31.2	205.4	54.3	201.6	176.4	89.2	130.5	315.6	160.6	141.6	134.6	372.1	43.8	212.6	144.2	71.2	129.8	102.6	123.9	353.4	463.9	98.8	254.2	19.3	117.8	145.5	208.1	36.5	56.9	556.8	64.9	77.9	60.9	187.6	307.8	100.8	73.2	271.6	1879.9	308.2	171.6	147.7	32.9	109.8	147.4	20.2	35.8	320.7	268.9	67.6	133.3	58.3	498.6	280.6
ATP1A2	"FHM2, MHP2"	ENSG00000018625	"ATPase Na+/K+ transporting subunit alpha 2"	P50993	1	160115759-160143591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 515.9;skeletal muscle: 882.2;tongue: 478.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 515.8;Cardiomyocytes: 158.7;Microglial cells: 141.5;Muller glia cells: 73.0;Oligodendrocyte precursor cells: 94.0;Sertoli cells: 85.5"	"Cancer enriched"	"Detected in many"	18	"glioma: 91.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 51.9;HHSteC: 14.6;RH-30: 16.8;U-87 MG: 10.3"	"Low region specificity"	"Detected in all"							CAB022230	Enhanced					NA	NA		170000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022230: "	"unprognostic (1.08e-2)"	"unprognostic (4.42e-2)"	"unprognostic (3.41e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.83e-1)"	"unprognostic (7.98e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.63e-4)"	"unprognostic (1.70e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.40e-1)"	"unprognostic (7.16e-2)"	"unprognostic (5.32e-3)"	37.4	4.1	401.5	1.5	480.5	0.0	27.4	419.8	412.8	9.3	164.9	55.8	3.6	5.6	12.5	33.5	14.5	8.0	144.6	337.4	398.5	3.9	1.2	6.4	0.3	429.5	478.8	18.9	1.4	0.3	32.3	3.3	375.3	28.5	8.1	58.5	18.2	28.5	882.2	4.7	15.9	7.8	365.0	1.8	15.7	5.8	515.9	0.6	3.5	478.0	0.5	29.9	9.8	327.7	0.0	0.0	51.9	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.1	4.6	0.0	0.0	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	401.5	480.5	419.8	412.8	337.4	398.5	429.5	478.8	375.3	365.0	515.9	327.7	1.4	0.0	0.0	515.8	0.1	0.5	1.6	0.0	0.6	1.3	2.5	0.9	158.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	1.2	11.1	0.0	0.0	5.5	0.0	0.0	4.8	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	1.3	1.4	28.9	0.5	0.0	141.5	0.5	73.0	0.0	94.0	2.5	0.0	0.0	39.5	0.0	0.8	0.0	0.1	0.1	3.9	85.5	54.9	45.8	0.3	0.2	0.2	0.6	0.1	0.1	5.8	0.0	0.6
ATP1A3	DYT12	ENSG00000105409	"ATPase Na+/K+ transporting subunit alpha 3"	P13637	19	41966582-41997497	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"	Translocase	"Deafness, Disease variant, Dystonia, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 645.2;heart muscle: 157.7;retina: 292.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 418.1;Cone photoreceptor cells: 171.0;Horizontal cells: 213.7;Inhibitory neurons: 119.1;Late spermatids: 115.6;Rod photoreceptor cells: 291.4"	"Cancer enriched"	"Detected in many"	5	"glioma: 21.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 57.7;JURKAT: 36.3;Karpas-707: 35.9;REH: 37.1;SCLC-21H: 128.2;SH-SY5Y: 57.7"									"CAB033630, HPA045367, HPA056446"	Enhanced	Approved				NA	NA		220000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB033630: AB_781528, HPA045367: AB_2679297, HPA056446: AB_2683136"	"unprognostic (1.90e-1)"	"unprognostic (8.65e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.20e-3)"	"unprognostic (8.94e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.16e-2)"	"unprognostic (7.66e-2)"	"unprognostic (8.02e-2)"	"prognostic unfavorable (3.44e-4)"	"prognostic favorable (6.15e-5)"	"unprognostic (4.02e-3)"	"prognostic unfavorable (3.02e-6)"	"unprognostic (6.84e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.27e-1)"	0.2	18.0	115.4	1.4	126.3	0.6	0.1	76.0	645.2	0.0	0.0	3.6	0.9	0.0	0.0	0.3	0.0	0.2	157.7	165.8	275.3	0.1	0.1	0.2	0.9	390.1	61.8	0.1	0.8	1.2	15.4	0.0	320.4	0.2	0.8	292.4	0.8	0.0	0.2	0.3	1.5	0.8	26.3	0.5	1.3	31.5	174.9	2.1	0.2	1.8	0.6	0.1	0.7	200.7	0.0	2.1	0.7	23.1	0.0	0.1	0.1	0.3	0.0	1.6	1.6	0.8	4.3	57.7	2.6	0.4	5.6	0.5	16.2	0.2	0.6	10.7	3.1	5.0	0.2	0.4	0.0	0.0	18.2	0.0	0.2	0.0	0.3	0.3	0.0	36.3	0.0	35.9	0.4	0.8	10.4	0.1	3.0	8.4	14.3	37.1	18.5	1.8	0.0	0.6	128.2	57.7	0.3	4.2	0.1	0.0	3.4	2.6	0.0	3.0	3.2	0.0	1.1	3.7	2.6	12.7	5.5	20.6	0.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	115.4	126.3	76.0	645.2	165.8	275.3	390.1	61.8	320.4	26.3	174.9	200.7	0.2	0.0	4.4	9.1	1.1	0.3	0.4	0.0	0.6	418.1	0.3	0.3	19.3	0.0	0.0	0.0	171.0	0.0	3.2	0.8	0.0	0.0	43.7	0.1	0.1	1.4	0.0	0.0	59.1	0.0	0.1	1.0	1.1	0.1	1.3	0.1	0.0	0.0	0.2	213.7	119.1	0.4	0.0	0.0	0.4	115.6	1.8	0.7	0.0	8.4	0.4	40.0	6.2	14.6	11.4	0.0	0.0	0.4	1.0	0.2	0.0	0.1	0.0	291.4	0.0	0.7	0.4	21.2	2.8	0.2	0.3	0.3	3.6	0.4	0.5	0.4
ATP1B1	ATP1B	ENSG00000143153	"ATPase Na+/K+ transporting subunit beta 1"	P05026	1	169105697-169132722	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 1337.8"	"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 1723.3;Proximal tubular cells: 1070.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 13.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"OE19: 919.7;RPTEC TERT1: 513.0;SH-SY5Y: 382.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012911	Enhanced					NA	NA		2100000	"Cluster 27: Non-specific - Gene expression"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA012911: AB_1845173"	"unprognostic (4.20e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.34e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.24e-1)"	"unprognostic (6.80e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (7.08e-7)"	"unprognostic (1.11e-1)"	"unprognostic (5.48e-2)"	"unprognostic (1.97e-3)"	"unprognostic (9.39e-2)"	12.4	146.9	197.7	48.0	216.2	4.4	79.4	370.0	451.1	37.5	369.3	246.1	336.6	108.8	64.3	159.8	48.8	178.7	160.5	326.4	332.1	1337.8	180.1	92.6	8.5	558.7	264.3	58.1	178.5	732.7	79.8	44.1	540.2	48.6	201.1	99.3	314.1	72.6	342.9	67.0	284.4	96.6	248.8	52.6	402.1	46.3	375.1	19.2	330.2	337.8	84.0	101.2	52.1	382.2	89.7	215.8	73.3	56.3	15.9	3.3	23.8	45.3	33.1	41.7	43.3	276.8	183.5	0.1	158.3	35.1	50.8	102.4	38.1	83.2	45.1	1.1	16.6	5.7	152.6	138.9	26.6	4.0	7.5	9.1	21.1	31.8	42.5	79.7	40.5	6.6	1.3	1.4	52.6	38.0	7.9	16.0	28.1	919.7	47.4	1.3	89.3	15.6	513.0	118.6	54.3	382.5	263.1	271.3	12.5	85.4	55.7	9.8	92.0	35.2	90.4	60.9	159.3	4.8	6.8	2.0	42.0	13.9	47.9	13.2	1.0	0.2	2.7	3.2	1.5	1.5	3.3	1.3	9.3	0.2	1.0	1.1	0.3	6.2	1.1	0.4	10.1	1.4	197.7	216.2	370.0	451.1	326.4	332.1	558.7	264.3	540.2	248.8	375.1	382.2	14.4	240.4	251.5	79.0	18.4	52.5	156.5	490.4	153.1	86.9	274.2	166.5	147.3	664.8	425.7	1723.3	14.6	4.8	21.0	817.1	923.4	629.9	3.8	199.6	11.6	18.6	160.9	6.9	344.7	591.9	9.0	78.7	353.7	190.6	23.4	89.0	45.7	273.3	385.3	580.5	602.3	296.7	370.2	99.5	676.1	9.0	89.8	101.5	247.3	81.5	27.1	23.4	1.0	94.5	514.7	377.9	666.4	149.0	16.9	84.4	646.8	1070.2	332.5	64.9	6.6	93.6	32.5	10.6	66.9	142.8	31.7	9.9	48.2	111.8	436.0	322.8
ATP1B3	"CD298, FLJ29027"	ENSG00000069849	"ATPase Na+/K+ transporting subunit beta 3"	P54709	3	141876124-141926549	"CD markers, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 982.6;Late spermatids: 930.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020697, HPA048963"	Enhanced		Supported	"Plasma membrane"		NA	NA		33000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB020697: , HPA048963: AB_2680574"	"unprognostic (2.31e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.75e-1)"	"prognostic favorable (5.19e-5)"	"unprognostic (2.60e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (6.32e-6)"	"unprognostic (8.11e-3)"	"unprognostic (6.99e-2)"	"unprognostic (5.37e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.29e-5)"	"unprognostic (5.14e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.19e-3)"	"unprognostic (6.15e-2)"	229.4	349.6	62.2	81.0	62.8	63.0	87.0	78.5	78.8	98.4	100.5	146.7	112.7	75.7	37.6	182.3	96.2	55.4	102.8	63.6	74.7	128.4	24.5	191.0	41.3	71.1	66.6	180.0	36.7	20.3	168.7	96.7	76.5	102.0	168.0	43.6	85.8	46.2	26.7	259.3	125.0	71.4	68.7	65.7	66.3	75.8	70.6	51.4	75.8	16.0	57.1	101.0	161.2	62.2	280.8	170.1	155.5	145.6	411.7	118.0	354.7	322.2	287.6	224.2	252.1	253.7	136.5	223.3	278.2	243.5	328.4	595.8	157.0	152.2	253.4	120.4	190.0	195.7	161.4	156.8	161.7	164.9	149.1	126.5	355.1	179.1	169.7	162.4	245.7	156.3	135.9	193.7	233.8	114.6	165.6	275.0	213.6	384.5	76.1	225.0	116.4	227.1	191.1	186.7	127.6	86.0	413.2	188.5	455.9	270.7	145.6	197.2	170.7	196.4	76.3	298.8	189.8	138.0	197.6	367.5	259.5	176.5	165.2	69.7	104.1	35.4	70.4	174.3	51.7	39.7	56.3	74.8	103.3	30.4	32.6	59.6	6.7	32.0	260.4	64.8	68.4	103.7	62.2	62.8	78.5	78.8	63.6	74.7	71.1	66.6	76.5	68.7	70.6	62.2	114.7	57.7	41.9	38.2	143.4	492.8	428.3	535.9	326.7	35.9	53.0	46.4	19.7	17.2	177.6	220.7	25.0	281.3	464.5	982.6	41.1	73.9	465.9	86.0	72.2	199.2	56.1	147.1	107.5	60.6	226.8	164.1	24.5	127.2	130.7	94.3	100.6	9.0	305.9	25.2	91.2	65.2	164.8	148.0	678.3	930.5	84.8	455.3	222.3	37.5	364.8	46.3	75.2	46.3	54.7	70.6	321.1	68.4	153.1	396.5	413.3	41.5	33.3	28.4	124.9	99.5	265.2	69.0	200.2	178.4	414.4	391.4	216.1	122.2	134.9	370.2
ATP2A2	"ATP2B, DAR, SERCA2"	ENSG00000174437	"ATPase sarcoplasmic/endoplasmic reticulum Ca2+ transporting 2"	P16615	12	110280756-110351093	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	12	"heart muscle: 1005.8;skeletal muscle: 2856.8;tongue: 2768.8"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 2119.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062605	Enhanced					NA	NA		2500000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA062605: AB_2684805"	"unprognostic (4.81e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.50e-1)"	"unprognostic (3.98e-3)"	"unprognostic (1.91e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.26e-1)"	"unprognostic (5.62e-2)"	"unprognostic (9.93e-2)"	60.4	49.6	26.2	57.8	34.6	46.0	34.1	36.0	28.0	43.4	23.2	64.2	47.5	46.6	39.0	181.2	67.0	60.5	1005.8	39.0	28.8	34.4	54.7	49.0	36.0	32.5	46.3	42.0	38.1	56.1	24.5	55.4	29.8	93.4	69.0	19.1	92.2	70.0	2856.8	46.5	56.4	74.4	29.8	30.5	47.2	74.1	57.6	36.2	73.3	2768.8	48.1	90.9	57.9	36.1	129.7	305.7	135.4	106.5	95.3	111.7	185.1	154.9	197.2	163.6	102.1	229.1	131.3	155.4	129.2	165.4	115.4	185.0	215.9	264.4	157.3	130.0	127.2	148.0	115.6	121.5	164.7	151.1	130.6	130.3	170.7	202.3	190.1	165.4	134.9	82.6	162.9	74.9	118.6	131.3	76.0	53.2	139.7	126.6	134.8	96.8	130.2	128.6	59.5	279.2	138.2	101.5	207.8	151.1	87.0	113.9	213.7	95.6	159.8	147.8	69.3	93.9	127.4	140.6	189.5	169.0	152.3	70.9	168.8	0.0	0.6	0.0	0.5	1.3	0.2	0.1	0.3	0.2	0.5	0.2	0.3	0.3	0.0	0.3	0.6	0.5	0.3	0.2	26.2	34.6	36.0	28.0	39.0	28.8	32.5	46.3	29.8	29.8	57.6	36.1	48.9	44.8	57.5	85.5	26.3	114.5	95.2	134.5	68.9	63.6	70.2	64.6	2119.9	41.5	103.5	51.5	64.6	33.4	37.4	155.1	1.9	43.7	14.8	291.6	90.8	59.7	137.3	14.1	161.0	71.0	37.6	104.2	49.5	258.1	45.0	47.3	40.7	122.2	64.3	84.1	146.1	109.6	65.1	54.6	64.9	13.4	30.4	65.3	67.6	63.7	33.8	27.5	15.5	119.6	96.4	98.0	89.4	83.1	56.8	117.4	78.0	25.3	176.4	42.9	52.6	88.0	110.2	80.3	47.7	142.3	109.0	30.6	32.7	40.0	97.7	126.4
ATP2B1	PMCA1	ENSG00000070961	"ATPase plasma membrane Ca2+ transporting 1"	P20020	12	89588049-89709300	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 106.8"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 781.6;Langerhans cells: 435.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 314.6;LHCN-M2: 501.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005605, HPA011166, HPA012945"	Enhanced	Supported	Supported	"Plasma membrane"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483"	"unprognostic (6.78e-2)"	"unprognostic (5.27e-2)"	"unprognostic (1.57e-2)"	"unprognostic (8.23e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.44e-2)"	"prognostic unfavorable (7.74e-4)"	"unprognostic (2.77e-2)"	"unprognostic (2.46e-2)"	"unprognostic (7.82e-2)"	"unprognostic (5.98e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.60e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	18.5	11.2	33.0	25.6	92.0	106.8	19.6	14.0	59.1	18.8	0.0	33.1	40.8	18.2	12.1	14.7	18.6	25.2	11.0	52.7	4.9	16.4	22.7	21.3	29.2	0.0	14.4	13.1	17.1	21.5	11.0	27.3	0.0	13.9	32.3	71.2	11.5	14.9	24.4	26.0	30.1	19.7	0.0	30.7	29.0	23.0	10.9	18.4	14.4	24.1	28.8	37.0	10.6	34.9	24.0	117.8	45.5	22.1	64.5	102.2	20.9	71.2	232.6	67.5	106.8	47.7	21.6	46.8	4.9	99.3	77.6	21.0	40.3	19.7	187.5	16.2	46.9	16.6	39.8	41.9	209.6	70.7	26.6	85.0	36.9	210.8	314.6	78.9	17.5	17.6	27.9	16.6	501.1	37.6	22.1	30.1	35.6	32.9	55.6	31.1	146.4	19.7	64.4	108.5	42.9	23.4	82.6	22.9	20.2	91.7	33.9	7.8	12.5	181.8	29.4	67.6	78.9	12.7	21.2	49.1	82.6	19.6	41.0	9.4	39.4	22.3	20.9	42.5	26.4	84.5	36.3	26.8	51.3	84.4	13.2	16.8	127.1	27.0	86.1	9.0	53.7	21.8	33.0	92.0	14.0	59.1	52.7	4.9	0.0	14.4	0.0	0.0	10.9	34.9	46.0	44.8	46.0	90.8	226.4	201.6	71.0	29.3	76.2	370.9	30.9	109.7	20.3	45.8	30.0	53.3	154.3	176.8	139.8	181.5	1.9	27.6	2.3	29.3	61.0	63.6	91.6	31.5	781.6	28.5	42.1	91.6	44.9	59.4	31.6	45.5	49.6	39.5	193.5	302.9	279.1	30.7	16.2	116.0	435.1	9.6	29.2	285.4	55.2	126.5	157.1	96.4	50.4	193.5	91.9	25.5	80.6	32.0	133.9	54.7	75.0	22.1	20.6	113.3	32.9	97.0	69.5	44.5	130.7	30.4	204.7	228.8	125.1	76.0	65.9	90.2
ATP2B2	PMCA2	ENSG00000157087	"ATPase plasma membrane Ca2+ transporting 2"	Q01814	3	10324023-10708007	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 104.0;choroid plexus: 43.0;salivary gland: 33.2;skeletal muscle: 37.4"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 117.5;Bipolar cells: 87.7;Excitatory neurons: 323.2;Horizontal cells: 104.3;Inhibitory neurons: 230.5;Oligodendrocyte precursor cells: 58.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 7.7"	"Region enhanced"	"Detected in many"		"cerebral cortex: 104.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"EFO-21: 4.0;RPMI-8226: 11.9;SCLC-21H: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005606	Enhanced					NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB005606: AB_2243199"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.59e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.62e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.65e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.32e-4)"	"unprognostic (2.70e-1)"	"unprognostic (1.46e-3)"	"unprognostic (1.08e-3)"	"unprognostic (1.33e-2)"	"unprognostic (8.34e-2)"	"unprognostic (7.95e-3)"	0.0	0.6	3.4	0.0	15.8	0.0	0.1	38.6	104.0	2.0	43.0	0.1	0.0	2.2	0.2	0.1	3.7	0.0	0.1	10.4	0.2	0.2	20.3	0.0	0.0	1.6	9.8	0.0	0.2	2.0	3.5	0.0	2.7	0.0	0.0	13.5	33.2	0.0	37.4	0.4	0.1	1.4	0.0	0.1	0.1	0.6	16.1	0.5	0.0	4.9	0.1	0.0	0.1	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	4.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	15.8	38.6	104.0	10.4	0.2	1.6	9.8	2.7	0.0	16.1	30.3	0.1	0.0	0.0	117.5	0.1	0.5	0.0	0.0	0.0	87.7	3.6	0.3	12.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	7.7	0.8	0.7	0.0	0.0	323.2	0.0	0.0	0.5	0.0	14.1	2.5	0.1	0.4	27.1	0.0	104.3	230.5	0.0	0.0	0.8	0.7	7.5	0.0	0.1	3.6	14.0	0.0	16.4	0.0	58.3	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	8.2	0.0	2.3	0.5	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0
ATP2B4	"ATP2B2, MXRA1, PMCA4"	ENSG00000058668	"ATPase plasma membrane Ca2+ transporting 4"	P23634	1	203626787-203744081	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calmodulin-binding, Translocase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"smooth muscle: 175.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 171.6;Oligodendrocyte precursor cells: 199.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ: 200.0;BJ hTERT+: 276.4;fHDF/TERT166: 212.8;SuSa: 222.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016118, HPA040431"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB016118: AB_2061729, HPA040431: AB_2676980"	"unprognostic (7.43e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.60e-2)"	"unprognostic (8.17e-2)"	"unprognostic (2.53e-2)"	"unprognostic (9.23e-3)"	"unprognostic (8.68e-2)"	"unprognostic (3.81e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (1.21e-4)"	"unprognostic (3.52e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.56e-3)"	58.9	25.0	39.7	25.6	36.3	16.0	16.6	0.0	33.5	47.5	0.3	58.2	12.5	104.5	20.1	32.5	48.4	25.2	59.5	40.2	13.3	9.9	9.3	35.1	12.8	8.0	8.0	40.6	9.9	11.8	3.8	40.6	11.2	33.0	30.2	42.5	7.1	69.7	14.4	54.8	14.4	175.3	0.2	12.2	15.4	27.4	44.7	21.7	15.1	27.7	19.4	37.2	15.3	2.6	45.7	7.8	15.6	15.1	120.4	175.1	84.5	200.0	276.4	32.1	27.4	3.8	22.8	9.8	28.8	212.8	43.5	43.5	22.6	27.7	34.3	126.5	8.0	28.7	37.4	2.5	43.1	42.0	51.3	130.5	26.9	102.9	16.2	81.6	63.5	57.1	12.9	20.3	25.1	2.5	44.3	14.5	9.7	8.7	24.2	22.3	11.6	16.7	11.3	4.0	4.6	6.7	68.3	10.5	30.2	222.1	9.3	21.4	54.9	80.5	11.4	136.6	48.3	13.4	20.9	5.4	80.7	31.0	24.5	3.2	2.0	0.0	8.7	1.3	6.4	0.9	5.4	7.2	2.2	0.3	1.3	3.4	4.0	3.8	2.2	3.7	5.7	2.7	39.7	36.3	0.0	33.5	40.2	13.3	8.0	8.0	11.2	0.2	44.7	2.6	171.6	89.8	68.2	127.6	9.9	97.1	18.9	43.1	41.5	4.8	11.2	9.4	76.5	7.2	35.0	18.4	2.1	27.9	56.2	2.2	0.0	35.3	5.8	78.0	92.4	67.6	23.9	35.9	55.9	14.9	18.9	56.0	13.7	89.7	10.1	30.6	58.9	18.2	38.5	117.8	9.8	2.4	14.2	14.7	38.8	4.8	43.8	20.4	26.6	37.5	18.1	136.1	66.9	199.0	40.4	31.4	11.1	38.0	27.6	48.2	7.2	3.3	39.7	7.8	19.7	50.7	81.2	21.7	2.8	54.7	150.9	26.0	59.7	8.0	3.3	62.0
ATP2C1	"ATP2C1A, BCPM, KIAA1347, PMR1, SPCA1"	ENSG00000017260	"ATPase secretory pathway Ca2+ transporting 1"	P98194	3	130850595-131016712	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 162.6;Excitatory neurons: 172.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010207, HPA035116, HPA069684"	Supported		Supported	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"CAB010207: AB_2061744, HPA035116: AB_10673106, HPA069684: AB_2686169"	"unprognostic (1.52e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.99e-1)"	"unprognostic (1.32e-2)"	"prognostic unfavorable (5.06e-6)"	"unprognostic (7.66e-2)"	"unprognostic (6.52e-2)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (8.44e-2)"	"prognostic favorable (1.55e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.73e-2)"	"unprognostic (3.06e-1)"	32.2	32.7	34.0	25.3	36.6	38.6	32.9	31.8	42.8	33.4	76.9	36.5	23.9	30.9	28.0	23.6	37.2	27.2	31.9	40.7	38.6	44.7	28.5	51.4	21.9	37.0	38.9	28.8	22.6	78.0	22.7	32.7	40.3	85.8	35.9	59.4	29.2	25.2	28.1	31.9	26.9	31.0	33.6	19.5	31.5	25.2	48.8	36.2	35.0	21.1	26.2	31.6	18.1	48.6	133.1	51.1	49.9	48.5	136.7	110.0	53.9	141.2	186.8	69.4	87.0	83.5	106.3	47.6	95.6	134.4	96.4	153.6	95.1	77.9	100.8	104.4	34.2	127.2	51.5	39.0	87.2	51.2	148.4	86.8	76.6	73.2	82.2	126.3	74.6	59.3	37.3	84.1	86.7	59.0	50.6	40.9	57.0	71.7	54.8	36.3	49.9	75.6	127.5	87.7	76.7	45.9	121.4	37.8	72.8	70.8	55.7	41.7	102.6	73.3	40.8	95.5	65.8	54.6	71.1	69.9	75.8	38.0	62.6	30.6	8.9	15.9	7.4	7.6	7.0	5.6	7.3	6.6	9.5	3.6	4.9	4.9	4.3	11.5	9.6	8.2	9.3	6.5	34.0	36.6	31.8	42.8	40.7	38.6	37.0	38.9	40.3	33.6	48.8	48.6	30.2	38.5	53.0	162.6	17.4	39.4	34.5	34.8	26.7	25.9	34.4	22.4	30.2	35.8	41.1	46.0	20.9	16.3	15.5	39.0	5.9	35.3	17.5	26.9	34.1	27.8	35.6	23.3	172.5	38.0	27.6	25.9	33.1	55.8	28.5	28.2	26.7	27.4	27.7	82.4	136.5	32.4	36.7	26.2	34.8	18.9	16.1	39.5	21.4	128.4	20.5	26.4	19.6	148.3	154.3	51.1	27.5	14.7	18.5	69.0	16.3	19.8	52.7	33.4	6.6	27.7	25.9	16.2	14.1	24.7	52.8	17.6	19.5	17.3	31.2	36.9
ATP2C2	"KIAA0703, SPCA2"	ENSG00000064270	"ATPase secretory pathway Ca2+ transporting 2"	O75185	16	84368527-84464187	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 37.4;skin 1: 26.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 56.2;Club cells: 50.0;Intestinal goblet cells: 82.3;Oligodendrocyte precursor cells: 58.8;Respiratory ciliated cells: 78.2;Undifferentiated cells: 77.1"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 24.5;OE19: 44.4;RT4: 19.3;SK-BR-3: 33.0;T-47d: 11.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA052262, HPA075812"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Focal adhesion sites"		"HPA052262: AB_2681776, HPA075812: AB_2686765"	"unprognostic (2.28e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.34e-2)"	"prognostic favorable (6.20e-6)"	"unprognostic (2.04e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.36e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.37e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.32e-4)"	"unprognostic (1.39e-1)"	0.0	0.0	1.4	2.4	1.4	11.0	2.5	0.5	1.3	6.4	0.5	30.1	27.3	1.0	0.1	4.7	6.8	4.6	0.0	1.3	1.1	1.8	0.1	10.5	0.0	1.0	0.9	0.0	0.7	3.3	1.0	0.9	1.0	12.5	37.4	0.9	19.6	0.2	0.1	26.0	20.3	0.6	0.6	0.4	5.9	0.4	1.1	0.0	8.9	0.0	0.5	4.0	4.6	0.8	6.2	0.4	0.9	0.1	0.0	0.0	6.4	0.2	0.0	0.0	0.0	5.8	5.2	0.0	0.1	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	24.5	0.0	0.0	0.0	44.4	0.1	0.0	0.0	0.2	0.0	19.3	4.9	0.0	0.0	33.0	0.2	0.9	11.1	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	1.4	0.5	1.3	1.3	1.1	1.0	0.9	1.0	0.6	1.1	0.8	0.0	32.1	56.2	4.2	0.0	0.6	14.3	39.9	0.6	1.3	20.8	3.2	0.8	5.7	50.0	0.0	0.0	2.0	0.1	44.4	0.0	9.0	3.2	26.8	2.5	0.7	34.2	0.0	8.3	2.5	2.4	0.5	22.4	28.0	8.9	0.0	0.0	0.1	0.3	0.0	1.8	82.3	8.2	0.0	1.2	1.9	0.0	0.6	1.8	1.0	0.0	1.9	0.0	58.8	2.4	4.7	29.2	0.0	0.0	13.8	10.2	1.8	78.2	5.2	0.0	0.1	1.8	0.8	1.0	1.5	1.1	24.1	0.9	0.2	77.1	9.9
ATP4A	ATP6A	ENSG00000105675	"ATPase H+/K+ transporting subunit alpha"	P20648	19	35550031-35563658	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Potassium transport, Transport"	Translocase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	83	"stomach 1: 841.9"	"Group enriched"	"Detected in some"	6	"Gastric mucus-secreting cells: 66.3;Late spermatids: 21.0"	"Cancer enriched"	"Detected in single"	21	"stomach cancer: 5.4"	"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA039154, HPA076684"	Enhanced					NA	NA				"Cluster 4: Stomach - Digestion"		"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA039154: AB_10672772, HPA076684: "	"unprognostic (3.54e-2)"	"unprognostic (6.98e-3)"		"unprognostic (2.77e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-3)"		"unprognostic (4.96e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.50e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.90e-3)"	"unprognostic (3.92e-2)"	"unprognostic (4.86e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.18e-1)"	1.1	2.5	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.1	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.0	10.1	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	841.9	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	1.2	0.4	0.0	0.0	66.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	21.0	0.6	1.2	0.0	0.0	0.6	0.1	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	2.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0
ATP4B	ATP6B	ENSG00000186009	"ATPase H+/K+ transporting subunit beta"	P51164	13	113648804-113658198	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Hydrogen ion transport, Ion transport, Potassium transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	305	"stomach 1: 1096.8"	"Cell type enriched"	"Detected in some"	76	"Gastric mucus-secreting cells: 145.8"	"Cancer enriched"	"Detected in some"	12	"stomach cancer: 8.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA045400, HPA052649"	Enhanced		Uncertain	"Plasma membrane"		NA	NA				"Cluster 4: Stomach - Digestion"		"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"		"HPA045400: AB_2679314, HPA052649: AB_2681900"	"unprognostic (9.92e-2)"	"unprognostic (2.19e-1)"		"unprognostic (2.66e-1)"	"unprognostic (4.86e-1)"			"unprognostic (6.43e-3)"	"unprognostic (7.81e-3)"	"unprognostic (1.95e-1)"	"unprognostic (3.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (6.65e-4)"	"unprognostic (2.25e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.78e-2)"		0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	3.5	0.3	0.0	0.0	0.0	0.3	3.3	0.0	0.2	0.2	0.1	0.4	0.1	0.4	0.0	0.5	0.6	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	1096.8	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.5	0.6	0.2	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	145.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1
ATP6AP1	"16A, Ac45, ATP6IP1, ATP6S1, CF2, ORF, VATPS1, XAP-3, XAP3"	ENSG00000071553	"ATPase H+ transporting accessory protein 1"	Q15904	X	154428633-154436516	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB015218	Uncertain					NA	NA		700000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"			"CAB015218: "	"prognostic unfavorable (2.40e-4)"	"unprognostic (1.95e-2)"	"unprognostic (2.06e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (1.84e-3)"	"unprognostic (4.99e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.83e-4)"	"unprognostic (1.07e-1)"	"prognostic favorable (5.26e-8)"	"unprognostic (2.45e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.62e-1)"	56.3	93.5	108.3	43.1	109.2	59.1	56.7	99.6	118.0	59.6	123.6	61.5	48.4	54.2	145.1	85.2	60.0	46.0	92.7	116.2	115.4	104.3	51.4	96.8	46.9	114.0	96.8	63.3	86.6	176.0	110.4	77.9	121.6	85.1	57.0	74.0	87.4	54.8	53.8	83.6	57.4	49.0	104.6	94.7	70.4	47.5	104.2	40.9	81.9	54.4	42.5	63.7	60.9	121.6	110.1	101.6	88.2	146.2	145.7	77.4	162.2	78.5	116.6	122.5	176.1	93.4	135.1	64.7	337.8	177.1	216.5	112.3	133.8	71.9	76.6	58.6	135.1	37.5	113.7	100.0	170.6	60.9	260.2	98.1	126.7	112.4	68.2	139.5	177.0	47.8	45.6	176.4	84.7	158.1	43.6	96.8	32.1	171.0	100.8	66.6	59.1	170.7	139.9	87.3	84.6	89.7	72.6	289.7	159.3	87.3	123.1	157.8	135.5	87.4	79.0	151.1	135.6	256.3	311.8	77.0	104.4	132.8	90.2	246.6	295.1	363.9	147.3	313.8	148.6	91.7	118.4	127.8	376.7	113.6	107.1	117.8	326.9	140.3	255.6	215.9	155.2	216.9	108.3	109.2	99.6	118.0	116.2	115.4	114.0	96.8	121.6	104.6	104.2	121.6	39.4	38.5	57.5	17.0	32.3	30.2	42.7	122.4	25.6	105.8	58.5	42.2	37.7	54.3	102.1	97.5	47.9	145.1	40.1	84.3	19.6	65.4	3.1	52.5	33.7	50.1	89.0	35.8	17.0	52.5	104.5	48.8	36.7	57.4	77.3	51.8	54.3	46.6	246.3	129.5	24.2	59.0	160.7	143.6	88.2	5.5	41.3	130.3	72.9	15.0	79.9	68.4	27.8	22.1	26.4	42.4	67.5	42.5	61.7	34.1	63.7	49.1	112.5	69.2	65.7	35.7	45.5	64.4	10.7	31.6	32.8	196.5	36.3	74.1	54.6	47.2
ATP6AP2	"APT6M8-9, ATP6IP2, ATP6M8-9, M8-9, PRR, RENR"	ENSG00000182220	"ATPase H+ transporting accessory protein 2"	O75787	X	40579372-40606848	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Congenital disorder of glycosylation, Disease variant, Epilepsy, Mental retardation, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"parathyroid gland: 765.1"	"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 702.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003156	Approved					NA	NA		140000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA003156: AB_1078245"	"unprognostic (1.45e-1)"	"unprognostic (3.80e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.58e-3)"	"unprognostic (1.29e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.01e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.01e-5)"	"unprognostic (2.34e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.86e-2)"	81.2	71.5	85.6	60.6	86.5	124.4	95.1	76.4	116.9	106.1	72.4	82.9	32.1	86.6	91.3	70.1	75.6	79.7	55.1	90.8	90.2	165.6	96.8	87.3	67.4	80.4	79.8	68.9	53.3	765.1	30.7	106.9	83.4	86.6	89.0	99.3	39.4	97.9	18.4	71.9	47.8	124.7	84.6	69.0	49.1	40.4	87.6	72.0	177.1	40.1	72.5	97.7	41.4	98.7	83.9	117.5	78.7	106.7	472.6	312.4	47.9	182.4	274.1	127.0	152.9	68.0	142.6	48.4	88.1	257.0	141.3	86.6	114.0	136.0	168.2	92.7	97.7	57.5	100.2	66.5	172.0	104.6	111.6	259.6	175.2	154.2	121.4	200.3	168.1	46.1	63.8	130.7	201.7	109.8	45.5	93.7	73.4	140.8	112.7	43.8	132.6	161.6	182.8	96.8	55.2	51.9	185.8	111.7	118.4	284.2	147.8	97.1	172.5	175.0	91.3	207.7	62.8	38.0	70.7	46.2	139.1	93.0	138.5	269.0	511.1	404.8	156.1	364.9	164.3	106.7	157.3	161.9	341.3	110.3	174.8	159.3	255.9	141.2	378.6	124.2	167.2	692.9	85.6	86.5	76.4	116.9	90.8	90.2	80.4	79.8	83.4	84.6	87.6	98.7	102.3	57.7	65.6	36.2	65.4	97.3	135.4	254.3	46.1	155.8	74.1	61.2	30.4	94.4	175.4	138.0	54.2	173.4	109.6	70.3	62.6	146.6	3.6	97.2	115.5	94.7	57.1	62.3	44.8	59.1	106.3	156.5	34.7	124.5	87.5	63.7	96.0	64.0	702.2	188.4	56.3	54.6	349.9	279.5	263.3	9.5	117.4	222.0	149.4	28.1	185.4	193.0	72.1	40.2	40.6	64.0	58.9	151.2	74.8	97.9	61.0	106.4	127.4	93.3	105.2	116.7	138.7	106.7	43.1	60.0	99.9	174.4	100.3	188.2	63.6	121.1
ATP6V0A1	"a1, ATP6N1, ATP6N1A, Stv1, Vph1, VPP1"	ENSG00000033627	"ATPase H+ transporting V0 subunit a1"	Q93050	17	42458844-42522582	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 130.7"	"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 294.0;Rod photoreceptor cells: 403.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022144	Enhanced		Approved	"Nuclear speckles,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"	"Nuclear speckles, Cytosol"	"HPA022144: AB_1845189"	"unprognostic (3.93e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.35e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.60e-2)"	"unprognostic (8.69e-2)"	"unprognostic (1.84e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (2.05e-4)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.28e-4)"	"unprognostic (3.07e-1)"	"unprognostic (3.68e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (6.90e-4)"	17.7	28.2	30.6	18.0	35.2	21.5	16.3	16.8	42.7	13.4	0.0	22.1	34.6	20.9	19.6	17.4	17.1	22.7	18.9	43.6	44.1	37.4	21.0	24.1	13.1	25.6	26.2	20.0	17.4	86.0	39.0	21.2	34.6	17.4	20.5	130.7	13.5	18.6	59.3	28.1	24.3	21.5	12.1	21.8	16.3	18.7	30.9	15.2	30.3	25.3	14.9	11.9	12.8	27.2	18.4	37.0	22.1	40.1	36.5	31.7	12.9	12.7	23.3	26.4	34.2	23.9	39.9	3.4	22.6	26.2	36.2	38.7	34.5	21.5	30.4	28.3	36.2	29.2	27.3	19.0	22.7	12.8	50.9	23.5	30.3	42.4	18.0	32.6	18.9	13.2	108.0	111.3	39.7	15.8	5.1	11.3	14.3	23.9	0.4	0.2	23.0	51.2	30.2	14.4	60.9	32.0	19.7	17.7	37.1	28.8	43.0	19.0	11.4	22.3	0.9	33.0	15.3	45.0	66.1	6.8	29.7	0.2	26.5	21.6	14.5	11.2	1.0	4.4	1.6	4.7	0.7	0.2	12.2	7.3	1.2	0.9	18.7	0.1	3.3	6.2	3.7	6.6	30.6	35.2	16.8	42.7	43.6	44.1	25.6	26.2	34.6	12.1	30.9	27.2	20.0	19.2	48.0	47.0	23.0	19.8	56.7	15.7	32.5	164.8	15.7	16.5	21.1	28.6	18.3	14.7	294.0	34.3	16.7	46.2	11.7	16.3	4.0	32.8	27.4	22.2	84.9	45.8	125.0	18.5	15.7	31.0	23.4	74.0	24.1	74.5	16.4	37.8	53.8	95.9	112.3	27.3	12.2	37.8	29.2	3.9	17.4	42.8	40.9	38.4	17.7	59.3	3.1	61.3	80.5	24.2	37.6	23.7	13.8	32.7	56.9	32.5	11.4	403.4	6.6	39.4	32.3	38.8	18.2	21.7	20.2	99.9	6.9	35.0	24.5	14.9
ATP6V0A4	"a4, ATP6N1B, ATP6N2, RDRTA2, RTA1C, RTADR, Stv1, Vph1, VPP2"	ENSG00000105929	"ATPase H+ transporting V0 subunit a4"	Q9HBG4	7	138706294-138799560	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"kidney: 63.6;salivary gland: 78.4"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 16.5;Cytotrophoblasts: 13.4;Distal tubular cells: 31.3;Ionocytes: 57.0"	"Cancer enriched"	"Detected in many"	8	"renal cancer: 25.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	11	"SK-BR-3: 55.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018029, HPA064555"	Enhanced		Uncertain	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"HPA018029: AB_1845190, HPA064555: AB_2685284"	"unprognostic (1.99e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.53e-2)"		"unprognostic (4.63e-2)"	"unprognostic (4.28e-1)"	"unprognostic (1.35e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.73e-1)"	"prognostic favorable (1.32e-6)"	"unprognostic (4.35e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.10e-2)"	0.2	0.0	0.3	0.0	0.4	0.0	4.7	0.1	0.5	3.7	3.1	0.0	0.1	0.1	1.2	4.9	0.0	0.0	0.0	0.6	0.2	63.6	0.0	0.4	0.0	0.3	0.2	0.0	0.1	1.6	0.1	2.5	0.2	0.9	0.0	0.0	78.4	1.5	0.0	10.2	0.0	0.0	0.2	0.0	0.1	0.2	0.3	0.4	0.0	0.0	3.7	0.1	0.2	0.3	0.2	0.5	0.0	0.0	0.0	0.0	0.5	0.8	0.1	0.6	0.6	1.8	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	5.0	1.9	0.0	0.1	0.0	0.1	0.1	0.6	0.0	4.5	0.2	0.0	0.0	0.1	55.7	1.9	2.9	0.1	0.0	0.2	0.6	1.3	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.1	0.5	0.6	0.2	0.3	0.2	0.2	0.2	0.3	0.3	0.0	0.0	1.1	0.3	0.0	0.0	1.1	0.9	0.0	0.0	2.5	1.4	0.5	0.0	1.7	16.5	2.1	13.4	0.3	0.0	31.3	0.0	2.2	0.9	0.1	0.1	0.0	0.0	1.4	0.0	0.7	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	57.0	0.0	0.0	2.8	0.3	0.0	7.2	1.0	0.0	0.0	0.0	6.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	4.4	0.1	0.0	0.0	0.1	0.6	0.7	0.0	0.1	5.1	0.2	0.0	0.0	1.3
ATP6V0D1	"ATP6D, ATP6DV, P39, VATX, Vma6, VPATPD"	ENSG00000159720	"ATPase H+ transporting V0 subunit d1"	P61421	16	67438014-67481181	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 380.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016938	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA016938: AB_1845191"	"unprognostic (1.12e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.79e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.93e-1)"	"unprognostic (1.20e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.02e-1)"	"prognostic favorable (1.20e-5)"	"unprognostic (5.72e-3)"	"prognostic favorable (1.76e-8)"	"unprognostic (2.72e-1)"	"unprognostic (6.42e-2)"	"unprognostic (2.63e-2)"	"unprognostic (4.33e-3)"	51.3	112.9	103.1	66.9	107.1	82.3	50.3	84.1	118.4	65.2	82.4	89.8	69.0	69.2	56.6	88.6	57.8	55.9	71.5	119.9	145.1	86.2	73.0	78.7	66.9	112.6	107.4	35.1	59.2	116.3	107.7	55.8	136.0	60.5	72.7	41.4	62.8	55.0	127.6	85.9	79.9	79.6	82.6	96.1	69.4	69.5	99.4	64.7	75.1	84.7	64.0	66.8	62.2	98.5	78.9	111.6	67.3	87.5	167.2	91.2	64.3	92.7	149.1	187.0	224.3	116.5	82.6	33.0	74.2	134.7	125.3	91.9	99.0	117.7	108.8	40.3	90.5	60.5	58.4	97.6	159.4	60.5	243.3	139.8	115.1	187.4	44.5	68.2	117.9	38.0	69.7	41.9	151.9	193.7	45.7	134.9	65.2	70.6	77.9	80.2	78.5	92.1	113.3	129.3	130.4	60.4	244.0	65.8	103.1	52.3	104.8	91.1	114.4	93.4	38.6	113.9	49.8	69.5	106.8	94.9	130.1	63.8	56.3	312.7	732.5	542.4	130.1	511.7	89.9	189.4	96.3	120.3	469.2	174.5	73.1	91.3	936.5	155.5	485.5	168.4	128.0	742.7	103.1	107.1	84.1	118.4	119.9	145.1	112.6	107.4	136.0	82.6	99.4	98.5	46.0	16.0	47.2	11.1	80.1	73.8	61.5	138.2	45.5	73.3	65.7	50.5	38.8	54.3	78.0	68.0	73.0	112.1	74.7	258.8	181.9	127.7	109.6	93.3	46.4	42.6	121.9	68.8	22.7	111.0	73.1	61.5	68.3	74.5	50.1	44.2	42.5	50.2	380.4	82.4	25.7	160.2	154.6	149.4	186.7	50.1	58.7	183.1	124.5	7.5	260.9	70.6	77.2	13.6	23.1	102.0	179.5	53.0	57.0	38.8	203.1	173.6	92.7	52.9	118.3	26.6	53.2	125.7	64.0	55.0	87.5	283.6	54.7	91.3	101.6	63.2
ATP6V1A	"ATP6A1, ATP6V1A1, VA68, Vma1, VPP2"	ENSG00000114573	"ATPase H+ transporting V1 subunit A"	P38606	3	113747033-113812056	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Translocase	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 463.7;Late spermatids: 870.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 79.2"	"Group enriched"	"Detected in all"	6	"dendritic cells: 38.8;granulocytes: 79.2;monocytes: 37.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006910, HPA035084"	Approved		Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Vesicles, Cytosol"	Nucleoplasm	"CAB006910: , HPA035084: AB_2674454"	"unprognostic (1.32e-1)"	"unprognostic (8.68e-2)"	"unprognostic (5.87e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.00e-1)"	"unprognostic (3.43e-2)"	"unprognostic (2.90e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.36e-2)"	"unprognostic (5.19e-3)"	"prognostic favorable (3.82e-12)"	"unprognostic (8.82e-2)"	"unprognostic (2.46e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.52e-2)"	18.1	32.2	40.1	21.6	46.4	16.6	24.5	14.7	53.0	25.3	62.4	22.1	18.5	14.2	15.1	22.7	19.0	20.9	9.0	47.5	58.5	92.7	36.4	24.5	25.1	39.6	23.0	11.3	20.9	60.1	17.1	24.5	39.0	20.9	22.5	58.7	37.5	14.9	7.9	25.0	15.9	15.8	16.9	26.5	22.1	18.1	28.4	22.9	40.8	11.0	28.0	19.6	14.2	21.9	61.7	27.4	33.9	29.7	70.0	30.9	36.0	32.7	49.4	33.7	46.1	52.4	48.3	50.4	75.5	48.0	37.3	39.1	77.5	43.2	43.8	23.1	21.4	44.8	39.3	40.6	57.6	33.2	50.0	42.0	29.1	43.7	30.2	52.0	55.7	25.1	52.0	37.0	50.5	40.5	24.4	14.9	42.8	42.9	34.3	20.8	24.6	57.4	92.5	58.0	65.4	24.1	57.3	38.6	44.9	46.4	58.5	26.6	51.4	31.1	23.1	21.7	19.8	38.4	44.5	46.2	61.1	41.2	35.3	26.8	37.0	12.8	6.3	27.7	5.9	8.2	5.6	6.0	38.8	6.8	5.4	6.2	79.2	9.2	23.9	10.8	8.1	16.7	40.1	46.4	14.7	53.0	47.5	58.5	39.6	23.0	39.0	16.9	28.4	21.9	18.8	28.9	35.0	43.4	24.2	30.3	15.9	30.3	23.9	94.1	27.9	17.1	10.4	31.5	32.9	99.3	41.7	22.0	20.8	38.3	82.2	29.5	463.7	41.7	24.5	26.8	55.8	49.6	119.4	27.5	22.6	17.9	20.9	100.6	10.8	19.4	36.0	74.3	74.3	101.0	107.7	25.4	197.4	104.7	73.3	870.3	18.0	70.9	46.2	34.7	82.8	45.6	11.3	54.3	53.2	27.1	30.5	23.0	23.6	25.6	24.1	80.8	38.3	44.4	6.6	15.3	21.6	28.7	15.7	40.8	47.9	43.9	19.0	25.8	27.2	26.8
ATP6V1B1	"ATP6B1, RTA1B, VATB, Vma2, VPP3"	ENSG00000116039	"ATPase H+ transporting V1 subunit B1"	P15313	2	70935900-70965431	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"kidney: 127.4;salivary gland: 139.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 197.3;Distal tubular cells: 49.0;Ionocytes: 321.4;Syncytiotrophoblasts: 64.9"	"Group enriched"	"Detected in many"	5	"ovarian cancer: 94.7;renal cancer: 23.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 21.6;HaCaT: 20.3;SK-BR-3: 49.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB009523, HPA031847"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		No	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Nuclear membrane"		"CAB009523: AB_677577, HPA031847: AB_2674072"	"unprognostic (2.28e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.20e-5)"	"unprognostic (1.15e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.63e-5)"	"unprognostic (1.97e-2)"	2.2	0.5	0.5	0.2	0.3	0.0	11.8	0.7	0.9	31.1	0.0	0.6	0.5	1.4	1.2	1.6	12.8	0.2	1.1	0.2	0.0	127.4	0.2	1.7	0.5	0.1	0.0	1.2	3.3	0.8	4.2	17.9	0.1	2.0	0.1	3.9	139.8	1.4	0.5	32.5	0.6	0.8	0.0	0.0	0.3	0.3	0.0	0.1	0.3	0.2	0.0	0.6	0.8	0.3	0.4	0.3	0.6	1.3	2.6	3.1	21.6	0.4	0.2	0.0	0.0	0.1	2.0	0.1	0.2	1.2	0.0	20.3	0.7	0.0	0.0	0.5	0.6	0.0	0.3	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.3	3.1	0.0	0.1	0.0	0.0	0.2	1.2	0.1	0.3	0.0	0.0	0.0	0.1	0.8	0.2	0.4	0.2	0.5	1.5	0.7	49.2	0.1	2.7	0.6	0.0	0.4	0.6	0.2	0.9	0.5	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.7	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.7	3.2	0.0	0.3	0.0	0.1	1.3	1.7	0.0	0.9	5.6	3.7	0.4	0.0	13.9	0.0	8.4	197.3	0.1	0.6	49.0	0.1	1.5	0.0	0.1	1.1	0.0	0.0	1.0	0.6	38.3	3.8	0.0	0.1	0.0	0.0	0.0	0.1	11.7	1.7	0.4	0.0	321.4	0.0	0.3	0.1	0.0	0.1	30.2	0.0	0.0	0.5	1.0	1.0	0.1	0.4	0.0	1.2	0.0	0.6	0.3	0.2	2.6	3.8	0.0	1.1	1.0	0.4	1.2	0.0	0.4	64.9	0.1	0.1	0.1	0.6
ATP6V1B2	"ATP6B2, HO57, VATB, Vma2, VPP3"	ENSG00000147416	"ATPase H+ transporting V1 subunit B2"	P21281	8	20197381-20226819	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 256.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1130.7"	"Group enriched"	"Detected in all"	10	"dendritic cells: 336.8;granulocytes: 1130.7;monocytes: 682.0"	"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 317.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008147	Enhanced		Supported	Vesicles		NA	NA		310000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA008147: AB_1845195"	"unprognostic (1.90e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.62e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.59e-3)"	"unprognostic (1.76e-2)"	"unprognostic (3.78e-2)"	"unprognostic (4.68e-2)"	"unprognostic (4.23e-3)"	"unprognostic (1.29e-2)"	"unprognostic (1.34e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (2.41e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.47e-2)"	"unprognostic (5.25e-2)"	46.4	76.4	112.6	71.9	111.2	45.7	35.3	72.8	126.0	30.1	72.5	38.0	43.9	29.4	31.0	51.3	32.8	39.0	38.2	124.0	135.5	145.8	49.2	72.7	54.1	103.4	120.0	27.5	34.5	71.4	74.5	50.5	138.2	28.1	43.0	205.7	40.4	27.0	66.7	62.5	57.8	40.1	74.8	66.1	32.8	67.8	100.3	50.2	33.4	64.7	48.9	44.5	36.1	99.5	44.2	71.5	87.4	29.2	117.7	72.3	79.1	96.6	61.5	121.5	125.2	81.7	25.4	77.7	38.4	93.1	123.7	36.8	70.1	64.6	129.0	32.9	47.2	54.2	29.9	63.6	137.6	39.0	108.0	65.0	57.9	76.0	69.3	134.1	77.2	101.2	82.0	72.8	132.5	25.0	114.6	46.2	65.6	64.6	31.5	46.6	113.4	40.8	112.9	68.2	68.0	97.9	46.9	62.7	317.9	72.4	81.6	70.7	82.8	61.1	46.3	101.9	78.5	29.4	42.7	90.9	84.6	91.6	158.4	183.7	682.0	485.9	52.9	618.6	57.7	50.2	54.1	56.8	336.8	44.5	54.4	53.7	1130.7	50.8	576.1	82.7	73.0	622.6	112.6	111.2	72.8	126.0	124.0	135.5	103.4	120.0	138.2	74.8	100.3	99.5	16.6	25.6	20.7	20.5	28.1	58.0	28.4	52.1	33.0	106.1	18.5	15.6	17.6	25.8	28.8	29.5	102.2	109.2	38.9	23.3	80.3	43.2	40.8	20.2	13.6	24.1	74.4	35.8	64.3	38.5	56.4	38.8	25.0	35.9	22.2	22.3	25.7	34.7	178.5	190.1	68.0	21.4	36.7	185.2	178.7	24.4	19.6	167.6	104.9	30.0	169.1	51.5	20.6	27.6	29.0	45.2	19.7	28.2	20.7	17.4	75.0	256.7	18.0	137.8	13.1	29.3	34.2	121.6	55.3	43.3	71.6	124.6	27.1	23.1	24.7	20.1
ATP6V1C1	"ATP6C, ATP6D, VATC, Vma5"	ENSG00000155097	"ATPase H+ transporting V1 subunit C1"	P21283	8	103021063-103073051	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 162.7;Late spermatids: 166.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023943, HPA057297"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA023943: AB_1845197, HPA057297: AB_2683402"	"unprognostic (5.73e-3)"	"unprognostic (3.30e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-2)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (3.29e-2)"	"unprognostic (3.87e-1)"	"unprognostic (5.62e-2)"	"unprognostic (1.19e-1)"	"unprognostic (5.59e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.88e-1)"	"unprognostic (2.83e-1)"	23.8	32.2	31.6	23.8	36.8	9.7	21.6	18.7	38.2	17.8	20.7	15.4	16.1	19.0	14.2	15.6	16.8	19.8	30.1	39.4	28.9	51.7	27.5	18.6	26.2	25.4	24.5	17.7	18.8	39.0	22.2	30.2	31.5	18.3	18.8	36.7	15.3	16.1	17.2	11.9	17.8	20.6	20.2	19.9	17.4	20.9	25.5	21.9	37.8	24.3	24.5	25.2	14.0	26.3	68.4	38.6	20.2	15.6	54.6	39.3	27.7	49.0	49.7	60.6	68.9	30.4	76.7	41.2	58.2	40.8	97.5	29.6	42.4	41.0	87.8	30.3	26.4	39.2	28.0	35.8	59.5	20.8	52.5	28.8	55.4	77.4	36.2	35.6	43.9	28.7	54.6	37.3	71.4	32.1	46.2	16.7	19.1	67.9	37.6	24.6	36.0	36.4	70.3	48.8	28.5	22.6	26.9	26.9	102.0	40.5	58.9	27.8	44.4	33.2	36.1	74.3	35.0	45.1	17.7	42.1	60.2	47.2	33.2	16.8	30.5	38.1	15.1	44.9	17.2	18.7	12.7	15.1	29.0	18.7	14.4	16.0	50.2	18.7	42.7	15.8	23.1	21.1	31.6	36.8	18.7	38.2	39.4	28.9	25.4	24.5	31.5	20.2	25.5	26.3	31.3	32.1	26.4	38.2	22.9	34.9	33.1	31.2	21.1	32.3	21.9	20.6	43.3	15.7	26.5	31.3	16.7	35.4	15.5	14.7	64.6	36.9	162.7	18.3	19.5	25.5	15.6	33.6	64.9	31.5	35.6	28.4	12.2	16.4	24.1	14.0	17.5	19.0	101.8	37.0	56.6	12.4	46.8	47.6	99.6	166.9	24.2	62.8	19.6	36.5	34.3	34.5	14.4	39.2	44.7	30.4	18.2	18.4	25.1	34.7	19.2	139.1	41.2	25.3	19.7	20.7	45.5	11.1	23.4	19.5	32.8	74.8	18.5	17.4	13.5	27.4
ATP6V1C2	"ATP6C2, VMA5"	ENSG00000143882	"ATPase H+ transporting V1 subunit C2"	Q8NEY4	2	10721100-10785110	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 80.3;salivary gland: 103.2;skin 1: 87.6"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 147.2;Distal tubular cells: 45.0;Enteroendocrine cells: 41.5;Glandular and luminal cells: 73.4;Ionocytes: 93.6;Syncytiotrophoblasts: 169.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"BEWO: 78.4;SK-BR-3: 27.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034734, HPA067305"	Approved		Uncertain	Mitochondria		NA	NA				"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Mitochondria		"HPA034734: AB_2674305, HPA067305: AB_2732763"	"unprognostic (2.29e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.55e-3)"	"unprognostic (2.69e-2)"	"unprognostic (2.20e-2)"	"unprognostic (7.03e-3)"	"unprognostic (8.53e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.77e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (1.12e-11)"	"unprognostic (6.17e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.37e-1)"	"unprognostic (8.27e-2)"	3.4	4.0	1.4	1.7	2.1	4.3	5.7	0.7	1.4	57.5	0.9	2.4	0.9	4.7	80.3	18.3	2.9	0.9	3.0	1.8	0.8	43.3	6.0	2.8	2.0	0.7	0.8	2.9	3.8	1.2	23.5	36.7	0.6	5.1	2.5	1.6	103.2	6.8	1.0	87.6	2.7	0.2	0.6	4.0	2.4	2.0	0.9	0.5	3.8	0.0	5.0	2.0	19.0	1.6	0.6	0.9	2.4	2.7	0.0	0.0	78.4	1.1	0.0	0.0	0.0	1.5	1.9	1.9	1.3	0.0	1.2	1.2	1.3	0.1	0.1	1.1	2.6	0.9	1.4	2.7	0.0	1.8	1.0	0.0	0.3	0.0	0.0	1.8	0.0	0.6	0.9	3.6	0.0	2.1	0.7	2.9	1.8	1.1	0.8	1.6	1.4	5.5	0.0	1.7	1.9	2.3	0.7	27.2	0.8	10.0	2.4	4.0	0.4	0.9	1.8	1.1	1.1	6.2	2.5	1.1	1.1	1.5	0.8	0.0	0.1	0.1	0.3	0.3	0.2	0.1	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.2	1.4	2.1	0.7	1.4	1.8	0.8	0.7	0.8	0.6	0.6	0.9	1.6	13.6	0.0	2.6	0.3	1.0	0.4	3.7	2.8	1.2	0.0	1.4	1.8	0.9	0.0	6.6	7.3	0.0	147.2	0.8	0.3	45.0	0.1	0.7	31.3	13.4	1.4	41.5	0.0	2.4	0.2	33.0	2.7	1.1	73.4	2.5	0.3	0.0	0.2	13.8	0.0	1.2	0.2	93.6	0.8	0.8	0.4	0.6	0.9	0.0	2.8	0.0	0.0	0.0	0.5	1.3	0.2	0.1	0.0	4.0	1.1	0.0	1.1	4.4	0.0	0.0	0.7	1.2	0.2	1.2	0.6	2.4	169.1	1.0	0.3	0.8	0.4
ATP6V1E1	"ATP6E, ATP6E2, ATP6V1E, P31, Vma4"	ENSG00000131100	"ATPase H+ transporting V1 subunit E1"	P36543	22	17592136-17628749	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 461.8;Proximal tubular cells: 411.3;Syncytiotrophoblasts: 479.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009528, CAB018699, HPA029196"	Enhanced		Approved	Nucleoplasm		NA	NA		34000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB009528: AB_2062678, CAB018699: AB_781534, HPA029196: AB_2672944"	"unprognostic (1.53e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.24e-3)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.72e-3)"	"prognostic favorable (4.18e-4)"	"prognostic favorable (7.66e-8)"	"unprognostic (3.81e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.58e-2)"	"unprognostic (2.75e-1)"	119.5	165.0	209.8	68.3	220.9	90.4	109.5	214.3	287.3	101.7	200.4	128.9	56.6	112.2	135.8	117.2	96.0	84.7	224.9	231.8	226.9	230.5	85.6	110.3	88.6	220.3	202.3	81.9	59.5	239.9	117.1	113.8	230.8	95.0	99.7	128.4	83.7	126.4	232.8	120.3	83.1	121.0	215.9	99.0	101.8	67.3	218.1	108.2	100.8	178.6	109.5	114.5	97.6	245.6	121.8	108.6	96.4	94.3	314.4	169.6	106.0	159.3	212.0	198.7	228.0	137.3	97.5	76.1	132.8	215.0	251.8	187.9	152.8	140.2	174.9	145.9	173.3	137.1	97.5	182.7	459.9	159.8	226.5	212.9	267.7	192.4	138.7	220.9	170.2	95.0	174.8	150.3	341.9	127.4	136.5	114.5	71.0	269.6	152.6	80.3	140.7	45.7	331.6	189.0	70.3	122.7	146.0	101.0	358.9	187.0	98.6	180.4	146.3	137.5	72.6	174.0	119.2	145.7	275.5	96.3	221.2	76.7	189.3	178.1	106.3	184.7	64.0	100.9	63.0	78.7	64.7	61.5	83.6	59.8	60.8	63.7	137.6	76.0	120.5	81.2	97.7	112.8	209.8	220.9	214.3	287.3	231.8	226.9	220.3	202.3	230.8	215.9	218.1	245.6	66.5	76.9	83.4	13.4	47.1	41.9	77.6	121.8	19.9	54.6	33.9	34.8	126.8	74.4	83.9	138.0	27.1	235.1	63.8	105.2	461.8	143.8	7.6	74.3	56.9	69.3	41.9	49.4	24.9	119.7	143.9	60.8	40.8	79.2	90.5	41.6	72.5	46.8	186.8	53.8	24.4	54.0	116.0	75.1	52.1	17.9	94.1	91.9	80.0	15.0	144.1	94.1	85.5	13.0	31.9	154.7	104.7	97.8	38.3	60.1	65.4	411.3	78.8	50.4	59.2	39.0	74.5	71.7	74.7	34.3	51.6	479.1	54.6	57.6	40.1	93.1
ATP6V1F	"ATP6S14, VATF, Vma7"	ENSG00000128524	"ATPase H+ transporting V1 subunit F"	Q16864	7	128862856-128865847	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 1054.6;Hofbauer cells: 1132.8;Proximal tubular cells: 1076.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009529, HPA048700, HPA062011"	Supported					NA	NA		26000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 4: Macrophages - Innate immune response"			"CAB009529: AB_2290237, HPA048700: AB_2680498, HPA062011: AB_2684656"	"unprognostic (1.70e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.14e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.99e-2)"	"unprognostic (8.46e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.28e-3)"	"unprognostic (2.70e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.06e-1)"	"prognostic favorable (2.49e-5)"	"unprognostic (2.20e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.36e-2)"	"unprognostic (7.33e-2)"	133.3	160.7	275.6	106.2	290.1	210.4	122.3	272.7	368.6	126.5	250.2	104.6	74.7	95.3	61.7	223.0	98.3	104.2	183.3	294.8	300.1	307.0	84.2	140.0	139.9	280.1	275.3	89.0	106.8	163.5	141.0	104.6	286.0	103.0	56.6	110.6	129.3	81.6	169.3	170.1	97.0	71.2	269.5	119.6	114.4	212.2	284.3	119.6	84.6	154.7	103.7	123.1	146.6	277.4	305.6	345.1	151.2	323.2	297.6	236.8	86.9	151.2	201.3	246.8	267.2	257.0	179.8	287.6	156.5	175.7	367.7	163.9	224.5	250.1	91.9	312.6	364.2	220.1	211.4	256.4	344.1	227.1	400.8	278.2	340.0	284.7	163.4	188.9	238.1	257.9	534.3	297.3	276.3	403.1	381.0	494.3	201.9	190.6	281.4	168.7	110.1	467.5	315.5	240.3	286.6	197.3	214.1	796.5	363.7	156.6	184.4	284.9	253.0	303.5	65.3	409.5	236.2	333.5	326.9	372.0	600.4	315.5	263.6	370.2	697.1	489.2	244.6	475.1	238.0	343.7	247.6	239.7	508.9	348.5	235.8	238.6	203.1	243.6	324.7	288.3	317.3	886.1	275.6	290.1	272.7	368.6	294.8	300.1	280.1	275.3	286.0	269.5	284.3	277.4	129.3	28.9	62.8	17.3	140.1	237.6	202.5	378.9	136.6	111.4	162.0	190.1	157.6	127.2	230.7	331.1	37.5	171.8	119.8	97.3	1054.6	241.0	574.0	128.6	96.3	163.1	113.2	63.1	27.0	222.2	289.0	155.1	78.5	131.0	275.1	114.0	124.6	112.0	1132.8	545.1	34.6	108.7	585.9	320.6	378.7	898.9	164.4	456.1	254.3	16.9	285.8	230.4	190.5	11.6	26.2	253.9	93.0	127.9	136.8	224.7	212.0	1076.3	200.2	96.4	85.5	69.7	168.9	399.6	102.0	328.4	326.6	401.4	136.3	184.5	98.9	362.7
ATP6V1G1	"ATP6G, ATP6G1, ATP6GL, ATP6J, DKFZp547P234, Vma10"	ENSG00000136888	"ATPase H+ transporting V1 subunit G1"	O75348	9	114587706-114598915	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004615, HPA042898"	Supported		Approved	Nucleoplasm,Nucleoli		NA	NA		96000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoli	Nucleoplasm	"CAB004615: AB_2258908, HPA042898: AB_2678217"	"unprognostic (3.85e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.84e-3)"	"unprognostic (2.49e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.28e-1)"	"unprognostic (3.47e-3)"	"unprognostic (9.40e-3)"	"unprognostic (4.13e-2)"	"prognostic favorable (1.73e-7)"	"unprognostic (2.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.11e-2)"	"unprognostic (3.92e-2)"	79.5	140.2	70.5	80.5	71.1	131.4	108.4	74.0	101.1	85.0	85.0	70.5	59.4	92.4	177.3	132.5	71.3	64.6	93.0	72.1	79.4	138.1	125.9	84.9	115.4	75.4	79.1	106.2	72.5	172.9	135.1	91.2	80.2	132.7	65.5	91.2	111.9	55.1	124.0	98.1	69.2	60.6	71.5	93.9	121.1	75.4	75.6	104.2	99.2	113.0	100.8	106.8	94.0	75.4	83.6	71.0	153.2	38.8	111.0	84.5	148.3	125.2	86.6	88.5	63.4	92.3	94.8	74.2	106.8	80.0	183.2	179.0	105.6	84.6	79.3	63.2	73.8	72.3	84.4	143.4	156.8	173.1	135.1	105.2	227.9	72.7	87.3	104.1	91.0	123.1	136.0	164.4	131.6	159.0	164.6	113.6	187.0	222.2	126.8	159.0	95.0	126.7	195.2	128.4	113.8	156.3	159.7	284.0	487.6	143.9	235.0	202.5	118.9	80.1	68.9	132.3	142.0	213.6	474.5	139.6	106.8	97.2	112.0	490.1	327.8	495.0	212.6	331.2	264.9	549.6	288.8	255.8	255.0	501.7	374.7	305.5	405.4	255.4	348.4	401.5	398.9	756.7	70.5	71.1	74.0	101.1	72.1	79.4	75.4	79.1	80.2	71.5	75.6	75.4	230.6	160.3	176.6	19.6	353.9	519.0	492.9	1068.9	277.7	170.5	470.4	494.1	151.6	163.0	629.7	331.1	41.7	346.1	268.2	198.5	970.5	374.1	85.7	381.6	223.8	227.7	360.7	157.6	35.0	263.6	336.5	247.0	231.4	594.9	267.4	156.8	219.2	337.1	548.1	164.9	37.4	346.8	1133.2	350.1	517.8	60.3	306.0	382.4	494.5	20.6	699.7	360.9	261.6	20.1	22.9	430.5	218.1	250.9	255.0	686.5	176.7	1021.5	426.3	158.6	236.7	155.6	393.0	400.6	326.7	361.4	576.7	757.4	304.0	280.3	201.6	852.2
ATP6V1G3	"ATP6G3, Vma10"	ENSG00000151418	"ATPase H+ transporting V1 subunit G3"	Q96LB4	1	198523222-198540945	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"kidney: 59.3"	"Cell type enriched"	"Detected in some"	48	"Distal tubular cells: 444.1"	"Cancer enriched"	"Detected in single"	140	"renal cancer: 11.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;BJ hTERT+: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.8;U-2197: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028701	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA028701: AB_10611681"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	59.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.8	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	1.1	0.8	0.3	0.0	0.0	0.0	0.2	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.5	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.2	0.0	0.0	0.0	0.0	444.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2
ATP6V1H	"CGI-11, SFD, SFDalpha, SFDbeta, VMA13"	ENSG00000047249	"ATPase H+ transporting V1 subunit H"	Q9UI12	8	53715543-53843558	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Hydrogen ion transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009532, HPA023421"	Approved		Supported	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		8300	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	"Actin filaments, Cytosol"	"Plasma membrane"	"CAB009532: AB_667834, HPA023421: AB_1845202"	"unprognostic (1.67e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.41e-2)"	"unprognostic (2.16e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.25e-2)"	"prognostic unfavorable (7.81e-4)"	"unprognostic (2.01e-1)"	"unprognostic (1.95e-1)"	"unprognostic (6.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (5.30e-2)"	"prognostic favorable (1.46e-7)"	"unprognostic (1.06e-1)"	"unprognostic (3.37e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.64e-1)"	24.1	44.6	42.5	15.9	46.7	25.6	26.0	27.5	58.8	23.9	30.2	31.6	12.9	25.4	32.9	34.1	22.6	20.7	31.2	57.4	38.0	60.5	19.1	24.2	21.4	30.5	30.2	24.1	17.4	47.7	42.4	23.9	32.7	30.2	20.4	37.4	28.7	27.4	37.8	35.2	19.1	24.1	29.4	20.3	31.8	18.5	31.0	26.6	52.4	27.3	22.0	28.5	26.4	37.9	42.8	35.6	29.8	31.8	50.9	32.9	23.4	40.5	44.5	54.8	56.7	33.5	54.1	27.2	38.7	40.9	69.7	67.8	52.6	58.9	56.1	39.9	35.8	28.8	34.3	40.9	69.1	19.6	31.8	46.5	82.3	37.2	66.4	52.5	37.8	28.9	39.4	14.0	81.6	36.0	30.6	32.5	27.4	37.0	17.4	28.2	10.6	18.6	88.4	67.4	23.5	34.9	28.7	54.6	79.5	34.4	64.0	16.3	43.2	24.4	19.7	54.6	25.5	25.9	30.4	32.3	57.8	27.4	27.5	25.7	14.8	36.2	13.2	16.6	14.9	13.6	14.3	15.4	20.2	12.0	14.4	16.0	14.5	22.6	23.4	15.9	20.7	11.8	42.5	46.7	27.5	58.8	57.4	38.0	30.5	30.2	32.7	29.4	31.0	37.9	18.2	38.5	27.4	84.2	39.0	29.6	40.1	55.5	42.1	72.8	27.8	21.0	28.9	38.6	50.3	58.8	112.6	76.0	35.9	39.0	105.7	49.1	8.3	94.1	27.7	25.4	35.3	27.0	154.7	31.1	43.6	23.6	26.0	145.7	15.8	22.0	28.9	21.9	64.7	62.2	105.8	17.4	75.3	43.0	103.6	8.5	43.2	52.9	30.2	42.2	35.1	48.4	37.0	58.3	57.7	44.1	30.1	48.2	20.9	32.5	31.4	64.9	39.6	76.4	19.7	16.8	24.6	28.5	52.9	37.6	31.4	100.0	38.1	36.4	21.8	41.4
ATP7A	MNK	ENSG00000165240	"ATPase copper transporting alpha"	Q04656	X	77910656-78050395	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ionocytes: 61.1;Microglial cells: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012887, HPA048107"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA012887: AB_1845205, HPA048107: AB_2680266"	"unprognostic (3.14e-2)"	"unprognostic (3.48e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.59e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (8.38e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.69e-1)"	"unprognostic (2.52e-1)"	3.0	4.3	1.2	3.6	1.7	5.9	6.3	2.3	2.1	3.9	1.6	3.4	3.9	3.6	5.0	4.9	3.5	3.6	2.5	1.3	2.1	4.4	2.3	4.5	4.1	2.1	2.1	3.6	2.4	7.3	2.5	4.0	3.8	5.3	3.4	3.0	5.1	3.4	1.8	11.1	3.4	3.2	1.1	4.7	5.5	1.6	1.6	4.7	4.6	2.9	4.6	3.9	2.8	2.9	3.2	8.3	5.4	5.5	5.0	5.3	0.9	4.8	6.6	2.8	5.7	1.0	3.6	4.7	6.9	4.8	3.3	3.8	7.1	3.9	5.2	7.0	4.8	2.4	7.8	0.8	6.3	4.1	4.1	5.6	1.6	5.9	1.8	6.5	7.3	4.7	19.6	17.4	5.2	2.8	4.6	1.4	1.5	11.2	1.7	3.7	9.0	15.8	4.6	8.8	1.6	20.4	11.9	2.8	6.0	3.3	2.2	1.3	9.4	3.7	3.6	5.2	1.9	5.6	10.7	5.2	6.0	2.5	5.7	7.1	1.5	4.5	1.8	1.5	0.9	1.8	1.2	1.2	1.0	1.4	1.4	2.1	8.1	1.2	1.9	1.0	0.4	1.0	1.2	1.7	2.3	2.1	1.3	2.1	2.1	2.1	3.8	1.1	1.6	2.9	14.3	0.0	8.4	15.7	12.6	7.4	5.1	5.8	13.1	6.4	17.3	10.0	5.1	1.5	8.2	9.2	4.2	2.0	15.0	4.5	1.9	5.6	0.5	5.3	9.2	9.7	4.8	22.5	11.1	13.6	2.2	9.4	20.4	8.8	9.5	6.4	14.6	3.6	14.3	1.7	12.5	4.8	61.1	11.7	6.7	1.1	7.2	12.6	19.6	44.0	5.5	4.4	11.3	37.7	35.0	6.2	4.1	9.8	10.5	4.8	4.1	5.5	10.2	4.1	32.9	10.3	8.7	1.8	5.4	20.5	16.6	2.2	13.8	6.7	5.2	6.6
ATP7B	WND	ENSG00000123191	"ATPase copper transporting beta"	P35670	13	51930436-52012125	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Translocase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Early spermatids: 30.2;Excitatory neurons: 24.5;Hepatocytes: 23.6;Inhibitory neurons: 25.4;Late spermatids: 74.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 32.8;CACO-2: 21.1;HEL: 53.0;RPTEC TERT1: 22.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA009137, HPA013187"	Supported		Supported	"Golgi apparatus"		NA	NA				"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 36: HEL - Hemostasis"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"HPA009137: AB_2668214, HPA013187: AB_1845206"	"unprognostic (1.13e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (3.49e-1)"	"unprognostic (5.51e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.77e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.26e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.54e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.40e-1)"	3.6	0.9	1.3	0.6	1.2	2.2	1.7	2.0	2.1	1.8	0.8	2.9	10.6	1.5	0.1	0.7	2.0	7.0	2.1	2.5	1.4	2.2	8.6	1.4	0.3	0.8	1.2	1.9	2.0	6.4	1.2	7.1	1.1	2.0	2.7	3.7	3.0	0.9	1.1	1.0	6.0	1.7	0.5	0.4	4.4	8.4	1.7	0.7	1.2	1.8	0.2	1.6	1.2	0.7	0.8	2.8	5.2	4.5	1.0	0.8	32.8	1.5	0.5	1.6	1.2	21.1	0.1	0.1	0.6	2.7	3.6	0.3	4.0	4.4	1.0	0.4	7.5	53.0	0.5	14.7	1.4	0.6	11.8	1.9	4.7	0.2	2.0	2.1	3.7	3.7	14.4	0.2	1.5	1.0	0.2	0.9	1.7	6.6	1.8	2.0	1.4	0.0	22.5	3.4	3.3	2.2	1.9	2.8	1.8	5.5	8.0	0.5	2.0	0.3	1.7	2.8	0.6	0.6	0.7	0.2	0.1	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.0	2.1	2.5	1.4	0.8	1.2	1.1	0.5	1.7	0.7	5.4	6.4	0.0	10.7	0.9	0.4	0.7	1.7	0.0	3.1	2.3	1.8	2.1	4.3	5.2	1.8	22.9	14.3	1.8	6.6	0.0	1.6	30.2	2.4	1.3	2.7	2.4	4.2	24.5	1.0	5.5	2.1	9.2	4.2	0.0	13.3	3.9	23.6	2.3	0.0	25.4	3.4	4.1	0.8	0.3	74.2	2.1	0.2	1.8	15.0	0.2	0.2	0.0	12.1	4.3	2.0	3.0	0.7	0.2	1.3	11.4	2.2	4.3	6.1	6.6	1.0	1.4	2.2	1.7	0.7	0.4	4.5	0.2	0.4	5.0	1.2
ATP8A1	ATPIA	ENSG00000124406	"ATPase phospholipid transporting 8A1"	Q9Y2Q0	4	42408373-42657105	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.5"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 1218.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 13.5"	"Region enhanced"	"Detected in all"		"white matter: 84.5"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 27.5;Daudi: 46.3;HEL: 16.4;REH: 16.1;SH-SY5Y: 14.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052935	Enhanced		Supported	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA052935: AB_2681992"	"unprognostic (8.63e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.61e-2)"	"unprognostic (6.59e-2)"	"unprognostic (6.82e-3)"	"unprognostic (7.69e-2)"	"unprognostic (2.02e-3)"	"unprognostic (3.99e-1)"	"unprognostic (2.99e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.71e-2)"	"prognostic favorable (5.54e-10)"	"unprognostic (2.43e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.21e-2)"	"unprognostic (2.25e-1)"	2.8	8.9	5.8	9.5	26.7	23.4	3.7	3.6	18.3	2.1	0.0	12.8	4.2	2.4	12.2	2.2	2.4	2.5	8.4	14.5	11.7	3.8	1.7	11.8	15.0	9.5	4.4	16.2	7.0	36.0	2.2	2.4	9.5	8.3	11.7	19.4	4.4	5.3	10.0	1.7	8.9	2.8	18.1	9.0	12.5	2.1	9.5	9.9	39.7	15.6	11.8	2.5	1.5	84.5	0.0	0.1	0.4	27.5	0.1	0.1	0.1	0.1	0.0	0.0	0.0	3.0	0.4	46.3	12.6	0.2	0.0	2.4	6.5	0.1	0.0	7.4	4.5	16.4	1.6	0.7	0.1	4.0	0.3	0.4	0.0	0.0	0.0	0.6	0.2	10.3	0.0	5.1	0.0	2.0	6.0	1.4	2.0	1.9	0.6	16.1	0.0	5.3	9.5	0.6	4.9	14.8	0.3	9.4	0.0	1.1	3.1	0.0	0.4	0.0	2.0	0.5	0.0	1.7	0.0	9.4	0.7	5.6	0.2	0.0	0.6	0.6	3.7	0.2	1.9	1.5	1.1	4.1	0.6	2.5	1.7	4.4	0.5	2.2	2.5	2.4	1.0	0.6	5.8	26.7	3.6	18.3	14.5	11.7	9.5	4.4	9.5	18.1	9.5	84.5	26.1	28.9	80.1	136.1	23.3	1.5	1.8	0.6	2.2	19.7	4.0	1.5	14.4	0.0	5.3	5.5	81.3	0.0	52.9	48.4	3.9	0.2	4.6	1.3	1.3	13.6	84.6	13.9	295.9	2.5	0.1	4.8	19.9	4.2	8.2	26.5	16.8	1.1	1.6	62.2	255.9	28.6	0.0	8.8	4.6	2.9	3.4	8.9	3.6	31.9	5.1	2.2	33.0	144.8	1218.1	0.6	10.2	1.9	37.6	9.6	45.6	2.0	0.3	38.1	0.0	6.3	2.7	1.5	3.6	5.0	1.4	0.0	51.6	8.6	25.0	3.0
ATP8B1	"ATPIC, BRIC, FIC1, PFIC, PFIC1"	ENSG00000081923	"ATPase phospholipid transporting 8B1"	O43520	18	57646426-57803315	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Lipid transport, Transport"	Translocase	"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 279.7;Intestinal goblet cells: 180.5;Paneth cells: 116.7;Undifferentiated cells: 185.7;Urothelial cells: 119.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 90.2;RT4: 168.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018673, HPA018674"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA018673: AB_1845207, HPA018674: AB_1845208"	"unprognostic (1.83e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (2.60e-4)"	"unprognostic (8.81e-2)"	"unprognostic (1.32e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.02e-1)"	"unprognostic (9.62e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.30e-3)"	"unprognostic (4.55e-3)"	"prognostic favorable (6.35e-4)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.25e-1)"	"unprognostic (8.60e-3)"	9.1	5.4	1.3	8.5	2.0	1.2	9.5	3.6	3.9	16.3	3.0	76.2	30.3	5.9	3.5	14.8	10.6	18.0	4.4	1.7	1.1	6.6	7.7	8.3	2.2	2.1	1.1	2.1	23.3	9.7	2.7	6.9	2.0	17.6	61.7	0.6	20.6	11.5	1.9	8.4	38.2	8.3	1.0	4.6	46.1	0.6	1.9	1.5	22.0	1.8	3.6	30.0	13.0	3.0	32.0	10.7	0.1	0.6	10.5	19.2	11.9	62.6	63.6	67.4	40.4	8.0	24.3	1.5	19.3	90.2	22.3	44.9	0.2	13.9	64.3	0.2	1.1	0.2	2.6	2.5	2.2	0.4	0.6	2.9	12.6	20.8	34.0	39.5	33.0	0.3	0.3	0.7	34.1	15.6	0.1	0.3	0.3	35.5	3.3	0.3	0.2	0.0	7.9	168.1	0.8	0.7	1.3	32.5	0.1	0.5	10.3	0.6	35.3	48.3	2.0	7.7	14.2	0.4	0.4	0.5	1.1	0.4	2.8	0.2	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.1	0.2	0.6	0.0	0.2	0.1	0.0	0.0	1.3	2.0	3.6	3.9	1.7	1.1	2.1	1.1	2.0	1.0	1.9	3.0	25.9	19.2	27.0	11.1	4.1	7.8	66.7	20.6	10.2	0.7	28.4	10.4	5.4	27.1	48.9	40.5	0.0	25.6	0.6	279.7	0.0	27.0	2.8	26.3	4.0	30.8	68.4	0.4	61.2	53.1	2.7	7.1	98.4	40.1	4.5	0.9	33.2	19.1	2.4	6.7	11.7	180.5	22.4	2.8	4.0	0.4	0.3	1.0	7.2	37.5	0.9	0.1	0.0	20.6	10.7	38.5	116.7	0.0	0.9	70.8	58.2	0.2	44.7	1.2	13.1	2.8	20.7	0.3	1.5	28.0	16.3	10.9	1.7	2.3	185.7	119.2
ATP9A	"ATPIIA, KIAA0611"	ENSG00000054793	"ATPase phospholipid transporting 9A (putative)"	O75110	20	51596514-51768390	"Enzymes, Predicted membrane proteins, Transporters"		Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 67.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 112.2;Inhibitory neurons: 87.1;Oligodendrocytes: 90.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 4.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 4.4"	"Cell line enhanced"	"Detected in many"		"EFO-21: 74.0;SK-BR-3: 69.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020699, HPA035630"	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 51: Myeloid cells - Hemostasis"			"CAB020699: , HPA035630: AB_10669526"	"unprognostic (5.19e-2)"	"unprognostic (5.28e-2)"	"unprognostic (3.46e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (5.67e-5)"	"unprognostic (5.82e-2)"	"unprognostic (5.81e-1)"	"unprognostic (8.74e-2)"	"unprognostic (2.82e-1)"	30.6	11.5	55.9	5.8	63.2	2.7	14.1	26.0	63.7	8.5	0.0	18.5	13.6	12.4	18.5	12.9	24.8	12.0	11.6	67.1	52.2	9.2	7.5	9.7	3.7	41.8	50.0	18.8	15.1	29.5	16.2	4.9	46.8	20.5	16.4	20.5	25.7	15.5	16.3	6.8	17.8	12.7	33.2	2.9	20.4	18.8	53.4	7.4	28.1	17.6	3.1	11.9	9.8	48.7	25.8	21.7	17.2	38.8	49.0	36.8	0.4	9.1	17.1	5.8	1.7	50.4	51.9	0.0	74.0	37.2	29.1	20.1	22.9	12.9	5.7	20.2	7.1	0.0	23.2	19.8	6.7	0.0	0.1	12.1	25.6	1.3	3.5	13.3	31.4	4.7	0.1	0.2	6.6	35.9	2.0	0.2	3.1	25.4	27.0	4.1	0.0	0.1	11.6	35.7	32.7	23.2	36.3	69.9	13.2	6.0	13.5	0.6	20.7	48.1	12.7	19.1	3.9	0.0	0.3	0.8	12.7	0.1	4.4	4.4	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.7	55.9	63.2	26.0	63.7	67.1	52.2	41.8	50.0	46.8	33.2	53.4	48.7	4.8	16.0	13.6	43.4	0.5	2.9	14.6	13.8	4.0	35.9	16.0	11.3	12.7	31.5	19.1	18.4	4.2	0.4	2.5	64.3	1.9	21.4	0.8	20.4	4.7	9.8	55.2	0.8	112.2	17.2	0.5	9.9	26.5	28.8	1.3	14.3	11.0	12.8	5.4	43.7	87.1	34.9	18.3	2.2	2.1	3.4	13.4	12.1	3.6	40.3	0.2	5.0	2.1	60.8	90.3	24.6	28.8	23.3	2.1	33.7	36.3	1.4	34.9	7.4	6.6	10.1	8.0	1.2	8.2	9.9	4.1	0.3	2.3	0.7	24.8	27.3
AVPR1B	AVPR3	ENSG00000198049	"Arginine vasopressin receptor 1B"	P47901	1	206106936-206117699	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	18	"pituitary gland: 6.8"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"renal cancer: 1.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA075404	Enhanced					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 44: Endometrium - Transcription"			"HPA075404: AB_2732291"		"unprognostic (4.87e-2)"		"unprognostic (1.44e-1)"	"unprognostic (4.82e-1)"			"unprognostic (2.82e-1)"		"unprognostic (2.87e-1)"	"unprognostic (1.08e-2)"	"unprognostic (3.33e-1)"	"unprognostic (2.96e-2)"	"unprognostic (6.23e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.86e-1)"	"unprognostic (6.66e-3)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.3	0.0	6.8	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
AVPR2	"DIR, DIR3, V2R"	ENSG00000126895	"Arginine vasopressin receptor 2"	P30518	X	153902531-153907166	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes insipidus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 8.1"	"Group enriched"	"Detected in some"	4	"Adipocytes: 48.0;Collecting duct cells: 49.7;Endothelial cells: 17.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	7	"cerebellum: 3.9"	"Group enriched"	"Detected in some"	28	"intermediate monocyte: 3.6;non-classical monocyte: 3.2"	"Lineage enriched"	"Detected in single"	29	"monocytes: 3.6"	"Cell line enhanced"	"Detected in some"		"EFO-21: 3.2;SCLC-21H: 3.7;U-266/84: 3.7;U-698: 3.6"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	22	"cerebellum: 6.8"							NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (3.05e-2)"	"unprognostic (5.62e-2)"	"unprognostic (1.99e-4)"	"unprognostic (2.50e-4)"	"unprognostic (2.76e-1)"	"unprognostic (7.10e-6)"	"unprognostic (3.80e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.56e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.38e-1)"	"unprognostic (9.83e-2)"	5.2	0.2	0.1	0.2	0.0	0.8	3.1	3.9	0.1	1.0	0.5	0.8	0.6	0.9	0.1	0.6	1.6	1.0	5.1	0.1	0.0	8.1	0.0	1.3	1.0	0.3	0.5	0.2	0.6	0.7	0.1	0.2	0.4	0.7	0.2	0.0	0.7	0.6	3.1	1.5	0.8	0.8	0.1	0.3	0.7	0.2	0.1	0.4	0.9	4.0	0.3	0.8	1.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.6	3.2	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.1	1.2	0.6	0.0	0.0	1.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.8	1.0	0.1	0.0	0.0	1.4	0.6	1.4	0.0	0.0	3.7	0.7	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.6	3.7	3.6	0.0	0.9	0.0	0.0	0.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.1	0.0	3.9	0.1	0.1	0.0	0.3	0.5	0.4	0.1	0.1	0.2	48.0	3.2	1.3	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.5	0.4	1.5	0.0	0.0	49.7	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.1	0.0	17.4	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	1.3	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	8.6	0.8	0.0	0.0	0.1	1.3	0.0	0.1	0.5	0.0	0.1
B2M		ENSG00000166710	Beta-2-microglobulin	P61769	15	44711487-44718851	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	Immunity		"Amyloidosis, Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 31919.3;NK-cells: 24726.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002572, HPA006361"	Enhanced		Enhanced	"Golgi apparatus,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA	1790000000	2100000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Golgi apparatus, Plasma membrane"	Cytosol	"CAB002572: AB_563434, HPA006361: AB_1078278"	"unprognostic (9.45e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.02e-1)"	"unprognostic (8.14e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.39e-1)"	"unprognostic (5.25e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.17e-2)"	3160.2	3214.7	697.6	5686.5	705.1	7839.2	2606.9	711.8	1145.0	2539.9	789.6	5139.0	5180.7	2192.2	1735.6	2283.9	1648.3	4948.8	2327.2	651.0	769.9	2462.6	6206.2	6159.2	9311.8	889.5	763.2	1945.7	1310.9	1940.5	318.4	3502.0	815.3	2345.0	5593.5	139.3	5657.1	1784.5	931.7	3015.6	5693.3	2545.3	838.3	7896.1	4878.2	615.6	771.9	4217.4	2340.8	2026.5	5333.4	5753.1	549.4	909.5	1735.4	378.9	226.0	633.6	4348.7	4719.4	1662.5	2045.5	4961.9	3609.7	6561.4	425.3	5417.9	554.8	2567.9	1948.8	2410.2	2537.0	497.2	878.7	1226.2	4762.2	435.9	2956.9	2263.6	600.3	3609.3	2074.5	3328.6	2735.9	609.8	1075.7	1044.4	2442.6	1884.1	965.4	611.9	3649.1	2195.5	476.9	1518.4	3213.8	206.5	629.8	1014.3	2240.2	1926.6	4789.2	2425.5	3486.4	254.1	179.1	1288.4	1571.2	1338.5	394.3	655.3	6180.6	2548.7	4531.4	676.5	5389.2	2193.3	4771.7	7118.6	1683.1	5384.6	3783.6	2567.3	48105.4	18117.1	33178.9	20639.1	17775.0	20836.8	15768.0	23783.0	22245.1	9978.8	11988.4	17122.9	22791.8	50453.6	18779.6	19034.9	12052.6	29659.1	56957.2	697.6	705.1	711.8	1145.0	651.0	769.9	889.5	763.2	815.3	838.3	771.9	909.5	12048.3	3387.8	3505.1	28.7	8472.8	7843.7	3197.1	8420.8	1628.8	33.3	2399.5	2015.2	1068.8	3593.1	5347.4	2100.3	27.1	1354.6	14028.8	8753.6	1038.9	13898.6	43.1	2073.7	2414.0	8385.6	2266.0	2087.2	7.3	9034.5	4397.5	3691.1	1981.7	2282.2	3029.5	1270.6	6835.7	3832.6	11985.7	5.0	22.0	5982.6	8701.4	12536.8	14507.0	158.8	3018.0	10687.9	6744.8	368.2	31919.3	322.0	24726.3	95.0	129.2	10115.7	7085.6	1688.8	11026.6	5300.4	18327.7	3122.5	8367.9	52.5	4016.7	2055.2	4107.1	64.2	72.1	1541.4	8619.8	804.8	14266.2	3229.8	3063.4	8248.6
BACE1	BACE	ENSG00000186318	"Beta-secretase 1"	P56817	11	117285207-117316259	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 119.1;pancreas: 271.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 118.9;Early spermatids: 99.9;Late spermatids: 343.0;Oligodendrocytes: 99.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 88.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016358	Approved		Supported	"Plasma membrane"		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	"Plasma membrane"		"CAB016358: AB_626716"	"unprognostic (7.96e-3)"	"unprognostic (8.05e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.94e-2)"	"unprognostic (3.39e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (4.54e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (6.76e-4)"	15.4	16.0	34.3	8.0	68.5	3.3	11.7	68.7	44.0	18.3	11.9	13.7	6.1	19.7	8.8	13.5	15.9	19.1	11.4	34.3	44.5	14.8	25.6	14.4	5.1	89.7	67.0	20.5	271.5	18.5	10.7	13.8	76.6	13.4	7.6	44.7	11.0	18.3	12.5	11.4	7.7	21.3	61.6	12.4	9.8	11.2	59.9	3.8	12.2	9.1	5.0	12.4	14.3	119.1	11.5	10.7	22.9	37.3	80.9	82.3	1.0	62.9	44.4	24.4	19.0	4.5	16.4	1.4	14.6	88.3	18.4	17.9	24.3	12.1	20.5	3.1	12.1	6.0	17.3	5.1	36.5	2.5	1.7	68.1	20.2	29.7	31.8	68.0	21.4	3.8	2.7	1.1	46.5	33.4	2.5	2.1	15.5	10.6	25.9	6.4	11.6	1.6	12.2	5.9	31.7	36.7	22.5	2.6	5.9	23.5	26.2	7.6	31.4	45.2	5.0	48.2	19.4	0.7	1.0	1.1	23.8	2.0	34.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	34.3	68.5	68.7	44.0	34.3	44.5	89.7	67.0	76.6	61.6	59.9	119.1	12.1	19.2	10.1	16.3	0.3	4.7	4.1	3.4	9.1	53.7	8.7	9.0	8.7	18.6	13.3	5.5	118.9	1.0	0.1	2.0	5.9	7.4	99.9	5.1	32.1	8.3	21.7	1.7	24.9	20.0	1.3	19.5	3.1	8.9	2.5	15.8	6.8	38.6	9.4	57.2	32.0	5.1	2.0	17.2	7.7	343.0	19.3	7.9	3.6	14.0	4.0	17.9	0.0	22.1	99.8	4.3	6.3	22.2	0.1	2.4	1.7	6.3	3.4	55.2	6.6	18.1	14.2	3.4	1.7	10.6	3.4	0.8	1.2	68.0	4.5	3.4
BACE2	"AEPLC, ALP56, CEAP1, DRAP"	ENSG00000182240	"Beta-secretase 2"	Q9Y5Z0	21	41167801-41282530	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Aspartyl protease, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 26.8"	"Cell type enhanced"	"Detected in many"		"Prostatic glandular cells: 290.4;Syncytiotrophoblasts: 514.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 2.9;eosinophil: 5.2"	"Lineage enriched"	"Detected in single"	8	"granulocytes: 5.2"	"Cell line enhanced"	"Detected in many"		"OE19: 73.8;SK-BR-3: 53.3;SK-MEL-30: 52.6;WM-115: 46.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035416	Approved				"Intracellular and membrane"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA035416: AB_2732467"	"unprognostic (1.71e-2)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (5.23e-2)"	"unprognostic (8.12e-3)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (1.52e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.64e-3)"	"unprognostic (7.24e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (8.50e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.04e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.76e-2)"	"unprognostic (5.83e-2)"	10.0	1.6	2.1	4.3	3.1	0.6	7.7	4.4	2.6	6.1	9.4	7.3	3.5	8.7	1.9	9.4	6.3	8.3	6.2	2.0	4.1	9.8	1.7	4.3	3.1	6.7	3.8	2.7	13.1	2.3	1.5	2.9	5.1	8.3	4.5	0.3	26.8	2.6	2.2	5.0	4.5	4.7	5.5	4.7	22.9	1.0	4.1	1.1	4.6	2.2	3.6	6.7	5.6	8.7	27.4	2.1	12.6	0.0	2.5	2.1	0.1	6.3	0.0	3.9	3.8	0.0	9.6	0.1	12.2	7.1	7.2	8.1	0.0	13.6	1.4	0.0	12.6	6.2	3.3	0.0	1.0	0.0	14.4	5.5	2.8	0.5	2.7	20.9	12.1	6.4	0.0	0.1	6.0	6.1	3.4	0.0	8.5	73.8	12.1	1.0	0.0	9.8	11.5	2.5	0.4	0.1	0.5	53.3	52.6	1.0	12.0	0.1	15.8	7.3	5.3	6.5	10.9	0.1	0.1	0.0	17.8	0.0	46.2	2.9	0.0	5.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	3.1	4.4	2.6	2.0	4.1	6.7	3.8	5.1	5.5	4.1	8.7	55.0	12.8	15.9	11.8	28.6	18.5	91.6	25.6	42.7	0.8	40.3	33.8	9.7	123.0	72.5	20.2	2.1	127.6	0.5	40.5	93.9	146.3	24.3	65.4	19.8	90.2	18.5	22.1	11.7	105.2	64.2	34.0	186.6	115.8	90.7	6.7	35.3	1.0	28.0	0.0	7.5	86.2	44.7	17.0	8.2	16.0	14.3	3.6	179.7	20.6	2.9	3.1	0.0	9.5	46.0	86.6	23.9	18.8	3.2	290.4	7.3	1.4	76.5	0.8	0.0	15.9	23.6	0.6	1.4	43.5	11.8	514.7	6.2	8.7	56.6	134.2
BAK1	"BAK, BCL2L7, CDN1"	ENSG00000030110	"BCL2 antagonist/killer 1"	Q16611	6	33572547-33580293	"Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 75.4;Proximal enterocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005029	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB005029: AB_562051"	"unprognostic (3.52e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (5.67e-2)"	"unprognostic (6.58e-3)"	"prognostic unfavorable (4.52e-4)"	"prognostic unfavorable (5.64e-4)"	"unprognostic (2.36e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.80e-3)"	"unprognostic (2.09e-1)"	"prognostic unfavorable (1.64e-5)"	"unprognostic (6.07e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	9.4	29.6	10.4	20.7	10.6	27.7	7.5	10.5	13.0	10.4	12.2	32.4	47.0	10.1	9.1	34.0	7.9	10.6	23.2	10.3	9.8	23.9	11.5	13.7	22.0	11.8	10.9	7.2	12.8	13.5	12.0	11.1	11.2	11.2	24.9	3.7	11.9	9.1	18.8	18.7	37.1	13.5	11.0	30.5	21.9	7.8	11.7	19.2	7.7	18.1	23.4	21.8	12.0	10.4	37.6	20.4	21.3	32.2	14.3	14.0	27.1	19.1	15.3	53.7	41.8	42.2	28.7	32.5	32.6	28.1	24.8	38.3	41.0	77.7	23.6	37.7	43.6	20.6	18.8	34.4	36.6	44.5	32.3	23.0	60.7	45.1	52.6	15.7	29.4	28.7	18.9	28.6	20.1	55.0	38.8	29.7	23.7	26.4	50.0	37.0	20.5	59.9	45.6	30.6	26.3	19.6	24.4	77.3	37.1	26.6	25.4	74.5	28.2	28.3	30.0	18.5	24.9	75.4	100.4	27.5	9.6	52.6	31.7	63.5	45.2	85.1	34.7	64.8	39.5	25.3	32.1	34.7	42.8	18.4	17.6	23.2	30.6	22.4	57.3	15.0	56.1	53.2	10.4	10.6	10.5	13.0	10.3	9.8	11.8	10.9	11.2	11.0	11.7	10.4	8.6	3.2	3.4	3.9	24.6	27.1	11.6	15.5	14.2	6.6	10.7	8.3	6.4	11.5	8.0	3.7	8.4	16.3	22.1	75.4	13.7	20.5	4.7	7.2	8.9	10.1	22.1	6.1	4.5	18.7	41.8	7.5	17.9	10.0	11.4	11.1	10.0	6.3	30.2	5.0	3.6	32.5	14.2	21.9	30.2	1.7	7.8	16.9	21.4	2.8	25.8	4.7	12.3	1.0	2.7	27.7	47.9	11.7	54.5	10.4	79.6	9.6	5.6	6.9	13.1	5.6	11.8	0.3	1.0	19.1	21.6	9.9	24.6	25.2	40.6	20.1
BASP1	"CAP-23, CAP23, NAP-22, NAP22"	ENSG00000176788	"Brain abundant membrane attached signal protein 1"	P80723	5	17065598-17276843	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"brain: 486.3;epididymis: 303.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 345.6;Extravillous trophoblasts: 362.9;Langerhans cells: 489.4;Muller glia cells: 796.9;Syncytiotrophoblasts: 738.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 128.5"	"Lineage enriched"	"Detected in many"	16	"granulocytes: 128.5"	"Cell line enhanced"	"Detected in many"		"GAMG: 467.0;HeLa: 800.8;SiHa: 830.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045218, HPA050333"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		63000000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 68: Epididymis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA045218: AB_2679263, HPA050333: AB_2681090"	"unprognostic (3.35e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (5.63e-4)"	"unprognostic (2.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (5.25e-11)"	"unprognostic (1.95e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.70e-1)"	35.3	13.8	235.9	73.6	257.0	87.6	14.0	103.0	486.3	56.9	79.9	12.5	7.3	37.3	303.3	10.9	11.4	29.2	13.9	247.3	210.9	15.1	17.2	36.5	80.9	134.7	153.1	36.6	3.7	3.4	21.2	92.1	184.3	79.7	10.8	74.3	13.2	21.6	2.3	22.0	22.2	33.4	107.7	76.5	22.7	2.9	157.1	24.1	11.3	6.8	91.5	57.9	27.3	281.8	0.1	125.6	152.7	0.2	71.7	76.1	227.1	161.7	50.9	127.9	135.0	6.1	0.1	51.3	22.4	112.0	467.0	10.6	98.2	109.2	164.8	21.3	57.9	0.4	800.8	0.3	158.9	101.3	1.4	131.2	132.7	145.6	121.0	163.9	140.1	0.2	0.4	0.5	138.2	183.7	0.3	92.5	115.7	0.3	39.6	0.1	0.5	28.0	46.5	31.3	99.3	21.3	830.7	72.3	0.2	336.5	0.3	101.9	187.7	169.3	0.6	14.2	26.1	1.7	0.2	27.1	171.2	123.0	23.1	25.0	3.1	25.3	0.0	1.5	0.0	5.4	0.0	0.0	4.9	7.9	0.0	0.0	128.5	1.8	2.1	0.5	0.3	0.8	235.9	257.0	103.0	486.3	247.3	210.9	134.7	153.1	184.3	107.7	157.1	281.8	8.0	9.6	4.8	22.2	158.7	215.9	88.0	21.3	58.1	54.8	9.8	10.2	1.6	0.0	15.8	9.2	12.5	155.0	3.8	0.6	0.0	0.6	0.9	98.4	345.6	30.2	0.0	18.1	254.0	3.4	362.9	102.6	23.4	156.4	27.3	18.1	35.7	2.5	53.8	244.0	125.3	0.7	12.2	227.9	489.4	0.0	0.6	298.5	28.4	53.4	275.1	796.9	1.0	115.1	23.7	1.0	0.2	0.0	173.0	121.0	0.0	0.3	93.5	58.4	0.0	2.0	66.2	0.4	3.4	21.0	58.8	738.5	11.9	8.3	1.8	13.2
BAX	BCL2L4	ENSG00000087088	"BCL2 associated X, apoptosis regulator"	Q07812	19	48954815-48961798	"Cancer-related genes, Human disease related genes, Predicted intracellular proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB004206, HPA027878"	Approved					NA	NA		1100000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"CAB004206: AB_626729, HPA027878: AB_10601687"	"unprognostic (4.11e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (4.92e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.71e-2)"	"unprognostic (3.66e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.47e-3)"	"unprognostic (6.22e-2)"	30.2	30.4	24.4	59.2	26.8	65.7	27.2	25.5	29.3	27.6	23.9	78.1	68.2	29.9	23.2	35.8	33.2	37.6	22.6	24.5	25.5	31.0	33.4	46.0	59.5	27.1	25.4	19.6	32.7	26.1	15.9	43.3	27.0	25.7	58.8	7.2	26.5	27.0	18.1	29.8	64.6	36.3	26.1	60.0	43.8	12.4	26.3	83.2	23.4	11.8	44.7	46.7	26.1	27.1	177.4	286.0	170.1	150.4	165.4	161.7	280.2	117.8	233.4	151.7	210.6	76.4	168.6	214.6	53.9	181.2	141.3	93.8	78.0	229.0	125.7	166.6	181.0	91.9	56.6	288.0	265.7	96.3	280.9	222.3	161.7	126.1	75.5	183.3	354.6	83.4	91.4	86.0	264.8	123.1	157.6	150.3	132.8	171.3	82.5	109.2	113.1	82.4	161.0	168.4	97.4	114.7	99.2	69.8	57.4	240.6	56.2	171.2	210.2	194.0	212.1	120.1	165.1	97.9	136.6	145.0	118.1	129.2	275.1	5.2	12.1	13.4	6.5	18.4	4.6	7.3	3.7	7.1	12.2	5.9	2.4	6.0	13.1	12.2	20.9	12.5	7.5	8.4	24.4	26.8	25.5	29.3	24.5	25.5	27.1	25.4	27.0	26.1	26.3	27.1	83.2	3.2	4.8	8.1	164.6	54.8	63.8	160.8	101.3	19.3	64.1	67.4	8.4	78.6	98.7	60.7	10.4	126.0	130.2	152.9	74.3	122.7	1.1	43.4	65.7	83.7	114.0	79.3	7.9	96.2	157.9	57.0	114.2	46.0	43.9	151.7	59.3	28.1	263.6	30.3	8.3	102.7	209.5	121.8	143.0	4.0	48.1	148.3	83.6	3.7	295.3	43.9	140.1	7.5	13.8	139.4	177.0	38.4	96.2	126.6	229.8	227.4	66.4	15.9	46.0	35.8	259.4	20.3	38.1	92.0	56.4	101.9	149.4	175.5	149.7	86.7
BCAP29	"BAP29, DKFZp686M2086"	ENSG00000075790	"B cell receptor associated protein 29"	Q9UHQ4	7	107580246-107629170	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029215, HPA049694"	Supported		Approved	Cytosol		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA029215: AB_10602331, HPA049694: AB_2680854"	"unprognostic (3.96e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.42e-3)"	"unprognostic (4.71e-3)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (6.43e-2)"	"unprognostic (7.22e-2)"	"unprognostic (9.64e-2)"	"unprognostic (2.31e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.34e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.78e-2)"	"unprognostic (5.28e-3)"	"unprognostic (1.81e-1)"	47.1	25.7	19.4	22.5	23.7	16.7	28.0	18.1	27.0	48.6	12.8	32.6	16.1	42.6	18.6	34.4	21.7	23.0	61.0	24.4	17.9	20.1	33.3	26.0	16.7	17.5	17.6	21.4	18.9	34.5	12.2	26.7	18.0	31.9	31.2	9.6	18.4	25.0	38.7	22.1	18.8	38.2	19.5	18.1	22.4	70.1	19.2	12.8	85.5	31.5	15.7	30.9	32.5	21.1	71.7	22.8	26.4	13.8	65.2	81.6	22.6	80.6	68.2	32.9	39.7	23.2	72.1	13.4	54.5	58.1	75.1	35.8	13.7	38.6	52.5	50.1	17.3	27.1	35.6	26.2	63.3	33.6	41.2	48.9	31.8	46.7	38.0	95.4	116.9	25.3	58.3	33.4	75.4	67.2	23.2	34.3	15.4	29.7	30.0	18.6	34.1	34.6	60.6	49.1	10.2	37.7	68.2	54.9	58.2	39.3	25.6	37.5	113.9	102.5	52.1	94.6	104.7	31.7	67.9	27.5	66.5	30.5	77.2	47.5	10.5	25.5	9.5	13.6	9.3	12.8	7.5	9.5	10.0	8.5	4.3	8.5	3.9	9.9	21.7	10.1	13.6	8.1	19.4	23.7	18.1	27.0	24.4	17.9	17.5	17.6	18.0	19.5	19.2	21.1	169.8	67.3	57.2	35.6	33.9	38.5	80.7	99.0	25.0	35.2	40.4	34.2	117.8	27.1	77.7	23.9	10.4	30.2	31.4	38.1	15.6	46.4	227.1	54.6	93.3	99.0	22.3	73.2	81.1	73.6	50.8	72.9	32.6	102.0	58.3	14.8	73.2	40.7	52.6	8.4	71.3	35.8	69.2	36.6	35.6	95.8	61.2	49.6	37.4	44.0	41.6	28.3	22.6	50.8	49.7	71.2	32.5	89.1	17.7	110.4	15.6	19.5	55.9	26.7	78.9	62.9	91.3	202.2	35.0	46.5	38.8	70.7	33.5	32.0	45.4	83.5
BCAP31	"6C6-Ag, BAP31, CDM, DXS1357E"	ENSG00000185825	"B cell receptor associated protein 31"	P51572	X	153700492-153724565	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Host-virus interaction, Protein transport, Transport"		"Deafness, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003906, CAB015350, CAB015424"	Supported	Approved	Enhanced	"Endoplasmic reticulum"		NA	NA		170000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB015350: AB_2243544, CAB015424: AB_781567, HPA003906: AB_1078270"	"unprognostic (1.02e-2)"	"unprognostic (2.14e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (9.87e-4)"	"unprognostic (3.25e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.28e-2)"	"unprognostic (8.61e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.02e-1)"	294.1	213.9	171.5	100.9	175.5	151.3	210.9	171.8	213.9	139.5	202.5	157.7	133.3	127.4	228.9	214.0	151.0	118.0	123.5	183.0	192.1	160.7	185.5	144.5	111.8	190.8	187.5	130.9	266.4	193.7	123.5	143.3	195.3	154.6	166.5	63.9	179.7	177.7	81.9	187.3	143.8	155.0	183.4	138.5	129.3	117.3	186.9	99.7	161.4	75.5	134.6	177.9	145.8	185.0	505.5	482.4	128.0	650.6	593.8	179.1	295.3	269.9	287.5	291.6	371.6	386.8	361.9	315.9	1068.1	412.2	373.9	506.8	337.3	518.6	221.0	152.8	436.9	198.4	350.4	323.3	276.4	335.1	373.2	233.8	454.2	282.3	330.1	298.4	372.6	172.0	268.0	528.3	332.7	535.3	187.3	402.5	145.8	704.6	431.7	207.5	152.8	693.2	459.3	546.8	173.3	241.8	111.8	520.6	350.0	200.3	196.2	320.2	380.0	248.9	234.7	338.9	495.1	518.0	1120.1	397.3	460.9	402.6	223.7	630.5	484.2	489.1	507.5	535.7	454.7	436.1	504.5	507.4	420.7	463.6	439.1	474.7	624.5	449.8	632.3	666.9	457.1	1110.8	171.5	175.5	171.8	213.9	183.0	192.1	190.8	187.5	195.3	183.4	186.9	185.0	184.9	112.2	114.1	14.7	97.5	141.9	232.2	374.0	172.4	53.0	127.3	165.7	60.3	134.4	222.8	128.8	45.9	467.5	113.5	194.1	37.2	252.4	7.8	99.7	70.1	165.5	103.2	59.3	16.9	210.0	444.8	103.6	78.5	103.9	95.6	68.5	199.6	216.0	356.2	32.0	12.8	155.1	244.1	148.4	125.6	20.6	105.3	166.2	160.1	17.8	137.5	138.2	111.2	11.6	12.9	247.1	187.4	98.9	120.8	191.8	242.8	170.9	172.6	51.8	157.8	42.9	106.5	310.3	231.3	174.0	130.4	538.1	114.6	120.4	187.0	260.4
BCL2	"Bcl-2, PPP1R50"	ENSG00000171791	"BCL2 apoptosis regulator"	P10415	18	63123346-63320128	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 271.6;Inhibitory neurons: 102.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	18	"B-cells: 5.4;T-cells: 8.5"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 44.2;HL-60: 43.7;Karpas-707: 72.9;U-266/70: 217.4"	"Low region specificity"	"Detected in all"							"CAB000003, HPA055295"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nuclear membrane"	Nucleoplasm	"CAB000003: AB_2064429, HPA055295: AB_2682776"	"unprognostic (1.11e-3)"	"prognostic favorable (5.13e-5)"	"unprognostic (5.49e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.93e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.23e-2)"	"unprognostic (8.51e-2)"	"prognostic favorable (1.29e-8)"	"unprognostic (6.67e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (2.47e-4)"	"unprognostic (2.63e-1)"	12.8	1.9	5.5	10.2	7.8	5.0	9.6	4.7	3.4	10.7	0.0	6.2	4.4	11.6	2.9	5.9	11.8	6.5	5.3	2.9	6.6	6.7	2.1	3.7	14.7	11.2	7.9	14.5	3.1	13.0	4.7	4.6	7.5	6.4	5.5	2.1	3.7	7.0	16.5	4.8	8.1	6.6	7.9	17.9	3.8	1.5	8.2	18.3	24.0	8.8	14.6	5.4	7.7	5.7	1.7	0.3	6.8	5.9	6.7	1.3	2.4	1.0	0.7	2.4	2.0	3.5	0.4	0.3	1.1	0.9	4.7	0.4	6.7	0.9	1.5	44.2	1.6	0.5	2.0	0.7	2.0	43.7	5.6	1.7	0.8	3.3	5.8	1.1	0.7	4.3	0.8	72.9	2.2	1.4	9.8	10.7	1.5	0.8	1.3	39.5	1.9	26.5	7.4	8.5	7.2	6.4	0.3	0.3	8.5	1.4	0.3	29.9	0.3	9.9	3.3	0.9	5.1	217.4	40.1	2.9	1.9	24.9	6.0	0.3	0.0	0.0	1.9	0.0	7.6	5.4	6.3	3.4	0.1	3.1	3.3	3.2	0.0	0.2	0.3	0.2	8.5	1.3	5.5	7.8	4.7	3.4	2.9	6.6	11.2	7.9	7.5	7.9	8.2	5.7	7.1	0.0	1.1	271.6	84.9	19.5	33.6	1.6	13.6	1.9	39.7	19.7	17.4	18.6	2.4	7.3	0.0	14.0	39.9	2.7	15.6	3.7	0.4	9.8	9.8	5.9	5.4	3.8	60.7	0.0	0.7	15.8	5.6	24.9	15.8	38.8	3.9	1.2	9.4	0.0	102.3	10.5	24.4	15.0	29.6	1.9	8.7	29.0	46.2	88.1	19.7	18.8	18.6	76.4	56.7	0.2	5.9	13.9	50.1	41.6	0.9	18.0	0.1	0.6	26.3	48.8	19.7	0.3	1.3	6.2	17.6	49.1	76.1	24.1	9.8	76.2
BCL2L1	"Bcl-X, bcl-xL, bcl-xS, BCL2L, BCLX, PPP1R52"	ENSG00000171552	"BCL2 like 1"	Q07817	20	31664452-31723989	"Cancer-related genes, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Apoptosis, Endocytosis"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 160.0;Pancreatic endocrine cells: 187.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035734, CAB072801"	Approved		Approved	Mitochondria		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	Mitochondria		"CAB072801: , HPA035734: AB_2674757"	"unprognostic (2.29e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.78e-2)"	"prognostic unfavorable (9.10e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.04e-2)"	"unprognostic (7.82e-3)"	"prognostic favorable (9.57e-4)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (5.87e-4)"	"unprognostic (1.06e-1)"	"prognostic favorable (8.89e-5)"	"unprognostic (9.67e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.32e-2)"	80.3	46.9	46.3	26.1	53.7	99.0	71.0	46.7	54.5	46.5	88.2	42.4	49.4	39.2	11.9	77.8	42.7	51.7	77.9	42.2	48.2	95.7	85.2	95.1	25.8	49.5	49.4	23.1	54.7	30.4	49.8	42.0	51.1	52.0	26.2	41.0	70.6	25.2	55.4	65.7	48.9	25.0	41.3	53.4	66.6	46.2	54.4	111.5	51.4	38.8	28.9	42.8	54.7	59.7	327.0	188.4	30.7	32.4	167.8	123.1	101.0	73.8	113.2	69.6	66.4	429.2	150.9	48.2	176.7	108.4	140.7	105.8	42.9	216.7	46.2	55.1	8.6	231.3	34.4	231.6	123.0	19.6	137.7	90.7	77.4	89.4	194.0	102.4	106.0	81.6	150.0	34.5	238.7	94.3	73.9	20.6	45.4	150.8	153.2	43.5	92.9	164.3	249.3	83.4	85.4	38.4	89.3	92.6	42.4	57.2	180.5	26.3	154.1	90.0	109.1	36.8	139.4	22.7	150.7	37.9	143.5	99.5	59.5	28.6	11.0	25.6	39.9	11.7	30.9	4.8	17.1	26.8	10.4	6.0	7.7	18.6	12.5	19.8	13.4	7.0	21.8	28.2	46.3	53.7	46.7	54.5	42.2	48.2	49.5	49.4	51.1	41.3	54.4	59.7	41.6	16.0	9.2	22.5	10.1	18.4	70.2	40.8	26.7	21.9	25.5	15.4	9.7	91.5	36.3	38.6	45.9	27.1	13.7	41.7	86.1	92.2	10.2	71.4	14.6	35.8	24.7	160.0	21.8	65.9	11.3	15.5	37.2	58.2	12.7	10.6	36.4	40.8	38.2	28.6	19.5	26.0	69.2	22.1	13.3	4.6	19.0	27.6	17.8	49.6	76.9	24.1	54.6	13.6	55.6	187.7	22.4	42.9	38.0	102.9	54.6	76.5	76.4	33.7	46.0	14.9	42.7	31.0	15.1	13.6	9.8	18.9	24.9	13.6	19.6	143.0
BCL2L11	"BIM, BimEL, BimL, BimS, BOD"	ENSG00000153094	"BCL2 like 11"	O43521	2	111119378-111168445	"Predicted intracellular proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 118.3;Plasma cells: 137.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-266/70: 91.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026332, CAB079899"	Approved		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Mitochondria		"CAB026332: AB_566386, CAB079899: AB_10981505"	"unprognostic (1.43e-1)"	"unprognostic (9.46e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.50e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.08e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.39e-1)"	"unprognostic (3.43e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.55e-2)"	"unprognostic (9.71e-3)"	"unprognostic (8.15e-3)"	"unprognostic (7.86e-2)"	8.1	7.4	4.2	16.4	5.0	38.8	12.5	3.7	3.7	7.2	4.6	11.0	7.2	6.5	4.9	9.8	7.0	8.8	5.7	3.0	3.9	10.7	14.3	8.5	24.2	4.3	4.0	10.3	10.3	18.8	9.4	6.0	4.5	7.8	11.9	12.1	10.1	7.1	12.3	5.8	11.7	4.8	3.9	16.3	7.0	8.1	4.4	18.9	16.6	7.3	23.0	8.9	8.2	6.7	8.0	2.4	10.8	10.4	9.1	4.7	29.1	1.2	2.3	3.3	3.3	6.6	24.9	32.0	6.5	1.2	18.9	9.5	10.0	3.9	2.0	24.9	18.2	39.7	8.1	10.5	3.9	14.6	8.8	4.8	10.5	3.7	3.8	7.0	4.6	14.2	20.8	46.6	0.7	5.2	15.3	14.7	13.2	6.3	7.5	19.5	10.3	40.7	4.5	13.0	9.3	24.0	11.0	14.5	8.3	7.1	5.0	31.2	1.9	1.7	11.4	3.7	4.3	91.2	19.5	45.3	2.7	10.1	1.5	5.2	3.7	1.8	1.7	2.6	1.8	3.3	2.3	1.9	1.9	1.9	1.5	1.5	5.2	1.7	5.7	0.4	5.9	1.5	4.2	5.0	3.7	3.7	3.0	3.9	4.3	4.0	4.5	3.9	4.4	6.7	33.9	3.2	9.9	2.9	61.3	17.5	18.2	7.0	34.7	7.4	19.5	29.2	19.3	12.8	10.3	9.2	10.4	4.6	43.9	37.6	13.7	9.7	118.3	36.6	10.8	18.0	21.5	26.5	2.2	6.5	7.8	11.6	8.6	54.7	11.4	5.9	14.6	11.3	10.9	0.0	4.8	15.2	12.2	26.8	52.6	39.2	5.9	34.8	23.2	6.5	41.0	12.1	5.2	3.0	5.3	8.8	16.4	3.8	137.9	15.9	16.6	6.4	15.2	21.1	0.0	11.8	11.9	7.3	17.7	66.1	10.9	5.7	41.0	2.5	12.3	16.0
BCL2L2	"BCL-W, KIAA0271, PPP1R51"	ENSG00000129473	"BCL2 like 2"	Q92843	14	23298790-23311751	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB040539, HPA048740"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"CAB040539: , HPA048740: "	"unprognostic (8.23e-3)"	"unprognostic (9.85e-2)"	"unprognostic (1.71e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.47e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.50e-3)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.99e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.00e-1)"	"unprognostic (6.60e-2)"	"unprognostic (5.38e-2)"	48.5	36.6	102.4	26.0	95.3	13.9	35.6	83.7	112.4	30.2	61.8	86.9	28.5	43.0	30.5	46.8	35.4	24.7	37.3	89.8	88.8	35.0	20.9	34.6	13.9	94.8	94.0	31.8	53.3	52.9	38.1	23.8	91.7	47.4	31.8	51.9	52.2	45.5	24.2	46.5	34.3	41.5	101.0	20.5	54.2	25.1	108.3	10.7	38.5	19.9	16.4	55.6	34.9	92.4	24.1	23.0	25.6	19.0	43.4	39.2	19.3	43.9	28.5	21.8	24.9	16.3	42.6	16.8	14.2	26.6	27.4	43.9	15.9	28.1	29.4	8.9	12.7	18.4	44.4	30.3	26.6	20.7	30.0	30.3	54.0	17.6	27.1	30.6	18.6	2.9	17.3	18.0	27.8	17.8	1.6	14.5	8.0	33.4	41.3	12.8	28.1	8.2	19.7	45.5	31.7	18.0	20.8	31.3	31.2	15.6	20.6	15.5	37.1	35.1	24.8	27.6	23.1	22.0	12.7	2.2	21.6	16.0	43.5	0.0	0.4	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.3	102.4	95.3	83.7	112.4	89.8	88.8	94.8	94.0	91.7	101.0	108.3	92.4	9.2	9.6	13.1	0.0	2.6	8.7	9.5	12.7	5.7	20.0	11.0	8.0	28.9	4.3	13.6	5.5	25.0	5.3	3.5	16.8	13.7	8.0	20.1	11.1	10.4	10.8	18.6	2.1	0.0	18.3	4.0	10.4	9.7	12.1	5.7	12.0	11.4	7.2	5.5	20.2	0.0	16.8	6.1	8.4	4.0	6.1	11.1	5.5	7.2	0.0	7.5	7.4	2.1	0.0	0.0	25.5	11.0	21.4	4.5	17.2	16.3	9.2	12.2	12.7	6.6	12.6	15.5	0.5	0.9	10.8	11.1	5.6	1.5	8.9	10.5	17.6
BCL2L2-PABPN1		ENSG00000258643	"BCL2L2-PABPN1 readthrough"	Q92843	14	23306833-23326175	"Cancer-related genes, Predicted intracellular proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.1;Excitatory neurons: 10.9;Inhibitory neurons: 14.4;Oligodendrocyte precursor cells: 16.6;Oligodendrocytes: 13.7"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"HPA000637, HPA048740"	Approved		Uncertain	"Nucleoplasm,Nuclear speckles"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear speckles"	"HPA000637: AB_1079553, HPA048740: "	"unprognostic (1.32e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-3)"	"unprognostic (9.82e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.05e-6)"	"unprognostic (4.39e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.84e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.72e-7)"	"unprognostic (3.13e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.46e-3)"	"unprognostic (4.95e-2)"	8.2	4.1	8.8	4.2	10.8	10.7	9.6	7.2	20.6	10.9	1.3	17.2	10.4	8.3	2.0	11.6	10.8	10.9	7.2	9.8	8.3	3.5	4.2	7.3	4.3	8.7	9.3	4.6	12.4	8.0	7.1	10.9	9.0	12.1	6.3	5.6	24.9	22.1	4.8	11.0	8.8	7.7	10.1	6.0	10.3	12.5	11.7	1.2	8.7	0.9	4.1	13.4	7.5	15.8	11.4	18.0	15.2	31.3	15.3	29.3	14.0	13.4	27.3	39.8	44.2	10.1	38.0	3.5	4.0	21.2	22.5	24.2	16.9	21.4	17.9	8.5	21.6	4.7	11.2	26.0	14.5	10.0	29.7	37.4	29.7	17.6	6.1	27.3	14.7	0.2	8.2	8.2	19.3	18.1	0.4	7.5	17.3	10.3	18.2	7.9	4.0	5.9	10.3	10.1	16.0	10.0	9.8	22.6	15.2	10.8	8.7	8.2	15.4	18.7	8.4	17.1	12.8	4.9	6.6	1.1	25.2	10.5	19.4	0.8	2.5	0.1	0.1	1.2	0.0	0.5	0.0	0.0	0.8	1.0	0.1	0.0	0.5	1.6	1.4	0.4	0.0	0.6	8.8	10.8	7.2	20.6	9.8	8.3	8.7	9.3	9.0	10.1	11.7	15.8	0.0	3.2	3.9	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	10.9	0.0	0.0	0.7	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.8	0.0	0.0	0.0	16.6	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0
BCS1L	"BCS, BJS, h-BCS, Hs.6719"	ENSG00000074582	"BCS1 homolog, ubiquinol-cytochrome c reductase complex chaperone"	Q9Y276	2	218658764-218663443	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone	"Deafness, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037700, HPA037701"	Supported					NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 35: Non-specific - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA037700: AB_10794619, HPA037701: AB_10805235"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.28e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.44e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.25e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.21e-2)"	"unprognostic (6.02e-2)"	"unprognostic (3.47e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.15e-2)"	"unprognostic (8.38e-2)"	"prognostic favorable (3.31e-4)"	19.9	29.3	24.0	11.5	24.8	12.4	21.3	25.0	25.9	24.9	23.9	22.6	15.9	21.6	14.3	28.2	20.3	10.9	40.8	24.3	25.0	30.5	39.9	16.3	15.5	25.2	25.4	25.2	41.2	17.8	17.4	11.8	26.1	27.2	16.5	13.5	20.8	17.4	32.0	24.2	20.9	16.8	24.5	24.2	25.8	10.1	24.8	9.8	22.1	22.5	14.4	25.5	23.5	26.1	17.1	34.3	19.3	26.8	42.8	28.6	28.9	28.4	15.7	44.9	32.9	92.1	28.0	25.2	40.4	29.1	30.3	46.2	63.0	73.1	25.4	37.2	67.9	40.4	45.5	76.0	49.4	35.6	24.4	36.6	55.0	61.1	79.5	18.4	46.0	35.3	58.3	35.6	41.1	57.7	26.6	48.2	23.7	39.9	43.5	38.3	23.8	40.0	37.6	31.1	41.1	17.9	20.1	48.2	36.9	30.4	25.4	34.9	26.7	33.3	27.7	22.3	39.5	28.1	23.2	43.2	21.1	54.2	32.6	20.1	12.2	10.5	10.3	7.7	11.7	13.5	8.1	9.7	24.6	12.8	9.9	11.9	1.4	7.7	1.1	13.7	13.4	10.2	24.0	24.8	25.0	25.9	24.3	25.0	25.2	25.4	26.1	24.5	24.8	26.1	16.0	9.6	7.5	6.5	6.4	10.6	15.2	29.9	8.6	13.3	13.0	16.0	32.7	20.0	18.3	5.5	6.2	31.4	5.4	9.2	21.5	18.1	1.3	9.2	15.4	13.7	6.1	7.8	3.8	10.1	18.0	13.8	11.2	10.8	11.4	14.6	10.4	11.8	17.4	6.7	3.9	11.0	20.3	5.0	9.0	2.2	9.0	6.6	14.2	2.8	9.2	12.1	11.3	8.0	6.9	11.4	12.7	15.4	9.8	11.6	13.1	22.2	10.7	15.9	6.6	14.7	19.4	5.5	11.6	16.6	9.9	14.5	6.4	18.8	17.0	12.9
BDKRB2	BK-2	ENSG00000168398	"Bradykinin receptor B2"	P30411	14	96204679-96244166	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"urinary bladder: 41.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.3;Endothelial cells: 18.2;Fibroblasts: 25.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 49.2;BJ hTERT+: 94.5;U-87 MG: 39.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA003551, HPA050841"	Approved		Supported	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Golgi apparatus, Vesicles"	"HPA003551: , HPA050841: AB_2681254"	"unprognostic (1.03e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.79e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.32e-3)"	"unprognostic (3.11e-2)"	"unprognostic (9.40e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.49e-2)"	14.0	1.4	0.8	5.5	1.0	0.0	5.8	3.8	1.1	15.6	0.9	12.4	7.9	6.7	2.4	17.2	7.2	20.8	1.2	0.9	0.8	13.4	0.7	2.5	0.3	4.9	1.3	1.0	9.4	0.9	0.8	1.3	5.0	4.8	12.2	0.0	3.5	6.2	0.9	5.4	9.7	10.2	1.0	0.1	4.9	0.2	1.5	0.9	3.6	1.8	1.7	41.1	15.4	1.2	1.7	6.1	0.1	11.0	16.2	49.2	0.0	5.5	94.5	3.2	3.7	0.3	10.4	0.0	0.2	8.7	3.7	14.8	0.0	2.4	2.8	1.2	0.1	0.0	1.1	0.0	7.8	0.0	0.0	15.1	7.5	9.4	4.7	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.1	20.4	0.0	0.0	2.2	0.0	3.2	0.0	3.4	1.1	1.8	15.6	0.1	2.1	1.0	0.0	0.0	0.3	0.3	3.3	0.1	0.2	0.0	0.0	39.7	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.0	3.8	1.1	0.9	0.8	4.9	1.3	5.0	1.0	1.5	1.2	8.2	3.2	3.1	0.0	0.0	9.2	0.7	5.3	6.8	0.0	0.2	0.5	0.6	10.0	11.6	9.2	0.0	1.2	0.0	19.3	7.9	11.5	0.0	7.5	16.1	18.2	7.1	0.0	1.8	3.8	3.6	25.8	1.1	4.6	0.0	0.0	3.3	0.2	0.2	0.0	0.4	7.2	8.2	0.0	15.2	0.0	0.9	0.4	5.4	0.0	0.0	0.0	0.0	1.0	1.9	6.9	6.2	1.2	0.0	1.0	10.6	0.2	12.5	0.0	0.0	4.5	1.2	0.0	0.0	15.3	5.8	4.0	0.3	0.1	0.9	2.9
BEST1	"BEST, BMD, RP50, VMD2"	ENSG00000167995	"Bestrophin 1"	O76090	11	61950063-61965515	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 26.3;brain: 41.7"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 272.8"	"Group enriched"	"Detected in some"	6	"glioma: 2.0;melanoma: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	7	"neutrophil: 37.6"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 37.6"	"Cell line enriched"	"Detected in many"	4	"SK-MEL-30: 71.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057464	Enhanced					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 11: Alveolar cells - Smell perception"			"HPA057464: AB_2683444"	"unprognostic (2.41e-3)"	"unprognostic (3.67e-2)"	"unprognostic (5.91e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.07e-3)"	"unprognostic (2.06e-1)"	"unprognostic (4.27e-10)"	"unprognostic (1.38e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.59e-3)"	"unprognostic (2.72e-3)"	9.1	3.7	16.3	8.3	30.5	26.3	5.3	24.9	23.2	5.3	10.2	3.8	1.7	4.1	10.0	2.8	5.9	5.1	5.7	16.5	20.2	3.7	2.6	10.3	2.3	27.9	27.3	4.6	2.5	0.3	3.4	2.4	26.7	4.0	1.0	6.7	2.2	2.0	1.6	2.7	3.9	1.8	19.2	11.0	3.3	5.4	28.6	0.4	2.7	1.4	0.4	5.3	4.7	41.7	0.8	0.8	0.4	0.7	17.7	3.8	1.4	1.0	1.8	0.4	1.3	0.5	0.5	0.1	1.7	1.1	2.0	1.1	0.0	0.0	0.3	0.3	0.2	0.0	6.7	0.9	4.9	0.2	0.5	5.6	1.6	1.9	4.1	1.8	0.0	0.8	0.8	7.6	1.9	0.6	0.1	0.6	0.0	0.8	2.1	0.0	0.1	0.3	0.0	2.0	1.0	0.9	1.6	0.1	71.6	0.8	0.7	2.3	0.2	0.9	0.5	0.7	0.3	10.3	0.8	0.7	4.8	0.6	1.2	2.6	3.9	3.9	0.2	4.6	0.2	0.7	0.2	0.1	2.6	0.2	0.1	0.1	37.6	0.1	5.1	0.4	0.3	1.9	16.3	30.5	24.9	23.2	16.5	20.2	27.9	27.3	26.7	19.2	28.6	41.7	2.7	25.6	59.3	9.1	11.4	36.3	6.3	54.8	18.8	2.0	22.0	7.4	3.3	14.3	57.2	1.8	0.0	14.5	5.6	22.5	0.0	3.8	8.3	5.3	9.0	16.4	10.3	29.0	0.3	3.3	23.4	32.4	9.2	9.0	76.4	1.9	21.0	13.8	37.1	0.0	0.7	10.7	22.4	75.4	272.8	2.9	15.2	49.0	55.2	1.0	14.1	6.0	3.1	17.1	43.0	3.1	21.0	6.8	5.9	11.8	28.0	5.6	37.7	9.6	6.6	16.1	20.8	3.2	4.1	6.2	32.7	20.4	24.5	0.9	11.9	13.2
BEST2	"FLJ20132, VMD2L1"	ENSG00000039987	"Bestrophin 2"	Q8NFU1	19	12751702-12758458	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 45.3;skin 1: 17.3"	"Cell type enriched"	"Detected in some"	36	"Intestinal goblet cells: 136.4"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 1.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.7"	HPA046229	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA046229: AB_10966140"	"unprognostic (3.19e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-2)"	"unprognostic (4.02e-3)"		"unprognostic (2.77e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.46e-3)"	"unprognostic (9.18e-6)"	"unprognostic (3.45e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.64e-5)"	0.2	0.2	0.6	0.7	0.7	2.3	0.5	2.8	0.8	0.2	0.5	45.3	0.1	0.5	0.7	0.2	0.3	0.6	0.4	0.7	0.5	0.2	0.3	0.4	0.5	0.9	0.8	0.5	0.2	0.3	0.0	0.4	0.8	0.3	14.0	1.5	0.9	0.3	0.3	17.3	15.5	0.7	0.2	0.5	0.3	0.4	1.1	0.2	0.6	0.1	4.9	0.2	1.4	1.5	0.3	0.2	0.7	1.3	0.0	0.0	0.6	0.3	0.0	0.2	0.1	0.8	1.3	1.1	0.3	0.0	0.2	0.7	0.0	0.2	0.2	1.3	0.6	0.9	1.2	0.3	0.1	0.4	1.9	0.1	0.1	0.1	0.1	0.4	0.1	0.2	0.2	0.5	0.2	1.1	0.3	0.6	1.0	0.1	0.7	0.1	0.4	0.2	0.3	0.3	0.7	0.7	0.5	0.0	0.1	0.8	0.6	0.1	1.0	0.3	0.3	0.6	0.7	0.3	0.5	0.3	0.5	1.0	0.7	0.5	0.1	0.1	0.3	0.1	0.2	0.5	0.2	0.1	0.0	0.7	0.5	0.4	0.4	0.4	0.1	0.6	0.1	0.2	0.6	0.7	2.8	0.8	0.7	0.5	0.9	0.8	0.8	0.2	1.1	1.5	0.1	0.0	0.0	0.3	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.1	0.0	0.0	0.2	0.1	3.7	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	136.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.5	0.0	0.1	0.3	0.1	0.0	1.8	0.1
BEST3	"MGC13168, MGC40411, VMD2L3"	ENSG00000127325	"Bestrophin 3"	Q8N1M1	12	69643360-69699476	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"skeletal muscle: 69.1;tongue: 55.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 10.3;Late spermatids: 17.9;Oligodendrocyte precursor cells: 70.4;Skeletal myocytes: 28.1"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"REH: 36.1;RPMI-8226: 38.4;U-698: 63.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA054582	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 37: Myocytes - Muscle contraction"			"HPA054582: AB_2682530"	"unprognostic (1.53e-1)"	"unprognostic (7.00e-2)"	"unprognostic (9.83e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.15e-3)"	"unprognostic (2.26e-3)"		"unprognostic (7.30e-7)"	"unprognostic (1.81e-1)"	"unprognostic (1.74e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.08e-2)"	"unprognostic (4.82e-2)"	"unprognostic (4.47e-2)"		"unprognostic (3.03e-1)"	0.0	0.6	3.9	0.1	3.7	2.8	0.6	15.4	5.8	0.1	0.7	0.2	0.2	0.1	0.6	1.9	0.1	0.2	0.4	4.2	1.4	0.4	0.3	0.1	0.2	5.2	3.8	0.2	1.1	0.1	1.1	0.3	5.3	1.9	0.2	2.6	3.1	0.1	69.1	0.9	0.1	0.0	2.7	0.1	0.1	3.1	3.2	1.4	0.1	55.8	0.2	0.0	0.0	7.8	0.2	0.5	1.3	0.1	0.0	0.0	0.3	0.3	0.3	0.7	0.8	0.3	0.4	2.4	0.6	0.0	2.0	0.2	0.0	0.1	0.8	0.5	0.1	1.0	0.8	0.3	0.0	0.3	0.0	0.3	0.0	1.1	0.2	0.1	0.4	0.1	0.5	0.0	1.5	0.2	0.0	0.1	1.4	0.7	0.5	36.1	1.1	38.4	1.8	0.1	0.7	0.0	0.2	0.2	0.0	2.3	0.3	0.0	0.2	0.3	0.9	0.2	1.3	0.2	0.4	63.7	2.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	3.9	3.7	15.4	5.8	4.2	1.4	5.2	3.8	5.3	2.7	3.2	7.8	0.0	0.0	0.0	1.0	0.0	0.3	0.1	0.0	0.0	0.0	1.2	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	10.3	0.1	0.0	0.0	0.0	1.3	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	17.9	0.0	0.2	1.8	0.0	0.0	7.6	0.0	70.4	0.1	0.8	0.0	0.0	0.0	0.6	0.0	7.0	0.0	0.3	0.0	28.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0
BEST4	VMD2L2	ENSG00000142959	"Bestrophin 4"	Q8NFU0	1	44783585-44788170	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"choroid plexus: 16.4;fallopian tube: 8.3;intestine: 27.4"	"Cell type enriched"	"Detected in some"	25	"Paneth cells: 1290.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 2.5;U-698: 1.8"					"Low region specificity"	"Detected in many"			HPA058564	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA058564: AB_2683759"	"unprognostic (5.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (3.15e-2)"	"unprognostic (6.20e-2)"	"unprognostic (6.51e-3)"	"unprognostic (1.09e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.45e-3)"	"unprognostic (1.04e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.69e-5)"	"unprognostic (1.43e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.28e-1)"	"unprognostic (4.13e-3)"	0.2	1.9	1.2	0.7	1.1	0.7	0.5	2.2	1.3	1.6	16.4	27.4	9.1	0.7	3.0	0.2	8.3	0.2	0.3	0.8	1.7	0.5	0.6	1.9	0.6	1.9	3.3	0.5	0.3	0.3	2.7	0.2	1.5	0.4	16.0	1.1	0.3	0.5	0.4	2.2	8.1	0.5	1.3	0.5	0.4	0.7	1.6	0.5	0.6	0.1	0.4	0.3	0.2	1.0	0.0	0.2	0.3	0.4	0.1	0.1	1.1	0.2	0.1	0.1	0.0	0.1	0.5	0.1	0.5	0.1	0.3	0.5	0.1	0.0	0.1	0.3	0.2	0.0	0.8	2.5	0.1	0.0	0.3	0.2	0.3	0.1	0.2	0.6	0.3	0.4	0.1	0.2	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.8	0.3	0.1	0.1	0.1	0.2	0.4	0.0	0.5	0.1	0.1	0.1	0.2	0.4	0.1	1.8	0.4	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.6	0.8	0.6	0.7	0.0	0.5	0.2	0.5	0.1	0.3	0.0	0.3	0.6	0.1	1.2	1.1	2.2	1.3	0.8	1.7	1.9	3.3	1.5	1.3	1.6	1.0	0.2	0.0	0.0	0.0	0.8	0.3	0.8	3.4	0.0	0.8	0.4	1.0	0.5	0.0	4.2	5.5	0.0	0.3	0.4	31.2	1.9	0.7	0.0	26.7	0.5	0.2	2.4	0.0	1.9	0.8	0.2	0.6	0.5	1.2	0.0	0.3	0.4	0.0	0.3	0.0	4.3	3.2	0.0	0.0	0.9	0.2	0.9	0.2	0.0	0.0	0.1	1.2	0.0	0.0	0.1	0.6	1290.4	0.4	0.4	0.7	6.1	1.0	50.1	0.2	0.0	1.2	0.8	0.7	1.6	0.0	0.6	0.3	1.4	0.4	9.1	0.5
BNIP3	Nip3	ENSG00000176171	"BCL2 interacting protein 3"	Q12983	10	131966455-131982013	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 361.5;skeletal muscle: 214.4"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 544.1;Hepatocytes: 437.4;Proximal tubular cells: 714.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 390.1;hTERT-RPE1: 286.7;U-87 MG: 347.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003015, CAB011676"	Supported					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB011676: , HPA003015: AB_1078290"	"unprognostic (1.01e-3)"	"unprognostic (1.42e-3)"	"unprognostic (1.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.62e-3)"	"unprognostic (6.57e-3)"	"unprognostic (1.12e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (2.37e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.29e-2)"	"unprognostic (2.98e-1)"	49.2	35.0	52.3	8.1	54.9	5.9	35.7	63.6	63.0	30.1	38.1	25.9	7.7	17.4	23.8	30.0	20.5	16.8	92.8	71.2	55.8	63.9	126.4	25.9	10.0	61.5	67.9	82.2	361.5	20.3	36.7	30.0	67.4	40.6	4.8	81.4	46.9	12.8	214.4	36.3	14.9	12.1	55.5	13.7	27.9	15.7	65.8	10.0	23.2	91.4	7.9	28.2	39.4	62.3	390.1	30.7	21.6	60.9	56.7	59.5	110.9	92.7	85.3	68.3	193.2	6.4	8.4	0.7	146.5	53.6	79.5	23.3	46.2	131.4	254.7	20.7	34.9	13.8	19.2	90.1	75.4	17.9	10.6	41.4	32.7	66.6	66.8	286.7	48.1	23.6	36.0	1.4	112.9	31.0	9.2	99.3	18.5	2.7	91.1	21.8	11.0	33.3	75.1	6.4	28.5	66.3	18.9	38.7	54.3	91.1	23.7	24.7	55.4	96.0	32.3	36.4	74.4	63.5	58.1	54.0	347.4	0.9	16.8	4.2	6.3	9.8	16.6	4.2	17.7	11.4	23.4	17.7	5.6	11.6	39.1	26.3	1.5	4.3	6.2	4.3	25.4	16.5	52.3	54.9	63.6	63.0	71.2	55.8	61.5	67.9	67.4	55.5	65.8	62.3	49.3	48.1	56.5	34.3	22.5	29.8	98.3	101.0	34.7	98.2	75.8	63.1	159.2	137.2	43.6	84.6	39.6	173.8	24.7	2.6	301.3	185.1	110.3	84.7	64.4	53.6	81.0	21.5	39.6	87.9	544.1	64.6	27.5	98.1	0.0	107.4	61.4	437.4	79.1	333.1	30.0	10.3	59.0	28.4	20.4	112.1	70.2	28.2	33.8	7.5	28.1	169.2	27.8	16.1	22.8	133.8	9.5	103.4	37.5	140.5	63.5	714.8	72.7	64.6	39.5	53.1	60.0	35.3	100.2	6.5	13.1	247.4	38.4	47.3	5.3	48.9
BNIP3L	"BNIP3a, Nix"	ENSG00000104765	"BCL2 interacting protein 3 like"	O60238	8	26383054-26505636	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 913.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015652, CAB025371"	Enhanced		Supported	"Nuclear speckles,Mitochondria"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	"Nuclear speckles"	"CAB025371: , HPA015652: AB_1845406"	"unprognostic (1.02e-1)"	"unprognostic (2.90e-1)"	"unprognostic (2.00e-1)"	"unprognostic (8.36e-2)"	"unprognostic (6.24e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.46e-2)"	"unprognostic (5.04e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.06e-2)"	"unprognostic (2.97e-2)"	"prognostic unfavorable (5.92e-5)"	"unprognostic (8.72e-3)"	"unprognostic (5.16e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (7.59e-3)"	130.6	53.4	42.7	37.2	60.4	192.6	77.9	55.6	62.0	63.9	38.9	39.6	22.2	52.8	66.3	48.3	50.5	54.7	63.2	50.0	49.6	79.4	45.4	62.9	39.4	60.7	54.0	119.7	20.1	55.1	25.4	104.5	58.4	44.4	28.2	146.5	44.1	64.4	38.9	71.5	28.4	51.3	46.6	40.7	28.9	68.6	48.8	39.9	41.9	31.7	52.1	48.9	49.5	80.8	90.6	33.8	79.1	53.9	214.5	134.0	66.8	89.0	259.9	81.9	179.6	15.3	42.7	27.7	82.5	169.0	113.4	44.8	39.6	114.5	270.0	17.8	21.8	114.9	32.0	26.9	119.3	10.3	191.1	162.5	89.2	92.9	55.3	269.2	106.2	66.9	52.6	65.0	173.7	39.1	72.7	38.5	26.2	56.7	36.6	38.4	99.9	55.6	85.3	58.3	83.9	74.4	43.2	8.8	70.0	85.9	43.7	21.7	140.4	152.2	64.6	96.2	20.5	93.2	46.0	36.8	232.6	20.6	35.1	334.9	298.3	182.9	39.5	154.8	34.9	68.4	58.4	43.3	166.9	78.0	89.3	65.5	369.0	47.6	104.1	38.0	86.1	239.3	42.7	60.4	55.6	62.0	50.0	49.6	60.7	54.0	58.4	46.6	48.8	80.8	118.3	86.6	157.4	28.7	72.2	98.8	56.0	231.7	82.6	142.5	90.6	85.3	34.0	50.1	126.4	103.0	33.3	33.2	55.6	32.7	49.0	115.4	194.1	173.5	140.8	101.2	120.6	913.9	50.6	39.1	166.5	179.9	38.7	341.2	120.9	96.5	167.0	32.2	132.1	82.4	39.4	46.8	118.0	221.3	300.4	206.7	320.3	233.6	106.7	30.0	165.0	406.4	32.0	29.1	75.8	154.1	39.8	347.5	64.6	83.6	44.0	306.4	107.6	64.0	144.7	59.1	183.9	154.4	110.7	65.4	126.6	162.5	67.0	117.6	27.6	79.3
BOK	"BCL2L9, BOKL, MGC4631"	ENSG00000176720	"BCL2 family apoptosis regulator BOK"	Q9UMX3	2	241551424-241574131	"Plasma proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 218.8"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 100.8;Oligodendrocytes: 47.0;Proximal tubular cells: 41.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.3"	"Lineage enhanced"	"Detected in single"		"T-cells: 2.3"	"Cell line enhanced"	"Detected in many"		"TIME: 65.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (6.16e-2)"	"unprognostic (3.01e-2)"	"unprognostic (1.24e-3)"	"unprognostic (6.30e-2)"	"unprognostic (8.63e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.24e-3)"	"unprognostic (1.16e-2)"	"unprognostic (8.45e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.47e-2)"	"unprognostic (2.27e-1)"	"prognostic favorable (1.09e-9)"	"unprognostic (9.48e-3)"	"unprognostic (6.81e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.09e-1)"	90.6	7.1	88.4	6.2	138.6	0.4	37.7	110.4	110.3	15.6	51.0	38.0	8.1	34.2	16.3	29.5	18.1	22.7	6.3	77.0	87.8	20.5	97.0	20.1	3.7	146.6	120.6	9.9	16.3	3.8	4.7	5.7	127.1	28.5	5.0	1.2	11.8	25.5	2.6	20.0	9.4	20.4	98.5	6.5	21.5	7.7	115.4	1.1	11.0	3.2	3.4	34.9	18.6	218.8	36.0	8.8	15.7	36.2	26.3	15.6	4.4	28.6	11.3	36.9	37.9	16.2	14.6	0.1	9.7	51.0	9.0	32.9	1.7	28.9	13.8	0.1	0.3	0.1	9.3	42.2	21.8	0.2	1.3	15.9	29.2	15.5	4.4	27.8	44.6	2.4	6.4	0.1	36.7	46.0	0.2	0.2	9.9	40.0	26.8	0.4	25.9	0.2	24.2	0.9	14.0	5.4	13.2	8.5	23.3	18.3	24.4	1.3	65.0	0.1	52.8	0.7	3.2	0.1	0.1	0.1	0.1	0.0	2.1	0.0	0.0	0.0	2.3	0.0	0.2	0.0	0.7	1.0	0.0	0.0	0.0	1.1	0.0	0.7	0.0	0.0	0.0	0.6	88.4	138.6	110.4	110.3	77.0	87.8	146.6	120.6	127.1	98.5	115.4	218.8	22.5	6.4	32.1	0.3	0.5	7.1	11.5	8.6	5.2	0.2	19.4	10.5	10.2	32.9	6.3	11.0	0.0	2.0	2.5	5.8	15.6	23.2	0.2	6.6	17.6	15.6	11.4	5.3	0.8	11.1	10.5	10.9	5.6	14.4	0.0	2.6	12.5	100.8	0.7	0.0	1.5	3.7	2.0	4.7	1.2	1.5	6.2	0.7	1.8	4.7	0.0	3.9	6.2	7.5	47.0	27.7	2.8	10.5	0.9	26.3	7.1	41.9	1.5	1.3	0.0	11.7	11.2	0.3	8.2	19.8	12.8	6.2	1.6	3.4	6.1	15.1
BPI	BPIFD1	ENSG00000101425	"Bactericidal permeability increasing protein"	P17213	20	38304150-38337505	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	88	"bone marrow: 1503.7"	"Group enriched"	"Detected in some"	8	"Early spermatids: 201.8;Late spermatids: 220.6;Proximal tubular cells: 99.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	17	"classical monocyte: 14.5;neutrophil: 7.1"	"Group enriched"	"Detected in many"	17	"granulocytes: 7.1;monocytes: 14.5"	"Cell line enhanced"	"Detected in single"		"HL-60: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061284	Enhanced				"Secreted to blood"	NA	NA	7290000	78000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA061284: AB_2684465"	"unprognostic (9.30e-4)"	"unprognostic (5.49e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.83e-6)"	"unprognostic (2.66e-4)"	"unprognostic (9.29e-2)"	"unprognostic (2.32e-2)"	"unprognostic (9.47e-3)"	0.5	0.2	0.1	0.1	0.2	1503.7	0.6	0.1	0.4	2.6	0.2	0.2	0.0	0.7	1.0	0.1	0.4	0.5	0.5	0.1	0.2	3.4	0.8	3.7	0.3	0.2	0.2	1.7	0.0	0.0	0.6	0.5	0.2	0.4	0.0	0.0	1.4	1.2	0.1	1.8	0.1	0.2	0.2	13.0	0.1	17.1	0.2	3.7	0.2	0.2	0.2	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	14.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	7.1	0.0	0.6	0.0	0.0	9.8	0.1	0.2	0.1	0.4	0.1	0.2	0.2	0.2	0.2	0.2	0.2	0.1	0.0	0.0	1.3	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.3	0.3	0.4	0.0	0.4	3.7	0.0	0.0	0.0	0.0	9.8	0.0	201.8	0.2	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.7	20.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	220.6	17.7	1.3	1.8	0.0	7.1	0.0	1.0	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	99.7	0.3	0.0	0.0	0.2	0.4	2.1	1.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0
BPIFB2	"BPIL1, C20orf184, dJ726C3.2, LPLUNC2"	ENSG00000078898	"BPI fold containing family B member 2"	Q8N4F0	20	33007704-33023703	"Plasma proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"salivary gland: 2294.3"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 6.1;Breast myoepithelial cells: 9.1;Early spermatids: 4.8;Late spermatids: 9.3;Prostatic glandular cells: 7.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	582	"Hep G2: 232.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA049491, HPA060121"	Enhanced		Approved	Vesicles	"Secreted in other tissues"	NA	NA		36000		"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 35: Glandular cells - Unknown function"	Vesicles		"HPA049491: AB_2680792, HPA060121: AB_2684207"	"unprognostic (1.94e-1)"			"prognostic favorable (1.97e-5)"	"unprognostic (2.24e-4)"	"unprognostic (9.48e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.02e-3)"		"unprognostic (1.72e-2)"		"unprognostic (2.71e-1)"		"unprognostic (9.28e-2)"	"unprognostic (5.35e-1)"	"unprognostic (8.19e-2)"		0.4	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.0	99.8	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.0	0.3	0.0	0.8	0.0	0.0	1.8	0.0	0.0	2294.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	232.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.1	9.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	7.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6
BRI3BP	"BNAS1, HCCR-2, HCCRBP-3, KG19"	ENSG00000184992	"BRI3 binding protein"	Q8WY22	12	124993645-125031231	"Predicted membrane proteins, Transporters"			Proto-oncogene	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 20.8"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 174.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 13.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"Daudi: 114.9;U-698: 161.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014957	Approved		Approved	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 52: Eosinophils - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Mitochondria"		"HPA014957: AB_1845447"	"unprognostic (1.62e-2)"	"unprognostic (6.82e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.95e-2)"	"unprognostic (4.66e-2)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (7.65e-3)"	"unprognostic (2.84e-2)"	"unprognostic (3.47e-3)"	"unprognostic (7.40e-2)"	"unprognostic (4.82e-2)"	"unprognostic (2.72e-3)"	"unprognostic (1.44e-3)"	"unprognostic (2.20e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.55e-1)"	3.3	2.0	9.2	8.9	10.7	5.5	5.5	8.2	10.7	3.0	7.1	15.5	20.8	2.1	2.2	6.8	4.1	4.8	2.5	9.2	7.9	6.9	4.8	2.8	13.8	9.6	9.7	1.5	5.1	9.1	2.1	2.1	10.2	2.9	15.3	10.0	2.5	2.2	1.7	5.5	18.8	2.6	9.1	5.9	8.2	1.8	9.1	7.0	4.4	2.1	16.2	2.5	2.6	9.4	34.1	43.8	13.8	12.5	10.9	5.6	24.1	22.2	4.6	13.7	7.1	36.1	22.3	114.9	27.8	5.0	8.9	38.7	30.7	17.3	10.9	26.9	25.5	58.4	16.9	24.8	2.2	86.8	72.2	2.5	9.9	15.0	7.1	5.3	5.1	41.0	23.5	8.0	12.0	31.3	45.1	33.3	9.9	29.9	17.3	30.2	23.0	30.7	17.3	46.8	19.0	13.2	27.6	26.9	9.2	4.6	48.8	60.8	5.9	13.0	16.2	12.5	23.4	26.9	49.7	161.8	11.9	28.7	29.1	4.2	2.2	13.1	0.8	1.6	0.8	1.4	0.6	0.7	1.7	1.5	0.5	0.7	2.2	0.9	1.2	4.2	0.7	0.6	9.2	10.7	8.2	10.7	9.2	7.9	9.6	9.7	10.2	9.1	9.1	9.4	3.4	9.6	10.4	13.4	23.6	12.2	9.1	8.2	5.2	37.1	14.9	6.3	7.2	31.5	9.2	9.2	14.6	15.4	24.3	65.5	3.9	9.1	25.6	16.1	7.2	5.1	7.8	21.5	32.6	10.4	24.0	7.1	32.1	18.0	18.4	7.2	4.2	27.4	19.8	25.2	43.8	42.8	8.2	31.5	26.1	174.4	1.2	23.6	10.6	11.2	28.8	12.1	9.2	11.1	23.4	17.1	43.3	4.1	39.5	9.6	60.2	12.7	15.0	27.9	0.0	9.2	6.9	1.1	11.5	20.7	18.3	5.2	11.5	6.8	72.6	9.7
BRINP1	"DBC1, DBCCR1, FAM5A"	ENSG00000078725	"BMP/retinoic acid inducible neural specific 1"	O60477	9	119153458-119369435	"Predicted intracellular proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"brain: 43.5"	"Group enriched"	"Detected in some"	8	"Astrocytes: 178.9;Excitatory neurons: 285.7;Inhibitory neurons: 163.4;Oligodendrocyte precursor cells: 204.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 8.6;NTERA-2: 17.0;SCLC-21H: 7.4;SH-SY5Y: 3.2;SuSa: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038828	Approved		Uncertain	Microtubules	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Microtubules		"HPA038828: AB_10670909"	"unprognostic (8.60e-5)"	"unprognostic (2.31e-2)"	"unprognostic (1.24e-1)"	"unprognostic (5.09e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.28e-4)"	"unprognostic (1.51e-2)"	"unprognostic (5.06e-3)"	"unprognostic (1.39e-3)"	"unprognostic (1.56e-1)"	"unprognostic (7.59e-2)"	"unprognostic (1.41e-1)"	0.1	3.8	28.8	0.0	23.3	0.0	2.4	20.5	43.5	0.5	0.0	0.2	0.2	0.7	4.9	0.6	0.0	1.4	1.8	35.7	17.8	1.7	0.6	1.9	0.0	9.6	20.6	0.1	0.0	0.0	1.6	0.0	16.8	1.5	0.1	5.3	0.7	5.2	0.3	0.1	0.6	0.1	16.0	0.3	0.2	0.5	27.7	0.8	0.3	0.1	0.0	0.3	0.2	18.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	17.0	0.0	0.0	0.0	1.7	0.0	0.1	0.0	7.4	3.2	0.0	0.0	0.0	6.0	0.6	0.0	0.0	1.1	1.8	0.0	0.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.8	23.3	20.5	43.5	35.7	17.8	9.6	20.6	16.8	16.0	27.7	18.8	0.1	0.0	0.0	178.9	0.0	0.0	0.5	0.5	0.0	8.7	8.1	4.2	0.9	0.0	0.1	0.0	25.0	0.1	0.0	0.3	0.0	0.0	2.1	0.5	15.9	0.5	2.4	0.0	285.7	0.0	0.0	0.4	0.0	0.4	0.0	0.2	2.9	0.0	0.3	1.7	163.4	0.0	0.0	0.3	0.0	1.0	0.0	0.3	0.0	8.4	0.0	1.6	0.0	204.6	4.9	0.1	0.0	0.4	0.0	0.4	0.0	23.9	0.0	2.6	0.0	0.0	0.4	1.0	1.7	0.0	0.0	0.0	0.2	0.1	0.0	0.3
BRINP2	"DBCCR1L2, FAM5B"	ENSG00000198797	"BMP/retinoic acid inducible neural specific 2"	Q9C0B6	1	177170958-177282422	"Predicted secreted proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 9.6;brain: 19.9"	"Group enriched"	"Detected in some"	4	"Astrocytes: 121.1;Excitatory neurons: 116.8;Inhibitory neurons: 148.3;Oligodendrocyte precursor cells: 96.5"	"Cancer enriched"	"Detected in some"	5	"glioma: 11.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.7;PC-3: 1.3;REH: 2.1;SCLC-21H: 5.6;SH-SY5Y: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050681	Uncertain				"Secreted in other tissues"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050681: "	"unprognostic (7.78e-2)"	"unprognostic (4.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.77e-1)"	"unprognostic (5.77e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.95e-2)"	"unprognostic (2.20e-4)"	"unprognostic (8.95e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.82e-3)"	0.6	9.6	17.2	0.0	16.5	0.0	0.9	1.3	19.9	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.2	17.9	10.7	0.0	0.1	0.0	0.0	4.5	9.6	0.0	0.0	0.0	4.2	0.5	4.9	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.0	2.1	16.2	0.0	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	1.3	2.1	0.0	0.0	0.0	0.0	5.6	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.2	16.5	1.3	19.9	17.9	10.7	4.5	9.6	4.9	4.9	16.2	13.4	0.0	0.0	0.0	121.1	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	3.4	0.2	0.3	0.0	0.0	0.0	116.8	0.0	0.0	0.2	0.0	0.2	0.0	0.7	0.0	0.0	0.1	15.2	148.3	0.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	25.3	0.0	0.5	0.0	96.5	15.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	1.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0
BSCL2	"GNG3LG, seipin, SPG17"	ENSG00000168000	"BSCL2 lipid droplet biogenesis associated, seipin"	Q96G97	11	62690275-62709845	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid degradation, Lipid metabolism"		"Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant, Hereditary spastic paraplegia, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 292.1;pituitary gland: 237.0"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 35.9;Late spermatids: 53.1;Plasma cells: 86.3;Spermatocytes: 32.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 242.1;RPMI-8226: 176.1;SCLC-21H: 181.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042394	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA042394: AB_10794047"	"unprognostic (7.78e-2)"	"unprognostic (8.74e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.08e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.41e-1)"	"prognostic favorable (7.55e-5)"	"unprognostic (3.56e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.96e-1)"	24.9	88.1	126.6	7.4	133.2	12.0	26.2	75.0	155.6	38.2	85.4	24.3	10.8	28.4	156.7	24.1	63.7	21.5	18.7	134.9	292.1	50.8	39.3	26.7	15.3	138.1	139.0	32.7	79.4	61.7	237.0	10.0	203.4	35.4	13.3	52.6	66.1	30.3	30.9	25.1	17.2	13.7	83.1	16.2	37.1	190.3	169.3	14.4	37.9	15.5	8.9	17.5	26.1	89.9	18.0	61.7	49.6	83.8	130.8	41.5	7.2	7.2	34.4	13.6	14.5	9.6	26.3	11.9	16.5	25.2	11.8	62.1	5.2	21.8	7.0	30.7	5.0	10.9	33.4	7.8	27.7	9.7	13.5	27.8	16.6	26.9	10.9	19.7	10.8	33.0	7.8	242.1	19.8	44.0	11.4	21.8	132.4	13.9	13.0	21.3	4.2	176.1	65.0	2.4	181.2	29.4	28.2	13.9	25.3	5.7	41.3	15.3	6.5	16.5	3.7	24.5	4.2	32.2	72.5	16.6	82.4	3.2	14.5	26.6	59.2	34.6	24.7	46.2	27.4	27.5	25.5	26.1	42.4	29.7	25.7	27.0	14.2	41.0	40.3	54.3	33.1	43.3	126.6	133.2	75.0	155.6	134.9	292.1	138.1	139.0	203.4	83.1	169.3	89.9	0.8	16.0	5.6	0.0	7.1	1.7	1.0	1.4	35.9	2.5	3.6	2.2	0.2	1.5	1.6	3.7	0.0	2.4	0.9	1.7	3.9	2.0	25.5	4.8	1.5	2.9	0.0	8.8	0.0	1.1	1.9	9.2	20.4	1.5	2.5	0.7	1.4	2.1	1.9	3.3	0.0	1.6	6.1	2.5	3.1	53.1	2.5	6.2	12.4	0.0	0.7	0.8	1.0	0.0	0.0	0.5	1.6	3.0	86.3	0.9	2.5	6.0	23.9	1.2	6.6	1.2	4.1	32.6	18.1	24.7	4.0	1.5	6.5	0.7	1.2	0.5
BSG	"CD147, EMMPRIN, EMPRIN, OK"	ENSG00000172270	"Basigin (Ok blood group)"	P35613	19	571277-583494	"Blood group antigen proteins, CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Host-virus interaction"	"Blood group antigen, Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1535.0"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 1408.0;Syncytiotrophoblasts: 1654.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002427, HPA036048, HPA074870"	Enhanced		Approved	Vesicles		NA	NA		340000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"CAB002427: AB_563501, HPA036048: AB_2674917, HPA074870: AB_2686719"	"unprognostic (1.88e-1)"	"unprognostic (4.85e-2)"	"unprognostic (9.53e-3)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.34e-1)"	"unprognostic (1.38e-2)"	"prognostic unfavorable (5.48e-6)"	"unprognostic (1.54e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.46e-2)"	"unprognostic (4.48e-3)"	"unprognostic (2.61e-2)"	"prognostic favorable (1.95e-6)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.22e-1)"	378.6	518.8	652.6	154.5	615.4	431.3	313.8	575.6	847.5	320.6	975.8	543.5	231.3	413.3	259.5	245.1	323.1	176.2	1535.0	629.0	606.0	469.7	186.0	253.6	101.9	578.5	611.2	300.7	301.6	255.3	331.2	320.2	599.8	228.8	155.9	189.6	274.8	194.4	472.3	226.6	239.7	164.1	551.0	200.0	455.8	486.0	724.3	92.8	302.1	292.2	74.2	366.9	233.0	581.2	622.6	739.3	339.5	852.3	975.0	426.0	800.4	499.2	507.6	506.1	437.9	607.1	569.4	208.4	564.3	383.5	148.7	967.8	341.0	575.0	129.6	468.1	840.3	150.0	545.5	812.3	683.6	361.6	679.0	455.5	578.5	302.4	304.5	613.1	383.3	198.3	722.9	992.5	298.6	1015.8	261.6	706.6	901.9	353.7	408.3	522.8	301.2	745.2	655.9	412.1	561.0	539.1	984.4	408.1	769.7	257.9	432.3	1118.9	478.7	557.5	353.4	940.1	751.5	639.7	701.8	201.1	1066.9	510.2	712.8	189.0	324.7	348.9	226.4	245.9	200.5	115.0	150.7	218.4	209.6	93.2	114.0	144.7	474.8	173.5	284.2	235.2	192.0	434.0	652.6	615.4	575.6	847.5	629.0	606.0	578.5	611.2	599.8	551.0	724.3	581.2	313.5	22.4	31.5	75.1	101.5	208.6	176.8	668.0	91.0	157.7	202.8	187.6	80.6	128.7	253.4	286.9	204.3	1408.0	156.5	1140.1	146.8	580.9	261.6	156.6	296.6	246.7	255.1	1091.4	35.4	371.4	1095.5	279.8	192.1	190.1	116.2	181.1	132.1	96.9	416.7	139.7	31.4	337.2	510.6	137.8	179.6	600.2	300.4	139.8	506.9	122.7	264.5	495.5	221.4	20.6	30.7	458.0	929.1	336.7	192.4	172.8	450.7	306.7	178.8	269.2	203.8	74.3	235.6	347.9	604.4	127.7	156.7	1654.9	130.9	223.5	478.2	181.4
BSND	"BART, DFNB73"	ENSG00000162399	"Barttin CLCNK type accessory subunit beta"	Q8WZ55	1	54998933-55017172	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Bartter syndrome, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"kidney: 9.4"	"Group enriched"	"Detected in some"	6	"Distal tubular cells: 25.4;Ionocytes: 87.5"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	25	"RPMI-8226: 4.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA053836, HPA060617"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA053836: AB_2682277, HPA060617: AB_2732651"	"unprognostic (3.38e-2)"	"unprognostic (9.17e-2)"		"unprognostic (2.27e-2)"	"unprognostic (6.97e-3)"	"unprognostic (3.35e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.51e-1)"		"unprognostic (1.78e-1)"	"unprognostic (4.93e-2)"	"unprognostic (6.92e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.57e-1)"			0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	9.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	1.1	0.0	0.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.6	0.2	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	9.2	0.0	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1
BST2	"CD317, tetherin"	ENSG00000130303	"Bone marrow stromal cell antigen 2"	Q10589	19	17402939-17405630	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, B-cell activation, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 694.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1193.2;Hepatic stellate cells: 455.8;Theca cells: 490.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+ RasG12V: 615.0;Karpas-707: 603.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA017060, HPA073472"	Enhanced		Supported	"Golgi apparatus,Vesicles"		NA	NA		260000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 72: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus, Vesicles"		"HPA017060: AB_1845467, HPA073472: "	"prognostic favorable (6.69e-4)"	"unprognostic (1.75e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.93e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.25e-1)"	"unprognostic (6.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.56e-9)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.46e-2)"	226.0	509.8	86.7	95.6	87.6	103.7	152.9	84.0	125.7	93.4	81.7	94.1	47.4	58.7	59.5	40.3	248.0	109.4	111.2	85.1	84.5	160.1	227.8	141.4	128.0	101.5	85.9	694.2	26.3	13.8	56.8	203.0	88.4	88.6	33.3	2.0	77.7	105.2	46.1	24.8	109.1	76.0	97.0	238.5	84.1	35.4	91.1	123.5	54.0	50.8	65.8	82.9	88.6	90.8	327.0	0.5	0.9	145.6	0.0	1.0	49.6	1.3	24.9	459.5	615.0	150.5	286.1	252.2	338.2	197.6	14.6	1.3	212.9	23.9	14.3	279.1	1.8	3.6	525.7	149.8	256.7	120.1	304.7	1.3	0.0	153.0	0.1	4.4	119.0	6.0	146.3	603.4	0.0	89.5	57.7	208.6	158.0	0.1	407.9	105.5	0.8	530.7	110.1	1.5	0.6	1.4	325.5	12.3	410.5	12.3	243.1	166.3	1.5	1.9	11.4	0.5	3.3	308.3	439.3	168.0	1.3	470.8	2.2	229.7	345.3	125.3	171.4	385.5	163.0	115.2	143.2	160.0	283.8	146.5	114.8	132.6	113.3	353.2	359.3	421.7	143.3	367.9	86.7	87.6	84.0	125.7	85.1	84.5	101.5	85.9	88.4	97.0	91.1	90.8	1193.2	57.7	13.6	4.9	90.7	33.1	19.6	255.7	48.9	0.2	86.2	168.5	7.0	50.1	68.5	49.7	0.0	7.8	184.2	1.5	37.2	18.7	10.7	27.8	11.2	420.2	1.2	74.0	0.0	1.2	61.5	152.4	14.8	50.1	227.8	260.9	455.8	211.1	388.9	0.0	0.0	2.8	28.5	189.4	187.6	12.0	346.7	220.4	74.7	32.8	214.5	1.3	211.2	0.5	0.3	3.3	4.8	419.4	192.8	10.3	3.7	1.3	27.4	2.1	164.3	30.7	146.3	1.3	1.2	15.5	26.1	13.1	135.8	490.6	5.0	28.6
BVES	"HBVES, POP1, POPDC1"	ENSG00000112276	"Blood vessel epicardial substance"	Q8NE79	6	105096822-105137157	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Developmental protein"	"Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 27.8;skeletal muscle: 43.9;tongue: 29.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 34.2;Early spermatids: 36.1;Late spermatids: 55.3;Oligodendrocytes: 17.8;Spermatocytes: 24.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 29.7;WM-115: 30.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA014788, HPA018176"	Enhanced		Supported	"Plasma membrane,Cell Junctions"		Yes	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cell Junctions"		"HPA014788: AB_1845504, HPA018176: AB_1845503"	"unprognostic (2.91e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.66e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.22e-2)"	"unprognostic (8.37e-2)"	"unprognostic (4.49e-2)"	"unprognostic (2.29e-2)"	"unprognostic (8.92e-2)"	"unprognostic (5.84e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.24e-4)"	2.9	0.7	2.6	2.3	7.1	0.2	1.5	5.8	3.6	2.5	4.6	14.9	1.4	5.8	1.7	5.3	2.8	1.8	27.8	2.7	4.3	1.6	0.3	1.9	0.6	7.3	5.6	1.0	0.6	0.7	2.4	3.5	7.4	5.2	3.3	0.2	1.4	10.0	43.9	0.7	3.0	17.7	5.2	0.3	6.9	11.5	5.2	0.2	1.3	29.3	0.4	9.3	2.2	10.8	1.3	2.0	7.6	1.3	10.9	14.9	3.3	5.8	4.1	8.8	11.6	0.5	0.0	0.0	0.0	10.9	14.7	0.1	3.3	2.0	8.1	0.0	2.8	0.0	1.0	0.3	2.4	0.0	0.6	8.7	6.9	13.6	1.1	6.6	4.0	3.3	0.1	19.3	19.7	0.1	0.2	1.0	1.6	0.0	0.0	5.7	29.7	0.0	0.0	0.0	9.9	17.1	3.7	0.1	7.7	5.5	0.0	20.0	8.9	14.0	0.0	0.0	15.3	1.8	0.8	0.0	8.3	0.0	30.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	2.6	7.1	5.8	3.6	2.7	4.3	7.3	5.6	7.4	5.2	5.2	10.8	2.1	0.0	0.0	1.6	0.0	0.3	0.4	0.1	0.6	0.0	0.4	1.0	34.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	36.1	1.9	4.4	3.1	0.0	0.0	3.3	0.0	0.2	2.6	0.0	6.0	0.0	0.9	2.2	0.1	2.3	0.0	0.6	0.0	0.0	0.0	1.9	55.3	1.2	0.5	0.0	3.7	1.0	0.0	0.0	5.0	17.8	0.1	0.0	3.4	0.0	0.5	0.1	0.1	0.1	0.0	13.1	11.8	4.4	24.4	5.4	0.1	0.9	0.1	0.2	1.3	0.0	0.3
C1QBP	"gC1Q-R, gC1qR, HABP1, p32, SF2p32"	ENSG00000108561	"Complement C1q binding protein"	Q07021	17	5432777-5448830	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Adaptive immunity, Apoptosis, Complement pathway, Host-virus interaction, Immunity, Innate immunity, mRNA processing, mRNA splicing, Ribosome biogenesis, Transcription, Transcription regulation"		"Cancer-related genes, Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026483	Supported		Approved	"Plasma membrane,Mitochondria"	"Secreted to blood"	NA	NA		410000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane"	Mitochondria	"HPA026483: AB_1847108"	"unprognostic (2.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.80e-2)"	"unprognostic (6.40e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.76e-2)"	"unprognostic (7.47e-2)"	"unprognostic (4.62e-2)"	"unprognostic (2.40e-3)"	"unprognostic (6.03e-2)"	"unprognostic (4.60e-3)"	"unprognostic (3.08e-2)"	"unprognostic (7.80e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.13e-1)"	"unprognostic (3.28e-1)"	"unprognostic (3.97e-1)"	79.3	135.4	85.5	84.1	85.7	121.2	108.7	91.5	118.3	58.4	119.6	140.3	95.9	66.4	68.3	138.6	74.5	48.7	126.3	89.5	94.3	136.4	134.5	54.7	115.7	89.6	92.3	52.7	72.9	127.7	81.3	75.8	93.2	63.9	141.6	86.7	66.2	73.1	174.2	81.3	78.4	80.9	93.1	73.5	74.3	62.5	90.7	98.5	65.1	160.1	135.6	108.4	73.9	97.3	443.8	671.0	233.0	378.0	169.8	207.7	313.7	330.4	268.5	751.4	458.8	646.8	143.7	941.8	317.8	251.3	271.3	385.8	756.7	448.9	689.8	216.6	1300.5	433.9	312.4	762.2	269.9	535.6	331.0	231.4	404.1	414.6	593.1	181.1	390.0	548.2	526.1	234.4	296.1	308.6	766.4	385.6	525.9	497.2	396.7	601.2	329.1	515.0	440.5	328.7	186.0	348.0	271.4	344.4	483.6	232.1	218.1	267.1	231.1	240.1	219.7	275.9	729.9	122.0	201.2	415.0	229.3	506.2	376.8	68.1	197.6	49.9	217.1	212.0	283.5	330.1	239.0	215.4	389.5	289.8	289.7	245.7	15.5	240.7	166.4	325.4	203.6	432.6	85.5	85.7	91.5	118.3	89.5	94.3	89.6	92.3	93.2	93.1	90.7	97.3	101.6	28.9	30.5	10.7	153.1	243.1	229.0	283.3	165.0	70.5	157.3	209.4	84.8	102.9	107.8	82.8	27.1	323.8	115.0	105.6	313.1	248.0	75.1	106.7	149.9	108.2	79.2	183.1	10.8	205.1	457.9	101.0	94.8	85.9	62.2	131.6	75.3	128.5	202.7	60.6	11.6	190.2	154.6	85.3	129.8	89.5	119.6	101.8	156.5	10.3	170.3	105.2	93.7	11.1	16.1	199.3	128.5	98.6	197.4	255.1	78.9	444.1	65.1	79.9	85.5	101.6	189.1	79.3	237.3	284.4	255.3	179.0	105.5	354.3	364.0	253.8
C1QTNF9	"AQL1, C1QTNF9A, CTRP9, MGC48915"	ENSG00000240654	"C1q and TNF related 9"	P0C862	13	24307166-24322535	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"skeletal muscle: 8.4"	"Group enriched"	"Detected in some"	10	"Adipocytes: 34.9;Endothelial cells: 12.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"hippocampal formation: 1.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA056632	Uncertain				"Secreted to blood"	NA	NA	210000000			"Cluster 13: Striated muscle - Muscle contraction"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA056632: AB_2683197"	"unprognostic (1.18e-2)"	"unprognostic (3.22e-2)"	"unprognostic (2.44e-2)"	"unprognostic (3.14e-3)"	"unprognostic (9.22e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.16e-2)"	"unprognostic (3.29e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.22e-1)"	3.1	0.2	0.3	0.1	0.2	0.2	1.5	0.4	0.3	0.3	0.0	1.6	0.6	0.3	0.4	0.4	0.3	0.8	3.8	1.9	0.5	0.3	0.5	0.2	0.2	0.1	0.1	0.1	0.6	0.1	0.1	1.3	0.2	0.6	0.3	0.4	0.4	0.1	8.4	2.1	0.6	0.6	0.0	0.3	0.5	0.9	0.2	0.2	0.2	3.3	0.1	0.8	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.1	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.4	0.3	1.9	0.5	0.1	0.1	0.2	0.0	0.2	0.2	34.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.3	2.2	0.0	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.1	2.0	0.5	0.1	12.9	0.0	0.0	0.2	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.4	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.9	0.9	0.0	0.0	0.0	0.0	2.2	0.0	0.1
C2CD2L	"KIAA0285, TMEM24"	ENSG00000172375	"C2CD2 like"	O14523	11	119102198-119118544	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 37.5;Distal enterocytes: 40.6;Proximal enterocytes: 33.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HMC-1: 50.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011044, HPA075369"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA011044: AB_2668414, HPA075369: "	"unprognostic (3.43e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.03e-3)"	"prognostic favorable (4.92e-4)"	"unprognostic (3.18e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.25e-3)"	"unprognostic (3.37e-3)"	"unprognostic (5.28e-2)"	"unprognostic (2.09e-1)"	"unprognostic (3.99e-3)"	"unprognostic (8.19e-2)"	"prognostic unfavorable (1.75e-4)"	"unprognostic (8.02e-2)"	"unprognostic (8.32e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.60e-1)"	6.6	8.2	26.9	6.5	27.6	13.6	5.8	15.5	28.9	6.4	15.3	11.1	16.1	6.2	4.8	10.8	8.8	5.3	10.2	26.8	19.6	11.6	13.1	10.3	8.1	18.0	18.4	6.0	11.0	5.7	23.9	3.9	18.4	7.1	7.3	14.1	9.6	5.3	15.3	15.3	17.1	5.1	15.2	14.9	8.1	4.3	21.4	8.5	6.7	7.3	5.7	7.0	6.6	23.7	6.1	4.5	6.0	12.5	7.7	3.2	3.9	9.0	7.8	8.7	7.2	7.3	6.3	9.1	23.1	6.3	9.1	13.4	7.6	3.9	3.4	14.3	6.2	35.7	5.9	5.3	10.2	10.5	50.5	3.7	7.9	16.4	6.1	9.8	5.4	13.5	15.1	16.1	8.3	16.2	11.9	24.9	2.2	15.0	11.8	7.4	5.3	10.5	8.7	3.8	18.7	10.5	3.8	20.1	5.9	2.3	35.3	13.9	6.7	8.1	2.8	9.9	16.1	6.8	4.5	3.5	4.9	17.6	9.1	0.5	1.3	2.7	0.2	1.4	0.4	0.1	0.6	0.6	0.5	0.0	0.6	0.3	0.4	0.8	2.0	0.3	0.6	0.5	26.9	27.6	15.5	28.9	26.8	19.6	18.0	18.4	18.4	15.2	21.4	23.7	5.1	6.4	4.2	9.4	3.7	10.7	1.6	2.3	10.2	15.6	6.8	5.0	2.4	2.8	4.3	1.8	37.5	0.9	7.4	40.6	3.9	3.4	5.4	12.1	2.6	5.7	1.2	7.0	15.1	2.8	1.7	2.5	3.6	4.6	2.5	2.2	11.4	5.4	9.4	21.9	15.0	8.0	0.0	13.9	16.1	1.3	2.1	11.4	7.2	5.6	15.3	5.9	7.2	4.5	8.4	5.1	10.4	1.5	7.2	3.2	33.0	4.0	21.9	29.9	6.6	2.1	3.6	3.7	2.0	10.3	10.9	1.1	8.6	3.6	5.5	1.9
C4orf3	"ALN, HCVFTP1"	ENSG00000164096	"Chromosome 4 open reading frame 3"	Q8WVX3	4	119296419-119304445	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal tubular cells: 1070.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026907	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"HPA026907: AB_10600760"	"unprognostic (2.97e-1)"	"unprognostic (4.68e-2)"	"unprognostic (3.32e-1)"	"unprognostic (6.85e-3)"	"unprognostic (9.30e-2)"	"unprognostic (7.15e-3)"	"unprognostic (2.04e-1)"	"unprognostic (8.85e-2)"	"unprognostic (4.90e-2)"	"unprognostic (7.11e-2)"	"unprognostic (9.94e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (8.32e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.90e-1)"	"unprognostic (1.59e-1)"	80.0	67.8	96.4	54.1	107.1	34.1	69.4	103.1	148.1	123.2	83.3	80.2	60.5	79.7	77.9	268.2	68.9	65.1	107.8	90.1	99.6	97.9	110.8	70.3	61.3	107.9	104.9	85.5	51.5	55.5	56.6	60.3	106.4	71.8	43.6	74.7	89.6	69.8	79.6	89.3	67.3	70.6	109.6	63.1	49.6	39.8	109.2	64.8	71.4	59.7	56.8	75.9	150.2	112.8	116.8	13.7	58.4	49.8	107.1	97.0	34.1	59.3	31.6	35.3	62.6	15.6	44.5	95.9	36.6	87.3	31.0	24.8	29.6	54.1	61.8	57.1	21.3	40.9	33.5	67.9	35.9	64.7	42.8	96.4	64.5	30.0	14.4	120.6	52.8	29.1	33.8	50.4	137.6	41.8	50.9	64.0	24.2	60.7	20.9	32.9	62.6	27.3	53.5	32.2	38.4	54.8	46.4	58.5	43.2	56.9	32.6	37.5	55.7	80.3	34.6	52.5	21.4	51.3	59.8	37.2	156.7	36.7	40.9	257.8	110.0	145.4	85.1	132.6	92.9	126.7	109.6	101.5	95.1	104.8	120.4	114.4	239.4	109.6	128.0	131.6	112.9	157.1	96.4	107.1	103.1	148.1	90.1	99.6	107.9	104.9	106.4	109.6	109.2	112.8	213.2	157.0	150.5	11.4	211.3	315.5	292.0	809.1	132.1	79.1	198.4	191.9	544.4	158.7	456.3	222.5	25.0	321.5	228.9	117.0	383.5	288.5	38.1	272.5	148.7	245.6	68.4	78.6	22.2	179.1	403.9	215.0	46.4	134.3	186.1	108.0	234.9	446.4	317.4	153.1	21.6	170.2	408.9	303.5	298.4	31.0	167.4	244.9	199.3	16.9	423.9	233.4	253.3	6.6	16.3	207.6	196.8	215.5	239.0	392.5	500.1	1070.2	542.7	78.9	197.2	145.8	246.0	182.7	67.0	245.9	346.6	445.7	203.2	150.3	135.8	428.1
C5AR1	"C5A, C5AR, C5R1, CD88"	ENSG00000197405	"Complement C5a receptor 1"	P21730	19	47290023-47322066	"CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 125.5;lymphoid tissue: 84.8"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 130.9;Kupffer cells: 228.3;Langerhans cells: 122.4;Macrophages: 446.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 394.0"	"Group enriched"	"Detected in many"	42	"granulocytes: 394.0;monocytes: 115.9"	"Cell line enhanced"	"Detected in some"		"A549: 3.9;CAPAN-2: 4.1;HMC-1: 4.7;U-87 MG: 6.2;U-937: 6.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"CAB002720, HPA014520, HPA048012"	Approved		Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"	Vesicles	"CAB002720: , HPA014520: AB_1846337, HPA048012: "	"unprognostic (5.95e-2)"	"prognostic favorable (4.71e-4)"	"unprognostic (1.70e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.08e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"prognostic unfavorable (9.55e-4)"	"unprognostic (2.02e-1)"	"unprognostic (9.56e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (1.96e-3)"	"prognostic unfavorable (7.99e-4)"	"unprognostic (1.82e-2)"	"unprognostic (6.54e-2)"	72.7	18.2	3.3	84.8	3.1	125.5	8.5	2.4	9.0	11.8	21.6	9.8	2.5	7.5	1.4	8.3	23.9	38.8	11.7	3.9	8.2	9.7	18.0	43.1	11.5	8.9	6.9	5.0	8.9	4.8	51.8	31.8	8.4	5.3	4.2	4.4	5.1	2.5	1.9	2.3	5.8	28.1	5.7	38.2	7.2	2.6	10.5	7.1	3.6	5.8	4.3	37.1	4.6	11.6	1.0	3.9	0.1	0.1	0.7	0.2	0.6	0.7	0.5	0.2	0.1	0.2	4.1	0.3	0.7	0.9	0.4	1.4	0.2	0.5	0.2	0.7	0.5	0.1	3.8	0.6	0.4	1.5	4.7	0.3	2.2	0.4	0.3	0.6	0.0	0.2	0.2	1.7	0.1	1.1	0.2	2.5	1.2	0.2	0.3	0.2	0.1	0.3	1.3	0.9	0.0	0.0	0.3	0.3	0.6	0.5	0.2	2.2	0.0	0.1	2.1	0.3	0.1	0.2	0.3	0.3	6.2	6.5	0.2	41.6	53.8	38.8	0.4	80.4	0.3	0.4	0.3	0.2	6.1	0.6	0.3	0.3	394.0	0.5	115.9	1.1	0.3	19.3	3.3	3.1	2.4	9.0	3.9	8.2	8.9	6.9	8.4	5.7	10.5	11.6	4.4	3.2	20.8	0.0	5.1	5.1	1.0	3.4	2.8	1.0	2.1	4.4	2.9	1.5	15.3	1.8	2.1	0.8	1.5	1.6	3.9	0.0	1.3	17.3	1.8	6.3	0.0	0.4	1.5	0.0	1.5	5.3	1.1	4.6	25.2	0.1	2.9	8.3	130.9	0.0	0.6	0.8	4.1	228.3	122.4	1.3	0.6	446.7	5.4	5.6	56.3	0.2	0.0	1.0	0.3	0.1	0.1	0.0	4.9	0.5	0.7	1.3	40.7	4.3	13.1	4.1	2.8	0.5	0.9	1.4	3.0	1.5	3.3	0.0	1.3	0.5
C6		ENSG00000039537	"Complement C6"	P13671	5	41142116-41261438	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement pathway, Cytolysis, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"liver: 665.9"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 127.2;Hepatocytes: 376.9;Late spermatids: 54.8;Leydig cells: 120.2;Respiratory ciliated cells: 58.0"	"Group enriched"	"Detected in many"	7	"liver cancer: 49.0;pancreatic cancer: 12.5"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"ASC diff: 4.5;ASC TERT1: 6.2;HSkMC: 16.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA043823, CAB069427"	Enhanced				"Secreted to blood"	NA	NA	45000000000	9200000000		"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB069427: AB_1614336, HPA043823: AB_10960262"	"unprognostic (9.79e-2)"	"unprognostic (1.96e-2)"	"unprognostic (5.94e-3)"	"unprognostic (3.02e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.12e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.04e-3)"	"prognostic favorable (4.31e-4)"	"unprognostic (2.69e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.40e-2)"	"unprognostic (3.51e-2)"	12.8	1.1	0.2	0.0	0.2	0.0	5.4	0.2	0.1	0.8	1.6	0.8	0.9	0.4	0.9	0.3	43.9	12.0	57.1	0.2	0.6	4.4	665.9	3.2	0.4	0.0	1.7	6.2	42.7	0.1	0.7	2.8	0.2	0.9	0.6	0.0	0.9	0.6	0.6	0.6	1.4	0.9	0.1	0.3	2.2	4.2	0.8	0.6	2.0	0.7	0.5	0.9	0.6	0.6	0.0	0.0	0.0	0.0	4.5	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	0.0	16.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.1	0.2	0.6	0.0	1.7	0.2	0.1	0.8	0.6	0.8	0.0	0.0	0.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	20.9	127.2	7.5	0.0	0.0	0.0	0.1	0.3	0.0	9.3	11.3	37.5	0.8	0.9	0.0	8.0	1.4	0.4	0.0	6.7	0.0	0.7	0.0	0.1	5.0	376.9	0.0	0.0	2.7	1.0	0.0	9.7	0.3	54.8	120.2	0.2	0.0	0.0	0.0	0.0	0.0	1.0	1.3	0.5	1.3	0.4	0.0	0.0	11.6	0.8	58.0	0.0	0.0	0.2	0.4	0.4	0.1	0.0	0.0	0.0	0.4	0.5	0.6	0.0
C8A		ENSG00000157131	"Complement C8 alpha chain"	P07357	1	56854797-56918223	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"	"Complement alternate pathway, Complement pathway, Cytolysis, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	195	"liver: 635.7"	"Cell type enriched"	"Detected in some"	36	"Hepatocytes: 296.4"	"Cancer enriched"	"Detected in single"	279	"liver cancer: 85.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"Hep G2: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA		6400000000		"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"										"unprognostic (3.73e-3)"	"unprognostic (2.44e-1)"			"unprognostic (1.28e-1)"			"unprognostic (6.40e-2)"		"unprognostic (9.82e-2)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.1	635.7	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.0	5.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	296.4	0.0	0.0	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1
CA9	"CAIX, MN"	ENSG00000107159	"Carbonic anhydrase 9"	Q16790	9	35673918-35681159	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Lyase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"stomach 1: 289.3"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 275.3;Cholangiocytes: 62.9;Early spermatids: 205.8;Gastric mucus-secreting cells: 259.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 85.9"	"Region enriched"	"Detected in single"	9	"cerebellum: 5.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"A-431: 189.3;HDLM-2: 98.1;hTERT-RPE1: 113.1;U-87 MG: 374.4"	"Region enhanced"	"Detected in many"		"cerebellum: 12.3"	"Low region specificity"	"Detected in all"			"CAB005100, CAB017107, HPA055207"	Enhanced		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB005100: AB_2066539, CAB017107: , HPA055207: AB_2682738"	"unprognostic (8.01e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.71e-5)"	"unprognostic (1.47e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.24e-3)"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.22e-7)"	"unprognostic (7.29e-2)"	"prognostic favorable (9.50e-4)"	"unprognostic (2.97e-3)"	"unprognostic (8.67e-2)"	3.8	0.4	0.0	0.2	0.0	0.0	0.1	5.6	0.6	0.5	0.0	0.6	14.5	0.2	0.1	0.8	0.4	24.4	2.0	0.2	0.1	0.2	1.3	0.2	0.0	0.0	0.1	0.7	6.6	0.0	0.5	0.0	0.2	0.5	0.0	1.0	0.1	0.1	0.1	8.2	13.6	0.1	0.0	0.0	289.3	5.5	0.5	0.0	0.0	0.0	0.0	0.7	0.7	0.0	189.3	0.3	0.0	0.0	0.0	0.0	0.0	0.2	3.6	0.3	2.5	0.0	0.1	0.0	0.1	0.0	0.5	5.7	0.0	0.9	1.5	98.1	0.0	0.0	0.7	0.4	0.0	0.0	0.2	0.4	0.0	0.0	0.3	113.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.3	0.2	0.5	0.0	0.0	10.6	0.0	0.6	1.6	0.0	0.0	0.1	0.7	0.0	0.0	0.2	0.0	18.9	0.4	0.0	4.7	0.0	0.4	0.1	374.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.6	0.6	0.2	0.1	0.0	0.1	0.2	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	4.5	0.7	275.3	0.0	0.4	0.1	0.0	0.4	62.9	28.1	0.0	0.0	0.0	0.0	0.1	0.0	49.1	205.8	0.0	0.1	0.2	0.0	0.0	0.1	50.9	0.6	1.2	259.5	0.2	0.0	0.4	0.7	0.0	0.1	0.0	0.6	4.0	18.3	0.0	0.0	19.6	1.5	0.1	0.0	0.0	0.6	1.3	0.0	0.0	0.0	26.6	0.0	0.7	0.3	0.8	0.7	0.1	5.5	0.0	0.0	0.0	1.5	0.9	4.0	0.0	3.1	0.3	0.1	0.7	5.3	0.4
CACFD1	"C9orf7, D9S2135, flower"	ENSG00000160325	"Calcium channel flower domain containing 1"	Q9UGQ2	9	133459965-133470848	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 58.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 75.5;Gastric mucus-secreting cells: 67.2;Hepatocytes: 47.9;Paneth cells: 53.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.8"	"Group enriched"	"Detected in many"	4	"B-cells: 2.0;granulocytes: 3.8"	"Cell line enhanced"	"Detected in many"		"T-47d: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015280			Approved	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA015280: AB_1845833"	"unprognostic (3.15e-2)"	"unprognostic (4.25e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.48e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-2)"	"unprognostic (5.49e-2)"	"unprognostic (3.97e-1)"	"unprognostic (3.17e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.91e-2)"	"prognostic favorable (2.83e-8)"	"unprognostic (5.10e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.99e-3)"	5.1	11.3	6.4	1.9	6.2	2.4	7.0	8.2	6.9	9.5	6.9	19.9	5.8	9.9	5.3	9.9	9.3	4.5	11.2	5.8	6.0	28.2	58.6	12.8	1.5	7.5	6.1	10.7	18.9	7.9	19.0	1.2	6.0	13.3	2.8	2.1	15.8	4.0	9.0	5.4	14.9	2.4	5.9	7.3	28.4	23.9	6.5	0.9	17.4	1.8	1.7	11.8	6.9	7.8	0.4	2.1	4.3	2.7	0.8	0.1	2.5	2.0	2.9	1.5	0.3	5.7	4.8	0.2	4.2	2.0	2.6	1.2	2.2	1.6	0.0	1.1	1.4	0.6	4.8	2.5	2.5	0.0	0.6	0.0	3.2	1.3	1.0	4.8	1.8	1.1	0.8	1.8	2.4	3.7	0.3	0.7	3.4	3.3	1.5	1.4	0.6	9.3	2.9	1.7	4.9	9.1	2.5	5.6	0.9	2.6	9.5	1.6	0.4	3.5	2.2	0.6	0.1	3.4	4.8	2.4	1.1	0.3	1.1	3.8	0.5	1.6	0.2	0.0	0.0	2.0	0.1	0.4	0.4	0.7	0.1	0.5	0.0	0.6	0.2	0.2	0.2	0.1	6.4	6.2	8.2	6.9	5.8	6.0	7.5	6.1	6.0	5.9	6.5	7.8	1.7	19.2	19.6	3.3	5.5	2.8	5.5	5.0	3.4	4.6	13.0	8.9	9.8	21.5	8.8	20.2	12.5	1.9	1.0	75.5	3.9	22.0	13.4	9.8	5.4	3.8	29.2	0.0	5.8	33.1	3.3	4.0	67.2	15.1	4.5	5.9	5.3	47.9	3.6	3.3	4.8	43.1	10.2	5.6	2.2	8.1	8.1	2.1	5.4	1.9	5.9	6.7	2.1	4.5	4.7	26.2	53.2	7.5	3.9	7.0	31.7	16.5	5.2	9.8	0.0	3.4	4.4	13.7	14.7	2.9	1.6	2.9	1.9	2.9	24.5	6.2
CACHD1	"KIAA1573, VWCD1"	ENSG00000158966	"Cache domain containing 1"	Q5VU97	1	64470129-64693058	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	4	"Astrocytes: 283.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 41.3;NTERA-2: 56.5;SuSa: 35.4;U-2197: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017202	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA		310000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli"		"HPA017202: AB_1852423"	"unprognostic (2.92e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.32e-2)"	"unprognostic (6.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.16e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.24e-3)"	"unprognostic (2.67e-2)"	"unprognostic (3.89e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.13e-1)"	11.1	13.1	17.5	2.0	18.7	0.1	11.8	6.4	11.3	11.9	22.8	2.9	1.5	10.8	9.1	3.7	14.4	4.5	4.0	14.9	12.9	6.3	1.8	9.0	1.9	12.0	18.1	22.6	7.3	6.9	9.1	10.2	10.9	8.2	2.7	6.4	8.2	7.6	2.9	7.7	3.5	9.6	8.6	4.5	6.7	2.3	18.9	5.1	6.4	5.4	1.6	6.0	10.6	5.7	0.3	1.7	41.3	6.1	16.1	5.6	0.0	5.9	7.8	10.0	9.7	24.8	0.2	0.0	16.8	9.7	8.0	3.1	23.4	5.0	10.4	4.6	12.2	8.9	2.9	0.0	0.0	3.8	0.1	5.0	3.4	1.2	6.2	6.0	5.7	6.0	0.0	0.0	0.0	0.7	0.8	0.0	56.5	0.3	4.2	5.2	4.2	0.0	0.0	1.3	2.1	23.5	12.7	0.0	5.2	35.4	1.7	0.5	3.7	1.0	7.3	29.1	5.3	0.0	0.0	0.0	1.0	0.7	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.5	18.7	6.4	11.3	14.9	12.9	12.0	18.1	10.9	8.6	18.9	5.7	25.2	6.4	49.9	283.7	0.1	17.3	7.5	6.1	6.8	15.5	8.3	7.0	1.3	0.0	11.5	3.7	0.0	0.0	0.2	0.1	0.0	2.3	9.5	14.0	8.1	20.2	0.0	0.0	19.4	2.7	0.1	11.1	5.6	16.9	2.5	26.0	4.2	1.3	0.2	0.0	6.9	0.2	4.1	0.3	6.1	4.1	14.3	0.8	1.8	24.4	0.2	6.4	0.0	57.8	1.8	1.2	0.1	3.0	0.0	2.0	0.5	4.2	10.2	1.3	6.6	25.2	6.4	0.5	0.8	2.9	14.8	0.0	0.9	0.8	0.5	5.1
CACNA1A	"APCA, CACNL1A4, Cav2.1, EA2, FHM, HPCA, MHP, MHP1, SCA6"	ENSG00000141837	"Calcium voltage-gated channel subunit alpha1 A"	O00555	19	13206442-13633025	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 99.3"	"Group enriched"	"Detected in many"	8	"Bipolar cells: 101.4;Enteroendocrine cells: 214.1;Excitatory neurons: 318.3;Horizontal cells: 249.0;Inhibitory neurons: 372.1;Oligodendrocyte precursor cells: 271.9"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in all"	4	"cerebellum: 99.3;cerebral cortex: 30.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"SCLC-21H: 45.1;U-87 MG: 23.9"	"Low region specificity"	"Detected in all"							"HPA064258, HPA068138, HPA071902"	Enhanced	Supported	Uncertain	"Endoplasmic reticulum"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"		"HPA064258: AB_2685229, HPA068138: , HPA071902: "	"unprognostic (1.09e-1)"	"unprognostic (3.73e-3)"	"unprognostic (2.27e-1)"	"unprognostic (2.78e-4)"	"unprognostic (4.00e-2)"	"unprognostic (2.29e-3)"	"unprognostic (5.47e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.14e-2)"	"prognostic favorable (4.32e-4)"	"unprognostic (5.31e-3)"	"unprognostic (5.03e-6)"	"unprognostic (6.29e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.61e-2)"	"unprognostic (6.25e-2)"	1.0	2.3	15.4	0.3	15.8	0.1	0.9	99.3	30.4	0.6	0.0	0.7	1.2	0.8	1.1	0.2	3.2	0.1	0.6	15.1	6.8	0.5	0.2	0.2	0.4	7.2	11.2	0.9	2.6	0.1	4.2	0.0	10.6	0.4	0.4	7.1	0.2	0.1	0.5	0.3	1.7	0.2	9.4	0.6	2.7	2.3	11.3	0.1	0.7	0.1	0.2	0.3	0.7	15.2	0.0	0.1	0.1	6.0	0.2	0.2	0.0	2.2	2.5	0.3	0.0	0.0	0.0	0.2	0.0	0.2	5.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	2.8	0.0	1.9	0.0	0.0	0.0	0.0	0.0	7.2	0.2	0.0	0.1	0.2	1.4	0.1	0.3	0.6	0.0	0.1	0.0	0.1	45.1	0.0	0.0	0.0	0.4	0.1	0.0	1.9	0.1	0.1	0.9	0.2	0.1	0.0	0.0	0.0	23.9	0.1	0.6	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	0.1	0.1	0.3	0.1	0.2	0.1	0.1	0.0	15.4	15.8	99.3	30.4	15.1	6.8	7.2	11.2	10.6	9.4	11.3	15.2	7.7	6.4	3.2	31.3	9.6	0.6	3.4	0.0	0.0	101.4	3.1	7.4	2.8	0.0	1.3	1.8	16.7	0.0	2.9	0.6	0.0	0.5	27.1	1.2	6.3	6.5	214.1	0.4	318.3	0.4	0.2	4.7	10.7	2.6	1.3	5.2	1.8	1.2	0.5	249.0	372.1	5.0	4.1	1.9	1.4	28.0	1.2	2.1	0.0	28.1	1.2	3.0	4.1	271.9	11.5	1.5	0.1	0.4	0.5	0.8	0.2	2.0	3.7	7.0	0.0	5.1	17.6	4.3	7.1	0.4	0.1	0.3	2.0	2.5	1.0	0.9
CACNA1C	"CACH2, CACN2, CACNL1A1, Cav1.2, CCHL1A1, LQT8, TS"	ENSG00000151067	"Calcium voltage-gated channel subunit alpha1 C"	Q13936	12	1970786-2697950	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Host-virus interaction, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Brugada syndrome, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 20.7;heart muscle: 27.1;intestine: 29.9"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 606.7;Horizontal cells: 301.2;Inhibitory neurons: 476.2;Oligodendrocyte precursor cells: 194.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	16	"HDLM-2: 87.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039796, CAB079031"	Enhanced	Approved				NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB079031: , HPA039796: AB_10673019"	"unprognostic (1.76e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.29e-2)"	"unprognostic (9.35e-2)"	"unprognostic (3.71e-2)"	"unprognostic (1.60e-2)"	"unprognostic (4.68e-2)"	"unprognostic (7.99e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.03e-5)"	"unprognostic (1.93e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.02e-7)"	"unprognostic (8.85e-2)"	"unprognostic (3.60e-2)"	"unprognostic (6.90e-2)"	"unprognostic (3.39e-2)"	3.0	0.9	4.5	1.4	0.9	0.0	1.9	0.0	3.0	5.6	0.0	29.9	0.7	20.7	0.5	2.1	4.2	2.3	27.1	2.0	0.5	2.5	0.4	4.6	0.3	0.0	0.5	1.9	0.9	0.1	5.2	2.1	0.0	6.5	1.3	1.7	1.0	3.3	0.9	1.3	5.0	10.2	0.0	3.0	5.4	2.5	1.8	0.2	1.3	0.8	0.3	12.3	3.4	0.1	0.0	0.0	0.1	0.0	3.3	2.0	0.2	3.4	4.1	2.2	1.5	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.8	87.0	0.8	0.1	0.0	0.0	2.1	0.0	0.1	5.1	0.0	1.1	0.0	0.2	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	5.4	0.6	5.2	0.0	0.1	0.2	0.0	4.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	4.5	0.9	0.0	3.0	2.0	0.5	0.0	0.5	0.0	0.0	1.8	0.1	2.2	0.0	0.0	96.6	0.2	0.6	1.0	0.0	0.0	20.7	0.8	8.3	48.8	0.0	0.0	0.0	2.1	0.2	1.3	0.6	0.0	0.1	35.6	5.1	14.6	5.2	36.6	0.8	606.7	0.0	0.4	4.2	2.0	0.9	0.0	2.7	2.2	0.1	0.3	301.2	476.2	0.6	0.0	0.0	1.1	90.3	0.9	0.2	0.0	72.1	0.0	6.0	1.0	194.5	21.7	0.4	1.2	4.1	0.2	1.2	0.0	0.1	0.0	1.3	13.1	1.6	26.7	3.4	5.8	0.1	0.1	0.1	1.1	0.2	0.5	3.1
CACNA1D	"CACH3, CACN4, CACNL1A2, Cav1.3, CCHL1A2"	ENSG00000157388	"Calcium voltage-gated channel subunit alpha1 D"	Q01668	3	53328963-53813733	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cancer-related genes, Deafness, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 251.2;Inhibitory neurons: 354.1;Microglial cells: 126.5;Oligodendrocyte precursor cells: 197.5"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 5.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	10	"basophil: 3.7"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 3.7"	"Cell line enhanced"	"Detected in some"		"HMC-1: 22.7;RPMI-8226: 55.5;SK-BR-3: 10.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020215	Uncertain		Approved	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane"		"HPA020215: AB_1845860"	"unprognostic (5.85e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.09e-2)"	"unprognostic (2.24e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.95e-1)"	"unprognostic (4.42e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.34e-8)"	"unprognostic (1.14e-1)"	"unprognostic (3.05e-2)"	"unprognostic (8.09e-3)"	"unprognostic (6.70e-3)"	0.1	6.6	7.0	0.2	4.3	0.7	1.8	2.3	10.4	6.0	0.0	1.5	1.7	3.7	7.3	0.5	7.7	2.0	0.6	3.6	0.8	2.2	1.0	3.7	0.1	0.0	1.2	0.5	2.8	1.2	3.5	0.6	0.4	3.0	1.5	4.3	0.5	1.8	0.2	0.7	2.4	0.7	3.5	1.8	0.8	1.6	6.1	0.2	2.9	0.2	0.1	0.6	0.1	6.0	0.0	0.5	0.1	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	2.7	2.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	2.1	0.1	0.0	0.4	0.9	0.0	0.0	0.2	55.5	0.5	3.6	4.7	2.1	0.3	10.1	1.1	0.0	2.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	3.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.0	4.3	2.3	10.4	3.6	0.8	0.0	1.2	0.4	3.5	6.1	6.0	0.6	3.2	36.2	7.8	0.6	0.9	0.8	4.6	2.2	33.3	7.2	1.8	2.3	10.0	9.1	1.8	35.5	0.9	0.5	3.0	0.0	7.2	4.9	4.3	40.1	2.4	59.4	2.7	251.2	2.3	0.2	3.4	5.1	3.3	12.6	1.7	0.0	3.4	0.2	8.4	354.1	3.8	2.0	0.8	4.0	8.3	4.4	2.1	5.4	126.5	0.5	4.0	0.0	197.5	29.9	3.8	5.6	27.1	0.1	1.7	9.5	2.7	9.5	12.9	0.0	0.2	8.6	1.0	3.7	0.5	1.0	0.3	1.7	9.6	7.6	0.9
CACNA1F	"AIED, Cav1.4, CORDX3, CSNB2, CSNB2A, CSNBX2, JM8, JMC8, OA2"	ENSG00000102001	"Calcium voltage-gated channel subunit alpha1 F"	O60840	X	49205063-49233371	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Sensory transduction, Transport, Vision"	"Calcium channel, Ion channel, Voltage-gated channel"	"Cone-rod dystrophy, Congenital stationary night blindness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	53	"retina: 125.3"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 66.5;Cone photoreceptor cells: 133.5;Rod photoreceptor cells: 97.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA068379	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 79: Retina - Phototransduction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA068379: AB_2732782"	"unprognostic (1.20e-3)"	"unprognostic (8.62e-2)"	"unprognostic (4.25e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.46e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.04e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.59e-1)"	"unprognostic (6.08e-7)"	"unprognostic (8.03e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.65e-2)"	"unprognostic (3.77e-3)"	0.2	0.4	0.7	0.4	0.7	1.9	0.7	2.3	1.4	0.2	0.8	0.6	0.8	0.2	1.0	0.2	0.5	0.2	0.2	0.8	0.4	0.3	0.0	0.6	1.3	0.4	0.1	0.3	0.6	0.0	0.1	0.0	0.5	0.1	0.7	125.3	0.6	0.4	0.0	1.0	1.6	0.2	0.0	0.8	0.6	0.2	0.4	0.8	0.4	0.0	0.5	0.2	0.1	0.8	0.1	0.7	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.3	0.1	0.0	0.8	0.4	0.5	0.4	0.5	0.0	0.0	0.0	0.3	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.2	0.2	0.6	0.3	0.0	0.0	0.0	0.0	1.4	0.5	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.4	0.1	0.2	0.5	0.1	0.3	1.3	0.1	0.0	0.7	0.7	2.3	1.4	0.8	0.4	0.4	0.1	0.5	0.0	0.4	0.8	0.2	0.0	0.5	0.0	1.1	0.0	0.1	0.1	0.0	66.5	1.1	0.9	1.9	0.0	0.0	1.8	133.5	0.1	2.8	0.2	0.0	0.0	0.0	0.4	0.0	1.0	0.0	0.4	0.9	0.2	0.2	0.1	1.1	0.2	0.0	0.0	0.0	0.0	0.2	6.7	0.4	2.3	0.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.1	7.4	0.0	0.0	0.3	0.0	0.1	0.4	0.1	0.1	0.4	0.1	0.1	97.5	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.3	0.1	0.3	0.1
CACNA1H	Cav3.2	ENSG00000196557	"Calcium voltage-gated channel subunit alpha1 H"	O95180	16	1153106-1221771	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 107.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 22.8;Late spermatids: 15.5;Peritubular cells: 25.9;Sertoli cells: 26.3;Smooth muscle cells: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.9;AN3-CA: 25.4;MCF7: 48.3;OE19: 16.0;T-47d: 13.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA039125	Approved		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Vesicles"		"HPA039125: AB_10795578"	"unprognostic (1.66e-3)"	"unprognostic (2.10e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.37e-2)"	"unprognostic (2.15e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.30e-2)"	"prognostic favorable (3.12e-5)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.78e-5)"	"unprognostic (1.93e-2)"	"unprognostic (4.65e-2)"	"unprognostic (1.70e-2)"	"unprognostic (5.55e-2)"	13.6	28.0	13.6	5.2	24.5	0.1	7.6	2.1	12.1	26.3	0.0	107.7	6.4	57.3	2.6	7.1	37.8	10.3	9.3	11.0	8.1	14.1	13.4	11.8	0.7	3.0	3.8	80.1	4.6	3.6	45.9	2.1	2.9	28.0	2.4	1.8	1.9	27.5	6.2	19.4	22.3	15.6	3.7	0.7	27.5	19.4	13.5	0.5	11.0	3.0	0.2	57.0	17.1	0.2	0.0	17.9	3.0	25.4	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	10.4	0.1	0.0	11.0	3.0	0.0	4.5	0.3	0.0	0.0	0.0	0.0	0.0	3.0	4.9	0.0	0.0	48.3	0.0	0.0	9.4	16.0	3.6	0.0	0.0	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.9	1.0	13.9	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	24.5	2.1	12.1	11.0	8.1	3.0	3.8	2.9	3.7	13.5	0.2	1.3	0.0	0.0	1.0	0.0	1.5	0.1	0.0	0.0	22.8	0.3	0.1	2.7	4.3	0.0	0.0	0.0	0.0	0.2	0.1	0.0	3.7	7.2	0.2	5.3	2.2	10.8	0.0	2.6	0.0	0.1	1.3	0.5	0.2	4.5	0.0	0.4	7.8	0.1	0.0	0.7	1.0	2.0	0.0	0.3	15.5	8.4	0.2	0.0	0.0	0.0	0.8	0.0	0.5	0.1	0.4	0.4	25.9	0.0	7.2	0.0	0.7	0.0	1.5	26.3	0.4	22.4	3.4	5.1	0.0	3.4	0.0	0.2	0.3	0.1	1.3
CACNA1I	Cav3.3	ENSG00000100346	"Calcium voltage-gated channel subunit alpha1 I"	Q9P0X4	22	39570753-39689735	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.7;thyroid gland: 5.3"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 16.9;Excitatory neurons: 16.8;Inhibitory neurons: 12.3"	"Cancer enriched"	"Detected in single"	5	"thyroid cancer: 2.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SK-BR-3: 1.9;T-47d: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA066992			Uncertain	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Cell Junctions"	"HPA066992: "	"unprognostic (3.97e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.63e-1)"	"unprognostic (7.21e-2)"	"unprognostic (5.20e-3)"	"unprognostic (1.64e-2)"	"unprognostic (8.64e-2)"	"unprognostic (1.62e-2)"	"unprognostic (6.14e-3)"	"unprognostic (1.57e-1)"	"unprognostic (3.78e-2)"	"unprognostic (8.27e-4)"	0.2	3.3	5.0	0.8	5.6	0.6	0.1	1.5	9.7	0.1	0.0	0.5	0.1	0.1	0.0	0.2	0.2	0.1	0.0	8.7	1.3	0.1	0.0	0.5	1.9	7.6	1.4	0.0	0.1	0.0	0.3	0.0	7.9	0.1	0.0	2.6	0.1	0.0	0.0	0.2	3.3	0.0	0.7	1.5	0.6	0.8	2.2	0.2	5.3	0.0	0.5	0.4	0.2	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	1.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	5.0	5.6	1.5	9.7	8.7	1.3	7.6	1.4	7.9	0.7	2.2	4.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	16.9	0.2	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.2	0.0	0.1	0.0	0.4	16.8	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	3.3	12.3	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.0	1.0	2.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.1
CACNA1S	"CACNL1A3, Cav1.1, HOKPP, hypoPP, MHS5"	ENSG00000081248	"Calcium voltage-gated channel subunit alpha1 S"	Q13698	1	201039512-201112451	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	86	"skeletal muscle: 254.9;tongue: 193.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.6;Cone photoreceptor cells: 6.2;Late spermatids: 5.9;Skeletal myocytes: 6.3"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"BEWO: 1.1;HSkMC: 1.8"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.8"	"Region enriched"	"Detected in single"	8	"olfactory bulb: 2.6"	"CAB009507, HPA048892, HPA056815"	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"			"CAB009507: AB_2069576, HPA048892: AB_2680548, HPA056815: AB_2683242"	"unprognostic (2.14e-2)"		"unprognostic (1.38e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.52e-3)"	"unprognostic (4.53e-2)"	"unprognostic (2.84e-1)"		"unprognostic (2.23e-1)"	"unprognostic (2.53e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.28e-2)"	"unprognostic (7.36e-2)"	"unprognostic (1.57e-1)"	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.0	0.9	1.5	0.0	254.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	0.0	193.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.2	0.1	0.6	0.2	0.8	0.2	0.1	1.1	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	5.9	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.2	0.0	6.3	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNA2D1	"CACNA2, CACNL2A, LINC01112, lncRNA-N3, MHS3"	ENSG00000153956	"Calcium voltage-gated channel auxiliary subunit alpha2delta 1"	P54289	7	81946444-82443777	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 78.7;tongue: 98.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 543.1;Inhibitory neurons: 383.3;Oligodendrocyte precursor cells: 357.9;Oligodendrocytes: 662.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 127.4;HUVEC TERT2: 54.9;SH-SY5Y: 62.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008213, HPA008621"	Enhanced				"Intracellular and membrane"	NA	NA		390000000		"Cluster 80: Striated muscle - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA008213: AB_1233654, HPA008621: AB_1845863"	"unprognostic (5.07e-3)"	"unprognostic (2.21e-1)"	"unprognostic (4.27e-3)"	"unprognostic (2.92e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.22e-1)"	"unprognostic (3.76e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.24e-3)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (1.16e-4)"	"unprognostic (4.28e-3)"	"unprognostic (2.13e-1)"	"unprognostic (9.18e-2)"	"unprognostic (1.03e-4)"	11.6	14.5	9.8	4.3	11.9	0.0	4.1	1.2	15.4	5.3	0.0	13.0	5.1	7.4	2.4	5.3	3.9	6.4	31.3	18.8	13.3	8.4	1.3	3.4	1.9	4.6	26.0	7.9	1.5	1.2	6.3	4.2	9.5	13.7	5.1	8.3	2.6	6.4	78.7	4.7	3.4	12.2	8.1	4.4	5.6	3.7	34.2	3.9	18.9	98.5	3.1	7.1	3.4	12.8	0.0	12.7	10.6	0.0	18.2	22.9	0.0	23.4	15.0	11.4	11.1	0.0	3.5	0.0	0.0	20.4	14.1	0.0	11.2	0.0	14.8	0.0	15.0	0.7	14.4	0.0	11.9	5.3	0.0	13.6	0.1	39.6	0.1	127.4	54.9	0.0	0.0	0.2	25.7	0.1	0.0	0.0	12.6	0.0	5.0	2.3	2.1	0.0	0.9	0.9	21.1	62.3	4.6	0.1	0.0	11.1	0.1	0.0	39.6	20.1	15.0	20.1	0.0	0.1	0.0	0.0	16.9	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	11.9	1.2	15.4	18.8	13.3	4.6	26.0	9.5	8.1	34.2	12.8	6.3	0.0	1.7	137.1	0.0	5.7	4.5	0.1	8.0	47.7	6.6	3.9	88.0	0.0	1.3	7.3	18.8	0.1	0.1	0.0	0.0	0.0	64.2	0.5	20.7	6.8	38.8	0.0	543.1	0.0	0.0	20.6	14.3	0.4	25.3	29.9	1.4	0.4	0.2	25.2	383.3	2.6	16.2	0.0	2.9	42.4	10.2	0.4	1.8	87.1	0.6	5.6	0.0	357.9	662.8	0.8	0.0	6.0	0.2	11.2	0.0	9.5	0.7	6.1	6.6	17.6	21.5	1.5	1.9	1.9	6.5	0.1	0.4	32.7	0.2	1.4
CACNA2D2	KIAA0558	ENSG00000007402	"Calcium voltage-gated channel auxiliary subunit alpha2delta 2"	Q9NY47	3	50362613-50504244	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 49.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 76.9;Alveolar cells type 2: 182.3;Inhibitory neurons: 36.0"	"Cancer enhanced"	"Detected in many"		"testis cancer: 20.4"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 192.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034771, HPA071829"	Enhanced		Approved	Vesicles		NA	NA		9700000	"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 11: Alveolar cells - Smell perception"	Vesicles		"HPA034771: AB_10603555, HPA071829: AB_2686454"	"unprognostic (2.06e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (7.62e-5)"	"unprognostic (6.59e-2)"	"unprognostic (6.37e-2)"	"unprognostic (6.91e-2)"	"unprognostic (6.57e-3)"	"unprognostic (4.39e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (1.21e-4)"	"unprognostic (2.71e-2)"	"unprognostic (1.57e-4)"	"unprognostic (3.03e-1)"	"unprognostic (4.14e-2)"	"unprognostic (3.55e-1)"	"unprognostic (4.22e-2)"	1.0	0.6	4.7	1.3	5.2	1.2	1.2	9.9	6.9	1.4	0.3	1.6	1.2	1.6	0.9	0.6	1.1	0.7	8.4	0.7	13.9	2.3	0.3	49.1	1.2	8.3	8.4	2.1	4.3	2.5	7.1	1.8	14.0	3.0	1.9	8.6	1.3	1.1	1.8	2.6	1.6	1.2	4.8	1.4	4.1	6.5	11.4	1.0	2.2	1.5	0.5	0.5	0.7	2.1	0.0	0.1	3.0	6.6	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.6	0.0	0.6	0.2	24.8	0.0	0.1	0.1	1.8	0.2	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.2	0.4	0.0	1.1	0.1	0.2	7.9	0.2	0.5	0.2	0.0	0.7	0.0	0.0	18.6	192.7	0.6	0.4	0.0	5.5	1.5	0.0	0.0	0.1	1.8	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.7	0.0	0.9	0.7	0.9	0.7	0.0	0.5	1.2	0.7	0.0	0.9	0.0	0.1	1.2	0.4	4.7	5.2	9.9	6.9	0.7	13.9	8.3	8.4	14.0	4.8	11.4	2.1	0.4	76.9	182.3	4.2	0.4	1.5	0.4	0.0	1.8	21.5	2.5	1.7	4.6	0.0	2.5	1.8	20.9	0.0	6.8	0.8	0.0	0.2	0.7	0.1	0.4	0.6	1.2	2.7	7.8	0.0	0.0	1.5	3.1	0.2	20.3	0.3	0.4	0.0	0.1	0.0	36.0	11.0	0.0	0.0	0.4	4.0	0.3	0.4	0.0	1.9	0.1	4.3	15.5	6.0	0.9	0.4	0.3	1.9	2.9	0.7	0.2	0.7	2.2	9.8	13.1	2.4	2.4	2.6	11.2	0.2	0.6	0.3	2.9	3.4	0.6	0.3
CACNA2D3	HSA272268	ENSG00000157445	"Calcium voltage-gated channel auxiliary subunit alpha2delta 3"	Q8IZS8	3	54122547-55074557	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 15.8;skeletal muscle: 9.9;tongue: 10.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 160.9;Excitatory neurons: 828.3;Inhibitory neurons: 456.4;Oligodendrocyte precursor cells: 317.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 4.1;HAP1: 1.9;HeLa: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030849			Uncertain	Nucleoplasm		NA	NA		69000		"Cluster 47: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm		"HPA030849: "	"unprognostic (6.92e-2)"	"unprognostic (1.35e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.34e-5)"	"unprognostic (5.53e-3)"	"unprognostic (2.64e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.17e-2)"	"unprognostic (5.84e-3)"	"unprognostic (7.22e-3)"	"unprognostic (1.14e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.47e-3)"	"unprognostic (2.19e-1)"	"unprognostic (3.62e-2)"	"unprognostic (6.95e-2)"	0.2	4.1	8.8	0.1	11.6	0.0	0.2	0.0	15.8	0.3	0.0	0.7	0.1	0.1	1.3	0.5	0.4	0.2	2.6	9.4	8.4	1.3	0.0	0.5	0.5	2.1	10.2	2.5	0.0	0.3	0.8	0.5	1.3	1.0	0.3	2.9	0.4	1.5	9.9	0.1	0.3	0.6	0.0	0.2	0.4	1.4	3.5	0.1	0.4	10.7	0.5	0.1	0.4	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.1	0.1	9.2	0.0	0.5	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	11.6	0.0	15.8	9.4	8.4	2.1	10.2	1.3	0.0	3.5	9.9	0.5	0.0	0.0	160.9	0.6	0.3	0.4	0.2	7.4	10.8	0.2	0.5	30.2	0.0	0.7	0.0	8.4	9.9	5.5	0.1	7.9	0.0	83.4	0.9	0.8	0.6	0.0	1.3	828.3	0.6	3.2	3.4	1.5	1.8	0.0	1.1	0.4	0.0	5.9	0.0	456.4	0.0	2.0	8.9	2.7	56.1	2.8	11.0	0.0	97.4	22.2	5.0	0.0	317.7	11.3	1.2	0.0	1.5	0.1	0.4	0.0	0.2	0.8	1.4	6.6	1.7	1.9	5.7	2.9	3.4	0.1	68.0	0.7	0.8	0.0	0.4
CACNA2D4		ENSG00000151062	"Calcium voltage-gated channel auxiliary subunit alpha2delta 4"	Q7Z3S7	12	1791963-1918666	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	39	"retina: 20.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 56.3;Cone photoreceptor cells: 156.4;Early spermatids: 56.3;Late spermatids: 117.6;Rod photoreceptor cells: 98.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	8	"dendritic cells: 2.9;monocytes: 4.4;T-cells: 4.2"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.7;HL-60: 2.8;HMC-1: 14.0;NB-4: 6.6"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA031952	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 79: Retina - Phototransduction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA031952: AB_10600798"	"unprognostic (5.04e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.32e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.10e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-1)"	0.3	0.1	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.1	0.0	20.2	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.3	0.2	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	4.7	0.2	2.8	14.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.3	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.4	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	4.4	0.0	2.1	1.7	4.2	0.0	1.0	1.5	2.9	0.0	0.5	0.3	0.1	0.4	0.5	0.1	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	1.7	0.0	1.9	0.7	2.4	0.9	0.4	0.1	1.2	56.3	0.7	1.0	0.9	2.8	0.8	0.0	156.4	0.1	5.5	2.4	0.0	0.8	56.3	0.2	1.2	1.5	1.2	0.4	0.8	0.4	0.2	1.8	1.1	0.2	15.2	0.8	1.4	1.2	23.7	0.0	0.4	2.1	0.0	29.2	5.7	117.6	0.9	23.2	3.6	0.0	17.3	6.9	18.6	0.0	1.8	0.3	3.4	0.4	0.8	0.2	12.2	1.3	1.1	98.5	0.0	0.3	2.3	9.0	4.9	0.4	0.6	0.1	8.6	0.6	3.4	0.3
CACNB2	"CACNLB2, MYSB"	ENSG00000165995	"Calcium voltage-gated channel auxiliary subunit beta 2"	Q08289	10	18140424-18543557	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 35.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 863.5;Excitatory neurons: 545.7;Inhibitory neurons: 357.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HAP1: 6.4;HSkMC: 8.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035326	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035326: AB_10669903"	"unprognostic (3.03e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.58e-3)"	"unprognostic (4.67e-4)"	"unprognostic (8.03e-2)"	"unprognostic (3.76e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.78e-4)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.56e-5)"	"unprognostic (3.48e-2)"	"unprognostic (5.72e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.16e-2)"	2.8	9.4	1.3	2.1	3.9	1.3	3.8	5.4	12.9	7.4	0.1	17.6	1.1	12.8	2.7	5.0	10.1	2.2	17.8	5.4	7.4	3.2	10.7	3.9	0.9	0.0	0.1	13.6	7.5	0.6	19.3	0.5	0.0	8.5	3.2	35.1	3.9	8.8	1.1	4.2	11.4	5.3	0.0	1.5	7.7	2.1	2.2	0.7	2.5	0.7	0.2	16.8	4.6	1.5	0.2	1.0	0.7	0.5	0.3	0.3	0.5	0.3	0.0	0.0	0.3	0.4	0.5	0.9	0.2	0.2	0.3	0.7	6.4	0.0	0.0	0.3	2.4	0.8	1.7	1.5	1.6	0.5	1.5	8.1	0.0	0.0	0.0	0.3	0.0	1.4	0.9	1.6	0.0	0.7	0.8	1.0	2.4	0.0	0.0	0.7	0.7	0.8	0.0	0.8	2.9	0.8	0.1	0.0	0.4	0.8	0.1	0.9	0.0	0.6	1.5	0.3	0.6	1.6	1.8	1.7	0.2	1.2	0.3	1.4	0.1	0.2	0.2	0.2	0.4	0.4	0.3	0.1	0.0	0.5	0.5	0.8	0.1	0.3	0.2	0.2	1.1	0.0	1.3	3.9	5.4	12.9	5.4	7.4	0.0	0.1	0.0	0.0	2.2	1.5	2.1	0.0	0.6	863.5	0.1	3.3	1.3	0.0	1.8	31.9	1.1	1.3	22.4	0.0	0.0	0.0	108.4	0.4	0.7	2.8	1.9	0.4	0.9	1.1	13.9	1.5	37.1	0.8	545.7	0.2	0.0	3.0	0.0	2.6	0.0	3.8	0.0	0.9	0.1	8.4	357.8	9.4	0.0	0.0	1.1	0.8	0.9	0.5	1.8	96.5	0.0	15.9	0.0	95.5	13.7	0.2	2.4	4.5	0.3	2.1	5.9	0.8	0.0	75.7	6.6	2.6	14.2	0.1	0.1	0.0	4.1	0.3	1.0	5.3	5.7	1.3
CACNB3	CACNLB3	ENSG00000167535	"Calcium voltage-gated channel auxiliary subunit beta 3"	P54284	12	48813794-48828941	"FDA approved drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 84.2"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 22.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.8"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 75.9;U-937: 109.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059515			Approved	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 36: Stromal cells - Cell proliferation"	"Golgi apparatus, Vesicles"		"HPA059515: AB_2684047"	"unprognostic (1.77e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (2.12e-2)"	"unprognostic (8.76e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.06e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.27e-2)"	"unprognostic (2.24e-1)"	"unprognostic (5.67e-3)"	"unprognostic (1.04e-1)"	"unprognostic (5.44e-3)"	"unprognostic (6.31e-3)"	"unprognostic (6.58e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.78e-3)"	10.1	3.9	67.9	2.8	69.9	1.3	9.0	56.8	84.2	33.7	44.1	18.1	4.1	31.1	8.5	21.5	19.6	7.2	8.4	72.6	56.7	12.4	1.9	11.8	1.8	50.2	56.2	43.7	4.5	5.1	12.3	5.8	53.4	13.7	8.2	4.7	13.0	9.1	2.8	11.5	10.8	23.1	49.9	6.1	9.2	8.6	59.6	7.6	9.6	5.9	4.1	14.5	20.2	58.7	17.3	13.2	21.1	46.1	26.8	18.0	12.9	16.8	39.4	25.6	14.5	4.5	13.4	2.2	21.5	30.7	4.4	17.2	21.6	19.5	10.1	18.4	5.9	8.5	11.7	0.6	11.0	1.7	9.1	11.7	10.6	10.2	5.5	75.9	31.1	18.6	1.2	7.2	16.9	42.6	22.1	2.2	13.3	18.1	10.9	24.0	5.0	6.6	19.9	31.6	32.9	31.8	5.5	37.1	12.0	18.6	25.2	7.7	27.3	15.5	21.7	7.7	9.5	7.1	3.5	0.7	12.9	109.9	5.0	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.6	0.6	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.8	0.2	67.9	69.9	56.8	84.2	72.6	56.7	50.2	56.2	53.4	49.9	59.6	58.7	5.6	3.2	4.3	1.0	0.5	2.9	3.2	5.9	4.0	3.2	8.7	5.7	2.8	1.5	5.1	1.8	4.2	0.8	2.1	12.6	1.9	9.5	1.0	10.0	22.0	5.9	10.2	0.8	15.1	4.3	10.4	7.9	6.1	7.1	1.3	12.0	3.6	0.2	1.6	0.0	4.5	9.5	16.2	0.6	2.9	2.7	13.4	2.4	1.8	3.7	3.7	1.0	2.1	2.0	1.1	10.4	4.6	10.9	1.3	2.9	8.7	0.7	9.4	1.0	0.0	1.5	12.2	1.6	8.1	9.6	5.1	1.1	3.5	6.1	14.4	1.9
CACNB4	EJM4	ENSG00000182389	"Calcium voltage-gated channel auxiliary subunit beta 4"	O00305	2	151832771-152099167	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 16.4;skin 1: 7.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 495.6;Inhibitory neurons: 470.7;Microglial cells: 136.8;Oligodendrocyte precursor cells: 155.3"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	5	"neutrophil: 3.4"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 3.4"	"Cell line enhanced"	"Detected in some"		"Hep G2: 4.1;HMC-1: 20.2;U-937: 5.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015601	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 6: Brain - Smell perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA015601: AB_1845873"	"unprognostic (2.92e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (9.42e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.55e-2)"	"unprognostic (7.26e-3)"	"unprognostic (3.93e-2)"	"unprognostic (9.55e-3)"	"unprognostic (2.45e-1)"	0.7	0.7	4.6	0.4	12.0	0.7	1.5	15.2	16.4	0.4	1.3	0.3	0.4	0.4	0.6	1.4	0.3	0.9	0.3	6.2	2.3	1.4	0.1	2.0	0.3	0.2	5.6	0.3	0.4	0.4	1.8	0.9	0.3	2.0	0.5	1.8	1.7	1.9	0.1	7.3	0.3	0.5	0.3	0.4	0.6	2.3	6.8	1.1	1.4	0.2	1.0	2.0	0.5	6.8	0.0	0.0	0.7	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.9	0.0	1.9	0.0	0.1	0.3	3.2	0.0	0.2	4.1	0.0	0.2	20.2	0.2	0.1	0.4	0.0	1.7	0.0	0.8	0.0	0.5	0.1	0.0	0.2	0.3	0.5	0.1	0.6	2.0	0.2	0.6	1.1	0.5	1.3	0.7	0.0	0.0	0.0	0.1	3.3	0.8	0.0	1.8	2.0	0.6	0.4	0.3	0.0	0.0	0.4	5.9	0.1	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	3.4	0.0	0.0	0.6	0.0	0.1	4.6	12.0	15.2	16.4	6.2	2.3	0.2	5.6	0.3	0.3	6.8	6.8	1.1	12.8	53.3	80.6	0.8	12.4	16.3	3.5	30.7	9.9	6.8	7.2	1.3	0.0	3.8	3.7	4.2	0.1	0.3	0.3	3.9	0.5	0.9	3.0	3.0	1.3	0.0	0.0	495.6	1.5	0.0	7.9	1.1	5.4	0.0	84.1	0.7	0.0	3.4	20.2	470.7	0.0	0.0	1.2	7.5	2.1	3.4	2.4	1.8	136.8	1.2	2.3	1.0	155.3	31.2	1.0	0.1	4.5	2.0	29.0	0.1	0.9	1.2	3.4	0.0	0.6	1.2	0.7	4.1	3.2	8.2	0.0	1.1	6.6	0.1	16.3
CACNG1	CACNLG	ENSG00000108878	"Calcium voltage-gated channel auxiliary subunit gamma 1"	Q06432	17	67044554-67056797	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	55	"skeletal muscle: 327.7;tongue: 121.8"	"Cell type enriched"	"Detected in single"	27	"Skeletal myocytes: 8.1"	"Cancer enhanced"	"Detected in some"		"breast cancer: 1.6;head and neck cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HSkMC: 2.9"	"Region enriched"	"Detected in single"	6	"basal ganglia: 3.4"	"Not detected"	"Not detected"									NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (1.76e-1)"	"unprognostic (9.83e-3)"		"unprognostic (1.75e-5)"	"unprognostic (2.60e-1)"	"unprognostic (6.72e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-2)"		"unprognostic (4.84e-3)"	"unprognostic (1.07e-1)"	"unprognostic (4.20e-2)"		"unprognostic (1.60e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.94e-1)"	0.0	1.6	0.6	0.0	0.7	0.0	0.4	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	3.3	0.0	327.7	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.6	0.0	121.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.1	0.6	0.3	0.2	0.2	0.2	0.2	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG2	"MGC138502, MGC138504, stargazin"	ENSG00000166862	"Calcium voltage-gated channel auxiliary subunit gamma 2"	Q9Y698	22	36560857-36703752	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 20.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 87.5;Horizontal cells: 26.9;Inhibitory neurons: 119.7;Oligodendrocyte precursor cells: 43.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"								"unprognostic (7.54e-2)"					"unprognostic (3.06e-1)"	"unprognostic (8.80e-3)"			"unprognostic (2.34e-2)"	"unprognostic (3.07e-2)"			0.0	0.7	5.7	0.0	7.1	0.0	0.0	13.8	20.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	6.0	0.0	0.0	0.0	0.0	5.9	3.8	0.0	0.0	0.0	1.2	0.0	6.5	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.1	6.2	0.0	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	7.1	13.8	20.7	6.0	6.0	5.9	3.8	6.5	2.6	6.2	11.0	0.0	0.0	0.0	3.9	0.0	0.0	0.2	0.0	0.0	8.4	0.0	0.0	0.4	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	87.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.9	119.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.5	0.0	0.2	0.0	43.7	2.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CACNG3		ENSG00000006116	"Calcium voltage-gated channel auxiliary subunit gamma 3"	O60359	16	24256335-24362412	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"brain: 53.4;retina: 17.7"	"Group enriched"	"Detected in some"	24	"Excitatory neurons: 157.1;Horizontal cells: 176.7;Inhibitory neurons: 107.6"	"Cancer enriched"	"Detected in single"	15	"glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077238	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA077238: "					"unprognostic (5.61e-2)"						"unprognostic (3.09e-1)"			"unprognostic (2.12e-1)"	"unprognostic (1.17e-1)"			0.0	1.8	22.1	0.0	32.0	0.0	0.0	2.9	53.4	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.2	7.1	0.0	0.0	0.0	0.0	6.1	15.5	0.0	0.0	0.0	0.1	0.0	11.9	0.0	0.0	17.7	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.2	7.3	0.0	0.0	0.0	0.0	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	32.0	2.9	53.4	36.2	7.1	6.1	15.5	11.9	5.8	7.3	26.9	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	157.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	176.7	107.6	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	5.6	0.0	0.4	0.0	6.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG4	"MGC11138, MGC24983"	ENSG00000075461	"Calcium voltage-gated channel auxiliary subunit gamma 4"	Q9UBN1	17	66964707-67033398	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 35.1;prostate: 11.7"	"Cell type enriched"	"Detected in some"	6	"Oligodendrocyte precursor cells: 145.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 30.3;glioma: 35.8;ovarian cancer: 14.8;prostate cancer: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	6	"SH-SY5Y: 387.4"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 118.1"	"HPA005803, HPA065370"	Enhanced		Approved	Vesicles		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Vesicles		"HPA005803: AB_2667439, HPA065370: AB_2685480"	"unprognostic (1.27e-1)"	"unprognostic (3.16e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.05e-2)"	"unprognostic (6.42e-2)"	"unprognostic (8.64e-3)"	"unprognostic (2.91e-1)"	"unprognostic (7.08e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.85e-2)"	"unprognostic (6.03e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.38e-10)"	"unprognostic (8.57e-3)"	"unprognostic (1.23e-1)"	"unprognostic (8.71e-2)"	"unprognostic (4.28e-1)"	0.5	0.8	26.5	0.1	35.1	0.0	5.3	6.9	26.8	0.4	4.2	0.8	0.2	0.5	0.1	0.2	4.2	0.4	0.2	14.5	17.9	0.2	0.0	5.7	0.0	11.7	16.7	0.1	0.4	1.2	0.3	0.7	15.0	11.7	0.1	0.7	1.7	1.3	0.1	0.5	0.1	1.1	14.3	0.0	1.5	0.2	29.6	0.0	0.1	0.0	0.0	0.4	0.7	9.5	6.4	4.1	15.6	0.0	0.0	0.0	4.4	0.0	0.0	1.4	0.0	4.6	0.2	0.0	0.2	0.0	41.2	64.1	0.1	0.0	0.0	0.0	0.3	0.0	1.8	3.7	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	34.5	0.1	0.3	15.7	7.3	0.0	0.0	0.4	8.7	0.0	11.1	15.8	387.4	3.6	10.4	0.0	38.1	38.5	0.0	0.0	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.5	35.1	6.9	26.8	14.5	17.9	11.7	16.7	15.0	14.3	29.6	9.5	0.0	3.2	1.3	0.0	0.0	0.0	1.1	0.3	0.0	0.2	6.4	3.4	1.3	0.0	1.4	0.0	0.0	0.3	0.1	0.6	0.0	0.1	2.6	1.0	0.2	0.1	7.7	0.0	1.8	0.2	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	20.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	3.7	0.0	3.4	0.0	145.3	0.3	0.7	0.2	0.0	0.0	2.6	0.0	0.0	1.9	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.7
CACNG6		ENSG00000130433	"Calcium voltage-gated channel auxiliary subunit gamma 6"	Q9BXT2	19	53991637-54012666	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"skeletal muscle: 90.7;tongue: 29.9"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 8.3;Horizontal cells: 1.7;Respiratory ciliated cells: 9.1;Skeletal myocytes: 2.3"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 2.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	107	"basophil: 13.3;eosinophil: 8.0"	"Lineage enriched"	"Detected in single"	133	"granulocytes: 13.3"	"Cell line enhanced"	"Detected in some"		"A549: 12.7;EFO-21: 23.6;HHSteC: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA056615			Approved	"Nucleoli fibrillar center,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center"	Cytosol	"HPA056615: AB_2683192"	"unprognostic (1.83e-1)"	"unprognostic (9.51e-2)"		"unprognostic (7.07e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.89e-2)"		"unprognostic (2.27e-1)"		"unprognostic (7.69e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.53e-1)"	"unprognostic (6.07e-8)"	"unprognostic (9.79e-2)"	"unprognostic (1.28e-1)"			0.0	0.0	0.4	0.1	0.3	0.0	0.0	0.1	0.9	0.3	0.2	0.1	0.2	0.2	0.0	0.3	8.8	0.0	0.0	0.6	0.6	0.0	0.0	2.2	0.0	1.0	2.0	0.0	0.0	2.9	1.9	0.0	0.8	0.4	0.0	0.1	1.0	0.0	90.7	0.0	0.2	0.0	1.0	0.1	0.3	2.3	0.4	0.0	0.0	29.9	0.1	0.0	0.0	0.5	0.0	12.7	0.2	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.1	1.1	0.0	23.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	5.6	0.0	0.1	0.1	0.0	0.0	0.0	1.9	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	1.1	1.6	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	3.2	0.0	2.8	0.0	0.0	0.0	3.5	0.1	0.2	0.0	0.0	13.3	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.9	0.6	0.6	1.0	2.0	0.8	1.0	0.4	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	8.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.7	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.5	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	9.1	0.0	0.0	2.3	0.1	0.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG7		ENSG00000105605	"Calcium voltage-gated channel auxiliary subunit gamma 7"	P62955	19	53909278-53943950	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 56.6;retina: 17.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 32.0;Horizontal cells: 134.6;Inhibitory neurons: 43.3;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 16.3"	"Cancer enriched"	"Detected in some"	16	"glioma: 29.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 52.8;GAMG: 14.6;HMC-1: 40.8;hTERT-RPE1: 51.4;SH-SY5Y: 32.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"							"unprognostic (3.11e-2)"	"unprognostic (7.18e-2)"	"unprognostic (6.24e-2)"				"unprognostic (3.06e-1)"	"unprognostic (1.24e-1)"		"unprognostic (1.01e-5)"	"unprognostic (1.51e-1)"	"unprognostic (7.36e-2)"			0.0	0.4	44.2	0.0	38.8	0.0	0.0	37.5	56.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.9	38.9	0.0	0.0	0.0	0.0	39.9	41.2	0.0	0.1	0.1	6.6	0.0	38.9	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.1	0.0	31.9	0.0	0.1	0.5	50.5	0.0	0.0	0.0	0.0	0.0	0.0	45.8	0.0	7.0	52.8	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	14.6	0.1	5.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.7	0.0	40.8	0.4	0.0	0.1	0.0	51.4	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	10.9	0.0	0.0	0.0	3.3	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.2	38.8	37.5	56.6	43.9	38.9	39.9	41.2	38.9	31.9	50.5	45.8	0.0	0.0	0.0	12.4	0.0	0.0	0.0	0.0	0.0	8.1	0.1	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.0	32.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	134.6	43.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.2	0.0	23.1	16.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.9	0.0	0.3	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CACNG8		ENSG00000142408	"Calcium voltage-gated channel auxiliary subunit gamma 8"	Q8WXS5	19	53962937-53990215	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	37	"brain: 33.9"	"Group enriched"	"Detected in many"	7	"Excitatory neurons: 61.9;Horizontal cells: 50.5;Inhibitory neurons: 66.0;Oligodendrocyte precursor cells: 29.7"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	9	"basophil: 5.5"	"Lineage enriched"	"Detected in single"	26	"granulocytes: 5.5"	"Group enriched"	"Detected in some"	5	"AF22: 7.2;HMC-1: 23.7;hTERT-RPE1: 8.4;TIME: 14.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041351	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA041351: AB_10796666"	"unprognostic (7.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.06e-1)"	"unprognostic (5.29e-4)"	"unprognostic (9.66e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.40e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.03e-1)"	"unprognostic (7.63e-2)"	"unprognostic (2.58e-1)"	"unprognostic (2.82e-8)"	"unprognostic (1.10e-1)"	"unprognostic (1.35e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	0.0	0.0	9.6	0.1	9.3	0.2	0.0	0.0	33.9	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	32.6	3.7	0.0	0.0	0.0	0.1	0.7	1.2	0.0	0.0	0.3	0.6	0.0	0.4	0.1	0.0	0.9	0.1	0.0	0.4	0.2	0.1	0.1	1.8	0.1	0.2	0.6	6.4	0.0	0.1	0.2	0.0	0.0	0.0	9.4	0.0	2.4	7.2	0.2	0.0	0.1	0.1	0.1	0.4	0.0	0.1	0.5	0.4	0.0	0.2	0.0	0.3	0.2	0.0	0.1	0.0	0.0	1.0	2.7	0.7	0.1	1.1	0.0	23.7	0.3	0.0	0.1	0.3	8.4	2.4	0.1	0.1	0.2	0.0	0.1	0.0	0.0	1.5	0.3	3.0	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.1	0.1	0.0	0.2	0.2	0.0	14.9	0.1	1.3	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.1	5.5	0.1	0.6	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	9.6	9.3	0.0	33.9	32.6	3.7	0.7	1.2	0.4	1.8	6.4	9.4	3.6	0.0	0.0	5.9	0.4	1.7	1.5	0.0	0.0	6.9	0.1	1.5	3.3	0.0	0.7	1.8	0.0	0.0	0.0	0.4	0.0	1.9	2.3	0.7	1.0	6.4	0.0	2.7	61.9	0.0	0.0	0.6	0.0	1.0	0.0	0.0	5.7	0.0	0.1	50.5	66.0	0.3	0.0	0.8	2.1	1.7	0.0	0.5	0.0	0.0	0.3	1.1	1.0	29.7	4.3	0.2	0.1	0.4	0.0	1.5	0.1	0.2	2.6	1.7	0.0	3.8	1.0	6.2	7.1	0.0	1.1	0.1	0.6	0.5	0.9	1.3
CALB2	CAL2	ENSG00000172137	"Calbindin 2"	P22676	16	71358713-71390436	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 100.5;brain: 131.9;breast: 53.5"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 97.8;granulocytes: 251.5;Granulosa cells: 44.1;Theca cells: 70.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"hypothalamus: 76.3;medulla oblongata: 89.5;midbrain: 42.2;pons: 86.7;thalamus: 131.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 21.5;HEL: 63.9;HMC-1: 133.0;U-2 OS: 38.0"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"thalamus: 449.0"	"CAB000106, HPA007305, HPA007306"	Enhanced	Supported	Enhanced	Cytosol		NA	NA		9600		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	Cytosol		"CAB000106: AB_2068519, HPA007305: AB_1078386, HPA007306: AB_1078385"	"unprognostic (1.10e-1)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (5.78e-5)"	"unprognostic (1.75e-3)"	"unprognostic (5.80e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (4.55e-3)"	"unprognostic (4.28e-1)"	"unprognostic (1.32e-1)"	"unprognostic (3.06e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.54e-4)"	"unprognostic (1.97e-3)"	"unprognostic (6.30e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.04e-2)"	100.5	36.6	19.9	4.1	15.4	0.0	53.5	16.5	20.0	3.5	4.1	13.8	0.7	0.7	0.5	7.7	7.7	1.1	7.7	12.8	76.3	0.3	0.2	3.6	0.1	89.5	42.2	11.4	0.7	0.0	14.3	0.0	86.7	0.9	4.7	23.6	11.1	0.4	0.5	4.9	6.2	1.7	16.0	0.1	1.0	13.0	131.9	0.1	0.2	0.2	0.9	2.0	2.7	8.4	19.1	2.0	17.0	0.0	0.6	0.1	3.3	0.6	0.3	0.5	0.1	0.1	21.5	0.0	0.3	0.2	2.7	3.7	0.0	0.0	0.2	0.1	0.1	63.9	0.0	0.6	0.1	0.0	133.0	0.0	0.0	1.3	0.2	0.3	0.0	1.6	0.0	0.5	0.1	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.2	0.1	0.1	0.2	0.1	0.6	0.0	0.1	0.0	3.1	38.0	0.3	3.8	0.0	0.1	0.0	3.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.9	15.4	16.5	20.0	12.8	76.3	89.5	42.2	86.7	16.0	131.9	8.4	0.5	9.6	7.2	0.3	0.0	0.3	0.1	0.2	0.0	12.5	10.3	2.3	0.4	1.5	0.0	0.0	6.2	0.0	0.0	0.0	0.0	1.8	2.6	0.3	10.8	0.7	0.0	0.0	0.4	97.8	0.1	29.6	0.0	0.1	251.5	44.1	0.0	0.1	0.1	30.3	17.4	0.0	0.0	0.0	0.4	2.4	6.2	1.2	5.4	1.0	0.0	2.5	0.0	0.0	0.6	16.5	0.0	0.0	0.1	0.1	0.0	0.0	1.5	10.3	0.0	0.2	1.9	1.8	5.0	0.0	0.0	0.1	3.5	70.2	0.0	0.2
CALCA	"CALC1, CGRP, CGRP-alpha"	ENSG00000110680	"Calcitonin related polypeptide alpha"	"P01258, P06881"	11	14966668-14972351	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted secreted proteins, Transporters"		Hormone	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 178.3;thyroid gland: 154.2"	"Cell type enriched"	"Detected in some"	64	"Ionocytes: 2368.1"	"Cancer enriched"	"Detected in many"	7	"lung cancer: 64.7"	"Region enhanced"	"Detected in many"		"pons: 34.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in all"	5	"pons and medulla: 57.9"					"HPA059886, HPA064453"	Enhanced	Supported			"Secreted to blood"	NA	NA	51500			"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA059886: , HPA064453: "			"unprognostic (1.97e-1)"	"prognostic unfavorable (4.49e-5)"	"unprognostic (5.99e-2)"		"unprognostic (2.42e-1)"	"unprognostic (1.17e-1)"		"unprognostic (6.45e-2)"	"unprognostic (1.28e-1)"	"unprognostic (7.66e-2)"	"unprognostic (3.33e-2)"	"unprognostic (7.49e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.53e-3)"	"unprognostic (1.02e-2)"	0.7	0.2	0.6	1.5	0.6	0.0	0.2	0.6	0.5	0.2	0.0	0.6	0.0	0.2	0.0	0.1	0.3	0.2	1.1	0.3	0.8	46.4	37.5	2.4	0.1	20.9	7.0	0.1	0.4	178.3	0.8	0.0	34.4	2.5	0.1	0.0	0.1	0.0	0.5	0.0	0.1	1.5	1.5	3.0	0.2	0.2	0.6	0.3	154.2	0.0	0.0	4.3	0.4	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.6	0.5	0.3	0.8	20.9	7.0	34.4	1.5	0.6	10.4	0.1	0.0	0.0	0.0	0.2	0.3	0.4	35.4	0.0	0.0	0.0	0.1	0.4	0.0	0.3	36.8	0.0	0.0	0.0	0.0	5.9	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	0.3	0.0	0.0	0.7	4.4	0.3	0.0	0.0	0.0	2368.1	0.0	4.0	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.2	0.0	0.0	0.4	5.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.4
CALCRL	"CGRPR, CRLR"	ENSG00000064989	"Calcitonin receptor like receptor"	Q16602	2	187341964-187448460	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 70.7;lung: 76.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 138.3;Endometrial stromal cells: 92.7;Endothelial cells: 248.7;Hepatic stellate cells: 259.2;Oligodendrocyte precursor cells: 293.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.6;myeloid DC: 9.2;plasmacytoid DC: 2.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 9.2;monocytes: 2.6"	"Cell line enriched"	"Detected in some"	4	"HUVEC TERT2: 173.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008070, HPA046515"	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA008070: AB_1845912, HPA046515: AB_2679681"	"unprognostic (7.06e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.60e-3)"	"unprognostic (9.25e-3)"	"unprognostic (4.14e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (3.77e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.50e-2)"	70.7	6.3	3.4	12.3	4.0	0.4	15.8	6.1	4.4	27.8	3.4	6.9	6.0	21.5	4.6	8.6	11.4	24.4	20.4	3.9	3.8	14.0	12.6	76.8	7.9	11.1	6.2	15.7	4.3	13.0	3.6	11.7	10.8	7.3	9.5	0.9	7.1	7.7	6.2	3.9	6.3	27.1	15.5	8.6	7.1	2.7	3.9	4.6	28.3	20.2	9.1	14.1	4.7	15.2	0.2	0.0	8.8	0.0	6.2	1.6	0.0	0.8	1.3	0.1	1.0	0.0	1.0	0.0	2.3	0.7	0.2	0.0	0.0	0.6	0.2	1.5	0.5	1.5	0.0	0.2	4.9	0.2	0.0	4.6	0.2	0.3	2.1	0.5	173.6	0.1	0.0	2.5	1.2	0.0	0.8	0.1	0.5	0.0	0.0	0.0	3.1	0.5	40.5	0.0	0.4	0.2	0.0	0.0	0.4	0.5	0.0	0.2	25.3	0.7	0.1	0.1	0.4	6.2	0.1	0.7	0.4	0.0	0.0	0.0	2.6	0.0	0.0	0.5	0.0	0.2	0.0	0.0	9.2	0.0	0.8	0.1	0.1	1.0	1.0	2.6	0.0	0.9	3.4	4.0	6.1	4.4	3.9	3.8	11.1	6.2	10.8	15.5	3.9	15.2	138.3	0.0	11.9	19.6	1.2	9.3	2.3	1.7	21.6	0.2	0.8	1.8	12.3	2.8	3.6	0.0	0.0	0.4	2.4	0.0	3.9	0.3	0.8	3.1	92.7	248.7	0.0	4.8	15.4	0.4	0.2	56.5	1.1	1.7	5.1	12.3	259.2	1.8	0.9	0.0	2.1	0.0	2.0	10.3	29.7	1.0	7.8	15.4	10.6	47.8	16.1	0.0	1.0	293.0	1.0	0.1	0.0	2.6	4.9	1.9	0.0	13.2	2.8	0.1	6.6	4.1	21.5	1.3	0.7	18.2	6.8	0.3	3.0	6.0	0.0	1.8
CALHM1	FAM26C	ENSG00000185933	"Calcium homeostasis modulator 1"	Q8IU99	10	103453240-103458900	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Sensory transduction, Taste, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.1"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 1.6;NK-cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPMI-8226: 1.3;U-266/70: 1.1;U-266/84: 1.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA061816	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA061816: "	"unprognostic (2.46e-1)"	"unprognostic (2.66e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.65e-3)"	"unprognostic (3.44e-2)"		"unprognostic (2.86e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.40e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.21e-8)"	"unprognostic (1.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.38e-2)"	0.0	0.0	0.8	0.1	0.6	0.1	0.0	1.1	1.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	1.2	0.8	0.0	0.0	0.0	1.9	0.9	0.0	0.1	0.0	0.1	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	1.6	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.8	0.6	1.1	1.1	0.7	1.2	1.9	0.9	2.1	0.1	0.5	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CALHM2	FAM26B	ENSG00000138172	"Calcium homeostasis modulator family member 2"	Q9HA72	10	103446786-103452402	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 75.1;Fibroblasts: 38.2;Hepatic stellate cells: 48.2;Hofbauer cells: 53.7;Leydig cells: 45.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 45.1;BJ: 37.7;BJ hTERT+: 37.5;fHDF/TERT166: 43.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA014706	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Mitochondria"	Cytosol	"HPA014706: AB_2243916"	"unprognostic (2.45e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.01e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.85e-2)"	"unprognostic (5.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.03e-6)"	"unprognostic (8.59e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.56e-1)"	"unprognostic (4.74e-1)"	49.7	18.5	7.2	12.5	6.5	2.1	38.9	6.3	9.0	54.4	7.0	18.4	6.5	58.1	5.5	12.2	43.3	21.6	34.2	7.0	7.3	10.7	4.5	23.2	13.7	8.0	6.4	48.1	7.1	3.1	7.3	10.0	7.8	21.1	4.3	0.4	14.9	10.6	9.7	17.9	19.6	15.9	7.7	35.3	13.8	11.5	8.0	5.6	21.6	11.1	6.1	33.9	39.3	7.9	11.0	7.5	1.8	2.4	27.3	45.1	9.1	37.7	37.5	11.2	15.7	3.3	5.3	3.3	4.2	43.2	0.7	5.0	3.8	0.0	2.1	0.4	21.5	7.8	2.5	0.6	12.4	1.3	0.7	15.6	0.0	3.3	0.1	20.8	13.5	8.3	1.8	19.8	7.5	25.0	3.0	3.7	4.8	2.3	6.7	9.2	3.0	7.5	1.0	0.9	5.3	2.3	1.5	6.2	2.1	0.8	1.2	2.5	24.5	3.6	4.4	12.6	2.7	3.0	7.6	3.8	31.0	24.0	0.8	70.0	91.9	1.8	83.7	178.4	69.6	27.7	56.5	69.7	152.1	7.3	10.8	42.3	3.6	62.9	214.6	17.8	82.7	85.6	7.2	6.5	6.3	9.0	7.0	7.3	8.0	6.4	7.8	7.7	8.0	7.9	18.2	3.2	0.6	1.0	4.9	5.4	2.9	0.6	4.0	0.1	3.4	4.4	3.3	1.5	0.0	3.7	0.0	3.1	11.3	0.1	0.0	4.2	1.0	1.4	19.8	25.5	1.2	5.7	2.3	0.2	75.1	38.2	1.5	2.1	8.8	11.4	48.2	0.6	53.7	0.0	0.5	0.1	2.0	28.8	18.8	2.5	45.7	21.5	8.8	2.8	17.3	0.2	33.0	1.0	0.2	0.1	0.1	16.1	3.1	0.8	0.0	0.3	0.0	0.1	19.7	16.8	27.9	0.8	0.9	0.8	3.8	19.2	19.4	6.0	0.0	1.0
CALHM3	"bA225H22.7, FAM26A"	ENSG00000183128	"Calcium homeostasis modulator 3"	Q86XJ0	10	103472804-103479240	"Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Taste, Transport"	"Ion channel"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.2;Early spermatids: 2.2;Extravillous trophoblasts: 6.7;Late spermatids: 2.0;Syncytiotrophoblasts: 1.0"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"U-266/84: 14.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018205	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 7: Monocytes - Unknown function"		"Cluster 16: U-266 - Nucleosome"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Nucleoplasm		"HPA018205: AB_2069267"	"unprognostic (2.88e-1)"	"unprognostic (4.00e-1)"	"unprognostic (3.48e-2)"	"unprognostic (3.26e-4)"	"unprognostic (2.87e-1)"	"unprognostic (2.06e-1)"		"unprognostic (1.25e-2)"		"unprognostic (1.88e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.44e-1)"		"unprognostic (4.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (5.05e-2)"	"unprognostic (1.53e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.3	2.6	0.3	1.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.8	14.3	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.0
CALHM4	"C6orf78, FAM26D, FLJ32239"	ENSG00000164451	"Calcium homeostasis modulator family member 4"	Q5JW98	6	116529013-116558868	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"placenta: 23.1"	"Group enriched"	"Detected in some"	24	"Cytotrophoblasts: 28.2;Syncytiotrophoblasts: 54.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 1.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA048014			Approved	"Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA048014: "										"unprognostic (7.95e-2)"			"unprognostic (3.44e-4)"		"unprognostic (1.99e-1)"	"unprognostic (1.44e-2)"		0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.3	0.0	23.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	4.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.6	0.0	0.2	0.0	0.0
CALHM5	"C6orf188, dJ493F7.3, FAM26E, MGC45451"	ENSG00000178033	"Calcium homeostasis modulator family member 5"	Q8N5C1	6	116511639-116524788	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 10.6;Endothelial cells: 2.6;Fibroblasts: 2.0;Granulosa cells: 2.6;Smooth muscle cells: 3.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 5.3;fHDF/TERT166: 5.6;HUVEC TERT2: 5.6;LHCN-M2: 5.9;TIME: 8.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA034969, HPA034970"	Uncertain		Approved	"Golgi apparatus"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"HPA034969: AB_10670299, HPA034970: AB_2674390"	"unprognostic (2.71e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.92e-1)"	"unprognostic (1.93e-2)"	"unprognostic (5.37e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.06e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.24e-7)"	"unprognostic (1.16e-2)"	"unprognostic (2.98e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.65e-3)"	3.3	0.5	0.6	1.1	0.7	0.0	1.6	0.5	0.6	1.3	0.7	1.5	0.6	1.3	0.6	1.2	0.9	1.5	2.3	0.6	0.5	1.9	0.5	1.7	0.9	0.6	0.5	0.5	0.1	0.5	0.3	4.4	0.6	0.9	1.0	0.0	0.6	0.7	1.6	1.0	0.9	2.1	0.5	1.7	0.6	0.7	0.8	0.1	0.8	2.5	0.5	1.4	1.2	0.6	0.0	0.0	4.5	0.0	2.7	4.3	0.0	3.6	5.3	1.4	3.8	0.2	0.0	0.0	0.3	5.6	3.8	0.0	0.0	0.0	1.5	0.0	0.2	0.8	0.0	0.0	0.6	0.0	0.0	2.6	0.0	3.4	0.0	1.0	5.6	0.0	0.0	1.0	5.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	8.9	2.5	0.8	0.3	0.2	0.0	0.0	0.0	2.1	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.7	0.5	0.6	0.6	0.5	0.6	0.5	0.6	0.5	0.8	0.6	10.6	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	2.6	0.0	0.0	0.0	0.7	0.0	2.0	0.0	0.0	0.0	2.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0
CALHM6	"C6orf187, dJ93H18.5, FAM26F, INAM, OTTHUMP00000017061, OTTHUMP00000017062, RP1-93H18.5"	ENSG00000188820	"Calcium homeostasis modulator family member 6"	Q5R3K3	6	116461370-116463771	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 136.6"	"Cell type enriched"	"Detected in some"	5	"Hofbauer cells: 138.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 724.6;non-classical monocyte: 861.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 28.0;Karpas-707: 45.1;RPMI-8226: 159.8;U-937: 59.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (1.14e-2)"	"unprognostic (2.31e-2)"	"unprognostic (6.46e-3)"	"unprognostic (7.15e-3)"	"unprognostic (9.53e-3)"	"unprognostic (4.10e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.68e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.19e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (9.31e-10)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.85e-3)"	"unprognostic (9.25e-3)"	7.4	7.3	4.9	60.2	5.2	41.4	10.0	4.5	6.6	4.3	5.0	10.4	12.2	2.4	3.6	4.1	4.1	7.2	4.3	4.7	5.2	4.1	24.7	10.8	73.0	8.1	4.7	4.5	1.8	1.7	4.8	12.5	5.3	5.4	7.0	1.1	5.7	3.0	1.6	1.9	20.9	11.8	5.6	136.6	7.9	8.2	5.3	14.0	2.4	2.6	23.1	11.4	3.0	5.4	6.4	0.0	0.6	0.4	0.5	2.0	11.7	0.2	1.3	2.0	1.3	0.0	1.0	0.2	3.5	1.5	0.0	0.0	0.3	0.2	4.2	0.7	0.4	28.0	0.0	0.0	2.8	0.1	0.1	2.2	0.0	0.2	0.2	0.5	0.7	0.0	0.0	45.1	5.5	0.0	2.7	4.8	3.6	0.0	0.0	2.4	0.0	159.8	2.2	0.3	2.7	0.1	14.9	0.1	11.7	1.6	0.2	7.3	0.1	0.0	0.2	0.1	0.9	11.4	0.2	0.0	0.3	59.7	3.9	22.0	205.7	50.1	16.6	724.6	16.6	231.8	23.0	15.5	193.8	308.9	28.9	15.2	115.8	27.4	861.9	86.5	2.7	175.6	4.9	5.2	4.5	6.6	4.7	5.2	8.1	4.7	5.3	5.6	5.3	5.4	0.6	0.0	1.7	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.8	3.2	0.0	0.0	0.0	0.0	0.0	1.7	2.7	0.0	0.0	0.6	0.0	0.2	0.3	0.8	0.0	0.0	0.0	10.0	9.0	0.7	0.0	0.1	0.0	1.4	0.0	0.0	138.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	0.0	0.0	10.3	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.7	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.2	1.2	1.8	0.0	0.0
CAMK2G	CAMKG	ENSG00000148660	"Calcium/calmodulin dependent protein kinase II gamma"	Q13555	10	73812501-73874591	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Neurogenesis"	"Calmodulin-binding, Developmental protein, Kinase, Serine/threonine-protein kinase, Transferase"	"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 154.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 410.7;Cytotrophoblasts: 163.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 133.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"PC-3: 154.8;SK-BR-3: 177.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040656, HPA051783, HPA051785, HPA053973"	Approved		Approved	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA		200000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA040656: AB_2677065, HPA051783: AB_2681608, HPA051785: AB_2681609, HPA053973: AB_2682328"	"unprognostic (8.63e-3)"	"unprognostic (2.01e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.27e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.48e-1)"	"unprognostic (6.25e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.48e-1)"	"unprognostic (8.28e-2)"	"unprognostic (9.64e-2)"	"unprognostic (4.62e-2)"	22.0	14.0	86.1	17.0	92.6	34.5	15.2	79.9	137.8	24.1	44.1	101.1	34.2	45.2	14.5	34.7	30.6	17.8	11.8	91.3	79.0	19.3	14.5	18.8	16.2	96.1	96.5	12.7	10.3	12.3	14.1	27.3	94.1	31.1	26.1	42.4	22.9	49.6	154.3	17.3	41.5	43.9	91.4	24.9	30.4	6.5	102.5	15.7	13.6	84.8	14.9	58.4	25.8	91.9	35.7	24.6	22.5	43.9	16.7	26.1	26.3	25.8	41.0	31.9	26.1	39.8	37.2	27.4	25.7	32.4	12.4	54.9	17.5	20.5	25.3	24.0	22.2	18.2	20.4	17.8	8.1	24.7	29.1	14.4	17.7	32.5	22.1	50.4	28.3	32.5	19.5	37.9	19.0	25.2	41.7	37.5	16.5	21.3	154.8	36.5	25.3	13.7	17.2	51.5	11.5	28.4	15.0	177.4	11.9	16.5	33.2	15.0	36.7	24.9	40.0	13.4	33.3	11.9	14.9	24.8	26.5	69.2	8.8	31.0	17.9	133.9	23.1	7.9	28.5	13.9	26.3	25.0	23.0	12.7	24.5	24.1	115.8	34.0	15.1	7.9	27.7	17.5	86.1	92.6	79.9	137.8	91.3	79.0	96.1	96.5	94.1	91.4	102.5	91.9	19.3	16.0	11.7	410.7	22.2	9.4	8.7	9.2	14.2	63.3	14.8	16.3	6.7	12.8	15.5	7.3	100.1	163.6	21.3	46.2	13.7	13.3	2.0	6.3	6.4	20.2	23.9	13.3	107.9	19.6	45.2	12.0	14.8	7.5	16.5	20.2	16.4	9.6	27.2	26.9	89.7	24.8	10.2	18.9	16.3	3.1	12.8	15.8	12.4	43.1	18.3	17.7	26.8	61.9	16.9	22.0	65.5	18.8	13.6	8.2	77.1	26.9	10.4	77.0	46.0	11.2	50.8	0.8	13.5	26.5	12.6	81.1	30.3	5.2	32.1	13.7
CAMLG	"CAML, GET2"	ENSG00000164615	"Calcium modulating ligand"	P49069	5	134738495-134752157	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Early spermatids: 845.6;Late spermatids: 1655.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052636, HPA056472"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 31: Spermatids - Spermatogenesis"	Vesicles	"Nucleoplasm, Nucleoli"	"HPA052636: AB_2681893, HPA056472: AB_2683143"	"unprognostic (9.23e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-2)"	"unprognostic (3.68e-2)"	"unprognostic (5.41e-3)"	"unprognostic (3.07e-1)"	"unprognostic (8.54e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.58e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (3.26e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.16e-1)"	52.3	37.2	50.6	17.5	52.1	31.7	42.1	50.7	69.4	57.0	48.2	54.8	34.4	45.8	48.2	29.5	45.3	27.4	26.9	52.3	55.9	29.7	29.3	28.6	26.2	51.9	53.8	68.6	30.7	27.0	43.1	17.9	54.3	34.9	15.9	29.1	29.0	31.8	60.4	36.7	30.4	28.5	52.8	26.1	36.5	51.3	52.1	25.8	27.0	35.6	25.3	44.2	41.1	53.3	27.5	22.2	33.0	64.1	76.3	118.3	14.4	39.0	55.8	26.8	52.8	38.9	40.1	113.9	56.2	27.5	42.7	34.2	29.2	46.9	35.0	54.3	54.5	29.9	33.2	32.8	56.3	13.7	89.2	96.9	49.5	35.1	57.9	92.3	54.8	49.0	18.6	47.1	39.9	31.2	43.1	58.2	17.1	34.7	21.5	46.2	40.7	44.3	46.0	26.4	52.2	36.9	27.1	15.3	97.1	40.8	48.4	33.9	53.2	24.5	16.4	40.2	35.2	45.8	55.1	42.5	46.2	48.5	14.8	62.0	26.4	60.7	30.5	31.8	41.1	43.5	43.5	38.4	29.1	39.5	45.0	44.2	47.9	31.4	44.6	26.1	52.6	31.6	50.6	52.1	50.7	69.4	52.3	55.9	51.9	53.8	54.3	52.8	52.1	53.3	86.8	38.5	36.4	13.7	92.9	167.1	107.0	113.6	157.1	80.5	121.9	124.7	45.1	100.1	68.9	42.3	25.0	50.3	93.3	42.8	92.0	63.9	845.6	57.6	116.4	99.5	62.4	76.6	29.4	90.9	62.5	107.4	32.6	61.7	123.4	66.6	102.4	69.1	69.9	55.5	32.0	69.4	107.8	111.5	130.8	1655.8	168.0	76.6	96.0	10.3	126.9	127.7	90.6	15.1	18.6	67.5	58.0	132.4	55.2	148.6	158.2	199.1	51.3	71.4	98.6	119.5	109.7	241.5	68.6	119.3	201.6	73.2	101.6	67.9	90.9	107.9
CAMP	"CAP18, FALL-39, FALL39, LL37"	ENSG00000164047	"Cathelicidin antimicrobial peptide"	P49913	3	48223347-48225491	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 2914.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.3;Fibroblasts: 6.9;Late spermatids: 17.4;Prostatic glandular cells: 9.4;Spermatocytes: 5.0;Spermatogonia: 7.2"	"Cancer enriched"	"Detected in many"	4	"testis cancer: 10.1"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"eosinophil: 84.4;neutrophil: 335.4"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 335.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 27.3;hTCEpi: 19.0;U-698: 77.5"	"Not detected"	"Not detected"							"CAB015949, CAB016522, HPA029874"	Enhanced				"Secreted to blood"	NA	NA	617000000	28000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 34: Spermatids - Unknown function"			"CAB015949: , CAB016522: , HPA029874: AB_10600859"	"unprognostic (2.14e-2)"	"prognostic favorable (5.73e-4)"	"unprognostic (4.59e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.41e-2)"	"unprognostic (4.57e-5)"	"unprognostic (3.09e-1)"	"unprognostic (5.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.08e-4)"	"unprognostic (1.23e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.03e-2)"	0.8	0.1	0.1	1.6	0.1	2914.5	0.5	0.1	0.5	0.6	0.1	0.3	0.0	0.6	339.9	0.4	0.1	0.3	1.4	0.1	0.1	0.4	3.9	7.4	6.8	0.2	0.1	0.2	0.1	0.1	0.5	2.4	0.2	0.5	0.1	0.0	15.2	0.6	0.2	3.7	1.7	0.1	0.1	23.2	0.4	1.9	0.1	10.7	5.7	0.2	2.9	0.4	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	27.3	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	19.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.1	0.1	1.0	1.4	0.1	0.0	3.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	77.5	0.0	3.4	0.1	37.9	5.5	84.4	0.0	9.8	0.0	2.3	0.0	0.0	7.7	2.4	0.0	0.0	335.4	2.6	28.1	4.7	0.0	86.9	0.1	0.1	0.1	0.5	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.9	0.8	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	16.3	0.9	0.3	0.2	0.0	2.1	0.0	0.2	0.0	6.9	0.5	1.4	0.0	0.0	0.4	0.0	3.2	0.0	0.0	0.0	0.0	1.3	1.1	17.4	0.9	3.6	1.8	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.8	9.4	0.0	0.1	0.7	0.0	0.0	0.0	0.1	5.0	7.2	0.0	0.0	0.0	1.0	0.0	0.4	0.6
CASC3	"BTZ, MLN51"	ENSG00000108349	"CASC3 exon junction complex subunit"	O15234	17	40140318-40172171	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Stress response, Translation regulation, Transport"	RNA-binding	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 239.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024592, HPA050262"	Approved		Approved	"Nuclear membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear membrane"		"HPA024592: AB_1846034, HPA050262: AB_2681067"	"unprognostic (3.76e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.48e-3)"	"unprognostic (3.40e-3)"	"unprognostic (3.38e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.29e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.41e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.48e-2)"	45.5	27.9	88.0	29.9	96.9	37.2	38.5	79.3	95.1	41.0	62.2	48.2	22.9	49.5	38.2	30.3	46.9	25.0	24.8	77.0	90.4	29.0	20.8	35.4	34.1	94.3	88.4	55.6	33.3	35.0	26.0	30.3	89.3	36.1	31.9	39.0	31.8	47.9	55.4	38.1	32.2	47.7	84.9	34.1	35.3	54.1	94.0	40.1	40.4	43.5	37.6	47.7	33.3	96.6	44.6	44.9	58.5	64.9	46.1	48.2	34.3	45.5	40.6	61.3	52.5	48.3	38.3	81.7	67.2	57.7	50.4	77.8	71.8	48.0	83.5	54.8	58.1	58.6	55.4	50.6	42.0	74.7	39.6	50.2	43.9	59.9	93.6	46.8	77.4	45.8	64.0	61.5	50.8	25.6	110.9	44.3	44.5	39.8	26.0	67.3	74.5	85.9	32.1	39.5	85.4	49.8	63.8	239.4	59.4	91.1	78.2	58.9	50.0	51.7	53.3	48.7	71.0	56.5	56.3	81.1	50.4	40.2	57.1	7.8	9.4	13.1	12.5	11.5	11.1	8.6	9.3	11.5	10.0	8.6	10.5	10.4	35.9	10.2	18.2	5.8	9.1	8.6	88.0	96.9	79.3	95.1	77.0	90.4	94.3	88.4	89.3	84.9	94.0	96.6	32.8	19.2	36.8	31.0	29.5	19.8	22.9	11.3	31.3	40.8	38.5	32.5	26.7	14.3	31.8	23.9	22.9	19.9	38.0	21.4	21.5	17.8	14.8	30.2	38.8	34.0	31.2	23.5	29.0	24.3	21.3	26.9	26.0	31.4	16.4	32.5	23.9	21.9	17.0	30.3	32.8	20.8	18.3	26.4	29.2	24.5	36.1	25.8	35.6	22.5	23.9	23.5	26.8	15.1	34.5	21.0	17.6	29.7	26.5	27.2	17.3	18.1	27.2	38.5	13.1	42.0	40.2	59.4	67.7	28.1	19.9	27.1	30.1	22.7	20.6	24.7
CASQ1	"CASQ, PDIB1"	ENSG00000143318	"Calsequestrin 1"	P31415	1	160190575-160201886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"Muscle protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	64	"skeletal muscle: 4442.6;tongue: 1892.7"	"Group enriched"	"Detected in some"	4	"Cardiomyocytes: 17.6;Rod photoreceptor cells: 25.2;Skeletal myocytes: 20.6"	"Cancer enhanced"	"Detected in many"		"glioma: 5.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"BEWO: 19.3;HDLM-2: 38.5;RT4: 67.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA007845, CAB015170, HPA026823"	Enhanced		Approved	Nucleoplasm,Mitochondria	"Intracellular and membrane"	NA	NA		270000		"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Mitochondria"		"CAB015170: AB_2071451, HPA007845: AB_1078388, HPA026823: AB_10603557"	"unprognostic (1.87e-2)"	"unprognostic (3.97e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.03e-2)"	"unprognostic (6.85e-2)"	"unprognostic (1.96e-2)"	"unprognostic (4.65e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.87e-2)"	"unprognostic (3.01e-2)"	"unprognostic (3.21e-3)"	"unprognostic (9.04e-4)"	"unprognostic (1.80e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (8.93e-5)"	0.9	0.4	5.1	0.8	6.0	1.5	1.4	4.9	10.0	0.5	3.3	3.3	0.5	1.7	0.3	43.1	1.9	1.2	44.9	6.5	3.1	0.3	0.4	0.7	3.0	3.7	3.9	0.4	0.3	0.2	1.0	6.2	3.2	16.2	0.5	49.7	16.7	5.0	4442.6	1.0	1.9	7.4	3.1	1.3	0.8	5.7	3.6	0.5	0.6	1892.7	1.0	5.7	0.9	6.2	0.0	0.0	0.5	0.0	0.2	0.0	19.3	0.0	0.2	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	38.5	0.4	0.1	0.0	0.0	0.1	0.6	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.7	0.4	0.1	0.0	0.2	0.3	0.2	0.0	67.4	0.0	0.1	0.3	0.2	0.0	3.5	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.7	0.8	0.3	0.3	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.1	6.0	4.9	10.0	6.5	3.1	3.7	3.9	3.2	3.1	3.6	6.2	0.1	0.0	0.0	1.3	0.0	0.1	0.2	0.0	0.0	1.9	0.7	0.9	17.6	0.0	0.0	0.0	2.1	3.0	0.1	0.0	0.0	0.1	3.0	0.1	0.1	0.2	0.0	0.0	2.0	0.0	4.9	0.3	0.0	0.1	3.8	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.3	0.6	0.6	0.2	0.0	0.0	0.0	3.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	25.2	0.0	20.6	0.6	1.2	1.9	0.0	0.0	4.5	0.1	0.1	0.0	0.3
CASR	"FHH, GPRC2A, HHC, HHC1, NSHPT"	ENSG00000036828	"Calcium sensing receptor"	P41180	3	122183668-122291629	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	29	"parathyroid gland: 654.4"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 25.6;Alveolar cells type 2: 20.2;Cholangiocytes: 27.1;Distal tubular cells: 13.7;Enteroendocrine cells: 11.5;Granulosa cells: 20.7;Respiratory ciliated cells: 15.3"	"Cancer enriched"	"Detected in some"	7	"pancreatic cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA039686, HPA050335"	Enhanced					NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"		"Cluster 40: Granulosa cells - Unknown function"			"HPA039686: AB_10673536, HPA050335: AB_2681092"		"unprognostic (1.97e-2)"	"unprognostic (7.40e-2)"	"unprognostic (8.20e-4)"	"unprognostic (3.15e-1)"	"unprognostic (8.55e-4)"	"unprognostic (1.58e-1)"	"unprognostic (7.32e-2)"		"unprognostic (7.67e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.91e-5)"	"unprognostic (2.72e-1)"	"unprognostic (2.26e-1)"		"unprognostic (1.24e-2)"	0.1	0.1	1.5	0.1	1.0	0.8	0.0	1.7	1.6	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.1	4.2	0.0	1.0	0.6	22.4	0.2	0.0	0.2	0.6	1.1	0.5	9.6	654.4	0.2	0.0	0.8	0.1	0.2	1.5	0.1	0.0	0.1	0.2	0.5	0.0	0.2	0.1	2.8	0.2	1.7	0.1	0.7	0.0	0.2	0.3	0.0	1.7	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.3	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.1	0.8	0.3	0.1	0.1	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.3	0.2	0.0	0.3	0.2	0.1	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.5	1.0	1.7	1.6	1.0	0.6	0.6	1.1	0.8	0.2	1.7	1.7	0.0	25.6	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	27.1	5.6	3.7	0.0	0.0	0.0	0.0	13.7	4.3	0.5	0.0	0.0	0.5	11.5	0.0	0.3	0.2	0.0	1.6	0.0	0.0	1.3	20.7	0.0	0.1	0.1	0.0	0.1	0.6	0.0	1.0	0.0	1.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	0.0	0.0	0.0	0.2	15.3	1.0	0.0	0.0	1.5	0.0	0.5	0.0	0.0	0.0	0.9	0.8	0.0	0.0
CATSPER1	CATSPER	ENSG00000175294	"Cation channel sperm associated 1"	Q8NEC5	11	66016752-66026479	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	34	"testis: 17.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 44.0;granulocytes: 99.6;Hofbauer cells: 19.9;monocytes: 27.3;NK-cells: 42.2"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 16.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.4;EFO-21: 4.0;HEL: 2.8;HMC-1: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"				"unprognostic (2.21e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.91e-1)"	"unprognostic (3.96e-3)"	"unprognostic (1.71e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.44e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.61e-2)"	"unprognostic (2.12e-8)"	"unprognostic (8.79e-3)"	"unprognostic (9.02e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.51e-1)"	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.8	0.4	0.3	0.0	4.4	0.0	4.0	0.8	1.4	0.0	0.0	0.8	0.4	0.0	0.0	2.8	0.1	0.0	0.0	0.0	5.1	0.0	0.0	0.3	0.5	0.9	0.2	0.0	0.0	0.1	0.7	0.0	0.0	0.5	0.0	0.0	0.3	0.0	1.5	0.1	1.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.6	0.2	1.1	2.2	0.1	0.2	0.0	0.0	0.0	0.8	0.3	0.6	16.9	5.8	0.1	0.2	0.8	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.6	3.7	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	0.2	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.3	9.6	0.0	0.0	0.4	44.0	0.1	0.1	0.4	0.0	0.8	0.1	0.7	6.0	0.2	0.0	0.0	99.6	0.0	1.4	0.1	19.9	0.0	0.2	0.0	0.0	17.0	12.2	4.3	0.9	15.4	1.8	0.0	27.3	0.0	42.2	0.5	0.0	3.7	0.0	0.4	1.4	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	1.9	1.2	0.0	0.3	0.4	4.5	0.0	0.0	0.3
CATSPER2		ENSG00000166762	"Cation channel sperm associated 2"	Q96P56	15	43628503-43668118	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.6;retina: 22.8;testis: 15.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 254.4;Early spermatids: 73.6;Rod photoreceptor cells: 221.8;Spermatocytes: 117.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 14.6"	"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HeLa: 11.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (6.88e-3)"	"unprognostic (6.79e-2)"	"unprognostic (2.08e-2)"	"unprognostic (2.65e-2)"	"unprognostic (4.05e-1)"	"unprognostic (1.05e-2)"	"unprognostic (7.11e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.35e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.37e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.04e-2)"	"unprognostic (8.87e-2)"	"unprognostic (8.23e-5)"	1.2	1.4	2.0	0.8	2.2	4.2	1.8	14.6	4.0	1.3	0.1	2.3	3.3	1.4	5.4	2.4	1.4	0.7	0.9	2.2	0.7	1.4	1.5	1.2	2.0	1.4	0.6	1.6	1.2	4.0	3.2	0.8	1.7	1.6	2.3	22.8	1.6	2.2	1.2	5.4	3.8	0.6	0.1	1.5	1.8	15.5	0.9	0.9	1.9	1.5	1.5	1.7	1.3	3.1	2.0	2.8	1.2	4.4	0.0	0.0	2.0	0.7	1.7	1.2	2.9	0.7	1.1	2.4	1.0	0.5	1.4	4.4	1.1	3.9	1.2	2.0	5.4	7.0	11.2	1.0	1.8	1.6	2.2	0.2	3.0	1.7	4.3	3.2	1.5	4.3	2.8	2.4	0.4	0.5	1.3	2.8	0.4	2.7	1.2	1.9	1.4	1.1	2.4	3.2	2.6	0.9	1.1	1.6	0.1	1.6	3.2	1.5	0.4	3.0	1.3	0.0	1.8	0.4	0.3	5.1	2.1	4.9	1.1	0.1	0.3	0.1	0.3	0.1	0.4	1.1	0.2	0.4	0.2	0.3	0.3	0.7	0.5	0.5	0.3	0.4	0.1	0.0	2.0	2.2	14.6	4.0	2.2	0.7	1.4	0.6	1.7	0.1	0.9	3.1	4.8	0.0	4.5	0.0	4.9	7.0	8.2	8.3	1.8	56.7	6.9	6.9	4.2	5.7	8.0	7.3	254.4	6.0	6.0	3.9	3.9	3.2	73.6	5.2	2.5	6.0	21.5	2.7	0.0	2.7	2.1	3.2	6.1	4.2	9.5	29.7	8.6	3.9	4.3	38.7	0.0	4.6	4.1	5.0	6.5	37.4	6.2	4.5	1.8	0.0	4.5	13.4	7.2	0.0	0.0	2.0	3.3	7.2	1.1	6.7	11.1	4.1	10.8	221.8	0.0	9.3	5.1	117.4	17.1	2.7	8.0	3.0	4.6	5.8	8.5	8.4
CATSPER3	CACRC	ENSG00000152705	"Cation channel sperm associated 3"	Q86XQ3	5	134967907-135011696	"Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"testis: 29.6"	"Group enriched"	"Detected in some"	5	"Early spermatids: 197.9;Late spermatids: 64.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 1.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+: 2.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (2.59e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.26e-1)"	"unprognostic (4.26e-2)"	"unprognostic (1.57e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.63e-1)"	"unprognostic (3.71e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.28e-3)"	"unprognostic (1.55e-1)"	"unprognostic (3.04e-2)"	"unprognostic (5.58e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.51e-1)"	"unprognostic (4.96e-3)"	0.5	0.8	0.8	0.2	0.9	0.6	0.5	0.9	1.2	0.7	1.8	0.7	0.6	0.5	0.6	0.5	1.0	0.1	0.7	0.7	0.9	1.6	1.8	0.4	0.3	1.0	0.9	0.8	1.4	0.4	0.8	0.2	0.9	0.9	0.5	2.7	0.8	0.4	3.0	0.5	0.7	0.3	0.8	0.7	0.8	29.6	0.9	0.5	0.7	1.8	0.4	0.7	0.5	0.9	0.1	1.4	0.5	0.6	0.4	0.1	0.3	0.2	0.1	2.8	0.2	0.8	1.2	0.5	0.7	0.1	0.2	0.4	0.9	0.4	0.2	0.8	1.0	0.1	0.8	0.4	0.2	0.4	0.3	0.1	0.7	0.2	1.0	0.2	0.0	0.3	0.6	0.9	0.1	0.6	0.6	0.9	0.1	1.1	0.7	0.7	0.2	0.3	1.2	0.2	0.4	0.4	0.5	0.4	0.4	0.4	0.5	0.8	0.4	0.0	0.4	0.1	0.6	0.4	0.4	0.1	0.2	0.9	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.2	0.2	0.4	1.7	0.5	0.1	0.1	1.2	0.0	0.2	0.0	0.1	0.8	0.9	0.9	1.2	0.7	0.9	1.0	0.9	0.9	0.8	0.9	0.9	0.1	0.0	0.0	21.9	0.2	0.0	0.3	0.5	0.0	0.2	0.3	0.1	1.0	1.5	0.3	0.0	0.0	0.1	0.1	0.2	0.0	0.7	197.9	0.5	0.1	0.3	0.0	0.0	6.4	1.1	0.3	0.2	0.0	0.2	0.0	0.9	0.4	0.8	0.4	0.0	7.8	0.1	2.0	0.3	0.4	64.3	1.5	0.3	0.0	7.5	0.7	1.4	0.0	9.0	7.9	0.3	0.0	0.7	0.0	0.3	0.7	1.5	0.3	2.4	0.0	0.3	0.2	4.7	1.4	0.0	0.3	0.1	0.1	0.1	0.6	0.2
CATSPER4		ENSG00000188782	"Cation channel sperm associated 4"	Q7RTX7	1	26190561-26202968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Differentiation, Ion transport, Spermatogenesis, Transport"	"Calcium channel, Developmental protein, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	53	"testis: 11.2"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 65.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045257	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA045257: AB_10968995"	"unprognostic (7.20e-2)"	"unprognostic (2.06e-2)"		"unprognostic (4.56e-2)"		"unprognostic (2.69e-2)"		"unprognostic (3.49e-1)"		"unprognostic (3.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (2.16e-1)"		"unprognostic (3.06e-1)"	"unprognostic (6.78e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.67e-5)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	12.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CATSPERB	"C14orf161, FLJ14298"	ENSG00000133962	"Cation channel sperm associated auxiliary subunit beta"	Q9H7T0	14	91580696-91780707	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pancreas: 10.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 22.9;Exocrine glandular cells: 10.9;Gastric mucus-secreting cells: 11.7;Glandular and luminal cells: 6.2;Pancreatic endocrine cells: 7.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 1.2;OE19: 1.3;U-937: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035134			Uncertain	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 32: U-937 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"	Vesicles		"HPA035134: AB_10671510"	"unprognostic (2.69e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.16e-3)"	"unprognostic (1.93e-1)"	"unprognostic (7.04e-3)"	"unprognostic (2.72e-5)"	"unprognostic (1.81e-1)"	"unprognostic (5.01e-3)"	"unprognostic (1.81e-3)"	"unprognostic (3.52e-3)"	"unprognostic (2.30e-2)"	"unprognostic (4.34e-1)"	"unprognostic (8.99e-3)"	"unprognostic (6.85e-2)"	"unprognostic (8.31e-2)"	"unprognostic (8.88e-2)"	"unprognostic (2.71e-3)"	0.5	0.2	0.5	0.6	0.5	0.3	0.8	1.0	0.5	0.4	0.1	0.6	0.4	0.2	0.4	0.5	0.4	0.8	0.4	0.3	0.2	0.2	0.1	0.6	0.9	0.3	0.1	0.3	10.7	0.3	0.2	0.2	0.3	0.6	0.5	0.8	2.5	0.2	1.2	2.3	0.9	0.2	0.1	0.6	1.4	1.1	0.2	0.3	0.5	0.0	0.5	0.2	0.2	0.8	0.2	0.0	0.2	0.5	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.7	1.2	0.4	0.3	0.0	0.0	0.2	0.0	0.1	0.2	0.4	0.6	0.1	0.4	0.7	0.0	0.5	0.2	0.1	0.2	0.1	0.1	0.5	0.0	0.3	0.1	0.0	0.1	0.7	0.2	0.2	0.0	1.3	0.1	0.1	0.0	0.0	0.1	0.3	0.5	0.0	0.0	0.2	0.5	0.5	0.1	0.7	0.3	0.0	0.0	0.0	0.1	0.2	0.3	0.1	0.0	1.2	0.3	0.3	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.5	1.0	0.5	0.3	0.2	0.3	0.1	0.3	0.1	0.2	0.8	0.1	3.2	1.5	0.3	0.1	0.1	0.3	0.2	0.0	0.0	3.3	1.0	0.2	0.0	2.1	0.0	0.0	0.1	0.3	2.2	0.0	2.7	22.9	1.6	0.9	0.6	0.0	0.0	4.9	10.9	0.1	0.6	11.7	6.2	0.0	0.1	0.0	0.1	0.0	0.0	1.3	3.0	0.0	0.3	0.3	3.2	0.6	0.1	0.0	1.9	0.6	0.0	1.0	0.5	1.8	7.5	2.5	0.0	0.4	0.9	0.1	0.5	1.5	0.0	0.0	0.9	0.3	4.5	0.2	0.8	0.0	0.3	0.7	0.1	1.4	0.8
CATSPERD	"MGC39581, TMEM146"	ENSG00000174898	"Cation channel sperm associated auxiliary subunit delta"	Q86XM0	19	5720637-5778734	"Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	19	"testis: 8.7"	"Group enriched"	"Detected in some"	6	"Early spermatids: 120.2;Endometrial ciliated cells: 67.5;Late spermatids: 165.8;Respiratory ciliated cells: 149.9"	"Cancer enhanced"	"Detected in single"		"endometrial cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	62	"HEL: 7.6"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA024056	Enhanced					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 36: HEL - Hemostasis"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA024056: AB_1858093"	"unprognostic (1.35e-1)"	"unprognostic (1.47e-1)"		"unprognostic (3.77e-3)"	"unprognostic (9.91e-2)"	"unprognostic (3.74e-2)"		"unprognostic (6.85e-2)"	"unprognostic (2.63e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.50e-1)"	"unprognostic (5.95e-8)"	"unprognostic (2.54e-2)"	"unprognostic (9.92e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.74e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	8.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.2	0.2	0.1	0.0	0.1	0.0	2.2	0.7	0.0	0.4	0.2	4.7	0.0	0.0	0.3	0.6	0.5	0.0	6.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	120.2	67.5	0.7	0.5	0.0	0.0	1.3	0.2	0.1	0.4	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	8.2	0.3	0.0	165.8	0.6	0.2	0.0	1.0	0.0	0.0	0.0	1.0	0.6	0.0	0.0	0.4	0.1	0.2	0.0	0.0	149.9	0.0	0.0	0.5	2.0	18.7	1.2	0.0	1.4	0.3	0.1	0.0	0.0	0.1
CATSPERE	"C1orf101, MGC33370"	ENSG00000179397	"Catsper channel auxiliary subunit epsilon"	Q5SY80	1	244454377-244641177	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"testis: 21.5"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Endometrial ciliated cells: 8.6;Respiratory ciliated cells: 8.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (3.22e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.02e-1)"	"unprognostic (7.31e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.50e-3)"	"unprognostic (3.76e-3)"	"unprognostic (5.39e-4)"	"unprognostic (1.96e-2)"	"unprognostic (3.41e-2)"	"unprognostic (4.37e-4)"	"unprognostic (4.43e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.79e-2)"	"unprognostic (6.74e-3)"	"unprognostic (5.85e-2)"	0.5	0.6	1.0	0.1	1.1	0.6	0.6	0.7	0.8	0.6	0.4	0.2	0.1	0.5	2.7	0.2	1.3	0.4	0.1	0.7	0.9	0.9	0.6	0.5	0.2	1.0	1.0	0.7	0.4	0.8	1.1	0.5	1.1	0.5	0.2	0.7	0.4	0.5	0.5	0.3	0.3	0.2	1.3	0.5	0.3	21.5	1.1	0.3	0.9	0.5	0.2	0.4	0.4	1.4	0.0	0.0	0.1	0.0	0.3	0.6	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.1	0.4	0.4	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.2	0.0	0.3	0.5	0.1	0.0	0.0	0.6	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.2	0.1	0.0	0.1	0.1	0.0	0.2	0.4	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.0	1.1	0.7	0.8	0.7	0.9	1.0	1.0	1.1	1.3	1.1	1.4	0.7	3.2	0.6	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.0	0.0	1.3	1.8	0.0	0.2	0.1	0.0	0.0	0.4	0.0	8.6	1.1	0.1	0.0	0.0	0.0	0.6	0.2	0.3	0.0	0.8	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	8.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.1	0.8	0.0	0.0
CATSPERG	"C19orf15, DKFZp434A1022, FLJ46353"	ENSG00000099338	"Cation channel sperm associated auxiliary subunit gamma"	Q6ZRH7	19	38335775-38370943	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"testis: 31.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 29.4;Gastric mucus-secreting cells: 27.0;Late spermatids: 49.2;Proximal enterocytes: 20.7;Spermatocytes: 28.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.4;HMC-1: 1.8;MCF7: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052777			Approved	Nucleoplasm,Nucleoli,Cytosol	"Secreted in male reproductive system"	NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"	Nucleoli	"Nucleoplasm, Cytosol"	"HPA052777: "	"unprognostic (8.50e-5)"	"unprognostic (5.12e-2)"	"unprognostic (3.57e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.63e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.87e-3)"	"unprognostic (1.00e-1)"	"unprognostic (2.92e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.37e-4)"	"unprognostic (9.99e-2)"	"unprognostic (2.01e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.07e-3)"	0.2	0.1	0.5	0.1	0.8	0.3	0.4	0.8	0.9	0.4	0.2	0.2	0.4	0.2	0.7	0.2	0.5	0.1	0.1	0.4	0.5	0.2	0.2	0.3	0.3	0.7	2.8	0.4	0.2	0.2	0.2	0.1	0.7	0.4	0.2	0.2	0.3	0.2	0.2	1.0	0.3	0.1	0.4	0.2	0.2	31.3	0.8	0.2	0.5	0.0	0.2	0.1	0.2	1.1	0.0	0.1	0.0	0.6	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.3	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.5	0.0	1.5	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.7	0.0	0.1	0.2	0.1	0.3	0.0	0.2	0.1	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	1.5	0.0	0.7	0.1	0.1	0.0	0.5	0.8	0.8	0.9	0.4	0.5	0.7	2.8	0.7	0.4	0.8	1.1	4.9	0.0	2.7	2.6	3.6	2.5	2.4	1.0	4.6	1.3	4.8	8.0	3.0	1.5	0.6	1.8	0.0	1.7	5.1	10.1	0.0	1.0	29.4	4.9	4.4	2.7	1.8	3.2	4.3	0.7	0.3	3.0	27.0	8.8	1.3	2.0	2.5	0.3	3.2	1.7	3.8	3.9	2.0	1.2	3.1	49.2	1.8	3.3	0.0	1.9	3.9	1.9	10.3	3.0	17.0	0.4	5.6	2.2	2.2	1.9	20.7	0.9	1.3	1.4	0.0	5.3	3.7	28.9	3.7	4.9	1.8	1.4	3.4	1.9	3.5	1.8
CAV1	CAV	ENSG00000105974	"Caveolin 1"	Q03135	7	116524994-116561179	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Cancer-related genes, Congenital generalized lipodystrophy, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 2160.5;Alveolar cells type 1: 3557.7;Basal keratinocytes: 1375.3;Endothelial cells: 1024.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"basophil: 14.6;memory B-cell: 5.1"	"Group enriched"	"Detected in many"	57	"B-cells: 5.1;granulocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 2140.5;BJ hTERT+: 2371.6;HBEC3-KT: 2333.7;LHCN-M2: 2372.1;U-138 MG: 1894.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"spinal cord: 122.1"	"CAB003791, HPA049326"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB003791: AB_562068, HPA049326: AB_2680714"	"unprognostic (5.98e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.35e-1)"	"unprognostic (5.37e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.35e-3)"	"unprognostic (8.07e-2)"	"prognostic unfavorable (7.17e-5)"	"unprognostic (1.31e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.79e-3)"	"unprognostic (7.92e-2)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (1.65e-3)"	"unprognostic (2.72e-1)"	"unprognostic (7.40e-2)"	"unprognostic (6.14e-3)"	621.1	17.4	12.7	44.7	15.3	0.6	284.5	14.3	21.6	267.0	11.8	298.8	32.3	190.9	72.5	135.1	152.5	148.2	276.5	12.2	13.9	18.4	26.6	592.0	30.3	15.1	13.4	137.4	24.6	21.4	6.8	449.2	14.6	110.3	93.6	31.4	58.0	175.5	102.9	104.9	89.4	274.2	14.3	199.1	120.8	25.8	16.1	25.2	168.4	184.6	20.3	202.0	124.1	16.2	458.7	344.3	9.5	3.7	1406.6	2140.5	20.6	1055.8	2371.6	566.0	591.2	3.0	652.4	0.1	365.8	1228.5	494.8	828.2	2.2	2333.7	840.3	36.0	19.5	0.4	128.7	0.3	196.9	0.1	2.1	736.9	481.6	805.7	536.0	539.0	1749.9	0.2	0.3	23.4	2372.1	45.2	0.5	0.8	33.7	1.2	173.9	5.2	25.2	251.0	317.0	2.0	1.0	0.6	328.3	20.1	52.3	137.8	1.6	3.9	1349.3	1894.8	212.4	730.6	298.9	96.8	15.8	1.9	758.4	0.9	701.0	14.6	0.0	0.0	0.0	0.0	0.0	5.1	0.1	0.1	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	12.7	15.3	14.3	21.6	12.2	13.9	15.1	13.4	14.6	14.3	16.1	16.2	2160.5	3557.7	123.0	0.0	15.8	1375.3	392.0	534.8	316.4	8.3	17.9	190.8	286.6	107.2	342.0	7.3	2.1	64.3	7.0	0.3	5.9	76.8	2.6	17.5	102.3	1024.0	1.8	16.0	0.4	0.7	449.5	326.8	1.5	21.3	13.9	6.3	450.5	5.2	15.0	0.0	0.5	7.0	20.3	11.0	187.1	13.4	377.2	10.7	439.4	19.7	3.7	249.0	0.0	1.0	1.3	43.1	0.1	565.4	56.2	512.7	0.7	0.3	30.6	7.7	558.8	152.4	751.4	2.1	5.7	39.4	610.9	117.0	16.7	59.7	2.4	93.3
CAV3	"LGMD1C, LQT9, VIP-21, VIP21"	ENSG00000182533	"Caveolin 3"	P56539	3	8733802-8841808	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant, Limb-girdle muscular dystrophy, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 182.7;tongue: 72.8"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 22.9;Early spermatids: 4.2;Sertoli cells: 6.6;Skeletal myocytes: 11.0"	"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"RH-30: 94.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB017518, CAB018557, HPA054488"	Enhanced		Approved	"Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	Vesicles	"CAB017518: AB_628860, CAB018557: AB_626814, HPA054488: AB_2682504"	"unprognostic (1.79e-1)"				"unprognostic (1.43e-1)"	"unprognostic (1.40e-2)"		"unprognostic (6.43e-2)"		"unprognostic (8.79e-2)"	"unprognostic (3.05e-3)"	"unprognostic (8.38e-3)"		"unprognostic (9.79e-2)"	"unprognostic (1.36e-1)"			0.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.2	5.7	0.1	0.1	27.4	0.1	0.1	0.0	0.0	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	2.5	0.2	182.7	0.2	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.2	0.1	72.8	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	94.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	22.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	2.5	0.3	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	11.0	2.3	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0
CCDC22	"CXorf37, JM1"	ENSG00000101997	"Coiled-coil domain containing 22"	O60826	X	49235470-49250520	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport, Ubl conjugation pathway"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000229, HPA000888, HPA075980"	Uncertain	Approved	Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 4: Macrophages - Innate immune response"	"Endoplasmic reticulum, Vesicles"		"HPA000229: , HPA000888: AB_1078420, HPA075980: "	"unprognostic (1.24e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.98e-2)"	"unprognostic (3.45e-1)"	"unprognostic (1.36e-1)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (2.17e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.62e-2)"	"unprognostic (1.70e-1)"	"unprognostic (4.57e-3)"	"unprognostic (3.61e-2)"	"unprognostic (4.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.40e-3)"	10.3	12.3	9.4	10.1	10.0	18.6	10.3	9.9	10.8	11.7	8.8	12.1	10.4	12.2	5.3	14.2	11.3	6.4	12.8	9.4	9.2	12.3	12.9	10.7	15.0	10.8	9.4	11.2	14.2	8.7	11.2	6.9	10.1	13.5	5.2	4.7	12.3	8.7	17.2	13.8	13.4	6.0	9.6	20.5	12.9	3.8	10.0	13.6	11.0	7.7	8.5	11.9	11.1	10.8	18.8	16.0	9.6	33.5	8.8	8.9	20.4	10.9	7.9	12.0	13.6	16.3	16.0	6.9	15.9	9.7	14.3	15.0	10.6	18.0	4.9	18.1	23.6	7.3	15.6	15.5	14.7	20.8	12.4	8.2	15.2	15.9	8.6	6.1	11.9	13.7	14.7	11.8	8.6	58.3	15.3	24.4	11.2	9.5	23.2	22.0	15.6	30.1	9.4	9.4	11.4	8.8	16.7	19.4	15.0	9.8	30.2	20.2	13.3	15.4	16.5	19.2	11.6	21.2	12.6	12.5	16.8	38.5	12.3	8.6	37.0	23.8	18.3	30.9	20.1	18.9	18.8	21.3	38.2	16.8	16.7	19.6	2.8	10.8	27.1	15.1	21.8	28.0	9.4	10.0	9.9	10.8	9.4	9.2	10.8	9.4	10.1	9.6	10.0	10.8	8.6	0.0	4.4	3.3	15.0	5.6	9.6	13.0	6.2	11.6	7.4	6.1	2.4	15.7	12.0	11.0	6.2	15.2	11.2	12.5	15.6	13.9	0.3	5.8	4.6	7.8	6.7	8.6	3.7	7.3	14.8	7.6	7.1	6.9	11.4	8.6	11.0	7.2	32.0	1.7	2.9	18.2	8.2	14.4	11.9	0.4	8.1	13.8	7.2	1.9	18.0	9.9	9.2	1.0	4.2	8.6	7.6	7.5	10.2	6.2	15.6	12.1	5.6	8.0	6.6	9.1	9.5	0.1	0.9	8.0	6.7	20.2	13.3	11.0	15.7	8.3
CCDC47	GK001	ENSG00000108588	"Coiled-coil domain containing 47"	Q96A33	17	63745255-63776351	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029674, HPA072573, HPA075958"	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA029674: AB_10602703, HPA072573: AB_2686535, HPA075958: "	"unprognostic (6.33e-2)"	"unprognostic (3.26e-2)"	"prognostic favorable (2.17e-4)"	"unprognostic (1.38e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.53e-2)"	"unprognostic (9.08e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.35e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (1.16e-1)"	57.9	67.3	24.3	42.5	33.6	29.0	57.1	28.8	39.2	47.7	46.9	83.4	87.1	39.1	53.7	52.6	43.9	48.2	65.5	29.3	27.9	72.0	102.2	52.7	33.5	28.8	27.4	35.3	59.8	84.6	21.9	54.8	29.9	60.2	80.6	46.9	62.4	52.0	115.3	52.2	78.2	42.1	30.1	35.6	78.5	32.1	26.0	29.9	62.0	83.7	40.5	58.5	29.3	34.3	143.3	133.8	81.4	71.9	112.4	74.0	158.0	141.9	92.6	96.1	112.4	118.7	127.0	112.9	74.3	100.9	110.8	114.3	99.3	88.1	168.9	39.4	101.2	160.9	106.4	117.3	107.6	129.9	81.3	78.5	121.3	132.4	113.2	67.9	81.3	55.3	183.5	95.5	79.4	116.1	100.5	48.1	70.8	179.4	134.0	92.2	157.9	154.6	115.3	161.1	74.2	101.5	95.2	242.8	120.3	103.0	159.8	70.4	104.0	177.6	112.9	130.6	166.0	93.9	119.9	112.8	103.9	81.4	147.3	53.2	59.7	75.6	40.7	61.5	47.9	38.4	39.8	37.9	82.5	31.7	41.1	36.2	47.6	43.4	65.9	54.7	49.0	52.0	24.3	33.6	28.8	39.2	29.3	27.9	28.8	27.4	29.9	30.1	26.0	34.3	96.9	144.2	122.2	16.3	46.6	100.8	108.5	95.9	98.4	40.9	65.9	53.6	129.0	72.9	128.3	60.7	14.6	111.1	59.0	99.8	9.8	115.3	17.9	80.3	73.9	83.9	52.2	76.6	26.2	105.1	98.3	85.3	65.7	126.0	45.5	31.2	68.2	96.3	57.5	57.2	25.9	95.1	83.4	56.9	58.3	11.5	47.8	60.7	39.2	13.1	52.9	55.3	25.7	22.6	25.5	92.0	62.6	56.1	56.0	89.6	87.5	32.6	83.0	27.9	72.3	117.2	92.1	82.0	44.7	90.1	90.8	144.1	42.7	53.0	110.5	83.3
CCDC93	FLJ10996	ENSG00000125633	"Coiled-coil domain containing 93"	Q567U6	2	117915478-118014133	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054183	Approved		Enhanced	"Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	Vesicles	"Plasma membrane"	"HPA054183: AB_2682408"	"unprognostic (1.47e-1)"	"unprognostic (6.55e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.02e-2)"	"unprognostic (3.32e-2)"	"unprognostic (2.47e-3)"	"prognostic unfavorable (2.97e-6)"	"unprognostic (2.51e-1)"	"unprognostic (8.12e-2)"	"unprognostic (8.99e-2)"	"unprognostic (1.52e-3)"	"unprognostic (8.56e-2)"	"unprognostic (4.87e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.67e-1)"	"prognostic unfavorable (9.66e-4)"	"unprognostic (2.40e-2)"	10.2	14.5	9.3	10.4	8.5	21.7	9.6	9.6	12.7	9.1	15.0	11.3	11.9	8.2	9.8	7.4	9.3	7.1	21.3	8.4	9.4	9.8	7.8	11.8	10.3	9.7	9.0	13.3	13.0	15.9	16.1	8.1	10.3	7.6	10.6	26.0	9.1	8.4	12.9	11.0	12.8	8.1	8.4	12.1	9.1	12.1	11.5	10.1	11.9	10.3	10.1	8.6	8.1	8.5	18.7	8.1	22.0	19.4	31.2	21.3	18.5	21.8	14.2	14.0	14.3	17.7	11.7	15.9	14.5	17.1	24.9	15.8	12.8	11.2	18.1	20.8	13.0	20.1	15.5	23.9	13.7	22.1	22.0	14.6	11.5	21.9	25.9	19.4	15.0	18.9	11.1	11.0	15.8	8.1	14.0	23.8	9.9	13.4	13.0	17.6	17.2	10.7	11.5	19.6	17.4	10.3	14.2	10.6	15.1	19.6	8.9	13.5	21.2	23.9	20.0	20.4	15.3	14.3	16.0	24.7	13.8	16.1	14.2	2.9	1.6	1.8	2.1	2.1	2.0	1.6	1.5	1.8	1.2	1.4	2.0	1.7	1.7	1.7	1.3	0.5	0.7	1.0	9.3	8.5	9.6	12.7	8.4	9.4	9.7	9.0	10.3	8.4	11.5	8.5	17.4	19.2	28.2	61.0	28.6	17.6	14.6	11.2	9.6	32.0	12.4	10.0	43.0	7.2	17.5	1.8	47.9	12.6	31.9	21.5	9.8	24.0	4.5	14.9	15.2	16.5	16.7	9.9	57.1	16.7	8.5	14.7	11.7	17.0	15.2	25.1	12.8	6.0	15.2	20.2	60.6	11.4	10.2	16.3	15.9	10.6	13.7	19.9	3.6	32.8	19.9	13.8	20.6	53.3	37.9	32.0	11.9	14.3	19.4	13.9	17.1	9.4	16.3	36.0	6.6	21.4	15.0	46.0	31.1	10.1	16.1	12.9	24.3	12.8	14.0	15.0
CCN3	"IGFBP9, NOV"	ENSG00000136999	"Cellular communication network factor 3"	P48745	8	119416446-119424434	"Plasma proteins, Predicted secreted proteins, Transporters"		"Growth factor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	44	"adrenal gland: 1105.4"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 25.2;Endothelial cells: 2.7;Fibroblasts: 9.8;Smooth muscle cells: 4.6"	"Cancer enriched"	"Detected in all"	4	"melanoma: 62.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	116	"eosinophil: 64.8;neutrophil: 30.8"	"Lineage enriched"	"Detected in single"	157	"granulocytes: 64.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 125.0;hTERT-RPE1: 38.1;U-2197: 128.2"	"Group enriched"	"Detected in all"	6	"amygdala: 129.2;basal ganglia: 51.5;cerebral cortex: 99.5;hippocampal formation: 152.5;white matter: 85.0"	"Region enriched"	"Detected in all"	6	"spinal cord: 114.6"	"HPA018449, HPA019684, CAB034423"	Enhanced		Enhanced	Vesicles	"Secreted to blood"	NA	NA	269000000	2800000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles		"CAB034423: AB_2151387, HPA018449: AB_1846189, HPA019684: AB_1846190"	"unprognostic (5.04e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.36e-3)"	"unprognostic (1.30e-3)"	"unprognostic (9.35e-3)"	"unprognostic (4.92e-1)"	"unprognostic (8.10e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.79e-2)"	"unprognostic (9.17e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.72e-2)"	23.7	1105.4	7.6	3.6	11.5	1.7	8.1	6.7	12.2	11.2	5.9	6.9	3.9	8.6	6.3	5.5	9.0	6.3	18.1	16.2	9.7	6.9	1.1	6.8	2.2	5.6	6.5	3.1	6.8	9.4	21.8	0.6	4.9	22.8	7.0	1.2	2.7	20.0	4.7	13.8	4.4	8.4	8.7	1.5	4.9	3.6	6.3	1.0	25.3	7.2	1.9	4.4	8.0	6.2	0.1	3.1	1.7	0.0	11.1	2.9	0.1	16.9	125.0	14.9	8.6	0.0	0.3	0.0	12.9	21.2	11.6	10.5	0.6	0.0	5.1	0.0	0.3	0.0	9.1	0.0	0.4	0.0	0.0	0.6	0.1	5.7	0.6	38.1	0.4	0.0	0.0	0.0	0.8	0.7	0.0	0.1	0.2	1.2	24.9	0.1	0.0	0.0	15.8	0.1	3.9	0.1	6.3	0.1	24.2	0.0	0.0	0.0	0.0	10.6	15.8	128.2	3.5	0.0	0.0	0.0	16.7	5.4	12.5	0.0	0.3	64.8	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	30.8	0.0	0.0	0.0	0.0	0.1	7.6	11.5	6.7	12.2	16.2	9.7	5.6	6.5	4.9	8.7	6.3	6.2	25.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
CCNB1	CCNB	ENSG00000134057	"Cyclin B1"	P14635	5	69167135-69178245	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 52.9;lymphoid tissue: 76.2"	"Cell type enriched"	"Detected in many"	6	"Extravillous trophoblasts: 723.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"basal ganglia: 3.0;white matter: 8.3"	"Not detected"	"Not detected"			"CAB000115, CAB003804, HPA030741, HPA061448"	Enhanced		Enhanced	Cytosol		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol		"CAB000115: , CAB003804: AB_562272, HPA030741: AB_2673586, HPA061448: AB_2684522"	"unprognostic (4.12e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.91e-3)"	"unprognostic (4.08e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (1.54e-7)"	"prognostic unfavorable (3.38e-4)"	"unprognostic (1.43e-2)"	"unprognostic (1.63e-2)"	"unprognostic (2.49e-3)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.11e-16)"	"unprognostic (2.44e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.15e-3)"	4.0	5.1	4.0	26.0	3.9	52.9	10.0	6.0	4.9	6.3	2.8	22.2	20.9	7.7	5.4	36.0	8.2	4.0	3.0	3.8	4.0	4.8	4.3	3.9	54.5	6.2	4.4	5.0	4.2	5.8	2.6	20.8	6.5	3.8	29.5	5.7	6.5	3.9	3.4	14.5	19.5	14.4	3.5	11.1	10.8	32.9	5.2	76.2	9.3	2.0	67.0	8.4	10.4	4.0	466.0	317.1	423.5	377.1	22.2	37.1	980.2	201.3	150.8	521.3	437.0	471.2	423.9	285.2	239.1	187.6	594.2	284.2	432.4	442.8	577.2	281.4	217.2	181.6	243.2	323.2	6.8	160.5	197.7	16.6	27.7	300.5	207.2	47.7	282.8	274.2	223.5	217.9	430.2	441.4	220.5	184.7	236.7	153.3	199.3	228.4	305.2	288.2	192.6	168.2	212.7	133.5	347.7	160.3	141.9	236.4	306.4	162.5	119.8	114.4	368.5	207.6	510.2	109.2	216.6	399.8	158.8	271.9	358.6	3.1	2.0	1.5	3.2	5.1	4.5	15.4	8.3	7.4	6.0	11.1	2.7	2.6	1.3	8.2	2.4	5.0	17.6	6.2	4.0	3.9	6.0	4.9	3.8	4.0	6.2	4.4	6.5	3.5	5.2	4.0	4.0	0.0	0.5	2.0	11.8	11.5	7.2	32.1	4.6	4.8	9.8	12.3	1.9	1.5	8.8	5.5	2.1	108.2	8.3	9.5	1.9	6.5	110.2	15.2	7.4	6.6	1.2	76.2	2.7	1.4	723.1	18.3	21.4	13.0	2.5	63.0	8.9	3.2	60.2	0.0	2.1	13.8	73.2	12.0	7.2	17.8	3.1	9.7	3.6	1.0	2.7	3.9	2.1	0.5	1.0	2.4	1.5	2.6	24.1	4.5	2.5	5.6	13.1	4.1	6.6	4.9	18.5	74.3	62.2	37.4	7.2	41.5	8.0	11.8	33.4	7.8
CCNB2	HsT17299	ENSG00000157456	"Cyclin B2"	O95067	15	59105126-59125045	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	Cyclin	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"bone marrow: 74.6;lymphoid tissue: 73.1;testis: 69.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 67.9;Early spermatids: 228.5;Erythroid cells: 123.6;Extravillous trophoblasts: 128.3;Spermatocytes: 288.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	5	"T-reg: 22.7"	"Lineage enriched"	"Detected in many"	6	"T-cells: 22.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA008873, CAB009575"	Enhanced		Enhanced	"Golgi apparatus,Cytosol"		Yes	Yes			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Cytosol	"Golgi apparatus"	"CAB009575: AB_2072392, HPA008873: AB_1078604"	"unprognostic (2.69e-2)"	"unprognostic (2.25e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (2.83e-4)"	"prognostic unfavorable (4.63e-4)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (4.48e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (1.96e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.98e-2)"	"unprognostic (4.44e-1)"	1.0	1.1	0.4	12.2	1.1	74.6	2.9	0.7	0.7	2.9	1.1	14.3	14.1	2.6	0.3	16.1	1.1	1.9	0.7	0.6	0.7	1.1	1.4	2.2	33.0	1.3	1.0	0.8	0.7	0.2	0.3	11.4	1.0	1.6	16.8	0.3	2.8	0.4	0.7	9.4	12.0	6.4	0.7	7.1	5.6	69.4	1.1	73.1	1.0	0.4	43.7	3.6	5.6	2.2	132.5	112.1	188.6	47.1	8.5	16.6	97.5	104.8	69.9	165.2	135.6	187.8	81.1	122.1	75.4	71.8	97.2	160.1	181.4	92.6	157.8	124.1	92.4	153.1	127.3	108.1	2.5	118.1	98.6	6.3	12.6	71.4	91.9	32.7	114.1	147.0	163.1	194.5	128.2	96.5	137.9	177.2	138.6	58.5	65.2	157.5	260.0	124.4	53.3	91.9	115.2	75.9	148.9	80.2	97.3	147.9	139.4	120.4	58.5	81.6	134.4	90.5	210.5	84.2	133.2	213.8	53.6	267.1	117.9	0.0	0.1	0.7	0.1	0.0	0.3	2.1	4.6	5.0	3.0	1.7	0.0	0.1	0.8	3.6	0.1	0.1	22.7	2.1	0.4	1.1	0.7	0.7	0.6	0.7	1.3	1.0	1.0	0.7	1.1	2.2	0.3	0.0	0.6	0.0	6.8	4.8	2.8	11.5	1.8	0.2	2.5	3.3	0.5	0.0	3.2	0.0	0.0	67.9	1.6	4.1	0.0	0.7	228.5	5.3	3.1	3.9	3.0	123.6	0.7	0.2	128.3	7.2	7.1	5.9	0.0	29.9	6.1	1.1	29.9	0.0	0.8	10.1	20.3	10.6	3.3	53.5	4.4	7.9	0.0	0.0	2.4	0.2	1.0	0.0	1.4	0.4	1.9	1.9	18.7	2.3	2.1	0.0	1.8	0.3	0.0	1.0	5.7	288.7	32.1	20.3	6.1	16.3	4.4	4.1	23.4	5.0
CD14		ENSG00000170458	"CD14 molecule"	P08571	5	140631728-140633701	"Cancer-related genes, CD markers, Human disease related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 403.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 2809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 3697.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 942.3;monocytes: 3697.0"	"Cell line enhanced"	"Detected in many"		"A549: 10.1;CACO-2: 17.0;SiHa: 21.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001887, HPA002127, CAB033631, CAB072865, CAB072866"	Enhanced		Approved	Vesicles	"Secreted to blood"	NA	NA	2750000000	10000000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB033631: AB_781932, CAB072865: AB_2665714, CAB072866: AB_2665715, HPA001887: AB_1078442, HPA002127: AB_1078440"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.71e-3)"	"unprognostic (4.88e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavorable (6.80e-5)"	"unprognostic (1.20e-2)"	"unprognostic (6.87e-3)"	"unprognostic (8.12e-2)"	"unprognostic (6.92e-2)"	134.5	151.3	15.9	236.1	16.0	68.8	50.5	14.7	33.1	27.9	26.8	55.9	31.4	23.5	21.0	23.9	40.5	79.8	35.6	14.5	23.2	41.6	403.4	91.6	107.9	33.6	26.4	21.4	27.0	16.7	35.5	183.0	29.6	18.3	47.6	4.0	121.8	30.4	10.6	13.5	38.0	111.7	25.4	87.6	33.9	26.6	30.3	20.9	23.0	17.5	23.0	102.5	12.6	42.1	0.1	10.1	0.1	0.8	1.3	0.3	0.5	0.9	4.7	1.9	2.1	17.0	3.1	0.4	1.0	5.9	1.4	4.9	0.0	2.6	0.5	0.1	1.4	0.3	1.1	2.0	5.1	1.1	0.3	4.8	0.3	0.3	1.5	0.4	0.0	0.3	0.3	0.3	1.7	0.3	0.1	1.2	0.4	0.3	0.3	0.4	0.6	1.8	0.2	0.1	3.6	1.3	21.1	0.5	0.5	0.2	0.3	2.1	0.6	0.4	0.4	1.9	2.1	0.8	1.6	0.8	0.4	0.5	0.1	13.5	3697.0	21.7	6.8	677.3	8.7	12.1	3.7	3.9	440.4	1.9	5.2	3.6	942.3	3.8	95.1	25.2	3.7	3034.0	15.9	16.0	14.7	33.1	14.5	23.2	33.6	26.4	29.6	25.4	30.3	42.1	17.9	9.6	27.6	0.7	9.0	5.1	3.4	5.2	6.2	7.2	164.9	23.4	2.6	22.8	18.3	1.8	0.0	18.1	5.3	77.2	1.9	5.1	2.3	0.6	1.7	46.5	7.2	29.5	0.7	1.8	16.3	19.7	1.1	1.0	8.8	0.6	340.2	348.0	2809.2	33.7	0.9	5.9	4.1	668.4	75.9	6.1	5.0	652.8	8.8	23.4	285.3	30.0	11.3	0.5	0.4	1.8	35.3	5.3	1.8	1.7	5.0	7.0	9.8	5.1	32.9	25.8	9.7	1.5	2.0	4.4	4.3	46.1	5.5	2.1	7.4	4.9
CD151	"PETA-3, RAPH, SFA-1, TSPAN24"	ENSG00000177697	"CD151 molecule (Raph blood group)"	P48509	11	832887-839831	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Blood group antigen"	"Deafness, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 716.2;Exocrine glandular cells: 636.7;Pancreatic endocrine cells: 736.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002428, HPA011906"	Supported					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 1: Pancreatic cells - Digestion"			"CAB002428: AB_564129, HPA011906: AB_1846245"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.45e-3)"	"unprognostic (4.10e-3)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (5.58e-4)"	"prognostic unfavorable (9.46e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.39e-2)"	"unprognostic (6.23e-3)"	"unprognostic (3.24e-1)"	"prognostic favorable (6.92e-4)"	"unprognostic (7.83e-2)"	332.4	159.5	54.0	79.7	53.5	25.0	277.8	52.5	67.6	181.6	66.1	219.7	140.6	264.6	103.0	97.5	184.3	132.4	345.8	54.2	65.3	194.3	145.3	240.1	35.4	64.5	57.4	116.2	278.3	85.9	81.1	110.1	60.5	182.9	99.8	9.6	243.5	194.2	113.1	107.0	149.4	255.2	58.3	94.8	187.3	44.8	58.6	15.0	133.5	77.0	30.6	203.1	151.3	58.0	380.0	475.3	71.8	256.3	1088.7	422.8	110.4	587.1	400.4	285.0	241.2	252.6	677.2	0.2	224.0	943.5	388.4	358.4	71.1	498.4	96.1	135.0	236.6	112.8	139.1	193.4	366.7	90.2	157.4	388.6	328.2	164.5	367.8	1089.2	348.8	16.4	135.1	56.3	485.9	196.1	1.9	99.5	48.0	232.9	569.4	20.0	173.7	106.4	642.8	102.1	99.5	111.8	578.9	371.5	121.5	81.6	145.8	102.4	600.0	462.6	209.3	147.5	352.9	62.0	66.5	4.5	437.5	89.7	265.8	24.6	19.1	15.2	5.7	19.3	6.8	3.0	4.7	5.0	11.9	2.0	1.9	3.0	7.3	8.2	24.1	1.8	2.9	10.8	54.0	53.5	52.5	67.6	54.2	65.3	64.5	57.4	60.5	58.3	58.6	58.0	294.4	208.3	79.1	13.1	12.8	70.6	143.2	328.2	60.9	16.6	180.9	203.7	180.0	133.0	159.8	248.3	4.2	222.6	15.6	542.3	19.6	716.2	2.6	60.8	114.6	214.8	127.6	28.6	10.0	636.7	423.8	173.8	236.5	143.7	81.3	103.7	265.2	54.0	130.0	37.0	5.5	388.5	138.4	59.3	70.4	11.3	123.6	81.8	128.1	15.9	75.6	94.8	23.7	3.5	0.7	736.6	477.9	283.2	26.6	307.1	440.6	124.6	52.2	17.0	210.4	96.6	310.3	5.6	13.6	73.4	54.4	185.7	29.7	61.1	289.8	199.6
CD247	"CD3H, CD3Q, CD3Z"	ENSG00000198821	"CD247 molecule"	P20963	1	167430640-167518610	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"bone marrow: 49.0;lymphoid tissue: 179.4"	"Group enriched"	"Detected in many"	9	"dendritic cells: 492.1;NK-cells: 727.1;T-cells: 247.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	25	"gdT-cell: 376.4;MAIT T-cell: 208.9;memory CD4 T-cell: 190.0;memory CD8 T-cell: 219.7;naive CD4 T-cell: 237.8;naive CD8 T-cell: 195.1;NK-cell: 225.3;T-reg: 254.5"	"Group enriched"	"Detected in all"	32	"NK-cells: 225.3;T-cells: 376.4"	"Group enriched"	"Detected in some"	25	"HDLM-2: 155.9;JURKAT: 113.1;MOLT-4: 167.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB004651, HPA008750"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB004651: AB_425347, HPA008750: AB_1857863"	"prognostic favorable (9.12e-4)"	"unprognostic (3.21e-3)"	"unprognostic (7.09e-3)"	"prognostic favorable (8.63e-6)"	"unprognostic (1.99e-2)"	"prognostic favorable (3.98e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.46e-3)"	"unprognostic (9.73e-3)"	"unprognostic (1.33e-2)"	"unprognostic (2.50e-1)"	"prognostic unfavorable (9.94e-6)"	"unprognostic (1.60e-1)"	"unprognostic (5.33e-2)"	"unprognostic (4.02e-2)"	"unprognostic (5.94e-3)"	3.2	1.7	2.3	25.3	2.3	49.0	1.9	2.2	2.5	1.9	1.9	4.3	7.1	2.3	3.1	2.1	1.8	5.5	1.3	2.3	2.3	2.0	5.4	10.9	57.7	2.3	2.2	0.8	0.8	0.5	0.8	1.4	2.2	1.8	4.6	0.2	2.4	1.6	1.4	1.1	14.3	1.5	2.1	40.2	7.0	0.4	2.9	179.4	2.5	0.9	36.4	7.3	1.9	2.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	155.9	0.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	113.1	0.0	0.1	0.0	0.0	167.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	8.3	1.0	0.4	376.4	1.4	208.9	9.3	190.0	219.7	1.5	4.9	237.8	195.1	8.7	225.3	1.2	2.8	254.5	231.2	2.3	2.3	2.2	2.5	2.3	2.3	2.3	2.2	2.2	2.1	2.9	2.5	3.4	3.2	16.0	3.3	8.2	1.5	0.1	0.0	0.6	0.4	3.5	3.2	0.6	1.5	1.3	0.0	0.0	0.1	492.1	0.4	0.0	0.5	0.2	0.7	0.8	1.8	0.0	14.7	8.8	0.0	0.1	2.2	6.1	1.1	6.3	0.4	7.1	1.4	0.3	3.3	9.4	0.5	0.0	7.8	1.4	0.2	0.0	5.9	3.6	14.0	7.6	0.1	727.1	0.5	3.7	0.0	1.2	0.0	51.9	0.1	0.2	1.3	2.2	0.2	0.0	0.9	1.2	0.1	2.5	1.4	0.6	0.1	247.2	0.0	0.1	0.1
CD2AP	CMS	ENSG00000198087	"CD2 associated protein"	Q9Y5K6	6	47477789-47627263	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 204.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 9.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003267, HPA003326, CAB004352"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		NA	NA		58000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Centriolar satellite"	"CAB004352: AB_627009, HPA003267: AB_1078458, HPA003326: AB_1078457"	"unprognostic (5.98e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.75e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.19e-1)"	"unprognostic (6.71e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (2.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (6.12e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (7.57e-5)"	14.0	10.5	3.4	15.0	3.4	14.3	17.8	6.3	4.6	18.1	8.8	40.0	56.9	12.0	13.2	19.2	14.1	15.0	7.7	2.7	3.8	34.1	20.2	17.1	15.9	4.3	3.9	6.4	20.2	35.6	6.0	21.6	4.7	19.7	36.9	6.9	17.0	13.5	6.9	18.0	59.5	10.9	4.3	13.7	40.4	9.4	3.9	34.0	18.2	10.3	17.4	30.1	10.1	4.6	58.0	22.5	6.9	14.3	9.4	13.6	54.8	13.9	16.9	18.5	23.3	37.3	39.9	74.5	56.9	18.2	24.0	21.2	23.0	34.7	29.9	29.9	37.2	41.3	18.4	33.6	12.5	23.3	15.4	9.7	32.1	17.7	25.5	35.7	30.1	24.4	73.5	23.2	16.9	18.2	44.6	8.7	20.3	69.6	8.1	23.6	17.6	34.1	115.6	101.7	20.9	8.1	27.9	36.9	27.7	31.1	35.0	14.8	36.2	36.9	30.8	12.0	39.9	17.5	31.3	52.6	39.4	12.4	19.2	1.8	0.5	3.2	1.2	0.4	1.8	0.9	1.0	1.1	1.2	1.0	0.9	1.5	0.1	3.1	0.4	9.9	0.9	0.5	3.4	3.4	6.3	4.6	2.7	3.8	4.3	3.9	4.7	4.3	3.9	4.6	81.7	96.1	67.1	32.0	40.5	32.2	52.1	26.5	39.9	10.0	40.4	26.4	17.2	35.8	68.9	71.7	16.7	53.0	96.1	204.1	21.5	84.6	10.4	97.9	25.0	56.6	55.8	42.9	40.7	98.0	17.1	20.6	101.4	136.7	24.1	28.5	37.5	24.2	17.4	15.2	45.3	97.3	40.7	26.2	12.6	10.5	16.8	30.6	14.2	83.4	18.0	12.5	22.6	28.6	30.8	151.3	114.0	10.9	27.7	89.0	182.3	67.4	60.0	13.0	26.3	34.9	27.8	38.9	27.2	44.2	41.1	40.9	29.4	48.0	68.8	143.6
CD36	"FAT, GP3B, GP4, GPIV, SCARB3"	ENSG00000135218	"CD36 molecule"	P16671	7	80369575-80679277	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Transport"	Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 1533.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 3219.2;Cardiomyocytes: 623.1;Hofbauer cells: 1369.8;Sertoli cells: 696.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 962.6;intermediate monocyte: 270.6;myeloid DC: 507.1"	"Group enriched"	"Detected in all"	46	"dendritic cells: 507.1;monocytes: 962.6"	"Group enriched"	"Detected in some"	4	"ASC diff: 322.6;HEL: 158.1"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"spinal cord: 16.9"	"HPA002018, CAB025866, HPA071026"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		5300000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"		"CAB025866: , HPA002018: AB_1078464, HPA071026: AB_2732170"	"unprognostic (7.16e-2)"	"unprognostic (1.80e-2)"	"unprognostic (1.06e-3)"	"unprognostic (6.52e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.63e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.23e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.84e-3)"	"prognostic unfavorable (4.47e-4)"	"unprognostic (7.05e-3)"	"unprognostic (4.87e-2)"	"unprognostic (2.73e-3)"	1533.6	24.6	3.4	51.7	2.5	148.2	540.4	1.6	2.0	11.6	2.7	40.5	113.6	8.7	38.2	19.6	40.5	84.0	540.9	2.6	6.9	7.0	80.8	131.2	18.8	22.0	21.2	4.0	31.2	25.0	2.0	413.3	15.7	5.0	40.9	0.3	31.9	8.6	248.5	28.6	119.7	39.4	14.0	309.9	31.2	7.7	24.0	22.1	69.1	381.6	7.2	22.2	13.4	3.9	0.0	0.0	1.0	0.2	322.6	3.3	0.7	0.9	10.7	0.1	0.1	0.0	0.0	0.1	0.6	1.4	0.3	0.1	4.3	0.5	0.1	0.6	0.4	158.1	0.5	25.7	0.2	0.1	0.1	31.0	12.6	0.1	0.2	7.7	0.9	0.0	5.8	0.0	1.8	0.2	0.1	1.0	0.0	0.0	0.0	0.2	0.0	0.5	0.5	0.1	0.9	1.3	0.8	0.6	0.3	2.7	11.1	19.3	0.4	0.5	0.5	0.6	0.3	0.2	0.8	0.4	0.1	54.3	41.8	12.3	962.6	3.7	1.9	270.6	2.1	3.6	0.6	0.6	507.1	0.5	0.8	0.4	15.8	5.9	72.0	128.3	1.5	692.4	3.4	2.5	1.6	2.0	2.6	6.9	22.0	21.2	15.7	14.0	24.0	3.9	3219.2	6.4	63.1	0.0	7.9	7.4	0.2	3.0	0.6	0.2	189.9	24.8	623.1	4.3	9.8	7.3	0.0	10.1	55.0	0.0	0.0	0.2	11.7	5.0	5.9	303.3	0.0	419.5	6.3	0.0	11.1	69.6	1.1	38.4	15.2	0.6	406.2	9.0	1369.8	0.0	2.2	0.6	8.2	153.7	67.3	3.9	0.6	159.6	16.0	17.8	255.2	0.0	7.2	0.5	1.3	0.1	0.0	0.0	4.2	0.8	9.9	0.4	1.2	0.3	696.8	33.1	452.1	4.6	0.7	0.8	4.7	18.3	5.9	1.9	0.2	0.3
CD3E		ENSG00000198851	"CD3e molecule"	P07766	11	118304730-118316175	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	17	"lymphoid tissue: 640.4"	"Group enriched"	"Detected in many"	7	"dendritic cells: 213.6;NK-cells: 154.5;T-cells: 601.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	26	"gdT-cell: 490.6;MAIT T-cell: 420.8;memory CD4 T-cell: 414.4;memory CD8 T-cell: 463.5;naive CD4 T-cell: 491.7;naive CD8 T-cell: 501.3;NK-cell: 202.2;T-reg: 426.3"	"Group enriched"	"Detected in all"	21	"NK-cells: 202.2;T-cells: 501.3"	"Group enriched"	"Detected in some"	67	"JURKAT: 544.9;MOLT-4: 764.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB000010, HPA040957, HPA043955, CAB072863, CAB072864"	Enhanced		Supported	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 63: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Endoplasmic reticulum, Plasma membrane"	"Golgi apparatus"	"CAB000010: AB_2631163, CAB072863: AB_2665707, CAB072864: AB_2665708, HPA040957: AB_2677222, HPA043955: AB_2678747"	"prognostic favorable (1.72e-4)"	"prognostic favorable (1.62e-4)"	"unprognostic (1.51e-2)"	"prognostic favorable (2.30e-6)"	"unprognostic (4.31e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (3.60e-3)"	"unprognostic (3.85e-2)"	"prognostic favorable (1.18e-4)"	"unprognostic (6.11e-3)"	"unprognostic (1.59e-1)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.12e-5)"	"unprognostic (5.46e-2)"	"unprognostic (9.28e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.12e-2)"	6.4	5.6	0.9	85.8	1.1	36.7	6.7	0.9	1.2	7.1	1.3	15.3	22.0	5.8	4.6	9.5	5.4	20.1	3.8	0.7	1.0	3.5	9.7	23.0	209.6	1.8	0.9	3.8	2.2	0.7	1.0	1.6	1.4	6.6	19.3	0.0	11.6	3.0	1.9	5.4	36.4	5.1	1.2	78.9	24.4	1.7	1.3	640.4	5.3	1.6	147.0	24.8	4.9	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	544.9	0.9	2.0	0.0	0.0	764.9	0.6	0.3	0.0	0.0	0.2	0.1	1.0	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	1.6	8.0	9.8	0.0	0.6	0.0	16.4	1.8	2.4	490.6	1.3	420.8	1.6	414.4	463.5	1.5	2.1	491.7	501.3	12.2	202.2	2.0	8.6	426.3	333.0	0.9	1.1	0.9	1.2	0.7	1.0	1.8	0.9	1.4	1.2	1.3	1.6	4.9	0.0	8.6	0.0	12.9	5.2	0.3	0.0	0.0	0.0	3.8	4.8	0.3	0.0	0.6	1.8	0.0	0.2	213.6	0.4	0.0	0.2	7.0	0.5	0.9	2.5	0.0	6.9	0.1	0.0	0.0	5.3	24.5	0.9	7.6	0.0	8.9	2.4	0.3	0.0	0.1	0.0	0.0	7.6	8.3	0.2	0.0	12.6	12.4	1.0	8.4	0.0	154.5	0.0	0.1	0.0	1.1	0.0	41.4	0.1	0.2	2.1	0.0	0.0	0.0	1.3	2.7	0.0	0.0	1.6	5.4	0.3	601.4	0.0	0.6	0.3
CD4		ENSG00000010610	"CD4 molecule"	P01730	12	6786858-6820799	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 152.9;lymphoid tissue: 219.3;parathyroid gland: 173.8"	"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 278.8;Hofbauer cells: 139.3;Kupffer cells: 247.1;Langerhans cells: 80.1;Macrophages: 109.0;monocytes: 104.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	18	"classical monocyte: 247.3;intermediate monocyte: 241.4;memory CD4 T-cell: 153.4;myeloid DC: 166.3;naive CD4 T-cell: 128.1;non-classical monocyte: 204.2;plasmacytoid DC: 263.8;T-reg: 154.5"	"Group enriched"	"Detected in many"	20	"dendritic cells: 263.8;monocytes: 247.3;T-cells: 154.5"	"Group enriched"	"Detected in some"	6	"HEL: 103.2;HL-60: 42.1;NB-4: 60.0;THP-1: 116.2;U-937: 109.7"	"Region enriched"	"Detected in many"	14	"basal ganglia: 46.2"	"Low region specificity"	"Detected in many"			"CAB000011, HPA004252, HPA004472, CAB068180"	Enhanced		Approved	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB000011: AB_442062, CAB068180: AB_2665653, HPA004252: AB_1078466, HPA004472: AB_1078465"	"unprognostic (1.39e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.75e-2)"	"prognostic favorable (2.16e-4)"	"unprognostic (7.76e-2)"	"unprognostic (4.82e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.06e-1)"	"unprognostic (4.65e-3)"	"unprognostic (9.08e-3)"	"unprognostic (2.95e-1)"	45.5	16.2	15.0	82.1	15.4	26.5	14.7	15.5	17.4	20.4	15.8	26.0	18.7	7.9	7.0	15.1	21.3	35.3	10.0	15.1	16.7	10.1	152.9	72.1	119.0	22.9	20.2	8.6	7.6	173.8	6.1	47.4	21.0	7.3	31.0	10.5	8.5	10.3	2.9	12.6	27.4	26.5	19.6	164.4	21.0	7.5	19.6	219.3	8.8	5.7	75.7	41.0	5.8	25.7	0.0	0.0	3.6	0.1	0.1	0.2	0.3	0.1	2.4	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	103.2	0.0	0.6	10.5	42.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	15.4	60.0	1.0	0.0	0.0	0.0	0.2	12.8	0.1	0.0	0.2	0.2	0.0	0.0	0.1	0.7	0.1	116.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.2	0.1	109.7	0.0	0.8	247.3	1.9	2.0	241.4	6.3	0.5	153.4	0.8	166.3	0.5	128.1	0.7	11.1	2.0	204.2	263.8	154.5	240.6	15.0	15.4	15.5	17.4	15.1	16.7	22.9	20.2	21.0	19.6	19.6	25.7	4.5	0.0	5.2	1.6	5.2	3.4	0.3	0.4	0.0	1.5	2.9	5.8	2.1	8.6	2.1	3.7	0.0	0.9	61.9	0.0	5.9	0.0	0.1	3.5	8.7	9.6	0.0	7.8	0.9	0.4	1.2	3.7	0.0	0.4	7.6	0.4	278.8	34.3	139.3	5.0	0.7	0.0	0.0	247.1	80.1	0.5	16.8	109.0	5.4	29.0	104.5	22.0	6.2	0.5	0.2	0.0	0.0	15.1	2.5	0.2	0.0	3.3	20.3	0.2	13.1	0.7	13.5	0.0	0.2	0.4	2.3	1.2	34.0	0.0	0.0	0.4
CD47	"IAP, MER6, OA3"	ENSG00000196776	"CD47 molecule"	Q08722	3	108043091-108091862	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 589.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016055, HPA044659"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA		49000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 1: Pancreatic cells - Digestion"	"Plasma membrane"	Vesicles	"CAB016055: AB_627086, HPA044659: AB_2679040"	"unprognostic (3.54e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.19e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (4.49e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.05e-3)"	"unprognostic (8.77e-3)"	"unprognostic (7.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.69e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (7.37e-2)"	"unprognostic (3.78e-1)"	"prognostic favorable (7.29e-5)"	"unprognostic (1.83e-1)"	51.8	64.9	39.2	116.4	47.9	232.2	89.3	64.4	63.5	57.4	30.4	89.0	74.6	53.0	92.4	93.9	100.5	86.7	59.5	47.2	41.9	44.4	71.4	154.6	137.9	53.1	40.5	46.1	41.5	27.2	34.6	80.1	48.5	122.2	99.3	285.7	105.3	55.7	57.9	59.8	79.3	55.4	50.9	100.1	104.2	59.0	49.2	79.1	91.2	22.8	161.7	110.1	52.4	76.4	303.3	49.9	108.0	62.1	130.3	122.6	147.9	106.0	139.4	70.8	126.0	2.1	159.1	129.6	180.0	90.7	216.5	201.0	52.2	98.7	91.7	81.5	35.8	311.6	45.9	3.9	73.8	227.4	467.6	85.7	58.1	71.6	53.6	118.5	73.4	132.6	85.1	323.6	108.5	148.1	268.5	77.0	46.7	298.4	133.6	154.2	69.3	187.8	185.3	115.8	69.7	37.9	63.6	111.7	124.4	56.5	227.4	85.8	76.5	210.9	40.9	120.7	79.4	124.2	100.8	208.0	131.5	119.8	65.6	185.2	119.2	232.8	178.1	244.2	155.6	191.6	209.7	192.0	181.6	188.7	149.2	169.0	145.4	232.6	339.2	133.3	334.5	296.9	39.2	47.9	64.4	63.5	47.2	41.9	53.1	40.5	48.5	50.9	49.2	76.4	72.3	368.6	157.4	98.6	192.9	165.3	311.7	504.4	101.3	102.9	119.0	93.1	51.9	110.1	205.7	93.8	95.9	169.9	218.6	36.5	15.6	589.6	81.5	157.2	17.0	76.5	63.8	112.6	219.2	412.5	85.5	119.1	36.2	120.4	57.7	250.0	83.6	34.2	186.4	122.8	129.3	70.8	148.5	79.6	200.7	52.2	34.2	121.5	117.4	39.4	100.5	51.7	219.4	107.1	150.4	344.7	92.6	48.5	143.8	439.0	53.7	16.3	162.2	229.7	65.7	47.1	85.4	111.5	19.6	97.1	140.1	121.2	160.8	80.6	94.3	321.3
CD53	"MOX44, TSPAN25"	ENSG00000143119	"CD53 molecule"	P19397	1	110871188-110899922	"CD markers, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 448.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 310.0;dendritic cells: 375.0;Hofbauer cells: 365.7;Kupffer cells: 324.3;Macrophages: 294.8;NK-cells: 383.1;T-cells: 297.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 473.5;HDLM-2: 214.8;HMC-1: 298.4;Karpas-707: 188.1;U-266/70: 251.2;U-698: 149.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047216	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA047216: AB_2679986"	"unprognostic (2.93e-2)"	"unprognostic (1.25e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.02e-3)"	"unprognostic (8.88e-2)"	"unprognostic (3.78e-2)"	"unprognostic (2.96e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (9.58e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.72e-2)"	63.4	30.8	10.1	284.4	11.1	126.6	27.0	12.6	16.3	20.8	12.3	41.5	37.9	17.3	10.5	20.0	22.8	58.5	12.2	9.7	13.4	15.1	46.8	114.9	397.9	18.9	16.0	9.2	11.9	6.6	6.2	58.5	18.9	12.8	54.8	2.0	19.3	12.8	4.5	6.7	103.4	55.8	18.3	269.4	44.3	5.7	17.5	144.9	11.3	10.6	448.3	85.1	9.0	31.9	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	473.5	0.2	0.0	0.2	0.5	0.0	0.0	0.0	214.8	0.0	26.4	0.1	0.0	0.0	60.4	298.4	0.0	0.0	0.0	0.0	0.0	0.0	139.2	11.2	188.1	0.0	0.0	103.1	71.1	0.4	0.0	0.0	98.0	0.7	104.2	0.0	0.0	0.0	0.1	0.0	0.2	0.2	1.5	0.0	88.4	17.2	0.2	0.4	0.1	0.5	251.2	123.2	149.2	1.5	68.7	3.4	1483.0	779.5	479.0	732.4	808.6	658.1	794.0	527.8	649.2	631.9	745.1	377.9	552.5	1144.2	526.6	882.9	517.5	740.3	1621.0	10.1	11.1	12.6	16.3	9.7	13.4	18.9	16.0	18.9	18.3	17.5	31.9	4.2	16.0	24.4	0.7	310.0	7.0	0.6	0.0	0.6	0.0	2.3	5.1	1.0	5.7	8.6	1.8	0.0	2.1	375.0	0.2	0.0	0.5	0.4	0.4	0.5	13.0	0.0	42.9	5.8	0.2	5.4	6.7	7.1	0.6	162.2	0.0	16.4	6.7	365.7	0.0	1.4	0.3	0.0	324.3	161.5	1.9	2.1	294.8	39.2	69.3	156.3	0.1	383.1	1.0	0.6	0.3	0.1	0.4	134.0	0.3	0.0	1.6	4.4	0.6	6.6	1.9	1.8	0.1	0.6	1.1	5.5	4.1	297.0	0.0	0.2	0.3
CD63	"ME491, MLA1, TSPAN30"	ENSG00000135404	"CD63 molecule"	P08962	12	55725323-55729707	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 1857.5"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 4897.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010088, CAB026356, HPA073506"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB026356: AB_629864, HPA010088: AB_1846323, HPA073506: "	"unprognostic (8.76e-3)"	"unprognostic (8.81e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.28e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.66e-3)"	"prognostic unfavorable (1.37e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.66e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.82e-2)"	"unprognostic (5.21e-2)"	"unprognostic (1.85e-3)"	"unprognostic (9.02e-2)"	954.0	882.1	509.4	457.9	526.5	747.2	769.6	532.6	717.1	715.6	611.8	809.3	394.5	854.6	1492.1	396.1	647.3	607.0	1152.2	508.5	565.7	625.3	565.1	882.2	325.0	564.7	539.9	645.9	830.1	524.7	486.6	588.0	544.3	520.0	736.0	269.1	871.6	547.4	919.3	410.0	559.3	744.5	534.9	597.7	790.8	224.3	583.6	193.3	657.7	587.4	284.9	835.3	539.7	561.7	481.0	669.0	432.6	430.8	4897.7	2932.4	577.5	1914.8	3104.6	979.2	1048.9	750.3	939.2	120.5	581.2	2608.7	787.7	436.3	301.7	732.6	1197.9	372.5	248.7	760.9	542.8	443.3	2006.7	338.5	1699.0	2315.1	639.7	1164.8	979.2	2305.1	1052.2	64.6	386.8	936.3	3062.5	626.3	64.1	439.5	395.7	1062.7	880.7	146.0	949.3	345.7	1699.3	1433.6	170.1	425.8	528.3	392.5	3348.6	630.4	546.4	1089.6	948.0	710.1	514.8	984.9	649.8	377.3	239.3	92.5	2023.9	208.1	1326.3	1279.9	610.3	1857.5	323.2	458.8	235.2	111.0	126.9	260.0	473.0	73.9	55.9	186.0	656.0	733.0	320.4	309.8	121.6	850.4	509.4	526.5	532.6	717.1	508.5	565.7	564.7	539.9	544.3	534.9	583.6	561.7	798.7	512.8	689.0	28.1	147.6	567.2	1382.5	3135.4	155.4	190.3	606.5	601.1	820.9	836.4	1789.7	875.4	152.2	608.3	322.0	1083.4	232.8	2621.2	16.7	446.7	766.7	916.3	581.1	97.0	8.8	3429.0	2756.5	1538.0	371.1	727.3	1030.0	531.6	739.6	423.9	3372.5	33.7	9.3	1251.6	1715.1	854.6	1698.3	65.5	1727.3	1146.7	1993.9	11.2	575.7	893.8	487.1	21.1	26.5	3437.4	1394.0	1157.0	326.9	2039.2	878.1	794.2	1012.6	258.8	1255.6	1845.2	1278.7	43.8	68.9	137.1	400.5	2708.1	310.4	645.8	761.6	1868.9
CD74	DHLAG	ENSG00000019582	"CD74 molecule"	P04233	5	150400041-150412969	"Cancer-related genes, CD markers, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 5258.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 10167.0;Kupffer cells: 5201.6;Langerhans cells: 23363.4;Macrophages: 7290.2;monocytes: 10305.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 11041.2;intermediate monocyte: 15961.1;memory B-cell: 26889.3;myeloid DC: 23750.6;naive B-cell: 27930.3;non-classical monocyte: 8003.3;plasmacytoid DC: 16940.0"	"Group enriched"	"Detected in all"	6	"B-cells: 27930.3;dendritic cells: 23750.6;monocytes: 15961.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 2171.7;Daudi: 3523.2;HDLM-2: 4787.6;REH: 3026.0;RPMI-8226: 2014.2;U-266/70: 1443.4;U-698: 1978.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002506, HPA010592, CAB079994"	Enhanced		Supported	"Golgi apparatus"		NA	NA		210000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"CAB002506: AB_563630, CAB079994: , HPA010592: AB_1078482"	"prognostic favorable (1.06e-4)"	"unprognostic (1.48e-2)"	"unprognostic (4.80e-3)"	"prognostic favorable (6.53e-6)"	"unprognostic (1.41e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.69e-3)"	"unprognostic (1.54e-2)"	"unprognostic (3.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.64e-1)"	"unprognostic (5.44e-3)"	"unprognostic (1.73e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.24e-2)"	1512.1	976.5	338.1	2741.2	301.9	984.3	1157.2	365.5	474.4	1562.8	429.1	992.3	1826.2	593.6	490.6	618.8	1139.0	1477.9	604.0	306.7	506.8	1271.1	1142.0	3786.3	4995.6	598.7	431.8	464.3	392.4	390.6	469.3	305.7	533.4	556.7	1155.8	58.1	1999.3	911.8	307.2	682.4	2438.8	1014.2	514.2	4897.4	1511.5	207.5	514.4	2160.2	853.5	374.2	5258.9	1557.5	483.5	771.8	35.7	0.3	1.5	2.4	2.3	2.5	11.0	0.0	0.0	0.7	0.6	443.0	2171.7	3523.2	124.2	0.0	9.2	9.4	0.0	0.0	0.1	4787.6	0.0	109.1	1.2	250.2	6.6	9.2	6.5	24.5	0.0	0.8	0.0	0.6	0.0	0.0	8.0	1270.7	0.4	0.0	4.2	14.0	5.3	0.0	0.1	3026.0	5.2	2014.2	9.0	133.5	5.1	8.2	5.5	4.7	94.9	19.2	81.2	414.4	5.6	10.3	9.9	9.0	4.5	1443.4	170.7	1978.6	745.9	154.2	678.6	410.8	11041.2	3996.9	808.7	15961.1	899.9	26889.3	688.4	1188.4	23750.6	27930.3	378.9	646.6	839.6	2378.1	8003.3	16940.0	2157.2	17779.7	338.1	301.9	365.5	474.4	306.7	506.8	598.7	431.8	533.4	514.2	514.4	771.8	2080.4	419.9	2160.4	0.7	10167.0	715.9	154.0	762.2	398.4	1.7	220.3	437.5	69.6	401.7	1063.3	502.1	0.0	28.3	3199.0	139.7	117.4	1264.4	10.4	111.3	11.5	1787.6	242.9	562.5	0.7	527.5	32.6	278.6	538.2	85.5	417.2	113.4	514.7	52.5	4361.8	1.7	0.6	475.7	390.6	5201.6	23363.4	31.3	117.1	7290.2	1197.1	137.7	10305.9	16.8	403.7	0.5	1.4	384.2	487.3	17.7	2068.3	174.9	5034.4	815.8	1153.1	10.0	164.3	45.1	146.7	2.8	12.6	170.9	575.8	41.6	790.7	12.9	450.7	743.4
CD81	"TAPA-1, TAPA1, TSPAN28"	ENSG00000110651	"CD81 molecule"	P60033	11	2376177-2397397	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Adipocytes: 1003.1;Endometrial stromal cells: 1050.9;Muller glia cells: 809.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"memory B-cell: 148.9;naive B-cell: 137.2"	"Lineage enriched"	"Detected in all"	4	"B-cells: 148.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 2960.6;fHDF/TERT166: 1752.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002507, HPA007234"	Supported		Supported	"Plasma membrane,Cytosol"		NA	NA		400000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Cytosol	"CAB002507: AB_563639, HPA007234: AB_1846333"	"unprognostic (2.96e-1)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.56e-4)"	"unprognostic (1.84e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (6.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.07e-3)"	"unprognostic (2.08e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.06e-1)"	892.1	299.1	560.6	270.7	598.4	77.8	773.6	614.8	590.2	952.7	498.9	992.0	150.7	1384.0	960.5	364.3	853.1	534.5	937.9	511.1	615.8	636.6	1175.7	768.4	429.0	665.7	640.8	656.8	449.5	258.3	409.1	441.0	651.1	634.0	234.4	75.9	531.1	1602.0	214.3	511.1	423.1	978.5	694.1	631.3	494.3	316.9	655.1	158.9	564.6	227.6	278.6	749.2	763.4	734.4	337.0	342.0	268.5	413.4	2960.6	1668.4	224.8	621.0	1361.6	490.3	492.2	322.8	1.8	285.4	218.3	1752.6	312.5	430.5	167.3	442.2	199.9	135.6	517.8	43.7	117.1	0.3	976.4	188.2	359.8	1222.3	619.9	201.1	302.1	757.9	476.6	204.0	198.7	484.9	696.4	257.2	160.7	239.1	324.4	304.7	274.2	324.7	135.5	183.3	529.1	223.3	288.8	319.2	198.4	514.4	383.8	214.3	171.0	337.8	641.3	249.0	181.6	471.2	216.6	356.9	88.1	529.1	361.3	111.0	435.0	0.9	3.3	22.9	21.1	5.8	34.4	148.9	14.9	33.0	2.6	137.2	9.2	16.9	1.0	14.7	7.3	7.7	12.0	10.7	560.6	598.4	614.8	590.2	511.1	615.8	665.7	640.8	651.1	694.1	655.1	734.4	1003.1	243.6	270.0	95.0	88.2	179.8	391.8	89.7	26.2	82.7	325.6	452.0	277.4	167.3	102.3	207.8	27.1	21.8	267.1	20.0	35.2	105.7	15.9	365.4	1050.9	344.5	71.9	30.7	19.0	55.1	31.7	560.4	21.4	462.7	81.7	204.0	293.4	603.9	251.5	148.0	32.4	48.2	50.8	232.7	179.7	50.2	389.2	277.6	151.2	60.0	23.0	809.2	45.3	145.8	93.6	61.3	14.7	251.3	50.7	147.6	5.0	29.9	85.8	76.1	118.3	356.9	423.6	15.6	19.4	30.6	164.9	20.1	136.8	379.0	41.5	298.1
CD9	"BA2, MIC3, MRP-1, P24, TSPAN29"	ENSG00000010278	"CD9 molecule"	P21926	12	6199715-6238271	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Fertilization"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 2822.0;Ionocytes: 4461.6;Urothelial cells: 2594.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	25	"basophil: 1957.3;eosinophil: 1156.4"	"Lineage enriched"	"Detected in all"	32	"granulocytes: 1957.3"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 1521.6;RT4: 1126.8;TIME: 2266.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002490	Supported		Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1200000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB002490: AB_563643"	"unprognostic (1.38e-1)"	"unprognostic (6.36e-3)"	"unprognostic (8.27e-3)"	"unprognostic (6.98e-3)"	"unprognostic (3.89e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.60e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (2.30e-1)"	"prognostic favorable (6.49e-5)"	"unprognostic (6.10e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (8.93e-5)"	"unprognostic (9.26e-2)"	204.4	287.8	116.9	96.5	162.9	17.3	298.9	139.8	193.3	399.5	157.3	496.9	127.2	242.4	270.9	1000.2	242.3	102.4	267.5	124.3	132.3	294.2	79.4	403.0	37.4	165.8	141.0	69.0	93.4	881.8	98.1	85.4	160.2	488.5	466.2	32.6	614.5	456.4	74.4	455.3	211.2	197.0	139.2	69.5	178.2	26.4	146.5	66.1	338.0	116.6	289.4	373.1	566.4	207.1	417.6	173.7	3.5	108.7	167.7	170.8	150.1	241.1	477.8	80.8	121.9	128.5	1521.6	1.4	59.2	51.4	239.0	885.6	92.7	475.5	62.7	21.5	63.1	2.0	117.1	26.6	71.3	1.1	497.0	0.6	347.0	147.3	126.0	225.3	976.3	28.9	19.3	1.7	51.5	578.6	1.8	45.4	136.0	504.3	175.7	4.1	290.1	529.7	802.1	1126.8	0.5	34.0	240.9	195.8	215.8	789.0	91.1	42.1	2266.0	8.6	214.6	8.8	29.5	1.7	1.3	63.2	137.2	1.0	221.7	1957.3	61.1	1156.4	1.3	23.6	2.2	5.5	1.4	1.6	10.2	20.5	4.2	11.5	30.9	2.6	0.6	3.7	0.4	71.7	116.9	162.9	139.8	193.3	124.3	132.3	165.8	141.0	160.2	139.2	146.5	207.1	250.0	794.9	403.1	35.6	27.8	1037.8	1864.4	2822.0	804.1	4.9	433.5	379.5	20.9	84.4	1403.7	1075.9	0.0	21.5	8.7	929.9	137.0	599.1	3.0	457.8	66.8	496.5	172.9	10.5	0.4	178.2	271.0	356.9	60.6	722.6	653.4	42.3	522.6	43.1	618.0	0.0	0.6	744.8	4461.6	35.2	685.3	13.1	32.0	253.4	940.9	11.2	151.7	375.1	2.1	56.3	169.5	352.9	896.4	70.7	59.3	1576.4	330.0	21.7	1409.8	14.7	664.0	322.6	397.5	7.3	74.1	1214.3	1279.8	54.0	77.8	838.5	761.1	2594.9
CDC20	"CDC20A, p55CDC"	ENSG00000117399	"Cell division cycle 20"	Q12834	1	43358981-43363203	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Mitosis, Neurogenesis, Ubl conjugation pathway"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.9;lymphoid tissue: 52.6;testis: 49.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 65.0;Early spermatids: 135.0;Erythroid cells: 96.0;Extravillous trophoblasts: 146.2;Spermatocytes: 126.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"memory B-cell: 4.2;memory CD4 T-cell: 3.2;memory CD8 T-cell: 3.5;NK-cell: 9.5;T-reg: 11.6"	"Group enriched"	"Detected in many"	9	"B-cells: 4.2;NK-cells: 9.5;T-cells: 11.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB004525, HPA045842, HPA055288"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes			"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB004525: AB_628089, HPA045842: AB_2679470, HPA055288: AB_2682773"	"unprognostic (1.66e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.14e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (4.00e-8)"	"unprognostic (9.06e-3)"	"unprognostic (1.17e-2)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (1.32e-4)"	"unprognostic (8.55e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.84e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.29e-2)"	1.6	1.5	0.6	16.2	1.1	53.9	5.2	0.8	1.3	3.5	0.4	14.8	13.7	2.3	2.5	27.2	1.7	1.2	0.9	0.7	1.1	2.3	1.7	2.5	32.6	1.3	1.1	0.7	0.6	0.2	0.3	9.7	1.1	0.8	16.0	0.2	4.4	0.7	0.3	11.3	12.2	7.3	0.8	11.7	7.0	49.1	1.7	52.6	1.7	0.2	50.8	3.3	7.0	1.3	311.9	148.2	202.8	133.4	6.9	17.6	193.5	140.3	125.0	400.0	211.4	234.5	250.9	178.3	80.1	130.1	140.6	212.8	225.3	267.9	331.5	140.8	165.6	261.4	143.6	147.3	2.1	184.3	91.4	6.0	12.4	278.2	249.6	35.1	172.2	167.5	120.2	119.3	184.0	120.4	179.2	113.5	257.2	147.0	196.9	255.8	277.9	112.9	98.5	81.3	119.2	58.9	248.1	165.8	76.6	154.9	116.3	231.7	90.2	118.9	276.2	133.7	445.0	90.6	86.7	185.7	85.2	227.6	181.6	0.0	0.1	0.0	0.3	0.0	0.0	4.2	3.2	3.5	0.9	0.9	0.1	0.3	0.7	9.5	0.0	0.2	11.6	2.8	0.6	1.1	0.8	1.3	0.7	1.1	1.3	1.1	1.1	0.8	1.7	1.3	2.1	0.0	1.1	0.0	12.2	10.5	3.8	17.6	6.2	0.5	6.4	9.7	0.7	1.5	4.8	0.0	0.0	65.0	2.8	16.9	0.0	2.2	135.0	14.6	2.4	4.5	0.0	96.0	0.2	0.4	146.2	9.3	11.7	4.6	0.0	46.5	7.9	1.3	37.4	0.0	0.0	18.5	24.4	6.2	7.5	18.5	2.8	9.3	0.0	0.0	1.8	0.3	0.0	0.0	1.6	0.7	0.5	1.9	34.4	2.7	3.2	3.1	8.3	2.9	0.0	1.0	25.4	126.5	39.8	47.3	8.4	10.7	5.1	1.6	37.5	7.4
CDC37	P50CDC37	ENSG00000105401	"Cell division cycle 37, HSP90 cochaperone"	Q16543	19	10391133-10420121	"Cancer-related genes, Predicted intracellular proteins, Transporters"		Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003928, CAB004214"	Supported		Supported	Cytosol		NA	NA		610000	"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Cytosol		"CAB004214: AB_627232, HPA003928: AB_1846373"	"unprognostic (2.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.33e-2)"	"unprognostic (2.46e-3)"	"unprognostic (6.21e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.90e-2)"	"unprognostic (1.25e-1)"	"unprognostic (7.61e-3)"	"unprognostic (1.96e-2)"	"unprognostic (1.82e-2)"	"unprognostic (1.84e-2)"	"prognostic favorable (2.33e-4)"	"unprognostic (5.80e-2)"	"unprognostic (1.23e-1)"	"unprognostic (3.02e-2)"	149.9	93.6	82.2	81.3	84.6	89.5	130.6	75.0	104.2	111.4	72.1	109.9	58.1	110.0	34.2	125.7	98.5	39.8	186.0	86.3	85.8	123.2	102.2	129.9	66.5	85.9	85.8	105.9	100.3	59.3	74.6	62.7	88.1	105.0	48.2	34.6	96.6	52.2	313.2	100.9	96.3	50.2	75.7	137.5	102.8	77.5	82.5	69.3	100.8	222.6	52.4	110.3	103.0	87.8	279.2	181.2	95.5	137.5	128.8	111.8	122.9	322.8	144.6	198.3	168.8	209.1	106.7	165.3	254.7	198.3	117.2	169.9	130.6	208.7	136.4	133.6	387.2	313.9	147.2	300.9	202.5	183.9	137.9	136.9	112.5	231.8	104.0	113.5	258.1	142.2	248.2	193.8	156.1	265.3	184.3	450.2	234.6	175.5	317.8	181.0	128.3	190.3	185.1	178.2	111.5	161.9	151.5	158.1	143.1	72.7	108.4	195.7	290.0	230.8	133.9	319.9	262.2	261.3	276.5	204.4	181.4	294.1	191.2	77.2	110.8	97.1	114.4	107.9	103.1	73.2	91.8	103.5	105.2	62.9	70.0	81.8	60.2	101.1	112.6	89.4	106.8	145.6	82.2	84.6	75.0	104.2	86.3	85.8	85.9	85.8	88.1	75.7	82.5	87.8	420.1	54.5	95.5	51.6	163.7	148.6	119.3	149.0	127.5	78.0	85.0	75.8	71.3	75.8	114.8	64.4	39.6	188.9	166.1	192.3	101.8	199.8	119.0	88.2	120.5	267.5	81.3	89.8	35.0	199.0	430.2	108.3	226.8	126.4	134.3	90.8	172.1	45.3	210.2	89.2	24.6	181.3	105.8	83.9	313.8	253.8	106.2	165.6	138.7	29.0	165.1	75.8	135.9	21.1	32.5	297.6	183.5	103.4	170.5	120.1	117.9	89.7	78.2	84.4	78.9	94.4	138.6	72.4	73.5	138.1	133.7	242.4	164.2	123.0	186.1	156.1
CDK1	"CDC2, CDC28A"	ENSG00000170312	"Cyclin dependent kinase 1"	P06493	10	60778331-60794852	"Cancer-related genes, Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Cell division, Host-virus interaction, Mitosis"	"Host cell receptor for virus entry, Kinase, Receptor, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 53.2;lymphoid tissue: 74.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.9;Erythroid cells: 209.6;Extravillous trophoblasts: 144.6;Spermatocytes: 110.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 3.2;T-reg: 3.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003387, CAB003799, CAB079974"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	Yes		51000	"Cluster 15: NK-cells - Transcription"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nucleoplasm, Cytosol"		"CAB003799: AB_344898, CAB079974: , HPA003387: AB_1846356"	"unprognostic (6.34e-2)"	"prognostic favorable (8.81e-4)"	"unprognostic (1.90e-1)"	"unprognostic (6.82e-2)"	"unprognostic (6.67e-2)"	"unprognostic (3.83e-2)"	"prognostic unfavorable (1.10e-6)"	"prognostic unfavorable (7.88e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.15e-6)"	"unprognostic (1.80e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.27e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.60e-1)"	3.8	1.8	0.9	17.0	1.0	53.2	7.4	0.9	1.5	5.2	0.9	17.6	16.3	7.1	12.2	17.5	3.7	4.3	1.4	0.9	1.0	3.1	3.2	4.7	40.6	1.2	1.2	2.3	0.8	2.5	4.1	19.4	1.1	1.7	20.8	1.3	3.2	5.2	1.4	13.2	14.5	8.0	0.9	9.0	10.1	25.1	1.4	74.0	3.6	2.2	47.5	7.1	6.9	1.0	249.9	93.5	241.1	96.0	15.4	23.6	99.0	183.8	132.7	218.8	209.0	218.9	213.7	226.2	69.6	50.6	79.6	149.9	166.2	106.8	225.8	162.3	121.1	119.4	84.4	128.1	2.8	184.5	117.6	4.7	10.4	142.1	137.0	49.6	133.3	146.2	185.1	270.3	246.9	66.3	234.0	131.1	106.6	149.3	193.1	199.7	224.5	111.3	84.3	81.4	112.7	98.7	123.5	184.9	96.3	130.0	199.9	111.5	55.4	92.8	197.9	99.1	255.8	104.9	180.8	205.6	79.9	203.5	117.6	0.0	0.0	0.0	0.3	0.1	0.2	0.5	0.7	1.3	0.3	0.4	0.2	0.7	0.0	3.2	0.1	0.9	3.4	0.9	0.9	1.0	0.9	1.5	0.9	1.0	1.2	1.2	1.1	0.9	1.4	1.0	7.7	0.0	3.2	0.3	7.1	39.8	5.4	29.9	2.8	1.1	5.3	6.1	0.8	0.0	10.2	18.4	0.0	80.9	3.6	8.9	3.9	0.8	18.7	10.8	6.2	10.5	3.0	209.6	0.4	0.0	144.6	13.3	13.3	9.4	0.0	51.5	7.5	1.3	57.2	0.0	0.2	14.6	30.5	20.5	18.1	10.4	2.1	16.5	1.8	1.9	1.0	1.0	3.1	0.0	0.1	0.4	0.7	0.7	32.1	4.3	2.2	3.0	17.6	0.7	0.0	0.5	24.6	110.0	39.6	33.8	18.6	22.0	10.3	2.1	26.6	10.4
CELSR1	"ADGRC1, CDHF9, FMI2, HFMI2, ME2"	ENSG00000075275	"Cadherin EGF LAG seven-pass G-type receptor 1"	Q9NYQ6	22	46360834-46537620	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 31.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 41.7;Basal respiratory cells: 28.1;Club cells: 31.1;Endometrial ciliated cells: 31.8;Glandular and luminal cells: 42.6;Respiratory ciliated cells: 60.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"memory B-cell: 2.2;naive B-cell: 1.9"	"Lineage enriched"	"Detected in single"	6	"B-cells: 2.2"	"Cell line enhanced"	"Detected in many"		"A549: 68.4;RPTEC TERT1: 48.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA052976, HPA060521"			Enhanced	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA		280000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA052976: AB_2682004, HPA060521: AB_2684303"	"unprognostic (5.62e-2)"	"unprognostic (4.93e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.54e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.66e-1)"	"unprognostic (3.36e-1)"	"unprognostic (5.31e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.67e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.07e-1)"	0.7	0.8	0.4	3.1	0.9	0.8	7.8	1.5	0.5	9.9	1.2	1.6	0.9	3.7	10.2	11.5	15.4	1.4	3.4	1.0	0.4	17.1	5.2	12.5	5.9	2.4	3.9	0.2	2.6	6.3	2.4	1.0	1.4	5.0	1.8	0.5	12.0	3.9	0.2	31.5	1.6	1.1	1.6	3.3	5.4	1.3	2.2	2.4	3.7	0.1	7.9	3.9	3.7	1.0	22.3	68.4	11.3	10.6	0.0	0.0	6.5	2.3	3.4	2.3	1.3	21.7	21.9	0.2	32.1	1.3	22.0	35.0	7.5	28.7	2.0	0.0	10.2	0.0	25.6	2.0	1.0	3.2	1.8	0.0	43.5	0.0	26.2	31.6	0.4	1.7	0.3	0.4	0.0	38.4	0.1	11.9	4.5	12.1	8.1	0.1	0.1	8.1	48.7	13.5	0.7	0.9	16.1	17.3	3.7	7.9	39.7	16.7	0.9	0.1	0.3	0.0	0.4	10.6	1.1	10.5	15.2	0.1	12.9	0.0	0.0	0.0	0.2	0.1	0.2	2.2	0.1	0.1	0.0	1.9	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.4	0.9	1.5	0.5	1.0	0.4	2.4	3.9	1.4	1.6	2.2	1.0	0.5	41.7	23.5	0.0	5.8	17.1	4.1	28.1	8.0	0.2	14.2	5.2	12.7	2.8	31.1	5.5	0.0	1.9	2.3	0.8	0.0	1.8	2.3	31.8	5.0	5.6	1.2	0.0	1.2	0.7	1.9	1.0	2.6	42.6	0.0	0.6	1.8	1.5	2.4	0.0	1.2	2.8	6.1	0.0	4.1	10.3	0.0	1.1	5.4	1.0	1.1	1.1	0.0	0.5	0.7	4.0	0.3	0.0	1.1	4.3	0.0	8.2	60.3	0.3	0.0	0.1	2.8	0.4	0.6	12.6	15.6	0.8	1.1	0.0	1.7	5.1
CEPT1		ENSG00000134255	"Choline/ethanolamine phosphotransferase 1"	Q9Y6K0	1	111139627-111185104	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 64: Macrophages - Immune response"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"				"unprognostic (1.16e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.47e-3)"	"unprognostic (1.83e-2)"	"prognostic favorable (4.96e-4)"	"unprognostic (5.52e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.54e-3)"	"unprognostic (1.84e-1)"	"unprognostic (9.20e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.60e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.88e-2)"	"unprognostic (1.27e-2)"	20.7	17.9	14.9	20.2	15.1	5.4	12.0	15.7	19.5	11.0	15.4	12.0	17.0	12.5	15.9	13.2	14.0	13.3	6.7	14.3	16.5	19.9	36.2	13.3	31.7	15.8	14.8	19.2	10.6	18.7	6.1	17.0	15.8	10.8	15.4	8.1	17.5	9.5	9.2	15.1	18.3	12.7	16.5	27.6	14.6	8.9	15.2	20.2	16.8	10.8	22.9	16.8	9.9	18.4	27.3	10.0	11.6	11.3	44.8	22.0	28.1	29.5	16.5	13.4	16.0	8.7	30.0	32.1	31.7	15.2	17.0	32.6	16.7	22.9	18.9	24.1	26.4	14.0	16.3	19.6	29.9	33.4	19.3	18.1	42.8	9.8	46.1	25.4	18.0	32.8	30.9	20.5	17.6	19.8	34.6	32.9	18.0	43.2	20.3	18.4	36.8	26.3	22.0	17.0	15.2	8.2	27.1	40.2	33.2	22.4	21.8	35.5	15.8	21.7	13.6	47.4	20.0	18.5	21.6	24.9	29.2	29.6	42.0	4.4	10.0	5.8	7.9	18.3	10.3	17.9	8.7	8.2	12.1	17.8	10.0	11.0	2.5	8.7	27.5	9.3	8.3	7.4	14.9	15.1	15.7	19.5	14.3	16.5	15.8	14.8	15.8	16.5	15.2	18.4	11.5	35.3	14.9	20.9	45.5	13.0	16.5	30.8	13.6	25.1	11.1	6.2	3.6	17.2	26.9	36.8	35.5	30.1	16.7	20.7	5.9	13.4	1.9	15.8	16.9	12.3	10.2	21.4	42.4	8.1	19.7	15.2	12.2	11.1	19.0	15.2	19.6	37.8	28.3	28.6	49.2	15.0	20.3	52.1	13.9	3.7	14.6	26.0	16.0	42.2	24.7	10.0	34.0	47.3	59.5	8.5	19.9	17.0	18.5	16.0	26.1	15.2	29.2	29.3	13.1	9.9	10.1	17.1	14.7	13.0	15.3	19.0	17.2	19.1	14.4	15.4
CETP	BPIFF	ENSG00000087237	"Cholesteryl ester transfer protein"	P11597	16	56961923-56983845	"Candidate cardiovascular disease genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Atherosclerosis, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 33.5;liver: 43.0;lymphoid tissue: 59.6;placenta: 36.2"	"Group enriched"	"Detected in some"	6	"Adipocytes: 48.6;Hepatic stellate cells: 75.0;Kupffer cells: 142.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"non-classical monocyte: 2.3;plasmacytoid DC: 3.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HEL: 2.3;HUVEC TERT2: 4.7;TIME: 2.8"														"Secreted to blood"	NA	NA	2470000000	360000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (6.52e-2)"	"unprognostic (4.17e-3)"	"unprognostic (2.48e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.01e-3)"	"unprognostic (4.03e-3)"	"unprognostic (3.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.05e-3)"	"unprognostic (4.92e-3)"	"unprognostic (7.17e-3)"	"unprognostic (2.62e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.20e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.34e-2)"	"unprognostic (9.97e-2)"	33.5	2.0	0.7	3.8	0.7	5.7	6.6	0.7	1.4	0.3	0.7	0.6	0.9	0.7	0.0	0.3	0.3	4.0	0.7	0.6	0.8	3.7	43.0	2.8	43.3	1.1	0.8	0.3	0.5	1.8	3.1	36.2	0.9	0.3	0.5	0.0	0.7	0.5	0.3	0.4	1.9	0.8	0.8	59.6	0.4	0.3	0.9	2.3	5.2	0.3	7.6	1.5	0.1	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.3	0.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.3	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	2.8	0.1	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.7	0.0	0.0	0.3	0.1	0.0	0.0	0.1	1.8	2.3	3.2	0.0	1.2	0.7	0.7	0.7	1.4	0.6	0.8	1.1	0.8	0.9	0.8	0.9	0.8	48.6	0.0	1.8	0.0	1.5	0.5	0.0	0.0	0.0	0.1	0.4	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.1	13.4	0.0	5.3	0.1	0.9	0.4	0.2	0.0	0.1	0.0	0.0	75.0	1.3	3.1	0.0	0.1	0.2	0.0	142.0	1.2	0.7	0.0	2.1	0.0	0.0	1.4	0.0	1.0	0.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.1	0.6	0.0	0.4	0.0	0.4	1.3	0.0	0.0
CFTR	"ABC35, ABCC7, CF, CFTR/MRP, dJ760C5.1, MRP7, TNR-CFTR"	ENSG00000001626	"CF transmembrane conductance regulator"	P13569	7	117287120-117715971	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Isomerase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 54.6;intestine: 42.7;pancreas: 210.7"	"Group enriched"	"Detected in many"	4	"Ductal cells: 485.4;Ionocytes: 252.3"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 23.9;pancreatic cancer: 28.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	25	"CACO-2: 29.5;MOLT-4: 98.9;U-266/70: 49.6"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"CAB001951, HPA021939, HPA079652"	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 1: Pancreatic cells - Digestion"			"CAB001951: , HPA021939: AB_1846578, HPA079652: "	"unprognostic (6.38e-3)"	"unprognostic (9.55e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.57e-2)"	"prognostic unfavorable (9.44e-4)"	"unprognostic (3.20e-3)"	"unprognostic (1.13e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.14e-2)"	"unprognostic (4.78e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.58e-1)"	"unprognostic (9.08e-2)"	"unprognostic (6.64e-2)"	0.4	0.0	0.5	4.7	2.0	0.0	0.4	0.7	1.3	8.5	0.0	42.7	36.2	1.1	1.1	0.8	2.2	54.6	0.1	0.3	0.7	2.1	1.6	8.2	0.0	1.1	0.7	0.0	210.7	0.2	0.1	0.6	0.7	2.2	40.7	0.0	21.5	0.5	0.0	1.9	19.9	2.0	1.7	0.0	3.1	1.7	1.0	0.1	0.1	0.0	0.3	0.7	0.0	2.9	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	98.9	0.1	2.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	49.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.0	0.7	1.3	0.3	0.7	1.1	0.7	0.7	1.7	1.0	2.9	0.0	6.4	65.6	0.0	0.5	0.0	2.0	2.6	0.0	0.5	0.5	0.0	2.4	55.8	17.8	0.0	0.0	0.0	0.0	45.8	0.0	485.4	3.2	9.6	1.2	0.4	7.2	0.0	2.2	4.5	0.0	0.3	4.1	19.8	1.3	0.1	0.0	0.4	0.0	0.0	1.1	13.9	252.3	0.0	0.0	2.6	0.3	0.1	0.0	1.0	6.7	0.5	0.0	0.5	23.8	14.8	86.4	0.0	0.0	4.0	8.6	0.0	5.6	0.0	0.0	0.0	1.6	2.2	0.5	0.0	0.0	0.0	0.3	0.1	87.3	5.8
CHP1	"CHP, p22, p24, Sid470p, SLC9A1BP"	ENSG00000187446	"Calcineurin like EF-hand protein 1"	Q99653	15	41230839-41281887	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	"Protein kinase inhibitor"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 434.4;Distal tubular cells: 389.4;Hepatocytes: 353.6;Proximal enterocytes: 425.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006616	Approved		Approved	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA006616: AB_1857461"	"unprognostic (2.06e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.84e-1)"	"prognostic favorable (9.63e-4)"	"unprognostic (7.29e-2)"	"unprognostic (3.74e-1)"	"prognostic favorable (4.07e-6)"	"unprognostic (2.20e-1)"	"unprognostic (7.46e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.26e-3)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.79e-6)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (4.62e-3)"	"unprognostic (2.04e-1)"	66.9	55.3	22.1	28.0	24.4	58.4	32.8	26.0	26.5	34.0	24.7	113.8	85.4	21.8	34.1	74.5	20.8	48.1	53.2	30.3	32.9	76.1	185.1	52.7	18.6	32.9	31.0	19.1	42.2	54.1	21.6	26.3	35.8	34.3	81.9	20.5	49.9	27.5	81.0	45.5	70.0	27.6	26.9	20.2	112.7	10.7	33.3	20.1	49.8	86.5	41.1	44.8	41.3	28.4	72.4	72.7	28.3	109.0	120.4	113.8	41.0	56.2	69.1	44.8	48.0	66.6	140.4	12.6	59.8	77.7	47.7	89.0	56.0	83.9	51.5	44.8	20.0	50.8	58.1	103.6	93.5	66.5	73.7	116.7	98.8	51.9	53.3	68.0	82.1	37.9	81.2	79.5	52.5	43.5	27.7	72.5	29.0	118.4	35.9	35.9	46.2	34.0	92.5	144.1	17.4	44.3	96.4	178.2	48.7	49.9	101.0	66.3	108.3	47.5	50.3	76.9	36.7	45.0	131.6	59.4	84.9	42.2	44.1	255.5	227.6	274.8	49.5	204.4	51.5	40.2	46.2	50.0	152.1	33.0	29.1	41.4	173.3	56.5	207.4	95.1	60.7	116.5	22.1	24.4	26.0	26.5	30.3	32.9	32.9	31.0	35.8	26.9	33.3	28.4	28.3	44.8	117.3	20.9	26.8	72.3	62.4	48.1	20.5	11.0	101.6	39.2	80.5	243.1	50.7	103.0	10.4	33.3	38.3	434.4	389.4	96.7	52.5	68.0	48.8	39.5	55.6	58.5	24.8	150.6	62.4	38.2	112.7	114.4	37.4	18.9	78.1	353.6	68.5	11.8	21.0	136.2	34.6	170.1	134.8	122.6	29.5	77.1	129.9	19.7	113.4	32.7	36.0	9.5	23.6	173.9	206.4	29.3	24.0	80.1	425.0	231.1	33.7	10.3	26.3	46.6	41.4	13.7	19.3	50.6	108.5	66.9	32.9	65.7	161.4	130.8
CHRNA1	CHRNA	ENSG00000138435	"Cholinergic receptor nicotinic alpha 1 subunit"	P02708	2	174747592-174787935	"Disease related genes, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"skeletal muscle: 170.1"	"Cell type enriched"	"Detected in some"	48	"Skeletal myocytes: 193.5"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Group enriched"	"Detected in some"	13	"cerebral cortex: 12.8;hippocampal formation: 5.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"LHCN-M2: 445.4;RH-30: 360.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071554	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"		"HPA071554: AB_2686416"	"unprognostic (1.49e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.96e-1)"	"unprognostic (8.55e-3)"	"unprognostic (5.34e-2)"	"unprognostic (5.29e-3)"	"unprognostic (9.59e-2)"	"unprognostic (9.64e-2)"	"unprognostic (9.66e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.18e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-1)"	"unprognostic (7.18e-2)"	0.2	0.0	0.2	0.2	0.4	0.0	0.5	0.1	12.8	0.6	0.2	1.5	0.2	0.0	0.2	0.6	0.0	0.0	0.3	5.5	0.2	0.0	0.2	0.6	0.8	0.5	0.2	0.0	0.0	0.0	3.3	0.2	0.5	2.0	0.9	0.0	3.2	0.0	170.1	0.5	0.0	0.0	0.3	0.0	0.0	0.4	0.3	1.1	0.0	20.4	1.2	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	21.5	0.0	0.2	0.0	0.0	1.4	0.0	0.1	0.2	445.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	360.2	0.0	0.0	0.3	2.9	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.8	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.4	0.1	12.8	5.5	0.2	0.5	0.2	0.5	0.3	0.3	0.7	0.1	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	4.0	0.0	0.0	1.7	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.5	0.0	0.6	0.4	1.7	0.3	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	193.5	0.3	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.2	0.0
CHRNA10		ENSG00000129749	"Cholinergic receptor nicotinic alpha 10 subunit"	Q9GZZ6	11	3665587-3671384	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"skeletal muscle: 47.8"	"Cell type enhanced"	"Detected in some"		"Glandular and luminal cells: 4.4;Ionocytes: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Region enriched"	"Detected in some"	6	"olfactory bulb: 7.2"	"Not detected"	"Not detected"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 44: Endometrium - Transcription"				"unprognostic (3.04e-1)"	"unprognostic (2.23e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.11e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.74e-1)"	"unprognostic (6.90e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.06e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.39e-3)"	0.8	0.7	1.1	0.5	0.9	0.3	0.4	1.3	1.4	0.9	1.1	0.8	0.5	0.6	0.3	0.7	0.8	0.1	1.1	1.0	1.0	2.1	1.5	0.8	0.4	1.0	0.9	0.8	0.7	0.1	1.4	0.2	1.0	1.5	0.1	0.7	0.8	0.1	47.8	0.5	0.9	0.1	0.7	1.9	0.8	1.1	0.9	0.4	1.1	0.1	0.2	0.6	0.4	0.8	0.5	0.5	0.7	1.0	0.3	0.1	0.5	0.6	0.1	0.4	0.4	0.4	0.9	0.9	0.3	0.3	0.3	1.1	0.5	0.3	0.3	0.6	1.8	0.2	1.7	0.1	0.4	0.2	0.9	0.3	0.3	0.3	0.1	0.2	0.2	1.1	0.7	0.2	0.3	0.1	0.5	1.5	1.0	0.9	0.7	1.0	0.3	0.1	0.3	0.7	0.6	0.3	0.3	0.3	0.5	0.6	0.2	1.1	0.2	0.6	0.8	0.4	0.7	0.2	0.6	0.5	0.3	0.4	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.1	0.9	1.3	1.4	1.0	1.0	1.0	0.9	1.0	0.7	0.9	0.8	1.5	0.0	0.5	1.3	0.5	1.8	0.6	0.5	0.0	1.6	2.2	3.6	1.3	0.0	0.4	0.0	0.0	0.4	0.4	0.9	0.0	0.2	1.4	2.1	0.9	0.9	0.0	0.0	1.3	0.4	0.3	0.4	2.0	4.4	0.0	0.8	1.1	1.2	0.6	1.7	1.3	0.9	4.1	0.6	0.7	0.8	0.3	1.1	1.8	2.8	0.6	1.2	0.0	1.0	0.6	0.4	0.2	0.4	0.4	0.8	0.6	0.0	2.1	0.8	0.0	3.1	0.9	0.4	0.5	0.1	1.1	0.3	0.6	0.7	0.8	0.7
CHRNA4	"BFNC, EBN, EBN1"	ENSG00000101204	"Cholinergic receptor nicotinic alpha 4 subunit"	P43681	20	63343223-63378401	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 28.8;liver: 58.0"	"Group enriched"	"Detected in some"	4	"Hepatocytes: 42.0;Horizontal cells: 139.7"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"U-2 OS: 2.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"midbrain: 21.8;pons: 20.5;thalamus: 33.5"	CAB034064	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"			"CAB034064: AB_2080535"	"unprognostic (3.40e-1)"	"unprognostic (1.71e-1)"		"unprognostic (2.87e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.03e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.10e-3)"	"unprognostic (5.72e-4)"	"unprognostic (9.02e-3)"	"unprognostic (9.79e-4)"	"unprognostic (6.77e-2)"	"unprognostic (1.08e-1)"	"unprognostic (3.81e-2)"		0.0	0.2	6.7	0.0	6.5	0.0	0.0	0.6	6.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	6.7	8.7	3.4	58.0	0.0	0.0	5.7	15.7	0.1	0.0	12.7	0.8	0.0	6.2	0.2	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	2.5	0.0	1.6	28.8	0.0	0.5	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.5	0.6	6.2	6.7	8.7	5.7	15.7	6.2	0.5	28.8	4.9	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	4.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	42.0	0.0	139.7	8.8	0.0	0.0	1.0	0.0	1.1	0.0	0.0	0.0	1.0	0.0	0.9	0.0	7.5	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	2.7	0.0	1.7	0.1	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CHRNA7		ENSG00000175344	"Cholinergic receptor nicotinic alpha 7 subunit"	P36544	15	31923438-32173018	"FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 7.8;intestine: 9.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 9.0;Gastric mucus-secreting cells: 26.0;Horizontal cells: 16.8;Inhibitory neurons: 30.7;Proximal enterocytes: 14.4"	"Cancer enhanced"	"Detected in single"		"stomach cancer: 0.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 6.3;RT4: 12.9;SH-SY5Y: 8.3;SK-BR-3: 13.3;U-2 OS: 10.8"									"HPA029422, CAB033624"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB033624: AB_784835, HPA029422: AB_10600863"	"unprognostic (3.43e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.61e-4)"	"unprognostic (6.19e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.14e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.63e-1)"	"unprognostic (4.31e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.40e-2)"	"unprognostic (4.36e-3)"	"unprognostic (5.44e-2)"	"unprognostic (7.41e-3)"	"unprognostic (2.43e-1)"	0.3	7.8	1.2	0.4	1.1	0.9	1.0	1.8	1.8	0.4	2.1	1.5	4.4	0.5	0.3	0.3	0.4	0.9	0.5	1.0	4.5	0.4	0.1	0.5	0.7	4.5	3.9	1.6	2.4	6.4	1.0	0.0	7.0	1.2	2.3	2.5	0.5	0.7	0.5	0.3	9.7	0.4	1.5	1.2	6.6	2.5	3.3	0.4	2.2	0.8	0.7	1.5	0.7	1.1	0.0	1.3	2.7	6.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.3	0.0	3.1	0.0	0.0	0.0	1.7	0.6	0.0	2.2	0.0	0.4	1.0	0.0	0.0	0.2	0.0	0.1	0.4	2.5	0.0	0.2	0.3	0.2	0.0	0.2	1.5	3.7	0.0	0.0	4.2	0.3	0.5	12.9	0.5	8.3	0.2	13.3	0.0	0.7	0.0	0.5	1.2	0.0	10.8	0.3	0.0	0.0	0.0	0.3	0.0	1.3	0.0	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	1.2	1.1	1.8	1.8	1.0	4.5	4.5	3.9	7.0	1.5	3.3	1.1	0.5	0.0	0.0	1.0	0.0	0.3	3.0	0.0	7.4	1.8	1.1	1.3	1.1	2.8	0.0	0.0	0.0	0.0	0.0	3.8	0.0	1.3	0.1	0.2	0.3	1.5	3.0	0.0	9.0	2.5	0.0	0.4	26.0	0.6	1.3	4.6	0.7	0.0	0.1	16.8	30.7	8.9	0.0	0.0	0.9	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.5	1.1	1.6	2.9	0.0	0.2	0.7	14.4	0.2	0.0	0.0	0.0	0.4	0.3	0.2	5.9	3.2	0.0	0.0	0.1	0.2	2.0	1.2
CHRNA9	NACHRA9	ENSG00000174343	"Cholinergic receptor nicotinic alpha 9 subunit"	Q9UGM1	4	40335333-40355217	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"breast cancer: 2.5;glioma: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"U-87 MG: 15.9"	"Region enriched"	"Detected in single"	6	"basal ganglia: 1.0"	"Not detected"	"Not detected"									NA	NA					"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (6.20e-3)"	"unprognostic (9.18e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.54e-1)"	"unprognostic (3.48e-1)"		"unprognostic (1.58e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.94e-1)"		"unprognostic (8.96e-6)"	"unprognostic (9.00e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.01e-2)"	"unprognostic (9.18e-3)"	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	0.1	0.1	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CHRNB1	CHRNB	ENSG00000170175	"Cholinergic receptor nicotinic beta 1 subunit"	P11230	17	7445061-7457710	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 158.4;tongue: 57.7"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 39.0;Skeletal myocytes: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"LHCN-M2: 34.6;RH-30: 71.0"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA005822, CAB011200"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 47: Cytotrophoblasts - Unknown function"			"CAB011200: AB_262151, HPA005822: AB_1079484"	"unprognostic (2.89e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.19e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.09e-1)"	"unprognostic (3.15e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.13e-2)"	"unprognostic (6.91e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.59e-1)"	7.0	30.6	6.9	2.4	7.8	9.1	6.7	7.3	7.5	7.5	8.8	6.3	2.9	6.6	5.1	7.0	5.4	1.9	11.5	6.9	6.9	10.7	16.5	5.1	3.6	7.5	7.0	5.4	16.5	9.1	6.7	6.7	7.3	5.1	2.5	3.2	10.7	3.0	158.4	8.1	5.5	3.2	7.3	7.9	5.2	3.2	7.1	6.5	13.0	57.7	3.9	5.5	7.2	8.1	1.6	2.2	3.8	4.5	6.0	4.0	8.6	1.1	3.8	5.6	4.6	1.3	2.0	6.2	4.0	2.5	2.0	13.6	1.4	25.1	2.0	7.6	4.8	3.5	2.3	8.1	2.6	2.2	8.6	8.8	6.8	3.4	11.0	9.3	3.8	12.0	4.6	3.4	34.6	1.0	6.7	4.1	2.7	1.5	1.1	4.4	71.0	15.8	15.3	1.2	0.6	11.1	2.4	4.0	4.7	5.9	3.9	3.0	3.6	2.3	6.4	1.7	5.0	8.1	9.6	1.7	2.1	4.9	2.1	9.9	5.4	13.6	7.9	6.3	6.1	6.7	8.7	8.0	7.0	7.0	7.0	9.2	1.7	11.0	10.4	5.2	7.9	6.1	6.9	7.8	7.3	7.5	6.9	6.9	7.5	7.0	7.3	7.3	7.1	8.1	8.8	0.0	4.8	4.6	8.9	6.4	3.8	12.6	6.2	3.9	9.3	11.2	9.8	4.3	7.2	9.2	2.1	39.0	17.7	5.2	23.5	16.1	2.2	5.1	7.1	10.1	2.4	3.4	1.4	13.4	9.4	8.1	3.6	7.1	13.3	5.8	10.4	10.8	12.6	15.2	1.5	4.8	14.2	7.2	8.7	2.1	21.8	7.9	12.4	1.0	17.0	14.0	29.9	1.0	5.6	17.3	4.9	17.0	5.8	4.1	10.2	15.5	9.5	7.1	0.0	47.3	8.1	2.8	2.8	6.1	6.5	30.4	11.2	12.1	5.9	3.8
CHRNB2		ENSG00000160716	"Cholinergic receptor nicotinic beta 2 subunit"	P17787	1	154567778-154580013	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 17.4;retina: 8.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 12.7;Cone photoreceptor cells: 14.6;Horizontal cells: 42.1;Inhibitory neurons: 7.8;Late spermatids: 11.8;Rod photoreceptor cells: 7.6"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"SCLC-21H: 25.7;SH-SY5Y: 25.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (1.13e-1)"	"unprognostic (6.33e-2)"	"unprognostic (8.15e-3)"	"unprognostic (3.32e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.25e-1)"	"unprognostic (3.51e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.65e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.24e-3)"	"unprognostic (1.83e-1)"	"unprognostic (4.36e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.84e-1)"	0.0	1.0	6.5	0.1	7.5	0.0	0.4	2.2	17.4	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	8.7	5.3	0.0	0.0	0.0	0.0	3.8	5.5	0.0	0.6	0.1	3.6	0.0	3.8	0.0	0.1	8.3	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.3	0.7	11.8	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.0	0.6	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	4.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	25.7	25.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	7.5	2.2	17.4	8.7	5.3	3.8	5.5	3.8	0.3	11.8	6.5	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	12.7	0.1	0.3	1.5	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.2	3.6	0.0	5.8	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	42.1	7.8	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	1.0	0.0	1.3	0.0	1.5	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	1.5	0.4	0.0	0.3	0.0	0.0	0.1	0.0	0.0
CHRND	ACHRD	ENSG00000135902	"Cholinergic receptor nicotinic delta subunit"	Q07001	2	232525993-232536667	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skeletal muscle: 57.6"	"Group enriched"	"Detected in some"	10	"Muller glia cells: 4.0;Skeletal myocytes: 4.4"	"Cancer enriched"	"Detected in single"	7	"head and neck cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	49	"RH-30: 99.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA056404, HPA065404"			Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA056404: AB_2732603, HPA065404: AB_2732734"				"unprognostic (1.69e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.28e-3)"	"unprognostic (7.75e-3)"	"unprognostic (6.04e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.90e-1)"		"unprognostic (4.97e-8)"	"unprognostic (7.52e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.46e-1)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	6.3	0.7	0.0	57.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	6.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	99.4	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.1	0.2	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
CHRNE	ACHRE	ENSG00000108556	"Cholinergic receptor nicotinic epsilon subunit"	Q04844	17	4897771-4934438	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"heart muscle: 55.3;pituitary gland: 27.6"	"Cell type enriched"	"Detected in many"	5	"Late spermatids: 161.5"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.5"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	9	"HEL: 5.0;HMC-1: 11.5"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	14	"basal ganglia: 6.3"							NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.00e-3)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-2)"	"unprognostic (4.35e-3)"	"unprognostic (6.55e-2)"	"unprognostic (2.27e-3)"	"unprognostic (7.80e-4)"	"unprognostic (7.75e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.58e-2)"	"unprognostic (8.42e-4)"	"unprognostic (1.39e-3)"	"unprognostic (1.26e-1)"	"unprognostic (5.83e-2)"	"unprognostic (5.70e-2)"	0.7	0.4	0.1	0.4	0.1	0.7	0.7	0.6	0.4	0.7	0.0	0.3	0.3	0.4	1.3	0.4	0.6	1.0	55.3	0.2	0.1	1.0	3.5	0.8	0.5	0.3	0.0	0.8	1.7	0.2	27.6	0.6	0.1	0.6	0.0	5.1	0.8	0.2	1.8	2.2	0.8	0.2	0.0	1.8	0.5	0.7	0.1	0.1	0.4	2.1	0.2	0.3	0.5	0.2	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	5.0	0.0	0.8	0.4	0.0	11.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.2	1.3	2.5	0.4	0.0	0.0	0.1	0.8	0.2	0.4	0.1	0.7	1.1	0.8	0.6	0.1	0.0	0.7	0.1	0.1	0.6	0.4	0.2	0.1	0.3	0.0	0.1	0.0	0.1	0.2	4.9	0.0	0.0	0.3	4.2	1.7	1.4	0.8	1.2	5.0	1.6	2.0	6.5	1.5	0.6	1.8	4.2	0.6	10.2	0.0	1.9	0.3	27.8	0.6	1.1	3.3	0.0	0.0	0.5	0.9	7.3	2.3	1.1	0.8	8.2	1.4	2.9	7.4	3.4	3.3	0.4	0.1	2.0	1.3	13.0	161.5	0.9	9.9	0.0	2.8	5.3	1.1	8.2	0.5	0.7	0.7	0.0	0.4	3.5	1.1	0.0	2.9	0.6	10.0	0.0	0.9	1.1	5.6	8.4	0.2	1.1	11.1	3.5	6.2	0.2	0.7
CHRNG	ACHRG	ENSG00000196811	"Cholinergic receptor nicotinic gamma subunit"	P07510	2	232539692-232548115	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	23	"skeletal muscle: 32.0"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"head and neck cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	19	"HSkMC: 2.7;RH-30: 7.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"				"unprognostic (2.26e-1)"	"unprognostic (8.97e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.92e-2)"	"unprognostic (4.38e-1)"	"unprognostic (4.86e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.18e-2)"	"unprognostic (4.32e-1)"	"unprognostic (4.19e-6)"	"unprognostic (6.13e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.24e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.1	32.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.3	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CIB1	"CIB, KIP, SIP2-28"	ENSG00000185043	"Calcium and integrin binding 1"	Q99828	15	90229975-90234047	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis, Cell adhesion, Cell cycle, Cell division, Differentiation, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 1385.8;Respiratory ciliated cells: 1103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012991, HPA042413, HPA048825"	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Plasma membrane"		"CAB012991: AB_2533205, HPA042413: AB_2732498, HPA048825: AB_2680533"	"unprognostic (1.20e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.73e-2)"	"prognostic favorable (2.26e-5)"	"unprognostic (7.56e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.21e-2)"	"unprognostic (8.29e-3)"	"unprognostic (1.77e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.25e-3)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.68e-2)"	65.6	163.6	65.4	79.7	69.2	205.5	67.4	67.8	76.5	93.8	96.7	147.9	130.1	44.6	88.1	127.3	146.6	77.4	101.9	62.7	68.8	220.1	195.7	86.7	97.0	70.1	70.3	43.9	214.1	98.3	93.0	38.0	68.7	127.6	138.1	29.1	116.6	72.7	58.8	40.4	128.5	45.3	69.3	117.0	99.3	113.8	69.2	64.4	89.1	42.3	120.9	93.7	68.3	69.3	119.5	261.4	23.8	83.7	98.7	102.7	38.9	123.8	107.2	99.6	87.2	104.7	207.4	34.7	129.7	144.0	125.7	124.2	48.0	141.8	54.0	81.9	114.2	77.5	182.3	175.9	96.2	155.2	71.4	72.2	84.9	91.9	64.6	113.7	129.1	83.7	105.8	53.5	76.4	233.3	118.4	179.4	36.7	223.9	134.0	66.1	62.8	139.7	256.1	199.4	18.7	22.8	168.7	136.5	135.7	41.5	105.3	93.3	81.7	109.6	77.0	132.0	153.2	73.0	122.0	40.3	176.1	174.9	47.8	168.9	201.8	271.3	226.9	248.9	188.0	476.4	269.9	249.4	224.4	418.0	221.5	218.0	118.2	205.7	230.0	149.7	245.8	399.6	65.4	69.2	67.8	76.5	62.7	68.8	70.1	70.3	68.7	69.3	69.2	69.3	77.4	89.8	104.2	14.7	203.7	85.7	253.6	520.1	84.8	12.0	152.0	118.5	86.9	128.7	469.1	183.9	10.4	106.7	198.7	670.9	453.9	372.1	380.8	480.8	101.3	83.9	97.1	62.3	7.7	662.9	117.6	96.5	149.9	222.8	138.8	66.9	79.6	230.1	209.0	3.3	6.6	379.5	463.9	102.5	148.0	1385.8	105.3	180.5	128.1	4.7	187.5	138.4	184.4	5.0	12.2	620.2	794.2	92.6	88.8	699.6	661.4	668.6	1103.6	25.5	39.5	62.3	140.4	160.3	69.0	218.1	67.3	66.1	227.5	91.8	315.5	577.8
CKAP4	"CLIMP-63, ERGIC-63, P63"	ENSG00000136026	"Cytoskeleton associated protein 4"	Q07065	12	106237881-106304279	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 198.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 106.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 106.8"	"Cell line enhanced"	"Detected in many"		"BJ: 549.7;BJ hTERT+: 687.6;fHDF/TERT166: 834.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000278, HPA000792"	Enhanced					NA	NA		560000	"Cluster 38: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA000278: AB_1078527, HPA000792: AB_1078526"	"unprognostic (5.25e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.91e-1)"	"unprognostic (7.13e-2)"	"unprognostic (2.44e-2)"	"unprognostic (4.65e-2)"	"prognostic unfavorable (6.61e-5)"	"prognostic unfavorable (5.61e-4)"	"unprognostic (5.02e-2)"	"unprognostic (9.66e-3)"	"unprognostic (1.95e-1)"	"unprognostic (6.23e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (7.20e-3)"	"unprognostic (6.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (3.66e-2)"	26.6	40.0	14.7	34.7	16.1	100.5	21.8	14.2	15.4	49.5	27.9	42.9	19.3	40.6	59.2	71.3	31.2	26.3	40.0	14.2	17.4	21.3	30.4	33.5	10.5	18.1	16.1	30.6	41.1	26.1	20.2	51.8	17.2	37.6	45.8	18.8	57.5	36.9	14.5	39.4	19.0	46.7	15.6	25.1	52.3	9.9	19.6	7.8	19.8	13.5	22.8	51.4	40.5	18.4	86.8	106.7	126.5	138.3	240.6	212.5	73.2	549.7	687.6	262.7	300.1	45.6	19.4	5.6	98.0	834.0	89.3	153.1	93.5	83.5	187.5	3.0	54.1	0.1	56.5	89.9	179.2	0.4	1.7	205.5	111.9	223.5	159.9	331.9	311.7	6.5	0.6	11.0	253.0	29.1	4.4	3.1	73.8	45.6	127.9	40.1	91.0	7.5	80.5	76.9	41.5	46.0	98.0	65.9	54.4	112.9	73.9	39.3	268.9	205.8	112.2	86.3	157.9	29.0	0.3	60.2	148.5	10.9	184.5	106.8	18.8	22.5	1.1	6.8	1.6	9.5	1.7	1.0	5.8	4.1	2.2	2.0	30.1	0.2	11.3	0.2	0.5	7.1	14.7	16.1	14.2	15.4	14.2	17.4	18.1	16.1	17.2	15.6	19.6	18.4	17.7	22.4	26.5	9.1	26.3	54.8	37.9	63.2	56.3	11.8	37.6	34.4	43.2	35.8	33.4	23.9	10.4	26.9	2.8	43.0	5.9	37.8	1.1	38.6	103.1	33.8	41.4	1.3	5.8	87.7	107.0	92.9	51.5	139.9	19.1	62.8	43.2	52.3	20.1	47.1	11.2	198.7	16.2	31.8	16.8	2.7	68.3	33.1	33.8	8.4	59.9	23.4	2.1	7.5	1.6	52.4	22.9	61.3	144.5	92.0	3.9	9.2	13.3	23.3	13.1	45.1	52.3	4.9	12.6	122.3	71.9	26.4	6.7	73.3	69.0	46.7
CLCA1	"CaCC, CLCRG1"	ENSG00000016490	"Chloride channel accessory 1"	A8K7I4	1	86468368-86500259	"Predicted secreted proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"intestine: 1399.9"	"Cell type enriched"	"Detected in some"	16	"Intestinal goblet cells: 3524.6"	"Group enriched"	"Detected in some"	9	"colorectal cancer: 86.8;pancreatic cancer: 27.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;NB-4: 2.5;RPMI-8226: 2.9;SH-SY5Y: 1.8;U-2197: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA052787, HPA059301"	Enhanced				"Secreted to digestive system"	NA	NA		77000		"Cluster 9: Intestine - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA052787: AB_2681947, HPA059301: AB_2683971"			"prognostic favorable (2.98e-4)"								"unprognostic (3.42e-1)"			"unprognostic (8.61e-2)"	"unprognostic (1.06e-1)"			1.1	0.0	0.0	109.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	739.9	909.7	1.2	0.0	0.3	0.1	0.7	0.0	0.0	0.0	0.6	0.0	0.0	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	1061.8	0.0	0.0	0.5	0.0	0.0	1399.9	15.4	0.0	0.0	3.2	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	24.1	0.0	0.0	0.1	0.0	0.0	0.0	6.7	0.0	0.3	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	3524.6	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	54.8	0.0	0.0	0.0	213.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.1	68.3	0.1
CLCA4	CaCC2	ENSG00000016602	"Chloride channel accessory 4"	Q14CN2	1	86547078-86580754	"Predicted membrane proteins, Transporters"	Transport	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 373.9;intestine: 257.8"	"Group enriched"	"Detected in many"	6	"Distal enterocytes: 597.0;Paneth cells: 183.2;Squamous epithelial cells: 158.7;Urothelial cells: 176.9"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 21.4;urothelial cancer: 15.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	1368	"RT4: 430.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA017045, HPA064770"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Aggresome"	"Intracellular and membrane"	NA	NA		150000		"Cluster 37: Intestine - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nucleoplasm, Aggresome"	"HPA017045: AB_2291679, HPA064770: "	"unprognostic (1.38e-4)"	"unprognostic (1.52e-1)"	"prognostic favorable (7.47e-4)"	"unprognostic (2.73e-2)"	"unprognostic (7.03e-2)"	"prognostic favorable (8.63e-4)"		"unprognostic (7.59e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.26e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.20e-1)"		"unprognostic (2.57e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.43e-2)"	0.6	0.0	6.3	13.9	9.4	0.0	2.2	6.7	8.0	44.6	3.2	257.8	0.1	0.1	0.1	373.9	0.2	0.2	0.1	6.2	6.6	0.1	0.1	0.0	0.0	10.9	7.0	0.0	0.1	0.0	0.5	0.0	8.7	2.5	143.5	0.0	23.1	0.2	0.1	17.1	29.1	2.9	7.1	0.1	0.6	0.3	8.0	0.1	0.0	0.0	30.1	99.3	66.9	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	430.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	9.4	6.7	8.0	6.2	6.6	10.9	7.0	8.7	7.1	8.0	12.7	0.1	0.0	0.0	0.0	2.9	3.3	40.3	6.5	2.8	0.0	1.9	1.8	0.4	0.0	17.5	1.8	0.0	0.0	0.2	597.0	0.0	0.0	0.4	7.3	0.1	0.3	8.3	0.0	0.1	0.0	0.0	0.4	0.0	3.5	8.9	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	183.2	0.0	1.2	9.7	4.7	0.0	1.9	0.0	0.0	0.0	0.4	0.1	0.0	158.7	11.9	0.0	1.5	0.0	12.0	176.9
CLCC1	MCLC	ENSG00000121940	"Chloride channel CLIC like 1"	Q96S66	1	108927361-108963504	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009087, HPA013210"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Endoplasmic reticulum"		"HPA009087: AB_1078532, HPA013210: AB_1846895"	"unprognostic (2.95e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (1.33e-5)"	"unprognostic (4.32e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.45e-1)"	"unprognostic (5.30e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.68e-3)"	"unprognostic (9.65e-2)"	14.6	16.5	10.1	11.4	14.3	6.1	16.3	10.6	11.7	17.0	7.8	15.4	13.2	17.0	24.3	9.9	15.1	14.0	18.3	10.7	11.5	11.0	22.2	13.0	10.5	12.8	10.9	18.6	24.8	21.3	18.3	17.7	12.1	20.2	13.2	11.8	22.3	20.0	27.2	10.3	12.7	14.9	11.0	11.5	16.1	7.6	11.8	5.2	21.9	24.8	10.8	15.2	13.4	16.0	44.2	22.3	25.1	45.8	36.7	33.9	35.6	43.8	34.2	30.1	34.2	22.6	21.0	10.8	43.7	33.3	18.5	17.1	23.9	16.1	39.4	38.0	23.2	30.4	24.7	23.5	28.9	28.7	28.2	25.2	21.9	33.2	25.7	28.3	27.1	12.1	38.6	47.7	22.1	18.9	2.3	10.1	21.5	16.6	19.8	24.5	13.1	31.2	24.3	30.5	15.9	22.7	46.9	49.6	38.9	18.9	15.9	19.7	26.7	38.3	27.7	35.1	38.4	32.1	33.3	17.1	44.7	21.8	82.5	4.1	5.6	6.1	5.6	8.4	6.1	6.1	4.5	4.4	5.6	3.2	4.9	4.5	1.4	4.7	12.4	6.4	6.8	4.4	10.1	14.3	10.6	11.7	10.7	11.5	12.8	10.9	12.1	11.0	11.8	16.0	13.3	25.6	20.9	26.8	11.8	3.7	14.0	11.7	1.8	12.3	11.8	9.1	5.9	20.0	18.0	11.0	29.2	28.7	9.0	7.1	0.0	18.6	6.7	8.1	21.3	10.9	3.6	5.9	25.0	21.1	12.8	19.5	10.7	13.5	12.0	16.3	9.7	22.3	13.1	21.9	30.3	9.0	16.2	6.7	5.1	2.8	19.9	9.3	8.8	14.0	12.0	11.4	3.1	35.7	39.3	17.7	3.8	18.8	17.7	17.7	7.2	5.0	14.9	18.9	19.7	18.6	10.7	5.5	5.4	6.4	6.3	18.5	8.4	12.5	9.8	9.9
CLCN1	"ClC-1, CLC1"	ENSG00000188037	"Chloride voltage-gated channel 1"	P35523	7	143316111-143352083	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"skeletal muscle: 65.9"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 149.6"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"HSkMC: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (5.16e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.56e-4)"	"unprognostic (8.71e-3)"	"unprognostic (2.35e-1)"	"unprognostic (2.90e-3)"	"unprognostic (3.12e-1)"	"unprognostic (2.35e-1)"	"unprognostic (4.30e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.55e-3)"	"unprognostic (3.57e-2)"	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.5	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.9	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	65.9	0.0	1.0	0.0	0.0	0.1	0.2	1.0	0.0	0.2	0.0	15.9	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.3	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.6	1.2	0.0	0.0	0.1	0.8	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	32.9	0.0	0.2	0.1	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.8	149.6	0.0	0.7	0.0	1.0	0.6	0.0	0.0	0.0	0.7	5.7	15.0	0.0	0.0	0.2	0.4	0.1	0.3	0.0	0.0	1.4	0.3	0.1	2.2	0.7	0.1	0.0	0.1	0.1	0.2	2.1
CLCN2	"ClC-2, CLC2, EJM6"	ENSG00000114859	"Chloride voltage-gated channel 2"	P51788	3	184346185-184361650	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.7;Proximal enterocytes: 27.4;Theca cells: 62.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009397, HPA014545, HPA024108"	Approved		Approved	Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB009397: AB_2079256, HPA014545: AB_1846881, HPA024108: AB_1846883"	"unprognostic (1.13e-1)"	"unprognostic (4.01e-2)"	"unprognostic (6.48e-2)"	"unprognostic (5.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (2.53e-2)"	"prognostic unfavorable (4.67e-8)"	"unprognostic (1.72e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.50e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.40e-2)"	"unprognostic (5.88e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.35e-1)"	1.4	5.1	2.2	1.8	3.1	1.0	1.6	3.1	3.0	3.0	1.6	16.2	9.2	3.6	3.8	1.7	2.4	7.5	1.2	2.0	2.4	3.0	1.7	1.2	0.7	3.4	3.0	4.0	4.5	3.4	2.8	1.0	2.7	2.3	10.8	0.6	2.8	2.9	0.9	1.6	8.4	1.6	2.9	1.5	2.2	10.6	3.3	1.3	2.7	0.5	0.9	2.1	2.0	4.3	8.9	3.2	2.5	6.9	2.2	1.8	5.8	2.9	1.7	3.1	2.0	16.8	3.0	3.0	8.2	1.6	8.0	15.1	3.6	3.5	0.9	2.8	4.2	2.7	7.0	7.7	1.3	1.2	2.6	3.6	2.7	2.6	3.0	1.5	2.9	3.3	1.0	1.6	1.1	5.9	0.8	1.6	3.7	7.6	4.4	5.4	2.3	10.7	3.8	6.9	4.0	2.4	3.3	11.4	5.2	1.6	9.4	1.2	1.4	1.5	4.5	7.7	7.7	3.6	5.5	2.1	2.7	5.3	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	3.1	3.1	3.0	2.0	2.4	3.4	3.0	2.7	2.9	3.3	4.3	2.2	3.2	4.1	16.6	0.4	1.0	0.9	0.8	1.2	2.1	2.5	2.8	1.2	14.3	1.1	0.0	0.0	1.0	1.9	81.7	0.0	3.7	2.3	2.5	4.5	1.9	3.0	0.8	4.1	2.0	0.6	2.6	2.6	4.4	1.3	11.3	2.5	0.6	0.7	1.7	8.1	3.7	0.0	1.0	0.3	2.7	5.3	1.1	0.0	1.9	0.6	1.7	0.0	6.0	15.1	2.2	16.0	4.9	0.8	0.6	27.4	2.3	2.6	2.5	0.0	0.9	2.1	3.3	1.7	1.1	0.4	1.5	1.2	62.5	9.0	0.5
CLCN4	"ClC-4, CLC4"	ENSG00000073464	"Chloride voltage-gated channel 4"	P51793	X	10156975-10237660	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 33.3;retina: 37.9;skeletal muscle: 45.0;tongue: 34.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 85.0;Cone photoreceptor cells: 102.2;Excitatory neurons: 45.7;Horizontal cells: 52.2;Inhibitory neurons: 54.0;Oligodendrocytes: 76.5;Rod photoreceptor cells: 42.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.6;neutrophil: 2.2"	"Group enriched"	"Detected in many"	6	"B-cells: 2.6;granulocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"GAMG: 25.3;HEL: 24.3;SCLC-21H: 24.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031313, HPA063637"	Enhanced	Approved	Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA031313: AB_10601358, HPA063637: AB_2685069"	"unprognostic (1.01e-1)"	"unprognostic (1.20e-2)"	"unprognostic (5.07e-2)"	"prognostic unfavorable (2.13e-5)"	"unprognostic (2.96e-1)"	"unprognostic (3.75e-1)"	"unprognostic (1.04e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.99e-2)"	"prognostic favorable (9.55e-4)"	"unprognostic (9.70e-2)"	"unprognostic (9.78e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.74e-1)"	2.6	2.7	16.2	1.5	27.4	1.8	1.1	28.8	23.1	1.3	5.2	0.9	0.8	0.6	22.6	1.7	2.9	2.1	12.3	19.6	19.7	2.8	3.2	3.0	2.8	27.1	24.1	1.6	2.2	10.8	5.3	1.1	24.5	1.5	0.7	37.9	2.2	1.0	45.0	1.0	0.7	0.7	18.5	2.6	1.5	1.8	26.8	2.6	6.5	34.2	1.8	1.2	0.7	33.3	5.9	4.6	2.7	0.0	1.5	2.5	0.1	0.2	0.0	0.0	0.0	9.1	4.6	5.0	13.0	1.5	25.3	1.4	1.4	2.9	0.2	0.1	5.7	24.3	2.2	3.5	7.3	0.0	0.1	12.9	3.4	7.0	1.5	4.7	9.4	0.0	1.5	0.1	3.3	1.1	0.0	0.2	4.0	7.1	15.3	0.0	4.5	0.0	2.1	0.8	24.1	8.7	8.6	1.1	0.0	2.7	1.7	2.7	7.4	3.1	5.8	15.3	0.6	0.5	12.1	1.8	10.5	0.0	4.5	1.6	0.3	0.0	0.0	0.2	0.0	0.9	0.0	0.0	0.4	2.6	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.3	16.2	27.4	28.8	23.1	19.6	19.7	27.1	24.1	24.5	18.5	26.8	33.3	1.0	9.6	3.1	11.8	4.9	0.5	0.6	2.0	0.0	85.0	1.1	0.4	31.1	8.6	2.2	7.3	102.2	0.2	0.0	0.1	0.0	2.5	0.1	2.6	1.3	3.0	15.0	9.4	45.7	3.6	0.1	4.0	1.1	3.1	1.3	0.7	13.6	5.1	3.1	52.2	54.0	0.6	4.1	4.8	2.3	0.0	0.9	3.4	0.0	15.9	1.0	15.4	0.0	24.6	76.5	4.1	0.1	3.8	0.4	0.8	0.0	2.9	5.3	42.6	0.0	8.7	6.0	0.0	0.5	0.2	0.1	0.3	0.1	2.6	0.3	1.3
CLCN7	"CLC-7, CLC7, OPTA2, PPP1R63"	ENSG00000103249	"Chloride voltage-gated channel 7"	P51798	16	1444934-1475084	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"		"Disease variant, Osteopetrosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 74.0"	"Cancer enhanced"	"Detected in all"		"melanoma: 42.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043019, HPA043586"	Supported					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 62: Horizontal cells - Visual perception"			"HPA043019: AB_10964727, HPA043586: AB_10965322"	"unprognostic (2.69e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (1.59e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.41e-2)"	"unprognostic (3.98e-1)"	"unprognostic (3.49e-3)"	"unprognostic (5.81e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (2.80e-1)"	"unprognostic (2.54e-1)"	18.1	37.3	14.4	16.9	14.2	34.3	17.3	12.8	18.0	18.7	18.0	20.0	16.6	20.3	6.3	12.4	17.0	12.3	16.6	14.2	14.1	21.1	22.0	19.1	18.3	17.9	19.2	15.1	21.8	20.8	21.7	12.4	20.7	16.5	7.1	9.2	16.8	12.0	28.0	23.1	22.7	13.2	11.9	27.3	22.3	19.2	18.0	15.6	23.1	8.3	12.1	16.0	11.9	15.8	14.2	36.9	21.0	33.7	41.3	21.5	34.3	18.9	36.4	35.2	41.5	30.8	51.2	16.3	38.6	23.7	73.8	29.4	18.4	21.0	11.4	26.1	31.5	11.6	37.9	30.0	72.4	29.4	45.1	42.9	28.4	32.1	28.5	23.9	23.0	36.3	48.0	29.2	18.5	28.4	21.3	50.6	21.7	9.0	21.8	96.7	13.3	45.2	16.4	18.2	22.5	24.9	30.8	37.5	120.2	11.8	33.6	78.0	26.3	34.9	16.2	39.1	18.4	47.3	32.1	16.5	28.2	54.3	22.6	0.0	1.6	1.2	0.8	2.7	0.3	1.0	0.4	0.4	1.2	1.0	0.2	0.3	0.3	0.3	3.4	1.1	0.1	1.0	14.4	14.2	12.8	18.0	14.2	14.1	17.9	19.2	20.7	11.9	18.0	15.8	12.6	0.0	7.5	25.1	16.5	7.4	5.5	6.3	9.1	45.0	14.5	12.7	4.4	4.3	8.2	20.2	35.5	10.2	12.3	20.4	1.9	16.2	10.2	14.0	14.9	11.1	12.0	8.0	22.3	17.8	8.9	11.0	18.8	17.9	6.3	24.0	16.8	15.6	36.3	74.0	20.6	14.5	4.1	28.3	11.5	8.6	11.5	29.6	39.2	24.4	22.4	27.3	13.4	8.5	17.9	17.9	7.3	8.2	9.3	9.0	14.5	14.7	7.8	28.1	0.0	9.9	11.9	13.5	10.7	5.6	6.8	15.5	9.4	19.4	15.1	5.2
CLDN1	"ILVASC, SEMP1"	ENSG00000163347	"Claudin 1"	O95832	3	190305707-190322446	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	Ichthyosis	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 309.8;skin 1: 288.2"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 440.1;Basal prostatic cells: 291.1;Prostatic glandular cells: 501.6;Squamous epithelial cells: 298.2;Suprabasal keratinocytes: 836.1;Urothelial cells: 562.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"EFO-21: 658.6;HaCaT: 236.5;hTCEpi: 288.6;RPTEC TERT1: 414.9;RT4: 267.0"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	12	"spinal cord: 25.4"	"CAB002602, HPA048319"	Enhanced					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB002602: , HPA048319: AB_2680355"	"unprognostic (5.89e-2)"	"unprognostic (4.58e-3)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.00e-4)"	"unprognostic (7.92e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.54e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.25e-2)"	"prognostic unfavorable (5.23e-4)"	"unprognostic (3.06e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.43e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.09e-3)"	"unprognostic (1.22e-1)"	40.8	47.9	1.5	1.2	1.1	0.2	22.7	0.8	1.3	17.7	20.7	1.7	1.1	64.2	31.9	40.9	56.6	15.5	2.5	1.5	1.2	10.5	309.8	9.1	0.5	1.2	2.8	6.3	34.3	0.4	2.4	5.3	1.7	13.6	1.6	0.9	34.0	46.0	1.1	288.2	0.7	126.6	0.7	1.5	1.0	4.3	1.1	9.4	36.2	4.9	44.2	40.4	35.9	1.0	34.0	29.7	0.2	0.1	0.0	0.1	0.0	2.5	52.7	1.1	2.1	17.7	69.1	0.0	658.6	0.3	58.5	236.5	1.5	77.7	6.2	0.9	1.4	0.1	9.3	41.5	49.6	0.4	0.2	0.5	288.6	6.0	87.0	2.4	0.6	0.0	0.1	0.1	0.1	6.5	0.1	0.1	1.5	2.3	5.5	0.0	0.6	0.2	414.9	267.0	0.2	0.0	31.0	5.7	18.4	3.5	53.5	0.5	12.9	0.6	9.9	0.2	1.4	0.7	0.6	1.2	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.1	0.8	1.3	1.5	1.2	1.2	2.8	1.7	0.7	1.1	1.0	0.4	12.8	34.7	0.0	0.5	440.1	291.1	217.3	84.2	0.0	35.6	2.0	1.0	170.1	143.2	31.3	0.0	2.4	0.6	0.6	0.0	203.3	0.1	44.4	10.0	7.0	1.8	0.0	0.7	56.3	0.3	29.2	2.0	100.0	1.3	0.4	1.4	188.2	1.0	0.0	1.6	0.3	54.9	3.8	66.5	1.7	15.5	8.5	32.0	0.0	5.7	0.0	0.0	24.6	0.0	139.9	0.0	35.3	0.0	501.6	0.1	4.1	144.6	0.0	0.0	0.3	11.2	0.3	0.8	298.2	836.1	33.8	2.6	5.0	1.0	562.9
CLDN15		ENSG00000106404	"Claudin 15"	P56746	7	101232092-101238820	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"adipose tissue: 65.4;intestine: 259.8"	"Cell type enriched"	"Detected in many"	4	"Proximal enterocytes: 594.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (8.85e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.81e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.79e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.02e-2)"	"prognostic unfavorable (5.31e-5)"	"unprognostic (9.98e-2)"	"unprognostic (2.89e-2)"	"unprognostic (9.64e-2)"	"prognostic favorable (3.30e-4)"	65.4	3.9	8.8	7.3	10.4	13.6	20.2	9.4	11.0	14.9	6.3	22.3	259.8	11.1	2.2	7.2	16.3	7.3	8.6	8.6	9.1	23.9	22.2	10.7	9.8	11.4	9.8	18.5	7.8	2.0	6.8	5.9	11.3	11.4	7.9	8.8	6.5	2.6	3.6	11.2	183.9	4.4	8.4	22.6	10.0	8.3	10.1	8.7	9.3	1.3	7.0	9.8	11.6	18.2	3.3	10.1	5.3	8.4	8.1	6.5	3.6	3.2	4.0	3.9	5.6	7.3	3.8	11.0	5.6	2.1	6.4	6.1	8.8	1.8	3.8	13.8	18.5	5.1	6.9	9.0	7.1	5.7	10.6	6.2	8.8	5.1	6.7	8.3	3.3	10.9	24.3	17.4	3.0	11.7	9.1	32.6	4.1	4.9	6.9	12.3	4.5	9.3	2.3	4.1	5.1	18.1	2.9	5.5	16.4	7.2	5.1	11.4	4.7	12.8	11.0	19.5	3.9	18.3	24.9	11.7	3.6	14.9	7.5	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.3	0.0	0.1	0.1	0.2	0.2	0.2	0.1	0.1	0.3	0.1	0.2	8.8	10.4	9.4	11.0	8.6	9.1	11.4	9.8	11.3	8.4	10.1	18.2	27.3	3.2	1.1	4.9	5.2	6.8	5.4	12.9	5.2	20.4	7.5	6.1	1.2	18.6	8.2	22.0	31.3	5.1	6.3	18.9	13.7	5.6	17.1	8.6	3.8	22.4	12.1	16.8	1.5	6.5	3.8	17.2	9.2	7.1	0.0	5.2	7.5	10.6	2.7	15.2	1.4	55.7	16.2	4.6	7.5	4.1	15.2	4.0	7.2	4.7	5.1	4.4	10.3	0.5	10.5	6.6	93.1	2.2	1.2	6.1	594.4	3.5	10.1	20.2	6.6	6.4	5.1	5.8	7.2	3.4	5.3	5.1	5.5	3.2	120.6	3.9
CLDN16	"HOMG3, PCLN1"	ENSG00000113946	"Claudin 16"	Q9Y5I7	3	190322541-190412138	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 63.6"	"Cell type enriched"	"Detected in some"	8	"Distal tubular cells: 187.9"	"Group enriched"	"Detected in many"	15	"ovarian cancer: 39.8;thyroid cancer: 29.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	153	"EFO-21: 691.6;RPTEC TERT1: 233.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056020	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA056020: AB_2683011"	"unprognostic (5.01e-2)"	"unprognostic (7.83e-3)"	"unprognostic (1.96e-1)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (6.06e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.31e-1)"	"unprognostic (4.20e-1)"	"unprognostic (2.76e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.15e-1)"	0.1	0.7	0.3	0.2	0.4	0.0	0.2	0.0	0.5	0.1	1.5	0.0	0.0	0.3	0.6	0.5	2.9	0.7	0.0	0.2	0.2	63.6	2.2	0.4	1.5	0.2	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.1	0.0	0.1	0.4	0.9	0.0	3.2	0.0	0.4	0.1	0.1	0.1	0.1	0.3	0.3	9.7	0.0	1.0	0.3	0.2	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	691.6	0.0	0.3	0.7	0.0	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.8	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	233.2	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	2.2	0.0	0.3	1.4	1.2	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.5	0.2	0.2	0.2	0.1	0.2	0.1	0.3	0.6	0.1	0.0	0.0	0.3	0.0	7.0	5.8	2.6	0.6	0.3	0.8	0.3	0.4	4.3	1.6	9.2	0.0	0.4	0.0	0.0	187.9	3.4	2.0	3.0	0.1	0.2	0.0	0.0	5.0	0.4	0.2	0.9	0.0	0.5	1.3	0.3	0.0	1.6	0.1	3.3	3.6	0.0	0.0	0.3	1.2	0.2	0.0	0.4	5.4	2.8	0.0	0.2	0.0	4.0	0.1	0.5	0.0	0.4	0.0	6.7	0.0	0.9	22.1	0.2	0.0	0.8	0.6	0.3	0.3	0.9	12.6	6.2	0.2	0.2	0.0	3.1
CLDN17	"MGC126552, MGC126554"	ENSG00000156282	"Claudin 17"	P56750	21	30165565-30166805	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"cervix: 2.3;esophagus: 6.1;salivary gland: 6.4;vagina: 7.2"	"Cell type enriched"	"Detected in single"	4	"Early spermatids: 4.4"	"Cancer enriched"	"Detected in single"	5	"head and neck cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA045903	Enhanced					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA045903: AB_2679491"						"unprognostic (2.41e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
CLDN19		ENSG00000164007	"Claudin 19"	Q8N6F1	1	42733093-42740254	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	14	"choroid plexus: 19.8;kidney: 39.1;placenta: 9.8"	"Cell type enriched"	"Detected in some"	6	"Extravillous trophoblasts: 221.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 3.0;Hep G2: 6.3;SuSa: 3.5"	"Region enhanced"	"Detected in many"		"olfactory bulb: 5.4"	"Region enriched"	"Detected in many"	6	"spinal cord: 41.8"							NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"				"unprognostic (6.23e-4)"	"unprognostic (1.80e-1)"		"unprognostic (1.85e-6)"	"unprognostic (5.30e-2)"	"unprognostic (1.73e-1)"	"unprognostic (3.21e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.45e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.68e-1)"	"unprognostic (7.22e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.12e-1)"		"unprognostic (3.29e-3)"	0.8	0.1	0.1	0.0	0.1	0.1	1.1	0.4	0.5	0.0	19.8	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	1.3	0.0	39.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	9.8	0.6	0.3	0.0	0.0	0.8	0.7	0.2	0.5	0.1	0.0	0.1	0.0	0.3	0.0	0.1	1.6	0.0	0.9	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.5	1.3	0.0	0.1	0.0	0.6	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.2	8.3	0.3	0.0	0.6	12.9	0.0	12.5	0.0	0.0	33.2	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.0	221.6	0.7	0.0	0.2	0.0	0.0	0.7	0.0	5.0	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.3	0.0	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	3.7	0.0	0.2	0.0	0.3	0.1	0.1	0.1	0.0	0.0	12.4	0.1	0.2	0.1	0.0
CLDN22	CLDN21	ENSG00000177300	"Claudin 22"	Q8N7P3	4	183318100-183320276	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"salivary gland: 4.9"	"Group enriched"	"Detected in some"	14	"Endometrial ciliated cells: 34.1;Glandular and luminal cells: 57.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 44: Endometrium - Transcription"																					0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.2	0.0	0.2	4.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.1	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	57.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
CLDN23	CLDNL	ENSG00000253958	"Claudin 23"	Q96B33	8	8701937-8704096	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 16.4;stomach 1: 15.6"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 418.8;Paneth cells: 449.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"myeloid DC: 1.3;plasmacytoid DC: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 7.7;Daudi: 6.4;RT4: 6.7;SK-BR-3: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA061306			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Plasma membrane, Cell Junctions"	"HPA061306: "	"unprognostic (1.86e-1)"	"unprognostic (1.53e-1)"	"prognostic favorable (3.46e-4)"	"unprognostic (2.97e-1)"	"unprognostic (8.32e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.44e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.14e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.97e-2)"	"unprognostic (8.25e-3)"	"prognostic favorable (9.65e-8)"	"unprognostic (7.76e-2)"	"unprognostic (3.17e-2)"	"unprognostic (9.59e-2)"	"unprognostic (1.33e-3)"	6.2	1.1	0.3	2.3	0.4	0.1	5.7	0.2	0.3	2.4	2.3	16.4	4.1	1.0	1.9	3.3	1.4	1.2	0.7	0.3	0.3	4.5	10.4	4.7	0.3	0.5	0.4	1.6	4.0	2.1	0.9	1.5	0.4	1.3	6.8	0.1	6.8	1.3	0.5	13.5	10.1	0.3	0.4	1.8	15.6	0.5	0.5	0.1	4.9	0.3	0.3	5.0	2.7	0.6	0.1	2.6	0.0	0.1	0.7	0.1	7.7	1.9	1.5	2.0	3.1	1.5	4.2	6.4	0.0	0.1	0.7	2.5	0.0	0.0	0.2	1.3	0.0	0.0	0.7	0.1	3.5	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.2	3.3	0.0	0.2	1.9	0.3	1.3	0.0	0.0	0.0	0.9	6.7	0.3	0.9	2.6	6.8	0.1	0.7	0.9	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.3	0.0	0.9	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.3	0.3	0.4	0.2	0.3	0.3	0.3	0.5	0.4	0.4	0.4	0.5	0.6	13.0	9.6	3.1	0.3	1.1	0.1	6.6	4.2	2.2	0.1	6.8	3.4	0.7	30.0	6.9	1.8	0.0	19.1	2.8	418.8	7.9	26.9	0.0	6.0	2.5	3.4	7.7	0.0	0.0	10.7	14.9	3.3	59.7	6.7	4.5	0.8	8.2	10.6	16.8	0.0	0.0	49.9	26.4	2.4	1.4	0.0	0.3	4.6	3.6	1.9	1.4	1.1	0.0	0.0	0.0	28.1	449.9	0.4	0.1	3.3	99.1	4.7	10.3	1.1	6.6	1.5	3.2	0.0	0.0	3.9	0.6	9.4	1.3	0.3	55.2	12.2
CLDN3	"C7orf1, CPE-R2, CPETR2, HRVP1, RVP1"	ENSG00000165215	"Claudin 3"	O15551	7	73768997-73770270	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 263.1;thyroid gland: 116.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1839.9;Endometrial ciliated cells: 1221.7;Glandular and luminal cells: 1555.7;Intestinal goblet cells: 1471.3;Paneth cells: 2326.0;Proximal enterocytes: 3162.1;Undifferentiated cells: 1266.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 529.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 230.7;PC-3: 47.6;RPMI-8226: 40.5;SCLC-21H: 58.0;T-47d: 105.4"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.5"	"Region enhanced"	"Detected in many"		"midbrain: 9.7"	HPA014361	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"HPA014361: AB_2668982"	"unprognostic (1.84e-1)"	"unprognostic (4.83e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.27e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.79e-2)"	"unprognostic (8.26e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.28e-3)"	"unprognostic (1.42e-1)"	"prognostic favorable (3.39e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.87e-1)"	"unprognostic (5.18e-2)"	"unprognostic (6.72e-2)"	0.7	0.2	0.2	7.8	0.3	0.2	26.7	4.2	0.3	12.3	37.6	263.1	54.4	7.5	1.4	1.3	29.6	2.2	0.1	1.1	1.2	46.5	40.4	10.7	0.2	1.3	1.9	0.5	96.6	1.5	27.7	1.0	0.6	58.3	17.5	0.4	72.9	8.3	0.1	9.6	169.5	0.8	0.5	0.2	1.4	0.7	0.9	1.0	116.3	0.0	1.2	1.5	0.2	0.2	2.5	3.6	0.0	0.4	0.0	0.0	17.8	0.0	0.0	0.0	0.0	4.2	35.7	0.0	9.9	0.0	0.0	1.0	0.4	0.0	0.0	0.1	4.9	0.0	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	230.7	0.4	1.2	2.1	9.1	47.6	0.1	0.0	40.5	2.1	0.2	58.0	0.7	0.0	33.6	0.0	0.2	105.4	0.0	0.2	0.2	0.6	0.9	0.1	0.2	0.6	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	4.2	0.3	1.1	1.2	1.3	1.9	0.6	0.5	0.9	0.2	1.6	38.5	37.8	0.0	13.2	0.1	60.3	43.7	0.0	0.7	289.9	182.5	0.6	287.4	86.3	126.9	4.2	63.9	5.1	1839.9	9.8	297.5	0.0	1221.7	130.5	10.3	606.1	5.3	0.0	19.1	17.7	4.1	16.8	1555.7	28.0	1.5	0.4	40.5	5.1	0.0	0.0	1471.3	116.0	0.3	0.0	0.3	2.5	9.9	10.6	0.0	2.0	11.8	0.0	0.0	0.0	36.7	2326.0	0.0	4.4	433.2	3162.1	58.6	498.4	10.6	0.0	0.0	20.3	0.1	0.3	2.7	0.0	72.4	17.5	0.0	1266.0	607.3
CLDN4	"CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8"	ENSG00000189143	"Claudin 4"	O14493	7	73799542-73832690	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Cancer-related genes, Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 305.0;urinary bladder: 303.5"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 3149.1;Glandular and luminal cells: 2298.8;Paneth cells: 2081.0;Prostatic glandular cells: 2184.8;Urothelial cells: 8033.4"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"midbrain: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 358.1;BEWO: 395.0;CAPAN-2: 761.4;MCF7: 400.2;OE19: 402.0;PC-3: 495.0;RT4: 340.2;SK-BR-3: 636.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB002610	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"CAB002610: "	"unprognostic (1.14e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.60e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.07e-1)"	"prognostic unfavorable (3.28e-4)"	"unprognostic (2.16e-3)"	"unprognostic (5.11e-1)"	"prognostic favorable (3.46e-10)"	"unprognostic (5.77e-2)"	"unprognostic (1.37e-1)"	"unprognostic (9.38e-2)"	"unprognostic (4.63e-2)"	2.6	0.4	0.1	23.0	0.0	0.2	69.0	0.8	0.3	61.2	4.8	256.3	126.9	26.7	24.4	305.0	75.8	48.9	0.4	0.2	0.0	116.2	4.8	64.0	1.0	0.4	1.5	1.2	116.2	51.9	13.1	36.3	0.3	82.2	123.3	0.3	204.6	39.1	0.5	180.8	190.6	7.3	0.0	0.7	13.3	0.6	0.2	10.7	111.7	0.3	37.5	303.5	105.7	0.0	358.1	4.4	0.0	1.5	0.0	0.4	395.0	3.3	0.2	0.3	0.4	184.9	761.4	0.6	28.0	0.1	2.6	193.3	0.0	0.5	0.4	0.7	0.4	0.2	20.3	127.0	0.1	0.1	0.9	0.0	1.9	0.1	0.4	0.3	0.0	0.2	0.3	0.7	0.0	400.2	0.7	1.9	0.7	402.0	495.0	0.5	6.9	7.6	92.4	340.2	79.5	1.7	0.4	636.8	0.8	21.6	250.9	0.9	0.5	0.9	13.7	3.1	3.5	0.9	0.7	0.7	0.6	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.3	0.2	0.0	0.4	1.5	0.3	0.0	0.2	0.0	5.1	275.7	230.2	0.0	12.2	16.2	3149.1	641.6	31.3	0.4	1255.2	548.4	0.8	287.4	954.3	218.8	0.0	771.7	18.7	1985.0	13.7	1026.1	0.0	1201.7	231.0	41.3	675.5	0.0	0.2	447.1	739.7	27.0	94.8	2298.8	27.3	0.2	0.4	0.5	76.3	0.0	0.1	1266.9	905.3	0.6	8.6	0.0	2.5	29.3	14.2	0.0	15.6	0.8	0.0	0.0	0.0	950.2	2081.0	0.0	2.5	2184.8	1906.1	21.6	635.6	0.0	0.0	0.1	68.2	0.0	0.2	1068.1	54.0	956.1	40.7	0.1	965.1	8033.4
CLDN5	"AWAL, BEC1, CPETRL1, TMVCF"	ENSG00000184113	"Claudin 5"	O00501	22	19523024-19527545	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 439.7;breast: 420.9;lung: 398.7"	"Group enriched"	"Detected in many"	10	"Adipocytes: 2644.3;Endothelial cells: 775.2;Hepatic stellate cells: 701.4"	"Cancer enriched"	"Detected in all"	4	"glioma: 32.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 18.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 18.8"	"Group enriched"	"Detected in some"	10	"HUVEC TERT2: 85.4;SCLC-21H: 53.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB002607	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB002607: "	"unprognostic (1.26e-1)"	"unprognostic (2.05e-3)"	"unprognostic (1.77e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.33e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.29e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.96e-2)"	439.7	16.2	124.1	6.1	101.0	0.3	420.9	111.7	127.4	70.2	205.2	75.9	9.2	86.1	3.0	54.4	83.1	6.5	138.3	93.8	103.3	45.5	16.9	398.7	9.6	124.5	114.0	36.4	20.7	1.5	16.9	12.5	127.8	50.2	3.6	2.0	36.0	3.5	101.6	95.9	71.0	6.4	109.2	44.8	41.4	10.5	160.7	1.8	122.5	14.9	2.2	103.7	75.9	107.4	0.1	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.1	0.1	0.2	1.1	0.0	0.0	0.0	0.0	85.4	0.1	0.7	0.2	0.1	0.0	0.1	0.5	0.2	0.0	0.2	0.9	0.7	0.1	0.0	0.0	53.0	0.3	0.0	0.0	0.0	0.0	0.4	0.2	7.1	0.1	1.1	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2	18.8	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.2	4.6	0.2	5.8	0.0	0.1	0.1	0.0	26.9	124.1	101.0	111.7	127.4	93.8	103.3	124.5	114.0	127.8	109.2	160.7	107.4	2644.3	3.2	7.7	0.7	2.4	32.4	1.1	0.1	3.4	1.8	5.9	7.6	14.8	2.8	0.6	7.3	0.0	0.3	4.2	0.0	0.0	0.7	5.0	8.1	0.7	775.2	2.4	8.0	0.0	0.8	0.1	12.5	0.0	1.0	1.3	0.3	701.4	2.7	0.8	0.0	0.1	0.2	4.1	17.0	33.3	5.5	5.3	46.2	14.2	129.3	0.7	2.4	1.0	0.5	0.3	0.0	0.0	0.7	2.8	4.0	0.0	0.0	0.3	7.3	0.0	61.7	12.1	1.1	1.9	1.2	30.5	0.0	4.6	25.0	0.0	6.7
CLDN7	"CEPTRL2, CPETRL2, Hs.84359"	ENSG00000181885	"Claudin 7"	O95471	17	7259903-7263983	"Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 341.3;intestine: 341.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 1391.1;Pancreatic endocrine cells: 822.1;Paneth cells: 1276.4;Proximal enterocytes: 1390.9;Urothelial cells: 975.8"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 84.1;CACO-2: 90.2;CAPAN-2: 173.2;HaCaT: 364.9;MCF7: 129.8;OE19: 139.6;SK-BR-3: 150.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB013063, HPA014703, HPA073662"	Enhanced		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles	"Cell Junctions"	"CAB013063: , HPA014703: AB_1846873, HPA073662: "	"unprognostic (5.47e-2)"	"unprognostic (2.22e-1)"	"unprognostic (4.12e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.67e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.98e-2)"	"unprognostic (5.64e-3)"	"unprognostic (8.34e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.62e-2)"	"prognostic favorable (8.96e-11)"	"prognostic favorable (4.09e-4)"	"unprognostic (1.87e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (1.62e-1)"	6.7	8.0	0.4	17.6	0.4	0.2	31.2	0.5	0.6	47.3	0.4	341.0	146.7	4.8	43.9	341.3	41.3	27.4	2.7	0.4	0.4	123.8	40.2	61.8	0.8	0.6	0.5	1.5	108.5	49.0	31.1	14.2	0.6	44.5	128.6	1.1	169.2	30.0	1.5	13.1	248.9	6.2	0.5	5.7	5.2	1.9	0.6	2.4	76.7	0.0	21.2	40.5	96.3	0.9	10.8	1.1	0.2	0.3	0.0	0.6	84.1	0.3	0.3	0.0	0.0	90.2	173.2	0.1	3.2	0.4	0.4	364.9	0.1	11.2	0.0	0.1	1.9	0.1	2.4	0.0	6.5	0.1	0.8	1.5	17.3	0.0	0.6	0.0	8.1	0.1	1.0	0.3	0.1	129.8	0.1	1.2	0.6	139.6	3.4	0.2	0.0	2.5	0.1	0.0	20.4	0.4	1.1	150.2	0.0	6.6	55.0	1.3	16.8	0.2	0.6	0.7	0.2	0.1	0.3	0.1	1.2	0.0	0.3	0.0	0.3	0.0	0.5	0.8	1.3	0.1	0.3	0.8	0.4	0.9	0.9	1.7	0.0	0.7	0.0	0.0	0.3	0.5	0.4	0.4	0.5	0.6	0.4	0.4	0.6	0.5	0.6	0.5	0.6	0.9	4.4	112.2	55.6	0.0	7.4	2.0	295.4	316.3	66.6	0.7	200.4	102.4	0.6	240.2	550.3	321.8	8.4	281.3	3.1	1391.1	39.2	787.5	0.1	210.1	26.6	9.0	326.8	4.0	0.0	790.0	342.7	5.2	15.3	225.5	5.7	0.1	3.6	41.2	33.7	0.0	0.0	741.7	362.2	4.1	6.4	0.2	1.2	11.0	24.9	1.9	11.0	1.6	0.0	0.0	0.0	822.1	1276.4	0.0	0.5	406.5	1390.9	78.6	498.5	6.7	0.0	0.2	38.6	0.4	3.5	366.1	2.6	588.9	10.2	1.0	691.9	975.8
CLDN8		ENSG00000156284	"Claudin 8"	P56748	21	30214006-30216097	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 68.9;intestine: 50.8;kidney: 69.3;salivary gland: 40.1"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 224.3;Distal enterocytes: 110.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 31.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	18	"HaCaT: 33.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060605	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA060605: AB_2684331"	"unprognostic (3.74e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.02e-1)"		"unprognostic (3.04e-2)"		"unprognostic (1.17e-1)"		"unprognostic (1.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.52e-1)"	"prognostic favorable (3.32e-4)"			"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	0.1	0.0	0.0	0.0	0.0	0.0	68.9	0.0	0.0	1.7	0.0	27.2	0.0	0.1	9.3	3.9	1.1	0.0	0.0	0.0	0.0	69.3	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.5	0.0	7.5	50.8	0.0	40.1	13.9	0.0	8.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	21.9	0.0	0.3	0.4	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.0	10.8	2.7	0.0	0.0	29.9	11.6	0.0	0.0	10.5	224.3	0.0	0.0	0.1	110.2	11.7	0.1	0.0	0.8	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.3	22.4	0.0	0.3	0.0	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.0	15.9	0.6	0.4	20.3	0.0	0.0	0.0	0.3	0.0	0.0	4.6	8.4	0.0	0.4	0.0	18.0	23.1
CLDND1	"C3orf4, Z38"	ENSG00000080822	"Claudin domain containing 1"	Q9NY35	3	98497912-98523066	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"brain: 1093.8;choroid plexus: 316.7"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 575.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029841	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 70: Brain - Nervous system development"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA029841: AB_10600658"	"unprognostic (1.64e-1)"	"unprognostic (3.63e-1)"	"unprognostic (3.13e-2)"	"unprognostic (8.50e-2)"	"unprognostic (9.15e-2)"	"unprognostic (7.30e-2)"	"unprognostic (2.43e-3)"	"unprognostic (4.08e-2)"	"unprognostic (3.65e-2)"	"unprognostic (8.30e-3)"	"unprognostic (1.21e-1)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.84e-6)"	"unprognostic (5.73e-3)"	"unprognostic (6.54e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.51e-1)"	53.6	42.6	477.0	40.7	757.5	49.1	48.8	696.1	804.5	59.0	316.7	58.3	36.5	58.8	43.1	77.8	46.7	50.6	57.6	483.5	577.6	39.2	50.0	46.9	54.7	851.3	670.8	63.9	23.6	32.6	28.2	73.8	837.8	49.5	46.9	46.5	29.8	51.9	43.6	64.8	42.2	63.5	643.7	44.0	37.4	106.6	638.3	44.7	40.5	68.9	54.9	64.0	65.8	1093.8	67.3	26.2	83.2	50.7	96.0	75.0	44.6	52.0	69.8	71.0	97.8	52.7	66.9	33.7	69.1	49.4	134.3	90.4	61.6	39.9	124.3	79.3	27.5	68.3	18.6	48.1	76.2	62.7	67.3	88.4	207.6	54.0	58.7	77.6	79.1	64.7	35.4	100.6	102.9	33.4	47.8	42.8	75.1	28.7	55.9	31.9	110.6	43.4	67.7	30.0	30.1	82.6	74.6	24.4	108.5	110.5	24.5	52.8	75.1	94.6	86.2	65.3	69.3	130.8	59.8	53.9	154.9	61.0	125.2	179.8	91.0	103.9	102.1	55.4	193.5	101.5	190.3	187.1	98.9	99.3	76.6	78.1	70.2	274.0	56.7	63.9	399.7	155.1	477.0	757.5	696.1	804.5	483.5	577.6	851.3	670.8	837.8	643.7	638.3	1093.8	83.3	35.3	36.6	17.9	72.1	144.0	131.7	122.3	87.0	20.1	43.6	45.3	53.8	17.2	71.4	27.6	25.0	52.0	72.8	16.9	29.4	21.2	105.3	21.1	47.7	70.8	28.7	65.4	25.1	16.2	160.6	86.6	30.1	41.7	36.8	25.2	61.4	19.4	35.6	15.2	23.6	19.6	89.5	29.2	168.1	76.7	51.6	46.9	113.8	20.6	42.3	28.1	38.1	30.7	575.2	30.3	16.8	46.6	131.7	98.1	34.6	23.3	27.5	35.0	52.6	53.2	128.4	182.4	55.3	90.1	196.5	95.8	147.1	22.8	17.5	121.9
CLIC1	"CLCNL1, G6, NCC27, p64CLCP"	ENSG00000213719	"Chloride intracellular channel 1"	O00299	6	31730581-31739763	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020825, CAB040557"	Enhanced		Supported	Cytosol		NA	NA		22000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"CAB020825: , CAB040557: "	"unprognostic (7.26e-2)"	"unprognostic (9.32e-2)"	"unprognostic (2.78e-3)"	"unprognostic (7.29e-2)"	"unprognostic (6.93e-2)"	"unprognostic (2.73e-2)"	"prognostic unfavorable (8.90e-7)"	"unprognostic (2.58e-2)"	"unprognostic (8.51e-2)"	"unprognostic (8.71e-3)"	"unprognostic (1.19e-3)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (8.11e-5)"	"unprognostic (4.51e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.35e-2)"	"unprognostic (7.31e-2)"	292.8	156.5	6.9	43.4	6.8	64.0	256.7	7.1	11.0	222.2	8.7	291.6	37.0	197.9	20.9	395.9	190.5	43.7	183.7	6.7	10.2	318.5	102.6	330.4	44.1	9.4	7.7	149.8	148.1	20.1	111.5	45.5	8.9	217.0	64.0	2.6	251.3	22.3	47.3	324.8	231.6	32.7	8.9	332.6	247.8	41.0	9.6	35.2	180.8	11.1	58.1	257.7	246.8	8.9	119.5	54.1	87.0	45.6	56.6	118.6	43.3	52.8	105.4	92.6	77.9	125.2	87.2	48.7	73.6	186.0	116.9	70.2	65.8	154.9	124.4	38.9	34.4	93.0	43.4	109.3	73.0	164.3	125.9	74.3	80.5	157.0	148.4	101.7	157.9	44.6	109.4	149.5	181.0	79.2	77.2	213.2	7.7	128.9	78.4	13.5	47.5	115.3	210.2	73.0	16.5	19.5	43.1	49.1	71.5	60.4	33.7	228.3	105.0	128.6	91.2	39.0	166.8	48.3	98.3	66.0	62.4	122.0	136.6	244.3	179.4	239.3	165.6	194.3	135.8	186.1	98.0	155.5	143.8	150.3	30.5	92.3	341.1	176.3	174.3	80.5	149.2	414.2	6.9	6.8	7.1	11.0	6.7	10.2	9.4	7.7	8.9	8.9	9.6	8.9	514.8	70.5	67.0	0.7	382.5	960.8	589.1	869.7	331.2	0.4	274.3	300.5	18.6	296.0	457.7	237.3	0.0	545.5	472.2	730.7	602.6	1096.2	31.8	271.1	212.7	490.1	381.4	208.6	0.0	1008.9	912.5	296.6	370.5	301.3	554.1	431.2	300.9	54.2	1047.6	0.0	0.0	665.6	516.8	533.7	1529.8	17.3	233.9	685.7	524.7	13.1	426.4	86.8	706.5	0.5	0.0	1470.4	997.1	188.1	420.2	851.1	707.7	572.1	473.6	6.9	203.8	136.1	554.0	28.7	16.2	464.1	928.0	572.7	522.2	283.3	675.0	1005.9
CLIC2	"CLCNL2, XAP121"	ENSG00000155962	"Chloride intracellular channel 2"	O15247	X	155276211-155334657	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 51.2;Alveolar cells type 1: 89.8;Alveolar cells type 2: 54.9;Endothelial cells: 60.4;Erythroid cells: 70.7;Kupffer cells: 73.5;Langerhans cells: 135.0;monocytes: 71.4"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 18.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"intermediate monocyte: 18.6;myeloid DC: 47.9;non-classical monocyte: 14.2"	"Group enriched"	"Detected in many"	16	"dendritic cells: 47.9;monocytes: 18.6"	"Group enriched"	"Detected in some"	5	"HDLM-2: 103.3;K-562: 60.4;Karpas-707: 53.4;RPMI-8226: 92.2"					"Low region specificity"	"Detected in all"			"HPA047381, HPA060101"	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		150000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA047381: AB_2680022, HPA060101: AB_2684204"	"unprognostic (3.27e-2)"	"unprognostic (5.21e-3)"	"unprognostic (9.70e-2)"	"unprognostic (7.25e-2)"	"unprognostic (9.71e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.31e-1)"	"prognostic unfavorable (1.74e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.97e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.54e-1)"	23.1	7.1	6.9	16.7	7.8	9.8	16.7	6.9	18.1	20.1	7.6	10.9	8.7	22.6	7.8	9.4	12.5	19.0	14.6	7.1	7.0	5.8	12.8	30.6	30.2	7.7	6.9	21.6	3.5	4.6	4.5	9.3	7.4	4.6	13.6	2.4	6.2	6.3	4.4	6.1	10.3	17.7	7.7	50.1	8.5	3.2	8.5	14.5	31.8	14.3	25.6	15.9	10.7	7.8	0.7	0.0	1.0	0.9	1.0	4.7	0.0	0.2	2.8	0.0	0.4	0.0	0.2	0.1	0.4	0.0	0.2	0.1	0.3	0.0	0.0	103.3	0.5	16.4	0.3	0.0	0.0	0.4	0.6	1.4	0.0	0.0	0.1	0.5	0.1	0.5	60.4	53.4	0.3	0.2	0.1	1.3	0.2	0.1	0.4	0.4	0.0	92.2	0.2	0.2	0.7	0.9	0.0	0.1	0.4	0.2	0.0	1.0	0.0	5.3	1.6	2.0	0.9	3.3	4.6	0.0	2.7	2.6	1.7	0.0	3.5	0.2	0.0	18.6	0.3	0.0	0.1	0.1	47.9	0.0	0.0	0.0	1.4	2.0	14.2	5.2	0.0	2.1	6.9	7.8	6.9	18.1	7.1	7.0	7.7	6.9	7.4	7.7	8.5	7.8	51.2	89.8	54.9	3.9	1.1	13.3	0.8	0.2	2.2	1.2	0.7	1.3	3.2	0.0	5.8	0.0	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.5	11.3	60.4	1.2	70.7	8.6	0.2	0.1	25.6	0.5	0.4	3.8	0.5	27.1	1.2	4.7	0.0	7.0	0.6	0.0	73.5	135.0	1.1	13.7	34.5	17.8	8.4	71.4	0.2	0.0	3.0	2.4	0.1	0.0	9.4	2.0	0.5	0.0	0.6	1.5	0.3	6.6	2.5	4.6	0.3	0.3	0.4	13.8	0.0	2.6	5.2	0.1	1.9
CLIC3		ENSG00000169583	"Chloride intracellular channel 3"	O95833	9	136994608-136996568	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 317.0;skin 1: 122.0;thyroid gland: 109.6;vagina: 132.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 811.8;dendritic cells: 456.0;Extravillous trophoblasts: 1219.2;NK-cells: 541.7;Syncytiotrophoblasts: 2039.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 130.8"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in many"	9	"plasmacytoid DC: 2635.7"	"Lineage enriched"	"Detected in all"	9	"dendritic cells: 2635.7"	"Cell line enhanced"	"Detected in many"		"BEWO: 350.3;MCF7: 168.1;SK-BR-3: 65.0;T-47d: 147.2;TIME: 118.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA005963	Enhanced		Supported	"Nuclear bodies"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nuclear bodies"		"HPA005963: AB_1078536"	"unprognostic (4.30e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.55e-2)"	"unprognostic (5.42e-3)"	"unprognostic (1.85e-1)"	"unprognostic (6.79e-2)"	"unprognostic (5.82e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.26e-3)"	"unprognostic (7.73e-3)"	"unprognostic (1.15e-1)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.95e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (7.74e-4)"	8.6	0.6	0.9	1.3	1.0	4.0	2.6	1.3	1.6	75.0	1.4	1.3	0.3	1.8	4.6	317.0	1.7	0.8	8.6	0.7	1.0	1.0	1.0	38.6	4.1	1.3	0.9	0.6	0.6	0.2	2.4	41.6	1.0	3.0	0.2	0.0	37.7	1.1	1.0	122.0	1.7	0.3	0.8	6.9	7.5	0.7	1.0	7.6	109.6	1.2	20.5	2.1	132.2	1.2	28.8	0.0	0.0	0.0	0.5	1.4	350.3	2.7	1.5	1.0	0.4	3.7	14.0	0.1	22.5	24.3	0.1	12.5	0.0	1.2	0.0	0.0	0.2	0.0	20.7	4.5	3.9	0.0	0.0	1.0	0.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.1	0.1	0.2	0.1	58.4	5.8	0.0	0.5	0.0	0.0	0.0	0.8	0.0	45.9	65.0	0.0	0.0	147.2	0.0	118.4	0.0	4.1	2.5	0.1	0.0	0.0	0.1	0.5	0.0	0.0	2.9	0.8	2.6	232.3	2.1	99.3	2.6	32.0	143.8	9.4	5.5	6.9	120.4	10.3	283.2	2.3	2635.7	11.5	168.3	0.9	1.0	1.3	1.6	0.7	1.0	1.3	0.9	1.0	0.8	1.0	1.2	11.5	214.7	42.0	0.0	11.6	3.8	3.6	86.6	8.0	0.0	7.3	20.6	3.2	2.8	95.2	1.8	0.0	811.8	456.0	25.2	9.8	1.8	1.7	16.7	2.3	13.4	4.9	5.3	0.0	6.4	1219.2	27.0	22.4	14.4	1.3	1.8	3.6	1.1	91.6	0.0	0.0	5.6	4.1	2.2	5.9	7.8	125.6	8.5	10.6	1.9	4.9	0.0	541.7	0.0	0.0	84.6	10.4	41.8	23.7	4.5	0.7	0.4	12.0	0.0	0.0	0.2	4.4	0.0	1.0	70.2	19.5	2039.4	78.4	1.0	5.2	18.1
CLIC4	"CLIC4L, DKFZP566G223, H1, huH1, P64H1"	ENSG00000169504	"Chloride intracellular channel 4"	Q9Y696	1	24745382-24844321	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal tubular cells: 346.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 13.4;naive B-cell: 11.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008019, HPA060804"	Enhanced		Supported	"Plasma membrane,Centrosome"		NA	NA		5800000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Centrosome"		"HPA008019: AB_1846946, HPA060804: AB_2684370"	"unprognostic (7.35e-3)"	"prognostic unfavorable (8.31e-4)"	"unprognostic (5.54e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.92e-2)"	"unprognostic (9.48e-2)"	"unprognostic (6.78e-3)"	"unprognostic (1.63e-2)"	"unprognostic (5.50e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.98e-2)"	"unprognostic (7.01e-2)"	"prognostic favorable (1.48e-5)"	"unprognostic (2.75e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.22e-2)"	"unprognostic (3.82e-3)"	154.0	58.6	51.8	97.7	70.2	32.3	88.1	61.8	82.7	165.4	39.4	136.3	32.4	201.5	84.6	119.3	103.0	106.5	197.2	50.8	66.5	256.8	72.3	114.6	51.0	73.6	68.0	46.0	49.7	29.3	14.1	120.6	67.0	112.8	66.8	53.1	49.4	152.8	30.7	33.6	54.2	280.4	62.4	43.1	80.0	34.2	88.9	59.6	47.6	53.2	56.4	156.1	73.4	91.4	219.3	25.3	222.7	176.8	299.1	645.6	116.7	561.0	571.4	253.9	304.2	48.3	114.1	129.8	320.1	799.2	77.0	76.8	155.0	151.5	635.7	33.3	64.9	50.0	60.8	88.3	417.3	17.5	6.3	299.3	256.8	363.0	365.1	417.3	427.0	76.0	40.4	138.2	739.0	38.4	34.8	28.5	212.6	50.4	101.8	83.5	247.3	51.5	260.0	58.4	38.9	101.3	144.7	68.4	453.7	228.3	60.0	116.1	601.0	452.2	168.8	199.4	230.1	75.4	111.7	108.6	333.8	151.1	140.5	0.8	5.4	2.5	0.4	4.4	0.0	13.4	0.3	0.2	5.6	11.9	0.1	0.2	1.2	0.0	4.0	1.7	0.0	3.5	51.8	70.2	61.8	82.7	50.8	66.5	73.6	68.0	67.0	62.4	88.9	91.4	178.7	16.0	30.5	24.8	50.8	61.6	50.4	79.8	37.0	3.7	49.9	33.0	172.5	21.5	35.2	14.7	10.4	71.5	2.2	18.1	41.1	39.2	44.9	20.9	103.0	177.1	9.6	40.8	1.5	43.1	211.4	120.5	21.4	53.6	40.0	10.2	88.5	34.4	39.3	1.7	4.2	22.6	20.3	28.2	100.2	27.3	28.6	52.6	129.9	75.9	50.8	13.0	4.1	41.7	196.9	54.7	10.6	87.6	171.2	114.5	0.1	346.1	16.7	26.5	46.0	87.9	162.5	44.0	29.1	29.3	52.0	177.0	8.1	46.5	2.6	49.1
CLIC5	DFNB102	ENSG00000112782	"Chloride intracellular channel 5"	Q9NZA1	6	45880827-46080348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Hearing, Ion transport, Sensory transduction, Transport, Vision"	"Chloride channel, Ion channel, Voltage-gated channel"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 102.7;skeletal muscle: 289.7;tongue: 98.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 509.6;Cardiomyocytes: 285.7;Distal enterocytes: 164.2;Late spermatids: 93.8;Proximal enterocytes: 126.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 11.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 5.1"	"Lineage enriched"	"Detected in single"	17	"T-cells: 5.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;EFO-21: 9.2;HDLM-2: 4.7;REH: 11.9;U-266/70: 12.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074371			Supported	"Nuclear speckles,Plasma membrane"		NA	NA		400000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Nuclear speckles"	"HPA074371: "	"unprognostic (4.95e-2)"	"unprognostic (1.59e-2)"	"unprognostic (8.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (2.44e-1)"	"unprognostic (6.73e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.79e-1)"	"unprognostic (6.46e-2)"	"unprognostic (5.50e-2)"	"unprognostic (3.65e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.01e-1)"	18.9	1.5	3.2	4.3	4.4	0.2	6.5	1.5	2.9	19.0	0.5	28.6	20.9	2.1	0.9	2.9	4.5	3.0	102.7	2.1	5.0	54.7	0.3	70.8	1.7	2.1	3.8	0.5	1.1	1.7	3.0	16.5	2.2	2.6	25.8	16.9	2.7	1.4	289.7	1.2	36.6	2.3	1.8	44.5	1.6	1.4	5.5	1.0	7.3	98.3	1.9	2.0	2.6	1.9	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	13.5	0.0	9.2	0.0	0.0	0.3	0.0	0.1	0.0	4.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.0	0.0	0.1	0.4	1.6	0.0	11.9	0.3	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.4	0.1	0.0	12.8	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	1.5	0.0	5.1	0.1	2.0	1.3	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.0	1.0	0.5	3.2	4.4	1.5	2.9	2.1	5.0	2.1	3.8	2.2	1.8	5.5	1.9	59.6	509.6	30.0	4.6	1.4	0.1	0.1	0.0	1.2	0.3	0.5	0.4	285.7	5.7	26.9	14.7	0.0	0.2	0.7	164.2	0.0	1.7	52.9	4.6	0.5	29.8	13.1	0.4	8.6	0.2	0.1	7.9	0.5	5.7	1.3	0.0	0.7	0.0	0.0	0.0	5.4	23.5	0.0	0.0	0.0	93.8	0.9	0.7	0.0	34.7	0.6	53.8	0.0	0.5	2.9	2.9	51.1	0.7	3.4	3.2	126.0	2.9	11.4	1.8	0.0	6.1	4.3	1.0	0.1	0.1	0.1	2.2	5.8	0.1	13.5	4.3
CLIC6	"CLIC1L, CLIC5"	ENSG00000159212	"Chloride intracellular channel 6"	Q96NY7	21	34668994-34718227	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"choroid plexus: 235.9;stomach 1: 138.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 30.0;Club cells: 41.6;Gastric mucus-secreting cells: 26.5;Respiratory ciliated cells: 81.1;Skeletal myocytes: 24.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 2.6;NTERA-2: 3.6;T-47d: 7.3;THP-1: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065285	Enhanced					NA	NA		180000		"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 49: Ciliated cells - Cilium organization"			"HPA065285: AB_2685454"	"prognostic favorable (6.11e-5)"	"unprognostic (2.17e-2)"	"unprognostic (1.65e-2)"	"unprognostic (4.27e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.78e-2)"	"prognostic favorable (3.15e-5)"	"unprognostic (4.90e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.52e-2)"	"unprognostic (3.26e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.43e-3)"	11.4	0.1	1.2	4.3	0.7	0.1	11.9	2.4	1.0	15.8	235.9	4.0	2.0	2.1	2.7	2.6	11.4	8.8	11.1	11.3	0.7	2.6	0.9	9.8	1.2	3.0	4.5	4.9	3.2	28.3	3.3	0.1	2.6	9.8	2.9	0.2	25.4	7.0	1.6	6.0	3.1	0.7	1.3	1.0	138.5	0.3	4.4	8.4	13.2	4.3	3.8	12.9	5.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.6	0.6	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.6	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.9	7.3	3.4	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.7	2.4	1.0	11.3	0.7	3.0	4.5	2.6	1.3	4.4	0.7	0.3	6.4	20.7	1.3	0.0	0.6	5.1	7.3	4.0	0.0	15.6	11.0	11.4	30.0	41.6	9.2	0.0	0.0	0.2	2.2	1.9	8.0	0.1	15.1	0.3	0.4	4.9	0.0	0.3	0.9	0.0	3.7	26.5	2.2	1.3	11.8	0.0	0.0	0.1	0.0	0.6	1.4	16.2	0.0	0.4	0.3	0.3	0.4	7.2	0.0	0.6	0.0	0.0	0.0	0.1	17.2	0.6	3.0	0.4	10.2	0.1	0.2	81.1	0.0	0.0	24.0	2.4	0.2	0.2	0.6	0.4	0.0	0.4	0.0	2.8	20.4
CLINT1	"CLINT, ENTH, EPNR, KIAA0171"	ENSG00000113282	"Clathrin interactor 1"	Q14677	5	157785743-157859145	"Plasma proteins, Predicted intracellular proteins, Transporters"	Endocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"basophil: 749.5"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 749.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043280, HPA056947"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA		540000	"Cluster 46: Basophils - DNA binding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	Nucleoplasm	"HPA043280: AB_10793944, HPA056947: AB_2683283"	"unprognostic (1.92e-2)"	"unprognostic (6.93e-2)"	"prognostic favorable (2.95e-4)"	"unprognostic (7.23e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.53e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.04e-1)"	"prognostic favorable (8.88e-5)"	"unprognostic (1.91e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (6.77e-4)"	"unprognostic (3.56e-1)"	28.6	34.4	10.3	42.8	11.9	101.1	31.4	10.6	14.8	36.4	17.7	53.9	68.3	26.4	54.2	72.0	37.8	61.4	34.2	11.8	12.7	70.4	89.5	36.3	49.4	11.8	11.9	26.9	49.3	113.2	17.8	47.1	11.4	29.5	53.4	16.0	50.8	42.4	53.1	39.7	55.7	31.9	11.0	31.0	69.2	20.3	12.4	50.7	56.0	41.0	73.8	64.5	38.8	11.4	65.6	91.7	64.3	59.8	86.3	71.0	91.6	89.7	87.5	83.4	115.9	128.7	100.0	121.3	100.3	82.6	112.0	95.8	87.1	100.4	120.7	57.9	70.4	80.6	80.4	65.2	85.5	112.9	105.6	52.5	75.6	94.7	105.6	53.6	80.0	69.6	70.6	66.1	69.9	56.7	88.7	60.5	67.8	63.6	93.9	78.8	96.9	103.0	84.8	115.4	56.6	62.1	64.5	111.7	87.4	81.2	76.4	78.0	83.7	74.6	56.3	69.5	89.4	76.1	77.9	154.4	61.0	126.2	67.5	749.5	46.5	179.7	43.6	49.2	75.2	47.5	41.4	43.7	62.7	46.2	35.9	38.8	17.6	58.6	53.4	48.5	66.2	53.1	10.3	11.9	10.6	14.8	11.8	12.7	11.8	11.9	11.4	11.0	12.4	11.4	68.6	60.9	132.9	25.1	76.0	57.1	83.7	69.4	80.2	21.6	74.4	44.2	103.9	105.8	137.8	68.0	8.4	45.1	73.8	73.5	95.9	93.4	4.1	116.5	82.4	52.8	54.5	54.9	31.9	64.0	71.9	71.8	119.3	141.9	84.7	40.2	21.0	86.8	30.5	11.8	29.0	78.9	38.7	42.9	87.8	5.6	47.2	73.0	35.6	28.1	94.1	25.5	73.2	39.2	31.4	53.7	62.6	28.6	158.3	92.5	50.3	94.5	148.5	19.0	39.5	67.2	61.9	44.2	40.2	156.3	78.3	68.3	65.5	82.0	99.0	271.5
CLN3	"BTN1, BTS, JNCL"	ENSG00000188603	"CLN3 lysosomal/endosomal transmembrane protein, battenin"	Q13286	16	28474111-28495575	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 315.9;Extravillous trophoblasts: 106.9;Syncytiotrophoblasts: 451.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 178.0;SK-BR-3: 186.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063280	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA063280: AB_2684975"	"unprognostic (2.38e-3)"	"unprognostic (2.41e-2)"	"unprognostic (7.06e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.36e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.38e-3)"	"unprognostic (8.16e-2)"	"unprognostic (6.27e-2)"	"unprognostic (5.26e-1)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.05e-2)"	18.1	30.5	13.1	19.6	14.2	13.4	21.4	14.2	16.0	16.9	16.5	38.3	21.9	15.9	9.9	22.2	16.0	15.2	11.7	13.2	13.6	21.2	31.9	23.6	13.8	14.6	13.6	16.8	27.7	30.0	8.2	36.9	15.1	17.3	29.2	3.1	34.5	21.0	14.5	24.1	25.7	13.3	13.5	20.4	26.1	7.9	15.6	14.0	24.7	13.8	12.1	19.3	15.6	17.1	23.1	39.2	15.4	38.4	41.1	19.9	178.0	14.8	40.7	28.3	34.9	19.7	52.9	16.0	45.8	24.8	52.0	23.5	25.8	24.7	12.9	38.0	38.5	15.6	24.1	60.6	60.5	23.3	64.7	28.0	66.8	21.9	14.7	26.3	32.9	24.9	30.9	55.0	28.8	61.9	20.7	45.1	21.8	35.3	26.0	37.2	13.4	54.5	30.2	53.0	20.8	19.6	5.7	186.5	18.3	14.0	62.2	32.4	20.2	19.2	10.1	24.9	22.5	58.3	64.2	15.9	28.4	47.3	11.9	63.4	59.8	98.4	57.6	47.6	42.7	24.3	43.6	53.6	63.8	29.3	38.3	40.6	23.8	41.2	38.7	68.1	53.5	46.6	13.1	14.2	14.2	16.0	13.2	13.6	14.6	13.6	15.1	13.5	15.6	17.1	1.2	22.4	15.9	11.1	10.8	0.1	17.2	0.0	23.9	10.9	1.7	0.6	0.0	38.6	6.2	1.8	12.5	315.9	25.8	46.4	0.0	2.2	1.1	1.8	1.3	11.2	17.0	17.5	7.5	0.5	106.9	9.3	20.9	2.6	2.5	7.6	21.0	39.0	70.1	13.5	8.1	39.3	0.0	36.7	0.4	2.5	19.0	17.7	0.0	2.8	17.5	25.0	40.2	7.1	11.4	1.5	43.7	12.4	13.1	10.6	53.1	0.8	1.5	12.1	13.1	9.9	3.5	3.2	8.4	17.1	0.1	451.4	15.9	3.6	50.2	13.3
CLN6	"FLJ20561, HsT18960, nclf"	ENSG00000128973	"CLN6 transmembrane ER protein"	Q9NWW5	15	68206992-68257211	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 181.8;Hofbauer cells: 88.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066046, HPA066759"	Approved		Approved	"Nucleoli,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 20: HeLa - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"	"Endoplasmic reticulum"	"Nucleoli, Vesicles"	"HPA066046: AB_2685604, HPA066759: "	"unprognostic (1.01e-1)"	"unprognostic (1.54e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.58e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.07e-2)"	"unprognostic (2.40e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (4.87e-4)"	"unprognostic (1.22e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.78e-2)"	11.6	17.6	12.7	14.8	13.0	29.9	11.5	13.3	14.9	11.0	13.2	17.5	14.6	9.8	6.8	16.9	9.8	9.6	9.3	12.1	12.6	20.0	22.7	13.2	16.2	13.3	13.1	6.8	19.1	10.4	10.1	11.6	13.8	12.4	14.9	11.8	14.8	9.2	17.0	14.7	14.6	10.4	12.8	20.7	13.3	10.9	13.0	11.6	12.9	7.3	16.7	10.7	9.6	14.5	38.2	93.1	23.9	33.9	14.5	11.8	57.1	35.3	17.0	42.8	34.9	72.1	60.5	57.6	17.2	21.4	31.7	69.5	69.8	34.5	17.0	38.5	82.3	84.3	66.1	54.3	29.7	95.6	58.1	20.8	11.4	34.7	23.7	9.0	29.1	33.1	56.9	116.0	33.6	103.8	44.0	69.4	57.1	67.3	38.3	42.1	71.8	80.6	36.2	97.0	48.2	20.0	39.5	61.7	34.3	18.0	33.1	95.5	19.3	48.1	55.7	35.8	127.2	81.3	97.3	47.4	30.0	115.4	47.6	0.0	8.8	0.6	3.0	13.0	4.0	2.9	2.2	4.3	5.2	2.3	2.8	1.3	10.5	2.0	16.1	4.4	2.3	3.5	12.7	13.0	13.3	14.9	12.1	12.6	13.3	13.1	13.8	12.8	13.0	14.5	1.4	9.6	6.9	7.2	13.4	20.1	22.0	13.9	14.8	181.8	2.0	1.9	27.4	10.0	9.6	5.5	16.7	42.8	7.1	22.7	0.0	3.3	0.4	1.0	4.8	9.7	15.1	32.8	8.9	1.8	58.4	9.1	8.2	1.4	8.9	5.6	11.0	21.9	88.4	21.9	8.1	20.5	16.2	24.2	14.0	1.4	9.0	11.3	19.6	8.4	12.9	16.9	11.3	5.0	10.2	3.6	26.0	8.2	33.4	23.7	15.6	2.1	3.3	32.7	6.6	7.5	5.6	1.0	19.5	21.1	14.1	21.8	9.5	5.3	35.6	16.3
CLNS1A	"CLCI, ICln"	ENSG00000074201	"Chloride nucleotide-sensitive channel 1A"	P54105	11	77514936-77637794	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017840, HPA031707, HPA031708, HPA032045"	Approved		Supported	Nucleoplasm,Microtubules,Cytosol		No	No		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 32: Non-specific - Translation"	Cytosol	"Nucleoplasm, Microtubules"	"CAB017840: , HPA031707: AB_2674002, HPA031708: AB_2674003, HPA032045: AB_2674123"	"unprognostic (1.30e-1)"	"unprognostic (3.26e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.30e-2)"	"unprognostic (5.12e-3)"	"unprognostic (5.09e-2)"	"unprognostic (9.63e-2)"	"unprognostic (5.56e-2)"	"unprognostic (2.06e-3)"	"unprognostic (5.56e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (2.05e-1)"	"unprognostic (9.19e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	53.1	88.7	86.1	63.1	91.8	72.3	79.9	89.3	92.7	62.2	82.0	72.7	49.7	63.5	99.6	85.3	74.8	53.2	76.4	79.9	94.1	59.6	105.6	45.7	99.5	88.0	86.6	103.3	90.0	60.2	54.0	65.6	89.8	61.2	77.5	97.0	58.2	57.5	98.4	54.0	53.6	56.8	90.5	61.9	65.7	45.7	87.9	102.8	79.0	100.7	105.4	74.6	61.0	94.8	138.4	134.7	216.6	160.7	157.1	224.8	86.8	119.1	181.3	189.0	168.9	326.5	190.0	308.6	194.5	144.6	148.1	162.8	263.0	245.6	227.2	178.6	160.1	301.9	161.7	188.8	132.5	451.8	134.1	182.9	278.9	165.9	311.7	185.5	217.4	187.1	404.8	91.9	186.6	205.0	299.2	364.5	205.7	458.8	243.9	161.5	419.8	332.7	136.7	191.9	219.0	250.1	158.2	177.7	112.1	155.2	241.8	195.8	144.4	138.7	171.2	274.4	116.8	184.3	276.6	330.1	55.0	166.9	114.4	48.1	100.6	39.1	61.1	107.1	68.9	96.5	76.1	66.3	138.7	99.5	91.1	77.8	7.1	101.2	93.6	85.3	72.8	105.7	86.1	91.8	89.3	92.7	79.9	94.1	88.0	86.6	89.8	90.5	87.9	94.8	47.9	16.0	20.3	14.7	91.6	82.7	107.0	248.2	116.7	67.2	75.4	78.6	71.6	71.4	102.6	58.8	50.1	132.9	70.0	27.4	84.1	76.4	17.0	45.1	57.4	53.1	31.8	123.6	21.7	87.5	145.9	72.5	43.8	34.5	78.0	117.0	57.5	62.2	91.1	58.9	24.3	65.3	87.5	108.7	99.3	13.6	87.7	74.9	76.5	10.3	153.8	221.9	57.7	17.6	24.9	65.4	54.3	68.4	64.8	108.2	79.3	97.6	71.6	60.3	52.6	61.8	54.5	116.0	109.4	128.0	86.1	80.6	69.2	126.7	112.5	103.9
CLPTM1		ENSG00000104853	"CLPTM1 regulator of GABA type A receptor forward trafficking"	O96005	19	44954585-44993341	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068767	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA068767: "	"unprognostic (1.40e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.07e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.94e-1)"	"unprognostic (5.93e-2)"	"unprognostic (6.60e-3)"	"unprognostic (2.67e-2)"	"unprognostic (1.46e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.56e-1)"	"unprognostic (7.46e-2)"	"unprognostic (1.59e-1)"	69.1	152.8	54.7	34.3	56.9	27.3	62.7	40.1	103.3	56.7	36.4	63.6	50.6	58.5	36.0	70.2	51.6	27.4	106.5	54.4	50.1	92.9	130.7	54.6	33.4	56.3	58.4	63.5	86.6	78.0	60.2	38.8	50.9	63.4	32.9	35.1	66.6	43.1	109.0	87.4	66.0	37.0	34.8	64.8	81.0	76.2	60.0	25.4	63.2	51.3	43.4	55.0	57.6	55.5	88.5	213.8	48.6	96.9	158.3	63.4	52.5	90.8	102.0	107.5	114.9	93.3	95.0	96.1	93.1	124.2	79.0	112.0	87.2	84.4	72.3	72.4	126.8	74.5	74.7	79.3	111.6	59.9	83.2	99.8	87.8	102.9	66.1	76.3	75.9	54.7	78.7	129.3	96.2	86.9	58.1	35.0	43.9	139.3	73.6	60.4	52.8	93.1	100.1	132.7	57.4	59.5	115.6	169.1	51.4	43.0	92.7	47.1	72.4	119.9	73.7	60.4	116.0	82.4	180.2	65.5	98.9	58.3	112.7	17.7	28.4	43.5	25.8	38.4	21.4	27.1	27.9	37.3	24.9	27.4	21.7	18.7	24.6	21.4	49.5	38.8	26.3	22.9	54.7	56.9	40.1	103.3	54.4	50.1	56.3	58.4	50.9	34.8	60.0	55.5	33.9	6.4	7.8	25.5	31.9	36.7	36.1	68.4	25.0	40.3	36.6	26.8	12.3	41.5	42.1	36.8	39.6	94.0	27.7	82.7	13.7	77.3	53.0	23.5	27.5	32.7	40.7	21.5	20.7	74.1	83.7	35.7	30.1	36.0	10.8	31.7	31.4	46.6	75.2	43.7	22.9	47.1	65.1	29.3	29.9	51.1	30.1	31.2	33.8	9.4	87.8	57.2	23.7	24.6	19.1	68.4	64.7	30.1	58.3	40.3	106.0	62.7	17.7	36.3	26.3	30.3	32.5	33.5	29.6	31.5	44.0	120.0	26.0	67.3	49.4	35.6
CLRN1	"RP61, USH3, USH3A"	ENSG00000163646	"Clarin 1"	P58418	3	150926163-150972727	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hearing, Sensory transduction, Vision"		"Deafness, Disease variant, Retinitis pigmentosa, Usher syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"adrenal gland: 4.9;retina: 12.8"	"Cell type enriched"	"Detected in some"	6	"Muller glia cells: 165.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"NTERA-2: 3.3"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (1.00e-3)"				"unprognostic (1.26e-1)"					"unprognostic (5.54e-1)"					"unprognostic (9.68e-2)"			0.0	4.9	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	165.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLRN2		ENSG00000249581	"Clarin 2"	A0PK11	4	17515165-17527104	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA042407	Uncertain					NA	NA									"HPA042407: AB_10806237"																		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
CLRN3	"MGC32871, TMEM12, USH3AL1"	ENSG00000180745	"Clarin 3"	Q8NCR9	10	127877841-127892941	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 89.0;kidney: 43.9;liver: 79.9"	"Group enriched"	"Detected in some"	5	"Distal enterocytes: 102.0;Enteroendocrine cells: 41.5;Hepatocytes: 43.0;Intestinal goblet cells: 75.3;Paneth cells: 95.9;Proximal enterocytes: 155.4;Proximal tubular cells: 68.3;Undifferentiated cells: 45.6"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 45.3;renal cancer: 30.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	41	"OE19: 96.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA014482	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"			"HPA014482: AB_2082885"	"unprognostic (7.34e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.22e-2)"		"unprognostic (1.06e-1)"	"unprognostic (5.08e-2)"		"unprognostic (2.62e-1)"	"unprognostic (6.22e-2)"	"unprognostic (4.67e-1)"	"unprognostic (8.86e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.89e-3)"	"unprognostic (3.00e-2)"	0.6	0.1	0.4	5.6	0.4	0.0	0.3	0.3	0.5	0.0	0.3	71.1	73.4	0.1	0.0	0.0	0.0	15.2	0.0	0.4	0.3	43.9	79.9	0.0	0.1	0.3	0.3	0.0	0.3	0.0	0.2	0.0	0.4	0.0	70.3	0.0	0.0	0.2	0.0	0.0	89.0	1.7	0.3	0.1	1.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	96.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.4	0.3	0.5	0.4	0.3	0.3	0.3	0.4	0.3	0.4	0.4	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	102.0	15.6	0.4	0.0	0.2	0.0	0.1	41.5	0.0	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.4	43.0	0.0	0.0	0.1	75.3	0.0	0.6	0.0	0.0	0.0	0.5	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.5	95.9	0.0	0.0	0.0	155.4	68.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	45.6	0.0
CLTA	Lca	ENSG00000122705	"Clathrin light chain A"	P09496	9	36190856-36304781	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1299.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002665, HPA050918, HPA054667"	Enhanced		Enhanced	Vesicles,Endosomes,Lysosomes		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"		"CAB002665: , HPA050918: AB_2681273, HPA054667: AB_2682565"	"prognostic favorable (5.64e-4)"	"unprognostic (7.62e-2)"	"unprognostic (9.22e-2)"	"unprognostic (8.45e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.92e-1)"	"prognostic unfavorable (9.46e-5)"	"unprognostic (1.42e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-3)"	"unprognostic (7.27e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.23e-3)"	"unprognostic (5.92e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (4.98e-2)"	172.8	174.2	131.6	80.8	139.1	67.2	165.6	144.7	165.1	170.9	137.5	163.3	107.9	165.6	100.7	207.1	158.9	64.4	98.1	133.3	143.8	236.0	146.8	146.2	84.1	145.1	138.5	205.6	164.3	104.3	139.3	124.4	151.4	145.0	108.6	84.8	162.8	71.2	87.7	163.2	136.0	84.9	141.6	153.0	161.4	108.5	141.7	85.2	160.1	51.5	93.4	150.9	158.4	151.5	326.3	257.2	188.4	146.3	270.0	269.8	302.6	328.5	248.2	258.1	301.5	194.2	143.9	243.8	177.0	220.9	460.7	136.2	238.8	228.2	238.4	166.0	193.1	187.5	255.0	199.8	359.4	201.0	166.5	297.3	250.5	297.4	234.3	241.0	329.6	129.3	166.0	126.4	399.0	113.3	182.2	254.8	301.8	218.8	360.3	173.3	124.8	142.1	353.7	229.1	146.1	245.3	137.3	160.0	289.4	220.2	146.9	244.2	418.4	209.4	234.0	240.3	347.9	83.0	208.9	259.5	256.9	278.0	188.9	142.2	221.7	115.4	97.1	239.6	101.9	121.0	104.9	100.2	222.6	119.6	92.9	82.0	86.7	96.2	191.8	192.2	162.9	209.4	131.6	139.1	144.7	165.1	133.3	143.8	145.1	138.5	151.4	141.6	141.7	151.5	291.5	128.2	143.9	14.4	105.9	197.3	274.3	374.3	169.0	139.4	274.0	315.0	51.5	217.3	247.4	180.3	60.5	958.0	140.1	349.3	463.7	480.5	51.9	241.5	174.3	244.0	183.8	154.8	28.5	335.6	469.1	187.5	142.2	182.7	73.5	198.4	312.7	170.6	903.7	92.5	30.4	350.5	248.2	391.7	172.0	97.6	262.9	249.3	195.7	20.6	343.5	282.8	117.4	16.1	49.0	465.2	426.4	215.5	97.7	320.5	411.5	651.7	304.7	127.3	177.5	170.0	310.4	288.0	216.8	210.9	193.2	1299.5	103.7	281.6	380.0	360.4
CLTB	Lcb	ENSG00000175416	"Clathrin light chain B"	P09497	5	176392501-176416539	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Pancreatic endocrine cells: 1839.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 704.2;MCF7: 641.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003692, HPA036458"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles	"Plasma membrane, Cytosol"	"CAB003692: AB_425372, HPA036458: AB_2675136"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (4.51e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (1.83e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.42e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (7.89e-5)"	"unprognostic (3.55e-1)"	"unprognostic (7.50e-2)"	"unprognostic (8.59e-2)"	"unprognostic (1.60e-2)"	102.9	133.6	125.8	50.1	125.1	40.6	82.9	117.8	176.7	180.4	125.3	133.9	92.3	85.9	23.2	473.7	82.4	34.1	320.8	130.8	129.6	90.4	82.5	96.5	32.9	136.9	122.8	107.2	68.2	70.1	112.8	57.5	138.1	88.1	45.5	37.9	128.6	44.4	322.5	453.1	99.7	41.2	114.5	68.7	123.3	38.9	127.9	43.7	69.5	120.8	58.5	106.2	300.8	133.6	229.1	107.6	29.9	128.2	65.7	49.2	244.4	286.3	110.9	178.6	127.0	140.3	103.9	49.6	165.0	130.2	71.8	213.3	51.4	704.2	69.7	341.7	95.3	33.6	163.3	87.7	102.9	53.2	85.6	52.6	241.5	98.1	114.7	36.0	84.7	39.2	65.2	123.4	100.3	641.9	84.5	81.1	24.4	189.5	158.2	91.3	52.9	165.2	95.6	92.0	127.7	43.7	136.6	148.0	103.6	34.7	61.4	101.9	185.2	64.0	96.3	117.5	165.1	96.5	73.3	68.5	51.4	112.7	74.4	6.6	19.7	61.7	13.6	15.8	7.0	5.9	11.9	13.2	20.0	10.1	10.0	10.0	36.6	15.0	20.8	16.1	24.9	8.1	125.8	125.1	117.8	176.7	130.8	129.6	136.9	122.8	138.1	114.5	127.9	133.6	113.7	57.7	19.8	8.5	54.7	634.0	238.7	155.7	180.4	310.5	105.5	124.6	208.5	72.9	93.4	82.8	64.6	141.1	82.3	794.5	135.0	324.7	9.5	58.4	72.7	102.2	151.8	43.6	25.4	453.1	586.9	136.7	193.2	85.2	48.2	40.8	70.3	96.3	111.9	336.5	24.1	348.5	114.0	80.7	226.1	13.7	122.1	88.4	220.5	6.5	85.7	136.1	107.1	8.0	15.2	1839.9	786.9	129.8	76.4	391.4	545.7	269.7	49.6	64.3	78.9	79.6	161.4	15.9	29.1	415.6	803.0	386.5	81.3	151.2	289.7	436.0
CLTC	"CLTCL2, Hc"	ENSG00000141367	"Clathrin heavy chain"	Q00610	17	59619689-59696956	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Cell cycle, Cell division, Mitosis"		"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010389, CAB011571, CAB017155, HPA059143"	Approved		Enhanced	"Vesicles,Endosomes,Lysosomes,Mitotic spindle,Cytosol"		Yes	No		14000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Endosomes, Lysosomes"	"Mitotic spindle, Cytosol"	"CAB010389: AB_2083184, CAB011571: AB_2083165, CAB017155: , HPA059143: AB_2683924"	"unprognostic (1.56e-1)"	"prognostic unfavorable (7.35e-4)"	"prognostic favorable (7.65e-4)"	"unprognostic (1.03e-1)"	"unprognostic (2.62e-1)"	"unprognostic (5.23e-3)"	"prognostic unfavorable (5.54e-4)"	"unprognostic (1.11e-1)"	"unprognostic (6.43e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (2.02e-4)"	105.4	95.2	42.1	89.7	54.9	96.3	81.6	67.3	103.9	92.3	36.7	121.7	74.1	83.1	126.4	82.1	67.8	88.9	90.7	60.7	65.1	125.5	117.7	82.1	75.5	95.5	52.4	73.2	56.8	186.8	51.6	139.6	95.2	97.8	128.3	163.6	68.6	104.2	88.4	81.3	73.3	121.0	43.8	78.8	91.2	71.3	68.2	76.0	114.1	83.9	86.8	101.1	51.6	55.0	293.3	426.1	207.6	207.0	345.8	280.5	240.0	305.7	321.7	268.2	278.9	264.7	175.2	200.6	340.1	436.4	296.9	186.2	313.6	255.1	356.2	214.4	166.8	328.2	248.8	414.0	262.3	228.5	182.3	266.9	154.6	408.0	262.3	211.4	302.0	99.9	334.4	280.4	429.1	511.1	135.6	65.1	179.6	263.3	248.2	118.7	343.6	244.9	297.5	404.1	184.1	216.7	188.3	122.9	180.4	270.5	290.3	142.3	385.6	492.4	287.9	237.0	317.8	213.3	320.3	181.4	357.7	151.6	305.3	16.6	33.1	21.3	17.5	36.3	21.7	13.7	16.1	19.2	36.5	12.9	13.4	15.0	19.9	18.9	32.5	22.8	22.1	23.3	42.1	54.9	67.3	103.9	60.7	65.1	95.5	52.4	95.2	43.8	68.2	55.0	62.6	99.3	107.9	80.3	46.3	63.9	44.4	75.6	28.5	91.9	58.5	34.7	77.9	71.4	103.3	77.3	60.5	109.1	60.7	184.0	27.4	76.2	23.3	95.5	95.6	79.7	120.6	115.9	137.7	97.7	47.7	84.5	99.4	106.1	68.4	75.5	120.7	185.4	182.5	85.8	135.9	120.7	77.3	195.0	93.2	77.2	74.0	128.3	53.4	79.6	102.8	53.9	38.1	73.4	124.2	106.2	76.1	93.6	83.0	86.3	102.7	132.4	128.0	65.2	78.9	66.0	82.8	52.7	38.0	60.5	79.3	107.9	45.9	81.3	127.8	91.6
CLTCL1	"CHC22, CLH22, CLTCL, CLTD"	ENSG00000070371	"Clathrin heavy chain like 1"	P53675	22	19179473-19291719	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 187.4;testis: 47.2;tongue: 61.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 11.3;Cone photoreceptor cells: 14.6;Early spermatids: 19.3;Late spermatids: 17.0;Oligodendrocyte precursor cells: 12.5;Oligodendrocytes: 12.5;Spermatocytes: 14.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 2.1;neutrophil: 5.2"	"Group enriched"	"Detected in many"	20	"granulocytes: 5.2;monocytes: 2.1"	"Cell line enhanced"	"Detected in many"		"HMC-1: 64.8;K-562: 31.8"									"HPA075327, HPA075795"	Enhanced		Approved	Vesicles		NA	NA		2300000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA075327: , HPA075795: AB_2686764"	"unprognostic (1.29e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.16e-3)"	"unprognostic (8.20e-2)"	"unprognostic (6.93e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.42e-2)"	"unprognostic (2.93e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.20e-1)"	"unprognostic (8.71e-4)"	"unprognostic (1.61e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.06e-1)"	6.8	16.0	5.4	0.8	6.1	15.6	4.8	6.2	6.5	5.0	5.0	2.4	0.5	3.1	1.6	3.6	3.8	1.2	14.8	5.2	7.8	3.2	6.5	3.0	0.7	7.4	8.6	3.6	2.5	2.1	13.4	1.5	8.5	5.2	1.0	2.0	3.9	0.8	187.4	4.1	1.8	1.7	5.7	3.5	2.8	47.2	9.1	3.9	8.0	61.3	0.5	2.8	3.7	6.9	4.5	4.6	3.0	4.9	10.8	5.9	1.4	3.1	3.3	4.2	6.3	1.7	1.4	1.9	0.4	7.0	3.3	1.5	4.7	8.5	3.5	0.3	4.6	0.2	4.4	5.3	5.5	6.5	64.8	25.0	7.0	7.8	10.9	12.5	2.7	2.4	31.8	1.7	10.0	3.6	0.6	22.4	3.8	18.1	2.8	2.4	24.2	0.1	3.4	1.8	6.9	1.2	6.6	4.1	0.4	3.6	8.9	27.1	0.8	7.6	15.5	4.2	5.2	3.1	8.4	0.8	4.5	17.4	1.6	0.0	2.1	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.4	5.4	6.1	6.2	6.5	5.2	7.8	7.4	8.6	8.5	5.7	9.1	6.9	1.4	3.2	0.5	9.4	0.1	0.6	0.5	1.0	1.2	2.4	0.7	0.3	11.3	1.5	1.8	0.0	14.6	0.4	0.2	1.2	0.0	0.8	19.3	1.2	1.9	0.9	0.0	0.8	4.5	0.0	0.2	1.4	1.5	1.4	0.0	3.5	1.1	2.4	0.3	0.0	8.9	1.3	6.1	1.0	0.7	17.0	2.5	0.5	0.0	4.7	1.3	1.5	0.0	12.5	12.5	1.2	0.8	4.1	0.1	1.3	0.2	1.3	1.0	2.0	0.0	2.6	4.5	14.5	4.7	1.0	0.9	1.1	0.1	6.2	0.9	0.0
CLTRN	"NX17, TMEM27"	ENSG00000147003	"Collectrin, amino acid transport regulator"	Q9HBJ8	X	15627318-15675012	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"kidney: 486.4"	"Cell type enriched"	"Detected in some"	16	"Proximal tubular cells: 885.4"	"Cancer enriched"	"Detected in many"	35	"renal cancer: 106.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 8.5;hTERT-HME1: 5.2;RPTEC TERT1: 8.5;SuSa: 5.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA048543	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Endoplasmic reticulum, Vesicles"		"HPA048543: AB_2680436"	"unprognostic (1.27e-1)"	"unprognostic (4.77e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.20e-2)"	"unprognostic (5.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.90e-2)"	"prognostic favorable (5.65e-4)"	"unprognostic (1.05e-2)"	"unprognostic (3.03e-1)"	"prognostic favorable (6.78e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.33e-2)"	0.5	0.8	0.5	0.0	0.6	0.3	2.0	0.7	0.8	1.0	16.6	0.6	1.3	1.5	3.1	0.6	2.4	3.7	1.1	0.7	0.6	486.4	61.5	1.7	0.4	0.6	0.5	3.2	5.3	10.5	0.6	0.5	0.6	1.5	0.3	1.2	0.8	1.3	0.1	1.2	0.4	0.4	0.4	0.2	10.9	1.0	0.5	0.8	4.1	0.1	0.3	0.8	0.4	0.9	2.3	1.8	1.1	0.3	0.7	1.0	0.7	0.0	0.0	0.1	0.1	0.1	0.5	0.1	1.6	0.2	0.2	8.5	0.7	2.3	0.0	0.3	0.7	0.2	0.0	0.8	1.0	0.0	0.0	0.2	2.0	0.3	5.2	0.6	0.0	2.1	0.5	0.4	0.2	2.8	0.1	0.3	2.9	0.8	2.6	0.2	0.3	0.9	8.5	0.1	1.1	1.0	0.6	0.1	1.8	5.1	0.6	0.2	0.0	0.2	0.4	0.3	0.0	0.4	0.2	0.3	0.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.1	0.1	0.2	0.6	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.6	0.7	0.8	0.7	0.6	0.6	0.5	0.6	0.4	0.5	0.9	0.1	0.0	4.1	0.0	5.7	0.0	0.0	0.0	0.0	0.0	3.0	3.2	0.0	0.0	1.8	27.6	0.0	2.1	0.0	0.0	54.8	25.1	0.0	2.8	0.6	0.1	0.0	0.0	0.0	0.6	0.5	0.3	0.0	3.3	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	885.4	2.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.0	3.7	0.5	0.0	0.0
CMKLR1	RVER1	ENSG00000174600	"Chemerin chemokine-like receptor 1"	Q99788	12	108288044-108339317	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 34.3"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 17.3;Hofbauer cells: 32.4;Kupffer cells: 69.6;Macrophages: 27.1;Microglial cells: 39.4;NK-cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 14.5;plasmacytoid DC: 18.1"	"Group enriched"	"Detected in many"	22	"dendritic cells: 18.1;monocytes: 14.5;T-cells: 7.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 11.9;ASC TERT1: 45.3;BJ hTERT+: 34.9;hTERT-RPE1: 13.6;LHCN-M2: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047865	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 64: Macrophages - Immune response"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA047865: AB_2680191"	"unprognostic (1.78e-1)"	"unprognostic (2.61e-2)"	"unprognostic (8.83e-3)"	"unprognostic (7.39e-2)"	"unprognostic (2.44e-1)"	"unprognostic (3.49e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.06e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.83e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.14e-1)"	10.4	5.9	3.3	11.7	3.0	0.9	4.9	2.5	3.2	4.7	4.2	7.5	4.5	8.3	1.6	3.1	4.4	5.5	6.4	2.6	4.9	3.3	6.9	12.8	17.6	5.9	4.7	1.9	3.2	1.7	3.4	22.2	5.3	3.8	8.9	0.3	4.7	4.5	2.4	4.2	5.1	14.7	4.0	34.3	2.8	2.6	5.9	4.2	8.7	5.1	8.1	8.1	2.5	7.5	0.0	0.0	0.1	0.0	11.9	45.3	0.2	0.0	34.9	0.1	0.0	0.0	0.0	0.2	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.2	13.6	0.7	0.0	0.0	0.0	10.6	0.0	0.0	1.0	0.1	0.0	0.0	0.0	1.9	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.0	4.1	0.0	7.0	14.5	0.0	0.0	1.1	5.1	1.1	0.0	0.4	3.5	0.3	0.6	2.8	18.1	0.3	5.1	3.3	3.0	2.5	3.2	2.6	4.9	5.9	4.7	5.3	4.0	5.9	7.5	1.9	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	0.0	0.1	0.3	2.2	1.5	0.6	0.0	0.0	0.4	17.3	0.0	0.0	0.0	0.1	0.0	0.7	5.8	0.0	2.7	0.5	0.0	0.5	7.8	0.0	0.0	0.0	0.0	11.4	0.6	32.4	0.0	0.4	0.0	0.0	69.6	2.5	0.3	0.3	27.1	3.6	39.4	7.6	0.0	30.9	1.0	0.0	0.0	0.0	5.3	0.8	0.0	0.0	0.0	0.7	0.1	6.6	4.1	5.1	0.0	0.0	0.1	0.6	0.5	2.2	0.5	0.0	0.0
CMTM1	"CKLFH, CKLFH1a, CKLFSF1"	ENSG00000089505	"CKLF like MARVEL transmembrane domain containing 1"	Q8IZ96	16	66566393-66579137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 31.3"	"Group enriched"	"Detected in some"	4	"Early spermatids: 75.5;Late spermatids: 144.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"basophil: 8.7;eosinophil: 6.2;neutrophil: 7.0"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.7"	"Cell line enhanced"	"Detected in many"		"REH: 19.8"									"HPA013801, HPA017136"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA013801: AB_1846990, HPA017136: AB_1846992"	"unprognostic (2.37e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.81e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.97e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (5.68e-5)"	"unprognostic (2.47e-2)"	"unprognostic (1.56e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-1)"	1.0	1.1	1.0	2.5	1.0	0.3	0.5	1.5	1.8	1.1	0.0	1.3	2.0	1.5	0.4	0.7	1.1	1.7	0.6	0.9	2.7	0.9	0.5	1.2	1.6	2.1	0.9	1.8	0.6	1.1	0.8	1.2	1.8	0.7	0.5	0.9	1.0	0.5	0.4	0.9	1.5	0.6	0.2	3.2	1.2	31.3	1.5	2.6	0.9	0.5	1.0	0.9	0.8	1.7	5.1	7.8	1.4	6.4	2.7	2.5	1.4	6.5	3.0	5.1	5.2	1.6	3.3	2.3	3.3	1.9	1.6	3.9	2.2	0.4	2.7	8.8	1.5	0.9	3.7	1.7	1.2	4.7	5.6	2.2	0.6	4.6	0.5	7.7	2.7	4.6	4.2	3.1	2.2	1.9	8.9	4.5	1.1	0.7	2.8	19.8	16.3	5.5	4.5	2.3	3.6	4.8	9.0	0.7	2.2	0.2	2.3	3.3	6.6	8.9	14.1	5.5	2.8	3.1	8.3	8.7	4.3	6.3	10.7	8.7	1.7	6.2	1.4	0.5	1.2	0.1	0.4	0.7	1.6	0.2	0.4	0.4	7.0	1.2	1.1	0.5	0.5	1.0	1.0	1.0	1.5	1.8	0.9	2.7	2.1	0.9	1.8	0.2	1.5	1.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.1	0.0	0.0	75.5	0.0	0.1	0.2	0.0	2.7	0.0	0.2	0.2	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	144.9	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	6.6	0.0	0.1	26.5	0.4	0.0	0.3	0.1	0.4	0.1	0.0	0.1
CMTM4	CKLFSF4	ENSG00000183723	"CKLF like MARVEL transmembrane domain containing 4"	Q8IZR5	16	66614750-66696743	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 45.5"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 68.0;Granulosa cells: 67.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014704, HPA023890"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA				"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA014704: AB_1847005, HPA023890: AB_1847007"	"unprognostic (2.65e-3)"	"unprognostic (1.16e-1)"	"unprognostic (6.17e-3)"	"unprognostic (3.43e-1)"	"unprognostic (5.13e-1)"	"unprognostic (8.30e-2)"	"unprognostic (2.88e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.35e-3)"	"unprognostic (6.06e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.08e-1)"	"prognostic favorable (4.72e-9)"	"unprognostic (1.41e-1)"	"unprognostic (2.31e-1)"	"unprognostic (4.94e-2)"	"unprognostic (1.00e-1)"	4.5	5.0	36.4	2.7	34.1	2.5	5.7	32.8	34.5	3.9	28.3	16.1	11.9	4.4	20.1	6.0	10.6	2.9	4.1	43.1	37.1	26.3	4.1	8.4	0.6	42.1	41.7	3.4	19.2	32.7	14.4	2.1	35.4	7.7	12.6	7.8	11.1	3.8	3.3	7.7	12.9	3.4	41.8	2.0	31.4	6.9	45.5	0.5	38.6	2.1	1.1	3.2	4.1	41.6	16.0	12.9	7.8	19.1	2.6	4.2	31.7	6.6	5.9	3.5	5.6	24.2	17.7	0.7	10.8	3.9	4.8	20.0	19.7	7.8	5.2	1.3	17.2	1.7	5.3	15.2	5.6	1.4	3.0	6.7	13.4	4.2	8.1	11.9	2.0	2.3	8.0	4.1	5.1	18.5	0.1	3.2	8.7	28.6	8.6	3.5	10.6	4.9	15.2	14.2	17.9	7.1	27.4	14.6	9.3	5.6	15.3	3.4	4.3	6.5	7.0	1.8	6.6	1.4	3.3	0.7	8.1	3.2	7.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	36.4	34.1	32.8	34.5	43.1	37.1	42.1	41.7	35.4	41.8	45.5	41.6	2.6	22.4	11.1	32.7	0.8	5.2	8.8	21.9	4.6	9.5	23.5	10.8	7.1	15.7	19.3	23.9	8.4	5.0	1.6	51.7	13.7	15.9	1.9	20.7	2.7	4.3	39.0	0.8	68.0	24.0	29.6	3.5	27.5	12.3	4.5	67.6	1.8	6.1	2.4	30.3	37.7	24.1	20.3	2.8	0.9	3.0	2.5	1.9	3.6	7.5	4.4	24.2	0.0	37.7	51.3	30.8	19.5	3.0	0.6	29.0	30.7	19.9	40.0	11.1	6.6	3.1	8.8	6.4	7.7	7.5	5.5	2.9	0.9	2.5	43.4	19.4
CMTM5	"CKLFSF5, FLJ37521"	ENSG00000166091	"CKLF like MARVEL transmembrane domain containing 5"	Q96DZ9	14	23376773-23379772	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 182.4;choroid plexus: 49.5"	"Cell type enhanced"	"Detected in some"		"Macrophages: 93.7;Muller glia cells: 32.0;Oligodendrocyte precursor cells: 20.6;Oligodendrocytes: 106.2"	"Group enriched"	"Detected in some"	37	"glioma: 8.4;melanoma: 3.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"basophil: 20.8"	"Lineage enriched"	"Detected in many"	19	"granulocytes: 20.8"	"Cell line enriched"	"Detected in some"	7	"HEL: 91.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052338	Enhanced		Approved	"Golgi apparatus,Vesicles"		NA	NA		540000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"	"Golgi apparatus, Vesicles"		"HPA052338: AB_2681793"	"unprognostic (2.73e-3)"	"unprognostic (1.51e-1)"	"unprognostic (5.24e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.40e-2)"		"unprognostic (8.34e-3)"	"unprognostic (1.78e-1)"	"unprognostic (2.27e-2)"	"unprognostic (8.40e-2)"	"unprognostic (6.24e-4)"	"unprognostic (3.03e-3)"	"unprognostic (1.97e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.11e-2)"	1.1	1.0	75.6	0.5	119.1	8.2	0.9	123.8	101.7	2.8	49.5	5.8	0.5	0.8	1.1	1.2	1.2	2.1	22.7	73.9	85.2	0.5	0.3	1.5	0.2	150.9	106.2	0.8	0.2	0.1	0.6	0.7	135.2	2.1	0.8	2.3	2.2	3.2	3.1	0.7	1.7	0.8	113.4	2.8	1.4	0.1	110.2	0.1	0.5	0.9	0.0	1.2	2.6	182.4	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	91.8	0.0	0.0	0.2	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	2.2	20.8	0.7	0.9	0.1	0.4	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.0	4.2	0.0	0.0	1.0	0.4	30.0	75.6	119.1	123.8	101.7	73.9	85.2	150.9	106.2	135.2	113.4	110.2	182.4	0.5	0.0	0.0	6.5	0.4	1.0	0.1	0.0	1.2	0.2	1.3	5.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	0.2	0.0	0.0	1.3	0.4	0.0	0.0	93.7	5.4	0.0	1.5	32.0	0.0	20.6	106.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.6	3.4	0.0	0.0	0.1	0.1	0.0	0.4	0.0	0.0	0.1
CMTM7	"CKLFSF7, FLJ30992"	ENSG00000153551	"CKLF like MARVEL transmembrane domain containing 7"	Q96FZ5	3	32391698-32483067	"Predicted membrane proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 102.3;Ductal cells: 105.6;Hofbauer cells: 120.3;Kupffer cells: 110.7;Langerhans cells: 102.8;monocytes: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 135.4;hTERT-RPE1: 135.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077409			Approved	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 3: Monocytes - Immune response regulation"	"Plasma membrane"		"HPA077409: AB_2686838"	"unprognostic (2.27e-3)"	"unprognostic (3.16e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.42e-2)"	"unprognostic (3.16e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (3.03e-2)"	"unprognostic (3.92e-2)"	"unprognostic (2.60e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.00e-6)"	"unprognostic (5.86e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.12e-2)"	22.8	10.4	7.5	20.7	7.7	43.7	32.6	8.6	12.9	15.2	8.7	8.4	5.3	11.1	10.9	3.9	38.7	16.0	10.1	7.3	8.2	22.1	10.1	33.0	32.2	8.9	8.3	5.5	19.9	4.0	3.7	19.2	9.2	12.1	9.3	0.6	13.1	19.9	4.0	10.1	18.3	10.5	8.7	49.3	13.4	8.6	9.5	46.1	20.5	3.1	31.4	24.1	7.2	10.8	0.4	15.8	32.8	40.2	29.8	29.0	93.4	15.5	18.0	26.5	24.3	18.0	135.4	0.1	46.7	18.1	33.0	17.4	40.6	69.1	23.2	0.0	32.8	18.5	0.1	40.6	120.8	4.7	29.0	31.0	9.0	27.2	42.6	135.1	60.0	0.2	15.8	40.9	19.6	0.4	0.2	42.9	39.7	7.0	71.7	90.5	12.3	85.0	37.7	30.9	1.6	33.9	2.0	2.6	80.8	13.9	21.3	48.7	36.2	25.3	25.5	27.9	54.4	11.6	4.6	0.2	9.3	57.9	54.2	32.4	198.7	110.8	21.3	196.8	12.7	44.2	72.1	44.2	106.8	34.7	76.5	54.1	77.3	21.6	173.6	45.0	164.1	112.6	7.5	7.7	8.6	12.9	7.3	8.2	8.9	8.3	9.2	8.7	9.5	10.8	10.3	25.6	16.7	1.0	65.5	9.8	20.2	102.3	1.8	0.5	63.4	86.0	2.1	28.6	51.9	18.4	0.0	22.2	25.0	2.0	0.0	105.6	0.2	17.4	12.8	24.2	17.3	11.6	0.5	15.5	10.0	15.2	26.0	33.1	29.8	29.0	20.7	1.3	120.3	1.7	1.4	4.4	40.7	110.7	102.8	1.2	1.5	77.2	24.9	20.6	108.1	1.4	12.3	1.0	0.3	91.8	8.1	1.2	62.9	42.0	1.2	27.5	23.3	0.2	6.6	1.2	13.5	1.2	10.4	0.9	5.5	6.8	57.4	6.1	2.8	16.3
CNGA1	"CNCG, CNCG1, CNG1, RCNC1, RCNCa, RP49"	ENSG00000198515	"Cyclic nucleotide gated channel subunit alpha 1"	P29973	4	47935977-48016681	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"retina: 264.4"	"Cell type enriched"	"Detected in many"	6	"Rod photoreceptor cells: 1139.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 4.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 9.2;RT4: 7.2;U-2 OS: 3.0"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.0"	"Not detected"	"Not detected"			HPA076168			Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 79: Retina - Phototransduction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Vesicles, Plasma membrane"	Nucleoplasm	"HPA076168: AB_2686781"	"unprognostic (2.68e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.33e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.18e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.48e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.66e-2)"	"unprognostic (8.23e-2)"	3.3	0.4	0.5	0.8	1.4	0.3	1.5	1.6	0.9	1.0	0.6	3.6	2.2	0.4	9.3	9.0	4.1	1.1	0.4	0.7	0.8	2.4	23.5	0.3	0.1	0.4	0.3	0.1	0.8	4.1	0.3	1.0	0.4	2.6	2.4	264.4	4.3	1.7	5.0	5.1	6.3	0.3	0.1	3.4	2.8	0.4	0.7	0.3	0.7	1.3	0.5	3.7	1.9	0.6	2.3	0.9	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	2.0	9.2	0.1	0.5	0.0	2.7	1.4	0.2	0.3	0.1	0.0	0.6	0.0	0.2	0.8	0.0	0.1	0.2	0.0	0.4	0.0	0.0	0.9	0.0	0.8	0.7	0.5	0.2	0.9	0.0	0.1	0.4	1.1	2.2	0.1	0.0	0.1	0.4	7.2	0.3	0.0	0.2	0.5	0.1	0.2	0.9	0.0	0.3	0.2	3.0	0.1	0.1	0.7	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.3	0.0	0.5	0.0	0.0	0.5	1.4	1.6	0.9	0.7	0.8	0.4	0.3	0.4	0.1	0.7	0.6	7.3	0.0	0.0	0.7	0.1	0.1	1.8	0.5	0.6	97.7	8.7	1.8	0.7	5.7	3.4	62.5	91.8	0.0	0.0	10.6	0.0	10.1	0.4	2.5	0.4	8.7	0.0	2.7	1.2	6.6	0.0	0.3	0.0	3.6	0.0	0.0	0.0	38.0	1.7	45.4	1.1	4.0	0.0	0.8	0.0	0.1	0.3	0.5	0.0	7.5	0.0	163.9	0.0	0.0	0.2	2.1	16.4	0.0	0.0	3.7	24.5	0.4	0.8	1139.7	0.0	0.6	17.1	0.6	1.3	10.3	2.7	0.3	0.2	0.1	4.7	35.1
CNGA3	"ACHM2, CCNC1, CCNCa, CNCG3, CNG3"	ENSG00000144191	"Cyclic nucleotide gated channel subunit alpha 3"	Q16281	2	98346188-98398601	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.7;intestine: 4.2;pituitary gland: 10.1;retina: 5.9"	"Cell type enriched"	"Detected in some"	14	"Cone photoreceptor cells: 43.8"	"Cancer enriched"	"Detected in some"	9	"glioma: 7.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"U-87 MG: 6.8"	"Group enriched"	"Detected in some"	6	"basal ganglia: 1.8;hypothalamus: 1.9"	"Not detected"	"Not detected"			"HPA049378, CAB079025"	Approved	Approved				NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB079025: , HPA049378: AB_2732551"	"unprognostic (2.34e-2)"	"unprognostic (1.83e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.18e-1)"		"unprognostic (4.17e-4)"		"unprognostic (4.65e-2)"	"unprognostic (1.86e-3)"	"unprognostic (2.88e-1)"		"unprognostic (3.85e-3)"	"unprognostic (8.98e-2)"	"unprognostic (5.90e-2)"	"unprognostic (3.71e-2)"	0.1	0.0	0.6	0.5	0.5	0.0	0.2	0.2	0.8	0.0	2.9	4.2	1.0	0.0	0.0	1.5	0.4	0.0	0.0	0.7	5.6	0.1	0.0	0.1	0.0	3.4	1.5	0.0	0.3	0.0	10.1	0.0	3.6	0.0	1.1	5.9	0.2	0.2	0.0	0.0	1.3	0.8	5.7	0.0	0.9	0.5	1.3	0.0	0.0	0.0	0.0	0.6	0.1	4.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.8	0.7	5.6	3.4	1.5	3.6	5.7	1.3	4.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.7	0.0	0.0	0.0	43.8	0.0	0.0	0.0	0.0	0.0	1.3	0.4	0.0	0.1	0.0	0.0	3.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.9	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0
CNGB1	"CNCG2, CNCG3L, CNGB1B, GAR1, GARP, RCNC2, RCNCb, RP45"	ENSG00000070729	"Cyclic nucleotide gated channel subunit beta 1"	Q14028	16	57882340-57971128	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Olfaction, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel"	"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"retina: 600.2"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 331.5;Rod photoreceptor cells: 1111.1"	"Cancer enriched"	"Detected in single"	6	"head and neck cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 1.5;RPMI-8226: 1.8;SCLC-21H: 5.0;SiHa: 2.9;SK-BR-3: 1.4"	"Region enhanced"	"Detected in some"		"hypothalamus: 4.5"					"HPA039159, HPA060355"			Approved	Vesicles,Cytosol		No	NA				"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"HPA039159: AB_10795579, HPA060355: "	"unprognostic (5.52e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.73e-3)"	"unprognostic (6.20e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.56e-4)"	"unprognostic (3.08e-1)"	"unprognostic (9.84e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.14e-4)"	"unprognostic (5.42e-2)"	"unprognostic (1.01e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.88e-1)"	"unprognostic (4.57e-2)"	"unprognostic (9.07e-2)"	0.1	2.5	15.5	1.1	13.2	0.2	0.0	0.0	20.4	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.1	0.3	0.0	24.5	24.8	0.0	0.1	0.1	0.2	2.8	3.2	0.0	0.5	0.0	0.2	0.4	4.4	0.0	0.4	600.2	0.0	0.1	0.0	0.2	0.6	0.1	2.4	0.1	0.0	0.4	36.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	1.5	0.0	0.5	0.0	0.0	1.3	0.0	0.1	0.0	0.3	0.9	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	1.8	0.0	0.6	5.0	0.0	2.9	1.4	0.0	0.0	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	15.5	13.2	0.0	20.4	24.5	24.8	2.8	3.2	4.4	2.4	36.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.4	0.0	61.6	0.3	0.0	1.1	0.0	0.1	0.0	331.5	6.9	0.0	0.0	0.0	0.4	1.6	0.9	0.1	4.2	0.0	0.0	3.2	0.4	0.9	0.2	0.0	1.3	0.0	0.0	0.0	0.0	0.4	25.2	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	89.5	0.0	1.0	0.1	0.2	1.1	0.0	0.0	0.2	0.0	0.3	0.0	1111.1	0.0	0.1	0.2	0.5	0.7	0.0	0.0	1.4	0.1	0.1	0.0	0.2
CNIH1	"CNIH, CNIL, TGAM77"	ENSG00000100528	"Cornichon family AMPA receptor auxiliary protein 1"	O95406	14	54423561-54441391	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002544	Approved		Uncertain	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA002544: AB_2081856"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-3)"	"unprognostic (7.09e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.93e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.71e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.62e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (8.95e-4)"	73.2	61.7	40.2	50.9	42.1	37.2	73.6	45.2	49.5	59.8	58.5	86.9	99.4	49.6	50.8	72.5	67.0	74.4	84.6	42.8	47.2	79.9	232.9	46.7	61.2	44.3	43.4	44.0	41.8	59.8	41.2	58.4	44.8	57.2	95.1	60.3	49.7	57.1	58.9	36.0	85.4	68.2	49.1	33.8	45.4	37.1	41.3	56.2	65.0	95.5	79.0	95.1	39.4	50.7	233.4	141.3	113.8	129.2	301.0	380.9	107.8	276.8	348.6	232.0	264.4	86.5	316.4	289.7	180.2	209.2	141.6	226.5	208.3	200.3	287.5	111.9	124.5	112.1	80.9	152.8	303.6	136.5	90.2	314.4	244.3	217.1	304.0	236.8	221.3	117.7	111.5	95.5	262.4	138.4	151.5	102.9	84.2	266.3	281.3	114.8	191.8	97.3	264.2	171.4	95.5	106.3	163.4	127.8	316.7	104.8	197.5	144.9	143.7	194.7	192.9	165.4	167.8	59.7	138.8	141.2	235.9	115.3	176.5	5.3	84.6	10.7	32.5	66.8	54.8	64.3	57.3	47.0	86.0	55.2	75.1	52.1	20.9	44.0	53.7	48.4	65.1	96.6	40.2	42.1	45.2	49.5	42.8	47.2	44.3	43.4	44.8	49.1	41.3	50.7	41.1	35.3	60.6	14.7	64.9	105.7	86.2	186.1	141.7	41.9	69.2	64.0	85.6	50.1	79.8	46.0	20.9	95.7	48.1	98.8	90.1	89.3	44.4	54.8	57.9	72.3	104.4	65.0	26.9	62.3	123.4	90.3	52.5	32.8	197.3	32.4	70.3	140.0	115.5	67.3	34.8	91.5	99.7	102.8	80.0	17.0	60.0	73.5	83.6	9.4	110.3	59.9	35.0	17.6	22.5	65.6	96.6	65.8	84.0	92.0	149.9	164.7	79.9	45.1	46.0	60.5	68.1	68.7	64.1	144.9	110.0	70.9	69.3	68.4	123.0	91.4
CNIH2	"CNIH-2, Cnil, MGC50896"	ENSG00000174871	"Cornichon family AMPA receptor auxiliary protein 2"	Q6PI25	11	66278175-66285301	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 270.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 75.7;Enteroendocrine cells: 49.6;Excitatory neurons: 17.7;Horizontal cells: 16.8;Late spermatids: 28.1"	"Cancer enriched"	"Detected in many"	5	"glioma: 20.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.8;AN3-CA: 13.9;MCF7: 13.9;NTERA-2: 15.1;SCLC-21H: 61.5;SH-SY5Y: 28.5;T-47d: 13.3"	"Low region specificity"	"Detected in all"													NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (1.84e-2)"	"unprognostic (3.53e-3)"	"unprognostic (3.40e-3)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (9.18e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.29e-1)"	"unprognostic (3.25e-1)"	"unprognostic (3.80e-2)"	"unprognostic (7.66e-3)"	"unprognostic (4.16e-2)"	"unprognostic (6.95e-8)"	"unprognostic (3.53e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.55e-2)"	0.4	3.3	88.4	0.2	74.6	1.6	0.3	28.8	270.1	0.6	11.0	1.0	0.6	0.4	0.0	0.8	0.6	0.2	0.3	234.9	61.3	0.5	0.4	0.7	0.1	28.3	37.1	0.4	3.4	0.1	45.9	0.5	34.5	0.5	0.2	1.1	0.3	0.0	0.1	1.4	0.6	0.2	30.3	0.6	1.0	5.1	53.4	1.3	0.4	0.0	0.0	0.3	0.5	47.5	0.4	0.8	15.8	13.9	0.2	0.3	2.0	1.0	1.1	2.0	0.1	0.4	0.0	0.1	0.3	0.2	0.9	0.2	3.6	0.0	0.3	1.5	1.4	0.0	0.5	0.0	0.0	0.1	1.1	0.0	0.3	0.1	0.0	0.3	0.0	1.6	0.2	2.1	0.9	13.9	2.1	0.3	15.1	0.0	1.0	6.8	0.0	0.1	0.1	0.8	61.5	28.5	0.1	7.6	0.6	0.7	13.3	0.2	0.0	1.8	0.7	0.5	0.6	0.3	0.4	0.6	4.2	0.4	10.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	88.4	74.6	28.8	270.1	234.9	61.3	28.3	37.1	34.5	30.3	53.4	47.5	0.8	0.0	0.5	2.9	0.2	0.6	0.3	1.4	0.6	2.3	1.6	1.3	0.7	1.5	0.8	0.0	0.0	1.4	0.7	0.1	0.0	0.2	75.7	5.7	0.6	0.4	49.6	0.0	17.7	0.2	1.6	0.7	2.0	0.6	0.0	0.5	0.4	0.1	0.2	16.8	11.7	1.5	0.0	0.0	0.3	28.1	0.6	0.4	0.0	1.9	0.1	0.7	0.0	1.5	2.7	0.6	0.1	0.4	0.9	0.3	0.2	0.2	6.8	2.6	0.0	0.9	0.7	6.0	0.9	0.6	0.4	1.2	1.4	0.1	0.4	0.3
CNIH3	"CNIH-3, FLJ38993"	ENSG00000143786	"Cornichon family AMPA receptor auxiliary protein 3"	Q8TBE1	1	224434660-224740554	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 13.5;pancreas: 8.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 65.3;Distal tubular cells: 31.3;Excitatory neurons: 61.1;Inhibitory neurons: 47.5;Late spermatids: 38.0;Oligodendrocyte precursor cells: 68.3"	"Group enriched"	"Detected in many"	4	"glioma: 6.0;melanoma: 7.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 18.7;hTEC/SVTERT24-B: 47.0;hTERT-RPE1: 26.4;NTERA-2: 17.3;U-266/70: 25.1;U-87 MG: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.36e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.90e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.88e-1)"	"unprognostic (7.18e-2)"	"unprognostic (4.96e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.41e-1)"	"unprognostic (4.63e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-5)"	"unprognostic (1.03e-1)"	"unprognostic (3.66e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.63e-1)"	0.9	0.3	6.9	0.2	7.2	0.0	0.9	1.8	11.0	1.1	1.8	0.5	0.3	0.7	0.4	0.2	0.9	0.6	0.3	11.9	13.5	0.7	0.3	0.4	0.4	6.7	6.7	1.9	8.0	0.1	1.0	0.1	2.7	0.5	0.2	1.2	0.6	0.5	0.4	0.4	0.2	0.4	3.2	0.2	1.0	2.2	5.0	0.2	0.5	0.4	0.4	0.8	0.9	5.4	0.5	0.3	0.6	0.6	0.5	0.9	0.2	3.5	18.7	0.5	1.0	0.1	4.3	0.1	1.8	8.2	1.4	0.0	0.0	0.0	3.1	0.1	1.0	0.0	0.0	0.0	0.3	1.7	1.4	0.6	0.0	47.0	0.5	26.4	0.0	0.2	0.0	0.1	2.8	0.1	0.1	6.0	17.3	0.2	2.2	0.1	0.9	0.0	3.0	1.7	0.6	0.4	0.0	0.0	12.1	1.8	0.1	0.4	0.1	0.1	4.2	0.1	0.5	25.1	1.1	0.0	55.3	0.2	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	6.9	7.2	1.8	11.0	11.9	13.5	6.7	6.7	2.7	3.2	5.0	5.4	2.7	0.0	2.0	65.3	1.8	2.8	2.1	3.6	2.8	2.8	5.3	7.7	2.4	1.5	2.9	1.8	0.0	2.3	1.0	1.4	31.3	0.9	16.0	3.0	3.3	2.9	1.2	4.0	61.1	3.0	0.6	3.9	0.5	1.9	2.5	6.9	3.3	2.6	6.2	0.0	47.5	2.7	0.0	0.6	2.5	38.0	2.8	1.9	0.0	19.7	1.1	15.1	2.1	68.3	25.3	0.6	0.8	1.2	0.8	1.9	0.4	17.3	28.8	0.7	0.0	5.0	2.5	2.3	8.6	3.2	2.3	5.1	2.5	5.3	1.5	2.7
CNNM1	ACDP1	ENSG00000119946	"Cyclin and CBS domain divalent metal cation transport mediator 1"	Q9NRU3	10	99329356-99394330	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.7;testis: 9.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 103.1;Excitatory neurons: 69.9;Horizontal cells: 50.5;Inhibitory neurons: 89.5;Late spermatids: 88.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 19.6;BJ hTERT+: 7.4;BJ hTERT+ SV40 Large T+ RasG12V: 11.3;HAP1: 8.7;OE19: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040408	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane, Cytosol"		"HPA040408: AB_10793963"	"unprognostic (9.04e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.70e-1)"	"unprognostic (7.60e-4)"	"unprognostic (4.08e-3)"	"unprognostic (9.51e-2)"	"unprognostic (6.01e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.09e-2)"	"unprognostic (2.45e-1)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (4.03e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.03e-1)"	0.2	1.1	9.9	0.2	9.9	0.0	0.5	5.4	16.7	1.8	0.0	0.7	0.4	0.9	1.7	0.8	1.0	0.3	0.1	7.3	7.3	1.7	0.2	0.1	0.0	3.6	2.9	2.6	1.1	0.6	3.6	0.0	3.5	1.7	0.4	5.2	0.8	0.8	0.0	1.2	0.6	0.4	2.0	0.1	0.6	9.8	4.7	0.1	0.1	0.1	0.1	1.7	1.4	10.1	0.0	19.6	0.0	0.0	0.0	0.0	0.0	2.8	7.4	6.7	11.3	0.0	4.4	0.0	0.0	1.4	0.1	1.7	8.7	0.0	4.8	0.0	0.9	1.9	2.8	3.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.0	0.1	0.0	0.0	0.4	2.7	0.3	0.0	0.9	7.7	0.8	0.0	0.0	0.0	0.9	0.0	2.2	6.1	2.0	0.4	1.0	0.5	0.0	0.0	0.0	0.6	0.1	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	9.9	5.4	16.7	7.3	7.3	3.6	2.9	3.5	2.0	4.7	10.1	0.6	0.0	0.0	4.6	0.0	2.3	3.3	0.1	5.2	25.3	0.7	2.8	1.4	0.0	0.2	1.8	14.6	0.0	0.0	0.0	0.0	0.6	103.1	0.5	1.0	0.4	0.0	0.8	69.9	1.5	0.0	1.0	0.0	0.3	0.0	0.2	1.8	0.0	0.0	50.5	89.5	0.1	0.0	0.0	0.8	88.0	2.1	0.3	1.8	4.7	0.1	1.3	0.0	10.6	2.2	2.0	0.3	2.6	0.0	5.9	0.1	0.7	0.6	3.4	0.0	2.0	0.5	1.9	1.6	1.5	1.0	0.0	0.2	1.2	0.1	2.4
CNNM2	ACDP2	ENSG00000148842	"Cyclin and CBS domain divalent metal cation transport mediator 2"	Q9H8M5	10	102918294-103090222	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Epilepsy, Mental retardation, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 37.9;parathyroid gland: 31.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 60.1;Excitatory neurons: 112.6;Inhibitory neurons: 146.9;Oligodendrocyte precursor cells: 92.5;Oligodendrocytes: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"NK-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"NK-cells: 1.5"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059954, HPA071631"			Enhanced	Vesicles		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA059954: AB_2684177, HPA071631: AB_2686427"	"unprognostic (2.18e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.19e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.80e-2)"	"unprognostic (4.51e-3)"	"unprognostic (3.75e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.39e-1)"	"prognostic favorable (2.39e-8)"	"unprognostic (2.44e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.65e-3)"	"unprognostic (1.56e-1)"	3.3	11.5	5.1	2.3	5.5	9.3	2.5	7.9	5.7	3.7	37.9	7.0	3.8	3.6	2.1	1.7	4.8	4.1	2.1	4.2	3.3	9.1	4.8	3.8	1.5	4.9	4.8	4.8	3.6	31.6	5.7	8.7	4.7	2.7	6.4	5.0	3.0	3.0	1.6	4.5	4.5	3.7	1.8	2.1	3.3	4.5	4.6	1.8	5.6	1.5	1.1	3.2	2.9	9.7	5.0	8.1	3.1	8.5	7.8	3.2	8.6	2.3	9.7	3.1	3.9	5.8	4.3	1.9	3.5	3.4	6.0	6.3	6.9	4.6	2.4	3.3	12.1	2.8	4.2	11.8	4.6	2.0	3.6	4.2	6.6	3.2	10.7	7.9	1.9	5.5	4.8	10.9	1.8	8.6	2.3	2.2	5.1	4.9	5.0	5.5	4.0	2.4	2.4	2.9	4.5	5.8	5.9	1.3	6.3	9.1	10.4	3.7	1.6	4.2	6.2	3.0	4.2	11.7	14.1	3.6	7.4	6.6	1.7	0.3	0.1	0.1	0.2	0.2	0.2	0.3	0.1	0.1	0.1	0.1	0.2	0.1	0.2	1.5	0.0	0.3	0.3	0.1	5.1	5.5	7.9	5.7	4.2	3.3	4.9	4.8	4.7	1.8	4.6	9.7	3.0	6.4	8.4	60.1	7.9	2.4	2.3	1.7	6.8	16.4	3.3	2.4	4.5	2.8	5.6	5.5	12.5	18.8	8.1	46.7	1.9	2.2	10.7	7.4	4.2	4.2	6.7	6.7	112.6	5.4	3.4	6.3	12.8	6.4	3.8	13.7	3.3	6.1	3.8	32.0	146.9	5.0	0.0	3.2	2.5	15.1	3.4	4.7	7.2	39.4	2.3	7.0	2.1	92.5	92.3	2.3	9.0	3.4	6.2	2.0	11.7	5.5	9.5	15.8	13.1	5.7	16.7	15.5	6.9	8.1	4.1	39.8	5.1	3.8	11.6	2.2
CNNM3	ACDP3	ENSG00000168763	"Cyclin and CBS domain divalent metal cation transport mediator 3"	Q8NE01	2	96816245-96835382	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Horizontal cells: 33.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016711	Supported		Approved	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 24: Non-specific - Transcription regulation"	Cytosol		"HPA016711: AB_1847394"	"unprognostic (1.50e-2)"	"unprognostic (6.96e-2)"	"unprognostic (2.71e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.03e-1)"	"unprognostic (1.59e-1)"	"unprognostic (8.32e-3)"	"unprognostic (3.64e-1)"	"unprognostic (5.31e-3)"	"unprognostic (7.35e-2)"	"unprognostic (3.36e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.48e-2)"	7.8	8.9	8.0	6.7	10.1	7.0	7.9	15.0	9.5	8.4	8.0	10.5	17.3	8.5	5.2	5.6	10.9	9.4	5.7	7.5	7.1	7.5	20.0	9.1	9.1	9.2	9.0	10.3	26.6	21.4	8.0	10.2	8.5	8.9	8.8	13.1	12.4	9.0	45.1	8.5	14.2	5.8	6.9	9.5	12.4	11.3	8.6	11.4	8.4	6.1	7.2	8.3	7.6	12.5	10.4	9.2	8.7	13.4	10.2	5.4	24.3	6.8	5.5	6.4	6.3	25.3	16.4	11.7	23.3	5.2	7.4	11.8	12.6	8.8	4.8	11.3	29.4	15.3	12.9	28.1	8.9	14.0	11.2	4.5	11.8	8.1	7.3	8.7	7.9	9.6	14.1	19.8	2.7	13.0	12.8	17.4	11.6	15.6	11.5	15.6	11.6	14.4	11.3	12.7	26.5	17.0	8.7	14.2	8.2	13.3	13.5	10.2	3.7	5.6	16.1	9.2	9.8	17.8	18.1	8.6	3.5	13.2	6.0	1.6	0.8	3.5	2.6	0.6	1.6	1.8	1.6	2.1	0.3	2.1	1.5	1.5	3.3	1.5	1.4	1.8	2.2	0.8	8.0	10.1	15.0	9.5	7.5	7.1	9.2	9.0	8.5	6.9	8.6	12.5	4.1	9.6	4.8	9.1	5.4	1.3	2.7	1.1	0.6	17.5	4.9	5.0	15.6	8.6	3.0	0.0	8.4	5.0	8.9	4.7	0.0	5.0	7.3	5.3	4.4	3.7	4.2	5.7	5.7	4.3	2.6	4.3	5.6	12.6	0.0	11.7	6.4	17.4	2.6	33.7	9.5	7.6	4.1	3.4	0.6	1.3	2.5	1.9	3.6	4.7	2.3	6.4	6.2	18.1	19.6	2.7	1.9	4.1	6.4	7.1	8.4	1.9	2.8	13.5	13.1	5.7	4.5	5.9	6.3	2.8	1.6	1.6	6.9	11.5	8.2	3.4
CNNM4	"ACDP4, KIAA1592"	ENSG00000158158	"Cyclin and CBS domain divalent metal cation transport mediator 4"	Q6P4Q7	2	96760902-96811874	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Biomineralization, Ion transport, Sensory transduction, Transport, Vision"		"Amelogenesis imperfecta, Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 38.8"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 112.6;Distal enterocytes: 103.4;Rod photoreceptor cells: 51.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 45.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017732	Enhanced		Uncertain	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Actin filaments"	"Plasma membrane"	"HPA017732: AB_1847395"	"unprognostic (1.98e-3)"	"unprognostic (8.95e-3)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (9.14e-4)"	"unprognostic (3.42e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.54e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.17e-1)"	"prognostic unfavorable (8.75e-4)"	"unprognostic (4.75e-3)"	"unprognostic (3.72e-1)"	"unprognostic (8.14e-2)"	"unprognostic (3.13e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.06e-1)"	2.8	3.6	5.0	6.1	6.8	4.9	7.0	11.2	5.4	5.8	2.8	32.4	6.2	4.0	4.7	7.1	10.4	4.4	12.5	4.9	4.4	6.8	4.4	8.0	4.6	4.1	4.5	5.1	7.4	6.3	9.1	5.8	4.2	5.7	34.3	38.8	6.8	5.1	24.8	7.2	11.3	4.7	3.5	5.3	12.8	7.9	4.5	3.5	9.5	13.1	4.9	5.5	6.4	5.7	11.1	7.2	5.7	10.5	5.8	3.9	15.6	4.8	6.8	6.9	9.3	13.2	11.8	8.1	13.5	5.0	9.5	14.1	14.9	8.1	6.3	16.3	11.7	6.4	4.8	7.2	8.1	3.1	6.2	3.8	10.0	11.0	6.6	4.6	3.8	8.0	3.3	22.3	3.6	15.7	6.6	4.5	7.5	20.5	9.8	9.7	2.6	9.3	6.9	8.6	26.7	8.0	9.1	45.7	6.8	15.9	22.3	5.3	3.4	4.0	8.9	8.8	5.4	7.7	6.6	4.0	5.9	6.1	7.2	1.2	0.4	0.1	0.8	0.4	0.2	0.9	0.4	0.4	0.6	0.5	0.2	0.5	0.2	0.2	0.7	0.4	0.2	0.3	5.0	6.8	11.2	5.4	4.9	4.4	4.1	4.5	4.2	3.5	4.5	5.7	4.5	38.5	7.7	12.4	6.4	5.7	4.9	4.0	4.6	43.1	14.7	11.2	14.1	4.3	11.6	7.3	112.6	5.4	6.1	103.4	0.0	3.2	4.9	14.3	4.4	4.0	10.1	0.8	9.8	4.2	1.7	3.2	12.2	16.1	1.3	5.9	2.2	3.3	3.3	33.7	8.3	26.4	6.1	5.4	4.8	1.6	0.9	5.9	0.0	8.4	2.3	8.3	2.1	11.1	14.6	5.2	21.3	1.2	4.5	4.1	22.3	1.2	10.6	51.5	0.0	4.6	4.3	4.6	2.5	7.3	4.1	6.7	5.4	6.7	26.5	6.1
CNR1	"CANN6, CB-R, CB1, CB1A, CB1K5, CNR"	ENSG00000118432	"Cannabinoid receptor 1"	P21554	6	88139864-88166359	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 23.0;brain: 25.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 44.6;Inhibitory neurons: 200.3;Sertoli cells: 98.6"	"Cancer enriched"	"Detected in many"	13	"glioma: 12.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"ASC diff: 81.4;HSkMC: 53.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042256, HPA069945"	Enhanced	Supported	Supported	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Actin filaments"	"HPA042256: AB_2677917, HPA069945: "	"unprognostic (1.28e-1)"	"unprognostic (7.04e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.08e-3)"	"unprognostic (1.21e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.59e-3)"	"unprognostic (2.68e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.00e-2)"	23.0	5.4	10.4	3.5	25.1	0.7	16.9	7.5	22.8	5.7	0.0	12.3	1.1	6.9	2.6	2.4	11.2	2.0	1.0	19.5	11.8	0.9	0.1	4.0	4.4	9.9	1.1	3.8	1.5	0.5	20.7	3.1	0.5	2.9	2.9	1.5	2.6	2.1	2.4	3.8	10.5	3.6	0.0	1.7	4.3	1.2	18.0	1.3	5.1	1.2	6.6	4.1	5.1	3.0	0.0	0.1	3.8	0.0	81.4	9.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.2	1.9	2.9	0.0	5.3	0.0	0.0	53.8	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.5	0.0	6.8	0.0	1.7	0.1	0.0	0.0	0.0	0.3	0.0	1.4	4.9	0.0	0.0	0.1	0.0	0.0	1.6	7.1	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	10.4	25.1	7.5	22.8	19.5	11.8	9.9	1.1	0.5	0.0	18.0	3.0	3.4	0.0	10.4	3.6	7.1	0.6	0.5	0.0	0.0	1.7	0.1	0.4	0.9	1.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.2	0.0	0.4	3.8	0.0	0.0	44.6	0.0	0.0	0.9	1.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	200.3	0.0	0.0	0.3	0.8	0.0	1.5	0.2	0.0	5.6	0.0	0.0	0.0	9.0	3.2	0.0	0.1	0.4	4.2	0.0	0.0	0.0	0.0	0.2	98.6	6.4	12.4	0.0	0.5	0.2	0.1	0.1	0.5	0.0	0.0	0.8
CNR2	CB2	ENSG00000188822	"Cannabinoid receptor 2"	P34972	1	23870515-23913362	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.4;lymphoid tissue: 8.8"	"Cell type enriched"	"Detected in some"	5	"B-cells: 27.8"	"Cancer enriched"	"Detected in single"	6	"testis cancer: 2.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"basophil: 49.3;eosinophil: 35.1;memory B-cell: 29.6;naive B-cell: 27.9;NK-cell: 19.4"	"Group enriched"	"Detected in many"	9	"B-cells: 29.6;granulocytes: 49.3;NK-cells: 19.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 5.3;HEL: 4.4;HMC-1: 19.7;U-698: 13.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			CAB009719	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"			"CAB009719: AB_2082784"	"unprognostic (9.45e-4)"	"unprognostic (5.40e-3)"	"unprognostic (8.50e-3)"	"unprognostic (8.19e-3)"	"unprognostic (3.55e-3)"	"unprognostic (9.34e-6)"	"unprognostic (5.58e-3)"	"unprognostic (6.96e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.87e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.04e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.75e-2)"	"unprognostic (4.91e-2)"	0.1	0.0	0.2	2.4	0.1	1.5	0.0	0.5	0.2	0.0	0.2	0.3	0.2	0.1	0.1	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	7.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.0	1.6	0.2	3.4	0.1	0.0	8.8	0.4	0.1	0.2	1.0	0.2	0.0	7.5	0.4	0.0	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.4	0.2	0.0	0.0	0.0	19.7	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.1	0.0	2.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	13.4	0.0	0.1	0.0	49.3	0.1	35.1	3.2	0.1	3.8	29.6	0.1	3.0	0.4	27.9	0.2	1.8	1.2	19.4	0.2	1.7	0.2	2.0	0.2	0.1	0.5	0.2	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.4	0.1	3.2	3.9	0.3	27.8	0.6	0.8	0.0	0.0	0.8	0.2	0.0	0.3	0.0	1.8	0.0	0.0	0.1	2.1	0.5	0.0	0.0	0.2	0.1	0.3	0.3	0.0	3.2	0.4	0.0	0.0	0.9	0.0	0.2	3.8	0.1	0.4	0.3	0.2	0.0	0.4	0.0	0.0	0.6	0.9	0.0	0.0	0.8	0.0	0.0	0.5	0.2	5.2	0.0	0.5	0.1	2.0	0.0	0.5	0.5	0.0	0.1	0.7	0.7	0.0	0.9	0.4	0.3	0.2	0.0	0.3	0.3	2.4	0.2	0.0	0.8
CNTN2	"AXT, TAG-1, TAX, TAX1"	ENSG00000184144	"Contactin 2"	Q02246	1	205042937-205078289	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cell adhesion"		Epilepsy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 248.9"	"Cell type enriched"	"Detected in some"	11	"Oligodendrocytes: 335.5"	"Cancer enriched"	"Detected in some"	9	"glioma: 6.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"NTERA-2: 3.9;SCLC-21H: 9.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001397, HPA012497"	Approved				"Secreted in brain"	NA	NA		58000		"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA001397: AB_1847146, HPA012497: AB_1847147"	"unprognostic (1.90e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.52e-3)"	"unprognostic (2.98e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.25e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.44e-3)"	"unprognostic (5.62e-2)"	"unprognostic (1.73e-7)"	"unprognostic (9.82e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.07e-2)"	0.3	0.5	82.6	0.4	145.4	0.0	0.1	125.7	112.4	0.6	32.4	2.1	0.1	0.0	0.0	0.2	0.1	0.1	0.7	85.2	96.6	0.1	0.0	0.0	0.0	161.6	128.1	0.0	0.1	0.0	8.0	0.0	139.8	0.3	0.5	1.2	0.4	0.6	0.0	0.5	0.9	0.2	110.1	0.1	0.5	6.1	125.7	0.1	0.1	0.0	0.3	0.2	0.7	248.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	82.6	145.4	125.7	112.4	85.2	96.6	161.6	128.1	139.8	110.1	125.7	248.9	0.4	0.0	0.6	1.3	0.1	0.0	0.0	0.0	0.0	2.4	0.9	1.3	3.7	0.0	0.6	1.8	0.0	0.0	1.2	0.0	0.0	0.6	13.7	0.6	0.5	0.5	0.0	0.0	18.4	0.6	0.0	0.4	0.0	1.2	0.0	2.6	0.0	0.0	0.0	3.3	16.0	0.0	0.0	0.0	0.0	29.0	0.6	0.5	0.0	4.7	0.0	0.2	0.0	9.5	335.5	0.6	0.0	0.0	0.4	0.0	0.0	0.3	1.5	0.8	0.0	0.0	0.3	3.2	0.6	0.0	0.0	0.0	0.5	0.2	0.0	0.2
COCH	"COCH-5B2, DFNA31, DFNA9"	ENSG00000100473	Cochlin	O43405	14	30874514-30895065	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"pancreas: 502.0"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 63.0;Horizontal cells: 84.1"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"basal ganglia: 71.3"	"Group enriched"	"Detected in some"	12	"memory B-cell: 38.3;naive B-cell: 17.7"	"Lineage enriched"	"Detected in many"	17	"B-cells: 38.3"	"Cell line enhanced"	"Detected in many"		"HEK 293: 95.7;Hep G2: 63.8;K-562: 129.1;NB-4: 105.5;SCLC-21H: 111.8"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"basal ganglia: 50.8"	HPA065086			Supported	Vesicles	"Secreted in other tissues"	NA	NA		160000	"Cluster 19: B-cells - Humoral immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 48: Smooth muscle cells - ECM organization"	Vesicles		"HPA065086: "	"unprognostic (8.36e-3)"	"unprognostic (2.51e-2)"	"unprognostic (8.61e-2)"	"unprognostic (1.64e-2)"	"unprognostic (6.48e-2)"	"unprognostic (6.53e-2)"	"unprognostic (9.61e-2)"	"unprognostic (4.03e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.91e-3)"	"unprognostic (5.42e-3)"	"unprognostic (3.92e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.72e-1)"	3.2	3.7	7.3	2.8	71.3	4.0	3.4	1.4	20.9	17.4	19.0	3.2	0.8	0.6	2.2	0.9	6.2	2.9	1.9	5.6	8.0	5.2	0.5	0.6	11.0	2.9	7.9	0.8	502.0	3.4	10.1	1.9	3.7	48.3	2.2	12.1	3.6	73.4	1.3	15.2	2.6	1.1	6.2	2.6	1.7	5.2	12.5	1.3	1.3	5.0	7.7	2.0	23.0	1.7	0.0	35.3	3.1	0.0	0.6	0.1	21.8	0.2	0.0	6.4	17.1	20.9	1.2	0.4	1.7	0.0	1.3	0.1	22.2	0.0	10.6	0.0	95.7	18.1	7.6	63.8	0.0	1.8	7.3	1.3	0.0	0.6	0.0	0.0	0.3	39.9	129.1	5.1	1.6	0.8	9.2	105.5	11.9	0.1	3.7	26.7	0.0	0.9	1.1	3.4	111.8	30.4	2.6	0.6	0.2	12.1	0.0	48.7	0.9	0.0	0.0	0.3	0.1	5.7	15.8	11.2	0.0	0.0	4.7	0.0	0.6	0.0	0.0	0.0	0.0	38.3	0.3	0.0	0.1	17.7	0.0	0.1	0.2	0.0	0.0	0.0	2.2	1.0	7.3	71.3	1.4	20.9	5.6	8.0	2.9	7.9	3.7	6.2	12.5	1.7	2.0	0.0	0.5	3.6	13.4	19.1	2.3	0.3	0.0	2.7	7.9	1.5	0.8	2.8	0.9	0.0	4.2	6.5	1.3	0.6	1.9	0.5	1.5	2.2	0.8	3.1	17.0	7.4	14.3	63.0	14.3	22.0	1.1	1.0	1.3	1.8	5.0	5.0	3.8	84.1	24.2	0.3	6.1	5.0	25.2	2.0	1.5	2.4	19.6	7.5	2.8	14.5	0.0	6.0	16.5	3.7	4.3	6.0	10.0	3.5	0.2	11.7	0.5	4.0	0.0	2.8	9.0	22.1	20.3	0.1	13.5	6.6	3.3	0.1	0.6	1.7
CORIN	"ATC2, CRN, Lrp4, PRSC, TMPRSS10"	ENSG00000145244	"Corin, serine peptidase"	Q9Y5Q5	4	47593999-47838106	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"heart muscle: 56.9"	"Cell type enriched"	"Detected in some"	6	"Cardiomyocytes: 69.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"ASC TERT1: 44.0"	"Region enhanced"	"Detected in some"		"basal ganglia: 2.6"	"Low region specificity"	"Detected in some"			HPA070941			Approved	"Nuclear bodies,Plasma membrane,Actin filaments"	"Intracellular and membrane"	Yes	No				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane"	"Nuclear bodies, Actin filaments"	"HPA070941: AB_2686324"	"unprognostic (1.05e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.58e-4)"	"unprognostic (3.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (8.22e-2)"	"unprognostic (9.78e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.86e-2)"	"unprognostic (5.18e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.33e-2)"	0.4	0.1	0.1	0.1	0.1	0.0	1.0	0.1	0.2	2.1	0.6	0.3	0.1	4.5	0.6	0.9	1.4	4.5	56.9	0.0	0.3	1.0	0.1	1.9	0.0	0.7	0.6	0.5	0.2	1.1	1.9	0.4	0.1	2.3	0.0	0.3	0.4	6.1	0.1	7.5	0.3	0.7	0.1	1.1	0.5	2.5	0.3	0.1	0.1	0.1	0.1	1.2	3.9	0.1	0.0	0.0	0.1	0.3	10.3	44.0	0.0	2.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	2.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.9	1.4	0.0	0.3	0.2	1.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.0	0.3	0.7	0.6	0.1	0.1	0.3	0.1	0.3	0.0	7.5	1.0	0.0	3.8	0.3	0.0	0.0	1.0	8.3	0.3	69.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.1	1.3	1.0	0.0	0.0	6.5	0.0	0.0	9.1	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	10.8	0.0	0.0	0.6	5.5	2.0	4.7	0.1	5.4	1.0	0.0	0.7	0.0	2.0	3.9	0.0	0.0	2.6	0.0	0.6	0.0	0.2	0.0	0.3	0.0	0.3	2.3	4.6	4.4	0.1	2.7	0.0	0.6	0.1	0.0	0.3
COX16	"C14orf112, HSPC203"	ENSG00000133983	"Cytochrome c oxidase assembly factor COX16"	Q9P0S2	14	70325081-70416984	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 302.9;Ionocytes: 187.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062659	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA062659: AB_2684823"	"unprognostic (5.44e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.63e-1)"	"unprognostic (6.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (8.22e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.73e-2)"	"unprognostic (6.80e-2)"	"unprognostic (7.44e-2)"	"prognostic favorable (1.03e-12)"	"unprognostic (4.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.97e-1)"	"unprognostic (1.72e-1)"	19.4	27.1	20.2	18.2	19.9	22.8	27.8	20.4	29.2	16.5	22.9	26.6	30.2	12.8	27.1	17.1	17.3	19.4	24.4	20.1	20.7	29.3	40.5	16.7	21.7	21.0	20.1	17.2	43.5	26.9	12.7	14.3	20.5	20.7	22.1	24.3	21.9	13.7	84.0	17.5	26.7	10.5	20.2	18.9	33.4	17.7	20.2	20.8	23.3	44.5	19.0	19.3	12.6	22.5	100.2	31.2	65.9	56.0	26.7	36.0	48.3	55.0	37.1	38.9	34.7	19.2	93.5	26.2	36.6	33.8	33.5	41.8	27.6	35.5	48.9	18.9	27.5	36.9	31.3	22.1	16.1	35.9	48.7	36.1	25.1	24.0	23.0	41.5	34.2	69.2	20.8	54.6	39.0	49.6	85.4	43.8	68.3	83.3	44.5	57.6	53.2	37.0	46.2	49.0	57.8	46.0	46.2	102.4	53.9	42.2	87.4	69.1	42.5	50.2	111.6	55.4	40.6	57.6	38.9	48.2	75.4	19.1	61.1	48.6	33.8	8.0	24.2	38.0	29.2	45.7	34.5	29.1	36.3	39.8	32.3	34.8	2.5	45.6	38.3	55.7	43.6	44.0	20.2	19.9	20.4	29.2	20.1	20.7	21.0	20.1	20.5	20.2	20.2	22.5	22.0	51.3	53.9	0.0	45.0	84.4	9.4	302.9	70.6	8.2	29.7	18.8	7.1	32.9	162.2	23.9	2.1	14.8	22.9	23.8	52.8	47.1	2.7	43.6	21.3	28.5	31.2	46.0	0.0	64.8	20.2	36.0	99.4	62.1	33.5	7.4	31.8	57.7	18.2	1.7	0.0	35.8	187.2	34.6	89.3	4.6	18.3	40.0	96.0	0.0	26.3	25.2	25.7	0.0	0.0	59.1	27.0	15.8	99.3	11.2	42.5	48.6	137.1	10.0	6.6	13.6	27.5	15.4	21.0	125.7	100.7	10.9	39.8	7.3	39.4	14.4
COX18	FLJ38991	ENSG00000163626	"Cytochrome c oxidase assembly factor COX18"	Q8N8Q8	4	73052362-73069755	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046772, HPA049489"	Approved					NA	NA				"Cluster 18: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 52: Non-specific - Transcription"			"HPA046772: AB_2679799, HPA049489: AB_2680791"	"unprognostic (3.32e-3)"	"unprognostic (2.01e-1)"	"prognostic favorable (6.31e-4)"	"unprognostic (9.01e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.17e-1)"	"unprognostic (3.81e-2)"	"unprognostic (6.97e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.29e-3)"	"unprognostic (1.58e-3)"	"unprognostic (2.85e-2)"	"prognostic favorable (8.22e-7)"	"unprognostic (1.28e-2)"	"unprognostic (2.94e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.22e-3)"	1.5	3.9	0.7	0.4	0.8	0.5	1.4	1.3	1.0	1.3	1.1	1.6	0.6	1.5	0.9	1.4	1.2	0.4	2.7	0.8	0.9	1.7	2.4	1.2	0.7	0.4	0.6	1.5	2.0	0.7	1.3	0.6	0.5	0.9	0.6	1.3	1.9	0.6	2.7	1.3	1.4	0.4	0.3	1.3	1.7	1.3	1.0	0.4	1.1	1.2	0.5	1.2	1.2	0.7	0.6	1.0	1.0	1.0	0.9	0.9	0.8	1.0	0.9	0.4	0.5	0.8	1.1	1.8	0.7	0.6	0.7	0.6	1.0	0.7	0.4	1.4	0.7	0.9	1.3	1.3	0.7	1.5	1.2	1.1	0.7	0.4	0.8	1.1	0.8	1.6	1.4	1.7	0.8	0.5	1.8	1.0	1.5	1.1	1.1	1.0	1.6	2.6	0.8	0.6	1.5	1.0	1.1	0.9	0.4	0.8	0.8	0.8	1.1	1.0	0.8	1.3	0.5	1.7	0.8	1.1	1.2	1.1	0.8	0.1	0.2	0.0	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.2	0.3	0.3	0.1	0.2	0.2	0.3	0.1	0.1	0.7	0.8	1.3	1.0	0.8	0.9	0.4	0.6	0.5	0.3	1.0	0.7	5.6	3.2	6.3	7.2	10.1	2.5	3.7	4.5	1.2	11.7	7.1	4.2	13.9	5.7	7.3	9.2	22.9	8.0	9.0	5.5	13.7	6.5	4.0	6.7	8.4	6.7	5.4	7.8	10.5	8.0	8.3	7.0	5.6	7.1	0.0	17.4	11.4	16.7	8.8	20.2	10.6	7.7	4.1	13.9	3.0	2.0	9.0	8.4	5.4	6.5	12.5	6.6	11.3	10.1	13.4	9.3	5.2	9.4	18.1	6.6	6.6	13.0	8.1	14.3	13.1	7.5	6.0	10.2	7.3	5.5	1.4	3.0	8.6	12.7	9.6	3.4
COX4I1	"COX4, COX4-1"	ENSG00000131143	"Cytochrome c oxidase subunit 4I1"	P13073	16	85798633-85807068	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002485, CAB004080"	Supported		Supported	Mitochondria		NA	NA		55000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB004080: AB_2085427, HPA002485: AB_1078559"	"unprognostic (4.73e-2)"	"unprognostic (9.14e-3)"	"unprognostic (2.65e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.47e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.97e-2)"	"unprognostic (7.82e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (2.56e-8)"	"unprognostic (4.23e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.38e-2)"	473.1	393.5	874.4	232.5	881.4	583.2	437.1	896.5	971.9	373.1	882.6	690.5	585.9	301.8	478.8	597.2	355.8	246.9	2047.0	869.5	909.5	632.7	611.2	318.6	412.8	896.4	891.1	366.2	490.4	900.7	362.1	256.7	908.6	377.1	707.7	261.2	421.2	312.3	1333.3	552.5	529.5	301.4	877.2	405.9	650.3	191.1	922.9	479.9	361.5	2063.3	538.7	422.6	420.9	881.0	433.7	677.7	460.2	616.8	823.6	761.2	785.7	379.6	771.2	702.3	346.7	1170.2	636.6	698.6	454.2	610.5	389.9	855.1	657.2	765.3	622.2	238.7	678.1	392.9	554.8	1093.8	741.9	362.9	282.0	893.1	1162.8	579.2	786.0	739.1	746.4	563.6	672.3	280.4	602.5	1510.6	730.9	1116.7	623.0	954.1	796.3	816.9	287.5	616.7	1066.7	840.2	543.2	441.1	807.4	513.2	656.2	489.6	753.2	996.6	529.9	355.5	409.5	330.7	419.0	561.4	562.5	1646.3	542.4	702.2	410.6	633.9	1373.2	805.2	700.3	1199.6	868.1	1302.9	930.5	833.2	1480.8	1231.2	1169.3	968.8	513.9	840.6	1089.3	1105.6	1106.1	2815.9	874.4	881.4	896.5	971.9	869.5	909.5	896.4	891.1	908.6	877.2	922.9	881.0	552.0	275.7	398.1	45.1	925.3	1129.4	1242.3	2031.6	1121.8	280.2	1365.2	1553.2	3479.9	1086.6	942.3	632.7	131.3	1223.1	714.3	1863.5	2752.8	1091.1	539.4	480.5	468.0	629.7	1009.6	524.6	44.0	1316.2	1094.7	591.2	813.0	575.6	521.4	554.3	660.7	1314.7	1602.3	212.0	51.7	1782.5	1125.0	1488.5	1376.5	1155.4	498.9	1010.5	1145.5	35.6	1451.7	562.9	785.8	35.7	65.5	1463.7	1950.7	357.7	726.2	1370.7	3811.3	2936.3	545.4	349.9	355.0	481.8	678.0	358.6	321.7	1721.9	1361.7	1481.9	816.5	1020.3	2147.9	1941.7
COX4I2	"COX4-2, COX4B, COX4L2, COXIV-2, dJ857M17.2"	ENSG00000131055	"Cytochrome c oxidase subunit 4I2"	Q96KJ9	20	31637912-31645006	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 49.1;placenta: 115.4"	"Group enriched"	"Detected in some"	5	"Sertoli cells: 414.2;Smooth muscle cells: 191.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"SH-SY5Y: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.64e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.76e-3)"	"unprognostic (2.18e-2)"	"unprognostic (4.51e-2)"	"prognostic favorable (6.04e-5)"	"unprognostic (5.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.04e-2)"	"unprognostic (5.35e-2)"	"prognostic unfavorable (9.78e-4)"	"unprognostic (1.11e-1)"	"unprognostic (3.30e-3)"	"unprognostic (1.43e-1)"	"unprognostic (5.59e-2)"	19.1	1.1	6.7	1.7	6.7	0.0	15.9	6.5	9.1	4.8	6.1	4.7	1.9	7.5	3.9	5.4	4.9	10.6	39.7	6.5	6.7	10.9	1.1	49.1	4.7	6.8	7.0	2.9	2.3	9.3	2.2	115.4	7.0	10.1	2.7	1.1	3.6	4.7	8.7	4.9	5.8	7.1	6.6	1.7	4.2	1.5	7.0	1.8	14.7	19.4	3.0	7.7	6.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	6.7	6.5	9.1	6.5	6.7	6.8	7.0	7.0	6.6	7.0	6.6	55.0	0.0	0.0	0.0	0.5	6.4	0.3	0.0	2.2	0.4	0.9	1.9	2.7	0.0	0.0	0.0	0.0	1.1	0.3	0.1	0.0	0.0	0.2	0.1	0.7	23.5	0.0	0.0	0.0	0.0	0.3	9.5	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	7.5	0.7	3.7	0.5	8.8	2.8	0.0	3.7	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.7	414.2	4.6	191.6	0.1	1.0	0.8	6.7	2.5	1.0	1.0	0.0	0.3
COX5A		ENSG00000178741	"Cytochrome c oxidase subunit 5A"	P20674	15	74919791-74938083	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1749.5;skeletal muscle: 1609.7;tongue: 1735.8"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1645.3;Distal tubular cells: 1475.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027526	Supported					NA	NA		530000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA027526: AB_10602802"	"unprognostic (7.32e-2)"	"prognostic favorable (2.15e-4)"	"unprognostic (4.06e-2)"	"unprognostic (9.85e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.78e-1)"	"unprognostic (3.79e-2)"	"unprognostic (9.63e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.62e-2)"	"prognostic favorable (6.06e-7)"	"unprognostic (9.78e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.81e-3)"	175.6	176.7	187.1	105.1	189.5	148.5	150.8	231.1	258.1	109.8	201.3	454.2	326.9	98.2	110.7	293.0	89.3	67.8	1749.5	193.1	229.3	373.5	349.6	133.0	125.6	216.1	207.5	71.1	259.3	385.3	141.1	88.0	208.8	118.4	398.2	194.1	211.2	99.2	1609.7	169.0	269.6	95.0	194.8	150.8	306.8	217.8	220.4	150.7	141.5	1735.8	197.9	141.2	146.3	193.8	300.4	309.1	376.8	331.1	227.2	260.2	443.1	262.7	222.3	317.7	294.8	346.0	352.1	700.0	322.0	219.5	387.8	567.7	898.3	368.4	263.7	401.0	906.2	566.6	299.7	436.0	283.9	642.7	335.0	266.6	389.9	198.3	445.1	217.4	377.7	450.0	522.2	429.9	321.2	222.4	558.8	494.6	408.7	575.8	540.1	499.0	369.7	778.4	469.8	472.4	570.5	250.1	396.6	569.2	871.3	407.6	286.3	507.6	274.3	241.4	238.7	303.9	421.1	508.4	1000.3	759.0	258.2	836.1	224.5	332.4	361.5	210.2	198.1	465.6	238.6	296.4	242.4	235.7	452.9	227.3	171.6	198.0	87.4	354.9	432.7	365.2	372.6	426.4	187.1	189.5	231.1	258.1	193.1	229.3	216.1	207.5	208.8	194.8	220.4	193.8	120.7	99.3	119.6	20.5	166.6	158.2	235.3	623.6	151.4	113.4	202.6	313.4	1645.3	221.6	324.0	171.0	39.6	502.8	162.7	987.6	1475.2	407.5	1046.3	199.4	124.3	163.8	461.4	227.3	18.9	436.7	528.2	156.3	247.2	192.8	104.0	143.3	117.8	471.8	571.5	92.5	25.1	890.5	496.4	286.0	209.1	819.6	100.3	238.6	250.8	17.8	413.7	159.9	162.7	15.6	20.2	412.1	817.3	85.7	350.7	319.3	1276.3	921.7	242.7	176.8	92.1	139.6	590.9	523.0	253.6	371.3	159.0	511.0	144.2	216.5	1045.6	393.3
COX5B		ENSG00000135940	"Cytochrome c oxidase subunit 5B"	P10606	2	97646062-97648383	"Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 1151.3;skeletal muscle: 1332.7"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 3614.3;Distal tubular cells: 3621.5;Proximal enterocytes: 2795.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034517	Supported		Enhanced	Mitochondria		NA	NA		230000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA034517: AB_10603561"	"unprognostic (4.61e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.92e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.86e-1)"	"unprognostic (2.72e-2)"	"unprognostic (1.79e-2)"	"unprognostic (4.20e-2)"	"unprognostic (4.02e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (2.73e-4)"	209.1	252.9	323.0	42.8	339.7	113.3	178.7	373.1	436.0	138.1	349.2	322.6	164.2	124.6	72.3	284.6	136.9	32.6	1151.3	319.2	357.2	478.6	372.8	120.4	40.3	341.7	339.9	138.4	165.6	234.0	169.0	47.1	339.9	158.2	113.4	74.5	196.7	90.1	1332.7	213.2	211.9	51.1	332.9	153.2	290.6	101.2	353.1	64.4	185.0	705.9	54.3	179.8	179.1	355.3	144.9	165.5	106.8	169.7	115.9	105.8	428.3	180.0	100.8	118.3	130.5	459.9	148.7	240.8	377.3	116.5	188.4	217.9	117.5	181.8	56.4	188.7	493.2	324.2	166.6	559.8	220.3	310.6	231.2	193.8	161.6	113.4	91.2	125.4	104.4	187.8	243.6	115.5	94.0	360.0	203.5	450.0	196.6	257.2	854.3	194.9	170.6	368.8	167.5	227.9	202.2	210.3	175.0	225.0	374.8	146.0	115.7	345.5	186.9	107.5	181.4	174.4	118.7	265.8	274.7	183.1	194.9	264.5	113.5	1086.6	1062.7	933.1	458.0	1057.0	445.1	801.5	547.4	481.8	990.1	666.0	528.0	468.8	1016.6	469.6	926.3	677.6	783.4	1543.0	323.0	339.7	373.1	436.0	319.2	357.2	341.7	339.9	339.9	332.9	353.1	355.3	461.0	221.2	256.0	33.3	292.7	386.6	629.5	1166.0	377.9	239.1	433.2	536.2	3614.3	567.6	618.5	800.0	227.2	736.0	257.4	1960.0	3621.5	599.5	207.5	399.4	300.8	380.0	740.3	308.8	27.3	604.1	897.1	391.6	616.7	439.7	330.6	392.2	361.3	1234.9	875.0	141.3	33.7	1430.5	1043.6	485.2	651.9	360.8	351.6	456.6	912.4	30.0	711.7	461.5	314.1	15.6	39.4	505.4	1836.0	304.6	353.3	468.2	2795.9	2663.5	485.4	386.3	447.0	340.2	569.9	265.2	310.7	944.2	479.9	613.2	291.9	455.7	1576.9	915.9
COX6A2		ENSG00000156885	"Cytochrome c oxidase subunit 6A2"	Q02221	16	31427731-31428360	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Oxidoreductase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	46	"heart muscle: 3905.3;skeletal muscle: 6742.0;tongue: 2096.1"	"Cell type enriched"	"Detected in some"	18	"Cardiomyocytes: 4861.8"	"Group enriched"	"Detected in many"	5	"head and neck cancer: 9.3;liver cancer: 2.9;prostate cancer: 3.6"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	150	"NK-cell: 15.0"	"Lineage enriched"	"Detected in single"	150	"NK-cells: 15.0"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 16: U-266 - Nucleosome"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.66e-1)"	"unprognostic (1.73e-3)"			"unprognostic (2.09e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.68e-2)"		"unprognostic (3.88e-1)"	"unprognostic (5.61e-2)"	"unprognostic (7.20e-2)"	"unprognostic (8.71e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.65e-1)"			1.9	0.9	1.8	0.1	1.3	0.0	2.9	2.3	2.3	0.4	0.2	1.4	1.1	1.0	0.0	74.8	0.9	0.0	3905.3	0.9	2.1	4.5	15.9	3.3	0.4	1.6	2.6	1.2	3.0	2.9	11.9	0.1	7.3	38.9	0.0	1.0	92.1	0.1	6742.0	3.5	1.2	0.0	0.8	0.5	1.3	1.3	2.6	0.5	2.0	2096.1	0.1	0.3	1.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.1	1.8	1.3	2.3	2.3	0.9	2.1	1.6	2.6	7.3	0.8	2.6	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.2	0.4	4861.8	2.8	0.0	3.7	0.0	0.0	0.4	0.0	5.9	0.0	0.0	0.0	0.1	48.8	0.0	0.0	0.0	0.4	0.0	96.2	0.0	0.1	0.0	0.2	0.4	75.7	2.9	3.3	0.0	0.1	0.0	1.6	0.0	0.8	0.3	1.3	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.3	0.0	0.7	0.0	0.1	1.3	24.9	0.0	4.2	19.7	258.0	53.7	0.2	1.2	0.0	0.0	0.0	2.1	0.0	0.0	0.0
COX6B2	"COXVIB2, CT59, FLJ32865"	ENSG00000160471	"Cytochrome c oxidase subunit 6B2"	Q6YFQ2	19	55349306-55354719	"Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"testis: 90.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 36.0;Late spermatids: 27.4;Respiratory ciliated cells: 12.6;Spermatocytes: 61.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in single"			"Group enriched"	"Detected in some"	6	"CAPAN-2: 24.9;SCLC-21H: 10.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			HPA035014			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA035014: AB_10601261"	"unprognostic (7.43e-3)"	"unprognostic (8.72e-2)"	"unprognostic (1.42e-1)"	"unprognostic (5.75e-2)"	"unprognostic (2.59e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.88e-2)"	"unprognostic (6.45e-3)"	"unprognostic (1.02e-1)"	"unprognostic (6.82e-2)"	"prognostic unfavorable (9.70e-5)"	"unprognostic (8.11e-2)"	"unprognostic (1.81e-6)"	"unprognostic (9.91e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.02e-1)"	0.7	0.1	0.3	1.0	0.2	1.1	0.9	1.0	0.5	0.4	0.4	6.7	0.2	0.2	1.2	1.2	0.7	0.2	0.1	0.3	0.3	0.8	0.1	0.3	0.2	0.3	0.5	0.5	0.2	0.0	0.9	0.2	0.4	0.7	4.8	0.4	1.4	0.2	0.3	2.5	0.3	0.2	0.1	0.3	0.2	90.5	0.3	3.3	0.1	0.0	1.9	0.5	0.9	0.6	3.1	0.4	0.1	0.1	0.0	0.0	0.2	0.4	0.1	0.3	0.5	0.2	24.9	0.1	0.2	0.3	0.3	1.8	0.7	0.2	0.2	0.9	0.7	0.0	2.0	0.1	0.3	0.2	1.8	0.2	2.7	0.5	0.6	1.7	0.0	0.1	0.4	0.2	0.0	0.6	0.1	0.2	0.6	2.6	0.5	0.1	0.0	0.2	0.1	0.4	10.1	0.3	0.4	0.1	0.0	0.6	0.4	0.0	0.5	0.2	0.5	0.1	0.3	1.6	1.4	0.1	0.1	0.3	0.1	0.8	0.2	0.3	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.3	0.2	0.2	1.5	0.5	0.2	0.4	0.2	0.3	0.3	0.2	1.0	0.5	0.3	0.3	0.3	0.5	0.4	0.1	0.3	0.6	0.2	0.0	0.5	0.0	0.0	0.5	0.7	3.5	1.2	2.4	0.9	1.3	0.6	0.0	2.1	0.0	4.2	0.5	1.8	8.0	0.0	0.5	36.0	1.3	0.5	0.2	1.2	0.0	0.0	0.6	0.3	0.6	0.0	0.8	0.0	0.2	0.0	0.0	0.1	3.3	0.1	1.3	4.1	0.0	0.0	27.4	0.6	0.3	0.0	0.0	0.0	1.4	2.1	0.0	0.1	9.6	4.1	0.0	0.3	0.7	3.4	0.1	12.6	5.4	0.0	0.4	0.5	61.1	1.7	0.3	0.4	0.4	0.6	0.1	6.5	2.3
COX7A1	"COX7A, COX7AH"	ENSG00000161281	"Cytochrome c oxidase subunit 7A1"	P24310	19	36150922-36152449	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	18	"heart muscle: 2260.5;skeletal muscle: 6947.0;tongue: 4960.0"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 21879.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 162.5;ASC TERT1: 122.3;BJ: 84.7;BJ hTERT+: 102.7;fHDF/TERT166: 178.6;HHSteC: 91.4;HSkMC: 109.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (5.48e-2)"	"unprognostic (1.19e-1)"	"unprognostic (6.13e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.33e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.77e-2)"	"unprognostic (9.93e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (7.84e-3)"	"unprognostic (7.27e-3)"	"unprognostic (9.44e-2)"	"unprognostic (6.23e-2)"	"unprognostic (1.54e-2)"	269.2	91.5	197.5	20.4	198.8	2.1	105.9	195.3	256.5	70.6	197.2	122.8	14.9	54.6	39.3	82.3	57.8	31.9	2260.5	210.0	214.7	86.9	11.9	63.3	12.0	197.7	188.7	46.0	40.6	147.8	105.6	27.4	199.5	86.6	23.7	49.7	88.0	119.1	6947.0	33.8	36.7	85.1	192.1	34.4	46.7	9.7	200.0	85.8	54.8	4960.0	7.3	88.5	50.1	217.9	0.5	5.9	0.6	0.1	162.5	122.3	0.0	84.7	102.7	3.4	0.0	0.0	1.8	1.4	13.0	178.6	0.0	0.7	0.0	0.0	0.8	0.2	1.8	0.4	2.1	0.3	91.4	0.0	0.8	109.0	0.0	0.0	0.0	0.0	11.3	0.0	0.6	0.7	0.0	0.8	0.0	0.7	1.0	0.6	1.2	0.2	0.0	0.4	0.0	1.6	0.0	0.6	0.0	0.0	0.0	0.2	0.6	0.1	20.7	0.0	1.3	0.5	0.4	0.8	1.9	0.7	0.2	0.8	1.2	0.0	0.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.3	0.1	0.0	0.0	197.5	198.8	195.3	256.5	210.0	214.7	197.7	188.7	199.5	192.1	200.0	217.9	309.7	0.0	5.1	2.3	2.2	26.4	1.0	28.2	2.8	80.6	25.0	89.4	21879.1	18.6	11.0	22.0	45.9	1.0	1.5	0.0	817.8	13.7	17.0	6.0	124.6	360.4	0.0	5.3	5.9	14.1	0.7	602.1	0.5	3.7	45.0	5.5	259.5	7.3	24.0	67.3	4.3	0.0	26.4	10.7	30.5	90.8	224.6	5.2	284.6	3.7	0.0	31.5	0.0	2.0	2.3	6.2	0.0	281.3	1.5	3.5	0.0	183.1	10.7	84.7	184.1	328.4	463.4	2.0	3.8	4.3	19.0	1.9	4.8	17.3	0.1	0.8
COX7B2		ENSG00000170516	"Cytochrome c oxidase subunit 7B2"	Q8TF08	4	46734827-46909245	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	70	"testis: 85.8"	"Group enriched"	"Detected in some"	9	"Early spermatids: 519.2;Late spermatids: 211.0;Spermatocytes: 391.5"	"Cancer enhanced"	"Detected in many"		"liver cancer: 7.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"Karpas-707: 33.9"	"Low region specificity"	"Detected in many"													NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 36: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"										"unprognostic (2.82e-1)"								"unprognostic (2.42e-1)"			0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	85.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	33.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.5	0.0	0.3	0.0	0.0	0.9	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	519.2	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	211.0	9.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	391.5	38.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
COX7C		ENSG00000127184	"Cytochrome c oxidase subunit 7C"	P15954	5	86617928-86620962	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 2380.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 4586.0;Distal tubular cells: 4724.9;Proximal tubular cells: 5650.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046647	Approved					NA	NA		39000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA046647: AB_2679736"	"unprognostic (1.45e-1)"	"unprognostic (1.74e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.85e-1)"	"unprognostic (8.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.70e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.23e-5)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.46e-2)"	338.6	433.9	600.9	274.3	610.7	314.7	324.9	620.1	771.4	329.2	657.2	563.0	545.8	271.8	402.9	420.1	288.0	194.7	1546.9	609.6	648.8	715.2	621.3	243.3	314.5	619.9	616.5	392.7	382.2	781.1	402.4	196.2	613.5	305.4	398.2	236.6	459.7	253.1	2380.2	274.3	537.4	207.5	614.4	270.0	429.7	174.6	624.6	370.8	328.0	1599.4	319.8	344.4	315.0	614.7	576.6	687.2	595.1	1043.0	551.4	550.5	653.4	432.8	364.4	298.2	416.7	806.4	989.9	794.6	459.2	342.3	799.3	594.8	539.3	876.2	487.2	585.2	829.5	623.6	1006.0	844.4	458.9	732.2	692.1	648.0	745.3	377.5	518.0	841.6	486.3	687.0	392.7	860.9	443.7	1209.9	766.2	954.2	594.7	593.0	1958.6	728.4	654.3	1426.2	909.4	1129.8	700.4	518.2	406.7	946.9	973.0	646.9	963.0	1008.6	449.2	254.2	470.5	448.4	846.6	832.8	1056.8	903.4	652.5	860.4	491.6	344.5	526.0	414.6	399.1	558.3	500.0	682.6	620.5	497.6	668.6	567.2	648.4	579.2	52.3	404.7	538.3	619.0	606.5	996.5	600.9	610.7	620.1	771.4	609.6	648.8	619.9	616.5	613.5	614.4	624.6	614.7	408.8	512.8	732.9	33.0	879.5	723.5	946.8	1663.7	715.4	276.2	1141.9	1079.4	4586.0	1574.2	959.9	1213.8	156.4	1271.2	657.5	1604.6	4724.9	1314.8	1011.8	856.3	538.7	570.2	916.6	651.1	24.6	1506.3	878.3	605.7	677.3	706.8	618.0	814.7	809.2	2748.0	1388.3	230.5	30.2	1829.4	933.8	1457.0	904.7	488.5	985.7	785.3	1115.3	18.7	1443.9	714.6	782.7	15.1	25.9	1114.6	1964.4	720.7	617.5	975.5	3353.2	5650.8	734.8	313.3	598.2	662.7	740.8	927.7	381.9	1319.3	935.4	1320.8	826.7	634.8	2108.4	1356.3
COX8A	"COX, COX8, COX8-2, COX8L, VIII, VIII-L"	ENSG00000176340	"Cytochrome c oxidase subunit 8A"	P10176	11	63974620-63976543	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2341.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055942	Supported					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA055942: AB_2682979"	"unprognostic (6.93e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.96e-2)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.70e-3)"	"unprognostic (2.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.46e-1)"	"unprognostic (6.49e-3)"	"unprognostic (1.00e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (2.51e-6)"	"unprognostic (2.70e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.44e-2)"	322.0	443.8	421.6	134.1	435.5	292.0	286.8	470.0	544.7	259.3	524.0	516.1	337.8	236.1	121.2	612.5	246.8	78.4	1287.8	415.9	469.2	771.1	449.9	265.4	119.9	421.5	420.4	248.0	275.7	366.3	373.9	105.7	414.7	316.0	250.2	149.5	362.1	223.8	1523.9	362.0	381.5	132.3	427.7	277.0	467.3	96.7	480.4	206.6	342.9	1005.3	175.8	307.1	331.2	427.9	613.9	803.9	505.6	505.2	213.8	260.8	365.3	317.0	355.2	621.2	480.1	543.1	489.1	290.1	680.8	447.1	581.6	597.7	395.7	550.9	212.5	427.6	687.8	423.2	621.8	650.3	341.4	431.0	527.7	336.7	412.4	497.3	398.6	274.1	391.9	676.2	503.9	613.3	397.7	1600.5	613.8	1461.1	460.7	726.4	1401.4	473.9	406.3	1234.3	512.9	512.7	457.8	645.0	377.1	541.2	816.1	215.0	796.1	459.8	240.7	356.1	481.0	769.2	374.2	760.8	662.4	461.7	462.0	420.9	436.9	764.9	743.9	692.9	407.0	848.8	301.5	398.5	441.6	403.5	867.0	347.3	337.1	369.6	530.6	418.3	794.1	851.2	589.5	723.9	421.6	435.5	470.0	544.7	415.9	469.2	421.5	420.4	414.7	427.7	480.4	427.9	236.7	224.4	259.8	13.7	255.3	294.6	392.2	640.4	385.3	196.8	394.3	458.2	1263.1	424.7	396.1	437.7	73.0	451.2	305.9	1382.7	2341.9	453.1	9.6	271.6	217.2	215.7	721.6	272.9	12.5	483.1	559.6	246.1	395.0	305.1	224.5	209.3	227.4	811.5	927.5	107.7	16.8	1011.7	592.0	535.2	427.0	25.6	239.6	455.4	627.9	11.2	508.9	429.3	416.1	7.5	15.2	562.9	1103.8	221.2	393.2	419.8	1417.0	1658.2	345.2	187.5	157.8	256.0	339.9	74.0	55.5	844.0	370.9	366.9	290.4	203.7	1088.7	593.4
COX8C	COX8-3	ENSG00000187581	"Cytochrome c oxidase subunit 8C"	Q7Z4L0	14	93347182-93348356	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	51	"testis: 76.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 865.6;Late spermatids: 1864.6;Spermatocytes: 424.3"	"Group enriched"	"Detected in some"	8	"ovarian cancer: 2.9;testis cancer: 6.7"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	14	"U-937: 27.4"	"Low region specificity"	"Detected in many"							HPA003127	Approved					NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 34: Spermatids - Unknown function"			"HPA003127: AB_1078560"	"unprognostic (1.29e-1)"	"unprognostic (1.19e-1)"		"unprognostic (1.47e-1)"	"unprognostic (3.76e-3)"			"unprognostic (2.11e-1)"		"unprognostic (2.77e-2)"	"unprognostic (7.71e-2)"	"unprognostic (3.83e-1)"	"unprognostic (1.99e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.15e-2)"	0.0	0.0	0.3	0.0	0.4	0.0	0.0	0.5	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.2	0.3	0.2	0.1	0.0	0.0	0.5	0.4	0.1	0.1	0.0	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	76.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.5	0.2	0.3	0.5	0.4	0.5	0.1	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	1.6	0.0	0.1	0.0	0.0	5.2	0.0	0.0	0.0	0.0	865.6	1.2	0.0	0.8	0.0	0.0	0.0	0.0	14.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1864.6	11.8	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.1	0.0	0.3	1.2	0.0	19.7	0.0	0.1	424.3	124.5	0.0	0.1	3.4	0.0	0.1	0.0	0.1
CP		ENSG00000047457	Ceruloplasmin	P00450	3	149162410-149221829	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 1871.4"	"Cell type enhanced"	"Detected in many"		"Club cells: 558.1;Glandular and luminal cells: 406.0;Hepatocytes: 1687.2;Muller glia cells: 720.5;Respiratory ciliated cells: 318.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 98.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"EFO-21: 318.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001834, CAB008591"	Supported				"Secreted to blood"	NA	NA	160000000000	440000000000		"Cluster 62: Liver - Hemostasis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB008591: AB_1613734, HPA001834: AB_1078502"	"unprognostic (3.58e-1)"	"unprognostic (4.24e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.80e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.97e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.75e-2)"	"unprognostic (6.03e-2)"	"unprognostic (1.70e-1)"	"prognostic unfavorable (1.14e-7)"	"unprognostic (2.68e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.70e-1)"	13.0	2.3	17.9	2.2	18.1	0.9	20.8	18.7	29.8	70.2	129.2	13.0	9.8	14.8	0.0	5.6	8.3	1.1	39.2	17.5	33.0	9.5	1871.4	13.4	18.9	28.1	20.3	0.8	6.5	3.9	28.6	3.4	24.9	7.9	16.4	246.5	39.9	0.9	2.6	13.0	20.8	2.4	19.2	23.1	3.0	1.5	20.1	0.5	16.1	8.3	20.0	23.9	2.3	29.0	0.2	18.8	15.6	0.0	3.3	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.1	0.1	318.8	0.0	29.4	0.1	0.2	0.0	0.0	0.2	0.2	0.0	0.4	32.7	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	2.5	5.4	0.0	0.0	0.0	0.4	6.7	16.2	0.0	0.2	0.3	1.0	0.1	0.4	0.0	0.4	0.0	0.2	1.7	0.2	0.2	0.0	0.0	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	17.9	18.1	18.7	29.8	17.5	33.0	28.1	20.3	24.9	19.2	20.1	29.0	2.3	19.2	76.6	3.3	10.6	3.3	8.3	28.6	0.6	6.9	14.0	0.6	0.6	65.8	558.1	9.2	6.2	0.1	0.3	0.1	0.0	83.4	0.9	190.5	51.0	12.6	0.0	34.7	1.5	21.4	0.2	16.3	0.0	406.0	2.5	0.1	34.6	1687.2	0.6	5.0	1.4	0.2	8.2	44.6	6.9	1.2	0.3	4.0	0.0	6.5	1.6	720.5	1.0	0.5	2.0	69.3	0.0	0.4	0.3	19.5	0.0	0.3	318.4	24.8	0.0	0.8	15.3	0.0	0.1	0.8	2.6	0.3	4.9	0.1	0.1	79.0
CPT1A	"CPT1, CPT1-L, L-CPT1"	ENSG00000110090	"Carnitine palmitoyltransferase 1A"	P50416	11	68754620-68844410	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 110.0;Hepatocytes: 108.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008835	Supported		Supported	Mitochondria		NA	NA		45000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA008835: AB_1078563"	"prognostic unfavorable (3.84e-4)"	"unprognostic (1.38e-3)"	"unprognostic (3.04e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.45e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.17e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.47e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.34e-1)"	"prognostic favorable (2.67e-7)"	"unprognostic (9.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.46e-3)"	24.3	27.7	16.0	22.3	18.4	38.9	22.7	20.2	17.3	20.4	32.0	67.4	70.7	25.1	7.3	22.0	25.4	27.7	25.4	14.7	17.7	38.4	67.9	25.3	15.9	20.6	22.0	18.3	23.6	27.6	14.3	18.4	19.3	20.3	44.6	22.6	26.0	21.9	9.9	17.0	71.3	34.9	15.9	27.4	35.6	13.5	22.1	14.0	15.4	14.3	12.3	18.7	18.0	13.9	29.4	50.9	7.3	48.6	31.2	28.0	2.1	22.9	18.8	17.7	3.6	2.0	96.0	0.1	82.2	60.4	62.2	93.5	63.9	13.6	5.3	46.8	6.3	71.5	52.3	24.0	46.4	41.9	82.6	29.2	6.6	35.5	21.4	24.1	63.5	28.2	7.6	56.8	16.5	83.6	34.4	73.7	0.8	149.7	53.2	94.7	1.2	127.1	41.7	71.7	1.0	31.8	63.0	119.9	20.2	4.8	107.4	40.0	64.5	38.3	0.9	77.7	33.5	43.9	60.1	29.2	40.3	30.3	42.8	8.2	6.6	9.5	7.3	7.7	4.2	1.9	4.4	4.4	4.4	2.0	2.7	5.5	3.2	4.9	6.7	10.4	2.8	2.7	16.0	18.4	20.2	17.3	14.7	17.7	20.6	22.0	19.3	15.9	22.1	13.9	44.4	38.5	28.8	35.6	13.5	9.4	11.0	9.0	28.5	4.8	9.6	7.6	25.5	22.8	18.0	23.9	64.6	15.9	39.3	110.0	19.6	13.8	14.7	33.2	22.6	30.4	16.2	30.9	5.6	9.5	3.9	16.6	31.1	56.7	29.7	23.0	40.7	108.3	15.7	1.7	5.7	48.9	10.2	39.1	11.5	43.9	9.6	24.6	0.0	28.1	31.4	12.7	23.7	7.1	1.7	8.5	43.4	32.0	28.6	9.6	83.4	11.8	23.8	43.0	39.5	18.3	21.1	14.5	10.0	14.8	7.7	7.8	24.0	17.3	67.4	9.2
CRAT	CAT1	ENSG00000095321	"Carnitine O-acetyltransferase"	P43155	9	129094142-129111189	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"	Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 227.5;tongue: 201.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 181.2;Late spermatids: 521.8;Proximal enterocytes: 136.4;Spermatocytes: 123.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019230, HPA020260, HPA022815"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA		8100	"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 6: T47d - Mammary gland"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA019230: AB_1847212, HPA020260: AB_1847210, HPA022815: AB_2732427"	"unprognostic (5.13e-2)"	"unprognostic (9.79e-3)"	"unprognostic (1.99e-2)"	"prognostic favorable (2.36e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-2)"	"unprognostic (2.18e-1)"	"unprognostic (5.11e-2)"	"unprognostic (3.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.03e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.65e-2)"	36.1	51.3	26.4	5.4	26.6	9.0	29.2	27.0	33.8	31.7	27.5	36.1	33.0	24.8	4.0	37.3	23.1	6.6	68.2	25.1	27.8	46.9	151.2	15.2	3.2	28.8	28.2	23.0	107.1	26.3	12.3	6.6	30.6	42.2	4.2	1.7	32.8	8.9	227.5	29.6	37.2	6.8	26.7	15.2	34.0	146.4	30.2	3.1	21.5	201.3	1.6	31.3	27.5	24.4	0.1	39.3	10.7	21.3	13.4	25.9	17.0	15.0	16.6	18.9	12.0	7.8	14.0	1.5	9.2	25.9	23.2	6.7	2.2	4.9	7.2	23.6	0.3	7.3	19.1	30.4	34.1	0.0	26.1	26.3	0.0	15.7	0.9	15.8	26.2	7.2	3.6	5.7	20.0	9.1	0.5	15.9	2.8	32.0	18.0	16.8	21.8	12.2	18.0	0.6	4.2	12.1	0.0	7.1	4.8	3.4	49.7	5.5	22.6	23.0	1.6	32.1	15.4	25.5	22.6	0.1	28.8	4.2	16.8	1.6	8.4	3.5	3.2	5.5	6.7	1.5	4.4	4.3	8.6	1.3	2.6	3.1	1.1	4.4	5.6	3.9	4.5	6.1	26.4	26.6	27.0	33.8	25.1	27.8	28.8	28.2	30.6	26.7	30.2	24.4	10.5	6.4	3.7	5.5	4.9	3.2	4.7	10.8	0.6	1.5	9.7	8.1	57.8	21.5	8.2	3.7	2.1	45.9	6.0	64.5	17.6	22.6	181.2	3.5	15.7	12.9	15.5	17.4	5.3	22.4	55.6	19.3	16.8	9.9	7.0	12.9	14.6	65.7	20.7	1.7	6.1	23.6	14.2	13.9	10.5	521.8	22.1	12.4	5.4	6.5	8.3	15.5	6.2	3.5	4.0	11.6	47.6	24.5	9.6	9.3	136.4	52.0	2.8	1.3	6.6	10.5	15.7	123.5	8.6	57.4	4.5	50.3	7.6	20.1	29.3	13.8
CRBN	"MRT2, MRT2A"	ENSG00000113851	Cereblon	Q96SW2	3	3144628-3179727	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"		"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 314.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045910	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 16: U-266 - Nucleosome"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA045910: AB_10960409"	"unprognostic (1.26e-1)"	"unprognostic (4.14e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.40e-3)"	"unprognostic (2.15e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.17e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.95e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.47e-2)"	25.1	20.9	25.6	17.1	30.2	44.0	33.8	32.7	41.6	22.9	42.0	21.4	21.8	26.2	23.9	20.6	21.7	21.0	30.9	29.2	28.5	31.0	35.4	24.4	28.6	33.7	26.8	32.1	21.9	29.9	11.1	29.5	35.5	23.5	22.9	26.8	36.3	23.6	41.8	24.8	22.8	24.8	22.9	30.6	22.9	48.2	29.1	23.5	31.9	38.5	21.6	20.0	14.6	48.1	12.9	10.5	32.5	14.4	38.8	37.3	13.6	14.3	23.9	18.4	24.6	15.6	18.7	13.9	19.4	17.8	22.3	12.2	19.9	24.1	20.0	24.0	30.9	35.9	20.1	19.4	26.0	32.5	22.4	28.7	31.1	19.9	15.1	36.1	25.2	29.9	21.5	29.4	16.1	18.7	28.6	32.5	27.3	17.8	24.8	25.9	19.5	30.5	21.8	20.0	16.3	23.7	15.9	21.6	35.7	24.1	28.9	24.0	16.3	18.8	9.8	30.0	18.6	33.2	55.8	35.2	29.2	29.5	23.5	314.2	44.3	99.3	61.6	53.6	65.2	46.4	82.6	66.8	39.8	36.9	84.3	72.4	28.1	103.6	58.1	21.4	63.0	96.1	25.6	30.2	32.7	41.6	29.2	28.5	33.7	26.8	35.5	22.9	29.1	48.1	89.7	44.8	39.1	30.3	46.5	36.1	35.5	70.9	33.0	61.5	30.6	43.4	73.5	38.6	45.2	38.6	27.1	52.6	81.2	21.4	72.4	33.3	184.2	23.9	31.7	72.0	15.6	54.5	72.6	21.2	35.3	47.9	17.3	22.3	140.4	50.2	68.6	35.0	36.0	43.7	74.1	24.6	54.9	52.7	33.4	56.6	62.7	54.8	33.8	28.1	68.8	66.4	121.5	42.7	74.0	20.4	33.5	66.5	34.1	26.0	53.4	73.2	36.4	64.5	59.2	58.0	46.2	206.2	96.2	19.2	38.5	50.2	70.9	49.4	30.5	24.7
CRHR1	"CRF-R, CRF1, CRHR"	ENSG00000120088	"Corticotropin releasing hormone receptor 1"	P34998	17	45784280-45835828	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 10.4;pituitary gland: 22.6"	"Group enriched"	"Detected in some"	4	"Early spermatids: 41.0;Late spermatids: 53.4"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebellum: 10.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"RT4: 3.4;SH-SY5Y: 1.8"									CAB025251	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"			"CAB025251: "	"unprognostic (4.59e-2)"	"unprognostic (1.43e-2)"		"unprognostic (2.59e-7)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"		"unprognostic (3.94e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.55e-4)"	"unprognostic (1.65e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.33e-4)"	"unprognostic (2.07e-5)"	"unprognostic (3.26e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.59e-1)"	0.2	0.0	4.1	0.0	1.7	0.0	0.4	10.4	4.8	2.3	0.0	0.0	0.0	1.1	0.1	0.1	0.7	0.0	0.0	1.9	0.4	0.1	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.1	22.6	0.0	0.2	0.6	0.0	3.5	0.2	0.3	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.2	2.8	0.0	0.2	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	1.7	10.4	4.8	1.9	0.4	0.0	1.5	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.0	2.8	1.1	1.3	1.2	10.2	0.7	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	41.0	0.0	0.0	0.4	0.0	2.1	0.0	0.0	0.0	1.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	53.4	0.6	0.3	0.0	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.1	0.4	3.2	1.6	0.1	0.1	0.4	0.5	0.0	0.5	1.6	5.1	1.5	9.9	3.3	0.0	2.5	0.0	0.1	1.7
CROT	COT	ENSG00000005469	"Carnitine O-octanoyltransferase"	Q9UKG9	7	87345664-87399794	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Transport"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 136.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTCEpi: 71.7;RT4: 72.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019052, HPA019364, HPA019365"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles		"HPA019052: AB_1847172, HPA019364: AB_1847173, HPA019365: AB_1847174"	"unprognostic (2.80e-2)"	"unprognostic (6.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (9.93e-3)"	"unprognostic (2.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (9.84e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (2.55e-6)"	"unprognostic (3.52e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.60e-3)"	"prognostic favorable (4.02e-4)"	5.4	10.5	4.8	6.3	6.1	3.2	16.1	5.9	6.1	11.8	7.9	12.6	31.9	7.8	18.5	19.3	10.7	14.1	6.6	5.7	5.1	16.9	35.0	6.6	6.2	4.6	5.0	8.6	6.7	18.7	6.0	19.0	4.5	21.1	11.0	35.4	9.3	27.5	11.3	24.6	23.6	8.6	4.9	5.4	6.8	3.3	5.3	7.6	40.5	9.5	8.5	25.2	19.0	5.6	15.3	10.9	13.5	4.7	12.6	11.5	9.9	15.7	14.8	9.4	10.1	6.0	7.9	6.4	13.6	13.6	18.9	18.9	2.3	21.2	13.5	9.1	9.5	13.9	7.8	7.6	8.1	8.8	8.3	9.4	71.7	7.6	6.0	12.1	13.7	10.4	0.7	9.0	25.2	15.0	11.2	8.8	3.0	5.5	16.4	5.0	18.6	1.1	12.3	72.1	2.2	10.5	19.2	22.3	10.6	9.2	14.2	3.1	7.2	22.0	9.5	29.8	15.2	13.6	21.0	8.8	14.8	0.1	13.3	2.0	1.3	3.4	6.6	1.7	8.7	2.0	6.7	5.5	1.9	1.9	5.3	5.9	0.8	13.0	6.2	2.2	6.2	2.8	4.8	6.1	5.9	6.1	5.7	5.1	4.6	5.0	4.5	4.9	5.3	5.6	8.6	22.4	10.0	18.9	5.1	16.8	56.4	45.0	65.4	16.9	17.5	12.7	14.9	14.3	35.0	53.3	45.9	136.5	9.0	21.0	9.8	7.6	28.7	9.5	9.3	7.2	7.3	4.8	26.3	8.7	7.9	12.0	11.2	12.1	7.6	9.5	5.3	29.7	13.6	15.2	11.1	15.8	16.2	6.3	4.8	63.1	15.8	5.9	19.6	7.5	6.3	25.9	22.6	15.6	16.1	11.1	9.9	13.9	4.8	20.1	53.7	19.9	24.1	79.7	6.6	10.0	10.1	2.4	4.8	29.6	15.3	49.0	9.6	8.7	15.1	48.4
CSE1L	"CAS, CSE1, XPO2"	ENSG00000124207	"Chromosome segregation 1 like"	P55060	20	49046246-49096960	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 164.0;Spermatogonia: 121.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002140, HPA038059, HPA038060"	Enhanced		Enhanced	Nucleoplasm,Cytosol		No	Yes		320000	"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB002140: AB_563461, HPA038059: AB_2675811, HPA038060: AB_2675812"	"unprognostic (4.01e-2)"	"unprognostic (3.15e-2)"	"unprognostic (5.63e-2)"	"prognostic unfavorable (2.91e-5)"	"unprognostic (4.86e-1)"	"unprognostic (4.91e-2)"	"prognostic unfavorable (2.42e-8)"	"unprognostic (3.44e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.72e-3)"	"unprognostic (2.54e-2)"	"prognostic unfavorable (1.89e-4)"	"unprognostic (2.59e-1)"	"unprognostic (4.84e-1)"	"unprognostic (5.71e-1)"	"prognostic unfavorable (6.91e-4)"	23.6	24.5	16.0	29.0	20.2	26.4	34.2	26.6	21.1	25.7	12.9	23.6	19.8	28.1	23.8	38.2	27.0	19.0	24.7	17.1	18.0	29.8	30.9	19.7	35.0	21.0	17.3	27.2	20.4	30.8	13.6	37.5	22.8	25.8	28.7	23.2	21.7	25.6	39.8	34.4	19.2	35.0	21.1	20.3	20.7	87.7	17.0	40.7	23.4	41.5	42.8	27.5	22.2	29.1	224.3	152.4	182.1	140.9	69.0	88.5	196.7	172.1	90.5	528.1	222.0	501.8	175.4	227.3	224.1	109.7	213.9	251.4	270.7	322.9	500.0	37.4	131.3	158.0	166.1	244.7	42.0	176.2	83.3	50.0	118.7	259.0	148.7	72.4	177.5	124.3	227.2	87.1	201.1	76.8	213.9	90.6	153.5	185.1	224.0	133.9	299.5	176.4	116.5	153.2	159.6	92.6	275.2	293.3	97.1	137.7	245.3	113.3	115.5	279.3	233.9	166.4	247.9	50.5	130.8	210.8	166.8	139.5	152.2	18.6	16.3	3.8	13.8	20.6	21.1	16.7	21.0	17.1	20.1	13.6	22.1	19.3	4.4	23.0	23.6	8.9	20.1	18.3	16.0	20.2	26.6	21.1	17.1	18.0	21.0	17.3	22.8	21.1	17.0	29.1	16.4	6.4	26.8	8.1	20.3	30.2	25.8	29.5	31.3	14.9	17.4	15.9	26.6	24.3	22.4	27.6	10.4	71.8	15.7	7.4	13.7	32.2	95.9	14.7	19.4	22.9	5.4	40.4	20.9	26.6	61.2	24.6	13.7	17.8	4.5	35.1	19.2	26.7	29.7	15.2	24.4	11.8	20.3	17.9	21.9	57.8	25.4	17.9	26.6	9.4	28.0	22.6	7.2	17.1	41.7	26.7	10.0	31.6	26.7	28.8	9.9	21.6	21.7	15.5	39.5	19.3	22.1	164.0	121.5	36.7	34.5	72.7	17.5	31.1	23.7	22.2
CSTB	"CST6, EPM1, PME, STFB"	ENSG00000160213	"Cystatin B"	P04080	21	43772511-43776330	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Protease inhibitor, Thiol protease inhibitor"	"Cancer-related genes, Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	8	"esophagus: 11304.7"	"Cell type enhanced"	"Detected in all"		"Basal respiratory cells: 5910.7;Club cells: 4352.8;Hofbauer cells: 2827.7;Squamous epithelial cells: 4910.2;Urothelial cells: 3198.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 2798.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017380, CAB047320, HPA058557"	Enhanced		Supported	Nucleoli,Cytosol		NA	NA		8700000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoli	"CAB047320: , HPA017380: AB_1847414, HPA058557: AB_2683755"	"unprognostic (1.69e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.05e-2)"	"unprognostic (5.92e-2)"	"prognostic unfavorable (6.66e-5)"	"unprognostic (1.90e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (3.63e-1)"	"unprognostic (4.88e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.24e-1)"	224.3	165.6	254.1	141.6	253.6	73.8	161.9	255.4	314.6	585.8	275.2	243.8	122.9	90.1	175.0	11304.7	154.1	150.7	192.2	252.8	263.0	144.7	189.4	290.1	176.4	258.4	257.8	136.1	116.2	154.4	70.1	132.1	259.6	137.3	194.7	78.9	738.3	138.6	100.1	256.9	135.6	110.4	257.5	125.8	249.9	71.7	262.8	268.2	147.9	197.4	1484.9	611.8	1001.9	262.9	1573.6	495.5	146.3	188.1	874.5	742.6	379.6	310.1	431.0	230.7	230.6	401.6	868.6	123.0	245.8	570.1	1814.0	260.5	384.4	405.7	153.5	529.0	388.4	332.4	385.3	473.8	753.0	85.5	267.1	754.5	439.6	621.2	314.7	389.3	331.2	111.8	276.9	681.1	359.7	431.4	100.1	267.6	336.0	1052.6	791.5	169.7	80.5	1472.0	669.1	2798.2	141.8	121.6	420.2	229.2	928.8	75.7	210.4	214.0	426.3	347.7	162.7	305.5	211.8	148.5	347.4	251.1	1432.5	430.2	242.3	390.1	505.5	313.1	242.9	840.3	224.5	198.5	315.4	255.4	766.1	172.7	221.0	217.6	445.6	152.4	1322.9	93.4	406.9	475.2	254.1	253.6	255.4	314.6	252.8	263.0	258.4	257.8	259.6	257.5	262.8	262.9	210.1	176.3	298.4	43.4	140.5	385.3	460.6	5910.7	191.2	69.8	317.8	345.1	105.7	268.8	4352.8	415.6	35.5	310.4	126.5	803.9	538.1	588.4	10.4	388.8	205.1	307.8	239.3	61.4	17.0	488.2	1199.4	238.6	297.7	458.8	228.2	131.5	250.6	464.5	2827.7	67.3	18.4	308.6	1462.8	483.4	1256.2	40.8	381.1	806.9	471.4	24.4	915.9	160.6	255.4	11.1	32.4	810.9	735.6	330.2	167.7	674.3	524.9	469.9	1997.3	72.9	118.3	86.5	320.0	33.7	111.7	4910.2	596.0	402.5	202.8	170.9	367.2	3198.3
CTIF	KIAA0427	ENSG00000134030	"Cap binding complex dependent translation initiation factor"	O43310	18	48539031-48863217	"Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay, Translation regulation"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 94.7;Excitatory neurons: 76.4;Inhibitory neurons: 80.6;Oligodendrocyte precursor cells: 75.9;Oligodendrocytes: 59.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016865, HPA024801"	Uncertain		Supported	Cytosol		NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Cytosol		"HPA016865: AB_1852311, HPA024801: AB_1852312"	"unprognostic (5.84e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.27e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.06e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.44e-1)"	"unprognostic (8.86e-2)"	"unprognostic (1.95e-3)"	"unprognostic (2.77e-3)"	"unprognostic (1.35e-1)"	"prognostic favorable (3.18e-4)"	"unprognostic (1.95e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.34e-3)"	"unprognostic (7.33e-3)"	35.3	20.0	15.7	3.3	13.9	2.0	24.3	10.7	23.2	14.0	0.0	26.0	2.5	21.5	2.6	11.4	16.3	7.5	24.8	16.0	15.5	11.1	24.8	14.3	1.3	20.7	17.4	28.0	9.8	4.6	12.4	4.3	23.3	13.9	1.6	7.4	11.0	5.4	15.8	14.0	9.9	7.0	9.1	6.7	19.6	7.3	19.0	1.4	10.7	4.3	1.0	26.1	12.6	16.7	3.2	3.4	4.5	5.8	11.3	6.0	2.5	15.9	13.2	12.4	11.2	3.5	1.9	0.0	3.5	22.0	5.2	6.7	3.3	9.0	5.3	0.0	2.7	1.4	7.9	8.4	21.6	2.6	4.5	8.4	14.5	7.8	13.8	8.9	8.9	4.1	4.0	9.8	8.0	1.7	0.9	2.0	2.2	3.4	2.8	1.6	5.2	4.2	3.7	4.3	9.6	9.7	5.6	6.0	4.5	3.8	3.8	3.1	18.1	11.4	10.5	3.4	2.9	3.3	4.2	0.0	10.1	1.6	5.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	13.9	10.7	23.2	16.0	15.5	20.7	17.4	23.3	9.1	19.0	16.7	7.3	35.3	3.7	94.7	1.9	3.3	2.1	3.5	2.8	25.6	11.2	8.4	16.0	5.7	5.6	7.3	16.7	1.9	0.8	4.6	7.9	5.1	11.1	1.7	7.7	8.5	3.5	0.4	76.4	4.8	2.8	13.1	7.1	3.6	4.5	19.5	7.5	23.0	4.2	11.8	80.6	3.5	4.1	6.4	2.7	19.3	25.1	5.0	3.6	30.0	1.5	3.6	3.1	75.9	59.7	5.7	2.7	50.8	4.8	3.0	5.9	5.8	4.7	8.8	6.6	8.8	9.4	2.3	1.8	3.5	2.3	1.2	0.7	34.7	3.3	3.3
CTNND1	"CTNND, KIAA0384, p120, p120cas, p120ctn"	ENSG00000198561	"Catenin delta 1"	O60716	11	57753243-57819546	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway"		"Cancer-related genes, Disease variant, Ectodermal dysplasia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 305.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 4.9;intermediate monocyte: 9.5;myeloid DC: 6.3;non-classical monocyte: 5.6"	"Group enriched"	"Detected in many"	19	"dendritic cells: 6.3;monocytes: 9.5"	"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			"CAB003837, HPA015954, HPA015955"	Enhanced		Enhanced	"Plasma membrane"		NA	NA		200000	"Cluster 7: Monocytes - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068"	"unprognostic (1.06e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.87e-2)"	"unprognostic (7.81e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.98e-2)"	"unprognostic (3.52e-3)"	"unprognostic (4.17e-1)"	"unprognostic (2.89e-2)"	"prognostic unfavorable (3.02e-4)"	"unprognostic (2.75e-1)"	"prognostic favorable (3.54e-4)"	"unprognostic (7.17e-2)"	"unprognostic (4.09e-2)"	"unprognostic (3.34e-1)"	"unprognostic (7.33e-2)"	72.6	48.8	29.6	34.8	28.1	5.9	83.3	28.2	33.0	86.0	50.0	107.9	97.8	70.8	49.3	209.7	58.4	56.3	49.0	26.6	26.8	77.9	82.6	83.9	19.0	34.8	30.6	49.3	120.0	76.1	57.7	106.0	32.5	78.9	102.0	23.5	121.8	57.1	26.8	129.4	104.9	54.8	32.3	51.5	105.4	44.3	38.0	24.4	98.6	19.9	48.4	83.5	111.9	33.5	156.6	106.4	70.2	63.3	46.1	71.6	141.7	65.1	78.8	58.5	55.6	88.5	163.9	1.0	113.2	72.5	50.9	201.7	58.8	97.4	71.1	1.0	21.9	32.0	35.8	109.9	52.6	5.0	52.7	70.0	133.5	67.1	73.5	103.8	197.2	1.7	55.1	0.4	55.1	48.0	1.7	13.9	54.7	101.2	56.5	0.7	67.4	1.3	90.2	171.0	4.9	40.1	91.5	133.6	113.1	176.3	138.9	6.1	166.0	59.6	50.3	53.2	34.6	1.2	0.9	2.3	53.2	3.4	111.5	0.0	4.9	0.1	0.0	9.5	0.2	0.2	0.0	0.1	6.3	0.3	0.0	0.0	0.2	0.4	5.6	1.4	0.1	1.1	29.6	28.1	28.2	33.0	26.6	26.8	34.8	30.6	32.5	32.3	38.0	33.5	116.2	147.4	84.0	0.0	8.8	117.1	96.9	82.9	126.9	21.0	101.5	70.5	17.5	125.8	96.6	141.6	39.6	94.0	2.3	305.5	13.7	106.7	14.1	91.1	58.5	98.6	86.2	21.3	0.0	97.2	85.6	34.5	165.1	139.4	32.4	61.1	91.8	127.6	44.4	15.2	0.0	160.7	52.9	64.3	55.5	10.5	28.3	46.4	48.0	0.0	28.5	30.2	2.1	0.0	0.0	141.8	169.3	38.4	5.0	116.9	179.6	57.6	88.2	26.4	26.3	32.3	38.1	37.0	21.1	285.1	200.5	90.8	6.2	39.9	127.0	194.6
CTNS	"CTNS-LSB, PQLC4, SLC66A4"	ENSG00000040531	"Cystinosin, lysosomal cystine transporter"	O60931	17	3636459-3663103	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Protein transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 35.5;Late spermatids: 29.3;Theca cells: 30.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 34.3;granulocytes: 27.9;monocytes: 10.4"	"Cell line enhanced"	"Detected in all"		"HDLM-2: 144.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046947			Supported	"Vesicles,Intermediate filaments"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 43: Testis - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	"Vesicles, Intermediate filaments"		"HPA046947: AB_2679872"	"unprognostic (1.64e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.21e-1)"	"unprognostic (8.25e-2)"	"unprognostic (8.39e-2)"	"prognostic favorable (7.33e-4)"	"unprognostic (1.28e-2)"	"unprognostic (8.02e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.62e-3)"	"prognostic favorable (6.39e-5)"	"unprognostic (8.40e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.80e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.52e-1)"	10.3	19.5	9.5	10.0	17.0	10.2	9.6	13.5	12.1	20.3	12.1	8.3	12.2	11.3	6.4	8.7	10.3	13.1	10.5	10.8	10.3	15.2	15.9	11.6	10.0	16.5	16.8	12.1	27.0	13.6	9.6	12.9	18.0	10.8	7.2	6.8	12.0	11.6	15.3	19.2	11.0	8.6	10.9	12.1	15.0	24.8	13.2	8.8	9.2	7.4	9.5	9.1	9.4	28.0	17.6	37.0	22.6	18.2	34.5	16.9	13.0	19.6	28.8	21.1	26.0	21.0	16.0	10.2	17.8	11.6	55.9	40.1	19.8	12.1	12.6	144.3	33.7	10.8	32.2	19.3	46.5	8.0	81.3	23.8	14.2	20.2	15.4	28.1	22.2	18.7	12.6	15.9	16.6	15.1	7.8	7.9	9.8	12.2	16.8	16.4	9.3	23.0	15.3	16.2	3.9	17.2	19.2	24.4	20.3	19.0	17.1	7.7	24.2	17.2	11.6	40.3	13.3	12.4	20.0	4.2	28.1	7.8	11.8	27.9	10.4	21.8	3.0	6.9	4.9	5.8	4.0	5.7	9.7	4.9	4.5	5.5	3.1	5.2	7.1	34.3	4.3	7.3	9.5	17.0	13.5	12.1	10.8	10.3	16.5	16.8	18.0	10.9	13.2	28.0	4.4	3.2	2.2	6.5	4.8	1.7	3.5	2.5	4.0	1.6	6.3	5.0	5.2	5.7	2.7	12.9	10.4	6.1	5.2	3.6	0.0	6.7	35.5	5.7	4.4	5.3	2.4	4.0	3.4	6.4	7.1	6.0	7.7	4.3	8.2	6.7	9.3	7.6	25.2	5.0	3.4	2.5	4.1	7.2	5.9	29.3	9.6	12.1	5.4	3.7	10.0	6.5	3.1	5.5	11.1	6.4	3.3	12.8	4.5	6.5	3.2	9.5	7.0	3.9	6.6	3.7	3.5	19.7	8.7	2.9	2.4	8.5	3.3	30.9	1.8	3.2
CUTC	CGI-32	ENSG00000119929	"CutC copper transporter"	Q9NTM9	10	99702558-99756134	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	7	"skeletal muscle: 385.5;tongue: 204.2"	"Cell type enriched"	"Detected in all"	4	"Spermatocytes: 163.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038619, HPA058231"	Enhanced		Enhanced	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 5: Granulocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA038619: AB_10672649, HPA058231: "	"unprognostic (1.25e-2)"	"unprognostic (5.92e-2)"	"unprognostic (2.70e-1)"	"unprognostic (8.66e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.55e-3)"	"unprognostic (8.67e-2)"	"unprognostic (5.36e-2)"	"unprognostic (1.81e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.06e-1)"	"prognostic unfavorable (3.81e-7)"	"unprognostic (1.00e-1)"	"unprognostic (3.42e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.97e-1)"	38.7	15.5	19.3	14.6	21.9	23.6	27.3	20.8	25.9	17.3	17.3	19.4	11.1	14.7	11.0	16.0	17.1	12.1	41.7	18.7	20.7	13.5	30.2	15.1	22.3	21.0	20.6	12.6	14.2	8.6	7.8	11.3	21.3	16.1	15.9	28.3	16.9	11.2	385.5	18.6	20.9	14.4	20.1	28.6	18.6	43.4	20.3	23.9	13.2	204.2	19.7	43.8	16.7	25.0	27.4	57.7	19.9	60.7	71.8	32.8	10.8	22.0	28.0	21.6	24.2	26.7	20.5	98.9	19.1	37.5	10.6	22.9	40.8	36.6	23.9	29.5	39.0	32.9	26.1	42.7	33.2	61.5	15.5	34.0	22.3	34.5	71.1	26.8	37.8	56.2	29.6	21.4	16.4	19.4	55.7	63.2	20.0	27.7	21.4	37.5	23.3	38.3	22.8	11.2	6.5	14.8	10.1	15.9	28.9	27.1	25.3	34.7	21.2	9.0	12.2	9.9	29.5	34.7	48.5	69.6	29.4	130.0	8.2	70.6	42.6	111.7	56.9	35.2	60.0	73.4	53.9	54.9	47.1	66.5	74.4	57.2	68.6	63.1	46.0	54.2	57.0	45.3	19.3	21.9	20.8	25.9	18.7	20.7	21.0	20.6	21.3	20.1	20.3	25.0	26.3	9.6	12.5	15.3	32.8	12.1	14.7	23.1	5.7	18.7	12.6	15.2	40.6	14.3	14.9	5.5	8.4	18.6	23.2	4.6	21.5	16.9	12.6	11.4	12.0	19.8	12.1	28.2	8.5	17.4	13.5	32.8	10.7	8.3	30.4	14.4	27.5	23.4	20.9	11.8	9.0	7.4	12.2	17.0	11.7	10.8	13.1	16.6	30.2	7.5	28.0	25.9	21.6	8.0	26.9	10.5	7.4	16.1	27.2	16.1	19.2	34.8	21.5	33.0	19.7	27.1	15.5	163.3	36.7	14.3	10.9	13.5	25.6	36.3	9.6	11.6
CXADR	CAR	ENSG00000154639	"CXADR Ig-like cell adhesion molecule"	P78310	21	17513043-17593579	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 323.4;Proximal enterocytes: 263.0;Suprabasal keratinocytes: 343.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"CACO-2: 93.4;Hep G2: 63.0;NTERA-2: 109.1;RT4: 104.4"					"Low region specificity"	"Detected in all"			"HPA003342, CAB005103, HPA030411, HPA030412"	Enhanced		Enhanced	"Plasma membrane,Cell Junctions"	"Secreted - unknown location"	NA	NA		18000	"Cluster 17: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"		"CAB005103: AB_2087557, HPA003342: AB_1078588, HPA030411: AB_10599620, HPA030412: AB_10601992"	"unprognostic (3.75e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.45e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.04e-1)"	"unprognostic (9.35e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.20e-1)"	"unprognostic (8.27e-2)"	"unprognostic (5.71e-3)"	3.6	2.9	7.0	2.8	8.7	2.6	9.8	6.6	10.8	7.7	22.8	22.5	42.3	5.3	15.2	14.5	10.6	18.3	9.3	8.9	7.1	8.3	49.3	13.6	0.7	10.4	6.8	0.4	15.8	6.8	4.7	0.3	9.3	15.1	25.6	4.9	15.4	14.2	0.4	53.4	42.6	3.3	9.7	2.4	30.9	12.5	7.3	1.5	22.1	0.0	4.1	25.6	10.9	17.7	16.8	9.0	44.6	0.1	0.0	0.0	26.7	0.2	0.2	0.7	2.7	93.4	14.6	6.2	19.7	0.0	13.3	28.1	22.8	6.2	1.0	9.3	19.0	0.1	24.1	63.0	2.9	1.8	0.1	0.0	24.6	1.3	0.4	10.8	9.0	5.5	0.3	0.4	0.0	1.1	3.7	0.1	109.1	15.2	0.0	0.1	15.2	12.5	38.7	104.4	18.5	12.3	10.9	12.6	6.7	45.8	25.4	0.3	0.5	0.2	25.8	0.4	6.6	4.5	7.7	0.4	3.6	0.1	0.6	1.0	0.1	0.1	0.1	0.0	0.2	0.0	0.6	0.1	0.0	0.1	0.6	0.2	0.3	0.2	0.0	0.0	0.1	0.2	7.0	8.7	6.6	10.8	8.9	7.1	10.4	6.8	9.3	9.7	7.3	17.7	0.2	141.1	79.0	2.6	1.0	323.4	172.7	110.6	132.6	16.9	58.6	28.2	29.8	161.5	106.6	103.0	27.1	0.8	0.3	238.4	5.9	130.0	5.3	118.9	8.3	4.8	80.8	9.9	60.4	93.7	0.2	8.6	94.3	128.9	5.7	1.1	47.8	127.7	0.6	0.0	43.0	107.5	81.4	22.9	13.1	7.7	2.1	3.3	23.2	40.3	0.7	13.4	0.0	78.9	161.4	93.4	155.3	0.0	1.6	125.1	263.0	4.0	85.6	11.2	6.6	0.2	5.3	6.4	24.5	117.0	343.8	0.7	4.3	0.5	107.0	202.7
CXCL16	"CXCLG16, SR-PSOX, SRPSOX"	ENSG00000161921	"C-X-C motif chemokine ligand 16"	Q9H2A7	17	4733533-4739928	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Chemotaxis	Cytokine		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Late spermatids: 4051.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 63.3;intermediate monocyte: 107.5;myeloid DC: 38.2;neutrophil: 103.2;non-classical monocyte: 141.6"	"Group enriched"	"Detected in many"	7	"dendritic cells: 38.2;granulocytes: 103.2;monocytes: 141.6"	"Cell line enhanced"	"Detected in many"		"A-431: 86.5;CACO-2: 63.5;CAPAN-2: 58.4;HaCaT: 97.9;T-47d: 57.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA053253, HPA066315"	Approved		Approved	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA	1100000	6800000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"	Vesicles	"HPA053253: AB_2682091, HPA066315: AB_2685657"	"unprognostic (4.64e-3)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.54e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.05e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.74e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.60e-1)"	27.6	18.1	18.7	56.0	19.4	70.4	29.3	20.0	30.7	19.8	20.8	21.9	45.7	11.7	15.3	24.6	24.0	54.0	7.8	17.4	23.0	19.6	52.6	106.0	23.7	32.5	22.7	10.5	20.8	61.8	14.4	31.1	27.9	16.3	25.8	10.2	47.1	14.4	2.6	21.8	39.3	17.6	25.2	43.8	41.2	112.6	28.7	12.5	10.5	3.3	17.9	60.6	14.3	34.2	86.5	12.4	0.4	44.7	0.7	3.1	11.5	1.1	8.9	11.2	15.6	63.5	58.4	0.1	10.0	1.5	8.6	97.9	20.0	14.1	5.3	8.9	14.8	0.4	1.7	29.5	8.5	0.1	15.8	0.7	26.6	5.9	1.3	7.4	3.1	0.9	0.4	0.7	0.8	20.9	0.3	1.8	0.4	42.1	7.2	1.2	0.0	13.2	30.4	15.8	0.4	1.4	17.6	11.3	5.5	2.3	57.4	1.4	0.4	1.5	6.8	2.2	5.3	3.0	3.9	0.1	0.5	2.9	2.4	0.6	63.3	16.7	0.5	107.5	0.7	9.5	1.1	0.8	38.2	13.0	0.8	1.2	103.2	0.6	141.6	16.0	0.1	29.2	18.7	19.4	20.0	30.7	17.4	23.0	32.5	22.7	27.9	25.2	28.7	34.2	9.7	73.7	46.6	1.6	17.4	70.1	130.4	133.4	40.5	2.6	64.8	50.3	0.8	58.6	132.4	40.5	2.1	3.4	11.1	28.1	3.9	151.0	795.4	22.1	4.1	25.4	30.9	2.7	0.1	145.9	2.5	14.2	36.7	32.7	74.1	2.3	132.1	9.0	196.4	3.3	0.3	32.2	44.7	231.6	406.3	4051.5	24.5	270.6	26.6	15.0	556.1	13.2	1.0	5.0	1.2	188.1	44.5	30.1	2.2	277.2	51.3	17.4	62.4	1.3	19.7	3.4	14.4	22.7	11.5	33.7	76.4	2.9	11.7	1.6	23.7	272.7
CXCR4	"CD184, D2S201E, fusin, HM89, HSY3RR, LESTR, NPY3R, NPYR, NPYY3R"	ENSG00000121966	"C-X-C motif chemokine receptor 4"	P61073	2	136114349-136118149	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"G-protein coupled receptor, Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1175.1;lymphoid tissue: 549.3"	"Cell type enhanced"	"Detected in many"		"B-cells: 1446.9;dendritic cells: 1015.1;Langerhans cells: 486.2;Macrophages: 513.6;Plasma cells: 534.2;T-cells: 1436.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 580.8;JURKAT: 323.6;Karpas-707: 302.1;MOLT-4: 538.9;REH: 281.0;U-266/70: 648.5;U-698: 677.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.19e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.12e-2)"	"unprognostic (4.99e-2)"	"unprognostic (9.25e-2)"	"unprognostic (6.06e-2)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.23e-1)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (1.41e-7)"	"prognostic unfavorable (5.67e-4)"	"unprognostic (1.57e-1)"	"unprognostic (3.47e-2)"	"unprognostic (9.33e-2)"	51.8	184.5	11.8	297.9	11.4	1175.1	39.6	14.6	23.8	36.1	20.1	33.2	12.6	35.2	5.5	34.9	64.9	84.5	21.8	10.6	19.7	29.0	52.4	95.5	383.8	24.3	12.8	12.9	10.0	12.3	32.6	57.5	18.2	34.1	48.6	7.8	30.2	11.8	5.2	9.8	246.5	28.1	16.7	346.5	64.0	4.0	15.2	491.2	36.7	12.0	549.3	99.3	26.9	32.3	0.8	0.3	9.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.9	0.0	580.8	1.8	0.0	0.4	0.7	1.7	0.0	0.0	29.6	6.9	35.1	84.3	0.0	0.0	81.5	60.7	0.0	0.0	0.0	0.0	0.0	54.5	323.6	1.0	302.1	0.0	1.5	538.9	72.8	9.3	45.4	2.9	281.0	62.6	102.5	4.5	0.0	30.9	26.1	0.6	2.0	0.3	2.9	0.7	156.7	8.1	0.0	2.0	0.5	0.4	648.5	116.7	677.4	0.1	131.8	0.1	87.0	28.5	117.8	83.8	15.6	67.3	115.6	76.5	79.6	25.7	166.2	113.1	109.5	143.3	17.2	9.1	63.7	76.1	51.9	11.8	11.4	14.6	23.8	10.6	19.7	24.3	12.8	18.2	16.7	15.2	32.3	32.0	16.0	42.2	8.5	1446.9	41.0	5.7	0.3	9.6	8.6	46.1	42.2	5.2	11.5	4.4	3.7	0.0	1.5	1015.1	1.1	13.7	5.1	1.2	20.0	8.9	67.6	1.8	67.5	0.0	0.9	4.2	28.9	52.0	71.0	12.6	9.0	29.6	9.1	159.9	0.0	0.2	2.0	10.2	270.0	486.2	2.9	1.5	513.6	113.8	3.7	189.2	1.0	153.5	0.0	2.0	2.3	1.1	2.6	534.2	3.2	0.0	3.2	2.4	0.8	46.0	99.1	23.1	0.5	7.8	8.5	35.7	6.3	1436.5	4.6	1.8	4.5
CYB561	"CYB561A1, FRRS2"	ENSG00000008283	"Cytochrome b561"	P49447	17	63432304-63446354	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	Translocase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 74.5"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"pons: 124.7"	"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 432.2;SK-BR-3: 209.2;T-47d: 168.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014753	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"			"HPA014753: AB_1847364"	"prognostic unfavorable (8.89e-5)"	"unprognostic (2.90e-1)"	"unprognostic (4.01e-1)"	"prognostic favorable (2.95e-5)"	"unprognostic (1.81e-3)"	"unprognostic (3.82e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.47e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.97e-2)"	"unprognostic (6.38e-2)"	"unprognostic (8.09e-3)"	"unprognostic (1.16e-3)"	"unprognostic (8.17e-2)"	"unprognostic (1.50e-2)"	"unprognostic (2.89e-1)"	14.8	125.6	22.2	12.3	24.4	4.1	32.8	6.8	23.1	45.0	70.6	26.4	36.6	12.3	57.2	51.9	55.8	17.3	16.2	20.4	33.2	24.5	21.0	30.9	8.3	17.2	23.2	9.4	118.0	76.1	74.1	16.2	124.7	63.3	21.1	9.8	85.0	37.8	6.0	37.3	31.9	9.2	9.8	8.7	48.1	6.0	28.0	3.5	40.8	4.6	12.8	16.4	27.4	17.9	99.3	31.9	2.6	20.5	11.5	52.7	43.3	10.3	12.0	12.3	4.9	29.2	96.9	0.2	23.0	75.5	3.3	83.1	20.3	8.0	4.8	26.1	8.7	12.7	20.4	2.0	21.7	1.3	4.3	8.6	84.1	11.2	1.5	17.9	23.9	0.1	41.2	17.7	4.0	140.3	0.5	4.9	20.9	80.5	49.9	0.3	0.2	31.0	40.0	49.8	73.7	432.2	26.0	209.2	10.4	7.3	168.6	6.2	3.6	25.9	29.4	60.6	3.1	0.4	0.4	0.1	22.6	5.1	14.0	0.3	2.0	0.2	19.2	5.7	24.6	0.6	14.4	13.2	2.1	0.6	1.3	4.2	5.2	20.3	7.7	0.1	0.0	5.8	22.2	24.4	6.8	23.1	20.4	33.2	17.2	23.2	124.7	9.8	28.0	17.9	14.6	28.9	37.8	3.6	3.5	16.4	23.7	16.0	26.2	6.1	37.4	24.6	12.8	20.0	36.7	23.9	0.0	25.1	7.0	22.2	3.9	41.1	6.9	74.5	12.5	18.3	21.6	3.4	14.1	50.5	29.2	15.0	30.1	53.9	15.9	7.3	11.4	11.1	4.7	0.0	10.7	31.7	18.3	7.0	9.8	6.2	3.7	4.1	3.6	9.4	6.0	5.2	2.1	0.5	0.6	30.8	11.4	3.4	15.3	41.6	32.1	11.9	68.5	26.8	6.6	5.1	7.6	6.9	7.2	34.2	27.8	24.8	11.4	0.4	26.2	22.6
CYBA	p22-PHOX	ENSG00000051523	"Cytochrome b-245 alpha chain"	P13498	16	88643289-88651054	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	Oxidoreductase	"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 742.0;lymphoid tissue: 693.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 1632.1;Hofbauer cells: 2171.9;Kupffer cells: 1734.2;Macrophages: 1682.8;monocytes: 1688.5;NK-cells: 1805.4;Plasma cells: 1990.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 733.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"MCF7: 1058.3;RPMI-8226: 1631.2;THP-1: 1231.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB009492	Enhanced					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 2: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB009492: AB_2090309"	"prognostic favorable (8.19e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.32e-2)"	"prognostic favorable (4.75e-5)"	"unprognostic (2.42e-1)"	"unprognostic (4.77e-2)"	"unprognostic (4.88e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.11e-1)"	"unprognostic (3.08e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.91e-1)"	"unprognostic (5.22e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.63e-2)"	149.9	68.0	40.3	344.4	41.8	742.0	93.3	46.0	58.0	81.9	62.4	200.9	196.6	60.8	38.5	80.9	95.4	122.5	93.2	38.6	55.0	187.7	71.5	234.6	333.8	73.8	49.3	40.0	108.6	13.4	40.6	54.9	64.1	75.2	79.9	1.8	116.7	26.6	41.8	39.4	245.3	51.3	65.4	693.1	236.0	10.4	62.4	87.1	136.5	19.9	192.8	144.6	74.1	92.2	2.5	663.0	2.6	1.5	1.3	0.4	329.5	155.7	77.3	39.3	24.1	447.2	819.6	510.5	420.7	56.4	0.0	250.5	21.4	0.9	5.8	146.1	564.1	99.0	217.7	694.9	75.7	156.3	397.6	80.7	0.0	1.6	0.3	1.9	23.9	103.6	278.5	567.5	3.2	1058.3	147.9	822.3	106.2	248.7	1.5	437.9	1.6	1631.2	324.9	490.9	84.2	76.5	482.7	78.8	138.5	60.8	1.4	1231.3	129.8	1.5	6.1	1.8	2.2	362.9	459.9	543.6	195.5	464.9	53.4	120.2	103.8	733.7	76.7	150.1	55.8	109.8	36.7	70.4	107.0	110.7	28.9	36.7	192.3	36.4	143.3	196.3	41.2	47.3	40.3	41.8	46.0	58.0	38.6	55.0	73.8	49.3	64.1	65.4	62.4	92.2	157.8	16.0	12.4	0.0	1290.9	119.4	233.4	420.8	53.5	0.4	131.7	133.2	12.8	368.9	487.1	285.1	2.1	45.3	1632.1	807.2	127.2	636.8	4.2	219.5	137.5	137.1	230.5	162.7	0.2	155.3	299.0	184.8	285.4	312.5	279.0	104.3	317.0	23.9	2171.9	0.0	0.2	540.3	233.9	1734.2	1370.8	14.0	50.1	1682.8	1152.6	32.8	1688.5	1.6	1805.4	1.0	0.2	682.8	1045.8	21.4	1990.6	191.8	390.4	1057.4	529.7	2.7	59.2	44.0	164.3	0.9	15.6	75.2	85.7	118.2	838.6	20.5	805.2	436.9
CYBB	"CGD, GP91-PHOX, NOX2"	ENSG00000165168	"Cytochrome b-245 beta chain"	P04839	X	37780059-37813461	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"	"Chronic granulomatous disease, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 160.9;lymphoid tissue: 158.9"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 157.2;Kupffer cells: 456.0;Macrophages: 469.3;monocytes: 396.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 276.3;intermediate monocyte: 261.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 90.9;granulocytes: 110.5;monocytes: 276.3"	"Group enriched"	"Detected in some"	5	"Daudi: 52.8;NB-4: 64.2;REH: 54.6;RPMI-8226: 210.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051227	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA051227: AB_2681395"	"unprognostic (5.83e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.15e-3)"	"unprognostic (1.48e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.29e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.32e-2)"	"unprognostic (5.73e-2)"	"unprognostic (5.18e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.48e-2)"	"unprognostic (1.32e-1)"	"unprognostic (9.72e-2)"	40.5	28.4	5.5	158.9	5.3	160.9	15.2	6.5	5.5	12.3	12.4	22.3	19.3	9.3	4.3	8.9	9.9	26.2	8.0	4.7	9.1	8.0	27.5	91.5	97.1	15.1	9.6	6.9	4.0	4.4	2.5	54.6	13.3	6.7	30.6	1.7	7.0	9.7	3.7	2.2	22.3	55.5	12.5	89.0	17.2	4.7	11.1	18.3	5.3	5.5	73.2	46.8	2.3	24.0	1.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	52.8	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.4	3.6	0.6	0.0	0.0	3.6	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.1	64.2	0.2	0.0	0.3	54.6	0.0	210.4	0.0	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.1	20.0	0.0	0.0	0.1	0.1	0.2	0.6	1.6	3.4	0.0	8.9	0.0	2.2	276.3	110.5	0.4	261.6	0.5	39.6	0.3	0.4	62.8	32.8	0.3	0.2	19.2	0.6	237.1	90.9	0.9	162.5	5.5	5.3	6.5	5.5	4.7	9.1	15.1	9.6	13.3	12.5	11.1	24.0	2.4	25.6	25.4	0.7	99.9	1.0	0.1	0.0	0.6	0.1	1.0	3.0	11.0	2.8	13.0	1.8	0.0	0.9	82.7	2.0	0.0	0.0	0.6	0.2	0.1	8.1	0.0	5.2	1.6	0.4	1.1	4.4	4.1	0.1	7.6	0.1	5.0	3.2	157.2	1.7	1.6	0.7	0.0	456.0	25.0	0.7	0.6	469.3	1.8	76.8	396.6	0.1	14.4	0.0	0.1	0.1	0.5	0.0	13.6	0.0	0.6	0.5	7.3	0.7	13.1	1.6	1.2	0.0	0.6	1.9	1.3	1.8	7.5	0.0	1.3	0.1
CYBRD1	"CYB561A2, DCYTB, FLJ23462, FRRS3"	ENSG00000071967	"Cytochrome b reductase 1"	Q53TN4	2	171522247-171558129	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport"	"Oxidoreductase, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 221.2;Fibroblasts: 243.4;Leydig cells: 202.0;Peritubular cells: 221.5;Proximal enterocytes: 689.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 17.4;intermediate monocyte: 17.7;myeloid DC: 16.8;neutrophil: 9.8;non-classical monocyte: 13.7"	"Group enriched"	"Detected in many"	4	"dendritic cells: 16.8;granulocytes: 9.8;monocytes: 17.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 1064.0;ASC TERT1: 453.8;BJ hTERT+: 408.2;HSkMC: 327.3;hTERT-RPE1: 276.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014757	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA014757: AB_1847374"	"unprognostic (1.35e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.87e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (5.44e-3)"	"unprognostic (8.90e-3)"	"unprognostic (3.57e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.93e-2)"	"unprognostic (8.48e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.51e-2)"	166.7	97.5	32.6	24.4	38.8	18.3	148.7	33.9	34.1	140.0	32.6	68.7	197.7	100.2	49.7	70.6	88.2	153.7	128.6	28.2	45.9	32.0	21.7	129.9	33.8	45.2	38.7	180.9	21.6	12.0	26.1	38.1	40.5	70.6	39.0	22.2	63.7	76.7	23.3	85.0	233.4	87.9	35.6	30.6	53.3	23.8	35.9	27.9	231.0	82.8	30.1	84.3	90.4	43.0	24.8	18.1	10.1	19.2	1064.0	453.8	1.3	88.3	408.2	45.0	56.4	1.1	33.8	0.0	14.8	214.2	46.2	12.2	8.4	7.2	53.2	18.9	2.2	20.7	26.1	0.4	222.7	22.0	1.9	327.3	68.8	70.5	13.7	276.3	29.6	12.4	7.0	0.2	128.3	0.0	7.1	20.4	5.1	0.0	4.6	2.5	125.3	1.5	7.0	1.4	1.3	4.7	104.2	0.2	56.5	3.6	35.8	13.5	59.5	101.0	14.4	96.1	38.3	0.3	0.4	0.2	49.5	18.3	55.6	0.0	17.4	0.8	1.6	17.7	0.3	0.0	0.3	0.2	16.8	0.0	0.0	0.0	9.8	3.6	13.7	0.7	0.0	7.5	32.6	38.8	33.9	34.1	28.2	45.9	45.2	38.7	40.5	35.6	35.9	43.0	37.6	221.2	109.0	45.1	0.9	121.2	47.3	20.3	38.7	0.0	54.7	48.0	18.4	37.1	34.7	25.8	0.0	1.9	3.4	16.1	0.0	1.0	1.5	4.2	35.6	33.9	0.0	85.0	0.9	6.4	2.3	243.4	13.3	8.3	2.5	1.6	73.5	2.4	48.5	0.0	1.5	22.2	2.0	60.7	92.0	6.1	202.0	28.4	44.4	36.5	29.3	27.9	4.1	12.1	54.2	1.8	16.2	221.5	2.2	22.5	689.4	0.3	6.9	1.5	19.7	89.6	49.9	1.2	1.2	7.0	60.1	1.4	5.9	2.8	27.6	18.2
CYGB	"HGB, STAP"	ENSG00000161544	Cytoglobin	Q8WWM9	17	76527356-76551175	"Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 104.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 94.3;Fibroblasts: 87.6;Leydig cells: 95.7;Melanocytes: 78.2;Sertoli cells: 92.1;Smooth muscle cells: 95.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 34.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive B-cell: 2.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 79.6;Hep G2: 61.7;HHSteC: 120.7;HSkMC: 95.4;SH-SY5Y: 129.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017757, HPA061642"	Approved	Approved	Supported	"Nuclear speckles,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Nuclear speckles"	Cytosol	"HPA017757: AB_1847410, HPA061642: AB_2684573"	"unprognostic (6.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.97e-2)"	"prognostic favorable (2.55e-5)"	"prognostic unfavorable (1.85e-4)"	"unprognostic (3.36e-2)"	"unprognostic (3.31e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.83e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.08e-2)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (3.34e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.49e-2)"	"unprognostic (7.76e-2)"	79.6	20.8	10.1	12.0	10.7	1.7	55.1	20.6	13.6	27.7	14.1	27.1	21.1	19.6	4.6	12.8	20.4	13.2	104.4	9.5	15.8	12.4	19.0	27.8	7.2	17.5	26.0	13.8	12.8	11.7	10.9	8.9	26.8	29.9	9.3	77.6	14.2	11.0	19.3	19.5	26.6	5.9	10.1	12.2	22.9	5.3	14.3	5.3	50.1	9.6	2.6	50.7	25.6	9.8	0.2	1.1	1.8	0.4	79.6	23.1	26.1	0.7	2.0	0.3	0.9	0.0	0.3	0.2	24.1	2.4	0.3	0.7	0.1	33.7	0.1	0.1	0.2	0.4	0.4	61.7	120.7	0.0	0.0	95.4	7.2	2.5	2.5	0.4	0.3	0.8	0.3	0.1	1.2	0.8	0.2	0.4	0.3	0.0	1.4	0.5	0.3	0.2	0.4	0.1	0.6	129.8	0.1	0.0	2.7	5.9	0.2	0.6	0.2	3.1	1.6	0.3	0.0	1.2	0.3	0.3	0.2	0.3	9.9	0.0	0.1	0.1	0.2	0.1	0.1	1.6	0.1	0.0	0.1	2.2	0.2	0.5	0.9	1.0	0.0	0.0	0.2	0.2	10.1	10.7	20.6	13.6	9.5	15.8	17.5	26.0	26.8	10.1	14.3	9.8	94.3	3.2	2.0	2.0	3.5	10.8	1.3	17.3	3.4	38.5	1.4	5.7	6.1	0.0	6.7	0.0	0.0	1.4	1.9	0.1	0.0	0.8	0.7	2.9	4.2	23.1	0.0	0.0	2.4	0.2	0.6	87.6	1.5	0.7	0.0	0.2	2.2	1.2	0.4	8.4	12.3	0.0	0.0	0.0	13.3	2.5	95.7	2.6	78.2	3.7	0.0	22.1	0.0	1.0	1.0	0.1	0.0	23.3	0.6	0.8	0.0	0.2	21.1	12.9	92.1	21.8	95.6	1.6	1.4	0.7	6.7	2.9	2.6	9.2	0.0	1.0
CYSLTR1	"CysLT(1), CysLT1, CYSLT1R"	ENSG00000173198	"Cysteinyl leukotriene receptor 1"	Q9Y271	X	78271468-78327691	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 11.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 67.3;Alveolar cells type 2: 68.4;B-cells: 64.1;dendritic cells: 44.7;granulocytes: 78.6;Plasma cells: 44.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 85.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HL-60: 19.8;Karpas-707: 12.4;NB-4: 27.1;RPMI-8226: 41.9;THP-1: 25.2;U-937: 28.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA010546	Approved					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA010546: AB_1078268"	"unprognostic (9.48e-2)"	"unprognostic (6.01e-5)"	"unprognostic (4.72e-3)"	"unprognostic (3.04e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.80e-3)"	"unprognostic (2.52e-1)"	"unprognostic (8.19e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.53e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.41e-4)"	"unprognostic (5.82e-2)"	"unprognostic (3.56e-2)"	"unprognostic (9.87e-2)"	"unprognostic (8.94e-2)"	4.7	1.7	0.6	7.6	0.6	3.5	2.3	0.7	0.8	2.6	0.8	3.6	2.4	1.7	0.7	7.3	1.7	5.6	1.7	0.6	0.8	1.0	1.6	7.3	9.5	1.0	0.7	0.4	0.6	1.4	0.3	3.5	1.0	2.3	4.9	0.3	1.9	1.0	0.5	3.3	3.9	4.5	1.0	10.6	2.9	0.2	0.7	4.1	2.0	1.8	11.6	6.9	0.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	19.8	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	0.0	0.0	0.0	27.1	0.1	0.0	0.0	5.7	0.0	41.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	25.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	28.1	0.0	19.5	15.1	85.8	0.0	26.5	0.1	19.1	5.5	0.2	11.7	15.2	8.3	0.1	45.2	10.6	31.2	18.0	1.4	6.9	0.6	0.6	0.7	0.8	0.6	0.8	1.0	0.7	1.0	1.0	0.7	0.9	20.4	67.3	68.4	0.7	64.1	3.7	3.7	0.6	5.2	3.7	1.6	0.9	1.4	0.0	36.7	0.0	6.2	0.3	44.7	1.1	0.0	0.2	0.0	0.3	0.3	21.5	0.0	3.8	0.5	0.2	0.3	7.6	0.0	0.3	78.6	1.3	5.7	0.3	29.8	0.0	0.3	0.3	2.0	39.3	14.7	0.0	0.6	37.5	7.2	16.9	21.4	0.5	23.7	0.0	0.0	0.2	0.0	0.0	44.9	1.4	1.7	0.5	35.9	0.7	0.0	0.7	3.2	0.1	0.3	1.4	3.7	0.8	20.6	0.2	0.5	3.4
DAD1	OST2	ENSG00000129562	"Defender against cell death 1"	P61803	14	22564907-22589224	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	Apoptosis		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028882	Uncertain		Uncertain	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Endoplasmic reticulum"	"HPA028882: AB_10602214"	"unprognostic (2.76e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-3)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (9.43e-3)"	"unprognostic (3.06e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.99e-2)"	"unprognostic (9.64e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.19e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.37e-3)"	204.0	229.3	209.2	159.1	224.4	129.0	224.0	236.2	259.4	229.6	252.2	197.7	165.8	184.3	473.8	187.0	230.5	190.8	202.6	211.4	238.0	296.8	275.7	183.4	169.6	240.2	218.7	174.5	200.2	254.1	201.6	141.8	238.7	145.5	209.9	86.2	286.3	205.5	156.6	137.2	173.8	206.6	237.2	165.3	197.0	150.7	219.2	211.6	272.8	197.5	191.0	200.0	163.4	252.0	373.3	344.7	274.6	375.8	740.2	529.9	238.3	387.0	473.0	340.5	478.1	219.6	520.1	233.7	242.1	453.1	381.4	330.0	291.1	375.7	543.3	319.8	265.1	228.5	180.9	886.0	514.5	321.2	315.8	395.8	498.7	356.0	454.4	383.1	506.2	220.9	176.4	532.1	509.9	459.3	153.6	391.4	169.7	816.1	557.8	211.7	232.4	306.7	503.2	306.1	211.5	263.4	294.9	416.1	445.9	328.7	251.4	323.1	381.1	291.8	232.2	358.2	248.3	391.2	502.6	308.5	263.8	225.5	431.0	532.4	421.9	460.9	528.4	371.9	518.9	527.2	543.8	501.4	401.0	477.1	564.8	497.6	481.5	437.2	332.3	783.9	560.3	941.8	209.2	224.4	236.2	259.4	211.4	238.0	240.2	218.7	238.7	237.2	219.2	252.0	357.9	160.3	161.7	15.0	183.9	198.3	188.3	581.8	149.7	25.1	201.0	274.6	173.8	187.3	315.2	255.6	27.1	260.9	204.6	174.8	215.2	525.4	196.8	270.3	242.9	267.8	135.7	130.2	10.6	415.2	383.1	276.5	145.2	255.6	302.6	150.8	187.7	231.9	350.3	21.9	11.0	242.3	360.1	146.2	224.8	101.5	214.3	166.8	330.8	8.4	217.3	216.8	198.8	18.1	42.5	396.8	160.7	199.0	408.6	172.5	244.8	420.8	393.7	42.6	151.2	141.5	291.0	300.3	128.1	179.6	215.8	289.0	211.7	266.6	183.8	174.4
DAG1	"156DAG, A3a, AGRNR, DAG"	ENSG00000173402	"Dystroglycan 1"	Q14118	3	49468703-49535618	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Congenital muscular dystrophy, Disease variant, Dystroglycanopathy, Limb-girdle muscular dystrophy, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Granulosa cells: 207.9;Skeletal myocytes: 326.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 280.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001960, CAB016353, HPA070563"	Enhanced		Supported	"Nucleoplasm,Vesicles,Plasma membrane"	"Intracellular and membrane"	NA	NA		84000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Plasma membrane"	Nucleoplasm	"CAB001960: , CAB016353: AB_627292, HPA070563: "	"unprognostic (1.58e-1)"	"unprognostic (5.14e-1)"	"unprognostic (6.71e-3)"	"unprognostic (3.32e-1)"	"unprognostic (7.39e-2)"	"unprognostic (9.91e-2)"	"unprognostic (1.67e-1)"	"unprognostic (3.27e-2)"	"unprognostic (8.18e-2)"	"unprognostic (3.91e-2)"	"unprognostic (5.70e-3)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.59e-4)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-2)"	25.2	22.0	31.5	17.9	32.6	5.4	26.6	30.7	30.7	26.2	25.5	38.8	24.0	32.1	16.2	28.3	31.8	26.4	68.9	30.1	28.9	28.1	43.0	31.8	9.4	33.3	31.4	24.6	51.4	44.3	18.6	77.0	28.6	29.5	30.6	9.8	31.8	37.9	93.8	28.5	24.0	45.9	30.2	12.6	32.0	26.9	34.1	10.5	25.5	95.7	14.3	27.8	22.0	31.2	92.3	92.4	61.9	152.3	80.3	38.8	280.9	63.9	93.7	108.0	69.0	74.2	96.0	13.0	62.2	103.2	87.6	168.4	55.6	81.2	67.2	12.7	18.6	9.6	84.3	87.2	35.5	11.2	17.4	33.3	72.5	100.3	33.3	96.7	97.1	15.3	14.5	9.8	31.2	75.5	10.1	8.1	66.4	110.0	31.2	5.5	60.5	22.3	82.5	126.4	21.8	45.2	74.8	206.0	105.5	170.3	171.6	22.8	51.8	39.1	63.9	76.0	91.4	11.0	24.2	8.1	50.4	12.6	245.9	2.3	1.2	0.7	1.1	1.3	1.2	1.2	0.9	0.9	0.7	1.0	1.0	1.0	2.2	1.1	2.5	1.3	0.7	1.4	31.5	32.6	30.7	30.7	30.1	28.9	33.3	31.4	28.6	30.2	34.1	31.2	19.0	54.5	18.4	32.0	4.0	14.3	8.0	31.7	17.1	7.4	36.1	46.4	56.6	30.0	20.6	35.0	4.2	116.4	5.8	37.3	1.9	32.4	30.0	30.2	17.3	20.9	33.0	14.3	15.6	79.6	118.4	26.1	37.8	37.9	7.0	207.9	16.8	59.9	21.2	3.3	16.5	29.7	14.2	8.6	7.0	20.0	21.5	6.3	33.8	9.4	5.6	27.1	5.2	19.6	10.7	57.2	21.4	36.9	5.1	14.4	18.9	7.6	23.2	8.7	46.0	326.1	36.2	7.1	19.9	19.0	17.0	95.9	5.9	10.0	29.2	10.2
DCD	"AIDD, DCD-1, DSEP, HCAP, PIF"	ENSG00000161634	Dermcidin	P81605	12	54644589-54648493	"Plasma proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"skin 1: 2476.8"	"Cell type enriched"	"Detected in some"	355	"Melanocytes: 8167.8"	"Cancer enriched"	"Detected in some"	9	"breast cancer: 91.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.0"									HPA063967	Enhanced				"Secreted in other tissues"	NA	NA		410000000	"Cluster 42: Non-specific - Transcription"	"Cluster 61: Skin - Cornification"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA063967: AB_2685163"	"unprognostic (3.55e-2)"													"unprognostic (1.61e-1)"				100.2	0.4	3.5	0.3	3.3	1.1	354.3	3.4	5.4	0.3	3.8	0.7	0.2	0.7	0.9	0.5	0.2	0.8	1.3	3.5	3.3	0.2	0.9	0.6	0.2	3.3	3.6	0.4	1.0	0.0	0.5	0.1	3.5	0.4	0.2	0.5	0.5	0.1	14.0	2476.8	0.7	0.1	3.0	0.4	0.7	1.1	3.2	0.3	0.5	0.0	0.2	0.2	0.7	4.1	0.2	0.3	0.4	0.4	0.3	0.4	0.4	0.5	0.1	0.0	0.2	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.6	0.4	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.2	1.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.5	0.2	0.0	0.2	0.1	0.3	0.2	0.2	0.0	0.2	0.2	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.1	1.9	0.4	0.5	0.4	0.3	0.6	0.5	0.4	0.3	0.2	0.4	0.5	0.5	1.1	0.9	0.7	0.5	0.6	0.2	3.5	3.3	3.4	5.4	3.5	3.3	3.3	3.6	3.5	3.0	3.2	4.1	0.0	0.0	0.0	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	0.1	0.0	0.0	8167.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.4	0.2	0.0	23.0	0.0	1.0	0.0	0.0	0.0
DCP1A	"HSA275986, SMAD4IP1, SMIF"	ENSG00000272886	"Decapping mRNA 1A"	Q9NPI6	3	53283429-53347586	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Nonsense-mediated mRNA decay"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013202	Approved		Supported	"Cytoplasmic bodies"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cytoplasmic bodies"		"HPA013202: AB_1857287"	"unprognostic (2.10e-1)"	"unprognostic (7.61e-2)"	"prognostic favorable (9.01e-4)"	"unprognostic (9.79e-3)"	"unprognostic (7.68e-2)"	"unprognostic (4.44e-2)"	"prognostic unfavorable (3.25e-5)"	"unprognostic (2.90e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.24e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.37e-2)"	"unprognostic (7.33e-3)"	"unprognostic (9.14e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.95e-1)"	9.3	8.2	4.3	8.7	4.9	29.9	8.9	11.3	6.8	8.5	5.5	8.5	6.1	11.7	5.8	7.9	9.1	8.2	8.0	4.6	4.9	6.0	6.4	7.7	10.3	4.6	4.6	14.9	6.3	10.3	6.3	10.2	4.8	7.9	8.4	8.6	6.1	6.9	9.5	7.4	7.3	10.4	4.1	9.2	6.8	8.2	5.2	14.2	8.7	9.5	9.8	9.0	7.0	6.3	8.3	8.3	19.4	15.8	13.1	13.5	26.3	9.5	12.5	20.5	19.0	24.7	14.5	18.9	3.7	12.0	12.3	6.8	25.3	9.7	17.8	16.9	11.3	18.5	11.8	12.9	11.4	23.0	24.6	10.7	9.4	18.5	15.0	12.6	15.1	13.2	16.4	20.2	10.1	5.0	30.6	11.2	13.1	8.6	12.1	14.0	12.9	13.2	8.6	18.2	10.1	16.7	16.3	10.7	14.3	14.4	7.0	17.8	16.3	9.8	14.1	10.3	14.5	12.9	11.9	21.9	12.0	12.8	17.8	46.9	25.0	43.0	41.0	25.5	50.4	38.9	41.4	47.8	27.1	48.7	49.6	46.8	26.0	54.3	52.3	31.4	30.9	38.5	4.3	4.9	11.3	6.8	4.6	4.9	4.6	4.6	4.8	4.1	5.2	6.3	28.6	28.9	30.7	26.4	43.6	57.5	48.5	32.4	48.9	27.5	32.7	25.5	26.4	15.7	24.7	7.3	47.9	41.1	34.5	25.5	3.9	29.2	10.8	21.5	33.4	33.5	51.8	20.2	43.4	35.1	52.3	33.6	18.3	34.0	36.8	34.8	24.7	13.2	19.9	28.6	40.5	27.6	24.4	27.6	48.9	26.3	24.8	29.2	10.6	20.6	35.2	18.3	30.9	40.7	44.2	45.0	19.6	25.9	31.8	48.4	22.3	13.5	14.2	30.3	13.1	39.2	32.5	12.8	19.1	27.4	41.2	64.0	39.1	27.7	27.9	62.1
DCSTAMP	"DC-STAMP, FIND, TM7SF4"	ENSG00000164935	"Dendrocyte expressed seven transmembrane protein"	Q9H295	8	104339087-104356689	"Predicted membrane proteins, Transporters"	"Differentiation, Immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 4.5;epididymis: 2.0;lung: 3.8"	"Group enriched"	"Detected in some"	5	"Hofbauer cells: 7.1;Macrophages: 6.5"	"Cancer enriched"	"Detected in some"	46	"thyroid cancer: 45.3"	"Group enriched"	"Detected in some"	4	"amygdala: 4.5;basal ganglia: 2.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (1.11e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.41e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.48e-4)"	"unprognostic (2.14e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.08e-2)"	"unprognostic (1.18e-2)"	"unprognostic (5.26e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.61e-3)"	"unprognostic (8.84e-2)"	"unprognostic (1.36e-1)"	"unprognostic (8.05e-2)"	"unprognostic (8.34e-3)"	0.8	0.0	4.5	0.1	2.6	0.2	0.3	0.0	0.8	0.2	0.0	0.0	0.0	0.0	2.0	0.0	0.1	0.1	0.0	0.8	0.1	0.0	0.4	3.8	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	4.5	2.6	0.0	0.8	0.8	0.1	0.0	0.1	0.1	0.0	0.8	0.1	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	7.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DDOST	"GATD6, KIAA0115, OST, OST48, WBP1"	ENSG00000244038	"Dolichyl-diphosphooligosaccharide--protein glycosyltransferase non-catalytic subunit"	P39656	1	20651767-20661544	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 350.7;Syncytiotrophoblasts: 349.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009746, HPA046841, HPA052867"	Supported		Supported	"Endoplasmic reticulum"		NA	NA		120000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB009746: AB_2092075, HPA046841: AB_2679834, HPA052867: AB_2681977"	"unprognostic (8.57e-3)"	"unprognostic (1.35e-2)"	"unprognostic (1.57e-2)"	"prognostic favorable (5.99e-4)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (4.88e-4)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (1.33e-1)"	"unprognostic (5.51e-3)"	"unprognostic (2.70e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (9.05e-7)"	"unprognostic (1.07e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.07e-1)"	98.1	132.7	44.6	108.5	46.4	191.4	111.9	44.9	46.3	130.7	64.1	161.4	119.4	115.8	224.5	113.2	137.4	98.2	123.4	47.2	53.7	100.6	137.2	104.4	104.6	48.1	45.3	139.5	259.8	112.7	119.1	183.3	46.9	99.8	165.7	42.1	151.7	130.4	80.0	87.3	108.4	122.8	46.1	113.1	139.0	83.4	52.4	84.0	185.6	66.4	121.6	119.3	92.8	51.4	366.0	206.7	178.8	533.9	347.4	359.8	376.6	286.1	545.9	435.5	445.3	278.9	678.8	275.8	501.8	447.0	238.7	292.7	250.4	334.3	321.3	257.0	256.3	235.7	138.5	375.0	513.2	377.5	618.8	371.6	370.2	365.2	439.5	522.8	504.1	180.5	116.3	445.0	266.5	251.1	179.6	308.2	196.5	529.8	214.2	164.5	238.6	492.2	358.7	150.4	133.0	238.3	294.0	299.1	413.5	257.1	237.8	566.8	260.2	249.7	279.6	435.1	274.6	586.1	677.5	195.6	409.4	489.4	342.0	272.0	268.3	257.3	255.6	284.2	270.3	230.4	218.1	239.9	389.7	207.8	203.1	209.6	63.8	266.1	251.4	320.1	256.0	490.6	44.6	46.4	44.9	46.3	47.2	53.7	48.1	45.3	46.9	46.1	52.4	51.4	62.0	35.3	72.3	7.5	93.6	50.2	95.8	200.6	47.3	18.3	70.0	62.5	22.1	77.2	120.0	35.0	29.2	350.7	92.9	52.5	39.2	162.5	29.9	44.7	71.9	65.2	71.8	49.6	10.9	148.3	270.0	102.8	74.5	71.6	79.1	113.2	55.3	74.4	140.8	16.8	9.4	152.6	79.3	66.8	78.8	13.9	74.6	74.5	85.4	6.5	96.4	54.1	87.6	15.6	10.7	93.5	89.7	60.9	320.5	68.9	69.1	54.3	78.9	24.6	46.0	42.5	103.3	136.0	171.3	55.1	53.6	349.7	78.5	122.9	133.7	84.3
DDX19A	"DDX19L, FLJ11126"	ENSG00000168872	"DEAD-box helicase 19A"	Q9NUU7	16	70346861-70373383	"Enzymes, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA045252, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA045252: AB_10961128, HPA066668: "	"unprognostic (3.11e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.07e-2)"	"unprognostic (3.95e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.38e-4)"	"prognostic unfavorable (8.05e-5)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.68e-3)"	20.1	19.1	11.3	14.2	12.0	12.6	17.6	12.5	12.6	16.3	12.6	21.4	10.3	20.8	14.1	19.8	17.2	16.0	22.9	11.1	12.4	17.5	21.8	15.6	19.1	12.2	12.2	21.7	17.3	24.8	11.9	23.6	12.6	15.4	15.0	12.6	14.5	20.8	58.4	16.4	14.0	26.9	12.1	15.2	16.9	7.4	12.7	21.0	20.3	38.5	20.5	22.3	14.5	12.5	36.5	39.9	42.4	43.8	60.8	41.7	39.6	45.8	46.7	70.0	54.1	60.9	27.5	60.4	41.8	49.2	34.1	41.6	75.3	45.2	60.4	20.0	41.1	31.7	32.0	75.5	55.0	56.9	26.3	51.0	31.7	65.3	49.8	35.1	46.3	43.5	77.6	15.6	42.6	53.0	62.2	47.8	68.6	43.6	24.6	79.2	27.9	84.8	42.3	23.0	35.1	45.8	115.3	25.4	35.6	43.8	47.4	35.5	31.0	49.0	39.2	31.4	43.9	44.6	70.5	132.7	32.8	50.8	50.5	9.3	8.6	4.7	7.3	8.0	6.7	5.3	6.4	7.2	10.5	5.8	7.0	7.4	0.8	7.1	7.6	5.9	6.0	7.0	11.3	12.0	12.5	12.6	11.1	12.4	12.2	12.2	12.6	12.1	12.7	12.5	14.8	16.0	20.7	15.3	19.1	9.9	21.2	8.6	14.8	35.0	10.4	11.0	18.0	22.8	17.5	11.0	33.3	23.0	12.7	8.2	9.8	14.7	3.2	14.7	18.6	15.6	14.4	21.0	23.4	13.8	16.3	16.0	7.1	15.2	17.7	18.0	12.5	19.5	14.0	23.5	25.7	10.1	2.0	14.2	9.5	2.0	26.1	11.2	10.6	2.8	19.2	15.6	27.8	8.5	10.9	14.0	9.5	12.4	19.8	23.0	8.7	13.3	12.8	32.3	26.3	14.7	15.1	14.7	15.7	16.3	10.2	17.2	16.3	18.0	13.6	16.0
DDX19B	"DBP5, DDX19"	ENSG00000157349	"DEAD-box helicase 19B"	Q9UMR2	16	70289663-70335305	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"		"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 207.8;Spermatocytes: 101.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037229, CAB037284, HPA046380, HPA066668"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Nucleoplasm		"CAB037229: AB_1840791, CAB037284: AB_1840792, HPA046380: AB_2679645, HPA066668: "	"unprognostic (2.91e-2)"	"unprognostic (5.37e-2)"	"unprognostic (6.48e-2)"	"unprognostic (3.55e-2)"	"unprognostic (3.98e-2)"	"unprognostic (4.05e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.05e-1)"	"unprognostic (6.33e-2)"	"unprognostic (4.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.32e-2)"	26.9	20.5	8.2	14.8	8.3	29.5	23.8	13.5	9.2	15.7	9.4	18.9	18.9	16.3	13.2	18.6	16.6	15.2	17.7	7.9	8.4	20.5	40.0	19.2	22.1	8.4	8.4	15.7	21.0	19.0	14.4	14.8	8.6	16.1	23.3	19.4	19.0	17.5	31.7	32.3	19.5	20.1	8.3	18.1	22.1	45.9	8.3	23.0	20.0	23.0	25.7	20.0	16.2	9.8	5.3	31.8	44.3	40.3	23.9	31.6	38.0	25.3	36.0	54.6	56.6	67.7	38.5	41.9	23.5	32.2	22.3	31.2	0.2	14.7	56.1	17.7	28.5	25.0	20.0	56.5	51.4	53.7	22.9	39.3	28.0	41.5	31.2	22.5	42.5	12.7	25.1	17.3	33.7	37.1	0.1	77.0	27.6	19.9	13.1	73.9	23.8	59.9	33.2	29.5	29.0	37.1	60.0	13.7	33.1	19.3	30.5	47.1	25.8	25.8	22.6	21.6	23.6	37.6	20.7	96.4	8.7	41.1	33.8	80.6	46.4	42.0	46.5	61.1	45.0	45.8	41.3	50.6	44.6	45.3	36.4	35.1	8.7	52.6	40.2	14.2	77.8	54.6	8.2	8.3	13.5	9.2	7.9	8.4	8.4	8.4	8.6	8.3	8.3	9.8	16.7	12.8	21.8	7.5	21.4	9.4	16.5	20.3	11.4	18.4	12.4	11.2	8.0	14.3	20.8	11.0	12.5	19.7	19.5	25.4	31.3	42.3	207.8	10.6	8.1	19.6	22.0	8.6	11.7	66.1	24.4	16.7	13.7	10.6	11.4	13.8	12.5	15.5	29.3	10.1	12.4	18.4	16.2	21.0	21.6	46.7	20.8	17.1	3.6	6.5	33.6	17.0	28.8	7.5	11.0	45.8	35.3	15.8	13.2	28.6	49.3	23.5	24.4	17.9	13.1	9.7	13.7	101.7	7.4	9.2	10.4	31.6	19.0	13.9	22.2	20.4
DDX39B	"BAT1, D6S81E, UAP56"	ENSG00000198563	"DExD-box helicase 39B"	Q13838	6	31530219-31542448	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Transport"	"Helicase, Hydrolase, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEK 293: 352.9;hTERT-HME1: 244.9;K-562: 255.5;NB-4: 254.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034012, HPA055334, HPA058450"	Enhanced		Enhanced	"Nuclear speckles"		NA	NA		270000	"Cluster 32: T-cells - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"CAB034012: AB_2243237, HPA055334: AB_2682787, HPA058450: AB_2683721"	"unprognostic (2.78e-2)"	"unprognostic (1.30e-2)"	"unprognostic (6.86e-3)"	"unprognostic (3.44e-2)"	"unprognostic (3.22e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.89e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.89e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.81e-2)"	"unprognostic (3.53e-3)"	"prognostic unfavorable (1.11e-6)"	"unprognostic (2.85e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.90e-2)"	"prognostic favorable (1.43e-5)"	130.5	138.3	11.9	23.7	12.3	5.5	125.0	12.8	13.1	147.7	12.0	126.6	3.0	127.6	103.5	105.9	133.9	6.2	141.8	11.4	12.4	123.0	125.9	117.5	34.5	14.4	12.5	173.0	187.5	7.9	125.0	14.6	12.6	141.8	16.6	34.3	103.1	30.3	181.6	104.3	134.1	9.5	13.5	178.1	117.0	59.8	12.0	40.1	133.4	60.4	26.4	118.6	113.2	14.6	9.0	130.9	37.7	19.7	121.4	78.1	24.7	9.6	11.5	28.8	25.4	13.3	17.8	24.3	75.0	145.0	106.3	16.5	42.8	223.1	26.7	8.1	352.9	19.9	14.3	28.7	13.2	35.1	18.8	129.0	117.8	28.9	244.9	131.0	18.3	157.0	255.5	7.1	24.1	6.3	22.7	254.1	17.2	18.3	13.0	17.9	41.6	10.8	143.5	11.8	18.4	151.2	26.3	9.0	15.6	35.7	6.5	36.5	10.3	3.7	13.9	3.6	26.7	68.2	78.9	229.9	2.3	39.5	16.6	2.5	6.4	4.8	4.8	7.6	6.4	4.2	6.9	6.7	9.3	6.2	10.2	8.8	4.3	5.2	4.6	7.7	7.1	5.6	11.9	12.3	12.8	13.1	11.4	12.4	14.4	12.5	12.6	13.5	12.0	14.6	31.5	22.4	36.9	0.0	43.9	14.4	41.9	13.2	35.9	21.3	21.8	15.7	4.0	5.7	22.2	3.7	22.9	13.9	58.1	15.2	5.9	9.7	1.4	23.0	37.8	26.5	17.3	26.3	0.0	8.2	11.8	28.0	64.2	32.4	37.2	58.3	13.2	6.9	9.8	15.2	0.0	11.7	12.2	14.8	14.4	2.6	16.1	34.9	8.8	0.0	17.1	8.5	66.9	0.0	0.0	10.4	11.7	11.7	44.5	23.0	17.5	5.1	31.5	27.2	26.3	57.9	35.2	6.4	6.7	44.2	13.5	17.0	50.3	79.6	12.7	33.9
DDX3X	"DBX, DDX14, DDX3, HLP2"	ENSG00000215301	"DEAD-box helicase 3 X-linked"	O00571	X	41333348-41364472	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Chromosome partition, Host-virus interaction, Immunity, Innate immunity, Ribosome biogenesis, Transcription, Transcription regulation, Translation regulation"	"DNA-binding, Helicase, Hydrolase, RNA-binding"	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 887.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001648, HPA005631, HPA059585"	Supported	Supported	Approved	Nucleoplasm,Cytosol		NA	NA		260000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 52: Non-specific - Ribosome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Cytosol	Nucleoplasm	"HPA001648: AB_1078635, HPA005631: AB_1078633, HPA059585: AB_2684073"	"unprognostic (2.42e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.01e-3)"	"unprognostic (1.66e-1)"	"unprognostic (8.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.88e-1)"	"unprognostic (9.80e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.25e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.95e-1)"	"unprognostic (4.77e-1)"	"unprognostic (9.44e-2)"	"unprognostic (2.93e-2)"	164.7	123.2	28.7	113.3	29.9	146.1	99.8	31.9	37.3	102.4	38.8	85.6	80.7	123.4	39.1	107.6	108.8	111.0	96.4	27.0	36.0	110.5	130.6	103.5	118.7	33.6	29.8	108.1	76.9	133.0	52.5	107.3	34.2	68.7	75.8	81.9	72.9	64.8	126.9	91.2	81.6	145.1	32.4	103.2	84.4	43.0	30.9	169.6	104.3	112.5	111.5	153.3	97.7	34.7	230.5	225.6	236.3	122.3	273.6	211.1	136.4	150.6	239.3	167.1	132.3	238.8	141.4	2.5	103.9	185.8	212.4	149.4	292.2	235.0	248.3	130.2	232.9	132.6	237.6	152.1	140.5	253.8	236.4	159.1	150.9	278.4	270.3	204.1	258.3	131.5	258.4	134.5	158.9	157.8	163.0	83.2	212.2	121.3	114.2	187.8	223.3	182.6	143.7	279.1	147.1	220.0	352.3	184.3	194.3	248.9	158.9	172.4	224.5	159.6	166.3	178.7	188.2	153.6	194.0	215.7	161.5	156.1	151.5	50.8	39.0	30.7	23.3	35.3	33.5	21.0	23.3	26.3	34.7	13.0	25.4	25.3	54.0	30.7	39.4	11.7	24.8	37.8	28.7	29.9	31.9	37.3	27.0	36.0	33.6	29.8	34.2	32.4	30.9	34.7	466.5	86.6	150.0	66.9	280.1	264.3	160.5	63.7	191.8	77.1	295.1	237.6	158.0	81.5	96.5	58.8	131.3	94.6	415.2	231.1	43.0	64.3	370.6	261.1	237.7	238.5	183.7	113.0	43.8	85.6	95.1	191.8	178.9	290.1	165.5	180.6	144.2	174.5	123.1	60.6	47.1	161.4	71.2	208.7	269.1	887.5	66.5	319.0	128.1	47.8	112.2	90.0	79.3	44.7	63.1	114.1	156.7	62.8	241.8	145.0	234.9	87.3	102.5	127.1	72.3	351.4	210.1	30.6	57.7	212.6	333.4	172.9	342.4	144.8	129.1	225.8
DEFA1	"DEF1, DEFA2, HNP-1, MRS"	ENSG00000206047	"Defensin alpha 1"	P59665	8	6977649-6980080	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Antiviral defense"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"bone marrow: 18020.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	18	"NB-4: 2.1"									"CAB032548, HPA052517"	Enhanced				"Secreted to blood"	NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 58: T-cells - T-cell receptor"			"CAB032548: AB_2277258, HPA052517: AB_2681860"																		31.6	4.3	0.7	0.6	0.8	18020.9	16.8	0.5	3.0	4.0	0.6	4.1	0.0	11.3	0.0	3.2	2.2	1.3	62.5	0.5	0.6	15.0	91.6	560.5	3.5	0.7	0.7	4.1	5.5	0.1	20.6	11.4	0.7	2.7	0.0	0.3	14.5	0.0	16.8	40.3	2.3	0.0	0.8	1803.8	6.4	3.1	0.8	37.0	15.8	0.0	0.8	3.4	5.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	0.5	3.0	0.5	0.6	0.7	0.7	0.7	0.8	0.8	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
DEFA1B		ENSG00000240247	"Defensin alpha 1B"	P59665	8	6996766-6999195	"Cancer-related genes, Plasma proteins, Predicted secreted proteins, Transporters"	"Antiviral defense"	"Antibiotic, Antimicrobial, Defensin, Fungicide"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"bone marrow: 872.0"	"Cell type enriched"	"Detected in single"	37	"T-cells: 3.8"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	4	"cerebral cortex: 2.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA052517	Supported				"Secreted to blood"	NA	NA				"Cluster 67: Neutrophils - Humoral immune response"		"Cluster 11: Alveolar cells - Smell perception"			"HPA052517: AB_2681860"																		2.3	0.3	0.1	0.8	0.1	872.0	1.1	0.1	2.0	0.0	0.1	0.2	0.0	0.9	0.0	0.1	0.1	0.0	3.8	0.2	0.1	0.9	9.1	52.1	0.0	0.2	0.1	0.3	0.1	0.0	1.4	7.2	0.4	0.1	0.0	0.1	9.4	0.0	0.8	0.2	0.2	0.0	0.1	150.4	0.6	0.1	0.4	27.8	1.2	5.8	1.4	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	2.0	0.2	0.1	0.2	0.1	0.4	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0
DEFB1	"BD1, DEFB-1, DEFB101, HBD-1, HBD1, MGC51822"	ENSG00000164825	"Defensin beta 1"	P60022	8	6870592-6877936	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 1746.1;pancreas: 747.8;salivary gland: 1975.0"	"Cell type enriched"	"Detected in many"	6	"Distal tubular cells: 13300.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 522.9"	"Group enriched"	"Detected in many"	4	"amygdala: 1.2;cerebellum: 1.5;hypothalamus: 1.0;midbrain: 2.4;thalamus: 3.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SCLC-21H: 43.3"					"Not detected"	"Not detected"								"Secreted in other tissues"	NA	NA		2500000	"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (2.31e-2)"	"unprognostic (8.35e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.89e-1)"	"unprognostic (2.16e-3)"	"unprognostic (4.41e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (2.77e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavorable (5.94e-4)"	"unprognostic (3.24e-1)"	"prognostic favorable (1.90e-5)"	"unprognostic (9.62e-2)"	"unprognostic (2.86e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.16e-1)"	11.1	0.7	1.2	1.5	0.0	5.3	41.5	1.5	0.4	305.4	0.3	20.7	5.1	6.2	16.4	190.6	21.2	54.9	1.3	0.0	1.0	1746.1	248.4	5.7	0.0	0.0	2.4	0.5	747.8	6.9	12.7	2.1	0.2	37.9	11.5	1.9	1975.0	24.5	2.9	217.6	8.7	0.3	0.0	0.3	33.3	0.4	3.0	3.0	3.6	0.0	9.0	11.6	152.2	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.2	0.0	0.5	0.0	2.2	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.5	4.2	0.0	0.1	0.3	0.0	2.7	1.2	43.3	0.3	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.5	0.0	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	0.4	0.0	1.0	0.0	2.4	0.2	0.0	3.0	0.2	0.7	3.2	4.5	0.0	6.8	90.1	641.5	210.5	134.9	0.4	46.9	26.9	0.1	1976.0	57.2	982.1	0.0	11.8	0.4	117.6	13300.4	1860.0	0.0	339.5	223.6	8.8	15.7	0.0	0.0	295.4	0.9	19.0	1.5	1529.3	0.0	0.0	3.3	319.3	3.6	0.0	0.0	8.6	46.8	4.4	7.3	0.1	17.4	17.0	7.2	0.0	15.3	0.6	0.0	0.0	0.0	156.9	91.2	0.0	1.2	537.6	59.1	218.9	9.5	0.7	0.0	1.4	14.3	0.0	0.0	237.0	537.6	3.7	13.8	0.0	15.4	257.0
DEFB103A	"DEFB-3, DEFB103, DEFB3, HBD-3, HBD3, HBP-3, HBP3"	ENSG00000176797	"Defensin beta 103A"	P81534	8	7881392-7882663	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 7.6;salivary gland: 3.2;vagina: 3.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 5.8;LHCN-M2: 1.7;U-2197: 3.0"														"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"																						0.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.6	2.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	7.6	0.0	3.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB103B		ENSG00000177243	"Defensin beta 103B"	P81534	8	7428888-7430348	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"cervix: 1.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"	NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"																							0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DEFB4A	"DEFB-2, DEFB102, DEFB2, DEFB4, HBD-2, SAP1"	ENSG00000171711	"Defensin beta 4A"	O15263	8	7894677-7896716	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"esophagus: 124.1"	"Group enriched"	"Detected in some"	8	"Basal respiratory cells: 79.5;Club cells: 38.3;Exocrine glandular cells: 37.4;Pancreatic endocrine cells: 41.0"	"Group enriched"	"Detected in many"	6	"head and neck cancer: 32.2;melanoma: 9.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"EFO-21: 1.4"														"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"					"unprognostic (6.96e-2)"		"unprognostic (1.17e-2)"		"unprognostic (2.72e-2)"		"unprognostic (4.37e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"				"unprognostic (2.75e-1)"				0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	124.1	0.1	3.6	0.0	0.0	0.0	0.1	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	3.2	0.4	0.0	0.0	0.0	7.3	0.0	0.0	5.0	0.0	0.0	7.6	0.2	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	79.5	0.0	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.1	0.0	5.6	0.0	4.3	0.0	5.3	0.2	0.0	0.0	0.0	0.0	37.4	0.0	0.0	3.1	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.0	1.1	0.0	0.0	0.1	0.0	0.1	3.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6
DEFB4B	DEFB4P	ENSG00000177257	"Defensin beta 4B"	O15263	8	7414855-7416863	"Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Defensin"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 12.0;lymphoid tissue: 3.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																"Secreted in other tissues"	NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 16: Pancreatic endocrine cells - Mixed function"									"unprognostic (1.35e-1)"												0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.4	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DERL1	"DER-1, DER1, derlin-1, FLJ13784, MGC3067, PRO2577"	ENSG00000136986	"Derlin 1"	Q9BUN8	8	123013170-123042302	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 225.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 825.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016562, CAB037269"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB037269: AB_609868, HPA016562: AB_1847611"	"prognostic unfavorable (2.43e-4)"	"unprognostic (4.30e-2)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (5.66e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.21e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.28e-3)"	"unprognostic (4.42e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.41e-3)"	"unprognostic (4.35e-1)"	"prognostic unfavorable (1.58e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	69.1	47.6	15.2	53.7	16.4	104.1	34.1	20.2	18.2	26.6	26.6	50.0	47.9	29.4	31.4	35.4	29.4	32.9	41.3	17.9	18.3	30.8	77.5	37.1	48.7	15.7	16.4	38.1	31.6	26.9	23.0	28.0	15.7	27.0	42.8	29.6	29.6	28.7	73.3	23.6	47.0	34.4	16.7	40.0	38.5	32.1	18.0	27.2	42.4	49.1	55.5	41.8	22.5	19.5	130.8	93.9	55.7	72.6	98.3	72.8	47.1	108.9	72.1	68.7	85.1	59.7	126.9	150.7	129.8	87.4	81.2	107.0	51.8	69.3	97.4	174.9	57.6	157.2	62.9	51.6	89.2	62.2	111.0	66.9	87.8	76.0	89.8	62.5	62.8	60.6	95.9	193.7	78.7	254.8	68.5	39.4	42.1	166.4	82.5	68.3	46.2	252.1	182.2	92.1	60.5	89.8	109.9	825.1	68.6	59.6	97.3	55.4	74.2	82.2	154.1	74.1	102.1	239.5	444.6	136.5	135.4	76.4	79.4	73.1	60.7	72.6	89.3	75.7	93.0	69.8	59.5	74.0	49.5	56.1	41.0	64.0	42.1	77.8	77.9	56.6	80.0	83.3	15.2	16.4	20.2	18.2	17.9	18.3	15.7	16.4	15.7	16.7	18.0	19.5	38.6	32.1	25.9	12.4	78.3	42.3	41.8	57.3	26.7	22.6	38.3	21.3	28.1	17.2	44.8	29.5	20.9	41.0	67.6	43.3	9.8	87.7	85.5	18.9	32.3	39.2	30.5	41.0	11.5	75.4	71.4	43.8	26.5	31.2	42.6	24.0	39.3	75.9	68.0	18.5	12.8	62.2	42.7	49.4	44.2	19.9	24.5	45.6	60.5	14.0	47.6	25.5	59.8	17.6	19.1	68.4	40.6	25.6	225.0	63.7	56.6	28.0	31.3	25.6	46.0	32.7	77.6	75.4	40.3	41.0	50.7	78.0	69.8	34.8	37.5	64.4
DERL2	"CGI-101, derlin-2, F-LAN-1, F-LANa, FLANa"	ENSG00000072849	"Derlin 2"	Q9GZP9	17	5471254-5486811	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 259.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037287, HPA048957, HPA056551"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Endoplasmic reticulum"		"CAB037287: AB_1078641, HPA048957: AB_2680570, HPA056551: AB_2683171"	"unprognostic (2.54e-1)"	"unprognostic (5.30e-2)"	"unprognostic (5.83e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (1.51e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.12e-3)"	"unprognostic (1.73e-3)"	"unprognostic (5.23e-2)"	"prognostic unfavorable (6.49e-4)"	"unprognostic (1.91e-1)"	"unprognostic (1.82e-1)"	"unprognostic (3.73e-1)"	"unprognostic (2.91e-2)"	14.5	18.8	5.7	16.4	6.0	33.9	12.9	6.3	7.6	13.1	7.0	12.9	14.9	12.8	29.6	15.3	14.0	17.3	10.2	5.4	6.2	14.0	28.0	11.3	18.2	6.4	6.4	12.8	28.5	14.7	12.1	13.4	6.6	14.0	12.3	8.1	28.3	11.4	10.6	10.1	17.5	12.4	6.2	15.1	15.5	24.4	6.1	10.8	24.6	4.9	15.4	14.9	11.1	7.6	32.0	40.4	18.8	31.7	31.5	23.6	24.0	44.5	36.1	30.0	36.4	27.8	27.9	22.0	39.2	28.5	33.6	35.0	13.2	25.7	29.9	29.3	27.6	10.8	25.8	30.0	43.4	8.1	25.2	22.0	21.0	40.6	34.9	26.4	31.4	22.4	12.0	37.5	40.9	16.5	17.3	12.3	18.2	20.7	16.0	20.8	26.6	16.3	32.5	16.2	7.9	23.2	27.1	18.5	47.6	20.6	24.8	11.8	23.9	35.4	23.9	21.8	43.3	26.0	31.4	20.0	37.0	20.1	28.4	71.9	62.6	77.0	64.6	70.4	67.2	66.5	61.2	68.7	48.2	65.5	48.3	59.3	59.9	60.4	56.4	69.2	81.0	117.5	5.7	6.0	6.3	7.6	5.4	6.2	6.4	6.4	6.6	6.2	6.1	7.6	36.1	12.8	23.9	12.4	46.4	34.3	50.5	157.7	27.9	17.7	48.4	48.5	31.3	35.8	82.7	44.1	22.9	70.6	70.5	28.1	15.6	79.9	259.2	32.5	41.7	35.7	18.5	35.3	8.1	89.7	103.6	51.3	22.4	41.6	49.4	38.8	30.4	57.5	74.5	11.8	9.0	37.2	89.5	33.6	44.8	63.4	43.8	37.8	46.2	6.5	64.7	35.1	48.4	6.6	16.2	86.7	25.2	35.3	119.9	68.7	37.1	50.4	55.6	24.8	59.2	33.9	54.3	126.4	45.4	26.2	31.1	96.2	47.7	45.8	30.4	62.8
DERL3	"C22orf14, derlin-3, FLJ43842, IZP6, MGC71803"	ENSG00000099958	"Derlin 3"	Q96Q80	22	23834503-23839128	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 61.6;pancreas: 60.8;salivary gland: 51.1"	"Cell type enriched"	"Detected in many"	6	"Plasma cells: 1428.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	14	"plasmacytoid DC: 187.4"	"Lineage enriched"	"Detected in many"	14	"dendritic cells: 187.4"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 26.9;RPMI-8226: 23.6;U-266/70: 48.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"CAB037234, HPA049306"	Approved		Uncertain	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"CAB037234: AB_1840802, HPA049306: "	"unprognostic (2.01e-3)"	"prognostic favorable (8.70e-5)"	"unprognostic (9.72e-3)"	"unprognostic (7.47e-2)"	"unprognostic (9.77e-3)"	"prognostic favorable (8.01e-4)"	"unprognostic (2.23e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.74e-2)"	"unprognostic (2.75e-1)"	"prognostic unfavorable (7.76e-13)"	"unprognostic (1.53e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.95e-1)"	2.6	3.2	1.4	4.3	1.4	1.8	5.4	1.3	2.2	6.1	1.9	30.6	10.0	3.7	0.2	4.3	7.1	2.3	7.7	1.3	1.6	5.7	9.1	9.2	9.2	1.8	2.2	2.0	60.8	0.8	8.1	0.8	1.7	3.3	10.9	0.2	51.1	3.8	2.7	0.8	33.7	0.7	1.7	61.6	29.4	24.8	1.7	1.6	14.6	0.2	17.6	3.6	2.3	1.5	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	4.5	4.8	0.9	0.0	1.4	0.0	1.1	1.3	0.0	0.5	4.8	0.4	4.6	0.0	0.7	3.2	0.6	0.0	0.2	0.5	0.0	0.1	0.1	0.5	0.8	26.9	0.0	0.0	1.3	2.2	1.0	2.3	0.3	4.2	0.0	23.6	0.9	0.3	0.6	0.1	0.1	0.0	0.2	0.7	0.0	1.5	0.0	0.0	0.0	0.4	0.1	48.5	6.3	8.3	0.8	6.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	13.8	0.0	0.0	0.0	12.4	0.1	0.0	0.1	0.0	0.0	187.4	0.0	1.3	1.4	1.4	1.3	2.2	1.3	1.6	1.8	2.2	1.7	1.7	1.7	1.5	0.5	0.0	1.1	0.3	183.8	1.8	1.5	3.7	0.6	1.1	19.3	1.8	3.5	1.5	4.1	0.0	2.1	0.8	141.7	2.7	0.0	0.5	113.2	33.8	0.9	1.1	1.8	8.2	0.3	5.8	6.2	2.2	7.7	1.7	2.5	15.7	4.6	7.8	3.4	0.0	1.7	7.9	4.1	2.2	2.1	158.2	2.5	5.4	224.1	1.9	0.5	0.8	0.0	1.0	0.5	1.1	0.5	4.1	1428.8	2.5	0.8	0.5	30.3	0.6	0.0	0.8	2.6	67.0	32.9	1.3	2.0	15.5	17.9	2.1	10.7	2.0
DGAT1	"ARGP1, DGAT"	ENSG00000185000	"Diacylglycerol O-acyltransferase 1"	O75907	8	144314584-144326910	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 40.6"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 213.5;Proximal enterocytes: 700.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Hep G2: 18.4;PC-3: 21.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032853	Enhanced		Approved	"Nucleoli,Nucleoli rim,Endoplasmic reticulum"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"	"Nucleoli, Nucleoli rim"	"CAB032853: AB_2090798"	"unprognostic (9.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.75e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.42e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.78e-2)"	"unprognostic (6.88e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.65e-3)"	"unprognostic (3.83e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.67e-3)"	15.0	24.7	4.6	1.8	4.6	5.1	11.8	5.5	5.6	6.1	4.1	16.7	37.0	5.6	1.0	8.6	5.1	2.0	11.7	4.7	4.1	7.9	16.5	6.9	1.8	4.5	4.6	4.3	6.5	3.9	6.5	1.5	4.2	6.6	4.2	1.6	7.4	2.4	11.7	6.9	40.6	1.6	4.1	9.3	8.7	14.7	4.4	2.3	7.4	3.5	1.4	6.7	6.4	4.5	5.2	4.9	2.2	4.1	3.5	1.5	2.9	3.4	3.1	2.9	2.0	11.2	3.1	2.1	12.4	1.9	1.6	4.0	1.8	4.3	0.6	3.7	5.1	3.3	4.2	18.4	2.5	1.0	3.4	2.1	3.2	2.0	2.1	2.1	2.3	7.3	2.9	5.2	1.9	3.7	6.8	4.1	1.1	10.9	21.2	7.7	0.9	3.4	2.8	2.5	2.6	4.2	4.7	5.2	2.3	0.8	2.9	3.3	2.0	1.6	5.6	3.6	2.8	2.3	0.6	0.8	1.8	6.3	3.2	0.0	0.4	0.7	0.2	0.3	0.4	0.1	0.2	0.2	0.5	0.1	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.2	4.6	4.6	5.5	5.6	4.7	4.1	4.5	4.6	4.2	4.1	4.4	4.5	34.0	16.0	19.0	15.7	8.5	8.0	12.5	6.3	4.0	24.6	21.6	16.0	20.8	12.8	8.7	18.4	29.2	11.3	17.6	213.5	1.9	9.4	19.2	12.3	13.7	26.5	23.4	17.7	11.2	11.9	10.3	9.3	48.4	21.3	7.0	23.9	12.5	57.4	18.8	18.5	12.8	93.6	4.1	25.5	11.8	25.8	6.8	22.8	5.4	8.4	9.2	21.3	4.1	17.6	7.0	13.3	113.4	6.8	18.8	8.1	700.1	7.4	5.6	23.6	0.0	11.9	12.3	27.7	17.4	12.3	9.2	16.4	12.3	41.1	108.0	20.7
DLG1	"dJ1061C18.1.1, DLGH1, hdlg, SAP-97, SAP97"	ENSG00000075711	"Discs large MAGUK scaffold protein 1"	Q12959	3	197042560-197299330	"Predicted intracellular proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 422.9;Oligodendrocytes: 1542.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016307, HPA069593"	Supported		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	"Plasma membrane"	"CAB016307: AB_2092015, HPA069593: "	"unprognostic (2.04e-2)"	"unprognostic (1.37e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.56e-3)"	"unprognostic (3.54e-2)"	"unprognostic (8.56e-2)"	"unprognostic (8.90e-3)"	"unprognostic (2.97e-1)"	"unprognostic (5.98e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.41e-2)"	"unprognostic (3.40e-2)"	"unprognostic (1.70e-3)"	"unprognostic (3.56e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.07e-1)"	20.7	14.5	26.4	14.7	57.0	16.2	18.4	33.2	36.4	23.8	15.4	24.2	24.0	19.7	11.6	37.6	16.1	17.1	19.4	25.4	29.3	27.6	25.9	18.0	14.7	36.9	43.3	23.3	17.2	31.7	14.4	21.3	34.8	15.9	26.3	38.8	20.2	18.6	25.2	18.8	25.4	21.2	19.9	13.0	22.9	15.5	50.3	27.1	43.3	28.2	20.6	20.3	20.5	73.5	128.0	20.0	40.3	75.7	34.2	36.2	40.7	52.2	46.2	49.2	59.0	60.4	59.8	41.5	127.1	47.7	95.7	86.4	39.3	76.4	97.7	10.9	22.5	35.2	31.1	40.5	35.2	35.0	33.3	27.8	43.3	49.1	101.3	163.1	64.8	32.2	26.7	51.4	125.6	41.5	51.3	12.9	35.3	71.1	35.4	26.7	51.6	26.8	51.9	55.3	19.7	32.3	72.9	49.5	49.4	46.7	108.8	26.0	62.5	127.5	33.5	36.1	79.9	76.0	50.6	50.6	50.3	51.8	40.0	2.5	0.7	1.2	0.8	0.7	1.3	1.6	1.3	0.9	0.8	1.2	1.3	1.3	2.4	1.1	0.4	1.1	1.0	0.8	26.4	57.0	33.2	36.4	25.4	29.3	36.9	43.3	34.8	19.9	50.3	73.5	24.0	25.6	25.7	113.3	28.5	53.3	52.3	45.5	40.5	42.0	29.6	23.0	25.6	35.8	44.6	49.7	95.9	48.9	25.2	72.4	5.9	22.8	12.9	51.8	37.4	28.1	28.9	17.5	422.9	20.2	19.5	27.7	51.5	68.5	12.0	29.9	27.8	54.6	14.9	37.0	117.8	34.4	28.5	26.4	26.0	19.2	28.6	19.2	37.4	165.8	18.3	71.9	43.3	257.3	1542.2	30.3	48.0	25.6	34.1	52.3	50.6	20.8	66.3	101.7	13.1	40.5	25.5	31.2	37.9	66.7	70.8	25.0	30.6	29.3	38.8	106.8
DLG4	"PSD-95, PSD95, SAP-90, SAP90"	ENSG00000132535	"Discs large MAGUK scaffold protein 4"	P78352	17	7187187-7219841	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 112.4;pituitary gland: 62.8;retina: 223.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 41.8;Cone photoreceptor cells: 102.2;Rod photoreceptor cells: 62.6"	"Cancer enhanced"	"Detected in all"		"glioma: 13.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HMC-1: 40.0;hTERT-RPE1: 45.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001999, CAB002000, HPA010122, HPA071006"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB001999: , CAB002000: , HPA010122: AB_1855169, HPA071006: "	"unprognostic (7.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.72e-2)"	"prognostic favorable (8.82e-6)"	"unprognostic (3.45e-2)"	"prognostic unfavorable (1.70e-4)"	"unprognostic (3.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.68e-2)"	"unprognostic (4.77e-3)"	13.1	19.1	41.9	9.3	49.6	3.6	10.0	32.1	112.4	23.5	0.0	18.5	4.9	23.1	6.9	6.3	20.7	10.8	19.6	86.3	17.5	10.3	7.1	14.7	4.4	7.2	0.4	30.3	6.3	7.2	62.8	8.9	5.6	16.6	3.5	223.2	7.2	12.8	6.1	4.7	8.4	11.1	0.0	13.9	10.3	18.9	7.7	8.7	11.0	2.8	2.9	13.3	16.4	36.2	0.5	15.2	29.4	9.1	8.4	14.6	1.5	14.1	12.5	10.8	11.3	0.7	4.0	2.4	6.4	12.1	1.6	1.8	1.1	6.7	3.3	17.6	6.0	9.4	35.1	1.4	8.0	0.3	40.0	17.5	0.9	7.7	11.0	45.5	11.5	10.1	3.1	10.1	15.2	1.0	9.3	5.1	3.8	0.8	1.6	10.5	1.6	1.0	6.6	0.3	12.4	10.5	0.4	0.8	2.6	7.0	6.5	7.2	16.4	30.6	12.6	7.4	7.8	1.5	0.9	2.1	19.3	6.9	8.5	0.4	0.2	0.1	0.2	0.1	0.0	0.1	0.0	0.3	0.0	0.1	0.1	0.1	0.4	0.1	0.1	0.4	0.0	0.1	41.9	49.6	32.1	112.4	86.3	17.5	7.2	0.4	5.6	0.0	7.7	36.2	3.4	0.0	1.5	14.0	1.5	2.7	2.2	1.8	6.2	41.8	4.8	3.7	3.2	1.5	2.2	3.7	102.2	0.6	3.3	0.4	0.0	0.9	1.8	2.4	9.5	7.0	15.0	0.8	22.8	0.2	0.4	5.5	2.0	3.2	7.0	3.4	10.0	2.2	3.9	20.2	17.5	0.8	4.1	11.0	10.3	1.3	7.2	7.8	3.6	8.4	5.5	11.1	0.0	4.5	4.2	0.2	0.1	10.1	0.2	1.7	1.3	0.3	3.0	62.6	0.0	1.4	4.5	6.5	2.9	3.2	1.8	0.5	1.1	6.8	0.5	1.1
DMD	"BMD, DXS142, DXS164, DXS206, DXS230, DXS239, DXS268, DXS269, DXS270, DXS272, MRX85"	ENSG00000198947	Dystrophin	P11532	X	31097677-33339609	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		Actin-binding	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 452.8;Excitatory neurons: 1275.8;Inhibitory neurons: 719.8;Oligodendrocyte precursor cells: 1161.6;Oligodendrocytes: 610.2;Rod photoreceptor cells: 375.9"	"Cancer enhanced"	"Detected in many"		"testis cancer: 8.0"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.3"	"Group enriched"	"Detected in many"	7	"B-cells: 1.1;granulocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"AF22: 27.9;Hep G2: 30.3;RH-30: 25.0;SuSa: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000119, HPA002725, HPA023885"	Enhanced					NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB000119: , HPA002725: AB_1078714, HPA023885: AB_1847931"	"unprognostic (3.91e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.83e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.17e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.60e-4)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.15e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.83e-2)"	"unprognostic (1.51e-2)"	16.3	14.7	11.8	5.3	12.5	0.6	16.8	0.2	14.2	7.1	7.1	38.0	5.4	18.1	11.2	9.1	16.8	21.5	37.8	15.5	0.5	5.4	50.0	7.2	4.7	1.1	0.6	13.9	52.9	4.3	4.4	15.1	0.4	13.4	8.4	80.0	30.2	30.7	73.4	11.5	9.4	22.0	0.0	2.3	15.5	8.3	4.8	3.3	7.3	67.4	6.4	21.1	7.2	9.9	0.3	0.2	27.9	0.3	0.3	0.3	7.6	6.1	0.6	2.8	3.1	13.3	0.6	0.4	0.2	12.5	2.3	8.5	10.5	15.0	4.2	7.4	8.6	3.3	10.5	30.3	14.7	1.2	3.7	3.3	9.5	4.6	17.1	15.3	6.1	2.0	2.9	0.4	8.3	0.5	4.4	0.6	13.3	0.1	9.8	0.3	25.0	0.1	0.3	3.3	0.5	8.5	0.1	2.3	2.8	27.7	2.2	0.1	1.6	0.3	0.5	1.1	4.6	0.4	23.8	0.6	1.0	2.3	14.4	0.8	0.1	2.0	0.1	0.1	0.1	1.1	0.1	0.1	0.3	0.9	0.1	0.1	4.3	0.1	0.1	0.4	0.2	0.1	11.8	12.5	0.2	14.2	15.5	0.5	1.1	0.6	0.4	0.0	4.8	9.9	8.5	28.9	25.3	164.9	6.7	20.1	7.0	6.3	3.4	78.0	26.5	50.0	452.8	7.2	15.0	3.7	308.6	33.7	0.7	0.8	3.9	3.8	22.4	22.5	1.4	9.9	8.4	0.0	1275.8	12.3	9.5	26.1	3.6	5.6	1.3	37.9	6.1	49.8	4.2	11.8	719.8	1.3	6.1	4.8	5.4	20.5	89.2	3.5	19.6	94.6	6.7	54.9	0.0	1161.6	610.2	6.0	0.1	118.8	0.2	3.6	3.6	2.1	60.4	375.9	118.3	95.2	50.3	4.0	8.8	1.8	11.5	5.1	1.0	33.1	4.2	4.8
DMXL2	"DFNA71, KIAA0856, RC3"	ENSG00000104093	"Dmx like 2"	Q8TDJ6	15	51447711-51622833	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Diabetes mellitus, Disease variant, Epilepsy, Hypogonadotropic hypogonadism, Neuropathy, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 138.9;Inhibitory neurons: 122.9;Kupffer cells: 96.1;Macrophages: 106.3;monocytes: 84.9;Oligodendrocyte precursor cells: 96.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	4	"classical monocyte: 2.8;intermediate monocyte: 2.2;neutrophil: 2.2;non-classical monocyte: 2.7"	"Group enriched"	"Detected in many"	4	"granulocytes: 2.2;monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"U-937: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039375	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA039375: AB_10673610"	"unprognostic (5.66e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.05e-2)"	"unprognostic (8.38e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.67e-3)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.70e-2)"	5.3	4.7	4.1	11.1	4.7	17.1	3.4	4.0	7.3	4.6	8.1	6.5	9.2	4.4	13.9	1.9	5.2	4.5	3.1	8.9	2.8	5.7	4.5	6.8	4.7	2.5	1.1	4.1	5.4	8.0	8.4	7.2	3.0	2.7	7.5	16.3	5.4	2.5	1.1	1.7	7.1	5.3	0.0	6.5	5.3	9.0	4.2	4.7	4.2	1.7	2.6	6.0	2.8	2.4	9.1	11.7	12.6	7.3	5.3	9.1	3.1	6.9	7.5	6.5	8.5	1.7	4.4	0.0	3.3	4.1	12.5	4.8	8.1	4.8	8.7	10.6	3.9	3.6	10.6	2.1	4.9	20.6	5.8	4.2	3.9	8.4	3.7	6.8	4.5	10.9	8.3	0.8	6.7	10.0	8.9	19.2	9.2	4.3	3.8	7.9	10.3	13.5	3.4	18.1	18.0	7.8	7.3	4.1	8.5	11.0	6.9	21.9	5.7	7.8	5.3	11.0	8.2	16.0	25.2	0.0	9.2	44.0	7.4	0.0	2.8	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	2.2	0.0	2.7	0.3	0.0	0.4	4.1	4.7	4.0	7.3	8.9	2.8	2.5	1.1	3.0	0.0	4.2	2.4	5.2	3.2	15.7	68.6	2.1	3.1	2.5	4.1	4.6	41.4	4.9	2.0	8.4	1.5	6.7	7.3	64.6	5.7	13.1	22.7	1.9	3.0	2.5	11.6	18.9	5.4	28.1	0.8	138.9	3.8	4.9	8.7	28.5	5.5	10.8	10.6	5.7	6.0	36.5	58.9	122.9	13.3	2.0	96.1	16.4	3.5	6.5	106.3	3.6	50.6	84.9	8.6	1.0	96.5	50.7	5.2	17.4	9.1	2.1	2.5	24.9	8.1	18.7	31.9	6.6	8.1	8.7	37.2	30.3	2.8	1.7	3.8	3.6	9.1	15.9	2.7
DNAJB12	"DJ10, FLJ20027"	ENSG00000148719	"DnaJ heat shock protein family (Hsp40) member B12"	Q9NXW2	10	72332830-72355149	"Predicted membrane proteins, Transporters"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 235.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010642, HPA072702"	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 31: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"	"Nuclear membrane"	"HPA010642: AB_1078692, HPA072702: "	"unprognostic (3.35e-2)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (4.79e-4)"	"unprognostic (6.01e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (5.73e-2)"	"unprognostic (5.60e-2)"	"unprognostic (8.85e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.87e-1)"	24.1	29.8	18.3	18.1	19.5	27.6	24.5	20.0	20.4	21.6	19.5	23.3	21.4	24.0	23.4	23.2	20.8	17.5	26.8	19.0	18.1	23.9	28.0	21.1	16.4	20.0	18.8	22.6	26.9	32.9	23.7	20.3	19.1	23.4	14.7	16.6	28.4	17.7	37.5	28.5	20.7	19.0	18.4	24.8	23.9	21.4	18.9	17.3	23.5	23.5	16.0	21.6	20.6	20.0	37.4	38.3	23.4	39.3	30.5	31.1	29.6	36.6	63.8	49.5	45.9	44.7	64.3	27.2	28.8	45.1	31.3	61.4	22.2	33.0	26.9	29.9	29.4	14.7	23.0	29.6	68.5	30.1	54.2	39.6	67.6	44.1	55.8	45.0	35.1	25.6	23.2	40.2	43.3	36.7	26.0	26.3	10.8	29.1	11.1	23.4	17.8	18.9	37.7	21.7	16.1	23.0	20.0	74.0	36.8	12.9	28.2	34.2	39.1	24.6	33.4	28.0	46.7	33.8	27.3	16.0	40.6	32.6	17.1	18.7	29.2	18.7	12.8	31.5	11.4	11.5	12.5	9.6	24.6	11.1	10.3	10.2	36.6	13.9	28.9	16.4	13.8	17.5	18.3	19.5	20.0	20.4	19.0	18.1	20.0	18.8	19.1	18.4	18.9	20.0	30.3	28.9	29.3	10.1	30.1	13.4	30.6	38.6	25.6	33.3	36.1	29.6	23.3	50.1	44.3	23.9	22.9	41.1	37.7	38.1	11.7	34.2	122.2	25.1	26.1	25.3	29.4	31.2	12.7	64.3	41.1	28.6	23.4	29.3	40.0	26.4	21.0	29.6	38.1	30.3	13.0	28.8	12.2	36.0	16.0	235.7	36.4	37.6	10.6	7.5	39.6	33.6	35.0	12.1	15.2	34.9	38.1	35.0	34.2	27.4	62.2	34.4	26.8	35.6	52.6	27.4	34.4	32.4	10.9	28.1	15.5	68.0	22.8	37.0	25.9	35.2
DNAJB14	FLJ14281	ENSG00000164031	"DnaJ heat shock protein family (Hsp40) member B14"	Q8TBM8	4	99896248-99946618	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036016	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"			"HPA036016: AB_10670594"	"unprognostic (1.90e-2)"	"unprognostic (1.68e-1)"	"unprognostic (9.04e-3)"	"unprognostic (5.33e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.35e-2)"	"unprognostic (4.34e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.75e-2)"	"prognostic favorable (2.12e-6)"	"unprognostic (1.42e-1)"	"unprognostic (1.07e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.01e-2)"	13.4	11.6	9.0	9.6	12.1	17.7	11.6	7.4	15.3	10.8	5.4	13.8	9.4	11.5	10.7	9.8	7.8	10.3	7.8	14.3	13.7	13.8	10.9	12.2	15.3	9.7	11.1	11.9	7.9	14.8	8.5	16.5	11.9	12.0	9.8	18.5	8.3	10.3	5.0	10.2	9.8	10.2	7.7	14.3	12.0	4.4	11.8	11.2	17.3	6.2	10.9	10.8	8.5	13.7	14.4	36.9	12.6	14.0	22.6	23.8	12.5	35.6	21.2	11.2	10.3	25.2	33.0	13.8	19.7	15.5	7.2	12.0	9.5	15.7	18.2	35.2	11.3	22.3	21.8	20.7	20.0	19.6	32.9	19.6	18.2	12.0	12.2	19.6	22.0	14.7	20.2	18.8	26.1	30.2	23.0	11.4	7.0	9.3	18.6	21.6	14.6	12.0	20.5	28.7	7.1	16.4	19.4	28.0	19.4	11.2	15.6	9.2	31.6	19.6	16.6	13.8	12.1	23.4	55.1	18.4	16.4	8.2	23.6	39.0	14.5	17.5	18.6	16.2	16.7	16.8	14.7	17.1	13.1	17.5	16.9	15.5	22.3	16.3	25.6	15.1	20.1	13.6	9.0	12.1	7.4	15.3	14.3	13.7	9.7	11.1	11.9	7.7	11.8	13.7	78.6	64.1	57.5	61.0	76.5	45.0	50.8	40.3	44.9	92.3	36.7	35.1	20.9	37.1	46.5	40.5	54.2	47.2	100.1	50.9	33.2	31.0	4.4	32.2	60.0	55.0	35.4	15.8	125.4	30.1	31.0	54.9	36.2	42.2	41.1	45.0	47.5	30.3	31.5	111.0	114.8	30.3	30.5	52.7	76.8	4.2	49.7	49.4	44.4	53.4	68.3	64.5	64.9	70.9	107.5	32.1	36.5	53.4	55.7	63.5	34.3	41.8	31.5	95.3	26.3	69.0	54.3	20.3	14.1	32.7	36.9	48.2	83.4	43.0	27.4	54.7
DNM1L	"DRP1, DVLP, DYMPLE, HDYNIV, VPS1"	ENSG00000087470	"Dynamin 1 like"	O00429	12	32679200-32745650	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Biological rhythms, Endocytosis, Necrosis"	Hydrolase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB009952, HPA039324"	Approved		Enhanced	Vesicles,Cytosol		NA	NA		2000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 46: Photoreceptor cells - Phototransduction"	Cytosol	Vesicles	"CAB009952: AB_2093533, HPA039324: AB_2676443"	"unprognostic (2.64e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.12e-1)"	"unprognostic (5.09e-1)"	"unprognostic (4.06e-2)"	"prognostic unfavorable (6.27e-6)"	"unprognostic (8.68e-2)"	"unprognostic (2.25e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.00e-1)"	"unprognostic (8.17e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.57e-2)"	23.2	23.2	25.3	23.5	27.5	40.0	21.1	27.7	32.3	18.4	15.7	24.0	18.6	23.6	23.9	28.6	19.8	17.5	38.9	28.4	26.1	27.9	14.2	16.7	20.9	22.5	22.0	20.0	13.5	40.5	25.3	23.9	23.6	27.0	22.7	44.9	16.0	28.7	43.8	18.3	16.8	32.0	22.2	18.8	17.3	36.0	21.6	21.4	22.4	57.2	24.8	29.9	18.5	26.6	66.8	62.3	64.3	68.3	51.2	52.7	123.2	72.0	55.4	67.2	61.7	80.6	48.0	87.3	50.0	65.8	66.9	57.8	69.2	80.3	79.3	46.6	57.6	102.3	57.2	48.2	41.7	72.5	50.1	48.6	37.4	70.7	66.1	63.5	81.1	41.4	74.4	37.5	75.3	21.7	29.1	61.7	138.2	41.0	30.8	48.6	125.0	61.5	56.5	79.1	57.1	59.3	76.3	51.8	56.7	129.4	59.7	49.0	74.0	57.3	54.4	135.3	68.2	26.1	75.8	86.3	55.6	47.0	43.5	7.4	10.0	3.2	5.6	15.6	6.9	7.0	6.2	6.1	18.8	6.0	7.3	8.4	1.8	8.1	15.6	5.6	7.3	7.9	25.3	27.5	27.7	32.3	28.4	26.1	22.5	22.0	23.6	22.2	21.6	26.6	42.5	38.5	38.4	82.6	36.0	30.0	34.7	28.0	44.3	80.9	32.5	29.2	82.8	20.0	33.3	25.8	131.3	30.0	53.8	26.7	31.3	34.8	63.9	38.8	55.8	42.0	30.5	28.4	139.4	25.1	63.7	41.0	23.9	59.4	50.7	48.8	26.4	16.0	30.8	126.2	150.0	24.9	34.6	27.5	30.7	78.0	26.8	43.3	14.2	44.0	45.6	59.0	34.0	99.5	121.7	45.7	14.4	30.5	48.5	42.8	11.4	23.3	22.8	164.8	19.7	55.0	55.5	79.3	52.3	39.6	27.6	36.0	42.2	26.0	31.5	36.4
DNM2	"CMT2M, CMTDI1, CMTDIB, DI-CMTB, DYN2, DYNII"	ENSG00000079805	"Dynamin 2"	P50570	19	10718079-10833488	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Endocytosis, Phagocytosis"	"Hydrolase, Motor protein"	"Cancer-related genes, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 242.8;Paneth cells: 177.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054246	Supported		Approved	"Golgi apparatus,Cytosol"		NA	NA		230000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Cytosol"		"HPA054246: AB_2682427"	"unprognostic (2.30e-1)"	"unprognostic (5.23e-2)"	"unprognostic (4.72e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"prognostic favorable (8.91e-4)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (1.03e-1)"	"unprognostic (3.79e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.75e-2)"	"unprognostic (5.35e-2)"	"unprognostic (5.47e-2)"	"unprognostic (5.40e-3)"	"unprognostic (2.68e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.99e-3)"	55.1	69.9	50.5	63.2	77.8	125.7	46.1	74.1	64.1	49.0	38.8	105.8	65.9	42.2	25.3	67.6	42.5	40.5	87.2	52.3	57.4	72.8	57.2	87.0	62.4	82.7	78.9	36.6	68.2	38.9	41.9	51.3	79.8	47.4	83.9	30.7	55.0	55.7	108.1	92.8	99.6	35.1	60.3	81.0	98.6	55.1	72.9	58.6	47.6	82.8	65.4	64.6	54.5	101.6	116.4	92.8	67.6	54.6	67.6	65.4	86.5	75.1	70.5	108.8	91.7	94.2	74.7	83.2	132.2	81.5	52.5	99.4	92.6	82.1	90.8	103.1	72.4	160.1	81.7	107.1	82.9	87.8	146.5	67.8	62.4	83.5	77.9	66.2	107.3	84.9	131.5	139.1	68.0	140.1	126.3	85.7	76.6	138.3	109.7	125.6	72.6	95.7	71.3	171.1	97.1	63.8	86.6	73.6	54.2	74.9	58.8	106.2	99.6	120.7	40.5	172.0	102.7	112.7	127.3	77.9	89.9	134.0	61.0	3.5	3.5	7.0	4.0	6.2	3.8	2.5	3.0	4.4	4.2	2.1	1.7	3.0	6.5	8.9	8.4	8.4	3.8	4.1	50.5	77.8	74.1	64.1	52.3	57.4	82.7	78.9	79.8	60.3	72.9	101.6	37.8	32.1	22.3	24.8	48.8	23.2	17.1	13.8	22.2	28.8	19.7	16.3	30.3	14.3	25.7	51.5	22.9	25.7	57.2	242.8	50.9	35.2	48.4	32.2	17.9	33.1	21.6	38.1	29.2	32.0	106.9	19.5	168.7	39.7	19.0	36.8	20.3	22.8	49.1	43.7	31.1	106.9	14.2	28.0	39.6	98.0	16.8	55.2	19.6	60.9	43.4	17.2	39.1	23.1	90.9	45.2	177.3	27.8	92.2	20.2	90.7	38.8	18.0	26.3	26.3	18.7	27.6	15.0	12.3	26.6	31.5	31.7	46.4	40.7	82.5	22.8
DPP10	"DPL2, DPPY, DPRP3"	ENSG00000175497	"Dipeptidyl peptidase like 10"	Q8N608	2	114442299-115845780	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			Asthma	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 10.7;brain: 20.2;pancreas: 17.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 4634.9;Excitatory neurons: 3067.4;Inhibitory neurons: 3258.7;Oligodendrocyte precursor cells: 990.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.1;HAP1: 6.2;HMC-1: 4.3;JURKAT: 3.4;NTERA-2: 3.7;RT4: 6.7;SCLC-21H: 9.7;SH-SY5Y: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048767	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA048767: AB_2680515"	"unprognostic (1.19e-1)"		"unprognostic (2.55e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.29e-1)"		"unprognostic (2.03e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.92e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.03e-2)"	"unprognostic (8.33e-2)"	"unprognostic (7.61e-2)"	"unprognostic (4.22e-2)"	0.2	10.7	12.4	0.3	20.2	0.1	0.0	0.0	16.6	0.3	0.0	2.2	1.2	0.4	0.0	0.0	0.1	0.8	0.1	19.3	0.5	0.2	0.1	0.2	0.0	1.9	3.1	0.0	17.3	0.0	0.8	0.8	2.0	0.0	2.8	4.1	0.2	0.0	0.0	0.1	1.2	0.8	4.5	0.0	1.0	1.0	6.0	0.0	0.6	0.0	0.0	0.3	0.0	11.7	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	6.7	9.7	3.9	0.0	0.0	0.0	1.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	20.2	0.0	16.6	19.3	0.5	1.9	3.1	2.0	4.5	6.0	11.7	0.0	0.0	0.0	4634.9	0.0	0.0	0.0	0.0	0.6	21.7	0.0	0.0	1.5	4.3	0.6	0.0	0.0	1.5	0.0	2.3	0.0	0.0	12.4	0.1	0.1	0.1	4.2	2.1	3067.4	2.7	10.2	0.5	0.0	0.3	0.0	5.8	0.7	0.0	0.3	5.0	3258.7	1.4	0.0	0.0	0.0	5.7	0.3	0.0	1.8	58.1	0.0	1.4	0.0	990.7	48.3	0.8	1.9	0.0	0.0	0.0	0.2	0.2	0.0	0.7	0.0	0.0	0.1	1.6	2.6	0.3	0.0	4.4	0.0	0.4	3.2	0.0
DPP6	"DPL1, DPPX"	ENSG00000130226	"Dipeptidyl peptidase like 6"	P42658	7	153887097-154894285	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 54.0;endometrium 1: 58.2"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 673.4;Inhibitory neurons: 1195.9;Oligodendrocyte precursor cells: 1947.8"	"Cancer enriched"	"Detected in some"	11	"glioma: 12.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"NTERA-2: 11.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050509	Enhanced	Supported				NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA050509: AB_2681150"	"unprognostic (1.29e-1)"	"unprognostic (3.55e-2)"	"unprognostic (5.68e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.73e-1)"	"unprognostic (5.83e-4)"	"unprognostic (1.55e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.45e-3)"	"unprognostic (4.04e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.85e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.61e-3)"	"unprognostic (6.11e-2)"	0.6	8.2	16.5	0.2	24.5	0.1	0.5	32.0	34.5	5.8	0.0	19.8	0.5	58.2	2.5	0.3	5.2	0.1	0.2	42.7	21.6	5.3	0.0	1.4	0.1	54.0	24.5	0.7	3.9	0.0	10.8	0.2	53.1	0.3	1.6	11.1	0.1	8.9	6.0	3.6	3.4	19.9	8.6	4.7	7.8	7.3	32.2	1.9	17.1	0.9	0.0	0.3	1.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.2	11.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	1.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.6	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	16.5	24.5	32.0	34.5	42.7	21.6	54.0	24.5	53.1	8.6	32.2	14.8	0.1	0.0	0.0	147.9	0.0	3.3	0.4	0.0	0.0	27.0	0.4	1.3	7.4	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	13.4	0.9	21.6	0.4	10.3	0.0	673.4	4.0	0.0	2.1	0.0	0.5	0.0	0.0	0.0	0.0	0.2	32.0	1195.9	0.4	0.0	0.0	0.0	18.4	1.2	0.2	16.0	22.5	0.0	17.1	0.0	1947.8	290.8	0.3	0.0	3.8	0.0	0.1	0.1	0.4	0.8	6.1	0.0	0.7	0.9	1.2	4.0	0.0	1.6	0.0	0.2	0.0	0.0	0.2
DRAM1	"DRAM, FLJ11259"	ENSG00000136048	"DNA damage regulated autophagy modulator 1"	Q8N682	12	101877580-102012130	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 94.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 321.8;Early spermatids: 145.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"BJ hTERT+: 532.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (8.82e-2)"	"unprognostic (1.80e-1)"	"unprognostic (7.19e-2)"	"prognostic favorable (6.52e-8)"	"unprognostic (1.15e-2)"	"unprognostic (2.35e-3)"	"unprognostic (1.29e-3)"	"unprognostic (1.23e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.35e-1)"	"unprognostic (6.17e-3)"	"unprognostic (5.02e-2)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.07e-2)"	14.9	15.4	3.5	18.9	3.9	36.9	11.3	5.0	4.2	8.9	7.5	10.2	7.0	10.2	5.3	10.7	9.4	16.8	8.3	3.6	4.5	23.7	7.8	94.1	18.2	4.3	3.4	7.3	8.4	6.1	5.9	20.1	3.7	9.1	9.4	4.3	11.1	7.2	4.7	9.0	9.3	12.6	3.2	11.4	15.7	4.9	4.7	9.3	7.4	5.4	10.5	37.2	7.9	5.5	10.6	20.5	7.4	2.3	93.4	21.4	40.4	77.2	532.4	76.2	118.3	6.9	19.8	1.9	8.5	128.2	29.4	15.5	1.9	32.2	104.8	11.3	6.2	2.6	17.5	27.2	43.1	3.0	5.5	25.5	14.0	26.8	28.7	65.1	41.5	2.4	9.5	3.6	20.0	8.3	1.8	9.0	5.1	26.3	4.9	3.4	5.4	1.9	80.9	49.4	1.4	1.6	42.8	4.8	20.5	20.3	14.9	11.7	25.3	53.3	9.5	9.3	14.2	10.7	5.3	1.4	17.9	26.8	14.2	10.2	9.0	6.0	1.6	10.2	2.0	2.7	1.3	1.8	3.1	1.4	0.9	1.1	8.6	3.3	5.8	0.8	1.9	2.8	3.5	3.9	5.0	4.2	3.6	4.5	4.3	3.4	3.7	3.2	4.7	5.5	17.2	54.5	321.8	4.9	10.7	20.9	21.5	42.4	28.5	1.6	12.8	8.0	4.3	10.0	25.2	29.5	0.0	28.1	5.0	1.3	1.9	11.4	145.0	12.7	30.8	16.5	0.0	11.3	0.5	21.4	30.9	30.5	10.2	15.6	24.1	3.2	10.0	2.0	60.6	0.0	4.7	1.6	14.2	40.5	31.1	80.6	14.0	51.9	8.8	3.7	24.6	3.2	5.2	10.1	0.6	21.7	0.3	10.5	30.9	34.2	0.3	23.4	7.4	0.2	13.1	14.4	9.9	1.2	4.5	3.2	6.1	22.0	6.4	7.3	1.2	22.1
DRAM2	"MGC54289, PRO180, RP5-1180E21.1, TMEM77, WWFQ154"	ENSG00000156171	"DNA damage regulated autophagy modulator 2"	Q6UX65	1	111117163-111140203	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018036, HPA061701"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus, Vesicles"		"HPA018036: AB_1858134, HPA061701: AB_2684590"	"unprognostic (9.38e-3)"	"unprognostic (1.58e-2)"	"unprognostic (2.16e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.12e-2)"	"unprognostic (2.65e-2)"	"prognostic unfavorable (3.45e-5)"	"unprognostic (6.57e-3)"	"prognostic unfavorable (6.43e-4)"	"unprognostic (2.69e-1)"	"unprognostic (4.37e-3)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.45e-4)"	"unprognostic (1.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.77e-3)"	38.0	23.1	13.9	33.1	14.5	17.9	26.8	17.7	19.9	23.1	22.7	26.7	28.6	17.7	17.6	15.0	30.1	36.4	23.7	13.5	15.2	26.5	24.9	25.0	55.3	15.6	14.9	24.3	25.6	28.3	4.6	41.2	16.2	17.8	30.7	16.9	25.8	16.7	16.6	17.9	26.3	17.0	15.5	45.3	23.4	10.3	15.0	27.8	22.0	23.6	50.3	29.4	4.2	17.8	38.0	12.9	24.0	10.8	57.3	56.2	23.4	28.7	29.9	24.7	24.9	12.5	38.2	28.7	17.2	25.6	12.1	37.4	30.5	24.0	31.9	26.8	25.6	16.8	18.4	16.4	41.4	19.4	15.4	38.5	41.4	18.3	38.4	53.6	29.9	29.1	34.1	19.6	30.1	19.6	16.6	28.8	14.5	43.3	13.2	11.1	40.0	14.0	42.5	25.8	19.1	18.2	16.8	52.4	80.1	33.1	16.7	84.6	24.8	20.6	13.8	16.2	18.9	25.7	9.6	29.8	33.4	34.7	29.6	41.7	47.3	11.5	14.2	61.0	19.4	65.7	17.5	15.3	45.1	54.1	22.3	19.0	7.2	25.0	49.8	28.6	17.7	35.5	13.9	14.5	17.7	19.9	13.5	15.2	15.6	14.9	16.2	15.5	15.0	17.8	34.5	12.8	12.0	17.3	146.2	47.0	54.4	82.5	34.1	11.6	53.6	43.9	29.7	32.9	53.1	44.1	2.1	98.1	38.9	41.2	43.0	59.2	8.5	51.7	19.5	36.4	13.2	28.6	20.6	46.6	102.3	39.2	24.5	17.6	23.6	18.5	42.8	26.0	183.1	20.2	31.7	45.7	77.3	189.4	97.8	7.8	33.5	110.3	81.8	39.4	89.0	27.1	56.7	31.7	42.6	41.9	64.3	24.8	54.7	46.3	88.4	80.4	95.8	10.1	39.5	26.4	32.5	4.7	14.6	40.8	53.0	73.3	38.6	26.3	43.7	70.1
DRD2		ENSG00000149295	"Dopamine receptor D2"	P14416	11	113409605-113475691	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 77.8;pituitary gland: 59.6"	"Cell type enriched"	"Detected in some"	12	"Horizontal cells: 60.6"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"basal ganglia: 77.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 88.3"	"Region enriched"	"Detected in many"	10	"basal ganglia: 205.3"	"Region enriched"	"Detected in many"	4	"basal ganglia: 146.3"	"HPA015139, HPA015691"	Supported	Supported				NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"			"HPA015139: , HPA015691: AB_1847834"	"unprognostic (8.49e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.15e-1)"		"unprognostic (1.97e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.40e-2)"	"unprognostic (8.33e-4)"	"unprognostic (1.10e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.71e-1)"	"unprognostic (4.82e-2)"	"unprognostic (8.49e-3)"	0.3	8.4	6.1	0.1	77.8	0.0	1.3	0.2	18.3	1.6	0.0	0.4	0.0	1.1	0.1	0.5	1.3	0.2	0.1	1.4	13.6	1.2	0.0	0.2	0.0	3.9	40.7	0.2	0.2	0.0	59.6	0.0	21.1	0.9	0.3	11.7	11.9	0.7	0.8	0.9	0.2	1.5	0.7	0.0	0.1	1.0	14.8	0.0	0.0	0.3	0.0	0.2	0.6	1.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	7.6	0.2	0.0	0.0	0.0	6.1	0.0	0.0	0.1	0.1	4.9	0.1	0.0	0.0	0.0	0.0	0.0	10.0	0.0	1.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	3.1	0.4	0.0	0.0	1.0	0.1	0.0	0.0	9.6	0.0	0.0	0.1	88.3	10.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	2.0	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	77.8	0.2	18.3	1.4	13.6	3.9	40.7	21.1	0.7	14.8	1.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	4.7	0.1	2.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	60.6	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DRD3		ENSG00000151577	"Dopamine receptor D3"	P35462	3	114127580-114199407	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets, Schizophrenia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 5.6"	"Group enriched"	"Detected in some"	12	"Early spermatids: 6.2;Late spermatids: 19.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	8	"basal ganglia: 5.6;cerebral cortex: 2.8;hypothalamus: 4.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"basal ganglia: 7.4"	"Region enriched"	"Detected in many"	10	"basal ganglia: 17.9"							NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 65: Brain - Ion transport"		"Cluster 25: Spermatids - Spermatogenesis"								"unprognostic (2.32e-1)"													0.0	0.0	0.3	0.0	5.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.3	5.6	0.0	2.8	0.1	4.1	0.0	0.2	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	19.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DTNA	"D18S892E, DRP3, DTN, DTN-1, DTN-2, DTN-3"	ENSG00000134769	"Dystrobrevin alpha"	Q9Y4J8	18	34493290-34891844	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 461.9;choroid plexus: 120.6;heart muscle: 150.0;skeletal muscle: 166.9;tongue: 209.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1756.1;Excitatory neurons: 506.0;Inhibitory neurons: 650.9;Oligodendrocyte precursor cells: 491.6;Oligodendrocytes: 367.4"	"Cancer enriched"	"Detected in many"	9	"glioma: 28.2"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"MCF7: 37.7;NTERA-2: 42.0;SCLC-21H: 51.9;U-87 MG: 52.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015196, HPA071177"	Enhanced		Approved	"Nucleoplasm,Cell Junctions,Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Cell Junctions, Intermediate filaments"	Nucleoplasm	"CAB015196: AB_2261797, HPA071177: "	"unprognostic (1.57e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.13e-3)"	"unprognostic (7.82e-6)"	"unprognostic (5.03e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.27e-2)"	"unprognostic (1.35e-4)"	"unprognostic (6.89e-2)"	"prognostic favorable (2.64e-7)"	"unprognostic (6.08e-3)"	"unprognostic (3.93e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.27e-5)"	11.6	6.6	252.7	5.4	248.2	0.8	9.6	243.3	260.1	5.4	120.6	22.4	3.9	8.1	20.5	22.9	11.7	9.4	150.0	250.1	423.0	2.3	2.2	6.6	2.3	461.9	326.9	7.0	18.1	2.4	10.8	4.1	360.4	23.6	7.6	19.8	11.3	25.3	166.9	2.7	8.4	19.4	308.1	4.8	6.8	6.1	269.2	0.5	12.3	209.9	2.0	32.0	5.2	331.0	0.7	0.5	17.3	0.0	9.5	25.1	2.6	3.2	14.8	0.6	1.7	3.8	0.2	0.1	8.9	1.9	15.3	1.1	2.1	7.5	1.8	0.0	10.7	0.1	0.9	5.7	7.1	0.2	0.2	19.2	1.8	11.9	4.5	14.2	6.7	0.1	2.4	1.9	3.8	37.7	0.1	0.2	42.0	0.6	8.1	0.1	7.7	24.1	0.9	0.3	51.9	6.9	0.0	1.7	4.9	23.8	21.8	6.3	0.5	16.7	9.9	0.3	5.2	1.3	2.0	1.0	52.5	0.0	8.4	1.0	0.7	0.0	0.8	0.0	1.1	0.8	1.5	1.1	3.5	0.7	1.6	1.3	0.3	0.8	0.0	0.1	4.3	1.0	252.7	248.2	243.3	260.1	250.1	423.0	461.9	326.9	360.4	308.1	269.2	331.0	5.1	0.0	1.1	1756.1	0.1	1.5	0.1	0.8	0.0	18.3	22.2	12.3	134.3	27.1	1.4	0.0	6.2	0.1	0.4	0.0	5.9	12.6	3.1	7.0	2.6	6.4	0.0	0.0	506.0	25.1	0.1	5.7	0.0	0.4	0.0	2.3	0.0	0.2	9.0	1.7	650.9	0.1	4.1	4.0	21.5	3.7	5.9	8.0	5.4	105.9	0.9	34.0	0.0	491.6	367.4	8.0	0.0	0.4	0.0	1.8	0.1	2.0	7.1	3.8	13.1	22.7	17.3	0.9	4.8	0.2	1.0	0.0	0.2	0.3	0.2	0.2
DUOX1	"LNOX1, NOXEF1, THOX1"	ENSG00000137857	"Dual oxidase 1"	Q9NRD9	15	45129933-45165576	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 108.5;skin 1: 81.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 83.3;Alveolar cells type 2: 168.6;Endometrial ciliated cells: 67.1;Glandular and luminal cells: 88.5;Respiratory ciliated cells: 64.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 32.4"	"Group enriched"	"Detected in many"	6	"cerebellum: 12.4;white matter: 3.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 64.4;hTCEpi: 30.5;RT4: 36.3"	"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	5	"cerebellum: 9.6"	HPA023544	Approved					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA023544: AB_1847878"	"unprognostic (2.85e-2)"	"prognostic favorable (4.31e-6)"	"unprognostic (2.49e-2)"	"unprognostic (8.84e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.57e-2)"	"unprognostic (5.87e-2)"	"unprognostic (6.02e-3)"	"unprognostic (5.13e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.91e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.03e-1)"	1.5	14.1	0.7	1.0	1.0	0.2	4.5	12.4	1.2	44.5	0.0	1.0	0.6	3.0	50.0	108.5	14.0	3.3	3.3	1.0	0.3	0.7	0.4	70.1	0.3	0.3	0.3	1.8	0.5	5.2	1.3	1.5	0.6	13.8	0.3	0.6	18.7	13.0	0.4	81.7	0.7	0.4	0.1	0.3	64.3	1.6	0.4	1.1	70.4	0.0	14.7	11.1	42.0	3.2	8.3	0.1	0.5	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	64.4	0.0	6.1	0.0	0.8	0.4	0.0	0.9	0.1	0.0	0.0	0.3	0.0	30.5	0.0	1.9	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.2	0.1	0.0	0.0	36.3	0.8	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.0	12.4	1.2	1.0	0.3	0.3	0.3	0.6	0.1	0.4	3.2	0.9	83.3	168.6	4.2	4.5	11.1	14.3	22.8	11.4	21.3	4.7	2.8	2.4	8.6	32.5	3.7	8.4	5.3	7.6	2.5	0.0	3.8	0.7	67.1	9.4	3.8	21.7	2.7	5.1	5.4	0.6	5.1	17.9	88.5	8.2	7.9	7.9	1.5	1.2	6.7	3.9	4.0	16.2	3.1	43.5	0.3	3.4	3.3	16.0	1.0	3.2	3.5	33.0	9.5	10.6	4.7	4.0	3.8	0.1	9.5	6.8	0.5	64.9	4.4	0.0	8.5	4.7	11.5	7.5	36.4	18.0	3.7	4.5	0.4	5.6	30.0
DUOX2	"LNOX2, P138-TOX, P138(TOX), THOX2"	ENSG00000140279	"Dual oxidase 2"	Q9NRD8	15	45092650-45114172	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Hydrogen peroxide, Thyroid hormones biosynthesis"	"Oxidoreductase, Peroxidase"	"Congenital hypothyroidism, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 290.2;thyroid gland: 75.7;urinary bladder: 92.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 159.3;Ductal cells: 225.2;Exocrine glandular cells: 125.5;Gastric mucus-secreting cells: 85.1;Pancreatic endocrine cells: 411.7;Urothelial cells: 110.4"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 60.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	8	"HaCaT: 6.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.2"	"Not detected"	"Not detected"									NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (3.19e-1)"	"unprognostic (7.51e-2)"	"unprognostic (3.77e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.40e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.49e-2)"	"unprognostic (9.59e-3)"	"unprognostic (7.11e-2)"	"unprognostic (5.32e-5)"	"unprognostic (1.71e-1)"	"unprognostic (1.62e-2)"	"unprognostic (4.12e-2)"	"unprognostic (1.63e-2)"	0.5	1.4	0.0	21.5	0.1	0.0	0.6	0.1	0.3	2.8	0.0	11.6	1.5	0.2	3.1	21.5	0.5	290.2	0.8	0.1	0.1	0.7	0.8	2.5	0.1	0.2	0.6	0.5	1.2	0.2	0.1	0.0	0.1	11.8	5.5	0.0	4.6	1.9	0.0	4.9	8.3	2.7	0.1	0.0	42.3	1.4	0.1	0.0	75.7	0.0	4.2	92.8	21.7	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	0.0	0.0	6.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.6	0.1	0.1	0.1	0.3	0.1	48.1	36.9	0.0	3.0	1.9	5.2	11.7	1.8	0.4	0.6	0.6	1.9	54.3	31.5	0.0	0.0	0.1	0.0	159.3	0.0	225.2	0.6	1.0	0.5	5.6	1.2	0.0	0.1	125.5	0.0	5.1	85.1	3.5	32.8	0.1	0.4	0.1	0.1	0.0	0.1	10.1	4.1	0.0	0.4	0.3	0.3	3.9	0.0	0.0	5.2	0.2	0.0	0.0	0.1	411.7	45.5	0.0	0.8	4.5	2.9	0.0	43.4	0.3	0.0	0.2	2.7	0.9	1.0	3.6	1.8	0.0	4.6	0.1	34.7	110.4
DUS4L-BCAP29		ENSG00000288558	"DUS4L-BCAP29 readthrough"	Q9UHQ4	7	107563971-107623317	"Predicted membrane proteins, Transporters"	"Apoptosis, ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 5.8;monocytes: 1.5"	"Cell line enhanced"	"Detected in all"		"U-87 MG: 18.7"									"HPA029215, HPA044301, HPA049694"	Approved		Approved	Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"		"Cluster 11: RPE1 & U-87MG - Synaptic function"		Cytosol		"HPA029215: AB_10602331, HPA044301: AB_10967460, HPA049694: AB_2680854"																		3.4	2.0	6.7	2.0	7.7	2.9	2.8	7.4	11.4	4.0	4.5	2.6	1.2	4.2	2.0	2.1	1.7	1.3	3.3	7.6	6.3	2.0	2.5	3.9	1.3	6.9	6.5	2.1	0.8	2.4		1.7	7.0	2.0	3.4	3.3	0.8	2.5	5.7	5.8	1.3	3.6	6.7	2.1	1.5	2.4	7.0	1.9	4.3	4.9	1.9	2.0		7.8	7.2	2.8	4.0	1.3	3.0	4.9	1.3	5.7	6.1	4.6	2.9	2.2	3.6	1.9	3.5	5.8	2.1	2.4	3.1	5.1	5.5	2.4	4.3	5.0	2.5	2.0	4.6	6.7	3.2	2.9	3.0	7.4	2.7	5.2	7.2	3.3	7.6	1.8	6.0	3.0	4.9	7.1	2.2	1.7	3.0	3.1	4.4	6.1	5.3	2.0	1.2	6.1	5.3	5.1	4.9	2.1	1.5	6.5	8.8	9.1	2.3	11.0	13.2	2.4	5.0	3.3	18.7	6.3	5.3	5.8	0.4	1.0	0.3	1.1	0.4	0.3	0.4	0.6	0.8	0.5	0.3	0.6	0.0	0.3	1.5	0.5	0.7	0.3	6.7	7.7	7.4	11.4	7.6	6.3	6.9	6.5	7.0	6.7	7.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DUX4		ENSG00000260596	"Double homeobox 4"	Q9UBX2	4	190173774-190185942	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, Developmental protein, DNA-binding"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.0"	"Group enriched"	"Detected in some"	26	"Early spermatids: 4.9;Late spermatids: 5.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 1.5;U-2 OS: 2.2;U-266/70: 4.7;U-266/84: 6.9;U-698: 1.5"	"Low region specificity"	"Detected in some"							HPA058451			Approved	"Nucleoplasm,Nucleoli,Golgi apparatus,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 34: Spermatids - Unknown function"	"Nucleoplasm, Nucleoli"	"Golgi apparatus, Cytosol"	"HPA058451: AB_2683722"																		0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	2.2	0.4	0.0	4.7	6.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
DYSF	"FER1L1, LGMD2B"	ENSG00000135636	Dysferlin	O75923	2	71453722-71686768	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Limb-girdle muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 95.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;Endothelial cells: 43.7;Excitatory neurons: 34.7;Hepatic stellate cells: 32.2;Kupffer cells: 27.1;Oligodendrocytes: 62.7;Syncytiotrophoblasts: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	7	"neutrophil: 27.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 27.0"	"Group enriched"	"Detected in many"	5	"hTERT-RPE1: 31.9;HUVEC TERT2: 85.5;LHCN-M2: 75.3;RH-30: 78.5;TIME: 58.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB002510, HPA017071, HPA021945"	Enhanced		Supported	"Plasma membrane,Centriolar satellite"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane, Centriolar satellite"		"CAB002510: AB_442097, HPA017071: AB_1847927, HPA021945: AB_1847928"	"unprognostic (1.04e-1)"	"unprognostic (7.66e-3)"	"unprognostic (5.43e-3)"	"unprognostic (1.66e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.70e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.93e-1)"	"unprognostic (6.43e-2)"	"unprognostic (4.88e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.97e-3)"	10.1	1.7	1.0	11.5	1.1	31.6	4.3	4.1	7.7	1.9	0.7	7.0	2.0	2.3	0.5	7.4	3.2	4.6	16.8	0.2	3.8	3.6	6.5	8.3	3.7	14.8	5.1	1.3	1.5	2.3	1.5	21.1	13.7	3.3	2.5	0.5	1.3	4.8	95.3	1.2	3.1	10.2	2.0	21.4	2.5	1.1	10.2	2.3	4.6	32.3	0.9	6.9	1.8	1.8	1.1	0.0	3.3	3.0	0.0	0.0	6.1	0.1	0.8	2.2	1.5	0.4	1.0	0.0	12.1	0.1	3.4	2.5	0.0	1.2	1.1	0.0	0.0	0.2	0.2	0.0	0.3	0.1	0.0	1.5	0.0	2.3	10.6	31.9	85.5	0.2	8.4	0.0	75.3	0.0	0.0	5.8	8.1	0.0	0.9	0.0	78.5	0.0	2.6	0.2	0.0	0.0	4.1	0.7	0.1	7.9	0.3	0.8	58.1	0.3	3.8	0.2	1.1	0.0	0.0	0.0	0.0	13.3	0.0	0.0	4.1	0.1	0.5	0.7	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	27.0	0.4	0.1	0.0	0.0	1.4	1.0	1.1	4.1	7.7	0.2	3.8	14.8	5.1	13.7	2.0	10.2	1.8	30.5	3.2	8.1	1.0	1.0	2.4	0.0	0.1	0.0	1.1	0.3	0.6	24.0	0.0	1.3	0.0	0.0	8.1	0.7	0.1	0.0	0.4	4.8	0.7	1.3	43.7	0.0	2.7	34.7	0.2	3.8	2.2	0.0	9.3	2.5	0.3	32.2	13.4	11.4	0.0	13.0	0.2	0.0	27.1	3.0	6.0	0.6	10.2	0.0	16.9	5.8	0.1	0.0	2.5	62.7	0.1	0.0	0.7	0.1	0.2	0.0	2.1	0.7	0.2	6.6	5.2	5.5	0.6	1.1	0.1	1.6	66.2	1.1	0.9	0.0	0.1
EFCAB3	FLJ25818	ENSG00000172421	"EF-hand calcium binding domain 3"	Q8N7B9	17	62343941-62416480	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 6.0"	"Cell type enriched"	"Detected in some"	8	"Early spermatids: 74.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA046862	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA046862: AB_2679844"													"unprognostic (2.99e-6)"					0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.1	0.4	0.0	0.3	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.3	0.0	0.1	0.0	0.2	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	74.6	0.2	0.4	0.4	0.0	0.0	1.3	0.0	0.2	0.4	0.0	0.3	1.3	0.3	0.4	0.3	0.0	1.7	0.9	0.0	0.0	0.0	1.1	8.4	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.1	0.0	0.4	0.0	0.1	0.0	0.1	3.1	0.3	0.0	0.2	0.1	0.1	0.5	0.0	0.0	0.4	0.1	0.0	0.0	0.1
EI24	"EPG4, PIG8, TP53I8"	ENSG00000149547	"EI24 autophagy associated transmembrane protein"	O14681	11	125569280-125584684	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 461.9"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 575.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HEL: 760.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047165, HPA051029"	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 36: HEL - Hemostasis"	"Cluster 2: Hepatocytes - Metabolism"	"Endoplasmic reticulum, Cytosol"	"Golgi apparatus"	"HPA047165: AB_2679965, HPA051029: AB_2681317"	"unprognostic (2.04e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.25e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.78e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.38e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (9.28e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.35e-1)"	"unprognostic (4.58e-2)"	"unprognostic (8.35e-2)"	"unprognostic (2.07e-1)"	"unprognostic (3.01e-1)"	53.4	32.6	61.1	36.2	62.5	23.2	72.6	59.7	72.4	51.3	59.8	77.8	49.6	46.2	57.4	80.8	50.8	46.3	55.7	60.2	61.5	61.0	248.4	45.0	28.4	60.2	62.5	42.4	101.8	461.9	30.6	48.5	60.2	49.6	80.4	39.4	75.3	58.0	119.5	70.2	49.3	62.5	62.4	30.5	59.7	33.1	64.4	35.3	40.5	104.6	42.3	78.9	48.4	61.0	156.6	115.6	129.5	160.5	207.7	155.9	162.4	159.6	116.8	104.3	93.4	178.9	303.4	158.0	264.0	146.5	110.8	176.1	199.0	326.8	135.2	42.0	142.6	760.9	77.2	179.9	154.1	170.9	78.4	147.5	292.7	157.4	230.2	102.8	223.9	85.1	351.1	61.1	149.4	113.8	79.0	96.4	173.6	398.3	139.5	113.9	155.4	132.8	177.0	272.4	120.1	116.9	187.1	215.5	63.4	212.3	436.4	165.7	195.2	133.8	93.3	94.7	128.7	39.7	84.8	200.5	58.5	256.1	182.2	4.3	7.0	5.9	7.2	6.7	7.2	8.4	5.7	9.0	10.9	6.3	8.1	6.7	0.8	6.5	4.9	14.5	9.1	5.3	61.1	62.5	59.7	72.4	60.2	61.5	60.2	62.5	60.2	62.4	64.4	61.0	73.5	32.1	38.3	13.4	34.8	120.6	130.3	132.6	120.1	58.9	148.8	100.6	61.9	124.4	69.5	110.3	37.5	166.9	32.4	66.4	144.8	178.6	31.1	34.4	59.3	87.1	98.4	102.7	25.1	181.8	201.2	80.1	87.7	46.5	27.3	76.2	74.6	575.0	110.5	82.4	24.0	115.3	105.8	49.8	96.1	49.7	71.4	40.9	90.7	11.2	40.9	107.1	50.4	13.0	23.0	182.1	67.6	72.2	79.1	270.0	68.5	122.7	43.9	36.9	46.0	60.8	80.1	95.9	112.3	176.3	181.4	140.1	31.0	71.3	135.7	189.4
EIF4A3	"DDX48, EIF4AIII, Fal1, KIAA0111"	ENSG00000141543	"Eukaryotic translation initiation factor 4A3"	P38919	17	80134369-80147151	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, rRNA processing, Translation regulation, Transport"	"Helicase, Hydrolase, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021878	Supported		Supported	Nucleoplasm		NA	NA		280000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA021878: AB_1848090"	"unprognostic (7.24e-2)"	"unprognostic (7.33e-3)"	"prognostic favorable (3.57e-5)"	"unprognostic (1.29e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.52e-2)"	"prognostic unfavorable (1.68e-5)"	"prognostic unfavorable (1.87e-4)"	"unprognostic (3.71e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.64e-2)"	"unprognostic (9.78e-3)"	"unprognostic (5.81e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.38e-2)"	"unprognostic (2.91e-3)"	65.8	81.4	19.0	49.1	21.1	185.8	44.2	21.5	27.2	51.2	22.8	44.3	38.6	46.6	38.8	81.9	54.7	40.1	38.0	22.3	21.0	45.1	42.6	44.0	67.0	19.9	19.5	66.5	37.0	58.5	41.1	52.9	20.3	38.7	47.5	32.3	42.4	32.6	37.3	64.8	38.9	42.6	22.7	47.6	41.4	42.8	20.0	78.2	37.0	34.9	74.7	83.4	55.1	24.7	237.2	208.9	140.5	103.8	105.5	63.2	114.4	119.3	91.0	177.7	141.4	223.7	110.3	221.4	67.9	112.9	126.4	152.2	194.9	136.2	195.0	71.5	192.3	142.5	159.3	244.3	103.1	253.8	133.4	98.7	68.7	149.5	119.4	71.8	147.2	128.7	189.8	140.2	105.3	178.9	224.8	132.8	145.0	223.8	190.0	168.5	282.7	172.2	85.8	196.5	186.1	100.1	170.9	334.2	151.9	130.1	219.3	166.7	100.5	108.7	138.6	159.9	200.3	104.4	86.2	403.2	88.0	158.7	113.3	126.1	167.0	137.4	101.1	174.6	131.2	142.4	128.2	119.4	200.0	119.8	116.9	115.2	98.7	132.9	143.4	326.0	158.2	232.6	19.0	21.1	21.5	27.2	22.3	21.0	19.9	19.5	20.3	22.7	20.0	24.7	117.9	41.7	48.0	6.8	135.1	283.1	273.4	212.9	107.0	23.3	77.0	109.2	61.5	38.6	107.8	29.5	16.7	140.1	165.7	75.4	64.6	85.6	33.2	132.9	109.2	70.5	60.3	24.4	4.1	115.2	225.1	144.3	149.4	248.2	92.6	42.6	32.2	27.0	108.5	6.7	4.3	83.2	89.5	63.4	255.0	12.1	67.1	199.6	103.2	10.3	67.9	48.6	23.7	5.5	7.6	86.6	83.1	49.7	118.6	96.0	47.9	65.0	61.4	32.5	85.5	109.7	207.8	99.4	123.2	77.6	299.1	261.9	138.4	98.0	77.7	252.5
EIF5A	"EIF-5A, EIF5A1, MGC104255, MGC99547"	ENSG00000132507	"Eukaryotic translation initiation factor 5A"	P63241	17	7306999-7312463	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"CAB005042, HPA061298, HPA074052"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	"Nucleoplasm, Plasma membrane"	"CAB005042: AB_562281, HPA061298: AB_2684472, HPA074052: "	"unprognostic (3.72e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.80e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (9.04e-4)"	"unprognostic (4.10e-1)"	"unprognostic (4.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (8.25e-2)"	"prognostic unfavorable (1.63e-5)"	"unprognostic (3.53e-1)"	"unprognostic (2.79e-1)"	"unprognostic (6.01e-2)"	"unprognostic (7.65e-2)"	317.2	309.3	82.3	138.3	83.8	221.5	240.7	85.5	99.0	222.7	77.8	247.5	113.0	206.2	85.8	575.9	188.1	73.7	316.1	87.8	89.8	241.7	495.6	244.5	135.0	87.7	86.4	161.2	295.0	79.7	166.7	96.4	93.0	189.1	125.7	47.6	230.9	65.6	572.1	407.8	207.5	106.1	86.5	227.4	226.7	201.7	92.3	122.5	181.6	160.3	154.4	221.3	281.8	88.6	838.2	958.6	275.8	570.6	220.8	270.2	427.1	546.2	360.7	730.1	501.6	583.6	343.3	749.7	350.9	451.4	300.3	572.3	610.0	777.8	665.9	466.2	987.2	477.9	710.1	750.6	388.6	324.0	431.7	302.5	374.9	587.8	736.0	259.1	501.4	232.0	673.8	192.2	527.3	496.2	388.6	523.3	525.8	477.2	498.0	412.0	320.5	732.4	464.6	393.8	340.5	431.8	330.0	469.4	360.8	212.3	327.2	258.4	427.7	567.6	379.5	326.2	896.4	168.8	229.9	443.6	515.1	527.2	642.2	146.8	137.6	102.0	157.4	193.1	187.5	154.5	153.1	137.2	215.9	149.1	139.6	144.6	62.0	195.1	186.5	225.0	156.7	200.3	82.3	83.8	85.5	99.0	87.8	89.8	87.7	86.4	93.0	86.5	92.3	88.6	180.1	54.5	37.9	6.2	241.9	349.0	67.9	226.5	378.5	88.3	258.8	138.7	77.8	125.8	72.7	62.5	14.6	324.3	200.3	316.0	74.3	317.3	153.8	136.4	255.2	176.6	150.6	456.1	6.8	239.8	633.8	199.6	172.8	187.8	138.4	87.3	105.7	236.4	296.8	50.5	7.0	317.4	83.4	133.6	283.1	112.9	100.6	151.9	263.3	4.7	245.0	122.2	216.3	2.0	11.5	322.0	223.7	81.3	386.7	507.1	229.3	127.1	41.3	65.0	92.1	160.7	262.1	200.4	82.6	572.0	313.7	428.4	179.3	290.7	384.7	207.0
EIF5A2		ENSG00000163577	"Eukaryotic translation initiation factor 5A2"	Q9GZV4	3	170888418-170908644	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 28.3"	"Group enriched"	"Detected in many"	12	"Early spermatids: 353.0;Late spermatids: 977.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029090	Approved		Supported	Vesicles		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 18: U-2197 - ECM organization"	"Cluster 34: Spermatids - Unknown function"	Vesicles		"HPA029090: AB_10671359"	"unprognostic (2.41e-1)"	"unprognostic (2.42e-1)"	"unprognostic (4.05e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (7.42e-4)"	"unprognostic (1.11e-3)"	"unprognostic (1.47e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.79e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.45e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.64e-2)"	"unprognostic (4.29e-3)"	4.1	2.7	1.9	3.1	2.8	4.2	2.9	5.8	6.1	3.1	1.9	3.4	1.7	4.5	1.3	2.9	2.4	3.5	4.0	1.9	5.4	5.0	1.6	2.2	2.8	7.2	4.6	4.4	3.3	3.7	1.8	1.8	8.2	2.6	2.6	2.8	1.9	3.0	1.3	1.9	1.6	7.2	4.1	2.3	9.1	28.3	5.5	4.3	2.2	3.1	3.1	3.5	2.0	7.2	22.7	11.6	4.2	5.9	21.7	14.2	10.0	17.1	22.3	17.4	25.1	23.6	14.4	14.2	30.9	23.4	38.9	7.4	13.4	6.0	21.9	15.8	5.8	6.9	4.6	7.5	14.6	18.2	19.9	16.6	8.7	26.3	21.4	24.2	9.1	3.7	5.8	0.1	28.7	7.6	8.1	7.9	8.1	17.5	7.8	0.0	12.0	0.0	7.3	4.0	3.4	6.4	17.7	4.6	14.4	6.5	10.0	11.9	12.0	21.2	15.0	44.8	38.9	21.6	0.3	33.3	7.2	6.2	15.4	14.9	1.4	1.5	12.4	1.5	8.7	2.2	8.4	11.9	1.0	3.5	5.0	8.3	0.7	8.8	1.4	1.0	11.3	5.0	1.9	2.8	5.8	6.1	1.9	5.4	7.2	4.6	8.2	4.1	5.5	7.2	16.6	0.0	0.5	4.9	4.4	17.1	8.5	7.8	10.8	2.5	2.1	2.7	9.5	0.0	1.8	1.8	0.0	1.2	18.1	1.6	1.9	6.4	353.0	0.9	7.7	12.8	4.9	2.1	7.1	7.5	1.9	11.7	8.6	0.6	2.5	2.6	3.3	2.5	8.9	0.0	8.8	0.8	2.0	3.8	7.2	977.9	12.8	4.5	10.6	3.7	7.9	8.0	28.8	4.0	10.1	19.6	6.1	11.3	3.7	8.2	1.7	21.1	3.4	2.7	46.0	9.6	11.6	54.3	10.0	2.3	21.6	0.7	15.7	2.2	1.8	5.7
EIF5AL1	"bA342M3.3, EIF5AP1"	ENSG00000253626	"Eukaryotic translation initiation factor 5A like 1"	Q6IS14	10	79512533-79516440	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein biosynthesis, Protein transport, Translocation, Transport"	"Elongation factor, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 10.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 79.2;Intestinal goblet cells: 96.7;Spermatocytes: 76.5;Undifferentiated cells: 121.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"U-251 MG: 2.2"									HPA074052			Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	"Plasma membrane"	"HPA074052: "	"unprognostic (2.16e-2)"	"prognostic favorable (4.23e-4)"	"unprognostic (2.55e-1)"	"unprognostic (4.14e-3)"	"unprognostic (1.50e-1)"	"unprognostic (3.48e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.50e-3)"	"unprognostic (2.04e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.01e-1)"	"unprognostic (8.79e-3)"	"unprognostic (1.56e-1)"	"unprognostic (8.63e-2)"	"unprognostic (1.87e-1)"	"unprognostic (6.68e-2)"	"unprognostic (1.81e-1)"	0.8	0.8	0.1	0.2	0.1	0.2	0.6	0.5	0.3	0.4	0.0	0.6	0.2	0.5	0.2	1.4	0.4	0.0	0.9	0.1	0.0	0.5	1.3	0.6	0.3	0.0	0.0	0.3	0.7	0.2	0.4	0.0	0.0	0.5	0.2	0.8	0.5	0.0	1.5	1.0	0.5	0.0	0.0	0.5	0.5	10.6	0.0	0.0	0.5	0.0	0.3	0.5	0.7	0.1	0.4	0.8	0.3	1.7	0.0	0.2	0.3	0.3	0.1	0.3	0.2	0.6	0.3	0.9	0.3	0.0	0.2	0.5	0.1	0.0	0.2	0.2	0.7	0.2	1.0	0.4	0.1	0.3	0.6	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.2	0.3	0.1	0.6	1.0	0.9	1.2	0.1	0.1	0.3	0.7	0.6	0.5	0.8	0.2	0.5	0.5	0.4	0.6	0.1	0.8	0.7	0.2	0.4	1.0	1.1	2.2	0.4	0.5	0.8	0.7	0.2	0.6	1.1	0.8	0.6	1.2	2.0	1.4	1.3	1.2	1.3	1.6	1.3	0.9	1.3	0.7	1.7	1.3	2.5	1.0	0.8	0.1	0.1	0.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	16.0	30.0	1.3	10.4	33.8	3.0	7.8	0.0	0.6	5.1	2.4	43.1	2.8	16.1	0.0	0.0	20.8	2.4	79.2	11.7	64.5	14.7	2.9	4.4	12.9	60.0	10.7	0.6	47.8	35.1	15.5	0.0	3.2	48.2	0.9	4.2	5.1	17.5	1.7	0.6	96.7	8.2	8.7	27.9	8.7	5.0	7.2	19.6	0.0	41.9	1.2	13.4	0.0	1.0	65.6	61.2	3.0	0.5	10.3	66.5	11.1	6.1	0.5	0.0	6.9	25.9	76.5	4.3	0.0	34.5	27.6	8.9	3.3	121.3	5.0
EMB	MGC71745	ENSG00000170571	Embigin	Q6PCB8	5	50396192-50443248	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 152.5;intestine: 72.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 108.4;dendritic cells: 133.3;NK-cells: 153.5;Proximal enterocytes: 137.5;T-cells: 150.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"THP-1: 281.5;U-937: 124.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"				"unprognostic (1.01e-3)"	"unprognostic (8.65e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-1)"	"prognostic unfavorable (2.76e-5)"	"unprognostic (4.96e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.22e-2)"	"unprognostic (8.86e-3)"	18.4	22.4	1.7	28.4	1.6	152.5	12.1	4.0	2.9	8.6	2.4	9.7	72.0	3.1	2.7	8.0	5.8	12.9	5.1	1.9	5.4	2.5	4.7	15.9	55.9	6.9	7.8	2.1	2.1	24.2	8.4	13.4	5.6	29.1	11.6	10.5	5.5	20.4	1.3	32.3	68.3	8.0	3.5	25.0	14.3	10.9	3.7	28.4	20.7	3.6	48.4	16.8	2.8	3.1	38.8	2.9	6.5	0.1	2.9	8.7	0.5	1.7	0.0	2.7	0.3	0.3	91.6	74.3	2.1	3.2	0.0	55.7	15.3	43.5	0.4	24.0	38.8	34.5	10.2	0.0	0.5	69.9	0.2	0.6	23.3	6.9	28.2	44.6	0.0	28.8	0.0	86.8	52.4	41.0	43.2	39.3	27.2	0.0	19.9	65.5	0.2	98.6	0.0	29.8	21.2	19.9	0.0	10.1	1.1	13.4	4.3	281.5	0.1	0.1	32.5	0.2	0.3	1.0	0.0	59.3	0.1	124.1	8.3	9.5	34.1	38.7	44.5	4.4	54.1	20.7	39.9	41.0	22.3	13.7	23.5	31.8	30.2	37.3	1.4	25.7	53.6	42.8	1.7	1.6	4.0	2.9	1.9	5.4	6.9	7.8	5.6	3.5	3.7	3.1	3.3	67.3	17.3	1.6	78.1	18.2	2.0	21.2	8.6	3.3	6.5	8.0	1.9	10.0	27.7	0.0	108.4	12.1	133.3	1.2	0.0	0.8	0.6	1.0	0.4	3.8	7.3	21.9	51.9	0.9	8.5	7.8	15.8	0.4	19.0	0.0	20.7	1.6	20.6	1.7	28.7	11.3	8.2	31.4	86.4	1.5	2.8	63.5	10.6	41.2	78.0	2.1	153.5	0.0	1.6	15.7	4.4	6.8	71.1	9.6	137.5	0.4	34.3	9.0	0.0	2.3	4.6	1.0	3.8	6.4	12.6	8.5	150.9	0.0	15.4	2.4
EMC1	KIAA0090	ENSG00000127463	"ER membrane protein complex subunit 1"	Q8N766	1	19215660-19251527	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Rod photoreceptor cells: 63.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048904	Approved					NA	NA		14000	"Cluster 27: Non-specific - Gene expression"	"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA048904: AB_2680552"	"unprognostic (9.46e-3)"	"unprognostic (1.91e-3)"	"unprognostic (1.75e-2)"	"unprognostic (4.11e-3)"	"unprognostic (2.05e-1)"	"unprognostic (5.31e-3)"	"prognostic unfavorable (8.56e-6)"	"unprognostic (5.98e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.08e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.19e-2)"	"prognostic unfavorable (1.43e-4)"	15.4	11.2	10.1	11.7	11.6	9.2	11.1	11.7	14.0	12.2	2.1	12.8	8.7	12.2	13.1	10.7	12.0	8.2	12.5	11.8	16.0	10.8	15.5	12.0	9.0	8.3	9.5	14.1	10.6	16.3	10.0	24.0	11.3	13.2	14.1	51.9	10.7	11.0	19.9	11.6	9.1	18.9	5.1	9.7	11.0	13.1	12.4	9.4	14.0	14.3	10.5	11.7	9.8	8.8	41.1	36.5	40.3	105.4	63.6	49.3	78.3	65.1	60.8	88.3	86.8	38.4	92.5	36.5	84.1	100.6	57.1	45.4	56.7	73.0	102.1	31.0	29.6	44.0	46.3	45.5	46.2	56.9	50.7	52.7	46.4	104.6	86.2	82.2	75.6	31.2	55.1	53.7	69.1	23.5	23.3	27.9	24.4	47.2	33.9	34.4	49.7	64.2	35.8	18.8	49.6	33.9	71.5	37.0	54.6	47.2	40.5	35.3	67.3	79.5	51.7	61.2	75.2	29.7	67.0	46.3	75.4	73.5	108.4	5.2	12.7	3.1	8.1	9.6	9.0	6.2	8.1	9.2	12.6	7.0	8.0	8.0	0.5	21.7	12.8	6.1	6.2	9.1	10.1	11.6	11.7	14.0	11.8	16.0	8.3	9.5	11.3	5.1	12.4	8.8	13.0	16.0	14.6	8.1	12.4	11.6	10.1	16.9	8.0	20.3	11.2	11.7	15.7	11.5	10.5	22.0	10.4	40.4	9.9	11.4	0.0	14.3	1.2	10.0	18.0	16.1	19.7	6.9	12.9	8.5	41.0	19.2	9.7	15.0	8.2	23.2	14.3	25.6	19.4	15.2	14.5	11.4	14.2	12.3	7.3	2.6	14.9	11.5	10.6	8.4	12.0	19.0	4.1	15.1	10.9	10.6	9.4	14.3	14.5	10.3	6.4	9.0	7.8	63.4	6.6	20.1	13.5	12.9	19.3	13.0	9.2	36.0	8.9	18.6	12.7	6.7
EMC10	"C19orf63, HSM1, HSS1, INM02"	ENSG00000161671	"ER membrane protein complex subunit 10"	Q5UCC4	19	50476400-50490871	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Angiogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 185.8"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEK 293: 193.0;PC-3: 137.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053905, HPA062723"	Approved				"Secreted to blood"	NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 37: Myocytes - Muscle contraction"			"HPA053905: AB_2682303, HPA062723: "	"unprognostic (2.48e-1)"	"unprognostic (1.93e-2)"	"unprognostic (9.86e-3)"	"unprognostic (1.65e-1)"	"unprognostic (6.94e-2)"	"unprognostic (8.38e-3)"	"unprognostic (3.23e-2)"	"unprognostic (9.87e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.99e-1)"	"prognostic favorable (4.39e-4)"	"unprognostic (5.01e-2)"	"prognostic favorable (6.64e-6)"	"unprognostic (2.81e-1)"	"unprognostic (3.49e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.44e-1)"	24.3	63.9	29.1	11.4	41.5	19.7	27.6	38.4	38.2	34.1	46.7	36.1	23.8	38.8	15.3	36.0	32.0	13.5	50.7	27.2	29.4	76.3	63.0	32.1	9.7	38.8	35.0	49.6	55.2	44.3	106.4	9.5	36.0	38.3	7.1	8.7	55.7	16.9	185.8	31.7	36.0	6.6	32.7	27.8	47.8	45.6	36.0	6.9	82.4	9.0	6.8	31.0	27.3	49.5	66.2	80.1	3.0	30.8	8.8	10.8	0.8	62.9	11.4	5.4	5.9	0.7	44.4	21.6	0.8	11.3	9.9	55.1	3.7	10.3	2.0	84.2	193.0	4.6	33.9	0.0	14.7	19.1	123.2	13.3	11.3	5.6	4.3	5.2	13.5	18.5	42.7	44.9	11.3	46.0	30.3	0.6	0.3	26.0	137.6	51.7	9.7	71.7	25.0	59.2	48.5	107.9	92.5	29.6	36.1	3.6	31.0	34.8	26.2	3.8	83.1	23.0	34.4	49.5	132.7	17.9	24.8	13.2	30.8	6.2	6.9	8.1	5.0	5.6	4.3	6.4	5.3	5.3	5.3	8.5	6.2	6.0	3.0	3.1	4.3	7.0	4.7	5.2	29.1	41.5	38.4	38.2	27.2	29.4	38.8	35.0	36.0	32.7	36.0	49.5	30.3	64.1	111.1	15.7	65.6	29.7	53.4	60.9	31.3	82.3	72.5	53.8	11.3	81.5	64.0	69.9	81.3	129.5	71.0	103.6	23.5	181.8	177.7	52.1	49.4	46.0	212.2	21.7	7.9	112.3	155.0	46.6	71.9	79.8	53.2	80.3	55.6	79.4	133.8	37.0	11.8	117.7	59.0	109.2	36.7	39.1	69.0	67.7	83.6	9.4	103.1	101.2	90.6	44.2	78.3	114.4	144.9	115.1	80.2	66.4	158.2	66.8	28.6	71.7	6.6	93.3	43.7	18.0	56.2	50.3	31.3	151.0	67.4	78.5	130.5	66.5
EMC2	"KIAA0103, TTC35"	ENSG00000104412	"ER membrane protein complex subunit 2"	Q15006	8	108443601-108489196	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 190.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA022838	Approved					NA	NA		11000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA022838: AB_2670967"	"prognostic unfavorable (2.64e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (5.46e-2)"	"unprognostic (5.76e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.15e-3)"	40.8	38.2	20.1	5.3	21.4	3.5	36.7	20.7	25.3	33.9	19.7	42.9	6.0	27.7	10.1	39.8	31.0	6.7	49.0	19.3	20.4	40.1	34.6	35.5	6.2	21.9	20.2	29.5	41.0	9.6	32.3	9.3	21.3	27.2	8.5	10.2	33.0	7.5	57.3	30.9	27.6	7.3	21.0	26.6	35.1	38.7	20.0	4.6	30.2	10.9	6.1	33.7	33.8	26.3	10.5	5.8	5.0	6.0	9.0	10.1	4.5	4.1	6.5	7.1	6.5	4.8	6.7	4.9	8.7	6.8	5.2	4.6	9.8	10.7	9.0	10.4	9.7	7.9	12.0	7.0	13.7	4.6	4.8	10.7	13.2	6.1	12.0	10.9	9.3	5.6	7.3	5.2	9.4	11.8	6.4	7.0	4.6	17.1	9.9	2.8	6.0	8.0	16.0	5.6	5.4	3.4	4.8	1.3	10.0	7.4	8.3	7.7	5.4	5.0	4.4	9.2	5.4	5.3	11.8	4.9	12.6	10.8	7.7	11.6	6.1	10.4	9.0	5.9	8.1	6.3	8.1	10.7	6.3	6.0	9.6	9.6	7.9	6.9	6.8	10.3	8.5	5.6	20.1	21.4	20.7	25.3	19.3	20.4	21.9	20.2	21.3	21.0	20.0	26.3	47.3	32.1	49.5	50.9	22.8	27.5	52.5	157.7	27.3	17.9	18.6	20.8	66.8	37.1	98.7	36.8	14.6	57.2	25.8	19.8	86.1	52.0	72.8	48.4	28.4	37.4	21.1	9.9	30.9	46.5	47.6	43.9	17.3	28.7	35.5	20.8	32.9	24.7	47.7	18.5	37.8	23.6	93.6	20.5	16.1	24.6	36.7	21.3	32.0	24.4	38.6	57.9	16.5	44.7	102.1	34.2	27.5	37.2	27.6	31.4	40.3	102.4	98.6	30.5	65.7	39.3	64.6	190.8	71.6	20.5	27.3	73.5	24.4	45.9	22.2	42.5
EMC3	TMEM111	ENSG00000125037	"ER membrane protein complex subunit 3"	Q9P0I2	3	9962537-10011116	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 360.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042372	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA042372: AB_10795609"	"unprognostic (1.31e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.05e-3)"	"unprognostic (2.46e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.91e-1)"	"prognostic favorable (2.81e-6)"	"unprognostic (2.73e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.71e-2)"	"unprognostic (5.58e-2)"	71.1	41.1	26.5	28.9	27.6	65.7	33.3	28.5	29.9	26.1	29.7	40.6	37.4	23.2	26.9	46.1	28.9	27.9	34.3	29.2	29.4	40.3	65.7	36.1	22.7	31.0	29.5	22.5	43.6	70.5	17.2	20.3	30.4	25.8	36.0	24.2	42.8	32.0	78.5	33.6	37.3	32.0	28.3	23.1	35.3	48.5	28.8	27.2	39.9	46.7	28.5	40.7	25.1	30.4	48.9	100.7	37.4	22.5	232.6	90.3	125.1	98.1	84.6	60.1	64.8	69.5	75.6	38.7	69.8	111.9	115.2	66.7	64.2	58.3	61.7	105.2	64.3	63.6	69.9	46.5	100.4	71.8	68.2	107.4	102.5	104.9	60.1	76.5	75.6	41.8	82.0	109.2	90.2	119.5	38.3	35.6	41.5	103.2	68.7	49.0	52.4	115.7	72.8	86.7	26.4	53.1	69.9	103.3	63.4	39.1	87.5	58.0	87.6	59.8	49.6	65.0	100.8	58.3	165.6	79.0	126.2	52.0	76.4	119.7	115.1	108.5	64.5	93.6	66.8	65.6	63.7	74.5	88.3	71.2	45.8	61.5	103.5	77.3	95.3	79.1	107.3	156.1	26.5	27.6	28.5	29.9	29.2	29.4	31.0	29.5	30.4	28.3	28.8	30.4	59.1	54.5	72.9	19.9	45.3	50.6	59.9	178.0	24.5	40.6	43.0	39.9	108.1	57.2	121.4	46.0	39.6	49.5	52.7	58.6	46.9	100.6	360.7	61.6	50.2	59.2	21.1	240.2	25.4	119.9	51.8	51.1	38.7	64.0	34.1	36.5	46.1	105.0	97.8	23.5	21.1	40.2	109.9	51.0	66.6	109.3	50.4	101.7	58.7	9.4	97.5	65.2	57.7	21.1	17.8	107.4	71.3	37.6	55.6	58.7	92.6	76.9	99.1	63.5	59.2	44.7	60.7	199.7	63.0	49.6	60.7	85.8	52.7	60.6	52.0	80.2
EMC4	"FLJ90746, MGC24415, PIG17, TMEM85"	ENSG00000128463	"ER membrane protein complex subunit 4"	Q5J8M3	15	34225013-34230156	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053440	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA053440: AB_2682151"	"unprognostic (8.99e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.68e-2)"	"unprognostic (3.29e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.29e-3)"	"unprognostic (3.25e-1)"	"unprognostic (3.61e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.78e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.20e-2)"	"unprognostic (2.52e-1)"	"unprognostic (5.42e-2)"	"unprognostic (4.20e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.97e-2)"	76.1	68.1	83.8	48.8	86.5	58.7	68.4	90.3	103.7	69.3	92.0	69.1	55.1	67.0	102.9	78.3	67.8	52.3	86.4	87.6	88.8	67.9	91.3	57.3	55.4	87.2	85.2	66.2	90.7	83.0	60.3	59.2	88.4	62.3	58.2	65.4	79.0	63.7	214.4	63.9	57.1	58.8	86.9	49.1	69.8	49.4	85.7	58.1	60.6	136.7	54.2	59.2	71.4	95.2	123.1	248.2	103.9	135.1	133.2	119.6	95.0	137.7	156.9	166.0	143.4	162.0	106.1	48.5	177.7	160.0	145.6	229.4	107.0	135.3	118.7	148.3	103.7	91.9	219.4	154.8	161.0	139.8	87.8	121.4	126.3	121.4	136.0	118.1	139.8	144.6	117.0	186.6	147.1	137.9	109.9	149.9	116.9	165.0	163.5	102.0	94.7	138.3	161.0	186.9	137.1	166.4	101.7	148.3	77.6	74.8	99.3	164.7	106.5	151.3	103.8	131.8	142.7	162.8	251.5	122.0	184.5	164.1	131.1	256.5	158.6	176.9	154.5	173.9	170.0	237.2	170.6	185.8	162.6	187.7	172.2	168.8	88.5	197.8	200.2	166.6	216.1	277.6	83.8	86.5	90.3	103.7	87.6	88.8	87.2	85.2	88.4	86.9	85.7	95.2	75.3	54.5	67.7	8.8	67.9	91.5	103.7	206.5	55.8	35.8	83.7	104.1	58.7	58.6	132.4	66.2	18.8	150.6	62.5	39.5	125.2	180.3	121.8	67.6	55.1	86.1	52.0	38.7	14.1	172.3	173.6	87.8	36.7	69.1	88.0	63.2	64.2	78.6	113.7	18.5	15.4	62.8	166.8	48.5	73.2	27.4	100.6	56.5	101.4	13.1	87.9	98.4	76.2	15.1	16.9	184.0	65.4	90.7	117.9	89.6	71.8	117.5	133.3	42.8	85.5	81.4	123.2	169.7	91.9	60.2	110.0	141.7	68.8	69.7	66.4	125.4
EMC6	"MGC2963, RAB5IFL, TMEM93"	ENSG00000127774	"ER membrane protein complex subunit 6"	Q9BV81	17	3668812-3669668	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 185.0"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA062681	Uncertain		Approved	Nucleoplasm,Centrosome		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"	Centrosome	Nucleoplasm	"HPA062681: AB_2684831"	"unprognostic (2.21e-1)"	"prognostic unfavorable (7.73e-4)"	"unprognostic (2.21e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.63e-1)"	"unprognostic (6.20e-3)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (9.39e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.30e-2)"	"unprognostic (7.58e-3)"	"unprognostic (4.17e-2)"	"unprognostic (1.94e-1)"	"unprognostic (6.37e-2)"	"unprognostic (3.27e-1)"	"unprognostic (6.32e-2)"	35.6	58.2	35.1	14.7	36.0	30.3	31.4	38.9	40.2	24.7	40.1	40.8	20.0	29.1	11.3	49.3	27.0	5.2	91.0	34.8	37.2	53.2	75.8	29.2	13.3	36.2	35.3	23.4	44.3	18.5	27.7	13.5	35.9	33.0	10.3	17.2	35.5	10.6	185.0	36.9	35.3	9.0	38.5	37.8	47.4	63.3	37.3	15.5	29.6	60.7	12.6	32.8	30.4	37.8	92.8	88.6	38.1	40.1	26.9	21.4	73.2	64.7	31.4	51.7	47.5	54.1	33.8	57.6	91.6	30.3	45.9	87.2	44.5	45.6	37.2	56.0	166.2	41.9	65.4	76.2	38.7	29.3	41.6	27.1	50.6	47.8	33.2	40.9	39.8	68.0	53.4	40.6	38.6	56.2	60.5	86.2	55.0	55.9	99.1	55.7	35.5	55.3	74.2	25.9	31.3	56.7	53.1	41.2	75.6	37.8	48.0	31.1	44.2	43.3	54.4	65.9	96.5	39.5	47.1	38.4	67.7	38.0	53.3	91.6	83.1	87.1	66.1	83.8	61.1	74.6	73.6	73.4	72.7	72.0	75.2	68.5	62.8	56.5	60.7	114.3	92.5	87.4	35.1	36.0	38.9	40.2	34.8	37.2	36.2	35.3	35.9	38.5	37.3	37.8	40.1	16.0	25.9	9.4	60.3	89.0	127.1	144.2	42.1	41.8	82.9	87.8	0.2	82.9	74.8	58.8	35.5	118.4	68.1	55.7	166.3	126.2	252.2	90.0	42.7	56.6	51.4	46.7	7.4	142.8	148.6	40.8	48.4	58.0	55.2	59.8	47.5	148.7	102.5	33.7	8.4	74.7	105.8	57.1	49.6	176.1	38.5	56.6	67.6	3.7	83.3	125.9	77.2	5.5	17.9	164.8	71.6	34.3	81.9	179.9	84.6	203.8	82.2	52.9	39.5	43.3	111.7	151.0	91.6	81.1	101.9	129.0	52.7	65.0	72.6	169.5
EMC7	"C11orf3, C15orf24"	ENSG00000134153	"ER membrane protein complex subunit 7"	Q9NPA0	15	34084017-34101862	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010029	Approved					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA010029: AB_1078335"	"unprognostic (2.16e-1)"	"unprognostic (8.16e-3)"	"unprognostic (5.28e-2)"	"prognostic favorable (4.68e-5)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (9.25e-5)"	"unprognostic (1.35e-1)"	"unprognostic (3.68e-2)"	"unprognostic (1.18e-1)"	"unprognostic (5.65e-3)"	"unprognostic (4.67e-2)"	"unprognostic (3.17e-1)"	"unprognostic (1.36e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.47e-3)"	65.4	86.5	74.2	48.3	78.2	75.2	58.5	82.6	92.9	47.2	91.4	61.3	52.1	49.6	104.4	47.6	45.9	50.4	70.4	74.1	85.7	90.7	103.8	54.4	43.8	78.5	79.2	43.1	79.1	93.2	54.7	77.3	79.7	62.2	64.8	67.2	59.9	57.0	91.0	56.0	46.8	58.8	82.1	42.5	57.7	76.9	79.6	40.1	71.0	70.9	46.2	63.0	44.0	87.0	68.1	185.7	62.2	84.2	249.3	143.3	69.3	190.4	199.3	174.8	181.0	170.6	79.7	40.4	187.4	189.5	181.3	128.9	94.7	96.3	128.5	99.7	96.5	99.4	273.6	147.3	229.1	101.2	135.0	155.1	181.5	125.0	178.7	117.3	110.3	75.9	99.5	259.9	170.7	79.8	54.5	115.2	58.1	157.2	122.3	69.5	76.2	140.3	187.3	119.1	107.2	78.2	114.0	151.8	97.7	75.5	110.0	161.2	94.9	185.8	71.6	123.7	144.4	172.4	219.7	86.2	187.8	153.3	154.8	316.0	161.1	178.1	139.7	184.2	136.9	137.0	138.6	144.0	150.6	102.9	100.4	124.1	143.8	122.7	206.2	242.6	195.8	196.4	74.2	78.2	82.6	92.9	74.1	85.7	78.5	79.2	79.7	82.1	79.6	87.0	65.5	28.9	36.1	20.2	51.7	86.9	56.8	194.6	40.9	58.6	44.0	50.3	92.9	54.3	117.9	103.0	45.9	127.5	92.1	56.5	39.2	124.4	117.3	52.4	66.2	67.3	45.6	48.0	15.5	172.4	153.4	90.1	32.6	52.6	45.1	40.2	60.3	78.6	112.6	30.3	17.8	57.6	146.5	65.2	60.1	81.6	90.1	61.2	103.2	12.2	70.9	112.4	40.2	17.6	27.7	137.9	63.0	104.2	97.1	61.3	72.5	90.8	94.5	62.9	118.3	65.4	136.5	257.9	57.4	43.1	86.4	160.1	65.8	100.4	61.3	55.2
EMC8	"C16orf2, C16orf4, COX4NB, FAM158B, NOC4"	ENSG00000131148	"ER membrane protein complex subunit 8"	O43402	16	85771758-85799608	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 230.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049476	Approved		Supported	"Endoplasmic reticulum,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Endoplasmic reticulum"	"Golgi apparatus"	"HPA049476: AB_2680784"	"unprognostic (2.69e-1)"	"unprognostic (2.62e-2)"	"unprognostic (4.21e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (1.30e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.03e-1)"	"unprognostic (6.91e-3)"	"prognostic favorable (6.39e-4)"	"unprognostic (9.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.24e-1)"	13.5	12.9	13.9	8.3	14.7	17.4	12.7	14.7	13.6	9.7	13.2	12.5	10.6	12.7	7.2	13.1	9.2	6.3	19.5	13.9	13.9	13.8	12.8	9.3	10.1	14.8	14.3	8.2	10.9	11.0	10.2	9.3	13.8	9.9	8.7	7.1	9.9	8.7	20.8	10.5	10.5	9.3	15.1	10.9	11.7	12.2	14.8	10.3	9.6	12.5	9.5	11.7	9.4	16.0	29.8	34.1	21.3	19.5	22.6	21.6	41.4	28.7	28.4	46.9	20.8	54.7	33.5	25.6	32.5	29.1	21.0	33.3	32.0	30.1	41.5	10.9	45.7	21.1	17.3	50.3	34.2	21.7	13.7	23.8	20.1	35.7	41.5	20.2	27.1	30.9	48.6	9.6	29.2	50.7	34.5	61.4	42.5	27.4	43.3	50.0	17.4	21.8	29.9	20.7	35.9	21.4	52.8	17.1	33.9	18.9	33.9	38.1	23.8	28.1	28.7	24.9	37.1	26.6	27.3	102.8	24.1	41.3	30.2	17.9	18.1	25.6	10.9	19.2	12.7	11.1	11.8	14.8	24.2	15.6	14.7	14.4	7.5	19.2	19.5	17.8	12.3	12.3	13.9	14.7	14.7	13.6	13.9	13.9	14.8	14.3	13.8	15.1	14.8	16.0	60.1	6.4	8.6	10.4	25.0	61.3	30.1	28.9	25.0	33.7	26.7	26.0	19.9	15.7	18.5	25.8	12.5	48.5	25.0	28.8	60.7	46.9	230.2	37.1	28.3	33.6	46.6	21.5	6.1	42.1	60.7	26.2	18.8	40.9	9.5	25.1	23.6	23.3	47.0	15.2	7.8	27.4	26.4	28.0	38.0	55.0	24.8	27.1	28.4	8.4	41.9	27.8	27.8	8.0	12.2	50.0	27.2	31.6	33.3	51.1	29.1	46.5	12.5	18.6	26.3	22.5	28.9	54.2	56.5	33.5	54.6	51.0	22.4	37.0	35.6	41.9
EMC9	"C14orf122, CGI-112, FAM158A"	ENSG00000100908	"ER membrane protein complex subunit 9"	Q9Y3B6	14	24138959-24141591	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 155.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 63.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078254	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA078254: "	"unprognostic (3.09e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.28e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.51e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.71e-2)"	"unprognostic (9.46e-2)"	"prognostic favorable (2.43e-4)"	"unprognostic (1.15e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.29e-2)"	"unprognostic (1.99e-1)"	10.4	30.2	9.5	2.7	9.5	6.0	10.4	9.7	10.9	11.4	11.7	14.9	9.9	11.0	4.8	14.5	11.5	2.5	17.6	9.5	10.4	22.2	26.8	10.1	4.2	9.9	9.1	13.3	20.8	5.0	31.9	3.0	10.1	19.5	3.4	12.5	14.4	5.2	39.6	16.6	14.4	3.1	8.8	17.3	13.8	16.3	9.6	6.1	14.4	18.4	3.6	13.2	11.9	9.1	14.1	32.6	9.0	25.0	4.7	2.5	8.3	8.7	7.0	12.5	12.5	14.2	10.5	11.6	7.5	7.0	9.7	12.6	7.4	13.8	7.4	9.3	18.0	2.7	13.2	63.3	5.8	10.3	5.7	3.4	5.6	6.8	11.9	10.0	14.1	16.3	2.7	14.9	9.9	33.0	10.2	8.8	10.4	14.3	23.7	6.4	22.3	12.1	9.8	16.7	15.7	12.7	16.3	28.9	7.7	4.4	16.1	5.2	7.1	5.4	15.0	8.0	14.7	18.7	17.7	13.5	8.4	4.4	8.8	0.8	4.2	3.5	3.7	2.3	4.2	4.6	5.1	5.0	4.3	4.8	2.5	3.4	0.4	3.4	2.1	10.2	7.5	3.5	9.5	9.5	9.7	10.9	9.5	10.4	9.9	9.1	10.1	8.8	9.6	9.1	14.1	0.0	7.0	3.9	17.3	18.1	10.4	24.7	24.5	46.4	23.3	23.1	19.7	17.2	15.5	23.9	18.8	33.0	17.3	22.1	56.7	17.6	83.3	12.6	12.3	12.3	21.0	32.6	6.1	11.7	24.2	16.6	6.1	12.9	5.1	24.2	8.6	26.1	30.5	11.8	6.6	29.6	24.4	14.0	19.6	155.7	11.5	11.4	16.0	3.7	15.4	21.2	9.2	4.0	3.2	9.7	14.0	21.8	21.6	17.9	75.9	61.0	18.6	54.4	13.1	15.5	18.5	20.9	5.6	18.1	23.9	24.5	13.4	32.0	30.9	10.3
ENY2	"DC6, FLJ20480, Sus1"	ENSG00000120533	"ENY2 transcription and export complex 2 subunit"	Q9NPA8	8	109334324-109345954	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Transcription, Transcription regulation, Translocation, Transport"	"Activator, Chromatin regulator"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024648	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA024648: AB_2100208"	"unprognostic (2.10e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.18e-1)"	"unprognostic (7.85e-2)"	"unprognostic (7.70e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.48e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.86e-3)"	"prognostic unfavorable (7.17e-6)"	"unprognostic (1.74e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.66e-1)"	54.4	55.5	28.1	44.7	29.1	87.6	57.0	29.3	45.3	44.2	32.9	59.5	54.5	37.9	53.8	48.2	36.1	29.9	64.2	29.1	32.2	74.4	101.3	40.4	49.6	31.5	30.5	29.5	44.9	47.2	34.4	41.3	30.1	39.0	55.1	24.5	43.7	36.0	71.7	34.7	47.9	44.1	29.8	47.7	47.9	34.8	29.7	60.3	38.0	68.5	53.8	48.4	38.9	30.9	180.3	145.9	213.6	97.1	79.5	101.0	61.4	140.0	89.9	141.2	177.2	109.0	109.1	115.3	127.9	110.9	63.6	89.7	96.8	99.5	171.7	184.1	113.9	223.5	106.7	227.4	85.4	78.3	133.5	77.5	66.7	92.5	87.3	102.2	215.1	111.5	216.5	63.7	162.7	289.9	235.9	175.5	156.1	207.1	140.3	148.4	93.2	144.5	192.5	134.7	128.9	137.5	87.7	109.3	127.2	117.0	138.6	132.3	146.9	94.1	158.9	97.8	144.7	107.9	125.6	222.2	95.2	128.3	112.7	65.6	102.5	93.5	28.9	112.8	36.7	41.4	39.0	35.6	93.8	27.3	31.9	35.8	56.8	42.4	121.8	80.3	42.3	74.5	28.1	29.1	29.3	45.3	29.1	32.2	31.5	30.5	30.1	29.8	29.7	30.9	231.3	70.5	93.8	16.3	135.0	185.6	196.3	305.7	159.9	63.8	149.2	192.7	170.6	138.7	184.6	145.3	123.0	263.3	157.0	171.5	381.5	214.3	173.3	146.4	134.7	226.3	154.2	160.1	22.7	200.0	284.5	161.0	88.7	144.8	91.8	99.3	142.5	371.1	276.8	45.4	23.9	245.1	225.9	230.3	265.7	111.0	148.2	205.0	158.3	17.8	260.9	112.4	126.7	19.6	27.6	251.2	237.1	112.5	147.2	230.3	264.5	546.1	125.0	139.9	78.9	163.9	262.9	208.7	130.4	151.0	174.6	167.3	132.4	143.9	209.1	208.0
EPB41	"4.1R, EL1"	ENSG00000159023	"Erythrocyte membrane protein band 4.1"	P11171	1	28887091-29120046	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"	"Actin-binding, Calmodulin-binding"	"Elliptocytosis, Hereditary hemolytic anemia, Pyropoikilocytosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 80.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 151.6;Cone photoreceptor cells: 137.6;Erythroid cells: 187.1;Rod photoreceptor cells: 171.4"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.2"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 136.3;K-562: 136.5"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	8	"cerebellum: 105.6"	"HPA028076, HPA028096, HPA028412, HPA028414"	Supported		Supported	"Nuclear bodies,Plasma membrane,Cell Junctions,Cytokinetic bridge,Mitotic spindle,Cytosol"		Yes	No		1100000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 34: Non-specific - Transcription"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cell Junctions"	"Nuclear bodies, Cytokinetic bridge, Mitotic spindle, Cytosol"	"HPA028076: AB_2672476, HPA028096: , HPA028412: AB_2672592, HPA028414: AB_10601366"	"unprognostic (2.16e-1)"	"unprognostic (1.96e-1)"	"unprognostic (8.92e-3)"	"prognostic unfavorable (4.58e-4)"	"unprognostic (5.00e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (5.01e-3)"	"unprognostic (5.40e-3)"	"unprognostic (2.52e-2)"	"unprognostic (6.65e-2)"	"unprognostic (7.81e-2)"	"unprognostic (1.42e-2)"	"prognostic unfavorable (1.75e-6)"	"unprognostic (2.66e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.22e-1)"	"unprognostic (6.67e-2)"	11.0	10.2	1.8	21.9	18.3	63.3	14.1	42.2	6.0	14.5	4.9	23.6	17.7	10.2	5.3	16.6	6.3	15.0	9.7	1.2	4.7	12.7	21.7	15.1	37.4	8.2	5.6	16.3	18.8	15.5	4.7	7.2	8.5	15.0	23.1	80.0	19.1	9.1	15.9	15.3	23.3	9.9	3.5	22.9	27.0	10.4	4.7	69.0	15.2	13.8	37.0	15.5	1.9	3.0	27.0	6.9	62.3	29.4	5.2	0.8	19.5	6.9	10.1	8.4	10.5	16.8	31.2	49.1	17.2	9.2	13.5	11.9	78.7	6.6	8.6	86.4	23.8	136.3	19.7	28.6	10.1	45.8	88.2	1.7	18.4	8.2	13.8	19.9	14.1	73.5	136.5	36.2	0.1	8.8	72.3	30.4	62.0	44.1	10.0	110.9	28.2	68.3	7.7	33.3	78.0	60.5	19.7	19.2	43.3	21.7	14.7	18.2	1.2	0.3	13.3	12.9	13.4	52.5	72.4	85.2	12.1	47.8	6.8	33.3	3.2	21.4	12.9	1.1	15.4	17.2	18.3	14.1	4.4	13.6	22.1	12.7	44.2	10.9	1.5	4.4	28.9	15.3	1.8	18.3	42.2	6.0	1.2	4.7	8.2	5.6	8.5	3.5	4.7	3.0	25.3	19.2	71.7	20.2	58.2	10.5	8.6	7.8	15.4	151.6	20.0	12.2	21.5	20.0	16.8	16.5	137.6	2.4	75.3	26.5	17.6	17.1	16.4	11.3	4.1	15.1	41.6	187.1	76.3	18.7	4.2	7.9	29.6	29.1	24.1	24.9	17.5	30.0	7.1	21.9	61.7	29.0	16.2	23.7	9.0	22.7	2.1	32.4	0.0	78.7	29.3	15.7	85.5	7.5	4.8	28.6	20.3	2.2	46.7	12.2	32.8	13.4	15.2	171.4	13.1	2.8	8.5	39.3	55.7	14.9	16.8	4.1	71.6	4.2	33.0	12.6
EPHB4	"HTK, Tyro11"	ENSG00000196411	"EPH receptor B4"	P54760	7	100802565-100827523	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Angiogenesis	"Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 68.5;Hepatic stellate cells: 113.2;Syncytiotrophoblasts: 206.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 2.0;neutrophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			CAB013537	Uncertain					NA	NA		1400000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"CAB013537: "	"prognostic unfavorable (8.56e-4)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (4.33e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.23e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.84e-1)"	"unprognostic (8.16e-3)"	"unprognostic (1.43e-1)"	"unprognostic (9.51e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.13e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (8.84e-4)"	26.4	49.8	5.0	8.0	4.3	5.6	32.6	4.6	4.8	45.6	6.8	20.7	8.3	61.5	3.8	24.7	27.1	18.0	26.1	4.1	4.1	28.3	33.3	28.2	5.8	5.5	5.1	36.0	26.8	10.1	6.3	35.5	5.3	28.9	10.2	0.3	24.2	22.4	7.7	35.8	17.5	22.2	5.1	47.9	21.4	12.3	6.3	3.1	17.6	13.3	4.9	17.3	28.1	4.8	37.7	33.1	32.5	94.2	20.4	13.0	94.7	14.1	31.2	22.3	29.0	27.4	28.3	4.8	63.6	15.3	31.3	38.2	14.3	38.3	11.9	6.2	25.6	1.3	19.0	43.2	11.8	0.7	0.9	15.3	56.7	14.2	33.1	24.8	84.0	1.5	71.9	1.8	18.4	66.4	0.7	15.0	54.7	56.3	47.5	51.4	15.6	8.9	28.6	19.9	0.2	27.4	22.0	10.4	22.1	45.1	26.1	6.7	71.3	27.6	42.6	51.3	21.4	0.2	0.8	1.7	4.0	12.0	51.2	0.0	2.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.3	0.0	0.1	0.1	0.0	0.7	5.0	4.3	4.6	4.8	4.1	4.1	5.5	5.1	5.3	5.1	6.3	4.8	47.1	9.6	12.6	1.6	1.9	20.5	10.3	13.9	15.9	0.1	22.0	19.7	5.7	7.2	8.5	5.5	0.0	68.5	1.1	9.1	0.0	12.3	28.5	4.8	21.8	51.2	3.0	10.8	0.3	6.6	11.2	6.5	12.8	8.0	1.3	10.7	113.2	22.4	9.0	0.0	0.2	17.4	8.2	4.1	3.4	9.9	8.1	1.3	3.6	1.9	1.5	1.7	0.0	0.0	1.0	20.6	7.6	4.1	1.4	13.3	1.3	4.0	4.2	0.2	6.6	5.7	6.3	1.4	10.2	12.1	17.8	206.5	1.2	2.9	19.9	8.0
ERBB4	"ALS19, HER4"	ENSG00000178568	"Erb-b2 receptor tyrosine kinase 4"	Q15303	2	211375717-212538841	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Lactation, Transcription, Transcription regulation"	"Activator, Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Amyotrophic lateral sclerosis, Cancer-related genes, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 16.9;fallopian tube: 11.2"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 2020.2;Inhibitory neurons: 6091.7;Oligodendrocyte precursor cells: 2369.0;Oligodendrocytes: 1049.9"	"Group enriched"	"Detected in many"	4	"breast cancer: 4.1;endometrial cancer: 2.1;glioma: 1.2;ovarian cancer: 2.8;testis cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 6.9;EFO-21: 5.1;HEK 293: 3.8;RPTEC TERT1: 5.6;SCLC-21H: 3.1;T-47d: 5.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000276, HPA012016, CAB025522"	Enhanced					NA	NA		220000		"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB000276: , CAB025522: , HPA012016: AB_1846541"	"unprognostic (1.48e-1)"	"unprognostic (3.28e-1)"	"unprognostic (4.31e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.59e-1)"	"unprognostic (2.75e-1)"	"unprognostic (2.88e-1)"	"unprognostic (9.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.67e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.61e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.49e-3)"	"unprognostic (1.41e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.11e-2)"	0.3	0.4	10.0	0.0	13.3	0.0	5.6	10.5	11.5	2.9	0.0	0.1	0.0	0.2	0.0	0.1	11.2	0.0	3.0	9.9	12.7	5.1	0.0	0.8	0.0	4.9	16.9	0.1	0.6	3.1	2.4	0.1	7.6	0.3	0.0	2.0	4.7	1.2	1.5	0.3	0.0	0.0	4.3	0.0	0.4	3.3	8.0	0.0	1.6	1.7	0.0	0.1	0.1	6.1	0.0	0.0	6.9	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.0	5.1	0.7	0.0	0.3	0.2	0.0	0.0	0.1	3.8	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	5.6	0.3	3.1	0.2	0.0	0.1	0.1	0.1	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	13.3	10.5	11.5	9.9	12.7	4.9	16.9	7.6	4.3	8.0	6.1	0.4	0.0	12.6	2020.2	0.0	0.6	0.9	1.1	0.6	15.9	45.6	17.0	27.2	0.0	10.2	12.9	0.0	0.0	0.2	0.0	5.9	0.5	6.7	25.4	1.0	1.0	0.0	0.0	62.0	0.5	0.2	1.8	0.0	25.8	0.0	5.4	0.0	0.0	0.1	0.0	6091.7	0.0	2.0	0.0	0.3	2.2	1.8	0.3	3.6	96.5	0.0	9.1	0.0	2369.0	1049.9	0.0	0.0	0.4	0.0	1.6	0.0	0.2	28.1	1.9	6.6	4.1	3.0	1.8	2.6	0.2	1.3	0.0	0.2	0.0	0.0	1.2
ERLEC1	"C2orf30, CL25084, ERLECTIN, XTP3-B, XTP3TPB"	ENSG00000068912	"Endoplasmic reticulum lectin 1"	Q96DZ1	2	53787044-53818819	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 394.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031501, HPA031502, HPA031503"	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA031501: AB_10600104, HPA031502: AB_10602174, HPA031503: AB_10670425"	"unprognostic (1.27e-2)"	"unprognostic (3.36e-3)"	"unprognostic (3.17e-1)"	"unprognostic (1.97e-3)"	"unprognostic (1.08e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.27e-3)"	"unprognostic (3.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.92e-1)"	"unprognostic (4.71e-2)"	"unprognostic (1.47e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.33e-2)"	"unprognostic (3.92e-2)"	38.4	51.0	30.2	31.3	32.1	33.8	48.7	29.3	41.9	66.4	39.3	45.8	37.7	40.9	93.9	26.1	36.2	41.0	45.2	32.9	39.2	38.1	43.4	44.1	32.4	28.7	31.1	38.0	67.1	57.3	59.4	56.6	31.5	72.8	50.2	54.5	54.0	55.9	32.1	20.1	34.0	38.5	30.1	33.1	55.3	42.4	31.5	28.1	72.5	39.5	41.2	44.7	27.2	34.4	42.1	47.3	44.4	27.4	123.3	111.3	65.5	100.5	109.1	49.0	51.4	31.3	55.7	29.4	94.5	106.3	86.3	29.7	29.2	42.3	62.1	67.0	38.7	36.1	29.1	93.8	84.4	60.2	63.9	70.5	69.4	51.6	83.3	99.4	58.1	28.6	39.0	115.8	73.6	35.3	27.7	48.0	34.1	67.1	30.4	24.9	53.1	82.7	57.7	39.3	26.5	46.3	36.6	79.0	64.6	50.3	38.0	45.9	63.3	53.9	47.2	44.0	60.3	170.1	120.3	16.5	88.2	35.8	64.5	77.0	25.1	30.7	41.4	27.8	45.8	36.8	36.3	39.9	28.0	28.6	33.9	39.0	9.6	45.4	33.3	40.1	36.6	41.5	30.2	32.1	29.3	41.9	32.9	39.2	28.7	31.1	31.5	30.1	31.5	34.4	57.2	89.8	116.7	22.2	86.3	25.1	42.5	88.0	34.1	77.0	76.3	54.6	83.5	52.9	93.5	66.2	31.3	100.2	60.9	43.4	33.2	76.1	168.4	67.7	77.5	63.8	55.1	23.1	24.0	115.7	105.8	99.7	54.6	101.7	74.1	36.6	68.6	81.8	60.1	95.9	28.5	169.7	107.8	39.7	31.5	117.9	88.3	41.7	80.0	17.8	61.7	79.7	72.1	20.6	25.3	90.2	42.8	84.2	394.0	113.4	32.3	51.4	118.2	68.6	52.6	55.6	109.5	146.1	65.3	40.3	33.4	183.6	57.0	48.3	57.1	67.5
ERLIN1	"C10orf69, Erlin-1, KE04, SPFH1, SPG62"	ENSG00000107566	"ER lipid raft associated 1"	O75477	10	100150094-100186033	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 114.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 77.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA011252	Enhanced		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Endoplasmic reticulum"		"HPA011252: AB_1853965"	"unprognostic (3.22e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.98e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.30e-1)"	"prognostic unfavorable (7.63e-4)"	"unprognostic (1.26e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.99e-3)"	"unprognostic (9.09e-2)"	"unprognostic (1.32e-3)"	"unprognostic (6.10e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.93e-1)"	29.4	14.2	8.6	21.4	10.5	76.2	21.4	9.5	10.1	27.5	10.3	37.0	40.4	21.8	17.6	32.8	31.6	16.3	11.0	9.6	9.4	27.2	114.1	19.1	14.5	8.6	8.2	30.4	19.2	19.4	5.4	42.2	9.0	17.7	38.2	10.8	15.1	16.4	8.6	22.5	30.2	22.4	8.8	16.6	36.8	28.0	9.0	15.6	26.2	13.6	21.2	28.6	19.1	9.7	97.4	95.3	46.9	86.3	113.5	107.9	96.8	148.7	138.3	120.2	137.5	64.0	109.9	42.6	59.7	139.9	100.5	98.5	42.6	90.0	164.1	26.1	38.8	36.7	38.5	83.5	47.6	128.4	39.4	62.6	53.6	105.8	129.2	114.9	90.1	43.5	36.8	25.2	130.2	40.7	33.5	65.9	33.8	66.2	40.4	28.3	77.2	31.6	53.9	37.6	19.1	31.1	85.6	23.6	56.0	53.8	59.3	109.0	101.7	118.7	92.4	72.4	160.8	19.6	35.2	57.1	105.6	204.8	60.6	8.1	20.4	24.4	10.5	15.1	9.3	7.4	7.9	8.6	16.3	6.7	8.1	10.9	15.0	9.9	11.9	4.1	5.6	9.7	8.6	10.5	9.5	10.1	9.6	9.4	8.6	8.2	9.0	8.8	9.0	9.7	28.2	0.0	11.5	5.2	6.4	15.8	11.3	16.1	12.5	4.6	13.4	12.3	4.8	5.7	14.6	14.7	6.2	20.6	6.4	31.5	0.0	9.9	28.9	16.3	19.5	18.8	13.2	19.1	16.2	10.9	62.7	17.1	20.4	20.9	8.2	19.7	13.6	77.6	14.3	3.3	14.8	27.5	0.0	14.4	7.2	12.9	15.2	12.9	10.6	12.2	13.3	5.9	6.2	15.6	21.0	9.5	19.8	7.9	4.7	12.7	25.6	12.6	30.2	6.2	0.0	14.3	11.8	50.9	15.4	20.6	20.3	24.8	6.6	19.6	27.6	15.6
ERLIN2	"C8orf2, Erlin-2, NET32, SPFH2, SPG18"	ENSG00000147475	"ER lipid raft associated 2"	O94905	8	37736601-37758422	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002025, CAB014894"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"CAB014894: , HPA002025: AB_1080077"	"unprognostic (5.82e-3)"	"unprognostic (2.45e-1)"	"prognostic favorable (5.16e-4)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (4.51e-4)"	"unprognostic (3.39e-2)"	"unprognostic (1.89e-1)"	"unprognostic (3.77e-2)"	"unprognostic (6.67e-2)"	"unprognostic (4.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.78e-3)"	"prognostic favorable (6.67e-6)"	"unprognostic (4.78e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.43e-1)"	"unprognostic (2.33e-1)"	20.3	17.8	15.7	14.6	17.3	14.4	25.0	16.5	16.8	20.0	27.2	24.2	17.7	21.2	32.3	17.9	30.1	19.8	17.8	14.2	16.3	40.4	40.8	15.5	11.5	18.0	18.5	30.8	26.2	41.4	8.3	21.2	17.7	25.4	25.0	21.6	29.4	23.8	18.9	15.3	23.6	19.5	17.9	14.6	24.9	17.0	15.6	14.7	46.5	14.1	12.6	16.8	10.3	18.6	39.0	38.5	43.0	31.4	47.3	33.9	47.2	59.1	51.9	31.8	33.2	20.1	50.8	18.9	95.8	63.4	30.3	41.4	31.2	48.4	46.8	11.2	24.2	27.8	22.7	22.7	31.5	17.8	34.1	43.3	49.1	46.3	48.1	39.6	30.7	17.2	51.1	17.7	47.4	18.3	25.8	14.7	45.9	53.8	17.7	17.9	29.9	15.2	42.8	41.9	7.7	20.7	39.3	12.6	35.6	50.1	62.0	27.1	31.1	30.9	26.4	56.8	31.1	24.3	41.0	24.2	55.0	28.4	40.7	1.3	6.5	13.4	4.4	7.0	3.6	4.5	2.7	3.5	5.4	2.3	4.1	3.8	6.1	2.5	9.6	7.6	5.5	3.1	15.7	17.3	16.5	16.8	14.2	16.3	18.0	18.5	17.7	17.9	15.6	18.6	14.7	12.8	14.3	21.5	7.1	9.7	10.0	18.5	13.1	25.2	24.9	20.7	30.2	25.8	22.8	33.1	20.9	17.9	6.0	19.0	9.8	23.8	21.3	31.3	18.5	13.6	11.4	8.0	3.7	22.1	27.0	18.8	17.3	27.8	3.8	14.4	17.5	41.0	20.6	16.8	6.4	24.3	20.3	23.9	6.6	16.8	11.8	16.1	14.2	7.5	12.3	23.5	5.2	11.6	16.7	18.8	17.4	17.7	16.8	15.2	25.4	19.8	47.6	18.7	19.7	19.1	14.8	47.4	18.5	21.9	7.4	15.7	7.1	12.9	25.4	12.8
ERN1	"IRE1, IRE1P"	ENSG00000178607	"Endoplasmic reticulum to nucleus signaling 1"	O75460	17	64039080-64130819	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Transcription, Transcription regulation, Unfolded protein response"	"Hydrolase, Kinase, Multifunctional enzyme, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 53.0;pancreas: 66.7"	"Cell type enhanced"	"Detected in many"		"Plasma cells: 325.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 17.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 7.7;granulocytes: 17.9;T-cells: 9.0"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 74.6;RPMI-8226: 40.2;U-266/70: 77.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009495, HPA027730"	Supported					NA	Yes			"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"CAB009495: AB_2098712, HPA027730: AB_10602494"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.05e-3)"	"unprognostic (3.63e-2)"	"unprognostic (2.81e-2)"	"unprognostic (9.14e-2)"	"unprognostic (2.72e-2)"	"unprognostic (4.55e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (4.65e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.11e-2)"	9.5	53.0	1.5	5.4	1.7	13.4	7.5	2.6	3.2	22.6	2.1	7.7	6.3	10.1	6.4	9.5	14.3	6.2	6.1	1.6	2.4	5.6	23.5	16.5	5.8	1.7	1.0	16.9	66.7	4.3	19.5	5.6	1.3	9.9	4.5	8.8	15.7	7.1	6.8	11.3	10.6	5.6	1.0	15.8	16.2	2.8	1.6	6.8	10.2	2.4	6.6	8.3	11.7	1.7	4.0	4.0	2.2	4.8	4.8	4.4	9.8	4.1	9.7	2.8	1.3	2.5	2.3	6.6	3.2	2.8	3.5	3.6	1.9	4.5	6.1	1.6	1.5	6.0	3.2	2.4	19.6	3.2	2.1	3.8	8.1	6.4	21.5	3.5	5.0	4.7	4.2	74.6	2.8	3.9	4.5	1.0	0.6	3.6	3.2	4.2	4.2	40.2	1.1	5.5	7.1	3.5	4.3	6.1	5.7	3.5	3.8	5.9	5.9	2.5	4.1	6.4	2.7	77.4	23.9	4.8	4.0	2.1	4.2	17.9	0.9	0.4	4.9	0.4	9.0	0.2	3.3	4.1	0.4	0.3	0.9	0.9	4.9	2.5	0.3	7.7	0.8	1.0	1.5	1.7	2.6	3.2	1.6	2.4	1.7	1.0	1.3	1.0	1.6	1.7	31.9	0.0	36.1	7.2	27.8	22.0	54.3	8.3	15.4	4.0	35.0	29.7	8.6	11.5	8.6	12.9	6.2	8.1	106.4	10.0	1.9	12.6	2.3	26.1	49.1	18.3	79.7	11.2	8.6	27.3	8.8	42.2	52.0	79.4	8.2	11.8	13.9	26.8	8.0	3.3	6.1	8.2	8.2	15.7	71.3	1.7	4.7	60.4	74.7	12.2	10.2	3.5	28.8	6.0	4.6	17.9	7.3	6.0	325.8	44.7	7.9	4.4	6.1	26.5	0.0	19.0	25.7	4.0	4.1	27.7	45.0	54.9	88.2	12.0	9.6	60.1
ERO1A	"ERO1-alpha, Ero1alpha, ERO1L"	ENSG00000197930	"Endoplasmic reticulum oxidoreductase 1 alpha"	Q96HE7	14	52639915-52695900	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Electron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 172.5"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 221.3;Extravillous trophoblasts: 215.8;Pancreatic endocrine cells: 264.7;Prostatic glandular cells: 171.4;Urothelial cells: 145.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026653, HPA030053, CAB034294"	Enhanced				"Intracellular and membrane"	NA	NA		110000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB034294: AB_2098744, HPA026653: AB_1848254, HPA030053: AB_10601467"	"unprognostic (8.64e-2)"	"prognostic unfavorable (8.47e-4)"	"unprognostic (1.86e-2)"	"unprognostic (5.89e-2)"	"unprognostic (5.69e-3)"	"unprognostic (4.23e-2)"	"prognostic unfavorable (7.59e-4)"	"prognostic unfavorable (1.10e-5)"	"unprognostic (4.98e-2)"	"unprognostic (4.95e-2)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (6.54e-9)"	"unprognostic (9.19e-2)"	"unprognostic (2.78e-2)"	"unprognostic (4.58e-1)"	"unprognostic (5.03e-2)"	17.9	8.6	12.2	20.4	11.7	47.0	16.4	11.8	12.9	59.0	11.3	18.5	17.9	12.0	15.1	172.5	10.0	18.9	15.5	12.1	16.6	14.6	31.2	15.2	14.9	11.7	13.3	8.5	18.9	11.1	12.6	44.4	12.8	9.6	17.8	30.6	37.4	14.0	9.1	18.9	16.5	12.0	9.9	14.6	29.0	5.4	15.1	8.3	13.4	8.2	30.4	32.6	62.4	10.9	100.6	24.2	19.9	21.4	54.4	61.3	38.0	42.4	52.7	34.1	56.9	33.4	158.0	26.3	50.7	28.3	42.0	61.1	27.1	84.1	84.9	22.0	14.5	3.6	25.1	42.1	46.2	60.2	72.1	54.5	54.2	43.9	44.5	79.9	48.2	32.3	18.1	50.8	46.2	15.8	36.0	37.8	11.8	46.5	15.5	21.5	59.8	38.1	52.3	97.1	18.5	49.6	28.9	17.8	39.4	25.7	24.8	22.3	40.0	60.7	29.5	49.6	37.4	26.9	28.8	22.7	88.0	30.3	28.7	20.6	5.9	11.7	5.0	6.9	11.0	4.6	9.4	6.3	4.9	3.1	5.5	5.5	14.7	6.7	9.4	3.7	11.9	2.5	12.2	11.7	11.8	12.9	12.1	16.6	11.7	13.3	12.8	9.9	15.1	10.9	33.8	16.0	27.6	0.0	18.8	0.0	79.2	0.0	19.4	23.4	29.7	11.8	0.0	38.6	15.5	38.6	16.7	24.3	23.3	33.4	3.9	221.3	0.6	32.4	23.8	32.6	10.9	9.9	0.0	130.6	215.8	20.5	56.1	64.0	6.3	10.9	21.0	62.5	42.9	42.1	0.0	10.7	0.0	42.7	0.0	1.6	6.2	49.7	0.0	0.0	45.0	12.2	15.5	0.0	0.0	264.7	18.1	12.8	60.0	171.4	29.0	15.1	13.1	26.4	19.7	14.6	20.9	0.6	3.6	25.7	0.0	91.4	32.1	10.4	20.3	145.8
ERVFRD-1	"envFRD, ERVFRDE1, HERV-FRD, HERV-W/FRD, syncytin-2"	ENSG00000244476	"Endogenous retrovirus group FRD member 1, envelope"	P60508	6	11102489-11111725	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"placenta: 37.0"	"Cell type enriched"	"Detected in some"	56	"Syncytiotrophoblasts: 575.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SuSa: 38.8"									HPA011812			Uncertain	"Nucleoplasm,Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 28: Placenta - Pregnancy"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Actin filaments"	"Nucleoplasm, Cytosol"	"HPA011812: AB_1857702"	"unprognostic (1.99e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.19e-3)"	"unprognostic (3.35e-1)"	"unprognostic (6.44e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-2)"	"unprognostic (2.78e-3)"	"unprognostic (5.80e-4)"	"unprognostic (3.40e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.37e-2)"	0.3	0.4	0.6	0.1	0.4	0.2	0.4	1.8	0.6	0.4	0.0	0.3	0.5	0.3	1.0	0.3	0.2	0.4	0.1	0.6	0.7	0.5	0.2	0.6	0.0	0.6	0.4	0.0	0.0	7.5	0.0	37.0	0.5	0.3	0.2	0.2	0.2	0.2	0.0	0.5	0.5	0.2	0.1	0.0	0.3	0.1	0.6	0.4	0.0	0.4	0.0	0.5	0.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	38.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.4	1.8	0.6	0.6	0.7	0.6	0.4	0.5	0.1	0.6	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.1	0.3	0.0	0.0	10.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	575.5	0.4	0.5	0.0	0.0
ERVW-1	"envW, ERVWE1, HERV-7q, HERV-W, HERV-W-ENV, HERVW"	ENSG00000242950	"Endogenous retrovirus group W member 1, envelope"	Q9UQF0	7	92468380-92477986	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"placenta: 54.5"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 272.2;Syncytiotrophoblasts: 853.9"	"Cancer enriched"	"Detected in single"	143	"testis cancer: 31.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"BEWO: 85.2;SuSa: 26.2"	"Not detected"	"Not detected"													NA	NA		54000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"				"unprognostic (2.85e-1)"	"unprognostic (1.29e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.48e-4)"	"unprognostic (4.80e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.33e-1)"	"unprognostic (3.96e-2)"	"unprognostic (8.02e-2)"	0.5	0.7	0.6	0.8	1.2	0.7	0.7	1.8	1.1	0.2	0.7	0.4	0.5	0.5	3.4	0.1	0.2	0.3	0.2	0.8	1.5	0.3	0.3	0.6	0.7	1.4	0.5	0.5	0.7	0.3	0.0	54.5	1.6	0.5	0.5	6.9	1.0	0.2	0.6	1.0	0.6	0.4	0.2	0.9	1.2	6.0	1.4	0.4	0.7	0.0	0.4	0.2	0.0	4.0	0.2	0.4	0.7	0.5	0.0	0.6	85.2	0.2	0.0	0.0	0.0	0.4	0.4	0.2	0.5	0.0	1.2	0.6	0.3	0.2	0.1	0.2	0.4	0.4	1.4	0.3	0.1	0.4	0.6	0.2	0.2	0.1	0.0	0.3	0.0	0.6	0.7	1.3	0.1	0.5	0.4	0.7	0.3	0.1	0.2	0.5	0.2	0.1	0.2	0.4	0.3	0.6	0.1	1.2	0.0	26.2	0.3	0.5	0.2	0.1	1.5	0.4	0.2	1.5	0.7	0.2	0.1	0.4	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	1.2	1.8	1.1	0.8	1.5	1.4	0.5	1.6	0.2	1.4	4.0	0.7	3.2	3.1	0.0	0.1	0.8	0.8	0.2	0.0	2.1	0.1	0.1	0.2	0.0	1.4	0.0	0.0	272.2	0.0	0.1	0.0	0.0	47.9	0.4	0.2	1.4	0.0	0.0	0.1	0.0	86.2	2.4	0.0	0.2	2.5	0.1	0.0	0.0	27.4	0.0	0.1	0.0	0.0	1.9	0.7	10.4	1.2	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	3.4	0.1	0.4	0.0	0.1	5.3	1.8	0.0	2.6	0.4	1.0	0.3	0.0	2.0	853.9	0.3	0.1	0.1	1.0
ESYT1	"FAM62A, KIAA0747, MBC2"	ENSG00000139641	"Extended synaptotagmin 1"	Q9BSJ8	12	56118250-56144674	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016858, HPA076926"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		720000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"		"HPA016858: AB_1848404, HPA076926: AB_2686819"	"unprognostic (5.02e-2)"	"unprognostic (3.62e-2)"	"unprognostic (6.26e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.28e-2)"	"unprognostic (8.44e-2)"	"unprognostic (5.41e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.29e-1)"	"prognostic favorable (3.86e-4)"	"unprognostic (3.04e-2)"	"unprognostic (8.43e-3)"	"unprognostic (1.52e-2)"	"unprognostic (3.98e-2)"	107.9	39.3	15.2	38.5	14.4	18.7	72.7	18.5	18.9	36.6	19.8	45.9	17.2	53.4	22.2	29.2	47.1	27.8	24.5	13.5	23.0	26.8	46.7	45.0	45.9	34.2	21.7	38.8	39.5	40.7	11.7	38.7	36.2	30.5	36.2	8.9	28.0	47.2	54.2	26.1	30.7	74.4	22.5	37.2	29.3	12.1	23.6	36.6	27.8	33.3	49.8	44.7	32.3	24.0	107.0	78.1	62.2	158.2	90.8	67.3	53.4	117.4	129.3	136.2	94.4	72.4	114.3	40.8	92.2	201.3	50.7	118.7	73.7	120.4	121.6	58.8	54.2	244.7	56.0	58.5	125.9	193.2	371.6	76.7	125.5	147.1	81.3	145.3	117.8	39.2	153.6	263.9	124.4	81.2	70.4	116.4	78.9	44.6	102.5	105.4	85.0	107.3	113.7	89.0	52.4	54.8	174.1	52.9	80.5	71.3	111.1	128.4	154.5	104.8	94.7	59.7	85.7	62.3	99.0	58.7	97.3	79.6	111.7	423.2	37.4	423.0	127.2	69.4	157.2	62.4	129.4	129.5	87.2	48.2	102.3	120.2	9.3	84.2	85.6	29.7	139.6	177.8	15.2	14.4	18.5	18.9	13.5	23.0	34.2	21.7	36.2	22.5	23.6	24.0	44.4	9.6	9.3	4.6	25.9	16.3	19.8	23.5	14.2	5.5	20.5	21.3	8.2	14.3	12.9	31.3	10.4	31.9	22.3	6.1	0.0	36.8	2.0	20.5	15.1	28.2	25.2	17.9	10.2	26.8	18.1	17.6	9.2	19.3	62.7	24.7	27.1	37.8	46.4	0.0	7.1	12.0	22.4	21.3	24.8	2.1	17.4	22.9	35.6	6.5	50.6	5.7	60.8	2.0	4.1	26.2	3.5	25.2	18.5	19.9	2.2	4.4	10.7	5.9	52.6	14.3	22.0	3.9	2.9	18.0	11.9	37.9	40.3	12.5	10.8	12.7
ESYT2	"CHR2SYT, FAM62B, KIAA1228"	ENSG00000117868	"Extended synaptotagmin 2"	A0FGR8	7	158730995-158830253	"Plasma proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Microglial cells: 185.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002132, HPA070823"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA		24000	"Cluster 48: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane, Cytosol"		"HPA002132: AB_1078807, HPA070823: "	"unprognostic (2.30e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.72e-2)"	"unprognostic (2.84e-2)"	"unprognostic (5.72e-2)"	"unprognostic (5.43e-2)"	"unprognostic (9.01e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.71e-3)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.13e-1)"	"unprognostic (7.54e-2)"	"unprognostic (6.70e-2)"	"unprognostic (4.58e-2)"	"unprognostic (3.70e-3)"	"prognostic unfavorable (2.81e-5)"	53.9	37.0	24.0	25.6	25.0	34.8	33.9	21.8	28.7	30.8	22.7	38.4	22.3	36.1	30.1	45.0	34.4	32.2	35.1	27.7	25.3	27.2	24.5	33.4	27.5	22.1	24.6	48.1	29.2	30.9	20.6	43.3	24.6	25.3	30.3	14.2	32.1	30.5	44.9	31.0	27.6	38.7	21.7	21.4	25.5	15.8	30.7	37.0	39.3	41.8	25.4	35.8	29.3	19.4	92.9	57.8	19.5	19.8	62.2	72.6	55.3	47.5	48.9	36.7	40.6	29.7	106.1	27.5	52.2	86.2	66.6	46.0	27.8	50.2	35.1	31.5	28.3	26.2	44.0	32.2	64.1	95.0	55.8	53.4	51.8	41.8	55.2	73.1	44.8	81.9	56.4	97.8	61.9	71.7	96.0	66.7	29.2	53.9	56.7	82.4	37.0	38.8	58.6	38.4	46.8	30.2	151.6	109.7	66.7	43.4	37.7	96.3	69.3	40.3	18.8	178.7	60.5	68.6	17.3	27.5	102.4	93.8	121.5	1.7	1.4	1.2	6.1	1.8	3.4	1.1	5.1	4.3	2.8	0.6	4.6	5.5	0.9	5.4	1.2	1.8	4.2	2.3	24.0	25.0	21.8	28.7	27.7	25.3	22.1	24.6	24.6	21.7	30.7	19.4	65.7	38.5	32.4	55.5	18.1	46.1	12.9	22.6	19.4	15.0	32.6	21.6	30.8	21.5	33.7	47.8	16.7	31.6	54.0	41.0	3.9	15.3	18.0	60.6	17.8	48.5	21.1	17.7	137.1	20.0	26.1	44.2	15.8	47.0	12.6	36.8	23.2	20.9	20.2	13.5	119.3	31.2	24.4	20.2	83.6	5.3	35.1	27.7	51.6	185.5	21.9	12.1	43.3	67.3	61.4	29.9	14.1	54.5	36.2	23.2	28.0	8.7	61.8	10.8	32.9	42.6	60.4	10.6	10.2	22.0	51.7	40.8	43.4	19.5	26.0	25.8
ESYT3	"CHR3SYT, FAM62C"	ENSG00000158220	"Extended synaptotagmin 3"	A0FGR9	3	138434586-138481686	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;skin 1: 7.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Alveolar cells type 2: 37.7;Excitatory neurons: 9.4;Inhibitory neurons: 9.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"JURKAT: 1.4;NTERA-2: 3.3;SCLC-21H: 3.5;SK-MEL-30: 1.7;SuSa: 1.4"	"Region enhanced"	"Detected in many"		"hypothalamus: 7.3"	"Low region specificity"	"Detected in all"			HPA039200	Approved					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 11: Alveolar cells - Smell perception"			"HPA039200: AB_10805356"	"unprognostic (4.48e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.38e-4)"	"unprognostic (2.23e-1)"	"unprognostic (8.22e-2)"	"unprognostic (3.55e-3)"	"prognostic favorable (8.30e-4)"	"unprognostic (3.38e-1)"	"unprognostic (5.57e-2)"	"unprognostic (6.19e-3)"	"unprognostic (4.88e-3)"	"unprognostic (3.16e-5)"	"unprognostic (3.46e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.13e-1)"	"unprognostic (6.43e-2)"	0.1	0.1	2.5	0.0	2.0	0.0	0.7	5.1	2.2	0.8	0.2	3.8	0.0	2.2	0.0	0.4	0.2	0.3	0.5	2.1	2.3	0.9	0.0	4.7	0.0	2.2	2.1	0.5	1.0	0.8	1.9	0.3	2.5	0.2	0.2	0.1	0.3	0.0	0.4	7.7	0.3	1.5	1.3	0.0	1.7	0.5	2.4	0.0	4.7	0.0	0.4	1.0	0.7	1.5	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.8	0.8	0.1	0.2	1.3	0.0	0.0	0.2	0.0	0.1	0.4	0.5	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.1	0.2	3.3	0.0	0.2	0.0	0.0	0.0	0.3	0.0	3.5	0.0	1.2	0.1	1.7	1.4	0.3	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.0	5.1	2.2	2.1	2.3	2.2	2.1	2.5	1.3	2.4	1.5	0.1	38.5	37.7	4.2	0.1	0.8	0.8	0.5	1.2	1.9	0.9	1.3	2.5	1.5	4.5	1.8	4.2	0.8	0.0	0.1	0.0	1.0	0.2	1.5	0.8	0.7	0.0	0.0	9.4	0.9	0.4	0.9	3.6	2.2	0.0	0.5	0.4	0.1	0.2	0.0	9.7	0.0	0.0	0.0	0.4	0.2	0.3	0.2	1.8	1.0	0.0	0.3	0.0	2.0	0.5	0.7	0.1	0.0	0.0	1.1	0.0	0.3	0.8	3.9	0.0	1.4	0.3	1.5	1.7	0.5	1.6	0.7	0.1	0.7	0.2	0.1
EVA1A	"FAM176A, FLJ13391, TMEM166"	ENSG00000115363	"Eva-1 homolog A, regulator of programmed cell death"	Q9H8M9	2	75469302-75569722	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"liver: 191.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 41.7;Cytotrophoblasts: 43.3;Hepatocytes: 78.1;Proximal tubular cells: 77.3;Syncytiotrophoblasts: 124.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 85.7;U-138 MG: 110.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008055	Approved		Supported	"Vesicles,Plasma membrane"		NA	Yes				"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles	"Plasma membrane"	"HPA008055: AB_1080308"	"unprognostic (2.72e-1)"	"unprognostic (2.61e-2)"	"unprognostic (4.14e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (7.33e-2)"	"unprognostic (1.22e-1)"	"prognostic favorable (5.80e-4)"	"unprognostic (8.19e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.43e-2)"	"unprognostic (9.07e-2)"	1.1	0.5	0.2	1.1	0.9	0.1	3.4	0.6	0.5	9.8	0.2	0.7	1.7	2.8	9.6	0.4	3.7	1.2	1.6	0.2	0.3	20.0	191.6	20.7	0.4	1.1	0.5	0.5	23.8	7.6	1.1	17.3	0.9	0.9	0.7	0.5	8.9	2.2	1.2	2.7	1.8	2.0	0.7	10.8	0.6	2.9	0.8	5.1	1.8	1.6	0.3	0.8	0.8	0.8	1.0	14.5	1.5	0.4	3.1	21.2	1.4	68.0	45.3	59.2	30.1	0.5	1.2	0.1	6.3	85.7	54.2	9.4	1.7	14.4	36.8	0.0	1.1	0.0	2.5	45.7	2.2	0.0	0.1	15.0	8.3	73.2	33.3	59.0	37.2	0.0	0.0	0.0	46.1	0.0	0.1	0.0	3.3	0.2	23.5	7.9	0.1	0.0	32.5	0.5	0.9	1.6	6.2	0.4	53.7	2.2	0.2	0.3	31.0	110.3	46.3	2.0	71.9	0.7	0.1	0.3	62.5	0.0	59.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	0.6	0.5	0.2	0.3	1.1	0.5	0.9	0.7	0.8	0.8	6.1	41.7	35.4	1.0	0.9	2.8	13.7	14.3	3.4	1.2	11.7	12.3	0.3	1.5	23.0	11.0	0.0	43.3	0.4	0.1	27.4	30.5	12.2	13.3	1.4	4.8	1.8	0.0	1.1	16.1	25.9	4.7	0.0	11.4	0.0	0.0	2.2	78.1	3.5	0.0	0.9	1.1	4.1	0.8	1.2	9.4	0.3	0.6	28.4	2.8	0.1	0.0	0.0	1.5	0.9	9.7	0.0	0.7	0.0	12.3	0.5	77.3	1.7	0.1	0.0	2.2	9.0	2.2	0.9	1.1	0.9	124.8	1.1	0.0	1.6	10.5
EXOC1	"BM-102, FLJ10893, SEC3, SEC3L1, Sec3p"	ENSG00000090989	"Exocyst complex component 1"	Q9NV70	4	55853648-55905086	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Exocytosis, Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037706, HPA044873"	Uncertain		Approved	"Plasma membrane,Microtubules,Cytosol"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Microtubules, Cytosol"	"HPA037706: AB_10670525, HPA044873: AB_2679125"	"unprognostic (7.10e-3)"	"unprognostic (4.48e-2)"	"unprognostic (8.85e-2)"	"unprognostic (9.22e-2)"	"unprognostic (9.81e-2)"	"unprognostic (2.63e-1)"	"prognostic unfavorable (2.63e-4)"	"unprognostic (2.84e-3)"	"unprognostic (4.65e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.93e-2)"	"unprognostic (6.24e-2)"	"prognostic favorable (5.50e-5)"	19.7	16.5	18.1	17.3	20.4	12.7	20.0	20.4	20.0	18.9	18.7	18.0	16.8	16.6	20.4	29.3	16.5	15.5	16.5	18.3	20.0	15.9	10.2	17.4	18.3	21.1	19.2	15.1	12.9	20.5	14.5	20.8	20.3	14.3	19.1	18.5	17.4	12.8	13.6	28.1	16.2	15.7	20.4	20.8	15.6	16.9	20.1	13.9	16.3	13.5	20.0	16.2	20.1	25.1	21.8	12.4	21.9	25.3	36.9	45.9	14.6	30.2	30.1	24.1	25.1	8.6	37.1	20.9	20.6	32.6	29.1	25.4	18.0	23.9	34.5	11.1	12.4	19.4	14.8	10.1	34.7	21.3	26.4	37.4	32.1	25.1	27.6	31.2	39.9	16.0	28.3	20.1	53.0	13.8	15.6	21.5	13.9	31.2	23.4	18.0	16.4	17.1	26.9	23.6	16.2	28.7	18.0	29.2	25.5	18.5	18.6	22.6	48.5	29.7	24.2	25.8	26.3	23.9	12.7	18.4	38.6	23.4	28.8	21.3	14.6	13.1	6.5	19.0	8.8	8.4	9.2	9.5	14.3	8.3	8.3	6.0	19.5	12.5	23.6	6.4	11.6	7.9	18.1	20.4	20.4	20.0	18.3	20.0	21.1	19.2	20.3	20.4	20.1	25.1	44.7	41.7	38.0	77.4	24.5	34.8	14.8	34.0	22.2	48.8	26.4	21.2	29.1	17.2	35.6	22.0	31.3	60.8	21.4	38.3	19.6	23.6	45.3	41.0	47.5	39.0	22.2	19.6	72.6	20.0	31.6	28.9	22.4	37.2	36.7	35.5	40.0	12.3	40.9	28.6	86.5	28.8	24.4	37.7	47.4	16.7	21.5	37.8	40.9	56.2	38.7	40.3	22.6	73.4	138.0	36.2	32.4	23.7	19.0	17.4	37.6	21.9	44.7	32.5	32.9	25.9	27.9	47.6	31.6	42.5	39.9	51.2	27.8	44.6	28.7	26.8
EXOC2	"FLJ11026, SEC5L1, Sec5p"	ENSG00000112685	"Exocyst complex component 2"	Q96KP1	6	485154-693139	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 75.8;Inhibitory neurons: 80.1;Microglial cells: 68.4;Oligodendrocytes: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032093			Approved	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA032093: AB_10611964"	"unprognostic (1.61e-1)"	"unprognostic (4.69e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.30e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.02e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.20e-1)"	10.2	8.3	11.0	11.5	11.7	6.6	10.9	11.4	11.2	10.1	11.6	9.1	8.6	8.7	5.2	12.2	6.5	8.9	11.6	11.2	11.5	9.3	10.3	11.3	13.4	11.6	11.6	7.8	6.6	11.6	8.2	18.0	12.5	7.9	10.0	13.4	8.0	7.9	10.1	11.8	9.3	9.2	11.0	13.1	8.9	16.1	11.3	18.6	14.2	10.4	14.1	10.8	9.1	14.4	21.0	15.2	26.0	28.5	23.2	20.8	15.7	18.5	21.5	21.7	25.8	20.4	11.0	15.5	44.0	22.3	32.7	17.7	29.2	32.2	25.7	48.4	30.9	19.8	18.5	20.4	29.1	21.2	18.8	18.1	25.9	15.5	18.0	21.4	36.9	30.0	39.4	11.1	27.3	18.1	28.6	20.6	26.4	18.6	15.1	26.6	22.5	31.3	19.5	22.4	25.4	14.9	14.8	9.0	29.1	48.4	23.2	12.9	54.1	19.6	14.1	24.6	17.4	27.2	56.8	16.4	19.8	17.4	61.0	11.6	9.0	10.2	17.1	11.0	20.9	13.5	17.2	18.3	14.1	14.5	16.2	15.7	2.8	14.8	17.7	11.1	21.1	14.4	11.0	11.7	11.4	11.2	11.2	11.5	11.6	11.6	12.5	11.0	11.3	14.4	12.6	3.2	14.5	35.6	15.9	4.8	3.8	6.2	6.2	9.0	10.1	9.3	8.6	2.8	6.5	5.5	8.4	16.0	18.5	6.1	7.9	6.2	11.0	7.3	7.0	11.1	2.4	8.2	75.8	5.1	7.1	7.6	6.1	8.2	5.1	11.8	8.6	8.2	10.0	8.4	80.1	6.8	12.2	9.0	5.8	3.8	6.8	8.7	5.4	68.4	10.8	4.6	13.4	49.3	73.4	6.9	5.1	9.1	11.3	6.4	4.1	8.2	9.0	9.3	0.0	7.3	8.9	21.8	17.5	9.9	7.7	12.9	18.3	7.4	5.9	6.0
EXOC3	"SEC6L1, Sec6p"	ENSG00000180104	"Exocyst complex component 3"	O60645	5	443175-471937	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 61.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037880			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA037880: AB_2675716"	"unprognostic (2.94e-1)"	"unprognostic (4.74e-3)"	"unprognostic (4.82e-3)"	"unprognostic (4.10e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.91e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.62e-2)"	"unprognostic (3.26e-1)"	"prognostic favorable (1.54e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.33e-1)"	"unprognostic (5.02e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.70e-1)"	27.1	22.0	16.7	20.3	19.1	24.3	25.5	20.9	18.7	27.0	18.5	38.1	20.8	29.1	10.7	36.4	25.6	19.3	28.6	19.0	19.0	22.7	21.8	22.3	23.6	18.5	18.4	26.1	31.7	22.1	26.0	18.5	19.8	24.6	14.4	8.0	26.7	20.3	78.8	34.4	27.0	19.0	16.6	26.5	32.9	35.6	18.2	22.9	25.0	41.2	20.1	31.4	27.6	20.3	33.5	55.3	18.2	40.9	30.6	26.3	45.2	29.1	29.9	28.6	34.5	28.0	48.0	28.4	44.2	36.6	35.3	37.2	14.7	25.2	20.9	105.8	25.7	30.6	114.0	21.3	28.6	46.0	73.9	26.8	18.4	32.1	28.0	30.0	32.5	18.3	23.6	18.1	22.5	39.7	33.2	54.8	15.1	20.5	33.0	27.0	20.9	36.5	24.1	41.4	18.2	23.2	72.5	40.5	28.8	17.7	54.8	52.5	24.5	28.3	34.6	22.0	23.8	30.3	23.6	20.2	29.8	55.1	26.2	10.4	10.5	61.0	11.2	12.4	9.8	6.0	8.8	9.1	6.6	6.4	11.1	10.2	14.8	19.4	9.1	4.8	12.4	7.1	16.7	19.1	20.9	18.7	19.0	19.0	18.5	18.4	19.8	16.6	18.2	20.3	15.5	22.4	29.1	15.0	14.1	42.8	16.3	18.6	20.5	14.0	18.1	16.5	31.4	14.3	21.1	14.7	35.5	25.3	15.6	28.9	27.4	27.3	31.8	16.4	16.2	17.1	5.4	14.7	12.6	30.2	24.2	16.6	23.4	17.0	22.9	27.7	13.9	16.9	24.0	63.9	11.2	20.3	18.3	26.9	23.8	65.3	20.2	24.6	26.6	10.3	25.2	17.0	13.4	10.6	16.7	26.4	23.1	17.0	18.6	18.0	25.5	23.1	29.3	20.2	19.7	19.1	24.8	33.9	29.7	29.4	53.8	34.1	22.7	21.1	23.5	24.6
EXOC4	"KIAA1699, MGC27170, SEC8, SEC8L1, Sec8p"	ENSG00000131558	"Exocyst complex component 4"	Q96A65	7	133253073-134066589	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 238.6;Excitatory neurons: 334.2;Inhibitory neurons: 306.8;Microglial cells: 341.0;Oligodendrocyte precursor cells: 395.6;Oligodendrocytes: 345.9;Rod photoreceptor cells: 231.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031443, HPA031444"	Approved		Approved	"Nucleoplasm,Nucleoli,Nucleoli rim,Cytosol"		NA	NA		10000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Nucleoli, Nucleoli rim"	"Nucleoplasm, Cytosol"	"HPA031443: AB_10602496, HPA031444: AB_2673886"	"unprognostic (1.70e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.09e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.06e-3)"	"unprognostic (8.63e-2)"	"unprognostic (2.33e-1)"	"unprognostic (4.40e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (6.19e-4)"	"unprognostic (9.78e-3)"	"prognostic favorable (6.85e-5)"	"unprognostic (5.91e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.37e-1)"	"unprognostic (3.35e-2)"	20.7	21.1	18.7	13.8	20.2	13.8	21.4	19.3	20.3	22.6	24.3	19.7	13.1	21.5	13.6	24.4	27.3	17.8	15.3	20.9	19.4	17.7	17.8	17.7	16.4	18.4	20.3	30.6	27.3	27.3	16.9	19.6	19.9	18.3	21.5	53.1	16.3	20.5	68.4	25.4	13.5	23.9	18.8	21.0	17.3	18.7	19.1	28.1	26.4	38.5	20.3	21.1	18.6	20.8	40.1	32.2	43.3	43.3	49.7	51.6	15.0	28.6	47.2	25.4	33.2	18.8	54.7	29.8	20.1	54.1	36.9	24.7	23.7	38.8	41.8	45.6	28.2	24.0	31.5	19.9	54.7	32.0	25.1	50.4	47.6	36.3	66.5	55.7	43.5	38.6	35.1	28.8	47.7	26.1	58.5	35.2	32.8	47.5	29.8	25.7	38.7	54.2	40.7	35.2	33.9	53.2	43.0	39.1	46.3	48.9	25.8	29.3	47.9	28.1	14.6	30.0	31.5	45.0	29.4	28.1	82.9	36.4	43.8	10.3	12.0	7.2	11.2	12.9	10.0	8.3	11.6	11.9	16.3	8.1	9.4	9.6	4.0	19.6	11.4	7.2	12.9	11.2	18.7	20.2	19.3	20.3	20.9	19.4	18.4	20.3	19.9	18.8	19.1	20.8	22.9	22.4	22.3	238.6	27.3	18.9	16.3	16.6	25.6	39.9	16.8	15.4	30.9	11.5	18.0	14.7	93.8	17.5	26.7	21.5	3.9	15.0	29.6	27.0	21.2	23.0	17.4	18.7	334.2	18.2	16.6	21.2	34.1	21.0	8.2	32.4	23.2	15.9	18.1	50.5	306.8	21.0	26.4	27.3	14.5	27.6	17.4	20.4	14.2	341.0	23.9	20.4	23.7	395.6	345.9	15.4	17.4	18.8	27.7	13.2	16.3	16.9	29.8	231.5	13.1	26.0	15.3	20.5	13.1	28.2	17.0	11.2	26.2	26.4	21.9	20.1
EXOC5	"SEC10, SEC10L1, SEC10P"	ENSG00000070367	"Exocyst complex component 5"	O00471	14	57200507-57268905	"Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 130.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060837	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA060837: AB_2684375"	"unprognostic (2.95e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.82e-2)"	"unprognostic (6.84e-2)"	"unprognostic (5.05e-2)"	"unprognostic (3.38e-1)"	"unprognostic (9.47e-3)"	"unprognostic (2.82e-2)"	"unprognostic (9.14e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.98e-2)"	9.0	6.3	4.9	6.6	6.2	5.1	5.1	6.4	6.5	4.5	7.5	4.8	5.6	4.7	4.9	6.5	4.5	4.7	5.2	5.3	6.4	7.7	8.4	6.6	7.2	6.2	7.5	4.6	3.7	6.9	3.4	7.7	7.4	5.6	4.5	9.8	5.4	4.9	5.7	5.6	5.9	6.4	5.5	7.9	5.7	11.1	6.0	8.7	7.4	5.9	6.6	5.7	3.7	8.4	21.7	13.4	26.3	13.4	17.4	17.1	20.1	33.1	15.6	12.3	14.3	12.6	13.4	31.9	19.6	17.9	12.5	17.3	16.3	13.5	19.1	37.7	9.6	20.4	9.9	9.6	16.1	25.2	25.7	10.3	14.0	12.1	13.5	16.2	22.6	22.4	19.9	23.5	25.0	9.8	34.2	5.7	14.2	12.4	23.8	23.9	38.7	11.8	15.4	17.7	20.4	17.5	26.8	10.7	16.4	22.1	19.9	12.2	24.9	26.7	29.9	17.1	16.5	12.0	15.9	26.7	24.5	14.1	17.5	6.8	5.1	6.1	4.8	5.5	5.9	5.6	4.9	5.2	6.3	5.8	5.4	4.7	2.8	6.3	5.2	3.2	6.3	6.8	4.9	6.2	6.4	6.5	5.3	6.4	6.2	7.5	7.4	5.5	6.0	8.4	32.1	25.6	18.6	34.3	26.7	22.6	23.1	18.8	22.2	32.2	23.4	13.2	28.3	21.5	24.2	14.7	29.2	17.4	24.2	17.1	17.6	18.6	130.7	29.4	32.5	35.7	34.6	34.7	56.2	17.3	19.4	27.5	21.9	23.2	34.9	20.6	45.0	38.6	21.6	63.9	56.5	17.0	32.6	31.5	34.1	108.6	23.6	31.4	21.4	38.4	34.3	28.6	23.7	49.3	71.9	25.2	10.8	35.7	27.7	24.7	11.1	41.1	29.4	30.2	19.7	31.1	33.9	128.6	53.2	32.8	30.0	18.7	26.0	34.6	15.3	20.1
EXOC6	"DKFZp761I2124, EXOC6A, FLJ1125, MGC33397, SEC15L, SEC15L1, Sec15p"	ENSG00000138190	"Exocyst complex component 6"	Q8TAG9	10	92826831-93059493	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"retina: 164.2"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 181.7;Microglial cells: 146.1;Oligodendrocyte precursor cells: 157.3;Rod photoreceptor cells: 177.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 30.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036285, HPA059111"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 77: Retina - Visual perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Vesicles	Nucleoplasm	"HPA036285: AB_10673617, HPA059111: AB_2683907"	"unprognostic (1.41e-1)"	"unprognostic (1.39e-3)"	"unprognostic (5.20e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.16e-3)"	"unprognostic (7.21e-3)"	"unprognostic (3.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.66e-1)"	"unprognostic (8.13e-2)"	"prognostic favorable (4.66e-4)"	"unprognostic (2.12e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.42e-1)"	"unprognostic (6.41e-2)"	8.7	14.4	5.9	8.2	7.5	12.9	8.0	7.7	8.6	6.5	8.0	9.6	8.1	6.1	5.7	4.2	5.8	10.1	7.1	8.2	6.0	6.4	10.1	10.7	9.5	3.4	2.4	3.9	10.0	6.3	6.1	37.4	3.7	8.6	10.2	164.2	5.6	4.3	31.8	5.0	9.5	7.7	3.3	9.1	7.0	9.9	6.1	8.5	28.4	19.7	8.2	10.1	3.5	7.1	19.8	24.3	25.7	16.8	1.3	1.6	9.1	9.0	24.9	8.1	9.7	9.1	16.5	22.5	19.0	4.3	6.6	12.3	20.8	5.7	10.1	20.1	20.9	35.1	8.3	11.7	9.6	36.4	30.6	2.2	3.0	7.2	4.8	14.6	113.8	14.6	29.2	14.5	4.0	10.7	15.3	23.2	3.5	40.2	7.0	22.5	11.2	11.6	17.4	13.2	8.5	11.9	9.2	9.2	11.8	6.4	18.2	18.8	22.4	0.6	8.2	7.5	14.7	10.8	12.4	18.1	2.8	41.6	9.3	6.2	4.9	15.2	3.0	3.9	3.0	6.7	3.4	2.8	5.1	6.6	2.7	3.2	30.6	2.8	3.9	11.1	3.3	2.4	5.9	7.5	7.7	8.6	8.2	6.0	3.4	2.4	3.7	3.3	6.1	7.1	28.3	16.0	16.7	33.6	27.6	3.3	10.7	8.6	3.4	40.2	9.8	6.5	12.0	20.0	15.0	16.5	39.6	22.9	24.1	14.3	5.9	28.3	5.4	8.8	3.0	53.1	25.6	39.2	181.7	15.4	7.8	7.8	13.7	16.5	10.8	24.3	77.1	14.2	21.4	23.5	100.3	16.6	14.2	18.2	12.5	12.6	4.4	18.9	5.4	146.1	22.8	27.1	19.6	157.3	84.7	14.1	10.3	14.7	13.8	14.1	10.8	8.4	10.0	177.8	13.1	13.6	9.0	25.0	25.5	4.9	4.8	20.5	18.4	29.8	11.9	15.8
EXOC7	"BLOM4, EXO70, Exo70p, KIAA1067, YJL085W"	ENSG00000182473	"Exocyst complex component 7"	Q9UPT5	17	76081016-76121576	"Human disease related genes, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022840, HPA022842"	Supported		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 52: Non-specific - Ribosome"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Cytosol	"Vesicles, Plasma membrane"	"HPA022840: AB_1848316, HPA022842: AB_1848317"	"unprognostic (5.20e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.37e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.02e-1)"	"unprognostic (2.47e-2)"	"unprognostic (7.39e-3)"	"unprognostic (1.53e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.18e-1)"	40.4	31.4	36.0	32.7	37.0	53.2	31.2	31.4	36.7	39.3	34.1	40.1	32.5	40.1	33.1	52.3	52.3	35.4	47.2	36.8	35.5	31.9	30.2	35.9	32.7	35.4	34.3	49.6	41.1	61.2	41.0	35.3	36.5	48.1	27.9	24.7	50.6	43.1	43.0	37.0	34.7	43.5	31.9	32.4	30.3	24.9	36.4	43.5	43.0	41.4	32.3	44.3	30.1	34.8	65.6	79.4	71.9	58.5	66.6	47.0	74.5	58.9	77.6	103.9	74.7	67.5	43.0	33.7	42.0	103.0	65.6	52.7	43.9	57.1	69.0	29.3	59.1	55.8	64.0	72.3	46.4	62.9	55.7	66.1	44.3	80.5	39.2	73.5	116.9	59.8	38.1	33.7	65.6	59.8	102.1	27.8	37.8	49.5	83.4	54.0	123.3	34.6	59.7	133.6	38.9	91.4	66.5	48.6	44.6	68.8	79.7	51.0	77.5	111.3	66.3	74.1	65.8	46.0	18.2	31.2	66.4	28.0	59.0	55.1	41.1	66.1	35.5	57.4	24.4	26.7	26.9	30.4	28.9	26.9	27.7	23.9	46.2	36.4	79.7	12.3	32.0	44.9	36.0	37.0	31.4	36.7	36.8	35.5	35.4	34.3	36.5	31.9	36.4	34.8	31.0	19.2	35.0	36.6	37.7	19.8	40.1	40.8	31.3	87.6	30.2	28.8	7.5	28.6	41.4	40.5	143.9	51.5	37.5	47.6	33.2	38.3	22.4	35.1	25.8	27.1	48.9	48.6	26.2	37.1	29.0	31.6	27.0	34.4	41.1	65.0	30.7	27.0	37.7	67.3	31.1	43.8	54.9	29.6	21.3	52.2	37.3	26.9	24.9	15.0	36.8	52.1	56.7	44.2	35.0	44.6	41.4	38.4	15.7	41.5	62.8	35.3	43.7	108.8	46.0	27.8	49.5	32.1	16.6	20.3	19.9	71.1	35.8	56.6	29.8	44.8
EXOC8	"EXO84, Exo84p, SEC84"	ENSG00000116903	"Exocyst complex component 8"	Q8IYI6	1	231332753-231337852	"Human disease related genes, Predicted intracellular proteins, Transporters"	"Exocytosis, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027438	Approved		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 44: Endometrium - Transcription"	Cytosol		"HPA027438: AB_1848318"	"unprognostic (3.85e-2)"	"unprognostic (6.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.05e-2)"	"unprognostic (4.83e-2)"	"unprognostic (5.82e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.69e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.74e-1)"	"unprognostic (8.39e-2)"	"unprognostic (1.77e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.04e-1)"	6.1	5.4	3.0	7.9	3.1	16.9	6.7	4.8	3.9	5.2	2.9	5.0	5.9	4.5	4.8	5.5	4.8	5.0	5.2	3.3	4.2	5.9	6.2	5.9	9.2	3.1	2.7	7.0	6.3	8.7	2.9	6.5	3.4	5.5	4.7	7.5	5.4	3.8	14.1	5.9	6.3	4.4	2.5	8.3	6.8	4.1	3.7	7.4	8.4	9.8	9.1	5.3	3.7	3.7	8.2	9.0	5.4	5.4	13.9	11.2	13.0	10.0	8.4	7.4	7.0	8.6	8.1	9.4	8.6	10.1	6.6	13.2	7.9	10.8	8.1	12.2	19.0	5.7	11.8	5.5	7.8	10.1	15.2	11.3	11.7	11.0	10.4	8.7	9.2	9.6	10.6	21.9	12.0	4.3	9.4	6.2	8.2	10.4	7.6	6.1	8.3	12.0	9.3	9.5	7.1	7.6	10.1	13.1	10.1	4.3	12.5	14.5	12.6	9.9	7.0	13.3	17.7	16.2	9.9	10.1	11.3	8.9	12.7	1.7	0.7	1.3	0.4	0.8	0.5	0.4	0.6	0.5	0.5	0.5	0.7	1.2	2.2	0.8	1.6	0.7	0.6	0.5	3.0	3.1	4.8	3.9	3.3	4.2	3.1	2.7	3.4	2.5	3.7	3.7	10.0	9.6	9.8	2.0	10.9	18.5	5.6	4.0	8.0	4.3	8.1	5.5	8.9	11.5	8.3	9.2	6.2	4.6	10.4	6.7	1.9	3.3	1.6	8.1	9.0	9.3	4.8	7.4	5.3	3.5	2.8	8.2	14.3	10.4	2.5	4.3	6.8	9.6	5.8	3.3	5.9	3.7	2.0	13.3	7.1	1.1	4.1	7.6	3.6	3.7	5.7	5.8	5.2	2.5	6.6	5.0	1.2	5.7	7.9	6.0	6.9	5.2	5.6	12.3	0.0	8.4	5.2	5.1	5.0	11.0	14.8	9.3	10.0	4.6	4.2	8.6
F2RL1	"GPR11, PAR2"	ENSG00000164251	"F2R like trypsin receptor 1"	P55085	5	76818933-76835315	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 59.4;stomach 1: 44.0"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 109.9;Distal enterocytes: 124.7;Gastric mucus-secreting cells: 74.5;Glandular and luminal cells: 74.7;Paneth cells: 86.1;Suprabasal keratinocytes: 168.4;Urothelial cells: 116.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 42.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 42.0"	"Cell line enhanced"	"Detected in many"		"PC-3: 126.0;RPTEC TERT1: 205.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB012989, HPA014091"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB012989: AB_2533199, HPA014091: AB_2668939"	"unprognostic (1.29e-2)"	"unprognostic (4.05e-2)"	"prognostic favorable (3.88e-4)"	"unprognostic (1.98e-2)"	"unprognostic (8.22e-2)"	"prognostic unfavorable (5.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (6.13e-2)"	"unprognostic (4.07e-1)"	"unprognostic (2.16e-3)"	"unprognostic (1.52e-2)"	"prognostic favorable (5.86e-7)"	"unprognostic (1.11e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.73e-2)"	1.0	1.3	0.8	6.2	0.9	1.7	8.0	0.5	0.8	3.6	8.9	59.4	45.8	2.9	4.8	8.2	8.2	29.9	4.6	0.5	0.8	31.8	7.1	4.1	1.4	1.7	2.2	0.5	23.6	5.2	1.5	3.9	1.4	5.0	53.0	2.6	8.9	11.5	0.3	37.5	41.0	2.7	1.0	3.8	44.0	0.6	0.9	1.1	8.3	0.2	1.6	27.5	5.8	0.8	32.7	52.1	4.3	0.2	1.5	4.0	33.1	1.6	17.1	0.9	2.7	45.0	81.8	0.0	69.5	3.7	78.1	54.4	27.1	24.0	1.5	0.1	26.8	0.8	1.0	32.8	10.6	0.0	0.3	5.5	67.3	8.0	49.8	8.0	84.9	7.8	0.4	0.0	0.1	17.6	3.8	0.1	5.7	17.9	126.0	0.1	0.0	0.8	205.9	58.5	2.1	0.4	12.3	12.6	0.3	48.5	5.3	0.3	57.1	0.1	31.8	0.1	0.3	4.8	1.0	0.1	18.7	0.0	1.4	11.9	10.0	1.8	0.4	3.2	2.1	0.5	3.8	1.9	4.7	0.1	3.4	2.1	42.0	0.7	0.5	0.5	1.0	4.0	0.8	0.9	0.5	0.8	0.5	0.8	1.7	2.2	1.4	1.0	0.9	0.8	0.3	9.6	3.7	0.0	0.9	109.9	17.8	4.5	10.8	0.5	10.5	6.3	0.3	32.9	12.7	31.3	0.0	5.4	0.2	124.7	1.9	28.0	0.0	40.9	5.1	1.2	13.1	2.5	0.2	15.0	7.9	2.9	74.5	74.7	2.5	1.0	1.1	9.6	0.9	0.0	1.4	50.8	4.1	1.9	3.8	0.0	0.0	2.1	1.8	1.0	2.6	0.0	0.0	0.0	0.0	44.7	86.1	0.0	0.1	34.1	62.9	19.3	25.0	2.0	0.0	0.4	2.8	0.9	1.3	37.0	168.4	2.1	2.1	0.1	50.7	116.0
F3	"CD142, TF"	ENSG00000117525	"Coagulation factor III, tissue factor"	P13726	1	94529173-94541759	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Blood coagulation, Hemostasis"		"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 902.0;Exocrine glandular cells: 464.1;Pancreatic endocrine cells: 1755.7;Peritubular cells: 530.7;Urothelial cells: 497.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 1062.0;HaCaT: 490.7;HBEC3-KT: 1270.5;U-2197: 473.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009438, HPA049292, HPA069132"	Uncertain		Approved	Vesicles	"Secreted to blood"	NA	NA	603000		"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Vesicles		"CAB009438: AB_668005, HPA049292: AB_2680701, HPA069132: AB_2686092"	"unprognostic (3.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-3)"	"unprognostic (4.93e-2)"	"unprognostic (8.00e-2)"	"unprognostic (5.88e-1)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (2.02e-8)"	"unprognostic (4.84e-2)"	"unprognostic (4.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.08e-1)"	118.2	21.3	53.1	28.8	69.9	4.1	70.1	53.2	74.4	48.0	44.1	52.2	36.8	61.1	44.2	41.3	89.9	59.6	36.8	54.0	62.7	18.0	5.1	59.8	12.9	77.7	62.6	114.8	96.5	17.2	81.2	133.4	57.1	56.8	42.1	72.6	93.3	60.4	7.6	56.0	47.3	10.7	60.8	7.2	42.6	34.6	62.0	5.6	62.6	9.9	14.9	65.4	73.0	55.4	1062.0	1.8	2.2	0.5	108.0	53.1	57.2	147.0	87.6	155.4	167.9	18.6	220.6	0.0	73.3	183.5	33.4	490.7	13.2	1270.5	254.4	0.9	1.6	0.0	35.0	3.3	35.9	0.7	0.6	91.9	28.2	73.8	356.5	293.7	1.1	1.1	0.9	0.8	110.0	1.8	1.5	22.3	9.8	6.8	2.2	1.2	10.3	0.5	19.8	3.2	1.3	2.6	117.4	48.3	3.6	29.6	1.3	13.9	0.3	93.7	2.5	473.0	44.6	0.9	1.3	0.9	71.9	5.7	3.8	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.0	53.1	69.9	53.2	74.4	54.0	62.7	77.7	62.6	57.1	60.8	62.0	55.4	9.4	131.4	243.3	196.6	0.7	16.3	902.0	359.6	2.2	3.6	29.6	20.4	26.4	18.6	380.3	14.7	0.0	16.5	0.6	20.9	0.0	133.5	8.6	61.3	125.0	13.2	13.1	0.0	0.4	464.1	6.0	125.3	23.0	123.0	2.5	38.1	7.5	0.4	6.1	3.3	4.6	70.3	65.1	2.8	5.2	14.5	281.1	9.1	3.6	45.9	2.1	340.6	0.0	15.6	1.2	1755.7	15.5	530.7	1.2	121.6	10.1	0.4	92.0	16.1	6.6	39.3	76.7	1.7	4.4	6.4	7.5	7.7	7.3	7.9	14.3	497.9
FABP5	"E-FABP, KFABP, PA-FABP"	ENSG00000164687	"Fatty acid binding protein 5"	Q01469	8	81280536-81284777	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 3691.0;vagina: 2600.3"	"Cell type enhanced"	"Detected in all"		"Adipocytes: 2511.2;Alveolar cells type 2: 1891.0;Hofbauer cells: 2385.2;Squamous epithelial cells: 9211.0"	"Group enriched"	"Detected in all"	4	"cervical cancer: 268.3;head and neck cancer: 288.8;urothelial cancer: 73.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 1167.2;MOLT-4: 1213.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017831, CAB040577, HPA051895"	Enhanced		Supported	"Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA		14000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 61: Squamous epithelial cells - Keratinization"	Cytosol	"Plasma membrane"	"CAB017831: , CAB040577: , HPA051895: AB_2681654"	"unprognostic (8.76e-2)"	"unprognostic (7.28e-2)"	"unprognostic (1.54e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.33e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.95e-3)"	"unprognostic (4.03e-3)"	"unprognostic (2.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.16e-2)"	"unprognostic (3.57e-2)"	"prognostic unfavorable (4.69e-10)"	"unprognostic (1.99e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.61e-1)"	"unprognostic (6.60e-2)"	379.8	15.5	107.9	137.8	112.9	111.8	241.8	112.3	146.5	1340.4	307.4	256.7	83.3	62.7	4.8	3691.0	22.4	87.7	343.4	116.6	130.7	34.0	27.5	272.5	191.4	162.8	120.5	12.1	73.1	443.0	32.7	338.8	155.7	22.9	210.6	33.3	514.9	17.1	119.1	692.7	122.3	52.4	133.1	127.4	181.2	45.1	118.2	137.6	74.9	306.1	292.9	362.3	2600.3	138.9	76.9	215.9	133.1	0.3	615.7	59.0	0.3	158.0	8.9	123.2	153.3	2.2	100.3	1167.2	86.7	38.3	1.1	69.2	328.9	254.8	103.7	597.6	603.2	449.0	136.2	345.0	54.2	421.6	107.9	45.0	507.0	146.8	306.1	121.3	708.9	328.6	125.9	124.1	73.7	69.3	1213.7	199.9	170.5	785.1	732.1	526.0	0.4	127.7	198.9	951.4	514.4	190.7	74.1	24.7	61.0	230.2	1.2	201.6	97.0	0.1	331.3	1.6	1.4	155.6	70.1	902.2	52.2	396.8	184.9	8.1	14.3	0.9	6.1	16.6	9.3	17.2	6.9	13.7	55.9	10.4	3.1	11.9	5.2	22.3	5.5	54.8	9.8	13.4	107.9	112.9	112.3	146.5	116.6	130.7	162.8	120.5	155.7	133.1	118.2	138.9	2511.2	288.4	1891.0	30.7	93.0	121.0	90.0	881.2	727.3	23.7	22.3	48.6	5.7	2.8	649.8	22.0	45.9	28.0	97.5	420.3	3.9	35.4	29.5	55.7	579.5	662.2	197.2	74.4	7.7	23.8	272.4	140.6	278.8	29.6	55.8	70.1	35.3	1.4	2385.2	21.9	10.9	216.3	175.0	182.2	764.3	46.0	6.2	405.5	206.3	4.7	697.1	273.0	15.5	6.0	16.3	43.3	561.0	5.3	132.9	71.3	10.4	2.3	115.7	43.5	361.6	140.0	336.8	179.4	182.5	9211.0	168.6	27.0	102.3	68.8	419.2	232.6
FAIM2	"KIAA0950, LFG, LFG2, LIFEGUARD, NMP35, TMBIM2"	ENSG00000135472	"Fas apoptotic inhibitory molecule 2"	Q9BWQ8	12	49866896-49904217	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 359.4;parathyroid gland: 98.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 141.9;Early spermatids: 202.2;Excitatory neurons: 77.6;Horizontal cells: 232.2;Inhibitory neurons: 105.1"	"Cancer enriched"	"Detected in many"	8	"glioma: 21.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 2.9"	"Lineage enriched"	"Detected in single"	8	"T-cells: 2.9"	"Cell line enhanced"	"Detected in some"		"HHSteC: 12.2;OE19: 16.7;SH-SY5Y: 6.7;U-87 MG: 38.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018790, HPA048800"	Enhanced		Uncertain	"Intermediate filaments"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Intermediate filaments"		"HPA018790: AB_1852822, HPA048800: AB_2680526"	"unprognostic (1.74e-1)"	"unprognostic (5.98e-4)"	"unprognostic (2.22e-1)"	"unprognostic (9.75e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.61e-4)"	"unprognostic (2.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (1.30e-2)"	"unprognostic (3.28e-6)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.47e-1)"	"unprognostic (6.78e-4)"	4.7	41.6	180.7	4.9	189.0	0.0	1.8	107.7	359.4	6.7	0.0	8.5	2.2	9.9	8.0	4.2	14.2	10.2	41.9	205.6	161.0	2.1	0.4	2.2	3.7	223.0	129.4	3.9	2.4	98.1	42.0	0.2	206.5	14.2	3.5	72.3	2.6	9.0	1.2	0.9	6.3	12.2	106.8	1.9	4.2	30.5	175.3	1.9	1.8	1.2	2.8	9.5	10.5	223.0	0.0	0.5	0.5	0.7	2.7	1.7	0.1	0.7	3.6	0.7	0.4	0.4	0.0	0.0	0.1	5.1	0.2	0.3	1.5	0.0	0.4	0.0	0.0	2.9	0.0	0.0	12.2	0.1	0.1	1.1	0.2	2.7	0.0	0.0	0.0	0.3	1.6	0.4	0.7	0.0	0.1	0.0	0.1	16.7	0.0	0.0	0.2	0.0	0.0	0.0	4.4	6.7	0.0	0.2	0.0	0.2	0.0	0.1	0.0	3.2	0.0	0.1	0.1	0.4	0.0	0.0	38.5	0.0	0.4	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.9	0.1	180.7	189.0	107.7	359.4	205.6	161.0	223.0	129.4	206.5	106.8	175.3	223.0	0.2	0.0	0.0	31.0	0.0	0.3	0.3	0.7	0.6	141.9	2.3	2.3	1.1	0.0	0.4	0.0	2.1	0.0	0.3	0.1	0.0	0.1	202.2	0.1	0.5	0.7	0.0	0.0	77.6	0.2	0.1	16.7	1.1	0.0	26.1	0.0	0.0	0.0	0.4	232.2	105.1	2.2	12.2	0.0	0.4	52.0	5.0	0.5	0.0	13.1	0.0	35.6	0.0	45.2	55.5	0.1	0.0	5.3	0.3	0.5	0.0	0.4	0.0	20.2	0.0	0.9	0.7	4.8	5.8	0.5	0.3	0.1	0.5	0.4	0.7	0.3
FAM189A1	"KIAA0574, TMEM228"	ENSG00000104059	"Family with sequence similarity 189 member A1"	O60320	15	29120254-29570723	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 5.3;thyroid gland: 3.2"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 202.9;Inhibitory neurons: 198.0;Oligodendrocyte precursor cells: 59.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 4.6;HDLM-2: 12.0;REH: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009410, HPA010637"	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm		"HPA009410: AB_1852332, HPA010637: AB_1852333"	"unprognostic (3.18e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.81e-2)"	"unprognostic (6.52e-2)"	"unprognostic (7.05e-2)"	"unprognostic (4.71e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.27e-1)"	"unprognostic (3.39e-1)"	"unprognostic (7.97e-2)"	"unprognostic (5.00e-1)"	"unprognostic (6.70e-3)"	"unprognostic (2.39e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.50e-2)"	"unprognostic (3.12e-1)"	0.6	0.4	2.2	0.0	1.8	0.0	0.1	0.0	2.4	0.3	0.3	2.6	0.1	0.2	0.0	0.0	1.0	0.0	0.8	2.5	0.4	2.1	0.1	1.1	0.0	0.2	0.3	0.2	5.3	0.4	0.4	0.0	0.2	0.4	0.5	0.1	0.6	0.0	0.0	0.1	0.9	0.0	0.0	0.2	0.4	2.0	1.2	0.0	3.2	0.0	0.1	0.9	0.2	0.8	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.2	0.0	0.0	0.0	0.1	12.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	1.5	0.0	0.4	0.0	0.0	0.3	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	1.8	0.0	2.4	2.5	0.4	0.2	0.3	0.2	0.0	1.2	0.8	0.5	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	4.3	0.8	0.0	0.0	0.4	3.0	0.0	202.9	0.2	0.0	0.7	0.0	0.1	0.0	0.3	0.7	0.0	0.1	0.0	198.0	2.0	0.0	0.0	0.0	1.1	0.9	0.0	0.0	29.0	0.0	0.2	0.0	59.8	8.1	0.2	2.6	1.5	0.0	1.0	2.2	0.8	0.0	0.4	0.0	0.0	0.2	0.6	1.7	0.0	0.0	0.0	0.0	1.0	3.2	0.4
FAM8A1	AHCP	ENSG00000137414	"Family with sequence similarity 8 member A1"	Q9UBU6	6	17600302-17611715	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"Early spermatids: 759.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.5"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044698, HPA073675"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA044698: AB_2679051, HPA073675: AB_2732236"	"unprognostic (4.06e-1)"	"unprognostic (2.32e-1)"	"unprognostic (9.11e-2)"	"unprognostic (6.90e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.17e-3)"	"unprognostic (6.13e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.04e-2)"	"unprognostic (1.09e-3)"	"unprognostic (4.44e-2)"	"unprognostic (3.50e-1)"	"unprognostic (1.56e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.71e-1)"	"unprognostic (7.59e-2)"	"unprognostic (2.98e-1)"	18.6	16.1	16.3	10.7	17.3	31.6	19.1	19.0	19.5	20.4	16.6	19.9	16.9	27.3	18.9	13.9	20.6	21.1	14.8	17.4	20.3	24.0	77.9	18.9	10.4	18.2	17.2	27.8	15.0	22.3	13.0	14.9	18.2	20.9	22.8	27.1	23.0	22.3	18.9	14.0	16.7	24.8	20.2	14.3	12.7	17.2	21.1	17.1	23.2	21.7	8.2	14.5	12.6	20.6	9.5	3.7	13.5	32.3	45.6	42.6	11.1	15.0	20.4	7.6	13.1	21.4	3.1	8.1	35.2	25.6	8.3	7.6	20.5	13.0	9.9	6.9	29.1	9.8	12.5	46.2	20.1	6.2	9.6	22.6	20.7	8.7	6.0	24.2	17.0	8.9	20.2	16.2	12.0	11.7	4.6	19.2	5.6	11.6	5.6	12.1	13.0	25.0	25.6	7.5	4.1	21.4	11.7	25.0	23.7	23.1	29.0	9.5	13.3	9.7	3.4	14.9	5.5	13.4	12.0	8.0	8.8	7.1	13.4	2.6	0.3	1.0	1.1	0.4	1.2	0.0	0.5	1.0	0.2	0.1	0.7	1.1	5.5	1.5	0.2	0.2	0.4	0.3	16.3	17.3	19.0	19.5	17.4	20.3	18.2	17.2	18.2	20.2	21.1	20.6	16.8	19.2	27.1	8.8	7.0	13.4	9.7	6.6	14.2	27.6	15.1	13.5	15.3	21.5	12.1	29.5	14.6	10.0	15.7	63.4	5.9	9.2	759.2	26.4	24.0	14.1	12.0	4.2	17.1	7.9	12.0	23.0	10.7	20.6	1.3	8.6	25.4	77.5	6.2	15.2	17.9	10.8	8.2	24.4	6.4	187.8	36.7	8.6	5.4	3.7	8.7	19.3	14.4	8.0	13.8	7.5	25.7	30.9	12.8	7.5	30.4	12.4	20.5	16.7	32.9	20.3	18.7	46.6	18.0	14.3	15.9	12.2	14.0	9.7	16.7	7.8
FFAR1	"FFA1R, GPR40"	ENSG00000126266	"Free fatty acid receptor 1"	O14842	19	35351552-35353862	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"bone marrow: 2.8;brain: 4.8;ovary: 2.5;pancreas: 4.4"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 1.8;granulocytes: 1.3;Granulosa cells: 1.4"	"Cancer enriched"	"Detected in single"	13	"pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-698: 1.6"	"Not detected"	"Not detected"							HPA048933			Supported	"Plasma membrane"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"HPA048933: "	"unprognostic (9.49e-2)"				"unprognostic (2.08e-1)"			"unprognostic (1.59e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.51e-2)"		"unprognostic (1.03e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.19e-2)"	"unprognostic (9.56e-3)"		0.0	0.0	1.5	0.1	2.1	2.8	0.0	1.4	1.9	0.0	0.8	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	1.3	1.5	0.0	0.0	0.1	0.4	2.1	1.6	2.5	4.4	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.3	0.3	0.6	0.2	1.9	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	2.1	1.4	1.9	1.3	1.5	2.1	1.6	2.1	1.3	1.9	4.8	0.1	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.3	1.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0
FFAR4	"GPR120, GPR129, O3FAR1, PGR4"	ENSG00000186188	"Free fatty acid receptor 4"	Q5NUL3	10	93566665-93604480	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Differentiation, Inflammatory response"	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 11.4;pituitary gland: 11.0"	"Cell type enriched"	"Detected in some"	4	"Intestinal goblet cells: 125.7"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 4.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"OE19: 12.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042563			Uncertain	"Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"		"HPA042563: AB_10794762"	"unprognostic (1.96e-1)"	"unprognostic (1.06e-2)"	"unprognostic (1.14e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.98e-4)"	"unprognostic (1.41e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.34e-2)"	"unprognostic (7.87e-2)"	"unprognostic (9.51e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.32e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-1)"	4.1	0.4	1.2	0.7	1.3	0.1	1.3	0.6	1.2	0.1	0.3	8.3	0.5	0.0	0.0	0.2	1.0	0.5	0.3	1.0	1.8	0.1	0.4	3.6	0.2	0.6	0.8	0.0	0.6	0.1	11.0	0.1	0.5	0.1	11.4	0.2	0.1	0.0	0.3	0.9	0.6	0.2	0.3	0.1	0.5	1.5	2.6	0.3	0.1	0.1	0.1	0.1	0.0	0.7	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.1	12.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.2	1.2	1.3	0.6	1.2	1.0	1.8	0.6	0.8	0.5	0.3	2.6	0.7	0.2	0.0	0.5	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.2	0.8	0.4	7.2	0.6	0.0	0.0	0.2	0.0	28.1	0.0	0.8	27.8	0.1	0.0	0.3	20.9	0.0	3.2	0.0	0.5	0.2	0.0	0.1	0.0	0.0	0.0	0.0	7.4	0.0	2.0	125.7	0.0	7.2	4.4	16.7	0.6	7.6	1.8	3.7	0.5	0.0	0.0	0.0	0.3	0.9	23.0	0.0	0.0	0.3	0.3	0.0	0.0	0.2	0.0	0.5	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.3
FGF2	FGFB	ENSG00000138685	"Fibroblast growth factor 2"	P09038	4	122826708-122898236	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Predicted intracellular proteins, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Heparin-binding, Mitogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 33.7;Astrocytes: 111.0;Endometrial stromal cells: 40.6;Fibroblasts: 77.1;Oligodendrocyte precursor cells: 42.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 243.8;BJ hTERT+: 148.4;fHDF/TERT166: 278.2;hTERT-HME1: 147.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000125, HPA065502"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies"	"Secreted in other tissues"	NA	NA	92500			"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear bodies"		"CAB000125: , HPA065502: "	"unprognostic (1.53e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.08e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.33e-1)"	"unprognostic (6.98e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (9.85e-4)"	"unprognostic (3.37e-1)"	"unprognostic (4.61e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.45e-3)"	24.3	2.6	14.8	5.3	16.1	0.1	9.5	12.2	14.7	8.7	14.2	14.1	1.7	14.2	4.5	4.7	8.0	7.1	5.0	12.2	18.8	4.0	2.0	8.3	1.8	18.6	20.5	12.6	1.5	4.7	3.2	6.4	15.6	7.6	4.0	3.4	3.5	8.7	1.4	1.9	3.7	12.6	16.8	1.1	6.2	1.9	18.3	1.6	2.4	4.8	1.8	14.8	6.1	13.3	4.7	14.1	7.8	30.5	18.8	31.1	0.0	243.8	148.4	104.3	60.2	0.2	0.4	0.0	20.5	278.2	81.8	0.7	8.1	0.5	104.3	12.3	3.3	0.0	28.7	0.2	55.3	1.4	0.1	16.8	1.7	103.6	147.6	52.0	11.8	0.0	6.9	8.4	27.4	0.1	0.1	0.2	21.6	0.1	5.4	0.0	3.9	0.1	33.0	0.0	4.4	4.0	48.4	0.1	2.0	44.7	0.1	0.5	10.6	85.7	12.2	32.0	20.0	8.6	10.3	0.0	24.7	0.1	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	16.1	12.2	14.7	12.2	18.8	18.6	20.5	15.6	16.8	18.3	13.3	33.7	6.4	0.0	111.0	0.3	1.7	1.6	0.8	2.8	4.6	4.5	8.9	4.7	0.0	1.3	7.3	0.0	2.7	0.4	0.0	3.9	8.2	10.9	1.5	40.6	11.5	1.8	0.4	1.8	1.0	0.1	77.1	0.0	1.6	0.0	5.7	17.2	1.3	0.5	0.0	6.6	0.0	0.0	0.0	2.4	3.8	9.9	1.7	5.4	15.9	0.6	9.3	0.0	42.3	5.8	11.0	0.0	8.2	1.6	16.0	0.0	0.6	0.0	2.0	0.0	15.2	14.2	4.7	1.1	0.3	1.3	4.8	0.5	0.1	0.0	2.0
FGF23		ENSG00000118972	"Fibroblast growth factor 23"	Q9GZV9	12	4368227-4379712	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	Differentiation	"Growth factor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	23	"brain: 126.3;choroid plexus: 104.9"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 10.4;Early spermatids: 6.6;Hepatic stellate cells: 13.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 10.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 10.8"	"Cell line enhanced"	"Detected in some"		"AF22: 1.9;HBEC3-KT: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"								"Secreted to blood"	NA	NA	56800		"Cluster 42: Non-specific - Transcription"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 23: Spermatids - Flagellum & Golgi organization"							"unprognostic (1.31e-1)"						"unprognostic (2.18e-2)"				"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"			0.2	0.1	74.8	0.1	73.5	0.5	0.2	73.8	126.3	0.0	104.9	0.2	0.3	0.3	1.2	0.2	0.3	0.1	5.0	74.1	74.1	0.2	4.1	0.2	0.2	73.8	86.6	0.2	0.1	0.1	0.0	0.2	77.8	0.1	0.6	2.3	0.5	0.0	1.2	0.3	0.1	0.3	72.9	0.5	0.2	0.5	73.3	0.1	0.1	0.3	0.6	0.1	0.0	78.6	0.0	0.0	1.9	0.6	0.9	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.7	0.1	0.0	0.3	0.1	0.4	0.2	1.4	0.0	0.0	0.2	0.0	0.3	0.2	0.5	0.4	0.1	0.5	0.0	0.9	1.1	0.1	0.1	0.0	0.1	0.8	0.0	0.0	0.2	0.5	0.5	0.1	0.0	0.3	0.0	0.3	0.2	0.4	0.4	0.3	0.0	0.6	0.1	0.3	0.4	0.3	0.0	0.7	0.1	0.5	0.1	0.0	0.0	0.1	0.4	0.1	0.4	10.8	1.4	2.0	1.6	1.5	1.9	1.8	1.5	1.2	1.2	1.9	1.7	1.7	4.8	2.2	2.5	1.9	1.6	1.1	74.8	73.5	73.8	126.3	74.1	74.1	73.8	86.6	77.8	72.9	73.3	78.6	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.9	1.5	0.0	0.0	10.4	0.1	0.3	0.0	0.0	0.0	6.6	0.0	0.2	0.5	0.0	0.0	0.8	0.0	0.1	0.4	0.0	0.1	0.0	0.0	13.6	0.0	0.2	1.7	0.3	0.0	0.0	0.6	0.3	1.8	0.3	0.1	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.2
FGFR1	"BFGFR, CD331, CEK, FLG, FLT2, H2, H3, H4, H5, KAL2, N-SAM"	ENSG00000077782	"Fibroblast growth factor receptor 1"	P11362	8	38400215-38468834	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Transcription, Transcription regulation"	"Heparin-binding, Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Craniosynostosis, Disease variant, Dwarfism, FDA approved drug targets, Holoprosencephaly, Hypogonadotropic hypogonadism, Kallmann syndrome, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 176.7;Leydig cells: 192.0;Oligodendrocyte precursor cells: 166.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 508.7;BJ hTERT+: 278.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033614, HPA056402"	Approved					NA	NA		78000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 50: Fibroblasts - ECM organization"			"CAB033614: AB_783377, HPA056402: AB_2683118"	"unprognostic (9.53e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.35e-2)"	"unprognostic (4.23e-3)"	"unprognostic (7.02e-2)"	"unprognostic (6.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.81e-1)"	"unprognostic (3.99e-2)"	"unprognostic (7.97e-3)"	"unprognostic (4.59e-2)"	"unprognostic (7.69e-2)"	"unprognostic (6.87e-3)"	"unprognostic (5.60e-2)"	"unprognostic (4.59e-3)"	"unprognostic (1.05e-3)"	95.1	12.8	27.5	15.9	24.6	14.1	87.1	48.8	22.4	79.8	37.2	97.2	8.8	74.2	15.8	35.8	85.9	57.1	89.9	30.9	28.8	40.1	9.1	55.7	16.6	35.9	37.3	108.2	98.6	20.4	57.1	51.3	63.7	60.5	17.9	15.8	31.4	53.6	24.8	35.6	41.7	57.1	30.3	9.9	40.4	20.4	33.4	17.1	33.7	23.3	16.1	79.3	63.9	29.6	12.9	42.0	198.0	508.7	120.1	91.2	142.9	136.7	278.8	90.0	95.8	27.3	6.5	1.8	38.3	127.7	103.9	0.2	90.0	6.8	104.3	39.2	24.1	0.0	7.7	27.8	69.7	31.1	0.6	80.5	0.7	70.9	13.3	45.6	86.9	6.0	11.9	0.4	40.5	12.5	91.5	9.2	145.9	1.6	21.6	86.3	21.1	0.4	35.6	0.3	7.9	19.4	23.4	1.0	5.1	93.4	9.3	5.4	51.4	49.2	28.9	149.6	29.7	2.4	4.1	0.5	60.3	1.7	27.1	0.2	0.3	0.1	1.7	0.1	1.1	0.3	0.7	1.2	0.0	0.6	0.5	1.5	0.6	0.4	0.2	0.2	1.0	0.1	27.5	24.6	48.8	22.4	30.9	28.8	35.9	37.3	63.7	30.3	33.4	29.6	101.0	3.2	15.8	55.8	1.8	31.5	95.9	1.1	37.0	4.4	28.7	77.7	52.5	24.3	5.1	9.2	4.2	8.3	6.3	0.4	0.0	27.3	15.3	48.2	40.6	75.5	25.0	3.6	25.4	65.2	80.5	176.7	3.1	75.3	8.2	40.4	47.5	0.8	25.3	21.9	21.1	0.6	4.1	5.6	75.2	15.0	192.0	11.7	33.8	19.7	1.7	88.1	6.2	166.4	14.2	21.6	0.3	99.6	6.4	94.7	0.1	7.9	1.0	3.3	13.1	118.9	59.9	1.6	14.1	4.8	19.7	10.4	14.1	2.1	0.7	11.7
FGFR4	"CD334, JTK2"	ENSG00000160867	"Fibroblast growth factor receptor 4"	P22455	5	177086905-177098144	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"		"Kinase, Receptor, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 82.5;lung: 65.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 78.6;Hepatocytes: 31.2;Skeletal myocytes: 141.2;Theca cells: 36.7;Undifferentiated cells: 38.6"	"Cancer enhanced"	"Detected in many"		"liver cancer: 42.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CACO-2: 173.9;Hep G2: 176.4;RH-30: 274.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB005196, HPA027273, HPA027369, HPA028251"	Approved				"Intracellular and membrane"	NA	NA		7400000		"Cluster 18: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"			"CAB005196: AB_631512, HPA027273: AB_10600212, HPA027369: AB_10599427, HPA028251: AB_10601221"	"unprognostic (1.96e-1)"	"unprognostic (2.10e-2)"	"unprognostic (1.12e-1)"	"unprognostic (9.06e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.95e-2)"	"unprognostic (7.85e-3)"	"unprognostic (9.19e-2)"	"unprognostic (4.25e-1)"	"unprognostic (4.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.71e-3)"	"unprognostic (2.41e-1)"	"unprognostic (5.75e-2)"	"unprognostic (4.68e-2)"	1.2	14.0	1.1	4.1	1.1	0.5	4.5	2.7	2.1	3.0	1.2	18.0	21.3	2.4	0.2	3.2	4.2	10.2	2.2	1.4	1.0	40.2	82.5	65.4	0.8	0.7	0.8	27.5	29.5	0.2	2.0	2.1	0.9	5.2	6.0	1.5	1.1	0.7	6.6	1.7	20.0	1.1	0.7	22.7	8.8	5.9	1.1	0.2	0.9	1.9	0.2	6.4	3.2	1.3	3.2	48.8	1.0	11.7	0.1	0.1	24.5	0.2	0.1	0.2	0.3	173.9	6.5	5.3	23.0	0.1	2.4	2.8	9.5	1.8	0.1	3.2	13.8	0.5	2.8	176.4	5.2	0.6	4.7	1.1	0.2	8.4	0.2	0.3	0.2	3.5	18.1	0.7	3.9	40.3	0.1	3.6	29.2	30.9	4.5	8.2	274.3	30.9	22.9	0.4	1.8	2.9	1.8	12.4	5.9	5.9	11.7	2.5	1.1	0.0	23.4	0.3	0.7	1.6	1.9	3.7	0.1	1.1	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	1.1	1.1	2.7	2.1	1.4	1.0	0.7	0.8	0.9	0.7	1.1	1.3	0.3	0.0	0.0	0.3	0.3	0.6	0.7	0.4	0.0	0.9	2.9	2.0	0.9	78.6	0.1	3.7	0.0	1.3	0.1	12.9	3.9	10.9	0.1	1.6	0.3	0.7	4.2	0.0	0.5	4.9	3.8	9.6	9.7	2.9	0.0	0.7	3.9	31.2	0.3	0.0	0.5	10.1	0.0	0.9	0.5	0.0	0.6	0.7	0.0	1.9	0.6	0.6	0.0	0.5	0.1	3.0	4.4	1.5	0.1	1.7	15.9	21.6	0.1	0.4	19.7	141.2	0.7	3.0	9.9	0.8	0.4	8.8	0.4	36.7	38.6	0.5
FGFRL1		ENSG00000127418	"Fibroblast growth factor receptor like 1"	Q8N441	4	1009936-1026898	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 34.0;Granulosa cells: 30.9;Hepatocytes: 37.5;Muller glia cells: 94.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 1.1;non-classical monocyte: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"U-251 MG: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB026019, HPA068828"	Approved		Supported	Vesicles		No	No			"Cluster 7: Monocytes - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"CAB026019: , HPA068828: AB_2686043"	"unprognostic (1.30e-2)"	"unprognostic (2.54e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.62e-2)"	"unprognostic (9.79e-2)"	"unprognostic (4.87e-3)"	"unprognostic (8.46e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.36e-3)"	"unprognostic (1.49e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.96e-2)"	38.1	56.0	40.8	5.0	43.3	7.6	24.1	40.6	49.5	15.7	29.8	10.2	7.3	9.9	3.4	5.5	36.0	9.3	19.8	39.2	33.5	25.4	52.8	15.1	3.1	49.9	45.8	25.4	71.6	16.1	21.6	3.0	46.5	12.4	4.9	10.5	37.6	2.7	20.6	10.7	13.5	4.0	42.2	9.1	27.2	5.5	47.9	1.4	67.1	9.6	2.2	11.2	8.0	42.1	23.2	31.6	11.3	34.3	11.9	12.3	2.9	40.4	6.2	12.9	8.4	23.1	47.9	2.6	49.3	63.3	58.3	5.8	21.8	14.1	11.8	8.3	21.0	0.3	41.2	61.5	24.0	13.7	5.6	25.7	11.7	22.4	9.5	48.4	12.5	9.3	25.3	8.9	7.9	30.8	16.0	37.7	14.2	39.7	83.8	24.7	16.3	16.7	22.6	3.6	1.2	2.2	38.1	0.8	15.2	13.4	22.5	11.9	26.1	68.8	27.2	35.2	99.8	8.9	12.9	3.8	18.1	15.6	22.8	0.6	0.0	0.0	0.2	1.1	0.0	0.1	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.1	40.8	43.3	40.6	49.5	39.2	33.5	49.9	45.8	46.5	42.2	47.9	42.1	3.8	3.2	4.1	34.0	2.8	6.5	3.7	5.4	2.2	5.4	13.2	6.1	8.5	11.5	6.9	7.3	0.0	1.6	4.1	4.4	0.0	9.6	0.2	6.0	4.2	2.6	1.8	4.8	3.2	10.2	26.6	5.1	6.6	13.5	1.3	30.9	5.3	37.5	3.2	0.0	2.8	11.0	0.0	1.6	2.5	1.2	4.4	3.4	7.2	1.9	1.3	94.0	1.0	5.0	5.4	19.9	2.7	3.4	2.2	11.4	2.9	7.6	7.0	5.6	0.0	3.3	5.1	0.4	4.2	1.2	4.7	1.5	4.2	17.5	3.6	8.8
FITM2	"C20orf142, dJ881L22.2, FIT2"	ENSG00000197296	"Fat storage inducing transmembrane protein 2"	Q8N6M3	20	44302840-44311202	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid metabolism"	Hydrolase	"Deafness, Disease variant, Dystonia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"heart muscle: 67.4"	"Cell type enriched"	"Detected in many"	9	"Cardiomyocytes: 153.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (2.92e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.10e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.57e-3)"	"unprognostic (1.63e-2)"	"unprognostic (3.90e-2)"	"unprognostic (8.43e-2)"	"unprognostic (5.19e-2)"	"unprognostic (6.56e-3)"	"unprognostic (1.19e-1)"	"prognostic favorable (8.98e-12)"	"unprognostic (2.07e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.38e-3)"	"unprognostic (2.49e-3)"	11.4	11.1	4.8	2.9	5.0	1.2	7.0	5.7	6.3	4.2	5.9	5.2	4.3	4.0	8.7	3.3	3.7	3.2	67.4	4.8	5.9	7.9	6.4	4.1	2.2	6.9	5.9	4.6	7.4	13.6	5.2	1.9	7.4	6.4	6.0	6.7	6.5	4.4	9.2	5.7	3.9	5.3	4.2	2.6	4.6	3.8	5.4	1.7	6.3	16.8	2.6	4.5	3.1	4.7	7.2	10.9	4.5	6.6	31.4	12.8	4.6	11.5	8.4	8.9	4.9	13.5	5.1	4.9	6.5	13.0	14.3	15.8	5.7	7.7	9.6	1.4	2.7	1.6	6.5	22.9	6.6	3.1	4.0	9.7	17.2	6.2	4.7	4.9	6.4	3.1	2.7	14.2	9.1	22.4	1.2	3.4	1.1	10.8	13.9	1.9	8.4	4.9	5.1	6.7	2.7	3.2	24.4	13.5	10.3	2.0	16.5	2.4	7.9	28.2	12.6	16.6	6.8	5.2	14.4	1.3	12.6	4.9	14.4	0.7	1.0	0.6	1.1	1.0	1.2	0.6	1.2	0.9	1.0	0.6	2.0	1.6	0.4	1.4	0.8	0.6	1.2	0.9	4.8	5.0	5.7	6.3	4.8	5.9	6.9	5.9	7.4	4.2	5.4	4.7	2.8	6.4	9.7	1.3	3.6	6.9	3.5	2.8	1.2	6.4	5.0	3.4	153.9	11.5	4.3	5.5	6.2	2.0	1.0	5.1	1.9	5.2	4.6	2.2	5.0	4.4	9.1	0.8	2.3	8.6	3.5	9.4	4.1	2.1	0.0	4.4	8.2	14.1	3.4	6.7	2.1	4.8	0.0	3.8	2.2	1.2	7.8	1.7	7.2	1.0	2.3	6.6	2.1	4.0	0.9	5.7	4.1	7.5	3.1	3.1	5.9	6.2	4.0	5.9	0.0	5.6	6.3	9.1	6.0	2.7	8.1	1.5	2.1	16.3	9.2	2.2
FKBP1A	"FKBP-12, FKBP1, FKBP12, FKBP12C, PKC12, PPIASE"	ENSG00000088832	"FKBP prolyl isomerase 1A"	P62942	20	1368977-1393164	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Isomerase, Rotamase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Paneth cells: 977.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"dendritic cells: 675.2;granulocytes: 974.2;monocytes: 1013.4"	"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 1749.2;TIME: 1929.6"									"CAB004639, HPA051798"	Uncertain					NA	NA		12000000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004639: AB_425434, HPA051798: AB_2681615"	"unprognostic (4.09e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.22e-3)"	"unprognostic (1.28e-2)"	"unprognostic (2.66e-1)"	"unprognostic (7.18e-3)"	"prognostic unfavorable (3.44e-7)"	"unprognostic (7.05e-3)"	"unprognostic (2.76e-1)"	"unprognostic (8.81e-2)"	"unprognostic (5.12e-3)"	"unprognostic (6.65e-2)"	"prognostic unfavorable (6.69e-5)"	"unprognostic (1.97e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	272.7	185.0	138.4	178.8	177.5	167.0	188.2	88.5	163.2	123.0	112.6	158.6	108.9	165.4	150.1	169.8	131.7	104.5	171.4	166.7	115.8	186.7	98.1	235.2	162.7	92.4	98.9	135.1	114.6	123.0	79.5	218.7	95.6	125.4	188.5	11.8	111.0	119.8	110.3	127.3	117.0	225.1	97.8	185.7	118.3	56.9	120.5	188.1	190.9	150.6	202.2	206.8	126.2	118.9	718.1	299.5	172.9	240.3	654.1	771.3	202.9	423.9	337.1	382.7	354.2	278.4	295.2	272.5	149.3	555.7	656.3	337.7	255.1	1007.2	419.7	68.8	170.5	284.2	113.9	473.3	406.4	390.5	168.0	484.7	332.0	410.3	412.6	513.3	1749.2	401.0	271.0	145.8	443.3	125.8	401.9	453.7	307.1	335.3	276.4	307.0	254.1	351.9	540.0	243.4	248.7	173.8	208.0	479.3	728.8	231.8	177.2	293.0	1929.6	1363.6	201.8	278.1	329.5	76.4	168.1	292.9	248.1	332.3	307.5	316.3	870.8	974.2	112.9	1005.8	104.3	128.1	135.5	133.2	675.2	136.2	140.1	132.6	805.0	160.6	1013.4	312.7	195.0	1153.8	138.4	177.5	88.5	163.2	166.7	115.8	92.4	98.9	95.6	97.8	120.5	118.9	779.1	86.6	77.2	0.0	160.6	263.1	211.2	393.3	152.0	17.6	175.6	156.5	59.7	170.1	179.5	172.9	0.0	281.8	148.3	456.2	238.7	432.4	47.7	98.7	183.8	814.8	330.6	196.4	0.0	337.5	702.0	212.2	160.0	122.5	143.5	95.3	623.6	113.5	746.7	35.3	0.0	245.9	329.6	541.8	436.5	52.2	200.0	428.8	241.9	0.0	527.4	52.2	152.4	0.0	0.0	483.6	977.5	162.9	214.8	221.1	210.8	332.1	123.0	11.7	138.1	87.4	224.7	169.3	141.8	329.4	299.3	231.5	150.1	347.3	318.0	245.7
FLNA	"ABP-280, FLN, FLN1, OPD1, OPD2"	ENSG00000196924	"Filamin A"	P21333	X	154348524-154374634	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cilium biogenesis/degradation"	Actin-binding	"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"endometrium 1: 1203.7;intestine: 1462.2"	"Cell type enhanced"	"Detected in many"		"Peritubular cells: 500.6;Sertoli cells: 420.7;Smooth muscle cells: 459.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000356, HPA000368, HPA001016, HPA001115, HPA002925"	Enhanced	Approved	Enhanced	"Plasma membrane,Actin filaments,Cytosol"		NA	NA		730000000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Actin filaments, Cytosol"		"CAB000356: , HPA000368: AB_2797215, HPA001016: , HPA001115: AB_1078871, HPA002925: AB_1078869"	"unprognostic (1.39e-1)"	"unprognostic (9.40e-3)"	"prognostic unfavorable (7.37e-4)"	"unprognostic (3.68e-2)"	"unprognostic (2.55e-1)"	"unprognostic (6.05e-3)"	"unprognostic (5.08e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.02e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.23e-2)"	"unprognostic (9.58e-2)"	"prognostic unfavorable (1.54e-6)"	"unprognostic (5.49e-3)"	"unprognostic (1.78e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (3.88e-4)"	267.4	55.9	14.4	223.2	18.5	157.9	164.2	15.2	43.0	392.1	54.7	1462.2	89.9	1203.7	35.5	454.7	609.4	137.9	108.4	14.8	23.0	70.5	21.2	238.9	65.0	39.9	19.9	236.7	50.5	13.4	30.5	79.2	24.4	369.2	86.9	9.0	80.3	617.2	49.7	124.7	354.6	706.6	21.1	102.7	508.0	33.7	34.0	48.1	85.6	31.2	38.1	1053.9	286.4	21.5	947.2	719.2	246.7	316.1	209.8	278.4	400.9	614.0	680.1	552.5	489.8	469.2	169.4	80.5	1551.4	966.4	970.1	528.3	224.0	538.1	152.7	333.6	77.8	262.2	914.9	159.7	375.9	309.3	324.9	266.1	126.1	825.5	327.0	533.8	417.1	94.9	74.7	538.7	401.3	210.7	148.5	93.1	258.3	97.9	470.9	147.8	221.2	71.6	197.2	193.4	52.9	119.7	515.8	80.2	381.1	187.3	79.1	96.3	1016.6	625.2	586.8	640.0	1147.1	333.7	212.8	162.3	580.3	202.4	638.7	7.6	24.9	11.8	32.6	23.1	21.2	10.2	15.6	29.2	22.4	4.6	6.0	14.3	3.6	10.5	34.2	2.7	20.7	56.2	14.4	18.5	15.2	43.0	14.8	23.0	39.9	19.9	24.4	21.1	34.0	21.5	105.1	57.7	38.7	30.0	76.9	124.3	85.9	127.8	85.4	3.5	40.9	153.5	34.5	38.6	26.1	35.0	0.0	24.6	257.7	2.6	1.9	272.0	2.1	33.8	186.3	107.0	1.8	39.7	11.8	133.1	90.9	137.9	13.3	55.8	26.0	334.5	81.8	4.3	120.3	11.8	8.6	2.5	22.4	141.0	263.0	13.7	122.4	227.7	88.9	30.9	207.9	39.4	270.8	8.0	2.6	347.4	1.5	500.6	98.7	96.1	1.9	3.0	9.1	4.3	420.7	118.3	459.3	4.1	8.9	48.8	73.6	20.0	172.3	134.7	3.3	35.3
FLNB	"ABP-278, FH1, FLN1L, LRS1, TABP, TAP"	ENSG00000136068	"Filamin B"	O75369	3	58008400-58172251	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Differentiation, Myogenesis"	"Actin-binding, Developmental protein"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 344.9;Pancreatic endocrine cells: 385.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 17.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"TIME: 523.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004747, HPA004886, CAB019322"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Actin filaments,Cytosol"		NA	NA		20000000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus, Actin filaments, Cytosol"	"CAB019322: , HPA004747: AB_1848599, HPA004886: AB_1848600"	"unprognostic (1.29e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.26e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.72e-1)"	"unprognostic (9.61e-2)"	"unprognostic (5.02e-3)"	"prognostic unfavorable (8.45e-5)"	"unprognostic (9.23e-2)"	"prognostic favorable (3.45e-6)"	"unprognostic (4.38e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.65e-3)"	"unprognostic (2.33e-1)"	74.6	63.1	42.8	22.3	51.3	7.4	90.4	50.9	52.4	45.5	57.1	122.2	52.8	75.5	120.3	57.7	75.9	19.6	47.2	40.1	41.6	96.7	71.5	49.9	24.4	54.4	52.3	68.9	83.2	59.9	38.1	48.0	52.6	124.4	74.4	10.2	64.0	51.4	16.3	91.3	92.7	36.2	48.1	55.3	70.2	30.4	50.0	74.8	91.1	17.8	23.8	114.7	58.6	58.3	134.4	225.0	22.3	32.9	14.8	25.0	385.7	49.0	39.3	106.6	108.4	227.1	223.1	21.9	18.1	172.9	172.8	215.9	42.1	311.5	103.0	121.6	20.8	18.4	192.7	110.5	107.8	16.2	63.1	40.2	132.1	148.5	448.3	125.2	365.4	94.7	30.9	6.6	67.0	29.2	49.3	38.5	34.5	146.6	192.1	21.6	5.8	18.7	143.8	224.6	24.7	23.1	247.3	132.6	27.4	160.9	110.3	44.6	523.3	27.8	84.5	334.1	175.6	4.8	1.7	17.0	102.2	29.2	29.9	10.1	0.3	5.0	0.5	0.8	2.7	4.1	1.7	0.8	1.4	1.6	5.1	3.8	0.2	7.3	1.5	17.9	2.0	1.5	42.8	51.3	50.9	52.4	40.1	41.6	54.4	52.3	52.6	48.1	50.0	58.3	133.7	51.3	30.2	3.9	11.0	50.6	42.9	73.2	29.0	3.3	86.6	43.4	10.0	57.2	62.0	47.8	39.6	28.7	36.8	344.9	0.0	93.8	15.6	103.6	24.4	92.9	49.2	10.3	34.1	67.1	207.1	28.8	88.7	133.8	24.7	34.4	151.3	52.0	14.6	1.7	34.3	82.8	38.7	11.3	12.2	22.4	16.1	11.1	5.4	22.5	11.6	9.1	2.1	25.1	40.9	385.7	161.0	27.8	3.4	115.2	157.3	6.5	76.1	10.6	0.0	4.4	25.9	4.4	6.9	46.4	51.7	49.8	9.9	84.6	93.0	88.4
FLNC	"ABP-280, ABPL, FLN2"	ENSG00000128591	"Filamin C"	Q14315	7	128830406-128859274	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Actin-binding	"Cardiomyopathy, Disease variant, Myofibrillar myopathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 635.2;skeletal muscle: 1384.8;tongue: 442.6"	"Cell type enriched"	"Detected in many"	26	"Cardiomyocytes: 1892.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 393.6;fHDF/TERT166: 180.2;hTEC/SVTERT24-B: 190.6;U-2 OS: 163.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA006135, HPA071007"	Enhanced		Supported	"Plasma membrane,Cytosol"		NA	NA		26000000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA006135: AB_1848602, HPA071007: "	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	"unprognostic (4.47e-2)"	"unprognostic (1.40e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (1.64e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (2.17e-5)"	"unprognostic (1.03e-3)"	"unprognostic (2.35e-2)"	"unprognostic (1.35e-3)"	"unprognostic (6.37e-2)"	"prognostic unfavorable (5.69e-4)"	"unprognostic (5.68e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (3.73e-5)"	13.1	3.4	5.8	25.9	11.5	0.0	5.9	11.5	9.9	16.9	3.0	215.4	9.4	96.6	4.6	40.3	35.4	13.8	635.2	5.9	16.7	2.8	1.1	12.5	0.6	52.1	11.1	9.4	2.1	3.2	1.6	2.4	29.9	71.1	9.8	0.5	16.5	100.7	1384.8	8.9	40.3	114.4	51.7	0.7	65.6	2.2	19.1	0.3	4.3	442.6	0.2	162.7	21.3	49.8	0.1	0.8	4.2	0.1	34.4	41.2	4.1	393.6	73.6	109.2	52.3	124.0	1.0	0.1	64.7	180.2	44.9	0.1	23.7	0.9	64.4	0.2	13.1	0.1	20.2	0.1	43.2	0.0	0.2	78.0	0.1	190.6	0.1	44.2	69.0	0.3	49.0	0.2	75.8	0.0	0.0	1.5	64.5	0.1	22.6	0.1	127.5	1.0	0.1	0.0	2.1	7.0	0.7	0.1	0.3	88.0	0.4	1.6	144.6	38.2	163.5	10.1	0.2	0.1	0.0	0.3	129.0	0.1	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	11.5	11.5	9.9	5.9	16.7	52.1	11.1	29.9	51.7	19.1	49.8	3.6	3.2	0.5	0.7	0.0	3.7	0.3	0.1	1.2	0.6	0.3	1.3	1892.3	0.0	1.9	1.8	0.0	0.4	0.2	0.5	0.0	0.7	0.4	1.8	5.0	31.4	0.0	0.0	0.2	0.2	3.0	31.6	0.0	2.9	0.0	0.6	1.8	0.0	0.9	0.0	1.1	0.3	0.0	0.0	6.9	0.9	5.3	0.5	5.4	0.0	0.0	0.1	0.0	0.0	5.8	2.6	0.1	10.5	1.2	2.7	0.0	1.1	0.0	0.2	0.0	71.8	38.1	0.3	1.0	0.2	4.5	1.9	1.0	0.1	0.2	1.0
FLOT1		ENSG00000137312	"Flotillin 1"	O75955	6	30727709-30742732	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 314.3"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"GAMG: 423.3;hTERT-RPE1: 242.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001393, CAB007766"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA		160000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Golgi apparatus"	"Vesicles, Plasma membrane"	"CAB007766: AB_562116, HPA001393: AB_1078892"	"unprognostic (2.68e-1)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (5.78e-4)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (3.41e-3)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.65e-1)"	"prognostic favorable (3.06e-4)"	"unprognostic (1.81e-2)"	"unprognostic (9.36e-2)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (6.43e-3)"	"unprognostic (3.92e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.46e-2)"	141.7	239.5	49.3	27.9	54.6	41.7	129.8	49.4	60.9	111.1	56.8	150.3	28.7	108.9	8.4	81.8	95.8	23.1	234.5	55.1	57.9	146.1	127.3	136.8	22.1	50.9	51.5	84.1	88.5	41.4	102.5	35.0	57.4	109.6	17.7	6.3	99.1	45.8	190.0	51.7	87.1	33.0	45.8	129.6	96.9	65.0	53.6	24.9	111.7	83.1	17.0	134.5	96.9	48.8	54.3	18.3	46.4	62.0	49.1	71.0	1.3	59.7	67.5	82.8	79.3	19.4	30.0	13.0	29.0	101.3	423.3	41.8	35.0	20.1	28.6	36.1	1.3	41.1	17.5	19.1	119.2	12.2	67.0	75.4	30.6	40.9	71.3	242.7	65.9	37.9	21.7	52.7	77.9	22.9	38.0	14.5	15.1	29.4	15.7	20.2	48.4	38.0	30.3	13.0	16.4	17.2	33.7	28.7	164.6	30.4	43.8	10.1	44.0	199.5	37.6	20.6	120.6	18.6	19.7	28.8	26.2	42.6	122.7	179.3	76.9	132.0	35.0	38.9	24.1	28.0	21.3	30.4	58.9	23.0	23.7	27.4	314.3	79.9	26.3	59.2	3.9	58.3	49.3	54.6	49.4	60.9	55.1	57.9	50.9	51.5	57.4	45.8	53.6	48.8	175.4	89.8	77.0	26.1	38.1	28.7	111.5	44.9	80.2	14.7	72.1	73.4	90.6	62.9	59.2	84.6	6.2	82.2	57.7	103.2	123.3	77.6	60.2	73.9	50.1	141.6	68.8	41.7	41.3	85.9	70.7	67.6	55.5	75.2	143.3	41.4	154.9	59.7	130.6	20.2	40.2	66.6	57.0	61.3	84.9	144.1	61.8	89.4	71.2	28.1	99.2	64.7	68.0	27.2	22.7	65.7	112.0	38.0	60.4	69.5	89.0	172.1	80.7	18.1	52.6	58.1	65.9	80.2	26.7	63.7	26.9	61.6	51.2	29.1	83.2	99.4
FLVCR1	"AXPC1, FLVCR, MFSD7B, PCA, SLC49A1"	ENSG00000162769	"FLVCR heme transporter 1"	Q9Y5Y0	1	212858275-212899363	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Erythrocyte maturation, Transport"	Receptor	"Disease variant, Neurodegeneration, Neuropathy, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.4"	"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"NTERA-2: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046646	Approved		Approved	"Cell Junctions"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 45: Enterocytes - Digestion"	"Cell Junctions"		"HPA046646: AB_2679735"	"unprognostic (2.09e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.83e-2)"	"unprognostic (2.48e-1)"	"prognostic unfavorable (2.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.88e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (1.06e-5)"	"unprognostic (7.15e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.91e-2)"	"unprognostic (7.29e-3)"	2.1	2.4	3.4	3.1	2.8	6.2	3.1	5.0	3.7	2.9	2.7	3.4	9.7	2.5	4.9	2.1	2.4	2.0	1.6	3.2	4.4	2.4	1.8	2.4	2.9	4.5	4.1	2.4	2.6	3.6	6.9	2.4	5.3	3.4	2.8	7.0	1.9	1.8	1.0	2.9	19.4	1.7	2.5	2.6	4.8	2.8	4.3	2.6	2.2	0.6	2.2	2.3	2.3	4.2	8.4	11.0	16.8	5.1	2.8	3.4	31.3	2.4	1.8	4.8	2.9	16.1	15.2	9.1	4.4	1.7	10.2	12.5	18.2	5.4	4.7	5.4	8.0	5.4	10.4	14.9	3.2	14.5	8.4	2.7	3.5	5.2	6.6	2.5	3.8	6.4	14.7	7.4	3.2	3.2	4.1	7.2	55.3	11.1	7.7	9.0	15.4	10.6	6.0	8.0	18.1	12.7	11.2	11.1	10.4	13.8	18.2	6.7	2.2	2.3	5.6	7.7	11.2	4.6	9.9	10.8	3.5	8.3	2.9	0.5	0.2	1.5	0.2	0.1	0.2	0.2	0.3	0.2	0.1	0.3	0.3	0.3	0.7	0.2	0.2	0.4	0.4	0.0	3.4	2.8	5.0	3.7	3.2	4.4	4.5	4.1	5.3	2.5	4.3	4.2	6.7	12.8	16.0	12.4	8.3	14.3	8.8	6.9	9.6	24.0	10.3	9.5	4.1	14.3	12.1	20.2	35.5	3.9	6.8	13.7	1.9	5.5	4.7	7.0	7.8	9.3	32.4	9.5	28.8	13.4	6.7	8.8	17.3	7.6	7.0	20.1	10.0	9.2	6.5	16.8	39.4	10.6	10.2	10.1	9.6	6.8	6.2	9.0	5.4	9.4	10.5	5.8	4.1	24.1	28.7	8.9	12.0	2.6	6.5	11.9	73.7	4.6	10.1	31.8	6.6	18.0	7.2	10.4	6.8	7.0	9.2	2.5	8.3	5.1	8.2	4.3
FLVCR2	"C14orf58, CCT, FLJ20371, MFSD7C, SLC49A2"	ENSG00000119686	"FLVCR heme transporter 2"	Q9UPI3	14	75578620-75663214	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 75.6;Kupffer cells: 44.9;Late spermatids: 142.5;Microglial cells: 41.2;Proximal enterocytes: 50.4;Syncytiotrophoblasts: 54.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"classical monocyte: 14.0;intermediate monocyte: 14.6;myeloid DC: 7.6;non-classical monocyte: 11.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 7.6;monocytes: 14.6"	"Cell line enhanced"	"Detected in many"		"ASC diff: 53.8;ASC TERT1: 23.2;BEWO: 73.5;MCF7: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037984	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA037984: AB_10672733"	"unprognostic (2.42e-1)"	"unprognostic (4.85e-2)"	"unprognostic (4.19e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.44e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.78e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.80e-2)"	"prognostic favorable (2.53e-5)"	"unprognostic (6.69e-2)"	"unprognostic (9.94e-2)"	"unprognostic (9.38e-2)"	"unprognostic (1.16e-1)"	5.1	13.6	3.5	9.3	3.7	5.4	2.5	3.2	3.8	2.1	16.2	8.4	17.4	1.0	1.4	2.9	1.9	3.5	2.2	2.9	2.7	11.3	20.5	16.2	5.3	4.7	3.7	2.2	0.6	2.1	3.4	10.3	3.9	2.3	7.1	0.7	12.7	1.7	8.3	5.7	24.4	4.2	5.2	13.8	0.9	21.1	4.8	1.2	3.2	1.6	5.0	4.9	2.6	5.5	3.7	2.8	0.8	4.0	53.8	23.2	73.5	0.7	3.1	3.3	2.6	6.2	0.4	0.0	0.2	0.2	5.4	0.4	9.8	0.2	1.3	19.3	0.6	0.1	2.8	13.3	4.3	0.1	0.6	10.9	7.7	4.0	2.4	0.1	0.8	0.3	0.2	0.5	10.1	26.4	0.2	1.9	1.6	1.1	4.4	0.1	2.6	0.0	3.5	5.1	0.0	0.1	2.0	8.1	1.6	4.6	4.5	10.1	8.8	4.0	1.4	2.0	0.1	0.6	1.1	0.0	11.4	2.5	0.7	0.0	14.0	0.7	0.4	14.6	1.1	0.0	1.1	0.3	7.6	0.1	0.8	0.2	0.5	0.5	11.8	0.1	1.6	4.1	3.5	3.7	3.2	3.8	2.9	2.7	4.7	3.7	3.9	5.2	4.8	5.5	0.3	6.4	6.4	2.6	0.5	0.6	0.3	0.4	0.6	0.0	1.5	0.6	0.8	0.0	3.2	3.7	0.0	23.2	1.7	14.0	0.0	0.1	75.6	2.1	3.9	2.5	0.0	0.0	0.2	0.2	31.0	2.2	0.0	2.7	1.3	0.2	1.8	21.1	16.4	0.0	0.2	2.2	4.1	44.9	5.6	142.5	3.4	19.0	0.0	41.2	10.1	1.3	2.1	0.0	0.2	0.1	3.2	1.9	0.5	0.8	50.4	7.0	0.3	0.3	0.0	0.4	0.3	2.4	1.3	0.2	0.9	54.5	1.2	2.3	5.5	0.2
FOLR1	"FOLR, FRα"	ENSG00000110195	"Folate receptor alpha"	P15328	11	72189558-72196323	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Transport	Receptor	Neurodegeneration	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 480.2;fallopian tube: 187.2;lung: 193.5;salivary gland: 219.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 496.8;Alveolar cells type 2: 213.3;Breast glandular cells: 211.3;Club cells: 276.3;Collecting duct cells: 318.2;Cytotrophoblasts: 462.2;Proximal tubular cells: 366.0;Syncytiotrophoblasts: 259.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 259.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HeLa: 444.2;RPTEC TERT1: 476.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA077030			Approved	"Nuclear membrane"	"Secreted to blood"	NA	NA	448000	140000		"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 30: Mammary glandular cells - Lactation"	"Nuclear membrane"		"HPA077030: "	"unprognostic (3.30e-1)"	"unprognostic (2.19e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.49e-2)"	"unprognostic (7.67e-3)"	"unprognostic (1.98e-2)"	"prognostic unfavorable (2.50e-4)"	"unprognostic (1.18e-2)"	"unprognostic (8.13e-2)"	"unprognostic (2.47e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.87e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.69e-1)"	0.1	1.7	2.7	0.2	1.8	0.1	28.3	11.8	1.8	123.5	480.2	0.5	0.3	1.9	7.6	3.4	187.2	2.4	0.6	14.1	4.1	153.0	0.2	193.5	0.0	5.7	7.8	0.7	7.1	17.5	8.1	36.2	3.8	1.5	0.4	0.5	219.5	15.2	0.1	2.5	0.4	0.2	3.2	0.2	33.0	0.2	7.7	0.2	45.9	0.0	0.4	0.1	0.1	2.7	0.2	0.2	0.0	0.2	0.0	0.0	64.7	0.1	0.1	0.1	0.1	44.5	46.0	0.0	45.5	0.8	0.0	0.9	2.4	2.1	0.2	0.1	1.4	1.0	444.2	1.3	0.0	0.0	0.1	1.8	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.3	0.5	0.1	0.1	2.2	0.7	0.0	0.5	15.1	0.0	476.5	0.0	0.1	3.0	1.4	7.1	0.1	38.5	65.7	0.5	0.0	0.0	8.4	0.3	0.0	0.2	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	1.8	11.8	1.8	14.1	4.1	5.7	7.8	3.8	3.2	7.7	2.7	1.0	496.8	213.3	0.0	1.3	0.9	7.9	80.3	0.0	0.0	211.3	62.9	0.2	34.3	276.3	318.2	0.0	462.2	1.1	0.0	133.1	14.3	0.1	33.6	2.3	3.4	1.8	0.0	0.0	1.4	110.9	4.3	9.7	33.7	5.1	0.0	0.0	0.0	29.5	0.0	0.0	0.1	87.5	0.0	0.4	0.0	0.6	3.8	0.0	0.0	0.0	2.2	0.0	0.0	0.0	6.7	0.0	0.0	0.0	6.3	0.0	366.0	149.1	0.1	0.0	0.1	6.3	0.0	0.5	3.2	0.1	259.0	2.2	0.3	0.3	10.4
FRMD7	"FLJ43346, NYS, NYS1"	ENSG00000165694	"FERM domain containing 7"	Q6ZUT3	X	132076990-132128020	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"endometrium 1: 2.9;kidney: 2.7;smooth muscle: 2.2"	"Cell type enriched"	"Detected in single"	19	"Distal tubular cells: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-87 MG: 1.5"	"Region enriched"	"Detected in many"	28	"olfactory bulb: 65.7"	"Region enriched"	"Detected in single"	86	"olfactory bulb: 21.3"	HPA000886	Uncertain		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 39: Non-specific - Basic cellular processes"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA000886: AB_1079269"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"			"unprognostic (1.36e-1)"	"unprognostic (3.07e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.84e-1)"	"unprognostic (3.54e-2)"			"unprognostic (3.00e-1)"			0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.0	2.9	0.5	0.0	0.5	0.0	0.1	0.1	0.1	2.7	0.4	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.1	0.2	0.0	2.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
FSHR	"FSHRO, LGR1, ODG1"	ENSG00000170820	"Follicle stimulating hormone receptor"	P23945	2	48962157-49154527	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 1.0;ovary: 2.0;testis: 2.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 10.1;Granulosa cells: 33.8;Late spermatids: 7.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA				"Cluster 21: Non-specific - Transcription"		"Cluster 40: Granulosa cells - Unknown function"													"unprognostic (5.94e-2)"			"unprognostic (4.06e-3)"		"unprognostic (5.78e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.6	0.8	2.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	1.0	0.6	0.8	0.4	0.3	0.5	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	10.1	0.0	0.0	0.1	0.0	0.0	0.0	33.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	3.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
FXN	"CyaY, FA, FARR, FRDA, X25"	ENSG00000165060	Frataxin	Q16595	9	69035751-69079076	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Heme biosynthesis, Ion transport, Iron storage, Iron transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022164, HPA068304"	Supported		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Mitochondria	Cytosol	"CAB022164: , HPA068304: AB_2685970"	"unprognostic (3.38e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.47e-2)"	"unprognostic (2.37e-3)"	"unprognostic (4.08e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.19e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.74e-2)"	10.3	20.1	8.9	7.8	9.2	29.1	10.1	9.7	8.9	9.3	11.7	10.4	7.4	12.1	12.1	9.5	10.2	5.3	27.0	9.0	10.4	12.9	46.3	7.1	9.8	9.8	10.2	17.6	15.1	22.2	8.1	9.1	9.8	10.2	12.3	4.1	11.7	13.6	25.5	5.2	7.7	13.3	9.5	12.6	10.1	10.7	9.9	5.4	10.4	19.8	10.4	12.3	7.9	10.4	27.0	22.1	34.2	17.0	15.7	23.1	34.3	18.6	16.3	28.0	21.2	11.8	16.6	45.9	14.0	19.5	28.8	28.6	41.8	42.6	34.9	53.9	47.5	66.2	14.1	87.2	26.7	48.7	27.7	25.7	33.7	27.8	29.9	9.6	37.7	28.0	50.3	43.9	26.1	25.6	14.0	21.0	47.5	53.1	42.8	32.7	24.0	32.0	32.2	21.5	26.9	12.1	19.2	12.5	20.7	24.3	14.1	14.4	22.7	18.0	32.0	24.1	27.6	11.6	11.4	27.8	8.5	39.7	18.5	8.1	39.9	0.4	48.6	45.4	37.5	36.3	48.0	48.4	42.8	22.7	61.6	59.8	1.9	60.8	36.2	33.2	43.3	49.5	8.9	9.2	9.7	8.9	9.0	10.4	9.8	10.2	9.8	9.5	9.9	10.4	11.0	3.2	11.5	13.1	19.9	9.7	19.8	36.6	14.8	6.8	16.9	20.8	38.2	10.0	10.5	14.7	4.2	39.9	14.9	4.9	21.5	17.5	2.4	11.7	22.5	16.9	7.2	56.1	14.2	14.7	22.3	14.7	14.3	8.7	7.0	15.4	11.0	69.0	33.4	0.0	18.6	15.3	18.3	22.1	16.1	6.3	15.8	13.9	17.8	9.4	18.3	7.6	28.8	6.6	10.8	15.0	3.7	13.2	42.0	17.1	5.8	27.2	7.4	1.6	13.1	10.1	19.8	5.1	32.3	29.8	8.1	14.6	17.1	27.9	17.5	14.1
FXYD1	PLM	ENSG00000266964	"FXYD domain containing ion transport regulator 1"	O00168	19	35138824-35143109	"Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1381.3;tongue: 838.7"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 225.1;Hepatocytes: 651.7;Leydig cells: 430.3;Muller glia cells: 343.4;Skeletal myocytes: 188.7;Smooth muscle cells: 205.7"	"Cancer enriched"	"Detected in many"	5	"liver cancer: 8.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"memory B-cell: 11.0"	"Group enriched"	"Detected in many"	4	"B-cells: 11.0;T-cells: 6.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 46.7;ASC TERT1: 13.5;HSkMC: 19.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026873			Approved	Nucleoplasm,Nucleoli,Cytosol		No	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA026873: AB_1855471"	"unprognostic (5.58e-3)"	"unprognostic (6.60e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (1.54e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.54e-3)"	"unprognostic (8.13e-2)"	"unprognostic (5.11e-2)"	"unprognostic (8.64e-2)"	"unprognostic (2.66e-1)"	"prognostic unfavorable (7.59e-8)"	"unprognostic (9.97e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.92e-2)"	141.4	26.1	496.5	9.6	528.9	2.2	125.1	506.1	637.3	291.9	616.5	168.3	14.3	173.3	62.1	70.7	187.3	56.3	557.7	487.5	503.4	28.6	558.7	85.8	6.6	568.0	515.0	144.7	19.2	3.8	39.8	29.3	494.8	116.0	25.6	35.9	37.2	73.5	1381.3	48.3	67.2	104.5	511.1	20.8	72.6	12.1	560.2	8.2	38.0	838.7	6.7	80.0	194.9	498.6	1.1	0.0	0.0	0.2	46.7	13.5	1.3	5.7	0.1	0.0	0.0	0.0	0.3	3.8	1.5	0.0	0.1	1.0	1.1	0.7	0.0	3.4	1.3	0.7	0.0	1.9	5.2	0.3	0.4	19.3	0.0	0.1	0.5	0.5	0.2	0.1	1.0	3.7	0.1	0.0	0.1	0.8	0.2	2.8	0.6	0.0	0.2	1.1	0.0	0.0	0.3	0.2	0.7	0.2	1.8	0.3	0.2	6.1	0.5	0.1	0.5	0.4	0.0	0.1	0.0	0.4	0.9	0.6	7.7	1.6	0.3	0.0	1.3	0.7	0.8	11.0	3.6	1.5	0.3	6.9	0.7	0.9	0.5	2.1	0.8	0.6	6.9	0.6	496.5	528.9	506.1	637.3	487.5	503.4	568.0	515.0	494.8	511.1	560.2	498.6	46.1	0.0	0.0	44.4	15.8	29.4	3.7	2.7	8.0	1.8	4.4	18.0	0.3	11.5	0.8	25.8	4.2	1.2	9.5	42.2	0.0	0.1	1.9	2.2	47.4	13.3	0.0	8.4	3.7	4.9	1.6	225.1	2.0	1.2	0.0	0.1	36.0	651.7	4.4	0.0	0.4	0.8	2.0	14.4	49.0	12.0	430.3	5.3	53.4	2.8	1.0	343.4	1.0	1.5	0.5	1.1	5.3	128.2	2.5	3.3	0.4	0.2	12.6	8.6	118.3	188.7	205.7	10.7	21.7	3.0	27.3	2.9	18.8	0.1	0.7	2.5
FXYD2	"ATP1G1, HOMG2, MGC12372"	ENSG00000137731	"FXYD domain containing ion transport regulator 2"	P54710	11	117800844-117828698	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"		"Disease variant, FDA approved drug targets, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 3645.4"	"Group enriched"	"Detected in many"	5	"Cholangiocytes: 1595.6;Distal tubular cells: 2952.4;Ductal cells: 892.8;Proximal tubular cells: 3423.7"	"Cancer enriched"	"Detected in some"	8	"renal cancer: 49.9"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in many"	4	"memory CD8 T-cell: 14.8;naive CD4 T-cell: 5.1;naive CD8 T-cell: 4.3;NK-cell: 9.6;plasmacytoid DC: 3.8"	"Group enriched"	"Detected in many"	7	"dendritic cells: 3.8;NK-cells: 9.6;T-cells: 14.8"	"Group enriched"	"Detected in some"	25	"MOLT-4: 2255.4;RPTEC TERT1: 4711.9"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"spinal cord: 27.7"	"HPA064218, HPA068838"	Supported		Approved	Mitochondria		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA064218: AB_2685214, HPA068838: AB_2686047"	"unprognostic (4.11e-4)"	"unprognostic (1.14e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.36e-3)"	"unprognostic (1.09e-3)"	"unprognostic (2.30e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.62e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.24e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (3.23e-9)"	"unprognostic (3.22e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.62e-1)"	"unprognostic (3.00e-2)"	2.0	0.9	0.7	1.4	0.6	3.3	1.2	1.4	1.7	1.0	0.0	2.1	1.4	1.5	1.2	0.8	1.8	353.1	1.2	0.8	0.0	3645.4	23.8	4.4	8.9	0.0	0.1	2.4	612.6	0.2	1.6	0.8	0.0	1.7	0.8	1.1	835.6	0.7	0.3	1.0	1.6	2.2	0.0	3.1	2.8	0.6	0.0	74.8	1.0	0.6	4.5	1.8	0.9	0.4	0.0	118.6	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.4	3.5	0.0	0.2	0.4	0.2	0.0	0.3	0.2	0.0	0.1	0.2	83.6	0.1	0.2	0.7	0.0	0.0	0.0	0.0	0.0	1.9	140.3	0.0	0.0	0.2	0.3	2255.4	0.0	1.2	0.0	0.0	0.6	0.0	4.6	4711.9	0.0	1.9	0.0	0.0	2.9	0.2	0.2	0.8	0.3	0.8	0.0	1.3	0.5	0.0	1.0	0.3	0.2	0.1	0.2	0.0	0.0	1.2	0.0	1.0	0.0	1.0	0.2	1.8	14.8	0.2	0.3	5.1	4.3	0.0	9.6	0.0	3.8	1.7	2.1	0.7	0.6	1.4	1.7	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.4	1.0	0.0	0.6	0.0	33.6	1.1	0.1	0.8	0.6	0.2	0.1	0.5	1.2	1595.6	0.1	435.9	0.0	0.1	0.7	0.0	2952.4	892.8	21.8	1.6	4.1	2.2	15.1	2.7	0.0	10.0	0.1	3.5	0.5	41.3	0.0	0.6	4.2	3.9	3.6	0.0	0.0	0.3	16.2	4.5	4.1	25.9	9.3	24.8	0.0	0.0	8.8	0.5	1.0	0.0	0.0	23.2	0.0	7.5	0.4	0.2	0.0	3423.7	0.1	3.3	6.6	1.6	3.8	0.3	0.3	0.2	0.9	0.3	27.7	1.2	0.1	0.0
FXYD3	"MAT-8, PLML"	ENSG00000089356	"FXYD domain containing ion transport regulator 3"	Q14802	19	35115879-35124324	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 1800.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 1870.8;Distal enterocytes: 5605.4;Intestinal goblet cells: 2165.8;Paneth cells: 3324.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 896.3;hTCEpi: 1603.2;OE19: 3112.0;RT4: 860.2;SK-BR-3: 830.8;WM-115: 589.7"									HPA010856	Supported		Approved	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Plasma membrane"	"HPA010856: AB_1078915"	"unprognostic (2.18e-3)"	"unprognostic (2.78e-2)"	"unprognostic (8.37e-3)"	"unprognostic (3.31e-3)"	"unprognostic (6.38e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.64e-3)"	"unprognostic (1.60e-1)"	"unprognostic (3.59e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-2)"	"unprognostic (3.88e-1)"	"prognostic unfavorable (1.15e-6)"	"unprognostic (4.17e-2)"	"unprognostic (2.08e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.69e-3)"	5.1	1.1	7.3	59.5	7.4	1.3	225.2	7.1	7.9	168.0	7.5	1466.2	102.7	13.2	15.2	685.3	104.3	100.5	5.8	7.1	6.5	12.0	2.0	150.2	0.8	8.0	7.3	1.8	64.3	0.1	24.7	84.9	6.8	512.1	1800.0	45.4	569.1	33.3	2.1	568.3	308.9	35.7	6.7	0.6	572.4	0.6	7.0	18.7	1.5	0.1	163.3	295.6	395.8	7.4	166.3	0.0	0.0	0.4	0.6	0.4	150.5	0.0	0.0	0.0	0.0	6.0	235.3	0.3	0.5	0.0	1.3	896.3	0.1	339.5	0.0	0.1	0.3	1.0	7.7	0.6	0.1	0.1	0.6	0.0	1603.2	0.0	0.7	0.1	0.1	0.1	0.1	1.1	0.0	304.5	0.8	2.2	0.8	3112.0	1.4	0.8	0.4	1.2	0.0	860.2	190.2	2.1	1.0	830.8	61.8	2.3	155.9	0.2	0.0	0.3	0.6	0.9	0.7	0.1	0.4	0.7	1.0	0.3	589.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	7.3	7.4	7.1	7.9	7.1	6.5	8.0	7.3	6.8	6.7	7.0	7.4	3.1	762.8	262.6	0.3	11.1	576.9	792.9	1870.8	340.4	2.9	557.5	515.7	1.3	201.6	1026.4	134.3	0.0	883.5	8.3	5605.4	1.9	35.6	0.4	180.1	29.5	19.7	974.3	2.7	0.1	708.4	138.1	20.3	356.8	194.1	22.3	0.0	0.0	0.9	81.4	1.7	0.0	2165.8	587.9	0.0	68.3	0.0	0.0	15.6	412.6	0.0	1.6	422.1	0.0	0.0	0.6	556.5	3324.0	0.0	6.5	1041.7	1693.0	0.5	1627.1	13.3	0.0	0.5	66.5	0.2	0.2	541.1	865.5	1512.1	17.9	0.0	1499.3	1509.9
FXYD4	CHIF	ENSG00000150201	"FXYD domain containing ion transport regulator 4"	P59646	10	43371636-43376335	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	43	"kidney: 297.7"	"Cell type enriched"	"Detected in some"	107	"Collecting duct cells: 5039.3"	"Group enriched"	"Detected in many"	5	"renal cancer: 10.7;urothelial cancer: 20.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	29	"SuSa: 10.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA058421	Enhanced		Uncertain	Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol		"HPA058421: AB_2683714"	"unprognostic (2.92e-3)"	"unprognostic (5.25e-1)"	"unprognostic (9.46e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.85e-1)"		"unprognostic (2.32e-1)"		"unprognostic (2.00e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.19e-1)"	"unprognostic (6.12e-2)"	"unprognostic (7.88e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.20e-1)"	"unprognostic (2.09e-2)"	0.1	0.0	1.5	0.0	2.6	0.0	0.0	1.5	2.7	0.0	1.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.3	1.4	2.0	297.7	0.0	1.1	0.0	1.6	2.2	0.0	0.0	0.0	0.1	0.0	1.7	0.1	0.0	0.0	5.6	2.7	1.3	0.0	0.0	0.0	1.4	0.0	6.9	0.8	2.2	0.0	0.0	0.4	0.0	1.7	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	2.6	1.5	2.7	1.4	2.0	1.6	2.2	1.7	1.4	2.2	2.7	0.0	6.4	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.1	5039.3	0.0	0.5	0.0	0.5	46.9	0.0	2.6	6.4	2.6	0.0	0.0	0.0	0.0	0.2	0.1	0.4	9.2	15.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.9	0.0	0.0	0.0	11.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.2	0.1	0.1	8.0	0.0	0.0	0.0	0.0	0.1	1.4	0.1	0.0	0.0	0.4	0.3	0.1	1.0	1.4
FXYD5	OIT2	ENSG00000089327	"FXYD domain containing ion transport regulator 5"	Q96DB9	19	35154730-35169881	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 462.9;Hofbauer cells: 430.3;Langerhans cells: 492.1;Pancreatic endocrine cells: 585.0;T-cells: 459.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in many"			HPA010817	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Endoplasmic reticulum"		"HPA010817: AB_1849214"	"unprognostic (3.97e-3)"	"unprognostic (5.49e-2)"	"unprognostic (6.37e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.39e-3)"	"unprognostic (4.68e-2)"	"unprognostic (1.56e-3)"	"unprognostic (3.85e-1)"	"unprognostic (5.66e-3)"	"unprognostic (4.78e-2)"	"unprognostic (4.75e-2)"	"prognostic unfavorable (3.71e-9)"	"unprognostic (6.07e-2)"	"unprognostic (7.88e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.74e-1)"	203.1	39.2	30.8	130.8	31.0	275.2	171.1	31.9	47.2	226.2	36.9	59.0	28.6	75.5	20.1	116.1	103.6	68.8	82.3	29.9	36.6	42.0	40.2	148.5	187.4	43.4	34.7	28.6	28.0	17.2	39.8	91.7	37.9	68.8	43.3	3.5	70.3	46.5	28.6	85.8	106.6	59.8	35.4	238.3	67.9	9.2	40.0	85.0	59.2	32.6	187.8	104.8	183.8	39.9	932.2	216.7	0.2	0.9	310.5	390.2	213.6	521.7	686.4	362.8	269.3	61.9	263.6	212.9	139.3	632.2	130.3	212.3	132.5	321.3	231.4	265.7	87.9	397.7	111.8	0.5	244.3	228.6	378.0	233.6	141.6	265.3	452.2	213.2	348.5	58.0	380.0	989.0	229.5	1.5	27.4	95.1	66.4	853.4	126.0	127.6	45.0	272.7	134.0	5.2	38.8	0.3	287.1	148.6	316.6	115.0	78.0	180.4	494.8	443.6	170.0	487.7	40.2	1.5	16.2	54.4	675.9	524.8	694.4	644.0	596.4	111.1	451.5	628.4	422.0	602.8	756.5	467.4	718.7	545.6	489.2	405.6	140.1	840.8	636.9	325.0	894.6	934.1	30.8	31.0	31.9	47.2	29.9	36.6	43.4	34.7	37.9	35.4	40.0	39.9	291.0	3.2	13.4	0.0	330.7	107.1	73.4	106.3	54.1	0.6	80.2	51.2	5.2	32.9	27.8	99.3	0.0	18.9	349.7	2.9	0.0	156.1	1.7	3.4	63.5	276.5	10.7	111.2	2.2	197.3	462.9	93.1	71.9	2.2	361.5	0.3	323.8	6.1	430.3	0.0	0.4	8.2	4.1	385.9	492.1	4.6	6.5	403.9	209.9	10.3	243.7	0.4	260.6	1.0	0.1	585.0	7.8	0.7	302.5	72.2	0.2	4.4	5.5	0.4	65.7	5.7	107.6	1.6	8.1	24.0	69.2	50.9	459.5	0.7	10.0	100.3
FXYD6		ENSG00000137726	"FXYD domain containing ion transport regulator 6"	Q9H0Q3	11	117836976-117877486	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	Schizophrenia	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 163.9;Leydig cells: 237.9;Muller glia cells: 128.7;Peritubular cells: 363.8;Sertoli cells: 355.0;Theca cells: 141.8"	"Cancer enriched"	"Detected in all"	6	"glioma: 71.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"classical monocyte: 37.7"	"Lineage enriched"	"Detected in many"	6	"monocytes: 37.7"	"Cell line enhanced"	"Detected in some"		"AF22: 136.0;HAP1: 92.9;RH-30: 57.1;SCLC-21H: 204.5;SH-SY5Y: 114.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041334, HPA042284"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Cytosol"		"HPA041334: AB_10970752, HPA042284: AB_2677931"	"unprognostic (2.18e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (1.05e-5)"	"unprognostic (3.31e-2)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.87e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.78e-2)"	"unprognostic (1.07e-2)"	"prognostic favorable (5.97e-4)"	"unprognostic (3.44e-2)"	"prognostic favorable (4.38e-5)"	"unprognostic (4.64e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.60e-4)"	58.4	116.3	230.8	30.1	258.5	9.8	39.5	82.5	293.2	112.3	28.1	371.1	22.2	321.5	61.0	29.8	181.6	93.1	117.1	244.3	187.3	70.6	32.8	86.6	30.0	91.8	173.6	281.1	30.1	9.8	175.0	16.7	149.5	107.8	35.9	47.1	29.5	73.2	37.3	22.2	104.6	197.6	71.4	151.9	98.9	86.6	136.4	31.2	66.5	78.3	18.9	202.9	80.4	179.3	0.3	0.9	136.0	2.5	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.6	0.1	4.8	0.7	92.9	0.0	0.0	0.0	8.7	0.0	0.0	0.0	0.3	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	2.2	0.2	2.6	0.0	1.7	6.3	0.5	27.2	0.0	0.0	0.1	57.1	1.0	3.5	0.1	204.5	114.0	0.0	0.5	5.1	36.9	2.4	2.4	0.0	0.0	30.0	0.5	0.0	0.4	0.3	0.1	1.0	0.4	0.4	0.0	37.7	0.0	0.0	9.4	0.6	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.9	0.0	0.1	0.6	0.0	9.9	230.8	258.5	82.5	293.2	244.3	187.3	91.8	173.6	149.5	71.4	136.4	179.3	72.2	6.4	2.2	0.0	1.1	6.6	2.4	1.1	0.6	3.5	2.1	21.5	9.3	1.5	0.7	0.0	2.1	0.8	1.0	0.0	1.9	6.4	3.6	0.6	23.9	71.8	12.5	10.7	0.0	0.4	1.1	78.6	0.5	1.0	0.0	29.7	163.9	1.6	72.7	1.7	0.0	0.2	6.1	32.4	9.6	14.3	237.9	18.7	16.0	0.0	9.8	128.7	1.0	0.0	0.0	0.4	0.0	363.8	1.2	4.9	0.0	0.1	1.7	4.4	355.0	49.6	79.6	4.6	3.5	1.4	3.8	1.4	1.4	141.8	0.0	1.7
FXYD7		ENSG00000221946	"FXYD domain containing ion transport regulator 7"	P58549	19	35143250-35154302	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"brain: 273.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 14.0;Excitatory neurons: 42.0;Inhibitory neurons: 12.9;Microglial cells: 9.4;T-cells: 19.2"	"Cancer enhanced"	"Detected in some"		"glioma: 4.2;ovarian cancer: 3.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 52.1"	"Group enriched"	"Detected in many"	23	"B-cells: 19.0;NK-cells: 52.1;T-cells: 23.7"	"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HMC-1: 5.3;Karpas-707: 2.0;NTERA-2: 1.5;WM-115: 3.1"									HPA026916	Approved					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA026916: AB_1849217"	"unprognostic (1.25e-3)"	"unprognostic (8.73e-3)"	"unprognostic (4.64e-2)"	"unprognostic (6.95e-4)"	"unprognostic (8.47e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.13e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.90e-1)"	"unprognostic (3.08e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (6.90e-5)"	"unprognostic (1.51e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.37e-1)"	2.1	0.4	119.1	1.7	140.3	0.6	1.1	45.1	273.1	5.8	37.8	2.7	0.6	1.9	0.0	0.4	0.9	0.4	0.7	153.8	75.1	0.4	1.1	1.1	2.8	124.3	83.1	1.0	0.2	0.0	2.1	0.1	129.5	1.0	0.2	1.6	0.5	0.3	2.7	1.3	2.0	0.2	70.1	2.8	1.0	1.3	101.6	0.2	0.5	0.1	1.5	0.8	3.1	185.5	0.6	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.3	0.5	0.1	0.0	0.0	0.2	1.8	0.0	0.2	0.3	0.1	0.2	0.6	0.0	0.1	0.0	5.3	0.4	0.0	0.0	0.0	0.1	0.1	0.1	0.5	2.0	0.0	0.0	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.0	0.5	0.2	0.0	0.0	0.2	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.4	0.1	3.1	0.0	0.0	0.0	15.0	0.0	9.5	19.0	23.7	17.2	0.1	14.6	7.5	13.8	0.6	52.1	0.1	1.3	7.5	4.9	119.1	140.3	45.1	273.1	153.8	75.1	124.3	83.1	129.5	70.1	101.6	185.5	1.1	0.0	1.3	7.2	8.0	2.0	0.1	0.0	0.0	0.0	0.4	0.6	0.1	0.0	0.0	1.8	0.0	0.0	14.0	0.0	0.0	0.0	0.1	0.0	1.0	0.9	0.0	0.4	42.0	0.2	0.1	1.1	0.0	0.0	1.3	0.1	0.7	0.2	0.1	1.7	12.9	0.0	0.0	0.0	4.4	0.2	1.2	0.7	3.6	9.4	0.2	1.5	0.0	3.5	6.2	0.2	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	6.6	0.7	1.1	3.1	5.0	0.1	1.1	0.3	19.2	0.0	0.0	0.0
FZD1	DKFZp564G072	ENSG00000157240	"Frizzled class receptor 1"	Q9UP38	7	91264433-91271326	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 44.9;Cholangiocytes: 45.8;Horizontal cells: 141.3;Peritubular cells: 45.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.0;non-classical monocyte: 2.8"	"Lineage enriched"	"Detected in single"	5	"monocytes: 2.8"	"Cell line enhanced"	"Detected in many"		"AF22: 24.8;HSkMC: 32.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB013008	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"		"CAB013008: "	"unprognostic (1.46e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.15e-1)"	"unprognostic (3.16e-2)"	"unprognostic (4.51e-3)"	"unprognostic (2.09e-1)"	"unprognostic (5.29e-3)"	"unprognostic (3.70e-2)"	"unprognostic (2.36e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.14e-1)"	"unprognostic (7.39e-3)"	"prognostic favorable (8.87e-7)"	"unprognostic (1.05e-2)"	"unprognostic (4.16e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.13e-2)"	5.4	4.4	2.4	2.7	2.5	1.1	10.7	5.8	2.4	9.9	11.1	5.9	5.1	8.6	4.3	5.2	5.5	5.7	12.7	4.7	2.9	9.6	2.5	10.7	1.3	2.5	6.2	10.1	4.7	2.4	3.9	10.0	2.3	10.3	3.7	2.0	9.0	16.4	1.9	10.4	5.1	5.3	2.3	3.2	4.6	1.6	3.4	1.8	20.5	2.4	1.3	6.4	11.2	2.0	0.8	2.5	24.8	2.6	19.8	17.0	4.5	9.2	5.8	3.3	2.3	1.1	4.3	0.0	2.2	5.9	4.2	4.7	3.9	2.0	2.2	0.0	4.9	0.2	4.6	1.3	1.4	4.2	1.0	32.3	3.6	7.6	2.4	12.6	0.7	2.8	1.5	3.6	9.7	6.2	0.8	1.1	6.4	1.3	4.2	5.1	15.3	0.4	5.3	11.8	3.4	6.5	7.0	5.6	1.6	5.7	3.0	3.8	3.8	13.9	10.4	15.0	3.8	3.3	2.5	0.4	15.0	3.5	16.5	0.0	0.6	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.2	2.4	2.5	5.8	2.4	4.7	2.9	2.5	6.2	2.3	2.3	3.4	2.0	5.7	3.2	1.5	4.6	1.1	4.2	44.9	7.0	10.8	1.6	27.7	29.5	18.5	45.8	4.6	12.9	2.1	3.4	0.6	7.4	0.0	4.3	0.3	12.0	13.1	4.5	3.5	0.8	0.6	2.0	2.2	18.5	2.0	15.7	12.7	1.8	15.4	0.9	3.5	141.3	1.0	3.0	4.1	17.4	16.2	1.1	33.2	14.3	17.8	1.9	4.6	3.0	1.0	1.0	0.2	1.9	4.8	45.1	0.4	11.7	6.0	11.6	2.4	2.9	0.0	6.2	10.3	0.5	3.7	9.1	5.1	2.1	0.6	2.6	4.6	7.3
GABARAP	"ATG8A, MM46"	ENSG00000170296	"GABA type A receptor-associated protein"	O95166	17	7240008-7242449	"Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 498.6;Ductal cells: 462.5;Plasma cells: 482.6;Squamous epithelial cells: 457.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065883			Approved	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA065883: AB_2685574"	"unprognostic (2.58e-1)"	"unprognostic (4.55e-3)"	"unprognostic (1.92e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.58e-1)"	"prognostic favorable (9.52e-5)"	"unprognostic (1.85e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.22e-2)"	"unprognostic (1.58e-1)"	609.8	848.2	777.0	344.7	799.2	478.8	610.9	826.8	1091.7	696.5	776.2	600.1	292.4	548.9	574.9	479.4	561.2	302.8	740.4	753.9	807.5	741.1	625.2	569.8	308.5	819.2	790.0	751.1	732.2	662.1	851.7	302.2	829.3	604.6	372.4	280.6	592.3	385.4	1001.1	662.8	496.8	341.4	817.6	651.6	658.9	604.5	803.0	389.2	552.3	916.4	411.0	534.0	547.5	862.7	233.5	342.1	598.0	404.5	887.1	999.5	227.0	377.1	645.5	330.1	491.2	141.9	200.6	233.9	233.2	672.0	430.6	206.9	428.1	329.7	441.7	421.8	474.4	182.8	301.3	377.3	858.3	118.7	369.6	1016.1	445.4	424.5	378.9	925.6	623.7	350.0	143.6	256.8	577.5	159.4	288.4	267.6	242.0	420.9	329.1	393.8	273.3	318.8	682.9	240.9	262.8	695.8	284.1	262.5	409.4	439.3	333.4	228.4	563.7	363.6	211.1	357.7	314.8	280.6	294.2	152.6	586.1	296.2	383.5	2968.2	4092.7	3746.6	766.9	3665.8	796.1	1262.2	906.3	810.4	3152.3	1156.6	812.9	765.5	7095.7	734.6	3213.5	2410.2	1132.5	4745.4	777.0	799.2	826.8	1091.7	753.9	807.5	819.2	790.0	829.3	817.6	803.0	862.7	24.0	89.8	120.1	44.4	183.6	20.8	3.9	21.3	498.6	2.4	64.1	31.9	0.5	54.3	81.3	27.6	0.0	24.3	35.8	302.0	43.0	462.5	24.1	25.5	32.4	61.5	396.5	179.3	36.7	309.6	31.1	124.2	264.6	24.8	150.0	6.9	45.0	39.9	78.2	1.7	37.7	314.3	34.6	147.0	60.8	71.3	21.1	397.4	33.8	43.1	399.2	15.1	32.0	21.1	87.8	375.2	374.3	13.9	482.6	6.0	384.7	72.0	166.4	3.0	6.6	5.2	74.2	22.1	5.8	457.2	23.2	52.9	105.2	5.2	237.1	4.9
GABBR2	"GABABR2, GPR51, GPRC3B, HG20"	ENSG00000136928	"Gamma-aminobutyric acid type B receptor subunit 2"	O75899	9	98288109-98708935	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 90.4"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 386.5;Inhibitory neurons: 395.1"	"Group enriched"	"Detected in many"	10	"glioma: 7.2;thyroid cancer: 11.6;urothelial cancer: 3.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 14.6;fHDF/TERT166: 7.3;HUVEC TERT2: 29.5;U-138 MG: 11.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013820, HPA031684, CAB079065"	Enhanced	Approved				NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB079065: , HPA013820: AB_1849364, HPA031684: AB_2673993"	"unprognostic (2.00e-1)"	"unprognostic (7.56e-2)"	"unprognostic (3.75e-1)"	"unprognostic (3.09e-5)"	"unprognostic (2.52e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.66e-1)"	"unprognostic (4.43e-2)"	"unprognostic (1.43e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.68e-2)"	"unprognostic (3.45e-2)"	0.0	3.6	26.0	0.2	40.8	0.0	0.0	10.6	90.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.6	39.9	18.0	0.0	0.0	0.3	0.0	12.7	19.6	0.0	0.1	0.2	0.6	0.1	12.5	0.0	0.0	8.5	0.0	0.1	2.8	0.2	0.0	0.1	8.3	0.0	0.2	0.6	39.5	0.0	1.4	0.5	0.2	0.5	0.0	36.3	0.0	0.0	0.0	0.0	0.1	0.1	1.2	14.6	2.9	3.0	5.5	0.1	0.1	0.0	0.9	7.3	0.6	0.0	0.1	0.2	1.0	0.0	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.4	0.0	0.9	0.2	0.0	29.5	0.0	0.3	0.1	0.0	0.4	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	4.0	0.0	0.1	3.5	0.0	0.0	0.0	0.1	1.2	11.5	0.7	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	26.0	40.8	10.6	90.4	39.9	18.0	12.7	19.6	12.5	8.3	39.5	36.3	0.1	0.0	0.0	14.0	0.0	0.1	0.0	0.0	0.0	86.4	0.5	0.1	1.9	0.0	0.1	0.0	0.0	0.5	0.0	0.1	0.0	0.0	90.3	0.1	0.0	0.6	0.0	0.0	386.5	0.2	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	395.1	0.0	0.0	0.0	0.0	34.5	0.3	0.1	1.8	11.2	0.0	1.8	0.0	26.2	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	7.4	0.0	0.3	1.3	0.7	0.9	0.0	0.1	0.4	0.0	0.3	0.1	0.0
GABRA1	EJM5	ENSG00000022355	"Gamma-aminobutyric acid type A receptor subunit alpha1"	P14867	5	161847063-161899981	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	30	"brain: 55.1;retina: 17.8"	"Group enriched"	"Detected in some"	11	"Bipolar cells: 198.0;Excitatory neurons: 220.5;Inhibitory neurons: 215.2"	"Cancer enriched"	"Detected in single"	5	"glioma: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022502, HPA029363, HPA055746"	Enhanced	Supported	Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Nucleoplasm	"CAB022502: , HPA029363: , HPA055746: AB_2682904"					"unprognostic (2.58e-2)"						"unprognostic (4.78e-3)"	"unprognostic (1.84e-1)"		"unprognostic (3.31e-1)"		"unprognostic (2.43e-1)"		0.0	1.2	6.7	0.0	11.1	0.0	0.0	24.8	55.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	7.7	21.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	17.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	14.3	0.6	0.0	0.0	0.2	0.0	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	11.1	24.8	55.1	7.7	21.7	0.0	0.0	0.0	0.0	14.3	24.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	198.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	220.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	215.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	17.8	0.0	3.5	0.0	8.0	16.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	9.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GABRA2		ENSG00000151834	"Gamma-aminobutyric acid type A receptor subunit alpha2"	P47869	4	46243548-46475230	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 31.5;epididymis: 8.8"	"Group enriched"	"Detected in many"	5	"Astrocytes: 425.4;Excitatory neurons: 156.2;Inhibitory neurons: 111.6"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.6;glioma: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"U-2 OS: 4.2;U-87 MG: 2.1;WM-115: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029363, CAB079061"		Supported	Uncertain	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"CAB079061: , HPA029363: "	"unprognostic (2.03e-2)"		"unprognostic (2.77e-1)"	"unprognostic (2.45e-4)"	"unprognostic (6.87e-3)"	"unprognostic (2.65e-1)"		"unprognostic (2.08e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.90e-3)"	"unprognostic (8.83e-2)"	"unprognostic (2.22e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.04e-2)"	1.2	0.3	20.2	0.4	29.9	0.2	1.3	2.6	31.5	0.5	0.0	3.0	0.9	0.4	8.8	0.7	0.0	0.5	0.2	29.4	16.0	6.3	0.4	0.1	0.3	0.3	1.9	0.7	0.1	0.0	0.5	0.4	0.0	0.1	2.1	2.4	0.2	0.7	0.1	0.2	6.0	0.2	1.3	1.2	0.5	0.5	13.8	0.4	0.1	0.1	0.4	0.2	0.7	8.8	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.4	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	4.2	0.2	0.0	0.2	0.6	0.0	2.1	0.1	2.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	20.2	29.9	2.6	31.5	29.4	16.0	0.3	1.9	0.0	1.3	13.8	8.8	4.9	0.0	0.0	425.4	0.0	0.1	0.0	0.0	1.2	15.3	0.2	0.0	0.6	0.0	0.0	40.5	4.2	0.0	0.0	23.1	3.9	0.0	9.1	1.2	31.7	1.0	31.8	0.0	156.2	0.0	0.0	0.5	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	111.6	3.4	0.0	0.0	0.0	17.1	0.6	0.1	1.8	16.9	0.0	0.2	0.0	13.0	5.5	0.0	4.7	0.0	0.0	0.0	38.1	0.1	0.0	1.1	0.0	0.0	0.2	0.0	1.3	0.0	0.1	0.0	0.1	0.0	2.7	0.0
GABRA3		ENSG00000011677	"Gamma-aminobutyric acid type A receptor subunit alpha3"	P34903	X	152166234-152451315	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 15.5;choroid plexus: 16.3;retina: 9.0"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 70.3;Hofbauer cells: 16.2;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 58.3"	"Cancer enriched"	"Detected in many"	7	"testis cancer: 16.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 9.9;HMC-1: 8.4;Karpas-707: 14.4;PC-3: 8.4;U-266/70: 7.7;U-266/84: 13.6;U-87 MG: 8.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000839, HPA029363"	Approved	Supported	Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"HPA000839: AB_1078929, HPA029363: "	"unprognostic (9.63e-3)"	"unprognostic (2.04e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.18e-2)"	"unprognostic (7.07e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.34e-6)"	"unprognostic (1.24e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (7.29e-6)"	"unprognostic (7.42e-3)"	"unprognostic (6.20e-2)"		"unprognostic (8.13e-2)"	0.0	0.0	10.0	0.0	13.7	0.0	0.0	0.0	13.2	0.9	16.3	0.1	0.1	0.3	0.0	0.4	0.0	0.0	0.0	9.6	15.5	0.0	0.0	0.0	0.0	0.9	4.0	0.0	0.0	0.0	0.6	2.9	3.0	0.1	0.0	9.0	0.1	0.6	0.0	0.2	0.1	0.0	0.6	0.0	0.0	0.7	11.2	0.0	0.0	0.0	0.1	0.4	0.2	2.7	0.0	0.8	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	14.4	0.0	0.0	0.0	0.0	2.6	6.4	8.4	0.0	0.0	0.0	0.0	0.0	0.2	5.2	0.0	5.3	0.4	0.3	0.1	1.3	0.1	5.3	7.0	0.3	1.6	7.7	13.6	0.0	8.4	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	13.7	0.0	13.2	9.6	15.5	0.9	4.0	3.0	0.6	11.2	2.7	0.0	0.0	0.0	3.6	0.0	0.0	0.1	0.0	0.6	1.2	0.0	0.0	0.3	0.0	0.0	0.0	2.1	3.2	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.1	0.0	0.0	70.3	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	16.2	1.7	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	3.0	0.0	58.3	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	1.2	0.9	0.0	1.9	0.0	0.0	0.0	0.5
GABRB2		ENSG00000145864	"Gamma-aminobutyric acid type A receptor subunit beta2"	P47870	5	161288429-161549044	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 71.7"	"Group enriched"	"Detected in many"	20	"Excitatory neurons: 570.3;Inhibitory neurons: 780.2"	"Cancer enriched"	"Detected in some"	20	"thyroid cancer: 10.2"	"Group enriched"	"Detected in many"	7	"cerebellum: 63.2;cerebral cortex: 71.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SCLC-21H: 22.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001964, HPA067632"	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB001964: , HPA067632: AB_2685874"	"unprognostic (5.46e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.26e-6)"	"unprognostic (2.33e-2)"	"unprognostic (6.65e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.19e-3)"	"unprognostic (2.24e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.18e-3)"	"unprognostic (1.04e-2)"	0.7	2.3	0.6	0.0	5.8	0.0	0.1	63.2	71.7	0.5	0.0	0.6	1.2	0.1	3.4	0.0	0.4	0.0	0.1	9.2	10.0	1.8	0.0	0.9	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.2	0.0	0.1	1.1	6.5	0.5	0.6	0.1	0.1	0.6	0.1	0.0	2.4	0.5	0.6	7.9	0.1	0.5	0.4	0.0	0.0	0.0	9.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	2.2	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	5.8	63.2	71.7	9.2	10.0	0.0	0.0	0.0	0.0	7.9	9.5	0.0	0.0	0.0	21.5	0.0	0.3	0.0	0.1	0.0	19.8	0.1	0.0	1.9	0.0	0.0	0.0	27.1	0.0	0.0	1.0	5.9	0.0	1.6	0.0	0.3	0.3	1.2	0.0	570.3	0.0	0.0	2.6	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	780.2	1.8	4.1	0.0	0.4	1.4	0.0	1.3	0.0	20.6	0.0	2.3	0.0	33.7	17.9	0.0	0.5	0.4	0.0	0.1	0.0	3.2	0.0	10.6	0.0	0.3	3.5	3.1	1.8	0.1	0.4	0.0	0.0	1.9	4.2	0.1
GABRB3		ENSG00000166206	"Gamma-aminobutyric acid type A receptor subunit beta3"	P28472	15	26543546-26939539	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 29.5;retina: 31.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 152.4;Excitatory neurons: 519.6;Inhibitory neurons: 258.7;Oligodendrocyte precursor cells: 139.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 68.5;HAP1: 27.9;NTERA-2: 48.3;OE19: 21.6;SCLC-21H: 44.2;U-2 OS: 18.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.72e-1)"	"unprognostic (4.91e-2)"	"unprognostic (3.20e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.07e-2)"	"unprognostic (1.00e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (3.62e-1)"	"unprognostic (3.56e-3)"	"unprognostic (2.99e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.33e-2)"	"unprognostic (4.05e-1)"	0.6	5.5	16.6	0.5	24.3	0.0	0.8	3.9	29.5	2.3	0.0	1.2	0.8	1.7	1.0	1.2	2.3	13.6	6.2	28.0	18.0	7.3	0.9	0.9	0.1	0.0	1.3	1.9	4.8	2.1	15.7	0.0	0.3	5.0	0.9	31.9	0.5	1.2	0.1	0.7	0.6	1.4	3.1	0.6	5.7	4.0	11.6	1.5	8.7	0.1	0.2	1.1	0.5	13.8	0.0	68.5	10.7	0.0	0.0	0.0	2.6	1.1	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.0	27.9	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.1	0.0	5.4	3.3	0.0	0.0	0.0	0.0	0.0	14.8	2.1	0.1	0.0	0.0	4.8	0.0	48.3	21.6	3.4	0.0	0.0	0.0	4.7	0.0	44.2	16.6	0.0	0.1	0.0	5.0	0.1	0.0	0.0	0.0	18.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.6	24.3	3.9	29.5	28.0	18.0	0.0	1.3	0.3	3.1	11.6	13.8	0.4	12.8	3.6	33.3	0.0	0.0	0.8	0.7	1.2	152.4	1.0	0.8	15.3	24.3	1.7	5.5	39.6	0.4	0.0	1.4	0.0	4.6	10.7	1.4	4.0	1.2	10.3	0.0	519.6	0.4	0.0	1.7	2.6	0.6	0.0	1.1	0.7	0.4	0.0	75.7	258.7	1.9	0.0	0.6	0.0	5.6	1.8	0.0	0.0	5.6	0.2	7.9	0.0	139.7	8.7	1.7	0.4	3.4	0.0	3.3	0.2	7.0	13.5	53.7	0.0	1.0	0.9	8.6	29.3	0.7	0.1	0.3	0.1	0.5	0.9	0.4
GABRG2		ENSG00000113327	"Gamma-aminobutyric acid type A receptor subunit gamma2"	P18507	5	162000057-162162977	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 20.0;retina: 10.9"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 119.0;Excitatory neurons: 239.9;Inhibitory neurons: 167.8"	"Cancer enhanced"	"Detected in single"		"glioma: 1.4"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.5"	"Group enriched"	"Detected in many"	5	"B-cells: 1.6;granulocytes: 4.5;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"CACO-2: 10.3;Karpas-707: 10.2;RPMI-8226: 13.4;SuSa: 13.0;U-266/70: 20.1;U-266/84: 18.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB079060		Supported				NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB079060: "					"unprognostic (2.88e-2)"			"unprognostic (1.56e-2)"			"unprognostic (6.31e-3)"			"unprognostic (3.07e-3)"	"unprognostic (1.52e-1)"			0.3	4.7	7.9	0.4	9.0	2.2	0.1	7.2	20.0	0.0	0.0	0.7	1.2	0.3	0.4	0.4	0.5	2.6	0.8	9.6	10.6	0.2	0.4	0.9	0.4	4.7	4.6	0.7	0.1	0.0	1.1	1.9	10.7	0.1	0.5	10.9	0.5	0.1	0.5	2.2	0.9	0.8	0.5	0.4	1.9	0.7	9.3	1.7	0.5	0.5	0.5	0.2	0.0	7.5	3.9	1.7	2.3	0.2	0.0	0.1	1.9	0.7	0.0	0.0	0.0	10.3	5.5	0.5	5.9	0.0	0.2	1.1	1.6	0.0	0.0	1.0	1.0	0.0	1.7	1.2	0.0	0.0	0.6	0.4	0.3	0.0	0.0	0.1	0.0	1.0	2.4	10.2	0.0	2.8	0.5	0.1	7.4	3.1	3.6	0.5	0.1	13.4	0.0	3.1	1.1	0.9	0.3	0.5	4.1	13.0	6.7	6.9	0.1	0.3	5.2	0.4	0.5	20.1	18.7	0.1	0.1	0.5	0.3	4.5	0.1	0.3	0.2	0.1	1.2	1.6	0.3	0.3	0.0	1.4	1.5	0.3	0.7	0.4	0.1	0.3	0.4	0.1	7.9	9.0	7.2	20.0	9.6	10.6	4.7	4.6	10.7	0.5	9.3	7.5	0.0	19.2	23.5	15.3	0.0	0.0	0.0	0.0	0.0	119.0	0.1	0.0	0.4	0.0	10.5	0.0	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	239.9	0.0	0.1	1.4	0.0	0.0	8.8	0.0	0.0	0.0	0.1	16.8	167.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	12.2	0.0	2.6	0.0	12.1	15.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	6.6	9.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0
GABRR1		ENSG00000146276	"Gamma-aminobutyric acid type A receptor subunit rho1"	P24046	6	89177504-89231278	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	25	"retina: 24.6"	"Cell type enriched"	"Detected in some"	12	"Bipolar cells: 63.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"NTERA-2: 1.2;OE19: 2.6;SuSa: 1.6"	"Region enhanced"	"Detected in single"		"midbrain: 1.3"											NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (5.75e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.90e-2)"	"unprognostic (5.78e-2)"	"unprognostic (4.90e-2)"		"unprognostic (8.32e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-5)"	"unprognostic (1.18e-1)"	"unprognostic (9.90e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.29e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	24.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.1	0.0	0.0	63.1	0.0	0.0	0.3	0.0	0.0	0.0	4.2	0.4	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.1	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	5.0	4.2	0.0	0.0	0.0	0.3	1.1	0.0	0.0	0.0	1.9	0.0	0.6	0.0	3.5	3.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	4.5	0.0	0.0	0.4	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.2
GAP43	"B-50, GAP-43, PP46"	ENSG00000172020	"Growth associated protein 43"	P17677	3	115623510-115721490	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Differentiation, Growth regulation, Neurogenesis"	"Calmodulin-binding, Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	26	"brain: 277.0"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 270.2"	"Cancer enriched"	"Detected in many"	43	"glioma: 245.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.9;NTERA-2: 81.1;SCLC-21H: 52.2;SH-SY5Y: 39.6;U-87 MG: 18.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004417, HPA013392, HPA015600, CAB078783"	Enhanced	Supported	Enhanced	"Plasma membrane"		NA	NA		35000	"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466"	"unprognostic (1.24e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.15e-2)"	"unprognostic (5.72e-5)"	"unprognostic (7.44e-3)"	"unprognostic (2.19e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.15e-3)"	"unprognostic (6.08e-4)"	"unprognostic (3.33e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.62e-1)"	"unprognostic (5.35e-8)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.29e-3)"	0.6	6.3	131.6	7.5	149.2	0.0	0.9	36.3	277.0	0.6	0.0	10.5	2.5	0.2	0.1	1.1	0.2	4.7	4.3	149.9	187.2	0.2	0.2	0.3	0.2	55.6	156.5	0.2	0.8	0.0	10.0	1.7	113.3	0.9	4.8	8.0	2.1	0.3	0.3	0.5	5.5	4.3	28.5	0.0	2.9	0.4	150.7	0.1	0.2	0.6	0.4	1.3	1.9	121.0	0.0	0.0	37.9	0.0	0.0	0.0	0.0	0.9	0.7	0.0	0.2	0.0	0.1	0.0	0.0	0.4	0.2	0.1	0.4	0.0	0.0	0.1	0.2	0.0	0.1	0.5	0.0	0.0	0.0	0.1	0.0	8.6	0.0	0.5	0.0	0.0	0.0	9.1	0.2	0.0	0.0	0.0	81.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	52.2	39.6	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	1.5	0.1	0.1	0.1	0.0	0.0	18.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	131.6	149.2	36.3	277.0	149.9	187.2	55.6	156.5	113.3	28.5	150.7	121.0	0.1	0.0	0.0	20.9	0.0	0.3	0.0	0.0	0.0	3.7	0.0	0.0	0.5	0.0	0.0	0.0	2.1	0.1	0.4	0.0	0.0	0.0	1.0	0.0	0.8	5.1	0.0	0.0	270.2	0.0	0.1	4.5	0.0	0.0	0.0	1.5	0.0	0.0	0.8	0.0	62.5	0.0	0.0	0.0	1.2	1.8	0.0	0.0	1.8	29.0	0.0	1.4	0.0	40.2	20.2	0.8	0.0	0.0	0.4	0.0	0.0	0.2	0.0	3.5	0.0	2.0	1.1	0.9	1.7	0.0	0.1	0.0	0.1	0.3	0.0	0.0
GCGR	GGR	ENSG00000215644	"Glucagon receptor"	P47871	17	81804132-81814008	"FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Diabetes mellitus, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	17	"kidney: 50.0;liver: 169.6"	"Cell type enriched"	"Detected in some"	7	"Hepatocytes: 74.6"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 10.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.0;MCF7: 1.4;SK-BR-3: 1.2;U-87 MG: 1.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA071228			Uncertain	"Golgi apparatus"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"HPA071228: AB_2686368"	"unprognostic (3.28e-4)"	"unprognostic (9.30e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.53e-4)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-3)"	"unprognostic (4.38e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.18e-1)"	"unprognostic (2.77e-1)"	"unprognostic (3.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.42e-2)"	"unprognostic (5.99e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.17e-3)"	"unprognostic (8.36e-3)"	0.2	2.5	0.0	0.0	0.1	0.0	0.2	0.2	0.1	0.2	0.0	0.8	0.2	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.4	50.0	169.6	0.0	0.1	0.3	0.1	0.0	1.4	6.3	0.2	0.0	0.2	0.2	0.0	0.7	0.1	0.0	0.0	1.5	0.6	0.0	0.1	0.1	0.1	0.9	0.0	0.0	0.2	0.1	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.4	0.3	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.9	0.0	0.6	0.0	0.5	0.0	0.3	0.6	0.0	0.3	3.7	2.1	0.0	0.0	0.1	3.9	0.2	0.1	0.4	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	1.4	74.6	0.1	0.0	0.5	0.0	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.1	0.6	0.4	0.0	0.0	0.0	0.2	0.4	0.5	0.4	0.0	0.2	0.0	0.1	0.0
GET1	"CHD5, WRB"	ENSG00000182093	"Guided entry of tail-anchored proteins factor 1"	O00258	21	39377698-39428528	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Adipocytes: 12.0;Cardiomyocytes: 38.3;Cytotrophoblasts: 37.6;Extravillous trophoblasts: 35.3;Fibroblasts: 10.4;Hofbauer cells: 31.5;Syncytiotrophoblasts: 13.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA018527	Approved					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 77: Retina - Visual perception"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"			"HPA018527: AB_1858860"	"unprognostic (4.34e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.37e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.08e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.57e-3)"	"unprognostic (8.74e-2)"	"unprognostic (1.15e-2)"	"unprognostic (4.02e-3)"	"unprognostic (9.48e-2)"	"unprognostic (6.50e-3)"	"unprognostic (2.21e-2)"	"unprognostic (2.67e-2)"	"unprognostic (5.78e-3)"	"unprognostic (8.13e-2)"	20.4	44.4	63.7	11.8	66.5	8.9	25.6	65.3	92.7	28.1	85.3	20.4	18.5	29.4	45.8	15.3	71.1	18.8	29.4	65.6	77.8	38.6	33.4	18.9	14.4	65.3	69.1	41.8	17.9	15.6	29.1	22.1	69.8	24.7	14.9	111.3	16.1	21.1	38.1	10.1	18.7	23.2	67.9	13.7	17.4	55.9	73.3	15.9	28.5	30.1	14.8	16.1	15.1	74.2	36.8	33.2	58.9	34.6	74.8	69.7	18.6	50.6	51.2	23.8	21.7	31.2	50.3	59.6	35.0	54.9	29.0	13.8	47.5	31.8	33.5	26.4	32.2	43.0	28.5	50.8	44.7	33.3	15.8	44.8	30.3	37.9	34.7	67.0	60.2	61.2	65.8	36.8	63.4	82.4	38.4	25.3	52.8	66.7	25.0	42.1	34.6	44.4	69.1	19.1	29.2	44.5	44.7	23.1	53.9	31.1	43.1	37.7	35.6	30.2	10.6	41.2	23.0	46.4	70.4	27.3	72.3	55.3	34.2	37.7	26.7	27.6	19.8	20.4	17.6	30.8	24.1	20.8	30.7	20.6	27.0	25.6	47.1	27.3	21.2	39.4	23.8	39.5	63.7	66.5	65.3	92.7	65.6	77.8	65.3	69.1	69.8	67.9	73.3	74.2	12.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.0	37.6	2.9	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	35.3	10.4	0.0	0.0	0.0	0.0	0.0	0.0	31.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	13.7	0.6	0.0	0.0	0.0
GET3	"ARSA-I, ASNA1, TRC40"	ENSG00000198356	"Guided entry of tail-anchored proteins factor 3, ATPase"	O43681	19	12737139-12748323	"Predicted intracellular proteins, Transporters"	Transport	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"Cytotrophoblasts: 106.6;Extravillous trophoblasts: 80.7;Hofbauer cells: 142.4;Syncytiotrophoblasts: 110.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045951, HPA048087"	Approved		Enhanced	Nucleoplasm,Nucleoli		NA	NA		37000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoli	Nucleoplasm	"HPA045951: AB_2679511, HPA048087: AB_2680258"	"unprognostic (2.87e-1)"	"prognostic favorable (9.53e-4)"	"unprognostic (1.01e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.05e-2)"	"unprognostic (5.70e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.33e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.39e-2)"	"prognostic favorable (4.27e-5)"	"unprognostic (6.11e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.32e-3)"	"prognostic unfavorable (8.47e-4)"	47.5	61.6	56.4	39.4	58.2	66.2	46.5	59.0	72.8	48.4	62.4	43.0	39.9	49.8	41.0	58.1	47.0	39.3	62.0	59.6	58.4	61.6	38.4	40.8	48.3	55.4	57.3	41.9	48.2	73.3	48.2	28.0	57.9	34.3	28.7	36.4	47.3	31.4	67.6	59.1	38.7	33.9	55.9	43.4	50.9	60.2	58.9	46.9	56.3	58.6	38.1	46.3	43.3	57.3	143.7	116.5	60.7	132.3	118.6	72.4	74.6	72.4	99.7	137.5	107.6	90.3	69.6	64.8	111.0	95.4	157.5	75.2	84.5	97.6	65.4	100.9	132.7	54.3	82.4	105.3	125.8	83.5	104.9	83.6	84.1	111.3	66.1	89.2	99.4	75.9	71.3	86.8	109.5	320.4	112.9	68.1	154.6	92.0	215.6	82.2	93.6	128.4	130.2	120.7	111.6	95.5	97.3	131.3	119.8	51.5	108.2	80.5	85.5	193.3	65.4	217.1	172.4	153.9	279.4	61.7	136.2	137.0	109.0	33.6	44.3	26.3	24.8	34.3	21.2	20.3	22.0	22.2	44.8	17.0	15.7	19.5	15.6	16.7	42.9	29.4	34.2	35.8	56.4	58.2	59.0	72.8	59.6	58.4	55.4	57.3	57.9	55.9	58.9	57.3	14.4	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	106.6	13.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	80.7	12.5	0.0	0.0	0.0	0.0	0.0	0.0	142.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	110.7	1.7	0.0	0.0	0.0
GGA1		ENSG00000100083	"Golgi associated, gamma adaptin ear containing, ARF binding protein 1"	Q9UJY5	22	37608725-37633564	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 179.3"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.2;Spermatocytes: 193.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048280, HPA051016"	Supported		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA048280: AB_2680338, HPA051016: AB_2681312"	"unprognostic (1.64e-1)"	"unprognostic (1.42e-2)"	"unprognostic (4.08e-1)"	"unprognostic (9.23e-3)"	"unprognostic (2.00e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (6.29e-4)"	"unprognostic (2.32e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.32e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (1.42e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.16e-3)"	25.0	49.3	35.9	23.3	39.7	37.2	27.3	39.0	42.3	38.0	41.0	35.0	24.3	32.1	21.5	41.1	37.4	20.4	29.5	35.3	35.0	42.4	42.1	33.7	29.1	41.1	37.6	46.3	34.5	33.2	52.7	19.1	38.4	40.0	17.8	22.8	34.9	19.6	43.1	35.7	40.7	16.9	36.1	55.6	34.9	179.3	41.2	26.9	44.7	24.6	21.1	31.6	33.5	45.0	37.4	28.3	32.9	31.1	28.0	23.0	35.4	30.8	25.0	27.0	29.6	23.3	21.8	59.9	20.6	22.9	17.0	35.0	29.4	35.6	24.8	51.0	53.6	24.0	52.3	27.3	28.1	56.1	42.6	28.4	31.3	38.9	24.2	45.1	26.5	30.3	48.0	36.8	27.8	37.7	24.8	64.2	26.2	39.2	28.7	28.5	25.8	25.2	28.8	31.0	30.4	54.0	18.7	39.0	48.9	31.3	42.4	42.0	31.0	36.8	35.2	32.1	24.4	81.1	35.3	62.5	39.9	33.6	30.8	8.1	10.7	6.1	18.0	10.2	22.1	8.3	7.2	23.3	6.7	5.0	5.1	16.5	4.5	11.6	7.9	5.8	8.0	11.5	35.9	39.7	39.0	42.3	35.3	35.0	41.1	37.6	38.4	36.1	41.2	45.0	17.9	25.6	38.5	26.8	50.9	24.2	31.1	36.5	21.1	57.6	26.5	20.8	19.2	20.0	34.5	44.1	83.4	38.8	34.7	67.3	5.9	34.9	148.2	27.6	19.8	32.6	32.4	38.3	18.4	20.1	37.4	18.8	44.4	26.5	49.4	33.3	40.7	20.4	77.1	25.2	19.3	40.4	32.6	66.9	40.3	221.2	26.4	50.5	16.0	20.6	47.9	37.0	73.2	16.6	28.7	36.6	51.6	22.6	24.4	24.7	55.4	13.2	46.7	74.1	26.3	26.9	22.1	193.4	50.4	19.7	28.6	56.8	59.6	44.4	42.8	33.6
GGA3	KIAA0154	ENSG00000125447	"Golgi associated, gamma adaptin ear containing, ARF binding protein 3"	Q9NZ52	17	75236599-75262363	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022945, HPA024645"	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA022945: AB_1849639, HPA024645: AB_2671629"	"unprognostic (9.16e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.69e-1)"	"prognostic unfavorable (8.26e-4)"	"unprognostic (1.20e-1)"	"unprognostic (4.60e-3)"	"prognostic unfavorable (2.77e-6)"	"unprognostic (6.33e-2)"	"unprognostic (1.42e-1)"	"unprognostic (9.30e-2)"	"unprognostic (4.63e-3)"	"unprognostic (4.90e-3)"	"prognostic unfavorable (3.41e-4)"	"unprognostic (1.27e-1)"	"unprognostic (2.99e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.68e-3)"	11.7	9.8	9.0	13.0	8.4	15.7	10.8	7.7	11.4	12.3	4.3	12.4	11.5	10.8	9.8	17.0	10.2	11.4	12.8	8.4	6.7	11.1	11.6	13.0	17.5	8.9	7.6	15.3	12.3	9.1	9.0	14.6	7.6	10.1	11.7	6.7	12.3	7.8	22.7	15.7	15.0	11.8	6.8	19.6	13.0	11.5	7.8	12.8	9.9	10.5	19.0	11.6	12.2	9.4	16.9	21.1	19.5	11.9	21.5	17.9	22.8	18.5	13.3	24.9	21.2	24.8	18.4	21.4	8.2	16.4	19.9	10.6	13.8	8.0	25.7	15.1	21.4	34.3	19.2	19.6	10.3	32.5	24.3	14.1	19.7	13.6	23.5	13.2	26.5	16.1	37.8	19.1	17.7	17.4	42.5	9.6	13.8	19.6	14.9	16.9	28.0	14.3	17.1	18.4	14.0	23.9	18.5	33.2	14.9	27.3	25.3	17.4	29.6	25.7	18.7	17.4	19.9	19.8	15.1	27.5	20.8	23.0	17.2	5.1	6.8	2.9	5.5	5.9	5.1	3.9	4.9	4.2	6.4	4.7	4.3	4.6	7.3	8.4	5.8	6.6	5.4	6.0	9.0	8.4	7.7	11.4	8.4	6.7	8.9	7.6	7.6	6.8	7.8	9.4	9.5	35.3	21.0	13.4	15.5	2.5	4.9	5.2	8.0	8.1	8.8	7.6	12.6	4.3	9.6	0.0	10.4	10.3	21.2	14.3	5.9	5.2	27.6	10.5	13.6	10.2	0.0	4.6	20.6	7.0	11.0	7.7	21.9	14.7	10.1	12.4	9.7	10.4	12.5	6.7	20.2	10.0	6.1	19.2	7.1	30.1	9.3	19.4	12.4	16.9	20.3	5.9	10.3	18.1	21.2	11.6	9.1	10.1	11.0	8.2	9.5	3.5	10.2	8.9	0.0	7.7	6.1	8.1	6.9	7.8	5.3	13.0	12.2	7.0	12.8	8.5
GHRHR		ENSG00000106128	"Growth hormone releasing hormone receptor"	Q02643	7	30938669-30993254	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	351	"pituitary gland: 211.7"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 1.5;Spermatocytes: 1.2;Spermatogonia: 3.0"	"Cancer enhanced"	"Detected in single"		"liver cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"				"unprognostic (8.32e-2)"		"unprognostic (1.45e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.39e-1)"		"unprognostic (7.23e-2)"	"unprognostic (4.15e-1)"		"unprognostic (2.28e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.43e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.87e-3)"		0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	211.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.9	0.0	0.0	0.0	0.0	0.1	1.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GHSR		ENSG00000121853	"Growth hormone secretagogue receptor"	Q92847	3	172443291-172448456	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	6	"hippocampal formation: 3.8;hypothalamus: 15.1;thalamus: 3.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hypothalamus: 3.3"	"Low region specificity"	"Detected in all"									NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"														"unprognostic (1.27e-1)"			"unprognostic (3.31e-2)"				0.0	0.2	0.7	0.1	0.5	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	15.1	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	3.2	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.6	3.8	15.1	1.3	0.2	0.8	0.3	3.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GIPR		ENSG00000010310	"Gastric inhibitory polypeptide receptor"	P48546	19	45668221-45683722	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 22.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 29.9;Gastric mucus-secreting cells: 28.1;Respiratory ciliated cells: 44.5;Rod photoreceptor cells: 17.4"	"Cancer enriched"	"Detected in many"	5	"pancreatic cancer: 4.9"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 9.8;HMC-1: 20.6;SCLC-21H: 13.9;U-266/70: 16.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB022710, HPA068054"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Vesicles		"CAB022710: , HPA068054: "	"unprognostic (2.40e-2)"	"unprognostic (9.03e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.65e-1)"	"unprognostic (3.70e-4)"	"unprognostic (1.82e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.78e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.37e-2)"	"unprognostic (2.59e-2)"	10.0	0.3	1.8	3.1	2.6	2.0	9.0	2.3	3.3	2.5	2.7	6.9	3.7	0.3	0.7	2.5	10.2	1.4	15.2	1.8	2.7	3.8	0.7	5.6	2.7	4.1	4.7	0.1	10.8	5.6	0.4	0.2	4.5	7.1	4.9	13.1	7.8	0.4	0.3	4.2	4.2	0.3	1.7	4.0	22.7	0.2	4.4	0.6	2.5	0.0	2.4	2.6	3.4	4.4	0.7	0.4	1.3	0.7	0.6	0.0	0.1	1.0	0.8	0.0	0.7	0.4	3.9	1.9	0.6	0.8	0.7	2.0	0.3	0.2	0.1	9.8	0.3	1.6	1.0	0.3	0.1	0.6	20.6	0.0	0.3	0.1	0.0	1.8	0.0	2.1	4.5	2.2	0.0	0.2	0.1	1.1	0.0	2.9	0.7	0.5	0.4	4.4	0.5	0.9	13.9	1.2	0.0	0.8	0.2	0.5	2.0	3.1	0.4	0.0	0.5	0.3	0.2	16.7	0.2	0.4	0.6	1.5	0.3	1.1	0.1	0.5	0.5	0.2	0.1	0.2	0.2	0.3	0.2	0.3	0.2	0.3	0.5	0.9	0.0	0.2	0.4	0.2	1.8	2.6	2.3	3.3	1.8	2.7	4.1	4.7	4.5	1.7	4.4	4.4	1.4	3.2	6.3	0.0	1.0	0.9	3.4	2.9	0.0	0.3	2.0	0.5	4.0	5.7	9.8	5.5	0.0	0.0	3.7	13.2	0.0	2.2	0.4	7.1	0.1	0.5	29.9	0.0	0.2	3.6	0.1	0.5	28.1	0.7	1.3	0.1	0.0	0.0	0.1	0.0	0.4	6.8	4.1	0.0	7.8	0.2	0.0	1.4	0.0	0.0	0.5	0.2	1.0	0.0	5.0	5.6	11.3	0.0	4.0	1.5	0.3	0.1	44.5	17.4	13.1	0.3	3.5	0.2	0.3	1.5	0.4	0.1	2.1	0.1	1.9	2.8
GJA3	"CX46, CZP3"	ENSG00000121743	"Gap junction protein alpha 3"	Q9Y6H8	13	20138255-20161052	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 7.8;parathyroid gland: 4.0;placenta: 2.5"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 13.6"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 1.3;melanoma: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 4.4;CAPAN-2: 7.7;HL-60: 6.6;U-266/84: 4.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014821	Supported					NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA014821: AB_2669097"	"unprognostic (2.32e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.58e-3)"	"unprognostic (2.98e-2)"	"unprognostic (1.04e-2)"	"unprognostic (6.87e-3)"	"unprognostic (1.84e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.52e-2)"	"unprognostic (7.70e-2)"	"unprognostic (4.02e-2)"	"unprognostic (9.65e-8)"	"unprognostic (2.87e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.55e-2)"	"unprognostic (8.04e-3)"	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	7.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	4.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	1.2	0.1	0.0	0.1	0.0	1.0	0.0	0.2	0.0	4.4	0.2	0.0	3.7	0.1	1.1	0.0	0.5	3.5	0.6	0.7	0.4	7.7	0.0	0.1	1.3	1.2	0.1	2.5	2.1	0.5	0.2	1.9	1.8	0.0	0.0	0.0	6.6	0.0	0.2	1.2	0.1	0.3	0.0	0.0	2.8	0.5	0.0	0.1	0.0	0.0	0.0	0.5	0.1	1.5	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	3.7	0.1	0.8	1.4	0.0	0.0	0.0	1.5	0.2	1.7	4.7	0.0	0.0	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	1.2	0.0	0.0	0.0	13.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	2.7	0.3	0.0	0.0	0.1	0.0	0.0	0.1
GJA4	CX37	ENSG00000187513	"Gap junction protein alpha 4"	P35212	1	34792999-34795747	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Hepatic stellate cells: 234.2;Sertoli cells: 664.0;Smooth muscle cells: 306.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"EFO-21: 74.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA047981	Approved					NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA047981: AB_2680228"	"unprognostic (2.22e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.67e-2)"	"unprognostic (4.48e-1)"	"unprognostic (5.24e-3)"	"prognostic favorable (3.28e-4)"	"unprognostic (2.01e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.17e-2)"	"unprognostic (6.83e-2)"	"unprognostic (8.81e-2)"	"prognostic unfavorable (7.44e-4)"	"unprognostic (3.47e-2)"	"unprognostic (3.74e-2)"	"unprognostic (3.82e-3)"	"unprognostic (7.96e-3)"	79.4	20.4	10.1	9.3	11.0	0.3	61.5	9.8	15.1	26.6	9.0	14.7	2.8	33.8	5.5	7.5	40.0	17.3	83.6	10.5	9.6	35.8	17.3	40.7	11.3	10.3	10.2	18.0	7.0	10.6	6.4	61.6	10.6	18.8	3.8	0.8	10.1	10.7	34.7	14.8	13.9	15.2	10.2	9.9	12.9	5.4	10.2	2.7	39.8	35.2	5.4	28.1	22.4	9.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	74.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	10.1	11.0	9.8	15.1	10.5	9.6	10.3	10.2	10.6	10.2	10.2	9.9	90.4	0.0	0.0	0.3	0.6	9.7	1.9	0.2	1.2	0.2	1.1	1.5	9.0	1.5	0.6	3.7	0.0	0.2	0.7	0.0	0.0	11.0	0.1	3.1	0.5	81.4	15.6	2.7	0.0	0.0	0.1	7.7	2.6	4.9	0.0	0.5	234.2	1.8	0.3	0.0	0.0	0.0	0.0	6.3	10.7	1.1	0.9	2.2	19.6	1.0	0.6	0.1	0.0	0.0	0.0	1.0	0.0	12.8	0.2	3.0	0.0	0.1	1.2	0.7	664.0	4.4	306.3	0.2	1.2	0.7	8.7	0.0	1.3	1.6	0.1	5.2
GJA5	CX40	ENSG00000265107	"Gap junction protein alpha 5"	P36382	1	147756199-147773362	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Atrial fibrillation, Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 36.7;placenta: 85.4"	"Group enriched"	"Detected in some"	6	"Cytotrophoblasts: 135.3;Extravillous trophoblasts: 345.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	10	"SK-BR-3: 133.8"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB013080, HPA071370"	Enhanced					NA	NA				"Cluster 28: Placenta - Pregnancy"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"CAB013080: AB_2533263, HPA071370: "	"unprognostic (1.25e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.88e-2)"	"unprognostic (8.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (5.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.16e-1)"	"unprognostic (4.27e-2)"	"unprognostic (7.57e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.44e-1)"	"unprognostic (4.41e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.93e-2)"	18.6	2.2	2.5	6.0	3.4	0.0	10.5	2.4	4.1	5.5	2.6	4.7	3.4	10.8	2.3	4.8	8.2	6.3	36.7	2.4	2.2	17.1	1.2	26.4	1.7	2.8	2.6	4.0	2.6	3.4	0.5	85.4	2.5	4.0	4.1	0.2	1.6	9.4	2.1	1.4	5.9	8.2	2.6	3.9	3.0	2.9	2.7	0.6	5.3	8.9	2.3	7.4	3.8	2.7	1.8	0.0	0.3	0.0	0.0	0.0	5.7	4.4	2.2	2.2	0.5	0.1	0.2	0.0	1.4	0.7	0.0	0.3	0.0	9.3	3.5	0.0	0.3	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	0.1	13.1	0.0	0.1	0.1	0.2	133.8	0.0	12.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.4	2.4	4.1	2.4	2.2	2.8	2.6	2.5	2.6	2.7	2.7	14.3	3.2	4.2	0.0	1.0	0.0	0.0	0.0	0.6	0.0	0.2	1.5	17.7	0.0	0.0	3.7	0.0	135.3	0.1	0.0	0.0	0.0	7.6	0.1	0.3	14.7	0.0	0.0	0.0	0.0	345.3	3.7	0.0	0.1	0.0	19.9	37.9	0.0	15.8	0.0	0.0	0.0	0.0	0.6	0.0	9.8	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	39.5	0.5	11.1	4.3	0.4	0.2	0.3	31.1	0.5	0.1	0.0	0.1
GJA8	"CAE, CAE1, CX50, CZP1"	ENSG00000121634	"Gap junction protein alpha 8"	P48165	1	147902795-147909269	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cataract, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	46	"testis: 5.8"	"Group enriched"	"Detected in some"	4	"Early spermatids: 14.6;Spermatocytes: 39.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014715, HPA062940"	Enhanced					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA014715: AB_2732411, HPA062940: AB_2732693"										"unprognostic (3.73e-2)"					"unprognostic (2.35e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	14.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJB1	"CMTX, CMTX1, CX32"	ENSG00000169562	"Gap junction protein beta 1"	P08034	X	71212811-71225516	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 100.9;liver: 335.7"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 114.4;Hepatocytes: 286.4;Proximal enterocytes: 118.8;Proximal tubular cells: 68.9;Undifferentiated cells: 66.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 163.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 143.2;SK-MEL-30: 155.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB012994	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"CAB012994: AB_2533228"	"unprognostic (2.09e-2)"	"unprognostic (1.39e-1)"	"unprognostic (8.78e-2)"	"unprognostic (2.71e-3)"	"unprognostic (2.70e-1)"	"unprognostic (4.11e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.63e-2)"	"unprognostic (2.22e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.80e-1)"	"prognostic favorable (2.85e-6)"	"unprognostic (1.03e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.79e-2)"	"unprognostic (4.97e-2)"	0.1	0.0	27.1	3.7	63.2	0.0	6.4	76.5	37.6	8.8	12.7	33.9	44.0	1.7	22.5	0.3	27.4	41.5	0.0	27.3	40.9	42.9	335.7	2.4	0.0	90.6	64.4	0.1	83.0	0.0	0.1	0.0	76.0	11.6	23.8	0.0	37.7	7.5	0.0	0.9	34.4	1.8	50.0	0.1	16.4	10.2	56.9	0.0	0.1	0.1	0.0	0.4	0.1	100.9	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	25.5	0.2	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	143.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	5.6	0.0	0.0	0.3	0.0	5.1	0.2	0.0	0.2	0.0	0.0	155.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	27.1	63.2	76.5	37.6	27.3	40.9	90.6	64.4	76.0	50.0	56.9	100.9	0.0	0.0	4.8	0.3	0.8	0.6	0.7	0.5	0.0	0.0	7.7	2.4	0.1	114.4	2.7	9.2	0.0	0.0	0.1	50.2	9.8	34.1	0.3	8.2	3.4	0.6	9.6	8.0	0.2	58.9	0.0	0.1	15.8	29.0	4.5	0.0	3.3	286.4	0.0	0.0	0.2	29.4	2.0	4.8	0.4	0.4	0.3	0.8	23.2	0.0	0.6	0.0	0.0	1.0	51.3	32.3	53.4	0.4	0.0	2.6	118.8	68.9	0.1	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.1	0.0	1.0	0.0	66.1	2.8
GJB2	"CX26, DFNA3, DFNB1, NSRD1"	ENSG00000165474	"Gap junction protein beta 2"	P29033	13	20187463-20192938	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease variant, Ectodermal dysplasia, Ichthyosis, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 328.1;esophagus: 812.1;vagina: 519.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 69.8;Basal respiratory cells: 237.4;Basal squamous epithelial cells: 55.8;Ionocytes: 50.8;Squamous epithelial cells: 160.9"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 447.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 144.6;hTCEpi: 105.4;OE19: 76.9;RT4: 169.9"	"Low region specificity"	"Detected in all"							"CAB013093, HPA014362"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"CAB013093: AB_2533903, HPA014362: "	"unprognostic (2.21e-1)"	"unprognostic (1.25e-3)"	"unprognostic (2.43e-2)"	"unprognostic (6.14e-2)"	"prognostic unfavorable (4.45e-4)"	"unprognostic (9.77e-2)"	"unprognostic (2.92e-1)"	"prognostic unfavorable (6.25e-4)"	"unprognostic (1.33e-1)"	"unprognostic (3.69e-3)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (2.53e-6)"	"unprognostic (5.78e-3)"	"unprognostic (2.40e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.93e-3)"	2.0	0.7	1.3	6.7	1.2	3.8	3.7	2.4	3.1	328.1	5.3	20.8	12.9	2.9	3.4	812.1	0.9	14.0	0.4	1.1	1.7	9.8	47.5	0.7	0.4	1.8	1.7	0.3	1.3	0.1	4.1	0.2	1.7	1.2	17.4	0.0	145.2	0.3	0.4	73.0	10.6	2.6	1.7	0.2	8.1	1.2	7.6	12.5	1.7	1.2	90.4	27.9	519.8	1.6	8.7	0.6	0.0	0.2	0.0	2.9	1.7	0.0	0.0	0.0	0.0	1.3	144.6	0.0	0.7	0.1	1.1	28.9	5.3	14.4	0.1	12.6	1.8	0.1	0.1	0.3	0.0	0.0	5.1	2.4	105.4	1.9	19.5	0.0	0.0	2.1	0.1	10.7	0.2	1.4	1.3	0.0	0.3	76.9	14.4	0.2	0.0	8.3	0.2	169.9	0.1	0.0	0.3	0.1	0.3	1.9	2.2	0.4	0.0	0.2	0.0	2.5	22.2	8.7	9.6	0.0	17.1	0.1	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.2	2.4	3.1	1.1	1.7	1.8	1.7	1.7	1.7	7.6	1.6	0.1	3.2	0.0	2.0	0.6	69.8	16.1	237.4	55.8	0.0	1.3	1.3	0.5	4.3	37.3	1.8	0.0	0.1	0.0	28.0	0.0	4.4	1.5	5.0	1.5	1.3	4.2	0.0	0.0	9.8	0.2	1.7	4.1	19.1	0.0	0.0	0.0	25.2	0.6	0.0	0.0	6.1	50.8	0.6	13.3	1.3	0.0	3.9	1.8	0.0	4.6	0.0	0.0	0.0	0.0	9.2	13.3	0.0	2.7	8.6	10.7	17.5	7.5	0.0	0.0	0.1	4.7	0.8	2.1	160.9	28.7	0.1	0.9	0.0	25.0	21.7
GJB3	"CX31, DFNA2, EKV"	ENSG00000188910	"Gap junction protein beta 3"	O75712	1	34781214-34786369	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"esophagus: 77.8;skin 1: 145.0"	"Group enriched"	"Detected in many"	5	"Basal keratinocytes: 138.4;Basal prostatic cells: 71.9;Basal respiratory cells: 43.6;Pancreatic endocrine cells: 119.8;Prostatic glandular cells: 63.4;Squamous epithelial cells: 91.9;Suprabasal keratinocytes: 170.6;Urothelial cells: 171.0"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 58.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 88.8;CAPAN-2: 121.7;HaCaT: 99.4;HBEC3-KT: 84.9;hTCEpi: 136.8;OE19: 54.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA074472			Supported	"Vesicles,Cell Junctions"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Vesicles, Cell Junctions"		"HPA074472: AB_2686694"	"unprognostic (1.34e-3)"	"unprognostic (2.30e-1)"	"unprognostic (2.84e-2)"	"unprognostic (5.22e-3)"	"unprognostic (3.82e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.21e-4)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (7.56e-5)"	"unprognostic (4.50e-2)"	"unprognostic (5.74e-3)"	"unprognostic (1.35e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.46e-2)"	0.3	0.2	1.3	1.7	0.6	0.0	5.5	1.1	1.0	8.9	0.0	4.2	0.2	0.3	2.8	77.8	1.1	7.0	0.1	0.6	0.0	0.5	1.5	0.6	0.5	0.2	0.0	0.1	0.3	0.0	0.1	1.4	0.1	4.0	5.0	0.0	8.9	1.7	0.6	145.0	1.3	0.1	0.0	0.0	5.9	0.8	0.1	0.8	0.2	0.0	12.9	11.9	26.4	0.2	88.8	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	121.7	0.0	11.6	0.1	0.1	99.4	0.0	84.9	0.0	0.1	0.0	0.3	5.0	0.0	0.0	0.0	0.0	0.0	136.8	0.0	35.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.4	54.2	22.3	0.0	0.0	0.0	40.8	33.0	0.0	0.0	13.1	0.9	0.0	0.1	1.0	0.1	0.0	0.1	5.7	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	1.1	1.0	0.6	0.0	0.2	0.0	0.1	0.0	0.1	0.2	0.0	3.2	0.0	0.0	0.0	138.4	71.9	43.6	16.5	0.0	2.0	1.3	0.4	1.5	15.5	5.5	0.0	0.3	0.0	18.3	0.0	14.6	0.0	4.1	0.4	1.7	1.8	0.0	0.2	7.3	0.2	1.7	3.1	8.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	6.1	0.0	12.5	0.0	0.0	0.4	14.2	0.0	0.0	0.0	0.0	0.0	0.0	119.8	8.1	0.0	0.0	63.4	0.5	0.0	10.1	0.0	0.0	0.0	2.1	0.1	0.3	91.9	170.6	0.1	0.5	0.0	19.1	171.0
GJB4	CX30.3	ENSG00000189433	"Gap junction protein beta 4"	Q9NTQ9	1	34759740-34762327	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 43.1"	"Group enriched"	"Detected in some"	4	"Basal prostatic cells: 31.1;Pancreatic endocrine cells: 37.0;Urothelial cells: 102.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 9.0;HaCaT: 12.2;HBEC3-KT: 8.3;hTCEpi: 5.7;OE19: 4.5;RPTEC TERT1: 4.8;RT4: 5.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA055112, HPA073904"	Enhanced		Supported	"Cell Junctions"		NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA055112: AB_2682699, HPA073904: "	"unprognostic (3.30e-2)"	"prognostic favorable (5.48e-4)"	"unprognostic (1.57e-1)"	"unprognostic (2.70e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.18e-2)"	"unprognostic (5.40e-2)"	"unprognostic (3.65e-1)"	"prognostic unfavorable (3.24e-5)"	"unprognostic (3.73e-2)"	"unprognostic (5.81e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.67e-1)"	"unprognostic (3.52e-4)"	"unprognostic (5.42e-2)"	0.0	0.0	0.0	0.3	0.1	0.0	2.6	0.0	0.2	0.7	0.0	0.2	0.0	0.0	5.5	2.3	0.2	4.8	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.8	0.3	0.0	0.5	1.0	0.2	43.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.4	0.1	0.0	2.3	7.9	1.4	0.0	9.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.0	1.3	0.0	0.1	12.2	0.0	8.3	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	4.8	5.9	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	31.1	13.9	1.2	0.0	0.3	0.1	0.1	0.0	5.7	0.0	0.0	0.1	0.1	0.3	0.0	3.7	0.0	0.3	0.0	0.2	1.8	0.0	0.0	0.6	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	37.0	1.3	0.0	0.0	12.9	0.1	0.0	6.8	0.0	0.0	0.0	0.7	0.0	0.0	3.5	6.0	0.3	0.1	0.0	0.4	102.6
GJC1	"CX45, GJA7"	ENSG00000182963	"Gap junction protein gamma 1"	P36383	17	44798448-44830816	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 40.0"	"Group enriched"	"Detected in many"	4	"Sertoli cells: 157.8;Smooth muscle cells: 101.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071788			Uncertain	"Nucleoli,Cell Junctions,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli	"Cell Junctions, Cytosol"	"HPA071788: "	"unprognostic (1.84e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.13e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.02e-2)"	"unprognostic (4.01e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (3.55e-8)"	"unprognostic (5.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (8.52e-2)"	"prognostic unfavorable (7.83e-4)"	9.5	0.7	3.1	3.6	2.8	0.8	5.2	10.1	3.8	9.2	5.5	28.6	1.6	24.7	2.9	2.7	5.3	5.4	11.8	2.3	1.4	2.2	0.7	7.2	2.7	2.1	2.9	2.2	1.4	3.4	0.6	40.0	2.6	8.9	2.9	1.0	1.1	18.6	4.6	2.0	5.3	32.7	1.3	0.7	7.6	8.8	4.0	1.6	6.7	5.9	2.0	11.4	6.1	3.0	44.5	21.9	62.0	18.9	8.3	10.6	20.5	50.3	36.6	50.0	52.6	12.4	24.7	0.5	2.3	46.4	69.9	10.1	29.2	13.7	70.8	0.5	19.8	0.4	12.1	1.6	3.8	0.3	1.7	8.8	1.6	37.0	11.8	20.4	17.1	9.6	1.8	0.5	31.4	0.4	6.7	4.3	29.5	0.1	16.2	39.5	73.8	0.3	11.4	16.8	10.2	21.5	4.6	0.5	16.2	41.3	10.9	8.0	12.3	43.8	39.3	22.2	38.9	0.4	11.3	32.5	15.9	0.3	40.7	2.0	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	0.0	0.2	0.2	0.2	1.0	0.5	0.1	0.2	0.1	0.1	3.1	2.8	10.1	3.8	2.3	1.4	2.1	2.9	2.6	1.3	4.0	3.0	11.7	0.0	0.0	0.7	0.2	2.0	1.7	0.5	0.0	3.4	0.6	1.4	25.1	0.0	0.2	1.8	2.1	0.5	0.4	0.1	0.0	1.5	1.5	1.4	14.9	19.5	0.0	0.0	8.1	0.0	2.6	6.3	0.0	3.0	0.0	9.4	4.2	0.3	1.5	13.5	1.4	0.0	0.0	0.3	4.2	0.3	1.5	1.2	3.6	1.0	0.6	0.2	0.0	0.0	0.3	0.6	0.0	2.2	0.0	1.4	0.0	0.3	0.2	0.9	157.8	4.8	101.1	15.6	28.4	0.6	3.0	0.5	0.8	7.8	0.1	1.3
GJC3	"CX30.2, GJE1"	ENSG00000176402	"Gap junction protein gamma 3"	Q8NFK1	7	99923266-99929620	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"breast: 8.7;pancreas: 11.1;salivary gland: 11.7"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 36.3;Breast myoepithelial cells: 26.9;Exocrine glandular cells: 24.0;Pancreatic endocrine cells: 12.8;Prostatic glandular cells: 13.0"	"Group enriched"	"Detected in many"	5	"breast cancer: 3.8;melanoma: 3.0;prostate cancer: 3.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.3;SK-MEL-30: 2.3;U-2197: 1.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015024	Uncertain					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 35: Glandular cells - Unknown function"			"HPA015024: AB_1847132"	"unprognostic (9.31e-2)"	"unprognostic (6.43e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.68e-2)"	"unprognostic (9.14e-2)"	"unprognostic (6.71e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.88e-3)"	"unprognostic (1.14e-1)"	"unprognostic (4.17e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.81e-3)"	1.6	0.5	0.8	0.1	0.9	0.1	8.7	0.1	1.2	0.3	0.0	0.5	0.4	0.2	0.0	0.2	0.3	0.3	0.4	0.9	0.3	1.0	2.7	0.2	0.2	0.2	0.4	0.4	11.1	0.0	0.4	1.0	0.2	4.6	0.0	1.0	11.7	0.1	0.2	2.6	0.3	0.2	0.0	0.3	1.4	1.7	0.6	0.1	0.3	0.2	0.0	0.3	0.3	0.5	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.0	0.0	0.0	0.4	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.1	0.9	0.0	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.4	0.7	0.5	0.6	0.1	0.5	0.2	0.4	1.1	1.3	0.0	0.0	0.4	0.3	0.0	0.4	0.1	0.2	0.1	0.3	2.3	0.5	0.7	0.0	0.3	0.1	0.4	1.8	0.1	0.1	0.5	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.9	0.1	1.2	0.9	0.3	0.2	0.4	0.2	0.0	0.6	0.5	1.1	3.2	3.7	0.0	0.4	0.3	4.9	1.4	0.0	0.0	36.3	26.9	0.0	4.3	2.1	1.8	0.0	0.0	0.6	0.0	1.9	0.4	0.4	0.0	0.0	1.5	1.2	0.0	0.7	24.0	0.0	0.2	0.0	0.0	4.5	0.2	1.1	5.0	0.1	0.0	0.4	0.1	8.2	0.0	0.3	1.1	0.3	0.1	0.0	0.0	0.6	4.0	0.0	0.0	0.6	12.8	0.0	0.0	0.0	13.0	0.0	9.7	0.3	0.0	0.0	0.0	0.3	1.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	9.4
GJD2	"CX36, GJA9"	ENSG00000159248	"Gap junction protein delta 2"	Q9UKL4	15	34751032-34754998	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.9;pituitary gland: 7.5;retina: 21.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.2;Cone photoreceptor cells: 39.6;Horizontal cells: 6.7;Rod photoreceptor cells: 13.7"	"Cancer enriched"	"Detected in single"	32	"pancreatic cancer: 4.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SuSa: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 12: NES - Nervous system development"	"Cluster 9: Photoreceptor cells - Phototransduction"								"unprognostic (4.30e-2)"						"unprognostic (2.87e-2)"			"unprognostic (1.28e-3)"	"unprognostic (1.15e-1)"			0.0	5.9	1.1	0.0	0.6	0.0	0.0	1.1	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.7	1.1	0.3	0.0	0.0	0.0	3.2	1.4	0.0	3.9	0.0	7.5	0.0	1.0	0.0	0.0	21.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	1.1	0.6	1.1	1.4	0.7	1.1	3.2	1.4	1.0	0.2	1.8	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	2.8	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GJD4	"CX40.1, FLJ90023"	ENSG00000177291	"Gap junction protein delta 4"	Q96KN9	10	35605341-35608935	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Paneth cells: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in single"		"RH-30: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038266	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"		"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA038266: AB_10672741"	"unprognostic (2.05e-1)"	"unprognostic (2.58e-1)"	"unprognostic (5.74e-6)"	"unprognostic (2.00e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.92e-2)"		"unprognostic (8.49e-2)"		"unprognostic (7.70e-2)"	"unprognostic (1.67e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.19e-10)"	"unprognostic (3.06e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.31e-1)"	0.0	0.1	0.0	0.0	0.2	0.7	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.2	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.5	0.0	0.3	0.2	0.2	0.2	0.1	0.5	0.2	1.4	0.0	0.0	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.2	0.2	0.3	0.2	0.4	0.1	0.1	0.2	0.1	0.0	0.2	0.1	0.2	0.6	0.2	0.2	0.1	0.0	0.1	0.2	0.1	0.1	0.1	0.2	0.2	0.2	1.7	0.2	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0
GLE1	"GLE1L, hGLE1, LCCS1"	ENSG00000119392	"GLE1 RNA export mediator"	Q53GS7	9	128504719-128542288	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 77.0;Late spermatids: 58.1;Spermatocytes: 51.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041689, HPA043538, HPA061560"	Supported		Supported	"Nuclear membrane,Nucleoli"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nuclear membrane"	Nucleoli	"HPA041689: AB_2677617, HPA043538: AB_2678539, HPA061560: AB_2684560"	"unprognostic (8.74e-3)"	"unprognostic (2.18e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.49e-4)"	"unprognostic (1.75e-1)"	"unprognostic (5.58e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.95e-2)"	"unprognostic (4.00e-2)"	"prognostic favorable (7.04e-4)"	"unprognostic (2.62e-1)"	"unprognostic (1.99e-3)"	"unprognostic (5.64e-2)"	11.6	14.0	9.2	15.7	9.2	15.1	15.7	12.4	11.3	13.0	13.4	17.4	16.2	11.6	10.8	16.4	14.1	7.8	14.9	8.9	8.8	14.1	16.3	12.3	20.4	8.7	9.2	16.2	9.5	17.6	14.1	9.2	8.6	11.8	18.3	16.5	11.1	12.4	22.5	19.1	15.8	12.9	8.4	15.2	12.9	32.0	9.3	25.9	13.3	12.4	22.2	12.8	12.3	8.9	29.6	54.5	26.2	44.9	25.3	25.5	34.6	29.2	24.9	40.2	28.4	36.8	20.1	59.6	23.0	33.0	38.6	101.4	45.9	41.7	34.5	56.9	29.8	30.6	57.8	34.6	28.5	49.9	38.8	18.1	39.7	45.6	48.5	22.3	22.9	54.7	44.7	51.0	46.7	68.6	49.5	35.2	22.2	79.1	46.7	49.8	64.2	79.0	27.3	26.1	30.9	23.1	71.3	42.7	25.9	21.1	78.9	34.9	17.0	42.5	28.1	50.2	41.2	50.9	131.9	45.9	39.9	37.5	46.8	40.0	21.1	24.4	22.1	26.0	18.1	13.4	17.2	20.0	22.1	20.5	15.2	17.7	18.0	27.4	27.5	13.0	22.3	19.8	9.2	9.2	12.4	11.3	8.9	8.8	8.7	9.2	8.6	8.4	9.3	8.9	4.0	9.6	9.0	11.1	11.4	6.5	5.3	10.4	8.6	7.6	8.8	7.6	13.0	5.7	7.2	7.3	8.4	16.1	6.9	13.2	5.9	11.7	77.0	12.2	7.4	3.6	5.4	12.0	14.0	6.2	11.7	7.6	10.2	9.4	9.5	10.9	4.6	14.2	15.7	10.1	15.5	12.7	8.2	15.1	5.7	58.1	10.2	13.5	3.6	10.3	20.0	8.9	15.5	18.1	15.5	8.3	8.0	6.4	13.4	6.1	16.3	13.7	12.6	8.6	13.1	7.7	7.3	51.3	25.5	14.4	6.8	13.3	12.1	7.1	14.1	5.4
GLIPR1	"GliPR, RTVP1"	ENSG00000139278	"GLI pathogenesis related 1"	P48060	12	75480753-75503863	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 216.3;Extravillous trophoblasts: 384.2;Hofbauer cells: 242.4;Kupffer cells: 273.9;Langerhans cells: 393.2;Macrophages: 259.6;monocytes: 220.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 189.3;U-138 MG: 363.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA011014	Approved				"Intracellular and membrane"	NA	NA		64000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA011014: AB_1849714"	"unprognostic (2.32e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.31e-1)"	"unprognostic (2.32e-3)"	"unprognostic (4.09e-1)"	"unprognostic (7.58e-2)"	"unprognostic (3.10e-1)"	"unprognostic (7.23e-2)"	"unprognostic (1.54e-1)"	"prognostic unfavorable (8.69e-9)"	"unprognostic (9.06e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.24e-1)"	17.2	16.9	2.0	47.0	1.7	18.3	11.5	1.5	5.6	15.6	3.8	11.4	6.6	32.6	6.0	7.9	17.9	33.5	9.2	2.3	2.8	5.6	12.5	22.1	32.7	4.0	3.3	13.7	3.7	2.3	3.9	25.8	3.9	9.2	12.6	1.7	9.7	17.1	3.1	3.4	14.1	39.9	3.4	36.4	10.8	4.8	4.2	19.8	5.4	7.3	32.3	35.0	6.7	8.4	7.2	7.0	5.9	0.6	22.0	46.2	0.9	93.0	97.5	76.8	55.7	3.8	2.7	23.9	19.1	101.7	67.6	1.2	0.2	38.6	124.7	38.0	1.6	1.2	8.4	6.1	25.1	8.4	1.3	43.0	14.1	189.3	41.4	123.1	62.0	1.7	1.7	29.0	144.7	0.1	4.0	20.2	0.6	0.2	2.8	1.0	4.5	0.8	8.1	1.6	0.2	0.2	38.5	0.3	0.2	12.5	0.9	6.7	102.6	363.8	35.4	39.2	144.1	5.1	0.8	2.1	144.4	9.9	5.6	25.3	352.7	40.9	115.0	232.6	77.2	73.9	80.5	90.7	240.2	90.2	24.3	50.4	462.1	20.4	265.6	202.1	91.2	265.0	2.0	1.7	1.5	5.6	2.3	2.8	4.0	3.3	3.9	3.4	4.2	8.4	6.5	12.8	16.0	2.0	121.6	13.6	189.2	23.0	4.0	2.9	15.5	19.9	0.9	5.7	10.0	3.7	4.2	4.8	216.3	0.3	0.0	102.8	14.3	11.3	119.4	7.0	3.5	11.8	13.3	83.9	384.2	46.1	2.0	16.4	10.1	0.8	10.4	4.4	242.4	6.7	14.6	0.4	4.1	273.9	393.2	5.9	14.3	259.6	16.0	28.1	220.9	1.4	123.6	2.5	1.5	90.9	2.5	53.8	66.8	106.5	0.1	1.5	10.6	3.2	13.1	8.1	50.2	7.9	1.0	4.6	9.8	16.8	161.9	26.7	0.6	42.8
GLMP	"C1orf85, MGC31963, NCU-G1"	ENSG00000198715	"Glycosylated lysosomal membrane protein"	Q8WWB7	1	156290089-156295689	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 197.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 224.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029121	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"HPA029121: AB_10600794"	"unprognostic (2.46e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.68e-2)"	"unprognostic (4.22e-3)"	"unprognostic (3.71e-2)"	"unprognostic (8.28e-2)"	"prognostic unfavorable (6.35e-5)"	"unprognostic (4.74e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.21e-3)"	"unprognostic (1.33e-1)"	"unprognostic (7.66e-3)"	"unprognostic (7.68e-3)"	"unprognostic (3.90e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.13e-1)"	"unprognostic (4.20e-3)"	33.9	68.3	11.8	17.1	12.8	19.4	25.6	12.9	15.4	38.1	21.1	24.6	30.3	24.4	23.2	29.8	21.1	44.7	18.1	11.7	13.9	52.2	59.8	28.9	22.6	13.6	13.6	22.0	27.0	29.4	19.7	48.0	15.0	57.3	21.1	2.7	35.2	20.4	7.4	29.2	26.9	24.5	12.4	32.3	28.8	6.4	16.0	12.2	23.6	9.6	15.4	36.0	26.8	14.4	22.7	40.8	3.9	27.0	224.8	121.7	27.5	40.8	172.0	58.1	79.0	50.9	68.7	0.0	83.2	59.0	1.9	14.6	0.6	30.0	18.4	4.6	41.8	7.0	22.9	60.6	101.4	19.7	58.1	119.9	36.0	55.9	17.9	85.1	89.0	17.6	32.8	3.1	34.6	28.5	10.1	0.1	46.5	56.9	20.9	17.4	0.0	74.3	53.7	24.5	12.9	42.2	27.1	76.4	120.6	45.6	38.3	54.2	45.7	25.7	5.0	46.2	26.9	24.9	45.9	11.3	44.0	15.7	36.3	35.0	71.3	12.2	23.4	74.5	21.7	13.1	23.0	20.5	31.8	7.7	22.7	21.7	19.4	18.0	55.6	21.3	43.4	36.9	11.8	12.8	12.9	15.4	11.7	13.9	13.6	13.6	15.0	12.4	16.0	14.4	11.7	3.2	19.1	3.3	7.3	0.0	16.4	0.0	10.8	2.0	12.3	11.6	5.8	31.5	5.0	31.3	0.0	70.3	7.6	13.8	27.4	51.3	0.6	8.5	19.1	17.5	10.9	18.5	1.6	38.3	68.5	33.4	18.8	14.2	8.8	14.9	42.8	69.8	197.7	1.7	1.9	19.4	0.0	66.8	0.0	1.4	16.4	41.1	0.0	1.0	29.8	21.0	13.4	2.0	3.9	29.8	22.2	13.9	23.0	28.9	44.9	67.3	5.8	1.5	13.1	11.9	17.1	0.9	1.9	17.8	0.0	69.6	9.3	17.6	11.8	18.7
GLP1R	GLP-1R	ENSG00000112164	"Glucagon like peptide 1 receptor"	P43220	6	39048781-39091303	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;heart muscle: 2.7;pancreas: 7.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 2.2;Early spermatids: 1.0;Inhibitory neurons: 1.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.1;SCLC-21H: 2.7"	"Region enriched"	"Detected in many"	4	"basal ganglia: 20.7"	"Low region specificity"	"Detected in some"									NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (4.06e-3)"			"unprognostic (5.38e-6)"	"unprognostic (1.80e-2)"	"unprognostic (4.16e-2)"	"unprognostic (4.98e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.76e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.60e-3)"	"unprognostic (2.47e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.42e-2)"	0.1	0.0	0.4	0.0	0.9	0.0	0.6	0.3	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.7	0.6	3.7	0.1	0.0	0.3	0.1	1.1	0.5	0.0	7.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.1	0.0	1.1	0.0	0.9	0.2	1.6	0.1	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.3	0.5	0.6	3.7	1.1	0.5	1.2	1.1	1.6	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GLRA1	STHE	ENSG00000145888	"Glycine receptor alpha 1"	P23415	5	151822513-151924851	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"brain: 40.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 7.4;Excitatory neurons: 1.7;Horizontal cells: 1.7;Inhibitory neurons: 5.0;Oligodendrocyte precursor cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"hypothalamus: 9.4;midbrain: 15.1;pons and medulla: 26.3"	"Low region specificity"	"Detected in many"			CAB079042		Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 56: Bipolar cells - Visual perception"			"CAB079042: "					"unprognostic (3.17e-1)"						"unprognostic (2.47e-1)"		"unprognostic (3.85e-7)"	"unprognostic (8.24e-2)"		"unprognostic (9.45e-3)"		0.0	0.3	1.9	0.0	0.6	0.0	0.0	12.2	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	7.0	0.0	0.0	0.0	0.0	40.7	13.9	0.0	0.2	0.0	0.0	0.0	31.4	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	20.9	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.6	12.2	1.8	0.2	7.0	40.7	13.9	31.4	20.9	12.1	10.9	0.0	0.0	0.0	0.7	0.0	0.1	0.9	0.0	0.0	7.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.7	5.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	1.0	0.1	0.2	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.5
GLRA2	GLR	ENSG00000101958	"Glycine receptor alpha 2"	P23416	X	14529298-14731812	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 28.4"	"Cell type enriched"	"Detected in some"	5	"Inhibitory neurons: 74.3"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.6;glioma: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	34	"AN3-CA: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070422	Approved					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB070422: AB_11153055"	"unprognostic (2.52e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.52e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.74e-2)"			"unprognostic (1.81e-2)"	"unprognostic (3.39e-1)"	"unprognostic (5.82e-2)"	"unprognostic (7.95e-3)"		"unprognostic (1.13e-1)"	"unprognostic (2.76e-1)"	"unprognostic (6.69e-2)"			0.0	0.0	5.4	0.1	3.4	0.1	0.0	8.3	4.6	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	4.6	23.4	0.0	0.0	0.0	0.0	4.9	28.4	0.1	0.0	0.0	0.3	0.1	13.7	0.0	3.8	4.9	0.1	0.0	0.0	0.1	0.1	0.1	5.9	0.0	0.0	0.2	12.6	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.1	17.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	3.4	8.3	4.6	4.6	23.4	4.9	28.4	13.7	5.9	12.6	1.5	0.0	0.0	0.0	0.7	0.1	0.1	0.0	0.0	0.0	2.6	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.4	0.0	7.6	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	8.7	0.0	0.0	0.1	0.0	0.1	0.0	1.9	0.0	0.0	0.0	1.7	74.3	0.2	0.0	0.0	0.3	0.2	0.0	0.0	0.0	1.0	0.0	0.3	0.0	2.0	12.4	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.5	1.1	0.0
GLRA3		ENSG00000145451	"Glycine receptor alpha 3"	O75311	4	174636920-174829247	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 10.5"	"Cell type enhanced"	"Detected in some"		"Breast glandular cells: 25.3;Early spermatids: 24.7;Excitatory neurons: 52.4;Inhibitory neurons: 11.2;Late spermatids: 22.8"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Karpas-707: 1.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 65: Brain - Ion transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.75e-3)"	"unprognostic (3.14e-1)"	"unprognostic (1.78e-2)"		"unprognostic (1.36e-1)"	"unprognostic (9.02e-2)"		"unprognostic (3.82e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.26e-2)"	"unprognostic (1.64e-5)"	"unprognostic (4.61e-4)"	"unprognostic (2.24e-1)"		"unprognostic (1.15e-2)"	0.0	0.8	4.2	0.0	3.4	0.0	2.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	4.5	0.0	0.0	0.0	0.2	0.8	3.6	0.0	0.4	0.0	0.6	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.5	10.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	4.2	3.4	0.0	3.0	2.6	4.5	0.8	3.6	0.6	0.9	10.5	0.0	0.0	0.0	0.6	1.3	1.6	0.0	1.3	0.0	0.0	5.0	25.3	0.3	2.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.7	0.0	0.1	0.4	0.0	0.0	52.4	0.0	0.0	1.3	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	22.8	0.0	0.1	0.0	2.8	0.0	0.2	0.0	1.0	1.0	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.6	0.0	1.0	0.3	0.7	1.6	0.1	0.1	0.0	0.3	0.0	0.0	0.4
GLRB		ENSG00000109738	"Glycine receptor beta"	P48167	4	157076125-157172090	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.5;parathyroid gland: 33.0"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 168.6;Inhibitory neurons: 110.7;Oligodendrocyte precursor cells: 110.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 28.6;hTERT-RPE1: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052363	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA052363: AB_2681800"	"unprognostic (7.36e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.59e-3)"	"unprognostic (5.65e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.19e-2)"	"unprognostic (2.99e-2)"	"unprognostic (6.81e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (4.89e-4)"	"unprognostic (4.32e-3)"	"unprognostic (1.85e-1)"	"unprognostic (5.61e-2)"	"unprognostic (1.66e-2)"	4.7	7.0	16.5	1.1	17.7	0.2	10.6	7.4	35.5	9.0	4.5	3.3	0.6	2.9	5.2	1.0	7.3	3.2	11.1	18.0	12.9	3.8	1.2	3.1	0.3	9.4	6.9	1.2	15.2	33.0	7.5	2.6	10.8	6.2	0.9	8.5	19.5	4.7	3.3	1.8	1.4	3.7	5.7	0.0	2.9	1.6	9.8	1.1	1.0	4.9	0.2	1.4	1.5	13.5	8.0	3.4	9.5	28.6	18.0	7.2	0.0	16.0	10.1	7.6	14.4	0.0	24.0	0.0	3.7	16.2	9.4	0.0	7.2	2.5	14.3	0.0	9.7	5.0	3.8	0.3	8.1	6.2	0.0	6.4	2.2	13.4	1.9	37.8	6.9	5.1	0.0	0.0	14.1	0.0	0.8	0.0	0.6	0.0	2.3	0.0	13.0	0.0	20.6	1.5	10.3	6.1	0.0	7.3	1.2	1.4	6.8	1.6	10.5	4.5	13.2	7.6	15.3	0.0	0.0	0.0	10.7	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	16.5	17.7	7.4	35.5	18.0	12.9	9.4	6.9	10.8	5.7	9.8	13.5	0.5	0.0	1.1	26.1	0.0	1.1	0.9	3.1	1.2	10.8	7.8	4.8	13.9	4.3	3.5	0.0	2.1	0.4	0.4	0.1	0.0	8.8	0.3	6.9	3.4	2.1	0.0	1.7	168.6	1.8	0.0	3.9	0.0	2.0	1.3	7.0	3.3	0.0	0.1	1.7	110.7	0.0	4.1	0.3	1.9	0.3	0.3	0.1	3.6	15.9	0.6	13.2	0.0	110.1	31.5	1.5	0.0	3.4	0.0	0.6	0.0	0.5	10.4	2.2	0.0	8.5	2.2	1.3	3.3	0.4	0.3	0.1	0.1	1.3	0.1	0.2
GML	LY6DL	ENSG00000104499	"Glycosylphosphatidylinositol anchored molecule like"	Q99445	8	142834247-142916506	"Predicted intracellular proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	56	"adrenal gland: 194.0"	"Cell type enhanced"	"Detected in some"		"granulocytes: 4.5;Sertoli cells: 6.6;Spermatocytes: 24.2;Spermatogonia: 7.5"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"basal ganglia: 2.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"								"Intracellular and membrane"	NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"		"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"																					0.0	194.0	0.0	0.2	2.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.5	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.0	0.0	6.6	0.0	0.0	24.2	7.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0
GNA11	"FBH, FBH2, FHH2, HHC2"	ENSG00000088256	"G protein subunit alpha 11"	P29992	19	3094362-3123999	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		Transducer	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 330.6;Proximal enterocytes: 323.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 5.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048886	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 45: Enterocytes - Digestion"			"HPA048886: AB_2680544"	"unprognostic (4.64e-3)"	"unprognostic (2.21e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.53e-2)"	"prognostic unfavorable (4.86e-4)"	"unprognostic (2.56e-2)"	"unprognostic (1.40e-1)"	"unprognostic (6.26e-2)"	"unprognostic (7.85e-3)"	"unprognostic (2.43e-1)"	"prognostic favorable (1.48e-11)"	"unprognostic (1.05e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.47e-1)"	"unprognostic (3.02e-1)"	33.5	32.5	36.4	16.2	31.2	8.3	32.6	53.8	35.3	31.7	18.9	66.7	117.5	42.4	12.7	28.7	44.5	20.0	51.7	33.5	27.3	40.4	26.2	34.7	7.5	30.3	29.6	32.5	33.9	26.3	29.8	22.3	28.6	40.4	38.7	11.0	33.3	47.1	54.2	34.4	139.3	28.7	26.6	21.4	34.9	50.6	31.3	8.5	32.9	39.2	7.0	38.8	27.0	31.1	56.1	31.2	27.9	48.5	41.7	28.4	30.9	53.8	53.7	71.8	57.8	41.7	27.3	12.0	29.2	76.4	43.6	39.0	37.8	42.7	44.3	30.1	21.9	3.3	35.7	23.6	42.2	3.8	11.8	36.9	36.8	48.4	29.2	36.9	57.8	3.4	27.8	1.9	49.1	25.8	3.0	14.4	20.5	38.4	29.4	23.2	26.4	11.9	33.8	40.8	66.0	40.7	38.3	45.2	27.2	18.9	33.3	7.9	50.0	45.7	33.3	85.4	73.5	1.3	3.9	7.9	33.0	2.9	52.3	2.5	1.4	0.3	0.7	0.7	0.8	0.9	0.5	0.6	0.2	1.1	1.2	0.9	5.1	0.5	1.5	2.3	0.1	0.3	36.4	31.2	53.8	35.3	33.5	27.3	30.3	29.6	28.6	26.6	31.3	31.1	62.3	32.1	24.1	5.2	3.5	32.6	9.5	15.4	13.6	22.7	43.2	47.9	17.8	35.8	12.6	27.6	37.5	13.2	2.4	330.6	7.9	21.4	45.2	26.9	23.0	33.9	54.6	5.2	8.8	25.4	13.5	25.3	29.6	26.1	4.5	24.1	58.2	28.5	9.0	45.4	11.3	84.1	26.4	9.1	16.4	20.0	50.1	5.1	23.2	11.2	1.1	29.0	0.0	7.1	14.1	36.1	96.0	80.5	1.2	16.0	323.0	18.9	35.4	15.8	19.7	28.5	30.5	23.7	8.9	20.6	41.2	20.4	2.0	22.1	94.9	13.4
GNAS	"GNAS1, GNASXL, GPSA, NESP, NESP55, SCG6, SgVI"	ENSG00000087460	"GNAS complex locus"	"O95467, P63092, P84996, Q5JWF2"	20	58839718-58911192	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Transducer	"Cancer-related genes, Cushing syndrome, Disease variant, Dwarfism, Obesity, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Horizontal cells: 1886.1;Late spermatids: 1756.9;Skeletal myocytes: 1998.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010337, HPA018122, HPA027478, HPA028386"	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"	"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	"Plasma membrane, Cytosol"	"CAB010337: AB_631538, HPA018122: AB_1849236, HPA027478: AB_10599284, HPA028386: AB_10601983"	"unprognostic (7.48e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.90e-2)"	"unprognostic (4.77e-2)"	"unprognostic (8.37e-3)"	"unprognostic (2.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (8.01e-2)"	"unprognostic (4.29e-2)"	"prognostic favorable (8.76e-4)"	"unprognostic (2.07e-2)"	"unprognostic (1.58e-1)"	"prognostic unfavorable (3.49e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.61e-1)"	"unprognostic (8.25e-2)"	"unprognostic (1.36e-1)"	784.8	1215.3	1564.4	512.6	1524.7	887.4	578.9	1413.1	1768.3	828.5	1373.3	657.1	492.4	611.4	1253.8	883.1	742.9	672.7	1990.6	1557.3	2716.9	625.0	651.1	640.3	769.2	1710.5	1949.4	766.5	1917.7	1799.4	1153.6	884.6	1963.4	577.3	607.3	731.2	2943.9	594.4	2400.4	526.8	527.3	782.4	1598.4	606.6	587.1	357.9	1882.0	854.4	3432.2	2813.1	800.0	687.1	239.3	1483.9	215.6	897.3	1501.9	663.3	2691.8	1822.3	1200.1	1219.1	1635.0	1937.3	1201.8	2480.5	1446.7	911.9	1670.3	2314.3	1305.6	976.1	1499.0	2195.3	1540.9	401.4	784.6	984.9	1651.7	2232.7	1420.7	641.6	483.0	1566.4	1113.6	875.1	1399.1	1561.0	1669.7	1100.6	692.0	1294.6	1319.1	4131.0	1759.5	1452.8	487.9	214.0	894.4	1436.7	1287.3	1589.4	2165.5	1315.8	1818.3	3853.2	2157.6	2117.1	1354.2	1921.8	1570.0	1581.7	1343.3	2210.2	1477.0	688.5	1452.3	1314.0	993.3	1583.2	900.0	473.7	1107.1	217.9	96.7	114.2	68.9	127.3	80.0	103.2	73.4	74.8	129.2	93.6	65.8	82.6	103.4	95.6	150.3	174.9	92.7	100.9	1564.4	1524.7	1413.1	1768.3	1557.3	2716.9	1710.5	1949.4	1963.4	1598.4	1882.0	1483.9	982.6	221.2	258.8	192.0	310.8	130.4	182.0	130.0	205.5	397.8	465.6	684.4	1025.3	237.4	212.2	261.1	56.3	832.6	390.8	357.3	444.1	233.9	734.9	487.7	515.7	518.3	463.1	252.1	232.5	228.9	342.0	380.9	196.3	685.0	138.6	542.3	380.1	256.4	379.1	1886.1	439.7	327.2	181.0	380.4	405.7	1756.9	265.3	437.1	222.3	236.1	204.0	1367.2	137.0	194.5	166.6	339.9	300.0	197.1	309.7	268.1	273.7	153.6	218.0	222.0	210.4	1998.0	560.4	226.0	73.6	240.5	117.8	1211.7	301.8	860.9	304.4	316.5
GNB1		ENSG00000078369	"G protein subunit beta 1"	P62873	1	1785285-1891117	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer	"Cancer-related genes, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	11	"retina: 2629.0"	"Cell type enriched"	"Detected in all"	5	"Rod photoreceptor cells: 1373.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040736	Supported		Approved	"Golgi apparatus,Plasma membrane"		NA	NA		1900000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Golgi apparatus"	"HPA040736: AB_2677106"	"unprognostic (9.49e-2)"	"unprognostic (4.91e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.34e-1)"	"unprognostic (9.07e-3)"	"prognostic unfavorable (3.61e-6)"	"unprognostic (1.99e-2)"	"unprognostic (3.60e-1)"	"unprognostic (7.27e-2)"	"unprognostic (8.47e-3)"	"unprognostic (1.95e-1)"	"unprognostic (9.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (4.62e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.90e-2)"	178.1	123.8	167.9	179.9	212.3	147.6	119.7	147.8	234.4	124.3	87.1	165.7	173.7	127.1	90.8	126.7	114.4	110.9	119.6	228.3	172.0	125.1	103.3	146.7	160.0	159.5	153.2	130.2	105.9	148.2	106.8	141.1	169.5	118.3	123.1	2629.0	120.6	118.9	66.8	111.8	208.2	156.1	131.6	142.6	129.7	99.0	168.9	167.3	113.6	97.1	145.6	152.6	102.7	203.9	373.2	344.2	400.2	280.4	222.4	242.4	154.4	515.4	339.9	456.2	355.2	282.8	361.8	385.5	369.3	522.5	258.6	192.0	405.5	373.5	411.4	595.9	199.2	375.0	308.2	325.6	279.1	227.7	394.4	216.4	256.6	437.2	402.9	306.1	376.8	298.8	236.8	337.8	440.0	230.3	501.9	177.4	230.8	190.0	275.0	482.9	308.7	306.4	310.8	227.5	489.9	556.5	477.1	306.6	420.5	272.8	214.8	305.9	579.4	399.3	267.5	314.8	379.1	227.1	432.8	888.7	341.4	470.1	230.5	11.4	13.3	21.9	9.9	16.4	9.1	9.0	9.9	11.2	13.3	9.6	6.7	7.2	22.1	12.8	17.5	22.7	12.5	8.2	167.9	212.3	147.8	234.4	228.3	172.0	159.5	153.2	169.5	131.6	168.9	203.9	172.0	70.5	42.6	57.5	67.9	86.3	51.6	47.4	33.0	149.8	65.3	57.8	60.6	52.9	42.4	75.4	175.2	44.2	124.4	140.9	46.9	88.0	29.1	93.3	112.9	131.6	122.9	40.3	102.4	100.5	99.4	77.8	52.0	121.6	53.8	101.9	95.3	60.3	100.8	180.0	101.9	95.5	40.7	152.7	114.6	33.8	76.1	128.0	53.4	115.2	119.5	250.3	73.2	70.9	110.1	175.4	91.0	88.0	75.3	100.5	167.6	67.4	41.1	1373.7	78.9	71.0	105.9	68.8	67.1	51.6	101.7	36.4	74.5	83.7	83.0	94.1
GNB2		ENSG00000172354	"G protein subunit beta 2"	P62879	7	100673567-100679174	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010032, HPA040736"	Approved		Supported	"Plasma membrane"		NA	NA		940000	"Cluster 52: Eosinophils - Transcription"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 10: Non-specific - Unknown function"	"Plasma membrane"		"CAB010032: AB_2263466, HPA040736: AB_2677106"	"unprognostic (1.55e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.01e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.68e-3)"	"unprognostic (3.52e-1)"	"unprognostic (6.58e-2)"	"unprognostic (2.54e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.75e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.29e-2)"	"unprognostic (2.98e-1)"	198.4	211.0	131.4	128.3	137.3	207.5	188.0	112.3	179.6	209.4	103.8	168.0	103.2	182.4	63.7	328.4	179.8	105.5	175.9	130.2	138.1	186.1	185.8	210.1	107.9	140.3	130.1	175.3	184.8	98.9	203.3	107.4	123.6	183.0	83.6	20.1	190.8	113.6	175.9	295.5	143.5	113.5	126.3	225.9	172.4	92.9	137.6	90.2	144.8	90.2	105.7	165.2	217.7	120.7	358.6	268.6	222.7	272.5	169.8	199.9	194.3	208.4	288.4	294.3	241.7	205.3	333.7	157.7	216.0	311.3	332.2	243.0	177.7	312.6	103.0	216.9	152.1	120.8	198.7	171.3	282.4	157.7	254.5	259.5	291.1	304.2	244.6	237.6	343.6	132.5	228.6	303.3	270.4	980.0	249.5	450.3	173.5	225.1	290.1	234.3	136.3	253.8	235.4	291.3	241.0	380.1	278.0	449.2	201.3	125.3	192.4	192.1	325.8	313.8	346.8	619.2	266.6	88.8	111.9	240.9	237.1	349.7	443.6	27.6	28.6	70.9	17.5	42.7	16.2	13.6	17.9	15.4	28.1	18.1	11.8	12.4	117.2	15.4	35.9	23.8	23.5	12.5	131.4	137.3	112.3	179.6	130.2	138.1	140.3	130.1	123.6	126.3	137.6	120.7	138.1	57.7	97.0	16.0	104.1	151.8	159.3	72.9	148.0	10.4	105.4	106.0	35.0	100.1	55.5	84.6	4.2	172.4	89.4	285.4	162.4	163.7	32.6	133.5	106.8	136.5	180.4	127.7	12.7	218.7	312.1	117.6	135.1	127.2	44.4	97.6	126.0	69.9	264.4	72.3	10.8	211.2	75.3	198.6	198.8	20.1	144.8	193.5	140.5	15.9	160.8	128.2	96.8	5.0	6.9	257.1	285.6	130.1	122.5	226.5	162.3	107.0	68.3	8.5	65.7	62.0	162.2	34.3	69.6	240.7	194.8	293.9	117.8	88.1	192.2	259.5
GNGT2	GNG9	ENSG00000167083	"G protein subunit gamma transducin 2"	O14610	17	49202791-49210574	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"		Transducer		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 157.0"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 73.0;Kupffer cells: 26.5;NK-cells: 52.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 66.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 64.8;HDLM-2: 54.5;HUVEC TERT2: 19.4;RH-30: 21.6;TIME: 19.9;U-698: 18.2"	"Low region specificity"	"Detected in all"							HPA043381	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA043381: AB_2678455"	"unprognostic (9.11e-2)"	"unprognostic (4.09e-3)"	"unprognostic (1.99e-2)"	"unprognostic (4.62e-5)"	"unprognostic (1.34e-1)"	"unprognostic (3.20e-3)"	"unprognostic (1.75e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.11e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.14e-1)"	"prognostic unfavorable (3.11e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.92e-2)"	"unprognostic (1.23e-1)"	3.1	2.6	2.7	7.7	3.0	2.5	1.8	3.4	4.0	2.3	3.0	2.9	3.5	2.4	0.6	2.7	2.0	4.5	3.0	2.7	3.7	4.4	3.4	7.2	14.1	3.9	3.2	1.5	1.6	1.0	1.2	2.7	3.7	2.1	3.8	157.0	1.1	1.3	0.9	0.9	5.2	3.7	3.4	19.9	2.4	0.8	3.3	5.5	2.4	2.7	18.4	3.3	1.6	4.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	2.3	1.5	1.0	0.9	0.3	0.0	64.8	0.7	0.1	0.0	0.0	0.0	0.1	4.6	54.5	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.7	0.1	0.0	19.4	8.8	0.0	0.4	1.5	0.0	4.6	3.6	0.6	0.0	0.0	12.0	21.6	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.3	19.9	0.0	12.6	0.0	0.1	0.2	2.9	18.2	0.3	0.2	0.0	0.1	8.8	1.1	30.4	47.3	27.3	3.7	4.6	21.1	20.3	4.5	2.9	11.7	1.9	26.7	66.7	1.9	3.4	12.7	2.7	3.0	3.4	4.0	2.7	3.7	3.9	3.2	3.7	3.4	3.3	4.6	4.5	0.0	1.1	0.0	4.6	0.4	0.0	0.0	0.0	2.7	0.2	0.3	0.8	0.0	0.6	0.0	73.0	0.0	15.5	0.0	3.9	0.0	1.1	0.1	0.1	5.2	0.0	8.0	0.2	0.0	0.1	0.8	0.5	0.1	0.0	0.1	2.5	0.1	11.1	0.0	0.4	0.0	0.0	26.5	2.0	8.2	0.6	13.6	0.0	1.0	9.5	5.9	52.5	0.0	0.1	0.0	0.0	0.0	3.5	0.1	0.0	0.2	0.0	14.8	6.6	0.1	0.3	0.1	0.1	0.0	0.1	0.3	11.4	0.4	0.0	0.0
GNLY	"D2S69E, LAG-2, LAG2, NKG5, TLA519"	ENSG00000115523	Granulysin	P22749	2	85685175-85698852	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 288.7;endometrium 1: 71.9;lymphoid tissue: 86.3"	"Group enriched"	"Detected in many"	5	"dendritic cells: 5070.6;NK-cells: 8318.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"NK-cell: 17623.2"	"Group enriched"	"Detected in all"	63	"NK-cells: 17623.2;T-cells: 7874.6"	"Not detected"	"Not detected"							"Low region specificity"	"Detected in many"			"CAB025186, HPA058021"	Enhanced				"Secreted to blood"	NA	NA	2920000	17000	"Cluster 48: NK-cells - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"		"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025186: , HPA058021: AB_2683581"	"unprognostic (5.80e-2)"	"unprognostic (5.64e-3)"	"unprognostic (6.68e-2)"	"prognostic favorable (3.48e-5)"	"unprognostic (4.34e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.60e-1)"	"unprognostic (2.79e-2)"	"prognostic favorable (6.60e-5)"	"unprognostic (2.61e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.82e-1)"	"prognostic unfavorable (1.50e-4)"	"unprognostic (8.46e-2)"	"unprognostic (3.37e-1)"	"unprognostic (1.86e-1)"	"prognostic favorable (8.07e-4)"	6.9	2.7	8.1	11.6	7.8	288.7	5.2	8.1	18.7	4.3	7.1	5.7	4.0	71.9	3.9	2.6	6.1	6.5	4.3	7.8	9.8	2.9	10.4	36.8	21.9	12.7	11.6	1.5	1.2	0.8	1.8	17.0	10.6	2.0	6.1	0.5	2.0	5.3	9.2	1.5	10.3	4.3	8.8	86.3	5.0	0.9	9.8	3.5	3.6	3.5	17.6	6.4	2.5	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.4	0.1	0.0	177.1	26.2	17.7	7874.6	26.3	2145.8	34.2	837.4	3344.7	22.4	23.0	231.3	2928.7	202.5	17623.2	32.3	58.2	40.3	8118.6	8.1	7.8	8.1	18.7	7.8	9.8	12.7	11.6	10.6	8.8	9.8	9.8	26.8	12.8	78.9	0.0	23.3	7.0	0.2	0.0	0.0	0.1	7.2	3.7	3.0	10.0	6.2	0.0	2.1	2.3	5070.6	1.3	1.9	1.9	0.0	7.5	12.0	13.0	1.8	47.2	0.2	0.0	3.4	29.3	0.5	10.6	52.4	0.1	23.2	5.3	6.0	0.0	0.1	3.3	0.0	22.4	7.2	0.2	0.3	28.4	80.0	9.4	48.6	0.1	8318.3	0.0	0.1	0.0	1.2	0.0	247.4	0.1	2.4	9.5	3.6	0.2	0.0	7.0	5.4	0.2	0.6	0.6	7.7	1.1	1230.0	1.0	1.6	0.6
GNRHR	"GRHR, LHRHR"	ENSG00000109163	"Gonadotropin releasing hormone receptor"	P30968	4	67737118-67754388	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"pituitary gland: 5.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1.2;Inhibitory neurons: 1.3;Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							HPA013424	Enhanced					NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA013424: AB_2668840"	"unprognostic (2.77e-1)"	"unprognostic (1.58e-1)"	"unprognostic (4.05e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.09e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.01e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (9.03e-2)"	"unprognostic (3.23e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.22e-3)"	"unprognostic (3.99e-2)"	0.0	0.7	0.4	0.1	0.7	0.0	0.0	0.2	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.8	0.1	0.1	0.0	0.3	0.8	0.5	0.1	0.1	0.0	5.4	0.0	1.2	0.1	0.0	0.5	0.1	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.1	0.0	0.3	0.9	0.0	0.3	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.6	0.0	0.0	0.1	0.2	0.1	0.2	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.2	1.0	0.3	0.8	0.8	0.5	1.2	0.5	0.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
GOLGA5	"golgin-84, GOLIM5, ret-II, rfg5"	ENSG00000066455	"Golgin A5"	Q8TBA6	14	92794305-92839947	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000992, HPA063876"	Enhanced	Supported	Supported	"Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA000992: AB_1079009, HPA063876: AB_2685140"	"unprognostic (2.06e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.15e-1)"	"unprognostic (1.78e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (7.67e-2)"	"unprognostic (6.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.49e-2)"	26.0	23.3	21.4	18.2	23.7	10.4	33.1	22.4	26.4	32.2	23.9	26.4	23.3	21.9	54.2	25.0	19.2	24.0	21.5	20.8	22.3	25.5	54.3	22.4	18.8	22.6	22.4	20.6	32.2	33.6	23.5	28.2	23.1	31.2	32.5	15.8	32.4	25.8	26.9	23.3	22.9	26.0	22.6	19.1	32.9	34.3	22.1	16.9	33.2	20.0	23.3	24.1	19.6	25.9	32.4	29.4	25.9	23.7	53.1	71.4	44.3	43.9	80.4	41.9	49.2	21.8	43.4	21.0	35.1	70.2	29.2	33.4	23.1	35.9	56.6	25.8	11.2	19.9	14.0	29.3	61.5	23.3	31.8	55.1	63.7	29.5	60.6	46.2	42.0	21.8	17.7	27.3	46.5	60.1	18.1	19.6	16.1	70.2	31.0	13.9	37.9	21.1	42.8	38.9	18.4	26.0	40.0	29.6	45.7	35.7	51.0	25.6	35.0	23.9	15.6	31.3	22.2	33.3	27.6	18.2	54.9	18.2	40.8	10.4	10.0	23.6	10.3	13.0	11.8	9.5	10.4	10.6	9.9	9.5	9.2	8.1	8.8	8.7	11.9	9.1	12.9	6.7	21.4	23.7	22.4	26.4	20.8	22.3	22.6	22.4	23.1	22.6	22.1	25.9	18.7	28.9	26.3	8.8	15.7	7.8	11.2	17.9	16.5	7.5	16.2	11.9	26.8	8.6	19.6	14.7	12.5	23.7	17.2	23.8	29.4	25.3	31.6	17.6	24.6	16.7	22.3	15.8	17.6	32.7	32.0	21.7	33.1	25.7	9.5	29.7	13.9	33.5	15.4	25.2	15.6	31.6	4.1	14.7	10.3	18.5	23.0	14.6	12.4	15.0	18.2	15.6	16.5	14.6	21.9	28.9	12.0	25.2	29.2	19.4	19.9	24.2	18.7	10.7	26.3	18.0	19.3	34.1	37.0	16.5	11.4	50.3	15.9	15.6	16.5	16.5
GOLGA7	"GCP16, GOLGA3AP1, GOLGA7A, HSPC041"	ENSG00000147533	"Golgin A7"	Q7Z5G4	8	41490396-41510980	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046878	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA046878: AB_2679854"	"unprognostic (2.93e-1)"	"unprognostic (9.56e-2)"	"unprognostic (8.68e-2)"	"prognostic unfavorable (1.36e-4)"	"unprognostic (1.22e-1)"	"unprognostic (3.01e-2)"	"unprognostic (6.74e-2)"	"unprognostic (1.91e-1)"	"unprognostic (2.80e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.56e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.88e-1)"	41.3	31.5	73.8	28.7	91.2	42.6	34.1	78.5	112.3	30.5	56.6	29.9	31.6	33.6	27.9	34.5	23.2	33.3	28.1	73.6	78.2	42.8	46.9	30.3	36.9	84.1	83.6	31.2	32.4	33.7	15.8	48.6	82.3	30.6	26.0	31.7	38.8	26.5	25.5	47.8	32.1	32.0	75.4	36.3	28.5	40.8	76.6	36.5	28.5	29.8	32.0	33.1	24.8	110.0	58.2	64.9	48.2	56.1	59.8	51.7	36.8	49.6	48.5	57.2	63.0	115.8	53.3	27.9	64.4	46.7	54.6	39.6	48.0	38.6	63.5	39.3	42.7	56.5	36.7	48.0	65.3	26.2	45.3	45.6	71.1	36.6	54.1	46.3	56.5	49.4	68.1	53.9	46.7	42.6	83.6	70.7	54.1	53.1	31.2	50.4	86.8	30.6	66.9	53.3	86.1	55.5	44.6	34.4	90.7	40.3	70.5	49.9	58.9	48.2	46.4	61.7	44.0	40.7	67.7	40.7	51.3	44.5	68.3	204.9	78.1	78.8	83.9	68.5	82.2	34.8	79.4	76.9	59.2	32.9	65.8	65.9	136.7	78.0	68.1	40.5	94.9	139.7	73.8	91.2	78.5	112.3	73.6	78.2	84.1	83.6	82.3	75.4	76.6	110.0	74.6	6.4	22.9	11.8	31.4	110.4	53.9	63.1	44.3	28.3	48.3	42.9	25.5	28.6	38.4	29.5	4.2	61.2	69.6	29.5	95.9	62.7	22.2	28.1	43.1	57.4	42.5	33.9	15.8	48.0	68.4	55.0	29.6	36.5	17.7	35.4	52.5	46.6	64.3	18.5	17.8	30.3	59.0	69.7	95.2	21.7	45.1	53.7	60.5	13.1	65.5	77.9	87.6	14.6	90.5	55.1	21.0	62.1	31.2	77.0	53.2	120.5	28.4	30.7	59.2	49.2	60.4	152.3	135.0	43.5	108.5	85.9	69.5	38.1	30.5	55.4
GOPC	"CAL, dJ94G16.2, FIG, GOPC1, PIST"	ENSG00000047932	"Golgi associated PDZ and coiled-coil motif containing"	Q9HD26	6	117560269-117602542	"Cancer-related genes, Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA019477, HPA024018"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA019477: AB_1849890, HPA024018: AB_1849891"	"unprognostic (2.48e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.71e-1)"	"unprognostic (5.56e-2)"	"unprognostic (1.84e-2)"	"unprognostic (3.17e-2)"	"unprognostic (3.12e-2)"	"unprognostic (9.21e-2)"	"unprognostic (6.22e-2)"	"unprognostic (6.77e-2)"	"unprognostic (8.23e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.40e-2)"	"unprognostic (2.67e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.55e-2)"	"unprognostic (3.01e-2)"	15.5	14.2	14.6	15.8	14.9	7.1	20.2	15.6	18.0	23.4	11.0	18.7	12.2	23.5	18.0	12.1	17.4	16.3	22.1	15.9	13.3	14.5	16.4	13.6	19.9	12.5	12.5	25.6	12.7	22.1	16.1	19.9	13.1	16.2	20.3	13.5	14.3	17.3	15.8	18.7	15.0	18.4	13.6	16.9	14.9	17.7	12.6	21.0	23.9	17.4	17.2	15.1	14.7	16.8	14.1	15.0	19.1	25.6	40.1	47.9	30.3	57.1	41.7	30.6	31.5	23.1	15.5	42.2	24.3	32.4	60.4	31.2	37.2	27.6	42.8	21.2	20.8	38.7	39.9	37.5	42.4	52.2	24.8	57.4	74.9	22.8	65.7	60.6	26.5	29.0	36.7	16.8	62.2	12.9	21.8	40.3	16.5	24.0	16.0	33.0	37.0	30.8	23.3	12.9	26.7	21.0	57.6	19.7	15.8	36.3	14.3	49.7	31.8	2.2	27.9	28.5	62.6	29.9	28.8	35.4	37.9	43.4	23.9	10.5	4.2	3.2	6.7	3.9	9.3	7.9	7.1	7.1	5.5	7.7	8.2	8.5	2.9	9.2	4.7	9.2	7.7	4.1	14.6	14.9	15.6	18.0	15.9	13.3	12.5	12.5	13.1	13.6	12.6	16.8	43.2	22.4	22.7	46.4	33.4	46.7	25.1	63.9	46.7	59.2	47.0	67.3	46.2	34.3	32.2	20.2	22.9	77.0	28.6	40.4	27.4	27.9	35.1	30.4	77.4	38.1	33.6	26.5	52.9	25.6	62.4	48.3	30.1	30.6	31.1	50.4	35.0	38.7	38.5	74.0	46.2	65.2	24.4	24.2	22.9	13.7	42.3	27.0	28.4	32.8	24.1	39.3	35.0	73.9	64.5	21.1	40.9	42.2	38.7	40.3	20.9	27.1	35.3	35.9	32.9	50.0	44.3	115.6	51.4	36.7	59.8	52.3	38.7	43.3	37.7	27.3
GOT2	"KAT4, KATIV, KYAT4, mitAAT"	ENSG00000125166	"Glutamic-oxaloacetic transaminase 2"	P00505	16	58707131-58734342	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid transport, Transport"	"Aminotransferase, Transferase"	"Cancer-related genes, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 698.4;tongue: 726.8"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 341.9;Hepatocytes: 176.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018139, HPA058537"	Enhanced				"Intracellular and membrane"	NA	NA		2800000	"Cluster 13: T-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA018139: AB_1849903, HPA058537: "	"unprognostic (1.50e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.73e-3)"	"unprognostic (2.63e-3)"	"unprognostic (3.02e-2)"	"prognostic unfavorable (1.61e-4)"	"prognostic favorable (5.75e-5)"	"unprognostic (1.12e-2)"	"unprognostic (3.19e-1)"	"unprognostic (3.72e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.00e-1)"	"prognostic favorable (2.90e-9)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.56e-2)"	"unprognostic (2.22e-1)"	19.6	73.9	52.4	27.4	55.9	21.1	36.3	62.5	66.9	34.1	129.4	57.6	37.4	36.5	66.3	66.9	46.7	24.1	313.2	57.9	59.3	88.0	321.4	25.2	35.6	60.6	51.0	29.4	33.2	98.6	46.7	24.7	62.5	59.0	65.0	91.4	47.7	65.7	698.4	41.1	35.7	46.7	50.1	28.5	54.9	28.9	58.7	35.9	42.6	726.8	57.0	57.0	45.1	61.0	137.2	182.4	93.8	114.8	66.6	59.8	122.0	101.4	108.8	197.6	107.7	158.9	120.1	302.3	117.3	114.6	86.5	195.5	203.2	199.2	250.1	83.1	182.0	81.4	92.1	179.3	84.2	132.3	71.9	58.4	110.9	125.2	108.2	112.4	201.8	141.9	167.0	30.6	102.2	122.5	164.0	128.0	127.7	90.8	338.0	177.8	142.7	291.1	187.9	197.7	148.2	107.6	195.2	208.5	74.8	84.2	105.5	42.7	82.3	71.4	129.3	56.2	132.4	69.9	68.6	247.4	76.7	130.9	73.8	4.6	20.6	7.4	28.3	16.9	43.7	26.5	33.1	34.1	34.7	22.3	30.1	28.4	1.8	30.2	18.4	30.0	48.7	31.2	52.4	55.9	62.5	66.9	57.9	59.3	60.6	51.0	62.5	50.1	58.7	61.0	15.1	9.6	15.8	11.8	19.8	32.0	37.0	39.4	34.1	34.5	27.5	16.3	341.9	22.8	22.5	36.8	77.2	42.6	11.8	42.6	56.7	50.8	4.0	30.4	20.0	23.8	20.5	39.3	24.7	42.5	38.8	21.1	30.1	25.4	14.5	37.5	23.2	176.1	39.1	20.2	27.1	33.5	26.4	17.0	15.1	8.1	18.0	13.5	24.9	5.6	12.7	16.1	8.2	11.6	17.6	40.3	13.3	22.6	39.2	38.2	27.6	63.2	17.5	48.9	0.0	15.2	24.0	11.9	15.0	68.9	30.0	23.7	17.4	36.4	54.4	69.6
GPBAR1	"BG37, GPCR, GPCR19, GPR131, M-BAR, MGC40597, TGR5"	ENSG00000179921	"G protein-coupled bile acid receptor 1"	Q8TDU6	2	218259496-218263861	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 31.9;breast: 17.8;gallbladder: 17.3"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 20.3;Enteroendocrine cells: 46.0;Hofbauer cells: 16.3;Kupffer cells: 50.6;Macrophages: 19.9;monocytes: 45.3"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 3.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"classical monocyte: 288.1;intermediate monocyte: 712.0;non-classical monocyte: 695.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 712.0"	"Cell line enhanced"	"Detected in some"		"ASC diff: 1.1;HHSteC: 1.7;U-937: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA062890	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA062890: AB_2684896"	"unprognostic (8.47e-2)"	"unprognostic (3.72e-3)"	"unprognostic (1.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.44e-2)"	"unprognostic (4.66e-2)"	"unprognostic (2.54e-1)"	"unprognostic (2.63e-1)"	"unprognostic (8.76e-3)"	"unprognostic (4.32e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.55e-1)"	"unprognostic (7.40e-7)"	"unprognostic (4.18e-2)"	"unprognostic (4.14e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.29e-1)"	31.9	1.6	0.1	2.7	0.2	2.2	17.8	0.4	0.7	0.6	0.2	3.8	1.0	0.9	0.0	0.5	1.2	17.3	5.1	0.2	0.1	5.3	1.9	2.2	0.8	0.1	0.1	1.8	1.7	0.0	0.8	3.9	0.1	1.1	0.5	0.0	0.8	0.3	0.5	1.4	4.9	10.1	0.1	7.5	6.4	2.4	0.3	0.4	1.7	0.7	0.2	4.8	0.8	0.1	0.1	0.0	0.1	0.0	1.1	0.0	0.3	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.1	1.7	0.1	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.9	0.8	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.3	0.0	0.1	1.9	0.1	0.6	288.1	0.4	0.7	712.0	0.7	0.2	0.5	0.7	140.2	0.7	0.6	0.4	6.5	0.5	695.6	6.0	0.9	156.5	0.1	0.2	0.4	0.7	0.2	0.1	0.1	0.1	0.1	0.1	0.3	0.1	6.2	0.0	3.4	0.0	1.1	0.3	0.2	0.2	0.0	0.0	0.1	0.3	0.5	1.5	0.1	3.7	0.0	0.5	1.8	0.2	11.7	0.2	8.2	1.0	20.3	1.5	46.0	0.0	0.0	0.5	4.5	2.8	6.6	0.8	1.3	6.2	1.8	0.0	16.3	0.0	0.0	2.7	0.0	50.6	1.2	1.9	3.4	19.9	0.0	1.9	45.3	0.0	0.0	0.0	0.0	0.5	1.5	2.6	0.3	0.3	0.4	0.2	0.0	0.0	0.0	0.0	3.7	0.1	0.0	0.1	0.4	1.6	0.8	0.1	0.2	0.4
GPER1	"CEPR, CMKRL2, DRY12, FEG-1, GPCR-Br, GPER, GPR30, LERGU, LERGU2, LyGPR"	ENSG00000164850	"G protein-coupled estrogen receptor 1"	Q99527	7	1082208-1093815	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Immunity, Inflammatory response, Innate immunity, Neurogenesis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 45.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 9.6;Distal enterocytes: 15.4;Endothelial cells: 11.3;Hepatocytes: 23.5;Kupffer cells: 16.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.9;intermediate monocyte: 2.8;myeloid DC: 5.8"	"Group enriched"	"Detected in many"	19	"dendritic cells: 5.8;monocytes: 2.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 11.5;Daudi: 12.1;fHDF/TERT166: 8.6;Hep G2: 22.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016718, HPA027052"	Approved		Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	Nucleoli	"Nucleoplasm, Vesicles, Cytosol"	"HPA016718: , HPA027052: AB_10612112"	"unprognostic (4.74e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.09e-2)"	"prognostic favorable (1.17e-4)"	"unprognostic (2.17e-1)"	"unprognostic (6.17e-2)"	"unprognostic (3.45e-1)"	"unprognostic (6.38e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.26e-2)"	"unprognostic (7.78e-2)"	10.6	12.6	12.7	1.5	11.7	0.2	8.4	9.0	15.9	5.4	8.1	10.8	0.6	5.8	0.3	2.2	4.3	1.2	7.1	10.0	9.6	9.7	27.9	12.1	1.9	9.9	10.2	2.4	2.1	0.4	6.1	6.3	10.5	7.2	1.4	0.9	2.9	5.0	4.3	2.8	3.6	1.8	8.4	8.5	45.3	1.5	11.6	0.9	9.7	1.3	1.0	6.1	4.7	9.2	1.1	0.4	0.3	11.5	2.7	2.6	1.1	6.7	4.4	2.1	3.7	0.2	0.3	12.1	1.1	8.6	0.1	0.6	0.1	0.0	0.2	2.6	2.1	0.0	1.4	22.8	0.4	0.1	0.7	1.5	0.0	1.3	0.0	1.6	0.6	0.2	0.1	0.1	0.5	0.8	0.0	0.4	2.2	2.4	7.9	1.1	0.0	0.0	0.2	0.0	0.1	4.5	0.0	0.5	2.5	0.8	0.2	0.1	1.6	0.4	2.8	6.9	2.1	0.0	0.0	4.4	3.8	0.2	0.2	0.0	2.9	0.0	0.0	2.8	0.0	0.2	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	1.4	12.7	11.7	9.0	15.9	10.0	9.6	9.9	10.2	10.5	8.4	11.6	9.2	9.6	0.0	0.0	1.0	1.2	0.5	0.0	0.5	1.8	0.0	0.5	0.5	2.8	0.0	0.0	5.5	0.0	0.0	0.0	15.4	0.0	0.1	0.0	4.4	0.1	11.3	1.2	0.0	0.8	3.1	0.6	1.5	0.5	1.0	0.0	0.4	1.1	23.5	0.6	0.0	0.5	2.8	0.0	16.9	2.7	0.7	2.8	2.9	0.0	1.9	0.6	4.4	0.0	0.5	0.1	0.8	7.4	1.2	0.1	0.8	0.2	5.6	0.0	0.4	0.0	0.7	7.2	0.5	2.7	0.1	0.3	0.0	0.0	0.1	2.0	0.1
GPR107	"FLJ20998, KIAA1624, LUSTR1, RP11-88G17"	ENSG00000148358	"G protein-coupled receptor 107"	Q5VW38	9	130053426-130140169	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031704	Supported		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 21: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Golgi apparatus"	Nucleoplasm	"HPA031704: AB_10601018"	"prognostic unfavorable (3.56e-5)"	"unprognostic (7.48e-2)"	"unprognostic (6.76e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.35e-2)"	"unprognostic (2.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.85e-1)"	"prognostic favorable (1.87e-5)"	"unprognostic (4.10e-2)"	"unprognostic (5.83e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.34e-3)"	18.9	17.3	21.0	15.1	22.1	12.2	20.3	21.9	21.3	20.1	24.4	21.3	11.6	18.8	15.3	18.7	22.0	16.1	18.3	19.5	23.9	20.5	13.0	20.3	11.0	23.4	25.3	17.9	18.8	28.7	16.6	23.3	25.6	23.6	22.6	26.3	18.3	19.9	17.8	22.7	12.9	23.2	21.8	13.4	16.7	17.3	23.5	14.3	34.9	17.0	14.2	15.8	14.2	23.8	29.7	42.0	39.6	31.7	42.4	44.6	39.9	45.9	52.5	37.9	37.5	40.6	39.5	16.4	33.4	52.1	44.5	73.0	30.7	28.6	32.3	24.7	20.3	17.0	49.1	23.8	40.9	36.2	24.4	37.5	44.3	38.1	38.7	44.1	35.9	19.0	25.0	15.8	33.6	36.6	19.4	14.7	26.8	60.0	31.7	18.3	58.7	25.9	32.1	40.2	13.6	30.7	59.8	42.8	33.1	34.9	75.0	19.3	42.9	48.1	25.1	40.3	35.3	9.8	35.6	15.2	43.5	17.0	46.9	1.5	2.8	1.9	0.7	3.4	1.0	1.0	0.7	0.8	1.8	1.0	0.5	1.2	3.3	0.9	3.6	1.1	0.7	1.3	21.0	22.1	21.9	21.3	19.5	23.9	23.4	25.3	25.6	21.8	23.5	23.8	14.8	25.6	19.3	47.7	8.0	6.4	5.1	14.8	5.2	16.9	17.8	12.2	23.0	14.3	16.4	16.5	39.6	15.4	11.4	20.7	0.0	13.4	6.5	23.7	19.3	14.3	9.6	4.6	32.7	17.6	19.2	16.2	16.8	26.4	6.3	17.9	24.3	11.6	15.1	18.5	39.7	19.4	6.1	17.0	17.6	5.7	19.0	13.8	14.2	22.5	15.6	11.0	9.2	38.2	48.6	21.9	15.9	19.2	11.2	13.2	9.3	6.5	24.5	15.5	0.0	16.3	15.3	16.2	11.5	12.2	10.9	26.7	10.4	13.5	18.4	10.9
GPR137B	TM7SF1	ENSG00000077585	"G protein-coupled receptor 137B"	O60478	1	236142505-236221865	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 135.6"	"Cell type enhanced"	"Detected in many"		"Langerhans cells: 139.0;Muller glia cells: 226.0;Proximal tubular cells: 115.1;Rod photoreceptor cells: 171.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 17.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 17.6;monocytes: 7.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 82.8;SK-MEL-30: 220.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026422	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA026422: AB_1849338"	"unprognostic (1.59e-3)"	"unprognostic (6.89e-2)"	"prognostic unfavorable (1.63e-4)"	"unprognostic (6.49e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.54e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.73e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.44e-1)"	15.8	6.9	33.4	15.4	39.4	6.4	13.7	35.6	39.8	25.2	18.8	11.4	9.7	19.1	39.9	9.1	6.1	20.3	22.2	32.8	35.4	68.1	22.1	16.7	18.4	36.9	38.3	12.2	3.7	13.1	3.3	30.0	37.3	10.4	10.8	135.6	6.2	14.7	1.4	18.8	8.7	15.9	34.2	16.4	11.0	3.5	37.3	6.3	15.1	5.0	16.9	28.7	13.2	38.1	5.6	7.8	6.4	5.7	82.8	46.6	2.0	12.3	27.5	7.4	10.3	1.8	6.7	0.9	19.1	13.0	16.7	4.3	8.4	7.6	7.2	5.4	15.8	3.2	1.0	1.4	11.7	4.3	29.7	30.5	25.4	5.7	2.8	23.3	12.0	7.6	0.5	0.1	12.6	6.7	3.6	1.7	3.1	2.4	2.9	6.1	10.0	2.4	10.8	20.1	4.6	9.3	4.2	16.9	220.5	4.9	22.1	7.5	10.7	11.2	7.8	26.2	12.1	1.0	7.2	0.8	6.7	3.1	17.3	17.6	0.9	9.6	0.9	4.1	0.4	0.5	0.6	2.7	1.1	0.3	0.3	0.8	0.1	0.1	7.3	0.3	1.7	0.4	33.4	39.4	35.6	39.8	32.8	35.4	36.9	38.3	37.3	34.2	37.3	38.1	7.3	0.0	1.7	17.6	10.3	25.7	22.2	8.0	14.2	31.9	8.2	4.8	23.0	7.2	5.1	12.9	35.5	46.7	9.7	1.1	17.6	14.4	0.1	1.9	10.2	7.1	8.5	4.0	14.8	10.4	9.9	19.3	6.6	2.1	20.3	2.8	11.7	4.1	88.0	52.2	15.4	2.7	0.0	81.4	139.0	0.9	9.0	55.0	69.4	8.4	83.8	226.0	4.1	30.2	14.9	11.1	2.7	6.0	8.4	21.4	2.2	115.1	6.1	171.2	0.0	7.1	10.5	0.1	1.1	9.4	19.9	40.8	19.9	3.5	2.7	29.8
GPR139	PGR3	ENSG00000180269	"G protein-coupled receptor 139"	Q6DWJ6	16	20028239-20073890	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	10	"brain: 4.9"	"Cell type enhanced"	"Detected in single"		"Oligodendrocyte precursor cells: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA046596	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 68: Oligodendrocytes - Mixed function"			"HPA046596: AB_2679713"					"unprognostic (2.94e-1)"													0.0	0.0	0.3	0.0	3.0	0.4	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.0	0.3	0.4	0.0	1.5	4.0	3.3	2.6	0.6	4.9	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GPR143	OA1	ENSG00000101850	"G protein-coupled receptor 143"	P51810	X	9725346-9786297	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 14.2;choroid plexus: 14.4"	"Group enriched"	"Detected in many"	8	"Cytotrophoblasts: 40.6;Melanocytes: 126.3"	"Cancer enriched"	"Detected in all"	9	"melanoma: 84.0"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	9	"basophil: 3.1"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 3.1"	"Cell line enriched"	"Detected in some"	7	"SK-MEL-30: 159.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA003648	Enhanced					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA003648: AB_2667028"	"unprognostic (4.60e-2)"	"prognostic favorable (8.73e-4)"	"unprognostic (7.43e-3)"	"unprognostic (5.41e-2)"	"unprognostic (4.62e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.64e-3)"	"unprognostic (3.78e-1)"	"unprognostic (5.89e-2)"	"unprognostic (8.18e-2)"	"unprognostic (8.40e-2)"	"prognostic favorable (2.45e-5)"	"unprognostic (2.75e-1)"	"unprognostic (2.07e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.59e-2)"	0.6	1.1	10.6	0.1	13.0	0.0	1.7	11.8	11.5	2.0	14.4	1.4	0.5	3.2	5.3	2.4	2.8	0.9	0.1	10.8	13.1	4.6	1.7	1.0	0.5	12.6	14.2	3.3	1.2	2.9	2.7	6.1	12.3	2.6	1.4	0.9	3.3	4.4	0.0	8.9	0.5	1.0	11.4	0.0	0.7	0.8	13.1	1.8	3.2	0.0	1.6	1.1	1.1	12.2	1.9	0.4	4.6	0.2	0.0	0.0	3.7	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.2	0.0	0.4	0.1	0.2	1.1	0.1	0.1	0.3	0.0	0.2	0.6	2.3	0.0	3.4	0.1	1.6	0.0	0.0	24.2	6.7	0.0	0.0	0.0	0.0	12.1	0.0	0.1	11.1	0.0	0.1	0.0	0.1	0.1	22.2	3.2	0.9	0.0	0.3	0.0	159.6	10.8	1.9	0.0	4.6	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.4	3.1	0.1	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	10.6	13.0	11.8	11.5	10.8	13.1	12.6	14.2	12.3	11.4	13.1	12.2	0.1	0.0	0.0	9.8	0.2	5.5	1.3	1.8	2.2	0.5	2.1	1.7	0.9	0.0	4.9	7.3	0.0	40.6	0.0	0.8	1.9	4.9	0.2	1.7	1.6	1.5	0.0	0.0	0.6	0.6	2.1	1.0	0.0	1.3	0.0	1.8	2.9	0.3	4.8	0.0	0.3	0.8	2.0	0.0	1.6	1.8	1.8	0.1	126.3	1.0	0.0	1.2	0.0	0.5	0.6	1.2	0.2	6.4	0.0	1.8	0.2	5.0	3.2	0.2	0.0	0.0	0.7	0.2	1.3	4.2	0.6	10.1	0.7	1.0	2.0	1.8
GPR156	"GABABL, PGR28"	ENSG00000175697	"G protein-coupled receptor 156"	Q8NFN8	3	120164645-120285222	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"testis: 2.7"	"Group enriched"	"Detected in some"	4	"Astrocytes: 15.0;Early spermatids: 8.3;Late spermatids: 17.9;Oligodendrocyte precursor cells: 13.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 1.3;PC-3: 1.3;SiHa: 3.5;U-2 OS: 1.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA028642, HPA028644"	Uncertain		Supported	"Plasma membrane"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane"		"HPA028642: AB_10599711, HPA028644: AB_10600441"	"unprognostic (2.85e-3)"	"unprognostic (1.02e-1)"	"unprognostic (3.53e-3)"	"unprognostic (2.02e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.79e-1)"	"unprognostic (2.62e-4)"	"unprognostic (2.03e-1)"	"unprognostic (4.54e-4)"	"unprognostic (5.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.03e-5)"	"unprognostic (2.43e-2)"	"unprognostic (3.43e-2)"	"unprognostic (4.91e-3)"	"unprognostic (6.71e-2)"	0.0	0.0	0.3	0.1	0.3	0.0	0.3	0.0	0.2	0.2	0.1	0.0	0.0	0.4	0.0	0.2	1.0	0.1	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.3	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.7	0.4	0.0	0.0	0.0	0.4	0.3	0.0	0.0	2.7	0.1	0.3	0.0	0.3	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.5	0.0	0.2	0.0	0.3	1.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.4	0.6	3.5	0.0	0.4	0.1	0.4	0.0	0.1	0.1	1.9	0.0	0.1	0.4	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.2	0.2	0.1	0.3	0.3	0.1	0.3	0.1	0.3	0.0	0.0	0.0	15.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.3	0.3	0.2	0.0	0.0	0.0	1.5	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	17.9	0.0	0.1	0.0	1.0	0.0	1.3	0.0	13.0	2.9	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.3	0.1	0.6	1.4	0.0	0.0	0.1	0.0	0.3	0.0	0.0
GPR160	"GPCR1, GPCR150"	ENSG00000173890	"G protein-coupled receptor 160"	Q9UJ42	3	170037995-170085392	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 107.9;parathyroid gland: 216.6"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 194.8;Proximal enterocytes: 362.1;Proximal tubular cells: 151.4;Rod photoreceptor cells: 153.2;Undifferentiated cells: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 123.9;SK-BR-3: 95.8;THP-1: 197.2;U-266/70: 206.2;U-266/84: 127.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA006970	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA006970: AB_1849275"	"unprognostic (1.70e-1)"	"unprognostic (5.08e-3)"	"unprognostic (2.96e-2)"	"unprognostic (2.39e-3)"	"unprognostic (2.20e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.21e-2)"	"prognostic favorable (1.21e-4)"	"unprognostic (5.71e-3)"	"unprognostic (1.35e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (4.93e-7)"	"unprognostic (1.40e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.43e-1)"	"prognostic favorable (3.61e-4)"	12.2	1.7	0.7	15.9	1.0	107.9	22.5	1.0	1.6	11.2	0.9	72.0	73.8	5.8	57.9	2.9	5.4	18.6	1.0	0.6	0.7	59.8	4.1	15.0	27.9	1.4	0.9	0.6	18.4	216.6	1.4	4.1	1.1	26.7	72.6	104.7	19.3	6.3	1.3	1.2	98.6	4.4	0.8	25.2	43.0	5.2	0.9	9.5	6.7	2.7	30.4	26.8	1.0	1.2	64.2	1.5	0.3	0.5	0.3	0.4	15.6	0.4	0.5	0.4	1.9	11.7	8.1	29.4	12.9	0.6	4.0	0.7	8.8	0.5	1.0	45.9	17.7	19.1	1.0	24.3	0.2	38.2	24.8	0.2	0.9	2.0	2.3	2.8	1.4	13.7	6.4	73.9	0.4	41.5	2.9	8.4	10.3	39.1	2.4	5.3	1.1	123.9	32.3	86.8	6.1	1.8	0.8	95.8	4.5	8.2	55.9	197.2	1.9	0.2	0.4	7.1	4.8	206.2	127.9	51.4	0.8	40.3	2.8	2.9	1.1	9.3	0.5	0.4	1.0	8.0	1.0	0.4	2.4	12.3	3.0	1.1	11.3	0.4	0.2	3.2	0.3	1.2	0.7	1.0	1.0	1.6	0.6	0.7	1.4	0.9	1.1	0.8	0.9	1.2	35.2	9.6	51.1	0.7	25.9	0.4	3.2	4.1	0.0	9.5	48.5	18.3	1.0	28.6	22.7	62.5	39.6	3.1	11.6	88.9	54.8	10.3	33.7	20.6	4.4	8.7	194.8	0.4	1.5	72.0	21.1	1.0	50.0	54.0	1.3	0.1	20.0	0.9	7.4	15.2	0.6	133.9	18.3	11.7	11.2	36.3	0.6	17.0	28.4	7.5	62.3	16.6	0.0	1.0	0.9	60.3	118.6	0.4	56.8	25.4	362.1	151.4	27.9	153.2	0.0	0.8	1.4	7.4	13.1	0.9	0.9	27.2	4.2	1.2	199.7	35.5
GPR161	RE2	ENSG00000143147	"G protein-coupled receptor 161"	Q8N6U8	1	168079543-168137667	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 41.5;smooth muscle: 27.6"	"Cell type enriched"	"Detected in many"	8	"Horizontal cells: 158.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 44.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA015576, HPA072047"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		Yes	No				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Nucleoli	"HPA015576: AB_1849283, HPA072047: AB_2686484"	"unprognostic (1.45e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.58e-3)"	"unprognostic (1.87e-1)"	"unprognostic (6.84e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.19e-1)"	"unprognostic (5.04e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.31e-2)"	"unprognostic (5.57e-6)"	"unprognostic (3.93e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-2)"	"unprognostic (6.34e-2)"	3.5	1.1	3.8	5.3	2.8	0.2	2.7	3.3	4.0	6.7	1.1	8.4	1.5	41.5	3.6	9.8	10.7	5.6	3.1	3.8	2.4	1.4	0.4	4.2	0.9	3.7	9.4	7.3	11.7	5.4	1.7	2.2	3.8	9.5	3.2	2.1	1.8	11.8	1.0	2.1	3.3	27.6	2.8	2.0	2.9	1.7	4.1	2.0	1.7	1.9	1.3	4.6	5.4	2.7	11.7	7.1	28.0	18.1	6.6	11.7	0.0	11.1	11.9	9.2	9.7	44.9	1.8	0.0	6.0	16.6	17.2	33.9	6.9	10.7	5.3	4.4	8.8	4.2	5.8	0.1	2.8	1.2	2.8	4.2	6.9	7.9	12.7	21.3	18.7	3.6	3.9	0.1	14.2	1.0	1.3	0.2	11.5	19.4	11.0	3.4	12.1	0.0	4.9	3.1	5.7	24.6	12.0	0.4	32.2	10.6	6.3	1.4	25.4	18.9	9.7	25.6	12.7	0.0	0.0	0.0	5.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.8	2.8	3.3	4.0	3.8	2.4	3.7	9.4	3.8	2.8	4.1	2.7	5.8	3.2	1.1	13.7	0.1	2.2	5.7	2.5	5.2	2.2	2.2	4.2	3.6	0.0	1.4	0.0	0.0	0.5	0.0	2.8	0.0	4.1	0.4	1.3	19.4	9.1	0.0	0.0	10.8	8.0	0.4	12.3	1.1	1.8	0.0	15.3	8.9	0.1	0.8	158.2	10.9	1.5	0.0	2.5	6.3	0.9	7.5	2.0	1.8	3.7	1.1	3.2	0.0	9.5	0.4	2.6	2.4	17.0	0.0	10.9	0.0	0.1	1.1	2.1	19.7	8.8	15.1	0.3	3.3	2.7	1.4	0.4	1.0	0.7	2.5	2.7
GPR35		ENSG00000178623	"G protein-coupled receptor 35"	Q9HC97	2	240605430-240631259	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 41.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 82.8;granulocytes: 38.1;Intestinal goblet cells: 32.2;Langerhans cells: 35.7;Paneth cells: 38.6;Proximal enterocytes: 99.3;Undifferentiated cells: 31.1"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 20.7;pancreatic cancer: 6.9;stomach cancer: 9.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	13	"classical monocyte: 36.3;eosinophil: 40.1;intermediate monocyte: 51.7;myeloid DC: 32.5;non-classical monocyte: 14.5"	"Group enriched"	"Detected in many"	16	"dendritic cells: 32.5;granulocytes: 40.1;monocytes: 51.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 20.7;CAPAN-2: 51.2;HDLM-2: 17.6;Hep G2: 33.6;HMC-1: 31.5;NB-4: 16.4;OE19: 38.7;U-937: 18.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (1.05e-1)"	"unprognostic (2.89e-2)"	"unprognostic (4.35e-2)"	"unprognostic (1.53e-1)"	"unprognostic (5.99e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.71e-2)"	"prognostic unfavorable (5.86e-4)"	"unprognostic (2.01e-1)"	"unprognostic (2.07e-1)"	"unprognostic (7.98e-2)"	"unprognostic (1.36e-2)"	"prognostic unfavorable (2.59e-5)"	"unprognostic (7.03e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-3)"	2.1	0.8	5.5	4.3	4.8	4.5	2.4	4.4	5.8	4.7	2.9	28.3	41.0	3.8	1.2	2.5	7.3	5.9	3.3	5.4	4.6	5.4	1.6	3.4	1.7	5.5	4.6	5.4	1.8	0.2	6.6	0.5	5.6	4.5	16.6	2.0	1.6	1.0	7.0	2.6	38.2	1.9	4.4	10.3	15.8	5.4	5.4	1.8	3.0	0.3	1.0	2.9	2.7	4.6	0.1	0.5	0.3	1.1	0.9	0.0	0.4	0.1	0.3	0.1	0.3	20.7	51.2	0.3	0.2	0.2	0.7	0.5	0.0	0.0	0.1	17.6	0.7	8.7	0.5	33.6	0.4	0.4	31.5	0.2	0.1	0.6	0.3	0.4	0.1	1.3	0.3	2.9	0.0	0.7	0.4	16.4	0.8	38.7	0.2	1.9	0.1	0.5	0.2	0.2	2.0	0.8	0.0	0.1	0.4	0.5	0.2	5.9	0.7	0.2	0.2	1.4	0.1	3.5	1.6	0.2	0.1	18.2	0.4	0.1	36.3	40.1	1.5	51.7	2.6	0.0	0.8	0.8	32.5	0.1	0.5	1.2	0.4	0.8	14.5	0.6	0.3	13.6	5.5	4.8	4.4	5.8	5.4	4.6	5.5	4.6	5.6	4.4	5.4	4.6	0.6	0.0	4.4	7.8	1.6	2.0	0.1	0.2	0.0	1.4	0.4	0.4	1.2	2.8	0.3	1.8	0.0	0.1	5.1	82.8	0.0	0.9	0.1	3.1	0.6	0.4	6.7	0.0	1.9	3.3	0.0	0.3	25.0	3.1	38.1	0.8	0.4	0.3	10.7	1.7	2.1	32.2	0.0	8.5	35.7	0.0	0.3	22.3	0.0	1.9	9.7	0.2	1.0	0.5	1.5	14.1	38.6	1.2	1.2	0.0	99.3	3.7	0.9	2.5	0.0	0.2	0.9	1.2	0.6	0.1	1.1	0.3	8.0	0.1	31.1	0.3
GPR37	"EDNRBL, hET(B)R-LP, PAELR"	ENSG00000170775	"G protein-coupled receptor 37"	O15354	7	124743885-124765792	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 109.5;retina: 39.0"	"Group enriched"	"Detected in many"	8	"Muller glia cells: 616.6;Oligodendrocytes: 324.9"	"Group enriched"	"Detected in many"	4	"glioma: 19.2;liver cancer: 5.7;melanoma: 10.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 7.5;fHDF/TERT166: 17.7;hTCEpi: 7.7;SK-BR-3: 6.8;SuSa: 8.0;TIME: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042903, HPA068009"	Approved		Approved	"Nuclear membrane,Cytosol"		No	No		900000		"Cluster 70: Brain - Nervous system development"	"Cluster 12: NES - Nervous system development"	"Cluster 5: Muller glia cells - Visual perception"	"Nuclear membrane, Cytosol"		"HPA042903: AB_2678219, HPA068009: AB_2685940"	"unprognostic (2.47e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.30e-2)"	"unprognostic (7.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (6.00e-5)"	"unprognostic (6.19e-2)"	"prognostic favorable (7.26e-4)"	"unprognostic (6.54e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.16e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.71e-4)"	0.5	0.1	28.3	0.1	65.3	0.0	0.5	53.8	43.4	0.3	5.2	0.6	0.0	1.6	0.2	3.7	0.6	0.2	0.1	31.2	40.4	0.3	10.0	0.2	0.1	62.8	56.3	0.0	1.5	0.1	0.2	5.1	62.5	0.5	0.3	39.0	0.9	0.5	0.6	2.3	0.6	1.2	45.2	2.1	1.3	10.6	47.8	0.0	0.0	0.1	0.0	1.4	0.6	109.5	0.1	1.4	7.5	0.0	0.0	0.0	2.1	0.5	1.9	1.9	0.4	0.3	0.7	0.0	0.0	17.7	0.2	0.1	2.2	0.0	0.4	0.3	1.0	0.1	4.4	0.0	2.2	0.0	0.3	0.0	7.7	0.0	0.1	0.0	3.6	0.0	0.0	3.4	0.0	0.4	0.0	0.0	1.1	0.0	3.5	0.0	0.0	0.0	0.0	0.1	1.7	2.7	0.0	6.8	2.6	8.0	1.7	0.0	12.7	1.5	0.6	0.0	0.0	1.1	0.0	0.0	0.7	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.3	65.3	53.8	43.4	31.2	40.4	62.8	56.3	62.5	45.2	47.8	109.5	0.1	0.0	0.0	5.9	0.0	4.6	0.5	4.4	6.8	55.8	4.6	3.0	0.6	7.2	1.8	1.8	6.2	10.1	0.0	0.1	0.0	5.1	0.4	2.0	0.4	0.7	0.0	0.0	6.0	0.6	19.7	1.9	0.0	3.4	0.0	0.3	0.4	22.4	1.2	18.5	1.1	1.1	2.0	0.3	0.7	1.7	2.8	0.2	3.6	1.0	0.6	616.6	0.0	1.5	324.9	0.4	0.2	0.7	0.0	3.2	0.0	0.0	1.4	22.5	0.0	4.8	0.7	0.6	2.2	4.6	10.2	3.0	0.5	0.1	0.0	0.4
GPR39		ENSG00000183840	"G protein-coupled receptor 39"	O43194	2	132416805-132646582	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 6.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Astrocytes: 12.1;Early spermatids: 20.6;Late spermatids: 19.4;Oligodendrocyte precursor cells: 18.6;Spermatocytes: 32.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"plasmacytoid DC: 1.4"	"Lineage enriched"	"Detected in single"	14	"dendritic cells: 1.4"	"Cell line enhanced"	"Detected in many"		"A-431: 32.0;CAPAN-2: 26.9;hTEC/SVTERT24-B: 30.8;RT4: 27.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA022111	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA022111: AB_1849298"	"unprognostic (4.06e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.54e-3)"	"unprognostic (3.81e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (2.28e-1)"	"unprognostic (1.64e-1)"	"unprognostic (3.72e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.58e-3)"	0.2	0.0	0.7	0.9	0.7	0.0	2.1	0.5	0.7	4.4	1.3	6.8	4.6	0.4	0.8	0.8	3.6	2.2	0.0	0.4	0.7	2.6	3.3	3.9	0.0	1.6	2.2	0.0	3.9	5.1	0.1	0.1	2.0	0.5	5.7	0.0	0.5	1.0	0.0	1.0	3.7	0.3	1.2	0.0	6.1	0.2	0.7	0.0	1.3	0.0	0.2	2.6	0.6	0.2	32.0	18.1	0.3	0.0	0.5	3.6	0.0	2.8	11.1	5.8	3.3	17.7	26.9	0.0	9.7	1.9	13.1	18.6	0.0	12.9	5.7	0.1	0.0	0.0	1.9	0.7	0.6	0.0	0.0	1.1	9.7	30.8	3.1	7.0	0.1	0.0	0.0	0.0	4.2	3.0	0.0	0.0	0.3	7.3	10.5	0.0	0.5	0.0	21.2	27.9	0.0	0.1	2.0	10.3	0.1	1.1	5.8	0.0	5.6	12.4	12.2	4.2	16.8	0.0	0.0	0.1	18.9	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.7	0.5	0.7	0.4	0.7	1.6	2.2	2.0	1.2	0.7	0.2	0.0	16.0	8.7	12.1	0.0	0.1	0.7	2.4	0.0	0.2	1.5	0.9	0.2	2.8	6.7	0.0	0.0	0.0	2.7	10.3	0.0	5.6	20.6	2.6	0.2	0.1	2.4	0.0	3.9	3.1	0.0	0.2	4.1	1.8	0.0	0.0	0.0	3.6	0.0	0.0	4.9	1.6	0.0	0.6	0.3	19.4	0.3	0.3	0.0	1.0	0.6	1.4	0.0	18.6	1.8	5.9	3.0	0.4	0.1	0.3	1.9	0.7	6.1	0.0	0.0	0.1	0.3	32.4	1.2	0.5	0.0	0.0	0.0	0.0	4.9	1.2
GPR87	GPR95	ENSG00000138271	"G protein-coupled receptor 87"	Q9BY21	3	151294086-151316820	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 35.9;skin 1: 32.8;vagina: 23.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 139.2;Basal respiratory cells: 150.0;Suprabasal keratinocytes: 68.2;Syncytiotrophoblasts: 205.0;Urothelial cells: 211.4"	"Group enriched"	"Detected in many"	6	"cervical cancer: 44.1;head and neck cancer: 40.1;lung cancer: 22.0;urothelial cancer: 23.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 110.8;CAPAN-2: 40.8;HaCaT: 90.6;HBEC3-KT: 116.7;hTCEpi: 152.8;hTERT-HME1: 62.2;RT4: 46.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA066313			Approved	"Nucleoplasm,Lipid droplets,Mitochondria"		No	No				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Lipid droplets, Mitochondria"	Nucleoplasm	"HPA066313: AB_2685656"	"unprognostic (5.81e-2)"	"unprognostic (2.12e-1)"		"unprognostic (4.07e-3)"	"unprognostic (8.60e-2)"	"unprognostic (1.28e-2)"		"unprognostic (4.61e-3)"	"unprognostic (3.28e-2)"	"unprognostic (1.27e-1)"	"prognostic unfavorable (4.62e-6)"	"unprognostic (8.64e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.66e-4)"	"unprognostic (8.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.17e-1)"	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.1	0.8	10.0	2.9	0.0	0.0	0.0	3.2	35.9	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.5	9.6	0.0	4.3	0.0	0.0	13.7	5.5	0.1	32.8	0.0	0.0	0.0	0.0	0.5	0.0	0.1	3.5	0.0	0.0	12.4	13.2	23.8	0.4	110.8	0.0	0.0	0.0	0.0	0.0	24.0	0.0	0.0	0.9	0.2	0.0	40.8	0.0	0.0	0.0	0.6	90.6	0.0	116.7	1.1	0.0	0.1	0.0	1.1	0.0	0.8	0.0	0.0	0.0	152.8	0.1	62.2	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.5	0.1	6.1	0.0	0.0	0.0	3.8	46.7	0.0	0.0	19.0	0.5	0.0	3.1	0.4	0.1	0.0	0.0	10.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	1.1	1.0	0.0	59.3	139.2	150.0	46.7	0.0	2.8	1.8	0.1	0.0	49.9	3.7	0.0	59.0	0.4	0.0	0.0	1.2	0.7	3.3	0.0	1.5	0.0	0.0	1.1	0.7	8.7	1.1	0.0	2.4	1.3	0.0	0.0	0.0	4.2	0.0	0.4	0.0	28.5	0.0	3.6	0.1	0.0	0.6	10.6	0.0	0.0	0.0	0.0	1.0	0.0	12.9	0.0	0.0	0.0	60.6	0.0	0.1	19.6	0.0	0.0	0.0	4.1	0.0	0.0	52.7	68.2	205.0	0.9	0.0	0.0	211.4
GPRC5C	RAIG-3	ENSG00000170412	"G protein-coupled receptor class C group 5 member C"	Q9NQ84	17	74424851-74451653	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 192.7;stomach 1: 230.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 211.3;Gastric mucus-secreting cells: 143.2;Hepatocytes: 183.6;Paneth cells: 153.8;Sertoli cells: 144.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 7.9"	"Group enriched"	"Detected in many"	9	"dendritic cells: 7.9;monocytes: 3.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 82.4;HMC-1: 146.7;PC-3: 80.8;RPTEC TERT1: 172.1;RT4: 89.9;T-47d: 108.0"	"Region enriched"	"Detected in all"	9	"cerebellum: 42.5"	"Low region specificity"	"Detected in all"			HPA029776	Enhanced		Uncertain	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	Yes		15000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Centriolar satellite"	"Nucleoplasm, Cytosol"	"HPA029776: AB_10602324"	"unprognostic (1.48e-1)"	"unprognostic (3.35e-1)"	"unprognostic (6.01e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.80e-2)"	"unprognostic (1.09e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.69e-2)"	"unprognostic (9.61e-3)"	"unprognostic (1.05e-1)"	"prognostic favorable (1.58e-5)"	"unprognostic (7.58e-2)"	"unprognostic (3.70e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.54e-3)"	16.1	19.3	17.4	3.1	18.4	0.4	20.1	48.9	18.1	42.0	28.0	38.7	25.0	17.1	10.2	12.2	30.0	21.3	33.7	14.8	16.9	135.7	192.7	23.0	2.1	18.1	18.7	38.2	136.1	28.2	14.8	11.9	18.6	45.6	14.6	1.5	37.4	24.3	110.1	43.9	30.3	4.0	16.6	22.3	230.3	4.0	17.0	4.4	74.8	33.9	3.0	30.8	20.9	15.7	17.3	61.6	3.8	5.5	0.0	0.0	0.2	0.3	0.0	0.0	0.0	66.4	73.0	0.0	45.0	0.3	18.5	52.9	7.7	1.0	0.1	0.2	10.7	0.0	4.0	82.4	15.8	0.0	146.7	1.3	26.7	0.0	0.0	69.2	0.0	0.1	4.8	1.2	0.0	18.0	0.7	17.2	9.2	79.5	80.8	0.2	0.1	2.8	172.1	89.9	27.5	2.5	3.7	5.9	0.1	33.1	108.0	4.6	0.0	0.0	5.5	0.1	0.1	0.1	0.4	0.2	6.5	2.5	0.4	0.0	1.1	0.1	0.0	2.5	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	3.7	7.9	0.0	0.3	17.4	18.4	48.9	18.1	14.8	16.9	18.1	18.7	18.6	16.6	17.0	15.7	11.2	3.2	57.7	13.4	1.4	13.6	39.2	79.6	26.7	0.8	27.3	19.4	211.3	67.2	76.2	136.1	0.0	0.8	11.8	74.9	29.4	65.5	0.1	62.5	6.6	20.9	45.5	5.3	0.1	68.1	20.3	11.3	143.2	74.9	10.2	0.1	48.2	183.6	12.3	5.0	0.5	50.8	69.2	16.3	4.6	1.7	18.0	6.3	3.6	2.8	4.1	15.9	0.0	5.0	0.2	41.2	153.8	22.2	1.2	44.6	61.0	73.5	45.4	1.5	144.7	4.7	64.0	0.5	5.0	14.8	11.2	25.3	2.4	1.5	48.5	63.1
GPRC6A	bA86F4.3	ENSG00000173612	"G protein-coupled receptor class C group 6 member A"	Q5T6X5	6	116792085-116829083	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Enteroendocrine cells: 1.8"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 0.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"U-266/70: 1.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA					"Cluster 29: U-266 - Adaptive immune response"	"Cluster 30: Mammary glandular cells - Lactation"						"unprognostic (9.16e-2)"									"unprognostic (2.48e-1)"			"unprognostic (4.38e-3)"			0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRAMD1B	"KIAA1201, LINC01059"	ENSG00000023171	"GRAM domain containing 1B"	Q3KR37	11	123358428-123627774	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 258.8;choroid plexus: 91.8;retina: 96.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 94.7;Cone photoreceptor cells: 114.7;Excitatory neurons: 120.7;Inhibitory neurons: 102.8;Oligodendrocyte precursor cells: 95.0;Rod photoreceptor cells: 92.3;Theca cells: 109.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 7.0"	"Lineage enriched"	"Detected in many"	4	"dendritic cells: 7.0"	"Group enriched"	"Detected in many"	4	"A549: 62.4;HDLM-2: 168.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008557, HPA075204"	Approved		Supported	"Endoplasmic reticulum,Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 58: Brain - Synaptic function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum, Plasma membrane"	Vesicles	"HPA008557: AB_1079197, HPA075204: "	"unprognostic (1.86e-1)"	"unprognostic (7.18e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.74e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.69e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.90e-2)"	"unprognostic (9.60e-2)"	"unprognostic (8.06e-2)"	"prognostic unfavorable (4.30e-7)"	"unprognostic (1.39e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.69e-1)"	1.8	258.8	22.5	4.3	27.4	18.6	1.1	80.1	52.3	0.9	91.8	1.6	34.6	1.1	9.4	0.6	3.6	12.1	15.0	55.6	19.4	15.5	1.5	2.6	5.4	25.7	20.1	15.2	2.4	0.7	16.6	5.0	24.2	1.1	1.1	96.7	1.9	2.0	3.4	0.5	25.2	1.2	9.4	3.6	11.4	16.8	33.5	6.6	4.9	2.2	3.5	1.2	0.8	26.1	0.1	62.4	3.5	0.1	0.3	0.7	9.5	20.5	14.6	4.1	1.8	2.6	0.4	3.8	10.4	10.1	6.8	0.0	6.2	0.0	4.3	168.5	5.0	0.0	28.3	0.7	0.0	22.1	0.0	1.0	0.1	7.1	0.0	5.2	1.8	1.6	0.0	0.2	3.7	0.5	3.8	7.2	7.6	28.3	23.0	10.8	9.8	6.8	0.2	0.0	20.0	16.3	4.9	0.5	0.1	8.1	0.5	12.0	12.3	23.8	3.2	4.2	1.0	0.0	0.0	0.0	4.6	20.5	1.1	0.0	1.2	0.4	0.4	0.7	0.2	0.0	1.5	1.2	1.7	0.0	0.2	0.2	0.1	1.6	0.7	7.0	0.7	0.5	22.5	27.4	80.1	52.3	55.6	19.4	25.7	20.1	24.2	9.4	33.5	26.1	1.4	0.0	0.5	94.7	0.6	0.0	0.0	0.1	1.2	44.3	1.1	1.0	5.7	21.5	0.2	5.5	114.7	6.9	17.9	0.1	3.9	0.7	9.6	1.6	0.6	1.0	0.0	0.0	120.7	0.4	3.7	1.6	16.3	0.9	0.0	41.9	0.7	0.0	2.6	45.4	102.8	1.8	0.0	3.8	2.6	2.7	0.6	7.5	0.0	37.5	2.5	23.4	0.0	95.0	5.5	3.9	1.3	0.7	2.4	0.1	17.3	8.9	0.4	92.3	0.0	3.0	4.2	3.9	1.9	0.1	0.4	2.5	7.2	109.3	1.5	0.0
GRIA1	"GluA1, GLUR1, GLURA"	ENSG00000155511	"Glutamate ionotropic receptor AMPA type subunit 1"	P42261	5	153489615-153813869	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 83.7;retina: 32.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 322.4;Inhibitory neurons: 608.8"	"Cancer enriched"	"Detected in some"	15	"glioma: 9.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 11.6;ASC diff: 3.5;BJ: 5.5;BJ hTERT+: 2.9;LHCN-M2: 8.1;U-266/70: 5.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035202	Enhanced					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA035202: AB_2674516"	"unprognostic (2.51e-1)"	"unprognostic (4.76e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.20e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.61e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.35e-2)"	"unprognostic (5.14e-4)"	"unprognostic (7.97e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.80e-1)"	"unprognostic (7.61e-2)"	1.2	0.4	38.7	0.1	42.8	0.0	0.4	43.5	79.8	0.2	0.0	0.6	0.2	0.1	0.7	0.1	0.1	0.0	0.8	83.7	23.2	0.1	0.0	9.3	0.0	3.4	3.6	0.2	0.3	0.2	1.2	0.0	2.7	0.1	0.1	32.6	0.1	0.5	0.2	0.3	0.3	1.0	5.3	0.0	0.6	0.9	27.9	0.1	0.3	0.4	0.0	0.1	0.3	18.1	0.0	0.0	11.6	0.0	3.5	2.3	0.0	5.5	2.9	0.3	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.7	42.8	43.5	79.8	83.7	23.2	3.4	3.6	2.7	5.3	27.9	18.1	0.2	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	36.3	0.3	0.0	1.2	0.0	0.0	0.0	6.2	0.0	0.0	0.2	0.0	0.0	5.1	0.1	5.6	0.4	0.0	0.0	322.4	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.7	608.8	0.0	0.0	0.0	0.0	3.4	0.0	0.9	0.0	7.5	0.0	49.0	0.0	94.5	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.1	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRIA2	"GluA2, GLUR2, GLURB"	ENSG00000120251	"Glutamate ionotropic receptor AMPA type subunit 2"	P42262	4	157204182-157366075	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Autism spectrum disorder, Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 78.4;retina: 29.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 335.0;Bipolar cells: 252.7;Excitatory neurons: 1090.5;Inhibitory neurons: 725.5;Oligodendrocyte precursor cells: 1106.8;Oligodendrocytes: 324.7"	"Group enriched"	"Detected in some"	10	"breast cancer: 2.7;endometrial cancer: 2.6;glioma: 6.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 16.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008441	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA008441: AB_1078983"	"unprognostic (1.36e-1)"	"unprognostic (9.60e-3)"		"unprognostic (4.15e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.02e-1)"		"unprognostic (8.70e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.92e-3)"	"unprognostic (7.40e-2)"	"unprognostic (2.91e-5)"	"unprognostic (2.42e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.82e-1)"	"unprognostic (6.55e-2)"	0.3	6.9	32.8	0.2	60.2	0.0	1.1	11.4	77.4	9.2	0.0	0.2	0.1	17.0	11.5	0.1	11.0	0.0	0.1	78.4	11.3	0.4	0.0	0.2	0.0	0.0	7.4	0.6	1.4	0.0	21.7	0.1	0.0	0.8	0.1	29.0	4.1	2.3	0.2	1.6	0.1	6.2	1.4	0.2	1.2	1.4	37.3	0.1	0.0	0.6	0.0	0.1	0.4	43.2	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	2.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.9	0.1	0.0	0.0	0.5	0.0	0.0	0.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	60.2	11.4	77.4	78.4	11.3	0.0	7.4	0.0	1.4	37.3	43.2	0.0	0.0	0.0	335.0	0.0	0.0	0.0	0.0	0.0	252.7	2.1	1.0	2.3	0.0	0.0	0.0	43.8	0.0	0.1	0.0	0.0	0.0	0.1	1.7	1.1	0.3	0.0	0.0	1090.5	0.0	0.0	0.2	0.0	2.7	0.0	0.1	0.0	0.0	0.1	138.0	725.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	58.1	0.0	4.2	0.0	1106.8	324.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	16.5	0.0	0.0	0.5	3.8	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1
GRIA3	"GluA3, GLUR3, GLURC, MRX94"	ENSG00000125675	"Glutamate ionotropic receptor AMPA type subunit 3"	P42263	X	123184153-123490915	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.6;retina: 17.8"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 468.4;Horizontal cells: 198.5;Inhibitory neurons: 396.3;Oligodendrocyte precursor cells: 385.0"	"Cancer enriched"	"Detected in some"	11	"glioma: 10.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 23.8;BJ hTERT+: 34.5;fHDF/TERT166: 45.9;U-2197: 15.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA058659, HPA073344"	Enhanced				"Intracellular and membrane"	NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA058659: AB_2683791, HPA073344: "	"unprognostic (2.14e-2)"	"unprognostic (6.00e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.94e-3)"	"unprognostic (5.09e-2)"	"unprognostic (4.29e-4)"	"unprognostic (2.42e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.78e-3)"	"unprognostic (8.05e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.03e-1)"	0.8	10.3	20.0	0.3	25.3	0.1	1.4	1.3	31.6	6.7	0.0	0.7	0.3	2.1	3.6	0.4	1.5	1.2	2.0	29.0	4.0	2.5	7.7	0.3	0.5	1.9	3.4	4.1	1.7	0.0	1.0	0.4	1.4	1.7	0.8	17.8	0.2	1.9	0.2	0.5	0.5	1.9	4.5	0.1	2.0	0.7	6.4	0.2	0.2	0.1	0.8	0.6	2.8	20.9	0.0	0.0	0.0	0.0	2.2	0.4	0.0	23.8	34.5	0.4	0.9	0.0	0.0	0.0	0.0	45.9	0.0	0.0	0.2	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	8.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	6.6	0.0	15.1	0.2	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	25.3	1.3	31.6	29.0	4.0	1.9	3.4	1.4	4.5	6.4	20.9	0.1	0.0	0.0	27.4	0.0	0.3	0.0	0.8	0.6	13.6	0.2	0.0	1.6	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.1	0.3	8.7	0.3	0.0	0.0	468.4	0.2	0.1	6.4	1.1	0.2	0.0	0.1	0.4	6.1	0.1	198.5	396.3	0.0	0.0	0.0	1.5	0.3	9.3	0.2	1.8	14.0	0.0	1.9	0.0	385.0	67.6	0.3	0.0	4.1	0.0	0.4	0.0	6.2	0.1	3.8	0.0	0.2	4.5	0.0	0.1	0.0	1.0	0.1	0.1	0.7	0.0	0.0
GRIK4	"GluK4, GRIK, KA1"	ENSG00000149403	"Glutamate ionotropic receptor kainate type subunit 4"	Q16099	11	120511746-120988906	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 10.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 82.9;Cone photoreceptor cells: 35.5;Excitatory neurons: 115.6;Inhibitory neurons: 43.7;Oligodendrocyte precursor cells: 196.1;Oligodendrocytes: 108.3"	"Cancer enriched"	"Detected in some"	5	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HDLM-2: 6.1;HEL: 18.9;T-47d: 4.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074453	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA074453: AB_2732255"	"unprognostic (9.63e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.64e-4)"	"unprognostic (1.48e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.53e-2)"	"unprognostic (2.50e-1)"	"unprognostic (4.84e-11)"	"unprognostic (1.35e-1)"	"unprognostic (2.81e-1)"	"unprognostic (4.47e-3)"	"unprognostic (2.58e-2)"	0.0	1.7	6.8	0.0	6.5	0.0	0.4	5.6	6.4	0.1	0.9	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.3	10.3	6.0	0.2	0.0	1.5	0.1	7.2	6.2	2.8	0.0	0.0	1.6	0.2	7.3	0.3	0.1	1.0	0.1	0.0	0.0	0.2	0.1	0.1	4.9	0.4	0.0	0.8	9.6	0.1	2.0	0.1	0.1	0.1	0.2	5.5	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.0	6.1	0.6	18.9	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.6	4.7	0.0	0.2	0.0	0.2	0.0	0.0	2.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	6.5	5.6	6.4	10.3	6.0	7.2	6.2	7.3	4.9	9.6	5.5	0.0	0.0	0.6	82.9	0.1	0.0	0.1	0.0	1.2	0.8	0.5	0.5	1.6	0.0	0.0	0.0	35.5	0.0	0.7	0.0	0.0	0.0	4.4	0.3	0.0	0.2	0.0	0.0	115.6	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	43.7	0.0	0.0	0.8	0.0	7.5	0.3	1.0	0.0	4.7	0.2	0.0	8.2	196.1	108.3	0.1	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	7.8	0.2	0.8	3.3	0.1	0.0	0.1	0.4	0.1	0.0	0.5
GRIK5	"GluK5, GRIK2, KA2"	ENSG00000105737	"Glutamate ionotropic receptor kainate type subunit 5"	Q16478	19	41998321-42069498	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.5;testis: 32.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 17.9;Bipolar cells: 23.0;Excitatory neurons: 32.4;Horizontal cells: 18.5;Inhibitory neurons: 31.1;Oligodendrocyte precursor cells: 31.7;Rod photoreceptor cells: 21.2"	"Group enriched"	"Detected in many"	5	"glioma: 15.4;ovarian cancer: 6.6;thyroid cancer: 6.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 13.7;hTERT-RPE1: 21.2;NTERA-2: 13.1;REH: 37.5;SCLC-21H: 10.3;SH-SY5Y: 22.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074001			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 14: REH - Unknown function"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Nucleoplasm	"HPA074001: AB_2732248"	"unprognostic (4.99e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.30e-3)"	"unprognostic (6.68e-3)"	"unprognostic (4.28e-2)"	"unprognostic (3.86e-1)"	"unprognostic (5.82e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.89e-2)"	"unprognostic (1.73e-2)"	"prognostic favorable (7.23e-4)"	"unprognostic (8.43e-2)"	"prognostic unfavorable (9.32e-4)"	"unprognostic (6.47e-3)"	"unprognostic (5.77e-2)"	"unprognostic (4.57e-2)"	"unprognostic (6.12e-2)"	1.6	4.0	20.0	1.7	17.3	3.0	1.2	6.2	26.7	5.3	0.1	16.4	0.7	7.3	1.8	1.6	6.8	1.9	4.9	36.5	15.5	7.0	0.3	0.5	0.7	3.6	4.8	3.6	2.7	14.8	18.3	0.0	7.0	6.2	1.0	12.5	0.7	6.5	0.5	0.9	3.4	5.2	3.0	1.3	5.3	32.9	14.6	0.9	11.3	0.7	0.6	5.0	2.7	6.6	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.1	0.0	0.2	0.2	0.0	0.0	0.4	0.3	13.7	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.1	0.0	21.2	0.0	0.6	0.1	0.6	0.0	0.2	0.2	0.0	13.1	0.1	0.0	37.5	0.0	0.1	5.8	0.1	10.3	22.7	0.1	0.0	0.2	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.1	1.4	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.0	17.3	6.2	26.7	36.5	15.5	3.6	4.8	7.0	3.0	14.6	6.6	0.2	0.0	0.0	17.9	0.1	0.4	0.1	0.0	0.0	23.0	0.2	0.8	3.1	0.0	0.0	1.8	2.1	0.0	0.0	0.1	0.0	0.8	1.6	0.2	0.2	0.4	0.0	0.0	32.4	0.0	0.0	0.6	0.0	0.3	4.5	7.2	0.0	0.0	0.0	18.5	31.1	0.0	0.0	0.0	0.0	2.3	0.9	0.1	0.0	2.8	0.0	9.1	0.0	31.7	0.9	0.1	0.0	0.4	0.0	0.4	0.0	0.0	0.0	21.2	0.0	4.9	1.7	4.2	2.2	0.2	0.4	0.0	0.0	0.0	0.0	0.1
GRIN1	"GluN1, NMDAR1"	ENSG00000176884	"Glutamate ionotropic receptor NMDA type subunit 1"	Q05586	9	137139154-137168756	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	49	"brain: 186.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 132.6;Inhibitory neurons: 134.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.9;prostate cancer: 1.8"	"Region enriched"	"Detected in many"	4	"cerebral cortex: 186.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 1.4;REH: 1.9;RPMI-8226: 2.5;SCLC-21H: 5.2;SH-SY5Y: 3.1;T-47d: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067773	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA067773: "	"unprognostic (3.58e-2)"	"unprognostic (4.51e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.48e-4)"	"unprognostic (5.20e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.81e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.21e-3)"	"unprognostic (4.47e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.56e-3)"	"unprognostic (4.72e-2)"	0.0	0.1	15.7	0.2	46.4	0.0	0.2	0.0	186.7	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	35.9	0.0	0.0	0.0	0.1	0.1	1.3	19.5	0.0	0.1	0.2	0.7	0.0	3.8	0.7	0.0	3.7	1.2	0.0	0.0	0.4	0.4	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.8	0.1	0.0	0.2	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.0	1.4	0.0	1.9	0.0	2.5	0.0	0.0	5.2	3.1	0.1	0.3	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	46.4	0.0	186.7	35.9	0.0	1.3	19.5	3.8	0.0	0.0	35.6	0.0	0.0	0.0	8.5	0.0	0.0	0.3	0.1	0.0	28.0	1.2	0.9	2.5	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	1.9	0.2	0.1	0.2	1.8	0.0	132.6	0.4	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	1.7	134.4	1.8	0.0	0.0	0.0	0.6	0.0	0.2	0.0	9.4	2.0	1.7	0.0	10.1	7.6	0.2	0.1	0.0	0.0	0.7	0.5	0.1	0.3	7.8	0.0	0.0	0.1	0.5	2.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4
GRIN2A	"GluN2A, NMDAR2A"	ENSG00000183454	"Glutamate ionotropic receptor NMDA type subunit 2A"	Q12879	16	9753404-10182928	"Cancer-related genes, Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, RAS pathway related proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"Cancer-related genes, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	10	"brain: 31.7"	"Group enriched"	"Detected in some"	13	"Excitatory neurons: 839.8;Inhibitory neurons: 904.7"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 0.9"	"Region enhanced"	"Detected in many"		"cerebral cortex: 31.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+ SV40 Large T+ RasG12V: 1.1;fHDF/TERT166: 4.4;hTERT-RPE1: 1.4;RPMI-8226: 1.8;U-138 MG: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022725	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022725: "	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (5.97e-2)"	"unprognostic (3.21e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.08e-1)"	"unprognostic (5.39e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.75e-3)"	"unprognostic (4.79e-3)"	"unprognostic (2.05e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.33e-2)"	0.3	0.3	4.7	0.0	8.4	0.0	0.1	0.0	31.7	0.3	0.0	0.2	0.3	0.3	2.5	1.1	2.1	0.1	3.0	20.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.1	0.2	2.2	0.2	0.3	0.0	0.5	0.2	0.4	0.0	0.0	0.4	2.1	0.1	0.6	0.2	0.2	0.2	0.1	0.4	10.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.3	1.1	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	8.4	0.0	31.7	20.0	0.0	0.0	0.0	0.0	0.0	0.1	10.3	0.2	0.0	0.0	16.0	0.0	1.9	2.2	0.5	3.4	10.3	0.3	0.0	18.2	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	2.1	17.2	0.3	0.1	0.5	0.0	0.0	839.8	0.2	0.0	2.7	0.0	0.7	0.0	3.3	0.0	0.3	0.1	1.7	904.7	0.0	0.0	0.3	0.4	15.1	0.9	0.1	0.0	15.9	0.0	15.6	0.0	27.6	65.8	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	13.9	0.0	0.0	5.4	8.2	10.0	0.2	0.4	0.0	0.0	0.0	0.1	0.3
GRIN2C	"GluN2C, NMDAR2C"	ENSG00000161509	"Glutamate ionotropic receptor NMDA type subunit 2C"	Q14957	17	74842023-74861504	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 58.7;heart muscle: 18.6;thyroid gland: 16.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 138.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 6.3;RPMI-8226: 2.3;SCLC-21H: 2.8"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in many"	14	"cerebellum: 43.2"							NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (7.21e-3)"	"unprognostic (4.68e-2)"	"unprognostic (9.38e-3)"	"unprognostic (2.24e-5)"	"unprognostic (3.42e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.95e-2)"	"unprognostic (3.31e-3)"	"unprognostic (3.25e-1)"	"unprognostic (1.14e-3)"	"unprognostic (4.20e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.14e-1)"	0.7	2.4	27.3	0.2	29.5	0.6	0.2	58.7	27.6	0.4	8.9	0.6	0.2	0.2	0.1	0.2	0.2	0.2	18.6	23.2	18.0	0.3	0.1	0.1	0.1	33.8	19.7	0.3	0.2	0.1	0.6	1.8	36.7	0.2	0.1	3.3	10.5	0.2	0.4	0.2	0.4	0.2	14.5	0.2	0.3	3.8	24.9	0.0	16.6	0.2	0.0	0.3	0.3	22.0	0.0	0.2	0.2	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.8	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	0.2	0.0	0.4	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.1	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.2	0.5	2.3	0.0	0.1	2.8	0.2	1.2	0.1	0.4	0.4	0.4	0.0	0.1	0.2	1.1	0.2	0.1	0.6	0.0	0.1	0.2	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	27.3	29.5	58.7	27.6	23.2	18.0	33.8	19.7	36.7	14.5	24.9	22.0	0.5	0.0	0.0	138.7	0.0	0.1	0.1	0.0	0.0	6.9	0.2	0.0	16.6	1.5	0.2	1.8	0.0	0.2	0.7	0.0	0.0	0.1	1.1	0.7	0.4	0.4	0.0	0.0	0.4	0.2	0.2	0.9	0.0	3.4	0.0	21.5	0.7	0.1	12.5	1.7	1.3	0.4	0.0	0.6	0.3	6.5	0.0	0.5	1.8	11.2	0.1	20.7	2.1	4.5	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.1	2.4	0.0	0.9	2.8	5.8	3.4	0.0	0.0	0.7	0.6	8.5	0.1	0.1
GRINA	"HNRGW, LFG1, NMDARA1, TMBIM3"	ENSG00000178719	"Glutamate ionotropic receptor NMDA type subunit associated protein 1"	Q7Z429	8	143990056-143993415	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 432.6;monocytes: 355.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036980, HPA036981"	Approved		Approved	"Nucleoli fibrillar center,Cytosol"		NA	Yes			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 3: Monocytes - Immune response regulation"	"Nucleoli fibrillar center"	Cytosol	"HPA036980: AB_10696791, HPA036981: AB_10962980"	"unprognostic (2.73e-3)"	"unprognostic (2.18e-3)"	"unprognostic (1.79e-2)"	"unprognostic (1.12e-1)"	"unprognostic (7.01e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.35e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.70e-2)"	"unprognostic (8.19e-2)"	"unprognostic (3.13e-3)"	"unprognostic (1.01e-3)"	"unprognostic (1.55e-1)"	"unprognostic (9.43e-2)"	"unprognostic (6.75e-2)"	"unprognostic (5.72e-2)"	273.1	218.3	154.1	109.0	147.4	215.1	236.4	143.9	226.4	178.9	99.4	144.9	72.1	137.8	79.7	134.2	149.0	74.5	154.8	158.9	149.8	200.8	447.1	233.9	77.7	151.6	155.6	152.7	97.2	144.4	127.7	86.2	160.5	176.0	33.2	180.7	116.7	181.7	145.4	167.1	138.1	75.1	152.1	311.3	104.6	269.4	163.1	58.5	187.4	57.4	55.2	162.1	139.3	140.2	79.3	155.9	76.4	129.5	392.6	196.9	114.5	112.5	258.9	184.4	168.7	95.5	64.3	57.9	120.2	249.7	128.6	69.8	136.8	162.3	75.5	83.1	95.9	60.2	85.9	114.5	412.0	12.7	90.7	254.2	441.0	132.7	193.3	194.5	90.1	23.9	56.1	76.8	160.7	489.5	34.7	32.6	53.4	75.8	231.2	45.4	39.9	111.4	93.2	229.1	52.3	84.8	163.5	177.9	225.8	104.1	342.2	77.6	91.8	115.4	127.1	158.0	82.1	124.3	78.3	44.6	147.4	79.0	67.6	1.8	32.0	9.7	2.5	36.4	3.5	8.3	2.5	2.9	13.3	7.1	4.5	4.1	18.6	3.3	36.1	22.9	2.3	16.0	154.1	147.4	143.9	226.4	158.9	149.8	151.6	155.6	160.5	152.1	163.1	140.2	54.5	19.2	52.7	35.3	45.4	37.2	32.5	58.7	121.3	91.1	62.7	79.4	23.2	45.8	27.9	53.3	79.2	137.2	22.6	29.1	23.5	75.0	273.8	36.8	56.1	47.7	42.1	60.0	21.3	69.1	55.8	67.7	16.8	36.1	16.4	76.2	51.4	194.5	178.4	33.7	26.6	24.3	42.7	225.1	86.7	432.6	61.5	184.3	37.4	22.5	355.1	89.9	6.2	12.5	9.3	66.0	54.5	67.7	44.4	46.7	72.9	73.6	29.4	95.8	46.0	32.4	45.6	96.0	16.9	83.2	36.9	264.2	20.8	38.7	31.4	25.5
GRIP1		ENSG00000155974	"Glutamate receptor interacting protein 1"	Q9Y3R0	12	66347431-67069162	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 16.4"	"Cell type enriched"	"Detected in many"	7	"Inhibitory neurons: 2829.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	5	"myeloid DC: 4.9"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 4.9"	"Cell line enhanced"	"Detected in many"		"BEWO: 44.4;HaCaT: 48.7;REH: 30.7;RT4: 31.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038856	Uncertain					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA038856: AB_10673297"	"unprognostic (6.25e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.52e-2)"	"unprognostic (8.25e-2)"	"unprognostic (1.50e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.42e-1)"	"unprognostic (4.21e-3)"	"unprognostic (4.25e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.00e-2)"	"unprognostic (4.14e-1)"	"unprognostic (2.82e-3)"	"unprognostic (7.44e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.27e-4)"	"unprognostic (8.57e-3)"	0.5	4.3	8.5	2.7	6.6	0.5	3.0	0.0	14.2	1.2	0.0	3.1	1.1	3.5	4.7	7.3	4.2	1.6	2.7	3.9	12.4	3.3	0.3	0.8	0.7	0.7	7.6	1.2	2.0	16.4	3.3	8.2	2.2	4.6	1.7	4.8	6.0	9.3	1.0	9.8	1.9	2.8	0.0	2.6	0.8	6.2	3.0	0.7	5.0	0.6	1.3	2.6	2.0	3.7	11.1	10.1	17.7	2.1	0.0	0.0	44.4	3.2	0.0	5.4	2.5	0.3	3.3	1.4	4.2	0.0	9.5	48.7	4.9	3.3	2.4	0.0	12.0	0.0	0.1	0.3	0.0	1.2	0.1	0.0	8.0	0.0	0.8	8.3	0.0	8.0	0.0	0.1	0.0	4.0	0.4	0.4	16.1	1.4	3.6	30.7	0.1	0.6	5.6	31.0	10.8	1.4	14.8	7.1	1.4	11.3	8.7	1.8	0.0	0.0	12.7	0.1	9.0	1.5	0.3	1.0	12.0	0.7	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.9	0.1	0.1	0.2	0.0	1.0	0.0	0.3	0.0	0.1	8.5	6.6	0.0	14.2	3.9	12.4	0.7	7.6	2.2	0.0	3.0	3.7	0.1	0.0	1.1	74.7	0.1	13.3	2.3	2.9	2.2	5.5	4.1	2.4	3.4	1.5	1.7	7.3	0.0	7.8	0.7	0.3	0.0	2.2	38.5	8.1	2.2	0.4	1.8	0.0	390.2	1.5	4.3	1.1	0.0	13.7	0.0	2.3	0.0	0.0	1.0	47.1	2829.7	0.7	0.0	2.4	1.6	34.0	0.6	2.1	7.2	20.6	1.0	0.5	0.0	158.3	44.4	1.9	0.5	0.7	0.1	3.8	0.2	0.4	1.1	1.8	0.0	1.0	0.6	0.3	1.2	2.3	17.8	16.6	0.8	1.2	0.7	3.1
GRM1	"GPRC1A, mGlu1, MGLUR1, PPP1R85"	ENSG00000152822	"Glutamate metabotropic receptor 1"	Q13255	6	146027646-146437601	"Disease related genes, G-protein coupled receptors, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 27.6"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 215.5;Inhibitory neurons: 138.8;Rod photoreceptor cells: 124.9"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebellum: 27.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015701	Approved	Supported	Approved	Vesicles		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA015701: AB_1853917"	"unprognostic (1.04e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.73e-3)"	"unprognostic (9.77e-3)"	"unprognostic (6.75e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.31e-2)"	"unprognostic (2.93e-2)"	"unprognostic (9.48e-3)"	"unprognostic (7.92e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.50e-2)"	"unprognostic (8.33e-3)"	"unprognostic (9.76e-2)"	0.0	0.0	3.3	0.0	3.6	0.0	0.0	27.6	6.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.8	7.3	2.3	0.7	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	5.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	7.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	3.6	27.6	6.8	7.3	2.3	0.0	3.1	0.9	0.0	7.7	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	0.0	13.8	0.0	0.0	3.7	0.0	0.0	1.8	16.7	0.0	0.0	0.0	1.9	0.0	8.5	0.1	0.0	0.2	0.0	0.0	215.5	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.6	6.7	138.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	3.7	0.0	4.0	0.0	8.0	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	124.9	0.0	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
GRM2	"GPRC1B, mGlu2, MGLUR2"	ENSG00000164082	"Glutamate metabotropic receptor 2"	Q14416	3	51707068-51718613	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"brain: 6.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 2.6;Cone photoreceptor cells: 6.2;Excitatory neurons: 16.2;Spermatocytes: 3.5"	"Cancer enriched"	"Detected in single"	4	"testis cancer: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027868, HPA065166"	Approved	Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA027868: , HPA065166: AB_2685425"	"unprognostic (1.01e-1)"	"unprognostic (8.61e-4)"	"unprognostic (7.66e-2)"	"unprognostic (7.29e-3)"	"unprognostic (1.98e-1)"	"unprognostic (3.68e-2)"	"unprognostic (7.10e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.19e-2)"	0.3	0.0	1.6	0.0	2.2	0.4	0.1	0.0	2.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	1.7	0.7	0.0	0.0	0.1	0.0	4.9	0.1	0.0	0.1	0.0	0.1	0.0	6.0	0.1	0.0	0.4	0.1	0.0	0.3	0.5	0.1	0.0	0.0	0.2	0.0	0.6	0.4	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	2.2	0.0	2.3	1.7	0.7	4.9	0.1	6.0	0.0	0.4	0.3	0.4	0.0	0.0	1.6	0.1	0.0	0.0	0.0	0.0	2.6	0.5	0.9	1.1	0.0	0.0	0.0	6.2	0.0	0.3	0.1	0.0	0.0	0.3	0.1	0.1	1.5	0.0	0.0	16.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.0	0.0	0.4	0.0	1.0	0.8	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.0	0.0	0.2	0.1	3.5	1.1	0.2	0.3	0.0	0.1	0.2	0.0	0.1
GRM5	"GPRC1E, mGlu5, MGLUR5, PPP1R86"	ENSG00000168959	"Glutamate metabotropic receptor 5"	P41594	11	88504576-89065945	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 23.8"	"Group enriched"	"Detected in some"	26	"Excitatory neurons: 903.1;Inhibitory neurons: 968.3;Oligodendrocyte precursor cells: 1040.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"amygdala: 14.9;basal ganglia: 17.3;cerebral cortex: 23.8;hippocampal formation: 20.4;white matter: 6.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"								"Intracellular and membrane"	NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 10: Brain - Neuronal signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.94e-1)"			"unprognostic (9.62e-2)"	"unprognostic (9.57e-2)"	"unprognostic (2.79e-2)"		"unprognostic (1.80e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.16e-2)"		"unprognostic (8.15e-4)"	"unprognostic (3.43e-2)"				0.0	0.0	14.9	0.0	17.3	0.0	0.0	0.0	23.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	20.4	1.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.1	0.3	0.0	0.0	2.8	0.0	0.0	1.7	3.7	0.0	0.0	0.0	0.0	0.0	0.0	6.4	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.9	17.3	0.0	23.8	20.4	1.0	0.0	0.0	0.0	2.8	3.7	6.4	0.1	0.0	0.0	36.6	0.0	0.0	0.0	0.0	0.0	28.9	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	7.5	0.1	0.0	0.0	0.0	903.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.7	968.3	0.0	0.0	0.0	0.0	23.6	0.3	0.0	0.0	22.5	0.0	0.8	0.0	1040.5	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	1.8	0.0	0.0	0.0	1.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0
GSDMA	"FLJ39120, GSDM, GSDM1"	ENSG00000167914	"Gasdermin A"	Q96QA5	17	39953263-39977768	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"skin 1: 58.9"	"Group enriched"	"Detected in some"	5	"Collecting duct cells: 3.7;Hofbauer cells: 5.0;Kupffer cells: 5.6;Macrophages: 2.6;Suprabasal keratinocytes: 2.7;Theca cells: 2.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 7.6"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 4.1;hTCEpi: 2.7;hTERT-HME1: 5.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA023313, HPA064826"	Enhanced		Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane,Cytosol"		NA	NA		44000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 61: Skin - Cornification"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"	"Nucleoplasm, Nuclear bodies"	"HPA023313: AB_1850378, HPA064826: AB_2685361"	"unprognostic (1.32e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.62e-1)"	"unprognostic (1.97e-1)"	"unprognostic (7.77e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.24e-1)"	"unprognostic (3.52e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (3.79e-2)"	3.4	0.7	0.2	0.9	0.2	0.4	3.5	0.4	0.4	0.8	0.2	0.7	0.6	0.4	6.6	3.2	0.3	0.8	0.3	0.3	0.2	0.3	0.3	0.4	0.7	0.4	0.0	0.1	0.3	1.3	0.1	1.6	0.4	0.1	1.2	0.0	0.8	0.0	0.4	58.9	0.5	0.6	0.0	0.2	0.3	0.3	0.4	0.5	0.1	0.1	3.4	1.1	1.5	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	4.1	0.0	0.1	0.2	0.5	0.4	0.2	0.0	0.1	0.8	0.0	2.7	0.5	5.4	0.0	0.0	0.0	0.1	1.3	0.0	0.5	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.5	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.4	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.0	0.9	0.1	0.1	2.2	0.0	2.6	0.0	1.3	0.8	0.1	0.1	0.6	0.9	0.7	0.1	0.1	0.2	0.5	0.5	0.2	0.2	0.4	0.4	0.3	0.2	0.4	0.0	0.4	0.0	0.4	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	3.7	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	5.0	0.0	0.1	0.7	0.0	5.6	0.6	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	2.7	0.0	0.2	2.8	0.0	0.0
GSDMB	"GSDML, PRO2521"	ENSG00000073605	"Gasdermin B"	Q8TAX9	17	39904595-39919854	"Predicted intracellular proteins, Transporters"	"Cytolysis, Necrosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 76.2;liver: 52.8;stomach 1: 47.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 45.7;Gastric mucus-secreting cells: 62.2;Intestinal goblet cells: 30.7;Paneth cells: 54.2;Proximal enterocytes: 108.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	8	"SK-BR-3: 458.1"					"Not detected"	"Not detected"			"CAB013681, HPA023925, HPA052407"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	Cytosol	"CAB013681: , HPA023925: AB_1850383, HPA052407: AB_2681819"	"unprognostic (5.78e-2)"	"prognostic favorable (3.41e-5)"	"unprognostic (1.27e-1)"	"unprognostic (5.70e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.10e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.81e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.71e-2)"	"prognostic unfavorable (5.13e-11)"	"unprognostic (1.88e-1)"	"unprognostic (1.99e-1)"	"unprognostic (8.91e-2)"	"prognostic favorable (5.91e-9)"	13.5	1.4	12.2	13.1	12.4	5.1	9.3	12.9	22.6	6.0	11.6	45.0	66.9	3.4	5.1	4.8	6.2	12.5	4.8	12.5	11.3	6.0	52.8	7.9	11.0	11.5	11.4	6.3	8.2	0.3	4.0	2.9	11.6	10.9	57.0	5.3	4.6	4.4	1.5	8.3	76.2	5.0	11.2	15.0	47.4	4.3	11.9	10.8	8.9	0.4	8.4	20.1	5.6	13.2	2.0	1.5	2.9	0.8	6.7	4.3	2.6	1.8	1.1	0.6	1.8	1.7	55.2	2.8	2.5	1.7	0.9	7.6	1.6	1.6	4.0	11.7	1.8	1.1	0.8	0.8	2.0	0.3	0.7	2.9	9.2	2.4	3.3	4.6	1.2	9.0	1.3	3.5	0.7	0.6	3.3	6.2	0.8	18.2	2.0	3.1	1.1	4.5	0.2	1.8	1.1	1.4	0.6	458.1	1.9	13.2	2.4	1.9	1.7	2.0	3.0	5.1	1.0	9.9	9.2	2.8	0.7	1.9	0.3	0.0	0.0	0.5	0.2	0.0	0.0	0.2	0.7	0.3	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.0	12.2	12.4	12.9	22.6	12.5	11.3	11.5	11.4	11.6	11.2	11.9	13.2	1.5	3.2	12.0	9.1	3.9	1.9	1.4	4.9	4.0	2.8	3.3	2.9	2.5	8.6	8.1	5.5	4.2	1.6	3.5	45.7	0.0	1.7	5.5	1.5	1.8	1.8	6.1	0.0	20.1	7.8	0.6	1.2	62.2	1.8	1.3	3.0	0.4	8.1	0.3	1.7	9.2	30.7	0.0	1.3	2.0	5.4	1.2	1.1	3.6	3.7	1.5	1.3	2.1	7.1	5.1	8.9	54.2	1.9	5.6	1.4	108.2	0.3	14.1	2.3	0.0	1.4	2.2	0.4	1.4	1.8	3.4	0.3	4.8	3.0	23.7	6.7
GSDMC	MLZE	ENSG00000147697	"Gasdermin C"	Q9BYG8	8	129748196-129786624	"Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 33.1;lymphoid tissue: 12.8;skin 1: 25.5;vagina: 11.4"	"Group enriched"	"Detected in some"	4	"Basal keratinocytes: 46.5;Basal squamous epithelial cells: 37.5;Squamous epithelial cells: 29.5;Suprabasal keratinocytes: 53.1"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 11.8;head and neck cancer: 19.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HaCaT: 3.7;hTCEpi: 1.8;HUVEC TERT2: 2.0;TIME: 5.8"					"Low region specificity"	"Detected in many"			"HPA023670, HPA024767, HPA026317"	Supported		Approved	Mitochondria		NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"	Mitochondria		"HPA023670: AB_1854006, HPA024767: AB_1854007, HPA026317: AB_1854008"	"unprognostic (6.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-3)"	"unprognostic (4.23e-2)"	"unprognostic (2.11e-2)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (8.28e-2)"	"unprognostic (7.51e-2)"	"unprognostic (4.92e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.93e-3)"	"unprognostic (1.87e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.66e-2)"	"unprognostic (1.90e-1)"	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.4	0.0	0.0	0.0	0.0	0.1	33.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	5.4	0.0	0.0	25.5	0.0	0.0	0.0	12.8	0.0	0.0	0.0	0.0	0.0	0.0	4.0	2.4	11.4	0.1	5.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.7	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.0	1.0	0.0	46.5	0.9	7.4	37.5	0.0	1.5	0.9	3.6	0.0	9.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.1	0.0	3.9	0.0	0.0	0.2	7.2	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.0	0.0	0.4	0.0	0.0	1.3	0.0	0.0	0.1	0.5	0.0	0.1	29.5	53.1	0.0	0.1	0.0	0.0	2.8
GSDMD	"DF5L, FLJ12150, GSDMDC1"	ENSG00000104518	"Gasdermin D"	P57764	8	143553207-143563062	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity, Necrosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 226.7;Proximal enterocytes: 297.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004656, HPA044487"	Uncertain		Supported	Nucleoplasm	"Intracellular and membrane"	NA	NA		11000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"CAB004656: AB_426076, HPA044487: AB_2678957"	"unprognostic (1.11e-2)"	"unprognostic (8.44e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.65e-1)"	"unprognostic (7.20e-2)"	"unprognostic (6.36e-2)"	"unprognostic (4.66e-2)"	"unprognostic (8.90e-2)"	"prognostic unfavorable (1.43e-4)"	"unprognostic (8.51e-3)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (6.77e-3)"	43.1	36.0	6.5	34.1	6.7	39.4	41.5	6.5	9.0	42.9	11.1	48.4	51.3	36.7	9.1	22.5	41.5	15.7	24.6	6.2	6.4	50.6	88.8	54.8	42.3	7.7	7.2	39.5	35.1	19.2	18.3	16.5	7.2	39.0	13.6	1.0	32.5	15.1	11.0	16.8	60.3	12.4	7.1	120.1	37.9	7.3	7.0	24.4	46.4	6.1	16.1	35.8	31.7	7.1	40.8	18.4	0.3	0.1	13.4	14.7	23.8	13.8	36.4	44.0	47.4	3.1	54.6	14.5	21.9	21.1	19.6	12.5	0.7	31.1	11.1	43.8	2.8	23.2	5.4	22.6	17.8	4.2	1.0	35.5	2.6	16.1	9.4	14.5	34.1	34.2	1.4	49.1	2.3	0.8	87.5	7.1	0.3	27.3	67.6	30.2	1.5	48.7	22.5	39.9	0.5	0.6	44.2	39.8	43.4	5.6	69.7	24.8	13.3	0.2	44.6	3.2	22.1	16.5	22.4	0.4	26.5	19.6	21.8	65.4	44.7	45.9	55.0	73.2	44.8	39.9	48.6	53.7	40.7	31.1	33.8	40.4	46.2	41.1	69.1	29.1	71.1	46.8	6.5	6.7	6.5	9.0	6.2	6.4	7.7	7.2	7.2	7.1	7.0	7.1	91.1	12.8	29.1	6.8	39.8	10.8	47.1	55.7	23.9	0.2	31.6	30.5	12.2	47.1	37.5	31.3	0.0	62.0	54.6	226.7	60.7	68.3	2.2	33.8	20.0	57.0	39.6	14.9	0.1	92.7	98.1	34.0	68.8	27.2	27.3	171.1	75.3	72.3	63.1	0.0	0.1	114.8	30.5	50.1	18.4	7.0	23.6	52.5	17.8	7.5	74.4	28.9	81.4	0.5	0.1	50.2	181.1	22.6	41.1	34.6	297.7	121.8	43.1	1.7	59.2	24.0	34.4	1.4	12.3	13.8	8.9	41.7	61.5	24.2	131.8	45.9
GSDME	"DFNA5, ICERE-1"	ENSG00000105928	"Gasdermin E"	O60443	7	24698355-24757940	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Necrosis		"Deafness, Non-syndromic deafness, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 168.1;Distal tubular cells: 41.1;Extravillous trophoblasts: 26.5;Hofbauer cells: 39.9;Syncytiotrophoblasts: 104.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"memory B-cell: 9.0;myeloid DC: 5.9;naive B-cell: 8.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011326, CAB019306"	Approved		Supported	Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB019306: , HPA011326: AB_1847629"	"unprognostic (1.08e-1)"	"unprognostic (1.77e-2)"	"unprognostic (6.29e-2)"	"unprognostic (6.36e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.49e-2)"	"prognostic unfavorable (2.49e-5)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.23e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.48e-3)"	"unprognostic (6.70e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.90e-2)"	13.5	7.8	16.4	2.9	16.7	0.5	7.6	13.3	18.0	17.3	9.2	6.4	7.7	24.8	15.3	3.6	14.3	8.5	9.7	18.1	15.0	13.3	4.5	4.4	5.8	19.4	18.7	16.9	2.6	7.3	7.0	35.0	16.1	7.5	2.4	6.3	3.1	21.1	7.8	3.0	26.8	15.1	16.5	1.8	3.9	12.9	14.1	5.8	14.5	5.2	3.8	15.0	10.1	26.6	31.4	21.7	9.6	41.2	51.4	28.6	16.4	24.1	63.6	24.5	34.3	22.9	1.1	0.5	20.6	66.4	81.7	20.5	5.8	105.4	42.8	0.1	2.1	0.8	39.3	48.0	43.0	0.1	1.5	31.3	75.3	43.5	103.1	73.0	42.3	13.8	3.0	5.2	55.3	0.4	1.9	0.8	10.2	0.1	15.7	0.2	33.6	0.0	74.5	21.9	0.4	60.0	36.5	0.6	42.3	24.3	2.2	2.8	27.9	23.1	39.7	31.6	29.2	2.4	0.6	15.5	69.8	0.1	5.8	0.0	1.9	0.0	0.0	0.2	0.0	9.0	0.1	0.0	5.9	8.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	16.4	16.7	13.3	18.0	18.1	15.0	19.4	18.7	16.1	16.5	14.1	26.6	1.0	6.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	2.1	3.9	0.0	0.0	0.6	5.5	0.0	168.1	0.0	0.0	41.1	1.9	0.0	0.7	16.9	1.3	0.0	0.0	0.0	0.9	26.5	4.3	0.0	1.0	0.0	4.8	0.0	0.0	39.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	8.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	8.8	1.5	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	104.7	0.7	0.9	0.0	0.0
GSG1	MGC3146	ENSG00000111305	"Germ cell associated 1"	Q2KHT4	12	13083532-13103683	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"testis: 429.9"	"Cell type enriched"	"Detected in many"	4	"Late spermatids: 10812.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 8.8;LHCN-M2: 9.8;RPTEC TERT1: 12.3;U-2 OS: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"								"Intracellular and membrane"	NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (1.50e-1)"	"unprognostic (2.21e-2)"		"unprognostic (6.33e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.52e-1)"	"unprognostic (6.85e-2)"	"unprognostic (8.23e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.65e-2)"	"unprognostic (1.79e-1)"	"unprognostic (6.32e-3)"	0.1	0.0	0.6	0.2	0.9	0.8	0.4	1.7	1.4	0.1	1.3	0.1	1.4	0.1	0.6	0.1	0.0	0.2	0.1	0.7	0.5	0.5	0.1	0.1	0.3	0.0	0.0	0.1	4.8	0.0	0.2	0.2	0.0	0.4	0.2	30.4	0.1	0.0	0.3	0.2	0.7	0.0	0.0	0.2	0.1	429.9	0.1	0.1	0.1	0.0	0.1	0.0	0.1	1.4	0.1	0.4	0.3	0.1	2.0	1.2	0.4	0.2	0.4	0.3	0.4	0.2	0.1	0.2	0.1	8.8	0.6	0.1	0.1	0.0	0.8	0.2	0.0	0.2	0.6	0.3	0.0	0.2	0.1	0.8	0.0	1.6	0.1	0.1	0.0	0.1	0.1	1.6	9.8	0.2	0.1	1.0	2.1	0.1	0.2	0.1	3.5	0.1	12.3	0.2	0.6	0.2	0.3	0.0	0.1	0.3	0.0	1.4	0.1	0.5	5.9	0.3	0.3	0.5	0.3	0.1	2.5	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.6	0.9	1.7	1.4	0.7	0.5	0.0	0.0	0.0	0.0	0.1	1.4	0.1	3.2	1.1	0.3	0.0	0.1	0.1	0.0	0.0	134.9	0.1	0.0	0.3	1.5	0.0	0.0	6.2	0.1	0.0	0.0	1.9	0.6	2248.2	0.1	0.2	2.8	27.5	2.7	1.8	0.0	0.1	0.7	0.0	0.1	0.0	0.0	1.4	0.0	0.6	1.7	0.8	2.0	2.0	0.3	0.0	10812.1	53.4	2.9	0.0	1.0	0.1	6.7	0.0	0.0	0.1	0.0	1.2	39.9	0.0	0.1	0.1	0.0	0.0	16.1	6.6	0.4	0.1	57.0	27.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1
GSG1L	"KTSR5831, MGC18079, PRO19651"	ENSG00000169181	"GSG1 like"	Q6UXU4	16	27787528-28063714	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.5;heart muscle: 23.0"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 26.0;Oligodendrocyte precursor cells: 89.5"	"Cancer enriched"	"Detected in some"	7	"glioma: 3.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"HMC-1: 8.3;THP-1: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014479	Enhanced					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA014479: AB_2247974"	"unprognostic (1.85e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.38e-1)"	"unprognostic (7.06e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.10e-1)"		"unprognostic (2.05e-2)"	"unprognostic (6.68e-2)"	"unprognostic (5.02e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.50e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.55e-1)"	"unprognostic (3.13e-1)"	"unprognostic (6.35e-2)"	"unprognostic (9.77e-2)"	0.2	0.2	15.6	0.1	19.4	0.2	0.1	9.4	19.5	0.2	4.4	0.4	0.3	0.3	0.3	0.1	1.5	0.0	23.0	17.9	11.0	0.3	0.4	0.4	0.1	21.8	20.0	0.1	0.1	0.0	0.5	0.9	19.0	0.2	0.1	2.4	0.2	0.1	0.3	0.8	0.4	0.0	12.5	0.3	1.1	1.6	22.5	0.0	0.3	0.0	0.0	0.4	0.1	11.8	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.2	0.2	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.1	0.1	0.3	0.5	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.2	0.0	3.2	0.7	0.0	0.5	0.0	0.1	0.6	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	15.6	19.4	9.4	19.5	17.9	11.0	21.8	20.0	19.0	12.5	22.5	11.8	0.0	0.0	0.0	2.6	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.1	8.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.8	7.4	0.1	0.0	0.0	26.0	0.0	0.0	1.8	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.7	7.4	0.4	0.0	0.0	0.0	3.6	0.0	0.1	0.0	4.7	0.0	0.2	0.0	89.5	1.4	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	1.5	0.0	3.7	0.3	0.5	1.4	0.0	0.0	0.0	0.1	0.4	0.0	0.0
GUCA1B	"GCAP2, RP48"	ENSG00000112599	"Guanylate cyclase activator 1B"	Q9UMX6	6	42183284-42194956	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Sensory transduction, Vision"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	99	"retina: 466.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 23.2;Cone photoreceptor cells: 83.4;Oligodendrocytes: 28.2;Rod photoreceptor cells: 53.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.3;U-698: 3.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA055479	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA055479: AB_2732598"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.14e-6)"	"unprognostic (5.39e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.87e-3)"	"unprognostic (6.06e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.34e-1)"	"unprognostic (5.57e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.28e-7)"	"unprognostic (4.50e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.76e-2)"	"unprognostic (2.59e-3)"	1.5	0.9	3.5	0.8	3.6	1.3	1.4	3.8	4.1	2.3	2.2	1.3	0.3	1.9	1.0	0.8	2.3	0.2	1.6	3.2	3.2	1.0	1.9	1.1	0.7	3.3	3.2	2.7	0.9	0.2	1.0	0.4	3.6	1.5	0.5	466.0	1.1	0.5	2.6	2.8	1.4	1.0	3.0	2.1	0.8	2.6	3.5	1.0	1.0	0.9	0.9	1.1	1.4	4.6	0.1	0.6	1.3	0.5	1.0	0.9	0.3	0.5	0.8	0.8	0.7	1.1	0.4	1.6	0.8	0.1	0.2	0.4	1.4	0.2	1.4	1.3	0.6	0.4	0.1	0.2	0.4	1.5	0.5	0.3	4.3	0.8	1.1	0.4	0.1	1.2	1.0	1.5	0.2	1.3	0.6	1.0	0.0	0.3	0.3	0.2	0.8	0.1	0.8	0.5	0.6	0.9	0.0	0.2	0.1	0.2	0.1	0.9	0.0	0.2	1.7	0.6	0.7	2.7	1.3	3.9	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.5	3.6	3.8	4.1	3.2	3.2	3.3	3.2	3.6	3.0	3.5	4.6	0.2	0.0	0.0	23.2	0.0	0.3	0.1	0.0	0.0	4.0	0.2	0.1	0.3	0.0	0.0	0.0	83.4	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.3	0.3	0.0	0.0	8.1	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	6.7	11.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.8	2.8	0.1	8.1	0.0	11.6	28.2	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	53.0	0.0	0.5	0.4	0.5	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.2
GUCY2C	"GUC2C, STAR"	ENSG00000070019	"Guanylate cyclase 2C"	P25092	12	14612632-14696599	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	20	"intestine: 68.2"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 34.4;Enteroendocrine cells: 176.7;Intestinal goblet cells: 56.0;Paneth cells: 97.9;Proximal enterocytes: 81.5;Undifferentiated cells: 47.6"	"Group enriched"	"Detected in many"	5	"colorectal cancer: 23.9;stomach cancer: 9.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.4;CACO-2: 1.1;CAPAN-2: 1.7;SiHa: 1.6"	"Region enhanced"	"Detected in some"		"midbrain: 1.8"	"Low region specificity"	"Detected in all"			"HPA037655, HPA073759"	Uncertain		Uncertain	Vesicles		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"	Vesicles		"HPA037655: AB_10672388, HPA073759: "	"unprognostic (1.08e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.58e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (9.14e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.95e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.40e-2)"	"unprognostic (2.35e-4)"	"unprognostic (8.02e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.98e-1)"	0.5	0.2	0.1	3.4	0.3	0.5	0.0	0.2	0.1	0.0	3.0	37.2	68.2	0.3	0.0	1.9	0.0	0.9	2.2	0.2	0.3	0.4	0.3	0.2	0.4	0.4	0.3	0.0	2.2	0.0	0.0	0.2	0.4	0.3	41.4	0.1	0.6	0.0	0.7	1.0	66.5	1.4	0.5	0.2	1.9	0.4	0.3	0.0	0.5	0.0	0.3	0.5	0.2	0.5	0.4	0.0	0.0	1.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.1	1.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.2	1.6	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.3	0.4	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.3	1.1	0.0	0.0	1.1	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.2	0.1	0.2	0.3	0.4	0.3	0.4	0.5	0.3	0.5	0.0	0.0	0.0	1.3	6.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	34.4	0.0	0.0	0.1	0.1	0.0	0.0	176.7	0.0	1.4	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	56.0	0.0	0.3	0.3	0.2	0.0	0.3	0.0	1.0	0.3	0.0	0.0	1.0	0.2	0.4	97.9	0.0	0.1	0.0	81.5	0.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	47.6	0.0
GUCY2D	"CORD6, CYGD, GUC1A4, GUC2D, LCA, LCA1, retGC, RETGC-1, ROS-GC1"	ENSG00000132518	"Guanylate cyclase 2D, retinal"	Q02846	17	8002615-8020342	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Sensory transduction, Vision"	Lyase	"Cone-rod dystrophy, Congenital stationary night blindness, Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"retina: 34.2"	"Group enriched"	"Detected in some"	4	"Cone photoreceptor cells: 62.6;Rod photoreceptor cells: 58.3"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	31	"plasmacytoid DC: 8.0"	"Lineage enriched"	"Detected in single"	50	"dendritic cells: 8.0"	"Cell line enriched"	"Detected in some"	5	"JURKAT: 5.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 79: Retina - Phototransduction"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"				"unprognostic (3.57e-4)"	"unprognostic (5.05e-1)"	"unprognostic (1.49e-1)"	"unprognostic (9.75e-5)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.44e-2)"	"unprognostic (3.81e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.54e-2)"	"unprognostic (4.44e-1)"	"unprognostic (7.59e-5)"	"unprognostic (1.05e-1)"	"unprognostic (3.46e-1)"	"unprognostic (3.08e-1)"	"unprognostic (1.07e-1)"	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	34.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.4	1.3	5.2	5.7	2.1	1.4	3.8	1.9	0.0	1.4	0.0	62.6	1.2	2.7	0.0	1.9	0.1	6.9	0.2	0.1	0.1	0.0	0.0	0.5	0.0	0.7	0.1	0.0	0.6	0.0	0.1	0.0	1.2	1.1	0.0	0.4	0.0	0.0	0.6	0.0	14.9	0.0	0.6	0.0	0.0	0.8	6.1	0.0	0.0	0.1	0.1	0.0	0.4	0.0	1.1	0.0	0.4	0.1	58.3	0.0	0.0	0.0	0.4	0.1	2.4	0.3	2.2	0.1	0.0	0.2	0.5
HAMP	"HEPC, HFE2B, LEAP-1, LEAP1"	ENSG00000105697	"Hepcidin antimicrobial peptide"	P81172	19	35280716-35285143	"Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"		"Antibiotic, Antimicrobial, Fungicide, Hormone"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"liver: 2054.8"	"Cell type enriched"	"Detected in many"	17	"Hepatocytes: 3227.7"	"Group enriched"	"Detected in many"	12	"glioma: 6.5;liver cancer: 16.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"myeloid DC: 1.5;plasmacytoid DC: 4.6"	"Lineage enriched"	"Detected in single"	10	"dendritic cells: 4.6"	"Cell line enriched"	"Detected in some"	440	"Hep G2: 448.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"								"Secreted to blood"	NA	NA	1900000	10000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (5.53e-2)"	"unprognostic (5.02e-4)"	"unprognostic (2.10e-3)"	"unprognostic (4.69e-3)"	"unprognostic (5.35e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.92e-2)"	"unprognostic (9.36e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.06e-1)"	"unprognostic (4.61e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.68e-7)"	"unprognostic (4.11e-2)"	"unprognostic (3.93e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.77e-2)"	1.0	1.2	17.7	2.0	17.6	5.4	1.5	17.4	30.4	2.3	20.8	0.8	0.9	0.3	0.6	0.5	2.8	0.6	415.0	17.8	20.2	1.1	2054.8	3.2	4.0	48.0	24.9	3.2	88.0	0.4	5.8	2.3	25.8	2.7	0.0	4.2	1.2	1.3	1.2	1.1	0.5	1.0	21.5	1.1	1.1	0.7	18.7	0.1	0.4	0.2	4.4	1.6	0.2	21.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.7	448.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.7	1.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.2	0.0	0.0	0.0	0.4	0.0	4.6	0.0	0.0	17.7	17.6	17.4	30.4	17.8	20.2	48.0	24.9	25.8	21.5	18.7	21.0	0.8	0.0	0.0	0.0	5.7	0.5	1.5	0.0	0.0	0.0	26.2	8.0	1.7	30.0	0.6	0.0	0.0	0.9	0.6	0.1	0.0	0.4	0.0	1.9	1.0	13.7	0.0	89.7	0.2	99.0	1.2	0.4	10.7	1.8	75.7	0.7	45.3	3227.7	187.9	0.0	0.0	0.7	0.0	63.2	1.2	0.0	0.0	28.4	0.0	0.0	0.0	0.6	0.0	0.0	0.1	22.6	0.1	0.0	0.1	4.2	0.0	0.1	0.0	0.6	0.0	0.2	0.6	0.0	0.0	0.0	18.6	0.7	4.3	0.5	0.2	2.2
HAS1	HAS	ENSG00000105509	"Hyaluronan synthase 1"	Q92839	19	51713112-51723991	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 49.6;ovary: 20.8"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 26.6;Bipolar cells: 20.3;Cholangiocytes: 38.6;Fibroblasts: 64.2;Suprabasal keratinocytes: 17.8"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	4	"eosinophil: 2.5"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.5"	"Cell line enriched"	"Detected in some"	4	"U-87 MG: 112.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA067602	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	Nucleoplasm	"HPA067602: AB_2685871"	"unprognostic (3.56e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.43e-2)"	"unprognostic (5.26e-4)"	"unprognostic (7.17e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.49e-4)"	"unprognostic (4.80e-2)"	"unprognostic (1.99e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.30e-11)"	"unprognostic (9.12e-4)"	"unprognostic (8.99e-2)"	"unprognostic (3.73e-4)"	"unprognostic (2.43e-2)"	49.6	0.5	1.4	6.3	1.1	3.6	1.3	1.1	1.1	0.1	0.0	2.8	0.1	1.0	0.0	0.8	9.0	5.5	9.2	0.9	2.0	0.5	0.6	3.7	0.0	1.8	0.8	20.8	2.1	0.3	0.9	0.3	0.7	0.2	0.5	0.2	0.2	0.0	0.2	5.4	1.3	0.7	0.3	0.3	1.7	0.3	2.2	0.1	0.7	0.0	0.0	6.3	0.6	1.3	0.0	0.5	0.0	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.1	3.2	0.0	27.0	0.0	0.1	0.0	0.0	0.0	0.2	6.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.3	0.8	0.0	0.0	0.0	0.0	112.6	0.0	0.2	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.4	1.1	1.1	1.1	0.9	2.0	1.8	0.8	0.7	0.3	2.2	1.3	1.5	0.0	1.8	0.0	0.2	26.6	0.1	0.8	0.6	20.3	0.0	0.0	1.3	38.6	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.5	0.5	0.0	0.0	1.7	0.0	0.2	64.2	2.6	0.0	2.5	0.0	0.0	0.1	0.2	0.0	1.5	0.0	0.0	0.8	9.0	0.2	0.3	8.3	8.8	0.0	0.0	0.2	0.0	0.0	0.9	0.1	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.5	0.0	3.1	10.6	0.1	0.5	0.4	17.8	0.1	0.3	0.0	0.0	0.2
HBA1	HBA-T3	ENSG00000206172	"Hemoglobin subunit alpha 1"	P69905	16	176680-177522	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"bone marrow: 24344.4"	"Cell type enriched"	"Detected in many"	51	"Erythroid cells: 224916.4"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.6;glioma: 6.3;ovarian cancer: 2.6;stomach cancer: 2.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 142.6;plasmacytoid DC: 101.1"	"Group enriched"	"Detected in all"	5	"dendritic cells: 101.1;granulocytes: 142.6"	"Group enriched"	"Detected in some"	36	"HEL: 3355.8;K-562: 2416.8"									"CAB032534, HPA043780"	Enhanced					NA	NA		14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB032534: AB_2294993, HPA043780: AB_2678667"	"unprognostic (1.16e-1)"	"unprognostic (1.45e-2)"	"unprognostic (8.87e-2)"	"unprognostic (9.78e-3)"	"unprognostic (3.02e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.21e-3)"	"unprognostic (1.92e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.59e-2)"	"unprognostic (3.79e-1)"	"unprognostic (6.61e-2)"	"unprognostic (2.67e-2)"	"unprognostic (9.56e-2)"	893.7	183.0	112.1	82.0	216.3	24344.4	316.6	159.4	246.9	237.7	340.5	141.4	10.6	41.4	2.4	244.9	350.9	60.1	1766.9	56.9	92.1	1405.5	1100.4	2201.7	5.0	141.5	169.4	159.7	100.5	5.1	465.7	1992.7	183.4	170.1	11.5	3.1	138.1	43.7	234.0	194.6	85.0	7.0	211.1	5527.7	135.9	104.8	125.3	20.7	609.2	1123.2	3.6	167.2	351.2	113.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	58.1	0.0	5.7	2.1	0.0	0.4	0.0	3.5	0.0	0.0	0.0	0.2	3355.8	0.0	37.1	0.0	1.3	0.0	0.3	0.0	0.0	0.7	0.0	0.0	1.7	2416.8	0.0	0.0	14.7	0.5	0.3	0.4	1.0	0.0	0.1	1.4	79.1	0.0	1.0	7.4	5.3	2.8	0.0	0.0	0.0	1.1	0.0	8.3	0.0	0.0	0.9	0.0	0.0	0.4	0.8	0.0	0.2	0.0	8.5	7.4	48.2	26.3	0.2	0.7	7.5	3.1	8.7	10.0	4.5	8.3	25.7	142.6	13.4	0.8	101.1	0.3	2806.3	112.1	216.3	159.4	246.9	56.9	92.1	141.5	169.4	183.4	211.1	125.3	113.5	72.7	0.0	0.0	0.0	56.8	10.6	0.1	0.0	0.0	0.4	11.3	12.3	1.8	55.8	0.1	0.0	0.0	0.0	93.2	3.2	7.9	0.0	6.0	0.5	0.5	20.4	1.2	224916.4	0.0	0.0	0.0	57.9	0.0	0.4	0.0	0.1	151.0	78.8	0.0	0.0	0.0	5.7	0.0	436.7	64.1	22.4	0.0	234.0	4338.2	0.0	12.7	1.3	1166.9	0.0	0.0	0.1	2.8	0.4	0.5	0.2	0.2	11.1	0.0	16.5	0.0	8.7	58.7	1.5	7.6	0.0	13.2	0.0	155.7	0.0	3.2	0.0
HBA2	HBA-T2	ENSG00000188536	"Hemoglobin subunit alpha 2"	P69905	16	172876-173710	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"		"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"bone marrow: 38218.6"	"Cell type enriched"	"Detected in many"	22	"Erythroid cells: 198314.0"	"Cancer enhanced"	"Detected in all"		"glioma: 59.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 315.1;neutrophil: 955.3;plasmacytoid DC: 486.7"	"Group enriched"	"Detected in all"	7	"dendritic cells: 486.7;granulocytes: 955.3"	"Group enriched"	"Detected in some"	18	"HEL: 1196.2;K-562: 328.3"									"CAB038417, HPA043780"	Enhanced					NA	NA		14000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB038417: , HPA043780: AB_2678667"	"unprognostic (1.57e-1)"	"unprognostic (7.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.59e-1)"	"unprognostic (3.18e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.12e-1)"	"unprognostic (4.99e-2)"	"unprognostic (4.43e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.72e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.92e-2)"	1592.0	322.5	162.6	186.3	292.4	38218.6	545.3	268.0	377.0	573.3	570.7	254.0	21.6	85.9	5.9	432.5	570.5	147.6	2590.3	86.6	156.5	2302.8	1853.6	4204.3	9.7	210.6	249.2	288.5	141.3	11.4	807.8	3618.9	260.6	302.7	26.7	4.0	305.4	131.9	568.3	188.5	154.3	12.9	316.4	8125.4	264.0	185.0	185.4	34.6	1192.5	1744.6	10.1	325.2	632.8	179.9	0.0	0.2	0.0	0.0	0.0	0.7	0.4	0.4	0.1	0.0	0.0	3.2	0.0	1.9	4.9	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.6	1196.2	0.5	0.0	0.0	0.2	1.7	0.4	0.1	0.4	0.0	0.0	0.0	0.1	328.3	0.0	0.1	0.6	0.0	0.3	0.1	0.5	0.0	0.0	0.0	43.4	0.0	0.9	11.9	9.7	1.1	0.0	0.0	0.1	1.4	0.2	5.6	0.0	0.3	0.4	0.0	0.4	0.0	0.0	0.3	0.6	0.2	119.6	28.1	315.1	99.6	1.7	3.7	39.2	8.5	7.1	42.5	19.1	22.8	73.9	955.3	49.5	3.3	486.7	1.0	15003.3	162.6	292.4	268.0	377.0	86.6	156.5	210.6	249.2	260.6	316.4	185.4	179.9	184.7	3.2	1.5	0.0	97.6	44.4	0.4	0.1	0.6	1.7	20.2	22.2	6.8	70.1	0.7	0.0	0.0	0.0	162.2	6.9	54.8	0.0	3.4	0.6	0.8	50.9	3.0	198314.0	0.0	0.0	0.0	241.0	4.1	0.9	1.3	0.3	142.8	131.2	0.0	0.0	0.0	7.5	4.1	770.6	149.6	16.9	0.0	402.9	8790.3	0.0	37.5	2.3	954.7	0.0	0.0	0.0	3.6	0.0	0.3	0.2	0.1	29.6	2.5	58.6	0.0	25.2	171.5	1.0	9.9	1.1	44.6	0.0	306.3	0.1	5.0	0.1
HBB	"beta-globin, CD113t-C"	ENSG00000244734	"Hemoglobin subunit beta"	P68871	11	5225464-5229395	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Hypotensive agent, Vasoactive"	"Congenital dyserythropoietic anemia, Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	10	"bone marrow: 133301.6"	"Cell type enriched"	"Detected in many"	24	"Erythroid cells: 672352.3"	"Group enriched"	"Detected in all"	4	"cervical cancer: 66.4;glioma: 244.6;renal cancer: 65.1"	"Region enriched"	"Detected in all"	11	"cerebral cortex: 3368.5"	"Group enriched"	"Detected in all"	5	"neutrophil: 658.1;plasmacytoid DC: 379.7"	"Group enriched"	"Detected in all"	11	"dendritic cells: 379.7;granulocytes: 658.1"	"Cell line enhanced"	"Detected in some"		"HEL: 6.0;SCLC-21H: 5.0;SH-SY5Y: 6.4;U-266/70: 23.1;U-266/84: 4.2"									"CAB009526, HPA043234"	Enhanced					NA	NA		10000000000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB009526: AB_2143058, HPA043234: AB_2678378"	"unprognostic (2.41e-1)"	"unprognostic (8.55e-2)"	"unprognostic (2.40e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.22e-1)"	"unprognostic (4.88e-2)"	"unprognostic (7.46e-2)"	"unprognostic (2.91e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	"unprognostic (8.11e-3)"	"unprognostic (2.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.87e-3)"	"unprognostic (6.41e-2)"	1641.5	481.4	155.7	217.3	219.2	133301.6	637.4	235.7	3368.5	546.2	384.6	278.2	28.8	78.8	45.6	505.7	829.6	792.7	2658.8	108.9	154.4	2333.1	1907.3	4039.6	26.8	209.6	243.5	289.0	158.5	50.5	808.2	6345.0	303.0	312.0	148.9	31.0	548.1	290.6	578.8	135.3	169.8	66.3	316.2	9225.9	269.1	170.6	171.4	196.8	1152.0	12902.5	40.3	320.1	633.5	180.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	2.2	0.0	0.0	0.0	0.8	0.2	0.4	0.0	0.0	0.4	0.3	0.0	0.0	5.0	6.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	23.1	4.2	0.0	0.0	0.0	0.0	99.5	25.3	73.7	37.8	1.3	4.0	21.5	6.8	1.1	35.2	13.8	13.7	39.9	658.1	47.9	5.0	379.7	1.4	22388.9	155.7	219.2	235.7	3368.5	108.9	154.4	209.6	243.5	303.0	316.2	171.4	180.7	441.7	3.2	8.4	0.0	280.5	157.0	2.3	5.1	0.0	4.0	54.7	72.0	3.4	217.3	4.5	7.3	4.2	2.2	369.9	5.2	50.9	0.0	0.0	6.8	6.6	151.7	3.6	672352.3	0.0	0.0	11.3	276.1	0.0	5.1	0.0	4.6	443.4	420.5	7.3	3.3	0.0	7.2	6.1	1452.1	702.6	0.0	0.0	1091.0	27383.1	0.0	72.7	9.7	38.1	0.0	0.0	0.1	3.5	0.0	1.9	0.0	0.1	272.4	84.9	117.8	0.0	126.0	396.8	0.0	0.0	0.0	252.5	2.2	769.8	0.3	3.0	0.1
HCAR1	"FKSG80, GPR104, GPR81, HCA1, LACR1, TA-GPCR"	ENSG00000196917	"Hydroxycarboxylic acid receptor 1"	Q9BXC0	12	122726076-122730844	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"breast: 11.5;parathyroid gland: 40.4"	"Group enriched"	"Detected in some"	4	"Breast glandular cells: 8.7;Breast myoepithelial cells: 5.2;Club cells: 3.2;Early spermatids: 9.6;Extravillous trophoblasts: 3.7;Late spermatids: 6.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 7.9"	"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.0"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.0"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 12.1;MCF7: 8.1;RT4: 35.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 15: RT4 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"				"prognostic unfavorable (3.61e-5)"	"unprognostic (8.90e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.31e-2)"	"unprognostic (1.93e-2)"	"unprognostic (3.80e-4)"	"unprognostic (5.43e-4)"	"unprognostic (1.41e-1)"	"unprognostic (7.74e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.85e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.66e-3)"	"unprognostic (2.14e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.38e-1)"	"unprognostic (1.87e-2)"	5.5	0.3	0.4	0.2	0.4	1.0	11.5	1.7	0.7	0.7	0.4	0.1	0.3	0.4	1.2	0.2	1.7	0.2	0.2	0.6	0.1	0.8	0.1	0.4	0.4	0.3	0.1	0.4	0.1	40.4	0.3	1.0	0.3	1.0	0.1	0.6	5.0	5.1	1.2	0.7	0.3	0.2	0.1	2.3	2.0	0.8	0.2	0.3	1.3	0.1	0.1	1.2	0.3	1.2	0.1	0.3	0.2	0.3	0.0	0.0	1.9	0.1	0.0	0.0	0.1	2.5	12.1	0.3	0.4	0.0	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.2	0.6	1.8	0.2	0.3	0.2	0.6	0.0	0.6	0.0	0.1	0.0	0.2	0.2	0.6	0.1	8.1	0.2	0.4	0.3	3.0	0.6	0.3	0.2	0.3	0.1	35.3	2.6	0.2	0.1	4.2	0.0	0.3	3.4	0.1	0.3	0.4	0.2	0.2	0.2	0.4	0.1	0.4	0.2	0.2	0.3	2.0	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.2	0.0	0.4	0.2	0.2	1.2	0.4	0.1	0.3	0.1	0.1	0.4	0.4	1.7	0.7	0.6	0.1	0.3	0.1	0.3	0.1	0.2	1.2	1.3	0.0	0.5	0.0	0.0	0.1	1.4	0.2	0.0	0.3	8.7	5.2	0.4	0.0	3.2	0.0	0.0	0.4	0.3	0.0	0.0	0.0	9.6	0.2	0.2	0.3	0.0	0.0	0.0	0.0	3.7	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.7	6.5	0.3	0.3	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.1	0.0	0.1	1.0	0.0	0.2	0.0	0.0	0.3	0.2	0.0	0.0	1.0
HCN1	"BCNG-1, BCNG1, HAC-2"	ENSG00000164588	"Hyperpolarization activated cyclic nucleotide gated potassium channel 1"	O60741	5	45254948-45696498	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"brain: 7.2;retina: 17.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 671.7;Inhibitory neurons: 766.5;Rod photoreceptor cells: 199.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"cerebral cortex: 7.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"WM-115: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019195	Enhanced					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA019195: AB_2670094"	"unprognostic (1.30e-1)"		"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (9.24e-3)"			"unprognostic (6.82e-2)"	"unprognostic (1.10e-1)"	"unprognostic (9.63e-3)"	"unprognostic (4.11e-3)"		"unprognostic (6.78e-2)"	"unprognostic (1.16e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.68e-3)"		0.0	0.4	1.8	0.0	2.5	0.1	0.0	2.4	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.5	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.5	2.4	7.2	2.5	1.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	24.5	0.0	0.1	0.1	0.0	0.0	29.4	0.0	0.0	7.4	0.0	0.0	0.0	133.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	0.0	0.0	671.7	0.7	0.0	0.6	0.0	0.1	0.0	0.6	0.0	0.0	0.0	6.7	766.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	51.5	0.0	14.8	0.0	21.1	14.4	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	199.4	0.0	0.3	0.1	0.6	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3
HCN2	"BCNG-2, BCNG2, HAC-1"	ENSG00000099822	"Hyperpolarization activated cyclic nucleotide gated potassium and sodium channel 2"	Q9UL51	19	589881-617159	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"brain: 146.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 60.4;Horizontal cells: 40.4;Inhibitory neurons: 18.7;Oligodendrocytes: 62.1;Rod photoreceptor cells: 14.9"	"Group enriched"	"Detected in many"	6	"glioma: 8.7;melanoma: 5.7;renal cancer: 2.8;testis cancer: 4.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 29.9;HeLa: 15.8;MCF7: 28.4;U-138 MG: 20.2;U-87 MG: 41.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (8.69e-2)"	"unprognostic (3.97e-3)"	"unprognostic (3.31e-4)"	"unprognostic (1.44e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.55e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.19e-3)"	"unprognostic (8.00e-2)"	"prognostic unfavorable (6.99e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.53e-4)"	"unprognostic (9.72e-3)"	0.1	4.2	34.9	0.2	58.1	0.4	0.1	84.7	111.8	0.1	0.0	0.6	0.1	0.1	0.2	1.6	0.0	0.1	11.6	38.2	56.6	1.3	0.2	0.2	0.3	86.6	76.7	0.1	0.3	3.4	12.8	0.1	84.9	0.3	0.0	7.5	0.3	0.1	0.1	0.9	0.4	0.1	38.2	0.4	0.4	3.1	146.0	0.1	0.1	0.0	0.3	0.1	0.4	66.9	0.1	29.9	0.3	1.0	3.1	2.1	1.0	2.1	2.4	0.8	0.2	4.3	0.3	0.0	6.5	2.9	2.1	0.2	0.6	0.1	0.1	5.1	12.6	0.0	15.8	0.4	2.2	0.3	5.6	5.6	0.5	0.2	0.1	0.9	0.1	0.7	1.8	0.2	2.1	28.4	0.1	0.0	1.4	0.7	0.8	0.2	0.1	0.7	0.5	0.9	11.3	5.8	7.3	0.1	2.3	0.5	5.9	1.0	2.8	20.2	3.0	0.4	8.4	0.5	0.4	0.2	41.7	1.4	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	58.1	84.7	111.8	38.2	56.6	86.6	76.7	84.9	38.2	146.0	66.9	0.5	0.0	0.0	2.0	0.6	0.6	0.0	0.0	1.2	60.4	0.7	0.9	4.1	0.0	0.0	0.0	2.1	0.0	1.6	0.3	0.0	0.1	0.1	0.6	0.4	0.9	1.2	2.7	12.8	0.0	0.3	0.2	0.0	1.2	0.0	0.2	0.7	0.1	0.1	40.4	18.7	0.0	0.0	1.3	0.3	0.4	0.0	1.1	0.0	2.8	0.0	2.7	0.0	5.5	62.1	0.1	0.0	0.7	1.4	0.1	0.0	0.3	0.0	14.9	0.0	0.1	0.5	0.1	1.7	4.5	0.6	0.3	1.2	0.1	0.1	0.1
HCN4		ENSG00000138622	"Hyperpolarization activated cyclic nucleotide gated potassium channel 4"	Q9Y3Q4	15	73319859-73368958	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Sodium transport, Transport"	"Ion channel, Ligand-gated ion channel, Potassium channel, Sodium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"brain: 8.5;heart muscle: 8.4;testis: 7.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 29.4;Late spermatids: 49.5"	"Cancer enriched"	"Detected in some"	4	"testis cancer: 3.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.3;CACO-2: 1.7;HDLM-2: 1.1;NTERA-2: 4.9;SuSa: 1.2;U-2 OS: 2.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA073174	Approved					NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA073174: "	"unprognostic (2.21e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.18e-2)"	"unprognostic (3.14e-2)"	"unprognostic (5.30e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.19e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.37e-1)"	"unprognostic (6.56e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-1)"	"unprognostic (6.05e-5)"	"unprognostic (5.56e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.51e-2)"	"unprognostic (7.95e-2)"	0.0	0.4	3.6	0.0	0.7	0.0	0.0	2.2	1.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	8.4	1.0	2.8	0.0	0.0	0.0	0.0	5.0	4.2	0.0	0.1	0.0	0.5	0.0	4.6	0.1	0.0	0.4	0.0	0.3	0.0	0.0	0.1	0.0	2.5	0.0	0.1	7.2	8.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.7	2.2	1.8	1.0	2.8	5.0	4.2	4.6	2.5	8.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	29.4	0.6	0.0	0.2	1.8	0.0	1.5	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	49.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.7	1.2	0.0	0.0	0.3	1.6	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HEPACAM	"FLJ25530, GLIALCAM"	ENSG00000165478	"Hepatic and glial cell adhesion molecule"	Q14CZ8	11	124919205-124936412	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell cycle, Growth arrest, Growth regulation"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 222.6;choroid plexus: 79.7"	"Group enriched"	"Detected in some"	9	"Astrocytes: 184.8;Oligodendrocyte precursor cells: 72.9;Oligodendrocytes: 163.2"	"Cancer enriched"	"Detected in some"	12	"glioma: 29.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	30	"Hep G2: 25.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA017613, CAB025486"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"CAB025486: , HPA017613: AB_1850595"	"unprognostic (3.22e-3)"	"unprognostic (1.06e-2)"		"unprognostic (1.64e-1)"	"unprognostic (6.41e-2)"		"unprognostic (1.47e-1)"		"unprognostic (9.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (7.58e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.06e-6)"	"unprognostic (2.62e-1)"	"unprognostic (3.21e-1)"			15.6	0.3	172.8	0.2	203.3	0.0	2.5	170.4	162.1	0.2	79.7	0.4	0.1	0.1	0.1	0.1	0.0	0.1	0.2	163.2	156.1	0.1	16.2	0.0	0.2	222.6	182.8	0.0	0.0	0.0	0.8	0.0	183.6	0.2	0.2	1.8	0.2	0.5	0.1	0.0	0.2	0.1	205.7	0.0	0.1	0.2	182.0	0.0	0.0	0.3	0.6	0.0	0.1	212.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	25.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.2	172.8	203.3	170.4	162.1	163.2	156.1	222.6	182.8	183.6	205.7	182.0	212.2	0.1	0.0	0.0	184.8	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	11.2	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.6	0.0	15.5	0.0	72.9	163.2	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
HEPH	"CPL, KIAA0698"	ENSG00000089472	Hephaestin	Q9BQS7	X	66162549-66268867	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 81.9;smooth muscle: 82.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 78.0;Distal enterocytes: 211.0;Intestinal goblet cells: 95.6;Paneth cells: 96.9;Proximal enterocytes: 156.2;Undifferentiated cells: 72.4"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 37.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 28.5;HEL: 25.4;HSkMC: 36.0;K-562: 72.5;LHCN-M2: 28.5;SuSa: 68.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA005824	Approved					NA	NA		3700000		"Cluster 37: Intestine - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA005824: AB_1850603"	"unprognostic (3.10e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.29e-3)"	"unprognostic (2.25e-1)"	"unprognostic (4.94e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.40e-2)"	"unprognostic (3.35e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavorable (7.00e-6)"	"unprognostic (3.08e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.17e-2)"	8.2	19.1	18.2	14.7	25.0	0.0	8.3	20.8	19.2	23.8	8.7	81.9	79.0	34.7	14.4	11.9	14.2	38.7	36.0	16.7	21.2	8.1	3.5	12.3	3.6	22.3	24.4	22.1	2.3	1.4	3.7	1.3	20.4	24.3	77.6	15.0	7.6	31.8	0.8	4.8	81.6	82.7	18.8	11.1	12.4	3.5	21.7	1.3	5.1	3.2	2.6	19.5	10.1	21.0	0.0	0.0	28.5	2.3	0.0	0.1	0.8	7.3	0.4	0.0	0.0	17.4	0.0	0.0	0.1	15.1	0.0	0.0	0.0	0.0	0.0	8.3	0.0	25.4	0.0	0.0	0.3	0.2	0.1	36.0	0.0	0.0	0.0	9.9	0.0	0.0	72.5	0.6	28.5	0.0	0.0	0.6	14.1	4.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	68.6	0.0	0.0	0.7	16.2	1.2	0.1	1.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	25.0	20.8	19.2	16.7	21.2	22.3	24.4	20.4	18.8	21.7	21.0	2.5	0.0	0.0	78.0	0.5	0.9	0.0	0.0	0.0	1.0	0.9	6.0	24.1	0.0	0.0	0.0	0.0	0.0	0.1	211.0	0.0	0.3	0.6	1.3	15.1	4.1	40.8	0.0	0.3	1.1	0.0	12.6	0.0	1.2	0.0	1.1	6.4	0.0	0.2	0.0	2.9	95.6	0.0	0.0	1.9	1.5	11.5	0.3	0.0	6.5	0.0	26.1	0.0	3.5	36.2	5.0	96.9	29.7	0.0	0.3	156.2	0.0	0.7	1.3	6.6	4.4	9.8	0.0	0.3	0.3	0.6	0.0	0.5	6.9	72.4	0.2
HEPHL1	DKFZp686F22190	ENSG00000181333	"Hephaestin like 1"	Q6MZM0	11	94021354-94114208	"Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"	Oxidoreductase	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"esophagus: 4.5;lymphoid tissue: 9.5;skin 1: 3.8;vagina: 4.5"	"Cell type enriched"	"Detected in some"	5	"Basal keratinocytes: 10.5"	"Cancer enriched"	"Detected in some"	5	"head and neck cancer: 20.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HaCaT: 1.4;HBEC3-KT: 2.6"	"Region enriched"	"Detected in single"	12	"olfactory bulb: 1.2"	"Not detected"	"Not detected"			HPA031517	Uncertain					NA	NA		260000000		"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"			"HPA031517: AB_10603769"	"unprognostic (9.16e-2)"	"prognostic unfavorable (4.94e-4)"	"unprognostic (2.40e-1)"	"unprognostic (3.26e-6)"	"unprognostic (3.17e-1)"	"unprognostic (3.45e-1)"	"unprognostic (1.72e-2)"	"unprognostic (6.71e-2)"	"unprognostic (5.34e-1)"	"unprognostic (1.09e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.25e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	9.5	0.0	4.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.4	0.0	2.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	10.5	0.0	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	1.8	0.0	0.6	0.0	0.1	0.0	0.0	1.4	0.0	0.1	0.1	0.0	0.4	1.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	1.5	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0
HEY1	"bHLHb31, CHF-2, CHF2, HERP2, HESR-1, HESR1, HRT-1"	ENSG00000164683	"Hes related family bHLH transcription factor with YRPW motif 1"	Q9Y5J3	8	79762371-79767857	"Cancer-related genes, Predicted intracellular proteins, Transcription factors, Transporters"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 105.2;Endothelial cells: 47.6;Extravillous trophoblasts: 112.6;Skeletal myocytes: 74.5"	"Cancer enhanced"	"Detected in all"		"glioma: 43.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"neutrophil: 6.9"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.9"	"Cell line enhanced"	"Detected in many"		"HEK 293: 125.7;PC-3: 28.8;SK-MEL-30: 93.3;WM-115: 31.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055599, HPA063472"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Nuclear membrane, Cytosol"	"HPA055599: AB_2682858, HPA063472: AB_2685018"	"unprognostic (1.15e-1)"	"unprognostic (5.06e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-3)"	"unprognostic (8.47e-2)"	"unprognostic (4.21e-3)"	"unprognostic (9.56e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.22e-2)"	"unprognostic (1.25e-2)"	"unprognostic (6.71e-3)"	"unprognostic (5.92e-3)"	"unprognostic (5.77e-2)"	"unprognostic (8.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.00e-1)"	21.1	2.2	17.4	2.1	23.0	0.6	19.0	19.4	19.1	7.2	9.6	6.7	1.7	3.5	0.9	2.8	3.9	4.2	23.9	18.4	20.3	2.8	2.8	15.2	2.2	18.1	21.0	2.0	3.4	3.3	18.4	17.8	19.3	6.0	2.6	5.3	10.1	1.7	19.5	4.2	5.8	3.2	19.1	2.4	4.8	3.1	22.8	3.4	6.5	16.2	2.5	9.3	5.2	15.4	1.7	0.1	1.1	9.1	0.8	0.7	22.0	2.1	2.1	0.3	0.3	0.1	0.1	3.3	2.3	1.0	1.0	4.6	4.9	0.1	0.2	0.5	125.7	0.0	4.1	2.1	1.4	0.0	0.7	1.3	3.7	0.1	16.2	0.4	3.4	0.0	9.0	3.6	1.3	0.1	0.0	0.5	0.1	0.3	28.8	0.0	4.6	3.3	0.4	3.9	5.2	14.6	0.1	2.4	93.3	19.6	0.1	0.1	2.0	0.7	2.4	0.0	1.8	3.3	0.7	0.2	3.4	0.0	31.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	0.0	1.3	0.0	0.0	0.0	17.4	23.0	19.4	19.1	18.4	20.3	18.1	21.0	19.3	19.1	22.8	15.4	105.2	0.0	1.8	15.0	0.8	3.2	3.4	27.6	2.8	6.8	8.6	12.2	4.3	0.0	19.5	0.0	0.0	6.8	1.8	5.3	15.6	2.6	4.6	12.6	4.1	47.6	36.8	0.0	7.7	1.2	112.6	5.3	1.5	33.5	10.8	1.9	41.0	0.9	1.8	21.9	8.0	2.0	26.4	0.6	5.7	3.2	0.0	2.3	33.8	20.6	0.0	10.9	0.0	18.6	1.0	0.7	7.5	0.4	0.8	1.7	0.2	0.4	7.7	12.2	0.0	74.5	12.1	0.6	15.4	3.4	3.0	23.4	1.1	1.5	2.5	2.6
HEY2	"bHLHb32, HERP1, HESR2"	ENSG00000135547	"Hes related family bHLH transcription factor with YRPW motif 2"	Q9UBP5	6	125747664-125761269	"Predicted intracellular proteins, Transcription factors, Transporters"	"Notch signaling pathway, Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 30.7"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 49.9;Endometrial ciliated cells: 46.1;Granulosa cells: 73.9;Late spermatids: 80.6;Sertoli cells: 52.6;Smooth muscle cells: 41.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 5.5;HEK 293: 7.1;SK-MEL-30: 6.6;TIME: 14.8;U-266/70: 17.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030205, HPA074851"	Approved		Approved	"Nuclear bodies,Aggresome"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear bodies"	Aggresome	"HPA030205: AB_10600712, HPA074851: AB_2686718"	"unprognostic (5.10e-2)"	"unprognostic (4.34e-2)"	"unprognostic (1.41e-3)"	"unprognostic (2.43e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.52e-3)"	"unprognostic (2.56e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.10e-3)"	"unprognostic (7.34e-2)"	"unprognostic (6.20e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.28e-1)"	"unprognostic (6.74e-2)"	"unprognostic (1.51e-3)"	"unprognostic (1.19e-1)"	6.5	0.9	8.8	1.0	12.0	0.1	5.7	9.4	7.6	8.0	3.0	2.5	1.3	7.5	16.4	1.8	13.5	1.7	30.7	7.2	10.4	3.1	5.3	3.2	0.5	12.7	10.0	7.1	3.3	2.6	5.5	3.7	10.6	2.1	1.3	5.7	2.0	2.7	16.2	2.4	2.1	1.7	14.1	1.9	2.0	6.6	11.8	0.7	3.1	4.9	0.6	2.7	4.7	12.2	0.0	0.0	0.0	5.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.0	0.8	0.2	0.2	0.1	0.0	0.5	7.1	1.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.6	0.0	0.4	0.0	0.0	3.2	0.0	0.3	0.5	0.6	0.9	0.0	0.1	2.3	0.0	0.0	0.0	6.6	3.2	1.9	0.0	14.8	0.3	0.0	0.1	0.8	17.6	0.3	0.1	0.6	0.0	2.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	8.8	12.0	9.4	7.6	7.2	10.4	12.7	10.0	10.6	14.1	11.8	12.2	2.8	3.2	1.1	12.4	0.7	3.8	0.5	8.7	3.4	0.4	9.8	5.7	21.5	0.0	2.7	0.0	8.4	0.0	1.4	0.1	9.8	0.1	49.9	46.1	4.2	6.0	0.0	2.7	0.1	1.8	0.1	3.3	1.1	36.8	0.0	73.9	1.8	8.0	0.1	1.7	0.4	0.0	2.0	0.8	3.0	80.6	6.5	0.6	3.6	5.6	0.0	34.8	3.1	2.5	23.4	1.1	0.1	23.3	3.1	0.3	0.0	6.4	5.4	5.2	52.6	17.5	41.8	16.2	15.1	7.7	2.0	0.0	2.0	2.8	0.1	0.3
HGSNAT	"FLJ32731, HGNAT, TMEM76"	ENSG00000165102	"Heparan-alpha-glucosaminide N-acetyltransferase"	Q68CP4	8	43140464-43202855	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant, Mucopolysaccharidosis, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029578	Approved					NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"			"HPA029578: AB_10602423"	"unprognostic (5.35e-2)"	"unprognostic (4.61e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (5.46e-4)"	"unprognostic (3.94e-3)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-3)"	"unprognostic (5.02e-2)"	"prognostic favorable (6.33e-5)"	"unprognostic (2.55e-2)"	"unprognostic (5.48e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.45e-2)"	32.3	20.0	13.1	17.5	13.0	21.7	27.8	10.6	13.5	35.0	13.8	25.4	18.4	30.1	30.6	24.0	29.0	25.9	23.3	13.3	17.6	20.0	26.6	24.5	11.7	13.3	12.0	35.9	29.9	22.7	30.7	28.4	13.2	26.9	17.2	12.5	25.9	23.3	14.4	35.4	20.9	25.1	11.4	17.6	23.2	7.6	15.8	11.3	26.9	17.6	15.7	25.2	28.7	13.0	27.4	36.0	8.9	18.0	71.7	53.8	13.3	30.5	36.2	21.8	19.3	5.1	39.2	14.8	20.5	42.9	15.2	15.5	4.0	18.5	12.7	6.4	6.9	16.3	22.2	8.1	23.0	3.7	2.5	36.2	25.9	11.7	24.9	34.5	39.2	7.0	7.5	22.1	40.4	10.0	14.8	7.2	8.0	16.3	5.4	1.6	16.1	7.7	36.1	22.8	4.7	14.0	39.0	12.6	17.4	19.0	43.7	20.9	46.3	33.2	5.4	20.9	12.7	17.9	18.2	6.1	26.8	6.3	20.8	0.2	8.8	9.4	2.7	5.4	3.0	1.9	2.3	2.8	15.8	2.1	1.7	1.9	3.2	8.8	8.6	2.0	1.7	5.0	13.1	13.0	10.6	13.5	13.3	17.6	13.3	12.0	13.2	11.4	15.8	13.0	39.1	16.0	31.9	48.0	26.7	18.0	19.5	22.6	8.6	50.6	23.9	21.7	10.5	28.6	17.8	51.5	50.1	39.2	30.1	27.2	3.9	26.7	0.5	23.5	42.1	37.8	24.1	15.3	61.8	28.1	39.4	34.3	32.6	36.5	8.2	51.2	49.6	23.5	29.2	25.2	76.3	28.0	18.3	34.3	58.8	3.2	35.1	43.3	19.6	44.0	33.5	13.5	34.0	50.8	43.8	29.9	17.0	31.6	19.8	20.7	31.4	9.9	23.5	39.6	26.3	30.2	28.2	1.1	3.0	22.3	21.2	30.1	25.0	37.4	21.7	17.7
HHAT	"FLJ10724, GUP2, MART-2, MART2, rasp, sit, ski, Skn"	ENSG00000054392	"Hedgehog acyltransferase"	Q5VTY9	1	210328252-210676296	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 25.8;Excitatory neurons: 47.7;Microglial cells: 20.6;Oligodendrocytes: 26.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.7"	"Group enriched"	"Detected in many"	5	"B-cells: 1.8;dendritic cells: 3.7;T-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 13.6;LHCN-M2: 11.6;RH-30: 12.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA016462	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"		"HPA016462: AB_2669360"	"unprognostic (1.26e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.86e-1)"	"unprognostic (5.02e-3)"	"unprognostic (8.89e-3)"	"unprognostic (4.81e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.67e-3)"	"unprognostic (1.43e-1)"	"unprognostic (4.13e-3)"	"prognostic favorable (8.47e-7)"	"unprognostic (2.55e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.13e-1)"	"unprognostic (5.67e-2)"	2.1	6.5	1.1	0.6	1.1	0.4	3.3	0.3	1.6	3.4	3.6	2.3	1.1	2.5	3.1	2.8	2.8	2.2	2.4	1.0	0.4	4.0	2.7	2.1	0.8	0.7	0.8	2.1	2.3	1.7	3.2	1.3	0.6	4.0	1.3	1.7	4.4	2.0	0.3	3.4	2.5	1.1	0.9	2.2	1.8	2.5	0.6	2.0	4.6	0.2	0.8	3.1	2.9	0.9	0.8	0.9	2.3	1.3	1.0	1.3	4.8	1.2	1.1	1.9	3.1	0.2	0.9	0.0	1.2	0.9	3.1	0.6	0.5	0.5	2.2	1.7	1.2	0.0	0.1	1.1	0.2	0.3	13.6	1.2	2.7	1.6	1.2	3.2	0.3	1.2	0.0	0.0	11.6	1.2	0.6	0.0	0.6	0.7	0.1	1.3	12.4	0.0	7.5	2.6	1.9	7.8	2.1	0.0	6.0	5.9	4.0	0.7	1.7	2.8	8.5	1.6	4.7	3.8	0.2	0.0	1.1	0.8	2.3	0.0	0.3	0.0	0.7	0.4	1.3	1.5	0.9	0.8	0.4	1.8	0.0	0.2	0.0	0.1	0.1	3.7	0.2	0.4	1.1	1.1	0.3	1.6	1.0	0.4	0.7	0.8	0.6	0.9	0.6	0.9	2.0	0.0	2.4	25.8	5.3	2.2	5.7	2.8	6.8	0.5	5.8	2.4	2.4	4.3	1.2	9.2	0.0	4.6	13.9	1.9	3.9	2.6	1.2	8.8	2.6	2.0	0.0	0.4	47.7	0.7	3.6	3.0	2.6	5.8	0.0	4.6	3.6	2.5	1.9	0.0	11.8	2.7	4.1	2.9	0.5	0.5	1.2	1.5	0.0	20.6	1.0	15.6	0.0	17.1	26.0	1.2	2.1	0.4	2.2	3.7	2.3	0.6	12.9	0.5	0.0	1.7	1.7	0.3	1.3	3.1	2.6	2.2	2.8	0.4	2.0	5.2
HIGD2A	"MGC2198, RCF1B"	ENSG00000146066	"HIG1 hypoxia inducible domain family member 2A"	Q9BW72	5	176388751-176389761	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA042715	Uncertain		Supported	Mitochondria,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 32: Non-specific - Translation"	Mitochondria	Cytosol	"HPA042715: AB_2678127"	"unprognostic (9.24e-2)"	"unprognostic (6.31e-3)"	"unprognostic (7.96e-2)"	"unprognostic (3.90e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.94e-2)"	"prognostic unfavorable (9.47e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.98e-2)"	"unprognostic (3.11e-3)"	"unprognostic (9.56e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.45e-1)"	"unprognostic (8.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.65e-2)"	146.1	175.6	143.3	87.0	146.2	133.1	113.5	147.2	175.0	104.7	168.0	199.4	118.9	111.7	51.3	130.0	105.0	80.5	318.7	139.8	146.0	182.7	163.3	95.7	132.9	143.9	142.2	118.7	108.7	204.9	125.1	54.6	141.6	127.9	96.3	45.5	163.2	92.7	422.5	140.8	136.6	68.1	145.3	129.3	148.6	66.0	149.0	110.7	114.0	297.9	92.7	152.3	105.2	145.7	104.9	166.6	99.0	172.6	98.5	186.4	262.2	66.6	109.7	164.7	206.4	176.0	202.2	183.3	149.9	107.1	214.2	127.3	146.2	260.6	65.9	424.0	234.0	92.6	161.7	244.7	137.4	149.7	230.1	238.2	213.2	93.7	113.3	126.3	141.7	146.5	104.0	341.5	124.0	315.9	165.3	178.1	124.8	195.5	181.7	157.1	75.6	324.7	265.5	158.7	107.9	141.5	71.4	295.2	310.5	100.7	173.3	233.7	96.8	118.5	124.7	110.2	142.5	165.2	216.6	158.4	150.5	254.1	77.5	284.2	743.6	219.8	391.2	975.8	389.5	618.1	540.1	452.6	930.0	496.0	488.1	464.2	124.6	308.0	1024.9	616.8	621.8	971.3	143.3	146.2	147.2	175.0	139.8	146.0	143.9	142.2	141.6	145.3	149.0	145.7	100.4	73.7	78.6	0.0	212.5	232.2	332.8	358.0	272.0	60.5	225.5	288.5	145.3	174.5	191.0	182.1	12.5	223.0	184.2	415.6	534.1	204.5	83.9	140.0	120.6	110.9	266.6	90.8	0.0	237.3	185.4	129.1	142.2	124.2	130.0	157.0	120.3	217.0	378.7	65.6	0.0	450.7	219.7	458.8	345.2	56.8	140.1	292.1	257.9	0.0	449.7	138.1	230.7	0.0	0.0	110.0	493.0	85.0	184.2	292.6	313.8	542.8	142.3	47.7	118.3	145.9	138.8	96.7	79.4	301.8	225.0	280.2	223.7	182.1	385.3	532.4
HLA-A		ENSG00000206503	"Major histocompatibility complex, class I, A"	P04439	6	29941260-29945884	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Innate immunity"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 3747.8;Proximal enterocytes: 5267.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 1363.9;fHDF/TERT166: 360.3;HBEC3-KT: 366.7;RPMI-8226: 372.1;U-266/70: 344.6"									CAB078470			Supported	"Golgi apparatus,Plasma membrane"		NA	NA		170000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB078470: AB_10985125"	"unprognostic (1.56e-2)"	"unprognostic (9.14e-2)"	"unprognostic (1.34e-2)"	"prognostic favorable (9.59e-4)"	"unprognostic (3.49e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.42e-2)"	"prognostic favorable (6.47e-4)"	"unprognostic (2.96e-1)"	"unprognostic (3.24e-1)"	"unprognostic (1.84e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.20e-2)"	"unprognostic (1.54e-2)"	635.4	714.2	15.0	34.8	15.5	137.7	566.7	14.7	36.5	504.9	18.0	737.5	278.3	476.1	181.1	366.8	390.3	239.9	473.4	14.6	17.0	687.0	392.0	1007.3	132.0	19.1	15.8	338.8	200.0	18.5	406.5	52.1	16.5	370.9	94.6	9.9	364.1	1.2	246.5	673.3	959.1	14.5	16.8	1413.1	442.2	132.6	18.0	138.9	531.9	14.5	178.3	412.3	466.8	18.3	1363.9	35.0	0.0	0.0	205.9	193.7	1.4	1.4	2.5	2.1	2.3	0.2	0.1	4.0	0.6	360.3	179.1	31.2	0.2	366.7	0.5	3.1	13.5	237.5	9.5	7.4	11.2	0.5	14.4	2.0	0.0	2.5	1.1	0.6	0.2	177.8	0.4	1.4	0.5	0.0	1.1	24.3	2.9	0.2	4.1	27.5	2.5	372.1	246.7	276.5	0.6	12.4	29.3	0.2	11.8	82.8	1.6	30.4	5.8	18.7	0.8	5.8	4.0	344.6	92.6	77.7	0.4	199.9	0.2	321.6	119.0	182.7	164.7	95.5	134.8	96.9	125.4	146.3	18.6	64.3	86.5	119.2	248.7	133.1	109.6	54.6	222.2	191.9	15.0	15.5	14.7	36.5	14.6	17.0	19.1	15.8	16.5	16.8	18.0	18.3	1622.4	371.8	478.6	22.9	1316.2	856.4	886.2	1417.5	228.8	30.8	289.6	188.5	147.4	936.5	952.5	503.9	6.2	18.3	1879.4	2631.8	88.0	3747.8	52.2	239.4	374.0	1717.8	955.2	499.4	3.6	1310.0	18.5	743.5	853.7	556.2	603.0	253.3	1266.2	276.4	1840.9	37.0	19.3	1755.3	1265.4	1575.0	1124.0	95.6	704.6	1419.1	635.0	67.5	3258.0	170.4	3201.9	49.3	16.1	1802.9	2452.4	484.1	1110.7	1026.6	5267.3	294.9	609.6	24.4	558.8	397.3	579.2	197.4	23.8	216.5	947.7	31.7	2234.9	1021.3	1225.4	1262.8
HLA-DQA1	"CELIAC1, HLA-DQA"	ENSG00000196735	"Major histocompatibility complex, class II, DQ alpha 1"	P01909	6	32628179-32647062	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 333.9;lymphoid tissue: 335.8"	"Cell type enriched"	"Detected in many"	4	"Langerhans cells: 4114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 666.6"	"Group enriched"	"Detected in all"	19	"B-cells: 287.6;dendritic cells: 666.6;monocytes: 257.6"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 1419.1"									HPA012315	Enhanced					NA	NA		200000	"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"			"HPA012315: AB_1853930"	"unprognostic (4.24e-3)"	"unprognostic (1.47e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.94e-3)"	"unprognostic (1.72e-1)"	"unprognostic (6.07e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.81e-3)"	"unprognostic (2.84e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.36e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.43e-2)"	"unprognostic (1.57e-1)"	61.7	45.7	2.3	111.0	2.2	7.1	41.6	2.4	2.8	49.9	5.2	76.8	0.1	27.7	32.2	32.1	29.1	127.4	20.8	1.6	5.1	39.6	95.1	333.9	335.8	4.3	2.6	18.6	15.0	2.6	15.2	13.7	2.7	15.1	115.8	1.9	34.8	7.8	7.5	30.0	74.0	19.2	5.4	180.0	103.3	12.2	3.4	234.3	26.0	0.0	322.3	175.9	16.3	11.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	213.6	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1419.1	0.9	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	4.1	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.0	2.4	0.4	0.0	0.1	0.6	0.6	63.2	1.5	156.1	24.4	0.0	0.0	1.9	105.8	0.5	2.4	257.6	1.0	287.6	3.3	16.5	666.6	274.1	0.4	4.3	3.0	8.2	68.3	162.7	21.6	129.0	2.3	2.2	2.4	2.8	1.6	5.1	4.3	2.6	2.7	5.4	3.4	11.1	67.9	12.8	86.3	0.0	972.8	50.2	0.4	4.3	4.6	0.1	9.8	28.6	2.1	7.2	19.4	0.0	2.1	0.8	179.8	0.9	1.9	4.6	0.6	0.5	0.4	97.4	0.0	38.3	0.1	4.6	2.4	14.7	10.7	0.9	50.4	0.8	12.8	0.6	381.0	0.0	0.1	0.4	2.0	518.6	4114.3	1.3	3.1	874.3	71.2	12.2	957.1	1.0	4.1	0.0	0.2	2.1	0.1	0.0	96.1	1.5	1.8	6.5	27.3	2.5	6.6	1.2	5.3	0.0	0.7	2.5	41.6	2.1	56.0	1.2	2.7	7.6
HMGCR		ENSG00000113161	"3-hydroxy-3-methylglutaryl-CoA reductase"	P04035	5	75336329-75364001	"Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cholesterol biosynthesis, Cholesterol metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism"	Oxidoreductase	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 105.7"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 239.5;Theca cells: 148.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008338, CAB016797, CAB078688"	Supported					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"			"CAB016797: , CAB078688: AB_2665607, HPA008338: AB_10960401"	"unprognostic (5.07e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.65e-3)"	"unprognostic (1.02e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.45e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.99e-2)"	"prognostic favorable (9.42e-6)"	"unprognostic (2.44e-1)"	"unprognostic (2.55e-2)"	"unprognostic (3.64e-3)"	"unprognostic (4.37e-2)"	10.8	39.5	19.8	18.1	20.7	24.6	30.8	15.7	23.0	20.1	16.2	45.2	38.1	16.8	25.3	49.1	12.2	15.2	7.4	21.5	25.0	21.1	105.7	24.2	14.7	26.6	21.3	9.7	16.5	24.8	8.2	17.7	25.2	23.3	37.3	18.7	15.5	8.1	6.4	55.2	26.5	12.9	14.2	14.8	27.6	23.3	20.5	17.8	23.4	7.1	18.6	14.1	26.7	17.5	68.5	25.6	260.7	89.2	54.9	103.4	65.5	19.3	53.6	38.6	85.0	95.8	163.7	60.3	68.7	31.7	245.2	84.5	136.4	225.9	39.4	20.8	50.8	47.0	36.7	78.6	80.8	39.8	32.9	66.8	130.7	133.6	65.6	19.2	31.5	84.8	50.4	86.4	61.0	45.2	72.7	39.9	112.5	17.7	19.7	50.7	78.7	86.5	155.2	154.5	91.0	41.3	41.4	43.7	38.3	89.6	43.1	102.4	37.2	20.5	30.0	22.4	32.8	28.1	38.1	83.2	29.7	75.2	43.7	10.0	14.8	8.8	7.7	8.9	6.2	5.1	5.2	7.8	16.9	5.2	5.3	7.2	28.8	12.5	10.5	4.9	9.0	7.5	19.8	20.7	15.7	23.0	21.5	25.0	26.6	21.3	25.2	14.2	20.5	17.5	11.6	19.2	43.3	23.2	14.9	41.4	10.1	37.6	43.3	23.5	19.0	12.1	7.0	12.8	33.3	27.6	18.8	19.7	25.7	80.4	3.9	13.5	46.6	124.4	34.3	13.4	43.0	11.6	49.9	22.0	24.0	13.7	28.5	239.5	24.1	71.3	7.9	97.5	13.1	40.4	35.8	56.0	28.5	14.8	11.8	22.2	9.3	19.5	16.0	15.0	12.1	9.7	7.2	28.1	24.7	15.0	40.0	6.0	14.4	18.4	15.5	6.9	31.6	15.2	13.1	7.0	20.2	23.4	12.0	69.8	91.6	46.7	19.2	148.7	30.4	18.8
HPCA	DYT2	ENSG00000121905	Hippocalcin	P84074	1	32885994-32898441	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Dystonia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 517.5"	"Group enriched"	"Detected in many"	7	"Bipolar cells: 198.3;Early spermatids: 155.4;Late spermatids: 119.7"	"Cancer enriched"	"Detected in many"	9	"glioma: 8.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"SCLC-21H: 4.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	6	"basal ganglia: 1309.6;hippocampal formation: 990.7"	"CAB012340, HPA043245"	Enhanced					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB012340: AB_2120209, HPA043245: AB_2678385"	"unprognostic (4.60e-2)"	"unprognostic (5.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.19e-3)"	"unprognostic (6.72e-3)"	"unprognostic (5.18e-2)"	"unprognostic (9.08e-3)"	"unprognostic (6.71e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.42e-2)"	"unprognostic (3.09e-2)"	"unprognostic (2.85e-3)"	0.2	0.4	99.4	0.0	517.5	0.0	0.1	50.3	322.2	0.7	37.5	0.7	0.1	0.5	0.0	0.1	0.3	0.2	0.3	326.8	52.2	0.3	0.2	0.1	0.0	43.0	54.8	0.6	0.5	0.3	1.8	0.0	41.6	0.5	0.4	18.4	0.1	0.1	0.2	0.1	0.4	0.2	54.8	0.1	0.2	3.6	105.8	0.0	0.4	0.0	0.0	0.2	0.4	82.6	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.2	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.0	0.0	4.9	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.5	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	99.4	517.5	50.3	322.2	326.8	52.2	43.0	54.8	41.6	54.8	105.8	82.6	0.1	0.0	0.0	3.6	0.0	0.0	1.4	0.5	0.0	198.3	0.4	0.9	0.4	0.0	0.1	0.0	6.2	0.1	0.1	1.7	0.0	0.3	155.4	0.0	0.4	0.3	18.0	0.0	21.9	0.5	0.3	0.7	0.0	0.1	0.0	0.9	0.0	0.0	0.1	13.5	7.8	2.8	0.0	0.0	0.0	119.7	1.2	0.1	0.0	2.8	0.0	9.1	0.0	4.5	3.7	0.3	5.9	0.4	0.0	1.3	2.0	2.0	0.2	19.3	0.0	0.1	0.5	4.2	8.5	0.1	0.3	0.1	0.0	0.0	2.2	1.4
HSP90AB1	"HSPC2, HSPCB"	ENSG00000096384	"Heat shock protein 90 alpha family class B member 1"	P08238	6	44246166-44253888	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Stress response"	Chaperone	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 4755.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005230, HPA055729, HPA072606, HPA074351"	Enhanced		Supported	Cytosol	"Intracellular and membrane"	NA	Yes		63000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005230: AB_2121392, HPA055729: AB_2682899, HPA072606: AB_2732203, HPA074351: AB_2732252"	"unprognostic (6.12e-3)"	"unprognostic (2.96e-3)"	"unprognostic (4.72e-2)"	"unprognostic (9.24e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"unprognostic (7.97e-2)"	"prognostic favorable (4.03e-4)"	"unprognostic (1.31e-1)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (3.02e-1)"	"unprognostic (9.53e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.06e-1)"	584.8	719.5	647.1	368.9	700.4	466.4	507.6	675.2	1529.5	581.3	651.0	425.3	215.8	594.2	540.1	463.8	708.5	332.5	783.8	699.9	811.5	494.6	396.5	526.9	427.7	707.0	738.2	1204.8	722.9	606.0	574.8	451.9	764.3	471.2	389.8	339.5	410.2	491.9	1379.0	483.7	332.6	526.8	655.1	346.0	538.8	251.6	745.8	362.1	456.8	998.8	571.4	525.0	509.4	818.8	2393.2	1495.7	1298.1	1606.0	871.2	904.4	1355.3	1049.1	1021.8	1898.3	1325.5	2254.5	708.0	3029.2	1106.3	1099.8	1928.1	1349.9	3197.5	1563.4	2326.7	1010.5	1292.5	2359.3	793.9	2978.8	628.9	2386.2	1563.2	842.6	1034.9	1495.5	1277.7	1658.4	1847.6	1533.9	3210.4	1095.1	1309.8	2404.3	2003.1	1432.6	1519.7	4378.9	1129.7	1900.7	1325.9	1658.7	1287.7	1422.1	1891.1	1154.8	816.3	1164.8	1526.2	1751.5	1518.6	1178.2	1169.0	1124.0	1875.7	931.1	2440.0	1255.6	2125.8	5370.7	1221.7	1720.8	1312.1	65.9	231.7	52.8	343.7	341.0	577.8	544.0	380.3	395.0	375.1	473.1	509.3	494.0	27.3	434.9	349.0	232.1	326.8	678.5	647.1	700.4	675.2	1529.5	699.9	811.5	707.0	738.2	764.3	655.1	745.8	818.8	1165.2	897.4	678.2	70.5	906.4	1059.3	4755.7	862.6	1331.1	329.3	938.9	1418.3	1407.0	519.0	942.6	366.0	227.2	1104.3	629.3	538.6	729.8	1011.1	185.5	1385.8	1359.6	1070.6	567.4	775.9	103.5	688.9	1107.1	1247.3	616.2	1444.8	1003.4	761.3	360.5	360.3	807.5	339.9	151.0	578.2	518.8	314.5	1262.5	198.4	686.0	896.7	736.4	76.8	573.3	326.1	200.8	69.9	127.4	811.7	504.8	611.2	725.0	1810.6	361.5	664.8	1219.1	262.1	348.4	1512.7	1437.2	266.1	694.1	1232.8	923.5	1123.3	1265.6	1350.0	739.6	2408.7
HSPA5	"BiP, GRP78"	ENSG00000044574	"Heat shock protein family A (Hsp70) member 5"	P11021	9	125234853-125241382	"Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction"	"Chaperone, Hydrolase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 1327.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005221, HPA038845, HPA038846"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	NA	NA		790000000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"CAB005221: AB_631616, HPA038845: AB_10673477, HPA038846: AB_10673478"	"unprognostic (3.98e-2)"	"unprognostic (2.50e-3)"	"unprognostic (6.64e-2)"	"unprognostic (9.60e-3)"	"unprognostic (1.54e-3)"	"unprognostic (6.02e-3)"	"unprognostic (9.08e-3)"	"unprognostic (9.11e-3)"	"unprognostic (4.50e-2)"	"unprognostic (7.45e-3)"	"unprognostic (1.49e-1)"	"unprognostic (8.96e-2)"	"prognostic unfavorable (3.05e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.34e-1)"	"unprognostic (7.28e-2)"	"unprognostic (3.66e-2)"	211.2	170.2	83.7	276.1	91.7	856.2	147.2	101.8	107.3	202.9	112.0	181.6	166.5	183.6	379.1	150.7	177.9	130.6	284.0	90.2	126.8	168.7	327.8	182.8	145.4	105.8	107.0	142.1	260.7	223.3	182.7	311.3	120.2	192.8	183.7	105.1	211.0	167.5	87.6	143.2	175.8	205.2	111.4	129.8	177.9	173.5	101.7	116.2	692.8	85.2	180.0	197.7	105.1	163.9	593.4	380.3	480.2	631.3	505.6	592.0	1152.8	1047.6	728.2	675.9	778.5	558.4	1093.4	649.5	644.7	682.4	1564.0	732.5	403.3	839.4	684.7	403.7	213.8	396.7	392.9	945.1	2692.4	547.4	730.2	363.6	1515.2	551.3	2309.4	728.1	1065.6	129.0	291.9	870.3	482.2	382.6	249.7	297.8	559.1	1327.5	362.2	233.2	492.4	1061.2	608.4	352.7	248.5	448.0	648.1	653.4	1079.3	715.5	694.3	378.0	791.8	439.5	433.0	462.7	484.2	939.0	994.7	551.2	1070.4	435.9	689.0	455.5	366.3	305.3	384.7	361.8	390.0	209.0	276.7	360.1	322.0	173.9	224.6	277.2	280.9	362.9	252.5	349.5	213.6	758.2	83.7	91.7	101.8	107.3	90.2	126.8	105.8	107.0	120.2	111.4	101.7	163.9	227.1	185.9	273.5	38.5	254.0	292.9	1225.2	573.2	192.9	97.3	193.7	166.2	803.4	97.2	416.9	112.2	352.3	505.9	408.7	426.5	45.0	415.0	86.2	372.1	402.2	247.9	508.8	82.3	19.7	258.4	955.2	455.5	258.4	467.4	334.2	304.6	147.4	379.4	449.4	63.9	34.6	508.2	195.3	133.4	271.0	50.3	175.2	261.6	181.5	30.0	135.0	134.6	80.3	29.7	41.1	313.7	408.3	174.5	1041.5	360.8	196.9	121.2	267.6	176.6	118.3	245.9	673.8	435.7	204.3	167.4	236.4	1327.5	323.8	243.0	376.4	795.4
HTN1	HIS1	ENSG00000126550	"Histatin 1"	P15515	4	70050438-70058848	"Predicted secreted proteins, Transporters"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	2602	"salivary gland: 48372.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA077315	Approved				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 11: Alveolar cells - Smell perception"			"HPA077315: "									"unprognostic (2.22e-1)"									0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	18.5	0.0	0.0	5.5	0.0	0.0	0.0	0.0	48372.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0
HTN3	HIS2	ENSG00000205649	"Histatin 3"	P15516	4	70028455-70036538	"Predicted secreted proteins, Transporters"	Biomineralization	"Antibiotic, Antimicrobial, Fungicide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	1102	"salivary gland: 136053.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"melanoma: 0.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;HL-60: 1.7"									CAB073541	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB073541: "																		0.0	0.1	0.7	0.3	1.3	18.9	0.1	2.8	2.3	0.0	0.0	2.4	0.3	0.2	0.4	0.2	0.1	0.1	26.2	0.9	0.0	0.1	0.1	0.2	0.3	0.1	0.0	26.0	123.4	0.1	1.8	13.1	0.2	0.2	3.0	0.7	136053.4	0.1	0.1	10.0	0.1	0.1	0.0	0.2	0.3	0.5	0.1	0.0	0.2	0.0	0.1	0.1	0.0	1.5	0.4	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.5	0.6	0.2	0.0	0.2	0.2	0.0	0.1	0.0	1.6	0.2	0.1	0.3	0.1	0.0	1.7	1.1	0.1	0.0	0.0	0.0	0.2	0.2	0.3	0.1	0.7	0.2	0.2	0.4	0.9	0.4	0.1	0.4	1.0	0.2	0.1	0.1	0.1	0.6	0.4	0.4	0.2	0.3	0.3	0.7	0.4	0.0	0.3	0.6	0.4	0.3	0.5	0.9	0.2	0.3	0.5	0.8	0.4	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.7	1.3	2.8	2.3	0.9	0.0	0.1	0.0	0.2	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR1A	"5-HT1A, ADRB2RL1, ADRBRL1"	ENSG00000178394	"5-hydroxytryptamine receptor 1A"	P08908	5	63957874-63962507	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 24.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"midbrain: 24.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"NTERA-2: 1.2;SCLC-21H: 1.1"	"Low region specificity"	"Detected in many"							HPA018073	Uncertain					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA018073: AB_1856704"					"unprognostic (1.81e-1)"													0.0	0.0	0.7	0.0	6.2	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.4	0.0	0.0	0.0	0.0	0.0	3.4	24.3	3.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	6.2	0.0	9.1	11.4	0.0	3.4	24.3	7.9	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR1B	"5-HT1B, 5-HT1DB, HTR1D2, S12"	ENSG00000135312	"5-hydroxytryptamine receptor 1B"	P28222	6	77460924-77463491	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 9.6;placenta: 6.7;stomach 1: 5.0"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"pancreatic cancer: 0.7;stomach cancer: 0.8;testis cancer: 1.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"HUVEC TERT2: 79.4;TIME: 35.1"	"Region enriched"	"Detected in all"	4	"basal ganglia: 38.6"	"Region enhanced"	"Detected in many"		"basal ganglia: 11.7"	HPA028808	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"		"Plasma membrane"	"Endoplasmic reticulum"	"HPA028808: AB_2672782"	"unprognostic (3.86e-2)"	"unprognostic (3.56e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-2)"	"unprognostic (2.67e-1)"	"unprognostic (2.11e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.08e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	0.8	0.6	2.1	0.4	6.0	0.0	0.2	0.0	3.8	0.8	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.5	0.0	1.2	2.1	0.5	0.0	0.4	0.0	0.6	4.3	0.3	0.1	0.0	0.2	6.7	1.2	0.2	0.1	0.3	0.2	0.5	0.1	0.2	0.1	0.1	0.1	0.0	5.0	0.5	9.6	0.0	0.2	0.3	0.0	1.3	0.5	1.4	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.4	3.5	1.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.0	0.4	0.2	0.6	2.2	1.4	79.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	35.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	6.0	0.0	3.8	1.2	2.1	0.6	4.3	1.2	0.1	9.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HTR2B	"5-HT(2B), 5-HT2B"	ENSG00000135914	"5-hydroxytryptamine receptor 2B"	P41595	2	231108230-231125042	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 17.4;cervix: 21.5;endometrium 1: 18.8;smooth muscle: 16.8"	"Cell type enhanced"	"Detected in some"		"Cone photoreceptor cells: 4.2;Endometrial stromal cells: 17.7;Endothelial cells: 4.1;Hepatic stellate cells: 5.7;Microglial cells: 4.7;monocytes: 6.2;Peritubular cells: 5.3"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"basophil: 1.8;T-reg: 1.0"	"Group enriched"	"Detected in many"	15	"granulocytes: 1.8;T-cells: 1.0"	"Group enriched"	"Detected in some"	4	"HHSteC: 8.7;HSkMC: 16.5;SK-MEL-30: 32.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA012867, HPA063658"	Enhanced		Supported	Nucleoplasm		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 36: Stromal cells - Cell proliferation"	Nucleoplasm		"HPA012867: AB_1856710, HPA063658: AB_2685079"	"unprognostic (1.86e-1)"	"unprognostic (3.55e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.15e-4)"	"unprognostic (3.59e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.42e-3)"	"unprognostic (7.44e-4)"	"unprognostic (1.81e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.14e-2)"	0.9	17.4	0.4	1.5	0.4	1.2	0.8	0.9	0.6	21.5	1.2	9.0	1.5	18.8	11.8	0.7	2.4	1.2	4.7	0.4	0.6	3.4	3.6	0.9	1.0	0.5	0.4	0.8	0.2	0.6	0.3	4.1	0.5	0.3	2.1	0.2	0.5	1.4	0.1	0.1	4.8	16.8	0.2	0.4	4.5	0.4	0.4	1.2	3.2	0.3	0.8	2.2	0.8	0.6	0.2	0.3	0.0	0.1	0.5	4.5	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	8.7	0.1	0.3	16.5	0.0	0.0	0.0	0.0	3.2	1.4	0.1	0.0	0.0	0.2	0.0	0.7	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.3	0.0	0.1	32.7	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.4	0.4	0.9	0.6	0.4	0.6	0.5	0.4	0.5	0.2	0.4	0.6	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.5	0.1	0.0	0.3	0.0	0.2	0.0	4.2	0.1	0.1	0.0	0.0	0.0	0.2	1.5	17.7	4.1	0.0	0.0	0.7	0.7	0.1	0.8	0.0	3.4	0.0	0.1	5.7	1.5	3.4	1.7	0.9	0.0	0.0	0.8	0.0	0.2	0.6	2.2	0.0	4.7	6.2	0.0	1.0	0.5	0.6	0.2	0.0	5.3	0.0	0.0	0.0	0.0	2.0	0.7	0.0	0.1	0.9	0.0	0.0	0.1	0.0	0.3	0.2	0.3	0.0	0.2
HTR3A	"5-HT3A, 5-HT3R, HTR3"	ENSG00000166736	"5-hydroxytryptamine receptor 3A"	P46098	11	113974881-113990313	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.0;salivary gland: 5.0"	"Group enriched"	"Detected in some"	11	"Ductal cells: 23.9;Exocrine glandular cells: 53.3;Pancreatic endocrine cells: 34.7"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 15.2"	"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	15	"memory B-cell: 3.9;naive B-cell: 13.8;plasmacytoid DC: 11.6"	"Group enriched"	"Detected in many"	127	"B-cells: 13.8;dendritic cells: 11.6"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;Daudi: 5.9;NTERA-2: 3.6;SCLC-21H: 18.7"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	16	"amygdala: 1.7;cerebral cortex: 2.7;hippocampal formation: 2.5"	HPA069442	Supported					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 16: Immune cells - Immune response"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 1: Pancreatic cells - Digestion"			"HPA069442: AB_2732132"	"unprognostic (6.46e-3)"	"prognostic favorable (6.26e-4)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (1.26e-4)"	"unprognostic (3.36e-3)"	"unprognostic (8.36e-3)"	"unprognostic (1.65e-5)"	"unprognostic (1.46e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.21e-2)"	"unprognostic (6.80e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.72e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.40e-2)"	0.0	0.4	0.7	2.1	1.2	0.0	0.0	0.4	1.0	0.0	0.4	2.1	0.6	0.1	0.0	0.5	0.0	0.0	0.0	1.1	0.5	0.1	0.0	0.0	6.5	0.4	0.5	0.0	2.6	0.0	0.0	0.0	0.4	0.0	0.4	0.0	5.0	0.0	0.0	0.7	1.7	0.7	0.4	0.5	0.8	0.1	0.5	0.4	0.0	0.0	8.0	0.1	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	5.9	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.6	0.0	0.0	0.0	18.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.6	13.8	0.0	0.0	0.0	0.0	0.0	11.6	0.0	0.2	0.7	1.2	0.4	1.0	1.1	0.5	0.4	0.5	0.4	0.4	0.5	0.6	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	1.8	0.0	0.0	3.0	0.1	0.0	23.9	0.0	0.3	0.0	0.0	0.0	0.0	0.3	53.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.1	34.7	0.1	0.0	0.1	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
HTR3D		ENSG00000186090	"5-hydroxytryptamine receptor 3D"	Q70Z44	3	184031544-184039369	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																			"unprognostic (3.08e-1)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
HVCN1	"Hv1, MGC15619, VSOP"	ENSG00000122986	"Hydrogen voltage gated channel 1"	Q96D96	12	110627841-110704950	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 162.1;lymphoid tissue: 72.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 178.4;Early spermatids: 87.3;Hofbauer cells: 57.0;Late spermatids: 76.4;Spermatocytes: 117.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"NB-4: 286.4;U-698: 90.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA039329	Enhanced					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 57: B-cells - Immune response"			"HPA039329: AB_10674284"	"unprognostic (3.43e-2)"	"unprognostic (6.32e-3)"	"unprognostic (7.05e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.62e-3)"	"unprognostic (3.89e-2)"	"unprognostic (1.96e-1)"	"unprognostic (5.85e-3)"	"unprognostic (2.40e-1)"	"unprognostic (3.09e-2)"	"unprognostic (1.54e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.35e-3)"	"unprognostic (4.82e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.68e-1)"	8.2	5.1	23.4	32.0	34.7	6.9	5.2	24.3	21.1	9.3	162.1	6.5	4.8	10.1	11.5	4.6	9.2	8.3	17.5	26.2	29.5	3.3	4.4	13.7	65.0	25.7	32.8	13.5	1.7	2.2	3.0	8.1	27.8	6.4	6.7	2.7	3.9	8.7	7.9	3.0	17.8	10.3	20.2	42.7	7.6	44.7	27.6	16.2	3.9	9.8	72.9	9.7	5.2	25.0	0.1	0.5	2.8	0.2	4.5	4.7	1.4	0.9	1.1	2.6	1.4	0.5	0.0	2.9	2.4	5.1	0.0	0.4	3.3	0.2	3.7	0.2	0.6	0.1	0.3	0.7	4.0	44.1	3.1	6.2	0.4	2.4	0.0	0.4	6.4	13.4	1.9	2.4	4.7	0.2	6.4	286.4	3.2	0.0	2.7	5.4	0.2	0.3	0.0	0.1	0.3	0.4	0.1	0.0	0.2	2.9	0.0	42.8	1.9	0.0	0.2	0.4	0.1	27.4	3.7	90.5	0.3	2.2	0.2	378.0	208.3	675.7	14.0	197.8	7.7	550.4	13.2	22.7	88.7	799.8	25.2	17.2	327.4	182.6	185.0	131.7	31.0	193.2	23.4	34.7	24.3	21.1	26.2	29.5	25.7	32.8	27.8	20.2	27.6	25.0	18.4	3.2	5.3	9.4	178.4	0.8	1.9	2.0	1.2	0.5	1.2	2.8	6.6	0.0	3.6	1.8	0.0	0.4	25.8	0.0	0.0	0.5	87.3	0.5	5.8	13.1	0.0	0.8	0.6	0.2	1.4	5.4	1.5	0.3	8.2	3.9	12.1	0.3	57.0	0.0	0.5	0.2	0.0	41.7	17.2	76.4	13.4	42.2	12.4	15.0	31.6	15.2	23.7	2.0	0.1	0.5	0.1	13.9	9.9	0.6	0.0	0.5	1.7	1.8	13.1	4.7	15.1	117.5	2.8	0.7	0.4	1.2	7.6	0.5	0.2	1.2
HYOU1	"Grp170, HSP12A, ORP150"	ENSG00000149428	"Hypoxia up-regulated 1"	Q9Y4L1	11	119044188-119057227	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Stress response"	Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 201.9"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 118.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 35.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 418.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049296	Approved				"Intracellular and membrane"	NA	NA		130000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA049296: AB_2680702"	"unprognostic (2.97e-2)"	"unprognostic (2.48e-2)"	"unprognostic (8.46e-2)"	"prognostic favorable (2.58e-4)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.81e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.01e-2)"	"unprognostic (2.33e-1)"	"prognostic unfavorable (5.10e-5)"	"unprognostic (3.86e-2)"	"unprognostic (1.04e-2)"	"prognostic unfavorable (5.00e-4)"	"unprognostic (1.38e-2)"	38.2	48.5	30.7	27.1	32.2	18.6	31.0	28.3	34.1	37.2	25.5	40.9	18.1	44.6	51.2	47.4	40.8	14.0	56.5	32.9	41.0	63.0	201.9	47.7	17.4	32.6	34.5	36.1	165.9	18.8	100.1	19.9	34.2	47.9	21.3	11.9	46.3	20.7	19.1	25.0	39.0	19.0	28.5	47.6	60.3	85.7	35.2	21.7	87.2	8.4	20.9	39.9	31.7	32.9	40.5	34.5	77.2	224.4	41.2	19.7	107.7	56.1	38.0	63.1	47.2	105.0	103.0	85.3	418.9	40.7	122.1	59.5	71.5	69.3	53.8	92.8	26.1	151.8	32.6	76.7	187.7	88.6	73.5	23.9	91.1	55.2	185.3	57.9	100.2	57.2	53.5	136.8	33.9	97.8	59.4	49.6	55.5	83.2	33.6	63.1	55.9	144.3	48.6	67.8	45.7	70.0	80.4	103.8	53.3	65.5	78.8	82.9	75.0	59.9	46.4	27.2	77.5	88.1	64.0	61.2	53.8	76.2	135.6	4.4	4.5	2.2	11.7	6.1	12.6	5.4	6.4	8.7	5.0	4.0	4.0	6.1	1.3	7.6	4.4	35.9	5.5	4.7	30.7	32.2	28.3	34.1	32.9	41.0	32.6	34.5	34.2	28.5	35.2	32.9	16.4	9.6	14.1	6.2	22.7	17.8	18.5	17.5	14.2	11.5	28.5	21.1	12.4	15.7	16.8	25.8	43.8	11.2	36.6	35.3	9.8	20.7	74.0	20.4	29.1	20.0	35.8	17.0	12.0	18.8	26.6	21.0	39.8	38.1	15.8	43.1	13.9	49.9	22.2	25.2	13.7	52.1	18.3	8.2	21.6	38.8	13.1	17.8	23.2	5.6	15.5	8.7	17.5	4.5	9.3	31.4	24.2	13.5	118.7	44.4	14.9	17.6	16.7	14.5	13.1	16.4	15.6	27.8	29.1	16.2	19.9	19.3	20.8	14.8	27.3	24.7
ICAM1	"BB2, CD54"	ENSG00000090339	"Intercellular adhesion molecule 1"	P05362	19	10271093-10286615	"Cancer-related genes, Candidate cardiovascular disease genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 219.3;urinary bladder: 215.3"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 612.2;Alveolar cells type 2: 561.6;Endothelial cells: 240.8;Langerhans cells: 232.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 158.3;Karpas-707: 459.7;RPMI-8226: 148.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002126, CAB002142, HPA004877"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA	87900000	2200000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Vesicles, Cytosol"	"CAB002142: AB_563596, HPA002126: AB_1078470, HPA004877: AB_1846317"	"prognostic favorable (7.09e-4)"	"unprognostic (1.88e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.63e-2)"	"unprognostic (3.25e-3)"	"unprognostic (3.05e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.48e-1)"	"unprognostic (3.18e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.49e-2)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (1.32e-6)"	"unprognostic (2.77e-1)"	"unprognostic (2.16e-2)"	"unprognostic (2.25e-1)"	"unprognostic (3.70e-3)"	87.9	23.6	9.1	44.6	9.6	117.1	32.4	7.9	12.0	11.2	9.9	17.7	16.8	23.9	3.5	11.0	26.2	56.4	39.1	8.8	9.9	43.9	67.1	219.3	38.3	12.3	8.7	13.0	11.1	8.3	9.3	27.8	10.2	22.2	18.1	10.5	18.0	6.3	15.1	17.9	22.6	23.4	10.0	55.9	21.5	5.6	15.4	28.4	30.8	12.8	32.9	215.3	12.5	10.2	46.3	0.5	7.9	0.2	2.0	4.4	9.7	8.6	91.6	21.8	62.0	14.0	49.8	39.6	130.3	3.8	99.3	8.9	1.7	0.4	45.6	123.8	0.1	3.8	1.4	62.0	158.3	1.3	23.9	55.7	4.0	13.7	20.3	2.0	10.7	4.9	15.0	459.7	1.5	3.3	0.5	34.9	3.1	0.5	24.7	1.0	0.2	148.5	36.8	0.3	0.3	1.1	61.2	3.3	94.5	3.7	6.9	2.8	34.3	22.3	1.9	12.3	0.8	137.4	142.7	25.5	35.1	26.3	32.6	5.0	28.3	5.2	5.3	25.8	9.8	3.8	4.0	6.3	24.7	1.5	1.9	3.8	40.8	15.2	17.0	14.1	6.1	20.8	9.1	9.6	7.9	12.0	8.8	9.9	12.3	8.7	10.2	10.0	15.4	10.2	150.3	612.2	561.6	0.3	31.7	85.3	22.2	62.6	28.5	0.0	50.2	24.9	1.1	21.5	133.5	3.7	0.0	1.1	28.9	2.9	0.0	176.8	2.0	14.1	15.5	240.8	2.4	1.3	0.5	98.7	3.3	136.6	13.7	29.8	139.8	0.1	48.2	12.1	86.7	0.0	0.4	0.7	32.6	53.6	232.6	1.3	4.7	168.3	76.5	7.5	101.9	4.6	5.2	0.5	0.2	113.7	0.3	1.5	57.6	27.1	0.3	15.0	83.2	0.4	6.6	38.2	57.6	0.8	1.6	4.3	69.3	1.2	28.8	0.5	1.6	14.1
IFITM1	"9-27, CD225, DSPA2a, IFI17"	ENSG00000185885	"Interferon induced transmembrane protein 1"	P13164	11	310041-315272	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, Osteogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 673.8;Endothelial cells: 364.4;Leydig cells: 300.8;Sertoli cells: 276.1;T-cells: 595.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"eosinophil: 1494.7;gdT-cell: 2906.3;MAIT T-cell: 2003.4;memory CD4 T-cell: 3120.6;memory CD8 T-cell: 3000.3;naive CD4 T-cell: 2939.3;naive CD8 T-cell: 2996.4;neutrophil: 2741.6;NK-cell: 4679.9;T-reg: 1944.8"	"Group enriched"	"Detected in all"	7	"granulocytes: 2741.6;NK-cells: 4679.9;T-cells: 3120.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 1038.8;BJ hTERT+ SV40 Large T+: 2266.3;BJ hTERT+ SV40 Large T+ RasG12V: 4016.8;HMC-1: 1138.9"									"HPA004810, CAB017615"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 58: T-cells - T-cell receptor"	"Golgi apparatus"	"Plasma membrane, Cytosol"	"CAB017615: AB_2264496, HPA004810: AB_1851419"	"unprognostic (1.03e-3)"	"unprognostic (6.79e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (2.57e-1)"	"unprognostic (9.06e-2)"	"unprognostic (7.58e-2)"	"unprognostic (3.03e-1)"	"unprognostic (6.21e-2)"	"unprognostic (5.53e-2)"	"unprognostic (6.64e-3)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (5.77e-9)"	"unprognostic (7.29e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.15e-2)"	"unprognostic (3.82e-2)"	477.7	102.3	291.8	282.0	303.4	367.1	401.7	293.8	402.1	563.3	321.5	249.0	128.4	314.6	1152.4	147.4	537.4	247.9	368.4	292.6	305.4	317.5	191.4	246.5	417.2	324.8	295.6	607.5	78.8	154.0	145.1	278.5	322.5	190.6	172.0	14.9	199.8	324.3	134.2	164.6	252.4	367.4	308.6	679.7	141.6	56.3	317.5	296.5	263.4	259.3	295.9	307.4	364.7	304.3	125.7	5.5	1011.4	74.5	79.1	279.8	7.4	250.1	1038.8	2266.3	4016.8	3.7	782.2	3.0	157.9	257.1	23.5	269.0	36.5	26.2	52.0	255.3	51.8	125.9	77.5	11.8	668.2	182.8	1138.9	496.3	0.2	26.6	2.6	27.0	4.2	41.1	450.0	880.7	1.7	23.9	85.1	318.2	264.5	0.5	33.5	27.1	3.1	24.5	654.9	0.0	1.0	2.2	122.7	11.9	196.9	138.5	42.1	17.0	8.8	3.8	4.7	1.5	1.1	61.6	44.8	6.8	3.4	253.8	3.1	544.4	62.1	1494.7	2906.3	312.7	2003.4	364.9	3120.6	3000.3	114.2	323.6	2939.3	2996.4	2741.6	4679.9	539.0	33.7	1944.8	4673.8	291.8	303.4	293.8	402.1	292.6	305.4	324.8	295.6	322.5	308.6	317.5	304.3	240.7	35.3	119.4	2.6	88.2	27.9	17.1	70.2	673.8	0.0	13.0	12.6	8.4	2.8	115.3	33.1	0.0	3.3	258.6	13.7	5.9	1.7	1.4	14.6	96.5	364.4	1.2	27.8	0.0	1.4	30.7	236.0	33.6	20.8	18.9	5.6	164.6	24.6	11.8	0.0	0.0	17.3	10.2	10.1	26.8	3.8	300.8	45.4	78.2	42.2	2.1	0.0	126.7	0.0	0.2	0.7	15.0	124.5	141.2	2.3	15.0	1.0	26.0	0.0	276.1	16.4	213.4	0.6	1.5	50.4	14.3	4.0	595.8	2.1	29.2	5.7
IFITM2	"1-8D, DSPA2c"	ENSG00000185201	"Interferon induced transmembrane protein 2"	Q01629	11	303655-309397	"Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 920.0;NK-cells: 1350.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	6	"neutrophil: 23410.9"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 23410.9"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 424.6;HHSteC: 547.7;HMC-1: 494.9;HSkMC: 710.9;NB-4: 603.3;U-937: 485.2"									"HPA004337, HPA044731"	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA		450000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 72: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Cell Junctions"	Nucleoplasm	"HPA004337: AB_1851427, HPA044731: "	"unprognostic (2.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.64e-2)"	"prognostic unfavorable (2.37e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	1086.2	307.0	90.3	258.0	90.2	177.0	681.0	89.6	116.6	785.6	101.4	358.6	40.9	702.8	52.1	237.2	903.8	97.4	619.6	92.0	97.9	703.1	1288.5	1069.9	99.9	94.4	89.4	650.1	211.1	112.0	200.6	145.3	94.9	406.1	41.8	27.0	228.9	102.5	195.9	236.7	305.6	200.4	92.8	1402.1	304.3	123.0	95.4	29.8	437.7	132.8	105.8	493.1	496.6	95.1	32.2	65.4	313.1	2.9	137.2	358.3	0.9	106.8	65.1	27.0	63.3	1.7	206.9	2.7	126.6	424.6	0.4	68.5	1.1	9.3	9.0	1.8	41.1	75.1	102.6	117.6	547.7	124.1	494.9	710.9	2.3	5.2	3.3	64.4	51.2	22.5	5.2	210.5	11.6	129.9	2.5	603.3	36.4	5.3	229.4	101.0	29.9	1.1	181.6	0.4	0.8	7.0	65.4	74.9	34.5	5.3	86.7	69.8	338.3	5.7	26.8	36.1	1.4	4.5	5.0	3.3	14.5	485.2	18.1	2706.4	537.4	3789.5	666.6	1421.9	480.8	846.9	590.1	639.5	612.5	799.2	511.7	510.3	23410.9	1225.0	2199.0	279.0	411.7	1376.6	90.3	90.2	89.6	116.6	92.0	97.9	94.4	89.4	94.9	92.8	95.4	95.1	920.0	307.7	540.0	5.9	301.1	104.4	251.1	161.4	215.1	0.3	59.7	66.5	51.8	154.4	209.2	248.3	0.0	8.3	814.7	22.5	487.2	433.0	7.8	67.1	468.6	828.4	9.6	100.7	0.0	256.7	16.9	515.8	30.5	78.5	530.5	68.8	752.1	684.1	223.4	0.0	0.0	39.4	24.4	372.8	255.9	31.5	507.6	645.9	209.9	12.2	177.3	80.5	1350.1	0.0	0.1	161.9	149.2	223.8	123.0	126.3	4.7	45.3	104.8	1.5	315.5	442.5	568.4	8.4	10.4	22.8	83.0	23.4	667.2	61.8	44.3	102.4
IFITM3	"1-8U, DSPA2b"	ENSG00000142089	"Interferon induced transmembrane protein 3"	Q01628	11	319676-329475	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 2128.0;Endothelial cells: 2064.8;Hepatocytes: 2268.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 2907.6;non-classical monocyte: 3344.3"	"Group enriched"	"Detected in all"	6	"granulocytes: 2907.6;monocytes: 3344.3;NK-cells: 926.2"	"Cell line enhanced"	"Detected in all"		"BJ hTERT+ SV40 Large T+: 3222.7;BJ hTERT+ SV40 Large T+ RasG12V: 4076.3;HHSteC: 3609.8;HSkMC: 3476.2"									HPA004337	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 33: Fibroblasts - ECM organization"			"HPA004337: AB_1851427"	"unprognostic (4.17e-2)"	"unprognostic (4.19e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.55e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.36e-2)"	"unprognostic (6.44e-2)"	"unprognostic (8.90e-2)"	"unprognostic (9.42e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (5.78e-7)"	"unprognostic (7.81e-2)"	"unprognostic (3.34e-2)"	"unprognostic (8.28e-2)"	"unprognostic (1.19e-1)"	1850.7	745.9	639.0	597.4	667.4	237.0	1281.1	644.9	909.9	1683.7	730.9	1212.1	235.2	1545.6	840.1	484.5	1933.7	702.4	1199.6	643.2	732.4	1299.5	2506.4	1573.4	272.7	745.4	671.4	1262.3	576.3	637.2	493.2	829.2	697.9	885.6	238.9	92.6	555.3	631.7	364.5	511.2	599.9	1121.8	666.2	1241.8	736.0	266.7	728.7	229.3	935.7	426.0	154.9	1203.7	1038.2	649.0	554.1	49.6	1930.0	508.9	952.4	1538.6	44.2	842.4	1638.0	3222.7	4076.3	65.4	1818.6	1.3	873.1	1276.4	826.0	872.0	1.1	619.9	176.8	19.2	57.1	8.1	578.4	570.2	3609.8	5.7	5.2	3476.2	136.1	257.3	561.7	418.1	610.5	5.2	3.1	5.0	290.3	1095.0	2.7	26.3	243.0	2.2	425.3	74.2	185.3	4.8	1741.5	50.1	1.5	3.5	1007.5	170.0	891.9	259.0	41.3	39.7	1130.9	192.1	131.9	180.6	34.8	2.5	3.4	10.3	89.6	7.6	315.3	520.4	740.1	563.7	115.7	2745.9	69.0	82.2	82.6	118.9	396.9	55.6	77.8	109.0	2907.6	926.2	3344.3	31.1	52.9	921.0	639.0	667.4	644.9	909.9	643.2	732.4	745.4	671.4	697.9	666.2	728.7	649.0	1971.3	532.0	709.5	32.0	35.5	317.2	684.3	856.2	1237.9	1.2	207.9	253.1	157.4	539.1	562.1	527.8	2.1	122.2	68.6	94.4	559.6	2128.0	27.3	164.2	1197.8	2064.8	54.1	92.0	0.0	1898.5	635.5	1572.4	103.5	207.0	242.7	223.5	2002.5	2268.4	539.7	0.0	0.1	228.2	132.2	491.4	463.2	102.3	1861.8	713.0	361.1	39.4	130.7	162.4	62.8	0.0	0.5	1135.8	198.3	1060.7	18.7	416.9	54.1	563.8	260.3	7.8	959.8	953.3	1483.2	26.9	12.5	222.4	209.1	125.7	96.6	303.3	263.4	270.6
IFNAR1	"IFNAR, IFRC"	ENSG00000142166	"Interferon alpha and beta receptor subunit 1"	P17181	21	33324429-33359864	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Karpas-707: 198.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029226	Approved					NA	NA		170000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA029226: AB_2672954"	"unprognostic (2.42e-3)"	"unprognostic (2.95e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.93e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.02e-1)"	"unprognostic (4.69e-2)"	"unprognostic (1.28e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.38e-3)"	"unprognostic (5.93e-2)"	"unprognostic (2.01e-1)"	"unprognostic (8.45e-2)"	"unprognostic (3.06e-2)"	40.8	22.3	14.3	36.4	14.6	30.8	32.3	15.7	15.2	26.3	9.6	28.9	26.7	22.4	23.2	25.2	23.8	30.2	21.2	15.0	16.2	32.0	76.6	29.7	28.8	17.4	15.6	23.5	29.2	40.5	7.7	49.5	16.9	27.2	30.5	23.6	30.2	24.1	32.7	20.5	27.4	24.0	15.7	33.5	31.6	20.9	17.5	33.1	41.2	24.8	29.7	39.8	9.0	18.6	47.3	24.4	27.4	24.2	55.8	80.8	23.7	44.6	74.2	32.9	36.1	31.7	57.2	42.4	35.4	49.4	36.3	28.4	23.3	37.0	43.8	33.8	26.0	62.8	29.0	20.2	33.9	50.8	43.3	58.2	38.4	43.6	37.7	39.4	63.1	40.3	67.6	198.2	56.5	22.8	38.7	22.2	24.9	46.6	25.6	29.5	75.0	62.4	33.7	44.0	22.5	24.1	50.5	42.4	39.3	20.8	58.2	36.8	61.3	39.3	24.7	58.2	28.2	102.3	132.7	43.2	66.3	64.4	50.5	77.3	45.4	27.7	23.6	64.0	23.1	56.2	31.5	28.6	37.4	57.0	37.0	29.0	166.7	28.0	80.3	54.3	41.2	35.2	14.3	14.6	15.7	15.2	15.0	16.2	17.4	15.6	16.9	15.7	17.5	18.6	101.2	109.0	45.8	17.6	69.3	45.8	57.0	72.3	18.8	51.9	42.5	29.7	33.5	34.3	78.8	44.1	29.2	28.1	43.8	25.3	21.5	73.0	17.7	37.9	58.4	75.5	26.9	27.1	26.3	90.5	92.4	61.1	35.7	44.5	39.2	30.3	53.9	81.3	69.2	58.9	29.4	28.9	46.8	82.1	47.5	10.7	32.6	77.6	37.4	30.9	86.8	34.3	42.2	34.2	27.2	64.7	25.5	30.9	137.3	63.9	37.6	28.7	59.6	30.0	19.7	54.9	44.9	38.5	17.5	21.5	44.9	20.1	38.3	25.1	27.5	72.2
IGF2R	"CD222, CI-M6PR, CI-MPR, CIMPR, M6P-R, MPR1, MPR300, MPRI"	ENSG00000197081	"Insulin like growth factor 2 receptor"	P11717	6	159969082-160113507	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 69.5"	"Cell type enhanced"	"Detected in many"		"NK-cells: 264.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 4.4"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009661, HPA011332"	Supported		Enhanced	"Golgi apparatus,Vesicles"		NA	NA		190000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus, Vesicles"		"CAB009661: AB_2122795, HPA011332: AB_1846276"	"prognostic unfavorable (3.01e-4)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (5.83e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.15e-1)"	"unprognostic (3.25e-1)"	"unprognostic (7.32e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.45e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"prognostic unfavorable (6.08e-4)"	20.3	21.9	1.8	11.4	3.7	13.3	16.0	3.9	4.3	15.2	11.7	17.4	7.4	19.3	4.8	16.7	13.9	10.7	21.8	3.2	4.2	14.8	23.9	22.2	8.2	4.3	3.6	17.0	16.6	14.3	9.5	15.3	3.8	11.0	11.6	3.2	18.4	6.7	69.5	16.5	14.7	16.0	3.2	23.2	15.5	7.7	4.8	15.9	14.5	27.2	7.8	15.3	16.5	5.9	20.8	18.1	32.6	44.6	108.4	76.4	36.9	30.1	80.4	30.3	52.8	28.3	37.2	7.3	30.9	38.4	101.7	25.4	27.0	140.0	52.0	47.7	19.4	3.6	30.0	32.1	49.2	20.7	31.2	52.7	45.4	57.6	144.8	65.4	19.2	36.0	42.2	48.2	46.4	10.1	8.8	13.4	13.1	19.3	23.2	23.2	20.6	46.1	29.9	20.8	11.3	25.4	45.0	34.5	44.8	41.4	15.7	49.4	25.3	27.0	27.9	57.3	60.4	16.7	40.2	9.1	49.0	23.7	38.9	0.5	1.0	0.8	1.1	0.3	0.4	0.2	0.5	0.4	0.2	0.2	0.5	0.7	4.4	0.7	0.4	1.3	0.2	0.3	1.8	3.7	3.9	4.3	3.2	4.2	4.3	3.6	3.8	3.2	4.8	5.9	44.7	48.1	47.3	34.6	16.7	22.2	10.0	16.0	17.1	13.0	20.2	14.7	33.6	24.3	22.1	16.5	20.9	7.5	107.0	46.2	0.0	29.3	7.5	25.8	38.7	29.6	22.3	9.5	33.0	19.4	12.3	29.9	16.8	39.7	3.8	41.7	28.9	63.4	22.2	15.2	34.2	18.4	12.2	59.4	12.8	5.2	47.5	37.6	12.4	31.9	65.9	11.7	264.7	30.7	40.0	40.8	17.2	38.4	35.9	17.1	23.2	23.6	12.2	15.1	65.7	63.7	32.6	10.9	10.4	28.9	19.7	9.3	38.8	38.8	20.9	16.7
IL13RA1	"CD213a1, IL-13Ra, NR4"	ENSG00000131724	"Interleukin 13 receptor subunit alpha 1"	P78552	X	118727133-118794535	"CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"monocytes: 199.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 10.9;eosinophil: 12.2;myeloid DC: 17.2;neutrophil: 29.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 17.2;granulocytes: 29.2;monocytes: 10.9"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 181.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001587			Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		17000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	Nucleoplasm	"HPA001587: AB_1079133"	"unprognostic (5.14e-3)"	"unprognostic (4.72e-2)"	"unprognostic (7.12e-2)"	"unprognostic (7.75e-2)"	"unprognostic (8.81e-3)"	"unprognostic (3.82e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.90e-1)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (1.19e-8)"	"unprognostic (1.88e-2)"	"unprognostic (2.37e-2)"	"unprognostic (2.82e-2)"	"unprognostic (5.08e-2)"	51.9	34.3	15.9	40.3	16.2	7.1	41.5	18.1	17.3	27.1	20.4	52.1	48.5	31.9	26.2	53.5	35.8	39.3	20.2	14.6	22.3	33.7	120.3	48.9	25.4	26.0	20.3	37.5	22.3	22.2	15.4	32.8	24.6	22.5	61.6	25.6	34.7	27.1	31.4	20.6	60.8	40.6	22.2	29.9	35.8	16.6	19.6	16.0	29.8	55.9	34.5	31.6	27.4	24.6	31.6	37.2	17.4	48.0	39.0	113.5	33.1	63.3	86.2	29.2	37.6	21.8	55.0	0.1	111.4	86.6	84.8	29.1	19.0	26.6	32.3	181.0	16.5	5.1	30.9	55.8	23.4	0.6	13.0	104.1	23.5	40.0	48.8	87.9	61.8	0.0	16.6	3.3	41.9	44.8	0.1	8.5	16.1	57.8	38.6	0.1	43.3	0.2	43.6	32.9	6.5	6.0	102.3	35.5	24.7	22.8	22.8	28.9	79.3	56.7	26.7	99.7	50.5	0.7	16.8	0.3	125.6	16.1	24.6	0.2	10.9	12.2	0.0	2.7	0.1	2.9	0.0	0.0	17.2	2.5	0.0	0.0	29.2	0.1	1.1	2.9	0.1	2.9	15.9	16.2	18.1	17.3	14.6	22.3	26.0	20.3	24.6	22.2	19.6	24.6	36.0	70.5	48.5	1.0	20.2	17.2	37.1	17.2	18.2	2.1	32.4	26.3	11.5	37.1	46.0	29.5	16.7	8.1	2.8	61.9	9.8	36.1	38.1	25.8	34.0	58.8	93.2	4.8	0.3	98.3	31.9	38.7	38.7	27.3	0.0	13.6	78.9	149.0	41.2	0.0	2.0	138.4	16.2	124.8	140.6	7.3	24.2	120.4	21.4	73.1	199.7	43.7	2.1	0.0	6.9	87.9	27.0	18.8	1.3	42.3	70.8	25.2	49.7	11.2	32.9	14.4	26.2	7.5	28.9	37.2	12.1	9.4	2.7	7.1	29.5	30.8
IL1A	"IL-1A, IL1, IL1-ALPHA, IL1F1"	ENSG00000115008	"Interleukin 1 alpha"	P01583	2	112773925-112784493	"Cancer-related genes, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 13.3;testis: 10.4;urinary bladder: 26.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 22.6;Club cells: 9.8;Endometrial ciliated cells: 11.5;Glandular and luminal cells: 29.4;Macrophages: 30.6;Squamous epithelial cells: 9.4"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 22.3;urothelial cancer: 17.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HBEC3-KT: 447.6;hTCEpi: 216.2;hTERT-HME1: 283.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	10800			"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"				"unprognostic (3.41e-2)"	"prognostic unfavorable (9.52e-4)"	"unprognostic (1.99e-2)"	"unprognostic (4.28e-2)"	"unprognostic (2.08e-1)"	"unprognostic (8.03e-3)"	"unprognostic (4.42e-3)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.62e-1)"	"unprognostic (2.45e-1)"	"unprognostic (4.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (4.30e-3)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (1.66e-1)"	"unprognostic (2.44e-1)"	"unprognostic (8.62e-2)"	0.5	0.0	0.3	1.3	0.4	1.0	0.4	0.5	0.4	4.8	0.2	0.3	0.1	2.5	0.8	13.3	0.1	2.3	0.0	0.4	0.5	0.0	0.0	2.3	0.3	0.9	0.8	0.0	0.0	0.4	0.2	1.5	1.0	0.1	0.2	0.1	1.2	0.4	0.0	0.8	0.1	0.0	0.7	0.3	0.1	10.4	0.5	0.3	0.2	0.0	8.7	26.0	1.3	1.2	12.5	0.0	0.5	0.0	0.1	0.0	0.2	0.4	13.5	0.0	0.2	0.5	0.8	0.0	52.5	0.0	65.9	3.6	0.0	447.6	1.7	0.1	0.1	0.1	0.7	0.2	1.0	0.2	0.1	0.0	216.2	3.8	283.4	3.4	0.3	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.2	0.2	0.5	0.0	0.0	0.0	0.1	55.0	0.1	0.0	1.6	0.0	0.0	0.6	0.0	0.1	1.7	1.3	0.6	0.3	0.3	0.0	0.1	0.2	5.2	0.1	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.5	0.4	0.4	0.5	0.9	0.8	1.0	0.7	0.5	1.2	0.9	6.4	1.1	0.0	2.2	1.5	0.7	22.6	1.2	0.0	0.5	0.3	0.2	0.0	9.8	0.0	0.0	0.3	0.3	0.6	0.0	4.6	8.3	11.5	2.8	0.2	0.0	0.0	0.0	0.9	0.1	0.1	0.0	29.4	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	2.0	0.0	4.8	3.8	0.0	30.6	0.0	5.6	0.0	0.0	0.0	0.0	0.1	3.5	0.0	0.0	0.4	0.3	0.0	0.0	1.9	0.0	0.0	0.0	1.1	0.1	0.1	9.4	1.0	0.0	0.4	0.1	0.2	2.4
IL1B	"IL-1B, IL1-BETA, IL1F2"	ENSG00000125538	"Interleukin 1 beta"	P01584	2	112829751-112836816	"Cancer-related genes, Candidate cardiovascular disease genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Cytokine, Mitogen, Pyrogen"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 201.7;urinary bladder: 126.2"	"Group enriched"	"Detected in many"	11	"Langerhans cells: 1451.9;Macrophages: 1510.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"neutrophil: 94.1"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 94.1"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 649.3;HBEC3-KT: 293.3;HMC-1: 235.1;hTEC/SVTERT24-B: 319.1;hTERT-RPE1: 277.0;U-87 MG: 571.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"								"Secreted to blood"	NA	NA	2330		"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 41: Macrophages - Immune response"				"unprognostic (1.55e-3)"	"prognostic unfavorable (1.31e-4)"	"unprognostic (2.75e-2)"	"unprognostic (5.71e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.12e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.61e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.72e-2)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (7.49e-5)"	"unprognostic (1.29e-2)"	"unprognostic (4.42e-2)"	"unprognostic (5.09e-2)"	"unprognostic (4.01e-2)"	43.9	7.6	2.5	53.6	2.2	201.7	2.0	3.1	4.6	3.7	4.2	8.1	3.0	7.4	2.0	3.4	4.1	19.0	3.3	2.3	3.4	7.7	9.1	17.4	9.5	4.8	4.6	0.8	4.4	3.0	2.6	7.8	3.8	6.1	6.5	0.3	3.8	1.8	0.1	0.7	3.5	9.2	4.4	17.8	25.5	1.1	2.8	9.4	2.6	7.0	12.8	126.2	1.0	6.6	6.3	0.1	0.2	0.0	0.4	0.0	0.0	2.1	649.3	3.1	6.5	0.0	0.0	0.0	18.0	0.5	11.3	14.7	0.0	293.3	39.2	0.0	0.0	29.5	0.4	0.0	2.2	0.0	235.1	1.1	8.9	319.1	103.5	277.0	0.0	0.1	0.0	0.8	0.6	0.0	0.0	2.9	0.1	1.2	26.2	1.0	0.0	0.0	0.0	48.2	0.0	0.0	1.7	0.0	2.5	0.0	0.0	2.8	0.0	15.3	0.2	0.7	0.5	0.1	0.0	0.2	571.5	14.0	22.7	1.7	12.3	4.4	0.0	19.5	0.0	0.0	0.0	0.0	19.5	0.0	0.0	0.0	94.1	0.2	7.7	0.0	0.0	3.4	2.5	2.2	3.1	4.6	2.3	3.4	4.8	4.6	3.8	4.4	2.8	6.6	23.8	9.6	28.2	0.0	14.1	30.8	5.4	25.4	0.0	0.2	8.2	13.3	4.8	0.0	16.2	1.8	0.0	1.5	7.5	2.8	0.0	33.2	0.3	4.9	5.0	20.0	0.0	58.9	0.0	0.6	2.6	8.1	44.4	8.4	41.7	0.0	1.4	0.4	108.1	0.0	0.0	12.7	14.2	130.5	1451.9	0.7	0.0	1510.7	23.2	1.9	7.9	0.3	0.0	0.0	0.0	2.9	10.0	0.0	9.3	4.7	0.2	0.7	8.6	0.3	0.0	1.5	4.3	0.0	0.4	8.3	20.3	4.4	6.3	0.0	1.9	6.1
IL1R1	"CD121A, D2S1473, IL1R, IL1RA"	ENSG00000115594	"Interleukin 1 receptor type 1"	P14778	2	102064544-102179874	"Cancer-related genes, CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial ciliated cells: 127.1;Endometrial stromal cells: 280.2;Glandular and luminal cells: 315.4;Hepatic stellate cells: 146.7;Langerhans cells: 188.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"ASC diff: 624.9;ASC TERT1: 276.8;HHSteC: 196.3;HSkMC: 770.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001237, HPA005823, CAB007779, HPA029560"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"	"Secreted to blood"	NA	NA		1400000	"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Vesicles"	"Plasma membrane, Cytosol"	"CAB007779: AB_562073, HPA001237: , HPA005823: AB_2667445, HPA029560: AB_2673094"	"unprognostic (6.16e-3)"	"unprognostic (3.55e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.44e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.77e-2)"	"prognostic unfavorable (6.92e-6)"	"unprognostic (2.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.83e-2)"	"unprognostic (7.73e-2)"	137.3	68.0	7.1	69.5	8.3	18.0	77.5	7.5	11.0	161.1	16.2	39.3	20.7	33.5	105.2	32.1	52.0	92.0	58.3	7.6	9.0	45.7	75.5	115.5	17.1	16.2	8.4	31.1	43.3	126.7	13.1	120.8	8.9	66.7	30.5	8.5	34.2	47.4	18.6	40.1	40.3	49.9	10.0	41.0	43.9	20.6	14.9	21.7	52.5	16.0	19.7	87.4	40.2	7.7	2.0	12.8	0.3	10.8	624.9	276.8	4.4	27.4	123.8	19.2	28.7	5.7	3.4	0.0	19.8	55.0	33.9	5.5	0.2	2.2	16.1	55.5	0.1	0.7	2.9	31.3	196.3	0.1	0.3	770.6	2.3	21.7	5.2	8.4	8.7	0.0	3.5	1.1	28.1	5.6	0.0	1.2	0.7	5.6	0.9	0.3	2.0	0.4	18.3	13.4	0.1	0.3	12.5	7.7	0.0	3.6	11.1	0.8	0.3	54.7	3.6	92.1	2.2	0.1	0.0	0.1	21.3	0.6	3.6	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.2	0.2	0.0	0.0	0.6	0.0	7.1	8.3	7.5	11.0	7.6	9.0	16.2	8.4	8.9	10.0	14.9	7.7	99.3	25.6	73.2	1.3	1.8	31.1	46.8	8.2	5.2	0.1	19.4	13.7	5.2	28.6	68.6	5.5	0.0	6.1	2.5	0.7	3.9	31.7	7.0	127.1	280.2	103.6	1.2	14.3	0.5	21.8	82.8	79.1	2.0	315.4	1.3	0.3	146.7	47.1	5.4	0.0	3.0	0.5	10.2	12.0	188.2	12.6	28.0	26.0	19.6	23.4	7.0	9.0	0.0	0.5	0.5	12.0	0.3	1.5	1.8	65.9	0.0	8.3	28.6	1.0	6.6	37.7	34.3	1.3	1.2	4.5	38.6	23.9	8.5	4.0	0.8	23.6
IL2RB	"CD122, IL15RB"	ENSG00000100385	"Interleukin 2 receptor subunit beta"	P14784	22	37125843-37175054	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	Receptor	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 50.2;placenta: 36.3"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 130.1;Extravillous trophoblasts: 85.5;NK-cells: 388.3;T-cells: 103.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"gdT-cell: 50.8;NK-cell: 186.4"	"Group enriched"	"Detected in many"	22	"NK-cells: 186.4;T-cells: 50.8"	"Cell line enriched"	"Detected in some"	8	"HDLM-2: 525.8"	"Region enriched"	"Detected in single"	7	"basal ganglia: 1.8"	"Low region specificity"	"Detected in some"			HPA062657	Enhanced					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA062657: AB_2684822"	"unprognostic (3.38e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (6.76e-4)"	"prognostic favorable (3.18e-5)"	"unprognostic (2.44e-2)"	"unprognostic (9.69e-3)"	"unprognostic (2.60e-1)"	"unprognostic (5.22e-2)"	"unprognostic (1.03e-3)"	"unprognostic (5.37e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.74e-1)"	"prognostic unfavorable (3.50e-7)"	"unprognostic (4.63e-2)"	"unprognostic (7.96e-2)"	"unprognostic (3.94e-3)"	"unprognostic (2.46e-2)"	3.2	1.3	2.0	22.4	1.6	36.8	1.9	0.8	2.3	2.2	1.5	5.1	5.5	7.6	2.9	3.5	2.9	6.8	1.9	2.2	1.0	1.0	8.5	12.4	35.7	2.4	2.2	1.6	0.8	0.4	0.6	36.3	1.9	2.3	5.2	0.0	4.3	3.2	0.7	8.9	8.3	2.5	1.7	50.2	6.4	1.5	3.3	14.9	1.8	0.7	24.0	8.0	1.0	1.8	0.4	0.0	1.0	0.0	0.0	0.0	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	22.0	0.0	0.0	0.0	0.0	0.0	0.0	525.8	0.6	1.0	0.0	0.1	0.0	0.0	24.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.3	0.0	0.7	0.1	4.2	3.3	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.2	0.6	2.3	0.0	0.9	0.0	0.0	13.2	0.0	0.6	36.2	66.0	0.1	0.4	0.4	0.5	5.4	0.1	0.5	50.8	0.6	27.4	0.4	11.4	28.6	0.1	1.9	3.6	15.0	1.2	186.4	0.5	0.3	24.4	37.3	2.0	1.6	0.8	2.3	2.2	1.0	2.4	2.2	1.9	1.7	3.3	1.8	1.5	3.2	6.8	0.0	3.6	3.2	0.7	0.1	5.7	0.0	1.0	0.8	1.7	0.0	0.6	1.8	0.0	0.6	130.1	0.2	0.0	0.3	2.2	0.5	1.2	1.0	0.0	16.8	0.1	0.2	85.5	1.4	5.6	1.2	10.1	0.1	7.1	1.8	2.3	0.0	0.1	0.1	0.0	5.3	1.7	1.6	0.3	3.7	5.4	0.0	2.0	0.0	388.3	0.0	0.1	0.0	0.0	0.0	18.6	0.2	0.1	0.2	0.7	0.0	0.0	0.2	0.9	0.0	0.3	0.5	1.6	1.2	103.6	0.0	0.3	0.1
IL4R	CD124	ENSG00000077238	"Interleukin 4 receptor"	P24394	16	27313668-27364778	"Cancer-related genes, CD markers, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	Immunity	Receptor	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"B-cells: 92.0;granulocytes: 110.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 78.1"	"Group enriched"	"Detected in all"	5	"B-cells: 78.1;granulocytes: 31.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 124.2;HBEC3-KT: 115.0;HDLM-2: 110.6;U-698: 119.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004451, HPA050124, HPA070380"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Centriolar satellite"	"Secreted to blood"	NA	NA	38500	110000	"Cluster 37: B-cells - Transcription"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Nucleoplasm, Plasma membrane"	"Centriolar satellite"	"CAB004451: AB_626889, HPA050124: AB_2681026, HPA070380: "	"unprognostic (6.80e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.84e-1)"	"prognostic favorable (6.43e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.34e-1)"	"unprognostic (1.54e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.23e-5)"	"unprognostic (1.49e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.58e-2)"	49.4	45.2	22.7	82.3	19.7	103.4	34.1	19.2	22.0	39.7	21.4	97.0	27.3	35.8	5.9	70.8	42.3	41.2	34.2	18.7	21.0	50.8	116.0	119.2	117.1	29.4	22.2	14.3	29.8	31.7	14.9	39.3	24.0	49.9	35.6	2.4	20.5	25.6	9.3	24.4	55.7	37.3	25.5	90.0	55.0	15.5	25.3	22.3	24.2	6.6	89.6	63.2	45.4	23.8	39.9	10.1	6.4	13.1	3.1	14.1	14.3	24.7	27.3	9.3	7.7	20.4	105.2	124.2	30.1	38.5	18.3	39.7	7.3	115.0	8.2	110.6	4.0	22.6	6.6	31.6	40.8	6.1	61.7	23.5	45.0	44.2	26.5	48.7	50.7	6.8	10.5	9.8	15.0	17.3	0.7	18.8	8.0	34.2	9.1	0.4	47.5	10.2	42.9	43.2	1.9	0.6	3.7	24.7	5.0	15.6	8.2	23.5	81.0	21.0	9.8	19.0	17.6	6.1	2.1	119.7	2.1	21.1	0.3	1.4	7.2	13.0	4.2	3.1	3.4	25.8	6.9	4.4	4.1	78.1	10.0	5.0	31.1	8.2	1.8	4.8	5.3	5.8	22.7	19.7	19.2	22.0	18.7	21.0	29.4	22.2	24.0	25.5	25.3	23.8	30.5	28.9	49.2	0.7	92.0	13.3	43.3	34.9	26.2	0.3	9.4	14.2	2.4	34.3	33.4	1.8	0.0	17.6	29.8	60.0	0.0	39.5	0.3	6.6	2.2	39.0	23.4	5.2	1.7	32.3	3.8	17.2	32.1	17.2	110.8	0.7	62.8	45.9	27.2	0.0	0.6	35.5	8.2	30.6	29.9	0.8	0.3	34.3	14.2	38.4	39.3	0.0	7.2	0.5	0.7	49.3	28.7	0.0	13.4	37.7	24.0	1.2	28.5	0.2	39.5	16.4	20.0	0.8	3.3	23.8	14.9	24.9	38.3	0.2	16.7	46.9
IMMT	"HMP, Mic60, MICOS60, MINOS2, P87, P89"	ENSG00000132305	"Inner membrane mitochondrial protein"	Q16891	2	86143932-86195472	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 288.9"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 223.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022439, HPA036164, HPA036165"	Supported		Enhanced	Mitochondria		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"CAB022439: , HPA036164: AB_2674979, HPA036165: AB_2674980"	"unprognostic (3.83e-3)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.45e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (5.66e-2)"	"unprognostic (1.53e-1)"	"unprognostic (8.10e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.21e-1)"	"prognostic favorable (3.51e-6)"	"unprognostic (2.06e-3)"	"unprognostic (6.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.82e-1)"	41.3	82.4	30.3	34.9	31.8	40.3	36.5	33.1	39.0	30.2	41.9	57.4	57.4	35.0	27.6	43.4	30.9	27.1	174.8	31.9	34.5	80.9	65.0	32.5	44.3	35.3	34.2	28.1	48.5	90.2	36.0	36.7	35.1	29.4	58.1	42.4	37.9	35.1	200.9	38.0	46.6	38.9	29.8	44.8	56.0	49.2	32.6	52.3	35.5	288.9	47.1	41.5	33.8	32.8	115.6	111.2	99.2	45.6	93.7	88.3	101.5	80.5	85.6	108.0	98.7	160.7	89.1	175.7	78.9	87.7	87.7	83.4	128.9	118.4	131.8	71.4	105.9	139.0	65.6	192.0	95.7	135.9	91.1	100.6	84.0	101.7	119.5	67.2	124.7	99.7	138.4	96.7	105.1	99.0	135.6	140.8	117.8	175.1	88.2	89.9	211.2	158.7	122.5	128.3	119.3	89.0	82.9	124.0	126.3	77.4	70.7	94.6	93.6	76.0	83.6	112.0	101.8	76.6	104.1	119.9	86.9	158.8	94.4	12.1	29.2	12.2	23.5	34.0	20.7	15.9	20.6	19.3	32.9	13.7	18.3	22.3	3.8	20.8	33.2	17.2	23.2	25.4	30.3	31.8	33.1	39.0	31.9	34.5	35.3	34.2	35.1	29.8	32.6	32.8	29.3	54.5	49.2	31.3	42.1	23.3	34.9	51.6	30.1	40.9	21.6	19.7	223.0	24.3	57.3	40.5	33.3	94.9	49.6	57.9	133.1	59.9	152.4	26.5	34.0	38.3	56.0	76.1	41.6	52.8	73.9	36.3	39.8	26.8	48.0	55.6	35.7	64.2	70.9	23.5	46.5	46.2	38.7	49.4	28.3	158.9	27.7	48.9	17.8	26.2	80.6	30.2	52.5	29.1	44.1	43.3	36.3	36.9	56.4	28.6	59.8	92.6	41.8	42.5	6.6	39.7	58.2	100.7	54.6	41.1	24.9	98.5	45.6	118.6	68.0	33.6
INAFM1	PRR24	ENSG00000257704	"InaF motif containing 1"	C9JVW0	19	47274885-47275723	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 100.3;Smooth muscle cells: 73.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 58.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 43.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA064015	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA064015: AB_2685177"	"unprognostic (3.88e-2)"	"unprognostic (8.88e-3)"	"prognostic unfavorable (3.20e-5)"	"unprognostic (7.46e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.15e-2)"	"unprognostic (3.60e-1)"	"unprognostic (2.32e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.22e-2)"	"unprognostic (9.99e-2)"	"prognostic unfavorable (3.04e-4)"	"unprognostic (3.52e-2)"	"unprognostic (2.02e-1)"	"unprognostic (4.03e-1)"	"unprognostic (4.36e-3)"	24.1	65.4	26.3	9.0	25.3	9.0	22.8	23.5	30.3	39.6	29.2	34.5	6.4	32.3	4.8	14.7	31.4	9.8	23.8	27.2	34.7	22.6	18.1	26.0	5.5	31.8	31.6	33.9	27.7	4.6	21.0	6.6	27.8	32.4	3.4	16.1	15.2	9.0	17.0	25.3	15.9	9.3	23.8	18.5	23.0	12.9	31.6	4.9	21.6	4.9	3.3	31.2	26.9	22.1	11.1	10.1	8.8	14.4	2.6	7.7	5.2	12.6	4.2	5.7	7.4	4.9	4.9	5.8	3.9	7.8	4.5	8.0	2.2	5.0	1.4	11.6	13.6	9.3	6.3	7.7	13.1	6.7	13.6	10.9	8.9	5.4	4.8	4.2	2.3	6.4	15.1	12.4	2.3	22.5	5.1	43.1	2.6	11.2	10.1	9.0	3.5	4.8	4.5	6.5	6.6	8.4	13.8	4.3	6.2	2.3	6.1	6.5	5.4	6.5	9.6	3.7	6.7	5.9	5.0	5.5	13.4	4.7	5.8	11.0	15.4	36.3	3.1	11.0	2.5	11.3	3.6	4.3	13.6	8.6	6.6	4.7	58.6	2.9	14.4	16.0	5.0	7.1	26.3	25.3	23.5	30.3	27.2	34.7	31.8	31.6	27.8	23.8	31.6	22.1	23.8	9.6	7.0	7.5	6.3	0.0	43.5	0.0	15.9	16.5	20.7	20.8	9.4	8.6	3.7	11.0	10.4	20.1	3.1	12.6	19.6	11.4	13.5	16.4	100.3	18.3	7.3	18.9	5.0	12.4	15.3	30.5	11.7	16.5	1.3	10.2	11.4	14.8	10.0	3.3	11.6	13.0	0.0	15.9	0.0	22.9	61.8	12.3	0.0	4.7	8.0	5.9	8.2	3.5	2.7	9.6	17.7	25.9	9.0	31.3	28.4	15.4	0.7	48.6	46.0	12.9	73.4	10.3	13.0	10.6	0.0	27.6	6.5	16.2	13.2	49.0
INAFM2	"LINC00984, OGU1"	ENSG00000259330	"InaF motif containing 2"	P0DMQ5	15	40323692-40326715	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 18.0;Early spermatids: 25.3;Hofbauer cells: 19.5;Spermatocytes: 32.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 2.6"	"Group enriched"	"Detected in many"	4	"dendritic cells: 1.1;granulocytes: 2.6;monocytes: 1.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 32: U-937 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"				"unprognostic (6.03e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.68e-2)"	"unprognostic (5.59e-2)"	"unprognostic (9.05e-2)"	"unprognostic (8.01e-3)"	"unprognostic (2.43e-2)"	"prognostic favorable (7.87e-4)"	"unprognostic (1.23e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.52e-2)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (1.88e-7)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.91e-1)"	11.3	8.4	16.1	9.9	17.9	12.7	7.6	15.5	17.1	8.5	15.2	49.9	6.7	12.2	5.8	8.1	21.3	11.0	28.8	16.4	18.4	7.9	6.7	11.5	5.8	19.3	16.9	10.0	11.5	12.2	10.4	17.6	16.9	10.8	13.4	12.6	9.4	22.5	13.6	6.5	12.9	17.3	18.2	10.7	28.2	10.2	17.0	5.2	26.9	15.0	6.2	14.4	7.8	22.2	18.7	1.8	16.8	10.7	14.2	6.9	38.6	23.0	11.5	18.0	14.8	6.9	3.7	1.6	19.8	12.6	10.6	41.7	26.3	27.1	25.1	5.5	8.8	50.4	6.9	3.9	18.3	27.0	34.3	18.2	9.8	6.7	18.8	26.5	18.7	12.9	27.6	39.6	25.4	2.7	7.9	21.5	12.3	14.5	14.1	3.9	20.2	44.8	13.2	21.3	35.9	14.2	8.2	9.7	8.3	28.6	9.4	33.1	24.5	24.8	18.4	12.6	16.8	10.2	2.7	4.8	18.4	43.5	24.1	0.6	1.0	2.6	0.1	1.1	0.1	0.3	0.1	0.0	0.5	0.0	0.0	0.1	0.7	0.1	1.0	1.1	0.2	0.6	16.1	17.9	15.5	17.1	16.4	18.4	19.3	16.9	16.9	18.2	17.0	22.2	6.4	0.0	3.7	3.9	2.3	0.0	1.2	0.0	0.0	7.8	6.8	5.5	18.0	4.3	0.6	3.7	4.2	3.3	3.1	4.3	0.0	2.3	25.3	2.2	3.8	6.0	2.4	1.7	3.4	2.6	0.6	2.4	3.6	2.3	1.3	1.8	12.1	2.7	19.5	8.4	4.5	1.4	0.0	14.1	0.0	4.6	1.2	13.8	0.0	6.5	8.0	6.7	4.1	4.0	1.4	2.3	1.9	4.9	0.4	3.2	1.4	0.8	1.5	4.8	0.0	2.4	9.8	32.4	4.4	1.1	0.0	1.4	1.7	4.9	1.5	2.4
INSIG1	"CL-6, MGC1405"	ENSG00000186480	"Insulin induced gene 1"	O15503	7	155297776-155310235	"Plasma proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 563.4"	"Cell type enriched"	"Detected in all"	4	"Langerhans cells: 4121.3"	"Cancer enriched"	"Detected in all"	5	"liver cancer: 142.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"intermediate monocyte: 272.8;non-classical monocyte: 500.8"	"Lineage enriched"	"Detected in all"	6	"monocytes: 500.8"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 1228.9;RPMI-8226: 605.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071524			Uncertain	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA071524: "	"unprognostic (8.11e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (9.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (2.05e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (9.62e-4)"	"unprognostic (4.97e-2)"	79.2	37.3	25.3	35.4	36.9	45.5	37.4	47.1	39.1	25.5	58.0	29.8	53.0	19.5	31.8	40.1	17.6	31.6	21.0	30.2	40.9	45.6	563.4	43.2	30.9	61.1	51.7	24.0	111.7	17.4	18.9	34.2	62.8	62.6	26.4	40.5	70.9	11.3	9.0	42.5	35.2	20.3	36.6	19.0	61.1	34.4	36.5	40.4	12.5	12.0	25.3	36.7	23.3	86.3	158.9	29.0	76.8	48.1	200.6	265.5	41.9	12.5	179.1	36.9	242.6	18.1	225.2	104.0	35.7	98.2	282.2	83.9	53.1	92.6	43.3	32.3	155.5	28.6	51.7	0.0	99.0	49.3	448.7	165.6	50.4	281.8	25.8	27.3	49.8	202.8	53.2	1228.9	47.9	82.2	238.7	128.6	80.0	30.4	20.4	43.5	0.2	605.1	291.6	77.8	57.2	45.5	41.6	29.9	67.8	28.7	29.0	162.0	56.3	40.5	11.8	77.2	33.3	296.8	57.4	93.3	177.6	187.2	38.2	21.3	29.7	13.4	49.3	272.8	25.5	46.5	32.8	41.9	78.5	60.2	32.6	36.7	62.6	27.5	500.8	44.7	77.0	85.2	25.3	36.9	47.1	39.1	30.2	40.9	61.1	51.7	62.8	36.6	36.5	86.3	91.4	41.7	121.5	39.8	100.5	140.2	59.4	148.2	74.6	16.5	58.0	31.6	43.6	35.8	114.4	40.5	10.4	47.7	79.0	129.1	17.6	52.0	21.2	30.8	11.6	135.6	126.8	38.3	11.1	140.4	189.0	120.4	57.6	67.4	60.4	18.1	33.2	828.9	46.9	38.7	16.9	91.5	185.1	63.6	4121.3	9.7	15.8	381.0	247.3	7.5	29.6	88.7	34.0	17.1	61.8	53.6	86.6	18.4	100.1	180.4	29.1	9.4	68.3	18.1	19.7	36.3	62.0	33.6	45.0	135.8	155.3	130.4	108.2	20.6	48.0	158.5
INSIG2		ENSG00000125629	"Insulin induced gene 2"	Q9Y5U4	2	118088452-118110997	"Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033861	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB033861: AB_2249149"	"unprognostic (3.84e-3)"	"unprognostic (4.54e-3)"	"unprognostic (1.84e-1)"	"unprognostic (7.00e-2)"	"unprognostic (6.24e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.80e-1)"	"unprognostic (7.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (2.19e-6)"	"unprognostic (2.40e-1)"	"prognostic unfavorable (4.11e-6)"	"unprognostic (1.40e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.75e-2)"	10.4	6.2	5.0	5.7	5.4	3.8	8.5	7.3	6.3	8.7	7.2	8.8	9.6	9.4	8.9	6.6	7.0	8.2	8.5	7.1	5.1	12.3	28.0	10.3	7.3	5.4	5.8	10.3	11.7	12.4	7.0	9.0	5.7	8.0	7.3	8.9	8.5	6.3	7.8	10.2	9.7	8.8	5.3	11.3	12.6	6.3	6.4	9.6	10.6	6.8	9.1	7.3	8.1	5.5	33.0	7.7	9.2	4.8	26.1	13.2	11.7	9.0	10.2	7.5	13.7	6.7	32.8	6.3	31.6	12.8	14.6	13.5	8.0	17.9	14.6	13.2	11.1	6.6	8.8	38.2	6.0	8.8	9.9	17.5	14.2	8.3	14.6	22.7	18.3	9.7	3.8	11.3	11.4	4.2	9.4	6.0	4.4	10.5	10.0	6.3	7.6	7.2	12.1	12.0	7.5	8.8	5.5	9.0	5.2	10.2	4.4	6.0	21.1	10.9	7.9	8.5	4.5	16.3	12.3	6.5	17.4	6.4	6.6	6.6	6.8	12.3	7.2	10.4	8.2	7.7	7.2	6.8	7.4	6.4	8.0	9.1	7.0	9.3	11.6	7.1	7.1	6.0	5.0	5.4	7.3	6.3	7.1	5.1	5.4	5.8	5.7	5.3	6.4	5.5	9.6	35.3	28.9	17.3	30.9	40.9	13.4	98.8	13.6	14.9	26.1	10.7	19.5	62.9	36.9	44.1	12.5	20.0	26.7	13.5	19.6	89.7	4.1	11.8	10.2	18.1	20.9	12.6	27.7	62.1	37.7	18.6	15.8	18.5	21.0	10.9	42.8	48.7	29.7	25.2	25.1	13.1	34.6	23.6	46.3	4.3	12.8	19.0	32.0	20.6	23.4	22.8	16.5	27.2	20.5	92.5	14.4	14.3	50.8	25.3	34.4	29.6	23.9	12.4	0.0	21.3	30.1	38.1	16.1	11.6	40.1	19.8	21.5	8.4	13.2	32.1
IPO11	RanBP11	ENSG00000086200	"Importin 11"	Q9UI26	5	62403972-62628582	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 68.4;Hepatic stellate cells: 65.0;Inhibitory neurons: 55.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"NK-cell: 22.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065346, HPA067097"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	Cytosol	"HPA065346: , HPA067097: AB_2685776"	"unprognostic (9.29e-2)"	"unprognostic (2.88e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.01e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (4.26e-2)"	"unprognostic (6.45e-2)"	"unprognostic (1.26e-3)"	"unprognostic (9.63e-2)"	"unprognostic (5.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.62e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.24e-2)"	16.0	9.1	13.4	9.7	13.7	6.6	14.4	13.6	14.6	10.6	16.3	9.2	6.9	9.4	8.5	12.0	10.2	10.7	14.7	14.7	13.7	11.9	11.4	7.7	10.4	14.1	13.7	9.4	8.6	13.4	6.0	16.5	13.6	9.0	8.6	6.3	8.5	8.4	12.6	8.8	7.9	11.0	14.4	13.4	8.5	21.4	13.9	10.0	14.0	14.4	10.1	13.4	9.9	15.7	27.1	25.4	22.3	34.6	17.0	23.4	30.9	28.4	20.5	29.1	31.9	27.5	20.2	45.3	22.2	28.9	35.5	21.4	47.3	32.0	45.6	17.5	24.6	21.6	24.5	24.4	12.8	23.7	11.6	16.7	17.7	34.3	35.7	13.7	113.8	22.4	41.5	14.5	27.9	26.0	26.1	32.2	28.0	15.4	14.5	31.6	33.7	41.6	17.7	26.4	24.1	13.9	24.8	19.3	21.0	21.9	24.9	17.0	51.8	17.4	19.3	19.8	26.4	11.3	20.0	31.3	21.2	33.4	21.3	16.5	2.4	2.2	3.8	3.8	4.5	3.3	3.9	3.9	4.0	4.8	5.5	4.0	2.5	22.7	7.0	2.4	2.8	3.6	13.4	13.7	13.6	14.6	14.7	13.7	14.1	13.7	13.6	14.4	13.9	15.7	39.6	9.6	3.7	35.9	11.8	8.5	4.2	3.3	13.6	4.2	6.2	4.8	13.2	5.7	4.5	7.3	2.1	7.6	7.9	2.7	3.9	4.2	42.2	8.4	7.0	40.0	3.0	21.7	68.4	5.5	6.7	7.6	6.1	5.6	13.3	9.6	65.0	6.2	5.2	5.0	55.0	4.4	2.0	6.5	6.4	25.3	5.6	7.4	3.6	20.6	2.6	3.9	10.3	28.1	48.3	3.3	1.7	4.1	10.7	5.2	2.6	3.6	25.6	4.9	6.6	9.7	8.7	14.6	16.2	10.9	8.8	5.1	8.8	4.6	5.7	4.8
IPO13	"IMP13, KIAA0724, RANBP13"	ENSG00000117408	"Importin 13"	O94829	1	43946950-43968022	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 122.1;skeletal muscle: 128.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 53.5;Late spermatids: 91.1;Oligodendrocytes: 79.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB070425	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB070425: AB_11157631"	"unprognostic (7.15e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.15e-2)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (8.26e-7)"	"unprognostic (1.21e-1)"	"unprognostic (9.61e-2)"	"unprognostic (1.56e-1)"	"prognostic favorable (2.21e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.93e-3)"	"unprognostic (6.42e-2)"	"unprognostic (4.22e-2)"	"unprognostic (8.13e-2)"	"unprognostic (5.93e-3)"	11.9	22.6	67.6	9.8	94.1	9.6	11.7	80.4	82.5	15.8	49.3	20.8	9.2	18.9	13.8	20.0	14.1	9.3	44.7	66.5	69.4	26.8	18.9	12.2	9.8	84.6	85.8	13.4	13.7	27.5	26.4	10.2	79.2	18.9	10.1	23.9	15.8	16.1	128.3	14.9	14.0	15.7	70.2	15.4	16.8	48.5	95.9	14.2	21.2	74.1	10.4	18.0	15.2	122.1	22.2	17.7	17.5	27.8	46.5	24.0	14.6	20.8	19.3	30.5	23.2	13.6	11.0	23.1	21.0	27.3	19.3	24.3	31.7	36.7	20.1	23.6	27.1	24.1	34.0	18.9	32.7	16.2	21.6	24.6	36.7	39.6	24.6	22.8	20.5	17.7	24.6	20.7	24.6	15.4	16.5	21.3	16.1	18.9	29.4	22.6	22.0	24.2	22.4	21.2	27.8	12.9	19.5	32.5	27.5	22.7	20.4	22.3	16.8	30.3	18.1	26.7	23.9	23.0	30.4	11.0	19.3	34.6	26.9	0.0	1.4	1.2	2.0	1.6	1.7	1.1	1.3	2.0	2.3	0.8	1.1	1.5	0.5	1.9	1.6	2.3	1.7	1.0	67.6	94.1	80.4	82.5	66.5	69.4	84.6	85.8	79.2	70.2	95.9	122.1	4.2	0.0	2.0	13.1	7.4	3.3	3.2	9.1	2.8	18.9	5.6	4.1	23.4	12.8	6.3	11.0	8.4	6.4	5.1	8.6	1.9	7.3	53.5	8.0	5.6	5.8	3.0	4.8	9.8	4.2	3.7	5.2	6.1	6.0	0.0	12.6	3.6	11.5	16.3	28.6	8.8	5.3	12.2	8.3	3.3	91.1	8.4	5.8	8.8	1.9	7.1	11.6	4.1	5.5	79.2	5.9	1.1	15.8	6.2	4.3	9.1	18.2	8.6	8.7	0.0	6.4	10.4	32.4	12.3	7.1	4.3	4.1	3.6	8.4	7.3	3.8
IPO4	"FLJ23338, Imp4"	ENSG00000196497	"Importin 4"	Q8TEX9	14	24180219-24188869	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 40.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 80.5;Late spermatids: 118.0;Spermatocytes: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039043, HPA064572"	Uncertain		Approved	Cytosol		NA	NA		17000	"Cluster 27: Non-specific - Gene expression"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA039043: AB_10673233, HPA064572: AB_2685291"	"unprognostic (2.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.93e-2)"	"prognostic unfavorable (8.08e-6)"	"unprognostic (9.45e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.13e-2)"	"unprognostic (6.75e-2)"	"unprognostic (9.28e-2)"	"prognostic unfavorable (3.20e-4)"	"unprognostic (8.59e-4)"	"unprognostic (5.45e-2)"	"unprognostic (2.18e-1)"	"unprognostic (2.15e-2)"	8.9	13.2	1.6	4.7	1.4	4.2	8.0	1.5	1.6	6.9	4.4	7.2	3.2	7.7	2.0	14.0	8.0	1.1	7.8	1.3	2.1	14.1	14.7	6.7	2.8	1.6	1.4	6.9	27.7	2.6	9.4	2.5	1.8	6.8	1.4	0.3	8.7	3.6	21.0	10.7	5.9	1.9	1.4	7.3	8.6	40.4	1.6	2.1	7.0	1.0	1.8	8.7	7.0	2.0	21.9	49.2	6.0	36.0	4.1	8.6	28.4	14.8	6.3	23.5	12.5	39.2	22.4	31.3	16.1	10.6	12.2	25.6	20.4	28.8	2.6	12.1	29.8	20.4	18.6	77.0	8.7	45.4	18.1	7.5	12.3	24.3	6.0	5.3	11.8	15.8	37.5	8.5	15.0	76.6	21.8	21.2	29.1	28.5	41.7	24.4	17.3	23.2	12.6	25.7	29.3	21.1	19.7	31.8	13.9	2.9	27.1	14.7	12.4	22.9	30.8	21.0	32.4	19.8	27.1	34.2	10.8	19.3	31.8	0.0	1.1	0.4	3.3	1.9	3.8	1.8	2.8	2.7	2.4	2.6	2.3	2.9	0.0	2.7	2.4	3.2	1.7	1.9	1.6	1.4	1.5	1.6	1.3	2.1	1.6	1.4	1.8	1.4	1.6	2.0	3.5	0.0	7.9	0.7	4.9	5.9	3.8	5.0	4.6	0.8	11.1	9.7	1.6	8.6	8.7	5.5	4.2	12.1	5.5	3.1	0.0	13.3	80.5	8.3	3.9	5.6	4.2	3.4	1.3	11.0	11.1	4.5	1.1	5.0	0.0	3.1	2.9	5.8	7.9	1.7	1.1	5.9	2.0	2.2	2.6	118.0	5.0	1.3	0.0	0.0	1.7	1.6	2.1	1.0	0.8	6.8	2.5	5.7	2.9	6.1	0.7	11.7	15.1	2.7	6.6	7.0	4.7	52.1	18.8	3.9	6.3	5.9	3.1	6.1	10.4	2.7
IPO5	"IMB3, KPNB3, MGC2068, Pse1, RANBP5"	ENSG00000065150	"Importin 5"	O00410	13	97953658-98024296	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.8"	"Group enriched"	"Detected in all"	11	"Early spermatids: 1152.2;Late spermatids: 2185.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009110, HPA040983, HPA056548"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		790000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"CAB009110: AB_2264985, HPA040983: AB_2677236, HPA056548: AB_2683169"	"unprognostic (5.20e-2)"	"unprognostic (6.94e-2)"	"unprognostic (9.47e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.96e-3)"	"unprognostic (2.16e-3)"	"unprognostic (2.19e-2)"	"unprognostic (5.27e-3)"	"unprognostic (6.19e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.06e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.73e-1)"	53.0	27.4	20.2	37.8	26.8	37.6	44.9	20.3	31.9	46.3	14.9	36.9	23.9	45.2	27.3	41.7	45.1	30.1	60.5	28.2	20.0	44.4	42.6	28.6	42.9	20.9	20.0	76.4	63.3	36.8	17.1	36.1	20.5	35.4	40.0	41.4	31.5	47.1	135.1	25.8	24.9	57.9	21.7	30.0	31.8	209.8	18.6	48.5	55.3	115.6	54.8	45.6	23.7	29.2	168.9	111.8	205.0	188.7	136.4	344.0	124.7	241.8	190.3	334.3	235.7	231.4	127.0	485.4	82.3	294.2	75.4	142.5	430.0	166.6	456.6	123.6	135.8	265.1	197.4	183.0	97.4	287.3	90.8	194.5	107.6	271.9	225.4	142.3	193.3	147.0	186.3	63.9	288.1	46.8	219.2	78.4	206.0	253.3	132.3	277.9	232.5	143.4	79.6	109.3	151.0	123.5	123.8	143.6	90.9	247.2	109.5	156.9	137.4	224.0	111.8	113.6	223.3	84.2	102.9	146.8	230.4	179.6	156.9	0.5	5.0	1.3	7.0	8.2	12.3	7.8	8.3	9.1	11.7	7.6	11.5	9.7	0.4	11.4	5.8	5.7	9.3	6.8	20.2	26.8	20.3	31.9	28.2	20.0	20.9	20.0	20.5	21.7	18.6	29.2	27.0	19.2	27.8	27.7	27.0	41.4	45.9	24.3	44.3	32.9	29.9	22.4	76.6	40.0	22.3	22.0	6.2	41.0	19.9	14.5	27.4	31.8	1152.2	24.9	37.5	39.5	35.3	72.8	53.4	42.3	47.5	45.1	21.4	29.3	14.5	75.6	32.9	44.2	23.9	63.9	39.5	24.8	18.3	33.3	31.6	2185.2	52.8	24.7	26.6	14.0	28.4	44.3	16.5	27.6	36.1	35.3	11.9	44.0	46.5	79.4	9.5	42.7	20.7	22.6	26.3	63.7	49.0	142.9	57.8	40.7	36.9	32.3	23.6	47.2	41.1	39.7
IPO7	"Imp7, RANBP7"	ENSG00000205339	"Importin 7"	O95373	11	9384652-9448127	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019002, HPA056590"	Approved	Approved	Supported	Nucleoplasm,Cytosol		NA	NA		220000	"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Cytosol"		"HPA019002: AB_1856059, HPA056590: AB_2683180"	"unprognostic (1.92e-1)"	"prognostic unfavorable (4.98e-4)"	"unprognostic (9.50e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (1.19e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (8.38e-6)"	"unprognostic (3.06e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.08e-2)"	"unprognostic (2.17e-1)"	"unprognostic (3.90e-3)"	37.9	29.1	24.1	31.3	25.7	22.7	40.4	27.3	30.7	35.7	27.5	34.6	27.2	33.9	29.2	37.9	31.3	31.8	50.4	23.2	28.0	41.4	38.5	28.9	30.1	27.6	27.4	33.1	33.8	38.9	13.0	41.1	27.3	32.1	34.1	47.8	33.3	33.2	110.3	25.3	26.0	43.4	26.8	22.9	25.6	12.7	27.4	31.8	54.0	93.4	34.8	51.8	22.8	29.9	148.7	110.8	130.6	104.4	129.4	165.7	104.4	176.0	112.4	127.1	136.4	99.1	132.6	138.1	62.5	136.3	115.5	113.5	187.5	136.7	210.7	66.3	154.5	114.3	118.8	100.1	80.7	177.0	83.3	106.7	144.8	84.0	195.6	129.5	152.8	46.7	174.7	80.5	167.9	60.3	107.5	86.3	129.0	136.3	130.2	111.4	205.5	63.0	105.3	137.5	51.7	101.5	78.6	153.5	129.1	103.2	70.7	87.6	120.9	155.6	107.4	162.0	190.9	23.2	95.3	93.6	102.0	93.6	86.4	0.1	1.5	0.3	1.4	2.6	2.7	1.9	1.5	2.0	3.2	1.4	1.9	1.7	0.7	3.5	3.8	1.4	1.5	1.0	24.1	25.7	27.3	30.7	23.2	28.0	27.6	27.4	27.3	26.8	27.4	29.9	41.3	67.3	71.5	19.6	46.4	144.0	103.3	44.8	68.9	40.1	65.5	42.4	131.9	25.8	59.7	35.0	58.4	52.8	39.7	27.2	33.2	34.2	4.6	55.9	92.5	55.7	31.1	50.9	43.9	42.2	63.8	58.0	47.4	99.5	37.9	56.5	25.0	46.8	35.3	35.3	49.7	38.8	32.6	48.0	92.2	7.1	28.0	56.6	39.2	17.8	39.2	31.8	13.4	28.1	44.9	45.5	32.9	35.7	47.6	150.6	26.5	45.7	48.4	39.8	13.1	96.2	71.0	21.6	19.8	82.2	147.9	36.7	37.7	49.0	50.9	127.4
IPO8	"IMP8, RANBP8"	ENSG00000133704	"Importin 8"	O15397	12	30628988-30695869	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018439, HPA023765"	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	Nucleoplasm		"HPA018439: AB_1851771, HPA023765: AB_1851773"	"unprognostic (1.63e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.73e-1)"	"unprognostic (5.14e-2)"	"unprognostic (2.15e-2)"	"unprognostic (1.74e-1)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (2.66e-2)"	"unprognostic (5.42e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (8.62e-5)"	"unprognostic (9.75e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.14e-3)"	"unprognostic (2.24e-1)"	20.1	21.6	17.8	23.0	21.8	16.5	22.2	25.3	19.9	22.1	26.1	29.4	26.6	23.9	17.1	24.2	17.2	21.4	16.7	19.1	21.4	32.2	34.6	23.1	28.1	22.0	19.8	26.6	27.8	51.9	15.5	22.5	20.9	21.8	32.2	22.8	19.8	25.4	18.5	24.3	23.7	26.8	18.1	25.2	24.1	24.5	20.9	29.3	31.7	21.7	27.5	23.9	15.5	22.8	41.2	46.8	44.3	32.9	40.9	46.8	62.3	44.4	42.5	34.9	40.6	32.9	41.8	52.9	38.1	54.8	37.0	25.8	49.7	48.4	50.5	62.0	35.1	43.1	56.0	29.8	26.8	63.3	32.8	37.8	29.8	55.5	47.1	62.5	58.5	36.4	39.2	38.7	49.9	21.0	47.6	39.3	86.7	56.5	18.1	38.5	93.1	42.7	43.6	55.5	27.3	33.7	46.6	33.7	25.0	78.6	53.8	22.7	52.4	33.2	29.0	72.3	39.3	38.0	54.9	78.4	40.6	37.4	58.7	3.4	1.9	2.4	1.9	2.5	2.8	2.4	2.1	2.0	1.4	3.2	2.2	3.0	2.5	2.6	2.6	1.4	2.8	1.3	17.8	21.8	25.3	19.9	19.1	21.4	22.0	19.8	20.9	18.1	20.9	22.8	18.4	9.6	21.0	22.2	17.3	9.6	6.7	6.3	12.5	13.4	12.2	7.4	20.3	8.6	16.6	11.0	12.5	11.8	13.5	17.2	3.9	10.1	51.5	14.3	17.5	17.5	6.7	14.5	38.8	14.0	6.8	13.4	16.8	14.2	12.0	25.0	21.0	25.1	16.1	8.4	35.0	13.8	8.2	24.8	10.8	11.9	8.7	17.4	8.8	30.9	16.7	12.7	18.6	59.8	35.7	14.1	8.1	13.2	17.5	7.6	15.0	15.7	9.9	14.3	13.1	17.0	14.8	17.4	5.2	23.4	9.2	17.9	13.6	11.1	14.8	9.0
IPO9	"FLJ10402, Imp9"	ENSG00000198700	"Importin 9"	Q96P70	1	201829149-201884291	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059540			Approved	Vesicles,Cytosol	"Intracellular and membrane"	NA	NA		70000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	Cytosol	Vesicles	"HPA059540: "	"unprognostic (1.20e-1)"	"unprognostic (1.37e-1)"	"unprognostic (7.44e-3)"	"unprognostic (2.02e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (4.11e-5)"	"unprognostic (8.92e-3)"	"unprognostic (2.23e-3)"	"unprognostic (2.52e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.11e-1)"	"prognostic unfavorable (2.86e-4)"	"unprognostic (5.05e-2)"	"unprognostic (2.57e-1)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (5.78e-4)"	17.0	18.2	17.8	12.0	17.8	10.1	16.5	18.0	22.5	18.9	16.4	15.9	9.2	19.2	18.2	15.7	15.2	9.2	15.9	18.8	17.6	17.4	26.9	17.9	13.7	17.3	16.7	17.2	17.9	14.8	20.7	14.5	16.8	17.5	13.9	23.7	12.3	10.8	14.0	17.7	15.1	16.7	15.0	19.6	14.3	14.4	17.8	16.2	19.3	10.7	16.7	16.6	15.0	17.1	45.4	46.9	63.0	51.4	35.7	24.1	47.1	34.2	34.3	55.6	53.8	75.6	38.4	26.8	18.9	32.9	48.8	41.0	43.0	47.2	47.9	24.5	38.1	20.0	75.2	57.2	27.2	26.2	31.4	26.7	21.3	60.2	48.5	37.1	56.7	36.0	40.5	24.6	40.4	45.1	30.5	34.2	63.4	40.6	15.2	32.2	65.8	26.6	30.7	71.0	53.3	60.5	37.5	58.7	30.8	96.6	43.1	32.8	31.1	52.1	46.6	29.5	63.5	18.1	12.0	31.5	25.9	30.5	39.8	10.1	10.1	8.7	9.9	13.2	8.6	9.5	9.5	10.9	12.6	8.5	7.6	8.3	2.3	10.2	13.8	6.6	9.5	7.8	17.8	17.8	18.0	22.5	18.8	17.6	17.3	16.7	16.8	15.0	17.8	17.1	25.7	22.4	45.6	48.0	22.1	15.8	14.9	14.3	13.6	57.9	14.5	14.7	23.6	10.0	20.4	7.3	60.5	27.8	17.6	7.5	1.9	16.9	8.0	9.2	28.9	27.3	11.3	28.6	60.1	18.7	20.8	25.4	16.3	11.2	11.4	32.6	23.2	18.1	19.5	75.7	60.7	16.3	10.2	17.6	21.5	8.8	20.2	13.3	14.2	36.5	21.6	38.1	26.8	46.8	50.6	17.6	10.6	28.2	18.2	16.4	8.9	9.0	10.5	56.5	39.5	35.4	26.1	42.0	37.3	16.4	14.2	22.6	17.0	26.0	17.0	12.5
IRAG2	"JAW1, LRMP"	ENSG00000118308	"Inositol 1,4,5-triphosphate receptor associated 2"	Q12912	12	25004342-25108334	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fertilization, Immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"bone marrow: 60.3;lymphoid tissue: 202.8"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 13.1;B-cells: 6.2;dendritic cells: 42.9;Hofbauer cells: 14.1;Plasma cells: 17.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 210.1"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"Daudi: 634.3;REH: 221.9;U-698: 722.4"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA002967, HPA007356, HPA018505"	Enhanced		Approved	"Endoplasmic reticulum,Plasma membrane"		NA	NA		6700	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum, Plasma membrane"		"HPA002967: AB_1079161, HPA007356: , HPA018505: AB_1851988"	"unprognostic (3.78e-2)"	"unprognostic (2.59e-3)"	"unprognostic (7.54e-2)"	"unprognostic (7.08e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.48e-3)"	"unprognostic (7.98e-2)"	"unprognostic (4.08e-2)"	"unprognostic (7.32e-2)"	"unprognostic (1.15e-1)"	"unprognostic (3.59e-2)"	"unprognostic (7.97e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.72e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.59e-2)"	9.6	1.9	8.5	47.2	5.4	60.3	6.5	2.3	5.6	2.4	3.2	10.1	8.7	2.5	2.8	5.2	5.1	7.8	2.4	6.6	2.6	9.4	6.2	7.7	171.7	6.0	4.4	5.7	30.7	1.5	2.4	4.4	6.1	3.4	9.2	1.1	3.6	4.4	1.1	5.8	19.1	4.5	3.6	37.5	10.1	1.0	2.8	95.1	4.9	1.6	202.8	14.5	8.3	4.6	0.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	634.3	0.3	0.0	0.0	0.2	0.0	2.4	0.0	22.1	0.0	37.8	0.0	0.1	0.0	49.7	54.2	0.0	0.0	0.7	0.0	0.1	0.0	31.5	7.8	40.6	0.0	0.0	54.5	91.2	0.1	0.0	0.0	221.9	0.3	63.8	0.7	29.7	0.2	0.1	0.2	0.3	0.2	0.1	0.0	36.7	0.5	0.0	1.5	0.0	0.1	40.4	7.8	722.4	0.2	21.8	0.0	80.2	21.0	210.1	23.6	40.8	20.2	66.1	14.9	24.2	22.4	51.0	25.5	25.4	151.3	49.0	51.5	20.8	2.7	20.2	8.5	5.4	2.3	5.6	6.6	2.6	6.0	4.4	6.1	3.6	2.8	4.6	13.1	0.0	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.2	42.9	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	14.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0
ITGA1	"CD49a, VLA1"	ENSG00000213949	"Integrin subunit alpha 1"	P56199	5	52787916-52959209	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 36.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 264.1;Endothelial cells: 120.5;Hepatocytes: 110.5;Sertoli cells: 98.6;Smooth muscle cells: 143.9"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 4.5;HHSteC: 4.5;SH-SY5Y: 1.7;WM-115: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042555	Uncertain					NA	NA		6300000		"Cluster 72: Non-specific - Transcription"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA042555: AB_10794281"	"unprognostic (1.48e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.89e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.79e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.62e-1)"	"unprognostic (9.86e-2)"	"prognostic unfavorable (2.24e-4)"	"unprognostic (3.13e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.62e-2)"	13.9	22.4	0.6	1.0	0.8	0.0	10.2	0.7	0.9	5.1	0.4	36.6	1.1	16.3	2.5	5.7	9.9	2.2	10.6	0.5	0.8	11.0	17.1	22.1	0.8	0.8	0.8	3.6	3.1	2.1	2.3	5.8	0.8	12.6	2.7	0.1	2.3	7.2	4.6	2.3	12.5	5.8	0.8	27.9	16.6	0.8	0.8	0.2	9.7	2.5	0.4	17.9	5.1	0.9	0.0	0.0	0.3	0.0	1.4	0.4	0.1	0.3	1.3	0.3	0.7	0.7	0.0	0.0	0.1	4.5	0.5	0.2	0.1	0.4	0.2	0.0	0.4	0.0	0.3	0.3	4.5	0.0	0.0	0.7	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.7	0.5	0.0	0.0	0.7	0.0	0.0	0.6	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.7	0.9	0.5	0.8	0.8	0.8	0.8	0.8	0.8	0.9	264.1	54.5	26.8	2.9	1.7	3.2	4.7	1.5	2.8	1.8	3.6	13.8	12.6	5.7	8.7	5.5	2.1	1.5	2.9	5.5	1.9	3.0	21.3	7.7	41.8	120.5	16.4	5.3	3.6	5.4	16.8	40.2	6.1	22.1	10.1	1.0	77.1	110.5	2.2	0.0	19.5	14.0	0.0	7.2	8.2	6.1	9.3	5.6	7.2	63.7	9.1	0.4	0.0	1.5	4.2	19.6	7.7	8.2	2.9	3.2	6.5	15.1	6.3	2.0	98.6	18.6	143.9	0.9	1.1	0.5	3.1	3.4	46.0	13.6	14.0	2.3
ITGA6	CD49f	ENSG00000091409	"Integrin subunit alpha 6"	P23229	2	172427354-172506459	"Cancer-related genes, CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"	"Integrin, Receptor"	"Cancer-related genes, Epidermolysis bullosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 327.2;Basal keratinocytes: 244.7;Urothelial cells: 247.6"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 144.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 22.9"	"Group enriched"	"Detected in many"	28	"granulocytes: 22.9;NK-cells: 7.1;T-cells: 12.8"	"Cell line enhanced"	"Detected in many"		"BJ: 326.2;HaCaT: 356.8;HBEC3-KT: 705.8;hTCEpi: 298.9;hTERT-HME1: 301.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009009, HPA012696, HPA027582"	Enhanced					NA	NA		3300000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"CAB009009: AB_2128038, HPA012696: AB_1851822, HPA027582: AB_10602606"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.96e-2)"	"unprognostic (4.93e-2)"	"prognostic unfavorable (1.03e-4)"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-3)"	"unprognostic (9.34e-2)"	"unprognostic (6.01e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.84e-1)"	"prognostic favorable (2.35e-11)"	"unprognostic (3.35e-2)"	"unprognostic (3.32e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.21e-3)"	45.9	8.3	20.1	27.8	16.7	5.8	55.6	16.6	20.3	64.3	42.8	65.4	74.2	43.1	9.5	25.1	25.3	37.2	29.2	17.2	20.9	42.7	8.8	29.3	18.7	20.8	18.8	5.6	42.0	14.0	6.2	76.8	19.3	24.4	62.4	7.3	81.0	30.8	27.7	46.6	67.4	39.0	20.5	41.2	66.1	26.1	25.0	33.9	21.1	42.6	21.4	55.0	26.8	16.5	77.5	64.8	26.7	49.1	1.4	0.9	146.3	326.2	34.6	32.1	20.0	36.2	141.3	0.7	90.9	86.8	73.8	356.8	17.7	705.8	58.1	0.7	16.6	1.9	64.8	58.7	4.8	21.4	2.4	6.2	298.9	2.0	301.4	32.9	209.6	40.8	0.3	5.5	41.6	3.7	5.9	17.8	48.2	214.2	54.5	1.1	82.3	1.6	48.0	106.6	0.8	3.4	61.2	0.1	69.7	28.0	13.1	1.4	97.9	44.9	41.1	84.2	56.8	4.8	3.6	1.9	1.7	7.2	185.0	4.4	0.2	22.9	5.3	0.0	10.7	0.2	6.7	6.4	0.1	0.5	12.8	5.9	0.7	7.1	0.0	0.0	8.1	4.3	20.1	16.7	16.6	20.3	17.2	20.9	20.8	18.8	19.3	20.5	25.0	16.5	327.2	9.6	19.5	88.5	8.8	244.7	236.4	43.4	88.8	1.4	55.0	72.8	32.5	22.8	10.5	27.6	56.3	103.8	14.4	139.6	5.9	34.4	31.2	82.5	34.8	196.0	57.4	1.7	4.0	62.1	26.5	20.8	219.7	149.3	8.2	103.4	11.7	21.5	25.5	1.7	6.1	128.8	20.3	3.2	20.8	46.8	4.1	10.0	51.6	119.9	1.7	1.3	29.9	1.5	8.8	127.9	104.2	2.6	109.0	184.8	54.5	52.2	9.2	13.9	0.0	11.8	18.4	7.7	20.2	141.5	84.0	22.3	30.1	44.0	146.3	247.6
ITGA7		ENSG00000135424	"Integrin subunit alpha 7"	Q13683	12	55684568-55716043	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Cell shape"	"Integrin, Receptor"	"Congenital muscular dystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 262.3"	"Group enriched"	"Detected in many"	6	"Astrocytes: 87.5;Cardiomyocytes: 124.5;Sertoli cells: 164.3;Skeletal myocytes: 65.8;Smooth muscle cells: 110.6"	"Cancer enhanced"	"Detected in all"		"glioma: 35.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	5	"hTERT-RPE1: 309.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008427	Uncertain		Approved	"Nuclear speckles,Vesicles,Plasma membrane"		NA	NA		1200000		"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane"	"Nuclear speckles, Vesicles"	"HPA008427: AB_1851823"	"unprognostic (4.71e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.02e-3)"	"unprognostic (2.50e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.66e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.20e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (1.75e-4)"	"unprognostic (2.85e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.79e-1)"	"unprognostic (5.10e-1)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (9.59e-5)"	133.4	8.2	18.5	18.5	21.2	1.8	69.0	15.9	30.2	28.7	16.1	97.8	17.7	45.5	12.3	23.9	56.1	30.8	157.9	34.5	17.8	11.5	10.2	15.5	6.4	21.2	21.1	19.1	5.1	6.1	12.6	1.9	20.3	33.9	8.9	2.4	14.9	37.3	262.3	16.0	27.4	95.2	16.4	10.2	35.2	8.9	23.8	3.4	26.1	154.1	3.3	46.5	25.5	21.0	0.2	4.1	7.5	12.3	66.5	13.4	0.7	5.4	8.7	11.7	11.8	8.4	6.5	2.3	7.4	3.4	0.9	1.1	5.1	0.3	10.0	0.2	3.8	0.8	2.8	3.2	0.5	0.3	2.7	19.1	0.2	64.2	0.3	309.1	0.2	2.2	0.9	1.6	37.8	5.3	0.3	3.1	20.9	1.7	0.4	0.1	28.7	0.6	0.2	0.2	0.9	2.8	0.6	0.2	48.0	4.0	0.9	13.9	0.0	1.3	12.4	0.8	8.4	3.2	2.2	0.9	57.8	8.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	18.5	21.2	15.9	30.2	34.5	17.8	21.2	21.1	20.3	16.4	23.8	21.0	11.9	0.0	0.0	87.5	0.3	1.9	0.5	0.1	0.6	2.4	1.2	3.4	124.5	2.8	0.0	1.8	4.2	0.0	0.3	0.7	0.0	0.3	0.3	1.1	1.2	9.5	7.7	0.4	17.6	0.0	0.1	5.0	0.5	1.1	0.0	6.2	0.7	1.4	0.6	0.0	9.4	1.8	0.0	1.9	2.7	0.1	6.5	2.2	3.6	9.4	0.0	3.4	0.0	6.6	3.7	0.3	0.1	6.4	0.1	0.8	2.6	0.8	0.1	0.6	164.3	65.8	110.6	4.1	2.9	0.7	2.3	0.1	0.5	0.3	0.9	0.3
ITGAL	"CD11A, LFA-1"	ENSG00000005844	"Integrin subunit alpha L"	P20701	16	30472658-30523567	"CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction, Phagocytosis"	"Integrin, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 36.8;lymphoid tissue: 64.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 118.6;monocytes: 36.8;NK-cells: 152.4;Plasma cells: 46.6;T-cells: 84.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"non-classical monocyte: 121.7"	"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in some"	5	"HMC-1: 608.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB025011	Enhanced					NA	NA		1600000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB025011: "	"unprognostic (1.10e-2)"	"unprognostic (4.26e-3)"	"unprognostic (3.72e-3)"	"prognostic favorable (5.63e-5)"	"unprognostic (2.88e-1)"	"prognostic favorable (3.34e-4)"	"unprognostic (1.63e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (5.57e-4)"	"unprognostic (3.37e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.84e-1)"	"prognostic unfavorable (2.69e-5)"	"unprognostic (2.89e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.71e-2)"	4.2	1.4	0.3	36.7	0.5	36.8	2.3	0.3	1.0	2.4	0.5	5.5	6.0	2.3	1.0	2.5	3.0	7.0	1.4	0.3	0.4	2.6	10.6	22.0	62.4	1.6	1.1	1.3	1.0	0.5	1.2	3.0	1.4	2.4	8.6	0.0	5.3	1.4	0.9	1.4	19.7	3.6	0.7	64.9	8.6	1.0	1.6	55.2	3.5	0.9	46.4	6.9	2.3	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	32.8	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.9	0.0	1.7	0.0	0.1	0.0	1.1	608.0	0.0	0.0	0.1	0.0	0.0	0.0	5.6	0.0	134.3	0.0	0.0	43.3	3.5	0.0	0.0	0.0	0.1	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.4	26.0	0.0	0.0	0.0	0.0	0.0	36.6	12.5	0.0	0.1	3.8	0.0	5.3	24.4	17.0	56.6	48.0	27.7	4.8	21.4	42.7	22.3	1.7	9.4	29.7	14.3	24.2	121.7	6.0	15.6	43.6	0.3	0.5	0.3	1.0	0.3	0.4	1.6	1.1	1.4	0.7	1.6	2.1	1.2	6.4	10.5	0.7	19.1	0.8	0.3	0.0	0.0	0.4	1.2	1.0	1.9	0.0	1.9	1.8	0.0	0.2	118.6	0.3	0.0	0.1	0.5	4.1	0.6	2.3	0.0	4.8	3.6	0.0	0.6	1.4	1.1	0.9	5.1	0.1	5.3	4.9	19.3	0.0	2.8	0.2	0.0	30.0	3.4	0.7	0.0	31.5	1.8	15.9	36.8	0.1	152.4	0.5	1.6	0.0	0.0	0.0	46.6	0.1	0.9	0.3	6.7	0.9	0.0	1.2	0.7	0.2	0.2	0.1	0.3	0.7	84.9	0.1	0.0	0.2
ITGAV	"CD51, MSK8, VNRA, VTNR"	ENSG00000138448	"Integrin subunit alpha V"	P06756	2	186590056-186680901	"Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"basophil: 6.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"RT4: 369.7;SuSa: 297.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002499, HPA004856"	Supported		Approved	"Focal adhesion sites,Cytosol"		NA	NA		2000000	"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 15: RT4 - Unknown function"	"Cluster 44: Endometrium - Transcription"	"Focal adhesion sites, Cytosol"		"CAB002499: AB_563594, HPA004856: AB_1846316"	"unprognostic (4.03e-2)"	"unprognostic (5.17e-3)"	"unprognostic (1.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (1.48e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (5.07e-4)"	"unprognostic (5.84e-2)"	"unprognostic (2.67e-2)"	"prognostic unfavorable (1.05e-6)"	"unprognostic (2.61e-1)"	"unprognostic (9.11e-2)"	"unprognostic (8.07e-2)"	39.9	38.7	20.1	36.5	30.8	6.4	27.7	39.7	23.5	39.7	40.3	20.1	15.9	36.8	10.5	24.5	26.3	47.3	80.0	18.2	32.7	52.1	18.0	25.7	15.8	42.5	33.0	64.7	25.7	82.7	11.9	47.4	46.4	29.8	21.6	80.4	32.1	28.1	16.3	41.4	16.3	56.7	45.3	21.4	34.2	14.7	30.2	18.0	62.6	30.5	21.6	43.1	16.0	54.6	49.1	57.5	37.4	119.9	134.1	90.0	141.7	93.8	75.5	32.5	32.5	50.7	164.0	0.4	179.7	106.3	113.4	60.2	19.3	88.5	46.7	9.7	17.2	11.7	69.1	69.6	52.8	8.3	7.0	65.8	41.3	72.7	61.1	194.1	78.7	5.9	11.6	23.9	87.4	19.4	5.0	6.8	28.3	29.1	28.5	0.1	76.2	6.8	83.5	369.7	7.7	23.0	108.6	33.2	40.1	297.0	26.2	22.4	240.5	199.4	61.9	41.4	80.3	5.9	10.4	5.5	80.3	3.3	100.6	6.2	0.6	0.9	0.4	1.1	0.3	0.1	0.2	0.4	0.4	0.0	0.2	0.2	0.2	0.2	0.6	0.2	0.6	0.2	20.1	30.8	39.7	23.5	18.2	32.7	42.5	33.0	46.4	45.3	30.2	54.6	39.8	28.9	22.9	134.8	4.9	128.4	64.0	127.7	42.7	118.4	50.4	23.4	145.5	80.1	35.3	77.3	77.2	55.1	9.4	32.4	1.9	78.7	0.6	61.7	61.1	47.2	7.3	2.1	36.3	101.8	26.9	65.4	57.6	100.2	49.5	21.2	27.8	18.2	27.6	15.2	35.9	19.9	14.2	44.3	56.7	3.1	19.3	29.3	46.2	75.9	17.4	70.9	2.1	184.5	156.1	165.9	23.8	25.9	9.2	103.4	11.2	32.4	27.0	60.2	32.9	29.0	63.3	1.7	2.4	27.7	103.7	39.7	10.9	18.1	15.5	77.7
ITGB1	"CD29, FNRB, GPIIA, MDF2, MSK12"	ENSG00000150093	"Integrin subunit beta 1"	P05556	10	32887273-33005792	"Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Host-virus interaction"	"Host cell receptor for virus entry, Integrin, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ductal cells: 1206.9;Pancreatic endocrine cells: 1393.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 2711.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003434, HPA059297, HPA069003"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane,Focal adhesion sites"		NA	NA		270000000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Plasma membrane, Focal adhesion sites"	"Endoplasmic reticulum"	"CAB003434: AB_303570, HPA059297: AB_2732634, HPA069003: AB_2732125"	"unprognostic (3.07e-2)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (8.67e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.60e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.22e-1)"	"unprognostic (2.36e-3)"	"unprognostic (3.68e-3)"	"unprognostic (2.42e-1)"	"unprognostic (1.02e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.48e-1)"	"unprognostic (3.08e-2)"	491.9	179.3	61.5	241.5	78.2	81.5	216.2	75.0	90.9	259.2	68.3	265.3	147.4	330.4	171.7	168.6	172.0	347.4	390.3	60.2	74.3	180.4	287.1	233.6	118.0	88.4	80.6	157.1	135.3	145.4	59.8	459.5	88.9	248.1	223.6	27.7	130.7	427.7	157.9	92.2	150.8	710.0	76.6	204.7	160.1	91.2	86.4	77.5	161.5	194.5	106.2	357.4	119.1	88.9	638.0	907.0	495.4	559.6	1183.4	1019.5	398.1	2063.9	1239.6	999.0	903.9	215.9	1478.2	164.5	354.1	1830.9	638.0	438.9	149.1	1204.1	1122.0	163.1	112.7	195.8	416.3	253.6	826.4	48.3	195.5	1027.7	658.2	1040.8	426.0	2711.1	1263.6	81.0	136.6	76.5	1700.8	109.0	80.1	46.7	107.4	200.6	428.2	52.0	357.0	30.9	1454.8	186.2	108.0	271.4	649.9	114.6	498.2	813.7	153.9	175.0	1362.6	1280.0	712.2	904.2	719.7	64.7	14.8	91.2	956.6	198.2	518.5	7.5	35.1	16.1	83.4	69.8	22.8	109.6	191.8	138.7	33.9	40.3	24.9	68.4	9.0	90.3	108.2	11.4	266.8	117.2	61.5	78.2	75.0	90.9	60.2	74.3	88.4	80.6	88.9	76.6	86.4	88.9	631.5	342.9	143.8	26.4	118.0	546.7	435.5	531.6	208.3	32.8	147.1	307.5	210.8	241.6	268.1	226.2	31.3	210.3	217.8	179.8	13.7	1206.9	6.6	194.6	437.9	421.1	193.3	153.0	37.2	411.3	515.2	374.7	95.8	406.5	88.7	561.8	375.9	268.1	179.8	38.7	52.4	97.4	213.6	170.1	206.7	18.3	254.5	217.8	343.3	67.5	119.4	72.0	111.2	42.7	66.8	1393.7	128.5	601.8	181.2	412.5	75.6	68.7	171.5	45.5	637.7	236.3	724.0	10.1	76.0	84.4	170.5	219.7	211.3	225.6	127.0	296.1
ITGBL1	"OSCP, TIED"	ENSG00000198542	"Integrin subunit beta like 1"	O95965	13	101452593-101720856	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"Fibroblasts: 76.1;Skeletal myocytes: 93.0"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 7.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 208.3;ASC TERT1: 138.7;fHDF/TERT166: 345.3;LHCN-M2: 311.8"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	12	"spinal cord: 56.9"						"Secreted - unknown location"	NA	NA		37000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (1.70e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.12e-4)"	"unprognostic (1.45e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.86e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.16e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.13e-5)"	"unprognostic (1.44e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (2.70e-4)"	16.9	9.2	1.8	0.7	1.8	0.1	18.0	2.6	2.3	23.8	2.5	1.5	0.5	2.0	0.5	9.7	4.9	38.3	18.3	1.9	3.6	2.7	7.7	25.4	1.3	3.9	2.3	5.3	7.9	5.6	10.3	33.4	4.3	4.0	2.5	0.1	11.7	4.4	4.5	13.2	0.5	4.1	3.5	4.0	7.2	2.5	2.2	0.9	8.4	14.9	4.3	17.8	10.0	6.5	4.2	0.3	0.0	0.0	208.3	138.7	0.0	65.8	67.7	29.3	18.7	0.0	2.4	0.0	0.3	345.3	13.9	70.9	0.0	24.1	46.0	0.0	0.0	21.3	0.6	0.0	21.7	0.0	0.0	59.3	1.5	16.8	46.6	55.3	76.8	0.0	1.5	0.7	311.8	0.0	0.0	0.0	0.0	0.0	24.0	0.1	0.0	0.0	0.0	2.7	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	8.8	24.0	33.2	27.3	0.1	8.3	0.0	0.0	50.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	2.6	2.3	1.9	3.6	3.9	2.3	4.3	3.5	2.2	6.5	1.9	3.2	0.5	5.5	0.1	4.0	0.1	1.3	0.6	1.8	4.2	19.0	0.5	0.0	0.1	0.0	0.0	0.7	0.1	0.0	0.0	0.5	4.5	0.5	7.7	1.2	0.0	0.0	3.6	0.2	0.8	76.1	5.6	1.1	0.0	0.0	8.6	0.5	0.7	5.0	6.7	0.0	0.0	0.0	4.7	2.1	0.0	0.8	5.4	13.1	0.0	0.5	0.0	2.0	5.0	1.1	0.0	8.2	0.6	0.2	0.0	0.1	0.0	0.7	0.0	93.0	4.8	11.6	8.4	0.7	2.4	0.8	0.4	1.2	0.0	0.2
ITM2B	"BRI, BRI2, BRICD2B, E25B, E3-16"	ENSG00000136156	"Integral membrane protein 2B"	Q9Y287	13	48232612-48270357	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Amyloidosis, Deafness, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 4375.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 4375.2"	"Cell line enhanced"	"Detected in all"		"HMC-1: 731.2;RPTEC TERT1: 1718.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029292, HPA071992"	Enhanced		Enhanced	"Golgi apparatus,Vesicles"	"Secreted to blood"	NA	NA		5800000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus, Vesicles"		"HPA029292: AB_10601917, HPA071992: AB_2686480"	"unprognostic (4.66e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.41e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.29e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.42e-1)"	"unprognostic (5.89e-2)"	"unprognostic (2.87e-2)"	"prognostic favorable (3.73e-5)"	"unprognostic (4.38e-2)"	"unprognostic (4.09e-2)"	"unprognostic (6.00e-2)"	"unprognostic (1.22e-1)"	510.2	367.4	286.9	172.5	301.0	125.6	323.8	328.6	489.0	416.1	406.6	260.1	289.2	388.8	1171.8	399.9	305.4	257.5	381.0	320.1	339.2	1306.3	391.2	376.1	236.7	334.9	308.0	507.2	179.6	233.7	290.5	573.8	304.4	312.5	191.4	174.4	408.7	386.2	164.7	399.6	287.4	232.5	373.6	435.2	312.8	121.4	308.8	188.3	386.1	206.2	187.4	305.1	402.2	394.8	67.6	51.8	73.1	116.3	348.5	254.5	119.2	215.0	202.2	87.5	100.6	29.1	248.3	16.6	168.8	121.6	48.5	214.1	61.3	107.0	107.4	69.9	147.3	137.9	29.0	99.0	138.5	140.6	731.2	113.4	149.1	45.1	62.0	375.7	131.2	78.3	24.5	90.9	174.8	29.6	200.4	310.1	266.0	116.5	103.6	100.1	100.5	73.6	1718.9	268.6	26.2	119.5	154.5	110.2	111.0	306.0	74.0	119.4	180.5	62.9	73.8	95.7	85.4	72.9	59.6	2.5	78.0	75.3	155.3	3091.4	864.5	2737.9	387.4	661.3	512.5	235.3	523.1	476.4	428.9	245.3	551.3	466.8	4375.2	356.5	692.7	196.2	563.4	1723.5	286.9	301.0	328.6	489.0	320.1	339.2	334.9	308.0	304.4	373.6	308.8	394.8	1380.0	695.5	300.4	174.6	408.6	862.4	1661.1	2606.2	1006.2	653.1	460.1	573.5	384.8	722.0	1121.9	1991.8	187.7	1164.3	448.2	754.2	545.9	910.2	23.6	751.8	802.2	1166.2	283.3	307.0	114.2	682.9	2362.8	1334.0	302.8	1177.2	578.0	421.2	1319.7	557.3	2117.8	353.3	142.6	503.2	1129.1	1569.8	900.6	76.7	1867.0	1381.5	681.3	252.0	1415.7	1634.9	425.3	174.4	237.9	515.7	788.3	2011.6	445.4	922.5	1259.3	2748.9	795.6	219.4	1222.7	602.4	1022.9	143.6	256.4	1384.6	1149.6	1471.5	723.2	665.5	440.9	1613.4
ITPR1	"ACV, Insp3r1, IP3R1, PPP1R94, SCA15, SCA16, SCA29"	ENSG00000150995	"Inositol 1,4,5-trisphosphate receptor type 1"	Q14643	3	4493345-4847840	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, Mental retardation, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 290.2;Inhibitory neurons: 183.1;Microglial cells: 84.3"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 49.9"	"Immune cell enhanced"	"Detected in many"		"naive B-cell: 13.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 76.4;HEL: 41.1;HeLa: 74.9;HMC-1: 40.0;U-87 MG: 56.7"	"Region enhanced"	"Detected in all"		"cerebellum: 697.2"	"Region enhanced"	"Detected in all"		"cerebellum: 208.8"	"HPA014765, HPA016487"	Approved		Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA014765: AB_1851843, HPA016487: AB_1851842"	"unprognostic (1.92e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.61e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.12e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.43e-4)"	"unprognostic (2.40e-1)"	10.6	12.0	1.8	11.8	12.0	7.2	17.3	49.9	20.1	11.5	15.6	19.5	4.5	36.5	10.0	10.6	27.1	14.1	10.1	5.9	0.0	13.9	3.9	13.7	11.2	0.0	0.5	25.3	6.7	45.3	16.0	8.0	0.0	21.7	6.3	3.9	16.1	27.9	3.0	5.0	11.5	24.5	0.0	9.2	11.1	4.5	0.0	10.3	31.7	5.3	10.5	27.9	11.8	6.1	0.4	4.1	1.0	3.0	27.7	1.9	11.8	0.9	0.5	1.3	0.8	1.3	1.2	14.5	0.6	1.9	6.5	0.1	2.2	2.6	2.1	76.4	3.2	41.1	74.9	3.5	27.4	17.7	40.0	9.2	4.0	5.8	1.1	7.6	7.2	8.4	7.9	13.9	3.7	1.8	7.2	3.0	2.1	0.5	9.7	4.2	1.0	1.1	1.7	5.5	0.7	19.5	5.4	4.3	4.3	0.9	2.6	20.6	13.5	1.8	4.3	3.7	2.3	17.7	12.0	9.6	56.7	17.0	2.7	5.8	2.0	1.5	2.3	0.9	1.7	6.7	1.6	1.6	2.2	13.4	2.7	1.6	1.8	1.8	0.9	4.7	1.4	1.1	1.8	12.0	49.9	20.1	5.9	0.0	0.0	0.5	0.0	0.0	0.0	6.1	30.1	0.0	31.4	24.8	49.7	3.8	6.1	6.3	11.4	4.0	40.0	29.7	8.0	2.8	11.2	9.2	0.0	0.5	17.8	0.3	3.9	2.4	5.4	9.1	11.9	31.2	3.5	8.4	290.2	5.1	0.5	21.5	20.4	12.7	26.5	22.6	36.0	2.0	4.7	1.7	183.1	1.3	2.0	12.9	17.4	7.9	30.1	23.9	7.2	84.3	14.2	4.3	6.2	25.1	12.7	1.5	1.2	52.6	8.8	5.4	0.3	3.9	13.1	1.5	39.5	8.8	28.2	1.5	2.9	4.9	3.1	1.0	25.7	22.0	0.8	3.3
IZUMO1	"IZUMO, MGC34799, OBF"	ENSG00000182264	"Izumo sperm-egg fusion 1"	Q8IYV9	19	48740852-48746909	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Fertilization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"testis: 18.9"	"Group enriched"	"Detected in some"	44	"Early spermatids: 156.4;Late spermatids: 112.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 1.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA038104	Enhanced					NA	NA				"Cluster 83: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"			"HPA038104: AB_10670655"	"unprognostic (2.03e-1)"	"unprognostic (1.86e-3)"	"unprognostic (3.73e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.17e-2)"	"unprognostic (7.92e-2)"	"unprognostic (3.49e-2)"	"unprognostic (2.53e-4)"	"unprognostic (3.61e-2)"	"unprognostic (1.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.83e-2)"	"unprognostic (1.32e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.31e-3)"	"unprognostic (6.92e-2)"	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.3	0.0	0.0	0.0	0.6	0.1	0.4	0.2	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.9	18.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.7	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.3	0.1	0.1	0.2	0.0	0.0	0.1	0.3	0.7	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	156.4	0.3	0.2	2.3	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.9	0.0	0.0	2.9	0.0	0.4	0.0	0.3	0.5	2.0	0.0	1.3	112.7	1.2	0.9	1.8	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.2	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.5	3.0	1.2	0.1	0.0	0.0	0.1	0.2	0.0	0.2
IZUMO1R	"Folbp3, FOLR4, JUNO"	ENSG00000183560	"IZUMO1 receptor, JUNO"	A6ND01	11	94305592-94307721	"Predicted intracellular proteins, Transporters"	Fertilization	Receptor		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA										"unprognostic (5.56e-3)"									"unprognostic (1.37e-1)"	"unprognostic (7.22e-3)"	"unprognostic (8.39e-2)"	"unprognostic (2.92e-3)"	"unprognostic (2.47e-1)"	"unprognostic (5.08e-2)"	"unprognostic (8.61e-2)"		0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.5	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IZUMO2	"C19orf41, MGC33947, SCRL"	ENSG00000161652	"IZUMO family member 2"	Q6UXV1	19	50152548-50163195	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	283	"testis: 64.6"	"Group enriched"	"Detected in some"	41	"Early spermatids: 730.7;Late spermatids: 355.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042143	Uncertain					NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"			"HPA042143: AB_10794078"			"unprognostic (1.21e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.31e-2)"			"unprognostic (1.81e-1)"		"unprognostic (1.94e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.82e-1)"		"unprognostic (1.07e-1)"	"unprognostic (1.63e-1)"	"unprognostic (8.75e-2)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	64.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.3	0.2	0.3	0.8	0.1	0.0	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	730.7	0.1	0.1	0.4	3.6	0.0	1.0	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.4	0.0	0.1	0.0	0.5	1.0	0.0	0.0	0.3	355.2	4.4	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	1.4	3.4	0.0	0.8	0.0	0.1	0.1	0.3	13.1	1.3	0.3	7.0	5.5	0.0	0.4	0.0	0.2	0.0	0.4	1.4
IZUMO3	"bA20A20.1, C9orf134"	ENSG00000205442	"IZUMO family member 3"	Q5VZ72	9	24542952-24545946	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	32	"testis: 13.6"	"Group enriched"	"Detected in some"	35	"Early spermatids: 248.7;Late spermatids: 103.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	28	"SCLC-21H: 2.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 74: Testis - Spermatogenesis"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 23: Spermatids - Flagellum & Golgi organization"																					0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	248.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	103.4	0.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
IZUMO4	C19orf36	ENSG00000099840	"IZUMO family member 4"	Q1ZYL8	19	2096429-2099593	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	21	"testis: 443.1"	"Group enriched"	"Detected in many"	51	"Early spermatids: 1750.8;Late spermatids: 2537.9;Spermatocytes: 824.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 8.5;RPMI-8226: 10.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048496	Enhanced				"Secreted in male reproductive system"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA048496: AB_2680419"	"unprognostic (2.75e-3)"	"unprognostic (1.10e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (7.08e-4)"	"unprognostic (1.40e-1)"	"unprognostic (2.18e-5)"	"unprognostic (2.67e-2)"	"unprognostic (1.02e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.48e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (2.12e-1)"	"unprognostic (6.58e-5)"	"unprognostic (6.38e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.68e-1)"	"unprognostic (7.51e-3)"	2.9	1.9	15.2	1.2	15.3	0.5	3.3	15.1	20.9	2.7	15.1	3.0	0.5	2.6	2.5	2.6	5.1	1.9	3.0	14.6	14.4	4.3	5.4	2.1	1.8	15.1	15.7	6.5	8.6	0.8	10.1	0.4	15.2	7.5	0.8	2.9	2.4	2.4	2.6	2.5	2.0	0.7	14.9	1.6	3.9	443.1	15.6	1.7	4.6	1.2	2.2	2.5	2.3	15.7	0.6	0.5	0.3	2.7	1.1	1.2	0.3	0.4	0.6	0.4	0.0	0.2	0.5	0.4	0.6	0.6	0.0	0.5	0.0	2.9	0.1	1.2	0.2	0.0	1.1	0.8	3.2	0.0	0.4	0.5	1.1	0.7	0.8	0.9	0.0	1.5	0.0	8.5	1.1	0.1	0.8	0.2	0.3	1.1	0.7	0.7	0.0	10.9	1.2	0.3	0.4	0.7	0.4	0.9	0.4	0.2	0.5	1.0	0.0	0.3	0.1	0.1	0.2	0.9	1.1	0.8	1.4	0.9	0.2	0.0	0.7	0.6	0.6	1.1	1.5	2.7	2.1	1.6	0.9	0.7	1.7	0.7	1.6	0.5	1.6	1.2	2.2	0.9	15.2	15.3	15.1	20.9	14.6	14.4	15.1	15.7	15.2	14.9	15.6	15.7	1.0	0.0	0.0	31.0	10.3	2.4	4.1	32.8	4.0	3.4	2.5	2.3	1.5	5.7	19.7	9.2	8.4	0.5	2.6	2.0	5.9	2.5	1750.8	4.6	1.9	1.7	7.7	0.4	1.2	5.8	4.5	3.7	1.1	2.3	0.0	2.2	0.7	9.5	1.0	0.0	1.6	1.9	14.2	3.2	8.2	2537.9	28.6	4.3	12.4	0.0	11.3	6.6	1.0	1.5	28.0	1.8	0.7	19.9	8.2	6.8	1.9	11.1	12.1	8.6	6.6	2.6	2.1	824.6	14.3	6.3	1.7	1.6	5.6	2.4	4.4	7.0
JPH1	JP-1	ENSG00000104369	"Junctophilin 1"	Q9HDC5	8	74234700-74321540	"Human disease related genes, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	13	"skeletal muscle: 237.4;tongue: 106.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Basal prostatic cells: 32.8;Cardiomyocytes: 35.7;Excitatory neurons: 82.2;Inhibitory neurons: 50.3;Prostatic glandular cells: 32.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MOLT-4: 15.1;OE19: 17.7;SK-BR-3: 34.4;T-47d: 24.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA008996, HPA009413, CAB013461"	Enhanced		Enhanced	Nucleoplasm		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"CAB013461: , HPA008996: AB_1852023, HPA009413: AB_1079163"	"unprognostic (2.91e-3)"	"unprognostic (3.01e-1)"	"unprognostic (8.85e-2)"	"unprognostic (8.73e-6)"	"unprognostic (2.07e-1)"	"unprognostic (1.86e-1)"	"unprognostic (3.63e-2)"	"prognostic favorable (5.77e-5)"	"unprognostic (8.97e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.38e-1)"	"unprognostic (5.99e-2)"	"unprognostic (9.80e-2)"	"unprognostic (6.87e-2)"	"unprognostic (3.03e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.08e-2)"	0.3	0.2	2.9	0.5	7.5	0.0	0.7	7.6	5.3	0.7	13.2	3.3	0.7	3.2	0.8	2.8	0.3	0.3	8.4	5.9	1.5	0.8	0.4	3.7	0.1	3.0	1.5	0.1	6.5	0.8	0.5	1.4	2.4	2.8	5.0	0.4	2.8	0.5	237.4	0.6	1.0	1.9	1.9	0.1	0.9	1.0	1.9	3.2	1.4	106.0	1.1	2.3	1.4	3.6	1.1	0.0	0.4	0.0	0.0	0.0	0.1	0.1	1.1	1.1	0.5	0.2	4.4	0.0	1.5	0.0	1.0	6.4	5.6	4.3	1.4	0.0	8.3	0.0	5.2	0.0	0.7	2.9	0.3	0.8	3.7	0.0	4.0	0.0	0.0	10.9	0.8	0.0	0.4	4.1	15.1	0.0	9.7	17.7	2.9	7.6	5.4	0.0	0.2	12.7	7.3	1.0	0.1	34.4	1.8	1.6	24.2	0.2	0.0	1.6	2.3	0.6	1.4	0.0	0.0	0.0	2.7	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.5	7.6	5.3	5.9	1.5	3.0	1.5	2.4	1.9	1.9	3.6	1.1	38.5	12.9	3.9	0.2	2.8	32.8	3.0	6.2	0.4	2.4	1.5	35.7	0.0	10.8	1.8	6.2	0.0	0.1	7.1	0.0	0.3	2.4	2.9	8.9	1.7	12.6	0.0	82.2	1.4	0.0	2.6	7.7	3.7	0.0	0.0	0.0	0.0	0.1	0.0	50.3	9.9	2.0	0.0	0.4	0.5	0.9	0.4	1.8	3.7	0.0	0.4	0.0	14.1	4.6	3.4	6.2	0.0	0.0	32.8	0.0	1.0	6.2	0.1	0.0	25.0	1.4	0.1	4.3	7.4	2.0	0.0	0.2	0.1	6.7	25.6
JPH2	JP-2	ENSG00000149596	"Junctophilin 2"	Q9BR39	20	44106590-44187188	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Transcription, Transcription regulation"	"Developmental protein, DNA-binding, Repressor"	"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 85.2;skeletal muscle: 120.4"	"Cell type enriched"	"Detected in some"	4	"Cardiomyocytes: 64.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 15.3;EFO-21: 15.0;fHDF/TERT166: 19.1;HeLa: 12.6;SiHa: 12.9"	"Low region specificity"	"Detected in some"							HPA052646	Approved					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA052646: AB_2681899"	"unprognostic (1.57e-1)"	"unprognostic (1.82e-2)"	"unprognostic (2.61e-4)"	"unprognostic (4.71e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.45e-3)"	"unprognostic (6.87e-2)"	"unprognostic (9.16e-2)"	"unprognostic (2.57e-2)"	"unprognostic (9.73e-2)"	"unprognostic (4.76e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.10e-2)"	6.0	1.9	0.5	4.5	0.6	0.1	5.7	0.4	0.7	15.1	0.7	63.3	2.1	51.6	2.9	11.9	30.0	3.5	85.2	0.4	0.5	1.4	0.3	5.2	0.2	1.1	1.1	3.9	0.3	0.1	1.2	3.8	0.8	23.8	4.5	0.2	5.8	22.1	120.4	3.8	11.8	27.5	0.9	1.3	16.0	0.8	0.6	0.1	1.5	48.3	0.1	40.5	10.6	0.7	7.5	0.8	0.4	0.0	0.3	0.4	1.5	2.2	4.1	5.4	2.3	15.3	5.9	0.0	15.0	19.1	6.1	10.5	0.0	0.5	2.1	0.0	0.0	0.0	12.6	0.1	0.1	0.3	0.0	0.7	1.1	2.7	3.7	3.3	0.0	0.0	0.0	0.0	7.3	4.3	0.0	0.2	0.3	0.0	0.9	1.7	3.4	0.0	0.4	0.1	0.0	0.1	12.9	3.1	0.1	8.6	10.8	0.1	0.3	2.4	2.7	0.5	4.7	0.1	0.0	0.0	0.2	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	0.7	0.4	0.5	1.1	1.1	0.8	0.9	0.6	0.7	0.2	0.0	0.0	0.3	0.0	6.6	0.5	0.9	0.0	0.0	0.4	5.1	64.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.9	0.0	0.0	0.8	0.0	0.5	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.2	0.2	0.0	6.6	15.9	12.8	0.0	1.5	0.0	2.0	0.5	0.1	0.0	0.2	0.1
JPH3	"CAGL237, HDL2, JP-3, JP3, TNRC22"	ENSG00000154118	"Junctophilin 3"	Q8WXH2	16	87601835-87698156	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 59.1"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 24.4;Cone photoreceptor cells: 22.9;Early spermatids: 41.1;Excitatory neurons: 33.2;Horizontal cells: 50.5;Inhibitory neurons: 28.7;Late spermatids: 14.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.7"	"Group enriched"	"Detected in all"	5	"amygdala: 17.1;basal ganglia: 24.6;cerebral cortex: 59.1;hippocampal formation: 42.7;white matter: 20.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MCF7: 6.5;NTERA-2: 5.7;SH-SY5Y: 7.2;SiHa: 5.0;U-2 OS: 22.5"	"Low region specificity"	"Detected in all"							HPA076304			Approved	Nucleoplasm,Cytosol		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 9: U-2 OS - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm	Cytosol	"HPA076304: AB_2686793"	"unprognostic (8.97e-3)"	"unprognostic (3.17e-2)"	"unprognostic (1.57e-3)"	"unprognostic (4.82e-3)"	"unprognostic (3.43e-1)"	"unprognostic (9.12e-2)"	"unprognostic (1.68e-2)"	"unprognostic (8.10e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.61e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.28e-4)"	"unprognostic (3.01e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.36e-2)"	0.2	1.3	17.1	0.2	24.6	0.0	0.1	1.1	59.1	0.7	0.0	1.1	0.1	0.2	0.0	0.6	0.4	0.0	0.1	42.7	5.6	0.0	0.1	0.1	0.0	6.4	5.8	0.1	0.3	0.0	14.1	0.0	1.1	0.2	0.0	1.8	0.0	0.3	0.0	0.1	0.5	0.0	1.1	0.1	0.5	1.4	1.1	0.0	0.1	0.0	0.0	0.1	0.3	20.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	3.0	0.0	0.9	0.0	1.2	0.0	0.0	0.1	0.9	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	6.5	0.0	0.0	5.7	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	7.2	5.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	22.5	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	24.6	1.1	59.1	42.7	5.6	6.4	5.8	1.1	1.1	1.1	20.6	0.0	0.0	0.0	2.3	0.1	0.0	0.2	0.0	0.0	24.4	0.0	0.0	3.7	0.0	0.0	0.0	22.9	0.0	0.0	0.1	0.0	0.0	41.1	0.0	0.0	0.8	0.0	0.0	33.2	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.2	0.0	0.1	50.5	28.7	0.0	0.0	0.0	0.0	14.4	0.3	0.0	0.0	0.0	0.0	1.3	0.0	10.6	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	9.6	0.0	0.2	0.1	1.1	3.7	0.0	0.0	0.1	0.1	0.5	0.0	0.1
KCNA1	"AEMK, HUK1, Kv1.1, MBK1, RBK1"	ENSG00000111262	"Potassium voltage-gated channel subfamily A member 1"	Q09470	12	4909905-4918256	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 50.1"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 15.1;Excitatory neurons: 39.6;Inhibitory neurons: 18.6;Oligodendrocyte precursor cells: 16.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074471	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA074471: "	"unprognostic (6.39e-3)"	"unprognostic (2.64e-1)"			"unprognostic (1.09e-1)"	"unprognostic (8.44e-2)"		"unprognostic (1.33e-1)"		"unprognostic (1.79e-2)"	"unprognostic (4.69e-3)"	"unprognostic (2.48e-1)"		"unprognostic (8.77e-5)"	"unprognostic (6.30e-2)"	"unprognostic (1.08e-4)"		0.2	0.0	10.6	0.0	22.5	0.0	0.3	27.6	50.1	0.6	3.9	1.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	21.0	7.9	0.0	0.0	0.0	0.0	24.9	10.7	0.0	0.0	0.8	0.9	0.0	25.2	0.0	0.0	1.3	0.5	0.0	0.0	0.0	0.2	0.1	9.5	0.0	1.2	0.0	24.3	1.2	0.6	0.0	0.0	0.3	0.3	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	22.5	27.6	50.1	21.0	7.9	24.9	10.7	25.2	9.5	24.3	28.2	0.1	0.0	0.0	2.0	0.0	0.4	0.0	0.0	0.0	15.1	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	39.6	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	18.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	2.8	0.0	0.2	0.0	16.1	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	0.5	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA2	"HK4, Kv1.2"	ENSG00000177301	"Potassium voltage-gated channel subfamily A member 2"	P16389	1	110519837-110631474	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 81.3"	"Group enriched"	"Detected in some"	4	"Astrocytes: 49.9;Excitatory neurons: 36.7;Inhibitory neurons: 37.1;Muller glia cells: 19.8;Oligodendrocyte precursor cells: 36.2"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2;testis cancer: 1.0"	"Region enhanced"	"Detected in many"		"cerebral cortex: 81.3"	"Immune cell enhanced"	"Detected in single"		"T-reg: 1.3"	"Lineage enriched"	"Detected in single"	8	"T-cells: 1.3"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 4.8;SCLC-21H: 1.4;U-2 OS: 1.2;U-266/70: 1.9;U-266/84: 3.1;WM-115: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB001976	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB001976: "	"unprognostic (1.84e-2)"	"unprognostic (9.70e-3)"	"unprognostic (1.97e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.17e-3)"	"unprognostic (6.68e-3)"		"unprognostic (5.05e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.29e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.08e-3)"	"unprognostic (2.93e-4)"	"unprognostic (2.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.83e-1)"	1.3	0.3	5.0	0.7	7.4	0.0	0.6	11.1	81.3	0.2	0.0	1.6	0.4	0.1	0.3	0.4	0.1	0.3	0.7	4.5	12.5	0.1	0.0	0.1	0.6	28.0	7.5	0.1	0.8	0.0	2.1	0.0	32.0	0.5	0.5	9.6	0.5	0.8	1.0	0.5	0.6	0.4	0.1	0.3	0.7	0.9	27.1	3.0	2.3	2.1	1.5	0.3	0.3	20.7	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.0	1.4	0.0	0.0	0.0	0.7	0.2	0.0	0.0	0.0	0.0	1.2	0.0	0.0	1.9	3.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.5	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	5.0	7.4	11.1	81.3	4.5	12.5	28.0	7.5	32.0	0.1	27.1	20.7	0.1	0.0	0.0	49.9	0.2	0.0	0.0	0.0	0.0	7.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.5	0.2	0.0	0.0	36.7	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	37.1	0.0	0.0	0.0	0.0	1.1	0.0	0.9	0.0	8.4	0.0	19.8	0.0	36.2	6.8	0.0	0.0	5.3	1.6	0.0	0.0	0.0	0.0	4.2	0.0	0.4	1.0	0.0	2.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0
KCNA3	"HLK3, HPCN3, Kv1.3, MK3"	ENSG00000177272	"Potassium voltage-gated channel subfamily A member 3"	P22001	1	110672465-110674940	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 25.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 13.1;Inhibitory neurons: 60.2;Plasma cells: 61.6;T-cells: 20.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"B-cells: 4.9;T-cells: 14.3"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 23.1;Karpas-707: 45.6;U-266/70: 32.6;U-266/84: 31.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016625	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 58: T-cells - T-cell receptor"			"HPA016625: AB_2669407"	"unprognostic (2.17e-2)"	"unprognostic (5.07e-3)"	"unprognostic (3.92e-3)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.76e-5)"	"unprognostic (1.70e-4)"	"unprognostic (8.48e-2)"	"unprognostic (1.49e-2)"	"unprognostic (5.92e-4)"	"unprognostic (1.81e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.13e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.40e-1)"	0.5	0.9	3.4	6.4	2.0	4.6	0.9	1.1	4.9	1.1	0.0	2.4	2.5	0.5	0.0	0.5	0.3	1.3	0.4	5.0	7.2	0.2	0.8	5.9	9.4	1.1	3.3	0.7	0.4	0.4	0.4	0.7	5.0	0.5	1.9	0.6	1.4	0.2	0.1	0.2	2.6	0.6	0.2	6.0	4.3	0.5	3.3	25.4	0.7	0.1	7.6	2.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	0.0	45.6	0.0	0.0	10.0	0.0	0.9	0.0	0.0	0.0	0.0	9.6	0.0	0.0	6.3	0.5	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.7	0.0	0.0	32.6	31.9	11.6	0.0	2.7	0.0	0.0	1.1	0.0	8.9	0.0	10.0	2.8	13.4	14.3	1.4	4.9	10.4	7.9	0.0	1.3	0.1	0.6	13.4	4.4	3.4	2.0	1.1	4.9	5.0	7.2	1.1	3.3	5.0	0.2	3.3	0.0	0.2	0.0	1.9	1.3	11.5	0.4	0.0	0.0	0.0	2.5	0.1	0.0	0.6	0.0	0.0	1.8	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	1.3	13.1	0.0	0.0	0.7	1.5	0.0	0.0	0.0	1.8	0.0	0.4	0.0	60.2	0.0	0.0	1.6	2.4	0.0	0.0	3.1	3.6	2.8	2.4	0.3	3.1	7.5	1.3	0.0	0.0	0.0	61.6	0.0	0.0	0.1	0.0	0.2	6.6	0.0	0.1	4.3	0.9	0.1	0.6	0.0	20.3	0.0	0.0	0.1
KCNA4	"HK1, HPCN2, KCNA4L, Kv1.4"	ENSG00000182255	"Potassium voltage-gated channel subfamily A member 4"	P22459	11	30009730-30017030	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cataract, Disease variant, Dystonia, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adrenal gland: 6.1;brain: 20.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.7;Excitatory neurons: 8.2;Horizontal cells: 13.5;Muller glia cells: 6.4"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 20.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB001977, HPA016422"	Approved					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 62: Horizontal cells - Visual perception"			"CAB001977: , HPA016422: AB_1855574"				"unprognostic (1.12e-2)"	"unprognostic (1.80e-2)"			"unprognostic (1.31e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.00e-1)"	"unprognostic (4.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (1.15e-2)"	"unprognostic (6.71e-2)"	"unprognostic (1.17e-1)"			1.5	6.1	4.7	0.0	20.0	0.0	0.1	0.0	6.5	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	2.2	4.7	4.4	0.2	0.0	0.7	0.0	1.6	1.7	0.0	0.0	0.0	1.3	0.2	1.3	0.0	0.0	1.9	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	6.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	20.0	0.0	6.5	4.7	4.4	1.6	1.7	1.3	0.1	6.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	11.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	8.2	0.0	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	13.5	2.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.4	0.0	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNA5	"HK2, HPCN1, Kv1.5"	ENSG00000130037	"Potassium voltage-gated channel subfamily A member 5"	P22460	12	5043879-5046788	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"choroid plexus: 52.7;heart muscle: 39.8"	"Cell type enriched"	"Detected in some"	4	"Bipolar cells: 143.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.2"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	122	"plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	122	"dendritic cells: 12.2"	"Cell line enriched"	"Detected in single"	13	"NTERA-2: 4.2"	"Low region specificity"	"Detected in many"							"HPA021516, CAB022562"	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 56: Bipolar cells - Visual perception"			"CAB022562: , HPA021516: AB_2670732"	"unprognostic (3.87e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.23e-1)"	"unprognostic (2.64e-1)"	"unprognostic (7.06e-3)"	"unprognostic (1.20e-1)"	"unprognostic (4.61e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.37e-2)"	"unprognostic (5.08e-3)"	"unprognostic (6.73e-4)"	"unprognostic (1.92e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.08e-2)"	2.2	0.5	3.1	0.2	4.6	0.1	1.4	2.2	3.8	0.8	52.7	3.6	0.3	1.5	0.3	4.9	1.8	0.8	39.8	6.0	7.5	1.1	0.2	2.8	0.2	3.7	6.2	2.4	1.3	0.0	7.1	1.9	2.7	0.6	0.5	7.5	0.3	0.9	3.8	0.5	1.2	0.5	4.3	0.5	3.6	0.2	5.4	0.1	1.3	4.8	0.4	3.6	1.1	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	3.1	4.6	2.2	3.8	6.0	7.5	3.7	6.2	2.7	4.3	5.4	4.7	0.7	0.0	0.0	0.3	1.6	0.9	0.0	0.0	0.0	143.1	0.0	0.0	20.9	0.0	0.0	0.0	2.1	0.1	10.7	0.0	0.0	0.0	0.0	0.0	0.1	2.9	3.5	0.0	0.3	0.0	0.0	3.7	0.0	0.0	0.0	4.2	0.0	0.0	0.3	0.0	1.0	0.0	0.0	0.0	1.4	0.0	0.0	0.3	0.0	3.7	0.1	1.9	0.0	1.5	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	4.0	13.1	3.5	29.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1
KCNA6	"HBK2, Kv1.6, PPP1R96"	ENSG00000151079	"Potassium voltage-gated channel subfamily A member 6"	P17658	12	4809176-4813412	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 8.6"	"Group enriched"	"Detected in some"	8	"Astrocytes: 14.0;Excitatory neurons: 27.8;Inhibitory neurons: 53.3;Oligodendrocyte precursor cells: 22.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Daudi: 1.7;JURKAT: 2.4;NTERA-2: 4.9;SuSa: 8.3;U-2 OS: 3.9;U-698: 1.6"	"Low region specificity"	"Detected in many"													NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"																					0.4	1.3	3.8	0.4	3.5	0.0	0.6	0.0	3.0	0.2	0.0	0.3	0.1	0.1	0.0	0.0	0.2	0.1	0.9	3.0	5.4	0.0	0.0	0.1	0.7	2.8	8.6	0.0	0.5	0.0	0.0	0.0	3.6	0.0	0.3	0.7	0.1	0.0	0.0	0.4	0.4	0.6	1.5	0.4	0.2	0.3	3.4	0.1	0.0	0.7	0.5	0.0	0.0	5.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	1.0	0.0	0.0	0.2	0.0	4.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.3	0.0	3.9	0.0	0.0	0.0	0.3	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	3.8	3.5	0.0	3.0	3.0	5.4	2.8	8.6	3.6	1.5	3.4	5.9	0.0	0.0	0.0	14.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNAB1	"AKR6A3, hKvb3, hKvBeta3, KCNA1B, Kvb1.3"	ENSG00000169282	"Potassium voltage-gated channel subfamily A member regulatory beta subunit 1"	Q14722	3	156037701-156539138	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 52.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 85.8;Excitatory neurons: 108.6;Inhibitory neurons: 605.4;Oligodendrocyte precursor cells: 206.6;Oligodendrocytes: 97.5;Sertoli cells: 78.9"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HEL: 3.4;hTEC/SVTERT24-B: 5.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036110, HPA044550"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA036110: , HPA044550: AB_10797032"	"unprognostic (1.52e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.98e-4)"	"unprognostic (1.24e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.51e-2)"	"unprognostic (3.72e-2)"	"unprognostic (5.87e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.00e-1)"	15.8	6.3	12.7	1.2	52.7	1.6	7.3	15.5	17.3	8.4	4.2	4.1	1.7	5.4	12.8	2.2	4.3	2.9	5.5	25.9	11.6	1.8	2.6	3.3	0.9	7.2	12.1	2.9	4.0	2.0	1.8	1.3	7.2	22.4	1.8	12.8	3.9	19.2	2.0	2.2	2.7	2.7	8.4	5.2	1.6	3.1	14.1	1.8	28.7	5.1	0.3	2.9	5.0	15.4	0.5	0.5	0.7	0.2	0.0	0.0	1.4	1.2	0.0	0.0	0.1	0.9	0.1	0.4	0.7	0.0	0.3	0.3	0.0	0.0	0.0	0.4	1.0	3.4	0.6	1.6	0.0	1.0	0.2	0.0	0.0	5.2	0.0	1.1	2.1	0.5	0.1	0.3	0.2	0.1	0.3	0.6	1.1	1.5	0.2	0.6	0.7	2.8	0.0	0.2	0.8	0.8	0.3	0.6	0.7	0.5	0.8	0.5	2.2	0.8	0.5	1.4	1.2	1.8	0.4	0.4	2.6	1.1	1.0	0.8	0.1	0.0	0.4	0.2	0.8	0.2	0.4	0.3	0.2	0.2	0.3	0.3	0.0	0.3	0.3	1.2	0.5	0.1	12.7	52.7	15.5	17.3	25.9	11.6	7.2	12.1	7.2	8.4	14.1	15.4	7.2	0.0	0.0	7.5	0.7	0.8	0.3	0.0	0.0	85.8	1.4	1.4	4.3	0.0	0.7	0.0	31.3	0.1	0.5	0.1	0.0	0.4	13.7	0.6	2.4	2.8	0.0	0.0	108.6	0.0	0.0	3.8	0.0	2.1	0.0	0.4	0.7	0.0	4.6	0.0	605.4	0.0	0.0	11.1	1.0	7.0	0.0	1.2	1.8	24.4	0.0	2.7	0.0	206.6	97.5	0.0	0.0	2.6	2.3	0.2	0.0	0.1	0.0	6.7	78.9	1.3	73.3	0.3	4.2	1.2	0.9	0.1	0.5	0.2	0.0	0.2
KCNB1	Kv2.1	ENSG00000158445	"Potassium voltage-gated channel subfamily B member 1"	Q14721	20	49293394-49484297	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Exocytosis, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"retina: 113.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 115.6;Cone photoreceptor cells: 212.7;Excitatory neurons: 150.6;Inhibitory neurons: 89.9;Rod photoreceptor cells: 386.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3"	"Region enhanced"	"Detected in many"		"cerebral cortex: 17.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 1.4;CACO-2: 2.2;HL-60: 1.1;hTCEpi: 1.2;U-2 OS: 1.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001979, HPA042434"	Enhanced					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 46: Photoreceptor cells - Phototransduction"			"CAB001979: , HPA042434: AB_2677996"	"unprognostic (4.51e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.87e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (8.09e-2)"	"unprognostic (6.22e-2)"	"unprognostic (5.31e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.87e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-3)"	"unprognostic (8.17e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.25e-4)"	10.7	1.5	4.3	0.3	6.6	0.0	2.8	0.0	17.8	1.2	0.0	6.2	0.2	7.3	0.8	1.7	6.0	0.6	1.2	6.6	0.0	0.3	2.4	0.3	0.0	0.0	0.0	0.4	0.3	0.2	2.7	0.1	0.0	2.2	0.6	113.3	1.6	3.1	7.3	0.5	2.0	5.0	0.0	0.3	3.4	0.4	0.0	0.1	0.1	4.4	0.0	3.8	0.9	7.9	0.0	0.0	0.3	0.0	1.4	0.1	0.0	0.0	0.1	0.1	0.0	2.2	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.1	0.0	0.2	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.5	0.1	0.0	0.9	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.0	0.9	0.7	0.6	0.9	0.0	0.0	0.7	0.0	0.0	0.9	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.3	6.6	0.0	17.8	6.6	0.0	0.0	0.0	0.0	0.0	0.0	7.9	20.2	0.0	2.2	7.8	0.5	0.8	0.2	0.0	0.0	115.6	0.9	0.5	3.4	1.5	0.7	0.0	212.7	0.0	0.4	0.0	0.0	0.0	0.7	19.8	2.9	8.0	0.0	0.0	150.6	0.0	0.0	1.4	0.0	4.2	3.8	1.5	0.0	5.7	0.1	18.5	89.9	0.0	0.0	0.0	0.3	0.8	4.4	0.4	0.0	12.2	0.0	38.2	0.0	43.2	3.3	0.1	0.0	34.6	0.1	0.1	0.0	0.2	4.0	386.9	0.0	0.9	7.0	0.2	0.5	0.2	0.3	0.1	0.4	0.2	0.0	0.1
KCNB2	Kv2.2	ENSG00000182674	"Potassium voltage-gated channel subfamily B member 2"	Q92953	8	72537225-72938349	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.6;lymphoid tissue: 2.3;retina: 4.6"	"Group enriched"	"Detected in some"	14	"Cone photoreceptor cells: 264.8;Excitatory neurons: 279.1;Inhibitory neurons: 241.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HaCaT: 1.4;HDLM-2: 1.4;HEK 293: 3.4;SCLC-21H: 2.7"					"Low region specificity"	"Detected in many"			HPA065970			Approved	"Nucleoli,Plasma membrane,Midbody"		Yes	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nucleoli, Midbody"	"HPA065970: AB_2685591"	"unprognostic (9.87e-3)"	"unprognostic (1.71e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.10e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.34e-1)"		"unprognostic (1.44e-2)"		"unprognostic (2.72e-1)"	"unprognostic (6.93e-5)"	"unprognostic (5.53e-3)"	"unprognostic (3.30e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.35e-2)"	"unprognostic (3.26e-1)"		0.1	0.4	1.7	0.0	2.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.4	0.0	0.0	2.4	2.2	0.0	0.0	0.0	0.0	1.0	2.6	0.0	0.5	0.0	1.1	0.0	0.4	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.3	0.0	1.3	2.3	0.4	0.3	1.5	0.8	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.4	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.0	0.0	1.4	2.4	2.2	1.0	2.6	0.4	1.3	1.5	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	1.2	17.4	0.0	0.0	0.3	0.0	0.0	1.8	264.8	0.0	0.0	0.1	0.0	0.0	4.0	0.0	0.0	0.1	17.9	0.0	279.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	241.2	0.6	0.0	0.0	0.0	6.8	1.2	0.0	0.0	3.7	0.0	0.7	0.0	11.6	4.7	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	4.0	0.0	0.1	0.1	0.4	1.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0
KCNC1	Kv3.1	ENSG00000129159	"Potassium voltage-gated channel subfamily C member 1"	P48547	11	17734774-17856804	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 47.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 79.6;Excitatory neurons: 48.2;Inhibitory neurons: 120.2"	"Group enriched"	"Detected in some"	5	"glioma: 1.1;testis cancer: 0.7"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"basophil: 3.2;neutrophil: 1.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 1.6;RH-30: 3.7;SCLC-21H: 3.5;SH-SY5Y: 2.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047634, HPA048249"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 6: Brain - Smell perception"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"HPA047634: AB_2680109, HPA048249: "	"unprognostic (1.79e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.33e-1)"	"unprognostic (4.09e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.40e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.37e-2)"	"unprognostic (2.14e-1)"	"unprognostic (7.04e-5)"	"unprognostic (5.89e-2)"	"unprognostic (7.32e-4)"	"unprognostic (1.29e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.05e-2)"	"unprognostic (7.83e-2)"	0.1	0.8	1.1	0.1	3.3	0.9	0.2	41.0	47.3	0.9	0.0	0.3	0.3	0.3	0.0	0.2	0.1	0.2	0.1	4.5	8.0	0.1	0.2	0.1	0.2	8.8	3.0	0.2	0.4	0.0	2.2	0.0	9.3	0.2	0.0	7.0	0.3	0.0	0.5	0.5	0.3	0.0	1.0	0.2	0.3	1.4	12.3	0.1	0.3	1.2	0.0	0.3	0.5	18.8	0.1	0.0	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.4	0.9	0.0	0.1	0.2	1.1	0.3	1.6	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.7	0.0	0.2	0.2	0.4	0.7	0.0	0.0	0.4	3.7	0.4	0.0	0.2	3.5	2.1	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	1.0	0.1	0.0	0.2	0.3	0.4	0.2	0.2	0.4	3.2	0.3	0.4	0.3	0.2	0.2	0.2	0.3	0.2	0.0	0.5	0.2	0.2	1.4	0.2	0.3	0.3	0.1	0.1	1.1	3.3	41.0	47.3	4.5	8.0	8.8	3.0	9.3	1.0	12.3	18.8	0.2	0.0	0.0	5.5	1.1	0.0	0.2	0.0	0.0	79.6	0.3	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	9.5	0.2	0.5	0.4	7.7	0.0	48.2	0.2	0.0	0.3	0.0	0.3	0.0	2.8	0.0	0.0	0.0	1.7	120.2	0.0	0.0	0.0	0.0	10.2	0.3	0.2	0.0	7.5	0.6	1.5	0.0	16.1	5.6	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	7.7	0.0	0.2	0.5	6.1	5.0	0.0	0.0	0.0	0.6	1.8	0.0	0.0
KCNC3	"Kv3.3, SCA13"	ENSG00000131398	"Potassium voltage-gated channel subfamily C member 3"	Q14003	19	50311937-50333515	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 75.8;thyroid gland: 52.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 20.2;Endometrial ciliated cells: 23.9;Excitatory neurons: 15.6;Glandular and luminal cells: 16.3;Inhibitory neurons: 18.3"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 75.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 7.7;CAPAN-2: 7.2;HDLM-2: 7.0;HMC-1: 20.3;K-562: 7.0;SK-BR-3: 14.0;T-47d: 12.0;U-2 OS: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018041	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA018041: AB_1855579"	"unprognostic (8.05e-2)"	"unprognostic (2.34e-2)"	"unprognostic (3.01e-4)"	"unprognostic (4.41e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.91e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.94e-3)"	"unprognostic (2.10e-5)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (1.68e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-2)"	"unprognostic (1.19e-1)"	0.8	1.3	3.1	2.8	1.9	0.7	3.5	17.3	75.8	6.2	0.0	0.8	0.6	2.8	2.6	1.6	23.2	0.5	2.4	12.5	0.0	17.8	4.4	4.6	2.6	20.0	3.4	0.4	5.7	14.1	21.1	1.2	11.4	4.4	0.5	8.0	3.0	8.1	1.3	2.9	3.3	0.7	3.1	5.7	1.2	3.6	15.0	2.5	52.1	0.1	1.9	2.0	1.5	20.2	0.0	0.5	0.0	1.2	0.0	0.0	3.8	0.1	0.0	0.0	0.0	7.7	7.2	0.7	0.9	0.0	0.5	1.1	0.2	0.0	0.0	7.0	1.7	0.0	0.0	2.0	0.0	0.0	20.3	0.1	0.0	0.0	0.0	0.0	0.1	0.3	7.0	0.0	0.0	2.7	0.1	0.0	0.9	1.1	3.3	0.0	0.1	0.0	0.5	0.3	0.0	1.2	1.7	14.0	0.0	0.1	12.0	2.4	0.2	0.0	8.2	0.0	0.0	0.0	0.1	0.5	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	3.1	1.9	17.3	75.8	12.5	0.0	20.0	3.4	11.4	3.1	15.0	20.2	0.3	0.0	0.5	3.3	2.4	0.8	1.0	0.2	0.0	8.8	4.4	2.5	2.7	1.5	2.4	20.2	8.4	2.3	0.2	0.2	0.0	1.6	0.3	23.9	1.2	0.7	4.2	0.0	15.6	1.4	0.9	0.2	0.5	16.3	0.0	0.1	1.1	2.4	2.8	1.7	18.3	0.1	4.1	7.3	1.9	0.6	0.6	6.3	0.0	3.7	3.2	0.8	0.0	2.0	1.9	0.3	0.1	0.0	0.3	1.3	0.0	3.3	1.1	6.2	0.0	0.1	1.1	1.3	1.2	0.4	0.6	2.3	0.4	0.0	0.1	0.9
KCND1	Kv4.1	ENSG00000102057	"Potassium voltage-gated channel subfamily D member 1"	Q9NSA2	X	48961378-48971844	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 3.5;Peritubular cells: 3.8;Rod photoreceptor cells: 3.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HSkMC: 10.6;NB-4: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000524, HPA001066"	Supported		Uncertain	Nucleoplasm		Yes	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 21: Non-specific - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA000524: AB_2666013, HPA001066: AB_1079662"	"unprognostic (6.00e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.01e-4)"	"unprognostic (2.19e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.79e-2)"	"unprognostic (2.79e-1)"	"unprognostic (8.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (2.41e-3)"	"prognostic favorable (2.66e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.30e-11)"	"unprognostic (3.13e-2)"	"unprognostic (3.49e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.22e-3)"	3.8	0.9	2.8	1.5	2.8	2.7	1.8	5.5	2.7	2.7	0.1	2.0	0.8	3.6	1.4	1.1	5.4	2.4	2.3	2.9	3.0	1.7	1.4	2.6	1.3	3.6	2.9	2.7	1.1	0.4	2.3	1.0	3.9	2.3	0.8	6.1	0.9	2.1	0.5	1.3	2.2	2.5	3.3	3.3	1.8	1.5	3.2	0.7	1.8	0.4	1.4	2.3	2.3	3.8	0.3	1.6	0.7	3.9	5.1	4.1	1.3	0.8	3.3	2.3	1.5	1.1	0.5	1.3	2.8	2.6	0.6	0.5	0.6	0.3	2.2	2.3	2.7	1.2	1.8	0.1	1.9	0.3	2.5	10.6	1.4	4.2	0.4	3.7	0.8	1.9	0.9	3.0	1.7	3.1	0.4	9.2	2.1	0.2	0.6	1.1	0.7	1.3	2.6	1.3	0.4	1.8	0.7	0.0	1.8	7.9	1.7	1.3	2.0	0.5	2.1	0.5	0.2	2.5	3.5	3.2	1.4	3.2	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	2.8	2.8	5.5	2.7	2.9	3.0	3.6	2.9	3.9	3.3	3.2	3.8	0.9	0.0	1.1	1.0	0.4	0.8	0.0	0.4	0.0	0.2	0.3	0.3	0.8	0.0	0.2	1.8	0.0	0.1	0.4	0.3	1.9	0.2	0.1	0.2	1.0	0.6	3.5	0.0	0.7	0.0	0.1	1.2	0.5	0.5	0.0	1.7	1.1	0.0	0.1	0.0	1.1	0.3	0.0	0.6	0.0	0.2	1.8	0.4	0.0	1.0	0.1	0.4	0.0	2.0	0.1	0.1	0.0	3.8	0.1	0.2	0.2	0.1	0.3	3.0	0.0	0.1	0.6	0.6	0.0	0.1	0.0	0.1	0.2	0.1	0.2	0.2
KCND2	"KIAA1044, Kv4.2, RK5"	ENSG00000184408	"Potassium voltage-gated channel subfamily D member 2"	Q9NZV8	7	120273175-120750337	"Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	11	"brain: 47.3"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 690.0;Inhibitory neurons: 1068.2;Oligodendrocyte precursor cells: 1952.8"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 4.8;HSkMC: 2.9;NTERA-2: 2.4;RT4: 2.7;SCLC-21H: 13.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029068	Enhanced					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA029068: AB_10601436"	"unprognostic (4.22e-1)"	"unprognostic (2.79e-4)"	"unprognostic (3.79e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.91e-2)"	"unprognostic (4.98e-3)"	"unprognostic (9.07e-3)"	"unprognostic (1.03e-1)"	"unprognostic (1.14e-1)"	"unprognostic (9.77e-3)"	"unprognostic (1.51e-1)"	"unprognostic (4.51e-4)"	"unprognostic (4.07e-5)"	"unprognostic (2.71e-2)"	"unprognostic (2.92e-2)"	"unprognostic (1.83e-3)"	1.7	0.5	8.1	0.5	10.5	0.0	1.0	47.3	8.6	1.1	0.0	0.3	0.3	3.2	0.1	0.1	1.2	4.2	0.2	5.5	10.1	0.0	0.1	0.2	0.1	29.3	15.4	3.3	0.2	0.7	1.9	0.4	26.8	0.2	0.2	1.0	0.3	0.9	0.2	0.1	0.1	2.0	4.9	0.0	0.2	1.7	19.2	0.3	0.4	2.8	0.0	1.1	0.5	2.5	0.0	0.0	0.2	0.0	1.3	4.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.5	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.0	2.4	0.0	0.2	0.0	0.0	0.0	0.0	2.7	13.2	0.0	0.0	0.0	0.0	0.1	0.2	0.7	0.0	0.4	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	10.5	47.3	8.6	5.5	10.1	29.3	15.4	26.8	4.9	19.2	2.5	0.6	0.0	0.0	108.7	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	1.2	4.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.1	2.7	1.0	1.9	0.3	0.0	2.7	690.0	0.2	0.0	6.0	0.0	0.8	0.0	6.6	0.7	0.0	0.0	0.0	1068.2	0.0	2.0	0.0	0.0	1.7	3.7	0.1	0.0	40.3	0.0	0.0	0.0	1952.8	9.7	0.3	0.0	0.4	0.1	0.0	0.0	0.0	0.3	0.5	0.0	10.9	3.0	5.0	3.4	0.0	0.1	0.0	0.0	4.3	0.0	0.1
KCND3	"KSHIVB, Kv4.3, SCA19, SCA22"	ENSG00000171385	"Potassium voltage-gated channel subfamily D member 3"	Q9UK17	1	111770662-111989668	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Brugada syndrome, Disease variant, FDA approved drug targets, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 35.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 46.8;Cardiomyocytes: 38.1;Excitatory neurons: 105.7;Hepatocytes: 37.8;Inhibitory neurons: 88.4;Oligodendrocyte precursor cells: 45.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 8.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 4.8;SCLC-21H: 10.1;U-2 OS: 1.6;WM-115: 2.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029452	Approved					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA029452: AB_10602239"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.42e-1)"	"unprognostic (1.41e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.15e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.44e-2)"	"unprognostic (3.64e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.51e-3)"	"unprognostic (6.64e-3)"	4.5	1.5	17.0	4.7	13.8	0.2	3.0	18.1	17.9	2.3	0.0	5.9	0.9	5.3	12.6	4.1	5.1	5.5	8.4	16.2	6.4	1.3	15.4	1.7	0.5	1.0	35.6	0.5	4.5	3.9	3.4	0.5	3.4	11.3	2.4	12.7	1.6	12.0	2.6	7.1	2.2	9.8	0.9	3.2	3.3	2.0	9.2	0.3	1.1	1.7	0.5	5.9	3.2	10.8	0.0	0.0	0.2	0.0	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	1.0	0.4	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.2	4.8	0.0	0.0	0.0	0.0	0.0	0.2	10.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.0	13.8	18.1	17.9	16.2	6.4	1.0	35.6	3.4	0.9	9.2	10.8	1.1	0.0	9.3	18.3	0.3	7.5	11.9	2.9	0.0	46.8	7.8	1.5	38.1	0.0	1.5	0.0	4.2	0.1	0.4	1.5	0.0	0.8	35.7	0.5	14.5	1.6	0.0	2.7	105.7	23.8	0.2	3.7	0.0	0.7	0.0	0.0	1.8	37.8	0.2	30.3	88.4	0.4	4.1	0.8	1.9	32.3	18.0	0.5	3.6	1.0	0.0	6.2	0.0	45.8	8.7	4.8	1.2	1.9	0.0	21.9	0.1	0.3	0.1	4.8	0.0	0.8	1.7	1.5	1.0	2.0	6.7	0.0	0.5	0.1	2.4	13.4
KCNE5	KCNE1L	ENSG00000176076	"Potassium voltage-gated channel subfamily E regulatory subunit 5"	Q9UJ90	X	109623700-109625172	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Alport syndrome, Deafness, Elliptocytosis, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 9.8;skeletal muscle: 4.0;tongue: 4.9"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 4.6;Erythroid cells: 3.8;monocytes: 9.4;Muller glia cells: 5.3;Peritubular cells: 3.8"	"Group enriched"	"Detected in some"	8	"glioma: 7.9;testis cancer: 2.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"myeloid DC: 2.2"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;hTEC/SVTERT24-B: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042316			Uncertain	Cytosol		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"HPA042316: AB_10795397"	"unprognostic (5.33e-2)"	"unprognostic (2.28e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.14e-3)"	"unprognostic (3.27e-2)"	"unprognostic (9.46e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.62e-3)"	"unprognostic (7.83e-2)"	"unprognostic (5.64e-6)"	"unprognostic (5.10e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.37e-3)"	1.1	0.8	3.2	0.1	5.4	1.6	0.5	9.4	2.7	0.2	0.7	0.1	0.0	0.0	0.1	0.1	0.0	0.4	0.7	2.7	6.6	0.7	0.2	0.4	0.0	6.3	9.8	0.5	0.1	0.0	0.3	0.2	6.9	0.3	0.0	0.2	0.2	0.3	4.0	0.1	0.1	0.1	4.0	0.9	0.1	0.3	7.8	2.3	0.1	4.9	0.0	0.3	0.2	4.6	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.7	0.1	0.2	0.2	0.0	0.1	0.1	0.0	0.1	0.3	0.3	0.0	0.8	0.3	0.0	0.1	1.0	1.1	0.7	0.0	0.0	1.5	0.2	0.5	2.0	0.5	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.0	0.4	0.5	0.0	0.9	0.4	0.7	0.3	0.3	0.9	0.2	0.2	0.1	0.4	0.4	0.1	0.0	0.3	0.0	0.3	0.8	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	3.2	5.4	9.4	2.7	2.7	6.6	6.3	9.8	6.9	4.0	7.8	4.6	0.1	0.0	1.1	4.6	0.1	0.0	0.0	0.0	1.2	0.0	0.3	1.1	0.6	0.0	0.0	0.0	0.0	0.4	2.2	0.0	0.0	0.3	0.0	0.5	0.1	0.2	0.0	3.8	0.1	0.4	1.2	1.4	0.0	0.5	1.3	0.7	1.1	0.0	0.6	0.0	0.1	0.0	0.0	2.0	0.0	0.0	1.2	2.1	0.0	1.0	9.4	5.3	0.0	0.0	0.0	0.3	0.0	3.8	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.2	0.4	0.0	0.0	0.1	0.0	0.8	0.2	0.1	0.0	0.1
KCNF1	"IK8, KCNF, kH1, Kv5.1"	ENSG00000162975	"Potassium voltage-gated channel modifier subfamily F member 1"	Q9H3M0	2	10911934-10914225	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 28.9;choroid plexus: 32.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9.3;Extravillous trophoblasts: 14.4;Inhibitory neurons: 8.8;Oligodendrocyte precursor cells: 18.1;Syncytiotrophoblasts: 7.7"	"Cancer enriched"	"Detected in many"	7	"glioma: 27.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 14.3;MCF7: 5.1;T-47d: 6.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014738, HPA062278"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	"Nucleoplasm, Vesicles"	"HPA014738: AB_1852114, HPA062278: AB_2732679"	"unprognostic (2.54e-1)"	"unprognostic (6.06e-3)"	"unprognostic (1.37e-1)"	"unprognostic (3.07e-2)"	"unprognostic (4.39e-2)"	"unprognostic (7.41e-4)"	"unprognostic (1.54e-3)"	"unprognostic (4.83e-5)"	"unprognostic (1.57e-1)"	"unprognostic (6.95e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.96e-1)"	"unprognostic (3.10e-4)"	"unprognostic (2.37e-1)"	"unprognostic (4.28e-2)"	"unprognostic (4.08e-2)"	0.1	0.0	20.6	0.1	28.9	0.0	0.2	0.0	21.5	0.0	32.1	1.2	0.2	0.6	0.0	0.2	0.1	0.1	0.7	28.8	14.7	0.4	0.0	0.3	0.1	0.0	5.3	0.0	0.9	0.3	0.8	0.0	0.0	0.7	0.2	0.2	0.1	0.3	0.0	0.0	0.6	0.0	0.6	0.5	0.3	0.5	12.5	0.3	0.0	0.0	0.0	0.6	0.0	15.8	0.1	14.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	5.1	0.0	0.0	2.1	0.1	1.5	0.0	0.1	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.1	6.1	0.7	0.0	0.0	1.6	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	28.9	0.0	21.5	28.8	14.7	0.0	5.3	0.0	0.6	12.5	15.8	0.0	0.0	0.0	1.3	0.1	0.0	0.0	0.2	0.0	2.0	0.8	1.4	1.4	0.0	0.0	0.0	2.1	0.0	0.1	1.6	0.0	0.0	2.2	0.8	0.3	0.9	1.2	0.0	9.3	0.0	14.4	0.7	0.0	2.0	0.0	0.2	0.0	0.0	0.2	0.0	8.8	0.2	0.0	0.0	0.0	3.4	0.3	0.1	0.0	1.9	0.0	0.3	0.0	18.1	1.4	0.1	0.2	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	7.7	0.0	0.4	0.3	0.1
KCNG1	"K13, KCNG, kH2, Kv6.1"	ENSG00000026559	"Potassium voltage-gated channel modifier subfamily G member 1"	Q9UIX4	20	51003656-51023107	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 46.8;endometrium 1: 87.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 53.7;Granulosa cells: 34.0;Syncytiotrophoblasts: 97.0"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 8.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	20	"naive B-cell: 7.1"	"Lineage enriched"	"Detected in single"	71	"B-cells: 7.1"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 53.5;U-138 MG: 40.4;WM-115: 34.6"	"Group enriched"	"Detected in many"	5	"amygdala: 20.6;basal ganglia: 19.1;cerebral cortex: 14.9;hippocampal formation: 18.1;white matter: 9.1"	"Group enriched"	"Detected in all"	5	"amygdala: 12.6;basal ganglia: 11.1;cerebral cortex: 22.4;hippocampal formation: 16.8"	"HPA039530, HPA040024"	Approved		Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA039530: AB_10795144, HPA040024: AB_10796338"	"unprognostic (1.19e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.70e-2)"	"unprognostic (3.49e-2)"	"unprognostic (4.07e-2)"	"unprognostic (5.05e-4)"	"unprognostic (2.53e-2)"	"unprognostic (3.89e-3)"	"unprognostic (3.64e-2)"	"unprognostic (3.43e-2)"	"unprognostic (8.74e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.83e-9)"	"unprognostic (1.52e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-2)"	0.4	3.0	17.3	2.2	26.7	0.0	0.4	0.0	21.7	17.9	0.1	5.0	0.2	87.4	0.8	6.7	19.2	0.9	1.3	14.9	0.6	0.5	0.2	0.3	2.2	28.9	46.8	0.7	2.7	4.1	0.8	7.1	3.2	5.6	0.8	0.1	2.2	12.8	0.0	0.5	5.3	4.1	1.0	2.7	0.7	9.5	1.2	0.2	0.2	0.0	0.9	3.4	6.2	1.1	0.9	3.6	2.7	13.3	1.5	3.4	0.2	11.6	0.1	6.7	5.3	0.2	0.2	0.0	7.1	3.5	18.8	3.4	1.7	3.5	6.9	0.4	4.7	0.0	13.6	0.0	23.2	0.0	0.4	6.8	53.5	25.7	26.1	1.3	1.8	0.1	0.2	0.0	0.6	13.4	0.0	0.4	13.7	0.0	25.0	0.0	0.0	0.0	0.0	4.1	3.9	15.0	25.5	29.3	19.9	4.3	2.1	1.9	0.7	40.4	23.9	0.3	3.4	0.1	0.0	0.0	11.8	1.0	34.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	17.3	26.7	0.0	21.7	14.9	0.6	28.9	46.8	3.2	1.0	1.2	1.1	0.2	3.2	1.1	0.3	10.5	1.1	11.0	0.6	13.6	0.3	1.1	2.3	1.1	7.2	0.9	0.0	0.0	53.7	0.0	7.5	0.0	2.6	18.2	9.3	2.0	1.2	0.0	0.0	2.0	0.0	2.7	1.5	0.5	15.9	0.0	34.0	0.4	0.3	3.3	1.7	2.2	0.6	0.0	0.0	0.3	20.3	1.5	0.3	0.0	1.0	0.0	0.2	1.0	0.0	0.6	0.2	3.4	4.1	0.0	18.1	12.8	0.1	0.9	0.2	0.0	1.1	7.1	12.7	0.7	5.4	0.3	97.0	0.4	0.3	0.4	9.9
KCNG4	Kv6.4	ENSG00000168418	"Potassium voltage-gated channel modifier subfamily G member 4"	Q8TDN1	16	84218667-84239750	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 3.4;retina: 4.3"	"Cell type enriched"	"Detected in some"	14	"Bipolar cells: 56.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	4	"cerebellum: 90.5;pons and medulla: 27.0"	"Low region specificity"	"Detected in many"			HPA063516			Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"	Nucleoplasm	"HPA063516: "					"unprognostic (3.54e-1)"									"unprognostic (6.67e-2)"				0.1	0.4	0.6	0.0	1.0	0.3	0.0	3.3	0.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.1	3.4	1.5	0.1	0.0	0.0	0.0	0.0	2.4	0.0	0.0	4.3	0.0	0.0	0.1	0.3	0.0	0.0	1.3	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.2	0.0	0.1	0.0	0.0	0.6	1.0	3.3	0.4	0.5	0.7	3.4	1.5	2.4	1.3	0.8	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	56.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	4.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1
KCNH1	"eag, eag1, h-eag, hEAG, Kv10.1"	ENSG00000143473	"Potassium voltage-gated channel subfamily H member 1"	O95259	1	210676823-211134165	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 533.5;Inhibitory neurons: 261.0;Oligodendrocytes: 116.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 6.2;RH-30: 10.1;RPTEC TERT1: 6.0;SH-SY5Y: 12.9;SK-MEL-30: 12.9;T-47d: 9.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basal ganglia: 34.0;cerebellum: 19.1;cerebral cortex: 23.9;hippocampal formation: 17.9;olfactory bulb: 8.9"	"HPA014551, HPA019445, HPA076421"	Enhanced		Supported	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA014551: AB_2669038, HPA019445: AB_1852118, HPA076421: "	"unprognostic (9.12e-2)"	"unprognostic (4.82e-3)"	"unprognostic (2.63e-1)"	"unprognostic (6.70e-2)"	"unprognostic (3.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.73e-1)"	"unprognostic (9.36e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.17e-1)"	"unprognostic (8.89e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.70e-2)"	0.2	0.9	6.8	0.4	9.2	0.0	0.2	9.5	17.9	0.7	2.7	0.5	0.3	0.4	0.2	0.1	0.6	0.2	0.0	11.2	5.3	0.1	0.1	0.0	0.0	4.8	4.4	0.1	0.2	0.0	0.7	0.3	4.0	0.5	0.3	0.3	0.1	0.1	0.2	0.1	0.8	0.2	4.0	0.0	0.5	1.5	4.9	0.2	0.1	0.6	0.0	0.2	0.4	8.3	0.0	2.1	0.4	0.1	0.0	0.1	0.1	1.0	0.2	2.1	2.4	0.0	0.0	0.0	0.0	1.4	2.4	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.5	0.0	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.2	0.0	0.0	0.0	10.1	0.0	6.0	0.0	0.4	12.9	2.4	0.2	12.9	1.7	9.2	0.0	0.0	1.6	0.2	2.0	1.2	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.8	9.2	9.5	17.9	11.2	5.3	4.8	4.4	4.0	4.0	4.9	8.3	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	11.2	0.2	2.8	0.1	0.0	0.0	533.5	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	261.0	0.0	0.0	0.0	0.0	18.6	0.0	0.0	0.0	7.5	0.0	0.0	0.0	19.1	116.6	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNH2	"erg1, HERG, Kv11.1, LQT2"	ENSG00000055118	"Potassium voltage-gated channel subfamily H member 2"	Q12809	7	150944961-150978321	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 42.3;pituitary gland: 43.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 217.3;Cardiomyocytes: 83.2;Erythroid cells: 76.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"K-562: 197.7;NB-4: 97.8;SH-SY5Y: 78.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"				"unprognostic (2.22e-1)"	"unprognostic (1.75e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (6.06e-5)"	"unprognostic (9.79e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.84e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.52e-1)"	"prognostic favorable (5.61e-4)"	"unprognostic (6.08e-2)"	"unprognostic (2.26e-2)"	"unprognostic (4.90e-2)"	"unprognostic (2.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (3.02e-2)"	0.8	3.7	9.8	2.6	8.0	42.3	0.1	13.5	9.0	4.4	4.4	36.1	2.7	16.9	1.7	1.5	7.3	3.2	29.6	5.6	14.8	1.1	0.2	2.0	0.3	23.5	14.7	3.2	3.4	18.1	43.3	1.4	23.0	9.8	1.0	6.7	1.1	8.0	0.2	0.3	8.3	7.8	6.3	1.8	10.9	30.8	17.1	0.4	0.2	0.0	0.1	12.9	2.7	4.1	0.0	0.3	0.9	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	8.0	2.9	0.0	0.2	0.0	3.1	0.0	0.0	0.8	0.4	18.3	0.0	0.0	0.2	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	4.4	197.7	0.0	0.0	0.9	1.6	97.8	1.3	0.2	0.0	0.1	0.1	10.1	0.0	0.0	3.8	78.2	0.0	0.1	0.0	1.1	0.0	1.8	0.6	0.0	1.5	0.0	0.0	5.3	0.2	2.1	0.0	11.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.8	8.0	13.5	9.0	5.6	14.8	23.5	14.7	23.0	6.3	17.1	4.1	0.0	0.0	0.0	1.6	1.6	0.0	0.2	0.1	0.0	217.3	0.4	0.3	83.2	0.0	0.0	0.0	4.2	0.2	0.0	0.0	0.0	2.1	2.0	0.5	0.8	0.9	16.3	76.4	5.2	0.2	0.9	5.0	0.5	0.1	26.1	6.3	1.4	0.1	0.3	16.8	13.9	0.7	12.2	0.0	0.3	4.8	2.5	0.0	0.0	2.8	0.0	4.5	0.0	5.5	1.7	0.3	0.0	13.2	1.4	0.1	0.2	0.1	0.4	10.3	0.0	1.7	2.6	2.5	5.1	0.0	0.0	0.3	0.9	0.7	0.3	0.4
KCNH3	"BEC1, elk2, Kv12.2"	ENSG00000135519	"Potassium voltage-gated channel subfamily H member 3"	Q9ULD8	12	49539030-49558337	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 39.4;pituitary gland: 25.7"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 11.4;Excitatory neurons: 58.2;Inhibitory neurons: 19.2;Late spermatids: 10.6;Respiratory ciliated cells: 10.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 9.8"	"Group enriched"	"Detected in many"	21	"amygdala: 29.6;basal ganglia: 25.6;cerebral cortex: 39.4;hippocampal formation: 30.6;white matter: 24.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 5.8;AN3-CA: 3.5;HMC-1: 3.4;RPTEC TERT1: 9.1;U-2 OS: 8.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA051088			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Mitochondria"		"HPA051088: AB_2681340"	"unprognostic (5.69e-3)"	"unprognostic (1.36e-1)"	"unprognostic (8.87e-4)"	"unprognostic (8.24e-3)"	"unprognostic (7.54e-2)"	"unprognostic (2.38e-2)"	"unprognostic (3.63e-2)"	"unprognostic (2.66e-1)"	"unprognostic (9.91e-3)"	"unprognostic (5.28e-2)"	"unprognostic (6.39e-5)"	"unprognostic (1.68e-1)"	"unprognostic (1.07e-4)"	"unprognostic (5.52e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.86e-1)"	0.3	2.9	29.6	0.0	25.6	0.2	0.6	0.0	39.4	0.8	0.0	0.2	0.1	0.6	0.1	0.1	5.8	0.3	0.8	30.6	1.3	3.4	0.3	1.0	0.5	0.0	0.2	0.3	1.3	2.6	25.7	0.0	0.6	0.7	0.0	0.0	0.3	0.3	0.1	0.3	0.3	0.0	0.0	1.4	0.3	2.8	1.4	0.2	1.3	0.0	0.2	0.1	0.3	24.8	0.4	5.8	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.4	0.0	0.2	1.7	0.6	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	9.1	0.0	0.9	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	29.6	25.6	0.0	39.4	30.6	1.3	0.0	0.2	0.6	0.0	1.4	24.8	0.1	0.0	0.5	4.9	0.0	0.1	0.2	0.5	0.0	0.1	0.1	2.0	1.0	5.7	0.2	0.0	0.0	0.0	0.4	0.1	0.0	0.2	6.0	11.4	0.4	0.1	2.4	0.0	58.2	0.0	0.1	0.6	0.0	0.5	0.0	2.4	0.7	0.0	0.0	1.7	19.2	0.0	0.0	0.6	0.5	10.6	0.3	0.6	0.0	1.0	0.7	0.4	2.1	6.0	2.6	0.1	0.1	1.2	0.1	0.0	0.0	0.2	10.9	0.3	0.0	0.4	0.3	1.1	3.4	0.0	0.3	0.0	0.7	0.0	0.2	0.0
KCNH5	"eag2, H-EAG2, hEAG2, Kv10.2"	ENSG00000140015	"Potassium voltage-gated channel subfamily H member 5"	Q8NCM2	14	62699464-63102037	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 8.5;retina: 4.5"	"Group enriched"	"Detected in some"	16	"Bipolar cells: 62.2;Excitatory neurons: 185.0;Inhibitory neurons: 74.4;Oligodendrocyte precursor cells: 65.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HeLa: 7.2;RT4: 10.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030487, HPA072351"	Uncertain		Approved	Nucleoplasm,Centrosome,Cytosol		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 15: RT4 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome	"Nucleoplasm, Cytosol"	"HPA030487: AB_10609995, HPA072351: "		"unprognostic (1.16e-1)"		"unprognostic (7.23e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.23e-2)"		"unprognostic (2.70e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.76e-2)"	"unprognostic (8.45e-2)"		"unprognostic (2.66e-1)"	"unprognostic (1.70e-3)"		"unprognostic (3.11e-1)"	0.2	1.0	2.4	0.0	2.1	0.0	0.0	0.0	5.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	1.8	0.0	0.0	0.0	0.0	2.9	3.3	0.0	0.0	0.0	0.3	0.2	3.0	0.1	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.3	8.5	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.6	0.8	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	1.3	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	2.1	0.0	5.9	4.5	1.8	2.9	3.3	3.0	0.8	8.5	1.2	0.1	0.0	0.0	2.3	0.0	0.0	0.1	0.0	0.0	62.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	5.8	0.1	0.2	0.2	0.0	0.0	185.0	0.0	1.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	74.4	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	2.8	0.0	0.5	0.0	65.9	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	4.6	0.0	0.0	0.1	1.6	1.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0
KCNIP1	KCHIP1	ENSG00000182132	"Potassium voltage-gated channel interacting protein 1"	Q9NZI2	5	170353487-170736632	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7;choroid plexus: 15.1;epididymis: 21.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 57.8;Horizontal cells: 50.5;Inhibitory neurons: 221.4;Microglial cells: 167.7;Oligodendrocyte precursor cells: 196.1"	"Cancer enriched"	"Detected in some"	18	"glioma: 22.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	24	"RPTEC TERT1: 58.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022864, HPA066717"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA022864: AB_1858712, HPA066717: "	"unprognostic (7.75e-5)"	"unprognostic (2.66e-2)"	"unprognostic (6.78e-2)"	"unprognostic (3.22e-4)"	"unprognostic (4.51e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.69e-1)"	"unprognostic (5.46e-2)"	"unprognostic (6.62e-3)"	"unprognostic (4.74e-2)"	"unprognostic (7.52e-2)"	"unprognostic (2.55e-1)"	"unprognostic (2.58e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.05e-2)"	0.5	4.2	23.5	0.5	26.5	0.0	1.0	19.4	28.3	2.7	15.1	0.7	0.2	1.6	21.6	0.3	1.7	1.8	0.4	21.8	32.6	3.8	0.1	1.0	0.5	24.3	26.6	0.3	1.4	1.3	1.0	1.2	24.7	1.5	0.5	5.8	0.4	5.6	0.1	0.4	0.3	1.1	28.7	1.5	0.4	2.7	32.7	0.1	0.7	0.2	0.4	0.5	0.6	19.6	0.0	0.0	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	58.7	0.0	0.6	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.5	26.5	19.4	28.3	21.8	32.6	24.3	26.6	24.7	28.7	32.7	19.6	0.0	0.0	0.0	57.8	0.0	0.4	0.1	0.0	0.0	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	2.0	1.2	0.0	0.0	18.6	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	50.5	221.4	0.0	0.0	0.0	0.6	0.7	5.0	0.1	0.0	167.7	0.0	0.2	0.0	196.1	2.8	0.0	0.0	11.7	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1
KCNIP2	KCHIP2	ENSG00000120049	"Potassium voltage-gated channel interacting protein 2"	Q9NS61	10	101825974-101843920	"Predicted intracellular proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 227.4;brain: 139.6;heart muscle: 307.5"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 54.3;Cardiomyocytes: 135.7;Cone photoreceptor cells: 25.0;Excitatory neurons: 23.3;Horizontal cells: 48.8;Inhibitory neurons: 41.9"	"Cancer enhanced"	"Detected in many"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive B-cell: 1.5"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HEL: 21.3;HMC-1: 12.7"	"Group enriched"	"Detected in all"	4	"amygdala: 96.8;basal ganglia: 234.9;cerebral cortex: 106.9;hippocampal formation: 142.6;olfactory bulb: 144.0"	"Low region specificity"	"Detected in all"			HPA066717			Approved	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles		"HPA066717: "	"unprognostic (5.92e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.48e-3)"	"unprognostic (5.77e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.31e-3)"	"unprognostic (8.80e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.14e-1)"	"unprognostic (5.34e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.20e-2)"	"unprognostic (1.49e-9)"	"unprognostic (9.85e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.27e-1)"	"unprognostic (8.37e-4)"	227.4	6.8	74.5	3.5	139.6	0.9	67.1	48.8	84.5	7.4	40.5	5.0	1.8	4.1	4.1	2.5	4.9	3.1	307.5	98.8	50.6	2.8	2.3	2.5	8.1	47.5	51.6	11.5	2.4	1.7	19.7	2.9	48.1	5.2	4.7	52.6	9.9	3.5	8.0	5.9	5.3	2.6	50.3	5.7	2.7	8.5	57.1	2.3	3.5	5.4	8.3	4.8	4.4	60.8	1.7	2.6	2.5	3.2	1.0	1.1	0.6	1.2	1.0	0.6	0.9	3.6	3.4	1.6	0.9	0.8	0.7	1.7	0.9	0.4	0.6	2.4	2.0	21.3	3.0	1.9	0.9	1.4	12.7	2.6	1.7	1.0	1.4	3.7	1.0	4.7	6.3	1.8	1.0	1.2	0.8	4.0	0.8	0.7	0.6	1.0	0.2	1.4	1.0	1.1	7.4	1.2	0.8	0.6	2.4	1.5	2.2	0.9	2.3	1.3	2.0	0.6	1.2	1.7	1.9	1.7	1.4	5.3	0.2	0.0	0.0	0.7	0.0	0.5	0.1	0.9	0.1	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	74.5	139.6	48.8	84.5	98.8	50.6	47.5	51.6	48.1	50.3	57.1	60.8	0.4	0.0	0.0	8.5	2.3	0.4	0.1	0.3	0.0	54.3	0.3	0.5	135.7	0.0	0.1	1.8	25.0	0.2	0.0	0.8	0.0	0.2	6.6	0.0	0.2	1.6	0.0	0.0	23.3	0.0	0.2	5.8	0.0	0.0	0.0	0.8	0.4	0.1	2.2	48.8	41.9	0.4	0.0	0.6	0.8	5.2	1.8	0.3	0.0	1.0	0.5	8.3	0.0	5.5	3.7	0.3	0.2	0.7	0.3	0.1	0.5	0.1	0.2	4.7	0.0	0.1	1.3	2.5	5.5	0.5	0.0	0.3	0.1	0.5	0.3	0.1
KCNIP3	"CSEN, DREAM, KCHIP3"	ENSG00000115041	"Potassium voltage-gated channel interacting protein 3"	Q9Y2W7	2	95297327-95386077	"Predicted intracellular proteins, Transporters"	"Apoptosis, Ion transport, Potassium transport, Transcription, Transcription regulation, Transport"	"Ion channel, Potassium channel, Repressor, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 39.0;Leydig cells: 25.4;Oligodendrocyte precursor cells: 54.8;Peritubular cells: 42.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 13.8;BJ hTERT+: 18.0;hTERT-RPE1: 23.2;RPTEC TERT1: 35.2;U-138 MG: 16.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066717, HPA069797"	Enhanced		Approved	Vesicles	"Intracellular and membrane"	NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA066717: , HPA069797: AB_2686199"	"unprognostic (1.05e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.33e-3)"	"prognostic unfavorable (1.58e-5)"	"unprognostic (2.67e-1)"	"unprognostic (6.73e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.96e-1)"	"unprognostic (2.73e-1)"	"unprognostic (7.42e-2)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-1)"	"unprognostic (1.44e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.51e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.04e-1)"	6.7	1.5	21.8	0.8	20.0	0.0	5.4	15.2	31.2	10.7	12.2	9.8	1.2	10.6	3.6	2.4	10.1	1.5	6.0	22.1	16.8	8.4	2.0	2.4	0.4	15.4	17.2	10.1	2.4	27.0	6.4	5.3	15.2	9.3	0.9	0.5	5.6	14.7	1.5	6.0	3.7	5.1	15.3	2.6	5.5	12.2	18.0	24.4	19.7	1.8	0.5	9.0	10.6	19.3	13.8	0.0	0.8	6.1	5.3	4.2	0.0	6.3	18.0	10.1	9.3	0.0	0.0	0.0	0.6	8.3	5.5	0.2	4.0	1.1	4.3	0.0	1.4	0.0	1.8	0.0	2.2	0.0	0.0	2.9	3.6	2.2	10.0	23.2	0.0	1.0	0.0	0.0	0.8	8.0	0.1	0.0	0.1	0.0	3.7	0.0	0.0	0.0	35.2	0.0	0.7	0.2	0.3	0.3	6.8	0.0	0.3	0.1	0.3	16.3	3.8	0.0	4.9	0.0	0.0	0.0	0.1	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.8	20.0	15.2	31.2	22.1	16.8	15.4	17.2	15.2	15.3	18.0	19.3	0.4	0.0	1.1	13.4	0.5	0.4	0.8	0.0	1.2	8.1	1.0	1.0	1.6	0.0	0.0	1.8	0.0	0.0	0.0	0.2	7.9	0.2	0.6	0.3	3.7	1.0	4.2	0.0	39.0	0.0	0.1	3.5	0.0	0.3	0.0	7.5	0.0	0.5	0.1	0.0	5.1	0.1	0.0	0.0	0.4	1.3	25.4	0.1	7.2	1.9	0.6	0.5	0.0	54.8	3.0	0.2	0.0	42.9	0.0	0.5	1.0	1.5	0.0	0.0	0.0	8.3	3.7	0.1	0.9	0.2	0.9	0.0	0.0	1.5	0.3	0.1
KCNIP4	"CALP, KCHIP4, MGC44947"	ENSG00000185774	"Potassium voltage-gated channel interacting protein 4"	Q6PIL6	4	20728606-21948772	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 24.5;retina: 18.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 9816.7;Inhibitory neurons: 1982.4;Oligodendrocyte precursor cells: 5175.8"	"Cancer enhanced"	"Detected in some"		"glioma: 3.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 6.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022862, HPA066717"		Supported	Approved	Vesicles		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA022862: AB_1852654, HPA066717: "	"unprognostic (8.08e-2)"	"unprognostic (1.05e-1)"	"unprognostic (7.36e-2)"	"unprognostic (4.14e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.13e-1)"	"unprognostic (3.11e-1)"	"unprognostic (1.03e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.59e-2)"	"unprognostic (2.10e-2)"	0.6	2.2	11.9	1.3	16.4	0.0	0.6	13.8	24.5	11.0	0.0	6.9	1.2	6.2	0.6	4.0	2.5	1.1	0.5	17.8	12.8	8.2	0.2	0.5	0.0	7.0	7.9	1.3	0.5	0.0	4.2	1.0	13.7	0.5	4.1	18.1	0.5	0.3	0.3	0.5	3.8	6.0	4.3	0.3	0.8	0.4	9.0	0.0	6.4	0.0	0.0	1.0	1.5	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.8	0.0	0.3	0.1	0.0	0.2	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.4	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.9	16.4	13.8	24.5	17.8	12.8	7.0	7.9	13.7	4.3	9.0	10.6	0.0	0.0	0.0	148.2	0.1	0.0	0.0	0.0	0.0	33.0	0.1	0.0	0.5	0.0	0.0	14.7	0.0	0.1	0.0	0.3	62.6	0.1	9.8	0.2	2.1	1.6	0.0	0.0	9816.7	0.0	0.0	3.1	0.0	0.2	0.0	12.3	1.1	0.2	0.2	0.0	1982.4	0.6	0.0	0.0	0.0	4.2	0.0	0.5	3.6	119.9	0.6	45.9	0.0	5175.8	91.4	0.0	7.8	0.0	0.0	0.0	0.4	15.2	0.0	12.6	0.0	0.2	0.4	0.1	0.7	0.1	0.1	0.1	0.1	14.5	0.7	0.1
KCNJ1	"Kir1.1, ROMK1"	ENSG00000151704	"Potassium inwardly rectifying channel subfamily J member 1"	P48048	11	128836315-128867373	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Bartter syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	117	"kidney: 198.0"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 195.6"	"Cancer enriched"	"Detected in some"	7	"renal cancer: 3.4"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	39	"RPTEC TERT1: 116.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA026962	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA026962: AB_10601934"	"unprognostic (1.75e-1)"	"unprognostic (4.38e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.19e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.01e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.47e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.05e-2)"	"unprognostic (4.99e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.28e-1)"	"unprognostic (7.81e-3)"	0.2	0.1	1.0	0.1	1.6	0.1	0.1	0.1	0.3	0.0	0.1	0.1	0.0	0.0	1.4	0.1	0.1	0.0	0.1	0.5	0.1	198.0	0.1	0.2	0.1	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.1	0.0	0.1	0.2	0.1	0.1	0.3	0.1	0.5	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	116.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	2.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.6	0.1	0.3	0.5	0.1	0.2	0.2	0.2	0.1	0.3	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	38.6	0.0	0.0	0.1	0.0	195.6	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0
KCNJ10	"Kir1.2, Kir4.1"	ENSG00000177807	"Potassium inwardly rectifying channel subfamily J member 10"	P78508	1	159998651-160070160	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Deafness, Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 100.7;kidney: 28.0;retina: 36.7"	"Group enriched"	"Detected in some"	5	"Astrocytes: 93.0;Muller glia cells: 75.7;Oligodendrocyte precursor cells: 35.7;Oligodendrocytes: 93.7"	"Cancer enriched"	"Detected in some"	6	"glioma: 27.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 6.7;SK-MEL-30: 2.1;U-266/70: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078302	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"			"HPA078302: AB_2732378"	"unprognostic (2.64e-2)"	"unprognostic (3.54e-3)"	"unprognostic (6.19e-2)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (6.98e-4)"	"unprognostic (1.96e-1)"	"unprognostic (7.13e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.28e-3)"	"unprognostic (5.80e-4)"	"unprognostic (9.52e-2)"	"unprognostic (2.09e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (3.77e-1)"	"unprognostic (6.70e-3)"	0.1	0.3	56.7	2.1	86.3	0.0	0.1	100.2	58.4	0.2	8.7	0.5	0.2	0.1	0.0	0.1	0.1	0.1	0.1	51.4	78.7	28.0	2.1	0.1	7.3	92.7	94.7	0.1	0.1	0.1	0.4	0.0	87.5	0.2	0.2	36.7	0.3	0.2	0.1	0.4	0.5	0.0	71.8	10.5	0.9	0.6	83.6	0.4	0.2	0.1	1.9	0.1	0.1	100.7	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	1.0	0.1	0.0	0.6	0.2	0.1	0.0	0.1	0.0	0.1	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	1.2	0.1	0.0	0.0	0.1	0.2	0.0	0.1	2.1	0.5	0.0	0.3	0.1	0.0	0.2	0.5	0.0	2.0	1.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.6	0.0	56.7	86.3	100.2	58.4	51.4	78.7	92.7	94.7	87.5	71.8	83.6	100.7	0.1	0.0	0.0	93.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.5	0.0	0.0	3.7	4.2	0.0	0.0	0.0	11.7	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	13.0	0.0	1.1	0.0	1.1	0.0	3.7	0.0	75.7	0.0	35.7	93.7	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.0	3.5	0.0	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNJ11	"BIR, Kir6.2"	ENSG00000187486	"Potassium inwardly rectifying channel subfamily J member 11"	Q14654	11	17385248-17389331	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Diabetes mellitus, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 134.7;tongue: 40.7"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 14.1;Collecting duct cells: 5.5;Enteroendocrine cells: 4.2;Excitatory neurons: 5.5;Inhibitory neurons: 5.9;Oligodendrocyte precursor cells: 4.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 6.6;HEK 293: 12.3;MCF7: 10.0;SCLC-21H: 8.5;U-266/84: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048891	Approved					NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA048891: AB_2680547"	"unprognostic (1.95e-2)"	"unprognostic (6.18e-3)"	"unprognostic (7.79e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.81e-5)"	"unprognostic (1.83e-3)"	"unprognostic (5.45e-2)"	"unprognostic (8.09e-3)"	"unprognostic (3.72e-3)"	"unprognostic (9.23e-3)"	"prognostic favorable (1.56e-4)"	"unprognostic (4.05e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.67e-1)"	"unprognostic (4.75e-2)"	2.7	0.6	5.1	0.4	8.3	0.2	3.0	12.4	11.9	0.6	0.0	1.1	1.0	0.9	1.6	1.5	0.7	0.5	13.8	5.3	4.2	4.7	1.5	2.5	0.8	8.0	3.4	0.3	11.3	5.0	7.4	0.1	8.2	2.2	0.4	1.3	2.2	2.4	134.7	1.5	1.3	0.1	2.6	1.6	13.1	0.6	6.4	0.3	5.1	40.7	0.5	0.9	0.4	5.9	1.5	2.1	0.2	4.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	2.0	0.2	6.6	0.2	0.0	0.3	0.3	4.1	0.1	0.2	1.6	12.3	3.4	0.9	0.5	0.1	0.5	0.3	0.1	0.2	0.0	0.1	0.1	0.0	5.6	3.5	3.6	0.0	10.0	0.7	0.1	1.1	4.0	0.3	1.3	1.6	2.0	0.3	0.9	8.5	0.7	0.0	3.4	0.0	0.0	4.2	0.2	0.0	0.0	1.1	0.0	0.0	0.2	6.5	0.8	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	8.3	12.4	11.9	5.3	4.2	8.0	3.4	8.2	2.6	6.4	5.9	1.5	0.0	2.7	3.3	0.1	0.0	0.1	0.0	0.0	2.1	2.6	0.9	14.1	0.0	0.6	5.5	0.0	0.0	0.0	0.2	0.0	0.4	0.1	0.3	0.3	0.3	4.2	0.0	5.5	0.4	0.0	0.9	0.0	0.6	0.0	0.2	0.4	1.3	0.1	0.0	5.9	0.9	0.0	1.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	4.0	0.8	0.1	0.0	0.0	0.0	0.8	0.1	0.2	0.0	0.7	0.0	1.3	0.2	0.2	0.3	1.0	0.0	0.0	0.0	0.1	0.4	0.2
KCNJ12	"hIRK1, IRK2, KCNJN1, Kir2.2, Kir2.2v"	ENSG00000184185	"Potassium inwardly rectifying channel subfamily J member 12"	Q14500	17	21376357-21419870	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 25.5;skeletal muscle: 69.1;tongue: 25.7"	"Cell type enriched"	"Detected in many"	6	"Horizontal cells: 89.2"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in all"		"cerebellum: 25.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 2.3;HeLa: 3.9;PC-3: 4.3;SCLC-21H: 4.8;SiHa: 2.5;SuSa: 5.2;U-2197: 4.2"									HPA027021	Approved		Uncertain	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"	"Golgi apparatus"	"Nucleoplasm, Cytosol"	"HPA027021: AB_10602912"	"unprognostic (3.81e-3)"	"unprognostic (2.69e-2)"	"unprognostic (8.60e-2)"	"prognostic unfavorable (7.84e-5)"	"unprognostic (2.29e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.80e-2)"	"unprognostic (1.54e-2)"	"unprognostic (4.39e-2)"	"unprognostic (4.91e-2)"	"unprognostic (8.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-1)"	"unprognostic (5.90e-2)"	"unprognostic (9.70e-3)"	1.3	1.1	2.9	0.6	2.2	0.4	0.8	25.5	3.3	1.2	0.0	0.9	0.1	0.5	0.6	1.4	2.1	0.4	6.4	1.5	2.9	1.3	0.1	1.9	0.1	4.0	6.0	0.4	0.2	5.5	0.8	0.4	3.1	0.6	0.3	1.3	0.7	0.6	69.1	3.6	0.4	0.6	1.1	1.2	1.1	0.8	10.8	0.1	1.1	25.7	1.0	0.7	0.5	1.4	0.0	0.7	0.3	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	2.3	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	4.3	0.0	0.6	1.1	0.0	0.0	4.8	0.2	2.5	0.0	1.1	5.2	0.0	0.0	2.0	0.0	0.3	4.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	2.2	25.5	3.3	1.5	2.9	4.0	6.0	3.1	1.1	10.8	1.4	1.4	0.0	0.0	0.7	0.0	1.5	0.0	2.3	0.0	2.9	0.0	0.3	14.3	0.0	1.2	1.8	0.0	0.0	0.1	1.1	1.9	0.0	0.5	0.4	0.5	3.4	1.2	0.0	2.8	0.0	0.0	3.4	0.5	1.8	0.0	0.0	6.8	0.1	0.2	89.2	5.7	1.4	4.1	0.0	1.2	0.5	7.5	0.1	0.0	2.8	0.0	10.2	0.0	0.0	0.2	0.0	0.5	4.1	0.0	0.2	0.0	0.8	0.1	1.5	0.0	3.0	0.7	0.6	2.5	0.0	2.3	0.1	0.5	0.0	1.8	0.2
KCNJ13	"Kir1.4, Kir7.1, LCA16"	ENSG00000115474	"Potassium inwardly rectifying channel subfamily J member 13"	O60928	2	232765802-232776565	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cataract, Disease variant, Leber congenital amaurosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"choroid plexus: 159.5;intestine: 91.3"	"Group enriched"	"Detected in some"	4	"Muller glia cells: 54.8;Proximal enterocytes: 217.4;Undifferentiated cells: 68.1"	"Cancer enriched"	"Detected in some"	5	"melanoma: 5.9"	"Group enriched"	"Detected in many"	4	"cerebellum: 7.3;hippocampal formation: 8.0;thalamus: 5.3;white matter: 3.4"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"U-2197: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051609			Approved	"Nuclear membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Nuclear membrane"		"HPA051609: "	"unprognostic (4.29e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.69e-1)"	"unprognostic (9.03e-5)"	"unprognostic (1.17e-1)"	"unprognostic (3.12e-2)"		"unprognostic (2.26e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.11e-2)"	0.1	0.1	0.4	0.0	1.3	0.4	0.1	7.3	1.1	0.1	159.5	0.1	7.9	0.1	0.3	0.1	0.0	2.2	0.1	8.0	0.4	3.3	0.2	0.1	0.2	1.3	0.8	0.2	0.8	15.8	0.2	0.0	1.3	0.1	0.0	13.7	0.2	1.1	0.1	3.2	91.3	0.1	0.4	0.1	2.3	0.5	5.3	0.1	7.0	0.0	0.0	0.1	0.2	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.3	0.0	0.2	0.2	0.1	0.0	1.9	0.3	0.3	0.3	0.0	0.4	0.2	0.6	0.2	0.1	0.3	0.7	0.3	0.3	0.4	0.4	0.3	1.0	0.0	0.4	1.3	7.3	1.1	8.0	0.4	1.3	0.8	1.3	0.4	5.3	3.4	0.1	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.5	0.0	0.5	0.5	0.0	0.0	1.8	0.0	0.0	0.2	0.1	1.9	0.0	3.0	0.7	0.3	0.2	0.0	0.0	1.1	1.3	0.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.2	25.7	0.0	0.0	0.0	0.6	0.0	0.1	21.4	0.0	0.0	54.8	0.0	1.5	2.0	0.0	8.8	0.0	0.0	0.1	217.4	0.2	0.0	1.7	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.0	68.1	0.0
KCNJ16	"BIR9, Kir5.1"	ENSG00000153822	"Potassium inwardly rectifying channel subfamily J member 16"	Q9NPI9	17	70053429-70135608	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 196.1;parathyroid gland: 269.2;thyroid gland: 139.4"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 54.3;Collecting duct cells: 244.6;Distal tubular cells: 41.1;Oligodendrocyte precursor cells: 54.8;Proximal tubular cells: 95.2"	"Group enriched"	"Detected in many"	10	"renal cancer: 37.2;thyroid cancer: 80.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 279.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059563	Approved		Uncertain	Vesicles		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Vesicles		"HPA059563: AB_2684065"	"unprognostic (2.81e-3)"	"unprognostic (2.10e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.20e-3)"	"unprognostic (1.16e-1)"	"unprognostic (7.53e-2)"	"unprognostic (4.38e-4)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.52e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.34e-1)"	"prognostic favorable (9.61e-7)"	"unprognostic (2.74e-1)"	"unprognostic (1.39e-1)"	"prognostic favorable (6.58e-4)"	"unprognostic (3.88e-1)"	0.3	0.4	10.0	0.4	14.0	0.6	3.8	22.7	11.6	0.1	2.3	0.6	0.7	0.5	15.9	0.3	5.1	18.8	0.6	6.8	39.5	196.1	1.3	0.9	0.8	39.7	37.6	0.2	44.2	269.2	1.0	0.9	25.7	0.2	0.2	1.2	11.8	21.7	0.3	0.8	2.5	0.0	29.9	1.5	23.4	1.7	27.3	0.2	139.4	0.0	0.1	0.0	0.0	20.8	0.1	0.4	0.2	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.6	0.0	1.2	0.5	0.0	0.2	0.0	0.0	0.0	0.2	1.2	0.8	0.3	0.3	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	1.1	0.2	0.0	0.0	0.0	0.3	0.6	0.1	0.0	12.7	0.0	0.0	279.8	0.2	0.3	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.4	0.0	0.3	0.1	0.1	0.0	0.2	0.8	0.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.3	0.3	0.3	0.1	0.0	0.3	0.2	0.2	1.6	0.3	0.0	0.1	0.3	0.1	10.0	14.0	22.7	11.6	6.8	39.5	39.7	37.6	25.7	29.9	27.3	20.8	0.1	0.0	0.0	12.1	0.0	0.0	0.0	2.7	0.0	0.0	2.3	1.1	0.4	54.3	2.6	244.6	0.0	0.0	0.0	0.0	41.1	12.4	0.0	2.8	0.1	0.0	0.0	0.0	1.0	1.4	0.0	0.3	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.0	54.8	0.1	6.0	0.0	0.0	0.0	0.0	1.0	95.2	9.8	0.0	0.0	0.2	0.3	0.2	0.6	0.0	0.0	0.0	0.6	0.2	0.0	0.0
KCNJ2	"IRK1, Kir2.1, LQT7"	ENSG00000123700	"Potassium inwardly rectifying channel subfamily J member 2"	P63252	17	70168673-70180044	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 42.9;parathyroid gland: 36.0"	"Group enriched"	"Detected in many"	4	"Horizontal cells: 240.6;Oligodendrocytes: 164.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 30.4"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 30.4"	"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 8.9;HUVEC TERT2: 6.3;REH: 7.5;RH-30: 29.2;U-138 MG: 10.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029109	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 62: Horizontal cells - Visual perception"			"HPA029109: AB_10602913"	"unprognostic (1.32e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.22e-2)"	"unprognostic (3.50e-1)"	"unprognostic (6.36e-3)"	"unprognostic (1.22e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.62e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.15e-3)"	"unprognostic (9.60e-3)"	"unprognostic (4.89e-2)"	"unprognostic (5.49e-3)"	1.9	0.8	7.2	5.1	19.5	1.9	4.9	13.4	13.1	0.9	0.0	3.9	0.9	0.9	0.6	2.9	6.6	1.4	9.8	5.9	11.8	1.0	1.3	2.1	1.3	18.6	16.2	0.7	0.4	36.0	0.6	6.3	18.2	1.8	3.2	7.6	1.3	1.8	9.7	4.7	1.4	1.0	10.5	7.3	0.8	0.3	14.5	1.8	1.2	8.4	1.5	1.9	1.8	42.9	0.0	0.9	1.8	0.0	1.9	0.5	0.0	0.6	4.5	0.1	0.1	0.0	0.0	0.0	0.4	0.5	1.2	0.5	0.1	0.3	0.1	0.0	0.2	0.0	0.6	0.0	5.4	0.0	0.0	2.0	0.1	2.8	0.3	8.9	6.3	0.0	0.0	0.0	1.9	0.0	0.7	0.0	0.2	0.8	0.2	7.5	29.2	0.0	0.7	0.0	0.4	0.8	0.5	0.1	0.0	3.5	0.3	0.5	0.1	10.6	0.1	0.1	2.4	0.0	0.0	0.1	2.3	0.0	1.5	4.2	3.5	5.6	0.0	6.9	0.0	0.2	0.0	0.0	1.0	0.0	0.0	0.0	30.4	0.0	7.3	0.2	0.0	0.8	7.2	19.5	13.4	13.1	5.9	11.8	18.6	16.2	18.2	10.5	14.5	42.9	12.0	0.0	3.2	0.0	0.6	8.2	4.1	4.9	16.5	43.5	5.8	9.3	19.3	0.0	1.9	1.8	0.0	0.5	0.1	13.5	0.0	0.1	0.3	2.3	0.2	16.0	10.7	0.4	3.8	0.0	0.4	1.7	4.1	1.6	0.0	0.1	3.3	0.1	6.8	240.6	16.2	2.7	0.0	36.9	7.4	0.0	1.5	7.8	3.6	2.8	8.2	5.8	0.0	1.5	164.7	0.0	12.3	1.2	0.0	2.2	0.9	0.1	4.9	5.2	0.0	3.9	2.6	0.1	0.9	6.9	3.3	1.4	0.8	0.2	8.5	0.3
KCNJ3	"GIRK1, KGA, Kir3.1"	ENSG00000162989	"Potassium inwardly rectifying channel subfamily J member 3"	P48549	2	154697855-154858354	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 32.7"	"Group enriched"	"Detected in many"	5	"Excitatory neurons: 309.6;Horizontal cells: 124.5;Inhibitory neurons: 431.3"	"Group enriched"	"Detected in many"	5	"breast cancer: 12.2;renal cancer: 4.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;SH-SY5Y: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA024231, HPA064138"	Uncertain		Approved	"Plasma membrane,Mitochondria"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria	"Plasma membrane"	"HPA024231: AB_1855558, HPA064138: "	"unprognostic (1.45e-1)"	"unprognostic (9.42e-2)"	"unprognostic (2.66e-2)"	"unprognostic (4.49e-4)"	"unprognostic (8.89e-2)"		"unprognostic (6.81e-2)"	"unprognostic (7.24e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.25e-3)"	"unprognostic (3.72e-3)"	"unprognostic (3.33e-1)"	"unprognostic (8.90e-3)"	"unprognostic (3.75e-2)"	"unprognostic (5.59e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.17e-1)"	0.5	1.4	5.7	0.1	8.7	0.1	0.3	32.7	17.0	1.6	4.7	0.8	10.7	0.1	1.1	0.1	0.4	1.3	15.1	14.6	3.7	10.5	3.1	0.2	0.0	2.2	4.3	0.1	2.1	10.4	6.8	0.0	2.4	6.5	0.8	5.0	0.0	11.3	5.3	0.1	9.5	0.2	1.6	0.4	0.7	0.4	4.1	0.0	0.1	0.2	0.0	0.4	0.6	6.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.4	1.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.9	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.2	0.1	0.1	0.3	0.3	0.2	0.1	0.1	0.1	5.7	8.7	32.7	17.0	14.6	3.7	2.2	4.3	2.4	1.6	4.1	6.4	0.3	0.0	0.0	38.8	0.0	0.8	5.3	0.0	0.0	10.9	3.7	1.7	49.0	5.7	0.0	20.2	14.6	0.0	0.0	0.1	5.9	0.1	0.3	0.0	0.0	1.3	31.1	0.0	309.6	3.2	0.0	5.4	0.0	0.0	0.0	0.0	0.0	1.3	0.1	124.5	431.3	7.0	0.0	0.0	2.1	0.0	6.2	0.6	1.8	5.6	0.0	0.7	0.0	32.6	6.8	0.0	1.2	4.1	0.0	6.1	16.2	8.7	0.0	3.9	0.0	8.0	1.6	0.4	0.3	0.0	1.8	0.0	0.8	1.9	8.4	4.7
KCNJ4	"HIR, hIRK2, HRK1, IRK3, Kir2.3"	ENSG00000168135	"Potassium inwardly rectifying channel subfamily J member 4"	P48050	22	38426327-38455199	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 28.9;heart muscle: 33.3"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 3.3;Excitatory neurons: 14.3;Horizontal cells: 10.1;Inhibitory neurons: 11.1;Microglial cells: 3.7;Muller glia cells: 6.2"	"Cancer enhanced"	"Detected in some"		"glioma: 2.1;liver cancer: 1.8"	"Group enriched"	"Detected in many"	5	"amygdala: 10.5;basal ganglia: 18.9;cerebral cortex: 28.9;hippocampal formation: 21.9;white matter: 10.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"SCLC-21H: 11.4"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	14	"amygdala: 5.9;basal ganglia: 13.7;cerebral cortex: 14.7;hippocampal formation: 12.3;olfactory bulb: 15.9"							NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"					"unprognostic (4.76e-2)"	"unprognostic (2.60e-3)"	"unprognostic (2.21e-3)"	"unprognostic (1.65e-1)"	"unprognostic (1.66e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.68e-3)"	"unprognostic (3.12e-1)"	"unprognostic (8.96e-2)"	"unprognostic (2.07e-1)"		"unprognostic (3.15e-3)"	"unprognostic (1.28e-3)"	"unprognostic (1.05e-1)"	"unprognostic (5.41e-2)"		0.1	0.2	10.5	0.0	18.9	0.0	0.0	0.0	28.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.8	0.6	33.3	21.9	3.5	0.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.4	0.8	0.0	0.0	0.0	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.1	1.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.4	0.8	0.0	0.3	0.1	0.0	1.7	0.0	0.1	0.0	0.0	11.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.7	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.5	18.9	0.0	28.9	21.9	3.5	0.0	0.0	0.0	0.0	0.0	10.3	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	11.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	3.7	0.0	6.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
KCNJ5	"CIR, GIRK4, KATP1, Kir3.4, LQT13"	ENSG00000120457	"Potassium inwardly rectifying channel subfamily J member 5"	P48544	11	128891356-128921163	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Cancer-related genes, Disease variant, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 64.3;pancreas: 20.4"	"Cell type enriched"	"Detected in many"	4	"Hofbauer cells: 48.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"HBEC3-KT: 13.3"	"Group enriched"	"Detected in many"	6	"basal ganglia: 2.9;hypothalamus: 6.8;midbrain: 1.9;thalamus: 3.6"	"Low region specificity"	"Detected in all"			"HPA014722, HPA017353, CAB022569"	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 4: Macrophages - Innate immune response"			"CAB022569: , HPA014722: AB_1852133, HPA017353: AB_1852135"	"unprognostic (2.01e-1)"	"unprognostic (2.43e-3)"	"unprognostic (2.56e-3)"	"unprognostic (5.81e-2)"	"unprognostic (4.24e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.54e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.17e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.82e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.88e-2)"	"unprognostic (2.23e-2)"	1.5	64.3	1.2	0.6	0.9	0.4	0.9	0.6	2.0	1.3	0.2	0.8	0.8	0.3	0.9	1.0	0.9	2.2	8.5	0.7	3.2	5.4	0.4	5.9	1.6	3.7	1.7	0.9	20.4	1.3	11.9	7.3	2.7	1.3	0.7	1.0	0.9	9.6	0.4	0.4	0.5	0.6	1.7	13.6	2.3	1.1	7.9	5.8	0.5	0.4	0.5	1.5	0.4	3.9	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.2	0.1	0.3	13.3	0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.1	1.2	0.9	0.6	2.0	0.7	3.2	3.7	1.7	2.7	1.7	7.9	3.9	0.2	0.0	10.0	0.3	0.2	1.5	2.2	4.7	0.0	2.7	0.2	1.4	7.6	0.0	0.3	1.8	0.0	0.8	0.1	0.0	0.0	0.1	2.3	0.2	0.2	0.6	0.0	0.0	0.2	3.9	0.7	1.1	0.0	0.3	0.0	0.2	0.4	0.1	48.3	1.7	3.1	0.0	0.0	2.2	2.9	7.8	0.9	10.9	3.6	3.7	1.2	0.3	3.1	0.5	0.1	0.8	0.0	0.7	0.3	0.6	0.0	0.1	0.3	1.4	0.0	0.9	0.2	0.9	0.5	0.5	1.7	1.2	0.6	2.3	0.0	0.6
KCNJ6	"BIR1, GIRK2, hiGIRK2, KATP2, KCNJ7, Kir3.2"	ENSG00000157542	"Potassium inwardly rectifying channel subfamily J member 6"	P48051	21	37607373-38121345	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Congenital generalized lipodystrophy, Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 24.2"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 152.6;Horizontal cells: 245.6;Inhibitory neurons: 146.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in all"	6	"cerebral cortex: 10.3;hippocampal formation: 10.6;midbrain: 24.2"	"Immune cell enhanced"	"Detected in some"		"basophil: 2.2;eosinophil: 1.3"	"Lineage enriched"	"Detected in single"	18	"granulocytes: 2.2"	"Cell line enriched"	"Detected in some"	7	"LHCN-M2: 29.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 62: Horizontal cells - Visual perception"				"unprognostic (1.43e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.26e-3)"	"unprognostic (6.75e-2)"	"unprognostic (3.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.64e-2)"	"unprognostic (3.49e-1)"	"unprognostic (1.96e-10)"	"unprognostic (2.42e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.87e-2)"	"unprognostic (1.21e-1)"	0.0	0.1	2.3	0.1	2.7	0.1	0.0	1.6	10.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	10.6	1.9	0.0	0.0	0.1	0.2	1.9	24.2	0.0	0.4	0.0	1.7	0.4	2.2	0.2	0.0	1.0	0.0	0.0	0.4	0.1	0.1	0.0	1.2	0.2	0.4	0.3	1.8	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.7	0.3	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.9	1.6	0.0	0.0	0.0	3.5	0.1	29.2	0.1	0.0	0.0	0.3	0.0	2.8	0.0	0.1	1.0	4.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.3	0.1	0.1	0.2	4.3	1.2	0.0	0.0	0.0	0.0	2.2	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.1	0.1	0.0	0.0	2.3	2.7	1.6	10.3	10.6	1.9	1.9	24.2	2.2	1.2	1.8	1.5	0.2	0.0	1.1	2.3	0.0	0.1	0.4	0.1	0.0	25.4	0.2	0.3	34.3	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.4	0.1	0.2	1.6	41.4	0.0	152.6	0.0	0.4	0.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	245.6	146.2	1.8	2.0	0.0	0.0	0.0	0.6	0.0	3.6	16.9	0.0	1.2	0.0	38.2	1.5	0.6	0.0	0.0	0.0	0.3	0.2	0.0	0.1	2.6	0.0	0.2	1.1	0.0	1.7	0.0	0.1	0.3	0.1	0.0	0.4	0.4
KCNJ8	Kir6.1	ENSG00000121361	"Potassium inwardly rectifying channel subfamily J member 8"	Q15842	12	21764955-21775600	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 71.3"	"Group enriched"	"Detected in many"	4	"Sertoli cells: 197.2;Smooth muscle cells: 61.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	15	"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Cell line enhanced"	"Detected in some"		"BJ: 11.1;CACO-2: 58.4;SH-SY5Y: 30.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031066	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA031066: AB_10602240"	"unprognostic (8.12e-3)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (9.29e-4)"	"unprognostic (7.81e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.36e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.66e-3)"	"unprognostic (2.88e-2)"	"prognostic unfavorable (1.62e-6)"	"unprognostic (4.70e-3)"	"unprognostic (9.61e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.54e-3)"	28.6	17.3	4.9	3.2	5.4	0.0	22.1	4.8	5.7	17.0	11.6	15.6	1.2	18.8	0.7	3.6	14.8	1.8	71.3	4.7	5.0	13.9	41.9	13.8	2.5	5.2	5.3	16.8	42.4	1.8	7.8	3.0	5.1	13.0	0.3	0.8	6.4	8.4	17.1	5.8	5.9	5.5	5.2	8.0	12.7	1.0	7.2	0.6	16.1	4.5	0.4	15.1	11.5	4.7	0.0	0.1	0.9	0.0	1.4	3.2	0.0	11.1	4.4	6.5	1.9	58.4	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	1.1	0.0	4.3	2.9	0.0	0.0	0.0	0.0	0.0	4.5	0.0	3.2	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	5.0	0.0	0.0	0.0	6.6	2.7	0.0	3.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.9	5.4	4.8	5.7	4.7	5.0	5.2	5.3	5.1	5.2	7.2	4.7	18.7	3.2	29.5	2.9	0.0	1.3	0.4	0.0	0.6	0.0	9.2	3.0	28.3	0.0	0.6	1.8	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.7	10.8	12.8	1.2	0.0	3.6	1.3	0.0	9.8	0.0	0.9	0.0	1.0	2.9	23.0	0.3	0.0	0.2	0.0	0.0	0.8	1.5	0.1	0.3	0.3	1.8	0.0	0.0	13.2	0.0	0.5	0.4	1.2	0.0	0.7	0.1	0.4	0.0	0.0	0.0	2.0	197.2	3.3	61.6	0.0	1.0	0.1	0.9	0.3	0.3	0.5	0.2	0.6
KCNJ9	"GIRK3, Kir3.3"	ENSG00000162728	"Potassium inwardly rectifying channel subfamily J member 9"	Q92806	1	160081538-160090563	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 65.8;choroid plexus: 20.4"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 11.9;Excitatory neurons: 23.5;Horizontal cells: 8.4;Inhibitory neurons: 12.6;Oligodendrocytes: 8.3"	"Cancer enriched"	"Detected in single"	35	"glioma: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070478	Enhanced					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA070478: AB_2686270"	"unprognostic (2.35e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.17e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.33e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.29e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.66e-1)"	"unprognostic (1.34e-1)"	"unprognostic (2.44e-1)"	"unprognostic (5.24e-2)"	0.0	0.3	55.2	0.0	57.0	0.0	0.0	64.9	65.8	0.0	20.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	56.8	38.6	0.2	0.0	0.0	0.0	38.1	49.8	0.0	0.0	0.0	2.0	0.0	41.5	0.0	0.0	7.4	0.0	0.0	0.0	0.1	0.0	0.0	37.2	0.0	0.1	0.4	58.5	0.0	0.0	0.0	0.0	0.0	0.0	61.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.2	57.0	64.9	65.8	56.8	38.6	38.1	49.8	41.5	37.2	58.5	61.5	0.0	0.0	0.0	3.9	0.1	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.9	0.0	0.0	1.8	2.1	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	23.5	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.4	0.0	0.0	8.4	12.6	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.0	1.0	0.0	0.7	0.0	1.5	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.1	0.5	0.7	0.0	0.0	0.0	0.1	0.0	0.0	0.0
KCNK15	"dJ781B1.1, K2p15.1, KCNK11, KCNK14, KIAA0237, KT3.3, TASK-5, TASK5"	ENSG00000124249	"Potassium two pore domain channel subfamily K member 15"	Q9H427	20	44745865-44752313	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 15.7;Collecting duct cells: 9.2;Exocrine glandular cells: 7.0;Granulosa cells: 6.3;Leydig cells: 6.5;Prostatic glandular cells: 5.6;Urothelial cells: 7.4"	"Cancer enriched"	"Detected in many"	7	"ovarian cancer: 47.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"MCF7: 48.9"	"Region enriched"	"Detected in single"	18	"olfactory bulb: 6.8"	"Region enriched"	"Detected in single"	7	"olfactory bulb: 3.9"	HPA064861	Uncertain					NA	NA				"Cluster 71: Testis - DNA repair"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA064861: AB_2685373"	"unprognostic (8.70e-2)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.05e-2)"	"unprognostic (2.96e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.50e-2)"	"unprognostic (4.22e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.60e-2)"	"unprognostic (6.27e-2)"	"unprognostic (6.11e-2)"	"unprognostic (7.38e-4)"	"unprognostic (4.76e-2)"	"unprognostic (4.79e-2)"	"unprognostic (2.21e-3)"	"unprognostic (2.11e-1)"	4.0	2.1	0.3	0.2	0.5	0.0	3.0	0.1	0.4	3.2	0.2	0.5	0.2	2.3	0.2	0.7	5.2	1.0	1.7	0.1	0.9	2.0	0.3	2.0	0.0	0.2	0.3	2.2	1.6	0.1	3.5	0.1	0.1	1.6	0.0	0.2	1.7	1.3	0.4	1.4	0.6	1.1	0.1	0.1	2.8	3.3	0.2	0.0	2.7	0.2	0.0	1.0	1.5	0.0	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.4	0.3	0.1	0.1	0.3	0.0	0.0	0.8	0.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	48.9	0.0	0.0	0.0	0.1	4.7	0.0	0.0	0.0	0.4	0.0	1.4	0.6	4.6	0.0	0.5	0.0	2.3	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.1	0.4	0.1	0.9	0.2	0.3	0.1	0.1	0.2	0.0	1.0	0.0	0.0	0.0	0.1	0.5	1.9	0.0	0.6	0.1	1.6	1.0	0.7	15.7	0.4	9.2	0.0	0.0	0.0	0.3	0.0	3.9	0.2	1.7	2.3	2.5	1.2	0.0	1.0	7.0	0.0	3.9	1.1	1.6	0.0	6.3	1.4	0.3	0.1	0.0	0.5	0.4	0.0	0.0	0.3	0.3	6.5	0.0	0.0	0.0	0.0	0.5	0.0	0.5	0.0	1.5	0.3	0.4	0.0	5.6	0.0	0.2	0.1	0.1	0.0	0.5	0.6	0.2	0.4	1.4	0.9	0.0	0.1	0.3	1.0	7.4
KCNK16	"K2p16.1, TALK-1, TALK1"	ENSG00000095981	"Potassium two pore domain channel subfamily K member 16"	Q96T55	6	39314698-39322968	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"pancreas: 23.7;stomach 1: 10.3"	"Not detected"	"Not detected"			"Cancer enriched"	"Detected in some"	17	"pancreatic cancer: 13.3"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	10	"basophil: 2.1"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 2.1"	"Cell line enriched"	"Detected in single"	390	"SCLC-21H: 127.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 25: Pancreas - Digestion"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 1: Pancreatic cells - Digestion"														"unprognostic (3.29e-2)"					"unprognostic (3.48e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	23.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	10.3	0.1	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	127.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNK17	"K2p17.1, TALK-2, TALK2, TASK-4, TASK4"	ENSG00000124780	"Potassium two pore domain channel subfamily K member 17"	Q96T54	6	39299001-39314461	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 7.7;thyroid gland: 6.5"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 11.0;Exocrine glandular cells: 7.9;granulocytes: 6.3;Microglial cells: 17.8;Smooth muscle cells: 5.4"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in some"	34	"plasmacytoid DC: 63.8"	"Lineage enriched"	"Detected in many"	34	"dendritic cells: 63.8"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 83.8"					"Not detected"	"Not detected"			HPA043892	Uncertain		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA043892: AB_10962838"	"unprognostic (5.33e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.33e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.70e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.95e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.77e-11)"	"unprognostic (5.89e-2)"	"unprognostic (5.36e-1)"	"unprognostic (2.82e-1)"	"unprognostic (3.86e-3)"	0.5	0.3	0.3	0.4	0.4	1.2	0.8	0.3	0.6	0.7	0.2	0.6	1.9	1.2	0.0	0.3	0.8	2.5	5.8	0.2	0.3	0.1	4.0	7.7	0.7	0.4	0.5	0.2	3.9	0.1	1.8	4.0	0.3	0.6	0.5	0.0	0.7	0.2	0.1	0.1	1.1	1.0	0.2	0.7	2.9	0.2	0.5	1.3	6.5	0.5	1.1	0.7	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	83.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.8	0.0	63.8	0.0	0.3	0.3	0.4	0.3	0.6	0.2	0.3	0.4	0.5	0.3	0.2	0.5	0.3	0.0	0.0	2.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.9	0.3	0.0	0.0	0.0	0.0	0.0	11.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.1	7.9	0.0	1.8	1.1	0.1	6.3	0.0	0.7	0.2	0.1	0.0	0.1	0.4	0.0	0.6	0.0	0.0	0.0	0.9	0.0	17.8	0.2	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.2	0.0	0.0	0.0	0.7	0.1	0.0	0.0
KCNK3	"K2p3.1, TASK, TASK-1, TASK1"	ENSG00000171303	"Potassium two pore domain channel subfamily K member 3"	O14649	2	26692690-26733420	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"adrenal gland: 181.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.1;Collecting duct cells: 103.0;Enteroendocrine cells: 23.4;Exocrine glandular cells: 95.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 9.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 5.1;EFO-21: 11.0;HeLa: 3.6;SCLC-21H: 25.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 1: Pancreatic cells - Digestion"				"unprognostic (4.16e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-4)"	"unprognostic (2.08e-1)"	"unprognostic (2.91e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.31e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.48e-2)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (3.09e-2)"	"unprognostic (7.45e-2)"	"unprognostic (1.44e-2)"	"unprognostic (9.24e-3)"	3.8	181.6	5.1	1.3	4.4	0.1	2.9	4.9	6.0	8.4	0.0	5.5	1.2	6.3	1.5	2.1	4.0	1.2	13.1	3.0	14.3	2.7	0.5	25.7	0.1	27.0	19.3	2.1	35.5	12.1	8.4	24.8	26.8	6.3	0.9	3.3	0.4	3.3	0.8	0.7	2.4	2.7	5.4	1.1	4.2	0.6	10.4	0.1	3.6	0.0	0.0	4.2	2.8	3.9	0.0	0.7	0.2	0.0	5.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	11.0	0.0	1.7	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	1.4	0.0	25.9	2.3	0.2	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	5.1	4.4	4.9	6.0	3.0	14.3	27.0	19.3	26.8	5.4	10.4	3.9	0.3	0.0	2.8	0.3	0.1	0.0	0.2	0.3	0.0	82.1	0.2	3.6	12.7	0.0	0.0	103.0	0.0	0.2	0.1	0.0	0.0	1.0	0.4	0.3	7.7	1.2	23.4	0.0	2.1	95.2	0.2	2.7	0.0	0.2	0.0	1.2	0.4	0.0	0.4	1.7	14.5	1.8	0.0	0.0	0.9	1.9	0.9	0.3	0.0	0.0	0.6	1.4	0.0	1.5	0.3	19.2	0.0	0.0	0.3	1.6	0.1	0.1	0.0	4.1	6.6	0.6	4.9	0.0	1.5	0.0	0.1	0.5	0.4	11.5	0.1	0.4
KCNK5	"K2p5.1, TASK-2, TASK2"	ENSG00000164626	"Potassium two pore domain channel subfamily K member 5"	O95279	6	39188971-39229475	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 35.4;kidney: 37.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 48.6;Distal enterocytes: 55.6;Gastric mucus-secreting cells: 31.6;Proximal enterocytes: 66.5;Proximal tubular cells: 45.4;Syncytiotrophoblasts: 45.6"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 34.9;HEL: 36.1;HMC-1: 31.8;K-562: 34.3;OE19: 27.4;T-47d: 25.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA059148	Uncertain		Approved	Nucleoplasm		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm		"HPA059148: AB_2683929"	"unprognostic (1.46e-1)"	"prognostic favorable (3.29e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.92e-3)"	"unprognostic (8.09e-4)"	"unprognostic (3.97e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-3)"	"unprognostic (7.14e-2)"	"unprognostic (3.43e-1)"	"prognostic unfavorable (5.85e-4)"	"unprognostic (2.98e-1)"	"prognostic favorable (4.98e-7)"	"unprognostic (2.34e-1)"	"unprognostic (7.13e-2)"	"unprognostic (1.03e-2)"	"prognostic favorable (4.45e-4)"	4.0	3.7	0.1	2.2	0.1	9.6	5.3	0.0	0.1	4.4	0.1	14.2	28.4	2.1	0.2	6.1	2.3	18.8	1.7	0.0	0.2	37.2	23.5	6.1	2.7	0.2	0.2	6.4	20.4	1.9	1.2	8.6	0.1	3.5	8.5	0.1	27.1	2.4	0.2	29.4	35.4	1.3	0.1	2.2	16.7	0.7	0.3	1.8	10.0	0.1	1.9	3.2	6.7	0.0	6.6	5.9	7.7	2.9	0.0	0.0	6.6	0.0	0.0	0.0	0.0	34.9	14.3	0.0	10.2	0.0	0.8	13.2	6.0	0.2	0.0	0.0	4.5	36.1	3.1	0.2	0.0	7.5	31.8	0.0	0.1	0.2	0.0	0.0	0.0	7.8	34.3	0.1	0.0	11.4	16.7	8.1	14.4	27.4	0.0	0.0	1.4	13.6	5.3	5.4	1.9	1.5	5.7	7.3	0.0	2.9	25.9	12.1	0.2	0.0	6.4	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.2	0.2	0.2	0.1	0.1	0.3	0.0	2.3	0.0	19.2	0.0	0.1	3.7	2.5	1.5	5.7	0.0	4.2	3.2	0.6	48.6	7.7	1.8	0.0	28.8	0.8	55.6	5.9	14.5	0.1	2.6	0.3	6.9	0.0	6.1	0.0	11.8	5.3	3.2	31.6	5.3	0.0	2.2	0.0	27.5	2.1	0.0	0.0	15.3	8.2	0.6	3.5	0.7	0.6	0.8	1.8	0.0	0.6	0.0	0.0	0.0	0.0	12.1	25.1	0.0	0.4	2.6	66.5	45.4	1.0	0.0	0.0	2.4	0.6	0.0	1.1	8.2	2.7	45.6	3.5	1.4	11.1	10.4
KCNK6	"K2p6.1, TWIK-2"	ENSG00000099337	"Potassium two pore domain channel subfamily K member 6"	Q9Y257	19	38319845-38332076	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 151.3;Urothelial cells: 131.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 26.2"	"Group enriched"	"Detected in many"	6	"dendritic cells: 11.4;granulocytes: 26.2;monocytes: 7.2"	"Cell line enhanced"	"Detected in many"		"HEL: 37.6;HMC-1: 40.3;T-47d: 22.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB022637, HPA040184"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"	"Actin filaments"	"CAB022637: , HPA040184: AB_2676876"	"unprognostic (7.98e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.29e-1)"	"prognostic favorable (1.45e-6)"	"unprognostic (3.76e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.08e-2)"	"unprognostic (4.31e-1)"	"unprognostic (4.91e-1)"	"unprognostic (4.10e-3)"	"unprognostic (3.15e-1)"	"prognostic unfavorable (1.04e-5)"	"unprognostic (1.07e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.88e-2)"	"unprognostic (4.59e-3)"	3.9	2.4	2.9	7.5	2.4	3.9	5.6	3.0	3.3	29.9	2.7	15.4	4.6	24.0	1.5	30.5	15.7	4.5	6.7	2.7	2.2	3.1	3.0	9.4	5.6	2.9	2.3	9.5	12.5	0.6	1.9	7.0	2.9	6.2	9.4	0.8	14.5	2.4	1.5	19.1	6.8	14.3	2.1	15.6	9.5	2.1	2.8	2.5	1.4	0.7	7.9	13.3	18.2	3.7	9.2	3.3	0.5	0.5	5.1	3.3	0.7	7.8	3.8	2.0	2.7	2.6	9.8	0.6	3.5	11.2	2.1	11.7	4.2	17.7	1.3	0.4	0.3	37.6	1.9	0.4	4.7	2.7	40.3	0.8	15.6	2.5	4.8	10.5	5.3	5.8	0.5	2.8	5.7	20.2	2.4	2.3	0.4	19.4	2.1	3.9	0.5	2.7	7.1	0.8	0.5	0.8	0.8	0.8	0.3	1.8	22.8	10.5	5.8	0.5	4.4	4.1	0.4	1.0	0.2	1.0	0.6	13.4	0.3	26.2	6.9	15.8	1.4	6.2	1.2	1.4	2.0	1.9	11.4	1.1	1.7	1.2	5.0	0.6	7.2	3.1	2.6	2.3	2.9	2.4	3.0	3.3	2.7	2.2	2.9	2.3	2.9	2.1	2.8	3.7	8.7	0.0	10.5	0.0	16.0	43.1	50.6	20.6	20.5	3.3	61.2	32.9	12.1	17.2	15.1	7.3	6.2	2.0	18.5	62.4	0.0	19.1	2.8	32.5	58.8	28.3	12.6	17.9	1.1	47.7	4.0	19.2	28.1	84.8	22.2	72.7	151.3	4.3	39.2	0.0	1.7	64.5	2.0	75.7	61.5	1.2	25.7	47.0	5.4	2.8	62.1	1.2	11.3	0.0	0.9	67.2	39.2	20.3	45.6	41.1	37.6	0.4	7.7	5.9	26.3	3.1	9.3	14.8	3.3	48.0	67.2	2.5	14.8	1.5	26.7	131.5
KCNK9	"K2p9.1, TASK-3, TASK3"	ENSG00000169427	"Potassium two pore domain channel subfamily K member 9"	Q9NPC2	8	139600838-139704109	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 7.8"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 16.0;Inhibitory neurons: 8.0;Late spermatids: 9.7"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in some"	4	"cerebellum: 7.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA075842			Approved	"Plasma membrane"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA075842: "	"unprognostic (1.84e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.96e-8)"	"unprognostic (1.91e-1)"	"unprognostic (8.17e-3)"	"unprognostic (2.19e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.87e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.00e-2)"	"unprognostic (3.21e-1)"	"unprognostic (5.12e-6)"	"unprognostic (2.94e-2)"	"unprognostic (1.64e-1)"	"unprognostic (9.99e-3)"	"unprognostic (1.76e-1)"	0.0	1.6	0.0	0.1	0.0	0.0	0.0	7.8	1.9	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.7	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.1	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	1.9	0.2	0.1	0.8	0.3	0.9	0.0	0.4	0.3	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.1	1.9	0.3	2.1	0.0	0.0	0.0	0.0	0.0	16.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.8	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KCNMA1	"KCa1.1, mSLO1, SLO"	ENSG00000156113	"Potassium calcium-activated channel subfamily M alpha 1"	Q12791	10	76869601-77638369	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 138.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 471.1;Bipolar cells: 409.8;Excitatory neurons: 1023.7;Inhibitory neurons: 635.9;Oligodendrocyte precursor cells: 708.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4;non-classical monocyte: 1.7"	"Lineage enhanced"	"Detected in single"		"monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"BJ: 100.8;hTERT-HME1: 115.3;PC-3: 159.6;U-138 MG: 112.6;U-87 MG: 109.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054648	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA054648: AB_2682556"	"unprognostic (1.25e-1)"	"unprognostic (2.23e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.29e-2)"	"unprognostic (9.43e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.81e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.12e-3)"	"unprognostic (1.20e-1)"	"unprognostic (2.26e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.99e-3)"	10.9	12.6	36.2	8.9	38.0	1.0	15.8	1.0	45.0	54.4	4.2	118.2	7.3	138.7	31.4	33.7	47.8	22.4	3.7	36.4	10.1	11.4	19.2	9.6	7.8	4.8	15.2	13.9	8.0	0.2	26.9	4.8	5.7	48.3	21.1	40.2	42.8	76.1	96.6	5.0	23.3	92.8	1.0	24.1	33.6	5.8	15.6	2.1	3.0	18.7	3.5	44.3	24.6	28.4	0.3	30.3	0.1	0.3	4.6	24.8	0.3	100.8	89.2	23.9	11.8	6.7	0.6	0.0	0.7	75.9	56.8	0.2	0.0	59.0	14.6	60.9	0.6	0.0	0.0	0.0	45.0	0.0	0.4	17.4	10.7	38.3	115.3	84.0	9.8	0.5	0.0	0.0	42.6	1.2	1.9	0.2	1.8	0.2	159.6	0.1	3.6	0.1	15.3	0.2	9.1	1.1	0.0	2.5	0.1	11.9	12.2	0.1	65.4	112.6	12.7	20.6	90.0	0.0	0.2	0.0	109.8	0.1	45.1	0.0	0.1	0.0	0.0	2.4	0.0	0.7	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.1	36.2	38.0	1.0	45.0	36.4	10.1	4.8	15.2	5.7	1.0	15.6	28.4	0.9	0.0	4.3	471.1	2.8	2.0	71.7	5.7	17.6	409.8	30.4	43.9	3.5	5.7	4.8	1.8	60.5	0.3	0.5	2.8	29.4	3.3	74.4	20.9	17.9	3.4	4.9	0.0	1023.7	10.7	0.2	16.2	0.5	29.7	0.0	1.9	2.5	27.3	10.8	6.7	635.9	59.6	46.8	106.0	3.9	63.1	3.7	36.7	48.0	133.0	4.0	52.3	0.0	708.2	33.9	8.7	1.4	1.2	8.7	64.0	1.4	0.9	0.1	17.2	6.6	20.6	19.2	3.4	2.5	7.7	0.3	0.3	0.7	177.2	1.7	2.4
KCNMB1	hslo-beta	ENSG00000145936	"Potassium calcium-activated channel subfamily M regulatory beta subunit 1"	Q16558	5	170374671-170389634	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 59.2;intestine: 75.1;smooth muscle: 53.1"	"Cell type enriched"	"Detected in many"	6	"Peritubular cells: 354.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 6.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 5.7;monocytes: 5.9"	"Cell line enhanced"	"Detected in some"		"REH: 8.8;SK-BR-3: 2.1;U-937: 3.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 14: REH - Unknown function"	"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (2.06e-2)"	"unprognostic (2.70e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.37e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.46e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.68e-2)"	"unprognostic (5.37e-1)"	"unprognostic (1.00e-1)"	"prognostic unfavorable (4.13e-6)"	"unprognostic (1.08e-1)"	"unprognostic (2.49e-1)"	"unprognostic (4.31e-2)"	"unprognostic (1.04e-2)"	5.7	1.8	2.7	10.5	2.3	1.7	6.9	2.5	2.7	16.8	1.4	75.1	4.3	59.2	6.2	16.6	20.6	7.3	4.2	2.1	2.4	1.4	0.7	4.0	1.7	5.9	4.0	4.0	0.7	0.3	0.5	1.1	6.2	24.5	8.9	1.1	6.8	50.6	1.0	2.9	14.3	53.1	3.4	2.3	21.5	2.7	4.2	1.0	1.4	1.1	1.3	32.6	11.2	3.9	0.1	0.1	1.5	0.3	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.3	0.3	0.1	1.0	0.1	0.4	0.1	0.0	0.0	0.0	0.3	0.1	1.2	0.6	0.2	0.0	0.4	0.2	0.2	0.0	0.1	0.2	0.1	0.1	0.4	0.3	0.7	0.1	0.7	0.0	0.8	0.3	0.0	0.1	8.8	0.0	0.2	0.0	0.2	0.4	0.2	0.1	2.1	0.0	0.7	0.1	1.0	0.5	0.2	0.3	0.3	0.0	0.4	0.2	0.1	0.1	3.8	0.1	1.3	3.3	0.3	0.1	5.9	0.1	0.2	0.2	0.1	5.7	0.3	0.1	0.1	0.9	0.4	5.1	2.0	0.2	1.0	2.7	2.3	2.5	2.7	2.1	2.4	5.9	4.0	6.2	3.4	4.2	3.9	1.3	0.0	6.3	0.3	1.2	2.0	1.2	0.4	0.0	1.6	2.5	55.1	3.7	4.3	4.5	1.8	6.2	0.5	1.7	0.1	0.0	0.1	0.6	0.6	14.4	3.6	0.0	1.3	0.1	0.4	0.6	9.8	0.0	0.6	19.7	0.4	1.8	0.4	7.4	1.7	0.3	0.2	0.0	18.9	10.9	4.5	38.5	15.6	3.6	4.7	27.8	0.6	2.1	0.0	0.1	0.0	0.0	354.3	0.3	1.3	0.0	0.1	4.5	2.3	46.0	2.2	43.6	0.7	1.2	0.1	1.7	0.5	1.7	1.4	0.0	0.7
KCNMB2		ENSG00000197584	"Potassium calcium-activated channel subfamily M regulatory beta subunit 2"	Q9Y691	3	178272932-178844429	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 35.4;fallopian tube: 13.9;ovary: 12.7"	"Group enriched"	"Detected in some"	4	"Inhibitory neurons: 791.1;Oligodendrocyte precursor cells: 1982.5"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 2.4;SCLC-21H: 3.3"									CAB022649	Uncertain					NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022649: "	"unprognostic (9.52e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.82e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.04e-2)"	"unprognostic (2.43e-2)"	"unprognostic (6.97e-2)"	"unprognostic (6.74e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.58e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.71e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.89e-4)"	"unprognostic (7.85e-2)"	0.3	5.1	2.5	0.0	3.0	0.0	0.7	1.5	4.0	1.4	0.9	1.2	0.5	2.9	35.4	0.4	13.9	0.5	5.8	4.0	2.3	3.4	0.2	1.1	0.0	3.0	2.7	12.7	4.0	0.2	1.7	0.1	2.3	0.5	0.3	0.2	0.2	1.1	0.2	0.3	0.5	1.9	2.2	1.3	3.0	0.2	2.1	0.0	0.3	0.2	0.0	0.2	0.7	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.2	0.0	0.0	0.6	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.9	0.0	0.5	3.3	0.0	0.0	0.1	0.0	0.2	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	3.0	1.5	4.0	4.0	2.3	3.0	2.7	2.3	2.2	2.1	2.1	0.0	0.0	0.0	18.3	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.3	0.0	0.8	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.1	8.7	0.2	0.0	13.8	0.0	311.8	0.0	0.0	2.7	0.0	1.9	0.0	12.7	1.8	0.0	0.0	0.0	791.1	0.0	4.1	0.0	0.0	0.1	2.8	0.1	0.0	12.2	0.0	0.0	0.0	1982.5	6.8	0.1	0.0	0.0	0.0	0.0	0.0	1.3	10.0	0.0	0.0	0.8	0.4	0.0	0.0	0.1	0.0	0.0	0.1	1.7	0.0	0.1
KCNMB3	"KCNMB2, KCNMBL"	ENSG00000171121	"Potassium calcium-activated channel subfamily M regulatory beta subunit 3"	Q9NPA1	3	179236691-179267002	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 14.6;Early spermatids: 11.2;Late spermatids: 13.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 4.8;HEL: 8.1;NB-4: 5.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA015665, HPA019185"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 32: U-937 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	Mitochondria	"HPA015665: AB_1852142, HPA019185: AB_1852144"	"unprognostic (2.50e-1)"	"unprognostic (1.32e-1)"	"unprognostic (6.76e-5)"	"unprognostic (2.65e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.59e-3)"	"unprognostic (1.14e-1)"	"unprognostic (9.15e-3)"	"unprognostic (5.09e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.95e-5)"	"unprognostic (5.93e-10)"	"unprognostic (7.22e-2)"	"unprognostic (4.72e-1)"	"unprognostic (8.69e-2)"	"unprognostic (3.49e-2)"	4.9	3.6	1.5	2.2	1.8	1.1	4.6	1.7	1.9	3.5	1.6	4.0	1.5	3.2	1.5	2.0	2.9	1.7	3.5	1.5	1.7	4.8	5.5	3.0	2.2	1.9	1.7	3.2	5.3	1.2	3.3	4.2	1.8	4.2	1.5	2.3	3.1	1.1	1.3	2.4	3.5	1.4	1.3	7.5	3.7	3.9	1.7	0.9	3.2	0.5	1.9	3.7	2.7	1.7	2.2	0.5	0.8	0.0	0.9	0.8	1.3	0.6	0.3	0.9	0.4	4.8	1.9	0.1	2.1	0.4	1.8	0.8	0.0	0.1	1.0	2.7	0.3	8.1	2.6	1.8	0.8	0.1	2.5	1.3	0.4	0.6	0.0	0.7	0.8	0.0	0.3	0.0	1.1	1.5	0.1	5.7	0.0	0.9	1.6	2.4	0.0	0.1	0.7	1.5	1.1	0.2	0.7	0.8	0.5	0.7	2.1	4.4	0.5	0.4	0.7	0.2	0.6	0.7	0.3	2.6	0.4	3.1	0.6	0.8	0.1	0.1	0.3	0.1	0.2	1.2	0.2	0.3	0.0	0.6	0.2	0.2	0.6	1.1	0.0	0.1	0.4	0.0	1.5	1.8	1.7	1.9	1.5	1.7	1.9	1.7	1.8	1.3	1.7	1.7	4.2	0.0	3.6	3.9	2.9	0.3	1.4	0.3	0.0	2.5	2.1	1.3	1.1	2.8	1.5	0.0	14.6	1.2	0.6	3.8	0.0	5.0	11.2	1.5	2.3	5.3	4.9	0.8	3.4	3.6	1.3	1.5	0.5	2.0	2.5	3.4	2.9	1.4	1.1	0.0	4.6	1.4	0.0	2.1	1.9	13.3	2.8	1.4	0.0	5.6	1.4	1.8	1.0	4.0	6.4	3.3	0.8	3.0	0.9	1.7	1.9	0.3	1.1	7.8	6.6	1.6	1.6	2.0	2.6	0.3	0.1	1.2	1.0	2.3	1.4	1.0
KCNN1	"hSK1, KCa2.1"	ENSG00000105642	"Potassium calcium-activated channel subfamily N member 1"	Q92952	19	17951293-18000080	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	41	"brain: 92.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 12.8;Langerhans cells: 19.8;Skeletal myocytes: 6.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 3.5"	"Group enriched"	"Detected in many"	7	"amygdala: 34.8;basal ganglia: 30.6;cerebral cortex: 67.2;hippocampal formation: 92.2;white matter: 30.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"REH: 155.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065938			Approved	"Actin filaments,Cytosol"		Yes	No				"Cluster 10: Brain - Neuronal signaling"	"Cluster 14: REH - Unknown function"	"Cluster 50: Fibroblasts - ECM organization"	"Actin filaments, Cytosol"		"HPA065938: AB_2685582"	"unprognostic (7.55e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.82e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.90e-1)"	"unprognostic (8.94e-5)"	"unprognostic (3.92e-3)"	"unprognostic (1.01e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.71e-3)"	"unprognostic (3.38e-1)"	"unprognostic (5.21e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (7.24e-3)"	"unprognostic (3.24e-1)"	0.3	0.2	34.8	0.4	30.6	0.1	0.2	0.0	67.2	0.9	0.0	0.3	0.1	0.6	0.1	0.2	0.1	0.1	1.1	92.2	0.0	0.2	0.0	0.1	0.1	4.4	0.0	1.8	0.1	1.6	1.0	0.0	6.8	0.6	0.0	0.8	0.4	0.2	0.1	0.1	0.2	0.0	0.0	0.1	0.2	2.2	0.0	0.1	0.1	0.0	0.1	0.1	0.2	30.6	0.1	0.6	0.2	6.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	1.6	0.0	0.5	0.2	5.3	0.0	0.2	0.2	2.5	5.0	0.3	0.1	0.0	0.0	12.8	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.4	0.0	0.0	1.8	0.0	0.1	155.3	0.0	0.2	0.0	0.0	0.2	8.6	0.0	0.0	0.1	0.4	0.3	0.2	0.1	0.0	4.7	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	30.6	0.0	67.2	92.2	0.0	4.4	0.0	6.8	0.0	0.0	30.6	0.4	0.0	0.0	3.6	1.1	2.5	3.7	0.0	0.0	2.3	0.2	0.3	0.8	0.0	0.7	0.0	2.1	0.1	1.5	0.2	0.0	0.0	0.2	1.3	1.5	1.9	0.0	0.0	12.8	0.0	0.2	2.6	0.0	1.9	0.0	3.6	0.4	0.2	0.1	0.0	4.4	0.0	0.0	0.3	19.8	0.4	0.9	2.1	5.4	1.9	2.2	1.4	1.0	3.0	0.7	0.2	0.0	1.9	0.7	2.8	0.0	0.2	0.0	1.0	0.0	6.8	1.8	0.6	4.0	0.0	3.8	0.1	1.5	2.2	0.0	1.8
KCNN2	"hSK2, KCa2.2"	ENSG00000080709	"Potassium calcium-activated channel subfamily N member 2"	Q9H2S1	5	114055926-114496500	"FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 27.8;brain: 20.8;liver: 31.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 36.2;Excitatory neurons: 149.9;Inhibitory neurons: 97.0;Oligodendrocyte precursor cells: 63.3"	"Group enriched"	"Detected in some"	7	"glioma: 3.5;melanoma: 3.2;prostate cancer: 12.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 17.5;NTERA-2: 6.4;SK-MEL-30: 12.9;THP-1: 21.8;U-937: 7.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038221	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA038221: AB_10673044"	"unprognostic (9.22e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.04e-1)"	"unprognostic (5.65e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.25e-1)"	0.4	27.8	7.8	0.2	10.8	0.0	0.5	11.3	14.0	2.0	2.2	1.4	0.3	2.9	0.3	0.2	0.4	0.4	6.8	20.8	7.5	3.9	31.3	2.3	0.4	11.1	4.7	0.7	4.5	0.4	7.6	0.0	6.7	9.6	0.7	2.5	0.5	4.3	9.5	1.3	0.3	2.0	9.0	0.5	0.7	3.0	8.2	0.2	0.3	6.7	0.2	2.3	1.0	11.1	0.1	0.0	0.0	0.0	0.0	0.0	2.1	17.5	2.7	0.3	0.0	0.0	0.2	0.0	0.5	0.0	2.3	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.8	0.0	0.2	0.0	0.3	0.0	1.4	6.4	0.0	0.0	0.0	0.0	0.8	0.2	0.1	2.1	0.0	0.0	0.2	12.9	0.4	0.3	21.8	0.3	0.0	0.5	1.8	0.0	0.1	0.0	0.1	2.0	7.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	10.8	11.3	14.0	20.8	7.5	11.1	4.7	6.7	9.0	8.2	11.1	1.4	0.0	1.1	36.2	0.0	0.3	0.3	0.0	0.0	7.9	0.6	1.3	15.1	0.0	0.0	0.0	2.1	0.0	0.0	0.3	0.0	0.6	0.6	0.5	0.0	8.2	0.0	0.0	149.9	0.9	0.0	0.8	0.0	1.3	0.0	0.8	5.0	18.3	0.0	0.0	97.0	1.0	0.0	1.0	0.3	0.5	0.0	0.1	21.4	6.5	0.0	0.4	0.0	63.3	9.2	1.0	0.1	0.0	1.2	4.7	0.0	0.7	0.0	7.8	0.0	0.1	0.3	0.3	6.5	0.3	0.3	0.0	0.0	0.2	0.5	0.6
KCNN3	"hSK3, KCa2.3, SKCA3"	ENSG00000143603	"Potassium calcium-activated channel subfamily N member 3"	Q9UGI6	1	154697455-154870281	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 33.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 168.8;Skeletal myocytes: 121.5"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.7;memory B-cell: 2.6"	"Group enriched"	"Detected in many"	11	"B-cells: 2.6;granulocytes: 4.7;monocytes: 1.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 39.3;HMC-1: 26.1;Karpas-707: 65.5;RPMI-8226: 18.7;U-266/70: 62.3;U-698: 21.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA057127	Enhanced		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm		"HPA057127: AB_2683345"	"unprognostic (2.09e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.22e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.03e-1)"	"unprognostic (3.43e-2)"	"unprognostic (9.51e-2)"	"unprognostic (4.07e-3)"	"unprognostic (4.89e-2)"	"prognostic unfavorable (1.97e-4)"	"unprognostic (1.71e-2)"	"unprognostic (1.54e-1)"	"unprognostic (6.93e-2)"	"unprognostic (1.80e-2)"	0.9	1.1	24.9	3.9	24.2	0.3	0.7	15.1	12.8	2.7	0.0	7.4	3.0	4.9	0.6	1.7	5.7	1.5	2.1	16.9	18.5	2.1	0.2	1.5	3.5	14.4	33.1	0.8	0.3	1.1	1.2	0.0	16.5	1.6	2.4	0.3	1.3	1.2	6.1	0.3	2.2	6.0	12.9	3.5	2.4	0.5	25.7	1.0	1.9	5.3	5.5	3.1	1.6	11.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	39.3	3.1	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	26.1	0.5	0.0	0.3	0.0	0.1	0.8	0.1	0.0	65.5	0.6	0.1	0.2	0.0	0.8	0.0	2.5	0.0	16.2	18.7	0.0	0.0	0.8	0.4	0.0	0.1	0.0	0.2	0.0	0.0	1.2	1.1	0.0	0.0	0.0	62.3	8.8	21.4	0.6	0.0	6.2	4.7	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	0.2	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.1	24.9	24.2	15.1	12.8	16.9	18.5	14.4	33.1	16.5	12.9	25.7	11.0	8.7	12.8	2.7	168.8	3.9	1.3	0.6	0.7	0.6	0.5	0.1	0.0	3.4	0.0	2.1	0.0	2.1	0.1	0.0	0.0	3.9	0.2	3.4	26.6	0.6	25.9	4.2	0.0	18.2	0.2	0.0	16.3	0.0	5.8	0.0	2.0	13.9	0.3	0.4	0.0	13.6	0.0	4.1	0.0	3.0	7.7	0.3	0.9	0.0	11.2	0.0	2.2	0.0	12.1	5.0	0.0	2.2	0.0	30.9	0.5	0.0	0.3	18.3	0.4	0.0	121.5	1.3	0.7	0.2	0.8	1.7	0.0	0.5	22.5	0.0	0.7
KCNN4	"hIKCa1, hKCa4, hSK4, IK, KCa3.1"	ENSG00000104783	"Potassium calcium-activated channel subfamily N member 4"	O15554	19	43766533-43781257	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, FDA approved drug targets, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 130.8"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 231.1;Syncytiotrophoblasts: 763.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 85.7;WM-115: 258.6"	"Region enhanced"	"Detected in single"		"olfactory bulb: 1.9"	"Not detected"	"Not detected"			"HPA013367, HPA053841, HPA059622"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"		"HPA013367: , HPA053841: AB_2682278, HPA059622: AB_2684085"	"unprognostic (1.23e-2)"	"unprognostic (3.22e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.74e-3)"	"prognostic unfavorable (2.68e-4)"	"unprognostic (1.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.48e-3)"	"unprognostic (4.12e-2)"	"prognostic unfavorable (4.56e-4)"	"unprognostic (9.96e-3)"	"prognostic unfavorable (1.05e-14)"	"unprognostic (3.70e-2)"	"unprognostic (2.17e-2)"	"unprognostic (7.50e-2)"	"prognostic favorable (1.75e-4)"	3.6	0.7	1.7	11.8	1.9	18.3	12.4	1.3	1.8	11.8	1.4	18.5	6.4	1.6	1.8	6.5	5.8	3.5	1.1	1.5	1.6	1.4	0.8	7.3	12.5	1.6	1.6	0.6	1.0	0.0	0.7	14.3	1.7	28.6	6.2	0.2	130.8	7.5	0.4	29.1	26.0	0.7	1.9	20.5	35.1	2.7	2.0	5.0	2.1	0.2	9.2	18.2	6.5	2.3	22.4	35.2	0.1	0.2	0.0	2.2	55.0	0.8	1.7	0.7	0.1	0.5	85.7	6.7	9.8	0.9	9.1	13.6	0.0	28.8	1.7	40.9	0.0	29.8	48.6	0.5	0.0	0.3	0.3	0.0	2.9	1.3	6.6	52.7	0.0	0.3	2.6	2.3	0.3	18.7	4.8	17.9	0.2	43.1	42.4	16.8	0.7	21.0	13.0	55.3	0.2	0.1	62.2	70.1	32.6	1.7	0.3	15.1	1.5	12.6	75.9	0.4	45.3	0.1	1.4	2.6	45.9	5.1	258.6	5.8	21.1	0.0	0.5	35.3	0.7	37.3	10.4	5.0	30.7	21.6	6.6	6.3	1.1	0.0	20.1	0.9	15.2	11.2	1.7	1.9	1.3	1.8	1.5	1.6	1.6	1.6	1.7	1.9	2.0	2.3	1.6	0.0	1.9	1.3	24.7	2.8	45.7	79.5	3.4	0.2	69.7	56.6	0.4	7.2	18.4	1.8	4.2	231.1	4.1	22.0	0.0	5.9	1.2	1.7	0.2	4.0	0.0	32.4	1.5	3.9	14.1	2.3	57.1	4.2	0.0	0.0	0.4	0.0	43.7	0.0	1.1	8.9	2.0	7.2	78.2	0.3	0.0	23.3	21.4	1.0	2.5	0.1	1.0	0.5	0.8	63.8	22.3	0.0	22.4	63.5	1.0	0.1	2.2	0.5	0.0	0.3	1.4	0.4	1.4	2.1	2.3	763.3	9.5	0.0	51.1	65.6
KCNQ1	"JLNS1, KCNA8, KCNA9, Kv7.1, KVLQT1, LQT, LQT1"	ENSG00000053918	"Potassium voltage-gated channel subfamily Q member 1"	P51787	11	2444684-2849105	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Calmodulin-binding, Ion channel, Potassium channel, Voltage-gated channel"	"Atrial fibrillation, Deafness, Diabetes mellitus, Disease variant, FDA approved drug targets, Long QT syndrome, Short QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 197.1;stomach 1: 98.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 47.6;Microglial cells: 71.2;Undifferentiated cells: 57.8"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 42.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HMC-1: 33.4;OE19: 41.4;RPMI-8226: 23.2;U-266/70: 11.5;U-937: 13.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB018656, HPA048553, HPA071107"	Enhanced		Supported	"Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	"Plasma membrane"	"CAB018656: AB_2131551, HPA048553: AB_2680438, HPA071107: "	"unprognostic (6.02e-2)"	"unprognostic (2.48e-1)"	"unprognostic (6.39e-3)"	"unprognostic (4.38e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.46e-2)"	"unprognostic (7.36e-2)"	"unprognostic (8.07e-2)"	"unprognostic (8.81e-2)"	"unprognostic (1.58e-1)"	"unprognostic (5.39e-2)"	"unprognostic (2.46e-3)"	"prognostic favorable (9.85e-4)"	"unprognostic (3.99e-2)"	"unprognostic (4.19e-2)"	"unprognostic (5.27e-2)"	5.4	197.1	2.1	9.0	2.4	14.2	3.0	2.4	2.6	16.5	5.7	22.6	47.8	2.9	14.1	2.9	8.9	19.5	28.4	2.6	2.6	25.3	1.8	15.9	5.0	4.1	3.1	1.4	61.2	21.4	5.5	7.6	3.9	6.1	15.2	0.7	20.0	50.2	1.0	1.2	39.7	3.1	4.0	8.2	98.9	1.6	4.2	3.6	71.6	1.6	2.9	14.7	1.6	4.4	0.0	0.1	0.0	5.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	2.6	1.9	5.2	0.0	0.4	0.1	0.7	0.0	0.0	0.4	1.3	0.0	3.7	0.4	0.3	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.7	0.0	0.7	1.3	41.4	0.2	0.1	0.0	23.2	8.0	2.7	0.7	5.6	0.7	0.0	0.0	0.5	0.2	10.3	0.0	0.0	0.3	0.2	0.0	11.5	0.0	0.0	0.0	13.4	0.0	0.7	3.1	3.1	0.0	1.8	0.0	0.8	0.4	0.1	3.8	0.3	1.0	1.2	3.3	0.0	2.8	1.3	0.3	1.0	2.1	2.4	2.4	2.6	2.6	2.6	4.1	3.1	3.9	4.0	4.2	4.4	7.1	3.2	12.9	0.3	8.4	0.6	8.0	4.2	0.0	1.7	6.1	1.8	18.6	14.3	7.1	29.5	0.0	1.1	0.3	34.0	15.6	23.2	2.0	3.3	0.4	6.3	6.6	0.4	13.7	21.7	1.4	1.0	23.4	4.9	19.7	47.6	9.3	1.1	17.3	0.0	20.0	26.1	8.2	25.4	15.9	0.9	0.3	19.6	1.8	71.2	11.0	0.5	1.0	43.7	34.9	15.3	20.2	0.0	6.4	5.2	30.9	2.0	4.4	0.5	6.6	0.4	1.7	0.2	0.2	0.1	1.0	2.1	4.0	16.6	57.8	20.4
KCNQ2	"BFNC, EBN, EBN1, ENB1, HNSPC, KCNA11, Kv7.2"	ENSG00000075043	"Potassium voltage-gated channel subfamily Q member 2"	O43526	20	63400208-63472677	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 91.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 16.5;Excitatory neurons: 61.7;Horizontal cells: 13.5;Inhibitory neurons: 37.5;Oligodendrocyte precursor cells: 50.8;Spermatogonia: 28.3"	"Cancer enriched"	"Detected in some"	9	"glioma: 8.7"	"Group enriched"	"Detected in many"	4	"amygdala: 55.7;basal ganglia: 37.2;cerebellum: 27.8;cerebral cortex: 91.9;hippocampal formation: 68.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.2;AN3-CA: 35.0;NTERA-2: 19.3;SCLC-21H: 67.8;SH-SY5Y: 119.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016642, HPA057112"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"		"HPA016642: AB_1855555, HPA057112: AB_2683339"	"unprognostic (2.35e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-4)"	"unprognostic (8.21e-6)"	"unprognostic (6.18e-2)"	"unprognostic (7.58e-2)"	"unprognostic (6.06e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.96e-2)"	"unprognostic (9.39e-2)"	"unprognostic (1.43e-5)"	"unprognostic (4.36e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.70e-2)"	0.0	6.2	55.7	0.1	37.2	0.0	0.0	27.8	91.9	0.0	0.0	0.6	0.1	0.0	0.1	0.0	0.3	0.3	0.2	68.1	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	1.1	0.0	19.1	0.0	0.1	1.6	0.0	2.2	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.2	10.6	1.0	0.0	0.0	0.0	0.0	0.0	0.1	12.9	0.0	0.0	21.2	35.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.6	0.0	8.3	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	19.3	0.5	0.2	0.0	0.0	0.1	0.0	0.0	67.8	119.3	0.1	0.0	0.0	0.8	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	55.7	37.2	27.8	91.9	68.1	0.0	2.6	0.0	0.1	0.0	1.0	12.9	0.6	0.0	0.0	7.2	0.1	0.1	0.0	0.0	0.0	5.7	0.0	0.3	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	16.5	0.0	0.1	1.0	0.0	0.0	61.7	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	13.5	37.5	0.2	0.0	0.0	0.0	8.1	0.6	0.1	0.0	1.0	0.0	0.9	0.0	50.8	2.1	0.0	0.0	0.4	0.0	0.3	0.0	0.1	0.0	2.5	0.0	0.1	0.1	7.4	28.3	0.0	0.0	0.0	0.3	0.0	0.1	0.0
KCNQ3	"EBN2, Kv7.3"	ENSG00000184156	"Potassium voltage-gated channel subfamily Q member 3"	O43525	8	132120859-132481095	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 23.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 501.5;Inhibitory neurons: 485.6;Microglial cells: 502.2"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 2.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-HME1: 6.6;JURKAT: 3.8;RPMI-8226: 2.8;U-2 OS: 4.3;U-87 MG: 3.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.90e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.45e-2)"	"unprognostic (3.65e-5)"	"unprognostic (2.32e-1)"	"unprognostic (4.60e-2)"	"unprognostic (5.57e-6)"	"unprognostic (5.82e-2)"	"unprognostic (7.32e-2)"	"unprognostic (6.09e-2)"	"unprognostic (7.09e-2)"	"unprognostic (3.22e-1)"	"unprognostic (2.71e-4)"	"unprognostic (1.14e-3)"	"unprognostic (3.52e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.50e-2)"	1.3	1.4	9.9	0.5	21.2	0.0	0.9	0.0	23.7	0.3	0.0	0.4	0.2	0.2	0.1	0.1	0.3	0.3	0.7	9.1	4.7	0.7	0.0	1.9	0.1	4.7	8.1	0.1	0.9	0.2	1.9	0.2	7.4	0.4	0.2	2.5	0.3	0.6	0.0	0.4	0.6	0.5	0.0	0.5	0.1	0.2	16.0	0.5	0.5	0.0	0.2	0.4	0.4	8.7	0.2	0.1	0.0	0.0	0.3	1.0	0.0	0.3	1.1	0.0	0.0	0.0	1.0	0.0	1.2	1.5	2.5	0.0	0.0	2.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	1.7	6.6	0.1	0.0	3.8	0.0	0.1	0.9	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	2.8	1.6	0.0	1.3	1.2	0.4	0.0	0.0	0.2	0.0	1.0	0.0	0.0	4.3	0.1	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	21.2	0.0	23.7	9.1	4.7	4.7	8.1	7.4	0.0	16.0	8.7	0.4	0.0	14.0	84.5	0.2	0.3	0.0	0.0	0.0	6.7	1.3	0.6	4.6	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	4.3	1.6	0.3	4.2	2.7	0.0	0.0	501.5	6.0	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.0	485.6	0.7	0.0	0.3	1.6	2.9	0.0	2.1	0.0	502.2	0.6	0.4	0.0	117.1	31.2	1.8	0.0	0.0	0.0	0.1	4.6	1.6	0.8	0.6	0.0	0.0	2.7	0.0	0.5	0.1	0.1	0.0	0.4	0.1	1.2	0.1
KCNQ4	"DFNA2, Kv7.4"	ENSG00000117013	"Potassium voltage-gated channel subfamily Q member 4"	P56696	1	40783787-40840452	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Hearing, Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 5.1;intestine: 5.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 5.1;Inhibitory neurons: 9.7;Muller glia cells: 4.2;Sertoli cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 5.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 1.8;HEK 293: 2.2;K-562: 2.6;MCF7: 1.4;REH: 1.3;THP-1: 1.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA018305	Uncertain					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA018305: AB_1855556"	"unprognostic (1.42e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.43e-3)"	"unprognostic (4.59e-3)"	"unprognostic (8.51e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.86e-2)"	"unprognostic (4.34e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.40e-2)"	"unprognostic (5.18e-4)"	"unprognostic (2.68e-1)"	"unprognostic (1.22e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.44e-2)"	0.9	0.1	0.1	0.3	0.6	0.0	0.6	0.2	1.7	0.9	2.4	5.4	0.4	2.8	0.1	1.0	2.3	0.3	0.6	0.2	0.2	0.1	0.1	0.5	0.0	0.7	5.1	0.5	0.4	0.2	0.3	0.5	0.7	1.1	0.3	0.4	1.4	1.1	3.2	0.6	1.2	1.5	0.8	0.0	1.3	0.2	0.1	0.3	0.2	1.0	0.0	2.3	0.7	2.0	0.0	0.1	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.0	2.2	0.9	0.1	0.0	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	2.6	0.0	0.0	1.4	0.3	0.0	0.2	0.0	0.0	1.3	0.0	0.0	0.2	0.0	1.1	0.2	0.0	0.6	0.2	0.1	0.1	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.2	1.7	0.2	0.2	0.7	5.1	0.7	0.8	0.1	2.0	0.3	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.4	1.8	1.5	2.1	0.0	0.0	0.0	2.1	0.1	0.0	0.5	0.0	1.2	0.2	0.2	0.1	0.3	1.8	0.8	5.1	0.2	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	2.2	0.0	9.7	1.2	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.0	4.2	0.0	2.5	1.5	0.6	0.5	0.7	0.3	0.2	0.0	0.0	0.0	0.3	6.6	2.0	2.8	0.2	0.7	1.0	0.4	0.0	0.0	0.1	1.1	0.1
KCNS1	Kv9.1	ENSG00000124134	"Potassium voltage-gated channel modifier subfamily S member 1"	Q96KK3	20	45091214-45101127	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"brain: 22.8"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.0;Cholangiocytes: 7.2;Collecting duct cells: 1.8;Excitatory neurons: 6.2"	"Cancer enriched"	"Detected in many"	5	"cervical cancer: 6.1"	"Region enhanced"	"Detected in many"		"cerebral cortex: 22.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HBF TERT88: 1.3;HHSteC: 2.1;hTEC/SVTERT24-B: 1.0;THP-1: 1.8;U-87 MG: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.46e-2)"	"unprognostic (2.95e-3)"	"unprognostic (2.03e-1)"	"unprognostic (3.11e-4)"	"unprognostic (8.91e-3)"	"unprognostic (6.01e-3)"	"unprognostic (7.47e-2)"	"unprognostic (8.94e-2)"	"unprognostic (4.37e-2)"	"prognostic unfavorable (6.45e-4)"	"unprognostic (6.74e-2)"	"unprognostic (4.65e-2)"	"unprognostic (6.35e-2)"	"unprognostic (5.62e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.39e-1)"	0.0	0.4	0.9	0.1	2.9	0.1	0.2	0.0	22.8	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.1	4.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	1.5	2.8	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.2	0.1	0.3	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.1	0.4	0.4	0.1	0.1	0.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.3	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.8	0.0	0.9	0.2	0.0	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.9	2.9	0.0	22.8	4.1	0.0	0.0	0.0	0.0	0.0	0.0	8.1	0.0	0.0	2.0	0.3	0.0	0.4	0.1	0.1	0.0	0.0	0.3	0.1	1.1	7.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	6.2	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.1
KCNS2	Kv9.2	ENSG00000156486	"Potassium voltage-gated channel modifier subfamily S member 2"	Q9ULS6	8	98426958-98432853	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 4.7"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.7;Endometrial stromal cells: 3.0;Excitatory neurons: 4.5;Inhibitory neurons: 1.7;Leydig cells: 1.5"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"cerebral cortex: 4.7;white matter: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"HSkMC: 2.1;SCLC-21H: 6.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051417	Uncertain					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA051417: AB_2681478"	"unprognostic (7.83e-2)"	"unprognostic (9.39e-3)"	"unprognostic (5.25e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.30e-5)"	"unprognostic (2.43e-2)"	"unprognostic (1.42e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-3)"	0.6	0.4	0.0	0.1	0.5	0.0	0.2	0.0	4.7	0.6	0.0	0.3	0.0	0.3	0.5	0.2	0.3	0.4	0.0	0.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.2	0.1	0.4	1.5	0.0	0.2	0.2	0.7	0.0	1.0	0.0	0.0	0.2	0.1	0.5	0.0	0.4	0.2	0.0	0.0	0.1	0.0	0.0	0.8	0.1	1.2	0.0	0.0	0.0	0.0	0.7	0.7	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	4.7	0.6	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	3.0	0.1	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0
KCNS3	Kv9.3	ENSG00000170745	"Potassium voltage-gated channel modifier subfamily S member 3"	Q9BQ31	2	17877847-18361616	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"lung: 23.5;skeletal muscle: 86.0;tongue: 45.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 28.9;Enteroendocrine cells: 32.5;Theca cells: 30.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 69.2;RPMI-8226: 28.9;RT4: 48.2;U-266/84: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014864	Approved		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus, Plasma membrane"	"HPA014864: AB_1852155"	"unprognostic (5.62e-2)"	"unprognostic (4.27e-3)"	"unprognostic (6.87e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.19e-1)"	"unprognostic (1.64e-2)"	"unprognostic (3.30e-1)"	"unprognostic (9.47e-3)"	"unprognostic (9.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.71e-2)"	2.9	1.1	2.6	3.8	2.9	0.0	6.2	3.9	4.0	7.8	9.5	12.5	3.7	3.2	2.6	6.0	3.9	5.4	6.6	2.9	4.2	5.0	3.8	23.5	0.6	10.5	7.9	1.0	9.8	2.9	1.2	11.0	12.5	6.5	5.0	0.4	11.2	3.1	86.0	5.6	5.4	3.3	5.3	1.0	9.5	3.9	4.3	1.4	2.3	45.5	2.0	6.8	6.3	4.4	8.5	1.4	0.7	0.0	1.6	0.8	3.8	2.8	8.5	1.7	2.0	0.1	17.1	0.0	0.9	3.0	1.9	2.7	20.7	0.1	1.8	0.0	5.7	0.0	0.2	0.1	8.1	0.2	0.7	0.7	12.9	0.1	1.2	15.5	0.4	3.9	0.4	0.0	1.0	2.2	0.0	0.0	10.2	11.5	0.2	2.4	69.2	28.9	1.8	48.2	20.3	0.7	0.0	5.3	6.1	4.8	2.8	0.0	0.2	2.7	0.0	0.2	21.6	0.1	34.9	0.1	15.2	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.9	3.9	4.0	2.9	4.2	10.5	7.9	12.5	5.3	4.3	4.4	3.8	28.9	8.2	0.0	0.0	13.9	16.8	6.9	21.1	0.2	11.5	7.0	0.5	18.6	6.8	11.0	0.0	0.6	0.0	10.9	0.0	21.5	0.3	0.9	0.6	5.9	32.5	0.0	0.3	0.4	3.5	12.1	8.2	0.9	1.3	4.3	2.5	5.4	0.5	0.0	16.9	5.6	14.2	0.0	4.5	1.2	1.5	0.4	21.4	1.9	0.7	0.1	0.0	7.1	2.5	2.4	4.9	3.8	1.2	13.6	4.1	5.5	1.7	0.2	6.6	13.5	10.6	0.3	3.4	8.0	5.8	0.8	0.6	30.6	10.3	7.1
KCNT1	"KCa4.1, KIAA1422, SLACK, Slo2.2"	ENSG00000107147	"Potassium sodium-activated channel subfamily T member 1"	Q5JUK3	9	135702185-135795508	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 37.1;lymphoid tissue: 15.8;skeletal muscle: 13.4"	"Group enriched"	"Detected in some"	8	"Excitatory neurons: 60.1;Inhibitory neurons: 55.0;Theca cells: 21.2"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Region enhanced"	"Detected in many"		"cerebral cortex: 37.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 2.5;RPMI-8226: 1.8;SCLC-21H: 3.7"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebellum: 42.8"	HPA059880	Uncertain					NA	NA				"Cluster 47: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA059880: AB_2684149"	"unprognostic (1.50e-3)"	"unprognostic (1.72e-2)"	"unprognostic (2.07e-3)"	"unprognostic (2.98e-13)"	"unprognostic (9.26e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.60e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.30e-3)"	"unprognostic (9.89e-2)"	"unprognostic (6.20e-2)"	"unprognostic (4.89e-7)"	"unprognostic (9.15e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.66e-2)"	0.4	0.1	3.9	0.1	7.9	0.1	0.3	1.9	37.1	0.3	0.0	0.3	0.1	0.1	0.1	0.2	0.6	0.2	1.2	4.2	0.0	0.0	0.1	0.3	0.0	4.5	0.0	5.0	0.1	0.0	8.7	0.3	2.8	0.1	0.0	0.4	0.2	0.0	13.4	0.1	0.2	0.0	0.0	15.8	0.5	0.9	0.0	0.0	0.1	8.2	0.0	0.2	0.2	12.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.0	0.0	0.8	1.8	0.0	0.0	3.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	7.9	1.9	37.1	4.2	0.0	4.5	0.0	2.8	0.0	0.0	12.5	0.0	0.0	0.0	3.6	0.1	0.0	0.3	0.0	0.0	1.3	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	60.1	0.0	0.0	0.4	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	55.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.0	0.3	0.0	3.5	2.7	0.0	0.0	0.7	0.0	0.1	0.0	0.2	0.0	0.6	0.0	5.1	1.1	0.3	1.0	0.0	0.0	0.0	0.1	21.2	0.0	0.0
KCNT2	"KCa4.2, SLICK, SLO2.1"	ENSG00000162687	"Potassium sodium-activated channel subfamily T member 2"	Q6UVM3	1	196225779-196609225	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"ovary: 3.8"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 220.2;Inhibitory neurons: 240.5;Oligodendrocyte precursor cells: 310.7"	"Cancer enhanced"	"Detected in some"		"renal cancer: 1.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HHSteC: 3.2;hTERT-RPE1: 9.0;SCLC-21H: 7.5;SH-SY5Y: 5.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA051218	Uncertain		Approved	Vesicles		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA051218: AB_2681392"	"unprognostic (5.06e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.10e-6)"	"unprognostic (1.22e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.03e-2)"	"unprognostic (5.90e-2)"	"unprognostic (2.18e-1)"	"unprognostic (9.56e-3)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.67e-5)"	"unprognostic (3.30e-4)"	"unprognostic (2.95e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.72e-3)"	1.0	0.6	0.9	0.1	2.0	0.0	0.4	0.0	2.0	0.4	0.3	0.5	0.2	0.3	0.4	1.0	0.5	1.4	1.8	2.5	3.3	0.3	2.8	1.8	0.1	0.0	0.2	3.8	0.1	0.0	0.9	0.2	0.0	1.0	0.5	0.1	0.5	0.6	0.1	0.3	0.4	0.5	0.6	0.2	0.5	1.1	1.0	0.1	1.1	0.8	0.1	0.8	0.4	0.5	0.0	0.1	1.8	0.0	0.2	0.2	0.0	0.0	1.0	0.1	1.8	0.0	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.9	0.0	3.2	0.0	0.0	1.2	0.0	0.4	0.1	9.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	2.4	0.0	0.1	0.0	0.1	0.0	0.0	0.5	7.5	5.6	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	2.0	0.0	2.0	2.5	3.3	0.0	0.2	0.0	0.6	1.0	0.5	0.8	41.7	1.1	6.8	0.0	0.4	0.2	0.0	0.6	0.0	0.0	0.1	1.4	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.0	0.2	0.8	0.0	0.0	220.2	0.0	0.0	9.3	0.0	0.0	0.0	6.1	2.5	6.2	0.0	0.0	240.5	0.0	0.0	0.0	0.7	3.3	6.5	0.0	1.8	58.1	0.0	0.0	0.0	310.7	6.1	0.0	0.0	4.9	0.0	0.1	0.0	0.4	0.0	0.0	0.0	1.4	4.0	0.6	0.2	0.0	0.0	0.0	0.0	3.9	0.0	0.2
KCNV2	Kv8.2	ENSG00000168263	"Potassium voltage-gated channel modifier subfamily V member 2"	Q8TDN2	9	2717510-2730037	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel, Voltage-gated channel"	"Cone-rod dystrophy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	59	"retina: 289.1"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 515.0;Rod photoreceptor cells: 530.1"	"Cancer enriched"	"Detected in single"	78	"testis cancer: 6.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031131	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA031131: AB_10609996"	"unprognostic (5.06e-2)"	"unprognostic (1.47e-3)"	"unprognostic (3.45e-3)"	"unprognostic (6.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.12e-3)"	"unprognostic (5.38e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.69e-1)"	"unprognostic (5.21e-2)"	"unprognostic (2.35e-1)"	"unprognostic (7.96e-8)"	"unprognostic (3.01e-1)"	"unprognostic (4.90e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.06e-2)"	0.0	0.0	1.1	0.0	1.0	0.0	0.0	0.1	1.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.9	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	289.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	4.9	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.0	0.1	1.3	0.9	0.1	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	49.6	0.0	0.0	0.2	0.0	0.0	0.0	515.0	0.0	0.0	0.0	0.0	0.0	81.5	0.0	0.0	2.3	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.2	1.3	0.0	0.0	0.0	0.0	25.3	0.6	0.0	0.0	0.0	0.0	69.1	0.0	0.5	1.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	530.1	13.1	0.0	0.0	7.4	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
KDELR1	"ERD2, ERD2.1, HDEL"	ENSG00000105438	"KDEL endoplasmic reticulum protein retention receptor 1"	P24390	19	48382575-48391551	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 605.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"NB-4: 856.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB017455	Approved		Supported	"Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	"Vesicles, Cytosol"	"CAB017455: AB_10615208"	"unprognostic (3.10e-2)"	"unprognostic (4.17e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (3.49e-4)"	"prognostic unfavorable (1.61e-4)"	"unprognostic (2.35e-2)"	"unprognostic (2.26e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.51e-1)"	"unprognostic (7.55e-2)"	"unprognostic (4.97e-2)"	"unprognostic (3.81e-1)"	"unprognostic (2.74e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.68e-2)"	109.3	124.4	58.0	61.7	56.5	45.8	106.6	54.5	59.7	132.5	78.1	120.3	132.5	110.0	117.3	107.3	112.2	100.9	96.6	56.1	62.5	119.5	127.2	101.4	53.3	61.1	59.1	165.8	138.9	191.7	116.2	128.7	59.0	102.5	128.5	39.0	137.7	105.0	76.8	103.8	114.5	100.6	56.2	79.5	120.1	93.7	62.9	51.6	121.8	58.4	73.2	102.5	102.4	58.0	216.2	305.3	173.1	184.7	379.7	440.6	126.5	207.4	363.9	247.0	281.0	202.3	238.7	89.1	132.6	456.4	154.4	187.6	211.1	222.2	234.0	72.7	224.5	74.4	99.4	382.2	329.6	84.1	133.4	419.6	268.0	168.5	178.5	387.4	233.0	75.3	131.7	160.9	333.1	173.6	79.4	856.7	126.3	426.8	122.5	112.1	103.4	141.0	316.2	176.3	172.9	134.5	182.1	160.6	113.1	196.7	126.6	102.1	182.6	173.4	142.6	145.3	179.3	451.1	382.0	60.2	110.1	112.4	181.1	10.8	41.0	12.6	18.1	34.7	20.8	17.0	17.6	19.7	30.6	14.3	14.3	16.1	9.9	20.2	30.2	45.4	20.4	18.2	58.0	56.5	54.5	59.7	56.1	62.5	61.1	59.1	59.0	56.2	62.9	58.0	150.8	35.3	54.2	8.5	82.2	75.3	130.6	147.1	124.7	39.4	141.0	154.4	28.8	98.7	110.9	93.8	6.2	231.7	59.5	153.0	56.7	224.1	6.2	72.0	188.8	111.4	145.0	56.8	8.7	169.0	605.5	161.0	120.3	166.3	62.7	149.2	102.8	79.6	180.0	40.4	12.7	379.6	93.6	107.6	73.5	14.2	163.5	103.1	92.5	8.4	102.3	89.8	35.0	10.6	10.6	190.3	199.8	132.0	365.9	161.2	213.8	149.6	49.2	28.1	85.5	87.9	131.6	41.8	69.1	127.7	70.2	387.7	55.4	191.3	202.9	157.6
KIDINS220	ARMS	ENSG00000134313	"Kinase D interacting substrate 220"	Q9ULH0	2	8721081-8837630	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Neurogenesis		"Disease variant, Hereditary spastic paraplegia, Mental retardation, Neurodegeneration, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 322.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014790	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA014790: AB_1852460"	"unprognostic (3.58e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.33e-2)"	"prognostic favorable (9.64e-4)"	"unprognostic (1.68e-1)"	"unprognostic (9.21e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.39e-2)"	"prognostic favorable (9.29e-6)"	"unprognostic (4.12e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.15e-1)"	21.2	21.6	20.9	14.5	40.6	24.4	19.6	34.9	27.5	22.3	21.6	19.6	11.4	29.3	15.3	15.1	16.6	17.7	21.9	22.1	28.9	22.1	15.7	23.6	13.1	43.9	31.5	37.7	18.8	42.8	16.9	21.4	43.4	20.0	16.5	38.0	14.5	18.0	14.5	16.7	13.8	23.6	35.7	17.1	16.5	10.6	32.0	21.6	20.0	16.7	12.3	16.7	17.9	73.9	13.5	21.3	41.8	26.8	51.4	33.9	21.9	26.2	21.6	16.4	15.0	21.5	13.5	25.2	26.1	39.4	31.5	22.5	37.9	16.1	24.0	36.4	25.7	22.7	15.9	22.6	36.3	23.6	29.9	35.3	24.9	26.1	33.7	25.1	25.9	21.6	44.7	30.8	29.2	14.8	24.2	12.7	22.7	22.3	18.8	22.7	30.7	12.7	21.7	25.4	35.4	59.3	20.8	20.7	23.6	21.7	13.3	26.6	34.4	36.1	19.0	36.6	28.5	22.4	21.1	33.5	21.1	31.2	28.1	4.1	3.4	4.2	3.6	3.9	2.6	1.9	2.6	3.0	2.7	1.8	2.7	3.1	5.3	3.2	4.6	1.8	2.4	2.2	20.9	40.6	34.9	27.5	22.1	28.9	43.9	31.5	43.4	35.7	32.0	73.9	57.1	99.3	115.7	129.6	25.2	32.8	27.6	25.1	19.9	86.2	31.3	25.0	40.2	25.8	48.6	29.5	139.7	21.5	35.0	33.9	0.0	33.3	1.3	32.3	77.8	51.8	43.3	36.4	108.3	23.6	10.0	55.0	39.8	53.1	35.4	144.0	47.8	30.9	28.8	154.8	149.2	23.4	44.7	52.7	46.0	5.9	69.6	45.9	24.9	60.9	44.2	60.5	34.0	162.3	322.2	29.0	29.8	65.5	27.3	25.7	24.5	10.5	34.4	58.0	6.6	65.4	54.2	28.1	23.4	26.4	29.5	10.9	40.2	52.1	23.9	36.0
KIF5B	"KNS, KNS1"	ENSG00000170759	"Kinesin family member 5B"	P33176	10	32009015-32056425	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"		"Motor protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009846, HPA037589, HPA037590"	Approved		Enhanced	"Centriolar satellite,Cytosol"		NA	Yes		97000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 10: Non-specific - Unknown function"	"Centriolar satellite, Cytosol"		"CAB009846: AB_2280915, HPA037589: AB_2675563, HPA037590: AB_2675564"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-2)"	"unprognostic (6.21e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.70e-1)"	"unprognostic (6.37e-3)"	"unprognostic (2.03e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.39e-1)"	"unprognostic (8.06e-2)"	"unprognostic (1.76e-1)"	59.7	41.8	110.0	46.7	128.2	84.9	45.3	107.7	149.7	47.3	75.6	66.4	52.0	54.1	30.3	52.7	39.2	59.8	87.4	85.8	100.2	44.7	31.9	52.5	39.9	121.9	123.8	27.6	41.8	91.6	22.9	54.4	120.6	65.9	63.6	45.1	39.1	52.0	65.0	38.9	54.7	81.3	128.1	48.1	51.4	64.4	116.8	44.0	50.5	67.3	36.6	60.8	29.8	143.4	115.8	96.4	127.3	89.9	89.2	97.7	54.4	155.6	73.3	117.6	99.6	106.6	124.0	78.7	65.8	185.8	66.9	93.3	117.6	99.4	156.4	68.4	64.1	100.2	87.9	104.5	102.5	70.5	105.6	79.9	138.0	135.8	94.0	93.4	152.8	68.2	122.9	80.5	164.7	69.7	74.0	39.7	20.7	110.1	43.4	95.7	237.2	32.6	90.6	79.5	123.3	89.9	120.4	47.5	117.3	88.0	57.5	99.4	128.4	118.7	111.0	139.3	117.2	24.2	29.8	90.9	113.2	142.2	114.1	41.8	25.9	44.0	19.1	33.0	18.7	23.7	24.0	20.6	24.7	24.3	21.1	20.8	51.1	24.3	35.7	47.9	29.4	18.4	110.0	128.2	107.7	149.7	85.8	100.2	121.9	123.8	120.6	128.1	116.8	143.4	160.3	182.7	206.8	49.3	86.3	213.1	177.7	200.6	66.0	181.9	119.0	103.8	396.0	115.8	198.4	104.8	100.1	121.0	125.5	145.0	45.0	209.4	185.5	167.8	171.4	181.0	132.3	69.2	44.6	176.0	134.9	141.2	85.6	158.9	91.2	159.7	88.5	46.2	132.7	151.4	56.0	227.3	213.6	111.8	129.1	51.8	59.0	137.2	101.4	84.3	169.3	160.5	82.4	61.9	83.3	202.2	164.9	130.9	84.2	254.1	120.2	59.5	206.1	123.8	85.5	176.0	244.8	566.0	195.6	87.6	236.7	331.9	116.0	137.4	208.1	246.8
KISS1R	"AXOR12, GPR54, HOT7T175"	ENSG00000116014	"KISS1 receptor"	Q969F8	19	917287-921005	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Hypogonadotropic hypogonadism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 8.5"	"Cell type enriched"	"Detected in some"	9	"Extravillous trophoblasts: 41.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 15.7;RPMI-8226: 37.4;SCLC-21H: 7.4;SH-SY5Y: 20.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"HPA007156, HPA071913"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	Vesicles	"HPA007156: , HPA071913: AB_2686471"	"unprognostic (1.54e-1)"	"unprognostic (3.01e-2)"	"unprognostic (9.42e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.46e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.23e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (7.17e-2)"	"prognostic unfavorable (3.33e-6)"	"unprognostic (1.87e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.05e-2)"	0.0	0.0	2.9	0.1	1.8	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	3.8	0.3	0.1	0.1	0.1	4.0	2.2	0.0	1.3	0.3	1.1	0.1	3.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.4	0.0	0.0	8.5	0.0	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.7	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.3	4.1	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	15.7	0.0	0.0	0.3	0.1	0.0	0.6	1.2	0.4	1.0	0.0	37.4	0.0	0.0	7.4	20.0	0.0	0.0	0.0	0.0	0.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.0	0.0	2.9	1.8	0.9	3.4	1.3	3.8	4.0	2.2	3.9	1.0	8.5	0.8	0.1	0.0	0.0	0.0	1.0	0.1	0.1	0.5	0.0	1.1	1.2	1.4	0.5	0.0	0.2	0.0	0.0	0.4	0.2	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.2	41.9	0.1	0.0	0.4	0.0	0.1	0.0	0.1	0.7	0.0	0.7	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.8	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.0	0.0	4.2	0.2	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.0	0.3	0.3	0.3	1.6	0.9	0.2	0.1	0.2
KL		ENSG00000133116	Klotho	Q9UEF7	13	33016423-33066143	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Glycosidase, Hormone, Hydrolase"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 47.1;kidney: 128.7;parathyroid gland: 135.2"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 123.3"	"Group enriched"	"Detected in many"	6	"prostate cancer: 5.9;renal cancer: 17.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HMC-1: 2.4;SK-BR-3: 4.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basal ganglia: 13.3;cerebral cortex: 6.7;hippocampal formation: 7.4;medulla oblongata: 4.2"						"Secreted to blood"	NA	NA	510000			"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.32e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.73e-3)"	"unprognostic (3.37e-1)"	"unprognostic (1.15e-4)"	"unprognostic (3.06e-2)"	"unprognostic (6.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (2.60e-1)"	"prognostic favorable (4.44e-4)"	"unprognostic (9.46e-2)"	"prognostic favorable (1.29e-9)"	"unprognostic (4.76e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.07e-1)"	3.3	1.4	0.9	0.8	3.1	0.1	2.5	0.8	1.5	1.8	47.1	2.1	2.7	1.2	8.8	1.1	0.8	1.3	1.1	4.2	1.1	128.7	0.4	3.5	1.0	0.5	0.5	0.1	1.2	135.2	0.3	30.4	0.5	8.0	0.9	0.0	0.8	2.5	0.7	0.6	2.6	1.2	0.6	2.4	2.0	0.5	0.8	0.5	1.3	1.5	0.5	1.6	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.1	0.8	1.5	4.2	1.1	0.5	0.5	0.5	0.6	0.8	0.5	15.8	0.0	0.5	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.6	0.3	1.0	0.0	0.7	12.9	0.0	0.2	0.0	0.4	5.9	0.0	1.8	0.1	2.5	10.2	16.3	0.4	1.2	0.0	0.1	1.6	0.0	0.1	0.0	0.1	1.1	0.2	2.8	0.0	0.5	1.1	0.0	0.9	1.0	0.8	0.3	1.9	0.0	6.5	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	3.6	1.8	123.3	0.7	0.0	0.0	1.1	2.3	1.4	0.5	0.0	0.1	0.1	1.1	0.1	1.9	0.1
KLB		ENSG00000134962	"Klotho beta"	Q86Z14	4	39406930-39451533	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"adipose tissue: 19.6;liver: 17.7;pancreas: 6.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 19.6;Enteroendocrine cells: 17.4;Hepatocytes: 51.4;Intestinal goblet cells: 12.1;Spermatocytes: 39.5"	"Cancer enriched"	"Detected in some"	16	"liver cancer: 11.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	24	"ASC diff: 6.7;Hep G2: 25.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA021136	Uncertain					NA	NA		320000	"Cluster 10: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA021136: AB_1852616"	"unprognostic (1.03e-2)"	"unprognostic (1.61e-2)"	"unprognostic (4.67e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.30e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.46e-1)"	"unprognostic (9.92e-2)"	"unprognostic (6.99e-3)"	"unprognostic (4.51e-3)"	"unprognostic (3.02e-3)"	"unprognostic (8.90e-3)"	"unprognostic (1.73e-1)"	"unprognostic (5.03e-2)"	"unprognostic (4.53e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.09e-2)"	19.6	0.1	0.2	0.2	0.4	0.3	3.5	0.9	0.6	0.0	0.0	0.6	0.2	0.0	0.0	0.3	0.2	0.1	0.1	0.2	0.2	0.2	17.7	1.6	0.0	0.3	0.0	0.0	6.0	0.1	0.0	0.0	0.2	0.1	0.5	0.0	0.4	0.0	0.0	0.6	0.6	0.0	0.0	0.0	1.3	2.8	0.1	0.0	0.0	0.2	0.1	0.1	0.1	0.3	0.0	0.3	0.1	0.0	6.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	25.7	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	0.1	0.3	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.2	0.4	0.9	0.6	0.2	0.2	0.3	0.0	0.2	0.0	0.1	0.3	0.6	3.2	19.6	0.0	0.7	0.5	1.1	1.4	0.0	1.6	0.7	1.1	1.2	0.0	1.2	0.0	0.0	0.4	0.5	1.6	0.0	1.1	8.5	4.4	1.5	0.4	17.4	0.0	0.5	4.3	1.5	0.5	2.6	2.2	0.0	0.2	0.4	51.4	0.2	1.7	0.6	12.1	2.0	1.0	0.6	3.2	1.5	0.4	1.8	0.0	0.1	0.4	0.0	0.5	0.2	0.9	4.8	0.7	0.0	1.2	2.1	1.1	0.4	2.3	0.0	1.2	0.5	39.5	0.9	2.0	0.9	1.4	0.8	0.5	1.1	1.1
KLRC4	NKG2-F	ENSG00000183542	"Killer cell lectin like receptor C4"	O43908	12	10407382-10409757	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 9.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 22.2;NK-cells: 8.2;Plasma cells: 4.7;T-cells: 11.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	20	"gdT-cell: 8.2;memory CD8 T-cell: 5.9;naive CD8 T-cell: 6.7;NK-cell: 4.7"	"Group enriched"	"Detected in many"	59	"NK-cells: 4.7;T-cells: 8.2"	"Cell line enhanced"	"Detected in some"		"HeLa: 5.5;SuSa: 1.8;U-698: 1.7"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 63: NK-cells & T-cells - Immune response"				"unprognostic (3.96e-2)"	"unprognostic (1.35e-2)"	"unprognostic (4.60e-1)"		"unprognostic (7.00e-2)"	"unprognostic (1.55e-4)"		"unprognostic (1.89e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.32e-1)"	"unprognostic (2.92e-1)"	"unprognostic (4.36e-1)"	"unprognostic (3.44e-7)"	"unprognostic (1.49e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (5.51e-3)"	0.8	0.7	2.0	2.3	2.1	1.7	1.5	0.9	2.0	0.6	0.2	1.2	1.3	0.8	0.6	0.8	0.5	2.2	0.3	1.6	2.0	0.2	1.2	1.8	4.7	2.2	1.6	0.4	0.1	0.0	0.1	0.5	1.8	0.4	1.3	0.1	1.1	0.1	0.0	0.1	2.6	0.5	1.2	9.4	2.3	0.6	1.9	0.6	0.7	0.0	3.2	0.6	0.5	2.8	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	5.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.3	0.0	0.0	5.9	0.0	0.0	0.0	6.7	0.1	4.7	0.0	0.0	0.0	1.8	2.0	2.1	0.9	2.0	1.6	2.0	2.2	1.6	1.8	1.2	1.9	2.8	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	22.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.4	0.0	0.0	0.4	0.0	8.2	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	11.1	0.2	0.0	0.1
KLRK1	"CD314, D12S2489E, KLR, NKG2-D, NKG2D"	ENSG00000213809	"Killer cell lectin like receptor K1"	P26718	12	10372353-10391874	"Cancer-related genes, CD markers, Predicted membrane proteins, Transporters"	"Adaptive immunity, Differentiation, Immunity, Innate immunity"	Receptor	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 22.1;lymphoid tissue: 42.9"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 7.2;NK-cells: 6.2;Plasma cells: 4.5;T-cells: 22.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	40	"gdT-cell: 287.4;MAIT T-cell: 111.5;memory CD8 T-cell: 261.2;naive CD8 T-cell: 258.8;NK-cell: 335.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 335.8;T-cells: 287.4"	"Cell line enriched"	"Detected in some"	9	"U-698: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"CAB021896, HPA068877"	Enhanced		Supported	"Plasma membrane"		NA	NA		47000	"Cluster 48: NK-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 58: T-cells - T-cell receptor"	"Plasma membrane"		"CAB021896: , HPA068877: AB_2686052"	"unprognostic (3.34e-4)"	"unprognostic (2.65e-4)"	"unprognostic (3.25e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.01e-5)"	"unprognostic (5.61e-4)"	"unprognostic (1.00e-3)"	"unprognostic (1.33e-1)"	"unprognostic (9.22e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.10e-2)"	"unprognostic (6.56e-10)"	"unprognostic (1.24e-2)"	"unprognostic (6.32e-2)"	"unprognostic (7.59e-2)"	"unprognostic (7.08e-10)"	5.5	2.1	1.7	12.6	1.9	22.1	4.1	1.7	2.8	2.2	1.2	3.9	4.7	2.5	2.3	2.2	2.8	7.3	1.8	1.7	2.0	2.0	5.5	12.1	37.0	2.0	1.7	2.4	1.1	0.5	1.1	1.4	1.8	2.5	4.5	0.4	4.4	0.9	0.8	1.3	12.2	1.8	1.7	42.9	7.2	2.5	1.7	9.9	3.6	1.5	19.0	4.5	3.2	2.4	0.3	0.0	0.7	2.8	0.2	7.1	0.7	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	2.6	0.0	0.0	0.2	0.2	0.0	0.7	1.4	0.0	0.3	0.0	0.4	0.2	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.1	0.8	0.3	0.1	0.1	0.0	2.0	0.2	0.3	0.1	0.1	0.8	0.0	0.0	0.0	0.0	64.2	0.2	0.0	0.3	0.4	0.5	0.2	287.4	0.6	111.5	6.2	1.7	261.2	0.6	6.1	2.3	258.8	4.8	335.8	1.3	1.9	0.7	127.9	1.7	1.9	1.7	2.8	1.7	2.0	2.0	1.7	1.8	1.7	1.7	2.4	0.0	0.0	1.3	0.0	2.4	0.0	0.1	0.2	1.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.4	0.2	0.0	0.5	1.8	0.0	0.5	0.0	6.2	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.1	0.0	22.2	1.0	0.0	0.0
KPNA1	"IPOA5, NPI-1, RCH2, SRP1"	ENSG00000114030	"Karyopherin subunit alpha 1"	P52294	3	122421902-122514945	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 221.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053627, HPA063426"	Supported		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA053627: AB_2682211, HPA063426: AB_2685013"	"unprognostic (6.23e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.82e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.02e-3)"	"unprognostic (2.86e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.77e-3)"	"unprognostic (7.89e-3)"	"unprognostic (5.22e-2)"	"unprognostic (9.09e-2)"	"unprognostic (5.43e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.77e-1)"	20.2	18.4	10.0	19.8	10.6	11.4	11.9	10.6	15.0	14.1	6.7	15.5	13.0	13.6	15.1	21.8	12.9	12.1	20.3	11.6	10.7	16.1	32.0	13.0	15.7	11.2	10.2	10.6	18.8	19.2	9.0	15.9	11.2	15.1	15.4	28.6	12.4	16.3	74.4	13.5	13.6	23.0	11.6	12.3	14.5	20.6	10.7	15.5	17.9	41.0	20.6	22.1	11.4	12.6	75.1	43.4	73.2	37.2	46.6	51.2	23.2	56.5	47.5	60.4	54.4	52.6	35.6	54.1	50.6	62.4	47.8	38.3	58.2	48.2	88.9	14.8	22.1	66.6	37.1	29.5	27.3	59.8	29.5	35.7	61.0	43.7	60.9	29.5	67.3	28.8	47.6	30.5	55.8	34.6	43.7	14.1	31.8	52.5	46.2	44.1	60.8	34.8	26.2	51.8	50.4	30.3	60.5	32.6	50.1	56.9	43.2	34.8	57.9	37.7	41.2	18.7	44.1	29.1	31.8	99.9	52.7	40.9	39.1	27.1	19.3	18.8	17.4	19.5	18.6	15.8	15.2	19.3	25.4	12.7	15.4	15.8	41.5	21.2	29.3	7.9	17.6	18.2	10.0	10.6	10.6	15.0	11.6	10.7	11.2	10.2	11.2	11.6	10.7	12.6	27.9	16.0	31.8	53.5	31.9	41.4	22.2	15.8	28.5	30.1	24.2	12.3	31.1	22.8	32.9	14.7	31.3	21.2	31.5	18.6	13.7	23.2	120.1	35.0	26.1	27.6	16.3	49.2	107.2	33.4	25.9	26.1	19.4	29.5	38.7	18.6	22.5	50.2	23.3	20.2	81.7	19.7	18.3	27.9	47.4	221.8	22.4	30.0	17.8	61.8	31.5	22.2	26.8	59.8	91.7	35.1	19.8	24.8	36.6	34.5	18.6	23.1	44.8	47.4	13.1	25.4	32.1	42.1	18.0	27.1	45.5	24.9	31.3	19.6	14.0	27.5
KPNA2	"IPOA1, QIP2, RCH1, SRP1alpha"	ENSG00000182481	"Karyopherin subunit alpha 2"	P52292	17	68035636-68047364	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 209.1"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 863.9;Extravillous trophoblasts: 279.7;Spermatocytes: 552.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB015460, HPA041270"	Enhanced		Enhanced	Nucleoplasm,Cytosol		Yes	Yes		160000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm	Cytosol	"CAB015460: AB_831493, HPA041270: AB_2677385"	"unprognostic (2.78e-2)"	"unprognostic (1.54e-1)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.64e-1)"	"unprognostic (5.16e-3)"	"prognostic unfavorable (2.12e-10)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (3.34e-2)"	"unprognostic (7.59e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.08e-2)"	"prognostic unfavorable (1.26e-13)"	"unprognostic (3.07e-2)"	"unprognostic (1.78e-1)"	"unprognostic (9.50e-2)"	"prognostic unfavorable (2.19e-4)"	25.9	15.9	18.9	45.2	19.3	99.2	15.2	18.7	23.3	17.4	15.7	30.7	26.1	17.6	25.7	41.4	10.8	19.4	23.9	20.8	24.7	16.2	23.1	17.9	72.1	19.1	20.5	6.5	10.0	10.6	15.6	43.8	22.2	8.2	35.8	22.2	15.4	11.6	14.8	21.0	23.3	34.6	20.5	28.3	19.0	209.1	20.0	94.7	10.9	16.7	104.9	38.6	17.7	22.7	556.0	712.3	667.1	264.4	95.7	93.9	421.1	467.9	372.9	758.1	587.9	499.5	250.4	514.4	146.7	273.4	375.1	297.4	753.8	359.4	870.7	203.8	437.5	446.5	311.7	482.7	101.9	387.6	294.3	58.1	69.3	426.0	267.2	105.8	746.8	211.0	360.8	346.0	686.1	517.3	484.4	249.8	451.4	455.2	365.8	271.5	605.1	280.6	304.0	250.0	262.2	286.3	269.5	839.1	291.9	609.6	495.6	196.9	288.6	416.7	506.2	290.6	647.3	291.5	451.9	504.7	203.0	334.9	458.0	30.1	31.0	12.7	24.1	46.5	19.2	45.8	18.8	27.3	56.2	39.6	13.3	21.5	0.9	43.9	39.6	41.4	37.7	31.3	18.9	19.3	18.7	23.3	20.8	24.7	19.1	20.5	22.2	20.5	20.0	22.7	41.0	12.8	31.0	6.2	49.4	109.7	32.2	73.7	43.3	20.1	39.8	45.5	13.8	7.2	39.7	18.4	8.4	128.3	96.4	27.7	15.6	31.4	863.9	70.8	55.1	48.6	42.9	70.9	8.5	25.5	279.7	64.9	31.1	68.0	44.4	68.2	21.8	17.2	126.0	32.0	7.3	27.6	97.6	42.9	132.1	266.6	19.3	60.0	53.4	3.7	72.1	31.2	18.6	6.6	5.9	20.7	11.9	14.7	60.3	27.6	9.3	31.2	22.7	20.0	32.9	52.4	74.1	552.9	185.2	61.3	88.5	118.9	79.8	28.0	49.3	24.2
KPNA3	"hSRP1, IPOA4, SRP1gamma, SRP4"	ENSG00000102753	"Karyopherin subunit alpha 3"	O00505	13	49699320-49792682	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport, Viral penetration into host nucleus, Virus entry into host cell"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 145.4;tongue: 94.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 316.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046852, HPA077643"	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA046852: AB_2679840, HPA077643: "	"unprognostic (4.20e-2)"	"prognostic unfavorable (2.80e-4)"	"unprognostic (3.69e-2)"	"unprognostic (1.23e-1)"	"prognostic favorable (2.03e-4)"	"unprognostic (6.27e-3)"	"unprognostic (6.79e-2)"	"unprognostic (9.40e-3)"	"unprognostic (1.56e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.93e-3)"	"unprognostic (4.66e-2)"	"prognostic unfavorable (3.81e-4)"	"unprognostic (9.78e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.68e-3)"	"unprognostic (4.60e-3)"	20.8	10.6	13.6	16.9	15.3	29.7	11.7	14.3	19.6	13.7	9.3	17.0	12.3	13.8	11.3	25.4	12.4	14.6	31.9	16.0	15.0	13.8	23.4	17.2	18.4	14.4	13.5	8.3	10.4	12.6	7.1	14.9	14.3	15.8	16.6	33.4	10.4	19.1	145.4	16.2	12.2	25.6	16.1	13.6	13.4	28.5	15.9	19.9	19.2	94.2	20.2	20.1	11.0	17.8	41.3	28.3	53.0	44.6	53.2	58.1	26.6	73.3	60.8	63.5	46.0	86.2	37.6	89.2	14.4	86.6	42.7	47.1	64.1	59.5	105.2	53.8	44.7	65.3	25.4	101.1	51.8	98.7	40.6	42.9	42.3	53.3	69.8	41.7	79.7	36.9	36.7	23.4	88.8	19.1	53.2	53.7	61.4	57.8	19.7	68.6	52.1	27.3	39.1	33.8	22.2	34.8	27.1	33.3	29.5	43.8	19.8	39.3	73.0	46.7	37.5	43.0	49.8	18.8	27.9	76.7	28.4	44.9	47.2	10.3	3.8	3.6	6.7	4.5	9.3	4.9	6.7	6.6	4.2	2.8	6.4	5.9	2.2	6.7	6.0	2.3	8.5	3.4	13.6	15.3	14.3	19.6	16.0	15.0	14.4	13.5	14.3	16.1	15.9	17.8	44.3	67.3	33.8	64.9	35.2	43.1	30.5	21.4	43.9	29.9	23.4	15.0	76.5	21.5	25.7	12.9	33.3	15.5	31.8	26.0	17.6	49.0	316.7	57.4	35.7	44.2	30.5	39.1	90.6	53.7	17.7	30.0	27.0	40.7	33.0	25.4	30.4	36.2	33.1	52.2	83.9	18.4	20.3	37.3	38.7	168.8	22.1	41.9	19.6	55.3	47.1	49.0	35.0	73.4	85.6	51.7	15.0	50.0	36.9	41.7	14.3	28.1	45.8	65.7	26.3	29.1	32.1	66.1	31.8	52.9	49.9	10.5	38.6	61.9	24.9	33.1
KPNA4	"IPOA3, MGC12217, MGC26703, QIP1, SRP3"	ENSG00000186432	"Karyopherin subunit alpha 4"	O00629	3	160495007-160565571	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.6"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034336, HPA043154, HPA045500"	Enhanced		Enhanced	Nucleoplasm		NA	NA		110000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB034336: AB_2281054, HPA043154: AB_2678343, HPA045500: AB_2679351"	"unprognostic (1.58e-1)"	"unprognostic (7.65e-2)"	"unprognostic (2.75e-2)"	"prognostic unfavorable (8.59e-4)"	"unprognostic (7.56e-2)"	"unprognostic (4.46e-2)"	"prognostic unfavorable (6.24e-7)"	"unprognostic (7.71e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (1.03e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.21e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.48e-1)"	20.2	8.1	4.4	12.0	5.4	15.2	11.1	7.2	10.8	11.1	2.7	16.9	8.8	12.7	8.5	16.5	9.0	9.7	23.3	5.8	7.3	11.1	12.2	11.0	10.4	6.2	5.5	9.0	13.2	11.0	6.3	11.9	6.5	11.6	8.5	13.2	10.5	12.4	124.6	11.3	9.8	13.5	5.9	11.2	12.1	12.2	5.5	11.2	10.3	59.8	12.0	14.3	11.8	6.9	103.4	29.9	20.0	32.7	30.3	27.8	39.7	70.7	39.6	41.0	33.0	38.5	32.1	52.6	73.8	59.9	52.5	45.8	27.4	38.2	50.2	77.0	20.5	52.8	15.2	9.0	37.7	49.3	33.8	22.0	18.5	38.5	76.6	27.5	53.9	26.5	44.2	33.5	45.5	13.8	38.0	17.7	53.9	33.7	31.4	33.9	41.6	50.4	21.9	22.9	23.3	24.8	60.8	29.7	55.7	22.8	33.7	14.4	72.9	39.4	36.0	37.3	87.9	80.4	50.4	96.3	30.9	45.4	31.6	7.7	2.3	2.9	1.8	3.5	2.5	2.3	1.6	2.6	1.7	1.5	1.3	2.0	4.2	4.0	5.7	1.5	2.7	1.8	4.4	5.4	7.2	10.8	5.8	7.3	6.2	5.5	6.5	5.9	5.5	6.9	70.5	38.5	25.1	40.1	62.8	123.6	87.3	24.3	60.3	58.6	59.4	48.1	158.8	30.0	38.4	11.0	79.2	26.1	54.5	65.0	35.2	36.5	24.3	71.2	63.2	60.7	28.7	38.1	48.5	37.7	25.3	55.1	45.9	92.1	31.6	57.6	37.5	34.7	39.2	53.8	52.9	38.1	28.5	47.9	97.2	18.4	33.8	80.0	44.4	49.6	43.2	57.5	28.8	45.8	69.2	77.4	44.3	34.6	65.2	86.5	32.0	40.2	40.6	69.6	32.9	102.4	67.4	38.2	25.3	85.3	126.0	40.6	60.6	36.1	43.7	104.4
KPNA5	"IPOA6, SRP6"	ENSG00000196911	"Karyopherin subunit alpha 5"	O15131	6	116681187-116741867	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 44.1"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 1: 227.6;Alveolar cells type 2: 240.9;granulocytes: 129.3;Respiratory ciliated cells: 143.6;Spermatocytes: 173.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"CAB026464, HPA054037"	Enhanced		Supported	Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 21: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB026464: , HPA054037: AB_2682351"	"unprognostic (9.64e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.72e-2)"	"unprognostic (3.56e-1)"	"unprognostic (6.60e-3)"	"unprognostic (6.98e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.19e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.12e-2)"	"unprognostic (1.51e-3)"	"unprognostic (3.02e-1)"	"unprognostic (6.12e-2)"	"unprognostic (8.00e-2)"	"unprognostic (4.79e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.43e-1)"	4.1	5.4	7.0	5.0	8.2	7.1	6.1	15.9	13.0	6.4	1.9	3.4	3.2	9.4	3.7	5.0	8.1	5.2	4.6	7.6	5.9	5.0	2.5	6.0	8.9	7.7	4.4	19.0	2.5	6.4	4.7	4.4	8.4	6.7	3.2	18.9	4.1	5.3	13.8	3.5	3.6	6.8	3.6	6.5	3.6	44.1	4.8	8.9	10.2	12.7	6.3	4.8	3.6	11.7	2.9	1.7	12.0	7.5	4.4	8.5	4.9	4.2	11.7	7.4	10.5	8.1	3.0	10.8	5.6	4.6	8.4	4.7	6.3	3.7	9.2	6.8	18.1	10.1	5.6	4.5	5.5	7.8	6.0	7.7	2.2	9.0	5.6	8.6	8.3	10.3	15.0	4.6	8.3	3.9	12.5	5.5	5.4	2.0	4.7	10.1	3.9	3.0	5.5	5.5	12.8	11.9	3.2	2.7	4.6	7.7	5.3	7.9	6.8	3.0	6.2	3.2	7.5	11.6	13.4	12.2	3.8	5.6	6.4	27.6	4.7	6.4	13.1	5.1	16.3	25.3	14.8	15.7	2.7	26.6	24.1	17.9	1.3	11.2	6.9	16.7	12.1	4.1	7.0	8.2	15.9	13.0	7.6	5.9	7.7	4.4	8.4	3.6	4.8	11.7	12.5	227.6	240.9	63.0	35.2	13.6	7.1	8.9	13.6	50.9	12.8	13.3	17.1	10.0	118.6	9.2	29.2	4.2	24.2	1.6	9.8	6.1	80.3	22.0	13.0	28.8	33.7	7.6	63.7	5.6	1.8	30.5	6.1	7.9	129.3	18.8	20.3	4.7	4.4	47.1	70.9	7.1	8.2	9.1	9.5	15.2	17.7	21.5	10.6	41.2	7.6	34.7	10.3	64.3	56.7	6.0	1.5	16.6	15.8	8.9	2.4	6.5	143.6	38.8	13.1	16.8	15.4	173.4	10.6	8.8	8.9	3.3	31.9	15.9	4.2	3.8
KPNA6	"FLJ11249, IPOA7, KPNA7, MGC17918"	ENSG00000025800	"Karyopherin subunit alpha 6"	O60684	1	32108056-32176563	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 294.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018863	Supported		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol	Nucleoplasm	"HPA018863: AB_1852632"	"unprognostic (8.58e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.95e-1)"	"unprognostic (3.30e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.34e-2)"	"prognostic unfavorable (9.28e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.24e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.32e-2)"	"unprognostic (1.73e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.57e-2)"	14.2	15.4	12.8	11.0	13.9	20.5	13.1	12.4	15.1	15.4	12.7	17.7	8.8	17.1	12.8	18.8	14.2	8.8	22.0	13.8	17.2	13.8	15.8	15.1	11.1	15.7	16.3	13.4	13.4	24.6	14.3	16.6	18.2	13.9	13.0	17.1	13.4	14.3	39.3	18.5	12.5	17.8	12.0	12.0	14.8	20.2	14.6	12.8	13.5	23.7	14.8	15.6	15.6	14.5	32.0	24.8	21.6	28.0	32.5	28.4	25.3	25.2	29.5	36.0	34.5	27.8	33.9	26.5	29.1	45.6	21.6	26.7	33.5	38.5	45.6	27.0	18.4	27.4	36.4	22.6	28.7	30.4	21.5	28.9	35.8	44.6	42.3	30.3	38.1	20.5	27.0	23.7	34.4	17.5	24.6	17.3	50.5	20.6	18.3	24.5	31.0	21.7	31.4	28.9	20.7	17.4	45.8	27.1	25.0	52.6	19.2	15.9	44.5	33.1	22.7	43.8	36.6	16.9	20.7	20.3	36.3	27.8	32.4	3.2	7.4	7.2	7.7	9.1	7.5	5.3	6.5	6.0	6.0	6.1	7.4	7.2	4.2	3.8	9.9	6.7	7.3	5.3	12.8	13.9	12.4	15.1	13.8	17.2	15.7	16.3	18.2	12.0	14.6	14.5	27.9	41.7	41.5	33.0	36.1	63.6	36.9	37.6	22.2	48.6	44.7	26.7	32.7	37.1	32.4	29.5	58.4	45.4	42.4	29.5	17.6	36.2	294.2	41.0	44.6	40.4	46.1	52.8	62.5	31.6	41.6	35.7	25.5	49.3	13.9	31.3	36.0	77.3	30.4	52.2	58.4	36.0	24.4	36.8	44.8	65.2	34.2	29.3	24.9	30.0	41.4	29.0	47.4	40.7	54.3	46.1	26.4	40.6	24.1	56.7	25.3	33.2	48.2	44.7	32.9	53.1	36.7	78.7	56.2	31.2	85.1	135.7	31.7	31.8	35.6	59.0
KPNB1	"IMB1, Impnb, IPO1, IPOB, MGC2155, MGC2156, MGC2157, NTF97"	ENSG00000108424	"Karyopherin subunit beta 1"	Q14974	17	47649476-47685505	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029878, CAB034449, HPA050302"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Cytosol"		Yes	No		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"CAB034449: AB_2133993, HPA029878: AB_10670041, HPA050302: AB_2681079"	"unprognostic (2.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.81e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.15e-2)"	"prognostic unfavorable (2.55e-7)"	"unprognostic (7.18e-3)"	"unprognostic (9.52e-2)"	"unprognostic (5.47e-3)"	"unprognostic (4.37e-2)"	"unprognostic (8.41e-3)"	"prognostic unfavorable (8.43e-6)"	"unprognostic (1.34e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.41e-2)"	"unprognostic (3.44e-2)"	57.6	44.9	31.6	74.4	33.6	35.9	53.4	34.7	32.2	49.9	30.5	55.3	35.9	47.5	29.5	66.0	49.6	47.2	53.6	31.2	37.1	48.8	50.6	42.6	81.7	38.2	39.8	64.3	38.1	56.3	28.1	55.4	37.1	44.4	63.6	49.0	39.2	45.7	91.0	38.7	38.8	66.6	37.2	54.0	43.3	100.9	33.9	117.3	57.4	88.3	108.7	79.6	40.5	47.3	273.2	485.0	324.6	259.1	152.8	265.8	271.6	345.4	307.0	441.6	339.3	853.2	161.5	385.8	210.4	343.8	301.8	186.3	607.2	316.3	691.1	212.1	344.7	421.2	408.7	241.6	148.4	485.5	238.9	209.6	140.5	511.7	509.2	202.3	305.8	203.0	461.3	237.5	349.4	288.8	464.9	97.2	270.6	199.4	300.2	250.1	563.3	216.4	156.2	444.2	267.5	240.5	233.3	121.7	176.6	388.4	253.9	157.6	248.7	463.9	264.7	252.8	412.9	258.8	373.0	542.6	216.1	224.2	325.8	3.1	2.9	6.1	4.1	3.6	5.8	4.0	4.7	5.1	1.8	4.0	4.5	4.3	12.2	3.5	4.4	3.0	3.4	2.4	31.6	33.6	34.7	32.2	31.2	37.1	38.2	39.8	37.1	37.2	33.9	47.3	76.8	128.2	71.9	42.7	138.3	125.7	101.1	67.8	165.0	96.5	110.8	89.5	132.7	88.6	75.2	44.1	68.8	132.7	93.9	69.5	41.1	117.1	55.8	71.2	123.1	110.5	123.8	148.7	51.4	119.5	147.5	102.9	72.4	106.3	76.1	147.2	128.8	97.5	124.1	80.8	48.2	82.2	44.7	115.0	91.6	41.7	96.9	102.7	60.5	30.9	152.8	83.4	80.3	39.2	58.2	147.0	69.8	121.5	163.4	149.7	49.2	48.0	60.6	90.2	98.6	107.0	104.6	291.6	186.0	163.9	143.5	158.2	108.1	138.8	128.4	128.1
LAMP1	CD107a	ENSG00000185896	"Lysosomal associated membrane protein 1"	P11279	13	113297239-113323672	"CD markers, Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 709.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004260, HPA014750"	Supported					NA	NA		370000000	"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB004260: AB_626851, HPA014750: AB_1846219"	"unprognostic (3.98e-1)"	"unprognostic (1.18e-1)"	"unprognostic (7.55e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.04e-1)"	"unprognostic (7.04e-3)"	"unprognostic (9.26e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.80e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.91e-3)"	"unprognostic (2.04e-1)"	"prognostic favorable (4.15e-5)"	"unprognostic (2.06e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.54e-1)"	139.2	95.3	83.6	84.1	118.7	72.1	124.6	114.3	89.9	119.3	54.5	108.0	109.8	136.0	103.4	125.1	98.7	91.3	101.3	82.9	96.9	149.1	183.8	148.7	77.2	120.6	106.5	101.7	174.3	109.9	95.0	107.9	119.7	98.0	65.9	35.7	145.0	94.8	71.3	182.3	112.7	92.5	104.7	102.3	108.5	84.8	112.6	63.4	126.7	46.6	55.6	118.6	110.9	138.0	271.7	92.3	93.9	258.1	514.7	192.5	176.7	311.9	325.1	189.8	252.1	181.8	491.1	63.7	139.1	318.6	324.9	338.7	92.9	198.1	128.7	133.8	153.1	105.5	167.6	172.5	265.9	324.5	236.2	236.4	264.6	176.3	114.4	308.4	232.2	61.0	89.3	90.9	236.8	108.9	66.0	158.2	71.5	258.4	99.9	96.1	81.4	96.5	172.3	200.9	85.7	90.1	183.3	268.5	187.6	89.8	259.6	228.0	355.1	193.5	208.2	258.8	141.4	169.4	178.8	66.6	323.4	318.8	229.7	3.8	4.9	9.5	4.0	4.0	3.4	2.2	3.1	4.4	2.5	2.1	3.4	2.8	6.8	3.9	4.4	5.4	3.6	2.1	83.6	118.7	114.3	89.9	82.9	96.9	120.6	106.5	119.7	104.7	112.6	138.0	152.4	86.6	67.2	31.3	64.5	140.8	144.5	68.3	70.0	42.4	131.1	92.5	56.9	123.0	51.4	183.9	77.2	195.6	103.6	248.7	41.1	99.0	272.1	72.7	73.4	113.9	119.2	50.9	22.3	62.3	198.5	173.6	60.6	101.3	71.0	71.3	162.1	303.3	282.9	30.3	22.4	111.1	32.6	208.9	56.8	709.0	163.8	167.6	99.6	34.7	77.6	50.1	104.0	29.7	83.2	82.7	199.2	170.4	51.8	101.4	288.1	178.1	45.1	84.5	118.3	85.0	107.1	163.1	124.7	96.1	197.5	312.4	94.8	72.4	128.6	124.0
LAMP2	CD107b	ENSG00000005893	"Lysosomal associated membrane protein 2"	P13473	X	120426148-120469365	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Disease variant, Glycogen storage disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 507.2;Syncytiotrophoblasts: 402.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 556.6"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 556.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005272, HPA029100"	Supported		Supported	Vesicles		NA	NA		520000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"CAB005272: AB_647855, HPA029100: AB_10795022"	"unprognostic (2.99e-3)"	"unprognostic (5.26e-2)"	"unprognostic (2.66e-3)"	"unprognostic (1.74e-1)"	"unprognostic (3.10e-1)"	"unprognostic (2.50e-2)"	"unprognostic (4.84e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.55e-1)"	"unprognostic (9.73e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.85e-1)"	"unprognostic (6.78e-2)"	"unprognostic (2.66e-1)"	"unprognostic (5.53e-3)"	54.2	68.7	80.3	38.3	144.2	62.8	56.3	109.1	135.5	64.9	52.7	39.2	44.3	44.3	55.1	79.4	44.1	69.6	45.3	81.6	101.8	85.5	129.9	54.2	34.1	113.0	112.6	49.1	57.8	64.2	32.2	47.9	120.6	62.2	35.0	32.6	102.1	55.1	111.6	67.2	42.4	42.8	100.5	39.5	51.8	26.2	100.9	59.3	61.7	67.4	36.6	43.4	63.3	211.7	53.8	47.5	40.1	49.7	367.0	140.9	91.5	79.3	130.4	77.1	134.4	42.7	90.3	47.9	73.1	132.7	236.2	84.9	56.7	67.2	125.5	43.6	37.2	35.8	46.4	54.3	148.1	158.9	73.2	151.5	114.8	108.1	75.1	188.6	107.5	32.5	42.1	122.9	117.2	79.3	45.3	80.2	29.0	63.7	42.6	35.1	65.3	73.1	102.3	36.9	14.0	22.6	99.7	93.0	196.5	57.4	64.7	173.0	122.5	114.1	58.7	176.2	261.5	68.5	78.6	30.2	131.4	182.4	284.4	30.6	114.9	224.1	27.1	97.1	20.6	17.1	24.3	24.5	64.2	22.5	23.4	21.8	556.6	31.8	96.2	33.4	33.4	66.3	80.3	144.2	109.1	135.5	81.6	101.8	113.0	112.6	120.6	100.5	100.9	211.7	75.7	73.7	53.8	52.2	29.8	100.9	92.5	262.7	64.9	17.6	74.0	58.3	37.3	173.0	155.3	66.2	14.6	163.7	44.3	52.1	39.2	217.7	3.3	103.4	74.1	69.9	36.6	14.1	32.4	70.6	128.3	113.7	38.7	168.1	17.7	46.7	87.8	176.8	208.0	18.5	40.7	32.6	134.3	133.1	80.4	8.6	113.7	135.5	131.6	33.7	132.7	116.3	50.4	57.3	507.2	62.5	54.4	109.9	66.6	100.8	97.5	154.7	75.6	11.5	39.5	176.8	61.7	6.4	13.7	78.8	136.2	402.4	34.5	71.0	34.8	92.9
LAPTM4B	LC27	ENSG00000104341	"Lysosomal protein transmembrane 4 beta"	Q86VI4	8	97775057-97853013	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"retina: 380.1"	"Cell type enhanced"	"Detected in all"		"Granulosa cells: 348.5;Rod photoreceptor cells: 575.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.3"	"Group enriched"	"Detected in many"	7	"granulocytes: 3.3;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"HEL: 611.7;RPTEC TERT1: 549.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB020782, HPA068830"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 54: Non-specific - Microtubule organization"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus"		"CAB020782: , HPA068830: AB_2686044"	"prognostic unfavorable (5.63e-4)"	"unprognostic (1.91e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.06e-2)"	"prognostic unfavorable (5.70e-4)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (9.25e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.26e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.14e-1)"	"unprognostic (9.16e-2)"	"unprognostic (1.49e-1)"	24.2	43.2	30.2	18.0	29.7	5.3	42.9	37.3	29.6	50.1	78.2	34.0	79.7	71.0	29.3	33.7	67.5	46.3	220.9	23.6	35.3	67.3	25.3	39.6	13.7	42.1	36.1	45.1	28.8	185.5	20.3	28.2	39.5	29.2	32.9	380.1	32.8	44.9	153.7	43.9	43.0	47.8	45.2	38.3	32.2	62.5	44.2	8.6	43.0	117.0	20.2	41.0	28.5	50.1	219.2	170.8	171.9	350.3	80.2	61.0	108.1	98.0	50.1	222.9	188.6	103.1	168.0	1.0	378.0	73.5	75.2	241.2	208.8	94.8	242.9	1.5	282.4	611.7	130.6	169.0	66.1	0.3	101.5	83.8	71.0	130.8	66.0	75.1	29.1	69.5	375.7	0.8	92.4	164.1	54.5	34.1	318.8	116.5	106.5	0.6	90.5	0.7	549.4	100.9	172.8	287.1	133.6	63.8	159.4	188.0	154.3	83.7	8.1	47.7	92.0	99.0	70.7	22.4	68.8	2.2	60.8	0.5	144.9	3.3	0.1	0.0	0.5	0.0	1.4	0.3	0.4	0.3	0.1	0.1	0.8	0.9	0.1	0.3	0.0	0.1	0.2	0.2	30.2	29.7	37.3	29.6	23.6	35.3	42.1	36.1	39.5	45.2	44.2	50.1	60.5	102.5	56.1	8.5	4.9	55.2	68.1	63.9	89.4	195.9	59.8	55.6	208.1	82.9	30.9	106.7	223.1	26.6	3.9	17.9	39.2	244.5	7.1	70.6	59.6	77.4	35.4	36.6	15.0	123.6	33.2	72.2	19.4	105.6	12.7	348.5	132.8	32.6	8.6	134.6	36.6	29.6	59.0	3.7	10.1	8.6	23.9	6.6	42.7	4.7	2.8	135.0	1.0	19.1	20.1	72.1	34.4	30.9	1.7	77.0	95.9	62.1	10.5	575.3	59.2	62.6	75.4	7.4	35.8	45.1	44.3	14.1	10.2	119.9	52.1	86.4
LAPTM5		ENSG00000162511	"Lysosomal protein transmembrane 5"	Q13571	1	30732469-30757774	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 1285.7;lymphoid tissue: 672.2"	"Group enriched"	"Detected in many"	4	"B-cells: 872.9;dendritic cells: 340.2;granulocytes: 639.8;Hofbauer cells: 1150.4;Kupffer cells: 942.2;Langerhans cells: 489.6;Macrophages: 925.0;monocytes: 446.1;NK-cells: 562.3;T-cells: 432.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 554.0;HEL: 1053.2;HL-60: 676.4;HMC-1: 2382.4;REH: 785.2;U-698: 898.1;U-937: 542.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051293	Approved		Approved	Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA051293: AB_2681424"	"unprognostic (3.12e-2)"	"prognostic favorable (3.40e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.05e-3)"	"unprognostic (1.63e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.22e-3)"	"unprognostic (2.30e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic unfavorable (5.89e-5)"	"unprognostic (9.47e-2)"	"unprognostic (8.18e-3)"	"unprognostic (5.98e-2)"	"unprognostic (3.94e-2)"	144.7	82.1	47.6	443.0	49.7	1285.7	60.4	49.7	90.4	53.1	55.7	82.2	68.1	27.3	16.7	49.5	46.8	137.9	31.6	45.2	62.7	30.5	98.6	284.9	672.2	82.4	67.3	16.4	30.2	21.8	22.6	145.2	75.8	31.5	90.6	5.9	38.5	30.9	9.2	24.0	155.9	93.5	69.2	491.1	72.9	10.9	81.1	298.3	38.5	20.9	636.5	161.1	22.8	114.9	1.2	0.0	1.7	0.0	0.1	0.1	0.6	0.9	0.3	0.5	0.1	0.7	1.2	554.0	56.0	1.7	1.9	2.2	0.0	0.8	0.5	62.3	0.0	1053.2	0.0	1.6	0.9	676.4	2382.4	0.6	1.2	0.6	4.1	0.3	124.2	70.7	13.8	34.0	8.8	0.0	117.5	142.2	0.7	0.0	0.0	785.2	99.6	391.6	0.8	0.1	0.6	0.4	1.3	1.3	1.1	1.0	0.5	422.2	145.3	0.6	3.0	0.6	3.4	2.7	0.7	898.1	3.1	542.8	1.8	1094.2	1522.8	1446.7	538.5	1046.1	616.3	823.6	485.5	502.8	825.7	1089.4	481.2	481.2	1709.5	327.0	1075.7	392.7	656.9	2740.4	47.6	49.7	49.7	90.4	45.2	62.7	82.4	67.3	75.8	69.2	81.1	114.9	62.9	25.6	100.4	0.0	872.9	23.8	1.1	1.3	4.0	0.0	6.2	10.4	5.5	14.3	13.9	3.7	0.0	5.8	340.2	0.8	0.0	1.2	2.0	1.4	0.9	60.2	1.2	78.2	0.2	0.7	8.4	12.3	10.2	1.1	639.8	0.2	47.2	9.4	1150.4	0.0	0.8	0.9	0.0	942.2	489.6	4.9	1.5	925.0	49.8	43.1	446.1	0.3	562.3	0.5	0.5	1.4	0.2	0.4	144.8	0.9	0.5	3.0	11.4	1.3	0.0	4.1	5.6	0.3	1.1	1.8	20.0	8.9	432.7	18.2	2.4	1.9
LBP	BPIFD2	ENSG00000129988	"Lipopolysaccharide binding protein"	P18428	20	38346482-38377013	"Plasma proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity, Lipid transport, Transport"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	23	"liver: 1338.5"	"Cell type enriched"	"Detected in some"	30	"Hepatocytes: 458.3"	"Cancer enriched"	"Detected in many"	20	"liver cancer: 356.7"	"Region enhanced"	"Detected in single"		"medulla oblongata: 1.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"ASC diff: 10.7;HSkMC: 12.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA001508, CAB025905"	Approved				"Secreted to blood"	NA	NA	25000000000	1300000000		"Cluster 62: Liver - Hemostasis"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB025905: , HPA001508: AB_1079241"	"unprognostic (4.20e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (4.54e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.80e-2)"	"unprognostic (2.53e-2)"	"unprognostic (5.50e-2)"	"unprognostic (2.48e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (3.62e-12)"	"prognostic unfavorable (5.76e-4)"	"unprognostic (1.69e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.67e-1)"	58.2	0.5	0.0	24.2	0.1	0.5	6.6	0.0	0.2	4.6	0.0	0.5	0.0	2.6	0.0	0.1	0.6	0.2	3.3	0.0	0.0	8.7	1338.5	1.2	2.8	1.1	0.1	0.2	1.7	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.4	0.0	22.8	0.6	0.6	1.5	0.0	0.5	0.6	0.7	0.4	0.1	3.9	2.0	0.3	0.7	0.2	0.3	0.0	0.1	0.1	0.0	10.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.1	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	1.1	0.1	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.5	8.6	0.7	0.0	0.0	0.1	0.0	0.0	7.9	0.8	1.0	0.1	0.2	0.5	0.0	10.7	0.3	11.0	0.1	0.8	0.0	0.7	0.0	0.0	9.7	458.3	0.3	0.0	0.3	0.0	0.0	8.5	0.0	0.3	0.6	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.2	5.1	0.0	0.0	0.0	0.1	0.0	15.2	0.1	0.0	0.0	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.0
LETM1	SLC55A1	ENSG00000168924	"Leucine zipper and EF-hand containing transmembrane protein 1"	O95202	4	1811479-1856156	"Human disease related genes, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 116.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011029, HPA011100"	Supported		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA011029: AB_1852804, HPA011100: AB_1852802"	"unprognostic (1.16e-1)"	"unprognostic (1.80e-1)"	"unprognostic (3.85e-2)"	"unprognostic (5.04e-2)"	"unprognostic (5.48e-1)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (1.79e-4)"	"unprognostic (1.37e-3)"	"unprognostic (1.87e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.77e-4)"	"prognostic favorable (8.90e-4)"	"unprognostic (8.06e-3)"	"unprognostic (3.24e-1)"	"unprognostic (1.57e-2)"	"unprognostic (2.42e-1)"	13.6	16.3	14.3	7.9	13.7	7.7	10.8	11.7	14.6	8.2	10.8	20.3	13.9	8.4	3.2	23.8	8.0	4.5	19.6	13.4	13.2	13.3	16.4	8.9	7.0	12.7	13.5	9.2	12.5	11.4	8.8	4.9	11.9	8.4	10.7	4.5	9.6	4.2	18.7	15.9	11.7	5.1	12.2	10.7	13.8	14.5	15.0	25.7	10.7	10.9	7.9	8.4	10.6	11.6	22.9	38.1	11.6	36.1	17.4	12.2	20.7	22.1	10.7	21.8	16.9	35.5	24.7	37.5	15.4	23.3	34.0	22.7	29.8	31.2	13.2	25.1	31.1	38.4	30.9	25.6	22.6	39.3	30.3	19.9	22.0	24.9	21.8	10.1	19.0	22.6	51.5	22.9	15.3	25.1	57.3	44.7	30.5	24.7	43.2	32.4	16.2	21.9	17.0	31.3	29.5	26.0	25.2	31.5	13.3	10.0	29.7	20.3	28.8	24.8	14.8	21.1	37.3	19.8	32.7	29.3	22.0	33.8	20.2	3.9	3.7	2.0	5.8	5.0	5.7	4.2	4.9	4.9	4.1	3.6	3.2	4.6	0.5	5.9	5.1	12.9	4.2	2.1	14.3	13.7	11.7	14.6	13.4	13.2	12.7	13.5	11.9	12.2	15.0	11.6	12.2	16.0	11.5	15.0	19.2	40.0	40.7	13.4	8.0	19.4	19.7	10.5	23.3	11.5	14.0	27.6	33.3	17.5	24.9	116.1	31.3	25.5	32.2	9.1	19.4	16.7	15.6	20.4	14.3	31.3	22.6	17.0	32.1	14.7	10.2	17.9	16.1	33.3	21.5	15.2	12.4	29.5	12.2	18.4	19.8	45.1	20.2	13.0	19.6	4.7	13.9	12.7	28.8	9.5	13.2	42.4	52.7	16.6	17.8	58.8	48.8	46.1	5.6	28.4	13.1	23.8	16.1	54.2	44.4	25.2	51.1	15.2	16.7	21.9	53.2	48.4
LHFPL4	GARLH4	ENSG00000156959	"LHFPL tetraspan subfamily member 4"	Q7Z7J7	3	9498361-9553822	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 15.5;pituitary gland: 12.2;retina: 9.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 42.4;Cone photoreceptor cells: 18.8;Excitatory neurons: 60.0;Inhibitory neurons: 67.2;Oligodendrocyte precursor cells: 34.2;Rod photoreceptor cells: 17.4"	"Group enriched"	"Detected in some"	4	"glioma: 6.8;testis cancer: 5.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 13.5;NTERA-2: 4.4;SCLC-21H: 10.0;SH-SY5Y: 12.5;U-266/84: 11.3;WM-115: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041421	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Golgi apparatus"	Nucleoplasm	"HPA041421: AB_10796673"	"unprognostic (6.81e-2)"	"unprognostic (3.65e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.77e-1)"	"unprognostic (1.90e-2)"	"unprognostic (6.78e-2)"	"unprognostic (2.99e-1)"	"unprognostic (3.03e-3)"	"unprognostic (8.21e-2)"	0.0	2.0	11.1	0.0	11.4	0.0	0.0	7.1	15.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	11.3	12.7	0.0	0.0	0.0	0.0	10.4	7.4	0.0	0.5	0.1	12.2	0.0	10.2	0.0	0.2	9.3	0.0	0.0	0.0	0.1	0.2	0.0	3.3	0.0	0.2	0.7	12.1	0.0	0.0	0.0	0.0	0.0	0.0	9.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.4	1.5	0.0	0.0	0.0	0.0	0.0	0.0	10.0	12.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.1	2.9	0.0	11.3	0.0	0.5	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	11.1	11.4	7.1	15.5	11.3	12.7	10.4	7.4	10.2	3.3	12.1	9.8	0.4	0.0	0.0	4.6	0.5	0.0	2.9	0.0	0.0	42.4	0.4	0.3	0.8	0.0	0.0	0.0	18.8	0.6	0.6	0.6	0.0	0.3	0.6	0.7	1.1	0.8	1.2	0.0	60.0	0.2	1.4	0.6	0.0	1.3	1.3	0.5	4.2	0.2	0.3	15.2	67.2	0.7	0.0	0.3	0.0	0.7	0.0	0.8	0.0	1.0	0.1	2.0	3.1	34.2	5.6	0.4	1.7	0.0	0.0	6.3	0.8	0.2	0.0	17.4	0.0	2.7	0.4	1.7	1.1	0.0	0.0	1.4	0.4	0.3	0.8	2.5
LHFPL5	"DFNB67, dJ510O8.8, MGC33835, Tmhs"	ENSG00000197753	"LHFPL tetraspan subfamily member 5"	Q8TAF8	6	35797206-35845397	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 18.8;epididymis: 12.4"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 13.5;Excitatory neurons: 8.0;Glandular and luminal cells: 2.8;Inhibitory neurons: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 3.3"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029421, HPA055110"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Vesicles		"HPA029421: , HPA055110: AB_2682697"	"unprognostic (2.35e-1)"	"unprognostic (6.45e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.22e-3)"	"unprognostic (1.96e-1)"	"unprognostic (1.78e-1)"		"unprognostic (4.89e-3)"		"unprognostic (2.96e-3)"	"unprognostic (2.46e-2)"		"unprognostic (1.47e-8)"	"unprognostic (5.53e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.41e-1)"	0.9	1.1	4.1	2.7	4.6	18.8	0.8	4.8	5.6	0.3	0.3	0.9	3.0	1.5	12.4	1.3	0.6	1.7	0.7	3.6	2.6	0.6	0.8	1.0	2.8	0.0	0.3	1.1	5.6	0.3	0.5	1.3	0.2	1.0	0.7	8.2	2.4	0.4	1.4	7.6	2.5	0.3	0.0	2.2	1.7	1.5	1.9	0.5	1.4	0.2	0.6	0.6	0.0	2.7	2.3	1.5	3.0	3.1	0.2	0.6	4.6	1.6	0.3	0.1	0.4	2.7	2.0	3.6	1.2	0.6	1.9	2.9	0.2	0.8	0.3	1.6	2.6	3.2	5.3	4.0	0.0	3.4	2.2	0.5	0.3	0.3	0.4	2.1	0.2	3.6	3.1	5.1	0.9	1.9	2.5	6.2	2.6	0.7	1.5	2.2	1.1	2.0	0.7	5.6	3.4	1.9	1.6	2.3	1.0	2.9	2.4	1.9	2.6	3.1	1.7	2.5	2.4	3.2	3.0	3.1	1.1	3.6	1.6	2.9	0.6	0.5	0.3	0.3	0.3	0.5	0.3	0.3	0.1	0.9	0.4	0.5	3.3	0.6	0.4	0.7	0.4	0.1	4.1	4.6	4.8	5.6	3.6	2.6	0.0	0.3	0.2	0.0	1.9	2.7	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.3	0.7	0.3	0.0	0.4	8.0	0.2	0.0	0.2	0.0	2.8	0.0	0.0	0.0	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.8	0.0	0.3	0.3	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0
LHFPL6	"LHFP, MGC22429"	ENSG00000183722	"LHFPL tetraspan subfamily member 6"	Q9Y693	13	39209116-39603528	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 195.2;Endometrial stromal cells: 78.1;Extravillous trophoblasts: 156.9;Fibroblasts: 113.0;Smooth muscle cells: 131.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"myeloid DC: 6.2;plasmacytoid DC: 2.1"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 6.2"	"Cell line enhanced"	"Detected in many"		"ASC diff: 255.1;HSkMC: 186.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058975	Approved		Approved	Nucleoli		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Nucleoli		"HPA058975: AB_2683866"	"unprognostic (6.98e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.00e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.13e-2)"	"unprognostic (4.10e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.76e-1)"	"unprognostic (5.45e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.90e-2)"	"prognostic unfavorable (1.20e-7)"	"unprognostic (4.41e-3)"	"unprognostic (5.25e-2)"	"unprognostic (7.75e-2)"	"prognostic unfavorable (2.30e-4)"	143.2	55.1	46.3	18.6	49.9	1.1	128.7	59.2	45.2	51.6	57.2	51.7	10.8	78.8	47.5	37.0	88.9	74.5	99.7	45.6	57.3	31.9	14.2	82.6	39.1	54.9	56.8	49.6	17.2	18.2	26.9	134.6	51.4	30.8	16.7	11.9	34.7	36.9	32.1	37.9	29.0	68.9	47.8	30.4	27.9	20.4	64.3	17.0	64.2	89.2	17.6	49.1	48.3	44.3	11.5	4.0	118.3	5.1	255.1	115.1	51.6	61.8	88.3	30.8	23.1	0.5	11.6	17.5	1.3	86.6	40.0	17.3	15.0	36.2	25.3	16.9	17.2	47.3	3.7	0.0	26.7	0.8	0.9	186.4	4.7	27.7	45.7	27.6	29.1	1.1	0.0	0.1	59.9	9.9	0.0	14.5	8.8	0.2	15.8	7.7	51.3	0.1	20.9	15.0	0.7	3.8	5.6	7.2	16.8	67.4	6.7	0.1	54.3	77.9	11.7	24.4	33.9	0.9	0.0	48.9	32.4	0.2	57.2	0.0	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.3	46.3	49.9	59.2	45.2	45.6	57.3	54.9	56.8	51.4	47.8	64.3	44.3	195.2	3.2	12.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	4.4	28.6	0.0	0.0	9.9	0.0	0.0	5.0	1.4	0.0	1.9	0.6	0.0	2.7	78.1	32.0	0.0	0.0	0.0	0.6	156.9	113.0	0.0	2.8	2.5	22.1	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.0	0.0	3.6	2.2	0.0	0.0	0.0	131.6	0.0	0.0	0.0	0.0	6.2	1.2	45.8	0.0	0.0
LINGO1	"FLJ14594, LERN1, LRRN6A"	ENSG00000169783	"Leucine rich repeat and Ig domain containing 1"	Q96FE5	15	77613027-77820900	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 56.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 271.0;Excitatory neurons: 271.6;Horizontal cells: 132.9;Inhibitory neurons: 220.5;Microglial cells: 167.7;Oligodendrocyte precursor cells: 240.8;Oligodendrocytes: 324.2"	"Low cancer specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"amygdala: 37.4;basal ganglia: 43.9;cerebral cortex: 56.1;hippocampal formation: 49.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 23.9;AN3-CA: 20.1;HAP1: 30.2;HEK 293: 21.0;MCF7: 13.5;NTERA-2: 56.9;SuSa: 21.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA074653	Enhanced		Supported	"Plasma membrane"		NA	NA		25000		"Cluster 10: Brain - Neuronal signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"		"HPA074653: AB_2686706"	"unprognostic (1.06e-1)"	"unprognostic (7.07e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.09e-1)"	"unprognostic (2.20e-1)"	"unprognostic (2.84e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.40e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.36e-2)"	"unprognostic (2.74e-2)"	"prognostic unfavorable (3.23e-7)"	"unprognostic (2.07e-1)"	"unprognostic (7.06e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.59e-2)"	3.9	1.1	37.4	1.2	43.9	0.0	3.5	0.0	56.1	4.6	0.0	2.2	1.5	4.5	2.2	0.9	2.7	2.1	11.8	49.1	0.0	4.2	0.8	1.0	0.7	0.0	0.0	2.3	2.5	4.1	1.9	6.7	0.0	1.6	0.8	16.2	3.2	2.0	0.8	2.8	1.7	4.6	0.0	3.3	1.4	5.3	0.2	0.3	2.2	1.4	0.3	2.3	2.9	4.6	0.0	2.1	23.9	20.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	1.4	0.0	0.4	0.1	30.2	0.0	0.0	0.0	21.0	0.0	0.0	0.4	0.3	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	3.3	0.2	0.0	13.5	0.0	0.0	56.9	1.3	0.0	0.0	0.0	0.5	0.0	0.0	4.2	1.2	0.1	2.4	4.9	21.6	0.3	0.4	2.1	0.0	5.1	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	43.9	0.0	56.1	49.1	0.0	0.0	0.0	0.0	0.0	0.2	4.6	2.1	0.0	0.0	271.0	0.0	0.3	0.1	0.0	0.0	21.8	0.7	0.3	7.3	1.5	0.0	0.0	2.1	0.1	0.0	1.8	0.0	0.3	8.6	0.8	3.7	2.3	0.0	0.0	271.6	0.2	0.2	1.8	0.0	0.2	0.0	14.9	4.2	0.0	0.3	132.9	220.5	0.3	0.0	0.0	0.0	16.5	0.3	0.1	3.6	167.7	0.0	51.1	0.0	240.8	324.2	0.2	7.7	0.4	0.0	0.0	0.0	0.0	0.0	19.5	26.3	0.0	21.9	0.2	3.1	0.0	0.1	0.3	0.1	0.5	0.2	0.0
LMAN1	"ERGIC-53, ERGIC53, F5F8D, FMFD1, gp58, MCFD1, MR60"	ENSG00000074695	"Lectin, mannose binding 1"	P49257	18	59327823-59359265	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 502.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002320, CAB037163"	Supported		Supported	"Endoplasmic reticulum,Vesicles"		NA	NA		18000000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles	"Endoplasmic reticulum"	"CAB037163: AB_532237, HPA002320: AB_1079256"	"unprognostic (5.64e-2)"	"unprognostic (8.96e-3)"	"unprognostic (4.20e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.65e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.16e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.40e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.79e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.71e-3)"	36.0	43.3	14.8	39.4	16.4	21.7	43.8	16.9	19.4	66.0	20.1	34.1	45.7	46.1	52.9	31.1	48.8	31.9	42.6	13.8	19.4	64.5	181.1	33.6	28.4	17.1	16.0	43.3	53.1	74.3	32.7	54.8	17.4	58.4	39.3	40.0	69.0	43.7	33.3	20.3	49.1	37.7	16.2	27.4	59.3	21.2	16.0	32.1	86.5	41.1	34.8	40.1	21.2	20.4	90.6	52.7	55.1	46.4	125.6	215.6	110.7	159.6	227.9	105.7	140.5	52.7	85.2	16.0	110.7	191.0	75.7	108.1	79.0	90.5	191.0	61.7	50.4	52.5	65.4	109.5	148.9	183.6	77.0	144.7	106.8	102.5	208.1	198.1	108.1	54.3	89.7	173.6	104.2	24.5	53.5	37.9	37.8	45.8	64.5	60.0	100.1	176.0	58.9	67.6	37.5	40.9	80.6	78.0	91.6	76.8	57.8	70.8	89.8	170.5	59.9	55.2	94.0	131.6	71.3	76.2	179.1	96.0	142.6	6.0	2.5	0.7	7.3	3.7	10.0	7.1	7.9	7.7	3.5	5.1	7.5	7.7	0.3	10.0	2.1	8.8	9.6	4.0	14.8	16.4	16.9	19.4	13.8	19.4	17.1	16.0	17.4	16.2	16.0	20.4	120.0	102.5	97.1	15.0	104.0	69.8	120.3	213.5	84.8	39.2	104.5	97.2	134.6	71.4	171.2	80.9	106.3	149.3	86.7	32.8	21.5	130.6	28.1	117.5	203.7	97.7	51.6	49.6	17.2	84.6	304.8	162.4	106.0	200.7	33.6	96.9	75.0	394.0	80.2	58.9	22.1	181.4	107.8	41.9	40.1	10.3	110.6	52.5	67.6	22.5	53.5	76.8	54.6	20.1	33.5	71.6	45.5	85.4	502.1	214.1	95.5	75.6	164.7	66.7	65.7	95.4	142.3	47.2	65.1	80.7	57.0	231.2	69.5	149.6	89.7	129.5
LMBRD1	"bA810I22.1, C6orf209, cblF, FLJ11240"	ENSG00000168216	"LMBR1 domain containing 1"	Q9NUN5	6	69672757-69867236	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Endocytosis, Gastrulation, Host-virus interaction, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"naive B-cell: 21.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 37.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016491, HPA019547"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 59: Non-specific - Transcription"	Vesicles		"HPA016491: , HPA019547: AB_2281256"	"unprognostic (1.44e-1)"	"unprognostic (3.84e-2)"	"unprognostic (7.67e-2)"	"unprognostic (7.64e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.37e-2)"	"unprognostic (2.26e-1)"	"unprognostic (4.39e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.47e-1)"	"prognostic favorable (1.07e-7)"	"unprognostic (7.99e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.68e-2)"	33.3	49.4	10.3	11.5	10.8	4.2	31.4	20.7	17.0	28.9	13.3	26.4	13.5	22.5	27.7	25.7	26.3	16.0	27.7	11.1	11.5	53.0	42.9	27.9	12.1	13.6	11.9	34.5	36.5	31.7	26.5	17.2	12.3	19.1	20.5	10.7	33.2	20.0	28.8	28.1	28.6	12.7	11.4	21.8	29.6	10.4	10.2	9.1	35.1	13.1	16.8	30.1	29.4	16.1	3.8	3.8	6.0	10.2	16.5	23.7	17.9	2.2	7.1	2.6	5.6	4.8	8.2	6.5	9.2	8.8	5.8	7.5	3.8	9.8	2.4	16.3	11.9	6.2	4.9	7.8	13.7	3.4	8.7	7.6	9.6	0.8	5.7	19.1	7.4	5.5	9.4	6.1	6.0	8.1	2.5	4.7	4.6	8.5	4.8	0.3	15.4	37.8	17.0	13.8	5.5	8.5	0.9	7.0	13.3	3.0	4.6	25.3	1.1	3.9	4.6	4.3	2.8	8.8	5.5	2.8	2.3	4.0	12.3	6.5	2.2	3.9	2.0	2.5	2.5	12.1	2.9	1.9	1.7	21.0	3.1	2.3	11.4	2.6	4.8	2.2	3.7	2.1	10.3	10.8	20.7	17.0	11.1	11.5	13.6	11.9	12.3	11.4	10.2	16.1	49.7	64.1	38.3	82.3	93.4	29.1	41.9	45.2	71.2	73.7	39.2	25.4	40.6	50.1	56.0	58.8	110.5	69.6	36.2	79.0	19.6	49.0	28.8	48.3	22.7	41.1	18.7	18.5	119.2	49.6	59.2	56.1	36.7	61.7	40.5	15.7	44.6	60.5	42.1	55.5	144.6	37.6	44.7	66.9	36.3	9.3	35.4	52.0	32.0	79.6	49.3	56.3	28.8	122.2	156.6	42.0	51.0	33.8	82.7	19.6	78.7	64.1	65.5	90.8	26.3	36.4	33.9	22.5	16.9	43.4	38.1	77.4	43.2	26.9	31.7	34.2
LNPK	"KIAA1715, LNP, LNP1, Ul"	ENSG00000144320	"Lunapark, ER junction formation factor"	Q9C0E8	2	175923882-176002839	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"	"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 19.3;Endometrial stromal cells: 24.6;Hofbauer cells: 24.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-138 MG: 159.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014205	Approved		Supported	"Nucleoplasm,Endoplasmic reticulum"		NA	NA		15000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"	Nucleoplasm	"HPA014205: AB_2234186"	"unprognostic (4.93e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.20e-1)"	"unprognostic (7.45e-2)"	"unprognostic (2.92e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.08e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.17e-3)"	"unprognostic (1.63e-1)"	"unprognostic (9.27e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.43e-2)"	13.5	8.9	6.3	7.7	10.1	30.1	9.8	10.2	8.7	12.0	4.2	12.0	7.6	8.6	6.2	13.1	6.3	7.7	12.2	7.6	13.2	8.2	14.4	6.7	7.2	11.3	9.2	10.7	5.5	15.6	6.0	6.1	14.1	10.1	10.2	24.1	6.4	8.2	34.1	12.1	7.5	9.6	11.3	5.9	7.8	24.5	9.3	14.0	8.8	26.8	7.9	7.6	9.2	19.0	24.5	12.3	28.3	40.1	58.5	36.1	14.3	70.8	33.7	32.2	45.1	17.0	28.2	24.4	39.4	31.5	42.3	26.5	26.9	18.9	44.6	37.5	27.4	27.6	14.8	15.2	13.8	47.2	32.9	29.9	17.5	31.4	15.4	26.4	6.0	19.3	28.9	31.5	44.9	16.0	31.4	18.8	9.2	24.9	23.4	31.3	28.6	18.0	13.6	22.2	32.6	32.9	31.3	17.5	24.1	26.6	26.2	15.4	9.2	159.0	23.6	53.9	33.7	18.5	36.6	20.3	49.4	15.2	30.4	3.7	4.2	7.9	4.9	4.8	5.8	4.3	4.2	5.4	3.9	3.3	4.2	6.7	3.4	6.5	4.5	4.4	7.8	3.4	6.3	10.1	10.2	8.7	7.6	13.2	11.3	9.2	14.1	11.3	9.3	19.0	10.8	19.2	13.6	0.0	4.4	0.0	0.0	0.0	0.0	0.0	19.3	15.0	0.0	0.0	6.2	16.5	0.0	5.7	14.5	0.0	5.9	14.0	0.0	10.1	24.6	3.5	0.0	0.0	0.0	9.6	17.3	12.8	0.0	12.7	11.4	10.6	0.0	0.0	24.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	3.3	0.0	0.0	9.1	8.7	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	8.3	7.2	12.0	0.0	0.0
LPAR2	"EDG-4, EDG4, LPA2"	ENSG00000064547	"Lysophosphatidic acid receptor 2"	Q9HBW0	19	19623655-19628930	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 76.0"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 39.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 73.3"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA019616	Approved					NA	NA			"Cluster 13: T-cells - Unknown function"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA019616: AB_1847988"	"unprognostic (1.60e-2)"	"unprognostic (1.83e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.29e-3)"	"unprognostic (1.12e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.05e-3)"	"unprognostic (8.07e-2)"	"unprognostic (6.03e-2)"	"prognostic unfavorable (1.61e-7)"	"prognostic favorable (1.43e-4)"	"unprognostic (2.40e-1)"	"unprognostic (5.87e-2)"	"unprognostic (2.29e-2)"	10.3	3.3	6.6	18.7	6.5	51.9	8.2	5.5	9.2	9.4	7.9	12.9	9.6	4.3	2.5	15.9	10.6	13.0	3.7	7.1	8.5	11.0	6.5	28.5	17.1	8.2	8.0	10.4	27.6	7.8	10.0	4.2	8.1	17.8	7.8	1.7	17.2	4.3	1.4	18.2	23.7	1.9	6.8	76.0	33.6	49.5	9.4	10.0	18.4	1.5	14.7	10.8	11.3	8.5	31.4	3.4	35.7	8.0	9.1	4.4	30.2	2.0	2.9	1.4	2.6	22.0	29.6	19.8	19.5	2.9	1.8	32.1	5.6	11.0	1.4	8.5	9.2	4.4	6.9	1.7	1.2	7.4	73.3	4.9	26.9	1.4	2.0	5.0	0.8	9.7	4.4	7.7	1.2	51.4	4.5	12.3	35.3	42.0	14.2	19.6	2.9	9.1	22.1	45.5	12.6	23.0	8.2	6.6	4.9	19.6	16.9	47.0	9.1	6.8	5.7	12.0	3.0	3.4	10.7	6.8	1.5	53.3	3.4	0.2	1.0	3.8	9.2	1.1	16.2	5.5	20.7	11.8	0.7	2.7	18.2	13.5	10.1	2.8	1.7	1.8	25.7	6.3	6.6	6.5	5.5	9.2	7.1	8.5	8.2	8.0	8.1	6.8	9.4	8.5	0.9	3.2	7.2	0.7	7.1	6.2	11.7	12.4	9.1	0.3	9.7	10.8	2.2	5.7	9.9	7.3	2.1	1.0	6.6	12.2	3.9	14.3	0.4	10.2	2.4	1.0	2.4	3.2	1.9	20.1	6.0	1.9	39.3	18.3	3.8	6.9	1.1	0.6	2.5	1.7	2.2	11.5	6.1	5.6	4.0	2.1	0.6	8.3	0.0	5.6	6.4	4.7	2.1	1.0	0.1	16.9	7.1	0.4	8.7	14.9	10.1	0.7	6.0	1.4	0.0	0.4	2.1	1.3	4.2	7.2	5.1	0.1	20.4	0.2	7.6	11.2
LPAR4	"GPR23, LPA4, P2RY9, P2Y5-LIKE, P2Y9"	ENSG00000147145	"Lysophosphatidic acid receptor 4"	Q99677	X	78747709-78757094	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.8;ovary: 3.6"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 10.1;Fibroblasts: 4.2;Leydig cells: 20.2;Oligodendrocyte precursor cells: 3.5;Skeletal myocytes: 3.6"	"Cancer enhanced"	"Detected in single"		"glioma: 0.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"basophil: 6.3"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 6.3"	"Cell line enhanced"	"Detected in some"		"AF22: 9.3;NTERA-2: 15.2;RH-30: 6.4;U-937: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA046563, HPA054951, HPA055571"	Uncertain		Supported	"Nuclear bodies,Vesicles,Plasma membrane"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 12: NES - Nervous system development"	"Cluster 50: Fibroblasts - ECM organization"	"Plasma membrane"	"Nuclear bodies, Vesicles"	"HPA046563: AB_2732529, HPA054951: AB_2682646, HPA055571: AB_2682853"	"unprognostic (1.62e-1)"	"unprognostic (3.53e-1)"	"unprognostic (1.58e-1)"	"unprognostic (5.81e-4)"	"unprognostic (3.12e-2)"	"unprognostic (4.85e-3)"	"unprognostic (2.81e-1)"	"unprognostic (2.57e-1)"	"unprognostic (6.75e-2)"	"unprognostic (6.73e-2)"	"unprognostic (8.91e-2)"	"unprognostic (4.86e-4)"	"unprognostic (2.99e-5)"	"unprognostic (9.27e-3)"	"unprognostic (1.00e-1)"	"unprognostic (3.58e-2)"	"unprognostic (6.03e-3)"	0.5	0.0	1.8	0.4	1.3	0.3	0.8	1.1	1.7	0.6	1.1	0.3	0.0	1.1	0.3	0.6	0.3	0.8	0.7	3.0	1.2	0.1	0.1	0.1	0.0	1.8	1.7	3.6	0.4	0.0	0.1	0.0	1.3	0.2	0.4	0.1	0.3	0.1	0.0	0.5	0.3	0.5	2.6	0.1	0.4	0.3	1.1	0.7	0.1	0.3	0.4	0.3	0.2	3.8	0.0	0.0	9.3	0.0	0.0	0.0	0.0	0.0	0.6	1.0	1.2	0.0	0.0	0.0	0.1	0.1	0.6	0.0	0.6	0.0	1.1	0.0	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.1	2.1	0.0	0.4	1.7	15.2	0.0	0.2	0.8	6.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	3.4	0.0	2.6	0.0	0.0	0.2	0.0	0.6	1.2	0.0	0.7	0.7	3.7	1.5	6.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	1.3	1.1	1.7	3.0	1.2	1.8	1.7	1.3	2.6	1.1	3.8	1.2	0.0	0.0	10.1	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.1	0.8	0.0	0.0	0.1	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.4	0.5	20.2	0.1	1.8	1.0	0.6	1.0	0.0	3.5	0.1	0.0	0.0	2.6	0.1	0.2	0.0	0.1	0.0	0.0	0.0	3.6	0.4	0.0	0.3	1.5	0.4	0.0	0.4	0.2	0.0	0.2
LRIG1	"DKFZP586O1624, LIG-1, LIG1"	ENSG00000144749	"Leucine rich repeats and immunoglobulin like domains 1"	Q96JA1	3	66378797-66501263	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 144.4"	"Cell type enriched"	"Detected in many"	5	"Astrocytes: 331.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.1"	"Lineage enhanced"	"Detected in single"		"T-cells: 1.1"	"Cell line enhanced"	"Detected in many"		"Daudi: 79.7;hTEC/SVTERT24-B: 55.2;U-698: 59.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011846	Approved		Approved	Cytosol		NA	NA		78000	"Cluster 35: T-regs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA011846: AB_2668545"	"unprognostic (6.41e-2)"	"unprognostic (4.18e-2)"	"unprognostic (4.35e-3)"	"unprognostic (4.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (3.01e-5)"	"unprognostic (5.12e-1)"	"unprognostic (7.86e-2)"	"unprognostic (2.62e-1)"	"unprognostic (2.18e-1)"	"unprognostic (2.12e-1)"	"unprognostic (8.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.21e-2)"	"prognostic unfavorable (1.50e-4)"	31.0	1.8	33.1	17.0	29.2	4.0	27.2	15.1	21.0	29.9	0.0	38.6	16.8	21.9	3.0	13.5	26.7	20.9	37.0	21.4	26.7	3.6	11.2	17.6	7.9	29.4	39.2	17.1	144.4	5.2	6.5	4.7	17.2	24.8	14.7	5.0	19.2	7.2	37.2	11.7	13.4	30.5	14.3	3.9	36.5	12.5	51.0	3.5	16.2	32.9	9.6	5.9	5.2	17.7	1.4	1.3	27.6	0.5	7.6	4.8	2.8	4.9	26.6	4.6	14.0	23.6	0.3	79.7	13.1	2.2	6.1	0.0	5.5	10.0	10.1	0.0	16.8	0.0	4.1	2.0	1.8	0.7	16.7	6.0	5.4	55.2	9.0	18.8	24.3	0.3	0.3	0.0	1.0	3.6	0.0	0.1	22.8	2.3	0.0	14.1	8.7	3.7	5.1	0.0	3.9	1.0	4.6	4.1	0.2	4.6	25.6	6.7	8.2	13.9	6.3	27.9	12.9	6.2	3.2	59.5	24.3	0.0	5.0	0.0	0.0	0.3	0.1	0.0	0.6	0.1	0.4	0.4	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	1.1	0.1	33.1	29.2	15.1	21.0	21.4	26.7	29.4	39.2	17.2	14.3	51.0	17.7	12.5	38.5	50.2	331.1	4.3	11.3	7.8	8.0	14.2	2.1	51.9	35.8	32.0	11.5	25.0	0.0	8.4	0.2	5.8	9.6	1.9	5.6	1.6	29.1	9.7	9.2	26.5	0.0	10.6	17.1	0.1	17.1	19.9	58.8	1.3	14.9	6.4	20.7	2.0	8.4	15.6	26.2	12.2	1.9	7.7	2.1	11.5	2.4	10.6	57.1	1.7	39.8	0.0	37.7	58.3	6.0	10.2	17.3	8.7	15.6	5.7	1.2	33.7	6.8	0.0	65.5	19.9	1.6	20.0	8.9	11.5	0.1	15.2	2.1	22.8	5.0
LRP1	"A2MR, APOER, APR, CD91, IGFBP-3R, IGFBP3R1, LRP, LRP1A"	ENSG00000123384	"LDL receptor related protein 1"	Q07954	12	57128483-57213361	"Candidate cardiovascular disease genes, CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Endocytosis	"Developmental protein, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 109.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 273.4;Hepatocytes: 188.4;Leydig cells: 233.3;Peritubular cells: 184.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	18	"classical monocyte: 4.3;intermediate monocyte: 2.2;myeloid DC: 1.6;non-classical monocyte: 2.4"	"Group enriched"	"Detected in many"	21	"dendritic cells: 1.6;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 484.8;ASC TERT1: 488.4;fHDF/TERT166: 222.2;HSkMC: 318.5;hTERT-RPE1: 248.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004182, CAB018621, HPA022903"	Supported		Approved	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		180000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	Vesicles	Nucleoplasm	"CAB018621: AB_627893, HPA004182: AB_2667163, HPA022903: AB_10602426"	"unprognostic (1.65e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.71e-1)"	"unprognostic (5.00e-2)"	"unprognostic (4.33e-2)"	"unprognostic (3.98e-1)"	"unprognostic (8.68e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.37e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.52e-5)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (2.80e-2)"	"prognostic unfavorable (1.29e-5)"	109.2	14.1	21.3	29.0	36.3	8.2	40.0	30.2	19.7	32.3	8.0	24.1	23.2	36.9	6.2	19.3	30.3	31.5	35.5	16.7	21.9	5.7	35.0	34.0	4.9	46.0	31.5	71.0	10.7	7.8	10.2	39.8	27.9	13.8	11.2	9.9	20.3	20.2	13.0	20.4	18.4	28.9	27.1	13.6	15.1	7.3	48.9	5.6	17.6	23.5	2.7	25.5	29.3	27.6	7.7	14.5	30.4	24.2	484.8	488.4	91.2	85.3	109.0	27.5	26.7	26.9	12.4	0.4	10.4	222.2	6.0	33.6	5.3	8.7	9.7	0.7	1.3	0.4	17.9	56.4	66.5	0.5	14.6	318.5	3.1	61.8	7.2	248.7	1.7	1.1	0.4	1.3	87.2	1.7	0.2	0.4	34.8	11.0	8.8	3.2	171.0	1.6	1.9	2.2	1.4	16.4	19.0	0.6	13.2	42.0	2.9	1.2	1.2	96.0	35.0	53.9	5.2	1.1	0.1	0.2	167.4	0.1	18.7	0.0	4.3	0.0	0.0	2.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	2.4	0.0	0.0	1.6	21.3	36.3	30.2	19.7	16.7	21.9	46.0	31.5	27.9	27.1	48.9	27.6	24.6	12.8	8.4	113.6	3.2	24.0	11.9	28.7	19.9	29.2	4.9	19.3	14.8	15.7	14.7	1.8	0.0	87.5	1.1	81.7	0.0	7.4	1.9	9.7	111.4	13.0	4.2	0.8	39.3	1.8	53.0	273.4	49.5	4.2	6.3	36.9	11.0	188.4	73.8	8.4	41.6	14.1	6.1	145.3	28.6	8.4	233.3	102.9	28.4	89.9	48.8	154.7	1.0	173.4	6.6	14.7	27.2	184.3	4.4	5.5	86.0	2.1	15.1	7.3	39.5	129.7	77.0	1.6	2.4	35.4	16.1	125.9	4.2	11.4	25.0	12.3
LRP2	"DBS, gp330"	ENSG00000081479	"LDL receptor related protein 2"	P98164	2	169127109-169362534	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Hearing, Neurogenesis, Transport"	Receptor	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 70.5;kidney: 34.8;parathyroid gland: 44.7;retina: 29.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 87.6;Cytotrophoblasts: 63.2;Oligodendrocytes: 300.1;Proximal tubular cells: 283.9"	"Cancer enhanced"	"Detected in many"		"renal cancer: 29.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"AF22: 39.4;CACO-2: 64.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA005980, HPA064792"	Enhanced		Approved	Vesicles,Mitochondria		No	NA		74000		"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Vesicles, Mitochondria"		"HPA005980: AB_1079278, HPA064792: AB_2685353"	"unprognostic (1.87e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.64e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.94e-1)"	"unprognostic (1.39e-1)"	"unprognostic (4.09e-2)"	"unprognostic (4.38e-1)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.37e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.62e-2)"	1.5	0.0	5.5	0.0	23.4	0.1	9.6	18.9	13.5	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.2	7.5	14.6	34.8	0.3	1.2	0.0	30.5	17.5	0.0	0.0	44.7	0.1	7.5	31.9	0.0	0.0	29.3	0.9	0.0	0.1	0.1	0.0	0.0	14.5	0.0	0.0	0.2	18.7	0.0	17.3	0.0	0.0	0.0	0.0	70.5	0.0	0.0	39.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	64.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	4.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.0	0.2	0.0	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	23.4	18.9	13.5	7.5	14.6	30.5	17.5	31.9	14.5	18.7	70.5	0.2	6.4	43.7	1.0	3.0	0.3	0.2	0.0	0.0	2.8	22.9	15.1	2.1	2.8	2.5	3.7	87.6	63.2	0.2	0.0	17.6	0.0	3.1	0.1	0.1	0.5	0.0	0.0	1.8	0.0	2.2	1.8	0.0	0.1	2.5	0.0	0.0	0.8	5.1	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	2.5	0.0	1.9	0.0	33.1	0.0	1.5	300.1	0.0	0.0	0.0	0.0	0.0	0.0	283.9	2.2	19.5	0.0	0.0	0.3	0.1	0.8	0.0	0.0	23.1	1.7	0.0	0.0	0.2
LRP4	"CLSS, LRP-4, MEGF7, SOST2"	ENSG00000134569	"LDL receptor related protein 4"	O75096	11	46856717-46918642	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Wnt signaling pathway"	"Developmental protein, Receptor"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 46.7;skin 1: 31.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 123.1;Cone photoreceptor cells: 41.7;Distal enterocytes: 31.1;Oligodendrocyte precursor cells: 137.2;Oligodendrocytes: 31.3"	"Group enriched"	"Detected in all"	4	"colorectal cancer: 12.2;endometrial cancer: 8.6;glioma: 13.2;testis cancer: 15.6;thyroid cancer: 28.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 21.3;SuSa: 16.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011934, HPA012300"	Approved		Uncertain	Nucleoplasm,Nucleoli,Mitochondria		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	"Nucleoplasm, Nucleoli, Mitochondria"		"HPA011934: AB_1853286, HPA012300: AB_1853288"	"unprognostic (1.46e-1)"	"unprognostic (4.07e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.39e-2)"	"unprognostic (9.73e-3)"	"unprognostic (5.29e-4)"	"unprognostic (8.61e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.33e-1)"	"unprognostic (7.59e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.76e-2)"	"unprognostic (9.90e-3)"	"unprognostic (6.79e-2)"	0.7	1.4	23.3	0.9	30.5	0.0	1.5	19.1	21.3	2.3	0.0	4.8	3.4	1.6	0.9	1.8	1.4	2.0	6.9	24.2	16.0	0.7	0.2	2.9	0.1	46.7	23.0	4.6	2.2	5.6	2.6	2.6	19.8	2.1	3.4	7.9	1.7	2.3	4.4	31.6	4.9	1.5	21.3	3.9	7.8	1.1	30.9	1.5	2.4	7.7	0.3	0.9	1.4	25.6	0.1	9.6	21.3	6.5	13.4	3.7	4.9	1.0	1.9	2.8	3.2	2.8	0.0	0.0	1.4	11.4	3.1	3.9	12.0	7.5	2.2	0.0	10.3	1.0	3.8	6.8	2.8	0.1	1.9	4.5	4.2	4.4	1.1	2.5	2.5	2.6	0.9	0.0	1.6	0.8	0.2	0.3	11.9	0.0	0.9	1.6	7.3	0.0	0.3	2.8	0.1	14.2	1.2	0.0	3.4	16.2	0.3	0.5	0.2	5.7	3.5	6.5	2.1	0.0	0.0	0.4	4.3	0.7	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	30.5	19.1	21.3	24.2	16.0	46.7	23.0	19.8	21.3	30.9	25.6	0.2	0.0	1.9	123.1	0.0	8.2	2.7	2.4	10.8	0.5	0.3	1.9	6.2	0.0	1.9	1.8	41.7	2.6	0.0	31.1	1.9	0.0	0.5	1.0	4.7	1.0	0.0	0.0	19.7	0.4	0.4	5.0	3.1	4.4	5.1	1.6	1.8	0.4	0.2	0.0	18.6	2.8	0.0	0.0	0.4	0.0	1.8	0.2	1.8	15.0	0.6	9.3	0.0	137.2	31.3	0.3	3.0	1.2	0.0	1.0	8.0	0.3	1.1	2.7	0.0	12.4	0.9	0.2	0.8	2.3	10.9	1.4	0.2	8.4	3.3	0.8
LRRC15	LIB	ENSG00000172061	"Leucine rich repeat containing 15"	Q8TF66	3	194355249-194369743	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 4.9;skin 1: 7.3"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 1.9;Endothelial cells: 1.0;Fibroblasts: 2.3;Hepatic stellate cells: 1.8;Langerhans cells: 3.0;Suprabasal keratinocytes: 1.4"	"Cancer enhanced"	"Detected in many"		"breast cancer: 25.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"fHDF/TERT166: 120.6;U-87 MG: 62.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035503	Uncertain		Approved	"Vesicles,Plasma membrane"		NA	NA		1700000		"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	"Plasma membrane"	"HPA035503: AB_10961253"	"unprognostic (3.20e-2)"	"unprognostic (1.45e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.19e-2)"	"unprognostic (2.04e-1)"	"unprognostic (7.11e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.88e-3)"	"unprognostic (1.22e-8)"	"unprognostic (5.81e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.62e-3)"	"unprognostic (7.54e-3)"	1.1	0.1	0.0	1.3	0.0	0.0	3.7	0.0	0.0	2.9	0.0	1.7	0.5	1.9	0.0	0.5	1.1	1.6	0.2	0.0	0.0	0.0	0.1	2.0	0.8	0.0	0.1	0.2	0.1	0.1	0.0	2.2	0.0	0.1	3.0	0.0	1.0	0.0	0.1	7.3	0.4	0.6	0.0	1.3	1.5	0.0	0.1	0.2	1.3	0.2	4.9	1.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.7	0.1	0.1	0.4	0.0	0.0	1.0	120.6	3.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	7.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	22.5	3.7	3.0	0.0	0.0	0.0	0.0	62.7	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0
LRRC26	bA350O14.10	ENSG00000184709	"Leucine rich repeat containing 26"	Q2I0M4	9	137168758-137170051	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"salivary gland: 290.0"	"Cell type enriched"	"Detected in many"	5	"Intestinal goblet cells: 598.0"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 47.6"	"Region enriched"	"Detected in single"	5	"cerebellum: 2.6"	"Immune cell enriched"	"Detected in single"	1177	"plasmacytoid DC: 117.6"	"Lineage enriched"	"Detected in single"	1177	"dendritic cells: 117.6"	"Cell line enriched"	"Detected in some"	6	"RPMI-8226: 130.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA056312	Approved		Supported	"Nucleoli fibrillar center,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane"	"Nucleoli fibrillar center"	"HPA056312: AB_2683098"	"unprognostic (1.75e-1)"	"unprognostic (2.28e-2)"	"unprognostic (1.04e-2)"	"prognostic favorable (4.82e-6)"	"unprognostic (3.39e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.13e-2)"		"unprognostic (1.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"		"prognostic favorable (3.48e-4)"	"unprognostic (3.27e-1)"		"unprognostic (2.29e-1)"	0.1	0.0	0.2	0.3	0.4	0.0	7.3	2.6	0.5	0.4	0.0	11.2	1.7	1.1	0.0	2.8	1.1	0.0	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.1	53.1	0.5	0.0	290.0	0.5	0.0	5.1	7.2	0.0	0.2	0.1	5.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	5.4	0.7	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.1	0.9	0.1	0.3	0.7	20.8	0.1	130.9	0.0	0.0	1.0	0.2	0.5	6.0	0.0	0.0	2.7	0.5	0.1	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	117.6	0.0	0.5	0.2	0.4	2.6	0.5	0.1	0.5	0.0	0.1	0.1	0.2	0.0	0.0	0.6	0.0	0.0	0.3	1.2	1.0	1.7	0.5	0.0	0.0	101.2	64.4	0.4	4.3	1.0	0.0	0.0	0.1	81.8	15.2	1.9	0.1	0.5	13.0	1.6	1.0	9.0	0.0	0.1	0.4	0.0	0.4	9.2	21.3	0.0	0.0	0.0	0.0	0.1	0.0	0.3	598.0	4.1	0.0	0.9	1.1	0.0	1.4	56.9	0.0	0.6	0.0	0.0	0.0	0.1	0.2	11.8	0.0	0.6	28.4	28.8	0.1	0.4	0.0	0.0	0.0	0.4	0.2	2.8	3.5	0.3	0.0	0.6	0.0	24.3	3.7
LRRC55	FLJ45686	ENSG00000183908	"Leucine rich repeat containing 55"	Q6ZSA7	11	57181747-57191717	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 15.0"	"Cell type enhanced"	"Detected in some"		"Endothelial cells: 2.1;Excitatory neurons: 1.9;Inhibitory neurons: 1.2"	"Group enriched"	"Detected in some"	9	"glioma: 9.0;ovarian cancer: 2.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"AF22: 19.4"	"Region enhanced"	"Detected in all"		"olfactory bulb: 105.4"	"Low region specificity"	"Detected in all"			HPA014053	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA014053: AB_2137630"	"unprognostic (1.40e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (2.78e-3)"	"unprognostic (2.29e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.26e-2)"	"unprognostic (3.39e-1)"	"unprognostic (9.43e-2)"	"unprognostic (2.11e-2)"	"unprognostic (3.32e-2)"	"unprognostic (7.17e-4)"	"unprognostic (6.66e-2)"	"unprognostic (3.59e-1)"	"unprognostic (3.79e-2)"	0.4	0.5	4.7	1.0	2.8	0.0	0.1	0.8	3.5	0.1	0.0	0.5	0.3	1.8	0.0	0.0	0.3	0.2	0.3	4.1	6.7	0.3	1.2	0.2	2.1	15.0	11.7	0.0	0.2	0.0	0.0	0.9	3.7	0.0	0.5	0.1	0.6	0.0	0.3	0.1	0.4	1.0	8.4	1.3	0.1	0.2	5.9	0.9	0.1	0.3	0.5	0.0	0.0	6.8	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	2.8	0.8	3.5	4.1	6.7	15.0	11.7	3.7	8.4	5.9	6.8	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
LRRC59	"FLJ21675, PRO1855"	ENSG00000108829	"Leucine rich repeat containing 59"	Q96AG4	17	50375059-50397523	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 272.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030827, HPA030829"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		740000	"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA030827: AB_10602704, HPA030829: AB_10670045"	"unprognostic (4.73e-2)"	"unprognostic (2.15e-2)"	"prognostic favorable (2.60e-4)"	"unprognostic (5.63e-3)"	"unprognostic (2.80e-1)"	"prognostic unfavorable (1.00e-5)"	"prognostic unfavorable (3.12e-6)"	"unprognostic (1.88e-3)"	"unprognostic (9.95e-2)"	"unprognostic (5.62e-3)"	"prognostic unfavorable (6.87e-4)"	"unprognostic (3.68e-2)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (2.77e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (1.90e-5)"	49.6	82.6	18.5	54.1	20.5	79.3	34.1	18.4	21.7	60.4	19.0	72.1	46.8	32.2	55.5	47.9	29.4	32.2	33.0	19.1	18.6	41.1	75.0	45.8	30.9	18.2	19.3	21.7	119.4	34.8	21.8	51.7	18.6	35.3	72.0	21.7	56.2	35.7	32.6	24.3	46.0	52.3	18.3	33.0	73.8	29.2	22.0	29.3	36.0	17.0	42.8	56.6	30.1	19.9	390.5	289.9	81.8	123.6	135.3	158.7	146.2	310.7	172.3	284.5	249.4	668.8	109.0	168.8	207.8	356.4	174.3	138.1	205.2	265.2	336.3	90.4	298.6	295.9	154.8	361.8	283.7	294.1	134.8	140.8	211.3	305.2	351.7	82.6	213.3	95.7	278.9	155.6	189.4	264.3	209.0	139.0	92.5	364.2	419.1	175.9	261.9	323.6	156.0	194.9	199.1	165.4	107.5	119.3	161.9	120.4	201.1	157.9	229.6	327.4	135.5	306.2	410.4	232.3	205.1	213.6	222.2	195.9	210.8	22.8	21.9	19.8	9.4	26.9	11.7	11.0	9.5	11.5	20.3	8.5	6.1	7.9	10.9	8.6	27.8	16.5	10.3	13.0	18.5	20.5	18.4	21.7	19.1	18.6	18.2	19.3	18.6	18.3	22.0	19.9	33.1	22.4	23.7	5.2	61.2	139.4	102.1	54.7	43.9	20.4	55.0	30.9	4.1	40.0	50.0	20.2	2.1	90.8	38.4	101.6	29.4	165.0	67.1	53.6	53.8	45.6	38.3	36.6	5.5	187.0	272.2	64.5	104.5	96.3	30.4	28.9	27.1	69.1	103.3	21.9	5.5	178.3	26.4	29.0	111.1	18.7	35.4	45.1	65.8	3.7	45.6	26.5	30.9	2.0	6.8	187.7	75.7	29.0	211.3	164.8	63.5	48.0	26.5	15.5	13.1	59.1	92.8	61.3	27.7	66.1	132.7	236.0	33.2	38.3	127.1	146.7
LRRC8A	"FLJ10337, KIAA1437, LRRC8, SWELL1"	ENSG00000136802	"Leucine rich repeat containing 8 VRAC subunit A"	Q8IWT6	9	128882133-128918039	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 192.0;Prostatic glandular cells: 207.0;Urothelial cells: 328.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HaCaT: 163.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"				"unprognostic (6.33e-2)"	"unprognostic (3.88e-2)"	"unprognostic (1.88e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.72e-1)"	"unprognostic (4.38e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.80e-2)"	"prognostic unfavorable (3.83e-4)"	"unprognostic (3.53e-1)"	"prognostic favorable (5.27e-5)"	"unprognostic (3.69e-1)"	"unprognostic (8.77e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.02e-2)"	31.4	17.4	68.2	16.2	69.4	17.3	27.3	69.4	77.1	30.8	44.6	31.4	9.7	36.3	7.3	71.7	23.5	23.3	32.0	57.2	67.9	18.2	28.9	42.4	9.3	76.7	77.2	18.8	21.2	32.4	13.7	23.1	67.9	29.3	8.5	13.4	28.1	25.5	13.9	35.2	17.3	29.1	63.9	16.2	25.0	11.8	82.6	9.9	25.6	18.4	10.1	32.7	44.2	52.4	35.1	54.2	32.0	27.5	73.6	28.3	40.4	39.8	26.2	24.1	17.1	24.1	73.2	12.8	43.6	43.3	30.1	163.8	19.9	87.5	11.3	13.1	16.4	11.5	33.4	29.2	49.8	13.8	20.3	22.1	60.9	42.7	50.8	48.6	84.1	17.5	25.8	12.4	31.8	30.3	15.6	13.2	95.9	58.3	58.4	21.4	37.0	20.6	37.9	17.3	19.2	39.9	44.4	27.3	15.8	23.9	19.9	10.2	149.4	69.9	30.2	29.9	58.8	14.4	36.5	15.5	38.7	10.3	41.3	0.7	0.7	1.9	3.9	1.1	1.8	1.2	1.9	2.5	1.0	0.9	1.9	1.8	1.4	3.5	0.3	1.6	3.5	1.0	68.2	69.4	69.4	77.1	57.2	67.9	76.7	77.2	67.9	63.9	82.6	52.4	98.8	16.0	15.6	57.1	7.5	105.7	192.0	91.6	113.3	13.1	38.3	29.2	31.3	17.2	73.6	7.3	6.2	13.8	17.4	31.9	0.0	28.9	6.9	22.0	50.5	57.4	16.1	13.7	11.8	21.2	17.6	27.5	24.5	47.0	6.3	35.1	55.6	16.5	6.1	25.2	14.2	28.7	24.4	5.0	17.4	4.5	23.0	9.9	26.6	12.2	5.1	41.3	36.0	8.5	9.7	78.1	23.0	44.4	13.5	207.0	10.9	8.1	33.2	10.2	65.7	38.2	35.2	3.2	8.6	91.6	145.1	20.8	15.5	9.6	14.5	328.5
LRRC8B	"KIAA0231, TA-LRRP"	ENSG00000197147	"Leucine rich repeat containing 8 VRAC subunit B"	Q6P9F7	1	89524829-89597861	"Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 97.0;Excitatory neurons: 177.4;Inhibitory neurons: 197.3;Oligodendrocytes: 140.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 35.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017950	Uncertain					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 58: Brain - Synaptic function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA017950: AB_1853346"	"unprognostic (2.50e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (7.15e-4)"	"prognostic unfavorable (9.99e-4)"	"unprognostic (1.22e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.72e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.30e-2)"	"unprognostic (1.85e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.06e-1)"	6.6	14.6	3.9	3.7	8.1	3.0	5.3	0.0	13.5	2.8	0.0	4.4	6.1	1.8	5.5	4.0	3.2	5.0	2.4	13.0	0.0	3.7	3.8	4.7	4.5	0.4	0.4	1.6	6.6	5.3	3.3	1.8	0.8	4.3	5.2	12.9	4.2	1.1	4.0	5.8	4.1	2.7	1.4	3.6	5.2	15.4	0.0	3.8	4.9	3.1	5.0	5.0	2.2	16.0	13.0	4.7	3.8	13.2	18.5	10.8	15.3	0.4	4.0	1.7	2.3	7.9	8.4	1.2	4.8	1.9	5.0	6.7	35.6	2.8	1.9	6.4	6.3	28.9	3.7	7.4	1.9	13.6	17.7	5.6	11.5	1.5	5.6	0.6	18.7	10.6	30.3	9.3	2.1	7.9	5.3	6.2	20.7	6.1	7.1	13.0	1.7	5.3	4.5	16.8	10.6	17.5	7.2	18.3	12.7	4.6	10.7	6.1	6.0	1.5	8.4	3.8	4.1	5.9	4.7	6.7	2.1	3.0	3.3	0.7	0.7	0.5	0.4	0.3	0.3	0.8	0.6	0.4	0.7	0.6	0.9	0.8	0.3	0.3	0.4	0.6	1.0	0.5	3.9	8.1	0.0	13.5	13.0	0.0	0.4	0.4	0.8	1.4	0.0	16.0	5.8	16.0	13.9	15.7	11.4	33.0	12.4	13.6	14.8	32.9	15.2	8.4	7.0	17.2	17.7	7.3	47.9	3.2	2.8	8.9	1.9	13.0	97.0	13.5	1.9	12.7	26.9	3.8	177.4	18.9	18.2	4.4	10.2	8.4	2.5	13.3	16.1	6.7	7.0	0.0	197.3	14.2	8.2	12.8	17.3	72.7	2.5	9.8	1.8	26.2	7.9	5.8	1.0	45.2	140.7	15.4	6.0	2.6	11.1	18.6	4.3	5.7	26.8	22.4	6.6	9.4	14.8	7.3	3.8	13.9	27.6	2.5	8.0	8.0	13.2	12.4
LRRC8C	AD158	ENSG00000171488	"Leucine rich repeat containing 8 VRAC subunit C"	Q8TDW0	1	89633072-89769903	"Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 73.5;Excitatory neurons: 73.6;Inhibitory neurons: 99.2;Microglial cells: 185.5;Oligodendrocytes: 85.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 8.9;monocytes: 6.6;T-cells: 11.3"	"Cell line enhanced"	"Detected in many"		"THP-1: 41.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029347	Uncertain		Approved	"Golgi apparatus"		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 28: Placenta - Pregnancy"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA029347: AB_10601544"	"unprognostic (2.61e-2)"	"unprognostic (3.09e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.76e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.02e-2)"	"unprognostic (3.76e-3)"	"unprognostic (4.28e-2)"	"unprognostic (4.90e-3)"	"unprognostic (5.32e-2)"	"unprognostic (2.36e-1)"	"prognostic unfavorable (3.75e-4)"	"unprognostic (2.78e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.38e-2)"	14.3	7.6	3.8	9.0	4.5	8.0	7.7	4.5	5.8	3.2	11.4	3.2	3.2	7.3	1.9	2.9	2.8	6.6	6.2	4.1	4.1	2.5	3.3	7.7	12.2	4.6	5.0	5.3	1.8	2.8	2.3	6.6	5.1	2.3	3.7	1.6	2.0	2.0	2.7	6.0	3.8	15.8	4.8	9.2	2.9	4.0	4.7	5.6	3.5	8.0	7.7	6.2	2.0	6.0	0.3	3.8	3.0	2.7	9.1	10.2	1.4	19.3	21.6	8.7	8.0	0.0	1.3	6.0	5.3	8.5	14.9	13.1	10.1	29.0	20.9	14.8	6.1	5.7	2.9	0.3	7.4	26.6	1.9	4.4	5.8	18.8	10.0	5.8	35.6	9.2	3.9	7.9	7.5	0.7	3.9	26.2	3.3	0.1	7.8	26.5	1.4	2.0	1.8	3.2	2.3	10.7	7.1	0.7	16.2	4.7	0.2	41.3	29.9	15.3	7.3	5.3	14.9	2.9	2.6	3.1	4.7	19.6	2.6	0.4	6.0	0.0	3.8	5.2	3.3	0.7	6.1	5.1	8.9	0.5	4.8	4.5	0.8	2.0	6.6	0.7	11.3	3.2	3.8	4.5	4.5	5.8	4.1	4.1	4.6	5.0	5.1	4.8	4.7	6.0	73.5	3.2	3.6	31.3	7.6	45.4	3.8	5.6	3.4	2.3	1.7	2.9	6.3	2.8	2.7	0.0	0.0	0.1	24.6	0.3	0.0	1.7	36.3	0.2	1.9	47.3	1.2	4.8	73.6	2.4	1.1	8.7	2.6	0.6	0.0	58.5	28.9	0.1	13.6	1.7	99.2	0.3	2.0	29.5	36.9	21.3	0.0	27.8	26.6	185.5	21.3	0.5	13.4	22.1	85.2	12.8	1.9	0.7	20.8	2.1	0.3	0.6	2.9	1.2	0.0	2.2	24.2	3.9	2.0	1.3	44.9	0.3	27.1	3.4	0.3	2.5
LRRC8D	"FLJ10470, LRRC5"	ENSG00000171492	"Leucine rich repeat containing 8 VRAC subunit D"	Q7L1W4	1	89821014-89936611	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 80.4"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 80.8;Oligodendrocyte precursor cells: 146.8;Oligodendrocytes: 346.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	No			"Cluster 20: T-cells - T-cell receptor"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (2.92e-3)"	"unprognostic (9.50e-2)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (3.21e-5)"	"unprognostic (4.98e-2)"	"unprognostic (7.03e-2)"	"unprognostic (7.71e-3)"	"unprognostic (7.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.42e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.91e-2)"	"unprognostic (9.52e-3)"	"unprognostic (1.23e-1)"	"unprognostic (2.65e-2)"	"unprognostic (9.61e-2)"	5.9	26.9	25.1	15.8	45.2	14.2	12.9	39.2	37.0	12.1	9.6	17.9	19.0	8.8	10.3	7.9	7.8	8.0	7.6	30.6	30.2	25.9	23.5	9.8	24.9	43.3	40.3	5.9	13.0	7.7	16.3	10.3	41.3	5.6	18.2	12.0	24.5	5.8	8.7	5.6	18.0	11.4	39.7	23.9	11.5	10.3	36.5	27.7	15.8	3.4	20.4	11.2	3.3	80.4	73.5	47.0	18.8	44.5	32.9	27.7	63.5	49.1	73.9	27.3	34.1	20.2	18.3	57.7	54.4	82.1	31.0	93.7	43.6	58.9	34.4	45.3	24.1	67.8	40.4	43.2	64.2	78.2	20.5	17.4	48.1	23.3	50.3	37.6	47.1	32.8	37.6	17.7	30.1	22.0	32.5	50.4	32.6	16.4	42.6	43.6	27.3	41.5	69.2	25.7	35.0	24.4	61.0	62.4	137.8	32.4	15.0	76.4	21.0	29.1	9.9	60.0	37.6	21.4	39.5	34.7	11.3	97.0	26.2	0.0	8.9	1.6	7.0	10.4	11.6	6.9	16.0	8.5	8.1	5.6	15.2	11.5	3.5	13.1	8.4	9.4	17.4	10.6	25.1	45.2	39.2	37.0	30.6	30.2	43.3	40.3	41.3	39.7	36.5	80.4	2.9	3.2	1.7	35.3	10.8	6.0	1.4	12.7	15.9	6.6	8.4	7.4	3.0	8.6	6.2	12.9	2.1	4.0	14.8	26.6	7.9	5.7	0.7	3.1	2.9	5.5	7.8	17.0	66.8	8.6	9.9	3.8	6.1	3.4	5.7	7.8	7.9	30.1	11.8	3.3	80.8	10.8	10.2	21.9	5.5	0.8	1.2	19.1	10.6	68.4	36.3	6.3	10.3	146.8	346.4	5.4	11.3	3.8	8.0	4.1	22.5	12.5	7.2	7.6	6.6	10.7	2.9	0.3	1.9	7.1	1.1	1.8	11.0	22.4	11.2	1.8
LRRC8E	FLJ23420	ENSG00000171017	"Leucine rich repeat containing 8 VRAC subunit E"	Q6NSJ5	19	7888505-7902021	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 9.6;Glandular and luminal cells: 13.0;Squamous epithelial cells: 11.6;Suprabasal keratinocytes: 11.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-87 MG: 36.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA020466	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 44: Endometrium - Transcription"			"HPA020466: AB_1853352"	"unprognostic (3.79e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.30e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.10e-3)"	"unprognostic (8.28e-3)"	"unprognostic (7.64e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.36e-1)"	"unprognostic (8.38e-2)"	"unprognostic (3.98e-6)"	"unprognostic (1.11e-1)"	"unprognostic (2.30e-2)"	"unprognostic (3.29e-2)"	"unprognostic (3.21e-1)"	"unprognostic (2.84e-1)"	"unprognostic (4.07e-1)"	0.6	4.9	0.4	0.8	0.5	1.9	4.6	1.0	0.6	3.3	0.6	1.0	0.9	1.4	6.2	6.4	2.1	2.3	0.9	0.5	0.1	1.9	4.1	4.3	0.7	0.4	0.2	0.3	7.2	3.3	0.5	1.3	0.7	3.5	1.1	0.4	7.7	2.1	0.5	10.6	0.5	0.4	0.0	0.3	3.6	0.7	0.3	0.1	2.0	0.4	2.8	2.9	4.7	1.4	23.5	6.0	0.2	0.6	1.1	5.6	3.5	10.1	8.7	15.8	12.3	7.7	5.3	0.6	7.5	9.8	22.5	18.3	7.7	9.8	14.9	0.4	8.5	0.3	3.1	8.2	4.1	0.3	0.5	9.1	13.9	10.5	7.8	21.2	2.0	4.1	6.5	0.8	1.9	11.9	0.1	0.5	1.7	4.3	21.9	1.4	0.2	0.6	12.0	21.3	0.5	0.4	7.6	9.6	0.3	1.7	12.8	0.5	2.6	4.8	8.7	13.2	5.8	1.5	2.9	0.3	36.4	0.8	1.7	1.7	0.4	0.5	0.5	0.3	0.6	0.6	0.4	0.4	0.1	0.8	0.5	0.6	1.5	1.1	0.4	0.5	0.4	0.2	0.4	0.5	1.0	0.6	0.5	0.1	0.4	0.2	0.7	0.0	0.3	1.4	0.1	3.2	5.5	0.0	0.1	9.6	5.0	1.5	6.2	0.0	8.2	5.7	0.2	1.5	5.4	1.8	0.0	0.7	0.0	1.1	0.0	6.2	0.0	7.7	2.4	0.5	0.0	0.0	0.1	6.0	1.0	1.0	3.6	13.0	1.3	0.4	0.0	3.2	0.1	0.0	0.1	1.2	4.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	0.1	0.0	0.0	5.0	0.1	0.5	6.5	0.0	0.0	0.8	0.9	0.0	0.3	11.6	11.2	1.9	0.5	0.1	1.3	5.9
LRRTM1	FLJ32082	ENSG00000162951	"Leucine rich repeat transmembrane neuronal 1"	Q86UE6	2	80288351-80304752	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.4;salivary gland: 12.8"	"Group enriched"	"Detected in some"	4	"Endometrial stromal cells: 4.8;Excitatory neurons: 7.2;Inhibitory neurons: 13.2;Oligodendrocyte precursor cells: 10.6;Sertoli cells: 6.6"	"Group enriched"	"Detected in many"	11	"endometrial cancer: 8.8;ovarian cancer: 16.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SH-SY5Y: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046607, HPA062660"	Approved		Approved	"Golgi apparatus"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA046607: , HPA062660: AB_2684824"		"unprognostic (2.47e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-3)"	"unprognostic (5.63e-2)"		"unprognostic (6.67e-2)"	"unprognostic (4.35e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.16e-2)"	"unprognostic (6.03e-3)"	"unprognostic (7.10e-4)"		"unprognostic (3.16e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.96e-4)"		0.5	0.9	6.4	0.3	13.4	0.0	0.1	0.0	10.0	2.2	0.0	3.7	0.6	0.6	0.3	0.3	1.2	0.2	1.3	16.3	5.2	0.3	0.4	0.1	0.0	0.9	9.4	0.3	0.1	0.0	1.9	0.0	2.0	1.0	0.3	0.4	12.8	1.2	0.0	0.1	1.3	0.3	0.2	0.0	0.7	0.2	22.4	0.0	1.6	0.1	0.0	0.6	0.8	4.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	13.4	0.0	10.0	16.3	5.2	0.9	9.4	2.0	0.2	22.4	4.6	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	1.3	1.0	4.8	0.3	0.0	0.0	7.2	0.7	0.0	0.1	0.0	0.9	0.0	0.4	0.0	0.0	0.0	0.0	13.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	10.6	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.4	6.6	0.0	0.9	0.3	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0
LRRTM4	FLJ12568	ENSG00000176204	"Leucine rich repeat transmembrane neuronal 4"	Q86VH4	2	76747685-77593319	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 17.6;retina: 6.8"	"Group enriched"	"Detected in some"	16	"Excitatory neurons: 3972.6;Inhibitory neurons: 2310.6;Oligodendrocyte precursor cells: 3758.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	10	"Karpas-707: 125.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.00e-1)"	"unprognostic (4.40e-2)"	"unprognostic (3.13e-1)"	"unprognostic (4.72e-4)"	"unprognostic (7.20e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.15e-2)"	"unprognostic (3.93e-1)"	"unprognostic (5.84e-2)"	"unprognostic (4.22e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.64e-1)"	"unprognostic (5.77e-3)"	"unprognostic (3.54e-2)"		"unprognostic (7.99e-2)"	0.4	0.6	5.8	0.3	11.4	1.7	0.2	0.1	17.6	0.4	0.0	0.5	0.8	0.4	1.5	0.8	0.2	0.7	0.1	13.5	1.6	0.2	1.3	0.8	0.4	0.2	4.1	0.6	0.5	0.0	1.0	0.9	1.2	0.6	0.5	6.8	0.9	1.5	1.6	0.8	0.5	0.3	0.0	0.5	0.6	0.3	0.0	0.1	0.7	0.3	0.2	0.3	0.5	14.5	1.4	1.7	0.9	0.8	0.0	0.0	0.9	0.3	0.0	0.0	0.0	2.1	0.5	1.0	2.2	0.8	0.7	0.8	0.2	0.0	0.3	0.8	2.5	0.5	4.8	3.1	0.4	1.3	0.0	0.3	0.0	0.0	0.2	0.1	0.0	0.1	0.5	125.8	0.0	2.8	0.5	0.7	12.2	0.2	1.2	0.5	0.1	2.6	0.0	4.1	3.7	1.4	0.8	0.7	0.8	2.0	1.4	0.9	0.0	2.9	3.7	0.1	0.2	0.0	2.4	0.1	2.8	0.0	2.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.5	0.2	0.1	0.0	0.1	0.0	5.8	11.4	0.1	17.6	13.5	1.6	0.2	4.1	1.2	0.0	0.0	14.5	0.0	0.0	0.5	208.6	0.0	0.0	0.0	0.0	0.0	21.2	0.0	0.3	0.3	0.0	0.0	0.0	4.2	0.1	0.0	0.0	0.0	0.0	1.1	0.4	0.2	0.4	0.0	0.0	3972.6	0.0	0.0	2.7	0.0	0.1	0.0	0.0	0.7	0.5	0.0	0.0	2310.6	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	84.3	0.0	2.8	0.0	3758.4	176.0	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.7	2.3	6.6	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
LTB4R	"BLTR, CMKRL1, GPR16, LTB4R1, P2RY7, P2Y7"	ENSG00000213903	"Leukotriene B4 receptor"	Q15722	14	24311450-24318036	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 103.1;skin 1: 110.1"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 45.5;Macrophages: 28.0;Suprabasal keratinocytes: 47.0"	"Cancer enhanced"	"Detected in all"		"head and neck cancer: 18.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 100.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 100.3;monocytes: 38.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 20.3;Karpas-707: 17.4"					"Low region specificity"	"Detected in single"			HPA003873	Approved					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA003873: AB_1078288"	"unprognostic (4.07e-2)"	"unprognostic (7.67e-2)"	"unprognostic (3.67e-3)"	"unprognostic (2.40e-3)"	"unprognostic (4.90e-2)"	"unprognostic (9.00e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.63e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (1.85e-4)"	"unprognostic (7.25e-2)"	"prognostic unfavorable (3.44e-15)"	"unprognostic (2.88e-1)"	"unprognostic (2.97e-1)"	"unprognostic (6.59e-2)"	"unprognostic (7.45e-2)"	12.5	12.5	1.3	5.0	1.4	16.0	11.8	1.6	1.4	33.3	1.5	6.2	4.2	6.6	5.3	103.1	10.4	2.2	5.4	1.2	1.3	10.3	18.0	15.4	5.4	1.6	1.4	8.4	7.7	0.5	10.8	2.2	1.6	16.8	1.6	4.2	23.5	2.2	5.8	110.1	12.2	1.6	1.5	40.7	6.0	7.8	1.8	4.0	10.2	0.7	9.2	6.8	51.5	1.6	2.7	5.7	2.0	1.6	1.3	1.3	8.4	1.1	0.8	1.2	1.4	4.2	3.2	4.2	1.9	1.1	2.1	20.3	1.8	3.1	1.7	11.5	6.3	4.0	8.4	2.9	0.6	5.7	5.9	0.7	5.5	2.3	3.0	1.8	2.0	6.8	3.7	17.4	0.5	5.6	2.5	10.1	1.4	0.2	4.3	9.9	1.8	7.4	0.7	4.3	4.3	1.7	5.3	2.9	3.0	3.5	4.9	6.2	1.3	4.3	4.2	4.2	1.5	9.9	2.3	7.1	0.9	14.9	2.8	17.0	38.4	40.5	3.4	4.9	2.4	0.0	2.5	2.7	11.2	0.2	1.2	0.8	100.3	2.1	1.2	1.1	0.6	13.7	1.3	1.4	1.6	1.4	1.2	1.3	1.6	1.4	1.6	1.5	1.8	1.6	10.1	0.0	0.6	3.6	2.5	24.0	10.5	18.5	12.0	3.0	6.3	5.0	1.4	5.7	4.3	0.0	6.2	0.9	14.2	2.2	0.0	2.1	0.3	4.6	1.8	5.6	0.0	1.3	1.5	6.1	0.8	2.5	3.1	4.5	1.3	1.4	7.9	4.1	15.6	0.0	1.3	2.8	8.2	45.5	3.7	1.1	3.4	28.0	3.6	2.8	25.4	1.6	18.6	1.0	1.2	4.6	5.4	1.5	6.2	2.7	5.4	0.9	6.4	10.8	6.6	2.0	1.8	1.5	1.4	22.6	47.0	0.8	13.5	1.3	3.2	2.5
LYPD6B	"CT116, LYPD7"	ENSG00000150556	"LY6/PLAUR domain containing 6B"	Q8NI32	2	149038107-149215262	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 95.5"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 245.7;Gastric mucus-secreting cells: 87.7;Inhibitory neurons: 77.8;Late spermatids: 118.5;Suprabasal keratinocytes: 69.0"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 17.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	4	"basophil: 13.8"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 13.8"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 64.8;LHCN-M2: 102.3;NB-4: 34.7;RT4: 54.7;SK-BR-3: 32.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA049239	Uncertain				"Intracellular and membrane"	NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 34: Spermatids - Unknown function"			"HPA049239: AB_2680688"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (8.42e-2)"	"unprognostic (3.12e-3)"	"unprognostic (1.64e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.01e-2)"	"unprognostic (6.27e-2)"	"unprognostic (3.64e-2)"	"unprognostic (7.95e-3)"	"unprognostic (2.59e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.85e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.32e-3)"	0.3	0.2	3.5	0.4	2.5	0.2	16.4	1.6	5.3	2.8	1.6	1.7	2.6	0.9	1.2	4.1	23.4	37.3	0.0	4.3	4.1	20.5	0.9	1.7	0.4	2.3	7.3	0.4	12.3	16.1	0.4	0.8	3.0	11.1	3.3	1.0	5.8	15.2	0.2	95.5	1.2	0.3	1.9	2.8	41.3	34.1	8.0	0.3	0.2	0.0	1.9	14.2	6.3	2.1	1.4	0.0	0.0	1.5	0.0	0.1	0.1	8.0	1.5	6.6	2.5	1.0	0.0	0.0	0.0	64.8	0.0	14.0	1.5	1.3	20.6	0.0	7.4	0.0	1.9	0.0	0.2	0.0	0.1	0.6	21.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	102.3	24.3	0.0	34.7	2.0	14.6	0.3	0.0	0.4	4.3	3.2	54.7	3.9	0.1	0.4	32.1	0.0	6.3	4.8	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.8	13.8	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	2.5	1.6	5.3	4.3	4.1	2.3	7.3	3.0	1.9	8.0	2.1	0.5	0.0	2.0	2.3	5.5	29.8	21.0	30.6	6.2	0.0	23.4	17.1	1.4	42.9	23.9	46.0	0.0	0.1	0.1	4.0	7.9	12.4	245.7	5.2	0.3	1.0	2.4	2.7	4.6	19.1	0.7	0.8	87.7	5.7	0.0	0.4	0.0	0.1	0.1	0.0	77.8	3.9	8.2	0.0	2.8	118.5	2.1	0.4	5.4	0.0	0.6	0.0	0.0	0.0	0.4	30.9	6.0	0.0	4.5	40.6	5.7	0.2	21.4	0.0	0.0	0.0	1.3	4.2	1.7	3.5	69.0	0.3	1.1	0.0	3.5	53.7
LYVE1	"LYVE-1, XLKD1"	ENSG00000133800	"Lymphatic vessel endothelial hyaluronan receptor 1"	Q9Y5Y7	11	10556966-10611689	"Plasma proteins, Predicted membrane proteins, Transporters"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 126.4;placenta: 149.3"	"Group enriched"	"Detected in many"	4	"Hepatic stellate cells: 238.8;Hofbauer cells: 807.4;Kupffer cells: 338.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	12	"HUVEC TERT2: 81.6"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in single"		"spinal cord: 1.8"	"CAB025860, HPA042953"	Supported					NA	NA		3300000000		"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"CAB025860: , HPA042953: AB_2678238"	"unprognostic (9.83e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.36e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-1)"	"unprognostic (7.80e-2)"	"prognostic unfavorable (1.07e-4)"	"unprognostic (7.53e-2)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (6.98e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.43e-3)"	126.4	68.9	2.7	19.3	3.5	0.9	37.3	2.0	5.1	17.6	8.9	19.9	13.3	8.1	5.7	26.2	23.0	20.2	13.5	2.9	2.4	8.1	44.2	23.8	8.4	3.0	2.2	11.8	4.9	2.3	2.7	149.3	3.1	4.0	20.0	0.3	5.4	11.2	5.0	7.1	17.6	67.1	2.1	61.6	10.5	4.3	3.3	1.7	13.5	27.4	3.0	35.1	6.8	3.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	81.6	0.0	7.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	2.7	3.5	2.0	5.1	2.9	2.4	3.0	2.2	3.1	2.1	3.3	3.2	5.7	0.0	2.8	8.1	2.1	3.7	0.1	0.0	0.0	0.0	0.5	0.3	4.6	8.6	0.0	0.0	0.0	5.3	0.3	0.0	0.0	0.0	1.0	0.0	0.2	102.7	0.0	5.3	0.8	0.0	5.7	3.4	0.0	0.0	1.3	0.0	238.8	4.5	807.4	0.0	0.4	0.0	0.0	338.1	10.7	2.3	3.7	86.0	7.2	12.2	0.1	0.0	0.0	0.5	0.6	0.0	0.0	0.4	2.7	0.2	0.0	0.0	1.5	0.0	13.1	3.4	6.8	0.0	0.0	1.4	3.3	11.1	1.4	0.7	0.0	0.2
M6PR	"CD-M6PR, CD-MPR"	ENSG00000003056	"Mannose-6-phosphate receptor, cation dependent"	P20645	12	8940361-8949761	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 242.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 859.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034464, HPA040445"	Approved					NA	NA		100000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 4: Macrophages - Innate immune response"			"CAB034464: AB_2139108, HPA040445: AB_2676989"	"unprognostic (2.43e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.54e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (3.89e-4)"	"unprognostic (1.76e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.82e-3)"	"unprognostic (1.44e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.53e-3)"	"unprognostic (3.79e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-1)"	"unprognostic (3.98e-1)"	76.6	64.8	79.5	113.9	83.3	104.1	81.5	80.7	95.5	61.5	79.2	78.4	61.1	73.7	63.1	63.3	70.4	74.0	82.0	83.5	85.9	79.1	78.9	97.5	138.8	85.7	83.8	62.8	59.6	95.0	34.0	78.6	86.2	64.9	91.8	73.7	79.2	74.5	51.9	60.4	64.5	81.1	84.0	132.5	74.8	59.7	90.8	105.4	96.4	56.0	125.4	98.0	37.5	96.4	103.6	159.7	103.0	122.0	187.7	86.8	306.2	129.7	159.4	186.2	210.7	176.4	268.4	188.9	48.9	133.0	374.4	160.0	142.7	131.2	218.8	859.9	86.6	331.3	125.0	122.4	213.7	355.6	566.6	126.0	166.3	184.4	232.5	179.2	105.5	123.3	93.0	114.6	165.2	103.7	120.7	142.3	412.8	189.0	72.4	118.0	248.0	108.4	151.9	241.2	26.5	109.9	159.8	159.4	223.9	363.8	39.0	251.3	106.0	156.3	175.1	186.6	193.2	139.3	253.5	201.4	183.2	226.4	120.5	706.9	292.0	319.1	177.4	477.6	201.5	123.2	210.7	195.5	334.0	111.4	152.7	170.6	44.5	186.3	567.4	205.0	182.3	497.3	79.5	83.3	80.7	95.5	83.5	85.9	85.7	83.8	86.2	84.0	90.8	96.4	49.9	57.7	57.0	13.4	75.2	44.1	73.0	73.1	43.9	46.1	50.1	40.8	10.7	44.3	68.0	31.3	22.9	64.4	107.0	23.4	19.6	91.8	7.9	31.3	36.7	39.6	38.3	60.1	25.9	66.9	71.4	37.2	30.5	33.7	132.3	39.9	37.1	28.3	242.8	55.5	29.0	30.5	40.7	138.9	95.4	7.9	35.1	166.4	67.6	21.5	212.2	35.8	159.6	17.1	22.7	56.1	29.5	32.0	73.7	65.4	25.7	41.8	53.1	37.4	26.3	52.5	43.7	117.5	54.4	51.6	40.5	53.1	96.4	55.8	43.8	68.2
MACF1	"ABP620, ACF7, FLJ45612, FLJ46776, KIAA0465, KIAA1251, MACF"	ENSG00000127603	"Microtubule actin crosslinking factor 1"	Q9UPN3	1	39081316-39487177	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	Actin-binding	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 1079.0;Cone photoreceptor cells: 779.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013713, HPA068064, HPA068103"	Approved		Supported	"Plasma membrane,Cell Junctions,Actin filaments"		NA	NA		25000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane, Cell Junctions, Actin filaments"		"HPA013713: AB_10600821, HPA068064: AB_2685946, HPA068103: AB_2685953"	"unprognostic (2.71e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (9.00e-2)"	"unprognostic (6.19e-3)"	"unprognostic (1.32e-1)"	"unprognostic (7.40e-3)"	"unprognostic (5.45e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.98e-1)"	"prognostic favorable (2.77e-5)"	"unprognostic (1.07e-1)"	"unprognostic (1.81e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.22e-2)"	69.1	62.5	172.0	27.7	197.5	36.2	54.6	174.6	181.6	65.9	119.1	148.6	18.6	130.3	48.7	46.4	92.0	46.4	127.0	159.7	166.1	85.7	63.8	183.6	35.9	190.2	179.0	92.6	51.2	96.9	69.3	34.6	182.9	68.2	25.1	121.2	57.7	41.6	73.0	121.0	62.6	54.2	155.6	84.9	71.3	50.2	193.2	39.3	73.3	55.2	22.8	80.3	62.7	185.3	48.1	54.9	66.7	29.3	53.8	47.3	29.8	62.2	79.4	38.0	33.7	34.3	56.5	24.4	64.6	84.0	62.1	30.6	12.5	45.7	51.2	43.5	33.1	34.0	43.4	56.5	66.0	30.8	15.9	37.0	46.5	105.1	54.3	83.5	104.7	52.0	63.2	25.7	137.0	16.0	23.3	52.7	95.8	20.0	31.7	38.5	89.6	4.5	206.0	50.8	38.2	38.6	24.9	17.2	62.5	76.3	7.5	37.9	115.1	61.6	48.5	28.8	101.9	19.4	19.7	28.8	101.0	32.6	55.2	7.5	1.3	3.8	12.2	2.7	5.9	2.2	5.8	7.8	1.8	3.8	4.7	6.1	1.3	6.5	2.9	2.5	3.0	2.0	172.0	197.5	174.6	181.6	159.7	166.1	190.2	179.0	182.9	155.6	193.2	185.3	135.3	150.6	128.2	1079.0	68.7	154.4	74.9	43.0	60.3	387.7	52.5	50.9	246.1	61.5	70.7	80.9	779.8	52.6	120.5	35.4	0.0	113.3	9.6	140.6	124.4	164.3	36.1	57.6	320.6	114.6	62.1	108.2	65.2	180.1	77.7	194.3	132.1	47.9	52.1	117.8	367.5	27.2	22.4	59.7	46.3	11.8	43.8	74.8	71.2	342.9	59.0	107.8	158.6	494.6	410.7	193.5	17.7	112.5	81.0	89.7	22.5	20.6	71.3	398.5	105.2	95.5	136.7	62.6	33.7	43.5	191.5	69.9	131.2	76.5	19.7	78.8
MACO1	"FLJ10747, TMEM57"	ENSG00000204178	"Macoilin 1"	Q8N5G2	1	25430858-25500209	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 38.8;Exocrine glandular cells: 62.3;Pancreatic endocrine cells: 48.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019680			Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Cytosol		"HPA019680: AB_1858125"	"unprognostic (2.42e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.54e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.10e-2)"	"unprognostic (5.39e-2)"	"unprognostic (1.69e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.71e-1)"	"unprognostic (7.02e-2)"	"prognostic favorable (7.13e-4)"	"unprognostic (2.54e-2)"	"unprognostic (4.22e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.35e-3)"	8.5	15.0	11.2	5.3	10.8	28.4	8.7	19.9	14.9	8.6	12.8	8.5	6.2	7.9	12.5	16.1	6.9	7.4	8.4	10.9	11.2	11.8	26.3	8.3	7.8	10.6	9.9	16.2	24.9	9.2	8.9	6.8	11.1	12.3	7.8	11.0	16.3	7.9	30.3	9.6	9.0	7.4	10.5	8.7	11.7	14.1	10.0	11.4	12.4	15.2	9.0	7.3	9.6	12.7	8.6	3.6	9.3	18.0	16.4	10.1	4.3	9.0	11.1	9.2	8.6	2.6	11.0	20.1	10.1	11.9	5.2	8.0	8.8	9.2	10.4	9.4	7.9	26.8	5.7	7.7	9.3	10.1	15.3	10.3	13.3	12.5	8.9	9.7	11.6	12.4	15.8	7.5	9.3	5.0	19.0	13.8	13.2	10.1	7.1	12.1	11.0	15.0	15.0	3.7	15.2	15.5	7.5	19.3	10.9	7.3	7.7	14.3	13.8	9.3	6.2	12.9	6.2	12.1	7.2	10.6	10.5	13.1	7.9	0.5	0.3	1.6	0.3	0.2	0.5	0.4	0.5	0.5	0.2	0.5	0.4	0.7	0.1	0.3	0.3	1.1	0.3	0.2	11.2	10.8	19.9	14.9	10.9	11.2	10.6	9.9	11.1	10.5	10.0	12.7	31.3	19.2	23.6	0.0	9.9	0.0	0.0	0.0	0.0	0.0	27.8	17.8	0.0	0.0	11.2	7.3	0.0	13.7	27.0	0.0	5.9	38.8	0.0	19.4	23.8	12.9	0.0	0.0	0.0	62.3	22.7	9.2	0.0	32.5	10.1	26.0	0.0	0.0	14.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	7.2	0.0	0.0	0.0	0.0	48.6	0.0	0.0	9.8	0.0	0.0	19.6	13.8	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	10.4	11.0	22.7	0.0	0.0
MAGI2	"ACVRIP1, AIP1, ARIP1, KIAA0705, MAGI-2"	ENSG00000187391	"Membrane associated guanylate kinase, WW and PDZ domain containing 2"	Q86UL8	7	78017055-79453667	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Neurogenesis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 27.1"	"Group enriched"	"Detected in many"	7	"Astrocytes: 1765.2;Excitatory neurons: 2453.9;Inhibitory neurons: 2438.2;Oligodendrocyte precursor cells: 1208.9;Oligodendrocytes: 4001.5"	"Cancer enriched"	"Detected in many"	5	"glioma: 7.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"Karpas-707: 81.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013650	Approved					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA013650: AB_1853501"	"unprognostic (4.32e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.70e-4)"	"unprognostic (5.04e-2)"	"unprognostic (3.33e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.80e-3)"	"unprognostic (1.64e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (4.34e-4)"	"unprognostic (2.17e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.01e-2)"	4.0	5.9	11.9	1.1	16.4	0.8	3.1	0.0	27.1	4.3	0.0	3.8	1.8	4.1	3.6	2.1	3.9	3.0	2.6	14.1	0.0	5.3	1.4	2.8	0.7	0.7	1.3	8.2	3.3	12.5	6.9	1.2	0.0	8.5	1.6	11.6	1.6	8.1	1.9	1.3	2.0	2.5	0.0	1.9	2.2	3.6	10.8	0.6	6.5	2.3	0.4	4.4	3.0	17.0	0.1	0.6	19.5	0.3	4.0	6.2	0.3	3.5	6.4	0.7	1.0	0.1	0.3	0.1	0.1	2.2	2.6	0.3	1.1	0.1	0.9	1.0	0.8	0.3	0.5	1.1	5.8	0.5	1.0	4.7	0.3	0.4	0.2	3.6	0.9	0.7	0.6	81.9	1.7	0.8	0.2	0.4	4.3	0.7	0.2	0.3	0.2	1.4	0.2	0.3	2.9	4.9	0.8	0.3	1.9	2.9	0.4	0.6	1.1	2.8	1.0	7.6	0.5	0.4	0.0	0.2	1.8	0.1	1.2	0.8	0.1	0.2	0.2	0.1	0.1	0.2	0.1	0.1	0.1	0.4	0.1	0.2	0.9	0.2	0.2	0.3	0.1	0.0	11.9	16.4	0.0	27.1	14.1	0.0	0.7	1.3	0.0	0.0	10.8	17.0	7.9	9.6	12.5	1765.2	0.3	1.0	1.3	0.6	6.2	29.3	3.2	6.7	7.5	4.3	3.3	1.8	20.9	0.4	0.7	1.6	5.9	0.4	25.1	9.1	18.3	5.8	2.4	0.0	2453.9	1.0	0.1	11.0	0.5	4.5	0.0	11.6	2.2	2.0	0.2	47.1	2438.2	1.6	0.0	0.0	0.3	32.5	6.5	1.0	1.8	327.9	0.0	24.5	0.0	1208.9	4001.5	0.4	1.5	19.9	0.5	3.5	1.1	1.7	2.1	23.3	13.1	11.0	12.8	4.8	0.9	1.3	1.0	0.4	0.7	8.9	1.4	0.7
MAGOH	"MAGOH1, MAGOHA"	ENSG00000162385	"Mago homolog, exon junction complex subunit"	P61326	1	53226900-53238518	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015425, HPA043036, HPA047754"	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB015425: AB_629914, HPA043036: AB_2678279, HPA047754: AB_2680148"	"prognostic favorable (1.85e-4)"	"unprognostic (2.61e-2)"	"unprognostic (5.39e-2)"	"unprognostic (2.33e-1)"	"unprognostic (3.59e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.18e-1)"	"unprognostic (5.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (1.45e-5)"	"unprognostic (2.01e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.60e-2)"	"unprognostic (6.75e-3)"	51.4	48.5	36.5	59.0	36.5	141.1	51.8	37.8	47.1	41.0	38.4	61.2	53.1	57.2	59.0	48.1	55.9	37.9	43.3	36.6	38.1	53.6	76.4	44.8	85.0	37.5	37.1	49.2	43.8	50.4	34.9	67.9	37.9	39.9	55.5	34.4	44.5	37.4	43.8	42.9	55.2	50.7	37.5	55.2	46.8	32.3	36.8	101.7	51.7	42.5	86.3	62.1	38.9	38.1	207.8	101.0	169.4	150.2	88.1	56.9	197.6	152.3	92.0	202.4	204.5	233.2	97.1	293.5	168.8	93.1	248.4	125.9	228.3	136.7	242.3	197.1	249.6	266.1	127.4	253.3	141.4	459.3	143.3	62.7	95.3	184.4	150.6	77.7	136.8	260.8	279.6	63.8	109.9	169.3	377.2	316.0	310.0	171.1	218.4	256.1	323.2	154.5	109.1	208.3	142.7	115.7	202.0	161.2	250.1	206.8	85.1	330.2	122.0	122.6	167.7	170.7	354.9	93.6	184.8	453.4	109.4	289.5	127.0	31.5	34.8	53.9	49.3	51.9	48.1	47.4	46.9	51.5	50.0	42.9	42.6	44.9	41.9	52.9	50.2	58.6	54.2	32.7	36.5	36.5	37.8	47.1	36.6	38.1	37.5	37.1	37.9	37.5	36.8	38.1	134.5	51.3	47.6	10.1	93.5	144.4	121.3	231.6	99.0	31.0	62.1	85.9	50.6	60.1	106.9	57.0	14.6	206.9	123.5	47.0	178.1	96.2	44.9	123.9	83.7	89.6	54.4	90.9	13.0	84.9	195.4	83.5	46.9	102.2	83.6	78.4	57.8	44.2	116.0	23.5	12.4	89.2	130.2	47.8	103.2	16.1	75.5	80.0	81.8	7.5	102.5	67.2	84.5	10.6	15.1	87.4	70.9	68.1	62.6	92.3	69.0	152.0	100.4	36.4	59.2	93.9	148.1	90.0	67.9	82.7	120.8	241.9	107.6	89.5	87.1	92.1
MAGT1	"DKFZp564K142, IAP, MRX95, OST3B, SLC58A1"	ENSG00000102158	"Magnesium transporter 1"	Q9H0U3	X	77825747-77895593	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 145.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049851	Approved				"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA049851: AB_2680913"	"prognostic unfavorable (1.30e-4)"	"unprognostic (3.32e-1)"	"unprognostic (6.47e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.81e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.47e-2)"	"prognostic unfavorable (8.98e-4)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (3.55e-4)"	"unprognostic (1.03e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.56e-3)"	"unprognostic (1.14e-1)"	"unprognostic (6.25e-3)"	"unprognostic (1.66e-1)"	25.3	22.6	12.9	24.2	19.4	20.8	36.5	17.2	17.4	39.4	14.4	28.3	25.7	27.5	53.7	25.6	25.9	25.1	37.5	13.0	16.4	41.9	71.2	26.8	22.5	20.9	18.5	23.6	31.9	38.4	18.5	36.4	21.9	33.5	27.0	5.2	34.6	28.0	17.1	18.3	26.2	24.3	16.6	23.5	29.4	11.3	17.9	21.0	78.0	21.9	23.5	29.1	18.2	27.0	62.5	34.1	41.7	48.8	75.0	49.3	64.8	66.9	67.4	51.7	56.5	45.6	99.5	45.6	90.9	71.7	53.3	56.4	88.4	50.8	80.0	32.3	55.4	30.6	46.2	42.5	66.6	64.9	31.1	45.3	43.5	64.6	56.7	55.1	74.0	31.2	36.5	123.2	64.7	40.4	36.2	23.9	56.1	64.6	41.3	43.3	72.5	84.7	61.9	45.8	14.1	26.3	91.6	64.8	58.0	43.6	43.8	35.3	75.2	45.6	51.1	71.7	33.2	44.8	103.1	58.1	49.7	60.5	61.0	15.3	12.9	13.7	17.2	19.7	18.4	12.5	15.6	16.6	11.1	10.7	14.9	17.7	11.0	18.6	21.0	22.2	12.8	15.7	12.9	19.4	17.2	17.4	13.0	16.4	20.9	18.5	21.9	16.6	17.9	27.0	50.2	41.7	53.6	9.8	37.3	33.0	55.3	51.6	24.5	5.2	39.1	25.1	53.4	42.9	51.6	40.5	4.2	33.3	43.4	44.8	3.9	35.3	2.2	23.7	38.9	40.7	22.7	33.0	6.1	34.9	59.3	43.7	33.1	58.0	30.4	24.5	43.2	145.6	42.3	1.7	6.3	39.6	32.6	49.8	46.1	2.5	30.7	45.1	33.8	15.9	33.9	17.1	18.6	13.6	28.0	36.2	37.2	27.1	87.4	65.4	31.2	32.0	20.7	5.2	19.7	38.7	31.2	6.6	16.7	36.5	45.6	81.3	36.0	31.2	26.0	69.4
MARCHF1	"FLJ20668, MARCH-I, MARCH1, RNF171"	ENSG00000145416	"Membrane associated ring-CH-type finger 1"	Q8TCQ1	4	163524298-164384050	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 31.6;retina: 27.5"	"Group enriched"	"Detected in some"	4	"B-cells: 21.4;Hofbauer cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	94	"classical monocyte: 41.8;eosinophil: 25.5;intermediate monocyte: 41.0;memory B-cell: 42.3;myeloid DC: 44.2;naive B-cell: 35.8;non-classical monocyte: 45.4;plasmacytoid DC: 16.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Daudi: 7.1;U-266/70: 7.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014600, HPA048024"	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Vesicles"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Vesicles	"Endoplasmic reticulum, Golgi apparatus"	"HPA014600: AB_1853573, HPA048024: "	"unprognostic (7.29e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.09e-2)"	"unprognostic (8.25e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.79e-3)"	"unprognostic (9.00e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.24e-1)"	"unprognostic (7.00e-2)"	"unprognostic (2.48e-2)"	"unprognostic (2.70e-1)"	"unprognostic (2.91e-2)"	6.4	3.5	7.8	21.5	8.1	3.9	2.7	3.6	7.7	3.1	1.8	3.5	3.9	2.5	0.7	3.0	2.8	5.3	1.7	6.6	10.1	1.8	4.1	8.0	31.6	8.0	8.2	2.7	2.8	0.8	2.5	9.9	6.9	2.3	4.5	27.5	3.2	1.2	1.0	4.5	7.0	6.2	7.0	25.8	3.9	1.7	12.1	5.6	2.1	1.0	25.5	7.7	2.9	14.4	0.6	0.5	2.1	1.2	0.0	0.0	1.3	0.9	0.0	0.0	0.0	1.2	2.4	7.1	2.5	0.0	0.2	1.0	0.0	0.0	0.0	0.8	0.7	5.0	3.0	0.5	0.0	3.1	1.6	0.0	0.0	0.0	0.1	2.8	0.0	1.3	1.9	3.6	2.4	0.7	1.8	1.9	2.6	0.2	0.9	2.0	0.3	0.5	0.1	1.1	1.0	0.9	0.6	1.0	0.4	1.4	2.9	0.5	2.3	0.8	1.4	0.5	1.7	7.0	2.5	1.9	0.9	1.5	1.1	0.0	41.8	25.5	0.1	41.0	0.0	42.3	0.1	0.0	44.2	35.8	0.0	0.0	0.3	0.3	45.4	16.5	0.0	18.4	7.8	8.1	3.6	7.7	6.6	10.1	8.0	8.2	6.9	7.0	12.1	14.4	0.1	0.0	0.0	0.0	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	46.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0
MARCHF2	"HSPC240, MARCH-II, MARCH2, RNF172"	ENSG00000099785	"Membrane associated ring-CH-type finger 2"	Q9P0N8	19	8413270-8439017	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Endocytosis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 23.1;Cardiomyocytes: 42.3;Extravillous trophoblasts: 11.6;Hofbauer cells: 66.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014063	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"	Cytosol	"HPA014063: AB_1853576"	"unprognostic (1.15e-2)"	"unprognostic (4.01e-3)"	"prognostic unfavorable (6.48e-4)"	"prognostic favorable (1.05e-5)"	"unprognostic (3.00e-1)"	"prognostic favorable (8.29e-4)"	"unprognostic (3.43e-2)"	"unprognostic (6.95e-2)"	"unprognostic (3.06e-3)"	"unprognostic (2.32e-1)"	"prognostic favorable (6.21e-4)"	"unprognostic (2.01e-1)"	"unprognostic (3.52e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.16e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.80e-2)"	65.7	33.0	102.2	20.3	101.5	29.4	49.8	99.5	106.6	24.2	66.4	96.2	15.7	34.4	53.9	32.4	27.1	15.3	101.1	90.9	94.3	35.6	59.1	41.9	19.5	113.7	102.5	15.8	19.2	15.3	30.5	19.8	106.0	40.8	14.0	9.1	25.5	28.8	89.5	34.5	31.4	30.1	109.2	51.2	32.9	18.9	105.1	14.2	47.9	48.6	14.5	49.8	26.1	96.7	11.4	14.2	6.3	29.5	37.9	12.6	10.7	12.3	14.7	9.5	9.8	7.0	5.5	4.4	34.8	26.7	12.6	8.1	8.2	17.5	7.3	22.7	20.3	34.2	6.6	15.9	20.5	5.0	49.6	14.7	20.1	9.2	8.1	13.9	38.2	17.8	4.9	24.5	7.5	21.5	7.0	16.7	13.3	14.0	34.2	11.0	2.0	11.4	22.4	13.9	3.1	17.7	0.8	12.9	24.2	21.5	10.2	10.8	38.9	13.3	8.4	44.5	10.4	21.7	28.2	5.0	21.6	10.2	10.7	52.6	18.5	31.3	10.6	28.6	10.8	7.2	10.6	8.6	13.1	7.3	7.2	9.6	23.4	7.9	25.7	51.8	14.9	17.4	102.2	101.5	99.5	106.6	90.9	94.3	113.7	102.5	106.0	109.2	105.1	96.7	23.1	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.3	0.0	0.0	0.0	0.0	8.1	9.9	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	11.6	7.7	0.0	0.0	0.0	0.0	0.0	0.0	66.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	0.0	5.7	1.5	0.0	0.0	0.0
MARVELD2	"DFNB49, FLJ30532, MRVLDC2, TRIC"	ENSG00000152939	"MARVEL domain containing 2"	Q8N4S9	5	69415065-69444330	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 15.7"	"Cell type enhanced"	"Detected in many"		"Urothelial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 29.5;CAPAN-2: 24.1;HaCaT: 18.9;RT4: 21.1;SCLC-21H: 26.7;T-47d: 18.3"	"Region enriched"	"Detected in some"	8	"cerebellum: 7.9"	"Low region specificity"	"Detected in all"			"HPA018119, HPA061726"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 22: Epithelial cell types - Mixed function"	"Cell Junctions"		"HPA018119: AB_2669771, HPA061726: AB_2684595"	"unprognostic (4.11e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.44e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	"unprognostic (8.84e-2)"	"unprognostic (2.43e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.75e-1)"	"prognostic favorable (2.84e-13)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.82e-1)"	0.3	0.2	0.5	0.9	0.5	0.2	4.0	0.5	0.6	2.1	3.2	5.7	7.7	1.1	1.3	6.9	3.9	2.9	0.4	0.5	0.5	8.0	10.7	5.6	0.1	0.7	0.7	0.1	9.3	4.6	2.9	1.8	0.7	3.0	6.2	0.3	4.6	2.6	0.0	4.3	7.7	0.4	0.4	0.2	8.1	1.5	0.7	1.0	15.7	0.0	1.3	3.0	3.4	0.7	10.8	3.5	0.1	0.0	0.0	0.0	29.5	0.2	0.2	0.2	0.7	14.1	24.1	0.1	2.0	1.8	0.0	18.9	0.0	14.0	0.5	0.2	5.8	0.0	1.1	7.8	1.7	0.0	0.1	0.4	15.3	0.1	1.9	0.7	0.9	0.1	0.0	0.1	0.0	9.8	0.0	0.0	1.8	6.3	0.3	0.0	0.1	0.5	10.0	21.1	26.7	0.0	2.3	2.0	0.3	4.3	18.3	0.0	1.5	0.0	0.1	0.0	0.0	0.1	3.5	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.5	0.5	0.5	0.6	0.5	0.5	0.7	0.7	0.7	0.4	0.7	0.7	1.0	22.4	26.5	0.7	1.0	5.0	22.2	14.8	10.2	0.3	15.5	8.5	2.8	35.8	23.1	16.5	2.1	22.9	0.2	31.4	17.6	25.1	5.8	33.5	3.4	4.1	16.8	3.4	0.5	25.8	8.2	1.1	17.9	30.4	1.3	3.7	5.0	37.9	1.9	0.0	0.4	23.1	18.3	0.6	0.9	3.2	0.0	0.6	1.8	1.0	7.8	0.5	0.0	0.5	0.6	25.0	29.7	0.0	0.6	25.5	33.5	6.1	38.4	0.6	0.0	0.8	1.5	4.1	2.4	19.4	6.5	12.0	0.9	2.9	25.6	46.9
MARVELD3	MRVLDC3	ENSG00000140832	"MARVEL domain containing 3"	Q96A59	16	71626161-71642114	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 150.1;Intestinal goblet cells: 68.2;Paneth cells: 102.9;Proximal enterocytes: 199.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in some"		"basophil: 1.8"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"A-431: 21.7;BEWO: 30.9;CACO-2: 23.6;CAPAN-2: 22.5;HaCaT: 21.4;MCF7: 40.8;RT4: 18.8;SK-BR-3: 18.5;T-47d: 26.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043514, HPA045471"			Approved	"Vesicles,Intermediate filaments"		No	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 45: Enterocytes - Digestion"	Vesicles	"Intermediate filaments"	"HPA043514: AB_10959475, HPA045471: "	"unprognostic (1.18e-1)"	"unprognostic (3.92e-1)"	"unprognostic (9.92e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (6.16e-3)"	"unprognostic (2.04e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.54e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.29e-1)"	"unprognostic (5.16e-2)"	"prognostic favorable (6.80e-10)"	"unprognostic (2.63e-3)"	"unprognostic (4.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.43e-1)"	0.2	0.3	0.5	3.1	0.6	0.6	6.2	1.8	0.9	4.0	6.5	23.6	31.1	1.8	7.3	4.2	4.2	4.8	0.3	1.1	0.5	12.9	5.3	2.4	0.5	0.4	0.5	0.5	17.1	12.5	1.0	5.7	0.5	6.0	18.7	2.1	11.6	2.5	0.8	3.3	33.1	0.6	0.1	0.4	2.8	0.9	0.5	0.9	3.9	0.0	1.7	3.8	2.5	0.9	21.7	0.7	0.5	0.9	0.0	0.1	30.9	0.0	0.0	0.0	0.0	23.6	22.5	0.2	2.3	0.0	0.1	21.4	1.9	10.3	0.1	0.0	12.1	0.0	0.4	6.2	0.0	0.1	0.2	0.9	12.5	0.1	0.2	0.1	0.0	0.1	0.3	0.1	0.0	40.8	0.2	0.3	3.5	13.4	0.2	0.0	0.1	8.8	0.3	18.8	3.7	0.2	0.4	18.5	0.0	2.4	26.3	0.3	0.0	0.0	0.4	0.4	0.2	0.2	0.3	0.1	0.2	0.2	0.2	1.8	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.2	0.1	0.4	0.2	0.2	1.2	0.4	0.1	0.3	0.2	0.1	0.5	0.6	1.8	0.9	1.1	0.5	0.4	0.5	0.5	0.1	0.5	0.9	0.3	9.6	8.4	0.3	0.8	7.9	28.7	9.6	22.8	7.0	25.4	10.7	0.6	40.0	17.9	9.2	0.0	36.5	1.5	150.1	1.9	29.8	4.4	14.2	1.5	1.0	61.5	0.0	0.6	33.7	2.5	1.5	6.1	19.4	0.0	3.8	0.4	9.1	3.1	0.0	0.6	68.2	14.2	1.0	1.0	3.3	0.3	1.2	0.0	0.0	0.8	1.0	0.0	0.0	0.6	26.3	102.9	0.7	0.0	38.4	199.3	27.6	17.4	19.6	0.0	4.1	1.6	9.6	5.0	19.6	3.7	4.8	1.4	0.0	61.3	44.3
MB	PVALB	ENSG00000198125	Myoglobin	P02144	22	35606764-35637951	"Candidate cardiovascular disease genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Oxygen transport, Transport"	"Muscle protein"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	38	"heart muscle: 13154.5;skeletal muscle: 40709.4;tongue: 29085.2"	"Cell type enriched"	"Detected in many"	12	"Cardiomyocytes: 5182.1"	"Group enriched"	"Detected in many"	7	"breast cancer: 13.6;head and neck cancer: 31.1;prostate cancer: 30.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"NK-cell: 1.3"	"Lineage enriched"	"Detected in single"	6	"NK-cells: 1.3"	"Cell line enriched"	"Detected in some"	4	"SK-BR-3: 175.6"	"Low region specificity"	"Detected in many"							"CAB000060, HPA003123"	Enhanced					NA	NA	13500000	140000000	"Cluster 48: NK-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB000060: , HPA003123: AB_1079442"	"unprognostic (7.51e-2)"	"unprognostic (3.92e-3)"	"unprognostic (1.07e-1)"	"unprognostic (7.71e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.66e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.18e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.74e-3)"	"unprognostic (1.17e-2)"	"unprognostic (8.34e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.44e-3)"	"unprognostic (1.19e-2)"	8.1	4.6	1.2	1.5	1.2	0.3	43.4	1.2	2.2	2.9	0.9	14.6	1.8	2.3	0.3	736.1	18.7	4.1	13154.5	1.0	1.9	2.8	5.8	14.9	5.3	1.4	1.4	5.3	26.9	16.1	10.6	3.1	1.2	214.2	12.9	0.2	367.1	0.5	40709.4	23.0	11.1	1.4	1.2	2.1	3.8	4.5	1.5	0.8	8.5	29085.2	1.8	1.3	4.5	1.0	1.9	7.6	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.0	0.0	4.6	0.7	0.1	0.3	1.0	0.8	0.2	0.0	0.0	5.4	0.3	0.1	0.5	0.1	0.0	0.0	0.2	0.1	0.2	0.4	0.0	0.2	0.0	0.0	0.5	0.5	0.0	19.2	0.1	0.6	0.0	1.9	2.3	0.9	0.5	8.0	0.0	6.4	1.5	0.2	19.0	175.6	0.0	0.3	39.4	0.1	0.4	0.5	1.2	2.2	0.2	0.0	0.0	0.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	1.2	1.2	1.2	2.2	1.0	1.9	1.4	1.4	1.2	1.2	1.5	1.0	0.3	0.0	0.0	0.3	0.1	0.3	4.3	12.5	0.0	0.0	30.7	23.9	5182.1	0.0	30.8	0.0	0.0	0.1	0.5	3.8	0.0	4.7	20.1	20.2	0.1	40.7	11.5	0.0	0.0	0.2	0.0	145.2	0.0	0.2	0.0	0.8	0.0	0.4	0.0	0.0	0.1	114.6	14.2	0.0	0.4	70.0	0.0	2.1	12.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.7	0.0	21.8	2.6	0.1	19.9	0.0	0.0	420.9	42.0	0.3	0.7	0.6	0.1	0.3	2.8	0.1	2.9	15.1
MBOAT4	"FKSG89, GOAT, OACT4"	ENSG00000177669	"Membrane bound O-acyltransferase domain containing 4"	Q96T53	8	30131671-30144665	"Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"pancreas: 3.6;stomach 1: 3.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 3.6;Cholangiocytes: 12.8;Ductal cells: 3.1;Enteroendocrine cells: 3.5;Excitatory neurons: 2.4;Inhibitory neurons: 3.1;Oligodendrocyte precursor cells: 3.0;Oligodendrocytes: 5.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.7"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"Hep G2: 3.1;OE19: 3.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044509			Supported	"Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 25: Pancreas - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 41: Macrophages - Immune response"	"Golgi apparatus"		"HPA044509: AB_2678966"	"unprognostic (4.35e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.99e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.76e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.48e-2)"	"unprognostic (2.56e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.30e-2)"	"unprognostic (7.02e-2)"	"unprognostic (4.24e-6)"	"unprognostic (9.87e-3)"	"unprognostic (1.58e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.66e-2)"	0.1	0.5	0.1	0.2	0.1	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.4	0.1	0.0	0.1	1.7	0.9	0.2	0.1	0.1	0.1	0.4	0.3	0.4	0.1	0.1	0.1	3.6	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.4	3.7	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	3.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.2	0.1	0.0	3.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.3	0.1	0.1	0.1	0.6	0.1	0.4	0.7	0.0	0.4	0.6	0.2	1.0	0.7	1.2	0.8	0.8	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	12.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	3.1	1.1	0.0	0.0	0.0	3.5	0.0	2.4	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.4	0.0	0.0	0.0	3.1	0.0	0.0	0.6	0.0	0.6	0.0	0.2	0.0	1.0	0.0	0.0	0.0	3.0	5.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0
MBOAT7	"BB1, hMBOA-7, LENG4, LPLAT"	ENSG00000125505	"Membrane bound O-acyltransferase domain containing 7"	Q96N66	19	54173412-54189882	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"	"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 108.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in all"	9	"basophil: 157.3;eosinophil: 265.9;neutrophil: 239.1"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 265.9"	"Cell line enhanced"	"Detected in many"		"HMC-1: 216.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055967	Approved		Approved	Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 22: Epithelial cell types - Mixed function"	Cytosol		"HPA055967: AB_2682990"	"unprognostic (1.89e-2)"	"unprognostic (2.60e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.31e-1)"	"unprognostic (3.54e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (5.55e-6)"	"prognostic unfavorable (5.13e-4)"	"unprognostic (5.36e-2)"	"unprognostic (2.31e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (6.62e-5)"	"unprognostic (1.31e-1)"	"unprognostic (4.75e-2)"	"unprognostic (3.95e-1)"	"prognostic favorable (4.31e-4)"	14.9	108.4	17.6	13.4	14.8	13.1	13.7	0.0	21.4	19.0	0.0	27.8	27.0	19.0	6.6	20.6	20.1	9.2	12.8	17.6	34.4	19.2	16.0	23.6	4.8	24.9	27.8	23.0	21.0	18.9	22.8	6.9	29.2	17.3	5.3	1.0	18.6	20.2	7.9	21.1	25.3	4.4	2.7	26.6	19.9	36.3	28.7	3.2	15.9	1.1	2.3	32.5	18.1	4.8	66.8	43.2	3.8	50.8	21.0	15.4	57.1	90.5	42.6	32.9	49.2	22.1	64.3	11.3	46.5	34.4	10.9	111.9	0.3	26.1	9.0	16.1	54.6	12.8	30.0	12.6	18.9	29.0	216.2	31.0	17.9	17.3	9.8	44.1	46.0	11.0	51.6	42.2	9.2	32.2	10.9	22.7	22.0	21.1	60.1	28.4	7.3	24.9	47.0	71.1	2.3	14.3	57.3	37.0	16.3	4.2	34.5	2.8	73.1	49.4	16.0	12.1	40.8	17.4	31.0	6.4	66.1	25.8	27.9	157.3	22.5	265.9	2.2	11.8	3.3	1.8	3.2	1.7	24.8	1.5	1.1	1.7	239.1	7.8	7.0	7.0	1.9	8.6	17.6	14.8	0.0	21.4	17.6	34.4	24.9	27.8	29.2	2.7	28.7	4.8	11.8	12.8	26.4	11.4	11.3	13.9	66.4	29.2	14.8	15.4	31.1	19.8	8.4	31.5	23.2	44.1	6.2	43.5	15.2	88.8	5.9	52.2	1.1	28.7	22.1	18.5	42.5	13.9	18.7	33.1	52.2	16.3	10.7	26.4	76.8	25.3	15.0	22.7	32.2	30.3	13.6	49.6	16.2	36.8	38.1	4.3	19.3	52.5	8.8	8.4	48.9	24.6	3.1	5.5	9.3	28.6	43.0	15.4	9.3	44.5	101.1	14.5	28.5	8.5	39.5	7.7	19.6	5.1	15.0	17.9	21.6	51.6	23.0	46.3	46.6	47.2
MC2R	ACTHR	ENSG00000185231	"Melanocortin 2 receptor"	Q01718	18	13882044-13915707	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	33	"adrenal gland: 57.9"	"Cell type enhanced"	"Detected in single"		"Late spermatids: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA079148	Enhanced					NA	NA				"Cluster 17: Adrenal gland - Steroid metabolism"		"Cluster 31: Spermatids - Spermatogenesis"			"HPA079148: "											"unprognostic (2.09e-1)"			"unprognostic (3.63e-2)"	"unprognostic (1.85e-2)"			0.0	57.9	0.0	0.1	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MC4R		ENSG00000166603	"Melanocortin 4 receptor"	P32245	18	60371062-60372775	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"brain: 3.5;fallopian tube: 3.0;retina: 3.9"	"Cell type enriched"	"Detected in some"	7	"Bipolar cells: 7.3"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	70	"fHDF/TERT166: 94.7"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebellum: 10.2"	HPA016719	Uncertain					NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 56: Bipolar cells - Visual perception"			"HPA016719: AB_1853617"	"unprognostic (2.29e-1)"			"unprognostic (5.31e-3)"	"unprognostic (5.78e-2)"	"unprognostic (1.41e-1)"		"unprognostic (1.35e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.48e-1)"			"unprognostic (2.49e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.59e-1)"		0.0	0.2	2.2	0.0	2.4	0.0	0.2	0.1	1.7	0.0	0.0	0.0	0.1	0.0	0.3	0.0	3.0	0.0	0.0	1.8	3.5	0.0	0.0	0.0	0.0	1.0	1.5	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	3.9	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.1	0.1	2.7	0.3	0.0	0.0	0.3	0.0	0.0	1.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	94.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	0.1	1.7	1.8	3.5	1.0	1.5	0.7	0.4	2.7	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MCFD2	"F5F8D, LMAN1IP, SDNSF"	ENSG00000180398	"Multiple coagulation factor deficiency 2, ER cargo receptor complex subunit"	Q8NI22	2	46901870-46941855	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 253.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022410, HPA034593"	Supported				"Intracellular and membrane"	NA	NA		1200000	"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 5: Muller glia cells - Visual perception"			"CAB022410: , HPA034593: AB_2674239"	"unprognostic (1.16e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.87e-2)"	"unprognostic (3.98e-2)"	"unprognostic (3.10e-2)"	"unprognostic (3.93e-2)"	"unprognostic (8.32e-2)"	"unprognostic (1.56e-3)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.64e-4)"	52.0	155.5	41.3	35.6	43.1	34.7	55.1	38.1	40.3	50.4	69.5	32.2	32.5	54.5	42.1	45.9	41.9	44.9	42.3	41.3	46.8	59.4	111.8	45.0	32.1	33.5	41.3	79.2	104.1	52.5	38.7	70.1	41.6	54.0	26.9	83.3	149.7	82.9	83.3	26.0	33.4	52.5	28.0	44.6	33.9	30.9	48.6	30.8	121.0	84.6	34.2	41.2	29.2	34.7	147.7	86.9	74.7	59.7	151.5	215.1	115.4	248.4	254.1	129.4	116.8	116.9	109.4	96.4	297.7	294.7	154.3	81.8	67.0	127.0	207.7	64.5	67.2	101.9	87.1	182.5	236.5	94.8	158.6	163.2	77.8	206.7	178.7	247.9	210.8	28.0	199.3	56.0	266.8	48.7	56.9	67.6	63.9	102.3	84.1	68.3	133.2	106.7	80.3	59.3	23.9	62.2	93.1	46.9	116.0	86.3	33.1	80.6	341.1	298.3	130.5	97.0	164.2	42.0	43.8	76.4	320.2	88.0	100.8	27.2	21.4	29.7	9.6	23.3	12.2	12.5	10.9	10.2	18.4	12.8	14.3	9.8	12.0	9.9	18.3	16.9	9.7	14.0	41.3	43.1	38.1	40.3	41.3	46.8	33.5	41.3	41.6	28.0	48.6	34.7	50.8	105.8	89.1	16.6	29.6	48.2	56.5	65.3	36.5	69.3	64.4	48.5	70.3	38.6	68.8	47.8	39.6	75.5	25.4	26.6	21.5	88.6	144.3	76.4	60.2	64.7	26.8	28.2	19.6	178.5	64.5	70.1	20.4	69.9	50.5	44.1	53.9	155.1	54.5	38.7	23.8	28.5	18.3	40.5	31.3	113.7	62.7	39.2	12.4	7.5	33.8	253.2	12.3	16.1	16.2	152.7	23.1	59.5	43.8	82.4	42.2	41.3	69.6	51.3	65.7	63.9	55.4	48.9	32.6	39.6	44.9	102.1	23.4	74.3	22.8	75.8
MCHR1	"GPR24, MCH1R, SLC1"	ENSG00000128285	"Melanin concentrating hormone receptor 1"	Q99705	22	40678750-40682814	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 3.7;endometrium 1: 3.6"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.7;Hepatic stellate cells: 2.2;Inhibitory neurons: 4.3;Leydig cells: 2.8;Melanocytes: 8.8;Microglial cells: 2.8;Oligodendrocyte precursor cells: 2.0"	"Group enriched"	"Detected in some"	7	"glioma: 4.9;liver cancer: 1.5;melanoma: 3.1;renal cancer: 2.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 1.2;RH-30: 1.6;SuSa: 4.7;T-47d: 1.4;U-87 MG: 1.5"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"basal ganglia: 22.9"							NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (3.37e-2)"	"unprognostic (1.37e-2)"	"unprognostic (2.45e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.84e-3)"	"unprognostic (4.92e-3)"	"unprognostic (4.51e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.58e-2)"	"unprognostic (9.35e-4)"	"unprognostic (3.05e-1)"	"unprognostic (2.26e-1)"	"prognostic unfavorable (1.49e-6)"	"unprognostic (3.07e-2)"	"unprognostic (5.40e-2)"	"unprognostic (2.42e-1)"	"unprognostic (3.91e-2)"	0.3	0.1	2.0	0.3	2.5	0.0	0.1	1.8	3.7	0.4	0.5	0.1	0.1	3.6	0.4	0.0	0.7	0.0	2.2	2.6	3.5	0.1	1.3	0.2	0.2	1.8	1.5	2.4	0.0	0.0	2.1	0.0	2.6	0.0	0.0	1.2	0.1	0.0	0.1	0.5	0.1	0.7	1.0	0.0	0.0	0.1	2.0	0.0	0.0	0.0	0.1	0.2	0.1	1.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	1.2	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	2.5	1.8	3.7	2.6	3.5	1.8	1.5	2.6	1.0	2.0	1.6	0.0	0.0	0.0	1.0	0.0	0.3	0.0	0.1	0.0	0.4	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	3.7	0.0	0.0	0.1	0.0	0.0	0.0	0.3	2.2	1.2	0.1	0.0	4.3	0.0	0.0	0.0	0.3	0.0	2.8	0.0	8.8	2.8	0.0	1.6	0.0	2.0	0.6	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
MCM3AP	"GANP, KIAA0572, Map80, SAC3"	ENSG00000160294	"Minichromosome maintenance complex component 3 associated protein"	O60318	21	46235133-46286297	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Immunity, mRNA transport, Protein transport, Translocation, Transport"	"Acyltransferase, Transferase"	"Mental retardation, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021527, HPA032103"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane, Cytosol"	Nucleoplasm	"HPA021527: AB_1853626, HPA032103: AB_2674152"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.31e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.72e-1)"	"unprognostic (6.31e-3)"	"unprognostic (1.48e-2)"	"unprognostic (2.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (4.76e-3)"	"prognostic favorable (2.05e-4)"	"unprognostic (1.96e-1)"	"unprognostic (2.81e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.85e-3)"	"unprognostic (2.28e-1)"	16.8	12.0	10.0	20.3	11.5	19.7	13.6	8.9	10.7	14.7	17.0	15.1	14.0	16.5	8.3	14.3	15.2	14.2	15.1	8.5	7.8	13.0	9.7	16.0	21.0	10.8	10.4	17.6	15.4	16.9	9.2	16.3	9.5	14.2	15.0	12.8	13.7	13.4	41.3	13.8	16.1	17.1	9.4	19.6	15.4	14.1	11.0	21.7	16.0	28.7	21.5	13.6	11.2	14.6	38.0	36.3	41.8	45.5	33.1	41.4	38.0	40.8	48.1	37.1	30.2	33.1	21.9	53.6	32.9	43.2	40.3	21.9	55.9	34.0	32.7	55.7	50.8	87.9	35.0	25.9	29.6	40.6	47.7	31.7	28.7	51.2	35.2	25.4	40.7	31.7	107.3	39.6	43.3	21.1	43.5	26.8	72.3	40.0	30.2	56.3	26.6	48.9	17.8	34.1	35.2	37.6	52.4	33.7	39.0	31.5	46.0	41.2	51.6	39.1	29.7	33.1	31.0	71.8	86.2	33.0	35.3	38.0	51.8	0.6	2.0	1.6	2.3	1.9	2.4	1.1	1.3	2.6	1.9	1.6	1.2	1.3	1.2	1.1	1.1	1.6	1.8	2.1	10.0	11.5	8.9	10.7	8.5	7.8	10.8	10.4	9.5	9.4	11.0	14.6	17.3	9.6	18.9	28.1	21.3	7.0	7.1	9.0	22.2	21.8	13.8	13.0	4.7	14.3	12.7	11.0	20.9	11.4	20.6	17.5	1.9	11.3	3.5	16.8	23.7	14.8	12.0	18.5	28.0	14.2	11.7	12.8	27.0	17.7	8.8	20.1	11.7	18.6	15.4	16.8	34.2	19.2	10.2	19.7	8.4	4.3	18.3	18.6	10.6	34.7	24.3	9.3	16.5	37.2	35.3	15.9	8.6	14.3	21.6	14.0	13.8	6.6	15.5	21.7	19.7	17.9	12.9	19.7	15.0	21.2	10.4	9.3	19.1	16.0	17.9	7.9
MCOLN1	"ML4, MLIV, MST080, MSTP080, TRPM-L1, TRPML1"	ENSG00000090674	"Mucolipin 1"	Q9GZU1	19	7522624-7534009	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Ion channel"	"Disease variant, Mucolipidosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 109.4;Kupffer cells: 117.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 117.5;classical monocyte: 45.2;eosinophil: 105.7;intermediate monocyte: 95.5;neutrophil: 41.1;non-classical monocyte: 105.1"	"Group enriched"	"Detected in all"	5	"granulocytes: 117.5;monocytes: 105.1"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031763, CAB032637, HPA069495"	Uncertain		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Vesicles"	Nucleoplasm	"CAB032637: AB_2142964, HPA031763: AB_10600822, HPA069495: "	"unprognostic (5.51e-2)"	"unprognostic (1.31e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.30e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.38e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.47e-1)"	"prognostic favorable (5.60e-5)"	"unprognostic (1.36e-1)"	"prognostic favorable (5.67e-4)"	"unprognostic (2.58e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.83e-1)"	21.2	37.4	6.4	9.2	6.5	10.4	15.3	7.0	8.4	11.7	8.3	13.6	8.3	11.6	2.7	11.0	12.2	10.1	15.7	7.0	7.4	11.7	14.7	20.3	13.2	8.2	7.4	10.0	9.9	10.2	21.7	15.9	9.0	8.7	5.6	5.0	12.3	6.1	22.2	20.8	12.1	8.1	7.1	48.2	12.8	5.6	8.2	6.2	8.5	11.7	4.1	15.8	10.9	9.9	11.6	11.7	5.6	19.1	32.0	10.3	16.1	21.2	16.9	25.2	21.6	9.0	10.0	6.5	25.5	14.5	22.2	5.3	9.5	7.3	7.4	12.7	21.1	5.8	11.0	7.3	28.0	6.6	24.5	14.5	16.8	24.1	4.2	7.9	10.7	14.2	10.9	27.9	14.7	3.9	9.1	6.6	12.6	6.1	24.8	12.6	9.4	13.8	9.6	9.9	14.4	17.8	9.1	15.8	26.8	6.1	9.6	11.4	13.5	12.0	6.9	48.8	16.0	21.5	35.5	4.7	19.2	9.2	18.4	117.5	45.2	105.7	7.7	95.5	6.3	4.2	6.5	6.3	19.2	4.1	6.0	6.5	41.1	10.3	105.1	21.1	10.0	17.1	6.4	6.5	7.0	8.4	7.0	7.4	8.2	7.4	9.0	7.1	8.2	9.9	15.1	3.2	2.6	5.9	8.0	13.4	6.5	16.9	10.2	27.3	15.9	15.0	2.3	15.7	8.1	31.3	22.9	11.6	12.1	32.0	1.9	23.7	4.8	5.0	19.8	14.1	16.8	21.7	10.6	23.1	20.0	16.0	9.7	6.5	1.3	22.2	13.6	13.6	109.4	58.9	8.0	10.0	22.4	117.1	32.2	17.0	16.4	70.6	21.4	7.5	18.0	23.0	16.5	7.5	11.4	23.4	19.3	15.8	8.0	5.6	21.8	12.3	6.5	44.1	6.6	11.2	14.8	10.3	14.7	8.9	17.3	29.6	8.7	17.3	9.4	4.8
MCOLN2	"FLJ36691, TRP-ML2, TRPML2"	ENSG00000153898	"Mucolipin 2"	Q8IZK6	1	84925583-84997113	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Calcium transport, Immunity, Innate immunity, Ion transport, Protein transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 15.1;lymphoid tissue: 13.1"	"Cell type enhanced"	"Detected in many"		"B-cells: 26.3;dendritic cells: 43.6;Distal enterocytes: 31.4;Early spermatids: 53.1;Langerhans cells: 100.8;monocytes: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 29.7"	"Group enriched"	"Detected in many"	14	"B-cells: 10.3;dendritic cells: 29.7;T-cells: 8.9"	"Cell line enhanced"	"Detected in many"		"Daudi: 21.9;HAP1: 14.7;HDLM-2: 26.9;HEK 293: 13.6;THP-1: 28.5;U-698: 18.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA019114	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"			"HPA019114: AB_1853645"	"unprognostic (3.02e-2)"	"unprognostic (5.67e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.47e-1)"	"unprognostic (5.66e-3)"	"unprognostic (2.38e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (8.92e-2)"	"unprognostic (1.48e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.12e-4)"	"unprognostic (3.68e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-2)"	0.7	8.8	0.2	5.3	0.2	2.9	1.0	1.0	0.4	1.1	0.7	10.2	1.7	1.0	4.0	0.7	2.6	1.6	0.4	0.3	0.1	1.1	0.7	5.4	12.9	0.4	0.1	0.5	0.8	1.1	0.6	2.6	0.3	0.7	15.1	0.1	0.8	0.2	0.2	2.1	5.5	0.6	0.1	6.7	2.1	1.5	0.3	2.3	0.5	0.2	13.1	1.6	0.7	0.5	1.5	1.6	0.0	4.0	0.8	0.2	0.3	1.0	5.5	1.6	2.0	0.0	0.1	21.9	0.5	0.0	2.6	0.1	14.7	1.8	1.5	26.9	13.6	1.9	0.4	0.0	1.3	0.0	1.8	0.3	0.0	1.3	1.0	0.1	0.0	5.1	0.0	0.0	0.3	0.5	0.3	0.0	1.6	0.0	2.9	0.0	3.3	0.0	0.1	0.2	0.9	0.0	0.1	0.2	9.2	0.2	2.4	28.5	0.1	1.3	2.1	0.0	4.2	0.0	0.0	18.5	1.2	0.0	4.0	0.1	0.3	0.0	5.9	1.1	2.1	10.3	5.0	8.9	7.1	3.7	0.6	4.5	0.2	0.4	0.2	29.7	0.2	2.6	0.2	0.2	1.0	0.4	0.3	0.1	0.4	0.1	0.3	0.1	0.3	0.5	0.4	0.0	0.6	0.0	26.3	4.5	0.4	0.1	1.2	0.0	1.1	1.8	0.5	0.0	1.3	1.8	0.0	0.1	43.6	31.4	0.0	0.1	53.1	12.3	6.0	0.4	2.4	1.3	0.9	1.4	0.1	1.5	1.5	24.5	0.0	0.1	0.7	0.0	0.7	0.0	0.5	4.5	0.0	1.3	100.8	19.6	0.0	14.4	8.8	2.8	32.3	0.0	1.0	0.0	1.4	0.4	4.7	0.0	13.8	0.6	0.0	2.3	1.5	0.0	0.0	0.7	0.3	1.6	4.3	0.0	3.3	0.3	21.8	1.6	5.4	0.1
MCOLN3	"FLJ11006, TRP-ML3, TRPML3"	ENSG00000055732	"Mucolipin 3"	Q8TDD5	1	85018082-85048500	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 43.5;epididymis: 13.9;parathyroid gland: 35.3"	"Group enriched"	"Detected in many"	7	"Enteroendocrine cells: 113.6;Melanocytes: 151.2"	"Cancer enriched"	"Detected in many"	6	"melanoma: 8.0"	"Group enriched"	"Detected in some"	5	"cerebral cortex: 4.0;hippocampal formation: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 12.9;HAP1: 12.7;RH-30: 15.7;SK-MEL-30: 29.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018106, HPA062137"	Enhanced		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoli, Cytosol"		"HPA018106: AB_1853647, HPA062137: AB_2684695"	"unprognostic (5.91e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.49e-2)"	"unprognostic (3.21e-5)"	"unprognostic (2.25e-1)"	"unprognostic (8.80e-3)"	"unprognostic (3.97e-3)"	"unprognostic (1.13e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.45e-3)"	"unprognostic (3.09e-2)"	"unprognostic (7.32e-5)"	"unprognostic (6.36e-3)"	"unprognostic (2.61e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.43e-2)"	3.0	43.5	0.7	0.2	0.2	0.0	2.2	0.0	4.0	5.1	3.3	1.0	5.4	5.7	13.9	0.3	1.7	0.3	4.4	3.5	0.1	5.0	0.1	4.5	0.1	0.0	0.1	2.1	7.4	35.3	7.0	2.5	0.1	0.3	1.0	0.1	3.7	0.6	0.2	4.3	2.2	1.9	0.2	0.9	2.6	0.6	0.5	4.3	1.9	1.1	0.2	0.4	2.4	0.0	9.0	2.0	0.0	0.0	6.6	5.9	2.4	0.1	12.9	3.2	8.8	0.6	1.5	0.0	0.9	0.1	3.0	0.0	12.7	4.2	2.0	3.6	8.6	0.0	0.7	0.0	0.0	0.0	0.0	0.6	1.5	2.6	1.5	3.2	0.0	0.0	0.0	0.0	6.3	0.7	0.0	0.0	1.0	0.0	1.1	0.0	15.7	0.0	0.4	0.0	0.5	0.0	0.4	0.0	29.3	0.9	5.2	6.5	0.0	2.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	0.0	4.0	3.5	0.1	0.0	0.1	0.1	0.2	0.5	0.0	16.6	16.0	1.7	0.0	0.0	8.7	3.5	7.0	0.6	0.0	4.2	1.9	6.8	11.5	2.5	3.7	0.0	9.0	0.1	0.3	0.0	1.7	0.4	0.8	8.1	2.0	113.6	0.0	1.2	9.6	0.2	18.4	1.5	1.9	0.0	0.3	0.0	0.1	3.5	0.0	0.4	2.5	6.1	0.0	7.1	0.1	1.8	3.2	151.2	2.8	1.6	0.0	0.0	0.0	0.1	3.6	12.9	0.0	0.3	1.4	4.1	3.4	0.7	0.0	6.6	6.3	1.2	1.8	4.1	0.4	3.4	2.6	1.4	1.0	3.8	0.6
MCTP2	"FLJ11175, FLJ33303"	ENSG00000140563	"Multiple C2 and transmembrane domain containing 2"	Q6DN12	15	94231538-94483952	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 72.8;NK-cells: 97.9"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 6.8"	"Immune cell enhanced"	"Detected in many"		"neutrophil: 32.1"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HEL: 20.8;HMC-1: 16.4;U-698: 22.4;U-87 MG: 24.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"HPA051176, HPA070541"	Uncertain		Enhanced	Nucleoplasm,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Cytosol"		"HPA051176: AB_2681373, HPA070541: AB_2686277"	"unprognostic (1.70e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.63e-2)"	"unprognostic (7.15e-4)"	"unprognostic (3.57e-2)"	"unprognostic (2.66e-3)"	"unprognostic (3.45e-2)"	"unprognostic (3.68e-3)"	"unprognostic (2.83e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (2.18e-5)"	"unprognostic (5.87e-2)"	"unprognostic (4.36e-1)"	"unprognostic (1.76e-3)"	"unprognostic (9.41e-2)"	4.1	3.8	1.0	6.6	1.8	18.0	2.9	0.0	6.8	5.4	0.8	10.6	6.9	1.8	8.6	3.9	4.1	4.5	0.6	1.1	2.8	2.3	1.5	8.7	6.1	0.0	0.3	1.6	5.7	3.5	7.3	19.3	1.0	5.4	12.2	2.6	5.9	4.1	0.1	3.6	6.4	1.6	0.0	21.1	4.7	1.0	1.3	3.0	5.5	0.4	6.2	6.6	3.7	0.6	3.6	0.0	0.1	0.0	0.0	0.0	2.5	1.9	1.1	0.3	0.1	2.4	4.4	10.3	0.5	0.1	0.1	8.0	0.1	6.6	0.0	2.1	0.8	20.8	2.9	1.2	1.4	4.4	16.4	1.1	7.8	0.1	8.2	0.0	0.0	3.6	0.8	5.9	0.0	0.0	2.0	11.4	0.8	3.6	3.7	4.7	0.1	4.0	0.5	10.7	1.9	0.4	0.2	3.4	1.3	0.8	0.0	0.3	0.2	0.1	1.7	0.0	0.0	12.0	0.3	22.4	24.1	11.1	1.2	6.6	0.8	12.1	6.1	0.2	3.0	3.5	1.7	2.8	0.0	3.6	0.7	2.7	32.1	10.9	0.9	0.3	0.1	1.9	1.0	1.8	0.0	6.8	1.1	2.8	0.0	0.3	1.0	0.0	1.3	0.6	1.1	3.2	18.6	1.0	38.9	4.2	12.9	8.6	22.8	15.6	3.8	4.3	1.1	7.2	13.2	3.7	0.0	17.0	72.8	39.4	0.0	3.4	4.0	6.5	3.4	1.8	15.6	35.7	15.6	4.7	7.3	7.8	5.6	6.6	36.2	0.3	1.4	1.4	9.6	0.0	10.3	43.8	8.2	8.7	2.1	4.8	0.3	11.1	1.8	25.3	4.7	0.1	97.9	0.0	0.7	4.2	24.6	0.0	45.8	14.2	18.1	1.9	8.7	0.6	0.0	2.5	1.6	3.4	2.5	15.0	2.3	24.5	26.6	0.5	21.5	19.6
MCUB	"CCDC109B, FLJ20647"	ENSG00000005059	"Mitochondrial calcium uniporter dominant negative subunit beta"	Q9NWR8	4	109560209-109688719	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 32.2"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 127.7;Exocrine glandular cells: 111.4;Extravillous trophoblasts: 91.9;Hofbauer cells: 106.8;Pancreatic endocrine cells: 67.9;Syncytiotrophoblasts: 73.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 93.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA048776	Enhanced		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Vesicles, Mitochondria"		"HPA048776: AB_2680518"	"unprognostic (6.12e-3)"	"unprognostic (1.70e-2)"	"unprognostic (3.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.70e-2)"	"unprognostic (3.06e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.26e-3)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (7.35e-6)"	"unprognostic (2.48e-1)"	"unprognostic (5.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.42e-2)"	10.2	2.0	2.6	18.4	3.0	10.6	7.6	2.1	3.4	7.0	3.5	5.3	3.8	8.8	1.5	6.8	5.8	7.8	10.5	2.7	4.6	3.5	2.2	7.2	32.2	4.3	3.0	5.6	1.5	1.2	3.7	6.1	3.2	3.0	6.3	3.7	4.9	2.1	1.4	6.2	7.8	8.2	3.7	13.5	4.6	3.0	5.2	31.4	3.3	3.5	25.7	9.2	7.5	4.6	26.9	11.7	6.4	32.6	6.9	18.1	23.9	23.3	14.2	24.9	22.1	0.6	21.6	93.0	4.6	20.2	13.8	7.6	24.1	14.0	21.9	59.2	18.4	11.3	11.6	1.6	12.1	23.6	0.4	11.7	3.8	15.1	13.0	17.7	33.9	35.0	3.3	59.4	19.2	34.0	54.1	0.4	28.2	4.8	15.6	20.4	47.7	10.8	29.6	12.1	25.6	11.1	24.2	73.4	7.7	5.3	9.2	1.2	23.9	9.8	12.6	51.8	40.2	22.3	16.4	22.7	29.9	4.9	6.9	0.4	51.4	0.8	18.9	32.2	26.6	43.6	79.1	56.5	49.8	50.7	114.7	66.2	3.6	65.0	24.4	35.1	74.9	92.2	2.6	3.0	2.1	3.4	2.7	4.6	4.3	3.0	3.2	3.7	5.2	4.6	21.5	9.6	5.2	0.0	19.5	0.0	0.0	0.0	0.0	0.0	12.7	9.9	0.0	0.0	2.5	5.5	0.0	127.7	36.0	0.0	0.0	25.2	0.0	7.0	5.9	11.7	0.0	0.0	0.0	111.4	91.9	15.1	0.0	8.9	1.3	9.1	0.0	0.0	106.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	14.5	0.0	0.0	0.0	0.0	67.9	0.0	0.0	5.8	0.0	0.0	0.9	2.2	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	73.5	28.2	7.4	0.0	0.0
MEP1B		ENSG00000141434	"Meprin A subunit beta"	Q16820	18	32185069-32220404	"Enzymes, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Inflammatory response"	"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	55	"intestine: 363.9"	"Cell type enriched"	"Detected in some"	42	"Proximal enterocytes: 231.8"	"Cancer enriched"	"Detected in some"	5	"pancreatic cancer: 3.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SCLC-21H: 4.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA029119	Enhanced				"Secreted to digestive system"	NA	NA		310000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 45: Enterocytes - Digestion"			"HPA029119: AB_2672913"	"unprognostic (1.33e-1)"	"unprognostic (6.72e-2)"	"unprognostic (2.79e-2)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-4)"	"unprognostic (1.27e-1)"	"unprognostic (1.74e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.55e-1)"	"unprognostic (8.31e-4)"	"unprognostic (4.74e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.39e-2)"	"unprognostic (3.75e-2)"	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.3	0.0	0.0	8.2	249.3	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	6.5	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.0	363.9	0.3	0.1	0.0	0.3	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	4.3	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.1	0.2	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	5.4	0.0	0.0	0.3	0.6	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.9	0.0	3.8	0.0	0.1	0.2	231.8	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.0	2.5	0.1
MFN1	FLJ20693	ENSG00000171109	"Mitofusin 1"	Q8IWA4	3	179347709-179394936	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Inhibitory neurons: 92.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033437, HPA059230"	Approved		Supported	Mitochondria		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 6: T47d - Mammary gland"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"CAB033437: AB_2250540, HPA059230: AB_2683952"	"unprognostic (2.94e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.44e-3)"	"prognostic unfavorable (6.70e-4)"	"prognostic favorable (6.11e-4)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (8.08e-5)"	"unprognostic (6.37e-2)"	"unprognostic (1.86e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.76e-3)"	"unprognostic (7.91e-2)"	"unprognostic (7.90e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.83e-1)"	"unprognostic (6.24e-2)"	"unprognostic (9.79e-2)"	9.5	9.0	5.6	9.4	6.6	8.4	11.0	8.8	8.5	9.5	8.8	12.5	8.9	11.4	14.9	14.1	10.2	9.6	23.4	5.6	5.5	10.4	8.8	8.8	12.8	6.3	5.8	9.1	17.9	13.3	6.7	7.9	6.0	12.4	10.5	10.3	14.1	9.6	14.0	14.5	9.8	11.4	5.2	9.9	10.8	9.0	5.7	8.6	10.4	16.4	11.9	12.7	8.9	9.5	32.2	9.4	17.9	29.1	25.1	23.2	23.6	19.6	20.2	20.2	23.9	23.5	13.0	10.8	20.0	29.1	40.9	18.5	25.4	19.4	35.3	17.2	19.5	17.8	19.4	13.1	20.5	9.5	16.3	16.2	16.7	21.9	15.4	16.8	26.0	17.9	13.2	14.1	28.6	17.1	14.0	7.1	21.3	32.1	17.3	9.7	28.1	40.4	19.1	33.4	16.8	23.9	18.3	48.5	26.6	18.2	66.6	6.8	22.0	17.6	19.4	27.6	29.0	18.6	21.9	18.0	19.7	15.8	19.5	4.2	2.5	5.8	2.6	3.1	4.5	5.1	3.0	2.7	2.3	6.2	2.7	3.2	5.8	2.9	2.4	2.8	2.9	1.4	5.6	6.6	8.8	8.5	5.6	5.5	6.3	5.8	6.0	5.2	5.7	9.5	21.3	25.6	36.8	39.8	27.3	16.7	12.3	12.6	20.5	18.8	19.1	14.4	29.3	14.3	23.7	18.4	39.6	11.2	20.9	18.2	9.8	12.6	6.6	36.9	28.5	16.3	10.2	24.0	77.2	17.4	11.0	22.6	26.0	43.4	8.8	22.1	14.6	18.3	7.8	11.8	92.5	18.2	12.2	11.7	11.4	3.3	13.4	14.9	12.4	28.1	12.2	11.2	18.6	56.8	85.1	16.5	11.8	17.7	21.2	20.0	10.4	13.4	31.9	16.5	6.6	26.8	21.2	33.2	13.7	24.9	27.0	13.1	15.1	25.3	16.6	20.7
MFN2	"CMT2A2, CPRP1, KIAA0214, MARF"	ENSG00000116688	"Mitofusin 2"	O95140	1	11980181-12015211	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 270.4;skeletal muscle: 310.5;tongue: 337.6"	"Cell type enriched"	"Detected in all"	7	"Cardiomyocytes: 336.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030554, CAB079902"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB079902: AB_2724683, HPA030554: AB_10603018"	"unprognostic (9.52e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.38e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.44e-1)"	"unprognostic (3.45e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.43e-1)"	"unprognostic (3.55e-1)"	"prognostic favorable (2.36e-8)"	"unprognostic (4.69e-2)"	"unprognostic (2.76e-1)"	"unprognostic (8.84e-3)"	"unprognostic (2.12e-1)"	34.7	31.4	39.9	20.9	42.4	26.7	31.8	39.1	41.4	29.3	17.4	59.7	41.9	37.0	12.7	57.3	26.2	21.8	270.4	34.7	43.0	36.5	58.5	31.1	19.8	41.1	44.8	27.0	22.5	76.7	28.7	27.6	40.6	36.3	38.1	35.0	32.2	62.3	310.5	58.9	46.3	41.2	43.5	31.5	44.9	25.4	48.8	26.1	56.1	337.6	30.4	51.2	36.2	40.5	93.6	54.0	52.6	72.7	59.7	47.2	58.8	76.0	66.1	96.5	72.6	88.7	51.8	68.8	74.8	92.6	60.6	80.5	101.7	156.1	90.6	60.6	75.4	94.5	81.8	54.2	53.8	114.2	51.9	57.0	105.1	133.1	124.5	40.1	66.2	26.4	106.1	53.6	69.7	30.2	60.2	15.2	39.7	57.8	77.4	68.2	95.8	58.5	44.9	61.4	68.2	44.6	88.4	81.0	74.6	41.4	43.8	49.2	71.2	63.1	58.3	88.4	71.2	59.0	86.4	120.7	69.0	99.6	69.8	10.4	11.5	7.6	8.9	14.0	10.2	6.7	6.7	7.9	9.7	4.8	5.0	6.2	16.2	6.2	18.3	4.2	8.1	15.7	39.9	42.4	39.1	41.4	34.7	43.0	41.1	44.8	40.6	43.5	48.8	40.5	18.1	22.4	15.8	16.6	10.2	22.8	9.4	18.9	19.9	26.7	17.4	16.4	336.9	7.2	14.9	14.7	12.5	15.1	12.5	39.2	21.5	13.6	4.7	8.9	12.1	18.5	18.0	32.4	21.5	20.4	15.5	17.3	17.3	12.8	10.8	12.8	11.7	46.3	16.0	30.3	24.5	22.2	18.3	23.9	9.7	8.0	7.2	19.1	17.8	8.4	17.3	14.6	8.2	11.1	16.7	18.5	16.8	15.1	10.9	13.9	41.8	14.3	12.9	21.0	13.1	16.0	16.5	25.9	15.6	25.1	30.1	25.2	10.3	12.5	26.4	16.6
MFSD12	"C19orf28, MGC20700, PP3501"	ENSG00000161091	"Major facilitator superfamily domain containing 12"	Q6NUT3	19	3538261-3574290	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Melanin biosynthesis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.7;Extravillous trophoblasts: 142.4;Melanocytes: 195.7;Syncytiotrophoblasts: 92.6"	"Cancer enriched"	"Detected in all"	7	"melanoma: 124.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HeLa: 261.4;SK-MEL-30: 339.8;WM-115: 628.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042149, HPA043088"	Uncertain					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 22: Non-specific - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"			"HPA042149: AB_2677875, HPA043088: AB_2678308"	"unprognostic (1.22e-1)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (5.66e-6)"	"unprognostic (1.56e-2)"	"unprognostic (6.51e-2)"	"prognostic unfavorable (6.61e-4)"	"prognostic unfavorable (2.34e-4)"	"unprognostic (3.19e-2)"	"unprognostic (9.12e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.95e-1)"	"unprognostic (3.90e-2)"	"unprognostic (1.73e-1)"	23.3	26.4	25.8	24.1	26.4	30.5	19.3	21.8	33.0	18.9	9.3	17.7	15.0	18.0	12.9	22.7	21.8	9.5	17.6	41.2	18.1	55.0	35.8	29.2	20.3	29.0	23.8	14.7	38.5	13.9	25.9	17.6	28.9	21.4	6.1	10.8	29.7	11.2	16.4	53.7	27.2	11.6	19.2	37.9	22.8	13.6	29.9	24.7	19.0	4.0	10.8	19.5	17.0	58.0	97.6	76.4	18.6	48.9	37.9	29.2	66.9	58.3	31.2	66.6	72.7	33.1	32.4	27.3	43.2	31.2	106.4	60.1	24.3	30.2	23.8	60.0	69.0	15.9	261.4	34.9	47.4	34.9	51.1	26.2	44.9	68.6	15.9	25.5	18.1	40.2	77.1	38.2	17.3	58.0	35.0	61.8	34.9	42.9	62.1	24.3	26.2	115.1	27.9	41.0	70.0	35.5	115.0	53.4	339.8	23.1	18.2	71.6	75.8	30.1	44.4	123.8	67.1	43.8	26.9	25.1	132.4	88.2	628.4	0.1	3.7	2.6	1.8	7.7	1.8	2.3	2.8	1.4	2.7	1.4	2.4	1.9	1.2	0.5	7.7	12.1	0.5	1.7	25.8	26.4	21.8	33.0	41.2	18.1	29.0	23.8	28.9	19.2	29.9	58.0	15.4	6.4	2.8	5.5	12.9	26.5	6.8	4.9	1.8	15.6	19.9	14.0	1.9	8.6	6.1	20.2	6.2	16.8	21.5	11.6	0.0	23.1	120.7	26.9	20.9	13.1	28.1	3.8	10.2	31.4	142.4	10.9	14.8	42.5	0.0	57.3	6.4	22.3	76.9	37.0	8.0	18.4	2.0	24.8	54.4	30.4	2.5	47.7	195.7	13.1	20.7	9.3	5.2	7.5	25.5	34.2	16.2	3.4	12.6	16.7	18.7	34.0	8.1	12.7	13.1	5.4	12.0	4.0	9.0	8.4	25.4	92.6	10.9	11.1	13.2	13.8
MFSD13A	"bA18I14.8, C10orf77, FLJ22529, TMEM180"	ENSG00000138111	"Major facilitator superfamily domain containing 13A"	Q14CX5	10	102461395-102477045	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 19.2;Alveolar cells type 2: 15.4;Hofbauer cells: 15.7;Horizontal cells: 21.9;Syncytiotrophoblasts: 28.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018031	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 6: Brain - Smell perception"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus, Cytosol"		"HPA018031: AB_2204891"	"unprognostic (2.24e-2)"	"prognostic favorable (8.29e-4)"	"unprognostic (7.73e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.11e-1)"	"unprognostic (9.16e-3)"	"unprognostic (4.70e-2)"	"unprognostic (4.03e-2)"	"unprognostic (8.10e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.82e-2)"	"prognostic unfavorable (8.51e-4)"	"unprognostic (1.66e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.02e-2)"	2.3	2.5	10.0	3.2	13.0	5.2	2.1	14.1	12.8	2.4	2.3	5.0	5.5	3.1	0.7	3.0	2.3	2.3	3.2	10.8	7.2	2.5	6.3	9.0	3.2	7.7	7.7	1.4	3.8	1.7	4.1	2.3	7.8	3.1	3.2	4.9	1.8	0.9	2.3	11.7	4.4	2.5	6.5	6.9	4.0	3.7	9.2	1.8	5.4	1.4	3.6	2.2	2.6	9.4	12.0	5.4	4.0	9.6	0.4	0.4	6.2	2.3	6.0	4.6	10.5	10.7	16.0	10.6	11.8	0.9	4.4	14.6	7.4	6.3	1.7	13.5	6.8	13.1	8.2	5.6	10.1	6.7	12.3	5.2	2.6	2.6	4.6	3.7	5.3	14.2	3.0	5.7	0.4	2.4	11.3	4.3	6.8	10.5	5.2	13.6	0.6	1.8	2.0	3.1	10.0	9.5	2.2	1.2	5.2	1.4	6.0	4.0	1.6	2.1	2.5	2.6	3.3	1.9	5.5	14.0	11.6	10.9	2.9	0.4	4.3	3.5	2.9	3.2	2.8	3.4	2.7	2.3	4.5	1.4	2.8	3.2	2.5	1.2	1.8	0.4	0.8	2.6	10.0	13.0	14.1	12.8	10.8	7.2	7.7	7.7	7.8	6.5	9.2	9.4	4.1	19.2	15.4	0.0	1.1	0.0	1.5	0.0	0.6	8.2	1.5	1.9	0.0	1.5	0.6	1.8	4.2	1.8	5.7	2.6	0.0	2.8	1.8	1.0	1.0	3.8	2.4	3.6	0.0	3.6	2.6	1.6	5.6	1.6	1.3	2.8	6.4	4.0	15.7	21.9	0.0	3.8	0.0	4.8	0.0	1.0	0.9	8.7	0.0	0.0	5.6	3.2	2.1	0.0	0.0	3.2	4.6	2.2	0.8	1.4	5.6	1.5	0.7	13.8	0.0	2.8	1.1	4.5	3.0	2.4	0.0	28.5	3.2	4.0	4.5	1.4
MFSD14A	"DKFZP564L0864, HIAT1"	ENSG00000156875	"Major facilitator superfamily domain containing 14A"	Q96MC6	1	100038095-100083377	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 131.4"	"Group enriched"	"Detected in many"	5	"Early spermatids: 303.1;Late spermatids: 373.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA073127, HPA073681"	Approved		Approved	Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA073127: , HPA073681: AB_2686625"	"unprognostic (1.37e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.51e-3)"	"unprognostic (1.54e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.08e-4)"	"unprognostic (2.16e-1)"	"unprognostic (7.75e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.41e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.15e-2)"	29.1	28.5	18.1	26.2	21.1	90.3	27.4	21.2	24.7	25.9	20.8	26.8	19.6	35.3	26.0	29.0	26.6	25.2	19.6	18.2	21.1	29.7	29.5	28.8	28.4	23.3	20.2	30.5	31.5	131.4	18.7	34.1	22.1	33.4	21.8	19.6	23.0	31.4	15.0	24.9	19.6	35.5	21.9	28.4	22.4	35.3	20.0	31.1	27.9	20.1	29.2	33.5	24.0	25.7	54.3	22.2	48.9	25.4	56.0	52.8	41.3	38.9	65.9	51.5	59.9	18.9	37.0	40.5	61.7	50.6	34.1	51.0	44.0	42.8	49.2	35.6	34.8	40.1	32.8	28.6	49.4	65.0	50.2	43.3	64.1	45.5	57.9	45.3	40.2	45.1	49.8	77.2	48.1	16.0	49.3	38.1	56.4	26.2	32.4	34.1	59.6	39.8	54.8	46.9	50.7	45.2	43.8	63.0	66.6	30.9	24.6	65.3	44.5	42.3	29.6	44.9	40.9	72.8	82.4	56.0	46.1	46.6	18.6	80.1	56.0	54.6	49.5	51.4	55.9	46.2	49.6	54.4	55.2	38.8	54.8	51.5	94.8	59.9	45.2	25.6	60.3	72.0	18.1	21.1	21.2	24.7	18.2	21.1	23.3	20.2	22.1	21.9	20.0	25.7	4.5	6.4	11.5	0.0	33.5	0.0	47.5	0.0	43.3	17.8	3.4	1.5	0.0	27.1	3.7	3.7	10.4	37.5	7.8	6.5	1.9	10.1	303.1	1.0	1.7	20.8	13.3	35.8	0.0	7.2	33.5	19.5	18.3	1.5	2.5	0.6	19.6	17.1	23.1	13.5	0.0	9.4	0.0	26.4	0.0	373.8	22.7	15.8	0.0	0.0	22.2	25.1	33.0	0.0	0.0	6.5	17.1	30.5	41.9	56.3	8.1	1.1	5.8	11.6	13.1	25.6	12.8	28.2	22.5	43.4	0.0	58.3	33.7	0.4	9.6	52.3
MFSD14B	"FLJ14753, HIATL1"	ENSG00000148110	"Major facilitator superfamily domain containing 14B"	Q5SR56	9	94374569-94461042	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Kupffer cells: 66.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017978			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA017978: AB_2116836"	"unprognostic (3.03e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.96e-3)"	"unprognostic (5.95e-3)"	"unprognostic (1.39e-1)"	"unprognostic (3.29e-2)"	"unprognostic (4.13e-3)"	"unprognostic (3.27e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.64e-2)"	"unprognostic (1.16e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.15e-1)"	"unprognostic (9.12e-2)"	"unprognostic (6.63e-2)"	"unprognostic (1.93e-1)"	"unprognostic (9.01e-2)"	24.4	32.3	25.5	26.1	28.0	18.4	24.6	26.6	33.1	24.0	34.6	24.4	18.8	24.1	29.0	40.2	26.7	20.7	20.8	24.0	26.3	21.9	15.2	32.0	29.4	29.1	28.5	19.0	18.1	95.1	12.7	33.3	28.5	21.3	28.5	17.9	20.8	21.3	12.4	42.4	21.3	23.8	28.5	25.2	24.9	14.1	27.3	30.7	25.7	14.1	34.6	34.7	27.6	29.8	76.4	48.3	36.9	28.8	79.3	56.4	58.4	72.5	62.7	63.3	61.6	24.4	88.9	91.2	42.2	63.1	73.0	163.9	44.6	46.3	61.0	65.7	23.9	31.6	43.0	36.8	56.2	100.0	55.8	52.2	68.5	67.1	51.2	35.4	54.9	49.3	60.6	52.5	85.2	57.8	73.7	56.6	54.2	111.0	38.4	36.6	84.6	29.6	68.2	57.8	35.4	46.4	61.6	71.6	79.6	44.0	32.9	58.3	59.4	65.6	46.1	102.1	68.2	57.6	77.2	24.8	58.6	48.1	60.1	0.5	6.1	4.9	4.1	9.2	3.7	3.3	3.6	4.2	6.2	2.1	3.6	5.1	8.0	3.1	6.3	6.0	4.0	3.0	25.5	28.0	26.6	33.1	24.0	26.3	29.1	28.5	28.5	28.5	27.3	29.8	21.6	6.4	20.0	0.0	17.3	0.0	23.2	0.0	22.2	12.2	29.4	15.6	0.0	14.3	6.8	44.1	4.2	14.2	20.6	16.2	7.9	16.8	3.6	32.2	20.7	18.9	7.3	30.7	0.0	19.0	26.4	17.3	16.3	32.7	3.8	14.1	26.4	13.5	28.9	5.0	0.0	22.9	0.0	66.1	0.0	3.1	16.8	31.0	0.0	0.0	39.1	19.5	15.5	0.0	0.0	26.7	12.1	16.1	12.7	38.5	11.7	7.6	7.3	9.9	13.1	18.1	14.9	14.1	18.2	37.6	0.0	19.2	15.7	17.7	14.4	42.6
MFSD2A	"FLJ14490, MFSD2"	ENSG00000168389	"Major facilitator superfamily domain containing 2A"	Q8NA29	1	39955112-39969968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Symport, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 96.9;liver: 162.0;skin 1: 87.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 136.2;Hepatocytes: 299.6;Proximal enterocytes: 235.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	10	"classical monocyte: 13.2;intermediate monocyte: 6.6;myeloid DC: 14.7;plasmacytoid DC: 24.3"	"Group enriched"	"Detected in many"	12	"dendritic cells: 24.3;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"hTEC/SVTERT24-B: 52.0;THP-1: 169.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043107	Uncertain		Approved	"Plasma membrane,Cytosol,Cytoplasmic bodies"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 15: Liver - Metabolism"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 2: Hepatocytes - Metabolism"	Cytosol	"Plasma membrane, Cytoplasmic bodies"	"HPA043107: AB_10794387"	"unprognostic (2.20e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.23e-3)"	"unprognostic (1.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.92e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.33e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.22e-6)"	"unprognostic (9.26e-2)"	"unprognostic (4.11e-1)"	"unprognostic (1.09e-1)"	"prognostic favorable (2.33e-4)"	6.3	1.4	34.0	3.4	31.7	8.4	13.4	34.8	36.0	4.8	22.2	7.2	14.6	8.5	96.9	12.5	3.5	2.3	1.4	30.9	33.4	5.8	162.0	36.1	2.3	38.5	33.8	2.2	0.6	0.7	8.0	17.1	38.6	2.4	5.0	2.6	4.0	79.2	0.5	87.8	32.0	3.5	32.8	1.5	1.9	33.9	37.2	1.6	7.5	0.1	3.6	20.2	14.1	33.1	6.2	2.7	12.5	18.9	8.7	1.6	0.0	5.9	11.2	12.8	15.1	0.8	3.4	38.0	3.4	3.0	8.8	15.0	12.4	21.8	9.8	4.9	6.0	4.6	0.1	0.1	28.8	6.8	21.8	9.7	13.3	52.0	21.5	2.3	3.1	11.5	0.0	9.5	5.7	0.8	10.6	10.4	10.1	21.4	4.7	7.4	18.5	8.7	2.1	17.9	4.4	6.7	4.5	31.7	3.0	1.1	1.5	169.8	2.0	2.7	5.3	9.5	24.9	1.8	3.5	8.5	28.9	26.0	9.2	0.0	13.2	1.4	0.1	6.6	0.2	1.5	0.1	0.2	14.7	0.2	0.0	0.1	0.7	0.2	1.2	24.3	0.0	3.6	34.0	31.7	34.8	36.0	30.9	33.4	38.5	33.8	38.6	32.8	37.2	33.1	0.5	19.2	136.2	3.3	6.3	52.8	21.2	40.0	51.2	2.0	6.3	2.3	0.6	12.8	30.8	16.5	0.0	0.5	5.7	62.2	0.0	3.4	1.0	25.8	5.5	22.9	1.2	5.7	1.5	24.8	7.6	9.7	24.5	61.8	17.2	0.1	7.1	299.6	6.7	0.0	1.3	34.5	12.2	9.8	43.3	2.7	0.6	16.1	0.0	38.4	5.5	38.8	0.0	0.0	1.6	27.2	39.3	0.4	5.0	13.9	235.1	6.1	33.9	2.7	0.0	5.0	3.3	1.0	1.3	49.3	54.8	52.5	3.3	0.1	20.7	26.6
MFSD2B		ENSG00000205639	"Major facilitator superfamily domain containing 2B"	A6NFX1	2	24010081-24063321	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	21	"bone marrow: 11.8"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 25.1;Erythroid cells: 65.2;Prostatic glandular cells: 41.0;Urothelial cells: 30.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	5	"basophil: 2.9"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	14	"HEL: 8.3;K-562: 3.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA044145	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA044145: AB_2678833"	"unprognostic (5.67e-2)"	"unprognostic (1.25e-3)"	"unprognostic (1.84e-1)"	"unprognostic (5.35e-5)"	"unprognostic (2.82e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.26e-2)"	"unprognostic (7.47e-2)"	"unprognostic (2.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.21e-3)"	"unprognostic (1.90e-2)"	"unprognostic (6.87e-6)"	"unprognostic (7.76e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.72e-1)"	0.0	0.0	0.2	0.0	0.4	11.8	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	3.6	0.0	0.4	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.9	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.0	1.3	0.2	0.4	0.5	0.3	0.1	0.3	0.2	0.1	0.1	0.0	0.3	0.2	0.1	0.0	1.3	0.3	1.6	10.1	25.1	0.7	0.0	0.9	0.3	0.3	4.6	1.5	0.5	0.0	4.2	6.9	0.2	0.9	3.9	5.0	0.6	0.1	0.3	1.7	1.2	65.2	0.3	1.8	4.4	1.6	0.0	0.3	5.1	0.3	0.4	0.0	3.1	0.0	0.5	2.9	2.0	1.4	5.9	0.8	0.0	4.5	0.0	1.0	0.6	0.1	0.0	0.0	0.3	10.6	2.3	0.0	0.2	41.0	3.1	0.2	0.0	1.5	0.0	1.1	0.7	0.9	2.1	0.0	11.2	7.5	1.1	0.0	5.5	30.3
MFSD4A	"DKFZp761N1114, FLJ25004, FLJ34577, MFSD4, UNQ3064"	ENSG00000174514	"Major facilitator superfamily domain containing 4A"	Q8N468	1	205568885-205602918	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"kidney: 66.7;stomach 1: 132.6"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 11.3;Collecting duct cells: 9.2;Distal tubular cells: 13.7;Endometrial ciliated cells: 9.9;Glandular and luminal cells: 40.5;Proximal tubular cells: 7.7"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	17	"amygdala: 11.4;basal ganglia: 8.4;cerebral cortex: 18.4;hippocampal formation: 14.1;white matter: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.5;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in all"		"cerebral cortex: 59.8"	HPA055407	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"HPA055407: "	"unprognostic (7.15e-4)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.60e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.25e-1)"	"prognostic favorable (4.59e-4)"	"unprognostic (2.73e-2)"	"unprognostic (1.65e-2)"	"unprognostic (3.20e-2)"	"unprognostic (6.97e-3)"	"prognostic favorable (2.27e-13)"	"unprognostic (1.58e-1)"	"unprognostic (4.44e-2)"	"unprognostic (5.75e-3)"	"unprognostic (8.78e-2)"	2.2	0.4	11.4	1.1	8.4	0.0	2.7	0.6	18.4	8.5	0.0	13.8	1.9	1.0	9.2	1.4	2.5	16.8	0.9	14.1	0.0	66.7	0.2	6.8	0.4	0.0	0.0	0.6	1.4	0.4	1.5	6.2	0.0	1.4	18.2	14.0	17.1	0.6	0.3	5.1	1.4	0.8	0.0	0.6	132.6	0.5	0.0	0.6	0.4	0.7	1.3	0.7	0.8	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.7	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.4	8.4	0.6	18.4	14.1	0.0	0.0	0.0	0.0	0.0	0.0	5.3	11.3	6.4	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	3.8	2.9	0.0	0.0	6.2	9.2	0.0	0.5	0.7	0.0	13.7	1.4	0.0	9.9	6.0	2.5	0.0	0.0	0.0	6.2	0.1	0.5	0.0	40.5	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	7.7	2.9	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.8	0.2	0.0	0.0
MFSD4B	"KIAA1919, MGC33953"	ENSG00000173214	"Major facilitator superfamily domain containing 4B"	Q5TF39	6	111259327-111445354	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 30.7;Cytotrophoblasts: 24.5;Glandular and luminal cells: 22.4;granulocytes: 20.2;Granulosa cells: 34.4;Syncytiotrophoblasts: 31.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-2197: 16.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031784	Approved				"Intracellular and membrane"	NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"			"HPA031784: AB_10603775"	"unprognostic (2.98e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.89e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.94e-1)"	"unprognostic (3.07e-2)"	"unprognostic (7.50e-5)"	"unprognostic (3.51e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.94e-2)"	"unprognostic (3.41e-1)"	"unprognostic (6.04e-3)"	"unprognostic (9.27e-2)"	"unprognostic (3.68e-1)"	"unprognostic (6.32e-2)"	"unprognostic (1.98e-4)"	1.3	1.7	1.5	1.8	1.6	2.2	2.1	2.0	1.5	2.3	7.2	1.4	3.6	1.5	2.4	1.3	1.7	1.3	1.1	1.3	1.6	2.9	2.6	1.4	1.6	1.0	0.7	1.1	1.3	1.8	1.6	4.7	0.5	1.3	1.7	3.0	1.7	1.8	2.0	2.5	3.4	1.6	0.1	1.6	1.6	4.3	1.7	1.4	2.0	0.9	1.3	1.5	1.1	0.8	1.5	3.3	2.8	7.1	2.8	1.7	4.4	2.1	3.1	3.2	4.2	5.5	2.7	3.9	3.3	2.7	3.1	3.4	5.5	2.2	5.1	2.6	1.4	5.0	5.4	3.6	3.9	3.9	8.3	1.2	3.8	3.7	3.0	4.2	2.7	4.9	5.5	5.9	3.5	2.7	3.5	2.4	2.2	3.5	0.9	3.9	2.4	1.6	4.1	4.0	2.0	2.5	2.2	2.7	1.3	3.0	2.2	5.4	2.1	3.3	1.8	16.7	4.0	2.0	2.9	3.9	4.5	3.2	4.0	4.4	1.4	1.9	1.7	1.7	2.0	2.1	1.1	1.1	1.5	1.2	1.5	1.7	1.9	1.7	1.6	1.8	0.9	1.0	1.5	1.6	2.0	1.5	1.3	1.6	1.0	0.7	0.5	0.1	1.7	0.8	4.2	9.6	30.7	0.0	3.2	0.0	0.0	0.0	0.0	0.0	3.7	2.2	0.0	0.0	13.6	5.5	0.0	24.5	5.3	0.0	1.9	5.6	0.0	15.0	9.4	4.1	0.0	0.0	0.0	3.6	11.5	4.9	0.0	22.4	20.2	34.4	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.4	0.0	0.0	1.8	0.0	0.0	6.6	10.2	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	31.1	2.8	5.7	0.0	0.0
MFSD5	"HsMOT2, MGC11308"	ENSG00000182544	"Major facilitator superfamily domain containing 5"	Q6N075	12	53251251-53254406	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039773	Uncertain					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA039773: AB_10793920"	"unprognostic (9.42e-3)"	"unprognostic (9.03e-3)"	"unprognostic (4.25e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.37e-2)"	"unprognostic (5.04e-2)"	"prognostic unfavorable (1.43e-6)"	"unprognostic (2.20e-2)"	"unprognostic (1.69e-1)"	"unprognostic (4.25e-1)"	"unprognostic (9.79e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.51e-3)"	"unprognostic (1.19e-2)"	18.5	28.8	15.9	12.2	16.9	22.1	16.5	18.1	17.7	19.7	18.8	19.1	13.5	16.6	12.8	61.3	13.3	11.4	21.8	16.0	17.0	19.3	15.8	15.6	14.7	17.4	17.2	9.9	22.1	19.8	11.7	16.1	17.2	15.7	14.6	26.9	26.1	13.3	19.0	60.1	18.5	13.4	17.4	20.4	19.6	10.6	17.7	9.8	12.9	14.0	20.3	18.2	30.6	18.9	23.8	51.1	15.2	27.9	57.7	32.7	17.6	34.7	43.3	36.4	34.1	27.2	43.8	19.4	29.6	50.1	34.4	43.1	24.9	28.7	24.2	25.0	34.7	14.8	18.6	36.2	40.0	28.6	35.8	40.8	39.5	34.5	17.1	39.4	33.7	18.7	27.8	34.4	35.5	89.2	14.0	35.3	26.4	27.3	44.5	17.1	15.3	26.3	26.8	41.1	12.5	18.8	25.0	34.3	28.0	17.8	59.6	26.4	32.2	30.9	20.0	32.0	22.8	20.8	27.3	15.1	41.1	27.4	30.2	58.3	32.3	103.7	26.6	25.9	32.7	50.1	31.4	30.2	38.1	44.6	23.4	22.4	17.5	27.8	17.7	31.9	27.9	23.4	15.9	16.9	18.1	17.7	16.0	17.0	17.4	17.2	17.2	17.4	17.7	18.9	5.5	9.6	10.6	6.2	12.1	13.0	5.8	15.9	14.2	5.4	9.4	7.4	9.5	10.0	18.1	12.9	31.3	38.4	7.8	20.3	5.9	20.4	0.5	5.2	8.0	10.8	2.4	9.9	2.2	26.5	24.5	12.1	9.2	7.7	5.7	7.6	11.4	10.9	28.6	3.3	2.7	10.9	10.2	18.8	13.4	2.0	6.2	11.7	16.0	0.0	17.2	7.8	14.4	3.5	3.4	21.9	13.3	4.9	10.9	8.7	12.0	10.9	10.3	14.3	6.6	7.7	8.4	4.7	14.2	21.3	17.0	33.2	12.1	6.2	8.5	7.9
MFSD6L	FLJ35773	ENSG00000185156	"Major facilitator superfamily domain containing 6 like"	Q8IWD5	17	8797110-8799365	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"pancreas: 9.4;testis: 25.5"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 125.7;Ionocytes: 28.5;Late spermatids: 46.1;Spermatocytes: 45.0"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 6.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 8.3"	"Not detected"	"Not detected"							HPA023164	Uncertain					NA	NA				"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA023164: AB_2142777"	"prognostic favorable (1.84e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (1.07e-4)"	"unprognostic (3.31e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.77e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	"unprognostic (7.26e-2)"	"unprognostic (3.98e-3)"	"unprognostic (1.33e-1)"	"unprognostic (2.84e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.25e-1)"	0.0	0.0	0.0	0.4	0.1	0.0	0.5	0.0	0.1	1.8	0.0	2.7	2.3	0.1	1.3	0.6	2.0	0.7	0.2	0.0	0.0	1.6	0.0	0.3	0.0	0.1	0.1	0.0	9.4	4.1	4.9	0.4	0.1	0.4	3.1	0.0	6.8	2.1	0.0	0.3	1.5	0.0	0.0	0.2	4.0	25.5	0.2	0.2	3.4	0.0	0.2	0.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.6	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1.7	0.8	0.2	4.3	1.1	1.8	0.0	2.9	0.0	1.7	0.0	7.2	125.7	1.2	0.1	0.1	1.2	0.0	0.0	7.6	0.3	0.0	3.6	2.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	5.9	28.5	0.6	0.0	46.1	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	1.7	1.2	0.1	0.8	0.2	0.0	0.8	0.0	0.0	0.0	0.2	45.0	0.3	0.6	0.0	1.5	0.0	0.0	4.5	1.0
MFSD8	"CLN7, MGC33302"	ENSG00000164073	"Major facilitator superfamily domain containing 8"	Q8NHS3	4	127917799-127966034	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neurodegeneration, Neuronal ceroid lipofuscinosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044802	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	Vesicles	Nucleoplasm	"HPA044802: AB_10963221"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.57e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.18e-1)"	"unprognostic (8.99e-2)"	"unprognostic (2.19e-2)"	"unprognostic (8.69e-2)"	"unprognostic (4.51e-2)"	"unprognostic (3.44e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.61e-3)"	"unprognostic (3.14e-1)"	"prognostic favorable (2.21e-4)"	4.6	5.7	1.3	6.8	1.3	2.6	6.9	1.9	1.6	6.2	1.1	6.8	10.0	5.6	3.9	5.4	5.5	4.8	3.8	1.1	1.7	6.4	10.0	4.8	5.4	1.4	1.3	6.8	8.1	9.1	7.1	5.9	1.5	5.5	8.2	4.6	5.8	4.4	3.7	5.9	7.6	5.8	1.1	7.3	6.4	3.9	0.8	5.2	7.0	4.4	7.9	5.3	5.9	2.2	10.9	7.3	9.5	4.6	7.2	6.9	7.0	8.3	10.3	10.2	10.5	5.2	14.3	5.2	14.5	14.3	14.8	7.8	10.2	7.4	14.4	10.8	7.9	5.7	9.1	8.0	9.4	6.0	6.6	8.3	2.7	8.6	7.7	5.0	10.6	6.6	9.5	5.9	14.6	8.9	5.0	1.9	1.7	11.8	5.2	5.3	0.6	4.7	7.5	13.9	8.5	2.9	9.0	12.0	3.5	6.4	5.6	5.1	6.7	2.9	3.1	10.7	7.8	12.5	22.1	9.6	10.3	5.3	8.8	1.9	1.6	2.8	2.5	2.4	2.4	2.5	2.7	2.2	1.6	1.1	2.4	2.6	2.5	2.4	3.7	2.2	3.4	1.2	1.3	1.3	1.9	1.6	1.1	1.7	1.4	1.3	1.5	1.1	0.8	2.2	9.5	12.8	14.1	17.0	18.8	3.2	4.9	8.5	10.2	17.2	8.1	5.3	3.0	5.7	14.0	16.5	20.9	12.5	17.9	7.2	1.9	8.5	10.4	7.7	7.2	7.2	4.2	3.8	32.1	7.0	7.3	8.6	11.7	8.2	12.7	18.4	8.9	10.1	7.6	11.8	34.9	6.8	10.2	8.5	3.3	14.7	9.3	6.5	3.6	27.2	10.5	8.6	20.6	20.6	24.6	7.8	9.5	9.4	19.9	5.4	11.1	6.3	12.1	24.9	6.6	5.8	6.6	12.6	8.4	8.9	5.7	22.0	13.7	11.4	7.3	4.8
MFSD9	MGC11332	ENSG00000135953	"Major facilitator superfamily domain containing 9"	Q8NBP5	2	102714630-102736888	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055293, HPA061859"	Approved		Approved	"Nucleoli,Nucleoli rim"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli, Nucleoli rim"		"HPA055293: AB_2682775, HPA061859: AB_2684627"	"unprognostic (1.27e-2)"	"unprognostic (5.07e-2)"	"unprognostic (5.00e-2)"	"unprognostic (1.93e-2)"	"prognostic unfavorable (8.38e-4)"	"unprognostic (2.22e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.42e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.94e-1)"	"unprognostic (2.16e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.28e-2)"	2.8	2.2	1.4	2.9	1.4	4.1	2.6	4.3	2.0	3.6	1.8	6.4	8.7	1.8	2.8	4.5	1.8	2.3	1.4	1.9	1.7	4.6	10.5	2.2	3.2	1.4	1.6	2.4	9.2	4.1	3.4	2.4	1.5	2.6	5.8	2.4	4.9	3.1	1.3	2.9	7.2	1.9	1.3	2.7	4.7	1.2	1.7	4.5	2.9	1.2	3.6	3.3	2.2	1.2	3.1	2.4	3.0	5.2	3.6	1.6	6.1	1.9	1.9	2.8	2.8	8.6	4.1	2.7	3.1	1.2	4.3	4.7	4.8	1.8	1.8	11.5	4.4	4.5	3.1	10.9	3.0	3.6	6.2	1.6	6.1	1.7	0.9	2.9	1.8	8.8	2.7	1.3	1.4	2.9	3.7	7.2	2.3	7.4	3.1	2.8	4.9	2.8	5.9	9.4	5.8	4.1	1.7	6.1	6.9	3.2	2.3	5.7	1.3	1.9	4.0	3.2	2.7	3.6	2.9	1.8	2.1	8.4	2.6	1.3	0.3	1.5	1.2	0.6	0.9	0.8	0.9	0.8	0.6	0.6	0.9	1.1	1.0	1.0	0.5	1.2	0.7	0.7	1.4	1.4	4.3	2.0	1.9	1.7	1.4	1.6	1.5	1.3	1.7	1.2	1.6	0.0	1.5	1.0	4.1	3.3	3.2	3.7	2.8	1.5	4.1	1.3	3.1	1.5	5.4	7.3	4.2	8.2	4.3	15.9	0.0	5.8	12.8	3.3	2.0	1.6	3.0	1.7	5.4	8.6	9.1	3.3	7.1	5.3	3.8	3.0	1.4	11.5	4.8	0.0	12.2	8.7	10.2	2.9	1.4	4.5	0.9	2.6	0.0	1.9	4.3	1.4	7.2	4.0	1.3	11.4	8.0	1.2	8.9	4.2	10.4	3.6	3.9	2.8	6.6	2.1	2.4	1.0	5.3	4.3	4.4	11.5	5.1	3.1	7.2	8.2
MIA2	"cTAGE-5A, cTAGE-5B, cTAGE-5C, cTAGE-5D, CTAGE5, FLJ22404, MEA6, MGEA, MGEA11, MGEA6, TALI"	ENSG00000150527	"MIA SH3 domain ER export factor 2"	Q96PC5	14	39230231-39388513	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 138.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 44.1;Ductal cells: 42.9;Endometrial ciliated cells: 78.7;Exocrine glandular cells: 42.7;Glandular and luminal cells: 93.5;Pancreatic endocrine cells: 41.3;Proximal tubular cells: 61.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 125.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000387, HPA000922, HPA054066, HPA055459"	Approved		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 7: Non-specific - Mitochondria"	"Endoplasmic reticulum"		"HPA000387: AB_1078582, HPA000922: AB_1078581, HPA054066: AB_2682368, HPA055459: AB_2682819"	"unprognostic (2.62e-1)"	"unprognostic (7.17e-3)"	"unprognostic (2.33e-1)"	"unprognostic (5.27e-4)"	"unprognostic (3.21e-4)"	"unprognostic (2.63e-1)"	"unprognostic (2.48e-1)"	"unprognostic (7.18e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.93e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.97e-2)"	12.1	26.6	5.6	16.8	6.9	23.6	22.1	5.8	7.9	29.7	58.0	30.8	80.4	15.7	40.2	26.9	22.2	30.3	16.6	9.4	6.5	78.4	138.9	15.5	16.2	5.6	4.7	9.6	43.6	40.5	15.5	11.2	6.4	21.1	34.6	12.8	52.5	19.2	54.5	9.9	78.4	12.3	4.1	14.5	45.3	21.0	5.1	14.3	46.7	20.7	19.8	16.2	17.2	7.1	23.0	25.1	10.4	18.5	20.6	23.2	14.5	13.3	13.9	9.3	9.6	19.7	125.4	27.5	40.1	15.0	18.9	34.1	12.7	15.0	11.0	21.4	10.6	17.2	11.5	106.1	48.2	23.2	30.7	14.4	83.7	9.2	69.2	59.0	15.3	31.8	16.6	68.3	14.0	22.1	14.9	18.9	12.0	87.2	20.8	15.2	18.3	34.9	42.7	24.7	8.7	5.1	31.0	32.5	20.4	13.1	31.2	24.8	24.3	14.1	9.2	10.4	8.8	38.7	35.7	27.2	7.9	14.5	12.0	40.9	16.3	25.9	15.4	18.0	14.0	11.7	11.6	14.4	17.8	13.1	14.2	13.2	34.5	14.6	21.0	12.3	11.8	11.8	5.6	6.9	5.8	7.9	9.4	6.5	5.6	4.7	6.4	4.1	5.1	7.1	26.7	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	33.1	19.9	0.0	5.7	0.0	44.1	0.0	5.6	35.9	0.8	7.9	42.9	0.5	78.7	30.7	7.1	0.0	0.0	0.1	42.7	5.0	4.6	0.0	93.5	0.0	10.3	0.0	3.8	7.6	0.0	0.1	1.8	0.0	0.0	0.0	0.6	0.0	12.7	0.0	0.0	23.8	0.0	1.0	0.0	0.0	41.3	0.0	0.0	8.1	0.0	6.6	61.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	7.0	13.6	20.0	0.2	0.0
MIA3	"FLJ39207, KIAA0268, TANGO, TANGO1, UNQ6077"	ENSG00000154305	"MIA SH3 domain ER export factor 3"	Q5JRA6	1	222618097-222668007	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA055922, HPA056816"	Supported		Enhanced	Vesicles		NA	NA		1400000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 52: Non-specific - Transcription"	Vesicles		"HPA055922: AB_2682971, HPA056816: AB_2683243"	"unprognostic (1.24e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.43e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.86e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.65e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.39e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.83e-1)"	"unprognostic (8.62e-3)"	"unprognostic (3.26e-1)"	25.6	22.0	11.0	23.4	13.1	33.2	21.4	12.9	14.9	23.9	13.2	24.3	23.9	23.7	29.2	13.7	16.0	20.6	20.6	10.9	13.6	21.1	74.5	21.5	26.9	10.8	12.3	25.4	38.7	30.1	15.2	23.1	11.7	39.3	29.5	24.4	33.2	22.1	23.7	17.4	25.9	23.8	10.7	27.3	45.0	36.5	11.5	25.7	31.7	20.5	26.2	21.0	14.1	12.8	24.8	18.8	26.5	42.5	92.8	47.1	46.5	34.8	49.4	36.2	43.1	16.6	26.2	24.0	33.0	41.8	20.5	39.9	28.5	31.3	37.8	38.1	21.6	27.7	21.5	31.5	88.6	50.7	34.7	45.2	35.0	35.9	60.8	44.8	41.4	28.9	34.8	44.4	30.7	15.9	34.3	33.8	33.2	76.8	27.5	24.4	70.8	47.8	23.1	22.8	30.4	31.3	38.6	36.2	30.4	36.2	38.2	37.5	31.7	27.5	17.9	44.5	41.3	48.4	30.9	23.8	36.7	25.4	37.5	26.8	15.6	36.5	17.6	22.4	17.7	20.7	14.7	17.5	11.7	18.6	16.4	17.8	27.1	22.5	26.0	13.2	19.2	13.5	11.0	13.1	12.9	14.9	10.9	13.6	10.8	12.3	11.7	10.7	11.5	12.8	48.5	70.5	49.6	31.3	46.9	18.7	26.8	20.4	29.0	60.9	24.3	35.3	65.0	25.8	47.1	5.5	31.3	28.6	73.8	35.2	0.0	25.1	37.0	34.9	72.5	36.4	60.4	26.3	51.4	34.8	17.0	53.0	79.5	42.0	17.7	44.2	25.4	63.3	20.4	45.4	58.0	95.3	32.6	22.0	14.0	24.9	37.0	32.9	19.6	35.6	32.1	31.8	44.3	41.2	29.1	26.4	25.8	48.9	54.4	39.0	41.3	19.4	44.7	41.5	19.7	57.9	46.6	55.7	42.1	21.9	16.1	35.8	47.8	70.2	24.6	29.4
MICOS10	"C1orf151, FLJ36999, Mic10, MINOS1, MIO10, RP5-1056L3.2"	ENSG00000173436	"Mitochondrial contact site and cristae organizing system subunit 10"	Q5TGZ0	1	19484403-19629821	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"Cardiomyocytes: 453.9;Cytotrophoblasts: 283.4;Extravillous trophoblasts: 279.7;Hofbauer cells: 531.0;Syncytiotrophoblasts: 183.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059930	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 24: Non-specific - Transcription regulation"	Mitochondria		"HPA059930: AB_2684167"	"unprognostic (3.84e-2)"	"unprognostic (8.74e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.03e-1)"	"unprognostic (1.35e-1)"	"unprognostic (6.98e-2)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.88e-1)"	"unprognostic (8.74e-2)"	"unprognostic (3.96e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.24e-3)"	"unprognostic (7.13e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.03e-2)"	"prognostic favorable (8.11e-4)"	4.9	5.0	11.5	3.1	11.6	2.6	6.0	11.9	13.6	8.6	11.0	9.3	5.1	7.0	6.2	7.2	7.3	4.1	12.6	11.5	13.1	9.7	4.0	4.6	4.3	12.9	11.7	6.4	5.2	11.1	9.5	4.0	13.1	8.5	8.8	5.9	5.1	8.3	14.3	4.8	6.0	7.0	11.3	3.6	6.7	3.4	13.8	4.0	6.5	16.8	5.9	7.0	6.2	11.1	10.0	13.3	7.3	8.4	13.7	13.6	4.5	8.3	9.6	9.5	10.1	9.3	8.7	8.1	6.8	11.0	7.7	6.9	12.8	10.9	15.2	12.7	9.1	7.1	21.2	13.0	6.0	11.6	5.1	10.7	17.5	9.5	11.6	7.4	14.1	6.0	15.8	5.9	14.4	17.2	5.8	15.0	6.2	12.5	16.7	5.7	9.3	10.8	23.3	5.9	15.4	6.7	9.6	7.4	7.1	5.7	7.1	6.7	9.3	7.4	5.7	9.5	8.3	3.8	6.8	8.4	5.8	21.3	7.1	3.8	4.8	5.7	3.6	6.6	3.3	4.3	4.9	4.1	5.1	4.1	6.3	4.5	3.2	2.3	7.0	5.0	4.9	5.9	11.5	11.6	11.9	13.6	11.5	13.1	12.9	11.7	13.1	11.3	13.8	11.1	63.3	0.0	0.0	0.0	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	453.9	0.0	0.0	0.0	0.0	283.4	25.0	0.0	0.0	0.0	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.0	279.7	52.8	0.0	0.0	0.0	0.0	0.0	0.0	531.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	0.0	0.0	0.0	0.0	183.5	5.3	0.0	0.0	0.0
MICU1	"CALC, CBARA1, EFHA3, FLJ12684"	ENSG00000107745	"Mitochondrial calcium uptake 1"	Q9BPX6	10	72367327-72626191	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Calcium transport, Ion transport, Transport"		Allergen	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 185.5;Inhibitory neurons: 205.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037479, HPA037480"	Approved		Supported	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA037479: AB_2675495, HPA037480: AB_10696934"	"unprognostic (8.18e-2)"	"unprognostic (6.98e-3)"	"unprognostic (6.71e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.91e-2)"	"unprognostic (3.60e-2)"	"unprognostic (2.96e-3)"	"unprognostic (3.38e-2)"	"unprognostic (7.43e-2)"	"unprognostic (2.23e-2)"	"prognostic favorable (4.66e-7)"	"unprognostic (1.70e-1)"	"unprognostic (1.55e-1)"	"unprognostic (5.35e-2)"	"unprognostic (6.70e-2)"	30.9	55.3	34.4	21.2	37.2	34.2	26.4	51.4	47.1	28.8	27.8	30.1	37.4	36.5	23.8	20.7	34.6	32.3	43.9	37.8	32.2	105.3	116.7	29.6	20.1	32.2	30.7	41.6	20.0	43.3	24.4	23.6	33.7	24.8	32.9	31.5	20.8	22.3	72.2	29.0	32.7	38.4	29.0	27.0	43.3	20.2	30.4	26.1	22.9	76.9	21.6	30.8	21.7	34.1	42.2	71.8	45.4	53.3	70.8	66.6	20.6	45.8	101.6	65.7	89.8	42.2	77.2	56.8	37.3	63.5	54.0	49.1	57.7	40.7	76.9	51.9	46.6	38.3	37.1	61.2	56.4	53.3	40.1	66.6	36.2	72.4	66.5	90.4	57.7	53.4	60.0	64.5	77.6	37.9	46.7	49.9	19.0	45.0	17.3	50.5	60.9	37.4	80.8	31.0	34.8	49.8	54.2	65.9	42.0	45.2	39.3	50.5	36.2	32.6	50.1	65.7	38.4	33.9	62.6	39.2	65.1	69.6	22.5	21.5	60.0	110.8	16.8	49.8	14.7	15.1	14.7	15.5	26.0	17.5	14.4	12.0	48.8	15.2	54.5	16.5	15.3	35.4	34.4	37.2	51.4	47.1	37.8	32.2	32.2	30.7	33.7	29.0	30.4	34.1	30.4	54.5	36.0	47.7	23.4	9.9	16.0	22.6	14.2	31.9	25.3	19.6	35.8	25.8	38.3	35.0	20.9	20.7	16.9	25.9	80.3	35.6	10.7	42.0	43.0	22.7	14.4	25.0	185.5	26.7	18.8	31.1	45.9	48.2	18.3	31.5	23.9	60.4	34.8	16.8	205.9	24.4	16.2	36.9	13.4	12.5	26.8	40.1	12.4	64.6	38.0	51.3	10.3	146.8	97.5	51.4	24.9	25.9	25.0	10.7	29.3	110.7	34.0	33.8	6.6	29.0	27.2	54.5	40.0	14.2	14.2	21.5	19.0	73.4	23.6	14.2
MICU2	EFHA1	ENSG00000165487	"Mitochondrial calcium uptake 2"	Q8IYU8	13	21492691-21604181	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045511, HPA058790"	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm	Mitochondria	"HPA045511: AB_10959894, HPA058790: AB_2683821"	"unprognostic (4.32e-3)"	"unprognostic (1.50e-2)"	"unprognostic (2.00e-1)"	"unprognostic (7.01e-2)"	"unprognostic (9.80e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.47e-2)"	"unprognostic (8.01e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.63e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.56e-1)"	"prognostic favorable (1.40e-7)"	"unprognostic (3.81e-2)"	"unprognostic (8.94e-2)"	"unprognostic (5.15e-2)"	"unprognostic (3.50e-1)"	22.6	44.4	19.3	24.5	21.0	36.3	32.4	23.9	29.7	26.2	24.2	37.6	26.5	22.1	27.8	23.2	25.1	20.2	57.5	20.4	20.4	76.3	32.2	23.0	26.9	21.8	20.6	22.7	21.3	45.9	27.0	24.5	20.2	28.5	34.1	45.7	23.4	22.1	56.4	22.9	27.4	21.1	20.8	22.6	30.6	27.0	19.7	28.8	37.6	61.5	29.7	23.5	18.7	24.2	35.2	20.0	46.2	29.6	40.4	53.8	39.7	58.3	47.5	60.8	42.0	29.0	55.6	54.4	36.8	56.0	31.3	45.9	45.9	49.1	83.4	55.5	46.5	94.2	20.5	34.3	48.7	71.4	52.7	46.8	47.7	34.5	24.4	54.4	41.2	50.5	33.9	23.9	100.3	30.8	47.9	68.1	31.5	123.2	30.3	51.9	117.2	36.6	121.3	28.6	36.9	28.6	39.8	46.4	39.6	40.2	45.3	66.7	51.1	26.4	23.6	54.1	48.9	17.7	24.8	39.6	26.1	59.0	66.8	34.0	24.8	35.1	30.6	30.5	28.0	42.1	26.9	30.9	27.3	24.4	23.7	30.2	23.3	30.2	25.6	25.1	40.3	23.9	19.3	21.0	23.9	29.7	20.4	20.4	21.8	20.6	20.2	20.8	19.7	24.2	22.0	38.5	26.8	70.2	51.3	30.0	39.8	51.9	26.2	27.1	24.0	17.8	74.5	30.0	46.8	51.5	22.9	60.7	31.8	52.2	144.8	43.3	40.7	39.7	28.4	24.3	30.5	65.2	126.1	27.2	42.6	32.0	27.0	28.7	24.7	26.5	17.9	24.0	36.5	42.1	142.5	25.7	57.0	28.8	22.1	16.2	33.8	28.5	48.0	55.3	43.1	63.9	43.3	77.9	121.7	36.9	51.7	36.1	29.3	27.8	31.3	108.4	56.0	49.0	59.2	37.6	30.7	86.9	48.5	23.0	25.6	70.3	45.5	47.4	34.2	30.0
MIGA2	"C9orf54, FAM73B, FLJ00199, FLJ14596"	ENSG00000148343	"Mitoguardin 2"	Q7L4E1	9	129036621-129072082	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Granulosa cells: 18.7;Theca cells: 22.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041363	Approved		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	Cytosol	"Cell Junctions"	"HPA041363: AB_10794664"	"unprognostic (2.10e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.93e-2)"	"unprognostic (3.07e-3)"	"unprognostic (2.90e-2)"	"prognostic favorable (3.04e-6)"	"unprognostic (1.12e-2)"	"unprognostic (1.44e-3)"	"unprognostic (8.57e-3)"	"unprognostic (1.25e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.15e-3)"	6.7	13.6	7.5	5.3	7.6	12.6	5.8	8.4	8.1	6.2	5.1	11.8	15.2	7.2	2.9	11.9	6.7	3.9	17.3	7.0	8.4	7.8	7.8	4.8	4.6	10.4	8.3	6.8	4.7	6.6	8.1	1.6	9.1	9.3	3.1	2.3	7.3	6.9	9.8	10.1	14.0	4.3	7.0	7.0	10.1	4.6	9.1	4.4	9.2	7.7	3.6	9.3	6.3	7.6	4.8	9.7	2.9	14.9	7.9	4.1	6.5	8.4	6.3	9.5	6.0	8.4	9.8	7.2	3.7	6.6	8.3	22.3	4.0	6.3	1.4	6.6	5.9	5.2	20.4	6.3	8.7	6.0	11.5	5.8	4.9	8.6	4.4	3.1	6.6	6.7	7.7	2.9	5.2	12.7	6.0	12.3	6.7	11.4	13.9	12.2	8.7	12.0	5.0	9.2	9.3	6.6	9.4	14.7	5.2	1.7	10.6	6.4	6.7	6.1	7.0	10.4	6.5	4.0	6.2	6.7	8.7	4.7	7.4	7.2	1.5	1.4	1.5	1.6	3.3	1.2	1.1	2.0	1.6	1.3	1.1	0.7	2.5	0.6	0.9	2.2	1.0	1.2	7.5	7.6	8.4	8.1	7.0	8.4	10.4	8.3	9.1	7.0	9.1	7.6	7.1	3.2	7.4	0.0	1.7	0.0	0.0	0.0	0.0	0.0	7.1	7.2	0.0	0.0	3.1	7.3	0.0	3.3	8.1	0.0	1.9	5.4	0.0	4.2	4.4	1.8	0.0	0.0	0.0	4.7	2.6	2.4	0.0	7.3	0.0	18.7	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	3.6	0.0	0.0	0.0	0.0	5.8	0.0	0.0	1.8	0.0	0.0	4.5	2.9	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	5.6	3.0	22.1	0.0	0.0
MLC1	"KIAA0027, LVM, MLC, VL"	ENSG00000100427	"Modulator of VRAC current 1"	Q15049	22	50059391-50085426	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 262.7;choroid plexus: 145.6"	"Cell type enriched"	"Detected in some"	6	"Astrocytes: 115.6"	"Cancer enriched"	"Detected in some"	69	"glioma: 122.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 20.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"HL-60: 228.2;NB-4: 219.8;THP-1: 401.5;U-266/70: 131.6;U-266/84: 120.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003040	Enhanced		Supported	Cytosol		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol		"HPA003040: AB_1079387"	"unprognostic (2.68e-2)"	"unprognostic (5.46e-6)"	"unprognostic (5.41e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.42e-3)"	"unprognostic (9.54e-3)"	"unprognostic (7.21e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.51e-3)"	"unprognostic (8.39e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.92e-1)"	0.3	0.1	239.3	0.7	235.7	36.4	0.1	212.7	261.8	3.0	145.6	0.1	0.4	0.3	1.0	0.1	1.8	1.0	0.6	225.8	234.5	0.1	0.4	1.6	0.3	262.7	243.1	0.3	0.1	0.0	1.1	2.3	221.8	4.8	0.0	4.1	0.1	1.4	0.1	1.0	0.1	0.2	231.9	2.2	0.2	3.8	231.5	0.5	0.1	0.0	0.5	0.4	11.9	217.2	0.4	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	68.1	0.0	0.0	0.1	228.2	68.4	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	1.8	219.8	0.3	0.0	0.1	24.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	401.5	0.0	0.0	0.2	0.1	0.3	131.6	120.2	0.4	0.3	35.7	2.2	0.0	1.1	0.0	3.9	6.8	0.1	0.1	0.3	1.6	0.9	0.0	0.1	1.8	0.1	20.2	9.2	0.2	0.1	4.0	239.3	235.7	212.7	261.8	225.8	234.5	262.7	243.1	221.8	231.9	231.5	217.2	0.0	0.0	0.5	115.6	0.3	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.7	0.0	0.6	0.0	0.0	0.1	17.2	0.0	0.0	0.0	1.1	0.1	0.4	0.1	0.0	7.8	0.4	0.0	0.1	2.4	0.0	0.1	1.3	4.4	0.4	0.0	3.5	0.0	0.5	0.0	0.0	0.3	0.0	0.7	0.0	0.6	1.8	7.5	0.6	16.3	18.6	0.5	0.8	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.2	1.0	0.0	0.0	0.1	0.3	0.4	0.0	0.0	0.3	2.7	0.1	0.0	0.0
MLKL	FLJ34389	ENSG00000168404	"Mixed lineage kinase domain like pseudokinase"	Q8NB16	16	74671855-74700960	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	Necrosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Endothelial cells: 25.9;granulocytes: 29.1;Macrophages: 28.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA078638			Supported	"Plasma membrane,Cell Junctions,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Cell Junctions, Cytosol"	"HPA078638: "	"unprognostic (7.53e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.57e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (1.23e-1)"	"unprognostic (3.07e-1)"	"unprognostic (5.69e-2)"	"unprognostic (3.67e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.64e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.30e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.53e-3)"	20.0	7.1	8.4	20.3	8.7	30.7	12.1	8.6	12.7	9.0	9.6	11.0	11.0	6.0	2.0	15.6	8.0	11.5	10.6	7.8	8.2	15.4	9.3	25.6	15.4	10.1	9.8	3.0	9.9	1.6	3.7	9.2	9.3	8.4	11.4	0.3	13.3	4.3	3.1	4.9	14.4	7.6	9.1	36.1	10.8	1.2	10.3	6.7	8.7	3.1	13.8	12.3	11.5	9.6	13.5	24.4	0.1	0.1	6.0	12.4	0.2	17.0	14.8	15.4	22.4	13.9	26.6	0.3	19.1	14.2	13.7	21.7	4.3	24.9	5.8	8.3	0.6	18.8	17.6	16.2	4.2	12.3	18.6	8.5	2.4	16.8	5.7	9.0	37.3	21.3	2.7	2.5	11.9	22.0	7.0	24.3	2.2	29.3	30.0	13.5	1.8	23.8	22.0	10.2	1.0	0.8	13.4	8.7	7.2	0.1	6.2	12.5	41.4	7.8	4.8	7.0	11.7	11.2	40.2	3.2	13.7	42.3	3.9	21.9	36.2	45.8	11.2	22.2	15.4	8.1	12.6	12.0	18.9	6.7	6.8	10.4	48.6	3.6	23.3	1.2	17.4	16.0	8.4	8.7	8.6	12.7	7.8	8.2	10.1	9.8	9.3	9.1	10.3	9.6	32.1	3.2	10.7	1.0	9.8	3.4	6.8	3.1	7.4	0.2	3.3	3.4	3.1	2.8	5.5	1.8	0.0	0.2	9.6	8.9	1.9	4.6	3.5	1.2	1.9	25.9	1.2	3.4	0.5	5.2	0.8	7.1	15.3	1.6	29.1	0.3	16.8	1.3	16.6	1.7	0.5	10.9	0.0	18.2	7.8	5.2	0.9	28.9	7.2	11.2	16.7	0.1	11.3	1.5	5.2	4.9	9.4	0.4	18.5	2.8	5.5	0.6	2.0	0.6	0.0	3.0	3.1	0.1	0.2	13.4	2.8	0.3	16.5	0.2	9.5	7.5
MMD	"MMA, PAQR11"	ENSG00000108960	"Monocyte to macrophage differentiation associated"	Q15546	17	55392622-55421924	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"adipose tissue: 152.2;brain: 87.5"	"Cell type enhanced"	"Detected in many"		"Kupffer cells: 56.4;Macrophages: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 110.0;HSkMC: 199.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026978			Approved	Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles		"HPA026978: AB_2672068"	"unprognostic (1.33e-1)"	"unprognostic (2.92e-2)"	"prognostic favorable (3.52e-5)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (2.48e-1)"	"unprognostic (4.16e-2)"	"prognostic unfavorable (6.39e-5)"	"unprognostic (8.07e-3)"	"unprognostic (6.67e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.06e-3)"	"prognostic unfavorable (2.85e-4)"	"unprognostic (3.71e-3)"	"unprognostic (7.93e-2)"	"prognostic unfavorable (8.62e-4)"	"unprognostic (1.12e-2)"	152.2	13.3	54.2	15.7	55.9	14.1	28.4	11.6	58.5	4.8	5.4	13.4	10.9	6.2	9.7	7.2	4.2	9.4	6.5	87.5	19.7	8.5	13.2	10.0	17.8	16.3	29.2	2.8	3.5	3.7	4.8	21.4	16.1	6.2	12.9	12.8	4.9	7.9	3.4	5.3	10.1	11.4	24.2	16.5	5.4	17.0	21.6	8.2	6.6	8.0	12.1	11.6	4.0	27.2	20.1	46.3	67.0	13.5	110.0	86.0	39.2	13.6	5.2	7.2	10.2	7.4	53.8	30.1	39.6	4.5	20.1	1.5	18.8	14.3	14.9	41.5	9.5	11.0	2.5	85.2	29.8	10.8	3.2	199.4	4.5	10.1	11.4	15.7	9.0	27.4	4.4	20.5	15.1	2.8	29.7	8.2	20.6	3.3	15.6	12.4	46.9	10.0	19.7	5.0	7.0	72.8	5.0	7.1	10.9	41.5	15.4	17.3	9.6	18.7	26.6	15.5	14.0	13.1	6.2	45.7	26.7	8.5	15.2	14.2	1.5	1.9	1.7	2.1	4.9	4.5	1.8	3.3	4.3	5.0	3.1	3.3	4.6	2.9	1.9	1.3	2.1	17.5	54.2	55.9	11.6	58.5	87.5	19.7	16.3	29.2	16.1	24.2	21.6	27.2	15.5	3.2	0.6	5.2	20.3	5.4	23.7	9.3	5.2	28.2	3.3	3.3	4.6	11.5	2.7	7.3	4.2	11.5	12.2	3.4	15.6	27.7	2.5	4.8	8.9	16.4	7.8	27.3	36.5	1.3	18.8	12.7	2.6	8.7	0.0	3.5	19.6	17.9	37.6	16.8	11.5	6.8	8.2	56.4	35.9	4.0	1.8	85.9	7.2	14.0	48.6	14.5	12.3	7.5	7.2	17.3	1.6	3.4	12.1	26.2	2.3	9.8	2.4	10.2	19.7	5.2	11.4	28.9	23.3	3.1	17.5	20.0	17.7	1.3	8.6	6.1
MMD2	PAQR10	ENSG00000136297	"Monocyte to macrophage differentiation associated 2"	Q8IY49	7	4905989-4959213	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 27.4;retina: 6.1;testis: 7.1"	"Group enriched"	"Detected in some"	14	"Astrocytes: 253.4;Oligodendrocyte precursor cells: 121.2"	"Cancer enriched"	"Detected in single"	59	"glioma: 3.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 64: Astrocytes - Nervous system maintenance"								"unprognostic (2.32e-1)"							"unprognostic (1.53e-2)"		"unprognostic (5.03e-2)"	"unprognostic (2.03e-1)"			0.0	0.2	23.8	0.0	25.9	0.0	0.0	8.5	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.0	26.6	0.0	0.0	0.0	0.0	25.6	22.3	0.1	0.0	0.0	3.2	0.0	18.2	0.0	0.0	6.1	0.1	0.1	0.0	0.0	0.1	0.0	14.3	0.0	0.0	7.1	27.4	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.8	25.9	8.5	19.4	22.0	26.6	25.6	22.3	18.2	14.3	27.4	15.9	0.0	0.0	0.0	253.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	13.1	0.0	2.6	0.0	121.2	9.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MMGT1	"EMC5, TMEM32"	ENSG00000169446	"Membrane magnesium transporter 1"	Q8N4V1	X	135960588-135974029	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA032037	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"			"HPA032037: AB_10670705"	"prognostic unfavorable (8.54e-4)"	"unprognostic (2.18e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.23e-3)"	"unprognostic (8.94e-3)"	"unprognostic (2.61e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.87e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.38e-1)"	"prognostic favorable (1.94e-5)"	"unprognostic (6.08e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.29e-2)"	17.5	11.0	8.8	12.2	9.3	26.3	12.4	8.3	9.1	15.3	6.2	15.2	11.3	16.3	11.4	17.1	13.7	15.9	18.1	7.9	14.3	17.2	9.0	13.1	11.3	9.3	9.9	14.1	13.4	17.3	9.3	12.4	9.2	12.1	15.1	13.3	14.2	11.6	17.4	10.6	12.8	16.5	8.9	10.3	12.2	4.3	11.0	14.6	24.2	20.0	12.4	15.2	9.6	9.8	28.6	12.9	16.5	25.5	29.6	32.6	21.9	33.1	31.1	27.1	53.2	15.1	43.3	18.7	61.0	32.2	30.3	23.7	45.0	22.9	39.3	22.3	26.3	13.3	16.5	8.9	22.8	26.5	18.9	27.3	36.1	46.1	29.2	27.0	20.1	21.5	18.1	38.9	26.8	20.8	21.2	12.6	12.4	30.9	27.2	17.7	27.6	36.7	20.2	14.2	23.2	23.8	18.2	17.6	41.2	23.5	17.7	12.9	21.9	32.4	18.6	50.7	42.7	23.1	41.4	22.8	28.5	35.6	37.5	12.9	12.1	7.5	8.2	11.8	10.1	7.0	10.5	9.7	11.1	5.7	10.5	9.1	6.6	9.8	13.0	6.7	13.4	10.0	8.8	9.3	8.3	9.1	7.9	14.3	9.3	9.9	9.2	8.9	11.0	9.8	17.6	12.8	13.7	5.5	25.3	22.2	19.8	12.0	37.0	16.6	14.8	15.1	25.3	11.5	12.0	14.7	8.4	7.9	17.9	19.4	7.9	12.1	0.3	12.3	24.4	15.5	25.8	18.7	5.9	12.4	12.6	20.1	13.3	17.1	14.0	3.9	15.7	10.2	14.1	20.2	5.6	15.1	18.3	33.7	23.2	0.6	13.7	29.7	26.6	1.0	25.1	17.9	7.2	6.0	7.4	13.7	9.2	19.2	28.7	23.6	17.0	13.4	9.2	12.6	6.6	20.6	25.0	2.2	7.5	35.6	24.7	11.5	22.3	4.4	17.9	19.6
MMP14	MT1-MMP	ENSG00000157227	"Matrix metallopeptidase 14"	P50281	14	22836560-22849041	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 244.0;Pancreatic endocrine cells: 144.7;Syncytiotrophoblasts: 122.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 923.8;HHSteC: 794.2;HSkMC: 887.0;hTERT-RPE1: 925.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009918, HPA051432"	Approved		Approved	"Intermediate filaments,Cytosol"		No	No		1400000		"Cluster 46: Fibroblasts - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Intermediate filaments"	"CAB009918: AB_2250767, HPA051432: AB_2681484"	"unprognostic (1.34e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.11e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.05e-3)"	"unprognostic (5.91e-3)"	"unprognostic (1.95e-1)"	"prognostic unfavorable (9.48e-4)"	"unprognostic (3.82e-3)"	"unprognostic (7.31e-2)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (5.02e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.00e-2)"	"unprognostic (3.41e-3)"	151.5	31.7	5.6	59.9	5.0	1.6	101.5	5.7	7.5	181.3	61.8	77.2	39.5	167.3	19.0	92.1	82.1	148.2	41.3	6.6	7.2	35.9	13.2	91.8	24.8	11.9	8.4	90.2	36.0	65.3	14.2	118.9	9.2	59.9	36.6	9.6	78.1	45.5	18.8	127.5	69.4	106.0	7.3	30.8	57.7	11.7	13.2	13.0	50.0	16.1	30.8	103.9	111.1	10.6	90.6	1.2	26.3	2.0	923.8	651.6	455.9	270.1	606.4	93.3	158.5	21.3	337.4	0.9	146.4	301.9	24.6	216.3	0.3	262.2	99.7	1.1	0.6	37.2	1.7	5.0	794.2	0.4	1.3	887.0	148.7	334.7	288.3	925.5	492.9	0.6	0.8	2.1	185.1	0.7	0.4	79.4	14.7	17.7	52.4	2.1	96.0	0.2	61.4	148.1	0.3	0.6	187.3	0.3	574.2	104.4	1.0	79.5	436.8	724.9	53.7	198.2	329.6	0.8	1.6	1.1	410.9	0.6	396.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	5.0	5.7	7.5	6.6	7.2	11.9	8.4	9.2	7.3	13.2	10.6	13.9	12.8	3.0	2.0	3.4	34.0	23.4	105.4	39.3	0.0	14.1	17.5	4.7	50.1	42.2	7.3	0.0	105.6	0.3	19.9	11.7	63.0	0.4	16.1	81.6	35.2	7.8	0.0	0.0	28.7	244.0	84.0	25.5	14.8	3.8	9.3	32.9	2.7	89.5	0.0	0.0	24.5	34.6	20.2	32.7	2.4	72.1	38.0	37.4	4.7	21.5	14.3	0.0	0.5	0.1	144.7	33.0	54.9	0.3	21.8	19.9	11.7	46.8	0.8	39.5	11.1	73.9	0.8	0.8	33.7	34.2	122.7	2.5	15.6	18.6	37.9
MMP23B	"MIFR, MIFR-1, MMP22"	ENSG00000189409	"Matrix metallopeptidase 23B"	O75900	1	1632163-1635263	"Enzymes, Predicted intracellular proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 29.9"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 90.5;Leydig cells: 98.2;NK-cells: 64.9;Peritubular cells: 177.9"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.8"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in some"	5	"plasmacytoid DC: 11.3"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 11.3"	"Cell line enhanced"	"Detected in some"		"HHSteC: 4.4;NTERA-2: 2.7;PC-3: 1.9;U-266/70: 3.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 7.8"	"Low region specificity"	"Detected in some"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (2.19e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.99e-2)"	"unprognostic (9.31e-2)"	"unprognostic (6.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (8.06e-2)"	"unprognostic (8.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.33e-1)"	"unprognostic (2.26e-11)"	"unprognostic (1.60e-3)"	"unprognostic (1.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (6.66e-2)"	7.1	2.8	0.4	0.3	0.5	1.3	4.1	0.1	1.0	16.7	0.0	5.0	1.9	15.4	0.0	2.8	11.0	2.9	15.0	0.3	0.0	3.2	3.3	14.3	1.1	0.4	0.0	29.9	1.6	0.0	5.7	2.8	0.1	11.8	0.1	0.1	1.0	1.1	0.5	3.1	3.4	1.2	0.0	3.0	4.3	5.2	0.1	0.0	2.4	0.0	0.1	11.9	10.9	0.2	0.6	0.0	0.0	1.8	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.4	0.5	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.7	0.5	0.2	1.2	4.4	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.1	0.0	0.4	0.0	0.2	2.7	0.0	1.9	0.9	0.0	1.1	0.0	0.0	0.4	0.2	0.3	0.0	0.1	0.0	0.5	0.0	0.4	0.2	0.1	0.3	0.0	3.9	0.2	1.1	0.0	0.2	0.1	0.0	0.2	0.0	1.5	0.0	0.9	0.0	0.3	1.0	0.0	0.1	0.0	0.7	0.1	2.2	0.1	11.3	0.3	1.7	0.4	0.5	0.1	1.0	0.3	0.0	0.4	0.0	0.1	0.0	0.1	0.2	2.2	0.0	0.5	1.0	1.1	13.4	0.8	0.7	0.6	1.3	1.7	1.5	9.6	1.5	0.4	1.8	0.0	4.0	27.4	3.0	0.0	1.2	1.0	4.0	3.5	2.2	3.0	2.7	0.3	0.5	2.2	90.5	4.6	1.0	0.0	1.4	12.1	1.0	5.7	3.3	0.6	1.9	4.1	1.0	18.5	6.2	98.2	1.3	19.6	0.0	1.2	0.5	64.9	0.0	0.2	4.3	0.9	177.9	4.3	0.5	2.7	1.0	0.5	7.7	0.0	0.7	5.3	2.1	10.5	0.7	15.8	10.3	8.1	2.1	1.7	0.9
MPC1	"BRP44L, CGI-129, dJ68L15.3, SLC54A1"	ENSG00000060762	"Mitochondrial pyruvate carrier 1"	Q9Y5U8	6	166364919-166383013	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 739.7;tongue: 559.2"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 950.0;Distal tubular cells: 1721.8;Proximal tubular cells: 573.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045119, HPA055790"	Enhanced		Enhanced	Mitochondria		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045119: AB_10960421, HPA055790: AB_2682923"	"unprognostic (3.30e-2)"	"prognostic favorable (1.45e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.17e-2)"	"unprognostic (2.85e-2)"	"unprognostic (7.61e-2)"	"prognostic favorable (1.29e-4)"	"unprognostic (3.27e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.11e-3)"	"unprognostic (5.64e-2)"	"prognostic favorable (4.79e-11)"	"unprognostic (4.13e-2)"	"unprognostic (1.03e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.45e-2)"	61.7	39.6	105.9	33.4	119.5	57.0	52.8	129.7	153.1	52.4	108.0	97.7	84.8	35.7	44.8	71.5	34.7	41.7	739.7	101.2	127.8	259.9	411.2	44.6	44.3	119.2	123.9	43.4	66.0	141.8	38.1	23.7	119.5	43.5	89.9	57.3	87.7	42.3	319.4	40.9	63.8	38.5	117.1	35.0	96.1	22.2	121.5	48.6	82.9	559.2	44.2	47.4	34.9	132.4	25.6	7.5	31.3	107.7	88.4	49.8	45.2	29.1	47.1	45.1	43.9	38.8	17.9	53.6	50.9	45.4	36.1	24.5	47.0	36.7	31.9	36.1	79.0	27.5	35.4	132.6	36.6	104.9	34.1	40.0	51.0	36.8	26.7	13.7	36.9	80.8	94.2	84.1	28.6	40.5	73.1	193.7	16.1	148.0	35.5	39.1	51.7	134.9	85.4	20.5	96.7	85.7	33.6	145.8	34.0	25.9	34.5	154.3	25.3	25.7	26.8	91.6	30.0	55.8	42.2	46.3	23.5	127.0	42.1	60.7	60.0	90.1	41.7	98.3	39.4	33.1	48.5	45.1	72.2	25.4	44.7	43.3	54.6	40.5	128.5	43.0	69.1	49.8	105.9	119.5	129.7	153.1	101.2	127.8	119.2	123.9	119.5	117.1	121.5	132.4	56.1	118.6	48.0	64.6	51.7	45.6	44.2	83.6	29.0	61.1	74.2	79.1	950.0	187.3	67.6	106.7	10.4	22.0	54.2	219.1	1721.8	89.3	66.8	73.7	50.7	51.7	37.2	72.6	49.0	140.3	78.3	74.1	63.7	93.2	71.0	28.0	47.5	391.0	121.4	48.8	74.7	122.1	166.8	89.6	81.7	10.2	66.5	80.3	129.9	20.6	104.7	199.9	58.7	32.2	108.0	65.2	125.0	89.9	114.5	32.0	162.0	573.6	46.3	66.7	92.1	76.9	80.4	163.2	79.6	67.3	55.8	24.4	58.4	39.9	146.7	53.6
MPC2	"BRP44, DKFZP564B167, SLC54A2"	ENSG00000143158	"Mitochondrial pyruvate carrier 2"	O95563	1	167916675-167937072	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 2288.1;Late spermatids: 5134.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056091	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA056091: AB_2683035"	"unprognostic (3.25e-1)"	"unprognostic (6.82e-2)"	"unprognostic (8.79e-3)"	"unprognostic (4.15e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.02e-1)"	"unprognostic (6.01e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.93e-2)"	"unprognostic (3.36e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.08e-2)"	"unprognostic (9.13e-2)"	"unprognostic (2.39e-1)"	"unprognostic (6.95e-2)"	"unprognostic (5.43e-2)"	"unprognostic (1.67e-1)"	53.6	89.9	32.3	15.8	37.1	63.3	50.7	34.2	39.0	34.3	35.0	80.3	47.8	30.6	15.8	38.8	34.5	19.6	174.0	36.8	35.6	148.1	266.6	35.1	14.0	31.8	33.4	35.3	52.4	35.6	73.5	13.8	31.6	89.3	33.7	28.4	55.3	16.0	162.1	42.5	65.8	14.8	31.5	28.9	140.4	240.4	34.9	20.1	32.3	66.3	15.0	43.0	35.4	34.4	40.7	43.2	14.6	32.3	31.5	26.2	4.1	70.2	26.9	23.7	27.2	92.3	19.6	75.0	49.4	29.1	21.4	31.4	17.0	28.1	20.3	98.3	34.5	33.2	34.1	60.7	22.4	38.1	21.9	19.6	23.6	41.8	21.8	20.0	20.3	52.5	39.6	34.9	38.7	18.1	52.4	31.4	26.2	73.7	45.2	27.8	31.3	54.7	155.0	30.5	25.8	28.4	41.6	39.1	34.3	29.2	73.9	38.9	30.4	27.8	24.8	45.3	29.9	61.2	65.9	74.5	73.5	28.6	14.6	95.0	33.1	92.5	44.1	30.5	45.7	50.2	51.6	45.8	58.7	41.3	48.6	46.7	61.4	55.6	38.5	40.2	81.3	84.2	32.3	37.1	34.2	39.0	36.8	35.6	31.8	33.4	31.6	31.5	34.9	34.4	81.6	35.3	43.7	14.4	75.0	126.1	157.7	213.8	52.9	54.5	167.2	166.9	428.0	513.3	119.2	130.6	22.9	468.6	78.2	267.5	1025.2	206.1	2288.1	153.3	38.5	75.0	331.5	388.3	23.5	145.5	55.3	119.3	112.1	98.3	88.2	332.1	55.3	679.5	159.6	45.4	19.9	326.4	146.5	77.1	113.3	5134.8	106.2	93.9	120.9	15.9	272.9	123.8	76.2	13.0	16.8	100.5	237.2	112.8	84.7	245.6	516.2	974.3	175.3	69.7	65.7	90.3	147.1	788.0	170.5	75.3	114.4	343.1	94.9	705.0	415.5	173.9
MPEG1	MPG1	ENSG00000197629	"Macrophage expressed 1"	Q2M385	11	59208510-59212927	"Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Immunity, Innate immunity"	"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 207.4"	"Group enriched"	"Detected in some"	4	"dendritic cells: 156.0;Kupffer cells: 409.8;Macrophages: 174.6;monocytes: 218.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"classical monocyte: 290.5;intermediate monocyte: 209.9;myeloid DC: 144.7;non-classical monocyte: 245.2;plasmacytoid DC: 204.9"	"Group enriched"	"Detected in many"	6	"dendritic cells: 204.9;monocytes: 290.5"	"Not detected"	"Not detected"							"Not detected"	"Not detected"			HPA046801	Approved				"Secreted to blood"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 16: Immune cells - Immune response"		"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA046801: AB_2679814"	"unprognostic (1.24e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.05e-2)"	"unprognostic (2.00e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.79e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (6.23e-2)"	"unprognostic (2.76e-1)"	"unprognostic (5.48e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.48e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.86e-2)"	29.2	15.8	1.5	112.4	1.6	21.3	13.5	1.7	2.4	11.6	3.2	32.9	40.9	10.9	3.7	12.6	6.9	36.2	10.3	1.4	2.1	6.0	41.1	35.4	96.3	3.3	1.9	4.9	4.6	4.6	1.6	35.8	2.5	8.0	43.4	0.3	7.3	9.3	3.9	7.1	52.8	28.2	2.9	207.4	19.2	4.5	4.0	42.8	5.9	8.3	75.2	42.7	2.1	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	290.5	8.4	0.5	209.9	0.5	12.6	0.3	0.2	144.7	14.0	0.2	0.1	38.5	1.2	245.2	204.9	0.6	214.5	1.5	1.6	1.7	2.4	1.4	2.1	3.3	1.9	2.5	2.9	4.0	4.0	0.7	0.0	7.9	0.0	33.8	1.1	0.0	0.0	1.2	0.0	0.3	0.9	1.7	1.5	0.6	0.0	0.0	0.3	156.0	0.1	0.0	0.0	0.2	0.0	0.1	1.7	0.0	4.4	0.0	0.0	0.6	0.8	0.5	0.1	2.5	0.0	4.6	3.7	52.4	0.0	0.0	0.0	0.0	409.8	48.0	0.6	0.0	174.6	1.8	10.3	218.2	0.2	7.2	0.0	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.7	0.7	0.1	6.6	0.7	0.4	0.0	0.0	0.3	1.6	0.3	2.7	0.0	0.0	0.1
MPV17	SYM1	ENSG00000115204	"Mitochondrial inner membrane protein MPV17"	P39210	2	27309492-27325680	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (9.34e-3)"	"unprognostic (2.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.89e-2)"	"prognostic unfavorable (6.99e-6)"	"unprognostic (1.05e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.44e-3)"	"unprognostic (2.59e-3)"	"unprognostic (2.52e-1)"	"unprognostic (5.10e-3)"	"unprognostic (4.62e-2)"	50.2	86.5	56.4	37.8	58.1	31.3	39.9	59.1	58.4	36.0	59.3	32.5	25.0	37.9	47.7	32.6	37.7	36.7	78.2	56.3	59.1	48.6	22.6	39.1	43.2	58.8	57.1	43.7	33.2	70.0	38.9	35.0	58.1	34.1	34.1	26.7	35.9	35.0	18.3	32.0	27.5	57.7	56.9	37.1	29.1	15.5	60.3	46.0	51.6	30.0	48.1	44.9	28.1	63.2	74.1	68.2	49.7	42.6	202.7	237.0	46.6	70.8	143.6	67.2	60.7	55.0	52.0	41.5	72.8	97.2	124.0	61.3	64.1	134.1	69.5	56.9	63.7	79.5	58.8	105.6	125.4	47.3	48.7	229.3	116.3	118.6	169.4	94.3	100.2	49.8	77.0	77.1	113.9	107.4	46.9	71.5	55.7	106.7	69.1	64.6	73.2	85.2	149.2	58.5	33.1	107.2	37.6	43.7	82.1	49.3	49.0	60.6	88.6	67.0	68.8	83.4	76.4	108.1	106.1	130.4	109.2	105.4	76.1	59.5	93.7	42.9	59.3	81.4	64.4	84.5	60.5	67.4	120.5	73.6	58.0	67.8	7.8	76.0	81.7	87.4	81.4	92.1	56.4	58.1	59.1	58.4	56.3	59.1	58.8	57.1	58.1	56.9	60.3	63.2	36.0	25.6	29.3	10.7	26.3	17.2	32.8	69.2	33.0	20.5	49.5	52.8	48.9	18.6	46.5	33.1	8.4	51.1	26.3	8.8	64.6	43.3	27.4	17.3	32.6	35.9	16.8	21.6	18.4	24.3	60.2	37.5	12.2	17.5	42.5	28.7	28.2	9.9	116.9	8.4	22.7	15.0	59.0	28.5	24.0	34.2	35.4	33.7	40.9	8.4	38.1	38.9	28.8	13.6	15.5	20.7	12.9	35.0	31.4	32.1	17.6	87.1	36.7	12.7	0.0	30.1	30.8	15.5	21.2	33.9	18.8	59.4	22.2	41.8	17.7	30.7
MRGPRF	"GPR140, GPR168, MGC21621, mrgF"	ENSG00000172935	"MAS related GPR family member F"	Q96AM1	11	69004395-69013382	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 171.2;intestine: 159.2"	"Cell type enhanced"	"Detected in many"		"Fibroblasts: 33.3;Leydig cells: 66.2;Peritubular cells: 100.8;Sertoli cells: 52.6;Smooth muscle cells: 63.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 67.6;ASC TERT1: 30.0;BJ: 39.5;BJ hTERT+: 99.1;BJ hTERT+ SV40 Large T+: 36.8;fHDF/TERT166: 30.8;U-2197: 46.8"	"Region enriched"	"Detected in many"	5	"cerebellum: 14.8"	"Region enhanced"	"Detected in some"		"spinal cord: 4.8"	HPA028811	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear membrane, Plasma membrane"		"HPA028811: AB_10603875"	"unprognostic (2.49e-2)"	"unprognostic (3.89e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.03e-2)"	"unprognostic (5.16e-2)"	"unprognostic (6.52e-3)"	"unprognostic (3.20e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.36e-1)"	"unprognostic (8.32e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.55e-7)"	"unprognostic (2.75e-2)"	"unprognostic (2.27e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.62e-3)"	41.7	3.8	2.6	12.8	2.9	0.0	32.5	12.0	3.9	103.6	5.5	159.2	9.3	171.2	14.2	16.2	98.0	16.7	13.7	2.4	3.1	17.1	7.0	18.7	4.5	4.7	2.8	37.0	3.4	0.5	4.1	11.6	3.3	48.3	8.9	0.2	10.8	45.6	5.1	15.2	38.3	59.3	2.8	13.4	44.1	7.3	2.8	0.7	10.7	3.0	1.3	75.2	65.6	2.5	0.0	0.1	0.1	0.0	67.6	30.0	1.4	39.5	99.1	36.8	24.3	0.0	1.8	0.0	0.8	30.8	0.1	0.1	0.1	0.0	6.8	0.0	0.0	0.0	2.8	0.0	8.5	0.0	0.0	22.1	0.0	23.5	0.0	0.1	0.0	0.2	0.0	0.0	0.6	0.0	0.0	2.9	1.5	0.8	0.1	0.0	3.4	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	2.5	0.0	0.0	0.0	22.4	0.0	46.8	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	2.9	12.0	3.9	2.4	3.1	4.7	2.8	3.3	2.8	2.8	2.5	3.2	0.0	0.0	0.0	0.6	5.0	0.2	0.0	1.2	0.0	0.3	2.3	0.6	2.8	0.0	11.0	0.0	0.7	0.1	0.0	0.0	0.0	4.9	1.1	20.6	2.3	0.0	0.0	1.1	0.0	0.6	33.3	0.5	0.8	0.0	0.0	3.9	3.8	1.1	0.0	0.2	0.0	0.0	0.0	7.3	7.9	66.2	0.2	7.2	3.7	0.0	3.0	0.0	0.0	0.2	0.1	0.0	100.8	0.1	0.3	0.0	0.9	0.0	0.3	52.6	19.1	63.7	1.3	0.5	0.4	3.8	1.1	0.6	0.6	0.0	0.4
MRLN	"Linc-RAM, LINC00948, M1, MLN, MUSER1"	ENSG00000227877	Myoregulin	P0DMT0	10	59736692-59756041	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	7	"skeletal muscle: 269.3;tongue: 147.3"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 118.8;Proximal tubular cells: 25.8;Respiratory ciliated cells: 35.7;Rod photoreceptor cells: 37.8"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.4"	"Region enriched"	"Detected in some"	4	"cerebellum: 4.5"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	7	"RH-30: 13.3"	"Region enriched"	"Detected in many"	11	"cerebellum: 21.6"											NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 49: Ciliated cells - Cilium organization"					"unprognostic (2.32e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.27e-1)"	"unprognostic (4.54e-1)"	"unprognostic (3.17e-3)"		"unprognostic (9.77e-2)"		"unprognostic (1.09e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.79e-2)"	"unprognostic (1.12e-2)"	"unprognostic (6.09e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.46e-1)"	0.1	0.2	0.4	0.1	0.4	0.3	0.2	4.5	0.7	0.5	0.4	0.2	1.0	0.5	0.8	1.2	5.1	0.7	0.1	0.4	0.2	8.1	0.2	0.7	0.1	0.5	0.3	0.3	2.8	0.0	12.0	0.1	1.0	1.3	0.1	30.6	7.0	0.1	269.3	0.6	1.1	0.1	0.1	0.5	1.0	0.8	0.3	0.3	0.3	147.3	0.1	0.0	0.1	0.6	0.0	0.8	0.4	0.8	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.8	0.6	1.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.7	0.2	1.8	1.1	0.1	0.0	0.6	1.0	0.0	0.6	0.0	0.1	0.0	0.1	0.1	1.0	0.0	1.1	0.0	1.0	0.2	0.2	0.8	0.5	13.3	0.0	0.0	0.2	0.6	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.3	0.3	0.6	0.2	0.5	0.1	0.1	0.4	0.3	0.0	1.7	0.3	0.4	0.6	0.1	0.4	0.5	0.3	0.3	0.2	0.6	0.2	0.5	1.2	0.3	0.3	0.4	0.3	0.0	0.4	0.4	4.5	0.7	0.4	0.2	0.5	0.3	1.0	0.1	0.3	0.6	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	2.9	0.2	0.1	1.0	0.0	1.8	0.0	2.1	0.0	0.1	1.5	0.0	0.2	5.6	118.8	0.8	0.7	0.0	0.0	1.3	0.2	6.4	0.4	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.3	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	6.1	0.0	0.5	0.6	0.3	0.0	0.4	0.0	0.1	0.0	25.8	35.7	37.8	0.0	10.1	0.2	2.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0
MRS2	MRS2L	ENSG00000124532	"Magnesium transporter MRS2"	Q9HD23	6	24402908-24426194	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017642	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA017642: AB_2669628"	"unprognostic (2.12e-3)"	"unprognostic (1.22e-1)"	"unprognostic (5.64e-3)"	"prognostic unfavorable (5.32e-4)"	"unprognostic (7.23e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.20e-1)"	"unprognostic (3.89e-3)"	"prognostic favorable (5.14e-11)"	"unprognostic (8.75e-2)"	"unprognostic (2.94e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (8.56e-2)"	"prognostic unfavorable (8.03e-4)"	"unprognostic (1.55e-3)"	14.6	17.0	10.7	12.0	11.8	6.7	14.3	17.1	13.7	10.9	15.4	14.1	15.4	10.3	14.1	14.1	10.2	9.3	30.7	11.2	12.2	24.2	20.5	10.9	14.9	10.8	11.7	12.3	18.8	22.5	13.4	16.4	11.2	12.8	15.4	30.1	15.9	13.4	52.9	12.3	12.1	10.7	10.9	11.4	15.7	6.3	12.2	8.7	16.3	49.4	14.8	13.2	11.5	11.4	36.7	21.0	24.7	46.3	15.9	14.4	54.8	16.6	19.3	20.5	18.5	80.9	16.9	21.2	67.3	14.6	32.2	21.8	25.6	31.6	22.0	26.8	44.9	33.6	16.4	93.7	23.0	38.7	30.0	22.8	24.7	20.9	16.7	23.8	22.2	27.2	49.5	0.0	22.6	28.9	37.1	35.3	64.6	20.6	18.9	0.2	4.3	48.4	90.5	37.1	39.3	23.7	28.1	84.9	46.5	72.0	43.3	26.3	9.6	9.1	13.8	18.9	30.8	37.4	68.1	29.4	11.3	45.4	38.3	3.4	16.8	7.3	11.6	20.2	14.9	14.4	12.4	12.5	24.8	11.9	13.4	12.6	1.9	15.3	18.8	14.8	11.5	12.1	10.7	11.8	17.1	13.7	11.2	12.2	10.8	11.7	11.2	10.9	12.2	11.4	10.5	35.3	20.0	18.6	18.0	7.1	13.6	18.8	16.5	33.5	15.7	10.4	55.6	20.0	16.4	20.2	39.6	46.5	23.3	13.6	52.8	22.6	0.6	15.7	11.5	11.3	9.6	17.1	33.7	19.1	24.6	14.8	13.3	12.9	12.0	23.3	11.4	14.4	21.9	50.5	35.6	15.4	22.4	15.8	10.0	0.7	12.2	14.8	7.2	9.4	19.6	21.8	16.5	15.1	16.5	15.9	14.9	16.6	19.7	14.7	20.0	40.7	14.4	43.6	19.7	9.2	12.9	5.4	11.6	22.7	11.2	25.3	13.1	27.2	22.3	15.7
MS4A1	"B1, Bp35, CD20, MS4A2"	ENSG00000156738	"Membrane spanning 4-domains A1"	P11836	11	60455846-60470752	"CD markers, Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"B-cell activation"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 673.3"	"Cell type enriched"	"Detected in some"	35	"B-cells: 970.5"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	96	"memory B-cell: 625.4;naive B-cell: 627.0"	"Lineage enriched"	"Detected in many"	96	"B-cells: 627.0"	"Group enriched"	"Detected in some"	26	"Daudi: 731.3;U-698: 364.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"CAB000015, HPA014341, HPA014391"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	"Plasma membrane"		"CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264"	"prognostic favorable (4.34e-5)"	"unprognostic (4.45e-4)"	"unprognostic (1.19e-4)"	"unprognostic (2.04e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.53e-7)"	"unprognostic (2.46e-3)"	"unprognostic (1.85e-3)"	"unprognostic (3.06e-2)"	"unprognostic (2.89e-4)"	"unprognostic (6.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (3.96e-5)"	"unprognostic (2.23e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.30e-1)"	3.6	0.4	0.0	149.7	0.0	19.1	0.8	0.0	0.1	0.5	0.1	9.0	3.0	2.2	1.0	4.2	0.5	8.4	1.8	0.0	0.1	3.4	2.1	4.0	500.4	0.2	0.0	0.3	0.2	7.3	0.3	0.9	0.1	5.1	10.6	0.0	8.9	0.3	0.8	0.1	123.5	1.2	0.1	253.8	18.4	1.2	0.1	50.6	6.7	0.1	673.3	16.3	1.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	731.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.3	0.5	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.4	0.0	0.5	0.2	0.0	0.1	0.0	364.1	0.0	0.2	0.0	0.8	0.5	0.3	2.4	0.1	3.7	625.4	2.8	5.5	0.5	627.0	0.5	2.1	2.0	6.5	0.6	0.5	0.8	32.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.1	0.3	0.0	3.8	0.0	970.5	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.4	0.0	0.0	0.0	0.0	0.0	14.5	0.3	0.0	0.0	4.5	0.7	0.1	0.3	0.0	7.0	0.0	0.0	0.1	1.8	2.0	0.1	2.5	0.0	1.1	0.3	0.1	0.0	0.0	0.2	0.0	0.6	0.3	2.0	0.0	4.6	7.2	0.0	2.5	0.0	2.1	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.5	0.2	0.1	0.8	0.1	0.0	27.3	0.7	0.2	0.0
MS4A10	"CD20L7, MS4A9"	ENSG00000172689	"Membrane spanning 4-domains A10"	Q96PG2	11	60785333-60801305	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	96	"intestine: 85.8"	"Cell type enriched"	"Detected in some"	25	"Proximal enterocytes: 319.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA014778	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"		"Cluster 45: Enterocytes - Digestion"			"HPA014778: AB_2669089"					"unprognostic (7.67e-3)"						"unprognostic (1.28e-1)"	"unprognostic (8.73e-3)"		"unprognostic (1.27e-1)"	"unprognostic (5.21e-2)"			0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.3	0.2	0.0	0.2	0.3	72.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	85.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.2	319.4	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.0	3.3	0.3
MS4A14	"DKFZp434H092, FLJ32856, MS4A16, NYD-SP21"	ENSG00000166928	"Membrane spanning 4-domains A14"	Q96JA4	11	60378530-60417756	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"testis: 73.0"	"Group enriched"	"Detected in some"	44	"Early spermatids: 262.3;Late spermatids: 672.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 5.5;non-classical monocyte: 8.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 8.0"	"Cell line enriched"	"Detected in single"	23	"THP-1: 9.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA058973	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	"Plasma membrane"	"HPA058973: "	"unprognostic (1.78e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.77e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.45e-2)"	"unprognostic (4.00e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.14e-1)"	"unprognostic (4.50e-6)"	"unprognostic (3.73e-2)"	"unprognostic (7.16e-3)"	"unprognostic (8.40e-2)"	"unprognostic (7.11e-2)"	5.1	3.7	6.2	3.5	5.6	0.6	3.6	5.8	8.8	1.2	7.5	2.7	0.7	0.9	0.6	0.9	1.3	0.9	2.6	5.8	6.3	1.8	2.0	11.9	1.3	7.7	6.8	0.7	1.3	0.3	1.5	2.4	7.2	1.8	1.1	0.4	1.9	0.5	0.9	0.9	2.7	1.2	6.0	10.4	1.2	73.0	8.5	0.3	1.5	0.3	1.9	2.0	1.2	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	3.4	0.0	0.0	5.5	0.0	0.0	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	8.0	0.0	0.0	0.9	6.2	5.6	5.8	8.8	5.8	6.3	7.7	6.8	7.2	6.0	8.5	8.0	0.2	0.0	1.1	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	262.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	7.3	5.5	672.0	4.1	10.4	0.0	3.7	5.7	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.1	0.0	0.0	0.0	0.7	0.0	6.6	0.1	0.0	6.5	3.4	0.0	0.3	0.1	0.1	0.0	0.0	0.0
MS4A2	"APY, FCER1B, IGER, MS4A1"	ENSG00000149534	"Membrane spanning 4-domains A2"	Q01362	11	60088261-60098467	"FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"IgE-binding protein, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 12.6"	"Cell type enriched"	"Detected in some"	20	"granulocytes: 967.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	908	"basophil: 275.5"	"Lineage enriched"	"Detected in single"	1467	"granulocytes: 275.5"	"Cell line enhanced"	"Detected in some"		"HEL: 2.7;THP-1: 1.3"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in all"		"spinal cord: 15.3"	HPA059967	Enhanced					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 36: HEL - Hemostasis"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA059967: AB_2684183"	"unprognostic (7.28e-2)"	"unprognostic (9.21e-2)"	"unprognostic (2.50e-4)"	"unprognostic (4.97e-2)"	"unprognostic (4.47e-1)"	"unprognostic (2.40e-6)"	"unprognostic (1.88e-2)"	"unprognostic (6.21e-3)"	"unprognostic (3.96e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.41e-1)"	"unprognostic (6.63e-3)"	"unprognostic (6.49e-3)"	"unprognostic (9.95e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.74e-1)"	2.6	0.2	0.3	2.4	0.3	0.9	2.7	0.5	0.5	6.3	0.6	4.9	5.5	4.2	3.7	4.8	0.9	8.2	0.6	0.3	0.3	0.5	0.4	12.6	1.1	0.4	0.3	0.1	0.5	0.3	0.1	0.3	0.4	3.0	5.4	0.0	1.8	2.4	2.9	2.5	6.7	4.1	0.3	0.2	5.3	1.0	0.3	1.2	0.1	1.2	1.8	3.8	2.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.7	0.2	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	275.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.1	0.1	0.1	0.0	0.4	0.3	0.3	0.5	0.5	0.3	0.3	0.4	0.3	0.4	0.3	0.3	0.5	0.1	0.0	30.9	0.0	0.3	0.0	0.9	0.0	0.0	0.3	0.1	0.1	0.5	0.0	6.8	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.4	0.1	0.1	0.3	0.0	46.7	0.1	0.0	0.1	1.1	0.0	0.1	967.4	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.3	0.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.5	0.0	0.0	0.7	0.4	0.0	0.7	0.2	0.1	0.1	0.0	0.0	0.0	12.2	0.0	0.0	0.2
MT-CO1	"COI, COX1, MTCO1"	ENSG00000198804	"Mitochondrially encoded cytochrome c oxidase I"	P00395	MT	5904-7445	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Deafness, Disease variant, Leber hereditary optic neuropathy, Non-syndromic deafness, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 222644.8;heart muscle: 255389.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 107039.5;Hepatocytes: 59794.3;Proximal enterocytes: 98329.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 54167.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016241, HPA069328"	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB016241: AB_2229888, HPA069328: AB_2686122"	"unprognostic (4.39e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (3.31e-1)"	"prognostic favorable (2.29e-4)"	"unprognostic (8.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.56e-3)"	"unprognostic (1.20e-2)"	"unprognostic (6.60e-2)"	"unprognostic (2.83e-2)"	"unprognostic (5.06e-3)"	"unprognostic (4.50e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.44e-2)"	22006.8	46968.9	171347.0	8727.7	151652.8	11321.8	17952.5	132201.9	222644.8	10440.9	179120.2	42606.0	27505.7	11582.9	14226.0	20791.8	10700.5	11452.7	255389.3	151507.6	137459.2	63061.8	96575.5	12744.7	9111.4	176794.8	152802.2	8124.5	19467.4	41236.2	7420.2	10527.8	168465.9	12427.0	28389.7	12503.0	23260.1	17753.2	147209.5	26849.0	35366.3	13146.2	138626.1	16284.7	44852.9	10932.5	176888.2	7461.1	14056.3	184587.7	8381.2	17415.3	10559.7	131378.4	5837.6	8554.3	11384.1	12431.0	25510.2	11563.1	12037.2	12867.2	4284.9	3189.4	5257.4	10383.6	18320.5	15138.9	6040.7	9857.6	3118.2	21430.9	1326.6	11407.4	4515.1	7226.0	8040.6	9130.6	54167.9	19725.4	3521.2	5336.1	11055.5	13603.9	11589.8	3149.9	6917.5	14668.4	3902.1	8485.5	5916.3	10551.1	9525.6	14037.0	4378.4	23591.9	2905.0	7814.2	6900.5	5664.0	3401.6	9177.9	15910.6	15016.1	5414.7	7189.1	4466.7	17018.9	8305.7	13626.1	9809.7	17703.3	15637.8	12617.8	8438.9	12565.9	6642.1	4951.2	5072.9	3542.6	6235.7	13711.8	6294.4	5305.8	9759.2	3824.6	3085.1	4907.9	3420.5	5374.6	3047.3	3425.6	3444.6	5567.3	3080.8	3911.2	1900.4	3759.1	5775.1	4847.5	2947.7	3929.0	171347.0	151652.8	132201.9	222644.8	151507.6	137459.2	176794.8	152802.2	168465.9	138626.1	176888.2	131378.4	3924.0	2900.6	3897.1	0.0	13282.9	9769.7	9713.9	22625.0	20857.7	0.0	12033.2	11841.6	107039.5	30777.5	16135.4	19596.3	0.0	0.0	9288.4	40726.1	4255.4	7191.4	1555.3	13044.7	9033.9	7847.9	7514.7	45610.3	0.0	5089.4	0.0	6305.3	19235.7	25645.6	3832.6	20400.0	25951.4	59794.3	0.0	0.0	0.0	24302.1	19071.0	45533.4	7744.0	7398.4	11696.4	12124.7	6894.2	0.0	15180.0	0.0	8901.3	0.0	0.0	6410.5	23865.9	8490.1	13829.3	9441.3	98329.8	33652.6	10474.0	0.0	13614.6	11019.8	9403.5	12096.5	14338.7	27110.9	11475.1	0.0	11502.4	15179.6	27138.6	21770.7
MT-CO2	"CO2, COX2, MTCO2"	ENSG00000198712	"Mitochondrially encoded cytochrome c oxidase II"	P00403	MT	7586-8269	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Electron transport, Respiratory chain, Transport"	Translocase	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 164780.5;heart muscle: 210840.8"	"Cell type enriched"	"Detected in many"	13	"Cardiomyocytes: 709929.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 73985.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016243, HPA051505, HPA054758"	Enhanced					NA	NA		240000	"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB016243: AB_2066366, HPA051505: AB_2681511, HPA054758: AB_2682595"	"unprognostic (2.67e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.57e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.96e-2)"	"prognostic favorable (2.89e-4)"	"unprognostic (1.06e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.72e-3)"	"prognostic favorable (7.10e-4)"	"unprognostic (1.25e-1)"	"unprognostic (9.30e-2)"	"unprognostic (3.05e-1)"	"unprognostic (1.70e-1)"	"unprognostic (9.50e-2)"	"unprognostic (3.72e-3)"	27287.7	50118.4	114427.0	5960.9	114629.6	9211.1	23112.5	102567.5	164780.5	8637.9	123709.0	47542.8	18239.3	10045.0	10813.1	24529.5	11015.1	5914.4	210840.8	108795.0	110116.5	112074.1	105449.6	14032.6	6314.3	129884.9	115346.3	7950.6	24515.9	29782.0	16861.9	10397.8	125082.8	25688.4	24989.1	8983.3	21379.6	12907.0	93258.6	22997.0	36121.9	9693.6	102620.8	18194.3	45409.4	14516.5	123032.8	6034.4	16877.7	109930.2	7889.2	21068.8	13184.5	102646.5	6276.2	9796.4	12777.6	12396.3	25548.5	9745.3	9393.2	7927.6	6429.8	4420.4	6584.3	10616.0	13681.5	12924.1	6467.6	11751.8	4522.1	23074.6	1724.1	16319.1	5925.8	10089.3	8726.0	9297.7	73985.8	20756.8	5543.0	7919.2	9987.0	14433.8	23568.7	2276.3	8072.8	14337.8	4979.3	12668.7	8862.9	12216.0	12212.6	13490.3	5804.8	22519.7	3353.4	12256.7	6160.6	5998.2	3899.6	10866.7	17578.2	17096.2	4758.2	7830.6	6527.3	15842.4	11881.3	18742.2	11084.6	31596.4	12345.0	10576.0	9043.3	10116.0	5740.6	6151.2	6563.0	7590.8	5638.0	15586.1	7129.7	20953.0	13541.7	15753.7	5586.8	8887.6	6782.0	11844.8	6189.5	6338.9	6316.7	10947.0	6386.1	7947.1	5329.9	6846.5	10055.3	8426.1	5367.4	7670.7	114427.0	114629.6	102567.5	164780.5	108795.0	110116.5	129884.9	115346.3	125082.8	102620.8	123032.8	102646.5	4337.7	1445.5	1999.8	0.0	11825.3	6754.0	8961.4	22171.6	22140.9	0.0	11994.6	16742.4	709929.9	18464.2	10323.3	18597.6	0.0	0.0	7569.1	29582.2	3709.5	3684.4	1119.7	12108.5	6979.9	16215.0	6396.9	27238.9	0.0	4873.7	0.0	10942.5	19089.4	20683.3	2144.6	17185.5	15141.7	53416.5	0.0	0.0	0.0	17158.1	14290.0	26774.7	4814.0	5284.9	7663.3	9292.7	5140.4	0.0	7967.0	0.0	6828.1	0.0	0.0	4709.1	15133.6	5123.0	14109.6	5949.4	40280.5	22569.2	7617.1	0.0	7060.4	9361.8	14171.2	7120.5	8965.1	26952.2	6702.8	0.0	8863.0	13639.8	19371.4	14261.8
MT-CO3	"CO3, COIII, COX3, MTCO3"	ENSG00000198938	"Mitochondrially encoded cytochrome c oxidase III"	P00414	MT	9207-9990	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		Translocase	"Disease variant, Leber hereditary optic neuropathy, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 189825.4;heart muscle: 231090.6"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 98114.9;Proximal enterocytes: 47697.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HeLa: 47821.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042788	Approved					NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA042788: AB_10793985"	"unprognostic (2.38e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.88e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.93e-1)"	"prognostic favorable (2.01e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.05e-2)"	"prognostic favorable (1.04e-4)"	"unprognostic (1.05e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.75e-2)"	"unprognostic (1.20e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.33e-2)"	27612.7	53681.0	106768.6	6403.7	100201.0	11914.6	26962.2	92217.9	189825.4	9972.2	122787.3	41553.8	21299.6	10118.8	12166.4	23137.6	10414.1	8134.8	231090.6	101700.1	98402.0	135745.7	93934.0	11738.0	7309.6	111323.1	103274.0	9356.4	21307.1	30833.6	18098.1	9332.4	106050.0	25270.8	25404.7	14193.4	21229.0	16620.0	98348.0	28350.1	31017.2	10682.4	91790.3	14201.4	41772.3	19009.4	106894.6	5959.0	20136.7	138793.4	9366.6	19763.5	13535.9	91700.3	6374.2	7329.2	11033.5	15732.2	21484.7	8772.8	6020.3	8032.3	4753.9	3111.6	4736.6	9884.1	9176.0	14020.9	3392.6	6719.8	3380.0	16891.6	1769.9	9653.6	5455.7	4794.4	7644.1	7478.3	47821.5	16704.0	4327.8	4505.2	9419.7	8504.4	13400.6	3422.1	5046.7	10915.4	5848.3	7900.3	6047.2	13759.0	10367.7	12916.5	4589.9	25941.9	2461.0	9979.3	5226.1	4852.9	3482.9	10181.9	19232.2	10970.2	4917.9	6797.0	3741.8	4032.3	8135.9	15244.2	8471.0	19585.6	9432.2	5152.8	8782.1	9756.5	5388.8	5622.3	3881.6	8183.5	5151.5	14362.6	3475.8	2863.0	4714.1	2004.7	1562.3	1885.5	1896.8	2933.1	1703.2	1823.0	1927.4	3253.5	2137.7	2759.1	3629.6	2089.5	1920.3	1612.4	1186.9	2432.3	106768.6	100201.0	92217.9	189825.4	101700.1	98402.0	111323.1	103274.0	106050.0	91790.3	106894.6	91700.3	2817.9	1910.3	2767.0	0.0	9010.7	8343.8	9724.5	21550.3	14394.8	0.0	8643.0	8027.7	98114.9	20354.3	11786.8	16547.0	0.0	0.0	5698.3	25285.3	4368.9	5152.0	1929.0	10274.3	6922.4	7282.3	6805.3	29321.2	0.0	6670.2	0.0	5902.5	8605.1	22503.2	2090.9	20302.5	15810.3	44494.8	0.0	0.0	0.0	19209.5	11157.0	28166.3	5603.1	9286.2	11579.8	7637.7	5553.1	0.0	9746.7	0.0	6001.1	0.0	0.0	5901.3	16542.9	7809.0	8204.1	6813.7	47697.3	33390.3	6427.3	0.0	12142.0	15068.6	7967.9	11927.7	12469.2	17772.8	8480.1	0.0	7584.6	21335.3	22667.3	15127.4
MTCH1	"CGI-64, PSAP, SLC25A49"	ENSG00000137409	"Mitochondrial carrier 1"	Q9NZJ7	6	36968141-36986298	"Predicted membrane proteins, Transporters"	"Apoptosis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 1002.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015971	Approved					NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 68: Epididymis - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA015971: AB_1854171"	"unprognostic (3.17e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.71e-1)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (1.40e-1)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.29e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.49e-2)"	"unprognostic (1.35e-3)"	"prognostic favorable (1.16e-7)"	"unprognostic (1.32e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.68e-2)"	"unprognostic (4.70e-2)"	151.0	279.7	314.7	97.4	331.9	194.1	140.2	290.1	341.2	194.5	257.9	151.7	93.7	136.3	312.1	130.8	154.2	99.6	259.7	326.1	333.3	168.1	117.2	202.5	95.4	306.1	310.3	177.3	165.4	142.1	284.8	106.0	333.1	183.1	96.4	92.0	144.2	196.5	133.7	176.6	125.2	114.7	305.1	148.7	156.2	81.1	349.0	88.2	364.1	89.0	88.6	156.4	166.2	340.8	196.3	130.8	173.3	214.0	254.7	171.9	99.0	225.3	208.2	312.1	322.1	218.0	118.3	97.1	197.7	379.8	301.8	167.1	189.2	181.8	360.2	104.5	183.9	101.3	223.4	165.4	184.1	65.7	92.1	194.5	140.5	289.7	140.5	271.8	269.3	133.0	186.1	97.5	199.8	221.4	134.3	149.8	170.1	175.2	147.5	122.9	135.4	102.6	169.1	160.5	278.8	119.9	163.9	141.2	206.8	173.6	182.5	181.9	299.6	311.5	246.1	241.3	247.3	85.3	92.5	1002.9	112.1	179.4	250.1	11.0	34.7	45.4	14.5	34.9	13.5	18.8	27.5	29.2	31.1	31.2	26.2	15.4	37.8	18.4	44.7	17.3	22.4	17.3	314.7	331.9	290.1	341.2	326.1	333.3	306.1	310.3	333.1	305.1	349.0	340.8	133.7	48.1	99.1	47.3	79.1	113.7	177.1	138.6	71.7	0.0	152.7	125.2	162.5	117.2	101.2	69.9	0.0	183.5	91.8	149.9	168.3	213.0	8.2	99.0	139.4	112.3	149.3	67.6	54.1	170.0	224.0	163.4	94.3	177.3	29.2	193.6	85.6	50.9	189.2	0.0	52.8	133.0	105.8	97.2	150.6	16.3	138.2	109.5	136.9	44.0	173.2	0.0	55.6	28.1	106.4	181.7	162.3	132.4	57.6	255.0	144.3	129.4	68.0	0.0	52.6	108.8	133.5	18.5	46.4	86.2	123.5	248.3	85.8	118.5	145.1	208.5
MTCH2	SLC25A50	ENSG00000109919	"Mitochondrial carrier 2"	Q9Y6C9	11	47617315-47642607	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 569.2;Proximal tubular cells: 508.1;Spermatocytes: 435.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038390	Approved		Approved	Mitochondria		NA	NA		14000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 18: U-2197 - ECM organization"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA038390: AB_10669723"	"unprognostic (4.94e-2)"	"unprognostic (3.29e-1)"	"unprognostic (1.93e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.27e-1)"	"unprognostic (7.63e-3)"	"unprognostic (1.80e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"prognostic favorable (9.05e-6)"	"unprognostic (1.12e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.77e-1)"	28.8	40.3	13.2	14.1	14.1	12.6	25.3	14.3	15.7	20.5	12.7	41.7	38.9	26.8	19.4	50.3	18.9	11.9	41.0	13.8	15.1	57.3	115.3	20.0	14.7	13.3	14.0	13.6	22.6	21.2	18.5	9.9	13.7	18.3	32.7	16.2	29.8	11.9	81.8	28.7	37.6	21.4	12.8	19.6	22.6	69.8	14.7	14.6	21.6	47.5	23.0	23.2	26.1	14.9	47.8	51.2	42.9	57.9	49.7	45.8	31.6	50.5	46.1	66.7	62.6	40.9	47.2	65.4	26.8	62.3	71.7	58.5	77.7	66.4	80.9	33.0	73.4	37.5	69.3	82.5	68.2	79.1	36.1	52.1	51.5	44.3	65.8	38.6	61.1	55.1	70.9	38.0	82.9	69.3	61.1	59.5	46.4	92.4	77.0	56.1	65.4	47.0	78.5	60.6	51.0	35.7	69.1	68.8	37.1	40.3	99.2	36.4	51.2	60.9	52.9	102.4	65.8	40.5	49.3	73.2	50.4	67.7	55.7	13.3	33.8	14.1	20.3	37.6	19.6	25.1	17.7	19.2	44.0	19.5	15.1	17.6	3.2	22.2	31.5	28.9	24.0	34.1	13.2	14.1	14.3	15.7	13.8	15.1	13.3	14.0	13.7	12.8	14.7	14.9	28.4	22.4	35.9	54.9	39.2	47.0	56.0	169.3	44.9	0.0	50.7	41.3	67.8	71.4	84.0	53.3	0.0	82.8	41.2	98.1	181.9	153.3	569.2	48.8	37.5	31.6	79.8	74.6	47.0	109.4	119.1	40.0	46.4	40.1	37.3	29.3	33.2	289.4	164.2	0.0	50.9	97.0	150.5	65.7	40.3	166.5	28.9	67.5	81.8	22.5	103.9	0.0	30.9	58.8	58.6	93.0	69.7	58.3	70.9	84.9	213.3	508.1	79.0	0.0	32.9	30.0	141.3	435.4	104.4	129.8	54.1	127.8	34.5	74.4	165.5	65.2
MTNR1A	MEL-1A-R	ENSG00000168412	"Melatonin receptor 1A"	P48039	4	186533655-186555567	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.0;intestine: 1.2;kidney: 2.1;testis: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	9	"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"						"unprognostic (7.99e-2)"			"unprognostic (2.27e-1)"		"unprognostic (2.16e-1)"		"unprognostic (3.67e-1)"	"unprognostic (2.14e-1)"	"unprognostic (9.88e-2)"	"unprognostic (9.20e-2)"	"unprognostic (8.81e-2)"				0.0	0.0	0.0	0.6	0.1	0.0	0.0	1.0	0.1	0.0	0.0	1.2	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
MUSK		ENSG00000030304	"Muscle associated receptor tyrosine kinase"	O15146	9	110668779-110806558	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation	"Developmental protein, Kinase, Muscle protein, Receptor, Transferase, Tyrosine-protein kinase"	"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.2;skeletal muscle: 4.1"	"Cell type enhanced"	"Detected in some"		"Late spermatids: 4.8;Leydig cells: 5.3;Oligodendrocytes: 17.0;Peritubular cells: 19.5;Skeletal myocytes: 23.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"LHCN-M2: 24.7;RH-30: 23.7"	"Region enhanced"	"Detected in some"		"basal ganglia: 5.0"	"Not detected"	"Not detected"									NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 50: Fibroblasts - ECM organization"				"unprognostic (6.12e-2)"	"unprognostic (9.01e-2)"	"unprognostic (5.39e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.14e-1)"	"unprognostic (1.20e-2)"		"unprognostic (1.50e-2)"		"unprognostic (2.46e-1)"	"unprognostic (3.13e-1)"	"unprognostic (7.58e-2)"	"unprognostic (6.03e-5)"	"unprognostic (4.58e-2)"	"unprognostic (1.62e-1)"	"unprognostic (9.67e-2)"	"unprognostic (5.11e-2)"	0.1	0.2	1.5	1.7	3.0	0.0	0.0	0.8	1.5	0.0	1.6	1.9	1.1	0.0	0.0	1.4	0.0	1.1	1.5	1.2	1.1	0.0	0.3	1.0	0.6	2.7	6.2	0.1	0.1	0.0	0.0	0.3	1.7	0.2	2.5	0.0	0.1	0.0	4.1	0.1	2.4	0.5	2.9	0.0	1.3	1.6	2.0	0.1	0.0	2.0	2.0	1.2	0.0	4.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	24.7	0.0	0.0	0.0	0.5	0.0	0.2	0.0	23.7	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	0.8	1.5	1.2	1.1	2.7	6.2	1.7	2.9	2.0	4.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.5	0.0	0.3	0.1	0.0	0.0	1.3	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.8	5.3	0.0	0.0	1.9	0.0	0.0	0.0	2.5	17.0	0.0	0.0	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.1	0.5	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0
MVP	"LRP, VAULT1"	ENSG00000013364	"Major vault protein"	Q14764	16	29820394-29848039	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	Ribonucleoprotein	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 504.7;Exocrine glandular cells: 310.8;Paneth cells: 338.3;Proximal enterocytes: 514.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 429.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002321, CAB002752, CAB022717, HPA064740"	Enhanced		Supported	Cytosol		NA	NA		110000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"CAB002752: , CAB022717: , HPA002321: AB_1079277, HPA064740: AB_2685342"	"prognostic favorable (4.51e-4)"	"unprognostic (1.06e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.80e-1)"	"unprognostic (8.17e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.11e-2)"	"unprognostic (2.22e-2)"	"unprognostic (6.03e-3)"	"unprognostic (2.19e-1)"	"unprognostic (6.85e-3)"	"unprognostic (2.86e-1)"	"prognostic favorable (5.49e-5)"	"unprognostic (2.22e-1)"	"unprognostic (5.19e-2)"	"unprognostic (5.69e-3)"	"unprognostic (2.65e-2)"	84.4	181.7	26.2	96.0	35.7	46.4	71.0	29.9	33.7	76.6	32.5	165.6	154.7	73.1	14.3	75.4	73.3	74.3	64.4	26.0	31.9	113.4	66.9	121.9	71.1	43.1	36.4	103.3	101.9	18.9	47.5	38.0	35.5	59.7	96.5	6.3	77.1	38.9	50.6	61.1	158.9	69.0	32.6	114.0	107.8	39.4	42.3	31.3	60.6	32.4	47.6	80.0	72.9	38.3	64.8	191.8	0.8	1.7	212.0	275.0	25.9	163.4	258.5	88.0	121.4	24.7	216.8	3.1	134.9	231.0	108.9	78.1	0.8	129.5	42.2	166.4	1.8	3.0	81.6	87.6	190.1	2.3	60.2	366.9	96.1	207.0	58.3	170.5	274.5	6.2	0.5	92.1	167.7	18.3	0.8	4.3	2.4	93.4	11.6	2.1	0.7	32.5	229.1	114.6	10.5	7.6	41.8	53.8	31.8	6.5	9.5	18.7	429.3	124.2	59.4	119.9	62.0	66.6	45.1	2.7	294.6	4.8	24.9	50.4	140.8	56.3	70.9	214.3	55.1	36.6	80.7	73.6	113.1	27.2	59.4	54.0	160.0	73.7	204.0	69.2	90.7	164.4	26.2	35.7	29.9	33.7	26.0	31.9	43.1	36.4	35.5	32.6	42.3	38.3	34.2	48.1	115.5	9.8	31.2	19.6	39.3	120.3	16.5	4.8	17.9	10.0	12.9	82.9	112.0	69.9	2.1	113.6	31.2	504.7	45.0	272.7	4.9	43.9	25.9	40.9	56.5	8.6	3.2	310.8	71.4	52.8	120.8	65.9	33.7	14.8	36.4	23.8	78.0	8.4	3.4	177.1	95.6	41.0	27.1	21.1	57.5	55.0	32.0	9.4	223.3	3.0	59.8	0.0	23.1	278.5	338.3	47.8	36.4	25.0	514.8	194.8	110.3	4.9	19.7	23.8	51.3	2.7	1.8	20.7	21.9	264.5	45.1	24.7	206.8	56.7
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361999-41409393	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Antiviral defense, Immunity, Innate immunity, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 30.4"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.1;Gastric mucus-secreting cells: 40.8;Macrophages: 57.6;monocytes: 42.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 150.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 150.8"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 143.6;BJ hTERT+ SV40 Large T+ RasG12V: 136.9;MOLT-4: 56.8;U-266/84: 84.2;U-937: 90.6"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain					NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"	12.5	1.4	0.5	16.3	0.6	13.2	9.7	0.6	1.0	11.9	0.6	5.3	6.8	2.5	0.9	6.0	5.0	13.4	7.1	0.6	0.6	3.4	2.3	6.7	14.2	3.5	1.3	3.3	2.4	1.5	1.4	5.0	1.6	2.7	2.9	0.0	5.9	1.6	2.4	4.8	9.5	5.8	4.5	24.8	13.1	2.3	1.0	30.4	4.4	4.2	14.0	14.8	6.7	1.3	0.3	0.0	0.0	0.0	3.4	6.5	0.0	0.0	19.9	143.6	136.9	0.0	31.1	0.0	0.0	1.9	27.6	0.0	0.0	0.0	4.9	1.1	0.0	30.4	0.0	20.3	0.8	1.1	0.0	11.9	0.0	2.7	0.0	0.0	0.0	0.9	1.4	18.3	0.0	0.0	56.8	23.0	36.1	7.1	0.0	8.6	0.0	4.5	0.0	3.8	0.0	0.0	2.4	0.0	2.5	0.0	0.0	24.6	0.0	0.0	0.0	0.0	0.0	0.0	84.2	1.2	3.9	90.6	15.3	6.0	31.4	24.4	11.7	37.5	14.7	13.8	19.0	14.1	22.6	11.5	19.1	13.2	150.8	7.4	35.9	10.8	16.3	21.8	0.5	0.6	0.6	1.0	0.6	0.6	3.5	1.3	1.6	4.5	1.0	1.3	32.1	6.4	7.1	0.0	28.4	4.1	2.2	1.2	2.2	0.1	1.8	2.3	3.7	0.0	9.8	1.8	0.0	0.4	27.2	1.4	1.9	0.8	0.5	0.9	9.5	15.6	3.0	1.3	1.0	2.9	1.3	19.7	40.8	0.9	12.6	1.0	3.3	0.2	15.1	0.0	0.4	3.2	0.0	28.6	27.4	1.7	6.8	57.6	10.6	5.6	42.4	0.2	24.7	1.0	0.3	5.2	1.1	4.1	10.3	2.7	4.6	0.1	9.1	0.3	26.3	2.6	11.1	1.4	7.3	3.5	1.4	0.3	30.3	2.2	2.1	5.8
MYADM		ENSG00000179820	"Myeloid associated differentiation marker"	Q96S97	19	53864763-53876435	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 207.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA056301			Approved	"Nuclear speckles"		NA	NA		27000	"Cluster 52: Eosinophils - Transcription"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 24: Non-specific - Transcription regulation"	"Nuclear speckles"		"HPA056301: "	"unprognostic (5.17e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (2.94e-1)"	"unprognostic (6.41e-2)"	"unprognostic (1.01e-2)"	"unprognostic (8.21e-3)"	"prognostic unfavorable (8.15e-4)"	"unprognostic (3.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.52e-1)"	"unprognostic (4.11e-1)"	"prognostic unfavorable (7.71e-7)"	"unprognostic (2.28e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.37e-2)"	"unprognostic (6.14e-3)"	179.4	25.7	21.5	66.5	20.2	196.3	82.4	3.1	21.6	97.4	24.6	155.6	48.9	248.6	22.2	76.8	146.5	124.6	92.3	16.7	22.2	19.8	46.4	110.7	37.2	16.9	24.7	73.4	101.1	31.1	17.9	89.6	13.7	75.0	39.9	3.6	48.8	100.9	36.7	45.2	63.8	180.9	6.4	42.5	79.5	28.4	17.3	37.1	57.8	21.1	15.2	104.6	64.8	18.8	28.8	231.6	29.2	23.3	96.2	66.0	45.3	145.9	105.9	57.0	58.7	94.4	84.1	2.6	53.7	187.4	61.6	56.4	14.6	56.7	48.5	34.9	34.2	38.0	35.8	75.6	219.2	78.4	131.3	72.3	12.7	73.4	10.5	93.4	52.0	14.9	41.5	68.7	36.4	32.0	21.4	60.9	27.9	104.3	65.3	82.1	31.0	13.3	63.8	3.0	0.4	43.8	1.2	44.6	14.1	58.4	44.4	66.8	105.5	125.8	44.5	17.0	66.2	44.7	29.9	0.6	78.4	37.1	2.1	74.3	48.1	165.5	20.9	27.1	19.6	5.4	13.4	15.2	59.5	7.1	12.5	11.0	207.4	17.8	23.5	22.3	5.4	20.0	21.5	20.2	3.1	21.6	16.7	22.2	16.9	24.7	13.7	6.4	17.3	18.8	125.9	163.5	59.1	2.9	138.9	103.0	173.3	73.1	96.8	4.1	141.0	105.8	67.1	97.2	91.5	20.2	4.2	46.2	143.3	43.8	0.0	106.6	2.7	97.0	164.1	117.2	202.4	35.7	9.1	51.8	243.9	279.7	83.1	195.5	347.6	27.0	182.8	18.5	73.5	10.1	8.3	203.9	24.4	120.4	217.2	2.2	90.1	180.3	60.5	11.2	68.0	4.0	19.6	7.1	13.9	71.4	54.7	116.6	189.9	56.6	2.7	0.5	57.0	1.4	151.2	340.1	199.0	35.9	14.5	19.7	59.8	49.5	221.5	20.5	93.8	75.0
MYMK	"TMEM226, TMEM8C"	ENSG00000187616	"Myomaker, myoblast fusion factor"	A6NI61	9	133514586-133528612	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Myogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	32	"HSkMC: 15.2;RH-30: 7.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA051846, HPA055785"	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA051846: AB_2681636, HPA055785: AB_2682920"						"unprognostic (9.17e-3)"	"unprognostic (8.63e-2)"	"unprognostic (3.76e-1)"		"unprognostic (1.13e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.37e-1)"	"unprognostic (9.32e-2)"			"unprognostic (1.91e-1)"		0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.5	0.2	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.4	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.1	0.5	0.2	0.1	0.5	0.2	0.4	0.2	0.0	1.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
MYO1C	myr2	ENSG00000197879	"Myosin IC"	O00159	17	1464186-1492686	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"	"Actin-binding, Calmodulin-binding, Motor protein, Myosin"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001768, HPA005924, CAB037023"	Enhanced		Enhanced	"Nuclear bodies,Plasma membrane"		NA	NA		3800000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear bodies, Plasma membrane"		"CAB037023: AB_477180, HPA001768: AB_1854252, HPA005924: AB_2667469"	"unprognostic (3.60e-1)"	"unprognostic (4.71e-3)"	"unprognostic (2.89e-1)"	"unprognostic (2.96e-3)"	"unprognostic (1.38e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (4.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (2.48e-1)"	"unprognostic (3.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (5.02e-2)"	"unprognostic (4.66e-2)"	"unprognostic (4.93e-2)"	"unprognostic (3.47e-2)"	169.3	27.0	12.4	34.4	11.8	4.9	115.9	13.3	12.7	77.4	17.1	104.9	47.4	97.1	21.5	64.7	66.4	46.1	97.5	10.2	14.7	56.8	39.5	87.2	24.1	14.8	11.2	43.6	69.3	34.3	22.9	56.9	14.6	69.9	41.7	2.1	91.7	58.2	49.5	57.7	65.6	65.7	11.9	30.8	76.3	17.1	13.7	21.3	60.6	35.8	25.1	86.3	67.8	10.8	169.8	182.1	19.3	79.5	88.8	87.6	74.2	168.6	138.9	108.7	91.0	122.3	90.7	16.9	118.7	261.1	72.7	139.9	29.2	117.2	56.3	75.2	74.5	16.2	96.4	46.2	131.7	1.6	81.5	68.7	57.3	100.2	57.3	99.5	141.7	10.5	13.1	13.7	93.5	129.5	1.9	1.4	12.4	105.8	34.0	6.9	26.4	30.7	100.5	86.9	7.8	43.0	105.9	152.6	67.4	47.5	125.3	8.7	187.9	156.6	119.1	77.7	147.8	10.7	9.1	7.2	124.7	4.1	138.8	0.1	0.9	0.0	0.9	2.0	0.4	4.8	2.1	0.9	1.1	3.8	0.7	0.4	0.5	0.0	1.7	1.0	1.9	1.5	12.4	11.8	13.3	12.7	10.2	14.7	14.8	11.2	14.6	11.9	13.7	10.8	133.7	125.0	35.9	5.5	20.8	39.8	38.2	27.8	31.9	4.1	44.0	33.0	75.4	48.6	36.3	86.5	0.0	57.8	2.5	159.0	21.5	62.3	17.4	26.3	44.4	78.0	39.5	13.5	2.5	52.0	28.4	51.8	66.3	75.5	12.0	25.4	83.6	38.5	20.0	5.0	3.8	111.8	14.2	14.5	43.4	11.4	42.3	16.7	64.0	15.0	20.3	5.6	0.0	2.5	1.0	92.8	88.7	48.5	12.8	64.7	92.8	15.4	12.9	2.1	118.3	37.7	90.6	9.4	7.5	39.5	42.6	47.6	10.0	10.6	88.1	39.2
MYOF	"FER1L3, KIAA1207"	ENSG00000138119	Myoferlin	Q9NZM1	10	93306429-93482334	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 123.4;Pancreatic endocrine cells: 153.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 20.4;non-classical monocyte: 26.6"	"Group enriched"	"Detected in many"	57	"dendritic cells: 8.1;monocytes: 26.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 452.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014245	Enhanced		Supported	"Vesicles,Plasma membrane"		NA	NA		190000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles	"Plasma membrane"	"HPA014245: AB_1848495"	"unprognostic (3.41e-2)"	"unprognostic (3.85e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.57e-3)"	"unprognostic (3.48e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (1.40e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.74e-3)"	"unprognostic (1.87e-1)"	"unprognostic (1.94e-2)"	"unprognostic (9.17e-2)"	"unprognostic (9.18e-2)"	31.7	8.1	2.9	20.6	4.1	1.5	43.3	5.0	2.5	56.4	37.4	22.4	5.3	27.5	7.1	36.4	36.9	26.6	13.8	3.4	4.1	10.9	2.9	32.2	4.4	8.9	6.8	9.8	5.9	23.8	3.8	55.2	8.1	27.5	29.3	0.9	19.7	31.4	3.6	56.1	9.0	44.3	6.2	6.5	13.4	2.2	5.4	5.1	35.7	6.2	9.1	62.0	29.4	6.2	228.9	206.3	21.4	14.6	159.4	318.4	62.0	190.3	452.7	110.1	109.2	51.1	177.1	0.0	76.9	353.7	116.2	350.0	1.8	204.7	82.6	1.4	0.9	0.0	80.8	2.1	55.2	0.0	0.2	183.0	71.6	77.7	323.8	289.4	299.7	0.0	0.0	0.5	275.6	39.4	0.1	0.9	1.6	72.0	171.6	0.0	15.8	0.1	314.3	281.5	0.1	0.0	130.4	29.7	46.1	83.1	141.5	4.7	378.5	167.3	11.8	111.3	113.9	0.2	0.3	0.3	128.2	2.6	201.0	0.0	5.4	0.0	0.0	20.4	0.0	0.0	0.0	0.0	8.1	0.0	0.0	0.0	0.3	0.0	26.6	2.8	0.2	1.6	2.9	4.1	5.0	2.5	3.4	4.1	8.9	6.8	8.1	6.2	5.4	6.2	42.5	60.9	52.5	1.6	1.2	23.7	63.0	101.4	39.3	0.1	48.4	34.3	9.2	14.3	91.5	22.0	0.0	56.6	3.8	74.1	1.9	54.8	0.6	50.9	45.9	28.8	1.8	0.0	2.7	33.7	23.7	38.1	23.0	123.4	1.3	1.7	35.7	0.4	22.9	0.0	0.8	29.6	42.7	29.2	20.2	0.6	5.9	28.5	8.8	60.0	12.8	0.1	0.0	2.0	0.7	153.7	22.2	9.1	0.8	86.7	0.6	1.5	60.7	0.8	6.6	15.9	39.6	0.1	0.3	53.4	30.7	51.2	1.9	8.3	18.7	100.7
NALCN	"bA430M15.1, CanIon, VGCNL1"	ENSG00000102452	"Sodium leak channel, non-selective"	Q8IZF0	13	101053776-101416508	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.1"	"Group enriched"	"Detected in some"	10	"Astrocytes: 125.4;Excitatory neurons: 265.8;Inhibitory neurons: 277.4;Oligodendrocyte precursor cells: 324.7;Oligodendrocytes: 477.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"basophil: 2.6"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.6"	"Cell line enhanced"	"Detected in many"		"HaCaT: 14.2;HHSteC: 14.4;hTERT-RPE1: 11.0;TIME: 19.8;U-87 MG: 11.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031889, HPA031890, HPA031958"	Approved					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA031889: AB_10669638, HPA031890: AB_10696056, HPA031958: AB_10601039"	"unprognostic (4.66e-1)"	"unprognostic (6.55e-3)"	"unprognostic (1.86e-3)"	"unprognostic (6.78e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.37e-3)"	"unprognostic (8.11e-2)"	"unprognostic (2.60e-1)"	"unprognostic (7.72e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.18e-1)"	"unprognostic (1.58e-5)"	"unprognostic (1.77e-3)"	"unprognostic (5.44e-2)"	"unprognostic (4.56e-2)"	"unprognostic (1.92e-2)"	0.5	4.3	7.5	0.4	9.8	0.6	2.7	6.4	10.3	1.5	0.0	0.4	0.6	0.5	1.5	0.2	1.0	2.3	3.3	8.6	10.2	0.3	1.2	1.1	0.3	8.2	5.8	2.8	1.3	2.9	6.8	3.0	7.0	0.3	0.6	6.1	0.8	1.0	0.3	0.5	0.5	0.5	6.8	0.4	0.7	0.6	8.3	0.0	2.4	0.2	0.1	0.5	0.2	13.1	0.1	7.8	1.4	0.2	0.7	0.3	0.1	0.8	0.8	1.8	0.4	0.2	8.9	0.0	0.3	3.6	0.8	14.2	0.0	2.2	5.5	0.0	1.2	0.4	3.8	0.1	14.4	0.2	0.3	0.4	0.5	1.7	4.6	11.0	8.2	0.1	0.1	0.4	5.9	0.0	0.1	0.0	0.4	1.3	1.8	0.0	0.0	0.0	4.6	1.9	1.2	0.6	0.1	0.0	0.8	0.9	0.2	0.1	19.8	0.4	0.1	0.3	1.8	0.1	0.1	0.1	11.4	0.1	0.3	2.6	0.1	0.2	0.3	0.0	0.1	0.2	0.1	0.1	0.0	0.3	0.2	0.1	0.5	0.2	0.1	0.2	0.1	0.1	7.5	9.8	6.4	10.3	8.6	10.2	8.2	5.8	7.0	6.8	8.3	13.1	0.1	0.0	0.0	125.4	0.0	0.3	0.0	0.3	0.6	15.4	3.5	4.6	6.2	0.0	0.1	0.0	6.2	1.0	0.0	0.0	0.0	0.8	4.5	0.1	0.2	0.6	0.0	0.0	265.8	0.2	0.2	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	26.9	277.4	0.0	0.0	0.0	0.0	0.9	0.3	0.1	0.0	23.4	0.0	2.0	0.0	324.7	477.4	0.3	0.0	1.9	0.0	0.0	0.0	0.1	0.0	2.6	0.0	3.6	0.5	0.2	0.8	0.0	0.1	0.5	0.0	0.1	0.0	0.0
NCBP1	"CBP80, NCBP, Sto1"	ENSG00000136937	"Nuclear cap binding protein subunit 1"	Q09161	9	97633668-97673748	"Predicted intracellular proteins, Transporters"	"mRNA capping, mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042411, HPA049031"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		25000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 59: Non-specific - Transcription"	Cytosol	Nucleoplasm	"HPA042411: AB_2677985, HPA049031: AB_2680606"	"unprognostic (4.76e-3)"	"unprognostic (2.16e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (4.63e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.14e-3)"	"unprognostic (1.53e-2)"	"unprognostic (3.26e-2)"	"unprognostic (9.46e-2)"	"unprognostic (3.16e-1)"	"prognostic unfavorable (4.17e-4)"	"unprognostic (4.11e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.17e-1)"	"unprognostic (7.04e-2)"	10.9	11.0	11.9	16.0	13.7	29.5	11.7	28.3	13.6	10.5	13.7	15.4	12.7	11.7	10.0	12.3	8.8	11.4	12.2	11.8	11.8	11.0	16.6	9.7	19.8	11.6	11.1	12.7	13.2	10.1	10.5	14.6	11.7	12.2	17.9	30.6	10.8	10.2	18.7	15.8	12.6	11.4	11.2	13.3	13.0	16.9	10.9	21.3	15.7	14.9	18.7	14.0	10.6	17.4	57.7	40.6	44.2	41.0	30.8	30.9	41.6	41.2	25.9	40.1	37.4	54.7	30.2	49.0	17.9	41.1	38.5	62.1	72.3	51.6	57.3	33.8	22.2	45.8	58.5	34.4	30.0	60.8	43.2	23.5	25.0	47.3	35.8	28.5	42.4	35.4	68.6	27.0	68.5	43.5	44.3	33.5	46.4	85.4	39.8	41.9	100.4	20.4	33.0	42.9	55.2	35.4	44.2	38.5	23.5	37.9	23.7	38.7	35.2	31.1	28.0	61.9	44.5	21.7	34.3	25.7	27.3	48.6	40.9	14.0	10.0	9.4	7.2	13.4	8.0	5.3	7.7	7.2	12.7	6.5	6.6	8.0	2.9	12.7	13.9	4.5	7.9	7.4	11.9	13.7	28.3	13.6	11.8	11.8	11.6	11.1	11.7	11.2	10.9	17.4	9.8	6.4	11.1	34.9	13.9	13.6	6.8	9.3	13.1	21.9	7.9	5.6	23.4	10.0	13.7	9.2	20.9	13.7	9.7	16.0	3.9	8.9	20.3	12.2	16.7	10.4	9.1	21.4	26.1	6.9	15.0	11.7	17.3	13.2	8.2	12.8	7.1	16.5	11.3	21.9	25.5	12.1	14.2	12.0	9.6	9.8	6.5	12.0	5.4	12.2	15.8	8.9	11.3	20.1	24.4	9.7	7.8	7.5	15.9	7.9	9.0	5.3	15.1	23.4	6.6	10.4	11.2	29.4	14.1	14.3	7.4	14.4	15.0	9.5	10.9	8.4
NCBP2	"Cbc2, CBP20, NIP1"	ENSG00000114503	"Nuclear cap binding protein subunit 2"	P52298	3	196935402-196942594	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, RNA-mediated gene silencing, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044850, HPA062483"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044850: AB_10961012, HPA062483: AB_2684779"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.04e-2)"	"unprognostic (5.12e-3)"	"unprognostic (3.17e-1)"	"unprognostic (5.13e-3)"	"prognostic unfavorable (2.37e-7)"	"unprognostic (2.86e-2)"	"unprognostic (9.63e-2)"	"unprognostic (1.83e-1)"	"prognostic unfavorable (4.75e-4)"	"prognostic unfavorable (2.27e-4)"	"unprognostic (3.28e-3)"	"unprognostic (6.38e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.30e-2)"	"unprognostic (5.04e-3)"	38.3	44.0	40.3	38.7	41.4	17.2	36.0	39.7	46.6	34.5	38.6	35.4	29.4	32.6	41.1	29.0	30.1	28.8	31.3	41.5	45.8	41.7	30.1	27.1	43.5	42.7	42.1	35.7	25.7	38.2	26.0	33.9	42.3	36.4	35.2	46.2	24.4	35.5	38.6	27.2	27.8	33.8	43.6	34.2	29.6	25.8	43.8	49.9	37.7	38.6	42.2	45.6	26.1	43.1	144.3	44.6	105.5	131.8	118.6	102.8	74.1	106.1	80.9	66.4	69.7	99.5	51.2	97.0	229.7	76.3	85.4	84.6	136.1	113.0	104.7	50.8	85.0	125.2	55.3	87.5	103.9	146.4	85.3	84.1	101.2	48.7	134.1	99.5	104.3	103.2	71.6	99.7	113.7	165.5	111.3	88.4	134.5	137.2	139.5	86.9	78.6	92.9	99.3	101.9	57.3	153.1	63.8	126.4	189.4	85.4	279.1	112.4	97.5	67.1	71.4	85.0	193.0	155.6	149.4	162.1	93.8	162.5	103.2	9.9	37.7	20.9	37.5	44.5	56.6	53.2	46.2	44.8	40.1	43.5	52.8	48.1	4.0	43.1	47.0	32.2	45.0	40.4	40.3	41.4	39.7	46.6	41.5	45.8	42.7	42.1	42.3	43.6	43.8	43.1	38.5	25.6	43.5	9.1	71.1	52.5	83.6	55.9	36.5	55.7	48.9	36.8	40.5	25.8	51.6	42.3	58.4	59.1	58.9	44.0	97.8	64.3	116.2	39.5	66.6	50.2	45.0	35.1	12.8	49.8	81.8	47.1	30.5	35.9	52.6	54.7	30.0	31.1	65.4	45.4	14.0	44.9	54.9	54.1	60.7	66.2	37.6	38.6	32.0	2.8	68.2	91.0	51.5	10.6	10.4	69.1	45.9	51.6	42.0	81.9	37.0	82.5	44.6	60.3	26.3	40.9	51.3	52.9	59.5	33.5	44.8	53.2	49.8	58.8	52.1	84.2
NCLN	"NET59, NICALIN"	ENSG00000125912	Nicalin	Q969V3	19	3185563-3209575	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 115.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006625	Approved		Approved	"Nucleoplasm,Lipid droplets"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Lipid droplets"	Nucleoplasm	"HPA006625: AB_1079453"	"unprognostic (4.32e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.19e-4)"	"unprognostic (8.55e-2)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (9.27e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.38e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.26e-3)"	"prognostic unfavorable (8.37e-5)"	"prognostic favorable (8.82e-5)"	"unprognostic (1.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (7.38e-2)"	25.8	62.4	19.7	16.2	18.5	33.3	22.3	18.6	25.2	23.1	13.9	36.5	31.1	25.9	4.3	31.0	23.4	6.9	28.0	22.2	15.7	29.5	59.8	33.1	12.7	20.4	18.8	22.0	53.6	11.0	23.5	7.5	18.6	28.9	8.7	3.5	22.9	8.0	29.2	25.8	35.8	8.6	17.4	42.8	29.7	21.8	21.1	8.6	24.4	10.5	6.6	26.3	21.7	17.5	70.8	74.2	21.6	60.3	20.3	15.4	55.4	84.5	33.2	57.5	45.5	103.6	36.8	43.3	67.0	49.4	37.8	87.2	24.7	57.1	12.7	57.4	61.3	31.7	46.2	73.2	41.1	56.8	51.3	29.0	36.2	46.4	24.7	15.2	31.7	41.7	84.1	41.4	25.6	59.3	48.9	64.1	59.3	43.2	63.6	77.8	23.2	71.9	36.5	42.6	45.3	47.1	31.1	56.2	50.3	10.3	38.3	61.9	47.6	45.4	45.8	77.3	100.4	59.0	58.1	36.0	51.1	71.5	72.7	1.4	13.4	9.8	7.1	13.1	5.8	5.4	4.3	7.9	9.2	4.5	4.6	6.2	7.6	4.8	5.6	18.8	4.2	9.6	19.7	18.5	18.6	25.2	22.2	15.7	20.4	18.8	18.6	17.4	21.1	17.5	15.3	16.0	14.7	12.1	19.8	8.3	9.4	18.2	5.7	15.1	15.6	11.9	10.2	15.7	14.8	11.0	10.4	20.4	26.0	71.0	3.9	31.0	15.0	11.3	15.6	14.3	12.6	12.4	13.6	37.4	49.3	14.9	30.5	17.4	15.9	31.1	12.8	43.8	39.3	23.5	14.6	41.2	14.2	18.8	9.2	49.1	9.3	18.1	14.2	8.4	19.2	5.8	14.4	9.0	10.3	35.8	45.3	9.1	51.7	22.0	75.7	11.7	10.5	13.2	13.1	11.8	16.9	13.6	20.1	12.4	12.5	17.0	12.0	115.1	72.7	14.2
NCOA7	"dJ187J11.3, ERAP140, TLDC4"	ENSG00000111912	"Nuclear receptor coactivator 7"	Q8NI08	6	125781161-125932034	"Predicted intracellular proteins, Transporters"	"Transcription, Transcription regulation"	Activator		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 709.7;Squamous epithelial cells: 515.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030289, HPA030290, HPA030291, HPA030292"	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 15: RT4 - Unknown function"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Nucleoplasm, Nuclear bodies"	"Golgi apparatus"	"HPA030289: AB_10670031, HPA030290: AB_10601971, HPA030291: AB_10669597, HPA030292: AB_10670834"	"unprognostic (1.01e-2)"	"unprognostic (3.21e-2)"	"unprognostic (7.32e-3)"	"unprognostic (7.27e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.67e-2)"	"unprognostic (1.26e-1)"	"unprognostic (6.27e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.14e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.37e-2)"	"prognostic favorable (1.78e-6)"	"unprognostic (2.10e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.10e-2)"	53.9	60.4	19.5	45.8	30.6	42.7	27.4	21.4	50.2	29.0	0.0	30.1	33.0	22.3	5.2	30.4	15.9	46.6	16.0	28.2	23.9	56.6	32.9	52.1	30.1	47.5	12.3	14.8	19.9	8.8	29.7	12.9	45.0	18.6	29.2	18.2	38.2	12.9	6.9	11.1	39.2	28.3	10.6	24.4	30.8	7.8	19.0	21.7	25.1	9.2	28.5	101.8	19.7	48.3	13.7	36.6	2.2	16.0	78.2	46.3	23.7	18.2	71.9	22.1	30.1	34.3	12.7	55.2	96.5	10.0	108.0	78.7	12.6	12.4	13.3	120.2	16.5	28.0	43.7	12.3	44.5	16.4	25.4	33.3	29.4	21.1	16.3	39.1	46.7	18.0	38.7	30.6	13.9	13.7	16.1	16.2	2.7	33.8	7.6	12.3	5.7	10.3	39.1	90.4	36.9	33.5	93.7	22.6	42.1	6.5	3.8	19.3	27.7	5.1	10.9	26.3	14.1	39.9	34.1	28.8	11.5	21.2	18.7	17.0	11.4	4.0	19.2	9.1	24.1	17.7	18.1	15.6	10.0	11.1	9.6	9.4	6.4	13.6	14.2	34.1	8.1	5.1	19.5	30.6	21.4	50.2	28.2	23.9	47.5	12.3	45.0	10.6	19.0	48.3	144.6	314.1	371.9	27.7	33.7	98.1	270.8	311.2	709.7	50.2	94.2	47.9	11.4	98.7	324.1	62.5	43.8	9.3	84.6	113.2	80.3	241.7	0.9	160.1	90.2	130.2	35.8	29.8	144.9	139.2	8.9	94.8	142.8	298.2	37.3	18.5	106.7	23.2	13.6	37.0	89.5	119.3	288.9	33.8	57.4	6.8	42.3	41.9	51.6	75.9	33.4	76.8	59.8	34.2	303.9	108.7	160.1	29.3	44.1	129.5	24.3	103.2	335.8	53.3	13.1	33.8	49.3	11.2	33.9	515.9	59.2	3.8	63.5	36.5	130.6	294.4
NDC1	"FLJ10407, NET3, TMEM48"	ENSG00000058804	"NDC1 transmembrane nucleoporin"	Q9BTX1	1	53765478-53838463	"Metabolic proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA069751, HPA070882"	Approved		Supported	"Nuclear membrane,Plasma membrane,Actin filaments"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 12: Non-specific - Cell cycle regulation"	"Nuclear membrane"	"Plasma membrane, Actin filaments"	"HPA069751: AB_2686189, HPA070882: AB_2686320"	"unprognostic (2.51e-1)"	"unprognostic (1.93e-1)"	"prognostic favorable (4.48e-5)"	"unprognostic (6.96e-3)"	"unprognostic (1.31e-1)"	"unprognostic (1.36e-3)"	"prognostic unfavorable (7.52e-7)"	"unprognostic (3.46e-3)"	"unprognostic (1.53e-2)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (3.58e-4)"	"unprognostic (9.27e-2)"	"unprognostic (6.22e-3)"	"unprognostic (3.00e-3)"	"unprognostic (4.38e-2)"	"unprognostic (9.24e-2)"	"unprognostic (6.07e-2)"	5.4	5.2	3.4	9.5	3.5	8.4	11.1	3.6	4.1	5.7	3.6	11.9	8.9	6.5	7.4	7.7	7.5	4.6	4.5	3.6	3.4	6.9	7.8	4.7	15.7	3.2	3.3	5.9	4.7	9.5	1.7	8.0	3.3	4.8	14.2	6.0	4.2	5.2	4.3	7.3	8.2	7.1	3.5	5.6	6.4	7.5	3.5	14.2	6.8	5.2	18.4	7.1	4.2	3.9	61.6	31.2	42.8	43.7	15.5	15.5	49.3	40.9	31.0	63.8	51.1	47.5	40.4	119.0	26.2	18.6	51.2	72.0	73.2	43.3	89.8	29.8	50.9	58.5	42.9	40.5	14.3	95.3	31.9	9.4	17.0	62.9	37.5	18.6	39.1	44.2	67.7	16.9	35.6	22.2	47.2	38.2	101.0	52.2	49.9	52.0	68.4	66.0	29.8	41.7	25.4	32.2	36.5	71.5	35.9	45.3	55.3	50.2	22.7	32.9	32.6	45.5	74.9	17.9	48.8	84.7	27.3	71.6	42.2	0.0	2.3	1.5	3.0	5.0	4.7	3.6	2.8	2.7	2.6	2.8	5.3	4.1	0.1	3.1	3.3	2.3	3.4	2.4	3.4	3.5	3.6	4.1	3.6	3.4	3.2	3.3	3.3	3.5	3.5	3.9	4.4	6.4	6.3	12.4	8.7	10.1	6.4	9.0	12.0	4.5	10.1	6.3	8.1	4.3	5.4	5.5	2.1	11.5	5.9	7.9	0.0	8.5	2.3	5.0	5.6	6.1	0.0	19.4	13.8	9.1	20.2	6.3	8.6	4.6	7.6	21.5	5.3	7.1	11.8	3.3	11.0	10.3	16.2	8.2	8.9	2.1	2.8	7.1	7.2	13.1	4.7	3.3	3.1	11.6	19.4	7.0	5.8	3.4	20.1	8.9	2.9	4.5	5.5	2.9	6.6	6.3	15.7	11.8	14.3	18.2	8.5	6.8	6.7	4.3	18.2	6.5
NEDD4	"KIAA0093, MGC176705, NEDD4-1, RPF1"	ENSG00000069869	"NEDD4 E3 ubiquitin protein ligase"	P46934	15	55826922-55993660	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Neurogenesis, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 67.6;tongue: 58.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 93.0;Alveolar cells type 2: 116.7;granulocytes: 73.2;Oligodendrocyte precursor cells: 69.9;Respiratory ciliated cells: 75.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001991, HPA039883, CAB072833"	Approved		Approved	Cytosol		NA	NA		6500	"Cluster 39: Non-specific - mRNA processing"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 11: Alveolar cells - Smell perception"	Cytosol		"CAB001991: , CAB072833: , HPA039883: AB_10795683"	"unprognostic (1.18e-1)"	"unprognostic (2.10e-2)"	"unprognostic (5.66e-3)"	"unprognostic (1.15e-1)"	"unprognostic (6.97e-2)"	"unprognostic (2.23e-1)"	"unprognostic (3.18e-3)"	"prognostic unfavorable (5.14e-4)"	"unprognostic (1.36e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.43e-2)"	"prognostic unfavorable (3.74e-6)"	"unprognostic (6.38e-3)"	"unprognostic (2.98e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.35e-2)"	6.2	3.6	1.7	4.0	2.0	6.2	6.9	1.9	2.0	5.4	1.9	5.7	4.1	7.1	2.9	4.3	3.5	5.6	4.5	1.5	2.7	6.7	27.4	5.3	3.1	2.5	1.9	4.0	1.8	5.4	2.1	15.6	2.6	5.5	4.4	4.5	3.1	7.6	67.6	9.2	8.1	8.0	2.0	4.9	3.4	1.8	2.2	5.6	7.1	58.1	3.0	5.6	4.4	2.6	21.5	32.8	9.0	8.8	11.5	18.5	14.1	40.0	62.9	29.1	28.5	14.5	6.3	4.8	10.4	15.4	70.2	34.6	9.7	26.3	48.2	11.1	5.6	26.1	7.2	7.9	59.0	10.6	2.3	30.8	64.7	35.2	58.9	14.2	24.3	14.9	11.5	0.0	86.4	10.7	15.2	0.1	2.2	10.9	5.1	10.5	67.5	3.1	11.9	42.3	0.7	5.1	17.4	12.5	15.7	15.8	15.2	8.8	84.5	63.9	20.6	13.5	66.0	3.4	8.1	12.3	42.0	24.6	15.7	0.0	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.2	0.2	0.1	0.1	1.7	2.0	1.9	2.0	1.5	2.7	2.5	1.9	2.6	2.0	2.2	2.6	35.9	93.0	116.7	28.4	1.6	12.1	3.4	5.5	8.6	0.7	4.6	8.0	5.7	7.2	44.8	0.0	22.9	23.2	2.0	5.2	1.9	3.3	1.7	1.7	13.3	31.1	0.0	17.5	4.2	5.8	7.5	18.5	5.1	1.6	73.2	4.2	17.5	20.5	4.7	0.0	11.9	4.0	2.0	2.2	2.3	1.6	5.6	8.8	1.8	30.0	1.1	8.6	6.2	69.9	28.7	2.9	0.8	7.2	1.9	4.5	25.8	13.4	75.5	6.7	0.0	11.5	17.7	5.3	7.2	7.1	10.4	13.8	9.4	4.8	5.6	1.9
NEK6	SID6-1512	ENSG00000119408	"NIMA related kinase 6"	Q9HC98	9	124257606-124353307	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Cell division, Chromosome partition, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 121.0;Hofbauer cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HMC-1: 250.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB045993, HPA056828"	Approved		Supported	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Cytosol"	"Centriolar satellite"	"CAB045993: AB_2150651, HPA056828: AB_2683250"	"unprognostic (6.27e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.15e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.22e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.13e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.30e-2)"	"unprognostic (1.38e-3)"	"unprognostic (6.53e-2)"	"unprognostic (5.03e-3)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (7.66e-4)"	"unprognostic (5.27e-2)"	"unprognostic (4.77e-3)"	18.0	6.1	33.5	32.6	34.3	19.6	14.7	28.1	32.4	26.1	26.5	22.3	17.5	12.2	3.4	8.5	11.2	25.4	7.4	31.8	37.0	17.2	68.2	24.3	27.4	49.8	41.2	9.0	16.7	1.9	6.1	30.2	33.9	19.6	22.5	11.3	20.6	16.7	8.2	5.4	25.8	18.7	34.4	16.6	27.1	7.8	44.2	10.2	7.3	3.1	31.7	24.3	6.4	30.4	31.8	50.0	47.8	18.8	88.3	113.9	59.3	38.8	61.1	58.4	48.4	47.7	57.0	38.2	61.0	74.6	133.2	5.9	24.7	111.7	39.4	43.7	21.8	104.4	42.1	85.4	105.2	19.4	250.0	152.8	17.8	55.4	56.9	152.3	64.3	17.6	19.5	1.7	105.6	32.6	0.9	20.8	12.2	163.7	45.5	40.6	35.6	19.6	62.6	11.4	21.4	7.5	12.6	23.6	54.5	48.3	51.4	76.4	127.5	42.2	42.8	29.5	26.7	8.4	11.4	21.6	53.5	42.3	57.5	28.1	47.6	76.4	9.2	32.1	5.9	52.5	5.5	7.8	29.0	30.2	0.9	3.8	58.8	23.3	41.4	26.9	7.6	21.6	33.5	34.3	28.1	32.4	31.8	37.0	49.8	41.2	33.9	34.4	44.2	30.4	8.4	9.6	4.7	37.9	24.5	2.4	13.8	18.9	4.6	1.0	9.4	6.5	3.3	18.6	8.8	3.7	0.0	47.1	11.3	8.5	1.9	41.3	18.2	9.4	17.7	8.4	6.0	4.0	8.3	23.3	121.0	11.1	19.4	22.2	22.2	1.1	5.0	43.5	112.0	0.0	5.3	18.2	18.3	10.4	22.5	20.0	5.0	31.2	7.2	12.2	57.7	34.6	8.2	15.1	2.4	30.6	11.9	3.8	5.5	17.1	17.2	38.0	3.3	2.1	0.0	4.9	6.4	1.3	17.1	2.4	1.1	36.1	4.5	2.1	18.7	10.2
NEK7		ENSG00000151414	"NIMA related kinase 7"	Q8TDX7	1	198156994-198322420	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"		"Kinase, Serine/threonine-protein kinase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 140.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 172.6;Oligodendrocyte precursor cells: 131.2;Oligodendrocytes: 153.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ: 554.5;fHDF/TERT166: 753.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015520, HPA018193"	Approved		Supported	Nucleoplasm		Yes	No			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA015520: AB_1854371, HPA018193: AB_1854372"	"unprognostic (2.08e-1)"	"unprognostic (2.98e-2)"	"unprognostic (1.65e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.00e-2)"	"unprognostic (2.14e-2)"	"unprognostic (5.47e-2)"	"unprognostic (4.77e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.46e-3)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.56e-1)"	63.8	49.9	48.3	29.3	58.7	11.1	27.7	45.9	53.3	26.1	35.7	30.0	21.1	26.6	19.7	31.2	22.3	27.2	140.4	39.5	56.1	29.3	30.0	41.6	30.8	61.1	51.3	29.6	20.3	25.1	12.3	42.1	60.0	27.1	23.3	19.6	22.3	36.5	56.6	14.9	25.3	32.2	59.7	32.1	20.1	13.7	49.1	27.7	26.8	63.7	23.6	30.9	20.1	64.2	47.8	12.3	14.8	6.0	37.5	42.6	17.4	554.5	227.6	218.7	102.9	23.0	46.2	17.1	39.4	753.3	12.6	29.0	22.7	30.3	220.8	56.0	32.7	23.6	48.7	9.6	45.3	40.2	46.3	26.7	25.3	144.8	43.5	82.2	42.4	140.0	18.8	41.2	102.3	15.1	34.7	23.4	8.4	37.5	9.9	18.5	36.5	30.7	37.3	24.5	9.5	17.0	92.1	53.0	63.5	20.6	38.8	36.0	95.7	61.8	52.0	178.6	58.9	29.3	28.5	11.8	26.9	36.3	48.7	1.8	2.2	3.3	2.9	1.8	12.8	1.4	3.2	4.1	2.0	1.9	2.7	3.1	6.0	3.6	1.6	1.3	6.0	1.4	48.3	58.7	45.9	53.3	39.5	56.1	61.1	51.3	60.0	59.7	49.1	64.2	34.3	28.9	30.7	78.0	32.4	51.4	15.0	10.2	33.6	8.2	22.8	18.2	172.6	10.0	18.7	18.4	14.6	15.0	32.9	25.8	11.7	10.6	2.8	21.6	20.9	29.3	19.8	32.6	17.0	19.6	15.9	30.0	18.8	19.6	8.8	11.8	40.4	23.5	17.5	3.3	34.6	19.5	8.2	49.5	51.6	3.3	29.2	35.5	30.2	124.6	29.0	11.4	15.5	131.2	153.5	50.1	19.3	38.4	28.5	30.6	25.1	16.6	27.9	24.2	19.7	28.1	35.9	7.7	6.0	29.2	49.2	64.3	41.6	28.7	15.6	33.1
NEK9	"DKFZp434D0935, MGC16714, Nek8, NERCC, NERCC1"	ENSG00000119638	"NIMA related kinase 9"	Q8TD19	14	75079353-75127344	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"	"Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001405	Approved					NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 59: Non-specific - Transcription"			"HPA001405: AB_1079467"	"unprognostic (1.00e-1)"	"unprognostic (5.37e-2)"	"unprognostic (9.97e-3)"	"unprognostic (2.64e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.77e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.60e-3)"	"unprognostic (2.81e-1)"	"unprognostic (1.15e-1)"	"prognostic favorable (5.63e-4)"	"unprognostic (8.58e-2)"	"unprognostic (1.36e-2)"	"unprognostic (4.54e-2)"	"unprognostic (9.22e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.57e-2)"	24.2	18.5	6.7	18.6	8.4	11.8	17.3	7.5	7.9	24.3	9.0	14.3	15.5	26.0	10.5	17.8	25.2	17.9	37.2	6.1	7.8	18.4	21.0	18.8	21.0	8.2	7.7	35.8	16.0	34.2	3.1	21.2	7.9	23.5	16.3	16.5	12.4	28.1	43.6	8.1	16.9	32.2	7.5	19.7	13.1	20.4	7.7	28.3	19.7	36.9	23.5	16.3	2.9	9.1	21.3	30.8	44.8	45.4	86.3	88.8	37.9	32.4	54.6	29.7	29.4	25.5	24.7	52.7	0.1	54.2	23.1	31.8	45.0	27.0	38.5	38.2	16.8	23.0	27.3	17.3	48.6	10.8	26.8	76.6	32.8	31.8	26.7	71.6	46.1	36.2	23.8	31.4	40.2	4.8	35.5	11.5	21.9	43.3	18.8	53.5	49.4	23.9	21.3	28.2	19.5	41.3	39.5	19.3	30.0	50.4	41.7	37.6	46.3	30.2	12.7	31.5	15.8	34.3	36.5	49.6	24.9	24.8	26.4	3.4	3.5	3.1	2.5	3.4	4.0	1.3	2.4	2.3	5.0	1.9	3.1	2.8	1.2	3.3	2.5	1.1	1.5	2.9	6.7	8.4	7.5	7.9	6.1	7.8	8.2	7.7	7.9	7.5	7.7	9.1	15.3	12.8	30.2	49.3	21.2	8.8	7.7	6.6	21.1	16.8	14.5	12.4	55.7	12.8	14.8	11.0	35.5	17.4	11.1	10.2	7.9	6.9	11.9	13.3	23.1	17.6	5.4	16.2	31.3	4.9	16.2	18.1	10.7	10.4	16.4	36.8	17.9	30.3	13.9	13.5	35.9	10.7	6.1	18.6	11.8	8.3	24.8	17.0	3.6	30.9	16.0	12.0	15.5	41.2	59.5	5.3	11.7	26.4	14.7	7.4	13.1	8.4	17.4	23.1	0.0	18.9	16.7	28.8	13.9	17.4	10.2	14.0	16.5	20.8	10.5	5.6
NEMP1	"KIAA0286, TMEM194, TMEM194A"	ENSG00000166881	"Nuclear envelope integral membrane protein 1"	O14524	12	57055643-57088063	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 22.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014394	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 12: Non-specific - Cell cycle regulation"	Nucleoplasm		"HPA014394: AB_2204899"	"unprognostic (9.24e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (4.57e-3)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (8.36e-2)"	"unprognostic (2.42e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (6.61e-2)"	"prognostic unfavorable (1.09e-5)"	"unprognostic (2.31e-2)"	"unprognostic (9.51e-2)"	"unprognostic (2.63e-2)"	"unprognostic (7.05e-2)"	6.2	5.1	3.3	8.0	3.5	6.8	6.3	3.6	3.9	6.6	3.7	8.7	3.8	8.2	5.3	5.6	6.3	4.3	3.0	3.2	3.3	4.3	6.1	6.3	12.2	3.3	3.2	7.2	4.0	3.7	3.5	7.8	3.7	6.8	6.8	9.3	4.5	5.2	2.3	10.8	7.5	7.4	3.3	7.3	5.4	7.7	3.2	16.1	5.4	3.0	11.6	6.5	5.7	4.2	20.0	16.8	37.5	40.5	12.3	12.0	21.5	30.2	17.1	41.1	33.3	20.0	37.2	47.2	38.1	10.4	35.0	28.8	50.4	13.0	47.0	25.3	22.9	27.9	19.5	10.6	5.2	35.0	30.7	4.1	12.3	33.8	21.0	17.1	11.6	42.2	57.5	91.2	35.0	10.9	38.5	29.7	21.0	18.8	18.4	38.5	53.2	21.5	9.0	12.2	22.3	15.1	25.7	21.3	24.1	26.4	38.5	34.7	8.3	39.0	22.5	36.4	28.6	40.8	83.2	40.5	23.1	32.9	41.1	2.4	0.5	0.8	1.1	1.5	1.5	1.9	1.2	1.5	0.5	1.6	1.8	1.6	0.2	2.4	0.9	0.9	1.2	0.8	3.3	3.5	3.6	3.9	3.2	3.3	3.3	3.2	3.7	3.3	3.2	4.2	4.7	22.4	2.6	0.0	7.1	0.0	3.1	0.0	8.0	2.6	5.0	2.9	1.6	2.8	1.8	5.5	4.2	5.0	4.1	1.4	0.0	1.8	1.2	3.3	4.4	4.0	0.0	12.2	0.0	0.8	3.6	4.4	3.1	3.7	0.0	11.1	5.7	3.6	5.8	1.7	0.0	1.8	0.0	7.1	0.0	1.0	6.2	7.2	0.0	0.0	4.4	3.5	3.1	0.0	0.0	2.0	0.7	5.3	4.9	4.1	1.0	1.3	2.9	4.0	13.1	3.6	3.4	12.2	7.4	7.6	0.0	3.0	4.1	3.1	2.2	2.4
NETO1	"BCTL1, BTCL1"	ENSG00000166342	"Neuropilin and tolloid like 1"	Q8TDF5	18	72742314-72868146	"Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"brain: 21.9;retina: 34.6"	"Group enriched"	"Detected in some"	14	"Bipolar cells: 206.4;Excitatory neurons: 307.1;Inhibitory neurons: 345.9;Oligodendrocyte precursor cells: 172.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.2"	"Group enriched"	"Detected in many"	41	"amygdala: 6.6;basal ganglia: 12.4;cerebral cortex: 21.9;hippocampal formation: 17.5;white matter: 16.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"MOLT-4: 21.9;REH: 20.6;RPMI-8226: 32.7;RT4: 24.7;SCLC-21H: 26.9;U-2 OS: 11.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064630			Approved	"Golgi apparatus"	"Secreted in brain"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA064630: AB_2685305"	"unprognostic (4.02e-2)"	"unprognostic (4.08e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.55e-2)"	"unprognostic (6.04e-2)"	"unprognostic (1.35e-5)"	"unprognostic (4.05e-1)"	"unprognostic (4.73e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.63e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.73e-2)"	"unprognostic (3.70e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.59e-1)"	"unprognostic (9.13e-3)"	1.2	0.0	6.6	0.3	12.4	0.1	1.0	0.0	21.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	17.5	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.2	0.1	0.2	0.0	0.3	0.0	0.1	34.6	0.2	0.0	0.0	0.3	0.5	0.0	0.0	3.1	0.2	0.8	0.2	0.4	0.6	0.0	1.2	0.1	0.0	16.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.9	0.0	8.7	0.0	0.0	20.6	0.0	32.7	4.0	24.7	26.9	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	11.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	12.4	0.0	21.9	17.5	0.0	0.3	0.0	0.3	0.0	0.2	16.3	2.0	0.0	0.0	16.6	6.1	0.0	0.0	0.0	0.0	206.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	307.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	345.9	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	17.8	0.0	2.2	0.0	172.4	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NETO2	"FLJ10430, NEOT2"	ENSG00000171208	"Neuropilin and tolloid like 2"	Q8NC67	16	47077703-47143945	"Predicted membrane proteins, Transporters"		Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.8;lymphoid tissue: 22.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 96.5;Inhibitory neurons: 176.6;Oligodendrocyte precursor cells: 79.4;Theca cells: 98.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013180	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"		"HPA013180: AB_1854383"	"unprognostic (2.67e-2)"	"unprognostic (3.46e-2)"	"unprognostic (3.90e-1)"	"unprognostic (1.51e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.26e-3)"	"unprognostic (1.10e-2)"	"unprognostic (5.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (3.98e-1)"	"prognostic unfavorable (5.53e-6)"	"unprognostic (3.48e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.79e-2)"	"unprognostic (1.32e-1)"	2.7	7.2	6.1	6.4	19.8	2.4	2.8	3.6	9.3	1.6	1.0	8.5	1.6	2.2	0.6	6.1	0.8	4.8	2.6	4.1	8.3	2.7	0.7	5.9	6.3	6.9	0.8	1.6	2.5	10.7	1.2	3.4	6.4	1.1	2.4	7.5	2.7	1.2	4.4	1.8	2.8	1.6	1.7	22.7	2.2	8.0	3.5	5.4	8.8	2.2	6.2	4.9	2.9	4.2	86.8	94.4	133.9	0.3	19.3	111.6	22.2	84.0	13.2	72.9	39.3	19.9	54.0	21.3	50.4	18.0	70.2	37.9	86.4	83.6	89.0	0.3	55.7	17.2	32.8	21.3	23.9	55.8	43.7	67.9	54.7	29.5	41.2	70.5	49.2	50.5	25.9	25.7	47.4	23.5	31.9	30.4	64.7	25.8	68.8	0.1	26.2	43.0	51.4	18.3	87.8	63.5	110.9	8.6	12.5	21.8	1.7	40.3	24.1	0.1	0.3	0.1	0.5	27.5	24.7	47.6	58.9	38.9	59.6	0.3	0.9	0.0	0.0	0.5	0.3	0.2	0.3	0.0	0.6	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.5	0.1	6.1	19.8	3.6	9.3	4.1	8.3	6.9	0.8	6.4	1.7	3.5	4.2	4.9	0.0	4.5	4.6	6.5	7.8	0.6	10.4	13.1	2.2	5.2	8.9	1.3	0.0	3.6	0.0	0.0	1.4	2.1	15.9	0.0	0.4	3.1	2.1	4.0	10.6	10.8	0.4	96.5	3.1	0.5	4.9	1.5	0.9	2.5	18.0	2.9	0.4	6.6	0.0	176.6	2.6	6.1	11.4	14.6	5.7	0.6	16.6	3.6	8.4	7.3	39.9	1.0	79.4	3.1	1.3	1.5	0.0	13.7	4.9	2.9	0.1	2.4	1.6	6.6	5.3	3.6	17.9	22.2	18.8	3.3	0.8	5.2	98.7	2.8	1.4
NGB		ENSG00000165553	Neuroglobin	Q9NPG2	14	77265483-77271312	"Predicted intracellular proteins, Transporters"	"Apoptosis, Oxygen transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 57.9;pituitary gland: 16.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 1.0;Excitatory neurons: 1.6;Inhibitory neurons: 1.7;Oligodendrocyte precursor cells: 3.5;Spermatogonia: 1.8"	"Cancer enhanced"	"Detected in some"		"cervical cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	29	"RPMI-8226: 6.1;SCLC-21H: 12.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA042615, HPA058596"	Enhanced					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042615: AB_2678079, HPA058596: AB_2683769"	"unprognostic (1.02e-1)"	"unprognostic (3.55e-2)"		"unprognostic (8.86e-2)"	"unprognostic (1.03e-1)"	"unprognostic (9.29e-2)"		"unprognostic (3.14e-1)"		"unprognostic (4.08e-2)"	"unprognostic (6.65e-2)"	"unprognostic (6.58e-2)"		"unprognostic (3.37e-4)"	"unprognostic (1.80e-1)"		"unprognostic (3.12e-1)"	0.1	7.5	20.6	0.2	17.2	0.0	0.0	11.8	26.8	0.0	10.7	5.5	0.2	0.0	0.1	0.1	1.3	0.0	0.0	15.2	57.9	0.0	0.0	0.0	0.0	24.8	29.0	0.0	5.0	0.0	16.9	0.0	29.9	0.0	0.5	0.5	0.0	0.0	0.0	0.0	1.0	0.1	15.5	0.0	1.0	0.5	40.9	0.2	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	6.1	0.0	0.0	12.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	17.2	11.8	26.8	15.2	57.9	24.8	29.0	29.9	15.5	40.9	15.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	1.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.8
NIPA1	"MGC35570, SLC57A1, SPG6"	ENSG00000170113	"NIPA magnesium transporter 1"	Q7RTP0	15	22773063-22829789	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 40.2"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 36.2;Inhibitory neurons: 33.8;Oligodendrocytes: 65.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 3.9"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023269	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA023269: AB_1854485"	"unprognostic (1.64e-2)"	"unprognostic (7.60e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (2.13e-2)"	"unprognostic (2.77e-1)"	"unprognostic (2.42e-2)"	"unprognostic (6.25e-2)"	"unprognostic (6.32e-2)"	"unprognostic (6.95e-2)"	"unprognostic (8.80e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.42e-3)"	"unprognostic (8.66e-2)"	3.1	4.2	27.7	3.7	36.9	1.2	2.8	36.8	38.1	3.7	17.9	4.6	6.5	2.2	2.1	4.3	2.5	4.8	3.5	22.8	28.7	6.2	5.7	4.7	5.3	35.4	36.9	1.5	5.7	8.7	3.6	3.5	33.8	6.7	4.3	6.2	3.6	3.4	2.5	4.9	6.6	2.6	36.1	4.2	6.4	4.3	36.0	8.2	7.3	3.5	5.5	3.2	3.5	40.2	14.9	17.4	5.4	12.4	6.9	5.6	3.8	17.6	12.7	8.5	7.1	13.3	7.4	6.9	13.5	7.3	17.4	9.7	16.0	4.6	10.1	40.2	9.8	10.8	10.8	11.4	8.3	0.1	20.8	1.7	15.2	5.5	9.2	13.6	8.2	15.2	8.4	11.3	4.8	5.6	5.9	9.7	5.9	15.9	18.2	12.1	7.7	5.4	13.0	14.9	15.2	15.4	13.2	1.6	16.7	7.0	10.3	13.8	15.4	23.9	12.2	10.1	27.2	12.7	13.6	12.4	12.3	0.0	15.6	0.4	0.1	0.2	0.6	0.0	0.6	0.9	0.7	0.6	0.5	1.1	0.4	0.3	0.3	0.3	0.0	3.9	0.8	0.3	27.7	36.9	36.8	38.1	22.8	28.7	35.4	36.9	33.8	36.1	36.0	40.2	5.9	12.8	5.9	14.4	7.4	8.8	4.0	5.9	2.2	4.1	4.4	3.0	4.3	15.7	5.2	5.5	6.2	2.6	10.5	9.9	3.9	5.7	3.3	3.6	2.4	5.9	3.0	4.0	36.2	11.6	2.1	4.5	10.2	5.7	0.0	4.1	4.6	6.0	4.1	5.0	33.8	7.1	2.0	4.4	6.9	4.2	2.1	2.9	5.4	4.7	3.8	4.7	4.1	15.6	65.2	17.7	6.8	3.0	7.2	8.6	11.8	5.8	6.2	6.6	19.7	3.0	3.6	3.4	8.5	4.2	14.9	1.5	7.1	1.6	7.5	7.3
NIPA2	SLC57A2	ENSG00000140157	"NIPA magnesium transporter 2"	Q8N8Q9	15	22838644-22869362	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067160, HPA071342"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 57: B-cells - Immune response"	"Golgi apparatus"		"HPA067160: AB_2685794, HPA071342: AB_2686391"	"unprognostic (2.88e-3)"	"unprognostic (1.82e-1)"	"unprognostic (9.34e-3)"	"unprognostic (1.17e-1)"	"unprognostic (4.49e-1)"	"unprognostic (2.34e-1)"	"unprognostic (3.02e-2)"	"unprognostic (1.22e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.46e-3)"	"unprognostic (2.94e-1)"	"unprognostic (7.75e-3)"	"unprognostic (3.53e-2)"	"unprognostic (1.59e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.93e-2)"	24.0	26.9	15.5	35.0	15.4	30.6	20.7	14.8	16.3	21.2	19.1	40.5	39.7	21.1	18.5	25.5	17.1	24.7	18.9	15.5	17.3	31.0	27.3	23.0	36.3	15.3	17.4	15.0	24.2	25.5	18.5	28.7	17.1	26.4	38.9	15.9	26.6	17.1	27.5	15.3	35.7	24.4	16.3	27.1	28.5	16.9	16.5	28.7	26.8	27.2	42.9	34.8	15.3	16.6	103.6	103.7	51.7	61.7	55.9	58.1	57.3	117.3	99.1	78.4	90.4	76.5	64.3	101.0	70.6	71.7	88.6	82.6	99.9	58.3	77.3	109.7	61.0	89.9	66.4	61.2	72.3	127.0	81.8	54.9	61.2	64.2	65.5	51.6	87.7	79.2	137.4	117.1	99.8	39.2	40.1	56.0	60.2	109.9	99.9	88.3	87.0	74.9	71.6	120.9	69.4	71.7	95.6	84.8	98.9	48.4	74.4	114.3	91.4	104.0	65.6	73.2	237.5	90.0	153.3	107.4	76.3	129.9	88.2	72.1	44.5	38.9	41.1	55.4	46.9	76.3	36.9	45.4	54.9	67.1	34.2	34.6	32.7	48.6	55.7	82.0	52.8	49.2	15.5	15.4	14.8	16.3	15.5	17.3	15.3	17.4	17.1	16.3	16.5	16.6	26.0	16.0	23.1	10.7	62.9	45.0	41.3	26.1	20.5	9.4	25.2	16.5	3.8	22.8	25.0	12.9	12.5	39.9	45.0	53.7	21.5	39.6	10.7	21.7	24.5	28.5	24.4	29.2	14.7	43.8	65.4	23.4	26.0	27.6	10.1	26.2	22.9	22.1	48.3	21.9	15.4	30.2	38.7	30.3	41.3	3.3	13.4	35.5	23.2	14.0	31.4	27.3	35.0	9.5	13.3	57.8	31.1	21.1	60.8	56.5	31.8	23.3	20.6	13.0	13.1	17.6	28.6	32.8	35.2	28.8	57.8	84.4	37.3	38.7	38.1	89.7
NIPAL3	"DJ462O23.2, NPAL3"	ENSG00000001461	"NIPA like domain containing 3"	Q6P499	1	24415802-24472976	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 88.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 110.5;Oligodendrocytes: 91.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 101.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039978	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 70: Brain - Nervous system development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 52: Non-specific - Transcription"	Nucleoplasm		"HPA039978: AB_10697712"	"unprognostic (9.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.19e-2)"	"unprognostic (5.96e-2)"	"unprognostic (5.38e-2)"	"unprognostic (3.72e-3)"	"unprognostic (3.60e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.79e-1)"	"unprognostic (3.14e-1)"	"prognostic favorable (3.03e-7)"	"unprognostic (1.46e-2)"	"unprognostic (1.94e-1)"	"prognostic favorable (3.95e-4)"	"unprognostic (2.85e-1)"	8.4	7.4	49.6	8.4	67.3	8.4	12.9	67.7	58.5	9.6	25.8	13.8	11.3	6.2	11.7	15.9	14.6	8.9	12.8	43.6	58.1	13.8	3.5	13.9	11.6	61.8	58.6	7.2	17.1	21.9	7.3	3.5	65.0	55.9	14.4	27.7	15.2	7.6	5.9	14.0	12.7	12.3	56.1	7.8	14.8	4.9	65.0	13.2	29.2	11.9	13.1	8.0	10.4	88.5	32.4	12.1	1.1	4.2	18.9	20.7	4.5	101.8	71.7	35.0	26.2	4.5	36.4	15.4	30.2	55.2	7.3	31.5	12.5	37.1	37.3	29.5	38.1	16.0	18.5	5.4	17.7	14.2	14.4	20.7	36.1	22.3	75.7	34.8	12.2	27.5	9.5	9.7	22.4	7.2	11.5	6.6	8.3	15.4	34.0	5.5	0.1	17.1	41.6	10.1	44.6	4.3	13.1	19.5	26.9	8.6	26.0	10.6	17.9	31.5	6.7	10.9	22.9	29.4	24.1	5.4	21.4	26.8	28.8	16.9	5.8	7.9	16.7	5.7	16.9	22.1	28.8	22.5	11.2	20.1	38.9	24.8	2.5	15.6	4.2	14.6	31.8	16.0	49.6	67.3	67.7	58.5	43.6	58.1	61.8	58.6	65.0	56.1	65.0	88.5	17.1	48.1	27.5	8.8	15.4	9.2	13.5	25.7	14.8	50.3	15.9	12.2	25.9	15.7	24.7	40.5	110.5	3.8	32.1	25.0	3.9	13.1	3.6	11.0	3.5	10.2	18.7	26.1	29.3	15.5	4.7	7.4	16.8	18.3	13.3	10.5	9.3	3.8	4.5	13.5	32.2	16.7	16.2	7.0	7.8	8.0	4.1	5.5	14.2	10.3	8.6	18.7	23.7	24.6	91.8	22.6	22.6	5.3	16.0	34.5	33.2	4.5	16.5	53.6	0.0	4.4	5.9	2.6	6.0	20.0	16.3	4.2	25.3	8.2	17.2	20.9
NIPAL4	ICHYN	ENSG00000172548	"NIPA like domain containing 4"	Q0D2K0	5	157460213-157474722	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	Receptor	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 18.7;skin 1: 61.2"	"Cell type enhanced"	"Detected in some"		"Basal keratinocytes: 29.7;Basal prostatic cells: 9.8;Oligodendrocytes: 21.0;Squamous epithelial cells: 9.8;Suprabasal keratinocytes: 42.1"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 17.0;urothelial cancer: 11.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	25	"memory B-cell: 1.6;naive B-cell: 4.8"	"Lineage enriched"	"Detected in single"	37	"B-cells: 4.8"	"Group enriched"	"Detected in some"	8	"hTCEpi: 31.7;RT4: 108.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038259	Approved					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 15: RT4 - Unknown function"	"Cluster 28: Keratinocytes - Keratinization"			"HPA038259: AB_10672510"	"unprognostic (6.74e-4)"	"unprognostic (9.54e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.61e-1)"	"unprognostic (6.56e-2)"	"unprognostic (3.55e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.53e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.76e-2)"	"unprognostic (5.28e-9)"	"unprognostic (3.12e-2)"	"unprognostic (8.66e-3)"	"unprognostic (1.18e-2)"	"prognostic favorable (6.82e-4)"	0.4	0.0	3.5	2.0	9.7	3.4	2.2	8.5	7.1	5.9	1.1	3.7	0.3	1.2	0.1	15.1	0.1	0.5	1.5	3.9	6.2	0.0	0.0	0.7	0.4	12.4	8.7	0.0	0.0	0.0	0.5	0.6	10.5	1.5	0.6	0.1	1.9	1.4	0.2	61.2	0.9	1.1	7.6	0.2	2.5	0.1	8.0	0.4	0.3	0.0	5.8	11.5	15.1	18.7	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.4	0.1	1.1	0.0	0.0	0.7	0.4	0.0	6.3	0.3	2.7	0.6	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.3	31.7	0.0	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.8	0.0	0.0	0.0	0.0	108.1	0.0	0.4	0.0	0.0	0.0	8.5	1.6	0.0	0.1	0.0	3.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.5	9.7	8.5	7.1	3.9	6.2	12.4	8.7	10.5	7.6	8.0	18.7	0.0	0.0	0.5	0.0	2.4	29.7	9.8	0.6	2.2	0.6	0.0	0.0	1.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.7	0.3	0.0	1.1	1.8	0.0	0.0	0.0	0.0	0.0	21.0	0.1	0.0	0.0	0.3	3.8	0.0	0.0	0.1	1.1	0.0	5.2	0.3	0.0	0.1	9.8	42.1	0.0	0.2	0.0	0.0	4.4
NKAIN1	"FAM77C, FLJ12650"	ENSG00000084628	"Sodium/potassium transporting ATPase interacting 1"	Q4KMZ8	1	31179745-31239887	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	5	"adrenal gland: 24.2;brain: 19.9;skeletal muscle: 19.4;tongue: 11.9"	"Cell type enriched"	"Detected in some"	12	"Oligodendrocytes: 43.9"	"Group enriched"	"Detected in many"	5	"breast cancer: 17.2;glioma: 4.6;prostate cancer: 10.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 21.2;AN3-CA: 35.8;NTERA-2: 92.7;SCLC-21H: 27.3;SH-SY5Y: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006873	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA006873: AB_1848410"	"unprognostic (1.58e-2)"	"unprognostic (7.99e-2)"	"unprognostic (8.54e-2)"	"unprognostic (6.11e-5)"	"unprognostic (6.59e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.30e-4)"	"unprognostic (1.04e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.01e-2)"	"unprognostic (8.07e-2)"	"unprognostic (6.31e-9)"	"unprognostic (1.00e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.62e-4)"	"unprognostic (5.50e-2)"	0.1	24.2	8.1	0.2	15.6	0.0	0.4	17.3	11.6	0.3	3.1	0.3	0.1	0.6	3.4	0.6	0.1	0.0	0.0	11.5	10.6	0.2	0.0	0.0	0.0	17.9	16.4	0.1	0.2	0.6	2.2	0.3	19.9	1.0	0.1	1.5	0.4	0.3	19.4	1.7	0.1	0.2	6.8	0.0	0.1	0.3	12.2	0.2	0.0	11.9	0.0	0.0	0.5	18.6	0.0	0.4	21.2	35.8	0.2	0.0	0.3	0.1	0.0	0.4	0.1	0.4	0.2	0.0	0.7	0.4	0.4	0.0	5.3	0.0	0.1	0.0	1.5	0.0	0.3	0.3	0.2	0.4	0.1	0.1	0.1	0.4	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.3	0.8	92.7	0.0	0.9	0.0	0.3	0.1	0.1	3.6	27.3	43.9	1.0	0.3	2.5	2.4	9.6	0.4	0.0	0.0	0.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.1	15.6	17.3	11.6	11.5	10.6	17.9	16.4	19.9	6.8	12.2	18.6	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.2	0.0	0.5	0.5	0.1	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.0	1.9	0.2	0.0	0.1	1.1	0.0	0.0	0.0	3.6	0.0	0.3	0.3	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	3.3	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	3.5	43.9	0.1	0.0	0.0	0.0	0.3	0.0	0.8	0.1	0.5	0.0	0.3	0.3	0.8	1.2	0.3	1.4	0.4	0.0	0.1	0.0	0.2
NKAIN2	"FAM77B, TCBA1"	ENSG00000188580	"Sodium/potassium transporting ATPase interacting 2"	Q5VXU1	6	123803865-124825640	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	6	"brain: 56.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 1721.6;Inhibitory neurons: 636.4;Oligodendrocytes: 2869.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	19	"basophil: 1.8"	"Lineage enriched"	"Detected in single"	19	"granulocytes: 1.8"	"Cell line enhanced"	"Detected in some"		"BEWO: 2.1;Daudi: 3.0;HEL: 6.4;Karpas-707: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045860			Approved	Cytosol		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol		"HPA045860: AB_10983192"	"unprognostic (3.09e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.33e-2)"	"unprognostic (4.53e-3)"	"unprognostic (5.67e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.02e-3)"	"unprognostic (2.61e-1)"	"unprognostic (5.95e-3)"	"unprognostic (3.63e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.63e-1)"	0.9	0.4	24.2	0.1	33.6	0.7	0.3	30.1	39.3	0.3	9.8	1.0	0.0	0.1	0.3	0.2	0.3	0.2	1.1	29.2	25.3	0.1	0.2	0.2	0.2	40.7	28.0	0.1	0.1	0.0	1.8	0.1	37.4	0.2	0.1	6.6	0.3	0.2	2.9	0.1	0.3	0.3	34.8	0.1	0.2	0.4	28.8	0.5	0.1	3.4	0.2	0.5	0.3	56.8	0.0	0.0	1.6	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	6.4	0.0	0.0	0.4	0.0	0.0	1.2	0.1	0.0	0.3	0.1	0.0	0.0	0.0	10.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.2	33.6	30.1	39.3	29.2	25.3	40.7	28.0	37.4	34.8	28.8	56.8	0.5	0.0	0.0	97.3	0.0	0.1	0.0	0.2	0.0	3.0	0.0	0.1	1.3	0.0	0.1	0.0	2.1	0.2	0.0	0.0	0.0	0.1	1.7	0.2	0.1	0.3	1.8	2.1	1721.6	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	47.1	636.4	0.1	0.0	0.0	0.0	0.0	0.3	1.0	0.0	47.8	0.0	15.8	0.0	19.1	2869.5	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.2	1.1	0.0	0.8	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1
NKAIN3	"FAM77D, FLJ39630, NKAIN3-IT1"	ENSG00000185942	"Sodium/potassium transporting ATPase interacting 3"	Q8N8D7	8	62248591-63014000	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	9	"brain: 18.9"	"Group enriched"	"Detected in some"	6	"Astrocytes: 1258.6;Oligodendrocyte precursor cells: 811.8"	"Cancer enriched"	"Detected in single"	5	"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.2;SCLC-21H: 3.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA018833	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA018833: AB_2669943"	"unprognostic (1.28e-1)"		"unprognostic (2.92e-1)"	"unprognostic (1.12e-2)"	"unprognostic (1.83e-1)"			"unprognostic (3.56e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.81e-3)"	"unprognostic (4.88e-2)"	"unprognostic (1.26e-1)"		"unprognostic (3.22e-2)"	"unprognostic (3.15e-2)"		"unprognostic (1.58e-1)"	0.2	1.7	18.9	0.3	11.8	0.9	0.3	0.8	9.9	0.6	0.0	0.4	0.3	0.4	0.7	0.2	0.2	0.3	0.3	16.1	10.6	0.4	2.0	0.2	0.3	3.7	11.2	0.4	0.3	0.7	0.0	0.2	2.2	0.3	0.4	1.7	1.2	0.4	0.6	0.7	0.4	0.2	1.4	0.4	0.3	0.4	16.1	0.1	0.2	0.1	0.1	0.2	0.0	4.8	0.4	0.6	2.2	0.3	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.2	0.6	0.5	0.3	0.2	0.2	0.2	0.5	0.1	0.1	0.4	0.1	0.9	1.2	0.3	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.3	0.5	1.3	0.1	0.2	0.3	0.5	0.8	0.4	1.1	1.9	0.3	0.2	0.0	0.6	3.7	0.3	0.3	0.4	0.2	0.6	0.3	0.4	0.4	0.5	0.5	0.4	0.3	0.6	0.5	0.2	0.6	0.4	1.2	0.9	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.1	0.0	0.3	0.1	0.2	0.5	0.2	0.2	0.2	0.1	0.0	18.9	11.8	0.8	9.9	16.1	10.6	3.7	11.2	2.2	1.4	16.1	4.8	0.0	0.0	0.0	1258.6	0.0	0.4	0.1	0.0	0.0	10.4	1.3	1.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.8	0.2	6.3	0.0	0.0	0.0	35.7	0.7	0.1	0.8	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	168.5	0.0	0.0	0.0	0.0	4.2	0.3	0.0	1.8	21.5	0.0	0.0	0.0	811.8	3.8	0.6	0.0	0.0	0.0	0.6	0.0	2.3	0.0	0.2	0.0	7.6	0.1	0.0	0.4	0.3	0.0	0.1	0.0	0.2	0.0	0.2
NKAIN4	"bA261N11.2, C20orf58, FAM77A"	ENSG00000101198	"Sodium/potassium transporting ATPase interacting 4"	Q8IVV8	20	63240784-63272694	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"brain: 68.1;choroid plexus: 20.3;kidney: 52.2"	"Group enriched"	"Detected in some"	5	"Muller glia cells: 80.8;Oligodendrocyte precursor cells: 76.4;Proximal tubular cells: 264.8"	"Cancer enriched"	"Detected in many"	6	"glioma: 45.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 24.9;MOLT-4: 42.8;SK-MEL-30: 9.3;SuSa: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA029876	Approved					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA029876: AB_10602038"	"unprognostic (1.26e-1)"	"unprognostic (4.27e-1)"	"unprognostic (6.07e-5)"	"prognostic unfavorable (3.14e-4)"	"unprognostic (6.65e-2)"	"unprognostic (2.59e-1)"	"unprognostic (7.07e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.62e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (1.44e-4)"	"unprognostic (5.66e-2)"	"unprognostic (6.74e-2)"	"unprognostic (4.01e-1)"	0.1	0.8	41.3	0.2	41.0	0.1	0.1	28.7	68.1	2.3	20.3	1.7	0.3	0.4	0.4	0.0	0.3	0.1	0.0	45.7	44.7	52.2	0.0	0.1	0.0	39.1	40.3	0.1	0.1	0.0	2.4	2.8	39.9	0.1	0.1	3.1	0.1	0.1	0.0	0.4	0.4	0.0	37.5	0.1	0.3	2.2	40.3	1.2	0.8	0.1	0.0	0.1	0.6	36.1	0.1	2.0	7.5	0.0	0.0	0.0	24.9	0.0	0.0	0.0	0.0	1.3	0.8	0.0	3.9	0.0	2.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.3	0.0	0.0	42.8	0.0	5.2	0.0	0.1	7.8	0.0	0.7	0.3	0.0	0.0	0.0	0.5	0.1	9.3	29.5	0.3	0.0	0.0	0.0	2.0	0.0	0.1	0.0	0.0	0.0	0.5	4.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	41.3	41.0	28.7	68.1	45.7	44.7	39.1	40.3	39.9	37.5	40.3	36.1	0.0	0.0	0.0	23.8	1.9	0.3	0.0	1.7	0.0	2.6	0.0	0.1	0.3	0.0	0.1	11.0	0.0	3.3	0.0	0.0	5.9	0.5	0.7	0.2	0.2	0.2	0.0	0.0	0.1	0.6	3.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	1.9	5.3	1.5	0.0	1.0	0.0	80.8	0.0	76.4	0.1	4.2	0.0	0.0	0.0	0.0	0.0	264.8	0.1	1.9	0.0	0.0	0.3	0.4	6.0	0.0	0.0	2.3	0.8	0.1	0.0	0.1
NLGN1	KIAA1070	ENSG00000169760	"Neuroligin 1"	Q8N2Q7	3	173396284-174286644	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Biological rhythms, Cell adhesion"		"Autism, Autism spectrum disorder, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 31.0;retina: 13.8"	"Group enriched"	"Detected in many"	31	"Excitatory neurons: 1484.7;Inhibitory neurons: 1700.0;Oligodendrocyte precursor cells: 4004.1;Oligodendrocytes: 1261.9"	"Group enriched"	"Detected in some"	9	"glioma: 3.8;melanoma: 2.2;renal cancer: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 25.9;HUVEC TERT2: 24.9;RH-30: 26.2;WM-115: 27.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006572, HPA006680, CAB033261"	Enhanced		Uncertain	"Nuclear bodies,Plasma membrane"	"Intracellular and membrane"	NA	NA		82000		"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	"Nuclear bodies"	"CAB033261: AB_2151659, HPA006572: , HPA006680: AB_1854400"	"unprognostic (2.81e-1)"	"unprognostic (9.86e-2)"	"unprognostic (3.08e-5)"	"unprognostic (7.52e-5)"	"unprognostic (1.03e-1)"	"unprognostic (2.31e-1)"	"unprognostic (6.67e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.07e-2)"	"unprognostic (3.21e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.08e-2)"	"unprognostic (8.81e-2)"	"unprognostic (2.41e-3)"	"unprognostic (5.37e-2)"	2.0	1.0	12.6	0.5	10.8	0.0	0.7	31.0	12.1	3.1	0.0	2.0	0.2	2.1	2.5	2.5	3.0	1.6	3.2	12.5	15.2	2.9	0.0	0.4	0.2	5.3	5.4	1.3	0.8	0.7	1.8	0.5	4.0	2.2	0.9	13.8	0.3	3.0	0.2	0.3	0.6	2.7	4.4	0.0	0.8	7.0	20.5	0.2	0.9	1.0	0.1	2.9	1.3	7.2	0.1	0.0	6.1	0.0	11.8	12.4	0.0	5.2	12.8	0.6	0.8	0.0	0.5	0.0	0.2	25.9	4.7	0.0	3.7	0.0	1.3	0.0	6.0	1.7	0.1	0.0	0.0	0.0	0.0	9.7	0.1	0.0	0.0	10.0	24.9	0.0	0.0	1.7	0.1	0.0	0.0	0.0	7.2	0.0	1.7	0.0	26.2	6.4	4.7	0.1	2.5	1.7	0.0	0.0	12.3	1.1	0.6	0.0	3.1	13.5	1.3	9.9	11.6	11.7	0.0	0.0	4.6	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.6	10.8	31.0	12.1	12.5	15.2	5.3	5.4	4.0	4.4	20.5	7.2	0.3	0.0	0.5	66.6	0.0	0.8	0.4	0.0	0.6	14.3	0.1	0.0	4.4	0.0	0.0	3.7	4.2	0.3	0.0	0.0	0.0	0.3	55.9	0.6	12.4	0.8	0.0	0.0	1484.7	0.0	0.2	8.2	0.0	0.3	0.0	0.3	0.0	0.0	0.1	0.0	1700.0	0.0	0.0	0.0	0.3	12.5	25.7	0.4	14.2	60.9	0.0	24.9	0.0	4004.1	1261.9	0.1	0.0	14.3	0.0	2.6	0.0	8.5	0.0	10.3	6.6	2.9	2.1	0.4	1.6	0.1	0.9	0.1	0.1	1.6	0.0	0.3
NLGN2	KIAA1366	ENSG00000169992	"Neuroligin 2"	Q8NFZ4	17	7404874-7419860	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 32.7;Horizontal cells: 57.2;Oligodendrocyte precursor cells: 45.8;Sertoli cells: 32.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 42.2"	"Low region specificity"	"Detected in all"							"HPA055321, HPA069278"	Enhanced		Approved	Mitochondria		NA	NA		14000		"Cluster 72: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA055321: AB_2682783, HPA069278: AB_2686105"	"unprognostic (1.31e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.35e-3)"	"unprognostic (2.58e-1)"	"unprognostic (1.12e-1)"	"unprognostic (9.79e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.50e-2)"	"unprognostic (2.24e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.23e-2)"	"prognostic unfavorable (3.44e-4)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (5.50e-3)"	"unprognostic (1.81e-2)"	25.0	18.1	25.6	4.8	26.0	0.4	21.2	13.5	25.3	61.9	0.0	36.4	1.5	57.9	7.5	10.2	46.1	7.7	18.2	23.7	18.6	16.6	9.3	16.7	2.7	18.1	15.2	66.6	9.4	7.6	23.7	3.8	13.9	29.7	2.2	15.5	13.6	9.0	11.7	14.8	16.6	12.3	12.1	16.9	16.3	6.7	20.9	0.8	14.2	2.4	1.8	31.2	32.4	19.0	7.1	9.8	42.2	24.4	12.6	18.0	1.0	11.6	18.2	19.4	17.9	2.2	2.4	0.1	5.5	16.4	11.4	3.9	7.9	4.9	10.0	10.8	7.9	3.1	9.6	1.6	6.3	3.1	10.4	14.1	3.8	15.9	2.4	29.1	6.5	3.9	2.9	5.6	7.9	6.6	1.4	3.1	7.2	0.4	4.7	12.9	5.0	1.4	5.6	1.5	0.6	17.0	5.3	2.5	3.0	8.3	6.9	0.4	9.0	16.6	20.6	10.5	5.7	6.4	2.2	1.2	17.3	2.8	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.6	26.0	13.5	25.3	23.7	18.6	18.1	15.2	13.9	12.1	20.9	19.0	5.4	0.0	2.6	25.8	0.5	4.7	3.1	3.3	7.4	32.7	5.6	5.2	11.0	5.7	1.0	0.0	8.4	0.4	3.4	0.1	0.0	2.7	2.0	1.5	25.3	6.8	0.0	0.0	23.5	0.4	6.3	11.5	0.5	2.3	0.0	5.8	6.1	3.2	1.0	57.2	24.8	0.3	0.0	0.8	1.8	2.9	17.1	0.7	1.8	5.6	0.6	22.3	0.0	45.8	13.6	1.6	0.0	22.2	0.3	3.0	0.1	1.3	0.8	16.8	32.9	10.8	10.7	0.5	1.1	1.2	3.8	0.8	1.7	4.3	0.3	1.2
NLGN4X	"HLNX, KIAA1260, NLGN, NLGN4"	ENSG00000146938	"Neuroligin 4 X-linked"	Q8N0W4	X	5840637-6228867	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion"		"Asperger syndrome, Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.5;lymphoid tissue: 14.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 113.9;Excitatory neurons: 162.2;Inhibitory neurons: 236.8;Oligodendrocyte precursor cells: 702.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 2.7;glioma: 8.5;testis cancer: 3.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 55.6;NTERA-2: 44.1;SuSa: 42.7"									HPA001651	Approved					NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"			"HPA001651: AB_1079470"	"unprognostic (2.21e-1)"	"unprognostic (4.01e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.57e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.48e-2)"	"unprognostic (9.32e-2)"	"unprognostic (5.10e-3)"	"unprognostic (7.16e-4)"	"unprognostic (6.70e-2)"	"unprognostic (2.98e-2)"	"unprognostic (1.10e-2)"	3.4	1.3	8.8	1.8	10.1	0.0	2.2	9.8	12.7	5.1	0.0	3.4	1.3	2.3	0.4	0.7	2.0	2.5	4.5	14.8	28.5	0.3	1.3	1.1	0.8	6.5	5.6	11.6	0.4	5.2	1.7	3.6	4.4	1.1	1.9	9.2	0.8	1.9	0.3	0.6	2.6	3.7	1.6	2.2	1.1	2.6	8.9	14.3	0.7	0.2	0.5	2.1	1.4	4.2	0.0	0.0	55.6	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.0	0.0	7.4	0.0	44.1	0.0	0.1	0.0	0.0	0.1	4.1	11.5	2.7	3.5	0.0	0.1	0.0	42.7	5.7	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.8	10.1	9.8	12.7	14.8	28.5	6.5	5.6	4.4	1.6	8.9	4.2	12.1	0.0	0.5	113.9	0.3	0.3	0.1	0.2	0.0	15.0	5.2	3.4	2.8	0.0	0.1	0.0	25.0	3.7	0.1	0.0	0.0	0.0	0.1	19.7	69.5	2.5	0.0	0.0	162.2	0.0	2.4	9.6	0.0	33.2	0.0	2.2	1.8	0.0	0.6	0.0	236.8	0.0	0.0	0.3	0.5	0.7	18.0	0.3	14.2	4.7	0.0	12.5	0.0	702.7	68.3	0.0	0.0	29.7	0.1	0.0	0.0	0.1	0.7	3.3	13.1	18.4	5.0	2.0	5.5	0.2	0.6	3.6	0.5	8.8	0.0	0.3
NMUR1	"FM-3, GPC-R, GPR66, NMU1R"	ENSG00000171596	"Neuromedin U receptor 1"	Q9HB89	2	231523187-231530445	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 8.2"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 13.7;Hepatic stellate cells: 7.9;NK-cells: 47.4;Rod photoreceptor cells: 17.2"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in single"		"cerebellum: 1.1"	"Group enriched"	"Detected in many"	7	"gdT-cell: 18.1;MAIT T-cell: 4.6;memory CD8 T-cell: 8.8;naive CD8 T-cell: 5.2;NK-cell: 10.9"	"Group enriched"	"Detected in many"	19	"NK-cells: 10.9;T-cells: 18.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA027895	Uncertain					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"		"Cluster 63: NK-cells & T-cells - Immune response"			"HPA027895: AB_10602713"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (6.74e-3)"	"unprognostic (9.44e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.07e-1)"	"unprognostic (4.08e-4)"	"unprognostic (3.76e-3)"	"unprognostic (2.26e-1)"	"unprognostic (2.61e-1)"	"unprognostic (5.25e-2)"	5.2	1.3	0.1	0.5	0.1	2.6	1.5	1.1	0.3	0.7	0.0	1.1	2.8	0.9	2.3	1.6	1.4	0.7	0.7	0.1	0.0	1.0	0.8	3.1	0.5	0.0	0.0	0.3	4.2	0.3	0.2	1.3	0.0	1.3	0.8	8.2	1.2	2.1	0.2	0.4	3.7	0.9	0.0	3.6	0.8	1.5	0.0	0.1	0.8	0.0	0.2	1.3	0.6	0.0	0.0	0.2	0.3	0.3	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.5	0.1	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.5	0.2	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.2	0.3	0.3	0.3	0.2	0.1	0.0	0.4	0.0	0.1	0.1	0.1	0.1	0.7	0.1	0.0	18.1	0.0	4.6	0.1	1.3	8.8	0.1	0.0	0.1	5.2	0.7	10.9	0.1	0.4	0.6	4.9	0.1	0.1	1.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	1.3	0.0	0.1	2.5	0.0	0.0	0.0	2.1	0.5	13.7	0.0	0.0	0.0	1.2	0.4	0.2	0.6	0.0	0.0	0.0	0.2	0.1	1.2	0.0	0.1	1.3	0.0	7.9	0.0	0.2	1.7	0.7	0.1	0.0	0.9	1.4	0.5	2.1	0.3	0.0	0.0	0.2	2.6	47.4	0.5	0.1	0.1	0.0	7.5	2.4	0.1	0.0	0.1	0.0	17.2	0.0	0.2	0.9	2.2	4.7	0.0	0.4	0.7	6.9	5.2	0.0	0.1
NOMO2	"NOMO, PM5"	ENSG00000185164	"NODAL modulator 2"	Q5JPE7	16	18417325-18562211	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 300.4"	"Cell type enriched"	"Detected in many"	5	"Cardiomyocytes: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA046697, HPA061174"	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 22: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"HPA046697: AB_2679758, HPA061174: AB_2684444"	"unprognostic (2.58e-3)"	"unprognostic (4.11e-3)"	"unprognostic (2.58e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.85e-2)"	"unprognostic (4.80e-2)"	"unprognostic (9.37e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.47e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-3)"	"unprognostic (2.22e-1)"	"unprognostic (3.42e-2)"	"unprognostic (8.39e-2)"	"unprognostic (1.54e-2)"	55.9	66.1	119.0	27.6	128.5	31.1	54.7	106.5	141.4	54.0	108.0	65.4	34.8	59.8	53.5	57.2	48.2	22.4	191.7	133.8	124.9	76.7	96.6	73.8	23.9	112.0	108.8	48.4	300.4	76.8	104.2	49.1	112.6	59.5	35.6	42.3	63.3	31.7	126.2	60.5	56.7	41.5	100.3	61.8	88.5	50.4	112.7	23.1	55.9	52.2	29.6	61.3	50.5	116.5	71.1	101.3	37.5	104.5	141.0	85.9	110.3	122.1	144.6	101.5	125.4	87.7	108.6	83.0	433.3	213.4	71.0	80.5	81.2	84.8	88.1	67.7	64.5	37.0	98.2	313.5	195.5	88.7	252.1	91.2	112.6	117.2	106.8	107.9	113.1	70.3	52.3	185.4	120.6	213.9	33.2	197.2	72.9	107.0	42.3	71.1	50.8	230.1	150.9	63.6	52.6	44.2	94.4	128.5	82.4	75.2	99.6	185.8	106.1	60.7	47.0	127.4	86.8	95.6	112.0	44.6	135.3	92.9	85.1	21.8	12.6	11.8	14.3	11.9	11.6	10.8	14.0	14.5	14.1	9.8	9.3	11.8	13.8	8.3	15.4	22.8	22.4	17.5	119.0	128.5	106.5	141.4	133.8	124.9	112.0	108.8	112.6	100.3	112.7	116.5	0.5	6.4	2.8	2.0	3.8	0.4	0.4	0.6	2.8	0.9	0.5	0.3	124.4	0.0	1.4	0.0	4.2	0.4	1.3	0.4	1.9	0.2	0.2	0.3	0.8	3.2	0.0	2.5	6.4	0.7	0.3	9.1	4.1	0.6	0.0	0.7	0.7	0.8	0.1	0.0	5.1	0.2	0.0	0.8	0.2	0.4	0.0	1.2	0.0	5.6	0.2	0.3	2.1	8.5	7.6	0.4	0.1	0.4	22.7	0.4	0.6	0.1	1.9	0.6	6.6	0.6	4.8	1.2	1.3	3.3	0.6	0.4	3.2	1.1	0.4	0.1
NOTCH1	TAN1	ENSG00000148400	"Notch receptor 1"	P46531	9	136494433-136546048	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Angiogenesis, Differentiation, Notch signaling pathway, Transcription, Transcription regulation"	"Activator, Developmental protein, Receptor"	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 56.2;Astrocytes: 67.3;Hepatic stellate cells: 68.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 2.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HaCaT: 47.0;HDLM-2: 32.3;HMC-1: 39.7;MOLT-4: 72.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB008112, CAB022466, HPA067168"	Supported		Approved	Nucleoplasm		NA	NA		29000000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 64: Macrophages - Immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"CAB008112: AB_2153490, CAB022466: , HPA067168: AB_2685795"	"unprognostic (1.77e-1)"	"unprognostic (2.65e-2)"	"unprognostic (2.16e-1)"	"unprognostic (8.38e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.13e-1)"	"unprognostic (7.56e-2)"	"unprognostic (1.02e-1)"	"unprognostic (5.74e-3)"	"unprognostic (5.50e-3)"	"unprognostic (8.78e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavorable (5.45e-4)"	"unprognostic (2.14e-2)"	"unprognostic (1.92e-1)"	"unprognostic (5.65e-2)"	"unprognostic (8.84e-2)"	18.2	4.2	10.4	4.9	16.1	4.3	15.0	12.1	9.3	14.3	0.0	19.8	4.3	12.7	0.2	16.3	11.9	0.9	14.9	8.6	5.5	11.8	9.2	22.2	3.0	13.5	12.3	5.1	14.0	0.7	6.3	2.6	9.8	15.4	0.6	0.6	10.7	3.1	5.0	24.2	14.2	1.3	9.7	24.8	10.0	2.5	13.9	4.0	11.2	1.2	0.9	14.2	16.5	14.0	8.8	10.6	4.0	2.6	0.0	0.4	17.7	3.3	0.4	1.4	0.4	1.8	0.9	13.3	10.3	1.3	1.6	47.0	1.0	8.6	0.1	32.3	2.0	5.5	6.1	0.6	2.1	6.9	39.7	0.3	16.7	1.4	1.9	0.7	9.0	3.7	3.6	1.1	0.0	9.0	72.3	13.1	8.4	2.9	7.7	15.7	9.2	19.3	0.6	4.2	0.0	0.7	6.1	4.3	3.4	1.0	3.2	10.4	22.7	5.0	9.3	5.9	4.3	2.4	2.6	4.1	3.7	5.0	26.1	0.2	0.4	0.6	0.3	0.1	0.1	0.1	0.1	0.5	0.3	0.0	0.1	0.3	2.3	0.7	0.1	0.1	0.1	0.5	10.4	16.1	12.1	9.3	8.6	5.5	13.5	12.3	9.8	9.7	13.9	14.0	56.2	9.6	21.9	67.3	8.4	24.9	12.3	35.1	23.9	0.8	10.7	12.4	11.0	5.7	16.3	1.8	2.1	1.1	14.2	11.8	0.0	5.1	0.3	12.3	9.9	53.2	2.4	5.2	0.3	4.0	2.2	6.4	1.1	17.3	34.9	1.0	68.2	7.7	9.3	1.7	0.4	14.8	18.3	10.1	17.5	0.3	1.2	15.2	7.2	18.7	14.3	46.6	24.7	33.7	19.6	2.1	11.5	0.7	5.7	8.4	4.1	3.4	3.8	2.0	6.6	14.7	18.4	0.2	3.3	20.6	29.8	1.1	15.0	1.4	28.8	15.6
NOX1	"GP91-2, MOX1, NOH-1, NOH1"	ENSG00000007952	"NADPH oxidase 1"	Q9Y5S8	X	100843324-100874359	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	24	"intestine: 71.7"	"Group enriched"	"Detected in some"	8	"Distal enterocytes: 45.8;Intestinal goblet cells: 21.4;Paneth cells: 29.1;Undifferentiated cells: 64.8"	"Cancer enriched"	"Detected in many"	18	"colorectal cancer: 82.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	15	"CACO-2: 30.9;OE19: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (8.31e-2)"	"unprognostic (2.07e-3)"	"prognostic favorable (9.71e-4)"	"unprognostic (1.67e-2)"	"unprognostic (3.37e-1)"	"unprognostic (6.55e-3)"	"unprognostic (5.48e-3)"	"unprognostic (8.68e-3)"	"unprognostic (1.32e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.86e-3)"	"unprognostic (2.56e-3)"	"unprognostic (1.64e-1)"	"unprognostic (1.78e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.81e-3)"	0.3	0.5	0.0	2.9	0.0	0.0	0.1	0.1	0.1	0.1	0.0	58.9	0.5	0.3	0.0	0.5	0.2	0.7	0.1	0.0	0.0	0.2	0.0	0.2	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.3	71.7	0.3	0.2	2.4	0.1	0.7	1.6	1.6	0.0	0.1	0.1	0.2	0.1	0.3	0.4	0.0	0.0	1.3	0.0	0.0	0.4	1.1	0.4	0.4	0.2	0.0	0.3	0.3	0.0	0.0	0.0	30.9	0.4	0.4	0.7	0.0	0.2	0.7	0.0	0.0	0.0	0.4	1.4	0.5	0.6	0.9	0.0	0.7	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.4	0.3	0.0	0.3	1.3	1.2	0.8	11.6	1.1	0.7	0.7	0.5	0.0	1.1	0.5	0.6	0.7	0.3	0.7	0.3	0.2	1.0	0.3	0.4	0.3	0.5	0.8	0.3	0.7	0.3	0.8	1.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.3	0.0	0.0	0.0	0.0	45.8	0.0	0.0	0.0	0.0	0.0	0.3	4.9	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.8	21.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	29.1	0.0	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	64.8	0.6
NOX3	GP91-3	ENSG00000074771	"NADPH oxidase 3"	Q9HBY0	6	155395368-155455839	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	10	"MCF7: 4.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA073837			Uncertain	Vesicles		NA	NA					"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA073837: "					"unprognostic (3.42e-1)"													0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NOX4	"KOX, KOX-1"	ENSG00000086991	"NADPH oxidase 4"	Q9NPH5	11	89324353-89498187	"Predicted membrane proteins, Transporters"		Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"kidney: 138.0"	"Cell type enriched"	"Detected in many"	5	"Proximal tubular cells: 164.0"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTERT-RPE1: 14.3;HUVEC TERT2: 27.7;TIME: 70.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.91e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.74e-3)"	"unprognostic (6.58e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.33e-1)"	"unprognostic (8.83e-3)"	"unprognostic (8.95e-3)"	"unprognostic (3.80e-1)"	"unprognostic (6.88e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.73e-1)"	"prognostic favorable (6.14e-4)"	"unprognostic (1.99e-4)"	"unprognostic (9.71e-2)"	"unprognostic (5.69e-2)"	"unprognostic (3.03e-3)"	7.8	0.7	0.7	0.7	1.2	0.2	3.8	0.7	1.2	1.5	0.0	1.2	0.2	4.9	0.4	0.4	1.3	2.4	7.6	0.4	0.6	138.0	0.3	1.5	0.2	1.0	0.7	0.8	0.3	3.6	0.9	3.1	0.9	1.0	0.3	17.1	3.0	1.3	1.7	1.4	0.6	3.4	0.8	0.4	0.5	0.3	0.7	0.1	2.1	3.5	0.5	1.4	1.1	1.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.5	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.7	0.1	0.0	0.1	14.3	27.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	6.1	0.0	0.0	0.3	7.1	0.4	0.0	70.6	0.2	5.0	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.7	1.2	0.7	1.2	0.4	0.6	1.0	0.7	0.9	0.8	0.7	1.7	4.4	0.0	0.0	2.9	1.0	0.6	0.1	0.4	0.0	7.5	0.2	0.3	1.0	0.0	0.0	11.0	6.2	2.2	0.2	0.1	15.6	0.0	0.8	1.0	1.4	5.9	0.0	0.0	30.0	0.0	0.8	9.2	0.0	3.0	0.0	0.6	2.5	0.1	0.2	0.0	21.1	0.0	0.0	0.0	0.5	0.7	0.3	1.3	0.0	6.5	0.1	4.5	0.0	7.1	28.4	0.1	0.0	1.2	0.3	0.1	0.0	164.0	0.0	27.1	0.0	1.2	1.0	0.6	0.7	0.1	0.3	2.5	1.1	0.1	0.0	0.1
NOX5	"NOX5A, NOX5B"	ENSG00000255346	"NADPH oxidase 5"	Q96PH1	15	68930525-69062762	"Predicted membrane proteins, Transporters"	"Angiogenesis, Electron transport, Ion transport, Transport"	"Ion channel, Oxidoreductase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"lymphoid tissue: 8.8;testis: 2.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 17.6;Excitatory neurons: 6.4;Inhibitory neurons: 5.4;Late spermatids: 11.2;Theca cells: 31.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA				"Cluster 64: Macrophages - Immune response"		"Cluster 52: Non-specific - Transcription"				"unprognostic (2.33e-1)"	"unprognostic (1.63e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.95e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.80e-2)"	"unprognostic (5.50e-3)"	"unprognostic (3.48e-2)"	"unprognostic (2.08e-1)"	"unprognostic (1.41e-1)"	"unprognostic (8.21e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.71e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.54e-1)"	0.1	0.2	0.2	0.0	0.1	0.0	0.2	0.0	0.1	1.0	0.0	0.0	0.0	0.4	0.9	0.2	0.3	0.1	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.4	0.3	0.2	0.1	0.7	0.0	0.5	0.0	0.2	0.0	0.1	0.2	0.8	0.0	8.8	0.2	2.2	0.1	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.3	0.5	0.2	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.0	0.0	0.1	0.2	0.0	1.7	0.4	0.3	1.2	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	17.6	0.4	0.3	0.6	0.0	0.0	6.4	0.0	0.1	0.7	0.0	0.1	0.0	0.6	0.0	0.0	0.5	0.0	5.4	0.0	0.0	0.0	0.0	11.2	0.6	0.1	0.0	1.9	0.0	0.4	0.0	1.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.8	0.0	0.3	0.1	5.0	2.3	0.0	0.0	1.8	0.0	31.0	0.0	0.1
NPAP1	C15orf2	ENSG00000185823	"Nuclear pore associated protein 1"	Q9NZP6	15	24675775-24683393	"Predicted intracellular proteins, Transporters"	"Differentiation, Spermatogenesis"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.8;testis: 2.9"	"Cell type enriched"	"Detected in some"	5	"Granulosa cells: 125.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA018828, HPA019562"	Uncertain		Supported	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Vesicles, Plasma membrane"	"HPA018828: AB_2669941, HPA019562: AB_2670190"										"unprognostic (4.40e-2)"	"unprognostic (1.85e-2)"		"unprognostic (6.98e-3)"	"unprognostic (7.45e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (5.11e-3)"	0.0	0.0	0.9	0.0	1.8	0.4	0.1	0.1	1.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.5	1.7	0.9	0.0	0.0	0.1	0.9	0.7	0.5	0.4	0.0	0.5	0.0	0.5	0.1	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.5	0.1	0.1	2.9	1.5	0.0	0.5	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.9	1.8	0.1	1.1	0.5	1.7	0.9	0.7	0.5	0.5	1.5	1.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.1	0.2	0.7	0.1	0.0	0.0	1.2	0.0	0.0	0.1	0.0	0.1	0.0	125.9	0.0	0.0	0.1	0.0	3.5	0.0	0.0	0.0	0.0	0.8	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	1.3	24.1	12.7	0.0	0.0	0.0	0.0	0.5	0.0	0.2
NPBWR2	GPR8	ENSG00000125522	"Neuropeptides B and W receptor 2"	P48146	20	64105820-64107171	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA																			"unprognostic (1.44e-1)"								0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NPC1	SLC65A1	ENSG00000141458	"NPC intracellular cholesterol transporter 1"	O15118	18	23506184-23586506	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Host-virus interaction, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 110.6"	"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 182.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 70.9"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 273.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA026618, CAB070132, HPA077445"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"		"CAB070132: AB_10001101, HPA026618: AB_1854580, HPA077445: "	"unprognostic (1.74e-1)"	"unprognostic (1.53e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.25e-1)"	"unprognostic (3.20e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (2.26e-6)"	"unprognostic (1.31e-1)"	"unprognostic (1.01e-2)"	"unprognostic (7.36e-3)"	"unprognostic (1.07e-2)"	"unprognostic (1.09e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.73e-2)"	"unprognostic (1.38e-1)"	"unprognostic (2.08e-3)"	17.5	76.7	35.1	16.9	69.6	42.6	20.0	55.3	47.8	16.7	28.6	13.7	14.5	16.7	15.0	20.5	13.4	15.3	11.5	41.1	44.3	16.8	15.2	29.0	20.4	73.3	55.8	16.0	11.9	72.6	15.0	27.8	66.6	13.1	12.0	28.0	36.8	13.2	22.9	24.3	17.8	15.1	49.8	17.1	20.4	13.7	55.8	12.2	11.8	14.1	15.6	15.8	18.0	110.6	21.5	41.4	17.8	29.3	55.8	44.6	40.7	37.3	81.1	38.8	84.3	28.1	30.7	18.4	28.0	55.0	132.8	59.3	22.6	63.2	35.2	15.0	17.9	6.8	35.7	63.2	79.2	25.0	28.5	42.2	61.3	81.7	273.2	76.8	40.3	20.7	20.1	47.5	44.2	32.4	10.6	14.9	12.5	24.4	37.3	15.3	28.1	45.0	88.8	51.9	7.5	14.5	44.6	62.0	54.3	27.7	15.9	19.5	50.0	81.1	15.3	32.4	32.3	29.7	97.1	12.2	177.7	21.8	37.1	4.4	9.0	8.8	29.7	8.7	20.5	5.0	12.4	20.7	4.0	6.7	5.5	15.0	7.9	10.5	13.8	70.9	17.4	10.6	35.1	69.6	55.3	47.8	41.1	44.3	73.3	55.8	66.6	49.8	55.8	110.6	18.4	25.6	56.1	32.7	9.6	9.3	34.1	16.5	8.0	6.7	10.5	9.4	4.4	11.5	21.8	9.2	18.8	15.1	61.0	24.8	0.0	11.2	1.2	23.3	12.2	16.4	3.6	2.5	23.8	15.1	7.8	13.0	15.3	53.9	10.8	31.6	6.8	9.8	28.9	3.3	20.2	7.3	2.0	11.9	6.5	1.5	9.0	21.0	12.4	59.0	7.2	15.1	25.7	39.2	182.0	34.4	22.6	10.5	15.6	41.5	8.3	5.4	10.0	12.7	0.0	10.3	14.4	13.9	25.1	17.6	14.5	23.8	19.1	52.4	7.6	64.0
NPC1L1	SLC65A2	ENSG00000015520	"NPC1 like intracellular cholesterol transporter 1"	Q9UHC9	7	44512535-44541330	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	9	"intestine: 54.2;liver: 48.1"	"Group enriched"	"Detected in some"	5	"Early spermatids: 12.3;Hepatocytes: 44.7"	"Group enriched"	"Detected in many"	5	"liver cancer: 8.5;pancreatic cancer: 7.8;stomach cancer: 4.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 6.8;Hep G2: 17.9;SCLC-21H: 14.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB070127, CAB070128"	Enhanced					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"			"CAB070127: AB_10002744, CAB070128: AB_10000815"	"unprognostic (2.96e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-3)"	"unprognostic (8.43e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.07e-1)"	"unprognostic (9.40e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.59e-2)"	"unprognostic (8.08e-10)"	"unprognostic (1.64e-2)"	"unprognostic (2.83e-1)"	"unprognostic (3.62e-2)"	"unprognostic (5.83e-2)"	0.6	0.1	0.4	0.0	0.7	0.0	0.4	0.9	1.1	0.6	0.3	1.6	54.2	0.4	0.0	0.4	0.5	5.8	0.1	0.7	0.2	0.9	48.1	0.2	0.0	0.3	0.4	0.6	0.6	0.0	0.0	0.0	0.4	0.4	0.1	0.0	0.1	0.1	0.1	0.3	50.5	0.1	0.3	0.0	1.5	1.1	0.3	0.0	0.0	0.0	0.0	0.5	0.5	0.6	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.0	0.0	0.0	0.0	6.8	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	17.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	14.3	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.9	1.1	0.7	0.2	0.3	0.4	0.4	0.3	0.3	0.6	0.2	0.0	0.0	0.3	0.2	0.6	0.0	0.0	0.0	0.0	0.7	0.8	0.8	5.7	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.3	12.3	0.3	0.1	0.2	1.8	2.7	0.3	0.5	0.0	0.2	0.0	0.5	0.0	0.0	1.4	44.7	0.0	0.0	0.1	0.3	0.0	1.0	0.3	2.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.5	0.0	0.0	0.0	0.2	3.4	1.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.6	0.3	0.1	0.3	0.7	0.2	0.1
NPC2	"EDDM1, HE1, NP-C2"	ENSG00000119655	"NPC intracellular cholesterol transporter 2"	P61916	14	74476192-74494177	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Lipid transport, Steroid metabolism, Sterol metabolism, Transport"		"Disease variant, Niemann-Pick disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"epididymis: 16783.1"	"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 2034.2;Hofbauer cells: 2898.5;Kupffer cells: 2035.4"	"Cancer enriched"	"Detected in all"	5	"thyroid cancer: 769.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 668.7;classical monocyte: 1300.7;intermediate monocyte: 1772.7;myeloid DC: 587.8;neutrophil: 674.2;non-classical monocyte: 1252.1;plasmacytoid DC: 2113.2"	"Group enriched"	"Detected in all"	5	"dendritic cells: 2113.2;granulocytes: 674.2;monocytes: 1772.7"	"Cell line enhanced"	"Detected in all"		"ASC diff: 1619.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000835, CAB032888"	Enhanced				"Secreted to blood"	NA	NA		53000000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032888: AB_2157036, HPA000835: AB_1079499"	"unprognostic (1.27e-3)"	"unprognostic (1.69e-2)"	"prognostic unfavorable (4.83e-5)"	"unprognostic (1.17e-1)"	"unprognostic (1.82e-2)"	"unprognostic (3.72e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (6.67e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.04e-1)"	"unprognostic (9.15e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.11e-3)"	"prognostic unfavorable (2.66e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (6.55e-4)"	"unprognostic (1.42e-1)"	260.1	297.0	127.1	261.3	145.4	305.3	221.3	152.2	190.6	284.5	434.0	259.7	201.7	196.7	16783.1	185.0	170.0	356.0	215.1	118.1	156.9	322.4	202.4	786.0	360.3	185.7	145.6	283.1	219.9	241.3	197.5	263.1	179.2	164.2	220.8	48.6	221.9	261.3	58.7	181.6	193.3	180.5	151.1	305.6	206.8	156.8	172.1	134.4	444.7	114.7	241.9	347.4	187.9	195.5	297.2	199.3	124.8	179.4	1619.3	498.6	404.8	194.1	707.1	200.9	398.9	351.7	420.3	78.6	141.6	181.9	372.6	595.9	170.0	405.5	188.6	120.4	126.3	29.6	96.7	296.2	348.6	51.0	548.4	467.7	388.9	173.7	336.9	930.2	298.1	87.0	32.9	601.4	224.0	106.9	70.1	75.9	52.9	489.0	307.9	39.5	219.1	281.6	511.1	735.0	5.5	91.3	296.3	120.3	298.0	359.6	205.2	225.7	268.9	291.9	342.0	396.1	188.2	253.7	452.5	24.2	292.1	168.4	163.4	668.7	1300.7	274.1	92.2	1772.7	87.9	295.2	126.5	92.3	587.8	241.8	120.9	100.5	674.2	99.5	1252.1	2113.2	187.8	1304.5	127.1	145.4	152.2	190.6	118.1	156.9	185.7	145.6	179.2	151.1	172.1	195.5	154.9	381.4	2034.2	11.1	160.2	374.9	557.8	1074.2	170.2	9.9	138.6	220.5	55.4	163.0	626.9	331.1	22.9	228.3	664.0	301.0	305.2	500.4	90.9	123.8	168.5	276.5	119.7	65.4	2.1	279.4	803.3	318.1	61.7	161.0	341.4	104.2	447.3	195.6	2898.5	8.4	3.8	264.8	832.1	2035.4	750.9	69.6	566.7	1462.6	602.9	6.5	790.5	167.4	117.4	7.5	24.4	368.3	405.1	291.9	287.4	357.9	298.1	969.0	393.3	25.1	131.5	118.3	155.9	268.1	166.7	182.6	320.7	210.4	109.9	330.0	298.5	521.6
NPHS1	"CNF, NPHN"	ENSG00000161270	"NPHS1 adhesion molecule, nephrin"	O60500	19	35825372-35869287	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Myogenesis"	"Developmental protein"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"kidney: 41.5;pancreas: 22.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 5.0;Early spermatids: 13.5;Endometrial ciliated cells: 4.5;Fibroblasts: 5.1;Glandular and luminal cells: 12.1;Late spermatids: 6.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 0.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 1.1;JURKAT: 1.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			CAB035555	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 44: Endometrium - Transcription"			"CAB035555: "	"unprognostic (3.42e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.39e-2)"	"unprognostic (6.47e-3)"	"unprognostic (2.25e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.32e-2)"	"unprognostic (3.17e-1)"	"unprognostic (3.83e-5)"	"unprognostic (4.30e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	0.3	0.0	0.4	0.6	0.9	0.2	0.0	0.8	0.4	0.0	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.2	41.5	0.1	0.0	3.9	0.4	0.4	0.0	22.8	0.0	0.1	0.0	0.5	0.0	0.0	0.7	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.2	0.3	0.7	0.6	0.7	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.4	0.9	0.8	0.4	0.4	0.2	0.4	0.4	0.5	0.1	0.6	0.7	0.3	0.0	0.5	0.0	0.2	0.8	0.8	0.0	0.6	5.0	0.3	0.3	1.0	0.0	0.0	3.7	0.0	0.0	0.2	0.0	0.0	0.3	13.5	4.5	0.4	0.7	0.0	0.0	0.7	2.4	0.0	5.1	0.0	12.1	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	2.1	6.9	0.0	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	1.2	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.1	0.0	0.4	0.5	0.8	0.4	0.1	0.4	0.0	0.3	0.0	0.1	0.3
NPHS2	"PDCN, SRN1"	ENSG00000116218	"NPHS2 stomatin family member, podocin"	Q9NP85	1	179550539-179575952	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	140	"kidney: 255.0"	"Group enriched"	"Detected in some"	7	"Collecting duct cells: 20.2;Early spermatids: 9.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	12	"NTERA-2: 1.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB037267, HPA049486"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"			"CAB037267: AB_261982, HPA049486: AB_2680788"													"unprognostic (6.77e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.86e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	255.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0
NPIPA1	"morpheus, NPIP"	ENSG00000183426	"Nuclear pore complex interacting protein family member A1"	Q9UND3	16	14922802-14952060	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 938.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.4;Excitatory neurons: 37.7;Respiratory ciliated cells: 37.4"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in all"	15	"cerebral cortex: 938.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 76.6"									HPA053611	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 29: Early spermatids - Spermatogenesis"	Nucleoplasm		"HPA053611: AB_2682206"	"unprognostic (2.77e-2)"	"unprognostic (1.25e-1)"	"unprognostic (4.48e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.87e-2)"	"unprognostic (2.29e-2)"	"unprognostic (9.21e-2)"	"unprognostic (1.65e-2)"	"unprognostic (5.12e-2)"	"unprognostic (1.08e-1)"	"unprognostic (8.82e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.74e-7)"	"unprognostic (2.28e-1)"	"unprognostic (8.76e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.66e-5)"	55.4	49.4	43.3	10.7	42.1	12.7	54.6	60.6	938.3	69.6	30.2	88.8	5.7	57.1	0.0	47.1	74.6	7.7	60.4	43.7	39.7	43.0	44.6	51.5	14.6	43.1	36.3	102.2	49.3	13.9	157.0	8.3	44.1	70.5	9.1	38.4	41.1	26.6	69.7	63.6	49.2	30.0	34.9	55.8	50.0	96.8	37.8	17.0	57.3	23.6	12.0	67.6	56.9	39.3	0.4	12.5	56.7	22.0	0.1	0.9	9.9	22.0	15.3	19.9	17.5	8.6	13.6	3.6	30.4	30.5	23.5	9.9	26.4	3.0	20.1	11.3	10.0	0.0	20.9	47.0	76.6	28.3	6.4	42.8	42.6	16.6	29.6	11.6	9.7	19.0	3.2	15.2	22.7	26.9	0.0	14.5	0.6	0.0	0.6	10.8	0.3	5.2	32.1	26.7	2.4	21.0	11.6	1.4	29.1	6.7	4.4	24.2	2.0	26.4	1.2	0.4	7.2	8.3	6.7	7.5	0.9	1.8	14.0	0.3	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.2	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	43.3	42.1	60.6	938.3	43.7	39.7	43.1	36.3	44.1	34.9	37.8	39.3	6.8	6.4	20.0	22.2	4.4	9.3	1.0	3.7	12.5	9.0	8.1	7.4	2.0	7.2	17.6	9.2	6.2	2.6	6.5	5.1	0.0	5.3	64.4	5.2	7.3	6.2	4.9	9.1	37.7	2.0	1.8	9.9	3.6	4.0	22.1	5.3	6.8	3.3	2.3	6.7	27.2	5.3	4.1	4.7	4.1	22.3	21.5	3.9	0.0	5.6	6.1	3.2	4.1	24.1	17.5	4.4	4.3	19.2	14.7	1.5	4.1	1.0	37.4	6.3	19.7	6.8	5.5	14.9	10.8	9.6	4.0	1.2	5.1	2.3	6.1	1.0
NPLOC4	"FLJ20657, KIAA1499, NPL4"	ENSG00000182446	"NPL4 homolog, ubiquitin recognition factor"	Q8TAT6	17	81556887-81648465	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 164.3"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"classical monocyte: 20.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021560, HPA023295"	Enhanced		Supported	Nucleoplasm,Cytosol		NA	NA		30000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Cytosol"		"HPA021560: AB_1854586, HPA023295: AB_1854587"	"unprognostic (3.17e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.00e-3)"	"unprognostic (8.72e-2)"	"unprognostic (2.33e-2)"	"prognostic unfavorable (1.16e-5)"	"unprognostic (1.06e-2)"	"unprognostic (4.42e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.15e-3)"	"unprognostic (1.21e-1)"	"prognostic unfavorable (6.95e-7)"	"unprognostic (1.01e-1)"	"unprognostic (6.98e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.72e-1)"	37.3	46.6	27.2	32.4	27.6	41.7	32.0	22.2	28.3	30.4	27.1	35.2	24.5	35.3	23.5	51.5	28.8	23.3	58.4	26.6	31.2	42.2	54.8	37.9	33.2	31.8	27.2	25.9	36.7	29.7	33.2	27.1	28.5	33.3	21.3	20.1	32.4	22.7	164.3	42.1	34.4	29.3	24.1	42.8	36.8	42.8	28.7	33.4	28.4	55.5	28.8	33.2	31.7	32.8	91.9	118.6	46.2	72.1	56.0	46.0	57.2	74.2	82.3	120.4	110.6	90.7	80.2	67.2	57.9	87.7	87.8	72.5	46.0	62.6	104.5	43.0	60.8	77.5	95.5	81.5	53.4	83.4	95.4	45.8	59.1	113.2	40.1	57.7	124.8	62.0	84.1	99.1	73.6	59.5	113.0	45.2	54.3	45.5	74.0	73.6	73.8	54.4	43.6	86.8	61.6	70.6	92.6	127.4	85.7	87.1	100.1	60.9	89.6	156.1	108.1	86.1	121.4	74.8	57.9	84.0	124.6	55.2	102.9	4.1	20.0	4.4	4.6	4.9	2.8	4.7	3.1	3.7	6.3	3.3	2.8	3.7	5.6	2.8	3.1	4.8	3.2	10.0	27.2	27.6	22.2	28.3	26.6	31.2	31.8	27.2	28.5	24.1	28.7	32.8	19.2	12.8	18.1	24.8	15.3	17.6	16.2	12.7	7.4	24.3	19.5	16.1	44.5	11.5	18.5	20.2	29.2	19.5	22.2	38.9	1.9	19.0	96.2	32.8	19.6	22.2	30.5	20.6	38.0	37.4	21.3	15.9	26.0	38.8	3.8	29.2	27.1	54.3	19.1	20.2	36.4	17.2	8.2	27.3	18.7	79.6	17.7	22.8	12.4	19.7	28.7	19.6	14.4	23.1	38.6	47.2	22.8	12.8	16.5	28.4	22.2	27.9	21.5	33.5	19.7	22.3	18.5	29.7	23.9	15.7	24.2	37.1	16.9	19.3	18.9	28.7
NPPC	CNP	ENSG00000163273	"Natriuretic peptide C"	P23582	2	231921809-231926396	"Predicted secreted proteins, Transporters"	Osteogenesis	"Hormone, Vasoactive"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"brain: 33.5"	"Group enriched"	"Detected in many"	8	"Basal squamous epithelial cells: 190.1;Skeletal myocytes: 264.2"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"medulla oblongata: 33.5;spinal cord: 30.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 8.4;NTERA-2: 3.9;SCLC-21H: 5.5;SK-MEL-30: 26.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"medulla oblongata: 15.5;spinal cord: 12.5"	HPA035362	Uncertain				"Secreted to blood"	NA	NA	6140			"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"			"HPA035362: AB_10671103"	"unprognostic (9.70e-2)"	"unprognostic (4.45e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.06e-2)"	"unprognostic (5.67e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.83e-1)"	"unprognostic (3.22e-3)"	"unprognostic (9.81e-3)"	"unprognostic (9.16e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.72e-1)"	"unprognostic (1.91e-1)"	0.3	0.1	0.8	2.1	0.9	1.3	0.7	2.8	3.4	1.3	0.0	4.1	0.1	0.6	0.0	3.2	2.6	0.0	5.3	2.0	3.9	0.2	0.0	0.0	1.4	33.5	4.4	1.3	0.1	0.0	2.7	0.2	4.8	4.3	0.2	2.4	1.1	0.4	0.7	0.6	0.9	0.5	30.9	0.4	2.4	0.2	4.6	2.9	0.5	0.1	2.0	0.2	0.4	6.5	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	1.9	0.0	0.0	0.0	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	1.0	0.0	3.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	5.5	0.3	0.2	0.2	26.1	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.9	2.8	3.4	2.0	3.9	33.5	4.4	4.8	30.9	4.6	6.5	2.1	0.0	0.0	0.7	1.3	3.4	27.1	5.9	190.1	1.1	6.5	18.3	1.9	0.0	0.1	11.0	10.4	0.2	0.6	4.2	0.0	1.1	0.3	3.6	1.3	1.6	3.5	0.0	0.0	0.0	0.0	10.9	5.6	4.8	0.0	0.3	0.0	0.0	0.1	0.0	1.5	3.2	0.0	0.0	1.7	0.0	0.3	1.6	1.8	0.0	2.5	15.2	0.0	0.0	1.3	0.8	3.1	0.0	5.8	11.5	0.0	0.0	0.0	4.1	0.0	264.2	2.0	1.2	7.0	13.2	1.1	0.3	1.7	0.0	2.9	3.1
NPR1	"ANPa, ANPRA, GUCY2A, NPRA"	ENSG00000169418	"Natriuretic peptide receptor 1"	P16066	1	153678688-153693992	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis"	"Lyase, Receptor, Vasoactive"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 67.1"	"Group enriched"	"Detected in many"	6	"Adipocytes: 99.6;Endothelial cells: 52.5;Hepatic stellate cells: 132.8"	"Group enriched"	"Detected in all"	4	"ovarian cancer: 39.2;renal cancer: 12.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"ASC diff: 158.5"	"Region enriched"	"Detected in all"	5	"olfactory bulb: 18.7"	"Low region specificity"	"Detected in many"			HPA031087			Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoli	"Nucleoplasm, Plasma membrane"	"HPA031087: AB_10601975"	"unprognostic (2.54e-1)"	"unprognostic (3.03e-3)"	"unprognostic (6.31e-2)"	"prognostic unfavorable (3.97e-4)"	"unprognostic (1.55e-1)"	"unprognostic (6.60e-2)"	"unprognostic (1.54e-2)"	"unprognostic (2.03e-1)"	"unprognostic (2.46e-1)"	"unprognostic (3.27e-2)"	"prognostic favorable (2.49e-4)"	"unprognostic (1.27e-1)"	"unprognostic (6.69e-2)"	"unprognostic (1.16e-2)"	"unprognostic (1.09e-1)"	"unprognostic (4.06e-1)"	"unprognostic (1.74e-2)"	67.1	8.7	1.7	3.4	1.5	0.0	44.3	1.4	1.4	8.8	1.5	10.1	1.5	31.0	5.5	4.3	36.4	5.9	15.8	1.3	1.4	28.8	4.3	24.2	2.3	1.5	1.5	27.7	3.9	8.4	3.8	17.7	1.5	4.4	2.0	0.1	3.7	12.1	7.2	6.6	9.3	9.7	1.8	2.2	8.8	1.3	2.4	1.9	14.0	11.1	1.3	12.8	9.7	1.4	0.0	1.3	0.1	0.0	158.5	0.6	0.1	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	28.0	0.0	19.0	0.0	0.0	0.3	0.0	0.3	0.0	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	15.9	0.0	0.0	2.1	0.0	0.1	0.0	1.9	0.0	5.7	1.0	0.1	0.0	0.2	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	1.5	1.4	1.4	1.3	1.4	1.5	1.5	1.5	1.8	2.4	1.4	99.6	0.0	6.9	0.0	0.2	1.5	0.5	0.0	0.6	0.0	0.5	0.5	4.5	2.8	0.0	14.7	0.0	0.2	0.1	0.0	0.0	0.7	9.1	6.2	8.8	52.5	0.0	0.0	0.0	0.0	1.3	15.2	0.0	15.4	0.0	0.0	132.8	2.4	0.3	0.0	0.0	0.0	0.0	4.7	4.0	11.5	10.2	0.5	0.0	0.0	5.2	0.0	0.0	0.0	0.0	1.0	0.0	4.1	0.0	0.5	0.0	4.0	0.0	0.0	0.0	1.4	2.2	0.5	0.1	0.2	1.0	0.7	0.3	1.4	0.2	0.0
NPR2	"AMDM, ANPb, ANPRB, GUCY2B, NPRB"	ENSG00000159899	"Natriuretic peptide receptor 2"	P20594	9	35791591-35809732	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"cGMP biosynthesis, Osteogenesis"	"Lyase, Receptor"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 35.6;Excitatory neurons: 69.1;Inhibitory neurons: 68.9;Microglial cells: 34.7;Oligodendrocyte precursor cells: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 30.9;ASC TERT1: 21.1;BJ hTERT+: 20.2;HHSteC: 20.1;HSkMC: 23.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (2.93e-2)"	"unprognostic (8.22e-3)"	"unprognostic (9.25e-3)"	"unprognostic (3.59e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.06e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.99e-2)"	"unprognostic (6.99e-3)"	"unprognostic (7.10e-2)"	"unprognostic (3.24e-1)"	"unprognostic (7.86e-2)"	12.4	8.2	9.3	1.7	9.4	0.3	10.3	14.4	9.9	25.7	7.7	15.6	1.8	20.5	8.7	3.2	15.1	3.2	12.8	9.1	11.4	6.7	8.6	9.1	2.3	11.8	9.4	9.4	3.2	1.3	13.8	4.7	11.5	10.9	2.8	4.1	5.3	6.5	10.8	8.3	7.5	9.9	8.2	4.9	7.8	4.8	10.7	2.2	6.0	8.6	1.7	12.1	14.7	7.9	0.0	2.9	2.2	0.0	30.9	21.1	1.9	9.3	20.2	7.0	6.4	4.5	4.3	1.8	3.0	17.9	12.8	1.2	3.6	0.2	6.1	2.2	1.0	1.8	4.3	3.4	20.1	0.4	0.0	23.8	1.8	8.9	0.6	7.6	12.7	2.5	0.7	0.2	13.4	1.0	0.5	0.8	3.5	1.0	3.7	2.4	0.2	0.5	1.8	1.4	1.1	0.7	0.4	0.1	0.6	3.8	0.2	0.0	8.2	8.5	7.8	3.2	1.2	0.5	0.6	4.8	10.4	0.6	5.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.0	9.3	9.4	14.4	9.9	9.1	11.4	11.8	9.4	11.5	8.2	10.7	7.9	2.7	3.2	3.4	35.6	0.0	1.1	0.6	0.6	1.2	5.1	0.7	1.4	0.7	1.5	0.3	0.0	2.1	0.4	0.5	0.7	0.0	0.6	0.3	1.4	9.2	4.4	0.0	0.0	69.1	0.8	0.2	7.2	0.5	2.0	1.3	9.6	6.1	4.5	0.4	3.3	68.9	0.7	0.0	0.3	2.1	0.3	9.3	0.3	0.0	34.7	0.0	6.8	0.0	51.8	16.3	0.6	3.6	7.9	0.2	2.7	0.2	0.6	1.1	2.2	0.0	5.1	3.4	4.5	3.1	0.1	1.6	0.3	0.7	0.8	1.1	0.4
NPSR1	"GPR154, GPRA, PGR14"	ENSG00000187258	"Neuropeptide S receptor 1"	Q6W5P4	7	34658218-34878332	"Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	Asthma	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 1.6"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.1;Early spermatids: 4.4;Excitatory neurons: 3.8;Inhibitory neurons: 2.2;Late spermatids: 2.1;Oligodendrocyte precursor cells: 1.0"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 2.3;pancreatic cancer: 2.0;stomach cancer: 2.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HAP1: 1.0"	"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"midbrain: 6.2"							NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"					"unprognostic (3.56e-1)"	"unprognostic (9.34e-2)"	"unprognostic (7.55e-2)"	"unprognostic (1.80e-1)"	"unprognostic (2.00e-2)"		"unprognostic (9.35e-2)"			"unprognostic (6.34e-3)"			"unprognostic (2.85e-1)"	"unprognostic (1.36e-2)"		"unprognostic (2.08e-2)"	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.0	0.0	0.6	1.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.1	0.2	0.4	1.6	0.6	1.1	0.3	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	3.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0
NPTN	"GP55, GP65, np55, np65, SDFR1, SDR1"	ENSG00000156642	Neuroplastin	Q9Y639	15	73560014-73634134	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell adhesion, Neurogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 216.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051497, HPA072453"	Approved		Approved	"Plasma membrane"		NA	No		15000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA051497: AB_2681507, HPA072453: AB_2686523"	"unprognostic (9.30e-3)"	"unprognostic (1.70e-1)"	"unprognostic (5.01e-2)"	"unprognostic (4.14e-1)"	"unprognostic (3.11e-2)"	"unprognostic (7.42e-3)"	"unprognostic (9.74e-2)"	"unprognostic (9.67e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.55e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.17e-1)"	84.6	95.7	81.4	75.9	104.4	32.7	82.6	52.1	176.7	112.4	72.4	133.0	134.9	180.7	150.9	133.9	135.0	97.2	196.4	122.6	65.6	126.5	74.0	110.5	48.7	42.9	42.2	79.1	96.6	167.2	47.1	123.1	39.8	170.8	142.0	135.5	101.0	204.4	51.2	68.1	124.9	298.4	28.5	71.8	96.4	69.2	60.4	42.6	112.4	70.1	69.4	140.6	84.9	87.9	101.9	179.1	100.9	74.5	201.6	180.7	141.1	229.1	373.5	258.3	228.4	122.4	317.7	58.7	133.0	331.2	319.2	411.1	164.4	191.3	147.6	105.6	109.3	46.7	83.3	110.2	143.1	72.6	124.9	149.1	165.2	167.4	100.7	254.8	139.5	52.0	26.7	65.2	187.2	81.2	32.4	45.3	93.5	127.3	63.3	52.1	115.8	49.9	353.7	148.3	61.6	19.2	222.4	122.4	151.3	249.6	110.9	97.7	159.0	199.7	133.8	116.0	135.8	56.5	113.8	51.4	185.8	111.0	140.0	5.9	13.5	13.8	6.4	18.5	5.2	3.8	3.6	5.9	5.3	2.9	3.6	4.2	28.0	3.9	14.8	5.5	4.3	13.6	81.4	104.4	52.1	176.7	122.6	65.6	42.9	42.2	39.8	28.5	60.4	87.9	67.1	76.9	66.0	72.1	18.3	65.0	27.0	43.3	51.2	93.0	50.5	45.7	106.9	48.6	60.6	82.8	50.1	7.0	28.8	133.8	1.9	18.1	3.7	73.4	46.7	44.6	103.0	7.4	216.6	24.0	9.2	64.5	41.3	92.1	28.4	33.9	50.0	43.1	25.0	38.7	162.7	90.9	42.7	77.4	46.6	9.9	15.2	61.8	42.7	86.2	43.4	41.2	12.3	63.8	67.4	41.4	66.7	38.4	20.2	26.9	52.3	20.7	92.1	49.7	19.7	35.5	74.0	11.7	10.8	61.9	54.6	6.8	23.9	35.3	52.6	30.7
NPTX1		ENSG00000171246	"Neuronal pentraxin 1"	Q15818	17	80466834-80477843	"Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 107.8;intestine: 31.6"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 175.2;Excitatory neurons: 88.6;Late spermatids: 44.8"	"Cancer enhanced"	"Detected in many"		"glioma: 4.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 32.0;HeLa: 26.0;SiHa: 40.7;U-138 MG: 85.2;WM-115: 120.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"amygdala: 55.3;cerebellum: 128.1;cerebral cortex: 102.2;hippocampal formation: 131.3"	HPA077062	Enhanced	Approved			"Secreted in brain"	NA	NA		1100000		"Cluster 6: Brain - Smell perception"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA077062: AB_2732329"	"unprognostic (2.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (6.95e-2)"	"unprognostic (4.16e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.63e-1)"	"unprognostic (1.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.81e-2)"	"unprognostic (9.63e-3)"	"unprognostic (1.05e-6)"	"unprognostic (1.41e-4)"	"unprognostic (1.35e-1)"	"unprognostic (8.86e-6)"	"unprognostic (2.71e-3)"	0.4	5.1	95.2	1.0	88.8	0.1	0.4	77.7	94.5	0.2	0.0	31.6	0.7	0.8	2.2	0.8	0.8	1.2	0.0	107.8	0.7	0.2	0.0	1.3	0.9	20.1	1.0	0.6	0.2	0.0	2.4	1.2	1.7	0.7	2.1	13.0	0.0	2.5	2.7	3.2	4.2	0.8	3.5	2.1	3.9	1.2	1.3	11.9	0.1	0.6	0.1	0.6	0.1	81.3	0.0	2.0	0.5	0.2	0.4	0.5	0.0	2.0	0.0	0.1	0.0	0.7	0.2	0.0	0.3	0.2	3.5	0.1	32.0	0.0	0.0	0.0	20.2	0.0	26.0	0.1	0.1	0.0	1.4	0.0	0.0	1.3	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.0	6.5	0.0	0.0	8.3	0.0	0.0	21.4	0.0	40.7	0.1	0.0	0.3	0.1	0.6	0.3	85.2	0.0	4.2	0.2	0.0	0.0	0.0	0.2	0.0	120.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	95.2	88.8	77.7	94.5	107.8	0.7	20.1	1.0	1.7	3.5	1.3	81.3	1.3	0.0	0.0	8.1	0.3	1.5	0.1	0.0	0.0	12.8	0.7	2.2	3.0	0.0	0.6	0.0	175.2	0.1	0.6	0.3	0.0	0.0	8.2	0.3	0.4	1.2	0.0	0.0	88.6	0.0	0.2	0.9	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	11.0	0.7	0.0	0.0	0.0	44.8	0.9	0.6	0.0	6.5	0.0	0.8	0.0	5.0	5.8	0.6	0.0	2.2	0.1	0.5	0.0	0.0	0.0	4.1	0.0	1.6	1.1	1.6	0.4	0.1	3.0	0.1	0.1	0.5	0.1	0.0
NR1H4	"FXR, HRR-1, HRR1, RIP14"	ENSG00000012504	"Nuclear receptor subfamily 1 group H member 4"	Q96RI1	12	100473708-100564414	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Immunity, Inflammatory response, Innate immunity, Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor, Repressor"	"Disease variant, FDA approved drug targets, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 39.1;liver: 120.6"	"Cell type enhanced"	"Detected in some"		"Cholangiocytes: 92.9;Hepatocytes: 105.1;Proximal enterocytes: 331.0;Proximal tubular cells: 153.8"	"Group enriched"	"Detected in some"	11	"liver cancer: 18.7;renal cancer: 12.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	30	"Hep G2: 28.3;HHSteC: 14.1;RPTEC TERT1: 44.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA047699			Approved	Nucleoplasm		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA047699: AB_10965320"			"unprognostic (1.78e-1)"		"unprognostic (1.81e-1)"		"unprognostic (6.68e-2)"	"unprognostic (2.49e-1)"		"unprognostic (1.60e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.43e-1)"		"unprognostic (3.77e-3)"	0.2	22.6	0.1	1.4	0.1	0.4	1.0	0.5	0.4	0.2	1.8	8.3	29.6	0.1	0.1	0.2	0.2	12.6	0.4	0.2	0.1	28.2	120.6	0.4	0.3	0.1	0.1	14.0	3.1	0.0	1.4	0.0	0.1	0.3	1.6	0.3	0.3	0.0	0.3	0.5	39.1	0.8	0.0	0.4	0.5	0.7	0.2	0.1	0.3	0.1	0.2	6.5	0.1	0.5	0.0	0.9	0.1	0.3	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	28.3	14.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.6	0.1	0.0	0.0	44.9	0.4	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.4	0.2	0.1	0.1	0.1	0.1	0.0	0.2	0.5	0.0	0.0	0.0	0.3	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	92.9	0.0	22.0	0.0	0.0	0.0	8.0	43.0	11.5	0.7	0.0	0.0	0.3	0.0	2.7	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.6	8.9	105.1	0.0	0.0	1.6	17.0	0.0	3.5	0.0	2.0	0.9	0.8	0.0	1.0	0.0	0.0	0.0	0.5	0.3	0.4	19.9	0.0	0.0	0.0	331.0	153.8	0.0	0.0	0.0	0.0	0.1	0.4	1.3	0.0	0.0	0.0	0.9	1.1	30.4	3.7
NR1I2	"BXR, ONR1, PAR2, PXR, SXR"	ENSG00000144852	"Nuclear receptor subfamily 1 group I member 2"	O75469	3	119780484-119818487	"FDA approved drug targets, Nuclear receptors, Plasma proteins, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"intestine: 31.2;liver: 47.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 26.1;Hepatocytes: 32.2;Paneth cells: 13.8;Proximal enterocytes: 51.7;Undifferentiated cells: 9.0"	"Group enriched"	"Detected in some"	24	"colorectal cancer: 9.0;liver cancer: 5.7;pancreatic cancer: 2.6;stomach cancer: 2.7"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	15	"NK-cell: 2.8"	"Lineage enriched"	"Detected in single"	15	"NK-cells: 2.8"	"Cell line enriched"	"Detected in some"	5	"Hep G2: 14.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA029309, HPA055121, HPA073926"			Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm		"HPA029309: AB_2672990, HPA055121: AB_2682703, HPA073926: AB_2686643"	"unprognostic (6.76e-3)"	"unprognostic (2.25e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.24e-4)"	"unprognostic (4.51e-2)"	"unprognostic (4.52e-2)"	"unprognostic (4.03e-3)"	"unprognostic (3.97e-2)"	"unprognostic (5.78e-2)"	"unprognostic (5.05e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.60e-2)"	"unprognostic (5.51e-6)"	"unprognostic (4.86e-1)"	"unprognostic (6.95e-2)"	"unprognostic (3.13e-1)"	"unprognostic (6.12e-3)"	0.1	0.1	0.2	1.0	0.1	0.6	0.1	0.0	0.1	0.0	0.2	12.3	28.2	0.0	0.1	0.0	0.1	5.2	0.0	0.1	0.3	0.0	47.4	0.0	0.2	0.2	0.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	13.3	0.2	0.0	0.1	0.0	0.0	31.2	0.6	0.1	0.1	1.7	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.8	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.7	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.3	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.1	0.1	0.3	0.2	0.3	0.2	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.7	1.5	0.0	1.8	0.0	0.0	0.1	26.1	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.6	0.2	0.0	0.1	3.1	0.0	0.0	1.7	0.0	32.2	0.2	0.0	0.4	6.4	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	13.8	0.0	0.1	0.2	51.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.5	9.0	0.0
NR5A2	"B1F2, FTF, FTZ-F1, FTZ-F1beta, hB1F, hB1F-2, LRH-1, LRH1"	ENSG00000116833	"Nuclear receptor subfamily 5 group A member 2"	O00482	1	200027614-200177420	"Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"Activator, DNA-binding, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"intestine: 17.8;liver: 38.6;pancreas: 61.1"	"Cell type enriched"	"Detected in many"	5	"Granulosa cells: 276.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.6"	"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in some"	4	"basophil: 3.2;neutrophil: 1.5"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 3.2"	"Cell line enhanced"	"Detected in some"		"A549: 25.0;CACO-2: 6.2;HAP1: 14.9;HMC-1: 6.4;HUVEC TERT2: 20.4"	"Region enhanced"	"Detected in single"		"hypothalamus: 1.2"	"Not detected"	"Not detected"			"HPA005455, HPA017067"	Approved		Uncertain	"Nuclear speckles"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles"		"HPA005455: AB_1078140, HPA017067: AB_1844767"	"unprognostic (7.47e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.19e-2)"	"unprognostic (6.63e-3)"	"unprognostic (4.46e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.34e-1)"	"unprognostic (8.50e-2)"	"unprognostic (4.64e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.00e-7)"	"unprognostic (5.48e-2)"	"unprognostic (5.07e-2)"	"unprognostic (9.23e-2)"	"unprognostic (1.37e-1)"	5.4	0.4	0.5	2.6	0.2	0.9	3.7	0.5	0.3	3.4	0.2	11.9	17.4	3.3	1.4	0.9	2.2	8.0	1.0	0.3	2.8	0.7	38.6	2.7	2.1	0.7	0.6	1.0	61.1	0.4	0.1	0.4	0.8	1.6	13.1	0.2	0.5	0.8	1.1	1.1	17.8	4.3	0.4	0.2	1.3	0.8	0.8	0.5	0.9	0.7	1.4	1.8	1.2	0.7	0.0	25.0	0.0	0.1	0.0	0.2	0.6	0.0	0.4	0.0	0.0	6.2	0.1	0.0	0.0	0.0	0.7	0.7	14.9	0.0	0.0	3.3	1.1	0.0	0.3	2.7	0.5	0.1	6.4	0.1	0.0	0.0	0.1	0.0	20.4	0.1	0.0	0.3	0.0	0.6	0.0	0.4	0.9	0.0	0.3	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	0.1	1.7	4.7	0.3	0.1	1.0	0.2	0.1	0.2	3.4	2.3	2.6	0.3	0.2	0.1	3.2	0.4	0.4	0.2	0.2	0.2	0.3	0.3	0.3	0.1	0.4	0.4	0.3	1.5	0.5	0.2	0.5	0.4	0.1	0.5	0.2	0.5	0.3	0.3	2.8	0.7	0.6	0.8	0.4	0.8	0.7	23.7	0.0	1.7	0.3	0.2	1.9	0.1	0.0	0.0	0.2	0.2	0.0	9.9	32.9	0.0	0.0	0.0	0.0	0.3	37.5	0.0	38.2	0.4	0.3	0.3	32.4	4.9	2.7	0.4	54.5	0.0	0.8	0.0	0.2	13.3	276.2	38.6	38.5	0.1	0.0	0.6	13.8	0.0	4.9	1.5	0.3	0.6	0.6	0.0	0.0	3.1	0.0	0.0	1.0	0.3	22.0	21.8	0.0	1.2	0.3	49.9	0.0	0.8	0.3	0.0	0.5	6.1	0.1	0.1	0.0	1.4	0.0	0.3	0.1	32.3	0.2
NRP1	"CD304, NRP, VEGF165R"	ENSG00000099250	"Neuropilin 1"	O14786	10	33177492-33336262	"Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Angiogenesis, Differentiation, Host-virus interaction, Neurogenesis"	"Developmental protein, Heparin-binding, Receptor"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 366.0;Endothelial cells: 174.4;Hepatic stellate cells: 184.6;Sertoli cells: 282.7"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"hippocampal formation: 48.6"	"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 39.3"	"Lineage enriched"	"Detected in many"	16	"dendritic cells: 39.3"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 444.6;hTERT-RPE1: 371.6;TIME: 369.5;U-87 MG: 425.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004511, HPA030278"	Approved				"Secreted in other tissues"	NA	NA		780000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB004511: AB_2282634, HPA030278: AB_10601976"	"unprognostic (3.19e-1)"	"prognostic unfavorable (7.10e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (6.17e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.66e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.78e-2)"	"prognostic unfavorable (3.87e-4)"	"prognostic unfavorable (1.22e-5)"	"unprognostic (3.83e-2)"	"unprognostic (5.48e-2)"	"unprognostic (7.79e-2)"	125.2	42.3	9.3	43.3	9.4	3.7	62.2	0.0	26.0	36.9	13.3	26.6	21.3	51.6	35.7	19.7	34.5	54.1	80.8	48.6	9.1	52.7	53.1	63.7	23.7	4.0	3.9	43.0	33.0	24.4	9.0	133.7	2.1	21.3	23.6	11.6	19.3	38.4	55.9	22.1	21.0	55.9	5.7	66.7	18.6	12.9	13.4	18.2	49.7	46.6	12.4	35.3	20.0	10.7	57.4	217.8	11.1	1.1	204.8	224.7	1.3	224.4	216.2	109.6	118.2	28.9	132.4	1.1	26.6	444.6	116.8	15.8	13.8	65.2	89.3	0.7	11.2	0.6	24.5	48.7	74.3	20.8	1.6	277.3	11.2	261.7	116.8	371.6	304.0	1.4	0.7	1.4	221.3	96.8	1.4	3.9	5.5	11.9	204.2	9.6	24.8	1.2	109.7	1.3	5.1	2.7	23.0	17.5	0.9	9.2	1.0	3.3	369.5	156.4	36.9	193.0	153.8	0.7	1.1	0.7	425.2	26.4	143.5	0.4	2.5	0.5	0.6	0.4	1.0	0.7	0.7	0.6	2.3	0.6	0.6	0.6	0.4	1.2	0.3	39.3	0.6	0.9	9.3	9.4	0.0	26.0	48.6	9.1	4.0	3.9	2.1	5.7	13.4	10.7	366.0	0.0	20.2	80.3	4.3	15.7	10.6	5.5	7.4	10.5	4.2	5.5	67.6	28.6	13.0	18.4	4.2	61.5	29.4	0.6	1.9	57.9	1.3	11.3	116.9	174.4	4.2	3.2	105.4	18.9	13.4	58.5	6.6	11.0	7.6	62.3	184.6	12.5	135.4	0.0	14.4	1.8	16.2	62.7	33.3	5.5	42.3	46.0	12.4	78.7	5.8	3.4	0.0	11.6	2.3	15.4	0.0	21.1	1.6	4.1	3.0	59.8	5.4	0.9	282.7	13.1	117.9	0.2	1.3	2.7	10.5	67.2	3.8	61.1	1.5	3.3
NRSN1	"p24, VMP"	ENSG00000152954	"Neurensin 1"	Q8IZ57	6	24126186-24154900	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	22	"brain: 542.9;choroid plexus: 474.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 139.1;Horizontal cells: 121.1;Inhibitory neurons: 111.9;Oligodendrocyte precursor cells: 69.9"	"Cancer enriched"	"Detected in single"	17	"glioma: 3.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"SCLC-21H: 11.2;SH-SY5Y: 9.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019681, HPA061006"	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA019681: , HPA061006: AB_2684413"	"unprognostic (1.22e-1)"		"unprognostic (4.26e-2)"	"unprognostic (8.00e-3)"	"unprognostic (8.01e-3)"					"unprognostic (1.70e-1)"	"unprognostic (4.53e-3)"	"unprognostic (7.29e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.40e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.57e-1)"		0.0	4.9	276.8	0.4	315.2	0.2	0.0	108.9	281.1	0.1	474.7	1.2	0.4	0.2	0.0	0.1	0.0	0.2	0.0	138.2	466.8	0.1	0.0	0.0	0.1	263.2	332.8	0.0	1.2	0.0	23.5	0.0	468.0	0.0	0.4	22.6	0.1	0.0	0.7	0.1	0.3	0.3	194.7	0.1	0.4	0.3	459.9	0.0	0.1	0.0	0.1	0.0	0.1	542.9	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.5	0.4	0.1	0.1	0.1	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	11.2	9.2	0.0	0.0	0.2	0.1	0.0	0.9	0.1	0.1	0.1	0.0	0.0	0.3	0.5	0.2	0.3	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	276.8	315.2	108.9	281.1	138.2	466.8	263.2	332.8	468.0	194.7	459.9	542.9	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	27.9	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.8	0.0	0.1	0.0	0.0	139.1	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	121.1	111.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	12.2	0.0	23.7	0.0	69.9	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
NRSN2	"C20orf98, dJ1103G7.6"	ENSG00000125841	"Neurensin 2"	Q9GZP1	20	346782-359660	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 154.7"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 29.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015967	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles	"Nucleoplasm, Cytosol"	"HPA015967: AB_1854647"	"unprognostic (5.67e-2)"	"unprognostic (3.47e-1)"	"unprognostic (7.50e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.05e-2)"	"unprognostic (4.48e-2)"	"unprognostic (1.48e-1)"	"unprognostic (4.96e-2)"	"unprognostic (5.92e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (6.96e-2)"	"unprognostic (1.96e-3)"	"unprognostic (2.94e-2)"	"unprognostic (1.96e-1)"	"unprognostic (7.85e-3)"	"unprognostic (1.73e-3)"	19.9	57.0	105.7	10.5	114.4	1.7	17.4	87.8	154.7	30.1	71.3	28.3	6.0	32.5	25.9	9.7	27.9	15.4	30.9	114.3	100.6	33.0	4.8	22.4	7.5	94.4	92.0	36.0	20.3	42.6	60.4	16.9	93.9	28.3	9.7	56.9	21.1	25.5	3.4	11.4	13.1	27.5	80.5	16.8	20.2	30.6	96.6	5.5	28.1	5.7	7.2	23.5	18.2	102.9	56.5	68.3	40.2	37.7	53.0	58.4	15.2	37.4	72.3	66.3	66.8	38.2	1.2	0.0	12.6	70.7	48.9	24.1	33.5	5.8	42.4	0.3	33.0	20.8	32.5	70.7	53.5	0.6	3.3	67.4	4.5	48.2	8.1	54.1	46.4	0.3	40.3	35.1	59.2	10.0	0.9	17.9	31.3	0.7	34.9	32.4	22.1	2.7	67.4	0.3	80.8	58.0	44.9	13.0	64.9	26.5	53.2	19.7	31.0	70.6	36.4	2.6	45.6	6.5	1.4	14.7	9.5	0.6	36.7	0.0	0.7	1.2	2.4	0.3	0.7	5.6	0.8	2.6	1.5	6.9	1.0	1.8	0.0	2.8	0.3	3.5	0.6	1.1	105.7	114.4	87.8	154.7	114.3	100.6	94.4	92.0	93.9	80.5	96.6	102.9	3.8	0.0	3.1	16.0	2.2	3.2	3.6	8.5	7.4	26.5	5.8	5.0	5.5	1.5	6.1	12.9	2.1	7.3	0.5	2.6	1.9	14.7	9.6	4.7	12.0	6.9	29.4	1.3	21.0	1.6	6.8	10.4	3.1	3.9	5.1	7.6	5.7	0.3	3.2	16.8	27.1	2.6	4.1	0.9	2.2	14.4	13.1	0.7	3.6	2.8	2.1	17.3	2.1	12.1	5.9	2.9	1.8	10.5	2.6	3.3	0.2	7.8	3.6	15.4	19.7	4.9	9.2	21.3	12.8	1.4	2.3	4.4	1.4	12.9	2.2	2.9
NRXN1	"Hs.22998, KIAA0578"	ENSG00000179915	"Neurexin 1"	"P58400, Q9ULB1"	2	49918503-51225575	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Angiogenesis, Cell adhesion"		"Mental retardation, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	13	"brain: 145.0"	"Group enriched"	"Detected in many"	5	"Astrocytes: 4025.1;Excitatory neurons: 3206.3;Inhibitory neurons: 2116.2;Oligodendrocyte precursor cells: 4897.8"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.3"	"Cell line enriched"	"Detected in some"	7	"SCLC-21H: 31.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071400			Supported	"Plasma membrane"	"Intracellular and membrane"	NA	NA		1400000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"		"HPA071400: AB_2732180"	"unprognostic (7.01e-2)"	"unprognostic (9.96e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.74e-4)"	"unprognostic (2.46e-1)"	"unprognostic (8.95e-2)"		"unprognostic (2.02e-2)"	"unprognostic (1.85e-1)"	"unprognostic (8.19e-2)"	"unprognostic (6.37e-4)"	"unprognostic (2.85e-2)"	"unprognostic (6.68e-7)"	"unprognostic (3.40e-2)"	"unprognostic (1.75e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.99e-3)"	1.1	2.0	40.9	1.1	60.9	0.3	0.8	145.0	74.4	2.2	0.0	11.3	0.9	1.1	3.0	2.0	0.8	1.2	5.2	62.7	16.8	0.4	0.5	0.4	0.3	0.0	2.2	0.9	1.4	0.0	6.0	0.0	7.2	2.8	2.6	7.2	2.4	8.4	0.2	0.9	2.6	1.0	4.7	0.2	2.3	5.6	15.7	1.2	0.6	0.8	0.2	2.3	3.1	22.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.3	0.0	0.0	31.3	1.2	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	3.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	40.9	60.9	145.0	74.4	62.7	16.8	0.0	2.2	7.2	4.7	15.7	22.0	0.1	0.0	0.0	4025.1	0.0	0.0	0.3	0.0	3.4	116.0	3.1	3.7	19.4	0.0	0.0	0.0	2.1	0.0	0.0	0.0	1.9	0.1	201.6	0.1	2.8	1.0	1.8	0.0	3206.3	0.0	0.0	2.3	0.0	0.1	0.0	0.2	3.3	0.2	0.1	77.4	2116.2	0.0	0.0	0.0	0.6	103.4	2.5	0.6	1.8	174.3	0.0	22.7	0.0	4897.8	678.0	0.2	0.0	0.7	1.4	0.5	0.0	0.2	0.0	9.7	0.0	2.5	1.3	13.3	5.8	0.6	0.1	0.3	0.1	0.1	0.0	0.1
NSF	"SEC18, SKD2"	ENSG00000073969	"N-ethylmaleimide sensitive factor, vesicle fusing ATPase"	P46459	17	46590669-46757464	"Enzymes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 276.3;Inhibitory neurons: 284.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003154, CAB009324, HPA071089"	Enhanced		Supported	"Golgi apparatus,Cytosol"		NA	NA		59000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 58: Brain - Synaptic function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol	"Golgi apparatus"	"CAB009324: AB_653479, HPA003154: AB_1079508, HPA071089: AB_2686343"	"unprognostic (5.70e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.07e-3)"	"unprognostic (1.98e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.30e-2)"	"unprognostic (1.09e-1)"	"unprognostic (3.95e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.07e-2)"	"unprognostic (3.09e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.74e-1)"	13.5	20.2	29.9	8.0	28.8	5.7	12.5	7.7	58.7	14.1	0.0	18.3	4.9	11.8	7.3	21.6	9.7	8.0	11.3	39.2	28.6	12.9	13.7	11.6	9.6	36.8	14.3	7.0	22.9	15.3	43.1	7.7	36.6	12.4	13.9	63.0	18.4	5.8	38.9	16.5	16.1	6.4	4.1	14.9	15.6	16.7	15.6	7.9	11.9	13.5	10.0	13.2	14.3	21.1	11.7	25.4	16.6	1.2	9.6	13.4	13.5	15.6	18.2	14.7	14.3	17.5	0.1	28.5	27.3	34.8	15.3	2.0	18.9	5.8	23.9	10.1	24.6	1.0	17.4	24.2	14.3	0.8	6.1	12.3	7.8	29.8	12.3	7.8	23.4	7.0	19.4	15.0	32.9	22.8	19.4	7.5	9.4	36.0	29.9	13.7	16.1	26.7	16.7	24.0	15.2	17.2	23.1	0.1	11.1	17.5	28.5	35.1	19.3	41.2	14.4	22.0	23.7	32.0	19.9	16.4	11.5	15.2	29.7	9.3	11.5	6.6	6.1	9.8	6.7	5.4	6.2	8.1	12.6	6.1	5.1	6.1	4.8	5.9	10.8	5.0	9.4	7.5	29.9	28.8	7.7	58.7	39.2	28.6	36.8	14.3	36.6	4.1	15.6	21.1	16.3	9.6	11.3	54.9	28.2	4.0	3.6	6.7	6.2	106.6	14.0	10.0	8.1	7.2	10.9	22.0	87.6	13.0	18.8	32.3	11.7	12.4	45.2	8.3	19.7	11.5	30.5	8.6	276.3	16.2	14.4	10.9	13.7	11.2	9.5	8.2	11.0	19.3	18.8	43.7	284.7	26.3	24.4	29.9	10.9	45.8	5.9	20.5	10.6	69.3	35.4	24.5	8.2	98.5	71.8	13.7	17.4	8.6	21.7	9.0	18.5	14.7	8.7	89.9	0.0	10.6	12.9	40.6	31.4	9.5	5.7	18.5	14.8	18.3	20.6	8.6
NTSR1	NTR	ENSG00000101188	"Neurotensin receptor 1"	P30989	20	62708836-62762771	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 11.2;intestine: 11.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.4;Cardiomyocytes: 1.1;Excitatory neurons: 1.6;Inhibitory neurons: 1.3;Kupffer cells: 2.9;Microglial cells: 1.0;monocytes: 1.4"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 2.9"	"Region enriched"	"Detected in many"	7	"midbrain: 11.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"PC-3: 57.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA050299			Supported	"Plasma membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA050299: "	"unprognostic (4.14e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.75e-2)"	"unprognostic (8.87e-4)"	"unprognostic (9.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.80e-3)"	"unprognostic (7.16e-2)"	"unprognostic (3.10e-3)"	"unprognostic (3.55e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.49e-1)"	0.0	0.0	1.1	0.0	1.5	0.6	0.0	0.0	1.4	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.4	0.0	0.0	0.0	0.0	0.4	11.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.2	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.0	2.0	10.9	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.3	0.0	0.0	2.8	0.2	2.7	0.3	1.1	57.7	1.8	0.0	9.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	10.8	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.5	0.0	1.4	1.4	0.4	0.4	11.2	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	4.4	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.3	0.0	0.0	2.9	0.3	0.0	0.0	0.5	0.0	1.0	1.4	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0
NUP107	NUP84	ENSG00000111581	"Nucleoporin 107"	P57740	12	68686951-68745809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 89.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031679			Uncertain	"Nucleoplasm,Nuclear membrane,Centrosome"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Nucleoplasm	"Nuclear membrane, Centrosome"	"HPA031679: AB_2673992"	"unprognostic (2.89e-1)"	"unprognostic (3.32e-1)"	"unprognostic (4.10e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.32e-2)"	"prognostic unfavorable (3.12e-9)"	"unprognostic (4.03e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.08e-2)"	"prognostic unfavorable (1.28e-6)"	"unprognostic (3.43e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.96e-1)"	15.4	11.1	5.0	17.9	6.3	24.0	17.8	8.2	6.0	12.9	6.3	13.0	10.3	16.7	14.3	10.7	13.5	9.3	11.4	4.6	5.0	10.6	11.8	12.8	25.8	5.6	5.7	16.3	9.3	11.8	6.8	13.8	5.5	12.0	16.2	14.7	10.3	12.2	11.7	15.8	12.9	14.0	5.4	15.8	11.0	20.9	5.5	25.6	10.3	12.1	25.5	12.4	10.7	7.6	53.1	66.8	77.8	56.7	22.6	28.6	84.1	56.6	32.4	83.0	68.9	67.6	43.7	96.3	53.7	27.2	36.9	59.4	88.4	41.7	109.8	90.8	65.6	110.1	46.2	57.4	14.2	97.9	35.6	15.2	19.4	66.5	43.2	29.0	50.3	54.9	133.7	67.3	52.8	64.3	81.3	85.2	85.8	20.3	64.6	81.9	93.6	57.8	36.1	55.3	45.7	46.9	62.7	46.5	34.4	60.4	69.8	46.7	31.1	45.0	45.8	53.0	69.9	29.2	62.2	115.2	34.7	70.2	54.2	10.5	9.2	14.4	17.7	12.5	23.4	18.7	17.5	19.3	10.2	18.7	21.5	19.5	2.4	30.5	23.2	8.1	20.0	11.8	5.0	6.3	8.2	6.0	4.6	5.0	5.6	5.7	5.5	5.4	5.5	7.6	18.3	12.8	17.7	13.7	38.1	17.3	18.4	28.1	25.0	23.8	12.5	11.4	13.5	12.8	18.9	9.2	18.8	30.7	30.3	12.2	11.7	22.8	45.3	12.6	18.2	20.6	8.5	64.4	23.8	17.6	30.8	19.6	16.3	10.2	15.8	35.6	15.4	7.0	17.5	13.5	20.1	12.6	42.7	13.9	16.2	9.6	38.8	18.3	19.6	15.9	27.0	16.7	36.0	21.6	34.3	22.1	9.9	21.8	22.9	19.4	10.5	6.4	21.9	29.6	13.1	18.4	18.2	89.4	51.9	18.7	17.6	14.1	27.0	24.5	16.8	12.5
NUP133	FLJ10814	ENSG00000069248	"Nucleoporin 133"	Q8WUM0	1	229440259-229508341	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 60.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA059767	Approved		Supported	"Nuclear membrane"		NA	NA		6300	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 59: Non-specific - Transcription"	"Nuclear membrane"		"HPA059767: AB_2684123"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.46e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.72e-2)"	"unprognostic (2.21e-1)"	"unprognostic (4.93e-2)"	"unprognostic (3.48e-1)"	"unprognostic (8.31e-2)"	"unprognostic (2.22e-1)"	"unprognostic (7.01e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.30e-2)"	12.3	10.7	9.2	11.2	10.8	12.6	15.8	13.1	11.9	11.7	7.5	11.2	8.6	14.4	11.2	10.6	13.9	8.6	15.2	9.2	9.2	12.2	10.1	10.8	14.3	9.5	9.0	16.5	10.0	17.9	9.9	15.1	9.8	11.7	11.4	19.1	10.0	11.8	17.9	13.4	9.6	13.2	10.1	11.6	9.8	13.0	8.9	16.8	13.8	14.3	15.4	11.1	10.4	14.5	30.6	24.3	37.0	19.2	26.0	27.8	71.9	24.8	25.1	36.0	32.4	28.8	29.4	44.1	20.9	24.8	16.1	39.4	51.8	26.3	38.4	26.8	64.2	26.7	23.6	21.8	20.9	54.8	20.8	21.8	19.4	25.9	30.8	25.0	30.5	37.1	61.2	20.6	28.6	13.7	40.8	23.4	55.6	42.7	21.8	39.1	38.5	43.6	20.3	26.6	31.7	39.3	36.9	22.9	27.6	18.0	35.7	42.8	26.8	16.3	19.9	28.5	37.3	19.7	26.1	46.8	18.6	31.2	34.6	5.5	5.7	4.4	5.6	5.7	7.0	5.8	5.9	6.2	7.1	4.4	5.9	6.3	1.9	5.5	10.2	4.0	5.9	5.2	9.2	10.8	13.1	11.9	9.2	9.2	9.5	9.0	9.8	10.1	8.9	14.5	10.4	9.6	18.9	26.4	19.9	9.1	6.8	10.1	13.6	16.5	9.9	8.5	21.2	14.3	10.7	14.7	8.4	21.4	11.5	4.4	5.9	8.3	1.5	10.9	8.7	10.3	10.2	21.7	48.9	8.5	13.8	13.8	15.8	8.4	7.6	17.1	11.7	12.0	9.8	16.8	44.1	7.5	8.2	13.6	8.6	3.7	12.5	10.8	7.2	25.3	13.4	12.4	5.2	28.1	60.2	7.0	4.9	12.0	19.0	6.7	4.7	7.9	13.1	12.3	0.0	16.3	10.7	12.6	18.2	14.6	10.7	18.3	13.6	11.8	9.0	6.6
NUP153	HNUP153	ENSG00000124789	"Nucleoporin 153"	P49790	6	17615035-17706925	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport, Viral penetration into host nucleus, Virus entry into host cell"	DNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027896, HPA027897, HPA027898, HPA027899"	Supported		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	"Nuclear membrane"		"HPA027896: AB_10611243, HPA027897: AB_10601108, HPA027898: AB_10601682, HPA027899: "	"unprognostic (2.49e-1)"	"unprognostic (5.37e-1)"	"unprognostic (3.17e-2)"	"unprognostic (6.20e-3)"	"unprognostic (3.36e-1)"	"unprognostic (7.64e-3)"	"unprognostic (2.53e-2)"	"unprognostic (6.49e-2)"	"unprognostic (1.95e-2)"	"unprognostic (7.16e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.60e-2)"	"unprognostic (3.66e-1)"	"unprognostic (5.40e-2)"	"unprognostic (8.69e-2)"	16.5	10.3	5.4	18.2	6.1	45.6	16.7	12.5	7.4	15.2	10.1	12.8	10.1	17.0	11.6	16.2	15.0	14.9	11.2	6.2	6.3	13.1	23.4	13.9	23.9	6.1	7.1	18.6	13.2	17.9	9.2	18.9	6.4	12.0	13.1	15.7	12.0	13.1	25.1	15.9	12.8	14.4	6.3	17.8	11.6	26.7	6.8	25.2	13.8	19.5	27.6	18.7	14.5	9.7	55.6	27.2	57.7	50.8	24.9	29.3	57.8	42.3	39.3	61.8	65.7	45.5	24.9	104.3	69.7	37.7	51.9	39.4	68.1	41.0	99.0	56.2	52.7	55.6	29.4	47.0	18.6	81.0	50.2	31.0	32.5	64.9	46.5	23.6	37.0	34.5	131.7	32.5	41.9	29.5	60.5	50.1	45.6	20.8	29.5	80.1	74.2	97.9	27.3	53.1	64.6	37.5	36.0	58.3	36.2	90.5	37.8	29.0	34.8	63.2	36.2	30.2	66.7	41.8	63.8	102.8	15.6	36.8	76.1	1.2	1.3	3.2	2.8	1.2	3.7	1.7	3.5	3.4	1.9	2.1	2.1	2.1	3.4	3.0	1.8	1.1	1.7	1.3	5.4	6.1	12.5	7.4	6.2	6.3	6.1	7.1	6.4	6.3	6.8	9.7	28.9	19.2	23.2	39.8	31.4	76.3	37.9	11.1	51.2	14.2	32.5	18.7	14.3	11.5	11.9	16.5	16.7	20.9	24.0	19.4	1.9	8.8	27.3	69.3	56.8	23.3	20.9	44.0	53.0	6.0	21.7	31.8	23.4	91.0	3.8	17.7	13.6	30.7	17.5	16.8	48.8	13.6	12.2	15.6	36.7	19.6	17.4	27.5	21.4	47.8	12.7	7.2	20.6	37.2	50.5	13.4	7.0	14.7	27.9	41.7	10.1	9.8	23.4	12.7	13.1	55.1	26.4	30.4	22.3	51.8	79.3	23.9	35.8	11.7	16.8	35.1
NUP155	"KIAA0791, N155"	ENSG00000113569	"Nucleoporin 155"	O75694	5	37288137-37371106	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Atrial fibrillation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"testis: 70.8"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.6;Late spermatids: 104.5;Spermatocytes: 48.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037775	Enhanced		Enhanced	"Nuclear membrane"	"Intracellular and membrane"	NA	NA		28000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 20: HeLa - Mitochondria"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"		"HPA037775: AB_10671885"	"unprognostic (1.10e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.28e-2)"	"unprognostic (8.58e-3)"	"unprognostic (7.14e-2)"	"unprognostic (6.30e-2)"	"prognostic unfavorable (1.35e-6)"	"unprognostic (2.18e-1)"	"unprognostic (9.91e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.51e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.49e-2)"	"unprognostic (6.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.05e-1)"	5.3	3.4	1.9	6.7	2.7	15.2	7.4	5.1	2.5	5.2	3.3	5.6	4.9	6.0	2.7	6.5	5.2	4.0	4.0	2.1	2.5	4.6	5.7	4.2	8.3	2.5	2.4	6.3	4.8	8.1	2.1	8.1	2.9	5.2	6.9	6.6	4.4	4.2	4.3	5.1	4.5	6.6	2.5	5.7	5.0	70.8	2.8	12.6	6.1	5.9	9.8	5.7	3.5	4.0	40.6	31.7	33.7	50.0	10.3	15.1	120.8	32.2	16.9	43.1	31.4	46.9	32.5	46.0	14.4	20.9	46.7	32.2	57.5	31.7	67.0	30.4	32.3	35.8	109.6	21.9	13.0	60.0	24.0	11.1	13.0	66.5	33.5	11.8	23.2	20.4	65.8	23.8	29.0	19.9	32.4	16.3	32.0	24.8	28.4	38.3	106.1	36.5	9.7	38.5	40.6	27.8	74.0	31.4	18.1	23.8	38.8	23.5	20.2	51.5	42.9	39.3	49.5	26.8	47.9	60.0	24.1	53.0	39.9	4.3	2.0	3.5	3.3	4.2	5.6	3.9	3.1	2.9	2.9	2.9	3.0	3.5	0.6	4.5	3.1	2.0	2.4	2.7	1.9	2.7	5.1	2.5	2.1	2.5	2.5	2.4	2.9	2.5	2.8	4.0	11.1	3.2	6.8	11.8	15.5	10.5	6.5	6.5	10.8	8.0	8.0	5.0	11.0	2.8	9.6	3.7	6.2	14.3	9.8	5.2	0.0	6.0	64.6	6.9	11.0	9.6	1.2	10.7	12.4	6.1	20.4	9.0	9.2	7.1	5.1	15.1	13.9	9.7	7.9	5.0	12.6	8.7	12.2	8.9	8.0	104.5	11.1	7.0	0.0	7.5	5.7	3.9	8.2	15.1	16.7	8.2	3.8	10.1	12.7	7.6	3.9	4.1	11.4	14.5	0.0	11.5	10.5	48.2	21.1	10.8	11.6	7.5	9.9	10.6	11.3	4.9
NUP160	"FLJ22583, KIAA0197"	ENSG00000030066	"Nucleoporin 160"	Q12769	11	47778087-47848555	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		15000	"Cluster 46: Basophils - DNA binding"	"Cluster 34: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"				"unprognostic (8.72e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.87e-2)"	"unprognostic (2.27e-1)"	"unprognostic (3.23e-1)"	"unprognostic (3.59e-3)"	"unprognostic (1.55e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.94e-1)"	"unprognostic (3.78e-2)"	"unprognostic (3.14e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.93e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.01e-1)"	13.3	9.5	5.1	17.3	6.6	20.0	16.5	9.4	6.5	13.5	8.6	12.1	11.8	17.6	11.4	11.0	15.5	10.9	8.7	5.1	6.2	14.2	14.5	14.0	20.6	6.4	6.2	19.6	14.7	16.3	9.9	20.7	6.1	12.7	14.9	15.2	11.7	11.5	11.1	12.6	11.5	16.5	5.8	15.1	10.8	14.5	5.9	30.9	16.9	9.3	21.6	14.6	11.7	9.2	24.4	31.7	52.2	36.6	30.3	34.8	67.3	30.7	22.7	40.8	46.8	40.3	36.2	33.2	20.3	28.0	41.0	52.1	96.5	30.4	45.3	29.1	66.7	36.6	131.3	44.1	20.2	108.1	24.0	27.4	18.7	29.0	56.5	16.6	32.5	52.9	103.7	45.5	22.0	41.9	72.9	47.6	78.4	53.7	33.1	86.2	78.3	29.8	20.9	42.2	43.0	49.0	72.8	35.6	27.6	45.7	44.6	41.1	22.1	44.6	38.4	75.2	41.7	19.7	19.9	83.8	22.0	45.2	45.2	8.6	7.5	13.3	9.9	9.5	13.6	15.3	11.7	10.8	12.3	14.8	15.4	11.5	4.3	9.7	6.8	16.3	9.8	7.1	5.1	6.6	9.4	6.5	5.1	6.2	6.4	6.2	6.1	5.8	5.9	9.2	15.0	22.4	18.8	39.5	31.0	22.9	35.7	18.6	20.5	24.8	14.8	11.2	7.8	12.8	19.4	20.2	43.8	33.1	31.4	10.3	15.6	17.7	27.6	17.9	16.3	17.9	19.2	19.6	35.2	16.7	30.4	19.2	15.3	20.3	19.7	23.3	19.2	12.0	15.2	6.7	50.1	14.6	20.3	10.1	19.8	11.5	24.2	14.4	10.6	44.0	15.7	19.7	24.7	61.9	53.8	16.4	8.6	21.8	21.8	32.9	10.9	10.5	15.0	48.4	19.7	19.6	17.2	18.2	22.0	16.4	27.7	30.8	25.3	20.5	15.7	34.8
NUP188	KIAA0169	ENSG00000095319	"Nucleoporin 188"	Q5SRE5	9	128947699-129007096	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cataract, Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 45.9;Spermatocytes: 52.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061750, HPA063942"	Approved		Uncertain	Nucleoplasm,Nucleoli,Cytosol		No	No			"Cluster 44: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Nucleoli, Cytosol"	"HPA061750: AB_2684602, HPA063942: AB_2685156"	"unprognostic (4.64e-1)"	"unprognostic (6.91e-3)"	"unprognostic (2.36e-1)"	"prognostic favorable (5.20e-5)"	"unprognostic (9.50e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.85e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.63e-1)"	"unprognostic (7.78e-2)"	"unprognostic (4.53e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.81e-3)"	"unprognostic (3.53e-3)"	13.1	15.5	9.5	16.2	10.9	21.4	11.9	13.1	10.0	15.6	10.0	14.8	7.5	13.1	8.0	23.7	11.9	9.4	13.6	9.0	9.7	10.4	9.9	16.7	18.0	11.4	11.1	11.4	12.0	13.1	14.9	11.8	11.8	13.5	11.5	13.7	13.9	9.8	15.7	21.4	13.4	13.9	9.3	16.8	13.6	56.6	10.9	27.3	12.6	10.3	20.4	16.1	15.6	11.7	33.6	62.6	50.8	69.7	37.7	37.2	45.4	45.9	35.9	82.1	54.4	76.3	26.2	58.2	16.7	50.7	52.9	96.6	115.2	56.8	61.0	47.1	55.5	51.9	113.3	60.8	23.9	89.6	50.2	26.0	26.3	86.5	43.8	24.1	47.8	74.1	116.0	40.3	58.8	84.6	77.3	36.5	68.2	63.8	59.4	69.9	109.8	59.2	25.5	37.3	71.2	34.3	118.8	44.7	17.1	37.2	49.3	32.7	39.0	67.7	48.2	69.2	83.5	34.1	67.9	76.9	39.5	56.3	51.2	8.2	4.8	1.7	7.5	8.9	9.7	4.9	6.4	7.4	6.8	4.3	6.4	7.0	0.6	5.4	5.2	2.9	8.3	6.8	9.5	10.9	13.1	10.0	9.0	9.7	11.4	11.1	11.8	9.3	10.9	11.7	9.6	0.0	12.6	15.7	10.4	6.5	6.6	6.4	5.7	16.2	7.6	7.6	3.5	10.0	5.9	5.5	45.9	8.0	8.6	6.0	1.9	6.1	14.5	7.9	13.2	9.4	9.1	8.6	11.3	6.5	6.5	9.5	9.7	12.2	6.3	24.0	11.0	5.0	8.4	20.2	13.1	7.2	6.1	4.7	6.1	5.7	9.6	8.1	1.8	12.2	5.3	6.8	9.2	12.5	13.0	9.0	2.3	11.7	8.3	10.1	3.3	2.5	6.3	24.4	26.3	18.2	7.1	52.9	37.8	13.6	11.2	8.6	9.4	12.5	7.4	8.2
NUP205	"C7orf14, KIAA0225"	ENSG00000155561	"Nucleoporin 205"	Q92621	7	135557917-135648757	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		24000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"				"unprognostic (3.64e-2)"	"unprognostic (2.13e-1)"	"unprognostic (6.05e-2)"	"unprognostic (3.66e-3)"	"unprognostic (4.00e-1)"	"unprognostic (2.96e-2)"	"prognostic unfavorable (1.90e-7)"	"unprognostic (2.33e-2)"	"unprognostic (2.12e-2)"	"unprognostic (3.27e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.22e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.35e-2)"	7.5	6.7	2.0	13.1	3.3	10.7	11.5	6.7	2.6	8.9	3.8	10.0	8.0	10.7	7.2	11.0	10.4	6.4	4.9	1.7	3.1	8.0	6.6	8.4	15.0	2.7	2.7	11.8	6.1	15.1	5.2	11.0	3.2	8.7	12.3	14.8	11.8	9.0	8.0	9.6	8.3	12.7	2.6	10.3	9.0	11.6	3.2	21.8	8.4	8.0	17.3	9.9	6.9	4.4	66.4	52.8	69.5	68.2	16.2	26.6	45.4	41.0	31.5	62.4	69.1	55.1	46.8	84.2	31.7	24.6	63.0	50.1	88.5	46.0	80.1	41.9	63.3	48.9	52.1	25.1	12.2	96.5	37.0	14.5	20.5	61.4	40.8	21.9	47.3	58.9	115.6	39.1	47.6	45.0	105.0	29.4	107.0	51.6	46.3	77.6	64.6	66.6	18.8	52.4	69.3	70.4	67.8	54.8	31.8	52.4	31.6	36.5	38.6	51.0	25.3	62.7	79.5	28.7	57.2	112.3	51.7	74.3	70.1	1.6	1.3	0.4	2.4	3.1	2.8	2.3	2.9	2.5	3.0	2.1	2.3	2.7	0.5	2.9	1.7	1.9	2.9	1.4	2.0	3.3	6.7	2.6	1.7	3.1	2.7	2.7	3.2	2.6	3.2	4.4	7.9	12.8	13.4	24.8	15.3	13.0	6.8	10.3	11.4	6.3	8.6	5.2	5.3	7.2	10.6	16.5	12.5	13.1	7.5	8.2	3.9	7.8	0.9	7.4	8.1	9.3	9.1	21.3	22.7	9.6	9.3	9.4	13.3	8.4	8.2	18.5	7.9	10.7	10.3	5.0	24.1	10.4	6.1	14.1	11.7	2.4	8.1	12.2	10.6	17.8	11.4	4.9	3.1	26.2	23.3	11.9	6.4	7.5	17.4	10.3	3.9	4.6	12.4	9.7	0.0	12.6	8.2	14.5	10.8	14.8	15.5	7.7	11.9	6.1	10.9	9.4
NUP210	"FLJ22389, GP210, KIAA0906, POM210"	ENSG00000132182	"Nucleoporin 210"	Q8TEM1	3	13316235-13420322	"Metabolic proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 53.4;lymphoid tissue: 41.7"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 57.7;Granulosa cells: 70.0;NK-cells: 69.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"RPMI-8226: 232.7;U-266/84: 261.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066888	Approved					NA	NA		78000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 40: Granulosa cells - Unknown function"			"HPA066888: AB_2685741"	"unprognostic (3.17e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.72e-3)"	"prognostic unfavorable (6.03e-6)"	"unprognostic (1.30e-1)"	"unprognostic (3.15e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.87e-2)"	"unprognostic (1.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.59e-2)"	"unprognostic (1.63e-2)"	2.0	5.2	5.3	23.2	5.8	53.4	5.4	7.8	6.5	2.3	4.8	6.4	7.3	2.6	8.4	7.1	4.1	4.6	2.3	5.0	6.2	8.8	19.8	7.6	41.3	6.1	6.7	1.2	13.0	9.7	13.5	6.4	5.5	5.4	5.6	4.8	6.4	2.8	5.2	5.6	22.2	2.4	5.2	32.5	8.5	9.2	5.8	41.7	8.1	1.8	29.0	5.8	2.2	7.3	41.5	72.0	34.8	90.8	0.0	0.0	138.1	0.6	0.0	8.6	0.4	37.2	66.3	167.7	55.6	0.1	3.9	23.8	77.5	0.0	3.2	135.9	57.9	65.2	81.1	39.6	0.0	210.8	22.7	0.0	0.0	0.0	0.0	6.3	0.1	124.1	102.5	174.9	0.0	103.8	112.6	83.4	40.2	12.8	14.8	0.2	0.2	232.7	16.9	38.4	39.8	39.8	51.3	67.7	21.0	15.5	64.8	172.6	0.5	0.1	11.7	0.2	31.8	176.1	261.0	144.9	0.1	116.0	0.3	0.0	2.5	0.9	7.3	3.2	5.8	5.4	5.2	7.2	5.4	3.1	4.3	5.8	0.1	5.5	2.0	5.6	4.8	3.7	5.3	5.8	7.8	6.5	5.0	6.2	6.1	6.7	5.5	5.2	5.8	7.3	0.7	16.0	5.4	16.6	37.3	1.7	1.3	0.5	0.0	25.4	9.6	5.3	11.6	8.6	4.1	5.5	14.6	17.6	57.7	2.9	3.9	5.7	19.2	4.3	1.0	1.0	8.3	41.8	17.9	4.4	5.6	1.1	3.6	8.3	5.1	70.0	3.6	17.0	16.7	35.3	23.4	8.8	4.1	11.3	4.9	23.5	0.6	14.9	1.8	10.3	16.7	3.0	69.0	30.2	17.7	2.6	0.8	0.4	43.7	2.6	2.1	4.5	3.0	19.4	0.0	2.1	1.1	6.4	10.0	3.5	2.4	4.9	37.2	17.8	11.5	1.9
NUP214	"CAIN, CAN, D9S46E, N214"	ENSG00000126883	"Nucleoporin 214"	P35658	9	131125586-131234663	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease variant, Proto-oncogene"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 124.2"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 281.4;Granulosa cells: 169.2;Kupffer cells: 274.8;Late spermatids: 404.3;monocytes: 224.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 425.3;neutrophil: 1259.6"	"Group enriched"	"Detected in all"	5	"granulocytes: 1259.6;monocytes: 425.3"	"Cell line enhanced"	"Detected in all"		"K-562: 260.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		46000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 71: Testis - DNA repair"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"				"unprognostic (1.30e-1)"	"unprognostic (9.51e-3)"	"unprognostic (9.92e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.42e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.07e-3)"	"unprognostic (2.10e-2)"	"unprognostic (3.35e-1)"	"unprognostic (4.95e-1)"	"unprognostic (6.60e-3)"	"unprognostic (1.08e-1)"	"prognostic favorable (2.39e-5)"	"unprognostic (5.49e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.82e-1)"	"unprognostic (1.53e-1)"	29.0	21.2	17.0	18.5	20.9	42.0	26.0	19.1	23.2	21.1	17.7	23.1	11.8	21.1	17.5	33.0	22.6	12.3	26.1	18.0	18.2	43.8	32.0	22.7	15.1	20.9	19.6	22.1	32.8	16.0	21.5	14.4	20.1	21.9	13.4	15.2	21.3	12.2	24.0	28.9	23.8	13.0	17.0	68.8	25.6	124.2	20.4	41.8	22.0	13.1	15.4	21.2	22.1	26.3	23.1	31.3	28.1	15.4	20.2	25.1	26.9	20.9	20.4	24.7	20.2	25.2	17.0	36.7	16.8	29.6	26.5	50.1	35.2	24.0	32.6	26.4	16.0	25.7	45.7	45.5	18.3	37.4	23.3	20.7	21.9	31.0	27.5	16.9	25.1	23.2	260.6	20.5	28.0	39.4	52.8	41.8	27.7	30.2	27.1	17.8	35.2	36.4	25.0	24.8	21.4	24.8	35.5	30.0	17.3	18.4	41.0	90.3	23.5	44.9	25.2	30.1	31.6	18.8	49.7	39.0	22.3	20.7	28.2	53.2	425.3	174.5	6.7	181.7	8.1	13.5	8.4	6.4	162.2	11.8	6.5	7.5	1259.6	10.2	154.8	16.9	5.2	211.2	17.0	20.9	19.1	23.2	18.0	18.2	20.9	19.6	20.1	17.0	20.4	26.3	24.3	19.2	17.9	46.7	27.8	8.7	11.3	11.4	20.5	31.0	14.7	14.6	21.3	10.0	15.6	23.9	45.9	13.2	31.2	18.6	9.8	10.4	281.4	17.3	20.1	18.6	20.4	20.4	39.7	15.2	11.8	17.8	20.4	18.8	8.8	169.2	21.4	14.5	81.2	16.8	41.1	16.6	22.4	274.8	35.3	404.3	23.3	120.6	10.6	50.6	224.1	14.9	33.0	41.2	75.8	13.8	7.7	20.3	23.4	14.3	15.0	9.1	19.8	32.3	6.6	24.4	36.3	90.8	49.8	16.5	10.9	10.9	22.4	23.0	17.6	11.3
NUP35	MP44	ENSG00000163002	"Nucleoporin 35"	Q8NFH5	2	183117513-183161680	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"Early spermatids: 151.6;Late spermatids: 424.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018401, HPA018410, HPA018441"	Enhanced		Supported	"Nucleoplasm,Nuclear membrane,Plasma membrane"		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"	"Plasma membrane"	"HPA018401: AB_1854719, HPA018410: AB_1854721, HPA018441: AB_1854720"	"unprognostic (6.18e-3)"	"unprognostic (3.15e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.58e-3)"	"unprognostic (1.37e-1)"	"unprognostic (9.91e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (3.95e-1)"	"unprognostic (6.21e-3)"	"prognostic favorable (3.45e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.61e-3)"	"unprognostic (1.78e-3)"	"unprognostic (6.78e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.96e-2)"	7.7	8.9	5.9	6.9	7.3	4.6	13.1	8.9	7.8	8.5	5.0	7.6	6.3	8.1	7.7	8.7	8.9	6.9	6.2	6.1	5.9	10.2	14.4	5.9	9.1	5.5	5.9	10.4	10.2	8.9	6.3	7.8	5.5	7.8	9.1	9.0	8.4	7.0	7.4	9.0	6.5	8.9	6.6	5.7	7.2	24.2	5.5	10.4	8.2	8.7	11.0	9.2	8.0	6.4	19.7	19.7	32.5	20.5	11.8	11.5	23.2	23.0	18.8	35.3	33.5	37.6	24.7	34.6	22.0	12.4	40.9	17.4	45.4	26.7	57.8	29.6	27.8	32.6	16.4	43.9	8.2	23.6	21.8	8.2	13.8	29.9	28.9	7.9	20.8	20.5	28.7	25.3	27.8	23.7	28.7	29.1	57.9	31.6	61.9	34.3	25.2	25.0	34.0	24.7	29.4	20.3	21.6	26.6	26.0	24.4	17.0	16.2	10.6	28.6	19.7	23.3	26.5	16.4	38.3	37.9	19.3	16.8	39.2	0.0	4.1	1.4	4.9	5.5	8.6	7.2	6.3	6.0	3.2	6.5	7.5	6.7	0.2	5.6	6.6	3.1	6.7	4.1	5.9	7.3	8.9	7.8	6.1	5.9	5.5	5.9	5.5	6.6	5.5	6.4	9.6	9.6	6.8	6.5	10.3	26.0	20.7	17.5	12.5	10.8	9.3	8.9	4.7	14.3	13.8	16.5	18.8	23.6	8.5	3.3	11.7	15.5	151.6	5.3	8.1	10.2	3.6	12.6	11.5	12.7	20.2	10.8	5.1	6.4	8.2	8.1	12.8	12.6	8.4	6.7	12.0	7.5	16.2	4.4	9.9	424.7	9.6	3.6	21.4	2.8	5.0	11.4	7.2	17.1	12.8	11.1	5.1	8.2	7.5	12.8	4.2	14.5	6.9	19.1	13.1	18.7	11.6	39.8	21.1	11.3	27.4	9.4	11.5	9.0	9.6	11.2
NUP37	"FLJ22618, MGC5585"	ENSG00000075188	"Nucleoporin 37"	Q8NFH4	12	102073103-102120120	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Disease variant, Primary microcephaly"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 92.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA056300, HPA073708"	Supported		Approved	Nucleoplasm		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA056300: AB_2683092, HPA073708: AB_2686629"	"unprognostic (1.42e-3)"	"unprognostic (5.39e-2)"	"unprognostic (3.31e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (6.72e-4)"	"prognostic unfavorable (7.70e-6)"	"unprognostic (2.48e-3)"	"unprognostic (2.37e-3)"	"unprognostic (7.77e-2)"	"unprognostic (2.90e-3)"	"unprognostic (1.67e-2)"	"unprognostic (7.47e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.06e-1)"	"unprognostic (3.64e-1)"	11.3	14.2	4.1	17.1	4.4	22.7	19.5	5.1	7.8	12.8	2.4	20.1	13.0	11.9	21.5	18.9	19.0	10.9	17.6	4.8	4.5	15.2	13.0	11.6	28.1	3.5	2.8	12.1	8.7	17.4	5.9	16.9	3.4	13.7	23.8	10.9	11.7	13.8	17.5	13.4	14.9	17.7	2.4	12.0	12.9	15.1	4.3	25.7	16.4	15.5	33.5	17.7	9.6	6.3	105.5	74.5	64.2	29.6	51.7	68.4	144.6	64.8	61.0	99.8	68.0	97.4	55.5	70.1	45.4	50.9	68.9	76.2	113.5	101.2	124.4	98.5	65.2	75.6	37.2	86.4	66.0	107.5	22.8	53.4	43.5	78.3	57.3	66.7	83.3	91.2	135.5	25.8	93.9	71.6	79.9	87.9	63.4	96.8	117.2	51.9	92.0	52.8	79.0	76.1	33.6	24.0	49.8	52.7	50.3	72.1	90.7	61.7	27.2	35.7	39.4	51.0	91.1	38.5	78.9	119.4	41.9	86.1	61.8	67.8	24.0	28.3	21.4	29.3	23.2	31.2	25.7	21.9	30.2	28.2	23.0	26.1	7.0	23.9	24.9	25.3	45.4	22.5	4.1	4.4	5.1	7.8	4.8	4.5	3.5	2.8	3.4	2.4	4.3	6.3	12.3	6.4	14.3	8.8	22.6	11.3	20.9	63.8	17.1	8.0	10.5	11.7	9.5	14.3	28.2	16.5	8.4	68.1	17.7	9.1	25.4	24.0	2.9	21.6	17.6	17.2	6.0	38.7	5.8	20.0	92.3	19.9	12.2	11.8	7.6	21.2	13.6	10.0	35.6	3.3	7.3	16.0	22.4	15.2	8.4	6.3	19.6	13.5	7.2	5.6	20.5	18.9	13.4	11.1	12.6	17.2	10.6	18.8	34.1	10.7	11.5	24.6	39.3	20.1	19.7	8.6	18.3	49.0	42.4	25.5	9.5	40.2	18.8	31.9	26.5	16.8
NUP42	"CG1, H_RG271G13.9, hCG1, NLP_1, NUPL2"	ENSG00000136243	"Nucleoporin 42"	O15504	7	23181841-23201011	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 7.7;Cardiomyocytes: 20.3;Cytotrophoblasts: 17.1;dendritic cells: 10.5;Extravillous trophoblasts: 11.6;Hofbauer cells: 28.1;Syncytiotrophoblasts: 6.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049036, HPA057251"			Supported	Nucleoplasm		No	No			"Cluster 17: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 24: Non-specific - Transcription regulation"	Nucleoplasm		"HPA049036: , HPA057251: "	"unprognostic (3.81e-2)"	"unprognostic (2.53e-1)"	"unprognostic (3.97e-1)"	"unprognostic (3.87e-1)"	"unprognostic (4.16e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.33e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.09e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.30e-3)"	"unprognostic (2.07e-2)"	"unprognostic (4.74e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.00e-3)"	"unprognostic (3.59e-1)"	"unprognostic (1.32e-2)"	10.8	14.7	12.9	10.8	8.8	20.6	11.4	21.2	13.8	11.2	18.0	11.1	14.9	14.2	15.1	13.6	12.9	13.1	19.7	11.2	10.4	15.1	13.9	10.0	21.6	11.6	9.9	12.0	6.2	17.1	6.4	8.6	8.9	12.1	14.3	8.2	10.7	10.1	11.6	16.4	12.4	15.0	3.6	15.8	11.6	18.9	10.7	19.4	14.4	9.0	18.3	13.2	7.7	22.6	31.1	14.0	21.5	44.5	21.3	25.0	17.8	23.1	16.6	25.2	26.4	21.2	31.9	52.4	22.0	16.1	54.1	41.6	37.9	17.2	32.6	15.9	39.0	32.0	36.5	21.7	24.6	67.4	47.1	11.6	25.5	21.8	14.5	20.4	29.0	22.0	58.9	31.4	25.5	7.7	32.5	54.6	45.1	38.4	21.9	31.6	19.0	40.5	27.1	21.6	33.2	31.2	22.9	14.0	44.9	41.2	17.0	86.3	21.6	16.5	21.8	28.3	39.7	44.9	64.8	52.3	17.6	46.7	44.4	33.2	10.3	8.1	11.0	10.1	10.7	18.8	12.8	12.1	15.0	13.6	10.6	12.7	8.0	17.8	9.3	14.4	16.2	11.1	12.9	8.8	21.2	13.8	11.2	10.4	11.6	9.9	8.9	3.6	10.7	22.6	7.7	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.3	0.0	0.0	0.0	0.0	17.1	10.5	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	11.6	5.2	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.0	6.6	1.3	0.0	0.0	0.0
NUP43	"bA350J20.1, FLJ13287"	ENSG00000120253	"Nucleoporin 43"	Q8NFH3	6	149724315-149749665	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 78.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA027126, HPA027291, HPA028500"	Enhanced		Approved	"Nucleoplasm,Nuclear speckles,Cytosol"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 16: Immune cells - Immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Nucleoplasm, Nuclear speckles"	Cytosol	"HPA027126: AB_10599301, HPA027291: AB_10601851, HPA028500: AB_10602287"	"prognostic unfavorable (2.08e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.86e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.29e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (7.13e-7)"	"unprognostic (5.14e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-2)"	"unprognostic (6.25e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.72e-2)"	"unprognostic (3.60e-2)"	8.4	8.6	6.2	11.4	7.5	6.2	13.6	7.2	6.9	9.7	6.5	9.4	8.7	9.8	7.5	9.5	8.2	6.4	10.8	5.6	6.6	9.9	9.6	8.0	15.9	6.6	6.6	9.1	12.2	8.9	5.6	11.4	6.9	10.3	9.7	9.8	8.8	9.2	14.2	13.5	10.9	9.4	6.6	13.6	9.8	7.9	6.5	12.8	11.1	11.6	17.0	9.0	9.1	8.3	21.1	34.9	31.1	49.6	20.0	23.7	48.9	36.3	20.3	34.0	43.0	49.5	19.5	61.4	36.6	20.2	32.1	33.5	54.6	31.6	58.3	27.8	38.2	70.9	35.5	49.6	13.4	73.2	44.1	15.3	16.4	49.9	33.1	13.0	27.5	34.6	71.4	33.6	29.6	20.7	52.2	30.4	28.3	24.1	21.0	50.2	43.2	20.6	23.2	28.9	12.9	21.2	43.4	27.1	14.2	25.6	28.7	30.9	21.3	28.3	30.2	41.2	53.9	20.5	43.3	63.9	25.2	49.3	40.5	2.9	4.9	3.4	3.5	5.4	3.8	4.3	4.2	3.5	2.6	6.2	4.3	5.5	1.9	3.7	4.8	5.0	4.9	2.2	6.2	7.5	7.2	6.9	5.6	6.6	6.6	6.6	6.9	6.6	6.5	8.3	5.8	3.2	7.8	9.1	11.5	7.9	5.5	4.7	2.8	11.9	4.5	5.0	14.3	11.5	5.2	3.7	6.2	10.9	11.3	4.7	3.9	9.0	33.3	4.3	8.7	5.7	10.2	7.6	4.8	7.8	12.2	6.4	6.1	6.0	0.0	12.8	8.2	4.4	7.8	6.7	5.1	6.9	2.0	11.9	6.9	78.9	10.2	6.5	8.8	9.4	15.1	10.5	9.2	11.1	17.4	6.6	2.3	10.5	8.7	6.2	3.9	5.4	4.2	9.5	13.1	6.9	22.1	7.1	9.2	5.5	8.5	6.6	7.6	7.4	8.4	6.7
NUP50	NPAP60L	ENSG00000093000	"Nucleoporin 50"	Q9UKX7	22	45163925-45188017	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA047162, HPA048328"	Enhanced		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoplasm, Nuclear membrane"		"HPA047162: AB_2679963, HPA048328: AB_2680360"	"unprognostic (2.64e-1)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-1)"	"unprognostic (1.57e-1)"	"unprognostic (5.46e-3)"	"unprognostic (5.83e-3)"	"unprognostic (4.94e-2)"	"unprognostic (4.94e-2)"	"unprognostic (7.22e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.97e-2)"	"prognostic favorable (4.06e-4)"	"unprognostic (1.43e-1)"	"unprognostic (3.17e-2)"	"unprognostic (3.63e-2)"	14.1	14.8	8.6	23.3	9.9	54.4	13.5	11.9	12.1	14.3	11.2	18.7	16.6	10.1	18.7	20.5	18.1	14.3	7.2	10.7	10.2	13.7	23.5	14.6	33.7	8.1	8.3	13.9	15.9	15.8	6.7	15.5	7.8	12.2	16.7	10.9	11.7	13.4	7.8	19.0	16.3	11.4	8.0	25.5	24.2	29.8	9.2	46.6	15.2	12.7	35.3	19.3	12.3	9.7	75.8	35.5	67.1	43.7	31.0	31.8	70.9	61.9	41.1	46.9	47.1	77.6	32.9	82.7	28.1	41.0	35.1	52.0	83.4	50.5	67.3	44.3	87.4	72.6	54.8	47.7	32.2	193.7	73.7	38.8	34.1	60.1	45.2	22.7	52.4	71.4	76.5	84.3	49.0	50.8	88.2	50.5	50.4	50.0	36.3	91.8	40.7	58.0	37.0	72.5	41.7	40.4	61.5	37.9	74.0	50.9	23.6	50.3	48.3	99.1	88.6	51.6	52.7	58.4	51.3	119.0	37.1	49.2	70.4	55.1	39.1	80.5	20.3	40.2	27.8	19.5	24.5	23.5	25.5	18.1	28.4	19.6	92.7	30.6	24.2	13.9	25.8	34.2	8.6	9.9	11.9	12.1	10.7	10.2	8.1	8.3	7.8	8.0	9.2	9.7	42.7	9.6	27.9	6.2	32.7	85.5	51.9	26.4	48.3	14.6	26.2	16.3	10.8	22.8	29.6	33.1	12.5	22.6	47.5	34.2	13.7	18.9	46.3	56.3	34.7	29.7	17.4	72.4	16.4	20.9	39.8	21.8	59.1	47.3	34.7	23.9	33.2	38.5	28.1	13.5	15.3	24.4	20.3	47.5	32.8	83.3	14.6	33.4	24.9	11.2	56.9	11.1	42.2	11.6	12.5	29.8	33.5	13.9	49.0	60.8	16.9	22.8	50.0	16.3	26.3	15.9	17.1	45.9	44.3	60.6	89.4	56.6	47.1	23.5	26.3	95.3
NUP54		ENSG00000138750	"Nucleoporin 54"	Q7Z3B4	4	76114659-76148444	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035929, HPA058122"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm		"HPA035929: AB_10671236, HPA058122: AB_2683613"	"unprognostic (6.70e-2)"	"unprognostic (3.51e-2)"	"prognostic favorable (8.80e-4)"	"unprognostic (3.02e-1)"	"unprognostic (3.58e-2)"	"unprognostic (4.24e-2)"	"prognostic unfavorable (4.64e-4)"	"unprognostic (1.51e-3)"	"unprognostic (3.05e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.49e-3)"	"unprognostic (3.36e-2)"	"unprognostic (2.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.65e-3)"	17.5	13.1	6.4	15.8	7.1	35.0	23.4	11.9	9.3	22.4	6.2	19.2	16.5	23.5	18.8	18.1	20.0	15.8	12.2	6.6	7.7	15.2	22.2	16.1	22.1	6.4	6.4	24.3	16.6	15.7	7.5	24.4	6.6	18.5	20.6	12.4	14.7	18.4	12.7	19.3	16.0	20.4	7.1	16.6	16.3	21.8	6.3	28.7	20.6	14.2	24.5	21.7	15.0	9.2	42.6	14.2	52.3	37.1	44.2	40.8	45.0	42.1	61.1	62.1	63.1	36.9	58.4	64.4	34.5	42.3	33.4	27.5	57.0	47.6	76.5	42.5	31.1	38.5	19.1	36.7	41.1	75.8	44.1	37.4	33.6	48.8	50.7	27.1	52.8	41.4	67.1	38.9	44.4	35.9	81.0	39.9	81.3	51.2	14.2	61.6	81.0	25.0	37.3	39.1	31.7	26.6	38.6	45.2	35.4	39.5	18.7	47.2	35.5	48.2	43.0	58.8	52.8	25.1	10.0	60.8	35.1	44.5	44.0	10.1	8.8	9.3	13.3	10.7	18.4	9.7	14.0	13.1	12.9	10.9	14.7	14.1	4.1	26.6	12.6	9.5	14.9	8.5	6.4	7.1	11.9	9.3	6.6	7.7	6.4	6.4	6.6	7.1	6.3	9.2	26.1	22.4	16.7	25.5	31.3	35.2	42.8	29.4	32.5	13.8	18.8	19.3	11.8	14.3	17.8	11.0	20.9	41.3	30.5	13.5	29.4	25.1	12.5	24.9	31.6	23.7	14.4	35.7	42.8	27.7	47.5	26.8	17.3	34.4	24.1	23.0	19.2	13.6	21.7	8.4	42.0	20.8	16.2	16.4	24.2	7.4	27.4	20.2	17.8	18.7	28.6	12.8	35.0	34.2	54.2	19.2	17.1	25.9	30.5	34.1	14.4	20.4	19.2	22.2	32.9	24.8	26.5	46.8	39.9	30.2	29.1	39.1	31.8	21.6	24.4	36.1
NUP58	"KIAA0410, NUP45, NUPL1"	ENSG00000139496	"Nucleoporin 58"	Q9BVL2	13	25301556-25349800	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 122.5;Late spermatids: 238.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039360	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA039360: AB_2676463"	"unprognostic (1.13e-1)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.94e-2)"	"unprognostic (3.35e-1)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.56e-4)"	"unprognostic (4.85e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.40e-1)"	"unprognostic (6.14e-2)"	"unprognostic (2.04e-2)"	"unprognostic (7.19e-3)"	"unprognostic (3.02e-3)"	"unprognostic (3.03e-1)"	"unprognostic (2.47e-2)"	"unprognostic (1.06e-1)"	13.2	14.1	11.9	17.2	12.1	34.7	16.1	14.1	14.3	13.6	11.0	12.3	11.8	15.0	12.0	13.7	13.2	13.8	14.1	12.9	13.4	15.5	16.0	19.5	21.5	11.8	13.3	18.4	12.3	10.7	20.9	20.6	11.1	15.4	14.6	27.3	10.7	11.2	20.4	14.2	11.5	14.6	11.1	12.2	13.2	47.6	12.4	26.9	19.5	24.3	18.9	18.7	12.8	14.9	38.5	22.6	53.8	40.6	17.9	25.4	40.9	55.8	41.6	57.9	47.3	37.8	40.5	65.0	26.4	31.6	49.7	41.8	61.6	45.6	92.4	60.5	30.0	90.8	20.8	26.7	33.0	66.5	103.9	17.4	61.8	47.8	106.4	28.6	36.3	55.5	49.4	27.6	66.4	15.2	86.1	47.0	32.4	61.4	19.5	59.1	70.5	29.8	32.1	29.4	63.5	32.0	36.0	27.2	44.6	43.3	18.4	60.6	29.6	37.4	37.2	36.3	66.5	33.9	29.9	87.4	27.6	38.9	65.2	1.4	6.3	1.8	2.4	5.3	3.2	2.4	3.1	2.9	3.8	1.9	3.5	3.1	8.9	2.3	6.3	1.9	4.3	3.4	11.9	12.1	14.1	14.3	12.9	13.4	11.8	13.3	11.1	11.1	12.4	14.9	25.9	41.7	105.2	0.0	53.6	0.0	24.1	0.0	52.3	34.6	27.4	20.7	0.0	20.0	13.6	25.8	54.2	27.2	30.2	8.5	11.7	13.4	122.5	30.6	51.4	23.9	9.7	41.2	0.0	10.9	39.8	27.4	26.0	47.7	24.0	32.9	19.2	27.1	23.0	25.2	0.0	13.7	0.0	40.5	0.0	238.7	19.3	56.6	0.0	0.0	31.7	22.7	19.6	0.0	0.0	19.3	6.8	24.8	41.6	39.7	11.7	37.0	5.8	49.5	19.7	35.8	22.3	86.7	78.8	33.8	0.0	39.5	38.1	21.6	14.0	28.7
NUP62	"DKFZp547L134, FLJ20822, FLJ43869, IBSN, MGC841, p62, SNDI"	ENSG00000213024	"Nucleoporin 62"	P37198	19	49906825-49929763	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Langerhans cells: 119.2;Late spermatids: 315.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005435, CAB020724"	Supported		Supported	"Nucleoplasm,Nuclear membrane"		NA	Yes		31000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 16: U-266 - Nucleosome"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	Nucleoplasm	"CAB020724: , HPA005435: AB_1079510"	"unprognostic (2.26e-1)"	"unprognostic (4.06e-2)"	"unprognostic (9.92e-2)"	"unprognostic (9.68e-2)"	"unprognostic (7.83e-2)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (2.50e-7)"	"unprognostic (2.76e-2)"	"unprognostic (3.61e-3)"	"unprognostic (3.97e-2)"	"unprognostic (4.06e-2)"	"unprognostic (2.03e-2)"	"prognostic unfavorable (5.71e-12)"	"unprognostic (3.89e-3)"	"unprognostic (3.62e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.27e-3)"	19.9	29.4	14.2	37.3	13.2	27.1	18.9	18.4	15.9	22.5	14.0	22.5	23.7	27.6	11.0	25.0	24.8	18.4	20.4	13.9	15.7	18.5	31.7	19.4	38.3	15.5	14.2	29.8	21.0	18.0	22.8	22.4	15.8	19.9	21.1	11.1	21.8	17.5	33.7	23.4	24.3	27.7	13.6	29.8	19.4	50.4	14.7	41.9	16.3	24.5	37.7	24.6	20.1	16.9	126.7	115.5	88.8	74.0	26.0	30.0	79.7	92.8	65.8	99.3	98.8	79.8	71.9	141.2	51.7	60.8	65.9	73.6	108.3	62.1	96.1	211.6	112.0	109.8	59.4	72.6	30.9	108.8	106.8	28.6	44.8	62.0	54.8	44.1	71.5	82.7	138.6	135.5	69.2	59.7	196.7	83.6	82.0	117.4	102.8	170.3	99.9	120.3	46.9	93.7	96.2	68.8	88.2	103.8	46.3	63.8	78.8	51.5	53.0	150.2	85.3	49.1	155.4	96.3	295.9	132.5	62.2	90.1	113.9	12.3	33.4	6.7	17.7	34.7	24.1	15.1	17.6	19.6	33.1	14.9	11.9	15.4	5.2	22.0	20.1	29.0	17.2	22.1	14.2	13.2	18.4	15.9	13.9	15.7	15.5	14.2	15.8	13.6	14.7	16.9	16.8	25.6	22.4	0.0	28.4	34.2	16.5	16.0	21.1	11.4	23.7	26.0	15.4	21.5	18.3	9.2	6.2	37.0	24.4	24.9	9.8	23.7	113.5	19.2	23.9	27.7	21.6	39.1	0.0	16.3	48.4	19.5	20.4	25.6	23.4	30.4	30.4	13.3	49.5	63.9	0.0	27.0	16.2	36.1	119.2	315.1	24.8	41.5	21.4	0.0	77.1	19.1	22.6	0.0	0.0	22.9	22.8	23.0	23.3	24.1	20.6	16.1	19.2	16.3	19.7	18.0	16.0	71.0	39.3	20.0	32.0	21.8	24.4	17.2	33.4	16.6
NUP85	"FLJ12549, NUP75"	ENSG00000125450	"Nucleoporin 85"	Q9BW27	17	75205659-75235758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061910, HPA062595"	Supported		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Cytosol	"HPA061910: AB_2684634, HPA062595: AB_2684801"	"unprognostic (2.30e-1)"	"unprognostic (5.10e-2)"	"unprognostic (5.12e-3)"	"unprognostic (2.52e-3)"	"unprognostic (2.25e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (1.73e-7)"	"unprognostic (3.46e-1)"	"unprognostic (1.09e-2)"	"unprognostic (9.93e-2)"	"unprognostic (2.94e-1)"	"unprognostic (3.33e-2)"	"prognostic unfavorable (3.32e-6)"	"unprognostic (1.03e-3)"	"unprognostic (2.16e-1)"	"unprognostic (9.10e-3)"	"unprognostic (2.11e-1)"	20.9	12.9	15.2	18.6	15.7	20.8	20.0	21.8	17.0	21.5	15.4	18.7	15.8	20.8	16.1	20.5	20.9	11.6	16.4	15.6	14.7	18.9	22.1	18.7	26.5	15.8	15.1	20.8	18.7	12.1	12.7	19.0	16.0	18.9	21.0	11.2	16.7	14.3	16.7	23.9	20.5	19.6	14.9	25.3	16.9	22.2	15.3	33.2	18.0	14.1	27.0	17.9	19.5	17.0	66.5	74.0	53.4	37.3	20.3	31.5	74.0	47.3	37.4	108.5	101.7	63.2	61.4	61.1	26.6	41.1	70.5	55.9	88.8	50.6	96.1	19.3	70.1	51.0	83.3	56.3	16.6	52.8	40.7	30.3	30.5	76.1	32.8	24.9	84.7	49.0	63.3	38.1	53.8	73.0	100.2	64.8	40.0	82.2	67.4	68.9	115.1	55.5	42.1	47.5	40.6	38.5	58.2	73.7	42.5	59.4	83.3	59.1	30.8	80.2	74.4	52.5	76.3	23.6	21.0	79.2	41.4	47.3	50.6	8.1	24.9	21.5	16.1	22.6	22.9	16.1	17.5	15.9	20.5	21.5	17.0	12.8	8.2	16.7	16.5	22.5	16.6	17.3	15.2	15.7	21.8	17.0	15.6	14.7	15.8	15.1	16.0	14.9	15.3	17.0	13.2	6.4	12.5	7.2	13.9	6.1	8.9	19.1	6.2	7.8	10.3	7.5	9.0	8.6	15.0	7.3	10.4	23.0	11.7	9.1	7.9	16.0	3.7	11.1	13.6	15.0	7.7	16.2	13.5	19.4	22.1	13.8	9.7	10.3	11.4	13.0	21.0	23.1	23.0	6.7	9.9	11.0	16.2	13.3	7.2	3.9	14.3	13.7	8.8	10.3	15.8	4.8	22.6	3.5	10.6	18.3	7.5	9.8	8.6	7.9	8.8	11.7	11.8	8.8	32.9	7.9	19.2	24.9	29.3	7.3	7.1	12.7	10.9	7.4	13.3	8.0
NUP88	MGC8530	ENSG00000108559	"Nucleoporin 88"	Q99567	17	5360963-5419676	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 146.0;Spermatocytes: 147.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002209, HPA021816"	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"CAB002209: AB_564128, HPA021816: AB_1854725"	"unprognostic (3.46e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.04e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.03e-1)"	"unprognostic (3.38e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.72e-2)"	"unprognostic (4.94e-2)"	"unprognostic (2.04e-2)"	"unprognostic (5.75e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.10e-1)"	"unprognostic (9.03e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.44e-2)"	11.8	12.0	4.2	16.3	3.8	20.8	15.2	7.5	6.0	10.8	3.3	13.2	9.9	10.4	16.4	12.1	12.4	8.0	12.2	3.9	3.9	15.2	27.3	9.4	26.4	4.1	4.0	8.5	10.2	15.3	9.0	10.9	4.3	11.5	19.3	9.6	13.2	10.3	31.2	12.9	11.7	13.7	3.6	14.8	12.3	49.3	3.8	24.1	14.6	21.6	32.9	15.1	9.0	4.2	46.2	50.0	44.0	33.3	18.3	20.0	40.2	35.8	29.0	58.7	52.0	41.5	17.8	88.6	13.3	33.1	38.1	43.5	73.6	39.6	74.7	22.7	48.6	40.0	42.7	32.5	24.8	31.8	34.6	14.3	28.2	43.7	71.3	24.5	41.0	34.3	42.3	22.2	46.5	24.3	46.7	23.4	41.2	46.4	23.9	44.1	48.5	38.7	30.7	22.3	17.5	33.9	44.0	20.4	28.1	33.7	22.9	37.3	26.8	26.4	28.3	27.1	66.9	15.0	19.4	39.5	31.3	36.3	37.4	5.4	7.6	4.3	12.4	12.2	12.3	39.1	13.3	15.0	10.9	35.7	14.3	15.9	0.9	21.1	14.3	12.2	17.6	11.5	4.2	3.8	7.5	6.0	3.9	3.9	4.1	4.0	4.3	3.6	3.8	4.2	6.9	12.8	17.8	10.1	38.0	22.2	31.5	13.5	14.2	13.3	8.9	6.2	10.7	11.5	18.1	16.5	16.7	30.1	19.3	15.2	11.7	27.9	146.0	26.1	15.0	11.5	13.8	28.6	22.9	25.4	24.8	12.2	15.3	47.2	7.6	14.9	9.3	16.5	11.4	10.1	20.4	10.1	14.2	7.9	12.3	38.0	15.2	10.6	3.6	11.2	19.4	7.8	26.8	13.0	17.8	23.3	15.4	10.9	9.4	21.7	9.9	7.5	11.5	11.0	13.1	19.5	20.5	147.5	61.8	15.8	17.0	36.0	17.9	13.6	17.6	42.8
NUP93	KIAA0095	ENSG00000102900	"Nucleoporin 93"	Q8N1F7	16	56730118-56850286	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017937	Uncertain					NA	NA		38000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA017937: AB_1854726"	"unprognostic (6.31e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.85e-2)"	"unprognostic (3.99e-3)"	"unprognostic (2.78e-3)"	"prognostic unfavorable (1.72e-6)"	"unprognostic (9.18e-2)"	"unprognostic (9.35e-3)"	"unprognostic (5.22e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.97e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (9.68e-2)"	"unprognostic (3.74e-2)"	17.9	13.9	13.2	21.3	17.4	52.7	15.5	6.8	23.9	15.3	0.2	17.7	9.9	16.9	12.4	22.3	15.3	12.4	14.2	30.6	10.7	12.8	9.3	15.3	27.7	10.7	9.3	14.9	14.2	14.8	10.8	19.1	9.9	17.7	18.1	31.7	12.2	12.7	20.0	21.6	14.5	19.5	8.3	24.2	15.2	39.8	11.4	34.1	34.3	14.2	30.3	17.1	16.1	11.5	71.3	84.5	71.6	81.0	25.9	34.8	81.0	58.7	48.2	156.2	100.1	119.4	66.1	107.7	60.4	54.9	54.2	120.6	143.3	90.1	149.8	34.0	81.3	72.6	64.7	97.3	35.0	96.7	82.8	29.3	35.7	104.2	64.7	31.6	90.8	95.3	87.8	22.3	72.3	52.4	136.2	81.1	92.1	44.2	95.4	163.9	129.4	108.9	53.1	47.8	66.6	44.1	159.1	54.6	47.3	77.4	43.0	57.9	55.3	68.1	74.0	57.8	67.5	35.0	60.7	190.2	47.4	88.5	67.5	19.3	49.9	195.7	38.9	77.2	45.2	45.4	28.3	40.9	60.9	45.4	28.7	41.0	11.8	51.8	77.5	28.7	39.7	47.4	13.2	17.4	6.8	23.9	30.6	10.7	10.7	9.3	9.9	8.3	11.4	11.5	11.3	6.4	12.3	17.6	13.4	12.0	13.6	20.7	6.2	68.6	9.0	7.6	11.8	1.5	20.2	9.2	10.4	21.1	9.4	8.6	11.7	24.6	11.7	10.9	8.8	16.5	4.9	33.2	51.1	25.5	31.7	12.8	13.7	10.6	17.2	22.3	10.8	7.2	26.6	38.7	49.4	11.2	24.4	17.8	23.8	7.7	23.3	17.3	16.0	33.7	30.3	11.7	8.2	18.1	22.1	21.4	7.2	13.5	8.1	16.5	3.6	11.0	13.0	20.8	13.1	11.4	27.9	54.6	62.2	14.3	16.1	10.3	13.5	22.3	15.3	18.0
NUP98	"NUP96, Nup98-96, Nup98-Nup96"	ENSG00000110713	"Nucleoporin 98 and 96 precursor"	P52948	11	3671083-3797792	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 118.7;Late spermatids: 158.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (1.11e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.41e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.71e-3)"	"unprognostic (3.40e-1)"	"unprognostic (4.08e-3)"	"unprognostic (6.47e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.02e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.09e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.21e-1)"	22.9	14.7	7.2	25.1	8.4	76.0	25.3	15.1	12.4	21.8	13.8	21.1	17.8	22.2	20.7	23.1	20.8	21.6	20.8	7.2	8.8	19.3	31.9	23.4	27.6	9.8	10.5	28.4	24.0	25.7	16.7	25.6	8.3	21.9	23.6	23.2	23.3	22.3	41.9	21.2	17.7	23.4	7.1	21.9	17.6	78.4	9.1	34.4	29.1	31.0	30.6	32.7	18.6	12.7	81.2	63.7	51.7	54.5	54.7	46.1	44.5	57.9	67.7	78.3	69.9	69.4	97.4	80.6	26.0	68.6	77.1	85.5	90.0	56.1	105.6	56.7	67.0	86.4	51.7	48.1	46.1	111.1	67.5	51.9	37.6	41.8	75.2	33.7	61.9	88.3	109.3	60.6	82.5	33.2	110.2	36.3	64.5	87.8	48.4	65.9	62.6	37.8	43.4	63.4	46.8	31.5	83.4	64.9	38.1	52.0	40.5	43.4	45.9	59.9	51.1	67.5	53.0	37.0	67.0	83.5	41.0	46.5	64.4	40.5	11.7	23.3	15.0	15.0	15.1	12.8	14.7	13.5	14.3	10.8	16.1	14.4	35.2	9.7	9.5	3.9	20.1	13.3	7.2	8.4	15.1	12.4	7.2	8.8	9.8	10.5	8.3	7.1	9.1	12.7	24.7	28.9	25.2	32.7	37.4	49.8	36.3	12.6	34.7	14.9	28.2	24.5	19.5	22.8	20.1	7.3	16.7	22.2	41.6	18.8	3.9	12.2	118.7	32.1	30.4	22.5	21.5	42.5	43.6	11.8	17.5	22.7	42.3	62.0	18.3	16.3	15.7	23.6	16.8	15.2	43.7	15.1	6.1	19.8	51.1	158.6	17.1	29.3	16.0	25.3	24.9	11.1	12.3	31.7	44.4	13.2	16.1	14.3	36.3	25.1	11.8	9.0	16.6	14.1	32.9	36.9	23.2	56.2	31.0	30.3	50.4	46.5	44.5	13.7	19.5	32.5
NXF1	"DKFZp667O0311, Mex67, TAP"	ENSG00000162231	"Nuclear RNA export factor 1"	Q9UBU9	11	62792123-62806302	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Translocation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB016327, HPA061593"	Supported		Supported	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"CAB016327: AB_627608, HPA061593: AB_2684565"	"unprognostic (2.45e-2)"	"unprognostic (1.15e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-2)"	"unprognostic (5.40e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (4.08e-4)"	"unprognostic (4.33e-3)"	"unprognostic (8.08e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.38e-1)"	"unprognostic (3.66e-3)"	"unprognostic (1.25e-2)"	90.2	103.4	57.2	47.9	56.8	204.6	81.8	61.6	71.9	100.1	66.8	106.0	39.4	94.6	55.2	80.2	86.8	51.8	78.0	57.3	59.0	100.3	130.0	82.0	69.9	56.6	57.2	97.3	98.3	63.8	136.7	58.9	56.1	107.2	45.6	49.9	77.3	57.8	75.7	110.6	96.1	66.6	55.2	143.8	97.1	59.5	58.2	75.5	123.1	41.5	56.1	83.1	78.8	59.9	44.6	48.5	82.8	56.5	69.6	50.2	50.2	67.5	60.5	89.0	52.6	66.8	35.1	70.0	39.1	54.4	35.7	54.1	89.9	42.3	80.2	55.5	61.3	52.9	82.1	56.4	52.8	66.3	73.6	74.5	59.9	65.6	31.5	66.5	58.9	60.7	69.3	50.7	64.4	61.1	81.3	85.1	50.4	54.8	41.6	77.5	46.0	74.6	61.7	51.7	43.6	36.5	66.4	52.8	49.8	59.9	60.3	57.9	60.3	51.2	41.5	64.6	61.3	61.4	56.8	70.2	39.6	55.2	52.1	7.6	21.3	23.5	18.9	26.0	20.5	16.0	18.4	18.5	23.6	12.8	19.6	18.4	16.1	20.2	23.6	18.3	24.0	17.1	57.2	56.8	61.6	71.9	57.3	59.0	56.6	57.2	56.1	55.2	58.2	59.9	53.2	38.5	45.3	14.7	40.2	83.4	27.0	29.4	42.7	13.2	45.9	74.7	24.6	21.5	23.4	22.0	31.3	50.4	44.1	42.2	9.8	17.6	32.6	30.4	36.8	36.8	31.6	17.7	11.0	12.3	25.9	35.1	43.3	51.7	49.9	19.8	26.0	18.6	28.6	5.0	13.0	35.9	22.4	33.8	43.2	12.3	36.7	62.5	32.0	11.2	21.8	12.7	21.6	7.1	10.1	14.7	28.6	25.9	29.7	22.0	24.0	10.2	18.6	17.2	26.3	48.6	40.4	28.2	19.9	53.4	70.0	99.2	42.3	15.4	30.4	15.2
OCA2	"BEY, BEY1, BEY2, D15S12, EYCL, EYCL2, EYCL3, P"	ENSG00000104044	"OCA2 melanosomal transmembrane protein"	Q04671	15	27754875-28099315	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"choroid plexus: 28.1"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 30.9;Inhibitory neurons: 40.8;Melanocytes: 42.7;Peritubular cells: 14.7"	"Cancer enriched"	"Detected in many"	17	"melanoma: 19.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SK-MEL-30: 24.6"	"Low region specificity"	"Detected in some"							HPA036402			Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Cytosol	"HPA036402: "	"unprognostic (6.07e-3)"	"unprognostic (1.97e-2)"	"unprognostic (3.25e-1)"	"unprognostic (2.82e-2)"	"unprognostic (4.60e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.10e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.20e-6)"	"unprognostic (2.61e-1)"	"unprognostic (4.21e-1)"	"unprognostic (3.28e-2)"	"unprognostic (2.28e-2)"	0.3	0.0	1.8	0.1	1.8	0.0	0.3	0.1	1.8	1.2	28.1	0.1	0.0	0.2	0.3	2.2	1.1	0.0	0.3	1.4	1.8	0.3	0.1	0.6	1.8	0.5	0.9	0.3	0.0	0.0	0.8	1.5	0.6	0.6	0.0	0.0	0.8	1.0	0.2	6.4	0.2	0.0	0.0	1.1	0.1	1.9	2.4	0.4	4.2	0.0	0.7	0.2	2.4	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.5	0.0	0.0	0.1	5.6	0.0	0.0	24.6	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.8	0.1	1.8	1.4	1.8	0.5	0.9	0.6	0.0	2.4	1.0	0.0	0.0	0.0	0.7	0.0	2.0	0.1	0.1	0.6	0.0	0.0	0.4	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	4.4	5.6	0.2	0.1	0.0	0.0	30.9	0.0	0.1	1.4	0.0	2.8	0.0	2.3	0.0	0.0	0.1	0.0	40.8	0.1	0.0	0.0	0.9	3.0	9.3	0.1	42.7	0.0	0.0	0.0	0.0	2.5	0.8	0.0	1.2	14.7	0.0	0.0	0.0	0.1	2.0	0.0	0.0	1.0	0.8	4.2	4.9	6.1	0.9	0.1	0.1	0.4	0.1	0.2
OCLN	PPP1R115	ENSG00000197822	Occludin	Q16625	5	69492292-69558104	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 31.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 109.0;Glandular and luminal cells: 119.7;Urothelial cells: 224.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 2.7"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 2.7"	"Cell line enhanced"	"Detected in many"		"A-431: 23.3;CAPAN-2: 39.8;HaCaT: 33.4;RPTEC TERT1: 25.7;SK-BR-3: 27.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005933, CAB013075, CAB068212, CAB068213, CAB068214"	Enhanced		Supported	"Plasma membrane,Cell Junctions"	"Intracellular and membrane"	NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cell Junctions"		"CAB013075: AB_2533101, CAB068212: AB_2665711, CAB068213: AB_2665712, CAB068214: AB_2665713, HPA005933: AB_1079520"	"unprognostic (2.28e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.39e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.08e-2)"	"unprognostic (8.25e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.58e-2)"	"unprognostic (3.48e-1)"	"prognostic favorable (6.59e-11)"	"unprognostic (2.83e-1)"	"unprognostic (4.01e-1)"	"unprognostic (1.33e-1)"	"unprognostic (3.35e-1)"	1.2	0.7	6.2	1.6	6.5	1.8	7.8	7.2	6.7	6.8	22.2	11.0	10.3	2.1	4.0	11.6	7.5	8.5	1.5	5.9	5.4	11.0	18.8	15.1	0.6	9.3	7.7	2.3	20.2	8.3	3.4	3.9	8.3	3.5	11.2	2.3	6.7	4.6	0.6	11.3	10.0	0.6	5.4	2.1	15.2	2.4	6.5	0.9	31.4	0.6	2.8	5.0	7.9	7.4	23.3	4.5	0.6	0.9	0.6	0.9	15.1	0.3	1.6	2.5	3.3	20.7	39.8	0.5	5.9	1.1	8.3	33.4	7.2	4.3	7.8	0.3	12.2	2.4	1.1	9.8	0.3	1.2	2.5	0.1	6.4	4.1	1.0	1.6	1.4	3.1	0.1	0.4	0.1	22.4	1.5	1.2	3.1	8.0	2.1	0.2	6.0	1.1	25.7	22.2	2.7	2.8	0.3	27.2	0.9	5.0	14.7	4.0	1.2	0.4	7.7	1.8	2.7	0.5	0.4	0.3	0.3	0.3	0.6	1.0	0.2	0.5	0.2	0.1	0.2	0.3	0.2	0.1	0.1	0.4	0.2	0.2	2.7	0.5	0.1	0.4	0.1	0.1	6.2	6.5	7.2	6.7	5.9	5.4	9.3	7.7	8.3	5.4	6.5	7.4	4.8	109.0	67.3	1.6	3.2	3.7	60.8	7.6	1.8	5.7	49.7	16.9	1.4	64.3	51.0	25.8	14.6	30.3	3.6	94.1	9.8	65.6	1.9	78.5	12.1	10.7	26.3	2.5	1.3	61.6	2.5	5.8	46.4	119.7	2.5	6.5	18.2	48.3	3.0	6.7	1.1	45.1	16.2	12.9	1.2	1.6	3.1	2.4	1.8	16.9	3.9	2.8	1.0	0.5	1.5	64.6	61.8	1.5	1.1	101.5	42.3	10.5	63.0	6.3	13.1	3.3	4.4	4.7	8.2	29.5	15.5	16.4	4.3	0.7	47.9	224.0
OCSTAMP	"C20orf123, dJ257E24.3"	ENSG00000149635	"Osteoclast stimulatory transmembrane protein"	Q9BR26	20	46540946-46550654	"Predicted membrane proteins, Transporters"	Differentiation			"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Langerhans cells: 1.9;Melanocytes: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.1;HMC-1: 2.2;Karpas-707: 1.3;NB-4: 2.5;RPMI-8226: 1.2;U-266/84: 2.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA031116	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"		"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"			"HPA031116: AB_10600758"	"unprognostic (2.77e-1)"		"unprognostic (3.04e-1)"		"unprognostic (8.80e-2)"	"unprognostic (5.02e-2)"		"unprognostic (2.42e-1)"	"unprognostic (2.71e-1)"					"unprognostic (2.65e-1)"	"unprognostic (9.59e-2)"	"unprognostic (2.08e-1)"		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	2.5	0.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.8	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.5	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OMA1	"FLJ33782, MPRP-1, YKR087C, ZMPOMA1"	ENSG00000162600	"OMA1 zinc metallopeptidase"	Q96E52	1	58415384-58546802	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 106.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055120	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Mitochondria"		"HPA055120: AB_2682702"	"prognostic favorable (1.63e-4)"	"unprognostic (2.67e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.60e-3)"	"unprognostic (1.61e-1)"	"unprognostic (9.57e-2)"	"unprognostic (3.94e-3)"	"prognostic favorable (8.52e-4)"	"unprognostic (8.22e-3)"	"unprognostic (6.91e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.40e-1)"	"unprognostic (9.54e-3)"	"unprognostic (2.52e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (5.24e-3)"	11.4	18.7	15.1	14.0	22.8	12.8	19.7	23.1	14.9	16.7	14.9	20.8	14.9	13.5	17.8	13.3	19.4	15.1	19.8	13.0	19.5	28.4	31.1	11.9	23.4	18.8	17.9	13.5	17.9	18.1	10.4	11.5	21.1	20.8	20.0	20.5	19.5	16.7	28.2	12.8	14.2	12.4	15.6	20.2	17.3	8.2	18.3	20.2	20.1	29.9	21.5	14.8	10.5	27.3	31.2	13.0	8.3	7.9	41.7	39.0	24.6	12.7	13.9	10.9	13.7	4.0	18.7	69.8	26.3	13.1	37.8	31.2	31.1	31.3	13.3	55.1	17.9	22.0	10.4	16.1	20.3	54.3	14.7	37.3	33.6	10.4	22.4	24.1	9.3	34.3	42.7	20.1	29.2	19.5	18.0	19.4	12.4	47.4	28.5	22.1	27.7	29.1	23.6	20.5	8.7	4.3	26.0	41.9	37.6	38.4	19.5	20.1	5.4	5.6	10.8	27.8	13.5	16.3	23.4	46.2	16.8	42.2	14.1	20.1	14.4	32.1	19.4	24.1	25.6	35.6	23.7	23.1	15.4	35.0	33.9	31.5	17.2	30.9	35.1	8.2	23.6	15.9	15.1	22.8	23.1	14.9	13.0	19.5	18.8	17.9	21.1	15.6	18.3	27.3	8.4	19.2	11.5	37.9	25.7	6.0	18.2	35.6	13.6	7.8	15.0	12.3	27.2	8.6	33.0	25.8	12.5	22.9	14.4	8.4	25.4	11.2	5.8	31.6	10.8	6.3	6.0	15.6	18.3	5.5	10.0	12.0	5.6	18.4	6.3	10.9	6.4	18.7	15.8	1.7	31.7	17.7	36.7	10.1	9.7	12.7	9.9	12.9	7.2	29.0	11.3	10.9	15.5	52.8	106.5	3.8	10.9	8.6	16.8	12.3	8.5	32.4	63.1	20.5	6.6	12.0	8.6	14.3	13.6	17.3	6.8	18.3	20.7	17.1	14.6	17.1
OPA1	"FLJ12460, KIAA0567, MGM1, NPG, NTG"	ENSG00000198836	"OPA1 mitochondrial dynamin like GTPase"	O60313	3	193593144-193697811	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Sensory transduction, Vision"	Hydrolase	"Cardiomyopathy, Deafness, Disease variant, Neurodegeneration, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036926, HPA036927"	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA		10000	"Cluster 14: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Mitochondria"		"HPA036926: AB_10671247, HPA036927: AB_2675388"	"unprognostic (2.10e-2)"	"unprognostic (9.23e-3)"	"unprognostic (7.98e-2)"	"prognostic unfavorable (8.61e-4)"	"unprognostic (1.62e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.08e-1)"	"prognostic unfavorable (8.44e-5)"	"unprognostic (3.48e-2)"	"prognostic favorable (1.84e-4)"	"unprognostic (2.92e-1)"	"unprognostic (4.75e-1)"	"unprognostic (4.50e-3)"	"unprognostic (3.21e-1)"	15.0	12.0	14.3	7.6	17.4	25.6	12.8	15.2	19.5	10.4	9.4	18.9	16.8	10.9	9.1	14.6	8.1	10.2	39.3	18.6	17.4	18.3	20.9	8.5	11.8	16.4	15.4	8.4	10.1	23.1	3.8	11.7	16.8	12.3	16.6	9.6	11.7	13.3	24.2	11.9	13.8	13.5	12.4	9.3	14.6	6.3	15.2	12.7	13.9	44.5	12.4	13.0	5.1	13.7	58.9	18.8	18.2	20.2	15.8	25.0	19.3	27.5	26.2	30.0	29.0	45.2	19.3	38.6	58.1	27.0	27.3	37.3	32.7	31.7	53.5	46.5	25.7	67.9	16.7	23.1	24.9	55.8	29.8	28.4	27.6	30.0	40.9	18.5	26.2	15.7	28.4	37.0	30.2	46.5	21.9	30.9	25.8	33.9	59.9	27.8	40.1	41.6	22.7	36.1	39.8	24.2	41.8	46.3	29.5	14.1	60.3	43.5	26.3	27.7	20.8	29.3	58.7	33.1	41.3	74.0	30.5	43.7	28.4	9.7	7.3	7.1	5.8	8.2	5.5	6.8	5.5	5.6	7.8	5.1	5.6	6.0	2.7	4.7	17.3	4.0	6.6	5.2	14.3	17.4	15.2	19.5	18.6	17.4	16.4	15.4	16.8	12.4	15.2	13.7	24.8	16.0	24.0	72.1	27.5	15.9	16.4	17.4	24.5	19.5	20.9	13.5	135.2	22.8	20.1	18.4	31.3	19.0	24.6	31.4	17.6	19.3	7.7	20.3	25.2	23.8	23.4	86.3	106.8	24.0	14.9	24.6	31.1	26.1	19.6	25.6	14.3	39.1	17.9	21.9	106.7	20.6	10.2	25.6	14.7	13.5	15.8	28.1	21.4	58.1	22.9	14.6	11.3	87.4	98.1	28.9	12.1	14.7	29.3	18.7	24.6	34.1	19.6	23.4	6.6	21.3	26.2	15.1	16.6	34.3	22.4	17.9	22.3	28.2	26.7	22.1
OPN1LW	"CBBM, CBP, COD5, RCP"	ENSG00000102076	"Opsin 1, long wave sensitive"	P04000	X	154144243-154159032	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	2568	"retina: 256.7"	"Cell type enriched"	"Detected in some"	20	"Cone photoreceptor cells: 725.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 9: Photoreceptor cells - Phototransduction"													"unprognostic (6.05e-2)"								0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	256.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	0.0	0.0	0.0	0.0	725.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPN4	"melanopsin, MOP"	ENSG00000122375	"Opsin 4"	Q9UHM6	10	86654547-86666848	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Biological rhythms, Sensory transduction"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.9;skeletal muscle: 2.5"	"Group enriched"	"Detected in some"	7	"Cardiomyocytes: 4.6;Excitatory neurons: 2.8;Inhibitory neurons: 1.9;Smooth muscle cells: 2.6"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in many"		"basal ganglia: 7.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039147	Approved					NA	NA				"Cluster 47: Non-specific - Unknown function"		"Cluster 48: Smooth muscle cells - ECM organization"			"HPA039147: AB_10673304"	"unprognostic (3.67e-3)"	"unprognostic (1.40e-2)"	"unprognostic (3.02e-2)"	"unprognostic (1.62e-1)"	"unprognostic (7.03e-3)"	"unprognostic (2.89e-2)"		"unprognostic (3.26e-1)"	"unprognostic (9.54e-2)"	"unprognostic (5.68e-2)"	"unprognostic (8.88e-3)"		"unprognostic (1.93e-6)"	"unprognostic (4.10e-2)"		"unprognostic (5.58e-2)"	"unprognostic (6.76e-2)"	2.0	0.1	1.5	0.0	7.9	0.0	0.7	0.0	3.0	0.1	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.8	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.4	0.3	0.0	0.2	0.0	0.1	1.1	0.6	0.0	2.5	0.7	0.4	0.0	0.1	0.0	0.2	0.0	1.4	0.0	0.8	0.4	0.0	0.2	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	7.9	0.0	3.0	1.6	0.0	0.1	0.1	0.2	0.1	1.4	1.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OPRK1	"KOR, OPRK"	ENSG00000082556	"Opioid receptor kappa 1"	P41145	8	53225724-53251637	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Behavior	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"brain: 14.5"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 4.5;Excitatory neurons: 6.7;Extravillous trophoblasts: 8.0;Glandular and luminal cells: 9.8;Inhibitory neurons: 10.1;Leydig cells: 4.7"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"U-937: 21.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA067549	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA067549: AB_2732770"	"unprognostic (1.01e-1)"	"unprognostic (1.17e-2)"		"unprognostic (8.70e-3)"	"unprognostic (3.73e-2)"	"unprognostic (6.74e-2)"		"unprognostic (2.22e-3)"		"unprognostic (8.09e-2)"	"unprognostic (9.71e-2)"	"unprognostic (4.28e-3)"		"unprognostic (3.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (9.54e-4)"	"unprognostic (1.61e-1)"	0.1	0.1	7.3	0.0	14.5	0.0	0.0	1.3	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	5.4	0.0	0.0	0.1	0.0	5.8	1.7	0.0	0.0	0.0	0.0	0.2	5.1	1.6	0.0	0.6	0.0	0.0	1.1	0.0	0.0	0.0	0.3	0.0	0.0	0.7	6.9	0.1	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.3	21.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	14.5	1.3	8.3	3.9	5.4	5.8	1.7	5.1	0.3	6.9	2.6	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.6	1.3	0.0	0.0	0.0	0.2	4.5	0.6	0.1	0.0	0.0	6.7	0.0	8.0	0.1	0.0	9.8	0.0	0.0	0.0	0.0	0.2	0.0	10.1	0.0	0.0	0.0	0.0	0.3	4.7	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	1.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0
OPRM1	MOR1	ENSG00000112038	"Opioid receptor mu 1"	P35372	6	154010496-154246867	"FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 10.6;testis: 2.8"	"Group enriched"	"Detected in some"	13	"Early spermatids: 29.2;Excitatory neurons: 41.1;Inhibitory neurons: 23.5;Late spermatids: 29.7;Microglial cells: 10.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in single"	11	"SH-SY5Y: 6.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA014509, HPA067435"	Enhanced	Supported				NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA014509: AB_1854801, HPA067435: "											"unprognostic (7.34e-2)"			"unprognostic (6.91e-2)"				0.1	0.8	2.9	0.3	2.5	0.7	0.4	8.8	3.5	0.2	0.0	0.2	0.2	0.3	0.6	1.1	0.2	0.3	0.1	1.5	2.6	0.2	0.2	0.2	0.4	2.2	5.2	0.4	0.2	0.2	0.0	0.2	1.0	0.3	0.2	0.9	0.3	0.2	0.4	0.6	0.2	0.2	1.7	0.4	0.4	2.8	10.6	0.2	0.5	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.3	0.3	0.1	0.3	0.2	0.3	0.2	0.2	0.1	0.2	0.5	0.4	0.2	0.1	0.4	0.2	0.4	0.4	0.2	0.3	0.2	0.3	0.5	0.2	0.3	0.4	0.3	0.2	0.6	0.2	0.5	0.2	0.2	0.3	0.3	0.6	0.4	0.2	0.2	0.4	0.1	0.2	0.1	0.3	0.2	0.2	0.3	0.4	0.4	6.8	0.1	0.2	0.4	0.4	0.3	0.2	0.1	0.4	0.2	0.3	0.1	0.5	0.2	0.3	0.3	0.3	0.2	1.1	0.1	0.3	0.2	0.1	0.3	0.2	0.2	0.2	0.1	0.2	0.2	0.2	0.7	0.4	0.2	0.4	0.2	0.1	2.9	2.5	8.8	3.5	1.5	2.6	2.2	5.2	1.0	1.7	10.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	41.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	23.5	0.0	0.0	0.0	0.0	29.7	0.0	0.2	0.0	10.3	0.0	0.0	0.0	1.5	2.0	0.0	0.0	0.7	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.6	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.2
OPTN	"FIP-2, FIP2, GLC1E, HIP7, HYPL, NRP, TFIIIA-INTP"	ENSG00000123240	Optineurin	Q96CV9	10	13099449-13138308	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Immunity, Innate immunity"		"Amyotrophic lateral sclerosis, Disease variant, Glaucoma, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"skeletal muscle: 879.4;tongue: 394.5"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 933.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003279, HPA003360, CAB019303"	Approved		Enhanced	Cytosol		NA	NA		370000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 31: Spermatids - Spermatogenesis"	Cytosol		"CAB019303: , HPA003279: AB_1079527, HPA003360: AB_1079528"	"unprognostic (2.84e-2)"	"unprognostic (3.37e-1)"	"unprognostic (3.79e-3)"	"unprognostic (6.46e-3)"	"unprognostic (5.58e-2)"	"unprognostic (3.74e-2)"	"unprognostic (5.15e-3)"	"unprognostic (3.14e-2)"	"unprognostic (2.68e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.40e-2)"	"unprognostic (6.14e-1)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (7.62e-2)"	"unprognostic (5.67e-2)"	"unprognostic (7.93e-2)"	"unprognostic (2.09e-2)"	92.7	90.4	45.7	35.8	53.5	50.1	64.0	45.9	55.9	52.3	36.8	55.4	63.2	39.7	21.9	61.8	37.7	41.6	105.7	54.9	49.2	72.3	73.8	58.9	45.7	48.0	53.9	92.1	35.4	33.1	33.8	57.5	52.9	34.1	57.2	48.8	46.3	41.4	879.4	77.9	69.6	43.4	44.3	57.3	56.1	72.8	45.4	30.1	27.1	394.5	37.6	43.8	56.3	49.0	83.3	23.1	12.8	17.8	171.4	175.6	15.2	97.6	110.7	72.1	119.0	41.1	108.1	0.7	37.6	134.3	113.2	75.6	17.3	93.5	54.8	192.9	9.2	17.2	32.1	22.0	175.4	0.6	59.5	94.6	72.6	69.2	71.8	177.9	62.4	23.8	21.5	123.7	98.7	17.6	8.3	2.3	5.2	22.4	10.3	1.4	25.5	8.5	87.9	57.6	2.8	13.6	84.9	25.0	64.3	49.9	54.6	11.4	171.6	58.8	28.9	81.0	27.5	63.3	23.5	0.6	88.3	14.3	11.4	47.9	2.5	0.3	56.1	1.5	43.3	18.0	71.2	65.8	0.5	11.7	28.0	34.5	1.7	51.2	3.8	5.2	109.6	30.2	45.7	53.5	45.9	55.9	54.9	49.2	48.0	53.9	52.9	44.3	45.4	49.0	68.2	67.3	29.4	18.6	25.9	74.4	46.6	104.5	67.2	38.7	30.5	32.9	237.7	68.6	81.3	31.3	18.8	112.8	89.8	199.8	33.2	135.5	281.9	36.0	38.6	82.4	42.6	126.5	48.9	114.0	39.8	91.6	88.7	37.4	70.8	92.8	47.8	30.9	31.6	90.9	26.6	106.4	65.1	15.1	26.0	933.6	95.7	14.5	90.7	25.3	36.6	36.4	119.4	13.6	28.1	166.3	186.9	103.4	86.3	92.3	209.9	162.4	73.7	103.4	111.7	63.1	106.6	102.0	13.7	58.1	77.9	75.4	107.5	166.3	44.1	75.0
OR1E1	"HGM071, OR13-66, OR17-2, OR17-32, OR1E5, OR1E6, OR1E9P"	ENSG00000180016	"Olfactory receptor family 1 subfamily E member 1"	P30953	17	3397104-3398410	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA														"unprognostic (1.12e-1)"										"unprognostic (1.33e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OR2AG1	OR2AG3	ENSG00000279486	"Olfactory receptor family 2 subfamily AG member 1"	Q9H205	11	6783020-6791558	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA						"Cluster 50: Fibroblasts - ECM organization"																					0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
OR51E2	PSGR	ENSG00000167332	"Olfactory receptor family 51 subfamily E member 2"	Q9H255	11	4680171-4697854	"Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters"	"Olfaction, Sensory transduction"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"intestine: 9.6;prostate: 28.9"	"Cell type enriched"	"Detected in some"	6	"Enteroendocrine cells: 77.4"	"Cancer enriched"	"Detected in some"	274	"prostate cancer: 217.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC TERT1: 1.9;BJ hTERT+: 1.1;hTERT-RPE1: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"				"unprognostic (1.98e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.09e-3)"	"unprognostic (1.57e-2)"	"unprognostic (8.00e-4)"	"unprognostic (3.61e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.05e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.61e-1)"	"unprognostic (5.04e-5)"	"unprognostic (3.34e-2)"	"unprognostic (4.66e-2)"	"unprognostic (5.76e-2)"	"unprognostic (3.29e-1)"	0.6	0.2	0.3	1.0	0.4	0.1	0.5	0.4	0.5	0.7	0.6	9.6	0.2	1.3	0.3	0.0	0.5	0.3	0.2	0.4	0.2	0.4	0.0	0.0	0.0	0.3	0.3	0.6	0.1	0.0	0.0	4.0	0.4	28.9	2.2	0.1	0.0	2.3	0.4	0.2	0.8	2.1	0.1	0.0	0.4	0.3	0.5	0.0	0.1	0.4	0.0	0.4	0.2	0.7	0.0	0.0	0.0	0.0	0.2	1.9	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.4	0.5	0.4	0.2	0.3	0.3	0.4	0.1	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	77.4	0.0	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	4.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1
ORAI1	"CRACM1, FLJ14466, TMEM142A"	ENSG00000276045	"ORAI calcium release-activated calcium modulator 1"	Q96D31	12	121626550-121642677	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Calcium transport, Immunity, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 60.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 92.3;NK-cells: 88.6;Theca cells: 86.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"NB-4: 81.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016583	Approved					NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 59: Non-specific - Translation"	"Cluster 24: NB-4 - Immune response"	"Cluster 24: Non-specific - Transcription regulation"			"HPA016583: AB_1848720"	"unprognostic (2.22e-2)"	"unprognostic (3.78e-3)"	"unprognostic (7.82e-3)"	"unprognostic (8.83e-2)"	"unprognostic (3.20e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.25e-3)"	"unprognostic (1.92e-1)"	"unprognostic (2.00e-2)"	"prognostic favorable (4.30e-4)"	"unprognostic (1.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (6.84e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.57e-2)"	10.8	5.4	4.4	9.6	4.6	8.8	10.9	5.2	6.8	7.3	22.1	10.6	20.8	7.6	0.0	8.7	7.7	3.3	9.3	3.8	4.9	11.2	12.3	15.5	12.0	5.5	4.9	6.7	8.1	8.7	2.6	4.5	5.5	6.4	0.3	0.0	15.6	2.6	60.1	46.6	13.8	2.2	5.4	23.1	12.5	11.5	5.1	6.1	10.4	14.0	2.8	11.1	7.8	5.1	18.3	42.0	3.4	16.9	4.0	4.9	18.4	20.5	2.9	8.8	4.7	33.1	16.2	13.3	31.4	3.1	11.8	30.2	3.4	13.7	0.0	41.9	7.8	23.9	6.8	16.6	10.1	18.5	43.7	2.0	5.1	14.4	0.9	4.9	12.9	30.0	16.8	6.9	2.3	41.4	46.1	81.7	19.6	10.3	35.7	16.8	7.9	20.5	5.0	13.4	16.4	3.3	10.7	11.7	17.5	0.2	29.3	11.6	23.5	21.0	8.4	28.6	15.9	9.4	8.7	5.6	15.7	25.9	19.1	9.4	6.3	8.2	18.6	5.4	13.9	6.3	15.4	18.8	7.5	9.0	14.3	12.5	6.9	7.5	5.2	1.9	13.7	7.6	4.4	4.6	5.2	6.8	3.8	4.9	5.5	4.9	5.5	5.4	5.1	5.1	32.0	28.9	16.4	1.0	41.0	22.6	10.1	3.4	6.8	2.1	48.4	22.9	4.2	18.6	10.3	1.8	4.2	3.7	92.3	8.4	1.9	13.3	3.4	14.1	11.1	40.6	2.4	23.8	0.3	19.5	15.2	9.5	8.6	17.4	7.0	24.0	43.2	17.9	38.6	0.0	0.5	9.3	2.0	28.2	65.0	11.8	13.4	42.8	21.4	4.7	27.2	5.8	88.6	3.0	1.5	29.5	6.3	9.4	30.5	14.8	17.2	12.1	6.3	6.9	0.0	6.3	10.8	1.7	6.0	6.9	37.4	7.8	70.3	86.0	20.1	10.7
ORAI3	"MGC13024, TMEM142C"	ENSG00000175938	"ORAI calcium release-activated calcium modulator 3"	Q9BRQ5	16	30949068-30956461	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 77.3;Hofbauer cells: 93.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 94.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015022	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Cytosol"		"HPA015022: AB_1854807"	"unprognostic (1.17e-1)"	"unprognostic (3.88e-2)"	"unprognostic (2.94e-3)"	"unprognostic (1.15e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.46e-1)"	"unprognostic (8.60e-2)"	"unprognostic (8.54e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.33e-3)"	"unprognostic (1.77e-1)"	"unprognostic (1.47e-1)"	"prognostic unfavorable (3.87e-5)"	"unprognostic (2.30e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.43e-3)"	"unprognostic (9.17e-3)"	17.3	34.1	18.0	8.2	16.5	17.6	15.2	16.9	17.1	24.4	26.0	22.7	9.2	18.3	16.3	15.4	19.2	9.9	16.7	15.3	16.3	19.3	70.2	14.2	11.9	18.6	18.5	18.9	17.7	18.9	18.0	14.9	17.1	26.3	8.6	4.0	14.6	17.0	7.9	14.3	16.1	9.8	17.4	22.5	17.1	15.6	20.5	11.2	16.4	8.1	10.6	27.2	20.2	17.7	2.8	15.8	8.1	10.7	68.1	60.7	0.6	9.3	62.3	6.8	17.2	1.5	26.1	3.9	20.7	17.9	27.5	12.7	1.4	17.6	4.6	12.3	5.2	10.2	4.9	16.1	94.9	11.2	30.5	65.5	45.9	13.1	25.5	63.8	11.7	2.2	11.7	20.6	22.1	10.8	0.7	42.6	6.6	9.1	4.3	8.6	6.3	30.8	26.2	6.8	2.0	13.5	8.4	2.6	14.9	19.5	19.7	45.5	8.5	5.1	3.5	11.4	2.2	50.4	4.0	3.1	25.3	26.4	7.9	23.2	8.7	26.6	3.4	9.2	3.6	7.1	1.8	2.7	8.5	6.7	2.2	2.9	15.3	11.7	12.6	9.5	2.7	3.3	18.0	16.5	16.9	17.1	15.3	16.3	18.6	18.5	17.1	17.4	20.5	17.7	12.1	6.4	10.8	0.0	23.9	7.9	24.5	25.6	32.5	1.5	11.1	19.6	6.9	5.7	11.6	16.5	2.1	28.1	25.9	11.1	13.7	21.4	61.1	16.5	21.8	16.5	15.0	16.2	0.0	11.4	2.7	25.9	4.1	10.5	7.0	17.9	23.6	77.3	93.8	35.3	0.0	11.3	10.2	43.7	11.5	36.7	53.1	31.4	21.4	0.0	39.1	24.4	17.5	0.0	0.0	9.5	18.4	43.2	18.1	14.0	9.5	48.2	14.7	3.6	26.3	11.0	14.0	26.5	2.5	17.0	4.5	4.4	9.7	61.0	5.8	20.4
OS9	"ERLEC2, OS-9"	ENSG00000135506	"OS9 endoplasmic reticulum lectin"	Q13438	12	57693955-57721557	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	7	"RH-30: 3551.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011518, HPA013694"	Supported		Supported	"Endoplasmic reticulum"	"Intracellular and membrane"	NA	NA		10000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB011518: AB_776918, HPA013694: AB_1854812"	"unprognostic (1.67e-2)"	"unprognostic (4.20e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.50e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-3)"	"unprognostic (4.78e-2)"	"unprognostic (8.54e-2)"	"unprognostic (2.67e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.67e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.83e-2)"	"unprognostic (2.78e-1)"	"unprognostic (1.67e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.21e-2)"	151.0	93.0	61.1	118.6	59.3	149.0	113.4	60.7	60.8	135.6	94.3	158.1	149.9	101.2	141.4	105.2	109.6	106.2	111.0	58.4	71.5	114.8	264.5	130.0	89.7	64.5	62.8	124.6	270.0	171.6	71.5	141.3	63.5	116.4	132.6	75.5	189.0	102.1	59.6	119.8	143.2	110.2	60.8	106.0	137.2	38.9	66.7	72.6	129.4	65.5	94.2	119.7	103.5	63.7	86.8	170.8	86.2	214.4	440.4	295.6	190.5	211.9	268.4	153.4	154.6	180.2	274.5	110.0	345.3	255.2	118.5	152.9	81.3	137.5	121.2	142.0	97.6	124.0	115.3	164.8	287.1	196.9	307.3	273.7	217.6	150.7	152.6	529.4	258.6	71.7	96.0	427.9	162.2	149.5	53.7	239.7	97.7	172.0	121.2	69.8	3551.9	281.5	116.5	210.6	88.4	116.4	300.3	205.5	176.6	158.1	245.4	381.0	238.9	206.0	122.3	140.4	136.4	253.4	234.6	112.9	173.8	141.6	290.4	175.7	241.2	274.6	72.9	213.0	68.5	50.5	61.1	65.0	172.6	54.3	46.8	54.1	246.4	58.8	182.4	149.0	74.4	218.9	61.1	59.3	60.7	60.8	58.4	71.5	64.5	62.8	63.5	60.8	66.7	63.7	83.3	86.6	116.7	22.2	65.8	57.7	85.4	103.3	43.9	44.1	61.2	46.6	14.1	80.1	111.8	73.5	77.2	142.4	64.5	153.0	9.8	144.8	6.7	34.0	73.3	90.2	103.6	53.4	19.5	110.1	124.6	113.6	65.7	60.0	91.1	61.6	81.4	161.1	144.8	50.5	27.0	167.3	107.8	121.1	99.1	10.7	113.4	106.1	119.2	29.0	125.0	87.2	53.5	23.6	24.4	94.7	155.4	79.0	141.1	56.5	154.0	53.9	74.0	50.9	92.1	68.3	66.9	38.1	46.4	51.3	51.6	197.7	59.5	64.9	102.4	65.0
OSBPL5	"KIAA1534, OBPH1, ORP5"	ENSG00000021762	"Oxysterol binding protein like 5"	Q9H0X9	11	3087107-3166739	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 34.6;Horizontal cells: 62.2;NK-cells: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 3.6;gdT-cell: 9.0;intermediate monocyte: 4.7;memory CD8 T-cell: 3.3;myeloid DC: 3.0;naive CD8 T-cell: 3.4;NK-cell: 11.0;non-classical monocyte: 11.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"NB-4: 75.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038335, HPA038712, HPA058727"	Approved		Enhanced	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 24: NB-4 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles		"HPA038335: AB_2675963, HPA038712: AB_10675949, HPA058727: AB_2683799"	"unprognostic (6.02e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.69e-2)"	"unprognostic (8.22e-3)"	"unprognostic (1.71e-1)"	"unprognostic (1.25e-1)"	"unprognostic (4.03e-3)"	"unprognostic (1.29e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.16e-3)"	"unprognostic (9.44e-2)"	"unprognostic (2.78e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.50e-2)"	"unprognostic (7.67e-2)"	"unprognostic (2.60e-1)"	22.0	8.0	7.1	7.2	7.7	13.6	19.2	7.8	11.5	42.2	2.1	28.2	5.9	26.6	2.9	12.5	22.3	5.0	14.9	5.2	6.4	13.5	3.1	17.5	2.4	50.3	13.3	14.5	10.4	2.3	10.3	5.0	56.0	25.6	3.2	1.8	16.4	9.9	9.9	25.9	16.6	7.6	5.4	24.9	15.5	3.3	19.8	22.0	14.9	5.9	1.4	24.6	28.3	10.5	3.7	5.6	6.6	7.6	18.9	8.8	0.1	17.9	8.8	7.1	5.0	0.0	10.4	0.0	5.3	10.1	4.9	13.3	1.3	5.0	1.1	3.5	6.0	15.1	19.2	0.0	15.9	13.6	2.3	13.9	5.7	2.5	2.6	5.2	4.8	26.7	5.5	0.0	3.5	10.3	30.7	75.5	4.8	2.4	11.5	15.9	9.0	2.2	3.0	3.3	10.8	1.3	7.6	26.1	7.0	3.7	10.8	35.9	16.4	8.8	12.1	21.2	3.1	3.8	0.0	0.5	9.5	25.3	11.5	0.2	3.6	1.2	9.0	4.7	1.2	0.0	0.9	3.3	3.0	0.0	0.6	3.4	0.4	11.0	11.5	1.3	0.1	5.2	7.1	7.7	7.8	11.5	5.2	6.4	50.3	13.3	56.0	5.4	19.8	10.5	19.5	0.0	5.5	8.1	0.5	4.8	2.6	4.2	5.2	11.5	7.7	5.2	6.9	2.8	4.8	3.7	8.4	0.4	34.6	8.3	1.9	3.0	0.1	2.2	22.1	12.1	0.0	5.7	25.6	2.0	0.6	12.3	5.1	2.5	1.3	3.5	3.9	0.5	1.7	62.2	20.6	8.0	2.0	8.7	3.1	1.2	9.0	3.9	3.6	17.8	2.3	4.1	56.7	20.1	28.2	2.2	8.5	17.0	4.9	3.2	6.1	3.2	5.5	1.2	13.1	7.4	11.4	0.1	0.6	3.8	6.8	0.0	9.1	2.5	8.2	2.5
OSBPL8	"MST120, MSTP120, ORP8, OSBP10"	ENSG00000091039	"Oxysterol binding protein like 8"	Q9BZF1	12	76351797-76559809	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001309	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 66: Lymphoid tissue - Immune response regulation"	"Cluster 36: HEL - Hemostasis"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Vesicles, Cytosol"		"HPA001309: AB_1079530"	"unprognostic (2.55e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.70e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.23e-1)"	"unprognostic (6.55e-3)"	"unprognostic (2.84e-1)"	"unprognostic (7.88e-2)"	"unprognostic (1.61e-2)"	"prognostic unfavorable (9.79e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.63e-3)"	"unprognostic (2.96e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.19e-3)"	24.2	13.5	18.1	24.3	43.3	32.5	21.1	9.7	22.5	22.6	12.3	11.2	9.3	22.3	7.7	24.4	10.5	18.4	14.0	15.3	13.7	36.4	19.2	19.6	30.9	11.7	13.4	17.4	14.0	13.0	5.6	18.2	14.0	14.9	11.7	14.2	13.5	12.7	10.7	28.7	13.0	18.9	9.1	26.7	16.0	16.6	13.1	33.7	14.3	11.5	32.0	19.1	10.2	16.6	36.5	22.8	49.7	35.5	67.5	94.8	31.6	54.7	76.3	34.2	31.1	33.2	14.6	50.8	30.4	65.3	21.5	14.9	37.2	31.6	51.3	43.6	33.3	136.0	21.0	19.8	41.7	87.2	53.1	50.4	58.7	51.2	63.3	61.8	30.0	29.1	95.0	22.7	57.3	25.0	58.8	41.4	24.3	13.2	22.6	30.4	67.7	29.3	26.4	30.3	27.2	28.4	46.7	16.6	34.0	38.9	13.0	52.4	70.6	55.0	27.5	57.5	29.7	22.7	38.4	54.6	21.0	47.9	32.8	134.8	50.8	74.1	29.2	37.4	27.9	45.3	31.2	24.6	46.9	40.8	27.9	23.2	195.7	36.0	44.5	54.9	41.1	31.8	18.1	43.3	9.7	22.5	15.3	13.7	11.7	13.4	14.0	9.1	13.1	16.6	63.5	57.7	58.3	54.5	87.8	116.2	65.7	39.6	114.9	49.7	68.4	55.5	42.5	25.8	36.1	51.5	89.6	34.8	111.3	13.6	60.7	53.9	47.4	29.0	102.6	68.7	9.5	63.5	246.3	55.2	28.7	98.0	28.5	44.1	254.8	36.3	52.1	45.9	77.1	42.1	248.6	25.8	40.7	98.0	127.0	22.1	65.9	142.0	35.6	79.6	149.3	50.2	125.7	113.6	92.9	104.0	28.3	82.8	56.8	54.6	23.9	180.2	37.4	37.3	46.0	79.3	83.1	66.2	129.9	89.9	124.5	48.2	105.3	58.4	20.0	62.4
OSCP1	"C1orf102, NOR1"	ENSG00000116885	"Organic solute carrier partner 1"	Q8WVF1	1	36415827-36450451	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"fallopian tube: 58.0;testis: 76.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 453.5;Endometrial ciliated cells: 88.6;Respiratory ciliated cells: 199.1;Spermatocytes: 163.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA028436, HPA052655"	Approved		Approved	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoplasm, Nucleoli"	"Plasma membrane"	"HPA028436: AB_10600885, HPA052655: "	"unprognostic (3.46e-3)"	"unprognostic (7.57e-2)"	"unprognostic (4.67e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (1.28e-2)"	"unprognostic (4.81e-2)"	"unprognostic (3.38e-2)"	"unprognostic (4.52e-2)"	"unprognostic (5.52e-2)"	"unprognostic (8.80e-2)"	"unprognostic (2.21e-2)"	"unprognostic (3.87e-2)"	"prognostic favorable (2.18e-6)"	"unprognostic (1.20e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.02e-2)"	"unprognostic (4.20e-2)"	6.8	8.2	9.7	2.4	10.4	2.0	9.4	7.4	10.5	9.5	31.3	7.3	2.9	10.0	22.0	5.0	58.0	8.8	7.9	11.1	13.0	19.1	2.8	11.0	1.9	11.3	14.7	9.1	8.2	30.2	23.1	5.6	10.9	9.9	3.9	23.1	8.7	8.9	4.9	6.8	2.7	7.9	9.9	1.4	6.3	76.1	13.5	3.6	17.9	5.2	1.5	5.9	4.8	8.3	6.7	6.3	7.6	8.9	8.9	8.6	1.4	4.0	9.7	9.7	6.6	0.1	5.8	1.5	7.3	7.3	7.1	5.1	0.2	7.5	6.2	1.1	5.9	0.1	3.9	0.7	10.9	0.8	1.2	9.8	12.0	13.7	5.9	14.1	6.7	6.3	0.1	1.7	7.7	4.8	3.6	2.5	7.8	2.6	2.6	3.8	3.1	1.2	16.0	2.3	20.4	9.0	7.5	3.5	5.4	7.2	7.6	1.1	5.8	7.0	2.6	12.7	6.9	2.8	3.1	0.8	13.4	0.2	4.7	0.0	0.2	0.0	0.2	0.6	0.0	0.1	0.3	0.2	0.6	0.2	0.6	1.0	0.1	0.1	0.0	1.2	0.7	0.2	9.7	10.4	7.4	10.5	11.1	13.0	11.3	14.7	10.9	9.9	13.5	8.3	3.0	9.6	10.9	4.6	0.4	1.5	5.5	21.3	3.4	5.4	7.9	7.5	5.5	5.7	21.3	12.9	16.7	12.2	0.0	2.0	23.5	15.1	453.5	88.6	5.8	3.3	4.9	1.7	8.1	9.3	3.4	6.4	6.1	7.7	0.0	4.8	2.2	2.3	4.2	5.0	6.9	2.3	32.6	0.8	1.2	66.8	12.5	1.4	3.6	1.0	0.1	12.9	0.0	5.0	2.6	7.2	4.0	9.1	0.4	3.5	0.5	26.1	199.1	21.3	0.0	4.7	7.7	163.7	20.6	3.6	3.1	20.1	0.7	13.9	2.3	5.2
OST4		ENSG00000228474	"Oligosaccharyltransferase complex subunit 4, non-catalytic"	P0C6T2	2	27070472-27071654	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 32: Non-specific - Translation"				"unprognostic (5.15e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.95e-3)"	"prognostic unfavorable (5.11e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.88e-2)"	"unprognostic (7.89e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (7.35e-5)"	"unprognostic (1.33e-1)"	"unprognostic (8.52e-2)"	"unprognostic (1.38e-1)"	"unprognostic (9.88e-2)"	302.0	323.9	359.4	276.6	368.6	446.0	288.7	370.1	440.9	365.2	371.6	366.6	255.3	214.6	458.9	268.4	258.6	297.8	541.4	357.5	387.2	313.6	392.9	220.8	370.4	373.4	375.4	329.2	295.3	377.2	169.0	232.2	375.8	268.4	327.6	146.3	411.8	320.7	396.9	211.7	298.1	325.7	375.9	260.8	269.2	137.9	371.6	443.2	277.0	534.2	352.1	480.9	231.8	387.8	526.7	444.8	492.1	336.3	1362.9	1154.9	327.7	635.8	749.7	386.9	559.9	450.5	435.2	248.4	427.1	1044.1	572.4	244.1	321.3	701.9	305.9	486.4	491.5	527.4	300.4	1082.4	769.3	386.5	465.7	1235.3	591.0	509.8	468.3	952.9	916.5	490.1	337.2	509.8	882.5	641.8	472.7	710.4	293.7	1029.8	695.8	274.1	543.6	617.9	906.6	577.2	289.7	660.5	337.8	541.2	469.8	622.6	294.5	449.5	683.7	541.5	461.0	409.5	449.6	835.8	720.7	893.5	551.9	427.2	466.0	3182.5	1405.3	2129.1	1337.7	1230.8	1558.0	1748.5	1752.0	1469.2	1341.1	1473.3	1607.2	1551.1	1133.7	1049.8	1221.4	2614.4	1818.9	4735.8	359.4	368.6	370.1	440.9	357.5	387.2	373.4	375.4	375.8	375.9	371.6	387.8	370.4	176.3	301.9	13.7	522.3	411.2	417.7	1106.0	233.9	58.1	754.0	1020.4	369.3	377.4	595.2	663.9	20.9	527.6	555.4	597.3	1195.4	611.5	211.3	296.4	453.3	395.7	435.1	465.9	4.7	661.7	841.8	394.3	215.6	561.8	460.2	316.1	616.8	808.5	843.3	33.7	6.1	993.1	573.7	569.5	600.1	142.5	504.2	577.1	597.7	6.5	1041.6	309.1	632.4	9.5	13.5	668.3	725.3	429.1	749.7	509.8	1012.6	1348.1	310.0	81.8	295.9	230.7	492.5	242.3	392.6	424.9	589.0	577.1	532.4	299.2	669.3	620.6
OSTC	DC2	ENSG00000198856	"Oligosaccharyltransferase complex non-catalytic subunit"	Q9NRP0	4	108650585-108667820	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 628.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 55: Plasma cells - Humoral immune response"				"unprognostic (1.26e-1)"	"unprognostic (1.00e-1)"	"unprognostic (2.10e-2)"	"prognostic favorable (1.44e-4)"	"unprognostic (6.05e-2)"	"prognostic unfavorable (6.66e-4)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (2.84e-4)"	"unprognostic (6.46e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.13e-3)"	"unprognostic (9.16e-3)"	"prognostic unfavorable (2.31e-8)"	"unprognostic (2.06e-1)"	"unprognostic (1.68e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.55e-2)"	72.6	74.1	22.8	84.2	23.7	98.9	99.8	24.1	29.8	118.6	35.0	85.1	96.2	87.1	180.0	77.5	72.7	82.4	51.6	22.3	26.5	74.6	193.9	64.6	87.8	25.9	24.1	69.7	132.9	51.1	82.8	105.4	24.7	64.6	98.4	22.6	83.5	59.6	24.3	47.8	89.1	82.7	25.1	70.1	87.1	39.2	26.4	91.6	106.2	30.6	80.9	92.5	60.4	26.8	123.2	75.5	200.2	138.2	419.3	556.1	158.0	328.3	316.8	166.9	203.0	161.6	274.7	258.5	236.0	388.7	101.2	81.6	159.8	133.5	192.8	108.8	117.4	133.0	99.7	357.0	336.8	304.0	124.1	362.8	253.7	137.4	280.2	349.9	379.6	160.1	255.0	295.1	329.5	152.2	213.1	264.7	137.2	332.2	95.7	216.2	217.5	284.6	292.1	85.9	99.9	123.4	111.8	265.0	262.9	245.2	122.4	246.5	298.5	175.4	185.3	132.2	135.9	168.0	183.1	254.0	225.1	183.9	195.7	146.4	136.2	76.4	130.4	145.5	202.4	120.2	138.0	143.0	204.0	91.5	128.3	139.2	18.6	152.7	125.9	375.9	105.5	227.2	22.8	23.7	24.1	29.8	22.3	26.5	25.9	24.1	24.7	25.1	26.4	26.8	123.1	38.5	48.5	11.8	128.4	97.3	114.1	413.8	86.6	15.1	178.3	197.1	34.2	124.4	235.4	84.6	16.7	276.9	199.9	54.6	88.0	221.7	9.4	105.4	337.0	120.0	58.0	105.5	9.4	159.5	628.6	200.2	120.8	180.5	122.4	169.5	111.4	187.1	256.1	11.8	13.3	274.2	209.5	139.9	196.7	10.1	164.1	138.5	161.9	6.5	140.0	50.2	140.1	12.1	17.5	160.3	90.4	109.1	424.4	183.7	166.5	173.9	126.9	17.3	72.3	108.8	175.3	74.5	72.4	134.9	117.9	365.4	117.2	197.4	178.5	145.2
OSTM1	"GL, HSPC019"	ENSG00000081087	"Osteoclastogenesis associated transmembrane protein 1"	Q86WC4	6	108041409-108165854	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			Osteopetrosis	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Melanocytes: 151.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010851	Uncertain		Approved	Nucleoplasm,Vesicles,Cytosol		No	No		210000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Vesicles"	"HPA010851: AB_1079533"	"prognostic unfavorable (4.36e-4)"	"unprognostic (4.03e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.72e-3)"	"prognostic unfavorable (4.26e-4)"	"unprognostic (9.40e-2)"	"unprognostic (2.56e-1)"	"unprognostic (2.25e-1)"	"unprognostic (4.06e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (1.34e-6)"	"prognostic unfavorable (1.20e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.77e-1)"	26.1	19.1	4.7	17.9	5.2	5.7	9.8	5.1	5.8	10.4	33.1	12.2	7.9	13.7	9.0	12.7	9.5	12.5	19.2	5.3	9.2	15.6	13.1	16.2	14.7	6.0	7.6	7.5	5.8	15.3	8.3	14.1	7.9	13.8	11.1	17.6	8.9	16.7	11.8	9.8	9.0	23.3	5.3	18.3	8.5	10.1	7.4	13.7	10.7	11.5	13.5	16.9	7.0	8.3	6.0	17.2	20.1	29.4	59.0	19.0	28.6	42.8	42.7	30.7	50.4	10.0	9.8	13.7	34.4	30.0	82.5	11.1	20.2	14.6	47.0	31.6	15.7	28.9	10.9	12.8	45.6	32.1	64.6	28.1	35.7	37.7	30.0	28.2	15.8	15.2	23.3	48.7	50.3	8.4	7.1	7.3	8.0	7.1	13.0	11.4	29.1	7.5	22.0	15.7	2.2	11.8	34.7	8.7	79.9	26.6	10.0	45.8	19.3	26.7	9.8	59.7	61.4	18.6	34.4	11.9	78.9	21.3	60.3	31.4	20.2	22.8	20.3	29.4	21.5	14.7	16.9	22.3	17.8	8.6	15.6	19.8	29.8	22.0	43.5	12.9	22.6	27.0	4.7	5.2	5.1	5.8	5.3	9.2	6.0	7.6	7.9	5.3	7.4	8.3	28.5	9.6	19.0	26.4	26.0	46.7	19.8	11.7	21.6	28.3	10.0	7.0	24.8	12.8	9.4	12.9	10.4	21.7	32.3	21.9	1.9	12.4	12.0	7.5	15.7	20.7	4.2	4.6	36.6	22.9	33.9	24.4	15.8	9.6	24.1	6.9	26.7	13.2	52.8	28.6	40.1	5.8	6.1	46.5	29.5	5.4	14.3	43.1	151.2	20.6	25.6	23.7	40.2	21.1	36.6	16.8	17.0	28.6	25.0	17.9	7.6	25.5	9.8	17.5	26.3	18.5	29.6	28.0	18.7	12.4	31.1	61.2	29.5	23.7	3.3	16.0
OTOP1		ENSG00000163982	"Otopetrin 1"	Q7RTM1	4	4188726-4226929	"Predicted membrane proteins, Transporters"	"Biomineralization, Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Microglial cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA035599	Uncertain					NA	NA						"Cluster 25: Spermatids - Spermatogenesis"			"HPA035599: AB_10600924"										"unprognostic (1.83e-1)"					"unprognostic (1.09e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
OTOP2		ENSG00000183034	"Otopetrin 2"	Q7RTS6	17	74922950-74933912	"Predicted membrane proteins, Transporters"	"Hydrogen ion transport, Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 20.1"	"Cell type enriched"	"Detected in some"	20	"Paneth cells: 627.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	41	"HDLM-2: 10.1"	"Region enriched"	"Detected in some"	12	"olfactory bulb: 12.7"	"Low region specificity"	"Detected in many"			"HPA024524, HPA053090"	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA024524: AB_2671592, HPA053090: AB_2682041"		"unprognostic (1.62e-2)"	"unprognostic (1.45e-1)"			"unprognostic (7.25e-2)"		"unprognostic (3.21e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.30e-1)"			"unprognostic (2.85e-2)"	"unprognostic (3.81e-1)"	"unprognostic (9.04e-2)"		"unprognostic (2.04e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.1	0.3	0.2	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.1	0.0	0.2	1.4	0.3	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	30.0	0.0	0.0	9.3	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.3	0.0	0.0	0.0	19.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	627.4	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	4.1	0.0
OXA1L	"MGC133129, OXA1"	ENSG00000155463	"OXA1L mitochondrial inner membrane protein"	Q15070	14	22766522-22773042	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003531	Approved		Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA003531: AB_1079539"	"unprognostic (4.04e-3)"	"unprognostic (2.41e-2)"	"unprognostic (3.39e-1)"	"unprognostic (2.24e-2)"	"unprognostic (7.25e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.82e-4)"	"unprognostic (8.35e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.15e-3)"	77.7	90.7	27.6	40.8	28.5	71.9	67.6	31.4	28.8	59.4	47.1	72.9	66.3	55.0	48.1	76.6	55.8	49.6	147.2	27.5	29.6	70.8	108.6	54.8	70.0	31.3	29.1	71.2	98.0	105.3	27.5	38.0	31.1	45.0	57.7	41.9	64.2	44.8	234.9	69.3	58.9	46.1	29.1	62.3	83.9	25.0	31.6	63.6	54.9	272.5	75.5	61.3	60.4	31.1	89.3	121.3	48.8	82.1	146.7	217.4	94.4	64.0	138.1	94.3	107.9	91.1	96.4	167.0	86.4	75.0	73.0	121.0	103.0	126.3	90.0	67.6	65.4	79.1	73.2	329.7	165.5	150.9	88.4	211.0	137.6	75.4	114.9	114.7	273.3	93.8	62.2	124.0	103.4	130.0	91.8	51.3	53.2	118.5	150.0	92.9	87.2	128.3	117.9	103.4	35.1	67.0	94.6	205.7	129.7	58.4	89.2	122.7	86.2	52.7	62.2	98.5	75.4	94.0	84.7	78.1	41.6	83.6	60.0	11.9	68.1	18.5	29.5	71.6	36.0	51.0	42.5	37.4	95.1	54.4	47.4	35.6	15.1	41.7	58.5	26.9	55.8	53.7	27.6	28.5	31.4	28.8	27.5	29.6	31.3	29.1	31.1	29.1	31.6	31.1	30.6	48.1	44.0	7.8	83.7	69.5	61.1	89.0	92.8	31.0	52.1	46.5	118.0	72.9	62.1	29.5	10.4	72.8	32.5	48.9	74.3	85.2	10.2	20.4	40.3	58.6	40.7	64.3	6.8	161.3	113.0	47.6	66.8	23.1	80.4	56.5	64.2	102.9	143.4	18.5	7.5	75.3	38.7	148.1	76.8	13.3	57.2	85.6	51.6	3.7	133.4	22.9	74.2	4.5	8.0	86.3	69.7	36.9	84.2	45.6	101.4	116.0	42.6	38.3	39.5	39.4	43.0	31.8	28.4	112.9	67.3	57.2	57.9	70.6	112.1	74.9
OXTR		ENSG00000180914	"Oxytocin receptor"	P30559	3	8750381-8769628	"FDA approved drug targets, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 14.7;breast: 54.1"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 122.6;Excitatory neurons: 25.8;Oligodendrocyte precursor cells: 21.1;Respiratory ciliated cells: 57.1"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 7.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 421.2;BJ hTERT+: 127.9;BJ hTERT+ SV40 Large T+: 119.4;fHDF/TERT166: 424.5;HBF TERT88: 92.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.18e-1)"	"unprognostic (7.94e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.02e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.56e-3)"	"unprognostic (2.12e-1)"	"unprognostic (3.42e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.80e-2)"	"unprognostic (4.24e-4)"	"unprognostic (8.25e-2)"	"unprognostic (4.60e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.84e-1)"	0.4	0.2	4.0	0.1	8.1	0.6	54.1	3.3	4.1	0.5	0.3	0.2	0.1	3.5	0.3	1.6	3.0	0.3	0.5	3.1	13.7	0.5	0.2	0.9	0.2	14.7	12.4	3.1	0.1	0.1	0.3	0.5	6.6	0.8	0.1	2.7	0.2	0.8	0.2	0.2	0.2	0.5	12.0	0.3	0.2	0.3	13.7	0.3	0.3	0.1	0.1	0.8	0.2	3.7	1.1	4.6	2.5	0.5	0.5	1.2	0.8	421.2	127.9	119.4	63.4	0.6	11.3	0.3	0.9	424.5	1.7	0.9	2.0	0.9	92.4	3.9	2.1	1.1	1.9	0.7	2.2	1.0	1.0	0.7	0.5	1.7	0.9	36.1	0.2	1.3	0.2	0.8	67.5	0.3	0.9	3.3	2.7	1.4	18.7	0.9	1.6	25.5	4.5	0.4	0.7	0.8	0.7	0.9	0.2	8.1	0.3	0.6	0.6	5.9	1.5	1.2	1.2	0.7	1.2	0.2	0.6	1.4	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	4.0	8.1	3.3	4.1	3.1	13.7	14.7	12.4	6.6	12.0	13.7	3.7	1.3	9.6	1.1	3.3	0.3	0.4	0.6	1.0	0.0	0.8	2.3	122.6	1.5	1.5	6.5	0.0	0.0	0.2	0.4	0.3	0.0	2.7	1.4	4.7	0.6	0.7	0.0	0.0	25.8	0.0	0.1	2.0	0.0	0.9	0.0	4.3	1.4	0.0	0.2	0.0	14.0	0.0	2.0	0.0	0.0	2.0	0.0	3.1	0.0	5.6	0.1	7.9	0.0	21.1	15.4	1.2	0.1	0.4	0.2	2.2	0.0	0.1	57.1	0.2	0.0	2.0	16.9	1.0	1.8	0.0	0.1	0.0	0.3	3.1	0.1	0.3
P2RX3	P2X3	ENSG00000109991	"Purinergic receptor P2X 3"	P56373	11	57338352-57372396	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"heart muscle: 2.9;liver: 1.7;testis: 5.2"	"Group enriched"	"Detected in some"	28	"Early spermatids: 34.5;Late spermatids: 16.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA057776	Uncertain					NA	NA				"Cluster 43: Testis - Unknown function"		"Cluster 29: Early spermatids - Spermatogenesis"			"HPA057776: AB_2683526"	"unprognostic (5.44e-2)"		"unprognostic (9.43e-2)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-3)"		"unprognostic (2.24e-2)"	"unprognostic (3.19e-3)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.49e-7)"	"unprognostic (1.58e-1)"	"unprognostic (2.88e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.29e-1)"	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	2.9	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.6	5.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.5	0.0	0.0	0.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	16.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
P2RX4	P2X4	ENSG00000135124	"Purinergic receptor P2X 4"	Q99571	12	121209861-121234106	"FDA approved drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 135.3;Distal enterocytes: 133.7;Hofbauer cells: 129.5;Syncytiotrophoblasts: 155.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039494	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA039494: AB_10969132"	"unprognostic (4.02e-3)"	"unprognostic (1.06e-1)"	"unprognostic (5.43e-2)"	"prognostic favorable (6.30e-10)"	"unprognostic (2.98e-2)"	"unprognostic (2.52e-1)"	"unprognostic (2.06e-3)"	"unprognostic (1.68e-1)"	"unprognostic (1.21e-1)"	"unprognostic (5.42e-2)"	"unprognostic (7.71e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.81e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.42e-2)"	"unprognostic (4.76e-3)"	10.1	9.9	4.8	15.1	5.0	14.1	12.7	8.3	5.6	18.8	4.6	33.5	28.9	8.5	3.7	5.0	15.3	16.8	7.2	5.1	5.3	13.0	11.5	20.4	15.9	6.7	5.4	18.1	37.4	33.1	5.1	32.7	6.0	12.1	30.2	2.0	30.1	12.0	1.0	4.5	32.8	10.7	6.3	12.6	20.2	6.0	6.3	7.8	12.9	2.3	8.9	12.1	4.1	7.6	6.6	15.4	1.1	21.7	10.3	8.3	40.6	4.9	26.1	6.7	13.3	10.9	23.1	6.4	18.5	17.4	48.2	2.3	4.7	3.2	4.1	17.5	11.8	3.1	0.9	12.5	25.3	7.6	42.5	11.9	6.8	11.0	14.5	20.4	24.2	7.7	6.1	16.2	5.0	31.8	4.7	10.7	5.5	31.8	10.5	6.6	29.5	34.6	3.1	18.0	6.1	9.0	16.0	8.8	55.0	5.7	38.5	21.2	2.1	10.0	11.2	1.2	5.2	28.0	26.1	3.7	19.6	10.2	9.1	72.3	59.1	10.7	13.6	63.1	15.1	11.3	21.9	13.3	32.5	7.1	16.4	9.6	0.8	29.6	54.6	4.4	17.1	32.6	4.8	5.0	8.3	5.6	5.1	5.3	6.7	5.4	6.0	6.3	6.3	7.6	8.4	6.4	19.2	6.5	14.0	3.8	8.9	11.9	6.8	11.1	17.7	11.9	3.8	21.5	11.2	20.2	2.1	135.3	13.7	133.7	0.0	69.7	15.2	9.8	8.9	9.2	21.5	2.1	6.4	35.4	73.8	14.3	19.4	15.1	13.9	14.3	23.6	9.4	129.5	15.2	5.3	90.3	20.3	43.7	20.8	25.1	8.7	53.7	10.6	18.7	57.9	6.5	19.6	4.5	8.0	33.1	80.6	9.8	21.9	10.2	98.7	23.2	6.4	8.6	19.7	7.4	12.0	8.1	6.6	3.4	4.0	155.7	17.8	15.4	24.7	9.7
P2RX5	"LRH-1, P2X5"	ENSG00000083454	"Purinergic receptor P2X 5"	Q93086	17	3672199-3696240	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 24.7;lymphoid tissue: 78.2"	"Group enriched"	"Detected in some"	4	"B-cells: 94.6;Plasma cells: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	19	"memory B-cell: 76.4;naive B-cell: 84.8"	"Lineage enriched"	"Detected in many"	20	"B-cells: 84.8"	"Cell line enhanced"	"Detected in many"		"Daudi: 53.2;Karpas-707: 32.7;RPMI-8226: 59.5;U-698: 47.1"									"HPA021948, HPA067827"	Supported		Supported	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Cytosol		"HPA021948: AB_1854878, HPA067827: AB_2685908"	"unprognostic (1.08e-3)"	"unprognostic (9.16e-2)"	"unprognostic (1.40e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.33e-2)"	"unprognostic (4.34e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-2)"	"unprognostic (1.99e-8)"	"unprognostic (1.60e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.50e-2)"	"unprognostic (3.63e-2)"	0.8	0.3	1.8	30.4	2.2	9.4	0.8	0.2	2.7	0.3	0.0	2.4	1.5	0.1	0.0	0.7	0.3	1.3	8.0	2.1	0.9	0.7	0.5	1.4	78.2	0.6	0.5	0.0	0.2	0.2	1.2	0.2	0.7	0.5	1.9	0.4	1.8	0.0	17.5	0.0	24.7	0.5	0.1	54.4	3.4	0.7	1.1	12.1	0.9	4.0	53.9	2.7	0.3	1.4	8.3	6.7	0.0	0.0	0.2	1.3	0.0	8.4	3.9	0.9	2.6	5.5	9.8	53.2	4.9	4.2	2.9	4.3	18.8	0.0	1.7	0.9	3.2	2.7	17.5	6.3	1.2	3.6	4.2	2.1	1.8	0.2	12.4	6.5	0.0	12.2	0.5	32.7	18.2	0.0	23.4	8.1	4.9	4.4	20.5	0.8	0.0	59.5	0.2	6.3	4.3	0.0	7.5	2.5	3.9	0.0	2.0	3.3	0.1	0.0	4.5	0.2	1.5	11.0	25.2	47.1	0.0	5.1	0.5	0.0	0.1	2.0	3.1	0.0	4.2	76.4	2.8	2.2	0.4	84.8	0.3	0.3	0.0	0.0	0.0	0.1	1.9	4.5	1.8	2.2	0.2	2.7	2.1	0.9	0.6	0.5	0.7	0.1	1.1	1.4	0.1	0.0	0.6	0.0	94.6	0.4	0.1	0.0	0.0	0.8	0.1	0.1	2.7	0.0	0.0	1.8	0.0	0.0	13.4	0.0	0.0	0.2	4.8	0.2	0.2	0.7	0.0	11.1	0.0	0.2	0.0	0.3	0.5	0.3	4.5	0.0	1.4	0.4	0.2	0.0	0.0	0.1	0.0	1.2	0.0	3.1	1.5	1.6	3.6	0.0	1.1	0.0	2.1	0.0	0.0	1.5	0.0	0.0	29.7	0.0	0.0	0.1	0.0	0.2	0.0	0.5	0.9	1.0	0.8	0.0	0.0	0.0	11.0	0.0	0.1	0.1
P2RX7	"MGC20089, P2X7"	ENSG00000089041	"Purinergic receptor P2X 7"	Q99572	12	121132819-121188032	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 47.3"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.8;Oligodendrocyte precursor cells: 87.9;Oligodendrocytes: 156.7"	"Group enriched"	"Detected in all"	5	"glioma: 7.2;melanoma: 19.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 2.9;gdT-cell: 1.3;intermediate monocyte: 4.5;myeloid DC: 2.6;non-classical monocyte: 3.3;T-reg: 1.4"	"Group enriched"	"Detected in many"	5	"dendritic cells: 2.6;monocytes: 4.5;T-cells: 1.4"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 40.0;RPMI-8226: 24.8;SK-MEL-30: 41.0;U-266/70: 21.7;U-266/84: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034968, HPA042013, HPA044141"	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA034968: AB_10673105, HPA042013: AB_2677797, HPA044141: AB_2678830"	"unprognostic (1.05e-1)"	"unprognostic (4.90e-2)"	"unprognostic (8.87e-2)"	"unprognostic (6.54e-3)"	"unprognostic (4.49e-2)"	"unprognostic (1.55e-2)"	"unprognostic (8.82e-2)"	"unprognostic (9.11e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.42e-1)"	"unprognostic (6.62e-2)"	"prognostic unfavorable (2.92e-4)"	"unprognostic (1.91e-1)"	"unprognostic (3.59e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.65e-1)"	2.8	2.5	20.2	5.1	28.5	2.9	2.0	23.1	30.7	6.1	11.3	3.6	1.5	4.1	1.5	1.4	2.3	3.5	1.3	21.8	20.7	0.7	4.6	6.5	5.9	26.3	24.7	8.3	1.4	1.7	1.8	2.9	28.3	1.8	2.3	0.5	2.5	1.8	0.6	13.1	1.8	4.2	21.3	5.9	1.6	1.3	26.2	1.7	1.0	1.0	3.6	2.3	4.4	47.3	0.1	0.0	0.0	1.0	1.1	0.4	0.8	0.1	1.9	0.7	1.7	0.0	0.0	0.1	0.1	0.7	4.3	0.2	0.0	0.0	0.5	1.8	0.1	0.7	0.0	0.1	0.8	1.6	11.6	1.0	0.0	2.0	0.0	0.0	1.9	0.4	0.0	40.0	0.0	0.0	0.2	4.4	0.1	0.0	0.4	3.8	8.9	24.8	0.0	0.0	0.5	2.3	0.2	0.0	41.0	0.0	0.6	7.8	0.0	0.6	0.1	0.1	0.2	21.7	20.2	0.1	2.4	11.8	6.1	0.4	2.9	0.0	1.3	4.5	0.5	0.3	0.6	0.6	2.6	0.2	0.5	0.6	0.3	0.6	3.3	0.4	1.4	0.9	20.2	28.5	23.1	30.7	21.8	20.7	26.3	24.7	28.3	21.3	26.2	47.3	2.0	3.2	4.8	12.1	3.9	6.9	3.0	0.0	1.8	3.9	1.8	2.2	2.4	5.7	3.7	0.0	2.1	3.5	9.0	1.2	0.0	1.2	0.6	0.7	1.6	3.9	0.0	1.7	52.8	0.0	0.9	3.7	0.0	0.3	6.3	2.6	5.3	3.9	23.4	1.7	18.4	0.2	0.0	21.5	35.0	1.5	11.1	34.2	16.0	34.7	21.2	1.3	7.2	87.9	156.7	0.2	0.0	10.5	1.3	1.2	0.1	0.0	3.6	1.0	6.6	3.2	1.9	1.2	0.9	1.0	3.7	4.0	6.6	4.1	0.1	1.0
P2RY1	"P2Y1, SARCC"	ENSG00000169860	"Purinergic receptor P2Y1"	P47900	3	152835131-152841439	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 25.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 23.3;Cholangiocytes: 21.5;Distal enterocytes: 25.4;Kupffer cells: 21.1;Squamous epithelial cells: 45.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 6.0;non-classical monocyte: 2.6"	"Group enriched"	"Detected in many"	9	"granulocytes: 6.0;monocytes: 2.6"	"Cell line enriched"	"Detected in many"	5	"HEL: 45.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA015577	Enhanced					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 36: HEL - Hemostasis"	"Cluster 51: Myeloid cells - Hemostasis"			"HPA015577: AB_1854882"	"unprognostic (3.30e-1)"	"unprognostic (4.52e-2)"	"unprognostic (2.68e-2)"	"unprognostic (4.76e-2)"	"unprognostic (9.70e-2)"	"unprognostic (1.40e-3)"	"unprognostic (3.32e-2)"	"unprognostic (2.53e-1)"	"unprognostic (5.14e-1)"	"unprognostic (2.58e-1)"	"unprognostic (4.68e-2)"	"unprognostic (2.70e-1)"	"prognostic unfavorable (2.04e-7)"	"unprognostic (1.36e-1)"	"unprognostic (8.98e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.20e-2)"	1.6	1.4	6.2	2.3	14.2	5.7	1.4	3.1	6.4	4.5	1.0	9.1	3.2	6.5	0.5	19.2	2.1	2.0	2.9	5.9	6.7	0.8	1.5	7.0	0.8	3.3	4.2	8.8	3.3	0.3	1.6	25.4	8.4	7.7	6.7	9.0	3.2	2.2	7.7	8.9	6.1	4.5	4.9	2.2	0.9	1.1	8.2	1.6	1.3	3.4	2.7	2.4	8.0	4.1	0.0	0.7	7.0	0.0	1.1	0.1	0.0	0.0	0.1	0.2	0.6	9.0	0.1	0.0	0.7	0.0	1.1	1.5	3.9	1.3	0.3	0.0	3.4	45.9	0.1	0.0	0.0	5.4	4.0	0.5	8.7	0.0	0.4	3.5	0.0	1.5	1.4	0.0	0.0	0.1	0.8	0.1	6.4	0.0	5.5	0.0	0.2	1.3	0.0	3.1	1.1	0.0	0.0	0.0	0.9	1.6	0.0	2.4	0.0	0.7	1.8	0.0	3.9	0.0	0.0	0.0	4.5	0.0	5.2	6.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.1	6.2	14.2	3.1	6.4	5.9	6.7	3.3	4.2	8.4	4.9	8.2	4.1	1.0	0.0	0.5	12.7	0.8	1.9	6.7	3.3	15.9	23.3	0.5	0.1	7.1	21.5	1.0	0.0	0.0	0.2	1.6	25.4	0.0	1.3	0.2	1.9	12.0	7.1	0.0	10.8	0.0	0.0	0.3	5.6	0.0	2.7	10.1	0.1	11.7	0.3	7.4	0.0	0.2	8.9	0.0	21.1	0.3	0.8	14.9	15.9	0.0	1.0	1.8	19.1	0.0	0.0	0.6	0.9	12.3	6.0	0.0	6.3	13.4	0.2	0.2	1.5	0.0	1.2	1.0	0.4	2.2	45.4	2.0	0.1	0.5	3.5	8.3	4.9
P2RY12	"HORK3, P2Y12, SP1999"	ENSG00000169313	"Purinergic receptor P2Y12"	Q9H244	3	151336843-151384753	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"	"Blood coagulation, Hemostasis"	"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 13.8;lymphoid tissue: 9.8"	"Cell type enriched"	"Detected in some"	27	"Microglial cells: 421.6"	"Cancer enriched"	"Detected in many"	14	"glioma: 17.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 8.3"	"Group enriched"	"Detected in many"	11	"dendritic cells: 3.2;monocytes: 8.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013796, HPA014518"	Enhanced					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 68: Oligodendrocytes - Mixed function"			"HPA013796: AB_1854884, HPA014518: AB_2669027"	"unprognostic (2.39e-2)"	"unprognostic (1.60e-3)"	"unprognostic (5.93e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.41e-2)"	"unprognostic (2.52e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.72e-3)"	"unprognostic (6.46e-2)"	"unprognostic (8.64e-4)"	"unprognostic (4.84e-2)"	"unprognostic (5.96e-2)"	"unprognostic (2.03e-1)"	"unprognostic (8.92e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.52e-2)"	"unprognostic (4.04e-1)"	8.6	4.0	4.8	1.9	5.1	0.5	3.7	5.1	6.1	1.3	2.4	1.6	1.2	0.7	0.6	1.2	2.5	2.2	1.3	5.7	6.9	0.6	2.5	2.5	9.8	10.2	8.1	1.6	0.8	1.6	0.3	2.3	11.8	0.9	1.4	0.3	2.9	2.0	0.1	0.4	2.8	1.6	11.5	5.5	1.1	0.2	8.5	0.9	0.5	0.6	8.7	1.1	0.4	13.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	8.3	0.0	0.3	0.0	0.0	3.2	0.5	0.0	0.0	0.3	0.0	2.2	0.3	0.0	1.3	4.8	5.1	5.1	6.1	5.7	6.9	10.2	8.1	11.8	11.5	8.5	13.8	0.2	0.0	0.0	2.6	0.1	0.0	0.0	0.0	0.6	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.5	0.0	0.0	0.3	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	2.1	0.0	0.0	2.6	0.0	0.0	0.0	3.1	0.0	421.6	0.7	0.4	0.0	15.6	4.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0
P2RY2	P2U	ENSG00000175591	"Purinergic receptor P2Y2"	P41231	11	73218281-73242427	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 29.7;skeletal muscle: 50.2;tongue: 31.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 16.5;Distal enterocytes: 18.0;Pancreatic endocrine cells: 18.9;Proximal enterocytes: 14.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"eosinophil: 57.6"	"Group enriched"	"Detected in many"	12	"granulocytes: 57.6;monocytes: 20.2"	"Cell line enhanced"	"Detected in many"		"HaCaT: 32.8;HL-60: 30.8;MCF7: 25.1;NB-4: 26.1;PC-3: 24.5;SK-BR-3: 29.6;THP-1: 76.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			CAB022642	Uncertain		Uncertain	Cytosol		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 59: Non-specific - Translation"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Cytosol		"CAB022642: "	"unprognostic (1.24e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.97e-3)"	"unprognostic (6.50e-4)"	"unprognostic (2.04e-2)"	"unprognostic (4.66e-3)"	"unprognostic (8.93e-2)"	"unprognostic (2.87e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (2.19e-5)"	"unprognostic (9.69e-2)"	"unprognostic (4.92e-4)"	"unprognostic (1.34e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.57e-3)"	0.8	3.8	1.4	1.8	1.6	15.8	1.7	1.3	1.0	6.9	1.1	3.3	2.7	0.5	0.3	29.7	1.4	0.7	10.0	1.3	1.8	2.7	3.9	3.5	0.1	2.1	1.9	0.4	0.7	4.8	1.6	2.0	1.6	2.1	2.8	1.2	6.2	1.2	50.2	6.0	5.9	0.5	1.3	3.9	1.1	1.2	2.6	0.2	8.8	31.3	2.8	2.2	19.0	1.4	7.2	6.7	0.0	0.0	0.0	0.0	2.4	0.1	0.0	0.0	0.0	17.2	5.4	0.0	10.4	0.4	0.0	32.8	0.9	15.2	0.0	0.0	0.6	2.3	0.6	3.2	0.1	30.8	0.0	0.0	6.8	2.3	0.5	0.0	1.4	0.0	1.4	0.0	0.0	25.1	0.1	26.1	0.4	6.8	24.5	0.0	0.0	1.1	2.4	17.9	0.0	0.0	0.5	29.6	0.0	0.2	12.9	76.5	10.2	0.0	0.3	0.0	0.0	1.0	0.4	0.0	0.0	5.6	0.0	0.5	6.6	57.6	0.0	20.2	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.3	0.0	13.5	0.0	0.0	2.5	1.4	1.6	1.3	1.0	1.3	1.8	2.1	1.9	1.6	1.3	2.6	1.4	0.7	3.2	0.5	0.0	0.2	3.7	8.6	13.2	1.2	0.7	2.8	0.5	6.1	5.7	10.3	0.0	0.0	16.5	0.0	18.0	1.9	5.8	6.0	1.4	0.1	1.5	0.0	0.8	0.0	6.3	1.3	0.7	0.5	0.8	0.0	1.2	0.0	5.2	2.6	0.0	0.0	5.1	0.0	3.7	0.7	8.8	0.0	4.5	0.0	0.0	2.8	6.0	0.0	0.0	0.1	18.9	10.9	0.0	0.2	5.3	14.2	0.3	2.8	0.4	0.0	0.8	1.4	0.1	0.1	12.6	7.2	10.9	0.1	0.1	3.0	11.7
PACC1	"C1orf75, FLJ10874, PAC, TMEM206"	ENSG00000065600	"Proton activated chloride channel 1"	Q9H813	1	212363928-212414901	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 35.1"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 13.1;Extravillous trophoblasts: 7.0;Hofbauer cells: 28.2;Syncytiotrophoblasts: 8.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008540	Uncertain					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 24: Non-specific - Transcription regulation"			"HPA008540: AB_10794083"	"unprognostic (2.18e-1)"	"unprognostic (2.22e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.74e-2)"	"unprognostic (3.09e-2)"	"prognostic unfavorable (3.71e-5)"	"unprognostic (1.14e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.06e-3)"	"unprognostic (6.33e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.10e-2)"	"unprognostic (6.98e-2)"	2.9	2.5	15.0	4.0	24.5	5.8	2.6	24.4	22.9	3.0	10.1	2.0	2.0	2.7	1.9	3.9	1.7	2.8	2.4	15.5	18.8	10.2	1.5	3.8	8.0	26.1	22.3	1.7	3.3	3.6	3.4	4.2	25.3	2.9	2.1	6.0	2.7	1.5	2.1	2.3	3.0	2.9	23.0	5.4	1.8	5.6	20.9	8.6	2.0	1.4	5.2	4.4	3.0	35.1	11.6	8.8	13.0	21.6	7.5	4.0	12.9	6.6	5.2	10.8	9.5	7.4	8.4	13.6	5.3	3.3	10.5	10.1	12.5	6.0	10.7	10.3	13.5	12.8	5.8	9.2	10.7	20.8	19.5	3.6	6.2	9.9	7.2	10.8	12.3	19.7	11.8	7.8	7.5	4.6	23.2	21.4	17.3	5.4	11.5	18.9	14.5	13.1	5.5	5.7	20.1	31.2	7.7	11.3	30.2	12.8	16.8	25.2	10.9	7.0	8.0	16.8	17.3	10.2	17.3	19.1	9.4	18.9	19.9	21.3	8.7	5.3	5.3	11.8	7.0	8.5	4.1	6.2	14.4	8.2	5.8	6.4	0.7	7.0	11.0	20.4	6.4	6.2	15.0	24.5	24.4	22.9	15.5	18.8	26.1	22.3	25.3	23.0	20.9	35.1	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	13.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	7.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	8.2	0.5	0.0	0.0	0.0
PACS2	"KIAA0602, PACS1L"	ENSG00000179364	"Phosphofurin acidic cluster sorting protein 2"	Q86VP3	14	105300563-105398147	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Apoptosis, Host-virus interaction"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 136.6;skeletal muscle: 98.5"	"Cell type enhanced"	"Detected in all"		"Horizontal cells: 97.6;Oligodendrocytes: 169.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077892			Approved	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 70: Brain - Nervous system development"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA077892: AB_2686865"	"unprognostic (4.31e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (3.09e-2)"	"unprognostic (4.08e-2)"	"prognostic unfavorable (3.11e-5)"	"unprognostic (1.18e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.90e-1)"	"prognostic favorable (2.95e-4)"	"unprognostic (1.49e-1)"	"prognostic favorable (1.56e-4)"	"unprognostic (2.08e-1)"	"unprognostic (3.80e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.30e-1)"	22.4	16.1	48.4	10.6	101.5	9.0	18.7	104.4	61.3	18.1	4.7	24.6	10.9	21.0	5.4	11.2	19.0	11.2	23.8	43.2	58.0	12.4	6.9	16.1	8.5	136.6	110.6	20.0	28.8	11.7	21.6	8.8	119.6	15.0	6.6	12.2	16.3	11.5	98.5	12.6	14.2	10.0	80.8	16.0	17.4	19.8	106.1	9.4	14.1	46.1	5.5	19.3	14.1	126.8	17.5	23.8	21.9	20.7	21.5	20.6	25.9	13.0	15.0	11.0	9.6	10.4	32.5	19.0	21.5	20.0	14.1	19.7	13.5	18.7	7.9	23.7	11.0	8.7	10.0	15.6	28.1	7.1	15.0	24.1	17.5	7.7	17.7	13.9	20.1	18.9	5.4	17.2	9.7	54.9	12.1	9.5	8.5	22.1	19.4	26.5	13.3	12.1	9.3	39.7	49.0	25.8	12.4	11.1	19.4	13.7	28.1	13.2	30.8	16.2	7.2	25.6	13.1	22.3	15.6	7.2	24.6	12.8	16.1	0.0	0.6	0.1	0.3	1.1	0.6	0.0	0.3	0.4	1.1	0.2	0.1	0.4	0.1	1.0	1.9	2.3	0.8	0.4	48.4	101.5	104.4	61.3	43.2	58.0	136.6	110.6	119.6	80.8	106.1	126.8	28.3	9.6	14.7	41.1	3.3	9.1	7.5	7.1	8.0	30.5	15.1	14.4	21.4	8.6	12.6	5.5	12.5	4.3	15.1	21.5	13.7	13.9	77.1	13.8	15.7	21.1	13.1	4.2	29.7	23.0	3.2	15.5	20.4	18.3	1.3	28.8	19.2	10.8	17.6	97.6	41.0	14.6	8.2	15.7	23.0	78.7	17.4	17.1	26.6	30.9	8.4	17.0	7.2	23.1	169.3	14.2	12.6	16.6	7.1	9.0	19.3	12.3	7.7	23.4	6.6	20.6	14.2	18.3	14.6	8.1	8.4	3.4	8.0	30.6	19.5	8.0
PANX1	"MRS1, PX1, UNQ2529"	ENSG00000110218	"Pannexin 1"	Q96RD7	11	94128841-94181968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Differentiation, Ion transport, Oogenesis, Transport"	"Calcium channel, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 102.0;Suprabasal keratinocytes: 72.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016930	Uncertain		Enhanced	"Plasma membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 28: Keratinocytes - Keratinization"	"Plasma membrane"		"HPA016930: AB_1854954"	"unprognostic (1.65e-2)"	"unprognostic (2.32e-2)"	"unprognostic (2.41e-1)"	"prognostic unfavorable (1.13e-4)"	"unprognostic (1.16e-1)"	"unprognostic (7.02e-2)"	"unprognostic (6.04e-2)"	"prognostic unfavorable (7.09e-5)"	"unprognostic (1.79e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.00e-3)"	"unprognostic (3.26e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.15e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.26e-3)"	11.4	7.2	5.1	12.1	5.2	4.1	6.4	1.2	5.5	7.9	2.7	8.4	5.4	8.5	5.2	7.9	5.2	11.5	9.9	5.0	7.1	6.9	16.8	10.2	6.4	2.1	2.9	7.1	7.4	4.4	4.7	9.7	3.3	7.7	7.2	3.1	6.0	7.0	20.8	8.3	5.8	12.8	2.8	5.8	7.4	9.9	4.9	8.1	8.7	10.8	7.0	21.9	6.5	2.7	24.6	10.2	26.2	16.0	23.9	32.3	17.1	29.8	63.0	25.1	30.7	26.2	37.6	7.8	27.3	30.5	46.1	50.5	20.9	49.2	25.2	33.6	10.9	36.0	10.2	13.5	23.1	18.7	31.0	25.7	33.9	32.8	29.2	16.1	21.2	20.1	23.8	27.5	28.3	7.8	31.3	4.4	21.0	19.7	18.2	36.7	35.0	9.7	16.3	24.0	11.0	31.9	20.9	11.9	14.4	13.3	25.2	9.5	15.4	49.5	25.5	16.4	29.9	4.5	18.2	12.6	20.6	19.0	32.2	3.2	4.0	0.3	2.1	2.2	2.4	1.3	1.7	2.3	2.7	1.2	1.6	1.7	0.2	2.6	1.4	0.4	2.9	3.2	5.1	5.2	1.2	5.5	5.0	7.1	2.1	2.9	3.3	2.8	4.9	2.7	3.8	0.0	8.7	4.6	6.6	102.0	12.3	14.9	13.6	1.3	4.5	2.0	4.7	4.3	4.7	1.8	0.0	12.8	5.3	4.7	0.0	15.7	5.3	9.1	13.0	6.8	2.4	5.2	8.9	18.2	32.4	17.5	7.1	13.9	9.5	4.0	2.2	8.1	20.5	0.0	15.4	4.1	0.0	3.1	21.6	3.9	4.4	11.5	17.8	8.4	3.7	1.1	1.0	9.5	5.8	26.1	3.4	3.8	7.4	10.2	2.6	2.1	6.2	1.1	0.0	16.9	10.6	1.7	8.2	8.3	72.2	23.8	6.6	10.1	4.2	12.7
PANX2	"hPANX2, PX2"	ENSG00000073150	"Pannexin 2"	Q96RD6	22	50170731-50180295	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 51.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 11.4;Excitatory neurons: 13.3;Hepatocytes: 10.7;Inhibitory neurons: 15.8;Muller glia cells: 29.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Lineage enhanced"	"Detected in single"		"granulocytes: 1.9"	"Cell line enhanced"	"Detected in many"		"EFO-21: 10.3;HDLM-2: 16.7;Hep G2: 19.6;MCF7: 10.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004624, HPA039117"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"		"HPA004624: , HPA039117: AB_10805354"	"unprognostic (1.00e-1)"	"unprognostic (7.25e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.11e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.43e-2)"	"unprognostic (3.08e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.65e-9)"	"unprognostic (2.23e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.00e-1)"	"unprognostic (4.08e-1)"	1.0	0.8	4.4	0.5	4.4	1.6	1.0	8.4	40.1	1.7	0.0	0.3	0.0	1.2	0.5	5.2	2.2	0.4	0.7	8.0	13.1	3.0	9.6	2.1	0.0	51.0	8.8	3.4	1.4	0.3	7.9	0.1	48.4	3.9	0.0	1.6	5.0	1.4	0.7	1.1	0.2	0.0	7.9	1.9	0.4	1.7	14.1	0.0	7.3	0.1	0.1	1.4	1.9	16.4	0.9	2.1	0.4	2.3	0.0	0.2	4.9	2.6	2.5	0.5	0.4	0.5	8.0	0.0	10.3	0.3	1.4	0.5	1.3	1.0	0.1	16.7	1.4	0.4	3.5	19.6	0.7	0.1	1.2	0.2	1.0	0.7	0.0	1.1	0.6	0.0	1.4	0.0	0.2	10.8	0.0	1.0	3.9	0.0	4.2	1.0	0.0	4.0	0.0	1.6	9.8	0.9	1.6	0.2	6.5	0.5	0.7	0.8	4.5	0.5	4.1	6.7	4.9	1.8	0.1	0.6	0.3	0.0	7.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.6	0.0	0.0	4.4	4.4	8.4	40.1	8.0	13.1	51.0	8.8	48.4	7.9	14.1	16.4	0.0	0.0	1.1	7.2	0.3	0.5	3.1	0.6	0.0	11.4	2.5	2.4	0.8	1.5	2.6	0.0	0.0	0.0	1.5	0.0	5.9	2.3	0.3	5.9	1.5	0.7	0.0	0.4	13.3	2.8	0.2	0.8	0.0	7.0	0.0	2.1	0.0	10.7	0.1	0.0	15.8	0.0	0.0	0.9	1.5	0.2	0.0	1.1	0.0	1.9	1.8	29.7	0.0	6.6	1.2	1.8	0.0	1.2	0.5	6.0	0.0	3.0	3.0	3.6	0.0	0.1	0.9	0.0	1.8	0.3	0.3	0.0	0.2	0.1	0.0	4.5
PANX3	Px3	ENSG00000154143	"Pannexin 3"	Q96QZ0	11	124611428-124620356	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA						"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"															"unprognostic (5.80e-2)"			"unprognostic (3.10e-1)"			0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PAQR8	"C6orf33, LMPB1, MPRB"	ENSG00000170915	"Progestin and adipoQ receptor family member 8"	Q8TEZ7	6	52361421-52407777	"Predicted membrane proteins, Transporters"	"Differentiation, Oogenesis"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 144.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 168.5;Distal enterocytes: 154.3;Microglial cells: 74.0;Oligodendrocytes: 298.2;Paneth cells: 80.7;Proximal enterocytes: 100.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 41.8;OE19: 87.9;SuSa: 34.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064625			Supported	"Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"	"Golgi apparatus"	"HPA064625: AB_2685304"	"prognostic favorable (4.61e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.77e-3)"	"unprognostic (8.23e-2)"	"unprognostic (4.33e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.66e-2)"	"unprognostic (5.67e-2)"	"unprognostic (6.37e-2)"	"unprognostic (4.30e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.55e-2)"	"unprognostic (8.82e-3)"	"unprognostic (1.04e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.14e-2)"	"prognostic favorable (6.40e-4)"	2.7	4.0	83.7	9.2	113.9	1.2	2.3	122.9	86.7	4.7	42.0	38.9	19.3	5.1	8.0	17.6	6.3	6.0	3.5	74.4	89.7	8.0	1.5	7.3	10.3	133.8	110.7	24.3	2.8	5.2	2.2	7.0	123.1	4.3	36.7	2.9	2.2	23.3	0.9	3.1	33.7	6.3	102.8	6.2	32.3	3.7	106.4	9.2	2.8	1.5	7.6	9.7	5.5	144.9	0.9	1.0	10.7	4.6	6.3	10.2	7.3	3.2	12.1	2.0	4.4	4.1	3.8	1.1	1.2	2.2	4.7	0.4	1.4	5.3	3.2	14.8	1.7	6.6	1.0	41.8	1.7	1.8	0.9	2.9	0.7	1.4	7.5	7.4	11.5	12.9	1.5	6.4	8.3	1.5	4.4	6.1	5.4	87.9	0.5	11.5	1.7	2.8	12.4	3.1	4.0	8.7	0.8	0.3	12.4	34.4	0.3	14.7	4.8	4.0	1.6	1.2	1.9	1.9	2.6	1.6	3.7	16.9	21.5	3.0	3.2	1.4	2.8	0.6	4.2	1.1	8.3	5.7	7.0	1.0	17.8	8.3	0.6	8.5	0.6	3.5	6.2	4.2	83.7	113.9	122.9	86.7	74.4	89.7	133.8	110.7	123.1	102.8	106.4	144.9	4.9	3.2	10.6	168.5	3.6	2.0	3.7	3.1	0.6	2.1	0.7	1.3	4.4	14.3	3.5	3.7	8.4	1.7	7.6	154.3	0.0	4.4	0.5	12.2	3.9	7.4	22.9	4.2	21.1	1.1	3.1	6.8	18.8	7.5	4.5	23.7	4.2	0.2	8.8	0.0	19.4	45.5	6.1	19.8	3.5	1.6	5.6	7.3	14.2	74.0	11.4	4.2	3.1	19.1	298.2	4.9	80.7	10.1	0.6	6.6	100.5	0.1	8.9	3.3	0.0	1.0	3.6	12.1	3.3	5.3	1.0	0.8	9.2	10.0	42.5	7.3
PARL	"PRO2207, PSARL, PSARL1, RHBDS1"	ENSG00000175193	"Presenilin associated rhomboid like"	Q9H300	3	183829271-183884933	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA019545	Approved		Approved	Mitochondria		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Mitochondria		"HPA019545: AB_1855796"	"unprognostic (2.10e-1)"	"unprognostic (1.53e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.17e-2)"	"unprognostic (5.76e-2)"	"unprognostic (9.55e-2)"	"unprognostic (3.17e-3)"	"unprognostic (8.97e-2)"	"unprognostic (1.81e-1)"	"unprognostic (3.62e-3)"	"unprognostic (1.52e-1)"	"unprognostic (2.13e-2)"	"unprognostic (4.28e-2)"	"unprognostic (5.49e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.73e-1)"	"prognostic favorable (9.11e-5)"	38.4	35.8	46.5	26.6	48.2	33.8	40.3	47.4	66.2	33.8	50.7	47.7	29.2	31.9	57.7	36.7	30.2	19.7	54.1	46.6	48.2	39.6	45.0	28.4	32.0	47.7	48.7	31.7	49.9	39.7	32.0	25.5	47.4	37.1	41.9	32.7	40.5	30.3	54.9	37.1	34.7	29.7	47.2	36.2	42.6	26.7	47.6	34.5	31.4	51.6	33.8	38.9	31.5	48.4	115.1	55.6	39.7	33.0	38.8	42.1	80.2	39.2	59.4	80.5	65.0	172.0	59.0	47.8	90.0	56.7	73.5	49.2	64.1	68.0	90.0	71.6	76.1	73.9	35.5	96.9	57.3	73.9	61.6	60.0	85.4	58.0	70.7	38.5	59.0	82.4	42.6	45.0	69.2	131.0	148.3	194.3	105.5	100.6	53.3	64.7	72.8	92.0	79.0	97.6	37.9	52.0	47.6	162.9	107.8	48.1	159.2	143.5	31.8	29.3	63.0	60.9	108.2	89.2	65.7	116.0	56.6	75.1	35.5	97.5	143.1	133.4	51.3	107.8	60.9	62.4	57.3	59.9	132.4	59.1	68.7	54.2	41.3	67.1	83.3	79.7	73.7	116.1	46.5	48.2	47.4	66.2	46.6	48.2	47.7	48.7	47.4	47.2	47.6	48.4	30.3	22.4	19.7	17.9	37.6	30.3	54.9	93.5	26.7	35.9	31.8	31.5	41.2	35.8	44.5	31.3	31.3	58.9	38.4	24.4	117.4	63.9	24.0	15.2	18.3	30.2	33.7	23.3	23.4	84.7	49.0	35.1	28.1	13.7	69.8	33.1	33.2	30.4	77.7	33.7	24.1	42.0	77.3	56.2	55.7	9.7	28.9	57.5	42.7	33.7	79.3	55.9	50.4	17.1	28.0	60.3	35.1	27.1	42.3	55.4	47.3	86.0	30.5	51.1	6.6	44.8	96.6	47.8	47.4	40.2	30.0	42.1	40.9	49.0	49.2	58.8
PDCD6	"ALG-2, PEF1B"	ENSG00000249915	"Programmed cell death 6"	O75340	5	271621-314974	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Apoptosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047221			Supported	Nucleoplasm,Cytosol		No	No		1800000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Cytosol	Nucleoplasm	"HPA047221: "	"unprognostic (1.32e-1)"	"unprognostic (5.01e-2)"	"unprognostic (2.10e-2)"	"unprognostic (4.41e-3)"	"unprognostic (4.94e-2)"	"unprognostic (1.01e-1)"	"prognostic unfavorable (5.47e-5)"	"unprognostic (1.56e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (5.16e-6)"	"unprognostic (7.97e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.67e-1)"	"prognostic favorable (2.19e-4)"	63.3	108.3	89.0	48.7	90.4	42.1	74.8	95.4	102.6	73.4	88.1	83.0	71.6	63.4	98.2	134.8	64.8	48.4	53.5	91.1	92.9	114.6	85.0	53.1	59.9	92.2	88.9	61.7	65.5	77.3	76.4	61.4	90.5	64.3	85.4	29.6	73.9	54.4	42.3	72.7	71.8	52.8	94.9	77.0	69.0	50.3	90.3	81.2	72.8	27.3	74.5	72.7	86.9	100.1	151.8	208.6	88.4	133.5	156.1	141.9	185.6	115.5	151.9	144.2	134.6	147.3	186.4	119.6	283.2	155.4	187.2	112.9	137.3	288.2	116.0	409.9	170.9	105.9	508.7	194.0	193.3	155.7	129.5	128.1	175.0	117.4	208.9	148.3	137.9	81.2	136.8	90.3	130.7	237.7	125.7	270.1	95.6	183.8	295.1	102.0	83.8	171.5	344.7	192.6	86.3	117.5	297.2	309.4	224.7	91.9	215.1	210.7	108.5	94.0	76.9	82.8	100.0	121.4	163.4	141.8	138.9	198.9	128.9	172.8	209.7	284.4	158.2	206.0	199.7	251.9	196.4	179.6	229.3	224.6	217.8	175.5	231.0	260.7	206.6	183.2	236.7	356.2	89.0	90.4	95.4	102.6	91.1	92.9	92.2	88.9	90.5	94.9	90.3	100.1	134.6	64.1	57.4	9.4	99.5	82.1	129.6	250.6	85.4	47.9	140.1	182.1	50.4	78.6	146.7	103.0	37.5	239.1	104.4	146.4	252.4	172.0	55.4	130.9	91.6	110.7	79.7	83.9	10.7	129.1	321.6	104.3	68.8	99.9	82.5	101.3	69.9	77.7	140.4	63.9	11.3	187.5	219.7	84.1	75.5	55.5	117.4	90.0	124.5	10.3	175.3	136.8	137.0	5.5	11.0	164.0	136.7	116.6	57.7	170.7	175.6	205.1	181.9	42.0	85.5	85.3	109.5	100.8	137.8	123.8	92.5	356.7	92.6	173.3	192.3	176.6
PDYN	"ADCA, PENKB, SCA23"	ENSG00000101327	Prodynorphin	P01213	20	1978757-1994285	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Neurotransmitter, Opioid peptide"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 47.0"	"Group enriched"	"Detected in some"	83	"Early spermatids: 47.8;Late spermatids: 119.0"	"Group enriched"	"Detected in some"	29	"glioma: 2.6;ovarian cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"THP-1: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 152.2;hypothalamus: 60.7"	"Region enhanced"	"Detected in many"		"basal ganglia: 132.2"	"HPA053342, CAB079777"	Enhanced	Supported			"Secreted in brain"	NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 31: Spermatids - Spermatogenesis"			"CAB079777: , HPA053342: AB_2682121"					"unprognostic (7.00e-2)"				"unprognostic (1.07e-1)"	"unprognostic (1.40e-1)"					"unprognostic (3.73e-2)"			0.0	0.0	43.2	0.1	31.1	0.0	0.0	0.0	43.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.0	17.6	0.0	0.0	0.0	0.0	1.8	4.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	21.0	0.0	0.0	8.3	9.2	0.2	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	43.2	31.1	0.0	43.1	47.0	17.6	1.8	4.1	0.2	21.0	9.2	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	119.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
PDZD8	"bA129M16.2, FLJ34427, PDZK8"	ENSG00000165650	"PDZ domain containing 8"	Q8NEN9	10	117277274-117375440	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 73.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 208.7;Late spermatids: 477.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HEL: 124.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015716, HPA051610"	Uncertain		Approved	"Nucleoli fibrillar center,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 25: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"	"Plasma membrane"	"HPA015716: AB_1855162, HPA051610: AB_2681549"	"unprognostic (1.12e-1)"	"unprognostic (2.87e-1)"	"unprognostic (9.65e-3)"	"unprognostic (2.75e-2)"	"unprognostic (6.29e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.10e-2)"	"prognostic unfavorable (6.10e-4)"	"unprognostic (1.90e-2)"	"unprognostic (5.37e-3)"	"unprognostic (7.60e-3)"	"unprognostic (1.44e-2)"	"unprognostic (3.18e-2)"	"unprognostic (2.01e-2)"	7.1	7.0	8.9	4.7	12.1	73.0	4.7	15.7	8.6	7.9	17.9	9.3	14.0	9.1	14.1	10.8	6.8	9.7	5.1	8.1	11.8	13.1	15.8	6.0	3.2	11.9	13.8	8.9	14.1	28.3	4.2	5.4	12.2	6.4	11.2	14.1	12.9	10.6	4.9	5.5	10.6	6.9	11.3	3.7	10.4	13.2	12.5	5.8	6.8	5.8	3.6	6.6	5.8	13.2	12.6	21.1	7.6	14.7	12.8	11.4	4.3	11.9	10.2	5.2	4.2	10.7	16.4	14.7	10.5	18.1	6.0	18.4	13.4	12.6	10.3	9.4	11.8	124.3	8.6	10.6	9.4	52.4	11.2	11.2	14.7	9.5	27.9	19.3	9.3	12.1	11.5	15.0	13.0	5.1	10.2	6.7	6.0	6.6	18.8	8.2	29.2	6.4	15.5	9.0	6.0	9.6	12.6	5.4	9.7	6.9	3.7	7.6	15.1	8.6	9.4	15.8	20.5	8.0	7.2	10.5	10.8	23.6	7.7	1.4	0.5	2.6	0.9	0.5	0.9	0.3	0.7	0.7	0.7	0.4	0.5	0.7	2.3	1.2	0.9	0.5	0.3	0.2	8.9	12.1	15.7	8.6	8.1	11.8	11.9	13.8	12.2	11.3	12.5	13.2	22.1	12.8	30.7	32.3	13.7	29.7	24.4	10.3	24.5	31.9	16.4	17.0	19.8	40.0	21.0	18.4	22.9	9.8	36.1	26.9	9.8	31.9	208.7	78.3	46.7	24.0	33.7	82.0	49.2	81.9	7.2	27.3	48.4	111.2	44.2	14.6	18.9	58.6	7.5	32.0	61.0	38.8	10.2	16.0	31.8	477.6	23.6	25.2	23.2	30.0	15.5	29.0	23.7	51.8	56.4	57.6	23.1	28.6	28.1	41.1	27.0	26.5	28.5	45.0	26.3	46.3	24.5	25.8	29.1	36.3	32.4	6.7	28.4	90.8	50.2	44.6
PENK		ENSG00000181195	Proenkephalin	P01210	8	56436674-56446671	"Plasma proteins, Predicted secreted proteins, Transporters"		"Endorphin, Neuropeptide, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"adrenal gland: 376.2;brain: 164.1;testis: 129.0"	"Cell type enhanced"	"Detected in some"		"Basal respiratory cells: 758.4;Leydig cells: 1137.9;Peritubular cells: 225.7;Spermatocytes: 274.1"	"Cancer enhanced"	"Detected in many"		"lung cancer: 4.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 14.3;ASC TERT1: 8.6;BJ: 7.7;THP-1: 7.7"	"Region enriched"	"Detected in all"	7	"basal ganglia: 3626.9"	"Region enriched"	"Detected in all"	7	"basal ganglia: 923.2"	"HPA013138, CAB016390"	Enhanced				"Secreted in other tissues"	NA	NA		220000	"Cluster 21: B-cells - Adaptive immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB016390: AB_2161515, HPA013138: AB_1855191"	"unprognostic (6.89e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.17e-3)"	"unprognostic (1.56e-2)"	"unprognostic (3.58e-3)"		"unprognostic (1.31e-2)"	"unprognostic (3.60e-1)"	"unprognostic (6.34e-2)"	"unprognostic (5.73e-2)"	"unprognostic (3.47e-2)"	"unprognostic (4.24e-2)"	"unprognostic (1.73e-3)"	"unprognostic (1.11e-1)"	"unprognostic (4.48e-2)"	"unprognostic (3.98e-3)"	8.6	376.2	29.9	4.4	164.1	0.0	4.9	45.2	45.6	9.2	0.5	23.1	1.1	8.1	0.0	1.4	7.6	12.5	25.6	2.7	74.0	0.2	0.2	3.7	0.1	81.4	15.9	29.7	1.1	0.0	17.1	2.9	51.3	22.4	2.0	0.6	2.7	23.4	3.0	0.8	4.2	4.6	54.0	0.1	10.0	129.0	38.0	0.2	1.0	5.3	0.1	0.6	6.2	10.1	0.0	0.0	0.1	0.0	14.3	8.6	0.0	7.7	2.5	1.3	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	1.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	29.9	164.1	45.2	45.6	2.7	74.0	81.4	15.9	51.3	54.0	38.0	10.1	0.2	0.0	1.5	0.3	0.5	0.1	0.2	758.4	0.0	0.3	0.1	0.6	0.8	0.0	8.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	85.7	0.1	3.1	0.9	0.0	0.0	0.4	0.0	0.1	16.8	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	15.4	0.0	2.0	0.0	0.7	60.8	1137.9	1.2	0.0	1.9	0.0	0.0	0.0	0.5	0.4	0.0	0.0	225.7	0.0	0.2	0.0	0.0	3.6	0.0	6.6	1.7	1.2	274.1	19.1	0.1	0.4	0.0	0.2	3.1	0.0	0.0
PEX1	"ZWS, ZWS1"	ENSG00000127980	"Peroxisomal biogenesis factor 1"	O43933	7	92487020-92528520	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis, Protein transport, Transport"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020235	Approved		Supported	Peroxisomes		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 52: Non-specific - Transcription"	Peroxisomes		"HPA020235: AB_1855224"	"unprognostic (4.67e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.53e-2)"	"unprognostic (4.85e-1)"	"unprognostic (2.41e-2)"	"unprognostic (7.81e-2)"	"unprognostic (9.79e-3)"	"unprognostic (2.17e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.68e-2)"	"unprognostic (3.61e-2)"	"unprognostic (2.95e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.35e-3)"	"unprognostic (4.90e-2)"	5.8	6.9	2.6	6.0	4.7	4.1	8.7	4.6	4.3	6.4	2.5	8.6	6.6	6.7	11.2	6.1	5.6	4.7	8.9	2.4	3.1	14.2	13.0	5.3	6.9	3.5	3.5	6.8	8.8	11.7	6.3	4.2	4.1	7.8	9.5	13.2	9.1	7.0	9.1	7.9	8.1	5.4	2.8	6.0	8.2	6.7	3.0	7.9	8.6	9.9	6.7	5.6	5.8	6.3	8.3	8.9	14.4	24.6	8.9	7.6	13.0	5.4	7.1	6.3	9.1	5.5	8.7	12.2	12.0	6.3	9.6	8.4	11.0	9.9	10.0	12.7	9.7	5.8	9.5	7.0	6.2	10.6	6.4	8.2	8.6	9.4	12.7	8.0	9.9	12.6	21.9	17.2	10.1	15.5	21.3	10.4	10.0	12.3	8.3	15.0	16.0	15.3	8.8	12.0	10.6	17.1	12.4	34.3	10.8	20.2	7.1	4.4	8.1	6.0	8.1	23.0	5.7	18.9	15.9	16.7	5.7	6.2	9.8	0.8	1.1	1.8	2.5	1.8	2.5	3.0	2.6	2.8	1.2	2.8	2.9	3.3	0.9	4.7	2.2	0.7	2.8	1.1	2.6	4.7	4.6	4.3	2.4	3.1	3.5	3.5	4.1	2.8	3.0	6.3	14.2	28.9	18.4	26.1	14.1	5.9	8.4	8.1	10.8	43.5	11.7	12.6	29.7	5.7	13.1	5.5	35.5	9.0	13.6	17.2	9.8	6.6	7.3	22.6	14.7	11.6	13.9	12.4	30.0	7.5	3.9	11.6	21.9	14.2	8.8	20.5	8.2	14.2	5.4	40.4	45.7	12.0	8.2	7.6	3.1	4.8	14.3	8.4	7.2	13.1	12.7	14.2	14.4	23.6	55.2	6.0	11.3	15.1	11.6	9.6	16.5	19.2	32.4	42.9	6.6	15.5	12.6	36.6	14.4	11.2	7.7	8.3	12.0	11.8	15.2	7.7
PEX10	RNF69	ENSG00000157911	"Peroxisomal biogenesis factor 10"	O60683	1	2403964-2413797	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 194.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049458, HPA049755"	Approved		Uncertain	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 35: Non-specific - Unknown function"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm		"HPA049458: AB_2680775, HPA049755: AB_2680867"	"prognostic favorable (4.50e-6)"	"unprognostic (1.96e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.50e-1)"	"unprognostic (2.16e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.91e-1)"	"unprognostic (9.06e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.95e-1)"	"prognostic favorable (4.16e-6)"	"unprognostic (4.78e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.42e-1)"	14.9	28.9	22.2	2.2	24.3	3.1	13.9	23.5	25.7	10.8	19.7	11.3	6.7	11.4	8.5	17.2	10.0	4.2	16.1	20.6	21.6	18.1	22.0	8.8	4.3	25.4	22.6	12.8	19.8	10.4	18.5	3.8	22.1	16.1	4.4	4.6	14.3	6.9	18.6	14.0	9.6	4.1	23.4	10.2	12.7	22.0	23.3	3.7	13.1	10.2	3.4	12.9	11.3	25.3	18.6	16.9	13.2	7.4	7.9	9.7	11.5	9.6	10.9	14.2	11.3	27.2	13.9	10.8	27.1	11.9	8.7	12.1	11.6	16.3	8.1	16.8	21.9	8.5	17.2	55.3	16.4	14.2	4.2	9.0	9.3	10.8	16.0	10.4	13.9	12.5	9.9	7.4	14.7	26.2	9.1	6.0	9.6	8.0	31.3	7.8	13.8	18.9	17.8	6.3	18.2	15.3	13.0	8.2	29.2	7.1	8.3	3.5	14.8	6.7	5.9	17.2	10.8	19.0	7.6	8.6	17.6	10.9	6.1	1.6	5.8	1.7	3.8	8.7	4.4	5.9	3.3	5.1	9.4	4.9	3.8	3.0	0.6	3.6	7.6	7.8	2.1	4.2	22.2	24.3	23.5	25.7	20.6	21.6	25.4	22.6	22.1	23.4	23.3	25.3	12.8	3.2	4.4	3.3	9.5	8.8	13.7	15.4	15.9	16.8	16.4	15.4	1.1	11.5	8.9	14.7	0.0	26.7	6.7	8.3	35.2	26.8	51.7	8.5	9.0	11.2	13.2	9.2	5.1	30.3	25.2	11.5	12.8	10.3	0.0	22.8	7.5	10.5	22.9	13.5	5.6	10.3	12.2	11.2	7.2	194.7	10.5	9.6	23.2	2.8	18.7	45.2	8.2	8.0	6.7	21.0	7.7	13.5	14.9	14.6	17.5	27.8	8.6	14.8	0.0	15.5	10.9	28.9	22.8	22.4	6.1	27.5	6.9	30.2	14.6	14.1
PEX11A	"MGC119947, MGC138534, PEX11-ALPHA"	ENSG00000166821	"Peroxisomal biogenesis factor 11 alpha"	O75192	15	89677764-89690783	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 38.7;Late spermatids: 39.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 54.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (3.67e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.08e-1)"	"unprognostic (3.73e-2)"	"prognostic unfavorable (2.57e-4)"	"unprognostic (1.40e-1)"	"unprognostic (6.17e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.82e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.74e-2)"	"unprognostic (1.10e-2)"	"unprognostic (5.44e-2)"	"unprognostic (4.82e-2)"	"unprognostic (1.32e-2)"	25.6	10.4	7.9	3.4	8.3	0.8	20.0	6.9	8.5	7.2	12.8	14.5	16.3	6.0	10.5	6.5	9.6	5.4	8.1	7.9	8.7	11.7	39.1	6.1	2.5	7.1	7.8	13.1	11.8	10.0	5.5	3.6	7.2	18.3	12.0	12.7	11.3	10.1	17.9	5.4	12.2	5.5	7.2	4.1	11.3	11.4	9.0	2.3	10.9	12.0	3.7	9.2	6.1	7.9	10.2	6.1	4.6	0.3	23.4	8.4	3.7	5.0	8.5	7.4	12.0	4.3	11.9	4.7	5.5	5.8	10.6	13.3	0.0	7.6	8.5	7.5	16.8	7.1	7.2	6.0	16.8	4.7	2.4	10.4	9.2	4.3	7.1	5.8	5.2	4.6	0.1	1.8	5.6	10.2	0.0	0.6	2.6	20.6	11.1	0.0	0.0	4.2	6.1	6.8	3.4	8.7	16.0	54.4	15.5	8.3	14.4	4.4	4.7	4.9	4.8	13.2	4.0	5.3	9.5	0.2	11.9	0.7	4.3	1.2	0.7	2.3	3.6	1.0	2.0	1.6	1.8	2.0	1.8	0.9	2.2	2.5	0.8	3.1	0.7	0.4	1.7	1.5	7.9	8.3	6.9	8.5	7.9	8.7	7.1	7.8	7.2	7.2	9.0	7.9	1.5	6.4	8.4	12.4	2.0	1.8	9.3	5.2	7.4	8.6	15.3	10.9	8.7	10.0	11.4	5.5	2.1	10.8	1.3	22.1	5.9	7.6	24.8	7.1	5.5	3.1	3.6	0.8	3.0	4.6	7.1	4.6	3.1	5.2	1.3	6.2	4.6	38.7	4.0	18.5	3.5	8.9	6.1	3.5	0.8	39.0	5.3	1.6	3.6	2.8	1.9	14.5	1.0	3.5	3.5	5.5	11.6	2.6	0.6	11.5	20.7	12.6	16.2	9.7	0.0	6.4	4.6	22.6	8.7	5.0	2.0	2.7	1.5	11.0	11.8	11.9
PEX12		ENSG00000108733	"Peroxisomal biogenesis factor 12"	O00623	17	35574795-35578863	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 17.2;Spermatocytes: 21.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069386	Enhanced					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"			"HPA069386: AB_2686135"	"unprognostic (1.45e-1)"	"unprognostic (6.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.49e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-1)"	"unprognostic (9.04e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.69e-1)"	"unprognostic (5.55e-2)"	"unprognostic (2.64e-2)"	"prognostic favorable (3.58e-5)"	"unprognostic (2.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.44e-1)"	3.9	6.8	6.7	3.6	7.2	1.5	5.5	7.9	9.1	5.3	6.7	3.4	3.6	4.3	10.7	3.4	5.6	3.2	9.1	6.8	7.1	8.2	9.0	3.4	4.8	6.8	6.9	8.2	4.0	7.8	4.7	4.7	6.8	5.7	2.9	4.6	5.5	6.9	10.3	4.2	3.5	3.5	7.3	3.9	3.9	6.8	7.0	3.2	7.7	10.8	4.5	3.7	2.7	8.4	2.8	3.7	5.4	4.4	11.0	9.9	3.9	7.3	8.3	6.0	6.3	3.2	3.0	6.4	11.6	4.1	4.9	7.3	6.6	4.8	5.2	2.3	8.7	4.7	3.8	5.9	12.8	6.7	1.2	9.2	9.2	3.7	10.9	7.7	4.6	5.2	7.5	6.6	7.2	2.9	7.9	3.8	2.2	6.3	5.8	3.8	9.3	6.4	7.1	4.2	4.0	4.0	4.6	3.0	9.6	6.5	7.4	3.7	3.7	5.6	3.5	6.3	4.9	13.3	9.9	7.5	6.0	5.1	5.2	2.2	1.5	3.0	1.8	1.1	3.2	2.3	3.0	1.8	1.7	2.6	4.1	3.5	1.0	2.0	1.2	1.7	2.4	1.4	6.7	7.2	7.9	9.1	6.8	7.1	6.8	6.9	6.8	7.3	7.0	8.4	2.7	3.2	0.5	6.5	3.3	0.6	1.9	1.3	1.8	2.1	2.4	2.2	6.3	0.0	2.7	3.7	0.0	6.7	1.4	1.3	3.9	3.5	17.2	1.9	2.3	3.9	1.2	0.8	1.3	1.1	4.1	2.6	2.6	1.5	2.5	2.0	3.3	5.4	2.9	1.7	1.9	1.7	2.0	2.6	0.6	3.0	3.1	1.5	1.8	1.0	0.9	8.3	1.0	4.5	2.8	2.2	1.0	1.5	0.5	2.4	2.7	3.3	1.8	2.2	0.0	2.6	3.7	21.0	10.2	1.4	1.3	5.2	2.8	3.0	2.2	1.3
PEX13		ENSG00000162928	"Peroxisomal biogenesis factor 13"	Q92968	2	61017225-61051990	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 125.8;Urothelial cells: 112.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032141, HPA032142, CAB032689"	Enhanced		Supported	Peroxisomes		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Peroxisomes		"CAB032689: AB_2162137, HPA032141: AB_2674176, HPA032142: AB_10669676"	"unprognostic (2.44e-3)"	"unprognostic (4.10e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.73e-2)"	"unprognostic (1.28e-1)"	"unprognostic (5.08e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.86e-2)"	"prognostic unfavorable (8.07e-5)"	"unprognostic (5.42e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.84e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.63e-2)"	9.5	8.0	6.6	6.7	7.1	7.4	11.1	9.7	9.2	10.2	10.2	10.2	10.2	9.2	7.5	10.2	6.6	8.8	11.9	6.8	7.4	13.6	25.0	9.3	6.8	6.7	7.1	11.0	11.8	9.6	7.4	9.3	6.8	14.6	10.7	8.8	8.7	5.8	14.6	7.9	9.8	8.1	6.6	6.7	10.1	14.9	7.1	7.3	13.7	13.6	6.7	13.8	9.1	7.7	15.5	11.3	15.7	20.3	14.8	11.5	24.2	15.9	12.3	10.6	10.8	16.9	22.9	10.0	16.7	15.6	19.9	22.8	14.1	19.2	20.0	9.9	9.7	9.2	15.1	28.0	17.5	13.9	10.8	14.2	28.9	14.5	22.3	16.2	19.4	11.3	22.8	8.7	16.3	14.1	10.4	16.6	17.2	28.6	11.2	11.1	17.4	12.7	20.3	38.2	17.7	12.2	17.7	23.7	14.9	18.5	15.8	7.1	15.3	20.2	27.0	11.8	13.6	14.2	11.6	25.0	12.7	14.0	14.5	12.4	3.9	5.9	5.0	3.9	4.7	5.4	5.8	5.5	5.1	4.1	6.1	4.6	3.7	5.5	5.0	4.5	5.4	3.9	6.6	7.1	9.7	9.2	6.8	7.4	6.7	7.1	6.8	6.6	7.1	7.7	12.9	19.2	19.1	14.0	13.8	51.2	35.1	61.9	25.6	11.9	23.0	13.2	21.9	28.6	53.0	22.0	8.4	36.9	13.4	27.6	25.4	28.8	125.8	24.5	16.1	15.1	2.4	9.9	18.8	28.5	43.1	14.5	12.8	28.8	8.2	15.6	13.6	49.3	20.9	16.8	16.8	14.5	36.7	14.6	25.9	28.7	9.6	14.8	16.0	25.3	19.3	12.6	18.6	14.1	19.4	23.2	13.2	11.7	9.9	43.9	28.8	33.2	38.7	15.0	6.6	11.6	18.8	66.8	26.4	21.8	50.3	68.7	15.0	11.4	18.1	112.0
PEX14		ENSG00000142655	"Peroxisomal biogenesis factor 14"	O75381	1	10472288-10630758	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Rod photoreceptor cells: 67.3;Syncytiotrophoblasts: 64.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046104, HPA049231"	Supported		Supported	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Peroxisomes	"Nucleoli fibrillar center"	"HPA046104: AB_2679539, HPA049231: AB_2680683"	"unprognostic (7.23e-3)"	"unprognostic (7.93e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.48e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.77e-1)"	"unprognostic (5.32e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.85e-2)"	"unprognostic (1.31e-1)"	"unprognostic (3.05e-3)"	"unprognostic (9.67e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.43e-1)"	"unprognostic (3.75e-2)"	15.9	13.9	15.5	9.5	15.3	7.8	16.2	11.7	21.8	15.5	10.7	16.8	15.1	17.1	6.4	20.9	13.7	9.3	19.6	15.8	13.6	15.8	33.0	14.3	10.5	14.1	13.1	14.9	11.2	11.8	14.1	11.8	13.8	26.4	8.2	28.1	16.8	23.8	22.6	18.6	16.2	8.5	12.2	12.6	13.8	14.0	14.3	9.7	14.0	11.3	8.6	48.8	17.6	16.0	22.5	21.1	17.2	19.2	12.3	11.6	11.2	25.2	20.8	27.4	26.1	22.4	40.1	16.4	24.9	19.4	16.3	26.3	17.9	24.6	12.9	23.1	30.3	20.4	22.6	31.2	18.8	23.0	27.3	14.2	19.2	20.7	19.0	16.3	17.9	21.2	32.2	16.3	12.4	18.7	21.9	30.4	17.7	17.2	24.6	23.5	14.5	23.3	21.7	14.8	20.5	23.5	24.4	20.2	23.9	13.2	18.4	16.2	17.7	19.9	21.5	19.6	22.0	23.3	20.4	32.3	21.8	31.2	21.7	1.4	2.2	4.6	4.5	1.6	2.8	2.2	2.3	3.4	2.7	2.0	2.9	2.8	0.3	2.6	1.5	2.8	3.0	2.4	15.5	15.3	11.7	21.8	15.8	13.6	14.1	13.1	13.8	12.2	14.3	16.0	5.9	9.6	2.0	32.0	9.2	7.1	13.9	29.2	4.0	15.1	8.3	6.9	8.4	4.3	12.3	9.2	27.1	49.7	11.3	14.1	7.9	17.2	5.9	10.6	4.9	7.8	9.0	4.6	42.0	14.7	18.7	8.1	4.1	7.4	6.3	7.8	8.2	51.1	22.7	18.5	48.4	9.7	14.2	9.0	3.1	3.1	8.1	8.0	12.4	28.1	19.9	21.2	10.3	29.7	29.9	18.2	12.3	5.7	14.7	10.8	29.7	18.5	23.5	67.3	6.6	4.5	11.0	7.1	12.8	7.1	8.1	64.7	9.8	8.3	12.0	13.5
PEX16		ENSG00000121680	"Peroxisomal biogenesis factor 16"	Q9Y5Y5	11	45909663-45918812	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043286	Approved					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 22: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 1: Pancreatic cells - Digestion"			"HPA043286: AB_10794179"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-2)"	"unprognostic (8.14e-2)"	"unprognostic (3.15e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.53e-1)"	"unprognostic (9.06e-3)"	"unprognostic (9.06e-3)"	"unprognostic (2.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (3.48e-3)"	"unprognostic (1.51e-1)"	"unprognostic (6.75e-3)"	"unprognostic (5.72e-3)"	"unprognostic (2.71e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (9.06e-4)"	23.4	27.1	22.3	10.9	23.8	20.3	22.2	23.4	24.4	18.2	16.6	20.6	21.3	18.7	6.3	21.3	18.9	10.1	17.0	23.0	22.7	26.7	50.2	16.2	16.6	26.2	23.6	18.3	40.0	10.1	32.0	6.7	23.2	21.7	5.1	4.4	21.6	9.7	18.1	27.2	25.3	6.0	21.9	24.5	27.6	25.8	23.6	11.8	21.8	7.5	8.6	20.1	18.0	26.0	15.0	19.9	6.7	16.8	11.0	13.2	19.4	11.6	15.2	15.5	12.0	22.6	10.7	25.6	15.0	10.9	14.7	27.2	6.9	23.0	3.7	22.4	23.6	16.7	28.8	20.1	34.8	24.9	33.8	21.3	20.1	9.4	15.1	9.1	17.0	21.9	13.4	29.6	10.7	42.0	21.3	32.5	15.1	28.7	20.0	18.4	16.8	29.4	10.0	26.5	17.0	22.7	13.3	27.1	24.5	4.2	40.4	21.1	13.6	14.8	19.0	36.9	21.5	47.1	33.1	16.2	16.2	14.7	16.2	35.3	44.1	36.8	47.9	51.0	44.9	57.0	48.9	49.6	47.8	50.5	44.4	46.7	32.2	44.9	38.6	44.7	61.1	46.1	22.3	23.8	23.4	24.4	23.0	22.7	26.2	23.6	23.2	21.9	23.6	26.0	25.1	3.2	5.4	3.9	35.7	16.6	24.4	47.6	19.4	15.7	25.9	22.4	3.8	22.8	25.1	14.7	10.4	39.9	31.9	45.8	50.9	37.3	25.9	19.7	13.8	21.5	28.1	25.9	4.8	88.7	22.2	15.7	17.9	20.3	21.0	16.2	21.8	68.6	34.2	15.2	5.1	26.5	30.5	37.7	19.7	32.6	19.3	20.0	21.4	3.7	46.6	28.8	26.8	5.0	10.6	55.9	49.2	14.3	27.1	26.1	90.5	68.1	26.4	18.0	32.9	16.8	24.4	27.2	15.4	21.6	21.0	64.0	33.0	19.9	29.6	28.2
PEX19	"D1S2223E, HK33, PMP1, PMPI, PXF, PXMP1"	ENSG00000162735	"Peroxisomal biogenesis factor 19"	P40855	1	160276807-160286348	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA044837, HPA051966"	Supported		Supported	Peroxisomes		NA	NA		7900	"Cluster 34: Basophils - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Peroxisomes		"HPA044837: AB_10962496, HPA051966: AB_2681677"	"unprognostic (1.49e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.42e-1)"	"unprognostic (4.80e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.79e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.53e-2)"	"unprognostic (8.06e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (2.92e-5)"	"unprognostic (3.46e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.24e-2)"	79.3	25.7	21.1	14.5	22.5	12.3	36.5	22.2	23.5	20.3	15.6	22.6	19.4	18.2	25.0	24.9	22.9	19.6	39.4	21.5	22.7	33.1	109.1	21.6	16.6	22.3	23.5	23.6	17.2	40.4	15.0	21.9	23.5	28.0	23.2	30.9	21.3	26.6	66.2	18.2	18.8	16.7	22.1	16.7	20.0	16.8	22.7	21.0	34.3	84.8	20.5	23.9	15.2	24.5	31.2	18.9	69.8	22.4	59.8	57.8	53.0	25.3	51.3	44.6	35.3	35.1	37.2	37.8	40.9	37.3	26.3	29.7	34.2	44.0	35.3	32.3	17.3	26.6	26.5	36.3	46.9	48.6	32.6	84.7	51.0	60.0	38.6	35.8	32.2	51.4	40.8	27.9	50.0	17.8	37.0	15.8	50.3	38.6	48.2	45.7	34.4	45.5	45.8	61.8	23.2	38.3	98.3	49.5	37.4	71.3	48.1	48.2	24.8	26.5	31.1	29.9	30.1	42.5	57.9	68.6	43.1	20.9	38.9	9.1	5.5	5.0	5.8	8.9	4.2	5.0	2.8	3.5	5.5	1.9	4.0	3.7	2.2	4.7	6.6	3.4	4.2	2.3	21.1	22.5	22.2	23.5	21.5	22.7	22.3	23.5	23.5	22.1	22.7	24.5	16.4	9.6	20.6	9.1	12.7	9.9	21.0	15.4	13.1	18.8	18.9	16.4	45.6	20.0	11.3	16.5	10.4	30.0	6.9	25.4	49.0	22.6	6.6	12.0	13.7	13.6	11.4	15.6	8.6	14.8	51.2	18.4	13.3	12.0	16.5	15.6	20.0	60.1	30.1	25.2	9.0	11.5	0.0	15.7	7.0	3.1	21.8	15.0	21.4	6.5	24.9	39.0	12.3	6.0	11.5	20.2	17.2	29.3	9.5	18.5	29.8	40.7	11.8	12.7	32.9	14.6	16.2	17.8	25.3	15.0	9.9	38.7	12.5	18.2	15.7	25.2
PEX2	"PAF-1, PMP35, PXMP3, RNF72, ZWS3"	ENSG00000164751	"Peroxisomal biogenesis factor 2"	P28328	8	76980258-77001044	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 133.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010983, HPA011410, HPA027729"	Approved		Supported	Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles		"HPA010983: , HPA011410: AB_1854922, HPA027729: AB_10610416"	"unprognostic (6.42e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.64e-2)"	"unprognostic (2.35e-1)"	"unprognostic (9.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (6.19e-2)"	"unprognostic (2.22e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.07e-2)"	"unprognostic (9.57e-3)"	"unprognostic (2.48e-1)"	"unprognostic (9.49e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.09e-3)"	39.8	45.9	33.1	33.5	36.6	35.8	53.9	34.2	45.6	40.7	38.6	43.1	39.8	33.3	42.4	32.9	41.8	31.9	39.7	32.1	35.1	53.6	43.7	36.5	39.4	37.3	34.5	33.3	39.0	57.7	27.2	24.7	37.6	44.2	39.6	66.5	50.9	83.4	61.8	24.5	41.0	35.3	37.3	36.5	48.3	22.1	34.5	48.8	53.2	44.6	35.7	35.7	31.3	43.3	88.2	29.3	46.9	47.9	50.7	63.2	24.5	64.4	75.3	49.9	55.2	18.4	76.9	50.2	93.6	59.9	39.7	33.3	33.1	50.1	61.2	93.3	28.5	61.1	26.0	28.3	33.9	51.5	46.5	70.9	43.5	37.8	45.6	77.0	55.3	79.3	34.4	46.7	53.9	26.4	90.4	30.1	27.2	126.4	26.3	16.5	37.4	42.1	59.9	61.6	16.7	43.0	41.9	192.0	36.9	39.8	58.7	36.1	54.7	44.4	58.1	57.7	32.4	86.0	53.8	87.9	56.5	26.7	50.2	179.9	55.6	102.6	57.2	58.0	51.2	46.1	39.6	46.5	46.3	50.5	51.6	49.3	38.6	83.1	67.8	46.8	48.6	71.7	33.1	36.6	34.2	45.6	32.1	35.1	37.3	34.5	37.6	37.3	34.5	43.3	28.0	48.1	25.2	32.3	29.7	18.1	31.0	57.8	28.5	28.9	38.9	33.1	27.2	28.6	38.4	27.6	12.5	42.8	38.3	30.2	133.1	52.3	5.6	36.5	19.9	20.7	28.9	25.6	11.9	49.1	24.8	29.8	20.4	22.2	18.3	20.2	25.7	36.7	26.6	13.5	15.2	37.5	48.8	39.1	22.4	7.3	29.5	26.8	28.4	16.9	36.3	68.4	53.5	31.7	45.9	42.0	28.2	35.7	41.7	36.3	43.3	61.4	36.6	34.4	6.6	34.9	24.6	13.7	20.8	28.6	21.0	34.8	37.6	27.7	30.0	43.0
PEX26	FLJ20695	ENSG00000215193	"Peroxisomal biogenesis factor 26"	Q7Z412	22	18077923-18105396	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 198.7;Proximal enterocytes: 91.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB070429	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"CAB070429: AB_11154363"	"unprognostic (2.25e-1)"	"unprognostic (5.75e-3)"	"prognostic favorable (9.92e-4)"	"unprognostic (1.77e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (3.10e-4)"	"unprognostic (1.59e-2)"	"unprognostic (5.34e-2)"	"unprognostic (8.19e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.96e-1)"	"prognostic favorable (1.38e-4)"	"unprognostic (3.17e-3)"	"unprognostic (4.53e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.49e-1)"	7.5	5.8	7.3	7.8	6.2	12.1	6.7	3.7	6.8	4.9	5.8	16.9	19.2	5.5	5.3	7.5	6.0	5.3	5.8	7.9	5.3	7.5	7.3	5.0	7.3	8.4	7.8	5.4	8.0	9.2	4.2	5.0	7.0	5.3	13.1	3.1	6.4	5.6	6.3	5.6	19.9	5.4	6.3	8.1	9.3	3.1	8.3	7.3	6.9	4.1	6.7	6.0	3.9	5.5	18.3	8.7	10.2	9.2	10.5	6.6	18.8	11.8	12.2	12.8	10.5	15.2	15.1	11.3	10.8	17.5	11.2	18.7	15.9	16.5	10.9	19.0	12.4	19.4	12.3	12.8	10.0	26.0	23.6	8.2	12.7	17.3	16.2	6.1	15.2	11.1	21.2	8.1	12.7	22.0	22.8	8.8	13.2	24.9	15.7	17.6	8.6	4.1	14.8	20.6	17.7	15.5	17.1	12.0	16.3	8.2	19.3	9.7	20.4	23.6	10.2	12.8	12.4	21.4	15.8	16.6	10.9	12.3	17.1	1.2	1.7	1.4	2.0	1.1	1.9	1.4	1.8	2.6	1.5	2.0	2.0	1.3	1.2	2.7	2.6	3.1	0.8	1.0	7.3	6.2	3.7	6.8	7.9	5.3	8.4	7.8	7.0	6.3	8.3	5.5	10.5	6.4	10.3	1.3	14.7	13.5	14.8	9.3	8.6	24.5	12.4	7.2	29.3	25.8	13.8	7.3	43.8	11.9	18.0	198.7	5.9	24.7	1.0	16.3	16.2	17.6	24.5	11.1	4.9	23.6	9.8	13.0	20.9	18.6	12.0	19.8	18.9	33.0	15.2	30.3	5.6	22.9	6.1	20.4	10.7	2.8	12.5	11.0	0.0	2.8	20.4	9.2	22.6	4.5	4.3	31.6	51.8	11.7	11.8	20.4	91.7	21.7	11.5	25.5	13.1	18.8	9.6	9.4	10.1	13.7	17.6	9.3	13.9	21.4	29.4	18.7
PEX3		ENSG00000034693	"Peroxisomal biogenesis factor 3"	P56589	6	143450805-143490616	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Peroxisome biogenesis"		"Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 80.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042830, HPA058006"	Supported		Approved	Nucleoplasm,Peroxisomes		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Peroxisomes"		"HPA042830: AB_10794918, HPA058006: AB_2683576"	"unprognostic (3.52e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.45e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (3.80e-4)"	"unprognostic (1.87e-1)"	"unprognostic (7.30e-2)"	"unprognostic (3.80e-2)"	"unprognostic (2.12e-1)"	8.7	38.4	4.4	7.6	4.8	3.2	11.8	4.5	5.6	11.7	7.3	7.5	6.0	9.8	12.5	17.8	9.6	7.3	12.6	4.2	5.3	18.3	24.4	7.9	8.8	3.6	3.4	10.7	6.7	24.4	9.0	9.4	3.9	11.7	6.2	10.0	10.6	11.2	11.6	12.8	7.4	8.9	3.9	7.2	9.7	12.2	3.6	8.3	15.5	9.6	9.5	8.9	13.4	7.5	21.4	4.6	11.0	21.1	17.8	15.6	12.2	17.8	13.8	23.7	28.3	31.5	12.8	31.7	21.1	17.4	27.8	17.3	14.4	23.9	30.8	19.4	16.5	22.8	10.2	20.0	15.0	38.7	9.6	18.1	16.6	22.4	17.2	10.3	13.0	18.5	21.1	15.7	24.0	14.1	20.2	15.3	6.1	12.6	18.2	15.3	22.2	14.0	28.0	9.2	15.3	5.3	23.0	19.3	14.7	9.5	10.2	12.7	10.3	16.7	15.9	26.9	20.9	10.7	16.4	36.1	21.1	26.0	13.3	12.9	6.3	6.4	15.5	10.1	17.2	23.2	16.3	15.5	9.9	18.6	21.1	20.7	1.0	15.6	13.4	10.6	21.2	9.8	4.4	4.8	4.5	5.6	4.2	5.3	3.6	3.4	3.9	3.9	3.6	7.5	13.1	16.0	14.4	23.8	19.7	26.6	12.7	19.2	14.8	14.5	9.9	11.8	14.8	5.7	19.0	9.2	4.2	41.7	9.0	4.1	19.6	12.3	12.6	15.2	10.4	12.0	6.0	5.9	61.0	9.5	11.6	13.5	10.2	13.1	25.3	9.6	13.6	20.5	11.5	16.8	67.4	5.4	16.2	7.6	6.6	4.9	13.7	6.0	8.8	28.1	8.0	15.4	10.3	40.7	59.6	9.6	2.3	11.3	18.1	6.6	8.2	28.8	27.2	12.1	6.6	12.2	13.6	80.0	18.5	20.2	34.8	58.7	13.7	20.9	7.6	8.5
PEX6	"PAF-2, PXAAA1"	ENSG00000124587	"Peroxisomal biogenesis factor 6"	Q13608	6	42963865-42979181	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Peroxisome biogenesis"		"Amelogenesis imperfecta, Deafness, Disease variant, Peroxisome biogenesis disorder, Zellweger syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"pancreas: 76.2"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 78.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025924, HPA074179"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Vesicles"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nucleoplasm, Vesicles"	"Nuclear bodies"	"HPA025924: AB_1855230, HPA074179: "	"unprognostic (7.32e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.38e-1)"	"unprognostic (9.16e-2)"	"unprognostic (9.18e-2)"	"unprognostic (3.27e-1)"	"unprognostic (8.88e-2)"	"unprognostic (5.92e-2)"	"unprognostic (3.36e-1)"	"unprognostic (7.12e-2)"	"unprognostic (7.24e-3)"	"unprognostic (5.31e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.86e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.55e-1)"	11.6	20.5	24.9	9.2	25.2	9.5	12.1	23.9	27.7	19.1	25.5	16.3	9.3	15.5	7.7	16.4	22.7	9.6	18.7	25.1	25.5	16.5	27.7	10.0	14.5	27.2	25.5	26.1	76.2	15.2	24.3	9.6	24.2	21.6	7.8	9.9	14.8	11.4	23.4	14.0	16.3	9.6	23.9	17.5	16.3	16.2	25.1	14.7	19.8	15.0	10.4	17.3	15.7	25.2	35.0	16.4	8.1	30.6	29.6	28.3	8.4	6.0	9.4	4.8	10.0	10.5	10.1	14.1	8.2	14.3	20.5	32.2	28.7	31.1	5.0	27.6	15.2	4.7	24.4	6.2	20.0	4.8	9.4	35.5	35.5	19.9	5.5	39.1	24.7	18.9	25.2	14.1	10.7	3.9	12.7	15.8	10.0	78.8	14.3	26.8	14.3	5.8	12.3	10.0	25.4	11.1	5.6	21.9	32.7	13.1	43.2	21.2	14.0	15.2	2.9	7.5	14.0	21.0	19.8	19.7	5.2	24.6	12.4	1.3	1.3	2.1	1.2	1.1	2.1	1.0	1.8	2.5	1.9	1.9	2.2	2.1	0.8	2.0	0.7	1.0	0.9	1.1	24.9	25.2	23.9	27.7	25.1	25.5	27.2	25.5	24.2	23.9	25.1	25.2	5.6	6.4	2.6	19.9	5.6	5.0	10.2	6.2	10.8	15.2	11.8	12.7	4.1	10.0	5.6	7.3	2.1	11.4	5.4	10.2	13.7	2.8	2.5	17.6	10.6	5.8	5.4	1.7	24.6	1.5	6.7	9.2	11.2	9.1	0.0	19.8	8.6	14.1	5.8	21.9	22.4	8.5	6.1	9.7	3.2	3.6	14.6	5.4	8.8	9.4	4.5	11.8	9.2	13.0	16.6	1.9	10.4	9.4	3.1	6.3	15.1	13.9	14.3	7.0	0.0	13.0	6.6	7.3	2.6	6.3	5.5	7.4	7.8	26.1	10.5	6.6
PEX7	"PTS2R, RD"	ENSG00000112357	"Peroxisomal biogenesis factor 7"	O00628	6	136822564-136913934	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cataract, Deafness, Disease variant, Ichthyosis, Peroxisome biogenesis disorder, Retinitis pigmentosa, Rhizomelic chondrodysplasia punctata"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 60.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049202	Uncertain		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Vesicles"		"HPA049202: AB_2680674"	"unprognostic (1.36e-2)"	"unprognostic (2.07e-2)"	"prognostic favorable (1.61e-4)"	"unprognostic (4.01e-3)"	"unprognostic (2.50e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.71e-2)"	"unprognostic (4.87e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.88e-2)"	"prognostic favorable (1.85e-10)"	"unprognostic (3.57e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.52e-2)"	"unprognostic (2.65e-1)"	5.2	14.8	4.6	2.0	4.8	3.8	11.9	6.0	5.2	6.8	5.1	7.9	5.3	4.2	17.2	7.3	8.7	4.5	11.7	4.2	4.2	15.6	9.1	4.9	3.2	4.3	4.4	5.0	26.9	17.1	6.0	4.1	4.5	10.4	8.4	6.9	10.6	6.4	10.7	11.2	4.7	3.3	4.4	3.3	15.6	10.0	4.7	3.7	11.0	9.8	3.3	5.4	6.7	5.5	4.4	4.3	4.4	6.2	6.6	9.8	2.4	6.1	8.9	7.5	7.4	4.9	6.0	1.5	11.3	8.3	8.5	5.3	3.3	13.8	9.8	5.7	7.5	6.4	4.3	0.9	13.9	8.1	5.3	9.6	13.1	5.4	7.9	8.7	5.4	12.0	13.0	5.2	10.6	13.4	3.5	7.9	5.0	13.9	8.3	4.8	3.4	5.7	17.4	6.4	8.3	10.6	6.5	9.0	8.4	4.9	5.8	7.7	2.5	4.8	1.7	7.3	5.3	6.9	5.1	0.0	4.2	6.4	4.9	2.9	1.3	2.2	0.7	1.0	0.7	1.5	1.3	1.6	2.3	1.0	2.4	1.5	0.9	1.6	1.9	1.8	2.3	0.9	4.6	4.8	6.0	5.2	4.2	4.2	4.3	4.4	4.5	4.4	4.7	5.5	4.9	3.2	9.4	10.7	6.3	12.1	14.9	16.5	9.1	9.1	19.5	13.8	18.7	11.5	14.7	11.0	8.4	19.6	2.3	11.6	60.7	16.5	12.5	18.7	6.4	5.6	10.3	15.8	12.4	22.7	21.0	6.8	10.2	11.1	14.0	7.9	6.1	7.0	12.4	0.0	14.7	21.8	30.5	5.7	6.2	10.2	9.0	6.4	14.2	5.6	11.9	20.8	4.1	17.6	19.9	16.7	13.2	9.8	3.7	16.0	15.0	38.3	16.1	9.9	6.6	5.7	8.2	30.6	16.7	15.4	18.2	17.1	6.6	24.3	17.2	17.4
PGAP2	"CWH43-N, FRAG1, MRT17, MRT21"	ENSG00000148985	"Post-GPI attachment to proteins 2"	Q9UHJ9	11	3797724-3826371	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"GPI-anchor biosynthesis"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"epididymis: 216.2"	"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 74.9;Early spermatids: 147.6;Late spermatids: 296.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063099	Approved		Approved	Microtubules		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	Microtubules		"HPA063099: AB_2684940"	"unprognostic (1.94e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.19e-1)"	"unprognostic (3.18e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.06e-2)"	"prognostic unfavorable (7.49e-4)"	"unprognostic (1.74e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.44e-2)"	"unprognostic (3.85e-2)"	"unprognostic (4.66e-3)"	"unprognostic (4.13e-2)"	"unprognostic (2.17e-2)"	"unprognostic (2.67e-2)"	8.9	14.9	16.4	6.4	17.5	9.5	11.5	15.9	18.2	13.7	17.0	13.9	18.4	8.3	216.2	34.9	19.2	7.6	21.7	16.6	16.3	13.9	30.9	16.2	10.4	17.8	16.6	11.2	28.9	17.6	15.1	14.2	17.2	16.7	13.3	9.2	18.4	33.4	11.4	48.0	16.0	7.6	16.3	11.3	14.1	28.5	17.3	13.1	19.4	9.5	13.5	10.9	18.8	20.9	27.1	36.3	17.2	15.8	15.2	28.9	27.3	10.9	9.4	15.6	14.2	31.1	46.6	29.0	12.3	8.0	9.4	44.1	27.6	30.2	15.5	35.5	30.9	17.7	14.7	38.4	10.7	23.0	22.0	22.8	41.9	11.6	39.3	10.2	18.0	38.4	38.4	41.8	16.6	39.9	28.0	19.3	32.4	56.7	21.5	44.0	2.0	27.8	30.0	31.6	22.7	22.5	19.7	52.0	12.3	20.1	43.2	9.6	16.5	9.9	9.2	23.8	6.8	26.2	31.3	21.6	12.9	15.3	19.1	3.0	6.4	5.9	9.1	9.2	11.0	11.4	13.2	11.3	9.7	12.7	17.3	11.8	18.2	10.7	9.2	6.6	13.3	8.8	16.4	17.5	15.9	18.2	16.6	16.3	17.8	16.6	17.2	16.3	17.3	20.9	8.4	12.8	10.6	7.5	10.6	31.7	15.1	23.3	33.6	14.1	19.2	18.0	13.7	11.5	13.0	12.9	22.9	74.9	5.2	11.4	1.9	15.6	147.6	11.7	6.6	9.0	3.0	13.2	15.4	21.3	18.4	7.6	10.2	14.7	8.8	13.4	3.6	14.6	16.0	3.3	19.1	10.5	10.2	5.0	8.0	296.8	8.7	5.5	5.4	4.7	8.9	9.3	8.2	10.6	23.0	14.2	9.3	6.8	12.2	9.1	39.8	10.2	15.2	9.5	6.6	11.0	7.2	17.7	21.6	31.1	28.6	29.3	9.4	11.8	20.1	13.0
PGAP6	"M83, TMEM6, TMEM8, TMEM8A"	ENSG00000129925	"Post-glycosylphosphatidylinositol attachment to proteins 6"	Q9HCN3	16	370788-387113	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Hydrolase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"Cytotrophoblasts: 63.7;Hofbauer cells: 29.2;Syncytiotrophoblasts: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 36.0"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 129.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051281, HPA064673"	Approved		Supported	"Nucleoplasm,Cytokinetic bridge"		Yes	No			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Cytokinetic bridge"	"HPA051281: AB_2681418, HPA064673: AB_2685317"	"unprognostic (5.84e-2)"	"unprognostic (6.13e-2)"	"unprognostic (3.85e-2)"	"unprognostic (3.21e-2)"	"unprognostic (5.77e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.56e-2)"	"unprognostic (8.89e-2)"	"unprognostic (7.73e-2)"	"unprognostic (3.43e-1)"	"unprognostic (1.38e-2)"	"prognostic favorable (1.29e-5)"	"unprognostic (4.20e-3)"	"unprognostic (3.19e-2)"	"unprognostic (4.93e-2)"	"unprognostic (2.48e-1)"	23.5	25.5	13.5	18.0	15.1	30.0	20.1	11.8	17.7	17.7	14.5	39.6	31.4	19.2	24.8	31.9	17.7	16.4	37.7	12.8	11.0	59.4	57.6	36.2	17.0	14.6	12.6	12.2	102.8	19.3	28.8	34.8	13.5	30.3	10.3	5.6	40.8	12.5	36.1	11.3	38.5	8.8	11.9	36.0	53.9	63.3	16.0	11.7	28.0	10.1	7.9	23.4	14.3	14.6	12.7	32.8	18.4	33.9	24.7	22.1	36.7	35.5	36.6	17.7	25.3	129.2	57.9	13.4	47.1	34.5	27.3	17.8	8.4	39.2	4.9	38.5	31.1	22.1	23.1	74.8	56.9	16.9	40.4	25.7	11.6	27.4	7.9	18.0	41.4	14.8	36.2	20.1	22.6	78.2	23.9	33.2	29.2	20.1	12.9	51.0	21.0	31.2	28.8	32.0	21.9	25.2	19.8	19.7	106.3	9.6	35.7	33.4	61.1	50.2	53.6	35.2	19.2	40.3	21.6	27.0	25.5	17.8	32.5	7.1	7.6	10.1	10.7	8.6	8.3	2.5	8.1	8.3	3.9	2.6	10.7	8.0	36.0	1.5	6.1	4.2	6.6	5.7	13.5	15.1	11.8	17.7	12.8	11.0	14.6	12.6	13.5	11.9	16.0	14.6	11.7	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.9	0.0	0.0	0.0	0.0	63.7	8.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	7.4	2.9	0.0	0.0	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	100.2	1.4	0.0	0.0	0.0
PGC		ENSG00000096088	Progastricsin	P20142	6	41736711-41754109	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	Digestion	"Aspartyl protease, Hydrolase, Protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	45	"stomach 1: 59821.1"	"Group enriched"	"Detected in some"	10	"Gastric mucus-secreting cells: 5737.5;Pancreatic endocrine cells: 1449.1"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 1050.3"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"Hep G2: 253.1;OE19: 152.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA031717, HPA031718"	Enhanced		Approved	Nucleoplasm	"Secreted to digestive system"	NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 4: Stomach - Digestion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Nucleoplasm		"HPA031717: AB_10670130, HPA031718: AB_10610148"	"unprognostic (9.18e-2)"	"unprognostic (1.87e-1)"	"unprognostic (9.83e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.18e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.47e-1)"	"unprognostic (8.50e-2)"		"unprognostic (1.86e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.33e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.65e-1)"		"unprognostic (8.74e-2)"	19.4	7.0	0.0	0.3	0.1	0.2	6.6	1.2	0.5	6.7	0.0	26.4	1327.3	2.8	0.9	85.5	9.2	2.3	6.2	0.1	0.0	4.9	11.0	378.8	0.3	0.0	0.0	3.9	136.3	0.0	7.4	2.8	0.0	83.9	0.3	0.1	4.6	437.7	2.5	3.4	3.2	0.0	0.0	7.7	59821.1	4.2	0.0	0.1	2.2	0.0	0.3	3.8	4.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.1	0.0	0.0	18.4	0.0	0.0	0.6	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	253.1	0.0	0.3	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.5	0.9	5.7	152.2	0.0	2.9	0.0	6.2	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.3	0.0	2.8	0.0	0.0	3.7	0.1	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.2	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	25.6	335.2	0.0	4.4	0.4	2.8	0.0	0.0	0.0	0.3	0.8	0.3	87.2	5.0	0.0	0.0	1.2	0.0	0.3	0.0	4.6	0.0	0.4	0.0	1.1	0.0	0.0	0.3	131.2	1.5	0.9	5737.5	0.1	10.1	0.0	0.0	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	1.7	0.0	0.0	2.0	0.0	0.0	0.0	0.1	1449.1	2.1	0.0	2.4	85.2	0.1	0.2	3.0	0.0	0.0	0.0	0.6	0.0	0.5	0.0	0.0	4.1	2.6	0.0	0.2	4.2
PGR	"NR3C3, PR"	ENSG00000082175	"Progesterone receptor"	P06401	11	101029624-101129813	"Cancer-related genes, FDA approved drug targets, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"cervix: 63.9;endometrium 1: 103.4;fallopian tube: 34.3;smooth muscle: 78.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.0;Endometrial ciliated cells: 90.1;Endometrial stromal cells: 177.1;Glandular and luminal cells: 76.3;Late spermatids: 40.9"	"Group enriched"	"Detected in some"	13	"breast cancer: 10.1;endometrial cancer: 11.1"	"Group enriched"	"Detected in many"	5	"hypothalamus: 7.7;thalamus: 9.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	338	"T-47d: 170.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB000068, HPA004751, HPA008428, HPA017176, CAB055100"	Enhanced					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 6: T47d - Mammary gland"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB000068: AB_442124, CAB055100: AB_2532076, HPA004751: AB_1079681, HPA008428: AB_1079680, HPA017176: AB_1855728"	"unprognostic (2.59e-2)"	"unprognostic (9.80e-3)"	"unprognostic (5.23e-3)"	"prognostic favorable (5.76e-8)"	"unprognostic (2.81e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.11e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.08e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.29e-2)"	"unprognostic (1.77e-1)"	"unprognostic (7.71e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-2)"	"unprognostic (1.15e-1)"	"unprognostic (5.44e-3)"	1.4	1.7	1.3	0.3	1.0	0.0	7.0	0.8	0.9	63.9	0.6	2.4	0.5	103.4	0.8	0.7	34.3	0.9	3.7	0.8	7.7	1.1	0.3	1.4	0.2	1.7	1.7	16.3	0.6	0.3	1.0	1.7	1.7	3.7	0.7	0.1	3.8	9.0	0.6	0.5	0.7	78.4	1.5	1.7	0.6	3.5	9.2	0.2	1.3	1.8	0.2	1.6	10.3	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	170.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.0	0.8	0.9	0.8	7.7	1.7	1.7	1.7	1.5	9.2	1.2	1.3	3.2	0.0	0.3	0.7	0.1	1.1	0.0	0.0	1.3	35.9	19.8	18.7	0.0	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	64.0	90.1	177.1	3.5	0.0	0.0	0.1	0.0	0.1	12.5	0.0	76.3	0.0	34.7	2.9	0.0	0.1	0.0	0.3	0.0	0.0	0.0	1.3	40.9	14.6	1.9	0.0	22.5	0.0	0.0	0.0	1.0	0.3	0.1	0.0	10.5	0.0	0.3	0.0	0.0	0.0	0.2	6.6	1.4	14.9	3.9	2.3	0.0	0.6	0.0	2.3	15.1	0.0	1.0
PHAX	"FLJ13193, RNUXA"	ENSG00000164902	"Phosphorylated adaptor for RNA export"	Q9H814	5	126600925-126627252	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059630, HPA070326"	Supported		Enhanced	Nucleoplasm		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA059630: AB_2684088, HPA070326: AB_2686253"	"unprognostic (1.06e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.35e-2)"	"unprognostic (2.64e-2)"	"unprognostic (6.11e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.59e-3)"	"unprognostic (9.20e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.91e-3)"	"unprognostic (7.21e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.07e-2)"	8.2	8.9	9.5	7.1	9.5	4.4	8.1	11.8	10.3	6.9	7.9	6.3	5.0	9.1	7.5	9.0	7.9	7.1	9.7	9.8	8.9	7.6	8.2	6.4	10.9	8.8	9.0	11.4	7.1	8.8	5.1	7.3	9.1	8.4	6.2	8.4	7.3	6.2	12.1	10.6	5.4	8.3	9.0	7.1	6.3	5.6	9.8	7.2	8.7	10.0	10.4	7.7	5.5	10.9	15.5	15.9	13.5	25.6	19.0	18.3	14.9	21.4	16.0	17.6	16.4	21.8	15.1	15.2	19.0	27.7	21.2	12.2	19.1	29.7	25.7	24.7	20.4	13.0	18.5	8.8	11.3	10.8	13.5	18.6	16.4	17.2	15.6	16.5	15.0	8.7	10.4	17.2	27.4	13.3	15.2	13.4	16.9	10.3	12.4	12.1	19.1	12.4	16.4	18.1	17.3	19.9	19.3	16.4	22.7	13.0	22.0	14.7	23.2	29.0	16.1	16.3	32.7	13.3	13.6	17.0	20.8	17.4	21.3	8.7	4.8	6.6	7.1	5.7	8.1	8.2	7.1	7.4	4.8	7.1	7.9	8.3	3.8	10.7	6.1	6.4	6.5	5.5	9.5	9.5	11.8	10.3	9.8	8.9	8.8	9.0	9.1	9.0	9.8	10.9	34.6	25.6	40.2	10.7	36.1	28.6	31.6	72.1	26.7	60.0	27.7	42.2	56.6	20.0	47.3	35.0	39.6	51.5	42.4	29.5	74.3	53.6	37.2	32.8	44.6	36.8	27.5	26.9	14.2	33.3	50.3	41.8	16.3	28.3	46.9	35.0	28.2	28.5	30.1	75.7	14.8	26.9	65.1	17.2	17.6	9.7	42.0	21.9	21.4	5.6	43.4	86.9	37.0	8.0	11.8	40.3	23.1	41.3	29.7	31.9	16.5	56.1	63.3	72.3	46.0	50.3	51.7	64.5	86.4	32.3	25.9	51.4	34.2	43.2	27.7	27.8
PIEZO1	"FAM38A, KIAA0233"	ENSG00000103335	"Piezo type mechanosensitive ion channel component 1"	Q92508	16	88715338-88785220	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Pancreatic endocrine cells: 85.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 270.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA047185	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA047185: AB_2679973"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.37e-4)"	"unprognostic (1.77e-1)"	"unprognostic (1.12e-2)"	"unprognostic (4.08e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (2.36e-5)"	"unprognostic (4.39e-2)"	"prognostic unfavorable (3.78e-4)"	"unprognostic (3.51e-2)"	"unprognostic (3.05e-2)"	"prognostic unfavorable (8.89e-7)"	"unprognostic (2.04e-1)"	"unprognostic (3.59e-2)"	"unprognostic (2.86e-2)"	"unprognostic (3.74e-1)"	79.0	26.4	15.2	20.5	16.0	29.8	65.1	16.5	19.0	30.7	10.4	86.7	7.7	40.4	0.5	48.4	38.1	9.0	29.4	12.9	13.8	57.2	48.2	67.2	14.8	25.0	17.6	15.8	21.9	5.2	6.8	18.6	22.5	49.4	4.8	1.7	33.3	11.2	6.8	48.8	41.1	14.3	17.6	55.2	38.0	5.2	17.4	7.2	32.4	4.3	5.9	65.3	40.4	21.2	42.0	42.1	6.5	31.3	27.6	30.0	155.2	99.9	43.9	36.1	14.0	61.3	68.5	34.2	68.2	48.4	18.0	88.4	13.9	36.0	7.3	33.8	56.0	58.3	77.9	49.4	41.6	26.4	9.3	24.6	19.4	28.3	23.3	21.3	43.9	56.1	80.4	42.8	21.2	270.1	32.7	91.2	14.7	19.7	25.7	77.7	9.3	86.9	16.4	61.1	12.8	3.4	130.5	68.0	17.8	6.5	93.0	76.5	120.1	86.0	49.6	58.4	51.6	8.7	21.1	21.2	67.9	46.5	52.2	1.8	5.0	3.3	8.1	9.7	7.8	2.3	6.0	5.5	9.7	3.1	1.0	2.5	0.1	1.0	13.1	1.7	5.0	3.9	15.2	16.0	16.5	19.0	12.9	13.8	25.0	17.6	22.5	17.6	17.4	21.2	69.1	73.7	19.8	27.1	14.3	19.1	12.9	27.6	5.2	2.2	23.5	16.3	5.0	10.0	17.1	58.8	16.7	6.7	16.8	19.3	0.0	37.3	1.6	6.2	15.4	45.0	21.0	12.6	0.4	21.7	30.5	13.7	25.0	9.9	8.8	0.7	55.3	22.0	23.6	3.3	0.5	29.5	10.2	16.8	19.0	1.0	5.6	21.8	16.0	21.5	15.6	1.5	3.1	16.6	5.0	85.9	18.0	2.6	30.8	48.3	8.1	5.5	9.7	4.1	0.0	30.3	9.0	0.3	2.0	18.9	15.9	5.1	21.6	5.6	12.0	21.8
PIEZO2	"C18orf30, C18orf58, FAM38B, FAM38B2, FLJ23144, FLJ23403, FLJ34907, HsT748, HsT771"	ENSG00000154864	"Piezo type mechanosensitive ion channel component 2"	Q9H5I5	18	10666483-11149569	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"brain: 58.3"	"Cell type enriched"	"Detected in many"	10	"Oligodendrocytes: 399.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 15.1;BJ hTERT+ SV40 Large T+: 16.9;BJ hTERT+ SV40 Large T+ RasG12V: 23.1;HeLa: 38.1;U-266/70: 23.0;U-698: 16.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA015986, HPA031974, HPA040616"	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 20: HeLa - Mitochondria"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"		"HPA015986: AB_1848395, HPA031974: AB_10603675, HPA040616: AB_2677043"	"unprognostic (1.36e-1)"	"unprognostic (1.92e-1)"	"unprognostic (9.21e-2)"	"unprognostic (2.53e-2)"	"unprognostic (7.84e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.87e-2)"	"unprognostic (4.34e-3)"	"unprognostic (6.55e-2)"	"unprognostic (3.89e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.23e-1)"	"prognostic unfavorable (9.57e-7)"	"unprognostic (1.12e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.04e-2)"	"unprognostic (1.83e-2)"	1.2	0.5	7.3	1.3	20.2	0.4	1.7	14.7	14.4	1.0	0.1	3.9	0.3	0.6	1.6	5.1	1.1	5.3	0.3	7.9	8.7	1.1	4.1	6.6	0.9	18.2	14.4	0.7	1.8	0.5	0.9	0.0	18.2	3.0	1.4	0.1	0.3	2.9	0.1	1.1	1.1	2.1	8.5	2.7	1.6	1.2	16.8	0.8	1.5	0.2	0.6	5.3	0.7	58.3	0.0	1.8	15.1	0.0	0.0	0.0	0.0	0.8	4.4	16.9	23.1	0.0	0.0	0.0	0.0	1.5	0.0	0.1	0.0	0.0	10.6	0.0	0.5	0.0	38.1	8.8	5.2	0.0	0.1	0.1	0.3	4.3	1.2	0.1	5.2	0.6	0.0	0.3	2.7	0.0	0.3	0.0	4.5	6.7	0.0	0.0	0.0	7.0	0.0	5.3	12.7	0.0	0.1	0.0	0.8	6.7	0.0	4.5	0.0	0.0	5.8	0.3	0.9	23.0	0.2	16.2	0.0	0.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.3	20.2	14.7	14.4	7.9	8.7	18.2	14.4	18.2	8.5	16.8	58.3	3.3	0.0	5.3	2.0	0.0	0.8	0.3	0.0	0.0	0.0	2.3	0.8	1.6	10.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	31.7	0.2	0.2	9.9	0.0	0.0	2.5	0.2	0.0	11.2	2.6	0.0	5.1	0.1	17.2	5.9	1.0	0.0	37.0	0.0	0.0	3.2	0.8	11.9	0.0	0.6	0.0	9.4	0.0	0.0	0.0	2.0	399.6	0.1	0.0	0.0	0.4	0.1	0.0	0.1	7.3	0.0	6.6	0.9	4.5	0.3	1.4	0.2	0.9	0.4	0.6	32.9	0.0	0.1
PIRT		ENSG00000233670	"Phosphoinositide interacting regulator of transient receptor potential channels"	P0C851	17	10822470-10838087	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 24.0"	"Cell type enhanced"	"Detected in single"		"Astrocytes: 2.6"	"Cancer enriched"	"Detected in single"	40	"glioma: 5.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA042337			Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 70: Brain - Nervous system development"		"Cluster 64: Astrocytes - Nervous system maintenance"	Cytosol	"Plasma membrane"	"HPA042337: AB_10794795"	"unprognostic (2.95e-1)"		"unprognostic (2.19e-2)"	"unprognostic (7.57e-2)"	"unprognostic (6.58e-3)"						"unprognostic (9.42e-2)"	"unprognostic (2.05e-1)"		"unprognostic (2.85e-3)"				0.0	2.5	7.5	1.1	8.7	0.0	0.0	11.5	6.8	0.0	1.7	4.0	1.0	0.0	0.0	0.1	0.2	0.1	0.0	5.4	11.6	0.0	0.0	0.0	0.0	22.4	16.5	0.0	0.0	0.0	0.0	0.0	14.0	0.1	2.6	0.2	0.0	0.0	0.0	0.3	1.9	0.8	11.8	0.0	1.4	0.0	24.0	0.0	0.0	0.0	0.0	0.0	0.5	10.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	8.7	11.5	6.8	5.4	11.6	22.4	16.5	14.0	11.8	24.0	10.8	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
PITPNM1	"DRES9, NIR2, PITPNM, Rd9, RDGB, RDGB1, RDGBA1"	ENSG00000110697	"Phosphatidylinositol transfer protein membrane associated 1"	O00562	11	67491768-67506263	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Distal enterocytes: 69.9;Endometrial ciliated cells: 63.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 91.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060227	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol	Vesicles	"HPA060227: AB_2684226"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	"unprognostic (1.69e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.83e-2)"	"unprognostic (8.68e-2)"	"unprognostic (8.16e-2)"	"unprognostic (4.55e-2)"	"unprognostic (1.77e-1)"	"unprognostic (2.26e-2)"	"unprognostic (4.61e-1)"	"unprognostic (3.27e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.58e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.69e-2)"	10.6	24.5	19.6	24.3	12.6	26.8	6.4	6.1	23.2	10.7	13.9	14.4	18.7	9.3	2.4	19.5	23.1	9.0	22.3	13.3	23.8	37.8	11.0	16.3	27.6	14.2	31.0	4.0	9.8	10.3	26.7	8.0	13.5	10.4	7.5	40.7	8.7	10.3	6.9	5.0	21.1	5.9	2.3	21.6	16.0	8.8	51.5	17.4	15.7	18.4	17.2	16.2	9.3	5.5	12.7	31.2	18.8	13.9	20.3	12.1	30.5	12.2	21.5	14.8	8.4	28.5	22.6	12.5	28.7	17.5	28.4	32.4	14.5	27.0	4.8	91.0	6.0	17.0	55.8	10.8	16.0	19.4	35.3	15.0	17.0	22.4	14.7	27.4	17.9	18.7	13.2	11.0	12.5	19.1	33.2	45.6	19.3	35.9	13.5	23.7	6.0	17.3	24.4	25.1	18.1	11.5	27.3	37.6	29.6	9.0	7.4	16.9	17.7	26.5	20.1	16.9	8.9	16.0	8.3	11.2	37.1	22.7	10.6	0.0	1.4	0.9	1.1	3.3	1.0	0.7	0.8	1.0	1.0	0.5	0.3	0.8	1.4	0.1	2.7	0.4	0.7	1.1	19.6	12.6	6.1	23.2	13.3	23.8	14.2	31.0	13.5	2.3	51.5	5.5	7.5	3.2	5.8	2.0	10.8	8.2	6.3	9.3	13.6	45.7	5.4	5.2	8.4	5.7	9.7	20.2	64.6	4.6	10.6	69.9	3.9	11.3	6.1	63.3	16.5	4.9	11.4	0.4	5.1	9.3	8.9	4.2	34.7	24.6	2.5	7.1	3.3	3.4	8.4	38.7	6.6	16.8	10.2	13.2	14.0	17.0	2.1	15.2	3.6	10.3	13.5	20.7	3.1	0.5	0.5	15.9	32.7	1.2	7.5	9.8	39.0	18.9	37.8	53.7	0.0	6.3	9.8	1.4	5.5	11.2	3.3	15.2	14.9	1.4	24.0	19.4
PJVK	DFNB59	ENSG00000204311	Pejvakin	Q0ZLH3	2	178451346-178462102	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Hearing		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 20.7"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Alveolar cells type 2: 9.1;Distal tubular cells: 3.9;Granulosa cells: 6.1;Theca cells: 4.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"plasmacytoid DC: 2.8"	"Lineage enriched"	"Detected in single"	5	"dendritic cells: 2.8"	"Cell line enhanced"	"Detected in many"		"SuSa: 6.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042621			Approved	Mitochondria		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA042621: AB_10797503"	"unprognostic (4.01e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.64e-1)"	"unprognostic (7.21e-3)"	"unprognostic (9.36e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.14e-1)"	"unprognostic (8.60e-3)"	"unprognostic (4.57e-2)"	"unprognostic (1.90e-3)"	"unprognostic (9.13e-2)"	"prognostic unfavorable (8.92e-4)"	"unprognostic (1.22e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.41e-2)"	"unprognostic (8.06e-3)"	3.0	1.8	6.9	1.3	7.2	1.4	4.8	6.9	10.7	2.7	6.9	1.9	1.2	3.9	7.3	1.2	2.8	2.9	1.4	7.0	7.0	3.2	2.8	1.5	1.9	7.6	7.3	7.1	1.3	1.1	4.1	1.2	7.5	2.8	1.2	6.4	2.7	3.0	3.5	4.2	1.4	2.0	7.3	1.4	1.2	20.7	7.1	1.2	2.5	0.9	1.7	1.9	1.4	7.7	0.2	1.8	2.3	1.9	3.0	3.1	1.2	1.5	1.4	1.2	2.0	0.7	3.1	2.1	1.5	0.9	1.0	0.9	1.7	1.0	0.9	0.7	0.6	0.7	2.9	0.4	3.0	0.6	0.2	3.2	2.2	1.4	3.2	3.8	1.5	4.1	0.4	1.3	1.5	0.5	2.1	1.3	2.8	0.2	0.8	2.7	1.7	1.3	2.0	1.0	1.6	1.3	0.5	0.3	0.6	6.8	0.7	0.7	1.0	1.5	0.6	0.4	0.1	4.3	2.8	0.7	0.7	1.1	0.6	0.1	0.1	0.0	0.1	0.1	0.2	0.3	0.2	0.1	0.0	0.5	0.5	0.3	0.4	0.2	0.0	2.8	0.0	0.0	6.9	7.2	6.9	10.7	7.0	7.0	7.6	7.3	7.5	7.3	7.1	7.7	1.6	6.4	9.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	3.0	2.4	0.0	0.0	1.8	1.8	0.0	1.1	0.5	0.0	3.9	1.4	0.0	1.8	2.6	0.4	0.0	0.0	0.0	0.9	0.5	1.4	0.0	1.6	0.0	6.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	2.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.6	4.7	0.0	0.0
PKD1	"PBP, Pc-1, TRPP1"	ENSG00000008710	"Polycystin 1, transient receptor potential channel interacting"	P98161	16	2088708-2135898	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pituitary gland: 72.4"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 138.1;Horizontal cells: 119.5;Inhibitory neurons: 101.0"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 65.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB046448	Approved					NA	NA		840000		"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 62: Horizontal cells - Visual perception"			"CAB046448: AB_2163360"	"unprognostic (1.95e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.43e-4)"	"unprognostic (1.35e-1)"	"unprognostic (1.79e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (1.98e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (3.38e-5)"	"unprognostic (7.86e-2)"	"unprognostic (4.07e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.81e-1)"	14.8	9.5	7.9	4.9	10.4	3.9	13.7	65.4	32.1	22.1	0.0	40.3	3.8	30.6	2.0	11.3	25.9	3.7	23.9	9.6	1.6	7.5	8.9	13.4	3.4	16.2	1.7	23.8	10.4	2.3	72.4	3.7	12.6	19.9	1.5	7.4	10.4	8.7	47.7	16.8	15.3	6.1	0.1	9.9	19.1	10.3	4.7	2.8	10.3	8.3	1.5	24.5	15.5	4.9	4.2	8.9	4.8	10.9	8.2	8.8	9.3	14.2	5.9	4.0	4.0	8.0	3.1	6.3	8.9	7.3	4.3	10.4	1.4	2.1	1.5	7.4	7.1	3.9	25.8	3.2	16.1	5.4	7.8	8.2	7.0	7.5	4.6	5.6	3.1	6.6	5.7	6.2	2.6	6.9	7.7	16.5	4.3	1.7	6.6	21.6	7.7	9.6	2.1	2.8	19.9	22.2	12.9	8.5	8.9	1.7	7.0	18.3	7.4	12.7	10.3	9.6	10.5	9.0	4.3	7.0	7.1	5.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	10.4	65.4	32.1	9.6	1.6	16.2	1.7	12.6	0.1	4.7	4.9	21.3	12.8	12.2	61.7	6.9	24.3	10.3	14.7	30.7	79.8	15.4	18.9	26.4	4.3	10.9	9.2	41.7	6.0	11.2	13.6	9.8	5.2	51.9	16.0	32.1	17.1	30.5	4.8	138.1	3.1	4.0	30.4	8.2	16.9	8.2	21.3	15.7	24.2	5.2	119.5	101.0	17.6	4.1	7.2	12.6	10.6	27.7	7.8	23.2	18.7	6.2	36.4	11.3	38.2	29.5	4.5	5.9	45.9	9.0	10.3	8.9	7.7	32.9	35.2	32.9	41.4	25.2	10.1	15.8	26.0	20.0	3.1	10.9	10.1	14.2	6.9
PKD1L1	PRO19563	ENSG00000158683	"Polycystin 1 like 1, transient receptor potential channel interacting"	Q8TDX9	7	47740202-47948466	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	Heterotaxy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 9.1;Astrocytes: 13.4;Early spermatids: 11.8;Excitatory neurons: 25.7;Inhibitory neurons: 37.9;Microglial cells: 15.0;Oligodendrocyte precursor cells: 11.6;Oligodendrocytes: 17.1"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"T-47d: 5.9;U-266/70: 14.7;U-266/84: 5.7"	"Not detected"	"Not detected"							"HPA020422, HPA022424"	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA020422: AB_1855434, HPA022424: AB_1855435"	"unprognostic (5.47e-2)"	"unprognostic (5.33e-3)"	"unprognostic (1.49e-2)"	"unprognostic (9.74e-2)"	"unprognostic (4.03e-2)"	"unprognostic (6.31e-2)"	"unprognostic (2.52e-2)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-3)"	"unprognostic (7.96e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.88e-4)"	"unprognostic (1.88e-3)"	"unprognostic (2.56e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.90e-1)"	1.7	0.1	1.1	0.4	0.9	1.1	0.5	2.1	1.9	0.2	0.0	0.4	0.9	0.3	0.6	0.4	0.3	0.4	2.6	0.4	1.3	0.3	0.8	0.4	0.9	0.5	0.7	0.3	0.3	0.1	0.4	0.6	0.7	0.3	0.5	1.7	0.4	0.1	2.8	0.5	0.4	0.4	0.1	0.3	0.4	1.5	0.8	1.5	0.4	3.3	0.6	0.6	0.1	1.1	0.4	0.7	0.6	0.8	0.1	0.0	1.2	0.3	0.2	0.2	0.4	0.8	0.4	0.3	0.3	0.4	0.4	0.8	0.5	0.6	0.6	0.2	0.4	0.3	0.3	0.8	0.0	0.5	0.3	0.2	0.1	0.3	0.2	0.2	1.1	0.4	0.4	1.1	0.5	0.2	0.3	0.3	0.4	0.0	0.2	0.2	0.3	0.3	0.1	0.7	0.5	0.4	0.5	0.3	0.4	0.5	5.9	0.1	0.1	0.5	1.1	0.2	0.3	14.7	5.7	0.5	0.2	0.2	0.3	0.9	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.4	0.2	0.1	0.2	0.1	0.1	1.1	0.9	2.1	1.9	0.4	1.3	0.5	0.7	0.7	0.1	0.8	1.1	9.1	0.0	0.0	13.4	0.3	0.1	0.0	0.0	0.0	3.1	0.1	0.3	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.8	0.5	0.1	3.7	0.0	0.0	25.7	0.2	0.2	1.7	0.0	0.3	0.0	0.2	2.2	0.1	1.4	1.7	37.9	0.7	0.0	0.3	0.0	5.3	0.3	0.2	0.0	15.0	0.0	0.5	0.0	11.6	17.1	0.0	0.0	0.0	0.4	0.1	0.3	0.0	0.0	1.5	0.0	0.4	0.2	1.4	0.6	0.0	0.0	0.0	0.1	0.3	0.8	0.0
PKD1L3		ENSG00000277481	"Polycystin 1 like 3, transient receptor potential channel interacting"	Q7Z443	16	71929538-71999978	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"liver: 1.0"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 1.9;Excitatory neurons: 2.5;Inhibitory neurons: 2.2;Microglial cells: 1.9;Oligodendrocytes: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA				"Cluster 85: Liver - Metabolism"		"Cluster 54: Cardiomyocytes - Muscle contraction"				"unprognostic (1.75e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.46e-2)"	"unprognostic (7.24e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.74e-1)"	"unprognostic (9.90e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.35e-6)"	"unprognostic (6.71e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.93e-3)"	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.1	0.2	0.2	0.0	0.0	2.5	0.0	0.0	0.2	0.0	0.3	0.0	0.5	0.4	0.3	0.5	0.0	2.2	0.3	0.0	0.0	0.0	0.3	0.3	0.3	0.0	1.9	0.0	0.0	0.0	0.5	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.2	0.7	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0
PKD2	"Pc-2, PC2, PKD4, TRPP2"	ENSG00000118762	"Polycystin 2, transient receptor potential cation channel"	Q13563	4	88007635-88077777	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Potassium transport, Transport, Wnt signaling pathway"	"Calcium channel, Ion channel, Potassium channel, Voltage-gated channel"	"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 129.1;Inhibitory neurons: 148.6;Microglial cells: 95.5;Oligodendrocyte precursor cells: 178.9;Oligodendrocytes: 219.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BJ: 137.2;BJ hTERT+: 207.1;fHDF/TERT166: 166.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004544, HPA015794, HPA055297"	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Endoplasmic reticulum"	Cytosol	"CAB004544: AB_672377, HPA015794: AB_1855437, HPA055297: "	"unprognostic (2.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.83e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.64e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.59e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.17e-3)"	"unprognostic (3.54e-3)"	"unprognostic (1.07e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.51e-1)"	30.7	24.2	9.6	13.9	12.2	10.7	18.6	10.0	12.0	40.0	7.3	32.5	10.7	61.1	14.7	12.7	39.3	26.9	19.7	9.0	8.9	48.6	15.0	22.2	11.5	10.4	11.2	47.7	14.8	27.9	9.0	24.5	10.0	23.3	13.2	14.0	9.7	39.2	5.8	10.3	14.8	53.7	9.1	10.9	20.0	10.3	11.9	7.6	16.4	11.7	8.7	20.6	18.4	14.6	7.4	40.8	44.9	23.2	101.8	67.6	13.3	137.2	207.1	62.9	62.2	2.0	12.8	4.0	29.3	166.4	24.0	9.1	8.1	20.4	54.5	21.2	7.1	6.6	21.8	4.3	56.5	16.2	12.9	56.4	9.1	49.4	26.4	85.6	28.8	7.6	0.9	10.9	55.5	14.4	11.4	7.7	23.4	5.3	6.7	21.5	26.8	6.0	55.6	17.2	9.0	20.1	25.5	1.2	32.5	45.0	9.7	12.1	44.7	59.1	12.9	16.8	18.8	8.7	2.9	4.4	35.2	2.5	55.3	1.4	0.1	0.2	0.2	0.2	0.4	0.1	0.2	0.1	0.0	0.1	0.2	0.1	0.2	0.3	0.1	0.4	0.1	0.1	9.6	12.2	10.0	12.0	9.0	8.9	10.4	11.2	10.0	9.1	11.9	14.6	14.8	3.2	6.3	59.4	3.5	7.4	5.3	7.4	23.3	16.7	7.4	11.3	7.1	18.6	7.2	69.9	10.4	10.4	2.7	0.6	0.0	14.0	0.3	10.3	41.7	19.2	6.7	13.5	129.1	3.8	3.4	42.0	2.0	11.1	1.3	12.7	21.4	10.6	12.2	26.9	148.6	3.4	4.1	5.0	6.8	1.1	23.0	9.8	23.2	95.5	9.5	17.3	4.1	178.9	219.4	2.2	4.6	50.8	3.1	6.5	3.9	17.0	12.3	1.9	26.3	53.0	31.5	0.8	3.8	13.3	6.7	2.7	6.1	11.5	2.8	3.4
PKD2L1	"PCL, PKD2L, PKDL, TRPP3"	ENSG00000107593	"Polycystin 2 like 1, transient receptor potential cation channel"	Q9P0L9	10	100288149-100330264	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.8;lymphoid tissue: 7.9;retina: 13.3"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 14.6;Hofbauer cells: 13.6;Horizontal cells: 60.6;Kupffer cells: 14.4;Late spermatids: 20.1"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"CAB022621, HPA070002"	Uncertain		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"		"Cluster 62: Horizontal cells - Visual perception"	"Plasma membrane"	"Actin filaments, Cytosol"	"CAB022621: , HPA070002: "	"unprognostic (2.67e-1)"	"unprognostic (3.66e-7)"	"unprognostic (8.07e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.70e-2)"	"unprognostic (5.31e-2)"	"unprognostic (2.19e-1)"	"unprognostic (2.85e-2)"	"unprognostic (2.01e-1)"	"unprognostic (9.25e-2)"	"unprognostic (1.55e-1)"	"unprognostic (9.37e-2)"	"unprognostic (1.49e-4)"	"unprognostic (3.00e-1)"	"unprognostic (2.05e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.25e-1)"	0.2	0.1	5.4	0.4	5.6	0.9	0.7	4.8	10.8	0.1	4.8	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	5.4	4.9	0.3	1.6	2.3	1.5	4.9	5.2	0.1	0.1	0.0	0.1	0.5	5.1	0.3	1.2	13.3	0.1	0.0	0.1	0.0	0.6	0.0	5.0	7.9	0.0	2.3	5.0	0.9	0.0	0.0	1.7	0.2	0.0	5.5	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.1	5.4	5.6	4.8	10.8	5.4	4.9	4.9	5.2	5.1	5.0	5.0	5.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	14.6	0.0	0.0	0.1	0.0	0.0	2.3	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.1	13.6	60.6	0.4	0.0	0.0	14.4	0.0	20.1	0.3	3.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0
PLN	"CMD1P, PLB"	ENSG00000198523	Phospholamban	P26678	6	118548296-118561716	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Cardiomyopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"heart muscle: 1563.4;skeletal muscle: 507.3"	"Cell type enriched"	"Detected in some"	8	"Cardiomyocytes: 2452.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"							"CAB005597, HPA026900"	Enhanced					NA	NA				"Cluster 38: Heart - Muscle contraction"		"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB005597: AB_2252716, HPA026900: AB_1855314"	"unprognostic (2.49e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.96e-3)"	"unprognostic (4.81e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.54e-2)"	"unprognostic (2.35e-3)"	"unprognostic (4.66e-2)"	"unprognostic (3.97e-1)"	"unprognostic (8.98e-2)"	"unprognostic (8.98e-2)"	"unprognostic (3.28e-1)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (2.98e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.11e-1)"	"prognostic unfavorable (5.59e-4)"	40.1	12.3	1.5	12.3	3.0	0.6	15.9	2.9	4.0	31.7	2.0	148.7	13.6	121.7	21.8	43.9	81.9	92.2	1563.4	1.6	1.6	15.0	1.2	15.4	2.7	1.8	2.0	20.4	3.2	1.3	1.5	0.3	1.8	35.1	24.4	0.2	5.3	37.0	507.3	8.3	41.6	128.4	1.5	3.0	34.1	4.3	2.2	1.0	12.7	230.2	0.9	44.1	22.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	3.0	2.9	4.0	1.6	1.6	1.8	2.0	1.8	1.5	2.2	2.0	4.5	0.0	0.0	0.3	0.2	4.2	0.2	0.0	1.2	1.8	0.4	0.6	2452.8	0.0	0.0	0.0	2.1	0.0	0.2	0.0	0.0	0.0	108.2	0.2	0.7	21.4	0.0	0.0	1.0	0.0	0.0	49.1	0.5	0.1	0.0	0.1	0.7	0.1	0.1	0.0	0.9	0.0	0.0	0.0	4.7	25.0	0.9	0.4	3.6	1.0	0.0	0.0	0.0	2.0	1.1	0.1	0.0	11.7	0.0	0.7	0.0	0.0	0.0	0.3	276.1	16.7	248.0	9.2	0.8	0.3	1.6	0.0	0.8	0.0	0.0	0.4
PLP2	"A4, A4-LSB, MGC126187"	ENSG00000102007	"Proteolipid protein 2"	Q04941	X	49171898-49175235	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 496.5;Exocrine glandular cells: 496.6;Pancreatic endocrine cells: 550.1;Suprabasal keratinocytes: 504.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042415	Approved					NA	NA		250000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA042415: AB_10796907"	"unprognostic (1.40e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.41e-1)"	"prognostic unfavorable (3.32e-5)"	"unprognostic (3.79e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-3)"	"unprognostic (4.14e-2)"	"unprognostic (2.58e-2)"	"unprognostic (9.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (5.55e-10)"	"unprognostic (1.66e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.29e-2)"	"unprognostic (2.30e-1)"	105.1	195.8	17.3	87.6	17.6	358.6	99.8	19.8	21.3	173.6	27.0	164.1	71.0	162.0	42.7	381.7	124.4	53.2	121.0	17.3	24.4	61.3	36.6	118.6	59.9	22.7	21.9	110.3	250.8	37.5	97.4	60.8	20.4	97.8	130.5	6.2	119.3	104.7	99.0	390.6	96.2	156.6	20.2	79.1	114.6	23.3	21.7	77.9	46.8	53.3	148.0	182.8	264.3	19.7	539.1	312.8	0.4	1.0	131.6	388.9	1.6	278.2	223.5	339.9	255.4	115.2	248.4	193.5	68.1	209.2	340.7	444.1	260.5	517.4	214.5	490.2	104.2	71.4	421.1	3.1	210.0	136.0	304.2	174.7	505.6	443.5	516.5	317.6	260.9	63.0	55.1	239.6	249.2	346.0	14.9	346.2	3.3	263.6	456.2	48.9	300.1	563.8	464.6	355.1	69.4	120.6	394.4	155.6	244.4	2.6	340.6	77.0	293.7	194.4	185.4	344.6	472.4	102.2	100.6	50.9	461.3	359.7	464.4	486.8	287.7	148.7	59.9	99.8	100.7	226.4	214.3	112.8	298.5	144.8	107.8	93.4	320.0	70.5	63.7	694.2	265.8	235.8	17.3	17.6	19.8	21.3	17.3	24.4	22.7	21.9	20.4	20.2	21.7	19.7	49.3	73.7	38.2	1.0	160.8	439.7	306.0	496.5	167.9	0.4	67.8	115.4	33.3	57.2	101.9	80.9	0.0	2.7	232.0	134.6	21.5	379.6	16.4	71.8	27.8	63.7	111.7	43.1	0.6	496.6	27.2	110.4	71.9	51.1	88.7	15.4	55.3	12.8	157.5	0.0	0.7	254.9	138.4	130.3	210.5	20.3	169.9	133.3	224.1	4.7	146.4	18.9	35.0	0.0	0.6	550.1	200.3	60.9	148.5	219.5	141.8	9.4	92.9	1.1	124.9	76.1	128.7	4.2	1.4	401.0	504.9	6.4	162.7	29.6	285.2	334.1
PLSCR1	MMTRA1B	ENSG00000188313	"Phospholipid scramblase 1"	O15162	3	146515180-146544856	"Predicted intracellular proteins, Transporters"	"Antiviral defense, Host-virus interaction"	"DNA-binding, Host cell receptor for virus entry, Hydrolase, Nuclease, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 291.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 319.8;BJ hTERT+ SV40 Large T+ RasG12V: 418.6;HHSteC: 292.9;SK-MEL-30: 569.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA068923, CAB070421"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	Yes			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 1: Pancreatic cells - Digestion"	"Nucleoplasm, Plasma membrane"	"Golgi apparatus"	"CAB070421: AB_11153452, HPA068923: AB_2686059"	"unprognostic (7.88e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.34e-2)"	"prognostic unfavorable (1.35e-4)"	"unprognostic (1.12e-1)"	"unprognostic (3.35e-1)"	"unprognostic (5.22e-2)"	"unprognostic (7.73e-3)"	"unprognostic (9.19e-3)"	"unprognostic (6.93e-3)"	"unprognostic (3.07e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.09e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.64e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-1)"	60.6	23.0	11.4	86.7	12.5	64.4	45.9	12.7	17.6	25.9	11.9	65.0	39.8	28.2	31.0	47.9	40.0	66.1	24.3	12.1	13.5	71.9	49.2	49.3	40.6	17.4	14.2	34.9	38.3	16.8	15.4	56.3	15.3	23.7	59.5	9.8	49.1	49.6	10.8	13.6	45.4	41.9	16.2	64.5	44.0	17.1	14.7	30.0	27.8	17.6	39.4	68.1	29.5	14.0	106.2	41.5	26.4	12.1	40.9	65.0	40.5	32.6	88.4	319.8	418.6	34.0	88.1	8.4	75.6	20.6	245.9	86.2	21.2	32.7	56.6	32.9	21.6	66.1	12.5	25.2	292.9	40.3	35.4	106.3	53.3	36.6	182.3	52.6	49.4	19.1	44.7	104.0	66.9	41.0	30.6	16.1	25.8	71.6	37.6	27.4	28.1	2.9	95.9	29.6	16.3	0.0	42.6	20.9	569.9	35.8	20.7	46.8	30.6	26.9	22.7	59.1	55.8	79.2	15.6	0.4	27.0	29.0	23.3	41.1	157.6	44.3	20.8	159.6	30.0	25.2	13.5	18.5	105.8	19.7	9.3	13.9	100.0	57.8	94.8	28.5	8.3	79.3	11.4	12.5	12.7	17.6	12.1	13.5	17.4	14.2	15.3	16.2	14.7	14.0	191.4	35.3	43.0	12.7	28.2	37.0	106.5	92.1	26.2	0.7	36.0	22.6	7.3	124.4	110.4	95.6	0.0	53.7	25.4	134.2	74.3	291.6	2.0	56.1	24.5	135.2	33.1	18.3	7.1	217.4	114.1	74.8	47.9	58.2	28.4	60.5	100.6	29.7	139.9	0.0	9.0	71.5	79.3	86.2	162.9	6.8	114.9	185.5	48.0	35.6	72.3	64.3	32.0	7.1	0.3	157.6	110.3	45.9	18.2	79.6	40.7	75.0	133.5	1.6	39.5	63.4	59.2	1.5	2.4	21.8	28.6	44.5	25.9	42.6	69.4	211.9
PLSCR2		ENSG00000163746	"Phospholipid scramblase 2"	Q9NRY7	3	146391421-146495991	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"testis: 13.2"	"Group enriched"	"Detected in some"	30	"Early spermatids: 195.5;Late spermatids: 246.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA051352			Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 83: Testis - Spermatogenesis"		"Cluster 34: Spermatids - Unknown function"	Nucleoplasm	"Endoplasmic reticulum, Vesicles"	"HPA051352: "	"unprognostic (1.11e-1)"	"unprognostic (9.83e-2)"	"unprognostic (8.94e-3)"	"unprognostic (7.53e-3)"	"unprognostic (3.81e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.11e-1)"	"unprognostic (5.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.88e-4)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.23e-2)"	0.2	0.1	0.4	0.3	0.2	1.1	0.3	0.2	0.7	0.1	0.2	0.3	0.2	0.1	1.8	0.2	0.7	0.5	0.0	0.1	0.7	0.6	0.2	0.2	0.1	0.9	0.6	0.1	0.9	0.2	0.1	0.2	0.7	0.3	0.4	0.5	0.3	0.5	0.0	0.0	0.2	0.2	0.6	0.1	0.4	13.2	0.6	0.2	0.5	0.0	0.1	0.2	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.1	0.0	0.4	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.2	0.0	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.4	0.2	0.2	0.7	0.1	0.7	0.9	0.6	0.7	0.6	0.6	0.6	0.4	0.0	0.0	0.3	0.2	0.3	0.1	0.1	0.6	0.0	1.3	0.6	0.0	1.5	0.2	7.3	0.0	0.2	1.5	0.7	1.9	1.6	195.5	1.4	0.1	0.4	1.8	0.0	1.0	0.6	0.1	0.5	1.5	0.7	0.0	0.4	0.4	0.1	0.1	0.0	1.1	0.3	2.0	0.0	1.1	246.0	1.8	0.6	0.0	1.0	0.0	1.2	0.0	0.0	0.2	0.5	1.0	1.5	0.0	0.3	0.1	1.5	1.4	0.3	0.0	0.7	0.3	5.4	2.6	0.1	0.1	0.0	0.2	0.2	0.9	0.3
PLSCR3		ENSG00000187838	"Phospholipid scramblase 3"	Q9NRY6	17	7389727-7394842	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Alveolar cells type 2: 3.0;Ductal cells: 5.8;Exocrine glandular cells: 3.6;monocytes: 2.0;Pancreatic endocrine cells: 8.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048387, HPA068609"	Supported		Supported	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA048387: AB_2680381, HPA068609: AB_2686011"	"unprognostic (1.86e-2)"	"unprognostic (5.29e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.36e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.27e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.11e-5)"	"unprognostic (1.24e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.55e-2)"	39.5	21.1	7.4	11.0	7.5	3.3	35.0	7.0	8.5	46.2	7.2	27.1	3.1	44.5	5.9	37.4	29.4	6.5	32.0	6.8	7.4	23.5	14.4	32.8	10.5	8.5	7.3	30.5	16.7	5.6	16.4	7.0	7.6	24.7	3.4	1.2	22.9	8.0	21.2	35.2	21.9	12.3	7.4	40.7	21.9	6.1	8.1	6.4	22.8	11.1	10.5	34.8	38.1	7.7	26.7	6.6	5.7	17.2	19.4	32.8	6.8	24.1	22.1	21.3	19.3	9.8	6.6	7.3	19.4	35.1	9.0	37.6	7.0	41.4	10.9	19.0	4.0	6.7	9.2	6.0	23.6	2.5	8.2	22.6	25.4	20.7	30.1	32.0	32.3	14.5	4.1	5.6	27.1	14.3	7.7	2.0	5.1	7.1	18.3	15.1	4.3	8.3	20.1	17.7	4.7	15.6	13.9	8.8	5.9	5.0	16.0	1.3	53.2	13.9	14.5	15.7	10.3	6.2	7.4	3.0	22.4	8.4	15.9	7.0	24.5	2.8	39.5	34.1	40.8	32.2	72.8	40.7	24.1	32.5	59.2	36.1	2.6	18.0	30.2	2.8	83.5	33.3	7.4	7.5	7.0	8.5	6.8	7.4	8.5	7.3	7.6	7.4	8.1	7.7	1.0	3.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	5.8	0.0	0.1	1.0	1.0	0.0	0.0	0.0	3.6	0.3	1.0	0.0	0.1	1.3	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	2.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.3	0.6	0.1	0.0	0.0
PLSCR4		ENSG00000114698	"Phospholipid scramblase 4"	Q9NRQ2	3	146192335-146251179	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 77.3;Astrocytes: 151.1;Endothelial cells: 63.4;Hepatic stellate cells: 110.3;Oligodendrocyte precursor cells: 61.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 60.5;ASC TERT1: 48.2;hTERT-RPE1: 62.1;HUVEC TERT2: 50.8;TIME: 106.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002276	Uncertain		Approved	"Nucleoplasm,Nuclear bodies"		NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nucleoplasm, Nuclear bodies"		"HPA002276: AB_1855479"	"unprognostic (3.73e-3)"	"unprognostic (4.03e-2)"	"unprognostic (9.83e-2)"	"prognostic unfavorable (3.90e-4)"	"unprognostic (2.62e-1)"	"unprognostic (6.77e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.36e-2)"	"unprognostic (7.33e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.17e-2)"	"prognostic unfavorable (4.13e-4)"	"unprognostic (1.79e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.13e-3)"	"unprognostic (2.97e-3)"	60.2	43.8	30.2	9.4	28.2	2.3	41.9	30.9	32.5	28.9	11.6	27.4	6.8	30.1	15.7	23.2	41.2	45.6	28.0	28.7	38.5	25.3	69.0	37.4	10.5	39.3	44.0	36.4	20.5	4.3	11.2	56.4	32.6	13.8	25.2	13.7	23.6	25.8	7.4	16.1	13.6	33.7	36.9	30.1	14.4	21.6	41.8	6.6	31.2	18.8	6.7	19.8	25.5	32.2	0.0	9.9	1.7	0.0	60.5	48.2	0.3	11.5	15.7	5.0	10.9	1.0	12.6	0.0	12.3	21.0	5.0	1.4	2.4	1.1	2.8	0.1	0.1	5.0	7.9	1.3	28.1	0.1	1.3	29.6	1.6	10.4	3.0	62.1	50.8	0.0	0.2	0.9	7.4	0.3	0.0	0.1	2.1	5.1	3.4	0.0	0.8	0.0	0.1	0.0	0.6	0.0	20.1	0.1	3.9	2.5	0.7	0.6	106.4	10.4	2.6	23.6	2.1	0.3	0.0	0.0	2.6	0.1	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	30.2	28.2	30.9	32.5	28.7	38.5	39.3	44.0	32.6	36.9	41.8	32.2	77.3	3.2	10.3	151.1	1.0	10.8	5.6	0.8	12.0	0.6	10.2	8.6	4.1	25.8	6.0	3.7	0.0	0.7	0.3	27.4	0.0	8.2	1.1	3.6	11.6	63.4	10.3	15.6	1.7	11.6	0.5	57.1	2.0	1.5	1.3	7.0	110.3	44.1	0.8	0.0	0.6	11.7	0.0	7.1	11.8	3.8	42.9	1.1	3.6	40.3	0.1	51.4	0.0	61.3	0.6	4.7	13.3	32.4	2.8	2.6	6.4	28.3	6.4	1.5	0.0	18.9	23.6	1.2	0.9	4.8	8.7	0.8	1.8	20.0	8.1	2.7
PLTP	BPIFE	ENSG00000100979	"Phospholipid transfer protein"	P55058	20	45898621-45912155	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"Hofbauer cells: 1640.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 33.1;eosinophil: 29.7"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 220.8;BEWO: 186.8;HHSteC: 233.2;HSkMC: 302.2;U-87 MG: 326.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB032873	Approved				"Secreted to blood"	NA	NA	9720000000	210000000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"			"CAB032873: AB_2283977"	"unprognostic (1.27e-1)"	"unprognostic (3.50e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.01e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.72e-2)"	"unprognostic (4.19e-2)"	"unprognostic (8.30e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.65e-2)"	"unprognostic (3.87e-1)"	"prognostic unfavorable (9.52e-8)"	"unprognostic (3.04e-2)"	"unprognostic (3.21e-2)"	"unprognostic (1.21e-1)"	"unprognostic (9.68e-2)"	437.9	188.9	107.9	80.5	109.8	20.7	122.6	100.8	142.0	155.4	197.6	76.9	41.6	114.9	72.6	62.0	173.5	182.3	123.4	100.4	119.0	198.9	29.5	97.1	61.3	119.5	152.2	159.5	296.9	22.1	38.5	428.8	126.0	50.7	42.4	4.8	132.1	71.5	24.0	68.0	71.6	181.9	124.7	57.6	89.7	32.3	114.5	229.9	44.4	20.8	21.1	339.7	113.1	118.1	13.8	1.9	94.9	0.1	220.8	66.8	186.8	5.3	16.3	18.5	11.0	78.7	15.9	3.5	151.6	23.6	0.4	154.7	29.2	0.6	8.4	1.8	0.2	28.8	3.3	37.7	233.2	0.0	35.5	302.2	7.7	49.1	0.9	74.1	41.3	3.2	9.5	44.9	6.2	3.9	3.2	123.1	16.9	12.5	74.5	1.3	0.1	1.7	0.5	0.0	10.1	35.4	3.7	110.3	160.9	15.7	1.5	117.2	9.0	46.2	1.1	24.2	0.8	19.7	5.3	5.4	326.4	34.3	7.8	33.1	2.7	29.7	1.6	7.1	1.2	8.7	0.4	1.6	2.5	3.2	0.0	1.0	1.4	4.9	12.6	17.5	0.8	2.7	107.9	109.8	100.8	142.0	100.4	119.0	119.5	152.2	126.0	124.7	114.5	118.1	21.9	0.0	2.3	30.3	3.8	40.7	34.9	53.0	33.0	0.4	9.5	22.6	1.5	5.7	9.6	27.6	0.0	14.8	3.5	0.5	1.9	3.4	16.3	54.6	36.9	27.9	0.0	9.0	0.8	103.2	97.7	256.8	3.6	5.7	0.0	23.4	121.1	2.8	1640.3	3.3	1.4	1.2	12.2	254.0	40.9	24.9	307.9	71.8	35.6	4.7	3.8	13.8	7.2	0.5	0.2	9.9	0.0	199.0	11.8	15.7	0.0	18.2	70.8	1.1	32.9	16.1	35.6	5.7	7.3	24.0	35.8	31.7	3.3	99.5	0.7	18.4
PMP22	"CMT1A, GAS3, HMSNIA, HNPP, Sp110"	ENSG00000109099	"Peripheral myelin protein 22"	Q01453	17	15229773-15272292	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes, Charcot-Marie-Tooth disease, Deafness, Dejerine-Sottas syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Fibroblasts: 404.1;Hofbauer cells: 558.3;Leydig cells: 324.3;Melanocytes: 343.3;Proximal enterocytes: 580.6;Skeletal myocytes: 288.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"basophil: 32.2;eosinophil: 43.0;plasmacytoid DC: 23.8"	"Group enriched"	"Detected in many"	22	"dendritic cells: 23.8;granulocytes: 43.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 383.5;HMC-1: 263.7;SuSa: 333.9;WM-115: 448.8"														"Intracellular and membrane"	NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"				"unprognostic (3.00e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.21e-1)"	"unprognostic (4.63e-1)"	"unprognostic (5.57e-3)"	"unprognostic (2.28e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.74e-1)"	"unprognostic (4.33e-2)"	"unprognostic (7.70e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (1.83e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.08e-2)"	275.6	45.4	113.6	55.1	161.0	4.9	184.5	153.2	140.7	192.2	77.9	212.2	41.7	142.1	36.5	68.2	163.4	106.5	167.6	113.5	129.0	53.5	11.7	208.4	27.8	163.3	144.2	102.9	22.8	10.8	26.3	201.9	159.9	81.2	74.7	6.5	77.5	80.6	252.4	112.7	239.1	122.0	135.0	27.9	96.2	20.7	141.1	17.3	95.3	127.0	21.8	208.9	157.4	216.7	7.0	44.1	61.9	62.2	383.5	167.1	12.6	60.5	68.8	58.7	38.0	48.7	1.1	0.1	7.0	172.3	22.7	0.7	74.0	1.1	15.4	0.2	13.9	4.3	76.7	17.2	201.8	0.1	263.7	126.9	1.1	32.6	1.8	72.1	66.1	2.8	24.5	0.8	33.2	6.1	0.2	2.0	3.5	4.0	74.7	22.0	39.3	0.0	44.6	4.8	0.1	40.6	16.6	0.6	134.2	333.9	0.2	0.5	81.4	12.7	45.7	216.9	62.0	0.5	0.1	0.3	84.7	0.1	448.8	32.2	1.4	43.0	0.0	0.9	0.0	0.0	0.0	0.0	7.6	0.1	0.0	0.1	0.2	0.1	0.2	23.8	0.0	0.9	113.6	161.0	153.2	140.7	113.5	129.0	163.3	144.2	159.9	135.0	141.1	216.7	86.6	28.9	11.5	50.9	2.8	90.1	6.7	6.1	9.6	1.4	43.0	82.7	68.4	4.3	7.4	0.0	0.0	8.8	2.5	9.1	3.9	4.5	17.7	20.1	118.6	148.0	4.8	10.1	3.7	3.3	23.1	404.1	2.6	11.0	119.7	25.0	88.5	0.9	558.3	0.0	1.8	23.8	0.0	23.4	116.8	11.0	324.3	93.0	343.3	29.0	11.8	61.6	0.0	46.8	217.1	1.7	25.2	246.4	1.9	4.9	580.6	0.7	3.0	2.2	230.1	288.8	141.1	3.0	4.8	3.0	103.0	19.0	8.7	49.2	17.9	5.2
PNN	memA	ENSG00000100941	"Pinin, desmosome associated protein"	Q9H307	14	39175183-39183220	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	"Activator, DNA-binding"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001378	Supported		Supported	"Nuclear speckles"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA001378: AB_1079648"	"unprognostic (9.28e-3)"	"unprognostic (5.07e-2)"	"unprognostic (5.46e-2)"	"unprognostic (3.91e-1)"	"unprognostic (7.38e-3)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (5.79e-4)"	"unprognostic (1.65e-2)"	"unprognostic (1.67e-3)"	"unprognostic (3.75e-2)"	"unprognostic (3.70e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (1.51e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.00e-1)"	"unprognostic (4.30e-2)"	57.8	60.6	42.7	68.0	46.6	135.9	60.2	50.6	48.1	82.2	77.8	83.1	56.5	81.5	129.5	74.0	77.0	41.8	54.9	42.9	51.4	87.6	124.8	61.4	87.6	47.5	45.1	84.5	78.5	40.8	90.7	53.8	47.2	83.8	63.1	76.0	65.6	48.4	59.9	67.7	90.5	48.0	43.9	103.6	70.7	58.5	47.1	65.6	88.4	27.0	69.5	69.2	73.3	50.9	152.4	72.0	193.2	94.0	45.5	37.4	141.4	116.6	35.4	82.4	81.2	112.3	232.6	229.1	72.7	53.2	69.7	156.4	153.3	85.5	138.5	105.1	109.0	158.6	243.7	246.0	39.1	201.0	107.6	55.8	73.5	80.1	65.1	115.5	57.3	119.0	149.1	128.2	65.8	122.6	145.5	170.3	126.6	76.2	114.3	188.4	137.0	64.2	65.6	219.3	93.8	50.5	126.2	90.5	69.1	133.2	114.4	117.5	92.7	115.9	90.9	52.7	142.2	102.5	87.8	194.0	59.5	167.3	70.6	9.2	13.7	22.0	17.0	11.4	16.1	22.2	12.1	10.9	11.8	25.5	17.2	16.6	27.6	15.4	16.4	22.1	14.2	6.1	42.7	46.6	50.6	48.1	42.9	51.4	47.5	45.1	47.2	43.9	47.1	50.9	105.6	192.3	125.0	40.8	170.5	126.2	244.5	84.4	153.1	203.1	77.5	87.5	63.4	61.5	164.8	60.7	56.3	113.2	230.9	129.3	35.2	89.4	59.0	155.0	178.9	127.9	136.2	121.1	33.1	58.3	100.0	117.1	101.9	289.4	142.5	273.5	69.3	67.8	62.3	153.1	35.6	96.6	71.2	69.3	72.5	53.7	156.3	93.9	49.8	25.3	89.2	138.0	193.6	41.2	54.6	76.7	126.3	151.6	116.7	172.1	82.9	28.9	111.7	172.4	151.2	166.2	161.3	212.8	149.3	145.0	112.0	99.6	170.6	211.8	123.7	245.4
PNOC	"N/OFQ, NOP, PPNOC"	ENSG00000168081	Prepronociceptin	Q13519	8	28316986-28343355	"Predicted intracellular proteins, Predicted secreted proteins, Transporters"		"Neuropeptide, Neurotransmitter, Opioid peptide"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.3;fallopian tube: 18.2;lymphoid tissue: 25.1"	"Cell type enhanced"	"Detected in some"		"B-cells: 61.5;dendritic cells: 12.6;Inhibitory neurons: 23.3;Melanocytes: 14.2;Plasma cells: 80.4"	"Cancer enriched"	"Detected in many"	8	"ovarian cancer: 32.2"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	20	"memory B-cell: 231.2;naive B-cell: 260.3;plasmacytoid DC: 194.0"	"Group enriched"	"Detected in many"	20	"B-cells: 260.3;dendritic cells: 194.0"	"Group enriched"	"Detected in some"	6	"Daudi: 38.3;Karpas-707: 29.2;RPMI-8226: 11.2;U-698: 23.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA044507, HPA056724"	Enhanced				"Secreted to blood"	NA	NA	12300		"Cluster 19: B-cells - Humoral immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"			"HPA044507: AB_10795043, HPA056724: AB_2683216"	"unprognostic (1.11e-1)"	"unprognostic (1.77e-3)"	"unprognostic (3.53e-2)"	"prognostic unfavorable (2.94e-6)"	"unprognostic (3.71e-2)"	"unprognostic (5.16e-5)"	"unprognostic (1.03e-1)"	"unprognostic (1.50e-1)"	"unprognostic (7.81e-4)"	"unprognostic (1.48e-1)"	"unprognostic (1.66e-1)"	"unprognostic (9.99e-3)"	"unprognostic (7.57e-9)"	"unprognostic (2.19e-2)"	"unprognostic (5.45e-1)"	"unprognostic (3.44e-1)"	"unprognostic (1.40e-1)"	0.2	0.8	5.4	9.9	5.1	2.7	0.6	1.3	10.8	0.2	1.3	2.9	4.3	0.1	0.0	0.6	18.2	1.1	0.1	2.9	9.9	0.7	0.2	1.0	25.1	10.4	6.3	0.4	0.0	0.0	0.0	0.0	9.9	0.2	1.5	0.0	1.6	0.1	0.0	0.1	5.8	0.5	14.3	14.4	3.2	0.6	4.3	2.7	0.4	0.0	23.6	3.7	0.2	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	38.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	29.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	11.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	4.0	4.4	23.0	0.1	0.1	0.0	0.2	11.5	2.3	0.2	7.7	0.1	231.2	0.2	0.1	1.1	260.3	0.1	0.1	1.3	1.2	3.2	194.0	0.5	11.1	5.4	5.1	1.3	10.8	2.9	9.9	10.4	6.3	9.9	14.3	4.3	3.0	0.1	0.0	1.9	1.3	61.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	3.9	0.1	0.0	0.1	0.0	0.0	0.6	0.0	0.0	0.2	0.5	0.0	0.0	0.0	1.4	0.4	0.2	0.0	23.3	0.1	0.0	0.0	0.3	2.8	0.3	1.7	14.2	1.0	3.0	0.0	1.0	0.0	0.9	0.1	0.0	0.0	80.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.8	0.0	0.0	0.0	1.1	0.0	0.3	0.5
POM121	"DKFZP586G1822, DKFZP586P2220, KIAA0618, POM121A"	ENSG00000196313	"POM121 transmembrane nucleoporin"	Q96HA1	7	72879365-72951440	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 98.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB003710, HPA043809, HPA049817"	Approved		Enhanced	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"CAB003710: , HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (2.33e-1)"	"unprognostic (3.05e-2)"	"unprognostic (9.71e-2)"	"unprognostic (5.86e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.40e-1)"	"unprognostic (6.38e-2)"	"unprognostic (7.07e-3)"	"unprognostic (3.08e-2)"	"unprognostic (3.84e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (2.40e-1)"	25.4	20.4	10.3	18.8	10.1	44.7	21.0	7.2	14.3	18.3	3.4	19.5	21.6	19.6	9.4	20.1	18.7	13.6	16.0	11.9	9.7	16.6	23.5	17.4	21.3	6.8	8.5	23.8	25.5	16.1	21.4	17.0	6.4	19.2	12.1	17.5	19.3	11.2	25.7	21.6	22.8	13.0	2.3	22.9	21.8	18.7	8.8	17.8	20.0	16.0	17.1	18.8	18.1	9.1	49.6	35.4	43.5	98.0	23.0	18.8	36.0	34.6	29.2	33.8	29.3	63.0	30.6	67.7	11.0	30.1	37.5	37.0	43.5	33.6	37.6	59.2	86.5	50.6	36.6	42.4	23.5	106.1	61.8	24.8	23.3	44.9	41.0	21.9	25.5	38.5	141.2	49.3	33.7	37.8	63.7	67.0	45.5	27.4	42.3	57.4	33.8	57.1	17.2	42.8	61.7	54.3	30.3	57.3	31.1	28.8	48.1	55.0	36.2	60.2	36.8	48.0	70.5	58.8	58.8	96.0	35.2	66.6	61.0	0.0	0.8	1.4	1.7	0.5	1.0	1.0	1.1	1.3	0.9	1.1	0.9	1.4	0.9	1.6	1.4	1.5	0.6	1.1	10.3	10.1	7.2	14.3	11.9	9.7	6.8	8.5	6.4	2.3	8.8	9.1	31.8	38.5	28.9	33.0	28.6	25.2	10.1	17.5	29.0	34.6	19.5	19.7	4.4	20.0	19.9	18.4	98.0	17.1	30.6	19.7	5.9	12.3	13.2	14.6	24.7	18.3	18.0	30.7	55.6	17.1	13.2	19.2	32.1	21.3	16.5	31.1	17.2	24.9	16.2	40.4	58.9	21.7	16.2	18.9	21.7	6.3	14.9	23.3	19.6	23.4	13.8	18.2	32.0	30.2	38.6	21.8	14.1	17.7	37.6	22.2	19.1	8.4	17.6	26.6	13.1	27.0	17.6	19.2	13.1	29.6	31.0	19.4	27.9	24.7	23.2	21.9
POM121C		ENSG00000272391	"POM121 transmembrane nucleoporin C"	A8CG34	7	75416786-75486299	"Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											"HPA043809, HPA049817"	Approved		Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Nuclear membrane"		"HPA043809: AB_2678680, HPA049817: AB_2680896"	"unprognostic (9.11e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.51e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.18e-1)"	"unprognostic (4.27e-2)"	"unprognostic (4.97e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-3)"	"unprognostic (2.03e-1)"	"unprognostic (5.06e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.00e-2)"	14.9	14.0	3.5	15.5	3.8	28.9	14.2	8.0	9.3	13.8	2.4	14.2	12.0	16.6	9.0	15.9	14.1	12.0	13.9	7.0	4.9	13.1	13.2	12.9	18.2	2.2	3.1	18.7	18.1	16.8	13.4	16.4	2.0	13.0	12.9	26.3	14.3	11.5	19.6	17.7	14.0	15.1	0.3	15.5	14.0	12.5	5.2	17.6	16.7	10.7	19.9	14.3	14.3	5.5	41.8	34.1	46.3	89.0	17.1	19.0	30.4	29.7	27.3	23.7	22.8	41.2	26.5	73.4	12.0	32.6	37.2	36.7	39.6	36.7	38.9	49.9	55.1	36.4	39.6	27.8	22.5	97.0	49.5	16.2	22.8	36.3	26.8	34.5	24.6	29.9	103.8	39.8	38.9	41.8	59.5	49.3	36.9	32.0	38.4	53.0	30.7	37.6	13.1	56.0	51.4	67.4	34.3	54.0	23.8	41.5	47.1	34.2	27.4	57.4	30.6	42.2	62.3	42.4	54.4	88.2	37.3	49.1	53.9	0.2	0.4	0.5	1.1	0.5	1.0	0.8	0.9	0.3	0.3	1.0	0.5	0.6	1.2	0.9	0.3	1.1	0.2	0.6	3.5	3.8	8.0	9.3	7.0	4.9	2.2	3.1	2.0	0.3	5.2	5.5	23.1	35.3	26.2	29.4	27.8	18.0	11.8	13.4	33.6	30.7	21.3	23.4	12.6	21.5	21.4	12.9	68.8	13.4	27.2	12.3	5.9	11.8	2.1	14.2	21.3	20.7	28.7	33.9	59.2	17.1	10.2	21.0	31.6	18.3	7.6	28.6	16.8	15.1	12.0	25.2	60.2	17.4	14.2	16.4	15.8	3.8	18.0	21.7	7.2	35.6	17.1	21.3	37.0	28.1	45.6	18.8	8.0	15.4	37.8	24.6	10.0	9.6	18.7	29.4	13.1	26.1	17.4	19.2	12.4	32.9	18.5	17.0	34.0	22.0	17.0	19.7
PON1	"ESA, PON"	ENSG00000005421	"Paraoxonase 1"	P27169	7	95297676-95324532	"Cancer-related genes, Candidate cardiovascular disease genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Hydrolase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	103	"liver: 531.8"	"Cell type enriched"	"Detected in some"	23	"Hepatocytes: 440.0"	"Cancer enriched"	"Detected in some"	78	"liver cancer: 97.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA001610	Approved				"Secreted to blood"	NA	NA	96000000000	17000000000		"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA001610: AB_1079656"	"unprognostic (2.02e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.04e-1)"	"unprognostic (3.54e-2)"	"unprognostic (2.70e-1)"		"prognostic favorable (7.24e-7)"	"unprognostic (2.24e-1)"	"unprognostic (1.95e-1)"	"unprognostic (9.02e-3)"	"unprognostic (1.76e-3)"	"unprognostic (3.97e-2)"	"unprognostic (6.74e-9)"	"unprognostic (1.09e-3)"	"unprognostic (2.29e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.54e-3)"	0.0	4.1	0.6	0.0	0.5	0.0	0.1	0.6	0.6	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.1	1.1	0.0	0.5	0.6	0.2	531.8	0.1	0.0	0.5	0.5	0.6	0.1	0.0	0.8	0.0	0.5	0.3	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.3	0.6	5.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.5	0.6	0.6	0.5	0.6	0.5	0.5	0.5	0.3	0.6	0.6	0.0	0.0	1.5	7.2	1.1	0.0	0.0	0.0	0.0	0.6	0.2	0.3	0.6	18.6	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.4	3.0	13.5	0.2	0.2	0.0	0.2	0.0	0.3	0.0	0.1	8.9	440.0	0.0	0.0	0.2	0.2	0.0	13.4	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.4	0.0	1.6	0.5	0.4	0.2	0.0	0.1	0.0	0.6	0.5	0.3	0.1
PORCN	"DHOF, MG61, por, PORC, PPN"	ENSG00000102312	"Porcupine O-acyltransferase"	Q9H237	X	48508962-48520814	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Acyltransferase, Transferase"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 37.3"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 68.5;Club cells: 44.2;Pancreatic endocrine cells: 36.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 176.9;LHCN-M2: 60.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049215, HPA058413"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA049215: , HPA058413: AB_2683711"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.98e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.09e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.35e-1)"	5.2	37.3	8.7	3.3	8.3	2.9	4.7	7.0	10.6	9.1	4.5	6.3	2.3	7.1	2.1	10.8	5.8	4.6	11.5	11.2	7.0	3.7	1.5	4.6	3.6	7.1	6.6	4.3	3.5	9.8	4.7	2.4	7.2	4.5	1.6	7.4	4.9	11.6	7.6	5.9	3.7	4.6	6.2	4.5	5.2	5.1	7.7	2.3	6.3	3.5	3.3	6.2	7.1	7.8	13.1	15.6	3.8	26.6	15.9	9.4	1.6	3.7	7.7	5.8	3.9	1.8	19.7	1.1	15.9	8.3	6.5	17.3	5.5	176.9	1.8	8.3	1.8	2.2	9.0	3.8	23.4	2.0	22.5	12.2	20.6	16.8	36.0	13.5	5.3	6.4	1.0	12.1	60.8	3.7	2.0	2.8	4.9	4.0	10.4	4.0	4.6	20.5	9.8	5.1	4.2	6.5	30.8	5.9	5.9	2.5	6.7	1.0	3.3	15.0	7.8	36.4	6.8	10.4	6.3	1.5	43.0	4.9	8.7	16.9	5.5	6.8	10.8	4.9	8.5	3.2	7.1	9.0	6.8	3.5	4.7	7.1	1.1	8.4	4.3	3.6	4.9	4.7	8.7	8.3	7.0	10.6	11.2	7.0	7.1	6.6	7.2	6.2	7.7	7.8	5.4	6.4	2.8	5.2	3.8	4.0	5.3	68.5	8.0	15.4	2.9	4.6	3.4	4.3	44.2	16.5	18.8	0.3	7.3	0.8	1.9	6.9	0.2	13.4	3.5	5.7	6.0	1.3	7.8	9.9	1.3	5.0	3.6	17.8	5.7	3.9	5.0	0.7	3.5	8.4	7.6	2.9	12.2	2.7	4.5	0.1	5.6	2.5	3.6	2.8	3.1	10.1	10.3	6.0	2.8	36.4	1.8	4.1	6.3	2.5	0.2	0.7	8.7	15.5	6.6	4.0	4.8	2.9	4.9	4.2	3.8	8.2	6.9	7.5	1.5	6.6
PRAF2	"JM4, Yip6a"	ENSG00000243279	"PRA1 domain family member 2"	O60831	X	49071161-49074002	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 163.4"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA002859, HPA005504, CAB011655"	Enhanced		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"	"Endoplasmic reticulum"	Vesicles	"CAB011655: , HPA002859: AB_1079672, HPA005504: AB_2667340"	"unprognostic (1.50e-1)"	"prognostic favorable (7.42e-4)"	"unprognostic (1.17e-2)"	"unprognostic (1.32e-2)"	"unprognostic (4.29e-1)"	"unprognostic (3.67e-1)"	"prognostic unfavorable (1.66e-6)"	"prognostic favorable (2.81e-4)"	"unprognostic (6.10e-2)"	"unprognostic (3.77e-1)"	"prognostic favorable (4.88e-6)"	"unprognostic (8.39e-3)"	"prognostic unfavorable (5.83e-6)"	"unprognostic (4.96e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	26.5	38.7	66.9	15.6	67.3	8.2	23.2	67.2	82.5	43.2	63.8	32.3	6.1	51.5	163.4	11.7	36.0	14.8	32.0	66.7	72.1	26.3	11.5	29.7	12.8	69.4	73.8	37.7	10.5	29.2	74.5	11.4	73.9	26.4	11.1	21.6	13.9	35.8	12.1	14.7	17.8	43.6	66.1	21.7	21.9	28.2	71.1	21.5	27.7	9.0	14.9	33.1	26.0	69.8	17.0	35.0	40.0	51.5	140.4	84.7	5.0	59.1	61.9	39.7	43.2	2.0	5.3	1.7	14.0	129.3	32.6	15.5	1.6	32.3	43.6	31.3	45.4	13.4	43.0	1.8	143.2	8.8	25.0	108.3	27.0	75.0	54.0	80.9	61.6	41.3	2.1	4.6	69.5	31.4	56.6	10.6	22.5	8.3	2.3	30.8	21.9	3.8	60.0	5.0	26.6	66.3	49.5	25.5	35.2	35.1	25.0	6.2	37.8	30.1	39.6	65.6	17.5	71.7	19.8	13.4	72.7	15.3	48.1	47.0	13.0	18.5	38.6	15.0	43.2	32.0	41.6	33.9	14.9	30.2	36.7	40.1	34.1	39.0	11.2	5.9	68.4	26.0	66.9	67.3	67.2	82.5	66.7	72.1	69.4	73.8	73.9	66.1	71.1	69.8	21.5	12.8	10.0	7.5	8.7	7.6	14.9	34.8	11.4	23.1	8.0	10.7	5.8	11.5	16.3	11.0	12.5	3.3	13.2	2.2	11.7	16.7	3.4	6.8	31.6	30.9	10.2	5.2	5.8	5.7	13.4	29.9	4.1	9.2	15.9	13.4	33.5	3.6	6.1	16.8	7.0	4.7	40.7	5.7	11.3	6.0	38.2	6.6	14.2	5.6	5.6	29.2	16.5	3.5	9.9	4.1	0.8	41.3	10.5	10.1	1.5	18.5	17.7	8.6	19.7	13.2	33.4	14.7	4.5	5.0	7.4	9.7	17.5	36.3	1.5	9.3
PREB	SEC12	ENSG00000138073	"Prolactin regulatory element binding"	Q9HCU5	2	27130756-27134666	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transcription, Transcription regulation, Transport"	"Activator, DNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 101.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RPMI-8226: 369.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013582, HPA014133"	Uncertain		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"HPA013582: AB_1855694, HPA014133: AB_1855695"	"unprognostic (2.32e-1)"	"unprognostic (2.11e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.21e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.44e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.24e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.33e-3)"	"unprognostic (5.13e-2)"	"unprognostic (4.14e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.28e-2)"	45.2	46.0	40.0	28.6	41.4	16.5	39.5	41.5	47.9	38.7	37.3	34.0	27.7	57.3	104.8	41.0	46.1	25.9	62.5	42.0	42.6	49.0	137.2	33.4	33.3	44.2	41.4	49.9	73.9	30.8	42.8	22.6	41.4	42.7	27.7	16.7	60.0	34.6	134.5	29.6	36.0	40.7	41.8	51.5	42.5	35.1	42.1	31.0	30.3	112.0	38.3	34.9	32.3	42.6	63.5	62.2	35.4	56.5	84.8	30.2	65.8	44.6	46.5	63.5	44.4	59.1	38.7	78.3	45.9	44.5	68.7	35.3	70.3	56.3	41.3	58.7	63.2	64.2	30.7	128.3	111.1	74.3	58.2	28.8	67.5	60.2	68.2	34.2	44.7	61.4	48.0	68.3	57.6	73.4	69.2	56.5	37.2	81.5	64.8	63.9	70.9	369.2	46.9	33.2	79.8	42.8	42.8	88.3	65.7	36.1	39.4	125.3	25.0	33.9	48.7	29.8	51.0	150.5	67.9	95.1	56.4	83.4	65.4	73.7	61.0	103.3	50.4	52.2	53.7	44.5	42.1	50.2	62.5	43.9	40.1	41.7	25.4	65.0	55.8	74.1	50.9	63.9	40.0	41.4	41.5	47.9	42.0	42.6	44.2	41.4	41.4	41.8	42.1	42.6	9.7	16.0	12.7	5.5	33.5	18.0	9.8	14.3	9.1	12.2	21.8	19.0	14.2	20.0	10.6	20.2	12.5	45.3	22.8	17.3	35.2	29.8	5.9	5.8	14.7	10.8	8.4	30.7	7.4	35.1	60.3	18.2	28.1	11.9	23.6	13.1	16.1	36.1	38.0	6.7	7.7	28.5	20.3	19.8	16.3	9.1	23.6	17.9	19.6	8.4	16.6	25.3	24.7	9.5	9.1	30.9	20.4	44.8	101.5	18.4	30.0	29.2	3.8	10.9	32.9	10.2	21.0	32.1	44.8	18.7	17.3	77.4	22.6	16.2	22.3	12.9
PRF1	"HPLH2, P1, PFP"	ENSG00000180644	"Perforin 1"	P14222	10	70597348-70602759	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Cytolysis		"Cancer-related genes, Disease variant, Familial hemophagocytic lymphohistiocytosis"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 28.6;lung: 16.5;lymphoid tissue: 49.4"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 542.1;NK-cells: 1231.7;T-cells: 265.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"gdT-cell: 900.4;MAIT T-cell: 628.8;memory CD8 T-cell: 499.1;naive CD8 T-cell: 313.0;NK-cell: 656.8"	"Group enriched"	"Detected in all"	50	"NK-cells: 656.8;T-cells: 900.4"	"Cell line enriched"	"Detected in some"	11	"HDLM-2: 240.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"CAB002436, HPA037940"	Approved		Approved	Cytosol	"Intracellular and membrane"	NA	NA		2100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 2: Immune cells - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"CAB002436: AB_563955, HPA037940: AB_2675747"	"unprognostic (6.11e-3)"	"unprognostic (1.26e-2)"	"unprognostic (1.71e-1)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.87e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (6.98e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.44e-3)"	"unprognostic (1.69e-2)"	"unprognostic (5.22e-2)"	"unprognostic (1.45e-1)"	"prognostic unfavorable (1.08e-5)"	"unprognostic (7.38e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.97e-3)"	"unprognostic (5.22e-3)"	5.0	2.0	0.7	7.6	0.7	28.6	2.7	0.7	1.3	1.3	1.3	2.2	2.3	3.5	1.1	1.9	1.9	4.2	2.2	0.6	0.6	1.7	6.3	16.5	20.3	1.4	0.7	1.0	1.0	0.5	0.9	2.7	1.0	1.5	1.4	0.0	2.3	1.2	2.6	0.9	5.2	2.0	1.3	49.4	4.7	0.6	1.0	5.8	2.6	1.5	4.9	3.8	1.9	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	240.1	0.0	1.4	0.0	7.4	0.0	0.3	11.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.1	22.2	0.0	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.2	0.0	0.1	0.0	5.2	1.9	0.9	900.4	1.7	628.8	4.0	125.8	499.1	2.0	3.5	52.1	313.0	15.4	656.8	2.6	2.9	108.8	587.5	0.7	0.7	0.7	1.3	0.6	0.6	1.4	0.7	1.0	1.3	1.0	1.0	3.1	3.2	13.6	0.0	4.4	0.4	0.1	0.0	0.6	0.0	0.5	0.5	0.8	1.5	2.5	0.0	0.0	0.2	542.1	0.1	0.0	0.3	0.0	0.2	0.3	1.9	0.0	19.0	0.0	0.0	0.1	2.1	7.7	0.4	8.8	0.0	10.8	2.7	0.1	0.0	0.0	0.0	0.0	7.8	2.3	0.0	0.0	5.7	0.0	1.9	7.4	0.0	1231.7	0.0	0.1	0.0	0.0	0.0	88.5	0.1	0.1	1.6	1.5	0.0	0.0	1.1	0.8	0.0	0.0	0.5	0.9	0.7	265.4	0.0	0.1	0.0
PRKAA2	"AMPK, AMPKa2, PRKAA"	ENSG00000162409	"Protein kinase AMP-activated catalytic subunit alpha 2"	P54646	1	56645314-56715335	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Autophagy, Biological rhythms, Cholesterol biosynthesis, Cholesterol metabolism, Fatty acid biosynthesis, Fatty acid metabolism, Lipid biosynthesis, Lipid metabolism, Steroid biosynthesis, Steroid metabolism, Sterol biosynthesis, Sterol metabolism, Transcription, Transcription regulation, Wnt signaling pathway"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.8;skeletal muscle: 38.7;tongue: 36.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 328.5;Excitatory neurons: 109.4;Inhibitory neurons: 119.0;Oligodendrocyte precursor cells: 84.9;Rod photoreceptor cells: 115.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 5.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 14.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044540	Approved		Supported	"Nuclear speckles,Golgi apparatus"		NA	NA				"Cluster 38: Heart - Muscle contraction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Nuclear speckles"	"Golgi apparatus"	"HPA044540: AB_2678977"	"unprognostic (4.17e-3)"	"unprognostic (1.62e-2)"	"unprognostic (4.17e-1)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (9.35e-2)"	"unprognostic (1.92e-3)"	"prognostic unfavorable (5.30e-4)"	"unprognostic (7.30e-2)"	"unprognostic (3.94e-1)"	"unprognostic (1.82e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.64e-2)"	"prognostic favorable (4.95e-5)"	"unprognostic (1.30e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.57e-2)"	"unprognostic (1.85e-1)"	1.4	1.4	2.0	0.5	3.5	0.0	3.3	3.0	3.5	1.4	4.1	5.0	0.5	1.8	1.1	4.7	2.7	1.9	40.8	3.9	2.1	13.6	0.7	1.4	0.1	0.9	1.3	1.5	1.8	8.3	1.3	0.5	0.9	3.8	1.4	13.5	4.3	2.6	38.7	0.7	1.3	3.1	0.3	1.3	2.2	1.1	1.3	0.4	3.3	36.4	0.1	1.8	1.3	1.5	0.0	3.8	2.1	0.0	0.7	0.5	2.3	1.9	1.5	2.5	4.3	3.9	4.9	0.0	0.6	0.6	7.5	0.1	8.0	0.0	7.1	0.0	8.8	0.0	7.0	5.5	0.0	0.0	0.1	0.6	0.0	3.5	0.3	5.8	0.8	2.0	0.0	0.0	1.1	0.1	0.0	0.0	5.6	0.0	5.5	0.0	0.0	0.0	14.1	1.3	2.0	5.5	6.0	0.1	0.0	6.0	3.3	0.0	0.0	1.5	2.3	2.8	6.6	0.0	0.0	0.0	4.5	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	3.5	3.0	3.5	3.9	2.1	0.9	1.3	0.9	0.3	1.3	1.5	1.1	9.6	4.8	30.7	2.0	0.9	8.0	6.7	2.2	42.0	19.4	9.5	328.5	24.3	14.3	49.7	50.1	1.0	0.2	6.1	54.8	9.5	3.9	14.4	2.9	10.3	14.4	0.0	109.4	4.8	0.4	15.3	5.1	17.4	2.5	11.7	9.7	8.1	0.1	26.9	119.0	6.3	8.2	0.0	1.6	4.8	6.8	1.4	5.4	18.7	0.0	18.6	0.0	84.9	20.4	6.2	3.0	29.3	0.0	21.2	0.2	82.4	10.7	115.5	6.6	24.5	17.2	7.2	3.7	17.7	0.4	0.4	1.2	5.3	6.1	13.4
PRKCB	"PKCβ, PKCB, PRKCB1, PRKCB2"	ENSG00000166501	"Protein kinase C beta"	P05771	16	23835983-24220611	"Cancer-related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Adaptive immunity, Apoptosis, Immunity, Transcription, Transcription regulation"	"Chromatin regulator, Kinase, Serine/threonine-protein kinase, Transferase"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 84.0;lymphoid tissue: 47.2"	"Cell type enhanced"	"Detected in many"		"B-cells: 185.1;Bipolar cells: 208.6;Excitatory neurons: 877.7;Inhibitory neurons: 320.2;Kupffer cells: 221.9"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	95	"amygdala: 28.9;basal ganglia: 53.9;cerebral cortex: 84.0;hippocampal formation: 35.3;white matter: 36.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"HEL: 161.8;HMC-1: 154.8;K-562: 234.9;THP-1: 72.7;U-937: 64.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB003843, HPA048321, HPA054203"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA		380000	"Cluster 6: Non-specific - Transcription"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoplasm	Cytosol	"CAB003843: AB_562197, HPA048321: AB_2680357, HPA054203: AB_2682416"	"unprognostic (1.53e-3)"	"unprognostic (4.53e-4)"	"unprognostic (2.52e-3)"	"unprognostic (3.07e-2)"	"unprognostic (1.72e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.67e-3)"	"unprognostic (3.19e-2)"	"unprognostic (1.79e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.17e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.12e-2)"	"unprognostic (3.28e-1)"	"unprognostic (4.95e-2)"	4.4	1.6	28.9	30.8	53.9	32.1	1.5	0.5	84.0	4.2	0.0	9.7	5.9	3.8	0.6	3.5	3.8	4.4	1.1	35.3	0.0	2.8	4.2	7.8	47.1	0.0	0.0	0.6	1.0	0.2	1.4	2.7	0.0	7.3	5.1	18.2	1.5	10.2	0.8	5.5	19.4	7.2	0.0	46.2	5.7	8.4	0.0	47.2	4.5	1.0	40.0	8.7	1.7	36.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.5	1.0	0.0	0.3	0.5	0.5	0.0	0.0	0.0	3.2	161.8	7.5	0.0	0.0	23.6	154.8	0.0	0.7	0.0	0.0	0.0	0.0	27.3	234.9	0.6	0.0	0.0	52.1	51.4	1.5	0.0	0.0	49.0	0.4	9.5	0.5	14.1	27.2	0.0	0.2	0.2	2.4	0.8	0.0	72.7	1.1	0.0	0.3	0.1	0.0	4.1	0.0	1.4	0.2	64.4	0.3	39.3	13.3	27.8	24.8	20.0	11.5	44.2	15.9	29.9	11.3	40.0	13.0	32.0	39.1	39.9	28.6	33.8	12.7	15.5	28.9	53.9	0.5	84.0	35.3	0.0	0.0	0.0	0.0	0.0	0.0	36.6	1.1	3.2	4.9	21.5	185.1	6.0	4.1	0.1	0.6	208.6	0.9	0.8	2.0	2.8	1.8	1.8	2.1	0.2	166.3	1.4	0.0	0.0	26.5	0.1	0.1	4.1	0.0	26.3	877.7	0.2	0.3	1.7	1.5	0.1	71.5	1.9	11.4	3.1	50.5	79.1	320.2	1.5	0.0	221.9	20.5	11.7	0.0	100.9	3.6	110.5	154.4	10.8	120.5	102.1	132.5	0.0	9.6	0.4	61.8	1.0	6.7	0.8	1.6	9.9	0.0	4.4	1.6	3.4	3.6	0.5	14.3	0.8	68.1	0.2	3.8	4.5
PRND	"dJ1068H6.4, DOPPEL, DPL, PrPLP"	ENSG00000171864	"Prion like protein doppel"	Q9UKY0	20	4721909-4728460	"Predicted membrane proteins, Transporters"	Fertilization	Prion		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	12	"choroid plexus: 31.3;testis: 70.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.3;Endothelial cells: 17.7;Late spermatids: 11.2;Spermatocytes: 4.7"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.6"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA043373	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA043373: AB_2678450"	"unprognostic (1.69e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (8.46e-2)"	"unprognostic (3.40e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.01e-1)"	"unprognostic (6.41e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.56e-1)"	"unprognostic (3.10e-1)"	"unprognostic (5.85e-2)"	"unprognostic (2.02e-3)"	"unprognostic (6.11e-2)"	"unprognostic (2.86e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.63e-3)"	0.2	0.0	0.1	0.1	0.1	0.1	0.2	0.7	0.2	0.1	31.3	1.9	0.1	4.1	0.0	0.1	0.0	1.2	0.2	1.0	0.0	0.0	0.0	0.1	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.1	0.2	0.2	0.4	0.1	0.0	0.0	0.1	0.2	0.0	1.2	0.0	0.1	0.1	70.9	0.6	0.1	0.1	0.1	0.3	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.2	1.0	0.0	0.3	0.0	0.2	0.0	0.6	0.1	5.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.5	0.1	0.2	17.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	11.2	2.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.3	4.7	1.9	0.0	0.0	0.0	0.1	1.3	0.0	0.2
PRNP	"AltPrP, CD230, CJD, GSS, PRIP, PRP"	ENSG00000171867	"Prion protein"	P04156	20	4686350-4701590	"CD markers, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"	Prion	"Amyloidosis, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 412.6;Basal squamous epithelial cells: 369.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	9	"basophil: 875.9"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 875.9"	"Cell line enhanced"	"Detected in many"		"WM-115: 1039.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042754, HPA043398"	Enhanced		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	Yes		5100000	"Cluster 38: Basophils - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 41: Macrophages - Immune response"	"Nuclear membrane, Cytosol"	Vesicles	"HPA042754: AB_10964203, HPA043398: AB_2678461"	"unprognostic (1.50e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (2.96e-4)"	"prognostic unfavorable (4.64e-4)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.94e-2)"	"prognostic unfavorable (7.41e-5)"	"unprognostic (7.60e-3)"	"unprognostic (2.50e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (6.75e-2)"	"unprognostic (7.28e-3)"	"unprognostic (3.37e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.69e-2)"	87.0	92.4	283.8	52.4	308.4	83.7	106.7	255.1	385.9	135.4	415.8	184.2	37.1	125.5	59.1	79.2	79.9	110.1	197.5	315.6	244.8	132.8	79.7	79.2	59.8	262.8	260.8	163.7	41.5	62.8	83.8	66.9	270.1	146.1	70.5	178.6	60.3	148.2	64.0	95.4	47.4	140.8	265.0	75.2	61.6	68.1	302.5	47.9	89.1	74.0	60.0	124.9	83.4	292.8	226.4	141.6	41.7	64.2	329.6	199.9	36.6	363.4	527.6	175.5	177.7	50.0	171.5	40.9	79.2	727.9	391.8	508.8	45.9	498.3	326.2	31.8	39.0	0.2	19.6	193.8	402.0	72.8	16.5	177.5	711.9	701.8	583.9	257.0	152.8	28.6	22.8	142.9	205.1	45.7	28.8	46.2	33.1	99.8	266.4	33.9	110.0	38.3	88.7	40.3	49.2	7.0	98.9	144.3	554.1	56.4	30.2	38.8	224.5	282.9	127.1	158.6	296.1	63.1	129.5	132.9	226.8	51.9	1039.0	875.9	74.1	5.4	67.3	60.9	100.7	25.1	56.9	55.8	62.9	25.6	33.5	40.1	4.6	23.6	50.4	24.6	72.8	72.7	283.8	308.4	255.1	385.9	315.6	244.8	262.8	260.8	270.1	265.0	302.5	292.8	44.9	80.1	45.4	120.2	85.3	412.6	211.8	132.5	369.3	265.4	60.8	103.0	257.7	32.9	68.2	33.1	116.7	7.7	71.8	2.6	11.7	58.1	6.0	14.1	73.2	66.7	29.9	31.8	125.5	14.7	6.3	177.4	14.8	18.2	173.0	25.5	41.0	36.2	63.6	45.4	170.8	5.4	40.7	219.1	200.4	13.6	143.2	126.3	168.9	59.0	54.5	142.4	42.2	95.0	158.8	18.7	4.5	170.0	47.0	120.3	2.2	84.0	38.1	99.0	13.1	73.0	82.3	36.6	4.5	81.6	284.4	14.4	107.2	10.3	8.8	122.6
PROM1	"AC133, CD133, CORD12, MCDR2, PROML1, RP41, STGD4"	ENSG00000007062	"Prominin 1"	O43490	4	15963076-16084378	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa, Stargardt disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"retina: 272.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 581.7;Respiratory ciliated cells: 144.8;Rod photoreceptor cells: 311.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 37.2;CACO-2: 70.6;CAPAN-2: 28.9;EFO-21: 62.2;NTERA-2: 97.4;RPTEC TERT1: 91.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA004922, CAB011525, HPA031053"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB011525: AB_470302, HPA004922: AB_1846238, HPA031053: AB_2673713"	"unprognostic (6.33e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.16e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.18e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-2)"	"unprognostic (9.06e-2)"	"prognostic favorable (2.56e-5)"	"unprognostic (2.16e-2)"	"unprognostic (1.02e-1)"	"unprognostic (9.38e-2)"	"unprognostic (1.17e-1)"	0.3	0.3	4.1	6.2	3.0	4.0	27.7	2.7	3.5	44.9	2.0	30.7	12.4	6.0	4.3	5.1	5.4	30.9	6.7	3.3	2.8	20.9	1.8	3.1	0.0	3.8	4.3	0.1	14.4	0.0	0.1	30.1	3.6	2.8	16.7	272.9	57.9	7.1	1.0	0.9	22.9	3.5	2.8	0.2	24.8	8.0	5.0	0.1	4.8	0.0	0.1	4.2	0.2	3.1	0.0	0.0	37.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	70.6	28.9	0.6	62.2	0.0	0.0	0.1	7.3	0.0	0.1	0.3	0.0	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	97.4	0.0	0.0	1.4	0.1	0.0	91.1	0.1	12.0	3.6	0.0	2.4	1.9	3.5	0.6	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	3.0	2.7	3.5	3.3	2.8	3.8	4.3	3.6	2.8	5.0	3.1	0.2	3.2	4.8	1.3	0.3	0.0	0.1	7.2	0.0	14.8	38.2	30.0	8.6	31.5	29.9	82.8	581.7	0.6	1.0	39.3	0.0	64.1	31.4	71.1	1.7	5.1	44.4	2.1	0.9	15.5	0.1	4.4	31.6	14.8	0.0	3.8	0.7	0.1	0.1	10.1	5.4	15.0	34.6	0.0	0.0	44.3	3.1	0.7	0.0	27.2	0.6	47.5	0.0	45.8	1.2	38.2	28.3	6.4	0.4	1.5	18.8	3.6	144.8	311.3	0.0	0.8	3.1	2.1	1.0	0.7	0.0	0.1	0.7	0.3	26.0	4.1
PROM2		ENSG00000155066	"Prominin 2"	Q8N271	2	95274449-95291308	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 88.1;skin 1: 60.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 37.1;Club cells: 39.9;Collecting duct cells: 33.1;Squamous epithelial cells: 37.2;Urothelial cells: 37.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 79.5;CAPAN-2: 135.9;HaCaT: 73.2;hTCEpi: 78.4;MCF7: 62.1;RT4: 83.8;SK-BR-3: 117.7"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			"CAB046005, HPA063728"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"	"Cell Junctions"	"CAB046005: AB_2284371, HPA063728: AB_2685104"	"prognostic unfavorable (2.16e-4)"	"unprognostic (1.60e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.12e-1)"	"prognostic unfavorable (2.90e-4)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (1.55e-6)"	"unprognostic (1.46e-2)"	"unprognostic (4.59e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.50e-2)"	0.7	0.3	1.1	1.5	1.3	0.3	10.3	1.0	2.1	16.6	0.2	11.4	10.5	1.9	27.9	88.1	5.5	27.0	1.1	0.9	0.6	32.4	0.8	1.7	0.1	1.4	0.7	1.1	10.2	25.5	1.5	4.5	1.2	24.7	9.8	0.4	35.2	27.7	0.7	60.0	4.8	0.8	0.3	0.6	26.3	0.6	1.4	2.0	11.9	0.2	7.9	25.7	37.9	2.1	79.5	0.1	0.2	0.8	0.3	0.1	38.5	0.1	0.2	0.3	0.4	0.8	135.9	0.0	0.0	0.1	0.1	73.2	0.0	42.4	0.4	0.2	0.1	0.0	0.5	0.0	0.0	0.0	0.3	0.0	78.4	0.1	0.4	1.9	0.0	0.1	0.0	0.1	0.0	62.1	0.4	0.5	0.1	3.7	0.5	0.2	0.0	0.1	0.2	83.8	0.6	0.2	0.0	117.7	0.1	0.9	37.2	0.1	0.0	0.2	0.4	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	1.3	1.0	2.1	0.9	0.6	1.4	0.7	1.2	0.3	1.4	2.1	0.4	3.2	4.2	1.3	0.1	6.6	25.2	27.6	14.2	0.4	29.1	14.9	1.7	37.1	39.9	33.1	4.2	19.0	0.1	8.0	11.7	15.6	0.5	2.7	0.6	0.9	3.6	0.0	0.6	11.0	3.5	0.6	25.5	5.5	0.0	0.7	0.0	0.0	2.4	0.0	1.2	10.4	12.2	0.0	0.8	1.4	0.3	0.2	7.2	0.0	0.6	0.1	0.0	1.5	3.2	17.5	12.4	0.7	0.0	14.1	0.7	0.1	12.3	1.1	0.0	0.4	2.2	0.6	0.1	37.2	12.8	11.2	0.2	0.8	17.4	37.5
PRPH2	"CACD2, rd2, RDS, RP7, TSPAN22"	ENSG00000112619	"Peripherin 2"	P23942	6	42696598-42722597	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Cone-rod dystrophy, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	48	"retina: 641.4"	"Group enriched"	"Detected in some"	8	"Cone photoreceptor cells: 260.6;Rod photoreceptor cells: 482.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.0;ASC TERT1: 3.4;fHDF/TERT166: 5.3;HHSteC: 7.8;HSkMC: 6.0;LHCN-M2: 3.5"	"Region enriched"	"Detected in single"	7	"hippocampal formation: 2.4"	"Not detected"	"Not detected"			HPA029458	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 79: Retina - Phototransduction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA029458: AB_10602193"	"unprognostic (2.37e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.43e-2)"	"unprognostic (1.15e-1)"	"unprognostic (2.87e-3)"	"unprognostic (4.73e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.18e-2)"	"unprognostic (7.07e-4)"	"unprognostic (1.13e-3)"	"unprognostic (1.59e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.96e-3)"	1.1	0.8	2.1	0.5	1.5	0.0	0.5	0.4	1.8	2.0	0.1	2.2	0.4	2.1	1.8	0.7	1.3	1.1	1.5	3.1	2.1	1.4	0.2	1.5	0.1	0.9	1.0	3.1	2.3	4.3	2.5	0.9	1.2	1.5	0.8	641.4	0.7	1.1	13.2	0.3	1.4	1.9	0.4	0.8	1.2	3.7	2.7	0.2	4.1	2.9	0.1	1.2	1.1	1.2	0.0	0.0	0.0	0.0	3.0	3.4	0.7	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	7.8	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.0	0.1	0.0	2.1	1.5	0.4	1.8	3.1	2.1	0.9	1.0	1.2	0.4	2.7	1.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	39.3	0.1	0.0	0.9	0.0	0.1	0.0	260.6	0.1	0.0	0.0	3.9	0.3	0.2	0.1	0.9	2.3	0.0	0.0	2.3	0.2	0.0	1.3	0.0	0.1	0.0	0.2	0.4	0.2	0.0	11.8	1.7	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.9	0.0	42.6	1.0	0.5	0.6	0.5	0.0	1.9	0.0	0.2	0.0	0.2	0.0	482.7	0.0	0.9	0.8	2.3	0.5	0.1	0.3	0.1	0.0	1.3	0.0	0.1
PRRT2	"DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC"	ENSG00000167371	"Proline rich transmembrane protein 2"	Q7Z6L0	16	29811382-29815892	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Dystonia, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"ovary: 124.3"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 82.3;Cone photoreceptor cells: 31.3;Leydig cells: 36.1;Peritubular cells: 40.3;Rod photoreceptor cells: 37.1"	"Cancer enhanced"	"Detected in many"		"glioma: 5.8"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"NK-cell: 3.2"	"Lineage enriched"	"Detected in single"	7	"NK-cells: 3.2"	"Cell line enhanced"	"Detected in many"		"AF22: 24.1;HeLa: 13.8;hTERT-RPE1: 14.0;REH: 17.6;U-138 MG: 14.5"									"HPA014447, HPA019203, HPA048045"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 35: Non-specific - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA014447: AB_1855786, HPA019203: AB_2670097, HPA048045: "	"unprognostic (7.60e-3)"	"unprognostic (3.00e-1)"	"unprognostic (8.32e-3)"	"unprognostic (4.34e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.85e-1)"	"unprognostic (1.23e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.45e-2)"	"unprognostic (3.26e-2)"	"unprognostic (3.43e-8)"	"unprognostic (1.22e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.12e-2)"	"unprognostic (2.44e-2)"	13.4	10.5	32.9	2.4	40.4	0.3	10.8	70.7	70.5	79.4	0.0	33.9	5.3	39.5	8.6	6.7	47.0	10.9	15.6	46.0	20.1	8.7	2.4	12.9	3.3	15.6	8.0	124.3	4.7	4.3	85.6	7.0	16.2	39.1	2.3	19.8	5.4	13.9	4.5	5.0	14.5	10.4	24.5	1.7	12.4	14.6	29.2	0.5	10.6	1.8	1.0	34.1	51.0	34.0	0.1	1.5	24.1	8.6	1.2	4.2	0.5	2.5	4.1	1.0	0.8	1.1	1.5	0.2	0.3	4.4	0.5	1.6	3.4	0.2	0.4	4.1	1.4	1.7	13.8	1.6	0.3	0.0	0.3	4.1	0.1	1.9	0.1	14.0	1.0	0.7	0.2	1.5	0.2	3.1	0.6	0.5	5.0	0.1	1.1	17.6	0.9	0.4	0.2	0.8	4.1	4.3	0.2	2.1	0.5	3.5	7.6	0.0	1.3	14.5	5.2	0.7	1.4	3.7	0.5	0.2	5.3	0.2	0.5	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.1	0.1	0.1	3.2	0.1	0.0	0.0	0.1	32.9	40.4	70.7	70.5	46.0	20.1	15.6	8.0	16.2	24.5	29.2	34.0	2.3	3.2	0.0	22.9	0.9	1.1	1.4	1.7	0.6	82.3	1.6	1.7	0.8	1.5	1.2	0.0	31.3	1.9	1.9	9.5	1.9	1.1	2.0	4.4	10.4	5.0	6.1	0.0	24.4	1.5	0.8	11.4	2.0	1.6	0.0	1.7	3.3	0.1	0.4	20.2	19.5	4.2	2.0	0.0	2.4	9.8	36.1	0.5	0.0	5.6	0.6	5.7	1.0	8.5	1.6	3.0	9.0	40.3	0.7	1.8	15.2	1.0	5.6	37.1	6.6	2.9	11.7	2.4	3.1	0.4	0.4	2.6	2.7	0.6	2.5	1.3
PSAP	"GLBA, SAP1, SAP2"	ENSG00000197746	Prosaposin	P07602	10	71816298-71851325	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Lipid metabolism, Sphingolipid metabolism"		"Disease variant, Gangliosidosis, Gaucher disease, Leukodystrophy, Metachromatic leukodystrophy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hofbauer cells: 2792.8;Kupffer cells: 2427.0;Macrophages: 1916.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"intermediate monocyte: 11615.6"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 5104.0;hTERT-RPE1: 6978.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004426, CAB004647"	Supported		Supported	Vesicles	"Intracellular and membrane"	NA	NA		88000000	"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	Vesicles		"CAB004647: AB_425625, HPA004426: AB_1079701"	"unprognostic (4.43e-3)"	"unprognostic (2.69e-1)"	"unprognostic (1.64e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.36e-3)"	"unprognostic (2.79e-1)"	"unprognostic (3.31e-2)"	"unprognostic (3.25e-2)"	"unprognostic (2.30e-3)"	"unprognostic (2.00e-2)"	"unprognostic (3.62e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.06e-1)"	1068.6	1192.2	831.4	874.2	946.7	834.2	683.8	873.7	831.7	1073.9	1023.0	667.1	475.6	879.3	951.2	605.5	724.7	1115.6	1413.3	830.5	1081.8	860.4	906.4	1118.6	956.1	957.6	894.0	1106.9	544.7	1167.5	563.5	869.3	885.3	773.9	625.5	665.2	580.9	936.8	1409.5	544.4	487.7	1138.6	1025.9	1045.9	664.0	489.1	1048.8	672.3	875.9	987.5	560.4	941.2	578.3	1325.1	455.9	847.4	540.4	1121.0	5104.0	2910.1	1900.2	799.9	2368.3	620.8	735.9	795.4	1131.9	245.6	1608.1	1321.6	1038.9	964.1	207.5	659.1	434.8	481.4	381.8	288.9	352.3	459.6	1970.7	188.8	1596.0	1871.8	1479.1	625.7	1177.6	6978.9	1128.1	345.8	420.5	1158.1	777.0	294.9	843.8	290.1	249.5	575.4	404.0	172.9	301.3	696.7	730.3	764.4	584.4	515.8	751.1	2248.3	3122.2	700.4	454.4	431.1	1467.0	861.8	610.0	587.1	670.5	1289.0	1038.7	435.4	1375.5	374.4	650.0	863.2	10095.9	1127.5	424.2	11615.6	349.8	466.7	342.9	368.8	3481.1	425.5	370.1	350.6	2890.4	365.8	10148.2	1758.2	422.8	15009.0	831.4	946.7	873.7	831.7	830.5	1081.8	957.6	894.0	885.3	1025.9	1048.8	1325.1	263.2	253.2	339.0	136.8	173.9	228.3	253.4	487.0	108.1	193.8	254.6	158.7	664.1	253.1	318.9	476.3	127.2	891.6	260.2	434.8	70.5	1043.6	19.3	147.0	246.6	311.4	261.9	160.5	86.1	456.1	872.6	623.8	187.6	195.2	398.1	210.8	426.9	509.2	2792.8	333.1	93.7	242.2	343.8	2427.0	779.7	54.1	458.6	1916.9	663.5	105.9	1528.9	495.6	182.3	92.5	117.6	357.7	298.3	551.8	503.0	244.8	370.6	311.6	297.2	164.3	276.1	273.6	263.8	55.2	126.3	137.2	198.0	1073.2	138.9	624.1	228.3	223.9
PSEN1	"AD3, FAD, PS1, S182"	ENSG00000080815	"Presenilin 1"	P49768	14	73136418-73223691	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Cell adhesion, Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cancer-related genes, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"Oligodendrocytes: 395.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB006844, HPA030760, HPA067496"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Cell Junctions"		Yes	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus"	"Nucleoplasm, Cell Junctions"	"CAB006844: , HPA030760: AB_10696211, HPA067496: AB_2685853"	"unprognostic (1.67e-1)"	"unprognostic (4.79e-2)"	"unprognostic (7.39e-2)"	"unprognostic (8.68e-3)"	"unprognostic (3.84e-1)"	"unprognostic (5.48e-3)"	"prognostic unfavorable (1.99e-5)"	"unprognostic (1.65e-1)"	"unprognostic (8.99e-2)"	"unprognostic (8.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.52e-8)"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.12e-3)"	"unprognostic (1.85e-1)"	25.1	22.6	44.3	26.5	80.7	39.6	28.2	62.4	56.0	28.1	48.9	49.5	50.2	25.3	26.9	35.2	22.9	31.7	18.0	47.4	51.6	35.5	31.9	32.1	22.4	73.0	63.8	22.0	22.9	35.1	11.6	43.1	71.5	24.3	46.3	23.4	22.9	23.4	18.4	38.2	49.0	27.1	55.7	22.6	31.0	32.5	60.8	26.2	36.9	23.3	30.7	35.0	19.2	119.1	37.1	55.9	50.6	20.0	68.9	49.9	46.7	52.5	60.1	52.6	66.7	69.9	88.9	23.7	34.1	50.5	43.0	94.9	43.2	40.1	57.3	54.6	26.7	27.1	35.1	34.4	63.8	27.7	50.7	50.4	71.9	44.3	54.4	48.5	43.2	26.2	31.0	46.6	50.0	72.8	21.0	35.7	22.0	64.5	40.4	26.4	42.7	30.2	73.7	76.5	28.1	38.3	57.4	53.0	47.1	45.4	66.3	60.7	45.7	53.1	43.5	44.1	25.3	30.3	47.9	23.7	44.9	32.8	33.3	126.8	94.5	96.3	23.1	106.0	22.6	23.1	22.3	19.0	83.4	31.8	20.7	20.1	129.3	42.8	125.0	43.6	37.0	70.3	44.3	80.7	62.4	56.0	47.4	51.6	73.0	63.8	71.5	55.7	60.8	119.1	22.2	28.9	30.5	35.9	25.8	28.6	24.6	24.7	12.0	17.1	25.0	17.7	12.5	15.7	30.2	23.9	39.6	27.1	30.7	79.1	5.9	27.1	22.9	26.3	26.4	22.3	16.2	12.0	38.9	26.7	29.2	23.7	32.1	47.4	18.3	29.6	15.7	24.6	30.5	13.5	40.2	39.5	24.4	50.5	40.8	12.9	16.4	52.3	16.0	39.4	51.8	13.8	14.4	48.7	395.8	38.2	58.8	15.4	23.6	38.8	76.2	13.0	29.0	28.0	26.3	20.0	19.0	40.2	14.4	20.4	33.0	49.9	21.6	18.6	41.3	51.5
PSEN2	"AD3L, AD4, PS2, STM2"	ENSG00000143801	"Presenilin 2"	P49810	1	226870184-226927726	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Notch signaling pathway"	"Hydrolase, Protease"	"Alzheimer disease, Amyloidosis, Cardiomyopathy, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ionocytes: 36.7;Syncytiotrophoblasts: 45.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"																	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 50: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (3.40e-2)"	"unprognostic (4.73e-3)"	"unprognostic (2.94e-1)"	"unprognostic (3.86e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.64e-3)"	"unprognostic (4.72e-2)"	"unprognostic (1.31e-1)"	"unprognostic (9.98e-2)"	"unprognostic (2.73e-2)"	"unprognostic (8.25e-3)"	"unprognostic (8.53e-3)"	"unprognostic (8.45e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.36e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.06e-1)"	11.2	19.8	9.7	7.5	9.8	1.6	10.6	12.5	10.7	9.7	10.7	15.2	10.5	15.9	9.0	10.3	13.4	8.3	14.0	9.4	10.6	13.5	12.6	11.5	8.0	9.8	10.9	12.8	45.5	18.1	17.1	9.0	10.8	14.9	8.1	7.4	13.0	13.6	26.5	10.1	13.8	10.4	8.5	15.6	11.5	13.5	10.7	3.3	9.5	16.7	5.0	13.5	9.7	9.7	14.1	24.5	7.2	21.9	10.0	3.5	10.2	12.4	26.5	16.9	12.9	13.8	21.5	1.0	17.0	16.8	10.5	7.9	12.1	11.9	6.7	13.6	20.7	8.7	10.5	12.0	15.4	7.5	15.7	9.1	13.9	18.9	10.4	11.2	6.9	0.7	18.1	6.4	10.0	14.7	0.4	8.2	20.5	22.0	16.0	0.4	22.6	26.4	15.9	13.4	11.3	18.3	9.7	30.6	51.6	18.4	26.5	13.1	8.5	11.2	8.9	9.9	15.2	25.6	45.0	0.9	21.5	2.5	15.7	37.4	8.7	18.4	4.5	9.7	5.1	7.4	1.5	4.6	11.4	3.1	0.7	2.0	1.6	20.0	30.2	0.8	2.4	5.2	9.7	9.8	12.5	10.7	9.4	10.6	9.8	10.9	10.8	8.5	10.7	9.7	11.0	16.0	10.8	2.6	3.9	1.7	4.5	4.0	1.8	6.2	6.6	4.1	12.9	15.7	4.7	5.5	0.0	15.9	1.3	5.9	1.9	13.0	2.5	4.5	3.0	10.0	6.0	6.1	4.2	18.0	4.1	5.9	7.7	5.2	14.5	10.1	19.2	8.4	17.2	16.8	4.5	5.1	36.7	7.2	6.5	1.3	7.2	8.2	33.8	5.6	18.9	21.2	2.1	2.5	1.5	15.2	7.8	13.2	9.9	5.3	13.8	7.2	4.9	5.8	6.6	9.4	10.6	1.5	6.1	3.8	1.8	45.8	2.9	6.6	4.3	4.6
PTAFR		ENSG00000169403	"Platelet activating factor receptor"	P25105	1	28147166-28193936	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	Chemotaxis	"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 41.1;lymphoid tissue: 30.8"	"Cell type enhanced"	"Detected in many"		"granulocytes: 75.4;Hofbauer cells: 71.7;Kupffer cells: 93.0;Langerhans cells: 67.8;Macrophages: 64.5;monocytes: 52.8;Pancreatic endocrine cells: 89.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 256.7;eosinophil: 906.5;neutrophil: 747.1"	"Group enriched"	"Detected in many"	5	"granulocytes: 906.5;monocytes: 256.7"	"Group enriched"	"Detected in some"	4	"HBEC3-KT: 36.6;HMC-1: 131.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA027543	Approved		Uncertain	"Nucleoplasm,Vesicles,Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Nucleoplasm, Vesicles"	"Plasma membrane"	"HPA027543: AB_10610287"	"unprognostic (2.22e-2)"	"unprognostic (2.59e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.75e-1)"	"unprognostic (3.74e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.79e-2)"	"unprognostic (3.52e-1)"	"unprognostic (2.59e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.38e-2)"	10.4	2.4	4.3	30.8	4.7	41.1	3.4	4.7	5.6	3.4	4.1	5.5	4.1	1.7	1.2	7.2	2.6	7.2	2.0	3.8	5.1	2.7	4.1	17.8	13.5	8.9	6.6	1.3	2.0	1.6	0.6	7.3	7.7	1.5	6.7	0.5	2.3	1.5	0.7	5.4	6.3	7.9	8.1	14.4	3.8	1.3	7.2	3.6	1.9	2.6	18.0	14.4	1.9	11.8	20.1	0.2	0.1	0.4	0.2	0.0	0.5	0.0	0.0	0.7	0.2	0.2	5.7	1.3	0.1	0.1	0.3	13.5	0.5	36.6	0.8	0.4	0.6	7.7	0.2	0.9	0.1	1.9	131.3	0.0	6.0	0.4	0.4	0.0	0.2	0.1	0.5	0.4	0.0	1.3	0.2	19.3	0.6	0.5	0.2	0.3	0.1	0.1	8.7	2.1	0.3	0.1	0.1	18.1	0.2	0.4	0.4	5.4	0.1	0.2	0.7	0.0	0.2	1.2	1.1	5.6	0.1	2.4	0.6	61.7	256.7	906.5	0.6	77.9	1.2	12.5	0.4	0.4	116.1	6.7	0.5	0.7	747.1	0.7	34.1	1.3	1.2	112.4	4.3	4.7	4.7	5.6	3.8	5.1	8.9	6.6	7.7	8.1	7.2	11.8	2.1	6.4	6.7	0.0	4.1	6.5	2.0	37.9	5.2	1.5	0.8	0.5	2.2	1.5	20.9	1.8	2.1	0.6	2.9	0.4	0.0	18.1	0.4	0.5	0.2	7.3	0.0	4.0	0.9	5.1	0.5	1.3	1.1	0.5	75.4	2.0	2.9	1.0	71.7	0.0	0.7	0.0	18.3	93.0	67.8	0.2	0.6	64.5	0.0	15.0	52.8	0.2	0.0	1.5	6.6	89.8	0.6	0.0	0.5	0.6	0.3	0.2	20.2	0.9	0.0	0.6	1.0	2.3	0.7	3.2	2.8	1.5	2.0	0.0	0.4	9.4
PTCH1	"BCNS, NBCCS, PTCH"	ENSG00000185920	"Patched 1"	Q13635	9	95442980-95517057	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease variant, Holoprosencephaly, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 26.7"	"Cell type enhanced"	"Detected in many"		"Late spermatids: 237.5;Leydig cells: 191.0;Peritubular cells: 444.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 6.1"	"Lineage enriched"	"Detected in single"	9	"T-cells: 6.1"	"Cell line enhanced"	"Detected in many"		"NTERA-2: 29.6;WM-115: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013717, HPA075072"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 52: Non-specific - Transcription"	"Golgi apparatus"		"CAB013717: , HPA075072: AB_2686733"	"unprognostic (1.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.16e-1)"	"unprognostic (1.79e-2)"	"unprognostic (3.22e-2)"	"unprognostic (9.01e-2)"	"unprognostic (2.13e-1)"	"unprognostic (3.54e-3)"	"unprognostic (2.63e-1)"	"unprognostic (8.66e-3)"	"unprognostic (1.52e-2)"	"unprognostic (2.82e-1)"	"unprognostic (1.13e-6)"	"unprognostic (8.63e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.82e-1)"	3.0	3.5	9.5	4.0	11.6	0.7	2.8	24.6	5.6	26.7	2.7	11.3	8.1	15.6	2.7	2.9	7.1	8.1	2.9	4.7	17.8	4.6	2.2	5.5	2.2	16.0	12.7	5.0	6.4	2.5	2.1	3.8	8.0	6.8	12.3	8.3	7.5	4.0	3.0	3.2	11.6	2.4	7.0	3.3	12.5	14.5	24.0	2.1	4.7	4.8	3.0	7.2	2.9	4.5	10.1	4.7	20.3	12.9	3.0	5.0	11.4	1.9	1.7	2.2	1.4	4.9	4.8	8.0	3.3	3.8	4.4	22.3	11.7	1.6	1.4	7.9	7.8	0.0	4.8	2.3	2.7	0.2	4.2	4.7	2.4	2.2	1.4	4.3	4.2	3.5	7.3	9.1	1.0	1.9	0.1	3.2	29.6	7.2	1.8	0.0	15.5	4.2	1.6	1.5	13.8	7.0	7.1	6.8	2.9	18.8	1.8	2.1	1.1	2.6	12.9	13.6	1.5	18.0	16.8	5.3	3.8	3.9	71.0	0.0	0.0	0.0	6.1	0.0	3.3	0.7	1.1	2.5	0.0	0.2	1.9	2.2	0.0	0.3	0.0	0.0	1.2	1.7	9.5	11.6	24.6	5.6	4.7	17.8	16.0	12.7	8.0	7.0	24.0	4.5	6.0	0.0	6.4	49.0	3.0	4.0	2.7	3.0	4.6	20.3	3.5	4.6	5.9	25.8	2.7	0.0	41.7	3.0	11.8	2.0	5.9	3.5	88.4	12.2	89.8	5.4	21.7	0.4	15.2	4.2	1.9	27.2	1.1	11.0	1.3	2.6	6.4	2.9	0.8	20.2	10.7	11.0	4.1	0.9	1.2	237.5	191.0	1.4	12.4	4.7	0.8	55.6	54.6	39.7	20.5	2.4	3.1	444.5	3.1	4.9	3.1	1.6	5.5	13.4	39.5	4.8	9.4	4.4	35.5	3.0	4.4	1.4	6.5	71.7	4.7	1.4
PTCH2		ENSG00000117425	"Patched 2"	Q9Y6C5	1	44819844-44843253	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Receptor	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"ovary: 24.6;parathyroid gland: 59.1;salivary gland: 75.2;testis: 25.6"	"Cell type enhanced"	"Detected in many"		"Leydig cells: 107.8;Peritubular cells: 68.1;Plasma cells: 67.1;Theca cells: 138.7"	"Cancer enhanced"	"Detected in many"		"testis cancer: 9.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-266/84: 11.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA046839			Supported	"Nucleoli,Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 16: U-266 - Nucleosome"	"Cluster 52: Non-specific - Transcription"	"Plasma membrane"	Nucleoli	"HPA046839: "	"unprognostic (6.54e-5)"	"unprognostic (1.05e-1)"	"unprognostic (7.29e-3)"	"unprognostic (3.65e-3)"	"unprognostic (3.89e-1)"	"unprognostic (7.42e-3)"	"unprognostic (3.01e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.67e-2)"	"prognostic favorable (5.74e-5)"	"unprognostic (2.92e-1)"	"unprognostic (5.74e-6)"	"unprognostic (1.55e-2)"	"unprognostic (4.86e-2)"	"unprognostic (6.31e-2)"	"unprognostic (6.81e-2)"	4.2	3.1	6.1	0.8	3.5	9.4	3.4	6.8	6.8	5.1	3.6	3.6	1.0	6.4	1.6	0.9	4.3	2.5	1.3	3.1	4.4	1.3	1.3	1.0	2.3	2.9	4.8	24.6	1.0	59.1	9.9	0.3	2.0	3.0	0.9	3.6	75.2	1.3	2.0	3.6	1.8	1.2	1.6	2.4	2.0	25.6	6.5	0.8	4.6	0.8	0.7	3.1	3.4	4.8	0.2	0.3	1.0	2.5	0.8	0.9	1.0	0.8	1.6	0.5	0.4	0.2	0.4	1.1	0.4	0.4	0.5	0.0	1.1	0.0	0.2	2.1	1.9	0.6	1.0	0.8	0.3	0.7	1.1	0.3	0.4	1.0	0.1	1.7	0.1	1.0	0.7	1.1	0.0	0.5	1.4	2.1	0.3	0.1	0.4	1.0	0.2	0.5	0.2	0.0	1.5	0.6	0.3	0.4	0.8	0.5	0.2	1.2	0.1	0.2	0.5	1.3	0.5	1.9	11.6	3.2	0.6	3.0	0.4	2.5	1.9	0.1	0.5	0.9	1.0	1.0	0.6	0.6	1.2	1.4	0.7	0.6	0.6	0.9	0.9	3.6	0.3	0.2	6.1	3.5	6.8	6.8	3.1	4.4	2.9	4.8	2.0	1.6	6.5	4.8	2.8	0.0	1.1	14.0	13.4	0.5	0.7	1.0	0.6	0.8	4.8	8.0	1.0	7.2	1.0	1.8	2.1	2.4	6.8	7.8	0.0	5.5	2.3	9.3	13.5	2.7	11.5	1.3	23.7	1.8	1.6	14.3	28.1	8.5	0.0	4.4	0.7	7.9	6.7	8.4	27.3	4.9	2.0	24.5	2.2	8.0	107.8	17.3	0.0	5.6	3.9	2.4	2.1	9.5	2.6	2.1	2.5	68.1	67.1	0.8	13.6	0.2	1.7	1.2	13.1	5.4	5.6	5.0	3.6	0.6	1.6	2.3	7.5	138.7	5.5	0.2
PTGER1	EP1	ENSG00000160951	"Prostaglandin E receptor 1"	P34995	19	14472466-14475354	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	5	"kidney: 30.9"	"Cell type enriched"	"Detected in some"	70	"Collecting duct cells: 198.6"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 4.1"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.4;NB-4: 1.3;PC-3: 3.2;SH-SY5Y: 1.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.44e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.68e-1)"	"unprognostic (3.50e-4)"	"unprognostic (8.69e-2)"	"unprognostic (5.58e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.19e-2)"	"unprognostic (2.05e-1)"	"unprognostic (3.53e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.74e-8)"	"unprognostic (1.19e-1)"	"unprognostic (4.41e-2)"	"unprognostic (4.27e-3)"	"unprognostic (4.88e-2)"	0.9	1.4	0.4	0.5	0.7	0.0	0.4	0.3	2.2	1.2	0.9	0.5	0.3	0.5	0.0	0.8	1.0	0.0	0.1	0.3	1.0	30.9	0.3	2.4	0.0	0.4	0.3	0.1	0.3	0.1	1.4	0.0	0.5	0.7	0.0	0.0	0.3	0.0	0.1	0.1	1.4	0.4	0.1	6.5	3.0	0.2	0.5	0.0	0.5	0.0	0.0	1.1	0.6	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.4	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.3	0.1	0.0	3.2	0.3	0.0	0.1	0.0	0.0	0.2	1.8	0.0	0.0	0.1	0.0	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.4	0.7	0.3	2.2	0.3	1.0	0.4	0.3	0.5	0.1	0.5	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.7	0.3	0.3	0.9	2.8	0.0	198.6	0.0	0.1	1.3	0.3	0.0	0.1	0.1	1.5	0.4	0.2	0.0	0.0	0.0	0.0	0.2	2.5	1.1	1.4	0.0	0.4	0.4	0.5	0.3	0.0	0.1	0.2	0.0	0.3	0.0	0.5	0.3	0.1	0.0	0.0	0.1	0.6	0.0	0.0	0.6	1.8	0.0	0.0	0.0	0.8	0.0	0.8	0.1	0.1	0.0	0.4	2.5	0.3	0.9	0.3	0.0	0.0	0.6	0.8	0.2	0.4
PTH1R	"PTHR, PTHR1"	ENSG00000160801	"Parathyroid hormone 1 receptor"	Q03431	3	46877721-46903799	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Disease variant, Dwarfism, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"kidney: 586.8"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 95.9;Extravillous trophoblasts: 60.8;Proximal tubular cells: 324.8;Sertoli cells: 138.1"	"Group enriched"	"Detected in many"	4	"renal cancer: 18.8;testis cancer: 5.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"RPTEC TERT1: 116.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075879	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA075879: "	"unprognostic (1.26e-1)"	"unprognostic (7.09e-2)"	"unprognostic (2.24e-5)"	"unprognostic (7.46e-2)"	"unprognostic (3.46e-1)"	"unprognostic (5.02e-2)"	"unprognostic (3.84e-3)"	"unprognostic (5.47e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (7.51e-2)"	"unprognostic (8.44e-2)"	"prognostic favorable (6.79e-6)"	"unprognostic (4.22e-3)"	"unprognostic (1.50e-1)"	"unprognostic (1.35e-4)"	"unprognostic (6.62e-3)"	32.5	72.2	45.0	1.1	43.8	0.0	20.2	45.7	60.8	43.8	38.0	10.3	1.2	19.1	2.7	3.7	20.3	3.5	33.0	42.6	43.5	586.8	84.6	25.6	2.4	46.5	44.9	22.2	7.6	1.2	5.9	16.0	46.7	12.4	0.6	0.7	2.7	3.5	7.7	9.8	9.6	2.6	44.5	54.4	7.6	10.3	46.2	0.4	6.5	2.2	0.4	12.3	20.3	43.3	0.0	0.2	0.2	0.2	15.9	1.9	0.2	0.4	0.2	0.3	0.2	0.4	0.0	0.0	1.6	0.1	0.2	0.0	1.8	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.0	15.5	0.0	0.1	0.0	0.2	0.1	0.0	0.0	2.6	0.1	0.1	0.0	0.3	2.1	0.0	0.1	0.1	5.3	0.0	116.9	0.0	0.2	0.7	0.0	0.1	0.0	5.2	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	45.0	43.8	45.7	60.8	42.6	43.5	46.5	44.9	46.7	44.5	46.2	43.3	4.6	0.0	0.0	17.3	2.5	1.3	0.1	0.0	0.6	1.5	2.9	0.4	5.0	2.8	0.0	33.1	0.0	0.6	0.1	0.0	95.9	0.0	11.6	0.6	20.5	4.1	0.0	8.0	1.6	0.5	60.8	9.6	0.0	0.6	0.0	0.1	17.2	0.7	2.0	1.7	2.8	0.0	0.0	1.3	2.8	32.5	5.9	2.1	0.0	1.9	0.0	3.2	0.0	1.0	0.3	0.3	0.0	2.2	0.0	0.0	0.0	324.8	0.0	1.7	138.1	6.5	21.7	0.9	2.7	0.0	0.9	0.8	2.0	0.3	0.0	0.1
PTPRC	"CD45, GP180, LCA, T200"	ENSG00000081237	"Protein tyrosine phosphatase receptor type C"	P08575	1	198638457-198757476	"Cancer-related genes, CD markers, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Hydrolase, Protein phosphatase"	"Cancer-related genes, Disease variant, SCID"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 208.6;lymphoid tissue: 329.9"	"Cell type enhanced"	"Detected in many"		"B-cells: 525.2;dendritic cells: 1026.4;Macrophages: 534.1;monocytes: 554.9;NK-cells: 769.3;Plasma cells: 474.2;T-cells: 1049.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in some"		"Daudi: 209.9;HEL: 118.0;HL-60: 108.1;JURKAT: 266.4;MOLT-4: 161.1;THP-1: 87.0;U-266/70: 93.7;U-266/84: 91.2;U-698: 123.4;U-937: 94.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB000052, HPA000440, CAB002800, CAB056154, CAB068221"	Enhanced		Uncertain	Nucleoplasm,Vesicles	"Intracellular and membrane"	NA	NA		24000000	"Cluster 14: Monocytes - Unknown function"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 24: Non-specific - Transcription regulation"	"Nucleoplasm, Vesicles"		"CAB000052: AB_2314143, CAB002800: AB_2237910, CAB056154: AB_2665572, CAB068221: AB_2665571, HPA000440: AB_611377"	"unprognostic (1.51e-2)"	"unprognostic (1.24e-2)"	"unprognostic (5.10e-3)"	"unprognostic (2.33e-3)"	"unprognostic (1.30e-1)"	"unprognostic (2.40e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.25e-1)"	"unprognostic (3.18e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.95e-1)"	"prognostic unfavorable (2.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.41e-2)"	"unprognostic (7.06e-2)"	32.8	11.6	3.8	248.5	3.3	208.6	13.9	4.4	4.3	14.9	6.9	26.4	27.4	11.3	5.6	15.1	8.4	45.7	7.3	3.5	5.6	7.0	29.6	68.6	329.9	12.9	8.6	5.7	5.6	4.0	2.9	23.5	11.5	11.6	30.5	2.0	13.8	6.6	4.6	5.7	42.9	25.3	7.9	202.5	37.9	5.5	6.9	306.9	7.0	7.6	251.2	62.1	5.2	14.7	0.4	0.0	0.2	0.2	0.0	0.0	0.8	0.3	0.3	0.1	0.0	0.0	0.1	209.9	0.3	0.7	0.2	0.3	0.0	0.2	0.4	0.6	0.0	118.0	0.2	0.1	0.0	108.1	0.7	0.0	0.0	0.3	0.0	0.4	0.5	266.4	2.4	3.3	0.3	0.1	161.1	65.0	0.5	0.2	0.2	4.6	0.4	0.3	0.1	0.1	1.2	1.8	0.1	0.4	0.5	0.2	0.3	87.0	1.3	0.0	0.8	0.8	0.4	93.7	91.2	123.4	0.1	94.5	0.4	226.1	480.0	521.4	634.4	885.8	541.8	249.0	437.0	618.1	385.8	245.8	489.8	494.1	844.3	506.9	1015.8	57.4	508.6	1340.6	3.8	3.3	4.4	4.3	3.5	5.6	12.9	8.6	11.5	7.9	6.9	14.7	12.6	44.8	62.3	0.7	525.2	15.8	0.9	0.0	4.0	0.3	6.0	9.3	4.6	5.7	14.2	1.8	0.0	0.6	1026.4	1.0	0.0	0.7	2.4	2.3	2.3	15.1	1.2	58.8	0.7	0.0	0.9	17.2	46.9	2.7	246.5	0.1	14.6	6.9	96.0	0.0	1.7	0.4	0.0	334.9	214.5	3.5	1.2	534.1	21.4	201.4	554.9	0.1	769.3	2.5	0.7	0.1	0.8	0.0	474.2	1.1	0.1	2.5	11.7	0.2	6.6	7.4	6.7	0.3	0.6	1.8	15.2	0.8	1049.1	5.4	0.9	0.8
PTPRN2	"IA-2beta, ICAAR, KIAA0387, phogrin"	ENSG00000155093	"Protein tyrosine phosphatase receptor type N2"	Q92932	7	157539056-158587823	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid metabolism, Phospholipid metabolism"	"Hydrolase, Protein phosphatase, Receptor"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 49.9;pancreas: 98.1"	"Group enriched"	"Detected in many"	4	"Enteroendocrine cells: 131.1;Excitatory neurons: 439.6;Inhibitory neurons: 433.4;Oligodendrocyte precursor cells: 138.2"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 40.8"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 23.6"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 23.6"	"Cell line enhanced"	"Detected in many"		"AF22: 45.5;HDLM-2: 42.0;MOLT-4: 22.1;NB-4: 43.0;SCLC-21H: 23.8;SH-SY5Y: 25.4;U-87 MG: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006900, HPA007255, HPA026656"	Enhanced		Approved	Vesicles		NA	NA		1600000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA006900: AB_1079715, HPA007255: , HPA026656: AB_1855912"	"unprognostic (2.42e-1)"	"unprognostic (4.17e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.69e-2)"	"prognostic unfavorable (9.37e-5)"	"unprognostic (7.12e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.55e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (8.68e-4)"	"unprognostic (2.60e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.43e-3)"	"unprognostic (6.16e-2)"	3.8	16.5	29.4	2.7	34.3	1.3	2.9	0.0	49.9	2.1	0.0	7.7	8.3	3.0	4.2	1.9	10.8	7.6	3.1	35.2	22.7	3.9	1.6	4.8	3.4	7.9	3.1	8.7	98.1	1.0	41.0	2.1	3.4	17.3	6.1	9.2	12.9	3.6	1.2	0.8	6.7	2.1	0.1	13.4	40.2	6.2	14.1	1.6	8.7	1.9	2.5	4.2	2.1	20.5	0.1	0.4	45.5	3.6	0.1	0.2	0.1	0.4	0.3	0.0	0.1	0.0	4.0	0.0	1.2	0.5	9.4	0.3	1.0	0.0	0.0	42.0	0.8	0.0	0.0	7.3	1.1	0.0	0.1	2.0	0.8	0.1	0.5	0.3	0.0	3.4	0.1	0.3	0.0	0.7	22.1	43.0	5.7	13.7	3.2	0.0	2.7	0.2	0.2	0.0	23.8	25.4	0.0	0.1	0.0	0.0	0.0	20.9	6.2	9.2	4.3	0.1	1.5	0.3	0.1	0.0	27.7	17.4	6.8	14.1	1.5	2.8	1.3	0.2	0.5	3.5	2.1	1.4	2.1	4.2	2.4	1.4	23.6	2.4	0.0	0.6	5.3	1.3	29.4	34.3	0.0	49.9	35.2	22.7	7.9	3.1	3.4	0.1	14.1	20.5	40.7	3.2	12.9	16.3	18.4	2.3	12.7	1.3	4.0	30.2	1.9	2.2	3.1	10.0	9.1	40.5	10.4	0.4	8.7	5.9	35.2	22.9	51.9	8.7	2.5	26.3	131.1	6.6	439.6	13.1	0.4	13.0	41.8	0.8	19.0	14.1	44.3	0.8	44.5	11.8	433.4	43.3	6.1	7.0	11.3	19.3	12.5	7.9	12.4	27.2	5.7	67.3	15.5	138.2	11.0	7.3	7.0	19.5	5.4	15.0	6.5	3.8	52.6	8.0	26.3	1.4	7.0	62.8	16.3	4.8	1.4	0.7	14.8	32.7	9.7	24.8
PXMP2	"MPV17L3, PMP22"	ENSG00000176894	"Peroxisomal membrane protein 2"	Q9NR77	12	132687587-132704985	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 312.0"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 187.3;Hepatocytes: 577.4;Proximal enterocytes: 333.3;Proximal tubular cells: 303.7"	"Cancer enhanced"	"Detected in all"		"liver cancer: 43.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 85: Liver - Metabolism"	"Cluster 14: REH - Unknown function"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.12e-2)"	"unprognostic (7.96e-2)"	"unprognostic (4.70e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (9.84e-4)"	"unprognostic (7.39e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.44e-2)"	"unprognostic (3.02e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.88e-1)"	"prognostic favorable (2.75e-4)"	"unprognostic (9.89e-2)"	"unprognostic (5.52e-2)"	"unprognostic (3.71e-3)"	"unprognostic (3.04e-1)"	24.8	14.7	23.7	7.5	24.3	23.4	18.7	24.5	29.8	14.3	37.7	49.5	52.1	14.9	22.3	16.2	18.7	15.4	62.9	28.5	24.1	58.2	312.0	12.9	11.5	24.1	24.2	23.0	42.5	14.5	9.3	8.1	22.9	19.8	39.2	7.5	18.6	9.7	42.3	16.8	55.1	9.5	23.0	13.1	98.2	9.1	24.9	25.9	14.7	30.5	10.7	15.9	12.8	23.5	60.5	24.8	36.6	34.1	21.5	16.6	21.4	21.0	19.4	44.7	39.6	30.3	22.4	37.2	24.9	30.0	15.7	42.0	49.1	26.6	24.3	21.3	77.8	33.2	43.9	33.8	41.7	24.8	14.4	21.7	21.8	18.6	14.7	31.2	12.1	56.2	58.2	28.4	23.8	54.2	78.9	39.2	35.7	70.0	33.9	80.1	39.2	30.6	32.9	25.2	69.0	22.5	45.6	23.6	29.6	28.1	63.2	56.0	14.3	21.9	51.1	19.1	35.6	25.7	26.7	60.6	24.6	34.9	17.7	0.0	1.2	2.9	2.3	0.6	2.1	2.5	1.8	2.4	2.1	2.7	1.8	1.5	0.7	1.5	0.6	6.3	3.1	1.2	23.7	24.3	24.5	29.8	28.5	24.1	24.1	24.2	22.9	23.0	24.9	23.5	10.9	3.2	7.2	8.1	8.2	8.4	20.0	10.6	15.4	6.1	50.3	51.1	35.8	138.7	6.0	25.8	4.2	60.1	7.3	187.3	166.3	16.5	18.7	11.8	16.9	14.1	18.7	55.9	5.9	10.3	36.6	17.0	65.7	17.4	4.5	32.4	46.8	577.4	34.9	0.0	7.1	85.1	2.0	19.2	9.4	38.8	31.1	8.1	12.4	5.6	2.7	45.5	13.4	4.5	1.0	10.2	143.4	35.0	20.9	28.1	333.3	303.7	2.1	7.3	19.7	7.5	14.8	44.9	30.2	31.2	10.7	28.5	8.1	12.4	158.6	23.2
PXMP4	PMP24	ENSG00000101417	"Peroxisomal membrane protein 4"	Q9Y6I8	20	33702758-33720319	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Alveolar cells type 2: 73.6;Late spermatids: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CACO-2: 42.3;SK-BR-3: 75.8;T-47d: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA050077	Approved		Approved	"Nucleoli fibrillar center,Peroxisomes"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 11: Alveolar cells - Smell perception"	Peroxisomes	"Nucleoli fibrillar center"	"HPA050077: AB_2681006"	"unprognostic (3.41e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.59e-1)"	"unprognostic (1.75e-1)"	"unprognostic (5.08e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.17e-1)"	"prognostic favorable (3.88e-4)"	"unprognostic (3.53e-1)"	"unprognostic (4.47e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.86e-1)"	"prognostic favorable (4.03e-10)"	"unprognostic (3.84e-2)"	"unprognostic (2.20e-1)"	"unprognostic (6.08e-2)"	"unprognostic (2.20e-1)"	4.1	11.2	5.1	3.0	5.2	3.2	11.9	3.8	5.6	5.6	4.3	6.2	8.2	4.1	5.1	6.3	6.0	3.3	6.4	5.0	4.0	4.9	8.9	13.9	3.6	4.6	4.5	6.8	6.8	14.7	3.5	3.2	4.1	8.7	5.7	4.4	15.2	6.4	8.0	11.1	7.4	5.1	4.2	4.6	6.8	2.5	5.3	3.5	11.5	6.9	3.9	5.4	5.8	6.5	2.8	12.1	3.3	11.9	5.7	8.3	8.5	8.7	4.7	6.6	2.9	42.3	13.2	0.1	16.2	7.3	16.1	12.5	9.0	10.1	4.7	3.7	3.4	14.0	9.7	0.1	5.3	0.7	10.3	6.4	10.8	9.0	3.0	3.3	4.3	4.4	7.9	8.6	4.7	26.4	12.9	9.8	0.3	21.7	0.0	6.8	16.3	1.7	4.2	9.0	10.7	5.4	24.2	75.8	7.9	1.9	64.0	4.7	8.2	4.7	5.4	11.9	8.2	5.5	13.2	0.2	9.0	4.6	8.1	2.2	11.1	17.5	10.8	22.2	11.3	7.6	10.9	10.9	8.8	9.9	8.3	11.2	2.9	9.1	34.2	5.3	8.5	8.6	5.1	5.2	3.8	5.6	5.0	4.0	4.6	4.5	4.1	4.2	5.3	6.5	5.2	19.2	73.6	7.2	5.5	1.7	4.3	9.4	4.0	11.1	16.8	12.3	12.6	7.2	17.8	18.4	14.6	12.9	3.5	14.2	9.8	8.2	28.7	6.3	6.1	7.6	4.2	9.9	6.4	9.9	24.3	8.5	6.6	5.7	3.8	6.7	8.9	36.0	15.1	5.0	5.7	10.8	6.1	7.5	1.6	44.0	10.5	6.2	3.6	6.5	7.5	13.6	9.2	9.0	10.8	8.5	10.3	11.3	7.0	4.5	23.0	11.2	7.8	11.4	6.6	8.8	7.8	4.6	9.8	9.5	2.4	4.4	5.8	16.9	13.0	4.0
RAB7A	"CMT2B, RAB7"	ENSG00000075785	"RAB7A, member RAS oncogene family"	P51149	3	128693669-128825942	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, Host-virus interaction, Lipid degradation, Lipid metabolism, Protein transport, Transport"	Hydrolase	"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006964, CAB037131"	Supported		Supported	Lysosomes		NA	NA		5700000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Lysosomes		"CAB037131: AB_477460, HPA006964: AB_1856015"	"unprognostic (1.99e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (1.52e-4)"	"unprognostic (1.45e-1)"	"unprognostic (7.82e-2)"	"prognostic unfavorable (9.89e-6)"	"unprognostic (2.15e-2)"	"unprognostic (2.38e-1)"	"unprognostic (3.50e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (4.69e-1)"	"unprognostic (6.73e-3)"	"unprognostic (1.88e-1)"	"unprognostic (1.97e-1)"	"unprognostic (3.03e-3)"	"unprognostic (5.64e-3)"	170.6	157.1	120.1	101.4	132.2	99.9	149.5	133.4	159.4	138.3	123.7	128.9	108.3	137.4	143.0	188.2	110.1	109.7	186.8	128.9	138.4	131.8	145.2	152.9	108.8	138.8	142.0	122.7	88.6	155.9	101.5	117.5	139.4	101.3	126.0	103.8	133.3	63.9	332.4	164.9	116.8	124.0	135.9	123.0	114.9	61.5	140.3	124.6	122.5	249.7	136.6	144.4	143.4	159.0	280.2	95.5	146.0	78.3	300.6	94.0	126.0	252.8	183.9	164.4	158.8	170.1	179.2	134.2	163.2	236.2	289.9	163.4	175.2	248.6	99.2	149.4	111.7	294.3	83.6	165.8	303.0	269.4	182.5	243.7	104.0	176.7	204.4	220.7	89.2	114.4	143.4	148.0	108.1	213.1	176.8	294.6	121.4	294.8	144.8	140.2	130.7	170.4	85.7	205.4	105.8	138.5	142.1	194.7	405.4	174.9	180.3	254.8	202.9	192.7	98.0	325.7	125.9	184.4	187.0	192.0	312.7	212.1	235.5	194.9	176.8	213.6	92.1	192.3	92.3	93.2	97.4	94.5	200.0	85.8	94.8	93.6	374.2	128.8	204.0	81.8	120.7	201.3	120.1	132.2	133.4	159.4	128.9	138.4	138.8	142.0	139.4	135.9	140.3	159.0	154.4	89.8	81.8	66.9	109.9	296.7	331.2	218.1	104.7	66.0	112.8	73.0	110.7	90.1	129.4	132.4	18.8	230.0	92.3	222.1	240.7	259.6	11.2	90.8	90.8	165.3	96.9	111.3	83.9	198.9	283.4	172.5	79.0	142.4	146.2	46.5	142.8	127.9	403.9	74.0	82.5	122.8	219.7	208.6	379.9	19.6	133.6	242.8	339.7	99.3	220.9	154.6	121.5	80.9	111.4	303.7	185.0	157.2	79.9	279.2	172.7	332.3	118.7	37.6	138.1	107.7	160.5	116.4	100.4	122.8	308.0	497.9	107.7	109.6	103.5	324.6
RABAC1	"PRA1, PRAF1, YIP3"	ENSG00000105404	"Rab acceptor 1"	Q9UI14	19	41956681-41959321	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019320, HPA029171"	Supported					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"			"CAB019320: , HPA029171: AB_10602121"	"unprognostic (7.70e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.93e-1)"	"unprognostic (3.41e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.32e-3)"	"unprognostic (9.69e-2)"	"unprognostic (1.76e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.31e-1)"	"unprognostic (6.97e-2)"	"unprognostic (7.45e-2)"	180.4	163.6	128.4	61.1	129.5	53.2	170.4	136.7	177.5	213.4	137.5	192.0	75.3	234.5	28.2	115.9	174.2	37.9	166.5	122.3	149.5	181.7	198.9	180.7	51.9	151.7	135.4	184.3	177.9	68.7	242.4	55.4	149.1	160.4	28.4	14.6	197.2	57.9	125.9	146.7	148.9	49.0	136.7	166.0	189.9	155.4	144.5	34.0	171.4	38.0	31.3	168.6	171.4	147.7	95.7	261.0	35.5	94.6	234.8	136.7	47.7	278.8	144.9	67.3	93.8	46.8	60.6	277.0	140.4	161.9	39.1	70.0	21.9	89.0	25.5	102.1	151.6	40.4	73.0	82.1	130.8	35.5	106.7	137.5	86.5	45.5	31.0	84.4	94.2	76.0	17.9	346.6	61.0	149.2	62.6	32.0	44.4	136.8	167.6	83.3	77.4	54.4	65.0	71.8	67.0	97.4	73.5	157.3	71.3	26.2	59.1	29.4	187.2	119.3	77.4	116.2	40.4	303.8	111.0	96.1	172.3	66.3	131.3	720.0	389.3	551.7	372.2	217.3	313.6	398.7	331.0	325.0	232.5	339.4	222.3	298.8	774.6	253.4	220.1	410.2	403.4	511.2	128.4	129.5	136.7	177.5	122.3	149.5	151.7	135.4	149.1	136.7	144.5	147.7	333.1	128.2	109.8	19.2	203.4	124.7	160.1	242.1	119.5	62.6	173.6	232.3	59.9	163.0	162.3	182.1	16.7	187.5	173.6	411.2	137.0	339.7	203.1	91.9	247.0	234.4	195.0	35.1	14.8	301.4	467.1	309.7	138.6	143.8	142.7	163.5	241.3	237.7	174.0	57.2	18.8	507.5	246.2	119.8	187.0	658.2	307.0	133.1	405.6	21.5	230.8	168.4	161.7	21.1	43.1	427.9	371.7	251.3	625.9	222.3	358.3	326.7	154.8	69.2	230.1	129.4	337.8	234.3	136.1	89.7	136.4	271.7	188.7	176.1	247.4	223.3
RABGEF1	"rabex-5, RABEX5"	ENSG00000154710	"RAB guanine nucleotide exchange factor 1"	Q9UJ41	7	66682164-66811464	"Predicted intracellular proteins, Transporters"	"Endocytosis, Protein transport, Transport, Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 76.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 91.4;Excitatory neurons: 124.5;Inhibitory neurons: 151.1;Oligodendrocyte precursor cells: 100.5;Oligodendrocytes: 244.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001407			Supported	Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Cytosol	Nucleoli	"HPA001407: AB_1856024"	"unprognostic (6.65e-2)"	"unprognostic (6.44e-4)"	"unprognostic (7.32e-2)"	"unprognostic (1.61e-1)"	"prognostic unfavorable (4.06e-5)"	"unprognostic (3.77e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.51e-2)"	"unprognostic (3.32e-1)"	"unprognostic (4.64e-4)"	"unprognostic (6.45e-2)"	"prognostic favorable (1.27e-4)"	"unprognostic (1.43e-1)"	"unprognostic (5.55e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.39e-1)"	16.2	14.1	15.0	11.2	14.9	76.7	13.0	14.9	18.8	13.1	15.6	10.7	8.0	11.5	10.0	19.6	8.8	14.2	9.8	15.2	16.1	11.5	14.8	10.5	11.5	15.6	14.7	12.0	9.7	14.8	4.4	13.2	15.3	12.0	11.9	49.8	8.6	17.3	13.0	23.9	9.2	12.4	14.3	9.4	10.5	25.1	15.5	13.2	15.9	13.3	16.9	19.1	14.1	17.6	47.5	10.2	10.0	16.9	32.1	45.2	10.4	40.9	52.8	42.6	40.2	12.2	28.5	22.4	13.9	60.7	28.2	17.7	16.8	22.3	59.0	14.9	11.2	12.5	14.6	11.8	25.5	21.5	16.9	22.2	28.5	54.9	60.4	33.2	11.3	13.7	21.6	13.9	42.9	19.2	13.2	27.7	15.0	20.2	19.3	12.2	20.1	14.7	37.4	19.5	12.2	17.8	16.8	37.5	19.6	15.6	19.4	12.3	14.0	65.8	12.2	42.4	32.0	19.8	28.7	25.1	31.6	23.0	18.6	18.3	6.5	7.8	7.4	5.7	8.1	9.1	6.3	8.9	6.1	12.5	6.3	6.3	11.8	13.8	12.9	8.1	5.1	6.4	15.0	14.9	14.9	18.8	15.2	16.1	15.6	14.7	15.3	14.3	15.5	17.6	7.3	12.8	12.8	91.4	11.5	4.1	11.4	3.2	10.2	9.9	11.5	7.7	4.8	4.3	10.9	5.5	16.7	3.8	13.2	10.0	11.7	5.4	5.4	13.6	12.5	5.7	18.0	3.0	124.5	5.5	3.8	14.6	8.6	22.0	14.0	8.8	5.7	8.0	4.8	8.4	151.1	4.3	2.0	15.2	5.0	2.8	5.9	19.9	1.8	60.9	6.2	5.5	7.2	100.5	244.1	18.1	13.4	9.4	15.2	13.4	4.4	5.5	11.9	18.9	0.0	10.6	8.5	8.4	6.5	8.3	6.7	13.5	9.5	7.0	5.5	12.3
RACK1	"Gnb2-rs1, GNB2L1, H12.3"	ENSG00000204628	"Receptor for activated C kinase 1"	P63244	5	181236897-181248096	"Plasma proteins, Predicted intracellular proteins, Ribosomal proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Gastrulation, Growth regulation, Host-virus interaction, Translation regulation"	"Developmental protein, Ribonucleoprotein, Ribosomal protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 3642.0;Breast myoepithelial cells: 3742.9;Cytotrophoblasts: 3252.2;Exocrine glandular cells: 3361.4;Extravillous trophoblasts: 4389.3;Syncytiotrophoblasts: 3206.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004288, HPA021676"	Uncertain		Supported	Nucleoplasm,Cytosol		NA	NA		630000	"Cluster 30: Non-specific - Translation"	"Cluster 50: Non-specific - Ribosome"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm	Cytosol	"CAB004288: AB_2247471, HPA021676: AB_1849868"	"unprognostic (4.02e-2)"	"unprognostic (2.94e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.03e-2)"	"unprognostic (1.07e-2)"	"unprognostic (7.43e-2)"	"prognostic unfavorable (2.98e-6)"	"unprognostic (4.19e-1)"	"unprognostic (3.04e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.81e-1)"	"unprognostic (1.05e-3)"	"unprognostic (3.67e-1)"	"unprognostic (1.78e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.62e-1)"	873.7	718.9	473.2	701.4	488.1	1590.2	1435.8	482.6	527.4	1091.1	505.6	1033.5	747.7	884.8	989.4	1154.9	1366.8	732.8	676.4	457.2	487.8	641.2	817.0	631.4	1358.7	519.6	485.3	2527.6	1504.7	721.7	582.6	763.8	514.8	716.2	922.6	286.5	1204.1	638.1	1167.2	1242.9	788.2	823.6	514.0	821.7	753.6	230.4	490.2	1703.2	820.4	1152.2	1590.1	1026.2	896.4	532.7	1606.0	1783.0	1498.7	2930.0	2671.8	4139.8	2576.4	1409.8	2832.1	2364.7	2463.4	3845.9	1671.3	3592.6	1735.5	2068.5	1668.5	1216.3	1867.9	6501.5	1729.1	3457.2	3068.4	1205.2	1939.5	2508.6	3610.1	3145.0	1193.1	4375.7	3664.7	1935.6	3427.8	2880.2	2705.8	2328.3	1610.6	2717.9	2117.6	3742.7	2435.7	2703.6	1535.1	1487.1	1504.9	2218.3	1536.5	3279.6	2733.5	2152.4	1969.8	2163.4	865.3	2682.2	4446.4	1015.6	1882.1	2802.9	2089.8	1297.4	1032.1	1029.1	2315.5	1767.8	2293.6	2063.5	1242.5	2470.7	1440.5	577.1	1163.9	290.3	829.2	908.1	1333.4	1732.3	1391.2	1062.0	1405.6	1689.0	1597.5	1348.6	138.6	1092.2	861.8	1037.0	1465.0	3377.9	473.2	488.1	482.6	527.4	457.2	487.8	519.6	485.3	514.8	514.0	490.2	532.7	896.6	576.9	935.7	0.0	698.1	0.0	0.0	0.0	0.0	0.0	3642.0	3742.9	0.0	0.0	452.5	498.4	0.0	3252.2	821.7	0.0	1749.1	1773.1	0.0	590.9	1560.3	523.7	0.0	0.0	0.0	3361.4	4389.3	783.3	0.0	818.8	671.1	1822.8	0.0	0.0	1964.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	669.4	0.0	0.0	1169.6	0.0	0.0	0.0	0.0	2097.2	0.0	0.0	200.2	0.0	0.0	2538.2	253.6	0.0	0.0	0.0	689.9	0.0	0.0	0.0	0.0	3206.0	503.5	2464.9	0.0	0.0
RAE1	"Gle2, Mnrp41"	ENSG00000101146	"Ribonucleic acid export 1"	P78406	20	57351223-57379211	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 103.0"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 113.6;Spermatocytes: 256.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048795			Supported	"Nucleoplasm,Nucleoli fibrillar center"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Nucleoplasm, Nucleoli fibrillar center"		"HPA048795: AB_2680523"	"unprognostic (1.20e-1)"	"unprognostic (5.98e-2)"	"unprognostic (4.55e-2)"	"prognostic unfavorable (2.44e-4)"	"unprognostic (3.23e-1)"	"unprognostic (2.04e-1)"	"prognostic unfavorable (2.12e-7)"	"unprognostic (1.88e-1)"	"unprognostic (8.26e-2)"	"unprognostic (1.22e-1)"	"unprognostic (5.50e-3)"	"unprognostic (3.88e-2)"	"unprognostic (7.48e-2)"	"unprognostic (3.55e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.89e-1)"	"unprognostic (2.01e-1)"	14.0	13.9	18.6	13.5	19.1	50.5	17.0	18.5	19.1	15.5	17.6	14.2	11.9	16.6	18.2	20.5	17.4	9.0	13.3	18.3	19.9	14.1	16.5	10.0	20.8	16.3	15.9	16.3	10.8	19.1	13.3	14.6	17.0	12.4	16.2	20.1	12.8	15.0	15.0	22.9	13.6	16.3	17.2	17.0	12.8	103.0	21.4	29.2	12.1	15.8	26.5	14.5	16.0	19.6	43.5	52.6	52.8	29.3	30.1	29.0	46.1	33.9	47.2	172.2	70.3	166.1	33.8	69.2	46.8	52.8	63.8	56.6	101.6	88.3	142.1	20.8	45.2	47.0	46.0	74.9	59.0	57.1	41.3	41.3	74.0	75.8	83.1	29.1	49.9	47.2	84.8	32.5	53.0	114.8	88.3	53.2	32.9	86.3	93.3	47.6	49.4	46.0	37.3	45.5	55.2	47.6	58.4	129.4	61.0	41.2	71.5	54.0	29.7	70.6	63.0	41.7	57.7	34.9	83.9	81.8	48.3	36.1	35.6	21.2	42.0	77.0	27.0	36.8	32.9	31.2	26.0	26.8	32.3	28.1	33.9	30.7	36.2	24.7	37.9	23.8	24.6	40.4	18.6	19.1	18.5	19.1	18.3	19.9	16.3	15.9	17.0	17.2	21.4	19.6	17.5	19.2	16.7	8.5	21.0	17.2	16.3	42.0	15.9	15.9	12.6	19.3	10.4	11.5	24.1	18.4	14.6	52.8	20.8	11.6	27.4	30.3	113.6	16.5	16.7	17.9	6.6	18.7	10.2	14.3	39.3	18.6	12.2	15.3	38.0	25.6	11.0	13.5	38.3	3.3	9.5	15.2	18.3	59.5	14.5	63.9	21.8	33.5	10.6	14.0	40.0	19.9	27.8	5.5	13.1	22.2	24.3	22.6	15.9	14.0	10.1	20.6	24.1	17.9	19.7	11.6	19.9	256.9	83.1	19.2	21.0	70.5	24.2	34.9	20.1	16.2
RALBP1	"RIP, RIP1, RLIP76"	ENSG00000017797	"RalA binding protein 1"	Q15311	18	9475009-9538114	"Metabolic proteins, Predicted intracellular proteins, RAS pathway related proteins, Transporters"	Transport	"GTPase activation, Translocase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Collecting duct cells: 480.1;Extravillous trophoblasts: 518.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"neutrophil: 195.6"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 195.6"	"Cell line enhanced"	"Detected in all"		"OE19: 239.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046010, HPA046651"	Approved		Approved	"Nuclear membrane,Vesicles,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 38: Extravillous trophoblasts - Unknown function"	Cytosol	"Nuclear membrane, Vesicles"	"CAB046010: AB_11126824, HPA046651: AB_2679738"	"unprognostic (1.23e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.53e-1)"	"prognostic favorable (8.47e-4)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"prognostic favorable (5.39e-6)"	"unprognostic (1.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-1)"	29.7	20.4	42.7	23.4	44.1	30.7	27.8	45.8	82.2	26.8	38.6	34.1	18.7	22.1	23.5	50.3	24.8	20.3	28.5	40.7	45.1	42.7	19.9	22.6	24.0	44.1	48.0	26.3	15.4	47.9	16.8	31.4	44.4	32.6	25.4	13.5	25.0	48.2	38.5	75.9	20.4	21.1	43.6	26.5	25.7	13.0	45.3	29.3	22.9	32.5	25.4	33.8	33.3	45.1	58.9	37.6	34.2	39.0	38.3	60.7	43.3	67.7	38.1	35.6	38.0	42.6	57.5	70.5	47.0	64.8	50.2	32.8	48.1	52.7	44.2	71.4	38.5	38.5	34.6	32.7	31.2	114.8	43.0	42.0	52.2	49.6	48.7	47.7	60.6	64.6	53.7	67.7	56.2	46.3	70.7	50.9	25.4	239.5	31.9	93.6	59.4	54.2	48.4	80.7	44.7	34.8	58.2	52.8	30.9	52.3	32.9	53.8	67.4	105.0	76.9	72.3	81.9	38.7	42.9	77.9	45.6	53.4	40.5	13.0	9.6	15.7	10.3	10.6	8.7	9.9	8.7	8.8	8.7	7.5	7.3	9.4	195.6	14.8	17.8	19.8	6.4	4.5	42.7	44.1	45.8	82.2	40.7	45.1	44.1	48.0	44.4	43.6	45.3	45.1	101.8	57.7	35.7	15.3	48.0	156.4	80.9	59.9	112.7	42.6	96.0	102.2	64.8	88.6	64.6	480.1	29.2	104.2	70.9	122.6	123.3	119.4	16.1	99.1	82.6	86.9	74.2	175.7	25.4	90.7	518.6	71.6	56.1	179.4	40.5	85.8	78.9	88.3	70.1	52.2	26.7	87.7	109.9	92.8	69.7	9.5	72.7	78.4	58.7	20.6	99.6	47.6	83.4	17.1	25.3	166.3	78.2	87.3	63.2	174.4	61.0	115.0	38.6	37.3	65.7	76.8	105.6	66.7	80.0	149.6	242.5	44.6	62.6	128.4	90.1	216.4
RAMP1		ENSG00000132329	"Receptor activity modifying protein 1"	O60894	2	237858893-237912106	"FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 706.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 190.0;Endometrial stromal cells: 546.4;Exocrine glandular cells: 278.2;monocytes: 433.5"	"Cancer enhanced"	"Detected in all"		"prostate cancer: 152.7"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	18	"NK-cell: 70.1"	"Lineage enriched"	"Detected in many"	18	"NK-cells: 70.1"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 47.4;HDLM-2: 146.0;PC-3: 173.8;SH-SY5Y: 201.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057814			Approved	"Nucleoplasm,Nuclear membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"		"HPA057814: AB_2683536"	"unprognostic (1.13e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.03e-3)"	"unprognostic (3.69e-1)"	"unprognostic (4.29e-1)"	"unprognostic (1.75e-1)"	"prognostic favorable (7.61e-4)"	"unprognostic (2.54e-1)"	"unprognostic (3.49e-1)"	"unprognostic (5.45e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.46e-3)"	"prognostic unfavorable (1.68e-4)"	"unprognostic (1.74e-1)"	"unprognostic (3.98e-2)"	"unprognostic (2.08e-3)"	18.7	29.2	170.9	21.0	171.2	0.9	7.4	168.7	253.4	362.4	153.7	349.6	57.5	706.0	25.0	9.4	256.6	28.5	287.6	176.0	181.8	26.0	82.7	32.5	6.6	198.8	164.5	45.2	225.0	1.4	15.2	8.6	163.0	142.2	6.4	0.8	10.0	54.6	212.3	11.6	73.5	125.4	171.7	12.3	103.4	5.1	183.5	2.9	6.8	68.8	2.9	171.4	75.1	173.2	29.8	0.0	0.5	0.0	12.4	17.9	1.1	2.1	3.6	1.7	1.5	0.0	47.4	0.3	0.4	0.9	0.1	0.2	7.6	0.1	0.2	146.0	4.0	0.1	0.0	1.2	40.6	0.0	0.2	15.6	22.3	0.1	0.3	0.2	0.0	0.0	0.0	0.3	3.7	2.7	0.1	1.3	0.4	0.1	173.8	0.0	1.5	0.8	0.0	0.0	1.5	201.7	3.5	0.0	0.1	1.8	1.3	0.1	0.0	0.8	0.6	0.4	0.5	0.3	0.3	0.0	0.6	0.1	2.7	0.0	0.0	0.0	3.8	0.0	0.0	0.3	0.6	0.1	1.0	0.0	0.5	0.2	0.4	70.1	0.0	0.2	0.0	3.4	170.9	171.2	168.7	253.4	176.0	181.8	198.8	164.5	163.0	171.7	183.5	173.2	1.0	0.0	1.5	64.9	3.1	11.6	13.2	26.9	10.2	2.0	4.4	4.4	190.0	78.6	43.8	11.0	0.0	3.0	44.0	2.1	0.0	62.7	0.2	26.5	546.4	6.2	115.4	4.4	14.2	278.2	5.5	41.7	31.1	11.3	1.3	0.6	30.7	104.0	22.7	1.7	19.2	73.7	10.2	3.1	50.3	0.6	8.4	20.3	64.0	13.1	433.5	6.9	61.8	71.9	11.5	63.5	87.7	11.3	1.9	66.1	96.8	0.2	97.0	2.7	6.6	16.6	78.6	0.3	5.8	2.6	5.8	2.3	7.3	0.5	105.8	28.5
RAMP2		ENSG00000131477	"Receptor activity modifying protein 2"	O60895	17	42758447-42763041	"FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Adipocytes: 1066.8;Endothelial cells: 562.9;Hepatic stellate cells: 344.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	21	"plasmacytoid DC: 2.9"	"Lineage enriched"	"Detected in single"	21	"dendritic cells: 2.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 120.4;EFO-21: 80.5;HUVEC TERT2: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052020			Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"HPA052020: AB_2681697"	"unprognostic (8.64e-2)"	"unprognostic (2.12e-2)"	"unprognostic (8.03e-2)"	"unprognostic (1.16e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-1)"	"unprognostic (4.50e-2)"	"unprognostic (5.18e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.79e-2)"	"unprognostic (1.28e-2)"	"unprognostic (6.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.25e-1)"	190.0	29.0	60.4	19.2	61.8	0.1	168.9	61.7	72.3	100.7	67.7	35.7	12.5	63.1	27.8	25.1	51.7	39.6	123.2	59.3	65.8	70.5	16.7	163.3	26.2	65.7	68.1	33.0	17.1	23.8	20.8	97.0	72.7	42.1	21.1	4.1	45.9	27.5	43.3	55.9	44.1	72.6	62.7	40.2	33.9	11.9	66.6	11.4	71.7	98.7	24.5	45.9	49.6	62.4	0.1	1.1	4.9	0.1	120.4	6.2	4.0	0.9	2.1	10.2	4.9	11.5	0.1	0.0	80.5	3.0	0.5	0.0	4.6	0.1	8.9	0.0	0.2	0.0	0.7	3.7	3.0	0.0	0.0	4.2	0.1	1.8	0.4	3.5	37.6	1.5	0.1	0.2	0.6	0.0	0.6	0.8	23.3	0.0	0.0	0.1	0.1	0.0	0.6	0.6	4.8	9.8	2.9	0.0	17.3	4.8	1.2	3.2	6.7	19.3	7.1	0.4	2.4	0.0	0.1	0.3	0.0	0.1	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.1	0.0	60.4	61.8	61.7	72.3	59.3	65.8	65.7	68.1	72.7	62.7	66.6	62.4	1066.8	0.0	5.7	1.6	6.2	34.4	5.4	0.9	9.6	0.6	24.0	24.8	2.2	0.0	1.0	3.7	0.0	1.1	3.7	0.1	3.9	0.6	1.6	22.2	52.8	562.9	4.2	0.0	0.2	0.7	1.7	126.9	3.1	38.5	0.0	1.4	344.8	1.3	3.4	0.0	1.0	0.2	20.3	8.4	40.5	3.6	38.8	4.1	23.2	45.0	2.6	15.5	0.0	1.5	0.3	0.0	0.0	21.8	5.2	4.8	0.0	1.0	0.1	1.8	6.6	10.5	26.3	26.6	59.1	2.6	27.6	1.5	4.0	14.0	0.1	4.3
RAMP3		ENSG00000122679	"Receptor activity modifying protein 3"	O60896	7	45157791-45186302	"FDA approved drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 144.6"	"Group enriched"	"Detected in many"	12	"Adipocytes: 287.8;Endothelial cells: 366.0;Hepatic stellate cells: 555.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"Karpas-707: 2.5"	"Group enriched"	"Detected in all"	4	"cerebellum: 62.2;cerebral cortex: 49.2;thalamus: 174.9;white matter: 60.0"	"Low region specificity"	"Detected in all"			HPA075527			Supported	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA075527: "	"unprognostic (1.62e-3)"	"prognostic favorable (2.89e-4)"	"unprognostic (4.85e-2)"	"unprognostic (6.88e-3)"	"unprognostic (3.68e-2)"	"unprognostic (1.44e-3)"	"prognostic favorable (2.50e-6)"	"unprognostic (1.14e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.19e-1)"	"unprognostic (2.79e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.43e-1)"	"unprognostic (1.91e-1)"	"unprognostic (9.21e-2)"	86.9	32.6	17.7	23.0	19.7	0.2	71.7	26.9	22.7	33.5	21.3	24.4	10.2	25.9	3.9	18.9	22.8	28.7	91.3	19.2	25.8	84.1	23.9	144.6	55.0	37.3	25.7	7.4	19.7	28.1	22.3	8.6	34.2	29.7	8.6	1.1	22.1	12.9	19.3	22.8	30.0	24.4	31.6	11.4	25.7	6.3	23.5	7.3	71.9	26.9	30.3	28.5	30.5	42.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.3	17.7	19.7	26.9	22.7	19.2	25.8	37.3	25.7	34.2	31.6	23.5	42.4	287.8	0.0	1.9	0.3	3.6	16.3	0.3	0.0	2.2	0.6	5.9	2.8	8.7	1.5	0.0	0.0	0.0	0.1	1.2	0.0	0.0	0.1	20.8	0.4	7.3	366.0	0.0	13.5	3.5	0.7	0.1	10.7	0.0	0.2	0.0	0.0	555.4	7.3	0.5	0.0	0.2	0.0	0.0	31.2	19.1	6.7	1.2	1.3	26.6	5.6	0.0	0.2	0.0	0.0	6.5	0.0	0.0	1.2	1.3	0.6	0.0	0.0	0.0	0.5	0.0	2.8	4.9	0.3	0.9	0.9	14.5	0.0	1.7	1.5	0.0	0.5
RAN	"ARA24, Gsp1, TC4"	ENSG00000132341	"RAN, member RAS oncogene family"	P62826	12	130872037-130877678	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Host-virus interaction, Mitosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA063353			Enhanced	Nucleoplasm		No	No		4000000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 53: Non-specific - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm		"HPA063353: "	"unprognostic (2.22e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.39e-3)"	"prognostic unfavorable (9.99e-8)"	"unprognostic (2.81e-3)"	"unprognostic (1.28e-1)"	"unprognostic (5.41e-3)"	"unprognostic (2.76e-2)"	"prognostic unfavorable (7.86e-5)"	"prognostic unfavorable (1.46e-7)"	"unprognostic (6.55e-2)"	"unprognostic (2.79e-1)"	"unprognostic (4.62e-1)"	"unprognostic (3.16e-2)"	285.3	333.2	207.7	340.1	222.3	406.0	220.5	212.1	265.0	193.6	204.5	269.1	177.8	207.6	238.1	445.6	180.6	148.9	256.9	220.6	260.3	249.0	208.2	225.9	416.4	207.2	213.3	180.7	192.9	210.6	180.1	243.0	231.0	149.7	266.6	213.3	200.4	155.5	415.0	231.2	220.0	250.1	228.5	255.9	223.4	308.6	236.5	577.6	166.8	383.7	480.6	380.9	244.7	230.2	1391.5	1850.5	1580.8	921.6	707.0	868.2	1219.5	1770.2	926.2	1695.1	1163.1	2003.5	1434.2	2260.7	1169.3	1290.0	1067.9	877.0	2327.1	1854.5	1830.8	766.9	1831.5	1331.9	1318.9	2068.9	864.1	2347.9	1100.3	821.9	1129.3	1470.6	2111.6	1119.9	1671.0	1593.5	2013.6	656.5	1686.3	1688.2	2306.9	2810.1	1857.8	1429.2	2936.2	1773.9	1347.2	1274.4	1608.2	2377.1	1441.5	875.0	1018.5	920.7	1334.4	1299.9	1817.9	1666.5	1157.6	975.6	1495.0	998.8	1694.1	905.2	1605.1	3245.4	1002.2	1410.7	1390.4	285.0	398.0	275.5	501.5	489.3	614.6	726.4	682.5	581.4	531.7	593.3	611.5	585.9	80.7	500.4	481.0	506.9	768.0	1005.0	207.7	222.3	212.1	265.0	220.6	260.3	207.2	213.3	231.0	228.5	236.5	230.2	321.3	182.7	141.5	18.6	337.4	635.3	693.4	702.0	406.3	155.3	239.0	316.0	112.6	165.8	310.5	169.2	37.5	734.2	273.6	157.0	387.4	642.1	90.2	212.9	280.8	306.2	201.9	540.9	27.8	452.8	1266.0	379.6	181.0	201.3	194.0	273.1	143.8	181.6	624.5	139.7	25.8	300.5	349.9	171.7	424.1	148.1	213.4	239.7	332.6	9.4	417.0	287.5	219.4	19.6	23.5	596.4	189.1	230.9	418.2	954.8	167.2	423.2	214.3	141.6	164.3	286.0	600.8	746.4	571.6	578.0	547.0	613.1	332.3	451.9	403.6	621.0
RANBP17		ENSG00000204764	"RAN binding protein 17"	Q9H2T7	5	170861870-171300015	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 2.3"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 112.7;Excitatory neurons: 100.6;Glandular and luminal cells: 59.5;Inhibitory neurons: 152.9;Oligodendrocyte precursor cells: 65.4;Oligodendrocytes: 87.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 4.0;SK-BR-3: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029568, HPA029569"	Uncertain		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies,Cytosol"		Yes	No				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Nuclear bodies"	"Nuclear membrane, Cytosol"	"HPA029568: AB_10599825, HPA029569: AB_10601571"	"unprognostic (4.63e-2)"	"unprognostic (2.63e-3)"	"unprognostic (1.06e-1)"	"unprognostic (8.28e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.12e-3)"	"unprognostic (1.50e-1)"	"unprognostic (2.45e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.54e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.19e-3)"	"unprognostic (2.72e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.56e-3)"	0.2	0.8	0.3	0.1	0.2	0.1	0.2	2.3	0.6	0.2	0.8	0.2	0.2	0.5	0.2	0.0	0.4	0.5	0.2	0.1	1.1	0.4	0.3	0.8	0.3	0.9	0.9	0.2	1.4	0.8	0.4	0.8	1.3	0.4	0.4	0.8	0.8	0.5	0.0	0.1	0.3	0.3	0.6	0.0	0.3	1.4	0.6	0.2	1.0	0.0	0.1	0.1	0.1	1.1	0.0	0.7	4.0	3.3	1.3	0.3	2.4	2.6	1.2	1.8	1.1	1.5	0.0	0.1	2.0	2.5	0.0	0.0	0.0	1.2	3.5	0.0	2.4	0.7	1.4	0.0	1.1	0.0	0.0	2.6	0.2	0.2	0.0	0.2	1.7	0.0	0.3	0.0	1.0	1.7	0.0	0.0	0.3	0.6	0.2	0.0	2.4	0.0	0.6	1.0	0.2	1.4	0.0	3.9	1.5	1.7	0.7	1.2	2.4	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	2.3	0.6	0.1	1.1	0.9	0.9	1.3	0.6	0.6	1.1	9.4	9.6	2.0	12.7	0.0	0.3	6.2	5.8	1.8	24.8	6.1	2.8	1.3	7.2	4.8	0.0	14.6	10.4	1.7	2.3	0.0	7.3	112.7	22.4	17.5	7.9	5.4	5.5	100.6	1.4	3.2	4.9	5.1	59.5	0.0	15.6	4.2	1.6	1.9	0.0	152.9	3.7	2.0	0.6	1.4	46.5	2.8	1.0	1.8	9.4	1.2	5.5	5.2	65.4	87.1	5.3	2.9	3.0	0.8	13.0	3.9	0.9	2.4	26.9	0.0	3.0	5.1	27.2	26.7	1.4	0.0	2.5	0.8	7.5	6.3	7.6
RANBP2	"ADANE, ANE1, NUP358"	ENSG00000153201	"RAN binding protein 2"	P49792	2	108719482-108785809	"Cancer-related genes, Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway"	"RNA-binding, Transferase"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018437, HPA023960, CAB034063, HPA049497, HPA051675, HPA067564"	Supported		Supported	"Nucleoplasm,Nuclear membrane,Vesicles"		NA	NA		160000	"Cluster 38: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Vesicles"	"CAB034063: AB_2176784, HPA018437: AB_2620151, HPA023960: AB_2671385, HPA049497: AB_2680794, HPA051675: AB_2681570, HPA067564: AB_2685862"	"unprognostic (2.51e-1)"	"unprognostic (3.99e-2)"	"unprognostic (1.22e-1)"	"unprognostic (4.37e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (5.47e-2)"	"unprognostic (2.91e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.54e-1)"	"unprognostic (4.23e-1)"	"unprognostic (5.23e-2)"	"unprognostic (1.62e-2)"	"unprognostic (8.74e-2)"	"unprognostic (3.08e-1)"	"unprognostic (3.40e-2)"	"unprognostic (2.53e-1)"	20.3	24.3	8.6	16.3	11.6	42.1	19.7	14.4	17.1	18.1	20.3	15.6	13.4	17.7	20.5	14.3	14.6	13.7	14.9	11.8	9.4	18.1	17.4	14.0	18.6	9.2	8.1	24.4	20.2	30.1	21.5	16.5	9.5	20.9	15.2	26.5	16.4	17.2	30.3	17.2	13.4	15.2	8.6	15.0	17.6	21.3	8.2	23.3	28.4	23.6	18.0	16.9	12.1	12.2	40.5	24.2	34.1	31.0	38.7	34.5	32.9	35.5	28.0	28.7	25.1	60.7	18.9	63.2	26.8	37.2	35.3	33.1	58.9	36.9	41.5	38.9	28.5	65.9	30.3	43.2	22.5	77.9	21.3	29.1	27.5	44.9	34.7	28.3	44.5	27.1	71.9	34.0	38.4	22.3	34.8	31.6	43.0	20.3	28.7	32.3	52.3	30.7	25.3	49.6	49.4	22.6	31.5	26.7	34.7	20.4	17.2	35.4	53.5	29.8	39.6	21.2	40.2	27.9	44.4	55.8	23.1	34.4	23.5	5.4	2.6	2.7	3.7	1.7	4.1	2.7	3.0	3.4	2.2	2.7	2.9	3.3	3.9	2.2	3.6	2.6	2.7	1.4	8.6	11.6	14.4	17.1	11.8	9.4	9.2	8.1	9.5	8.6	8.2	12.2	54.5	76.9	85.3	48.6	91.5	55.7	34.5	39.1	61.5	51.2	34.1	25.8	103.9	38.6	63.0	58.8	73.0	28.8	96.1	28.9	1.9	34.7	77.3	83.6	65.3	55.7	106.4	50.5	125.5	50.9	17.5	56.5	68.3	142.1	84.9	52.2	31.4	56.6	47.9	32.0	92.2	59.5	44.7	44.9	80.7	32.9	38.5	114.0	48.0	55.3	57.0	20.0	34.0	44.2	80.0	41.5	29.9	56.1	118.4	44.1	28.8	15.6	67.0	40.5	46.0	56.9	59.0	78.3	65.4	53.3	67.8	40.6	104.8	25.3	38.3	38.7
RANGAP1	"Fug1, KIAA1835, SD"	ENSG00000100401	"Ran GTPase activating protein 1"	P46060	22	41244779-41286187	"Plasma proteins, Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"Late spermatids: 1717.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004293, HPA050110, HPA062034"	Supported		Enhanced	"Nuclear membrane,Vesicles,Cytosol"		Yes	Yes		75000	"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"	"Nuclear membrane"	"Vesicles, Cytosol"	"CAB004293: AB_2176987, HPA050110: AB_2681018, HPA062034: AB_2684667"	"unprognostic (1.30e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (7.97e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.54e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (8.28e-3)"	"unprognostic (8.09e-2)"	"unprognostic (9.87e-2)"	"unprognostic (5.84e-2)"	"unprognostic (7.56e-2)"	"unprognostic (7.07e-3)"	"prognostic favorable (5.39e-4)"	"unprognostic (2.06e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-1)"	27.5	72.9	78.2	26.0	86.0	48.1	29.6	70.8	102.3	34.4	47.7	29.2	18.1	24.9	12.0	79.8	23.6	17.2	45.1	79.5	85.2	43.9	88.0	41.6	30.6	102.7	77.9	32.5	60.9	12.7	57.4	22.8	105.1	39.3	13.2	32.7	38.0	17.6	43.0	96.9	30.6	17.5	68.7	42.3	39.6	178.1	82.0	40.4	34.4	14.2	31.8	34.7	45.4	109.1	228.0	112.2	75.9	77.3	38.8	31.4	85.9	194.5	103.8	182.8	98.4	135.9	71.9	118.0	154.0	137.4	94.8	203.0	135.5	145.4	125.2	95.7	199.2	103.3	115.0	107.9	46.7	171.6	72.5	30.0	69.5	132.2	123.4	67.6	102.1	45.0	127.7	83.3	111.9	186.1	96.3	130.0	84.5	217.6	127.6	118.8	73.4	126.0	72.5	123.7	66.6	44.1	139.1	117.7	71.7	74.6	72.2	64.4	146.5	141.7	138.5	78.6	154.6	60.1	92.8	124.2	99.3	119.3	82.0	2.7	7.6	6.9	8.1	9.0	9.5	5.9	8.2	7.8	5.6	6.4	7.4	5.9	2.0	5.9	12.9	5.9	9.5	8.2	78.2	86.0	70.8	102.3	79.5	85.2	102.7	77.9	105.1	68.7	82.0	109.1	10.9	3.2	20.9	8.5	15.0	23.1	22.2	10.9	18.2	16.0	22.4	16.9	19.6	25.8	9.6	9.2	14.6	22.7	20.3	22.9	3.9	33.3	270.7	21.0	14.7	16.1	25.0	16.6	28.3	20.3	35.3	13.3	25.5	25.1	6.3	74.4	8.9	21.8	16.6	15.2	20.8	19.1	16.2	13.9	20.9	1717.0	14.9	16.8	12.4	5.6	8.9	10.1	14.4	6.0	32.2	39.8	5.7	12.0	25.8	37.4	7.1	13.1	11.4	26.4	0.0	6.8	18.2	25.6	17.7	38.8	31.0	23.7	24.3	42.5	24.8	23.3
RBM8A	"BOV-1A, BOV-1B, BOV-1C, RBM8, RBM8B, Y14, ZNRP"	ENSG00000265241	"RNA binding motif protein 8A"	Q9Y5S9	1	145917714-145927678	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, mRNA transport, Nonsense-mediated mRNA decay, Translation regulation, Transport"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 735.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018403	Supported		Supported	"Nuclear speckles"		NA	NA		100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Nuclear speckles"		"HPA018403: AB_1858908"	"unprognostic (3.81e-1)"	"unprognostic (3.99e-3)"	"unprognostic (1.59e-1)"	"unprognostic (6.83e-2)"	"unprognostic (1.12e-1)"	"unprognostic (3.16e-1)"	"unprognostic (4.62e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.38e-1)"	"unprognostic (8.79e-3)"	"unprognostic (7.27e-3)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (3.30e-3)"	"unprognostic (2.18e-1)"	"unprognostic (3.77e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.64e-3)"	86.1	74.9	37.2	105.4	39.1	214.7	82.3	38.7	43.0	69.6	35.6	70.5	70.1	67.7	49.3	163.6	62.2	58.0	73.0	36.8	41.7	81.6	77.5	72.8	126.4	39.7	39.8	72.0	59.9	78.4	65.8	85.3	40.8	66.4	56.4	45.0	79.2	48.2	214.9	92.0	69.2	57.7	42.1	81.6	67.5	71.3	40.0	120.7	68.8	100.1	123.7	112.8	80.4	43.9	377.0	300.7	268.8	215.7	94.6	92.2	330.0	224.3	150.7	315.0	230.1	400.0	277.4	342.0	344.9	155.3	166.5	252.5	289.3	245.3	257.0	305.6	275.7	264.2	229.2	299.8	133.6	446.6	222.6	102.2	180.8	283.0	300.3	137.4	238.1	291.9	405.2	314.7	246.2	1033.8	452.3	352.2	463.7	323.9	518.4	394.4	234.6	341.2	203.2	355.6	274.6	335.7	334.5	169.7	316.5	231.0	318.0	534.3	247.3	252.3	324.0	250.9	626.0	352.2	603.4	502.6	226.4	264.9	223.2	464.6	316.5	513.6	337.2	363.9	322.1	444.3	317.6	346.4	318.0	389.6	296.1	328.3	363.7	389.8	361.3	498.4	386.3	582.7	37.2	39.1	38.7	43.0	36.8	41.7	39.7	39.8	40.8	42.1	40.0	43.9	289.1	70.5	132.4	8.1	251.0	332.9	396.7	475.4	244.2	66.3	168.5	184.7	78.0	98.7	262.8	88.3	54.2	376.2	276.0	125.3	187.9	224.1	243.7	148.0	134.3	206.0	158.9	149.2	10.8	223.2	506.3	174.1	80.5	152.8	244.0	136.8	120.3	124.4	204.3	35.3	9.1	127.6	313.3	100.3	265.2	54.4	102.2	170.7	208.1	9.4	197.7	120.3	165.8	6.0	16.1	245.4	159.8	85.4	174.9	259.6	119.5	204.1	195.1	86.3	98.6	213.7	208.1	212.0	168.9	208.1	318.0	735.5	282.1	139.7	141.7	393.0
RBP2	"CRABP-II, CRBP2, CRBPII, RBPC2"	ENSG00000114113	"Retinol binding protein 2"	P50120	3	139452884-139480747	"Metabolic proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	294	"intestine: 2713.5"	"Cell type enriched"	"Detected in some"	26	"Proximal enterocytes: 6095.4"	"Group enriched"	"Detected in many"	4	"colorectal cancer: 7.1;pancreatic cancer: 4.5;stomach cancer: 8.4;testis cancer: 2.9"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"CACO-2: 78.8"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA035866	Enhanced		Approved	"Golgi apparatus"		NA	NA		140000		"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"HPA035866: AB_10672232"	"unprognostic (1.74e-1)"	"unprognostic (2.66e-2)"	"unprognostic (3.34e-2)"	"unprognostic (6.72e-6)"	"unprognostic (2.33e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.24e-1)"	"unprognostic (8.51e-3)"	"unprognostic (3.92e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.24e-3)"	"unprognostic (5.57e-3)"	"unprognostic (1.10e-1)"	"unprognostic (9.23e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.21e-1)"	0.4	1.1	4.6	1.1	3.2	0.7	0.5	0.3	3.2	0.2	0.0	4.0	2713.5	2.0	0.0	0.2	0.3	1.8	0.2	3.3	5.0	2.6	0.0	7.6	2.2	8.1	9.2	0.3	3.0	0.0	0.1	0.1	3.4	0.4	2.4	2.2	0.1	0.0	0.2	1.1	1886.7	1.0	3.4	0.1	3.6	1.0	9.0	0.0	0.5	0.0	0.0	0.0	0.0	5.3	0.0	0.2	0.2	0.2	0.0	0.0	7.1	0.0	0.0	0.0	0.0	78.8	0.1	0.6	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	5.9	0.1	0.2	0.1	0.1	0.0	11.7	0.0	0.0	4.0	10.1	0.0	0.1	0.0	0.5	0.4	0.0	0.0	0.0	0.2	0.5	0.0	0.2	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	3.2	0.3	3.2	3.3	5.0	8.1	9.2	3.4	3.4	9.0	5.3	0.0	9.6	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.1	0.0	0.1	12.9	8.4	0.0	0.0	14.0	0.0	0.6	0.0	0.0	0.0	0.2	1.2	0.0	1.0	6.1	0.0	3.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.1	185.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.5	0.9	6.1	226.3	0.0	0.0	0.0	6095.4	0.0	0.7	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	142.6	0.1
RCVRN	RCV1	ENSG00000109047	Recoverin	P35243	17	9896320-9905271	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Sensory transduction, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	434	"retina: 463.8"	"Cell type enriched"	"Detected in some"	4	"Rod photoreceptor cells: 1926.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	5	"WM-115: 1.8"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.3"	"Low region specificity"	"Detected in many"			"HPA015783, CAB022363"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"CAB022363: , HPA015783: AB_2669298"	"unprognostic (1.65e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.39e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.32e-1)"	"unprognostic (7.95e-3)"		"unprognostic (4.82e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.94e-4)"	"unprognostic (1.62e-2)"	"unprognostic (2.28e-1)"	"unprognostic (1.41e-2)"	"unprognostic (9.23e-2)"	0.1	0.0	0.6	0.0	0.6	0.0	0.0	0.0	1.0	0.2	0.3	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	463.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.0	1.0	0.7	0.2	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	230.5	0.0	0.0	0.5	0.0	0.0	0.0	475.4	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	11.5	0.0	0.0	1.5	0.0	0.0	2.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	107.7	0.7	0.0	0.0	0.0	0.9	0.7	2.5	0.5	1.8	0.0	0.1	393.9	0.0	0.5	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	1926.6	0.0	1.7	0.3	0.1	0.5	0.0	0.3	0.1	0.1	0.0	0.0	0.0
REG3A	"HIP, PAP, PAP1, PBCGF, REG-III, REG3"	ENSG00000172016	"Regenerating family member 3 alpha"	Q06141	2	79157003-79159753	"Plasma proteins, Predicted secreted proteins, Transporters"	"Acute phase, Inflammatory response"	Antimicrobial		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	61	"intestine: 6743.6;pancreas: 12212.2"	"Group enriched"	"Detected in some"	11	"Exocrine glandular cells: 1988.6;Pancreatic endocrine cells: 5382.1"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 710.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 17.6;EFO-21: 15.8;HDLM-2: 15.4;NB-4: 17.7;RPMI-8226: 24.6;SH-SY5Y: 14.6;U-2 OS: 28.5;U-251 MG: 11.0;U-266/84: 15.1"									"HPA047894, HPA048334, HPA060705"	Supported		Approved	Cytosol	"Secreted to digestive system"	NA	NA		23000000		"Cluster 25: Pancreas - Digestion"	"Cluster 24: NB-4 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"	Cytosol		"HPA047894: AB_2680202, HPA048334: AB_2680363, HPA060705: AB_2684346"			"unprognostic (2.43e-2)"				"unprognostic (2.12e-1)"				"unprognostic (3.62e-2)"			"unprognostic (1.42e-1)"				18.5	10.0	0.0	13.3	0.0	0.2	0.6	0.0	0.0	0.3	0.0	19.2	5180.0	2.9	0.0	1.4	0.2	24.9	1.0	0.0	0.0	2.6	2.0	0.5	4.9	0.0	0.0	0.9	12212.2	0.0	2.1	0.1	0.0	0.5	0.0	0.0	2.1	0.0	0.6	0.4	6743.6	0.2	0.0	1.3	156.5	0.9	0.0	0.0	0.6	0.0	0.1	0.2	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	0.0	0.0	0.0	0.0	0.0	0.0	15.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	0.1	0.4	0.0	0.0	0.0	24.6	0.0	0.0	1.8	14.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	28.5	5.4	11.0	0.0	15.1	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	152.8	7.7	0.0	0.0	3.0	0.0	0.0	0.0	1988.6	0.0	0.0	189.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.2	0.0	0.0	0.0	6.8	0.0	1.4	0.0	0.0	55.8	0.0	0.0	0.0	0.0	5382.1	32.5	0.0	0.2	0.0	215.0	0.0	0.0	0.0	0.0	0.0	16.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	315.9	0.0
RER1		ENSG00000157916	"Retention in endoplasmic reticulum sorting receptor 1"	O15258	1	2391775-2405442	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037240, HPA051400"	Supported		Supported	"Golgi apparatus"		No	No			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 37: Intestine - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus"		"CAB037240: AB_2179604, HPA051400: AB_2681469"	"unprognostic (2.90e-2)"	"unprognostic (3.35e-2)"	"unprognostic (3.17e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.72e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (8.23e-8)"	"unprognostic (1.01e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.27e-2)"	100.4	154.2	60.0	89.3	67.6	81.6	97.1	67.0	62.8	93.6	78.3	137.4	114.8	74.4	122.7	176.4	86.1	86.9	75.7	61.1	64.1	106.3	224.8	79.6	94.6	67.0	65.1	92.9	122.3	100.9	82.9	99.0	66.9	94.3	151.4	73.8	101.1	104.2	105.2	101.7	120.0	104.6	65.6	102.2	118.6	107.1	68.5	94.5	85.9	85.1	143.5	101.0	106.5	76.1	203.1	111.0	131.1	146.8	233.7	275.7	100.9	297.1	261.1	254.3	253.2	157.6	299.3	143.9	242.7	297.7	205.1	213.3	152.2	176.7	322.2	180.8	156.1	163.9	247.2	153.0	252.5	181.3	188.6	225.0	176.1	264.3	233.1	175.4	235.8	160.3	197.8	232.6	299.8	141.5	127.2	127.3	87.5	314.1	279.0	146.0	131.9	183.7	227.5	94.3	109.9	126.2	167.9	376.9	242.9	143.7	149.6	127.4	171.8	197.3	114.1	355.9	219.5	223.0	270.2	255.3	209.6	254.8	102.8	239.1	235.5	284.5	195.9	268.2	180.0	169.0	169.8	210.0	221.2	151.7	127.0	155.9	351.3	164.8	275.9	256.1	244.5	309.0	60.0	67.6	67.0	62.8	61.1	64.1	67.0	65.1	66.9	65.6	68.5	76.1	88.7	64.1	50.0	23.5	73.1	53.2	84.4	214.2	50.1	33.6	111.9	123.6	41.6	118.7	131.4	104.8	33.3	233.8	97.5	218.9	66.5	213.4	475.6	89.5	93.5	68.2	36.5	57.2	16.7	258.4	321.8	94.3	71.9	118.8	44.3	76.5	82.1	233.5	217.9	37.0	16.8	158.6	122.1	104.3	73.2	464.0	82.6	99.9	62.2	15.9	126.1	97.0	114.4	19.1	25.8	256.4	195.4	76.0	145.1	142.5	238.7	119.6	136.3	62.6	111.7	60.9	141.6	291.4	145.2	103.4	67.1	467.9	74.3	159.0	162.0	141.0
RETNLB	"FIZZ2, HXCP2, RELMb"	ENSG00000163515	"Resistin like beta"	Q9BQ08	3	108743424-108757384	"Predicted secreted proteins, Transporters"		Hormone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	58	"intestine: 245.5"	"Cell type enriched"	"Detected in some"	38	"Intestinal goblet cells: 210.1"	"Cancer enriched"	"Detected in some"	10	"colorectal cancer: 16.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"OE19: 2.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049152	Enhanced				"Secreted to blood"	NA	NA	123000			"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA049152: AB_2680655"			"prognostic favorable (6.86e-5)"			"unprognostic (1.19e-3)"		"unprognostic (3.37e-2)"		"unprognostic (4.69e-2)"				"unprognostic (2.67e-2)"	"unprognostic (5.78e-2)"		"unprognostic (4.26e-1)"	0.1	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	75.7	16.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	245.5	0.0	0.0	0.1	0.0	0.0	34.5	0.8	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	2.4	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	210.1	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.5	0.0
RETREG1	"FAM134B, FLJ20152, JK1"	ENSG00000154153	"Reticulophagy regulator 1"	Q9H6L5	5	16473038-16617038	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Autophagy		"Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 91.4;skeletal muscle: 141.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 73.7;Cytotrophoblasts: 53.7;Exocrine glandular cells: 59.3;Glandular and luminal cells: 197.7;Pancreatic endocrine cells: 51.5;Proximal tubular cells: 152.8"	"Cancer enhanced"	"Detected in all"		"renal cancer: 28.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.3"	"Group enriched"	"Detected in many"	6	"granulocytes: 2.3;T-cells: 1.7"	"Cell line enhanced"	"Detected in many"		"ASC diff: 26.0;GAMG: 20.3;HSkMC: 28.8;MOLT-4: 20.4;RPTEC TERT1: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012077			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum"		"HPA012077: AB_2668621"	"unprognostic (1.63e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.80e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.96e-2)"	"unprognostic (9.17e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.90e-1)"	"unprognostic (4.35e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.48e-1)"	"prognostic favorable (5.25e-10)"	"unprognostic (3.75e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.58e-1)"	15.6	3.5	20.6	6.6	26.4	2.0	13.6	23.9	33.2	13.2	21.6	24.6	12.6	4.0	5.2	3.6	7.5	13.4	91.4	19.4	22.1	61.0	44.2	9.3	6.4	27.2	25.2	2.1	37.7	30.1	9.9	13.2	27.8	11.1	32.4	7.5	5.2	5.0	141.8	10.0	25.6	2.6	23.6	2.3	10.9	12.3	25.0	20.6	6.7	81.9	4.3	2.3	5.2	37.6	1.3	0.5	0.1	3.5	26.0	3.2	15.1	0.1	3.5	3.1	4.1	2.3	0.1	0.3	2.4	0.0	20.3	3.9	7.8	0.8	1.0	4.1	3.4	0.0	10.6	0.0	0.1	5.3	0.0	28.8	11.7	0.6	3.1	7.5	0.0	15.4	0.0	0.1	1.2	1.0	20.4	0.1	0.8	3.4	0.6	3.2	0.0	1.2	26.2	0.9	17.4	2.0	1.0	1.1	13.1	1.9	5.9	2.4	0.0	2.4	0.2	6.4	3.1	0.7	0.0	0.0	14.9	18.0	6.5	2.3	0.1	0.0	0.2	0.0	0.6	0.0	0.6	0.3	0.0	0.3	1.7	1.0	0.9	0.0	0.0	0.0	0.8	0.2	20.6	26.4	23.9	33.2	19.4	22.1	27.2	25.2	27.8	23.6	25.0	37.6	4.2	73.7	8.6	0.0	3.4	0.0	0.0	0.0	0.0	0.0	33.3	19.0	0.0	0.0	9.9	44.1	0.0	53.7	2.2	0.0	17.6	31.1	0.0	33.5	45.2	1.2	0.0	0.0	0.0	59.3	2.0	7.8	0.0	197.7	1.3	3.3	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	51.5	0.0	0.0	0.8	0.0	0.0	152.8	19.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	10.9	8.1	0.3	0.0	0.0
RFT1	CDG1N	ENSG00000163933	"RFT1 homolog"	Q96AA3	3	53088483-53130453	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA060327, HPA069022"	Approved		Approved	Vesicles		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA060327: AB_2684253, HPA069022: AB_2732126"	"unprognostic (5.74e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.35e-3)"	"unprognostic (5.16e-3)"	"unprognostic (2.08e-1)"	"unprognostic (2.45e-1)"	"prognostic unfavorable (1.69e-4)"	"unprognostic (1.09e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.48e-2)"	"unprognostic (1.96e-1)"	"unprognostic (1.22e-1)"	"unprognostic (5.06e-2)"	"unprognostic (3.54e-2)"	11.8	12.5	5.7	14.5	6.2	8.3	12.5	5.5	6.6	9.0	4.9	11.8	10.3	9.1	13.0	12.1	12.4	10.5	9.0	6.1	5.3	8.7	14.0	9.2	16.7	5.6	5.2	12.5	22.3	15.6	6.2	13.8	5.9	9.3	13.2	4.3	18.0	10.4	5.1	9.9	10.5	11.2	5.5	9.9	10.4	13.5	5.4	14.2	14.6	6.7	15.8	12.6	8.8	8.0	39.1	36.3	24.3	39.0	27.9	29.5	50.6	34.8	32.3	59.2	53.7	35.9	74.6	51.0	21.3	33.5	55.6	40.7	55.4	56.8	51.9	48.4	24.5	50.6	24.8	36.0	48.8	46.7	28.4	31.4	46.8	79.6	57.1	26.2	37.9	52.7	27.1	45.2	39.4	39.6	44.2	27.3	48.8	67.5	47.3	18.1	23.5	77.5	32.8	26.1	13.8	18.7	43.0	30.9	31.2	26.2	23.3	65.5	25.5	54.3	35.2	37.7	69.1	28.6	37.1	38.4	38.9	58.8	58.3	50.2	40.2	18.4	22.2	40.5	22.5	21.2	20.6	22.9	42.9	35.5	23.7	23.7	13.4	23.1	29.4	48.9	20.1	25.7	5.7	6.2	5.5	6.6	6.1	5.3	5.6	5.2	5.9	5.5	5.4	8.0	6.0	3.2	3.7	8.8	8.7	5.0	10.8	18.3	5.2	4.6	7.6	5.5	7.4	11.5	12.6	9.2	4.2	39.4	6.0	5.1	1.9	17.4	1.9	5.6	9.5	8.1	2.4	17.7	9.4	21.1	33.1	9.2	4.1	5.7	2.5	17.8	10.4	10.7	22.0	5.0	8.9	6.4	10.2	9.9	5.0	2.3	8.7	9.8	7.2	9.4	11.7	5.8	3.1	7.5	11.3	12.2	8.8	6.0	19.3	9.1	5.7	5.6	8.3	6.4	0.0	7.0	8.7	10.1	8.9	8.0	4.3	24.2	7.7	22.0	11.7	8.1
RHAG	"CD241, RH50A, SLC42A1"	ENSG00000112077	"Rh associated glycoprotein"	Q02094	6	49605175-49636839	"CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"		"Disease variant, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"bone marrow: 119.6"	"Cell type enriched"	"Detected in some"	170	"Erythroid cells: 494.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	202	"HEL: 506.0;K-562: 491.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA046051, HPA055331"	Approved		Approved	"Endoplasmic reticulum"		NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endoplasmic reticulum"		"HPA046051: , HPA055331: AB_2682785"					"unprognostic (8.16e-2)"						"unprognostic (6.86e-2)"	"unprognostic (1.25e-3)"		"unprognostic (1.65e-1)"				0.2	0.0	0.0	0.0	0.0	119.6	0.0	0.0	0.0	0.7	0.0	0.5	0.1	0.1	0.0	0.1	0.2	0.0	2.1	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.2	0.0	0.2	0.2	0.0	0.2	0.6	0.0	0.1	0.4	0.0	0.0	1.7	0.2	0.1	0.0	0.1	0.1	0.1	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	506.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	491.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.4	0.4	0.1	0.3	0.0	494.2	0.2	0.2	0.6	0.3	0.0	0.6	2.5	0.0	1.1	0.1	0.5	0.0	0.1	0.0	0.0	0.6	0.3	2.9	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.4	0.1	0.0	0.0
RHBDD1	DKFZp547E052	ENSG00000144468	"Rhomboid domain containing 1"	Q8TEB9	2	226835581-226999215	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Differentiation, Spermatogenesis"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 66.9;Microglial cells: 57.1;Oligodendrocyte precursor cells: 55.8;Oligodendrocytes: 109.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-698: 73.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013972, HPA057125"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 57: B-cells - Immune response"	"Endoplasmic reticulum"		"HPA013972: AB_2178629, HPA057125: AB_2683343"	"unprognostic (1.42e-1)"	"unprognostic (5.37e-2)"	"unprognostic (3.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.18e-1)"	"unprognostic (9.40e-2)"	"unprognostic (4.74e-3)"	"unprognostic (4.97e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.77e-2)"	"unprognostic (3.04e-2)"	10.3	8.9	11.2	13.6	20.9	11.9	11.5	12.2	13.6	11.6	1.8	11.5	10.3	13.6	12.5	11.5	12.9	10.9	10.3	8.8	15.2	12.0	15.1	9.9	16.1	15.6	15.0	13.6	13.9	16.5	4.4	9.9	17.1	13.1	11.2	7.4	9.6	13.3	8.9	8.8	11.8	14.3	15.7	14.2	11.4	17.4	16.8	37.5	15.6	8.6	16.9	11.5	7.0	22.8	10.7	9.3	9.9	15.1	28.6	28.8	0.0	24.1	20.9	12.6	14.6	8.3	18.7	10.1	19.8	25.2	18.0	11.9	0.1	26.8	23.9	25.1	9.9	15.3	5.9	6.7	31.5	15.2	8.0	25.6	38.2	23.8	51.4	14.3	9.8	26.7	41.7	25.6	13.4	18.9	27.8	8.5	0.0	12.2	10.3	12.0	0.1	14.9	10.3	13.3	9.7	7.3	13.6	5.1	18.8	17.6	14.1	18.9	13.1	5.6	12.2	22.0	7.5	28.8	14.9	73.9	17.8	19.6	16.2	10.4	13.7	12.8	7.3	20.0	11.8	22.1	11.0	8.9	17.2	24.5	12.6	10.6	3.3	11.8	13.8	21.1	16.2	10.8	11.2	20.9	12.2	13.6	8.8	15.2	15.6	15.0	17.1	15.7	16.8	22.8	6.6	12.8	6.4	66.9	28.4	5.2	8.5	7.2	8.0	8.0	7.6	4.2	16.6	4.3	8.1	11.0	16.7	7.6	9.3	6.6	3.9	7.0	16.7	8.3	8.6	6.8	1.8	15.2	28.4	9.3	4.1	9.3	8.2	7.8	8.2	22.7	3.3	14.0	5.2	11.8	41.5	6.1	6.1	8.2	4.4	24.4	5.6	7.6	12.4	57.1	6.2	6.3	9.2	55.8	109.0	8.3	1.9	6.8	48.8	13.2	6.8	3.4	7.1	6.3	0.0	5.6	6.6	15.2	9.5	7.3	5.5	5.6	8.6	25.7	5.7	8.9
RHBDD2	"NPD007, RHBDL7"	ENSG00000005486	"Rhomboid domain containing 2"	Q6NTF9	7	75842602-75888926	"Enzymes, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 380.1"	"Cell type enhanced"	"Detected in all"		"Late spermatids: 300.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 398.8"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 165.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045074, HPA051960"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA045074: AB_10965705, HPA051960: AB_2681673"	"unprognostic (2.75e-1)"	"unprognostic (3.89e-2)"	"prognostic unfavorable (3.31e-5)"	"unprognostic (9.79e-2)"	"prognostic unfavorable (1.81e-4)"	"unprognostic (2.05e-2)"	"unprognostic (1.18e-2)"	"unprognostic (2.37e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.75e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.87e-2)"	"prognostic favorable (8.68e-6)"	"unprognostic (3.73e-1)"	"unprognostic (6.53e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.03e-1)"	43.9	232.5	247.5	20.0	248.6	26.9	47.7	169.0	313.0	46.7	224.2	39.4	35.7	36.4	59.3	48.5	47.0	23.2	54.7	255.0	380.1	97.7	99.8	72.0	16.2	216.3	252.8	61.2	56.8	182.8	299.6	16.5	274.5	79.0	16.0	39.1	53.3	94.8	35.0	49.4	44.9	11.8	187.5	50.2	57.6	87.2	321.2	19.9	91.1	11.6	12.5	45.3	43.6	208.3	24.0	80.2	34.5	57.9	16.3	11.5	12.8	12.8	50.6	26.6	27.2	43.6	59.7	7.5	13.0	26.3	59.4	33.7	22.4	17.6	10.3	25.9	46.3	9.0	48.0	41.4	45.0	13.8	61.5	25.0	35.7	31.1	12.3	43.9	20.4	51.2	19.0	51.6	26.9	165.3	26.1	74.9	31.7	41.0	45.1	19.4	22.7	66.8	47.2	42.9	43.3	88.7	59.3	107.8	47.9	23.2	66.3	23.2	20.4	43.5	39.6	29.2	27.9	48.4	18.5	12.9	50.4	20.4	59.9	398.8	62.8	79.0	80.0	66.1	68.9	51.7	89.1	71.7	63.0	50.8	72.5	65.3	104.7	63.6	35.1	49.7	126.8	61.2	247.5	248.6	169.0	313.0	255.0	380.1	216.3	252.8	274.5	187.5	321.2	208.3	20.5	41.7	31.9	16.6	23.7	23.2	46.5	127.6	18.2	34.9	42.3	22.4	8.8	55.8	76.8	86.5	33.3	54.8	20.7	48.3	19.6	94.1	171.2	30.2	12.8	26.9	89.8	10.3	27.0	102.1	41.3	34.7	39.8	16.2	192.7	72.4	57.8	43.1	45.5	18.5	31.9	35.1	128.1	35.9	32.7	300.8	42.6	47.8	60.5	5.6	21.4	68.8	29.9	13.0	11.0	78.1	37.6	52.6	27.9	47.8	52.8	52.5	89.3	35.7	6.6	19.0	26.4	57.3	29.7	27.9	23.7	52.0	61.2	198.1	30.2	50.1
RHBG	SLC42A2	ENSG00000132677	"Rh family B glycoprotein"	Q9H310	1	156369211-156385219	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 9.8"	"Group enriched"	"Detected in some"	4	"Granulosa cells: 89.9;Theca cells: 91.3"	"Group enriched"	"Detected in some"	5	"liver cancer: 14.2;renal cancer: 5.1;urothelial cancer: 4.1"	"Region enriched"	"Detected in single"	17	"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CACO-2: 2.9;Hep G2: 3.0;RT4: 5.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"HPA042726, HPA048489"	Enhanced		Approved	Nucleoplasm		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm		"HPA042726: AB_2678131, HPA048489: AB_2680417"	"unprognostic (1.20e-1)"	"unprognostic (2.05e-1)"	"unprognostic (4.55e-3)"	"unprognostic (5.04e-2)"	"unprognostic (2.95e-2)"	"unprognostic (3.76e-3)"	"unprognostic (2.00e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.45e-1)"	"unprognostic (3.72e-1)"	"unprognostic (3.63e-2)"	"unprognostic (4.91e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.91e-3)"	"prognostic favorable (8.06e-4)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	9.8	1.9	0.0	0.0	0.1	0.0	2.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	22.0	0.0	0.0	0.0	0.0	19.6	0.3	10.3	0.3	0.0	0.1	0.0	0.0	0.2	0.6	0.1	1.3	0.0	0.1	0.0	89.9	0.0	10.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	12.4	0.3	0.1	0.0	0.0	0.6	1.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.1	0.1	1.3	0.2	0.0	0.0	0.0	0.8	2.3	0.4	0.0	0.4	0.0	0.0	91.3	0.0	0.1
RHCE	"CD240CE, RH"	ENSG00000188672	"Rh blood group CcEe antigens"	P18577	1	25362249-25430192	"Blood group antigen proteins, CD markers, Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"bone marrow: 48.5"	"Cell type enriched"	"Detected in some"	67	"Erythroid cells: 511.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HEL: 81.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (1.37e-1)"	"unprognostic (3.53e-1)"	"unprognostic (2.38e-1)"	"unprognostic (6.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.91e-2)"	"unprognostic (7.01e-2)"	"unprognostic (3.12e-2)"	"unprognostic (3.81e-2)"	"unprognostic (1.35e-1)"	"unprognostic (6.08e-2)"	"unprognostic (4.61e-2)"	"unprognostic (5.77e-5)"	"unprognostic (1.38e-1)"	"unprognostic (3.94e-2)"	"unprognostic (7.15e-3)"	"unprognostic (1.63e-1)"	0.3	0.6	1.5	0.1	1.9	48.5	0.3	1.6	3.3	0.3	1.2	0.2	0.2	0.2	4.2	0.6	1.0	0.3	1.2	1.5	1.4	0.4	1.7	0.4	0.5	1.9	1.6	0.5	1.2	0.1	3.4	1.1	1.9	1.0	0.3	2.2	5.5	0.2	1.5	0.6	0.1	0.0	1.5	1.1	0.4	2.2	1.6	0.8	0.6	0.9	0.3	0.1	0.5	2.2	0.2	0.1	0.2	0.5	0.9	0.6	0.1	0.3	0.3	0.4	0.1	0.1	1.5	0.7	1.1	1.0	0.1	0.3	0.0	0.2	0.2	0.4	0.1	81.3	0.0	0.0	1.1	0.0	0.6	1.9	1.5	0.6	0.5	0.0	0.0	0.6	17.5	0.4	0.5	0.8	0.0	0.6	1.7	0.7	0.5	0.2	0.2	2.6	0.0	0.0	0.7	0.8	0.3	0.3	1.0	0.8	0.5	0.0	0.1	0.2	0.0	0.9	0.0	5.1	1.4	1.0	2.9	0.9	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.5	1.9	1.6	3.3	1.5	1.4	1.9	1.6	1.9	1.5	1.6	2.2	0.8	0.0	0.0	5.5	0.8	0.5	0.5	0.3	0.6	4.2	1.1	2.5	0.7	1.5	0.2	0.0	0.0	0.8	1.2	0.5	0.0	0.3	1.1	1.2	0.7	0.4	0.0	511.8	2.9	0.2	0.7	0.4	3.6	0.8	4.5	0.6	0.0	0.7	0.2	6.7	2.3	0.0	0.0	0.6	0.4	0.5	0.6	1.7	0.0	0.0	0.0	4.7	1.0	2.0	2.7	0.5	0.0	0.7	3.0	0.3	0.1	0.0	0.9	2.4	6.6	0.5	0.5	3.0	7.6	0.6	1.4	0.8	0.8	0.7	0.3	0.7
RHCG	"C15orf6, PDRC2, RHGK, SLC42A3"	ENSG00000140519	"Rh family C glycoprotein"	Q9UBD6	15	89471398-89496589	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ammonia transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 4022.4;vagina: 1728.8"	"Cell type enriched"	"Detected in many"	21	"Squamous epithelial cells: 1544.7"	"Cancer enhanced"	"Detected in many"		"cervical cancer: 152.9;head and neck cancer: 154.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 3.8;hTCEpi: 2.0;RT4: 1.2"	"Region enriched"	"Detected in many"	5	"olfactory bulb: 8.4"	"Low region specificity"	"Detected in some"			"HPA041874, HPA043317"	Enhanced					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA041874: AB_2677719, HPA043317: AB_2678424"	"unprognostic (1.60e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.86e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.39e-3)"	"unprognostic (2.07e-1)"	"prognostic unfavorable (3.80e-4)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.84e-2)"	"unprognostic (2.55e-3)"	"unprognostic (2.68e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.45e-3)"	1.3	2.1	5.3	0.0	5.4	0.0	0.8	4.9	6.9	823.5	3.9	0.5	0.0	0.6	0.0	4022.4	0.7	0.7	1.4	5.1	4.9	117.4	3.4	0.3	0.0	4.8	4.9	0.8	3.2	0.0	4.3	0.0	4.8	3.4	0.0	2.5	593.6	0.8	1.0	14.6	0.9	0.3	5.1	0.6	3.5	1.3	5.0	0.8	0.5	0.0	461.7	3.7	1728.8	5.2	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.1	0.0	0.3	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.3	5.4	4.9	6.9	5.1	4.9	4.8	4.9	4.8	5.1	5.0	5.2	0.0	0.0	0.0	2.0	0.3	1.3	28.9	22.9	6.2	1.0	0.9	0.5	0.7	0.0	47.6	14.7	0.0	0.0	0.0	0.6	15.6	1.5	2.0	0.0	0.1	0.7	0.0	0.0	6.0	0.4	0.0	2.6	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	2.0	0.0	0.7	1.4	0.0	1.5	0.0	0.0	0.0	64.4	0.0	4.0	0.3	0.7	4.8	0.0	0.0	34.8	0.0	0.0	1.6	2.8	0.0	0.0	5.4	1.5	0.1	1544.7	17.8	0.0	0.3	0.0	0.2	70.5
RHD	"CD240D, DIIIc, RH, Rh30a, Rh4, RhII, RhPI"	ENSG00000187010	"Rh blood group D antigen"	Q02161	1	25272393-25330445	"Blood group antigen proteins, CD markers, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"bone marrow: 15.8"	"Cell type enriched"	"Detected in some"	21	"Erythroid cells: 153.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 6.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 6.3"	"Group enriched"	"Detected in some"	7	"HEL: 43.0;K-562: 13.0"									"HPA060951, HPA077385"	Supported		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Nucleoplasm, Plasma membrane"		"HPA060951: , HPA077385: "	"unprognostic (4.75e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.09e-2)"	"unprognostic (4.84e-2)"	"unprognostic (1.11e-2)"	"unprognostic (5.25e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.27e-2)"	"unprognostic (1.89e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.93e-1)"	"unprognostic (8.09e-2)"	"unprognostic (5.53e-2)"	"unprognostic (4.92e-3)"	0.1	0.4	0.4	0.5	1.0	15.8	0.1	1.4	0.7	0.3	0.1	0.1	0.3	0.4	0.1	0.3	0.2	0.4	0.3	0.4	0.1	0.1	0.1	0.2	0.7	0.3	0.1	0.5	0.4	0.0	0.2	0.3	0.2	0.3	0.1	1.9	2.4	0.0	3.8	2.0	0.3	0.0	0.0	0.6	0.2	0.5	0.5	0.1	0.3	0.0	0.1	0.1	0.1	1.2	0.2	0.0	0.3	0.3	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.3	0.6	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.7	0.2	43.0	1.0	0.2	0.0	0.3	0.4	0.0	0.1	0.1	0.1	0.2	0.1	0.2	13.0	0.9	0.1	0.2	0.2	0.3	4.0	0.0	0.2	0.3	0.2	0.1	0.0	0.1	0.6	0.4	0.1	0.2	0.1	0.1	0.2	0.6	0.4	0.7	0.2	0.5	0.2	0.4	0.2	0.2	0.6	0.2	0.2	4.3	0.9	2.0	0.6	0.4	0.7	1.0	0.8	0.5	0.1	1.3	0.9	0.8	6.3	1.0	0.6	0.4	0.7	0.6	0.4	1.0	1.4	0.7	0.4	0.1	0.3	0.1	0.2	0.0	0.5	1.2	0.2	0.0	0.5	1.0	0.6	0.1	0.2	0.0	0.0	0.3	0.1	0.1	1.0	0.0	0.6	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.2	0.1	0.3	1.0	0.0	153.0	5.2	0.2	0.0	0.2	0.0	0.3	0.0	0.2	0.4	0.0	0.1	0.0	4.3	0.0	0.0	0.3	0.3	0.0	0.0	3.0	0.0	3.7	0.0	0.4	0.0	7.1	6.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.4	0.0	1.2	0.4	0.1	0.6	0.0	0.0	0.0	0.7	0.2	0.0	0.1
RHO	"CSNBAD1, OPN2, RP4"	ENSG00000163914	Rhodopsin	P08100	3	129528639-129535344	"Disease related genes, G-protein coupled receptors, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sensory transduction, Vision"	"G-protein coupled receptor, Photoreceptor protein, Receptor, Retinal protein, Transducer"	"Congenital stationary night blindness, Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5994	"retina: 4062.1"	"Cell type enriched"	"Detected in some"	7	"Rod photoreceptor cells: 4509.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	4	"hippocampal formation: 9.7"	"Region enhanced"	"Detected in single"		"hippocampal formation: 1.1"	"HPA013440, CAB022486, CAB034887, CAB034888"	Enhanced					NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"CAB022486: , CAB034887: AB_785511, CAB034888: AB_785512, HPA013440: AB_2668844"	"unprognostic (4.32e-2)"			"unprognostic (1.21e-1)"	"unprognostic (1.68e-1)"		"unprognostic (1.83e-1)"	"unprognostic (2.87e-1)"		"unprognostic (1.94e-1)"			"unprognostic (9.19e-11)"	"unprognostic (4.24e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.91e-1)"		0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4062.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	369.9	0.0	0.0	0.6	0.0	0.0	0.0	454.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	26.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	218.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	590.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4509.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
RIC3	"AYST720, FLJ11608, PRO1385"	ENSG00000166405	"RIC3 acetylcholine receptor chaperone"	Q7Z5B4	11	8106056-8169055	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Chaperone		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 175.2;Cone photoreceptor cells: 143.9;Rod photoreceptor cells: 204.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in all"	4	"B-cells: 12.8;granulocytes: 4.5;T-cells: 6.7"	"Cell line enhanced"	"Detected in some"		"GAMG: 2.3;HMC-1: 2.6;NTERA-2: 5.0;SCLC-21H: 8.3;SH-SY5Y: 5.8;SuSa: 4.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065016	Approved				"Intracellular and membrane"	NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 52: Non-specific - Transcription"			"HPA065016: AB_2685404"	"unprognostic (2.51e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.21e-1)"	"unprognostic (6.98e-4)"	"unprognostic (3.22e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.45e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.23e-9)"	"unprognostic (4.37e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.52e-2)"	3.1	13.5	17.9	5.2	17.8	1.9	6.4	24.6	21.7	8.9	14.8	11.3	1.9	10.9	21.5	5.7	10.1	3.5	9.8	17.0	20.3	10.5	3.5	3.7	7.7	15.5	15.5	19.7	18.0	11.7	31.3	0.3	16.0	16.9	2.1	42.2	16.0	10.3	5.9	14.2	8.2	6.1	14.1	7.3	8.5	7.4	16.2	2.1	22.9	2.4	7.1	10.5	5.9	17.3	0.0	0.9	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.0	0.0	0.0	2.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	8.3	5.8	0.1	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.9	0.1	1.2	0.5	0.0	0.0	0.1	0.0	0.1	4.5	0.6	1.3	2.2	0.8	1.4	11.9	4.6	2.4	0.6	12.8	6.7	5.9	1.9	1.8	1.7	1.6	2.6	0.8	17.9	17.8	24.6	21.7	17.0	20.3	15.5	15.5	16.0	14.1	16.2	17.3	1.5	6.4	15.5	56.2	79.1	36.3	55.9	8.2	58.6	175.2	34.8	47.0	14.0	42.9	20.7	23.9	143.9	0.5	7.2	0.1	0.0	33.5	2.9	0.2	1.6	4.2	7.7	4.4	95.3	28.5	0.3	10.8	2.0	0.2	24.6	9.5	6.4	4.9	0.2	95.9	90.1	4.4	8.2	1.0	2.2	4.5	33.5	2.2	12.4	17.8	3.3	52.3	4.1	101.0	50.4	14.6	1.4	46.6	18.6	38.6	3.1	6.6	19.4	204.9	0.0	9.0	7.0	51.0	39.5	15.9	39.6	0.5	19.8	1.1	1.5	38.2
RNASEK	MGC71993	ENSG00000219200	"Ribonuclease K"	Q6P5S7	17	7012417-7014532	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Endonuclease, Hydrolase, Nuclease"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 246.4;Macrophages: 174.7;Plasma cells: 253.2;Squamous epithelial cells: 250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA044708	Uncertain					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 59: Non-specific - Transcription"			"HPA044708: AB_10962051"	"unprognostic (7.59e-2)"	"unprognostic (2.22e-2)"	"unprognostic (5.63e-2)"	"unprognostic (5.92e-2)"	"unprognostic (9.73e-3)"	"unprognostic (4.82e-2)"	"unprognostic (3.65e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.44e-1)"	"unprognostic (6.50e-3)"	"prognostic favorable (1.92e-4)"	"unprognostic (2.93e-3)"	"unprognostic (1.72e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.33e-3)"	309.4	592.6	276.9	173.8	296.6	292.9	278.5	285.0	391.0	252.6	339.9	271.8	161.1	254.5	135.1	241.5	239.4	173.3	325.9	298.9	381.3	515.3	280.2	347.4	217.8	307.5	307.5	265.2	233.9	287.8	505.1	158.7	323.9	255.0	118.2	81.6	246.4	161.1	321.9	297.0	229.1	144.9	275.9	396.8	275.2	180.2	300.6	159.6	256.0	226.6	166.8	231.1	225.3	288.4	223.4	353.3	160.9	276.4	406.6	363.4	142.8	224.5	389.5	283.9	320.6	149.6	205.6	157.2	221.3	435.5	343.2	328.5	199.1	274.7	153.6	319.2	520.8	157.0	264.7	252.9	466.1	99.9	748.3	462.4	321.7	338.5	194.0	316.1	344.6	168.0	138.1	327.7	348.4	206.0	137.0	327.4	111.7	178.2	314.0	160.7	92.3	180.9	374.2	192.4	82.1	291.9	191.0	135.6	421.5	157.8	176.0	177.3	322.5	304.6	132.8	383.9	289.3	267.6	278.0	68.6	475.7	225.3	253.2	993.4	1136.6	1378.0	373.6	1031.0	369.9	593.4	413.9	381.0	848.3	542.0	329.5	321.0	2175.1	420.9	1007.1	1070.5	451.1	1052.7	276.9	296.6	285.0	391.0	298.9	381.3	307.5	307.5	323.9	275.9	300.6	288.4	21.3	57.7	65.7	0.0	109.7	20.5	9.2	16.3	246.4	16.3	21.6	14.9	0.8	8.6	47.9	5.5	41.7	5.3	31.5	21.0	3.9	21.4	5.8	45.4	32.4	37.9	13.2	62.0	0.0	5.5	3.4	58.9	110.1	38.6	54.2	14.4	20.0	16.2	14.2	11.8	0.0	15.9	8.2	62.3	47.0	6.2	9.0	174.7	21.4	0.0	42.4	7.6	28.8	0.0	0.0	12.1	10.8	6.4	253.2	12.1	20.4	6.7	58.8	31.5	26.3	11.4	35.6	3.6	1.2	250.2	21.7	11.8	98.0	15.9	15.1	13.8
RNPS1		ENSG00000205937	"RNA binding protein with serine rich domain 1"	Q15287	16	2253116-2268397	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Nonsense-mediated mRNA decay"	RNA-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044014	Approved		Supported	Nucleoplasm		NA	NA		13000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"HPA044014: AB_10966286"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (3.46e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.92e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.18e-3)"	"unprognostic (1.96e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.30e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.13e-3)"	"unprognostic (2.38e-1)"	"unprognostic (4.64e-2)"	"unprognostic (2.27e-1)"	82.8	78.7	91.9	55.1	96.1	144.9	83.4	82.6	112.6	89.0	60.5	108.8	51.3	98.8	51.1	98.0	84.6	39.9	101.0	99.1	93.0	81.4	63.8	73.5	76.5	96.0	84.5	92.6	71.8	52.5	101.4	53.5	94.9	95.0	43.9	47.4	70.0	54.9	229.7	97.3	84.0	52.4	72.5	94.9	76.8	88.4	88.5	69.8	74.2	105.2	71.3	94.1	83.6	90.7	119.6	154.5	167.7	163.9	89.0	78.6	194.2	125.2	88.4	170.6	147.0	306.1	142.8	251.1	124.0	103.2	108.6	160.0	217.3	152.5	128.9	175.2	283.2	172.8	133.9	198.3	150.2	185.5	159.0	99.3	168.3	149.1	207.1	80.8	134.8	144.6	302.1	195.3	143.3	259.7	296.2	363.6	340.1	135.2	128.4	441.4	196.6	322.3	122.5	66.6	354.8	218.3	172.3	157.6	166.4	77.1	152.7	187.7	102.2	155.4	155.2	143.0	182.1	199.7	282.5	582.9	63.3	168.0	185.6	48.1	144.0	123.2	169.5	170.5	167.7	177.9	162.2	172.9	153.8	205.5	153.3	162.0	43.4	182.9	187.8	131.6	196.1	290.2	91.9	96.1	82.6	112.6	99.1	93.0	96.0	84.5	94.9	72.5	88.5	90.7	90.6	44.8	62.7	29.7	148.2	206.6	208.7	148.9	119.5	119.7	99.5	95.9	36.3	65.8	85.5	51.5	139.7	182.3	138.5	90.8	70.5	115.5	16.3	76.5	88.9	102.1	122.0	130.4	72.1	93.2	237.4	90.7	79.0	108.4	103.4	114.9	77.1	37.5	104.7	97.6	61.1	100.6	124.1	71.3	117.0	21.4	94.1	80.1	97.8	23.4	123.9	98.0	180.2	31.7	37.3	121.7	76.5	68.8	117.2	209.5	81.1	64.3	50.2	132.8	85.5	103.9	102.3	132.9	267.4	117.6	212.4	162.0	131.7	101.7	125.7	203.5
ROMO1	"bA353C18.2, C20orf52, MTGMP"	ENSG00000125995	"Reactive oxygen species modulator 1"	P60602	20	35699272-35700984	"Predicted intracellular proteins, Transporters"		"Antibiotic, Antimicrobial"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"Hep G2: 1349.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012782	Uncertain					NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"HPA012782: AB_1845685"	"unprognostic (1.55e-1)"	"unprognostic (3.86e-2)"	"unprognostic (3.00e-1)"	"unprognostic (1.06e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.27e-3)"	"unprognostic (5.84e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.35e-2)"	"unprognostic (6.55e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.47e-2)"	126.3	185.8	164.8	71.6	170.7	112.3	125.8	174.7	216.3	112.3	182.8	131.7	99.8	113.0	81.6	185.6	102.9	50.8	246.2	165.5	169.8	188.4	206.2	99.8	79.2	171.0	170.0	111.3	134.7	122.3	163.6	63.0	170.5	126.4	66.3	33.0	133.9	79.6	259.2	122.0	105.1	51.7	170.2	104.6	126.0	121.6	175.1	102.3	122.5	168.9	59.3	108.6	119.7	176.4	304.5	493.7	164.5	202.1	125.3	169.2	269.2	165.7	196.2	256.6	251.0	1196.7	263.5	154.6	370.6	125.5	380.3	320.6	88.5	438.3	64.9	84.6	615.1	267.2	547.2	1349.5	259.4	166.6	134.7	216.2	204.3	182.1	133.1	118.5	209.7	285.9	224.6	309.7	124.7	966.0	373.0	456.6	251.8	327.6	867.8	246.5	319.0	342.3	246.9	516.1	229.3	236.0	288.6	546.5	306.6	150.0	502.6	353.8	172.5	425.0	240.1	281.1	279.8	504.6	481.5	409.3	371.0	130.9	249.7	602.8	590.1	459.5	398.5	511.9	378.4	587.2	408.8	393.7	573.0	523.1	346.7	384.9	330.0	391.8	486.2	1054.9	538.0	726.4	164.8	170.7	174.7	216.3	165.5	169.8	171.0	170.0	170.5	170.2	175.1	176.4	168.1	102.5	187.2	2.3	147.5	118.3	87.5	339.7	124.7	28.7	235.9	237.9	662.8	264.5	256.3	257.5	8.4	284.8	101.0	691.8	403.0	364.1	23.8	334.5	192.2	150.9	328.1	152.3	2.2	571.6	256.0	194.8	253.8	268.5	193.2	125.9	166.7	641.1	219.9	20.2	2.1	412.9	203.4	157.9	164.3	50.9	130.5	165.0	236.5	3.7	266.4	176.1	108.1	1.0	4.8	567.4	574.0	128.2	323.2	124.8	573.0	753.7	355.8	39.5	118.3	109.7	262.4	283.9	225.4	270.7	153.2	326.9	141.5	64.4	387.0	115.6
RPN1	OST1	ENSG00000163902	"Ribophorin I"	P04843	3	128619969-128681075	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 424.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009748, HPA026828, HPA051520"	Enhanced		Enhanced	"Endoplasmic reticulum,Cytosol"		NA	NA		730000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"	Cytosol	"CAB009748: AB_2182230, HPA026828: AB_10610418, HPA051520: AB_2681521"	"unprognostic (4.83e-2)"	"unprognostic (5.92e-2)"	"unprognostic (1.10e-1)"	"unprognostic (7.67e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (4.80e-4)"	"unprognostic (2.71e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.58e-3)"	"unprognostic (2.87e-1)"	"unprognostic (7.68e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.44e-1)"	"unprognostic (9.74e-2)"	97.9	88.3	56.7	94.5	65.5	97.1	105.5	69.0	63.3	142.0	96.2	124.0	97.1	92.0	352.4	76.6	124.8	90.5	82.6	56.1	71.4	119.5	226.3	112.7	76.8	72.7	65.8	80.8	118.8	143.8	83.7	139.8	69.4	100.2	134.3	46.9	120.4	113.9	89.2	63.5	94.5	111.6	66.7	85.2	115.0	90.9	68.1	86.0	177.7	77.7	102.4	117.2	64.0	77.9	358.5	190.9	156.2	289.8	412.7	273.1	351.3	300.0	393.2	391.4	452.1	399.4	328.2	221.9	274.8	437.3	363.2	349.7	255.4	268.2	374.7	158.8	160.3	392.7	127.9	332.3	454.3	322.5	198.2	229.5	307.3	258.4	377.5	260.9	308.6	164.2	164.2	289.6	260.4	327.8	179.7	353.0	198.1	476.6	170.2	193.6	209.4	540.6	272.7	212.0	238.6	137.4	246.3	253.6	313.6	199.0	271.0	329.0	203.2	200.9	154.7	297.0	226.9	306.1	259.9	234.4	329.4	235.9	296.9	178.0	171.6	137.6	129.3	147.0	154.7	91.5	104.7	117.7	159.5	60.7	63.8	99.3	233.2	90.3	159.3	192.4	114.2	250.8	56.7	65.5	69.0	63.3	56.1	71.4	72.7	65.8	69.4	66.7	68.1	77.9	82.9	60.9	74.1	13.1	72.4	49.5	83.6	102.8	55.2	13.0	53.7	26.9	42.4	51.5	91.6	112.2	8.4	113.7	59.1	126.0	15.6	111.5	19.1	85.3	73.9	72.4	43.3	63.5	11.7	93.3	199.1	91.7	113.2	126.8	43.7	40.2	96.0	180.0	135.7	20.2	16.3	158.4	73.2	154.1	70.8	29.5	94.1	87.6	58.7	11.2	77.0	30.3	39.1	18.1	21.3	104.0	83.1	64.3	424.1	93.3	109.1	90.7	110.2	13.2	46.0	43.9	53.7	65.9	62.6	67.0	53.4	156.7	65.8	54.0	130.2	78.9
RPN2	"RIBIIR, RPN-II, RPNII, SWP1"	ENSG00000118705	"Ribophorin II"	P04844	20	37178410-37241619	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 599.6;Syncytiotrophoblasts: 621.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008297, CAB019277, HPA025922"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA		1300000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum"		"CAB019277: , HPA008297: AB_1856457, HPA025922: AB_1856458"	"unprognostic (9.59e-3)"	"unprognostic (5.22e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.20e-2)"	"prognostic unfavorable (1.38e-4)"	"unprognostic (1.82e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.14e-1)"	"prognostic unfavorable (1.44e-10)"	"unprognostic (2.83e-1)"	"unprognostic (6.99e-2)"	"unprognostic (2.03e-1)"	"prognostic unfavorable (2.44e-4)"	112.6	132.5	48.2	131.9	50.4	180.8	146.1	49.9	55.9	161.8	98.0	156.9	125.5	108.7	344.1	106.8	122.9	119.8	107.3	49.5	56.5	145.1	212.1	129.7	109.2	54.0	50.6	94.8	159.6	180.9	79.1	257.9	53.9	164.4	175.2	117.0	158.2	157.5	110.4	91.5	110.9	156.6	53.8	118.1	145.1	144.2	55.4	108.5	232.5	75.1	143.3	165.4	87.9	61.9	328.2	290.6	302.7	401.2	413.1	308.2	586.7	426.7	516.8	544.8	459.2	939.2	564.8	255.3	501.6	572.3	506.4	468.4	318.8	516.4	492.0	121.2	196.5	295.3	308.4	634.1	398.9	468.4	467.0	294.6	505.1	432.3	447.5	519.8	530.4	239.2	458.7	805.1	389.1	300.9	270.6	451.0	240.4	839.3	415.7	242.3	549.1	852.7	371.6	304.3	246.4	261.0	517.9	1231.1	489.4	353.6	606.1	765.6	338.0	600.8	358.2	317.1	371.9	474.7	608.4	259.9	583.4	314.9	493.2	424.2	427.5	285.5	365.5	410.5	417.0	291.0	336.1	363.8	481.2	232.4	298.8	308.7	78.3	398.8	357.6	591.0	338.2	676.5	48.2	50.4	49.9	55.9	49.5	56.5	54.0	50.6	53.9	53.8	55.4	61.9	85.7	118.6	158.0	22.2	107.8	61.8	134.1	264.6	62.0	72.6	90.0	74.2	81.4	133.0	197.7	80.9	45.9	461.6	109.6	113.9	23.5	278.0	37.3	73.2	103.5	98.6	63.0	91.7	18.8	241.1	599.6	127.4	84.1	151.2	105.2	109.3	100.6	206.3	233.2	63.9	18.6	168.5	162.8	150.4	75.3	24.4	105.0	117.0	90.7	20.6	122.2	136.8	65.9	24.1	20.5	160.1	109.5	110.9	392.3	121.3	64.6	82.3	98.5	100.8	85.5	65.3	122.0	335.2	288.9	67.7	57.8	621.0	81.5	213.7	138.7	117.6
RS1	"RS, XLRS1"	ENSG00000102104	"Retinoschisin 1"	O15537	X	18639688-18672108	"Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, Transporters"	"Cell adhesion, Sensory transduction, Vision"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	207	"retina: 213.7"	"Group enriched"	"Detected in some"	6	"Cone photoreceptor cells: 160.6;Rod photoreceptor cells: 162.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA059546	Enhanced				"Secreted in other tissues"	NA	NA				"Cluster 79: Retina - Phototransduction"		"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA059546: AB_2684058"	"unprognostic (8.31e-2)"	"unprognostic (1.79e-1)"	"unprognostic (4.99e-2)"	"unprognostic (2.39e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.80e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.77e-3)"	"unprognostic (4.14e-1)"	"unprognostic (7.03e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.06e-2)"	"unprognostic (5.12e-2)"	"unprognostic (2.04e-4)"	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	213.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.1	0.3	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	6.4	0.0	1.0	0.0	0.0	0.0	0.0	0.0	15.3	0.0	0.0	1.9	0.0	0.0	0.0	160.6	0.2	0.0	0.0	1.9	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	162.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0
RTBDN	FLJ36353	ENSG00000132026	Retbindin	Q9BSG5	19	12825478-12835428	"Predicted membrane proteins, Predicted secreted proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"retina: 288.0"	"Group enriched"	"Detected in some"	5	"Cone photoreceptor cells: 350.3;Rod photoreceptor cells: 524.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"SCLC-21H: 8.3;SH-SY5Y: 5.4;U-266/84: 23.1;U-87 MG: 4.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			HPA052511			Approved	"Endoplasmic reticulum"	"Secreted in other tissues"	NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Endoplasmic reticulum"		"HPA052511: AB_2797243"	"unprognostic (4.55e-4)"	"unprognostic (3.94e-3)"	"unprognostic (2.18e-1)"	"unprognostic (1.54e-4)"	"unprognostic (3.33e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.08e-2)"	"unprognostic (2.45e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.55e-1)"	"unprognostic (6.48e-2)"	"unprognostic (7.04e-3)"	"unprognostic (7.66e-9)"	"unprognostic (3.55e-2)"	"unprognostic (1.00e-1)"	"unprognostic (7.05e-2)"	"unprognostic (2.24e-2)"	0.0	3.5	5.1	0.1	5.9	0.2	0.0	1.9	10.0	0.0	0.9	1.1	0.4	0.0	0.6	0.0	0.0	0.0	0.0	6.7	2.7	0.0	0.0	0.1	0.0	2.7	1.9	0.0	1.2	0.3	34.3	0.0	5.8	0.0	0.3	288.0	0.0	0.0	0.0	0.1	0.5	0.1	0.9	0.0	1.1	3.3	2.9	8.7	0.0	0.0	0.0	0.0	0.1	3.2	0.9	0.1	0.1	0.6	0.0	0.0	0.7	0.0	0.0	0.4	0.0	0.3	0.0	0.9	0.9	0.0	0.6	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.4	0.9	0.0	0.1	2.4	0.0	0.0	0.4	0.2	0.0	0.0	0.1	1.3	2.7	0.0	0.1	0.1	0.0	0.9	0.7	1.1	0.7	0.1	1.1	0.1	0.0	8.3	5.4	0.1	0.0	0.4	0.4	2.8	0.7	0.0	0.8	1.0	0.7	0.1	1.2	23.1	4.3	4.9	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.1	5.9	1.9	10.0	6.7	2.7	2.7	1.9	5.8	0.9	2.9	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	50.5	0.0	0.0	1.4	0.0	0.1	0.0	350.3	0.0	0.0	0.5	0.0	0.0	0.5	0.1	0.0	1.8	0.0	0.0	2.8	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.6	2.5	0.6	4.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	84.4	0.0	1.0	0.7	0.1	0.1	0.0	0.5	0.0	0.7	0.1	0.0	524.0	0.0	0.1	0.0	16.2	5.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0
RTN1	NSP	ENSG00000139970	"Reticulon 1"	Q16799	14	59595976-59870776	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 160.6;pituitary gland: 60.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 495.8;Horizontal cells: 240.6;Inhibitory neurons: 394.3;Oligodendrocyte precursor cells: 188.0;Oligodendrocytes: 247.7"	"Cancer enhanced"	"Detected in many"		"glioma: 19.0"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"classical monocyte: 2.9;intermediate monocyte: 3.1;myeloid DC: 5.4"	"Group enriched"	"Detected in many"	14	"dendritic cells: 5.4;monocytes: 3.1"	"Group enriched"	"Detected in some"	4	"HEL: 61.7;SCLC-21H: 71.8;SH-SY5Y: 115.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002745, HPA040945, HPA044249"	Enhanced		Supported	"Nuclear bodies,Endoplasmic reticulum"		NA	NA		150000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"	"Nuclear bodies"	"CAB002745: , HPA040945: AB_2677217, HPA044249: AB_2678874"	"unprognostic (9.40e-3)"	"unprognostic (1.43e-3)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (4.24e-2)"	"unprognostic (3.04e-3)"	"unprognostic (8.67e-2)"	"unprognostic (1.23e-2)"	"unprognostic (2.49e-1)"	"unprognostic (2.79e-1)"	"prognostic favorable (3.69e-4)"	"unprognostic (5.79e-2)"	"unprognostic (2.23e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.75e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.62e-2)"	11.1	12.0	111.1	9.3	127.5	0.4	7.2	57.0	134.7	2.2	0.0	7.6	2.5	1.3	0.4	1.6	12.8	5.5	0.9	133.0	160.6	1.6	1.0	6.4	2.7	37.5	24.9	0.7	4.0	17.4	60.1	2.4	46.7	6.4	2.8	34.1	3.4	1.9	0.8	3.2	4.1	2.4	10.8	18.3	3.9	2.3	68.3	1.0	2.5	0.7	1.8	1.9	3.6	50.2	0.0	0.0	0.7	1.0	2.9	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.9	0.1	0.4	0.0	2.1	61.7	0.0	0.0	3.4	0.1	0.2	0.0	0.1	0.0	2.1	0.0	0.5	0.4	0.0	0.3	0.7	0.3	0.0	0.0	4.9	0.0	0.0	0.0	0.6	0.1	0.0	0.0	71.8	115.1	14.9	0.0	0.0	0.2	0.0	0.0	0.0	9.9	2.8	0.1	5.6	0.0	0.0	0.0	19.4	4.4	0.7	0.0	2.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.7	111.1	127.5	57.0	134.7	133.0	160.6	37.5	24.9	46.7	10.8	68.3	50.2	1.0	0.0	1.1	64.3	0.5	4.8	0.4	0.0	0.0	34.1	11.4	4.3	1.0	1.5	0.6	0.0	25.0	1.2	1.4	0.8	0.0	0.0	16.2	23.5	0.3	2.9	54.2	0.8	495.8	0.0	5.0	1.5	5.6	0.4	0.0	0.2	0.0	0.5	17.8	240.6	394.3	3.6	0.0	14.4	59.7	21.4	2.8	23.8	10.6	87.1	22.8	14.3	0.0	188.0	247.7	1.4	0.1	1.2	0.1	5.8	0.8	0.9	0.7	33.3	0.0	10.7	2.5	2.3	3.8	0.2	6.5	2.5	0.7	0.1	0.5	0.3
RXFP1	"LGR7, RXFPR1"	ENSG00000171509	"Relaxin family peptide receptor 1"	Q9HBX9	4	158315311-158653372	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adrenal gland: 5.3;brain: 7.6;endometrium 1: 6.2"	"Group enriched"	"Detected in some"	5	"Endometrial ciliated cells: 61.4;Excitatory neurons: 167.9;Glandular and luminal cells: 174.6"	"Cancer enriched"	"Detected in single"	9	"endometrial cancer: 3.9"	"Group enriched"	"Detected in many"	4	"amygdala: 4.6;basal ganglia: 5.3;cerebral cortex: 7.6;hippocampal formation: 4.6;white matter: 3.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"EFO-21: 29.0;HEL: 9.7;RPTEC TERT1: 14.4;THP-1: 4.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in many"	6	"cerebral cortex: 11.8;hippocampal formation: 7.8"	HPA027067	Approved					NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 44: Endometrium - Transcription"			"HPA027067: AB_10602127"	"unprognostic (3.07e-3)"	"unprognostic (3.02e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.97e-2)"	"unprognostic (4.15e-3)"	"unprognostic (6.13e-2)"	"unprognostic (6.18e-3)"	"unprognostic (3.01e-1)"	"unprognostic (5.14e-6)"	"unprognostic (8.21e-2)"	"unprognostic (1.34e-1)"	"unprognostic (8.33e-4)"	"unprognostic (3.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.22e-3)"	0.1	5.3	4.6	0.2	5.3	0.0	0.1	0.0	7.6	2.7	0.0	0.2	0.1	6.2	1.0	0.1	0.8	0.7	0.0	4.6	1.2	2.1	1.4	3.8	0.4	0.0	0.0	0.3	0.1	0.2	0.1	2.7	0.0	0.4	0.1	0.0	0.1	2.8	0.0	0.0	0.2	0.8	0.0	0.3	0.4	0.2	0.0	0.0	1.3	0.0	0.3	0.1	0.8	3.5	0.0	0.0	0.0	0.0	0.0	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	29.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.3	0.0	7.6	4.6	1.2	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	0.5	4.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	61.4	23.5	4.2	0.0	1.7	167.9	0.0	0.0	0.2	0.0	174.6	0.0	0.0	0.0	0.0	0.7	0.0	7.8	0.0	0.0	0.0	0.5	0.2	0.0	0.8	0.0	7.5	0.0	0.0	0.0	10.1	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.6	0.8	0.0	0.1	0.1	0.6	0.0	0.0	0.0
RXFP3	"GPCR135, RLN3R1, RXFPR3, SALPR"	ENSG00000182631	"Relaxin family peptide receptor 3"	Q9NSD7	5	33936386-33938918	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA027833	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"					"HPA027833: AB_1849247"	"unprognostic (1.93e-2)"					"unprognostic (3.66e-1)"		"unprognostic (2.89e-1)"		"unprognostic (2.86e-1)"	"unprognostic (9.68e-2)"	"unprognostic (1.72e-1)"		"unprognostic (8.67e-3)"				0.0	0.9	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	1.1	2.1	0.0	0.1	0.0	0.1	0.0	1.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.1	0.1	0.8	1.1	2.1	1.4	0.1	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
RYR1	"CCO, MHS, MHS1, PPP1R137, RYR"	ENSG00000196218	"Ryanodine receptor 1"	P21817	19	38433691-38587564	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"skeletal muscle: 1618.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 29.4;Basal squamous epithelial cells: 22.8;Microglial cells: 49.6;Muller glia cells: 50.6;Skeletal myocytes: 41.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"intermediate monocyte: 1.8;myeloid DC: 2.9;non-classical monocyte: 3.8"	"Group enriched"	"Detected in many"	8	"dendritic cells: 2.9;monocytes: 3.8"	"Cell line enhanced"	"Detected in some"		"A549: 7.7;HaCaT: 18.9;hTCEpi: 7.6;RH-30: 15.3;SiHa: 30.7;U-2 OS: 12.4"	"Low region specificity"	"Detected in single"							HPA056416	Enhanced		Approved	"Golgi apparatus,Vesicles,Cytosol"		NA	NA		46000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 37: Myocytes - Muscle contraction"	"Golgi apparatus, Vesicles"	Cytosol	"HPA056416: AB_2683121"	"unprognostic (2.22e-3)"	"unprognostic (1.91e-3)"	"unprognostic (9.59e-2)"	"unprognostic (5.34e-4)"	"unprognostic (2.50e-1)"	"unprognostic (6.00e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.20e-3)"	"unprognostic (3.52e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.07e-5)"	"unprognostic (1.13e-2)"	"unprognostic (8.10e-2)"	"unprognostic (6.62e-3)"	"unprognostic (1.34e-1)"	1.4	2.4	10.3	1.6	8.0	0.3	2.1	8.5	9.3	2.1	1.0	1.2	0.5	0.7	1.3	17.2	1.7	1.1	0.9	7.5	20.5	1.9	0.4	2.6	2.1	8.6	9.7	0.9	0.4	1.9	1.5	1.8	7.7	3.8	0.3	10.6	14.0	1.4	1618.9	13.3	1.3	0.8	2.6	1.7	1.0	8.9	22.6	1.5	1.2	286.6	2.6	1.0	3.3	6.1	0.0	7.7	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	2.8	0.4	0.5	6.3	0.0	0.0	18.9	0.2	0.0	0.0	0.0	0.4	1.5	0.0	0.0	0.0	0.0	0.6	1.7	7.6	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.5	1.0	0.0	0.0	15.3	1.5	0.8	0.0	0.0	1.5	30.7	0.0	0.0	0.6	0.7	5.9	0.0	0.0	12.4	0.3	0.0	0.4	1.4	0.4	0.1	0.0	0.0	0.0	0.3	0.0	0.2	1.8	0.2	0.2	0.1	0.3	2.9	0.3	0.0	0.0	0.0	0.0	3.8	0.0	0.4	0.3	10.3	8.0	8.5	9.3	7.5	20.5	8.6	9.7	7.7	2.6	22.6	6.1	0.3	0.0	1.1	29.4	1.4	11.3	3.8	6.6	22.8	8.9	0.5	7.9	3.6	0.0	1.1	0.0	2.1	0.2	1.2	0.0	5.9	0.1	6.7	0.2	0.9	1.0	0.0	0.4	10.2	0.0	0.4	0.9	0.0	0.5	0.0	0.3	0.7	0.0	8.8	1.7	17.2	0.0	2.0	2.9	15.2	5.9	3.1	6.2	0.0	49.6	1.3	50.6	0.0	13.6	2.0	0.0	0.0	1.9	0.9	0.8	0.0	0.2	0.4	1.8	0.0	41.7	1.2	6.3	7.4	7.5	4.7	0.3	2.6	0.4	0.0	0.7
RYR2	"ARVC2, ARVD2, VTSIP"	ENSG00000198626	"Ryanodine receptor 2"	Q92736	1	237042184-237833988	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Developmental protein, Ion channel, Ligand-gated ion channel, Receptor"	"Cardiomyopathy, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"heart muscle: 132.0"	"Group enriched"	"Detected in many"	10	"Cardiomyocytes: 2180.6;Excitatory neurons: 1320.5;Inhibitory neurons: 790.6"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 7.7;HEK 293: 8.5;K-562: 2.3;NB-4: 2.7;NTERA-2: 3.1;U-937: 4.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020028	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane, Cytosol"		"HPA020028: AB_1856528"	"unprognostic (5.23e-3)"	"unprognostic (2.15e-2)"	"unprognostic (5.02e-4)"	"unprognostic (6.26e-2)"	"unprognostic (8.74e-2)"	"unprognostic (2.99e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.45e-3)"	"unprognostic (2.69e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (0.00e+0)"	"unprognostic (2.36e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.13e-2)"	"unprognostic (1.06e-2)"	0.7	0.7	9.1	0.8	15.9	0.0	0.6	8.7	24.0	1.5	0.0	2.0	0.2	0.7	0.4	2.9	0.7	1.9	132.0	10.5	0.0	0.1	0.1	1.8	0.1	0.0	0.0	2.9	8.4	0.0	1.8	1.2	0.0	2.9	0.5	6.5	0.5	1.7	0.1	0.3	0.5	0.7	0.0	1.3	1.5	1.1	0.0	0.1	4.4	0.3	0.0	1.2	0.4	13.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.2	0.0	0.0	0.9	0.3	0.0	0.0	7.7	8.5	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.0	0.0	2.3	0.4	0.0	0.0	0.0	2.7	3.1	0.6	0.3	0.0	0.1	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	9.1	15.9	8.7	24.0	10.5	0.0	0.0	0.0	0.0	0.0	0.0	13.2	0.2	0.0	0.5	17.0	0.0	0.4	0.0	0.0	0.0	74.2	0.3	0.1	2180.6	0.0	1.3	1.8	10.4	0.1	0.1	0.0	0.0	0.0	21.1	0.2	3.4	10.6	3.5	0.0	1320.5	2.9	0.1	53.6	0.0	0.5	0.0	0.5	1.1	0.0	0.1	1.7	790.6	0.0	0.0	0.0	0.2	15.3	1.2	1.3	8.8	48.7	0.0	1.3	0.0	29.7	140.6	0.4	0.0	0.0	0.1	0.0	1.0	0.2	0.7	5.3	0.0	0.5	21.6	5.8	2.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0
S100A1	"S100-alpha, S100A"	ENSG00000160678	"S100 calcium binding protein A1"	P23297	1	153627926-153632039	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 3076.8;skeletal muscle: 3060.2;tongue: 4911.5"	"Cell type enriched"	"Detected in many"	4	"Proximal tubular cells: 1848.3"	"Group enriched"	"Detected in all"	5	"melanoma: 210.5;ovarian cancer: 110.1;thyroid cancer: 123.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"Hep G2: 325.8;SK-MEL-30: 1130.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002599, HPA006462"	Enhanced		Supported	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA		290000	"Cluster 10: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Cytosol	"Nucleoplasm, Golgi apparatus"	"CAB002599: AB_2315307, HPA006462: AB_1079857"	"unprognostic (6.13e-2)"	"unprognostic (7.60e-2)"	"unprognostic (5.96e-5)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (1.19e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.36e-1)"	"unprognostic (2.34e-3)"	"unprognostic (6.83e-3)"	"unprognostic (5.22e-1)"	"unprognostic (5.04e-3)"	"unprognostic (9.62e-2)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.68e-1)"	"unprognostic (4.56e-2)"	"unprognostic (2.70e-3)"	"unprognostic (9.74e-4)"	179.7	8.3	811.3	6.5	898.6	2.3	77.2	851.4	952.4	2.9	643.9	14.5	11.1	4.2	1.0	81.0	41.8	4.9	3076.8	779.4	813.6	194.9	4.5	3.9	5.1	907.6	894.8	2.0	16.8	160.9	54.6	18.1	871.2	29.0	1.2	36.5	622.1	9.3	3060.2	23.0	6.9	1.6	847.7	4.2	23.1	5.9	882.9	9.4	167.9	4911.5	4.0	4.3	2.9	967.6	6.0	3.4	3.9	33.7	0.5	0.2	2.9	7.7	0.2	0.6	0.2	6.6	3.4	3.7	137.7	0.6	2.7	10.3	0.3	0.4	0.0	4.2	3.3	8.2	5.4	325.8	0.4	3.0	2.3	0.7	0.0	0.0	0.1	7.9	0.0	1.5	27.2	3.7	0.1	10.6	1.2	4.9	1.8	4.3	2.6	22.5	3.3	8.0	6.0	12.1	6.1	1.9	3.5	10.6	1130.2	11.1	32.8	16.2	2.7	3.3	2.8	3.0	3.8	6.1	5.7	6.2	2.5	6.2	2.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	811.3	898.6	851.4	952.4	779.4	813.6	907.6	894.8	871.2	847.7	882.9	967.6	4.3	0.0	0.0	59.4	9.5	9.7	1.2	0.4	1.8	1.1	369.9	354.1	74.4	8.6	0.2	154.5	2.1	1.1	5.9	1.1	162.4	0.9	0.6	90.5	17.3	5.3	1.8	0.0	0.3	3.7	1.9	6.0	0.0	193.3	0.0	0.0	7.9	4.7	199.1	0.0	0.3	3.7	0.0	0.6	3.5	2.2	6.5	15.6	341.5	2.8	0.0	163.5	0.0	2.0	45.8	1.9	0.6	9.1	0.0	1.8	0.9	1848.3	0.2	2.7	0.0	67.0	4.2	3.8	2.8	1.0	2.3	3.4	8.2	2.3	1.8	0.7
S100A10	"42C, ANX2LG, CAL1L, CLP11, P11"	ENSG00000197747	"S100 calcium binding protein A10"	P60903	1	151982915-151993859	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 1760.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 3820.4;Langerhans cells: 3945.6;Pancreatic endocrine cells: 4570.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"dendritic cells: 2005.4;monocytes: 1235.2;T-cells: 1180.0"	"Cell line enhanced"	"Detected in all"		"OE19: 4936.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003340, CAB025484"	Enhanced		Approved	Mitochondria		Yes	No		270000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"CAB025484: , HPA003340: AB_1856531"	"unprognostic (2.13e-1)"	"unprognostic (1.51e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.20e-2)"	"prognostic unfavorable (3.33e-4)"	"prognostic unfavorable (1.00e-4)"	"prognostic unfavorable (2.66e-5)"	"unprognostic (1.09e-2)"	"unprognostic (9.48e-2)"	"prognostic unfavorable (3.88e-4)"	"unprognostic (1.36e-1)"	"prognostic unfavorable (3.80e-8)"	"unprognostic (1.09e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (3.84e-4)"	775.1	376.9	71.1	244.8	76.6	133.7	519.6	75.5	139.8	478.0	78.5	867.3	461.4	110.1	56.7	1760.5	188.7	212.4	340.9	72.4	132.8	735.0	157.7	689.8	133.3	148.2	105.0	234.0	145.0	36.3	71.0	326.9	108.5	164.9	924.2	51.3	422.8	105.0	106.0	483.4	448.0	288.2	98.2	111.2	189.1	145.8	138.8	118.3	143.5	145.4	289.8	338.4	803.1	110.3	1251.3	1085.9	3.4	241.6	1351.4	1711.3	972.5	730.1	912.1	613.8	606.5	1975.4	1671.4	2.3	689.1	1208.0	661.7	2227.5	337.0	2786.6	495.3	242.5	127.1	163.8	461.5	468.1	507.0	60.2	126.7	470.8	2195.5	660.6	738.6	487.6	1326.0	78.9	2.9	3.6	753.8	940.0	11.0	376.5	163.6	4936.7	1671.4	1.6	242.4	27.1	2348.3	317.0	11.1	9.5	1259.2	374.3	539.8	1213.0	882.2	130.5	1654.9	285.5	737.2	1362.3	459.2	34.4	7.8	225.2	1709.5	51.7	977.8	359.5	1235.2	299.7	425.7	758.7	443.3	232.4	652.3	539.0	2005.4	140.1	237.7	363.1	43.6	355.0	664.7	329.6	1180.0	1313.4	71.1	76.6	75.5	139.8	72.4	132.8	148.2	105.0	108.5	98.2	138.8	110.3	1197.3	2554.5	537.7	3.9	244.0	1594.8	1171.4	2183.2	795.6	11.6	241.1	281.4	111.2	693.4	994.6	950.9	4.2	1271.5	476.2	3820.4	1524.1	1811.7	314.2	901.0	104.6	1061.2	1078.1	114.2	0.4	2105.0	527.4	1751.3	432.8	1270.7	289.5	840.0	864.5	206.9	1023.1	16.8	0.9	1723.1	272.6	795.2	3945.6	274.2	647.1	1338.1	1632.8	28.1	1544.2	24.8	285.3	4.0	0.6	4570.5	3391.8	64.7	244.5	2782.5	2146.1	495.6	620.3	32.5	144.7	801.6	529.5	30.4	115.9	1940.1	1242.0	375.8	801.0	38.5	1998.0	2290.6
S100A16	"DT1P1A7, MGC17528, S100F"	ENSG00000188643	"S100 calcium binding protein A16"	Q96FQ6	1	153606886-153613145	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 2477.7"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 995.4;Pancreatic endocrine cells: 1307.3;Prostatic glandular cells: 1141.1;Squamous epithelial cells: 1028.7;Suprabasal keratinocytes: 908.8;Theca cells: 1528.4;Urothelial cells: 1522.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 1369.9;SK-BR-3: 1618.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045841	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA		190000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol	"Plasma membrane"	"HPA045841: AB_10966282"	"unprognostic (9.86e-3)"	"unprognostic (1.69e-1)"	"unprognostic (2.23e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.71e-1)"	"unprognostic (7.03e-2)"	"prognostic unfavorable (3.18e-4)"	"prognostic unfavorable (3.14e-5)"	"unprognostic (1.70e-1)"	"unprognostic (4.59e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.60e-1)"	"prognostic unfavorable (3.91e-5)"	"unprognostic (1.01e-1)"	"unprognostic (1.92e-1)"	"unprognostic (3.45e-2)"	"unprognostic (5.29e-3)"	166.8	79.1	81.3	61.9	79.8	0.8	159.7	78.6	98.0	333.0	70.8	139.7	121.5	78.4	19.8	2477.7	68.2	81.6	122.3	79.8	80.1	219.0	209.9	161.3	28.4	104.2	80.9	83.4	41.0	76.6	42.0	71.8	84.9	77.8	105.0	7.0	438.1	38.1	51.7	474.9	109.8	79.0	84.8	118.5	100.4	60.3	103.4	25.0	72.4	52.1	205.0	163.2	713.3	84.6	670.4	318.1	16.0	36.7	102.5	386.8	42.8	367.9	341.4	302.7	265.2	315.4	366.1	0.3	577.5	553.0	69.0	479.6	1.1	839.2	175.3	1.9	0.6	0.4	260.5	90.8	117.5	0.2	0.9	182.7	787.6	731.6	567.9	390.9	1369.9	0.0	8.5	0.8	677.3	918.7	0.9	1.4	69.0	1171.0	887.9	0.9	187.4	1.8	1150.3	236.1	0.8	1.9	267.6	1618.0	55.7	140.5	504.7	3.5	743.9	178.2	289.5	171.5	848.6	0.5	3.5	2.4	525.0	0.9	122.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	81.3	79.8	78.6	98.0	79.8	80.1	104.2	80.9	84.9	84.8	103.4	84.6	275.6	38.5	25.5	10.4	6.8	633.9	995.4	531.6	157.6	0.5	225.4	191.3	33.0	124.4	290.6	108.5	2.1	20.3	4.4	500.7	72.4	610.9	4.9	50.9	172.5	293.5	139.0	16.0	0.0	193.9	8.7	112.2	96.8	128.5	19.1	154.1	365.9	132.7	5.0	0.0	0.1	286.4	164.8	15.7	95.4	17.4	67.1	7.4	112.1	5.6	7.2	72.5	0.0	7.5	0.7	1307.3	610.0	61.3	5.6	1141.1	353.3	169.7	48.6	2.1	6.6	70.9	91.2	8.0	1.3	1028.7	908.8	8.2	12.9	1528.4	320.2	1522.5
S100B	S100beta	ENSG00000160307	"S100 calcium binding protein B"	P04271	21	46598604-46605208	"Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 1499.3;choroid plexus: 781.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 126.3;Breast myoepithelial cells: 124.8;Granulosa cells: 261.7;Langerhans cells: 206.8;Melanocytes: 99.6;Oligodendrocytes: 332.1"	"Group enriched"	"Detected in all"	58	"glioma: 463.5;melanoma: 495.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 360.9"	"Lineage enriched"	"Detected in all"	6	"T-cells: 360.9"	"Group enriched"	"Detected in some"	7	"SK-MEL-30: 547.1;WM-115: 992.8"									"CAB000073, HPA015768, CAB078196"	Enhanced	Supported	Supported	Nucleoplasm,Vesicles,Cytosol		NA	NA		300000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Cytosol"	Vesicles	"CAB000073: AB_10013383, CAB078196: AB_2665776, HPA015768: AB_1856538"	"unprognostic (5.67e-3)"	"unprognostic (6.39e-3)"	"unprognostic (2.08e-3)"	"unprognostic (2.08e-2)"	"unprognostic (4.54e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.68e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.57e-3)"	"unprognostic (6.70e-2)"	"unprognostic (4.41e-7)"	"unprognostic (3.55e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.74e-1)"	151.1	25.7	877.1	10.5	1072.5	2.3	87.0	1254.5	1191.2	28.6	781.0	121.0	7.4	2.4	12.1	14.6	6.9	14.3	28.1	858.4	989.0	3.6	3.2	6.4	21.4	1491.0	1054.2	5.6	5.0	0.3	44.7	0.8	1359.0	29.3	14.2	14.1	19.3	26.2	3.6	15.8	36.3	6.8	1162.2	26.2	23.6	2.4	998.8	18.4	5.2	6.4	20.3	15.9	26.9	1499.3	0.5	0.0	110.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.3	0.0	0.0	0.6	0.0	0.0	0.0	0.2	0.5	0.9	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	15.9	0.6	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.5	0.0	0.0	547.1	0.0	0.1	0.5	0.0	0.3	0.3	0.0	3.2	0.0	0.3	0.0	1.4	6.7	992.8	0.1	0.5	0.2	360.9	9.5	103.3	0.2	1.0	67.6	16.3	1.4	3.2	153.1	3.2	58.7	10.1	3.9	0.0	63.6	877.1	1072.5	1254.5	1191.2	858.4	989.0	1491.0	1054.2	1359.0	1162.2	998.8	1499.3	4.5	3.2	4.8	126.3	4.6	16.8	0.7	0.0	17.6	1.3	41.2	124.8	6.0	0.0	0.0	0.0	0.0	0.0	14.7	0.1	0.0	0.1	0.4	0.1	0.1	2.7	0.0	2.7	0.9	0.0	0.1	4.4	0.5	0.2	0.0	261.7	4.6	0.4	9.3	0.0	1.4	0.0	0.0	38.6	206.8	1.7	5.6	37.0	99.6	9.4	33.3	25.7	63.8	83.4	332.1	0.1	0.0	0.0	2.2	0.1	0.0	0.1	0.0	4.7	0.0	5.6	7.8	0.1	0.1	0.7	12.6	0.1	37.9	0.0	0.2	0.4
S1PR1	"CD363, D1S3362, edg-1, EDG1"	ENSG00000170989	"Sphingosine-1-phosphate receptor 1"	P21453	1	101236865-101243713	"Cancer-related genes, CD markers, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Angiogenesis, Chemotaxis"	"G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 236.1;Endothelial cells: 122.3;Hepatic stellate cells: 114.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 1248.4"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ: 73.0;HUVEC TERT2: 198.9;TIME: 113.3;U-251 MG: 147.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010104, HPA075568"	Supported		Supported	Vesicles		No	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles		"CAB010104: AB_2238920, HPA075568: AB_2686758"	"unprognostic (1.41e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.61e-1)"	"unprognostic (9.78e-2)"	"unprognostic (4.49e-3)"	"unprognostic (1.34e-3)"	"unprognostic (1.99e-1)"	"unprognostic (1.36e-1)"	"unprognostic (9.12e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.23e-1)"	"unprognostic (5.82e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.64e-1)"	"prognostic unfavorable (8.78e-4)"	114.7	14.4	58.8	29.8	62.7	18.5	91.9	59.8	59.0	18.5	27.8	19.5	9.4	24.7	3.9	26.8	22.9	28.0	71.8	51.3	65.1	18.0	31.3	78.3	46.3	65.2	73.0	8.2	20.3	23.3	8.7	48.1	61.3	13.7	10.1	14.6	15.0	7.8	27.9	17.9	22.3	31.2	57.6	63.1	17.1	2.6	76.5	21.4	35.9	51.5	26.9	34.3	19.2	52.6	15.6	0.2	14.2	0.0	1.4	32.7	0.1	73.0	13.5	47.9	16.6	0.1	0.7	0.0	17.8	25.2	0.4	0.0	1.8	0.8	27.0	6.1	1.2	6.8	0.3	0.0	6.6	0.0	3.5	45.0	0.3	0.1	3.7	1.7	198.9	5.8	0.2	14.4	13.5	0.0	20.6	0.0	3.9	0.4	4.8	0.0	13.4	0.5	0.1	0.0	0.0	0.1	0.7	0.0	0.2	0.9	0.0	0.2	113.3	6.8	2.9	2.0	147.1	1.3	0.0	1.0	0.7	0.0	0.4	1248.4	2.2	55.4	589.4	2.1	441.5	294.7	502.6	492.1	2.6	346.9	383.3	396.3	15.4	397.5	3.4	3.1	329.4	438.7	58.8	62.7	59.8	59.0	51.3	65.1	65.2	73.0	61.3	57.6	76.5	52.6	236.1	0.0	8.9	37.9	36.0	7.6	0.2	0.0	2.2	0.4	1.1	1.1	23.8	2.8	1.3	0.0	0.0	5.9	25.0	0.0	0.0	0.0	0.0	1.1	1.0	122.3	0.0	0.4	0.1	0.0	0.3	11.7	0.5	1.8	7.6	9.7	114.2	8.9	9.9	0.0	0.3	0.0	0.0	6.5	5.7	0.0	0.9	3.0	5.4	13.1	9.9	31.1	40.2	0.5	0.2	0.0	0.0	0.0	18.2	0.5	0.0	0.1	0.0	1.4	0.0	3.6	4.8	0.7	0.7	0.6	5.1	2.6	29.9	1.8	0.1	0.4
SAMM50	"CGI-51, OMP85, SAM50, TOB55, TRG-3, YNL026W"	ENSG00000100347	"SAMM50 sorting and assembly machinery component"	Q9Y512	22	43955442-44010531	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 240.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034537	Enhanced		Supported	Mitochondria		NA	NA			"Cluster 23: Antigen presenting cells - Antigen presentation"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA034537: AB_10602794"	"unprognostic (2.92e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.95e-3)"	"prognostic favorable (2.63e-7)"	"unprognostic (2.43e-3)"	"unprognostic (2.28e-1)"	"unprognostic (5.28e-3)"	"unprognostic (1.70e-3)"	"unprognostic (3.37e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.42e-1)"	"unprognostic (3.52e-1)"	"prognostic favorable (4.43e-8)"	"unprognostic (1.08e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.60e-1)"	41.7	50.6	26.1	27.0	27.0	32.5	35.8	29.8	30.6	43.4	31.1	35.6	50.8	27.0	29.3	31.7	41.9	29.3	65.5	27.1	29.2	48.8	37.2	22.2	34.6	29.8	28.5	40.0	33.3	114.4	24.4	20.1	30.4	26.5	35.5	25.5	35.2	25.1	240.4	35.9	38.3	27.7	27.0	24.4	43.8	26.1	28.5	34.4	28.1	177.0	37.0	27.9	24.0	28.0	64.6	59.8	57.1	69.5	72.2	75.9	79.8	61.7	65.7	89.1	76.4	86.1	46.0	105.9	44.3	70.8	51.4	75.6	85.4	82.6	79.7	29.4	105.3	57.5	73.9	102.6	50.4	184.0	83.1	88.3	64.7	77.0	35.5	62.3	93.1	49.9	49.9	34.0	80.9	91.7	72.6	72.0	56.0	77.4	70.9	83.8	61.8	85.9	74.4	81.0	34.1	55.4	68.3	72.2	104.1	60.4	67.7	59.8	57.7	57.3	68.8	53.6	51.2	50.1	74.4	82.1	72.0	66.3	58.7	47.5	39.2	46.9	39.8	39.0	55.4	55.1	36.6	40.5	67.7	51.0	37.8	36.0	6.1	39.1	31.8	26.7	45.7	40.2	26.1	27.0	29.8	30.6	27.1	29.2	29.8	28.5	30.4	27.0	28.5	28.0	52.9	35.3	18.9	10.4	31.6	20.6	27.0	72.0	30.7	20.1	32.1	40.9	68.6	18.6	39.5	9.2	8.4	41.6	31.7	36.1	60.7	47.2	40.3	47.3	24.9	35.1	18.6	51.4	12.0	55.5	54.1	24.6	42.3	32.7	27.3	43.9	30.0	41.8	51.1	32.0	12.7	35.2	46.8	28.6	20.5	50.1	26.1	25.0	16.0	12.2	41.4	32.8	33.0	9.5	9.1	43.7	34.5	30.5	31.0	16.2	82.4	116.8	39.9	30.1	19.7	23.2	33.4	45.8	31.2	34.3	22.6	20.5	28.5	69.9	59.8	19.3
SAP18	"2HOR0202, MGC27131, SAP18p"	ENSG00000150459	"Sin3A associated protein 18"	O00422	13	21140514-21149084	"Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011352, CAB012273"	Supported		Supported	"Nucleoplasm,Nuclear bodies,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Nuclear bodies"	Cytosol	"CAB012273: , HPA011352: AB_1856563"	"unprognostic (5.08e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (1.19e-3)"	"unprognostic (2.84e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.02e-1)"	"unprognostic (3.18e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.01e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.33e-2)"	"unprognostic (7.75e-3)"	"unprognostic (4.70e-2)"	"unprognostic (3.70e-3)"	"unprognostic (2.78e-2)"	125.7	164.3	140.9	122.9	152.2	242.3	121.6	149.6	198.9	120.4	137.8	141.8	137.4	123.8	97.5	159.2	112.9	82.4	195.8	147.4	160.7	190.4	171.1	106.5	118.0	154.7	153.8	109.5	134.6	114.2	129.6	111.7	157.7	109.7	58.5	89.5	126.3	73.0	297.9	119.5	127.5	51.7	164.1	107.6	119.5	194.3	155.7	115.5	110.7	156.3	64.8	131.7	118.5	170.7	182.1	99.3	159.5	173.1	169.0	140.5	246.9	227.1	167.2	205.5	151.3	181.1	342.4	187.3	272.0	189.1	223.4	186.5	198.1	142.4	231.5	288.0	100.4	267.6	121.2	305.9	191.8	367.1	207.5	143.0	159.7	157.5	187.1	158.4	157.3	223.1	128.8	103.6	188.2	231.0	417.0	599.0	200.7	501.5	109.7	261.1	251.4	187.1	295.7	160.7	185.0	161.1	145.7	213.8	296.5	176.5	206.8	528.0	192.6	126.0	141.9	230.1	268.9	159.6	243.6	536.7	122.5	214.9	236.4	433.0	431.5	540.0	344.1	485.0	349.3	493.7	418.2	410.9	427.8	443.6	405.9	402.9	430.5	395.3	547.4	568.8	517.5	909.3	140.9	152.2	149.6	198.9	147.4	160.7	154.7	153.8	157.7	164.1	155.7	170.7	638.0	134.6	143.5	15.0	291.7	458.6	336.3	640.9	310.7	101.5	298.9	594.9	592.9	194.5	383.8	233.6	41.7	566.2	397.4	353.6	759.2	396.5	1259.5	334.1	231.1	273.1	234.5	214.4	20.8	365.6	528.0	374.0	170.2	256.2	258.6	176.6	180.2	242.0	396.0	119.5	23.4	364.5	468.0	189.5	440.9	206.0	342.3	260.4	407.4	17.8	385.0	370.8	233.8	19.6	26.2	401.9	417.6	303.6	182.3	325.9	475.0	1100.6	446.8	132.3	203.8	362.5	438.3	547.7	319.9	271.7	422.2	908.3	338.8	254.2	344.7	419.9
SARAF	"MGC8721, TMEM66"	ENSG00000133872	"Store-operated calcium entry associated regulatory factor"	Q96BY9	8	30063003-30083208	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040400			Supported	"Endoplasmic reticulum,Rods & Rings"		NA	NA		41000	"Cluster 20: T-cells - T-cell receptor"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 24: Non-specific - Transcription regulation"	"Endoplasmic reticulum"	"Rods & Rings"	"HPA040400: AB_2676962"	"unprognostic (1.11e-1)"	"unprognostic (4.78e-2)"	"unprognostic (4.27e-3)"	"unprognostic (1.38e-3)"	"unprognostic (7.86e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.28e-4)"	"unprognostic (1.98e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.03e-2)"	"unprognostic (6.70e-3)"	"unprognostic (1.06e-2)"	"unprognostic (5.09e-2)"	"unprognostic (3.88e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.18e-1)"	139.9	294.5	208.6	169.1	228.0	253.0	169.9	187.2	246.6	153.8	196.2	143.0	123.9	152.1	408.6	91.0	205.9	182.1	151.8	234.6	308.8	205.2	302.3	167.5	218.9	214.0	258.8	255.7	231.4	236.5	138.9	309.2	247.6	228.2	143.5	219.1	212.9	172.7	111.1	70.8	140.5	139.1	219.5	159.0	161.1	104.3	290.5	243.4	245.4	129.0	186.5	141.0	64.0	218.5	119.9	112.4	147.9	79.9	209.3	149.8	69.7	139.2	247.0	128.5	173.7	72.2	139.9	80.9	183.5	156.0	134.7	97.7	100.8	112.4	146.9	33.6	49.5	112.2	87.3	119.2	189.6	48.8	130.6	175.2	260.0	121.6	125.5	257.4	192.0	150.7	128.4	191.2	142.9	74.2	128.4	88.8	96.0	253.6	61.3	98.7	88.4	107.4	220.3	100.4	48.6	162.5	140.6	160.5	208.2	115.7	112.2	93.3	144.0	89.6	230.5	35.0	56.5	103.4	110.6	81.0	215.8	118.4	146.5	964.6	252.9	443.1	321.2	253.2	364.8	233.1	473.0	377.9	247.0	302.4	776.2	543.6	478.1	258.8	335.3	212.0	483.8	920.3	208.6	228.0	187.2	246.6	234.6	308.8	214.0	258.8	247.6	219.5	290.5	218.5	179.8	169.9	147.6	79.0	458.5	0.0	331.6	0.0	154.8	291.5	247.8	166.2	135.4	261.7	82.3	211.5	123.0	235.9	566.8	142.2	127.2	387.5	629.8	235.9	114.8	170.8	115.3	145.4	128.0	358.9	254.5	181.7	170.7	133.6	223.3	325.7	240.2	273.4	292.0	139.7	157.8	122.0	0.0	448.6	0.0	908.1	218.7	387.9	0.0	60.9	298.5	317.2	358.4	82.9	111.7	250.1	137.0	294.2	505.1	280.7	252.6	289.7	212.1	252.5	177.5	203.7	177.1	194.7	133.9	133.4	0.0	276.9	794.4	167.8	115.9	310.6
SCAMP1	SCAMP37	ENSG00000085365	"Secretory carrier membrane protein 1"	O15126	5	78360611-78480739	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044753, CAB079009"		Supported	Uncertain	"Nucleoplasm,Vesicles,Cell Junctions"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"	"Cell Junctions"	"Nucleoplasm, Vesicles"	"CAB079009: , HPA044753: "	"unprognostic (8.25e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.40e-3)"	"unprognostic (5.34e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.57e-3)"	"unprognostic (5.51e-2)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-1)"	"unprognostic (8.23e-3)"	"unprognostic (2.35e-2)"	"unprognostic (2.56e-1)"	"prognostic favorable (1.92e-4)"	"unprognostic (8.44e-3)"	"unprognostic (7.56e-2)"	"unprognostic (3.12e-2)"	"unprognostic (4.99e-2)"	17.9	22.4	18.4	12.7	20.5	8.5	28.2	24.5	29.1	23.9	23.9	19.6	16.0	25.0	23.2	24.7	29.6	20.2	24.7	20.4	22.4	28.6	17.8	17.8	12.1	18.4	21.5	22.8	25.2	47.1	15.7	23.4	21.4	34.3	22.3	40.2	31.5	29.8	10.6	17.7	15.6	26.6	20.0	13.6	27.9	14.1	23.3	14.6	39.8	16.3	13.4	25.0	11.4	19.0	32.7	23.9	23.4	76.1	35.5	45.5	40.8	30.0	46.1	26.5	56.1	9.3	61.1	48.1	31.4	45.5	65.7	26.2	34.9	57.0	45.9	17.4	32.5	20.5	17.8	20.1	22.7	13.6	16.5	28.6	54.5	27.3	41.2	62.5	41.3	25.0	8.4	33.6	50.9	39.2	25.2	26.7	19.9	14.3	26.0	29.5	38.3	55.3	43.5	38.6	70.9	40.6	27.6	38.5	26.7	24.9	52.5	26.1	36.6	26.3	19.3	30.0	24.2	20.9	29.4	27.6	50.1	50.4	22.6	20.3	11.4	13.2	7.5	12.7	9.3	7.6	8.7	9.2	14.8	6.5	7.1	6.3	6.8	10.3	16.6	4.5	9.1	8.0	18.4	20.5	24.5	29.1	20.4	22.4	18.4	21.5	21.4	20.0	23.3	19.0	59.5	25.6	22.4	45.7	20.3	39.1	31.5	33.6	38.7	72.1	33.4	22.7	36.1	21.5	30.4	40.5	70.9	13.8	21.7	19.1	13.7	24.2	42.2	34.9	30.2	31.4	35.4	12.0	80.0	30.5	24.8	34.3	36.7	34.1	12.0	41.7	27.1	15.7	19.2	32.0	100.1	34.2	20.3	33.7	33.1	15.3	20.2	25.1	30.2	45.0	19.1	47.4	19.6	76.4	60.3	29.8	14.9	28.6	23.9	44.6	14.2	24.7	65.4	68.2	13.1	33.5	25.4	25.6	23.1	30.8	45.3	10.5	21.2	30.8	18.8	33.7
SCAMP2		ENSG00000140497	"Secretory carrier membrane protein 2"	O15127	15	74843730-74873365	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014699, HPA019194"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA		71000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 10: Non-specific - Unknown function"	"Golgi apparatus, Vesicles"		"HPA014699: AB_1856605, HPA019194: AB_1856604"	"unprognostic (1.74e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (5.23e-3)"	"unprognostic (2.89e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.53e-2)"	"unprognostic (7.23e-2)"	"unprognostic (9.73e-3)"	"unprognostic (7.26e-2)"	"unprognostic (8.44e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (1.12e-6)"	"unprognostic (3.40e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.10e-2)"	43.1	46.7	27.8	40.3	32.8	51.5	40.7	31.9	31.2	40.5	38.8	76.0	75.7	36.9	36.9	103.4	47.4	35.4	32.4	26.1	29.8	44.9	42.0	49.6	47.9	40.7	30.9	26.5	54.5	85.6	29.4	48.9	36.7	35.5	72.7	4.7	92.7	32.4	34.2	68.3	80.1	33.6	33.6	66.8	64.9	36.2	33.3	33.0	38.3	18.9	53.4	38.1	49.4	35.4	44.7	57.3	24.2	37.6	72.0	37.2	72.0	45.0	56.6	46.9	50.1	83.0	102.6	36.5	57.8	68.1	67.7	157.8	72.3	55.9	19.4	145.8	71.1	92.8	31.2	57.6	54.3	48.0	170.9	48.0	97.6	44.4	32.0	37.0	46.0	42.0	31.3	67.5	33.3	68.1	24.6	55.3	24.1	111.0	36.6	42.6	22.3	126.4	54.0	63.1	24.9	25.0	36.7	64.3	42.4	35.4	88.5	76.3	43.4	40.2	23.9	43.8	53.0	46.1	73.2	37.6	37.8	112.2	30.2	118.3	111.3	90.0	94.1	106.9	76.1	80.8	85.3	95.9	81.8	70.9	69.4	75.8	74.4	83.8	119.3	128.7	105.3	120.8	27.8	32.8	31.9	31.2	26.1	29.8	40.7	30.9	36.7	33.6	33.3	35.4	36.0	73.7	31.7	17.9	49.5	17.5	41.7	40.5	19.4	6.8	28.0	24.8	14.4	24.3	53.1	40.5	2.1	156.9	63.4	116.8	15.6	67.4	132.3	30.8	22.0	36.2	37.3	29.0	7.7	92.8	61.9	37.2	54.0	40.6	79.2	31.3	26.4	27.7	164.7	6.7	6.1	77.5	42.7	78.3	44.5	56.2	32.0	77.0	32.0	21.5	56.9	41.4	63.8	12.1	17.9	96.1	75.5	23.0	73.1	54.0	105.7	48.1	52.6	8.4	26.3	25.6	35.8	47.1	35.3	39.6	22.3	136.4	55.1	40.0	64.2	58.5
SCAMP3	C1orf3	ENSG00000116521	"Secretory carrier membrane protein 3"	O14828	1	155255979-155262430	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071167			Supported	Vesicles		NA	NA		75000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA071167: AB_2686352"	"unprognostic (4.31e-2)"	"unprognostic (1.30e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.17e-2)"	"unprognostic (5.33e-2)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (2.92e-5)"	"unprognostic (8.78e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-1)"	"unprognostic (3.74e-2)"	"unprognostic (8.46e-3)"	"unprognostic (1.60e-1)"	"unprognostic (4.79e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.18e-2)"	45.1	69.6	4.6	7.1	6.8	7.9	43.5	6.3	8.2	38.1	4.5	37.4	7.7	35.2	0.2	49.9	31.9	5.0	65.0	5.0	4.5	49.0	48.4	40.9	12.1	6.3	5.2	34.9	51.9	4.7	33.8	7.3	5.6	37.0	2.4	1.1	49.3	6.1	90.9	56.4	38.4	3.5	6.4	46.5	47.0	28.3	5.4	8.3	38.6	3.2	7.2	39.5	38.6	8.2	19.7	30.2	11.2	8.8	8.3	6.8	14.5	21.6	20.7	26.3	19.4	30.0	15.7	45.1	49.3	10.9	15.7	20.5	9.0	18.7	1.8	29.8	68.3	25.7	11.7	8.5	26.1	30.5	17.4	9.7	20.9	21.2	10.3	3.3	18.9	49.3	38.2	18.3	11.6	38.3	50.5	14.6	16.5	27.9	59.4	43.1	9.1	67.5	4.8	13.1	8.3	20.0	26.2	8.0	39.1	3.4	32.1	13.7	29.0	20.9	17.5	29.3	29.6	43.3	84.8	52.9	16.7	41.1	15.2	41.0	47.5	52.8	94.4	51.7	86.8	98.8	91.3	91.1	58.1	100.3	83.3	86.6	6.7	76.0	71.4	102.4	101.0	100.9	4.6	6.8	6.3	8.2	5.0	4.5	6.3	5.2	5.6	6.4	5.4	8.2	23.0	16.0	37.1	12.4	33.8	38.2	23.8	57.3	54.1	18.5	27.3	19.3	39.1	30.0	43.7	33.1	4.2	86.4	27.2	19.0	9.8	49.0	1.7	16.3	20.8	33.1	30.1	14.5	9.9	69.4	55.1	27.1	27.0	26.3	25.3	16.6	32.9	37.9	57.3	18.5	11.9	24.3	42.7	21.3	26.7	5.3	17.1	23.0	24.9	7.5	41.3	20.2	30.9	9.5	17.4	48.5	19.9	18.8	56.1	24.7	36.8	24.4	22.6	10.9	13.1	16.7	27.3	20.0	5.5	46.7	40.1	71.3	33.4	20.5	30.1	22.5
SCAMP4	FLJ33847	ENSG00000227500	"Secretory carrier membrane protein 4"	Q969E2	19	1905372-1926013	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043284	Approved		Approved	"Golgi apparatus,Vesicles,Lipid droplets,Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus, Vesicles"	"Lipid droplets, Plasma membrane"	"HPA043284: AB_10806501"	"unprognostic (1.60e-1)"	"unprognostic (3.62e-1)"	"unprognostic (5.04e-2)"	"prognostic favorable (4.40e-6)"	"unprognostic (2.58e-1)"	"unprognostic (4.58e-1)"	"prognostic unfavorable (1.92e-5)"	"unprognostic (2.04e-1)"	"unprognostic (1.58e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.01e-3)"	"unprognostic (5.66e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.16e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.03e-1)"	23.2	27.4	31.1	15.5	39.9	11.4	25.4	41.3	33.3	28.1	33.6	23.3	19.8	26.0	17.5	39.9	38.3	19.5	15.5	28.9	33.1	34.4	28.3	25.5	15.6	51.5	42.9	27.1	36.5	15.8	31.8	18.8	47.7	31.7	9.8	7.4	43.9	20.4	13.9	36.3	20.3	12.3	39.7	25.1	26.4	22.0	40.6	8.3	32.7	5.8	9.4	22.0	25.0	53.5	53.6	53.9	25.7	56.8	50.7	31.7	29.6	35.5	33.1	39.3	46.7	44.9	51.1	22.5	32.1	30.7	23.1	63.7	24.7	38.2	14.5	34.8	21.7	15.8	19.0	44.3	65.6	16.9	23.2	48.8	24.2	34.8	21.2	32.9	27.2	25.2	35.7	25.3	23.3	67.8	21.5	31.6	38.8	31.1	18.6	25.9	18.1	34.6	49.8	47.5	33.8	45.0	23.9	49.9	31.4	18.1	50.6	41.5	29.6	44.8	30.5	81.1	35.7	57.8	62.6	21.0	59.1	26.9	30.1	1.7	4.4	1.9	3.9	4.9	2.0	5.1	2.7	2.6	4.8	3.4	1.5	2.9	2.1	5.8	4.5	12.0	2.3	3.7	31.1	39.9	41.3	33.3	28.9	33.1	51.5	42.9	47.7	39.7	40.6	53.5	16.9	9.6	7.3	12.1	22.9	17.1	25.0	20.8	33.0	19.7	40.0	23.5	3.0	21.5	14.1	49.7	75.0	40.0	59.6	53.0	7.9	20.8	0.8	63.2	23.2	17.8	18.7	11.6	8.3	12.5	38.1	18.2	43.3	42.1	17.2	27.8	15.7	13.4	38.0	21.9	8.0	36.1	20.3	20.1	24.9	1.9	21.8	24.2	21.4	5.6	21.0	29.6	33.0	16.6	18.9	16.1	25.3	17.3	16.0	30.0	47.6	10.1	33.2	52.2	0.0	15.8	15.7	19.0	26.1	30.8	20.2	59.0	20.4	26.9	31.1	28.1
SCAMP5	MGC24969	ENSG00000198794	"Secretory carrier membrane protein 5"	Q8TAC9	15	74957219-75021495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 179.9;parathyroid gland: 103.1;retina: 283.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 113.3;Cone photoreceptor cells: 125.1;Enteroendocrine cells: 62.5;Excitatory neurons: 75.1;Horizontal cells: 70.7;Inhibitory neurons: 99.3;Rod photoreceptor cells: 168.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	33	"plasmacytoid DC: 27.7"	"Lineage enriched"	"Detected in single"	33	"dendritic cells: 27.7"	"Cell line enhanced"	"Detected in many"		"SCLC-21H: 88.1;SH-SY5Y: 49.3;THP-1: 34.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046645	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA046645: AB_2679734"	"unprognostic (1.37e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.20e-2)"	"unprognostic (2.74e-1)"	"unprognostic (4.46e-2)"	"unprognostic (2.56e-1)"	"unprognostic (4.13e-1)"	"unprognostic (2.34e-1)"	"unprognostic (8.37e-2)"	"prognostic favorable (5.67e-5)"	"unprognostic (9.82e-2)"	"prognostic favorable (1.34e-6)"	"unprognostic (7.27e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.31e-2)"	3.0	20.6	106.7	4.3	125.2	2.6	3.1	75.1	179.9	2.8	12.5	5.8	41.6	5.7	3.6	1.5	5.0	5.6	5.5	128.7	74.8	16.7	4.2	2.8	7.9	113.9	67.4	6.0	53.4	103.1	67.7	6.7	112.5	4.6	4.9	283.7	7.2	2.7	0.6	2.1	30.4	3.2	35.8	8.5	15.6	10.7	80.6	4.4	6.5	0.8	10.0	5.9	1.8	124.4	1.5	17.8	3.8	12.6	0.3	0.2	0.5	0.4	0.6	4.0	1.4	4.9	8.9	28.0	8.5	1.1	3.3	1.2	15.6	1.1	1.4	4.4	2.0	3.5	2.1	25.8	2.7	0.4	11.5	1.3	2.1	1.0	0.3	2.8	1.7	10.1	0.2	22.1	1.0	15.1	1.1	10.2	13.4	2.1	7.1	0.4	3.2	6.7	1.0	8.6	88.1	49.3	19.8	13.6	27.6	2.7	7.7	34.0	1.1	1.2	8.2	1.6	1.3	1.8	2.4	2.6	3.0	21.2	4.3	0.6	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.8	0.4	0.1	27.7	0.0	0.4	106.7	125.2	75.1	179.9	128.7	74.8	113.9	67.4	112.5	35.8	80.6	124.4	2.2	0.0	1.1	14.7	2.5	0.3	0.5	0.4	2.8	113.3	3.2	2.7	3.0	7.2	0.4	5.5	125.1	0.1	35.5	2.9	1.9	4.4	0.5	0.4	0.7	3.6	62.5	0.0	75.1	43.3	0.3	1.9	12.8	0.3	0.0	4.1	6.8	0.6	13.8	70.7	99.3	5.0	0.0	6.9	0.2	0.7	2.1	2.0	1.8	6.5	0.4	29.9	0.0	32.2	26.2	6.8	5.3	6.4	8.9	0.8	34.0	13.0	2.7	168.0	0.0	0.9	2.8	1.8	4.7	1.7	0.1	0.1	0.6	2.0	2.7	0.3
SCARB1	"CD36L1, CLA-1, CLA1, SR-BI, SRB1"	ENSG00000073060	"Scavenger receptor class B member 1"	Q8WTV0	12	124776856-124882668	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"adrenal gland: 995.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 133.9;Granulosa cells: 114.6;Hepatocytes: 159.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 6.2;myeloid DC: 8.9;plasmacytoid DC: 21.0"	"Group enriched"	"Detected in many"	6	"dendritic cells: 21.0;monocytes: 6.2"	"Cell line enhanced"	"Detected in many"		"RPMI-8226: 148.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA066285, CAB070124, HPA072449"	Enhanced		Approved	"Vesicles,Lysosomes,Rods & Rings"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles	"Lysosomes, Rods & Rings"	"CAB070124: AB_10107658, HPA066285: AB_2685649, HPA072449: AB_2732201"	"unprognostic (9.70e-3)"	"unprognostic (4.94e-3)"	"unprognostic (1.32e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.65e-3)"	"unprognostic (4.21e-3)"	"prognostic unfavorable (1.83e-5)"	"prognostic unfavorable (4.02e-4)"	"unprognostic (2.30e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.80e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.49e-5)"	"unprognostic (3.50e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.13e-1)"	59.2	995.8	12.3	4.0	22.7	1.3	55.4	7.2	13.2	12.9	21.7	14.7	12.5	13.7	0.9	9.2	13.1	12.9	10.5	12.3	8.9	6.8	235.7	15.3	6.2	11.0	10.0	54.8	9.6	4.0	15.2	111.5	12.0	13.0	9.2	12.0	21.2	2.3	9.8	26.4	14.9	7.8	7.2	12.7	8.8	19.1	15.5	2.9	11.7	5.0	10.4	12.3	12.7	11.5	30.1	50.0	22.2	51.4	12.3	23.1	0.0	24.2	20.0	21.4	12.1	56.7	61.7	91.6	66.4	12.4	31.1	39.2	58.0	109.3	13.2	45.5	51.4	18.5	53.1	68.3	33.2	35.9	17.2	39.5	19.7	41.0	32.5	36.7	57.2	9.1	41.5	21.5	4.3	27.7	12.9	23.5	22.8	30.7	66.0	51.0	18.8	148.7	0.8	32.9	38.8	12.1	126.5	95.9	70.2	13.3	55.8	29.9	4.6	2.6	23.8	14.3	29.8	10.1	3.8	15.7	11.3	29.0	23.9	0.0	6.2	0.0	0.2	3.0	0.1	2.3	0.0	0.2	8.9	0.9	0.0	0.0	0.8	0.0	0.6	21.0	0.0	3.8	12.3	22.7	7.2	13.2	12.3	8.9	11.0	10.0	12.0	7.2	15.5	11.5	133.9	3.2	2.7	25.8	8.6	5.6	3.6	9.0	6.8	6.1	14.8	17.0	6.5	8.6	5.3	3.7	29.2	10.7	10.5	46.7	3.9	5.4	18.1	1.0	5.3	44.2	10.7	8.2	21.0	7.4	13.8	7.9	11.7	3.4	1.3	114.6	21.4	159.4	51.6	16.8	24.8	13.1	8.2	14.8	11.4	12.6	9.0	16.7	48.0	74.9	5.9	52.9	0.0	23.1	27.3	5.8	12.9	5.3	8.0	9.9	10.0	2.9	4.7	7.5	0.0	3.1	5.0	25.0	1.6	6.5	3.1	43.4	1.8	60.0	9.4	4.4
SCARB2	"CD36L2, HLGP85, LIMP-2, LIMPII, SR-BII"	ENSG00000138760	"Scavenger receptor class B member 2"	Q14108	4	76158737-76234536	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"	"Host cell receptor for virus entry, Receptor"	"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"basophil: 12.5;classical monocyte: 14.1;intermediate monocyte: 26.0;myeloid DC: 8.2;non-classical monocyte: 24.9;plasmacytoid DC: 28.9"	"Group enriched"	"Detected in all"	5	"dendritic cells: 28.9;granulocytes: 12.5;monocytes: 26.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 499.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB015415, HPA018014"	Supported		Approved	Cytosol		NA	NA		9200	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 35: Glandular cells - Unknown function"	Cytosol		"CAB015415: AB_831511, HPA018014: AB_1852881"	"prognostic unfavorable (2.82e-5)"	"unprognostic (2.73e-2)"	"unprognostic (4.09e-2)"	"unprognostic (4.96e-2)"	"unprognostic (4.17e-3)"	"unprognostic (1.12e-3)"	"unprognostic (2.08e-1)"	"unprognostic (5.48e-2)"	"unprognostic (4.06e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.11e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.91e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.89e-2)"	60.6	24.0	33.5	27.7	63.5	7.3	56.7	58.9	38.9	60.8	18.9	61.6	39.2	44.1	58.4	33.9	45.4	60.0	61.6	29.6	48.6	46.8	89.9	77.1	20.2	62.2	49.6	58.9	58.9	63.6	11.1	80.2	62.5	72.3	64.0	53.2	80.5	55.4	89.8	26.0	49.1	57.8	60.1	47.0	60.7	19.4	50.7	21.3	65.9	81.3	20.6	65.3	25.1	92.9	39.8	38.4	48.9	97.1	499.7	242.0	35.8	131.5	250.2	114.0	178.2	72.5	112.3	0.0	85.1	262.3	109.6	28.3	28.3	78.9	96.0	138.8	30.1	3.2	32.9	25.3	129.9	19.0	12.1	186.9	72.3	117.3	54.5	268.9	200.6	10.0	15.6	188.6	159.2	58.2	1.6	4.0	9.7	120.3	23.6	23.3	82.7	42.0	64.4	43.6	101.3	110.2	104.7	61.3	115.5	49.3	34.6	17.1	131.3	125.9	48.5	104.7	47.5	167.6	98.8	0.2	158.1	22.2	170.9	12.5	14.1	3.1	2.8	26.0	2.6	3.8	1.9	1.5	8.2	3.0	2.6	4.3	1.9	1.1	24.9	28.9	3.0	6.1	33.5	63.5	58.9	38.9	29.6	48.6	62.2	49.6	62.5	60.1	50.7	92.9	89.0	176.3	52.4	47.3	20.1	24.0	90.5	64.8	34.1	109.6	69.7	36.4	53.0	87.2	52.1	99.3	60.5	35.3	43.6	109.0	7.9	119.9	7.1	50.3	74.0	69.9	102.4	28.6	57.4	72.9	47.5	108.3	40.8	88.8	3.8	84.8	79.6	108.7	143.4	60.6	55.4	77.1	44.7	165.7	27.5	5.6	45.4	76.2	67.6	38.4	43.5	87.2	6.2	106.1	201.1	78.0	68.3	66.5	82.2	133.5	103.2	27.6	54.4	81.7	92.1	91.0	68.1	18.2	16.5	34.8	33.8	59.4	16.3	56.5	55.3	93.4
SCN11A	"NaN, Nav1.9, SCN12A, SNS-2"	ENSG00000168356	"Sodium voltage-gated channel alpha subunit 11"	Q9UI33	3	38845764-39052157	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, FDA approved drug targets, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 3.0;placenta: 1.9"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 5.4;Astrocytes: 7.8;Early spermatids: 7.0;Sertoli cells: 6.6;Spermatocytes: 4.4;Spermatogonia: 6.3"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"HDLM-2: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA036746, HPA036747"	Uncertain					NA	NA				"Cluster 64: Macrophages - Immune response"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA036746: AB_10696785, HPA036747: AB_2675287"	"unprognostic (6.11e-2)"	"unprognostic (5.16e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.75e-2)"	"unprognostic (4.21e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.79e-2)"	"unprognostic (5.66e-2)"	"unprognostic (4.44e-2)"	"unprognostic (5.21e-2)"	"unprognostic (2.30e-4)"	"unprognostic (1.91e-2)"	"unprognostic (5.43e-2)"	"unprognostic (5.02e-2)"	"unprognostic (2.95e-1)"	"unprognostic (3.12e-2)"	"unprognostic (8.30e-4)"	0.5	0.1	0.4	0.2	0.2	0.0	0.3	0.2	0.3	0.1	0.1	0.6	0.3	0.0	0.4	0.0	0.1	0.1	0.0	0.4	0.3	0.5	0.2	0.1	0.2	0.3	0.4	0.1	0.1	0.0	0.3	1.9	0.3	0.1	0.6	0.1	0.0	0.1	0.1	0.4	0.5	0.3	0.3	3.0	0.1	1.3	0.5	0.2	0.1	0.0	0.1	0.8	0.2	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.2	0.3	0.4	0.3	0.3	0.4	0.3	0.3	0.5	0.4	5.4	0.0	0.0	7.8	0.1	0.8	0.9	0.0	0.0	0.2	0.2	0.3	1.2	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	7.0	0.4	0.5	2.5	0.0	2.7	1.6	0.2	0.1	0.6	0.0	0.2	0.0	1.1	1.4	0.4	0.3	0.0	1.0	0.0	0.0	0.3	1.6	2.1	0.0	0.2	1.8	0.0	0.1	0.5	0.0	1.5	2.4	0.1	0.0	0.0	0.1	0.7	0.0	0.2	2.3	0.5	6.6	1.0	0.4	4.4	6.3	0.0	0.9	0.3	0.6	0.7	0.0	0.8
SCN1A	"FEB3, GEFSP2, HBSCI, NAC1, Nav1.1, SCN1, SMEI"	ENSG00000144285	"Sodium voltage-gated channel alpha subunit 1"	P35498	2	165984641-166149214	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Autism, Autism spectrum disorder, Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 24.7"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 409.9;Inhibitory neurons: 494.6;Oligodendrocyte precursor cells: 692.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"ASC TERT1: 6.1;Hep G2: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078664			Supported	"Nucleoplasm,Nuclear bodies,Plasma membrane"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"	"Nuclear bodies"	"HPA078664: AB_2686888"	"unprognostic (9.25e-2)"	"unprognostic (3.97e-2)"		"unprognostic (6.88e-2)"	"unprognostic (7.44e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.70e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-1)"	"unprognostic (9.59e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.03e-9)"	"unprognostic (6.92e-2)"	"unprognostic (3.69e-2)"	"unprognostic (5.06e-3)"	"unprognostic (6.93e-1)"	0.0	0.0	4.2	0.0	4.2	0.0	0.0	2.1	24.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.1	2.1	6.9	0.0	0.0	1.4	0.0	14.2	6.2	0.0	0.0	0.0	2.0	0.0	18.5	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	10.9	0.0	0.0	0.0	0.0	0.0	0.0	10.9	0.0	0.0	0.9	0.0	0.0	6.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	3.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	4.2	2.1	24.7	2.1	6.9	14.2	6.2	18.5	2.2	10.9	10.9	0.0	6.4	33.9	27.4	0.0	0.0	0.0	0.0	0.0	47.4	0.6	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	4.5	0.0	0.3	1.8	0.0	409.9	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	494.6	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	18.7	0.0	2.8	0.0	692.1	11.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SCN2A	"HBSCI, HBSCII, Nav1.2, SCN2A1, SCN2A2"	ENSG00000136531	"Sodium voltage-gated channel alpha subunit 2"	Q99250	2	165194993-165392310	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 26.1"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 440.4;Inhibitory neurons: 364.7;Oligodendrocyte precursor cells: 246.3"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HSkMC: 2.1;U-138 MG: 3.4;U-266/84: 8.1;U-87 MG: 2.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022567	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 16: U-266 - Nucleosome"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB022567: "	"unprognostic (1.16e-1)"	"unprognostic (3.56e-4)"	"unprognostic (5.28e-2)"	"unprognostic (6.12e-3)"	"unprognostic (2.97e-1)"	"unprognostic (8.62e-3)"	"unprognostic (1.18e-1)"	"unprognostic (7.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.32e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-1)"	"unprognostic (4.88e-2)"	"unprognostic (2.14e-1)"	0.2	1.3	15.8	0.1	17.5	0.0	0.7	26.1	20.1	0.2	0.0	0.1	0.2	0.5	0.9	0.0	0.1	0.8	0.1	22.2	8.0	3.5	0.1	0.2	0.0	0.0	0.0	0.2	0.1	0.0	3.7	0.1	0.0	0.1	0.1	4.6	0.2	0.4	0.0	0.0	0.2	0.6	0.0	0.1	0.3	0.3	2.5	0.3	0.0	0.0	0.0	0.1	0.3	5.8	0.0	0.0	0.3	0.0	0.1	0.4	0.0	0.0	1.7	0.0	1.6	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.7	0.4	0.0	0.2	0.0	0.3	0.0	0.1	2.1	0.0	0.1	0.0	1.5	0.0	0.0	0.0	0.2	0.9	0.0	0.1	0.0	1.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.8	1.9	0.0	0.0	0.0	0.7	0.0	0.0	0.0	3.4	0.2	0.2	0.0	0.3	8.1	0.0	2.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.8	17.5	26.1	20.1	22.2	8.0	0.0	0.0	0.0	0.0	2.5	5.8	0.1	0.0	1.7	18.3	0.5	0.3	0.1	0.2	0.0	49.8	0.3	4.7	0.8	0.0	0.0	11.0	47.9	0.1	0.2	0.0	5.9	0.2	1.6	0.1	2.3	0.3	0.0	0.0	440.4	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	15.2	364.7	0.0	0.0	0.0	0.0	1.4	1.2	0.0	0.0	60.9	0.0	3.4	0.0	246.3	17.0	0.3	0.0	6.0	0.0	0.0	0.0	0.3	0.0	4.3	0.0	0.0	0.6	0.0	0.9	0.1	0.1	0.0	0.4	1.0	0.0	0.0
SCN2B		ENSG00000149575	"Sodium voltage-gated channel beta subunit 2"	O60939	11	118162806-118176639	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 34.0;heart muscle: 12.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 8.8;Cardiomyocytes: 16.8;Excitatory neurons: 21.9;Horizontal cells: 13.5;Inhibitory neurons: 32.0;Oligodendrocytes: 7.4"	"Cancer enhanced"	"Detected in some"		"glioma: 1.3;thyroid cancer: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (9.01e-2)"	"unprognostic (3.50e-2)"	"unprognostic (7.58e-2)"	"unprognostic (2.12e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.02e-1)"	"unprognostic (2.71e-4)"	"unprognostic (5.17e-2)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (7.89e-2)"	"unprognostic (1.61e-2)"	"unprognostic (3.51e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.35e-2)"	"unprognostic (4.55e-1)"	"unprognostic (2.88e-3)"	0.6	1.5	19.1	0.3	20.7	0.0	0.7	14.9	34.0	1.4	0.0	1.7	0.6	1.6	1.3	1.8	1.3	1.3	12.8	20.9	12.3	0.4	0.0	1.1	0.0	5.7	13.3	1.3	0.1	0.0	0.8	0.0	9.1	1.0	0.7	3.7	0.5	1.2	7.3	0.2	1.1	1.9	4.9	0.1	0.3	0.2	19.5	1.8	0.7	7.5	0.0	0.3	0.4	22.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	19.1	20.7	14.9	34.0	20.9	12.3	5.7	13.3	9.1	4.9	19.5	22.1	0.1	0.0	0.0	3.9	0.0	0.4	0.6	0.7	1.8	8.8	0.1	2.0	16.8	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.1	0.2	0.5	0.2	0.0	0.0	21.9	0.0	0.0	1.6	0.0	0.3	0.0	0.2	0.0	0.0	0.1	13.5	32.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	1.9	0.0	0.9	0.0	2.5	7.4	0.0	0.0	2.2	0.0	0.2	0.0	0.0	0.1	1.9	0.0	0.9	0.8	0.1	0.6	0.0	0.1	0.0	0.1	0.5	0.0	0.3
SCN4A	"HYKPP, HYPP, Nav1.4, SkM1"	ENSG00000007314	"Sodium voltage-gated channel alpha subunit 4"	P35499	17	63938554-63972918	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"skeletal muscle: 137.4;tongue: 54.0"	"Cell type enriched"	"Detected in some"	6	"Adipocytes: 46.4"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 2.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	11	"REH: 15.0;RH-30: 45.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA053992			Approved	"Nucleoplasm,Centriolar satellite"		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm	"Centriolar satellite"	"HPA053992: AB_2797249"	"unprognostic (2.47e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.57e-2)"	"unprognostic (1.78e-3)"	"unprognostic (2.80e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.87e-4)"	"unprognostic (3.84e-3)"	"unprognostic (1.61e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (3.15e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.38e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.15e-1)"	"unprognostic (6.45e-2)"	17.9	0.7	0.0	0.2	0.1	0.0	16.0	0.3	0.1	0.1	0.0	1.1	0.0	0.1	0.0	1.1	0.2	0.3	0.8	0.0	0.0	0.7	0.1	0.0	0.4	0.0	0.0	0.2	0.2	0.7	1.5	0.1	0.0	0.5	0.1	0.0	1.8	0.0	137.4	0.7	0.3	0.0	0.0	0.8	0.5	1.7	0.0	0.2	4.3	54.0	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	1.5	0.0	0.0	15.0	45.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	2.8	1.4	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.4	0.0	0.0	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.2	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.5	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	1.1	2.2	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	4.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.1	5.9	0.3	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0
SCN4B	LQT10	ENSG00000177098	"Sodium voltage-gated channel beta subunit 4"	Q8IWT1	11	118133377-118152888	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 109.6;tongue: 56.8"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 12.3;Excitatory neurons: 18.2;Sertoli cells: 46.0;Smooth muscle cells: 38.8"	"Cancer enhanced"	"Detected in many"		"glioma: 8.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AN3-CA: 1.3;HBEC3-KT: 1.0;NTERA-2: 1.4;U-2 OS: 1.2"	"Region enriched"	"Detected in all"	11	"basal ganglia: 816.3"	"Region enriched"	"Detected in many"	4	"basal ganglia: 134.6"	HPA017293	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 48: Smooth muscle cells - ECM organization"			"HPA017293: AB_2184174"	"unprognostic (1.98e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.45e-1)"	"unprognostic (1.07e-1)"	"unprognostic (9.82e-3)"	"unprognostic (9.17e-3)"	"unprognostic (1.20e-2)"	"unprognostic (1.23e-2)"	"unprognostic (1.03e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.18e-3)"	"unprognostic (1.53e-1)"	"unprognostic (5.31e-4)"	23.5	5.4	2.6	1.2	86.6	0.0	9.2	41.3	109.6	2.1	0.0	2.6	2.4	3.1	1.6	5.3	5.4	3.2	11.8	2.1	14.0	2.1	0.4	8.9	2.1	53.3	15.4	0.5	5.1	6.8	2.7	1.8	45.9	2.2	2.1	0.9	2.5	2.3	30.4	3.9	4.7	7.1	15.2	0.0	2.9	0.7	23.1	8.6	14.5	56.8	0.7	3.0	1.4	28.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	86.6	41.3	109.6	2.1	14.0	53.3	15.4	45.9	15.2	23.1	28.5	12.3	0.0	0.0	2.9	0.0	1.3	0.6	2.0	2.8	1.7	0.5	5.7	4.6	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.3	0.1	3.0	0.0	0.0	18.2	0.0	0.1	3.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	2.0	1.2	1.4	8.7	2.1	1.1	0.0	1.9	0.0	0.5	0.0	1.5	1.4	0.0	0.0	1.5	0.0	0.1	0.0	0.1	5.8	0.8	46.0	0.6	38.8	0.1	0.6	0.5	1.1	0.0	0.1	0.0	0.0	0.2
SCN5A	"CDCD2, CMD1E, CMPD2, HB1, HB2, HBBD, HH1, ICCD, IVF, LQT3, Nav1.5, PFHB1, SSS1"	ENSG00000183873	"Sodium voltage-gated channel alpha subunit 5"	Q14524	3	38548057-38649687	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Calmodulin-binding, Ion channel, Sodium channel, Voltage-gated channel"	"Atrial fibrillation, Brugada syndrome, Cardiomyopathy, Disease variant, FDA approved drug targets, Long QT syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"heart muscle: 42.8"	"Cell type enriched"	"Detected in some"	5	"Cardiomyocytes: 77.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"LHCN-M2: 27.6;RH-30: 22.8"	"Group enriched"	"Detected in many"	5	"amygdala: 3.1;basal ganglia: 10.1;hypothalamus: 6.0"	"Region enhanced"	"Detected in many"		"basal ganglia: 5.4"	HPA063346			Supported	"Nucleoplasm,Nucleoli,Plasma membrane"		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Plasma membrane"	"Nucleoplasm, Nucleoli"	"HPA063346: "	"unprognostic (9.29e-4)"	"unprognostic (4.05e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.21e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.48e-1)"	"unprognostic (7.36e-2)"	"unprognostic (8.48e-2)"	"unprognostic (7.12e-3)"	"unprognostic (5.28e-2)"	"unprognostic (1.16e-4)"	"unprognostic (4.85e-3)"	"unprognostic (1.09e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.95e-3)"	0.2	0.1	1.9	0.1	1.2	0.2	0.2	0.0	0.7	1.7	0.0	0.2	0.2	0.7	0.0	0.1	0.3	0.1	42.8	0.2	1.5	0.0	0.0	0.1	0.0	0.0	0.7	0.5	0.0	0.0	0.4	0.2	0.0	0.3	0.1	2.0	0.2	0.5	1.6	0.1	0.2	0.3	0.2	0.1	0.1	0.3	2.6	0.0	0.2	1.0	0.0	0.4	0.7	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.1	0.4	0.1	0.0	0.2	3.6	0.0	0.0	0.0	1.0	0.5	2.7	0.0	0.4	0.0	1.0	1.0	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.4	0.0	2.1	2.8	0.4	0.0	0.0	27.6	1.4	0.0	0.0	2.6	0.0	0.0	0.0	22.8	0.0	0.0	3.2	0.4	3.1	0.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	5.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	1.2	0.0	0.7	0.2	1.5	0.0	0.7	0.0	0.2	2.6	0.2	0.1	0.0	0.0	0.0	0.0	0.3	1.3	0.0	0.0	2.7	0.0	0.3	77.1	0.0	0.1	0.0	14.6	0.2	0.0	0.0	0.0	0.1	1.2	0.1	3.2	2.8	0.0	0.0	0.5	0.0	0.3	3.1	0.0	0.3	0.0	0.8	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	6.3	0.3	0.6	0.2	0.0	3.7	0.0	0.6	0.0	1.5	0.1	0.1	0.0	0.0	0.0	1.0	0.0	0.1	0.0	0.9	0.0	7.3	3.1	0.2	1.0	0.0	0.0	0.0	0.1	0.1	0.0	1.4
SCN8A	"CerIII, CIAT, MED, NaCh6, Nav1.6, PN4"	ENSG00000196876	"Sodium voltage-gated channel alpha subunit 8"	Q9UQD0	12	51590266-51812864	"Disease related genes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"brain: 35.0"	"Group enriched"	"Detected in many"	8	"Excitatory neurons: 336.7;Inhibitory neurons: 280.1;Oligodendrocyte precursor cells: 104.5"	"Low cancer specificity"	"Detected in some"			"Region enhanced"	"Detected in many"		"cerebral cortex: 35.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 13.7;ASC TERT1: 13.5;WM-115: 13.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022169, HPA043937, HPA073590"			Approved	"Vesicles,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cell Junctions"	"CAB022169: , HPA043937: , HPA073590: "	"unprognostic (2.96e-2)"	"unprognostic (8.49e-2)"	"unprognostic (6.93e-2)"	"unprognostic (3.52e-6)"	"unprognostic (8.13e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.16e-1)"	"unprognostic (7.77e-2)"	"unprognostic (5.44e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.73e-4)"	"unprognostic (1.69e-2)"	"unprognostic (1.29e-5)"	"unprognostic (4.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.75e-2)"	0.2	1.0	5.6	0.4	8.9	0.7	0.5	2.5	35.0	0.4	0.0	0.7	0.2	0.4	0.7	0.1	0.2	0.9	0.1	11.4	0.2	0.9	2.6	0.1	0.4	4.2	0.0	0.5	1.6	0.5	6.7	0.1	3.8	0.6	0.9	7.9	0.6	0.2	0.3	0.3	0.2	0.1	0.0	0.6	1.0	1.7	2.4	0.5	0.5	0.1	0.2	0.2	0.2	11.5	1.7	1.3	13.7	0.2	1.8	13.5	0.3	8.0	12.5	9.1	8.5	2.8	1.6	0.4	1.9	9.9	4.4	0.1	2.3	0.0	10.5	1.6	0.8	0.1	0.3	0.3	0.1	0.2	1.1	1.8	0.0	6.5	1.4	3.4	9.8	3.5	0.2	0.2	5.5	1.0	2.5	0.2	4.9	0.9	4.8	0.1	0.7	0.0	0.0	0.5	5.6	2.2	4.5	2.1	0.3	2.1	0.4	0.2	2.8	8.9	6.3	3.3	5.2	0.2	0.1	0.0	1.8	1.9	13.0	0.5	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.4	0.1	0.0	0.1	0.0	0.0	5.6	8.9	2.5	35.0	11.4	0.2	4.2	0.0	3.8	0.0	2.4	11.5	1.2	0.0	0.0	27.1	0.0	0.0	0.5	0.0	3.4	16.7	2.6	1.8	1.4	1.5	0.0	0.0	10.4	0.0	0.3	1.0	0.0	0.5	0.6	0.0	0.7	1.3	11.4	0.0	336.7	0.5	0.0	0.1	3.1	0.0	0.0	0.7	1.1	4.3	0.0	5.0	280.1	1.3	0.0	0.0	0.0	0.7	0.0	0.0	0.0	20.6	0.0	4.7	0.0	104.5	14.2	0.7	0.5	0.7	0.0	0.4	0.0	0.7	0.0	11.2	0.0	0.4	0.3	3.8	10.2	0.1	0.0	0.0	0.3	0.0	0.9	0.3
SCN9A	"ETHA, Nav1.7, NE-NA, NENA, PN1"	ENSG00000169432	"Sodium voltage-gated channel alpha subunit 9"	Q15858	2	166195185-166376001	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sodium transport, Transport"	"Ion channel, Sodium channel, Voltage-gated channel"	"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 21.9"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 43.2;Hofbauer cells: 67.5;Inhibitory neurons: 48.2;Langerhans cells: 42.8;Oligodendrocyte precursor cells: 133.7"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	16	"plasmacytoid DC: 23.6"	"Lineage enriched"	"Detected in single"	26	"dendritic cells: 23.6"	"Cell line enhanced"	"Detected in many"		"BJ: 23.0;BJ hTERT+: 16.8;HHSteC: 19.0;hTERT-RPE1: 15.6"	"Region enriched"	"Detected in many"	5	"hypothalamus: 9.3"	"Low region specificity"	"Detected in many"			"CAB013679, HPA061843"	Uncertain		Approved	"Plasma membrane,Actin filaments,Focal adhesion sites"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 68: Oligodendrocytes - Mixed function"	"Plasma membrane, Actin filaments, Focal adhesion sites"		"CAB013679: , HPA061843: AB_2684625"	"unprognostic (2.10e-1)"	"unprognostic (2.83e-1)"	"unprognostic (1.13e-1)"	"unprognostic (8.98e-5)"	"unprognostic (1.47e-3)"	"unprognostic (9.43e-3)"	"unprognostic (2.28e-2)"	"unprognostic (2.24e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.64e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.27e-1)"	"prognostic unfavorable (2.30e-5)"	"unprognostic (1.69e-3)"	"unprognostic (6.74e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.46e-1)"	1.7	1.7	5.3	0.9	4.2	2.0	0.6	0.1	3.4	0.6	0.0	3.2	0.5	0.2	0.1	0.5	0.4	1.2	0.4	2.9	21.9	1.7	3.9	2.0	0.6	8.2	19.4	0.3	2.0	0.1	1.5	4.3	12.0	0.3	3.1	0.7	0.4	0.4	0.2	0.7	1.8	2.4	2.2	3.1	0.4	5.1	18.2	1.6	0.3	0.6	0.4	0.5	0.5	1.7	0.0	2.5	0.1	0.0	9.6	7.9	0.0	23.0	16.8	5.2	1.7	0.5	0.1	0.0	0.0	2.8	0.2	0.1	6.5	0.6	8.6	0.0	2.1	1.7	1.8	1.9	19.0	0.1	0.0	0.6	0.2	9.1	1.7	15.6	1.1	1.2	6.1	6.6	0.8	0.0	3.6	0.0	1.9	0.1	0.6	0.8	3.3	9.0	2.4	9.5	1.0	9.5	0.0	0.1	0.3	4.8	0.3	0.0	0.1	0.0	1.5	0.1	0.4	0.1	0.1	0.0	3.2	0.0	2.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.9	0.5	0.1	23.6	0.0	0.1	5.3	4.2	0.1	3.4	2.9	21.9	8.2	19.4	12.0	2.2	18.2	1.7	0.9	12.8	23.8	0.7	1.3	1.0	0.4	0.5	0.6	0.6	0.8	0.9	2.5	8.6	4.4	5.5	0.0	0.3	43.2	9.0	3.9	23.4	2.5	0.1	0.1	5.7	33.0	4.2	15.8	31.5	0.3	2.0	0.0	0.1	3.8	18.1	13.6	9.5	67.5	0.0	48.2	19.3	10.2	1.9	42.8	3.2	1.2	11.3	3.6	2.8	1.0	2.3	0.0	133.7	0.4	12.7	7.8	0.0	1.2	0.3	14.7	11.5	2.2	0.2	0.0	7.8	1.6	1.3	0.4	0.5	0.4	1.1	0.9	4.4	12.9	0.2
SCNN1A	"ENaCalpha, SCNN1"	ENSG00000111319	"Sodium channel epithelial 1 subunit alpha"	P37088	12	6346843-6377730	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 157.3"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 114.0;Distal enterocytes: 230.9;Glandular and luminal cells: 189.8;Intestinal goblet cells: 180.3"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in some"	5	"hippocampal formation: 6.8"	"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.5"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 300.5;HBEC3-KT: 202.4;hTCEpi: 85.3;RPTEC TERT1: 103.7;RT4: 114.1;SK-BR-3: 96.7"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA012743	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"			"HPA012743: AB_1856627"	"unprognostic (1.68e-1)"	"unprognostic (4.16e-2)"	"unprognostic (1.62e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.16e-2)"	"unprognostic (6.77e-3)"	"unprognostic (3.09e-2)"	"unprognostic (2.62e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (8.86e-4)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (5.56e-2)"	"prognostic favorable (9.21e-8)"	"unprognostic (2.38e-1)"	"unprognostic (3.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.01e-2)"	3.4	12.5	0.2	5.6	0.1	0.5	20.6	1.1	0.2	64.7	113.6	66.4	18.7	7.6	43.2	140.1	57.9	17.7	0.7	6.8	0.0	148.5	8.2	62.9	0.2	0.1	0.3	3.5	40.0	0.7	16.6	0.4	0.1	43.7	65.4	0.0	157.3	49.5	0.5	54.6	26.0	2.9	0.1	0.7	63.6	4.7	1.3	1.9	94.3	0.1	12.5	20.8	57.6	0.1	21.6	4.1	0.0	1.9	0.3	0.4	17.6	0.0	0.1	0.1	0.0	6.1	300.5	0.3	0.8	0.1	0.1	14.0	0.0	202.4	0.0	0.0	0.0	0.0	17.5	3.1	20.9	0.0	0.1	5.1	85.3	0.0	61.6	0.4	0.0	0.5	0.0	0.1	0.5	1.9	0.1	0.3	17.6	38.9	0.8	0.2	0.0	0.5	103.7	114.1	1.2	0.1	2.3	96.7	0.1	17.1	22.3	0.0	0.0	0.2	0.7	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.5	0.1	1.5	0.0	0.0	1.0	0.5	0.1	0.2	0.1	1.1	0.2	6.8	0.0	0.1	0.3	0.1	0.1	1.3	0.1	1.7	73.7	75.7	0.0	1.3	1.9	25.1	17.0	10.8	0.9	17.7	21.2	0.8	54.3	52.5	114.0	4.2	1.4	1.8	230.9	5.9	45.0	0.5	85.3	17.8	3.2	27.1	0.0	0.3	33.9	0.3	2.0	97.3	189.8	2.5	1.3	1.4	3.2	0.3	1.7	0.2	180.3	63.1	1.9	3.1	0.6	1.8	2.5	0.0	0.0	1.6	0.3	1.0	0.5	0.1	39.4	95.8	1.5	0.3	30.9	12.2	6.2	36.7	1.4	0.0	5.6	4.3	1.2	3.7	48.1	8.8	1.6	3.6	0.2	31.5	42.1
SCNN1B	ENaCbeta	ENSG00000168447	"Sodium channel epithelial 1 subunit beta"	P51168	16	23278231-23381294	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 82.8;intestine: 94.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 99.3;Club cells: 64.8;Collecting duct cells: 57.0;Distal enterocytes: 262.8;Ionocytes: 107.8;Paneth cells: 73.7"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 26.4"	"Region enriched"	"Detected in single"	9	"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 33.3;RPMI-8226: 9.2;RT4: 18.5;U-266/70: 55.4;U-266/84: 20.2"	"Region enriched"	"Detected in single"	5	"cerebellum: 1.0"	"Low region specificity"	"Detected in many"			HPA015612	Uncertain					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA015612: AB_1856629"	"unprognostic (7.45e-2)"	"unprognostic (1.76e-3)"	"unprognostic (1.39e-1)"	"unprognostic (6.74e-3)"	"unprognostic (1.74e-2)"	"unprognostic (5.11e-3)"	"unprognostic (7.74e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.60e-1)"	"unprognostic (2.40e-1)"	"unprognostic (3.68e-1)"	"unprognostic (2.84e-1)"	"prognostic unfavorable (2.09e-6)"	"unprognostic (2.32e-1)"	"unprognostic (4.66e-2)"	"unprognostic (3.93e-3)"	"unprognostic (1.25e-2)"	18.5	0.4	0.0	1.1	0.0	0.2	17.7	1.0	0.0	48.5	0.0	94.2	2.5	2.8	0.1	82.8	3.7	0.5	0.3	0.0	0.0	31.7	0.2	23.9	0.8	0.0	0.0	0.7	2.1	0.3	1.0	3.6	0.1	10.5	35.6	0.0	39.5	2.4	1.4	36.0	4.3	0.8	0.0	3.7	24.1	0.3	0.0	0.7	9.2	0.8	5.4	8.3	56.4	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	33.3	0.0	0.1	0.0	0.0	0.0	0.0	2.0	0.0	1.8	0.0	0.0	0.0	0.0	7.0	0.0	0.0	9.2	0.0	18.5	0.2	0.0	0.0	0.5	0.0	0.1	3.6	0.0	0.0	0.0	0.0	0.0	0.0	55.4	20.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	25.7	99.3	28.3	0.0	7.1	3.1	15.4	27.8	5.7	0.0	4.4	3.0	0.7	0.0	64.8	57.0	0.0	0.7	0.1	262.8	0.0	0.0	0.1	11.9	1.6	6.2	7.7	0.0	0.3	0.4	0.3	1.0	36.7	23.4	8.2	0.0	1.1	0.1	0.1	0.0	0.3	21.4	107.8	0.0	0.0	0.2	0.0	1.0	10.6	0.0	0.0	0.0	0.0	0.0	0.1	0.4	73.7	0.0	38.7	6.1	0.0	0.1	9.2	0.0	0.0	0.1	0.7	0.1	0.4	29.8	5.4	2.2	1.4	0.0	15.2	19.7
SCNN1D	"dNaCh, ENaCdelta"	ENSG00000162572	"Sodium channel epithelial 1 subunit delta"	P51172	1	1280436-1292029	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 35.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 10.7;Early spermatids: 10.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-266/70: 9.3"					"Low region specificity"	"Detected in all"			HPA026884	Enhanced		Supported	"Plasma membrane,Actin filaments"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 29: Early spermatids - Spermatogenesis"	"Plasma membrane, Actin filaments"		"HPA026884: AB_10601501"	"unprognostic (2.08e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.39e-4)"	"unprognostic (1.06e-2)"	"unprognostic (2.74e-1)"	"prognostic favorable (1.60e-4)"	"unprognostic (1.44e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.08e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.27e-2)"	"prognostic unfavorable (6.67e-5)"	"unprognostic (3.13e-1)"	"unprognostic (4.18e-2)"	"unprognostic (2.13e-1)"	"unprognostic (7.06e-2)"	5.6	7.1	10.3	1.7	10.4	3.2	6.0	11.7	18.1	11.1	5.9	9.4	5.2	8.0	0.9	4.0	14.0	1.2	6.2	9.7	7.5	7.7	13.7	3.7	2.3	10.7	8.5	14.7	4.8	0.7	18.5	1.1	10.9	9.7	0.3	1.7	5.8	1.7	3.4	4.7	7.6	0.8	6.9	8.0	6.3	35.5	9.9	0.9	6.3	1.4	0.7	5.1	7.6	11.7	0.5	4.2	1.6	4.3	1.1	0.6	0.7	2.8	0.8	1.3	1.5	0.8	2.4	3.0	1.5	1.2	2.2	0.7	0.7	0.6	0.2	5.8	2.5	0.4	5.9	1.1	1.1	0.1	2.9	1.8	0.9	2.3	0.0	1.8	0.4	5.5	2.1	7.0	0.3	1.5	1.2	2.0	0.8	0.5	3.0	8.1	0.3	0.7	0.6	0.2	2.2	3.1	1.2	1.2	1.9	0.6	5.4	1.6	1.2	2.6	2.1	4.1	0.9	9.3	0.6	2.5	2.3	5.2	2.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.3	10.4	11.7	18.1	9.7	7.5	10.7	8.5	10.9	6.9	9.9	11.7	1.7	3.2	2.3	10.7	1.0	0.8	0.2	1.2	1.2	3.7	2.2	3.4	4.0	0.0	1.7	0.0	4.2	0.1	0.6	1.0	0.0	0.5	10.5	0.6	2.1	0.6	1.2	2.7	5.2	0.5	0.4	1.7	4.1	1.3	2.5	3.2	0.7	3.5	0.4	5.0	6.0	0.4	0.0	0.8	0.5	4.0	0.9	1.1	0.0	1.0	0.1	1.4	0.0	4.5	5.4	2.0	3.8	1.9	0.7	0.1	3.9	0.7	1.9	2.8	0.0	1.8	1.5	2.8	2.2	0.8	1.6	0.0	1.0	0.5	0.9	0.3
SCNN1G	"ENaCgamma, SCNEG"	ENSG00000166828	"Sodium channel epithelial 1 subunit gamma"	P51170	16	23182745-23216883	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Ion transport, Sensory transduction, Sodium transport, Taste, Transport"	"Ion channel, Sodium channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 42.4"	"Cell type enriched"	"Detected in some"	4	"Collecting duct cells: 90.1"	"Cancer enhanced"	"Detected in many"		"urothelial cancer: 15.6"	"Region enriched"	"Detected in single"	6	"cerebellum: 4.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"hTCEpi: 46.8;RT4: 21.7"	"Region enriched"	"Detected in single"	13	"cerebellum: 2.5"	"Not detected"	"Not detected"			HPA071194			Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA071194: AB_2686359"	"unprognostic (2.90e-1)"	"unprognostic (5.21e-3)"	"unprognostic (5.79e-2)"	"unprognostic (4.31e-2)"	"unprognostic (1.92e-3)"	"unprognostic (1.71e-3)"		"unprognostic (1.97e-1)"	"unprognostic (4.85e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.57e-2)"	"prognostic unfavorable (3.20e-7)"	"unprognostic (2.80e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.17e-3)"	0.7	0.2	0.4	0.0	0.3	0.3	2.3	4.4	0.2	16.0	0.2	10.3	0.0	1.8	0.7	9.9	0.4	0.0	0.0	0.8	0.2	42.4	0.0	7.4	0.0	0.2	0.2	0.0	3.2	0.0	3.8	0.5	0.4	13.8	1.2	0.2	17.7	3.4	0.0	9.7	0.4	0.1	0.0	0.0	10.1	0.1	0.1	2.0	5.7	0.0	1.2	1.4	15.3	0.3	1.1	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	46.8	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	2.9	0.0	0.0	0.1	0.0	21.7	1.5	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	4.4	0.2	0.8	0.2	0.2	0.2	0.4	0.0	0.1	0.3	0.4	19.2	4.2	0.0	0.0	0.4	4.7	8.8	19.9	0.0	0.8	1.3	0.8	0.0	17.4	90.1	0.0	0.2	0.0	3.4	0.0	2.0	0.0	9.8	1.1	0.1	0.0	0.0	0.2	1.7	0.0	0.4	15.3	18.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.2	10.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.5	1.1	0.0	0.1	5.3	0.0	0.2	1.9	0.0	0.0	0.0	0.2	0.1	0.1	4.4	0.3	0.1	0.2	0.0	0.4	1.8
SCTR		ENSG00000080293	"Secretin receptor"	P47872	2	119439843-119525301	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 26.6;pancreas: 68.2"	"Group enriched"	"Detected in some"	6	"Alveolar cells type 2: 54.4;Ductal cells: 92.0;Exocrine glandular cells: 93.8;Pancreatic endocrine cells: 41.9"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 15.3"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	5	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.5"	"Cell line enriched"	"Detected in single"	5	"Karpas-707: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA007269	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"			"HPA007269: AB_1856640"	"unprognostic (1.51e-1)"	"unprognostic (2.22e-1)"	"unprognostic (4.99e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.12e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.68e-2)"	"unprognostic (9.08e-2)"	"unprognostic (7.35e-2)"	"unprognostic (2.38e-2)"	"unprognostic (6.11e-3)"	"unprognostic (1.65e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.38e-2)"	0.3	0.4	0.3	0.2	0.3	0.3	0.0	0.6	1.2	0.0	0.3	0.1	26.6	0.2	0.2	0.3	0.4	0.4	0.3	0.4	0.4	12.5	0.4	8.6	0.1	0.3	0.2	0.4	68.2	0.1	0.2	0.1	0.4	0.0	0.0	2.4	0.0	0.0	0.2	0.2	3.8	0.0	0.2	0.3	4.5	0.5	0.6	0.1	0.9	0.0	0.1	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.2	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.1	0.1	0.0	0.3	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.6	1.2	0.4	0.4	0.3	0.2	0.4	0.2	0.6	0.4	0.0	0.0	54.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	3.4	0.0	1.8	5.5	0.0	0.0	0.0	0.1	11.7	92.0	4.5	0.0	0.2	0.1	2.4	0.0	3.0	93.8	0.0	0.1	0.0	0.0	2.5	0.0	0.0	0.0	0.7	5.0	4.1	0.1	0.0	0.0	0.0	1.7	0.0	0.2	0.0	1.0	1.6	0.3	0.0	0.0	0.7	41.9	0.0	0.0	0.0	0.1	0.1	0.5	0.0	1.9	0.0	0.0	0.6	0.3	0.9	0.0	0.0	0.3	0.4	0.0	0.1	0.0
SDC1	"CD138, SDC, SYND1, syndecan"	ENSG00000115884	"Syndecan 1"	P18827	2	20200797-20225433	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 491.6;liver: 484.7;skin 1: 447.4"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 267.4;Hepatocytes: 603.1;Squamous epithelial cells: 246.6;Syncytiotrophoblasts: 250.8;Urothelial cells: 492.8"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	7	"midbrain: 17.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 482.2;hTCEpi: 436.6;U-251 MG: 470.0;U-266/70: 467.4;U-266/84: 1069.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"CAB002424, HPA006185, HPA067477"	Enhanced		Approved	"Focal adhesion sites"	"Secreted to blood"	NA	NA	63100000	3100000	"Cluster 43: B-cells - Humoral immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 22: Epithelial cell types - Mixed function"	"Focal adhesion sites"		"CAB002424: AB_442050, HPA006185: AB_1857705, HPA067477: "	"prognostic unfavorable (2.22e-4)"	"unprognostic (6.80e-3)"	"unprognostic (6.80e-2)"	"unprognostic (7.84e-2)"	"prognostic unfavorable (5.02e-4)"	"unprognostic (1.15e-1)"	"unprognostic (4.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (1.70e-1)"	"unprognostic (3.66e-1)"	"unprognostic (2.27e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-2)"	"unprognostic (4.27e-1)"	"unprognostic (1.62e-2)"	"unprognostic (1.52e-1)"	2.4	17.4	0.7	17.2	0.2	1.2	23.8	2.3	0.8	127.2	0.7	61.8	75.8	2.2	19.9	491.6	10.5	77.1	0.6	0.3	2.0	99.5	484.7	59.6	7.3	0.6	17.3	1.6	16.6	5.4	2.0	32.6	0.8	56.3	33.3	0.7	85.8	25.9	1.6	447.4	53.6	2.2	0.2	20.1	87.3	3.3	2.5	5.1	18.3	0.0	43.2	104.8	242.1	0.1	252.6	137.6	42.7	108.1	11.6	1.6	134.9	68.7	65.4	62.7	52.8	29.5	148.9	0.3	24.8	48.8	34.8	241.4	19.0	482.2	41.8	1.3	12.5	0.0	12.2	150.2	10.3	11.0	1.0	6.4	436.6	56.5	132.9	87.2	6.9	0.0	6.4	94.7	34.0	149.6	0.6	2.6	38.7	189.6	263.1	5.3	15.7	189.9	80.5	370.0	12.4	99.7	51.9	342.4	15.2	17.1	34.5	2.8	10.7	246.9	78.6	9.2	470.0	467.4	1069.8	1.0	74.5	0.6	28.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.2	2.3	0.8	0.3	2.0	0.6	17.3	0.8	0.2	2.5	0.1	0.4	93.0	99.0	0.0	33.0	113.9	189.1	162.8	81.4	0.6	29.9	26.7	0.9	267.4	161.8	42.3	0.0	3.8	0.7	147.2	31.3	61.3	0.1	16.6	5.0	3.5	10.8	13.5	0.3	21.8	46.3	5.0	55.0	22.9	6.3	7.5	7.5	603.1	2.3	21.9	0.2	73.1	50.8	10.6	11.9	0.3	0.6	2.5	21.4	0.0	0.6	0.3	0.0	1.0	0.0	111.4	78.0	1.2	165.1	78.0	106.5	88.5	43.4	0.4	0.0	0.1	15.0	1.0	14.0	246.6	229.0	250.8	4.0	0.1	85.1	492.8
SDC4	"amphiglycan, ryudocan, SYND4"	ENSG00000124145	"Syndecan 4"	P31431	20	45325288-45348424	"Cancer-related genes, Predicted membrane proteins, Predicted secreted proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 410.9"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 515.9;Pancreatic endocrine cells: 476.4;Suprabasal keratinocytes: 472.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 512.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005716, CAB013240"	Enhanced		Approved	"Golgi apparatus,Plasma membrane"	"Secreted to blood"	NA	NA		320000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 1: Pancreatic cells - Digestion"	"Golgi apparatus"	"Plasma membrane"	"CAB013240: AB_2533250, HPA005716: AB_1080160"	"unprognostic (1.34e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.71e-2)"	"unprognostic (2.16e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.59e-3)"	"unprognostic (1.16e-1)"	"unprognostic (5.93e-2)"	"unprognostic (2.68e-1)"	"unprognostic (2.95e-2)"	"prognostic unfavorable (4.20e-4)"	"unprognostic (1.97e-1)"	"prognostic favorable (2.44e-7)"	"unprognostic (3.00e-1)"	"unprognostic (2.18e-1)"	"prognostic favorable (2.67e-4)"	"unprognostic (7.42e-2)"	68.0	73.1	90.3	26.3	116.8	10.1	113.1	90.2	120.7	53.0	68.5	102.6	37.8	53.0	11.8	124.3	76.6	72.2	65.9	66.4	90.2	166.9	410.9	168.3	9.8	120.5	127.8	26.3	90.3	34.7	43.2	27.3	95.4	53.0	62.6	35.1	103.7	45.9	101.5	190.4	42.4	53.8	89.9	32.3	140.1	47.1	151.9	8.2	51.1	35.4	35.2	124.7	68.7	71.4	162.1	20.7	11.1	0.8	269.2	164.3	474.4	201.5	273.0	222.9	158.6	242.7	400.0	0.2	88.1	255.4	224.5	203.1	8.2	512.2	269.0	46.7	7.4	4.9	15.8	95.8	292.4	1.0	8.2	223.1	336.5	92.4	223.2	123.3	29.9	3.7	8.2	0.5	130.5	159.9	0.2	14.2	20.4	139.9	63.1	0.3	99.7	0.6	367.7	211.7	4.3	15.6	277.2	169.4	51.4	125.2	123.1	9.7	56.4	169.4	141.4	17.3	131.8	8.5	6.7	0.7	266.2	16.4	103.2	1.5	1.6	0.4	0.7	0.6	2.1	0.3	2.0	0.8	1.5	0.3	0.4	0.5	0.8	0.7	0.6	1.4	4.4	0.7	90.3	116.8	90.2	120.7	66.4	90.2	120.5	127.8	95.4	89.9	151.9	71.4	21.9	291.7	391.2	106.7	3.8	373.7	322.2	352.8	75.1	14.5	208.8	90.6	59.3	245.9	218.4	189.4	12.5	38.9	7.8	174.3	64.6	296.0	1.2	116.6	20.8	16.0	55.1	7.4	0.2	515.9	230.0	43.0	170.7	179.0	13.9	10.8	11.4	260.6	18.8	0.0	0.3	131.9	160.7	19.3	106.0	3.8	4.1	39.5	76.5	5.6	33.0	10.0	0.0	3.5	1.8	476.4	121.7	5.3	2.1	284.2	59.0	153.8	178.6	23.6	0.0	34.9	33.5	1.8	2.5	170.9	472.8	67.5	16.8	3.2	90.7	423.9
SDCBP	"MDA-9, SYCL"	ENSG00000137575	"Syndecan binding protein"	O00560	8	58552924-58582859	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 959.8;Melanocytes: 889.4"	"Cancer enriched"	"Detected in all"	4	"melanoma: 244.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1908.0"	"Group enriched"	"Detected in all"	5	"granulocytes: 1908.0;monocytes: 562.9"	"Cell line enhanced"	"Detected in many"		"HHSteC: 787.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012245, HPA023840"	Approved		Supported	"Nucleoplasm,Nuclear membrane,Cytosol"	"Intracellular and membrane"	NA	NA		1300000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Cytosol"	"Nuclear membrane"	"CAB012245: , HPA023840: AB_1857712"	"unprognostic (2.39e-2)"	"unprognostic (3.34e-2)"	"unprognostic (1.84e-2)"	"unprognostic (4.45e-2)"	"unprognostic (9.15e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.04e-3)"	"unprognostic (1.11e-1)"	"unprognostic (5.68e-2)"	"unprognostic (3.05e-2)"	"unprognostic (3.01e-1)"	"unprognostic (1.53e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.02e-2)"	"unprognostic (2.82e-2)"	"unprognostic (2.92e-1)"	228.5	126.4	94.1	160.8	111.8	245.6	167.1	102.0	130.1	160.9	112.2	119.6	83.1	109.8	83.6	88.8	95.7	194.8	120.6	103.7	112.6	126.6	174.0	223.9	121.2	113.7	103.8	89.1	80.8	132.9	45.8	264.3	113.5	70.8	134.7	26.8	124.9	78.3	65.9	84.8	92.8	151.2	107.4	203.0	130.0	41.1	110.8	129.9	120.7	113.7	92.8	248.8	91.9	123.7	123.5	185.9	194.2	101.4	711.7	607.1	86.1	122.9	439.6	175.3	228.9	74.8	250.7	0.4	194.8	166.4	321.2	49.7	106.0	142.4	215.7	22.6	91.3	184.3	156.0	60.6	787.9	47.7	287.1	417.9	188.1	176.5	525.2	273.0	428.0	125.2	92.3	104.6	403.4	32.4	104.1	55.9	122.2	478.6	52.3	49.6	59.4	24.3	282.1	127.0	84.9	153.5	133.8	56.1	630.0	213.8	51.0	127.9	382.3	168.8	72.5	200.8	81.5	31.4	45.6	74.8	428.9	0.5	155.1	777.4	562.9	528.1	61.2	349.6	78.0	69.4	82.0	67.3	251.8	61.0	103.9	80.2	1908.0	42.6	329.1	69.9	103.0	453.2	94.1	111.8	102.0	130.1	103.7	112.6	113.7	103.8	113.5	107.4	110.8	123.7	382.7	211.5	115.9	26.8	170.3	338.7	321.2	312.5	108.1	10.8	86.7	54.6	70.6	88.6	181.3	206.0	16.7	284.3	220.2	192.9	225.0	392.9	7.8	110.9	87.0	412.7	112.3	116.6	18.5	291.6	756.8	308.1	162.1	120.5	396.9	62.9	378.3	101.9	782.5	15.2	23.7	180.3	248.2	552.1	959.8	15.9	233.9	626.0	889.4	71.2	312.4	94.3	51.5	21.6	16.3	297.9	152.9	159.9	65.1	307.4	78.4	211.2	169.8	11.1	98.6	82.7	177.4	14.8	8.4	73.3	173.2	483.0	256.2	117.0	129.2	457.6
SDF4	Cab45	ENSG00000078808	"Stromal cell derived factor 4"	Q9BRK5	1	1216909-1232067	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 406.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011249, HPA011895, CAB015227"	Supported	Supported	Supported	"Golgi apparatus"	"Intracellular and membrane"	NA	NA		2600000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus"		"CAB015227: , HPA011249: AB_2668468, HPA011895: "	"unprognostic (1.98e-1)"	"prognostic unfavorable (5.89e-4)"	"unprognostic (3.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (5.88e-2)"	"unprognostic (7.95e-3)"	"unprognostic (3.73e-3)"	"unprognostic (1.06e-1)"	"unprognostic (2.01e-1)"	"unprognostic (8.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.07e-1)"	"unprognostic (8.39e-3)"	"unprognostic (1.09e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.04e-2)"	86.5	91.8	44.2	78.8	47.8	56.2	80.2	47.2	65.3	84.4	72.5	95.9	117.1	91.8	43.9	66.3	74.6	66.2	134.6	45.5	44.8	89.6	160.7	82.0	53.4	53.2	46.1	85.4	104.6	61.5	78.5	73.3	47.0	76.9	60.4	25.7	83.5	52.2	78.9	72.9	116.8	58.2	43.5	78.0	93.6	71.7	50.5	34.6	81.8	47.7	39.6	82.2	71.6	45.9	139.7	123.7	67.1	214.0	320.0	160.4	80.5	266.1	241.4	191.2	159.4	147.0	236.2	87.8	201.8	258.0	137.4	140.4	77.5	117.1	58.2	147.9	133.0	153.6	185.7	207.8	147.4	156.7	199.2	199.0	59.5	144.6	81.2	186.5	155.9	57.3	129.2	225.0	95.7	101.1	77.8	158.9	61.7	158.0	167.1	85.8	86.5	234.4	127.2	66.4	243.3	86.7	177.2	208.2	182.8	59.0	108.0	176.7	198.8	196.2	107.0	149.5	154.2	138.9	141.2	144.6	222.9	289.7	87.1	14.4	21.5	30.8	19.3	14.6	14.6	13.5	27.6	28.4	21.9	16.8	16.0	14.1	16.9	26.8	23.2	14.0	25.1	11.8	44.2	47.8	47.2	65.3	45.5	44.8	53.2	46.1	47.0	43.5	50.5	45.9	92.9	22.4	19.2	18.6	62.5	119.8	74.0	24.6	46.7	34.5	51.2	47.6	35.7	68.6	28.9	49.7	18.8	124.1	68.4	240.0	11.7	79.0	39.1	49.0	76.2	77.8	65.5	32.8	21.1	71.4	284.4	117.1	81.1	60.8	36.2	61.4	76.4	117.1	122.4	38.7	23.5	174.9	30.5	73.7	154.8	36.8	95.4	62.8	167.2	13.1	50.8	64.9	111.2	13.6	17.5	73.0	213.5	76.0	202.5	101.5	406.2	57.7	18.4	40.0	59.2	69.8	75.1	101.7	63.5	53.2	114.2	168.0	73.4	88.7	181.0	71.1
SDHA	"FP, SDH2, SDHF"	ENSG00000073578	"Succinate dehydrogenase complex flavoprotein subunit A"	P31040	5	218241-257082	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Cardiomyopathy, Disease variant, FDA approved drug targets, Leigh syndrome, Primary mitochondrial disease, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 601.0;skeletal muscle: 479.0"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"CAB034929, HPA041981, HPA064582"	Enhanced		Supported	Nucleoli,Mitochondria		No	No		360000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoli	"CAB034929: AB_2183443, HPA041981: AB_2677779, HPA064582: AB_2685293"	"prognostic unfavorable (6.00e-4)"	"unprognostic (1.93e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.62e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.14e-2)"	"unprognostic (2.88e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.53e-8)"	"unprognostic (1.11e-2)"	"unprognostic (2.62e-1)"	"unprognostic (3.57e-1)"	"unprognostic (1.79e-1)"	70.6	148.0	60.5	29.6	62.7	38.4	65.8	78.7	71.3	50.2	63.2	131.9	148.9	53.2	27.3	67.1	50.3	33.9	601.0	60.8	73.4	139.1	276.8	54.3	43.1	74.1	62.7	65.8	71.5	122.9	44.8	28.8	75.7	46.3	82.1	42.7	66.8	35.6	479.0	58.9	116.8	36.1	61.7	66.4	115.6	56.4	71.7	41.8	49.6	224.8	36.5	63.2	56.3	63.7	88.4	154.2	54.8	95.0	96.9	68.5	154.1	63.3	81.8	107.2	108.4	163.9	115.9	108.3	218.6	70.2	92.1	111.8	102.4	129.7	66.3	241.9	98.9	50.1	390.8	224.1	60.0	69.5	70.7	70.6	84.3	83.6	33.7	93.6	123.9	83.5	84.6	83.1	48.7	155.8	93.9	206.9	19.3	101.4	193.5	119.0	84.6	223.2	245.4	122.7	62.3	35.4	332.5	205.5	90.7	36.1	115.0	93.2	91.1	80.3	82.1	48.2	52.5	93.0	40.9	79.8	81.6	99.9	52.5	66.6	70.8	88.1	95.2	85.7	86.8	79.5	92.5	94.5	93.3	73.3	89.2	85.0	14.1	85.5	74.7	59.5	149.3	111.3	60.5	62.7	78.7	71.3	60.8	73.4	74.1	62.7	75.7	61.7	71.7	63.7	29.4	35.3	71.1	20.2	50.9	61.2	81.4	105.8	31.3	51.0	24.6	17.0	272.6	64.3	78.5	75.4	102.2	109.6	39.3	169.7	142.8	94.7	58.7	39.1	30.1	39.1	47.5	56.8	34.4	44.9	102.8	49.4	47.9	48.5	43.7	64.8	47.5	167.0	67.5	101.0	39.9	96.3	105.8	41.0	55.0	28.8	68.3	38.8	90.7	12.2	60.2	50.7	52.5	19.1	37.9	54.2	100.1	55.7	67.5	37.0	274.4	190.7	75.2	87.2	78.9	33.2	51.7	96.9	54.3	40.9	35.9	154.7	56.7	85.0	160.1	88.2
SDHB	"SDH, SDH1"	ENSG00000117118	"Succinate dehydrogenase complex iron sulfur subunit B"	P21912	1	17018722-17054032	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"	Oxidoreductase	"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 491.5;tongue: 580.6"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 405.5;Proximal tubular cells: 449.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002868, CAB009822, CAB068233, CAB068234, CAB068235"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Mitochondria"	"Intracellular and membrane"	NA	NA		7900	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	"Nucleoplasm, Plasma membrane"	"CAB009822: AB_2183458, CAB068233: AB_2665638, CAB068234: AB_2665639, CAB068235: AB_2665640, HPA002868: AB_1079889"	"unprognostic (1.06e-1)"	"unprognostic (2.86e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.79e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.51e-2)"	"unprognostic (3.93e-2)"	"prognostic favorable (2.93e-7)"	"unprognostic (1.46e-1)"	"unprognostic (2.75e-1)"	"unprognostic (7.82e-2)"	"unprognostic (3.82e-2)"	85.8	95.7	68.0	59.0	72.2	94.6	68.7	80.6	84.3	56.8	81.1	134.3	163.0	56.0	71.0	77.4	59.8	48.0	302.8	69.9	76.9	228.0	336.1	56.1	75.3	74.8	71.4	44.4	80.3	144.3	42.8	57.6	73.8	55.7	132.4	62.9	74.0	60.5	491.5	55.6	121.9	70.4	73.9	60.5	92.8	64.4	74.9	62.7	64.3	580.6	84.2	71.3	52.0	78.9	157.3	152.7	72.2	107.8	141.6	135.2	95.9	122.4	145.2	254.3	227.7	216.8	183.1	206.8	159.3	156.4	176.1	180.1	290.7	226.8	284.8	128.7	280.6	183.4	149.2	168.2	172.8	276.0	135.6	140.4	154.9	224.5	370.1	138.7	183.6	176.5	165.2	236.9	179.6	129.5	182.4	175.1	70.4	224.6	302.6	146.1	142.5	265.4	252.4	88.7	157.5	86.0	172.3	216.3	392.3	76.4	131.1	169.1	94.9	115.8	131.0	206.4	176.0	98.9	133.3	198.6	170.4	438.5	128.3	68.7	149.8	149.5	71.4	206.5	70.7	89.9	81.0	77.5	186.8	81.1	73.5	74.8	174.3	85.3	185.7	89.3	113.8	116.1	68.0	72.2	80.6	84.3	69.9	76.9	74.8	71.4	73.8	73.9	74.9	78.9	48.2	64.1	47.4	20.9	57.4	52.1	93.3	199.8	40.5	31.5	45.2	49.4	405.5	101.5	97.0	47.8	14.6	107.1	48.3	176.1	354.1	134.3	220.3	48.7	38.2	54.7	48.6	77.3	27.7	149.2	142.2	62.0	46.9	45.5	66.6	39.9	46.8	226.0	177.4	37.0	32.1	103.1	116.0	88.7	67.9	30.5	57.8	78.4	64.0	29.0	123.1	78.3	48.4	15.6	24.6	111.5	218.3	67.7	62.2	74.4	300.5	449.0	79.8	53.8	39.5	57.1	191.6	148.9	71.5	72.9	54.6	121.8	46.8	69.3	162.0	110.9
SDHC	"CYB560, cybL, PGL3"	ENSG00000143252	"Succinate dehydrogenase complex subunit C"	Q99643	1	161314381-161363206	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 776.7;Proximal tubular cells: 916.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (1.48e-2)"	"unprognostic (6.88e-2)"	"unprognostic (6.38e-3)"	"unprognostic (1.86e-2)"	"unprognostic (1.90e-2)"	"unprognostic (5.02e-2)"	"unprognostic (7.08e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (2.43e-2)"	"unprognostic (1.29e-1)"	"prognostic favorable (2.20e-4)"	"unprognostic (9.14e-2)"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-3)"	"unprognostic (3.77e-1)"	128.9	143.7	73.7	64.1	79.7	60.5	100.3	84.5	85.1	78.7	92.9	118.9	127.8	70.9	76.0	109.7	98.6	63.3	154.1	68.4	83.4	285.7	319.4	65.5	74.7	78.8	79.1	69.2	62.5	173.6	52.4	73.1	76.7	77.3	132.2	84.3	74.8	84.7	277.4	69.8	101.4	101.4	85.1	62.8	89.9	52.7	84.8	93.1	89.5	288.4	105.1	88.4	61.3	85.6	161.1	129.7	157.5	147.7	248.3	213.3	196.3	150.9	190.3	180.3	137.3	185.4	208.7	53.7	190.6	214.8	121.6	178.5	244.3	214.2	193.2	185.6	205.6	110.2	106.6	196.7	126.9	193.8	109.1	211.5	181.7	174.3	119.4	167.9	177.5	164.0	178.9	43.8	266.3	167.0	152.4	112.5	145.4	376.3	123.7	131.6	151.0	217.1	330.3	167.8	118.3	180.7	211.0	385.1	225.4	207.9	342.1	259.3	133.5	103.7	125.1	127.9	147.3	173.3	287.8	269.4	140.3	139.2	193.6	88.6	111.0	65.7	76.6	99.6	79.6	68.6	66.2	75.4	136.1	65.7	71.2	71.0	52.0	66.9	87.5	100.6	78.3	130.0	73.7	79.7	84.5	85.1	68.4	83.4	78.8	79.1	76.7	85.1	84.8	85.6	50.9	44.8	59.4	14.7	70.1	61.8	151.2	342.6	59.7	74.9	81.4	58.3	94.0	131.5	163.5	150.8	64.6	248.0	65.5	95.9	776.7	218.4	18.6	87.1	63.8	80.7	66.8	81.4	19.3	145.2	248.5	79.8	79.5	62.6	58.3	66.6	83.2	249.1	237.3	72.3	27.4	103.4	215.7	100.6	74.4	34.7	102.9	94.6	129.9	9.4	176.1	107.8	107.1	17.6	24.5	142.7	89.5	109.1	71.9	100.2	139.1	916.5	177.9	69.3	52.6	74.5	94.4	115.3	114.4	111.2	76.4	307.6	72.0	215.7	154.2	155.0
SDHD	"cybS, PGL, PGL1"	ENSG00000204370	"Succinate dehydrogenase complex subunit D"	O14521	11	112086824-112120016	"Cancer-related genes, Citric acid cycle related proteins, Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Transport, Tricarboxylic acid cycle"		"Cancer-related genes, Disease variant, FDA approved drug targets, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 530.2;Proximal tubular cells: 449.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			HPA045727	Approved				"Intracellular and membrane"	NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA045727: AB_10963114"	"unprognostic (9.13e-2)"	"unprognostic (3.51e-2)"	"unprognostic (4.47e-3)"	"unprognostic (4.21e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.98e-2)"	"unprognostic (5.69e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.83e-3)"	"unprognostic (7.10e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.80e-1)"	"prognostic favorable (1.99e-10)"	"unprognostic (5.14e-2)"	"unprognostic (1.58e-2)"	"unprognostic (1.56e-2)"	"unprognostic (7.51e-2)"	117.5	95.7	60.0	84.5	63.1	72.9	102.6	68.6	76.3	92.5	65.1	185.2	208.1	88.2	96.7	126.7	92.6	85.6	254.7	60.1	65.4	319.9	391.8	79.3	131.7	63.4	62.5	91.6	77.8	152.4	37.0	95.0	63.2	87.9	190.8	37.4	112.6	100.9	354.7	64.3	175.6	98.1	64.7	85.1	101.1	34.1	63.7	102.5	136.8	449.6	124.8	117.9	76.4	68.2	84.0	67.3	58.1	89.4	212.0	170.7	97.3	97.5	147.6	106.8	132.2	244.8	222.1	155.5	288.4	131.0	156.1	203.5	175.4	139.8	129.8	129.9	92.4	142.8	51.9	140.1	165.6	222.4	107.5	189.6	160.2	110.5	189.1	124.6	153.0	109.6	156.0	208.7	135.0	95.2	143.9	215.0	77.4	333.8	211.6	126.2	145.8	294.4	221.6	175.2	83.5	55.8	135.3	194.8	107.0	81.8	198.9	164.2	108.0	103.8	132.3	114.7	95.0	59.1	73.2	270.7	58.8	297.0	100.5	233.7	293.3	208.8	158.4	390.1	173.1	235.2	170.8	168.8	308.7	198.1	204.3	191.8	257.5	207.9	322.9	151.7	189.9	348.9	60.0	63.1	68.6	76.3	60.1	65.4	63.4	62.5	63.2	64.7	63.7	68.2	104.3	80.1	51.1	12.4	78.0	81.6	102.2	262.2	83.6	12.2	61.0	78.4	216.5	120.1	108.1	90.1	8.4	154.3	55.2	203.8	530.2	82.9	9.9	41.6	67.6	76.4	50.4	70.2	9.6	58.9	124.1	104.6	75.4	41.2	65.9	32.3	76.8	169.7	162.9	11.8	11.2	129.1	154.6	97.1	74.4	37.0	104.1	94.2	76.5	9.4	118.6	52.9	75.2	8.0	9.7	54.1	134.2	99.6	80.9	61.6	253.1	449.9	60.5	18.9	92.1	78.3	110.7	70.4	55.8	127.1	74.4	179.0	71.4	86.2	176.0	98.6
SEC13	"D3S1231E, npp-20, SEC13L1, SEC13R"	ENSG00000157020	"SEC13 homolog, nuclear pore and COPII coat complex component"	P55735	3	10293131-10321112	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035292, HPA057943"	Approved		Supported	Nucleoplasm,Vesicles		NA	NA		35000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 55: Plasma cells - Humoral immune response"	"Nucleoplasm, Vesicles"		"HPA035292: AB_10959451, HPA057943: AB_2683560"	"unprognostic (3.33e-3)"	"unprognostic (6.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (4.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (2.64e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (2.43e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.69e-1)"	"unprognostic (4.58e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.60e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (8.33e-2)"	62.1	71.5	51.0	61.8	55.6	58.4	58.9	55.9	57.6	83.7	59.2	68.8	114.7	66.4	59.4	72.6	57.4	47.5	71.1	52.2	57.2	67.4	92.1	64.3	54.6	54.6	54.6	52.6	85.2	64.6	109.2	68.5	55.2	53.8	65.7	21.2	96.2	64.9	111.5	62.7	96.6	76.6	54.3	59.4	67.3	39.4	54.2	70.3	57.6	87.3	65.4	69.9	59.2	58.2	122.6	182.1	142.9	55.2	228.0	251.6	474.4	243.8	296.1	279.3	319.8	150.3	97.6	110.7	109.6	390.1	156.8	49.0	186.4	218.3	142.4	97.8	194.5	136.2	137.3	363.7	311.8	156.7	115.5	224.7	173.1	292.6	181.5	205.6	337.0	146.2	148.4	159.8	219.5	250.2	153.8	169.9	160.9	158.0	218.7	148.1	102.4	198.2	172.4	90.2	80.3	99.4	107.3	98.7	101.3	119.3	127.5	150.8	253.6	114.2	130.2	172.6	213.3	131.7	198.4	258.6	215.5	217.5	193.0	127.3	163.2	106.6	84.4	144.9	94.6	96.5	83.6	82.1	222.5	82.6	68.0	71.2	105.8	93.9	116.4	198.3	106.1	176.5	51.0	55.6	55.9	57.6	52.2	57.2	54.6	54.6	55.2	54.3	54.2	58.2	23.9	48.1	61.9	14.0	45.8	39.4	50.4	73.6	31.3	16.2	29.5	26.4	40.2	30.0	68.3	27.6	10.4	119.9	36.5	60.1	66.5	79.3	25.6	31.8	44.0	51.0	41.4	33.0	17.3	109.2	166.6	74.1	73.9	47.1	43.1	35.5	33.9	57.3	104.9	11.8	13.7	108.2	50.8	33.0	46.7	10.2	53.4	45.0	26.6	12.2	64.2	37.4	35.0	11.6	12.6	81.8	56.1	52.6	203.2	52.4	187.5	112.0	64.5	21.1	13.1	37.7	63.6	54.9	38.9	43.7	40.2	168.6	36.5	35.8	74.2	62.3
SEC31A	"ABP125, ABP130, KIAA0905, SEC31L1"	ENSG00000138674	"SEC31 homolog A, COPII coat complex component"	O94979	4	82818509-82901166	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"		Proto-oncogene	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005457	Approved		Supported	Vesicles,Cytosol		NA	NA		40000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	"Vesicles, Cytosol"		"HPA005457: AB_1079896"	"unprognostic (3.50e-2)"	"unprognostic (2.28e-3)"	"unprognostic (2.55e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.52e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (6.14e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.17e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.62e-1)"	"unprognostic (1.64e-1)"	"unprognostic (5.53e-3)"	"unprognostic (2.92e-1)"	"unprognostic (2.85e-1)"	"prognostic unfavorable (2.69e-4)"	98.7	103.3	52.2	78.4	54.3	119.4	111.4	62.4	70.1	145.5	94.9	107.1	124.2	119.7	162.1	92.6	90.9	122.1	110.7	54.0	61.4	133.6	174.8	96.2	88.2	58.4	58.7	152.8	192.6	116.4	108.4	143.2	58.7	113.4	127.2	87.9	134.0	111.3	96.8	107.8	111.0	131.5	50.9	76.5	110.1	77.8	54.4	93.8	168.0	85.6	102.1	113.1	94.1	63.9	146.2	65.2	183.6	130.4	318.9	394.5	133.3	264.8	295.4	146.0	179.2	113.2	182.3	188.3	113.7	532.2	84.6	68.1	183.3	176.2	200.4	193.4	72.7	115.3	110.5	302.1	316.4	124.4	140.7	380.5	217.7	223.5	254.3	251.2	240.5	83.8	178.4	181.1	264.2	128.6	164.9	99.6	126.1	154.0	58.3	121.2	100.1	140.3	237.2	83.0	118.6	131.2	105.7	180.7	174.9	184.8	142.1	137.8	248.2	190.7	98.9	169.0	168.8	135.1	62.4	256.7	190.6	147.8	224.2	84.3	66.9	51.2	65.1	74.0	80.5	60.0	57.6	64.3	73.3	50.0	56.9	54.6	19.2	89.9	83.1	61.1	52.7	71.8	52.2	54.3	62.4	70.1	54.0	61.4	58.4	58.7	58.7	50.9	54.4	63.9	62.6	105.8	85.3	50.9	58.1	60.5	60.5	64.1	56.9	52.3	54.5	43.7	85.5	51.5	109.8	47.8	54.2	57.3	61.0	62.8	27.4	65.8	30.6	90.1	164.6	65.0	38.3	41.2	61.0	71.2	85.3	125.2	100.9	119.7	75.2	241.0	65.0	94.0	45.9	42.1	60.0	99.4	50.8	51.2	55.3	19.3	139.1	63.8	51.6	67.5	60.4	36.5	38.1	74.9	72.6	67.5	46.3	126.0	152.2	76.3	121.0	65.9	100.5	66.9	52.6	86.5	98.9	30.3	34.6	62.2	74.2	81.5	55.4	78.9	54.9	101.1
SEC61A1		ENSG00000058262	"SEC61 translocon subunit alpha 1"	P61619	3	128051641-128071683	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"	Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022076			Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"CAB022076: "	"unprognostic (1.84e-1)"	"unprognostic (8.00e-2)"	"unprognostic (8.21e-2)"	"prognostic favorable (7.82e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.07e-6)"	"unprognostic (2.84e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.23e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (6.84e-9)"	"unprognostic (2.73e-2)"	"unprognostic (3.18e-2)"	"unprognostic (8.33e-2)"	"unprognostic (2.51e-2)"	82.1	100.7	31.3	88.3	33.4	79.5	75.3	33.5	34.7	144.5	52.4	90.7	81.9	88.9	128.9	88.7	78.1	81.7	74.2	32.3	39.6	64.6	134.8	93.3	60.2	40.9	37.6	67.3	272.1	111.7	93.5	112.8	36.0	90.0	90.0	37.0	176.3	97.0	70.5	66.9	75.8	110.7	36.6	73.7	105.5	38.8	46.6	61.4	104.8	59.3	80.6	97.0	68.7	35.8	272.8	136.5	132.0	240.3	367.9	317.3	256.9	426.9	470.8	349.0	371.2	259.1	186.9	184.7	259.5	534.8	266.2	232.6	209.0	291.3	334.2	168.1	126.2	213.5	143.5	273.6	542.9	264.1	225.9	348.1	345.4	329.3	422.4	265.0	314.3	122.2	136.9	415.3	412.8	237.7	135.1	87.5	184.6	231.6	202.8	144.2	125.5	349.8	181.4	229.3	155.8	162.4	216.0	193.5	270.7	152.0	184.2	215.1	327.3	278.3	164.7	333.7	201.4	386.6	210.6	265.8	456.3	166.2	369.1	160.3	88.6	67.0	89.0	79.6	120.0	43.8	62.9	78.2	82.6	26.1	38.8	46.2	22.5	65.0	84.2	114.0	45.1	116.9	31.3	33.4	33.5	34.7	32.3	39.6	40.9	37.6	36.0	36.6	46.6	35.8	31.9	32.1	33.1	18.6	46.6	37.0	25.7	44.4	30.7	17.0	63.5	41.3	15.0	37.1	43.3	49.7	35.5	64.3	59.2	107.2	3.9	81.0	42.2	28.2	72.9	45.9	73.6	19.5	12.6	154.5	136.3	57.4	77.5	68.6	26.0	55.6	49.6	118.2	75.9	26.9	18.5	150.8	38.7	34.8	32.1	25.7	41.0	38.2	33.8	26.2	32.1	22.4	28.8	19.1	17.2	104.9	50.2	43.6	192.8	69.6	63.5	26.8	31.0	15.5	32.9	25.6	47.2	12.3	18.4	42.5	29.5	127.9	32.4	52.6	100.4	44.6
SEC61A2	FLJ10578	ENSG00000065665	"SEC61 translocon subunit alpha 2"	Q9H9S3	10	12129637-12169961	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 41.2;Horizontal cells: 35.3;Inhibitory neurons: 42.4;Late spermatids: 31.1;Oligodendrocytes: 44.2;Spermatocytes: 35.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (6.83e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.01e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.28e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.97e-1)"	"unprognostic (3.95e-2)"	"prognostic favorable (1.08e-5)"	"unprognostic (3.14e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (6.41e-2)"	"unprognostic (4.95e-2)"	"unprognostic (6.18e-2)"	"prognostic favorable (8.75e-4)"	4.2	4.8	24.0	4.9	23.2	15.1	4.5	18.3	27.6	8.2	8.0	7.0	3.4	6.9	7.9	4.1	6.6	4.5	9.9	24.1	25.9	5.8	12.6	5.2	5.6	21.1	24.1	7.1	4.2	3.8	13.1	4.0	24.4	7.5	5.0	18.9	4.5	5.1	7.8	8.2	5.9	5.0	18.8	7.2	4.9	15.2	22.5	6.2	5.9	7.1	5.4	6.2	6.5	28.9	8.4	13.2	19.2	12.0	7.3	5.0	6.3	8.6	4.6	15.4	16.1	13.3	5.7	3.4	4.4	12.3	20.1	7.2	24.9	10.4	13.2	9.7	10.2	4.0	19.7	9.7	7.6	2.5	9.1	7.2	6.4	27.2	4.5	7.2	4.1	18.7	4.7	9.1	12.9	7.2	8.1	4.2	18.4	6.9	4.4	8.7	7.2	2.0	9.8	8.8	8.6	13.2	11.7	6.3	6.1	14.3	12.3	4.1	7.9	13.5	15.3	17.8	5.9	8.4	12.4	5.2	10.6	3.2	4.1	0.0	0.1	0.1	0.8	0.0	0.7	0.2	0.5	0.5	0.3	0.5	1.0	0.7	1.7	0.9	0.2	2.5	0.7	0.1	24.0	23.2	18.3	27.6	24.1	25.9	21.1	24.1	24.4	18.8	22.5	28.9	2.4	3.2	2.8	19.2	6.3	1.8	2.6	2.5	2.2	14.6	2.8	1.9	7.3	1.5	3.3	9.2	8.4	3.4	7.5	3.7	0.0	2.8	19.8	6.2	5.8	2.6	1.2	3.6	41.2	2.3	2.3	4.9	3.1	4.2	2.5	5.6	3.9	14.1	2.9	35.3	42.4	2.2	6.1	1.9	2.3	31.1	6.8	2.6	5.4	15.0	1.4	5.8	2.1	26.2	44.2	2.0	2.8	4.5	5.0	3.0	1.3	1.4	4.2	15.9	0.0	2.7	4.8	35.2	14.3	1.7	1.4	3.4	4.9	2.8	1.0	2.0
SEC61B		ENSG00000106803	"SEC61 translocon subunit beta"	P60468	9	99222064-99230615	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"monocytes: 1573.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA049407	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Endoplasmic reticulum"		"HPA049407: AB_2680750"	"unprognostic (1.11e-1)"	"unprognostic (5.99e-3)"	"unprognostic (3.46e-1)"	"prognostic favorable (1.26e-5)"	"unprognostic (1.96e-1)"	"unprognostic (4.54e-2)"	"unprognostic (1.21e-3)"	"unprognostic (1.09e-1)"	"unprognostic (6.67e-2)"	"unprognostic (1.87e-2)"	"unprognostic (2.90e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.57e-1)"	"unprognostic (6.87e-2)"	"unprognostic (2.75e-1)"	173.5	235.8	101.0	154.7	104.0	255.5	153.4	104.3	120.8	179.4	105.3	139.3	155.0	167.7	259.4	169.8	155.0	129.8	106.7	104.4	110.8	213.7	465.3	169.0	184.0	104.5	102.1	158.5	546.0	145.9	209.5	98.3	105.8	168.0	102.8	48.5	347.7	124.3	61.0	122.5	132.9	106.3	106.8	173.1	186.5	76.4	103.8	188.8	179.8	44.2	146.7	148.8	139.1	111.6	226.5	213.3	244.1	243.7	234.5	296.0	293.9	327.6	335.8	299.9	259.2	307.3	172.6	305.3	244.3	298.7	328.9	272.0	171.9	259.5	143.1	325.4	238.7	160.7	200.7	440.3	509.9	278.9	198.3	268.0	389.4	237.3	210.3	268.1	369.8	246.7	255.0	581.1	285.6	407.7	255.6	404.9	196.3	533.9	497.7	244.2	207.7	398.1	332.3	158.3	252.7	179.2	183.6	421.1	441.5	190.8	163.4	378.6	265.1	215.3	260.0	363.5	277.7	312.0	226.6	200.7	359.3	176.6	145.6	875.3	460.3	453.3	354.6	387.9	480.8	356.5	389.3	360.4	481.0	257.1	242.9	267.7	388.5	325.7	350.8	1661.8	388.0	525.0	101.0	104.0	104.3	120.8	104.4	110.8	104.5	102.1	105.8	106.8	103.8	111.6	255.6	102.5	206.1	18.3	370.9	395.8	308.3	712.8	213.9	59.3	499.1	530.7	55.5	271.7	416.8	200.5	31.3	336.6	605.9	239.9	633.9	498.6	184.2	274.7	410.2	286.1	302.0	226.8	16.2	792.5	577.9	343.2	214.1	391.3	214.8	258.8	213.8	822.0	509.8	53.8	15.5	534.0	406.9	295.3	553.2	51.8	328.0	316.3	496.2	17.8	1573.9	197.3	284.2	15.6	25.9	633.4	280.0	304.3	1190.6	654.2	290.3	767.6	331.4	81.5	138.1	237.1	404.7	218.4	171.0	337.5	443.4	553.8	270.1	333.0	334.0	501.5
SEC61G	SSS1	ENSG00000132432	"SEC61 translocon subunit gamma"	P60059	7	54752250-54759974	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Cancer enriched"	"Detected in all"	5	"glioma: 333.4"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053196	Uncertain					NA	NA		37000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA053196: AB_2682077"	"unprognostic (1.39e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.82e-2)"	"unprognostic (2.46e-2)"	"prognostic unfavorable (4.64e-7)"	"prognostic unfavorable (3.85e-6)"	"unprognostic (2.09e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (6.60e-8)"	"unprognostic (1.23e-1)"	"unprognostic (1.12e-1)"	"unprognostic (7.95e-3)"	"unprognostic (8.43e-2)"	161.2	163.7	83.1	143.3	82.2	171.1	170.0	85.9	111.2	177.6	94.5	189.7	116.6	127.8	342.2	169.6	132.0	99.5	206.8	82.6	89.1	212.8	221.5	144.2	127.9	84.0	81.7	120.9	311.7	101.6	253.4	115.5	83.7	143.8	162.5	82.4	160.4	121.0	148.3	113.3	126.5	142.4	84.5	140.6	149.3	110.8	84.5	130.9	159.6	126.6	156.5	134.9	134.4	87.6	448.7	256.0	343.4	384.8	339.4	415.5	216.8	705.5	430.3	352.0	647.6	378.3	294.7	383.8	355.2	517.5	758.6	332.9	285.5	491.4	749.5	328.2	249.7	250.0	571.0	439.5	495.2	457.8	248.9	318.2	418.6	364.5	623.2	491.9	479.3	246.2	375.2	950.4	755.2	232.8	243.1	785.9	497.1	547.5	414.9	180.4	206.4	655.7	435.6	281.6	328.5	400.7	287.3	678.0	324.3	602.4	347.0	435.6	405.2	323.1	423.5	1273.5	526.0	385.8	392.5	737.5	672.8	256.9	639.4	294.5	135.4	119.7	145.8	141.0	201.1	144.6	166.5	156.3	154.9	105.5	116.8	140.5	45.1	124.5	156.1	696.8	168.7	136.4	83.1	82.2	85.9	111.2	82.6	89.1	84.0	81.7	83.7	84.5	84.5	87.6	258.9	99.3	139.0	10.4	318.3	378.8	264.8	1105.6	180.4	51.0	330.4	343.8	235.2	283.1	456.4	252.0	8.4	282.2	361.6	467.4	602.6	646.0	67.0	317.2	405.1	256.9	306.5	224.3	8.1	1006.7	775.2	325.7	311.4	524.7	147.2	190.2	267.0	706.0	472.5	23.5	13.1	735.0	506.6	333.3	450.8	46.8	251.0	258.2	498.0	13.1	537.4	166.1	292.5	6.6	12.5	814.2	476.0	222.7	962.7	544.6	544.6	652.0	343.1	45.4	111.7	229.4	500.1	287.6	233.4	290.4	463.9	507.3	257.1	192.2	423.4	362.5
SEC62	"Dtrp1, HTP1, TLOC1"	ENSG00000008952	"SEC62 homolog, preprotein translocation factor"	Q99442	3	169966635-169998373	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014059, HPA061450"	Approved		Approved	"Endoplasmic reticulum,Intermediate filaments"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endoplasmic reticulum"	"Intermediate filaments"	"HPA014059: AB_1858029, HPA061450: AB_2684524"	"unprognostic (8.15e-2)"	"unprognostic (6.84e-2)"	"unprognostic (2.72e-1)"	"unprognostic (4.93e-3)"	"unprognostic (5.13e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.24e-1)"	"unprognostic (4.04e-1)"	"unprognostic (6.78e-2)"	"unprognostic (5.97e-2)"	"unprognostic (6.36e-2)"	"unprognostic (3.15e-1)"	"unprognostic (2.83e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.02e-1)"	104.9	86.5	82.9	58.6	94.3	94.4	64.5	88.1	120.6	74.4	74.6	60.9	58.5	74.7	131.9	44.4	52.3	58.5	49.1	81.8	108.1	118.6	193.7	67.6	63.3	94.9	97.7	75.9	116.5	109.7	41.5	71.0	97.9	82.5	56.6	128.9	130.4	83.5	55.3	27.4	59.4	68.3	95.5	83.5	91.1	34.6	92.3	51.1	120.9	60.2	67.0	63.7	31.7	99.9	140.4	96.6	74.2	66.3	217.9	114.7	46.7	175.5	128.3	80.0	82.5	104.0	143.9	156.8	190.7	125.9	132.5	130.3	92.3	84.8	124.7	123.1	89.2	108.6	57.2	105.6	157.9	111.6	68.5	115.0	79.7	88.0	85.3	108.8	80.1	47.3	68.0	147.2	96.3	117.2	58.9	59.0	76.4	110.8	62.5	77.6	107.6	212.8	115.1	88.5	76.1	71.9	143.7	155.8	125.3	71.3	233.5	101.0	107.8	113.1	51.0	95.6	143.1	168.8	134.9	240.8	118.5	85.1	108.0	17.2	34.8	62.3	44.2	37.1	49.2	77.6	40.6	43.5	30.9	82.1	50.9	46.6	52.0	31.8	29.0	35.1	39.1	27.6	82.9	94.3	88.1	120.6	81.8	108.1	94.9	97.7	97.9	95.5	92.3	99.9	419.0	237.2	291.5	64.6	362.7	254.4	252.8	511.1	144.0	362.0	223.3	278.5	582.1	320.3	431.7	680.5	277.3	218.7	209.5	144.7	195.6	256.4	31.6	302.9	424.8	363.7	261.1	874.1	79.3	347.6	215.0	396.3	104.5	455.3	293.5	105.2	463.7	1081.6	214.7	452.6	86.8	285.4	364.2	237.2	268.0	43.4	560.1	208.4	279.3	48.7	280.0	486.8	183.4	47.3	103.1	283.4	217.4	435.6	469.8	223.5	233.7	416.9	385.8	418.4	295.9	358.9	423.4	206.5	142.2	90.2	172.3	434.1	205.5	175.9	182.2	176.8
SEC63	"DNAJC23, ERdj2, PRO2507, SEC63L"	ENSG00000025796	"SEC63 homolog, protein translocation regulator"	Q9UGP8	6	107867756-107958208	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Protein transport, Transport"	Chaperone	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Theca cells: 354.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053295, HPA060535"	Supported		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 52: Non-specific - Transcription"	"Endoplasmic reticulum"		"HPA053295: AB_2682105, HPA060535: AB_2684312"	"prognostic unfavorable (3.32e-4)"	"prognostic unfavorable (4.01e-4)"	"unprognostic (4.08e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.36e-3)"	"unprognostic (1.51e-2)"	"unprognostic (8.33e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.27e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (6.16e-4)"	"unprognostic (2.35e-1)"	"unprognostic (1.93e-1)"	"unprognostic (1.56e-1)"	"unprognostic (4.41e-2)"	27.5	33.0	11.6	22.0	14.3	32.9	23.3	14.4	12.9	30.2	25.7	19.2	16.8	25.2	29.6	19.5	21.8	22.0	19.0	12.4	15.3	20.0	46.6	21.7	16.7	13.3	12.0	40.4	61.2	31.7	14.4	20.9	14.2	27.7	18.6	21.2	77.8	23.3	14.3	15.5	18.0	22.2	12.3	16.1	23.1	33.0	12.1	22.6	52.1	14.1	17.3	21.8	14.0	17.7	28.5	17.1	46.0	57.6	47.1	55.2	41.4	59.2	65.0	27.8	39.2	30.8	34.6	52.8	49.4	53.7	34.4	40.9	32.3	38.3	42.5	63.8	35.7	57.2	25.2	31.6	73.2	65.9	32.5	43.5	61.4	44.5	97.6	50.0	39.3	31.7	48.5	82.8	57.7	22.7	20.6	29.5	36.4	30.0	18.1	65.2	54.4	43.7	33.5	37.1	40.3	45.7	32.9	48.8	59.1	31.2	34.9	95.8	42.5	41.6	25.8	42.2	46.6	31.4	25.0	52.9	45.9	56.4	48.7	5.6	5.2	5.0	4.8	4.7	7.5	4.4	3.9	3.9	5.4	4.0	4.3	3.4	1.7	7.1	9.8	6.9	2.2	3.5	11.6	14.3	14.4	12.9	12.4	15.3	13.3	12.0	14.2	12.3	12.1	17.7	55.6	118.6	143.3	38.2	64.4	85.0	70.5	90.9	42.7	57.7	67.8	54.2	78.8	81.5	125.5	53.3	39.6	80.8	71.6	39.2	11.7	86.0	40.3	48.7	102.8	61.6	53.5	31.5	52.5	125.4	96.4	107.1	46.9	54.8	68.9	84.8	59.6	126.7	62.7	47.1	50.8	80.0	83.4	56.7	78.9	23.9	106.2	54.8	80.0	42.2	54.3	61.0	59.8	60.3	64.8	81.9	53.5	118.8	144.6	91.1	37.2	38.4	116.7	49.9	46.0	108.2	77.2	143.1	75.0	44.7	80.0	91.0	52.3	354.8	60.8	73.8
SEH1L	"SEC13L, Seh1, SEH1A, SEH1B"	ENSG00000085415	"SEH1 like nucleoporin"	Q96EE3	18	12947133-12987536	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Mitosis, mRNA transport, Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA039964	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA039964: AB_10795241"	"unprognostic (5.14e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.14e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.87e-2)"	"unprognostic (1.13e-3)"	"unprognostic (7.14e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.45e-3)"	"unprognostic (7.12e-2)"	"unprognostic (8.06e-2)"	"unprognostic (3.81e-3)"	"unprognostic (5.91e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.67e-1)"	"unprognostic (7.05e-2)"	17.4	12.0	15.8	16.5	17.0	12.8	14.5	14.8	22.9	12.5	12.5	15.0	11.6	13.7	12.2	19.7	12.1	9.8	15.6	19.8	18.3	14.9	22.4	12.3	19.8	12.2	12.1	12.1	15.1	10.7	14.2	12.6	12.7	11.1	13.9	6.5	11.9	9.1	37.3	15.8	12.0	13.4	13.4	13.2	12.0	15.0	16.6	23.8	12.5	26.9	21.5	19.2	13.2	17.8	53.6	40.6	30.9	49.2	21.2	31.5	45.1	45.5	46.3	52.3	59.8	104.7	27.5	114.8	54.0	53.1	46.8	26.6	72.8	52.0	67.5	31.9	46.8	71.6	38.4	62.3	47.7	197.0	45.4	22.5	40.1	60.6	88.8	21.8	27.7	51.6	98.1	41.5	42.9	57.9	106.3	84.4	39.2	215.5	41.9	70.6	71.8	74.6	40.6	53.4	59.8	35.7	58.2	43.7	47.9	22.3	27.3	64.7	22.4	53.5	123.6	81.4	80.7	30.6	48.1	122.1	35.1	70.1	35.0	4.1	23.5	5.6	14.0	31.6	18.5	23.7	16.3	17.0	37.8	23.9	20.9	18.0	2.6	23.6	26.4	20.6	12.2	22.6	15.8	17.0	14.8	22.9	19.8	18.3	12.2	12.1	12.7	13.4	16.6	17.8	13.1	6.4	20.2	8.5	26.5	54.7	47.0	24.6	40.9	8.0	16.3	12.8	14.0	14.3	18.3	12.9	12.5	23.6	16.1	12.9	9.8	15.0	9.2	18.5	19.2	19.3	19.2	26.1	15.3	13.3	31.8	17.9	15.8	27.6	7.6	17.8	13.2	21.6	21.3	3.3	10.1	20.3	14.2	13.2	20.4	11.4	9.3	19.7	16.0	12.2	16.9	5.8	7.2	6.0	13.3	16.0	15.3	10.9	23.9	46.7	11.5	16.5	8.5	10.1	13.1	26.8	22.3	16.9	14.0	41.6	59.8	23.7	16.0	19.6	24.9	43.0
SEL1L	"Hrd3, IBD2, SEL1L1"	ENSG00000071537	"SEL1L adaptor subunit of ERAD E3 ubiquitin ligase"	Q9UBV2	14	81471547-81533853	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Notch signaling pathway"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"pancreas: 403.4"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 238.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/70: 339.5;U-266/84: 313.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024267	Enhanced				"Intracellular and membrane"	NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA024267: AB_1856659"	"unprognostic (4.94e-1)"	"unprognostic (8.69e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.29e-1)"	"unprognostic (2.78e-1)"	"unprognostic (9.97e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.76e-3)"	"unprognostic (4.86e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.30e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.83e-2)"	"unprognostic (1.25e-2)"	30.6	19.1	13.9	31.1	17.8	17.7	25.2	17.0	17.0	21.4	11.5	35.7	36.7	24.2	18.1	16.8	17.1	22.0	22.8	14.5	17.4	28.8	66.6	27.6	21.6	18.9	16.7	17.1	403.4	29.9	8.7	38.4	19.3	31.6	31.8	15.7	19.6	22.8	22.2	15.5	32.5	28.1	18.4	30.6	35.0	11.2	17.6	17.8	54.3	21.1	29.3	29.0	12.1	25.9	35.3	69.3	27.4	35.5	60.2	58.6	48.5	54.6	52.3	31.2	33.0	26.6	53.7	36.0	58.8	63.2	38.1	32.8	19.2	30.6	56.1	56.0	13.6	26.3	21.7	33.2	86.0	53.6	60.3	47.8	72.0	31.4	68.0	45.9	51.7	29.5	16.2	195.2	38.6	42.7	30.6	15.1	8.7	58.7	29.6	21.2	38.9	28.4	24.0	54.1	15.5	25.7	42.7	39.4	44.9	23.5	68.5	35.5	86.8	87.7	49.0	49.2	34.1	339.5	313.1	35.4	96.5	24.1	34.4	31.5	19.7	24.8	16.8	25.6	13.7	14.2	12.9	13.4	18.9	13.1	12.0	12.9	45.7	16.7	22.5	13.7	14.0	14.5	13.9	17.8	17.0	17.0	14.5	17.4	18.9	16.7	19.3	18.4	17.6	25.9	51.6	12.8	35.2	27.1	44.8	26.8	19.0	27.1	15.9	23.5	31.5	18.9	67.0	32.9	24.9	27.6	31.3	23.5	44.1	48.8	5.9	24.1	3.5	21.1	48.9	40.0	21.6	15.4	35.9	45.6	21.9	44.7	37.8	28.0	34.2	32.0	38.9	125.7	31.9	30.3	35.2	38.9	50.8	58.1	40.4	5.4	23.6	47.6	53.4	29.0	39.7	18.3	30.9	42.3	70.7	40.1	33.1	28.2	238.9	40.0	34.8	20.2	27.8	18.3	46.0	28.5	51.8	14.0	18.8	16.0	26.1	41.9	32.9	38.9	32.0	33.9
SENP2	"AXAM2, DKFZp762A2316, KIAA1331, SMT3IP2"	ENSG00000163904	"SUMO specific peptidase 2"	Q9HC62	3	185582496-185633551	"Enzymes, Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA transport, Protein transport, Translocation, Transport, Ubl conjugation pathway, Wnt signaling pathway"	"Hydrolase, Protease, Thiol protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 249.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029247, HPA029248"	Approved		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 29: Early spermatids - Spermatogenesis"	Cytosol		"HPA029247: AB_10599305, HPA029248: AB_10601855"	"unprognostic (4.57e-2)"	"unprognostic (1.84e-2)"	"unprognostic (6.80e-2)"	"prognostic unfavorable (7.98e-5)"	"unprognostic (7.85e-2)"	"unprognostic (2.90e-2)"	"unprognostic (4.41e-3)"	"unprognostic (1.45e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.85e-1)"	"unprognostic (8.41e-3)"	"unprognostic (5.12e-2)"	"unprognostic (6.92e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.56e-1)"	7.4	7.3	13.4	4.4	15.8	10.7	7.5	13.3	16.2	6.0	12.0	7.8	6.0	6.1	9.7	6.5	7.2	4.5	8.3	13.9	13.1	7.3	9.5	6.4	6.2	12.9	13.6	10.0	7.4	9.6	10.5	9.0	12.4	6.6	6.1	12.8	7.6	6.3	18.9	9.2	6.6	4.8	12.2	6.7	8.0	15.1	14.2	8.1	7.2	13.0	6.0	7.1	6.3	14.4	24.4	4.6	11.6	13.4	20.6	13.8	15.1	10.9	12.6	13.8	14.6	18.3	7.5	13.2	20.3	10.2	23.6	12.6	24.3	9.0	20.3	9.7	11.6	8.9	9.8	11.0	10.9	13.2	5.6	8.6	13.3	7.8	9.5	10.2	9.6	12.5	10.8	18.1	12.0	12.0	11.4	14.7	42.4	12.3	8.1	13.1	15.8	22.1	7.7	7.9	11.9	13.4	9.3	20.4	18.3	23.0	27.8	17.5	6.1	9.0	9.8	16.4	17.7	20.9	26.8	23.8	14.9	13.9	12.5	5.1	1.3	2.6	1.6	1.3	1.6	1.3	1.3	1.3	1.0	1.9	1.5	1.5	3.4	2.3	1.6	2.0	1.3	0.9	13.4	15.8	13.3	16.2	13.9	13.1	12.9	13.6	12.4	12.2	14.2	14.4	12.3	28.9	27.4	17.9	21.2	10.8	23.7	12.6	6.2	22.8	21.6	15.4	24.2	11.5	26.2	9.2	31.3	25.0	22.6	15.7	5.9	12.9	249.6	26.3	12.0	12.8	5.4	11.1	42.9	15.2	19.9	16.1	15.3	25.2	10.8	21.3	17.2	20.5	13.2	11.8	43.0	15.1	14.2	12.5	9.1	43.0	22.7	11.1	17.8	26.2	13.6	17.8	21.6	41.2	41.3	17.9	6.6	17.7	25.7	17.0	24.2	18.2	28.8	38.1	19.7	23.2	16.3	84.2	31.8	13.4	12.5	39.7	18.2	33.7	15.8	22.5
SERINC3	"AIGP1, DIFF33, SBBI99, TDE, TDE1, TMS-1"	ENSG00000132824	"Serine incorporator 3"	Q13530	20	44496221-44522085	"Predicted membrane proteins, Transporters"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 558.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048116	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA048116: AB_2680269"	"unprognostic (3.16e-2)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (2.60e-1)"	"unprognostic (2.74e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.85e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.41e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.60e-2)"	"unprognostic (1.30e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.64e-2)"	81.6	91.6	50.1	49.3	60.0	48.7	61.8	57.8	80.4	73.3	22.4	56.6	47.2	62.4	48.9	65.2	54.8	68.9	72.8	66.1	60.3	49.2	92.7	67.7	46.4	57.6	56.7	67.6	50.3	107.0	44.6	115.8	61.5	57.7	63.2	47.9	66.3	63.5	81.6	63.9	53.3	70.1	56.8	57.1	54.1	110.2	55.7	60.0	81.5	81.1	50.3	63.3	50.1	67.9	70.3	73.9	34.8	44.1	297.4	211.8	53.7	140.8	243.1	111.5	101.3	167.3	169.2	51.0	187.5	168.8	127.1	123.0	41.9	144.9	117.3	59.5	47.1	59.7	71.9	85.7	161.4	74.2	124.5	152.1	207.4	109.7	163.3	135.3	110.0	81.6	67.5	146.2	117.7	88.2	76.5	58.9	20.5	91.6	110.9	38.1	51.9	78.5	88.7	79.5	43.4	32.9	135.2	129.8	91.8	47.9	93.0	82.6	141.5	262.1	43.3	117.0	99.1	86.2	102.0	38.9	195.3	51.7	83.9	217.1	92.6	119.4	96.5	96.7	98.4	57.6	82.9	94.5	95.4	63.4	84.7	85.0	177.3	111.0	113.5	87.4	104.4	137.7	50.1	60.0	57.8	80.4	66.1	60.3	57.6	56.7	61.5	56.8	55.7	67.9	139.7	73.7	70.7	20.5	52.1	54.8	75.3	96.5	60.3	39.2	55.3	44.4	75.9	78.6	84.7	47.8	35.5	85.8	86.1	84.4	15.6	77.2	239.8	44.5	76.2	115.1	66.4	94.9	58.7	69.9	85.6	97.5	41.3	65.1	102.5	32.9	122.4	105.7	57.7	45.4	52.4	60.4	71.2	93.5	50.0	558.0	105.0	79.7	39.2	34.7	44.2	47.4	37.0	27.6	63.8	100.4	63.8	114.0	76.1	75.3	55.6	24.6	65.4	36.6	98.6	69.5	88.9	210.9	99.3	54.6	84.1	165.4	72.0	85.9	54.7	82.2
SERINC5	"C5orf12, TPO1"	ENSG00000164300	"Serine incorporator 5"	Q86VE9	5	80111651-80256048	"Predicted membrane proteins, Transporters"	"Antiviral defense, Host-virus interaction, Immunity, Innate immunity, Lipid biosynthesis, Lipid metabolism, Phospholipid biosynthesis, Phospholipid metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocyte precursor cells: 223.2;Oligodendrocytes: 222.5;Urothelial cells: 254.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 56.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037898, HPA037899"	Supported		Supported	"Vesicles,Plasma membrane,Centrosome,Cytosol"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane, Cytosol"	"Vesicles, Centrosome"	"HPA037898: AB_10673649, HPA037899: AB_2675727"	"unprognostic (2.95e-1)"	"unprognostic (1.80e-1)"	"unprognostic (4.98e-3)"	"unprognostic (1.08e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.80e-2)"	"unprognostic (8.00e-2)"	"unprognostic (2.10e-1)"	"unprognostic (2.68e-2)"	"unprognostic (7.71e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.40e-2)"	"unprognostic (4.81e-2)"	"unprognostic (8.09e-2)"	"unprognostic (4.93e-2)"	"unprognostic (9.17e-2)"	12.9	34.8	19.2	9.8	31.0	6.3	11.8	27.2	20.7	16.4	17.4	28.3	9.2	9.2	21.1	17.6	16.2	14.2	5.3	18.0	22.7	6.2	45.4	14.1	8.2	26.5	27.6	15.1	7.6	7.1	4.1	16.5	26.8	33.7	29.4	16.3	13.3	7.0	2.7	19.1	9.7	7.6	22.2	4.8	16.6	29.2	28.0	7.9	5.8	2.9	11.4	17.8	11.3	44.4	11.3	19.7	6.6	4.2	8.9	9.5	19.6	9.0	6.0	3.9	4.0	40.0	56.7	1.7	9.0	11.7	9.2	31.7	8.9	23.9	5.6	1.6	4.8	1.4	2.2	21.7	3.3	1.3	4.1	10.8	13.1	10.2	26.0	11.0	7.3	54.0	3.6	9.4	10.4	19.4	22.8	5.5	9.3	15.8	6.8	26.9	5.8	3.0	11.5	54.4	0.4	6.3	8.0	18.5	35.4	33.5	8.2	6.9	8.0	11.3	3.2	11.6	11.3	7.1	3.5	28.1	21.0	3.9	46.9	10.4	9.1	6.7	2.1	4.9	1.6	0.8	18.7	5.7	5.8	1.1	23.3	14.1	5.2	0.6	1.5	1.4	6.6	7.5	19.2	31.0	27.2	20.7	18.0	22.7	26.5	27.6	26.8	22.2	28.0	44.4	48.5	60.9	30.2	46.0	10.5	6.4	56.8	5.6	19.9	3.6	27.7	14.1	8.2	31.5	18.3	16.5	0.0	16.1	12.9	127.4	9.8	26.5	1.7	82.0	29.6	24.5	60.1	24.8	20.9	19.5	25.7	24.9	40.2	157.0	8.2	27.6	35.3	82.7	21.8	3.3	78.3	60.0	4.1	29.2	27.8	7.6	18.3	38.4	5.4	66.5	44.8	65.1	1.0	223.2	222.5	35.4	56.4	39.9	8.7	148.2	27.7	5.1	4.3	5.3	32.9	7.5	17.4	3.1	12.8	44.4	9.8	129.2	37.7	15.2	85.9	254.2
SFXN1	"FLJ12876, SLC56A1"	ENSG00000164466	"Sideroflexin 1"	Q9H9B4	5	175477062-175529742	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, One-carbon metabolism, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 99.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"basophil: 99.8"	"Group enriched"	"Detected in all"	5	"granulocytes: 99.8;T-cells: 36.4"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019543, HPA063745"	Approved		Enhanced	Mitochondria		NA	NA		23000	"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 58: T-cells - T-cell receptor"	Mitochondria		"HPA019543: AB_1856789, HPA063745: AB_2685111"	"unprognostic (4.77e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.54e-2)"	"unprognostic (3.62e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.30e-2)"	"unprognostic (3.59e-2)"	"unprognostic (8.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.31e-1)"	"unprognostic (7.30e-2)"	"unprognostic (4.98e-1)"	"unprognostic (1.08e-3)"	"unprognostic (4.23e-2)"	7.6	15.4	14.0	18.2	14.8	21.9	8.1	15.0	17.4	9.3	15.0	28.1	19.3	8.5	8.0	14.7	8.7	9.8	12.3	13.3	15.3	41.6	99.7	5.9	27.0	12.1	12.6	18.7	13.1	15.8	12.9	15.3	13.2	9.6	17.7	20.7	9.6	10.4	10.9	8.8	20.1	11.3	13.0	10.5	14.6	6.6	13.8	24.0	10.5	15.7	27.0	13.8	11.2	14.8	39.9	123.1	61.7	67.0	21.0	44.4	99.2	99.1	41.5	81.3	78.3	156.5	77.6	82.3	74.9	51.9	100.4	49.7	119.0	171.9	87.8	202.1	102.4	60.6	103.4	69.0	30.3	119.6	73.3	36.5	33.1	90.3	39.2	48.3	63.3	74.9	89.1	63.4	60.2	138.3	140.3	9.7	48.7	66.5	41.1	116.3	63.1	87.8	31.3	154.2	104.6	66.7	95.6	88.9	47.8	50.5	43.1	38.3	62.3	63.9	100.3	47.5	130.2	80.2	101.8	184.6	105.1	104.9	68.1	99.8	5.1	26.3	26.2	6.7	21.4	10.7	36.4	29.2	7.3	9.3	28.4	29.3	1.6	12.7	4.3	3.5	32.3	14.2	14.0	14.8	15.0	17.4	13.3	15.3	12.1	12.6	13.2	13.0	13.8	14.8	6.0	3.2	13.5	55.2	29.1	19.5	33.5	30.6	48.9	59.3	13.7	9.9	18.1	17.2	18.8	18.4	47.9	41.4	19.0	68.9	25.4	27.7	1.2	10.9	23.3	14.2	31.2	45.4	77.3	18.7	74.2	24.8	26.0	11.3	9.5	38.1	12.8	98.7	17.2	77.4	62.9	23.9	26.4	8.1	11.4	4.0	47.2	9.5	10.6	30.9	9.0	19.8	37.0	55.3	60.1	31.8	20.1	35.0	63.4	31.6	89.8	51.1	15.5	49.9	26.3	21.7	23.1	2.8	7.4	43.6	21.6	30.9	61.9	67.2	21.7	27.0
SFXN2	SLC56A2	ENSG00000156398	"Sideroflexin 2"	Q96NB2	10	102714538-102743492	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 17.9;parathyroid gland: 12.7"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 33.3;Hepatocytes: 21.2;Proximal tubular cells: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"T-47d: 38.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA018150, HPA026834"	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA018150: AB_1856790, HPA026834: AB_1856791"	"unprognostic (1.70e-2)"	"prognostic favorable (2.28e-4)"	"unprognostic (3.30e-2)"	"unprognostic (2.95e-1)"	"unprognostic (6.10e-2)"	"unprognostic (1.44e-2)"	"prognostic favorable (9.95e-4)"	"unprognostic (4.24e-2)"	"unprognostic (9.69e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.98e-3)"	"prognostic favorable (2.28e-5)"	"unprognostic (1.20e-1)"	"unprognostic (2.14e-1)"	"unprognostic (3.77e-2)"	"prognostic favorable (6.52e-4)"	1.5	1.1	1.2	1.9	2.8	3.0	2.8	3.9	1.7	1.6	3.6	1.9	2.5	2.7	3.6	1.4	3.6	1.1	0.6	1.8	0.8	17.9	4.2	1.6	2.6	1.0	0.5	3.4	3.1	12.7	2.7	3.4	1.2	2.2	3.0	2.7	4.9	1.3	0.7	1.9	1.9	1.1	0.2	2.1	3.3	1.2	1.8	3.2	3.8	0.2	1.9	0.9	0.7	2.1	4.2	2.3	3.5	3.7	1.3	0.9	5.1	1.4	0.6	1.8	0.9	7.2	1.9	9.1	2.7	1.2	1.0	3.0	0.7	4.8	1.0	1.6	2.8	13.1	4.4	4.5	0.6	7.5	1.1	1.0	0.7	1.8	1.8	1.1	1.7	7.7	6.0	4.2	1.1	4.0	11.5	2.5	2.3	4.0	0.8	5.5	4.3	1.3	1.7	3.5	2.6	2.5	1.2	3.1	0.6	1.4	38.4	1.6	1.2	1.4	4.4	1.8	3.1	4.6	6.5	7.9	1.7	9.0	1.2	1.6	0.5	0.2	1.9	0.2	1.7	0.8	1.9	2.0	0.7	2.5	3.0	2.5	0.9	1.9	0.3	1.7	2.0	0.7	1.2	2.8	3.9	1.7	1.8	0.8	1.0	0.5	1.2	0.2	1.8	2.1	1.0	0.0	10.1	5.2	3.8	0.9	3.0	0.8	4.0	6.1	7.3	5.2	2.5	4.3	2.0	1.8	33.3	9.1	2.4	2.5	9.8	1.9	0.8	7.3	4.2	2.2	3.6	4.2	5.4	2.8	4.4	3.2	8.2	10.0	0.0	9.2	5.0	21.2	9.6	0.0	5.5	5.0	0.0	7.5	0.6	0.5	2.1	2.4	0.0	8.4	0.8	1.1	4.1	7.1	2.9	1.4	0.8	1.5	6.7	4.4	2.4	43.1	0.4	15.1	0.0	2.7	1.7	1.2	1.3	3.3	1.3	4.5	2.8	2.6	7.3	2.9
SFXN4	SLC56A4	ENSG00000183605	"Sideroflexin 4"	Q6P4A7	10	119140767-119165714	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA018028, HPA020872"	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Mitochondria"	Vesicles	"HPA018028: AB_1856792, HPA020872: AB_1856793"	"unprognostic (8.13e-2)"	"unprognostic (6.11e-2)"	"unprognostic (3.61e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.49e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.84e-2)"	"unprognostic (4.56e-2)"	"unprognostic (8.58e-2)"	"unprognostic (2.94e-2)"	"unprognostic (1.70e-3)"	"unprognostic (4.22e-3)"	"unprognostic (1.43e-1)"	"unprognostic (6.21e-3)"	"unprognostic (3.07e-3)"	13.3	35.9	9.9	10.1	12.5	16.4	14.1	12.8	13.6	14.2	17.0	21.9	20.4	11.1	13.5	19.1	14.3	8.6	33.1	10.2	12.4	24.5	36.4	8.5	14.4	11.3	12.5	16.0	33.7	23.1	21.5	8.8	11.6	18.8	22.7	5.7	27.8	13.2	51.4	11.5	17.3	12.2	10.6	20.9	17.3	11.9	11.3	11.0	24.7	59.3	17.8	16.4	13.8	12.5	26.2	27.6	8.7	41.8	10.4	19.7	33.0	16.3	19.8	21.0	21.8	45.9	43.2	62.6	15.6	14.9	22.4	48.2	57.5	36.3	24.3	33.1	65.7	28.7	18.4	47.3	37.1	49.7	28.8	21.1	34.4	22.0	63.8	19.5	25.0	46.5	45.2	17.5	13.6	29.6	53.8	60.4	11.8	50.2	32.5	51.7	27.1	49.0	24.3	17.3	25.2	13.9	10.8	42.2	61.9	11.1	26.0	28.4	11.5	10.6	21.9	19.8	37.6	42.6	53.0	56.3	16.2	72.6	7.2	2.5	18.1	1.9	6.5	19.5	10.8	12.5	7.9	7.1	21.2	7.0	12.1	9.8	2.2	7.3	15.9	10.6	6.0	11.1	9.9	12.5	12.8	13.6	10.2	12.4	11.3	12.5	11.6	10.6	11.3	12.5	8.0	6.4	5.6	29.0	16.9	12.0	25.8	39.9	23.3	7.9	17.8	18.2	36.2	12.8	19.1	14.7	2.1	37.6	6.2	13.2	58.7	28.4	27.4	7.6	8.9	8.4	18.0	33.6	22.3	23.8	25.8	12.4	14.3	7.9	5.7	28.5	7.1	31.5	29.2	6.7	29.1	24.7	30.5	17.6	5.0	69.3	8.7	13.1	12.4	8.4	11.3	7.7	10.3	22.1	19.5	17.6	12.1	13.5	31.9	28.0	29.8	65.6	13.5	11.3	6.6	22.3	10.6	27.7	15.2	26.9	9.1	21.9	9.2	44.5	45.8	20.5
SGSM3	"DJ1042K10.2, RabGAP-5, RABGAP5, RUSC3, RUTBC3"	ENSG00000100359	"Small G protein signaling modulator 3"	Q96HU1	22	40370591-40410289	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Growth arrest"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Gastric mucus-secreting cells: 176.4;Intestinal goblet cells: 135.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048980	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA048980: AB_2680585"	"unprognostic (4.63e-2)"	"unprognostic (7.51e-3)"	"unprognostic (3.02e-2)"	"prognostic favorable (4.47e-5)"	"unprognostic (1.81e-1)"	"unprognostic (6.83e-3)"	"unprognostic (5.70e-3)"	"unprognostic (7.53e-2)"	"unprognostic (3.57e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.71e-3)"	"unprognostic (1.93e-1)"	"unprognostic (2.97e-1)"	"unprognostic (4.08e-3)"	"unprognostic (2.10e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.98e-3)"	24.8	42.6	34.6	26.1	34.8	19.3	29.4	27.3	43.6	37.3	32.6	46.6	32.8	31.9	14.5	49.2	37.1	28.7	37.0	33.2	33.3	36.4	37.3	33.8	32.9	36.5	34.3	30.8	107.7	24.7	55.0	21.9	34.8	62.6	24.3	11.0	70.1	25.9	34.2	36.7	46.1	17.4	27.6	51.5	91.4	39.8	33.6	27.5	48.7	23.4	28.3	33.1	35.6	31.9	37.8	21.1	30.6	34.1	33.2	18.1	43.4	35.0	22.9	26.0	33.7	12.0	30.9	23.3	23.7	37.9	15.6	30.0	29.2	42.9	10.4	58.4	68.8	15.9	56.9	11.3	31.6	23.1	33.1	30.2	29.5	29.1	17.4	29.2	46.0	48.6	19.8	31.4	19.4	60.5	32.1	23.5	20.5	75.8	14.0	59.3	19.3	51.1	26.8	33.0	18.8	24.2	38.6	55.4	27.5	24.2	46.3	38.9	40.2	8.8	31.8	23.4	20.6	47.1	23.2	31.0	37.4	19.0	22.9	1.1	14.6	16.3	18.7	15.7	15.6	17.7	11.5	14.9	18.9	22.3	13.8	11.3	3.3	35.4	11.9	31.6	11.7	15.8	34.6	34.8	27.3	43.6	33.2	33.3	36.5	34.3	34.8	27.6	33.6	31.9	5.3	3.2	10.3	14.0	32.8	11.5	32.4	33.1	14.8	57.0	12.1	7.1	8.3	27.1	42.1	7.3	18.8	42.8	23.9	46.4	1.9	20.2	17.5	5.1	3.8	14.3	31.3	18.1	27.1	45.3	54.3	14.0	176.4	6.7	15.9	3.1	21.8	24.0	24.2	26.9	34.6	135.3	50.8	17.2	8.3	31.7	22.7	11.8	16.0	13.1	21.6	13.4	30.9	15.6	15.1	21.3	40.6	19.2	30.5	46.1	36.2	4.4	60.2	34.0	39.5	14.4	13.8	83.5	44.4	19.8	10.4	45.6	16.7	3.3	47.7	60.0
SH3GLB1	"Bif-1, CGI-61, KIAA0491, PPP1R70"	ENSG00000097033	"SH3 domain containing GRB2 like, endophilin B1"	Q9Y371	1	86704570-86748184	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Autophagy"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 634.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 301.4"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004650, HPA015608, HPA019900"	Enhanced		Supported	Cytosol		NA	NA		28000	"Cluster 9: Neutrophils - Innate immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"CAB004650: AB_425966, HPA015608: AB_1845355, HPA019900: AB_1845356"	"unprognostic (1.72e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.52e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.42e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.90e-5)"	"unprognostic (8.34e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.29e-1)"	"prognostic unfavorable (2.53e-4)"	"unprognostic (1.56e-1)"	"unprognostic (4.04e-3)"	"unprognostic (7.70e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.69e-1)"	106.5	38.1	20.5	55.3	22.5	66.2	56.1	21.0	25.4	39.2	15.7	53.7	48.4	35.9	31.0	79.4	27.9	47.0	72.8	19.2	23.7	40.4	45.0	49.0	40.9	25.3	19.7	24.2	64.0	41.3	30.3	57.5	24.4	34.3	57.9	39.0	56.4	36.1	172.0	35.8	47.0	50.3	23.4	46.5	36.3	109.5	21.0	34.1	38.6	98.4	51.9	63.8	41.8	27.4	78.1	28.1	44.2	40.4	180.1	155.1	72.2	115.1	114.5	106.8	112.3	81.4	63.3	39.7	72.0	143.5	132.9	44.5	39.4	75.0	101.2	86.1	28.1	94.7	39.2	87.1	108.7	51.5	92.4	111.8	85.5	118.3	128.7	114.5	171.4	41.7	36.0	108.5	145.1	23.1	46.7	32.7	43.0	56.8	47.6	53.1	184.6	29.7	92.3	132.2	47.9	34.7	64.8	82.4	140.8	65.2	32.7	51.8	151.4	102.2	61.9	129.3	96.5	56.8	56.3	58.6	50.8	52.1	63.5	153.0	59.0	66.5	43.0	64.5	42.4	36.8	40.2	43.8	45.5	35.3	19.1	34.3	301.4	62.4	77.0	43.8	65.4	49.5	20.5	22.5	21.0	25.4	19.2	23.7	25.3	19.7	24.4	23.4	21.0	27.4	192.0	83.3	65.6	39.2	75.0	89.6	119.5	124.1	44.3	31.2	96.9	69.1	157.0	60.1	104.0	55.2	52.1	84.3	145.7	182.0	86.1	145.2	634.6	86.3	104.5	135.4	86.6	64.4	49.9	169.8	203.4	99.7	45.9	110.0	113.5	61.0	157.1	79.4	143.7	16.8	50.5	130.3	128.1	149.2	99.4	236.9	70.2	116.0	81.8	40.3	163.7	71.9	124.6	46.8	65.2	201.7	173.4	85.0	123.9	103.4	108.8	134.0	90.2	55.4	78.9	146.7	111.7	403.5	86.3	100.6	118.1	101.9	90.4	57.1	87.4	199.8
SHISA6	FLJ45455	ENSG00000188803	"Shisa family member 6"	Q6ZSJ9	17	11241213-11564063	"Predicted membrane proteins, Transporters"	"Wnt signaling pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 46.2;cervix: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 50.3;Excitatory neurons: 27.4;Inhibitory neurons: 181.4;Oligodendrocyte precursor cells: 77.4;Peritubular cells: 29.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	23	"OE19: 52.0"	"Low region specificity"	"Detected in all"							HPA023440	Uncertain		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 21: OE19 - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Plasma membrane"		"HPA023440: AB_1848945"	"unprognostic (1.70e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.44e-1)"	"unprognostic (2.39e-3)"	"prognostic unfavorable (8.41e-4)"	"unprognostic (3.11e-2)"	"unprognostic (1.71e-1)"	"unprognostic (8.80e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.63e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.40e-4)"	"unprognostic (1.14e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.20e-2)"	"unprognostic (2.47e-2)"	1.7	0.6	17.7	0.0	11.0	0.0	1.1	23.2	25.3	16.8	0.8	0.6	0.2	6.2	0.7	0.8	1.8	0.3	0.8	46.2	18.9	1.9	0.0	0.2	0.0	43.3	25.5	0.6	1.0	3.4	0.2	0.1	24.4	4.3	0.4	1.1	0.2	7.3	0.7	0.8	0.3	0.5	44.8	0.0	4.2	2.9	34.7	0.0	0.5	1.3	0.0	1.1	3.4	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	52.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.7	11.0	23.2	25.3	46.2	18.9	43.3	25.5	24.4	44.8	34.7	27.0	0.9	0.0	0.0	50.3	0.0	0.1	0.1	0.0	1.2	4.0	1.8	0.9	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.5	16.9	1.6	1.2	0.0	27.4	0.0	0.0	2.1	0.0	0.5	0.0	5.6	0.4	0.0	0.1	0.0	181.4	0.0	0.0	0.0	0.3	15.2	5.0	0.0	1.8	12.2	0.0	0.8	0.0	77.4	2.4	0.0	0.0	29.0	0.0	0.8	0.0	0.2	0.0	0.2	0.0	0.2	1.7	0.4	2.5	0.1	0.1	0.0	0.1	4.4	0.2	0.2
SHISA7		ENSG00000187902	"Shisa family member 7"	A6NL88	19	55428740-55443277	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 25.9"	"Group enriched"	"Detected in some"	6	"Erythroid cells: 13.5;Excitatory neurons: 19.4;Inhibitory neurons: 16.1;Oligodendrocyte precursor cells: 23.1;Oligodendrocytes: 16.1"	"Cancer enriched"	"Detected in single"	9	"glioma: 2.3"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"HEL: 2.9;HMC-1: 2.8;THP-1: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058935	Uncertain		Approved	Cytosol		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Cytosol		"HPA058935: AB_2683857"	"unprognostic (3.98e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.78e-1)"		"unprognostic (3.08e-1)"	"unprognostic (4.40e-1)"	"unprognostic (7.17e-2)"	"unprognostic (2.11e-3)"	"unprognostic (1.22e-2)"	"unprognostic (6.87e-7)"	"unprognostic (7.53e-3)"	"unprognostic (2.82e-1)"	"unprognostic (3.29e-4)"	"unprognostic (4.04e-1)"	0.0	0.4	20.2	0.0	19.7	1.1	0.0	0.5	20.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.9	10.4	0.0	0.0	0.0	0.0	5.1	4.9	0.0	0.0	0.0	4.9	0.0	3.6	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	1.3	9.6	0.1	0.0	0.0	0.0	0.0	0.0	12.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.9	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.4	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.2	19.7	0.5	20.2	25.9	10.4	5.1	4.9	3.6	4.6	9.6	12.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	0.0	13.5	19.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	16.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	23.1	16.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SHISA8	"C22orf17, Orf26"	ENSG00000234965	"Shisa family member 8"	B8ZZ34	22	41909554-41914667	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	13	"adrenal gland: 13.8;brain: 51.1"	"Cell type enriched"	"Detected in some"	18	"Horizontal cells: 477.8"	"Low cancer specificity"	"Detected in some"			"Region enriched"	"Detected in many"	9	"cerebellum: 51.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"HEK 293: 19.3"	"Group enriched"	"Detected in many"	4	"cerebellum: 7.8;olfactory bulb: 15.7;white matter: 4.0"	"Low region specificity"	"Detected in all"			HPA059173	Uncertain					NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 62: Horizontal cells - Visual perception"			"HPA059173: AB_2683938"	"unprognostic (8.76e-2)"	"unprognostic (2.98e-4)"	"unprognostic (1.03e-1)"	"prognostic favorable (2.76e-4)"	"unprognostic (4.42e-2)"	"unprognostic (1.45e-3)"	"unprognostic (4.40e-1)"	"unprognostic (1.16e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.57e-1)"	"unprognostic (1.45e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.12e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.60e-2)"	"unprognostic (6.22e-4)"	"unprognostic (7.84e-2)"	0.0	13.8	1.7	0.5	0.5	0.1	0.0	51.1	3.4	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.2	0.0	1.3	0.6	0.7	0.4	0.0	0.1	1.2	1.5	3.4	0.0	0.0	0.1	1.7	0.0	3.8	0.1	0.0	0.3	0.8	0.0	0.3	0.3	1.5	0.0	5.3	2.5	0.2	0.2	5.4	0.0	0.1	0.1	0.7	0.0	0.0	0.8	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	19.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	2.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.5	51.1	3.4	0.6	0.7	1.5	3.4	3.8	5.3	5.4	0.8	0.1	0.0	0.0	0.3	10.8	0.0	0.0	0.0	0.0	11.5	22.7	0.0	3.7	0.0	0.0	0.0	4.2	0.0	0.5	0.0	1.9	0.0	1.1	5.2	0.5	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.0	7.9	0.0	0.1	0.0	0.0	0.0	477.8	25.9	0.0	0.0	0.3	0.0	1.1	0.0	0.1	0.0	0.0	0.0	1.5	0.0	1.0	1.6	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	4.5	0.0	0.0	0.1	1.9	2.3	0.0	0.0	0.0	0.3	0.0	0.0	0.1
SHISA9		ENSG00000237515	"Shisa family member 9"	B4DS77	16	12901598-13240416	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 14.8"	"Group enriched"	"Detected in many"	17	"Excitatory neurons: 265.0;Inhibitory neurons: 427.9;Oligodendrocyte precursor cells: 636.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"EFO-21: 48.5;LHCN-M2: 40.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072399			Approved	Vesicles,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"		"HPA072399: AB_2686517"	"unprognostic (1.88e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.69e-5)"	"unprognostic (2.23e-2)"	"unprognostic (2.03e-2)"	"unprognostic (5.90e-5)"	"unprognostic (1.50e-2)"	"unprognostic (1.98e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.66e-1)"	"unprognostic (1.38e-1)"	"prognostic favorable (1.53e-4)"	"unprognostic (1.19e-1)"	"unprognostic (2.09e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.26e-2)"	0.5	2.8	12.5	0.8	12.7	1.3	0.6	0.0	14.8	0.3	0.0	3.2	0.8	0.4	1.1	0.5	0.2	0.4	0.6	10.9	6.3	1.9	0.6	0.2	0.4	6.9	5.9	0.4	0.6	0.1	0.9	0.4	6.2	4.2	0.9	3.7	0.9	0.7	1.5	0.9	0.9	0.6	1.7	0.4	0.5	0.7	11.0	0.1	2.1	0.0	0.3	0.2	0.2	4.2	0.8	0.4	0.6	0.5	0.2	0.2	0.5	0.4	0.0	0.0	0.0	0.3	0.5	0.5	48.5	0.1	0.7	0.6	0.1	0.2	0.1	0.6	0.2	0.6	0.9	0.3	0.1	0.6	0.6	1.5	0.1	0.1	3.3	0.4	0.1	0.6	0.4	1.0	40.5	5.5	0.4	0.7	10.2	0.7	0.5	0.6	0.4	0.3	10.9	1.5	10.1	0.5	0.4	1.4	0.4	4.4	0.9	0.4	0.4	0.6	5.8	0.6	0.4	0.9	1.0	0.5	0.4	0.3	1.0	0.8	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	12.5	12.7	0.0	14.8	10.9	6.3	6.9	5.9	6.2	1.7	11.0	4.2	0.0	25.6	20.1	5.2	0.1	0.1	0.5	0.2	0.0	0.8	1.7	0.8	1.3	1.5	7.0	1.8	0.0	0.1	0.0	0.3	1.9	1.4	4.8	0.1	0.5	1.1	0.0	0.0	265.0	0.0	0.0	2.0	0.0	0.3	11.4	0.0	0.0	0.0	0.0	0.0	427.9	0.3	0.0	0.0	0.4	3.4	0.3	1.0	0.0	5.6	0.0	0.5	0.0	636.3	4.9	0.1	2.3	0.0	0.0	1.8	0.0	1.3	11.8	0.3	0.0	6.6	0.2	0.5	2.0	0.0	0.1	0.1	1.3	0.0	0.8	0.6
SIAH1	hSIAH1	ENSG00000196470	"Siah E3 ubiquitin protein ligase 1"	Q8IUQ4	16	48356364-48448402	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Cell cycle, Differentiation, Spermatogenesis, Ubl conjugation pathway"	"Developmental protein, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Cytotrophoblasts: 187.4;Syncytiotrophoblasts: 746.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB018724	Enhanced		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Mitochondria	Nucleoplasm	"CAB018724: AB_2188865"	"unprognostic (7.08e-2)"	"unprognostic (1.16e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.92e-3)"	"unprognostic (1.25e-2)"	"unprognostic (7.93e-3)"	"unprognostic (1.12e-2)"	"unprognostic (9.22e-3)"	"unprognostic (3.26e-1)"	"unprognostic (8.02e-2)"	"unprognostic (7.84e-3)"	"unprognostic (7.67e-3)"	"unprognostic (4.38e-2)"	"unprognostic (4.00e-1)"	"unprognostic (9.55e-2)"	"unprognostic (1.26e-2)"	23.3	14.1	12.0	10.8	13.9	28.2	22.8	16.2	16.0	19.3	13.3	15.9	16.0	19.4	15.6	14.0	17.4	15.8	15.0	12.3	12.4	14.6	22.6	17.6	14.0	13.6	14.6	19.2	14.1	14.6	10.3	50.1	13.2	16.8	14.6	19.1	16.1	13.8	21.5	22.3	16.2	14.5	12.2	13.4	15.7	23.3	13.5	14.1	17.5	17.3	13.0	14.1	17.1	16.9	15.5	13.7	29.1	26.3	24.5	21.3	29.6	14.2	19.2	20.6	10.1	10.5	19.7	20.1	15.3	18.0	14.4	17.6	20.3	20.7	25.3	8.1	16.4	10.8	10.6	27.8	34.2	10.7	15.8	25.8	36.5	12.1	27.9	23.1	17.5	18.5	17.7	18.4	17.0	10.6	29.1	21.9	35.5	17.1	21.0	33.3	43.7	21.3	19.5	19.3	33.1	29.3	42.0	20.9	37.7	24.8	13.3	24.4	18.8	22.0	19.8	12.0	15.4	24.0	10.7	36.8	16.3	13.1	20.2	13.7	8.1	35.4	4.1	3.6	4.5	20.4	4.4	6.3	13.0	19.2	8.7	6.6	4.7	8.7	2.2	12.5	2.5	5.8	12.0	13.9	16.2	16.0	12.3	12.4	13.6	14.6	13.2	12.2	13.5	16.9	43.0	12.8	9.7	8.8	24.7	85.7	55.7	45.0	71.2	22.3	43.5	32.0	13.3	20.0	20.5	16.5	8.4	187.4	15.3	27.3	31.3	24.5	70.5	21.9	26.7	35.7	22.6	27.0	20.1	22.7	34.0	42.5	21.9	34.5	4.5	37.8	33.9	23.6	34.3	35.3	20.9	17.8	40.7	20.3	99.2	71.3	22.7	31.1	49.8	23.4	27.0	38.3	4.1	25.6	40.2	22.3	18.2	19.5	17.9	49.7	23.5	28.9	17.0	18.6	19.7	36.2	34.4	70.0	51.0	67.7	75.7	746.2	17.3	17.4	20.6	50.8
SIAH2		ENSG00000181788	"Siah E3 ubiquitin protein ligase 2"	O43255	3	150741125-150763477	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Erythroid cells: 226.7;Syncytiotrophoblasts: 389.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA061293, CAB069930"	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 85: Liver - Metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	Vesicles	"CAB069930: AB_1217916, HPA061293: AB_2684470"	"prognostic favorable (1.17e-4)"	"unprognostic (1.04e-3)"	"unprognostic (3.83e-2)"	"unprognostic (9.15e-2)"	"unprognostic (1.69e-1)"	"unprognostic (6.91e-2)"	"unprognostic (1.86e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.26e-2)"	"unprognostic (1.95e-2)"	"prognostic unfavorable (8.21e-5)"	"unprognostic (1.34e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.38e-2)"	"unprognostic (5.56e-1)"	"unprognostic (1.66e-1)"	"unprognostic (4.69e-2)"	15.8	78.6	16.4	20.8	19.0	44.7	17.1	17.4	24.9	48.0	17.3	17.7	13.5	33.4	18.6	46.1	27.2	14.3	16.2	16.9	16.7	12.1	61.2	13.2	35.8	15.8	15.5	24.4	20.9	15.9	11.0	43.1	17.9	19.4	15.4	7.8	16.4	34.7	12.3	30.4	12.9	29.4	15.5	24.4	17.9	8.0	16.5	25.1	8.0	12.8	45.3	23.5	39.6	26.0	54.0	13.4	10.5	20.1	35.4	26.4	41.7	22.9	26.5	27.3	32.4	28.4	24.7	31.3	31.0	24.1	22.8	31.4	28.6	20.7	25.6	24.4	19.5	61.5	16.0	94.7	50.4	34.3	16.0	24.1	47.0	16.3	36.9	21.7	21.5	60.2	15.5	110.8	17.4	66.4	58.7	17.4	33.1	52.3	26.0	44.0	22.7	110.4	17.4	17.9	38.4	19.1	17.4	15.4	39.8	23.8	99.5	50.0	15.0	17.7	15.8	40.1	31.0	130.6	55.9	42.0	17.6	48.6	9.2	8.9	2.2	8.6	1.6	1.2	2.5	2.2	2.8	2.5	2.0	2.2	1.4	1.4	4.7	1.4	1.3	2.6	1.6	0.9	16.4	19.0	17.4	24.9	16.9	16.7	15.8	15.5	17.9	15.5	16.5	26.0	15.9	6.4	4.8	6.8	99.0	146.7	82.3	11.8	153.1	47.0	32.3	22.2	17.8	25.8	11.7	22.0	37.5	192.0	62.6	30.2	13.7	8.5	3.4	56.0	29.2	22.5	38.3	226.7	14.1	6.6	23.4	28.8	44.4	96.5	10.2	18.7	20.7	54.4	32.6	35.3	11.0	39.9	14.2	115.5	102.7	2.1	44.1	70.4	44.4	14.0	22.7	32.7	32.0	5.0	11.5	10.5	17.9	30.9	128.7	56.7	20.7	17.9	16.5	2.8	13.1	11.8	29.9	0.7	10.8	154.1	142.4	389.4	86.1	28.6	34.5	81.8
SIDT1	"FLJ20174, SID-1"	ENSG00000072858	"SID1 transmembrane family member 1"	Q9NXL6	3	113532555-113629575	"Predicted membrane proteins, Transporters"		RNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 10.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 47.4;dendritic cells: 34.5;Excitatory neurons: 117.8;Inhibitory neurons: 86.8"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 33.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"MCF7: 15.4;OE19: 16.2;PC-3: 21.0;RT4: 14.9;T-47d: 13.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA035862	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA035862: AB_10671110"	"unprognostic (4.23e-1)"	"prognostic favorable (3.78e-4)"	"unprognostic (3.43e-3)"	"unprognostic (1.33e-3)"	"unprognostic (2.28e-1)"	"unprognostic (6.64e-4)"	"unprognostic (2.93e-4)"	"unprognostic (1.50e-1)"	"unprognostic (4.02e-1)"	"unprognostic (3.29e-3)"	"unprognostic (2.21e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.02e-1)"	"unprognostic (5.86e-2)"	"unprognostic (1.32e-2)"	"prognostic favorable (4.09e-5)"	1.2	2.8	5.2	5.2	5.6	3.4	5.4	4.7	6.4	3.1	0.0	6.2	2.0	0.7	0.2	1.4	1.9	3.7	0.4	6.4	3.6	0.8	0.6	1.8	8.8	2.8	3.5	0.2	0.7	0.5	5.4	1.0	2.1	5.1	10.2	0.4	10.8	1.5	0.3	0.5	5.4	0.7	5.7	7.1	3.5	0.9	4.9	5.2	0.4	0.4	8.8	4.5	0.9	3.3	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.2	0.2	0.2	0.0	1.5	0.0	0.5	0.0	0.0	0.0	4.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.8	0.0	4.2	0.0	15.4	4.2	0.2	0.0	16.2	21.0	6.2	0.0	0.5	0.0	14.9	0.2	0.1	0.0	4.2	0.2	0.0	13.8	1.1	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.3	7.0	0.1	7.1	7.5	4.7	5.8	1.5	6.6	5.9	5.1	0.3	9.1	0.0	33.7	3.9	3.4	5.2	5.6	4.7	6.4	6.4	3.6	2.8	3.5	2.1	5.7	4.9	3.3	1.6	6.4	3.3	7.2	47.4	0.4	1.4	1.9	0.0	1.4	9.7	4.7	1.1	4.3	4.2	1.8	0.0	0.0	34.5	17.2	0.0	0.4	5.0	3.1	0.7	1.0	10.2	0.8	117.8	1.1	0.2	0.4	8.2	6.3	3.8	0.0	0.4	0.5	11.2	0.0	86.8	23.3	2.0	3.5	1.8	1.5	0.0	10.1	5.4	23.4	2.6	0.1	21.6	4.5	4.0	0.8	3.9	0.0	14.5	3.9	2.2	0.1	9.3	0.2	0.0	0.7	0.7	0.2	0.1	0.9	0.3	0.1	16.4	0.3	7.0	1.9
SIDT2	CGI-40	ENSG00000149577	"SID1 transmembrane family member 2"	Q8NBJ9	11	117178736-117197445	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 67.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"intermediate monocyte: 83.5;non-classical monocyte: 151.0"	"Lineage enriched"	"Detected in all"	7	"monocytes: 151.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052352	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 25: Pancreas - Digestion"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 41: Macrophages - Immune response"			"HPA052352: AB_2681797"	"unprognostic (3.83e-1)"	"unprognostic (4.30e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (3.01e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.29e-1)"	"prognostic unfavorable (4.18e-5)"	"unprognostic (2.74e-2)"	"unprognostic (2.20e-1)"	"unprognostic (4.36e-2)"	"unprognostic (5.22e-3)"	40.2	25.1	23.5	21.2	28.4	12.4	36.3	27.4	27.1	32.8	19.4	28.8	44.2	30.5	16.0	15.1	31.3	18.5	31.8	24.1	23.2	20.6	40.8	36.4	23.4	37.0	29.2	60.2	113.4	13.6	35.7	22.4	33.9	48.6	23.1	14.4	31.5	21.2	25.2	32.7	42.3	20.8	29.7	34.6	75.9	28.5	29.2	10.0	31.7	12.3	20.4	26.2	20.4	48.9	8.7	8.8	10.5	15.4	34.4	30.7	34.8	14.8	19.5	9.3	8.6	25.1	32.8	8.9	23.1	39.1	11.7	9.0	10.2	11.5	7.6	13.2	12.4	6.3	15.8	17.3	17.8	5.3	15.5	38.1	12.8	12.0	12.9	28.6	19.1	11.4	12.0	19.2	22.1	18.2	7.5	6.2	4.9	45.6	6.5	5.6	7.2	25.5	12.2	9.1	3.2	7.9	15.8	38.1	2.6	11.7	30.8	6.3	11.9	12.3	7.9	8.2	3.4	13.6	5.3	9.4	7.1	10.8	9.2	0.3	14.2	0.5	1.9	83.5	1.5	18.3	1.1	1.3	11.5	21.2	1.7	1.3	1.7	1.5	151.0	6.2	1.4	9.6	23.5	28.4	27.4	27.1	24.1	23.2	37.0	29.2	33.9	29.7	29.2	48.9	12.2	6.4	12.3	11.8	24.1	67.7	25.4	4.1	4.0	13.0	11.1	13.0	7.9	4.3	4.5	11.0	6.2	9.2	6.7	16.7	0.0	4.4	7.4	11.6	22.2	12.7	11.4	8.2	7.7	9.6	33.4	19.7	61.2	11.2	2.5	43.5	16.4	25.6	16.9	18.5	8.8	32.9	2.0	54.2	29.3	11.5	13.4	30.6	19.6	7.5	13.6	6.1	7.2	12.1	16.8	8.0	9.4	13.5	6.6	20.5	40.7	1.8	6.0	12.1	19.7	46.1	18.7	5.8	4.8	4.2	42.9	32.3	9.5	38.2	13.5	15.5
SIGMAR1	"OPRS1, SR-BP1"	ENSG00000147955	"Sigma non-opioid intracellular receptor 1"	Q99720	9	34634722-34637844	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"	Receptor	"Amyotrophic lateral sclerosis, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 187.6"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 98.7;Hepatocytes: 97.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB013470, HPA018002, HPA024071"	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 33: Fibroblasts - ECM organization"			"CAB013470: AB_2533521, HPA018002: AB_1854802, HPA024071: AB_1854803"	"unprognostic (1.39e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.95e-1)"	"unprognostic (8.06e-2)"	"unprognostic (3.71e-2)"	"unprognostic (4.89e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.01e-3)"	"unprognostic (3.88e-2)"	"unprognostic (4.28e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.44e-3)"	"prognostic unfavorable (3.42e-4)"	42.0	52.4	25.2	19.4	25.3	20.5	38.1	26.2	27.1	53.0	27.4	42.0	46.0	50.7	45.0	54.1	46.9	22.1	34.0	25.8	30.2	25.5	187.6	27.5	16.9	28.3	28.7	46.1	45.7	39.0	22.0	27.6	29.4	35.5	31.2	7.2	35.0	38.5	17.6	53.9	40.0	34.8	26.2	24.2	42.1	20.2	33.3	19.1	29.7	13.5	22.2	46.3	43.5	27.1	184.3	162.6	59.8	175.3	205.7	138.7	66.5	127.1	91.2	115.8	105.9	97.6	76.8	87.8	71.9	151.7	69.8	108.8	94.5	151.3	57.8	144.7	175.6	78.0	225.0	112.7	131.7	145.0	67.6	142.9	163.0	131.2	197.7	59.4	90.2	114.5	30.1	156.2	139.7	1.8	88.2	215.2	68.8	101.5	184.4	101.4	59.6	258.3	111.0	36.5	57.6	65.5	123.3	89.5	70.0	32.0	106.9	98.7	68.5	90.0	69.9	96.4	19.2	43.2	71.6	2.5	97.2	123.9	191.8	24.3	39.5	24.2	43.0	39.3	46.2	26.5	62.5	51.3	48.9	21.1	51.7	43.6	10.7	28.7	42.5	35.1	65.5	43.5	25.2	25.3	26.2	27.1	25.8	30.2	28.3	28.7	29.4	26.2	33.3	27.1	11.0	3.2	13.6	6.8	12.3	18.4	16.8	24.6	14.2	10.1	26.8	18.9	9.2	15.7	12.1	7.3	0.0	44.8	10.7	33.0	0.0	33.0	0.9	7.0	23.7	14.4	10.3	23.5	5.6	33.5	98.7	29.2	18.3	10.1	7.0	19.4	13.9	97.5	38.8	5.0	6.4	28.2	12.2	10.5	7.8	1.8	27.4	10.8	19.6	5.6	9.5	13.8	14.4	5.0	4.4	32.1	31.5	25.6	22.4	25.9	58.4	13.7	6.8	7.7	19.7	12.1	23.9	6.0	10.3	40.0	21.5	36.5	13.6	26.2	47.3	16.1
SIRPB1	"CD172b, SIRP-BETA-1"	ENSG00000101307	"Signal regulatory protein beta 1"	"O00241, Q5TFQ8"	20	1561385-1620061	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 52.2;lung: 19.4;lymphoid tissue: 28.6"	"Cell type enhanced"	"Detected in some"		"dendritic cells: 10.9;Hofbauer cells: 14.7;Kupffer cells: 29.4;Macrophages: 30.9;monocytes: 26.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 1594.8"	"Group enriched"	"Detected in all"	6	"granulocytes: 1594.8;monocytes: 502.2"	"Group enriched"	"Detected in some"	4	"HMC-1: 54.0;NB-4: 76.2;THP-1: 58.9"									HPA047463	Uncertain		Uncertain	Vesicles,Centrosome		NA	NA		44000000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 24: NB-4 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles	Centrosome	"HPA047463: AB_2680057"	"unprognostic (1.88e-2)"	"unprognostic (6.19e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.24e-1)"	"unprognostic (5.38e-2)"	"unprognostic (1.60e-1)"	"unprognostic (4.40e-2)"	"unprognostic (7.18e-2)"	"unprognostic (4.11e-3)"	"unprognostic (9.12e-2)"	"unprognostic (6.31e-2)"	"unprognostic (4.57e-2)"	"unprognostic (2.65e-3)"	"unprognostic (5.76e-2)"	"unprognostic (2.39e-3)"	"unprognostic (5.00e-3)"	"unprognostic (1.19e-2)"	5.4	1.6	1.3	28.6	1.3	52.2	1.9	1.2	4.2	1.2	0.1	2.1	1.5	0.8	0.8	1.3	2.2	11.2	1.6	1.4	0.8	1.2	3.1	19.4	11.0	0.7	0.8	0.7	1.3	0.3	0.6	2.8	1.3	0.8	1.8	1.2	1.7	0.9	0.8	0.8	2.8	3.2	0.9	24.5	1.5	0.6	2.1	4.5	0.9	1.5	4.3	8.1	0.8	1.9	0.2	0.0	0.2	0.1	0.3	0.5	0.2	0.4	0.1	0.2	0.0	0.2	0.1	0.1	0.8	0.4	7.1	0.3	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	0.2	14.9	54.0	0.1	0.2	0.3	0.0	8.0	0.5	1.1	0.0	0.2	0.4	0.1	0.0	76.2	0.2	0.0	3.3	0.2	0.0	0.1	10.8	0.3	0.1	0.2	0.2	0.0	0.5	0.0	0.0	58.9	1.6	0.7	0.1	0.4	0.3	0.1	0.1	0.1	1.1	13.4	0.2	6.1	502.2	868.9	7.3	419.7	10.3	2.8	6.5	5.7	175.2	3.4	8.8	5.5	1594.8	8.2	357.6	165.7	11.8	287.0	1.3	1.3	1.2	4.2	1.4	0.8	0.7	0.8	1.3	0.9	2.1	1.9	0.6	3.2	5.2	0.3	1.2	0.0	0.1	0.2	0.6	0.2	0.1	0.0	0.5	0.0	1.6	0.0	0.0	0.2	10.9	0.1	0.0	0.1	0.1	0.0	0.0	0.2	0.0	1.3	0.3	0.0	0.1	0.7	0.0	0.2	7.0	0.0	1.8	0.2	14.7	0.0	0.1	0.0	0.0	29.4	0.0	0.0	0.0	30.9	0.0	0.0	26.7	0.1	0.0	0.5	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	1.8	0.0	0.0	0.0
SLC10A1	NTCP	ENSG00000100652	"Solute carrier family 10 member 1"	Q14973	14	69775416-69797241	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	164	"liver: 426.9"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 147.2"	"Cancer enriched"	"Detected in some"	79	"liver cancer: 65.2"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042727	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"			"HPA042727: AB_10960691"	"unprognostic (3.42e-1)"	"unprognostic (9.39e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.93e-2)"	"unprognostic (6.51e-3)"	"prognostic favorable (9.53e-6)"	"unprognostic (6.07e-3)"	"unprognostic (8.95e-2)"	"unprognostic (2.17e-1)"	"unprognostic (5.75e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.21e-1)"	"unprognostic (2.45e-1)"	"unprognostic (5.69e-2)"	0.0	0.0	0.4	0.1	0.5	0.3	0.0	2.5	1.2	0.0	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.8	0.4	0.1	426.9	0.0	0.0	0.4	0.4	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.4	0.5	2.5	1.2	0.8	0.4	0.4	0.4	0.3	0.0	0.5	0.5	0.4	0.0	0.0	1.3	0.6	0.1	0.1	0.4	0.0	0.6	0.2	0.1	0.5	5.7	0.2	0.0	0.0	0.2	1.4	0.0	0.0	0.0	1.1	0.1	0.6	0.7	0.0	2.7	4.2	0.0	0.1	0.6	0.5	0.6	0.0	0.1	1.4	147.2	0.1	0.0	2.7	0.0	2.0	3.8	0.0	5.4	0.0	0.3	0.0	2.8	0.0	0.2	0.0	3.0	2.4	0.0	0.1	0.0	0.5	0.1	0.2	0.0	0.1	0.2	0.0	3.4	0.7	0.1	0.0	0.2	0.0	0.3	1.7	0.2	0.0	0.1
SLC10A2	"ASBT, ISBT"	ENSG00000125255	"Solute carrier family 10 member 2"	Q12908	13	103043998-103066417	"Disease related genes, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"intestine: 80.8"	"Cell type enriched"	"Detected in some"	29	"Proximal enterocytes: 371.2"	"Cancer enriched"	"Detected in single"	11	"renal cancer: 4.3"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA004795	Approved					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 45: Enterocytes - Digestion"			"HPA004795: AB_1856953"											"unprognostic (2.82e-2)"		"prognostic favorable (5.78e-5)"	"unprognostic (1.64e-2)"	"unprognostic (1.29e-1)"			0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.3	0.2	0.0	0.0	0.4	23.8	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.2	16.9	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	80.8	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.2	0.0	0.2	0.5	0.3	0.5	0.1	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.0	0.0	371.2	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.1
SLC10A3	"DXS253E, P3"	ENSG00000126903	"Solute carrier family 10 member 3"	P09131	X	154487306-154490690	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 63.6;Syncytiotrophoblasts: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	10	"basophil: 218.6"	"Lineage enriched"	"Detected in all"	17	"granulocytes: 218.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021656	Approved		Approved	"Intermediate filaments"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 51: Myeloid cells - Hemostasis"	"Intermediate filaments"		"HPA021656: AB_1856955"	"unprognostic (1.60e-1)"	"prognostic favorable (4.53e-4)"	"prognostic unfavorable (4.15e-5)"	"unprognostic (8.00e-3)"	"prognostic unfavorable (9.97e-4)"	"unprognostic (5.47e-2)"	"unprognostic (2.28e-3)"	"unprognostic (9.76e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (7.22e-4)"	"unprognostic (3.42e-1)"	"unprognostic (2.52e-3)"	"unprognostic (6.23e-2)"	"unprognostic (2.99e-1)"	"unprognostic (7.29e-2)"	"unprognostic (2.99e-2)"	23.3	22.9	6.1	13.1	6.2	34.0	21.0	6.8	7.9	27.1	5.8	22.5	13.9	29.6	18.4	31.2	22.8	21.3	23.2	5.9	6.1	20.6	10.3	22.7	15.1	7.4	6.8	40.8	22.8	9.6	18.8	21.1	7.4	22.9	8.3	2.0	17.4	15.7	18.3	42.9	18.7	13.5	6.9	19.3	18.9	8.9	8.1	9.8	20.6	9.4	11.2	31.8	26.0	7.7	66.4	27.0	7.3	38.3	25.2	27.6	48.9	49.2	29.2	32.5	32.3	25.0	31.8	51.0	91.1	46.8	41.3	55.9	24.4	24.7	8.6	32.7	11.8	15.9	36.0	20.3	47.0	19.0	24.9	34.8	28.1	29.9	15.8	28.5	22.6	8.7	17.6	48.6	21.6	90.0	10.2	17.0	5.9	32.4	54.9	16.8	19.9	38.8	24.7	24.2	6.8	12.0	29.8	55.4	13.0	8.5	17.9	15.0	29.5	38.0	23.9	89.6	63.2	34.3	35.6	52.8	40.9	39.6	20.2	218.6	4.5	21.1	12.9	6.5	9.6	5.3	8.5	9.2	3.9	5.2	6.0	5.9	6.1	8.8	5.6	9.5	6.4	6.3	6.1	6.2	6.8	7.9	5.9	6.1	7.4	6.8	7.4	6.9	8.1	7.7	13.3	3.2	7.0	2.3	21.1	22.6	27.1	15.2	50.7	2.8	13.7	11.8	4.0	15.7	7.3	18.4	6.2	49.5	17.4	22.1	7.9	17.8	3.6	13.0	14.8	15.8	10.2	11.1	1.6	19.4	63.6	21.2	13.7	21.0	12.7	15.8	16.8	2.3	19.4	3.3	1.4	15.5	4.1	8.4	19.6	1.2	27.1	22.7	3.6	1.0	13.2	3.0	23.7	1.5	1.6	20.9	16.0	13.2	19.8	14.1	17.2	10.4	6.9	1.9	6.6	12.1	14.3	1.9	2.9	45.5	27.8	103.0	24.5	5.4	11.7	23.5
SLC10A4	MGC29802	ENSG00000145248	"Solute carrier family 10 member 4"	Q96EP9	4	48483343-48489526	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 36.8"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 16.2"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 1.8;glioma: 5.9"	"Region enhanced"	"Detected in many"		"midbrain: 36.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 9.2;HEL: 5.3;K-562: 13.1;SH-SY5Y: 32.1"	"Group enriched"	"Detected in many"	4	"basal ganglia: 26.2;hypothalamus: 10.7;midbrain: 26.5;pons and medulla: 13.2;thalamus: 8.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 14.2;midbrain: 56.7;pons: 23.5;spinal cord: 44.7"	HPA028835	Uncertain	Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA028835: AB_10603025"	"unprognostic (4.06e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.05e-3)"	"unprognostic (2.49e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.67e-1)"	"unprognostic (1.86e-1)"	"unprognostic (4.08e-3)"	"unprognostic (9.98e-3)"	"unprognostic (1.46e-1)"	"unprognostic (3.50e-1)"	"unprognostic (5.14e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.72e-1)"	"unprognostic (8.73e-2)"	0.1	2.7	0.5	0.2	1.8	1.1	0.1	0.0	4.6	0.9	0.0	1.1	0.1	0.1	0.0	0.0	0.1	0.0	0.3	0.2	9.0	0.2	0.1	0.2	0.0	8.6	36.8	0.1	0.1	0.0	6.7	0.0	23.3	0.2	0.1	0.1	1.4	0.0	0.1	0.1	0.4	0.1	0.6	0.1	0.5	0.4	3.8	0.0	0.4	0.0	0.0	0.1	0.6	2.6	0.0	3.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	1.0	0.0	9.2	0.0	0.1	0.0	2.8	5.3	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.1	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.9	32.1	0.4	0.0	0.1	0.3	0.0	4.3	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.8	0.0	4.6	0.2	9.0	8.6	36.8	23.3	0.6	3.8	2.6	0.4	0.0	3.2	0.0	0.0	0.4	0.1	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.1	1.7	0.1	0.2	0.4	0.0	3.0	0.6	0.0	0.3	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	16.2	0.0	0.0	0.0	0.4	2.4	0.3	0.0	0.0	1.0	0.1	0.0	0.0	4.0	0.5	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.2	0.5	0.7	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0
SLC10A5		ENSG00000253598	"Solute carrier family 10 member 5"	Q5PT55	8	81693631-81695058	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"intestine: 3.9;liver: 11.3"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 4.1;Enteroendocrine cells: 3.6;Gastric mucus-secreting cells: 6.1;Hepatocytes: 2.8;Proximal enterocytes: 7.2;Respiratory ciliated cells: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"OE19: 3.6"	"Not detected"	"Not detected"							HPA025966	Uncertain		Approved	"Plasma membrane"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"		"HPA025966: AB_1856959"	"unprognostic (6.42e-2)"	"unprognostic (3.89e-1)"	"unprognostic (1.25e-2)"	"unprognostic (2.34e-2)"	"unprognostic (8.13e-3)"	"unprognostic (1.91e-1)"	"unprognostic (5.71e-2)"	"unprognostic (5.63e-2)"	"unprognostic (3.67e-1)"	"unprognostic (2.41e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.22e-1)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.82e-7)"	0.1	0.2	0.9	0.3	0.9	0.0	0.2	1.8	1.4	0.3	0.0	2.8	3.2	0.3	0.7	0.3	0.3	1.7	0.2	0.8	0.9	1.8	11.3	0.2	0.0	0.6	0.7	0.3	1.0	0.2	1.0	0.0	0.7	0.6	3.7	0.5	0.3	0.2	0.2	0.4	3.9	0.2	0.2	0.3	3.4	0.1	1.0	0.1	0.5	0.3	0.2	0.3	0.2	0.8	0.2	0.2	0.2	0.3	0.2	0.5	0.2	0.2	0.1	0.2	0.1	0.2	0.1	0.4	0.5	0.0	0.0	0.2	0.3	0.1	0.2	0.2	0.8	0.6	1.3	0.5	0.1	0.0	0.1	0.1	0.6	0.2	0.8	0.6	0.1	0.2	0.5	0.3	0.3	0.2	0.2	0.4	0.0	3.6	0.2	0.0	0.1	0.2	0.2	1.4	0.5	0.3	0.1	0.2	0.1	0.1	0.5	0.1	0.3	0.3	0.5	0.4	0.5	0.3	0.9	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	1.8	1.4	0.8	0.9	0.6	0.7	0.7	0.2	1.0	0.8	0.2	0.0	0.0	0.3	0.1	0.0	0.1	0.2	0.0	0.3	0.3	0.3	0.6	0.0	0.5	0.0	0.0	0.0	0.0	4.1	1.9	0.4	0.0	0.4	0.3	0.2	3.6	0.0	0.9	1.1	0.1	0.1	6.1	0.3	0.0	0.3	0.7	2.8	0.0	0.0	0.8	1.5	2.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.5	1.9	0.0	0.0	0.4	7.2	1.7	4.1	0.2	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.5	2.4	0.5
SLC10A6	SOAT	ENSG00000145283	"Solute carrier family 10 member 6"	Q3KNW5	4	86823468-86849384	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 9.1;skin 1: 13.4"	"Group enriched"	"Detected in some"	5	"Early spermatids: 59.5;Late spermatids: 191.7"	"Group enriched"	"Detected in many"	5	"cervical cancer: 3.5;head and neck cancer: 6.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 1.5;BJ hTERT+: 1.2;HaCaT: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA016662	Enhanced					NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA016662: AB_1669899"	"unprognostic (2.79e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.05e-1)"	"unprognostic (8.31e-3)"	"unprognostic (5.88e-2)"	"unprognostic (8.87e-3)"	"unprognostic (1.32e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (3.84e-4)"	"unprognostic (1.54e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.22e-2)"	"unprognostic (5.89e-4)"	5.2	0.3	0.1	0.7	0.3	0.0	2.8	0.1	0.2	3.1	0.0	0.4	0.1	0.5	0.3	9.1	0.6	1.0	0.7	0.1	0.4	0.1	0.1	0.3	0.1	0.2	0.3	0.1	0.7	0.6	0.2	0.1	0.3	0.4	0.3	0.0	1.5	0.2	0.7	13.4	0.2	1.0	0.1	0.2	0.3	4.3	0.9	0.3	1.0	1.1	1.2	0.9	4.7	0.7	0.0	0.0	0.0	0.0	0.5	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.2	0.1	0.4	0.2	0.3	0.3	0.1	0.9	0.7	9.3	0.0	0.0	6.2	0.0	13.8	0.0	0.8	0.0	0.0	0.4	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	59.5	1.7	1.0	2.6	0.0	0.0	2.5	0.0	0.1	0.6	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	1.2	191.7	1.5	0.1	0.0	2.8	0.0	0.0	0.0	3.5	4.8	0.1	0.0	0.4	1.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	1.2	1.2	0.6	6.0	24.9	0.0	0.0	0.0	0.0	0.2
SLC10A7	"C4orf13, DKFZp313H0531, DKFZp566M114, DKFZp779O2438, MGC25043"	ENSG00000120519	"Solute carrier family 10 member 7"	Q0GE19	4	146253975-146521964	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 44.4;Microglial cells: 50.6;Oligodendrocyte precursor cells: 62.4;Oligodendrocytes: 82.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039996	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA039996: AB_10673266"	"unprognostic (9.44e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.39e-3)"	"unprognostic (5.07e-2)"	"unprognostic (1.01e-1)"	"unprognostic (9.02e-2)"	"unprognostic (7.96e-2)"	"unprognostic (2.54e-1)"	"unprognostic (3.55e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-2)"	"unprognostic (8.99e-2)"	"unprognostic (2.79e-1)"	"unprognostic (6.69e-2)"	"unprognostic (9.57e-2)"	5.4	4.6	2.6	4.9	4.0	6.0	6.0	3.2	2.6	7.2	1.7	7.0	4.6	4.9	12.0	5.8	4.4	5.6	2.9	2.9	3.6	3.8	7.2	5.9	5.6	4.6	3.8	5.6	6.5	3.7	3.6	8.9	4.9	6.3	9.2	3.9	6.9	3.3	2.2	3.7	5.4	5.9	3.8	5.3	9.7	3.4	3.5	6.5	7.0	3.2	5.9	4.7	4.8	5.1	5.2	1.7	12.2	5.0	8.6	10.3	5.8	6.3	8.2	5.7	5.8	4.7	21.6	9.6	4.4	6.9	3.6	5.2	7.2	8.6	6.8	11.1	3.5	11.8	4.2	8.5	5.5	20.5	18.3	4.9	6.8	6.9	8.7	3.1	10.2	10.2	13.2	25.6	4.3	3.6	15.6	5.2	2.2	11.4	8.6	8.6	8.9	13.7	4.0	3.8	3.7	3.1	4.3	12.8	5.3	6.4	7.5	8.1	5.8	5.1	5.4	7.8	4.4	20.7	24.9	13.4	7.0	8.2	7.4	10.9	3.0	4.5	3.7	4.8	3.8	3.9	3.7	3.3	4.0	2.8	3.5	3.4	0.3	5.1	3.9	2.7	4.9	2.2	2.6	4.0	3.2	2.6	2.9	3.6	4.6	3.8	4.9	3.8	3.5	5.1	10.8	3.2	3.9	44.4	7.9	3.3	4.2	2.0	2.8	6.8	5.2	3.7	2.1	8.6	3.2	1.8	4.2	6.4	8.2	6.2	1.9	4.0	2.3	4.8	6.2	5.4	4.8	9.9	34.3	5.1	13.2	6.1	11.2	6.0	22.9	5.8	8.9	10.3	5.8	8.4	37.1	14.7	2.0	7.3	3.1	1.2	7.5	6.1	0.0	50.6	4.9	3.4	6.2	62.4	82.0	3.6	3.4	4.9	15.8	3.3	4.2	1.9	7.3	11.8	0.0	4.0	5.5	7.0	4.5	5.2	4.8	6.2	8.6	2.3	7.6	4.1
SLC11A1	"LSH, NRAMP, NRAMP1"	ENSG00000018280	"Solute carrier family 11 member 1"	P49279	2	218382029-218396894	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 78.6;lymphoid tissue: 46.6"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 108.0;Kupffer cells: 166.8;Macrophages: 209.4;monocytes: 101.2"	"Cancer enhanced"	"Detected in many"		"glioma: 7.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	7	"classical monocyte: 6.1;intermediate monocyte: 4.5;myeloid DC: 1.9;neutrophil: 4.1;non-classical monocyte: 6.0"	"Group enriched"	"Detected in many"	11	"dendritic cells: 1.9;granulocytes: 4.1;monocytes: 6.1"	"Cell line enhanced"	"Detected in some"		"HEL: 1.2;HMC-1: 1.0"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA029590, HPA050378, HPA068540"	Uncertain		Approved	Nucleoli,Mitochondria		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Mitochondria	Nucleoli	"HPA029590: AB_10794613, HPA050378: , HPA068540: "	"unprognostic (2.64e-1)"	"unprognostic (3.05e-2)"	"unprognostic (1.46e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.83e-2)"	"unprognostic (1.04e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.58e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (2.58e-8)"	"unprognostic (9.55e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.78e-2)"	"unprognostic (1.08e-2)"	14.1	8.5	3.5	7.1	4.3	6.7	4.9	3.9	11.1	2.7	4.7	3.5	0.2	2.2	0.1	1.6	7.4	1.0	8.0	3.3	5.0	3.4	5.1	78.6	0.2	7.4	5.2	1.7	3.2	0.3	3.1	2.7	6.9	3.2	0.0	0.6	3.2	0.1	1.7	1.5	2.2	1.9	5.2	46.6	3.0	0.9	17.3	0.3	2.7	1.3	0.0	7.2	2.4	7.4	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	1.2	0.2	0.2	0.0	0.0	1.0	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.2	0.0	0.4	0.0	0.9	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.1	0.3	6.1	0.6	0.3	4.5	0.2	0.1	0.2	0.1	1.9	0.2	0.3	0.2	4.1	0.2	6.0	0.2	0.2	2.0	3.5	4.3	3.9	11.1	3.3	5.0	7.4	5.2	6.9	5.2	17.3	7.4	1.5	22.4	38.5	1.6	4.1	0.9	4.3	1.9	1.2	3.1	4.5	4.6	8.6	2.8	13.8	9.2	0.0	1.8	3.1	1.8	9.8	1.3	1.8	6.1	2.3	17.0	1.2	1.7	1.3	2.1	7.8	5.8	2.0	2.8	25.3	0.9	6.8	7.3	108.0	1.7	0.9	4.0	6.1	166.8	6.3	0.5	2.1	209.4	1.8	4.7	101.2	12.9	10.3	0.5	1.4	0.4	1.6	0.7	5.6	3.9	2.5	11.7	11.0	3.3	19.7	2.9	4.2	0.8	1.8	2.1	1.0	8.1	6.7	3.3	2.9	3.3
SLC11A2	"DCT1, DMT1, NRAMP2"	ENSG00000110911	"Solute carrier family 11 member 2"	P49281	12	50979401-51028566	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 109.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032139, HPA032140"	Uncertain		Supported	Mitochondria		No	No			"Cluster 27: Non-specific - Gene expression"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Mitochondria		"HPA032139: AB_10964213, HPA032140: AB_10962932"	"unprognostic (4.40e-3)"	"unprognostic (1.41e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.07e-3)"	"unprognostic (2.35e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.07e-6)"	"unprognostic (1.06e-2)"	"unprognostic (1.99e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.28e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.20e-2)"	"unprognostic (2.61e-1)"	"unprognostic (2.32e-2)"	"unprognostic (2.24e-1)"	12.1	17.0	12.8	14.0	21.6	15.9	30.3	19.6	18.1	29.3	12.7	16.4	53.8	15.7	17.6	23.9	21.4	17.7	14.7	13.2	16.5	22.5	25.6	23.2	10.3	22.8	18.3	12.8	22.6	42.5	10.9	23.7	22.9	24.4	16.2	23.1	31.2	19.3	18.4	20.3	13.8	15.3	19.1	8.7	17.8	13.3	18.5	19.2	41.6	20.3	17.2	20.4	13.9	31.1	19.0	22.4	31.4	28.7	33.5	28.6	106.3	19.7	73.9	19.0	21.8	30.6	35.3	11.8	38.8	22.8	35.7	25.3	26.6	19.2	21.9	17.1	17.4	27.4	29.2	35.5	35.7	19.0	54.5	31.6	24.3	32.7	35.1	45.6	22.8	23.6	24.4	5.6	22.4	21.7	21.8	12.9	46.6	19.8	15.5	14.7	28.6	21.1	23.4	27.7	21.6	19.0	16.3	47.1	20.9	36.2	50.8	12.6	26.8	19.2	15.8	21.5	10.9	14.1	20.4	4.7	54.1	10.2	8.3	0.6	4.7	1.9	4.2	6.8	3.7	2.6	3.3	4.3	7.0	3.3	4.6	4.3	2.3	6.0	4.8	2.9	2.9	3.4	12.8	21.6	19.6	18.1	13.2	16.5	22.8	18.3	22.9	19.1	18.5	31.1	9.8	38.5	46.1	32.7	6.9	15.4	24.8	84.0	22.2	26.6	37.6	18.5	15.5	25.8	69.4	57.0	18.8	27.0	11.9	14.0	3.9	30.6	1.5	31.7	11.6	13.1	16.4	64.8	33.6	28.3	22.5	17.3	15.3	43.6	71.4	20.1	11.4	41.3	35.2	28.6	38.1	14.3	42.7	16.9	25.4	1.7	9.6	30.1	26.6	26.2	15.7	26.5	6.2	51.8	94.5	20.6	15.0	8.6	8.2	47.8	13.2	9.0	109.6	17.8	6.6	14.2	13.2	9.0	12.2	14.3	13.4	19.4	10.7	10.4	15.0	23.1
SLC12A1	NKCC2	ENSG00000074803	"Solute carrier family 12 member 1"	Q13621	15	48178438-48304078	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"Bartter syndrome, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	878	"kidney: 705.6"	"Cell type enriched"	"Detected in some"	5	"Distal tubular cells: 209.4"	"Cancer enriched"	"Detected in single"	4	"renal cancer: 1.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	26	"RPTEC TERT1: 25.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA014967, HPA018107"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 39: Non-specific - Basic cellular processes"	Vesicles	Nucleoplasm	"HPA014967: AB_1854503, HPA018107: AB_1854504"	"unprognostic (3.52e-2)"	"unprognostic (1.30e-2)"		"unprognostic (9.65e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-1)"	"unprognostic (8.72e-2)"	"unprognostic (2.06e-1)"	"unprognostic (9.85e-3)"	"unprognostic (2.81e-4)"	"unprognostic (9.75e-2)"	"unprognostic (2.61e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.03e-1)"	"unprognostic (5.20e-4)"	"unprognostic (8.52e-2)"	0.1	0.0	0.3	0.1	0.2	0.2	0.1	0.5	0.4	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.6	705.6	0.4	0.0	0.0	0.5	0.6	0.0	0.0	0.0	0.1	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.5	0.4	0.2	0.6	0.5	0.6	0.4	0.2	0.3	0.1	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.7	0.0	0.0	38.6	0.0	0.0	0.0	0.0	209.4	0.0	13.5	0.0	0.0	0.0	0.0	0.0	9.7	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	13.2	0.3	0.1	0.0	1.0	0.0	0.0	0.0	1.5	1.6	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.2	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC12A2	"BSC, BSC2, NKCC1, PPP1R141"	ENSG00000064651	"Solute carrier family 12 member 2"	P55011	5	128083766-128189677	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 75.6"	"Cell type enhanced"	"Detected in all"		"Intestinal goblet cells: 480.6;Oligodendrocytes: 566.6;Undifferentiated cells: 370.0"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 54.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 6.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"OE19: 153.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA020130, HPA063697"	Approved		Approved	"Vesicles,Plasma membrane"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	Vesicles	"Plasma membrane"	"HPA020130: AB_1854502, HPA063697: AB_2685094"	"unprognostic (4.61e-2)"	"unprognostic (2.63e-1)"	"unprognostic (4.20e-3)"	"prognostic favorable (8.60e-4)"	"unprognostic (3.99e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.44e-3)"	"unprognostic (1.81e-1)"	"unprognostic (3.30e-1)"	"unprognostic (2.95e-2)"	"unprognostic (7.22e-2)"	"unprognostic (1.39e-1)"	"prognostic favorable (7.09e-4)"	"unprognostic (1.63e-1)"	"unprognostic (2.30e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.88e-3)"	8.4	17.5	15.0	10.8	48.4	4.4	43.9	46.3	23.2	7.2	40.4	48.5	41.7	8.4	2.4	4.6	6.0	39.4	6.1	13.5	31.1	6.6	4.2	10.3	5.6	40.8	43.1	5.4	6.1	14.7	5.5	4.9	38.6	23.5	58.9	16.8	75.6	2.6	15.4	28.4	49.1	10.2	27.1	4.5	61.8	8.0	32.4	4.1	8.6	8.3	6.0	7.3	3.5	64.8	13.5	65.3	65.8	25.6	16.1	10.4	13.6	12.2	9.1	8.6	8.9	26.4	20.9	19.9	16.1	10.6	7.8	39.5	12.7	14.0	13.2	20.0	15.8	5.7	11.4	3.8	4.9	7.3	9.5	11.1	5.0	19.1	11.2	6.4	14.2	8.5	9.4	13.2	13.4	14.2	13.0	6.1	7.7	153.6	21.1	7.1	18.5	8.2	10.0	45.0	11.5	7.3	24.6	10.6	9.9	7.0	5.9	3.7	24.1	21.2	14.2	16.3	15.7	11.0	10.7	21.6	11.2	4.2	17.6	0.3	0.4	0.2	1.1	0.7	1.9	1.7	1.0	1.4	0.6	2.1	1.1	1.6	0.2	2.4	0.5	6.4	1.1	0.3	15.0	48.4	46.3	23.2	13.5	31.1	40.8	43.1	38.6	27.1	32.4	64.8	38.3	16.0	46.2	23.8	20.5	22.9	20.1	44.9	10.8	76.6	186.9	86.7	18.0	137.2	52.1	33.1	127.2	1.4	34.4	48.2	1.9	68.6	55.8	33.1	43.1	44.2	74.4	2.5	160.6	48.2	2.7	21.3	199.3	38.4	18.4	28.8	12.8	8.8	4.2	80.8	73.2	480.6	57.0	8.6	12.0	95.3	85.4	11.4	204.5	105.9	2.5	22.6	11.3	55.3	566.6	50.1	60.6	29.0	20.2	131.6	38.8	10.6	19.6	86.4	72.3	33.9	64.3	29.1	27.1	14.9	30.0	1.4	21.1	14.1	370.0	21.5
SLC12A3	NCCT	ENSG00000070915	"Solute carrier family 12 member 3"	P55017	16	56865207-56915850	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	101	"kidney: 101.7"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 3.7;dendritic cells: 4.2;Distal tubular cells: 5.9;Endometrial ciliated cells: 2.1;Glandular and luminal cells: 4.7;monocytes: 4.2"	"Cancer enhanced"	"Detected in some"		"renal cancer: 2.5"	"Low region specificity"	"Detected in single"			"Immune cell enriched"	"Detected in single"	20	"plasmacytoid DC: 14.9"	"Lineage enriched"	"Detected in single"	20	"dendritic cells: 14.9"	"Group enriched"	"Detected in some"	11	"BEWO: 7.0;HAP1: 4.0;HeLa: 8.9;SuSa: 2.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA028748	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA028748: AB_10603886"	"unprognostic (1.54e-3)"	"unprognostic (7.09e-5)"	"unprognostic (1.35e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.91e-1)"	"unprognostic (2.38e-4)"	"unprognostic (1.81e-1)"	"unprognostic (9.70e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.25e-2)"	"unprognostic (6.84e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.70e-1)"	0.0	0.0	0.3	0.4	0.8	0.0	0.1	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	101.7	0.0	0.1	0.8	0.2	0.2	0.0	0.2	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.1	0.0	0.2	0.4	0.0	0.0	0.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	4.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	14.9	0.0	0.1	0.3	0.8	0.0	1.0	0.6	0.0	0.2	0.2	0.3	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	3.7	0.0	0.0	4.2	0.0	5.9	0.0	0.4	2.1	0.4	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.3	0.0	0.9	0.0	0.0	4.2	0.0	0.0	1.0	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
SLC12A4	KCC1	ENSG00000124067	"Solute carrier family 12 member 4"	Q9UP95	16	67943474-67969601	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 63.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 7.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041138	Approved		Approved	Endosomes		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Endosomes		"HPA041138: AB_10794544"	"unprognostic (5.07e-2)"	"unprognostic (6.18e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.68e-2)"	"unprognostic (9.28e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.28e-2)"	"unprognostic (3.26e-3)"	"unprognostic (9.58e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.01e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (2.25e-6)"	"unprognostic (6.42e-2)"	"unprognostic (1.42e-1)"	"unprognostic (7.64e-2)"	"unprognostic (2.26e-1)"	30.2	29.1	11.0	11.8	13.6	5.0	28.9	15.2	10.9	33.5	60.6	32.4	7.2	34.0	8.6	13.0	27.5	14.7	46.1	10.8	13.7	20.2	17.4	34.7	9.4	17.5	17.0	23.9	19.1	23.2	13.0	27.2	14.8	30.4	5.8	3.7	18.0	26.8	20.9	24.3	16.5	27.3	14.9	15.4	18.6	12.3	14.8	12.0	35.4	16.8	5.7	27.3	23.2	15.3	13.4	17.5	13.3	25.3	43.0	37.5	71.6	39.9	41.1	33.5	29.1	35.2	20.8	4.7	19.3	55.3	18.7	23.7	6.2	49.2	25.2	4.8	5.3	3.4	23.4	38.9	48.7	0.4	16.0	41.6	31.6	45.3	16.3	39.1	21.0	8.6	10.9	3.8	46.6	2.1	5.2	13.3	10.0	3.8	9.2	5.3	25.1	4.4	18.5	11.4	0.1	8.0	76.1	4.5	6.8	32.8	35.8	5.4	28.8	47.6	33.4	21.4	17.6	23.2	6.3	8.0	27.9	3.6	42.1	7.1	2.5	1.2	0.8	3.3	0.5	0.3	0.5	0.5	1.4	0.5	0.4	0.4	0.9	1.9	2.4	0.7	0.9	1.1	11.0	13.6	15.2	10.9	10.8	13.7	17.5	17.0	14.8	14.9	14.8	15.3	25.8	16.0	9.1	10.4	2.4	10.1	15.8	13.3	17.6	1.2	3.9	6.6	26.9	2.8	10.6	14.7	0.0	30.1	2.2	0.5	0.0	13.7	3.5	4.0	10.7	15.6	0.0	2.5	0.2	8.3	16.4	19.5	3.1	3.2	1.3	10.9	12.1	10.3	8.0	0.0	0.3	0.1	24.4	5.3	4.3	2.7	19.9	4.2	10.6	4.7	11.4	20.5	3.1	2.0	0.7	15.5	0.1	36.5	10.8	16.9	0.1	5.3	8.3	1.0	39.5	17.3	23.1	12.0	9.1	2.4	5.3	63.5	2.6	13.9	0.2	12.9
SLC12A5	"KCC2, KIAA1176"	ENSG00000124140	"Solute carrier family 12 member 5"	Q9H2X9	20	46021690-46060150	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 145.8;retina: 117.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 244.0;Cone photoreceptor cells: 383.7;Excitatory neurons: 92.7;Inhibitory neurons: 91.3;Rod photoreceptor cells: 170.9"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 2.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"Hep G2: 24.9;NB-4: 50.8;SK-BR-3: 24.8;U-2 OS: 28.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072058	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 9: Photoreceptor cells - Phototransduction"			"HPA072058: AB_2686485"	"unprognostic (2.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (7.55e-2)"	"unprognostic (9.44e-4)"	"prognostic unfavorable (5.60e-4)"	"unprognostic (2.48e-1)"	"unprognostic (5.16e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.49e-1)"	"unprognostic (6.63e-2)"	"unprognostic (3.72e-3)"	"unprognostic (5.61e-4)"	"unprognostic (8.78e-4)"	"unprognostic (3.25e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.99e-1)"	"unprognostic (2.34e-2)"	1.5	26.7	101.3	0.9	103.5	0.4	1.0	97.6	145.8	0.9	14.9	1.4	1.0	0.7	0.9	0.4	0.5	0.7	5.1	107.0	96.6	1.1	1.2	2.5	2.2	76.3	80.5	2.3	2.2	1.8	41.5	2.0	69.9	1.0	0.9	117.4	0.7	0.5	0.4	0.6	1.6	0.4	69.3	3.0	1.9	7.8	86.7	2.9	0.7	0.2	1.4	0.6	0.7	88.4	0.0	15.2	6.6	4.9	0.6	0.0	1.5	0.6	0.0	0.0	0.5	2.0	0.0	5.8	22.5	0.4	5.9	1.4	4.3	2.3	0.4	3.7	5.7	4.9	3.0	24.9	2.5	0.0	6.5	0.8	0.0	0.0	0.3	10.0	1.4	5.4	9.3	0.0	0.0	23.1	3.5	50.8	2.4	2.1	7.7	5.8	4.2	1.3	2.3	0.0	8.1	11.5	2.9	24.8	7.9	6.0	9.0	14.4	2.3	2.7	28.0	0.2	1.1	0.0	4.2	8.2	5.9	5.9	0.2	0.0	0.6	0.0	1.1	0.4	0.5	0.4	0.1	0.1	0.1	0.5	2.4	1.3	0.0	0.4	0.1	0.0	1.9	0.3	101.3	103.5	97.6	145.8	107.0	96.6	76.3	80.5	69.9	69.3	86.7	88.4	2.2	0.0	0.0	10.4	0.4	0.5	0.0	0.0	0.0	244.0	0.8	2.2	1.2	0.0	0.0	0.0	383.7	1.6	0.9	0.0	1.9	0.1	1.9	0.4	0.1	2.9	19.9	4.4	92.7	0.2	2.5	0.4	1.5	0.6	0.0	14.4	4.6	1.3	19.8	13.5	91.3	0.7	0.0	2.6	5.3	6.1	0.0	3.4	5.4	10.3	0.6	28.2	0.0	3.5	6.3	0.4	0.0	0.0	0.8	0.2	0.0	0.3	0.0	170.9	0.0	0.0	2.2	4.2	7.7	0.1	0.6	1.6	1.0	8.5	0.3	0.1
SLC12A6	"ACCPN, KCC3"	ENSG00000140199	"Solute carrier family 12 member 6"	Q9UHW9	15	34229784-34338060	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"		Neuropathy	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 85.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	6	"basophil: 15.2;neutrophil: 23.4"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 23.4"	"Cell line enhanced"	"Detected in many"		"HaCaT: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034563	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 57: B-cells - Immune response"	"Vesicles, Cytosol"		"HPA034563: AB_10603887"	"unprognostic (3.53e-1)"	"unprognostic (4.82e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.60e-1)"	"unprognostic (3.55e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.68e-1)"	"unprognostic (6.58e-2)"	"unprognostic (1.83e-1)"	"prognostic favorable (3.33e-6)"	"unprognostic (2.39e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.87e-2)"	"unprognostic (1.41e-1)"	6.4	4.0	5.9	11.5	7.4	26.8	5.5	7.2	7.9	11.9	2.5	5.5	7.3	5.2	7.0	18.8	4.6	5.2	7.3	6.5	7.3	15.9	3.9	9.1	10.1	8.9	7.3	4.2	3.5	3.1	5.6	4.3	9.3	3.5	6.1	31.1	6.4	3.8	10.6	7.6	9.1	4.9	6.6	12.9	6.7	25.9	7.7	15.5	9.0	10.9	11.6	8.3	17.6	8.4	4.4	5.2	3.1	4.7	10.0	11.4	2.4	5.9	15.1	4.9	7.1	3.1	7.2	3.1	5.9	7.2	4.3	44.0	7.9	5.3	5.8	1.2	5.1	24.6	14.0	7.0	6.4	14.5	24.6	6.9	9.1	14.1	29.1	10.9	14.9	6.8	5.4	6.8	6.7	1.6	1.6	11.0	2.4	3.8	5.7	7.1	5.5	3.3	5.5	11.2	7.2	5.0	7.1	0.2	1.5	7.1	2.8	4.8	9.4	5.9	4.2	21.0	1.4	6.4	6.8	1.9	6.6	10.5	2.2	15.2	1.4	2.6	0.6	1.8	0.4	1.4	0.9	0.9	0.9	2.4	1.6	1.4	23.4	0.7	0.8	1.0	3.2	1.0	5.9	7.4	7.2	7.9	6.5	7.3	8.9	7.3	9.3	6.6	7.7	8.4	16.4	22.4	21.0	30.0	32.0	1.1	4.5	1.5	7.4	15.3	5.2	4.3	8.7	5.7	4.2	5.5	85.5	3.2	11.5	8.6	0.0	5.6	15.6	9.8	7.4	17.7	6.7	35.9	47.7	4.7	1.6	7.0	17.9	22.4	5.1	8.4	16.1	7.5	13.2	8.4	52.0	7.0	2.0	37.1	3.8	8.3	8.1	25.6	0.0	50.6	34.5	8.7	15.5	40.7	58.4	13.1	9.7	8.6	29.9	6.5	18.3	16.4	4.2	56.6	19.7	7.0	4.0	39.9	21.2	14.8	0.9	1.1	18.0	4.1	7.4	43.6
SLC12A7	"DKFZP434F076, KCC4"	ENSG00000113504	"Solute carrier family 12 member 7"	Q9Y666	5	1050384-1112063	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 77.3"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 281.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"REH: 43.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041652	Approved		Uncertain	Cytosol		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 14: REH - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Cytosol		"HPA041652: AB_10793971"	"unprognostic (2.22e-2)"	"unprognostic (1.56e-1)"	"unprognostic (8.92e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.69e-2)"	"unprognostic (8.72e-2)"	"prognostic unfavorable (2.12e-6)"	"unprognostic (1.67e-1)"	"unprognostic (1.71e-3)"	"unprognostic (4.40e-2)"	"unprognostic (4.50e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.17e-3)"	"unprognostic (1.26e-1)"	"unprognostic (3.93e-2)"	"prognostic favorable (3.16e-5)"	21.1	14.6	8.9	7.2	8.0	4.0	18.8	7.2	10.4	15.8	12.3	24.1	24.0	13.8	1.0	8.0	16.6	12.0	77.3	7.9	12.0	45.1	72.4	23.1	5.7	8.0	10.7	12.3	27.6	4.4	20.5	2.9	8.0	20.7	5.4	5.5	18.9	3.0	6.3	15.8	31.9	3.3	6.8	34.9	28.1	29.9	9.4	7.8	24.7	3.1	2.2	14.5	10.8	7.1	3.8	10.0	5.5	17.3	0.8	0.9	8.7	0.2	1.1	0.8	0.0	24.5	6.4	0.0	20.0	0.3	6.8	7.6	4.6	6.1	0.0	23.0	6.1	4.8	13.4	8.6	12.2	0.0	10.4	1.8	0.8	0.0	1.8	0.3	5.5	2.2	7.6	0.2	0.0	12.0	14.8	0.1	11.9	14.4	16.3	43.9	24.0	20.5	6.5	14.8	3.1	3.8	5.6	0.1	6.0	3.3	9.7	2.7	4.8	0.0	5.7	0.0	0.0	0.3	0.0	2.5	0.0	0.6	2.8	0.2	1.8	0.0	1.1	2.7	1.2	0.6	1.1	1.3	2.1	0.6	1.2	1.2	0.0	1.4	3.8	0.9	1.1	1.3	8.9	8.0	7.2	10.4	7.9	12.0	8.0	10.7	8.0	6.8	9.4	7.1	21.3	9.6	15.2	8.5	7.3	7.0	6.3	8.9	6.8	25.3	18.4	13.8	35.8	31.5	13.6	29.5	2.1	0.2	14.2	42.0	1.9	23.5	0.4	40.9	11.0	27.9	13.2	19.1	0.3	18.1	0.4	11.6	39.8	63.4	8.2	16.6	11.7	34.5	19.8	281.0	0.5	19.4	18.3	28.0	19.8	1.9	3.7	29.0	16.0	14.0	9.1	5.2	5.2	1.5	0.0	28.8	35.8	5.7	5.3	15.7	27.3	23.2	23.1	3.6	19.7	5.2	8.4	1.0	3.4	3.5	6.8	0.3	9.8	5.4	19.3	15.2
SLC12A8	CCC9	ENSG00000221955	"Solute carrier family 12 member 8"	A0AV02	3	125082636-125212864	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 22.9"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Excitatory neurons: 38.4;granulocytes: 17.8;Inhibitory neurons: 27.8;Intestinal goblet cells: 36.6;Oligodendrocyte precursor cells: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 19.6;HHSteC: 33.6;OE19: 27.6;U-2197: 67.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA031123	Uncertain		Approved	Nucleoplasm		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	Nucleoplasm		"HPA031123: AB_2301872"	"unprognostic (4.74e-2)"	"unprognostic (1.46e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.91e-3)"	"unprognostic (7.35e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.07e-1)"	"unprognostic (3.76e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.84e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.13e-2)"	"prognostic unfavorable (5.56e-4)"	"unprognostic (7.18e-2)"	"unprognostic (3.47e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.78e-2)"	1.5	1.1	2.9	1.2	3.2	0.0	2.3	1.0	3.1	1.4	11.7	3.5	5.6	0.6	3.6	4.1	2.0	8.3	0.6	3.4	2.4	3.2	6.8	2.2	0.6	1.6	2.0	0.3	10.0	4.3	2.2	2.7	1.9	2.8	4.2	0.1	11.9	0.6	0.1	1.3	3.6	0.7	1.0	0.3	4.1	2.3	2.0	0.5	22.9	0.0	0.9	2.1	2.2	2.0	14.7	0.0	2.7	0.0	3.3	4.6	6.7	0.8	2.0	0.9	1.7	19.6	6.8	0.0	1.9	5.6	2.8	8.5	0.0	0.0	0.5	0.0	0.0	0.0	7.2	0.0	33.6	0.0	1.0	8.7	8.3	1.9	0.9	16.3	0.0	0.0	0.0	0.6	1.3	3.9	0.0	0.0	9.3	27.6	0.7	0.0	0.2	0.0	6.8	1.3	4.2	0.0	7.0	8.4	0.1	0.9	15.6	0.4	0.2	0.2	1.3	67.9	0.0	0.1	1.9	5.0	3.3	0.0	1.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	3.2	1.0	3.1	3.4	2.4	1.6	2.0	1.9	1.0	2.0	2.0	0.2	0.0	0.5	7.2	0.1	1.0	1.3	3.3	3.4	0.0	5.6	4.3	1.1	2.8	2.5	23.9	0.0	0.5	0.1	1.6	0.0	3.9	0.3	0.8	1.4	0.3	5.4	0.0	38.4	3.5	6.5	2.1	7.7	2.7	17.8	1.8	0.0	9.4	0.9	0.0	27.8	36.6	0.0	0.0	0.7	0.5	0.0	0.5	0.0	7.5	2.1	0.0	1.0	31.7	2.0	2.9	3.4	0.0	0.2	6.2	2.6	1.5	0.4	0.0	0.0	0.2	0.7	0.6	0.4	4.3	0.3	3.0	0.8	0.1	5.6	1.0
SLC12A9	CIP1	ENSG00000146828	"Solute carrier family 12 member 9"	Q9BXP2	7	100826820-100867010	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 90.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 61.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA067536	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA067536: AB_2732768"	"unprognostic (6.53e-2)"	"unprognostic (3.65e-1)"	"unprognostic (8.75e-3)"	"unprognostic (3.11e-3)"	"unprognostic (3.47e-2)"	"unprognostic (2.37e-2)"	"unprognostic (8.38e-3)"	"prognostic favorable (5.97e-4)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.00e-4)"	"unprognostic (2.47e-2)"	"unprognostic (1.03e-2)"	"prognostic unfavorable (4.92e-4)"	"unprognostic (1.52e-2)"	"unprognostic (6.00e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.38e-2)"	6.9	8.1	7.4	8.7	11.2	7.6	6.3	10.7	10.8	8.3	6.5	8.3	7.8	8.2	1.2	7.3	6.7	9.5	4.2	7.3	8.7	7.4	6.8	8.2	7.3	12.5	10.6	6.7	10.5	6.3	3.6	14.0	11.4	8.0	5.6	0.7	7.4	6.4	2.6	7.9	8.3	6.7	10.1	14.1	7.0	2.7	9.3	5.9	5.8	3.1	3.8	9.2	6.1	13.1	16.1	12.4	4.2	33.9	12.4	7.3	42.2	7.9	15.1	11.7	16.6	17.7	26.7	11.5	25.1	15.0	18.8	17.3	7.3	17.6	3.1	12.3	12.1	4.4	13.8	12.6	15.1	5.4	18.0	18.0	9.9	9.3	9.4	9.5	23.2	9.1	10.5	6.1	16.8	49.8	5.7	25.5	8.3	33.3	24.6	13.3	4.2	17.9	11.6	14.3	7.0	15.8	8.7	61.7	16.7	7.0	7.7	19.1	14.5	14.4	14.3	23.8	14.4	3.2	13.7	4.0	10.2	18.0	17.4	0.0	1.5	0.0	0.2	1.8	0.3	0.6	0.1	0.1	2.4	0.6	0.2	0.1	1.4	0.2	1.9	1.2	0.3	0.9	7.4	11.2	10.7	10.8	7.3	8.7	12.5	10.6	11.4	10.1	9.3	13.1	10.6	3.2	16.1	3.9	12.3	11.0	12.0	6.9	10.8	6.6	12.6	11.0	2.1	11.5	10.1	18.4	2.1	90.0	21.7	14.1	0.0	12.7	0.9	5.6	9.1	13.6	11.4	1.7	2.0	13.4	28.2	10.2	18.3	9.5	1.3	14.7	15.7	6.9	31.2	6.7	2.6	13.6	10.2	23.9	18.3	0.7	9.0	27.2	8.8	3.7	24.6	18.7	8.2	6.0	5.8	14.9	23.7	6.4	9.7	8.3	14.7	10.9	4.8	6.7	13.1	9.4	7.3	1.7	7.8	12.9	11.4	50.2	13.4	17.2	19.6	9.6
SLC13A1	"NAS1, NaSi-1"	ENSG00000081800	"Solute carrier family 13 member 1"	Q9BZW2	7	123113531-123199972	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sulfate transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"kidney: 81.9"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 452.1"	"Cancer enriched"	"Detected in single"	219	"renal cancer: 10.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA053615, HPA062714"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA053615: AB_2682207, HPA062714: AB_2684846"											"unprognostic (1.86e-1)"		"prognostic favorable (8.95e-5)"	"unprognostic (1.71e-1)"	"unprognostic (3.76e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.0	81.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	7.3	0.0	0.0	0.0	0.1	27.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.0	0.0	0.1	0.3	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	75.3	452.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	4.1	0.0
SLC13A2	NaDC-1	ENSG00000007216	"Solute carrier family 13 member 2"	Q13183	17	28473293-28497781	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 119.6;kidney: 38.2;salivary gland: 44.9"	"Group enriched"	"Detected in some"	6	"Proximal enterocytes: 290.2;Proximal tubular cells: 97.8"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014963	Enhanced					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA014963: AB_1857096"	"unprognostic (8.47e-2)"	"unprognostic (7.63e-3)"	"unprognostic (4.36e-3)"	"unprognostic (2.06e-1)"		"unprognostic (2.36e-3)"	"unprognostic (3.06e-1)"	"unprognostic (2.28e-4)"		"unprognostic (1.50e-1)"	"unprognostic (1.74e-1)"	"unprognostic (1.00e-2)"	"prognostic favorable (9.00e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.64e-1)"		"unprognostic (1.50e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.7	6.1	119.6	0.0	3.0	0.0	0.0	6.8	0.0	0.0	0.0	38.2	0.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.8	0.8	44.9	11.4	0.0	3.1	90.8	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.0	13.7	10.9	0.6	27.1	1.6	3.7	12.5	0.0	0.7	29.3	9.8	0.7	0.0	0.0	0.0	0.2	4.8	0.0	0.1	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.1	31.4	0.0	0.0	0.4	0.0	0.0	0.7	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.2	15.7	0.0	0.0	0.0	290.2	97.8	0.3	0.4	0.0	0.0	0.2	0.4	0.2	0.0	0.0	0.0	0.5	0.0	25.8	0.5
SLC13A3	"NADC3, SDCT2"	ENSG00000158296	"Solute carrier family 13 member 3"	Q8WWT9	20	46557823-46684467	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	9	"kidney: 407.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.8;Cytotrophoblasts: 106.6;Excitatory neurons: 65.0;Oligodendrocytes: 178.1;Proximal tubular cells: 245.9;Syncytiotrophoblasts: 79.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 11.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 16.1;EFO-21: 18.8;Hep G2: 56.1;HHSteC: 18.4;K-562: 15.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014333, HPA014353, HPA014736"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA014333: AB_2732407, HPA014353: AB_1856968, HPA014736: AB_1856970"	"unprognostic (1.07e-2)"	"unprognostic (7.40e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.19e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.19e-2)"	"unprognostic (2.15e-1)"	"unprognostic (2.82e-2)"	"unprognostic (1.66e-2)"	"unprognostic (9.50e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.87e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.05e-2)"	1.3	2.4	12.5	0.7	22.8	0.2	1.9	16.5	16.1	2.0	4.9	0.8	0.3	1.8	1.0	0.9	2.4	1.9	1.0	10.1	16.2	407.6	21.7	1.4	0.6	18.3	19.5	4.5	9.0	0.2	2.6	43.2	19.0	6.3	0.5	1.1	4.9	0.8	1.0	2.2	0.4	1.9	12.5	0.6	4.7	8.7	19.9	1.1	1.4	0.3	0.7	1.8	1.4	37.4	0.1	0.0	1.6	5.6	8.3	7.7	16.1	3.5	2.0	1.9	1.4	0.0	0.1	0.2	18.8	0.2	0.1	2.1	0.1	2.6	4.5	0.0	0.6	6.8	0.4	56.1	18.4	0.1	4.8	10.5	7.5	10.9	5.4	5.4	0.0	0.0	15.3	0.3	0.0	0.6	0.1	0.7	10.3	0.2	0.0	0.2	0.0	0.1	1.2	0.4	0.7	0.2	0.0	4.0	0.8	1.0	2.9	0.3	0.2	0.1	4.0	8.7	0.1	0.5	1.2	0.1	0.6	0.0	0.4	0.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.0	0.5	0.0	0.0	12.5	22.8	16.5	16.1	10.1	16.2	18.3	19.5	19.0	12.5	19.9	37.4	0.3	0.0	2.2	53.8	3.8	1.3	1.0	0.8	6.2	0.7	1.2	1.7	1.7	0.0	0.5	7.3	0.0	106.6	0.0	0.1	15.6	0.2	23.3	0.5	2.0	0.6	0.0	0.0	65.0	0.9	7.1	2.3	3.1	0.8	0.0	3.0	0.4	17.5	9.5	0.0	40.3	0.0	0.0	0.3	0.7	27.8	3.1	2.0	0.0	11.2	0.0	0.4	0.0	24.1	178.1	0.9	0.0	0.4	1.2	3.5	0.0	245.9	6.4	0.2	0.0	0.4	1.0	6.6	1.2	1.2	0.6	79.4	1.5	2.2	0.0	0.6
SLC13A4	"SUT-1, SUT1"	ENSG00000164707	"Solute carrier family 13 member 4"	Q9UKG4	7	135681237-135729258	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"choroid plexus: 809.0"	"Cell type enriched"	"Detected in some"	4	"Syncytiotrophoblasts: 786.0"	"Cancer enhanced"	"Detected in single"		"testis cancer: 1.3"	"Region enhanced"	"Detected in many"		"hippocampal formation: 45.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HDLM-2: 30.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048582	Enhanced					NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA048582: AB_2680450"	"unprognostic (2.40e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.70e-3)"	"unprognostic (1.78e-1)"	"unprognostic (7.69e-2)"	"unprognostic (3.96e-6)"	"unprognostic (3.33e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.56e-3)"	"unprognostic (9.23e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.30e-6)"	"unprognostic (1.53e-1)"	"unprognostic (3.07e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.73e-2)"	0.0	0.0	1.6	0.0	0.7	0.0	0.0	9.2	3.4	0.7	809.0	0.0	0.0	0.0	0.0	2.4	0.5	0.0	0.1	45.4	0.7	0.0	0.0	0.0	0.0	0.9	1.7	0.0	0.2	0.0	1.4	54.4	0.6	0.0	0.0	2.3	0.5	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	3.9	12.9	0.0	0.0	0.0	2.0	0.0	1.1	0.9	0.0	0.0	0.0	0.0	0.0	0.4	5.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	30.3	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.1	0.0	0.0	0.0	0.1	0.0	2.4	0.1	0.1	2.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.7	9.2	3.4	45.4	0.7	0.9	1.7	0.6	0.7	12.9	0.9	0.0	0.0	0.0	3.3	0.0	0.0	0.5	0.1	0.0	3.4	0.1	0.1	1.9	0.0	0.1	0.0	4.2	189.9	0.0	0.0	0.0	0.2	0.6	0.5	0.5	1.0	0.0	0.0	2.7	0.0	9.5	1.2	0.0	0.1	0.0	0.1	0.0	0.0	14.9	3.3	3.0	0.0	0.0	0.0	0.3	0.5	0.3	0.4	0.0	1.0	0.0	2.1	0.0	3.5	2.5	0.1	0.0	0.0	0.1	0.5	0.0	0.1	4.3	14.9	0.0	0.6	0.3	0.3	0.5	0.0	0.1	786.0	0.1	0.1	0.0	0.4
SLC13A5	"INDY, NACT"	ENSG00000141485	"Solute carrier family 13 member 5"	Q86YT5	17	6684719-6713377	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	11	"liver: 414.0"	"Cell type enriched"	"Detected in some"	15	"Hepatocytes: 381.0"	"Cancer enriched"	"Detected in some"	15	"liver cancer: 27.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	79	"Hep G2: 58.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044343	Approved		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 15: Hepatocytes - Hemostasis"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA044343: AB_10961771"	"unprognostic (8.46e-3)"	"unprognostic (3.89e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.75e-2)"	"unprognostic (7.33e-2)"	"unprognostic (1.07e-1)"	"unprognostic (6.79e-2)"	"unprognostic (8.79e-3)"	"unprognostic (1.32e-1)"	"unprognostic (3.23e-1)"	"unprognostic (1.26e-3)"	"unprognostic (1.30e-3)"	"unprognostic (3.78e-11)"	"unprognostic (2.42e-2)"	"unprognostic (2.46e-1)"	"unprognostic (2.05e-2)"	"unprognostic (2.04e-1)"	0.3	2.7	4.8	0.0	7.0	0.0	0.3	4.8	8.0	0.3	2.7	0.0	0.0	0.3	0.0	1.1	2.1	0.0	0.1	5.3	7.9	0.7	414.0	0.0	0.2	6.8	6.1	0.6	0.3	0.0	0.8	0.0	5.4	0.0	0.0	1.7	38.0	0.0	0.0	0.1	0.0	0.0	4.8	3.3	0.0	2.3	8.4	0.0	0.0	0.0	0.0	0.0	0.2	3.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	58.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.8	7.0	4.8	8.0	5.3	7.9	6.8	6.1	5.4	4.8	8.4	3.9	0.4	0.0	0.0	24.8	4.8	0.5	0.6	0.6	1.2	0.6	0.1	0.1	0.9	7.2	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.1	1.9	0.0	24.0	0.3	0.5	0.1	0.4	0.0	0.1	0.0	0.9	16.8	381.0	0.0	0.0	0.2	0.0	0.0	23.2	1.1	0.4	0.6	0.3	0.0	1.9	0.0	7.0	0.0	1.5	0.1	16.9	0.0	0.0	0.0	0.3	0.0	0.0	0.1	1.6	0.0	0.5	0.5	2.4	2.8	1.2	0.4	0.1	1.0	7.8	0.0	0.3
SLC14A1	"HsT1341, JK, RACH1, RACH2"	ENSG00000141469	"Solute carrier family 14 member 1 (Kidd blood group)"	Q13336	18	45687025-45752520	"Blood group antigen proteins, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 133.8;prostate: 78.3;urinary bladder: 90.9"	"Group enriched"	"Detected in many"	7	"Adipocytes: 136.6;Astrocytes: 228.5;Basal prostatic cells: 313.4;Erythroid cells: 102.5;Prostatic glandular cells: 192.6;Urothelial cells: 249.9"	"Group enriched"	"Detected in many"	5	"glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"T-reg: 4.1"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"GAMG: 273.4;RT4: 113.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059570, HPA077233"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"	"Plasma membrane"		"HPA059570: AB_2684066, HPA077233: "	"unprognostic (2.04e-1)"	"unprognostic (2.56e-3)"	"unprognostic (5.20e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.86e-2)"	"unprognostic (1.84e-2)"	"unprognostic (1.70e-2)"	"unprognostic (7.97e-2)"	"unprognostic (8.17e-2)"	"unprognostic (9.99e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.31e-1)"	"unprognostic (1.52e-1)"	"unprognostic (9.09e-2)"	"unprognostic (6.93e-2)"	3.4	1.6	70.2	1.0	97.1	15.2	2.0	110.5	53.6	3.6	24.9	1.7	1.3	0.5	0.7	0.4	0.3	10.1	23.7	60.5	96.0	37.9	1.1	4.3	2.3	109.4	131.0	0.3	1.7	0.9	1.0	1.6	114.2	78.3	1.3	0.3	2.3	3.0	3.9	4.1	3.4	0.5	97.7	4.6	1.8	0.2	133.8	7.7	6.4	7.8	2.3	90.9	2.2	104.6	0.0	0.4	0.0	0.1	0.0	0.2	0.7	0.4	8.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	273.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.2	0.1	0.2	0.0	0.0	0.0	0.0	38.3	0.0	0.2	0.0	0.2	0.3	0.1	0.9	0.3	0.0	0.3	0.2	0.0	0.0	0.2	3.0	113.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	1.8	0.5	0.9	0.1	4.1	0.2	0.1	2.7	1.3	1.3	0.0	0.0	1.1	0.8	0.0	0.0	0.3	0.9	0.9	0.0	0.3	0.2	1.5	0.0	0.9	0.0	0.1	4.1	0.6	70.2	97.1	110.5	53.6	60.5	96.0	109.4	131.0	114.2	97.7	133.8	104.6	136.6	0.0	0.6	228.5	3.1	0.3	313.4	0.1	0.6	0.3	5.4	1.5	10.9	5.7	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.2	0.6	0.0	0.1	28.7	0.0	102.5	0.6	0.2	0.1	3.8	0.0	0.1	0.0	0.2	21.4	0.3	0.1	0.0	0.7	0.2	18.3	0.6	0.3	0.4	0.0	2.0	12.4	5.6	0.1	0.0	5.2	3.5	0.7	0.3	0.0	1.2	2.1	192.6	0.0	0.0	0.0	0.2	0.0	1.7	3.7	0.1	0.2	0.2	0.4	0.0	6.1	0.1	0.0	249.9
SLC14A2	"HUT2, UT2"	ENSG00000132874	"Solute carrier family 14 member 2"	Q15849	18	45212995-45683688	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 1.5;kidney: 3.2"	"Cell type enriched"	"Detected in many"	7	"Collecting duct cells: 77.3"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.1"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"eosinophil: 1.5"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 1.5"	"Cell line enriched"	"Detected in single"	7	"U-266/70: 4.9"	"Region enhanced"	"Detected in many"		"basal ganglia: 16.9"	"Not detected"	"Not detected"									NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.33e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.80e-2)"	"unprognostic (1.11e-2)"	"unprognostic (7.89e-3)"	"unprognostic (3.76e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.27e-3)"	"unprognostic (8.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (7.64e-2)"	"unprognostic (7.52e-2)"	"unprognostic (6.62e-2)"	1.5	1.1	0.2	0.2	0.2	0.3	0.1	0.3	0.6	0.0	0.0	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.1	0.4	0.0	3.2	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.2	0.2	0.1	0.1	0.2	1.1	0.0	0.0	0.1	0.0	0.5	0.1	0.1	0.7	0.1	0.1	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.2	0.2	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.3	0.0	0.1	0.2	0.2	0.1	0.0	0.2	0.1	0.0	0.5	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.7	0.2	4.9	0.2	0.1	0.2	0.7	0.1	0.5	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.2	0.2	0.3	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	6.4	9.6	5.2	0.7	0.6	0.9	0.3	0.0	1.1	0.4	0.3	0.9	0.0	1.9	77.3	2.1	0.3	0.6	0.3	0.0	0.0	1.3	0.2	0.3	0.9	0.0	0.0	8.8	0.0	0.5	2.4	0.0	0.3	3.8	0.1	1.1	0.0	0.4	1.7	10.6	0.5	0.0	0.3	2.0	1.4	0.6	0.8	1.8	2.8	0.2	0.9	1.0	6.6	1.0	0.1	1.2	0.7	0.1	0.5	4.9	0.2	1.5	2.0	0.0	0.4	0.2	0.3	0.4	0.0	0.1	0.8	1.0	0.2	0.2	0.5
SLC15A1	"HPECT1, HPEPT1, PEPT1"	ENSG00000088386	"Solute carrier family 15 member 1"	P46059	13	98683801-98752672	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 203.0"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 414.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"CAPAN-2: 55.5;SK-BR-3: 54.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA002827	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Cytosol"		"HPA002827: AB_1856974"	"unprognostic (8.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.49e-1)"	"unprognostic (6.76e-3)"	"unprognostic (6.26e-2)"	"unprognostic (7.83e-2)"	"unprognostic (5.47e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.37e-1)"	"unprognostic (6.79e-2)"	"unprognostic (6.88e-4)"	"unprognostic (2.11e-2)"	"unprognostic (2.84e-1)"	"unprognostic (2.64e-1)"	"unprognostic (9.01e-2)"	"unprognostic (3.87e-2)"	0.1	0.0	0.3	0.4	0.3	0.5	1.1	0.6	0.4	2.4	1.4	4.5	151.6	5.5	5.9	2.1	0.1	43.1	0.0	0.2	0.6	6.1	18.2	0.1	0.3	0.3	0.6	0.1	8.3	20.6	0.3	0.1	0.4	1.4	2.7	0.0	0.5	0.5	0.7	23.2	203.0	0.4	0.1	0.1	1.2	0.2	1.4	0.2	0.3	0.0	0.6	2.5	3.9	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	9.2	55.5	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.5	12.8	0.0	0.1	0.1	3.3	3.2	1.2	0.1	0.6	0.1	54.7	0.0	2.6	0.2	0.0	0.0	0.4	0.1	0.2	0.2	0.1	0.0	0.0	0.1	0.0	0.1	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.0	0.1	0.0	0.1	0.3	0.3	0.6	0.4	0.2	0.6	0.3	0.6	0.4	0.1	1.4	0.7	0.6	3.2	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.5	50.1	2.4	1.8	0.0	0.0	0.0	33.0	1.9	10.7	0.0	8.2	9.9	0.4	3.6	0.0	0.3	0.9	0.0	0.2	0.0	77.6	0.0	7.2	0.4	32.4	0.1	0.0	0.2	12.0	0.0	0.8	0.0	0.0	0.0	0.4	1.8	0.0	0.0	0.0	0.0	0.5	0.3	2.2	13.8	0.0	0.0	0.6	414.1	10.4	1.7	0.0	0.0	1.3	0.8	0.0	0.3	0.0	0.9	0.1	0.4	0.0	5.8	0.5
SLC15A2	PEPT2	ENSG00000163406	"Solute carrier family 15 member 2"	Q16348	3	121894401-121944188	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 50.9;epididymis: 39.2;prostate: 39.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 99.3;Astrocytes: 139.7;Club cells: 64.8;Microglial cells: 49.6;Muller glia cells: 51.4"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 12.1"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"NB-4: 5.7;U-937: 4.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 32: U-937 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (4.72e-2)"	"prognostic favorable (2.37e-4)"	"unprognostic (3.50e-2)"	"prognostic favorable (6.96e-4)"	"unprognostic (1.80e-2)"	"unprognostic (1.78e-1)"	"unprognostic (8.03e-3)"	"prognostic favorable (6.74e-4)"	"unprognostic (3.21e-1)"	"unprognostic (1.28e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.43e-1)"	"unprognostic (5.53e-3)"	"unprognostic (1.63e-1)"	"unprognostic (2.58e-1)"	"unprognostic (2.67e-2)"	"unprognostic (4.60e-2)"	1.0	1.3	14.0	3.0	15.0	5.9	4.8	10.1	15.0	50.9	2.4	2.6	2.2	2.0	39.2	3.4	11.3	6.3	2.0	12.9	11.8	11.0	0.9	20.1	6.0	9.4	13.6	0.8	5.5	1.7	3.4	2.2	12.6	39.7	2.9	20.9	24.6	22.0	0.8	0.9	2.0	1.2	9.0	6.0	1.6	4.1	17.1	1.6	6.7	0.4	6.0	4.9	2.3	7.7	1.3	0.6	0.7	0.2	0.8	0.4	0.9	0.1	0.1	0.3	0.4	1.2	2.1	2.4	0.1	0.1	0.4	1.4	0.5	1.2	0.4	2.0	0.5	3.3	1.0	0.6	0.1	3.6	3.2	0.7	3.6	0.4	0.2	0.4	0.2	0.7	0.5	1.0	0.4	1.0	0.7	5.7	3.7	1.4	0.3	0.8	0.3	0.7	0.8	0.8	0.3	0.3	0.3	0.2	0.1	1.1	0.2	3.1	0.1	0.3	0.2	0.2	0.3	1.2	0.4	3.3	0.4	4.8	0.3	0.9	0.4	0.1	0.0	0.1	0.1	1.3	0.1	0.0	0.1	1.3	0.1	0.1	0.2	0.0	1.0	0.6	0.0	0.1	14.0	15.0	10.1	15.0	12.9	11.8	9.4	13.6	12.6	9.0	17.1	7.7	0.4	99.3	22.8	139.7	5.9	0.5	2.8	22.5	1.2	1.0	5.0	2.0	2.6	4.3	64.8	11.0	0.0	2.5	3.2	1.4	3.9	0.6	0.4	8.9	2.0	1.0	0.0	1.7	15.4	8.3	0.6	1.3	0.5	21.3	3.8	1.0	1.4	0.0	2.7	0.0	22.6	1.4	14.2	13.5	3.8	0.6	6.5	5.3	0.0	49.6	3.1	51.4	1.0	16.6	5.0	2.0	1.0	5.3	7.7	14.4	0.2	1.6	28.8	2.9	0.0	0.9	2.4	0.4	0.5	10.4	0.6	1.4	1.2	0.3	1.6	12.7
SLC15A3	"hPTR3, PHT2"	ENSG00000110446	"Solute carrier family 15 member 3"	Q8IY34	11	60937060-60952653	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 90.6;Kupffer cells: 59.3;Macrophages: 65.5;monocytes: 70.9;Muller glia cells: 211.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 9.0;intermediate monocyte: 12.8;memory B-cell: 4.9;myeloid DC: 6.5;neutrophil: 13.4;non-classical monocyte: 6.4;plasmacytoid DC: 10.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 23.4;BJ hTERT+ SV40 Large T+: 58.0;BJ hTERT+ SV40 Large T+ RasG12V: 74.0;HHSteC: 34.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047880, HPA057642"	Approved		Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 5: Muller glia cells - Visual perception"	Vesicles		"HPA047880: AB_10959455, HPA057642: AB_2683487"	"unprognostic (5.61e-2)"	"prognostic favorable (4.07e-5)"	"unprognostic (8.79e-2)"	"unprognostic (1.67e-2)"	"unprognostic (8.48e-2)"	"unprognostic (9.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.46e-1)"	"unprognostic (9.78e-3)"	"unprognostic (6.47e-2)"	"unprognostic (4.42e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.02e-1)"	27.5	12.8	11.6	30.7	10.3	35.3	18.2	10.7	15.1	19.7	13.0	34.9	12.0	13.9	3.9	9.3	18.2	19.1	27.1	9.7	13.1	14.9	15.1	52.2	40.1	14.5	10.9	29.2	6.5	4.4	8.4	27.5	13.8	16.7	9.4	17.5	10.0	8.5	6.4	7.9	28.7	15.1	13.5	63.9	18.5	5.5	14.3	12.9	10.5	10.1	15.7	15.6	17.6	15.5	4.3	0.0	2.2	0.0	12.6	9.9	23.4	1.2	21.8	58.0	74.0	0.1	1.9	9.7	0.3	8.8	14.2	1.7	0.0	0.7	3.4	9.4	0.0	0.1	0.1	0.6	34.9	0.0	0.9	6.6	0.0	15.3	0.0	0.1	2.8	0.0	0.0	0.5	3.6	0.5	0.0	1.8	9.8	0.0	0.1	3.9	0.0	3.3	0.0	1.3	0.0	0.1	2.8	9.6	0.4	0.4	4.2	5.7	0.3	0.3	1.2	1.0	0.1	0.0	0.0	3.8	3.9	0.0	13.7	0.0	9.0	1.2	0.1	12.8	0.0	4.9	0.0	0.0	6.5	1.9	0.9	0.9	13.4	0.0	6.4	10.7	0.0	2.4	11.6	10.3	10.7	15.1	9.7	13.1	14.5	10.9	13.8	13.5	14.3	15.5	19.3	9.6	13.2	0.0	7.7	1.7	0.2	4.5	2.2	1.6	0.7	1.4	2.5	1.5	3.7	0.0	0.0	3.6	9.6	1.1	0.0	0.3	7.9	0.1	2.0	12.6	0.0	0.4	0.1	2.2	15.1	5.6	1.1	0.3	15.2	3.7	20.3	3.1	90.6	5.0	0.0	1.2	2.0	59.3	35.5	3.8	8.1	65.5	1.8	4.7	70.9	211.7	1.0	0.0	0.1	2.2	2.8	4.9	2.0	0.1	0.3	0.1	3.1	5.5	13.1	3.1	3.0	4.2	0.7	0.6	1.4	2.6	1.9	4.5	1.1	0.3
SLC15A4	"PHT1, PTR4"	ENSG00000139370	"Solute carrier family 15 member 4"	Q8N697	12	128793194-128823958	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Immunity, Innate immunity, Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"dendritic cells: 125.8;Early spermatids: 92.3;Late spermatids: 110.1;Muller glia cells: 91.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 31.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA016713	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"			"HPA016713: AB_1856978"	"unprognostic (3.12e-1)"	"unprognostic (1.00e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.46e-1)"	"prognostic unfavorable (8.45e-4)"	"prognostic unfavorable (6.78e-4)"	"unprognostic (5.14e-3)"	"unprognostic (6.39e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (7.56e-6)"	"unprognostic (1.28e-1)"	"unprognostic (2.06e-1)"	"unprognostic (2.34e-2)"	"unprognostic (2.57e-1)"	11.0	6.3	3.5	10.8	4.8	22.1	9.0	5.3	4.3	10.1	27.4	6.8	6.0	12.5	5.0	9.4	9.2	10.4	9.9	3.8	4.7	7.3	15.1	10.1	17.5	6.2	4.4	10.3	7.7	7.5	3.6	9.6	6.4	7.6	5.7	23.3	6.1	8.8	27.8	10.1	6.0	12.5	5.6	11.5	7.4	11.3	4.6	11.4	7.5	19.9	19.6	10.3	7.2	7.6	12.0	19.3	4.9	10.8	41.9	26.9	17.9	20.6	17.1	14.3	16.1	8.9	16.9	43.7	10.6	18.0	14.3	13.5	13.5	12.8	15.5	21.6	12.5	6.0	11.1	15.8	43.7	20.2	6.2	17.4	22.9	11.9	31.0	42.9	10.1	8.8	9.9	26.9	29.5	8.4	10.8	5.5	17.4	13.0	11.3	9.0	10.6	17.2	28.3	15.4	8.8	7.3	8.5	15.8	22.5	13.1	21.0	5.8	15.5	15.9	8.9	8.1	12.7	9.0	21.1	20.3	21.5	14.2	0.2	0.0	2.8	7.2	7.3	3.8	3.6	2.9	1.3	4.4	1.7	2.8	1.4	3.5	18.8	6.8	1.6	31.8	0.7	3.1	3.5	4.8	5.3	4.3	3.8	4.7	6.2	4.4	6.4	5.6	4.6	7.6	8.6	19.2	8.0	15.7	14.8	10.3	8.7	10.4	8.6	11.4	10.2	12.3	8.5	12.8	9.0	22.0	12.5	5.5	125.8	4.5	1.9	24.9	92.3	9.3	14.1	6.5	10.8	11.8	23.6	11.1	7.0	14.5	6.6	40.1	11.4	9.7	12.8	20.0	22.0	15.2	23.0	4.4	4.1	24.6	28.2	110.1	12.5	24.5	24.9	21.5	33.0	91.6	45.3	37.7	25.7	24.8	6.8	13.5	11.6	9.3	5.5	6.1	5.1	15.6	6.6	14.4	11.4	51.1	10.6	7.5	9.1	4.0	16.7	10.8	6.5	6.9
SLC15A5		ENSG00000188991	"Solute carrier family 15 member 5"	A6NIM6	12	16188485-16277685	"Predicted membrane proteins, Transporters"	"Peptide transport, Protein transport, Symport, Transport"			"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"Astrocytes: 2.0;Early spermatids: 4.2;Excitatory neurons: 1.1;Late spermatids: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA041638	Uncertain					NA	NA						"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA041638: AB_2677590"	"unprognostic (3.68e-3)"				"unprognostic (1.64e-1)"								"unprognostic (4.89e-6)"		"unprognostic (1.34e-1)"	"unprognostic (1.72e-3)"		0.2	0.0	0.4	0.0	0.4	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.4	0.5	0.2	0.2	0.2	0.2	0.2	0.3	0.2	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC16A1	"MCT, MCT1"	ENSG00000155380	"Solute carrier family 16 member 1"	P53985	1	112911847-112957593	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 158.4;Granulosa cells: 322.8;Muller glia cells: 184.8;Rod photoreceptor cells: 277.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 6.1"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003324, CAB017489, HPA071055, CAB079035"	Enhanced	Supported	Enhanced	"Plasma membrane,Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane, Cell Junctions"		"CAB017489: AB_2189197, CAB079035: , HPA003324: AB_1856982, HPA071055: AB_2686337"	"unprognostic (1.19e-1)"	"unprognostic (1.61e-2)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (8.37e-6)"	"unprognostic (1.53e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.15e-3)"	"prognostic unfavorable (4.05e-4)"	"unprognostic (6.92e-2)"	"unprognostic (6.31e-3)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (6.78e-8)"	"unprognostic (1.30e-1)"	"unprognostic (2.31e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.53e-3)"	20.7	10.4	35.7	11.8	36.1	4.3	7.5	37.8	99.4	7.1	37.8	46.8	32.5	28.6	22.8	15.3	13.1	14.8	67.9	33.5	35.2	11.4	55.6	4.9	9.5	38.6	35.9	7.9	2.0	10.0	5.2	34.0	37.0	14.4	35.3	68.9	3.5	11.2	67.5	13.0	16.6	39.2	37.0	6.6	26.6	29.8	38.3	11.7	8.6	59.6	11.6	11.9	7.1	38.2	111.1	24.0	86.9	74.3	61.9	52.1	272.7	64.6	51.1	52.0	80.9	85.4	67.1	113.8	82.3	61.6	32.6	113.1	126.3	124.8	96.8	75.6	105.2	108.9	63.4	112.9	104.6	123.2	9.9	72.2	144.6	75.7	146.4	79.2	131.4	53.8	131.3	78.0	61.9	19.9	70.2	70.1	271.4	36.7	74.5	67.9	130.7	92.8	67.3	1.9	86.9	46.5	121.8	3.8	97.5	130.0	3.7	48.9	80.9	45.4	72.0	89.3	93.1	39.7	33.9	116.7	137.1	78.5	56.0	0.0	1.4	0.0	1.5	1.6	1.7	0.9	1.8	2.0	2.5	0.3	0.8	1.5	0.1	0.6	0.3	0.2	6.1	0.8	35.7	36.1	37.8	99.4	33.5	35.2	38.6	35.9	37.0	37.0	38.3	38.2	15.1	0.0	2.6	8.5	16.5	89.3	6.5	39.9	87.6	16.9	16.5	9.9	126.3	10.0	5.7	0.0	158.4	77.4	20.3	99.8	0.0	2.5	107.2	14.3	70.7	22.8	3.5	20.2	9.8	3.3	67.6	32.8	67.2	35.8	8.9	322.8	6.4	37.5	15.4	20.2	11.6	17.3	20.3	9.0	15.7	118.3	11.8	12.8	39.2	20.6	4.3	184.8	0.0	9.0	23.8	7.4	7.7	7.5	25.5	16.5	9.3	10.8	3.9	277.5	0.0	38.2	22.1	45.3	23.6	29.6	39.5	46.0	20.9	49.6	23.3	1.3
SLC16A10	"MCT10, TAT1"	ENSG00000112394	"Solute carrier family 16 member 10"	Q8TF71	6	111087503-111231194	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 53.7;skeletal muscle: 41.2"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 32.8;Excitatory neurons: 33.9;Inhibitory neurons: 47.8;Macrophages: 33.8;Melanocytes: 44.4"	"Cancer enriched"	"Detected in many"	6	"testis cancer: 4.5"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"naive CD4 T-cell: 1.7;T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HAP1: 49.4;HEK 293: 20.2;RPMI-8226: 37.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA016860	Approved		Supported	"Vesicles,Cell Junctions"		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 41: Macrophages - Immune response"	"Vesicles, Cell Junctions"		"HPA016860: AB_2189211"	"unprognostic (2.03e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.11e-2)"	"unprognostic (3.56e-4)"	"unprognostic (2.24e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.86e-3)"	"unprognostic (5.22e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.10e-3)"	"unprognostic (2.73e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.91e-1)"	2.9	5.5	1.4	3.0	8.6	0.8	0.8	4.2	3.4	0.6	53.7	1.2	8.5	0.5	1.4	0.8	0.8	1.5	2.3	2.0	1.2	10.0	13.5	4.6	0.9	1.1	5.0	0.9	29.7	7.9	1.0	23.7	2.8	1.3	1.8	0.7	3.1	0.2	41.2	15.3	5.0	0.3	0.2	1.8	5.3	4.2	9.6	10.9	2.7	6.0	1.3	1.9	1.2	1.1	0.9	1.0	0.4	2.2	0.1	0.1	3.1	0.0	0.2	0.8	1.2	9.0	0.4	5.2	1.4	0.3	2.5	0.1	49.4	0.1	1.0	0.1	20.2	8.2	0.7	7.4	0.1	7.6	7.4	0.0	0.0	0.1	0.0	0.2	0.0	10.9	1.4	0.2	0.1	3.6	9.8	0.8	14.6	0.2	3.2	5.4	6.8	37.2	0.0	0.5	10.7	3.3	0.2	0.7	1.8	3.6	1.8	0.9	0.1	0.1	1.8	0.5	2.5	2.6	0.1	1.5	0.3	5.8	0.8	0.4	0.0	0.0	0.1	0.0	0.1	0.1	0.4	0.1	0.0	0.2	1.7	1.5	0.3	0.1	0.0	0.1	1.6	0.1	1.4	8.6	4.2	3.4	2.0	1.2	1.1	5.0	2.8	0.2	9.6	1.1	0.4	9.6	32.8	2.0	1.5	9.7	10.7	0.0	4.6	6.9	2.0	1.3	9.1	0.0	3.1	5.5	2.1	1.9	0.7	2.1	1.9	0.2	9.0	0.4	0.8	1.4	6.6	1.7	33.9	12.5	1.8	8.9	3.6	1.3	1.3	2.5	4.2	25.4	21.4	1.7	47.8	4.8	0.0	12.4	12.4	8.2	0.0	33.8	44.4	0.0	0.7	1.6	0.0	16.6	0.3	2.0	0.9	0.0	4.8	3.9	10.9	17.7	0.7	0.7	0.0	18.5	1.0	11.6	11.2	1.2	14.8	1.2	5.8	9.2	8.5	1.2
SLC16A11	"FLJ90193, MCT11"	ENSG00000174326	"Solute carrier family 16 member 11"	Q8NCK7	17	7041621-7044092	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid metabolism, Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 13.5"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 12.8;Muller glia cells: 32.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 12.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Group enriched"	"Detected in many"	8	"B-cells: 1.0;T-cells: 1.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 18: Non-specific - Mitochondria"		"Cluster 5: Muller glia cells - Visual perception"				"unprognostic (4.65e-4)"	"unprognostic (9.40e-3)"	"unprognostic (6.10e-2)"	"unprognostic (8.85e-2)"	"unprognostic (6.97e-5)"	"unprognostic (5.22e-3)"	"prognostic favorable (2.56e-4)"	"unprognostic (2.22e-3)"	"unprognostic (5.38e-2)"	"unprognostic (2.58e-1)"	"prognostic favorable (1.45e-5)"	"unprognostic (1.30e-2)"	"prognostic favorable (3.19e-7)"	"unprognostic (1.24e-1)"	"unprognostic (1.83e-1)"	"unprognostic (3.76e-1)"	"unprognostic (5.83e-2)"	1.5	0.7	1.4	0.3	1.4	0.0	3.7	2.2	1.9	1.9	7.1	1.3	0.4	1.3	1.4	2.3	12.8	0.4	3.0	1.4	2.0	4.7	9.6	2.8	0.4	1.6	1.8	2.6	4.0	5.4	4.8	0.0	2.0	3.1	0.0	0.2	10.4	1.9	0.5	6.0	1.8	0.0	2.1	1.8	1.3	0.8	1.1	0.2	13.5	0.1	0.2	0.9	1.8	1.8	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.9	0.6	0.3	1.4	0.0	1.0	0.7	1.3	0.0	0.1	0.0	0.0	0.0	0.2	1.4	1.4	2.2	1.9	1.4	2.0	1.6	1.8	2.0	2.1	1.1	1.8	9.8	12.8	8.4	2.6	5.9	1.8	5.4	4.0	4.6	0.4	7.0	8.8	2.6	8.6	8.3	7.3	0.0	0.0	3.0	0.2	1.9	3.9	0.3	0.4	0.1	4.0	9.6	0.0	0.6	1.3	0.0	1.7	0.0	0.2	0.0	0.0	1.4	5.0	0.0	0.0	0.3	1.2	6.1	0.3	0.4	0.7	6.8	0.4	3.6	0.0	0.4	32.0	9.2	2.0	0.1	0.1	0.1	4.9	1.1	3.1	0.0	1.5	6.5	1.9	0.0	1.2	1.3	1.5	1.2	5.9	3.1	0.1	3.9	0.4	1.4	7.9
SLC16A12	MCT12	ENSG00000152779	"Solute carrier family 16 member 12"	Q6ZSM3	10	89430299-89556641	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		Cataract	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"choroid plexus: 92.2;epididymis: 51.8;kidney: 85.2;pancreas: 25.3"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 18.1;Leydig cells: 27.1;Peritubular cells: 26.7;Proximal tubular cells: 69.2"	"Cancer enriched"	"Detected in many"	10	"renal cancer: 18.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"ASC TERT1: 23.0;HSkMC: 8.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037587			Approved	Mitochondria		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA037587: AB_2732475"	"unprognostic (5.38e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.79e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.51e-1)"	"unprognostic (5.35e-2)"	"unprognostic (2.45e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.78e-2)"	"unprognostic (2.42e-1)"	"unprognostic (9.60e-2)"	"unprognostic (2.31e-1)"	"prognostic favorable (4.50e-12)"	"unprognostic (3.84e-2)"	"unprognostic (7.91e-2)"	"unprognostic (8.29e-2)"	"unprognostic (1.84e-3)"	1.8	2.5	0.8	0.1	1.1	0.0	1.9	1.0	2.7	9.2	92.2	0.8	0.1	1.4	51.8	0.3	4.1	0.1	4.9	2.9	0.3	85.2	2.0	2.5	0.1	0.5	1.6	1.3	25.3	0.1	3.4	11.6	0.6	0.6	0.2	0.0	0.4	14.1	1.6	0.5	0.3	0.3	1.2	0.0	1.0	3.3	1.0	0.4	6.2	2.5	0.0	0.4	0.7	0.6	0.2	0.0	0.0	0.0	3.0	23.0	0.2	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	1.2	0.2	0.0	0.3	0.5	0.0	0.0	0.0	0.5	0.0	3.7	0.0	0.0	8.2	0.2	1.2	1.5	2.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.8	0.0	2.8	0.0	0.1	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	1.1	1.0	2.7	2.9	0.3	0.5	1.6	0.6	1.2	1.0	0.6	0.8	3.2	3.9	3.3	0.6	0.0	2.2	0.1	0.0	0.1	4.6	0.1	3.3	1.5	2.9	14.7	0.0	16.4	0.1	0.0	15.6	0.0	8.3	11.5	0.8	1.3	18.1	0.0	0.3	4.1	1.1	2.2	0.0	1.0	1.3	0.0	0.4	2.2	1.2	3.3	0.4	0.2	0.0	0.0	0.9	4.8	27.1	1.0	0.0	11.2	0.1	0.0	0.0	0.0	0.4	2.1	0.1	26.7	0.0	0.7	0.0	69.2	6.2	0.6	13.1	3.4	7.8	0.2	0.5	0.0	0.3	9.0	0.9	0.1	0.0	1.8
SLC16A13	MCT13	ENSG00000174327	"Solute carrier family 16 member 13"	Q7RTY0	17	7036015-7040117	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 36.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 8.2;NK-cells: 6.2;Squamous epithelial cells: 7.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"A549: 22.8;GAMG: 26.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065245			Supported	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"	Cytosol	"HPA065245: AB_2685443"	"unprognostic (5.61e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.83e-2)"	"unprognostic (1.78e-1)"	"unprognostic (2.22e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (1.50e-4)"	"unprognostic (2.44e-2)"	"unprognostic (7.31e-3)"	"unprognostic (9.70e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.14e-1)"	1.4	1.0	1.1	2.1	0.8	0.4	1.4	1.8	1.1	1.8	1.0	2.2	9.2	0.8	1.3	5.3	1.8	3.7	1.6	0.9	1.0	6.8	36.1	2.4	2.8	1.2	1.2	0.5	1.2	2.9	0.8	1.5	1.0	1.4	1.6	0.3	3.3	0.8	0.4	5.3	5.5	0.9	0.9	3.5	1.9	0.5	1.0	1.8	3.3	0.2	2.5	1.2	2.6	0.8	13.1	22.8	5.3	3.2	3.2	1.8	2.2	1.3	3.3	2.9	6.5	7.4	14.3	8.3	2.2	2.1	26.2	20.1	4.1	7.0	1.2	10.3	2.9	3.4	1.8	18.0	3.6	1.2	7.6	2.1	7.8	4.3	3.5	3.9	11.9	7.4	4.0	2.3	3.1	6.5	5.1	2.1	2.2	6.6	1.8	2.4	1.8	1.4	2.7	3.6	0.2	1.4	4.0	2.2	1.8	7.8	6.1	1.8	4.5	1.8	4.1	3.0	1.9	4.0	8.9	0.5	5.4	3.0	0.8	0.0	0.8	1.0	1.2	0.8	0.9	1.1	1.0	1.5	0.8	2.5	1.1	1.1	0.9	1.2	0.9	1.1	1.2	0.5	1.1	0.8	1.8	1.1	0.9	1.0	1.2	1.2	1.0	0.9	1.0	0.8	2.3	0.0	1.5	0.7	5.1	0.5	0.9	1.3	4.0	0.4	1.6	0.9	0.4	1.5	0.8	5.5	0.0	1.9	2.4	1.1	0.0	1.0	0.0	0.5	0.5	2.8	0.0	0.4	1.8	0.2	0.4	0.6	4.1	0.7	3.8	1.1	2.2	8.2	0.5	3.3	1.1	1.2	2.0	0.6	3.1	0.0	0.9	1.6	0.0	1.0	1.4	0.9	6.2	0.5	0.0	0.5	0.1	0.0	2.9	0.9	2.4	1.9	1.4	0.5	0.0	0.3	1.1	0.0	0.0	7.4	1.6	2.5	4.7	0.5	1.0	1.0
SLC16A14	"FLJ30794, MCT14"	ENSG00000163053	"Solute carrier family 16 member 14"	Q7RTX9	2	230034982-230068993	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 18.6"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 17.0;Excitatory neurons: 18.5;Inhibitory neurons: 21.1;Microglial cells: 45.0;Oligodendrocyte precursor cells: 13.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	24	"eosinophil: 11.3"	"Lineage enriched"	"Detected in single"	24	"granulocytes: 11.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 24.2;Karpas-707: 15.2;REH: 19.5;RPMI-8226: 17.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040518	Uncertain		Approved	"Endoplasmic reticulum"		No	No			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA040518: AB_10794877"	"unprognostic (2.99e-1)"	"unprognostic (1.74e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.74e-3)"	"unprognostic (2.20e-3)"	"unprognostic (2.01e-1)"	"unprognostic (4.96e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.15e-1)"	"unprognostic (5.70e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.03e-3)"	"unprognostic (3.51e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.10e-1)"	4.6	3.9	7.9	1.7	7.2	5.6	3.2	8.9	7.7	5.0	2.4	3.7	1.0	3.9	2.3	4.0	3.1	2.8	2.4	7.1	7.2	2.3	2.0	1.9	1.3	5.2	6.1	7.3	0.8	7.0	1.4	1.2	4.7	4.5	4.0	2.5	18.6	3.6	1.0	11.0	1.3	3.8	3.8	5.9	1.4	1.2	9.4	2.2	1.5	2.0	1.5	2.0	2.7	4.7	2.9	1.6	1.3	0.0	0.0	0.3	0.0	0.3	0.0	0.6	0.4	0.0	0.5	0.0	0.3	0.1	0.0	0.5	5.1	1.4	0.1	0.0	9.7	0.2	3.1	0.0	0.3	24.2	0.0	0.5	3.6	0.0	0.0	3.9	0.2	4.7	0.0	15.2	0.3	0.0	2.4	2.7	1.0	0.3	2.7	19.5	0.0	17.3	5.6	2.6	6.3	2.3	4.9	0.0	0.1	0.1	7.7	1.9	0.0	0.0	1.3	3.3	2.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	11.3	0.4	0.0	0.3	0.3	0.1	0.0	0.4	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.9	7.2	8.9	7.7	7.1	7.2	5.2	6.1	4.7	3.8	9.4	4.7	17.0	0.0	0.0	2.3	1.5	2.5	0.5	1.9	3.4	3.3	1.2	0.8	3.9	0.0	3.5	0.0	2.1	0.0	0.1	1.8	0.0	0.8	0.0	0.5	2.6	10.8	3.6	0.0	18.5	0.6	0.0	2.3	0.0	0.3	0.0	0.2	4.2	2.1	0.1	3.3	21.1	0.3	4.1	0.3	0.6	0.0	1.2	0.1	1.8	45.0	0.0	1.9	0.0	13.6	1.8	0.8	1.0	3.0	8.4	0.9	0.0	0.3	1.6	1.6	0.0	0.5	1.4	0.2	0.2	6.8	4.7	0.3	1.4	8.4	1.3	0.3
SLC16A2	"AHDS, DXS128, MCT7, MCT8, MRX22, XPCT"	ENSG00000147100	"Solute carrier family 16 member 2"	P36021	X	74421493-74533917	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 40.7"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 22.2;Hepatocytes: 63.7;Inhibitory neurons: 21.6;Oligodendrocyte precursor cells: 23.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 83.9;GAMG: 70.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072719			Approved	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA072719: AB_2686552"	"prognostic unfavorable (8.88e-5)"	"unprognostic (2.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (2.90e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.58e-3)"	"unprognostic (2.47e-2)"	"unprognostic (1.48e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.67e-2)"	"unprognostic (3.51e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (2.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.89e-3)"	"prognostic unfavorable (3.16e-4)"	13.8	24.7	4.6	4.8	5.8	0.0	5.4	1.7	5.7	9.4	1.2	7.0	3.3	10.3	1.7	2.9	9.3	6.0	10.4	7.7	4.9	7.9	40.7	7.5	0.9	5.6	3.9	12.8	5.5	11.7	9.8	9.2	1.8	6.2	1.8	1.1	5.0	5.8	2.7	2.5	3.1	6.9	3.5	1.2	4.7	0.9	8.1	5.7	12.6	3.7	1.8	6.6	6.2	3.0	8.4	10.4	7.2	43.1	20.8	11.1	0.0	83.9	29.7	38.2	20.6	0.1	0.9	0.0	1.3	37.5	70.8	1.7	1.1	40.2	22.1	6.1	3.6	0.0	0.0	0.0	1.5	0.0	0.0	16.5	9.5	19.3	23.3	14.6	0.1	0.1	0.0	0.0	9.1	0.0	0.5	2.7	27.2	0.0	7.8	17.4	19.9	0.0	18.0	0.1	1.9	12.0	9.6	50.2	0.3	2.5	0.6	1.1	0.0	32.5	8.8	35.7	41.9	0.0	0.0	0.0	34.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	5.8	1.7	5.7	7.7	4.9	5.6	3.9	1.8	3.5	8.1	3.0	5.6	0.0	0.6	22.2	0.2	0.8	4.3	2.4	0.6	5.7	4.3	3.4	4.5	8.6	2.9	3.7	0.0	5.7	0.1	0.0	3.9	4.3	0.1	0.3	9.8	6.1	8.4	0.0	14.5	2.4	4.9	11.8	0.5	0.5	2.5	1.7	3.6	63.7	1.0	3.3	21.6	0.3	0.0	1.3	0.8	1.2	15.2	0.1	3.6	15.9	0.6	6.2	0.0	23.1	7.1	4.6	0.0	20.7	0.1	5.1	0.4	4.7	2.4	1.5	13.1	9.7	5.6	0.1	0.1	0.9	1.3	2.1	0.4	1.4	0.2	4.9
SLC16A3	"MCT3, MCT4"	ENSG00000141526	"Solute carrier family 16 member 3"	O15427	17	82217934-82261129	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 198.3"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 1667.1;Syncytiotrophoblasts: 748.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 109.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017490, HPA021451"	Approved		Supported	"Nuclear membrane,Plasma membrane"		NA	NA		260000	"Cluster 52: Eosinophils - Transcription"	"Cluster 59: Non-specific - Translation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Plasma membrane"	"Nuclear membrane"	"CAB017490: AB_2189333, HPA021451: AB_1853663"	"unprognostic (2.49e-1)"	"prognostic unfavorable (6.07e-4)"	"unprognostic (4.31e-1)"	"unprognostic (1.74e-1)"	"unprognostic (3.47e-3)"	"unprognostic (4.26e-3)"	"prognostic unfavorable (1.19e-7)"	"prognostic unfavorable (2.02e-5)"	"unprognostic (2.52e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.35e-3)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.71e-7)"	"unprognostic (2.27e-1)"	"unprognostic (4.00e-2)"	"unprognostic (8.00e-2)"	"unprognostic (1.36e-2)"	30.4	16.9	3.8	25.3	5.8	22.7	15.7	6.6	9.7	26.2	5.0	28.9	11.6	11.6	1.3	42.4	18.5	12.8	26.0	4.5	7.3	48.2	11.3	46.4	5.7	17.3	8.5	9.1	5.8	2.5	12.1	24.7	11.9	19.6	5.7	5.7	27.5	5.9	198.3	8.4	22.9	6.0	8.4	57.5	22.0	32.0	13.8	2.9	29.1	73.2	5.2	26.3	28.5	15.1	52.8	24.4	0.6	1.3	7.8	28.8	51.7	225.6	107.7	117.4	142.2	10.1	119.1	0.7	158.0	122.5	127.9	18.9	15.6	242.0	51.8	78.1	1.2	87.4	144.0	236.4	164.1	105.2	111.5	64.8	38.2	77.0	38.5	185.8	69.1	2.2	1.0	26.6	116.1	14.0	1.4	166.3	1.9	22.1	223.5	0.9	1.6	33.2	75.9	3.0	2.9	1.7	196.7	166.9	3.2	20.4	25.4	131.4	124.0	281.7	5.1	4.5	200.9	97.3	1.9	3.9	140.2	94.7	3.0	56.6	32.6	92.1	9.6	30.4	13.4	8.1	7.7	10.5	24.1	6.2	4.2	5.3	109.1	25.3	31.4	15.2	7.3	16.0	3.8	5.8	6.6	9.7	4.5	7.3	17.3	8.5	11.9	8.4	13.8	15.1	19.2	9.6	9.8	3.6	27.9	6.5	47.5	210.1	2.8	13.4	3.2	2.5	6.1	4.3	182.3	57.0	4.2	67.6	72.4	216.7	0.0	136.1	3.0	33.7	15.4	29.9	20.9	9.1	0.3	18.0	1667.1	17.2	45.3	65.1	75.0	15.9	16.8	1.1	271.0	127.9	0.3	28.3	148.5	99.9	84.6	3.8	3.1	168.6	14.2	9.4	184.9	20.3	40.2	0.0	1.0	305.5	190.2	3.8	35.7	16.5	62.4	5.6	91.1	11.6	0.0	1.6	50.5	1.9	9.5	1.6	6.7	748.8	38.5	0.8	33.4	119.6
SLC16A4	"MCT4, MCT5"	ENSG00000168679	"Solute carrier family 16 member 4"	O15374	1	110362851-110391082	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"kidney: 124.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 71.7;Proximal tubular cells: 192.3"	"Cancer enhanced"	"Detected in all"		"renal cancer: 35.1"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	4	"memory B-cell: 1.5"	"Lineage enriched"	"Detected in single"	4	"B-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"BEWO: 20.4;BJ hTERT+: 20.7;CAPAN-2: 30.8;HHSteC: 19.2;hTERT-RPE1: 42.6;SK-MEL-30: 30.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046986, HPA060163"	Approved		Approved	"Microtubules,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Microtubules, Cytosol"	"Cytokinetic bridge"	"HPA046986: AB_2679892, HPA060163: "	"unprognostic (2.04e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.56e-1)"	"unprognostic (2.77e-3)"	"unprognostic (1.53e-1)"	"unprognostic (2.22e-1)"	"unprognostic (2.00e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.50e-1)"	"prognostic favorable (1.69e-4)"	"unprognostic (3.68e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.71e-2)"	"unprognostic (9.46e-2)"	4.9	2.9	2.7	4.6	3.1	1.0	6.9	5.8	4.4	4.2	15.4	3.6	9.5	3.0	22.4	2.7	4.0	13.7	4.6	3.5	4.1	124.1	16.3	9.2	3.4	4.1	3.1	21.4	0.9	0.4	3.8	28.6	3.9	3.8	1.6	2.3	3.6	5.8	1.3	1.3	11.4	3.4	4.1	2.7	2.7	5.2	3.0	0.6	8.5	3.9	1.1	7.9	3.5	4.2	0.4	9.8	2.3	2.7	6.3	12.9	20.4	5.3	20.7	1.8	5.3	3.1	30.8	0.6	5.7	17.1	0.1	0.5	0.1	1.9	1.9	0.5	2.5	0.5	2.7	3.3	19.2	0.9	0.5	10.0	0.3	3.0	0.2	42.6	4.1	0.8	0.5	1.2	3.3	1.0	0.4	0.6	0.9	0.0	0.3	0.2	1.3	0.1	3.7	0.4	1.2	0.9	0.6	9.8	30.6	9.0	0.7	0.1	0.4	1.4	0.7	0.3	1.5	0.5	0.1	1.6	1.1	0.4	6.1	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.3	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.1	2.7	3.1	5.8	4.4	3.5	4.1	4.1	3.1	3.9	4.1	3.0	4.2	1.9	12.8	20.8	2.3	5.8	3.1	6.1	11.2	1.2	11.5	14.7	6.5	1.1	11.5	6.8	71.7	6.2	39.5	5.8	0.9	3.9	2.7	0.5	3.3	6.8	4.6	3.5	2.7	8.2	0.9	34.6	18.2	1.5	3.3	5.1	5.2	4.2	5.0	4.2	3.3	7.1	0.9	4.1	1.6	3.0	2.2	18.0	1.8	10.6	15.0	1.8	2.4	9.2	2.5	4.7	1.9	1.2	11.7	1.2	3.1	38.4	192.3	3.5	20.1	0.0	4.5	5.4	3.4	1.9	0.5	3.7	35.2	3.9	7.0	1.4	7.2
SLC16A5	"MCT5, MCT6"	ENSG00000170190	"Solute carrier family 16 member 5"	O15375	17	75087727-75106162	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 92.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Collecting duct cells: 88.3;Early spermatids: 42.2;Proximal enterocytes: 40.9;Respiratory ciliated cells: 45.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"classical monocyte: 13.2;neutrophil: 34.9"	"Group enriched"	"Detected in all"	6	"granulocytes: 34.9;monocytes: 13.2"	"Cell line enhanced"	"Detected in many"		"A549: 65.9;OE19: 71.5;RPTEC TERT1: 68.8;RT4: 139.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.86e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.51e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.72e-1)"	"unprognostic (6.30e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.26e-2)"	"unprognostic (8.43e-3)"	"unprognostic (8.07e-2)"	"unprognostic (9.63e-2)"	"unprognostic (3.53e-3)"	"unprognostic (5.44e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.80e-1)"	6.5	1.4	1.1	4.8	1.1	8.7	7.2	1.2	1.2	9.4	5.0	15.2	34.0	8.5	4.4	11.2	16.1	8.2	13.9	1.0	1.7	92.8	3.3	24.6	3.4	2.2	2.2	8.1	4.7	4.6	2.7	10.8	1.7	15.0	10.3	0.1	7.9	12.5	9.4	15.9	24.9	4.2	1.9	10.6	26.0	6.5	2.4	1.9	14.3	4.6	3.9	18.5	11.1	1.8	14.2	65.9	1.2	0.1	3.2	4.2	22.0	7.7	19.8	7.7	5.4	16.9	39.6	0.0	9.2	24.1	1.0	39.7	3.2	10.8	2.9	0.0	0.2	5.1	33.5	8.9	14.9	0.0	0.2	10.1	12.8	7.8	0.1	0.1	15.8	0.7	1.1	0.2	0.5	2.3	0.5	7.1	5.0	71.5	0.2	1.6	0.0	0.5	68.8	139.8	0.0	0.4	19.4	4.5	9.7	11.0	32.0	7.1	5.7	0.1	0.1	0.5	0.1	0.2	0.0	0.0	0.3	4.3	4.3	4.1	13.2	3.5	0.5	5.0	0.3	1.4	0.6	0.1	3.9	0.3	1.4	0.6	34.9	1.0	2.6	0.1	0.8	4.4	1.1	1.1	1.2	1.2	1.0	1.7	2.2	2.2	1.7	1.9	2.4	1.8	4.4	38.5	34.5	0.0	0.9	2.5	7.7	10.1	6.2	0.0	5.6	6.1	5.5	7.2	23.5	88.3	0.0	18.5	0.5	17.1	5.9	6.4	42.2	9.7	1.5	5.0	6.7	0.4	0.2	1.3	3.7	3.7	11.7	6.1	7.0	3.9	12.8	0.4	6.5	0.0	0.3	13.2	4.1	8.5	1.8	31.8	0.6	5.5	7.2	3.7	7.9	0.2	3.1	0.0	0.1	1.0	23.8	0.0	0.2	11.3	40.9	1.9	45.4	0.0	0.0	0.8	2.1	0.3	1.5	3.6	1.3	19.6	1.4	1.1	11.8	25.5
SLC16A6	"MCT6, MCT7"	ENSG00000108932	"Solute carrier family 16 member 6"	O15403	17	68267026-68291267	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 51.0;epididymis: 33.3;retina: 31.0"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 22.9;Glandular and luminal cells: 27.4;Kupffer cells: 16.7;Macrophages: 21.8;Rod photoreceptor cells: 45.1"	"Group enriched"	"Detected in many"	6	"breast cancer: 10.9;melanoma: 11.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	13	"SK-MEL-30: 481.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054459, HPA066328"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 41: Macrophages - Immune response"	Vesicles		"HPA054459: AB_2682494, HPA066328: AB_2685660"	"unprognostic (2.53e-2)"	"unprognostic (2.09e-3)"	"unprognostic (8.41e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.10e-1)"	"unprognostic (5.26e-3)"	"unprognostic (5.08e-3)"	"unprognostic (5.39e-2)"	"unprognostic (1.63e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.44e-2)"	"unprognostic (8.78e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.16e-3)"	"unprognostic (2.09e-2)"	"unprognostic (9.46e-2)"	1.5	2.7	3.0	7.2	4.8	9.7	5.8	4.3	4.3	1.6	51.0	0.7	0.5	2.6	33.3	10.9	0.9	1.3	0.9	5.0	5.2	0.7	1.4	3.0	5.3	5.1	4.2	1.5	0.5	0.1	1.7	2.3	5.3	0.6	0.8	31.0	2.2	4.2	5.0	4.5	1.2	0.8	2.4	5.7	1.0	2.3	5.2	1.6	3.5	0.7	4.7	2.1	2.6	3.2	2.1	1.8	0.6	0.8	0.4	0.6	14.2	0.8	18.0	1.7	1.2	0.7	2.5	17.6	1.4	0.0	0.2	0.6	2.5	0.0	0.7	5.4	1.3	1.4	2.2	22.3	3.2	5.7	1.1	0.8	0.2	1.0	1.0	1.7	0.8	2.5	1.1	3.8	0.0	18.1	8.5	3.6	0.2	0.1	1.0	0.1	0.4	2.4	0.8	1.5	4.2	0.3	0.8	10.7	481.5	3.8	15.0	3.5	2.7	5.9	1.1	0.5	2.0	4.2	17.5	14.6	36.0	4.6	2.6	0.8	3.1	0.2	1.8	2.7	0.8	0.4	0.6	1.4	1.9	0.0	0.4	0.8	5.4	0.4	1.4	0.3	1.5	0.9	3.0	4.8	4.3	4.3	5.0	5.2	5.1	4.2	5.3	2.4	5.2	3.2	0.6	0.0	2.5	1.6	1.8	0.3	0.2	0.1	1.2	8.2	2.5	0.9	0.8	0.0	4.0	9.2	22.9	0.4	8.4	0.0	0.0	0.0	0.7	4.7	2.5	3.2	0.0	2.7	6.7	0.0	11.5	0.9	0.5	27.4	1.3	0.1	0.7	0.3	5.6	0.0	6.2	0.0	0.0	16.7	7.0	0.3	0.0	21.8	10.6	4.7	11.1	6.2	5.2	0.5	0.8	0.0	0.0	1.9	5.0	0.2	0.0	0.3	1.6	45.1	0.0	0.8	0.3	1.7	0.7	6.7	0.4	0.4	5.3	0.4	0.1	0.2
SLC16A7	MCT2	ENSG00000118596	"Solute carrier family 16 member 7"	O60669	12	59596029-59789855	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 34.4"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 135.4;Early spermatids: 117.3;Excitatory neurons: 150.5;Inhibitory neurons: 128.2;Late spermatids: 135.5"	"Cancer enhanced"	"Detected in many"		"renal cancer: 3.6"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 22.2"	HPA005911	Approved		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"	Nucleoplasm	"HPA005911: AB_1853659"	"unprognostic (1.52e-2)"	"unprognostic (9.47e-3)"	"unprognostic (9.48e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.29e-2)"	"unprognostic (5.35e-2)"	"unprognostic (8.09e-2)"	"unprognostic (1.90e-1)"	"unprognostic (1.04e-1)"	"unprognostic (8.39e-2)"	"unprognostic (9.79e-2)"	"prognostic favorable (8.85e-5)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-1)"	"unprognostic (9.35e-2)"	"unprognostic (2.45e-2)"	20.1	6.8	1.2	3.9	1.2	4.7	4.1	5.7	3.9	2.8	3.7	2.0	1.6	3.0	1.5	6.3	2.2	5.4	34.4	1.3	0.3	11.6	3.9	4.5	4.9	2.9	0.4	2.7	9.8	1.0	1.5	1.6	2.9	1.6	2.5	1.8	2.9	1.6	1.8	7.9	2.5	3.5	0.5	6.3	10.0	2.2	1.3	4.5	1.6	3.6	4.2	4.0	3.0	4.2	0.2	3.6	0.8	0.5	10.9	18.1	0.2	8.8	8.1	4.0	3.4	0.3	6.3	5.8	2.5	16.8	3.8	0.8	1.0	1.7	6.0	2.4	0.5	10.7	12.6	0.5	5.9	14.3	0.1	8.5	3.9	1.4	10.3	7.5	1.6	7.2	0.2	13.0	6.5	3.4	5.5	3.2	0.8	1.2	3.3	0.5	0.1	2.7	9.5	16.0	3.0	1.0	0.1	0.4	6.2	0.7	0.5	2.4	0.0	8.6	3.3	15.6	0.5	11.3	0.2	10.0	10.2	0.1	1.6	0.2	1.5	0.0	4.2	3.2	5.6	1.8	3.3	3.6	1.5	4.1	3.5	5.8	0.1	3.0	8.4	2.1	3.8	2.3	1.2	1.2	5.7	3.9	1.3	0.3	2.9	0.4	2.9	0.5	1.3	4.2	15.3	28.9	21.4	13.7	28.4	10.1	7.8	9.9	16.5	24.5	1.5	3.9	135.4	90.1	16.5	46.0	10.4	0.3	29.7	0.8	23.5	53.3	117.3	2.1	25.0	22.0	0.0	2.5	150.5	67.1	0.3	36.2	7.1	9.1	10.1	4.7	9.3	14.5	3.6	8.4	128.2	27.2	6.1	32.7	6.1	135.5	6.8	24.8	3.6	14.0	14.9	1.3	37.0	63.8	82.8	28.0	1.2	10.1	26.3	8.1	1.0	0.7	14.4	6.0	6.6	14.0	18.9	4.2	4.5	61.5	12.6	0.7	35.8	80.1	1.5	3.4
SLC16A8	"MCT3, REMP"	ENSG00000100156	"Solute carrier family 16 member 8"	O95907	22	38078134-38084093	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 9.1"	"Cell type enhanced"	"Detected in some"		"Leydig cells: 4.4;Melanocytes: 5.4;Oligodendrocytes: 4.0;Spermatogonia: 7.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.0;SiHa: 2.1;T-47d: 1.3;U-2 OS: 1.2;U-266/70: 4.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA075017	Approved		Approved	"Intermediate filaments,Focal adhesion sites"		No	NA				"Cluster 65: Brain - Ion transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 20: Spermatogonia & Spermatocytes - Spermatogenesis"	"Focal adhesion sites"	"Intermediate filaments"	"HPA075017: AB_2732276"	"unprognostic (1.22e-2)"	"unprognostic (2.25e-2)"	"unprognostic (5.07e-6)"	"unprognostic (2.99e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.84e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.32e-2)"	"unprognostic (2.34e-4)"	"unprognostic (7.69e-2)"	"unprognostic (1.15e-1)"	"unprognostic (4.06e-1)"	"unprognostic (9.71e-5)"	0.5	0.3	1.1	0.0	3.3	0.2	0.6	0.2	6.0	0.7	0.0	0.3	0.1	0.4	0.0	0.3	0.9	0.1	0.6	0.8	1.1	0.4	0.2	0.3	0.0	4.0	1.4	0.3	0.4	0.0	1.6	0.0	3.6	1.7	0.0	0.1	1.2	0.0	0.5	0.7	0.2	0.0	0.3	0.3	0.4	0.8	2.8	0.0	0.7	0.0	0.0	0.4	0.7	9.1	0.3	0.0	0.1	0.0	0.0	0.0	2.0	0.1	0.0	0.0	0.0	0.1	0.7	0.1	0.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.4	0.1	2.1	0.0	0.2	0.1	1.3	0.0	0.0	0.0	1.2	0.0	0.0	4.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.3	0.2	6.0	0.8	1.1	4.0	1.4	3.6	0.3	2.8	9.1	0.6	0.0	0.0	0.7	0.0	1.3	0.5	0.6	0.6	0.1	0.6	0.8	0.7	0.0	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.3	0.1	0.9	0.2	0.0	0.0	0.4	0.0	0.0	2.2	0.0	0.4	0.0	1.7	0.7	0.1	1.0	0.0	0.4	0.2	0.0	0.8	1.4	2.5	4.4	0.7	5.4	0.0	0.0	1.4	0.0	0.5	4.0	0.3	0.0	2.2	0.0	0.3	0.0	0.0	0.0	0.7	0.0	1.5	2.4	2.1	7.7	0.5	0.9	0.0	0.3	0.6	0.1	0.7
SLC16A9	"C10orf36, FLJ43803, MCT9"	ENSG00000165449	"Solute carrier family 16 member 9"	Q7RTY1	10	59650764-59736002	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"adrenal gland: 151.3;kidney: 191.1"	"Group enriched"	"Detected in many"	4	"Astrocytes: 83.9;Distal enterocytes: 108.6;Proximal tubular cells: 252.6;Theca cells: 99.4"	"Cancer enhanced"	"Detected in many"		"renal cancer: 21.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HAP1: 10.8;NTERA-2: 20.1;SuSa: 10.1;U-251 MG: 10.6;U-937: 18.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049286	Approved		Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Nucleoplasm	"Cell Junctions"	"HPA049286: AB_2680699"	"unprognostic (3.39e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.60e-3)"	"unprognostic (1.76e-2)"	"unprognostic (5.96e-2)"	"unprognostic (3.50e-3)"	"unprognostic (5.01e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.99e-2)"	"unprognostic (4.60e-2)"	"prognostic favorable (2.56e-6)"	"unprognostic (7.57e-3)"	"unprognostic (1.27e-2)"	"unprognostic (3.72e-1)"	"unprognostic (1.94e-1)"	1.2	151.3	12.8	1.2	12.8	1.7	1.7	11.9	14.8	18.5	18.4	12.5	0.4	16.2	5.2	10.9	22.0	3.1	3.4	12.9	16.6	191.1	2.5	1.1	1.7	14.0	13.7	34.1	3.0	29.2	6.9	0.1	12.0	7.8	16.7	5.6	2.9	10.2	4.3	0.4	1.2	7.2	13.3	40.8	6.0	8.9	12.3	1.2	13.9	2.8	2.8	2.2	9.0	15.0	0.0	0.3	5.2	6.8	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.3	0.0	0.7	0.0	0.0	0.9	10.8	0.0	0.0	0.0	1.8	0.1	0.3	0.1	0.1	2.3	0.0	0.5	0.2	0.0	2.8	0.1	0.4	5.4	8.0	0.1	0.6	4.2	3.0	0.0	20.1	2.0	9.3	3.6	0.2	7.2	0.0	0.3	3.4	9.6	0.1	0.4	0.0	10.1	3.4	4.5	3.2	0.5	1.1	0.1	10.6	0.0	0.0	0.0	0.0	18.6	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	12.8	11.9	14.8	12.9	16.6	14.0	13.7	12.0	13.3	12.3	15.0	0.3	0.0	0.0	83.9	1.0	0.1	2.1	9.4	0.6	4.3	3.1	1.5	3.9	0.0	26.2	7.3	0.0	0.0	0.0	108.6	25.4	1.0	0.2	2.3	2.0	1.5	20.0	4.2	2.5	0.0	1.7	4.1	3.6	2.4	0.0	28.4	0.4	0.0	0.1	3.3	4.8	19.1	4.1	18.8	0.7	1.5	13.7	1.5	3.6	1.9	0.6	11.8	0.0	14.6	1.0	0.1	23.2	12.0	0.0	17.7	2.2	252.6	7.4	1.0	0.0	2.4	3.4	0.3	0.2	17.0	0.1	0.0	0.7	99.4	11.9	6.5
SLC17A1	"NAPI-1, NPT1"	ENSG00000124568	"Solute carrier family 17 member 1"	Q14916	6	25782915-25832052	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	49	"kidney: 169.3;liver: 49.4"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 13.5;Hepatocytes: 10.3;Proximal tubular cells: 49.2"	"Group enriched"	"Detected in some"	150	"liver cancer: 7.6;renal cancer: 19.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	647	"RPTEC TERT1: 64.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050513			Approved	"Golgi apparatus"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Golgi apparatus"		"HPA050513: AB_2681152"			"unprognostic (6.98e-2)"		"unprognostic (2.99e-1)"		"unprognostic (1.03e-1)"				"unprognostic (1.26e-1)"		"unprognostic (2.71e-3)"	"unprognostic (1.32e-1)"	"unprognostic (2.37e-1)"	"unprognostic (4.74e-1)"		0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	169.3	49.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	49.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.1	0.0	0.0
SLC17A2	NPT3	ENSG00000112337	"Solute carrier family 17 member 2"	O00624	6	25912754-25930691	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	165	"liver: 79.5"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 30.9"	"Cancer enriched"	"Detected in some"	8	"liver cancer: 14.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	21	"Hep G2: 3.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA038270	Uncertain					NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA038270: AB_10672511"							"prognostic favorable (8.54e-4)"						"unprognostic (1.90e-2)"		"unprognostic (4.14e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	79.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	30.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A3	NPT4	ENSG00000124564	"Solute carrier family 17 member 3"	O00476	6	25833066-25882286	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 164.3"	"Cell type enriched"	"Detected in some"	13	"Proximal tubular cells: 197.8"	"Cancer enriched"	"Detected in some"	17	"renal cancer: 57.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	210	"RPTEC TERT1: 114.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (5.31e-3)"				"unprognostic (1.56e-2)"		"unprognostic (2.51e-1)"	"unprognostic (4.65e-2)"			"unprognostic (5.05e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.34e-1)"	"unprognostic (4.49e-1)"		0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	164.3	37.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	114.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	1.5	0.0	1.8	0.0	0.0	0.2	0.1	7.9	0.1	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.8	1.1	15.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	197.8	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.8	0.2	0.0	0.1
SLC17A4	KIAA2138	ENSG00000146039	"Solute carrier family 17 member 4"	Q9Y2C5	6	25754699-25781199	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in some"	8	"gallbladder: 16.3;intestine: 31.9;liver: 47.3;pancreas: 22.7"	"Group enriched"	"Detected in some"	5	"Cholangiocytes: 94.4;Distal enterocytes: 133.5;Hepatocytes: 41.8;Paneth cells: 44.1;Proximal enterocytes: 51.2"	"Group enriched"	"Detected in some"	6	"liver cancer: 11.0;renal cancer: 7.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	7	"RPTEC TERT1: 1.4"	"Not detected"	"Not detected"			"Region enriched"	"Detected in single"	8	"cerebellum: 1.5"	HPA055564	Approved					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA055564: AB_2682852"			"unprognostic (6.52e-2)"				"unprognostic (5.64e-3)"			"unprognostic (1.72e-1)"	"unprognostic (2.43e-1)"	"unprognostic (1.19e-3)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (7.27e-3)"			0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	20.6	28.7	0.0	0.0	0.0	0.0	16.3	0.0	0.0	0.0	3.7	47.3	0.0	0.0	0.0	0.0	0.0	22.7	0.0	0.0	0.1	0.2	0.0	26.7	0.0	0.0	0.0	0.0	0.0	31.9	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	94.4	0.0	0.0	0.0	0.0	0.0	133.5	0.0	8.3	0.8	0.0	0.0	0.0	13.1	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.7	41.8	0.1	0.0	0.0	11.7	0.0	0.8	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	44.1	0.0	0.0	0.0	51.2	1.0	0.0	0.0	0.0	0.0	0.1	0.4	0.1	0.0	0.0	0.0	0.1	0.0	11.5	0.0
SLC17A5	"AST, ISSD, NSD, SD, SIALIN, SIASD, SLD"	ENSG00000119899	"Solute carrier family 17 member 5"	Q9NRA2	6	73593379-73653992	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	7	"parathyroid gland: 310.5"	"Low cell type specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.0"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"ASC diff: 99.9;ASC TERT1: 74.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044479			Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cytosol"		"HPA044479: "	"unprognostic (6.48e-3)"	"unprognostic (7.95e-3)"	"unprognostic (9.23e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.08e-1)"	"unprognostic (2.59e-3)"	"unprognostic (4.44e-2)"	"unprognostic (4.18e-2)"	"unprognostic (2.60e-1)"	"unprognostic (3.14e-2)"	"unprognostic (8.29e-2)"	"unprognostic (4.59e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.09e-1)"	10.4	10.5	5.9	6.4	6.0	6.8	13.8	6.2	7.0	10.7	5.9	20.4	16.4	9.4	44.6	8.4	5.3	10.4	8.5	6.5	8.5	31.9	17.6	13.2	5.3	6.5	7.0	4.0	11.6	310.5	9.9	21.7	7.8	16.8	22.1	18.3	30.3	14.7	5.4	7.1	21.1	10.6	5.7	7.0	14.4	6.1	7.1	4.5	43.5	6.2	5.6	12.6	6.3	7.6	7.4	9.9	9.7	15.6	99.9	74.2	12.8	23.8	59.4	6.3	22.0	6.6	17.6	6.8	11.2	32.9	14.8	12.6	13.7	5.9	11.2	4.8	15.5	2.8	5.1	15.4	19.4	5.6	10.8	34.2	8.8	14.2	9.7	26.4	16.2	9.0	7.1	7.2	22.3	4.9	2.3	3.3	7.1	30.9	5.7	5.0	12.1	28.5	16.0	20.2	3.8	6.7	4.8	14.0	14.4	14.0	6.3	34.1	23.5	3.0	2.8	12.1	5.7	20.4	30.6	1.9	10.5	11.6	9.0	13.3	7.9	3.3	6.0	7.4	5.8	3.9	6.6	5.8	7.6	2.4	5.4	6.0	5.7	8.9	4.8	5.5	6.6	4.9	5.9	6.0	6.2	7.0	6.5	8.5	6.5	7.0	7.8	5.7	7.1	7.6	8.8	22.4	20.7	16.3	8.2	9.6	13.2	13.7	5.7	8.2	22.6	5.5	6.8	18.6	17.4	51.5	29.2	19.4	11.0	46.4	3.9	14.2	36.6	16.6	7.8	13.8	12.1	3.8	47.7	13.7	13.5	25.8	14.8	19.6	14.5	3.2	23.9	32.9	64.6	0.0	46.8	47.7	20.3	24.8	22.7	48.3	7.5	25.4	10.6	14.0	11.2	8.3	13.4	17.6	16.3	19.2	17.5	11.3	20.6	29.1	23.9	36.3	21.5	28.9	0.0	10.5	9.1	8.4	3.6	10.2	11.2	22.8	11.0	2.9	19.2	30.7
SLC17A6	"DNPI, VGLUT2"	ENSG00000091664	"Solute carrier family 17 member 6"	Q9P2U8	11	22338381-22379503	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.6"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 14.4;Rod photoreceptor cells: 5.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	229	"SCLC-21H: 30.3"	"Group enriched"	"Detected in all"	5	"basal ganglia: 51.9;hypothalamus: 139.9;midbrain: 172.4;pons and medulla: 86.4;thalamus: 164.9"	"Low region specificity"	"Detected in many"			"CAB037130, HPA039226, CAB078204"	Supported	Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB037130: AB_477611, CAB078204: AB_2665794, HPA039226: AB_2676400"					"unprognostic (1.39e-1)"						"unprognostic (1.93e-1)"							0.0	0.0	6.6	0.0	1.5	0.0	0.0	13.4	11.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.8	16.6	0.0	0.0	0.0	0.0	38.3	16.1	0.0	0.2	0.0	3.6	0.0	35.6	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	39.6	0.0	0.0	0.0	0.0	0.0	0.0	4.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.6	1.5	13.4	11.0	3.8	16.6	38.3	16.1	35.6	7.1	39.6	4.4	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	14.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.5	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC17A7	"BNPI, VGLUT1"	ENSG00000104888	"Solute carrier family 17 member 7"	Q9P2U7	19	49429401-49442360	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	63	"brain: 405.4;retina: 315.8"	"Group enriched"	"Detected in some"	13	"Bipolar cells: 362.7;Cone photoreceptor cells: 369.1;Excitatory neurons: 107.8;Rod photoreceptor cells: 358.0"	"Cancer enriched"	"Detected in some"	6	"glioma: 7.5"	"Group enriched"	"Detected in many"	7	"amygdala: 176.7;basal ganglia: 243.4;cerebral cortex: 289.7;hippocampal formation: 405.4;white matter: 169.9"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 20.8;K-562: 7.0;REH: 4.0;SCLC-21H: 4.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"amygdala: 201.2;cerebellum: 204.6;cerebral cortex: 339.5;hippocampal formation: 471.2"	"CAB037183, HPA050458, HPA063679"	Enhanced	Supported				NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB037183: AB_261840, HPA050458: AB_2681134, HPA063679: AB_2685086"	"unprognostic (1.79e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.52e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.03e-2)"	"unprognostic (1.44e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.70e-3)"	"unprognostic (8.32e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.26e-12)"	"unprognostic (8.36e-4)"	"unprognostic (4.27e-1)"	"unprognostic (1.35e-2)"	"unprognostic (6.17e-3)"	5.7	1.4	176.7	0.2	243.4	0.0	3.0	32.2	289.7	2.0	0.0	1.5	0.4	1.2	0.6	1.1	2.2	0.9	2.8	405.4	0.0	1.0	0.3	0.6	1.0	31.7	0.8	0.6	0.6	0.6	1.6	0.1	37.8	0.5	0.5	315.8	1.2	0.3	1.7	2.2	1.5	0.6	0.0	0.1	0.9	2.3	0.0	0.3	2.3	2.5	0.6	1.6	1.8	169.9	0.0	0.3	0.2	0.4	1.6	0.3	0.1	0.0	0.1	0.2	0.2	0.0	0.0	0.2	0.3	0.5	1.2	0.1	1.9	0.0	0.1	0.1	0.8	0.0	0.0	0.0	0.0	0.0	20.8	0.0	0.1	0.3	0.0	0.3	0.0	0.3	7.0	1.0	0.0	0.2	0.0	0.1	0.0	0.3	0.3	4.0	0.1	0.1	0.0	0.0	4.9	0.4	0.0	0.1	0.1	0.3	0.1	0.1	0.1	0.3	2.3	0.9	0.0	0.4	0.3	0.3	0.6	2.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	176.7	243.4	32.2	289.7	405.4	0.0	31.7	0.8	37.8	0.0	0.0	169.9	1.9	0.0	0.0	9.4	0.0	1.3	0.2	0.0	0.0	362.7	0.5	0.8	3.2	0.0	0.0	0.0	369.1	0.1	0.0	0.2	0.0	0.0	5.6	0.0	0.0	1.7	0.0	0.0	107.8	0.0	0.1	5.5	0.0	0.1	0.0	0.1	0.0	0.0	0.3	11.8	3.4	0.0	0.0	0.0	1.3	0.5	6.5	0.3	1.8	11.2	0.0	22.6	0.0	6.0	8.0	0.1	0.0	0.4	0.0	0.1	0.1	0.0	0.0	358.0	6.6	0.4	4.3	3.5	4.4	0.6	0.6	0.0	0.1	0.0	0.3	0.1
SLC17A8	"DFNA25, VGLUT3"	ENSG00000179520	"Solute carrier family 17 member 8"	Q8NDX2	12	100357074-100422055	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 11.3;intestine: 5.2"	"Group enriched"	"Detected in some"	4	"Endometrial ciliated cells: 13.3;Proximal enterocytes: 43.1"	"Cancer enhanced"	"Detected in single"		"glioma: 0.5"	"Group enriched"	"Detected in many"	5	"basal ganglia: 11.3;midbrain: 8.3;pons: 6.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			CAB079058		Supported				NA	NA				"Cluster 45: Intestine - Brush border"		"Cluster 45: Enterocytes - Digestion"			"CAB079058: "	"unprognostic (4.52e-3)"			"unprognostic (2.18e-1)"	"unprognostic (8.56e-2)"		"unprognostic (1.32e-3)"	"unprognostic (3.65e-1)"		"unprognostic (7.67e-2)"	"unprognostic (1.25e-1)"		"unprognostic (1.71e-2)"	"unprognostic (8.89e-2)"	"unprognostic (3.55e-1)"			0.0	0.0	0.4	0.0	11.3	0.0	0.0	0.0	1.6	0.0	0.7	0.4	0.7	0.1	0.0	0.0	0.3	0.0	0.0	0.4	1.3	0.0	0.5	0.0	0.0	0.4	8.3	0.0	0.0	0.0	0.0	0.3	6.5	0.0	0.3	1.2	0.0	0.0	0.0	0.0	5.2	0.0	0.2	0.0	0.0	0.1	1.6	1.4	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	11.3	0.0	1.6	0.4	1.3	0.4	8.3	6.5	0.2	1.6	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	13.3	0.1	0.1	0.0	0.0	0.4	0.0	3.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	6.6	1.1	0.0	3.2	0.0	0.0	0.3	0.0	0.0	1.0	0.0	0.0	0.0	1.5	0.2	0.0	1.7	0.0	0.0	0.0	43.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0
SLC17A9	"C20orf59, FLJ23412, VNUT"	ENSG00000101194	"Solute carrier family 17 member 9"	Q9BYT1	20	62952707-62969585	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Exocytosis, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 43.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 18.2;Gastric mucus-secreting cells: 29.0;Hepatocytes: 48.8;Hofbauer cells: 18.0;Intestinal goblet cells: 19.7;Plasma cells: 38.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"NK-cell: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ: 35.7;CACO-2: 32.9;Hep G2: 69.5;NB-4: 39.0;RPMI-8226: 36.1;U-937: 43.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA047470			Approved	Nucleoplasm		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm		"HPA047470: AB_2680060"	"unprognostic (2.65e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.08e-2)"	"unprognostic (1.97e-1)"	"unprognostic (4.33e-3)"	"unprognostic (5.33e-2)"	"unprognostic (6.03e-2)"	"unprognostic (6.84e-3)"	"unprognostic (1.00e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.21e-1)"	"unprognostic (7.11e-2)"	"prognostic unfavorable (2.78e-15)"	"unprognostic (6.06e-3)"	"unprognostic (5.51e-2)"	"unprognostic (5.96e-2)"	"unprognostic (1.06e-1)"	1.3	1.0	0.3	5.8	0.5	11.4	1.3	0.7	0.7	1.9	0.7	3.7	5.5	1.5	0.2	0.8	1.9	1.3	1.3	0.6	0.8	0.9	43.0	3.5	5.2	1.2	0.9	1.7	1.4	0.0	2.2	1.7	1.3	1.3	3.1	0.0	4.0	0.6	1.0	0.7	4.2	1.4	0.9	11.1	9.5	0.4	1.2	0.7	1.2	0.1	4.2	2.7	1.7	2.0	0.0	0.0	0.0	0.2	0.3	3.1	0.1	35.7	10.0	11.4	18.0	32.9	0.0	25.9	0.0	28.3	0.0	0.0	5.0	0.0	2.8	0.0	0.0	11.5	0.9	69.5	7.7	20.9	0.0	2.5	0.0	13.6	0.0	0.0	7.6	0.1	0.1	14.6	0.0	0.0	0.9	39.0	0.0	12.9	0.2	26.9	0.0	36.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	19.4	2.6	0.0	0.0	1.2	0.0	5.0	0.3	14.2	0.0	43.8	0.0	0.0	0.9	0.0	0.7	1.7	0.5	2.2	0.0	0.4	2.6	1.7	0.0	0.3	0.0	4.9	0.3	0.0	0.1	0.7	0.3	0.5	0.7	0.7	0.6	0.8	1.2	0.9	1.3	0.9	1.2	2.0	1.1	0.0	1.1	0.0	18.2	0.9	0.2	0.3	0.0	0.4	1.0	1.0	1.3	12.8	1.0	0.0	0.0	0.3	5.5	6.4	0.0	0.3	0.7	2.6	7.3	1.4	3.0	1.7	0.7	0.4	0.9	4.0	29.0	2.5	5.1	2.4	1.4	48.8	18.0	0.0	0.4	19.7	0.0	5.1	12.4	0.6	1.2	7.2	5.4	2.8	1.3	0.1	4.1	1.0	0.1	1.7	3.1	0.7	38.6	0.6	0.2	0.4	0.8	0.1	0.0	1.6	4.2	0.4	1.0	0.0	1.1	0.8	3.6	3.8	9.3	0.6
SLC18A1	"CGAT, VAT1, VMAT1"	ENSG00000036565	"Solute carrier family 18 member A1"	P54219	8	20144855-20183206	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"adrenal gland: 25.1"	"Cell type enriched"	"Detected in some"	27	"Enteroendocrine cells: 139.0"	"Cancer enhanced"	"Detected in some"		"colorectal cancer: 0.8"	"Region enriched"	"Detected in single"	19	"midbrain: 3.9"	"Immune cell enhanced"	"Detected in single"		"non-classical monocyte: 2.8"	"Lineage enriched"	"Detected in single"	19	"monocytes: 2.8"	"Cell line enriched"	"Detected in some"	8	"SH-SY5Y: 67.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA006877, HPA063797"	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 17: Adrenal gland - Steroid metabolism"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA006877: AB_2667690, HPA063797: AB_2685125"	"unprognostic (8.03e-4)"	"unprognostic (1.02e-1)"	"unprognostic (3.75e-3)"	"unprognostic (3.50e-1)"	"unprognostic (6.61e-2)"	"unprognostic (3.09e-3)"	"unprognostic (1.67e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.61e-1)"	"unprognostic (2.48e-2)"	"unprognostic (8.25e-2)"	"unprognostic (4.41e-2)"	"unprognostic (2.06e-1)"	"unprognostic (1.05e-1)"	0.1	25.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.1	0.2	3.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	1.1	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	3.8	67.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.1	3.9	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	139.0	0.0	0.0	0.0	0.0	3.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.9	1.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1
SLC18A2	"SVAT, SVMT, VMAT2"	ENSG00000165646	"Solute carrier family 18 member A2"	Q05940	10	117241093-117279430	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.1;cervix: 30.0"	"Cell type enriched"	"Detected in many"	5	"granulocytes: 636.0"	"Low cancer specificity"	"Detected in some"			"Group enriched"	"Detected in many"	11	"hypothalamus: 20.8;midbrain: 81.1;pons: 70.5"	"Immune cell enriched"	"Detected in some"	15	"basophil: 59.5"	"Lineage enriched"	"Detected in many"	15	"granulocytes: 59.5"	"Cell line enriched"	"Detected in some"	19	"HMC-1: 351.0"	"Region enhanced"	"Detected in many"		"midbrain: 62.7"	"Region enriched"	"Detected in all"	4	"midbrain: 111.6"	HPA073224	Enhanced		Approved	Vesicles,Centrosome		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"	"Vesicles, Centrosome"		"HPA073224: AB_2732222"	"unprognostic (1.49e-1)"	"unprognostic (2.48e-1)"	"unprognostic (2.33e-3)"	"unprognostic (9.00e-2)"	"unprognostic (2.85e-1)"	"unprognostic (5.33e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.71e-2)"	"unprognostic (1.40e-1)"	"unprognostic (4.55e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.06e-3)"	"unprognostic (7.94e-5)"	"unprognostic (2.95e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.43e-1)"	"unprognostic (3.57e-2)"	1.1	14.6	0.1	0.9	1.1	2.4	1.8	0.1	0.3	30.0	0.2	2.3	1.5	2.6	1.6	2.5	0.5	3.6	0.7	0.2	20.8	0.9	2.8	7.4	0.6	3.8	81.1	10.4	3.4	0.2	0.2	0.1	70.5	9.2	3.5	0.4	0.8	1.3	0.8	6.3	2.1	2.3	0.0	0.3	4.4	0.9	5.0	6.1	0.0	0.5	0.9	2.9	7.9	0.2	0.2	1.1	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.7	0.3	0.6	0.0	0.1	0.7	0.0	0.0	0.0	0.1	0.7	18.6	0.1	0.2	0.0	1.0	351.0	0.0	0.0	0.0	0.0	0.2	0.0	3.7	0.0	0.7	0.0	0.1	1.0	0.3	0.2	0.3	0.6	0.2	0.4	0.2	0.0	0.2	3.4	0.7	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.1	2.5	0.3	0.8	0.5	0.4	0.2	0.4	1.9	0.3	59.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.0	0.0	3.8	0.0	2.0	0.1	1.1	0.1	0.3	0.2	20.8	3.8	81.1	70.5	0.0	5.0	0.2	0.0	9.6	16.2	1.0	0.2	1.9	0.0	0.0	0.0	2.1	0.2	0.0	0.3	0.0	2.5	0.0	4.2	0.0	5.7	0.4	0.0	0.0	0.0	13.1	16.1	0.7	8.9	4.2	1.1	0.0	0.0	3.4	4.1	112.4	636.0	2.4	9.7	0.3	0.8	0.0	1.7	0.0	0.0	1.0	3.6	0.2	0.6	3.5	1.8	0.0	0.1	0.4	0.0	0.5	0.6	0.1	0.1	4.9	1.9	3.8	0.0	0.1	0.7	0.8	0.0	0.4	1.3	0.2	2.1	0.0	2.7	0.0	5.6	9.8	0.1	0.1
SLC18A3	VACHT	ENSG00000187714	"Solute carrier family 18 member A3"	Q16572	10	49610310-49612720	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"		"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	21	"brain: 25.6"	"Cell type enriched"	"Detected in some"	4	"Fibroblasts: 7.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 7.2"	"Low region specificity"	"Detected in many"			"Region enriched"	"Detected in many"	5	"spinal cord: 78.1"	CAB079011		Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"CAB079011: "				"unprognostic (2.14e-4)"	"unprognostic (1.55e-1)"			"unprognostic (1.01e-1)"		"unprognostic (9.39e-2)"	"unprognostic (4.55e-2)"	"unprognostic (3.00e-1)"		"unprognostic (5.85e-3)"	"unprognostic (7.56e-2)"	"unprognostic (1.16e-1)"		0.0	0.0	0.7	0.3	2.0	0.0	0.0	0.0	19.7	0.0	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.9	0.0	0.0	0.0	0.0	18.9	8.0	0.0	0.0	0.0	1.2	0.4	25.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	3.6	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.5	6.6	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	7.2	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	2.0	0.0	19.7	0.1	4.9	18.9	8.0	25.6	3.6	0.7	6.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.4	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	1.5	0.0	0.0	0.0	0.0
SLC18B1	"C6orf192, dJ55C23.6"	ENSG00000146409	"Solute carrier family 18 member B1"	Q6NT16	6	132769370-132813339	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 93.4;Hofbauer cells: 65.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"K-562: 40.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029747	Approved		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Cytosol	"HPA029747: AB_10600797"	"unprognostic (1.84e-2)"	"unprognostic (3.94e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.41e-2)"	"prognostic favorable (3.55e-4)"	"prognostic unfavorable (7.90e-4)"	"unprognostic (1.53e-1)"	"unprognostic (2.39e-1)"	"unprognostic (4.09e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.13e-1)"	"prognostic favorable (9.24e-4)"	"unprognostic (7.20e-3)"	"unprognostic (1.08e-1)"	"unprognostic (2.08e-2)"	"unprognostic (7.88e-2)"	9.9	8.9	21.0	6.3	21.6	4.6	9.7	22.5	28.0	9.4	23.1	9.7	14.5	6.4	5.8	13.6	9.8	11.9	3.9	21.2	22.2	12.7	7.6	5.7	7.7	21.6	22.3	6.9	9.9	12.9	8.3	15.7	21.0	5.4	10.1	2.6	13.1	4.5	3.2	9.5	10.5	5.9	22.8	8.3	16.1	2.0	25.1	7.9	10.2	3.5	8.1	11.1	7.2	22.8	6.8	6.5	10.0	0.0	1.5	3.2	5.7	2.5	7.2	4.4	13.4	14.9	13.8	0.2	9.2	1.5	7.9	17.3	13.4	15.4	3.3	10.3	27.6	3.6	11.3	16.8	7.5	3.0	0.3	9.3	13.7	7.2	14.5	7.3	13.6	20.7	40.4	2.5	3.8	9.4	10.5	0.3	14.1	15.8	8.7	15.7	11.7	11.8	36.6	11.4	21.2	0.0	12.9	25.2	20.1	6.0	8.9	0.1	6.0	1.9	5.3	2.1	5.7	8.5	0.5	0.4	11.5	0.1	1.7	0.0	14.4	0.8	4.3	3.2	8.1	6.6	6.5	6.0	19.9	9.7	9.5	6.6	0.8	3.4	0.3	15.5	11.9	8.1	21.0	21.6	22.5	28.0	21.2	22.2	21.6	22.3	21.0	22.8	25.1	22.8	10.4	0.0	6.5	93.4	15.2	10.1	10.3	30.4	22.8	5.5	13.0	7.4	3.1	40.0	20.6	27.6	2.1	53.1	8.2	5.4	9.8	32.0	0.2	12.6	4.8	7.8	16.3	49.1	32.2	15.1	19.3	7.8	20.4	5.8	0.0	5.8	18.2	15.6	65.6	0.0	25.3	11.9	32.6	21.5	9.0	0.5	6.8	26.7	14.2	27.2	11.4	9.3	5.2	51.3	4.4	14.6	6.0	4.5	6.6	8.8	7.2	6.4	27.9	3.5	0.0	8.6	4.8	0.3	0.5	25.5	10.9	28.5	7.3	21.7	15.3	13.2
SLC19A1	"FOLT, RFC1"	ENSG00000173638	"Solute carrier family 19 member 1"	P41440	21	45493572-45573365	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 82.6"	"Group enriched"	"Detected in many"	5	"Cytotrophoblasts: 158.0;Syncytiotrophoblasts: 362.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"neutrophil: 102.9"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 102.9"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024802	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA024802: AB_10602892"	"unprognostic (4.31e-3)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.87e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavorable (1.07e-10)"	"unprognostic (1.44e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.97e-5)"	"unprognostic (3.10e-1)"	7.7	9.4	8.2	5.7	4.0	8.1	5.9	5.6	12.4	10.0	82.6	6.8	22.5	6.4	0.9	3.2	6.9	1.9	4.2	11.8	2.7	8.0	20.9	15.7	4.2	5.3	5.2	11.8	6.9	0.8	5.4	13.6	6.0	5.8	0.8	2.3	3.3	0.8	2.6	3.9	7.9	1.1	3.0	15.1	7.4	4.6	6.6	2.2	13.8	0.5	0.7	4.3	5.2	4.1	28.9	23.7	4.9	19.4	1.5	2.1	40.2	12.5	1.9	11.1	7.0	55.1	26.1	26.8	24.9	2.8	9.1	14.1	9.0	8.5	2.7	25.2	51.2	54.7	12.4	38.8	6.1	37.2	8.5	2.7	6.3	11.6	3.3	3.3	9.1	27.3	67.6	11.8	3.5	29.3	49.6	29.9	28.5	11.2	30.0	66.5	5.4	79.2	4.6	16.9	29.7	26.7	14.9	23.5	11.2	6.7	18.4	41.4	10.7	14.6	18.8	4.3	21.1	4.8	18.5	23.5	6.7	56.4	11.9	1.6	18.5	24.1	0.9	16.3	2.8	2.5	1.4	2.0	13.4	0.8	2.0	1.5	102.9	1.1	10.8	4.1	3.2	7.9	8.2	4.0	5.6	12.4	11.8	2.7	5.3	5.2	6.0	3.0	6.6	4.1	1.4	48.1	6.3	13.7	2.9	2.4	2.0	2.6	1.8	23.6	3.9	3.4	2.5	1.5	6.2	0.0	0.0	158.0	0.5	8.2	0.0	8.0	3.7	2.2	5.8	3.4	0.0	6.7	3.4	4.9	21.5	3.7	4.1	4.5	1.3	12.7	1.1	16.2	27.3	8.4	4.0	4.1	8.2	11.1	5.0	6.6	6.5	8.6	3.6	23.4	8.3	5.7	0.0	2.0	1.7	7.6	5.4	11.3	9.4	4.6	20.5	2.4	0.9	3.6	0.0	3.3	4.1	1.5	4.8	1.8	1.6	362.4	2.6	5.1	8.5	0.9
SLC19A2	"THTR1, TRMA"	ENSG00000117479	"Solute carrier family 19 member 2"	O60779	1	169463909-169485944	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 124.1;tongue: 84.9"	"Cell type enhanced"	"Detected in many"		"Skeletal myocytes: 84.5;Syncytiotrophoblasts: 156.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006119, HPA016599"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	Cytosol		"HPA006119: AB_1079996, HPA016599: AB_1857005"	"prognostic favorable (8.41e-4)"	"unprognostic (8.82e-2)"	"unprognostic (1.90e-1)"	"unprognostic (3.29e-3)"	"prognostic favorable (2.90e-4)"	"unprognostic (4.45e-2)"	"unprognostic (9.69e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"prognostic favorable (2.70e-5)"	"unprognostic (1.08e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.60e-2)"	"unprognostic (2.14e-2)"	42.2	17.8	3.0	8.3	3.1	8.7	20.9	5.1	4.2	10.5	9.3	11.8	3.5	8.6	6.1	11.3	21.3	25.8	31.2	4.0	3.6	13.0	37.1	19.5	2.6	4.9	3.7	20.5	22.2	24.8	19.0	18.1	4.0	10.5	4.3	7.5	12.5	3.8	124.1	16.5	11.4	6.1	3.7	2.8	19.2	7.8	4.2	4.1	15.7	84.9	2.8	18.1	12.9	3.5	7.4	5.1	11.4	9.0	34.4	12.7	25.0	5.8	4.3	4.6	6.5	20.9	7.6	6.5	6.4	3.9	8.5	7.7	13.9	8.5	5.1	18.8	13.0	6.2	16.7	19.3	18.7	15.8	5.9	15.0	12.2	7.4	18.8	6.4	7.0	11.3	25.3	4.1	7.9	5.0	8.2	7.1	25.8	14.1	7.7	0.0	24.6	7.5	12.2	15.5	9.9	13.3	8.0	13.6	29.2	12.8	8.5	10.1	5.8	5.5	7.7	6.9	11.4	5.6	5.6	2.1	8.1	6.0	7.4	0.0	0.6	1.1	0.3	0.2	1.1	0.4	0.4	0.7	0.7	0.4	1.0	1.0	0.4	0.9	2.0	0.2	0.3	0.2	3.0	3.1	5.1	4.2	4.0	3.6	4.9	3.7	4.0	3.7	4.2	3.5	13.6	9.6	19.3	11.8	7.3	29.6	16.5	4.4	43.9	5.3	34.1	13.6	27.7	7.2	11.4	5.5	2.1	26.9	11.3	10.6	0.0	7.4	4.3	22.6	9.7	3.7	9.0	5.2	15.6	5.3	4.5	52.7	49.5	42.7	10.2	4.1	1.1	29.8	7.0	6.7	22.8	6.4	12.2	2.9	8.8	2.7	6.8	18.3	21.4	7.5	1.0	2.5	2.1	16.1	3.3	9.6	5.4	4.9	14.0	16.5	5.6	2.0	12.7	5.1	0.0	84.5	14.2	6.7	4.1	35.2	50.4	156.4	7.5	3.1	6.7	28.9
SLC19A3	THTR2	ENSG00000135917	"Solute carrier family 19 member 3"	Q9BZV2	2	227683763-227718028	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 46.7;breast: 28.4;placenta: 24.1"	"Group enriched"	"Detected in many"	4	"Cytotrophoblasts: 65.4;Syncytiotrophoblasts: 160.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 6.8"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"ASC diff: 13.9;BEWO: 6.2;CACO-2: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038898	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Nucleoplasm	"Plasma membrane, Cytosol"	"HPA038898: AB_10673481"	"unprognostic (3.37e-2)"	"unprognostic (3.59e-5)"	"unprognostic (1.95e-3)"	"unprognostic (1.24e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.82e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.67e-2)"	"unprognostic (3.12e-3)"	"unprognostic (7.28e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.71e-2)"	"unprognostic (7.01e-3)"	46.7	0.6	5.0	1.9	3.3	1.2	28.4	4.7	4.3	0.5	1.0	2.6	9.1	0.5	0.1	0.7	0.5	5.7	0.7	3.4	4.4	2.2	13.8	4.1	0.8	5.2	4.2	0.9	1.7	0.1	0.1	24.1	5.4	0.3	1.8	2.2	1.1	0.1	0.9	1.6	5.6	0.4	4.4	0.5	0.5	0.5	5.7	0.2	0.4	0.8	0.4	1.0	0.4	4.0	0.3	0.9	0.2	0.8	13.9	0.3	6.2	0.1	0.2	0.2	0.6	20.2	0.4	0.2	0.1	0.1	4.6	0.4	0.6	0.5	0.8	0.0	1.0	0.1	1.1	0.8	1.8	0.2	0.1	3.4	0.4	0.1	0.8	0.3	0.0	0.3	0.1	0.6	0.0	1.6	0.1	0.5	3.0	0.7	0.1	0.3	0.1	0.2	0.2	0.2	0.9	0.1	0.3	1.9	0.5	2.6	0.2	0.2	0.6	0.4	0.4	4.1	0.4	0.1	0.1	0.6	1.4	0.2	0.5	6.8	0.8	1.0	0.4	0.6	0.3	0.8	0.4	0.4	0.2	1.3	0.5	0.5	3.3	2.2	0.7	1.0	0.2	0.3	5.0	3.3	4.7	4.3	3.4	4.4	5.2	4.2	5.4	4.4	5.7	4.0	0.2	9.6	5.1	2.3	0.0	0.0	0.5	0.0	0.6	5.3	0.2	0.1	0.4	5.7	0.0	1.8	0.0	65.4	0.1	5.7	1.9	4.4	0.3	0.1	0.0	2.6	1.2	0.0	0.4	0.0	7.4	3.2	0.0	0.1	0.0	0.3	0.0	13.1	5.1	0.0	0.9	1.6	0.0	0.6	0.0	0.7	0.3	0.9	0.0	25.3	0.0	0.8	0.0	4.5	0.3	0.4	1.0	0.0	0.1	0.4	9.3	3.0	0.0	0.2	0.0	1.7	1.6	0.0	0.3	0.0	0.0	160.6	0.2	0.1	6.5	0.4
SLC1A1	"EAAC1, EAAT3"	ENSG00000106688	"Solute carrier family 1 member 1"	P43005	9	4490468-4587469	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Schizophrenia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 45.0;intestine: 64.7;kidney: 51.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 163.5;Glandular and luminal cells: 98.7;Hepatocytes: 68.4;Microglial cells: 67.5;Oligodendrocyte precursor cells: 161.4;Proximal enterocytes: 110.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 29.1;HDLM-2: 70.9;HUVEC TERT2: 32.5;RPTEC TERT1: 66.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062356	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA062356: "	"unprognostic (1.28e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.07e-3)"	"unprognostic (2.04e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.58e-1)"	"unprognostic (2.71e-1)"	"unprognostic (1.35e-2)"	"unprognostic (1.25e-2)"	"prognostic favorable (2.86e-8)"	"unprognostic (2.68e-1)"	"unprognostic (9.49e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.64e-1)"	4.6	1.7	13.2	2.3	15.4	0.1	4.1	9.5	14.8	5.8	12.9	12.4	34.8	3.7	45.0	2.3	2.6	25.5	2.8	16.5	12.6	51.0	41.2	20.9	2.6	10.8	13.0	0.6	2.1	0.3	6.8	8.1	13.6	6.3	10.2	6.0	4.8	3.2	1.4	1.5	64.7	3.2	10.9	0.4	5.2	0.8	13.9	0.4	29.5	1.3	8.2	5.6	1.5	10.1	0.1	2.0	1.6	9.5	24.3	29.1	8.3	10.4	21.4	3.2	3.1	17.2	0.5	13.7	0.6	5.4	3.9	0.0	3.6	5.7	2.9	70.9	4.5	0.0	13.6	0.1	0.8	0.9	0.0	2.0	0.2	12.1	0.0	1.6	32.5	0.2	0.0	0.0	2.2	0.3	0.0	0.3	4.2	10.5	1.8	0.0	0.0	0.2	66.4	6.1	2.2	2.0	0.8	3.8	0.0	7.7	1.4	0.5	17.6	4.9	0.4	9.5	3.0	0.1	0.1	0.0	23.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	13.2	15.4	9.5	14.8	16.5	12.6	10.8	13.0	13.6	10.9	13.9	10.1	12.2	163.5	3.2	4.2	0.4	0.0	1.1	0.6	4.6	3.9	2.0	0.8	2.3	28.6	6.1	0.0	0.0	0.1	0.0	52.4	3.9	8.1	4.3	10.7	13.3	10.6	0.0	0.0	48.4	0.8	0.0	1.8	2.0	98.7	0.0	0.6	2.5	68.4	0.1	0.0	50.3	10.1	0.0	1.3	0.3	11.2	0.3	1.1	0.0	67.5	0.0	0.8	0.0	161.4	3.5	9.3	10.6	0.0	0.0	2.4	110.6	43.1	3.3	1.1	0.0	0.5	3.1	0.1	0.2	1.0	0.6	0.1	1.4	0.4	8.5	1.8
SLC1A2	"EAAT2, GLT-1"	ENSG00000110436	"Solute carrier family 1 member 2"	P43004	11	35251205-35420063	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 782.3;choroid plexus: 202.7"	"Cell type enriched"	"Detected in many"	7	"Astrocytes: 4607.2"	"Cancer enriched"	"Detected in some"	5	"glioma: 28.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 2.1;BJ hTERT+: 2.4;fHDF/TERT166: 1.7;Hep G2: 2.9;NTERA-2: 3.1;SCLC-21H: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002574, HPA009172, HPA067499"	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB002574: AB_564087, HPA009172: AB_1849764, HPA067499: "	"unprognostic (8.00e-2)"	"unprognostic (5.71e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.77e-2)"	"unprognostic (1.33e-1)"	"unprognostic (5.65e-3)"	"unprognostic (1.39e-2)"	"unprognostic (9.27e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.65e-2)"	"unprognostic (1.79e-3)"	"unprognostic (2.35e-1)"	"unprognostic (8.33e-4)"	"unprognostic (6.34e-2)"	"unprognostic (8.06e-2)"	"unprognostic (5.24e-2)"	"unprognostic (3.49e-2)"	0.6	4.6	546.9	0.6	731.2	0.4	3.8	388.1	782.3	1.2	202.7	0.2	0.5	1.0	0.3	0.2	0.3	0.2	0.9	631.1	432.5	0.2	34.9	0.6	1.9	450.6	533.6	0.1	9.5	0.1	2.6	1.1	384.2	0.3	0.1	60.1	4.6	0.1	0.3	1.3	0.2	0.3	409.7	0.5	2.1	1.7	498.7	0.2	0.3	0.5	1.6	0.3	0.6	453.4	0.0	0.1	0.5	0.0	0.2	2.1	0.0	0.5	2.4	0.1	0.1	0.0	0.0	0.0	0.0	1.7	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.3	2.9	0.1	0.3	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.1	0.0	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.6	0.2	0.0	1.1	0.0	0.1	0.5	0.0	0.3	0.1	0.1	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.1	1.3	0.1	0.2	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.2	0.2	0.1	0.5	0.2	0.1	0.1	0.1	0.1	546.9	731.2	388.1	782.3	631.1	432.5	450.6	533.6	384.2	409.7	498.7	453.4	0.4	3.2	4.8	4607.2	0.4	2.9	0.0	0.0	0.0	109.9	8.1	2.4	3.1	0.0	0.0	0.0	148.0	25.6	0.3	0.1	0.0	0.1	96.6	1.8	11.7	1.6	0.0	0.0	83.7	3.4	1.0	3.1	1.1	1.5	0.0	0.7	0.0	6.7	3.3	6.7	81.5	0.0	0.0	0.0	3.0	97.9	0.0	0.6	1.8	194.9	31.6	10.1	0.0	634.9	12.3	0.4	0.0	0.0	0.1	0.3	0.0	0.1	0.8	161.2	0.0	0.3	1.8	0.5	1.3	0.0	1.1	269.4	0.2	0.0	0.0	0.1
SLC1A3	"EA6, EAAT1, GLAST"	ENSG00000079215	"Solute carrier family 1 member 3"	P43003	5	36596588-36688334	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	10	"brain: 776.8;choroid plexus: 400.6;retina: 221.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 1735.2;Microglial cells: 332.6;Muller glia cells: 472.6;Oligodendrocyte precursor cells: 237.7;Oligodendrocytes: 249.0"	"Cancer enriched"	"Detected in all"	21	"glioma: 168.1"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"classical monocyte: 1.5;intermediate monocyte: 1.2;myeloid DC: 1.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 1.6;monocytes: 1.5"	"Cell line enhanced"	"Detected in many"		"AF22: 50.0;CACO-2: 112.6;HaCaT: 71.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002573, HPA037467, HPA037468"	Enhanced	Supported	Approved	Nucleoli,Vesicles		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoli, Vesicles"		"CAB002573: AB_564088, HPA037467: AB_10795027, HPA037468: AB_10671371"	"unprognostic (1.23e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.58e-3)"	"unprognostic (1.74e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.70e-2)"	"unprognostic (3.89e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.84e-2)"	"unprognostic (4.17e-3)"	"unprognostic (3.28e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.17e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.31e-2)"	30.7	16.4	500.4	7.4	544.2	3.3	17.7	549.4	776.8	8.7	400.6	3.0	0.5	1.6	1.1	10.5	6.0	8.0	45.4	514.6	502.5	2.2	3.8	10.2	17.4	477.6	510.1	12.6	5.0	2.2	18.1	20.3	502.4	3.2	1.1	221.1	4.7	4.7	14.1	6.0	3.2	4.1	495.4	9.3	2.2	1.2	532.8	3.6	3.4	9.2	5.4	7.0	5.3	494.9	1.3	0.2	50.0	5.3	5.9	14.3	37.7	0.3	0.0	2.4	4.9	112.6	5.6	0.0	27.8	2.3	1.0	71.4	16.9	9.1	2.2	1.8	33.0	0.0	0.5	0.0	2.5	1.3	0.6	26.9	34.5	14.4	5.3	1.8	0.0	1.1	0.0	0.2	8.7	0.2	0.1	0.1	6.0	0.1	5.9	0.0	0.5	0.0	0.1	3.1	4.7	0.0	5.1	14.6	2.1	24.4	0.2	3.1	0.0	6.2	10.3	0.1	20.7	0.0	0.0	0.3	21.7	37.7	12.6	0.0	1.5	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	500.4	544.2	549.4	776.8	514.6	502.5	477.6	510.1	502.4	495.4	532.8	494.9	1.1	3.2	0.5	1735.2	0.7	10.7	14.3	19.0	83.1	7.1	3.7	3.4	36.0	0.0	3.1	0.0	2.1	32.9	0.1	0.0	0.0	0.8	0.7	16.3	1.2	8.9	0.0	0.8	2.6	0.0	15.9	7.8	2.0	11.7	0.0	0.2	1.1	0.5	41.2	3.3	4.7	0.0	0.0	77.6	5.9	4.1	4.4	59.6	7.2	332.6	3.3	472.6	0.0	237.7	249.0	0.3	0.0	0.0	0.7	5.2	0.0	0.0	5.3	19.1	6.6	2.6	3.1	0.3	0.3	32.7	7.1	9.2	1.0	20.7	0.0	3.6
SLC1A4	"ASCT1, SATT"	ENSG00000115902	"Solute carrier family 1 member 4"	P43007	2	64988477-65023865	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 59.9"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 69.9;Granulosa cells: 49.2;Melanocytes: 85.4;Plasma cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"SK-MEL-30: 294.5;U-266/70: 132.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034963, HPA034964"	Approved		Enhanced	Centrosome		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Centrosome		"HPA034963: AB_2797223, HPA034964: AB_2674386"	"unprognostic (7.61e-2)"	"prognostic favorable (3.59e-4)"	"unprognostic (2.49e-1)"	"unprognostic (3.19e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.24e-2)"	"prognostic unfavorable (4.23e-5)"	"unprognostic (1.26e-2)"	"unprognostic (2.10e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.28e-2)"	"unprognostic (3.48e-1)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (6.37e-3)"	"unprognostic (4.14e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.98e-2)"	4.3	26.4	49.1	9.1	46.8	13.4	13.6	32.1	48.6	14.0	18.0	9.4	6.1	12.8	8.2	7.5	4.8	3.9	6.2	43.4	56.6	1.9	9.0	4.9	10.7	37.2	43.1	13.2	29.6	5.5	13.7	6.6	52.1	9.6	8.4	19.3	7.5	7.1	40.1	18.6	5.6	12.3	29.5	7.5	8.1	11.7	59.9	20.5	5.7	17.0	19.0	4.8	6.2	30.3	15.3	11.6	6.6	34.9	14.7	9.5	9.4	28.5	14.0	11.7	19.8	3.2	2.2	49.7	6.5	44.8	14.7	43.2	13.7	3.6	12.0	20.1	5.4	26.0	13.1	30.9	31.0	43.8	23.1	4.4	73.8	15.8	24.2	3.9	7.3	49.1	20.7	122.0	8.4	13.5	37.7	29.1	4.7	20.1	13.9	13.5	1.9	125.5	4.9	7.7	29.3	14.1	17.9	16.1	294.5	3.0	19.3	47.8	1.6	16.0	19.0	31.2	17.5	132.8	71.2	118.8	23.6	86.5	86.2	0.0	2.1	1.8	0.9	4.8	1.2	0.9	0.9	1.5	3.9	0.3	0.0	0.8	0.0	5.1	9.4	7.2	3.5	1.4	49.1	46.8	32.1	48.6	43.4	56.6	37.2	43.1	52.1	29.5	59.9	30.3	3.6	0.0	2.7	69.9	13.6	20.0	2.1	6.7	46.1	6.3	21.0	7.1	5.5	1.5	1.7	1.8	33.3	2.4	20.2	2.9	0.0	2.0	32.4	5.4	8.2	5.3	8.4	6.1	20.6	9.3	1.3	4.0	5.1	5.6	7.0	49.2	7.5	13.1	17.7	6.7	25.5	9.0	6.1	6.8	11.8	47.5	11.1	11.1	85.4	8.4	5.1	14.6	2.1	5.0	3.9	7.1	0.8	29.7	65.7	2.6	0.4	1.5	5.4	17.7	0.0	5.1	7.3	2.0	0.9	5.9	6.1	2.5	10.9	0.4	5.8	1.0
SLC1A5	"AAAT, ASCT2, M7V1, RDRC"	ENSG00000105281	"Solute carrier family 1 member 5"	Q15758	19	46774883-46788594	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Host-virus interaction, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 148.6;Erythroid cells: 143.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 95.8"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA035239, HPA035240"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 61: Squamous epithelial cells - Keratinization"	"Plasma membrane"		"HPA035239: AB_10670587, HPA035240: AB_10604092"	"unprognostic (8.26e-3)"	"unprognostic (6.38e-2)"	"unprognostic (7.24e-2)"	"unprognostic (7.94e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.24e-1)"	"prognostic unfavorable (1.66e-8)"	"unprognostic (2.08e-1)"	"unprognostic (1.06e-2)"	"unprognostic (9.82e-2)"	"unprognostic (9.40e-3)"	"unprognostic (9.57e-3)"	"prognostic unfavorable (1.18e-7)"	"unprognostic (1.28e-2)"	"unprognostic (6.30e-2)"	"unprognostic (1.06e-2)"	"unprognostic (9.83e-2)"	97.2	15.9	5.8	29.6	6.5	60.9	77.7	6.6	6.1	57.4	6.1	50.1	16.2	39.1	98.0	98.0	48.9	36.5	26.4	5.9	8.5	45.6	8.1	65.3	27.9	15.8	11.1	45.8	73.2	2.9	24.5	46.9	13.3	98.6	42.4	1.4	120.5	77.0	8.5	55.7	36.2	33.0	9.5	40.4	55.5	40.3	9.8	19.9	14.1	10.7	30.3	109.6	83.0	11.5	179.6	323.6	76.3	116.1	194.7	164.3	180.0	249.6	283.0	183.2	264.1	296.1	197.1	194.8	118.9	624.2	105.2	281.1	224.9	296.9	135.5	130.1	203.7	324.3	115.1	281.9	501.3	228.2	182.9	268.6	727.3	215.5	541.1	61.3	98.9	255.0	348.9	500.1	99.5	304.5	105.4	611.1	134.0	636.5	140.9	117.8	86.5	282.7	104.2	384.8	117.3	86.0	123.4	331.8	275.4	58.8	191.6	296.6	74.1	109.4	174.1	86.4	205.7	308.0	325.3	164.0	206.3	281.0	274.3	0.1	36.1	2.9	14.1	55.0	11.4	17.8	8.0	9.9	50.2	8.1	1.9	6.0	1.0	21.0	66.3	95.8	15.5	27.8	5.8	6.5	6.6	6.1	5.9	8.5	15.8	11.1	13.3	9.5	9.8	11.5	63.6	0.0	17.3	0.0	31.1	57.7	148.6	95.9	64.9	0.2	52.0	43.1	20.3	21.5	41.2	0.0	0.0	80.8	86.3	44.6	3.9	38.5	27.0	2.6	32.9	29.0	10.7	143.3	0.6	65.7	129.3	48.0	21.9	2.7	29.2	20.9	29.6	0.7	38.4	0.0	0.8	111.3	40.7	21.6	34.7	14.0	19.0	39.8	19.6	3.7	26.0	0.6	12.3	0.0	0.6	43.4	74.8	19.5	68.6	59.0	6.5	23.1	13.0	0.8	6.6	15.8	44.0	35.9	4.0	69.0	28.3	24.4	38.7	6.1	62.9	100.0
SLC1A6	EAAT4	ENSG00000105143	"Solute carrier family 1 member 6"	P48664	19	14950034-15022990	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 88.2;testis: 28.0"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 17.1;Early spermatids: 35.3;Horizontal cells: 23.5;Late spermatids: 31.8;Syncytiotrophoblasts: 40.0"	"Cancer enriched"	"Detected in some"	7	"urothelial cancer: 5.2"	"Region enriched"	"Detected in all"	6	"cerebellum: 88.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 7.4;NTERA-2: 6.1;U-698: 28.3"	"Region enriched"	"Detected in all"	6	"cerebellum: 136.3"	"Region enhanced"	"Detected in all"		"cerebellum: 53.8"	"HPA041505, HPA044066"	Enhanced	Supported	Supported	"Plasma membrane,Intermediate filaments"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Intermediate filaments"	"HPA041505: AB_2677520, HPA044066: AB_2678796"	"unprognostic (3.62e-2)"	"unprognostic (1.35e-1)"		"unprognostic (4.41e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.12e-1)"		"unprognostic (5.94e-3)"	"unprognostic (8.90e-2)"	"unprognostic (6.52e-4)"	"unprognostic (1.55e-1)"	"unprognostic (5.40e-3)"	"unprognostic (1.11e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.57e-2)"	"prognostic unfavorable (6.88e-6)"	0.1	0.2	9.1	0.2	10.8	0.9	0.4	88.2	14.4	0.1	0.5	0.2	0.3	0.4	1.7	0.1	0.2	0.2	0.2	14.5	5.0	0.1	0.2	0.2	0.3	3.7	7.5	0.3	0.6	0.9	0.3	0.7	8.1	0.5	0.3	2.3	0.4	0.5	0.3	8.6	0.3	0.2	3.2	0.4	0.2	28.0	6.6	0.2	0.3	0.1	0.3	0.1	0.1	5.1	0.1	0.1	0.3	0.4	0.2	0.2	0.9	0.1	0.1	0.1	0.1	0.2	0.2	0.1	0.1	0.2	0.1	1.4	7.4	0.2	0.1	0.2	0.1	0.2	0.4	0.3	0.0	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.1	0.6	0.1	0.6	0.0	0.5	6.1	0.0	0.1	0.1	0.1	0.1	0.1	0.3	0.5	0.2	0.2	2.8	0.0	1.1	0.3	0.1	0.0	0.3	1.1	0.3	0.1	0.5	0.1	28.3	0.1	0.3	0.1	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.3	0.0	0.0	0.1	0.0	0.0	9.1	10.8	88.2	14.4	14.5	5.0	3.7	7.5	8.1	3.2	6.6	5.1	0.0	0.0	0.0	0.7	0.0	3.2	0.7	0.0	0.0	17.1	0.0	0.1	2.1	0.0	0.0	1.8	0.0	1.9	0.0	0.0	0.0	0.0	35.3	0.0	0.1	0.1	0.0	0.0	8.2	0.4	9.9	0.4	0.0	0.0	0.0	5.8	0.0	0.0	0.5	23.5	8.6	0.0	0.0	0.0	0.7	31.8	0.6	0.0	0.0	1.0	0.0	0.7	0.0	4.5	0.9	0.0	0.0	0.7	0.0	0.2	0.0	0.2	0.0	0.8	0.0	0.0	0.4	2.2	6.3	0.0	6.8	40.0	0.0	0.0	0.0	0.1
SLC1A7	EAAT5	ENSG00000162383	"Solute carrier family 1 member 7"	O00341	1	53087179-53142638	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"retina: 40.2"	"Group enriched"	"Detected in some"	6	"Bipolar cells: 207.7;Cone photoreceptor cells: 70.9;Rod photoreceptor cells: 72.3"	"Cancer enhanced"	"Detected in many"		"lung cancer: 3.4"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"gdT-cell: 2.2"	"Lineage enriched"	"Detected in single"	22	"T-cells: 2.2"	"Cell line enriched"	"Detected in some"	8	"HHSteC: 21.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA049124	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA049124: AB_2680643"	"unprognostic (2.33e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (9.48e-4)"	"unprognostic (2.31e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.52e-2)"	"unprognostic (6.26e-3)"	"unprognostic (4.35e-1)"	"unprognostic (1.45e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.19e-3)"	"unprognostic (2.58e-3)"	"unprognostic (5.43e-2)"	"unprognostic (8.12e-2)"	"unprognostic (4.70e-3)"	1.6	0.2	1.5	0.2	1.0	0.0	1.1	1.0	1.5	1.4	0.8	1.0	2.3	1.3	0.0	1.2	1.8	5.2	1.6	1.2	1.1	0.4	1.0	0.6	0.1	1.6	1.9	2.4	0.2	0.4	0.1	0.2	1.8	0.8	0.0	40.2	0.5	0.0	1.3	0.8	3.1	0.0	1.5	0.0	0.8	0.5	2.3	0.0	0.6	3.0	0.0	1.0	1.1	1.2	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.3	1.5	1.0	1.0	1.5	1.2	1.1	1.6	1.9	1.8	1.5	2.3	1.2	1.9	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	207.7	0.0	0.0	0.6	0.0	0.0	0.0	70.9	0.1	3.0	2.1	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.5	0.2	5.9	4.1	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.0	1.0	0.0	0.3	0.0	0.0	1.2	0.5	0.0	7.5	0.0	8.5	16.5	0.0	0.1	0.0	4.0	1.2	0.7	0.0	17.7	0.7	0.0	72.3	0.0	1.1	0.5	0.0	0.3	0.0	0.0	0.0	1.7	0.1	0.3	0.0
SLC20A1	"Glvr-1, GLVR1, PiT-1"	ENSG00000144136	"Solute carrier family 20 member 1"	Q8WUM9	2	112645939-112663825	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Phosphate transport, Symport, Transport"	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 353.3;Paneth cells: 261.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTERT-RPE1: 522.4;U-87 MG: 507.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB019279, HPA035834"	Approved		Approved	"Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"CAB019279: , HPA035834: AB_2674809"	"unprognostic (1.81e-1)"	"unprognostic (2.18e-1)"	"unprognostic (5.38e-2)"	"unprognostic (4.03e-3)"	"unprognostic (1.39e-1)"	"prognostic unfavorable (6.56e-5)"	"unprognostic (1.50e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.39e-1)"	"unprognostic (7.43e-3)"	"unprognostic (1.44e-1)"	"prognostic unfavorable (3.44e-5)"	"unprognostic (6.85e-2)"	"unprognostic (1.09e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.68e-3)"	36.1	11.7	16.2	33.2	24.3	74.6	15.6	27.8	26.3	11.8	25.0	53.6	14.4	13.7	8.4	15.0	14.5	26.4	21.8	20.7	19.8	22.1	49.0	29.2	37.1	25.5	20.7	9.2	30.7	10.4	15.9	29.7	25.2	13.3	21.9	52.3	12.8	9.3	19.7	14.5	28.4	15.0	18.6	29.5	20.2	15.7	24.5	27.2	15.9	7.5	27.5	40.8	13.3	21.2	69.0	55.5	71.1	57.8	52.9	128.8	54.4	181.6	215.3	79.1	102.2	85.0	164.9	124.0	97.5	67.7	305.0	70.5	78.8	138.0	114.8	68.5	80.4	105.5	57.1	81.3	78.2	61.2	178.9	66.0	53.8	279.1	193.9	522.4	102.2	52.9	199.5	126.3	346.7	26.8	83.9	235.9	119.3	31.8	147.6	77.8	63.5	34.9	114.5	312.8	64.4	60.8	91.7	54.9	127.9	31.4	56.0	42.9	223.6	143.5	94.7	50.8	142.4	52.1	143.7	102.2	507.2	57.9	178.3	13.4	33.5	30.1	52.8	59.8	59.4	8.3	22.2	38.4	25.4	5.0	17.5	27.6	14.7	50.2	37.2	41.8	14.6	33.9	16.2	24.3	27.8	26.3	20.7	19.8	25.5	20.7	25.2	18.6	24.5	21.2	61.7	12.8	25.9	42.4	40.3	112.8	59.1	38.7	104.7	60.0	41.9	31.6	49.6	32.9	35.3	9.2	210.6	44.7	119.1	353.3	13.7	18.1	1.5	86.0	34.3	48.2	35.7	53.2	47.3	14.0	13.5	61.5	96.4	167.8	25.3	20.6	41.0	58.1	28.2	20.2	27.2	85.8	32.6	58.5	86.2	3.3	3.7	80.5	26.6	19.7	42.8	31.8	66.9	18.6	26.1	26.9	261.6	4.9	59.8	34.0	156.3	5.2	59.6	84.6	0.0	36.9	25.9	8.5	18.7	119.5	61.8	74.3	70.4	19.0	96.5	90.3
SLC20A2	"Glvr-2, GLVR2, MLVAR, PiT-2, Ram-1"	ENSG00000168575	"Solute carrier family 20 member 2"	Q08357	8	42416475-42541926	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction, Ion transport, Phosphate transport, Sodium transport, Symport, Transport"	"Host cell receptor for virus entry, Receptor"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 130.6;skeletal muscle: 131.2"	"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 250.2;Oligodendrocytes: 151.7;Urothelial cells: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 132.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026540	Approved					NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA026540: AB_1855408"	"prognostic unfavorable (7.67e-4)"	"unprognostic (3.22e-1)"	"unprognostic (3.24e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (7.62e-2)"	"unprognostic (2.06e-1)"	"unprognostic (3.43e-2)"	"prognostic favorable (1.01e-4)"	"unprognostic (2.13e-1)"	"unprognostic (1.27e-1)"	"unprognostic (5.86e-2)"	"unprognostic (4.95e-2)"	11.9	8.0	33.4	9.8	45.3	3.0	12.1	55.4	37.1	15.8	130.6	22.8	46.7	18.5	9.9	32.7	24.5	15.1	63.2	30.1	48.7	17.5	39.7	15.1	6.5	46.5	56.5	8.1	51.6	15.0	10.5	13.5	47.5	13.6	19.0	7.5	87.9	17.6	131.2	23.3	18.8	17.9	42.7	7.4	15.1	15.9	67.8	11.9	82.8	57.6	9.1	22.0	21.7	52.8	52.7	14.3	19.0	16.0	10.4	8.8	41.1	46.9	80.8	23.9	58.7	38.9	132.9	17.4	53.6	42.1	13.5	81.1	11.4	45.2	41.6	4.3	8.7	27.8	4.8	22.0	14.9	9.9	12.3	9.5	40.2	24.7	22.7	16.7	12.0	13.7	27.2	14.0	47.3	14.4	18.1	16.1	19.2	50.5	8.8	14.9	20.9	18.5	21.4	47.5	5.1	19.2	12.8	21.8	12.8	15.0	17.5	17.3	34.9	50.0	17.4	12.3	25.7	9.0	22.2	12.6	15.8	19.5	28.3	3.2	2.2	0.2	3.6	1.6	4.3	2.1	4.0	3.5	3.7	2.1	4.8	3.7	0.8	6.8	1.3	2.0	4.1	3.1	33.4	45.3	55.4	37.1	30.1	48.7	46.5	56.5	47.5	42.7	67.8	52.8	11.1	28.9	18.6	51.6	9.1	98.9	250.2	22.7	96.2	13.4	21.7	14.9	60.2	14.3	21.7	16.5	16.7	23.9	14.3	76.2	13.7	29.6	10.4	79.9	15.8	18.9	12.0	6.9	88.9	31.4	23.7	15.8	15.8	61.2	3.8	17.1	6.4	30.7	10.2	6.7	88.4	11.5	18.3	7.7	12.2	10.0	7.2	10.2	10.6	78.7	7.3	14.4	14.4	63.3	151.7	47.4	35.8	11.7	8.6	76.6	20.0	7.3	57.6	10.2	6.6	22.9	28.3	5.2	7.2	73.9	74.3	25.4	14.2	23.7	12.5	170.3
SLC22A1	OCT1	ENSG00000175003	"Solute carrier family 22 member 1"	O15245	6	160121815-160158718	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	381	"liver: 609.6"	"Cell type enriched"	"Detected in some"	20	"Hepatocytes: 966.3"	"Cancer enriched"	"Detected in some"	81	"liver cancer: 83.0"	"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	12	"neutrophil: 3.5"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA029846	Approved					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 62: Liver - Hemostasis"		"Cluster 2: Hepatocytes - Metabolism"			"HPA029846: AB_10603026"	"unprognostic (8.28e-2)"	"unprognostic (2.10e-1)"	"unprognostic (7.80e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.10e-2)"	"prognostic favorable (1.35e-5)"	"unprognostic (2.28e-1)"	"unprognostic (8.61e-2)"	"unprognostic (3.35e-1)"	"unprognostic (9.11e-2)"	"unprognostic (9.94e-2)"	"unprognostic (1.46e-7)"	"unprognostic (1.58e-1)"	"unprognostic (1.24e-1)"	"unprognostic (4.72e-2)"	"unprognostic (8.07e-4)"	0.3	0.3	0.2	0.1	0.1	0.4	0.3	0.0	0.9	0.3	0.3	0.2	0.0	0.3	0.1	0.2	0.3	0.7	0.1	0.5	0.0	0.9	609.6	0.4	0.2	0.1	0.1	0.4	0.4	0.0	0.3	0.0	0.3	0.4	0.1	0.1	0.4	0.1	1.0	0.5	0.3	0.0	0.0	1.6	0.3	0.3	0.1	0.1	0.7	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.2	0.4	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.1	0.1	0.2	0.0	0.8	0.0	0.0	0.4	0.1	0.4	0.2	0.1	0.2	0.6	0.0	0.3	0.3	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.4	0.4	0.0	0.2	0.1	0.0	0.6	0.0	0.4	0.3	0.0	0.0	0.0	0.1	0.1	0.4	0.3	0.3	0.7	0.2	0.0	0.2	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	3.5	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	0.9	0.5	0.0	0.1	0.1	0.3	0.0	0.1	0.0	0.2	0.0	1.3	2.0	1.4	0.0	0.1	0.0	0.0	0.0	0.5	0.3	0.5	47.1	0.0	0.0	2.1	0.0	0.4	0.1	0.0	0.5	0.3	0.5	0.1	0.9	0.0	13.5	6.1	0.2	0.1	0.2	0.0	0.7	0.0	0.2	11.4	966.3	0.1	0.0	3.7	0.1	0.0	16.3	0.0	0.2	0.3	0.4	0.0	1.0	0.0	0.9	0.0	0.0	0.9	0.1	0.0	0.7	0.1	0.3	0.1	1.8	0.1	0.0	0.0	0.7	0.3	0.0	0.4	0.0	0.3	0.1	1.2	0.3	0.1	0.2
SLC22A10	"hOAT5, OAT5"	ENSG00000184999	"Solute carrier family 22 member 10"	Q63ZE4	11	63137867-63369718	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	160	"liver: 100.8"	"Group enriched"	"Detected in some"	10	"Excitatory neurons: 6.4;Hepatocytes: 21.0"	"Cancer enriched"	"Detected in single"	14	"liver cancer: 6.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (1.17e-2)"				"unprognostic (9.77e-2)"		"unprognostic (7.07e-3)"	"unprognostic (7.46e-4)"			"unprognostic (7.62e-3)"	"unprognostic (2.87e-1)"	"unprognostic (1.56e-1)"	"unprognostic (6.52e-2)"	"unprognostic (4.25e-1)"			0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	100.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	6.4	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	21.0	0.0	0.0	0.7	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SLC22A11	OAT4	ENSG00000168065	"Solute carrier family 22 member 11"	Q9NSA0	11	64555690-64572875	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	72	"epididymis: 10.6;kidney: 31.9;placenta: 33.4"	"Group enriched"	"Detected in some"	19	"Cytotrophoblasts: 654.0;Syncytiotrophoblasts: 1520.6"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 15.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.3;Hep G2: 1.0"					"Not detected"	"Not detected"			HPA026076	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA026076: AB_1854756"	"unprognostic (8.21e-5)"	"unprognostic (3.29e-2)"	"unprognostic (3.57e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.20e-2)"	"unprognostic (4.57e-3)"	"unprognostic (3.48e-1)"	"unprognostic (1.93e-1)"	"unprognostic (4.86e-2)"	"unprognostic (4.51e-2)"	"unprognostic (7.56e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (3.68e-5)"	"unprognostic (4.62e-2)"	"unprognostic (6.52e-2)"	"unprognostic (3.50e-2)"	"unprognostic (8.24e-3)"	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0	0.0	31.9	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	33.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.0	0.0	654.0	0.0	0.0	5.9	0.0	1.2	0.0	0.2	1.7	0.0	0.0	0.0	0.4	22.5	3.4	0.0	0.0	0.0	0.0	0.4	0.2	50.3	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.3	0.3	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	1520.6	0.2	0.1	0.2	0.0
SLC22A12	"OAT4L, RST, URAT1"	ENSG00000197891	"Solute carrier family 22 member 12"	Q96S37	11	64590641-64602353	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	204	"kidney: 109.4"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 173.1"	"Cancer enriched"	"Detected in some"	4	"renal cancer: 16.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA024575	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA024575: AB_1858650"					"unprognostic (5.88e-2)"		"unprognostic (2.33e-1)"						"prognostic favorable (2.63e-4)"	"unprognostic (6.19e-2)"	"unprognostic (3.91e-2)"			0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	109.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	9.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	173.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
SLC22A13	"OAT10, OCTL1, OCTL3, ORCTL3"	ENSG00000172940	"Solute carrier family 22 member 13"	Q9Y226	3	38265812-38278757	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	10	"kidney: 9.0"	"Group enriched"	"Detected in some"	12	"Excitatory neurons: 2.3;Inhibitory neurons: 1.8;Proximal tubular cells: 7.1"	"Cancer enriched"	"Detected in single"	7	"renal cancer: 0.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035603, HPA035962"	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA035603: AB_10672869, HPA035962: AB_2674890"	"unprognostic (2.73e-2)"	"unprognostic (6.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (5.68e-2)"	"unprognostic (7.13e-3)"	"unprognostic (3.50e-3)"	"unprognostic (6.83e-2)"	"unprognostic (1.49e-1)"	"unprognostic (3.48e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.92e-1)"	"unprognostic (8.65e-5)"	"unprognostic (3.39e-1)"	"unprognostic (1.96e-2)"	"unprognostic (5.24e-2)"	"unprognostic (2.74e-1)"	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.1	0.1	0.4	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A14	"OCTL2, ORCTL4"	ENSG00000144671	"Solute carrier family 22 member 14"	Q9Y267	3	38282294-38318575	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"testis: 11.6"	"Group enriched"	"Detected in some"	7	"Early spermatids: 70.1;Late spermatids: 101.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (6.26e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.17e-1)"	"unprognostic (6.25e-2)"	"unprognostic (4.78e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.07e-1)"	"unprognostic (4.97e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.69e-1)"	"unprognostic (3.57e-4)"	"unprognostic (2.19e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.35e-1)"	0.1	0.0	0.6	0.0	0.6	0.3	0.1	0.7	2.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.6	0.0	0.6	0.2	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.3	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.1	0.1	11.6	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.4	0.1	0.2	0.0	0.0	0.1	0.1	0.2	0.3	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.1	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.4	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.6	0.6	0.7	2.1	0.6	0.0	0.5	0.0	0.5	0.0	0.0	0.9	0.0	0.0	0.0	1.6	0.0	0.0	0.1	0.1	0.0	1.0	0.2	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	70.1	0.5	0.2	0.1	0.0	0.0	11.0	0.0	0.0	0.3	0.0	1.3	0.0	0.0	0.0	0.0	0.1	1.7	8.3	0.0	0.0	0.0	0.0	101.8	0.9	0.5	0.0	0.0	0.0	0.0	0.0	1.0	0.7	0.5	0.0	0.0	0.1	0.3	0.1	0.3	0.0	0.1	0.0	0.1	0.2	1.4	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.2
SLC22A15	FLIPT1	ENSG00000163393	"Solute carrier family 22 member 15"	Q8IZD6	1	115976513-116070054	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 30.6;brain: 31.8"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 250.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 1.3;non-classical monocyte: 1.2"	"Group enriched"	"Detected in many"	8	"granulocytes: 1.3;monocytes: 1.2"	"Cell line enhanced"	"Detected in many"		"hTCEpi: 36.0;hTERT-HME1: 47.4;NB-4: 27.4;THP-1: 29.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019785	Uncertain					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA019785: AB_1857011"	"unprognostic (3.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (7.65e-3)"	"unprognostic (1.01e-3)"	"unprognostic (5.62e-2)"	"unprognostic (5.22e-2)"	"unprognostic (5.85e-5)"	"unprognostic (8.91e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.97e-2)"	"unprognostic (5.15e-2)"	"unprognostic (9.06e-2)"	"unprognostic (7.29e-3)"	"unprognostic (8.78e-3)"	"unprognostic (3.44e-1)"	"unprognostic (9.97e-4)"	"unprognostic (1.30e-1)"	3.2	3.1	7.8	2.3	16.5	30.6	1.7	12.3	12.0	3.1	0.9	1.3	1.0	1.1	1.3	5.2	1.5	1.9	4.7	8.6	11.6	3.4	1.1	4.9	0.9	13.3	11.6	1.1	3.1	4.2	2.7	2.0	14.3	1.9	1.7	6.7	4.5	1.6	0.6	9.4	1.9	1.0	11.6	3.4	3.5	1.1	13.1	0.5	2.8	1.0	1.1	1.7	5.0	31.8	3.0	0.2	2.1	0.0	3.7	4.4	1.5	4.7	6.9	2.8	5.0	0.0	0.5	3.3	5.0	2.3	2.4	4.5	3.6	9.7	2.7	0.0	2.3	3.2	3.7	0.5	12.3	4.9	4.3	4.5	36.0	0.1	47.4	0.2	0.0	0.0	0.1	0.0	4.7	2.7	0.0	27.4	3.0	2.8	2.3	0.0	0.0	0.1	3.9	1.6	2.2	1.9	8.1	1.7	13.8	3.1	0.4	29.4	0.0	5.0	2.7	1.0	1.2	4.8	4.8	0.4	5.3	8.0	8.1	0.3	0.8	0.3	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	1.2	0.0	0.0	0.1	7.8	16.5	12.3	12.0	8.6	11.6	13.3	11.6	14.3	11.6	13.1	31.8	0.2	0.0	13.7	46.7	2.3	2.8	3.1	3.6	5.2	3.0	0.3	0.4	7.8	0.0	3.2	5.5	10.4	0.6	0.8	0.5	1.9	1.1	1.3	2.5	0.7	0.2	8.4	0.4	44.2	0.4	0.4	4.6	4.6	1.4	1.3	0.6	1.1	0.0	2.8	8.4	33.9	0.3	0.0	9.4	0.5	0.1	0.9	6.9	1.8	9.4	8.7	1.0	1.0	53.3	250.2	1.6	1.2	0.4	0.7	1.1	0.1	0.3	5.2	2.1	0.0	0.4	1.4	0.3	0.7	5.7	3.0	0.0	1.0	1.2	0.5	1.3
SLC22A16	"CT2, FLIPT2, OAT6, OKB1"	ENSG00000004809	"Solute carrier family 22 member 16"	Q86VW1	6	110424687-110476641	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"bone marrow: 20.5;testis: 21.4"	"Group enriched"	"Detected in some"	10	"Early spermatids: 34.9;Erythroid cells: 60.4;Late spermatids: 31.8;Spermatocytes: 43.1"	"Cancer enriched"	"Detected in single"	5	"endometrial cancer: 0.8"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"basophil: 5.7;classical monocyte: 6.9"	"Group enriched"	"Detected in many"	56	"dendritic cells: 4.0;granulocytes: 5.7;monocytes: 6.9"	"Group enriched"	"Detected in some"	18	"NB-4: 16.9;REH: 14.6;THP-1: 53.1;U-937: 30.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA036902	Uncertain		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane, Cytosol"		"HPA036902: AB_10672274"	"unprognostic (1.01e-1)"	"unprognostic (1.88e-2)"	"unprognostic (5.11e-3)"	"unprognostic (2.19e-3)"	"unprognostic (2.70e-4)"	"unprognostic (1.45e-1)"	"unprognostic (8.15e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.48e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.02e-3)"	"unprognostic (2.49e-1)"	"unprognostic (2.61e-6)"	"unprognostic (5.78e-4)"	"unprognostic (2.72e-2)"	"unprognostic (2.74e-2)"	"unprognostic (2.65e-2)"	0.3	0.0	0.1	0.6	0.2	20.5	0.1	0.2	0.2	0.2	0.0	0.0	0.0	0.9	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.1	0.4	0.0	0.2	0.2	0.0	0.0	3.8	0.0	0.5	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	1.8	0.2	0.5	0.0	21.4	0.1	1.2	0.0	0.1	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	14.6	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	53.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	30.9	0.0	5.7	6.9	1.3	0.0	1.5	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.5	0.1	0.2	0.2	0.2	0.1	0.1	0.2	0.2	0.3	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.4	0.1	0.0	0.0	60.4	0.1	0.0	0.1	0.3	0.0	0.2	0.0	0.0	0.0	0.0	2.7	0.0	0.1	0.0	0.0	1.8	0.5	31.8	1.5	1.1	0.0	0.0	1.8	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.3	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.1	43.1	0.4	0.0	0.4	0.0	0.1	0.0	0.0	0.0
SLC22A17	"BOCT, BOIT, NGALR"	ENSG00000092096	"Solute carrier family 22 member 17"	Q8WUG5	14	23346306-23352912	"Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"brain: 304.0;choroid plexus: 372.6;pituitary gland: 149.1"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 71.4;Horizontal cells: 201.9;Inhibitory neurons: 111.1;Muller glia cells: 74.2;Oligodendrocyte precursor cells: 120.6"	"Cancer enhanced"	"Detected in all"		"glioma: 51.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 20.7;AN3-CA: 31.4;ASC diff: 23.2;SH-SY5Y: 41.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002728	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"			"HPA002728: AB_1079998"	"unprognostic (9.34e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.31e-2)"	"unprognostic (6.23e-3)"	"unprognostic (2.85e-2)"	"unprognostic (1.07e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.26e-2)"	"unprognostic (4.23e-2)"	"unprognostic (3.22e-1)"	"prognostic favorable (1.73e-4)"	"unprognostic (1.78e-1)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (5.95e-4)"	"unprognostic (3.50e-2)"	"unprognostic (1.23e-2)"	"unprognostic (3.87e-2)"	7.3	30.1	159.4	3.9	159.6	0.6	11.8	98.0	159.1	25.4	372.6	24.6	4.6	14.8	10.3	4.4	19.1	6.4	22.0	145.5	304.0	16.3	2.5	8.3	3.4	165.6	143.8	17.0	17.2	11.4	149.1	5.0	145.5	39.8	2.4	26.4	25.4	25.7	1.5	7.6	10.2	7.0	125.5	4.2	13.3	8.9	231.8	1.7	19.1	2.7	1.6	15.2	17.9	139.5	0.0	1.9	20.7	31.4	23.2	11.4	3.4	7.5	11.6	2.5	1.9	0.0	1.9	0.0	2.8	11.0	6.6	0.4	0.7	0.5	0.0	0.0	1.4	4.4	0.0	0.2	13.1	0.0	4.4	16.7	1.2	2.6	0.0	11.3	0.8	9.1	0.0	0.2	3.8	3.2	0.1	0.2	11.3	0.0	0.0	0.0	0.7	0.2	0.0	2.0	19.9	41.5	5.8	0.0	0.0	4.0	3.5	0.6	0.0	2.9	8.9	16.6	0.0	0.1	3.2	0.0	1.9	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.0	0.0	0.0	159.4	159.6	98.0	159.1	145.5	304.0	165.6	143.8	145.5	125.5	231.8	139.5	7.7	0.0	2.7	46.7	2.3	12.6	18.6	2.6	12.5	53.0	23.4	30.1	10.0	2.8	5.5	20.2	43.8	2.4	1.0	0.0	1.9	0.7	0.2	1.8	10.6	12.0	20.8	1.7	71.4	1.3	4.9	21.7	3.6	0.6	4.5	12.0	16.8	0.9	1.0	201.9	111.1	0.0	0.0	0.6	5.1	2.3	21.1	1.2	7.2	19.7	0.7	74.2	0.0	120.6	49.2	1.5	0.0	42.9	9.2	31.3	0.0	16.9	3.2	69.0	0.0	14.1	18.0	1.1	2.3	3.0	10.9	4.8	2.0	4.5	0.3	6.1
SLC22A18	"BWR1A, BWSCR1A, IMPT1, ITM, ORCTL2, SLC22A1L, TSSC5"	ENSG00000110628	"Solute carrier family 22 member 18"	Q96BI1	11	2899721-2925246	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 42.3;liver: 45.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 368.4;Late spermatids: 499.1;Paneth cells: 385.7;Proximal enterocytes: 730.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 33.4;Karpas-707: 29.1"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			"HPA067812, HPA071461"	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 45: Enterocytes - Digestion"			"HPA067812: AB_2685902, HPA071461: AB_2686401"	"unprognostic (1.10e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.80e-1)"	"unprognostic (7.75e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.67e-1)"	"unprognostic (8.25e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.48e-2)"	"unprognostic (9.35e-2)"	"unprognostic (8.60e-2)"	"unprognostic (8.36e-2)"	"unprognostic (9.51e-2)"	"unprognostic (5.97e-3)"	"unprognostic (1.55e-1)"	"unprognostic (2.82e-1)"	6.9	3.0	0.1	2.1	0.1	1.5	6.7	0.0	1.2	6.5	0.8	27.8	42.3	6.8	0.2	13.3	8.2	4.0	16.7	0.1	1.0	16.7	45.2	6.8	2.3	0.6	0.5	4.8	6.4	1.7	3.2	5.4	0.4	8.0	4.2	0.0	10.3	2.8	1.7	16.1	28.0	0.9	0.2	9.1	11.3	2.1	1.0	0.7	12.0	0.0	1.1	6.5	9.7	0.8	2.3	14.1	0.0	7.2	1.3	2.0	5.8	4.4	7.4	2.5	4.2	8.0	33.4	1.0	14.1	5.8	5.6	7.3	0.4	0.7	0.5	6.8	1.3	0.3	3.3	7.4	13.5	0.1	6.2	5.7	1.3	2.1	0.4	2.2	0.0	4.5	0.3	29.1	1.4	6.8	0.2	0.8	0.7	10.6	3.3	2.6	0.0	4.7	1.1	4.2	0.3	2.5	1.8	17.6	15.7	0.1	3.6	3.8	0.5	1.9	4.2	6.1	0.3	5.5	1.4	0.3	7.7	3.9	7.5	32.1	28.7	27.4	6.8	28.2	3.7	4.2	5.1	4.8	17.9	3.0	2.7	4.0	42.3	6.3	22.9	13.2	9.4	13.5	0.1	0.1	0.0	1.2	0.1	1.0	0.6	0.5	0.4	0.2	1.0	0.8	1.6	6.4	9.6	1.6	5.6	7.4	22.5	48.8	14.2	1.2	16.8	11.0	11.2	54.3	29.0	27.6	0.0	102.6	9.0	368.4	7.9	31.4	161.7	9.3	5.3	2.7	19.8	1.3	3.0	8.7	20.9	9.4	47.9	14.1	15.9	7.6	6.4	158.6	46.3	0.0	0.6	93.2	52.9	33.0	16.7	499.1	10.5	23.5	19.6	4.7	18.8	6.9	10.3	0.5	1.6	22.5	385.7	7.5	3.1	10.2	730.9	122.1	26.6	1.1	0.0	2.7	11.2	5.8	4.1	19.2	8.8	181.3	13.7	7.3	121.3	20.3
SLC22A2	OCT2	ENSG00000112499	"Solute carrier family 22 member 2"	O15244	6	160171061-160277638	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	105	"kidney: 153.9"	"Group enriched"	"Detected in some"	13	"Distal tubular cells: 92.0;Proximal tubular cells: 198.3"	"Cancer enriched"	"Detected in single"	493	"renal cancer: 30.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Region enhanced"	"Detected in some"		"midbrain: 1.9"	"HPA008549, CAB068236, CAB068237"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB068236: AB_2665668, CAB068237: AB_2665669, HPA008549: "	"unprognostic (1.01e-1)"	"unprognostic (3.67e-1)"	"unprognostic (2.26e-1)"	"unprognostic (3.67e-2)"	"unprognostic (4.24e-1)"	"unprognostic (3.33e-1)"	"unprognostic (2.51e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.15e-4)"	"unprognostic (1.41e-1)"	"unprognostic (3.68e-1)"	"prognostic favorable (1.85e-7)"	"unprognostic (1.65e-2)"	"unprognostic (8.20e-2)"	"unprognostic (4.11e-1)"	"unprognostic (2.45e-2)"	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.7	0.0	1.0	0.1	0.2	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.1	153.9	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.5	0.0	0.1	0.0	0.0	0.1	1.4	0.2	0.0	0.2	0.2	0.1	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.7	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	11.0	0.0	0.0	0.0	0.1	92.0	0.6	7.2	0.3	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.2	0.3	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	198.3	0.0	0.0	0.0	1.0	0.6	0.1	0.3	0.0	0.3	0.1	1.4	0.0	0.0	0.0
SLC22A23	"C6orf85, FLJ22174"	ENSG00000137266	"Solute carrier family 22 member 23"	A1A5C7	6	3268962-3457050	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 50.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 86.8;Late spermatids: 229.3;Oligodendrocytes: 285.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"T-47d: 31.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014697	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Nucleoplasm, Vesicles"	Cytosol	"HPA014697: AB_1844371"	"unprognostic (4.58e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (6.57e-4)"	"unprognostic (5.16e-3)"	"unprognostic (3.25e-3)"	"unprognostic (1.40e-1)"	"unprognostic (4.53e-3)"	"unprognostic (9.74e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.07e-2)"	"unprognostic (2.62e-2)"	"prognostic unfavorable (2.39e-4)"	"unprognostic (8.91e-2)"	"unprognostic (4.30e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.74e-1)"	7.3	3.4	17.7	4.5	28.9	9.6	8.4	25.4	25.0	9.1	1.8	18.4	20.7	4.1	12.2	23.7	11.0	4.9	3.6	16.2	18.6	7.7	18.1	8.3	4.4	29.9	29.7	4.1	15.5	27.1	8.8	8.5	30.4	18.6	14.8	4.8	14.6	2.4	8.9	17.1	22.4	2.8	22.1	6.3	26.5	11.5	30.2	7.2	5.6	7.8	5.9	4.3	15.5	50.9	4.3	10.1	20.1	22.6	7.2	7.8	26.6	0.7	0.3	1.2	0.5	22.5	0.7	1.0	2.5	4.8	18.2	6.1	4.2	10.8	0.4	3.5	13.1	10.4	3.9	18.9	1.0	0.7	0.6	2.0	21.3	19.4	1.0	4.3	0.7	5.4	9.6	5.3	0.7	5.3	1.0	2.4	7.1	23.2	3.9	2.2	1.3	18.1	0.1	26.9	2.4	0.3	5.7	7.8	7.0	20.9	31.8	0.2	5.6	12.0	4.0	15.9	2.6	12.7	0.2	0.4	21.2	0.7	7.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.1	0.0	0.2	17.7	28.9	25.4	25.0	16.2	18.6	29.9	29.7	30.4	22.1	30.2	50.9	22.6	6.4	17.5	46.7	1.0	11.6	5.0	18.7	4.6	8.0	9.5	8.1	2.8	10.0	18.0	5.5	8.4	16.1	0.5	43.3	0.0	2.9	86.8	11.6	2.5	8.2	4.2	11.0	59.9	8.0	1.3	1.9	39.8	4.1	0.0	13.1	6.4	12.7	12.9	0.0	67.4	49.7	12.2	13.0	3.0	229.3	1.8	4.8	3.6	77.8	6.4	8.6	0.0	45.8	285.5	6.1	20.5	0.7	0.4	13.9	34.3	4.2	42.0	3.5	0.0	4.5	2.6	2.5	1.2	10.3	12.6	9.2	1.3	0.1	25.3	4.5
SLC22A25	"HIMTP, MGC120420, UST6"	ENSG00000196600	"Solute carrier family 22 member 25"	Q6T423	11	63163776-63229652	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	18	"liver: 11.3"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 3.4;Hepatocytes: 6.4;Inhibitory neurons: 1.2;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 1.2"	"Cancer enriched"	"Detected in single"	66	"liver cancer: 3.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA039390	Uncertain					NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"		"Cluster 15: Hepatocytes - Hemostasis"			"HPA039390: AB_10671996"	"unprognostic (3.19e-2)"				"unprognostic (2.38e-1)"	"unprognostic (4.51e-1)"	"prognostic favorable (7.04e-4)"							"unprognostic (1.01e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	11.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.4	0.0	0.0	1.2	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC22A3	"EMT, OCT3"	ENSG00000146477	"Solute carrier family 22 member 3"	O75751	6	160348378-160452577	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 67.4"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 78.9;Hepatocytes: 68.8;Leydig cells: 33.8;Pancreatic endocrine cells: 57.3;Skeletal myocytes: 29.8"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 19.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 27.6;HeLa: 38.1;Hep G2: 23.7;OE19: 12.0;RPTEC TERT1: 13.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA029750	Approved		Approved	Vesicles,Cytosol		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"	Vesicles	Cytosol	"HPA029750: AB_10603888"	"unprognostic (8.61e-2)"	"prognostic unfavorable (7.19e-5)"	"unprognostic (4.14e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.36e-2)"	"unprognostic (9.74e-2)"	"unprognostic (9.36e-4)"	"unprognostic (1.33e-2)"	"unprognostic (2.58e-2)"	"unprognostic (7.28e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.21e-2)"	"unprognostic (8.13e-4)"	"prognostic unfavorable (7.26e-4)"	11.7	15.2	2.1	3.8	2.7	0.0	6.6	3.3	2.1	15.9	1.8	8.8	1.7	18.4	27.6	7.7	18.7	11.0	1.5	2.0	3.5	6.3	34.9	16.4	16.2	6.2	3.8	21.1	0.7	0.2	1.3	44.3	4.5	43.4	2.4	0.2	51.8	52.6	67.4	10.7	5.7	26.3	3.3	0.6	6.0	2.6	4.2	0.5	2.0	8.5	4.9	6.2	15.7	3.2	0.0	27.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.3	1.5	0.0	0.0	0.0	0.0	7.3	0.0	0.0	0.4	0.0	0.0	0.0	38.1	23.7	1.2	0.0	0.0	0.8	6.9	3.4	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	4.0	12.0	7.7	0.0	0.0	0.0	13.8	0.0	0.0	0.0	3.1	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.7	3.3	2.1	2.0	3.5	6.2	3.8	4.5	3.3	4.2	3.2	0.6	16.0	78.9	6.2	0.1	4.7	0.3	2.1	2.8	0.2	0.2	0.3	2.9	5.7	6.4	0.0	0.0	0.3	0.1	0.2	5.9	8.2	0.6	0.2	10.2	1.0	0.0	0.0	0.5	3.0	0.3	10.0	12.8	0.3	2.5	0.8	0.0	68.8	0.7	0.0	25.1	1.6	2.0	1.0	2.4	1.6	33.8	0.3	3.6	7.5	0.0	0.0	0.0	19.6	0.2	57.3	0.1	24.5	0.1	6.1	2.1	2.9	0.8	0.1	0.0	29.8	12.3	0.3	0.2	3.7	6.7	0.4	1.2	0.0	2.8	0.8
SLC22A31		ENSG00000259803	"Solute carrier family 22 member 31"	A6NKX4	16	89195761-89201651	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 24.5;lung: 40.6;pancreas: 33.0"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 130.7;Late spermatids: 33.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 26.2;thyroid cancer: 20.4"	"Region enriched"	"Detected in many"	10	"cerebellum: 24.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 33.7;Hep G2: 28.7;NB-4: 14.7;RPMI-8226: 17.7;THP-1: 9.3"															NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 11: Alveolar cells - Smell perception"				"unprognostic (2.71e-3)"	"unprognostic (2.53e-1)"	"unprognostic (5.02e-3)"	"unprognostic (6.82e-2)"	"unprognostic (8.20e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.00e-2)"	"unprognostic (1.93e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.98e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.89e-1)"	0.2	0.8	0.0	0.2	0.4	0.9	0.1	24.5	1.0	1.1	0.0	0.5	0.4	0.2	0.0	0.1	0.9	0.0	0.3	0.0	0.1	0.8	1.2	40.6	0.1	0.5	1.1	3.1	33.0	0.1	0.5	0.0	2.5	0.6	0.0	0.0	0.4	0.1	0.0	1.8	0.6	0.0	0.3	3.6	3.3	5.2	0.3	0.0	0.4	0.0	0.0	0.2	0.5	0.5	0.0	0.1	0.0	1.6	0.0	0.0	33.7	0.1	0.0	0.0	0.0	1.3	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	28.7	3.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.0	0.0	0.5	0.0	14.7	0.8	0.3	3.4	0.0	3.7	17.7	0.0	0.0	1.4	1.0	0.0	0.0	0.0	0.1	0.3	9.3	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	24.5	1.0	0.0	0.1	0.5	1.1	2.5	0.3	0.3	0.5	0.0	6.4	130.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	19.2	0.0	0.0	0.0	0.0	0.0	0.0	4.9	0.2	0.1	1.1	0.0	8.2	0.0	0.4	0.3	0.7	0.0	0.4	0.0	0.0	0.3	0.0	33.6	0.6	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.2	0.9	3.2	0.0	0.1	0.0	0.4	0.0	0.0	0.0
SLC22A5	"CDSP, OCTN2, SCD"	ENSG00000197375	"Solute carrier family 22 member 5"	O76082	5	132369710-132395613	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 56.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 63.9;Proximal enterocytes: 56.2"	"Cancer enhanced"	"Detected in all"		"renal cancer: 8.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HeLa: 34.7;SiHa: 37.8"	"Low region specificity"	"Detected in some"							HPA063062			Approved	Mitochondria		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 20: HeLa - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA063062: AB_2684934"	"unprognostic (3.88e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.19e-2)"	"prognostic favorable (2.87e-5)"	"unprognostic (5.37e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.50e-2)"	"unprognostic (9.24e-2)"	"unprognostic (1.57e-1)"	"unprognostic (5.09e-2)"	"prognostic favorable (7.36e-4)"	"unprognostic (3.53e-2)"	"prognostic favorable (8.36e-4)"	"unprognostic (1.12e-2)"	"unprognostic (2.98e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.17e-2)"	5.3	6.6	7.5	2.0	7.9	0.9	4.9	7.8	7.8	5.0	14.4	12.4	13.7	4.0	11.1	3.9	8.4	4.1	14.2	7.3	8.0	26.7	7.8	3.2	1.2	7.8	7.8	5.6	8.2	17.9	11.0	4.2	7.4	9.1	9.4	3.7	6.4	11.2	56.1	6.0	16.9	2.5	7.5	2.5	6.0	3.8	8.0	2.1	5.4	22.3	1.8	5.0	5.0	7.8	6.1	14.4	0.9	11.3	4.4	2.1	19.3	2.7	2.9	4.5	6.2	10.7	12.2	2.9	6.0	2.6	13.1	14.3	9.4	7.0	5.3	3.6	11.6	1.5	34.7	4.9	7.3	2.4	2.4	2.0	12.9	3.1	15.8	7.6	1.2	5.2	6.8	1.8	4.4	10.4	3.6	2.4	1.0	10.5	6.2	1.3	0.0	15.9	13.5	15.2	4.8	3.3	37.8	28.9	7.6	2.9	13.5	3.1	0.7	0.7	3.9	9.5	3.3	6.0	12.8	0.1	2.9	5.9	2.7	0.0	2.0	0.0	1.1	1.0	1.2	0.6	1.1	1.4	3.1	0.6	1.1	1.4	0.2	0.8	0.3	0.2	2.1	1.0	7.5	7.9	7.8	7.8	7.3	8.0	7.8	7.8	7.4	7.5	8.0	7.8	3.0	9.6	8.2	23.5	3.8	7.6	7.5	4.7	13.1	6.7	16.9	5.3	5.6	21.5	5.5	16.5	12.5	23.6	3.2	63.9	1.9	9.8	2.0	13.7	10.3	2.6	7.2	1.7	11.9	5.2	5.5	5.6	16.3	26.6	0.0	6.1	2.9	8.6	4.2	10.1	11.1	14.3	8.2	6.7	1.6	2.8	6.5	5.9	5.4	17.8	1.3	9.4	0.0	7.1	4.2	6.4	26.3	4.1	4.8	14.2	56.2	22.2	9.4	7.1	0.0	17.7	3.8	8.4	2.8	9.6	6.3	8.2	4.0	0.3	18.0	9.0
SLC22A6	"OAT1, PAHT, ROAT1"	ENSG00000197901	"Solute carrier family 22 member 6"	Q4U2R8	11	62936385-62984967	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"			"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	26	"kidney: 196.5"	"Cell type enriched"	"Detected in some"	17	"Proximal tubular cells: 310.4"	"Cancer enriched"	"Detected in single"	102	"renal cancer: 18.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA074559, CAB075704"	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB075704: , HPA074559: AB_2732260"					"unprognostic (2.42e-2)"								"unprognostic (2.25e-3)"	"unprognostic (4.43e-1)"				0.0	0.0	1.3	0.0	2.5	0.0	0.0	3.6	2.3	0.0	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	3.8	196.5	0.0	0.0	0.0	7.0	5.5	0.0	0.0	0.0	0.6	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	7.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.5	3.6	2.3	1.3	3.8	7.0	5.5	3.1	3.3	7.6	1.2	0.0	0.0	0.0	4.9	1.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	7.3	0.0	0.0	0.0	0.0	17.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.3	0.0	1.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	310.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0
SLC22A7	"NLT, OAT2"	ENSG00000137204	"Solute carrier family 22 member 7"	Q9Y694	6	43295694-43305538	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"liver: 427.9"	"Group enriched"	"Detected in some"	17	"Hepatocytes: 254.5;Proximal tubular cells: 91.8"	"Cancer enriched"	"Detected in some"	37	"liver cancer: 81.5"	"Region enhanced"	"Detected in single"		"cerebellum: 1.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	20	"Hep G2: 9.9"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"			HPA030220	Approved					NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA030220: AB_10603027"	"unprognostic (9.17e-2)"			"unprognostic (9.73e-4)"	"unprognostic (2.13e-1)"		"prognostic favorable (5.48e-6)"			"unprognostic (1.45e-1)"	"unprognostic (1.54e-3)"	"unprognostic (1.74e-2)"	"prognostic favorable (8.98e-4)"	"unprognostic (1.29e-1)"	"unprognostic (1.07e-1)"			0.0	0.0	0.3	0.0	0.4	0.0	0.0	1.5	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	47.6	427.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.3	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	1.5	0.6	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.1	9.8	0.0	0.0	0.0	0.0	0.0	0.0	5.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	254.5	0.0	0.0	0.7	0.0	0.0	4.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	1.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	91.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0
SLC22A8	OAT3	ENSG00000149452	"Solute carrier family 22 member 8"	Q8TCC7	11	62989154-63015841	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Detoxification, Ion transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	61	"choroid plexus: 111.4;kidney: 335.0"	"Cell type enriched"	"Detected in some"	38	"Proximal tubular cells: 347.6"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.6"	"Region enhanced"	"Detected in some"		"hippocampal formation: 3.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044174	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044174: AB_10963058"							"unprognostic (5.35e-4)"					"unprognostic (4.66e-1)"	"unprognostic (6.88e-3)"	"unprognostic (1.72e-1)"	"unprognostic (2.20e-1)"			0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.7	0.7	0.0	111.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	335.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.7	0.7	3.6	0.0	0.1	0.1	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	9.0	0.0	0.0	1.2	0.0	0.0	5.5	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	347.6	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0
SLC22A9	"FLJ23666, OAT4, OAT7, UST3"	ENSG00000149742	"Solute carrier family 22 member 9"	Q8IVM8	11	63369785-63410294	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	25	"liver: 46.3"	"Cell type enhanced"	"Detected in some"		"Erythroid cells: 2.7;Excitatory neurons: 5.0;granulocytes: 4.5;Hepatocytes: 15.4"	"Cancer enriched"	"Detected in single"	166	"liver cancer: 19.3"	"Region enhanced"	"Detected in some"		"cerebral cortex: 1.8"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 62: Liver - Hemostasis"		"Cluster 15: Hepatocytes - Hemostasis"									"unprognostic (2.45e-1)"	"unprognostic (7.24e-2)"	"unprognostic (8.86e-2)"		"unprognostic (2.10e-2)"	"unprognostic (1.08e-2)"		"unprognostic (2.26e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.71e-1)"		"unprognostic (3.09e-2)"	0.1	0.0	0.5	0.0	0.5	0.2	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	1.4	0.0	0.2	46.3	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.8	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.0	0.1	0.0	0.1	0.5	0.5	0.0	1.8	1.4	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.1	0.0	2.7	5.0	0.2	0.0	0.1	0.0	0.0	4.5	0.1	0.0	15.4	0.0	0.0	0.3	0.0	0.0	0.6	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.1
SLC23A1	"SLC23A2, SVCT1, YSPL3"	ENSG00000170482	"Solute carrier family 23 member 1"	Q9UHI7	5	139367196-139384553	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	7	"fallopian tube: 54.2;intestine: 65.3;kidney: 40.2;liver: 22.5"	"Cell type enhanced"	"Detected in some"		"Endometrial ciliated cells: 65.2;Hepatocytes: 19.3;Proximal enterocytes: 131.7;Proximal tubular cells: 27.0"	"Group enriched"	"Detected in many"	5	"endometrial cancer: 2.1;liver cancer: 7.7;prostate cancer: 4.0;renal cancer: 3.9"	"Region enhanced"	"Detected in some"		"midbrain: 3.2"	"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"CACO-2: 9.4;HDLM-2: 8.3;Hep G2: 13.6;JURKAT: 15.5;Karpas-707: 10.9;RPMI-8226: 10.9;U-266/70: 16.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA047612	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA047612: AB_2680102"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-3)"	"unprognostic (2.63e-2)"	"unprognostic (1.75e-3)"	"unprognostic (1.93e-1)"	"unprognostic (6.36e-6)"	"unprognostic (7.41e-2)"	"unprognostic (6.55e-2)"	"unprognostic (5.88e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.22e-1)"	"unprognostic (6.51e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.65e-3)"	0.2	0.1	0.1	1.2	0.2	2.8	0.2	1.1	0.2	2.3	0.1	3.3	26.3	0.7	0.0	0.3	54.2	2.4	0.1	0.2	0.4	40.2	22.5	0.9	1.7	1.1	3.2	0.3	1.2	0.3	0.2	0.1	0.8	6.3	1.5	0.6	3.2	0.6	0.4	1.9	65.3	0.2	0.1	1.3	1.5	0.2	0.2	5.5	0.2	0.0	1.2	0.4	0.3	0.6	0.3	2.1	0.4	0.5	0.0	0.0	1.0	0.0	0.0	0.0	0.0	9.4	1.3	5.8	3.0	0.0	0.1	0.3	0.0	0.0	0.1	8.3	0.1	0.2	0.8	13.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	15.5	0.1	10.9	0.0	0.2	5.7	1.0	0.1	0.8	0.1	6.8	0.3	10.9	0.5	0.4	0.3	0.3	0.3	1.9	0.0	0.7	5.0	0.1	0.3	0.3	0.3	0.1	0.0	16.6	2.2	7.6	0.1	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	1.3	0.1	0.0	0.1	0.2	1.1	0.2	0.2	0.4	1.1	3.2	0.8	0.1	0.2	0.6	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.1	0.3	0.3	0.3	1.5	2.0	0.0	4.2	0.4	0.4	1.9	5.9	0.2	0.0	65.2	0.7	0.1	0.0	0.0	1.1	0.2	0.0	0.0	0.0	1.5	0.0	0.1	0.4	19.3	0.1	0.0	1.2	3.6	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	1.4	0.1	3.1	0.0	0.4	0.9	131.7	27.0	13.4	0.7	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.8	0.2	0.0	4.2	0.2
SLC23A2	"KIAA0238, SLC23A1, SVCT2, YSPL2"	ENSG00000089057	"Solute carrier family 23 member 2"	Q9UGH3	20	4852356-5010293	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 99.3;choroid plexus: 88.4;retina: 107.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 236.8;Cone photoreceptor cells: 114.7;Excitatory neurons: 102.8;Inhibitory neurons: 117.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052825, HPA059314"	Approved		Uncertain	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 56: Bipolar cells - Visual perception"	Vesicles	"Golgi apparatus"	"HPA052825: AB_2681965, HPA059314: AB_2683975"	"unprognostic (3.83e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.95e-3)"	"unprognostic (1.64e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.09e-1)"	"prognostic favorable (3.35e-4)"	"unprognostic (6.22e-3)"	"unprognostic (2.08e-1)"	"unprognostic (6.36e-3)"	"prognostic favorable (7.14e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.60e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (6.08e-5)"	10.2	99.3	26.3	8.2	27.2	7.8	9.4	24.1	26.0	13.5	88.4	9.4	6.4	12.9	8.7	6.1	15.9	10.1	8.3	28.5	26.7	13.0	57.0	12.1	10.2	28.1	32.0	38.5	10.0	17.7	23.3	8.1	29.5	12.5	6.1	107.2	5.9	10.3	3.3	11.4	12.5	10.0	25.6	20.9	9.4	11.4	34.6	8.2	25.0	4.5	9.9	18.9	8.9	33.1	21.2	24.5	32.2	12.2	22.2	12.4	40.9	8.9	12.1	10.3	9.6	12.7	23.6	9.6	9.4	12.4	29.1	20.1	9.1	24.2	19.2	6.0	16.2	13.3	4.3	48.0	12.5	18.9	7.6	10.6	13.8	25.8	15.4	21.5	15.2	15.5	9.3	7.9	13.7	7.9	20.7	10.5	11.4	16.9	14.9	19.0	21.2	14.3	5.6	34.2	10.7	12.0	17.0	17.7	63.3	11.4	9.8	10.9	13.1	23.0	10.7	27.8	17.4	11.2	22.2	25.5	8.1	11.2	36.8	0.0	1.1	0.1	1.1	0.7	1.0	1.8	0.8	0.8	1.5	1.0	0.8	0.8	1.2	0.3	0.9	2.4	0.5	0.9	26.3	27.2	24.1	26.0	28.5	26.7	28.1	32.0	29.5	25.6	34.6	33.1	9.3	6.4	7.2	50.3	14.5	7.4	4.5	7.0	12.5	236.8	8.3	7.4	7.9	15.7	9.4	14.7	114.7	4.9	12.6	0.8	0.0	5.0	4.6	2.8	10.1	13.0	7.2	8.6	102.8	5.5	6.6	14.2	3.6	1.9	8.2	13.5	17.5	71.3	10.6	85.8	117.4	1.9	0.0	30.2	7.5	9.3	20.2	16.3	16.0	60.0	8.8	24.8	7.2	77.4	78.3	3.4	6.7	29.3	11.9	8.2	0.6	1.3	7.8	71.5	13.1	12.6	12.2	0.6	8.0	5.5	6.1	4.0	8.2	65.6	2.8	14.7
SLC23A3	"FLJ31168, SVCT3, Yspl1"	ENSG00000213901	"Solute carrier family 23 member 3"	Q6PIS1	2	219161465-219170095	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	8	"intestine: 18.4;kidney: 45.6"	"Group enriched"	"Detected in many"	5	"Proximal enterocytes: 55.9;Proximal tubular cells: 14.4"	"Cancer enriched"	"Detected in some"	9	"renal cancer: 5.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"hTCEpi: 4.9;U-266/70: 3.1"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.3"	"Not detected"	"Not detected"			HPA019059			Approved	"Nucleoplasm,Cell Junctions"		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Cell Junctions"	"HPA019059: AB_1857017"	"unprognostic (2.49e-2)"	"unprognostic (6.65e-2)"	"unprognostic (2.05e-4)"	"unprognostic (6.97e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.22e-2)"	"unprognostic (9.07e-2)"	"unprognostic (1.93e-1)"	"unprognostic (4.01e-2)"	"unprognostic (4.35e-2)"	"unprognostic (3.10e-1)"	"unprognostic (6.12e-4)"	"unprognostic (9.42e-2)"	"unprognostic (6.48e-2)"	"unprognostic (2.41e-2)"	"unprognostic (3.34e-1)"	"unprognostic (6.52e-5)"	1.1	0.4	1.0	0.9	1.0	0.1	0.9	1.2	0.9	2.8	1.0	3.8	7.6	1.6	0.5	2.2	1.5	0.5	1.0	1.0	1.0	45.6	4.0	1.3	0.7	1.1	1.0	1.8	1.1	0.8	0.5	1.0	1.0	2.4	1.5	0.2	1.0	0.6	0.2	1.9	18.4	0.7	1.0	1.5	1.2	0.1	1.1	0.3	2.4	0.1	0.8	1.1	2.3	1.0	0.5	0.2	0.1	0.6	2.0	1.1	0.4	1.2	0.3	0.2	0.7	1.1	0.7	0.2	0.4	0.8	0.0	1.7	0.4	0.1	0.3	1.1	0.9	1.1	1.2	0.1	0.4	0.1	0.4	0.4	4.9	0.4	1.5	1.9	0.6	0.6	0.1	0.4	0.3	0.2	0.0	0.5	0.0	0.4	0.1	0.3	0.3	0.4	1.6	1.9	0.2	0.5	0.1	0.0	1.3	0.5	0.5	0.5	1.4	1.1	0.7	1.0	0.4	3.1	0.1	1.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.0	1.2	0.9	1.0	1.0	1.1	1.0	1.0	1.0	1.1	1.0	0.6	0.0	0.5	0.0	1.7	1.5	1.4	0.5	0.6	1.1	0.9	1.1	0.3	1.5	0.3	1.8	0.0	0.3	0.5	3.8	1.9	0.2	0.0	0.2	0.8	1.0	1.8	0.4	0.3	0.0	0.1	0.8	0.0	0.9	0.0	0.5	1.1	1.2	0.2	0.0	0.3	4.0	0.0	0.9	0.8	0.0	1.5	1.0	1.8	1.0	1.1	1.2	0.0	0.0	0.0	0.4	6.0	1.2	0.2	1.5	55.9	14.4	0.1	0.2	0.0	0.8	1.0	0.0	0.2	0.7	1.6	0.4	0.8	0.6	3.9	0.9
SLC24A1	"CSNB1D, HsT17412, KIAA0702, NCKX, NCKX1, RODX"	ENSG00000074621	"Solute carrier family 24 member 1"	O60721	15	65611366-65660995	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Symport, Transport, Vision"		"Congenital stationary night blindness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	34	"retina: 193.5"	"Cell type enriched"	"Detected in many"	11	"Rod photoreceptor cells: 338.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA039370	Enhanced		Approved	Microtubules		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 79: Retina - Phototransduction"	"Cluster 21: OE19 - Mitochondria"	"Cluster 46: Photoreceptor cells - Phototransduction"	Microtubules		"HPA039370: AB_10960279"	"unprognostic (9.47e-2)"	"unprognostic (9.97e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.66e-3)"	"unprognostic (6.39e-3)"	"unprognostic (4.64e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.86e-1)"	"unprognostic (4.69e-2)"	"unprognostic (3.94e-1)"	"unprognostic (2.01e-1)"	"unprognostic (9.91e-2)"	"prognostic favorable (2.33e-6)"	"unprognostic (8.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (3.04e-2)"	"unprognostic (1.96e-2)"	4.0	3.0	2.4	1.9	2.2	1.8	4.9	5.7	2.7	4.8	2.5	2.6	2.2	3.8	4.7	2.4	5.1	3.8	1.6	2.1	2.1	5.1	2.9	3.1	3.3	2.3	2.3	5.4	2.9	3.8	2.7	3.6	2.3	3.2	2.4	193.5	2.6	3.1	1.0	5.1	3.0	2.9	2.3	3.9	2.5	4.1	2.1	2.4	5.1	1.3	1.8	3.0	3.2	2.5	1.5	3.0	3.2	2.9	4.7	7.9	4.0	3.7	4.2	3.7	2.4	1.4	6.5	2.1	12.4	3.7	1.3	4.1	3.9	4.2	2.1	2.2	2.8	4.6	2.5	6.8	6.8	3.1	6.0	6.7	5.9	2.1	12.3	5.1	6.4	4.8	5.0	7.0	6.0	6.4	2.0	2.8	4.1	13.5	1.2	2.0	1.0	1.4	5.6	6.0	1.5	2.1	1.0	2.8	8.0	4.4	6.0	4.2	9.3	3.7	3.7	1.4	2.6	2.8	5.5	2.4	3.9	6.4	3.1	2.6	0.4	0.7	0.4	0.4	0.5	0.4	0.4	0.4	0.3	1.0	0.3	0.4	0.6	0.8	0.2	0.8	0.1	0.1	2.4	2.2	5.7	2.7	2.1	2.1	2.3	2.3	2.3	2.3	2.1	2.5	4.0	6.4	5.1	5.2	3.4	1.5	1.4	1.2	1.8	29.8	3.5	2.8	2.3	0.0	3.8	0.0	27.1	4.2	1.6	2.9	0.0	1.5	1.6	6.3	5.4	15.6	1.8	1.7	2.2	1.3	2.7	2.6	4.1	7.9	2.5	4.7	3.6	1.4	1.9	20.2	2.0	2.5	2.0	3.1	1.6	2.5	3.1	2.7	1.8	4.7	1.2	26.1	2.1	3.0	1.4	2.6	0.5	2.2	3.3	1.4	2.6	0.7	4.1	338.3	0.0	3.4	2.5	20.3	10.1	2.9	1.0	2.5	2.5	8.3	2.6	0.9
SLC24A2	NCKX2	ENSG00000155886	"Solute carrier family 24 member 2"	Q9UI40	9	19507452-19786928	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport, Vision"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 117.1"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 2710.1"	"Group enriched"	"Detected in some"	4	"breast cancer: 0.5;glioma: 1.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"K-562: 2.6;SCLC-21H: 2.2;U-87 MG: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA079359			Supported	"Plasma membrane"		NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 70: Brain - Nervous system development"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA079359: "	"unprognostic (1.30e-1)"	"unprognostic (8.57e-2)"	"unprognostic (4.20e-1)"	"unprognostic (1.05e-2)"	"unprognostic (3.33e-2)"	"unprognostic (1.48e-2)"		"unprognostic (8.46e-2)"	"unprognostic (8.37e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.50e-2)"	"unprognostic (6.51e-2)"	"unprognostic (1.57e-2)"	"unprognostic (2.08e-4)"	"unprognostic (1.58e-1)"	"unprognostic (2.11e-3)"	"unprognostic (1.51e-2)"	0.1	5.9	28.4	0.0	64.7	0.1	0.0	42.3	64.6	0.1	0.0	0.1	0.0	2.0	0.0	0.0	0.5	0.1	0.0	19.2	19.1	0.1	0.0	0.0	0.0	81.3	36.3	0.0	0.0	0.0	0.8	0.1	87.7	0.1	0.0	18.7	0.0	0.0	0.1	0.1	0.0	0.0	19.4	0.1	0.1	0.2	81.9	0.0	0.0	0.3	0.0	0.0	0.0	117.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	0.1	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.3	0.2	0.2	0.1	0.1	0.0	28.4	64.7	42.3	64.6	19.2	19.1	81.3	36.3	87.7	19.4	81.9	117.1	0.0	0.0	0.0	18.9	0.1	0.0	0.0	0.0	0.0	58.7	0.0	0.0	2.3	0.0	0.0	0.0	273.1	0.0	0.0	0.1	0.0	0.0	1.1	0.0	0.1	0.1	0.0	0.0	668.6	0.0	0.1	0.9	0.0	0.1	0.0	0.0	1.4	0.0	0.1	97.6	637.3	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	25.3	0.0	4.1	0.0	217.6	2710.1	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	10.4	0.0	3.2	0.2	0.2	0.7	0.0	0.1	0.3	0.0	0.0	0.1	0.0
SLC24A3		ENSG00000185052	"Solute carrier family 24 member 3"	Q9HC58	20	19212642-19722926	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 81.7"	"Group enriched"	"Detected in many"	9	"Astrocytes: 134.5;Inhibitory neurons: 327.0;Oligodendrocyte precursor cells: 375.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	39	"basophil: 5.8;eosinophil: 1.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Cell line enriched"	"Detected in some"	4	"HMC-1: 75.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043400, HPA045497"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 47: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Golgi apparatus"	Cytosol	"HPA043400: AB_2678462, HPA045497: AB_2679349"	"unprognostic (8.74e-2)"	"unprognostic (1.13e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.41e-1)"	"unprognostic (7.40e-2)"	"unprognostic (2.09e-1)"	"unprognostic (2.40e-1)"	"unprognostic (7.62e-2)"	"unprognostic (3.04e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.21e-3)"	"unprognostic (3.85e-2)"	"unprognostic (1.89e-1)"	"prognostic unfavorable (6.08e-4)"	"unprognostic (7.36e-3)"	10.4	3.1	16.2	4.0	11.7	1.4	4.9	13.3	56.1	17.8	2.7	10.8	3.8	28.3	24.3	20.6	20.0	13.0	1.1	81.7	18.6	1.1	0.7	5.5	1.0	13.6	19.2	14.6	0.7	7.5	1.2	3.0	9.1	10.9	5.4	7.3	4.7	17.5	40.9	7.0	5.0	29.1	10.3	2.4	3.8	1.5	34.8	1.9	3.0	16.9	2.7	8.6	8.9	5.4	0.0	0.0	0.0	0.0	0.3	0.8	0.0	0.8	13.3	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.0	18.2	0.0	0.0	0.7	0.0	75.7	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	8.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.0	9.0	0.0	0.6	17.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	5.8	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	16.2	11.7	13.3	56.1	81.7	18.6	13.6	19.2	9.1	10.3	34.8	5.4	0.2	3.2	1.1	134.5	0.1	1.1	1.1	0.4	0.0	19.1	5.0	2.3	0.4	0.0	1.3	1.8	0.0	8.5	0.1	0.3	0.0	0.1	17.0	1.2	29.8	0.4	7.7	3.4	11.8	0.0	0.3	1.9	0.0	1.6	26.6	0.1	0.4	0.0	0.6	1.7	327.0	4.1	0.0	0.0	0.7	18.3	3.7	1.1	0.0	12.2	0.0	3.1	0.0	375.5	2.4	0.2	2.8	4.1	0.4	0.8	0.4	0.0	0.0	2.2	0.0	2.7	3.0	0.5	0.8	2.9	4.1	3.4	0.4	0.1	0.7	3.8
SLC24A4	NCKX4	ENSG00000140090	"Solute carrier family 24 member 4"	Q8NFF2	14	92322581-92501481	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Olfaction, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport"		"Amelogenesis imperfecta, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"choroid plexus: 92.6"	"Group enriched"	"Detected in some"	4	"Bipolar cells: 251.6;Cone photoreceptor cells: 200.1"	"Group enriched"	"Detected in some"	5	"glioma: 0.5;melanoma: 0.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	4	"classical monocyte: 11.1;intermediate monocyte: 14.7;non-classical monocyte: 11.6"	"Lineage enriched"	"Detected in many"	5	"monocytes: 14.7"	"Cell line enhanced"	"Detected in single"		"SCLC-21H: 1.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063206			Approved	"Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	"Plasma membrane"		"HPA063206: "	"unprognostic (1.53e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.22e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.43e-3)"	"unprognostic (1.34e-1)"	"unprognostic (2.04e-3)"	"unprognostic (3.40e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.48e-3)"	"unprognostic (3.21e-1)"	"unprognostic (1.48e-3)"	"unprognostic (1.25e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.58e-2)"	0.5	0.2	7.1	1.4	10.3	3.5	0.1	17.5	8.1	0.2	92.6	0.2	0.2	0.1	0.1	0.2	0.2	0.6	0.2	7.2	5.3	0.0	0.1	0.8	1.2	22.7	14.1	0.2	0.1	0.0	1.4	0.3	19.1	0.2	0.2	12.3	0.1	0.3	0.8	0.1	0.3	0.4	14.7	2.7	0.1	1.1	16.5	0.4	0.1	1.0	0.4	0.3	0.2	12.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	11.1	0.0	0.0	14.7	0.2	0.0	0.0	0.0	3.0	0.1	0.0	0.0	1.5	0.1	11.6	0.5	0.0	2.7	7.1	10.3	17.5	8.1	7.2	5.3	22.7	14.1	19.1	14.7	16.5	12.9	0.8	0.0	1.9	47.0	0.4	0.0	0.1	0.0	0.0	251.6	0.3	0.1	1.8	0.0	0.0	0.0	200.1	0.0	0.1	0.0	0.0	0.0	4.0	0.5	0.1	0.9	0.0	0.8	19.9	0.0	0.1	0.5	0.0	0.8	0.0	0.0	1.1	0.0	4.0	0.0	28.5	0.0	0.0	22.2	1.8	5.6	0.3	16.6	0.0	2.8	44.3	4.1	1.0	10.1	1.3	0.1	0.0	0.4	0.1	0.2	0.0	0.2	0.7	10.6	0.0	9.9	0.2	0.1	1.6	0.0	0.0	0.3	0.3	0.0	0.0	0.1
SLC24A5	"JSX, OCA6"	ENSG00000188467	"Solute carrier family 24 member 5"	Q71RS6	15	48120990-48142672	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Potassium transport, Sensory transduction, Sodium transport, Symport, Transport"		Albinism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"skin 1: 8.2"	"Group enriched"	"Detected in some"	7	"Early spermatids: 20.7;Melanocytes: 76.5"	"Cancer enriched"	"Detected in single"	162	"melanoma: 8.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	800	"SK-MEL-30: 251.8"	"Group enriched"	"Detected in some"	5	"hippocampal formation: 3.0;pons and medulla: 4.1;thalamus: 1.5"	"Low region specificity"	"Detected in all"									NA	NA				"Cluster 61: Skin - Cornification"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"								"unprognostic (3.47e-2)"				"unprognostic (1.80e-1)"	"unprognostic (1.35e-1)"			"unprognostic (1.92e-3)"					0.0	0.0	0.3	0.0	0.3	0.0	0.2	0.3	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.1	0.0	0.1	0.9	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.3	0.1	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.1	1.7	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	251.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.3	0.2	0.1	0.5	0.1	0.9	0.2	0.0	0.9	0.2	0.3	0.0	0.5	0.7	0.2	2.4	0.0	0.0	0.0	6.4	0.0	0.1	0.3	0.0	0.0	0.0	2.1	0.0	0.1	0.0	0.0	0.0	20.7	1.5	0.1	0.1	0.0	0.4	2.9	0.0	0.0	0.5	0.0	0.9	0.0	0.1	0.0	0.0	0.1	5.0	2.7	0.0	0.0	0.0	0.7	6.6	0.0	0.0	76.5	1.0	0.0	0.9	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.7	4.6	0.0	0.1	0.1	0.1	0.1	0.0	1.0	0.0	0.1	0.0	0.0	0.0
SLC25A1	"CTP, SLC20A3"	ENSG00000100075	"Solute carrier family 25 member 1"	P53007	22	19175581-19178739	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Congenital myasthenic syndrome, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 197.7"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 221.1;Proximal enterocytes: 304.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 101.9"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (2.12e-1)"	"unprognostic (3.98e-1)"	"unprognostic (8.17e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.39e-2)"	"unprognostic (2.61e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.74e-2)"	"unprognostic (3.90e-2)"	"unprognostic (5.72e-2)"	"unprognostic (4.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (3.46e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.03e-2)"	113.3	76.3	45.8	22.3	46.9	14.2	90.3	49.5	58.6	43.5	47.6	63.9	114.1	40.0	16.2	59.2	34.7	21.5	27.3	41.5	65.8	86.8	197.7	33.6	21.4	61.0	58.3	43.6	54.8	33.1	39.3	27.4	73.0	53.9	33.9	5.6	39.5	30.0	17.3	49.1	92.4	21.0	49.4	31.4	52.9	36.3	51.8	16.3	46.1	7.7	25.5	43.9	40.8	55.2	111.9	114.3	85.9	73.6	209.1	102.5	91.2	77.5	96.9	65.7	90.4	136.4	77.2	66.9	38.8	110.5	70.5	95.4	82.9	138.1	37.2	59.6	164.1	35.5	97.7	278.4	148.2	67.3	107.5	145.1	81.7	75.7	58.4	73.3	62.8	53.4	184.6	61.9	74.7	288.1	37.0	80.8	57.5	173.5	70.0	70.4	44.6	29.9	196.2	135.8	55.5	71.2	83.1	163.0	48.6	52.6	122.6	171.7	63.6	80.3	69.3	62.0	53.2	78.2	39.9	35.4	82.5	31.5	41.4	11.6	15.7	101.9	16.6	17.9	10.6	33.3	18.7	18.2	13.7	43.5	16.7	14.3	8.1	13.7	23.8	10.5	19.6	10.6	45.8	46.9	49.5	58.6	41.5	65.8	61.0	58.3	73.0	49.4	51.8	55.2	18.5	9.6	18.9	10.7	35.0	22.0	27.2	21.6	31.9	7.8	44.2	41.9	7.2	38.6	17.0	33.1	2.1	135.6	18.4	178.6	50.9	33.5	30.5	41.4	37.0	16.8	41.0	21.7	5.2	45.6	139.5	27.1	50.4	83.7	2.5	67.5	21.4	221.1	47.5	13.5	6.1	107.3	28.5	30.5	18.2	98.8	28.9	32.6	28.4	2.8	29.6	27.7	16.5	3.0	10.1	39.7	128.1	29.3	38.7	28.7	304.3	127.3	11.1	4.2	13.1	14.5	37.8	15.3	29.5	60.5	30.4	127.7	24.6	55.7	108.3	30.4
SLC25A10	DIC	ENSG00000183048	"Solute carrier family 25 member 10"	Q9UBX3	17	81712236-81721016	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 183.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 42.3;Late spermatids: 76.9;Proximal enterocytes: 50.9;Proximal tubular cells: 84.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"NK-cell: 1.0"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"Hep G2: 158.9;SK-BR-3: 116.6"									HPA023048	Supported		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	Nucleoplasm	"HPA023048: AB_2301950"	"unprognostic (7.17e-2)"	"unprognostic (2.38e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.36e-1)"	"unprognostic (9.50e-2)"	"prognostic favorable (2.56e-4)"	"unprognostic (5.66e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.78e-2)"	"prognostic favorable (8.14e-4)"	"unprognostic (6.73e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.02e-2)"	"unprognostic (6.32e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.05e-1)"	"prognostic favorable (1.31e-4)"	17.8	14.8	5.3	3.0	5.0	9.5	16.8	5.6	6.2	6.5	6.4	26.1	21.4	3.8	2.7	38.8	9.2	5.5	10.4	4.6	5.2	72.9	183.3	4.3	2.5	6.6	5.2	4.8	35.8	17.3	6.3	1.8	5.1	17.2	6.8	0.6	26.0	6.1	5.8	17.3	20.1	0.9	5.8	4.8	24.0	35.0	5.4	3.9	9.6	1.9	2.9	9.1	11.5	6.6	45.3	81.8	7.6	38.1	2.9	2.3	15.3	19.2	6.1	23.2	17.4	49.5	18.4	20.2	14.3	4.5	11.2	28.3	10.8	19.3	4.2	14.9	66.2	16.7	49.0	158.9	3.3	37.5	19.5	1.6	10.0	16.5	3.2	4.5	13.6	27.9	28.0	24.3	8.2	85.4	54.3	40.0	7.8	18.8	63.9	41.0	16.3	63.6	21.1	39.6	49.8	34.0	18.1	116.6	4.0	2.0	50.3	20.4	6.1	17.9	58.6	26.5	34.4	15.3	8.3	12.0	7.8	39.0	15.9	0.0	0.2	0.0	0.1	0.3	0.3	0.0	0.1	0.4	0.1	0.2	0.1	0.0	0.0	1.0	0.0	0.1	0.2	0.2	5.3	5.0	5.6	6.2	4.6	5.2	6.6	5.2	5.1	5.8	5.4	6.6	1.4	0.0	2.2	1.6	1.3	0.0	4.5	0.0	2.2	4.9	14.6	7.5	3.8	17.2	3.1	14.7	0.0	16.4	2.3	10.2	25.4	16.9	30.5	22.3	3.8	1.5	4.9	8.2	1.2	22.9	6.9	2.3	18.8	16.4	0.0	5.1	3.6	42.3	8.0	0.0	1.7	15.3	0.0	2.4	0.0	76.9	2.1	2.0	0.0	0.0	0.8	1.9	3.1	0.5	1.2	9.9	19.3	1.9	4.3	4.7	50.9	84.6	7.3	4.2	0.0	1.3	1.6	27.9	3.1	15.9	0.0	4.2	1.5	5.3	27.2	7.9
SLC25A11	"OGC, SLC20A4"	ENSG00000108528	"Solute carrier family 25 member 11"	Q02978	17	4937130-4940053	"Disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"heart muscle: 233.6;skeletal muscle: 314.5;tongue: 450.4"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021167	Approved					NA	NA		25000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA021167: AB_1857021"	"unprognostic (8.58e-2)"	"unprognostic (4.06e-3)"	"unprognostic (9.43e-2)"	"unprognostic (2.47e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.99e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-1)"	"unprognostic (9.48e-2)"	"prognostic favorable (6.41e-6)"	"unprognostic (2.84e-1)"	"prognostic favorable (2.84e-9)"	"unprognostic (1.26e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.70e-2)"	"unprognostic (1.09e-1)"	35.6	52.5	69.2	33.8	70.7	31.7	32.0	77.7	79.8	35.3	70.8	46.7	47.5	36.7	22.1	50.5	41.6	30.7	233.6	76.8	73.6	66.6	66.7	30.0	40.7	69.2	72.7	30.7	27.9	70.8	36.4	27.6	69.6	34.0	36.1	23.2	41.6	38.4	314.5	48.7	40.2	33.4	70.2	37.5	39.9	10.9	77.0	45.1	38.5	450.4	33.9	38.5	33.3	71.5	51.1	134.6	67.3	66.3	64.7	39.9	47.3	56.2	57.2	96.2	79.3	85.1	24.7	78.3	74.5	55.3	46.8	99.6	88.1	101.5	37.8	99.6	113.8	86.4	70.9	74.5	66.0	37.6	100.7	57.7	65.1	85.4	71.7	46.7	67.8	83.2	38.7	74.1	82.7	91.2	121.6	38.3	35.6	56.1	89.6	108.6	41.4	71.0	74.8	52.6	59.9	62.1	70.9	79.0	65.2	33.6	73.3	58.7	46.0	43.0	28.1	58.8	109.7	39.3	25.4	30.7	84.8	62.6	108.4	126.0	170.3	132.3	98.8	176.8	90.8	87.5	75.1	87.8	160.4	74.3	74.1	81.2	111.8	151.6	165.1	107.0	97.3	186.2	69.2	70.7	77.7	79.8	76.8	73.6	69.2	72.7	69.6	70.2	77.0	71.5	39.7	25.6	23.3	12.7	32.9	38.1	47.1	92.7	25.6	60.3	47.5	51.3	150.6	51.5	40.0	66.2	16.7	132.2	39.0	67.0	185.9	60.7	15.2	30.3	29.7	41.0	27.6	50.3	8.0	53.6	138.7	40.2	30.5	28.2	39.3	45.6	33.5	61.5	109.1	47.1	10.5	51.6	99.7	45.3	44.4	19.6	30.4	56.2	51.6	9.4	106.9	59.2	47.4	9.5	10.4	47.4	58.7	38.4	45.8	43.1	99.9	202.5	26.5	56.0	52.6	43.1	48.4	15.1	31.3	46.9	44.3	102.5	38.4	57.5	88.3	42.1
SLC25A12	Aralar	ENSG00000115840	"Solute carrier family 25 member 12"	O75746	2	171783405-171999859	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 97.0"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 97.7;Excitatory neurons: 148.5;Inhibitory neurons: 175.2;Oligodendrocyte precursor cells: 111.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035333, HPA035334"	Enhanced		Uncertain	"Nuclear speckles,Cytosol"		NA	NA		9100	"Cluster 32: T-cells - Unknown function"	"Cluster 38: Heart - Muscle contraction"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear speckles"	Cytosol	"HPA035333: AB_10603028, HPA035334: AB_2674577"	"unprognostic (3.24e-2)"	"unprognostic (2.52e-2)"	"unprognostic (4.07e-2)"	"prognostic unfavorable (7.86e-4)"	"unprognostic (2.65e-2)"	"unprognostic (7.27e-2)"	"unprognostic (4.21e-3)"	"unprognostic (5.23e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (1.13e-1)"	"prognostic favorable (2.91e-8)"	"unprognostic (8.64e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.70e-1)"	11.1	11.5	8.5	4.0	9.0	2.8	11.6	9.3	12.3	11.5	6.1	25.2	2.2	13.4	4.3	12.7	11.7	3.7	62.7	8.9	9.0	13.4	1.8	7.1	4.4	6.9	6.7	14.5	3.9	12.0	17.1	3.2	6.8	13.7	6.1	15.8	16.8	9.5	97.0	14.5	10.7	8.5	5.8	8.9	16.4	6.1	7.4	5.6	15.1	51.1	5.2	16.2	12.4	8.4	4.9	3.0	4.2	8.0	9.5	11.7	0.0	5.3	11.2	7.7	7.3	2.2	3.2	14.5	2.6	7.5	4.3	4.3	7.9	8.5	10.7	6.3	10.4	6.9	4.4	5.5	3.8	14.8	4.9	12.6	7.0	11.0	2.3	4.1	8.0	7.0	5.0	5.2	4.4	3.2	9.7	6.5	3.0	3.8	4.7	9.6	4.7	7.4	8.0	4.5	5.1	1.6	2.6	8.5	4.0	2.5	2.8	3.1	6.4	6.2	2.0	6.0	3.2	8.8	4.2	13.6	9.1	7.5	2.9	0.0	0.4	0.1	1.0	0.4	0.8	0.7	0.5	0.9	0.4	0.5	0.9	1.5	0.0	0.9	0.7	0.1	0.7	0.4	8.5	9.0	9.3	12.3	8.9	9.0	6.9	6.7	6.8	5.8	7.4	8.4	9.8	0.0	9.8	71.2	11.3	6.9	10.2	13.2	19.9	25.5	9.3	11.8	97.7	0.0	18.4	18.4	25.0	7.5	10.7	11.6	19.6	1.7	3.2	5.0	10.3	8.7	14.4	6.9	148.5	3.3	1.8	15.1	12.8	6.1	10.8	7.3	7.9	0.6	4.5	37.0	175.2	6.1	16.2	8.4	5.4	2.1	12.5	7.2	16.0	25.3	9.7	19.8	5.2	111.6	44.1	2.0	4.7	24.5	19.5	4.6	4.1	13.2	11.2	25.5	13.1	12.5	16.6	7.8	9.1	16.8	7.7	1.2	15.0	11.0	7.6	8.3
SLC25A13	"ARALAR2, CITRIN, CTLN2"	ENSG00000004864	"Solute carrier family 25 member 13"	Q9UJS0	7	96120220-96322147	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant, Intrahepatic cholestasis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 150.1"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 153.4;Oligodendrocytes: 439.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018997	Enhanced		Supported	Mitochondria		NA	NA		21000	"Cluster 14: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria		"HPA018997: AB_1857023"	"unprognostic (3.61e-2)"	"unprognostic (7.99e-2)"	"unprognostic (6.99e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.14e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.42e-2)"	"unprognostic (6.67e-2)"	"unprognostic (2.31e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (9.14e-4)"	"unprognostic (1.15e-1)"	"unprognostic (1.05e-1)"	"unprognostic (3.32e-1)"	"unprognostic (7.09e-2)"	9.2	14.3	7.0	8.9	13.7	8.0	10.3	13.7	10.0	8.0	15.1	16.3	16.0	7.6	10.2	9.6	9.5	9.9	6.6	6.7	9.9	32.3	150.1	7.9	7.1	13.6	12.2	7.8	9.6	13.8	8.3	16.1	13.0	8.2	17.8	19.4	7.7	12.5	7.0	12.3	13.4	6.7	10.1	10.0	14.4	7.4	11.3	3.9	13.7	3.3	8.7	11.0	7.6	20.2	45.3	39.2	44.2	15.5	7.5	6.0	61.8	11.2	8.5	26.5	26.7	70.7	41.2	20.2	51.9	7.2	57.8	26.3	50.1	16.2	31.0	8.0	33.0	23.0	34.4	55.4	17.4	29.5	17.4	15.8	16.9	22.7	20.4	10.1	31.0	3.0	65.9	7.6	13.0	49.6	0.1	27.6	78.0	47.8	24.0	11.6	26.3	46.8	63.7	42.1	21.1	69.0	38.8	81.1	67.3	72.9	24.2	22.4	18.2	19.6	43.6	46.8	34.5	15.2	40.8	12.7	24.1	28.0	32.9	0.4	3.1	2.2	1.4	4.5	1.5	2.4	1.1	1.3	6.1	1.2	0.7	0.9	0.6	2.0	5.1	3.1	1.2	1.4	7.0	13.7	13.7	10.0	6.7	9.9	13.6	12.2	13.0	10.1	11.3	20.2	31.5	9.6	12.6	60.7	19.7	7.4	8.5	8.6	16.5	36.5	13.6	17.1	8.3	27.1	9.2	18.4	54.2	29.2	8.9	32.1	27.4	19.8	11.0	44.0	23.2	20.7	37.8	15.3	26.6	19.1	26.5	18.8	44.4	34.2	14.5	30.4	11.7	153.4	23.2	10.1	43.7	22.3	12.2	23.8	10.0	11.1	13.1	21.5	21.4	82.4	13.2	17.6	8.2	53.3	439.6	22.6	23.7	15.8	12.7	14.9	27.1	74.9	14.2	47.3	13.1	19.0	16.9	7.0	14.5	25.4	8.0	20.0	7.9	21.6	25.5	15.4
SLC25A14	"BMCP1, UCP5"	ENSG00000102078	"Solute carrier family 25 member 14"	O95258	X	130339888-130373361	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Respiratory ciliated cells: 34.2;Spermatogonia: 37.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA060316			Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 16: U-266 - Nucleosome"	"Cluster 49: Ciliated cells - Cilium organization"	Mitochondria		"HPA060316: AB_2684251"	"unprognostic (1.65e-2)"	"prognostic favorable (1.72e-5)"	"unprognostic (1.82e-1)"	"unprognostic (2.74e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.16e-1)"	"unprognostic (3.36e-3)"	"unprognostic (8.92e-3)"	"unprognostic (3.52e-2)"	"unprognostic (2.95e-3)"	"prognostic favorable (1.78e-4)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (5.52e-6)"	"unprognostic (6.05e-2)"	"unprognostic (1.12e-1)"	"unprognostic (6.92e-2)"	"prognostic favorable (1.39e-5)"	2.5	5.6	10.7	2.1	11.5	2.7	3.3	8.2	12.6	3.3	7.3	3.6	1.3	4.1	6.5	2.6	5.9	2.6	4.7	11.4	14.3	3.2	2.5	2.8	2.8	8.7	9.0	4.0	3.4	4.2	10.8	2.2	9.8	3.0	2.4	10.2	3.2	3.7	3.7	2.9	2.4	4.5	8.2	2.3	3.0	6.6	11.5	3.9	3.4	2.3	3.3	2.6	2.5	8.8	9.0	11.7	8.1	6.1	5.4	5.0	4.4	6.6	8.7	12.3	12.6	4.7	5.3	6.1	22.6	9.0	14.7	4.9	11.9	5.0	12.2	7.6	15.0	2.0	10.7	11.1	7.8	7.7	3.5	4.7	5.9	15.8	4.8	7.4	7.1	8.4	4.9	8.5	20.2	13.8	8.2	10.8	6.7	9.7	18.4	6.9	10.6	12.2	7.5	3.8	10.4	9.2	7.0	7.0	11.7	5.3	4.5	4.3	4.8	6.8	4.5	15.6	13.6	7.8	21.0	5.0	12.3	9.3	6.2	3.2	3.4	2.6	3.0	2.8	3.6	3.9	2.4	2.8	3.7	2.0	1.9	3.1	4.1	3.8	2.7	4.5	4.7	2.4	10.7	11.5	8.2	12.6	11.4	14.3	8.7	9.0	9.8	8.2	11.5	8.8	4.5	6.4	2.2	5.9	5.6	9.9	8.3	13.3	7.4	10.0	6.6	6.1	4.1	8.6	5.3	3.7	2.1	9.1	4.3	4.5	17.6	10.2	15.8	16.0	5.5	5.1	9.0	3.4	12.7	9.1	8.2	5.4	5.6	4.2	3.8	9.7	7.5	4.3	5.2	6.7	11.9	3.8	12.2	4.7	4.1	7.7	5.0	4.9	8.8	5.6	4.5	8.2	3.1	4.5	5.3	9.0	4.2	8.2	9.0	4.2	4.7	10.7	34.2	13.6	6.6	5.3	9.2	29.1	37.3	7.3	8.4	5.3	5.8	6.5	4.5	6.5
SLC25A15	"D13S327, HHH, ORC1, ORNT1"	ENSG00000102743	"Solute carrier family 25 member 15"	Q9Y619	13	40789412-40812460	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 37.6;liver: 88.3;pancreas: 52.1"	"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 44.5;Hepatocytes: 39.8;Proximal enterocytes: 19.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA042146	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA042146: AB_2677874"	"unprognostic (4.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (2.86e-2)"	"unprognostic (5.19e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.85e-1)"	"prognostic favorable (2.16e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.37e-2)"	"prognostic favorable (1.74e-4)"	"unprognostic (4.04e-3)"	"unprognostic (1.12e-1)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (5.46e-4)"	2.3	1.4	2.0	4.1	2.2	5.6	4.6	2.3	2.5	2.1	2.3	5.9	37.6	3.1	1.1	3.2	2.6	5.0	2.8	1.9	2.6	5.6	88.3	2.3	4.8	2.6	2.3	2.9	52.1	3.4	1.3	2.8	2.5	2.8	6.5	2.8	3.4	1.8	5.9	3.7	26.7	3.4	2.1	2.5	5.5	9.4	2.4	5.3	17.3	6.0	5.3	2.6	1.6	2.9	7.4	14.7	16.5	21.3	6.5	8.2	17.3	5.6	2.9	6.8	3.9	17.6	15.2	48.0	6.4	10.3	12.7	12.6	26.6	15.5	7.0	11.9	12.4	37.0	8.6	26.6	12.7	15.0	5.3	9.0	8.6	9.6	21.9	4.6	11.2	23.8	18.1	7.8	11.8	28.2	10.2	9.9	33.2	32.7	7.9	25.5	12.0	10.6	11.7	7.0	7.7	20.1	10.2	18.4	10.1	11.5	13.6	23.2	8.4	8.4	12.1	12.7	17.0	8.9	9.6	27.9	8.4	11.4	16.4	1.3	0.5	0.1	1.6	0.9	1.0	0.6	1.0	1.1	1.1	0.7	1.0	2.0	0.7	1.4	0.5	0.5	0.9	0.5	2.0	2.2	2.3	2.5	1.9	2.6	2.6	2.3	2.5	2.1	2.4	2.9	0.3	3.2	0.5	3.9	1.3	0.3	1.0	0.8	2.2	1.4	2.1	1.4	1.1	1.5	0.2	0.0	0.0	2.2	1.3	0.6	7.9	2.1	4.6	1.2	2.1	0.9	1.2	9.0	2.4	4.3	44.5	1.0	1.5	2.1	0.0	1.5	0.7	39.8	1.7	0.0	4.3	0.6	2.0	1.6	0.3	6.8	0.6	1.0	1.8	1.0	0.0	0.4	2.1	5.0	1.4	1.7	2.7	0.0	6.2	1.6	19.0	4.3	0.1	1.9	0.0	1.0	1.1	5.4	9.3	2.1	0.1	1.5	3.2	4.3	3.5	0.8
SLC25A16	"D10S105E, GDA, HGT.1, ML7"	ENSG00000122912	"Solute carrier family 25 member 16"	P16260	10	68477998-68527523	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036243, HPA044580"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA036243: AB_2675019, HPA044580: AB_10962723"	"unprognostic (1.71e-1)"	"unprognostic (1.54e-1)"	"unprognostic (3.08e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.68e-2)"	"unprognostic (1.23e-2)"	"unprognostic (9.13e-3)"	"unprognostic (1.92e-1)"	"unprognostic (4.13e-2)"	"unprognostic (8.65e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.10e-1)"	"unprognostic (2.79e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.44e-3)"	10.3	3.6	5.1	2.1	5.3	3.7	4.1	7.1	7.9	2.1	0.0	3.2	3.8	3.5	3.2	2.6	2.1	2.3	2.8	5.0	5.6	5.8	11.4	3.1	2.7	2.7	3.5	2.3	5.1	3.5	2.6	2.8	3.4	8.2	2.8	4.7	4.5	2.8	4.9	3.0	3.8	2.6	2.2	2.4	4.5	1.5	7.0	2.0	3.5	2.3	2.0	2.7	2.1	6.1	2.8	1.1	3.2	4.4	4.2	5.0	3.4	3.8	4.2	2.4	2.6	6.6	1.9	3.0	2.7	7.6	1.3	1.6	10.2	1.9	6.1	2.2	6.3	1.6	3.5	2.9	5.1	5.2	3.4	4.3	4.9	4.6	6.4	3.6	2.0	2.6	1.8	4.8	5.2	2.6	2.9	3.7	0.7	0.8	14.8	1.6	2.3	1.0	6.8	9.2	2.2	1.8	5.4	5.2	4.4	2.2	2.9	2.1	8.9	3.6	4.8	6.1	4.5	4.9	2.8	4.9	3.5	4.2	1.6	1.4	0.7	0.7	0.4	0.5	0.4	0.4	0.4	0.3	0.5	0.8	0.4	0.6	1.3	0.6	0.4	0.8	0.4	0.3	5.1	5.3	7.1	7.9	5.0	5.6	2.7	3.5	3.4	2.2	7.0	6.1	9.6	44.8	20.7	23.5	9.9	6.4	6.3	4.9	4.6	19.2	11.0	6.7	10.4	12.8	7.4	12.9	39.6	19.0	12.4	12.9	11.7	8.1	9.9	9.6	9.3	7.8	15.0	9.9	44.0	19.2	32.3	8.8	20.9	14.1	8.2	6.1	13.9	37.7	10.6	20.2	53.7	9.4	8.2	10.3	6.5	13.0	3.1	7.9	1.8	13.1	8.2	9.5	15.5	29.7	48.0	14.4	7.8	7.9	16.4	13.5	17.7	21.4	9.9	31.2	0.0	13.4	11.3	4.5	2.5	10.5	6.8	59.8	9.4	9.4	9.0	10.6
SLC25A17	PMP34	ENSG00000100372	"Solute carrier family 25 member 17"	O43808	22	40769630-40819399	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052708, HPA060972"	Approved		Supported	Peroxisomes		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Peroxisomes		"HPA052708: AB_2681924, HPA060972: AB_2684400"	"unprognostic (2.75e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.91e-3)"	"unprognostic (2.44e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.96e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.72e-1)"	"unprognostic (1.63e-3)"	"unprognostic (8.44e-2)"	"unprognostic (2.72e-1)"	"unprognostic (5.59e-2)"	"unprognostic (8.54e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.18e-1)"	7.4	12.3	9.4	5.3	9.2	3.3	14.3	9.9	10.7	9.3	11.5	6.3	5.4	13.2	19.6	7.1	11.4	5.7	4.3	9.2	10.2	13.6	16.9	6.6	9.4	9.9	9.6	20.6	8.8	13.6	9.2	10.0	9.7	10.7	7.3	9.2	9.8	5.9	3.9	9.6	6.0	10.5	10.1	7.3	7.8	10.0	10.0	9.3	12.7	3.6	9.7	8.1	7.2	11.2	23.5	13.5	21.0	18.5	12.8	15.9	16.8	20.7	22.7	32.5	35.7	16.5	8.8	26.7	12.2	20.4	17.7	18.6	30.6	16.6	33.4	27.0	41.3	31.1	18.4	21.1	18.3	35.8	16.2	15.3	22.8	28.6	18.4	14.7	19.4	21.4	46.5	12.9	26.5	19.2	22.0	24.2	17.7	33.2	20.6	23.8	32.4	40.3	27.6	19.7	14.2	12.5	42.8	26.6	26.7	20.3	22.0	10.7	11.8	18.5	24.4	16.1	19.2	13.9	29.6	25.7	19.7	18.4	20.4	7.0	3.3	4.2	4.9	3.9	6.9	8.4	5.8	5.5	4.2	7.6	8.2	6.7	1.5	8.3	3.3	5.4	8.6	4.7	9.4	9.2	9.9	10.7	9.2	10.2	9.9	9.6	9.7	10.1	10.0	11.2	8.4	19.2	9.5	23.2	10.9	16.6	16.8	29.8	10.8	12.1	13.6	9.3	4.0	7.2	20.7	12.9	8.4	39.8	8.0	5.8	21.5	17.9	9.6	17.9	16.5	10.4	6.1	11.6	17.3	17.7	31.9	15.9	8.2	14.2	5.1	15.5	8.2	24.8	12.9	11.8	21.5	6.5	26.4	7.9	6.0	16.0	27.1	7.4	16.0	7.5	17.6	7.9	10.3	18.1	28.0	18.1	4.4	26.7	11.9	18.1	8.2	21.1	15.0	7.0	32.9	9.3	11.6	51.0	38.0	11.7	17.2	28.6	9.7	16.4	7.5	14.9
SLC25A18		ENSG00000182902	"Solute carrier family 25 member 18"	Q9H1K4	22	17563450-17590995	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	8	"brain: 143.8;choroid plexus: 90.7;liver: 111.5"	"Group enriched"	"Detected in many"	4	"Astrocytes: 195.2;Hepatocytes: 72.8"	"Group enriched"	"Detected in some"	5	"glioma: 10.6;liver cancer: 11.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 3.8;BEWO: 8.5"	"Low region specificity"	"Detected in all"							HPA068110			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 64: Astrocytes - Nervous system maintenance"	Mitochondria	Nucleoplasm	"HPA068110: "	"unprognostic (2.15e-1)"	"unprognostic (6.07e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.79e-1)"	"unprognostic (3.98e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.72e-2)"	"unprognostic (8.70e-4)"	"unprognostic (1.44e-1)"	"unprognostic (3.92e-2)"	"unprognostic (1.67e-2)"	"unprognostic (1.29e-1)"	"unprognostic (5.24e-2)"	"unprognostic (1.62e-1)"	14.4	1.0	130.1	0.3	132.1	0.1	7.2	116.5	141.1	2.5	90.7	2.9	0.3	2.9	0.2	0.3	3.8	0.9	2.8	119.4	123.3	1.9	111.5	1.2	0.3	121.7	129.2	1.2	1.1	0.2	1.5	0.1	112.5	7.8	0.1	1.9	0.5	0.4	6.2	1.2	1.9	0.5	106.5	4.8	1.5	4.2	143.8	0.3	0.6	4.0	0.1	0.8	1.4	110.7	0.3	0.6	2.2	0.4	3.8	0.0	8.5	0.3	0.0	0.0	0.0	0.2	0.2	0.2	0.2	0.0	2.5	0.7	0.0	0.0	0.0	0.3	1.0	0.3	0.3	0.5	1.5	0.3	0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.2	0.4	0.3	0.0	0.4	0.1	0.5	2.0	0.9	1.4	2.9	0.8	0.0	0.1	0.4	0.8	0.3	0.2	0.4	0.7	1.6	2.5	1.0	0.1	0.1	0.3	0.2	0.3	0.9	1.2	0.0	1.8	0.2	0.4	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	130.1	132.1	116.5	141.1	119.4	123.3	121.7	129.2	112.5	106.5	143.8	110.7	1.0	28.9	10.3	195.2	0.3	0.0	0.3	0.1	0.6	0.6	0.3	0.0	1.5	5.7	7.0	0.0	0.0	0.5	0.0	0.0	0.0	0.3	0.6	0.4	0.9	1.7	0.0	10.7	2.0	0.0	0.3	4.7	0.0	0.7	6.3	8.5	3.6	72.8	0.3	0.0	3.0	0.3	0.0	4.1	0.3	0.6	0.9	3.9	0.0	10.3	0.1	2.2	1.0	13.0	11.5	0.0	0.0	2.6	0.1	4.3	0.1	0.8	15.8	3.4	0.0	2.7	2.5	4.8	5.9	0.0	0.1	1.8	2.6	2.6	0.0	0.2
SLC25A19	"DNC, MCPHA, MUP1, TPC"	ENSG00000125454	"Solute carrier family 25 member 19"	Q9HC21	17	75272981-75289510	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 82.2;Langerhans cells: 160.3;Spermatocytes: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021936			Supported	Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA021936: "	"unprognostic (2.28e-1)"	"unprognostic (7.05e-3)"	"unprognostic (8.21e-2)"	"prognostic unfavorable (8.72e-5)"	"unprognostic (2.31e-1)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (1.21e-7)"	"unprognostic (6.71e-2)"	"unprognostic (2.73e-1)"	"unprognostic (2.85e-1)"	"unprognostic (7.72e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.71e-3)"	"unprognostic (3.58e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.13e-1)"	10.9	31.2	11.6	16.0	12.4	8.0	6.4	13.1	13.3	7.3	12.4	9.8	9.4	6.7	2.4	8.6	6.3	6.2	10.6	11.7	12.6	10.9	8.8	11.7	22.9	14.9	12.6	6.2	8.8	8.1	4.8	12.1	13.2	6.1	8.8	3.1	6.2	3.7	14.5	4.9	8.5	7.1	13.0	14.6	10.9	33.0	14.7	8.6	6.0	16.7	18.8	11.5	5.7	14.7	28.3	34.8	6.2	18.4	13.6	7.0	20.0	18.1	7.0	20.3	20.5	59.8	17.4	89.8	12.8	6.4	17.7	24.7	43.5	20.9	25.3	26.5	70.5	41.1	40.4	58.4	11.5	58.7	44.9	6.1	11.6	31.5	25.2	4.7	33.9	44.9	51.0	41.9	6.5	59.3	61.8	59.3	13.5	55.3	67.8	47.4	19.8	85.1	14.1	19.7	60.7	15.3	19.3	51.4	22.2	10.2	32.1	47.3	12.0	12.1	24.1	23.5	49.0	102.7	53.4	95.8	9.5	66.9	15.5	0.3	21.0	2.3	16.2	25.2	16.6	36.3	12.7	15.4	24.9	29.7	14.2	14.7	1.7	10.0	14.8	31.0	17.7	14.5	11.6	12.4	13.1	13.3	11.7	12.6	14.9	12.6	13.2	13.0	14.7	14.7	5.1	6.4	6.7	3.3	27.6	15.2	10.8	6.0	2.8	1.2	5.4	7.5	0.6	2.8	6.1	7.3	2.1	7.5	13.3	8.6	23.5	6.5	18.0	5.6	8.7	6.7	3.0	11.1	3.1	5.3	82.2	8.6	9.7	3.5	11.4	2.7	2.5	2.9	44.1	3.3	3.5	6.2	4.1	9.5	160.3	24.1	3.1	31.5	24.9	4.7	38.8	1.6	11.3	2.0	2.4	5.1	8.6	3.4	26.5	14.1	6.5	6.4	3.9	6.0	6.6	5.9	10.0	79.6	11.9	7.9	12.9	8.9	12.5	11.4	11.0	9.7
SLC25A2	ORNT2	ENSG00000120329	"Solute carrier family 25 member 2"	Q9BXI2	5	141302635-141304049	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	24	"testis: 6.6"	"Group enriched"	"Detected in some"	21	"Early spermatids: 18.2;Late spermatids: 12.0;Spermatocytes: 27.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA042146	Uncertain					NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA042146: AB_2677874"	"unprognostic (1.55e-1)"	"unprognostic (3.53e-1)"	"unprognostic (4.63e-2)"	"unprognostic (4.30e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.30e-1)"	"unprognostic (4.72e-3)"	"unprognostic (2.81e-1)"		"unprognostic (2.62e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.17e-1)"	"unprognostic (8.82e-10)"	"unprognostic (2.56e-1)"	"unprognostic (1.87e-1)"	"unprognostic (1.26e-2)"	"unprognostic (1.14e-1)"	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	6.6	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	27.6	0.9	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SLC25A20	"CAC, CACT"	ENSG00000178537	"Solute carrier family 25 member 20"	O43772	3	48856926-48898904	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 148.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 42.2;Hepatocytes: 64.2;Proximal enterocytes: 51.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 96.1;RPMI-8226: 138.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016862, HPA029863"	Approved		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Mitochondria, Cytosol"		"HPA016862: AB_1857028, HPA029863: AB_10602893"	"unprognostic (1.02e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.46e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.97e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.96e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.73e-1)"	"unprognostic (1.36e-2)"	"unprognostic (2.51e-1)"	"unprognostic (3.71e-3)"	"unprognostic (3.34e-1)"	"unprognostic (5.12e-1)"	"unprognostic (4.22e-2)"	"unprognostic (3.49e-2)"	20.7	29.9	16.3	11.9	18.2	10.7	17.9	18.6	16.4	8.3	15.3	26.5	65.6	10.4	4.6	9.1	12.8	15.7	62.8	15.5	17.9	25.6	148.3	15.6	14.6	17.7	17.4	5.9	30.4	17.3	11.6	7.3	17.8	11.7	23.5	4.5	19.9	9.0	66.5	10.4	52.7	15.1	17.4	20.6	21.0	9.1	17.5	17.3	11.4	61.1	16.1	11.3	8.4	18.4	4.1	12.8	9.7	13.8	30.1	11.8	1.9	22.3	11.8	15.2	15.8	16.3	19.1	19.0	15.6	35.1	18.7	4.1	24.5	9.8	11.6	47.9	11.8	26.4	19.2	20.4	14.0	27.8	48.1	14.9	11.2	20.6	3.8	6.1	20.2	28.1	24.1	96.1	20.2	10.9	30.4	13.7	5.1	22.9	27.6	10.6	5.9	138.4	16.4	10.1	3.9	13.6	20.7	0.2	11.4	13.6	30.5	12.9	16.6	17.2	3.2	25.5	16.4	35.6	27.0	21.8	24.5	19.5	23.3	60.8	101.1	215.2	97.4	79.7	62.2	36.8	53.1	71.2	97.5	33.0	41.2	69.1	48.6	64.6	83.7	120.5	60.7	112.3	16.3	18.2	18.6	16.4	15.5	17.9	17.7	17.4	17.8	17.4	17.5	18.4	7.5	6.4	2.7	13.1	7.0	1.8	2.5	4.6	3.4	1.1	4.0	3.6	42.2	4.3	4.4	0.0	6.2	2.3	13.6	28.4	3.9	3.5	1.3	2.3	4.6	5.5	7.3	16.4	2.2	4.3	2.3	6.1	9.2	2.1	1.3	3.8	7.5	64.2	16.9	0.0	3.8	12.7	2.0	13.4	4.5	1.8	10.5	10.0	1.8	1.0	31.3	2.9	32.0	1.0	6.0	3.7	16.4	12.4	12.6	3.9	51.8	16.7	5.9	1.3	0.0	5.4	5.3	8.3	7.1	4.1	1.3	1.2	14.4	27.7	16.6	2.9
SLC25A21	"ODC, ODC1"	ENSG00000183032	"Solute carrier family 25 member 21"	Q9BQT8	14	36677921-37172606	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 6.3"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 27.8;Excitatory neurons: 14.1;Exocrine glandular cells: 10.0;Inhibitory neurons: 10.4;Oligodendrocyte precursor cells: 11.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	4	"K-562: 26.4;Karpas-707: 54.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA000662	Uncertain					NA	NA				"Cluster 23: Testis - Cell cycle regulation"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA000662: AB_1080000"	"unprognostic (6.81e-3)"	"unprognostic (6.98e-2)"	"unprognostic (7.21e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.78e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (7.32e-2)"	"unprognostic (6.86e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.70e-4)"	"unprognostic (9.09e-3)"	"unprognostic (1.95e-2)"	"unprognostic (3.52e-1)"	"unprognostic (1.07e-1)"	0.9	1.2	0.2	0.3	0.3	6.3	0.5	0.3	0.3	0.6	0.1	0.6	0.7	1.3	0.2	1.2	0.7	0.6	1.3	0.2	0.4	1.6	0.4	0.5	0.1	0.4	0.3	2.0	2.8	0.9	0.3	0.1	0.4	1.6	0.3	1.0	1.6	0.4	0.7	0.3	1.2	0.7	0.4	0.5	0.8	3.9	0.3	0.3	1.5	0.9	0.1	0.6	0.3	0.5	1.3	1.0	0.4	3.2	0.1	1.0	0.0	0.3	0.8	1.7	0.7	0.2	0.9	0.1	1.4	0.4	0.0	1.0	0.0	0.7	0.6	0.8	9.5	0.9	0.8	0.8	1.0	0.0	0.0	0.7	1.1	0.0	0.5	0.9	3.9	0.0	26.4	54.4	0.8	2.7	0.0	0.0	2.1	0.0	4.1	0.0	0.0	0.0	0.8	3.9	2.6	0.0	2.6	0.2	1.3	0.4	2.9	0.0	1.9	0.0	1.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.2	0.4	0.4	0.3	0.4	0.4	0.3	0.5	0.3	0.0	0.0	2.3	0.2	1.0	1.8	1.8	6.8	0.1	1.0	0.9	1.5	0.0	0.6	0.0	0.0	0.0	0.0	0.1	1.9	0.9	1.4	0.1	1.0	0.7	1.8	27.8	14.1	10.0	0.0	0.9	0.0	0.2	0.0	0.4	0.7	0.3	0.2	1.7	10.4	0.5	2.0	0.0	0.4	1.4	1.5	0.1	0.0	4.7	0.0	4.3	0.0	11.6	5.2	3.7	0.0	0.7	0.0	2.7	0.1	4.2	0.4	1.5	0.0	1.1	1.1	3.1	3.6	3.6	0.9	0.0	0.1	1.9	1.0	0.6
SLC25A22	"EIEE3, FLJ13044, GC1, NET44"	ENSG00000177542	"Solute carrier family 25 member 22"	Q9H936	11	790475-798281	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 83.1;pancreas: 83.4"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 143.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014662	Approved		Uncertain	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 22: Non-specific - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria	Nucleoplasm	"HPA014662: AB_10600808"	"unprognostic (1.01e-2)"	"unprognostic (2.12e-1)"	"unprognostic (7.28e-2)"	"unprognostic (4.68e-2)"	"unprognostic (2.09e-3)"	"unprognostic (1.43e-1)"	"unprognostic (2.72e-3)"	"unprognostic (8.67e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.70e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.16e-1)"	"unprognostic (8.97e-3)"	"unprognostic (2.61e-2)"	"unprognostic (8.47e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.50e-1)"	15.8	13.6	49.1	11.0	59.8	7.5	11.2	17.9	83.1	9.0	0.0	10.0	12.9	9.6	2.1	15.2	10.4	4.1	7.7	74.2	7.9	15.1	40.2	15.1	10.1	24.5	11.1	12.7	83.4	4.0	48.7	5.0	25.4	13.9	3.0	16.1	14.4	4.3	2.0	14.2	12.2	3.7	2.4	13.9	13.5	19.1	19.1	6.3	9.4	0.5	6.2	10.3	10.3	40.2	56.2	35.7	20.4	18.6	8.3	14.8	19.4	26.3	21.3	28.0	17.7	34.9	37.1	16.8	19.2	21.6	31.9	48.8	22.4	31.1	6.3	31.9	41.4	15.4	18.2	21.9	35.8	24.7	25.0	14.9	18.6	21.4	22.6	8.8	13.0	19.3	31.8	25.3	12.7	33.9	26.3	23.5	44.8	33.9	53.7	30.9	11.2	38.9	16.8	9.2	100.3	45.3	15.0	35.9	18.7	3.1	17.4	12.5	13.0	32.1	21.5	14.8	25.0	22.1	14.3	21.5	37.8	22.2	19.3	0.0	1.6	2.5	3.7	3.3	2.2	1.3	2.3	3.9	1.8	1.0	1.3	2.3	0.9	2.0	3.4	0.5	1.3	1.6	49.1	59.8	17.9	83.1	74.2	7.9	24.5	11.1	25.4	2.4	19.1	40.2	5.7	6.4	8.6	7.8	8.4	12.6	8.7	9.5	9.1	143.2	9.1	7.5	2.5	8.6	5.0	9.2	33.3	7.1	8.8	3.9	3.9	22.0	12.4	9.5	9.0	7.0	13.1	2.5	11.8	19.3	10.3	5.1	12.8	11.2	2.5	7.2	3.3	17.6	4.3	43.7	10.0	7.6	2.0	2.8	4.6	7.7	4.7	4.1	3.6	3.7	6.6	16.0	13.4	2.5	1.4	14.1	7.8	4.9	13.7	23.8	13.0	7.1	5.8	32.0	0.0	2.8	6.7	1.8	10.4	7.4	13.4	3.1	8.2	13.7	5.9	8.8
SLC25A23	"APC2, FLJ30339, MGC2615"	ENSG00000125648	"Solute carrier family 25 member 23"	Q9BV35	19	6436079-6465203	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 238.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 164.2;Proximal enterocytes: 106.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009675, HPA050883"	Approved		Supported	Mitochondria		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA009675: AB_2668252, HPA050883: AB_2681260"	"unprognostic (3.51e-1)"	"unprognostic (1.53e-3)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (1.29e-4)"	"unprognostic (2.05e-2)"	"unprognostic (3.65e-3)"	"unprognostic (3.43e-2)"	"unprognostic (1.31e-3)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.30e-1)"	"unprognostic (3.25e-1)"	"prognostic favorable (1.10e-12)"	"unprognostic (8.95e-2)"	"unprognostic (3.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (4.22e-1)"	28.8	38.0	144.8	12.0	238.7	0.8	18.0	77.5	200.1	32.1	72.0	94.4	39.3	41.8	24.0	64.7	36.6	21.4	79.0	206.5	95.1	45.0	38.5	24.0	9.2	108.8	98.2	33.6	24.2	58.8	22.2	4.7	109.5	35.0	49.1	41.2	68.9	40.0	90.8	33.5	40.5	65.5	82.7	11.9	41.3	9.5	101.4	7.2	60.7	78.2	31.2	55.8	31.1	115.8	58.2	22.9	32.2	101.9	42.3	18.6	14.9	17.0	26.4	31.0	37.2	58.2	37.1	32.2	40.0	41.3	34.1	48.0	66.3	39.0	24.3	0.1	58.6	23.2	46.7	46.2	39.2	1.6	52.5	53.3	33.4	27.6	12.0	62.9	32.8	34.7	68.8	39.4	6.2	41.6	20.7	32.8	23.6	61.0	71.1	10.0	8.8	49.4	83.3	10.2	2.4	31.9	11.7	70.8	30.0	34.8	37.1	50.1	11.7	9.8	41.8	2.6	11.2	7.3	10.7	28.3	4.5	54.2	15.6	0.5	0.0	0.0	2.0	0.0	0.4	1.0	1.1	0.9	0.2	0.4	1.5	1.4	0.0	0.3	0.0	0.4	1.3	0.4	144.8	238.7	77.5	200.1	206.5	95.1	108.8	98.2	109.5	82.7	101.4	115.8	6.2	9.6	20.9	11.8	7.0	10.5	8.8	11.5	12.0	13.1	18.9	15.6	39.5	47.1	10.0	46.0	8.4	1.4	4.5	164.2	19.6	54.7	15.9	8.2	6.4	8.0	13.8	1.3	24.7	28.5	1.8	10.2	12.8	17.5	7.0	17.9	16.1	38.0	2.7	8.4	17.9	34.5	10.2	3.0	2.6	71.2	19.0	1.4	17.8	12.2	1.0	28.7	4.1	17.1	12.6	55.5	57.9	29.3	17.6	13.6	106.8	28.7	6.4	22.0	13.1	12.1	12.7	0.5	4.6	34.1	23.3	0.8	5.2	39.5	34.2	30.3
SLC25A24	"APC1, DKFZp586G0123"	ENSG00000085491	"Solute carrier family 25 member 24"	Q6NUK1	1	108134043-108200849	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 126.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA028519, HPA063636"	Enhanced		Enhanced	Mitochondria		NA	NA		19000	"Cluster 7: Monocytes - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Mitochondria		"HPA028519: AB_10603890, HPA063636: AB_2685068"	"unprognostic (1.94e-2)"	"unprognostic (7.30e-3)"	"prognostic favorable (1.01e-4)"	"unprognostic (7.11e-2)"	"unprognostic (1.64e-2)"	"unprognostic (2.91e-1)"	"unprognostic (8.54e-4)"	"unprognostic (1.51e-2)"	"unprognostic (7.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-3)"	"unprognostic (6.18e-2)"	"unprognostic (6.76e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.29e-1)"	10.0	6.2	0.8	5.3	0.7	3.8	8.2	0.6	1.3	12.5	0.8	13.5	11.4	6.6	3.2	6.0	6.7	6.8	4.9	0.7	0.8	6.3	1.6	9.1	5.1	0.8	0.7	5.9	4.2	8.2	2.8	9.4	0.9	4.0	16.0	6.7	6.7	4.6	3.7	4.3	12.3	8.7	0.6	5.7	6.9	3.2	1.0	5.0	7.1	4.5	4.9	10.1	7.0	0.7	38.2	8.9	28.8	8.6	17.9	23.4	11.4	13.0	17.0	25.1	27.4	11.3	12.9	0.0	10.3	28.7	10.9	14.1	7.9	24.0	35.1	7.9	4.4	2.4	13.4	5.2	14.9	6.1	4.9	17.6	17.0	15.0	18.5	16.8	19.6	5.7	6.2	13.0	32.2	28.7	3.7	1.4	14.3	17.3	8.1	5.7	33.9	12.6	16.9	22.8	5.0	8.7	17.4	14.9	17.5	27.5	13.3	10.7	10.5	13.8	6.2	23.2	15.0	3.0	2.3	0.0	5.0	11.8	8.2	0.4	0.5	0.4	0.3	0.5	0.3	0.1	0.2	0.2	0.4	0.4	0.1	0.3	0.1	0.2	0.7	0.3	0.4	0.1	0.8	0.7	0.6	1.3	0.7	0.8	0.8	0.7	0.9	0.6	1.0	0.7	33.9	54.5	27.8	5.5	24.2	15.6	20.4	20.6	17.1	14.7	25.5	16.8	15.5	17.2	33.5	18.4	8.4	7.1	16.3	126.7	21.5	31.2	3.2	62.0	46.7	28.6	18.1	6.7	18.0	36.9	60.2	23.2	40.2	61.7	22.2	20.9	29.6	1.2	54.1	10.1	14.9	43.2	18.3	51.8	32.8	2.9	19.6	50.0	23.2	16.9	44.7	12.7	11.3	14.6	20.8	67.6	51.2	18.0	9.7	14.3	54.4	24.9	55.2	33.9	52.6	27.2	26.5	6.2	2.4	24.8	14.9	6.2	23.9	41.8	59.1	33.8
SLC25A25	"KIAA1896, MCSC, PCSCL"	ENSG00000148339	"Solute carrier family 25 member 25"	Q6KCM7	9	128068201-128109245	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 136.5"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020381	Uncertain		Supported	Vesicles,Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 44: Endometrium - Transcription"	"Vesicles, Mitochondria"		"HPA020381: AB_1857037"	"unprognostic (4.62e-2)"	"unprognostic (2.66e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.40e-1)"	"prognostic favorable (1.01e-4)"	"unprognostic (1.20e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.60e-2)"	"unprognostic (4.96e-2)"	"unprognostic (3.70e-2)"	"prognostic favorable (4.65e-6)"	"unprognostic (1.21e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.66e-3)"	"unprognostic (1.42e-2)"	55.3	22.9	16.0	12.5	16.5	9.5	22.9	14.7	19.7	33.2	10.6	17.2	11.9	26.8	3.3	35.0	40.7	39.9	12.8	18.1	17.4	28.6	136.5	27.9	11.2	19.9	18.1	25.3	82.6	19.6	45.7	11.5	17.9	15.2	7.8	31.2	16.5	14.2	82.0	24.4	18.3	26.3	15.4	15.6	23.7	7.6	19.6	15.3	18.9	21.1	6.2	19.0	21.4	14.9	9.5	9.8	13.6	19.8	10.1	8.6	9.0	19.3	17.8	15.9	10.5	17.7	9.7	12.2	5.8	9.0	8.8	16.6	10.8	6.3	6.0	14.3	8.9	7.1	21.6	10.7	16.0	8.3	15.7	11.0	6.0	15.5	11.3	5.2	10.9	20.1	26.1	25.7	10.1	22.9	14.7	8.4	13.8	30.5	15.1	14.3	11.6	26.1	6.1	9.8	33.6	14.5	20.2	12.9	27.8	5.3	14.2	4.7	7.0	17.9	10.6	13.6	19.3	22.3	42.2	13.2	12.1	4.4	15.0	2.6	1.7	0.9	3.0	5.1	1.6	1.2	3.4	3.1	3.1	1.8	2.7	4.9	0.3	1.0	6.1	1.0	2.7	3.2	16.0	16.5	14.7	19.7	18.1	17.4	19.9	18.1	17.9	15.4	19.6	14.9	59.3	22.4	34.2	17.6	9.3	26.1	46.2	24.3	56.3	18.8	71.7	73.5	3.2	58.6	22.8	20.2	127.2	10.1	7.6	45.6	11.7	11.2	0.3	72.0	34.5	44.7	51.7	11.0	19.7	11.5	12.9	21.0	43.8	110.3	8.2	18.7	26.0	84.5	9.1	18.5	20.5	26.5	28.5	20.1	42.9	1.5	9.3	16.8	21.4	13.1	12.6	15.2	12.3	11.1	2.4	12.1	42.7	8.2	14.5	28.6	47.7	10.2	30.8	70.4	19.7	48.1	40.3	5.6	7.9	89.5	43.0	23.0	14.2	11.9	22.3	58.3
SLC25A26		ENSG00000144741	"Solute carrier family 25 member 26"	Q70HW3	3	66133610-66388116	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026887	Supported		Supported	Mitochondria		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 59: Non-specific - Translation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA026887: AB_2189921"	"unprognostic (1.93e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.83e-2)"	"unprognostic (7.94e-2)"	"unprognostic (5.38e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.54e-1)"	"unprognostic (9.21e-2)"	"unprognostic (8.43e-2)"	"prognostic favorable (1.73e-5)"	"unprognostic (4.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-1)"	15.8	16.0	9.6	5.6	9.9	12.9	15.0	8.7	11.0	12.7	6.8	18.1	7.8	13.3	9.4	15.9	12.7	7.8	28.3	10.1	8.7	18.5	25.9	11.6	10.7	9.1	9.3	16.5	15.5	14.9	10.2	7.7	9.2	13.5	9.5	8.5	16.1	9.0	42.4	22.0	13.3	7.8	9.3	13.5	17.4	14.3	11.1	8.6	15.8	21.0	9.6	17.5	14.1	11.3	10.7	10.4	6.5	12.4	13.9	13.1	13.9	9.0	15.7	10.7	10.2	13.5	13.9	12.3	5.5	15.1	14.3	7.6	7.3	15.8	11.7	11.5	16.8	16.3	8.1	19.2	14.7	22.5	13.4	17.7	29.6	8.4	21.3	11.2	8.9	21.5	9.2	12.8	12.9	12.5	9.9	28.3	20.8	23.2	6.8	10.0	11.7	19.4	10.1	8.3	5.4	14.6	12.4	11.8	21.4	10.9	9.8	19.7	10.4	12.7	11.0	15.9	16.6	21.1	30.6	15.1	17.4	21.1	14.7	1.8	9.9	6.1	15.4	10.8	14.5	19.3	16.9	16.4	18.3	16.2	20.5	17.5	0.9	18.1	6.7	17.5	17.7	13.4	9.6	9.9	8.7	11.0	10.1	8.7	9.1	9.3	9.2	9.3	11.1	11.3	11.6	32.1	22.2	22.9	29.5	35.8	38.6	45.7	28.5	17.7	36.1	34.0	106.9	30.0	25.0	18.4	12.5	36.8	27.3	14.1	35.2	28.8	33.3	17.2	13.6	20.5	18.6	9.2	55.5	45.1	44.6	26.1	17.3	19.1	19.6	21.1	13.2	39.1	30.3	11.8	51.4	29.2	28.5	22.3	26.5	28.6	16.1	15.8	37.4	31.9	21.4	26.5	32.0	32.2	63.9	27.6	20.8	21.8	18.7	49.1	30.8	57.7	16.2	24.5	19.7	31.7	22.1	29.4	32.9	28.2	36.8	32.7	39.6	22.3	33.3	37.8
SLC25A27	"FLJ33552, UCP4"	ENSG00000153291	"Solute carrier family 25 member 27"	O95847	6	46652915-46678190	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 53.2;Excitatory neurons: 78.1;Inhibitory neurons: 78.1;Oligodendrocyte precursor cells: 127.2;Oligodendrocytes: 88.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HeLa: 53.6;hTCEpi: 24.2;U-698: 27.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069732			Supported	Mitochondria		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 68: Oligodendrocytes - Mixed function"	Mitochondria		"HPA069732: AB_2686185"	"unprognostic (2.16e-2)"	"unprognostic (2.19e-1)"	"unprognostic (9.86e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.81e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.22e-1)"	"unprognostic (1.35e-1)"	"prognostic favorable (6.16e-4)"	"unprognostic (3.82e-3)"	"unprognostic (1.01e-1)"	"unprognostic (7.53e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.74e-1)"	"unprognostic (7.47e-3)"	33.7	23.7	34.7	5.9	46.5	1.5	31.6	76.5	45.5	57.9	42.1	50.4	6.7	41.4	69.9	18.6	52.9	19.8	36.0	41.3	34.0	52.2	43.8	25.2	5.7	35.9	36.7	94.3	34.1	21.1	114.7	3.0	36.5	72.2	15.5	118.8	28.4	24.4	21.2	41.1	24.4	22.2	28.5	15.8	31.7	32.5	44.9	1.2	70.8	10.9	4.8	43.0	40.9	57.1	3.5	2.3	3.9	13.1	14.6	10.0	0.1	2.0	6.2	1.8	0.4	0.0	4.9	1.4	8.9	3.3	4.3	6.9	1.8	5.8	1.2	0.0	19.7	0.0	53.6	5.0	7.7	0.1	0.6	15.7	24.2	0.1	15.2	9.4	0.4	13.5	0.2	0.1	1.6	1.4	0.0	0.2	2.0	3.5	5.2	0.0	5.0	0.2	9.7	12.5	11.8	1.3	9.2	0.6	5.4	5.7	9.8	0.0	1.4	8.1	5.3	0.8	1.7	5.3	0.0	27.4	1.3	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.7	46.5	76.5	45.5	41.3	34.0	35.9	36.7	36.5	28.5	44.9	57.1	3.6	3.2	4.6	53.2	0.2	0.9	4.4	0.5	9.1	32.0	3.6	7.5	9.5	2.8	1.7	5.5	29.2	0.0	0.0	0.7	0.0	1.2	29.0	5.7	6.1	4.5	6.0	2.5	78.1	0.7	0.1	7.2	1.1	5.1	1.3	7.3	1.8	2.2	0.2	20.2	78.1	1.3	2.0	0.3	0.3	22.7	3.1	0.8	1.8	27.2	0.0	7.0	0.0	127.2	88.5	0.2	0.7	5.3	0.2	4.5	0.5	1.0	5.0	36.2	0.0	8.8	7.5	0.5	1.8	4.4	2.4	0.0	0.2	8.8	1.5	2.8
SLC25A28	"MRS3/4, MRS4L"	ENSG00000155287	"Solute carrier family 25 member 28"	Q96A46	10	99610522-99620609	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 148.9;Late spermatids: 390.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.87e-3)"	"prognostic favorable (2.18e-6)"	"unprognostic (8.59e-3)"	"unprognostic (6.86e-2)"	"unprognostic (4.29e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.39e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.40e-2)"	"unprognostic (9.80e-3)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (7.28e-5)"	"unprognostic (1.12e-1)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (7.62e-3)"	55.6	74.0	107.1	32.8	110.6	86.0	51.1	104.4	125.4	60.1	98.7	82.0	22.9	46.9	46.4	70.5	59.0	24.9	69.2	106.6	108.9	53.6	96.7	73.4	41.6	108.5	112.8	60.9	66.0	32.4	55.7	28.2	109.0	78.6	33.7	54.4	51.7	45.7	100.3	58.8	56.3	35.8	105.8	80.4	58.5	90.2	107.8	30.9	48.6	45.4	37.8	89.8	62.9	111.9	28.7	28.5	17.8	42.8	32.3	40.1	18.1	33.8	40.4	45.2	37.0	22.4	35.2	36.9	19.9	30.8	20.5	47.6	22.1	31.6	27.8	27.5	28.3	16.3	46.4	23.9	31.8	29.3	21.6	33.9	46.0	29.4	58.1	58.9	32.4	32.1	11.7	27.9	23.5	39.6	25.4	66.1	4.2	23.1	21.9	31.9	21.2	20.6	30.0	31.1	11.9	14.9	19.2	20.7	25.4	23.1	37.3	28.8	19.9	27.6	19.0	36.9	41.0	22.8	15.5	18.3	26.5	55.8	11.7	0.0	1.4	4.0	2.7	1.3	1.2	1.7	1.9	1.6	2.1	1.6	1.4	1.2	1.2	1.6	1.3	5.8	2.4	0.7	107.1	110.6	104.4	125.4	106.6	108.9	108.5	112.8	109.0	105.8	107.8	111.9	30.4	12.8	11.0	37.2	11.8	25.4	16.4	17.5	4.6	30.7	12.5	14.1	19.7	15.7	7.3	5.5	20.9	21.0	18.3	9.2	7.9	3.8	148.9	11.1	13.6	17.1	4.2	4.8	34.1	8.0	8.7	15.8	4.1	13.2	6.3	36.2	9.7	19.1	9.8	43.7	34.0	11.9	6.1	9.2	20.0	390.1	12.8	16.2	19.6	20.6	10.6	29.0	8.2	28.6	36.3	6.3	9.6	18.0	10.6	31.1	7.2	8.3	4.0	29.2	13.1	20.5	15.6	63.4	9.2	13.6	27.4	14.5	12.2	58.2	11.4	20.6
SLC25A29	"C14orf69, FLJ38975"	ENSG00000197119	"Solute carrier family 25 member 29"	Q8N8R3	14	100291116-100306547	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"thyroid gland: 419.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 108.7;Collecting duct cells: 123.2;Endometrial ciliated cells: 136.7;Glandular and luminal cells: 136.0"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 47.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030781	Uncertain					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"			"HPA030781: AB_10603029"	"unprognostic (8.64e-3)"	"unprognostic (1.20e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.23e-1)"	"unprognostic (3.63e-3)"	"unprognostic (3.39e-3)"	"unprognostic (2.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.00e-1)"	"prognostic favorable (2.90e-4)"	"unprognostic (1.32e-3)"	"unprognostic (1.17e-1)"	"unprognostic (2.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.21e-1)"	"prognostic favorable (5.26e-4)"	28.0	44.6	57.6	5.3	66.1	13.5	34.4	71.1	74.2	46.8	72.2	20.2	8.1	32.1	37.5	36.3	84.4	12.2	30.5	56.9	57.8	124.5	35.9	44.1	8.1	91.8	69.3	49.9	22.2	6.6	62.8	6.6	83.8	69.1	5.3	47.4	45.5	12.6	11.9	42.4	18.5	8.2	68.7	20.5	26.6	44.8	66.8	8.8	419.6	6.0	5.7	26.9	27.0	94.9	11.0	23.2	29.7	39.0	6.8	2.5	17.4	8.2	8.9	16.8	9.9	5.4	6.7	0.0	20.4	2.8	8.6	11.5	12.7	4.2	5.6	4.2	5.4	10.4	35.8	9.9	16.1	6.1	13.0	7.4	12.9	7.7	7.1	25.5	23.3	35.7	3.4	1.2	4.9	34.8	37.9	33.6	14.8	9.7	22.5	49.1	12.4	0.8	55.5	7.7	42.9	52.8	19.3	13.2	15.4	12.5	33.0	10.2	24.5	6.1	11.7	8.6	12.9	2.9	1.3	1.4	6.9	14.9	7.6	1.5	1.1	2.1	0.9	0.2	0.0	0.1	0.4	0.9	1.2	0.5	0.1	0.6	1.2	0.1	0.0	0.5	0.6	0.2	57.6	66.1	71.1	74.2	56.9	57.8	91.8	69.3	83.8	68.7	66.8	94.9	23.5	9.6	26.5	108.7	5.8	6.5	16.3	14.8	22.8	17.9	57.1	38.5	1.4	11.5	23.3	123.2	75.0	6.2	17.8	9.4	17.6	31.4	19.7	136.7	24.8	20.9	20.9	3.8	26.4	11.8	0.7	10.9	12.2	136.0	14.5	22.6	31.8	9.5	7.4	21.9	22.4	8.8	12.2	2.8	30.0	62.4	2.5	11.7	10.6	30.9	8.8	21.0	12.3	42.7	78.5	14.2	17.0	6.0	4.1	39.6	4.6	13.1	45.1	82.7	13.1	7.0	12.6	4.2	5.0	24.5	6.5	18.6	6.4	6.3	14.3	13.8
SLC25A3	PHC	ENSG00000075415	"Solute carrier family 25 member 3"	Q00325	12	98593591-98606379	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 1537.4"	"Cell type enhanced"	"Detected in all"		"Cardiomyocytes: 1748.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045709			Supported	Mitochondria		NA	NA		83000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA045709: AB_10965843"	"unprognostic (1.16e-2)"	"unprognostic (4.68e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.56e-2)"	"unprognostic (6.38e-2)"	"unprognostic (3.25e-3)"	"unprognostic (9.41e-2)"	"unprognostic (4.98e-2)"	"unprognostic (6.43e-2)"	"unprognostic (5.65e-2)"	"unprognostic (7.40e-2)"	"prognostic favorable (8.11e-7)"	"unprognostic (3.45e-1)"	"unprognostic (2.99e-1)"	"unprognostic (8.66e-3)"	"unprognostic (4.72e-2)"	300.9	550.7	131.2	184.7	136.0	209.2	267.5	159.3	146.5	224.3	209.3	418.9	396.4	283.5	226.1	437.7	248.9	136.2	1237.8	132.6	160.4	419.8	370.1	255.7	201.7	148.9	149.6	290.2	392.2	499.7	216.9	192.4	153.0	209.9	347.6	167.2	302.7	220.9	1537.4	275.7	321.2	257.4	150.4	235.1	423.5	90.8	159.0	205.7	225.1	1233.2	312.8	294.7	264.6	135.4	731.4	447.1	620.0	509.6	534.1	891.5	1005.3	622.8	724.1	704.3	573.4	787.6	316.4	1003.2	376.9	633.0	320.3	573.7	616.9	741.3	680.6	402.9	651.8	589.5	297.4	563.3	683.0	665.7	416.6	857.3	616.8	494.2	681.2	994.3	990.8	488.8	654.9	240.5	782.7	436.5	642.5	724.2	605.4	540.6	988.5	703.0	730.3	1075.0	858.8	559.6	355.5	506.1	740.1	565.5	1009.8	504.4	771.0	676.3	782.0	371.2	390.0	442.8	603.4	486.5	648.5	678.1	295.6	368.3	494.9	184.7	408.9	223.2	244.7	520.2	285.6	298.5	270.8	271.4	534.7	222.6	281.3	269.8	166.6	288.5	545.2	321.7	377.4	637.0	131.2	136.0	159.3	146.5	132.6	160.4	148.9	149.6	153.0	150.4	159.0	135.4	319.2	214.7	294.8	46.0	392.2	376.0	590.6	751.4	495.1	223.1	442.5	549.3	1748.6	370.3	384.5	215.2	79.2	785.9	480.8	727.5	874.6	512.1	41.7	217.9	275.3	328.6	312.4	413.5	44.9	879.5	946.2	393.1	390.4	288.7	210.4	477.9	278.1	416.3	589.4	292.7	49.7	470.7	370.2	467.9	280.7	29.0	255.1	449.1	437.6	34.7	593.5	317.3	294.5	32.2	42.2	632.9	602.7	256.5	442.7	652.4	945.5	1029.4	201.1	230.2	302.4	470.5	733.5	126.1	169.9	796.6	362.4	814.7	356.3	536.0	729.1	769.9
SLC25A30		ENSG00000174032	"Solute carrier family 25 member 30"	Q5SVS4	13	45393316-45418455	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 71.6;skeletal muscle: 86.3;tongue: 63.3"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 38.8;Hepatocytes: 43.6;Proximal tubular cells: 29.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"							HPA045260			Approved	Nucleoplasm		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Nucleoplasm		"HPA045260: AB_10962505"	"unprognostic (9.23e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.28e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.35e-2)"	"unprognostic (3.16e-1)"	"unprognostic (3.50e-2)"	"prognostic unfavorable (3.32e-4)"	"unprognostic (5.69e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (9.91e-8)"	"unprognostic (2.24e-1)"	"unprognostic (5.19e-2)"	"unprognostic (4.12e-1)"	"unprognostic (6.19e-3)"	9.5	9.9	5.2	6.0	6.2	10.5	8.4	5.1	6.0	9.7	8.6	5.6	4.3	9.1	6.8	7.0	6.5	7.5	71.6	4.7	6.5	41.9	32.2	7.7	8.3	5.6	5.4	18.5	5.5	5.1	4.3	4.3	6.0	13.6	6.0	1.6	8.2	12.7	86.3	5.9	4.4	10.1	5.3	11.5	5.1	6.1	5.6	5.1	11.4	63.3	7.9	6.3	6.2	5.4	3.9	8.4	5.0	21.4	24.4	15.5	1.7	18.2	10.5	15.3	9.2	8.8	10.4	0.0	15.5	18.6	11.4	7.4	11.6	18.2	18.1	12.8	9.4	14.6	5.5	23.8	14.4	20.9	18.9	10.1	12.1	22.6	16.7	18.0	26.9	14.3	8.9	0.0	31.3	4.6	7.7	14.6	7.3	4.5	10.7	19.1	8.3	7.8	33.3	3.2	1.0	5.0	10.2	16.1	14.7	8.6	12.0	28.0	10.0	14.2	8.0	16.0	12.6	3.7	8.0	0.3	15.6	19.5	22.3	0.0	1.2	1.9	0.8	1.3	0.6	0.6	0.9	0.9	1.7	0.6	1.0	0.4	0.0	0.7	0.6	2.2	0.3	0.5	5.2	6.2	5.1	6.0	4.7	6.5	5.6	5.4	6.0	5.3	5.6	5.4	6.2	6.4	2.2	4.2	4.5	12.9	2.0	4.2	1.2	1.9	8.6	4.4	38.8	8.6	2.5	14.7	4.2	0.8	5.6	1.6	23.5	3.2	10.1	7.4	3.5	6.0	2.4	3.0	3.6	1.4	0.9	2.6	1.1	7.8	5.1	7.7	9.3	43.6	4.1	0.0	4.2	3.4	6.1	10.0	7.7	7.7	5.0	6.5	5.4	5.6	6.6	0.9	3.1	4.0	0.8	2.2	1.6	6.4	3.9	3.9	2.1	29.5	3.4	1.0	6.6	3.6	3.3	0.3	1.8	3.8	6.1	0.5	6.6	8.6	3.3	1.5
SLC25A31	"ANT4, DKFZP434N1235"	ENSG00000151475	"Solute carrier family 25 member 31"	Q9H0C2	4	127730400-127774292	"Predicted membrane proteins, Transporters"	"Antiport, Differentiation, Spermatogenesis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	272	"testis: 47.3"	"Cell type enriched"	"Detected in some"	8	"Spermatocytes: 198.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015064, HPA016841, HPA046835, HPA071684"	Uncertain		Enhanced	Mitochondria		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria		"HPA015064: AB_1847691, HPA016841: AB_1847690, HPA046835: AB_2679831, HPA071684: AB_2686431"					"unprognostic (8.15e-2)"									"unprognostic (1.62e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.32e-1)"		0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	47.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	0.1	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	13.5	3.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	198.2	23.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A32	MFTC	ENSG00000164933	"Solute carrier family 25 member 32"	Q9H2D1	8	103398635-103415189	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA024763, HPA047402"	Uncertain		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 59: Non-specific - Transcription"	Mitochondria	Nucleoplasm	"HPA024763: , HPA047402: AB_2680032"	"unprognostic (2.45e-3)"	"unprognostic (8.19e-2)"	"unprognostic (3.87e-3)"	"prognostic unfavorable (7.23e-4)"	"unprognostic (2.06e-2)"	"unprognostic (6.50e-3)"	"unprognostic (1.22e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (9.47e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.08e-1)"	"unprognostic (9.21e-2)"	"prognostic unfavorable (1.53e-6)"	"unprognostic (7.82e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.49e-2)"	13.5	7.2	3.1	12.5	3.9	14.6	11.2	4.1	4.8	8.6	2.9	7.7	6.8	10.7	7.5	7.3	9.3	11.5	9.7	4.1	4.5	9.6	17.9	8.5	16.9	4.7	4.6	9.6	8.5	8.8	11.3	10.1	4.6	8.0	7.7	1.4	6.4	7.5	9.6	6.9	7.6	10.9	4.6	12.7	7.0	6.4	4.0	8.7	7.1	9.2	12.8	15.0	7.0	5.3	33.7	11.5	10.5	18.3	21.3	23.3	10.3	27.4	39.9	30.6	31.4	14.0	19.6	73.8	25.8	29.5	17.7	20.4	22.5	22.5	47.0	45.5	16.1	53.5	8.5	18.3	37.4	26.5	23.1	23.1	17.9	34.5	51.2	8.6	32.5	19.4	33.9	25.9	30.5	13.5	45.0	21.6	17.1	39.3	23.6	33.6	16.3	50.8	20.8	12.7	28.0	17.2	13.6	22.3	48.9	10.5	19.3	18.5	22.6	36.7	24.9	44.2	36.2	19.2	19.7	76.8	31.0	38.1	27.5	0.6	3.3	1.6	6.0	3.7	7.3	7.0	6.4	6.9	4.1	4.8	6.5	6.7	0.8	5.2	4.3	3.5	5.5	5.7	3.1	3.9	4.1	4.8	4.1	4.5	4.7	4.6	4.6	4.6	4.0	5.3	28.9	3.2	3.3	10.1	46.9	23.1	16.7	6.9	32.5	9.4	10.3	6.7	10.4	11.5	5.4	5.5	6.2	11.9	20.9	4.1	7.9	9.8	4.8	8.3	14.0	22.2	11.4	16.2	30.3	9.4	13.6	19.6	27.0	9.1	8.9	8.0	20.0	15.2	10.2	8.4	25.8	7.1	8.2	7.3	11.6	4.7	9.3	16.2	10.6	24.4	9.9	7.6	15.5	25.6	46.6	10.0	3.1	8.6	56.3	14.4	4.1	9.5	2.6	8.1	19.7	13.5	14.7	22.9	17.1	32.6	25.9	14.0	27.7	9.5	7.5	15.1
SLC25A33	"BMSC-MCP, MGC4399, PNC1"	ENSG00000171612	"Solute carrier family 25 member 33"	Q9BSK2	1	9539465-9585173	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"tongue: 27.5"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 422.0;Late spermatids: 559.8;Spermatocytes: 358.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.8"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049982	Uncertain					NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA049982: AB_2680981"	"unprognostic (1.61e-1)"	"prognostic favorable (4.86e-4)"	"unprognostic (2.94e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.18e-2)"	"prognostic favorable (7.02e-4)"	"unprognostic (1.88e-3)"	"unprognostic (1.07e-1)"	"unprognostic (8.59e-2)"	"unprognostic (2.77e-1)"	"unprognostic (4.55e-3)"	"unprognostic (7.27e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.25e-2)"	"unprognostic (3.77e-2)"	11.3	3.4	12.4	2.6	13.6	9.0	6.0	15.1	13.8	2.5	11.9	4.6	2.2	3.0	12.6	2.9	3.0	3.7	5.2	12.2	14.5	10.0	12.6	2.7	3.3	14.1	14.7	2.7	3.7	3.9	5.6	1.4	13.7	4.1	3.7	11.2	5.4	2.0	18.1	2.5	2.6	2.7	14.5	2.3	4.4	13.4	15.8	3.5	5.1	27.5	3.5	4.0	2.3	14.5	6.9	3.1	8.7	13.4	7.0	4.0	5.6	6.5	6.1	10.8	9.5	6.9	5.2	19.8	7.8	5.4	11.3	2.8	22.2	4.3	13.3	15.3	13.9	19.5	4.2	27.5	15.1	19.6	14.8	4.8	7.5	10.8	5.2	2.6	6.4	14.5	19.2	10.0	6.1	7.2	12.5	13.4	10.7	12.5	7.3	16.5	9.2	12.8	6.9	3.8	15.1	9.7	7.3	22.2	20.0	7.5	8.2	14.2	2.8	6.8	9.0	9.2	8.4	11.8	23.6	33.5	4.9	21.6	8.4	2.8	0.3	0.1	0.5	0.4	0.3	0.8	0.4	0.3	0.6	0.3	0.6	0.7	0.4	0.5	0.4	0.5	0.0	0.1	12.4	13.6	15.1	13.8	12.2	14.5	14.1	14.7	13.7	14.5	15.8	14.5	25.7	3.2	13.1	59.1	34.4	51.5	107.3	4.2	69.4	15.1	60.0	39.5	9.3	37.1	6.8	9.2	52.1	14.0	32.9	22.5	199.6	11.5	422.0	38.1	19.0	19.9	66.3	8.2	12.3	15.1	38.6	27.2	30.1	39.8	23.6	9.5	11.4	55.8	21.3	10.1	18.2	27.5	6.1	9.2	66.8	559.8	9.9	30.7	32.0	5.6	11.7	195.3	9.2	13.6	13.7	11.5	14.4	10.1	20.4	94.7	6.6	29.5	8.0	53.3	6.6	41.5	37.0	358.5	115.1	42.6	35.8	39.3	22.7	16.7	32.4	96.2
SLC25A34	DKFZp781A10161	ENSG00000162461	"Solute carrier family 25 member 34"	Q6PIV7	1	15736258-15741392	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Group enriched"	"Detected in many"	4	"heart muscle: 14.4;intestine: 14.0;skeletal muscle: 37.8;tongue: 47.3"	"Cell type enriched"	"Detected in many"	5	"Proximal enterocytes: 44.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"SK-MEL-30: 3.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069806			Approved	Mitochondria		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA069806: AB_2686202"	"unprognostic (2.06e-1)"	"unprognostic (4.72e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.58e-1)"	"unprognostic (8.08e-3)"	"unprognostic (1.98e-2)"	"unprognostic (9.92e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.80e-4)"	"unprognostic (5.74e-2)"	"unprognostic (6.10e-2)"	"unprognostic (4.02e-1)"	"unprognostic (1.82e-1)"	"unprognostic (4.04e-2)"	"unprognostic (2.40e-4)"	2.4	4.4	3.7	1.0	3.8	3.4	1.8	6.8	4.8	3.6	2.4	5.7	14.0	3.1	0.8	1.7	2.9	1.5	14.4	3.6	3.4	4.7	5.6	2.4	1.2	3.2	3.1	4.2	4.9	0.6	3.8	1.3	3.5	2.4	2.0	1.9	4.7	0.8	37.8	1.8	13.7	1.1	2.7	3.7	2.2	2.5	3.7	0.5	3.4	47.3	0.5	2.8	2.3	3.6	0.3	0.2	1.5	0.6	0.7	0.3	0.6	0.2	0.1	0.3	0.2	0.6	0.8	0.4	0.3	0.3	0.8	0.3	0.2	0.2	0.3	0.5	0.3	0.7	0.5	0.2	0.2	0.2	0.9	0.3	1.1	0.4	0.1	0.9	0.2	2.0	0.3	1.3	0.2	0.7	1.7	0.9	1.3	0.2	0.4	0.9	1.3	0.4	0.1	0.0	0.3	1.2	0.3	0.4	3.4	1.4	0.7	1.0	0.8	0.7	1.0	1.0	0.2	1.7	1.6	0.3	0.2	0.9	0.6	0.5	0.1	0.1	0.4	0.0	0.9	0.1	0.9	0.6	0.0	0.2	1.2	0.7	0.6	0.6	0.0	0.1	0.4	0.3	3.7	3.8	6.8	4.8	3.6	3.4	3.2	3.1	3.5	2.7	3.7	3.6	0.9	0.0	0.0	6.2	0.4	0.3	0.3	0.6	0.0	2.6	0.5	0.5	2.7	1.5	0.2	0.0	0.0	0.3	0.3	8.8	0.0	0.2	0.3	0.4	1.3	1.2	3.5	0.0	5.1	0.2	0.4	0.8	2.0	1.7	0.0	1.3	2.2	2.3	1.5	3.3	4.6	3.1	0.0	1.9	0.3	1.0	0.9	1.5	0.0	2.8	1.1	1.8	0.0	2.5	1.7	0.3	8.0	0.4	0.0	0.6	44.6	3.7	0.0	1.8	0.0	2.7	0.9	0.6	0.6	1.1	0.1	1.4	0.6	0.4	5.5	0.7
SLC25A35	FLJ40217	ENSG00000125434	"Solute carrier family 25 member 35"	Q3KQZ1	17	8287763-8295400	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 20.9;Syncytiotrophoblasts: 17.4"	"Cancer enhanced"	"Detected in all"		"endometrial cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051720	Uncertain		Approved	Vesicles,Mitochondria		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 71: Testis - DNA repair"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Vesicles, Mitochondria"		"HPA051720: AB_2681584"	"unprognostic (4.73e-2)"	"unprognostic (1.36e-3)"	"unprognostic (1.21e-2)"	"prognostic favorable (3.37e-7)"	"unprognostic (1.61e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.27e-2)"	"unprognostic (2.58e-1)"	"unprognostic (8.30e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.18e-1)"	"prognostic favorable (1.14e-6)"	"unprognostic (5.31e-3)"	"unprognostic (2.34e-1)"	"unprognostic (1.00e-1)"	"prognostic favorable (1.91e-5)"	5.7	8.3	2.9	4.9	3.9	6.1	8.6	3.5	4.4	10.0	4.6	7.7	6.1	13.4	7.6	5.4	7.1	5.2	4.8	2.9	3.2	15.0	4.6	6.8	5.0	3.9	4.0	2.9	12.2	6.1	12.8	4.1	4.1	8.7	5.3	4.5	6.4	5.2	2.2	4.5	7.7	4.1	3.3	8.9	12.5	24.5	4.4	5.2	9.1	1.5	3.5	6.0	5.0	4.2	5.0	13.5	2.4	10.0	7.5	2.9	5.5	3.2	2.8	3.4	3.7	1.6	12.4	5.8	3.3	3.7	7.1	11.0	2.8	3.8	1.9	3.2	3.6	4.8	11.1	1.9	2.7	0.7	12.8	5.9	2.1	6.5	1.2	2.5	5.4	6.8	1.4	2.0	2.9	2.7	5.3	2.7	0.8	3.4	4.4	5.8	1.6	2.6	2.6	12.6	1.2	3.0	9.2	5.4	4.1	2.4	12.2	3.6	7.6	2.3	1.7	5.6	2.7	4.3	2.9	2.1	5.9	8.6	6.1	4.1	5.6	7.6	4.0	8.8	3.3	1.9	3.7	4.3	5.7	3.6	1.3	2.5	1.1	2.8	6.5	3.0	4.1	2.5	2.9	3.9	3.5	4.4	2.9	3.2	3.9	4.0	4.1	3.3	4.4	4.2	3.1	0.0	5.4	5.2	3.6	0.8	1.5	1.4	2.8	4.3	6.3	4.1	1.0	5.7	1.8	11.0	8.4	9.2	2.1	3.8	11.7	2.8	3.8	10.2	1.9	2.8	9.0	4.6	0.5	7.1	2.3	3.0	5.1	10.6	5.1	1.3	1.8	2.8	6.7	1.7	0.7	3.0	2.0	6.4	1.5	5.5	1.5	4.2	0.0	4.7	5.8	7.9	3.1	1.0	2.5	3.2	6.0	1.2	3.7	1.9	2.4	7.3	2.0	9.0	0.0	1.1	1.2	20.9	0.8	1.9	0.3	17.4	3.2	9.1	3.1	1.9
SLC25A36	"FLJ10618, PNC2"	ENSG00000114120	"Solute carrier family 25 member 36"	Q96CQ1	3	140941830-140980995	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027036	Approved		Approved	Nucleoplasm,Mitochondria,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 52: Non-specific - Ribosome"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 52: Non-specific - Transcription"	"Mitochondria, Cytosol"	Nucleoplasm	"HPA027036: AB_1857048"	"unprognostic (4.12e-2)"	"unprognostic (9.98e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.37e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.46e-1)"	"unprognostic (9.00e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.99e-2)"	"unprognostic (2.47e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.34e-1)"	"unprognostic (6.03e-2)"	"prognostic favorable (1.55e-4)"	27.1	22.2	16.6	14.3	16.2	61.6	33.5	16.2	22.7	31.9	13.9	25.7	30.9	34.4	47.7	15.0	32.6	18.4	39.8	16.1	20.1	38.7	4.2	27.5	21.3	17.0	16.4	39.0	45.2	28.9	26.9	26.4	17.5	27.1	19.5	42.6	23.4	20.8	38.4	22.5	22.9	19.2	16.9	20.1	34.0	23.8	18.2	20.6	31.8	20.8	17.6	23.0	23.9	21.5	52.3	11.5	36.0	30.8	33.0	40.7	46.2	19.4	23.6	18.2	27.3	28.6	24.0	42.1	46.9	17.3	31.2	34.9	40.1	15.2	40.6	33.8	36.5	33.9	29.8	20.9	45.9	48.8	21.3	44.1	61.1	15.4	45.8	44.4	22.0	32.0	17.6	27.4	29.2	22.8	30.6	34.1	37.8	12.8	18.4	34.2	32.0	59.6	23.5	17.7	22.4	38.2	26.7	45.1	80.9	30.3	32.6	29.2	24.1	29.5	17.1	52.2	19.0	56.4	36.8	51.2	36.0	21.1	15.0	10.7	9.2	15.1	9.6	11.5	11.8	16.3	9.6	10.2	14.0	15.1	13.5	12.6	1.7	18.3	13.5	9.7	9.9	9.8	16.6	16.2	16.2	22.7	16.1	20.1	17.0	16.4	17.5	16.9	18.2	21.5	60.3	99.3	143.0	85.5	47.6	68.2	68.0	38.1	116.7	106.0	72.2	77.5	90.3	38.6	52.0	71.7	133.5	58.8	58.2	22.7	64.6	26.4	10.6	113.4	78.0	45.8	59.3	27.3	127.7	38.3	38.0	73.9	58.1	106.3	65.9	92.8	35.7	0.5	26.5	92.5	115.6	32.5	30.5	38.2	45.8	16.0	59.7	38.4	56.9	46.9	36.9	68.2	25.7	108.6	109.1	29.3	22.8	59.5	48.2	88.9	44.9	57.5	98.8	121.8	59.2	80.0	59.2	59.4	68.8	61.3	54.4	49.4	49.1	83.2	46.8	78.9
SLC25A37	"HT015, MFRN, MFRN1, MSCP"	ENSG00000147454	"Solute carrier family 25 member 37"	Q9NYZ2	8	23528956-23575463	"Metabolic proteins, Predicted intracellular proteins, Transporters"	"Ion transport, Iron transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 138.4"	"Cell type enhanced"	"Detected in all"		"Early spermatids: 707.8;Erythroid cells: 4197.2;Late spermatids: 1087.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	19	"neutrophil: 57.7"	"Lineage enriched"	"Detected in all"	19	"granulocytes: 57.7"	"Cell line enhanced"	"Detected in all"		"HEL: 118.7;hTERT-RPE1: 65.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045680	Uncertain		Approved	Mitochondria,Cytosol		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	Cytosol	"HPA045680: AB_10963693"	"unprognostic (6.15e-3)"	"unprognostic (7.33e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.12e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.58e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.24e-1)"	"prognostic unfavorable (4.37e-6)"	"unprognostic (8.27e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.37e-1)"	"unprognostic (7.40e-2)"	14.5	41.9	13.5	16.5	16.9	138.4	17.9	13.4	21.0	26.8	15.2	11.4	50.6	9.8	6.0	9.9	17.2	6.7	15.3	13.4	14.0	20.1	25.2	26.4	6.0	15.0	14.1	23.0	29.5	10.9	15.0	8.0	15.4	35.5	5.7	10.3	36.7	7.5	16.2	10.1	21.8	5.7	13.0	46.1	11.1	6.8	15.0	2.8	14.6	12.7	5.0	13.4	20.4	14.6	9.6	10.3	10.7	9.9	13.7	16.8	15.7	7.4	9.6	5.3	5.9	10.4	19.9	15.3	8.7	6.3	34.5	12.0	9.9	20.0	7.2	2.3	4.9	118.7	19.4	3.7	11.5	6.7	4.4	14.5	19.2	11.6	11.5	65.9	8.4	12.3	26.3	7.5	8.5	4.2	8.1	28.1	5.4	11.6	7.5	8.3	5.3	6.0	16.4	5.2	3.2	4.6	10.1	15.2	7.6	10.0	4.4	10.3	13.3	25.6	3.8	15.3	14.5	5.9	2.4	9.4	24.1	16.1	16.5	1.4	3.0	2.7	1.1	1.1	0.9	2.3	0.6	0.5	2.8	1.5	2.1	1.2	57.7	1.3	1.5	0.6	1.3	1.4	13.5	16.9	13.4	21.0	13.4	14.0	15.0	14.1	15.4	13.0	15.0	14.6	43.5	38.5	61.7	36.6	45.5	93.3	125.2	95.8	28.5	35.6	120.0	49.1	35.6	61.5	75.8	77.3	68.8	44.6	19.1	78.4	15.6	93.8	707.8	33.1	68.6	94.5	20.4	4197.2	44.0	226.4	76.4	95.4	43.8	50.0	36.8	49.7	151.3	38.8	41.7	6.7	37.3	44.7	36.7	59.0	141.2	1087.9	52.5	86.8	69.4	73.1	45.5	30.5	10.3	16.1	21.9	176.9	47.7	37.2	24.0	347.1	189.0	34.1	42.5	59.7	19.7	55.9	52.3	24.6	42.3	23.3	53.8	18.3	32.4	86.7	70.3	137.6
SLC25A38	FLJ20551	ENSG00000144659	"Solute carrier family 25 member 38"	Q96DW6	3	39383370-39397351	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 73.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041027	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA041027: AB_10794403"	"unprognostic (3.82e-2)"	"unprognostic (3.27e-2)"	"unprognostic (1.96e-1)"	"unprognostic (6.05e-2)"	"unprognostic (1.13e-1)"	"unprognostic (2.58e-1)"	"unprognostic (1.25e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.26e-2)"	"unprognostic (5.54e-2)"	"prognostic favorable (1.58e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.06e-1)"	"prognostic favorable (7.29e-4)"	19.1	35.4	22.2	18.8	23.3	70.0	21.0	25.9	26.8	23.8	33.6	28.1	25.3	27.3	27.6	14.5	27.3	19.4	20.7	22.9	26.3	28.7	58.0	21.0	36.2	24.2	24.1	44.1	45.6	38.7	30.7	15.4	25.3	29.2	36.9	23.0	22.5	23.9	48.2	16.7	25.2	20.3	22.6	27.2	33.8	18.7	26.0	33.6	52.0	35.7	35.4	27.8	19.1	23.3	24.3	38.3	24.3	41.2	56.4	46.4	30.8	33.6	46.1	48.3	43.7	26.3	5.6	67.8	19.6	31.6	40.7	18.4	55.2	40.1	36.0	43.6	45.0	52.0	33.5	40.2	75.6	37.7	33.9	58.8	46.1	46.2	93.2	44.6	31.5	52.8	47.7	40.6	36.4	35.2	44.7	67.0	66.2	35.9	44.3	16.2	26.4	47.7	37.5	45.4	24.3	31.1	11.9	65.9	34.0	44.5	33.5	35.0	26.9	38.3	26.4	56.2	48.9	54.7	93.1	41.9	29.3	48.3	24.7	30.7	9.6	18.1	38.8	5.7	44.7	50.8	39.1	43.3	14.9	37.8	41.7	40.5	1.0	57.0	8.4	18.5	55.3	29.2	22.2	23.3	25.9	26.8	22.9	26.3	24.2	24.1	25.3	22.6	26.0	23.3	10.4	22.4	27.4	8.5	35.6	11.5	13.0	12.5	28.5	13.2	26.1	22.6	16.8	22.8	9.6	27.6	6.2	35.2	33.1	21.9	21.5	15.7	6.5	26.6	16.3	11.1	12.6	73.7	8.9	16.9	32.6	13.7	16.8	38.5	22.2	24.0	9.7	27.0	15.2	5.0	10.1	25.6	12.2	7.0	13.7	12.9	15.5	9.8	12.4	1.9	11.2	18.9	29.9	7.1	6.2	13.4	22.2	13.5	23.3	17.7	23.1	31.3	12.3	12.6	6.6	15.2	14.9	11.0	7.8	19.4	10.2	19.4	36.6	32.8	26.7	8.4
SLC25A39	"CGI-69, FLJ22407"	ENSG00000013306	"Solute carrier family 25 member 39"	Q9BZJ4	17	44319625-44324870	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Heme biosynthesis, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 491.0;Erythroid cells: 1310.3;Late spermatids: 756.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA026785	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA026785: AB_10601715"	"unprognostic (8.10e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.29e-1)"	"unprognostic (6.04e-2)"	"unprognostic (2.35e-3)"	"prognostic unfavorable (5.90e-5)"	"unprognostic (1.52e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.05e-1)"	"prognostic favorable (3.58e-5)"	"unprognostic (1.67e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.22e-1)"	"unprognostic (3.21e-2)"	52.4	123.2	71.4	49.3	72.6	305.6	49.6	72.1	84.4	53.3	84.4	77.5	73.9	47.3	39.8	143.4	44.6	41.7	68.4	67.8	72.4	178.0	142.8	56.1	48.7	75.3	72.7	44.9	120.8	98.9	73.4	46.3	74.9	75.3	47.3	9.4	77.7	43.9	44.7	87.1	62.7	30.4	72.4	89.2	81.8	89.4	76.2	35.6	87.1	47.9	40.2	55.9	62.2	71.4	247.0	152.9	47.0	198.0	89.3	68.8	163.0	79.9	71.8	101.8	78.3	151.9	116.0	131.0	137.7	114.0	180.6	124.0	147.2	242.6	35.9	154.9	236.2	68.9	131.2	281.2	97.1	120.9	145.0	104.8	211.9	95.5	122.2	92.2	105.2	195.3	205.7	204.0	87.4	463.5	153.3	118.0	92.5	187.3	417.4	182.6	129.1	375.6	177.9	128.8	316.1	118.2	92.5	146.5	166.8	85.9	281.3	102.4	76.2	132.9	185.9	229.6	160.3	126.9	165.1	122.6	119.7	93.8	82.4	36.5	56.2	29.2	73.7	83.5	83.0	96.1	79.1	79.0	89.5	78.0	80.3	74.1	8.2	139.6	87.7	103.5	80.3	93.2	71.4	72.6	72.1	84.4	67.8	72.4	75.3	72.7	74.9	72.4	76.2	71.4	36.1	9.6	25.4	17.6	52.2	53.3	71.2	117.2	42.1	18.8	93.2	77.0	27.0	52.9	79.9	69.9	10.4	93.1	42.3	123.7	491.0	188.1	223.6	28.6	24.7	44.5	65.3	1310.3	20.7	310.6	166.3	35.2	71.9	54.1	32.9	44.4	30.0	75.7	134.7	13.5	19.5	120.9	132.2	62.5	44.7	756.5	39.7	61.6	92.5	10.3	99.9	45.3	62.8	8.0	16.0	176.7	88.9	38.7	80.0	162.4	130.9	322.8	41.3	15.3	19.7	27.9	52.3	134.4	105.5	110.7	64.6	117.5	51.8	75.4	157.7	108.2
SLC25A4	"ANT1, PEO2, PEO3, T1"	ENSG00000151729	"Solute carrier family 25 member 4"	P12235	4	185143266-185150382	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Host-virus interaction, Transport"		"Cardiomyopathy, Disease variant, FDA approved drug targets, Primary mitochondrial disease, Progressive external ophthalmoplegia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"heart muscle: 245.1;skeletal muscle: 190.8;tongue: 346.6"	"Cell type enriched"	"Detected in all"	4	"Cardiomyocytes: 4722.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		380000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-2)"	"unprognostic (3.11e-1)"	"unprognostic (8.85e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.90e-3)"	"unprognostic (8.25e-2)"	"unprognostic (1.26e-2)"	"unprognostic (7.87e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (3.41e-4)"	"unprognostic (2.05e-1)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.98e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.28e-3)"	4.7	5.7	14.0	1.6	15.3	0.4	4.6	22.6	30.6	3.4	6.8	21.0	3.0	5.9	3.5	10.1	5.8	3.9	245.1	16.7	11.8	10.4	7.3	4.5	1.5	11.6	10.7	4.9	5.2	7.8	9.5	1.7	11.8	8.9	3.9	19.9	9.0	12.6	190.8	3.3	6.8	8.1	9.4	3.1	15.7	4.7	12.5	1.4	5.2	346.6	1.2	9.8	3.6	18.2	0.7	3.1	2.5	5.1	2.7	0.3	4.6	2.6	0.8	3.1	3.0	6.8	1.7	2.3	1.8	3.1	2.4	2.5	9.8	2.7	2.0	3.9	8.4	1.6	4.7	8.1	5.5	1.4	1.5	2.0	6.6	4.7	1.3	7.2	2.3	4.0	3.8	1.7	1.9	5.0	1.6	3.1	4.1	2.2	6.6	2.5	1.3	3.2	6.9	4.8	8.1	6.2	3.1	1.3	12.5	4.5	2.4	1.1	1.7	0.2	1.4	1.5	3.4	7.3	3.5	2.9	2.2	0.3	2.8	0.0	0.0	0.0	1.7	0.0	1.3	1.5	0.5	1.4	0.0	1.0	0.4	1.2	0.1	0.3	0.0	1.3	0.5	0.6	14.0	15.3	22.6	30.6	16.7	11.8	11.6	10.7	11.8	9.4	12.5	18.2	37.5	86.6	76.4	22.9	37.9	44.1	159.0	119.9	30.1	180.6	42.9	53.5	4722.0	115.8	80.0	71.7	104.3	69.2	41.1	44.4	988.0	75.3	20.6	77.8	7.4	80.1	53.8	3.0	35.1	74.1	56.5	120.1	54.0	33.6	12.0	18.6	27.5	92.1	65.9	159.9	43.7	40.6	215.7	8.5	13.8	16.7	46.6	6.8	190.3	19.7	9.0	541.2	16.5	26.7	29.2	51.4	28.5	112.8	76.4	59.1	113.8	178.3	144.0	221.0	105.2	134.5	402.7	28.0	34.0	33.2	18.2	40.5	27.7	23.7	54.2	50.7
SLC25A40	MCFP	ENSG00000075303	"Solute carrier family 25 member 40"	Q8TBP6	7	87833568-87876360	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA055197	Uncertain					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"HPA055197: AB_2682735"	"unprognostic (4.19e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.30e-2)"	"unprognostic (2.15e-1)"	"unprognostic (8.80e-2)"	"unprognostic (4.03e-2)"	"prognostic unfavorable (1.93e-4)"	"unprognostic (3.73e-1)"	"unprognostic (3.51e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.78e-2)"	"prognostic favorable (1.52e-5)"	"unprognostic (8.42e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.88e-2)"	"unprognostic (4.85e-2)"	4.8	7.0	4.0	8.5	4.3	7.6	8.0	6.4	6.5	5.9	2.6	7.8	6.6	6.8	6.1	5.8	6.2	5.5	9.7	4.6	4.6	8.2	6.7	5.9	10.6	4.7	4.9	8.6	4.3	9.4	3.6	3.8	4.9	8.6	9.6	8.7	6.0	5.1	6.3	8.1	7.1	5.3	2.9	8.9	7.1	4.8	6.0	9.6	7.1	5.2	9.9	5.2	4.2	5.0	20.3	5.3	16.3	6.3	6.5	10.4	4.8	14.3	12.6	10.1	14.7	4.6	28.2	23.8	9.1	7.1	16.3	8.7	8.0	8.2	14.5	15.1	4.0	12.6	12.3	5.7	6.2	30.8	16.2	6.3	5.8	9.2	7.2	8.5	11.0	18.9	13.9	34.0	17.5	8.6	35.7	25.6	7.6	16.6	5.9	17.6	20.6	21.0	14.7	10.8	8.0	19.2	18.4	17.8	14.1	13.1	8.7	24.0	7.7	17.3	12.8	27.2	13.8	18.7	21.6	30.6	12.0	37.0	36.1	9.1	3.5	5.0	1.1	3.7	1.8	1.5	1.6	1.6	3.9	1.7	1.7	1.6	1.9	4.0	4.0	1.0	1.9	1.5	4.0	4.3	6.4	6.5	4.6	4.6	4.7	4.9	4.9	2.9	6.0	5.0	5.8	3.2	5.3	33.0	12.3	7.5	6.1	4.0	12.0	5.7	8.3	5.2	16.6	12.8	7.7	7.3	10.4	8.6	10.5	9.6	15.6	3.8	10.0	5.7	5.0	5.9	3.0	17.9	35.2	3.9	8.4	5.7	9.2	6.4	5.1	9.1	6.1	8.1	11.1	3.3	37.0	8.9	6.1	28.6	4.1	3.9	7.8	19.4	21.4	19.7	17.5	4.5	5.2	32.2	30.8	6.5	13.8	10.9	18.8	3.5	7.2	8.6	5.2	4.9	13.1	4.6	4.4	9.0	5.0	10.4	8.0	3.7	9.4	9.1	10.0	5.5
SLC25A41	"APC4, FLJ40442, MGC34725"	ENSG00000181240	"Solute carrier family 25 member 41"	Q8N5S1	19	6426037-6433779	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"brain: 6.3;choroid plexus: 4.3;testis: 2.1"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 92.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HMC-1: 3.0;U-937: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043591	Uncertain					NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 29: Early spermatids - Spermatogenesis"			"HPA043591: AB_10964585"	"unprognostic (1.87e-3)"	"unprognostic (2.52e-3)"	"unprognostic (6.81e-2)"	"unprognostic (8.75e-2)"	"unprognostic (2.67e-1)"	"unprognostic (8.29e-4)"	"unprognostic (4.43e-3)"	"unprognostic (2.81e-2)"	"unprognostic (9.26e-2)"	"unprognostic (6.85e-2)"	"unprognostic (2.19e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.56e-1)"	"unprognostic (3.63e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.24e-1)"	0.1	0.1	4.7	0.0	5.3	0.0	0.0	4.6	6.3	0.2	4.3	0.6	0.0	0.1	0.0	0.3	0.2	0.0	0.3	4.8	4.7	0.2	0.3	0.0	0.0	4.6	4.6	0.3	0.1	0.0	0.2	0.0	4.9	0.4	0.0	0.3	0.1	0.1	0.3	0.2	0.2	0.1	4.4	0.1	0.2	2.1	4.5	0.0	0.2	0.0	0.0	0.3	0.2	4.4	0.1	0.1	0.4	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.9	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	3.0	0.2	0.6	0.0	0.0	0.1	0.0	0.2	0.8	0.0	0.0	0.3	0.0	0.7	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	5.3	4.6	6.3	4.8	4.7	4.6	4.6	4.9	4.4	4.5	4.4	0.0	0.0	0.0	2.0	0.1	0.0	0.1	0.3	0.0	1.0	0.2	0.3	0.5	0.0	0.0	0.0	2.1	0.4	0.1	0.4	0.0	0.3	92.2	0.1	0.1	0.0	0.0	0.0	5.0	0.0	0.1	0.1	0.0	0.1	0.0	0.5	0.0	0.0	0.1	3.3	4.5	0.4	0.0	0.0	0.0	20.6	0.9	0.1	0.0	0.0	0.0	1.1	0.0	1.0	1.6	0.6	0.2	0.0	0.0	0.2	0.2	0.2	0.1	1.2	0.0	0.1	0.1	0.3	0.6	0.0	0.3	0.5	0.0	0.0	0.4	0.1
SLC25A42	MGC26694	ENSG00000181035	"Solute carrier family 25 member 42"	Q86VD7	19	19063994-19113030	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 82.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 67.7;Hepatocytes: 52.1;Proximal tubular cells: 39.6;Rod photoreceptor cells: 41.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"gdT-cell: 2.7;MAIT T-cell: 1.4;memory B-cell: 3.3;memory CD4 T-cell: 1.5;memory CD8 T-cell: 2.4;naive B-cell: 3.2;naive CD4 T-cell: 1.0;naive CD8 T-cell: 1.4;NK-cell: 1.8;T-reg: 1.7"	"Group enriched"	"Detected in many"	6	"B-cells: 3.3;NK-cells: 1.8;T-cells: 2.7"	"Cell line enhanced"	"Detected in many"		"K-562: 20.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049449	Approved		Supported	Mitochondria		Yes	No			"Cluster 43: B-cells - Humoral immune response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 56: Bipolar cells - Visual perception"	Mitochondria		"HPA049449: AB_2680772"	"unprognostic (2.27e-1)"	"prognostic favorable (5.04e-4)"	"unprognostic (5.79e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.42e-3)"	"unprognostic (1.27e-3)"	"prognostic favorable (4.11e-4)"	"unprognostic (6.89e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.37e-3)"	"unprognostic (3.04e-2)"	"unprognostic (5.29e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.17e-2)"	"unprognostic (2.03e-2)"	8.5	7.5	17.2	4.3	16.9	8.3	7.9	14.5	18.3	13.1	16.7	8.4	5.1	10.1	3.7	5.2	12.5	3.5	15.8	17.9	16.9	34.1	82.0	6.6	9.0	14.9	15.2	16.9	11.3	6.0	14.4	2.6	14.7	9.9	2.4	8.4	9.2	5.2	46.5	6.7	9.3	4.9	13.9	12.7	8.3	7.0	18.0	8.1	25.6	32.6	7.5	9.6	9.1	13.9	7.3	1.0	1.8	3.2	6.8	5.6	2.8	3.5	5.2	5.3	6.0	1.4	14.3	5.2	8.0	3.3	5.3	1.3	3.7	2.9	3.0	1.3	7.0	1.8	2.0	11.8	5.4	0.8	3.6	5.6	2.0	4.0	2.4	4.3	2.4	16.8	20.9	9.2	2.8	6.6	9.0	8.4	1.0	2.0	7.4	6.8	3.2	10.2	2.1	1.3	2.0	1.5	3.7	0.1	1.6	2.4	6.5	4.1	2.2	3.9	2.2	8.2	3.4	10.7	6.2	4.1	4.1	11.2	2.0	0.0	0.1	0.1	2.7	0.3	1.4	3.3	1.5	2.4	0.2	3.2	1.0	1.4	0.0	1.8	0.3	0.4	1.7	0.9	17.2	16.9	14.5	18.3	17.9	16.9	14.9	15.2	14.7	13.9	18.0	13.9	4.6	0.0	13.1	12.4	14.2	3.2	2.8	3.3	2.8	67.7	5.9	6.6	9.7	5.7	4.1	9.2	18.8	7.7	16.5	3.1	13.7	1.5	1.2	2.5	5.4	4.1	8.4	13.7	18.6	3.1	3.8	5.1	4.1	3.6	3.8	8.3	5.3	52.1	1.8	3.3	25.0	3.8	6.1	0.6	1.9	1.6	5.0	1.4	3.6	6.5	1.3	12.5	32.0	16.1	8.6	2.5	4.6	6.4	16.4	2.4	9.2	39.6	3.0	41.4	6.6	9.6	5.8	10.6	7.6	0.9	2.8	4.7	10.9	8.0	3.1	1.7
SLC25A43		ENSG00000077713	"Solute carrier family 25 member 43"	Q8WUT9	X	119399336-119454478	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 30.7;Oligodendrocyte precursor cells: 36.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA035188, HPA078530"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Cytosol		"HPA035188: AB_10602400, HPA078530: "	"unprognostic (6.05e-3)"	"unprognostic (1.48e-1)"	"unprognostic (9.92e-2)"	"prognostic unfavorable (3.76e-5)"	"unprognostic (4.99e-3)"	"unprognostic (1.59e-2)"	"unprognostic (3.26e-2)"	"unprognostic (2.74e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.14e-1)"	"unprognostic (2.80e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavorable (5.06e-8)"	"unprognostic (2.63e-1)"	"unprognostic (2.62e-1)"	"unprognostic (1.96e-2)"	"unprognostic (4.92e-2)"	10.6	2.6	3.1	7.3	3.4	1.8	9.3	3.3	4.1	8.2	5.4	14.0	14.2	5.0	3.4	21.4	5.3	4.3	5.0	3.2	3.6	7.7	10.6	10.2	5.5	4.3	3.5	6.0	5.9	6.9	1.9	8.3	3.9	4.6	15.5	0.5	10.8	4.6	1.6	16.3	12.8	8.8	3.5	4.9	8.9	2.1	3.6	3.6	4.2	4.5	11.3	7.9	11.3	3.8	32.4	23.3	1.9	9.2	30.0	44.5	12.2	17.9	21.7	13.8	13.2	12.4	16.0	4.0	10.2	47.4	41.1	23.2	18.2	16.0	12.4	28.5	5.4	11.3	7.4	16.4	19.3	10.6	11.7	18.8	28.3	22.5	19.8	18.9	16.6	6.1	2.3	17.1	15.7	58.9	0.1	15.9	10.3	16.6	35.1	3.2	0.0	4.6	22.3	10.9	1.5	0.0	23.0	47.8	29.1	7.3	8.5	11.0	24.2	22.2	7.1	25.0	28.0	0.4	14.2	8.3	22.3	17.8	19.7	0.0	3.5	0.2	0.9	4.9	1.7	4.4	1.8	2.9	6.0	3.7	0.9	1.8	0.1	6.4	11.2	1.6	1.5	1.6	3.1	3.4	3.3	4.1	3.2	3.6	4.3	3.5	3.9	3.5	3.6	3.8	8.3	6.4	9.7	30.7	8.0	7.8	7.3	8.9	9.6	0.2	6.1	6.6	1.6	2.8	5.6	3.7	0.0	11.9	9.1	21.8	9.8	4.5	0.0	0.9	7.6	6.9	7.3	3.4	10.3	8.9	7.1	11.8	9.7	1.8	8.2	2.1	6.4	5.8	10.3	0.0	6.2	9.6	4.1	7.1	13.6	0.4	8.1	7.5	10.6	1.0	11.9	0.2	9.2	36.7	1.4	13.9	11.4	5.7	2.8	5.4	19.8	9.6	2.0	0.4	0.0	7.8	9.2	0.5	2.3	19.8	13.9	6.8	6.8	1.0	12.2	5.8
SLC25A44	"FLJ90431, KIAA0446"	ENSG00000160785	"Solute carrier family 25 member 44"	Q96H78	1	156193932-156212796	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 114.1;Late spermatids: 95.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 70.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065411			Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	Mitochondria	Nucleoplasm	"HPA065411: AB_2685486"	"unprognostic (1.58e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-1)"	"unprognostic (2.44e-3)"	"unprognostic (2.75e-1)"	"unprognostic (1.32e-1)"	"unprognostic (5.72e-2)"	"unprognostic (8.92e-2)"	"unprognostic (1.97e-1)"	"unprognostic (3.58e-1)"	"prognostic favorable (2.49e-4)"	"unprognostic (3.37e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.71e-1)"	"unprognostic (2.67e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.37e-1)"	18.3	11.6	17.5	10.4	18.7	12.8	9.5	14.4	23.1	8.8	8.5	11.2	18.2	9.5	11.2	11.9	9.2	11.2	14.1	19.5	17.2	27.7	35.3	11.4	10.4	15.8	16.9	6.8	8.8	17.2	13.4	8.3	17.4	9.4	11.5	18.2	8.7	9.3	17.6	11.1	13.0	11.5	13.6	16.6	11.4	12.4	18.0	14.6	10.4	21.2	12.4	14.8	8.4	18.3	18.3	30.5	14.6	19.5	31.0	16.7	11.6	19.2	27.9	33.8	27.5	30.1	16.4	14.4	16.3	28.6	18.3	26.6	53.9	22.5	29.8	16.6	18.0	13.1	18.8	18.4	23.8	17.2	23.2	23.6	19.3	34.3	20.6	16.3	27.8	17.5	14.0	23.0	23.6	32.7	18.1	12.2	34.6	34.6	31.2	11.5	14.8	24.6	44.2	21.2	22.8	30.7	22.3	40.0	26.1	25.6	30.1	27.8	22.7	19.6	16.4	22.0	23.1	23.4	19.2	21.5	21.6	17.8	19.8	14.2	18.2	19.3	9.3	19.1	9.6	8.2	7.4	8.9	13.4	5.4	6.0	7.3	70.5	9.4	16.1	5.8	7.3	13.5	17.5	18.7	14.4	23.1	19.5	17.2	15.8	16.9	17.4	13.6	18.0	18.3	16.4	12.8	22.4	7.5	11.1	27.8	6.2	5.5	10.8	14.4	33.0	25.4	41.1	11.5	11.5	9.2	20.9	5.2	12.0	10.4	5.9	6.0	114.1	17.9	12.3	16.6	6.0	9.5	12.0	5.6	4.0	15.6	12.2	35.4	5.1	5.3	11.7	34.0	7.5	20.2	12.4	11.7	8.2	11.3	34.4	95.6	7.2	19.1	12.4	6.5	10.1	8.2	22.6	5.5	11.6	6.2	6.1	5.7	10.2	6.6	13.8	17.1	5.2	9.0	19.7	40.7	10.8	9.6	10.3	17.6	34.1	8.2	12.8	7.3	8.5	6.9
SLC25A45		ENSG00000162241	"Solute carrier family 25 member 45"	Q8N413	11	65375192-65383701	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 34.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 46.7;NK-cells: 103.0;Proximal enterocytes: 90.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 17.5;Karpas-707: 22.8;RPMI-8226: 17.1"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA042495, HPA050821"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 25: Pancreas - Digestion"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	Cytosol		"HPA042495: , HPA050821: AB_2681249"	"unprognostic (3.73e-2)"	"unprognostic (2.19e-3)"	"unprognostic (8.44e-4)"	"unprognostic (6.17e-3)"	"unprognostic (2.57e-2)"	"unprognostic (2.84e-7)"	"unprognostic (7.57e-3)"	"unprognostic (4.59e-2)"	"unprognostic (1.44e-1)"	"unprognostic (4.06e-2)"	"prognostic favorable (2.83e-4)"	"unprognostic (1.96e-1)"	"unprognostic (1.08e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.54e-1)"	"unprognostic (6.18e-2)"	"unprognostic (1.43e-1)"	3.7	3.3	3.1	5.8	3.3	4.9	4.7	2.8	4.1	1.9	2.6	3.4	5.6	1.8	2.5	2.5	2.0	2.0	3.8	3.1	3.1	6.5	12.1	3.9	10.1	3.7	3.1	1.9	34.2	3.0	6.6	1.9	3.5	3.8	1.8	0.3	6.3	1.9	7.1	2.9	7.6	1.3	3.3	13.3	2.8	1.9	3.1	8.0	12.1	3.7	6.6	2.0	1.9	4.0	0.4	5.8	0.2	8.5	1.5	0.7	4.2	1.0	2.6	0.5	0.5	1.4	2.7	5.2	4.7	2.4	2.1	0.8	0.6	0.4	0.0	17.5	1.2	5.7	3.2	0.4	0.9	1.8	5.7	1.9	0.1	0.7	0.5	0.4	0.9	9.9	0.8	22.8	0.9	1.9	4.2	0.1	0.3	0.3	2.6	7.7	1.1	17.1	0.9	0.1	2.8	3.7	1.8	4.5	1.0	0.5	2.4	0.9	1.7	0.6	2.0	5.5	0.4	9.5	6.4	1.5	1.7	1.3	3.3	10.5	6.3	4.8	8.8	11.2	9.3	10.6	7.8	8.5	6.9	11.9	12.4	9.3	3.9	17.1	13.3	23.0	7.7	3.1	3.1	3.3	2.8	4.1	3.1	3.1	3.7	3.1	3.5	3.3	3.1	4.0	5.0	0.0	5.6	0.3	40.0	2.8	5.9	4.2	3.4	12.3	10.7	7.7	5.6	8.6	4.7	12.9	0.0	2.1	46.7	14.4	0.0	5.9	5.1	6.2	3.1	6.0	6.7	3.0	5.2	5.4	1.7	7.7	5.6	7.9	4.5	21.8	6.8	14.0	7.3	6.7	0.6	16.7	4.1	9.7	14.4	3.9	6.8	11.7	5.4	4.7	18.4	5.5	103.0	1.5	3.9	5.2	12.5	3.8	15.3	7.0	90.9	6.9	12.3	0.4	6.6	12.6	3.6	2.2	0.4	2.2	2.0	1.5	31.6	11.8	13.3	4.6
SLC25A46		ENSG00000164209	"Solute carrier family 25 member 46"	Q96AG3	5	110738136-110765161	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 238.9;Late spermatids: 448.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039601, HPA071582"	Approved		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	Mitochondria		"HPA039601: AB_2676592, HPA071582: AB_2686422"	"unprognostic (1.86e-1)"	"unprognostic (3.29e-1)"	"prognostic favorable (8.41e-4)"	"unprognostic (4.91e-2)"	"unprognostic (2.27e-2)"	"unprognostic (2.25e-1)"	"unprognostic (2.34e-1)"	"unprognostic (1.77e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.97e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.40e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.62e-1)"	"prognostic unfavorable (2.52e-4)"	"unprognostic (1.98e-1)"	22.9	15.9	10.4	19.9	11.8	17.6	16.4	12.7	16.7	18.5	7.8	22.1	23.8	14.7	10.5	21.2	10.7	15.8	31.1	12.2	12.2	29.7	30.0	16.7	22.5	12.4	10.2	11.7	15.4	20.6	4.9	17.0	13.2	15.7	21.6	18.8	13.3	16.0	55.8	14.9	20.9	20.8	10.3	15.7	20.1	21.9	11.2	24.8	19.8	60.2	26.8	19.0	6.6	14.1	36.2	27.7	25.7	20.7	65.2	60.2	9.9	44.3	55.9	47.5	59.3	37.6	28.7	96.8	44.8	50.1	61.9	29.6	41.0	71.2	54.3	61.8	20.8	40.1	35.2	25.6	53.1	37.3	40.2	49.9	25.4	55.5	39.6	29.5	31.9	37.2	31.4	56.4	54.1	27.3	54.0	17.2	18.1	25.7	24.7	26.0	57.0	71.5	35.1	39.2	46.7	33.5	37.7	29.7	49.7	23.7	30.9	35.3	42.5	43.6	21.0	40.7	54.4	111.8	76.2	68.4	48.0	43.8	24.0	29.2	16.0	13.2	12.3	19.0	12.5	14.4	13.7	12.9	17.0	14.5	14.5	14.8	6.6	20.9	17.7	11.1	18.2	17.4	10.4	11.8	12.7	16.7	12.2	12.2	12.4	10.2	13.2	10.3	11.2	14.1	21.3	22.4	24.8	40.8	26.7	22.9	9.1	16.0	31.9	16.8	15.7	10.8	63.5	11.5	12.9	20.2	22.9	21.7	18.0	34.8	19.6	18.1	238.9	10.4	20.1	18.9	23.4	29.9	73.3	25.6	18.2	22.6	34.7	12.1	19.0	16.2	26.7	43.9	27.2	18.5	63.9	28.3	32.6	26.1	21.0	448.2	21.1	23.9	30.2	31.9	28.1	21.9	17.5	49.8	91.8	18.9	22.8	22.2	73.8	8.0	26.5	41.7	14.9	14.1	19.7	18.5	22.6	23.3	14.2	30.0	26.9	20.5	23.9	22.7	24.0	6.8
SLC25A47	C14orf68	ENSG00000140107	"Solute carrier family 25 member 47"	Q6Q0C1	14	100323339-100330421	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	355	"liver: 534.7"	"Cell type enriched"	"Detected in some"	40	"Hepatocytes: 270.2"	"Cancer enriched"	"Detected in single"	273	"liver cancer: 56.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"Hep G2: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"									NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (2.54e-3)"	"unprognostic (2.57e-3)"	"unprognostic (5.12e-2)"	"unprognostic (2.27e-2)"	"unprognostic (6.07e-2)"	"unprognostic (1.30e-2)"	"unprognostic (4.25e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.89e-2)"	"unprognostic (2.50e-1)"	"unprognostic (1.96e-3)"	"unprognostic (4.46e-1)"	"unprognostic (1.44e-1)"	"unprognostic (4.50e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.02e-2)"	"unprognostic (1.94e-1)"	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	534.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.5	0.0	1.8	0.0	0.1	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	2.7	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	2.9	270.2	0.0	0.0	0.0	0.6	0.0	6.7	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.8	0.0	0.0	0.0	3.5	3.5	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.7	0.0	0.0	0.4	0.1
SLC25A48	"FLJ44862, HDMCP"	ENSG00000145832	"Solute carrier family 25 member 48"	Q6ZT89	5	135579202-135889770	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 28.2;skeletal muscle: 8.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 31.0;Distal tubular cells: 9.8;Proximal enterocytes: 11.1;Proximal tubular cells: 45.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 2.7;HEK 293: 2.0;HEL: 1.7;RPMI-8226: 1.9;SCLC-21H: 1.9;U-2 OS: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA014674	Uncertain		Approved	"Intermediate filaments,Actin filaments"		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Intermediate filaments"	"Actin filaments"	"HPA014674: AB_1859512"	"unprognostic (2.09e-1)"	"unprognostic (2.24e-1)"	"unprognostic (6.34e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.37e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.62e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.32e-1)"	"unprognostic (8.02e-7)"	"unprognostic (9.13e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.20e-1)"	0.9	0.1	13.5	0.3	14.4	0.2	1.1	10.9	16.4	0.3	4.8	0.9	0.7	0.2	0.1	0.4	0.1	0.2	0.2	14.4	17.7	7.5	0.5	0.0	0.3	14.7	18.0	0.1	2.1	0.0	0.1	0.4	17.5	0.4	0.9	0.5	1.7	0.0	8.8	1.9	2.4	0.1	16.8	0.2	0.1	0.4	18.3	0.0	0.2	2.3	0.1	0.1	0.2	28.2	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.0	0.2	2.7	0.0	0.0	0.3	2.0	1.7	0.3	0.3	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.7	0.3	0.0	0.0	0.0	0.0	1.9	0.1	0.2	1.9	0.2	0.3	0.2	0.4	0.7	1.0	0.2	0.1	0.1	2.3	0.1	0.1	0.8	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	13.5	14.4	10.9	16.4	14.4	17.7	14.7	18.0	17.5	16.8	18.3	28.2	0.1	0.0	0.0	31.0	0.0	2.4	0.1	0.0	0.0	0.2	2.3	0.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	3.0	9.8	0.0	0.0	2.0	1.2	0.1	0.0	0.0	0.6	0.0	0.2	0.7	0.0	7.1	0.0	0.0	0.0	1.3	0.1	0.0	3.1	2.8	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.2	0.0	5.0	4.2	0.1	5.0	0.0	0.0	0.3	11.1	45.8	0.0	0.2	0.0	0.5	0.1	0.5	4.3	0.0	0.9	0.1	0.1	0.0	1.6	0.1
SLC25A5	"2F1, ANT2, T2, T3"	ENSG00000005022	"Solute carrier family 25 member 5"	P05141	X	119468422-119471396	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Chromosome partition, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 2533.6;Proximal enterocytes: 2785.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		640000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 45: Enterocytes - Digestion"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.25e-2)"	"prognostic favorable (7.35e-4)"	"prognostic favorable (7.47e-4)"	"unprognostic (1.48e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.36e-1)"	"unprognostic (6.52e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.60e-1)"	"unprognostic (2.17e-1)"	"prognostic favorable (8.06e-6)"	"unprognostic (1.41e-1)"	"unprognostic (2.65e-1)"	"unprognostic (4.36e-2)"	"unprognostic (3.03e-1)"	178.1	178.3	116.9	176.0	116.1	260.9	161.3	141.6	126.0	155.0	114.3	458.7	740.2	134.5	63.9	411.0	118.6	100.4	196.1	109.0	141.5	491.8	336.1	216.5	255.4	120.6	118.0	108.2	629.1	295.3	89.0	138.1	126.4	111.9	503.0	127.7	250.2	103.8	61.6	294.9	562.8	150.5	119.3	182.6	492.1	54.2	126.4	351.9	128.8	65.1	297.7	200.8	235.3	121.5	845.1	789.6	303.3	525.4	189.5	277.3	561.0	306.8	331.3	631.7	560.8	662.4	518.4	1059.3	400.9	296.1	456.1	576.9	752.1	640.5	572.5	281.1	711.2	357.5	418.7	477.0	239.8	984.0	566.1	303.7	705.2	652.2	412.6	240.1	660.4	535.0	292.5	425.9	350.1	1868.4	878.6	995.1	640.4	1147.6	1244.3	474.5	383.4	825.7	486.9	663.6	365.0	344.5	526.7	793.3	646.7	306.7	327.7	491.0	279.5	297.3	428.9	670.8	1122.2	494.6	656.3	847.4	329.5	987.7	492.2	113.4	603.4	170.2	170.7	1045.7	198.1	459.2	248.3	224.6	872.6	376.0	243.3	232.1	99.2	318.1	824.2	476.1	443.1	931.8	116.9	116.1	141.6	126.0	109.0	141.5	120.6	118.0	126.4	119.3	126.4	121.5	260.4	163.5	308.6	28.7	339.6	815.7	567.0	1615.3	398.9	109.8	406.2	413.5	131.2	301.7	609.2	187.6	60.5	1038.8	336.2	1379.0	2533.6	578.2	4.0	137.3	134.2	257.5	401.0	349.1	16.8	1056.4	463.1	214.4	543.3	157.6	192.9	306.0	146.7	333.6	881.7	26.9	25.5	856.4	1129.1	610.6	650.9	18.1	145.4	473.2	547.8	15.0	441.2	140.8	218.3	24.1	19.2	554.1	1061.8	110.6	419.9	522.3	2785.2	1622.3	239.5	199.0	131.5	163.9	506.7	11.5	119.2	1046.8	960.2	1589.1	291.2	626.6	1053.7	809.7
SLC25A51	"CG7943, MCART1, MGC14836"	ENSG00000122696	"Solute carrier family 25 member 51"	Q9H1U9	9	37879400-37904353	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Early spermatids: 93.6;Late spermatids: 169.6;Spermatocytes: 44.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 16.7"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 16.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA046388, HPA058261"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA046388: AB_2679649, HPA058261: AB_2683657"	"unprognostic (5.46e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.67e-2)"	"unprognostic (5.63e-2)"	"unprognostic (1.00e-2)"	"unprognostic (1.35e-2)"	"prognostic unfavorable (5.67e-5)"	"unprognostic (6.87e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.98e-3)"	"unprognostic (1.26e-3)"	"unprognostic (5.37e-2)"	"prognostic favorable (1.52e-4)"	"unprognostic (8.27e-3)"	"unprognostic (2.31e-1)"	"prognostic unfavorable (2.21e-4)"	"unprognostic (2.08e-2)"	9.0	3.1	3.1	5.0	3.5	12.0	4.1	3.4	4.4	5.4	2.3	4.5	7.5	4.1	4.7	5.6	3.4	5.0	4.5	3.7	4.1	6.3	3.1	5.2	5.7	3.4	3.3	3.8	5.9	8.3	4.1	4.7	4.0	3.5	4.1	4.8	4.7	3.7	6.1	5.7	6.0	5.8	2.6	5.7	4.3	8.0	3.1	5.6	4.6	7.4	6.5	4.3	3.5	4.4	12.4	10.1	7.3	11.6	34.4	15.2	7.4	10.6	10.7	8.8	12.6	13.0	5.2	26.2	5.9	24.2	12.5	6.1	19.6	14.5	16.5	18.0	6.1	8.0	27.5	18.0	19.1	12.5	11.1	15.3	16.7	13.4	16.6	13.6	16.1	24.4	17.9	20.2	19.1	7.3	15.2	3.2	9.2	12.7	7.1	10.6	9.9	16.1	8.7	8.9	15.2	10.0	8.3	10.1	6.0	12.2	5.4	13.7	17.3	14.7	17.4	7.2	12.8	7.7	17.5	17.5	19.4	9.3	12.3	16.7	1.5	2.8	1.6	3.1	2.7	2.6	1.7	2.3	1.1	1.5	1.6	1.8	1.3	1.9	1.3	0.5	2.7	0.9	3.1	3.5	3.4	4.4	3.7	4.1	3.4	3.3	4.0	2.6	3.1	4.4	4.3	9.6	1.1	13.4	9.3	4.7	5.8	7.6	8.6	4.0	5.1	3.8	6.3	5.7	4.6	1.8	4.2	3.7	7.6	3.8	17.6	9.5	93.6	2.5	5.3	4.3	3.6	6.9	22.0	7.2	14.1	5.2	8.2	5.1	3.8	3.4	3.9	3.6	11.7	1.7	21.3	5.8	0.0	5.7	4.7	169.6	3.7	8.8	1.8	19.7	8.4	5.3	3.1	16.1	22.1	7.3	7.2	4.1	14.3	3.8	17.4	16.8	2.2	3.7	0.0	4.3	4.5	44.0	10.2	11.7	5.8	4.0	6.5	4.8	3.6	3.8
SLC25A52	MCART2	ENSG00000141437	"Solute carrier family 25 member 52"	Q3SY17	18	31759584-31760880	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	14	"testis: 8.9"	"Group enriched"	"Detected in some"	4	"Early spermatids: 55.3;Late spermatids: 106.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											"HPA046388, HPA058261"	Uncertain		Approved	Mitochondria		NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 31: Spermatids - Spermatogenesis"	Mitochondria		"HPA046388: AB_2679649, HPA058261: AB_2683657"	"unprognostic (8.97e-2)"	"unprognostic (4.85e-2)"			"unprognostic (2.93e-1)"	"unprognostic (4.87e-1)"	"unprognostic (2.50e-1)"	"unprognostic (9.05e-2)"	"unprognostic (2.97e-2)"	"unprognostic (1.30e-4)"	"unprognostic (7.15e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.41e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.41e-2)"	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.6	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.1	0.0	8.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.1	0.3	0.3	0.1	0.1	0.1	0.1	0.2	0.3	0.1	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.2	0.1	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	55.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	106.9	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.6	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC25A6	"ANT3, ANT3Y, MGC17525"	ENSG00000169100	"Solute carrier family 25 member 6"	P12236	X	1386152-1392113	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Apoptosis, Host-virus interaction, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA046835, HPA071684"	Approved		Supported	Mitochondria		NA	NA		450000	"Cluster 39: Non-specific - mRNA processing"	"Cluster 25: Pancreas - Digestion"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 32: Non-specific - Translation"	Mitochondria		"HPA046835: AB_2679831, HPA071684: AB_2686431"	"unprognostic (1.13e-1)"	"unprognostic (1.65e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.45e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.01e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.37e-3)"	"unprognostic (2.51e-1)"	"unprognostic (3.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.69e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.57e-3)"	356.6	410.1	227.8	223.3	241.4	441.5	307.3	210.8	296.7	253.7	351.6	350.9	466.0	277.9	80.6	344.8	243.4	127.2	201.5	227.9	216.1	386.8	130.0	239.4	275.0	222.6	222.8	460.8	626.9	323.5	275.8	147.1	228.0	264.1	141.5	108.3	697.7	178.8	115.5	331.3	387.7	129.4	208.3	263.7	413.9	62.2	227.4	232.7	321.5	89.2	159.3	292.0	244.6	219.2	290.4	596.8	393.8	422.6	267.5	527.4	466.2	396.8	386.1	296.8	289.2	796.7	330.6	1023.0	334.1	264.9	445.6	179.2	269.5	482.0	89.8	260.3	886.0	545.0	396.0	899.7	642.2	398.1	649.8	870.1	882.2	235.8	335.9	367.5	441.6	315.7	407.2	233.8	284.5	575.4	791.1	733.3	516.0	105.5	802.2	378.8	333.8	828.3	351.4	693.6	682.9	1096.5	271.1	817.7	1239.7	224.1	466.1	832.5	505.5	305.1	169.6	596.5	422.1	606.7	110.5	705.9	48.7	389.9	170.3	34.2	739.8	47.2	319.5	808.7	466.9	671.4	431.3	377.9	985.9	532.5	396.1	399.7	34.4	359.9	832.3	461.2	447.6	1120.7	227.8	241.4	210.8	296.7	227.9	216.1	222.6	222.8	228.0	208.3	227.4	219.2	194.2	147.4	244.3	13.7	724.4	1151.2	1447.6	1800.6	421.8	286.1	981.3	710.8	106.0	371.8	704.7	316.3	98.0	1581.2	448.5	690.4	1659.2	752.6	11.4	164.4	388.1	473.0	928.4	471.3	15.1	1473.5	1229.8	507.8	374.1	245.3	343.6	698.0	529.4	149.7	1264.7	242.3	20.4	1208.1	819.9	1553.5	1299.4	45.8	667.9	764.0	754.2	17.8	1450.5	184.6	531.4	8.0	13.7	789.8	1127.8	366.3	604.9	1452.4	1564.9	1320.8	180.3	280.0	341.8	631.7	665.6	13.3	80.7	796.7	1321.5	1744.1	494.7	847.8	1524.3	1723.2
SLC26A1	"EDM4, SAT-1"	ENSG00000145217	"Solute carrier family 26 member 1"	Q9H2B4	4	979073-993440	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 16.8"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 6.2;Excitatory neurons: 4.4;Hepatocytes: 10.4;Inhibitory neurons: 4.4;Oligodendrocyte precursor cells: 5.5;Proximal enterocytes: 6.4;Proximal tubular cells: 9.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 5.5"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	6	"basophil: 5.4"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 5.4"	"Cell line enhanced"	"Detected in many"		"Hep G2: 13.8;HMC-1: 8.7;T-47d: 9.1"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			HPA041654	Uncertain		Approved	Microtubules		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Microtubules		"HPA041654: AB_10796350"	"unprognostic (1.96e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.67e-4)"	"unprognostic (5.13e-2)"	"unprognostic (5.82e-2)"	"unprognostic (2.16e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.53e-3)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.19e-4)"	"unprognostic (1.18e-2)"	"unprognostic (2.22e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.65e-3)"	1.8	7.0	2.5	1.5	2.5	1.4	2.7	5.4	3.3	2.9	0.1	2.2	5.2	2.1	0.2	1.6	2.1	1.2	1.2	2.9	2.0	5.8	16.8	2.0	1.5	3.9	2.5	2.5	3.3	0.1	3.3	0.3	3.2	3.0	0.1	0.6	3.2	0.1	1.4	2.5	4.5	0.0	1.0	2.4	3.1	1.2	2.0	0.1	3.2	0.3	0.1	1.8	1.9	2.6	1.3	2.1	0.0	1.6	0.1	0.4	4.1	1.7	0.1	0.0	0.0	4.6	2.7	0.7	2.4	0.0	1.6	1.3	0.1	0.0	0.0	2.7	0.8	3.0	3.3	13.8	0.1	2.1	8.7	0.5	0.2	0.1	0.0	1.0	0.3	2.6	3.3	0.0	0.3	2.8	1.4	3.5	0.8	1.6	7.2	6.9	0.0	0.3	0.7	4.5	0.2	1.2	0.4	0.2	1.2	0.3	9.1	1.3	2.0	4.4	0.9	4.8	1.3	6.5	3.2	1.0	1.4	4.1	2.1	5.4	0.3	0.2	0.2	0.1	0.3	0.2	0.5	0.4	0.1	0.0	0.3	0.7	0.0	0.6	0.1	0.1	0.8	0.3	2.5	2.5	5.4	3.3	2.9	2.0	3.9	2.5	3.2	1.0	2.0	2.6	0.3	0.0	1.1	6.2	0.2	0.0	0.2	0.3	0.0	0.0	0.8	0.8	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	1.9	0.1	0.0	0.7	0.3	0.3	0.0	0.0	4.4	0.4	3.6	0.3	0.5	0.8	1.3	0.8	1.4	10.4	0.7	0.0	4.4	0.8	0.0	0.3	0.0	0.0	0.9	0.4	1.8	1.0	0.3	0.3	0.0	5.5	1.7	0.4	1.3	0.4	0.1	0.2	6.4	9.7	0.0	0.3	0.0	0.4	0.3	0.1	0.1	0.2	0.1	0.8	0.5	0.6	0.7	0.1
SLC26A11		ENSG00000181045	"Solute carrier family 26 member 11"	Q86WA9	17	80219699-80253500	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 58.4;Rod photoreceptor cells: 40.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029893	Approved		Supported	"Nucleoplasm,Golgi apparatus,Vesicles"		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Vesicles"	Nucleoplasm	"HPA029893: AB_10600809"	"unprognostic (5.86e-2)"	"unprognostic (6.66e-2)"	"unprognostic (3.84e-2)"	"prognostic unfavorable (1.55e-5)"	"unprognostic (3.80e-2)"	"unprognostic (2.63e-3)"	"prognostic unfavorable (1.82e-6)"	"unprognostic (2.05e-2)"	"unprognostic (3.54e-2)"	"unprognostic (1.03e-1)"	"prognostic favorable (1.43e-5)"	"unprognostic (2.86e-1)"	"unprognostic (3.50e-1)"	"unprognostic (9.54e-3)"	"unprognostic (8.40e-2)"	"unprognostic (8.69e-2)"	"unprognostic (7.32e-2)"	12.2	36.5	27.4	8.9	24.8	16.4	11.8	14.1	23.2	16.3	21.9	12.1	7.2	11.6	8.9	7.5	13.5	7.6	7.1	21.1	45.5	19.1	10.2	18.8	14.1	27.8	33.3	22.5	10.6	11.8	35.1	9.0	30.1	16.8	4.1	11.6	11.3	9.2	5.9	13.0	11.2	6.0	17.7	22.6	10.0	4.8	42.2	3.4	24.8	3.6	5.6	11.6	12.1	17.4	0.7	12.4	14.3	11.1	7.1	5.2	16.1	6.7	8.4	15.6	9.4	13.6	2.5	0.1	13.1	7.4	11.3	4.4	8.0	5.2	6.1	15.7	14.4	0.0	17.5	13.5	18.6	0.0	2.2	9.5	8.4	7.5	3.4	1.4	13.3	2.7	6.4	16.8	9.3	11.6	0.6	0.3	6.5	3.5	11.7	0.5	1.6	5.7	14.2	13.6	5.4	16.9	6.8	17.0	18.3	22.0	20.4	0.3	9.9	11.8	6.9	10.4	0.9	17.8	7.4	1.8	6.2	0.0	10.1	0.0	1.0	0.0	0.7	0.4	1.1	0.2	1.2	1.0	0.6	0.1	1.9	0.8	0.0	0.0	0.1	0.0	1.7	0.9	27.4	24.8	14.1	23.2	21.1	45.5	27.8	33.3	30.1	17.7	42.2	17.4	8.8	6.4	13.4	22.2	3.9	4.6	8.9	5.0	5.2	27.2	9.6	9.9	2.5	5.7	5.6	12.9	58.4	14.5	5.6	3.2	1.9	7.5	0.6	7.1	7.0	12.4	10.2	2.7	13.4	6.0	8.8	8.1	3.6	11.6	1.3	15.4	8.2	2.2	15.2	3.3	17.2	3.2	8.2	11.4	10.5	0.7	17.1	15.1	3.6	12.2	4.2	22.8	5.2	12.1	13.3	3.4	3.9	12.4	2.2	9.0	7.0	6.0	4.4	40.8	32.9	6.4	7.7	0.2	5.3	2.4	4.7	26.0	8.2	16.4	2.6	5.3
SLC26A2	"DTD, DTDST"	ENSG00000155850	"Solute carrier family 26 member 2"	P50443	5	149960758-149993455	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant, Dwarfism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"intestine: 212.0"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 2026.2;Glandular and luminal cells: 684.5;Syncytiotrophoblasts: 808.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 4.9"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"EFO-21: 66.1;RPTEC TERT1: 151.7;TIME: 80.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041957, HPA058090"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 37: Intestine - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA041957: AB_10795646, HPA058090: AB_2683602"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.03e-2)"	"prognostic favorable (7.29e-4)"	"unprognostic (2.59e-2)"	"unprognostic (5.64e-2)"	"prognostic unfavorable (4.66e-4)"	"unprognostic (2.59e-1)"	"unprognostic (5.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (7.43e-2)"	"unprognostic (2.10e-1)"	"prognostic unfavorable (3.27e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.06e-1)"	5.2	30.7	2.2	7.8	2.3	2.5	9.2	9.5	3.8	6.3	4.0	212.0	12.9	9.3	22.8	10.7	5.0	5.5	2.8	2.2	3.5	4.9	1.7	7.3	4.0	3.8	3.4	4.8	3.4	37.7	7.1	34.0	3.5	12.2	189.6	20.8	35.8	18.4	3.9	7.8	16.1	9.3	3.8	3.7	3.3	4.2	3.9	4.2	4.5	3.7	5.9	4.7	3.0	3.4	9.5	8.6	10.5	17.3	12.6	8.8	2.5	8.9	8.0	7.0	8.5	44.7	5.1	7.4	66.1	9.5	16.8	6.8	10.0	20.5	12.4	6.0	6.4	9.3	6.7	5.2	9.4	17.3	15.2	9.8	11.8	11.7	15.2	17.3	16.8	9.0	2.4	7.1	29.6	3.0	6.6	9.1	3.2	3.2	13.5	9.5	16.3	3.9	151.7	41.6	3.2	8.1	15.6	3.6	27.2	8.1	7.3	10.0	80.4	16.0	11.8	14.2	10.7	5.2	7.3	4.3	14.7	20.6	23.5	4.9	0.5	0.3	0.9	0.3	1.1	0.5	0.5	0.8	0.7	0.5	0.8	0.9	0.3	1.1	1.6	0.7	1.1	0.5	2.2	2.3	9.5	3.8	2.2	3.5	3.8	3.4	3.5	3.8	3.9	3.4	47.4	44.8	11.3	3.3	8.5	4.6	13.2	22.9	7.4	17.1	23.8	14.6	7.8	7.2	24.2	33.1	16.7	219.2	11.5	2026.2	1.9	6.1	32.7	237.0	92.3	29.8	21.1	16.6	5.4	9.9	7.7	21.5	5.1	684.5	90.0	29.6	17.2	2.0	30.4	6.7	7.9	52.5	20.3	15.3	11.8	15.7	17.4	17.4	90.7	17.8	19.6	15.2	15.5	16.6	6.0	12.1	177.4	12.4	15.2	15.1	91.7	5.1	26.6	84.5	0.0	18.7	13.9	8.7	11.4	73.9	5.1	808.9	14.0	26.3	208.9	5.5
SLC26A3	"CLD, DRA"	ENSG00000091138	"Solute carrier family 26 member 3"	P40879	7	107765467-107803225	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"intestine: 1120.4"	"Cell type enriched"	"Detected in some"	4	"Distal enterocytes: 2328.4"	"Cancer enriched"	"Detected in many"	14	"colorectal cancer: 52.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPMI-8226: 2.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA036055	Approved					NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA036055: AB_10602401"	"unprognostic (1.26e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.69e-1)"	"unprognostic (4.02e-1)"	"unprognostic (4.09e-2)"	"unprognostic (3.05e-3)"	"unprognostic (6.31e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.05e-2)"	"unprognostic (8.85e-2)"	"unprognostic (8.01e-2)"	"unprognostic (5.52e-2)"	"unprognostic (2.54e-2)"	"unprognostic (3.58e-3)"	1.1	0.0	0.0	19.7	0.0	0.0	59.5	0.2	0.1	0.3	0.0	1120.4	576.9	0.9	15.3	0.5	0.8	17.8	0.0	0.0	0.0	0.8	0.5	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.1	878.8	0.1	0.0	129.9	0.0	0.1	118.5	15.0	0.0	0.0	1.3	0.9	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	165.9	4.2	0.0	0.3	0.0	0.0	0.0	51.4	41.7	0.3	34.3	0.0	0.0	0.0	0.0	0.0	2328.4	0.0	0.0	6.4	1.8	0.1	0.3	14.3	0.0	110.2	0.0	0.0	0.1	0.0	0.2	26.7	0.2	0.0	0.1	0.0	0.0	114.3	32.5	0.0	0.0	0.0	0.6	0.3	0.1	0.0	89.9	0.0	0.0	0.0	101.6	182.1	0.0	503.4	0.0	0.0	0.3	388.9	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	0.0	86.0	0.1
SLC26A4	"DFNB4, PDS"	ENSG00000091137	"Solute carrier family 26 member 4"	O43511	7	107660828-107717809	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	22	"thyroid gland: 263.7"	"Cell type enhanced"	"Detected in many"		"Club cells: 19.0;Excitatory neurons: 29.3;Inhibitory neurons: 53.9;Ionocytes: 54.9;Prostatic glandular cells: 17.3;Urothelial cells: 19.9"	"Cancer enriched"	"Detected in some"	8	"thyroid cancer: 37.6"	"Group enriched"	"Detected in many"	88	"amygdala: 4.0;basal ganglia: 10.2;cerebral cortex: 11.8;hippocampal formation: 8.8"	"Immune cell enriched"	"Detected in single"	8	"naive B-cell: 1.0"	"Lineage enriched"	"Detected in single"	8	"B-cells: 1.0"	"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.6;hTERT-RPE1: 3.7;LHCN-M2: 2.1"	"Region enriched"	"Detected in many"	4	"hippocampal formation: 9.7"	"Region enhanced"	"Detected in some"		"hippocampal formation: 4.8"	HPA042860	Approved					NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA042860: AB_10796680"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-2)"	"unprognostic (5.44e-2)"	"unprognostic (8.44e-2)"	"unprognostic (3.25e-2)"	"unprognostic (3.26e-2)"	"unprognostic (6.69e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.58e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.03e-1)"	"unprognostic (6.46e-3)"	"unprognostic (1.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.39e-1)"	0.4	0.1	4.0	0.1	10.2	0.0	0.8	0.0	11.8	1.4	0.0	0.2	0.1	0.5	0.1	0.1	0.3	0.4	0.6	8.8	0.0	6.4	0.1	0.5	0.4	0.0	0.0	0.3	0.3	3.9	0.3	0.3	0.0	3.8	0.2	0.1	0.4	0.2	0.5	0.2	0.1	0.3	0.0	0.1	0.7	0.6	0.0	0.2	263.7	0.1	0.2	1.5	0.3	0.0	0.3	0.1	0.2	0.0	0.3	0.6	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.1	0.2	0.0	0.0	1.6	0.4	0.0	0.1	0.1	0.1	0.1	0.5	0.0	0.4	0.2	0.0	3.7	0.0	0.3	0.0	0.1	2.1	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.3	0.2	0.1	1.3	0.3	0.3	0.1	0.3	0.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.0	10.2	0.0	11.8	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	3.2	7.7	2.6	0.2	1.7	0.7	6.5	0.0	6.6	3.2	1.8	0.6	0.0	19.0	0.0	2.1	0.3	0.4	0.4	0.0	0.2	3.9	0.3	0.5	4.9	7.3	0.0	29.3	0.0	0.1	1.5	0.0	1.8	5.1	0.2	1.1	0.2	0.3	1.7	53.9	0.0	54.9	0.6	2.0	2.7	0.9	0.7	7.2	3.7	0.7	1.2	1.0	1.5	1.6	0.1	0.1	1.2	0.0	17.3	0.0	0.1	15.2	1.8	0.0	2.9	1.6	2.0	0.4	0.1	1.4	0.0	1.7	0.2	0.5	19.9
SLC26A5	"DFNB61, PRES"	ENSG00000170615	"Solute carrier family 26 member 5"	P58743	7	103352730-103446207	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cell shape, Hearing"	"Motor protein"	"Deafness, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"brain: 2.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 6.4;Astrocytes: 5.5;Excitatory neurons: 4.1;Gastric mucus-secreting cells: 7.1;Hepatic stellate cells: 5.3;Inhibitory neurons: 3.5;Microglial cells: 6.5;Oligodendrocytes: 4.2"	"Low cancer specificity"	"Detected in single"			"Region enhanced"	"Detected in single"		"cerebellum: 2.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in many"	4	"basal ganglia: 10.4"							NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 69: Cerebellum - Gene expression regulation"		"Cluster 48: Smooth muscle cells - ECM organization"				"unprognostic (3.86e-2)"	"unprognostic (5.13e-2)"	"unprognostic (6.38e-3)"	"unprognostic (2.76e-2)"	"unprognostic (1.02e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.36e-1)"	"unprognostic (3.56e-4)"	"unprognostic (4.21e-3)"	"unprognostic (8.92e-3)"	"unprognostic (2.82e-1)"	"unprognostic (2.97e-1)"	"unprognostic (3.67e-5)"	"unprognostic (3.05e-1)"	"unprognostic (2.81e-1)"	"unprognostic (2.94e-2)"	"unprognostic (2.69e-3)"	0.1	0.1	0.3	0.0	0.3	0.0	0.7	2.2	0.2	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.2	0.4	0.1	0.4	0.5	0.0	0.2	0.3	0.0	0.0	0.3	0.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.6	0.2	0.3	0.0	0.2	0.0	0.0	0.3	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	2.2	0.2	0.1	0.4	0.4	0.5	0.3	0.4	0.3	0.5	0.3	6.4	2.6	5.5	0.2	0.3	0.0	0.0	0.0	0.2	0.3	0.1	0.7	0.0	0.6	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.4	0.2	0.5	0.0	0.0	4.1	0.0	0.0	2.2	7.1	0.2	0.0	0.0	5.3	0.0	0.0	0.0	3.5	0.0	0.0	0.3	0.3	0.0	0.3	0.0	0.0	6.5	0.0	0.3	0.0	2.0	4.2	0.3	0.0	0.0	0.0	0.8	0.0	0.0	2.2	1.2	0.0	0.2	0.1	0.3	0.5	0.0	0.3	0.0	0.6	0.0	0.0	0.6
SLC26A6	DKFZp586E1422	ENSG00000225697	"Solute carrier family 26 member 6"	Q9BXS9	3	48625723-48635493	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 69.7;Intestinal goblet cells: 34.0;Paneth cells: 40.9;Proximal enterocytes: 43.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048363	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA048363: AB_2680371"	"unprognostic (1.54e-1)"	"unprognostic (4.94e-2)"	"unprognostic (3.34e-1)"	"unprognostic (3.15e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (3.92e-4)"	"unprognostic (2.39e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.09e-1)"	"unprognostic (9.66e-3)"	"prognostic unfavorable (1.53e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.55e-1)"	"unprognostic (3.58e-2)"	5.6	6.8	4.8	5.2	5.2	18.1	5.5	5.1	6.5	9.3	5.4	28.0	8.2	7.4	3.6	5.2	6.6	3.7	8.1	4.7	5.0	19.6	7.6	9.5	3.9	5.6	5.1	7.3	11.4	3.6	5.5	5.5	5.9	12.4	21.6	4.1	5.8	4.2	9.5	6.7	22.4	5.6	5.2	12.5	26.8	5.6	5.6	3.8	6.3	6.1	3.2	6.6	7.9	6.2	8.5	8.9	13.2	15.0	39.9	19.8	11.2	13.7	17.7	25.8	27.4	17.6	7.6	12.0	4.6	11.6	28.7	11.2	12.1	12.5	7.2	9.3	12.0	10.8	29.6	34.3	29.4	5.2	16.5	27.4	44.0	17.7	12.4	22.1	8.0	12.4	8.6	13.2	6.2	9.8	10.4	27.0	18.5	23.0	17.9	5.2	4.8	14.5	18.8	7.9	3.3	6.2	17.7	21.3	25.2	17.9	11.2	19.2	6.9	11.6	9.2	15.0	31.7	15.7	17.8	5.6	9.7	20.5	28.4	6.8	11.1	2.3	3.0	10.8	2.7	0.9	1.8	1.9	9.0	0.2	1.0	1.5	1.5	0.6	10.1	5.1	3.4	5.0	4.8	5.2	5.1	6.5	4.7	5.0	5.6	5.1	5.9	5.2	5.6	6.2	4.3	3.2	5.9	10.7	2.1	3.2	2.6	8.0	5.7	2.1	3.8	2.7	6.6	1.5	3.8	1.8	14.6	9.3	2.4	69.7	0.0	2.9	1.2	1.3	3.2	5.1	20.4	4.0	2.0	6.3	15.0	4.0	13.3	2.7	0.0	3.1	4.2	6.3	7.0	5.0	2.1	34.0	10.2	5.3	7.4	0.9	3.7	6.3	5.4	1.9	5.8	1.6	6.2	2.5	2.5	5.8	40.9	9.4	5.8	2.0	43.6	6.2	3.7	6.9	0.0	1.3	4.5	2.9	6.9	2.4	3.4	10.5	3.8	13.5	26.8	1.0
SLC26A7	SUT2	ENSG00000147606	"Solute carrier family 26 member 7"	Q8TE54	8	91209494-91398155	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"thyroid gland: 330.3"	"Cell type enhanced"	"Detected in some"		"Collecting duct cells: 23.9;Endometrial ciliated cells: 31.6;Endometrial stromal cells: 23.9;Enteroendocrine cells: 45.2;Glandular and luminal cells: 52.0;Hepatic stellate cells: 24.7"	"Group enriched"	"Detected in some"	11	"renal cancer: 8.7;thyroid cancer: 32.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 1: Thyroid gland - Transcription"		"Cluster 44: Endometrium - Transcription"				"unprognostic (1.63e-1)"	"unprognostic (1.17e-1)"	"unprognostic (5.84e-2)"	"unprognostic (8.04e-3)"	"unprognostic (4.15e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.39e-3)"	"unprognostic (2.94e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.41e-2)"	"unprognostic (8.26e-2)"	"unprognostic (4.82e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.07e-1)"	"unprognostic (5.19e-3)"	"unprognostic (6.83e-3)"	1.5	0.1	0.1	0.0	0.2	0.0	0.3	0.2	0.1	1.4	0.2	0.2	0.1	2.7	0.1	0.0	0.5	0.6	0.7	0.0	0.1	23.8	0.0	0.1	3.7	0.1	0.1	0.1	1.2	0.2	0.3	0.3	0.2	0.1	0.4	0.0	0.4	0.2	0.1	0.2	0.1	0.2	0.1	0.1	6.1	0.5	0.2	0.0	330.3	0.3	0.3	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.4	3.9	0.0	1.5	5.9	0.1	0.3	0.4	0.2	0.0	0.0	1.9	0.6	1.1	0.0	0.3	23.9	0.0	0.0	0.0	0.3	13.7	0.1	11.9	31.6	23.9	1.5	45.2	0.0	0.5	0.2	0.0	1.5	1.5	52.0	0.0	0.1	24.7	0.1	0.1	0.0	0.7	0.7	2.0	0.6	0.3	2.9	3.7	0.2	3.6	0.0	0.0	0.1	0.0	0.0	3.8	1.4	0.2	0.0	0.0	0.3	0.0	0.3	1.9	0.2	0.0	0.0	4.4	0.6	1.1	0.0	0.1	0.0	0.4	0.5	0.3	0.1
SLC26A8		ENSG00000112053	"Solute carrier family 26 member 8"	Q96RN1	6	35943516-36024868	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Differentiation, Ion transport, Meiosis, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"testis: 44.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 54.1;Excitatory neurons: 15.8;Inhibitory neurons: 12.1;Late spermatids: 12.0;Spermatocytes: 64.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	11	"neutrophil: 2.3"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 2.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			HPA038081	Enhanced					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA038081: AB_10670653"	"unprognostic (8.18e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.46e-1)"	"unprognostic (7.07e-3)"	"unprognostic (2.93e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (3.78e-1)"	"unprognostic (4.63e-6)"	"unprognostic (7.14e-2)"	"unprognostic (4.24e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.24e-8)"	0.2	0.1	0.6	0.3	0.5	4.8	0.1	0.8	0.8	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.4	1.1	0.0	0.1	0.3	0.0	0.9	0.6	0.0	0.1	0.0	0.2	0.1	1.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.3	1.0	0.0	44.0	0.9	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.1	0.6	0.5	0.8	0.8	0.4	1.1	0.9	0.6	1.1	0.3	0.9	0.2	0.1	3.2	1.1	2.0	0.0	0.4	0.4	0.1	0.0	0.3	0.1	0.1	0.6	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.1	54.1	0.4	0.2	0.3	0.0	0.0	15.8	0.0	0.0	0.3	0.0	0.8	0.0	0.1	0.4	0.8	0.1	0.0	12.1	0.0	0.0	1.2	0.4	12.0	0.9	0.5	1.8	1.0	0.9	0.0	0.0	0.5	1.0	0.1	0.0	0.4	0.1	0.4	0.3	0.1	0.3	0.3	0.0	0.7	0.1	64.8	0.8	0.0	0.1	0.3	0.3	0.0	0.0	0.2
SLC26A9		ENSG00000174502	"Solute carrier family 26 member 9"	Q7LBE3	1	205913048-205943460	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"salivary gland: 72.4;stomach 1: 33.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 50.1;Cardiomyocytes: 26.2;Gastric mucus-secreting cells: 29.0;Proximal tubular cells: 25.4"	"Cancer enhanced"	"Detected in many"		"pancreatic cancer: 9.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 13.5;Hep G2: 5.1;OE19: 22.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA051485	Enhanced		Approved	"Cell Junctions"		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 11: Alveolar cells - Smell perception"	"Cell Junctions"		"HPA051485: AB_2681503"	"unprognostic (1.55e-2)"	"unprognostic (2.70e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.14e-1)"	"unprognostic (1.83e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.49e-1)"	"unprognostic (8.07e-2)"	"unprognostic (8.85e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.43e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.45e-3)"	"unprognostic (2.01e-1)"	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.1	1.3	0.2	0.0	0.0	0.1	0.0	7.7	0.0	0.3	0.3	0.0	0.4	0.0	0.2	0.0	0.3	0.0	0.0	0.0	72.4	0.0	0.0	2.0	0.0	0.0	0.0	0.0	33.9	0.0	0.1	0.0	0.4	0.3	5.3	0.0	0.5	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.5	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.3	0.0	0.1	0.1	0.0	3.2	50.1	1.0	1.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	26.2	0.0	2.7	1.8	0.0	0.0	0.0	0.0	1.9	4.3	0.5	0.2	0.0	0.3	0.0	0.0	0.1	2.2	0.0	1.7	29.0	0.2	2.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.5	0.0	0.0	0.0	0.4	0.0	25.4	2.3	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.5	1.5	0.0	0.4
SLC27A1	"ACSVL5, FATP, FATP1, FLJ00336, MGC71751"	ENSG00000130304	"Solute carrier family 27 member 1"	Q6PCB7	19	17468769-17506168	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 84.5;Oligodendrocytes: 67.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 27.7;SK-MEL-30: 47.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA076520			Approved	"Plasma membrane,Mitochondria,Cytosol"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"	"Mitochondria, Cytosol"	"HPA076520: AB_2732311"	"unprognostic (1.48e-3)"	"unprognostic (3.03e-2)"	"unprognostic (5.72e-3)"	"unprognostic (5.84e-2)"	"unprognostic (2.16e-3)"	"unprognostic (4.36e-2)"	"unprognostic (8.56e-2)"	"unprognostic (3.36e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.28e-1)"	"prognostic favorable (4.70e-4)"	"unprognostic (5.01e-2)"	"unprognostic (2.25e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.12e-1)"	18.5	24.2	32.9	4.5	41.5	1.5	19.3	37.3	39.0	22.0	45.9	15.2	3.6	13.1	2.9	8.5	17.0	8.2	29.0	32.0	32.8	10.9	7.9	10.4	4.7	41.1	40.3	33.0	14.4	17.7	19.3	6.2	38.6	23.2	1.8	4.0	24.1	10.3	24.9	14.4	7.6	3.9	34.4	10.5	13.7	17.5	35.9	2.2	16.8	12.4	1.6	13.9	14.0	46.7	6.2	3.0	4.1	9.8	27.7	15.2	3.5	4.4	11.2	4.8	7.2	0.5	18.2	2.1	8.1	7.2	4.3	7.3	0.4	6.8	1.3	2.4	1.4	1.2	0.5	2.3	5.4	0.5	6.4	14.1	4.6	4.8	1.9	19.7	3.3	3.9	0.8	1.3	3.2	2.5	3.3	4.9	1.2	6.0	5.2	4.7	3.2	1.4	3.2	1.8	1.4	2.9	3.0	1.5	47.8	2.5	5.2	1.6	2.1	9.4	6.1	7.5	3.0	4.0	3.1	0.7	9.6	5.3	6.7	0.0	9.2	0.2	1.4	4.0	2.6	0.4	1.0	1.7	6.3	0.3	1.3	1.7	0.0	1.6	1.8	6.5	0.7	4.6	32.9	41.5	37.3	39.0	32.0	32.8	41.1	40.3	38.6	34.4	35.9	46.7	19.7	3.2	11.9	84.5	1.8	6.6	14.1	12.7	10.2	8.4	15.5	26.9	19.5	11.5	11.1	9.2	27.1	4.3	8.3	1.2	1.9	11.1	1.1	8.4	6.9	7.8	5.4	0.8	16.1	4.8	15.6	10.4	9.2	4.9	2.5	8.4	10.4	8.1	26.1	6.7	23.9	3.0	6.1	22.4	4.0	2.5	21.5	13.4	8.8	15.0	14.7	11.6	4.1	37.2	67.5	5.2	0.6	11.7	1.7	12.0	0.1	3.6	16.1	17.7	6.6	10.9	7.3	9.1	5.8	5.0	4.5	2.3	4.9	13.8	2.2	8.7
SLC27A2	"ACSVL1, FACVL1, FATP2, hFACVL1, HsT17226, VLACS, VLCS"	ENSG00000140284	"Solute carrier family 27 member 2"	O14975	15	50182196-50236385	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 157.7;liver: 288.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 265.5;Hepatocytes: 205.7;Proximal enterocytes: 81.0;Proximal tubular cells: 198.9;Respiratory ciliated cells: 70.2"	"Cancer enhanced"	"Detected in many"		"liver cancer: 49.2"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	30	"basophil: 63.5"	"Lineage enriched"	"Detected in many"	30	"granulocytes: 63.5"	"Cell line enhanced"	"Detected in many"		"A549: 50.0;HaCaT: 89.3;HL-60: 66.3;OE19: 101.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA026089	Enhanced					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA026089: AB_1857060"	"unprognostic (3.03e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.06e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.89e-1)"	"unprognostic (6.38e-3)"	"unprognostic (4.83e-2)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.48e-6)"	"unprognostic (5.01e-3)"	"unprognostic (4.08e-1)"	"unprognostic (1.22e-2)"	"prognostic favorable (6.40e-4)"	4.8	16.0	1.7	2.9	2.0	6.5	13.3	1.7	3.2	1.6	9.2	18.2	11.1	0.3	65.9	2.6	10.9	2.3	0.0	2.7	2.4	157.7	288.0	1.7	1.5	0.8	1.1	0.1	7.2	4.1	12.4	17.3	0.8	5.4	16.2	3.4	0.9	1.0	0.0	1.2	21.3	0.8	0.8	0.4	1.8	0.9	2.5	0.5	4.6	0.0	1.7	3.6	1.2	0.7	0.0	50.0	0.0	0.0	0.0	0.0	0.1	0.9	0.4	0.9	1.3	26.2	6.9	0.0	0.6	1.2	0.6	89.3	22.8	0.7	2.3	36.0	27.9	37.5	43.0	23.6	0.5	66.3	25.8	0.0	2.1	0.2	0.1	0.0	0.0	16.9	11.6	0.0	0.0	8.3	1.8	44.5	1.7	101.8	1.8	0.0	0.0	1.8	4.7	45.7	40.4	2.6	8.7	1.1	0.0	1.1	4.7	22.8	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.0	0.0	21.2	0.0	63.5	0.0	0.9	0.8	0.0	0.7	0.3	0.7	0.8	0.0	0.2	0.1	0.2	0.3	2.0	0.0	0.0	0.9	0.5	1.7	2.0	1.7	3.2	2.7	2.4	0.8	1.1	0.8	0.8	2.5	0.7	0.3	0.0	1.1	0.7	2.2	1.0	1.3	8.7	1.2	1.1	1.1	0.3	0.3	0.0	13.6	9.2	0.0	265.5	1.6	17.2	11.7	0.6	0.7	9.8	0.1	0.8	4.2	8.0	4.9	2.0	7.6	0.9	1.5	0.7	6.3	0.1	3.9	205.7	16.4	1.7	6.6	18.9	10.2	3.2	0.3	0.9	0.3	1.2	0.0	1.0	0.0	0.6	1.0	0.0	0.4	1.4	26.6	0.0	0.8	3.3	81.0	198.9	70.2	1.9	0.0	0.0	1.0	4.4	4.2	5.1	0.3	54.9	4.6	0.2	25.9	4.9
SLC27A3	"ACSVL3, FATP3, MGC4365"	ENSG00000143554	"Solute carrier family 27 member 3"	Q5K4L6	1	153774354-153780157	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	Ligase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Hepatic stellate cells: 106.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"dendritic cells: 7.4;granulocytes: 12.6;monocytes: 11.1"	"Cell line enhanced"	"Detected in many"		"ASC diff: 53.3;MCF7: 30.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"HPA006935, HPA067508"	Enhanced		Enhanced	"Endoplasmic reticulum"		Yes	No			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Endoplasmic reticulum"		"HPA006935: AB_1080003, HPA067508: AB_2685857"	"unprognostic (1.88e-1)"	"unprognostic (2.66e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.57e-2)"	"unprognostic (2.70e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.08e-2)"	"unprognostic (3.18e-2)"	"unprognostic (4.22e-2)"	"unprognostic (3.39e-2)"	"prognostic favorable (5.23e-4)"	"unprognostic (4.67e-2)"	"prognostic unfavorable (6.33e-4)"	"unprognostic (1.95e-1)"	"unprognostic (4.41e-1)"	"unprognostic (2.59e-1)"	"unprognostic (2.08e-1)"	18.9	5.0	4.1	3.3	4.1	2.5	17.7	3.3	5.7	8.3	4.6	8.8	2.4	6.3	37.7	6.1	9.8	5.7	8.3	4.0	4.1	11.1	20.4	19.0	4.7	4.2	5.6	9.2	8.0	9.2	9.9	6.4	3.9	7.1	5.0	0.6	5.1	8.0	3.1	12.3	7.7	5.8	3.6	8.6	19.3	12.2	3.9	2.3	9.4	3.7	2.8	7.4	9.5	4.0	2.6	0.5	3.1	1.5	53.3	10.8	0.8	0.5	3.9	1.2	1.0	1.8	1.8	1.1	1.6	2.4	0.6	9.3	3.0	1.5	0.7	0.4	1.4	1.5	2.8	1.9	6.7	1.4	5.8	5.5	6.6	0.3	1.4	1.1	7.0	0.3	0.8	1.4	0.3	30.8	0.3	8.1	3.4	12.2	1.4	8.6	0.6	0.9	1.5	0.9	2.7	1.7	0.6	9.6	3.0	4.1	3.9	5.5	0.0	1.5	2.8	3.3	0.1	2.4	2.4	0.3	2.5	5.7	1.2	9.5	10.7	12.6	2.1	8.8	1.3	0.6	0.6	2.1	7.4	0.7	0.2	0.6	0.9	2.5	11.1	1.0	0.2	3.4	4.1	4.1	3.3	5.7	4.0	4.1	4.2	5.6	3.9	3.6	3.9	4.0	47.3	19.2	51.8	6.5	5.5	11.7	12.6	9.0	8.0	0.9	4.4	11.3	4.6	34.3	10.1	3.7	0.0	27.2	20.7	4.2	0.0	4.3	0.6	5.1	12.1	42.4	4.2	0.4	2.6	7.3	13.0	20.3	16.8	7.9	25.4	1.8	106.1	30.6	33.2	1.7	2.6	23.7	6.1	31.7	39.8	3.2	19.0	21.3	23.2	1.9	44.6	2.0	35.0	0.5	1.6	3.1	42.3	14.3	7.9	3.4	2.5	3.6	6.6	1.0	6.6	3.4	15.7	1.7	2.9	5.5	7.7	8.8	13.0	5.2	10.7	7.0
SLC27A4	"ACSVL4, FATP4"	ENSG00000167114	"Solute carrier family 27 member 4"	Q6P1M0	9	128340527-128361470	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase	"Disease variant, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 53.7;Proximal enterocytes: 100.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007293, CAB009771"	Approved		Approved	Vesicles		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 45: Intestine - Brush border"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 45: Enterocytes - Digestion"	Vesicles		"CAB009771: AB_2270540, HPA007293: AB_1857062"	"unprognostic (7.25e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.60e-1)"	"unprognostic (3.92e-3)"	"unprognostic (3.74e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.85e-3)"	"unprognostic (1.31e-3)"	"unprognostic (4.51e-1)"	"unprognostic (4.69e-2)"	"unprognostic (7.72e-2)"	"unprognostic (5.07e-2)"	"prognostic favorable (2.61e-5)"	"unprognostic (7.29e-3)"	"unprognostic (2.11e-1)"	"unprognostic (3.45e-2)"	"unprognostic (8.01e-3)"	11.4	14.7	22.5	8.5	23.7	2.7	11.6	25.4	30.3	17.2	12.4	22.8	66.9	14.4	6.3	61.8	10.4	7.3	20.4	22.7	25.9	28.8	40.0	11.8	6.4	29.4	23.9	8.3	21.6	15.5	12.1	5.6	28.8	13.1	9.4	6.8	16.4	7.5	16.1	41.8	41.1	9.3	19.7	11.6	16.4	25.8	27.1	5.8	15.5	6.2	9.6	15.5	23.5	24.1	20.8	41.8	21.1	28.1	31.5	9.8	23.3	16.7	11.7	20.3	14.5	30.1	20.7	19.1	13.5	19.8	24.8	70.6	25.5	20.7	6.7	19.5	37.2	11.4	35.6	28.5	17.1	21.0	17.8	12.7	29.6	21.2	17.0	9.4	23.1	26.3	27.5	13.7	20.2	56.2	26.0	22.7	9.2	51.6	63.0	30.4	19.6	36.4	38.1	32.0	34.8	19.2	27.6	57.0	20.3	11.3	26.7	8.8	32.4	23.7	22.9	26.6	22.0	11.4	17.4	6.5	24.3	13.0	27.7	0.0	2.5	1.7	4.7	3.3	3.4	2.1	2.9	3.6	4.4	0.9	2.3	2.4	1.0	1.4	4.3	3.9	2.2	2.4	22.5	23.7	25.4	30.3	22.7	25.9	29.4	23.9	28.8	19.7	27.1	24.1	4.7	0.0	1.1	12.7	2.0	2.8	1.4	4.0	1.2	9.6	5.8	3.0	5.2	7.2	2.8	9.2	12.5	6.1	2.1	53.7	1.9	13.1	4.8	3.6	5.2	5.3	13.1	4.0	27.7	16.0	6.8	3.5	14.3	9.3	8.9	5.9	3.6	20.1	11.3	8.4	29.2	18.6	8.2	6.1	1.9	5.4	1.2	5.4	1.8	15.9	10.0	5.0	6.2	8.5	26.4	26.4	30.0	4.1	3.2	3.2	100.6	9.7	1.8	7.8	6.6	4.4	4.4	11.8	7.9	11.9	6.1	5.2	2.4	7.9	25.7	2.8
SLC27A5	"ACSB, ACSVL6, FACVL3, FATP5, FLJ22987, VLACSR, VLCS-H2, VLCSH2"	ENSG00000083807	"Solute carrier family 27 member 5"	Q9Y2P5	19	58479512-58512413	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism"	"Ligase, Oxidoreductase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	21	"liver: 1023.6"	"Group enriched"	"Detected in many"	4	"Early spermatids: 144.4;Hepatocytes: 439.9;Late spermatids: 464.4"	"Cancer enriched"	"Detected in all"	26	"liver cancer: 49.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA007292, CAB056160, CAB068239"	Enhanced					NA	NA			"Cluster 30: Non-specific - Translation"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 2: Hepatocytes - Metabolism"			"CAB056160: AB_2665590, CAB068239: AB_2665592, HPA007292: AB_1857064"	"unprognostic (5.97e-2)"	"unprognostic (9.12e-2)"	"unprognostic (9.95e-2)"	"unprognostic (6.36e-3)"	"unprognostic (2.52e-1)"	"unprognostic (7.46e-2)"	"prognostic favorable (1.57e-4)"	"unprognostic (1.04e-1)"	"unprognostic (1.85e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.78e-2)"	"unprognostic (8.56e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.27e-1)"	"unprognostic (3.33e-2)"	"unprognostic (7.80e-2)"	"unprognostic (2.16e-1)"	5.9	9.9	35.8	3.3	36.3	3.7	6.5	34.5	49.9	7.5	32.7	7.7	2.5	5.4	2.9	5.4	9.1	2.9	6.6	35.4	36.0	11.0	1023.6	4.0	4.4	35.3	36.7	6.8	10.6	7.1	10.8	1.6	35.2	8.0	1.7	3.0	9.9	4.5	4.8	6.6	3.9	4.4	35.4	5.2	7.2	20.7	38.2	6.2	6.6	4.3	4.6	8.2	6.2	34.9	41.2	55.0	9.6	10.2	9.0	9.3	6.1	2.3	5.3	7.5	10.3	4.4	8.7	52.9	6.5	2.8	1.4	8.4	11.0	35.3	3.2	24.8	37.0	35.8	58.3	46.7	13.5	18.9	12.2	10.9	5.9	1.2	20.5	12.9	3.9	39.4	33.5	0.0	9.1	33.4	47.2	39.8	5.8	34.4	31.9	23.4	0.2	72.6	25.0	19.3	13.1	17.8	0.1	53.5	12.1	2.7	15.8	16.3	3.1	0.0	6.8	0.0	4.7	33.5	41.0	22.7	10.9	35.0	2.0	0.1	4.0	3.8	13.5	5.3	29.6	24.3	17.5	18.0	10.8	15.8	21.3	21.7	0.5	18.1	4.0	18.2	23.3	13.9	35.8	36.3	34.5	49.9	35.4	36.0	35.3	36.7	35.2	35.4	38.2	34.9	12.5	0.0	7.3	3.3	9.8	9.1	15.5	16.0	14.2	11.8	50.1	73.2	8.3	20.0	9.9	5.5	0.0	7.3	6.9	4.6	39.2	9.6	144.4	12.4	10.1	11.3	10.1	25.0	4.3	15.4	3.3	8.9	8.6	8.0	5.1	20.2	16.8	439.9	10.5	10.1	5.3	4.7	6.1	16.7	9.6	464.4	10.8	6.7	16.0	1.9	3.4	12.0	12.3	5.0	7.4	8.0	1.2	9.4	8.9	32.2	1.8	57.6	11.5	8.5	6.6	7.4	18.4	50.9	12.7	15.5	14.1	3.4	11.3	26.7	6.1	15.0
SLC27A6	"ACSVL2, FACVL2, FATP6, VLCS-H1"	ENSG00000113396	"Solute carrier family 27 member 6"	Q9Y2P4	5	128538013-129033642	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Fatty acid metabolism, Lipid metabolism, Lipid transport, Transport"	Ligase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 24.4;fallopian tube: 21.3;heart muscle: 23.5"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 25.0;Cardiomyocytes: 29.6;Cytotrophoblasts: 54.8;Extravillous trophoblasts: 37.3;Muller glia cells: 33.0;Skeletal myocytes: 18.0;Syncytiotrophoblasts: 27.5"	"Cancer enriched"	"Detected in many"	8	"thyroid cancer: 19.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"BEWO: 43.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			HPA008987	Approved		Approved	"Nuclear bodies"		NA	NA				"Cluster 43: Testis - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nuclear bodies"		"HPA008987: AB_1857065"	"unprognostic (5.39e-5)"	"unprognostic (4.79e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.15e-1)"	"unprognostic (3.55e-1)"	"unprognostic (1.34e-2)"		"unprognostic (1.01e-1)"	"unprognostic (1.34e-1)"	"unprognostic (3.22e-1)"	"unprognostic (2.78e-1)"	"unprognostic (1.53e-1)"		"unprognostic (2.64e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.54e-2)"	"unprognostic (9.66e-4)"	0.4	24.4	1.8	0.3	2.4	0.1	3.0	3.0	1.4	3.9	0.7	0.9	0.4	4.3	0.2	4.2	21.3	2.7	23.5	1.2	3.6	0.0	0.1	0.8	0.2	9.7	5.2	9.7	0.1	0.0	6.0	6.7	7.5	3.6	1.7	7.4	3.5	0.3	0.4	2.0	1.1	0.8	5.8	0.1	0.5	13.0	5.5	9.6	1.8	0.9	5.7	1.1	2.9	8.4	0.0	0.0	0.1	0.0	0.0	0.0	43.7	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	1.6	0.0	0.1	0.9	0.2	0.7	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	3.5	0.0	3.3	2.0	0.0	0.0	2.3	0.0	0.0	0.0	0.3	0.3	4.4	0.0	5.1	0.0	3.1	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.4	3.0	1.4	1.2	3.6	9.7	5.2	7.5	5.8	5.5	8.4	0.0	0.0	0.0	0.0	0.0	3.2	0.9	0.0	25.0	0.6	0.2	5.5	29.6	0.0	0.0	0.0	0.0	54.8	0.0	0.0	0.0	0.0	13.2	3.8	1.0	0.3	0.0	0.0	0.4	0.0	37.3	2.7	0.0	1.9	0.0	1.7	0.0	0.0	3.8	3.3	4.6	0.0	0.0	0.0	0.4	2.8	0.3	0.2	0.0	0.0	0.0	33.0	0.0	1.0	1.7	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.9	0.0	18.0	0.3	1.1	1.0	1.8	0.9	27.5	0.0	2.3	0.1	0.1
SLC28A1	CNT1	ENSG00000156222	"Solute carrier family 28 member 1"	O00337	15	84884654-84945798	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	21	"intestine: 49.1;kidney: 48.2;liver: 111.3"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 38.6;Hofbauer cells: 54.3;Proximal enterocytes: 86.9;Proximal tubular cells: 93.4"	"Group enriched"	"Detected in some"	63	"liver cancer: 10.9;renal cancer: 33.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA019551, HPA056247"	Enhanced		Approved	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nuclear speckles, Cytosol"	"HPA019551: AB_2670187, HPA056247: "	"unprognostic (3.81e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.22e-1)"	"unprognostic (7.49e-2)"	"unprognostic (5.08e-2)"	"unprognostic (7.08e-2)"	"unprognostic (8.68e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.63e-1)"	"unprognostic (8.37e-2)"	"unprognostic (1.35e-1)"	"unprognostic (7.42e-2)"	"unprognostic (7.72e-3)"	"unprognostic (6.65e-2)"	"unprognostic (1.55e-1)"	0.2	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.1	0.3	0.0	0.0	37.9	0.0	0.5	0.1	0.7	0.2	1.0	0.1	0.3	48.2	111.3	0.0	0.2	0.9	0.3	0.0	0.0	0.2	0.2	1.2	0.7	0.0	0.0	0.0	0.1	0.0	1.5	0.0	49.1	0.0	0.4	0.0	0.1	0.1	0.2	0.0	0.0	3.3	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.3	0.9	0.3	0.7	0.4	0.2	0.6	0.2	0.0	0.0	0.3	0.0	0.0	0.0	1.0	0.0	0.0	0.5	0.3	2.2	4.3	0.6	7.3	0.0	0.5	0.0	0.0	11.7	3.0	0.0	0.4	0.1	0.1	0.0	0.0	0.5	0.0	0.5	0.4	0.0	0.6	0.0	0.0	0.4	38.6	54.3	0.0	0.5	2.8	0.0	0.6	0.0	0.0	0.0	0.9	0.0	0.0	0.6	0.0	0.0	0.5	1.1	0.3	2.5	0.0	0.0	0.0	86.9	93.4	1.4	0.0	0.0	2.6	0.2	0.0	0.0	0.0	0.0	0.8	0.4	0.3	1.5	0.1
SLC28A2	"CNT2, HCNT2, HsT17153, SPNT1"	ENSG00000137860	"Solute carrier family 28 member 2"	O43868	15	45252234-45277846	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"intestine: 92.3"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 19.6;Paneth cells: 35.7;Proximal enterocytes: 43.4;Undifferentiated cells: 48.9"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 3.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046068, HPA055623"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nuclear membrane"	"Nucleoplasm, Cytosol"	"HPA046068: AB_2679523, HPA055623: AB_2682866"	"unprognostic (2.75e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.62e-3)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-1)"	"unprognostic (6.85e-2)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.40e-4)"	"unprognostic (3.34e-3)"	"unprognostic (2.63e-1)"	"unprognostic (1.28e-2)"	"unprognostic (2.74e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.44e-2)"	"unprognostic (8.95e-2)"	0.1	0.3	0.4	0.7	0.4	0.1	0.0	0.3	0.4	2.6	0.0	9.5	68.0	0.5	0.4	0.1	0.1	9.8	0.3	0.3	0.1	3.5	0.8	0.1	0.3	0.4	0.0	0.3	0.3	0.0	0.0	0.6	0.4	0.1	34.6	0.7	0.2	0.0	0.3	0.3	92.3	0.0	0.1	0.2	22.8	0.4	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.3	0.4	0.3	0.1	0.4	0.0	0.4	0.1	0.2	0.6	0.5	0.0	8.1	1.6	0.9	0.1	0.4	0.4	0.0	2.9	0.3	0.0	0.7	8.6	4.5	0.0	2.1	12.3	0.3	19.6	0.0	0.1	0.7	1.0	0.4	1.0	13.9	2.7	1.8	0.0	2.7	1.0	4.6	1.2	8.8	0.7	0.7	0.3	0.9	1.7	1.5	14.5	0.0	0.3	0.4	0.4	0.0	1.3	0.0	0.0	0.2	1.0	2.1	2.0	2.0	0.0	35.7	0.7	0.4	0.2	43.4	1.2	4.6	6.6	0.0	0.3	0.2	2.4	2.1	0.0	0.3	4.7	1.3	0.2	48.9	0.2
SLC28A3	CNT3	ENSG00000197506	"Solute carrier family 28 member 3"	Q9HAS3	9	84275457-84340758	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 22.4;salivary gland: 12.0"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 10.7;Breast glandular cells: 9.5;Cholangiocytes: 8.6;Ductal cells: 24.9;Endometrial ciliated cells: 9.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	6	"HMC-1: 58.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA023311, HPA024729"	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA023311: AB_1857067, HPA024729: AB_1857069"	"prognostic favorable (3.37e-4)"	"unprognostic (1.28e-2)"	"unprognostic (3.01e-1)"	"unprognostic (2.50e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.82e-3)"	"unprognostic (3.74e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.06e-2)"	"unprognostic (4.13e-2)"	"unprognostic (1.54e-7)"	"unprognostic (1.03e-1)"	"unprognostic (9.87e-2)"	"unprognostic (8.75e-2)"	"unprognostic (4.03e-2)"	5.2	0.0	0.1	0.3	0.0	9.4	8.9	0.1	0.0	1.0	22.4	0.7	1.0	0.5	0.5	4.2	2.3	7.3	0.4	0.8	0.1	0.1	0.3	1.1	0.1	0.9	1.0	0.0	8.2	0.1	1.2	0.3	0.4	0.1	2.5	0.0	12.0	2.8	0.0	10.0	1.9	0.1	0.4	0.3	0.8	0.4	0.3	0.5	0.1	0.0	1.3	0.3	1.5	0.1	0.7	0.0	0.0	0.0	0.0	0.1	6.2	0.7	1.5	0.8	0.7	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.9	0.1	0.0	0.0	0.0	0.0	0.4	0.2	58.1	0.1	0.5	0.4	0.4	0.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	1.2	0.0	3.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.0	1.0	0.1	0.0	0.5	0.1	9.3	0.0	0.1	6.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.9	1.0	0.4	0.4	0.3	0.1	0.0	0.0	0.5	1.6	0.1	0.3	0.0	10.7	0.0	0.0	9.5	3.8	0.8	8.6	4.2	1.8	0.0	0.2	0.3	0.7	0.0	24.9	1.4	9.2	0.8	0.2	3.0	0.0	0.4	3.1	0.1	0.5	2.0	6.7	1.3	1.5	0.0	0.0	2.1	0.0	0.4	5.4	2.0	1.2	0.0	2.5	0.0	0.7	0.0	0.0	1.5	0.4	0.0	0.0	0.1	4.5	0.3	0.0	0.4	0.1	1.0	0.0	4.2	0.0	0.0	0.0	0.4	0.6	0.3	3.4	0.9	0.1	0.1	0.0	4.8	0.2
SLC29A1	ENT1	ENSG00000112759	"Solute carrier family 29 member 1 (Augustine blood group)"	Q99808	6	44219553-44234142	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 216.6;Extravillous trophoblasts: 224.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	26	"eosinophil: 1046.6"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 1046.6"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA012384	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 38: Heart - Muscle contraction"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 38: Extravillous trophoblasts - Unknown function"			"HPA012384: AB_1857073"	"unprognostic (1.82e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.81e-1)"	"unprognostic (2.49e-3)"	"unprognostic (2.76e-1)"	"unprognostic (5.13e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.76e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (1.38e-2)"	"unprognostic (4.60e-2)"	"unprognostic (9.02e-2)"	"unprognostic (1.34e-1)"	76.4	95.8	10.2	22.3	10.2	53.4	50.4	13.0	14.8	25.4	4.5	59.7	13.1	37.3	15.9	25.3	34.5	44.2	119.7	10.1	12.2	17.8	57.9	33.1	25.9	13.2	10.2	12.9	91.2	22.8	22.6	58.8	15.3	16.5	17.8	21.1	35.6	19.3	144.5	53.0	17.2	46.2	9.5	14.5	53.7	14.9	10.7	81.3	30.7	100.7	17.0	32.8	17.7	10.8	85.3	84.2	58.5	95.1	87.8	8.1	347.1	61.2	24.0	83.6	57.4	91.8	34.8	171.2	60.8	18.5	51.7	103.8	105.2	72.8	51.9	97.6	97.2	150.5	57.8	122.5	14.1	170.3	139.7	10.9	18.4	123.0	42.7	171.6	216.0	137.2	205.4	100.1	46.9	94.0	142.0	114.4	89.0	218.4	55.4	94.0	117.8	208.9	49.1	49.5	75.0	97.0	18.4	58.9	43.9	61.5	80.7	107.1	333.1	46.4	74.8	62.6	117.7	67.0	93.8	221.9	28.8	136.8	57.1	21.9	12.1	1046.6	5.1	38.8	4.2	4.4	2.7	3.9	6.8	2.4	1.1	2.4	1.8	3.1	32.5	40.0	8.2	6.6	10.2	10.2	13.0	14.8	10.1	12.2	13.2	10.2	15.3	9.5	10.7	10.8	64.2	0.0	10.5	1.3	4.0	10.7	9.0	4.1	2.2	10.9	20.2	30.1	46.4	17.2	6.0	7.3	14.6	216.6	5.7	3.0	3.9	24.2	0.5	4.3	3.5	31.7	31.2	49.2	18.4	56.7	224.6	40.0	26.5	11.2	8.2	25.4	25.7	16.7	63.6	5.0	25.4	2.9	79.3	37.0	13.3	2.8	32.9	19.2	35.6	16.9	8.3	4.3	0.0	5.0	2.6	61.9	3.4	53.8	14.2	18.2	0.7	0.9	6.9	11.9	92.1	21.0	22.5	0.4	11.0	4.6	15.6	42.0	3.2	4.1	6.2	9.8
SLC29A2	"DER12, ENT2, HNP36"	ENSG00000174669	"Solute carrier family 29 member 2"	Q14542	11	66362521-66372214	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"skeletal muscle: 90.8;tongue: 47.3"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"BEWO: 44.3;CAPAN-2: 53.5;T-47d: 55.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018168	Approved		Uncertain	Nucleoplasm		NA	Yes			"Cluster 32: T-cells - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 47: Cytotrophoblasts - Unknown function"	Nucleoplasm		"HPA018168: AB_1857077"	"unprognostic (3.20e-2)"	"unprognostic (4.50e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (3.37e-1)"	"unprognostic (5.08e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.96e-1)"	"unprognostic (2.09e-1)"	"unprognostic (1.76e-1)"	"unprognostic (5.28e-2)"	"prognostic favorable (2.78e-4)"	"unprognostic (2.55e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.13e-1)"	"unprognostic (6.38e-3)"	6.7	0.9	4.2	2.5	4.3	0.8	7.4	9.8	5.6	1.9	4.2	5.7	7.8	0.9	3.1	3.3	3.6	1.4	11.9	4.1	4.0	6.9	1.5	4.4	2.8	7.4	6.9	0.7	8.7	12.9	6.1	4.1	8.2	5.2	4.1	3.1	7.2	2.4	90.8	2.8	7.4	0.3	4.1	2.1	9.4	0.5	5.9	2.3	5.4	47.3	1.9	1.2	2.6	3.7	14.2	11.4	8.2	1.8	1.2	0.3	44.3	0.6	0.0	0.4	0.6	20.2	53.5	6.1	10.4	0.1	3.1	12.9	11.4	9.7	0.0	0.5	18.6	11.7	12.4	1.5	1.3	21.9	0.4	0.7	4.3	1.5	4.1	5.2	0.5	5.1	33.0	0.0	0.0	34.5	1.6	31.9	21.8	35.1	8.1	1.3	0.3	26.4	22.2	10.4	16.1	6.6	1.0	18.4	1.2	2.4	55.2	4.1	0.0	0.3	11.2	0.4	0.0	0.3	0.8	0.5	0.9	0.5	0.7	0.0	0.0	0.0	1.3	0.0	0.4	0.2	0.7	1.7	0.3	0.7	1.7	1.7	0.1	0.0	0.0	0.6	0.1	0.5	4.2	4.3	9.8	5.6	4.1	4.0	7.4	6.9	8.2	4.1	5.9	3.7	0.6	3.2	6.3	9.4	2.2	0.6	4.7	5.4	1.2	2.5	7.6	5.8	12.3	4.3	6.5	14.7	12.5	46.4	0.7	6.0	3.9	5.0	0.1	2.1	0.5	0.9	2.4	2.1	11.2	6.7	16.5	1.7	11.2	5.4	4.5	1.8	0.4	0.9	4.4	5.0	10.8	9.2	4.1	0.8	0.4	0.0	0.0	0.5	0.0	2.8	0.9	2.3	0.0	7.5	0.8	3.5	4.7	0.4	1.5	4.7	1.6	0.5	3.8	3.7	0.0	4.4	2.1	0.4	0.5	3.5	0.0	13.5	2.1	0.4	10.6	3.4
SLC29A3	"ENT3, FLJ11160"	ENSG00000198246	"Solute carrier family 29 member 3"	Q9BZD2	10	71319259-71381423	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 46.1;Extravillous trophoblasts: 45.3;Hofbauer cells: 34.7;Syncytiotrophoblasts: 31.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 31.8;Hep G2: 35.9;RT4: 29.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA046085, HPA054976, HPA057905"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA046085: AB_2679531, HPA054976: AB_2682659, HPA057905: AB_2683550"	"unprognostic (1.73e-1)"	"unprognostic (2.38e-3)"	"unprognostic (3.23e-3)"	"unprognostic (1.07e-1)"	"unprognostic (3.06e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (6.07e-6)"	"unprognostic (1.28e-1)"	"unprognostic (4.71e-1)"	"unprognostic (1.81e-1)"	"unprognostic (2.53e-1)"	"unprognostic (3.80e-2)"	"prognostic unfavorable (5.53e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.36e-1)"	"prognostic favorable (1.16e-4)"	"unprognostic (3.43e-3)"	4.7	2.6	3.1	4.1	3.9	1.1	4.8	3.7	3.7	7.3	2.7	4.4	2.1	6.8	2.5	2.2	5.8	4.4	2.4	3.0	3.6	2.5	9.4	6.7	7.1	4.7	3.7	9.7	5.2	3.5	1.7	11.2	4.2	5.1	3.5	0.3	4.9	2.9	1.4	2.6	3.7	5.1	4.2	6.5	6.1	3.7	4.4	3.7	3.8	0.6	3.8	9.8	4.4	5.0	2.1	12.3	1.8	7.8	6.8	5.3	31.8	2.3	2.2	0.7	0.4	13.8	8.8	7.4	6.4	4.7	3.2	18.3	5.7	2.9	0.1	5.6	5.6	2.2	1.0	35.9	3.3	1.8	4.5	5.2	12.9	0.3	0.6	1.5	3.2	8.5	6.5	6.8	0.9	19.1	4.2	3.8	4.2	19.2	4.5	5.7	0.6	5.9	2.3	29.5	8.5	9.6	6.4	20.3	1.7	5.2	3.2	4.0	5.2	0.2	3.8	2.3	0.1	1.8	3.1	4.0	7.6	24.0	1.3	4.2	19.3	2.2	5.4	15.3	4.6	4.9	4.5	5.1	29.1	1.9	3.5	5.0	1.5	9.4	10.3	20.2	5.5	9.5	3.1	3.9	3.7	3.7	3.0	3.6	4.7	3.7	4.2	4.2	4.4	5.0	2.0	3.2	1.1	2.0	3.1	0.3	1.5	4.0	1.8	2.3	2.7	3.8	0.8	1.5	3.8	0.0	0.0	46.1	6.3	2.6	0.0	6.1	3.6	1.8	3.2	1.8	1.8	4.2	2.4	8.9	45.3	4.7	7.1	2.4	2.5	10.2	3.3	5.4	34.7	0.0	1.3	2.5	8.2	11.8	4.4	15.2	2.8	10.9	1.8	16.9	8.5	3.0	3.1	2.5	2.7	7.9	13.1	1.5	6.0	3.2	0.1	2.0	2.6	0.4	0.0	0.2	2.5	0.6	5.0	0.7	0.0	31.7	2.9	10.0	2.5	1.7
SLC29A4	"ENT4, FLJ34923"	ENSG00000164638	"Solute carrier family 29 member 4"	Q7RTT9	7	5274369-5306912	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adipose tissue: 43.3;choroid plexus: 55.5"	"Group enriched"	"Detected in many"	5	"Enteroendocrine cells: 103.2;Horizontal cells: 168.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 49.2;SH-SY5Y: 70.7;U-2 OS: 23.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052829			Approved	"Microtubules,Cytokinetic bridge"		Yes	No			"Cluster 40: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 62: Horizontal cells - Visual perception"	"Microtubules, Cytokinetic bridge"		"HPA052829: AB_2681967"	"unprognostic (6.04e-2)"	"unprognostic (1.22e-2)"	"unprognostic (8.49e-5)"	"unprognostic (2.53e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.24e-2)"	"unprognostic (9.59e-3)"	"unprognostic (2.05e-1)"	"unprognostic (2.55e-2)"	"unprognostic (5.73e-2)"	"prognostic favorable (4.52e-4)"	"unprognostic (2.06e-1)"	"unprognostic (3.02e-2)"	"unprognostic (3.24e-2)"	"unprognostic (2.63e-2)"	"unprognostic (1.29e-3)"	"unprognostic (6.60e-2)"	43.3	8.2	13.2	0.7	16.2	0.6	13.3	16.0	20.0	4.9	55.5	3.1	4.6	5.4	5.0	1.1	4.0	1.6	3.7	26.3	28.5	7.9	9.2	0.9	0.2	23.2	26.1	2.2	15.4	1.7	3.6	0.6	23.6	5.8	1.8	4.1	1.3	0.7	2.6	3.0	5.5	1.8	17.2	1.6	6.5	2.6	30.0	0.3	9.7	0.4	0.1	2.4	2.0	7.4	0.0	21.7	12.6	49.2	0.6	0.2	2.4	1.8	0.1	1.6	0.9	12.3	0.4	0.0	2.4	1.9	8.1	0.3	4.8	0.4	0.5	0.1	2.8	0.2	0.7	18.3	3.8	0.2	3.0	1.5	16.2	0.3	0.9	2.9	1.5	4.5	3.6	0.1	1.2	10.8	2.0	0.9	16.0	1.5	1.3	8.3	2.1	1.9	3.2	0.5	8.4	70.7	1.3	4.4	0.9	10.7	5.5	5.9	0.7	17.3	23.4	1.6	0.5	1.1	0.0	0.1	2.2	0.7	8.0	0.8	0.3	0.2	0.2	0.1	0.4	0.2	0.1	0.2	0.1	0.4	0.2	0.2	1.3	1.6	0.1	0.3	0.1	0.1	13.2	16.2	16.0	20.0	26.3	28.5	23.2	26.1	23.6	17.2	30.0	7.4	0.5	3.2	0.5	8.8	0.0	0.1	0.2	0.1	0.0	6.9	0.7	0.6	2.5	0.0	0.2	0.0	16.7	0.3	0.2	6.3	0.0	5.3	0.1	3.3	3.0	0.6	103.2	0.0	2.4	0.2	0.4	2.2	2.0	0.7	0.0	25.7	0.0	1.0	0.4	168.2	14.3	4.4	0.0	0.3	0.7	0.7	0.3	0.3	0.0	0.0	0.1	4.8	0.0	4.0	0.6	1.4	0.5	0.4	0.1	2.3	0.8	0.2	1.4	1.6	0.0	0.5	2.2	0.4	4.2	0.1	0.3	0.3	0.3	1.7	1.0	0.2
SLC2A1	"CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR"	ENSG00000117394	"Solute carrier family 2 member 1"	P11166	1	42925353-42958893	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Cancer-related genes, Cataract, Disease variant, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"placenta: 98.7;skin 1: 79.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 833.8;Erythroid cells: 520.4;Extravillous trophoblasts: 536.4;Syncytiotrophoblasts: 2482.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BEWO: 241.0;CACO-2: 219.9;Hep G2: 157.4"	"Low region specificity"	"Detected in all"							"CAB002759, HPA031345, HPA058494"	Enhanced	Supported	Enhanced	"Plasma membrane"		No	No		2000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"CAB002759: , HPA031345: AB_2673835, HPA058494: AB_2683734"	"unprognostic (3.60e-2)"	"unprognostic (5.85e-3)"	"unprognostic (7.59e-2)"	"unprognostic (1.31e-2)"	"unprognostic (4.10e-3)"	"unprognostic (3.22e-2)"	"prognostic unfavorable (3.65e-8)"	"prognostic unfavorable (1.09e-4)"	"unprognostic (1.10e-1)"	"unprognostic (4.84e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (1.87e-1)"	"prognostic unfavorable (4.55e-9)"	"unprognostic (1.11e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.17e-1)"	"prognostic unfavorable (4.05e-4)"	6.9	3.6	24.1	2.5	26.1	41.6	7.8	33.7	27.7	28.6	43.6	6.1	0.4	5.1	1.4	54.1	8.2	1.7	10.0	20.6	28.5	14.2	1.7	3.3	1.0	31.9	29.3	5.5	2.1	4.5	4.8	98.7	34.5	6.0	1.0	24.6	17.6	5.1	2.0	79.8	4.6	0.4	24.7	7.5	8.4	2.1	41.2	1.0	3.0	1.5	2.1	19.3	54.2	29.4	60.5	52.9	66.3	6.2	3.5	1.2	241.0	47.8	36.9	15.5	27.8	219.9	96.3	22.2	138.9	6.0	26.5	43.6	12.5	52.3	14.8	16.4	10.3	29.8	20.9	157.4	12.9	16.8	8.1	3.3	21.3	18.3	20.5	96.7	2.9	12.8	81.2	1.5	11.7	46.6	7.4	11.7	35.1	22.1	17.9	8.4	20.6	23.3	21.7	17.9	27.0	23.8	47.7	95.6	11.0	70.0	3.8	16.9	14.9	25.6	28.6	6.1	83.8	5.3	6.5	11.5	57.1	8.2	25.5	0.5	0.1	1.2	10.6	0.3	8.5	10.9	5.1	6.7	3.7	8.3	3.8	4.8	0.2	4.3	0.1	18.4	6.2	4.0	24.1	26.1	33.7	27.7	20.6	28.5	31.9	29.3	34.5	24.7	41.2	29.4	3.1	0.0	1.8	12.7	25.4	286.1	48.8	286.3	66.0	15.8	41.4	21.8	26.7	20.0	159.3	27.6	66.7	833.8	33.5	53.1	5.9	53.2	4.0	112.1	46.0	100.5	18.4	520.4	2.8	11.7	536.4	25.9	11.7	118.9	6.3	6.8	2.2	2.1	84.8	5.0	3.2	22.4	65.1	1.6	34.2	0.3	7.8	5.0	21.4	71.2	36.0	350.1	18.6	8.0	9.9	120.3	51.9	14.7	11.6	31.2	1.9	2.2	118.1	32.1	0.0	9.8	32.1	0.1	2.4	99.1	238.3	2482.5	20.8	5.5	11.8	105.8
SLC2A10	GLUT10	ENSG00000197496	"Solute carrier family 2 member 10"	O95528	20	46709649-46736347	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hepatocytes: 43.6;Intestinal goblet cells: 56.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	75	"basophil: 20.9"	"Lineage enriched"	"Detected in single"	75	"granulocytes: 20.9"	"Cell line enhanced"	"Detected in many"		"ASC diff: 45.8;HSkMC: 56.6;OE19: 49.8;SK-MEL-30: 60.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA041015, HPA055673"	Approved		Supported	Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA041015: AB_2677252, HPA055673: AB_2682879"	"unprognostic (8.94e-3)"	"unprognostic (2.62e-3)"	"unprognostic (2.06e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.17e-3)"	"unprognostic (1.04e-1)"	"unprognostic (7.68e-2)"	"unprognostic (2.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.06e-2)"	"unprognostic (4.94e-3)"	"unprognostic (1.70e-1)"	"unprognostic (3.63e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.96e-2)"	7.0	5.9	4.0	3.5	4.1	1.2	15.3	3.4	3.9	19.4	18.9	12.7	5.4	7.9	8.7	5.1	9.9	10.3	5.2	3.8	3.7	3.5	41.4	6.9	1.7	5.2	4.7	9.9	17.4	19.5	6.3	11.6	4.0	31.3	16.0	1.6	24.0	9.9	1.5	3.6	5.3	8.5	3.8	2.6	22.8	2.6	4.0	1.6	19.5	2.7	2.1	9.3	8.4	3.4	0.0	0.1	11.3	11.7	45.8	38.9	34.2	22.2	30.2	10.1	12.0	0.9	38.9	0.0	16.3	40.6	0.0	0.2	0.0	1.1	4.8	0.0	0.3	3.3	0.0	18.6	32.2	0.0	0.0	56.6	1.0	6.2	0.0	11.8	4.2	0.0	0.2	0.1	17.5	41.3	0.0	1.2	4.3	49.8	2.9	0.0	1.6	0.1	0.0	10.6	0.0	1.8	4.3	7.2	60.3	8.1	5.4	9.2	2.6	21.7	9.1	17.2	2.9	0.3	0.1	0.0	0.1	0.0	4.6	20.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	4.0	4.1	3.4	3.9	3.8	3.7	5.2	4.7	4.0	3.8	4.0	3.4	4.2	6.4	6.3	12.4	0.8	0.6	6.1	7.8	5.2	0.0	29.6	14.4	6.4	7.2	15.8	1.8	0.0	2.7	0.4	11.4	0.0	7.4	0.2	3.2	17.8	4.6	3.6	6.1	0.1	5.6	16.3	16.7	23.4	4.0	6.3	10.7	8.6	43.6	1.1	0.0	0.4	56.6	12.2	1.9	1.3	1.6	26.4	0.4	1.8	2.8	0.0	5.5	0.0	10.1	0.3	5.1	10.3	17.3	2.8	23.9	1.7	0.8	27.5	0.5	13.1	5.1	6.3	0.8	0.3	4.2	1.0	2.1	0.5	3.6	14.6	10.9
SLC2A11	"GLUT10, GLUT11"	ENSG00000133460	"Solute carrier family 2 member 11"	Q9BYW1	22	23856703-23886309	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 298.2;Rod photoreceptor cells: 188.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"SK-BR-3: 9.2"					"Low region specificity"	"Detected in all"			"HPA042960, HPA071184"	Uncertain		Uncertain	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Cell Junctions"	Nucleoplasm	"HPA042960: AB_2678241, HPA071184: AB_2686355"	"unprognostic (1.31e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.69e-2)"	"unprognostic (6.97e-2)"	"unprognostic (7.93e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.24e-2)"	"unprognostic (1.60e-3)"	"unprognostic (3.53e-1)"	"unprognostic (4.89e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.32e-1)"	"prognostic favorable (5.77e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.70e-1)"	"unprognostic (3.85e-1)"	"unprognostic (6.29e-2)"	2.3	6.3	3.9	1.7	3.7	1.1	3.3	5.3	4.5	4.8	3.4	5.2	1.2	3.4	3.0	1.6	3.6	1.3	10.2	3.3	4.1	16.5	5.1	2.3	2.7	3.7	3.7	4.9	12.9	6.1	13.2	2.7	4.1	5.1	2.0	19.5	3.9	2.9	6.3	2.3	4.6	1.8	3.0	4.2	4.4	3.2	4.1	0.7	7.2	1.9	2.2	4.3	2.2	3.5	2.2	1.0	1.2	5.7	1.2	2.5	0.6	1.3	1.6	1.4	0.9	1.3	1.5	2.7	0.7	1.7	1.2	1.7	2.4	0.8	0.7	2.0	2.2	1.3	2.5	2.0	1.8	1.3	1.4	1.0	2.4	2.0	1.7	6.3	0.5	2.1	0.5	6.4	0.7	2.2	0.3	0.5	2.1	1.3	1.6	3.7	0.2	3.1	4.3	0.6	3.2	1.8	0.6	9.2	2.2	1.5	4.8	0.7	0.4	0.5	0.9	0.5	0.6	5.5	1.6	2.6	1.1	0.9	1.4	0.4	0.1	0.4	0.2	0.3	0.1	0.6	0.2	0.2	0.0	0.5	0.4	0.2	0.2	0.3	0.2	1.4	0.0	0.1	3.9	3.7	5.3	4.5	3.3	4.1	3.7	3.7	4.1	3.0	4.1	3.5	2.9	19.2	15.0	14.4	23.4	3.2	9.3	4.4	8.6	56.0	15.0	13.5	31.2	7.2	5.6	25.8	298.2	9.8	15.5	5.7	13.7	4.9	8.4	4.8	8.2	4.4	10.8	5.0	21.6	5.6	9.8	8.3	5.1	5.3	2.5	19.5	6.1	7.3	5.8	37.0	30.0	5.8	10.2	4.8	4.6	10.4	9.3	4.3	3.6	4.7	4.2	16.4	10.3	8.0	14.2	2.7	2.7	9.8	15.2	7.3	3.7	24.7	6.3	188.8	0.0	11.8	7.5	4.2	5.7	5.3	3.1	20.0	8.3	28.3	7.5	6.0
SLC2A12	"GLUT12, GLUT8"	ENSG00000146411	"Solute carrier family 2 member 12"	Q8TD20	6	133987581-134052624	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 87.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 24.8;Oligodendrocytes: 14.5;Syncytiotrophoblasts: 36.7"	"Cancer enriched"	"Detected in many"	6	"prostate cancer: 18.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 7.6;hTERT-RPE1: 14.8;SuSa: 21.7;U-2 OS: 7.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA031593, HPA031594"	Approved		Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 12: NES - Nervous system development"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"	"Cell Junctions"	"HPA031593: AB_10600810, HPA031594: AB_2673948"	"unprognostic (2.06e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.69e-2)"	"unprognostic (5.55e-3)"	"unprognostic (2.18e-1)"	"unprognostic (6.02e-2)"	"unprognostic (2.24e-3)"	"unprognostic (2.54e-2)"	"unprognostic (2.08e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.83e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.55e-3)"	0.5	1.0	3.6	0.3	4.8	0.0	1.1	7.8	4.6	3.0	87.3	2.1	7.3	8.2	2.1	6.1	2.8	2.6	10.7	5.7	2.6	5.8	6.8	3.1	0.1	2.3	3.1	1.2	1.1	2.3	1.4	1.6	2.5	22.4	1.0	2.3	5.1	9.3	3.8	2.7	9.8	3.1	1.6	0.1	14.3	0.4	3.4	1.0	0.2	4.1	1.2	3.5	1.2	3.1	2.5	0.9	2.3	0.0	1.4	0.7	0.1	1.5	5.4	0.7	2.9	0.0	7.6	0.3	1.2	0.1	5.7	5.9	0.0	0.5	1.0	0.0	5.3	0.0	0.8	0.1	0.2	0.0	0.0	1.0	0.5	0.6	0.1	14.8	0.4	0.4	0.5	0.8	0.1	0.8	0.1	0.1	2.0	0.0	0.5	0.0	1.0	2.2	1.6	0.8	0.2	0.7	0.1	2.1	0.0	21.7	0.1	0.0	0.1	0.2	7.6	0.2	0.9	3.2	2.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	3.6	4.8	7.8	4.6	5.7	2.6	2.3	3.1	2.5	1.6	3.4	3.1	0.2	0.0	7.7	24.8	0.1	2.0	1.0	3.3	8.6	0.4	0.5	2.2	6.3	0.0	2.2	0.0	0.0	2.0	0.1	1.2	3.9	1.5	0.1	3.4	0.4	2.3	4.2	0.0	8.0	0.2	0.6	2.2	2.6	1.6	0.0	0.4	0.0	1.1	0.3	0.0	3.2	0.2	6.1	0.0	0.3	0.0	0.0	0.1	0.0	4.7	0.1	9.8	0.0	4.5	14.5	1.1	2.4	1.5	1.6	10.5	0.5	0.5	10.4	0.5	0.0	2.1	1.3	0.0	0.0	8.6	1.8	36.7	0.2	3.5	0.4	1.3
SLC2A13	HMIT	ENSG00000151229	"Solute carrier family 2 member 13"	Q96QE2	12	39755025-40106089	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"parathyroid gland: 22.6"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 506.5;Inhibitory neurons: 465.0;Oligodendrocyte precursor cells: 351.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 18.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006584, HPA061679"	Enhanced		Approved	"Nuclear membrane"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 18: U-2197 - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nuclear membrane"		"HPA006584: AB_1849755, HPA061679: "	"unprognostic (1.66e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.04e-1)"	"unprognostic (3.31e-1)"	"unprognostic (4.06e-2)"	"unprognostic (1.20e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.65e-1)"	"unprognostic (2.25e-2)"	"unprognostic (2.12e-3)"	"unprognostic (4.07e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.24e-2)"	"unprognostic (9.16e-2)"	3.8	7.2	6.8	3.4	9.6	0.9	2.5	0.0	14.2	12.4	15.6	7.8	6.3	5.8	5.1	3.4	2.6	3.9	5.0	9.7	10.2	10.7	6.4	3.7	1.6	0.2	11.9	2.1	5.1	22.6	4.0	4.7	3.5	2.7	7.0	3.2	4.6	2.2	0.6	1.5	8.5	4.3	0.1	2.2	5.6	1.8	9.8	1.7	1.6	1.4	1.1	3.6	2.9	2.0	0.6	3.6	2.6	1.2	18.0	7.4	5.1	5.7	4.2	2.6	3.3	0.0	1.7	2.2	4.1	4.7	3.5	0.3	1.8	1.8	2.1	1.9	5.1	1.8	9.1	1.3	2.8	5.1	2.8	3.7	1.7	1.2	2.2	1.5	1.2	2.2	0.7	5.7	6.0	0.7	0.7	4.3	2.8	0.0	2.3	0.0	3.9	1.3	4.7	2.3	3.3	3.3	2.3	4.5	1.5	3.9	2.5	4.5	1.0	3.4	1.2	12.4	3.4	4.1	0.1	1.4	6.2	2.9	2.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	6.8	9.6	0.0	14.2	9.7	10.2	0.2	11.9	3.5	0.1	9.8	2.0	6.5	9.6	14.7	31.3	5.4	4.1	1.6	1.2	2.2	5.3	3.7	2.0	4.4	12.8	2.2	9.2	0.0	6.3	3.9	58.3	0.0	5.6	3.8	2.2	7.7	4.6	20.4	5.7	506.5	12.6	2.9	14.3	23.0	1.3	10.2	3.7	11.0	9.1	8.6	92.5	465.0	33.1	4.1	10.8	4.1	3.3	23.0	10.3	16.0	109.6	7.1	2.5	8.2	351.8	14.4	10.5	40.2	7.5	6.4	2.4	28.2	8.3	7.0	1.3	6.6	5.2	6.6	3.3	2.3	3.4	5.3	3.7	6.0	21.0	16.7	2.1
SLC2A14	"GLUT14, SLC2A3P3"	ENSG00000173262	"Solute carrier family 2 member 14"	Q8TDB8	12	7812512-7891148	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Spermatogenesis, Sugar transport, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	12	"testis: 81.3"	"Cell type enriched"	"Detected in many"	5	"Spermatocytes: 65.7"	"Cancer enriched"	"Detected in single"	35	"testis cancer: 7.1"	"Region enhanced"	"Detected in many"		"cerebellum: 4.7"	"Immune cell enhanced"	"Detected in some"		"basophil: 3.7;neutrophil: 3.4"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"BEWO: 18.4;CACO-2: 31.0;SuSa: 35.5"									HPA006539	Supported		Approved	"Plasma membrane"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Plasma membrane"		"HPA006539: AB_1078984"	"unprognostic (2.52e-1)"	"unprognostic (4.74e-3)"	"unprognostic (1.79e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.82e-3)"	"unprognostic (8.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.89e-1)"	"unprognostic (9.91e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.27e-1)"	"unprognostic (8.46e-4)"	"unprognostic (3.92e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.26e-2)"	"unprognostic (1.22e-2)"	0.8	5.7	0.7	0.3	0.9	6.2	0.9	4.7	1.0	0.2	1.8	0.9	0.2	0.2	0.2	1.5	0.4	0.9	0.7	1.5	0.9	0.6	3.0	0.5	0.5	0.2	0.1	2.7	6.6	0.0	0.4	1.1	0.5	1.2	0.5	1.4	0.1	0.1	0.5	0.7	0.5	0.5	0.0	0.3	0.2	81.3	1.3	0.2	0.2	0.1	0.2	1.0	0.3	0.5	0.4	1.5	0.7	0.4	0.3	0.8	18.4	0.2	0.0	0.0	0.5	31.0	0.2	0.1	0.8	0.0	0.3	0.2	0.1	0.0	0.0	0.7	0.2	3.3	1.2	8.1	0.1	2.0	4.5	0.0	0.2	0.2	0.0	0.1	0.0	1.1	3.6	0.8	0.0	0.7	0.4	1.6	3.6	0.1	0.0	0.2	0.1	1.1	0.0	0.5	0.6	0.2	0.5	0.7	0.1	35.5	0.1	2.7	0.5	0.1	3.0	0.5	0.5	3.0	1.3	0.6	0.9	0.1	0.6	3.7	0.4	1.0	0.6	0.1	0.6	0.3	0.5	0.4	0.2	0.3	0.3	0.4	3.4	0.6	0.1	0.2	1.0	0.2	0.7	0.9	4.7	1.0	1.5	0.9	0.2	0.1	0.5	0.0	1.3	0.5	2.1	0.0	1.1	0.0	0.9	0.6	0.0	0.0	0.0	0.1	0.1	0.3	2.4	0.0	0.0	0.0	4.2	0.4	0.5	0.1	0.0	0.0	8.9	0.1	1.3	3.2	0.0	6.9	1.9	1.5	1.5	1.9	0.0	0.2	9.5	6.4	5.3	0.5	0.2	0.0	2.2	0.0	0.0	2.5	12.2	5.4	0.3	1.4	1.8	1.9	0.0	0.1	0.0	0.5	0.4	0.3	5.7	2.6	0.1	0.0	0.1	0.0	0.0	0.5	0.0	0.2	2.7	65.7	3.1	0.0	0.1	0.4	3.6	4.2	0.1	0.0
SLC2A2	GLUT2	ENSG00000163581	"Solute carrier family 2 member 2"	P11168	3	170996347-171026743	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"liver: 836.1"	"Cell type enriched"	"Detected in some"	4	"Hepatocytes: 457.6"	"Cancer enriched"	"Detected in some"	12	"liver cancer: 105.2"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	55	"CACO-2: 7.7;Hep G2: 27.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"CAB010444, HPA028997"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"CAB010444: AB_641068, HPA028997: AB_2672860"			"unprognostic (9.56e-2)"		"unprognostic (1.24e-1)"		"prognostic favorable (2.63e-5)"				"unprognostic (3.10e-1)"		"unprognostic (1.02e-1)"	"unprognostic (2.95e-2)"	"unprognostic (6.31e-2)"			0.0	0.0	0.2	0.0	0.8	0.0	0.0	0.2	0.4	0.0	0.2	0.0	66.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.3	30.8	836.1	0.0	0.0	0.5	0.4	0.0	2.4	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.0	0.0	0.4	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	27.6	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.8	0.2	0.4	0.3	0.3	0.5	0.4	0.8	0.4	0.4	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	90.1	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.2	6.7	0.0	0.0	0.1	0.0	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	457.6	0.0	0.0	0.1	3.0	0.0	10.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	2.5	0.0	0.0	0.0	105.4	63.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	1.8	0.0
SLC2A3	GLUT3	ENSG00000059804	"Solute carrier family 2 member 3"	P11169	12	7919230-7936187	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 427.9"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 362.1;Endothelial cells: 356.2;Extravillous trophoblasts: 382.4;granulocytes: 485.1;Langerhans cells: 710.4;Macrophages: 305.2;T-cells: 328.9"	"Cancer enriched"	"Detected in all"	7	"testis cancer: 107.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	7	"basophil: 166.1;neutrophil: 223.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 223.4"	"Group enriched"	"Detected in many"	5	"BEWO: 1473.1;CACO-2: 1646.2;SuSa: 1119.9"									"CAB002763, HPA006539"	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"CAB002763: , HPA006539: AB_1078984"	"unprognostic (9.20e-2)"	"unprognostic (9.63e-3)"	"prognostic unfavorable (8.58e-4)"	"unprognostic (2.65e-1)"	"unprognostic (5.29e-3)"	"unprognostic (2.16e-3)"	"unprognostic (1.12e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (8.47e-3)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.36e-8)"	"prognostic unfavorable (2.89e-5)"	"unprognostic (1.70e-1)"	"unprognostic (1.14e-2)"	"unprognostic (2.91e-3)"	124.9	19.3	26.3	58.2	28.4	427.9	77.0	26.0	38.3	16.4	26.4	29.6	6.7	20.8	2.0	12.7	27.4	56.1	62.3	33.3	31.6	37.7	28.0	92.8	29.4	28.9	25.6	26.4	11.2	7.9	28.0	102.8	33.0	19.7	12.7	87.3	12.3	5.6	24.1	20.7	15.7	41.5	24.6	45.7	19.8	4.9	31.1	18.4	43.3	10.0	20.8	98.7	26.2	23.3	0.3	7.9	68.5	27.4	25.2	85.9	1473.1	24.7	26.7	23.9	55.9	1646.2	11.0	1.6	0.0	17.1	33.1	0.6	2.4	3.9	43.0	48.4	2.0	96.3	6.5	219.3	67.3	35.0	135.4	36.2	2.8	63.6	28.5	55.8	22.6	7.5	44.8	22.8	21.9	0.1	2.6	38.4	300.9	1.2	0.0	2.1	8.0	1.4	0.1	0.1	0.3	0.6	0.0	2.4	32.8	1119.9	0.0	4.9	23.1	29.7	15.6	57.4	2.5	0.2	68.8	5.2	86.9	15.9	16.6	166.1	19.3	29.7	25.3	2.3	20.2	7.4	16.9	19.5	10.0	7.0	10.8	14.8	223.4	15.6	1.0	0.8	24.9	17.4	26.3	28.4	26.0	38.3	33.3	31.6	28.9	25.6	33.0	24.6	31.1	23.3	362.1	144.2	98.8	5.5	301.0	129.5	3.5	1.7	8.6	33.0	5.1	7.6	21.0	7.2	26.8	3.7	62.6	69.6	112.1	0.2	0.0	0.2	3.1	5.0	84.3	356.2	1.2	13.7	24.4	0.0	382.4	188.9	12.2	4.3	485.1	6.5	96.4	2.4	113.4	5.0	20.8	0.3	0.0	76.4	710.4	3.1	10.2	305.2	183.2	34.7	43.4	28.5	41.2	6.6	5.0	0.7	1.3	7.9	93.2	5.3	0.1	1.4	10.3	70.2	118.3	21.5	187.1	2.4	1.2	4.9	82.0	111.4	328.9	41.7	0.1	4.0
SLC2A4	GLUT4	ENSG00000181856	"Solute carrier family 2 member 4"	P14672	17	7281718-7288257	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Diabetes mellitus, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 98.8;skeletal muscle: 223.6"	"Cell type enriched"	"Detected in many"	4	"Cardiomyocytes: 135.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	4	"Hep G2: 2.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			CAB016544	Enhanced					NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"			"CAB016544: AB_629533"	"unprognostic (2.53e-1)"	"unprognostic (7.40e-3)"	"unprognostic (2.27e-1)"	"unprognostic (8.12e-4)"	"unprognostic (2.40e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.70e-2)"	"unprognostic (1.66e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.83e-2)"	"unprognostic (9.66e-2)"	"unprognostic (2.24e-2)"	"unprognostic (1.34e-3)"	"unprognostic (4.23e-2)"	"unprognostic (3.10e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.07e-2)"	16.9	5.2	1.4	0.2	1.7	1.1	11.2	0.9	1.5	9.2	0.9	53.1	0.8	9.3	1.2	5.9	11.3	0.7	98.8	1.3	1.1	2.6	3.7	2.1	0.2	1.0	1.5	3.2	0.8	3.4	4.4	0.6	1.2	9.9	1.1	0.4	6.3	3.3	223.6	4.1	9.7	4.3	1.0	0.3	11.7	3.3	1.3	0.1	4.5	63.2	0.0	27.0	5.6	1.1	0.0	0.0	0.4	0.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.4	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.6	0.1	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.4	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.4	1.7	0.9	1.5	1.3	1.1	1.0	1.5	1.2	1.0	1.3	1.1	1.7	0.0	0.0	1.0	0.0	1.8	0.9	0.3	2.2	0.1	1.5	1.3	135.2	0.0	0.2	0.0	0.0	0.3	0.0	1.0	7.9	0.1	16.6	0.2	0.1	3.7	0.0	10.7	0.0	0.0	0.0	4.0	0.0	0.1	0.0	0.3	1.8	2.8	0.1	0.0	0.0	0.8	0.0	0.3	0.3	4.8	0.0	0.1	7.2	1.0	0.0	6.0	0.0	0.0	0.0	0.1	1.2	8.6	0.0	0.8	0.8	0.3	0.4	0.4	32.9	7.0	19.8	1.7	2.2	0.5	1.1	1.0	0.1	0.5	1.0	0.7
SLC2A5	GLUT5	ENSG00000142583	"Solute carrier family 2 member 5"	P22732	1	9035106-9088478	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 97.3;intestine: 109.1;skeletal muscle: 78.8;testis: 76.4"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 64.3;Paneth cells: 55.6;Plasma cells: 35.3;Proximal enterocytes: 189.4;Spermatocytes: 83.2"	"Group enriched"	"Detected in many"	6	"glioma: 11.0;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	5	"naive B-cell: 23.3"	"Lineage enriched"	"Detected in many"	5	"B-cells: 23.3"	"Group enriched"	"Detected in some"	5	"Daudi: 190.3;THP-1: 47.8;U-266/70: 154.0;U-698: 178.2;U-937: 68.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA005449, HPA075145"	Enhanced		Enhanced	"Plasma membrane"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA005449: AB_1078985, HPA075145: "	"unprognostic (1.53e-1)"	"unprognostic (1.23e-1)"	"unprognostic (8.00e-3)"	"unprognostic (2.25e-2)"	"unprognostic (6.13e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.47e-2)"	"unprognostic (5.35e-2)"	"unprognostic (4.18e-1)"	"unprognostic (6.85e-2)"	"unprognostic (3.77e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (5.44e-5)"	"unprognostic (8.56e-2)"	"unprognostic (2.07e-1)"	"unprognostic (8.19e-3)"	"unprognostic (8.61e-2)"	7.7	3.4	9.2	5.4	9.2	97.3	5.1	10.5	11.8	2.6	10.1	4.8	109.1	1.3	10.5	3.9	2.6	1.1	2.3	10.3	12.0	38.4	0.6	1.2	20.4	24.1	14.5	2.8	0.6	1.5	2.9	4.9	20.4	15.1	3.6	2.7	2.4	5.1	78.8	6.9	85.3	4.4	14.3	5.6	0.9	76.4	16.1	1.7	0.8	65.9	18.3	3.0	4.2	19.6	0.3	0.1	0.0	0.2	0.2	1.2	0.5	0.2	0.7	0.0	0.6	1.3	0.0	190.3	0.2	0.4	0.1	0.4	1.7	0.1	0.4	25.1	0.2	0.2	3.4	0.0	0.3	3.0	1.6	2.7	2.6	0.6	0.0	2.9	0.0	0.1	0.3	2.0	0.0	0.0	0.1	10.0	0.2	0.0	0.2	4.9	0.0	5.9	0.2	2.0	0.6	0.3	0.3	0.5	0.7	0.1	0.3	47.8	0.2	3.0	0.9	0.5	0.2	154.0	0.2	178.2	0.2	68.2	0.2	4.8	2.5	0.2	0.2	0.5	0.2	4.3	0.2	0.2	0.9	23.3	0.2	0.2	1.4	0.3	0.1	0.2	0.1	1.2	9.2	9.2	10.5	11.8	10.3	12.0	24.1	14.5	20.4	14.3	16.1	19.6	0.3	0.0	0.0	2.0	5.2	2.0	2.0	0.2	10.2	0.0	0.1	0.4	1.9	0.0	0.0	1.8	0.0	0.1	0.0	1.4	7.9	0.3	64.3	0.1	0.3	4.9	1.2	0.0	1.0	0.0	1.1	0.8	0.0	0.4	1.3	0.1	0.4	0.1	4.3	0.0	1.2	7.6	0.0	0.8	1.2	19.3	2.8	2.7	0.0	31.9	0.6	0.6	0.0	2.5	0.9	0.6	55.6	0.4	35.3	2.1	189.4	24.2	0.0	0.1	6.6	2.1	0.4	83.2	8.2	2.7	0.6	0.5	0.3	0.3	8.0	0.2
SLC2A6	"GLUT6, GLUT9, HSA011372"	ENSG00000160326	"Solute carrier family 2 member 6"	Q9UGQ3	9	133471094-133479127	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 11.9;lymphoid tissue: 13.3"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 52.1;granulocytes: 47.4;monocytes: 60.4;Paneth cells: 39.8;Rod photoreceptor cells: 46.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"non-classical monocyte: 73.2"	"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 33.1;HMC-1: 67.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042272, CAB046014"	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"			"CAB046014: AB_2270444, HPA042272: AB_2677924"	"unprognostic (2.12e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.87e-3)"	"unprognostic (1.71e-3)"	"prognostic unfavorable (1.39e-4)"	"unprognostic (1.18e-1)"	"prognostic unfavorable (8.82e-4)"	"unprognostic (1.26e-1)"	"unprognostic (2.23e-1)"	"unprognostic (5.93e-2)"	"unprognostic (1.05e-2)"	"unprognostic (2.49e-1)"	"prognostic unfavorable (1.02e-11)"	"unprognostic (7.24e-2)"	"unprognostic (3.43e-2)"	"unprognostic (9.36e-2)"	"unprognostic (6.28e-3)"	4.0	3.8	5.9	4.6	5.7	4.3	2.9	6.6	9.2	1.3	2.5	2.4	0.9	2.5	0.7	1.1	1.5	0.8	4.7	5.7	7.4	3.9	3.5	8.4	4.1	11.9	7.1	0.9	2.7	0.5	2.3	0.7	11.9	1.9	0.4	0.6	1.5	0.4	1.1	1.0	6.7	0.9	4.7	13.3	2.5	1.6	8.1	0.5	1.8	0.3	2.3	4.5	1.4	6.1	5.7	9.6	3.2	9.4	1.8	2.7	2.8	5.2	8.5	4.9	5.2	4.3	7.5	4.5	14.0	4.8	23.3	8.3	2.0	5.7	1.1	33.1	1.9	5.5	6.8	5.2	6.3	0.1	67.8	3.7	0.9	7.2	0.8	0.3	5.0	5.3	0.8	4.3	3.4	12.4	2.9	5.3	4.8	2.2	12.0	2.3	5.8	23.3	6.8	14.5	4.0	5.5	8.2	3.9	2.6	1.7	14.9	2.4	13.9	12.3	5.0	14.0	4.2	2.4	2.0	6.3	3.2	1.3	2.8	46.3	18.2	1.8	1.6	36.9	1.1	9.3	0.3	1.1	16.3	8.8	0.5	1.3	0.9	1.2	73.2	17.3	0.2	9.3	5.9	5.7	6.6	9.2	5.7	7.4	11.9	7.1	11.9	4.7	8.1	6.1	6.2	3.2	4.1	9.1	24.6	0.4	1.2	17.3	0.6	25.9	1.1	0.1	1.8	5.7	6.2	3.7	52.1	0.4	31.3	2.8	0.0	36.0	6.0	1.2	1.1	9.6	3.6	0.4	21.7	8.9	0.7	2.6	5.1	1.9	47.4	1.2	2.5	0.6	4.5	23.5	15.6	2.4	2.0	15.6	10.3	2.4	0.9	30.6	3.6	1.9	60.4	5.6	4.1	3.5	6.9	21.5	39.8	0.0	10.8	1.0	1.9	0.3	3.3	46.0	32.9	3.8	7.6	2.2	6.8	0.2	0.4	0.3	5.5	5.2	2.3	0.6
SLC2A7	GLUT7	ENSG00000197241	"Solute carrier family 2 member 7"	Q6PXP3	1	9003300-9026345	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	11	"intestine: 3.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 1.6;Microglial cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA039931	Uncertain					NA	NA				"Cluster 56: Intestine - Transmembrane transport"		"Cluster 45: Enterocytes - Digestion"			"HPA039931: AB_10671046"	"unprognostic (4.19e-2)"	"unprognostic (3.68e-1)"				"unprognostic (1.96e-2)"		"unprognostic (2.20e-1)"		"unprognostic (1.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (9.05e-2)"	"unprognostic (5.69e-4)"	"unprognostic (5.09e-2)"	"unprognostic (7.12e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.35e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0
SLC2A8	"GLUT8, GLUTX1"	ENSG00000136856	"Solute carrier family 2 member 8"	Q9NY64	9	127397138-127408424	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 145.8;Endometrial stromal cells: 86.5;Late spermatids: 310.1;Spermatocytes: 98.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"plasmacytoid DC: 75.9"	"Lineage enriched"	"Detected in all"	5	"dendritic cells: 75.9"	"Cell line enhanced"	"Detected in many"		"CACO-2: 122.9;Hep G2: 73.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011935	Uncertain		Approved	Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 25: Spermatids - Spermatogenesis"	Vesicles		"HPA011935: AB_1849760"	"unprognostic (6.49e-2)"	"prognostic favorable (2.57e-6)"	"unprognostic (9.13e-2)"	"unprognostic (1.85e-3)"	"unprognostic (4.23e-2)"	"unprognostic (9.43e-3)"	"unprognostic (2.62e-1)"	"unprognostic (1.30e-1)"	"unprognostic (6.33e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (9.86e-6)"	"unprognostic (1.70e-1)"	"prognostic favorable (6.55e-6)"	"unprognostic (4.25e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.59e-3)"	"unprognostic (2.04e-3)"	17.3	46.9	23.0	7.5	24.8	3.4	13.1	22.5	22.7	19.7	14.6	42.1	15.7	16.5	13.4	12.0	11.1	6.4	18.2	20.9	18.4	15.4	41.0	11.5	7.4	23.6	23.3	12.0	12.4	6.3	9.9	11.6	20.9	17.8	5.3	3.1	10.2	11.6	33.1	14.2	15.5	6.0	23.5	16.7	23.1	64.2	22.8	1.6	14.8	12.7	3.6	60.6	12.8	25.5	4.9	18.8	8.4	18.5	0.0	0.0	26.3	7.4	4.9	11.5	6.9	122.9	4.5	7.5	16.3	3.9	18.4	25.4	10.1	11.7	2.9	7.2	16.2	1.1	15.4	73.3	10.5	0.0	7.8	0.2	10.6	1.1	4.7	5.7	9.0	10.2	8.1	16.4	4.7	35.1	0.0	0.2	13.4	27.1	29.4	2.9	11.5	20.7	11.0	50.6	13.8	9.6	17.6	29.8	6.6	10.6	19.2	4.3	7.9	0.0	11.7	0.8	16.7	49.7	50.6	11.3	7.8	0.0	8.9	0.0	7.0	16.6	10.4	13.5	7.7	5.0	3.3	7.1	10.6	4.7	0.7	2.5	0.5	3.3	12.5	75.9	15.0	4.7	23.0	24.8	22.5	22.7	20.9	18.4	23.6	23.3	20.9	23.5	22.8	25.5	10.8	9.6	8.4	6.2	6.4	11.1	7.4	8.5	9.6	9.5	12.2	10.7	7.6	8.6	7.8	5.5	10.4	78.3	24.5	12.5	15.6	15.6	145.8	6.0	86.5	10.2	12.1	7.0	7.7	16.7	12.8	11.0	10.7	8.0	7.0	15.9	12.1	26.8	75.0	6.7	7.7	14.9	2.0	16.7	8.5	310.1	10.8	14.9	26.6	2.8	7.2	13.4	13.4	2.0	5.4	17.4	22.3	11.7	8.5	14.1	35.0	14.0	5.3	8.4	13.1	11.6	8.6	98.7	15.5	8.7	10.5	67.3	5.9	9.3	19.8	5.8
SLC2A9	"Glut9, GLUTX, URATv1"	ENSG00000109667	"Solute carrier family 2 member 9"	Q9NRM0	4	9771153-10054936	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 29.3;liver: 21.4"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 27.4;Proximal tubular cells: 72.6"	"Cancer enhanced"	"Detected in many"		"renal cancer: 6.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 36.9;myeloid DC: 30.5"	"Group enriched"	"Detected in many"	30	"dendritic cells: 30.5;monocytes: 36.9"	"Cell line enhanced"	"Detected in some"		"HBEC3-KT: 48.1;Hep G2: 23.6;hTCEpi: 19.9;THP-1: 20.5;U-937: 13.5"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA066229, HPA075669"	Enhanced					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA066229: AB_2685639, HPA075669: "	"unprognostic (3.21e-1)"	"unprognostic (8.99e-3)"	"unprognostic (1.25e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.14e-2)"	"unprognostic (2.56e-2)"	"unprognostic (8.94e-2)"	"unprognostic (6.94e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.28e-2)"	"unprognostic (3.16e-1)"	"unprognostic (2.23e-1)"	"prognostic favorable (1.32e-11)"	"unprognostic (1.01e-1)"	"unprognostic (3.88e-2)"	"unprognostic (3.17e-3)"	"unprognostic (1.20e-1)"	1.6	2.6	1.0	2.0	1.2	2.1	4.2	1.3	1.2	2.5	2.7	1.8	10.7	1.4	2.4	5.2	3.5	2.4	2.3	1.1	1.6	29.3	21.4	4.2	2.0	2.3	1.5	1.6	1.0	2.4	1.4	7.6	2.0	3.5	1.6	1.2	16.6	18.8	0.5	2.2	8.4	2.0	1.8	1.8	1.0	0.7	2.0	4.2	2.7	0.5	1.4	6.4	4.0	3.0	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.6	0.3	0.1	0.0	0.3	2.4	0.0	3.5	0.7	0.0	7.3	0.0	48.1	0.0	8.2	0.3	0.0	0.0	23.6	1.6	0.1	6.3	3.4	19.9	0.0	4.8	0.0	0.1	0.8	0.0	0.1	0.1	0.0	0.3	2.4	0.0	0.4	0.1	1.5	0.0	0.0	0.2	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.5	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	13.5	0.1	0.0	36.9	0.9	0.3	7.6	0.3	0.3	0.3	0.1	30.5	0.1	0.2	0.1	1.1	0.2	0.9	12.2	0.2	9.1	1.0	1.2	1.3	1.2	1.1	1.6	2.3	1.5	2.0	1.8	2.0	3.0	1.4	0.0	0.0	8.1	1.3	0.9	13.4	27.4	6.2	0.0	4.6	6.1	2.4	0.0	5.7	3.7	2.1	18.7	0.5	1.7	3.9	0.5	5.1	4.1	2.1	1.5	0.0	1.3	4.4	1.1	1.8	1.6	1.1	11.5	1.3	0.5	2.2	5.2	10.3	0.0	5.6	0.9	10.2	8.7	3.7	3.4	0.0	8.8	0.0	15.9	4.4	1.2	1.0	10.6	1.1	0.6	0.5	0.4	0.3	2.0	8.1	72.6	3.0	0.4	0.0	4.6	1.6	1.1	1.9	5.4	0.6	8.5	0.9	0.7	2.5	7.7
SLC30A1	"ZNT1, ZRC1"	ENSG00000170385	"Solute carrier family 30 member 1"	Q9Y6M5	1	211571568-211579161	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 86.1"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 94.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015275, HPA049000"	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	Vesicles	"HPA015275: AB_1857083, HPA049000: AB_2680593"	"unprognostic (1.13e-1)"	"unprognostic (2.67e-3)"	"unprognostic (6.94e-2)"	"unprognostic (1.81e-3)"	"unprognostic (3.47e-1)"	"unprognostic (1.80e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.82e-3)"	"unprognostic (4.72e-1)"	"unprognostic (1.01e-1)"	"unprognostic (1.42e-3)"	"unprognostic (4.78e-2)"	"unprognostic (2.23e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.02e-1)"	"unprognostic (4.53e-2)"	14.8	18.0	15.7	10.9	17.0	29.8	8.5	15.2	19.3	18.6	27.8	15.4	28.2	10.8	9.9	8.0	12.5	12.4	10.0	16.9	15.4	20.5	86.1	7.2	6.1	17.9	17.3	7.8	11.3	10.3	4.6	10.1	16.8	7.8	13.6	6.1	9.3	7.9	1.8	16.0	19.9	11.6	16.7	15.4	9.5	13.4	18.9	4.5	16.9	4.8	7.1	12.2	7.5	13.2	10.3	15.0	7.7	9.9	32.4	14.9	70.5	27.3	19.3	13.8	13.6	6.4	46.6	5.8	24.1	24.4	19.3	17.2	11.5	15.4	16.4	15.0	9.3	4.7	28.8	14.7	18.1	15.8	10.0	22.5	37.5	17.7	28.4	20.5	8.6	3.4	18.7	25.5	17.2	9.1	3.2	9.9	24.2	10.6	12.0	10.0	3.7	20.4	42.5	26.4	7.8	13.7	26.7	13.6	62.7	14.2	7.0	20.2	14.6	10.4	24.8	35.4	22.1	11.9	19.0	4.5	9.8	15.7	9.3	1.4	1.3	0.5	0.4	1.5	0.5	0.2	0.3	0.2	0.9	0.1	0.3	0.4	0.1	0.4	1.2	0.5	0.3	0.4	15.7	17.0	15.2	19.3	16.9	15.4	17.9	17.3	16.8	16.7	18.9	13.2	29.7	9.6	9.8	3.9	8.8	28.6	8.2	3.0	16.5	11.0	24.9	14.7	21.0	18.6	4.2	36.8	6.2	11.6	19.9	54.5	1.9	6.9	44.0	37.0	19.1	27.3	9.5	26.1	0.6	12.5	32.7	15.9	8.6	66.4	5.1	7.5	17.9	94.9	32.0	6.7	0.6	22.8	2.0	27.2	14.5	6.8	9.9	25.5	21.4	3.7	18.8	29.0	1.0	1.0	0.1	9.5	41.7	7.5	8.6	13.9	49.2	29.8	6.4	9.4	6.6	15.9	11.7	37.9	17.4	24.2	46.2	24.5	14.2	14.8	23.3	13.7
SLC30A10	"DKFZp547M236, ZnT-10, ZNT8, ZRC1"	ENSG00000196660	"Solute carrier family 30 member 10"	Q6XR72	1	219685427-219958647	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 23.9;liver: 33.5"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 20.2;Distal enterocytes: 44.3;Early spermatids: 38.3;Hepatocytes: 21.1;Late spermatids: 36.1;Paneth cells: 14.4;Proximal enterocytes: 13.6"	"Cancer enriched"	"Detected in some"	14	"liver cancer: 7.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.0;HEL: 1.5;K-562: 1.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA064547	Enhanced					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 45: Intestine - Brush border"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA064547: AB_2732715"	"unprognostic (7.88e-2)"	"unprognostic (1.07e-2)"	"unprognostic (1.02e-1)"	"unprognostic (7.25e-2)"	"unprognostic (1.75e-2)"	"unprognostic (3.74e-3)"	"unprognostic (6.96e-2)"	"unprognostic (3.72e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.95e-2)"	"unprognostic (5.10e-2)"	"unprognostic (3.10e-3)"	"unprognostic (4.47e-7)"	"unprognostic (3.16e-1)"	"unprognostic (6.11e-2)"	"unprognostic (6.19e-3)"	"unprognostic (5.72e-2)"	0.0	0.0	6.0	0.0	6.1	0.3	0.0	4.4	7.6	0.0	7.4	3.8	23.9	0.0	0.0	0.0	0.0	0.4	0.0	5.9	5.7	0.0	33.5	0.0	0.0	5.4	5.9	0.2	0.0	0.0	0.0	0.0	5.6	0.1	5.0	0.4	0.0	0.0	0.7	0.1	8.9	0.0	4.5	0.0	0.0	0.7	6.5	0.0	0.0	0.0	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	1.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.2	0.1	0.2	0.2	0.2	0.1	0.1	0.1	0.2	0.2	0.2	0.3	0.3	0.3	0.2	0.1	0.1	6.0	6.1	4.4	7.6	5.9	5.7	5.4	5.9	5.6	4.5	6.5	4.7	0.0	0.0	0.0	20.2	0.2	0.3	0.0	0.2	0.0	0.3	0.2	0.0	1.2	1.5	0.1	0.0	0.0	0.1	0.0	44.3	0.0	0.2	38.3	0.0	0.0	1.0	0.0	2.7	4.3	0.0	0.3	0.1	0.0	0.0	0.0	0.5	0.4	21.1	0.1	0.0	4.3	0.6	0.0	0.6	0.3	36.1	1.2	0.0	1.8	9.4	0.0	3.1	0.0	3.0	3.3	0.0	14.4	1.5	0.0	0.0	13.6	0.0	0.0	0.1	0.0	0.0	0.1	1.8	0.9	0.0	0.1	0.3	0.0	1.3	0.8	0.0
SLC30A2	ZNT2	ENSG00000158014	"Solute carrier family 30 member 2"	Q9BRI3	1	26037252-26046118	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"pancreas: 99.8"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 31.0;Endometrial ciliated cells: 30.5;Glandular and luminal cells: 93.7;Proximal tubular cells: 36.2;Syncytiotrophoblasts: 85.1"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 19.5"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 2.1;RPTEC TERT1: 4.5;WM-115: 3.5"	"Region enriched"	"Detected in single"	5	"olfactory bulb: 1.2"	"Not detected"	"Not detected"			HPA017979			Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA017979: AB_1857085"	"unprognostic (4.87e-2)"	"unprognostic (6.70e-2)"	"unprognostic (3.79e-2)"	"unprognostic (1.79e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-2)"	"unprognostic (2.25e-2)"	"unprognostic (2.59e-1)"	"unprognostic (3.67e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.99e-2)"	"unprognostic (1.10e-1)"	"prognostic favorable (2.86e-6)"	"unprognostic (9.38e-2)"	"unprognostic (3.50e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.01e-2)"	0.1	1.2	0.4	0.3	0.5	0.6	1.1	1.9	1.0	0.2	0.3	0.5	0.5	0.5	0.3	0.1	0.4	6.7	6.3	0.4	0.3	20.2	0.1	0.2	0.2	0.2	0.0	0.1	99.8	2.2	0.0	4.5	0.1	0.2	0.1	0.5	1.6	2.3	3.8	1.0	0.8	0.1	0.0	0.3	0.3	0.2	0.6	0.0	19.8	0.7	0.1	0.5	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.0	2.1	0.1	0.1	0.0	0.0	0.3	0.4	0.1	0.4	0.0	0.1	0.3	0.1	0.2	0.0	0.3	0.1	0.2	0.2	0.0	0.0	0.3	0.2	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.3	0.7	0.0	0.3	0.2	0.3	0.3	0.2	0.0	0.1	0.3	0.3	4.5	0.1	0.4	0.1	0.3	0.5	0.1	0.7	0.3	0.1	0.2	0.2	0.5	0.2	0.1	0.3	0.2	0.3	0.2	0.2	3.5	0.9	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.2	0.1	0.1	0.6	0.3	0.1	0.2	0.1	0.0	0.4	0.5	1.9	1.0	0.4	0.3	0.2	0.0	0.1	0.0	0.6	0.2	0.2	3.2	3.0	0.0	0.6	0.4	0.7	0.0	0.0	4.5	9.1	0.4	13.9	8.6	0.0	9.2	0.0	31.0	0.1	0.5	5.9	11.5	0.0	30.5	9.7	1.0	0.0	0.0	0.0	21.1	2.8	0.5	0.0	93.7	4.5	0.1	0.0	0.0	3.6	0.0	0.0	0.4	0.0	0.0	0.8	0.0	0.3	0.9	3.6	0.0	1.0	0.7	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.6	3.9	36.2	0.0	2.3	6.6	2.1	1.0	0.2	0.4	0.0	0.9	85.1	0.9	0.1	1.1	0.7
SLC30A3	ZNT3	ENSG00000115194	"Solute carrier family 30 member 3"	Q99726	2	27253684-27275817	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 22.2;epididymis: 68.5;testis: 35.2"	"Cell type enhanced"	"Detected in some"		"Cardiomyocytes: 8.4;Early spermatids: 17.8;Excitatory neurons: 15.6;Late spermatids: 42.4;Peritubular cells: 15.1;Spermatocytes: 16.6;Spermatogonia: 10.7"	"Cancer enhanced"	"Detected in some"		"thyroid cancer: 1.3"	"Group enriched"	"Detected in many"	10	"amygdala: 14.5;basal ganglia: 10.3;cerebral cortex: 18.2;hippocampal formation: 22.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 8.8;HAP1: 11.2;Hep G2: 12.0;REH: 22.8;RH-30: 11.0"	"Group enriched"	"Detected in all"	4	"amygdala: 130.7;basal ganglia: 48.2;cerebral cortex: 110.9;hippocampal formation: 69.1;white matter: 34.7"	"Group enriched"	"Detected in many"	6	"amygdala: 18.5;cerebral cortex: 55.5;hippocampal formation: 43.0"	"HPA060505, HPA067637, CAB079044"	Enhanced	Approved	Approved	Nucleoplasm,Nucleoli,Vesicles,Cytosol		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 14: REH - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Nucleoplasm, Nucleoli, Cytosol"	"CAB079044: , HPA060505: AB_2684296, HPA067637: AB_2685875"	"unprognostic (2.05e-4)"	"unprognostic (1.17e-1)"	"unprognostic (6.84e-4)"	"unprognostic (5.26e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.05e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.65e-12)"	"unprognostic (3.23e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.63e-4)"	0.1	2.1	14.5	0.1	10.3	0.3	0.1	0.0	18.2	0.2	0.0	0.1	0.0	0.4	68.5	0.1	0.3	0.1	7.9	22.2	0.0	0.1	0.2	0.2	0.5	0.5	0.0	0.2	0.0	0.5	0.3	0.0	0.8	0.3	0.0	0.2	0.0	0.5	0.1	0.1	0.1	0.1	0.0	0.1	0.1	35.2	0.0	0.0	0.2	0.0	0.1	0.0	0.2	1.5	0.4	1.3	0.1	2.0	0.2	0.2	0.3	0.0	0.0	1.3	1.4	0.5	0.5	0.0	0.1	0.0	8.8	0.3	11.2	0.0	0.3	0.0	1.2	5.9	0.5	12.0	0.2	0.2	2.3	0.0	0.0	0.6	0.0	0.2	0.9	2.9	1.7	0.1	0.2	3.9	0.1	0.4	1.8	0.4	0.0	22.8	11.0	1.4	0.0	0.3	0.0	0.7	2.8	0.0	0.0	0.1	0.0	0.8	0.1	0.3	5.1	0.3	0.2	0.1	0.0	0.0	0.1	0.2	0.2	0.4	0.1	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.3	0.1	0.1	0.1	0.1	0.0	14.5	10.3	0.0	18.2	22.2	0.0	0.5	0.0	0.8	0.0	0.0	1.5	0.3	0.0	0.0	2.0	0.1	0.0	0.2	0.0	0.0	0.0	0.3	0.1	8.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	17.8	0.0	0.1	0.4	0.0	0.0	15.6	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.4	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.4	42.4	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.0	0.0	15.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.3	16.6	10.7	0.0	0.1	0.1	0.1	0.0	0.0	0.0
SLC30A4	ZNT4	ENSG00000104154	"Solute carrier family 30 member 4"	O14863	15	45479606-45522755	"Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"prostate: 39.9"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 76.3;Late spermatids: 78.5;Prostatic glandular cells: 39.2;Spermatocytes: 52.1"	"Cancer enriched"	"Detected in all"	20	"prostate cancer: 34.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.64e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.71e-1)"	"unprognostic (9.49e-2)"	"unprognostic (1.98e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.15e-2)"	"unprognostic (9.74e-2)"	"unprognostic (7.38e-3)"	"unprognostic (1.51e-1)"	"prognostic favorable (6.02e-4)"	"unprognostic (2.66e-2)"	"unprognostic (4.72e-3)"	"unprognostic (1.29e-2)"	"unprognostic (9.83e-2)"	"unprognostic (8.28e-3)"	"unprognostic (2.01e-3)"	2.8	1.8	2.6	1.9	9.3	0.8	1.9	3.1	4.5	2.8	1.5	3.2	7.0	2.9	2.7	4.2	2.0	2.0	1.9	2.7	2.4	4.2	2.5	1.8	2.7	2.2	2.6	2.5	1.8	4.1	1.5	3.4	2.4	39.9	3.1	3.7	1.3	2.2	1.7	2.5	8.5	3.4	2.1	3.0	2.0	6.3	3.8	1.0	4.7	1.9	3.4	1.8	2.5	7.3	1.8	2.1	0.6	4.7	8.3	5.8	0.4	4.5	4.1	2.7	3.8	0.3	1.5	6.9	1.5	4.7	1.1	1.2	2.0	2.1	2.5	1.7	1.8	0.1	2.0	0.1	5.3	0.1	3.5	4.9	3.4	3.6	0.9	4.2	3.2	3.2	1.0	3.8	5.1	0.8	2.4	0.3	0.1	0.4	0.4	3.6	4.0	1.1	2.2	0.4	1.5	2.3	3.0	3.4	0.8	0.6	2.9	0.2	6.1	4.0	2.3	4.9	1.5	7.0	5.5	1.7	1.7	0.2	3.1	1.3	0.1	0.1	2.2	0.1	2.1	2.0	1.5	1.3	0.2	3.5	1.5	2.1	0.5	1.3	0.1	0.2	0.2	0.7	2.6	9.3	3.1	4.5	2.7	2.4	2.2	2.6	2.4	2.1	3.8	7.3	6.7	3.2	3.9	5.5	6.6	6.8	2.2	1.1	6.8	3.2	2.8	2.2	3.1	0.0	0.1	1.8	16.7	1.0	3.9	15.2	0.0	1.3	76.3	5.0	8.4	6.9	1.2	0.4	14.0	1.1	0.9	7.5	4.6	12.7	1.3	1.9	11.0	3.3	3.1	13.5	9.4	7.1	0.0	1.6	30.8	78.5	6.2	4.4	7.2	9.4	5.3	4.3	10.3	6.0	28.8	0.7	22.0	8.2	6.0	39.2	32.4	12.5	0.7	2.2	6.6	6.2	5.2	52.1	19.9	7.4	6.5	0.3	5.4	3.6	5.1	1.7
SLC30A5	"FLJ12496, FLJ12756, MGC5499, ZnT-5, ZNT5, ZNTL1, ZTL1"	ENSG00000145740	"Solute carrier family 30 member 5"	Q8TAD4	5	69093949-69131069	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035373	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA035373: AB_10794630"	"unprognostic (9.81e-3)"	"unprognostic (3.33e-1)"	"unprognostic (2.82e-2)"	"unprognostic (8.16e-2)"	"unprognostic (1.65e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.16e-3)"	"unprognostic (2.47e-2)"	"unprognostic (4.65e-2)"	"unprognostic (5.41e-2)"	"unprognostic (3.57e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.07e-1)"	"unprognostic (2.11e-2)"	"unprognostic (1.40e-1)"	25.8	25.6	9.8	21.0	10.3	19.6	30.3	11.7	15.9	29.7	17.4	26.9	24.7	25.6	38.2	19.3	24.3	24.0	24.1	9.7	10.6	29.1	29.0	21.1	24.7	10.1	11.4	22.3	33.0	35.9	24.0	27.4	10.2	29.4	24.7	18.5	30.8	24.0	16.4	27.1	23.6	22.8	9.7	21.9	26.3	16.4	10.9	20.8	37.5	16.5	23.7	23.6	19.7	12.1	37.4	29.9	26.3	46.2	69.1	53.2	82.5	58.8	53.6	36.4	55.1	26.0	45.7	50.2	70.6	41.4	63.7	38.8	38.6	46.1	61.5	60.2	43.5	55.7	35.0	43.2	55.0	34.8	58.3	35.7	57.1	38.3	46.5	50.1	36.6	34.2	34.9	57.0	46.1	46.9	46.4	71.6	29.4	25.3	33.3	35.5	33.2	89.9	53.6	34.5	46.0	36.8	47.4	45.0	84.5	36.0	43.7	76.2	33.3	23.2	29.5	58.7	58.2	49.5	67.5	37.9	46.6	62.3	58.9	11.9	5.1	8.5	4.1	5.3	4.4	6.9	6.4	6.2	6.3	4.3	5.9	4.8	4.1	4.0	5.5	9.6	4.9	2.8	9.8	10.3	11.7	15.9	9.7	10.6	10.1	11.4	10.2	9.7	10.9	12.1	17.3	19.2	21.5	14.7	26.9	18.7	27.9	27.5	19.9	15.3	28.5	20.6	29.2	18.6	23.2	25.8	22.9	42.0	35.3	19.9	29.4	22.0	6.9	28.8	35.8	19.3	13.2	29.9	29.6	27.1	80.4	24.8	34.7	23.7	41.3	15.4	21.8	19.8	22.3	8.4	30.6	27.9	32.6	17.2	18.4	9.9	24.2	16.8	14.2	19.7	21.2	14.9	15.5	22.1	23.3	19.0	16.7	22.2	51.8	34.7	16.9	21.3	27.7	24.7	26.3	17.5	21.4	11.0	14.9	26.6	21.5	51.6	23.4	20.9	23.2	28.6
SLC30A6	"FLJ31101, ZNT6"	ENSG00000152683	"Solute carrier family 30 member 6"	Q6NXT4	2	32165841-32224379	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA055032, HPA057328"	Uncertain		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 16: U-266 - Nucleosome"	"Cluster 59: Non-specific - Transcription"	"Golgi apparatus"		"HPA055032: AB_2682677, HPA057328: AB_2683411"	"unprognostic (5.61e-2)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-3)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (9.58e-6)"	"unprognostic (2.98e-1)"	"unprognostic (9.47e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.30e-3)"	"unprognostic (7.05e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.51e-1)"	"unprognostic (3.00e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.90e-1)"	10.3	8.9	4.0	8.5	4.8	4.2	10.1	5.2	4.8	10.1	5.1	10.0	8.6	9.2	7.5	8.8	8.0	9.0	7.6	4.0	4.5	11.7	11.2	8.4	9.8	5.0	4.4	9.0	10.4	11.3	4.3	12.1	4.9	8.8	10.0	6.0	7.7	7.8	7.8	8.0	8.4	9.4	4.8	7.8	9.2	6.2	4.4	9.4	11.8	7.6	10.3	9.9	5.6	6.2	27.7	20.3	20.5	18.0	25.4	22.6	22.7	25.3	25.0	20.4	18.5	15.8	25.4	13.1	16.4	20.4	23.4	17.0	24.7	17.4	25.8	26.6	13.7	28.6	10.9	20.3	16.3	30.4	16.9	17.0	26.7	27.4	21.8	20.7	16.6	9.2	24.6	17.2	23.6	10.2	16.1	13.9	31.0	30.8	10.6	14.2	24.7	19.3	22.5	23.9	15.3	23.3	19.9	21.2	20.4	19.0	11.7	13.6	14.3	25.9	14.3	17.2	30.3	23.1	43.5	19.2	23.0	23.4	26.6	12.8	2.4	1.9	2.5	2.0	3.5	3.0	2.3	2.8	2.9	2.7	3.4	3.2	2.4	7.0	2.3	2.0	4.6	2.0	4.0	4.8	5.2	4.8	4.0	4.5	5.0	4.4	4.9	4.8	4.4	6.2	8.6	9.6	9.9	19.9	14.9	9.1	5.3	14.9	13.6	4.5	9.0	5.7	4.1	8.6	8.3	7.3	6.2	19.8	8.4	9.5	5.9	7.5	2.8	7.4	10.1	10.9	3.6	13.2	29.2	8.7	14.7	9.5	11.7	10.5	3.8	12.9	11.4	15.3	10.7	1.7	31.0	7.9	14.2	8.8	9.3	1.0	6.5	6.6	8.8	10.3	7.7	7.5	12.3	27.2	37.2	9.8	7.0	7.9	20.0	8.7	9.1	8.3	10.0	7.1	13.1	7.3	7.3	12.3	9.4	13.6	6.3	27.5	9.5	9.0	9.0	5.2
SLC30A7	"ZNT7, ZnTL2"	ENSG00000162695	"Solute carrier family 30 member 7"	Q8NEW0	1	100896076-100981757	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018034	Uncertain		Supported	"Golgi apparatus"		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 18: U-2197 - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA018034: AB_1857089"	"unprognostic (1.94e-1)"	"unprognostic (1.08e-1)"	"unprognostic (8.05e-3)"	"unprognostic (1.79e-1)"	"unprognostic (2.50e-1)"	"unprognostic (3.18e-1)"	"unprognostic (2.89e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.78e-2)"	"unprognostic (1.95e-1)"	"unprognostic (5.46e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.46e-1)"	"unprognostic (2.25e-1)"	"unprognostic (3.37e-1)"	6.8	6.8	2.5	7.2	3.0	6.7	6.5	3.7	3.5	7.2	6.6	5.9	6.6	4.7	7.8	5.0	4.6	6.7	4.2	2.5	3.0	5.3	10.2	9.3	7.5	2.9	3.1	4.5	8.0	6.8	5.7	8.7	3.0	5.9	7.1	4.7	8.6	3.6	2.6	6.1	6.1	4.4	2.7	7.1	7.6	3.0	3.2	7.0	6.9	2.1	7.0	7.8	5.3	3.9	11.3	5.2	6.1	12.5	16.5	14.9	16.2	8.5	17.0	7.3	9.4	5.3	7.7	5.0	17.2	14.1	4.9	10.7	6.5	11.1	12.7	6.4	4.7	8.5	8.4	11.4	19.5	11.7	7.6	17.3	8.4	12.9	18.9	10.9	15.3	8.4	4.9	15.9	12.5	4.4	9.4	8.1	7.7	5.6	5.5	4.2	10.8	5.8	10.6	10.0	3.3	7.4	11.4	15.8	12.2	5.3	6.7	8.1	17.9	18.2	6.3	19.9	13.7	14.0	5.7	4.6	23.1	11.1	5.7	8.3	5.8	4.2	5.2	6.6	4.9	2.7	5.3	4.8	3.9	2.5	5.5	5.7	2.7	3.5	8.7	3.9	4.3	3.1	2.5	3.0	3.7	3.5	2.5	3.0	2.9	3.1	3.0	2.7	3.2	3.9	28.3	32.1	21.6	32.3	26.3	57.4	19.7	22.8	21.1	10.1	25.8	13.2	6.1	20.0	22.1	23.9	6.2	32.6	24.5	24.1	1.9	24.1	0.9	14.9	27.0	34.5	22.8	11.6	44.8	26.4	24.3	29.1	29.0	29.4	37.4	16.3	33.5	44.6	22.1	5.0	39.6	38.3	14.2	37.0	39.1	1.1	17.1	28.5	32.0	34.7	29.6	6.5	28.8	52.8	59.2	36.0	27.9	16.6	48.1	46.0	20.7	15.7	23.5	13.7	6.6	30.2	20.9	11.4	9.2	19.3	63.9	41.7	28.8	34.8	24.3	32.7
SLC30A8	"ZnT-8, ZNT8"	ENSG00000164756	"Solute carrier family 30 member 8"	Q8IWU4	8	116950273-117176714	"Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"pancreas: 61.8"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 4.9;Late spermatids: 7.5;Pancreatic endocrine cells: 5.0;Proximal tubular cells: 3.6;Spermatogonia: 5.0"	"Group enriched"	"Detected in some"	28	"breast cancer: 10.6;pancreatic cancer: 15.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	36	"U-266/70: 48.0;U-266/84: 36.2"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in some"		"hippocampal formation: 4.1"	HPA076165	Enhanced					NA	NA				"Cluster 25: Pancreas - Digestion"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA076165: AB_2732304"	"unprognostic (2.14e-2)"		"unprognostic (1.48e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.41e-1)"	"unprognostic (5.38e-2)"		"unprognostic (5.57e-2)"	"unprognostic (4.38e-1)"	"unprognostic (3.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.66e-2)"	"unprognostic (6.51e-3)"	"unprognostic (2.15e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.99e-1)"	"unprognostic (9.16e-3)"	0.0	0.0	0.3	0.0	0.4	0.3	0.6	0.2	0.2	0.1	0.0	0.3	0.6	0.7	0.0	0.2	0.1	0.2	0.2	0.3	0.2	4.3	0.0	0.1	0.1	0.2	0.1	0.0	61.8	0.3	0.3	0.3	0.3	0.1	0.2	0.2	12.9	0.0	0.0	0.8	1.0	0.2	0.0	0.0	1.1	2.0	0.1	0.1	0.1	0.0	0.1	0.5	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	48.0	36.2	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.2	0.2	0.3	0.2	0.2	0.1	0.3	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.1	4.9	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	2.0	0.9	5.0	0.0	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	1.8	5.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SLC30A9	"C4orf1, GAC63, HUEL, ZNT9"	ENSG00000014824	"Solute carrier family 30 member 9"	Q6PML9	4	41990502-42090461	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transcription, Transcription regulation, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004014	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 39: Non-specific - Basic cellular processes"			"HPA004014: AB_1080005"	"unprognostic (4.26e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.31e-3)"	"unprognostic (1.44e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.01e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.63e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.55e-1)"	"unprognostic (6.99e-2)"	"prognostic favorable (2.86e-14)"	"unprognostic (4.67e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.39e-2)"	8.8	15.4	11.4	6.9	12.4	5.8	13.8	12.0	16.1	11.8	12.2	13.4	12.6	10.3	16.0	9.3	9.9	8.6	21.1	12.8	11.9	30.5	14.2	8.9	7.4	11.1	11.3	11.1	12.9	22.7	14.6	9.4	11.6	13.6	13.9	19.8	12.2	10.0	14.7	9.6	11.6	8.5	10.9	7.9	12.9	6.8	11.5	9.1	17.3	20.5	7.8	9.5	8.0	11.7	12.7	6.2	20.3	23.2	15.3	21.3	11.4	17.3	20.8	14.8	17.5	6.4	16.2	13.0	12.2	20.0	19.1	6.3	17.3	14.3	21.1	4.4	10.2	14.9	10.7	10.9	27.1	20.8	10.3	17.0	14.4	12.7	16.5	23.8	16.3	12.9	20.4	6.0	26.2	6.1	12.0	19.6	15.6	19.7	8.5	5.9	18.4	10.8	30.2	10.6	22.5	25.3	12.3	13.5	15.9	14.3	17.2	15.5	17.7	17.4	10.1	17.6	20.3	11.9	9.5	12.3	23.8	17.4	15.5	3.1	1.8	1.0	1.2	2.3	1.3	1.3	1.3	1.5	2.5	1.1	1.7	1.4	0.8	2.1	1.9	1.8	1.6	1.4	11.4	12.4	12.0	16.1	12.8	11.9	11.1	11.3	11.6	10.9	11.5	11.7	19.7	48.1	44.5	48.3	26.5	15.2	22.8	24.7	24.5	34.9	30.3	16.9	90.7	32.9	33.8	38.6	25.0	44.4	11.4	33.8	103.7	35.9	7.1	27.3	29.2	22.1	33.5	32.2	70.0	36.4	34.0	27.7	37.8	26.8	34.2	33.3	21.4	25.4	24.2	50.5	74.7	36.7	30.5	22.2	21.1	8.7	20.8	23.8	24.9	43.1	28.0	29.7	9.2	63.3	84.7	34.3	17.4	22.6	35.8	27.1	25.5	111.7	43.6	39.3	6.6	29.3	28.1	16.1	18.0	40.8	22.7	49.4	21.2	44.8	38.3	24.2
SLC31A1	"COPT1, CTR1, hCTR1"	ENSG00000136868	"Solute carrier family 31 member 1"	O15431	9	113221544-113264492	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 107.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 97.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"classical monocyte: 20.9;intermediate monocyte: 26.8;myeloid DC: 16.3;neutrophil: 8.2;non-classical monocyte: 31.0"	"Group enriched"	"Detected in all"	4	"dendritic cells: 16.3;granulocytes: 8.2;monocytes: 31.0"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013810	Approved					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"			"HPA013810: AB_1857095"	"unprognostic (1.22e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.29e-2)"	"unprognostic (5.48e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.07e-1)"	"unprognostic (6.99e-3)"	"unprognostic (7.58e-2)"	"unprognostic (2.30e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.18e-2)"	"unprognostic (3.61e-1)"	"prognostic favorable (2.20e-6)"	"unprognostic (1.22e-2)"	"unprognostic (2.18e-2)"	"prognostic unfavorable (2.03e-4)"	"unprognostic (2.51e-2)"	11.5	23.9	5.7	11.1	5.8	11.7	12.7	6.6	6.5	20.7	26.3	16.3	45.1	7.2	13.7	12.0	6.5	9.6	7.4	6.9	6.6	28.7	107.6	17.7	6.3	7.2	6.9	4.9	19.1	15.2	5.8	13.5	11.7	21.3	17.0	7.1	66.5	12.8	3.5	18.5	37.4	10.0	6.8	7.6	19.4	6.4	7.0	5.5	10.9	5.8	12.4	14.3	6.5	6.5	22.1	23.4	18.7	41.4	42.0	29.8	68.8	38.3	58.0	26.0	30.1	33.5	18.8	17.2	15.2	33.0	32.9	53.3	35.8	21.8	29.0	15.2	19.9	14.2	18.7	37.6	102.3	26.1	20.6	36.1	48.3	33.6	54.6	17.4	24.0	19.6	32.8	30.9	24.8	23.6	17.9	13.2	30.4	84.2	26.0	18.3	49.1	17.2	23.6	27.2	17.7	23.1	37.0	73.0	101.5	26.2	37.2	22.0	22.3	19.3	11.9	39.1	23.2	18.5	40.5	23.6	31.9	24.2	23.1	3.0	20.9	2.5	2.3	26.8	3.2	1.7	1.6	2.4	16.3	1.5	1.8	1.7	8.2	4.4	31.0	2.3	1.8	7.6	5.7	5.8	6.6	6.5	6.9	6.6	7.2	6.9	11.7	6.8	7.0	6.5	8.0	35.3	33.5	7.5	6.6	15.2	10.6	27.4	10.2	12.6	21.4	14.9	7.4	21.5	50.8	5.5	33.3	16.5	6.9	40.2	9.8	18.3	0.3	16.2	15.6	11.6	9.0	25.4	16.8	27.2	24.1	16.0	15.3	14.5	5.1	11.4	11.4	97.1	43.4	6.7	17.0	18.9	42.7	39.4	19.9	0.9	6.2	40.3	12.4	20.6	21.8	12.2	4.1	16.1	12.3	22.3	11.1	7.2	16.1	28.9	61.7	24.7	30.1	11.2	6.6	8.4	15.2	24.4	30.7	15.1	15.8	22.4	5.5	15.2	19.9	22.6
SLC31A2	"COPT2, CTR2, hCTR2"	ENSG00000136867	"Solute carrier family 31 member 2"	O15432	9	113150976-113164140	"Predicted membrane proteins, Transporters"	"Copper transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"parathyroid gland: 571.4;salivary gland: 409.1"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 96.4;Kupffer cells: 145.6;Macrophages: 101.3;monocytes: 84.1;Oligodendrocytes: 113.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	12	"classical monocyte: 226.0;intermediate monocyte: 331.9;myeloid DC: 134.6;neutrophil: 355.8;non-classical monocyte: 423.3"	"Group enriched"	"Detected in all"	47	"dendritic cells: 134.6;granulocytes: 355.8;monocytes: 423.3"	"Cell line enhanced"	"Detected in many"		"ASC diff: 54.4;hTCEpi: 85.0;hTERT-HME1: 57.7;LHCN-M2: 68.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014861	Approved		Approved	"Nuclear speckles,Plasma membrane,Intermediate filaments"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 41: Macrophages - Immune response"	"Nuclear speckles"	"Plasma membrane, Intermediate filaments"	"HPA014861: AB_1857098"	"unprognostic (2.26e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.79e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.81e-3)"	"unprognostic (5.63e-2)"	"unprognostic (3.31e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.86e-1)"	"unprognostic (6.05e-3)"	"unprognostic (1.76e-1)"	"unprognostic (3.56e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.89e-2)"	48.2	16.7	45.0	18.4	72.6	20.1	24.4	68.2	77.8	7.3	34.2	11.3	10.8	4.4	16.7	9.3	6.9	8.6	10.3	45.1	54.0	27.8	33.4	27.4	16.1	76.6	65.8	5.1	19.2	571.4	2.5	23.6	71.4	4.4	12.1	0.8	409.1	42.6	16.7	48.2	17.2	10.8	61.5	32.7	11.8	13.8	61.7	12.1	6.3	14.6	17.6	13.3	10.7	108.2	7.8	3.1	1.3	1.7	54.4	22.3	6.5	4.0	13.9	12.8	12.3	2.4	1.5	0.3	0.5	9.1	7.9	37.7	5.1	31.0	12.0	2.2	1.3	0.1	1.2	3.3	20.7	1.9	0.8	25.3	85.0	30.0	57.7	1.8	6.9	3.0	1.4	2.6	68.9	6.5	1.6	0.7	0.4	1.8	2.6	0.2	39.3	0.0	4.5	4.2	0.9	2.5	6.9	36.4	1.4	0.8	8.6	2.5	2.4	2.0	1.9	13.7	3.2	2.1	5.0	0.1	12.5	3.2	2.0	5.1	226.0	24.0	4.3	331.9	6.5	1.2	4.9	5.2	134.6	1.0	3.8	3.9	355.8	1.0	423.3	2.1	3.0	104.9	45.0	72.6	68.2	77.8	45.1	54.0	76.6	65.8	71.4	61.5	61.7	108.2	13.8	9.6	9.2	2.3	7.0	37.1	6.4	37.7	13.6	7.0	15.3	10.8	0.6	4.3	10.9	1.8	35.5	96.4	3.6	12.8	3.9	13.5	4.1	23.5	4.9	6.4	3.5	0.4	2.1	7.7	9.0	14.4	3.6	8.4	0.0	2.7	12.8	18.1	57.2	6.7	1.8	4.5	10.2	145.6	65.6	4.6	15.8	101.3	0.0	4.7	84.1	6.9	3.1	0.5	113.7	18.5	11.0	9.4	9.1	10.2	51.3	18.2	14.8	9.1	19.7	8.7	7.8	31.0	5.2	3.3	38.4	43.1	7.9	4.6	5.7	7.6
SLC32A1	"bA122O1.1, VGAT, VIAAT"	ENSG00000101438	"Solute carrier family 32 member 1"	Q9H598	20	38724486-38729372	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 39.8"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.7;Horizontal cells: 58.9;Inhibitory neurons: 20.7"	"Cancer enhanced"	"Detected in single"		"glioma: 1.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MOLT-4: 1.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB037156, HPA058859, HPA059985"	Enhanced	Supported	Approved	Cytosol		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 65: Plasmacytoid DCs - Unknown function"	Cytosol		"CAB037156: AB_532294, HPA058859: AB_2683836, HPA059985: AB_2684187"					"unprognostic (1.13e-2)"					"unprognostic (2.09e-1)"				"unprognostic (1.17e-1)"	"unprognostic (6.57e-2)"			0.0	0.0	12.4	0.0	39.8	0.2	0.0	3.4	22.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	36.5	0.3	0.0	0.0	0.0	14.2	6.8	0.0	0.0	0.0	7.6	0.0	8.7	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.5	5.1	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.4	39.8	3.4	22.0	2.4	36.5	14.2	6.8	8.7	6.3	5.1	1.2	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	14.7	0.0	0.0	0.4	0.0	0.1	0.0	4.2	0.0	1.3	0.0	0.0	0.0	2.5	0.2	0.0	0.4	1.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.9	20.7	0.0	0.0	0.0	0.4	0.6	0.0	0.5	0.0	0.0	0.0	1.0	0.0	0.5	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	3.1	0.0	0.0	0.1	2.6	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC33A1	"ACATN, AT-1, AT1, SPG42"	ENSG00000169359	"Solute carrier family 33 member 1"	O00400	3	155821024-155854456	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Cataract, Deafness, Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042430	Uncertain		Approved	Vesicles,Cytosol		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Vesicles, Cytosol"		"HPA042430: AB_10806238"	"unprognostic (5.12e-3)"	"unprognostic (7.78e-2)"	"unprognostic (1.13e-2)"	"unprognostic (7.21e-2)"	"unprognostic (1.88e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.57e-2)"	"unprognostic (5.65e-2)"	"unprognostic (6.61e-2)"	"unprognostic (4.36e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.93e-1)"	"unprognostic (2.08e-2)"	"unprognostic (2.92e-1)"	"unprognostic (4.73e-2)"	"unprognostic (5.74e-2)"	8.8	11.0	3.9	4.9	4.8	2.9	8.4	4.6	4.7	12.3	9.2	7.2	6.9	8.8	12.9	8.0	9.5	7.8	7.6	4.6	5.3	10.4	17.2	8.4	5.0	4.4	4.2	8.0	30.9	11.6	5.9	6.6	4.6	8.3	6.4	6.8	11.2	11.0	4.7	6.4	7.7	7.1	5.2	5.8	8.8	5.4	5.2	7.1	18.8	4.8	6.2	6.8	7.9	7.3	18.9	17.7	7.3	8.3	24.4	23.5	12.9	13.1	21.2	19.8	18.7	8.5	22.0	9.9	24.1	13.1	19.8	17.1	14.3	15.2	20.8	16.5	13.3	11.3	6.5	15.8	41.5	13.3	8.9	18.4	26.7	9.7	49.5	20.5	19.8	12.4	8.6	27.8	14.3	14.3	5.0	3.7	6.8	17.7	14.9	5.6	8.1	29.1	9.7	11.8	7.9	5.9	11.1	24.5	21.4	11.3	8.1	11.2	21.4	10.1	4.9	17.9	13.1	33.2	14.4	12.3	14.6	8.8	14.0	12.7	8.4	6.2	8.9	6.3	9.6	5.4	6.0	6.8	10.4	3.5	5.4	5.5	1.7	6.6	6.5	16.1	5.7	5.9	3.9	4.8	4.6	4.7	4.6	5.3	4.4	4.2	4.6	5.2	5.2	7.3	9.0	22.4	25.0	16.0	14.8	8.9	11.7	20.8	18.2	17.5	16.0	9.0	23.8	18.6	21.5	11.0	27.1	18.2	21.1	14.2	5.9	15.3	13.7	11.2	20.3	13.7	12.5	8.4	17.9	15.4	28.3	19.7	20.9	16.6	12.0	12.8	16.4	64.3	19.5	18.5	17.4	18.1	12.2	14.7	15.8	13.2	18.6	15.2	12.4	10.3	19.0	15.4	12.3	11.1	20.8	14.4	5.3	21.4	33.3	19.5	18.9	17.1	23.4	23.0	13.1	16.0	16.0	19.5	9.2	12.2	9.5	37.6	15.3	10.2	13.9	10.9
SLC34A1	"NAPI-3, NPT2, NPTIIa, SLC11, SLC17A2"	ENSG00000131183	"Solute carrier family 34 member 1"	Q06495	5	177379235-177398848	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	54	"kidney: 155.4"	"Cell type enriched"	"Detected in some"	14	"Proximal tubular cells: 143.2"	"Cancer enriched"	"Detected in single"	12	"renal cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"HEL: 2.4;U-937: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA051255, HPA077175"	Approved		Approved	"Nucleoplasm,Nuclear speckles,Plasma membrane,Mitotic spindle,Cytosol"		Yes	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nuclear speckles, Plasma membrane"	"Nucleoplasm, Mitotic spindle, Cytosol"	"HPA051255: AB_2681409, HPA077175: "	"unprognostic (1.17e-1)"	"unprognostic (3.33e-3)"	"unprognostic (1.49e-1)"	"unprognostic (3.49e-2)"		"unprognostic (1.56e-3)"	"unprognostic (2.28e-1)"	"unprognostic (4.50e-2)"	"unprognostic (4.43e-3)"	"unprognostic (1.91e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.95e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.01e-1)"	"unprognostic (1.28e-2)"	"unprognostic (4.66e-2)"	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	155.4	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	7.3	0.0	0.0	0.2	0.0	9.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	143.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.1
SLC34A2	NAPI-3B	ENSG00000157765	"Solute carrier family 34 member 2"	O95436	4	25648011-25678748	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Cancer-related genes, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	8	"lung: 753.0"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 477.5;Alveolar cells type 2: 1315.9;Club cells: 179.9;Glandular and luminal cells: 241.3;Respiratory ciliated cells: 217.0"	"Group enriched"	"Detected in many"	4	"lung cancer: 252.6;ovarian cancer: 191.7;thyroid cancer: 585.2"	"Region enriched"	"Detected in single"	6	"cerebellum: 2.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	82	"BEWO: 32.2;EFO-21: 121.0;RPTEC TERT1: 86.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA037989, HPA066474"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA				"Cluster 19: Lung - Lung function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 11: Alveolar cells - Smell perception"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA037989: AB_10670536, HPA066474: "	"unprognostic (1.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.38e-1)"	"unprognostic (4.25e-2)"	"unprognostic (7.33e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.37e-2)"	"unprognostic (6.60e-3)"	"unprognostic (6.27e-2)"	"unprognostic (1.89e-2)"	"unprognostic (5.77e-2)"	"unprognostic (2.24e-1)"	"unprognostic (7.08e-3)"	"unprognostic (3.25e-1)"	"unprognostic (6.75e-2)"	"unprognostic (2.57e-2)"	"unprognostic (1.93e-1)"	0.4	0.8	0.0	0.3	0.0	0.0	19.1	2.1	0.2	66.6	6.9	0.1	16.4	34.6	0.1	1.5	69.8	9.0	0.2	0.1	0.0	16.7	1.2	753.0	0.1	0.0	0.0	1.3	7.3	0.0	2.1	4.8	0.1	1.0	0.0	0.5	90.2	16.8	0.1	2.6	4.3	0.2	0.0	0.7	2.5	2.7	0.3	2.1	33.6	0.0	7.4	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	32.2	0.0	0.0	0.0	0.0	0.2	0.1	0.2	121.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.1	0.0	0.2	0.1	0.1	86.8	0.0	0.1	0.1	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.7	0.9	0.0	0.5	0.4	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.2	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.2	477.5	1315.9	0.0	0.1	0.0	0.1	79.1	0.0	0.0	41.5	7.5	0.8	34.3	179.9	20.2	0.0	1.4	0.0	0.0	5.9	72.2	5.4	78.6	30.3	2.5	0.0	0.0	0.1	8.5	0.0	2.6	0.0	241.3	29.0	0.0	0.0	0.0	0.2	0.0	0.1	1.2	26.4	0.0	0.0	20.8	1.2	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.8	2.5	0.0	0.0	11.8	13.6	3.4	217.0	0.0	0.0	0.0	5.8	2.1	0.1	0.0	0.0	0.3	4.8	0.0	1.8	4.0
SLC34A3	"FLJ38680, NPTIIc"	ENSG00000198569	"Solute carrier family 34 member 3"	Q8N130	9	137230757-137236555	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"intestine: 9.7;kidney: 13.6"	"Group enriched"	"Detected in some"	9	"Proximal enterocytes: 83.7;Proximal tubular cells: 40.3"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 4.0;HDLM-2: 2.8;HeLa: 3.3;MCF7: 7.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA023776	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA023776: AB_1857102"	"unprognostic (2.69e-1)"	"unprognostic (4.16e-1)"	"unprognostic (9.08e-3)"	"unprognostic (1.83e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.29e-3)"	"unprognostic (4.02e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.84e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.20e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.94e-2)"	"unprognostic (9.12e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.20e-1)"	0.0	0.1	0.1	0.1	0.3	0.3	0.0	0.0	0.5	0.2	0.0	0.1	0.5	0.2	0.0	2.9	0.4	0.5	0.2	0.2	0.2	13.6	0.0	0.3	0.2	1.8	2.0	0.0	0.6	0.0	1.2	0.0	0.5	0.3	0.0	0.2	1.6	0.0	0.1	0.4	9.7	0.0	0.5	0.2	0.4	0.4	0.8	0.0	0.3	0.0	0.0	0.1	0.5	1.1	0.6	1.2	0.7	1.5	0.0	0.0	0.3	0.4	0.0	0.1	0.0	0.5	4.0	0.5	0.1	0.0	0.1	1.8	0.0	0.0	0.1	2.8	0.3	0.1	3.3	1.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.5	0.0	0.2	0.3	0.6	0.0	7.6	0.0	0.1	0.3	0.7	0.8	0.9	0.5	0.0	0.0	0.6	0.0	1.3	0.4	0.9	0.2	0.6	2.2	0.0	0.3	0.3	0.3	1.5	0.1	0.7	0.3	0.3	0.7	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.5	0.2	0.2	1.8	2.0	0.5	0.5	0.8	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.3	0.0	0.0	0.0	83.7	40.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0
SLC35A1	"CMPST, hCST"	ENSG00000164414	"Solute carrier family 35 member A1"	P78382	6	87470623-87512336	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 103.0;Inhibitory neurons: 87.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"				"unprognostic (3.04e-2)"	"unprognostic (1.93e-1)"	"unprognostic (6.33e-2)"	"unprognostic (2.55e-2)"	"unprognostic (2.82e-1)"	"unprognostic (4.07e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.58e-2)"	"unprognostic (3.01e-3)"	"unprognostic (7.26e-2)"	"unprognostic (3.85e-1)"	"prognostic unfavorable (2.70e-6)"	"unprognostic (2.85e-1)"	"unprognostic (8.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (1.04e-1)"	16.4	24.0	24.6	15.6	25.4	11.2	30.9	28.3	31.6	27.8	28.5	39.6	18.8	24.9	22.1	13.9	20.2	19.5	16.0	26.0	25.5	21.2	32.9	37.6	17.9	24.3	24.1	23.1	15.8	23.7	18.9	19.7	24.4	36.8	47.6	14.4	31.6	16.5	13.8	24.9	21.5	22.0	24.5	19.0	29.2	13.2	24.9	16.3	16.9	15.7	16.3	21.5	16.7	25.4	4.8	11.5	20.4	24.1	54.4	49.3	16.4	13.9	12.2	11.4	15.6	9.9	86.0	17.6	16.8	17.3	31.7	18.5	24.8	11.3	14.6	25.3	18.4	20.0	14.7	17.8	35.7	26.3	13.3	25.3	26.6	13.5	26.1	26.8	27.5	25.5	26.1	28.4	17.0	44.6	7.3	39.6	11.0	60.4	18.6	22.4	19.9	19.0	35.6	20.4	13.3	14.6	25.7	47.4	23.2	23.3	42.2	53.0	26.0	16.4	11.1	18.2	11.3	21.1	32.7	6.5	13.7	46.2	23.7	52.1	54.1	22.8	17.5	42.8	27.1	17.8	18.7	21.5	46.9	16.7	23.7	22.3	13.2	17.5	44.2	17.3	26.8	36.9	24.6	25.4	28.3	31.6	26.0	25.5	24.3	24.1	24.4	24.5	24.9	25.4	14.7	44.8	33.6	19.2	11.7	14.8	18.1	37.1	18.8	6.2	23.6	16.6	6.2	20.0	25.5	16.5	12.5	25.0	16.1	27.1	7.9	10.1	10.6	6.3	9.9	15.8	15.0	8.2	103.0	8.9	19.7	19.2	13.3	6.8	21.6	14.2	42.8	20.7	15.6	11.8	87.2	73.5	48.8	28.2	11.1	7.1	16.4	15.8	21.4	24.4	27.4	17.3	16.5	42.3	26.9	11.5	19.0	19.2	9.4	17.5	14.5	11.3	25.4	7.0	19.7	8.9	16.9	9.6	14.2	9.0	14.8	27.5	14.9	12.5	32.7	8.9
SLC35A2	"UGALT, UGAT, UGT, UGT1, UGT2, UGTL"	ENSG00000102100	"Solute carrier family 35 member A2"	P78381	X	48903180-48911958	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease variant, Epilepsy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036087	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 30: Mammary glandular cells - Lactation"	"Golgi apparatus"		"HPA036087: AB_10604093"	"prognostic unfavorable (3.16e-4)"	"unprognostic (3.34e-1)"	"unprognostic (4.88e-3)"	"unprognostic (1.11e-1)"	"unprognostic (8.15e-3)"	"unprognostic (4.25e-3)"	"prognostic unfavorable (9.64e-5)"	"unprognostic (3.47e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.94e-3)"	"unprognostic (9.58e-2)"	"unprognostic (3.16e-2)"	"prognostic favorable (8.23e-4)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (5.13e-2)"	15.8	20.5	13.7	12.7	14.3	15.9	14.9	14.3	14.8	18.7	19.4	29.3	17.3	13.1	28.4	24.7	32.6	15.2	15.0	14.5	15.8	19.8	31.8	18.2	11.4	14.6	15.0	9.3	30.0	24.7	21.3	19.9	15.4	17.1	28.2	3.1	23.8	14.8	14.0	21.9	18.0	11.7	14.4	14.7	25.0	7.1	15.9	11.8	15.4	7.2	14.7	19.8	15.4	15.9	48.8	55.2	18.8	27.3	36.5	31.6	29.7	49.7	54.1	51.3	59.9	64.0	84.5	18.8	22.2	54.2	64.4	67.0	51.7	40.0	39.7	27.9	34.0	20.5	33.1	49.6	47.8	38.7	40.9	35.7	69.9	48.6	39.8	28.9	30.6	25.9	38.7	29.8	37.6	47.1	20.5	35.0	39.7	55.3	67.7	22.3	35.5	61.1	44.4	39.1	21.8	36.1	52.9	54.5	28.7	35.1	80.8	30.7	28.2	30.3	30.6	55.4	27.5	45.1	32.8	19.6	38.4	34.1	40.3	18.1	22.3	40.0	15.3	23.4	15.8	10.7	12.6	13.9	27.7	9.9	8.3	14.6	24.2	13.8	17.5	27.7	13.1	11.9	13.7	14.3	14.3	14.8	14.5	15.8	14.6	15.0	15.4	14.4	15.9	15.9	16.2	9.6	17.0	3.3	13.1	14.1	11.7	29.0	2.8	4.5	26.5	10.9	5.2	10.0	23.5	16.5	0.0	31.0	15.6	24.1	3.9	27.4	3.3	24.2	12.0	13.5	12.7	19.0	2.6	32.3	30.6	14.0	18.8	16.8	2.5	8.0	11.0	15.6	23.4	6.7	2.5	31.5	28.5	10.1	14.5	1.3	9.9	12.3	10.6	4.7	21.9	9.4	8.2	4.5	4.4	27.1	19.7	10.9	19.3	18.7	17.8	10.5	50.5	5.7	6.6	9.7	19.4	10.3	6.8	10.9	17.5	48.0	13.8	12.2	21.7	23.4
SLC35A3		ENSG00000117620	"Solute carrier family 35 member A3"	Q9Y2D2	1	99969351-100035634	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Autism spectrum disorder, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 211.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015253	Uncertain					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 9: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA015253: AB_1857106"	"unprognostic (1.05e-1)"	"unprognostic (2.69e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.89e-2)"	"unprognostic (9.64e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.72e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.59e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.76e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.32e-1)"	"unprognostic (2.73e-2)"	"unprognostic (9.34e-2)"	11.6	7.3	4.3	10.4	5.1	11.4	18.3	6.6	5.8	19.1	10.0	53.3	49.7	9.6	11.4	14.4	13.1	13.5	5.5	4.1	4.7	21.3	37.3	11.5	8.0	4.7	4.6	8.1	11.5	19.8	4.8	10.2	5.1	23.0	53.8	6.9	22.0	11.6	4.9	10.8	41.4	8.8	4.5	7.9	33.4	2.8	4.9	18.9	24.9	6.1	8.9	10.5	10.2	6.3	28.3	7.6	6.7	7.1	14.8	12.9	26.7	24.5	14.8	9.4	13.6	4.9	15.1	15.1	30.0	14.3	13.3	16.0	12.7	11.0	21.6	18.7	9.4	13.7	10.7	11.8	9.2	22.1	1.6	6.8	12.1	11.5	22.2	11.3	11.1	11.9	23.0	21.9	19.3	7.1	14.6	11.4	8.2	16.0	24.9	4.5	20.4	9.4	17.1	16.0	8.6	4.8	17.0	32.3	13.7	6.2	19.7	16.6	13.0	14.3	13.0	32.0	13.3	12.9	16.2	11.2	23.0	13.5	6.1	4.4	2.1	1.1	2.2	2.1	2.5	2.5	2.2	2.6	1.7	1.8	2.7	2.3	0.6	4.3	1.7	5.0	2.8	1.9	4.3	5.1	6.6	5.8	4.1	4.7	4.7	4.6	5.1	4.5	4.9	6.3	23.5	80.1	28.6	12.4	17.8	25.0	21.6	30.5	18.8	15.7	33.9	15.4	8.8	27.1	50.5	55.2	20.9	19.4	51.4	211.0	7.9	18.1	4.4	49.4	22.4	20.5	19.8	9.7	24.4	15.3	30.5	17.0	43.3	46.3	17.1	19.5	20.7	49.3	14.2	10.1	26.6	110.6	22.4	17.8	17.1	2.1	13.4	14.2	8.8	23.4	18.0	19.0	14.4	30.2	46.7	21.7	82.8	13.2	25.6	43.3	112.4	25.3	92.6	25.1	6.6	14.4	17.7	16.2	8.3	21.2	29.7	23.3	23.8	12.8	116.4	48.4
SLC35A4		ENSG00000176087	"Solute carrier family 35 member A4"	"L0R6Q1, Q96G79"	5	140564446-140569100	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 127.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062210			Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 59: Non-specific - Translation"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	Nucleoplasm	Cytosol	"HPA062210: AB_2684712"	"unprognostic (3.01e-3)"	"unprognostic (1.35e-2)"	"unprognostic (5.88e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.65e-2)"	"unprognostic (1.91e-3)"	"unprognostic (9.63e-2)"	"unprognostic (3.61e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.78e-2)"	"unprognostic (2.87e-1)"	"prognostic favorable (4.56e-5)"	"unprognostic (2.96e-2)"	"unprognostic (3.04e-2)"	"unprognostic (2.06e-2)"	"unprognostic (1.55e-1)"	45.6	62.1	34.0	39.8	37.3	23.2	42.2	38.9	35.6	36.7	29.9	51.6	45.6	38.0	31.3	69.1	39.4	33.9	72.2	31.5	36.7	58.6	53.8	46.3	42.0	39.6	38.7	32.7	44.3	59.4	24.1	33.1	38.2	41.1	47.5	19.5	66.0	33.6	138.5	64.3	44.0	36.1	36.9	47.5	46.4	45.1	38.0	44.3	44.6	94.1	44.4	42.2	41.6	34.9	43.9	134.2	57.5	124.6	77.5	43.0	92.4	60.8	45.5	84.3	91.3	186.2	57.0	115.7	80.0	65.7	105.2	55.2	0.0	107.7	59.3	155.0	96.7	91.3	109.1	1.3	74.7	91.7	83.7	65.5	92.6	83.3	71.0	38.2	74.2	73.0	83.6	136.4	80.5	98.3	110.5	62.7	43.5	74.2	92.1	82.5	93.5	129.2	69.1	79.5	66.6	91.1	79.8	157.1	84.0	50.4	131.4	52.7	69.3	78.2	52.9	70.0	78.7	57.8	127.8	53.9	54.0	127.6	91.9	16.6	65.0	37.0	56.5	83.1	54.4	29.9	45.5	52.1	75.5	32.7	53.5	49.3	24.5	63.4	79.4	28.3	33.7	83.4	34.0	37.3	38.9	35.6	31.5	36.7	39.6	38.7	38.2	36.9	38.0	34.9	13.0	12.8	22.4	4.9	17.0	10.5	23.2	20.3	15.4	13.7	21.1	15.4	30.0	32.9	21.8	16.5	4.2	32.1	13.2	56.4	45.0	33.3	71.3	9.4	11.8	18.1	25.2	19.0	3.3	35.1	50.2	16.2	24.5	15.5	21.0	14.3	25.4	25.0	32.9	13.5	3.5	27.9	20.3	24.2	13.3	127.2	12.5	18.9	17.8	5.6	27.6	28.6	44.3	3.5	5.7	39.5	26.4	12.4	15.7	22.1	33.5	39.9	10.5	10.3	32.9	11.8	15.0	9.7	17.5	20.4	11.6	30.5	17.6	18.1	38.5	28.8
SLC35A5	FLJ20730	ENSG00000138459	"Solute carrier family 35 member A5"	Q9BS91	3	112561709-112585579	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"Early spermatids: 156.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035519, HPA057964"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 29: Early spermatids - Spermatogenesis"	"Golgi apparatus"		"HPA035519: AB_10601487, HPA057964: AB_2683566"	"unprognostic (7.89e-2)"	"unprognostic (2.33e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-1)"	"unprognostic (7.09e-2)"	"unprognostic (1.45e-1)"	"unprognostic (4.78e-2)"	"unprognostic (8.60e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.21e-2)"	"unprognostic (3.51e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.05e-2)"	"unprognostic (3.42e-1)"	15.5	19.3	18.2	13.4	23.9	5.7	14.8	22.4	26.9	15.5	18.4	15.6	16.7	15.6	16.0	14.3	14.6	15.4	9.7	18.1	21.4	20.2	21.0	14.7	15.7	24.0	21.7	17.9	9.5	17.2	9.1	18.4	24.3	16.0	16.1	21.7	11.4	13.9	6.1	9.2	18.3	15.9	23.2	14.2	14.5	18.8	21.2	12.7	26.1	10.2	15.3	12.6	8.3	30.0	20.4	18.4	31.2	18.8	39.3	37.4	18.0	33.2	23.7	27.5	31.5	13.6	22.8	18.1	27.4	28.8	31.3	25.3	22.4	15.6	34.6	14.2	11.1	23.2	15.9	11.4	33.6	20.7	21.5	31.8	30.9	24.3	14.9	34.8	25.1	13.8	13.5	22.1	38.7	7.2	16.2	13.1	20.8	24.0	19.2	14.4	11.4	19.7	34.2	14.9	18.3	24.1	21.3	10.4	38.0	20.9	14.2	13.9	28.3	40.3	21.8	8.6	15.7	15.7	24.4	32.2	29.9	17.2	30.8	14.8	16.4	21.0	10.9	25.9	10.3	14.7	10.2	8.6	19.7	13.6	13.6	11.2	14.6	7.3	27.4	9.4	11.2	10.8	18.2	23.9	22.4	26.9	18.1	21.4	24.0	21.7	24.3	23.2	21.2	30.0	9.9	3.2	10.1	13.1	12.5	6.4	8.3	9.9	11.4	12.8	8.5	6.5	5.5	7.2	12.6	14.7	0.0	36.1	12.5	16.4	9.8	7.8	156.8	9.2	9.1	12.9	7.7	9.2	15.0	7.7	25.6	14.0	10.7	10.0	14.0	9.0	19.6	13.1	17.9	37.0	15.2	11.8	20.3	23.2	9.2	23.5	17.1	13.0	26.6	5.6	14.0	20.3	9.2	23.1	36.6	8.1	13.1	17.3	14.3	8.5	25.8	14.8	10.4	16.9	26.3	9.6	10.6	14.9	15.7	8.9	6.7	29.8	10.7	14.6	10.0	6.5
SLC35B1	UGTREL1	ENSG00000121073	"Solute carrier family 35 member B1"	P78383	17	49700934-49709014	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048655, HPA057418"	Approved		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"	"Endoplasmic reticulum, Vesicles"	Nucleoplasm	"HPA048655: AB_2680481, HPA057418: AB_2683432"	"unprognostic (1.35e-1)"	"unprognostic (2.15e-2)"	"unprognostic (1.09e-3)"	"unprognostic (6.36e-2)"	"unprognostic (8.31e-2)"	"unprognostic (2.86e-3)"	"unprognostic (6.17e-3)"	"unprognostic (4.39e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.00e-3)"	"unprognostic (3.37e-2)"	"unprognostic (4.42e-2)"	"prognostic unfavorable (5.69e-7)"	"unprognostic (6.28e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-2)"	13.4	9.9	16.8	15.6	17.1	19.4	18.6	17.3	20.0	16.7	21.7	19.9	26.8	11.4	52.8	17.2	18.1	12.5	32.2	17.1	20.0	28.8	46.4	15.3	14.3	17.4	17.8	8.5	18.4	31.6	13.7	17.0	17.4	13.7	24.2	17.0	16.4	15.5	61.4	10.8	26.0	15.6	16.5	12.4	17.4	14.0	18.4	15.3	36.0	60.3	21.6	23.0	7.9	17.2	45.2	75.5	52.4	87.7	47.5	32.9	59.7	46.4	77.8	98.7	80.5	156.6	52.3	31.5	104.7	66.7	55.0	32.6	87.1	55.3	103.5	38.3	65.3	38.5	43.8	94.0	85.3	71.9	34.9	31.9	60.3	73.1	83.6	24.6	64.7	46.5	40.0	84.2	68.1	94.2	51.9	52.5	23.6	82.4	92.2	37.4	56.6	85.6	47.1	45.5	45.8	60.4	25.9	21.3	34.0	57.7	68.7	50.0	26.6	74.0	33.3	84.0	61.9	48.3	79.6	42.7	50.2	54.6	63.8	25.1	27.2	10.1	15.8	27.7	12.0	11.6	10.9	15.4	32.1	6.8	11.2	10.0	11.2	13.5	19.3	43.3	13.6	16.1	16.8	17.1	17.3	20.0	17.1	20.0	17.4	17.8	17.4	16.5	18.4	17.2	32.1	16.0	29.7	10.7	37.1	22.3	40.0	56.4	22.8	28.2	37.1	29.0	40.5	21.5	45.3	27.6	35.5	57.8	47.4	34.9	35.2	78.4	52.4	19.1	25.1	39.2	50.6	20.4	11.7	101.7	121.0	28.6	16.3	24.1	42.5	22.8	27.8	56.6	73.5	21.9	10.4	56.2	59.0	28.0	45.2	17.6	30.1	34.0	37.4	4.7	39.6	44.6	26.8	11.6	11.2	77.5	33.2	20.7	103.7	70.1	139.9	51.3	33.9	35.4	13.1	25.3	47.9	63.2	41.2	24.5	25.1	80.4	31.1	24.1	41.7	50.6
SLC35B2	UGTrel4	ENSG00000157593	"Solute carrier family 35 member B2"	Q8TB61	6	44254096-44257890	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029638	Approved		Approved	Vesicles		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA029638: AB_10602402"	"prognostic unfavorable (7.90e-4)"	"unprognostic (2.47e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.39e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.65e-2)"	"prognostic unfavorable (8.59e-5)"	"unprognostic (3.84e-1)"	"unprognostic (2.51e-1)"	"unprognostic (7.03e-3)"	"unprognostic (4.27e-2)"	"prognostic favorable (6.07e-4)"	"unprognostic (3.60e-2)"	"unprognostic (1.13e-1)"	"unprognostic (4.07e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.06e-1)"	20.1	36.7	21.2	19.6	25.7	18.4	25.2	27.0	42.3	23.3	24.1	27.1	19.6	28.5	29.5	17.5	26.2	30.0	26.4	19.5	23.3	30.3	30.6	21.7	21.5	25.8	25.1	21.3	41.8	42.5	14.6	25.0	25.6	24.0	28.8	14.6	46.4	27.4	22.4	21.9	23.9	29.7	26.1	24.7	30.6	14.7	26.1	18.5	24.4	23.7	22.3	28.1	19.5	30.9	87.2	48.8	61.4	117.6	106.4	102.3	44.1	95.1	152.3	89.3	109.4	43.3	79.3	19.2	81.9	117.3	97.7	81.1	42.5	106.3	64.4	57.4	53.3	39.8	37.9	59.5	94.1	85.2	61.5	107.0	112.1	85.5	43.1	129.1	67.4	43.2	56.8	81.4	112.5	106.9	32.5	71.0	27.2	271.3	58.9	30.9	38.3	100.2	100.3	65.5	75.4	71.4	45.9	52.2	109.6	37.6	93.3	75.7	65.8	71.0	46.2	71.3	83.3	62.4	75.7	45.6	95.6	67.6	147.5	51.9	14.5	23.5	33.1	11.4	28.3	19.7	18.6	25.2	12.9	13.2	16.6	22.0	1.3	20.3	3.9	23.5	16.4	17.7	21.2	25.7	27.0	42.3	19.5	23.3	25.8	25.1	25.6	26.1	26.1	30.9	8.0	6.4	11.5	8.5	19.2	13.5	32.0	58.3	23.9	9.7	31.6	30.1	7.8	37.1	34.8	27.6	2.1	59.2	15.3	15.2	13.7	84.0	0.6	16.0	17.8	11.1	19.7	10.5	3.5	73.8	52.1	27.5	14.3	19.5	34.9	11.9	13.6	18.7	38.4	10.1	4.3	21.6	57.0	11.4	10.8	2.3	23.3	22.0	53.4	4.7	22.0	38.8	23.7	9.5	13.8	67.4	25.9	19.9	23.3	36.3	18.8	13.5	18.4	12.5	0.0	18.3	24.5	21.0	60.8	17.4	13.9	35.2	14.0	14.8	31.5	24.2
SLC35B3	"C6orf196, CGI-19, dJ453H5.1, PAPST2"	ENSG00000124786	"Solute carrier family 35 member B3"	Q9H1N7	6	8411435-8435561	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054661, HPA057801"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 27: Mucus-secreting cells - Mucin production"			"HPA054661: AB_2682561, HPA057801: AB_2683532"	"unprognostic (2.84e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.19e-1)"	"unprognostic (4.93e-2)"	"unprognostic (5.23e-3)"	"unprognostic (5.00e-2)"	"unprognostic (9.45e-2)"	"unprognostic (9.27e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.32e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.08e-3)"	"unprognostic (3.88e-3)"	11.3	9.7	6.0	10.2	7.6	4.6	12.9	6.3	10.6	12.2	7.2	24.2	14.8	9.4	43.0	10.3	9.6	15.1	10.3	6.3	6.2	16.4	23.4	10.6	12.2	7.2	6.6	8.1	18.4	14.6	12.0	14.7	7.1	12.1	24.9	5.2	15.0	17.4	5.7	10.7	16.9	9.4	6.4	13.4	17.9	8.8	6.6	9.9	18.2	4.5	11.8	12.3	10.9	9.4	14.8	7.7	10.4	14.1	23.4	35.7	8.5	37.9	31.4	13.5	17.3	24.7	13.9	12.5	20.9	27.7	19.5	10.6	11.5	10.3	22.6	18.0	8.4	6.1	6.1	15.0	24.5	9.1	13.2	24.4	14.3	14.3	15.5	17.5	18.5	7.4	13.2	5.1	30.5	10.2	6.9	13.7	8.2	20.6	9.2	6.2	9.7	12.6	36.7	13.2	9.9	8.4	9.8	8.6	17.9	29.6	6.5	18.4	15.9	22.3	6.4	15.9	17.2	12.8	23.9	6.3	12.8	10.0	29.6	5.4	4.5	4.8	6.2	3.5	6.9	4.2	6.2	6.6	4.0	5.8	7.0	5.5	5.2	10.8	5.8	2.7	7.0	4.3	6.0	7.6	6.3	10.6	6.3	6.2	7.2	6.6	7.1	6.4	6.6	9.4	13.3	6.4	10.6	21.9	14.9	13.5	13.0	29.4	10.8	5.7	20.9	10.3	9.1	20.0	27.5	29.5	4.2	21.1	18.5	42.8	7.9	20.5	9.9	28.6	19.4	15.1	14.9	5.5	19.5	24.3	29.1	21.8	28.1	15.5	6.3	11.5	18.5	23.6	19.9	10.1	17.7	47.3	36.7	15.1	10.4	7.6	15.5	11.3	21.4	24.4	16.7	7.1	13.4	30.7	65.7	15.4	33.4	12.0	22.2	22.6	31.1	27.5	46.8	3.7	13.1	9.9	15.7	32.1	14.2	13.7	17.6	16.4	13.1	10.7	33.5	22.9
SLC35B4	"FLJ14697, YEA4"	ENSG00000205060	"Solute carrier family 35 member B4"	Q969S0	7	134289332-134316930	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 95.2;Syncytiotrophoblasts: 83.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049779	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA049779: AB_2680878"	"unprognostic (1.84e-1)"	"unprognostic (1.94e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.49e-2)"	"unprognostic (1.77e-3)"	"unprognostic (3.47e-2)"	"unprognostic (3.23e-2)"	"unprognostic (1.25e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.32e-2)"	"unprognostic (6.88e-3)"	"unprognostic (1.86e-1)"	"unprognostic (2.24e-3)"	"unprognostic (3.18e-2)"	"unprognostic (2.86e-1)"	"unprognostic (9.81e-2)"	"unprognostic (1.00e-1)"	5.1	6.4	8.8	5.2	8.7	1.9	3.3	9.8	8.5	4.0	7.6	4.0	2.9	6.0	6.3	3.3	4.4	3.9	2.5	8.5	8.9	10.4	8.5	3.3	4.5	8.0	8.5	6.4	2.6	4.6	4.2	11.8	7.7	5.2	3.5	12.3	2.3	6.1	2.5	3.1	4.1	7.1	7.7	4.2	3.5	4.7	10.1	4.8	3.4	2.9	4.8	4.0	2.8	8.7	6.8	22.5	19.3	29.0	18.4	15.3	9.9	16.9	14.1	14.7	12.4	8.7	6.3	22.9	5.6	18.3	19.2	7.2	29.0	15.0	24.3	14.5	21.4	15.5	12.9	11.6	13.6	22.1	13.4	13.6	6.3	17.7	14.9	11.0	14.4	15.6	15.2	8.2	22.2	6.1	19.7	16.1	40.0	7.0	20.0	14.1	17.0	11.2	8.3	8.3	6.7	39.5	15.1	5.0	19.0	16.0	2.7	12.4	16.1	19.0	6.2	11.5	16.9	26.9	39.9	25.9	34.0	20.5	22.4	0.7	1.5	0.3	1.6	2.1	2.5	1.3	1.5	2.1	3.1	1.4	1.4	2.1	0.1	1.9	1.7	2.1	1.7	1.4	8.8	8.7	9.8	8.5	8.5	8.9	8.0	8.5	7.7	7.7	10.1	8.7	7.2	9.6	5.4	22.9	10.2	2.2	5.7	10.7	6.2	52.6	4.9	3.4	6.9	11.5	8.5	1.8	45.9	95.2	3.7	2.2	11.7	8.1	2.4	5.3	15.2	11.8	4.2	8.8	33.4	5.3	27.8	13.3	14.8	6.5	1.3	27.8	7.5	15.1	20.9	42.1	36.6	5.7	22.4	9.3	3.9	3.4	11.1	11.9	5.4	14.0	8.4	16.2	14.4	24.1	24.3	9.0	4.9	12.4	9.2	4.9	7.0	13.9	6.2	21.6	6.6	10.0	10.0	10.8	24.0	9.3	3.3	83.2	10.7	31.3	4.1	3.7
SLC35C1	"FLJ11320, FUCT1"	ENSG00000181830	"Solute carrier family 35 member C1"	Q96A29	11	45804072-45813016	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 84.5"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 50.6;Distal enterocytes: 54.6;Pancreatic endocrine cells: 50.6;Paneth cells: 54.0;Proximal enterocytes: 58.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064001	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Golgi apparatus"		"HPA064001: AB_2685171"	"unprognostic (2.62e-2)"	"unprognostic (5.16e-2)"	"unprognostic (7.82e-2)"	"unprognostic (1.57e-2)"	"prognostic unfavorable (9.68e-4)"	"unprognostic (8.22e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.83e-2)"	"unprognostic (1.28e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.73e-1)"	"unprognostic (7.68e-2)"	"unprognostic (1.83e-3)"	"unprognostic (2.18e-1)"	"prognostic favorable (3.64e-4)"	"unprognostic (2.30e-2)"	28.2	7.3	6.6	10.7	6.3	2.4	19.8	7.0	7.0	9.6	6.1	19.8	24.4	8.8	2.3	41.5	7.3	12.2	9.0	6.2	7.2	7.0	84.5	10.2	6.6	8.2	7.9	6.3	13.4	5.6	10.4	15.0	7.7	9.9	14.3	1.6	26.1	5.9	6.8	5.1	24.1	9.9	6.5	8.4	18.5	5.2	8.8	4.5	6.6	6.9	10.0	13.8	14.9	6.3	10.3	25.8	6.3	16.3	19.9	19.8	19.5	22.1	20.1	13.3	14.4	10.7	15.2	10.4	9.9	27.3	19.4	26.0	13.4	13.6	6.5	24.8	14.5	5.9	20.4	20.6	42.6	11.4	16.2	23.8	16.3	9.2	11.1	16.2	17.6	10.3	13.3	13.8	14.4	21.8	5.9	9.0	27.5	39.9	34.6	7.2	10.5	21.5	15.1	25.4	6.0	8.6	16.6	16.3	9.5	6.6	13.7	6.0	25.7	25.0	14.7	46.1	15.6	9.8	26.9	4.9	18.5	14.4	14.2	9.7	11.6	12.5	11.0	11.9	12.3	5.0	18.0	14.7	9.6	3.7	9.3	8.0	1.8	5.6	8.7	8.2	13.0	10.1	6.6	6.3	7.0	7.0	6.2	7.2	8.2	7.9	7.7	6.5	8.8	6.3	5.5	0.0	11.2	2.6	6.2	3.6	8.9	12.7	3.4	1.9	11.1	3.0	50.6	22.8	26.7	5.5	2.1	13.8	6.4	54.6	0.0	18.4	4.9	7.3	6.7	10.6	9.6	3.6	2.0	41.9	14.0	10.5	23.4	11.4	2.5	5.2	6.8	42.2	14.7	3.3	2.1	40.6	4.1	9.3	4.8	6.0	6.5	6.3	1.8	2.8	9.5	2.8	7.2	1.0	2.1	50.6	54.0	5.7	13.6	11.8	58.0	4.7	11.4	1.1	0.0	3.6	9.7	4.0	4.3	12.7	2.4	15.3	6.5	5.7	26.4	20.1
SLC35C2	"bA394O2.1, C20orf5, CGI-15, OVCOV1"	ENSG00000080189	"Solute carrier family 35 member C2"	Q9NQQ7	20	46345980-46364458	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027011	Approved		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA027011: AB_2672082"	"unprognostic (7.25e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.27e-2)"	"unprognostic (1.06e-2)"	"unprognostic (2.90e-1)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (1.34e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.56e-1)"	"unprognostic (4.05e-2)"	"unprognostic (1.29e-2)"	"prognostic unfavorable (8.68e-4)"	"unprognostic (9.31e-2)"	"unprognostic (7.15e-2)"	"unprognostic (1.18e-2)"	"unprognostic (3.88e-1)"	23.2	36.3	23.1	17.2	22.3	27.1	23.2	21.3	25.2	26.4	22.6	23.9	21.3	23.1	17.4	31.8	23.2	18.2	17.2	21.8	20.6	27.7	38.3	22.8	24.0	22.6	23.1	25.5	34.9	14.9	20.3	18.2	22.3	31.2	10.1	11.3	30.3	14.0	18.3	32.7	26.4	10.4	21.2	33.6	27.7	25.0	23.4	14.4	29.2	8.2	13.4	22.4	25.6	22.8	35.9	45.1	17.5	15.0	23.9	23.2	36.3	17.6	33.7	19.7	22.6	60.9	54.6	22.5	63.2	19.9	24.7	49.0	9.3	40.5	6.7	19.6	32.5	20.2	29.5	49.0	46.6	27.6	23.6	33.6	51.0	27.4	29.8	20.8	15.2	23.7	33.3	41.5	14.2	85.0	19.8	40.7	24.3	34.1	36.7	18.9	19.7	45.3	25.8	35.1	28.1	39.6	16.4	87.1	60.9	10.4	56.0	47.8	15.7	53.2	33.7	27.5	32.0	55.6	51.5	25.2	58.0	29.7	23.9	42.7	37.9	48.0	37.5	39.9	35.4	29.7	39.0	38.8	42.4	27.9	44.5	40.3	33.5	33.4	30.8	72.9	41.1	44.1	23.1	22.3	21.3	25.2	21.8	20.6	22.6	23.1	22.3	21.2	23.4	22.8	17.0	16.0	19.1	24.5	27.6	14.4	29.0	35.5	29.0	41.3	32.4	25.4	6.7	21.5	29.2	27.6	41.7	89.5	32.6	26.9	13.7	41.3	5.9	12.8	13.0	18.4	21.0	12.4	13.6	61.8	49.2	24.0	26.0	13.9	14.7	20.3	31.8	27.5	38.7	18.5	13.6	35.1	26.4	22.8	8.2	6.7	19.3	23.6	21.4	14.0	36.4	23.4	34.0	11.1	14.2	35.0	26.9	19.2	28.8	50.0	34.8	18.3	18.7	33.6	19.7	20.1	19.0	16.1	23.6	24.8	16.6	79.2	25.9	24.8	30.2	33.1
SLC35D1	"KIAA0260, UGTREL7"	ENSG00000116704	"Solute carrier family 35 member D1"	Q9NTN3	1	66999350-67054148	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"		Dwarfism	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 74.7"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 75.6;Early spermatids: 73.5;Hepatocytes: 114.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 8.5"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (6.91e-2)"	"unprognostic (3.69e-2)"	"unprognostic (1.20e-3)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.63e-1)"	"unprognostic (6.53e-2)"	"unprognostic (2.49e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (2.12e-3)"	"unprognostic (6.39e-2)"	"unprognostic (6.75e-2)"	"unprognostic (2.07e-1)"	"unprognostic (7.65e-2)"	"unprognostic (1.55e-1)"	"unprognostic (2.43e-1)"	"unprognostic (4.08e-3)"	"unprognostic (3.20e-1)"	4.9	6.6	4.0	7.8	4.6	8.9	5.2	4.1	4.2	7.6	9.9	26.0	15.9	5.7	4.9	5.3	5.0	6.4	3.7	3.8	4.2	12.5	74.7	3.7	7.5	4.7	6.1	7.8	7.5	8.1	5.6	9.5	4.8	7.2	26.8	12.3	4.4	5.7	7.5	9.8	16.3	6.9	4.0	4.2	12.9	6.2	5.8	10.1	6.4	5.0	8.6	7.3	6.8	7.0	8.3	4.7	14.2	12.0	14.4	16.6	16.8	18.4	24.1	13.1	9.1	10.2	2.0	25.7	7.9	14.6	15.4	12.5	9.9	11.6	16.4	25.8	4.6	19.2	9.8	20.2	12.1	22.0	12.2	16.3	25.4	15.4	10.9	21.0	5.1	10.6	11.8	13.3	32.0	2.8	13.6	6.8	5.9	22.5	6.4	10.4	29.3	2.9	6.0	15.6	1.7	6.3	27.8	8.5	11.9	7.9	7.0	16.2	5.6	24.2	5.7	15.0	17.9	27.6	15.4	14.1	17.2	3.3	10.4	8.5	0.9	2.6	2.0	0.7	2.4	1.3	1.5	1.6	1.1	0.9	2.1	2.0	0.2	3.5	1.7	0.6	2.8	0.9	4.0	4.6	4.1	4.2	3.8	4.2	4.7	6.1	4.8	4.0	5.8	7.0	4.9	6.4	2.2	34.6	12.8	5.5	5.9	9.4	13.1	6.9	7.5	4.8	3.1	20.0	4.6	5.5	12.5	40.5	18.3	75.6	0.0	3.1	73.5	6.3	10.9	4.3	15.0	9.1	22.8	9.6	5.7	8.3	14.8	8.7	4.5	13.2	7.5	114.3	6.9	6.7	28.2	18.9	2.0	8.8	4.6	13.7	6.2	5.5	1.8	23.4	3.1	17.8	9.2	37.7	51.2	8.3	20.8	4.5	9.3	5.8	24.9	10.6	7.5	9.4	0.0	8.6	7.5	7.7	6.4	8.2	7.7	16.3	12.8	11.3	21.7	8.8
SLC35D2	"SQV7L, UGTrel8"	ENSG00000130958	"Solute carrier family 35 member D2"	Q76EJ3	9	96313444-96383711	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 117.2;Proximal enterocytes: 67.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 103.8;Hep G2: 132.3"									HPA064047	Approved		Supported	"Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"		"HPA064047: AB_2685182"	"unprognostic (3.67e-1)"	"unprognostic (5.73e-2)"	"unprognostic (2.59e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.17e-1)"	"unprognostic (8.86e-3)"	"unprognostic (4.25e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.12e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.74e-2)"	"unprognostic (1.33e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.99e-2)"	"unprognostic (1.44e-1)"	14.7	8.8	13.5	14.4	20.6	11.4	16.4	17.8	20.6	16.5	12.3	49.1	65.1	14.9	12.1	13.7	14.6	20.6	12.2	14.3	16.0	32.1	56.4	19.2	12.4	25.5	19.7	17.3	31.4	16.4	7.2	25.5	22.1	14.2	46.4	4.3	13.0	11.0	3.9	9.4	65.8	13.9	16.6	10.0	43.1	7.2	20.1	7.5	29.5	6.9	11.7	17.2	13.1	27.8	33.2	27.6	15.8	30.2	20.3	37.3	27.9	14.7	30.2	21.6	17.5	60.4	103.8	0.6	24.5	13.5	49.9	47.6	22.2	21.8	18.7	16.4	16.8	11.3	9.8	132.3	32.5	0.1	0.0	32.2	27.6	16.3	48.7	51.0	46.7	0.0	22.3	0.4	23.7	27.2	0.3	0.1	13.2	67.5	28.5	0.1	0.0	0.0	54.4	21.3	5.5	35.9	11.9	24.8	68.5	53.3	16.4	24.7	41.3	14.5	16.2	21.2	13.8	0.0	0.9	0.1	30.2	0.1	20.4	1.2	0.9	0.6	1.3	1.1	1.6	0.7	2.1	2.9	1.2	0.9	0.7	1.4	0.1	1.8	2.1	0.2	3.9	0.5	13.5	20.6	17.8	20.6	14.3	16.0	25.5	19.7	22.1	16.6	20.1	27.8	14.5	9.6	11.0	12.1	4.3	5.2	8.9	2.1	1.8	1.1	15.1	13.1	7.2	27.1	4.6	12.9	2.1	28.1	12.9	61.7	11.7	8.1	0.2	21.0	14.0	12.6	9.6	1.3	0.8	24.5	45.1	9.5	20.4	31.6	4.5	20.0	13.2	43.2	20.5	1.7	1.1	42.0	4.1	23.0	9.7	0.6	10.8	17.7	17.8	20.6	8.9	10.2	7.2	11.1	117.2	25.4	43.5	6.0	6.3	15.5	67.0	23.6	6.7	3.6	13.1	6.8	11.2	1.4	4.4	8.6	5.4	26.5	14.6	7.0	34.9	17.9
SLC35D3	FRCL1	ENSG00000182747	"Solute carrier family 35 member D3"	Q5M8T2	6	136922301-136925660	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	6	"brain: 5.3"	"Cell type enriched"	"Detected in single"	9	"Ionocytes: 8.2"	"Group enriched"	"Detected in some"	5	"colorectal cancer: 3.3;stomach cancer: 0.9"	"Group enriched"	"Detected in many"	7	"basal ganglia: 3.4;cerebral cortex: 1.5;hypothalamus: 5.2;midbrain: 2.1;thalamus: 5.3"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"SH-SY5Y: 15.4"	"Group enriched"	"Detected in many"	5	"basal ganglia: 29.6;olfactory bulb: 8.5"	"Region enriched"	"Detected in many"	6	"basal ganglia: 20.1"	"HPA030431, HPA067497"	Uncertain		Approved	"Centriolar satellite"		NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 51: Myeloid cells - Hemostasis"	"Centriolar satellite"		"HPA030431: AB_10601716, HPA067497: AB_2685854"	"unprognostic (6.56e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.43e-1)"	"unprognostic (5.45e-2)"	"unprognostic (1.08e-1)"	"unprognostic (5.84e-2)"		"unprognostic (2.48e-1)"		"unprognostic (9.94e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.65e-2)"		"unprognostic (1.37e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.45e-1)"	"unprognostic (1.03e-1)"	0.0	0.9	0.4	0.0	3.4	0.2	0.0	0.0	1.5	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.4	0.0	0.3	2.1	0.0	0.4	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.6	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	3.6	15.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	3.4	0.0	1.5	0.0	5.2	0.3	2.1	0.2	0.2	5.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.2	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.1
SLC35E1	FLJ14251	ENSG00000127526	"Solute carrier family 35 member E1"	Q96K37	19	16549831-16572415	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016570, HPA062214"	Approved		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus"		"HPA016570: AB_2190214, HPA062214: AB_2684713"	"unprognostic (1.76e-2)"	"unprognostic (2.81e-1)"	"unprognostic (7.31e-2)"	"unprognostic (2.92e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.35e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.20e-1)"	"unprognostic (6.99e-2)"	"unprognostic (9.07e-2)"	"unprognostic (3.02e-2)"	"unprognostic (2.23e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.54e-1)"	"unprognostic (3.75e-2)"	10.7	9.8	5.9	5.6	4.8	8.0	9.6	3.7	6.6	9.6	6.3	9.2	6.6	8.5	5.9	11.5	7.4	6.1	10.1	5.6	4.7	7.8	11.4	9.1	7.1	4.8	5.9	8.8	22.3	15.2	11.2	7.2	5.0	11.7	6.1	7.4	15.4	10.0	20.5	11.9	7.7	6.8	3.6	6.7	15.3	4.1	9.1	8.5	9.2	14.0	8.1	10.1	8.7	4.5	26.2	10.4	6.9	16.2	25.2	19.8	16.4	17.8	20.3	15.1	18.2	11.8	18.7	13.6	30.2	29.3	14.9	17.6	19.7	21.5	15.2	15.8	29.5	11.9	11.6	14.4	21.1	19.6	14.5	16.5	24.2	17.0	24.5	19.2	14.8	16.0	19.9	17.3	19.4	25.3	15.3	9.3	8.1	24.8	34.6	14.9	10.6	16.6	15.7	16.1	11.9	11.9	12.3	19.6	11.5	8.3	14.7	9.9	15.3	19.5	9.6	26.9	21.2	23.6	26.9	15.1	29.3	21.4	12.6	1.8	1.3	3.2	1.3	0.9	1.8	2.2	1.4	1.3	1.0	0.8	1.0	0.8	1.3	1.8	2.0	1.1	1.8	1.1	5.9	4.8	3.7	6.6	5.6	4.7	4.8	5.9	5.0	3.6	9.1	4.5	21.7	38.5	42.5	6.8	14.9	21.9	15.3	22.1	5.7	28.8	34.1	21.5	16.1	22.8	31.3	29.5	35.5	14.4	43.3	25.2	0.0	20.4	3.6	26.6	20.1	20.2	18.5	13.7	13.9	36.8	29.8	14.8	13.3	50.8	8.2	21.2	22.9	26.9	17.4	30.3	13.9	29.7	8.2	21.1	28.0	4.2	17.1	23.3	8.8	10.3	22.8	19.4	17.5	9.0	6.2	41.7	13.1	21.1	29.3	30.9	22.1	7.0	24.0	29.4	6.6	30.1	14.3	10.2	14.3	13.6	25.9	32.6	29.4	16.2	20.4	28.4
SLC35E2B		ENSG00000189339	"Solute carrier family 35 member E2B"	P0CK96	1	1659529-1692795	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 77.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045641, HPA062711"	Uncertain		Uncertain	Nucleoplasm		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 68: Epididymis - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 9: Photoreceptor cells - Phototransduction"	Nucleoplasm		"HPA045641: AB_2679402, HPA062711: AB_2684844"	"unprognostic (9.00e-2)"	"unprognostic (2.13e-1)"	"unprognostic (8.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (1.82e-1)"	"prognostic favorable (7.64e-4)"	"unprognostic (1.18e-1)"	"unprognostic (4.09e-2)"	"unprognostic (5.70e-2)"	"unprognostic (5.83e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.20e-1)"	"unprognostic (2.92e-1)"	"unprognostic (2.68e-2)"	"unprognostic (6.61e-2)"	"unprognostic (2.54e-2)"	"prognostic favorable (5.15e-4)"	21.0	29.7	38.1	20.9	35.9	17.3	25.8	30.7	38.5	35.3	31.3	30.8	31.9	31.8	34.2	20.8	29.2	19.5	19.4	38.8	27.8	27.8	26.1	22.9	32.4	28.8	29.9	39.0	30.7	20.3	43.1	20.4	29.4	30.2	22.1	42.6	29.1	22.5	29.1	29.5	34.1	30.6	26.2	40.1	28.7	10.9	31.1	34.5	30.8	14.6	28.0	26.0	26.5	33.3	13.0	17.4	58.3	49.8	42.3	40.0	16.9	15.6	35.8	16.9	19.7	12.8	33.6	22.6	24.2	33.7	20.9	16.9	23.0	14.9	16.8	28.4	20.1	30.6	37.2	21.7	31.5	24.6	26.2	35.0	31.2	21.4	30.5	47.3	35.5	40.9	31.1	30.8	19.4	9.2	32.3	29.2	19.0	11.2	18.5	28.3	15.9	29.5	29.1	13.1	50.9	46.8	26.4	31.5	50.8	23.8	38.9	34.8	33.5	29.9	12.6	11.7	8.6	25.0	19.6	35.2	22.8	45.2	16.5	1.8	3.7	2.8	7.0	3.3	7.6	3.9	5.9	8.1	2.4	3.9	6.8	5.9	5.5	4.0	2.4	7.6	6.0	5.0	38.1	35.9	30.7	38.5	38.8	27.8	28.8	29.9	29.4	26.2	31.1	33.3	8.2	12.8	28.3	9.8	19.8	7.4	7.1	14.1	18.8	35.5	12.0	8.6	17.1	34.3	24.6	3.7	77.2	14.1	26.0	28.3	0.0	5.7	1.1	9.1	14.8	16.8	25.4	21.5	12.0	6.1	9.6	18.4	30.5	6.8	23.4	13.9	25.4	22.2	10.5	30.3	12.1	24.3	18.3	31.5	8.2	3.9	30.4	13.8	12.4	9.4	21.8	12.3	29.9	14.6	12.9	6.2	17.8	26.7	28.0	9.3	38.1	3.4	23.4	66.5	6.6	16.8	12.0	8.5	16.1	16.3	9.7	8.8	23.1	10.1	26.4	8.7
SLC35E3	BLOV1	ENSG00000175782	"Solute carrier family 35 member E3"	Q7Z769	12	68746125-68793964	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049403	Uncertain					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 52: Non-specific - Transcription"			"HPA049403: AB_2680747"	"unprognostic (1.49e-1)"	"unprognostic (6.47e-2)"	"unprognostic (2.19e-1)"	"prognostic favorable (1.78e-4)"	"unprognostic (1.61e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.26e-4)"	"unprognostic (2.64e-1)"	"unprognostic (2.65e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.25e-2)"	"unprognostic (6.98e-2)"	"unprognostic (6.85e-3)"	"unprognostic (1.48e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.89e-3)"	"unprognostic (1.80e-1)"	0.9	1.3	1.2	0.6	1.2	1.5	0.7	2.6	1.6	0.8	0.4	0.7	0.4	0.6	0.8	0.9	0.5	0.5	0.7	1.1	0.6	0.7	1.1	0.8	0.7	1.2	0.7	0.7	1.0	0.3	0.6	0.3	1.5	0.8	0.3	1.4	1.0	0.2	0.9	1.5	0.7	0.3	0.3	0.9	0.6	0.4	1.4	0.5	0.6	0.3	0.4	0.8	0.8	2.6	0.4	0.4	0.6	0.5	0.5	0.4	0.7	0.4	0.2	0.3	0.1	0.8	0.4	1.6	0.2	0.3	0.3	0.6	0.3	0.3	0.3	0.5	0.5	0.7	1.0	0.9	0.2	0.6	0.5	0.5	0.4	0.4	0.3	0.5	0.3	0.6	0.5	0.9	0.3	0.4	0.3	1.1	0.5	0.2	0.6	2.1	0.8	0.3	0.2	0.7	0.5	0.7	0.6	0.6	0.3	0.3	0.6	0.4	0.5	0.9	0.4	0.7	0.5	1.0	0.5	2.2	0.9	0.6	0.4	2.0	0.4	0.3	0.3	0.2	0.2	0.4	0.3	0.3	0.1	0.7	0.3	0.4	1.9	0.6	0.3	0.5	0.4	0.1	1.2	1.2	2.6	1.6	1.1	0.6	1.2	0.7	1.5	0.3	1.4	2.6	15.1	12.8	22.4	10.7	21.5	7.9	23.7	20.7	8.6	72.0	16.9	17.3	18.4	12.8	19.7	18.4	39.6	24.8	22.7	5.0	5.9	18.8	7.8	17.7	15.7	16.2	13.1	15.6	16.0	22.7	23.9	20.7	6.1	15.2	18.3	32.9	16.8	23.7	15.7	43.7	19.1	10.2	12.2	29.6	6.6	2.0	15.2	30.2	7.2	4.7	27.4	29.2	28.8	17.6	40.4	18.9	6.7	23.0	24.3	17.1	11.2	11.7	19.4	68.2	26.3	31.0	16.3	8.8	14.3	19.0	7.5	12.4	20.9	30.3	12.6	17.9
SLC35E4		ENSG00000100036	"Solute carrier family 35 member E4"	Q6ICL7	22	30635781-30669016	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 22.9"	"Group enriched"	"Detected in many"	4	"Early spermatids: 122.2;Late spermatids: 108.6;Spermatocytes: 55.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 22.8;U-2197: 21.0;U-87 MG: 22.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049558	Approved		Approved	Cytosol		NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol		"HPA049558: AB_2680817"	"unprognostic (2.09e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.01e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.03e-4)"	"unprognostic (5.71e-2)"	"unprognostic (7.85e-2)"	"unprognostic (1.76e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.39e-2)"	"unprognostic (3.45e-7)"	"unprognostic (2.77e-3)"	"unprognostic (1.77e-1)"	"unprognostic (2.24e-2)"	"unprognostic (8.05e-3)"	2.6	1.8	3.5	1.4	5.0	1.5	2.2	2.9	6.7	2.6	0.4	3.2	1.0	3.5	1.3	2.8	2.5	1.1	3.4	4.1	3.5	2.4	0.5	2.0	0.8	4.7	4.5	1.9	1.7	1.7	2.3	0.4	4.7	2.3	1.7	1.5	2.1	1.3	11.1	5.3	1.8	1.4	1.9	1.9	3.4	22.9	4.5	0.3	1.6	2.8	0.5	3.1	2.8	7.3	10.0	4.3	1.6	3.2	4.3	10.9	0.9	6.4	5.6	4.3	4.0	0.3	2.6	0.7	3.4	6.6	6.1	6.2	2.8	3.7	2.2	22.8	3.1	0.1	3.3	0.3	6.1	0.4	2.7	3.5	1.6	17.3	5.4	6.8	14.9	0.8	0.9	2.8	6.8	2.8	0.4	1.9	1.9	2.9	16.2	1.8	3.2	0.3	2.0	0.8	8.7	3.4	6.6	2.8	3.2	0.7	2.0	0.7	20.0	18.2	5.8	21.0	6.2	0.8	0.9	0.3	22.3	0.3	4.9	0.6	0.6	0.1	0.2	0.8	0.4	0.0	0.6	0.9	1.1	0.1	0.5	0.5	0.2	0.6	0.7	0.3	0.7	0.3	3.5	5.0	2.9	6.7	4.1	3.5	4.7	4.5	4.7	1.9	4.5	7.3	5.7	0.0	1.5	2.6	2.7	14.5	2.5	1.9	8.0	10.6	2.0	3.7	1.9	0.0	1.2	1.8	22.9	0.1	4.8	5.4	0.0	3.4	122.2	6.0	4.9	9.1	2.4	0.8	4.2	2.3	0.5	3.7	2.6	2.0	1.3	4.1	4.2	0.3	1.8	11.8	4.9	4.4	2.0	1.2	7.7	108.6	3.4	8.0	3.6	4.7	2.5	17.2	1.0	2.5	9.2	2.5	11.1	3.8	3.1	1.7	1.2	0.4	5.7	10.5	0.0	3.9	5.0	55.1	3.8	4.2	19.0	0.1	4.9	2.4	5.0	2.1
SLC35F1	"C6orf169, dJ230I3.1"	ENSG00000196376	"Solute carrier family 35 member F1"	Q5T1Q4	6	117907264-118317676	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 21.3;retina: 13.2"	"Group enriched"	"Detected in some"	17	"Astrocytes: 380.0;Excitatory neurons: 394.8;Inhibitory neurons: 503.6;Oligodendrocyte precursor cells: 1344.6"	"Cancer enriched"	"Detected in some"	4	"glioma: 15.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	9	"AF22: 47.8;WM-115: 81.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019576	Enhanced		Approved	"Nucleoplasm,Centriolar satellite,Cytosol"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 68: Oligodendrocytes - Mixed function"	Nucleoplasm	"Centriolar satellite, Cytosol"	"HPA019576: AB_2190216"	"unprognostic (1.46e-1)"	"unprognostic (5.67e-2)"	"unprognostic (7.08e-2)"	"unprognostic (1.37e-3)"	"unprognostic (3.31e-1)"	"unprognostic (4.99e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.64e-2)"	"unprognostic (3.04e-2)"	"unprognostic (4.44e-3)"	"unprognostic (2.19e-1)"	"unprognostic (8.83e-4)"	"unprognostic (3.04e-3)"	"unprognostic (6.03e-2)"	"unprognostic (8.32e-2)"	"unprognostic (2.02e-1)"	1.4	1.2	17.1	0.9	19.0	0.0	0.6	6.3	21.3	1.2	0.6	4.9	0.4	1.2	3.0	0.6	1.8	0.6	3.4	16.2	11.0	0.6	0.0	0.1	0.0	8.5	12.4	0.3	0.4	0.1	0.5	0.0	8.3	1.2	0.9	13.2	0.5	1.3	0.3	0.4	1.4	1.1	9.0	0.7	1.1	0.6	12.3	0.0	0.6	0.3	0.0	0.7	0.9	16.4	0.0	0.0	47.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.0	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	1.6	0.0	0.9	0.0	0.0	0.4	0.0	6.1	6.9	0.0	0.0	0.3	0.0	81.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.1	19.0	6.3	21.3	16.2	11.0	8.5	12.4	8.3	9.0	12.3	16.4	0.9	0.0	0.0	380.0	0.1	0.4	0.1	0.0	0.0	15.8	0.1	0.0	6.9	0.0	1.3	0.0	2.1	0.0	0.3	0.0	0.0	0.0	17.9	0.0	0.2	0.2	0.0	0.0	394.8	0.4	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.1	16.8	503.6	0.0	0.0	0.0	0.0	38.3	0.6	0.3	14.2	27.2	0.0	27.6	0.0	1344.6	10.3	0.0	0.0	1.2	0.1	1.0	0.0	0.1	0.0	2.2	0.0	1.1	5.4	3.0	2.6	0.0	0.0	0.0	0.1	0.1	0.0	0.1
SLC35F2	FLJ13018	ENSG00000110660	"Solute carrier family 35 member F2"	Q8IXU6	11	107790991-107928293	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 37.4"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 46.0;Basal prostatic cells: 34.5;Suprabasal keratinocytes: 50.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"PC-3: 188.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA048185, HPA060150"	Enhanced		Approved	"Golgi apparatus"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA048185: AB_2680304, HPA060150: "	"unprognostic (7.73e-2)"	"unprognostic (3.28e-3)"	"unprognostic (8.37e-3)"	"unprognostic (5.77e-2)"	"unprognostic (1.38e-3)"	"unprognostic (3.07e-2)"	"unprognostic (7.26e-2)"	"prognostic unfavorable (4.03e-4)"	"unprognostic (6.22e-2)"	"unprognostic (8.20e-2)"	"prognostic unfavorable (5.92e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.10e-2)"	"unprognostic (1.34e-1)"	"unprognostic (7.33e-2)"	"unprognostic (3.25e-2)"	"unprognostic (1.19e-1)"	4.1	1.2	3.3	7.2	3.9	5.1	5.5	2.3	3.6	16.3	3.2	17.9	19.0	6.3	11.6	12.2	13.5	5.1	3.5	3.8	4.2	10.0	0.5	5.7	7.9	3.5	3.4	5.0	5.4	6.0	3.4	3.2	3.3	22.3	20.4	12.7	37.4	6.1	1.1	20.5	17.8	4.6	4.3	4.0	7.0	4.5	3.5	5.5	7.2	1.5	13.9	7.9	9.5	3.6	30.8	19.8	2.3	30.1	15.2	22.6	29.0	6.8	3.9	17.3	22.7	84.2	31.4	51.2	67.7	20.1	94.1	63.1	37.3	60.5	34.2	40.3	34.8	28.5	18.1	34.1	24.8	65.0	14.2	15.7	36.9	58.3	123.1	53.2	91.7	38.3	74.0	20.7	13.0	17.0	28.3	69.7	20.5	67.5	188.4	57.7	23.9	68.9	100.1	26.7	46.6	20.1	21.9	54.8	14.8	24.7	38.1	15.2	68.0	33.4	53.9	0.8	73.5	54.6	62.5	53.9	21.4	22.0	22.4	0.3	0.2	0.0	3.1	0.1	8.2	10.6	5.3	5.4	6.9	6.5	1.9	2.7	0.6	3.7	0.0	0.3	13.5	1.8	3.3	3.9	2.3	3.6	3.8	4.2	3.5	3.4	3.3	4.3	3.5	3.6	2.7	9.6	1.5	2.0	10.3	46.0	34.5	6.4	14.8	1.1	3.7	2.3	0.6	7.2	9.6	3.7	12.5	0.9	2.5	21.5	3.9	9.5	0.3	13.6	2.8	13.7	6.0	1.7	3.9	8.2	19.1	8.3	6.1	22.9	2.5	5.0	0.7	0.0	4.8	0.0	4.4	10.1	4.1	0.3	15.0	1.0	0.9	3.6	23.2	6.5	3.7	1.2	1.0	4.0	0.4	25.9	10.0	2.6	23.6	20.6	15.1	6.4	0.1	8.0	6.6	2.8	3.1	0.3	7.5	8.6	50.3	4.5	5.7	4.9	24.7	16.6
SLC35F3	FLJ37712	ENSG00000183780	"Solute carrier family 35 member F3"	Q8IY50	1	233904676-234324511	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.7"	"Group enriched"	"Detected in some"	6	"Excitatory neurons: 485.2;Inhibitory neurons: 216.1;Oligodendrocyte precursor cells: 190.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	35	"plasmacytoid DC: 3.5"	"Lineage enriched"	"Detected in single"	35	"dendritic cells: 3.5"	"Cell line enriched"	"Detected in some"	7	"HDLM-2: 111.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA051327, HPA061582"	Uncertain		Approved	"Nucleoli,Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Golgi apparatus"	Nucleoli	"HPA051327: AB_2681443, HPA061582: AB_2684563"	"unprognostic (1.11e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.07e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.26e-1)"	"unprognostic (8.62e-2)"	"unprognostic (2.69e-5)"	"unprognostic (3.38e-2)"	"unprognostic (1.94e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.86e-2)"	"unprognostic (9.09e-2)"	"unprognostic (1.57e-3)"	"unprognostic (7.83e-2)"	"unprognostic (2.11e-1)"	"unprognostic (3.62e-1)"	"unprognostic (3.58e-1)"	0.0	1.1	6.9	0.3	17.7	0.1	2.5	9.5	15.5	0.3	0.0	0.4	0.1	0.3	0.7	0.5	0.4	0.1	0.0	5.4	0.7	0.7	0.0	0.2	0.8	1.6	0.3	0.1	3.5	1.4	2.6	0.0	1.9	0.5	0.1	0.3	2.5	0.2	0.2	0.6	0.2	0.2	0.2	0.2	0.7	0.2	2.5	2.3	0.5	0.1	0.5	0.0	0.5	9.5	3.0	7.9	1.6	0.0	0.0	0.0	0.0	1.1	0.1	0.0	0.0	0.0	14.9	0.0	0.0	0.1	0.2	0.6	0.1	7.7	0.0	111.9	0.2	0.0	5.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	12.1	1.7	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	9.0	0.0	0.0	0.0	7.7	0.0	4.2	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.1	0.2	0.1	0.0	0.0	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.0	0.0	6.9	17.7	9.5	15.5	5.4	0.7	1.6	0.3	1.9	0.2	2.5	9.5	0.1	0.0	0.0	8.5	0.9	0.4	2.4	0.3	10.8	2.1	3.0	8.9	0.7	0.0	0.1	0.0	0.0	0.0	9.5	0.0	3.9	1.4	0.7	5.9	1.6	0.1	1.8	0.0	485.2	3.4	0.0	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	216.1	0.1	26.4	0.0	0.0	0.9	0.0	0.6	0.0	9.4	0.9	0.0	0.0	190.5	45.4	0.6	0.0	0.0	0.0	1.1	0.0	0.1	0.0	0.5	0.0	0.8	0.1	0.6	1.5	0.8	0.1	0.0	0.4	0.0	0.0	0.2
SLC35F4	"C14orf36, FLJ37712"	ENSG00000151812	"Solute carrier family 35 member F4"	A4IF30	14	57563920-57982194	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"brain: 5.6;retina: 6.4;seminal vesicle: 3.5"	"Cell type enriched"	"Detected in some"	12	"Inhibitory neurons: 166.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPMI-8226: 1.5;U-87 MG: 2.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043853	Uncertain		Approved	"Nucleoli fibrillar center"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoli fibrillar center"		"HPA043853: AB_10963083"	"unprognostic (2.37e-1)"	"unprognostic (2.10e-1)"	"unprognostic (3.56e-1)"	"unprognostic (2.66e-4)"	"unprognostic (4.88e-2)"	"unprognostic (8.64e-2)"		"unprognostic (1.38e-1)"		"unprognostic (1.76e-2)"	"unprognostic (3.94e-2)"	"unprognostic (1.39e-1)"	"unprognostic (4.03e-3)"	"unprognostic (3.50e-2)"	"unprognostic (1.05e-2)"	"unprognostic (9.68e-3)"	"unprognostic (9.23e-2)"	0.0	0.0	0.7	0.0	0.9	0.0	0.0	5.6	0.7	0.3	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.4	1.4	0.0	0.0	0.0	0.0	1.7	1.4	0.0	0.1	0.0	0.0	0.0	1.8	1.3	0.0	6.4	0.0	3.5	0.0	0.0	0.0	0.3	2.9	0.0	0.0	1.0	2.3	0.0	0.8	0.0	0.0	0.0	0.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.9	5.6	0.7	0.4	1.4	1.7	1.4	1.8	2.9	2.3	0.6	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.0	7.1	0.0	0.0	0.4	0.0	0.0	0.0	4.2	0.0	0.0	0.0	0.0	0.1	11.7	0.1	0.0	0.2	0.0	0.0	12.2	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	166.3	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.5	5.3	0.1	0.0	3.0	0.0	0.0	0.0	0.1	0.0	13.7	0.0	0.0	0.1	2.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC35F5	FLJ22004	ENSG00000115084	"Solute carrier family 35 member F5"	Q8WV83	2	113705011-113756693	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034828, HPA049229"	Uncertain		Uncertain	"Plasma membrane"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 59: Non-specific - Transcription"	"Plasma membrane"		"HPA034828: AB_2674350, HPA049229: AB_2680682"	"unprognostic (1.59e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (8.37e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.62e-2)"	"unprognostic (4.73e-3)"	"unprognostic (3.94e-2)"	"unprognostic (5.68e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.93e-2)"	"unprognostic (1.77e-1)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.64e-1)"	"unprognostic (1.84e-1)"	"unprognostic (2.33e-1)"	"unprognostic (4.83e-2)"	9.8	22.8	4.6	6.0	5.9	8.0	14.3	12.0	6.6	9.3	31.5	14.7	13.7	10.3	11.5	11.1	8.0	11.1	11.0	6.1	6.4	18.0	14.6	9.9	9.0	6.7	4.8	12.4	15.1	17.4	5.2	11.1	7.1	11.2	13.6	14.1	9.8	6.9	12.3	20.3	12.9	8.9	5.4	10.1	12.9	7.1	5.2	5.7	23.7	11.2	10.0	8.0	6.3	12.0	9.7	9.6	7.7	4.9	48.6	36.8	14.0	15.9	13.2	7.7	12.9	24.3	18.9	18.5	22.1	21.9	21.3	8.7	12.2	12.5	17.9	5.7	4.9	9.7	9.6	19.7	20.8	12.8	24.0	46.8	17.4	17.9	25.9	22.1	15.2	4.6	7.7	11.2	19.1	8.5	5.6	14.0	3.6	15.0	5.2	6.5	13.1	9.7	52.5	15.8	2.1	6.0	12.9	14.5	11.5	12.8	9.4	12.6	12.7	14.3	6.3	9.2	6.7	9.7	8.7	8.2	16.8	8.9	13.6	2.9	0.7	0.6	0.5	0.8	0.6	0.9	0.5	0.4	0.6	1.2	0.6	0.6	2.1	1.0	1.2	0.9	0.9	0.6	4.6	5.9	12.0	6.6	6.1	6.4	6.7	4.8	7.1	5.4	5.2	12.0	18.9	22.4	19.8	39.5	18.0	25.4	31.1	20.0	31.9	10.3	20.4	9.8	25.4	21.5	30.4	73.5	22.9	46.3	11.6	44.1	11.7	28.7	28.3	32.4	21.9	15.4	14.5	9.9	43.4	28.5	72.0	24.8	28.5	38.6	24.1	14.4	12.5	20.8	28.3	5.0	47.0	25.6	12.2	13.4	17.2	15.6	12.5	14.6	8.8	39.4	15.5	21.0	7.2	65.4	83.2	23.1	29.7	13.9	37.5	35.3	47.9	45.1	26.3	19.6	0.0	14.2	22.7	60.0	20.5	32.7	34.0	66.4	10.8	41.0	24.8	35.1
SLC35F6	"ANT2BP, C2orf18, FLJ20555, TANGO9"	ENSG00000213699	"Solute carrier family 35 member F6"	Q8N357	2	26764284-26781231	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HHSteC: 129.9;Karpas-707: 117.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034655	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 31: Skin - Epidermis development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Nucleoplasm, Cytosol"	"HPA034655: AB_10696359"	"unprognostic (2.26e-1)"	"unprognostic (7.45e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.54e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (1.11e-4)"	"prognostic unfavorable (3.71e-4)"	"unprognostic (3.44e-2)"	"unprognostic (1.35e-1)"	"unprognostic (3.24e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.84e-1)"	"unprognostic (1.07e-2)"	"unprognostic (9.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.06e-2)"	18.6	20.7	9.6	7.3	10.5	4.6	16.2	10.1	9.2	14.5	8.4	10.1	7.9	11.9	7.3	22.0	10.7	7.3	13.8	9.6	11.8	19.5	17.7	11.9	6.5	13.9	12.9	8.5	10.3	21.3	10.8	9.4	12.3	11.4	5.7	5.8	14.5	8.1	12.8	21.2	10.0	10.1	10.4	10.8	11.3	5.1	13.0	5.7	16.0	9.9	7.6	12.1	13.0	11.6	24.6	43.6	12.3	32.6	41.7	19.4	20.4	14.9	20.3	16.8	15.2	27.9	44.5	6.6	23.4	18.7	42.0	29.4	18.1	26.9	11.8	11.5	10.1	7.6	16.4	23.3	129.9	7.8	36.4	29.8	26.9	18.9	62.7	7.6	19.9	9.6	14.2	117.3	16.9	40.5	10.0	7.0	7.6	17.2	10.9	8.9	35.9	10.9	44.1	20.3	9.6	12.7	22.8	37.4	25.4	10.1	14.1	8.2	19.2	21.8	24.0	30.7	15.2	23.9	32.6	12.9	23.6	13.4	21.0	12.1	18.1	8.0	11.9	25.6	7.0	4.8	8.2	10.8	11.4	3.6	5.3	7.9	11.7	13.6	30.9	7.8	5.9	9.5	9.6	10.5	10.1	9.2	9.6	11.8	13.9	12.9	12.3	10.4	13.0	11.6	39.0	12.8	10.5	11.8	5.9	17.0	13.2	10.2	7.4	17.2	17.5	10.2	13.5	28.6	11.1	33.1	6.2	24.1	12.0	21.5	7.9	34.2	1.7	13.4	29.7	20.8	9.1	0.8	6.9	38.7	22.3	25.2	12.2	22.8	1.3	11.9	31.8	25.4	51.2	15.2	7.9	11.2	8.2	61.0	16.8	1.5	18.3	28.8	28.4	4.7	19.8	19.2	11.3	9.0	10.8	48.2	14.3	12.0	5.5	18.3	21.5	57.2	9.0	11.1	26.3	17.8	20.2	3.7	7.1	14.9	25.7	38.0	10.6	16.8	11.2	11.7
SLC35G1	"C10orf60, FLJ33990, TMEM20"	ENSG00000176273	"Solute carrier family 35 member G1"	Q2M3R5	10	93893973-93956062	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 68.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 26.9;Peritubular cells: 36.5;Proximal enterocytes: 47.4;Theca cells: 59.2"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"				"unprognostic (1.94e-2)"	"unprognostic (1.90e-1)"	"unprognostic (9.48e-2)"	"unprognostic (1.65e-1)"	"unprognostic (7.90e-4)"	"unprognostic (8.89e-2)"	"unprognostic (9.01e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.47e-2)"	"unprognostic (7.90e-2)"	"unprognostic (2.09e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.65e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.28e-1)"	"unprognostic (3.02e-1)"	"unprognostic (2.30e-1)"	0.8	0.8	0.1	1.0	0.1	0.3	0.7	0.2	0.1	0.4	1.0	6.0	68.4	0.8	0.8	1.1	0.4	0.6	1.4	0.1	0.2	0.5	3.7	0.8	0.8	0.3	0.2	1.0	9.5	2.1	1.1	0.8	0.4	0.7	5.8	0.2	1.4	0.8	0.6	1.5	33.4	0.9	0.1	0.6	2.0	3.4	0.2	0.4	1.4	0.2	0.6	1.1	0.7	0.1	6.2	6.1	2.9	3.3	0.9	2.5	3.8	5.4	6.2	5.2	6.5	4.8	4.2	3.9	2.1	3.6	3.4	11.1	6.7	2.1	7.9	4.8	7.0	3.2	3.7	3.6	1.3	6.1	6.1	2.4	2.1	3.9	2.3	1.7	2.3	3.5	3.0	2.2	3.1	2.2	2.9	1.3	3.7	2.2	7.1	0.0	4.6	1.5	2.5	5.3	3.7	3.4	7.2	3.5	4.6	2.4	3.7	2.0	2.9	3.8	6.1	6.8	5.6	2.5	2.4	1.3	2.8	0.0	2.7	0.0	0.1	0.7	0.1	0.1	0.4	0.1	0.8	0.5	0.1	0.1	0.8	0.5	0.0	0.0	0.0	0.1	1.1	0.2	0.1	0.1	0.2	0.1	0.1	0.2	0.3	0.2	0.4	0.1	0.2	0.1	3.2	3.2	3.9	1.0	2.4	3.1	2.1	2.2	2.2	4.3	1.5	2.7	4.7	5.7	1.6	7.3	4.2	3.0	0.6	26.9	3.9	2.3	20.3	1.8	5.0	4.7	4.2	3.0	2.6	9.7	6.1	4.4	3.1	1.3	0.0	19.9	5.0	5.8	2.3	1.7	6.4	5.0	2.0	3.3	1.2	9.2	17.1	0.9	5.4	1.0	3.1	4.8	0.0	5.0	0.9	3.1	18.3	36.5	2.2	1.3	47.4	1.2	1.3	2.7	0.0	3.6	2.4	19.1	9.2	4.1	1.8	0.8	3.6	59.2	8.3	2.3
SLC35G2	"DKFZp564K2464, MGC3295, TMEM22"	ENSG00000168917	"Solute carrier family 35 member G2"	Q8TBE7	3	136818647-136855888	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 54.2;Early spermatids: 65.4;Inhibitory neurons: 42.4;Spermatocytes: 35.5"	"Cancer enhanced"	"Detected in many"		"glioma: 6.2"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"memory CD8 T-cell: 1.0"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.0"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 73.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052054, HPA064728"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA052054: AB_2681709, HPA064728: AB_2685336"	"unprognostic (1.04e-1)"	"unprognostic (1.46e-2)"	"unprognostic (6.91e-4)"	"unprognostic (2.56e-4)"	"unprognostic (5.34e-2)"	"unprognostic (6.73e-2)"	"unprognostic (1.16e-5)"	"unprognostic (1.83e-3)"	"unprognostic (1.12e-1)"	"unprognostic (6.39e-2)"	"unprognostic (1.49e-2)"	"unprognostic (3.32e-1)"	"prognostic unfavorable (1.16e-7)"	"unprognostic (1.00e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.07e-2)"	"unprognostic (2.30e-2)"	14.9	15.4	20.9	2.1	21.2	0.5	11.1	23.1	26.4	5.1	16.5	3.8	1.0	4.3	4.6	2.6	5.7	5.3	8.1	20.0	24.4	3.9	4.4	7.0	1.9	21.4	25.0	5.5	7.6	6.7	19.3	7.4	26.9	4.1	2.0	5.3	3.1	2.6	2.4	3.7	2.9	5.1	22.1	3.2	2.9	14.4	22.6	2.8	8.5	5.4	1.2	6.5	5.0	21.0	3.9	10.7	10.6	4.8	20.8	17.1	0.0	16.9	73.1	24.7	37.0	10.1	5.7	0.0	12.7	17.5	39.3	1.3	12.7	0.7	22.8	0.1	3.5	3.2	12.0	6.3	26.6	0.1	0.0	24.2	1.8	21.5	5.9	18.0	18.8	6.8	1.8	0.1	32.1	0.0	4.7	3.3	2.3	0.0	7.9	4.2	7.1	0.2	21.1	0.9	17.5	11.7	13.7	0.0	24.0	3.6	0.0	1.8	13.1	18.4	4.7	8.2	18.6	0.0	0.0	0.0	25.4	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.1	20.9	21.2	23.1	26.4	20.0	24.4	21.4	25.0	26.9	22.1	22.6	21.0	22.4	12.8	7.0	54.2	2.5	3.3	4.9	12.0	7.4	4.7	0.7	0.8	2.5	1.5	7.1	1.8	12.5	1.3	2.7	0.8	1.9	3.3	65.4	1.0	1.6	30.6	4.2	4.4	34.0	10.7	1.3	12.4	0.5	1.3	2.5	3.6	27.8	2.3	0.7	6.7	42.4	1.0	0.0	2.2	7.3	30.3	9.9	2.1	3.6	17.8	3.7	7.8	15.5	15.6	6.1	10.0	0.1	3.0	3.7	4.7	0.6	0.7	1.4	4.6	6.6	4.7	4.8	35.5	16.1	1.2	3.0	2.2	3.8	3.1	0.6	2.0
SLC35G3	"AMAC1, FLJ40154, TMEM21A"	ENSG00000164729	"Solute carrier family 35 member G3"	Q8N808	17	35192520-35194523	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	7	"testis: 2.3"	"Cell type enriched"	"Detected in some"	9	"Early spermatids: 30.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"		"Cluster 23: Spermatids - Flagellum & Golgi organization"					"unprognostic (1.88e-1)"		"unprognostic (2.67e-1)"		"unprognostic (6.17e-3)"				"unprognostic (3.83e-1)"				"unprognostic (6.24e-2)"	"unprognostic (3.06e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SLC35G4	"AMAC1L1, SLC35G4P"	ENSG00000236396	"Solute carrier family 35 member G4"	P0C7Q5	18	11609596-11610612	"Predicted membrane proteins, Transporters"				"No human protein/transcript evidence"	"No human protein/transcript evidence"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC35G5	"AMAC, AMAC1L2"	ENSG00000177710	"Solute carrier family 35 member G5"	Q96KT7	8	11331012-11332360	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"testis: 2.4"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 13.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 71: Testis - DNA repair"		"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (7.00e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.05e-1)"	"unprognostic (9.67e-2)"	"unprognostic (2.60e-4)"	"unprognostic (6.48e-3)"	"unprognostic (4.09e-1)"	"unprognostic (5.79e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.61e-2)"	"unprognostic (3.44e-1)"	"unprognostic (2.06e-6)"	"unprognostic (7.88e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.34e-1)"	"unprognostic (2.04e-3)"	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.2	0.2	0.3	0.0	0.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.0	0.0	0.6	0.1	2.4	0.0	0.0	0.2	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.3	0.7	0.1	0.2	0.2	0.0	1.7	0.5	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.5	0.1	0.0	0.2	13.8	0.2	0.3	0.4	0.0	0.0	0.3	0.4	0.3	0.2	0.0	0.2	0.0	0.2	2.2	0.1	0.5	1.7	0.3	0.3	2.0	0.3	0.3	1.8	0.0	0.2	0.0	1.0	0.1	0.2	0.0	1.0	0.6	0.4	0.0	0.4	0.1	0.5	0.1	0.0	0.4	3.1	0.0	1.3	0.1	2.3	0.3	0.0	0.1	0.0	0.6	0.1	0.4	0.3
SLC35G6	"AMAC1L3, TMEM21B"	ENSG00000259224	"Solute carrier family 35 member G6"	P0C7Q6	17	7481332-7483496	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	9	"testis: 5.1"	"Cell type enriched"	"Detected in some"	5	"Early spermatids: 31.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA				"Cluster 78: Testis - Spermatogenesis"		"Cluster 29: Early spermatids - Spermatogenesis"				"unprognostic (3.81e-2)"	"unprognostic (5.10e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.11e-3)"		"unprognostic (1.37e-2)"	"unprognostic (1.65e-3)"	"unprognostic (3.29e-1)"	"unprognostic (9.19e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.13e-1)"	"unprognostic (5.21e-2)"	"unprognostic (3.79e-2)"	"unprognostic (2.01e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.6	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	1.6	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SLC36A1	"LYAAT-1, PAT1, TRAMD3"	ENSG00000123643	"Solute carrier family 36 member 1"	Q7Z2H8	5	151437046-151492379	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 76.3;parathyroid gland: 103.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 52.9;Early spermatids: 76.7;Excitatory neurons: 92.8;Inhibitory neurons: 62.1;Oligodendrocyte precursor cells: 48.7;Proximal enterocytes: 48.4"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in many"	9	"cerebellum: 76.3"	"Group enriched"	"Detected in many"	4	"basophil: 21.7;classical monocyte: 8.7;neutrophil: 19.6"	"Group enriched"	"Detected in many"	5	"granulocytes: 21.7;monocytes: 8.7"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035937	Approved					NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035937: AB_10672995"	"unprognostic (5.49e-2)"	"unprognostic (4.04e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.27e-3)"	"unprognostic (1.91e-1)"	"unprognostic (2.02e-1)"	"prognostic unfavorable (6.30e-5)"	"unprognostic (1.86e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.29e-3)"	"unprognostic (5.08e-2)"	"unprognostic (2.78e-1)"	"prognostic unfavorable (1.83e-6)"	"unprognostic (2.66e-2)"	"unprognostic (1.03e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.42e-1)"	6.3	4.9	2.0	7.9	2.8	29.5	4.0	76.3	8.4	3.6	0.0	14.8	44.2	4.0	4.4	5.4	3.3	10.4	3.1	3.1	0.0	4.7	2.8	5.6	6.1	4.6	3.2	3.2	6.2	103.2	3.7	5.5	5.3	12.5	22.5	1.9	4.8	6.2	7.8	4.9	39.3	6.6	0.0	8.5	4.4	13.4	0.6	18.4	3.1	5.9	5.3	6.0	4.2	4.1	5.4	9.2	4.7	3.2	11.6	8.5	25.4	15.4	8.6	10.4	11.7	21.2	7.8	12.4	8.9	18.5	11.1	13.0	15.1	9.5	10.2	3.4	13.1	3.8	14.7	7.1	14.9	9.3	20.3	6.2	10.8	8.8	5.8	2.9	9.4	6.7	9.0	10.5	8.9	5.9	2.7	4.6	4.7	6.8	8.6	0.0	11.4	4.9	2.7	8.0	4.2	8.0	9.6	11.4	5.6	9.5	8.7	13.4	9.5	13.8	7.7	22.8	8.7	5.0	7.6	7.9	8.8	16.0	9.4	21.7	8.7	3.6	1.5	3.8	1.1	2.0	1.4	2.5	3.0	2.1	1.1	1.0	19.6	0.4	4.1	0.6	1.6	1.3	2.0	2.8	76.3	8.4	3.1	0.0	4.6	3.2	5.3	0.0	0.6	4.1	2.1	0.0	1.7	10.4	2.3	1.5	1.4	1.1	1.2	1.0	4.1	1.3	3.0	4.3	1.3	1.8	2.1	0.6	1.9	52.9	0.0	1.8	76.7	1.1	3.6	1.4	0.0	32.4	92.8	2.0	8.1	3.6	10.2	1.3	1.3	18.0	3.6	2.0	13.9	1.7	62.1	5.4	0.0	22.7	3.0	29.5	5.0	10.6	1.8	11.2	6.2	0.8	1.0	48.7	30.4	1.8	22.2	11.7	2.3	1.9	48.4	4.6	0.6	1.1	0.0	1.7	2.4	0.5	2.0	4.5	1.3	0.3	2.4	0.8	9.8	1.8
SLC36A2	"PAT2, TRAMD1, tramdorin"	ENSG00000186335	"Solute carrier family 36 member 2"	Q495M3	5	151314972-151347590	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	60	"kidney: 67.6;skeletal muscle: 80.2;tongue: 29.8"	"Cell type enriched"	"Detected in some"	8	"Proximal tubular cells: 53.0"	"Cancer enriched"	"Detected in single"	9	"renal cancer: 0.5"	"Not detected"	"Not detected"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA044002, HPA062229"	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 8: Non-specific - Mitochondria"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA044002: AB_10964214, HPA062229: AB_2684717"	"unprognostic (3.47e-1)"	"unprognostic (3.40e-1)"		"unprognostic (2.26e-2)"	"unprognostic (6.23e-2)"	"unprognostic (8.38e-3)"	"unprognostic (4.66e-3)"	"unprognostic (3.03e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.92e-1)"	"unprognostic (1.20e-3)"	"unprognostic (1.43e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.18e-1)"	"unprognostic (3.89e-2)"	0.2	0.1	0.2	0.1	0.1	0.3	0.1	0.8	0.6	0.0	0.1	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.2	0.1	0.0	67.6	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.2	0.9	0.0	80.2	0.2	0.0	0.0	0.0	0.1	0.0	0.9	0.1	0.0	0.0	29.8	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.2	0.3	0.1	0.1	0.1	0.3	0.1	0.1	0.0	0.4	0.2	0.2	1.1	0.4	0.1	0.4	0.1	0.1	0.2	0.1	0.8	0.6	0.1	0.0	0.2	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	0.0	0.0	0.0	0.0	5.9	0.0	6.1	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	5.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	53.0	0.0	0.0	0.0	1.8	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1
SLC36A3	"PAT3, TRAMD2, tramdorin2"	ENSG00000186334	"Solute carrier family 36 member 3"	Q495N2	5	151276358-151303766	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	30	"testis: 7.5"	"Group enriched"	"Detected in some"	132	"Early spermatids: 48.4;Late spermatids: 110.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 83: Testis - Spermatogenesis"		"Cluster 25: Spermatids - Spermatogenesis"					"unprognostic (5.41e-1)"				"unprognostic (5.38e-1)"		"unprognostic (7.01e-2)"	"unprognostic (2.13e-1)"				"unprognostic (2.20e-2)"	"unprognostic (3.98e-1)"	"unprognostic (2.57e-2)"		"unprognostic (2.18e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	48.4	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	110.9	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC36A4	"FLJ38932, PAT4"	ENSG00000180773	"Solute carrier family 36 member 4"	Q6YBV0	11	93144174-93197991	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017887	Enhanced		Approved	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Golgi apparatus, Plasma membrane, Cytosol"		"HPA017887: AB_2190238"	"unprognostic (1.23e-2)"	"unprognostic (1.08e-1)"	"unprognostic (2.17e-3)"	"unprognostic (1.32e-3)"	"unprognostic (3.66e-2)"	"unprognostic (8.77e-2)"	"unprognostic (1.08e-3)"	"unprognostic (7.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (7.97e-2)"	"unprognostic (2.09e-2)"	"unprognostic (8.04e-3)"	"unprognostic (7.07e-2)"	"unprognostic (4.40e-2)"	"unprognostic (1.74e-1)"	"unprognostic (9.45e-3)"	"unprognostic (4.20e-2)"	5.8	7.4	4.2	9.3	4.6	19.4	4.6	8.1	5.8	5.1	6.2	5.4	2.0	7.1	2.1	5.3	4.8	5.7	6.0	4.0	8.5	9.4	7.8	6.0	5.3	7.2	6.9	5.7	5.7	6.5	7.7	6.2	7.7	4.9	6.4	15.3	3.7	5.9	2.4	4.1	3.1	8.1	5.5	4.1	4.3	4.3	6.1	7.3	8.8	2.3	6.7	6.9	3.6	7.0	10.4	18.2	36.5	7.3	12.7	25.6	20.5	17.6	29.2	25.6	31.0	14.6	33.1	12.5	9.9	16.5	13.3	12.5	11.4	6.5	23.4	21.1	13.3	14.5	35.3	9.8	10.0	36.6	20.6	12.4	20.0	14.9	9.2	12.0	14.0	17.6	1.3	0.2	26.5	2.6	16.3	27.4	14.8	4.0	18.4	7.2	21.7	5.1	8.7	15.1	33.6	43.8	25.7	9.9	6.4	26.4	18.0	10.6	15.7	48.0	14.8	28.6	26.0	5.1	10.9	0.0	10.9	15.0	25.4	0.1	4.9	5.3	0.8	2.6	1.0	0.9	0.6	1.0	1.9	1.0	1.5	1.0	1.5	0.5	1.7	0.7	0.5	1.1	4.2	4.6	8.1	5.8	4.0	8.5	7.2	6.9	7.7	5.5	6.1	7.0	11.9	12.8	11.5	35.9	29.5	30.7	43.2	9.7	25.6	21.2	10.3	8.0	11.5	20.0	7.1	20.2	22.9	10.7	13.6	3.1	35.2	24.4	9.9	15.5	19.2	18.5	27.6	5.5	66.8	43.6	25.8	21.9	18.8	5.7	4.5	29.0	13.2	9.1	13.6	26.9	71.0	19.6	10.2	52.3	47.1	4.2	18.0	50.1	21.4	27.2	42.8	20.7	13.4	45.2	59.4	33.2	6.3	15.4	22.1	70.4	0.4	16.2	20.8	24.2	6.6	18.0	18.1	7.3	3.3	11.8	32.0	16.3	15.7	20.6	4.3	30.6
SLC37A1		ENSG00000160190	"Solute carrier family 37 member 1"	P57057	21	42496008-42581440	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 45.8"	"Group enriched"	"Detected in many"	5	"Early spermatids: 308.6;Late spermatids: 319.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 125.4;MCF7: 50.1;OE19: 54.0;SK-BR-3: 42.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA030418, CAB034154"	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 9: Intestine - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 34: Spermatids - Unknown function"			"CAB034154: AB_2190373, HPA030418: AB_10601602"	"unprognostic (1.44e-2)"	"unprognostic (2.93e-2)"	"unprognostic (2.12e-1)"	"prognostic favorable (9.22e-5)"	"unprognostic (1.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.10e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.99e-2)"	"unprognostic (5.94e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.16e-1)"	"unprognostic (4.08e-2)"	"unprognostic (7.94e-2)"	"prognostic favorable (3.43e-5)"	"unprognostic (1.61e-2)"	4.2	8.9	7.2	10.3	6.0	12.5	9.1	5.8	6.4	5.4	1.8	23.9	45.8	3.3	6.3	13.7	9.6	13.5	4.4	5.5	6.5	6.0	5.7	11.7	9.8	5.7	4.7	3.9	6.5	3.7	17.9	5.4	5.4	15.1	19.5	6.4	19.3	5.1	9.5	6.6	39.2	3.4	4.7	9.2	24.0	8.3	5.6	7.1	12.3	3.4	9.3	12.5	8.6	4.1	13.7	5.3	1.4	2.5	0.1	0.2	11.5	0.5	0.0	0.5	0.3	3.3	27.0	9.6	13.7	0.0	8.2	5.4	2.7	6.9	0.0	4.5	6.6	125.4	4.6	0.2	3.2	2.7	11.9	0.7	4.0	0.1	0.3	0.0	4.0	10.8	2.5	12.9	0.0	50.1	9.7	7.0	9.3	54.0	3.1	9.9	0.0	0.3	11.2	25.8	14.1	1.7	8.0	42.4	3.5	1.3	16.1	14.0	7.1	0.0	2.5	0.1	0.0	24.7	16.4	9.2	0.0	20.6	1.4	5.4	4.9	37.1	7.5	13.2	9.5	11.1	5.2	6.7	7.0	7.4	4.3	6.1	5.7	6.9	17.0	19.8	3.0	6.8	7.2	6.0	5.8	6.4	5.5	6.5	5.7	4.7	5.4	4.7	5.6	4.1	6.7	19.2	27.7	11.8	17.7	2.2	8.5	9.9	0.6	3.0	36.6	7.0	4.1	17.2	17.6	12.9	6.2	7.1	20.9	59.5	0.0	26.1	308.6	34.1	3.6	5.2	30.1	11.0	18.6	30.9	6.0	3.1	52.5	18.9	1.3	3.2	3.9	5.5	8.8	3.3	16.0	39.6	14.2	9.1	3.0	319.3	7.2	12.3	7.2	18.7	15.2	36.6	1.0	6.0	1.5	33.8	56.2	2.6	17.2	27.0	61.9	2.2	32.9	4.1	0.0	2.2	5.4	51.7	5.4	4.7	1.6	8.6	10.6	2.7	37.9	20.8
SLC37A2	FLJ00171	ENSG00000134955	"Solute carrier family 37 member 2"	Q8TED4	11	125063302-125090516	"Predicted membrane proteins, Transporters"	"Antiport, Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 78.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 13.4;Hofbauer cells: 36.5;Kupffer cells: 22.0;Macrophages: 22.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	10	"classical monocyte: 12.3;intermediate monocyte: 14.1;myeloid DC: 5.5;non-classical monocyte: 19.2"	"Group enriched"	"Detected in many"	9	"dendritic cells: 5.5;monocytes: 19.2"	"Cell line enhanced"	"Detected in many"		"A-431: 33.8;CAPAN-2: 70.3;hTCEpi: 34.9;hTERT-HME1: 64.8;U-138 MG: 47.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA014948	Uncertain					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 4: Macrophages - Innate immune response"			"HPA014948: AB_2190374"	"unprognostic (8.47e-2)"	"unprognostic (4.85e-1)"	"unprognostic (9.64e-2)"	"unprognostic (2.91e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.84e-1)"	"unprognostic (5.47e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.06e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.15e-2)"	"unprognostic (3.11e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.94e-3)"	"unprognostic (1.66e-3)"	"unprognostic (7.01e-2)"	"unprognostic (3.24e-2)"	4.2	24.2	1.7	16.9	2.6	1.4	4.6	2.4	3.7	2.3	2.1	8.0	9.1	1.0	1.3	13.4	1.2	5.1	1.5	1.9	2.3	0.7	5.9	5.9	5.7	4.3	2.7	1.0	1.2	1.1	0.2	7.4	3.8	2.6	10.2	0.5	78.8	1.4	0.6	20.9	7.7	3.1	3.2	15.8	2.1	1.6	5.2	2.1	0.6	0.9	5.1	11.9	7.7	7.3	33.8	0.1	1.0	0.4	0.6	0.8	0.6	1.6	2.8	1.0	2.5	0.2	70.3	0.4	9.4	0.4	2.5	21.0	0.4	20.9	3.8	0.9	0.6	6.6	1.6	2.4	0.1	0.3	0.9	0.7	34.9	2.6	64.8	2.7	1.7	1.3	0.5	2.2	3.1	0.3	0.3	4.6	1.9	0.2	1.0	0.4	2.7	0.8	1.0	17.6	0.3	0.3	4.8	2.9	2.6	0.5	0.3	1.8	3.7	47.2	1.9	0.7	1.6	1.8	1.5	1.1	1.7	2.4	4.1	0.2	12.3	0.0	0.0	14.1	0.0	0.4	0.0	0.1	5.5	0.1	0.1	0.1	1.3	0.0	19.2	0.2	0.0	5.4	1.7	2.6	2.4	3.7	1.9	2.3	4.3	2.7	3.8	3.2	5.2	7.3	0.7	0.0	0.6	0.3	3.8	0.3	1.4	0.5	1.2	1.5	1.4	1.1	1.1	1.5	1.6	0.0	2.1	0.6	0.7	13.4	0.0	0.1	1.6	1.9	1.4	1.3	0.0	2.7	0.3	0.0	0.8	0.5	0.0	4.9	2.5	0.4	1.8	0.3	36.5	0.0	0.3	0.1	0.0	22.0	1.4	2.2	0.9	22.7	0.0	8.4	7.3	0.3	3.1	1.0	0.2	0.1	3.3	1.2	1.7	1.0	0.0	0.1	0.2	0.8	0.0	0.8	0.6	2.7	1.1	5.7	0.9	3.4	1.2	0.4	0.1	3.2
SLC37A3	DKFZp761N0624	ENSG00000157800	"Solute carrier family 37 member 3"	Q8NCC5	7	140293693-140404433	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"									NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"				"unprognostic (2.39e-1)"	"prognostic unfavorable (9.54e-4)"	"unprognostic (1.44e-1)"	"unprognostic (5.59e-2)"	"unprognostic (2.69e-2)"	"unprognostic (2.35e-1)"	"prognostic unfavorable (4.78e-5)"	"unprognostic (1.97e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.16e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.82e-1)"	"unprognostic (1.49e-1)"	"unprognostic (5.50e-2)"	19.2	10.2	10.6	10.6	11.5	12.3	21.5	10.9	14.0	30.2	7.4	26.4	14.1	44.0	23.9	11.4	23.4	19.1	12.8	10.8	11.3	15.8	12.8	16.5	9.1	10.3	9.3	20.7	25.7	35.0	17.1	21.8	10.6	14.7	24.5	11.3	23.3	12.7	7.8	13.5	16.4	31.9	8.9	15.7	18.4	7.4	11.7	11.7	21.3	9.9	10.6	22.1	18.3	11.0	18.0	29.9	30.3	53.3	42.7	46.6	36.2	26.3	30.8	17.9	26.6	23.9	38.1	2.7	32.6	24.0	45.8	14.5	18.5	32.0	27.3	40.6	27.1	3.5	7.8	24.1	35.9	0.2	9.7	36.8	32.3	19.0	22.0	31.2	27.9	15.5	18.2	7.3	27.8	34.3	17.5	1.6	44.9	43.2	18.4	9.5	8.1	8.2	34.5	37.0	29.8	36.7	7.3	29.5	29.7	32.3	15.9	1.7	32.0	20.4	14.8	51.8	27.3	14.0	28.4	6.9	21.6	0.2	47.7	7.6	3.6	3.7	6.5	2.0	3.5	2.3	6.9	5.1	3.0	1.7	7.3	5.5	12.3	5.9	1.3	0.9	8.6	3.6	10.6	11.5	10.9	14.0	10.8	11.3	10.3	9.3	10.6	8.9	11.7	11.0	8.5	9.6	12.4	14.4	6.0	15.2	39.8	11.8	8.6	11.4	12.1	8.6	5.1	10.0	16.1	12.9	10.4	17.5	5.8	21.0	1.9	22.3	1.6	24.9	43.8	11.6	21.6	6.1	37.1	26.9	26.4	30.6	19.9	21.3	8.2	15.0	13.2	7.3	4.0	13.5	29.0	22.2	14.2	5.1	9.7	2.3	20.2	3.3	19.6	13.1	7.4	3.6	11.3	26.7	22.4	28.6	14.7	13.5	4.2	31.4	11.2	5.7	18.4	9.0	6.6	15.1	16.9	4.6	5.9	8.5	12.4	13.1	10.6	5.1	18.1	37.4
SLC38A1	"ATA1, NAT2, SAT1"	ENSG00000111371	"Solute carrier family 38 member 1"	Q9H2H9	12	46183063-46270017	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 443.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"U-698: 386.1"	"Low region specificity"	"Detected in all"							"HPA039460, HPA052272"	Uncertain	Supported				NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"			"HPA039460: , HPA052272: AB_2681781"	"unprognostic (8.92e-3)"	"unprognostic (3.23e-2)"	"unprognostic (9.47e-2)"	"prognostic unfavorable (4.76e-6)"	"unprognostic (1.00e-1)"	"unprognostic (3.74e-1)"	"prognostic unfavorable (6.95e-8)"	"unprognostic (2.01e-3)"	"unprognostic (1.38e-1)"	"unprognostic (4.19e-3)"	"unprognostic (2.44e-2)"	"unprognostic (3.99e-2)"	"unprognostic (1.19e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.00e-1)"	"unprognostic (5.55e-2)"	8.2	5.3	20.0	38.5	18.6	26.0	81.8	48.2	18.9	13.6	0.6	39.3	16.7	16.4	8.7	26.6	15.5	16.6	44.6	15.3	42.3	20.3	6.4	13.2	64.4	44.1	25.4	9.9	23.8	78.7	19.3	22.5	34.6	29.5	38.5	79.0	20.5	35.6	90.7	30.5	22.9	27.8	48.4	31.9	21.3	1.1	26.8	59.5	42.5	82.4	54.4	23.4	11.2	59.7	77.6	79.2	28.2	104.9	12.4	4.5	142.8	60.6	98.2	27.3	42.7	136.6	74.9	176.3	113.0	74.7	83.6	116.5	94.8	124.5	50.4	109.6	49.8	12.3	127.4	51.2	108.3	126.1	4.5	21.7	186.7	8.2	325.1	67.5	61.6	112.0	65.2	144.2	86.5	96.5	112.7	22.0	104.1	0.1	122.7	99.8	6.9	124.6	105.4	109.8	111.6	77.2	126.2	152.9	71.7	108.0	88.9	91.1	129.8	21.2	19.7	0.6	62.7	136.2	126.5	386.1	67.9	242.2	18.6	1.0	0.8	26.3	51.8	0.2	71.0	50.4	54.1	61.0	34.9	57.8	62.6	57.1	2.4	68.3	0.4	44.3	63.5	46.4	20.0	18.6	48.2	18.9	15.3	42.3	44.1	25.4	34.6	48.4	26.8	59.7	10.3	35.3	44.7	75.4	150.0	97.8	73.8	103.8	30.1	443.5	136.5	64.8	207.5	38.6	61.8	213.3	141.8	106.9	216.3	99.3	3.9	56.3	0.2	78.1	9.8	26.7	40.6	25.6	104.7	46.4	79.3	14.6	19.4	123.7	3.8	30.9	5.7	6.1	12.2	8.4	157.8	73.6	79.3	12.9	76.1	0.3	2.1	23.3	26.6	30.9	13.6	51.4	107.1	94.5	59.7	53.5	52.8	0.7	138.8	66.5	23.6	1.1	29.7	54.2	0.0	62.9	34.5	0.1	0.4	70.3	122.7	185.7	167.9	1.6	93.6	75.4
SLC38A10	"MGC15523, PP1744"	ENSG00000157637	"Solute carrier family 38 member 10"	Q9HBR0	17	81244811-81295547	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021374, HPA023161, HPA024631"	Enhanced		Enhanced	"Golgi apparatus"		NA	NA		70000000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA021374: AB_1853858, HPA023161: AB_2190402, HPA024631: AB_1853860"	"unprognostic (2.18e-2)"	"unprognostic (1.54e-1)"	"unprognostic (7.40e-2)"	"unprognostic (3.00e-3)"	"unprognostic (2.06e-2)"	"unprognostic (1.69e-1)"	"unprognostic (2.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.92e-2)"	"prognostic favorable (2.92e-4)"	"unprognostic (8.39e-2)"	"prognostic unfavorable (5.34e-7)"	"unprognostic (6.55e-2)"	"unprognostic (3.15e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.45e-1)"	37.6	37.0	12.7	23.4	14.0	30.8	31.2	12.7	16.1	33.0	14.7	31.7	31.8	35.3	17.3	24.0	31.7	25.8	36.8	10.5	13.8	31.6	75.2	31.4	21.4	21.5	14.9	37.7	91.4	15.6	62.1	24.6	15.7	34.2	9.5	4.4	51.1	20.8	20.0	25.2	34.7	15.4	13.3	43.8	38.8	30.5	16.6	12.9	41.3	6.3	10.6	37.6	26.8	19.4	45.2	77.5	13.3	70.2	49.8	23.3	77.6	53.7	48.2	32.5	38.2	36.1	73.0	34.4	59.2	37.3	36.0	53.0	13.5	27.1	12.0	34.7	40.0	34.6	28.5	61.2	44.4	34.1	78.4	40.7	19.7	29.2	18.9	26.2	62.2	24.5	26.3	51.3	24.6	56.5	21.0	59.4	12.9	41.3	37.6	33.8	27.8	34.8	22.2	42.3	25.7	65.7	43.2	26.9	59.2	18.3	38.1	70.0	61.9	52.2	29.9	38.9	29.4	44.6	21.4	20.0	30.9	51.8	54.5	12.7	10.6	18.6	7.4	11.9	8.7	6.2	7.1	9.1	6.2	7.0	4.8	5.4	8.0	4.6	15.9	9.8	5.6	9.5	12.7	14.0	12.7	16.1	10.5	13.8	21.5	14.9	15.7	13.3	16.6	19.4	24.4	25.6	35.6	25.8	28.6	8.3	12.3	21.9	13.6	10.9	25.3	18.0	19.3	31.5	24.6	11.0	18.8	61.0	29.8	66.4	5.9	31.9	25.4	17.3	13.7	22.4	45.0	22.3	12.3	26.9	62.4	35.9	44.9	32.8	15.2	64.6	27.5	79.2	49.3	25.2	14.3	58.8	12.2	40.6	15.1	75.6	32.9	35.7	14.2	28.1	29.1	27.7	23.7	9.0	20.5	25.1	53.1	27.4	96.5	16.0	59.1	23.9	21.4	9.1	32.9	17.0	21.2	19.7	22.8	11.8	7.2	62.5	25.0	39.9	48.2	11.4
SLC38A11	"AVT2, FLJ39822"	ENSG00000169507	"Solute carrier family 38 member 11"	Q08AI6	2	164896186-164955525	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 28.7;epididymis: 38.6"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 28.6;Enteroendocrine cells: 174.1;Excitatory neurons: 53.4;Sertoli cells: 72.3;Smooth muscle cells: 39.8"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 7.6"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	28	"memory B-cell: 1.6;naive B-cell: 3.9"	"Lineage enriched"	"Detected in single"	39	"B-cells: 3.9"	"Cell line enriched"	"Detected in some"	9	"BJ hTERT+: 249.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA043432	Uncertain					NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 17: Intestinal endocrine cells - Hormone signaling"			"HPA043432: AB_10793948"	"unprognostic (1.52e-1)"	"unprognostic (2.59e-1)"	"unprognostic (4.14e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.69e-2)"	"unprognostic (6.28e-3)"	"unprognostic (3.53e-2)"	"unprognostic (2.41e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.15e-3)"	"unprognostic (1.99e-1)"	"prognostic favorable (2.00e-8)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (2.43e-2)"	"unprognostic (2.36e-2)"	2.0	4.0	6.0	1.5	6.4	0.1	0.8	3.8	11.2	2.6	28.7	1.5	6.0	1.7	38.6	1.0	0.8	17.7	1.3	6.2	3.9	7.9	2.6	0.4	2.0	3.9	4.2	0.3	2.2	1.3	3.3	0.3	4.3	10.8	2.7	0.3	0.6	16.9	0.9	0.6	2.7	2.0	3.5	8.1	11.7	0.2	5.8	0.3	2.1	4.0	1.3	1.5	1.1	6.3	0.0	0.6	0.0	0.0	0.0	0.0	0.1	28.9	249.7	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.4	0.0	0.1	0.0	5.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	6.0	6.4	3.8	11.2	6.2	3.9	3.9	4.2	4.3	3.5	5.8	6.3	0.9	0.0	0.0	6.2	7.0	0.0	0.3	0.0	0.0	0.1	0.1	0.0	0.9	28.6	0.0	3.7	0.0	0.7	2.7	0.5	0.0	3.2	2.1	0.1	0.5	2.7	174.1	2.7	53.4	0.6	0.6	0.3	5.1	0.1	0.0	0.0	0.4	3.7	0.0	0.0	2.9	6.4	0.0	0.0	0.3	1.2	0.0	0.0	0.0	17.8	0.0	0.1	0.0	0.5	1.2	0.8	2.3	0.0	0.0	3.2	1.0	2.0	0.0	0.1	72.3	0.5	39.8	0.1	0.0	0.2	0.3	1.5	0.9	4.4	0.7	0.2
SLC38A2	"ATA2, KIAA1382, SAT2, SNAT2"	ENSG00000134294	"Solute carrier family 38 member 2"	Q96QD8	12	46358188-46372773	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal keratinocytes: 1118.3;Suprabasal keratinocytes: 1078.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 1198.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035180, HPA069672"	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 85: Liver - Metabolism"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	"Plasma membrane"		"HPA035180: AB_10669901, HPA069672: "	"unprognostic (6.61e-3)"	"unprognostic (2.87e-2)"	"unprognostic (4.88e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.96e-1)"	"unprognostic (1.00e-2)"	"unprognostic (7.78e-2)"	"unprognostic (5.50e-3)"	"unprognostic (1.20e-1)"	"unprognostic (3.79e-1)"	"unprognostic (9.24e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.08e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.68e-2)"	112.8	113.0	36.1	71.6	48.5	95.4	88.5	53.9	50.2	91.7	25.8	58.3	33.6	92.9	38.6	108.1	83.6	131.3	60.7	32.4	46.1	64.8	307.3	117.0	67.1	52.2	42.7	130.1	74.7	91.5	27.9	162.1	53.5	52.8	49.7	27.0	77.2	43.1	108.5	204.4	54.4	115.8	44.2	75.3	63.0	25.4	44.2	100.4	63.1	174.7	78.1	98.9	88.0	73.0	83.7	179.9	157.6	444.1	356.7	347.7	118.1	382.8	921.2	313.0	254.0	108.2	151.2	0.1	504.2	627.9	215.3	271.1	107.9	335.1	299.1	67.0	61.0	105.8	208.7	339.9	548.8	88.0	108.7	357.2	718.4	199.5	1198.9	778.5	265.7	116.3	103.8	163.1	560.4	100.0	110.3	122.8	138.2	0.1	185.1	97.5	115.5	200.9	191.6	173.4	103.9	89.8	263.5	68.5	233.7	171.0	140.5	193.8	467.3	156.7	121.8	67.8	62.2	187.8	194.3	100.6	148.0	304.5	76.8	41.1	24.9	18.9	22.7	13.1	17.4	19.2	19.0	23.0	35.2	17.8	23.5	24.8	17.5	51.6	18.4	40.6	23.7	27.6	36.1	48.5	53.9	50.2	32.4	46.1	52.2	42.7	53.5	44.2	44.2	73.0	237.7	83.3	77.4	31.3	187.7	1118.3	134.1	262.8	653.9	40.5	315.7	252.2	153.6	108.7	123.9	57.0	70.9	53.8	292.3	114.6	5.9	41.2	5.5	228.5	245.0	234.7	76.7	109.0	54.6	51.1	49.3	219.1	328.2	464.0	81.6	138.3	227.7	265.9	54.0	53.8	58.9	175.0	130.2	143.3	303.6	12.4	263.2	193.8	250.8	59.0	52.6	74.3	70.0	42.3	136.2	79.4	83.5	85.0	322.2	181.7	67.4	24.4	50.3	68.7	282.7	184.8	339.5	6.7	15.5	532.6	1078.3	38.4	252.4	84.0	110.7	150.8
SLC38A3	"G17, SN1"	ENSG00000188338	"Solute carrier family 38 member 3"	Q99624	3	50205246-50221486	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"liver: 331.6;retina: 172.9"	"Group enriched"	"Detected in many"	6	"Bipolar cells: 88.3;Cone photoreceptor cells: 187.7;Hepatocytes: 114.6;Muller glia cells: 80.1;Rod photoreceptor cells: 124.0"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 140.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.9"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 2.9"	"Group enriched"	"Detected in some"	5	"Hep G2: 49.8;SCLC-21H: 15.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031871			Approved	Microtubules,Cytosol		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	Cytosol	Microtubules	"HPA031871: AB_2674080"	"unprognostic (2.14e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.60e-2)"	"unprognostic (6.19e-4)"	"unprognostic (7.37e-2)"	"unprognostic (9.61e-2)"	"unprognostic (2.34e-2)"	"unprognostic (2.30e-2)"	"unprognostic (4.68e-3)"	"unprognostic (1.46e-1)"	"unprognostic (2.06e-1)"	"unprognostic (5.71e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.96e-1)"	1.4	0.1	30.8	0.1	33.8	1.0	1.4	38.7	42.1	0.5	27.4	0.2	1.3	0.3	0.4	1.1	0.6	0.4	5.6	29.8	30.8	5.1	331.6	0.2	0.5	35.8	40.5	6.3	37.2	7.9	4.6	1.2	34.9	0.5	0.1	172.9	1.8	0.1	35.8	0.8	0.6	0.2	32.4	0.2	1.9	1.9	36.4	0.0	1.3	35.8	0.3	0.1	0.4	35.0	0.0	0.0	1.2	7.0	0.1	0.0	1.7	0.0	0.0	1.3	0.6	4.1	0.0	0.1	1.1	0.0	0.3	0.0	1.9	0.0	0.9	0.1	0.6	0.0	1.0	49.8	0.1	0.5	0.0	0.1	0.0	0.1	0.0	5.6	0.0	0.3	0.1	0.3	0.0	0.0	0.0	0.6	0.7	0.0	0.0	0.5	0.5	0.0	0.2	0.2	15.4	1.3	0.7	0.2	0.0	2.1	2.0	0.3	0.0	0.2	1.2	0.0	1.0	0.3	0.0	0.1	0.2	0.3	0.1	2.9	0.2	0.3	0.2	0.0	0.1	0.3	0.1	0.1	0.0	0.2	0.2	0.2	0.8	0.4	0.0	0.2	0.1	0.1	30.8	33.8	38.7	42.1	29.8	30.8	35.8	40.5	34.9	32.4	36.4	35.0	0.3	0.0	0.0	17.6	0.4	0.0	0.1	0.0	0.6	88.3	3.2	1.7	3.3	17.2	0.0	0.0	187.7	0.2	0.0	0.0	0.0	1.8	0.3	0.4	0.0	3.9	3.5	2.7	0.2	2.2	0.1	0.2	0.0	0.5	0.0	0.1	2.2	114.6	0.1	8.4	0.6	0.2	0.0	2.6	0.0	0.0	2.1	0.1	0.0	7.5	0.6	80.1	0.0	4.5	3.7	0.6	0.0	0.4	0.0	0.0	0.0	4.2	0.0	124.0	0.0	0.6	0.3	2.9	3.3	0.9	0.0	1.4	0.2	0.0	0.2	0.0
SLC38A4	"ATA3, NAT3, PAAT"	ENSG00000139209	"Solute carrier family 38 member 4"	Q969I6	12	46764761-46832408	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	60	"liver: 609.9"	"Cell type enriched"	"Detected in some"	25	"Hepatocytes: 289.5"	"Cancer enriched"	"Detected in many"	14	"liver cancer: 61.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"ASC diff: 17.7;LHCN-M2: 43.2;RH-30: 14.6;RT4: 86.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 62: Liver - Hemostasis"	"Cluster 15: RT4 - Unknown function"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (3.81e-2)"	"unprognostic (7.46e-3)"	"unprognostic (5.22e-3)"	"unprognostic (1.75e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.11e-1)"	"prognostic favorable (5.37e-4)"	"unprognostic (3.06e-2)"	"unprognostic (2.57e-3)"	"unprognostic (1.75e-2)"	"unprognostic (1.95e-1)"	"unprognostic (6.06e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.89e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.31e-3)"	"unprognostic (2.21e-2)"	0.8	1.1	0.2	0.3	0.2	0.0	1.2	0.1	0.4	0.5	0.5	5.1	0.4	2.2	0.2	1.7	0.9	0.3	0.3	0.1	0.6	4.4	609.9	0.3	0.2	0.2	0.3	0.2	6.6	0.2	0.1	2.2	0.1	1.3	1.3	0.1	0.8	0.5	10.2	2.6	0.5	5.4	0.2	1.2	0.2	0.3	0.7	1.4	0.3	2.6	0.8	2.0	0.2	0.3	0.0	0.0	0.1	0.0	17.7	2.2	3.4	2.3	5.6	2.0	1.8	1.1	4.3	0.0	3.5	7.8	0.0	1.0	0.0	0.6	1.7	0.0	0.0	0.1	0.0	0.2	0.7	0.5	0.0	4.2	0.1	0.1	1.4	0.1	0.0	0.0	0.2	0.0	43.2	0.0	0.1	0.0	1.3	0.0	0.0	0.0	14.6	0.0	0.0	86.0	0.3	0.0	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.2	0.5	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.4	0.1	0.6	0.2	0.3	0.1	0.2	0.7	0.3	0.1	0.0	0.0	2.6	0.5	0.8	0.0	2.2	3.4	0.0	0.1	0.0	1.5	11.5	0.2	1.8	0.0	2.5	0.0	1.9	0.0	0.0	0.2	0.4	0.2	1.2	0.0	5.3	0.6	0.0	0.7	1.2	0.0	0.2	0.0	1.6	3.9	289.5	0.5	0.0	2.2	0.4	2.0	6.7	0.0	0.8	0.3	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.2	1.2	0.0	0.0	0.7	0.3	0.4	0.2	0.0	0.0	0.3	0.2	0.0	0.1	2.8	0.6	0.8	0.4	2.7	1.3	0.1
SLC38A5	"JM24, SN2"	ENSG00000017483	"Solute carrier family 38 member 5"	Q8WUX1	X	48458537-48470260	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"pancreas: 237.2"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 196.3;Erythroid cells: 74.3;Exocrine glandular cells: 80.8;Pancreatic endocrine cells: 129.4;Plasma cells: 62.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HaCaT: 214.0;HBEC3-KT: 326.7;HeLa: 300.0;hTCEpi: 237.8;Karpas-707: 282.8;RPMI-8226: 539.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047411	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Vesicles, Plasma membrane"	Cytosol	"HPA047411: AB_10964355"	"unprognostic (2.81e-1)"	"unprognostic (4.87e-2)"	"unprognostic (7.92e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.26e-1)"	"unprognostic (7.75e-2)"	"unprognostic (5.79e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.80e-3)"	"prognostic unfavorable (2.13e-4)"	"unprognostic (2.99e-2)"	"prognostic unfavorable (2.22e-16)"	"unprognostic (1.27e-3)"	"unprognostic (1.45e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.20e-1)"	4.2	1.9	29.9	13.0	21.8	55.7	2.5	22.6	26.3	9.4	10.6	13.2	13.3	4.2	2.7	10.2	4.9	3.7	6.1	21.6	22.5	1.8	0.9	25.3	8.8	30.4	23.1	6.7	237.2	0.4	0.9	1.1	28.0	5.6	16.2	3.4	9.3	8.6	0.6	21.3	9.2	7.0	22.0	13.8	15.9	0.7	30.4	8.5	20.3	1.3	9.1	9.4	8.7	21.1	143.0	0.3	0.1	1.6	2.8	11.6	0.3	9.4	0.0	0.3	0.1	0.4	0.3	147.8	0.2	61.7	0.3	214.0	164.4	326.7	0.0	47.4	0.2	80.7	300.0	102.4	23.2	166.7	0.2	22.0	237.8	2.9	0.6	0.2	2.8	35.5	150.7	282.8	32.2	0.2	36.3	57.9	74.2	0.0	0.7	131.5	0.7	539.6	0.0	0.1	13.1	0.7	0.1	0.9	0.2	1.1	0.5	6.9	4.7	0.6	0.4	0.4	0.4	0.4	1.0	53.0	1.6	0.8	0.7	0.1	0.4	0.4	17.3	0.6	24.2	11.4	18.6	16.4	2.3	8.9	8.7	11.3	0.5	9.6	0.1	13.1	21.7	9.1	29.9	21.8	22.6	26.3	21.6	22.5	30.4	23.1	28.0	22.0	30.4	21.1	2.3	0.0	0.6	0.3	15.4	26.6	2.7	196.3	17.1	3.2	0.2	0.3	0.4	0.0	33.6	5.5	18.8	0.2	6.7	9.9	0.0	5.5	0.4	1.1	9.1	11.8	0.0	74.3	0.3	80.8	0.6	8.9	3.6	2.7	4.5	1.0	0.4	0.4	2.4	0.0	0.5	17.5	4.1	0.3	3.9	1.3	2.5	2.1	8.8	32.8	1.8	0.3	8.2	0.5	0.2	129.4	5.5	1.2	62.3	4.5	1.2	0.0	4.2	0.3	0.0	0.7	4.6	0.1	0.4	6.4	8.5	0.0	9.5	4.6	21.4	1.9
SLC38A6	NAT-1	ENSG00000139974	"Solute carrier family 38 member 6"	Q8IZM9	14	60981114-61083733	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 178.2;Excitatory neurons: 98.8;Hofbauer cells: 100.3;Inhibitory neurons: 77.4;Late spermatids: 124.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 68.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018508	Approved		Approved	"Plasma membrane,Cell Junctions,Microtubules"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 4: Macrophages - Innate immune response"	"Cell Junctions"	"Plasma membrane, Microtubules"	"HPA018508: AB_2190518"	"unprognostic (7.08e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.49e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.74e-2)"	"prognostic unfavorable (9.47e-6)"	"unprognostic (9.89e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (1.37e-5)"	"unprognostic (1.73e-1)"	"unprognostic (4.63e-2)"	"unprognostic (1.47e-1)"	"unprognostic (2.90e-1)"	7.6	9.1	6.0	4.7	6.6	2.9	7.4	6.1	9.5	7.3	8.9	4.8	3.1	5.1	13.2	3.3	5.6	9.9	3.7	6.9	6.5	12.0	6.3	8.6	7.8	5.4	6.0	5.8	3.4	21.3	7.2	9.6	6.0	5.1	6.6	7.5	5.9	3.9	2.1	2.9	3.5	5.3	5.0	6.6	3.8	5.0	7.4	5.0	6.3	3.0	4.8	7.0	5.0	6.7	16.2	21.5	6.8	12.3	68.7	25.3	4.9	11.6	34.5	10.7	10.2	5.4	41.0	4.0	19.2	10.6	22.5	13.5	6.8	11.9	9.8	6.0	3.2	6.7	8.6	14.2	22.7	3.7	12.1	19.9	4.9	10.5	12.2	43.2	14.3	6.8	9.3	8.4	37.5	9.2	6.6	8.4	4.0	9.5	14.3	1.6	20.1	11.9	30.7	8.5	3.3	3.0	9.9	7.0	19.1	9.3	10.4	5.8	15.6	16.4	7.1	20.0	6.5	1.6	4.9	1.6	34.0	3.0	13.1	0.0	6.6	0.1	1.7	7.1	2.2	2.2	3.1	2.4	3.6	2.0	2.7	3.4	0.2	0.8	4.5	4.4	4.5	2.8	6.0	6.6	6.1	9.5	6.9	6.5	5.4	6.0	6.0	5.0	7.4	6.7	6.8	22.4	6.7	31.6	6.0	5.2	11.4	14.6	8.0	19.7	7.2	7.5	4.3	7.2	10.0	5.5	22.9	5.6	4.9	2.6	1.9	5.3	178.2	13.0	11.0	7.2	4.2	3.4	98.8	2.8	9.4	11.2	5.1	6.2	6.3	7.3	4.2	4.6	100.3	5.0	77.4	3.1	6.1	24.8	10.0	124.4	10.8	26.2	5.4	20.6	6.4	11.7	2.1	54.3	30.8	7.4	1.9	6.0	5.8	6.6	3.3	23.1	40.4	24.9	0.0	12.3	9.1	16.6	11.5	6.4	2.8	6.7	7.8	5.0	2.8	6.9
SLC38A7	FLJ10815	ENSG00000103042	"Solute carrier family 38 member 7"	Q9NVC3	16	58665109-58684770	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 32.8"	"Group enriched"	"Detected in all"	13	"Early spermatids: 271.8;Late spermatids: 753.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041777, HPA049428"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 25: Spermatids - Spermatogenesis"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA041777: AB_10796782, HPA049428: "	"unprognostic (2.16e-3)"	"unprognostic (2.30e-2)"	"unprognostic (6.23e-3)"	"prognostic favorable (6.87e-4)"	"unprognostic (3.49e-1)"	"unprognostic (8.08e-3)"	"unprognostic (9.76e-3)"	"unprognostic (6.34e-3)"	"unprognostic (1.98e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.77e-1)"	"unprognostic (4.90e-2)"	"prognostic favorable (2.87e-4)"	"unprognostic (1.85e-1)"	"unprognostic (4.38e-2)"	"unprognostic (7.50e-2)"	"unprognostic (4.93e-3)"	6.0	11.4	7.5	6.0	7.8	2.6	5.3	6.0	8.9	5.1	6.1	5.1	4.3	5.5	6.2	6.5	4.0	5.6	15.9	7.9	7.4	7.3	13.6	5.4	4.3	7.7	7.6	4.6	4.8	14.1	7.2	7.5	8.1	5.5	5.9	4.7	6.2	4.6	9.4	5.3	5.5	7.4	5.8	10.3	5.4	32.8	9.8	3.6	7.8	8.3	4.6	5.4	4.9	7.0	6.9	10.9	10.8	16.5	22.0	12.9	19.3	16.2	18.7	22.7	15.6	9.9	11.0	4.5	8.9	22.9	17.9	15.9	10.2	11.7	13.3	2.8	9.4	5.1	9.3	16.5	32.9	10.6	14.0	25.9	23.6	16.1	10.3	12.3	23.5	10.4	14.9	6.3	16.7	8.0	4.3	6.3	11.7	7.5	16.0	15.2	11.6	12.1	10.0	15.4	7.9	11.3	25.7	17.0	7.0	14.4	7.6	4.2	18.7	12.3	9.3	21.8	5.0	9.7	6.7	5.2	16.8	6.3	9.3	0.1	6.8	2.0	4.0	6.6	2.2	1.3	2.4	2.9	4.5	2.5	1.9	2.1	0.5	1.8	6.4	1.7	1.8	5.5	7.5	7.8	6.0	8.9	7.9	7.4	7.7	7.6	8.1	5.8	9.8	7.0	3.3	3.2	4.4	7.8	2.0	3.8	4.0	4.4	1.2	9.8	4.7	3.2	12.8	4.3	4.8	11.0	12.5	8.4	5.0	3.7	3.9	14.0	271.8	3.5	6.8	6.2	13.1	2.1	13.3	8.5	9.5	5.1	9.7	6.0	1.3	10.7	8.2	9.3	38.6	16.8	15.5	3.1	12.2	10.1	8.2	753.3	9.6	11.6	8.8	9.4	4.0	7.1	8.2	5.0	7.6	12.8	2.7	8.6	1.8	3.7	4.8	5.9	3.8	7.1	6.6	4.8	5.1	6.9	7.6	4.6	4.3	15.3	2.7	8.6	4.9	3.2
SLC38A8		ENSG00000166558	"Solute carrier family 38 member 8"	A6NNN8	16	84009667-84042795	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Sodium transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.9"	"Cell type enriched"	"Detected in some"	4	"Late spermatids: 16.1"	"Cancer enriched"	"Detected in single"	14	"melanoma: 6.5"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"SCLC-21H: 2.5"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"									NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 31: Spermatids - Spermatogenesis"				"unprognostic (9.69e-2)"	"unprognostic (6.16e-2)"		"unprognostic (8.00e-3)"	"unprognostic (6.40e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.89e-1)"	"unprognostic (7.70e-2)"	"unprognostic (2.59e-1)"	"unprognostic (2.16e-2)"		"unprognostic (3.54e-2)"	"unprognostic (1.37e-1)"	"unprognostic (1.45e-1)"			0.0	0.1	3.7	0.0	3.9	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.7	1.0	0.8	0.0	0.1	0.0	0.0	1.1	1.6	0.0	0.2	0.1	0.7	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.3	0.4	3.0	0.5	0.0	0.1	0.0	0.0	0.0	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	3.9	0.0	1.3	1.0	0.8	1.1	1.6	0.9	0.6	3.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	0.2	0.0	0.1	0.0	0.0	0.6	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	1.0	0.0	1.4	0.0	0.0	0.0	0.0	16.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.5	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC38A9	FLJ90709	ENSG00000177058	"Solute carrier family 38 member 9"	Q8NBW4	5	55625845-55773194	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"placenta: 57.8"	"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 182.5;Early spermatids: 262.6;Syncytiotrophoblasts: 619.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 110.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043785, HPA061702"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA043785: AB_10961859, HPA061702: "	"unprognostic (4.80e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.26e-2)"	"prognostic unfavorable (7.24e-5)"	"unprognostic (2.49e-1)"	"unprognostic (8.19e-2)"	"unprognostic (8.35e-2)"	"unprognostic (7.95e-2)"	"unprognostic (5.47e-2)"	"unprognostic (9.44e-2)"	"unprognostic (1.74e-1)"	"unprognostic (4.87e-1)"	"unprognostic (4.18e-3)"	"unprognostic (1.76e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.12e-1)"	6.1	4.8	5.4	8.8	7.3	7.1	8.2	8.1	6.3	6.5	4.1	9.4	8.1	6.6	6.6	8.4	5.0	8.3	3.8	4.3	6.6	7.4	16.6	8.0	11.2	6.3	5.9	5.4	12.1	10.7	3.3	57.8	6.6	6.1	9.8	10.0	6.4	6.0	4.4	7.6	6.6	8.5	5.5	8.4	8.1	19.2	6.3	8.8	7.7	3.8	14.5	8.4	4.8	8.9	17.9	17.3	17.1	20.0	22.0	20.4	110.0	16.5	21.3	18.3	30.4	29.5	27.2	31.6	28.6	12.7	32.1	22.5	20.2	18.2	22.8	15.4	18.4	10.8	16.4	18.7	31.1	18.9	10.8	26.3	21.0	20.2	25.7	13.7	20.0	21.3	20.9	18.6	16.5	15.0	23.6	16.4	29.4	7.2	15.6	17.6	28.6	32.2	24.7	14.0	8.1	14.5	17.3	9.3	25.4	24.0	20.1	34.4	29.6	3.6	11.7	26.8	16.6	20.5	47.6	20.8	10.9	17.4	11.4	3.3	9.3	5.5	5.2	8.7	7.5	7.4	4.5	6.1	8.4	4.2	6.2	5.3	2.0	7.7	6.9	8.0	5.9	4.9	5.4	7.3	8.1	6.3	4.3	6.6	6.3	5.9	6.6	5.5	6.3	8.9	7.3	6.4	3.1	21.9	14.2	3.2	4.2	8.5	2.8	6.6	5.7	3.9	2.8	11.5	9.8	9.2	8.4	182.5	10.4	8.9	1.9	8.9	262.6	4.4	9.2	8.1	4.2	8.4	56.2	11.4	71.5	7.2	8.6	7.3	2.5	8.0	10.4	22.1	26.3	1.7	57.3	4.3	8.2	10.0	8.0	82.4	7.5	11.7	5.4	38.4	11.0	5.6	4.1	55.8	103.2	10.9	9.7	4.9	8.4	4.6	4.4	7.2	6.3	7.4	6.6	3.3	7.0	15.8	6.5	8.1	3.4	619.9	8.7	4.0	5.2	4.7
SLC39A1	"ZIP1, ZIRTL"	ENSG00000143570	"Solute carrier family 39 member 1"	Q9NY26	1	153959099-153968184	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 342.4;Ductal cells: 219.3;Extravillous trophoblasts: 297.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"				"unprognostic (6.27e-2)"	"prognostic unfavorable (4.83e-4)"	"unprognostic (1.13e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.07e-2)"	"prognostic unfavorable (5.26e-5)"	"prognostic unfavorable (4.12e-7)"	"unprognostic (2.36e-2)"	"unprognostic (2.62e-2)"	"unprognostic (4.41e-1)"	"unprognostic (4.83e-3)"	"unprognostic (1.93e-1)"	"unprognostic (5.10e-3)"	"unprognostic (2.54e-2)"	"unprognostic (1.23e-1)"	"unprognostic (5.51e-2)"	"unprognostic (6.68e-2)"	67.1	73.2	39.0	48.6	42.7	10.6	62.5	41.9	41.6	56.7	45.1	53.8	36.2	59.9	33.8	50.1	53.8	55.2	62.1	37.4	42.1	77.0	76.7	87.4	35.3	51.7	43.8	54.7	48.9	65.5	30.5	94.9	44.5	56.8	38.2	10.2	51.9	46.4	45.4	65.3	48.4	49.9	44.8	56.0	59.0	20.6	45.3	26.1	56.6	38.7	36.2	60.5	48.3	43.7	122.5	138.3	111.5	93.7	103.4	105.2	244.2	76.8	188.7	128.1	140.2	203.6	303.0	47.2	240.0	108.5	106.8	266.8	114.8	118.9	72.6	146.5	92.5	64.3	138.9	92.9	118.3	49.4	71.1	128.6	108.9	101.1	99.8	119.2	92.7	54.2	62.6	53.5	104.5	251.5	51.0	64.1	158.6	253.4	107.2	56.3	96.3	57.2	202.7	88.1	49.3	116.0	143.6	363.4	136.4	142.9	195.7	104.8	81.6	114.7	105.6	84.3	113.6	64.8	87.1	61.8	82.0	38.8	157.0	16.6	68.1	20.3	33.9	78.9	21.1	34.8	25.1	25.6	56.0	39.8	27.2	24.7	67.3	30.6	95.5	51.3	26.9	58.1	39.0	42.7	41.9	41.6	37.4	42.1	51.7	43.8	44.5	44.8	45.3	43.7	71.0	9.6	3.3	7.5	21.9	56.5	97.7	105.8	59.2	7.7	56.7	50.2	13.5	61.5	39.0	53.3	2.1	342.4	35.6	33.9	13.7	219.3	1.0	21.4	38.9	70.1	19.2	17.4	1.8	113.8	297.2	60.6	17.3	35.7	36.8	22.2	49.6	25.6	116.5	18.5	3.1	28.4	40.7	63.6	43.4	3.4	48.4	57.8	48.0	8.4	78.6	36.5	28.8	6.0	6.6	127.8	33.9	62.1	19.8	127.4	49.8	39.6	19.2	6.9	46.0	41.3	55.2	31.3	35.7	26.1	53.4	153.1	21.3	42.5	32.3	74.0
SLC39A10	"DKFZp564L2123, FLJ90515, KIAA1265"	ENSG00000196950	"Solute carrier family 39 member 10"	Q9ULF5	2	195575977-195737702	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"thyroid gland: 48.4"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 170.8;Microglial cells: 362.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036512, HPA036513, HPA066087"	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		250000	"Cluster 6: Non-specific - Transcription"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"HPA036512: AB_2675165, HPA036513: AB_10670801, HPA066087: AB_2685613"	"unprognostic (1.06e-1)"	"unprognostic (3.87e-3)"	"unprognostic (5.33e-2)"	"unprognostic (1.33e-3)"	"prognostic favorable (1.46e-5)"	"unprognostic (7.40e-2)"	"prognostic unfavorable (4.39e-5)"	"unprognostic (2.10e-2)"	"unprognostic (8.73e-2)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (3.23e-4)"	"unprognostic (8.46e-2)"	"unprognostic (9.71e-2)"	"unprognostic (1.34e-2)"	"unprognostic (3.68e-1)"	"unprognostic (2.47e-2)"	"unprognostic (6.89e-2)"	8.2	9.7	7.9	6.3	7.4	4.6	7.1	0.0	21.0	10.8	0.0	4.3	3.9	11.0	3.7	3.6	9.5	8.8	4.3	15.8	0.0	8.7	2.0	7.4	8.3	0.1	0.4	7.9	4.8	5.2	1.1	12.8	1.7	19.1	4.2	5.1	3.7	6.7	1.3	7.0	4.0	7.7	1.4	18.3	5.0	9.3	9.9	10.6	48.4	3.1	7.6	6.3	2.1	5.8	7.3	27.1	46.8	13.0	9.5	21.1	24.3	34.8	16.4	16.1	8.1	38.4	26.4	10.4	51.3	19.6	12.4	10.4	28.6	31.6	19.9	5.4	21.8	11.7	37.1	34.0	10.8	45.4	4.9	12.9	5.1	17.7	20.2	56.9	37.3	10.5	34.9	14.3	26.7	7.3	12.7	14.0	53.8	44.1	18.8	28.9	16.6	27.0	74.8	12.7	17.5	24.7	34.4	65.1	18.7	81.2	11.2	26.5	36.1	28.7	33.6	19.0	18.7	4.6	3.7	6.3	24.5	19.9	29.9	41.5	4.7	3.7	7.5	4.4	6.1	12.3	6.8	6.7	6.4	15.8	6.0	7.8	0.8	21.7	3.3	32.8	7.6	2.6	7.9	7.4	0.0	21.0	15.8	0.0	0.1	0.4	1.7	1.4	9.9	5.8	72.1	3.2	12.8	40.8	42.0	25.6	12.1	51.3	13.1	23.0	16.9	23.1	7.6	5.7	33.2	36.8	8.4	49.3	60.2	4.3	1.9	17.7	28.5	13.2	48.7	75.4	15.6	26.9	170.8	11.3	66.0	35.3	11.2	16.5	13.3	25.7	26.4	2.8	24.5	8.4	78.3	5.9	26.4	20.7	27.1	16.0	19.0	31.8	7.2	362.6	16.2	17.0	20.6	49.3	49.5	24.3	2.8	18.8	21.3	20.1	4.5	14.7	9.5	20.0	13.1	41.9	29.1	61.3	33.6	7.5	20.5	23.4	35.4	30.8	6.2	7.8
SLC39A11	C17orf26	ENSG00000133195	"Solute carrier family 39 member 11"	Q8N1S5	17	72645949-73092712	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 205.3;Excitatory neurons: 107.7;Oligodendrocytes: 360.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HMC-1: 217.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021455			Approved	Nucleoplasm		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm		"HPA021455: AB_2670710"	"unprognostic (2.29e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.82e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.37e-1)"	"unprognostic (3.45e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.57e-3)"	"unprognostic (5.26e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.96e-3)"	"unprognostic (3.85e-2)"	12.6	7.8	14.0	10.8	27.8	21.2	17.4	22.5	17.2	14.9	9.5	24.0	20.3	5.5	15.7	15.5	9.1	11.0	4.9	14.1	17.9	13.4	39.4	10.9	8.8	25.7	23.7	3.4	29.3	4.7	2.9	8.7	24.0	7.7	24.1	2.3	30.3	8.0	4.5	14.2	22.8	7.3	16.9	7.9	48.2	6.8	23.9	5.5	36.1	3.5	12.4	12.5	9.3	35.3	20.5	36.8	4.3	17.2	30.7	24.8	24.4	21.6	19.0	9.7	13.0	13.7	90.7	25.4	21.5	22.1	15.4	17.2	6.2	10.9	14.8	27.6	12.8	23.8	9.9	16.3	18.3	25.4	217.5	21.2	20.3	20.1	11.6	10.6	10.1	13.1	12.6	31.0	12.4	28.9	16.3	55.1	3.5	62.4	15.6	10.9	16.3	21.5	16.0	20.9	10.2	13.8	11.6	84.7	12.7	16.8	58.4	34.9	8.5	19.0	17.7	16.3	13.4	24.9	12.2	17.9	30.8	50.6	11.1	19.3	39.9	26.0	16.7	40.4	10.9	16.7	12.5	12.5	37.9	9.8	8.8	12.1	6.6	22.6	33.1	26.8	17.1	18.1	14.0	27.8	22.5	17.2	14.1	17.9	25.7	23.7	24.0	16.9	23.9	35.3	4.9	0.0	6.3	205.3	7.6	4.5	5.3	5.6	10.2	2.6	13.7	5.5	2.3	4.3	8.6	3.7	0.0	5.6	6.9	15.8	0.0	9.4	18.5	5.6	3.6	4.0	8.4	9.9	107.7	14.1	17.4	4.7	29.0	9.5	29.9	7.9	3.6	30.1	26.3	5.0	32.1	79.0	10.2	21.0	5.6	66.7	4.1	14.4	10.6	64.6	19.6	4.1	8.2	22.6	360.3	9.1	20.5	3.4	15.1	6.0	24.8	11.5	7.8	1.6	13.1	2.6	7.1	2.0	2.9	10.3	4.4	4.9	5.4	4.4	18.3	7.5
SLC39A12	FLJ30499	ENSG00000148482	"Solute carrier family 39 member 12"	Q504Y0	10	17951839-18043292	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	9	"choroid plexus: 353.4"	"Group enriched"	"Detected in some"	31	"Astrocytes: 133.5;Muller glia cells: 69.5"	"Cancer enriched"	"Detected in single"	8	"glioma: 3.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"		"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (1.43e-2)"				"unprognostic (2.67e-1)"	"unprognostic (3.30e-1)"		"unprognostic (8.70e-2)"	"unprognostic (1.02e-1)"		"unprognostic (8.35e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.40e-6)"	"unprognostic (1.94e-1)"	"unprognostic (8.11e-2)"	"unprognostic (3.76e-2)"		0.1	0.0	27.6	0.0	27.7	0.0	0.7	25.3	39.9	0.0	353.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.5	27.1	0.0	0.1	0.1	0.0	29.9	35.8	0.0	0.1	0.0	1.3	0.1	28.1	0.0	0.1	15.7	0.0	0.0	0.0	0.0	0.0	0.0	22.0	0.1	0.0	0.2	36.6	0.0	0.0	0.0	0.0	0.0	0.0	23.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	27.6	27.7	25.3	39.9	36.5	27.1	29.9	35.8	28.1	22.0	36.6	23.1	0.1	0.0	0.0	133.5	0.0	0.0	0.0	0.0	0.0	0.7	2.4	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.9	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.7	0.2	0.0	0.0	0.4	0.8	0.3	0.2	0.0	2.8	0.0	69.5	0.0	1.5	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0
SLC39A13	FLJ25785	ENSG00000165915	"Solute carrier family 39 member 13"	Q96H72	11	47407132-47416496	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Ehlers-Danlos syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	13	"Early spermatids: 298.2;Late spermatids: 905.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043971	Approved					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA043971: AB_10959744"	"unprognostic (7.84e-2)"	"unprognostic (1.02e-2)"	"prognostic unfavorable (2.60e-4)"	"unprognostic (1.18e-1)"	"unprognostic (8.56e-3)"	"unprognostic (3.81e-2)"	"unprognostic (7.44e-3)"	"unprognostic (1.36e-1)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (2.73e-5)"	"unprognostic (1.39e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (1.96e-4)"	"unprognostic (3.16e-1)"	"unprognostic (1.73e-1)"	"unprognostic (8.61e-2)"	"unprognostic (4.12e-1)"	40.9	42.4	28.3	24.2	31.4	8.3	37.5	30.6	36.3	51.1	30.4	53.4	14.0	77.9	8.8	21.8	48.1	20.2	59.5	26.0	27.3	80.4	26.7	61.4	18.2	33.0	29.7	50.9	42.3	27.2	51.3	40.6	30.4	52.7	6.8	11.0	31.3	26.2	31.4	32.4	31.8	26.6	26.8	36.5	41.2	73.4	35.0	12.3	46.8	12.6	8.7	45.6	37.4	28.5	23.3	20.4	23.5	26.7	56.3	78.2	6.8	89.7	66.2	50.4	57.0	8.1	15.7	8.8	22.9	69.6	49.6	38.3	7.1	61.7	13.9	25.7	25.9	4.7	52.7	16.7	84.3	8.1	11.0	65.4	43.4	31.9	26.1	62.9	53.4	16.9	4.5	19.6	54.8	20.7	17.4	11.5	11.0	19.8	28.2	20.6	33.6	8.9	86.1	11.1	19.9	37.0	26.9	49.1	26.2	8.7	32.8	11.7	76.0	76.6	34.6	88.1	42.7	14.9	5.2	4.1	85.2	11.2	57.3	2.1	3.6	3.2	12.4	13.3	8.5	4.1	8.2	8.9	4.6	5.1	7.5	6.4	6.6	7.4	15.3	4.9	4.5	5.9	28.3	31.4	30.6	36.3	26.0	27.3	33.0	29.7	30.4	26.8	35.0	28.5	20.0	9.6	6.4	18.6	6.7	18.2	18.3	23.0	17.1	24.0	11.5	15.6	18.3	15.7	8.0	29.5	12.5	11.1	11.6	3.4	9.8	32.9	298.2	6.5	20.3	20.9	9.6	4.4	9.6	20.7	16.4	37.8	6.6	13.1	5.7	15.4	21.8	6.2	18.9	32.0	11.7	7.9	14.2	5.3	12.2	905.5	32.9	9.3	19.6	4.7	26.6	16.7	11.3	8.0	10.1	35.5	8.3	40.3	8.1	23.5	8.2	8.8	4.5	17.0	46.0	16.1	36.2	12.7	6.4	2.4	4.1	19.6	9.6	36.7	5.7	8.3
SLC39A14	"KIAA0062, NET34, ZIP14"	ENSG00000104635	"Solute carrier family 39 member 14"	Q15043	8	22367278-22434129	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant, Dystonia, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 551.3;pancreas: 252.7"	"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 266.7;Hepatocytes: 611.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 321.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016508, HPA056732"	Enhanced		Approved	"Endoplasmic reticulum,Golgi apparatus,Plasma membrane"		NA	NA		1100000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum, Golgi apparatus, Plasma membrane"		"HPA016508: AB_1857148, HPA056732: "	"unprognostic (1.67e-1)"	"unprognostic (6.67e-3)"	"prognostic favorable (5.00e-5)"	"unprognostic (9.83e-3)"	"unprognostic (9.21e-3)"	"unprognostic (8.99e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.91e-2)"	"unprognostic (4.95e-2)"	"unprognostic (5.66e-2)"	"unprognostic (6.64e-2)"	"unprognostic (1.53e-1)"	"prognostic unfavorable (3.79e-7)"	"unprognostic (4.88e-2)"	"unprognostic (8.73e-2)"	"unprognostic (1.63e-2)"	"unprognostic (1.11e-3)"	63.5	72.4	13.0	35.5	11.0	1.4	39.8	11.9	13.1	17.3	39.7	48.2	142.2	30.2	6.2	11.6	25.9	32.0	76.7	14.5	22.9	30.8	551.3	23.9	7.6	43.0	30.4	27.7	252.7	12.9	21.5	19.0	25.7	22.3	50.3	18.6	21.8	18.7	43.0	20.0	84.9	33.0	13.3	8.1	80.5	26.5	25.3	6.0	87.7	17.4	6.9	56.0	14.5	14.8	51.8	68.3	18.4	37.6	65.1	54.7	40.1	72.8	321.0	111.3	173.5	226.9	47.9	51.1	39.9	86.1	288.9	55.6	92.8	91.1	181.9	53.1	49.2	40.8	51.0	230.7	154.3	28.5	43.2	58.4	72.6	198.0	136.9	56.3	50.5	36.5	36.2	51.2	57.3	24.0	43.4	18.2	113.4	81.9	49.8	60.1	34.9	110.8	40.8	22.3	31.3	48.7	74.3	31.3	151.4	39.7	25.1	39.4	28.0	137.3	69.2	87.4	75.7	29.2	28.7	66.9	194.3	37.7	81.9	0.0	0.4	2.1	6.7	0.1	7.2	4.0	3.8	5.0	1.5	1.9	4.3	5.9	0.1	2.7	0.1	0.7	3.4	3.4	13.0	11.0	11.9	13.1	14.5	22.9	43.0	30.4	25.7	13.3	25.3	14.8	12.4	3.2	7.7	11.4	9.1	33.3	11.5	10.8	18.8	7.8	20.3	16.6	66.6	41.5	3.8	7.3	2.1	0.4	3.6	91.6	1.9	47.6	0.5	136.1	58.3	32.2	33.4	10.5	26.2	74.7	2.7	58.8	47.9	266.7	0.0	20.8	29.6	611.4	1.8	48.8	24.6	60.6	6.1	15.4	25.8	3.2	23.9	2.9	44.4	6.5	2.7	5.2	2.1	9.0	3.9	47.3	39.1	41.8	13.5	26.5	75.6	24.6	1.1	8.2	0.0	47.1	32.2	0.7	3.0	4.1	21.0	0.5	7.4	14.7	43.5	9.4
SLC39A2	ZIP2	ENSG00000165794	"Solute carrier family 39 member 2"	Q9NP94	14	20999255-21001871	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 18.8;seminal vesicle: 33.2;skin 1: 37.5"	"Cell type enhanced"	"Detected in some"		"Muller glia cells: 22.3;Squamous epithelial cells: 12.0;Suprabasal keratinocytes: 6.0;Urothelial cells: 4.4"	"Group enriched"	"Detected in many"	4	"cervical cancer: 5.1;colorectal cancer: 3.3;head and neck cancer: 6.1;melanoma: 1.9;urothelial cancer: 6.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	71	"HaCaT: 23.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA030489, HPA073231"	Uncertain		Approved	"Plasma membrane,Cytoplasmic bodies"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 5: Muller glia cells - Visual perception"	"Plasma membrane"	"Cytoplasmic bodies"	"HPA030489: AB_10601488, HPA073231: "	"unprognostic (2.76e-2)"	"unprognostic (4.86e-2)"	"unprognostic (9.72e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.46e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.70e-1)"	"unprognostic (4.43e-1)"	"unprognostic (6.20e-3)"	"unprognostic (3.31e-1)"	"unprognostic (2.80e-1)"	"unprognostic (3.62e-2)"	"unprognostic (1.91e-1)"	"unprognostic (5.80e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.30e-3)"	0.1	0.0	0.2	0.1	0.2	0.0	1.9	0.3	0.3	8.0	0.2	1.9	0.0	0.3	0.1	18.8	0.5	0.4	0.2	0.2	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.0	0.0	2.3	0.1	0.3	0.2	12.2	1.3	3.7	4.1	33.2	0.2	37.5	0.1	0.2	0.3	0.0	0.0	0.1	0.3	2.8	0.0	0.0	2.7	0.3	14.1	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	23.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.3	0.3	0.2	0.2	0.2	0.3	0.2	0.3	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.8	1.1	0.9	0.0	0.2	0.8	0.3	0.4	0.0	0.7	0.0	2.1	0.1	0.0	0.5	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	22.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	2.8	0.2	0.0	0.0	0.9	0.0	0.0	0.2	0.0	0.0	12.0	6.0	0.3	0.0	0.0	1.4	4.4
SLC39A3	ZIP3	ENSG00000141873	"Solute carrier family 39 member 3"	Q9BRY0	19	2732204-2740028	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"testis: 100.3"	"Group enriched"	"Detected in all"	4	"Early spermatids: 302.1;Late spermatids: 433.3;Spermatocytes: 185.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"U-937: 409.6"	"Low region specificity"	"Detected in all"							"HPA042139, HPA058526"	Uncertain		Approved	Vesicles		NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 32: U-937 - Innate immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Vesicles		"HPA042139: AB_10793875, HPA058526: AB_2683743"	"unprognostic (1.81e-1)"	"unprognostic (1.47e-2)"	"unprognostic (1.16e-1)"	"prognostic favorable (9.76e-5)"	"unprognostic (2.26e-1)"	"unprognostic (2.44e-2)"	"unprognostic (9.88e-3)"	"unprognostic (1.01e-1)"	"unprognostic (6.03e-2)"	"unprognostic (3.66e-2)"	"unprognostic (4.37e-3)"	"unprognostic (4.07e-2)"	"unprognostic (1.75e-3)"	"unprognostic (9.22e-3)"	"unprognostic (6.58e-2)"	"unprognostic (7.97e-2)"	"unprognostic (1.80e-2)"	17.9	27.0	19.0	14.7	22.0	46.3	17.4	18.3	23.6	19.6	14.8	18.4	16.7	25.1	30.5	17.3	23.2	15.3	23.3	23.6	18.5	19.8	32.8	16.3	19.1	20.0	18.0	13.5	20.7	34.7	27.2	12.3	18.7	19.3	14.4	10.2	21.3	17.8	22.9	14.9	16.5	23.0	16.7	22.7	17.4	100.3	20.1	21.8	20.5	24.7	16.1	22.3	14.4	18.6	53.3	44.1	32.5	80.3	66.1	45.0	30.6	38.6	46.5	71.3	72.4	47.8	35.0	32.2	23.6	68.2	56.3	42.9	50.2	52.7	44.3	0.4	37.1	144.4	31.4	48.9	72.1	123.2	209.5	40.6	83.3	53.1	43.3	25.6	36.9	61.8	162.8	147.6	48.6	35.2	61.4	99.0	34.6	48.8	59.4	81.4	20.9	100.7	34.1	42.7	44.1	40.3	33.9	24.4	82.4	20.9	42.4	162.7	22.4	49.5	27.0	75.6	56.4	38.7	66.6	32.6	37.4	409.6	59.7	41.1	36.0	67.9	35.9	35.6	30.1	53.3	30.5	29.2	48.9	53.7	24.5	29.2	16.7	29.7	34.1	83.9	21.2	35.2	19.0	22.0	18.3	23.6	23.6	18.5	20.0	18.0	18.7	16.7	20.1	18.6	18.1	3.2	2.8	2.6	31.6	10.3	16.6	37.1	2.2	19.2	25.5	23.6	7.8	24.3	22.6	7.3	8.4	37.5	16.8	20.2	17.6	50.7	302.1	17.8	16.4	21.8	24.0	57.6	5.0	61.8	56.3	18.4	10.7	13.3	24.8	24.2	21.8	31.0	64.9	48.8	5.9	19.7	32.6	25.7	12.9	433.3	21.5	39.3	24.9	4.7	26.7	33.5	26.8	6.6	5.6	46.9	25.8	27.8	12.9	33.3	23.0	23.6	17.6	22.0	26.3	14.0	23.6	185.8	29.7	10.5	9.8	26.4	14.5	29.4	25.6	17.6
SLC39A4	"AEZ, AWMS2, ZIP4"	ENSG00000147804	"Solute carrier family 39 member 4"	Q6P5W5	8	144409742-144416844	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"intestine: 88.1"	"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 406.4;Proximal tubular cells: 230.3"	"Low cancer specificity"	"Detected in all"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"CAPAN-2: 36.4;Hep G2: 97.4"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (2.59e-1)"	"unprognostic (2.35e-3)"	"unprognostic (9.16e-2)"	"unprognostic (3.84e-2)"	"unprognostic (5.63e-3)"	"unprognostic (1.46e-1)"	"unprognostic (5.40e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.61e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (9.04e-4)"	"unprognostic (2.78e-2)"	"unprognostic (3.97e-1)"	"unprognostic (9.04e-3)"	"unprognostic (1.87e-1)"	0.1	0.2	0.1	1.4	0.2	0.5	0.3	0.0	0.7	0.7	0.0	33.1	88.1	0.4	0.1	0.2	0.9	0.5	0.0	0.2	0.0	18.4	1.3	3.1	0.1	0.0	0.0	3.3	1.4	0.0	0.2	1.0	0.0	1.3	0.5	0.0	1.2	0.3	0.0	0.5	74.9	0.1	0.0	0.7	2.9	1.3	0.0	0.0	3.9	0.0	0.0	0.6	0.6	0.0	2.3	0.2	0.0	0.1	0.0	0.0	2.5	0.1	0.0	0.0	0.0	2.1	36.4	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.0	6.4	0.8	1.6	0.6	97.4	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.7	1.5	2.2	0.0	1.7	0.0	0.4	0.1	0.5	0.1	0.4	0.0	1.1	0.0	0.4	0.9	1.9	0.2	0.4	0.1	0.4	1.7	0.1	0.0	0.1	0.2	0.0	0.0	0.9	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.7	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.4	19.2	24.8	0.3	21.3	18.7	36.6	46.9	38.7	0.2	45.0	50.3	7.4	20.0	24.1	42.3	0.0	17.0	15.4	112.8	50.9	40.0	1.4	41.8	12.9	10.9	42.6	26.3	1.0	42.9	69.7	16.8	29.6	51.9	37.4	8.5	8.9	27.4	32.1	3.3	0.2	95.0	30.5	18.2	21.0	2.0	8.1	23.5	21.4	0.0	25.9	11.3	23.7	0.0	0.1	75.6	135.0	6.4	31.9	60.8	406.4	230.3	26.9	1.0	6.6	7.5	11.1	2.9	33.1	46.4	30.0	11.2	15.4	23.2	98.2	46.3
SLC39A5		ENSG00000139540	"Solute carrier family 39 member 5"	Q6ZMH5	12	56230049-56237846	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	32	"intestine: 237.4;kidney: 110.0;liver: 171.1;pancreas: 306.8"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 798.4"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 30.6;liver cancer: 36.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	53	"CACO-2: 39.9;Hep G2: 58.5"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.1"	"Not detected"	"Not detected"			HPA018423			Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 29: Non-specific - Vesicular transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Vesicles	Nucleoplasm	"HPA018423: AB_1857154"	"unprognostic (5.94e-3)"	"unprognostic (8.29e-2)"	"unprognostic (1.82e-2)"	"unprognostic (2.19e-7)"	"unprognostic (1.73e-1)"	"unprognostic (7.79e-2)"	"unprognostic (1.56e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.32e-1)"	"unprognostic (7.33e-2)"	"unprognostic (2.93e-3)"	"prognostic favorable (5.05e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.15e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.96e-4)"	0.3	0.1	0.2	5.5	0.2	0.1	0.3	0.5	0.4	0.3	0.2	73.7	237.4	0.4	0.0	0.1	0.3	6.5	0.2	0.1	0.1	110.0	171.1	0.2	0.4	0.2	0.1	0.4	306.8	0.0	0.2	0.1	0.1	0.3	45.9	6.4	0.1	0.3	0.1	0.3	219.0	2.6	0.1	0.3	1.4	0.2	0.1	0.0	0.3	0.2	0.0	0.2	0.2	0.1	0.0	0.3	0.1	0.2	0.2	0.3	0.5	0.0	0.0	0.1	0.0	39.9	0.4	0.1	0.1	0.1	0.0	0.2	0.0	0.3	0.0	0.6	0.1	0.2	0.2	58.5	0.2	0.1	0.2	0.2	0.1	0.2	0.0	0.1	0.0	0.1	0.1	0.3	0.0	0.2	0.0	0.8	0.0	0.9	0.1	0.2	0.2	0.3	0.5	0.1	0.3	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.5	0.4	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.0	1.4	0.6	0.1	0.0	0.0	0.9	0.1	0.3	0.2	15.7	0.0	3.7	116.7	0.0	0.0	171.9	19.6	0.3	0.6	0.0	0.1	0.2	25.3	2.7	0.2	20.6	0.0	0.1	0.0	0.0	0.0	0.0	2.2	138.9	0.1	0.0	0.2	112.7	0.0	1.6	1.2	1.4	0.0	1.3	0.0	0.0	0.6	0.6	0.0	0.0	0.1	7.4	192.8	0.0	0.0	0.1	798.4	169.9	0.0	1.8	0.0	0.2	0.2	0.0	0.0	0.0	0.4	0.0	0.8	0.0	168.7	0.0
SLC39A6	LIV-1	ENSG00000141424	"Solute carrier family 39 member 6"	Q13433	18	36108531-36129385	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Breast glandular cells: 307.0;Prostatic glandular cells: 197.9"	"Group enriched"	"Detected in all"	4	"breast cancer: 361.9;prostate cancer: 127.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042377	Approved		Uncertain	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 35: Glandular cells - Unknown function"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA042377: AB_2677968"	"unprognostic (7.60e-2)"	"unprognostic (2.27e-2)"	"unprognostic (5.50e-3)"	"unprognostic (2.58e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.87e-3)"	"prognostic unfavorable (5.33e-4)"	"unprognostic (1.79e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.19e-1)"	"unprognostic (4.50e-2)"	"unprognostic (7.63e-3)"	"unprognostic (2.16e-1)"	"unprognostic (4.74e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.30e-1)"	27.3	25.9	23.3	21.6	28.5	11.6	147.2	28.6	26.1	34.5	48.9	13.9	9.6	56.9	56.2	17.0	63.6	24.2	14.0	20.0	28.8	28.2	16.5	18.9	17.3	28.8	33.6	43.1	37.7	86.5	23.9	31.7	30.6	129.0	13.4	50.2	30.9	114.3	12.7	51.3	8.9	30.2	28.6	15.5	16.4	19.3	26.7	18.5	37.3	16.6	28.4	52.6	16.1	34.2	43.7	54.0	127.1	75.1	131.4	96.6	33.0	116.2	137.3	76.5	88.7	30.3	47.5	47.1	57.3	113.1	53.1	104.1	112.4	109.2	115.5	105.4	40.7	20.6	69.5	44.4	83.2	69.8	49.6	88.7	236.1	116.2	100.5	69.9	11.7	38.6	10.7	92.1	108.9	67.0	69.0	15.6	30.6	24.0	30.4	70.6	72.8	61.4	84.4	145.2	132.8	116.8	143.5	41.5	200.6	52.1	56.7	32.4	18.9	184.9	30.5	35.5	59.2	85.9	90.0	35.7	64.0	48.3	99.8	29.2	13.3	31.2	16.3	19.7	19.7	16.7	13.8	14.7	16.4	17.3	12.0	17.7	10.2	18.1	19.4	33.6	17.0	14.2	23.3	28.5	28.6	26.1	20.0	28.8	28.8	33.6	30.6	28.6	26.7	34.2	13.3	38.5	18.7	8.8	22.5	45.9	58.2	79.6	59.2	41.5	307.0	132.2	19.6	10.0	66.4	42.3	33.3	6.6	36.7	4.0	1.9	53.1	21.3	37.1	76.1	12.9	25.6	4.6	13.0	37.8	56.7	45.6	9.2	73.8	23.5	18.9	8.9	11.0	20.4	23.5	23.9	7.4	38.7	20.1	30.0	18.1	37.3	26.0	67.6	1.9	25.7	38.2	10.3	34.2	36.5	39.5	1.9	47.8	24.4	197.9	2.7	13.6	44.3	41.3	39.5	40.4	38.6	43.9	27.8	32.6	74.4	23.8	23.2	23.0	5.7	69.3
SLC39A7	"D6S2244E, H2-KE4, HKE4, KE4, RING5, ZIP7"	ENSG00000112473	"Solute carrier family 39 member 7"	Q92504	6	33200445-33204439	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 168.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053999	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA053999: AB_2682338"	"unprognostic (3.63e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.24e-2)"	"unprognostic (8.95e-2)"	"unprognostic (2.51e-1)"	"prognostic unfavorable (3.62e-4)"	"unprognostic (4.87e-2)"	"unprognostic (9.92e-2)"	"unprognostic (7.20e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.99e-2)"	"unprognostic (4.80e-1)"	"unprognostic (1.50e-1)"	"unprognostic (8.22e-3)"	"unprognostic (1.12e-2)"	52.5	73.7	2.2	3.6	2.4	2.4	51.1	2.5	2.7	51.0	5.4	66.7	7.2	60.8	8.6	47.1	44.4	5.8	63.2	2.0	2.8	45.1	75.0	64.9	3.0	3.1	2.6	40.9	98.7	12.8	74.1	8.2	3.2	55.8	8.7	1.9	90.9	7.5	31.5	38.4	58.5	8.3	2.5	47.7	71.4	29.0	3.2	2.8	67.2	2.8	4.4	42.4	41.2	2.9	10.7	9.6	8.6	8.2	25.8	15.9	13.2	17.8	25.3	23.1	23.1	16.7	6.6	5.1	11.9	22.9	12.4	7.5	8.3	14.5	9.7	16.6	10.1	9.4	10.0	25.1	18.2	10.0	30.7	16.0	13.6	15.1	20.6	13.5	11.7	8.3	15.5	7.7	10.2	9.8	4.3	7.4	8.1	23.2	9.9	5.7	6.8	12.2	14.0	5.8	6.8	5.1	8.6	37.2	13.2	5.4	25.0	10.3	10.9	13.1	17.4	8.2	9.8	18.3	15.1	3.9	7.5	8.7	15.0	2.2	1.8	2.0	3.3	1.1	4.4	1.2	2.0	1.2	0.7	1.2	1.8	1.7	0.8	2.1	1.0	1.3	1.0	1.5	2.2	2.4	2.5	2.7	2.0	2.8	3.1	2.6	3.2	2.5	3.2	2.9	40.0	25.6	34.8	7.2	23.4	36.1	29.4	53.6	19.4	27.4	36.7	18.5	33.1	34.3	54.7	25.8	29.2	103.0	22.9	75.5	5.9	73.8	0.8	26.9	47.3	40.9	25.3	28.4	4.3	86.1	129.1	64.4	66.8	53.7	20.8	29.5	28.2	34.4	42.9	11.8	5.9	135.1	48.8	14.8	35.3	2.7	46.0	22.1	40.9	5.6	23.7	42.9	24.7	8.5	8.3	67.8	54.9	42.9	91.6	60.2	56.0	25.9	28.3	26.8	19.7	35.4	43.0	9.4	11.5	26.0	40.9	168.7	23.1	69.2	61.7	51.3
SLC39A8	BIGM103	ENSG00000138821	"Solute carrier family 39 member 8"	Q9C0K1	4	102251041-102431258	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"		"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lung: 171.1"	"Group enriched"	"Detected in many"	5	"Alveolar cells type 1: 778.8;Alveolar cells type 2: 305.6;Extravillous trophoblasts: 217.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 158.9;HL-60: 120.9;Karpas-707: 171.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038832, HPA038833"	Approved					NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 19: Lung - Lung function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 11: Alveolar cells - Smell perception"			"HPA038832: AB_2676226, HPA038833: AB_10670910"	"prognostic favorable (6.69e-4)"	"unprognostic (1.29e-2)"	"prognostic favorable (1.34e-4)"	"unprognostic (1.91e-2)"	"unprognostic (6.50e-2)"	"unprognostic (9.59e-2)"	"unprognostic (6.07e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.20e-3)"	"unprognostic (6.32e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.78e-2)"	"prognostic favorable (6.34e-6)"	"unprognostic (3.25e-1)"	"unprognostic (6.54e-2)"	"unprognostic (6.40e-2)"	"unprognostic (7.13e-3)"	45.5	3.5	9.6	28.9	10.7	36.5	18.1	10.2	12.1	84.7	9.9	37.8	6.7	11.0	5.7	3.0	11.9	7.8	30.4	8.3	10.5	18.3	40.0	171.1	13.3	14.6	10.7	14.0	54.5	42.0	8.0	13.0	14.4	8.4	43.0	6.4	89.3	6.6	1.1	9.4	7.3	9.1	14.2	6.7	7.8	2.6	13.5	14.4	12.3	2.0	12.3	20.8	6.8	11.6	20.2	19.5	4.4	0.1	15.8	35.4	10.1	2.2	158.9	5.8	9.3	0.9	72.5	19.3	21.0	0.6	20.0	1.4	13.5	4.4	3.4	34.1	39.5	51.0	37.5	0.3	6.3	120.9	16.8	19.1	5.0	3.1	9.1	15.4	2.1	47.1	51.6	171.2	30.7	13.4	43.7	55.9	13.0	26.8	19.0	11.0	0.2	63.8	33.3	7.4	5.6	14.0	55.0	1.0	5.3	3.8	13.4	44.4	11.3	19.3	7.3	39.1	31.6	76.3	34.1	90.4	31.0	77.4	18.2	0.0	1.8	1.4	6.3	1.1	10.9	1.8	11.7	10.0	3.3	3.9	8.6	5.9	0.1	13.7	0.4	1.2	5.0	4.2	9.6	10.7	10.2	12.1	8.3	10.5	14.6	10.7	14.4	14.2	13.5	11.6	16.1	778.8	305.6	15.7	14.5	11.7	9.2	35.9	5.2	2.6	42.8	13.1	21.3	4.3	23.9	5.5	4.2	19.2	14.9	20.3	11.7	1.8	0.7	17.7	5.2	19.8	24.0	46.7	6.6	32.7	217.5	17.4	4.1	40.9	3.8	32.4	5.7	26.1	42.9	3.3	1.5	74.1	6.1	29.8	79.0	0.7	1.2	28.9	28.4	60.9	10.8	5.2	9.2	5.0	1.7	11.8	26.2	1.2	56.0	9.6	2.1	17.7	2.9	1.6	6.6	2.6	8.8	2.3	6.0	2.1	7.0	60.6	23.6	31.0	64.3	6.8
SLC39A9	FLJ11274	ENSG00000029364	"Solute carrier family 39 member 9"	Q9NUM3	14	69398015-69462390	"Predicted membrane proteins, Transporters"	"Ion transport, Transport, Zinc transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA007921, HPA075390"	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 6: T47d - Mammary gland"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Endoplasmic reticulum"		"HPA007921: AB_1080007, HPA075390: AB_2686748"	"unprognostic (2.37e-1)"	"unprognostic (9.29e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.53e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.10e-1)"	"unprognostic (5.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.75e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.92e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (1.20e-1)"	"unprognostic (1.83e-1)"	"unprognostic (1.09e-2)"	"unprognostic (2.16e-2)"	15.2	21.6	17.3	12.1	17.5	10.7	24.4	17.7	24.6	18.2	20.9	20.3	21.5	14.8	25.6	23.1	15.6	14.3	12.2	17.4	18.9	29.8	43.0	15.6	12.7	17.0	17.3	13.7	28.5	26.4	22.8	17.7	17.0	19.0	21.5	12.7	33.8	15.1	7.9	18.3	19.4	15.5	18.7	16.0	21.8	8.9	18.3	18.0	22.2	11.6	17.8	15.3	15.3	20.1	55.0	46.3	26.9	28.7	46.2	34.6	25.1	31.9	40.2	30.7	34.8	35.4	49.7	49.3	23.8	39.8	14.2	45.3	30.9	30.5	37.4	31.9	17.0	28.9	23.0	24.8	36.0	20.9	38.1	30.3	50.3	27.1	40.5	30.6	30.8	38.1	22.2	44.2	32.5	33.6	33.0	26.1	20.9	47.7	31.2	32.8	37.6	30.3	40.9	56.1	28.3	46.1	32.2	55.1	22.2	20.2	76.9	37.8	30.4	50.8	36.2	22.1	24.6	48.8	27.4	36.6	47.1	25.4	42.0	11.2	10.3	9.4	7.9	9.7	8.1	6.9	6.8	7.7	11.3	4.8	6.7	7.0	8.7	6.8	9.4	5.9	5.5	6.8	17.3	17.5	17.7	24.6	17.4	18.9	17.0	17.3	17.0	18.7	18.3	20.1	13.3	19.2	12.6	37.9	13.4	12.1	8.0	19.2	17.1	8.4	27.7	14.1	7.9	18.6	18.0	16.5	6.2	14.1	7.3	42.8	5.9	15.0	16.2	16.0	16.1	17.0	29.4	15.4	31.0	25.1	17.3	14.3	22.4	17.8	12.0	13.8	22.1	67.7	15.9	10.1	30.9	30.3	14.2	24.5	8.7	22.4	13.1	13.8	7.2	24.4	16.4	9.5	12.3	30.2	37.0	28.6	22.4	12.8	18.6	18.7	34.6	15.8	24.6	11.2	6.6	12.6	12.0	13.9	9.2	18.3	12.5	17.8	9.2	14.2	25.7	20.2
SLC3A1	"ATR1, CSNU1, D2H, NBAT, RBAT"	ENSG00000138079	"Solute carrier family 3 member 1"	Q07837	2	44275458-44321494	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 136.2;kidney: 649.3;pancreas: 217.5"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 74.4;Glandular and luminal cells: 128.9;Proximal enterocytes: 258.9;Proximal tubular cells: 363.0"	"Cancer enriched"	"Detected in many"	7	"renal cancer: 61.9"	"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enriched"	"Detected in some"	22	"RPTEC TERT1: 106.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA038360, HPA071102"	Enhanced		Approved	"Nuclear bodies,Mitochondria"		NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nuclear bodies"	"HPA038360: AB_2675975, HPA071102: AB_2732171"	"unprognostic (1.67e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.43e-2)"	"unprognostic (6.14e-2)"	"unprognostic (9.45e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.90e-1)"	"unprognostic (8.73e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.17e-1)"	"prognostic favorable (3.67e-7)"	"unprognostic (6.10e-2)"	"unprognostic (1.26e-1)"	"unprognostic (3.77e-1)"	"unprognostic (1.58e-4)"	0.5	0.3	1.2	1.1	1.7	0.6	0.4	6.8	3.4	1.0	0.1	22.4	113.9	1.4	1.9	0.2	0.6	51.5	0.4	1.6	1.3	649.3	36.6	0.4	0.4	0.6	0.6	0.5	217.5	0.0	0.5	0.1	0.7	1.0	22.7	3.5	0.3	0.3	1.0	0.6	136.2	0.5	0.0	0.5	0.9	1.7	1.0	0.0	0.4	0.1	0.1	0.3	0.3	1.7	0.0	1.0	0.0	0.2	0.2	0.1	0.3	0.1	0.0	0.0	0.1	4.9	0.0	0.1	4.3	0.0	0.0	0.2	0.0	0.1	0.2	0.1	0.0	0.1	0.1	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.2	0.0	0.2	0.0	0.4	0.2	0.0	0.0	0.4	0.1	1.2	0.5	0.1	0.1	0.2	106.1	0.0	0.2	0.2	0.2	0.0	0.2	0.0	0.1	0.1	0.0	0.2	0.3	0.2	0.1	0.4	0.2	0.3	0.1	0.3	0.2	0.4	0.3	0.3	0.7	0.3	0.4	0.5	0.6	0.3	0.1	1.0	0.6	0.7	0.4	0.4	0.1	0.3	0.2	0.1	1.2	1.7	6.8	3.4	1.6	1.3	0.6	0.6	0.7	0.0	1.0	1.7	0.2	3.2	1.5	0.3	6.1	0.0	0.3	0.0	0.0	12.1	0.2	0.0	0.4	74.4	0.0	42.3	10.4	0.1	0.8	18.2	62.6	37.0	12.4	62.2	14.4	0.6	0.0	0.0	9.1	13.8	0.0	0.9	1.1	128.9	0.0	0.1	0.4	4.6	0.1	21.9	9.0	8.4	0.0	0.0	0.0	8.5	1.2	3.2	0.0	1.0	1.6	1.0	1.0	3.0	3.7	4.8	18.6	0.4	1.5	1.1	258.9	363.0	0.0	11.2	0.0	2.6	1.2	0.8	0.4	0.7	0.1	0.1	2.8	0.2	15.7	1.2
SLC3A2	"4F2, 4F2HC, 4T2HC, CD98, CD98HC, MDU1, NACAE"	ENSG00000168003	"Solute carrier family 3 member 2"	P08195	11	62856004-62888880	"Cancer-related genes, CD markers, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 780.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 1441.0;SiHa: 1287.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010455, HPA017980"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA		170000000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Plasma membrane"		"CAB010455: AB_638288, HPA017980: AB_2669723"	"unprognostic (1.79e-1)"	"unprognostic (9.61e-3)"	"unprognostic (3.59e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.06e-1)"	"unprognostic (2.41e-3)"	"prognostic unfavorable (8.17e-4)"	"unprognostic (2.09e-3)"	"unprognostic (2.62e-1)"	"unprognostic (4.16e-2)"	"unprognostic (2.29e-2)"	"unprognostic (3.71e-1)"	"prognostic favorable (8.22e-4)"	"unprognostic (2.92e-2)"	"unprognostic (5.52e-3)"	"unprognostic (3.49e-3)"	"prognostic unfavorable (1.48e-4)"	103.3	105.6	130.5	46.7	138.0	122.0	108.9	140.1	160.4	101.6	115.6	60.6	51.5	97.2	65.3	112.9	94.0	35.8	52.0	123.1	133.3	171.2	71.9	117.8	34.9	138.4	132.6	93.0	109.7	189.7	65.3	55.4	134.0	100.8	23.1	22.8	110.6	41.9	122.3	127.1	79.7	33.8	135.8	77.4	90.2	65.1	154.5	30.1	110.2	26.0	28.8	77.7	95.1	130.6	155.5	675.7	60.2	213.2	89.7	69.7	596.7	267.5	106.2	154.0	126.3	643.3	293.0	173.9	290.5	185.4	284.5	540.0	123.1	588.9	84.3	319.3	114.0	117.5	422.4	299.2	825.7	136.0	169.4	144.9	1441.0	175.3	528.8	46.2	83.6	380.7	232.9	347.4	95.1	792.6	149.8	181.3	106.9	222.5	214.2	153.8	92.7	341.8	113.9	84.0	112.5	53.5	1287.0	499.6	948.5	121.2	161.5	182.6	146.2	138.3	200.0	204.4	195.5	436.0	556.1	561.2	135.0	225.1	418.0	37.8	149.0	49.7	117.9	147.4	157.7	58.3	107.3	122.1	88.6	72.1	90.1	97.2	31.2	90.3	123.9	304.7	112.5	186.3	130.5	138.0	140.1	160.4	123.1	133.3	138.4	132.6	134.0	135.8	154.5	130.6	97.8	48.1	37.3	91.1	78.8	218.1	244.2	321.7	399.5	58.4	124.2	120.8	13.4	30.0	141.1	49.7	66.7	222.5	136.2	109.6	33.2	161.9	31.5	122.0	96.3	149.2	84.3	117.7	16.9	151.1	143.7	102.9	71.4	179.7	84.3	43.2	99.2	27.0	202.9	53.8	25.1	60.4	223.8	54.1	140.9	28.9	30.4	141.5	224.1	29.0	104.7	188.4	40.2	21.1	11.3	130.6	58.7	30.5	140.9	156.9	120.7	227.4	63.4	61.2	6.6	71.8	114.6	21.3	31.9	160.7	150.6	780.7	118.1	52.4	60.7	194.9
SLC40A1	"FPN1, HFE4, IREG1, MTP1, SLC11A3"	ENSG00000138449	"Solute carrier family 40 member 1"	Q9NP59	2	189560590-189583758	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Iron transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 489.8;Kupffer cells: 1340.2;Syncytiotrophoblasts: 2463.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 326.2"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 509.0;CACO-2: 123.1;HEL: 430.0;HMC-1: 110.5;T-47d: 207.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065634	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 14: B-cells - Humoral immune response"	"Cluster 36: HEL - Hemostasis"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane, Cytosol"	Nucleoplasm	"HPA065634: AB_2685524"	"unprognostic (1.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.41e-2)"	"unprognostic (1.83e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.36e-2)"	"unprognostic (1.66e-1)"	"unprognostic (6.22e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (6.43e-2)"	"unprognostic (6.44e-2)"	"prognostic favorable (8.55e-5)"	"unprognostic (4.66e-1)"	"unprognostic (1.61e-1)"	"unprognostic (8.96e-2)"	"unprognostic (4.11e-2)"	59.6	333.5	9.3	52.6	11.9	45.8	97.7	9.6	9.8	156.3	10.4	124.7	289.3	95.4	61.6	30.5	214.2	148.7	52.6	7.2	12.0	79.9	251.5	122.9	172.6	15.6	15.7	317.2	53.2	91.8	19.0	250.1	12.8	39.5	130.8	29.5	58.7	53.1	64.2	12.2	127.9	69.3	15.5	368.1	96.8	33.2	13.9	62.6	68.0	60.3	59.1	53.1	21.8	11.3	0.0	7.4	0.6	0.0	509.0	3.3	25.4	0.2	6.6	1.9	3.1	123.1	0.4	0.2	1.0	0.2	1.4	0.4	2.4	0.3	1.6	0.3	1.7	430.0	1.7	45.8	1.9	1.5	110.5	35.9	0.2	1.2	0.0	11.7	13.0	16.4	44.6	1.1	6.3	0.0	18.2	28.8	1.5	92.7	1.7	0.2	5.0	2.5	5.3	18.1	1.0	5.4	0.8	35.4	0.0	39.5	207.6	6.2	0.3	0.8	11.7	0.5	0.1	1.1	0.2	0.3	0.1	0.2	0.1	129.8	101.5	172.1	2.2	23.7	3.2	0.2	54.4	4.9	115.6	0.7	80.2	17.8	326.2	4.6	2.6	18.8	5.3	105.8	9.3	11.9	9.6	9.8	7.2	12.0	15.6	15.7	12.8	15.5	13.9	11.3	44.2	125.0	40.3	3.6	12.0	9.2	51.3	10.5	19.9	4.8	83.8	30.0	48.0	138.7	31.6	33.1	4.2	489.8	5.7	328.9	49.0	54.7	10.5	39.6	38.2	39.8	18.6	253.7	0.3	71.8	20.3	81.9	76.5	129.5	9.5	12.8	245.9	259.7	86.4	6.7	6.8	60.8	6.1	1340.2	26.8	9.2	121.2	172.7	8.8	34.7	41.7	17.5	2.1	14.6	0.2	71.5	86.2	58.6	4.1	26.2	163.0	150.0	34.4	48.4	65.7	13.7	49.1	7.4	3.9	12.5	8.1	2463.5	11.9	84.8	48.9	27.7
SLC41A1	MgtE	ENSG00000133065	"Solute carrier family 41 member 1"	Q8IVJ1	1	205789094-205813748	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 99.3;tongue: 75.9"	"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 175.0;Theca cells: 100.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014721, HPA015138"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 38: Heart - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"HPA014721: , HPA015138: AB_1857160"	"unprognostic (1.18e-1)"	"prognostic unfavorable (1.48e-4)"	"unprognostic (2.77e-2)"	"unprognostic (1.30e-2)"	"unprognostic (2.30e-1)"	"unprognostic (1.38e-2)"	"unprognostic (2.37e-3)"	"unprognostic (5.23e-2)"	"unprognostic (5.53e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.87e-2)"	"unprognostic (4.46e-2)"	"unprognostic (3.09e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.65e-1)"	9.7	10.8	10.1	6.4	10.4	5.8	4.7	11.0	8.2	4.8	36.7	5.8	2.1	6.5	5.1	5.6	11.0	7.1	99.3	8.6	6.4	9.2	1.4	8.4	7.4	11.1	10.2	11.3	61.6	9.3	4.6	3.7	9.5	7.5	1.8	6.1	3.7	6.7	48.8	3.8	3.8	6.0	8.9	5.3	9.8	18.5	13.7	5.7	17.8	75.9	5.1	6.2	3.9	9.5	18.2	16.1	9.6	15.6	11.7	11.6	13.2	17.9	17.8	18.2	15.9	8.0	10.1	25.9	11.3	16.5	14.9	18.5	9.5	13.4	6.2	48.6	14.8	6.4	16.5	1.2	11.2	0.0	17.4	14.9	10.8	20.8	14.7	14.9	11.3	20.5	11.9	10.5	14.7	11.2	11.8	1.8	11.5	4.8	7.1	13.8	29.0	6.4	4.1	22.0	8.1	10.4	14.0	12.3	11.0	8.0	8.8	6.7	14.3	21.5	13.8	19.9	19.2	34.7	24.9	8.5	16.6	8.3	13.6	0.0	0.1	0.0	1.6	0.1	2.0	0.6	1.5	1.5	0.0	0.7	1.4	1.5	0.0	0.4	0.0	0.0	1.5	1.0	10.1	10.4	11.0	8.2	8.6	6.4	11.1	10.2	9.5	8.9	13.7	9.5	18.2	3.2	23.0	20.5	11.2	20.8	24.3	4.6	10.8	14.6	14.4	10.2	175.0	5.7	8.5	0.0	50.1	1.8	11.5	1.6	1.9	9.6	2.4	6.8	9.8	24.1	6.0	6.5	5.3	11.0	14.5	15.7	11.7	6.2	7.0	13.9	8.6	2.2	3.4	18.5	6.6	2.7	4.1	2.4	6.5	2.7	9.9	3.5	8.8	15.9	0.8	17.0	8.2	7.1	8.3	9.3	1.3	9.4	8.3	24.9	0.0	15.7	7.9	20.3	0.0	29.7	16.1	8.1	12.9	7.5	18.2	3.1	14.5	100.2	1.5	22.0
SLC41A2	DKFZP434K0427	ENSG00000136052	"Solute carrier family 41 member 2"	Q96JW4	12	104802553-104958744	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 114.9"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 100.6;Hepatocytes: 51.6;Inhibitory neurons: 93.8;Oligodendrocyte precursor cells: 55.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	10	"myeloid DC: 4.1;plasmacytoid DC: 12.2"	"Lineage enriched"	"Detected in single"	15	"dendritic cells: 12.2"	"Cell line enhanced"	"Detected in many"		"HDLM-2: 56.2;SK-BR-3: 44.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038658	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 85: Liver - Metabolism"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA038658: AB_10671747"	"unprognostic (7.19e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.94e-2)"	"unprognostic (2.38e-1)"	"unprognostic (6.06e-3)"	"unprognostic (3.05e-2)"	"prognostic favorable (9.94e-4)"	"unprognostic (1.35e-1)"	"unprognostic (3.68e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.20e-2)"	"unprognostic (1.81e-1)"	"prognostic unfavorable (3.35e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.30e-2)"	8.6	8.7	4.5	8.1	5.9	1.3	10.3	6.0	6.1	9.4	9.1	21.0	31.4	4.6	15.8	1.9	3.2	14.4	2.4	4.8	9.9	8.3	114.9	6.5	4.8	1.5	3.6	5.3	18.3	8.6	6.3	3.7	4.3	3.2	15.1	1.9	14.2	9.4	0.7	1.4	27.8	8.6	0.3	3.2	37.1	8.5	9.0	2.8	12.1	1.6	4.7	5.6	1.6	3.1	11.6	25.6	0.9	5.3	21.0	15.2	9.9	7.9	12.9	5.4	9.1	16.1	10.8	4.7	8.4	15.8	19.8	1.1	5.7	2.6	10.1	56.2	14.4	0.4	9.6	7.3	4.6	1.8	6.2	5.2	2.1	5.8	1.6	11.7	7.0	3.1	0.3	11.9	0.9	5.3	2.3	0.1	2.4	20.6	8.2	1.0	11.0	11.2	21.5	0.3	10.1	2.6	13.5	44.5	2.2	3.9	17.3	0.1	2.0	8.2	5.8	8.7	9.0	14.1	19.1	6.2	13.0	0.9	5.7	0.2	0.2	0.0	0.1	0.1	0.8	0.5	0.1	0.1	4.1	0.2	0.3	0.1	0.2	0.3	0.0	12.2	0.1	0.3	4.5	5.9	6.0	6.1	4.8	9.9	1.5	3.6	4.3	0.3	9.0	3.1	3.8	19.2	9.6	16.6	4.5	2.4	3.2	1.8	1.8	2.6	6.3	2.3	0.8	25.8	6.5	7.3	0.0	1.7	4.4	34.0	0.0	27.9	29.5	6.4	2.5	2.5	1.2	0.0	100.6	38.5	19.7	12.3	29.0	16.7	0.0	0.4	1.8	51.6	5.3	5.0	93.8	9.8	2.0	2.9	33.2	5.9	2.1	8.5	0.0	10.3	18.7	1.8	1.0	55.3	5.2	29.9	9.2	6.4	6.9	4.9	37.0	7.4	3.1	0.1	0.0	4.7	4.8	6.4	4.3	0.2	2.3	9.0	2.2	0.5	11.8	4.9
SLC41A3	FLJ20473	ENSG00000114544	"Solute carrier family 41 member 3"	Q96GZ6	3	126006357-126101561	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045847	Approved		Supported	"Plasma membrane"		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA045847: AB_2679472"	"unprognostic (1.77e-1)"	"unprognostic (3.35e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.37e-2)"	"unprognostic (7.68e-3)"	"unprognostic (2.20e-1)"	"prognostic unfavorable (1.49e-7)"	"unprognostic (1.36e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.82e-3)"	"unprognostic (5.74e-2)"	"unprognostic (3.57e-1)"	"prognostic favorable (6.04e-7)"	"unprognostic (1.26e-1)"	"unprognostic (5.88e-2)"	"unprognostic (2.85e-1)"	"unprognostic (7.54e-2)"	29.5	47.2	53.3	13.3	55.6	11.3	29.5	55.0	56.1	42.4	53.0	24.8	18.1	44.4	55.1	22.2	40.2	28.6	34.3	57.7	54.9	27.7	14.3	21.4	18.1	56.8	54.0	54.5	32.7	34.9	40.0	19.7	59.6	23.1	19.2	25.7	31.1	23.7	61.8	24.6	23.8	29.4	49.8	19.6	27.8	44.7	54.7	34.4	32.0	47.9	19.3	28.9	29.6	48.4	43.7	17.4	28.5	24.1	78.7	45.3	42.4	24.4	42.1	32.9	39.0	23.3	38.7	31.4	44.8	48.9	35.7	33.3	10.8	42.1	29.0	31.1	32.0	17.2	32.1	34.2	65.3	31.4	18.4	44.0	50.8	20.0	41.1	48.7	46.5	38.2	14.7	26.2	44.0	22.2	35.1	25.7	21.7	57.4	26.3	18.6	29.3	43.5	39.6	31.6	22.1	23.8	37.8	12.3	104.0	26.6	12.2	41.9	32.2	30.8	23.2	47.1	28.0	19.4	17.2	15.8	27.7	14.0	28.9	13.0	6.3	4.6	12.0	9.4	9.6	9.4	11.1	12.2	9.8	9.0	9.6	9.1	1.2	14.9	6.1	9.6	21.8	6.1	53.3	55.6	55.0	56.1	57.7	54.9	56.8	54.0	59.6	49.8	54.7	48.4	25.6	16.0	10.9	9.8	13.5	13.8	22.3	24.9	20.5	15.4	22.9	23.5	14.4	32.9	20.5	22.0	4.2	34.6	14.6	7.5	3.9	35.8	36.7	34.1	15.3	28.5	21.1	5.0	17.0	24.7	36.1	19.7	11.7	17.9	5.7	21.2	35.0	7.2	16.1	28.6	20.7	12.1	30.5	12.8	10.3	14.7	37.6	8.6	14.2	15.0	13.5	25.9	7.2	11.6	8.0	24.3	6.8	54.9	10.3	15.3	14.7	12.6	14.8	12.1	26.3	23.1	20.7	16.7	45.4	18.2	15.3	25.3	17.7	42.4	15.6	19.0
SLC43A1	"PB39, POV1, R00504"	ENSG00000149150	"Solute carrier family 43 member 1"	O75387	11	57484534-57515780	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	5	"liver: 128.6;pancreas: 233.2"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 47.1;Erythroid cells: 82.9;Exocrine glandular cells: 35.4;Hepatocytes: 138.2"	"Cancer enhanced"	"Detected in all"		"liver cancer: 45.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Hep G2: 62.7;NB-4: 74.3;U-937: 70.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA018813, HPA018826"	Enhanced		Approved	"Golgi apparatus,Vesicles,Plasma membrane"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus, Vesicles, Plasma membrane"		"HPA018813: AB_1857164, HPA018826: AB_1857165"	"unprognostic (3.04e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.19e-2)"	"prognostic favorable (3.19e-4)"	"unprognostic (2.51e-2)"	"unprognostic (5.48e-2)"	"unprognostic (2.32e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.12e-2)"	"unprognostic (6.06e-2)"	"unprognostic (2.72e-1)"	"prognostic unfavorable (2.97e-5)"	"unprognostic (1.39e-2)"	"unprognostic (1.48e-1)"	"prognostic unfavorable (5.27e-4)"	"unprognostic (7.30e-2)"	13.9	10.7	3.6	4.7	4.2	35.7	11.1	2.7	5.0	13.1	2.7	15.7	8.7	12.6	10.3	4.4	13.5	18.2	8.6	3.6	2.8	7.3	128.6	9.9	7.4	3.8	3.2	20.3	233.2	1.8	4.4	6.3	3.5	12.8	9.4	1.3	13.8	6.2	17.1	18.8	9.2	8.7	2.7	8.5	30.4	3.4	3.4	2.1	12.7	9.1	6.6	16.2	9.9	3.9	1.1	1.7	1.8	20.3	25.7	18.8	0.2	10.4	13.8	3.0	7.6	6.5	2.8	59.5	2.7	7.9	3.9	1.0	18.1	1.2	3.7	2.8	4.6	30.9	0.5	62.7	33.7	54.3	7.2	23.8	4.4	5.2	23.2	7.3	13.4	34.7	43.9	10.7	3.8	2.3	0.5	74.3	6.6	27.0	13.6	51.0	9.8	27.2	0.5	0.1	23.5	3.6	1.9	0.3	23.8	0.5	1.6	27.3	5.5	3.1	7.1	26.2	1.7	12.1	4.3	35.3	1.5	70.6	4.2	11.1	6.2	0.7	10.9	2.4	9.2	2.9	4.9	7.7	8.4	1.5	4.9	6.9	0.5	7.5	0.2	1.9	9.5	5.5	3.6	4.2	2.7	5.0	3.6	2.8	3.8	3.2	3.5	2.7	3.4	3.9	4.4	0.0	7.3	1.6	3.3	7.0	1.6	0.0	3.4	5.7	1.8	2.4	6.8	47.1	0.6	0.0	0.0	0.2	3.6	3.1	3.9	3.4	21.5	5.3	6.0	4.7	6.0	82.9	3.5	35.4	0.4	10.9	4.6	13.4	3.8	1.3	15.4	138.2	7.4	0.0	1.4	8.8	0.0	8.1	2.9	14.8	15.5	3.2	5.4	5.6	1.3	0.2	5.2	4.0	0.6	11.1	2.9	7.9	6.2	3.2	0.3	0.1	0.7	0.4	6.6	6.4	7.7	0.7	1.5	0.3	3.7	0.1	6.4	2.9	9.0	0.9
SLC43A2	MGC34680	ENSG00000167703	"Solute carrier family 43 member 2"	Q8N370	17	1569268-1628886	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 60.5"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 399.3;Syncytiotrophoblasts: 943.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 15.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 17.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA021564	Enhanced					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA021564: AB_1857169"	"unprognostic (5.95e-3)"	"unprognostic (4.45e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.58e-2)"	"unprognostic (2.80e-2)"	"unprognostic (1.05e-2)"	"unprognostic (5.02e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.80e-1)"	"prognostic favorable (1.05e-6)"	"unprognostic (1.96e-1)"	"prognostic favorable (5.40e-5)"	"unprognostic (1.84e-1)"	"unprognostic (4.14e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.20e-1)"	16.1	8.4	5.4	12.0	5.5	12.4	12.3	6.3	6.4	6.5	0.7	8.6	6.1	6.7	3.1	3.4	12.0	3.0	5.5	4.7	5.7	37.1	3.4	21.6	2.8	10.8	5.2	4.1	6.1	1.8	15.8	22.4	10.5	7.9	1.8	1.4	14.7	2.0	60.5	5.3	15.9	2.3	5.2	30.6	9.9	4.7	9.0	3.1	13.0	4.7	1.6	11.2	3.8	4.9	1.1	2.9	0.9	8.6	1.6	1.4	11.5	0.6	0.3	2.1	0.9	17.8	2.0	5.2	5.8	0.9	0.8	2.1	5.2	1.0	0.3	0.0	0.4	0.9	2.4	4.5	2.0	0.2	1.6	1.8	1.6	1.2	0.5	0.2	8.3	0.6	2.3	0.0	0.3	4.2	10.9	1.0	0.9	2.8	0.4	3.0	0.0	6.2	3.8	10.1	3.4	1.8	2.6	7.1	0.2	3.6	7.0	6.2	10.3	0.2	1.2	2.3	0.7	0.5	11.1	2.5	0.4	1.0	0.3	3.2	6.5	6.2	0.3	4.9	0.1	1.3	0.2	0.2	3.4	1.1	0.2	0.2	15.6	0.5	5.2	1.7	0.2	2.8	5.4	5.5	6.3	6.4	4.7	5.7	10.8	5.2	10.5	5.2	9.0	4.9	16.4	16.0	35.9	17.3	19.0	4.8	6.0	20.8	0.0	29.4	12.2	10.7	2.9	12.8	37.4	36.8	25.0	399.3	13.2	13.7	19.6	26.7	3.4	11.5	12.1	10.9	11.3	0.8	20.5	7.1	42.0	11.6	6.6	12.1	12.0	0.7	12.1	1.2	90.2	20.2	18.3	13.6	87.5	102.6	91.3	3.0	10.8	93.5	0.0	14.0	84.3	19.6	6.2	11.1	5.0	6.7	17.8	9.1	15.7	6.3	92.2	25.6	33.2	39.3	0.0	10.1	8.0	3.4	2.9	1.6	4.3	943.4	5.5	11.7	11.4	5.3
SLC43A3	"DKFZp762A227, Eeg1, FOAP-13, PRO1659, SEEEG-1"	ENSG00000134802	"Solute carrier family 43 member 3"	Q8NBI5	11	57406954-57427580	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 146.9"	"Cell type enhanced"	"Detected in many"		"Ductal cells: 75.5;granulocytes: 67.0;Hofbauer cells: 73.7;Langerhans cells: 74.6;Sertoli cells: 65.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"classical monocyte: 105.7;intermediate monocyte: 127.0;myeloid DC: 85.8;non-classical monocyte: 146.3;plasmacytoid DC: 85.7"	"Group enriched"	"Detected in all"	4	"dendritic cells: 85.8;monocytes: 146.3"	"Cell line enhanced"	"Detected in many"		"HL-60: 513.8;HMC-1: 428.4;RPMI-8226: 570.9;WM-115: 532.1"	"Region enhanced"	"Detected in many"		"olfactory bulb: 10.3"	"Low region specificity"	"Detected in all"			"HPA030551, HPA077244"	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane"		NA	Yes			"Cluster 51: Monocytes - Innate immune response"	"Cluster 85: Liver - Metabolism"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Vesicles	"Nucleoplasm, Plasma membrane"	"HPA030551: AB_10604094, HPA077244: AB_2732335"	"unprognostic (2.64e-1)"	"unprognostic (7.63e-2)"	"unprognostic (9.67e-3)"	"unprognostic (7.41e-3)"	"unprognostic (6.59e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.29e-1)"	"unprognostic (4.91e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.26e-1)"	"unprognostic (5.73e-2)"	"unprognostic (3.97e-2)"	"prognostic unfavorable (3.97e-13)"	"unprognostic (8.16e-2)"	"unprognostic (1.77e-1)"	"unprognostic (8.34e-2)"	"unprognostic (1.00e-1)"	61.4	16.8	5.2	34.8	5.9	58.0	50.3	5.9	7.3	40.2	6.8	23.7	8.3	28.1	4.5	34.8	30.0	28.5	34.8	5.5	7.1	15.9	146.9	46.9	26.5	6.7	6.4	24.3	13.7	3.9	4.9	14.3	7.3	14.4	11.8	0.9	35.2	7.5	15.6	34.6	20.6	25.5	6.3	20.8	20.1	4.7	11.1	23.2	76.3	13.3	28.9	30.7	28.2	8.5	289.2	0.0	16.0	0.4	52.9	76.9	0.7	22.0	93.0	31.6	54.1	0.0	61.4	165.0	9.8	52.0	16.3	161.8	47.0	28.8	63.3	1.0	0.2	257.3	93.0	0.0	106.6	513.8	428.4	231.7	0.9	306.5	3.5	22.9	89.7	75.0	299.8	154.4	123.7	0.6	108.6	328.2	24.3	0.0	5.3	221.8	3.3	570.9	76.1	0.0	38.0	0.0	62.2	1.4	263.5	1.5	24.1	77.3	48.1	1.5	81.4	209.2	62.5	0.3	0.9	41.3	187.3	183.2	532.1	15.2	105.7	23.4	19.6	127.0	22.2	9.6	13.5	26.8	85.8	7.1	10.4	10.5	9.0	3.9	146.3	85.7	26.5	60.7	5.2	5.9	5.9	7.3	5.5	7.1	6.7	6.4	7.3	6.3	11.1	8.5	19.8	16.0	49.1	1.6	6.1	46.8	7.4	30.8	48.3	0.5	8.0	14.2	3.7	28.6	26.1	1.8	0.0	0.6	11.9	0.3	0.0	75.5	1.0	1.0	3.1	33.0	0.0	38.3	0.1	6.4	5.0	33.4	2.0	3.0	67.0	2.9	14.3	61.7	73.7	0.0	0.2	0.6	16.2	21.0	74.6	1.7	9.9	47.0	30.2	8.4	10.2	0.6	3.1	8.5	0.8	9.4	0.5	12.4	22.5	14.5	0.0	0.1	4.9	0.1	65.7	15.5	22.0	0.7	1.1	13.6	17.6	0.8	11.8	12.3	1.2	3.0
SLC44A1	"CD92, CDW92, CHTL1, CTL1"	ENSG00000070214	"Solute carrier family 44 member 1"	Q8WWI5	9	105244622-105439171	"CD markers, Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		Neurodegeneration	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 284.9"	"Cell type enriched"	"Detected in all"	8	"Oligodendrocytes: 2444.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 285.9;ASC TERT1: 224.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA064714, HPA074007"	Enhanced		Supported	Nucleoplasm,Mitochondria		NA	NA		99000	"Cluster 24: B-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Mitochondria	Nucleoplasm	"HPA064714: AB_2685334, HPA074007: "	"unprognostic (3.49e-1)"	"unprognostic (2.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.54e-3)"	"unprognostic (4.77e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.21e-2)"	"prognostic unfavorable (4.49e-4)"	"unprognostic (2.48e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.64e-3)"	"unprognostic (6.20e-2)"	"prognostic favorable (1.85e-4)"	"unprognostic (2.13e-1)"	"unprognostic (2.07e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.07e-2)"	16.9	13.3	112.9	12.9	204.4	11.4	26.2	166.7	138.7	16.7	79.4	50.2	22.6	15.9	32.4	18.4	15.2	20.2	12.7	116.2	136.1	21.8	38.0	18.4	9.7	204.3	167.7	14.1	15.1	23.2	5.3	23.3	205.5	11.8	49.0	14.1	9.6	25.0	9.4	21.5	27.0	17.3	161.1	9.5	35.2	3.5	150.8	13.6	43.6	20.2	15.5	21.8	15.6	284.9	29.0	23.8	6.4	7.9	285.9	224.1	20.3	23.9	61.7	15.1	20.2	25.6	74.8	38.4	12.0	90.2	17.1	56.1	19.3	34.4	25.7	34.0	15.7	47.8	15.8	32.0	19.3	9.6	23.7	125.3	27.6	29.0	26.1	38.8	48.6	19.7	1.4	77.1	17.3	40.8	38.8	10.9	35.9	51.1	22.9	8.0	24.7	29.3	20.9	66.6	30.6	12.0	33.4	36.5	33.3	37.8	36.2	28.7	41.9	15.1	13.5	16.5	17.7	59.1	41.7	28.4	29.2	20.6	20.2	1.7	3.3	0.7	0.7	1.2	0.4	1.1	0.7	0.4	2.2	2.0	0.8	0.3	0.5	5.3	0.7	0.8	0.8	0.9	112.9	204.4	166.7	138.7	116.2	136.1	204.3	167.7	205.5	161.1	150.8	284.9	48.6	35.3	26.5	83.2	22.2	70.6	36.0	28.3	75.1	10.3	76.9	27.2	10.1	67.2	19.9	106.7	235.6	53.3	7.6	296.5	3.9	17.5	2.9	59.2	40.3	45.2	157.2	20.4	174.2	36.5	12.1	64.0	84.1	175.2	100.1	16.7	48.9	170.0	21.3	6.7	108.1	160.0	14.2	46.5	46.5	6.1	110.0	48.6	74.7	81.5	91.0	9.0	13.4	257.3	2444.2	36.9	161.2	79.7	162.9	23.8	95.4	27.1	31.4	53.3	39.5	43.8	34.9	2.3	4.4	86.9	74.3	70.6	20.3	12.1	199.1	34.8
SLC44A2	CTL2	ENSG00000129353	"Solute carrier family 44 member 2"	Q8IWA5	19	10602457-10644557	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 171.1;Extravillous trophoblasts: 257.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"A-431: 333.2;SK-BR-3: 306.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003228, HPA070799"	Approved		Approved	"Vesicles,Cell Junctions"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Vesicles, Cell Junctions"		"HPA003228: AB_1080009, HPA070799: AB_2686314"	"unprognostic (6.35e-3)"	"unprognostic (5.75e-2)"	"unprognostic (4.34e-1)"	"unprognostic (3.06e-3)"	"unprognostic (4.38e-2)"	"unprognostic (8.41e-3)"	"unprognostic (1.64e-1)"	"unprognostic (2.52e-1)"	"unprognostic (2.66e-2)"	"unprognostic (4.32e-1)"	"prognostic unfavorable (6.01e-4)"	"unprognostic (8.63e-2)"	"prognostic favorable (1.71e-5)"	"unprognostic (1.28e-1)"	"unprognostic (1.67e-1)"	"unprognostic (8.21e-3)"	"unprognostic (3.61e-2)"	74.7	33.2	69.6	43.9	85.0	65.0	72.7	78.4	67.4	64.6	33.4	58.3	26.7	43.0	36.2	81.6	59.0	55.8	71.4	62.7	69.7	68.7	17.8	98.5	75.3	99.6	76.5	32.3	41.2	48.7	20.5	157.5	87.0	43.8	49.5	29.1	55.5	65.8	141.2	78.3	50.8	43.6	84.3	115.5	112.9	82.5	79.1	48.8	64.9	92.4	77.7	56.3	69.2	97.6	333.2	8.3	70.0	42.1	103.9	63.5	201.1	69.6	169.5	112.3	131.6	75.6	154.9	65.6	91.1	193.9	13.6	254.1	10.7	53.2	71.6	1.7	9.3	42.0	39.3	3.1	115.0	0.6	33.9	69.2	69.8	42.3	37.2	91.0	86.8	30.2	20.2	10.8	172.6	243.6	35.1	32.1	24.9	96.9	29.3	74.1	102.7	2.9	37.1	171.8	6.9	42.0	56.7	306.1	7.7	73.8	123.0	3.2	79.8	50.1	18.4	60.5	18.0	4.0	7.9	64.8	12.5	29.1	57.3	146.3	39.4	227.9	114.1	113.0	90.4	92.1	78.5	87.4	20.7	94.8	83.3	87.1	482.8	79.2	278.3	100.4	95.7	147.4	69.6	85.0	78.4	67.4	62.7	69.7	99.6	76.5	87.0	84.3	79.1	97.6	84.0	54.5	29.1	32.3	53.4	9.7	17.3	17.2	13.1	12.3	45.8	29.1	38.6	28.6	47.7	92.0	14.6	137.8	51.9	49.9	1.9	44.1	171.1	15.8	31.4	52.7	9.6	45.0	14.3	44.3	257.0	22.6	84.6	38.6	20.3	7.1	75.7	1.9	37.0	3.3	15.5	17.7	14.2	38.7	3.9	35.1	38.8	22.8	5.4	15.9	10.2	36.4	88.6	18.6	18.4	41.1	31.9	56.4	18.9	9.8	20.1	3.7	19.0	3.0	59.2	26.3	29.4	3.2	2.9	33.5	8.5	93.4	41.2	6.8	23.4	20.6
SLC44A3	"CTL3, MGC45474"	ENSG00000143036	"Solute carrier family 44 member 3"	Q8N4M1	1	94820342-94895246	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"MAIT T-cell: 1.8"	"Lineage enriched"	"Detected in single"	18	"T-cells: 1.8"	"Cell line enhanced"	"Detected in many"		"OE19: 35.9;RPTEC TERT1: 101.4;RT4: 69.5"	"Region enhanced"	"Detected in single"		"pons and medulla: 1.1"	"Low region specificity"	"Detected in all"			HPA047433	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA047433: AB_2680046"	"unprognostic (8.06e-2)"	"unprognostic (7.65e-2)"	"unprognostic (4.63e-3)"	"unprognostic (3.57e-2)"	"unprognostic (1.53e-2)"	"unprognostic (2.37e-1)"	"unprognostic (1.14e-1)"	"unprognostic (4.03e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.46e-1)"	"unprognostic (5.78e-2)"	"unprognostic (2.44e-2)"	"prognostic favorable (7.63e-5)"	"unprognostic (9.09e-2)"	"unprognostic (8.28e-2)"	"unprognostic (5.95e-2)"	"unprognostic (3.31e-3)"	2.2	8.8	15.7	6.2	15.3	0.1	8.1	17.9	16.9	8.8	14.0	31.5	26.1	7.2	6.6	9.4	8.0	10.9	3.9	14.8	17.0	29.3	6.3	10.3	0.8	20.7	16.4	1.7	27.0	5.2	15.0	3.4	16.4	10.8	35.4	4.3	23.4	7.7	0.2	6.0	28.0	2.8	17.6	0.9	29.3	2.5	15.7	4.9	5.2	0.6	2.2	22.1	6.5	18.3	23.4	3.2	0.8	0.0	2.5	3.2	15.9	0.4	3.4	0.8	3.7	21.4	5.8	0.0	15.4	0.4	6.9	7.7	3.5	5.5	1.4	0.0	4.1	0.0	1.2	1.7	1.1	0.0	0.0	9.9	5.1	1.6	0.0	6.3	0.4	0.0	0.0	0.0	1.4	3.4	0.0	0.3	1.0	35.9	0.8	1.8	0.7	1.3	101.4	69.5	10.4	17.0	1.0	10.8	7.8	7.3	6.2	0.7	0.0	0.5	3.5	1.5	0.2	0.0	0.0	0.0	2.3	0.0	0.4	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.7	15.3	17.9	16.9	14.8	17.0	20.7	16.4	16.4	17.6	15.7	18.3	0.4	25.6	6.7	26.1	0.6	3.1	27.8	14.6	4.0	0.7	15.6	8.3	5.7	37.1	22.7	12.9	0.0	15.9	0.1	18.2	15.6	33.4	32.5	12.8	3.2	1.3	16.3	0.0	1.4	27.8	0.8	3.8	16.3	22.5	1.3	5.3	0.7	2.1	1.3	0.0	4.6	32.2	20.3	0.3	0.4	5.3	5.0	0.8	5.4	2.8	1.0	17.0	0.0	5.5	2.0	38.3	36.5	10.9	0.0	12.9	22.8	38.6	11.4	0.2	0.0	9.6	3.4	0.1	0.2	10.2	3.8	6.7	0.8	4.1	42.8	30.3
SLC44A4	"C6orf29, CTL4, DFNA72, FLJ14491, NG22, TPPT"	ENSG00000204385	"Solute carrier family 44 member 4"	Q53GD3	6	31863192-31879046	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 132.0;prostate: 83.0;stomach 1: 83.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 546.0;Exocrine glandular cells: 213.4;Intestinal goblet cells: 327.8;Paneth cells: 299.3;Proximal enterocytes: 267.7;Respiratory ciliated cells: 406.7;Undifferentiated cells: 259.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 222.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"OE19: 14.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA046977, HPA054176"	Enhanced					NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA046977: AB_2679887, HPA054176: AB_2682404"	"unprognostic (5.84e-2)"	"unprognostic (4.90e-2)"	"unprognostic (3.86e-3)"	"unprognostic (4.85e-3)"	"unprognostic (2.75e-2)"	"prognostic favorable (3.54e-4)"	"unprognostic (2.65e-3)"	"unprognostic (2.44e-3)"	"unprognostic (3.08e-1)"	"unprognostic (2.45e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.89e-1)"	"prognostic favorable (1.06e-6)"	"unprognostic (1.37e-2)"	"unprognostic (2.48e-1)"	"unprognostic (4.54e-2)"	"prognostic favorable (6.06e-4)"	0.8	8.2	0.0	2.5	0.0	1.0	5.3	0.0	0.0	22.4	0.0	132.0	100.8	5.9	2.5	2.0	46.9	18.8	0.0	0.0	0.0	32.1	0.4	14.9	0.1	0.3	0.1	1.6	8.9	0.0	16.1	3.5	0.1	83.0	30.3	0.0	42.6	3.9	0.0	1.1	86.8	2.9	0.0	1.6	83.4	0.7	0.0	0.2	1.9	0.0	0.7	11.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	14.6	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	3.7	22.4	36.0	0.0	3.8	0.5	23.0	71.4	0.6	0.3	14.6	6.1	0.4	38.6	180.2	66.2	0.0	0.3	0.5	546.0	3.9	111.2	2.3	127.4	8.9	6.2	46.7	0.0	0.1	213.4	0.5	2.4	208.5	67.5	2.5	1.1	0.4	0.0	0.5	0.0	0.1	327.8	91.6	0.0	0.0	3.2	1.5	2.5	0.0	0.0	1.6	0.7	0.0	0.0	0.0	184.0	299.3	0.4	0.3	142.0	267.7	61.5	406.7	0.6	0.0	0.8	11.9	0.2	0.2	0.5	0.4	0.7	2.3	5.5	259.6	139.4
SLC44A5	"CTL5, MGC34032"	ENSG00000137968	"Solute carrier family 44 member 5"	Q8NCS7	1	75202131-75611116	"Metabolic proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skin 1: 10.7"	"Group enriched"	"Detected in many"	4	"Excitatory neurons: 274.5;Inhibitory neurons: 563.3;Oligodendrocyte precursor cells: 265.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CACO-2: 7.7;RPTEC TERT1: 7.4;SH-SY5Y: 11.5;SuSa: 11.7;TIME: 14.7"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA047455, HPA051011"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA047455: AB_2680054, HPA051011: AB_2681309"	"unprognostic (9.00e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.57e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.78e-3)"	"unprognostic (6.41e-2)"	"unprognostic (9.19e-2)"	"prognostic unfavorable (6.52e-4)"	"unprognostic (1.70e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.68e-2)"	"unprognostic (4.30e-1)"	0.3	0.7	1.5	0.5	1.9	0.3	5.5	0.0	3.4	1.1	0.0	2.1	1.2	0.7	0.4	6.6	3.6	1.0	2.5	2.3	1.7	2.0	1.0	0.6	0.5	2.6	1.6	1.1	1.7	3.7	3.1	3.8	2.8	0.8	2.7	2.5	1.4	0.2	1.6	10.7	1.4	0.2	2.0	0.8	1.5	4.5	2.3	2.5	0.7	1.5	2.1	1.6	2.0	1.2	0.2	0.2	4.6	5.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.7	0.0	0.0	2.7	0.0	0.0	0.0	0.9	0.0	0.0	0.0	4.7	0.6	1.2	6.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	1.9	0.4	2.7	2.7	0.0	0.0	1.9	0.0	4.7	3.2	0.6	0.0	0.0	2.3	7.4	5.2	1.1	11.5	0.0	4.8	0.0	11.7	0.2	0.0	14.7	0.4	1.3	0.0	1.5	2.1	2.1	3.2	0.2	0.0	0.7	0.1	0.0	0.0	0.0	0.0	0.2	0.7	0.1	0.2	0.0	0.5	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	1.5	1.9	0.0	3.4	2.3	1.7	2.6	1.6	2.8	2.0	2.3	1.2	0.1	0.0	1.1	12.4	0.4	1.9	1.0	0.4	0.0	4.0	2.9	1.7	0.8	0.0	1.0	0.0	0.0	9.1	0.0	2.0	0.0	0.1	86.9	1.0	0.1	0.6	2.4	0.0	274.5	0.9	3.9	0.4	0.0	0.3	0.0	20.1	7.5	0.0	1.1	0.0	563.3	1.0	0.0	0.0	0.2	35.2	0.9	0.1	0.0	6.5	0.0	0.0	0.0	265.4	10.1	0.2	0.2	0.0	0.1	1.1	0.0	0.1	2.5	0.8	0.0	0.6	0.2	0.4	0.4	0.9	6.7	3.8	0.1	0.5	1.2	3.6
SLC45A1	DNB5	ENSG00000162426	"Solute carrier family 45 member 1"	Q9Y2W3	1	8318114-8344167	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Sugar transport, Symport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 10.0;Horizontal cells: 10.1;Inhibitory neurons: 11.1"	"Cancer enhanced"	"Detected in many"		"glioma: 4.4"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	5	"non-classical monocyte: 3.9"	"Lineage enriched"	"Detected in single"	5	"monocytes: 3.9"	"Cell line enhanced"	"Detected in some"		"ASC diff: 3.7;GAMG: 2.7;HHSteC: 4.9;U-87 MG: 6.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA078818	Enhanced					NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA078818: "	"unprognostic (1.77e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.32e-3)"	"unprognostic (8.32e-2)"	"unprognostic (3.22e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.39e-3)"	"unprognostic (3.18e-1)"	"unprognostic (5.67e-2)"	"unprognostic (8.53e-3)"	"unprognostic (2.16e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.51e-3)"	2.2	1.8	3.4	0.5	3.3	0.0	2.1	2.6	5.6	3.5	1.9	4.0	0.5	5.1	0.8	0.9	4.3	1.1	1.9	3.4	3.7	4.2	0.2	0.9	0.4	5.0	3.3	3.0	1.0	1.1	6.7	0.3	6.0	2.9	0.3	1.6	0.9	2.1	1.2	0.8	1.9	1.1	1.1	1.4	1.7	1.4	3.9	0.1	1.4	1.3	0.1	3.0	2.6	2.9	0.0	1.8	0.3	0.8	3.7	2.6	0.0	0.1	0.8	0.2	0.5	0.0	0.2	0.0	0.2	0.5	2.7	0.0	0.0	0.2	0.0	1.5	0.0	0.0	0.1	0.0	4.9	0.0	1.4	1.2	0.1	0.6	0.0	0.9	0.4	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.9	0.0	1.2	0.0	0.8	0.0	0.0	0.0	1.3	1.8	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.0	0.3	1.5	0.2	0.0	0.0	0.0	6.5	0.0	0.1	0.0	0.1	0.0	0.6	0.6	0.8	0.3	0.4	0.4	0.1	0.0	0.2	0.3	0.0	0.0	3.9	0.0	0.3	0.4	3.4	3.3	2.6	5.6	3.4	3.7	5.0	3.3	6.0	1.1	3.9	2.9	6.3	0.0	0.0	5.2	0.6	0.4	1.8	0.8	0.6	7.0	0.3	0.0	1.4	0.0	0.1	1.8	4.2	0.1	0.2	0.0	0.0	0.6	2.5	0.6	2.4	2.9	0.0	0.0	10.0	0.2	0.0	3.1	0.0	0.9	0.0	1.6	1.1	0.0	0.1	10.1	11.1	0.2	0.0	0.3	1.5	5.4	3.4	0.7	0.0	0.0	0.0	6.1	0.0	5.0	4.4	0.1	0.0	5.7	0.3	0.9	0.0	0.5	0.1	5.0	6.6	2.7	2.5	0.6	0.5	0.0	0.3	0.0	1.0	1.4	0.1	0.4
SLC45A2	"AIM-1, MATP, OCA4"	ENSG00000164175	"Solute carrier family 45 member 2"	Q9UMX9	5	33944623-33984693	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Melanin biosynthesis, Sensory transduction, Vision"		"Albinism, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"liver: 1.2;skin 1: 1.0;testis: 1.0"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 3.1;Excitatory neurons: 4.1;Inhibitory neurons: 5.4;Late spermatids: 5.1;Melanocytes: 12.4;Oligodendrocyte precursor cells: 2.5;Oligodendrocytes: 4.7"	"Cancer enriched"	"Detected in some"	18	"melanoma: 47.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	28	"SK-MEL-30: 60.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (2.97e-1)"	"unprognostic (3.99e-2)"	"unprognostic (3.55e-1)"	"unprognostic (2.39e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.09e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.34e-3)"	"unprognostic (4.06e-2)"	"unprognostic (8.45e-2)"	"unprognostic (7.39e-4)"	"unprognostic (1.40e-2)"	"unprognostic (1.84e-3)"	"unprognostic (1.55e-1)"	"unprognostic (1.50e-3)"	"unprognostic (2.48e-2)"	"unprognostic (3.39e-1)"	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.3	0.4	1.2	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.4	0.0	0.0	0.1	1.0	0.0	0.0	0.1	0.0	0.2	1.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	60.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.7	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.3	0.0	0.3	0.1	0.1	0.2	0.1	0.2	0.4	0.1	0.0	0.0	1.0	0.0	0.6	0.1	0.0	0.0	0.6	0.2	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.1	0.3	0.1	0.3	0.0	0.0	4.1	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.0	0.0	0.4	5.1	0.0	0.0	12.4	0.0	0.0	0.1	0.0	2.5	4.7	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.1	0.1	0.0
SLC45A3	"IPCA-2, IPCA-6, IPCA-8, PCANAP2, PCANAP6, PCANAP8, prostein"	ENSG00000158715	"Solute carrier family 45 member 3"	Q96JT2	1	205657851-205680509	"Cancer-related genes, Predicted membrane proteins, Transporters"	Transport		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"prostate: 306.4"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 19.9;granulocytes: 119.2;Oligodendrocytes: 47.1;Prostatic glandular cells: 67.2"	"Cancer enriched"	"Detected in all"	49	"prostate cancer: 539.9"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	382	"basophil: 40.5"	"Lineage enriched"	"Detected in single"	382	"granulocytes: 40.5"	"Cell line enriched"	"Detected in many"	29	"HMC-1: 834.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA019073, HPA019075"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 35: Glandular cells - Unknown function"	Vesicles	Nucleoplasm	"HPA019073: AB_1857177, HPA019075: AB_1857179"	"unprognostic (1.80e-1)"	"unprognostic (1.08e-3)"	"unprognostic (3.13e-2)"	"prognostic unfavorable (4.04e-5)"	"unprognostic (6.93e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.18e-1)"	"unprognostic (3.03e-2)"	"unprognostic (3.16e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.96e-1)"	"prognostic favorable (7.33e-5)"	1.4	3.6	6.7	3.2	19.5	0.8	1.6	17.6	13.4	3.7	1.9	4.8	4.6	1.7	0.5	1.6	2.1	3.8	1.5	8.0	10.3	2.1	11.2	3.4	2.7	25.1	17.3	2.7	0.8	0.3	4.7	0.5	21.8	306.4	3.2	0.1	2.8	0.6	5.6	1.5	4.8	1.0	12.6	12.4	16.8	1.4	16.6	0.5	1.0	2.3	0.8	2.8	1.1	44.7	9.7	3.0	2.8	2.7	0.0	0.1	2.2	1.3	0.3	3.3	2.7	7.1	18.0	2.7	4.6	0.3	3.0	3.5	1.6	3.3	0.5	3.9	2.9	29.0	0.6	2.0	1.9	5.0	834.2	0.3	1.1	2.3	0.0	2.2	9.4	4.5	4.9	1.7	1.4	2.3	0.8	8.5	12.2	16.7	10.7	1.0	4.1	1.5	3.7	13.7	1.2	2.9	1.5	20.6	3.9	2.3	4.7	1.4	9.6	1.4	9.5	3.5	7.1	0.4	0.6	0.4	1.8	1.5	7.1	40.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	6.7	19.5	17.6	13.4	8.0	10.3	25.1	17.3	21.8	12.6	16.6	44.7	0.2	0.0	3.2	1.0	4.0	0.0	1.0	0.6	0.0	0.4	1.5	1.8	2.0	2.8	1.0	1.8	0.0	0.5	0.1	5.7	0.0	1.7	0.2	1.9	0.2	1.7	0.0	3.4	0.2	0.5	0.1	0.7	19.9	0.2	119.2	0.2	0.7	6.6	1.9	0.0	0.3	6.9	2.0	1.0	0.3	0.4	1.8	2.0	0.0	0.0	0.6	0.1	0.0	2.0	47.1	3.9	8.0	1.5	0.3	67.2	0.9	1.8	3.2	0.1	6.6	0.1	0.8	0.0	2.6	0.4	0.1	0.0	0.9	0.2	6.7	0.9
SLC45A4	KIAA1126	ENSG00000022567	"Solute carrier family 45 member 4"	Q5BKX6	8	141207166-141308305	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 49.7;Cone photoreceptor cells: 54.2;Endometrial ciliated cells: 57.6;Glandular and luminal cells: 97.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	7	"eosinophil: 8.3;neutrophil: 7.0"	"Lineage enriched"	"Detected in single"	22	"granulocytes: 8.3"	"Cell line enhanced"	"Detected in many"		"HMC-1: 18.3;OE19: 30.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023154	Uncertain		Approved	"Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"		"HPA023154: AB_2191204"	"unprognostic (7.79e-3)"	"unprognostic (1.06e-1)"	"unprognostic (4.30e-2)"	"unprognostic (1.44e-1)"	"unprognostic (6.06e-2)"	"unprognostic (3.96e-2)"	"unprognostic (1.26e-1)"	"unprognostic (4.49e-3)"	"unprognostic (1.02e-1)"	"unprognostic (5.31e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.84e-1)"	"prognostic favorable (1.73e-6)"	"unprognostic (8.79e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.40e-2)"	3.5	2.5	3.8	3.7	4.8	5.8	2.9	1.2	16.6	7.1	14.7	4.4	2.3	4.3	1.5	3.3	7.1	2.7	6.6	5.1	1.5	10.2	0.9	6.7	2.7	6.6	1.0	3.1	7.9	2.5	14.9	5.0	6.6	6.6	1.6	5.4	7.8	5.3	4.6	5.7	4.1	1.7	0.7	4.8	12.5	13.7	2.2	2.3	5.8	1.4	2.0	3.4	2.8	6.1	4.6	9.8	3.7	5.9	0.3	0.3	16.1	2.5	1.5	2.2	1.7	6.4	12.2	0.9	11.8	1.0	3.1	3.7	2.1	1.2	1.0	7.2	3.3	2.7	3.1	0.0	1.7	1.1	18.3	0.8	1.9	1.6	0.9	0.5	1.5	5.0	5.6	0.7	0.8	11.9	11.0	2.5	4.7	30.8	4.1	3.3	0.2	3.1	8.9	7.9	5.5	4.6	2.7	0.8	4.5	2.6	1.9	7.2	0.8	0.0	2.4	3.8	4.9	3.9	12.7	1.3	2.1	4.3	4.0	1.1	0.1	8.3	0.1	0.1	0.1	0.0	0.1	0.3	0.1	0.0	0.1	0.1	7.0	0.2	0.1	0.3	0.2	0.1	3.8	4.8	1.2	16.6	5.1	1.5	6.6	1.0	6.6	0.7	2.2	6.1	3.3	9.6	12.7	6.5	3.0	2.7	6.6	3.6	5.2	33.1	6.4	5.8	13.5	15.7	8.9	49.7	54.2	8.7	7.5	14.7	0.0	9.3	12.5	57.6	10.8	3.4	2.4	0.0	29.0	2.7	0.8	2.9	37.2	97.1	1.3	1.8	1.1	0.0	6.7	3.3	21.7	7.7	8.2	2.5	3.3	5.9	2.1	8.6	3.6	7.5	1.8	4.3	5.2	6.6	0.9	7.8	4.5	2.2	5.3	6.0	3.7	3.2	22.3	9.2	0.0	1.5	3.2	5.7	2.6	4.4	2.4	16.3	4.6	4.0	5.1	11.3
SLC46A1	"HCP1, MGC9564, PCFT"	ENSG00000076351	"Solute carrier family 46 member 1"	Q96NT5	17	28394642-28407197	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 93.9"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 26.6;Hepatocytes: 27.8;Hofbauer cells: 25.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"CACO-2: 205.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011614	Approved		Supported	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane, Cytosol"		"CAB011614: AB_2270597"	"unprognostic (1.10e-1)"	"unprognostic (8.62e-2)"	"unprognostic (1.40e-1)"	"unprognostic (7.59e-2)"	"prognostic unfavorable (5.62e-4)"	"unprognostic (9.11e-2)"	"unprognostic (4.05e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.94e-1)"	"unprognostic (3.80e-2)"	"unprognostic (1.04e-3)"	"unprognostic (6.15e-2)"	"unprognostic (2.10e-3)"	"unprognostic (2.16e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.04e-1)"	6.7	24.8	8.1	5.7	10.6	3.4	5.7	14.7	9.2	5.6	26.7	5.7	93.9	4.6	8.5	2.4	13.4	4.6	4.6	8.0	8.4	7.5	27.3	6.9	5.5	11.2	9.7	8.7	11.2	15.0	15.5	8.2	10.4	7.4	5.6	8.7	12.5	9.0	3.6	2.3	40.5	5.5	9.8	11.1	5.5	3.1	10.0	23.4	6.4	2.8	2.1	5.0	2.6	12.1	5.4	22.5	7.4	12.2	5.9	1.3	22.9	6.3	4.6	5.1	5.7	205.4	6.4	0.4	3.6	3.4	14.8	17.3	8.4	14.1	4.3	13.1	19.6	0.2	14.0	17.6	2.1	0.1	10.1	2.8	25.3	5.3	15.8	7.1	0.4	1.8	8.9	1.2	0.9	7.2	0.1	0.6	4.4	5.2	2.9	0.3	6.0	2.7	4.0	11.8	19.4	10.2	43.6	20.1	2.4	10.1	15.6	3.4	0.6	0.8	8.6	1.2	6.6	9.0	11.1	0.3	1.2	1.3	4.7	5.2	0.9	0.6	0.4	3.0	0.7	1.6	0.4	0.3	1.4	0.8	0.5	0.8	1.0	1.6	2.6	0.5	0.9	0.5	8.1	10.6	14.7	9.2	8.0	8.4	11.2	9.7	10.4	9.8	10.0	12.1	1.2	12.8	5.3	7.5	1.0	0.4	1.9	2.8	4.0	26.6	5.1	6.1	2.3	17.2	2.2	7.3	4.2	20.8	0.2	3.7	0.0	3.5	3.6	18.2	1.8	1.9	1.2	0.4	2.8	4.6	9.7	3.6	3.1	1.5	1.3	4.2	1.8	27.8	25.7	20.2	4.6	2.4	0.0	21.5	1.0	19.5	4.1	8.0	0.0	5.6	2.0	2.2	0.0	8.0	6.9	3.8	3.6	3.4	3.0	2.6	3.9	4.6	4.3	6.0	6.6	3.7	1.4	0.3	0.3	1.2	0.3	4.4	0.6	5.8	1.3	1.6
SLC46A2	"Ly110, TSCOT"	ENSG00000119457	"Solute carrier family 46 member 2"	Q9BY10	9	112878920-112890876	"Predicted membrane proteins, Transporters"	Transport			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"cervix: 16.5;lung: 10.4;lymphoid tissue: 16.0;skin 1: 24.1"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 39.8;Endometrial ciliated cells: 15.8;Glandular and luminal cells: 6.9;Kupffer cells: 11.8;monocytes: 12.4"	"Cancer enhanced"	"Detected in some"		"lung cancer: 1.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 24.6;intermediate monocyte: 12.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 24.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA020098	Approved					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 31: Skin - Epidermis development"		"Cluster 11: Alveolar cells - Smell perception"			"HPA020098: AB_2670363"	"unprognostic (1.26e-1)"	"unprognostic (5.15e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.53e-3)"	"unprognostic (3.57e-3)"	"unprognostic (2.10e-2)"	"unprognostic (4.56e-1)"	"unprognostic (2.18e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.50e-3)"	"unprognostic (3.50e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.77e-2)"	"unprognostic (2.37e-1)"	"unprognostic (2.71e-2)"	"unprognostic (1.83e-1)"	"unprognostic (7.82e-2)"	0.1	0.0	0.1	0.6	0.1	0.1	0.9	0.5	0.2	16.5	0.0	0.0	0.0	3.0	4.7	1.2	0.0	0.0	0.0	0.1	0.1	0.0	0.0	10.4	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.2	1.5	0.0	24.1	0.0	0.4	0.0	0.9	0.0	0.6	0.5	16.0	0.0	0.0	0.1	3.0	0.7	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	24.6	0.0	0.1	12.1	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.3	0.0	10.1	0.2	0.0	6.6	0.1	0.1	0.5	0.2	0.1	0.1	0.1	0.1	0.2	0.0	0.5	0.3	0.0	0.0	39.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.7	1.5	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	15.8	0.8	0.3	0.0	0.0	0.9	0.0	0.0	0.2	0.0	6.9	0.0	0.0	0.4	0.1	2.1	0.0	0.4	0.0	0.0	11.8	1.8	4.4	0.0	4.1	0.0	0.0	12.4	0.0	1.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.7	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.2
SLC46A3	"DKFZp686A1775, FLJ42613"	ENSG00000139508	"Solute carrier family 46 member 3"	Q7Z3Q1	13	28700064-28718970	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 76.0;liver: 96.0"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 53.2;Hepatocytes: 51.3;Proximal enterocytes: 125.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"RPTEC TERT1: 27.0;T-47d: 20.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039930	Approved		Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cytosol"	"Actin filaments"	"HPA039930: AB_10673263"	"unprognostic (5.16e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.61e-1)"	"unprognostic (3.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.53e-3)"	"prognostic favorable (7.09e-4)"	"unprognostic (3.13e-1)"	"unprognostic (3.33e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.69e-2)"	"unprognostic (7.35e-2)"	"unprognostic (1.14e-1)"	"unprognostic (5.60e-2)"	"unprognostic (9.14e-3)"	"unprognostic (6.47e-3)"	13.8	11.7	5.1	10.2	5.7	2.9	10.0	7.7	5.2	14.7	10.0	19.8	46.7	5.6	11.1	4.0	7.5	23.8	12.3	4.7	5.7	18.2	96.0	11.5	16.3	5.9	6.0	3.9	6.7	23.9	10.2	9.5	6.1	6.5	18.8	15.9	9.0	9.9	8.5	4.2	76.0	8.2	6.6	18.2	7.8	11.0	6.6	11.6	12.5	8.6	11.1	7.0	2.2	5.6	0.0	2.8	0.0	7.6	6.0	2.3	0.2	2.7	15.7	3.0	4.4	0.1	6.6	5.2	4.7	4.0	11.5	0.6	3.5	1.4	4.5	3.9	6.2	3.6	0.0	0.0	11.4	0.0	4.3	9.8	2.9	4.5	7.3	3.0	5.6	15.7	3.9	0.0	14.5	3.0	8.6	0.6	0.3	8.0	2.2	3.5	13.3	0.2	27.0	0.9	1.2	0.4	0.0	14.1	5.7	3.1	20.6	4.6	2.0	1.4	2.7	0.4	16.0	4.0	2.0	0.8	0.9	0.0	2.8	33.1	8.9	3.8	10.3	13.1	8.6	7.4	8.0	10.1	11.7	9.7	11.4	10.8	9.8	7.0	19.4	11.0	10.6	8.7	5.1	5.7	7.7	5.2	4.7	5.7	5.9	6.0	6.1	6.6	6.6	5.6	6.2	0.0	5.4	16.0	14.5	1.9	0.1	7.4	1.8	33.7	15.1	3.3	9.6	17.2	15.6	9.2	8.4	0.6	16.4	49.0	1.9	15.5	4.6	2.1	1.7	12.2	3.6	4.6	11.6	5.6	0.3	6.2	0.0	2.1	25.9	53.2	17.5	51.3	10.8	21.9	13.0	6.8	2.0	32.1	36.6	1.8	1.5	22.5	7.2	16.9	9.3	14.2	12.3	14.6	15.6	3.5	5.3	2.2	6.5	0.6	125.0	10.1	15.4	9.8	0.0	2.8	7.2	2.6	0.9	4.9	1.7	0.7	11.4	16.8	13.9	0.2
SLC47A1	"FLJ10847, MATE1"	ENSG00000142494	"Solute carrier family 47 member 1"	Q96FL8	17	19495385-19579034	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 127.3;kidney: 100.3;liver: 103.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 189.2;Hepatocytes: 43.3;Proximal tubular cells: 52.9;Skeletal myocytes: 67.8"	"Cancer enhanced"	"Detected in many"		"renal cancer: 37.4"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"eosinophil: 12.2;plasmacytoid DC: 6.6"	"Group enriched"	"Detected in many"	6	"dendritic cells: 6.6;granulocytes: 12.2"	"Cell line enhanced"	"Detected in many"		"A549: 21.3;AN3-CA: 16.7;Hep G2: 41.5;U-266/70: 31.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA021987	Enhanced					NA	NA		18000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 40: Granulosa cells - Unknown function"			"HPA021987: AB_1857185"	"unprognostic (1.17e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.46e-1)"	"prognostic favorable (5.54e-8)"	"unprognostic (7.87e-2)"	"unprognostic (8.34e-2)"	"unprognostic (2.92e-2)"	"prognostic favorable (1.88e-5)"	"unprognostic (4.84e-2)"	"unprognostic (6.89e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.60e-1)"	"prognostic favorable (1.06e-5)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.91e-2)"	"unprognostic (9.40e-2)"	1.9	127.3	2.1	0.8	2.6	2.7	1.3	3.5	15.8	29.4	9.3	2.0	1.3	16.2	2.5	1.9	7.4	3.8	5.4	15.7	1.6	100.3	103.9	7.0	1.6	3.0	2.5	7.7	0.3	1.4	16.5	0.4	3.1	6.3	1.0	1.2	2.6	12.3	34.1	25.0	1.3	7.7	2.5	3.7	1.2	14.5	4.3	1.5	6.2	37.7	1.3	1.0	10.6	3.3	0.1	21.3	0.6	16.7	0.5	0.1	0.1	0.6	0.5	2.5	2.3	0.0	0.6	0.2	3.9	3.1	8.3	0.1	7.4	0.6	0.6	0.1	9.8	0.2	10.6	41.5	0.2	0.2	0.5	0.4	3.7	1.9	0.3	2.8	5.9	0.0	0.0	0.0	0.0	3.0	0.1	0.4	2.2	0.3	0.8	0.2	0.2	0.2	0.0	1.3	3.9	3.4	7.0	0.1	1.9	5.6	7.1	1.9	0.0	0.1	0.8	0.3	2.0	31.0	13.1	0.1	0.8	0.1	3.6	0.3	1.4	12.2	0.3	0.9	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.6	0.2	0.0	0.1	6.6	0.0	0.5	2.1	2.6	3.5	15.8	15.7	1.6	3.0	2.5	3.1	2.5	4.3	3.3	0.5	6.4	3.7	0.7	1.3	4.7	2.3	0.4	6.2	0.9	0.1	0.8	4.1	4.3	0.1	1.8	0.0	0.0	1.7	0.0	3.9	0.1	15.5	3.0	1.3	1.2	0.0	0.0	3.5	0.0	0.0	4.4	0.0	9.2	5.7	189.2	0.0	43.3	1.5	0.0	14.4	0.0	0.0	2.9	1.2	4.8	3.7	2.5	1.8	3.7	0.4	1.4	0.0	2.5	0.3	0.0	0.0	1.5	3.9	2.3	0.0	52.9	0.8	0.9	6.6	67.8	3.3	0.6	1.1	1.1	6.7	0.0	1.7	0.3	0.0	1.5
SLC47A2	"FLJ31196, MATE2, MATE2-K"	ENSG00000180638	"Solute carrier family 47 member 2"	Q86VL8	17	19678288-19718979	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 22.3;choroid plexus: 39.6;kidney: 55.8"	"Cell type enriched"	"Detected in some"	4	"Proximal tubular cells: 91.3"	"Cancer enhanced"	"Detected in some"		"glioma: 2.6;renal cancer: 4.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"hTCEpi: 2.1"					"Not detected"	"Not detected"									NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (4.52e-3)"	"unprognostic (8.28e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (8.95e-4)"	"unprognostic (5.22e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.99e-2)"	"unprognostic (3.29e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.36e-3)"	"unprognostic (7.77e-2)"	"unprognostic (1.04e-3)"	"unprognostic (4.33e-2)"	"unprognostic (1.61e-1)"	"unprognostic (6.44e-2)"	"unprognostic (5.71e-2)"	0.1	0.2	2.5	0.0	2.1	0.0	0.2	2.0	1.5	0.1	39.6	0.0	0.0	0.1	6.7	0.4	10.0	0.0	0.1	3.5	6.4	55.8	0.0	0.0	0.0	11.6	22.3	0.1	0.0	0.0	0.0	0.0	11.5	0.0	0.0	0.6	0.4	0.2	1.1	2.3	0.3	0.1	8.4	0.0	0.0	0.0	5.0	0.0	0.2	0.2	0.0	0.0	0.1	4.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.4	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.3	0.0	0.6	0.3	0.0	0.0	0.0	0.0	2.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.2	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	2.1	2.0	1.5	3.5	6.4	11.6	22.3	11.5	8.4	5.0	4.7	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.7	0.6	0.0	0.0	0.9	0.7	0.0	0.2	5.5	0.0	0.1	0.0	0.2	5.9	0.0	0.6	20.9	0.4	0.1	0.0	0.0	3.3	0.0	0.0	0.5	0.0	0.9	0.0	0.2	0.0	0.0	0.0	0.0	1.6	0.0	2.0	0.0	0.0	0.7	0.3	0.9	0.0	1.9	0.0	1.3	0.0	2.0	1.4	0.1	0.0	0.0	0.0	0.8	1.7	91.3	2.5	0.5	0.0	3.5	0.1	0.6	0.8	1.0	0.3	0.0	0.6	0.0	0.2	0.2
SLC48A1	"FLJ20489, hHRG-1, HRG1"	ENSG00000211584	"Solute carrier family 48 member 1"	Q6P1K1	12	47753916-47782751	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 135.6"	"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 100.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"EFO-21: 102.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA065396, HPA073994"	Approved		Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Vesicles		"HPA065396: , HPA073994: "	"unprognostic (9.60e-2)"	"prognostic favorable (4.27e-4)"	"unprognostic (1.13e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.79e-1)"	"prognostic unfavorable (9.39e-5)"	"unprognostic (1.12e-1)"	"unprognostic (1.83e-1)"	"unprognostic (9.88e-2)"	"unprognostic (1.54e-2)"	"unprognostic (6.63e-3)"	"prognostic favorable (1.34e-6)"	"unprognostic (1.45e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.72e-2)"	27.5	37.4	98.8	6.9	131.6	12.3	27.6	116.7	104.3	26.8	58.5	26.8	7.4	20.2	16.2	28.9	28.4	15.4	29.0	96.2	99.8	44.1	15.2	22.3	7.0	125.5	127.0	53.1	19.5	29.4	17.7	17.7	113.4	20.4	10.6	11.2	20.2	22.7	29.9	22.0	14.3	16.6	103.2	25.8	22.1	9.9	126.8	7.9	52.6	21.5	8.2	27.6	22.6	135.6	11.9	36.3	5.7	42.8	36.4	15.5	12.3	8.3	18.3	7.8	8.0	11.7	31.0	7.2	102.7	23.3	15.5	45.4	7.3	9.6	6.0	59.1	6.8	49.4	30.4	16.1	20.8	13.3	27.9	9.2	19.3	11.2	13.6	40.6	22.1	20.0	13.1	28.3	5.1	24.7	6.5	13.7	3.9	21.9	17.1	6.0	1.6	39.0	31.5	31.3	7.3	3.3	11.0	13.8	7.8	10.2	46.0	12.2	12.3	10.9	14.3	21.1	6.0	21.6	14.3	2.2	14.2	62.8	6.7	0.1	17.9	12.4	5.2	13.5	4.7	10.4	6.4	5.5	12.9	9.9	7.7	6.4	36.7	2.0	7.7	2.6	5.5	6.3	98.8	131.6	116.7	104.3	96.2	99.8	125.5	127.0	113.4	103.2	126.8	135.6	35.2	9.6	13.5	35.3	6.2	6.6	9.7	6.4	22.2	11.1	15.5	15.2	16.4	20.0	5.5	51.5	2.1	9.5	2.3	9.0	23.5	10.4	8.5	10.9	6.2	22.3	8.4	53.0	9.1	9.8	2.3	15.6	4.6	18.0	1.3	16.4	16.8	11.8	24.1	15.2	8.3	13.5	6.1	18.0	9.9	12.5	32.6	14.1	5.4	8.4	28.4	26.8	2.1	11.1	100.3	6.6	5.2	23.0	10.1	12.9	9.2	34.9	2.3	11.2	6.6	11.9	11.6	4.1	10.5	20.9	11.9	3.6	3.3	18.0	7.5	11.6
SLC49A3	"FLJ22269, LP2561, MFSD7"	ENSG00000169026	"Solute carrier family 49 member 3"	Q6UXD7	4	681829-689271	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Adipocytes: 12.8;Breast glandular cells: 14.6;Collecting duct cells: 14.7;Ductal cells: 19.2;Extravillous trophoblasts: 33.9;Hofbauer cells: 35.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"BEWO: 8.7;CAPAN-2: 5.8;SK-BR-3: 8.2;T-47d: 25.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA043593	Uncertain					NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 77: Retina - Visual perception"	"Cluster 6: T47d - Mammary gland"	"Cluster 4: Macrophages - Innate immune response"			"HPA043593: AB_10959611"	"unprognostic (1.10e-2)"	"unprognostic (1.91e-1)"	"unprognostic (8.77e-2)"	"unprognostic (4.70e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.84e-3)"	"unprognostic (2.22e-1)"	"unprognostic (1.56e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.56e-1)"	"unprognostic (9.22e-2)"	"unprognostic (2.08e-1)"	"prognostic favorable (2.66e-5)"	"unprognostic (8.35e-2)"	"unprognostic (4.92e-2)"	"unprognostic (7.48e-2)"	"unprognostic (1.11e-1)"	8.2	3.2	2.4	4.4	2.1	3.5	9.0	2.7	3.0	4.5	3.5	4.2	5.9	3.4	4.2	4.4	3.3	3.7	8.3	1.7	2.3	8.3	5.8	8.1	3.0	3.2	2.2	1.2	4.8	4.6	1.9	2.7	3.0	5.0	2.3	12.6	8.4	2.1	3.0	10.2	5.9	2.1	2.7	8.5	8.4	8.9	3.5	0.6	8.5	1.9	1.7	4.3	4.9	2.9	0.1	0.1	2.7	1.9	1.9	3.7	8.7	1.0	0.0	0.7	0.6	0.4	5.8	0.1	0.2	4.5	0.4	0.2	0.0	0.0	0.2	0.6	0.6	1.6	0.7	0.2	0.8	0.0	1.2	2.5	0.0	3.4	0.0	0.0	1.3	0.3	0.4	0.5	0.0	0.1	0.1	0.7	0.3	0.4	0.5	0.0	0.3	0.6	0.0	0.3	0.9	0.7	0.0	8.2	0.5	0.5	25.8	1.6	0.3	0.8	0.3	0.4	0.3	2.8	1.6	0.1	0.3	0.7	0.0	0.0	0.6	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.4	0.2	0.0	0.1	0.3	2.4	2.1	2.7	3.0	1.7	2.3	3.2	2.2	3.0	2.7	3.5	2.9	12.8	3.2	1.7	0.0	0.4	0.0	0.0	0.0	0.0	0.0	14.6	8.4	0.0	0.0	1.8	14.7	0.0	0.7	3.1	0.0	1.9	19.2	0.0	2.1	6.0	4.3	0.0	0.0	0.0	0.4	33.9	4.3	0.0	4.1	0.0	0.8	0.0	0.0	35.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.9	0.0	0.0	3.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.8	0.0	0.0	2.4	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	4.9	0.7	0.5	0.0	0.0
SLC49A4	"DIRC2, FLJ14784, RCC4"	ENSG00000138463	"Solute carrier family 49 member 4"	Q96SL1	3	122795069-122881139	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 44.0;Extravillous trophoblasts: 61.2;Syncytiotrophoblasts: 226.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA072579			Supported	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA072579: AB_2686536"	"unprognostic (1.40e-1)"	"unprognostic (8.53e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.16e-1)"	"unprognostic (5.36e-2)"	"prognostic unfavorable (7.48e-4)"	"unprognostic (9.74e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.95e-2)"	"prognostic unfavorable (5.81e-5)"	"unprognostic (1.87e-1)"	"prognostic favorable (8.81e-11)"	"unprognostic (2.36e-1)"	"unprognostic (2.64e-1)"	"unprognostic (1.73e-1)"	"unprognostic (7.13e-2)"	4.4	5.0	4.9	2.7	5.1	5.9	3.1	4.9	5.3	3.0	6.2	4.1	1.9	2.6	3.8	5.6	3.1	3.7	6.4	5.7	5.9	4.6	3.5	5.2	2.0	4.8	5.6	2.2	6.5	12.7	2.4	7.6	5.6	4.9	4.5	5.7	3.7	3.6	15.9	6.6	2.6	2.7	5.2	2.8	3.1	2.5	5.6	1.9	5.2	14.0	2.5	4.0	2.6	5.9	7.4	6.1	5.9	3.3	7.5	6.1	19.6	3.1	6.7	4.9	5.0	14.4	8.0	1.0	3.9	3.5	10.9	10.5	4.3	5.6	4.7	1.6	3.2	1.2	3.3	6.2	5.5	0.7	0.7	5.0	15.0	3.5	5.9	7.6	5.6	2.0	0.7	1.3	6.3	3.3	0.9	0.8	5.3	2.5	9.8	2.0	13.3	1.5	7.0	8.4	6.1	4.6	9.1	4.1	8.4	3.7	4.8	1.6	8.0	7.6	2.8	4.6	2.6	1.3	1.2	0.4	3.8	1.3	4.2	0.0	0.2	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.9	0.0	0.2	0.0	0.0	0.0	4.9	5.1	4.9	5.3	5.7	5.9	4.8	5.6	5.6	5.2	5.6	5.9	3.5	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.0	0.0	0.0	0.0	0.0	44.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	61.2	2.4	0.0	0.0	0.0	0.0	0.0	0.0	12.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	226.6	0.4	0.0	0.0	0.0
SLC4A1	"AE1, CD233, DI, EPB3, FR, RTA1A, SW, WD, WR"	ENSG00000004939	"Solute carrier family 4 member 1 (Diego blood group)"	P02730	17	44248390-44268141	"Blood group antigen proteins, CD markers, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Transport"	"Blood group antigen"	"Disease variant, Elliptocytosis, Hereditary hemolytic anemia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"bone marrow: 407.2"	"Cell type enriched"	"Detected in some"	80	"Erythroid cells: 1629.2"	"Cancer enriched"	"Detected in single"	91	"renal cancer: 16.3"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 3.0;neutrophil: 2.7"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in single"		"K-562: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA015584, CAB034438, HPA063911"	Enhanced					NA	NA		22000000	"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB034438: AB_2123479, HPA015584: AB_1844824, HPA063911: AB_2685151"	"unprognostic (1.36e-1)"	"unprognostic (1.42e-1)"	"unprognostic (3.36e-1)"	"unprognostic (2.44e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.56e-2)"	"unprognostic (1.55e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.68e-1)"	"unprognostic (1.58e-1)"	"unprognostic (6.72e-3)"	"unprognostic (1.19e-1)"	"unprognostic (9.28e-3)"	"unprognostic (1.93e-2)"	"unprognostic (2.18e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.13e-1)"	0.5	0.3	0.7	0.3	0.7	407.2	0.2	2.2	1.4	0.1	1.7	0.2	0.3	0.1	0.3	0.3	0.1	0.3	0.9	0.6	0.5	72.1	2.2	1.8	0.4	0.8	0.6	0.1	0.2	0.0	0.6	10.9	0.9	0.1	0.1	0.7	0.4	0.1	2.2	0.5	0.2	0.0	0.3	12.8	0.3	0.3	1.1	0.7	0.3	1.5	0.1	0.1	0.1	1.7	0.2	0.0	0.3	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.6	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.3	0.1	0.2	0.4	0.4	0.0	0.2	0.6	0.1	0.1	0.0	0.0	0.1	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.8	0.2	0.2	0.1	0.6	0.0	0.3	0.1	0.1	0.4	0.2	0.3	0.3	0.1	0.1	0.6	0.6	0.1	0.3	0.3	0.2	0.2	0.1	0.2	0.1	0.4	0.5	0.2	3.0	0.3	0.5	0.2	0.3	0.2	0.3	0.2	0.2	0.1	0.5	0.2	0.2	2.7	1.1	0.4	0.3	0.1	0.2	0.7	0.7	2.2	1.4	0.6	0.5	0.8	0.6	0.9	0.3	1.1	1.7	0.8	6.4	0.6	0.3	2.0	0.0	1.3	0.0	0.0	0.4	1.0	1.1	0.7	0.0	0.6	20.2	0.0	0.4	0.1	0.2	3.9	0.1	0.8	0.2	0.4	0.7	0.0	1629.2	0.2	0.0	1.6	0.5	0.0	0.5	0.0	0.1	0.7	0.9	1.4	0.0	0.2	0.1	0.0	1.0	0.0	0.0	0.0	1.9	0.0	1.0	0.6	0.2	2.1	0.0	0.0	0.0	0.0	0.4	0.3	0.9	0.2	0.4	0.0	0.2	0.0	1.2	0.2	0.7	0.5	0.0	0.0	0.8	1.5	0.7	0.1	0.6
SLC4A10	"NBCn2, NCBE"	ENSG00000144290	"Solute carrier family 4 member 10"	Q6U841	2	161424332-161985282	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.3;choroid plexus: 121.4;retina: 34.3"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 604.4;Inhibitory neurons: 560.9"	"Cancer enhanced"	"Detected in single"		"glioma: 1.3"	"Region enhanced"	"Detected in many"		"cerebral cortex: 21.3"	"Immune cell enriched"	"Detected in some"	8	"MAIT T-cell: 63.3"	"Lineage enriched"	"Detected in single"	65	"T-cells: 63.3"	"Cell line enriched"	"Detected in single"	11	"Karpas-707: 8.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA034755, HPA076725"	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA034755: AB_10670296, HPA076725: "	"unprognostic (4.64e-4)"	"unprognostic (3.88e-1)"	"unprognostic (2.88e-2)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"unprognostic (7.89e-3)"	"unprognostic (5.99e-4)"	"unprognostic (1.12e-1)"	"unprognostic (2.27e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.50e-2)"	"unprognostic (9.27e-2)"	"unprognostic (5.65e-2)"	"unprognostic (9.23e-3)"	"unprognostic (1.87e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.26e-1)"	0.0	2.0	6.3	0.7	10.3	0.2	0.2	0.2	21.3	0.1	121.4	1.8	0.3	0.0	1.3	0.0	0.6	0.4	0.0	11.8	1.1	0.0	0.2	0.0	0.1	0.0	0.0	0.0	1.5	0.0	1.3	0.0	0.0	0.2	1.3	34.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.4	0.1	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.5	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	2.5	0.0	63.3	0.0	1.2	7.8	0.0	0.0	0.0	0.1	0.1	0.9	0.0	0.0	0.0	0.5	6.3	10.3	0.2	21.3	11.8	1.1	0.0	0.0	0.0	0.0	0.0	3.6	0.1	0.0	0.0	21.2	0.1	0.0	0.0	0.0	0.0	116.3	0.0	0.0	0.6	0.0	0.0	0.0	8.4	0.0	2.6	1.1	0.0	0.0	18.3	0.0	0.0	0.3	0.0	0.0	604.4	0.0	0.0	0.0	0.5	0.0	2.5	0.0	1.8	0.6	0.0	0.0	560.9	2.8	0.0	0.6	0.0	10.5	0.0	0.1	0.0	16.9	0.5	2.8	1.0	129.2	16.5	0.1	0.1	0.0	0.7	0.0	0.0	0.0	0.0	7.0	0.0	0.0	0.0	1.0	0.2	0.0	0.0	0.0	9.4	0.0	0.3	0.0
SLC4A11	"BTR1, CDPD1, CHED2, dJ794I6.2, FECD4, NaBC1"	ENSG00000088836	"Solute carrier family 4 member 11"	Q8NBS3	20	3227417-3239559	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Symport, Transport"		"Corneal dystrophy, Deafness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 51.3;salivary gland: 54.0;thyroid gland: 60.9"	"Cell type enhanced"	"Detected in many"		"Club cells: 25.5;Collecting duct cells: 112.2;Ionocytes: 79.3;Respiratory ciliated cells: 48.1;Sertoli cells: 26.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 70.6;Hep G2: 43.0;RT4: 30.7"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018120, HPA058377"	Uncertain		Uncertain	Nucleoplasm,Vesicles		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Nucleoplasm	Vesicles	"HPA018120: AB_1857186, HPA058377: "	"unprognostic (2.33e-1)"	"prognostic favorable (9.03e-4)"	"unprognostic (1.18e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.00e-1)"	"unprognostic (6.52e-2)"	"unprognostic (9.66e-3)"	"unprognostic (3.73e-2)"	"unprognostic (3.10e-3)"	"unprognostic (1.52e-3)"	"unprognostic (2.94e-1)"	"unprognostic (2.64e-1)"	"prognostic favorable (6.21e-6)"	"unprognostic (7.37e-2)"	"unprognostic (4.30e-1)"	"unprognostic (2.33e-1)"	"unprognostic (6.89e-3)"	2.4	6.9	4.5	0.7	3.5	0.4	3.4	2.3	3.1	10.9	5.6	0.4	0.1	0.5	2.6	16.5	1.7	1.1	0.8	2.9	1.4	51.3	0.2	2.0	1.4	2.0	2.3	0.2	0.5	0.6	4.3	0.2	2.6	5.4	0.3	0.4	54.0	7.0	5.2	12.8	0.6	0.3	0.8	0.7	2.5	5.9	4.3	1.0	60.9	0.1	1.8	3.4	5.8	1.9	11.0	15.5	1.8	7.9	5.1	1.3	21.1	5.4	3.4	2.8	1.6	1.1	14.1	0.0	6.1	1.9	6.6	70.6	8.3	16.8	0.5	0.1	3.2	0.7	7.5	43.0	3.2	4.0	13.6	0.7	6.8	3.4	3.2	2.3	7.0	9.8	1.6	9.7	2.9	7.2	0.5	0.4	12.1	13.6	20.7	2.6	10.3	3.5	16.9	30.7	0.9	4.9	2.7	17.5	0.3	5.4	6.7	7.0	12.1	2.1	7.0	0.5	2.7	0.4	0.6	0.1	0.1	2.8	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	4.5	3.5	2.3	3.1	2.9	1.4	2.0	2.3	2.6	0.8	4.3	1.9	0.8	0.0	0.0	1.6	0.0	0.8	2.2	16.3	8.0	0.2	4.9	4.4	1.1	0.0	25.5	112.2	0.0	0.1	0.6	0.8	0.0	0.7	5.8	2.3	0.6	0.7	0.0	0.0	0.3	0.5	0.1	0.3	5.1	4.2	0.0	0.2	1.1	0.0	0.4	0.0	0.1	0.2	79.3	0.3	0.0	2.2	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.3	3.0	1.3	0.4	0.0	3.7	0.0	0.5	48.1	0.2	26.3	0.6	5.8	3.0	4.7	3.3	0.4	0.0	0.2	0.1	0.2	5.7
SLC4A2	"AE2, BND3L, EPB3L1, HKB3, NBND3"	ENSG00000164889	"Solute carrier family 4 member 2"	P04920	7	151057210-151076526	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"choroid plexus: 492.1"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 91.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019339	Enhanced		Uncertain	"Nuclear speckles,Plasma membrane,Cytosol"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	"Nuclear speckles, Plasma membrane"	Cytosol	"HPA019339: AB_1844825"	"unprognostic (1.19e-1)"	"unprognostic (3.33e-3)"	"unprognostic (8.12e-3)"	"unprognostic (1.10e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (9.04e-6)"	"unprognostic (1.24e-1)"	"unprognostic (4.23e-1)"	"unprognostic (3.30e-1)"	"unprognostic (1.07e-1)"	"unprognostic (3.21e-1)"	"prognostic favorable (1.26e-4)"	"unprognostic (4.67e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.28e-1)"	"unprognostic (2.36e-2)"	28.4	34.8	16.9	19.2	29.4	12.7	23.7	29.1	21.9	38.9	492.1	45.0	22.5	40.3	4.9	21.0	31.1	19.7	31.3	39.4	23.2	38.6	52.3	33.2	13.1	32.8	27.9	31.9	52.5	72.4	13.8	27.0	32.0	28.2	7.1	4.7	23.1	14.0	18.8	21.7	29.3	16.5	20.2	27.0	82.2	13.7	32.7	12.4	25.4	12.3	6.3	31.9	25.8	40.2	60.9	196.9	37.8	78.9	37.6	17.9	87.1	72.9	37.0	56.9	48.0	113.0	91.6	35.8	154.1	35.0	84.6	58.2	38.2	31.4	9.8	105.3	59.1	48.5	91.9	57.5	59.6	25.2	147.0	29.0	27.4	65.6	15.7	60.9	31.3	50.6	151.8	27.1	44.3	118.0	69.2	43.3	90.4	80.7	73.2	55.2	21.2	42.2	44.6	41.0	31.5	113.9	67.0	118.4	62.0	27.3	51.2	46.7	72.0	78.1	39.1	77.5	106.5	31.2	47.7	20.5	118.7	61.4	160.6	0.0	1.6	0.4	0.8	1.6	0.7	0.9	0.7	0.7	1.0	0.3	0.7	0.8	0.2	0.1	1.0	2.1	0.2	0.9	16.9	29.4	29.1	21.9	39.4	23.2	32.8	27.9	32.0	20.2	32.7	40.2	15.6	9.6	8.2	9.8	7.2	11.1	5.9	13.6	15.4	7.7	14.5	11.9	4.0	18.6	9.6	20.2	25.0	36.1	14.2	17.6	17.6	35.7	1.0	21.9	18.9	13.6	27.6	2.5	0.4	35.8	9.4	13.6	30.1	17.0	47.1	62.1	17.9	34.6	26.0	15.2	1.4	12.1	16.2	16.1	12.0	1.6	13.7	17.0	26.6	4.7	11.6	21.6	3.1	3.0	16.8	43.8	14.0	19.9	9.9	5.9	24.9	19.1	11.4	8.2	13.1	12.8	17.6	3.1	7.9	10.6	7.0	91.5	8.5	11.2	22.1	4.5
SLC4A3	"AE3, SLC2C"	ENSG00000114923	"Solute carrier family 4 member 3"	P48751	2	219627394-219641980	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"heart muscle: 283.1;ovary: 124.1"	"Group enriched"	"Detected in many"	9	"Cardiomyocytes: 207.1;Horizontal cells: 558.6"	"Cancer enhanced"	"Detected in all"		"glioma: 13.5"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	34	"myeloid DC: 1.4;plasmacytoid DC: 5.8"	"Lineage enriched"	"Detected in single"	54	"dendritic cells: 5.8"	"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 13.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063498			Approved	Nucleoplasm		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 62: Horizontal cells - Visual perception"	Nucleoplasm		"HPA063498: AB_2685025"	"unprognostic (9.49e-2)"	"unprognostic (5.72e-3)"	"unprognostic (8.92e-4)"	"unprognostic (1.77e-2)"	"unprognostic (6.61e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.39e-2)"	"unprognostic (4.13e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.88e-1)"	"unprognostic (8.15e-3)"	"unprognostic (1.97e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (4.12e-4)"	6.3	16.7	36.1	1.0	36.6	0.4	3.9	21.2	32.1	11.4	6.3	2.9	0.7	15.3	2.7	3.2	9.3	2.3	283.1	31.7	34.5	9.3	0.3	1.6	0.9	44.1	20.7	124.1	3.9	7.7	41.4	2.7	43.1	10.4	0.2	13.0	3.8	5.3	0.9	2.0	1.1	3.7	10.6	3.3	2.7	14.2	32.7	1.0	2.5	0.6	0.6	2.6	4.7	18.0	6.9	0.2	2.3	6.8	0.4	0.4	4.9	4.1	4.2	5.4	3.8	4.8	3.8	0.0	1.6	1.5	9.3	3.8	1.2	7.3	1.6	0.0	1.0	0.0	0.1	0.1	1.1	0.1	0.3	3.1	7.0	0.0	2.1	13.4	0.0	0.0	0.3	0.0	1.6	2.3	0.0	0.0	3.8	0.2	5.5	0.0	0.0	0.0	3.7	1.5	1.3	6.7	2.7	6.9	3.7	7.2	0.7	1.7	0.0	3.4	6.0	0.0	3.3	0.0	0.0	0.0	2.7	0.0	9.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	36.1	36.6	21.2	32.1	31.7	34.5	44.1	20.7	43.1	10.6	32.7	18.0	0.3	0.0	0.0	19.2	0.2	0.3	0.7	1.5	0.0	14.4	2.2	4.8	207.1	0.0	0.8	1.8	0.0	11.4	13.5	0.0	1.9	3.0	2.3	0.9	3.5	1.8	0.0	0.0	11.5	1.7	3.0	10.4	0.0	1.4	0.0	38.3	0.0	0.0	1.8	558.6	32.7	0.0	0.0	0.3	5.6	25.6	15.2	1.1	0.0	3.7	1.3	7.6	0.0	3.5	0.6	1.1	0.0	22.6	0.0	0.4	0.0	0.3	0.2	7.5	6.6	3.9	3.5	0.6	1.2	0.0	0.9	13.8	0.1	8.7	0.0	0.1
SLC4A4	"hhNMC, HNBC1, NBC1, NBC2, pNBC, SLC4A5"	ENSG00000080493	"Solute carrier family 4 member 4"	Q9Y6R1	4	71062667-71572087	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 119.5;pancreas: 260.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 819.1;Cholangiocytes: 133.0;Distal enterocytes: 282.9;Ductal cells: 129.2;Proximal tubular cells: 211.0"	"Group enriched"	"Detected in many"	5	"glioma: 23.9;pancreatic cancer: 22.5;prostate cancer: 47.4;renal cancer: 19.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BJ: 13.0;fHDF/TERT166: 6.1;HBF TERT88: 5.7;hTERT-RPE1: 6.0;RPTEC TERT1: 15.4;U-138 MG: 7.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022493, HPA035628, HPA035629, HPA079220"	Enhanced					NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 64: Astrocytes - Nervous system maintenance"			"CAB022493: , HPA035628: AB_2674708, HPA035629: AB_2674709, HPA079220: "	"unprognostic (3.92e-2)"	"unprognostic (1.63e-1)"	"prognostic favorable (7.69e-4)"	"unprognostic (5.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (5.09e-2)"	"unprognostic (4.24e-2)"	"unprognostic (7.49e-2)"	"unprognostic (1.46e-1)"	"unprognostic (9.22e-3)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-1)"	"prognostic favorable (1.18e-4)"	"unprognostic (7.00e-2)"	"unprognostic (2.92e-1)"	"unprognostic (2.05e-3)"	"unprognostic (2.04e-1)"	5.1	0.7	30.0	2.2	43.6	0.5	1.0	47.0	32.5	11.5	0.0	41.1	54.3	0.4	0.3	1.2	0.9	29.4	6.2	21.5	37.9	119.5	21.7	6.9	0.2	38.6	28.0	0.8	260.3	17.2	5.8	2.7	24.8	34.7	41.2	5.1	2.5	1.1	2.2	0.1	14.6	1.7	38.2	0.8	18.6	0.5	38.5	3.5	22.0	3.5	0.0	4.5	0.4	33.2	0.0	3.5	1.0	0.0	0.0	0.0	0.1	13.0	1.9	2.2	1.6	0.0	0.1	0.0	0.1	6.1	0.5	0.0	0.2	0.0	5.7	0.0	1.7	0.9	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.0	6.0	0.0	0.7	0.0	0.5	1.2	0.0	4.8	0.2	0.1	0.2	0.0	0.0	0.0	0.9	15.4	4.1	0.9	0.1	0.0	0.0	0.2	1.3	0.0	0.0	0.0	7.7	0.7	5.5	0.6	0.0	0.0	0.0	5.1	0.0	0.2	0.0	0.0	0.0	0.7	0.0	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.1	30.0	43.6	47.0	32.5	21.5	37.9	38.6	28.0	24.8	38.2	38.5	33.2	1.5	3.2	37.1	819.1	2.2	0.0	4.3	3.2	0.6	3.2	0.9	0.3	24.0	133.0	31.1	25.8	0.0	0.3	7.2	282.9	15.6	129.2	11.5	2.8	0.5	1.3	8.5	4.0	51.4	24.2	0.1	4.9	33.1	5.8	1.3	0.6	3.9	35.8	0.2	0.0	93.4	65.6	2.0	0.6	0.2	1.5	0.0	2.3	1.8	34.7	1.0	3.9	1.0	29.1	3.7	16.2	60.8	0.0	1.7	40.8	31.8	211.0	10.4	1.5	6.6	1.0	6.2	0.1	1.0	5.5	0.0	0.3	6.8	2.4	68.1	12.3
SLC4A5	NBC4	ENSG00000188687	"Solute carrier family 4 member 5"	Q9BY07	2	74216242-74343414	"Cancer-related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Ion transport, Sodium transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"choroid plexus: 73.4;retina: 42.0;thyroid gland: 26.7"	"Cell type enriched"	"Detected in many"	4	"Horizontal cells: 168.2"	"Cancer enriched"	"Detected in single"	11	"thyroid cancer: 3.3"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"basophil: 4.3"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"U-266/70: 8.8"	"Group enriched"	"Detected in many"	5	"basal ganglia: 1.6;hippocampal formation: 5.2;pons and medulla: 6.5;thalamus: 3.5"	"Low region specificity"	"Detected in many"			HPA036621	Uncertain					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"			"HPA036621: AB_10696779"	"unprognostic (1.30e-1)"	"unprognostic (3.78e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.83e-4)"	"unprognostic (3.38e-1)"	"unprognostic (2.36e-2)"	"unprognostic (2.56e-3)"	"unprognostic (5.37e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.55e-3)"	"unprognostic (3.24e-2)"	"unprognostic (1.72e-5)"	"unprognostic (1.57e-1)"	"unprognostic (1.06e-2)"	"unprognostic (8.47e-2)"	"unprognostic (9.27e-4)"	1.6	0.7	3.3	1.1	5.2	2.3	1.4	12.5	4.6	1.3	73.4	1.2	0.7	1.4	2.3	0.9	2.1	1.0	1.4	6.1	4.1	1.0	1.0	2.6	1.8	5.3	4.8	1.6	1.5	12.4	2.4	0.6	4.8	1.2	0.7	42.0	1.7	1.3	1.8	5.0	1.0	1.5	2.8	1.3	0.9	16.1	5.3	1.0	26.7	1.5	0.8	1.1	1.1	8.5	0.3	0.5	0.9	0.9	0.9	1.6	0.9	0.2	0.9	0.5	0.7	0.3	0.7	1.5	0.2	0.0	0.3	0.1	1.0	0.1	0.2	1.2	0.6	2.2	0.7	0.5	0.1	0.5	1.3	0.4	1.3	0.0	0.2	0.5	0.3	1.0	0.5	1.5	0.2	3.5	0.3	1.5	0.4	0.5	0.3	0.8	0.7	0.0	0.2	0.6	0.6	1.2	0.3	1.1	1.6	0.7	0.8	1.5	0.0	0.9	1.6	0.9	0.3	8.8	1.4	1.0	0.6	0.8	0.2	4.3	0.3	0.3	0.6	0.3	0.4	0.7	1.0	0.9	0.3	0.9	0.8	1.0	1.9	0.7	0.1	2.5	1.2	0.2	3.3	5.2	12.5	4.6	6.1	4.1	5.3	4.8	4.8	2.8	5.3	8.5	1.1	3.2	10.8	16.0	0.5	0.6	0.6	0.3	0.0	13.9	0.6	0.5	0.4	1.5	2.6	0.0	35.5	0.1	3.3	0.3	0.0	0.4	0.6	1.0	0.7	0.9	0.0	0.4	7.3	0.6	0.0	0.8	0.0	0.8	0.0	1.1	0.7	0.0	0.1	168.2	10.6	0.5	0.0	0.0	0.4	0.6	1.2	0.4	1.8	4.7	0.1	3.3	2.1	4.0	31.1	0.5	0.3	0.4	0.1	0.6	0.3	0.1	4.1	40.4	0.0	2.5	1.1	1.7	1.3	0.0	0.4	0.0	0.6	0.3	0.2	0.7
SLC4A7	"NBC3, SBC2, SLC4A6"	ENSG00000033867	"Solute carrier family 4 member 7"	Q9Y6M7	3	27372721-27484420	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 57.6;retina: 72.9"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 733.9;Rod photoreceptor cells: 704.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"hTERT-HME1: 78.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022494, HPA035857"	Enhanced		Supported	"Plasma membrane,Focal adhesion sites,Cytosol"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 20: Retina & Lymphoid tissues - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Plasma membrane"	"Focal adhesion sites, Cytosol"	"CAB022494: , HPA035857: AB_10795135"	"unprognostic (2.94e-2)"	"unprognostic (6.34e-2)"	"unprognostic (1.80e-3)"	"unprognostic (1.91e-1)"	"unprognostic (8.48e-3)"	"unprognostic (2.68e-1)"	"unprognostic (6.79e-4)"	"unprognostic (4.13e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.64e-1)"	"unprognostic (1.83e-1)"	"unprognostic (8.58e-3)"	"prognostic unfavorable (7.91e-6)"	"unprognostic (1.09e-2)"	"unprognostic (6.68e-2)"	"unprognostic (1.93e-1)"	"unprognostic (7.26e-2)"	8.6	5.1	3.2	9.0	5.2	4.0	18.7	3.4	16.9	10.5	1.6	16.2	57.6	6.4	8.2	8.6	6.0	13.7	7.8	19.3	2.5	12.7	3.9	8.3	11.2	0.5	3.2	6.8	3.4	1.7	3.4	5.8	0.6	7.9	7.4	72.9	5.8	8.7	5.0	4.6	17.4	6.6	1.8	7.0	6.0	7.1	4.4	5.8	4.9	27.2	10.3	12.1	8.8	2.6	13.0	23.8	21.0	9.8	9.6	17.2	15.0	43.3	20.0	16.3	12.6	6.5	6.6	29.4	3.6	16.8	15.7	5.5	20.2	21.1	25.7	25.1	6.6	13.5	15.4	7.1	16.5	30.9	11.3	13.7	9.0	24.8	78.9	34.2	27.1	19.0	9.1	10.1	33.8	4.7	31.1	7.2	13.8	1.6	23.4	21.0	16.7	5.9	38.1	9.2	5.3	13.1	19.7	14.4	6.9	17.9	32.9	11.8	19.0	38.2	10.6	26.7	33.7	3.8	4.3	16.6	33.3	21.4	17.8	0.0	0.2	0.0	1.0	0.2	0.7	0.4	1.3	1.4	0.5	0.5	0.5	0.9	0.0	1.0	0.3	0.7	1.2	0.3	3.2	5.2	3.4	16.9	19.3	2.5	0.5	3.2	0.6	1.8	4.4	2.6	30.0	0.0	11.2	10.7	37.5	29.3	39.5	23.4	11.4	130.2	72.4	30.4	23.1	21.5	22.8	62.5	733.9	5.8	51.8	5.5	9.8	15.5	10.2	73.6	40.7	53.6	38.2	7.2	46.2	7.1	29.3	52.2	15.8	124.1	23.5	24.6	17.5	6.2	17.0	6.7	88.7	58.5	36.7	48.4	61.6	7.6	9.0	46.5	35.6	185.5	26.7	45.7	20.6	60.8	20.9	19.1	23.4	9.8	27.8	93.1	142.5	10.2	9.6	704.2	39.5	56.4	43.7	40.0	21.7	21.7	30.7	8.1	56.1	19.0	26.7	35.2
SLC4A8	NBC3	ENSG00000050438	"Solute carrier family 4 member 8"	Q2Y0W8	12	51391317-51515763	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 24.1;pituitary gland: 17.9;retina: 11.1;testis: 11.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 92.6;Cone photoreceptor cells: 179.3;Excitatory neurons: 115.0;Horizontal cells: 116.1;Inhibitory neurons: 127.8;Oligodendrocytes: 248.9;Spermatocytes: 91.9"	"Group enriched"	"Detected in some"	6	"breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BEWO: 21.0;HMC-1: 14.8;SCLC-21H: 15.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA077895			Approved	"Plasma membrane"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA077895: "	"unprognostic (4.01e-1)"	"unprognostic (8.15e-2)"	"unprognostic (2.49e-2)"	"unprognostic (6.39e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.96e-2)"	"unprognostic (3.46e-2)"	"unprognostic (7.72e-4)"	"unprognostic (3.13e-2)"	"unprognostic (7.03e-3)"	"unprognostic (1.07e-4)"	"unprognostic (1.70e-1)"	"unprognostic (9.60e-6)"	"unprognostic (1.35e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.47e-1)"	0.2	3.1	6.7	0.9	7.5	0.6	1.3	10.3	18.1	1.1	0.0	0.4	0.4	0.3	2.5	0.1	1.7	0.3	0.3	9.8	10.6	1.9	0.1	1.2	1.4	23.3	8.6	3.3	1.0	2.2	17.9	0.2	24.1	0.4	0.4	11.1	0.9	0.6	0.1	0.2	0.8	0.3	3.6	1.0	1.3	11.7	9.0	0.6	0.2	0.0	1.2	0.2	0.1	11.4	0.2	1.0	11.9	0.1	0.5	0.6	21.0	3.3	5.5	5.2	3.3	7.2	0.2	4.5	0.5	4.5	2.9	0.1	4.7	0.2	4.8	0.9	0.6	2.3	0.3	0.0	0.0	0.7	14.8	0.2	0.2	2.7	0.5	3.1	6.2	1.9	0.1	7.6	2.7	2.6	6.6	1.4	5.1	1.4	3.6	0.1	0.0	0.0	0.6	0.1	15.7	10.7	1.3	1.6	0.0	3.6	2.0	0.5	5.7	3.3	1.7	0.2	4.3	3.8	1.3	0.2	4.6	0.6	0.4	0.4	0.5	0.9	0.4	0.3	0.0	0.1	0.1	0.4	0.7	0.2	0.1	0.2	0.5	0.5	0.8	0.2	0.0	0.2	6.7	7.5	10.3	18.1	9.8	10.6	23.3	8.6	24.1	3.6	9.0	11.4	1.2	0.0	8.7	33.6	3.1	0.0	0.8	0.2	0.0	92.6	5.0	1.5	1.9	0.0	5.4	1.8	179.3	1.4	4.9	0.5	7.9	0.1	61.9	1.7	0.6	2.4	6.0	0.8	115.0	1.3	5.2	2.1	13.3	0.7	7.6	11.5	1.1	0.2	2.2	116.1	127.8	0.4	0.0	4.7	2.2	32.8	2.8	4.5	1.8	18.7	3.4	11.5	7.2	20.1	248.9	0.1	5.4	3.8	3.5	1.0	1.9	1.0	25.0	19.9	0.0	0.7	1.0	91.9	8.2	0.1	0.1	0.4	4.3	0.9	0.2	1.1
SLC4A9	AE4	ENSG00000113073	"Solute carrier family 4 member 9"	Q96Q91	5	140360194-140375141	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Anion exchange, Antiport, Ion transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in some"	24	"kidney: 35.5"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 1.9;Excitatory neurons: 2.4;Inhibitory neurons: 2.4;Ionocytes: 2.0;Oligodendrocyte precursor cells: 1.5;Oligodendrocytes: 6.4;Spermatocytes: 1.7;Spermatogonia: 1.9"	"Cancer enriched"	"Detected in single"	8	"renal cancer: 0.9"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA051307	Uncertain		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane, Cytosol"	Vesicles	"HPA051307: AB_2681434"	"unprognostic (1.68e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.20e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.13e-1)"	"unprognostic (1.02e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.78e-1)"	"unprognostic (2.47e-1)"	"unprognostic (4.78e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.24e-2)"	"unprognostic (2.99e-2)"	"unprognostic (3.06e-2)"	"unprognostic (5.04e-2)"	"unprognostic (1.82e-2)"	0.1	0.0	0.3	0.0	0.7	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.3	0.5	35.5	0.0	0.1	0.0	0.9	0.6	0.0	0.1	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.6	0.0	0.2	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.7	0.4	0.7	0.3	0.5	0.9	0.6	1.0	0.5	0.6	1.5	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.4	1.9	0.0	0.0	0.1	0.0	0.1	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.4	0.0	2.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	0.0	0.0	1.5	6.4	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.0	0.3	0.0	1.7	1.9	0.0	0.1	0.0	0.1	0.1	0.1	0.2
SLC50A1	"HsSWEET1, RAG1AP1, RP11-540D14.5, RZPDo834D038D, SCP, slv, SWEET1"	ENSG00000169241	"Solute carrier family 50 member 1"	Q9BRV3	1	155135344-155138857	"Predicted membrane proteins, Transporters"	"Sugar transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Extravillous trophoblasts: 130.7;Intestinal goblet cells: 195.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 166.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018095	Approved					NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 30: Mammary glandular cells - Lactation"			"HPA018095: AB_1856048"	"unprognostic (4.75e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.57e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.29e-1)"	"unprognostic (9.30e-2)"	"unprognostic (1.64e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.51e-2)"	"unprognostic (3.53e-3)"	"unprognostic (2.59e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (4.36e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.50e-3)"	"unprognostic (4.39e-2)"	23.0	42.3	9.3	17.0	9.4	14.2	22.5	10.2	11.0	28.2	11.9	45.4	40.4	16.0	101.5	34.3	21.3	13.9	13.3	9.6	11.3	44.4	48.1	26.3	21.4	10.7	9.8	13.2	57.8	34.3	18.1	18.2	12.6	29.9	53.7	2.6	28.9	15.3	6.5	32.3	36.1	15.7	9.6	35.4	47.3	11.9	11.1	17.1	27.6	6.6	26.9	20.3	19.7	10.7	48.0	15.0	13.5	16.9	42.9	42.4	31.2	19.1	28.9	24.6	31.7	28.7	166.5	34.1	58.8	27.3	34.6	62.6	16.3	52.5	14.7	72.7	8.4	29.2	17.9	18.3	72.0	18.2	35.1	44.0	144.2	41.3	98.0	43.1	25.7	20.5	32.2	53.1	23.6	56.0	15.0	21.6	18.7	99.7	59.1	26.3	9.5	117.8	53.0	16.9	23.5	19.2	31.2	63.7	50.6	21.0	140.3	19.3	13.3	18.0	17.9	25.6	9.8	68.5	45.1	32.0	30.1	42.0	19.4	22.9	24.1	24.5	20.0	36.2	24.3	54.5	25.2	24.0	29.7	60.6	27.0	23.8	10.3	51.7	34.6	30.3	28.8	30.8	9.3	9.4	10.2	11.0	9.6	11.3	10.7	9.8	12.6	9.6	11.1	10.7	33.0	22.4	33.6	2.6	40.4	16.2	21.1	43.5	18.8	7.4	78.8	22.5	5.3	12.8	41.3	23.9	12.5	37.0	26.3	66.5	13.7	43.7	0.6	28.7	20.7	33.2	23.4	20.4	4.3	48.8	130.7	21.4	60.6	42.2	24.1	17.7	24.7	22.1	45.2	6.7	4.8	195.0	71.2	32.2	33.4	1.5	13.4	35.8	28.4	5.6	33.8	5.3	16.5	4.0	1.8	42.1	54.3	5.7	47.0	40.8	69.8	23.8	38.6	7.2	6.6	11.1	20.4	8.2	5.2	27.9	18.5	62.8	23.2	28.5	52.5	39.3
SLC51A	OSTalpha	ENSG00000163959	"Solute carrier family 51 subunit alpha"	Q86UW1	3	196211487-196243178	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	11	"intestine: 64.5;liver: 71.3"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 49.1;Leydig cells: 61.5;Peritubular cells: 101.5;Proximal enterocytes: 271.8;Sertoli cells: 144.7"	"Cancer enriched"	"Detected in many"	7	"liver cancer: 15.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"REH: 3.9;U-266/84: 2.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA045488	Enhanced					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA045488: "	"unprognostic (1.63e-2)"	"unprognostic (1.27e-3)"	"unprognostic (2.80e-1)"	"unprognostic (7.66e-2)"	"unprognostic (5.16e-2)"	"unprognostic (2.40e-2)"	"prognostic favorable (7.54e-4)"	"unprognostic (5.02e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.98e-3)"	"unprognostic (5.41e-2)"	"unprognostic (2.90e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.58e-5)"	1.3	5.2	0.2	1.3	0.2	5.9	1.2	0.1	0.7	2.0	0.0	11.3	30.5	0.8	0.8	1.4	1.6	0.6	1.3	0.2	0.4	5.5	71.3	2.0	0.6	0.2	0.1	1.4	0.9	2.7	1.2	0.2	0.3	1.1	0.7	0.7	1.2	0.0	1.6	2.5	64.5	0.2	0.0	1.8	0.9	4.1	0.7	0.1	1.5	0.0	0.5	1.0	1.8	0.5	0.5	0.7	0.6	0.7	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.3	0.2	0.0	0.8	0.5	0.0	0.4	0.0	0.0	0.0	0.3	1.3	0.5	0.4	0.8	0.1	0.6	0.6	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.1	1.5	0.0	0.3	0.0	0.6	0.0	0.1	0.9	3.9	0.0	0.2	0.0	0.4	0.1	0.2	0.2	1.4	0.1	0.1	1.1	0.2	0.2	0.7	0.3	0.6	0.4	1.5	2.0	0.2	0.5	0.2	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.1	0.7	0.2	0.4	0.2	0.1	0.3	0.0	0.7	0.5	1.1	0.0	0.5	0.3	1.0	3.3	2.5	10.9	0.0	0.5	0.6	0.3	4.1	1.5	18.2	0.0	4.2	0.7	3.0	43.5	3.9	0.2	20.7	2.7	1.6	1.6	0.0	2.7	1.0	0.2	0.4	2.4	0.0	1.6	0.0	2.3	3.9	49.1	0.6	1.7	0.7	8.4	22.4	4.4	7.3	12.9	61.5	1.3	3.6	1.0	0.8	0.4	1.0	0.5	0.2	0.1	12.1	101.5	0.8	1.5	271.8	11.5	18.0	1.1	144.7	2.3	2.6	2.4	1.3	0.0	2.6	1.0	3.0	13.6	11.8	2.8
SLC51B	OSTbeta	ENSG00000186198	"Solute carrier family 51 subunit beta"	Q86UW2	15	65045387-65053397	"Metabolic proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 41.8;intestine: 107.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 354.6;Paneth cells: 145.1;Proximal enterocytes: 721.4"	"Cancer enhanced"	"Detected in many"		"liver cancer: 9.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"CACO-2: 18.5;EFO-21: 11.9;Hep G2: 15.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA008398, HPA008533"	Enhanced		Approved	Vesicles,Mitochondria		No	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	Mitochondria	Vesicles	"HPA008398: , HPA008533: AB_1854824"	"unprognostic (6.18e-2)"	"unprognostic (6.75e-3)"	"unprognostic (1.66e-1)"	"unprognostic (1.31e-2)"	"unprognostic (5.88e-2)"	"unprognostic (9.49e-2)"	"unprognostic (9.77e-3)"	"unprognostic (1.81e-2)"	"unprognostic (3.35e-2)"	"unprognostic (2.76e-1)"	"unprognostic (2.24e-1)"	"unprognostic (4.34e-2)"	"prognostic favorable (8.46e-5)"	"unprognostic (5.87e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.05e-2)"	"unprognostic (1.17e-2)"	0.7	1.1	5.8	3.5	5.5	0.8	0.3	4.0	3.9	41.8	0.0	41.9	86.9	3.0	0.3	2.4	3.6	2.8	2.3	3.8	6.5	19.5	2.2	6.1	0.6	7.3	10.9	1.1	0.3	0.0	0.4	0.6	7.7	2.7	29.4	0.7	1.0	0.6	1.0	0.8	107.1	1.7	6.5	0.8	0.8	9.6	11.8	0.0	0.7	0.0	0.0	1.5	0.9	4.2	0.0	1.5	0.2	0.8	0.0	0.1	0.4	0.0	0.0	0.2	0.0	18.5	0.0	0.1	11.9	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.1	15.7	0.1	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.2	0.0	0.4	0.1	0.4	0.4	0.1	0.4	0.0	0.0	0.9	0.4	0.0	0.6	0.5	0.0	0.0	0.0	2.2	0.5	0.0	0.0	0.3	0.0	0.1	0.2	0.2	0.4	0.2	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	5.5	4.0	3.9	3.8	6.5	7.3	10.9	7.7	6.5	11.8	4.2	0.0	0.0	1.1	0.3	1.3	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	1.5	0.7	0.0	0.0	0.1	0.0	354.6	13.7	0.0	60.8	10.4	0.2	1.2	1.8	2.7	0.0	0.0	0.0	0.5	0.0	1.9	4.5	0.0	0.4	1.8	0.1	0.0	0.0	23.0	0.0	0.3	0.0	14.1	0.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	145.1	0.0	0.0	0.0	721.4	73.3	15.6	0.0	6.6	1.0	0.4	27.9	0.5	0.0	0.0	0.1	0.6	0.1	45.8	0.0
SLC52A2	"D15Ertd747e, FLJ11856, GPCR41, GPR172A, hRFT3, PAR1, RFVT2"	ENSG00000185803	"Solute carrier family 52 member 2"	Q9HAB3	8	144333957-144361286	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport	"Host cell receptor for virus entry, Receptor"	"Deafness, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 149.0;PC-3: 167.6"	"Low region specificity"	"Detected in all"							HPA063036	Approved					NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA063036: AB_2684928"	"unprognostic (7.80e-3)"	"prognostic unfavorable (7.55e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.94e-1)"	"unprognostic (3.09e-2)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.04e-6)"	"unprognostic (7.74e-3)"	"unprognostic (9.20e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.85e-2)"	"unprognostic (3.99e-2)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.12e-2)"	"unprognostic (1.73e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.07e-1)"	29.7	31.6	13.7	5.4	13.4	5.6	27.8	15.3	18.5	21.7	14.5	35.7	9.4	23.0	8.0	33.3	17.3	3.2	26.4	13.5	14.5	29.2	16.9	24.6	5.6	15.0	14.9	15.6	41.6	5.3	24.5	7.7	14.6	22.2	5.7	1.3	29.8	6.3	13.5	30.4	29.6	4.3	14.0	34.8	31.4	31.5	15.1	4.0	21.7	2.7	4.1	24.9	21.2	14.1	38.7	65.0	7.5	17.9	19.3	12.3	37.3	28.1	18.9	26.5	24.6	57.9	42.3	16.3	42.3	27.5	20.7	42.6	18.4	25.3	9.8	18.3	34.5	26.3	31.3	50.1	51.7	9.4	29.4	14.8	34.7	27.4	24.4	19.2	15.8	16.2	40.9	23.7	18.7	149.0	15.6	38.0	17.9	51.5	167.6	29.8	8.9	44.9	30.6	34.4	25.9	29.4	31.1	44.1	35.7	9.9	27.8	18.7	20.2	20.9	46.9	48.2	37.9	9.4	13.8	12.4	37.8	26.6	25.7	0.5	4.2	9.2	5.6	5.9	3.8	3.3	3.9	5.6	4.5	9.8	3.6	2.6	1.1	5.2	7.5	7.6	5.7	1.5	13.7	13.4	15.3	18.5	13.5	14.5	15.0	14.9	14.6	14.0	15.1	14.1	31.9	6.4	8.7	5.5	24.3	31.2	27.0	41.5	12.0	11.1	30.6	17.0	3.1	12.8	34.4	12.9	2.1	85.0	36.3	81.8	0.0	62.3	3.3	11.6	16.6	24.3	17.4	7.8	3.2	66.9	92.1	22.2	42.3	21.5	10.2	16.6	18.9	5.5	52.4	11.8	3.7	56.3	36.7	13.5	27.8	5.8	12.8	21.4	30.2	2.8	40.7	14.3	19.6	7.1	2.4	85.1	46.7	19.9	43.3	54.7	52.4	14.5	11.7	10.8	19.7	12.1	31.1	34.0	40.2	20.2	36.1	52.5	24.8	23.4	65.6	36.7
SLC52A3	"bA371L19.1, C20orf54, hRFT2, RFVT3"	ENSG00000101276	"Solute carrier family 52 member 3"	Q9NQ40	20	760080-776015	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Deafness, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 19.2;testis: 40.1"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 23.9;Cytotrophoblasts: 32.8;Distal enterocytes: 18.8;Glandular and luminal cells: 21.3;Paneth cells: 21.7;Proximal enterocytes: 35.5;Syncytiotrophoblasts: 52.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"basophil: 2.1"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 42.1;OE19: 31.8;RT4: 12.3;SK-BR-3: 15.4;T-47d: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049391, HPA059078"	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA049391: AB_2680743, HPA059078: AB_2732630"	"unprognostic (4.53e-2)"	"unprognostic (1.11e-1)"	"unprognostic (8.60e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.03e-3)"	"unprognostic (2.12e-3)"	"unprognostic (1.43e-3)"	"unprognostic (1.15e-2)"	"unprognostic (4.36e-2)"	"unprognostic (4.39e-3)"	"unprognostic (4.82e-2)"	"unprognostic (2.04e-3)"	"prognostic favorable (5.51e-6)"	"unprognostic (3.04e-1)"	"unprognostic (2.21e-1)"	"unprognostic (1.44e-1)"	2.1	0.2	11.0	1.5	8.9	0.4	2.6	9.5	11.4	2.3	5.5	11.5	14.4	2.0	2.0	4.9	1.8	2.6	5.7	9.0	11.1	9.4	0.1	1.2	0.4	12.9	9.8	0.9	1.6	0.2	0.3	4.3	12.3	8.0	7.1	0.6	6.1	4.0	0.6	1.8	19.2	1.7	9.8	0.2	5.6	40.1	12.5	0.1	0.5	0.9	0.8	4.9	2.5	9.7	6.6	2.2	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.1	4.6	42.1	0.0	7.0	0.0	0.6	6.9	0.0	6.0	0.0	0.0	0.0	0.8	0.7	0.3	0.0	0.0	0.3	0.0	1.8	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.1	0.0	0.1	0.6	31.8	4.5	0.0	0.0	1.1	0.0	12.3	0.1	0.2	7.2	15.4	0.1	0.8	20.1	0.0	0.0	0.2	0.1	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.1	2.1	0.2	0.3	0.2	0.0	0.2	0.2	0.2	0.1	0.0	0.4	0.2	0.3	0.8	0.5	0.1	0.3	0.1	0.2	11.0	8.9	9.5	11.4	9.0	11.1	12.9	9.8	12.3	9.8	12.5	9.7	3.8	9.6	3.1	0.0	0.1	0.6	2.2	5.3	1.8	0.4	3.2	2.4	0.7	4.3	5.3	23.9	2.1	32.8	0.0	18.8	1.9	6.6	1.1	8.9	1.1	10.8	0.0	0.0	0.1	2.0	0.9	0.4	4.6	21.3	0.0	5.9	0.0	0.0	2.6	0.0	0.0	6.0	6.1	0.0	1.3	3.2	0.9	0.2	1.8	2.8	0.0	0.0	0.0	0.0	0.0	5.2	21.7	0.4	0.1	4.3	35.5	0.1	2.4	0.1	0.0	0.4	0.6	0.6	0.8	2.3	1.1	52.1	0.2	1.3	10.8	5.8
SLC5A1	"D22S675, NAGT, SGLT1"	ENSG00000100170	"Solute carrier family 5 member 1"	P13866	22	32043261-32113029	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	7	"intestine: 528.1"	"Cell type enriched"	"Detected in many"	6	"Proximal enterocytes: 768.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 20.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	13	"OE19: 34.2"	"Region enriched"	"Detected in single"	26	"cerebellum: 7.6"	"Low region specificity"	"Detected in many"			"CAB015467, HPA051805, HPA055106"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"	"Nucleoplasm, Golgi apparatus"	"Nuclear membrane, Cytosol"	"CAB015467: , HPA051805: AB_2681618, HPA055106: AB_2682695"	"unprognostic (1.96e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.24e-2)"	"prognostic favorable (2.59e-4)"	"unprognostic (3.85e-2)"	"unprognostic (2.75e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.15e-1)"	"unprognostic (9.22e-2)"	"unprognostic (4.83e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.53e-2)"	"prognostic favorable (6.97e-7)"	"unprognostic (4.68e-3)"	"unprognostic (1.98e-1)"	"unprognostic (6.00e-2)"	"unprognostic (1.45e-2)"	0.1	0.0	0.1	4.2	0.1	0.0	9.7	0.2	0.1	12.3	0.0	10.7	528.1	0.5	3.5	5.1	1.1	26.9	75.2	0.1	0.0	6.6	1.7	2.1	0.3	0.1	0.0	0.0	1.6	0.3	1.0	0.0	0.1	3.0	9.7	0.2	19.0	2.4	0.3	13.5	302.4	0.7	0.0	2.9	7.2	2.3	0.5	0.1	0.0	0.0	4.0	0.0	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	2.6	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.0	0.0	34.2	0.0	0.0	0.0	2.1	0.0	0.0	0.7	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.1	0.1	0.0	0.1	0.0	0.1	0.0	0.5	0.2	0.1	0.0	0.0	0.3	0.2	0.6	1.7	4.2	0.0	0.0	11.6	6.5	115.2	115.8	8.2	0.0	0.0	0.0	0.2	19.8	0.0	3.0	38.4	2.4	1.4	1.0	25.4	0.0	0.4	1.4	0.0	1.4	5.6	10.3	0.0	0.0	0.0	0.3	0.0	0.0	0.3	34.1	0.0	0.0	0.0	71.3	1.2	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.9	32.6	1.5	0.0	17.6	768.7	6.4	2.0	0.0	0.0	0.0	0.7	10.1	4.2	2.0	5.5	0.0	0.1	0.1	41.2	6.7
SLC5A10	SGLT5	ENSG00000154025	"Solute carrier family 5 member 10"	A0PJK1	17	18950345-19022595	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"kidney: 41.6"	"Group enriched"	"Detected in some"	5	"Late spermatids: 33.7;Proximal tubular cells: 76.9"	"Cancer enriched"	"Detected in some"	11	"renal cancer: 6.3"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"intermediate monocyte: 1.8;non-classical monocyte: 4.8"	"Lineage enriched"	"Detected in single"	7	"monocytes: 4.8"	"Cell line enriched"	"Detected in some"	5	"U-937: 5.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA052014	Uncertain					NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA052014: AB_2681694"	"unprognostic (3.74e-1)"	"unprognostic (2.92e-1)"	"unprognostic (3.04e-2)"	"unprognostic (6.11e-2)"	"unprognostic (6.56e-2)"	"unprognostic (3.36e-4)"	"unprognostic (7.36e-2)"	"unprognostic (2.39e-1)"	"unprognostic (1.52e-1)"	"unprognostic (8.94e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.09e-2)"	"unprognostic (3.43e-2)"	"unprognostic (2.61e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.11e-1)"	0.2	0.2	0.1	0.6	0.1	2.3	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.4	0.1	0.1	0.9	0.0	0.0	41.6	0.5	0.4	0.9	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.9	1.4	0.0	0.1	3.5	0.1	0.5	0.1	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.3	0.0	0.0	1.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	5.3	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.0	4.8	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.3	1.4	0.6	0.0	0.0	0.0	0.0	0.2	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.2	9.8	0.3	8.8	0.0	0.0	0.1	0.0	0.0	0.6	0.2	0.6	0.0	0.0	0.1	0.0	0.2	1.1	0.0	0.1	0.0	0.5	0.1	0.0	0.0	0.0	33.7	0.0	0.5	1.8	0.0	0.1	0.0	0.0	1.0	0.3	0.5	0.0	0.0	0.7	0.1	0.0	76.9	0.0	0.0	0.0	0.0	0.0	0.4	0.6	0.0	0.3	0.3	0.6	0.0	0.0	0.0
SLC5A11	"KST1, SGLT6, SMIT2"	ENSG00000158865	"Solute carrier family 5 member 11"	Q8WWX8	16	24845841-24911628	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Ion transport, Sodium transport, Sugar transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 43.9"	"Cell type enriched"	"Detected in some"	19	"Oligodendrocytes: 677.9"	"Cancer enhanced"	"Detected in some"		"glioma: 1.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"Hep G2: 8.3;Karpas-707: 2.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA035331	Uncertain		Approved	Nucleoplasm,Cytosol		NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Nucleoplasm	Cytosol	"HPA035331: AB_10601489"	"unprognostic (2.57e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.34e-2)"	"unprognostic (2.65e-2)"	"unprognostic (2.00e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.27e-2)"	"unprognostic (9.90e-2)"	"unprognostic (8.08e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.85e-3)"	"unprognostic (6.68e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.58e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.45e-3)"	0.1	0.1	8.5	0.0	24.2	0.0	0.6	22.0	22.6	0.0	5.0	0.3	3.3	0.0	0.0	0.0	0.1	0.2	0.1	8.6	17.0	3.0	0.8	0.1	0.0	27.2	21.5	0.1	0.3	0.0	0.3	0.0	27.3	0.1	0.0	0.0	0.1	0.0	0.0	0.1	8.1	0.0	14.5	0.2	0.1	0.4	20.7	0.0	0.1	0.2	0.0	0.1	0.1	43.9	0.0	0.4	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.5	24.2	22.0	22.6	8.6	17.0	27.2	21.5	27.3	14.5	20.7	43.9	0.0	0.0	0.0	2.9	0.3	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	2.3	0.0	0.8	0.0	0.0	0.1	0.0	0.1	0.0	0.6	0.1	0.0	2.0	1.5	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.5	677.9	0.0	2.4	0.0	0.1	0.0	35.2	7.2	0.2	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.2	0.6	0.0
SLC5A12	"MGC52019, SMCT2"	ENSG00000148942	"Solute carrier family 5 member 12"	Q1EHB4	11	26667020-26723427	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 47.7;intestine: 30.1;kidney: 171.7"	"Group enriched"	"Detected in some"	23	"Proximal enterocytes: 286.0;Proximal tubular cells: 181.0"	"Cancer enriched"	"Detected in single"	26	"renal cancer: 9.0"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.3;NTERA-2: 1.7;SuSa: 3.3;T-47d: 1.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA060904	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	Nucleoplasm	"HPA060904: AB_2684385"	"unprognostic (3.69e-3)"	"unprognostic (6.92e-2)"	"unprognostic (1.79e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.01e-2)"	"unprognostic (9.35e-3)"	"unprognostic (4.21e-3)"	"unprognostic (4.49e-2)"	"unprognostic (2.36e-3)"	"unprognostic (1.71e-1)"	"unprognostic (2.03e-2)"	"unprognostic (3.43e-1)"	"unprognostic (2.91e-3)"	"unprognostic (1.34e-1)"	"unprognostic (8.53e-2)"	"unprognostic (1.42e-2)"	"unprognostic (9.40e-3)"	0.1	0.1	0.3	0.0	0.5	0.9	0.1	0.9	0.4	0.0	0.3	0.2	4.9	0.1	47.7	0.0	0.1	0.1	4.3	0.3	0.4	171.7	1.7	0.1	0.1	0.2	0.1	0.2	0.0	0.0	0.0	0.6	0.2	0.1	0.2	1.0	0.1	0.1	0.1	0.3	30.1	0.0	0.0	0.6	0.3	0.2	0.2	0.1	0.1	0.1	0.0	0.1	0.0	0.5	0.2	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	0.1	0.2	0.3	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.2	1.7	0.3	0.0	0.0	0.0	0.3	0.0	0.5	0.8	0.1	0.7	0.1	0.0	3.3	1.2	0.2	0.2	0.2	0.1	0.2	0.1	1.0	0.3	0.1	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.5	0.9	0.4	0.3	0.4	0.2	0.1	0.2	0.0	0.2	0.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.1	3.7	0.0	0.1	0.0	2.4	9.8	0.0	1.4	0.2	0.0	0.2	0.0	0.0	0.7	0.0	0.2	0.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.3	6.7	0.0	0.0	0.0	0.2	0.0	0.7	0.0	1.0	0.0	0.8	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	286.0	181.0	0.1	0.3	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.1	0.6	4.5	3.5	0.1
SLC5A2	SGLT2	ENSG00000140675	"Solute carrier family 5 member 2"	P31639	16	31483002-31490860	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Sugar transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	18	"kidney: 54.2"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 59.7;Late spermatids: 145.7;Proximal tubular cells: 142.9;Spermatocytes: 31.7"	"Not detected"	"Not detected"			"Region enhanced"	"Detected in single"		"cerebellum: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA041603	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA041603: AB_10960540"	"unprognostic (1.61e-1)"	"unprognostic (2.95e-1)"	"unprognostic (2.84e-1)"	"unprognostic (3.00e-2)"	"unprognostic (8.04e-2)"	"unprognostic (8.23e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.25e-3)"	"unprognostic (2.57e-1)"	"unprognostic (1.12e-2)"	"unprognostic (6.43e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.42e-3)"	"unprognostic (5.88e-2)"	"unprognostic (2.14e-1)"	"unprognostic (4.18e-2)"	"unprognostic (3.22e-1)"	0.1	0.0	0.1	0.0	0.1	0.0	0.0	1.0	0.3	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	54.2	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	2.9	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	0.1	1.0	0.3	0.2	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.3	0.0	3.7	0.3	0.2	0.3	0.1	0.2	0.0	0.5	0.2	0.4	0.5	1.5	0.1	9.2	0.0	0.2	0.1	0.1	7.9	0.6	59.7	0.6	0.5	0.2	0.0	0.0	0.1	0.5	0.1	0.4	1.5	0.2	0.0	0.1	0.0	0.1	0.2	0.0	0.3	0.5	2.0	0.0	0.5	145.7	2.1	0.9	0.0	0.0	0.0	0.0	0.0	0.5	0.1	1.0	0.1	1.5	0.0	0.1	4.7	142.9	1.7	0.2	0.0	0.1	0.2	31.7	1.1	0.0	0.3	0.1	1.4	0.1	0.6	0.0
SLC5A3	"SMIT, SMIT1"	ENSG00000198743	"Solute carrier family 5 member 3"	P53794	21	34073578-34106260	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 96.0"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 129.1;Collecting duct cells: 138.0;Granulosa cells: 148.6"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.3"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029791			Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 40: Granulosa cells - Unknown function"	"Plasma membrane"		"HPA029791: AB_10601892"	"unprognostic (9.70e-2)"	"unprognostic (4.99e-2)"	"unprognostic (2.23e-1)"	"unprognostic (7.57e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.54e-2)"	"unprognostic (4.48e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.02e-2)"	"unprognostic (2.55e-1)"	"prognostic unfavorable (1.98e-5)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.82e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.60e-2)"	6.9	5.9	8.6	4.5	9.2	1.9	6.6	5.7	11.4	3.7	96.0	4.5	2.6	6.8	5.2	3.1	4.8	2.5	2.4	10.7	17.0	29.0	5.9	3.9	4.9	9.3	9.9	3.9	1.9	3.2	4.1	10.6	9.2	2.9	5.2	5.6	2.8	3.5	2.5	6.7	3.7	2.9	8.2	2.4	3.9	6.2	20.3	3.9	25.2	2.6	4.8	3.8	3.4	9.2	10.5	9.3	19.0	13.4	15.5	12.7	9.1	11.8	35.7	7.2	10.9	15.5	22.5	16.9	9.3	24.0	13.5	5.3	23.3	6.7	12.2	17.7	6.0	17.5	9.0	5.2	4.1	7.6	7.1	6.1	17.0	19.7	7.8	22.0	4.4	13.7	17.6	3.9	18.7	7.1	8.1	6.1	9.6	4.0	9.0	8.1	3.4	7.7	28.1	14.5	9.9	4.6	24.5	6.4	5.6	11.3	3.9	8.0	4.2	14.0	10.7	27.1	4.8	20.1	18.5	12.4	28.2	10.9	9.6	0.0	0.2	0.0	0.6	0.2	0.5	0.1	0.3	0.4	0.2	0.1	0.4	0.6	0.1	0.2	0.1	0.5	0.1	0.1	8.6	9.2	5.7	11.4	10.7	17.0	9.3	9.9	9.2	8.2	20.3	9.2	18.8	16.0	10.2	0.0	33.3	0.0	46.5	0.0	129.1	33.8	37.4	34.9	11.4	10.0	13.0	138.0	20.9	27.4	43.0	39.1	21.5	4.0	9.0	38.7	59.9	16.4	49.3	17.0	0.0	5.5	19.7	42.3	18.3	42.5	41.3	148.6	5.0	20.7	15.2	37.0	0.0	69.3	0.0	14.4	0.0	7.2	6.5	41.0	0.0	0.0	23.3	6.7	16.5	0.0	0.0	7.6	49.7	20.7	54.1	88.4	16.3	9.4	8.7	20.9	13.1	15.4	33.7	14.8	18.5	39.7	0.0	28.2	48.3	14.0	36.3	69.5
SLC5A4	"DJ90G24.4, SAAT1, SGLT3"	ENSG00000100191	"Solute carrier family 5 member 4"	Q9NY91	22	32218464-32255347	"Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 19.8"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 28.1;Inhibitory neurons: 20.5;Microglial cells: 31.9;Oligodendrocyte precursor cells: 9.5"	"Cancer enriched"	"Detected in some"	10	"melanoma: 7.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	20	"SK-MEL-30: 27.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (1.93e-1)"	"unprognostic (1.57e-1)"	"unprognostic (3.10e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.85e-3)"	"unprognostic (2.97e-2)"	"unprognostic (3.80e-2)"	"unprognostic (3.58e-2)"	"unprognostic (1.06e-1)"	"unprognostic (2.65e-3)"	"unprognostic (4.50e-1)"	"unprognostic (1.99e-5)"	"unprognostic (2.34e-1)"	"unprognostic (1.63e-1)"	"unprognostic (2.28e-1)"	"unprognostic (2.69e-1)"	0.7	0.2	0.1	0.1	0.1	0.1	0.8	0.4	2.9	1.2	0.0	0.1	17.6	0.8	0.3	0.2	0.7	0.6	0.6	0.6	0.0	0.7	0.2	1.5	0.2	2.1	0.0	0.3	0.4	0.3	0.1	0.0	2.7	0.5	0.1	0.1	0.2	0.3	0.1	0.3	19.8	1.4	0.0	0.3	0.2	0.4	0.3	0.0	1.3	0.0	0.1	0.4	0.7	0.7	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	27.8	0.0	0.0	0.0	0.0	1.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.4	2.9	0.6	0.0	2.1	0.0	2.7	0.0	0.3	0.7	0.9	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.6	0.0	0.0	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	20.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	31.9	0.1	0.0	0.0	9.5	1.9	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.4	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC5A5	NIS	ENSG00000105641	"Solute carrier family 5 member 5"	Q92911	19	17871945-17895174	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	8	"choroid plexus: 163.3;salivary gland: 64.4;stomach 1: 58.8"	"Cell type enriched"	"Detected in some"	40	"Gastric mucus-secreting cells: 244.7"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 3.7"	"Group enriched"	"Detected in many"	5	"cerebellum: 5.6;hippocampal formation: 10.6;thalamus: 3.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in some"	4	"BEWO: 11.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB022364, HPA049055"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB022364: , HPA049055: AB_2680614"	"unprognostic (2.72e-2)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.81e-1)"	"unprognostic (4.02e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.07e-1)"	"unprognostic (2.01e-2)"	"unprognostic (3.03e-1)"	"unprognostic (3.93e-2)"	"unprognostic (5.51e-8)"	"unprognostic (1.07e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-2)"	"unprognostic (3.23e-1)"	0.0	0.0	0.3	0.2	0.1	0.3	0.1	5.6	1.4	5.6	163.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	10.6	0.1	0.0	0.0	0.1	0.3	0.2	0.7	0.0	0.0	0.0	0.3	0.0	0.4	0.1	0.0	0.1	64.4	0.0	0.4	0.2	0.2	0.0	0.1	0.2	58.8	0.4	3.3	0.0	12.0	0.0	0.1	0.2	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.0	11.1	0.0	0.0	0.0	0.0	0.1	0.3	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.3	0.0	0.1	0.1	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	2.6	0.0	1.1	0.1	0.1	0.3	0.4	0.4	0.3	0.9	0.1	0.2	0.3	1.2	0.9	0.6	0.2	0.1	0.1	0.6	0.3	0.3	0.1	5.6	1.4	10.6	0.1	0.2	0.7	0.4	0.1	3.3	0.3	0.0	0.0	0.6	0.3	1.1	0.4	0.0	0.0	0.0	0.0	1.7	0.0	0.8	0.0	4.7	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.2	0.2	0.2	0.0	0.0	0.5	0.6	1.3	0.1	244.7	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.3	0.6	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.9	0.1	0.0	0.0	2.9	0.0	0.0	1.2	0.2	0.1	6.1	0.2	0.3	0.0	0.9	0.0	0.0	0.2
SLC5A6	SMVT	ENSG00000138074	"Solute carrier family 5 member 6"	Q9Y289	2	27199587-27212958	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 104.0"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 119.1;Extravillous trophoblasts: 111.7;Hepatocytes: 67.7;Syncytiotrophoblasts: 227.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BEWO: 310.9;SK-BR-3: 337.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA036958	Approved		Approved	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 15: Liver - Metabolism"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Plasma membrane"		"HPA036958: AB_10672343"	"unprognostic (5.85e-2)"	"unprognostic (8.32e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.61e-3)"	"unprognostic (9.38e-2)"	"unprognostic (7.14e-2)"	"unprognostic (3.20e-3)"	"unprognostic (7.92e-2)"	"unprognostic (6.96e-2)"	"unprognostic (9.80e-2)"	"unprognostic (2.05e-2)"	"unprognostic (7.46e-2)"	"prognostic unfavorable (3.60e-7)"	"unprognostic (2.40e-3)"	"unprognostic (1.20e-2)"	"unprognostic (4.56e-3)"	"unprognostic (4.18e-2)"	42.4	8.6	27.5	14.2	25.2	18.1	31.5	24.0	30.6	9.4	46.2	13.0	20.9	14.3	67.4	10.9	11.5	7.5	7.7	23.4	23.9	8.5	104.0	7.9	13.8	24.0	24.4	10.2	11.6	9.8	8.0	39.1	25.9	9.3	12.7	6.4	12.5	11.1	17.0	10.0	15.3	9.7	23.9	9.1	10.1	23.4	30.6	11.6	8.0	8.8	26.5	11.3	8.8	21.9	78.9	79.6	49.9	66.1	45.4	16.5	310.9	28.1	19.1	41.8	28.7	118.8	27.0	54.2	41.3	15.4	44.7	42.8	108.3	32.4	29.1	42.2	63.5	96.6	34.9	184.4	53.8	125.1	47.8	57.1	27.1	51.4	39.7	11.1	38.2	43.3	143.6	21.1	27.0	161.0	42.7	60.4	144.8	90.1	29.0	70.7	58.7	78.2	24.0	74.5	42.0	61.7	30.3	337.1	40.1	48.6	74.9	26.0	17.5	45.3	62.5	27.9	76.1	35.7	88.6	84.7	24.5	86.1	65.2	0.1	5.9	1.8	7.4	6.6	8.9	5.8	7.0	7.0	8.7	5.3	7.1	8.6	0.3	6.3	8.9	8.9	7.6	5.8	27.5	25.2	24.0	30.6	23.4	23.9	24.0	24.4	25.9	23.9	30.6	21.9	2.5	0.0	4.4	7.8	13.4	8.0	8.6	3.8	7.4	5.3	41.9	31.9	6.8	8.6	3.1	7.3	4.2	119.1	12.5	6.7	1.9	9.8	15.1	3.9	7.4	6.2	5.4	12.6	7.2	8.2	111.7	6.0	5.6	6.9	0.0	18.1	7.1	67.7	21.8	11.8	9.0	9.2	4.1	9.1	6.0	32.0	7.2	6.6	0.0	29.0	47.9	2.5	6.2	6.6	5.0	7.0	4.3	13.9	10.0	14.1	11.7	3.9	2.9	3.1	13.1	5.5	5.2	35.1	21.5	7.6	6.3	227.9	8.6	9.4	15.2	7.8
SLC5A7	"CHT1, hCHT"	ENSG00000115665	"Solute carrier family 5 member 7"	Q9GZV3	2	107986523-108013994	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Neurotransmitter biosynthesis, Sodium transport, Symport, Transport"		"Congenital myasthenic syndrome, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	12	"brain: 32.9"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 3.2;Club cells: 3.1;Respiratory ciliated cells: 1.5"	"Cancer enhanced"	"Detected in single"		"testis cancer: 0.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	20	"RT4: 3.6;SCLC-21H: 1.0"	"Group enriched"	"Detected in many"	4	"basal ganglia: 23.1;hypothalamus: 9.0;midbrain: 9.4;pons and medulla: 14.4;thalamus: 6.2"	"Group enriched"	"Detected in many"	6	"basal ganglia: 20.4;pons: 26.5;spinal cord: 46.7"	HPA046105			Approved	"Nuclear bodies,Cell Junctions,Intermediate filaments"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 15: RT4 - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cell Junctions, Intermediate filaments"	"Nuclear bodies"	"HPA046105: "	"unprognostic (2.98e-1)"		"unprognostic (1.01e-1)"					"unprognostic (1.29e-3)"			"unprognostic (7.10e-2)"	"unprognostic (1.66e-1)"	"unprognostic (3.39e-4)"	"unprognostic (1.05e-2)"	"unprognostic (9.78e-3)"	"unprognostic (6.42e-2)"	"unprognostic (1.61e-2)"	0.1	0.7	1.1	0.5	3.0	0.0	0.1	0.0	10.3	0.7	1.0	2.6	0.7	0.1	0.1	0.3	0.1	0.1	0.3	0.2	5.3	0.3	0.0	0.2	0.0	20.2	21.2	0.2	0.1	0.0	0.0	0.0	32.9	0.3	0.7	0.9	0.3	1.1	0.0	0.0	0.8	0.7	2.8	0.0	0.5	0.1	1.6	0.0	1.2	0.1	0.0	1.3	0.6	7.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.6	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	3.0	0.0	10.3	0.2	5.3	20.2	21.2	32.9	2.8	1.6	7.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.3	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3
SLC5A8	AIT	ENSG00000256870	"Solute carrier family 5 member 8"	Q8N695	12	101155493-101210238	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Ion transport, Sodium transport, Symport, Transport"		"Tumor suppressor"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"cervix: 20.3;kidney: 5.6;thyroid gland: 15.5"	"Cell type enhanced"	"Detected in some"		"Club cells: 9.1;Early spermatids: 7.9;Enteroendocrine cells: 31.5;Excitatory neurons: 14.6;Horizontal cells: 10.1;Inhibitory neurons: 17.3;Proximal tubular cells: 21.4"	"Group enriched"	"Detected in many"	4	"breast cancer: 2.7;renal cancer: 7.6;thyroid cancer: 5.3"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	19	"SK-BR-3: 5.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"prognostic favorable (9.04e-6)"	"unprognostic (1.84e-1)"		"unprognostic (1.17e-2)"		"unprognostic (1.27e-3)"		"unprognostic (1.24e-1)"			"unprognostic (5.20e-1)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.97e-4)"	"unprognostic (6.16e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.87e-2)"		0.0	2.4	0.5	0.0	0.5	0.0	0.0	0.3	1.2	20.3	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.8	5.6	0.0	0.9	0.0	0.9	0.3	1.0	0.0	0.0	0.1	0.0	0.5	0.8	0.0	0.1	0.9	0.0	0.0	0.1	0.3	0.0	0.5	0.0	0.0	0.2	1.5	0.2	15.5	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.3	1.2	0.4	0.8	0.9	0.3	0.5	0.5	1.5	0.8	0.0	0.0	5.3	1.3	0.0	0.0	0.0	4.6	0.0	3.9	0.1	0.1	0.6	0.0	9.1	1.8	0.0	0.0	0.0	0.3	1.9	0.0	7.9	0.0	0.1	0.0	31.5	0.0	14.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.1	17.3	0.2	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.6	0.2	21.4	2.1	0.1	0.0	0.0	0.2	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.9
SLC5A9	SGLT4	ENSG00000117834	"Solute carrier family 5 member 9"	Q2M3M2	1	48222685-48248644	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"intestine: 43.3"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 1: 22.4;Proximal enterocytes: 84.0"	"Cancer enhanced"	"Detected in many"		"liver cancer: 4.1;renal cancer: 3.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	8	"Hep G2: 15.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA050263			Approved	"Actin filaments,Cytosol"		NA	NA				"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"	"Actin filaments"	Cytosol	"HPA050263: "	"unprognostic (3.09e-3)"	"unprognostic (1.89e-1)"	"unprognostic (6.75e-2)"	"unprognostic (5.66e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-3)"	"unprognostic (3.64e-2)"	"unprognostic (4.59e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.59e-1)"	"unprognostic (7.42e-2)"	"unprognostic (1.97e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (4.56e-1)"	"unprognostic (2.11e-1)"	"unprognostic (4.30e-3)"	"unprognostic (1.06e-2)"	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.1	0.2	0.8	43.3	0.1	1.2	0.2	0.1	2.5	0.0	0.0	0.0	3.8	7.8	3.0	0.0	0.2	0.2	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.8	0.1	1.1	42.0	0.0	0.0	0.0	0.5	0.5	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.2	0.3	0.2	22.4	1.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.5	2.8	0.0	0.0	0.0	0.0	0.0	3.1	1.9	0.5	6.3	0.5	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.3	0.0	0.5	4.5	0.0	0.7	4.4	0.1	0.0	0.2	2.9	0.0	1.3	0.0	11.0	0.3	0.3	0.0	1.9	0.1	0.0	0.0	7.5	2.9	0.1	1.7	0.4	0.0	0.0	84.0	4.1	0.0	0.0	0.0	0.2	0.1	0.6	0.3	0.0	0.0	0.0	0.1	0.0	3.0	0.0
SLC66A1	"FLJ20320, LAAT-1, LAAT1, PQLC2"	ENSG00000040487	"Solute carrier family 66 member 1"	Q6ZP29	1	19312326-19329300	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in some"	13	"Cytotrophoblasts: 26.9;Extravillous trophoblasts: 17.0;Hofbauer cells: 37.4;Syncytiotrophoblasts: 60.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057810	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Vesicles		"HPA057810: AB_2683535"	"unprognostic (7.84e-3)"	"unprognostic (6.56e-2)"	"unprognostic (6.54e-2)"	"prognostic favorable (3.50e-4)"	"unprognostic (3.77e-3)"	"unprognostic (2.19e-1)"	"prognostic unfavorable (2.64e-5)"	"unprognostic (2.61e-1)"	"unprognostic (4.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.42e-3)"	"unprognostic (3.82e-2)"	"unprognostic (4.70e-3)"	"unprognostic (8.64e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.56e-2)"	"unprognostic (4.46e-2)"	10.7	24.8	12.4	5.6	13.8	13.1	10.7	17.9	14.7	12.9	11.3	11.6	10.7	10.8	9.1	9.8	10.1	6.9	11.3	12.5	13.0	15.2	26.6	10.7	7.9	15.7	13.6	11.0	17.4	7.9	23.2	7.1	14.7	14.2	4.7	12.1	10.5	6.3	14.2	14.1	16.7	5.7	12.1	14.6	14.5	18.6	14.2	4.3	13.5	6.1	5.6	9.9	10.6	15.1	14.6	15.0	13.9	22.4	13.3	12.4	17.6	18.0	24.6	24.7	20.7	22.1	18.0	4.7	23.0	13.3	34.2	10.6	13.7	16.2	11.1	9.9	16.5	3.6	13.4	24.0	37.8	3.1	6.3	20.6	16.7	34.9	11.1	13.8	9.6	8.1	26.8	10.7	24.0	12.8	2.1	10.2	13.3	5.2	13.3	8.1	17.5	8.2	18.9	9.4	17.2	14.3	13.5	9.1	35.5	12.4	15.1	35.8	12.8	20.4	11.8	35.0	16.1	18.4	13.8	2.7	25.1	18.3	17.3	1.3	10.5	10.3	3.7	9.1	2.6	6.0	3.9	3.1	13.7	5.4	1.1	2.3	6.4	4.1	13.8	20.5	3.8	4.5	12.4	13.8	17.9	14.7	12.5	13.0	15.7	13.6	14.7	12.1	14.2	15.1	2.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	26.9	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	17.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	60.5	0.1	0.0	0.0	0.0
SLC6A1	"GABATHG, GABATR, GAT1"	ENSG00000157103	"Solute carrier family 6 member 1"	P30531	3	10992186-11039247	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Epilepsy, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 71.3;liver: 87.3;retina: 37.0"	"Group enriched"	"Detected in some"	4	"Astrocytes: 221.0;Inhibitory neurons: 332.3;Microglial cells: 108.7;Oligodendrocyte precursor cells: 130.2;Oligodendrocytes: 107.9"	"Group enriched"	"Detected in some"	16	"glioma: 16.1;liver cancer: 24.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013341, CAB022293"	Enhanced					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB022293: , HPA013341: AB_1849509"	"unprognostic (1.66e-3)"	"unprognostic (1.30e-3)"	"unprognostic (4.12e-3)"	"unprognostic (1.70e-1)"	"unprognostic (2.53e-1)"	"unprognostic (2.53e-1)"	"prognostic favorable (3.20e-4)"	"unprognostic (1.05e-1)"	"unprognostic (4.27e-2)"	"unprognostic (8.26e-2)"	"unprognostic (2.90e-1)"	"unprognostic (2.69e-1)"	"prognostic unfavorable (5.05e-6)"	"unprognostic (7.32e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.35e-1)"	"unprognostic (5.34e-2)"	1.9	0.8	51.5	0.4	56.0	2.2	1.0	45.4	67.1	3.3	0.0	1.1	0.4	1.2	2.9	9.1	1.2	1.2	4.1	35.8	53.6	2.9	87.3	2.0	0.5	39.4	63.5	2.1	0.3	15.9	3.6	0.8	34.8	2.4	0.5	37.0	0.4	4.0	2.7	1.7	0.9	0.5	43.0	0.7	0.5	4.1	71.3	17.6	0.7	0.8	0.4	0.9	2.6	39.4	0.2	0.2	0.5	0.3	0.4	0.1	0.3	0.2	0.0	0.2	0.3	0.4	0.3	0.4	0.1	0.1	0.5	0.4	0.6	0.2	0.2	0.0	0.5	0.4	1.6	0.8	0.2	0.6	0.6	0.3	0.0	0.0	0.3	0.1	0.1	0.5	0.3	1.0	0.0	0.3	0.2	0.5	0.2	0.3	0.4	0.3	0.0	0.0	0.1	0.5	0.2	0.0	0.2	0.2	0.0	0.3	0.3	0.3	0.1	0.2	0.1	0.2	0.2	0.3	0.1	0.3	0.2	0.5	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	51.5	56.0	45.4	67.1	35.8	53.6	39.4	63.5	34.8	43.0	71.3	39.4	0.3	0.0	0.5	221.0	0.0	0.3	0.0	0.0	6.2	26.6	0.1	0.0	2.1	14.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.1	0.0	0.1	2.6	0.0	0.0	3.7	0.0	0.0	1.4	0.0	0.0	2.5	0.2	0.0	25.2	0.0	0.0	332.3	0.0	0.0	0.8	0.0	1.6	5.6	0.2	0.0	108.7	0.0	36.6	0.0	130.2	107.9	0.0	0.0	10.1	0.0	0.0	0.0	0.2	0.0	3.7	13.1	9.4	6.8	3.8	0.1	4.9	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A11	GAT3	ENSG00000132164	"Solute carrier family 6 member 11"	P48066	3	10816201-10940714	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	14	"brain: 153.3"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 85.2;Excitatory neurons: 13.7;Inhibitory neurons: 25.8;Muller glia cells: 26.4;Oligodendrocyte precursor cells: 23.1"	"Cancer enhanced"	"Detected in many"		"glioma: 7.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 5.2;HaCaT: 13.5;Hep G2: 16.0;hTCEpi: 11.9;NTERA-2: 6.7;T-47d: 5.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA037981	Supported	Supported	Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 64: Astrocytes - Nervous system maintenance"	Nucleoplasm	Vesicles	"HPA037981: AB_10671383"	"unprognostic (6.04e-2)"	"unprognostic (8.01e-2)"		"unprognostic (1.21e-7)"	"unprognostic (8.60e-2)"	"unprognostic (8.68e-2)"	"unprognostic (9.72e-3)"	"unprognostic (6.39e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.92e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.51e-3)"	"unprognostic (6.06e-2)"	"unprognostic (4.44e-2)"	"unprognostic (9.83e-2)"	"unprognostic (2.31e-2)"	0.0	0.0	50.5	0.0	78.7	0.0	1.1	57.3	32.6	0.7	9.6	0.0	0.0	0.5	0.1	8.2	0.5	0.0	0.0	22.6	96.6	0.0	0.1	0.0	0.0	60.0	128.4	0.0	0.1	0.5	0.3	0.4	61.9	0.7	0.0	11.0	1.0	0.0	0.2	5.7	0.0	0.1	41.8	0.4	0.0	1.4	153.3	0.0	0.0	0.0	0.1	0.4	1.8	21.1	5.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	13.5	0.0	2.2	0.0	0.0	0.2	0.3	0.0	16.0	0.0	0.0	0.0	0.0	11.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.7	0.0	0.0	0.0	0.0	0.0	0.0	3.1	1.9	4.5	3.9	0.1	0.0	0.1	5.0	0.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.5	78.7	57.3	32.6	22.6	96.6	60.0	128.4	61.9	41.8	153.3	21.1	0.0	0.0	0.0	85.2	0.0	1.3	0.7	0.3	4.0	8.4	0.9	0.9	1.4	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.2	0.0	0.0	13.7	0.0	7.2	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	25.8	0.0	0.0	0.0	0.8	0.9	3.4	0.2	0.0	6.5	0.0	26.4	0.0	23.1	0.8	0.2	0.0	6.8	0.0	0.5	0.0	0.0	0.0	1.5	0.0	0.6	0.1	0.6	1.8	10.6	3.7	1.0	0.1	0.0	0.0	1.7
SLC6A12	BGT-1	ENSG00000111181	"Solute carrier family 6 member 12"	P48065	12	190077-214570	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"brain: 35.2;kidney: 36.0;liver: 81.5"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 46.0;Hepatocytes: 22.7;monocytes: 10.7"	"Cancer enhanced"	"Detected in many"		"liver cancer: 8.8;renal cancer: 11.9"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	50	"classical monocyte: 5.7;intermediate monocyte: 5.7;myeloid DC: 2.4;neutrophil: 3.0;non-classical monocyte: 7.9"	"Group enriched"	"Detected in many"	45	"dendritic cells: 2.4;granulocytes: 3.0;monocytes: 7.9"	"Cell line enhanced"	"Detected in some"		"Hep G2: 7.2;RPTEC TERT1: 13.8;SuSa: 2.9"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA034973	Approved		Approved	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 15: Liver - Metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Vesicles		"HPA034973: AB_10610427"	"unprognostic (3.48e-1)"	"unprognostic (4.73e-2)"	"unprognostic (8.69e-2)"	"prognostic unfavorable (1.59e-4)"	"unprognostic (1.70e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.88e-2)"	"unprognostic (8.30e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.68e-1)"	"prognostic favorable (2.70e-6)"	"unprognostic (2.30e-1)"	"unprognostic (4.92e-4)"	"unprognostic (3.35e-1)"	"unprognostic (4.31e-4)"	0.2	0.4	22.6	1.1	23.3	0.1	0.4	18.0	35.2	0.8	12.4	0.7	4.5	1.1	6.8	0.0	3.4	1.0	0.3	18.5	21.5	36.0	81.5	2.4	0.5	19.8	25.2	0.3	1.6	0.4	0.8	0.5	20.9	0.1	1.8	0.5	0.1	0.0	0.1	0.2	0.8	0.9	16.5	0.5	2.4	1.6	22.4	0.3	6.3	0.0	0.3	0.4	0.3	17.7	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	7.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.8	0.1	0.0	0.4	0.0	0.0	0.1	2.9	0.2	0.4	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	5.7	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.4	0.0	0.0	0.0	3.0	0.0	7.9	0.0	0.0	1.9	22.6	23.3	18.0	35.2	18.5	21.5	19.8	25.2	20.9	16.5	22.4	17.7	0.1	0.0	0.5	4.2	0.6	0.1	0.0	0.0	0.0	0.5	0.9	0.6	0.7	0.0	0.1	46.0	0.0	0.0	0.0	1.6	1.9	0.0	4.6	3.5	1.7	0.2	0.0	0.0	0.4	0.4	0.0	0.6	2.0	8.8	0.0	0.1	0.7	22.7	2.4	0.0	0.3	1.7	0.0	1.9	2.5	6.2	0.6	1.6	0.0	8.4	10.7	5.2	0.0	0.5	9.2	0.0	1.2	0.0	0.0	0.0	0.0	8.0	0.0	0.4	6.6	0.6	0.4	2.3	4.5	0.0	0.4	0.8	0.1	0.1	1.0	0.1
SLC6A13	GAT2	ENSG00000010379	"Solute carrier family 6 member 13"	Q9NSD5	12	220621-262873	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	4	"kidney: 153.1"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 324.9"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 32.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"RPTEC TERT1: 4.6;SuSa: 1.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036449, HPA052726"			Supported	Nucleoplasm,Nucleoli,Mitochondria,Cytosol		NA	NA				"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria	"Nucleoplasm, Nucleoli, Cytosol"	"HPA036449: AB_2675130, HPA052726: AB_2681927"	"unprognostic (8.45e-3)"	"unprognostic (4.20e-1)"	"unprognostic (5.44e-2)"	"unprognostic (1.64e-5)"	"unprognostic (1.13e-1)"	"unprognostic (8.02e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.75e-1)"	"unprognostic (2.15e-1)"	"unprognostic (7.21e-4)"	"unprognostic (2.93e-1)"	"unprognostic (1.25e-3)"	"unprognostic (3.79e-2)"	"unprognostic (2.62e-1)"	"unprognostic (6.23e-2)"	"unprognostic (1.91e-1)"	0.2	0.3	13.4	0.0	16.5	0.1	0.1	11.0	20.1	0.1	13.9	0.1	2.6	0.1	0.3	0.0	7.1	0.0	2.6	12.2	11.9	153.1	36.8	0.8	0.0	11.6	12.6	0.2	0.0	0.0	3.0	0.0	11.7	0.5	0.0	1.1	0.1	0.1	0.5	0.2	0.6	0.0	12.1	0.3	0.1	3.1	13.8	0.1	6.3	0.0	0.0	0.0	0.0	11.7	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.0	0.4	1.6	0.0	0.0	0.1	0.0	0.5	0.0	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.4	16.5	11.0	20.1	12.2	11.9	11.6	12.6	11.7	12.1	13.8	11.7	0.0	0.0	0.6	1.3	1.9	0.0	0.0	0.4	0.0	0.4	0.1	0.1	1.5	0.0	0.1	18.4	2.1	0.0	0.1	0.0	49.0	0.0	1.4	0.6	0.1	0.2	0.0	5.3	3.6	0.0	0.0	0.3	0.0	0.6	0.0	0.0	1.8	27.0	0.0	0.0	1.2	0.0	2.0	1.6	0.0	0.6	0.3	1.7	0.0	17.8	0.0	0.0	0.0	1.5	1.3	0.0	0.0	0.0	0.0	0.1	0.5	324.9	0.7	0.7	0.0	0.4	0.1	0.6	0.4	0.0	0.0	0.3	0.9	0.0	0.0	0.0
SLC6A14		ENSG00000268104	"Solute carrier family 6 member 14"	Q9UN76	X	116436606-116461458	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		Obesity	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 16.0;salivary gland: 20.6"	"Group enriched"	"Detected in some"	4	"Alveolar cells type 2: 115.7;Basal respiratory cells: 94.9;Club cells: 225.6;Pancreatic endocrine cells: 170.4;Respiratory ciliated cells: 58.1"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.7;Hep G2: 3.4;OE19: 1.2"									HPA003193	Uncertain		Approved	Vesicles		NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	Vesicles		"HPA003193: AB_2190122"	"unprognostic (3.06e-2)"	"unprognostic (3.55e-2)"	"unprognostic (8.49e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.30e-3)"	"unprognostic (1.49e-2)"	"unprognostic (7.41e-3)"	"unprognostic (3.67e-3)"	"unprognostic (2.66e-1)"	"unprognostic (1.83e-2)"	"prognostic unfavorable (9.74e-4)"	"unprognostic (1.34e-2)"		"unprognostic (3.89e-2)"	"unprognostic (2.08e-2)"	"unprognostic (1.71e-1)"	"unprognostic (1.59e-1)"	0.0	0.0	0.1	2.2	0.0	0.1	7.7	0.3	0.1	7.0	0.0	1.4	0.9	0.2	0.0	2.3	0.2	0.8	0.0	0.1	0.0	0.0	0.0	16.0	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.1	1.0	0.7	0.0	20.6	1.3	0.0	3.2	0.6	0.1	0.0	0.0	3.8	0.1	0.0	0.0	0.0	0.0	1.1	1.6	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	1.7	3.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	22.4	115.7	0.0	0.1	0.1	0.3	94.9	0.0	0.0	17.6	11.6	0.2	0.0	225.6	0.0	0.0	0.0	0.1	18.1	0.0	17.6	0.1	0.2	0.0	0.5	2.4	0.0	0.0	32.0	0.0	1.0	10.7	0.4	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	6.1	0.0	0.0	0.1	0.0	0.5	16.0	0.0	0.0	0.0	0.0	0.0	0.0	170.4	10.2	0.0	0.0	10.5	0.2	0.0	58.1	0.0	0.0	0.0	6.8	0.0	0.0	0.0	0.4	0.0	0.4	0.0	8.9	23.4
SLC6A15	"FLJ10316, hv7-3, NTT73, SBAT1, V7-3"	ENSG00000072041	"Solute carrier family 6 member 15"	Q9H2J7	12	84859491-84913629	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Ion transport, Neurotransmitter transport, Sodium transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 21.9;retina: 15.7"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 42.1;Bipolar cells: 19.7;Excitatory neurons: 63.9;Inhibitory neurons: 57.4;Melanocytes: 32.0;Oligodendrocytes: 46.9"	"Group enriched"	"Detected in some"	4	"head and neck cancer: 2.2;melanoma: 7.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 93.5;ASC TERT1: 55.4;hTERT-HME1: 135.3;SCLC-21H: 91.7;SK-MEL-30: 71.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008609	Uncertain		Approved	Nucleoli,Vesicles		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli	Vesicles	"HPA008609: AB_1857190"	"unprognostic (1.01e-4)"	"unprognostic (9.02e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.65e-6)"	"unprognostic (1.25e-2)"	"unprognostic (2.92e-1)"		"unprognostic (7.65e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.51e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.69e-4)"	"unprognostic (2.57e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.23e-2)"	"unprognostic (2.63e-3)"	0.6	1.4	8.0	0.2	7.8	0.0	0.4	4.0	12.7	0.9	0.0	0.4	0.1	0.5	0.0	2.8	0.2	0.0	0.0	6.9	12.9	0.2	0.0	0.1	0.0	7.4	21.9	0.3	0.0	0.0	5.5	3.8	16.7	0.2	0.2	15.7	0.8	0.1	0.0	1.4	0.4	0.3	0.2	0.0	0.1	0.4	8.8	0.1	0.3	1.6	0.2	0.2	1.3	5.0	0.0	2.5	10.3	0.0	93.5	55.4	0.1	0.1	21.0	1.5	1.0	0.0	0.0	0.0	0.0	0.2	12.0	1.2	0.0	23.7	0.1	0.0	25.1	0.0	4.1	0.0	33.5	0.0	0.2	31.4	48.2	11.9	135.3	25.3	0.3	0.0	0.0	0.0	25.9	0.0	0.1	0.0	28.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	91.7	22.6	0.1	31.1	71.0	0.2	0.0	0.0	0.0	12.7	6.5	0.1	0.0	0.0	0.0	0.1	23.1	0.0	27.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.0	7.8	4.0	12.7	6.9	12.9	7.4	21.9	16.7	0.2	8.8	5.0	0.0	0.0	0.0	4.2	0.1	2.7	0.0	3.1	42.1	19.7	0.1	0.1	0.5	0.0	0.0	0.0	6.2	0.3	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.2	0.0	0.0	63.9	0.0	0.6	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	11.8	57.4	0.0	0.0	0.0	0.4	0.6	0.0	0.0	32.0	1.9	0.0	1.1	0.0	4.0	46.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	11.1	0.0	0.5	1.0	0.4	0.5	5.8	0.6	0.3	0.0	0.0	0.0	0.0
SLC6A16	NTT5	ENSG00000063127	"Solute carrier family 6 member 16"	Q9GZN6	19	49289638-49325215	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"testis: 94.2"	"Group enriched"	"Detected in many"	8	"Early spermatids: 125.9;Late spermatids: 46.8;Spermatocytes: 153.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AF22: 18.2;SuSa: 9.9"	"Not detected"	"Not detected"							HPA076812			Supported	"Golgi apparatus"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 12: NES - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"		"HPA076812: AB_2686816"	"unprognostic (1.98e-1)"	"unprognostic (7.15e-3)"	"unprognostic (6.39e-3)"	"unprognostic (1.36e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.83e-3)"	"unprognostic (7.89e-2)"	"unprognostic (7.92e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.55e-3)"	"unprognostic (1.63e-1)"	"unprognostic (3.23e-2)"	"unprognostic (3.31e-1)"	"unprognostic (2.10e-1)"	"unprognostic (8.93e-2)"	"unprognostic (4.18e-2)"	4.5	2.0	2.8	2.9	2.2	4.5	3.2	1.2	2.1	4.6	17.9	3.8	1.2	4.0	2.4	1.7	5.8	2.3	2.5	2.2	1.8	8.5	10.0	4.9	7.3	5.0	4.9	7.0	6.9	0.9	1.6	3.2	4.3	5.0	1.1	5.0	1.5	2.9	1.0	2.2	3.7	1.8	2.9	4.7	3.5	94.2	2.5	2.3	3.2	0.5	5.5	3.6	3.4	2.1	0.0	7.3	18.2	6.5	0.3	2.8	3.3	0.9	1.5	0.6	2.0	0.2	0.6	8.5	1.1	0.8	0.3	0.3	2.0	0.3	2.2	1.3	2.1	0.7	0.7	1.7	1.4	0.6	3.0	2.8	1.1	1.4	1.0	5.2	1.6	1.5	1.7	1.1	2.4	1.6	0.5	0.3	6.4	0.3	0.9	0.3	4.4	1.6	1.0	0.0	0.2	0.4	2.9	0.1	0.6	9.9	2.9	0.3	9.3	1.4	6.7	4.2	0.0	4.0	4.6	7.5	0.1	2.0	0.4	0.2	0.3	2.6	1.6	1.2	1.5	4.5	0.5	1.6	0.4	2.2	1.4	0.9	1.9	1.8	2.1	1.1	0.9	1.3	2.8	2.2	1.2	2.1	2.2	1.8	5.0	4.9	4.3	2.9	2.5	2.1	4.4	0.0	1.1	3.6	5.8	1.5	0.9	0.4	2.2	8.6	1.7	1.7	1.5	2.8	0.1	1.8	2.1	0.0	1.7	0.1	11.7	0.8	125.9	2.3	1.6	3.9	0.0	0.0	4.1	0.6	0.0	1.7	0.0	1.5	1.3	0.3	2.2	5.5	0.9	0.0	8.1	0.1	0.0	1.4	1.8	46.8	3.7	0.8	5.4	12.2	1.2	0.5	5.2	2.5	1.7	0.2	0.0	3.4	1.5	0.5	0.0	0.3	11.3	1.2	0.0	1.7	4.9	153.5	8.3	0.3	1.3	0.0	1.1	1.8	0.1	0.3
SLC6A17		ENSG00000197106	"Solute carrier family 6 member 17"	Q9H1V8	1	110150494-110202202	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 52.9;pituitary gland: 25.3"	"Group enriched"	"Detected in some"	5	"Excitatory neurons: 60.6;Inhibitory neurons: 59.4"	"Cancer enriched"	"Detected in some"	9	"melanoma: 17.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"SK-MEL-30: 36.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008043, HPA008044"	Enhanced		Approved	Mitochondria		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA008043: , HPA008044: AB_1857192"	"unprognostic (1.13e-1)"	"unprognostic (1.37e-3)"	"unprognostic (5.52e-3)"	"unprognostic (3.00e-2)"	"unprognostic (1.17e-1)"	"unprognostic (4.88e-2)"	"unprognostic (6.11e-3)"	"unprognostic (3.87e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.80e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.89e-2)"	"unprognostic (1.73e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.38e-3)"	"unprognostic (1.68e-3)"	0.4	5.9	21.6	0.2	26.3	0.1	0.3	1.2	52.9	0.1	0.0	0.3	0.0	0.1	1.0	0.4	0.1	0.1	0.1	20.1	9.6	1.3	0.0	0.1	0.0	13.7	8.2	0.0	1.4	8.8	25.3	0.8	10.5	0.1	0.1	6.0	0.6	0.1	0.1	6.2	0.1	0.1	0.0	0.0	0.7	1.8	24.8	0.0	0.3	0.1	0.0	0.1	0.1	15.7	0.0	1.5	0.0	0.0	0.0	0.0	0.0	5.5	0.5	2.1	0.2	0.0	0.0	0.0	0.3	0.2	0.0	0.2	0.0	0.0	1.9	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.1	1.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.9	0.8	6.2	1.9	36.0	1.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	7.1	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.6	26.3	1.2	52.9	20.1	9.6	13.7	8.2	10.5	0.0	24.8	15.7	0.0	0.0	0.0	2.6	0.0	0.5	0.0	0.1	0.0	5.1	0.2	0.4	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.1	1.9	0.0	1.2	0.0	0.0	0.5	0.0	0.0	60.6	0.0	0.5	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	59.4	0.0	4.1	0.0	0.0	0.7	0.0	0.0	10.6	3.7	0.0	0.7	0.0	4.5	2.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.8	0.0	0.7	0.4	0.0	1.8	0.0	0.4	0.1	0.0	0.0	0.0	0.0
SLC6A18	"FLJ31236, Xtrp2"	ENSG00000164363	"Solute carrier family 6 member 18"	Q96N87	5	1225381-1246189	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	76	"kidney: 8.2"	"Cell type enriched"	"Detected in some"	7	"Proximal tubular cells: 55.6"	"Cancer enriched"	"Detected in single"	44	"renal cancer: 4.2"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA011885	Enhanced					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA011885: AB_1857198"			"unprognostic (2.02e-1)"										"unprognostic (5.69e-3)"	"unprognostic (2.90e-1)"				0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	55.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0
SLC6A19		ENSG00000174358	"Solute carrier family 6 member 19"	Q695T7	5	1201595-1225111	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	35	"intestine: 142.4;kidney: 88.7"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 561.5"	"Group enriched"	"Detected in many"	4	"renal cancer: 7.9;stomach cancer: 5.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 14.3;HEL: 18.3;OE19: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA037415, HPA043207"	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 36: HEL - Hemostasis"	"Cluster 45: Enterocytes - Digestion"			"HPA037415: AB_10672346, HPA043207: AB_2678363"			"unprognostic (1.26e-1)"				"unprognostic (1.01e-3)"				"unprognostic (6.04e-2)"	"unprognostic (3.64e-1)"	"prognostic favorable (4.14e-6)"	"unprognostic (1.37e-1)"	"unprognostic (7.36e-2)"			0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.1	139.7	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	88.7	0.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.7	5.6	0.0	0.0	0.0	0.0	0.0	142.4	0.3	0.0	0.0	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.4	0.0	5.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	64.3	0.6	1.8	0.0	0.0	0.0	104.4	1.9	0.1	0.1	0.0	0.0	0.1	4.8	2.7	0.0	0.0	14.6	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	13.4	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	28.1	0.0	0.0	0.0	561.5	76.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.4	0.0	8.7	0.0
SLC6A2	"NAT1, NET, NET1, SLC6A5"	ENSG00000103546	"Solute carrier family 6 member 2"	P23975	16	55655604-55706192	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 149.4"	"Group enriched"	"Detected in some"	4	"Early spermatids: 4.3;Extravillous trophoblasts: 10.6;Late spermatids: 4.4;Spermatocytes: 11.5;Syncytiotrophoblasts: 5.6"	"Cancer enhanced"	"Detected in some"		"liver cancer: 1.9"	"Region enriched"	"Detected in some"	10	"pons: 149.4"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	29	"SH-SY5Y: 489.1"	"Region enriched"	"Detected in some"	4	"pons and medulla: 7.8"	"Region enriched"	"Detected in single"	19	"pons: 13.8"	"HPA004057, HPA076311, CAB078195"	Enhanced	Supported	Approved	Mitochondria,Cytosol		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	Mitochondria	"CAB078195: AB_2665806, HPA004057: AB_1080012, HPA076311: AB_2732307"	"unprognostic (9.58e-3)"	"unprognostic (5.48e-2)"		"unprognostic (1.26e-4)"	"unprognostic (4.07e-1)"	"unprognostic (4.16e-1)"	"unprognostic (8.38e-2)"	"unprognostic (2.97e-2)"	"unprognostic (3.29e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.27e-1)"	"unprognostic (2.12e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (6.02e-2)"	"unprognostic (8.48e-2)"	"unprognostic (1.43e-2)"	0.9	21.7	0.1	0.0	0.1	0.0	0.8	0.0	0.2	2.4	0.0	0.2	0.1	5.4	0.2	0.2	0.5	0.1	0.0	0.1	0.0	0.4	0.4	0.1	0.0	3.8	14.6	0.1	0.0	0.5	0.0	12.6	149.4	0.2	0.3	0.0	1.9	0.6	0.0	13.3	0.2	0.8	0.1	0.0	0.1	6.2	0.0	0.1	0.0	0.0	0.1	0.2	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	1.4	0.0	0.0	0.0	0.0	0.0	0.0	5.2	3.7	489.1	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.1	0.0	3.8	14.6	149.4	0.1	0.0	0.5	1.8	0.0	0.0	0.0	0.0	1.5	0.2	0.4	0.0	0.0	0.3	0.1	0.8	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	4.3	0.1	0.0	0.3	0.0	0.0	0.0	0.0	10.6	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.5	4.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.1	11.5	0.3	0.0	0.4	5.6	0.0	0.0	0.0	0.1
SLC6A20	"IMINO, SIT1, XT3, Xtrp3"	ENSG00000163817	"Solute carrier family 6 member 20"	Q9NP91	3	45755449-45796536	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"choroid plexus: 59.2;intestine: 24.2"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 74.7"	"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"cerebral cortex: 4.7"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.7;OE19: 3.9;SuSa: 1.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (1.57e-1)"	"unprognostic (5.26e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.70e-2)"	"unprognostic (1.48e-1)"	"unprognostic (9.43e-3)"	"unprognostic (3.26e-2)"	"unprognostic (4.33e-3)"	"unprognostic (2.76e-1)"	"unprognostic (1.34e-1)"	"unprognostic (1.68e-3)"	"unprognostic (1.46e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (2.87e-1)"	"unprognostic (1.23e-1)"	"unprognostic (7.55e-2)"	"unprognostic (2.09e-2)"	0.2	0.1	0.4	0.7	1.7	0.4	0.4	1.8	4.7	1.3	59.2	0.5	24.2	0.8	0.1	0.1	0.2	6.9	0.2	2.0	0.2	1.9	0.1	1.9	0.3	0.3	0.3	0.1	3.0	0.1	1.3	0.1	0.4	0.4	0.2	0.5	0.7	0.1	0.8	0.7	17.6	0.3	0.3	0.1	5.2	0.4	0.7	0.9	0.1	0.5	0.1	0.0	0.1	0.6	0.1	0.1	0.2	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.9	0.7	0.1	0.5	0.0	0.2	1.7	0.0	0.0	0.1	0.0	0.1	0.2	0.7	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.1	0.0	0.2	0.1	0.2	0.0	0.2	0.2	0.1	0.4	3.9	0.1	0.2	0.0	0.2	0.1	0.1	0.1	0.2	0.8	0.1	0.0	1.1	0.1	0.0	0.0	0.2	0.2	0.2	0.1	0.4	0.1	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.4	1.7	1.8	4.7	2.0	0.2	0.3	0.3	0.4	0.3	0.7	0.6	0.1	0.0	5.0	0.0	0.1	0.5	0.6	0.6	0.0	0.3	0.7	0.4	1.2	17.2	2.7	0.0	0.0	0.1	0.2	3.5	0.0	13.7	0.6	1.7	0.5	0.1	0.0	0.0	1.4	0.2	0.1	0.7	17.9	2.1	0.0	0.2	0.4	0.0	0.0	0.0	0.2	4.8	0.0	0.0	0.0	1.7	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	9.4	1.2	1.2	0.4	2.3	74.7	3.5	1.4	0.3	0.0	0.6	0.3	0.2	0.2	0.0	0.3	0.0	0.3	0.1	7.0	4.2
SLC6A3	"DAT, DAT1"	ENSG00000142319	"Solute carrier family 6 member 3"	Q01959	5	1392794-1445440	"Disease related genes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant, Dystonia, FDA approved drug targets, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	73	"brain: 60.6"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 2: 2.3;Cardiomyocytes: 1.2;Smooth muscle cells: 1.4"	"Cancer enriched"	"Detected in some"	18	"renal cancer: 25.7"	"Region enriched"	"Detected in some"	26	"midbrain: 60.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	8	"midbrain: 80.6;thalamus: 29.0"	"Region enriched"	"Detected in some"	152	"midbrain: 302.6"	"HPA012763, HPA013602, CAB016249, CAB078172"	Enhanced	Supported	Approved	Vesicles		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 43: Cardiomyocytes - Nuclear processes"	Vesicles		"CAB016249: AB_627402, CAB078172: AB_2665810, HPA012763: AB_2732405, HPA013602: AB_1847484"	"unprognostic (2.25e-4)"	"unprognostic (2.22e-1)"	"unprognostic (8.45e-2)"	"unprognostic (5.24e-2)"	"unprognostic (7.75e-2)"	"unprognostic (1.41e-2)"	"unprognostic (4.64e-5)"	"unprognostic (9.31e-2)"	"unprognostic (7.89e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.12e-2)"	"prognostic unfavorable (3.40e-7)"	"unprognostic (6.98e-2)"	"unprognostic (1.64e-1)"	"unprognostic (2.22e-2)"	"unprognostic (4.74e-2)"	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.5	0.0	0.3	0.0	0.0	60.6	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.3	2.3	0.1	0.8	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	0.0	60.6	0.3	0.0	2.3	0.0	0.0	0.0	2.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.1	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0
SLC6A4	"5-HTT, HTT, OCD1, SERT1"	ENSG00000108576	"Solute carrier family 6 member 4"	P31645	17	30194319-30236002	"FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 232.0"	"Group enriched"	"Detected in many"	6	"Cytotrophoblasts: 125.4;Proximal enterocytes: 100.9;Syncytiotrophoblasts: 106.4"	"Cancer enhanced"	"Detected in some"		"breast cancer: 2.3"	"Group enriched"	"Detected in some"	11	"midbrain: 232.0;pons: 86.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.9;CACO-2: 3.9;Hep G2: 10.4"	"Region enriched"	"Detected in some"	4	"midbrain: 58.4"	"Group enriched"	"Detected in some"	7	"midbrain: 38.9;pons: 29.1"	"HPA054723, HPA071354, HPA074728"	Supported	Supported	Supported	"Golgi apparatus,Vesicles"		NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus, Vesicles"		"HPA054723: , HPA071354: , HPA074728: AB_2686708"	"unprognostic (7.45e-2)"	"unprognostic (7.13e-2)"	"unprognostic (2.26e-1)"	"unprognostic (3.72e-4)"	"unprognostic (2.07e-1)"	"unprognostic (8.42e-3)"	"unprognostic (2.73e-2)"	"unprognostic (3.39e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.17e-3)"	"unprognostic (2.70e-3)"	"unprognostic (1.16e-1)"	"unprognostic (8.78e-2)"	"unprognostic (4.98e-2)"	"unprognostic (1.76e-1)"	"unprognostic (4.05e-2)"	"unprognostic (7.18e-2)"	0.1	0.1	0.1	0.0	0.0	0.2	0.2	0.3	0.2	0.2	0.0	0.5	10.3	0.0	0.0	2.8	1.7	0.0	0.9	0.1	0.2	0.2	0.0	28.8	0.1	14.8	232.0	0.1	1.4	0.2	0.0	18.4	86.1	0.1	0.1	0.1	0.7	0.2	0.1	0.5	40.3	0.0	0.0	0.1	0.9	0.3	0.2	0.0	0.5	0.0	0.2	0.1	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	3.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	10.4	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.7	0.0	0.4	0.5	0.0	0.0	0.1	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.3	0.2	0.1	0.2	14.8	232.0	86.1	0.0	0.2	0.2	1.1	16.0	5.0	0.3	0.0	0.1	0.4	0.1	17.1	1.2	0.1	0.0	1.0	0.0	1.9	1.8	0.0	125.4	1.5	0.2	0.0	0.0	2.8	0.2	0.6	3.2	0.0	0.0	0.9	0.0	8.6	1.3	0.0	0.5	2.5	0.2	2.2	0.3	9.5	0.0	0.6	2.3	0.0	1.0	1.2	2.2	0.3	5.9	0.0	0.0	0.1	0.5	2.1	0.5	0.5	0.4	0.0	0.4	0.1	0.3	100.9	0.4	0.7	0.8	0.0	1.3	0.5	0.5	0.9	4.8	0.3	106.4	0.5	0.2	4.1	0.3
SLC6A5	"GLYT2, NET1"	ENSG00000165970	"Solute carrier family 6 member 5"	Q9Y345	11	20599594-20659285	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	23	"brain: 22.2"	"Group enriched"	"Detected in some"	39	"Early spermatids: 20.6;Late spermatids: 66.9"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"medulla oblongata: 22.2;pons: 20.0;spinal cord: 7.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Region enriched"	"Detected in some"	9	"pons and medulla: 49.3"	"Group enriched"	"Detected in many"	8	"medulla oblongata: 30.5;spinal cord: 18.3"	CAB079052		Supported				NA	NA				"Cluster 73: Brain - Neuropeptide signaling"		"Cluster 31: Spermatids - Spermatogenesis"			"CAB079052: "					"unprognostic (6.94e-2)"	"unprognostic (2.28e-1)"									"unprognostic (4.75e-2)"			0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.3	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.9	0.0	22.2	1.3	0.0	0.0	0.0	0.6	0.0	20.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	1.3	0.2	0.2	0.0	22.2	1.3	20.0	7.6	0.1	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	20.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	66.9	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC6A6	TAUT	ENSG00000131389	"Solute carrier family 6 member 6"	P31641	3	14402576-14489349	"Disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"retina: 68.5"	"Group enriched"	"Detected in many"	4	"Cone photoreceptor cells: 571.3;Rod photoreceptor cells: 547.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"neutrophil: 59.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 59.2"	"Cell line enhanced"	"Detected in many"		"HeLa: 66.6;RPTEC TERT1: 111.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015028, HPA016488"	Enhanced		Approved	"Cell Junctions,Cytosol"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 34: Non-specific - Transcription"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Cell Junctions, Cytosol"		"HPA015028: AB_1857200, HPA016488: AB_1857202"	"unprognostic (8.25e-2)"	"unprognostic (7.29e-3)"	"unprognostic (2.63e-2)"	"prognostic favorable (5.22e-5)"	"prognostic unfavorable (5.75e-8)"	"unprognostic (4.14e-2)"	"prognostic unfavorable (8.78e-4)"	"unprognostic (2.58e-1)"	"unprognostic (2.56e-1)"	"unprognostic (3.81e-1)"	"unprognostic (6.96e-2)"	"unprognostic (2.38e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.11e-1)"	"unprognostic (1.01e-2)"	"unprognostic (9.65e-2)"	"unprognostic (1.90e-1)"	10.9	25.6	1.7	8.4	6.9	54.7	8.5	5.0	7.7	11.3	0.0	3.9	0.9	10.4	0.0	6.7	6.7	9.4	24.4	3.5	3.8	12.2	1.5	20.5	7.5	9.6	6.6	28.9	2.3	2.5	7.4	7.9	6.7	4.3	2.4	68.5	17.1	7.2	30.9	18.3	17.1	6.9	1.7	15.6	9.4	3.7	11.0	4.5	9.3	8.7	9.1	8.1	6.1	6.8	4.1	18.4	4.6	10.1	11.6	5.7	15.9	4.3	26.4	8.4	6.2	8.8	5.6	12.6	4.5	10.9	11.7	4.3	4.5	10.1	16.5	3.7	9.7	8.8	66.6	24.2	0.0	3.7	22.3	1.9	2.6	7.8	1.6	7.7	14.5	6.2	10.1	3.5	18.6	8.1	9.4	20.3	6.1	7.1	10.8	6.1	7.3	24.9	111.8	28.5	7.2	4.6	3.1	3.2	0.6	36.8	11.5	4.5	15.3	9.7	3.9	5.2	6.2	3.9	6.0	7.1	19.3	6.6	23.2	5.6	9.2	8.6	2.5	7.3	1.3	4.0	2.7	3.0	2.8	2.1	0.5	0.6	59.2	1.8	9.4	1.4	8.7	4.6	1.7	6.9	5.0	7.7	3.5	3.8	9.6	6.6	6.7	1.7	11.0	6.8	42.7	6.4	21.5	1.3	16.4	49.3	17.1	51.5	43.9	126.1	9.5	6.9	4.2	7.2	52.8	20.2	571.3	3.0	14.5	0.5	0.0	12.0	19.6	82.1	23.0	29.4	14.4	9.4	17.4	8.2	15.8	13.5	29.0	126.9	13.3	2.5	11.7	0.6	27.2	10.1	18.5	3.5	46.8	60.1	59.5	16.6	17.4	58.8	17.8	32.8	110.9	30.8	10.3	3.0	23.9	31.1	12.6	17.3	13.3	17.6	51.3	23.3	69.5	547.8	0.0	11.4	8.3	0.4	1.3	15.7	23.9	5.1	25.5	46.8	3.6	16.8
SLC6A7	PROT	ENSG00000011083	"Solute carrier family 6 member 7"	Q99884	5	150190062-150222788	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	37	"brain: 21.5;intestine: 5.5"	"Cell type enriched"	"Detected in some"	4	"Excitatory neurons: 41.5"	"Cancer enhanced"	"Detected in single"		"colorectal cancer: 0.8"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA028907	Uncertain					NA	NA				"Cluster 6: Brain - Smell perception"		"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA028907: AB_10602404"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-2)"	"unprognostic (3.70e-2)"	"unprognostic (1.42e-3)"	"unprognostic (1.09e-2)"	"unprognostic (1.82e-4)"	"unprognostic (6.42e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.55e-1)"	"unprognostic (3.50e-1)"	"unprognostic (3.73e-4)"	"unprognostic (8.11e-2)"	"unprognostic (5.46e-2)"	"unprognostic (2.73e-1)"	"unprognostic (3.70e-3)"	0.1	0.0	10.2	0.3	12.7	0.0	0.1	14.6	21.5	0.1	0.0	5.5	1.2	0.0	0.0	0.0	0.0	0.0	0.1	10.6	3.2	0.0	0.0	0.1	0.1	1.9	3.4	0.0	0.0	0.0	0.1	0.0	2.1	0.0	4.0	0.1	0.2	0.0	0.0	0.0	3.3	0.1	2.0	0.0	0.0	0.1	9.4	0.0	0.0	0.0	0.1	0.0	0.0	8.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.2	12.7	14.6	21.5	10.6	3.2	1.9	3.4	2.1	2.0	9.4	8.9	0.0	0.0	0.0	2.9	0.0	0.3	0.0	0.1	0.0	0.3	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	7.7	0.0	0.1	0.0	0.0	0.0	0.2	3.6	0.0	41.5	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	2.6	5.4	0.0	0.0	0.4	0.0	0.3	0.5	0.0	2.8	0.0	0.0	0.0	0.5	1.6	0.1	8.7	0.0	0.0	0.1	1.9	0.0	0.1	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	4.7	0.1
SLC6A8	"CRTR, CT1"	ENSG00000130821	"Solute carrier family 6 member 8"	P48029	X	153687926-153696588	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Sodium transport, Symport, Transport"		"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 142.0;Distal enterocytes: 382.0;Proximal enterocytes: 235.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A-431: 155.8;AN3-CA: 151.3;SK-BR-3: 156.8"	"Low region specificity"	"Detected in all"													NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (5.80e-2)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-2)"	"unprognostic (9.98e-2)"	"unprognostic (1.47e-1)"	"unprognostic (7.16e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.10e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.43e-1)"	"prognostic unfavorable (1.53e-4)"	"unprognostic (1.41e-1)"	"unprognostic (1.06e-1)"	"prognostic unfavorable (7.39e-4)"	"unprognostic (2.87e-1)"	31.6	66.6	77.2	9.0	99.4	34.5	23.9	77.8	80.0	17.5	39.9	73.5	51.3	32.4	13.0	54.6	17.3	31.3	130.4	76.8	82.1	81.4	4.5	9.2	1.9	89.0	90.5	12.4	20.0	45.6	21.4	36.2	76.9	31.3	30.5	34.7	52.3	35.9	166.6	45.9	75.9	20.7	71.3	13.1	30.8	38.5	87.6	11.9	8.2	75.5	3.0	41.2	36.5	116.6	155.8	6.7	39.5	151.3	14.7	9.9	10.2	22.2	37.7	28.7	35.5	20.1	2.1	0.2	17.0	27.9	33.6	54.3	85.3	78.0	17.0	2.7	83.3	0.6	50.6	59.7	50.0	1.2	10.1	20.9	16.5	27.3	103.3	50.7	14.9	0.9	37.3	2.4	15.7	9.3	0.8	3.6	47.0	30.9	67.0	7.6	5.2	2.1	30.8	29.5	56.0	64.2	33.8	156.8	107.9	9.8	30.9	23.9	14.1	45.2	73.1	58.2	66.5	5.2	3.0	1.8	105.5	4.5	47.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	77.2	99.4	77.8	80.0	76.8	82.1	89.0	90.5	76.9	71.3	87.6	116.6	5.9	0.0	1.9	14.0	2.7	23.2	14.3	91.1	13.1	142.0	19.6	18.4	106.9	21.5	55.6	5.5	110.5	15.3	2.8	382.0	3.9	4.6	1.5	21.4	38.9	6.5	25.9	23.4	8.2	22.2	37.7	8.8	6.1	16.1	4.5	14.4	3.9	0.9	4.9	119.5	9.9	44.2	38.7	1.9	5.7	3.7	9.0	4.1	24.9	2.8	3.2	19.0	0.0	9.0	23.7	47.5	101.1	8.2	0.8	28.3	235.8	53.3	31.3	49.3	32.9	15.6	19.0	2.9	3.9	16.9	15.6	90.8	2.9	1.5	20.7	18.6
SLC6A9	GLYT1	ENSG00000196517	"Solute carrier family 6 member 9"	P48067	1	43991500-44031467	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Neurotransmitter transport, Symport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 72.4;skin 1: 46.6"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 30.7;Distal enterocytes: 17.8;Erythroid cells: 33.1;Ionocytes: 20.3"	"Cancer enhanced"	"Detected in all"		"glioma: 18.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 62.3;hTCEpi: 106.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA013977	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Golgi apparatus"	Nucleoplasm	"HPA013977: AB_1849835"	"unprognostic (2.73e-2)"	"unprognostic (1.92e-2)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (9.50e-4)"	"unprognostic (5.98e-2)"	"unprognostic (6.83e-3)"	"unprognostic (3.06e-2)"	"unprognostic (9.72e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.52e-2)"	"unprognostic (1.41e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (5.93e-4)"	"unprognostic (5.36e-3)"	"unprognostic (1.59e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.20e-2)"	3.9	31.0	21.7	4.9	45.5	10.8	4.6	53.2	24.2	12.1	6.3	11.0	2.3	7.4	1.1	23.1	9.5	4.8	2.1	16.1	31.3	4.3	2.3	11.6	1.1	66.3	43.5	2.9	8.2	2.8	1.7	1.4	63.6	3.9	6.3	17.2	11.5	5.5	1.1	46.6	6.0	9.1	45.6	1.9	7.4	1.1	45.9	1.4	5.3	0.6	4.3	12.3	25.1	72.4	19.7	13.7	7.1	18.0	11.2	3.7	15.6	14.7	41.0	24.3	30.1	4.8	7.5	0.3	1.6	42.9	0.0	62.3	11.0	12.5	5.0	0.1	1.8	17.1	33.9	5.8	50.3	3.8	0.7	11.3	106.6	11.9	28.5	15.3	0.6	12.3	13.0	48.5	1.0	10.4	2.9	0.1	5.4	7.4	19.1	2.2	0.0	22.9	2.3	2.2	4.4	4.2	7.4	35.3	7.0	1.7	9.1	10.3	0.2	2.8	11.0	2.4	8.0	53.1	39.2	4.4	9.2	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	21.7	45.5	53.2	24.2	16.1	31.3	66.3	43.5	63.6	45.6	45.9	72.4	1.5	0.0	2.0	5.9	1.1	7.5	0.9	3.2	8.0	30.7	2.2	0.9	0.7	4.3	2.2	1.8	16.7	0.5	0.5	17.8	0.0	3.7	5.9	4.8	0.4	0.7	0.0	33.1	2.2	8.9	1.0	0.9	1.5	2.7	0.0	0.0	0.0	0.3	0.3	1.7	1.5	2.7	20.3	0.0	1.0	0.8	1.5	0.1	3.6	0.0	1.0	1.2	0.0	3.0	16.4	4.2	3.0	1.5	1.3	2.0	9.1	1.1	12.5	11.1	6.6	0.1	10.0	0.1	0.4	8.9	12.9	0.5	0.3	1.2	2.6	3.2
SLC7A1	"ATRC1, CAT-1, ERR, HCAT1, REC1L"	ENSG00000139514	"Solute carrier family 7 member 1"	P30825	13	29509414-29595688	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 55.1"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 235.6;Microglial cells: 162.1;Squamous epithelial cells: 175.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039721, HPA077838"	Approved					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA039721: AB_10672893, HPA077838: "	"unprognostic (1.85e-1)"	"unprognostic (1.04e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.96e-1)"	"unprognostic (3.95e-3)"	"unprognostic (2.43e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.02e-3)"	"unprognostic (4.98e-2)"	"unprognostic (1.23e-2)"	"unprognostic (7.45e-2)"	"unprognostic (9.14e-2)"	"prognostic unfavorable (1.32e-5)"	"unprognostic (3.20e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.19e-1)"	"unprognostic (7.37e-3)"	6.2	6.0	34.8	10.7	21.9	11.3	7.7	28.6	31.1	8.5	24.4	10.1	10.2	8.4	10.2	55.1	7.4	4.5	7.5	31.0	25.9	6.6	2.0	4.9	8.6	40.5	27.6	2.8	30.5	4.5	7.5	3.0	41.4	7.7	7.4	9.0	16.1	9.2	2.1	17.7	14.8	9.1	33.9	5.9	11.3	6.9	39.5	7.8	9.6	1.7	10.4	11.0	11.1	27.6	42.2	33.2	28.7	58.0	14.5	28.6	32.6	87.8	58.3	74.2	55.0	68.0	72.1	82.9	23.3	134.5	82.8	188.0	50.4	62.2	97.1	78.3	30.1	62.1	36.3	37.0	75.0	91.6	39.4	36.6	129.4	82.6	96.9	17.4	37.1	92.8	40.5	37.6	31.5	56.5	67.2	24.6	27.5	74.2	22.1	45.7	59.1	48.3	47.2	27.5	97.3	46.3	50.0	48.3	79.4	17.9	21.3	76.6	35.1	58.2	40.6	51.6	63.6	42.1	33.1	93.8	46.4	36.3	60.1	0.0	0.4	0.1	1.0	0.4	0.8	0.6	0.7	0.8	0.6	0.4	0.5	0.9	0.0	0.2	1.0	1.2	0.6	0.7	34.8	21.9	28.6	31.1	31.0	25.9	40.5	27.6	41.4	33.9	39.5	27.6	12.1	0.0	5.0	7.2	14.4	49.8	53.9	33.0	235.6	15.6	21.4	12.8	10.2	12.8	16.2	71.7	16.7	1.1	10.3	14.7	1.9	19.9	0.2	32.5	10.0	29.2	31.1	54.7	28.9	56.9	40.0	10.3	26.5	69.2	7.0	8.0	5.7	0.4	6.1	25.2	27.0	34.5	26.4	5.7	18.2	0.8	6.2	8.6	8.8	162.1	5.7	3.1	3.1	23.6	13.1	56.5	21.1	3.8	36.8	55.2	20.7	0.3	10.1	18.6	6.6	28.1	9.0	4.5	2.1	175.1	34.9	4.0	11.3	10.8	33.5	41.6
SLC7A10	asc-1	ENSG00000130876	"Solute carrier family 7 member 10"	Q9NS82	19	33208664-33225850	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"adipose tissue: 31.8;brain: 12.7;breast: 12.7"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 40.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"BEWO: 1.9;HHSteC: 1.1;HSkMC: 1.6;THP-1: 3.9;U-2 OS: 1.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041884, HPA057036"	Uncertain		Uncertain	Nucleoplasm,Nucleoli		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"	"Nucleoplasm, Nucleoli"		"HPA041884: AB_10794494, HPA057036: AB_2683317"	"unprognostic (1.85e-2)"	"unprognostic (1.69e-3)"	"unprognostic (2.79e-2)"	"unprognostic (1.79e-6)"	"unprognostic (1.16e-1)"	"unprognostic (2.08e-1)"	"unprognostic (1.31e-1)"	"unprognostic (4.98e-3)"	"unprognostic (4.64e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.28e-3)"	"unprognostic (1.10e-1)"	"unprognostic (2.22e-2)"	"unprognostic (1.34e-3)"	"unprognostic (8.91e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.18e-2)"	31.8	0.3	7.9	0.1	9.7	0.0	12.7	10.1	11.1	0.0	3.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	7.3	9.2	0.5	0.0	0.0	0.2	8.5	12.4	0.0	0.1	0.0	0.0	0.2	8.4	0.0	0.0	0.5	0.8	0.0	0.1	0.2	0.5	0.0	6.0	0.0	0.1	0.5	12.7	0.0	0.5	0.4	0.3	0.3	0.0	5.1	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	3.9	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	9.7	10.1	11.1	7.3	9.2	8.5	12.4	8.4	6.0	12.7	5.1	0.1	0.0	0.0	40.8	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.8	0.0	2.4	0.0	9.5	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	4.4	0.0	0.1	0.1	0.1	0.0	0.0	0.0
SLC7A11	xCT	ENSG00000151012	"Solute carrier family 7 member 11"	Q9UPY5	4	138164097-138242349	"FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 26.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 368.6;Microglial cells: 148.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"hTCEpi: 84.2;TIME: 95.2;WM-115: 138.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064215			Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 64: Astrocytes - Nervous system maintenance"	Vesicles		"HPA064215: AB_2685213"	"unprognostic (3.55e-3)"	"unprognostic (4.64e-3)"	"unprognostic (2.43e-2)"	"unprognostic (7.18e-3)"	"unprognostic (2.59e-1)"	"unprognostic (8.80e-3)"	"unprognostic (2.07e-8)"	"unprognostic (1.98e-2)"	"unprognostic (1.09e-2)"	"prognostic favorable (1.77e-4)"	"unprognostic (1.90e-2)"	"unprognostic (4.07e-2)"	"unprognostic (2.22e-8)"	"unprognostic (3.81e-2)"	"unprognostic (3.76e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.54e-2)"	0.2	0.1	18.8	2.2	17.5	1.0	0.4	16.5	16.5	0.9	7.2	0.7	0.4	0.3	6.7	2.6	4.5	1.6	1.7	16.2	26.5	0.1	0.2	1.7	0.4	24.3	22.8	0.5	2.7	0.3	0.8	0.7	19.0	0.6	1.0	4.2	0.7	0.1	0.0	0.6	0.4	0.1	19.8	0.4	4.9	0.8	20.1	0.3	4.6	0.0	0.8	2.7	0.5	20.1	5.2	42.1	18.4	14.5	3.9	5.0	5.1	23.2	15.9	5.2	11.8	4.7	17.7	9.7	29.5	80.8	27.6	6.7	10.0	19.8	21.7	18.5	2.1	6.9	37.7	10.7	59.6	18.1	6.3	11.9	84.2	14.6	64.6	7.6	65.1	9.6	9.5	24.4	27.3	3.7	2.5	1.7	3.6	25.1	11.9	2.8	6.1	11.5	3.1	20.1	7.6	1.5	10.1	2.9	35.4	3.9	4.4	38.1	95.2	6.7	18.8	10.2	18.3	20.5	10.3	9.7	11.4	9.7	138.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.9	0.0	0.0	18.8	17.5	16.5	16.5	16.2	26.5	24.3	22.8	19.0	19.8	20.1	20.1	0.5	0.0	8.4	368.6	2.5	4.6	7.5	8.8	1.8	7.3	2.2	1.3	5.4	1.5	8.1	0.0	2.1	3.6	28.5	7.9	0.0	4.4	3.2	3.2	2.3	27.8	27.0	0.8	12.5	25.1	0.7	5.7	65.2	18.3	4.5	1.0	2.9	0.4	0.6	1.7	7.3	19.8	22.4	0.3	63.5	0.8	2.5	18.3	5.4	148.9	51.7	47.9	0.0	12.1	8.6	30.4	1.5	2.2	4.1	58.5	0.4	0.1	7.3	2.0	0.0	2.1	4.0	1.1	0.7	1.9	3.1	1.1	0.9	7.0	4.2	37.6
SLC7A13	"AGT-1, XAT2"	ENSG00000164893	"Solute carrier family 7 member 13"	Q8TCU3	8	86214063-86321146	"Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	234	"kidney: 42.0"	"Cell type enriched"	"Detected in some"	6	"Proximal tubular cells: 27.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 67: Proximal tubular cells - Tubular reabsorption"				"unprognostic (3.34e-1)"						"unprognostic (2.62e-1)"					"unprognostic (1.12e-1)"	"unprognostic (2.96e-5)"					0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	42.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.0	0.0	1.8	0.0	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	27.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLC7A14	"KIAA1613, PPP1R142"	ENSG00000013293	"Solute carrier family 7 member 14"	Q8TBB6	3	170459548-170586075	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 15.9;pituitary gland: 7.3;retina: 6.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 28.4;Excitatory neurons: 61.9;Horizontal cells: 28.6;Inhibitory neurons: 90.2;Oligodendrocytes: 67.4"	"Group enriched"	"Detected in some"	11	"glioma: 0.8;pancreatic cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"LHCN-M2: 3.2;SCLC-21H: 3.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA045929	Approved		Approved	"Nucleoplasm,Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Vesicles, Cytosol"	"Nucleoplasm, Plasma membrane"	"HPA045929: AB_2679501"	"unprognostic (1.00e-1)"		"unprognostic (9.56e-2)"	"unprognostic (1.03e-1)"	"unprognostic (4.15e-2)"	"unprognostic (1.43e-2)"	"unprognostic (7.46e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.29e-1)"	"unprognostic (6.68e-3)"	"unprognostic (6.36e-2)"	"unprognostic (3.03e-6)"	"unprognostic (1.54e-2)"	"unprognostic (8.05e-2)"	"unprognostic (1.71e-2)"	"unprognostic (3.24e-3)"	0.0	2.3	8.9	0.4	8.1	0.1	0.0	5.5	8.8	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	0.1	0.0	7.9	15.9	0.1	0.0	0.0	0.0	15.6	6.4	0.1	0.7	0.0	7.3	0.0	14.9	0.1	0.4	6.1	0.0	0.0	0.1	0.1	0.3	0.1	4.0	0.0	0.2	0.1	8.9	0.0	0.0	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.1	0.0	0.5	0.9	0.0	0.3	0.0	0.3	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.5	0.3	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	8.9	8.1	5.5	8.8	7.9	15.9	15.6	6.4	14.9	4.0	8.9	7.7	0.8	3.2	2.2	4.6	0.1	0.4	0.3	0.1	0.0	28.4	0.1	0.0	1.0	0.0	2.5	0.0	2.1	0.1	0.1	0.0	0.0	0.0	0.6	0.2	0.2	0.5	1.8	0.0	61.9	0.0	0.1	0.4	0.0	0.1	2.5	0.1	0.4	0.9	0.0	28.6	90.2	0.1	0.0	0.0	1.2	0.6	2.1	0.4	3.6	6.5	0.0	1.8	0.0	9.5	67.4	0.1	1.2	2.6	0.1	0.3	0.1	0.2	3.0	4.3	0.0	0.7	0.5	0.0	0.2	0.0	0.6	0.0	0.4	0.1	0.0	0.2
SLC7A2	"ATRC2, CAT-2, HCAT2"	ENSG00000003989	"Solute carrier family 7 member 2"	P52569	8	17497088-17570573	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 176.7;parathyroid gland: 224.1"	"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 93.1;Glandular and luminal cells: 139.8;Hepatocytes: 249.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HHSteC: 204.3;RT4: 55.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009277			Supported	"Plasma membrane,Cell Junctions"		NA	NA				"Cluster 8: Non-specific - Mitochondria"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane"	"Cell Junctions"	"HPA009277: AB_2668229"	"unprognostic (1.31e-1)"	"unprognostic (2.28e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.24e-3)"	"unprognostic (3.11e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.49e-1)"	"unprognostic (1.34e-2)"	"unprognostic (1.11e-2)"	"prognostic unfavorable (2.65e-7)"	"prognostic unfavorable (3.08e-4)"	"unprognostic (1.46e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.79e-1)"	28.6	11.6	7.9	3.4	7.0	0.2	17.2	9.5	9.6	32.5	16.6	6.2	2.4	15.2	17.8	11.3	42.5	11.2	12.2	10.0	8.0	8.0	176.7	7.5	2.7	14.1	6.2	84.4	83.1	224.1	7.1	9.8	12.6	14.2	4.3	17.6	5.1	7.2	114.5	8.1	4.5	13.4	12.7	3.8	8.3	15.4	7.1	3.1	45.1	45.8	3.5	10.5	14.9	15.9	0.0	3.1	1.0	32.4	0.2	0.3	35.1	0.3	22.1	1.7	2.0	10.7	0.1	0.0	7.4	0.0	4.7	0.0	23.5	5.4	7.4	0.0	12.3	0.0	24.8	23.2	204.3	10.3	0.0	27.7	4.5	27.2	25.7	0.0	10.2	0.0	0.2	0.0	24.9	35.5	1.3	11.7	11.8	7.4	2.9	0.0	16.2	17.6	2.7	55.3	0.4	4.3	1.7	0.8	9.9	23.5	0.0	1.2	22.9	0.0	11.8	0.1	0.1	0.0	0.0	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	7.0	9.5	9.6	10.0	8.0	14.1	6.2	12.6	12.7	7.1	15.9	9.4	12.8	78.1	58.8	0.4	8.3	6.6	5.8	20.5	2.9	52.0	25.8	15.5	38.6	16.3	7.3	35.5	22.6	0.1	0.4	0.0	8.3	12.8	67.0	40.4	5.6	87.9	10.7	0.5	93.1	15.1	20.6	0.5	139.8	2.5	0.4	7.1	249.0	5.8	0.0	19.9	3.6	0.0	6.7	2.3	22.9	37.9	1.4	3.6	1.9	0.6	23.5	0.0	11.6	2.6	20.5	0.6	27.8	0.1	50.2	0.3	3.7	53.9	38.0	59.2	8.8	75.7	0.3	1.1	7.8	3.8	26.0	1.6	9.5	3.2	8.4
SLC7A3	"ATRC3, CAT-3, FLJ14541"	ENSG00000165349	"Solute carrier family 7 member 3"	Q8WY07	X	70925579-70931125	"FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 19.8"	"Cell type enhanced"	"Detected in some"		"Breast myoepithelial cells: 1.5;Early spermatids: 6.9;Granulosa cells: 1.5;Inhibitory neurons: 1.6;Late spermatids: 2.3"	"Cancer enriched"	"Detected in some"	12	"testis cancer: 43.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"HAP1: 64.2;NTERA-2: 130.9;SuSa: 154.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 63: T-cells - Adaptive immune response"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 23: Spermatids - Flagellum & Golgi organization"				"unprognostic (1.42e-4)"	"unprognostic (4.30e-4)"	"unprognostic (3.59e-3)"	"unprognostic (1.81e-2)"	"unprognostic (6.45e-2)"			"unprognostic (1.45e-2)"		"unprognostic (3.66e-1)"	"unprognostic (9.18e-3)"	"unprognostic (1.89e-1)"		"unprognostic (7.99e-5)"	"unprognostic (1.31e-2)"	"unprognostic (5.42e-4)"	"unprognostic (3.57e-2)"	0.0	0.0	4.2	0.1	0.7	0.9	0.7	0.0	1.1	1.7	0.1	0.1	0.1	5.3	1.3	0.4	1.6	0.1	0.0	0.9	3.5	0.0	0.0	0.0	0.3	0.9	2.0	1.0	0.0	0.0	0.3	0.0	2.2	5.8	0.0	0.1	0.2	5.4	0.0	0.0	0.2	2.7	0.4	0.0	3.1	0.8	5.5	19.8	0.0	0.0	0.3	1.0	0.8	0.5	0.0	0.0	4.3	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	23.7	0.5	0.0	0.2	0.0	64.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	26.4	0.0	130.9	0.0	0.0	28.4	9.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	154.2	0.0	0.0	0.0	0.1	1.1	0.0	0.0	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	4.2	0.7	0.0	1.1	0.9	3.5	0.9	2.0	2.2	0.4	5.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.5	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.9	0.0	0.3	0.1	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	2.3	0.6	0.0	0.0	1.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.5	0.0	0.0	0.0	0.0	0.3	0.0	0.1
SLC7A4	"CAT-4, HCAT3, VH"	ENSG00000099960	"Solute carrier family 7 member 4"	O43246	22	21028718-21032840	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"testis: 15.4"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 21.2;Endometrial ciliated cells: 16.4;Glandular and luminal cells: 32.0;Intestinal goblet cells: 8.9;Ionocytes: 12.2;Syncytiotrophoblasts: 10.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	21	"BEWO: 140.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA031023	Enhanced					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 44: Endometrium - Transcription"			"HPA031023: AB_10669669"	"unprognostic (1.02e-3)"	"unprognostic (4.34e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.91e-2)"	"unprognostic (3.68e-2)"	"unprognostic (2.51e-2)"	"unprognostic (2.58e-2)"	"unprognostic (1.21e-3)"	"unprognostic (9.69e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.62e-1)"	"unprognostic (1.32e-2)"	"unprognostic (4.00e-3)"	2.7	2.6	3.1	0.2	2.6	0.0	1.0	3.8	2.8	1.5	4.5	1.1	1.0	1.0	0.3	5.6	1.1	1.3	1.1	2.3	3.8	0.4	0.3	0.8	0.3	1.8	2.6	0.3	0.2	0.5	4.7	3.3	4.5	2.5	0.9	0.3	2.2	3.2	0.4	1.6	1.2	0.3	0.3	0.5	1.4	15.4	4.8	0.3	0.0	0.0	0.5	1.1	0.6	0.7	0.0	0.0	0.0	0.1	0.0	0.0	140.5	0.0	0.0	0.3	0.1	1.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	6.5	0.0	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	1.6	0.0	0.0	0.0	1.3	0.5	0.3	0.0	0.1	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.2	3.1	2.6	3.8	2.8	2.3	3.8	1.8	2.6	4.5	0.3	4.8	0.7	0.0	6.4	1.9	0.3	0.0	0.0	0.3	7.4	0.6	0.5	0.7	0.6	0.3	1.5	3.1	0.0	0.0	21.2	0.0	0.5	0.0	0.0	0.3	16.4	2.1	0.3	1.2	0.0	1.4	0.4	7.7	2.0	1.1	32.0	4.5	0.7	1.1	0.0	1.4	0.0	0.8	8.9	12.2	0.0	0.0	1.8	1.8	0.1	0.0	1.0	0.0	2.0	0.0	0.0	0.1	0.8	0.3	0.7	0.0	0.5	0.3	0.0	2.6	0.1	0.0	0.3	0.4	0.3	1.5	1.8	0.0	10.1	0.7	0.0	0.6	0.6
SLC7A5	"CD98, D16S469E, E16, LAT1, MPE16"	ENSG00000103257	"Solute carrier family 7 member 5"	Q01650	16	87830023-87869507	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 110.7;brain: 121.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 178.7;Microglial cells: 109.6;Plasma cells: 135.1;Syncytiotrophoblasts: 107.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	10	"plasmacytoid DC: 17.2"	"Lineage enriched"	"Detected in many"	10	"dendritic cells: 17.2"	"Cell line enhanced"	"Detected in all"		"HBEC3-KT: 1326.5;hTCEpi: 2229.0;MCF7: 1264.6;SiHa: 1873.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052673, HPA056077"	Approved		Supported	"Vesicles,Plasma membrane,Cytosol"		NA	NA		51000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Plasma membrane, Cytosol"	Vesicles	"HPA052673: AB_2681909, HPA056077: AB_2683031"	"unprognostic (2.71e-3)"	"unprognostic (1.10e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.64e-1)"	"unprognostic (3.22e-2)"	"unprognostic (2.99e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (2.43e-4)"	"unprognostic (6.86e-2)"	"unprognostic (4.46e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (5.93e-2)"	"unprognostic (5.52e-3)"	"unprognostic (1.64e-2)"	"unprognostic (7.19e-3)"	10.6	3.9	121.9	18.3	87.8	110.7	6.0	89.5	119.4	11.0	64.5	11.4	6.6	5.2	35.7	100.2	6.4	6.6	21.1	96.0	91.0	18.0	26.6	9.8	14.1	111.3	104.3	8.1	14.0	1.8	22.8	17.0	104.9	9.8	2.7	42.5	28.6	10.4	30.1	25.1	8.9	3.2	93.0	16.7	34.4	65.6	117.1	6.9	3.9	2.8	11.5	24.6	22.6	88.1	187.4	693.5	13.2	192.1	5.1	10.6	487.3	147.1	52.8	87.4	56.3	456.3	260.4	170.1	126.7	187.6	30.5	818.3	142.5	1326.5	61.0	179.9	71.9	140.3	618.0	331.2	199.5	131.2	246.0	35.9	2229.0	107.8	791.4	28.5	18.0	588.8	212.6	185.1	71.1	1264.6	159.2	192.7	63.3	116.7	166.0	152.0	52.4	264.1	98.3	15.7	109.2	43.5	1873.1	368.9	406.9	123.0	170.0	171.8	14.3	30.9	201.3	127.8	114.5	237.9	213.2	728.2	120.1	322.1	296.4	1.0	0.0	0.0	1.0	0.0	1.3	0.5	0.5	0.9	0.4	0.0	0.1	0.4	0.2	0.2	0.0	17.2	1.6	0.5	121.9	87.8	89.5	119.4	96.0	91.0	111.3	104.3	104.9	93.0	117.1	88.1	3.7	0.0	0.6	8.1	23.0	73.3	17.9	27.0	178.7	15.2	12.0	8.9	2.9	2.8	6.3	1.8	16.7	15.4	80.0	3.4	0.0	18.1	1.0	20.5	7.6	29.1	86.3	86.3	12.0	9.6	35.4	9.5	43.3	51.0	66.9	4.5	1.8	17.3	9.2	10.1	13.2	6.3	8.2	3.0	50.5	5.0	1.8	51.0	39.2	109.6	2.6	14.8	2.1	15.1	1.6	25.7	2.3	1.5	135.1	18.2	1.0	0.4	3.2	52.7	0.0	33.6	31.5	1.6	4.5	58.8	37.5	107.4	65.8	2.7	4.2	42.8
SLC7A6	"KIAA0245, LAT-2, LAT3, y+LAT-2"	ENSG00000103064	"Solute carrier family 7 member 6"	Q92536	16	68264516-68301823	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Antiport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 75.0"	"Cell type enhanced"	"Detected in many"		"Microglial cells: 55.3;Syncytiotrophoblasts: 47.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA050713	Uncertain		Uncertain	"Vesicles,Plasma membrane"		NA	NA			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	Vesicles	"Plasma membrane"	"HPA050713: AB_2681218"	"unprognostic (6.35e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.24e-3)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-1)"	"unprognostic (5.16e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.76e-2)"	"unprognostic (1.89e-3)"	"unprognostic (7.82e-2)"	"unprognostic (2.66e-1)"	"unprognostic (4.79e-3)"	"prognostic unfavorable (1.84e-4)"	35.3	8.8	1.7	15.5	1.9	8.4	26.9	6.5	3.3	5.5	17.3	8.3	3.9	5.8	11.5	4.5	8.6	4.4	18.5	3.3	2.2	5.9	2.0	10.9	18.6	1.0	1.3	2.7	3.8	2.5	9.6	18.6	1.5	6.2	11.1	5.0	7.3	5.2	75.0	10.2	12.0	7.7	1.0	10.7	6.6	5.1	2.2	37.6	16.7	26.9	21.5	6.8	4.8	1.1	22.6	22.1	16.3	16.8	46.9	27.6	42.9	24.9	18.7	36.9	30.6	97.9	16.2	43.7	19.8	33.4	10.9	33.1	32.0	32.2	39.7	9.5	22.9	23.8	47.3	31.0	7.7	28.2	20.3	19.3	26.1	27.5	13.5	11.4	25.3	21.0	35.1	7.3	20.5	11.7	36.4	19.3	12.4	14.6	8.1	45.0	10.2	36.0	12.0	19.6	23.7	13.5	75.7	20.8	6.8	13.4	30.9	13.3	38.4	24.6	19.0	20.5	32.8	16.7	33.5	50.3	15.6	20.1	17.2	3.4	3.2	2.8	4.3	1.7	5.4	6.8	6.6	4.3	3.6	6.3	11.7	6.7	6.1	7.1	1.4	16.8	3.1	1.5	1.7	1.9	6.5	3.3	3.3	2.2	1.0	1.3	1.5	1.0	2.2	1.1	8.5	41.7	18.8	12.4	18.4	19.6	9.3	8.5	13.6	6.1	5.9	4.8	19.9	2.8	4.9	18.4	37.5	25.1	23.3	7.3	0.0	3.3	5.5	10.7	16.8	12.0	2.4	2.1	39.3	4.0	2.5	12.8	4.1	3.3	4.5	1.8	6.8	1.4	14.6	10.1	40.3	10.5	4.1	8.5	12.1	18.3	5.9	9.9	10.6	55.3	10.0	1.8	14.4	13.0	10.7	5.6	5.9	3.8	16.0	8.0	2.5	0.6	10.4	2.7	0.0	10.8	7.2	17.3	10.9	6.7	21.9	47.9	23.5	4.3	7.8	2.6
SLC7A7	"LPI, y+LAT-1"	ENSG00000155465	"Solute carrier family 7 member 7"	Q9UM01	14	22773222-22829820	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 131.6;kidney: 300.6"	"Group enriched"	"Detected in many"	4	"Hofbauer cells: 216.5;Kupffer cells: 410.6;Macrophages: 146.2;monocytes: 164.0;Proximal enterocytes: 423.1;Proximal tubular cells: 327.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 299.9;intermediate monocyte: 410.0;non-classical monocyte: 457.1"	"Lineage enriched"	"Detected in many"	5	"monocytes: 457.1"	"Group enriched"	"Detected in many"	4	"BEWO: 217.2;CACO-2: 385.7;OE19: 329.0"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA036227	Enhanced					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA036227: AB_10696653"	"unprognostic (1.34e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.25e-2)"	"unprognostic (2.52e-1)"	"unprognostic (6.12e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.84e-3)"	"unprognostic (1.47e-1)"	"unprognostic (2.88e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.60e-3)"	"unprognostic (7.15e-2)"	"prognostic unfavorable (6.28e-6)"	"unprognostic (2.68e-3)"	"unprognostic (1.86e-2)"	"unprognostic (2.61e-1)"	"unprognostic (1.12e-1)"	15.1	9.0	3.1	37.4	3.2	19.7	6.8	3.8	7.5	7.3	4.3	13.8	107.0	5.3	2.0	3.7	7.8	17.0	5.1	2.8	3.8	300.6	16.4	54.1	29.1	6.9	4.7	2.1	5.2	78.4	1.4	18.2	6.4	3.5	15.0	1.0	5.4	2.8	2.0	3.2	131.6	15.6	5.1	56.8	8.6	32.8	7.1	9.6	4.6	2.8	25.2	14.7	4.1	8.1	0.2	11.2	1.2	0.5	1.9	3.7	217.2	2.2	16.3	0.4	1.4	385.7	34.4	17.0	72.2	1.4	1.2	13.3	0.1	0.0	0.6	0.6	0.2	0.9	0.4	3.7	9.1	1.9	1.6	7.1	1.0	1.0	0.5	1.8	25.3	1.5	0.1	12.8	2.9	0.6	0.4	1.7	3.6	329.0	0.1	2.9	35.5	9.8	0.8	1.3	0.4	0.8	0.6	0.5	2.5	9.4	0.4	8.3	1.3	0.8	1.7	0.6	0.5	2.7	0.9	8.9	0.9	0.8	0.2	0.2	299.9	1.1	0.5	410.0	0.4	19.1	0.2	0.2	99.5	13.8	0.7	0.4	36.5	0.3	457.1	3.4	0.9	155.1	3.1	3.2	3.8	7.5	2.8	3.8	6.9	4.7	6.4	5.1	7.1	8.1	5.3	12.8	7.1	2.0	14.3	1.0	0.2	6.7	1.8	0.2	0.5	1.7	0.9	67.2	5.6	3.7	0.0	1.2	5.7	3.0	11.7	8.2	61.1	1.7	1.2	5.0	1.2	0.0	0.6	6.4	5.2	4.4	2.6	0.4	1.3	0.7	16.1	3.0	216.5	0.0	1.4	7.2	2.0	410.6	16.8	11.8	3.7	146.2	5.4	20.6	164.0	0.4	4.1	0.0	0.8	8.9	12.5	0.0	20.1	0.1	423.1	327.6	9.2	1.3	6.6	0.8	1.4	17.8	2.2	0.4	0.4	1.8	2.7	38.8	6.4	0.1
SLC7A8	"LAT2, LPI-PC1"	ENSG00000092068	"Solute carrier family 7 member 8"	Q9UHI5	14	23125295-23183674	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 331.1"	"Cell type enhanced"	"Detected in many"		"Endometrial stromal cells: 74.1;Kupffer cells: 90.0;Proximal tubular cells: 144.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"basophil: 9.3;eosinophil: 14.0"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 14.0"	"Cell line enhanced"	"Detected in many"		"ASC diff: 68.8;BEWO: 110.6;K-562: 136.9;NTERA-2: 64.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046015, HPA051950, HPA060672"	Enhanced					NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"CAB046015: AB_2239464, HPA051950: AB_2681670, HPA060672: AB_2684340"	"unprognostic (1.50e-1)"	"unprognostic (1.52e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.12e-2)"	"unprognostic (3.03e-2)"	"prognostic unfavorable (1.97e-4)"	"prognostic favorable (3.15e-4)"	"unprognostic (1.24e-1)"	"unprognostic (2.37e-1)"	"unprognostic (1.39e-3)"	"unprognostic (9.44e-2)"	"unprognostic (7.00e-2)"	"unprognostic (2.96e-2)"	"unprognostic (8.56e-3)"	"unprognostic (1.64e-1)"	"prognostic unfavorable (1.52e-4)"	27.6	15.2	1.2	7.0	7.1	1.6	27.7	5.5	7.6	31.3	42.8	12.5	36.3	43.6	4.8	37.5	45.9	18.6	7.9	3.4	6.5	119.3	6.9	15.4	4.5	3.4	3.1	67.5	19.9	331.1	15.8	16.0	5.8	39.2	13.7	13.9	23.8	35.5	49.4	31.6	24.2	20.9	0.0	18.5	63.4	21.2	6.7	4.9	23.7	15.4	9.0	29.9	37.5	1.4	1.6	0.0	52.9	0.1	68.8	8.5	110.6	6.0	26.3	0.3	2.0	60.4	3.6	0.4	0.8	13.9	5.4	11.7	8.5	3.5	0.3	0.0	5.2	0.6	0.3	0.0	25.5	0.2	35.8	54.1	33.2	0.9	0.9	11.6	5.2	5.4	136.9	0.3	1.5	1.2	0.3	0.8	64.0	12.9	47.4	0.1	0.9	12.5	0.7	21.4	8.2	0.3	0.2	12.0	32.3	60.1	42.8	0.6	0.5	2.3	1.8	0.7	0.0	0.3	15.9	0.2	6.9	0.0	0.4	9.3	0.1	14.0	0.0	0.1	1.1	0.1	0.9	0.1	0.0	0.0	0.9	3.3	0.4	0.0	0.1	0.0	0.5	2.3	1.2	7.1	5.5	7.6	3.4	6.5	3.4	3.1	5.8	0.0	6.7	1.4	0.5	16.0	15.0	2.3	1.8	3.1	28.8	6.4	29.0	26.4	31.6	15.2	5.7	0.0	9.0	16.5	0.0	18.7	0.5	8.3	5.9	1.9	2.2	13.6	74.1	2.1	33.0	0.0	24.8	2.4	4.4	15.5	53.5	18.4	5.1	27.3	66.4	1.3	59.2	26.9	53.5	33.7	4.1	90.0	3.3	3.1	9.6	15.3	19.6	15.9	0.5	39.3	0.0	4.0	2.6	3.0	6.5	7.9	1.6	26.4	27.3	144.8	1.0	4.4	0.0	2.8	4.7	1.1	1.3	25.3	3.0	41.3	2.9	3.4	18.5	32.3
SLC7A9	CSNU3	ENSG00000021488	"Solute carrier family 7 member 9"	P82251	19	32830509-32869767	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"		"Cystinuria, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	6	"intestine: 124.6;kidney: 68.2"	"Cell type enriched"	"Detected in some"	7	"Proximal enterocytes: 772.0"	"Group enriched"	"Detected in some"	7	"liver cancer: 6.6;renal cancer: 5.2;stomach cancer: 1.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	16	"BEWO: 3.4;CACO-2: 8.2;Hep G2: 8.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA042591	Enhanced					NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"			"HPA042591: AB_10962500"	"unprognostic (4.12e-2)"	"unprognostic (5.40e-2)"	"unprognostic (6.19e-2)"	"unprognostic (3.37e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.54e-1)"	"unprognostic (4.17e-2)"	"unprognostic (3.87e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.39e-1)"	"unprognostic (9.69e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.20e-1)"	"unprognostic (4.94e-3)"	"unprognostic (5.10e-5)"	0.2	0.1	0.7	0.1	0.7	0.0	0.3	0.7	0.9	0.8	0.6	0.8	78.3	0.4	1.4	0.2	0.5	0.2	0.1	0.7	0.7	68.2	17.3	0.2	0.1	0.7	0.7	0.6	0.3	0.0	0.7	0.1	0.7	1.0	0.2	1.0	0.2	0.2	0.0	0.3	124.6	0.2	0.6	0.3	0.2	0.4	0.7	0.2	0.8	0.0	0.0	0.3	0.5	0.7	0.0	0.1	0.0	0.0	0.1	0.0	3.4	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	8.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.7	0.7	0.9	0.7	0.7	0.7	0.7	0.7	0.6	0.7	0.7	0.1	0.0	0.0	2.3	0.5	0.0	0.1	0.0	0.0	1.3	0.2	0.6	0.4	0.0	0.0	5.5	4.2	0.2	0.1	0.0	1.9	0.1	1.6	0.3	0.2	0.1	0.0	0.0	3.1	7.2	8.8	0.2	0.0	0.2	0.0	0.4	0.0	12.2	0.2	0.0	3.0	18.2	0.0	0.0	0.0	0.1	0.6	0.5	0.0	2.8	0.0	0.2	0.0	0.0	1.7	0.6	27.5	0.0	0.0	0.0	772.0	97.8	1.8	1.2	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.1	11.7	0.0
SLC8A1	NCX1	ENSG00000183023	"Solute carrier family 8 member A1"	P32418	2	40097270-40611053	"FDA approved drug targets, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 117.5"	"Group enriched"	"Detected in many"	8	"Cardiomyocytes: 743.1;Excitatory neurons: 1267.5;Inhibitory neurons: 631.3;Microglial cells: 574.3;Oligodendrocyte precursor cells: 753.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"neutrophil: 44.2"	"Group enriched"	"Detected in many"	6	"granulocytes: 44.2;monocytes: 11.5"	"Cell line enhanced"	"Detected in many"		"BJ: 28.9;fHDF/TERT166: 70.4;hTERT-HME1: 19.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022694, HPA070007"	Uncertain		Supported	"Nucleoplasm,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Plasma membrane"		"CAB022694: , HPA070007: AB_2686227"	"unprognostic (2.46e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.42e-2)"	"unprognostic (7.57e-6)"	"unprognostic (1.56e-1)"	"unprognostic (3.94e-1)"	"unprognostic (2.28e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.31e-1)"	"unprognostic (7.71e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.66e-2)"	"unprognostic (7.04e-3)"	"unprognostic (3.93e-2)"	"unprognostic (5.46e-2)"	"unprognostic (6.77e-2)"	6.1	4.0	25.7	7.2	25.8	2.0	1.6	0.0	28.0	4.7	0.0	9.6	5.0	19.7	5.6	5.9	5.6	6.5	117.5	30.6	11.0	17.5	3.1	5.8	3.3	1.5	19.8	2.5	1.8	0.7	0.8	11.2	0.7	18.8	4.8	5.9	1.0	27.1	0.3	1.5	5.5	23.4	2.7	7.3	3.5	0.7	19.5	2.0	0.8	0.9	1.5	8.9	2.5	24.1	3.0	2.2	2.1	0.2	3.1	6.4	0.0	28.9	11.1	9.4	6.1	0.0	4.7	0.1	2.2	70.4	10.1	1.1	0.5	4.8	9.5	0.0	3.9	0.0	0.0	0.0	0.1	0.0	0.5	3.7	0.0	10.8	19.8	4.3	0.7	0.0	0.0	0.4	12.1	0.0	0.9	0.1	1.4	0.3	4.0	7.8	14.8	0.0	3.3	0.4	3.2	0.6	0.0	0.0	0.0	9.7	0.1	0.6	9.8	8.8	0.3	0.0	3.1	1.6	0.0	0.0	1.4	1.7	1.4	0.0	8.3	0.0	0.0	9.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	44.2	0.0	11.5	0.3	0.0	1.1	25.7	25.8	0.0	28.0	30.6	11.0	1.5	19.8	0.7	2.7	19.5	24.1	10.3	3.2	2.8	39.5	3.6	1.3	0.0	0.2	1.2	79.1	0.5	5.8	743.1	2.8	0.6	35.0	4.2	0.5	0.3	0.0	0.0	0.0	1.1	2.3	52.8	15.1	0.0	3.0	1267.5	0.0	1.6	26.6	1.5	3.0	0.0	0.2	12.1	0.3	29.3	0.0	631.3	2.5	0.0	78.0	26.7	1.4	0.0	88.8	1.8	574.3	42.7	32.0	1.0	753.0	20.5	0.1	3.8	8.2	0.7	0.2	24.7	0.5	0.0	7.2	13.1	1.4	46.6	0.2	1.2	0.5	3.1	1.1	1.2	0.7	2.5	0.1
SLC8A2	"KIAA1087, NCX2"	ENSG00000118160	"Solute carrier family 8 member A2"	Q9UPR5	19	47428017-47471893	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"brain: 38.3"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 14.6;Excitatory neurons: 40.3;Inhibitory neurons: 13.6;Oligodendrocytes: 6.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"NTERA-2: 3.0;SCLC-21H: 8.9;SH-SY5Y: 4.4;SiHa: 3.9;U-2 OS: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA050818, HPA054671"	Enhanced					NA	NA				"Cluster 6: Brain - Smell perception"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA050818: AB_2681248, HPA054671: AB_2682568"	"unprognostic (3.75e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.32e-2)"	"unprognostic (1.34e-1)"	"unprognostic (6.00e-3)"	"unprognostic (1.38e-1)"	"unprognostic (2.79e-1)"	"unprognostic (1.34e-1)"	"unprognostic (8.95e-2)"	"unprognostic (4.77e-2)"	"unprognostic (2.04e-2)"	"unprognostic (2.81e-3)"	"unprognostic (6.13e-2)"	"unprognostic (9.40e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.63e-2)"	0.3	2.6	16.9	0.1	22.5	0.0	0.1	31.6	34.0	0.8	0.0	5.9	0.2	6.5	0.1	1.1	1.9	0.1	0.1	38.3	7.6	0.0	0.1	0.1	0.0	0.0	0.0	0.1	7.7	0.0	7.8	0.0	0.0	0.8	0.3	3.4	0.2	2.5	0.2	0.1	0.8	3.5	0.0	0.0	1.3	1.5	2.5	0.1	0.1	0.0	0.0	2.0	0.5	13.3	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.1	3.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	8.9	4.4	3.9	0.4	0.3	0.2	0.1	0.0	0.0	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	16.9	22.5	31.6	34.0	38.3	7.6	0.0	0.0	0.0	0.0	2.5	13.3	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	14.6	0.6	0.3	1.8	0.0	0.0	0.0	2.1	0.0	0.0	0.2	0.0	0.3	2.1	0.3	0.1	0.2	1.8	0.0	40.3	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	13.6	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.4	0.0	5.0	6.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.2	0.0	0.5	0.4	1.3	1.8	0.0	0.0	0.1	0.0	0.0	0.0	0.1
SLC8A3	NCX3	ENSG00000100678	"Solute carrier family 8 member A3"	P57103	14	70044215-70189070	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sodium transport, Transport"	Calmodulin-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"brain: 10.8;retina: 9.6;skeletal muscle: 20.6;tongue: 9.4"	"Group enriched"	"Detected in some"	9	"Bipolar cells: 32.8;Excitatory neurons: 80.5;Inhibitory neurons: 129.4;Oligodendrocyte precursor cells: 107.1"	"Cancer enriched"	"Detected in single"	8	"glioma: 1.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 4.2;LHCN-M2: 7.9;SH-SY5Y: 24.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA				"Cluster 80: Striated muscle - Unknown function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.65e-1)"	"unprognostic (5.53e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.69e-1)"	"unprognostic (3.46e-3)"	"unprognostic (4.74e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.45e-3)"	"unprognostic (8.53e-2)"	"unprognostic (5.86e-2)"	"unprognostic (1.14e-3)"	"unprognostic (1.48e-1)"	"unprognostic (1.48e-1)"	"unprognostic (3.38e-1)"	0.3	1.2	7.1	0.3	6.0	0.3	0.2	1.7	6.6	0.4	0.0	0.3	0.3	0.2	0.2	0.3	0.1	0.4	0.6	5.3	7.7	0.1	0.1	0.6	0.2	6.1	7.6	0.0	0.2	0.7	0.9	0.1	7.1	0.3	0.2	9.6	0.3	0.1	20.6	0.3	0.4	0.3	5.4	0.1	0.3	0.1	10.8	0.2	0.0	9.4	0.2	1.2	0.2	4.7	0.0	0.0	4.2	0.0	0.0	0.0	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	0.1	24.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.1	6.0	1.7	6.6	5.3	7.7	6.1	7.6	7.1	5.4	10.8	4.7	0.0	0.0	0.6	2.9	0.0	0.1	0.0	0.0	0.0	32.8	0.0	0.0	1.4	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	80.5	0.0	0.4	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.1	8.4	129.4	0.5	0.0	0.0	0.3	0.1	0.0	0.0	0.0	4.7	0.0	0.8	0.0	107.1	8.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	1.2	0.0	1.8	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0
SLC8B1	"FLJ22233, NCKX6, NCLX, SLC24A6"	ENSG00000089060	"Solute carrier family 8 member B1"	Q6J4K2	12	113298759-113359493	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Calcium transport, Ion transport, Sensory transduction, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 75.4"	"Cell type enhanced"	"Detected in many"		"Theca cells: 96.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 54.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040668	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 52: Non-specific - Transcription"			"HPA040668: AB_10793861"	"prognostic favorable (9.52e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.30e-1)"	"unprognostic (1.93e-2)"	"unprognostic (2.80e-3)"	"unprognostic (1.90e-1)"	"unprognostic (6.52e-2)"	"unprognostic (1.84e-1)"	"unprognostic (2.68e-2)"	"unprognostic (2.60e-1)"	"unprognostic (5.14e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.54e-3)"	"unprognostic (9.39e-2)"	"unprognostic (1.14e-1)"	"prognostic favorable (5.02e-4)"	18.5	75.4	7.6	14.8	10.3	17.7	15.1	8.6	8.6	19.3	4.4	15.6	10.6	11.9	7.9	15.8	13.1	11.3	11.0	7.5	8.0	17.2	17.6	20.6	13.8	14.2	9.5	55.5	18.1	7.5	15.3	8.1	10.6	16.9	9.3	1.4	16.9	9.1	10.0	19.4	16.9	6.9	9.3	29.4	12.1	13.6	11.6	18.0	13.1	5.6	9.9	12.7	15.2	11.2	25.3	5.5	3.2	7.0	15.5	10.9	10.6	8.3	23.8	10.6	10.3	5.4	21.1	6.6	18.5	10.8	9.2	20.1	9.8	5.7	5.1	16.3	3.1	13.3	13.1	6.2	25.8	33.9	28.7	11.1	16.9	12.2	5.2	9.1	24.5	24.0	27.7	3.3	6.0	5.9	10.6	27.5	5.7	8.2	14.2	3.9	4.2	8.3	11.4	34.7	0.2	5.4	22.5	45.1	5.4	4.2	8.0	13.1	54.3	7.5	8.8	22.4	5.0	4.5	10.3	5.0	9.6	19.2	6.0	4.1	16.5	32.8	8.0	24.1	10.2	3.3	14.5	7.9	19.1	4.4	28.8	13.5	10.3	6.1	24.8	14.3	19.4	15.8	7.6	10.3	8.6	8.6	7.5	8.0	14.2	9.5	10.6	9.3	11.6	11.2	9.3	12.8	12.6	13.7	5.8	4.5	13.2	8.0	4.6	2.4	8.4	6.5	4.3	8.6	10.9	12.9	10.4	7.8	9.2	30.6	5.9	13.0	1.5	6.0	9.4	9.6	4.9	1.7	7.7	17.4	8.6	13.6	14.3	15.5	21.5	32.4	6.4	12.0	21.6	0.0	3.9	13.3	4.1	21.8	22.6	1.5	24.5	32.4	1.8	22.5	17.8	2.8	5.2	4.0	6.2	22.5	20.7	28.2	3.3	19.1	23.6	3.3	4.5	0.8	32.9	9.9	13.3	1.0	3.9	12.2	7.1	10.7	9.8	96.7	13.3	21.3
SLC9A1	"APNH, NHE1, PPP1R143"	ENSG00000090020	"Solute carrier family 9 member A1"	P19634	1	27098809-27166981	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"	Calmodulin-binding	"Deafness, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"salivary gland: 76.5;stomach 1: 65.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 81.5;Gastric mucus-secreting cells: 160.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB022371, HPA048532, HPA052891"	Enhanced		Supported	"Plasma membrane"		NA	NA		21000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981"	"unprognostic (6.18e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.21e-1)"	"unprognostic (8.48e-2)"	"prognostic unfavorable (7.47e-4)"	"unprognostic (2.70e-2)"	"unprognostic (4.33e-3)"	"unprognostic (3.18e-2)"	"unprognostic (9.74e-2)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (3.44e-2)"	"unprognostic (6.95e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.60e-1)"	"unprognostic (3.34e-1)"	"unprognostic (1.16e-2)"	9.6	10.7	6.1	10.4	14.7	11.5	9.0	2.8	10.8	10.9	0.2	18.6	29.3	10.9	8.0	11.0	7.6	16.9	13.7	2.3	5.3	5.8	2.4	13.2	7.0	13.8	4.7	7.0	8.6	20.7	8.2	21.9	11.2	9.0	13.6	4.5	76.5	19.4	4.6	10.5	19.0	10.7	0.5	11.6	65.9	10.1	10.4	6.3	9.5	4.9	6.7	15.1	9.2	2.4	32.3	10.7	9.9	10.1	21.8	15.7	60.8	25.9	38.5	21.7	23.5	13.0	20.0	14.4	21.9	33.4	10.5	38.9	9.8	62.4	13.4	17.4	9.4	21.9	7.1	5.5	66.1	13.1	16.0	19.7	29.5	36.5	50.7	15.8	36.3	9.8	6.3	13.4	32.3	18.7	6.8	6.4	14.0	38.2	21.9	11.8	9.0	6.7	10.9	46.3	11.4	3.7	21.5	28.4	12.6	10.0	13.3	7.9	39.9	23.0	9.4	21.7	14.5	12.6	8.6	4.3	24.6	14.1	13.5	0.0	0.6	0.6	0.7	0.3	1.5	0.1	0.8	0.7	0.2	0.3	0.5	0.6	2.0	0.1	0.6	0.0	0.3	0.8	6.1	14.7	2.8	10.8	2.3	5.3	13.8	4.7	11.2	0.5	10.4	2.4	13.5	6.4	14.8	6.5	7.9	31.2	17.9	14.6	13.1	7.4	21.7	23.2	13.5	7.2	8.3	11.0	0.0	40.3	11.9	81.5	0.0	9.1	26.5	13.8	15.9	9.7	12.5	0.4	14.1	12.5	19.4	12.7	160.0	26.5	27.3	7.5	6.8	1.2	12.9	20.2	14.1	15.0	4.1	5.7	5.1	14.4	9.3	12.7	7.2	8.4	4.3	8.2	12.3	4.0	4.6	28.1	43.1	13.2	4.8	9.6	38.9	1.2	5.9	3.8	6.6	20.8	9.8	3.6	4.4	15.0	25.1	52.9	9.8	4.8	18.3	18.3
SLC9A2	NHE2	ENSG00000115616	"Solute carrier family 9 member A2"	Q9UBY0	2	102619553-102711355	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 20.7;stomach 1: 26.4"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 41.3;Early spermatids: 46.5;Gastric mucus-secreting cells: 41.8;Intestinal goblet cells: 23.4;Late spermatids: 31.4;Paneth cells: 38.7;Undifferentiated cells: 29.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 10.0;OE19: 37.3;RT4: 16.9;SK-BR-3: 14.7;T-47d: 18.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"HPA035121, HPA035122"	Approved		Supported	"Cell Junctions"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Cell Junctions"		"HPA035121: AB_10602894, HPA035122: AB_2674477"	"unprognostic (1.53e-2)"	"unprognostic (8.05e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.00e-3)"	"unprognostic (3.12e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.12e-1)"	"unprognostic (1.86e-1)"	"unprognostic (1.55e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.37e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.60e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.39e-2)"	"unprognostic (1.70e-1)"	0.0	0.1	1.4	2.1	0.7	0.0	1.4	0.8	1.5	1.4	0.2	20.0	6.3	0.1	3.9	0.3	0.3	1.1	0.0	1.9	0.9	5.4	0.0	0.1	0.1	1.4	0.7	0.0	0.0	5.8	1.0	0.0	1.5	5.8	20.7	0.1	4.9	2.1	6.4	0.8	3.4	0.7	0.8	0.0	26.4	5.7	1.2	0.4	1.0	6.2	4.5	1.0	0.0	0.5	10.0	6.1	0.0	1.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	6.7	0.2	0.0	3.4	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.3	3.4	2.9	0.0	0.0	0.5	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	7.7	0.0	0.1	0.2	37.3	5.0	0.0	0.1	0.0	1.1	16.9	0.1	0.0	0.0	14.7	0.0	0.0	18.5	0.0	0.0	0.0	0.7	0.0	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.8	1.5	1.9	0.9	1.4	0.7	1.5	0.8	1.2	0.5	0.0	0.0	0.0	2.0	0.3	0.4	0.2	0.1	0.0	0.0	1.1	0.1	0.8	0.0	0.3	9.2	0.0	0.5	0.0	41.3	0.0	0.2	46.5	0.5	0.2	0.3	9.7	0.0	3.0	0.0	0.0	0.0	41.8	3.1	0.0	0.0	0.0	0.0	0.1	0.0	14.6	23.4	6.1	0.0	0.4	31.4	0.6	0.0	0.0	5.6	0.0	0.5	0.0	1.0	1.0	8.5	38.7	0.0	0.2	4.1	3.2	1.4	0.1	0.1	0.0	0.5	0.1	4.5	0.2	0.0	0.6	0.3	0.2	0.0	29.6	0.8
SLC9A3	NHE3	ENSG00000066230	"Solute carrier family 9 member A3"	P48764	5	470456-524449	"Disease related genes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 45.4;intestine: 94.3;kidney: 62.5;stomach 1: 50.1"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 16.0;Collecting duct cells: 16.5;Proximal tubular cells: 40.7"	"Cancer enhanced"	"Detected in many"		"stomach cancer: 14.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 37.8"	"Region enriched"	"Detected in single"	14	"cerebellum: 4.1"	"Low region specificity"	"Detected in many"			"HPA036493, HPA036669"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"		"HPA036493: AB_10673353, HPA036669: AB_10670843"	"unprognostic (1.27e-1)"	"unprognostic (4.88e-1)"	"unprognostic (9.35e-3)"	"unprognostic (1.11e-1)"	"unprognostic (2.37e-1)"	"unprognostic (3.35e-1)"	"unprognostic (2.51e-1)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (8.49e-4)"	"unprognostic (5.18e-2)"	"unprognostic (1.29e-1)"	"unprognostic (3.69e-2)"	"unprognostic (3.84e-1)"	"unprognostic (1.30e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.32e-1)"	2.9	4.4	3.0	10.4	2.5	1.9	3.1	6.1	5.0	3.8	1.7	94.3	46.0	2.9	4.0	8.7	4.9	45.4	3.2	4.7	2.5	62.5	2.4	2.8	3.8	3.8	2.3	4.3	6.7	6.2	0.7	2.1	3.7	7.3	10.8	1.7	9.9	3.8	6.2	19.0	68.1	3.3	1.3	3.7	50.1	5.8	3.4	3.5	4.9	3.9	3.4	2.5	2.5	2.6	6.7	5.1	10.4	10.5	2.5	3.0	7.8	5.3	3.9	8.0	5.0	11.0	7.4	14.0	7.5	3.0	5.5	10.0	6.1	4.0	3.9	37.8	10.7	6.7	23.4	5.4	3.9	5.5	8.2	4.2	8.1	3.5	5.4	3.9	2.4	6.3	9.6	7.5	2.9	9.0	6.0	24.3	4.0	17.8	8.3	8.6	9.3	8.3	2.8	4.8	11.5	5.0	19.0	5.3	4.2	4.5	12.3	4.2	2.9	8.0	7.2	5.3	3.9	12.4	5.8	8.5	5.2	21.2	5.6	0.0	0.7	0.1	2.6	0.3	2.2	0.9	3.3	2.4	0.9	1.0	3.9	3.1	0.1	2.4	0.2	1.2	2.7	1.8	3.0	2.5	6.1	5.0	4.7	2.5	3.8	2.3	3.7	1.3	3.4	2.6	3.8	16.0	5.8	0.0	1.5	0.0	0.0	0.0	0.0	0.0	7.3	8.9	0.7	0.0	5.6	16.5	0.0	0.0	3.4	0.7	5.9	9.0	0.0	3.8	3.6	2.3	0.0	0.0	0.3	8.8	0.0	2.2	0.0	2.6	2.5	5.3	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	4.6	0.0	0.0	0.0	0.1	7.7	0.0	0.0	0.7	0.0	1.1	40.7	2.9	0.0	0.0	0.0	2.4	0.0	0.0	0.0	0.0	0.0	2.3	5.4	0.0	0.0
SLC9A3R1	"EBP50, NHERF, NHERF1"	ENSG00000109062	"SLC9A3 regulator 1"	O14745	17	74748628-74769353	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Wnt signaling pathway"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"esophagus: 352.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 295.8;Proximal enterocytes: 536.9;Proximal tubular cells: 433.0;Squamous epithelial cells: 303.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"MCF7: 572.4;SK-BR-3: 450.7;T-47d: 873.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB001962, HPA009672, HPA027247"	Enhanced		Approved	"Vesicles,Plasma membrane,Centriolar satellite"		NA	Yes		940000	"Cluster 2: Granulocytes - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 6: T47d - Mammary gland"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	"Vesicles, Centriolar satellite"	"CAB001962: , HPA009672: AB_1857215, HPA027247: AB_10601162"	"unprognostic (1.29e-1)"	"unprognostic (4.58e-2)"	"unprognostic (1.73e-2)"	"unprognostic (5.51e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.73e-1)"	"prognostic unfavorable (9.83e-5)"	"unprognostic (7.41e-2)"	"unprognostic (5.61e-2)"	"unprognostic (5.38e-2)"	"unprognostic (7.53e-2)"	"unprognostic (4.49e-2)"	"unprognostic (1.56e-3)"	"unprognostic (7.81e-3)"	"unprognostic (5.53e-2)"	"unprognostic (3.84e-2)"	"unprognostic (2.08e-2)"	27.0	146.3	98.9	43.7	103.0	115.7	64.1	105.6	118.1	58.3	127.5	85.1	257.8	22.6	26.0	352.8	89.7	96.6	24.3	98.3	91.0	203.5	269.2	26.5	67.9	100.2	97.6	11.1	85.4	110.3	20.8	33.6	95.6	43.9	59.3	13.0	192.2	71.1	5.2	51.1	274.4	11.6	92.2	61.1	78.2	22.5	102.0	57.7	21.4	10.0	89.2	25.7	103.3	106.1	102.1	82.6	40.4	42.1	23.9	17.5	179.9	24.1	22.4	60.3	58.2	259.6	59.6	22.2	23.9	51.4	32.3	142.2	69.8	46.4	28.3	25.9	66.2	167.4	210.9	350.8	48.6	110.3	108.9	14.4	25.6	48.0	20.6	124.9	50.2	65.8	54.0	115.9	93.8	572.4	262.5	246.7	36.1	286.3	47.6	28.0	45.4	100.6	83.5	71.7	34.6	45.3	25.2	450.7	51.9	110.4	873.8	87.3	17.0	18.7	53.5	43.8	40.2	200.0	98.9	40.9	30.2	145.4	11.2	581.6	91.9	440.8	421.5	133.0	279.8	58.6	255.5	360.4	87.8	52.1	147.5	266.1	318.8	308.8	172.1	90.8	309.0	345.9	98.9	103.0	105.6	118.1	98.3	91.0	100.2	97.6	95.6	92.2	102.0	106.1	12.3	6.4	17.2	29.0	41.8	46.1	21.4	128.7	50.1	2.2	135.3	78.7	17.8	163.0	120.8	31.3	4.2	74.5	122.9	295.8	66.5	194.9	15.8	61.8	7.8	12.0	18.7	24.8	0.4	99.0	56.6	24.7	45.3	85.0	25.3	7.3	7.9	190.6	85.4	5.0	0.5	58.0	105.8	25.7	18.8	9.9	8.7	43.5	28.4	3.7	27.0	86.2	203.9	5.0	11.4	76.5	143.8	41.8	151.1	27.5	536.9	433.0	76.0	5.0	6.6	27.6	20.0	22.5	19.5	303.4	57.4	111.5	126.1	17.1	57.1	34.6
SLC9A3R2	"E3KARP, NHERF-2, SIP-1, TKA-1"	ENSG00000065054	"SLC9A3 regulator 2"	Q15599	16	2025356-2039026	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 568.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 1013.8;Endothelial cells: 398.9;Hepatic stellate cells: 374.4;Hepatocytes: 227.4;Pancreatic endocrine cells: 326.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.2;intermediate monocyte: 1.6;myeloid DC: 3.9;plasmacytoid DC: 2.9"	"Group enriched"	"Detected in many"	5	"dendritic cells: 3.9;monocytes: 2.2"	"Cell line enhanced"	"Detected in many"		"A549: 188.6;MCF7: 306.8;PC-3: 281.2;SK-BR-3: 188.3;U-251 MG: 193.6;WM-115: 202.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001672, HPA066520"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"		"HPA001672: AB_1080017, HPA066520: AB_2732748"	"unprognostic (6.99e-2)"	"unprognostic (4.56e-2)"	"unprognostic (2.06e-2)"	"prognostic favorable (1.03e-4)"	"unprognostic (1.41e-2)"	"unprognostic (1.54e-1)"	"unprognostic (2.94e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.70e-2)"	"unprognostic (2.20e-2)"	"unprognostic (6.20e-3)"	"unprognostic (9.10e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.80e-2)"	234.7	81.7	107.0	20.7	98.6	0.7	181.7	83.4	119.7	92.6	60.6	77.4	27.2	92.7	10.7	47.3	77.7	34.8	568.2	82.4	88.5	207.5	408.3	289.1	22.0	96.4	95.5	57.9	47.7	24.0	95.6	51.3	99.3	129.1	11.9	3.0	149.1	42.4	144.6	45.3	81.2	18.8	87.0	143.8	109.5	36.3	116.2	7.9	188.4	109.0	7.4	77.4	72.6	94.7	32.5	188.6	5.0	38.6	6.2	8.6	5.7	138.1	81.9	67.9	22.5	25.4	41.9	0.1	63.4	59.2	9.1	30.9	15.0	13.7	7.1	0.4	45.0	3.1	80.8	61.6	44.3	0.5	13.9	9.2	13.7	20.2	5.9	32.1	68.2	15.0	24.0	2.9	4.8	306.8	0.6	35.7	7.5	76.8	281.2	27.6	8.1	50.5	16.0	2.9	35.3	33.1	9.7	188.3	12.8	5.0	152.6	16.8	176.4	21.5	30.7	1.9	193.6	5.1	4.6	0.7	2.5	3.6	202.4	0.0	2.2	0.0	0.5	1.6	0.2	0.0	0.1	0.1	3.9	0.0	0.4	0.5	0.0	0.0	0.5	2.9	0.1	0.7	107.0	98.6	83.4	119.7	82.4	88.5	96.4	95.5	99.3	87.0	116.2	94.7	1013.8	3.2	10.5	4.2	7.3	15.2	19.6	17.1	7.4	2.6	79.5	65.0	25.5	88.6	47.3	12.9	0.0	1.0	11.4	13.3	5.9	36.1	16.1	37.2	36.8	398.9	21.5	17.3	3.4	8.8	0.8	53.5	33.6	67.8	0.0	5.1	374.4	227.4	2.6	3.3	5.5	77.0	22.4	30.9	35.1	35.8	82.0	7.0	33.8	31.9	2.2	17.2	7.2	4.0	3.6	326.8	9.3	44.4	4.9	51.8	1.2	14.7	27.3	5.0	26.3	22.3	69.1	7.0	15.4	3.4	11.4	1.0	8.8	9.5	18.0	66.6
SLC9A4	NHE4	ENSG00000180251	"Solute carrier family 9 member A4"	Q6AI14	2	102473226-102533972	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"stomach 1: 53.8"	"Group enriched"	"Detected in some"	12	"Collecting duct cells: 25.8;Gastric mucus-secreting cells: 54.0"	"Cancer enhanced"	"Detected in some"		"urothelial cancer: 2.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 2.3;OE19: 6.8;RT4: 4.1"	"Group enriched"	"Detected in some"	18	"hippocampal formation: 10.6;olfactory bulb: 6.8"	"Low region specificity"	"Detected in single"			HPA036096	Supported		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Plasma membrane"		"HPA036096: AB_2674939"	"unprognostic (1.41e-1)"	"unprognostic (3.76e-2)"	"unprognostic (9.31e-2)"	"unprognostic (3.09e-3)"	"unprognostic (7.58e-2)"	"unprognostic (1.46e-1)"		"unprognostic (7.17e-2)"	"unprognostic (5.35e-1)"	"unprognostic (9.44e-3)"	"unprognostic (3.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (2.46e-2)"	"unprognostic (3.12e-1)"	"unprognostic (5.04e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.98e-2)"	0.0	0.0	0.4	0.1	0.5	0.8	0.2	0.7	0.7	0.3	0.0	0.0	2.0	0.1	0.1	1.5	0.1	1.2	0.6	0.4	0.4	8.6	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.4	1.3	0.5	1.4	0.4	0.0	0.0	0.0	0.2	53.8	0.3	0.2	0.1	0.1	0.0	0.5	0.4	0.1	0.6	0.1	0.1	0.1	0.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.2	0.0	1.3	0.0	0.1	0.1	0.0	0.0	0.0	2.3	0.1	0.1	0.2	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.5	6.8	0.2	0.0	0.2	0.1	0.0	4.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.1	0.2	0.5	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.4	0.5	0.7	0.7	0.4	0.4	0.1	0.1	0.2	0.0	0.2	0.6	0.0	3.2	3.2	0.0	0.1	0.0	0.0	0.2	0.0	0.0	1.0	0.0	0.4	0.0	0.9	25.8	0.0	0.1	0.0	0.0	0.0	0.0	2.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	54.0	0.6	1.3	0.0	0.0	0.0	0.0	0.0	0.2	0.3	2.0	0.0	0.0	0.2	0.0	0.3	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	1.8	0.0	0.0	0.0	0.0	0.6	0.8	0.0	0.0	0.1	0.4	0.0	0.3	0.3
SLC9A5	NHE5	ENSG00000135740	"Solute carrier family 9 member A5"	Q14940	16	67237683-67272191	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 6.6;lymphoid tissue: 17.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 11.1;Horizontal cells: 16.8;Inhibitory neurons: 12.2;Oligodendrocyte precursor cells: 7.1;Spermatocytes: 17.2;Theca cells: 6.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"U-138 MG: 6.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA041004, HPA041329"	Uncertain		Uncertain	"Plasma membrane,Cytosol"		NA	NA				"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Plasma membrane"	"HPA041004: AB_10794433, HPA041329: AB_10794373"	"unprognostic (8.90e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.39e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.44e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.24e-2)"	"unprognostic (5.17e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.12e-1)"	"unprognostic (2.50e-3)"	"unprognostic (4.84e-2)"	"unprognostic (9.85e-11)"	"unprognostic (9.21e-2)"	"unprognostic (1.95e-1)"	"unprognostic (8.12e-3)"	"unprognostic (9.07e-2)"	0.9	0.6	4.2	0.3	6.6	0.1	1.0	5.4	6.5	0.8	2.5	0.5	0.4	0.4	1.0	0.2	0.5	0.6	1.6	4.6	3.9	0.8	0.2	1.4	0.8	4.8	4.1	1.2	0.6	0.1	0.8	0.6	5.3	0.9	0.3	1.2	0.8	0.3	1.8	1.5	0.5	0.1	3.4	17.4	0.5	3.2	4.2	0.1	0.8	0.7	0.4	0.4	0.5	4.0	0.3	2.9	2.6	0.9	4.7	3.2	0.3	1.1	4.1	2.4	2.2	0.1	2.0	0.0	0.6	1.2	1.2	0.1	0.6	0.4	1.0	0.8	0.8	2.1	0.5	0.7	0.5	1.0	4.7	3.8	1.0	1.5	0.2	4.5	1.0	0.9	0.5	1.3	1.6	1.7	0.0	0.2	1.5	0.2	0.2	0.0	0.5	0.7	0.4	0.5	1.6	0.9	2.4	0.1	1.2	0.6	1.1	0.2	0.8	6.4	0.9	1.1	0.4	2.4	0.5	1.3	4.5	0.5	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	4.2	6.6	5.4	6.5	4.6	3.9	4.8	4.1	5.3	3.4	4.2	4.0	0.6	3.2	2.8	4.2	0.4	0.6	0.2	0.1	1.2	3.4	1.8	1.3	1.5	1.5	0.2	0.0	0.0	0.3	0.1	0.5	0.0	0.3	1.8	0.2	0.8	0.8	1.2	0.0	11.1	0.2	0.1	0.7	0.0	0.9	0.0	0.9	1.4	0.0	0.1	16.8	12.2	0.3	0.0	0.0	0.4	0.7	0.3	0.5	0.0	1.9	0.6	0.3	0.0	7.1	2.6	0.5	0.1	2.2	0.0	0.5	0.2	0.0	0.7	0.9	0.0	0.6	1.4	17.2	4.6	0.3	0.9	0.0	0.3	6.8	0.3	0.2
SLC9A6	"KIAA0267, NHE6"	ENSG00000198689	"Solute carrier family 9 member A6"	Q92581	X	135973841-136047269	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 40.3;Horizontal cells: 48.8;Inhibitory neurons: 42.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA059445, HPA059590"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 18: U-2197 - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles		"HPA059445: AB_2684021, HPA059590: AB_2684075"	"unprognostic (1.35e-1)"	"unprognostic (8.28e-3)"	"unprognostic (4.36e-1)"	"unprognostic (4.93e-2)"	"unprognostic (1.84e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.60e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.72e-2)"	"unprognostic (7.43e-2)"	"unprognostic (1.29e-1)"	"unprognostic (7.07e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.75e-1)"	"unprognostic (4.49e-2)"	"unprognostic (5.06e-2)"	5.1	6.3	11.6	5.6	11.9	4.6	3.3	1.2	15.7	5.6	0.0	6.0	8.5	6.4	3.3	6.3	5.7	5.5	8.6	12.7	19.0	6.9	4.5	6.7	5.7	7.8	4.4	8.0	3.8	10.4	2.2	4.7	8.9	4.0	6.1	14.4	4.1	4.9	7.5	4.7	7.8	7.4	3.4	5.7	5.8	5.8	15.3	5.6	6.7	7.1	6.6	5.6	1.6	4.2	20.0	10.5	9.1	3.8	14.8	14.2	17.3	15.9	16.9	13.3	27.9	9.2	15.5	14.8	35.2	18.4	19.8	11.6	14.3	14.0	19.1	11.7	12.9	4.0	15.3	5.3	7.9	11.6	13.3	7.7	11.6	22.0	10.8	9.4	11.2	12.5	7.5	20.5	14.9	8.7	15.5	3.4	6.0	7.1	14.0	10.4	16.0	15.2	9.4	9.8	9.5	7.2	11.4	1.2	8.9	8.8	4.5	8.7	16.4	16.5	10.9	24.5	20.7	9.6	23.8	12.7	10.0	19.4	9.4	2.0	5.0	3.0	6.4	7.0	11.1	4.1	7.1	5.9	5.8	2.6	7.6	5.7	2.0	5.1	6.0	3.5	6.9	5.4	11.6	11.9	1.2	15.7	12.7	19.0	7.8	4.4	8.9	3.4	15.3	4.2	4.3	3.2	5.4	22.9	5.9	7.5	1.4	6.2	7.4	14.2	2.7	3.4	11.2	12.8	4.0	12.9	8.4	2.5	6.1	8.9	0.0	4.3	0.8	4.2	4.1	4.9	10.7	5.0	40.3	6.0	2.4	5.1	8.6	6.8	1.3	4.6	8.2	9.6	9.9	48.8	42.0	4.0	8.2	13.0	7.0	1.4	5.6	9.8	8.8	15.9	8.2	12.9	4.1	19.6	22.7	6.1	6.0	4.5	3.8	2.0	10.3	6.0	3.1	7.8	0.0	5.1	8.4	9.0	11.9	7.0	6.8	2.9	8.9	3.1	6.0	3.1
SLC9A7	NHE7	ENSG00000065923	"Solute carrier family 9 member A7"	Q96T83	X	46599251-46759118	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Potassium transport, Sodium transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"brain: 41.6"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 43.3;Inhibitory neurons: 66.8;Oligodendrocyte precursor cells: 69.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"plasmacytoid DC: 2.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048938, HPA075385"	Approved		Supported	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA048938: AB_2680565, HPA075385: AB_2686747"	"unprognostic (2.77e-1)"	"unprognostic (4.68e-2)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (8.58e-4)"	"prognostic unfavorable (8.14e-4)"	"unprognostic (2.16e-2)"	"unprognostic (2.73e-3)"	"unprognostic (5.26e-3)"	"unprognostic (1.28e-2)"	"unprognostic (9.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.08e-1)"	"unprognostic (7.20e-2)"	"unprognostic (2.62e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.13e-1)"	0.5	5.0	9.1	2.4	41.6	3.6	5.8	6.3	14.6	1.2	0.5	0.6	1.2	0.8	2.6	1.9	1.7	1.6	1.1	8.6	17.0	2.6	3.1	1.3	6.3	13.9	7.5	4.3	3.4	8.9	9.2	1.1	14.2	4.6	0.9	4.9	6.0	2.0	5.7	2.1	2.2	0.7	6.7	3.7	6.3	0.8	14.5	3.2	4.3	2.5	6.3	1.8	1.3	5.1	10.4	7.7	1.1	3.3	1.2	7.4	4.3	9.6	12.0	5.7	4.5	7.9	10.9	22.7	2.9	15.6	11.0	4.6	7.4	10.9	10.3	11.9	3.9	2.3	3.1	3.3	4.6	1.0	17.9	4.6	1.4	16.1	10.6	26.8	8.2	7.7	0.2	0.3	7.9	15.7	2.6	1.2	5.3	5.0	9.2	10.0	0.4	0.2	4.4	11.4	8.2	1.0	4.9	7.3	2.1	9.2	9.7	0.4	0.4	12.0	4.0	1.8	5.7	2.3	0.5	11.2	17.1	0.1	4.0	0.5	0.2	0.1	0.1	0.2	0.1	1.7	0.2	0.1	1.1	1.7	0.1	0.1	0.8	0.5	0.2	2.8	0.3	0.2	9.1	41.6	6.3	14.6	8.6	17.0	13.9	7.5	14.2	6.7	14.5	5.1	0.5	3.2	8.2	11.4	21.0	0.6	10.1	0.9	1.2	13.0	16.9	8.6	5.7	1.5	2.6	16.5	4.2	7.9	24.4	0.3	0.0	17.6	0.0	1.8	2.0	1.5	2.4	5.5	43.3	14.2	0.7	2.7	13.3	1.7	0.0	4.5	0.7	6.5	6.4	13.5	66.8	2.0	0.0	6.3	8.4	0.6	0.9	9.2	1.8	3.7	8.0	6.1	1.0	69.9	1.6	16.4	0.1	0.4	2.8	21.0	0.1	2.1	0.1	3.5	6.6	12.1	1.9	0.0	1.6	4.2	1.0	7.3	2.9	1.3	0.9	11.5
SLC9A8	"KIAA0939, NHE8"	ENSG00000197818	"Solute carrier family 9 member A8"	Q9Y2E8	20	49812713-49892242	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 35.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB033682	Approved					NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"CAB033682: AB_2270441"	"unprognostic (1.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (6.11e-2)"	"unprognostic (2.73e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (3.22e-1)"	"unprognostic (3.96e-2)"	"unprognostic (5.89e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.32e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.48e-2)"	"unprognostic (5.28e-2)"	5.3	6.8	3.9	7.0	3.7	20.3	4.5	3.0	3.4	4.4	2.0	5.4	5.7	4.2	3.9	8.6	4.8	4.8	3.8	3.5	4.5	3.9	6.4	5.5	6.7	5.4	4.4	3.9	5.6	5.5	5.0	3.7	4.0	5.0	5.0	4.0	6.5	4.2	11.4	4.2	5.7	3.3	4.1	8.1	7.6	6.7	5.0	6.8	6.5	4.8	5.8	5.4	4.4	3.9	5.7	10.3	4.5	4.5	5.6	3.5	11.4	5.8	7.8	10.8	5.1	7.3	12.7	6.8	7.3	8.3	8.9	12.5	4.8	5.9	5.5	6.0	2.7	3.4	7.1	3.8	7.8	6.1	8.0	6.7	6.6	5.7	11.5	5.6	4.7	8.9	6.7	6.9	6.7	6.3	5.6	4.1	3.7	8.6	4.8	4.1	5.3	4.9	6.4	6.1	4.5	3.9	9.6	35.3	7.0	3.0	11.5	9.8	7.1	14.7	8.1	7.2	5.7	10.5	4.9	4.9	20.1	8.0	6.2	1.9	0.6	1.6	0.9	0.4	0.9	0.7	0.7	0.8	0.6	0.8	0.7	0.4	2.9	0.4	0.7	0.3	0.5	0.7	3.9	3.7	3.0	3.4	3.5	4.5	5.4	4.4	4.0	4.1	5.0	3.9	6.3	12.8	8.8	24.5	9.9	2.5	4.4	9.2	4.0	5.7	5.7	5.0	4.9	7.2	14.8	3.7	14.6	6.1	10.6	17.9	1.9	7.1	2.7	12.3	6.5	5.4	6.7	9.3	13.8	6.4	4.1	5.1	19.4	18.7	22.2	7.0	8.6	15.5	5.1	6.7	20.0	7.0	6.1	9.2	4.1	8.4	3.7	11.8	1.8	19.7	5.8	5.7	5.2	15.1	25.3	9.4	9.0	4.9	8.0	5.2	7.6	3.4	21.5	9.6	0.0	5.9	5.2	8.9	6.7	10.2	1.8	3.4	9.8	4.7	7.3	9.4
SLC9A9	"FLJ35613, NHE9"	ENSG00000181804	"Solute carrier family 9 member A9"	Q8IVB4	3	143265222-143848485	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"		"Autism, Autism spectrum disorder"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Astrocytes: 149.8;Inhibitory neurons: 159.5;Microglial cells: 396.3;Oligodendrocyte precursor cells: 272.9;Oligodendrocytes: 431.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"ASC diff: 19.3;ASC TERT1: 24.9;HSkMC: 17.6;Karpas-707: 62.8;RPMI-8226: 30.4;U-266/70: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058234	Approved					NA	NA		280000	"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA058234: AB_2683648"	"unprognostic (8.22e-2)"	"unprognostic (6.88e-2)"	"unprognostic (7.23e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.65e-2)"	"unprognostic (7.05e-2)"	"unprognostic (1.24e-1)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.66e-1)"	"unprognostic (1.35e-3)"	"unprognostic (7.73e-2)"	"unprognostic (4.51e-2)"	"prognostic unfavorable (5.57e-7)"	"unprognostic (5.01e-2)"	"unprognostic (4.69e-2)"	"unprognostic (1.56e-1)"	"unprognostic (4.28e-2)"	12.8	5.1	9.7	8.8	14.4	2.0	5.3	12.5	11.3	6.9	6.9	7.3	3.0	4.2	3.7	12.8	6.8	9.6	5.4	9.9	16.3	2.3	7.1	5.9	14.7	20.4	13.5	7.9	1.0	3.0	3.4	15.9	19.5	8.8	5.8	1.3	4.5	8.5	2.1	7.7	7.0	8.0	14.4	13.1	5.0	1.8	13.8	15.5	3.5	5.0	13.5	11.4	7.7	18.2	0.5	0.5	0.8	1.0	19.3	24.9	0.3	1.0	6.6	0.5	3.1	0.0	0.2	3.0	0.2	2.9	1.5	0.7	0.9	1.9	0.8	12.8	0.2	1.6	0.4	0.0	2.2	0.8	1.3	17.6	5.2	0.7	0.9	1.1	0.3	2.3	0.0	62.8	4.2	0.0	1.5	0.0	0.2	0.0	0.5	2.6	0.1	30.4	0.0	0.5	0.4	0.0	1.5	0.0	0.0	0.4	0.2	0.6	0.0	2.4	0.6	2.8	1.4	29.1	0.1	0.1	4.3	0.4	1.2	0.2	6.2	0.7	4.7	10.6	4.0	3.3	4.9	7.5	8.4	3.7	2.7	4.0	0.5	4.2	9.0	0.6	9.3	4.8	9.7	14.4	12.5	11.3	9.9	16.3	20.4	13.5	19.5	14.4	13.8	18.2	4.5	0.0	1.1	149.8	13.2	3.7	10.4	8.7	22.8	0.2	0.6	1.3	1.5	0.0	3.4	3.7	2.1	0.5	10.4	0.0	0.0	1.0	4.8	0.8	10.1	4.4	0.0	9.9	25.6	0.2	0.5	26.5	7.1	0.8	0.0	0.7	21.8	0.0	55.4	0.0	159.5	0.0	6.1	30.5	9.9	4.4	9.3	31.0	7.2	396.3	24.3	2.8	13.4	272.9	431.8	0.8	0.1	7.2	10.9	11.1	0.0	0.4	1.6	0.1	0.0	18.0	7.0	0.3	0.4	23.9	5.1	1.1	19.7	3.7	0.1	3.9
SLC9B1	"NHA1, NHEDC1"	ENSG00000164037	"Solute carrier family 9 member B1"	Q4ZJI4	4	102885048-103019719	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Fertilization, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	10	"testis: 40.4"	"Group enriched"	"Detected in many"	4	"Early spermatids: 177.8;Late spermatids: 106.0;Spermatocytes: 224.8"	"Low cancer specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in some"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA058971, HPA065520"			Supported	"Centriolar satellite,Mitochondria"		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 66: Spermatocytes - Spermatogenesis"	Mitochondria	"Centriolar satellite"	"HPA058971: AB_2683865, HPA065520: AB_2685502"	"unprognostic (4.87e-3)"	"unprognostic (2.38e-1)"	"unprognostic (1.18e-1)"	"unprognostic (8.26e-4)"	"unprognostic (2.53e-1)"	"unprognostic (3.39e-1)"	"unprognostic (5.06e-4)"	"unprognostic (5.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.54e-1)"	"unprognostic (1.07e-3)"	"unprognostic (7.68e-2)"	"unprognostic (3.03e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.85e-1)"	"unprognostic (5.66e-5)"	"unprognostic (5.78e-2)"	1.0	0.8	1.7	0.6	2.6	0.6	0.5	2.0	2.1	0.4	0.0	0.4	0.7	1.3	2.1	0.3	0.6	1.5	0.8	1.2	1.8	0.5	0.2	0.5	1.0	2.5	2.3	1.4	1.2	0.7	0.5	0.8	2.9	0.9	0.7	1.7	0.2	0.7	0.2	1.8	0.5	0.6	2.5	0.9	0.4	40.4	2.3	1.1	1.0	0.0	1.0	0.8	0.2	4.1	0.1	0.0	0.9	1.5	1.9	1.4	0.3	0.3	0.4	0.0	0.1	0.0	0.1	0.7	0.2	0.8	0.3	0.0	0.7	0.4	0.6	1.5	0.9	1.2	1.0	0.0	0.0	0.4	0.2	0.2	0.4	0.0	0.8	0.4	0.5	2.0	0.5	0.8	0.7	0.6	0.4	1.0	0.4	0.2	0.0	1.3	0.8	0.2	0.4	0.2	0.9	2.3	0.2	0.3	1.1	0.6	0.2	0.8	0.3	0.4	0.1	0.5	0.5	2.5	1.9	0.7	0.5	0.4	1.0	0.2	0.2	0.0	0.4	0.1	0.5	0.5	0.3	0.6	0.2	0.5	1.5	0.9	0.1	0.1	0.1	0.6	0.6	0.2	1.7	2.6	2.0	2.1	1.2	1.8	2.5	2.3	2.9	2.5	2.3	4.1	1.3	3.2	1.5	26.1	3.4	1.3	0.5	1.8	1.8	1.8	1.0	0.6	0.9	1.5	0.4	0.0	16.7	0.6	1.1	0.2	1.9	0.3	177.8	0.8	1.1	1.7	0.0	0.4	6.0	0.4	0.4	2.3	0.0	0.6	0.0	1.9	1.4	0.2	1.3	3.3	8.3	0.1	6.1	3.9	3.1	106.0	5.3	1.3	1.8	4.7	1.5	2.5	1.0	24.1	40.5	1.1	0.0	3.0	1.8	0.9	0.4	0.9	0.2	5.0	0.0	6.4	1.8	224.8	9.5	0.7	0.6	0.5	2.9	2.0	0.3	0.6
SLC9B2	"FLJ23984, NHA2, NHEDC2"	ENSG00000164038	"Solute carrier family 9 member B2"	Q86UD5	4	103019868-103085829	"Predicted membrane proteins, Transporters"	"Antiport, Hydrogen ion transport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 38.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 57.9;Exocrine glandular cells: 68.5;Inhibitory neurons: 57.2;Pancreatic endocrine cells: 94.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 11.8"	"Group enriched"	"Detected in many"	5	"B-cells: 5.1;NK-cells: 11.8;T-cells: 6.4"	"Low cell line specificity"	"Detected in many"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA047008	Uncertain		Approved	"Nucleoplasm,Cell Junctions"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 15: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Nucleoplasm, Cell Junctions"		"HPA047008: AB_2679901"	"unprognostic (1.85e-1)"	"unprognostic (5.43e-2)"	"unprognostic (2.68e-1)"	"unprognostic (1.11e-1)"	"unprognostic (8.83e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.43e-2)"	"unprognostic (3.78e-2)"	"unprognostic (3.26e-1)"	"unprognostic (2.53e-2)"	"unprognostic (3.53e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.51e-5)"	"unprognostic (2.23e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.90e-2)"	"unprognostic (2.35e-5)"	7.8	6.0	11.2	5.2	11.7	4.6	5.7	10.9	12.8	6.2	3.2	6.2	1.1	6.8	2.3	3.4	5.6	7.6	6.2	12.5	11.1	2.5	38.7	3.6	5.9	11.4	9.1	6.7	2.4	0.3	8.5	3.9	12.7	4.1	2.7	12.8	2.4	5.0	3.0	3.0	3.7	7.7	7.0	3.6	4.9	3.6	10.0	3.6	2.9	3.5	5.6	6.5	4.9	11.2	4.9	2.1	5.2	10.5	26.0	20.7	0.0	22.0	7.8	3.2	3.0	2.5	3.0	29.3	3.7	24.3	5.1	1.4	12.2	9.3	4.8	24.7	7.5	30.2	7.5	21.8	13.5	22.5	8.8	18.7	10.8	7.7	27.3	11.1	15.3	8.3	10.1	22.1	10.7	1.7	15.3	10.8	4.4	0.1	6.4	0.0	6.0	12.2	9.0	2.4	17.5	14.9	10.0	2.3	6.0	1.4	2.6	13.4	17.6	7.5	4.3	11.6	6.9	16.8	14.2	21.7	8.7	17.5	3.0	0.0	0.1	0.0	4.9	0.0	6.4	5.1	5.1	4.1	0.9	3.0	3.1	3.8	0.0	11.8	0.1	1.6	2.4	1.8	11.2	11.7	10.9	12.8	12.5	11.1	11.4	9.1	12.7	7.0	10.0	11.2	13.9	0.0	0.5	15.0	15.6	4.8	3.4	2.0	6.2	9.7	3.1	2.8	2.5	8.6	1.1	0.0	27.1	0.5	6.5	0.2	0.0	14.1	12.1	1.1	8.6	17.8	3.0	17.2	57.9	68.5	2.3	13.2	22.4	0.9	1.3	10.3	6.1	39.5	1.4	8.4	57.2	1.1	4.1	1.3	5.3	6.9	5.6	3.4	10.6	5.6	3.9	0.7	0.0	32.6	17.6	94.7	0.3	5.3	12.0	4.9	0.0	1.4	1.1	2.3	6.6	16.5	11.5	5.8	4.2	5.6	3.8	0.3	7.9	4.8	0.3	1.3
SLC9C1	"NHE, SLC9A10"	ENSG00000172139	"Solute carrier family 9 member C1"	Q4G0N8	3	112140898-112294227	"Predicted membrane proteins, Transporters"	"Antiport, Differentiation, Ion transport, Sodium transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"skin 1: 2.1;testis: 8.1"	"Cell type enhanced"	"Detected in some"		"Adipocytes: 4.1;Early spermatids: 3.3;Excitatory neurons: 4.3;Oligodendrocyte precursor cells: 5.0;Oligodendrocytes: 5.1;Spermatocytes: 15.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 27: Brain & Skin - Unknown function"		"Cluster 66: Spermatocytes - Spermatogenesis"				"unprognostic (1.21e-2)"	"unprognostic (3.63e-1)"	"unprognostic (4.79e-2)"	"unprognostic (2.92e-1)"	"unprognostic (1.57e-3)"	"unprognostic (9.56e-2)"	"unprognostic (3.92e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.40e-2)"	"unprognostic (2.41e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.65e-2)"	"unprognostic (8.32e-2)"	"unprognostic (5.89e-2)"	"unprognostic (9.62e-3)"	"unprognostic (3.25e-1)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.1	8.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	0.0	0.0	1.3	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	3.3	1.0	0.1	2.5	0.0	0.0	4.3	0.0	0.3	0.2	1.1	0.6	0.0	0.2	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	1.6	0.0	0.0	0.0	2.8	0.0	0.0	0.0	5.0	5.1	0.1	0.1	0.0	0.3	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.1	15.2	0.4	0.0	0.0	0.4	0.0	0.4	0.1	0.1
SLC9C2	"MGC43026, SLC9A11"	ENSG00000162753	"Solute carrier family 9 member C2 (putative)"	Q5TAH2	1	173500460-173603072	"Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Sodium transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 1.3;choroid plexus: 1.9;testis: 6.0"	"Cell type enriched"	"Detected in some"	4	"Astrocytes: 27.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			"HPA059122, HPA079529"	Enhanced		Approved	"Nuclear speckles,Plasma membrane"		NA	NA				"Cluster 49: Ciliated cells - Cilium organization"		"Cluster 64: Astrocytes - Nervous system maintenance"	"Plasma membrane"	"Nuclear speckles"	"HPA059122: , HPA079529: "	"unprognostic (2.10e-1)"	"unprognostic (2.69e-1)"		"unprognostic (8.52e-2)"	"unprognostic (5.88e-3)"	"unprognostic (3.24e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.19e-1)"	"unprognostic (4.21e-2)"	"unprognostic (4.92e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.18e-6)"	"unprognostic (1.66e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.81e-1)"	0.0	0.0	0.4	0.0	0.5	0.0	0.0	0.2	0.2	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.5	0.3	0.0	0.0	0.0	0.0	1.3	1.2	0.2	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.2	0.1	6.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.5	0.2	0.2	0.5	0.3	1.3	1.2	0.8	0.8	0.4	0.6	0.0	0.0	0.0	27.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	1.6	0.0	1.3	0.0	6.2	0.1	1.3	0.1	0.0	0.1	6.2	1.7	0.1	0.4	0.0	0.0	5.0	0.0	0.5	0.3	0.0	0.1	0.0	0.5	0.4	1.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	4.7	0.0	0.7	0.0	1.5	0.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.1	0.1	0.0	0.1	0.1	5.4	0.4	0.0	0.0	0.1	0.0	1.3	0.0	0.0
SLCO1A2	"OATP, OATP-A, OATP1A2, SLC21A3"	ENSG00000084453	"Solute carrier organic anion transporter family member 1A2"	P46721	12	21264600-21419594	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 82.0;choroid plexus: 28.6"	"Cell type enriched"	"Detected in some"	4	"Oligodendrocytes: 487.6"	"Cancer enhanced"	"Detected in some"		"testis cancer: 2.5"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in single"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 16.7;RPMI-8226: 12.0;SuSa: 16.1;U-266/70: 23.1;U-266/84: 9.8"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA071152			Supported	"Plasma membrane"		No	No			"Cluster 1: Neutrophils - Mixed function"	"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Plasma membrane"		"HPA071152: AB_2686350"	"unprognostic (5.43e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.28e-1)"	"unprognostic (8.59e-2)"	"unprognostic (1.08e-1)"	"unprognostic (6.36e-2)"	"unprognostic (7.63e-2)"	"unprognostic (1.53e-1)"	"unprognostic (3.82e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.51e-1)"	"unprognostic (8.82e-2)"	"unprognostic (1.66e-4)"	"unprognostic (2.52e-2)"	"unprognostic (3.20e-1)"		"unprognostic (1.24e-1)"	0.0	0.1	48.9	0.1	65.9	0.1	4.0	43.5	80.2	0.0	28.6	0.1	0.0	0.1	0.2	0.1	0.3	0.2	0.9	41.3	46.4	1.2	11.5	2.8	0.7	54.0	51.9	0.2	2.4	0.2	0.4	1.2	52.6	0.7	0.0	0.6	15.8	0.0	0.4	0.5	0.1	0.0	45.2	0.5	0.3	1.9	48.3	0.6	0.2	0.0	0.4	0.2	0.0	82.0	2.1	0.6	0.8	0.1	0.0	0.0	3.4	0.0	0.0	0.1	0.0	3.8	1.4	0.1	2.1	0.2	0.0	0.3	0.3	0.2	0.5	0.7	0.9	0.0	0.5	1.5	0.0	0.4	0.3	0.0	1.7	0.2	0.2	1.5	0.1	0.4	4.0	1.2	0.0	2.6	0.4	0.1	16.7	2.0	0.2	0.2	0.2	12.0	0.0	2.2	1.9	2.9	0.0	0.2	0.2	16.1	3.2	0.9	0.0	0.1	1.7	0.8	0.4	23.1	9.8	0.2	0.1	0.3	0.0	0.2	0.1	0.1	0.4	0.1	0.6	0.4	0.6	0.4	0.0	0.2	0.6	0.4	1.3	0.3	0.0	0.2	0.5	0.1	48.9	65.9	43.5	80.2	41.3	46.4	54.0	51.9	52.6	45.2	48.3	82.0	0.0	35.3	3.1	5.9	0.0	0.0	0.0	0.0	0.0	0.2	3.5	2.8	0.5	0.0	0.0	1.8	0.0	0.2	0.0	0.0	0.0	0.0	5.0	0.0	0.0	2.8	0.0	0.0	0.7	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.1	0.0	0.8	0.0	0.0	0.0	0.0	4.5	0.0	0.1	0.0	102.1	0.0	0.1	0.0	2.5	487.6	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.1	0.4	1.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0
SLCO1B1	"LST-1, OATP-C, OATP1B1, SLC21A6"	ENSG00000134538	"Solute carrier organic anion transporter family member 1B1"	Q9Y6L6	12	21131194-21239796	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	614	"liver: 537.2"	"Cell type enriched"	"Detected in some"	9	"Hepatocytes: 83.1"	"Cancer enriched"	"Detected in some"	96	"liver cancer: 52.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HeLa: 1.1;NTERA-2: 1.3;RPMI-8226: 1.8;SuSa: 2.2"									"HPA050892, HPA073093"	Supported		Supported	"Plasma membrane"		NA	NA				"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA050892: AB_2681265, HPA073093: "			"unprognostic (5.45e-1)"			"unprognostic (1.82e-4)"	"unprognostic (2.43e-3)"	"unprognostic (1.96e-3)"		"unprognostic (1.80e-1)"	"unprognostic (2.41e-1)"	"unprognostic (8.82e-2)"		"unprognostic (5.63e-2)"	"unprognostic (3.86e-2)"		"unprognostic (3.49e-1)"	0.0	0.0	0.0	0.0	0.2	0.0	0.8	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	537.2	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.7	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.1	0.0	0.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.3	0.0	0.1	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.1	0.2	0.1	0.2	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	83.1	0.0	0.0	0.2	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	8.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.0
SLCO1B3	"OATP1B3, OATP8, SLC21A8"	ENSG00000111700	"Solute carrier organic anion transporter family member 1B3"	Q9NPD5	12	20810702-20916911	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	16	"liver: 265.1"	"Cell type enriched"	"Detected in some"	26	"Hepatocytes: 203.4"	"Cancer enriched"	"Detected in many"	4	"liver cancer: 5.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 65.3;A549: 17.5;CAPAN-2: 12.6;GAMG: 13.6;HeLa: 14.2;PC-3: 17.3;U-2 OS: 14.7"									"HPA004943, HPA050892"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 62: Liver - Hemostasis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"		"HPA004943: AB_1854758, HPA050892: AB_2681265"		"unprognostic (5.36e-2)"	"unprognostic (1.25e-1)"	"unprognostic (6.95e-2)"		"unprognostic (1.63e-2)"	"unprognostic (1.89e-2)"	"unprognostic (7.09e-2)"		"unprognostic (3.08e-2)"	"unprognostic (1.54e-2)"	"unprognostic (7.37e-2)"		"unprognostic (1.50e-1)"	"unprognostic (6.61e-3)"		"unprognostic (2.36e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	13.0	16.2	0.3	0.2	0.1	0.4	0.3	0.0	0.3	0.0	0.5	0.0	0.0	265.1	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.8	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.1	1.2	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	65.3	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	12.6	0.0	4.3	0.0	13.6	0.1	0.0	0.5	0.0	0.0	0.0	0.0	14.2	0.0	0.0	0.0	0.0	0.0	0.5	0.0	2.9	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	17.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	14.7	0.0	1.3	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.2	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	203.4	0.0	0.0	0.5	0.0	0.0	1.6	0.0	7.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.1	0.0	0.2	0.2
SLCO1C1	"OATP-F, OATP1, OATP1C1, SLC21A14"	ENSG00000139155	"Solute carrier organic anion transporter family member 1C1"	Q9NYB5	12	20695332-20753386	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"brain: 22.2;choroid plexus: 28.3;pituitary gland: 8.1"	"Cell type enriched"	"Detected in some"	12	"Astrocytes: 292.2"	"Cancer enriched"	"Detected in single"	17	"glioma: 4.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	15	"HeLa: 4.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 20: HeLa - Mitochondria"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (1.15e-1)"	"unprognostic (8.18e-4)"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (4.64e-1)"	"unprognostic (3.16e-2)"	"unprognostic (1.76e-1)"	"unprognostic (7.32e-2)"	"unprognostic (8.89e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.38e-2)"	"unprognostic (2.70e-2)"	"unprognostic (2.37e-4)"	"unprognostic (1.56e-3)"	"unprognostic (1.51e-1)"	"unprognostic (3.35e-1)"	"unprognostic (1.76e-2)"	1.6	0.1	14.1	0.1	19.6	0.0	0.4	12.9	22.2	0.0	28.3	0.2	0.1	0.0	0.2	0.1	0.0	0.7	0.5	16.4	13.5	0.1	0.0	0.1	0.2	12.8	13.9	0.0	0.1	0.2	8.1	0.0	12.9	0.1	0.2	2.8	0.1	0.0	0.0	0.2	0.3	0.1	12.4	0.0	0.1	1.5	16.6	0.1	0.7	0.5	0.2	0.2	0.0	14.5	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.6	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.1	19.6	12.9	22.2	16.4	13.5	12.8	13.9	12.9	12.4	16.6	14.5	2.4	0.0	0.0	292.2	0.0	0.1	0.0	0.0	0.0	1.4	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.1	9.5	0.0	0.1	1.0	0.0	0.0	0.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	2.8	0.1	0.0	0.0	0.0	13.4	1.8	0.0	0.0	23.4	0.1	4.8	0.0	3.5	0.5	0.0	0.0	0.4	0.0	0.0	0.4	0.0	0.0	0.2	0.0	1.0	5.3	0.5	0.2	0.0	0.0	0.0	0.0	1.2	0.4	0.0
SLCO2A1	"MATR1, OATP2A1, PGT, SLC21A2"	ENSG00000174640	"Solute carrier organic anion transporter family member 2A1"	Q92959	3	133932701-134052184	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 123.7"	"Group enriched"	"Detected in many"	4	"Distal enterocytes: 47.1;Endothelial cells: 65.2;Hepatic stellate cells: 146.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"EFO-21: 90.6"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			HPA013742	Enhanced					NA	NA				"Cluster 1: Thyroid gland - Transcription"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA013742: AB_2668877"	"unprognostic (4.39e-3)"	"unprognostic (2.84e-1)"	"unprognostic (1.33e-1)"	"prognostic favorable (9.69e-4)"	"unprognostic (8.53e-2)"	"unprognostic (2.32e-3)"	"prognostic favorable (9.24e-5)"	"unprognostic (1.92e-1)"	"unprognostic (1.29e-1)"	"unprognostic (7.60e-2)"	"unprognostic (2.04e-2)"	"unprognostic (6.87e-2)"	"unprognostic (5.63e-3)"	"prognostic unfavorable (3.25e-4)"	"unprognostic (2.78e-1)"	"unprognostic (1.45e-1)"	"unprognostic (3.07e-2)"	30.4	42.5	1.6	16.8	1.6	0.0	18.1	1.3	2.7	30.9	9.1	24.7	10.2	46.3	6.1	18.8	28.3	18.8	26.4	1.5	1.6	52.8	2.4	123.7	9.2	2.0	1.6	5.2	20.8	28.7	15.8	23.4	2.2	36.5	18.0	0.0	20.8	84.7	2.1	13.5	29.3	33.5	1.9	24.2	23.6	1.3	2.3	8.4	89.3	3.4	9.6	21.3	20.3	1.7	0.0	0.0	0.0	0.0	0.0	0.4	0.0	3.5	4.3	0.5	0.0	0.1	0.1	0.0	90.6	0.9	0.0	11.2	0.1	0.0	0.1	0.1	0.1	0.0	5.8	0.0	2.4	0.0	0.0	3.4	0.2	0.0	0.2	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.7	0.6	6.0	0.0	0.0	0.0	0.0	8.7	0.0	0.1	0.0	4.6	1.5	0.0	3.7	0.1	0.0	22.1	0.0	4.5	0.1	0.4	0.0	0.0	0.1	0.0	2.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.6	1.6	1.3	2.7	1.5	1.6	2.0	1.6	2.2	1.9	2.3	1.7	19.8	0.0	2.5	0.0	2.1	5.1	9.1	0.5	8.6	0.0	0.8	3.9	4.6	1.5	1.6	3.7	0.0	1.5	0.0	47.1	0.0	2.8	1.0	0.9	0.2	65.2	1.2	0.0	8.1	3.3	4.0	8.7	18.8	1.6	1.3	0.1	146.7	0.6	0.2	0.0	1.7	4.1	0.0	2.2	0.4	0.8	0.3	0.7	0.0	2.8	0.0	0.0	0.0	0.0	0.1	14.0	15.8	0.0	0.0	1.5	3.2	2.1	0.8	0.0	0.0	0.4	1.1	0.4	0.2	2.0	1.7	0.8	1.1	0.1	0.6	2.2
SLCO2B1	"OATP-B, OATP2B1, SLC21A9"	ENSG00000137491	"Solute carrier organic anion transporter family member 2B1"	O94956	11	75100563-75206549	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 229.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 204.5;Hofbauer cells: 122.2;Kupffer cells: 155.8;Macrophages: 92.4;Microglial cells: 232.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 90.3;GAMG: 21.2;Hep G2: 20.4;HMC-1: 25.8;OE19: 111.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020659	Uncertain					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 21: OE19 - Mitochondria"	"Cluster 4: Macrophages - Innate immune response"			"HPA020659: AB_1857219"	"unprognostic (8.25e-2)"	"unprognostic (5.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.57e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.58e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (2.00e-3)"	"unprognostic (1.99e-1)"	"unprognostic (2.09e-1)"	"unprognostic (9.75e-3)"	"unprognostic (2.54e-2)"	"unprognostic (4.57e-3)"	"unprognostic (1.04e-1)"	"unprognostic (3.87e-2)"	39.9	31.5	40.1	34.0	35.9	2.9	12.1	34.0	37.4	18.1	21.3	30.9	42.1	9.5	3.6	19.7	13.2	28.4	15.6	31.9	47.2	21.0	229.6	60.7	60.1	75.7	53.4	9.4	22.1	7.9	5.1	43.9	63.0	6.1	23.6	1.5	8.4	9.6	5.6	4.3	51.3	26.3	49.7	46.4	15.0	6.0	80.4	16.7	10.1	8.0	28.5	26.3	6.2	55.1	0.0	0.7	2.8	0.0	0.0	0.0	1.4	0.0	0.0	0.1	0.0	90.3	0.0	0.1	0.1	0.0	21.2	0.2	0.0	0.0	0.0	1.1	0.0	15.0	1.0	20.4	0.0	1.1	25.8	0.0	0.0	0.5	0.0	0.0	0.0	0.0	8.3	8.7	0.0	0.1	0.0	0.1	0.1	111.1	0.0	0.0	2.4	9.6	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.8	0.0	0.0	1.9	0.0	0.1	0.3	0.0	1.5	1.8	0.0	1.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	40.1	35.9	34.0	37.4	31.9	47.2	75.7	53.4	63.0	49.7	80.4	55.1	4.7	0.0	8.9	1.3	0.7	1.9	0.0	0.0	1.8	3.4	0.9	1.4	2.8	11.5	1.8	0.0	0.0	0.9	0.1	14.7	1.9	0.0	2.8	0.0	0.1	28.8	0.0	2.7	0.5	0.2	2.3	3.6	0.5	0.0	22.9	6.1	3.6	204.5	122.2	0.0	0.5	6.6	0.0	155.8	8.9	1.7	10.8	92.4	0.0	232.3	2.0	0.2	0.0	1.5	0.6	0.1	14.6	10.5	1.4	0.0	46.7	8.2	0.7	0.7	0.0	3.0	1.1	0.4	0.2	4.5	0.4	2.5	0.7	0.4	13.3	0.1
SLCO3A1	"OATP-D, OATP3A1, SLC21A11"	ENSG00000176463	"Solute carrier organic anion transporter family member 3A1"	Q9UIG8	15	91853708-92172435	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 39.5"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 625.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 63.1;HaCaT: 95.5;HMC-1: 55.3;RPMI-8226: 44.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA066327	Approved					NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA066327: AB_2732743"	"unprognostic (1.05e-3)"	"prognostic favorable (8.61e-4)"	"unprognostic (5.40e-2)"	"prognostic unfavorable (6.57e-6)"	"unprognostic (1.03e-1)"	"unprognostic (7.39e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.57e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.64e-2)"	"unprognostic (3.06e-2)"	"unprognostic (1.86e-1)"	"unprognostic (7.17e-2)"	"unprognostic (1.62e-2)"	11.7	6.2	19.3	6.8	29.5	9.6	8.6	33.7	23.0	8.4	24.1	4.0	1.8	5.3	3.3	10.6	6.9	6.3	26.4	20.3	20.2	10.6	2.9	13.8	6.3	30.2	29.6	4.2	3.0	15.7	6.7	1.0	27.8	4.3	3.4	1.5	4.7	6.2	5.8	15.7	4.2	5.0	22.5	11.1	4.6	17.9	26.1	2.6	10.6	9.6	6.2	8.6	10.8	39.5	10.1	12.3	13.9	0.2	20.9	12.6	0.2	4.0	3.4	1.6	0.4	0.0	63.1	12.1	5.3	1.3	9.1	95.5	2.7	6.3	0.2	8.8	0.4	27.8	20.9	0.0	0.9	0.6	55.3	5.7	6.7	2.9	7.3	5.4	0.0	3.6	0.0	0.1	0.0	1.8	0.0	5.1	3.7	0.2	1.7	0.0	1.1	44.0	13.4	10.0	2.0	3.3	10.5	0.9	0.1	2.0	0.1	8.5	0.0	3.3	4.7	0.0	10.3	25.5	16.0	11.7	4.2	16.9	6.0	4.3	2.4	6.9	1.4	2.0	1.1	0.2	1.5	1.7	1.6	0.0	0.5	0.6	7.5	0.3	1.7	0.0	2.7	0.6	19.3	29.5	33.7	23.0	20.3	20.2	30.2	29.6	27.8	22.5	26.1	39.5	53.5	48.1	32.0	17.0	4.3	39.0	29.3	14.2	22.8	28.1	3.1	13.0	44.0	24.3	16.4	51.5	4.2	0.0	33.1	6.2	1.9	26.6	105.6	15.8	29.0	26.2	37.8	6.1	89.5	8.7	0.1	22.9	0.5	36.2	22.8	94.9	34.6	0.8	4.6	0.0	149.4	7.2	8.2	24.7	95.2	38.5	5.0	34.0	10.6	56.2	43.6	5.2	25.7	20.6	625.8	8.4	11.1	3.0	17.3	41.5	0.0	0.4	22.1	3.1	39.5	17.4	62.0	69.5	11.9	22.6	60.1	0.0	23.3	0.8	7.9	38.2
SLCO4A1	"OATP-E, OATP4A1, SLC21A12"	ENSG00000101187	"Solute carrier organic anion transporter family member 4A1"	Q96BD0	20	62642503-62685785	"Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 57.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 61.8;Extravillous trophoblasts: 239.4;Melanocytes: 60.5"	"Cancer enhanced"	"Detected in all"		"colorectal cancer: 21.0"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"T-reg: 1.6"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"PC-3: 197.2;RPTEC TERT1: 193.9"	"Region enriched"	"Detected in some"	5	"cerebellum: 6.7"	"Low region specificity"	"Detected in some"			"HPA030669, HPA030670"	Uncertain		Supported	"Cell Junctions"		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Cell Junctions"		"HPA030669: AB_10601163, HPA030670: AB_10670033"	"unprognostic (8.94e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.41e-1)"	"unprognostic (2.46e-3)"	"unprognostic (3.34e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.84e-3)"	"prognostic unfavorable (4.74e-4)"	"unprognostic (4.94e-2)"	"unprognostic (1.21e-2)"	"unprognostic (3.49e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.84e-3)"	"unprognostic (9.27e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.25e-1)"	32.4	5.6	26.2	1.8	24.0	1.3	23.4	24.2	35.7	11.1	19.6	9.8	1.2	8.7	0.3	16.7	13.1	1.8	48.6	23.9	25.4	35.8	5.0	57.2	2.4	26.5	24.8	6.5	4.9	3.8	2.9	4.7	28.0	5.9	1.8	21.5	8.5	1.0	18.8	25.6	9.2	0.8	25.7	6.6	13.5	2.1	31.6	1.1	8.6	5.6	3.2	12.0	16.8	24.9	14.8	19.1	0.8	10.8	2.5	2.1	26.5	4.7	16.6	14.1	5.4	32.0	14.9	17.8	44.2	0.5	9.6	22.0	16.4	1.0	5.4	2.1	9.6	21.7	22.1	23.8	0.1	16.6	6.7	0.0	6.5	0.3	6.2	4.2	2.5	10.7	17.1	4.6	0.0	14.8	17.2	63.9	5.4	74.1	197.2	30.6	1.1	26.2	193.9	14.2	17.4	25.1	4.1	4.4	15.7	6.5	1.0	7.5	2.8	0.4	10.5	7.0	27.2	9.2	15.9	11.1	38.1	24.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.1	0.0	0.9	0.7	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.2	26.2	24.0	24.2	35.7	23.9	25.4	26.5	24.8	28.0	25.7	31.6	24.9	61.8	3.2	1.3	1.3	13.1	27.3	1.4	19.8	1.2	14.1	1.2	0.8	4.4	1.5	5.9	25.8	31.3	2.1	3.7	7.5	0.0	5.9	0.3	8.7	3.6	40.3	0.0	2.1	7.9	2.5	239.4	4.3	20.9	35.6	0.0	0.0	14.6	0.6	5.5	0.0	6.6	8.4	2.0	9.7	33.5	0.7	0.3	11.9	60.5	3.7	0.0	6.1	0.0	1.5	0.3	11.8	1.9	0.7	19.1	3.5	0.8	9.6	1.3	43.2	0.0	1.9	2.9	0.2	3.0	1.1	16.1	23.5	5.6	0.1	7.5	11.0
SLCO4C1	"OATP-H, OATP4C1, OATPX, SLC21A20"	ENSG00000173930	"Solute carrier organic anion transporter family member 4C1"	Q6ZQN7	5	102233986-102296284	"Predicted membrane proteins, Transporters"	"Differentiation, Ion transport, Spermatogenesis, Transport"	"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"kidney: 41.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 49.7;Early spermatids: 21.6;NK-cells: 26.8;Proximal tubular cells: 32.8"	"Cancer enriched"	"Detected in many"	5	"renal cancer: 22.4"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"basophil: 9.5;neutrophil: 9.8"	"Group enriched"	"Detected in many"	5	"granulocytes: 9.8;NK-cells: 2.6;T-cells: 3.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 17.5;RPTEC TERT1: 98.8;U-937: 25.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA058249			Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Nucleoplasm, Cytosol"	"HPA058249: "	"unprognostic (1.63e-2)"	"unprognostic (2.47e-2)"	"unprognostic (4.48e-4)"	"unprognostic (5.70e-6)"	"unprognostic (7.43e-2)"	"unprognostic (7.71e-3)"	"unprognostic (3.24e-3)"	"unprognostic (2.05e-3)"	"unprognostic (2.13e-1)"	"unprognostic (7.12e-2)"	"unprognostic (3.87e-3)"	"unprognostic (5.83e-2)"	"prognostic favorable (1.12e-4)"	"unprognostic (3.29e-2)"	"unprognostic (1.07e-1)"	"unprognostic (5.91e-2)"	"unprognostic (8.22e-2)"	0.4	0.8	0.2	0.6	0.3	8.6	0.5	0.0	0.4	0.3	0.0	1.0	2.2	0.1	0.2	0.1	0.2	2.3	0.3	0.2	0.0	41.6	7.6	7.8	0.5	0.2	0.0	0.1	0.4	0.1	0.2	0.1	0.2	0.0	0.8	0.1	2.0	3.6	0.1	0.3	1.5	0.1	0.0	1.3	0.6	0.8	0.3	1.0	1.6	0.1	0.2	0.2	0.0	0.3	0.0	0.1	0.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	2.0	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.7	1.1	0.0	1.0	0.2	1.8	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	17.5	0.0	1.3	0.1	0.3	0.8	0.0	0.0	0.0	0.0	1.2	98.8	0.1	0.7	0.5	0.0	0.3	0.0	2.3	0.0	2.4	0.0	0.0	0.7	0.0	0.0	1.6	0.0	0.0	0.0	25.8	0.1	9.5	1.0	7.3	3.8	0.0	0.3	0.0	0.6	2.1	0.4	0.1	0.2	1.3	9.8	2.6	0.0	0.2	0.0	1.0	0.2	0.3	0.0	0.4	0.2	0.0	0.2	0.0	0.2	0.0	0.3	0.3	0.1	6.4	49.7	0.3	0.6	0.0	0.1	1.2	0.0	0.0	1.8	0.3	0.3	1.5	6.4	5.5	0.0	0.0	9.6	1.4	1.9	0.2	21.6	0.0	0.1	0.3	0.0	5.7	9.1	0.8	0.0	0.3	0.0	1.6	5.7	0.0	0.4	11.0	0.2	0.0	6.6	0.1	2.0	0.6	0.3	2.6	0.3	2.4	0.0	1.0	3.2	0.0	26.8	1.5	0.3	0.3	0.1	0.0	1.4	0.0	1.8	32.8	3.1	0.0	0.0	0.1	0.1	2.5	2.4	0.0	0.0	0.0	3.4	0.1	1.1	0.4
SLCO5A1	"OATP-J, OATP5A1, OATPRP4, SLC21A15"	ENSG00000137571	"Solute carrier organic anion transporter family member 5A1"	Q9H2Y9	8	69667046-69834978	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 6.5;skeletal muscle: 7.6;tongue: 11.1"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 10.1;Cardiomyocytes: 14.4;Enteroendocrine cells: 15.6;Excitatory neurons: 8.6;Inhibitory neurons: 30.1;monocytes: 21.2;Oligodendrocyte precursor cells: 26.2;Plasma cells: 14.3;Prostatic glandular cells: 11.8"	"Cancer enhanced"	"Detected in some"		"prostate cancer: 1.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HAP1: 5.5;NTERA-2: 3.7;RPMI-8226: 3.6;SCLC-21H: 3.9;U-266/70: 2.1"	"Group enriched"	"Detected in some"	7	"basal ganglia: 2.3;olfactory bulb: 6.7"	"Region enriched"	"Detected in some"	7	"olfactory bulb: 12.8"	HPA025062	Uncertain		Supported	"Vesicles,Plasma membrane"		NA	NA				"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Plasma membrane"	Vesicles	"HPA025062: AB_1857220"	"unprognostic (1.30e-3)"	"unprognostic (7.35e-3)"	"unprognostic (4.13e-2)"	"unprognostic (1.14e-2)"	"unprognostic (1.48e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.46e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.37e-4)"	"unprognostic (1.75e-1)"	"unprognostic (4.48e-4)"	"unprognostic (1.74e-2)"	"unprognostic (2.92e-6)"	"unprognostic (2.20e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.13e-1)"	"unprognostic (4.50e-2)"	0.1	0.0	0.3	0.9	0.4	0.9	0.1	0.0	0.4	0.2	0.0	0.2	0.2	0.2	0.0	0.5	0.3	0.2	3.7	0.2	0.6	0.0	0.0	0.1	1.0	0.2	0.0	0.0	0.4	0.0	1.5	0.0	0.2	2.3	0.4	0.7	0.3	0.0	7.6	0.1	0.3	0.1	0.0	0.5	0.2	0.3	0.1	6.5	0.0	11.1	0.9	0.6	0.0	0.1	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.5	0.0	0.0	1.5	1.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.7	3.7	0.0	0.6	0.6	0.6	3.6	0.0	0.0	3.9	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.7	2.1	0.3	0.0	0.2	0.0	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.4	0.2	0.6	0.2	0.0	0.2	0.0	0.1	0.1	0.1	3.2	0.0	3.6	3.6	0.3	1.8	0.0	0.6	10.1	0.2	0.3	14.4	0.0	0.6	0.0	2.1	0.0	0.0	0.6	0.0	1.8	0.6	0.4	1.7	2.0	15.6	0.0	8.6	1.3	0.0	4.0	0.0	1.7	0.0	0.0	0.0	0.2	0.1	1.7	30.1	2.0	0.0	0.0	3.6	0.6	0.0	0.7	0.0	3.7	21.2	0.5	0.0	26.2	2.2	2.1	0.1	0.0	14.3	11.8	0.0	0.1	0.0	0.3	0.0	3.4	2.0	1.1	2.6	0.4	0.4	0.0	0.1	0.4	1.5	1.5
SLCO6A1	"CT48, MGC26949, OATP6A1, OATPY"	ENSG00000205359	"Solute carrier organic anion transporter family member 6A1"	Q86UG4	5	102371774-102499016	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	109	"testis: 30.2"	"Group enriched"	"Detected in some"	5	"Early spermatids: 168.8;Spermatocytes: 127.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Low region specificity"	"Detected in all"			HPA054126	Enhanced					NA	NA				"Cluster 36: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"			"HPA054126: AB_2682390"		"unprognostic (1.17e-1)"			"unprognostic (2.59e-1)"	"unprognostic (4.37e-2)"		"unprognostic (4.65e-1)"		"unprognostic (1.84e-1)"					"unprognostic (2.60e-2)"		"unprognostic (6.70e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	168.8	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	26.0	1.8	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	3.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	127.7	2.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SLN	"MGC12301, MGC125854, MGC125855"	ENSG00000170290	Sarcolipin	O00631	11	107707378-107719693	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"skeletal muscle: 8190.2;tongue: 3399.6"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 730.3;Muller glia cells: 462.5;Skeletal myocytes: 225.1"	"Group enriched"	"Detected in many"	5	"glioma: 21.6;head and neck cancer: 22.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 1.1;HSkMC: 2.5;Karpas-707: 1.2;PC-3: 1.1;SuSa: 2.5;U-2 OS: 1.1"									CAB011628			Approved	Microtubules		NA	NA				"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 12: NES - Nervous system development"	"Cluster 37: Myocytes - Muscle contraction"	Microtubules		"CAB011628: AB_2195046"	"unprognostic (6.85e-2)"	"unprognostic (6.18e-8)"	"unprognostic (2.60e-1)"	"unprognostic (3.66e-2)"	"unprognostic (2.40e-3)"	"unprognostic (4.12e-3)"		"unprognostic (5.28e-3)"	"unprognostic (1.31e-2)"	"unprognostic (2.76e-1)"	"unprognostic (6.35e-2)"	"unprognostic (1.68e-1)"	"prognostic unfavorable (3.52e-9)"	"unprognostic (3.27e-2)"	"unprognostic (2.54e-1)"	"unprognostic (5.09e-4)"	"unprognostic (3.77e-2)"	5.1	8.3	2.8	0.0	3.4	0.0	2.1	3.9	7.8	0.2	1.3	4.7	0.3	0.2	0.8	149.2	0.7	0.3	975.1	2.4	1.4	2.6	0.7	6.4	0.2	1.5	2.3	0.6	1.8	0.2	0.7	1.3	2.3	37.0	0.1	60.7	59.4	0.3	8190.2	4.4	1.5	1.4	1.3	0.3	0.8	1.3	1.4	2.7	2.0	3399.6	0.9	0.4	1.0	2.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	0.3	0.0	0.1	0.0	0.0	0.0	1.2	0.0	0.1	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	1.1	0.0	0.1	0.4	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	3.4	3.9	7.8	2.4	1.4	1.5	2.3	2.3	1.3	1.4	2.0	0.0	0.0	0.0	0.0	0.0	1.0	1.2	0.0	0.0	2.4	0.0	0.0	730.3	0.0	0.0	0.0	2.1	1.0	0.0	0.0	0.0	0.0	9.1	0.0	0.0	10.5	0.0	0.0	0.3	0.4	1.9	42.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.3	0.0	0.0	0.0	0.0	1.1	8.8	0.0	1.0	0.0	0.0	0.0	462.5	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.2	0.0	0.4	0.0	19.9	0.0	225.1	40.5	0.1	0.0	0.0	1.4	5.7	1.0	0.0	0.0	0.1
SLURP1	"ANUP, ARS, ArsB, LY6-MT, LY6LS, MDM"	ENSG00000126233	"Secreted LY6/PLAUR domain containing 1"	P55000	8	142740949-142742406	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted secreted proteins, Transporters"		Cytokine	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"esophagus: 1039.2;skin 1: 858.5"	"Group enriched"	"Detected in some"	16	"Squamous epithelial cells: 20.8;Suprabasal keratinocytes: 65.8"	"Cancer enhanced"	"Detected in many"		"head and neck cancer: 66.3"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HaCaT: 1.3;MCF7: 1.5;RT4: 1.1;T-47d: 2.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA050967	Approved				"Secreted in other tissues"	NA	NA		7700000		"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 6: T47d - Mammary gland"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA050967: AB_2681293"	"unprognostic (1.22e-2)"	"unprognostic (5.08e-2)"		"unprognostic (1.16e-2)"		"unprognostic (1.42e-2)"		"unprognostic (1.84e-1)"	"unprognostic (7.32e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.33e-4)"	"unprognostic (1.58e-1)"		"unprognostic (2.98e-1)"			"unprognostic (1.43e-1)"	0.9	0.6	0.1	0.0	0.0	0.0	11.3	0.7	0.5	105.0	0.0	0.3	0.0	0.2	0.0	1039.2	0.2	0.2	0.4	0.1	0.0	0.2	0.5	0.3	0.0	0.0	0.0	0.2	0.6	0.0	0.5	0.0	0.0	0.3	0.0	0.0	70.1	0.0	1.4	858.5	0.3	0.0	0.0	0.2	0.8	0.3	0.1	0.9	0.2	0.0	17.4	0.3	206.7	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.2	0.6	0.0	0.0	1.8	1.5	0.1	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	20.8	65.8	0.0	0.0	0.0	0.0	0.8
SMDT1	"C22orf32, DDDD, dJ186O1.1, EMRE"	ENSG00000183172	"Single-pass membrane protein with aspartate rich tail 1"	Q9H4I9	22	42079691-42084284	"Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA032117, HPA060340"	Uncertain		Supported	Nucleoplasm,Mitochondria		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Nucleoplasm	"HPA032117: AB_10601093, HPA060340: AB_2684257"	"unprognostic (1.11e-2)"	"unprognostic (1.46e-3)"	"unprognostic (5.77e-2)"	"prognostic favorable (5.32e-8)"	"unprognostic (1.25e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.07e-2)"	"unprognostic (2.55e-1)"	"unprognostic (4.84e-2)"	"prognostic favorable (5.87e-4)"	"unprognostic (2.96e-1)"	"prognostic favorable (2.36e-9)"	"unprognostic (1.91e-1)"	"unprognostic (2.65e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.72e-3)"	12.2	13.9	21.6	6.1	22.2	17.6	19.5	25.7	27.7	14.6	21.2	14.7	10.3	12.3	19.5	12.6	15.2	7.4	20.0	22.1	22.0	18.2	15.1	9.7	16.1	21.6	21.4	22.5	21.5	18.0	14.9	7.3	22.2	16.1	11.2	16.0	22.7	13.4	35.6	14.8	13.5	8.4	21.3	12.6	17.7	6.9	21.3	12.4	18.6	37.9	12.2	12.4	11.9	22.4	5.7	3.7	7.4	8.9	13.1	9.5	5.8	2.0	10.0	12.1	10.5	7.1	5.3	7.8	2.4	10.3	3.4	6.1	9.8	10.4	7.7	3.8	15.7	4.7	8.1	10.3	16.5	8.6	5.9	7.4	17.3	4.8	9.9	6.9	12.2	5.1	7.9	12.3	8.4	11.2	12.1	13.0	2.8	14.1	2.7	10.8	6.5	20.8	15.5	6.4	9.2	6.0	5.0	11.1	12.8	3.7	9.3	9.3	4.8	5.1	5.3	4.5	3.9	8.2	9.8	16.9	7.9	8.5	4.1	4.0	5.8	2.9	3.1	3.1	5.9	5.9	8.6	4.5	8.4	7.2	9.3	6.0	0.5	5.5	4.5	6.4	5.4	5.4	21.6	22.2	25.7	27.7	22.1	22.0	21.6	21.4	22.2	21.3	21.3	22.4	161.1	83.3	109.3	11.8	295.0	166.7	202.2	157.3	191.2	71.6	400.9	477.3	350.9	237.4	160.3	204.1	20.9	308.7	127.8	285.6	573.2	160.0	114.0	156.8	81.1	138.2	345.2	135.7	10.5	199.6	190.6	127.8	150.3	127.2	91.4	55.4	161.3	380.1	256.1	55.5	12.8	356.5	262.4	164.5	200.6	131.9	189.2	187.7	211.7	5.6	125.8	196.4	124.6	7.5	13.8	193.7	314.0	149.0	275.8	238.2	486.7	623.4	223.7	109.5	124.9	133.6	202.7	256.0	55.5	271.5	274.1	308.8	186.3	151.7	308.8	272.2
SMIM1	Vel	ENSG00000235169	"Small integral membrane protein 1 (Vel blood group)"	B2RUZ4	1	3772749-3775982	"Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Blood group antigen"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 40.3;testis: 42.2"	"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 84.1;Erythroid cells: 404.4;Granulosa cells: 81.5;Proximal tubular cells: 247.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	11	"eosinophil: 48.5"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 48.5"	"Group enriched"	"Detected in many"	4	"HEL: 68.0;Hep G2: 32.5;K-562: 33.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in some"			HPA069088	Enhanced					NA	NA		340000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 43: Testis - Unknown function"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA069088: AB_2686080"	"unprognostic (9.50e-3)"	"unprognostic (7.19e-4)"	"unprognostic (5.40e-2)"	"unprognostic (2.10e-2)"	"unprognostic (2.50e-3)"	"unprognostic (3.25e-1)"	"unprognostic (2.63e-3)"	"unprognostic (2.13e-2)"	"unprognostic (2.31e-2)"	"unprognostic (9.85e-2)"	"unprognostic (2.90e-1)"	"unprognostic (1.87e-1)"	"unprognostic (2.25e-2)"	"unprognostic (7.10e-2)"	"unprognostic (2.91e-2)"	"unprognostic (5.56e-2)"	"unprognostic (1.32e-2)"	2.6	2.7	1.8	0.4	2.6	32.1	3.2	3.8	3.0	5.8	6.2	2.9	0.7	2.8	1.1	1.4	3.4	1.3	40.3	1.4	3.9	16.9	13.1	3.7	1.0	8.7	5.3	8.7	9.4	4.3	16.0	2.1	9.0	6.9	0.1	0.4	17.3	5.5	1.1	2.1	2.1	0.2	5.5	4.0	6.6	42.2	3.6	0.4	9.3	0.2	0.5	3.4	3.6	6.2	0.3	1.4	1.4	3.0	0.0	0.0	5.0	0.9	1.2	0.0	0.0	3.5	3.9	0.1	6.3	0.0	0.2	1.3	0.4	1.5	0.0	6.1	3.6	68.0	0.0	32.5	2.4	0.0	1.2	2.1	0.8	0.3	0.5	2.9	0.0	0.3	33.9	1.2	0.0	7.8	0.0	2.1	0.3	3.4	6.0	0.0	0.0	9.9	3.8	1.0	1.6	6.3	0.2	6.8	4.8	0.5	7.0	3.7	0.4	0.0	0.8	0.0	0.0	2.8	0.8	0.2	0.0	0.0	0.2	4.4	2.0	48.5	1.1	1.0	0.4	2.5	1.6	0.6	0.6	3.7	4.0	1.9	3.2	0.2	0.4	0.6	1.2	2.2	1.8	2.6	3.8	3.0	1.4	3.9	8.7	5.3	9.0	5.5	3.6	6.2	1.1	6.4	20.1	0.7	5.9	1.7	13.1	4.4	10.2	0.4	31.1	35.9	57.0	8.6	8.1	16.5	0.0	23.4	1.4	1.6	84.1	17.2	10.8	3.7	1.2	3.9	5.4	404.4	0.1	14.5	18.8	10.1	6.6	3.5	1.3	81.5	3.9	50.2	10.4	1.7	0.1	3.9	8.2	8.9	1.0	27.8	9.9	8.5	42.7	0.0	4.3	47.0	2.1	0.0	1.6	13.7	1.7	9.8	11.1	10.2	1.9	247.9	2.2	1.5	0.0	3.6	4.3	8.7	20.4	1.7	1.1	6.7	4.6	3.0	4.3	9.1
SMIM6	"C17orf110, ELN"	ENSG00000259120	"Small integral membrane protein 6"	P0DI80	17	75646243-75647975	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 24.1;kidney: 22.1;stomach 1: 33.1;testis: 26.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 565.7;Endometrial ciliated cells: 233.1;Enteroendocrine cells: 197.1;Late spermatids: 1243.9"	"Cancer enhanced"	"Detected in many"		"endometrial cancer: 12.6"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	42	"plasmacytoid DC: 34.2"	"Lineage enriched"	"Detected in single"	42	"dendritic cells: 34.2"	"Cell line enhanced"	"Detected in some"		"A549: 11.7;CACO-2: 3.8;EFO-21: 8.7;HEL: 6.7;Hep G2: 3.6;OE19: 10.5;RPTEC TERT1: 4.2"									HPA065721	Uncertain		Approved	Nucleoplasm		Yes	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	Nucleoplasm		"HPA065721: AB_2685546"	"unprognostic (4.34e-2)"	"unprognostic (3.08e-2)"	"unprognostic (7.07e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (3.42e-1)"	"unprognostic (1.22e-2)"	"unprognostic (6.53e-2)"	"unprognostic (1.94e-1)"	"unprognostic (1.13e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.76e-2)"	"unprognostic (8.06e-2)"	"prognostic favorable (4.09e-4)"	"unprognostic (2.77e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.58e-2)"	"prognostic favorable (1.64e-4)"	0.2	0.1	3.4	0.8	5.8	1.1	0.1	4.9	5.1	2.4	2.5	6.5	9.5	1.1	2.8	0.1	24.1	9.6	0.0	3.6	3.9	22.1	6.6	2.4	0.4	5.4	5.6	0.1	5.6	2.1	0.0	0.3	5.8	0.2	6.6	0.1	0.1	1.4	0.1	0.3	5.9	0.1	4.1	0.2	33.1	26.1	4.7	0.1	0.1	0.0	0.3	1.8	0.1	8.2	0.7	11.7	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	3.8	3.3	0.0	8.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.3	6.7	0.4	3.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.0	0.0	0.0	10.5	0.0	0.0	0.0	0.2	4.2	1.9	0.2	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.2	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	34.2	0.0	0.3	3.4	5.8	4.9	5.1	3.6	3.9	5.4	5.6	5.8	4.1	4.7	8.2	0.1	3.2	3.1	0.0	0.9	0.1	3.4	2.3	0.0	0.0	0.2	0.1	0.1	35.8	5.4	35.0	0.0	0.5	9.5	56.2	137.0	35.9	565.7	233.1	2.9	0.8	197.1	0.0	0.0	16.6	3.7	0.3	70.3	22.1	0.0	0.0	0.4	7.0	0.6	0.0	0.0	51.5	8.2	0.0	0.3	1243.9	6.5	1.4	0.0	0.0	1.6	0.0	0.0	0.0	4.5	55.8	129.5	1.9	0.5	2.6	32.7	24.5	38.4	0.0	6.6	0.2	0.4	5.2	2.6	0.0	0.0	4.1	0.9	0.0	4.4	9.6
SMO	"FZD11, SMOH"	ENSG00000128602	"Smoothened, frizzled class receptor"	Q99835	7	129188633-129213545	"Cancer-related genes, Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		"Developmental protein, G-protein coupled receptor, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 27.4;Granulosa cells: 13.0;Leydig cells: 20.8;Muller glia cells: 16.6;Peritubular cells: 21.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AF22: 45.3;AN3-CA: 84.9;NTERA-2: 64.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB011446	Approved					NA	NA				"Cluster 15: Liver - Metabolism"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 36: Stromal cells - Cell proliferation"			"CAB011446: "	"unprognostic (2.48e-2)"	"unprognostic (2.69e-2)"	"unprognostic (7.09e-2)"	"unprognostic (1.10e-1)"	"unprognostic (8.16e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.63e-1)"	"unprognostic (5.89e-2)"	"unprognostic (5.38e-3)"	"unprognostic (1.59e-1)"	"unprognostic (1.17e-2)"	"unprognostic (8.74e-3)"	"unprognostic (1.62e-1)"	"unprognostic (5.15e-3)"	"unprognostic (2.09e-1)"	"unprognostic (2.25e-1)"	"unprognostic (2.61e-2)"	5.2	6.0	9.4	2.6	10.8	0.4	5.5	9.9	9.6	27.4	18.4	9.6	2.5	19.2	18.6	12.0	14.5	8.4	8.0	8.9	10.0	19.0	23.9	3.6	2.2	12.4	12.4	28.3	6.3	16.1	19.2	2.6	9.9	20.0	2.1	2.0	11.5	12.3	3.7	17.1	5.7	8.1	11.8	2.8	6.3	5.6	11.4	4.4	9.1	3.7	2.0	9.0	16.7	9.7	1.6	18.2	45.3	84.9	1.1	0.2	14.3	5.2	6.7	10.1	5.8	13.8	0.1	0.0	13.9	10.4	22.8	28.3	27.4	1.5	3.9	0.0	23.0	9.4	0.0	22.5	5.5	0.4	0.0	16.2	11.0	3.3	0.0	19.9	5.8	24.9	1.5	0.0	3.1	0.0	24.4	0.1	64.2	0.0	5.3	35.1	19.7	0.0	5.2	0.0	1.3	30.2	0.0	0.0	12.3	16.8	11.1	5.8	0.0	0.7	14.1	17.6	10.1	0.6	0.0	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.4	10.8	9.9	9.6	8.9	10.0	12.4	12.4	9.9	11.8	11.4	9.7	0.4	0.0	0.0	27.4	0.2	1.9	2.3	3.9	2.8	0.7	3.3	5.2	1.4	2.8	3.8	11.0	0.0	0.3	0.4	0.0	1.9	3.4	0.4	1.0	8.6	0.6	0.0	0.0	1.4	1.1	0.3	7.6	0.0	1.3	0.0	13.0	1.4	8.4	4.2	0.0	0.8	0.1	2.0	1.6	1.8	1.3	20.8	1.0	0.0	3.7	0.6	16.6	0.0	4.5	0.5	1.3	0.1	21.8	0.0	2.7	0.0	3.9	0.7	0.4	6.6	3.5	3.9	0.0	2.0	3.3	2.8	0.5	0.1	6.9	0.6	0.7
SNAP23	"HsT17016, SNAP23A, SNAP23B"	ENSG00000092531	"Synaptosome associated protein 23"	O00161	15	42491233-42545356	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 326.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"eosinophil: 675.6"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001214, CAB037083, CAB037317"	Approved		Supported	"Plasma membrane"		NA	NA		3900000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 16: Immune cells - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 51: Myeloid cells - Hemostasis"	"Plasma membrane"		"CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037"	"unprognostic (1.77e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.76e-3)"	"unprognostic (2.42e-2)"	"unprognostic (1.65e-1)"	"unprognostic (9.67e-3)"	"unprognostic (1.60e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.93e-1)"	"unprognostic (7.31e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.04e-2)"	"unprognostic (1.59e-1)"	"unprognostic (8.95e-2)"	"unprognostic (1.10e-1)"	"unprognostic (3.93e-2)"	44.4	30.3	23.0	62.9	27.7	35.1	38.2	25.7	46.3	37.5	28.6	52.8	50.3	43.2	35.3	31.9	29.8	40.2	44.6	23.5	24.8	42.4	44.4	45.2	84.6	28.0	25.9	34.6	24.2	36.2	12.9	68.9	31.3	49.2	51.2	12.8	45.2	30.9	43.9	26.5	56.4	48.3	25.6	70.3	39.9	36.1	27.5	38.0	33.1	28.7	78.7	42.5	23.9	37.2	58.3	29.7	55.7	54.7	91.8	70.4	85.1	77.6	61.8	50.8	59.1	93.0	27.8	35.1	91.3	52.3	48.1	52.7	63.2	50.1	70.9	58.4	35.3	149.2	30.5	89.1	66.8	57.4	136.6	59.1	37.9	43.5	70.4	64.7	192.9	69.4	121.6	31.4	67.1	24.1	68.3	69.4	46.0	94.3	22.8	122.4	33.8	55.1	71.8	57.8	9.0	36.3	57.2	51.3	56.4	83.5	76.2	91.6	155.0	46.6	61.2	52.1	80.4	59.1	122.3	153.2	56.3	120.0	62.8	244.8	159.8	675.6	51.4	237.6	60.2	110.2	53.5	50.2	148.2	103.9	68.0	52.4	361.9	70.7	236.0	62.6	66.4	179.4	23.0	27.7	25.7	46.3	23.5	24.8	28.0	25.9	31.3	25.6	27.5	37.2	58.9	112.2	30.5	30.7	79.0	50.7	107.6	30.8	34.7	7.7	41.9	19.8	19.2	38.6	32.8	20.2	20.9	75.9	45.3	61.3	56.7	71.1	207.6	34.4	38.6	77.1	14.9	25.0	21.2	52.2	109.5	44.3	32.6	41.2	83.5	22.4	77.4	28.0	88.9	5.0	23.6	80.2	52.9	125.4	112.8	326.0	39.1	131.8	44.4	36.5	120.0	14.6	53.5	39.7	54.6	110.8	52.8	60.5	27.9	79.9	55.0	76.2	42.6	18.4	52.6	42.1	40.6	16.7	7.9	29.3	38.5	142.6	48.2	47.8	39.7	64.7
SNAP25	"bA416N4.2, dJ1068F16.2, RIC-4, RIC4, SEC9, SNAP, SNAP-25"	ENSG00000132639	"Synaptosome associated protein 25"	P60880	20	10218830-10307418	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Transporters"			"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	20	"brain: 1658.7;retina: 492.0"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 559.2;Excitatory neurons: 1015.8;Inhibitory neurons: 552.8;Rod photoreceptor cells: 254.4"	"Cancer enriched"	"Detected in many"	4	"glioma: 28.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 23.8;SCLC-21H: 78.2;SH-SY5Y: 46.6;U-87 MG: 56.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000360, HPA001830, HPA071013"	Enhanced	Supported	Approved	"Vesicles,Plasma membrane"		NA	NA		9000		"Cluster 6: Brain - Smell perception"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Vesicles	"CAB000360: AB_2286342, HPA001830: AB_1080039, HPA071013: "	"unprognostic (1.64e-3)"	"unprognostic (7.26e-3)"	"unprognostic (4.36e-2)"	"unprognostic (2.49e-7)"	"unprognostic (6.86e-3)"	"unprognostic (5.87e-3)"	"unprognostic (1.15e-2)"	"unprognostic (9.94e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.82e-3)"	"unprognostic (4.80e-3)"	"unprognostic (8.06e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.18e-3)"	"unprognostic (2.48e-1)"	"unprognostic (6.28e-3)"	"unprognostic (1.02e-2)"	1.5	43.6	251.0	4.1	383.5	0.2	4.4	598.0	1658.7	0.8	0.0	5.7	3.7	7.9	12.9	0.5	7.7	2.3	3.2	420.4	142.2	1.4	1.0	1.8	0.4	427.4	24.7	6.9	6.3	1.2	54.3	0.6	386.6	3.2	2.3	492.0	0.5	19.6	0.8	0.7	3.9	8.1	38.1	0.2	6.3	3.6	147.6	0.5	0.7	0.1	0.4	1.1	1.6	726.9	0.0	4.7	3.9	0.0	0.4	0.1	0.0	2.0	0.0	4.8	1.4	0.0	0.0	0.0	4.3	0.0	3.4	0.8	0.6	0.0	9.6	0.5	0.3	0.0	6.8	0.7	3.5	0.0	0.5	4.4	0.0	3.9	0.0	10.7	0.0	2.8	0.0	23.8	1.6	0.0	0.0	0.0	0.8	3.0	0.0	0.0	0.0	0.1	0.9	0.0	78.2	46.6	0.7	0.1	0.0	2.4	0.0	6.5	0.0	5.0	6.8	0.0	2.3	0.1	12.9	0.1	56.0	0.0	4.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	251.0	383.5	598.0	1658.7	420.4	142.2	427.4	24.7	386.6	38.1	147.6	726.9	0.5	0.0	0.0	117.2	0.0	0.8	1.4	0.1	0.0	559.2	0.2	1.3	0.5	8.6	0.0	0.0	106.3	0.0	0.2	0.0	0.0	0.2	16.3	0.1	0.7	5.2	43.5	0.0	1015.8	0.0	0.1	3.9	0.0	0.2	0.0	0.6	0.0	0.2	0.1	65.6	552.8	3.4	0.0	0.0	0.4	83.3	17.1	0.1	1.8	120.9	0.0	71.9	0.0	179.4	113.3	1.0	2.6	68.8	0.0	0.6	0.1	3.0	0.0	254.4	0.0	0.0	1.3	1.1	0.4	0.0	0.9	0.0	0.0	2.6	0.1	0.1
SNAPIN	"BLOC1S7, BORCS3, SNAPAP"	ENSG00000143553	"SNAP associated protein"	O95295	1	153658703-153661852	"Predicted intracellular proteins, Transporters"	"Exocytosis, Host-virus interaction"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046974	Approved		Approved	"Nucleoli,Golgi apparatus"		NA	NA		20000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus"	Nucleoli	"HPA046974: AB_10962506"	"unprognostic (3.65e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.47e-1)"	"unprognostic (5.66e-2)"	"unprognostic (1.75e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.64e-3)"	"unprognostic (1.54e-1)"	"unprognostic (4.86e-2)"	"unprognostic (2.05e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.20e-1)"	"prognostic unfavorable (5.42e-4)"	"unprognostic (2.31e-1)"	"unprognostic (4.73e-1)"	"unprognostic (1.31e-3)"	"unprognostic (4.89e-2)"	34.6	50.8	41.5	18.5	42.9	13.1	30.3	44.3	43.0	23.9	38.7	35.7	12.8	30.7	34.1	35.1	27.5	21.7	63.7	39.9	43.5	37.8	32.1	21.0	27.4	43.1	42.3	24.0	17.5	41.2	16.4	19.0	42.9	24.4	20.2	25.1	22.1	29.4	91.5	27.9	23.2	30.4	44.5	30.9	26.3	19.2	43.0	30.6	25.5	77.0	31.9	31.1	23.5	45.1	50.8	60.6	51.5	31.0	63.2	42.7	32.4	41.7	46.1	57.8	43.9	43.9	39.3	35.8	82.6	42.9	29.0	65.6	42.5	54.4	40.9	49.3	57.4	39.6	41.3	21.1	65.4	39.3	24.4	50.5	41.1	43.6	49.0	61.0	54.8	41.7	34.7	27.8	59.5	82.7	46.0	23.9	27.5	78.6	64.7	42.9	44.1	96.8	65.0	47.6	38.9	67.8	48.0	55.0	57.8	50.3	84.0	43.5	48.4	27.2	40.5	54.4	40.0	65.6	77.4	56.0	51.4	24.9	36.1	106.2	146.9	139.7	86.8	154.1	100.6	130.1	88.2	88.9	153.5	119.6	96.9	87.9	30.4	118.1	126.8	115.6	136.3	146.6	41.5	42.9	44.3	43.0	39.9	43.5	43.1	42.3	42.9	44.5	43.0	45.1	41.7	19.2	16.6	7.2	31.6	20.6	35.1	88.7	35.9	14.2	39.1	44.4	39.8	40.0	45.3	29.5	8.4	64.4	35.9	18.0	74.3	71.4	9.6	31.5	24.2	34.9	13.8	33.6	5.9	65.2	49.5	31.2	16.3	25.6	30.4	31.9	40.7	35.1	90.2	21.9	6.5	20.0	40.7	48.3	21.8	26.6	30.7	34.7	26.6	4.7	76.5	84.8	59.8	8.0	14.4	53.5	25.5	49.7	23.8	34.7	26.6	76.7	40.9	21.7	46.0	25.3	39.7	29.3	42.6	45.5	23.4	73.7	26.9	44.2	24.6	36.2
SNCA	"NACP, PARK1, PARK4, PD1"	ENSG00000145335	"Synuclein alpha"	P37840	4	89700345-89838315	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"			"Alzheimer disease, Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	6	"bone marrow: 273.6;brain: 128.2"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 1225.0;Excitatory neurons: 251.5;Melanocytes: 352.2;Oligodendrocytes: 195.4"	"Cancer enriched"	"Detected in many"	8	"melanoma: 37.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 102.9"	"Group enriched"	"Detected in all"	4	"dendritic cells: 102.9;granulocytes: 51.5;monocytes: 66.9"	"Cell line enhanced"	"Detected in many"		"HEL: 221.5;HUVEC TERT2: 269.8;RT4: 137.3;SK-MEL-30: 271.6;TIME: 311.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005459, CAB010877"	Enhanced				"Intracellular and membrane"	NA	NA		28000000	"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 6: Erythroid cells - Oxygen transport"			"CAB010877: AB_261518, HPA005459: AB_2667324"	"unprognostic (4.80e-2)"	"unprognostic (1.52e-1)"	"unprognostic (8.13e-2)"	"unprognostic (1.05e-3)"	"unprognostic (2.65e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.78e-2)"	"unprognostic (3.44e-2)"	"unprognostic (1.73e-2)"	"unprognostic (3.85e-3)"	"unprognostic (1.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.51e-3)"	"unprognostic (1.68e-1)"	"unprognostic (3.93e-4)"	"unprognostic (7.48e-3)"	16.0	9.9	91.5	10.0	112.2	273.6	7.8	47.2	128.2	26.1	16.1	28.5	3.3	34.3	3.4	8.5	11.2	5.4	20.9	115.2	69.1	12.4	2.9	16.6	2.2	97.5	88.3	29.3	2.2	1.1	28.7	28.3	89.9	17.3	6.9	20.3	15.9	9.7	1.2	16.4	8.6	33.3	36.0	15.2	6.4	3.2	76.2	5.3	10.2	8.5	4.8	9.3	23.2	107.0	0.5	1.0	40.1	0.0	0.7	0.0	0.6	0.4	44.5	1.6	3.0	0.0	0.0	0.2	12.0	0.0	0.0	9.3	53.6	97.7	1.5	0.0	22.6	221.5	115.4	0.5	84.2	0.0	1.4	2.1	38.2	0.0	109.5	117.3	269.8	2.2	2.0	0.6	0.2	0.0	2.1	0.3	10.6	0.2	4.8	0.0	15.8	0.0	0.3	137.3	23.2	15.6	0.2	0.3	271.6	29.0	0.0	0.4	311.4	1.3	8.0	0.1	0.8	0.2	0.2	0.1	8.8	0.2	87.4	51.5	66.9	0.1	0.3	27.7	0.1	4.2	1.9	0.3	84.6	1.7	1.0	0.5	11.1	17.3	8.2	102.9	0.0	63.7	91.5	112.2	47.2	128.2	115.2	69.1	97.5	88.3	89.9	36.0	76.2	107.0	1.8	0.0	0.6	40.1	2.6	76.6	16.3	173.4	101.3	10.4	0.9	14.4	13.4	0.0	21.5	11.0	0.0	10.1	10.1	0.1	1.9	0.0	0.6	0.3	1.1	19.4	1.8	1225.0	251.5	0.2	1.9	32.7	0.0	0.3	0.0	23.9	7.5	0.8	62.3	10.1	53.8	0.0	44.7	17.2	64.2	1.5	2.1	100.7	352.2	76.8	24.4	19.4	4.1	95.5	195.4	0.2	0.0	0.0	0.5	11.3	0.0	2.0	6.6	7.4	13.1	0.5	5.3	19.6	16.9	4.5	22.6	3.4	3.8	43.6	0.0	3.4
SNCB		ENSG00000074317	"Synuclein beta"	Q16143	5	176620082-176630556	"Human disease related genes, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	18	"brain: 439.2;retina: 182.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 105.1;Excitatory neurons: 36.8;Horizontal cells: 50.5;Inhibitory neurons: 32.6;Rod photoreceptor cells: 49.7"	"Cancer enriched"	"Detected in some"	8	"glioma: 11.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"SCLC-21H: 54.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002681, HPA035876"	Enhanced	Supported				NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 56: Bipolar cells - Visual perception"			"CAB002681: , HPA035876: AB_10670592"	"unprognostic (3.55e-2)"	"unprognostic (1.05e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.46e-2)"	"unprognostic (3.41e-3)"	"unprognostic (2.95e-2)"		"unprognostic (6.07e-2)"	"unprognostic (3.41e-1)"	"unprognostic (2.39e-1)"	"unprognostic (2.29e-3)"	"unprognostic (3.31e-1)"	"unprognostic (5.41e-5)"	"unprognostic (1.31e-3)"	"unprognostic (8.57e-2)"	"unprognostic (2.81e-1)"	"unprognostic (8.42e-3)"	0.1	3.2	81.7	0.0	154.5	0.0	0.1	74.3	439.2	0.1	0.0	1.0	0.1	0.1	0.0	0.1	0.0	0.0	1.5	136.3	41.9	0.1	0.2	0.2	0.2	104.2	23.8	0.3	0.8	0.0	17.1	0.0	77.7	0.1	0.0	182.2	0.1	0.0	1.9	0.3	0.4	0.0	1.3	0.2	0.3	0.6	63.1	0.0	0.2	2.8	0.0	0.1	0.1	237.7	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	1.8	0.7	0.0	6.0	0.3	2.7	0.4	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.1	0.3	1.8	1.0	0.0	0.0	3.9	0.0	2.3	0.0	0.0	0.3	0.0	0.0	54.6	2.0	0.0	0.2	5.4	0.1	2.5	0.3	0.0	0.0	2.2	0.0	0.0	0.7	0.0	0.1	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	81.7	154.5	74.3	439.2	136.3	41.9	104.2	23.8	77.7	1.3	63.1	237.7	0.0	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	105.1	0.0	0.0	1.5	0.0	0.0	0.0	16.7	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0	0.0	36.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	50.5	32.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	7.5	0.0	10.3	0.0	3.5	6.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	49.7	0.0	0.0	0.1	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0
SNCG	"BCSG1, persyn, SR"	ENSG00000173267	"Synuclein gamma"	O76070	10	86958599-86963258	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"adrenal gland: 268.3;brain: 411.2"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 164.9;Breast myoepithelial cells: 156.1;Endothelial cells: 143.3;Hepatic stellate cells: 206.0;Smooth muscle cells: 234.3;Urothelial cells: 358.3"	"Group enriched"	"Detected in all"	8	"ovarian cancer: 84.1;urothelial cancer: 301.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 748.2;RT4: 483.5;T-47d: 151.7;TIME: 160.9"	"Region enhanced"	"Detected in all"		"pons and medulla: 279.9"	"Low region specificity"	"Detected in many"			"CAB001452, HPA014404, CAB040581, CAB080022"	Enhanced	Supported				NA	NA		23000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 48: Smooth muscle cells - ECM organization"			"CAB001452: AB_564020, CAB040581: , CAB080022: , HPA014404: AB_1857715"	"unprognostic (2.06e-1)"	"unprognostic (2.58e-1)"	"unprognostic (6.87e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.91e-1)"	"unprognostic (4.76e-3)"	"unprognostic (8.99e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.44e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.75e-1)"	"prognostic unfavorable (2.29e-8)"	"prognostic unfavorable (7.15e-4)"	"unprognostic (2.35e-1)"	"unprognostic (2.36e-2)"	"unprognostic (3.77e-3)"	208.2	268.3	215.6	11.9	150.8	0.0	98.1	199.9	313.3	33.3	44.0	27.0	9.2	22.9	15.1	25.4	64.5	12.7	31.7	190.2	387.7	22.3	4.3	13.9	11.6	411.2	276.4	42.1	5.3	3.3	11.1	11.9	357.8	36.6	4.9	52.7	22.9	101.6	14.6	28.6	18.8	10.1	155.3	64.2	16.4	5.4	304.7	9.0	20.3	13.7	25.6	204.8	38.9	148.8	2.6	6.8	0.7	1.1	0.3	3.9	0.7	0.8	0.0	0.0	0.0	1.1	748.2	0.0	22.6	1.4	0.0	71.0	0.0	3.4	0.0	0.1	1.4	3.6	109.6	2.0	1.4	0.0	1.8	2.8	55.5	0.0	0.6	0.2	49.8	0.0	5.3	0.0	0.0	0.6	0.2	0.4	11.3	0.0	0.4	0.0	0.4	0.3	0.2	483.5	0.1	0.0	6.5	8.7	0.9	1.0	151.7	0.3	160.9	1.1	3.7	0.3	0.0	0.2	0.0	0.0	0.8	3.6	0.5	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.2	0.0	0.0	0.1	215.6	150.8	199.9	313.3	190.2	387.7	411.2	276.4	357.8	155.3	304.7	148.8	164.9	0.0	0.0	7.5	1.5	28.8	65.9	16.3	11.4	32.2	61.1	156.1	1.9	8.6	14.6	55.2	6.2	19.4	2.8	0.1	125.2	3.6	0.6	0.4	0.8	143.3	0.0	2.7	9.9	1.1	0.6	14.2	0.5	0.6	0.0	0.1	206.0	0.8	5.5	87.5	28.0	0.0	20.3	1.8	27.3	3.7	59.0	2.2	23.2	6.5	0.9	66.4	0.0	4.5	7.5	4.7	2.2	9.8	0.0	14.2	0.3	1.3	2.4	109.3	92.1	2.5	234.3	0.6	0.7	2.6	19.7	6.2	2.7	16.9	0.0	358.3
SNX17	KIAA0064	ENSG00000115234	"Sorting nexin 17"	Q15036	2	27370496-27377535	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043867	Supported		Enhanced	Vesicles,Cytosol		No	No			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 72: Non-specific - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 47: Cytotrophoblasts - Unknown function"	Vesicles	Cytosol	"HPA043867: AB_10961129"	"unprognostic (2.57e-1)"	"unprognostic (7.14e-3)"	"unprognostic (1.26e-1)"	"unprognostic (2.61e-2)"	"unprognostic (1.03e-1)"	"unprognostic (2.32e-1)"	"unprognostic (1.06e-3)"	"unprognostic (1.86e-1)"	"unprognostic (4.73e-2)"	"unprognostic (4.38e-2)"	"unprognostic (1.04e-2)"	"unprognostic (9.25e-2)"	"unprognostic (1.33e-1)"	"unprognostic (6.20e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.39e-1)"	"unprognostic (6.32e-3)"	62.5	74.6	32.2	23.1	32.6	19.8	57.0	35.3	31.8	59.7	32.1	58.5	17.3	62.8	16.6	62.2	57.7	22.1	60.3	30.3	32.7	54.6	62.9	53.8	32.3	33.5	33.1	62.4	53.9	42.5	61.1	28.1	37.1	54.2	23.3	12.8	50.3	31.6	49.2	57.0	53.3	33.4	36.3	80.8	54.1	34.1	35.0	43.9	54.3	33.9	33.8	59.8	50.9	37.0	40.1	70.0	45.3	56.4	85.9	71.5	29.0	47.3	85.2	71.8	52.2	43.5	37.8	39.5	55.4	113.9	61.9	23.7	42.4	63.8	57.9	40.7	72.5	44.8	20.3	55.4	80.9	47.6	41.6	66.9	56.7	49.6	59.5	54.1	78.3	32.7	35.5	32.8	87.2	47.7	50.2	31.3	29.2	62.5	67.1	22.7	74.0	64.9	53.5	34.1	46.3	55.1	38.6	39.0	18.1	31.9	30.5	29.6	50.6	57.4	31.6	33.8	45.5	56.8	47.5	49.4	50.0	49.8	60.9	87.5	138.7	88.9	65.6	135.2	66.9	72.7	61.2	67.6	135.6	73.2	57.5	60.6	30.8	72.2	146.9	73.8	78.5	231.9	32.2	32.6	35.3	31.8	30.3	32.7	33.5	33.1	37.1	36.3	35.0	37.0	60.8	16.0	39.1	6.5	68.3	32.5	48.2	78.3	32.5	30.9	47.1	61.3	31.5	35.8	43.3	29.5	14.6	173.5	69.3	56.9	82.2	84.0	8.9	34.4	39.9	52.7	55.1	49.2	6.8	63.9	132.7	60.3	35.2	25.6	43.1	64.5	47.5	64.9	134.9	45.4	7.7	48.3	79.3	118.1	42.7	9.7	58.4	83.4	69.4	2.8	141.9	80.1	76.2	11.1	11.2	64.8	54.1	85.0	60.3	41.4	75.4	95.3	38.6	23.2	32.9	41.4	68.4	58.0	53.2	55.0	34.4	99.6	63.2	102.1	60.0	34.9
SNX27	"KIAA0488, MGC20471, MY014"	ENSG00000143376	"Sorting nexin 27"	Q96L92	1	151612006-151699091	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"basophil: 21.4;classical monocyte: 35.8;intermediate monocyte: 30.8;myeloid DC: 16.3;neutrophil: 40.4;non-classical monocyte: 35.4"	"Group enriched"	"Detected in all"	5	"dendritic cells: 16.3;granulocytes: 40.4;monocytes: 35.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA028551			Approved	Vesicles		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA028551: "	"unprognostic (3.35e-1)"	"unprognostic (4.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (2.13e-2)"	"unprognostic (2.79e-2)"	"unprognostic (3.42e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.96e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.63e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.81e-1)"	"unprognostic (4.15e-1)"	"unprognostic (7.30e-2)"	"unprognostic (1.04e-1)"	7.6	8.6	18.1	7.7	24.7	8.7	7.2	20.2	21.1	9.1	9.2	14.4	5.3	9.1	9.2	7.5	8.6	6.7	8.8	17.1	23.2	14.5	8.5	8.9	6.8	21.5	21.5	9.7	6.9	11.8	10.2	10.7	21.8	9.5	7.4	15.9	7.2	11.6	17.6	9.6	8.3	10.0	20.5	11.2	8.5	7.9	20.1	7.2	7.4	21.3	6.5	12.4	8.2	22.3	9.7	14.2	14.7	18.6	22.9	16.8	32.7	5.1	10.5	8.9	9.5	11.6	12.5	9.1	10.9	8.3	9.5	11.7	19.1	10.4	11.0	13.1	6.9	14.7	8.4	13.1	15.1	17.8	9.6	13.4	7.7	10.2	11.6	9.0	10.1	14.3	9.0	54.8	11.8	17.3	10.6	12.2	26.1	19.0	9.0	10.8	14.3	11.8	13.9	14.3	14.7	12.6	13.8	25.4	10.1	15.8	16.3	14.9	13.4	12.5	8.2	13.1	10.9	11.4	12.2	17.8	14.8	11.2	14.2	21.4	35.8	5.4	4.6	30.8	6.6	3.2	5.8	4.2	16.3	4.4	5.5	4.6	40.4	3.5	35.4	4.2	5.1	17.3	18.1	24.7	20.2	21.1	17.1	23.2	21.5	21.5	21.8	20.5	20.1	22.3	18.4	12.8	27.1	24.8	17.9	21.2	15.5	14.6	13.1	45.8	21.6	13.7	29.9	20.0	17.3	29.5	27.1	56.0	20.4	13.8	25.4	25.7	32.6	18.5	28.0	19.7	18.7	10.8	58.3	20.9	22.4	25.4	14.3	22.7	3.8	20.8	25.7	19.4	43.3	40.4	77.6	12.8	20.3	85.4	21.3	10.4	30.4	51.9	30.2	40.3	71.4	24.6	11.3	45.2	60.0	26.9	10.5	39.9	16.4	16.2	19.6	57.7	13.7	26.6	32.9	27.6	27.0	53.3	28.8	17.0	24.7	104.8	19.4	33.8	15.3	17.9
SNX3	Grd19	ENSG00000112335	"Sorting nexin 3"	O60493	6	108211222-108261246	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		Microphthalmia	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		270000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"				"prognostic unfavorable (4.37e-5)"	"unprognostic (1.70e-2)"	"unprognostic (2.44e-1)"	"unprognostic (1.04e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.82e-2)"	"unprognostic (7.74e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (5.76e-2)"	"unprognostic (1.87e-1)"	"unprognostic (7.66e-2)"	"prognostic unfavorable (2.30e-4)"	"unprognostic (2.32e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.67e-1)"	224.3	220.8	217.3	131.3	220.4	296.3	182.6	216.5	304.6	169.5	208.3	167.6	119.4	137.9	152.8	172.4	144.5	132.0	266.6	224.3	219.6	168.6	199.0	147.3	184.0	214.2	219.8	187.5	123.6	124.4	95.4	199.3	215.8	104.6	112.9	88.3	134.5	119.4	323.0	129.0	125.2	157.0	221.1	145.1	122.0	109.8	218.9	123.4	123.2	285.3	163.6	166.5	147.8	234.9	164.9	98.2	94.9	314.3	505.0	377.9	147.6	241.3	240.3	187.5	231.2	155.0	118.8	138.5	232.8	315.3	328.8	128.6	212.5	207.9	254.6	161.2	136.7	268.1	110.2	182.6	272.9	183.9	175.3	324.4	279.9	180.1	202.1	296.9	312.9	131.0	261.6	161.1	263.1	156.6	70.4	403.7	80.1	199.1	166.2	76.2	229.7	145.4	300.0	225.1	111.0	154.9	155.5	197.7	260.4	212.2	100.6	623.8	235.8	161.0	108.2	218.0	319.7	65.0	90.7	148.9	284.2	332.5	197.2	118.5	75.9	169.1	37.4	70.5	48.2	215.3	43.8	39.5	109.8	181.6	44.6	37.0	48.4	64.5	68.6	132.1	48.8	70.4	217.3	220.4	216.5	304.6	224.3	219.6	214.2	219.8	215.8	221.1	218.9	234.9	329.6	105.8	70.0	39.2	332.6	378.9	328.7	264.3	231.1	44.6	254.0	244.3	395.2	161.5	160.3	191.3	16.7	685.3	219.3	199.1	643.7	307.1	387.8	144.6	161.1	352.6	128.0	611.8	55.7	253.8	581.2	323.0	101.9	120.0	167.1	127.2	275.9	240.6	974.2	43.7	43.1	154.7	189.2	451.6	786.3	496.6	288.6	415.7	368.2	31.9	409.1	325.7	209.1	27.2	39.7	260.1	200.9	266.7	187.1	247.7	321.4	697.8	198.8	53.7	256.4	186.0	304.1	316.5	173.3	354.5	440.8	618.3	181.0	259.4	180.6	337.9
SNX31	MGC39715	ENSG00000174226	"Sorting nexin 31"	Q8N9S9	8	100572889-100663415	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 6.5;urinary bladder: 16.4"	"Cell type enriched"	"Detected in some"	4	"Early spermatids: 81.8"	"Cancer enriched"	"Detected in many"	22	"urothelial cancer: 24.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	49	"RT4: 80.7"	"Region enriched"	"Detected in single"	5	"thalamus: 2.6"	"Not detected"	"Not detected"			"HPA024284, HPA053466"	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 29: Early spermatids - Spermatogenesis"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA024284: AB_1853894, HPA053466: AB_2682161"	"unprognostic (1.39e-1)"	"unprognostic (3.83e-2)"	"unprognostic (7.99e-2)"	"unprognostic (1.52e-1)"	"unprognostic (7.20e-5)"	"unprognostic (1.04e-1)"	"unprognostic (1.01e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.21e-1)"	"unprognostic (2.09e-2)"	"unprognostic (1.69e-1)"	"unprognostic (7.79e-3)"	"unprognostic (1.66e-1)"	"prognostic favorable (1.47e-4)"	"unprognostic (2.54e-1)"	"unprognostic (4.05e-2)"	0.6	0.1	1.0	0.0	1.2	0.2	0.4	0.8	3.1	0.4	0.6	0.3	0.0	0.3	0.2	6.5	0.3	1.1	1.7	1.0	1.1	0.2	0.5	0.1	0.4	0.0	0.0	0.4	0.3	0.3	0.2	0.0	0.0	1.4	0.1	0.2	1.2	0.2	0.6	0.6	0.1	0.5	0.4	0.1	0.7	4.0	0.7	0.3	0.5	0.5	3.6	16.4	1.7	1.5	0.0	0.0	0.0	0.3	0.4	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.0	0.0	0.6	0.1	0.1	0.1	0.1	0.0	0.0	0.0	80.7	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.3	1.6	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	1.0	1.2	0.8	3.1	1.0	1.1	0.0	0.0	0.0	0.4	0.7	1.5	0.5	0.0	0.0	6.2	0.1	0.4	3.3	0.2	9.6	0.0	0.2	0.6	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.0	1.9	0.0	81.8	0.2	0.1	0.4	0.0	0.0	12.8	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	5.1	0.0	0.0	0.0	0.0	19.7	0.6	0.2	0.0	1.0	0.0	0.0	0.0	1.0	0.9	0.0	0.0	1.2	0.1	0.8	0.0	0.1	0.0	0.0	0.0	0.3	3.7	0.3	0.5	9.7	0.4	0.0	0.1	0.0	0.0	6.0
SOAT2	ACAT2	ENSG00000167780	"Sterol O-acyltransferase 2"	O75908	12	53103486-53124535	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Cholesterol metabolism, Lipid metabolism, Steroid metabolism, Sterol metabolism"	"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"intestine: 19.5"	"Cell type enriched"	"Detected in some"	5	"Proximal enterocytes: 14.3"	"Group enriched"	"Detected in some"	8	"liver cancer: 5.2;testis cancer: 5.5"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"MAIT T-cell: 1.1"	"Lineage enriched"	"Detected in single"	5	"T-cells: 1.1"	"Group enriched"	"Detected in some"	5	"CACO-2: 9.5;Hep G2: 22.6;U-266/70: 7.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (2.53e-1)"	"unprognostic (2.72e-3)"	"unprognostic (1.15e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.30e-4)"	"unprognostic (3.88e-3)"	"unprognostic (9.26e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.29e-1)"	"unprognostic (1.06e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.83e-2)"	"unprognostic (9.05e-2)"	"unprognostic (2.37e-1)"	"unprognostic (7.58e-3)"	"unprognostic (3.28e-1)"	0.3	0.0	0.0	0.1	0.0	0.2	0.3	0.0	0.1	0.8	0.0	0.2	11.6	0.4	0.2	0.1	0.6	0.4	0.1	0.0	0.0	0.4	2.9	0.1	0.3	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.4	0.1	0.0	0.4	0.1	0.0	0.3	19.5	0.0	0.0	2.1	0.2	0.2	0.0	0.1	0.2	0.1	0.2	0.3	0.6	0.0	0.2	0.2	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.3	0.4	9.5	0.1	0.0	0.0	0.5	0.0	0.8	0.0	0.0	0.7	0.0	0.0	1.0	0.0	22.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.4	2.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	7.2	1.4	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.4	0.7	0.0	0.0	0.1	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.3	1.5	0.6	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.1	1.3	0.0	0.0	0.0	0.2	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.2	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.2	0.0	2.5	0.0	0.0	0.0	14.3	0.8	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.0	0.6	0.0	0.3	0.0
SON	"BASS1, C21orf50, DBP-5, FLJ21099, FLJ33914, KIAA1019, NREBP"	ENSG00000159140	"SON DNA and RNA binding protein"	P18583	21	33543038-33577481	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023535, HPA031755, HPA031756"	Supported		Enhanced	"Nuclear speckles"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 32: U-937 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	"Nuclear speckles"		"HPA023535: AB_1857362, HPA031755: AB_2674029, HPA031756: AB_2674030"	"unprognostic (1.58e-2)"	"unprognostic (2.08e-1)"	"unprognostic (4.69e-1)"	"unprognostic (2.30e-1)"	"unprognostic (5.63e-2)"	"unprognostic (2.75e-1)"	"unprognostic (4.22e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.05e-1)"	"unprognostic (2.31e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.75e-2)"	"unprognostic (4.18e-1)"	"unprognostic (9.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.54e-1)"	69.1	62.5	45.6	57.8	52.1	161.9	65.0	56.4	58.6	59.4	71.9	64.1	44.9	66.9	61.5	60.7	68.5	43.2	60.3	43.7	45.7	49.4	60.3	65.2	81.0	49.8	46.8	76.7	63.4	92.8	63.9	60.9	51.3	61.2	56.4	91.8	64.3	52.6	89.4	64.1	67.8	51.1	47.6	71.5	66.8	48.0	47.8	92.8	64.4	53.8	76.2	62.9	55.9	65.8	105.7	59.7	126.1	72.7	108.1	98.3	89.2	77.2	88.1	73.0	69.6	89.5	75.2	163.8	45.9	114.8	86.6	76.4	152.4	113.0	109.7	85.4	77.9	220.0	78.2	111.3	79.3	215.0	110.8	100.6	128.7	88.0	124.5	91.3	110.1	91.2	172.9	150.9	101.1	101.6	121.0	112.9	136.0	108.5	60.7	121.5	133.8	118.1	109.7	102.1	84.1	77.6	124.2	100.3	91.3	103.6	93.6	128.3	116.0	83.4	73.1	66.6	87.0	144.8	143.2	193.9	84.7	172.3	78.9	33.7	20.3	28.7	20.7	18.4	20.8	30.4	22.9	22.1	15.8	28.2	22.7	22.3	37.4	22.3	24.5	38.5	22.1	15.8	45.6	52.1	56.4	58.6	43.7	45.7	49.8	46.8	51.3	47.6	47.8	65.8	374.1	410.3	298.2	201.4	355.2	433.1	312.2	310.6	250.4	389.7	213.1	219.2	351.5	320.3	298.0	301.6	221.0	224.1	423.2	276.8	193.7	209.7	97.0	296.9	412.2	342.1	186.8	375.8	93.1	207.3	164.7	333.4	208.0	335.8	418.2	216.1	304.8	344.6	170.1	455.9	105.8	256.0	219.7	237.2	307.4	66.0	393.9	261.0	218.7	146.1	256.8	335.7	347.1	131.7	162.3	190.0	217.2	393.4	294.4	250.7	198.0	225.7	288.3	372.0	381.3	505.0	399.2	470.1	334.6	197.8	394.2	327.1	378.2	183.2	246.3	226.5
SORCS1		ENSG00000108018	"Sortilin related VPS10 domain containing receptor 1"	Q8WY21	10	106573663-107164534	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 10.3;thyroid gland: 11.0"	"Group enriched"	"Detected in some"	7	"Excitatory neurons: 522.2;Inhibitory neurons: 179.7;Oligodendrocyte precursor cells: 381.5"	"Cancer enhanced"	"Detected in some"		"melanoma: 3.2"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	12	"RH-30: 80.8;SH-SY5Y: 104.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011948	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane, Cytosol"		"HPA011948: AB_1857366"	"unprognostic (5.86e-3)"	"unprognostic (8.45e-3)"	"unprognostic (1.55e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.92e-2)"	"unprognostic (3.52e-2)"	"unprognostic (5.58e-2)"	"unprognostic (6.82e-3)"	"unprognostic (5.81e-2)"	"unprognostic (6.48e-4)"	"unprognostic (2.51e-2)"	"unprognostic (8.89e-3)"	"unprognostic (2.22e-1)"	"unprognostic (2.69e-4)"	0.6	3.1	3.0	1.9	6.2	0.0	1.3	0.0	10.3	2.5	0.0	9.4	0.7	1.1	0.3	0.9	1.6	1.1	3.1	5.4	5.8	4.7	0.1	0.1	1.0	0.6	4.5	0.7	1.6	0.0	0.9	0.0	2.7	2.2	1.9	9.6	1.1	2.5	0.3	1.5	3.6	1.4	0.5	0.8	2.5	1.2	5.8	1.0	11.0	1.7	1.5	3.6	2.8	6.6	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.9	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	1.6	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	1.6	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	80.8	0.1	0.0	0.0	0.0	104.9	0.0	0.0	3.3	0.3	0.0	0.0	0.0	0.0	0.6	6.1	0.0	0.0	0.0	0.0	0.0	0.0	7.9	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.0	6.2	0.0	10.3	5.4	5.8	0.6	4.5	2.7	0.5	5.8	6.6	0.0	0.0	0.5	7.2	0.0	0.6	0.0	0.0	1.2	2.0	0.1	0.5	2.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.1	16.6	0.1	4.9	0.2	0.0	0.0	522.2	0.0	0.0	3.6	0.0	0.1	0.0	1.0	0.0	0.0	0.2	1.7	179.7	0.0	0.0	0.3	0.3	5.2	0.0	0.2	1.8	26.2	0.0	49.1	0.0	381.5	10.0	0.1	0.0	0.4	0.0	0.0	0.0	2.2	0.0	2.1	0.0	1.0	0.3	0.2	1.9	0.2	0.1	0.0	0.3	0.0	0.0	0.0
SORCS3	"KIAA1059, SORCS"	ENSG00000156395	"Sortilin related VPS10 domain containing receptor 3"	Q9UPU3	10	104641290-105265242	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	6	"brain: 11.7"	"Group enriched"	"Detected in some"	15	"Excitatory neurons: 270.4;Inhibitory neurons: 193.7;Oligodendrocyte precursor cells: 462.9"	"Group enriched"	"Detected in some"	13	"glioma: 1.8;renal cancer: 2.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RPTEC TERT1: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 65: Brain - Ion transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"				"unprognostic (2.39e-2)"			"unprognostic (8.47e-2)"	"unprognostic (1.39e-1)"	"unprognostic (3.20e-1)"		"unprognostic (1.98e-1)"	"unprognostic (3.63e-1)"	"unprognostic (4.78e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.01e-1)"	"prognostic unfavorable (5.72e-4)"	"unprognostic (2.63e-2)"	"unprognostic (1.97e-1)"			0.2	2.0	6.5	0.1	7.7	0.0	0.1	1.8	7.5	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.2	0.0	7.0	11.7	0.2	0.0	0.0	0.0	3.6	4.1	0.8	0.0	0.0	0.2	0.0	2.2	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.1	0.2	1.7	0.0	0.1	1.0	10.3	0.0	0.0	0.0	0.1	0.0	0.0	4.8	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.5	7.7	1.8	7.5	7.0	11.7	3.6	4.1	2.2	1.7	10.3	4.8	0.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	19.5	0.0	0.1	0.1	0.0	0.0	270.4	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	193.7	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.0	3.7	0.0	0.0	0.0	462.9	4.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.8	1.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SORL1	"C11orf32, gp250, LR11, LRP9, SorLA, SorLA-1"	ENSG00000137642	"Sortilin related receptor 1"	Q92673	11	121452314-121633763	"Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Transport"	Receptor	"Alzheimer disease, Amyloidosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 79.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 387.8;Excitatory neurons: 247.4;Microglial cells: 404.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 125.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 125.7"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 142.8;Daudi: 68.7;OE19: 93.5;RT4: 102.1;U-698: 139.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011500, HPA031321"	Uncertain				"Secreted to blood"	NA	NA		79000	"Cluster 5: Granulocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"CAB011500: AB_443414, HPA031321: AB_2673826"	"unprognostic (1.54e-1)"	"unprognostic (1.74e-1)"	"unprognostic (4.08e-2)"	"unprognostic (9.53e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.59e-3)"	"unprognostic (1.74e-1)"	"unprognostic (1.86e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.45e-1)"	"prognostic favorable (1.80e-7)"	"unprognostic (2.48e-1)"	"unprognostic (1.87e-1)"	"unprognostic (5.07e-2)"	"unprognostic (1.21e-2)"	7.0	6.1	29.1	24.4	39.1	47.4	13.9	49.5	35.5	44.4	0.0	17.3	11.6	5.4	8.9	5.4	40.1	7.3	2.4	33.8	39.7	19.0	58.2	10.4	21.1	40.3	46.8	9.0	8.0	10.4	16.8	2.3	47.0	20.8	16.9	20.3	21.8	25.4	1.7	3.4	18.1	4.5	45.3	21.8	10.3	5.1	38.8	17.0	13.5	4.0	23.0	15.7	6.6	79.1	1.3	8.1	7.3	1.1	0.0	0.0	7.4	0.4	2.4	0.3	0.0	11.9	142.8	68.7	8.5	1.8	10.5	47.4	9.1	7.0	0.1	0.0	2.6	0.0	10.3	16.8	0.1	29.6	0.1	0.0	7.6	0.0	25.8	4.0	0.0	8.7	0.0	0.7	0.0	9.7	7.1	15.3	8.8	93.5	10.8	7.7	0.4	1.6	15.8	102.1	5.1	1.5	15.2	21.5	0.0	16.0	21.0	9.5	0.3	0.1	4.9	1.0	0.0	0.0	0.0	139.8	0.1	38.6	0.4	44.3	15.9	59.1	22.1	6.9	29.3	1.9	24.6	20.0	6.6	5.1	23.1	20.8	125.7	20.9	9.4	16.4	19.3	21.2	29.1	39.1	49.5	35.5	33.8	39.7	40.3	46.8	47.0	45.3	38.8	79.1	1.6	6.4	23.3	160.9	20.7	4.5	42.3	23.3	18.2	68.8	44.5	22.0	12.3	18.6	36.8	79.1	387.8	0.4	130.1	132.1	0.0	10.3	1.2	21.6	2.9	10.3	6.1	8.8	247.4	0.7	0.7	5.8	14.3	24.7	12.0	20.6	34.6	114.5	39.1	50.5	80.1	54.6	40.7	62.4	16.9	5.0	77.9	67.0	3.6	404.7	97.5	28.0	146.2	74.9	86.0	6.4	81.1	57.9	28.6	36.1	168.6	1.0	15.6	31.2	0.0	19.5	10.3	2.9	18.8	20.8	2.4	0.4	60.2	32.7	42.2	33.4
SORT1	"Gp95, NT3"	ENSG00000134243	"Sortilin 1"	Q99523	1	109309568-109397918	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Endocytosis, Osteogenesis, Transport"	"Developmental protein, Receptor"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 285.6"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 447.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 9.2;non-classical monocyte: 10.8"	"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006889, CAB011498"	Enhanced		Supported	"Golgi apparatus,Plasma membrane,Cytosol"		NA	NA	7170000	110000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Golgi apparatus, Cytosol"	"Plasma membrane"	"CAB011498: AB_2192606, HPA006889: AB_1080056"	"unprognostic (2.10e-2)"	"unprognostic (7.46e-2)"	"prognostic favorable (7.74e-6)"	"unprognostic (4.12e-1)"	"unprognostic (9.41e-2)"	"unprognostic (1.40e-1)"	"prognostic unfavorable (1.23e-4)"	"unprognostic (3.34e-3)"	"unprognostic (4.27e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.42e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.45e-2)"	"unprognostic (2.15e-1)"	"unprognostic (3.95e-1)"	"unprognostic (4.46e-3)"	48.2	11.3	71.0	12.0	168.3	21.4	25.1	124.3	114.2	17.7	21.5	29.5	22.1	24.7	139.8	41.5	27.5	17.8	64.7	131.8	90.0	38.7	6.5	37.4	2.8	151.9	133.8	6.1	17.5	46.5	11.3	44.8	153.1	18.3	26.9	40.0	25.2	44.0	85.0	19.0	21.9	27.8	102.8	10.2	18.2	43.5	118.0	6.4	42.7	71.8	10.3	16.9	18.0	285.6	38.8	15.3	37.5	45.8	107.0	21.2	107.3	28.2	44.9	27.2	29.0	39.8	14.0	0.3	35.2	11.9	19.9	9.4	44.7	22.3	38.9	1.1	21.2	10.7	23.5	43.1	41.8	0.2	33.5	53.2	3.6	33.3	7.3	72.6	4.2	31.7	81.3	4.0	38.7	41.1	27.9	0.8	14.1	17.5	6.3	30.7	87.9	18.9	52.0	27.8	38.3	21.8	16.6	109.3	120.6	53.1	46.1	6.7	1.1	5.8	21.7	1.0	47.6	37.0	32.2	0.3	9.8	0.3	24.3	0.0	7.1	2.5	0.0	9.2	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	1.8	0.4	10.8	1.6	0.0	2.0	71.0	168.3	124.3	114.2	131.8	90.0	151.9	133.8	153.1	102.8	118.0	285.6	10.6	38.5	47.9	54.5	1.9	1.3	4.7	6.7	1.2	14.9	27.5	14.2	98.9	27.1	20.3	75.4	35.5	30.6	3.2	70.2	5.9	23.9	65.1	33.2	5.2	15.9	16.8	4.0	87.9	23.7	30.2	9.8	16.8	34.9	7.6	10.4	7.9	22.1	30.1	13.5	56.7	27.7	6.1	38.7	9.9	79.7	8.7	34.6	21.4	78.7	37.7	21.7	0.0	48.7	447.8	25.6	23.2	49.7	1.5	7.1	64.0	13.1	29.6	50.7	32.9	25.1	53.6	46.3	21.6	9.3	1.8	36.8	2.1	1.8	28.3	10.8
SPAST	"ADPSP, FSP2, KIAA1083, SPG4"	ENSG00000021574	Spastin	Q9UBP0	2	32063556-32157637	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cell cycle, Cell division, Differentiation, Neurogenesis"	"Allosteric enzyme, Developmental protein, Isomerase"	"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 55.2;Oligodendrocyte precursor cells: 59.3;Oligodendrocytes: 62.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017311	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 24: NB-4 - Immune response"	"Cluster 44: Endometrium - Transcription"	Nucleoplasm	Cytosol	"HPA017311: AB_1857415"	"unprognostic (1.89e-1)"	"unprognostic (1.59e-2)"	"unprognostic (5.33e-2)"	"unprognostic (3.90e-2)"	"unprognostic (3.75e-2)"	"unprognostic (4.00e-2)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (3.26e-2)"	"unprognostic (2.35e-2)"	"unprognostic (7.39e-2)"	"unprognostic (5.98e-2)"	"unprognostic (3.52e-1)"	"prognostic unfavorable (4.15e-4)"	"unprognostic (5.71e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.13e-1)"	5.8	5.9	9.0	7.2	12.7	9.9	6.2	10.8	12.9	8.6	1.6	7.1	7.4	7.7	5.0	6.9	6.5	6.5	3.9	9.0	10.6	5.9	9.6	6.3	9.7	10.8	11.2	9.1	5.3	6.2	4.4	6.8	10.5	6.3	7.5	6.9	4.2	5.3	7.8	7.4	8.0	7.3	11.6	7.0	6.3	9.8	10.7	14.1	8.5	10.0	9.2	7.3	4.4	13.9	17.5	12.2	19.7	19.5	12.0	14.2	17.8	9.4	13.7	9.7	8.6	16.9	14.8	30.2	8.5	13.1	14.2	12.0	19.5	9.6	11.9	20.7	11.8	33.3	6.0	20.5	11.0	23.2	22.4	7.9	12.3	12.4	11.6	11.7	21.5	9.6	27.6	10.0	10.7	7.4	37.8	19.4	20.5	19.2	7.1	19.8	27.9	19.5	13.0	10.7	27.9	29.9	16.0	13.2	15.9	16.0	8.7	15.8	18.8	10.6	16.2	9.5	11.1	14.7	29.7	23.8	11.6	19.9	13.0	1.8	3.5	3.8	1.8	4.9	2.5	2.4	2.8	2.9	3.9	1.9	2.9	3.0	5.3	3.9	3.8	1.7	4.2	2.5	9.0	12.7	10.8	12.9	9.0	10.6	10.8	11.2	10.5	11.6	10.7	13.9	15.0	9.6	4.4	26.4	12.2	9.6	5.9	7.9	11.4	15.4	11.7	6.9	8.0	8.6	7.9	5.5	22.9	9.6	21.4	11.4	0.0	6.6	4.4	16.9	11.8	11.3	10.8	10.3	38.9	8.0	7.4	8.1	9.7	13.7	10.1	16.7	7.9	12.0	9.7	10.1	55.2	10.8	10.2	17.5	9.9	8.5	8.7	17.6	1.8	36.5	21.1	7.9	18.6	59.3	62.7	10.4	9.8	10.1	12.5	8.7	10.9	7.0	13.0	14.1	0.0	11.9	11.9	16.7	21.2	11.7	13.1	8.1	13.3	10.9	10.4	7.2
SPNS1	"HSpin1, LAT, nrs, PP2030, SLC62A1, SPIN1, SPINL"	ENSG00000169682	"Sphingolipid transporter 1 (putative)"	Q9H2V7	16	28974221-28984548	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041995, HPA042988"	Enhanced		Approved	"Nucleoli fibrillar center,Golgi apparatus,Vesicles,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 24: NB-4 - Immune response"	"Cluster 51: Myeloid cells - Hemostasis"	Vesicles	"Nucleoli fibrillar center, Golgi apparatus, Cytosol"	"HPA041995: AB_10959609, HPA042988: AB_10964587"	"unprognostic (3.54e-2)"	"unprognostic (4.57e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.08e-1)"	"unprognostic (3.66e-1)"	"unprognostic (7.86e-5)"	"unprognostic (1.01e-1)"	"unprognostic (2.00e-1)"	"unprognostic (1.27e-1)"	"unprognostic (4.12e-2)"	"unprognostic (3.02e-3)"	"unprognostic (8.85e-7)"	"unprognostic (1.48e-1)"	"unprognostic (6.15e-2)"	"unprognostic (1.26e-3)"	"unprognostic (1.12e-2)"	26.8	30.8	17.0	19.3	17.4	37.0	24.8	17.1	26.3	27.7	18.6	32.5	22.4	30.9	6.6	25.9	23.0	18.0	27.5	16.9	15.7	32.1	33.9	31.5	20.1	19.1	16.6	22.0	24.4	20.8	21.1	19.8	17.2	26.5	10.0	6.5	24.4	14.9	25.0	35.7	27.8	15.1	15.8	33.9	28.2	20.3	19.8	20.8	27.8	14.9	10.5	30.5	25.2	18.3	25.9	59.6	22.2	51.9	41.5	22.8	62.9	28.2	28.9	46.1	40.9	55.0	60.4	16.4	67.8	25.5	38.2	53.3	36.4	31.2	16.4	19.0	61.6	23.8	57.1	69.3	70.4	26.7	49.2	38.4	40.9	49.7	21.0	26.8	42.9	30.0	54.4	28.7	23.4	68.8	29.3	75.8	52.6	20.8	39.1	36.7	26.7	73.6	24.9	24.8	39.5	51.3	20.1	59.3	44.9	18.5	59.2	31.9	36.6	37.3	28.2	52.7	22.0	43.2	36.7	15.6	47.7	40.4	30.8	13.4	32.8	13.5	9.9	42.1	8.3	5.7	9.8	13.0	27.6	4.3	10.0	6.8	5.6	7.7	28.8	11.5	12.1	18.1	17.0	17.4	17.1	26.3	16.9	15.7	19.1	16.6	17.2	15.8	19.8	18.3	24.4	6.4	7.2	8.8	14.9	21.3	21.3	29.8	14.8	31.0	17.2	15.7	0.3	20.0	20.1	20.2	29.2	63.3	26.5	10.5	13.7	58.1	2.1	15.3	19.2	24.1	12.2	21.8	10.2	45.7	72.3	24.6	16.8	18.9	22.7	40.9	19.2	14.3	98.7	26.9	10.3	13.8	46.8	45.6	28.4	3.7	22.7	61.8	33.8	15.0	32.7	28.5	24.7	7.1	8.6	37.3	16.0	16.6	18.6	14.4	41.5	18.2	26.2	38.6	6.6	17.4	23.8	24.8	33.5	16.4	22.7	87.3	20.7	37.8	20.0	19.4
SPNS2	SLC62A2	ENSG00000183018	"Sphingolipid transporter 2"	Q8IVW8	17	4498881-4539035	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 51.0"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.7;Endothelial cells: 34.5;Microglial cells: 37.5;Oligodendrocytes: 97.8;Urothelial cells: 39.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 31.0;RPTEC TERT1: 161.7;SK-BR-3: 76.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA068717	Uncertain					NA	NA				"Cluster 27: Brain & Skin - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA068717: AB_2686021"	"unprognostic (3.03e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (2.78e-1)"	"unprognostic (6.30e-3)"	"unprognostic (1.10e-3)"	"unprognostic (2.33e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.99e-2)"	"unprognostic (2.98e-2)"	"unprognostic (4.48e-2)"	"unprognostic (2.20e-2)"	"unprognostic (1.68e-1)"	"unprognostic (2.19e-2)"	"unprognostic (6.89e-2)"	17.3	2.6	13.1	5.2	14.0	7.9	14.7	13.1	18.2	14.6	0.1	6.5	12.2	8.6	0.6	51.0	7.8	12.1	10.7	14.1	12.1	28.6	3.8	28.3	4.9	26.4	16.2	1.8	10.0	1.1	2.1	7.9	28.9	5.3	2.1	0.6	16.5	2.0	4.4	24.8	10.8	4.8	13.9	11.4	21.0	1.3	15.5	1.7	8.5	3.9	13.3	6.6	22.6	25.1	9.7	1.2	0.0	0.2	0.0	0.0	31.0	0.0	0.0	0.0	0.0	0.5	8.1	0.5	11.8	0.0	0.1	0.5	0.0	0.7	0.0	0.1	0.2	0.6	0.2	0.0	0.1	3.0	0.0	0.0	0.2	0.0	0.0	0.0	4.2	4.7	0.0	0.0	0.0	3.8	0.2	17.0	0.1	17.6	0.3	0.8	0.0	0.3	161.7	0.5	5.4	0.2	0.0	76.7	0.0	5.1	2.7	7.5	0.2	0.2	0.7	0.3	0.1	0.3	0.3	0.1	0.0	8.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	13.1	14.0	13.1	18.2	14.1	12.1	26.4	16.2	28.9	13.9	15.5	25.1	32.7	6.4	10.6	1.6	0.2	1.8	0.4	2.1	0.0	1.2	4.3	3.6	1.2	22.8	16.2	22.0	0.0	1.3	0.2	2.8	1.9	16.7	0.2	0.5	1.0	34.5	0.0	3.2	23.4	3.0	30.5	1.7	26.0	2.8	0.0	0.0	12.5	6.7	1.1	6.7	26.2	12.7	2.0	0.3	1.6	0.2	0.6	1.9	1.8	37.5	0.0	0.4	0.0	3.5	97.8	18.6	0.0	0.4	1.2	11.7	1.9	24.3	16.9	1.1	0.0	1.4	3.1	0.6	0.5	0.6	2.4	1.9	1.6	0.1	1.1	39.8
SPNS3	"MGC29671, SLC62A3"	ENSG00000182557	"Sphingolipid transporter 3 (putative)"	Q6ZMD2	17	4433940-4488208	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	8	"bone marrow: 31.2"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 30.9;Langerhans cells: 16.4;Proximal tubular cells: 51.8;T-cells: 23.7"	"Cancer enhanced"	"Detected in many"		"renal cancer: 2.6"	"Not detected"	"Not detected"			"Group enriched"	"Detected in many"	5	"eosinophil: 354.8;plasmacytoid DC: 127.7"	"Group enriched"	"Detected in many"	37	"dendritic cells: 127.7;granulocytes: 354.8"	"Group enriched"	"Detected in some"	4	"JURKAT: 29.5;NB-4: 46.8;THP-1: 35.5;U-937: 22.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA023928	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 24: NB-4 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"			"HPA023928: AB_1844393"	"unprognostic (4.39e-2)"	"unprognostic (8.10e-5)"	"unprognostic (2.37e-1)"	"unprognostic (1.27e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.94e-4)"	"unprognostic (2.86e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.81e-2)"	"unprognostic (6.46e-2)"	"unprognostic (1.37e-1)"	"unprognostic (3.96e-2)"	"prognostic unfavorable (8.09e-4)"	"unprognostic (6.18e-2)"	"unprognostic (6.57e-2)"	"unprognostic (4.13e-2)"	"unprognostic (9.69e-2)"	0.1	0.1	0.3	1.4	0.2	31.2	0.3	0.4	0.4	0.2	0.0	0.2	0.4	0.0	0.0	0.1	0.7	0.7	0.2	0.2	0.7	0.2	0.1	0.2	2.0	0.8	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.9	0.3	0.0	0.3	0.7	0.1	0.6	2.1	0.3	0.0	0.5	3.6	0.0	0.0	1.1	0.3	0.0	0.7	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	1.2	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.5	0.0	2.4	0.0	0.0	8.1	46.8	0.0	0.2	0.0	0.1	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.5	0.0	0.0	0.1	0.0	0.1	0.0	0.1	6.6	0.0	22.1	0.0	0.3	6.5	354.8	1.1	1.3	0.7	0.2	0.0	1.5	47.6	0.3	0.4	1.7	1.0	0.2	0.1	127.7	0.0	6.2	0.3	0.2	0.4	0.4	0.2	0.7	0.8	0.4	0.5	0.6	0.5	0.7	0.5	3.2	1.1	0.0	4.3	1.3	0.1	0.4	0.0	0.0	1.0	0.8	0.8	1.5	1.6	0.0	0.0	0.3	30.9	0.5	3.9	2.0	1.1	0.8	0.0	0.6	0.0	4.8	0.9	0.0	6.1	0.3	2.0	0.1	0.0	0.0	0.7	0.3	1.4	0.0	0.8	2.1	6.1	5.5	16.4	2.6	0.0	9.8	1.8	3.7	6.7	0.0	11.3	0.0	0.1	1.1	1.4	0.0	0.6	0.5	10.9	51.8	5.0	0.0	0.0	0.3	0.6	0.0	0.3	0.2	0.4	0.3	23.7	0.0	2.5	2.1
SPPL2A	"IMP3, PSL2"	ENSG00000138600	"Signal peptide peptidase like 2A"	Q8TCT8	15	50702266-50765709	"Enzymes, Plasma proteins, Predicted membrane proteins, Transporters"		"Hydrolase, Protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036062, HPA067304"	Enhanced		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA036062: AB_10611670, HPA067304: AB_2685820"	"unprognostic (1.66e-1)"	"unprognostic (1.03e-1)"	"unprognostic (2.70e-1)"	"unprognostic (5.82e-3)"	"unprognostic (3.71e-1)"	"unprognostic (1.70e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.88e-1)"	"unprognostic (2.22e-2)"	"unprognostic (6.36e-2)"	"unprognostic (2.04e-2)"	"unprognostic (4.00e-2)"	"unprognostic (3.11e-2)"	"unprognostic (2.26e-2)"	"unprognostic (1.44e-2)"	"unprognostic (6.96e-2)"	"unprognostic (3.66e-1)"	41.1	34.7	8.3	57.6	10.9	54.5	32.0	11.1	8.5	36.6	48.6	93.4	79.6	27.9	21.5	26.5	26.8	39.4	37.1	6.8	12.3	57.9	107.0	43.4	40.2	15.3	12.8	13.6	63.7	158.5	13.0	54.1	12.5	29.5	82.8	12.5	44.5	32.6	109.3	25.2	67.6	41.0	11.2	37.3	41.7	18.5	12.1	39.5	35.2	81.8	41.7	51.7	20.9	14.5	57.3	96.9	37.0	49.2	142.3	84.3	58.2	89.1	149.1	80.5	114.1	113.1	64.3	35.1	65.0	176.3	120.7	83.5	45.2	54.3	89.5	72.2	27.5	67.0	61.5	58.9	117.4	42.0	104.5	73.9	98.3	66.8	106.7	59.4	80.2	37.7	51.3	134.2	107.6	131.5	20.1	16.2	15.8	90.8	22.0	24.2	57.3	77.6	109.7	130.4	29.7	33.4	54.0	102.7	63.4	74.0	73.2	81.6	98.9	128.7	51.7	83.7	106.7	54.0	100.2	38.8	58.1	69.4	90.3	48.7	52.3	48.9	27.9	48.6	17.4	18.3	22.3	25.5	37.4	19.2	12.4	20.5	37.7	23.5	56.6	33.1	30.4	50.2	8.3	10.9	11.1	8.5	6.8	12.3	15.3	12.8	12.5	11.2	12.1	14.5	66.2	48.1	35.9	20.5	51.9	43.1	79.1	76.3	37.5	14.8	36.4	21.3	77.5	52.9	44.3	68.0	20.9	136.5	72.7	215.5	23.5	87.1	18.8	107.2	56.6	59.6	38.4	30.3	32.0	167.1	88.3	74.3	52.0	57.3	45.7	20.5	46.8	124.1	85.9	8.4	31.4	86.5	36.7	68.7	55.7	7.0	44.7	83.0	32.0	23.4	134.5	27.5	64.9	25.6	26.2	131.9	127.3	36.5	49.9	92.2	143.0	46.8	41.8	17.2	26.3	88.0	51.6	31.7	15.3	39.3	38.8	204.5	60.6	30.8	76.0	94.1
SPRN	"bA108K14.1, FLJ41197, Shadoo"	ENSG00000203772	"Shadow of prion protein"	Q5BIV9	10	133420666-133424572	"Predicted intracellular proteins, Transporters"		Prion		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 13.4;liver: 17.7"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 7.5;Hepatocytes: 22.5;Horizontal cells: 3.3;Inhibitory neurons: 5.1;Oligodendrocyte precursor cells: 5.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in some"			"Low region specificity"	"Detected in all"												"Intracellular and membrane"	NA	NA				"Cluster 35: Non-specific - Unknown function"	"Cluster 20: HeLa - Mitochondria"	"Cluster 15: Hepatocytes - Hemostasis"				"unprognostic (2.66e-1)"	"unprognostic (1.64e-3)"	"unprognostic (3.38e-3)"	"unprognostic (1.95e-1)"	"unprognostic (1.35e-1)"	"unprognostic (3.31e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.90e-3)"	"unprognostic (1.68e-1)"	"unprognostic (2.07e-1)"	"prognostic favorable (1.54e-6)"	"unprognostic (1.88e-2)"	"prognostic unfavorable (3.95e-4)"	"unprognostic (1.76e-2)"	"unprognostic (1.13e-1)"	"unprognostic (7.17e-2)"	"prognostic favorable (1.58e-7)"	1.5	4.1	6.2	0.3	8.4	0.0	1.6	5.9	13.4	2.2	0.0	2.4	0.5	1.6	0.0	2.9	1.8	0.2	1.7	7.7	1.4	5.4	17.7	1.7	0.1	0.9	1.9	2.1	3.0	0.2	5.1	0.2	0.2	3.7	0.0	0.6	2.1	0.0	1.9	1.9	3.3	0.3	0.2	4.7	3.6	3.1	2.6	0.0	3.5	0.0	0.0	1.7	2.0	4.3	0.6	0.2	0.4	0.9	0.0	0.0	1.2	1.6	0.0	0.7	0.1	1.2	0.5	1.2	0.3	1.6	0.0	0.9	0.5	0.0	0.0	0.6	1.3	0.3	2.3	0.8	0.2	1.6	0.5	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.6	0.4	0.4	0.8	0.6	1.2	0.5	0.0	0.3	2.2	0.4	0.4	0.0	0.4	0.2	0.8	0.0	0.1	0.8	0.2	0.4	0.3	0.6	0.6	1.1	0.8	0.9	0.8	0.7	1.1	0.3	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.2	8.4	5.9	13.4	7.7	1.4	0.9	1.9	0.2	0.2	2.6	4.3	0.1	0.0	0.0	1.3	0.7	0.0	0.0	0.0	0.0	2.4	0.0	0.1	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.2	0.7	0.0	0.0	7.5	0.0	0.0	0.4	0.0	0.1	0.0	0.0	1.4	22.5	0.0	3.3	5.1	0.0	0.0	2.1	0.0	0.3	0.3	0.0	0.0	0.0	0.1	0.5	0.0	5.0	0.4	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SRC	"ASV, c-src, SRC1"	ENSG00000197122	"SRC proto-oncogene, non-receptor tyrosine kinase"	P12931	20	37344685-37406050	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell adhesion, Cell cycle, Host-virus interaction, Immunity"	"Kinase, Transferase, Tyrosine-protein kinase"	"Cancer-related genes, Disease variant, FDA approved drug targets, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 42.0;Gastric mucus-secreting cells: 43.8;Langerhans cells: 46.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"intermediate monocyte: 2.4;non-classical monocyte: 2.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 1.4;monocytes: 2.4"	"Cell line enhanced"	"Detected in many"		"A549: 110.8;HBEC3-KT: 102.6;RT4: 106.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB004023, HPA030875"	Approved		Supported	"Nucleoplasm,Plasma membrane,Cell Junctions,Cytosol"		NA	NA		3200000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 15: RT4 - Unknown function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Plasma membrane, Cell Junctions"	"Nucleoplasm, Cytosol"	"CAB004023: AB_2106059, HPA030875: AB_2673640"	"unprognostic (5.58e-2)"	"unprognostic (9.83e-2)"	"unprognostic (3.56e-1)"	"unprognostic (4.54e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (4.90e-5)"	"unprognostic (3.89e-2)"	"unprognostic (7.04e-2)"	"unprognostic (8.13e-2)"	"unprognostic (1.54e-2)"	"prognostic unfavorable (1.63e-4)"	"prognostic unfavorable (1.22e-4)"	"unprognostic (2.33e-2)"	"unprognostic (4.72e-2)"	"unprognostic (3.65e-2)"	"prognostic favorable (5.22e-5)"	9.7	25.3	5.7	13.3	5.2	8.4	10.1	0.4	6.2	25.1	1.5	30.3	39.8	31.9	3.2	26.1	23.8	27.9	8.8	6.4	5.5	21.4	4.3	16.1	6.3	2.6	3.4	23.6	30.8	11.1	15.9	8.1	2.2	30.8	17.1	5.5	11.8	27.4	2.4	13.0	38.8	17.2	1.7	14.2	39.9	25.2	5.0	6.1	9.8	1.5	8.1	35.6	24.6	3.0	24.6	110.8	24.9	22.6	9.3	14.7	51.6	22.0	18.9	26.3	16.6	41.9	21.5	0.7	13.4	40.2	29.9	43.5	15.1	102.6	10.3	0.1	13.7	6.2	3.9	65.9	22.0	0.3	9.3	15.7	34.2	17.3	22.8	29.4	24.3	14.2	0.6	0.2	4.4	16.7	6.0	0.8	11.7	67.3	98.8	26.5	6.6	0.7	11.0	106.3	23.1	83.6	25.0	34.5	27.2	19.1	31.1	9.0	35.8	31.4	20.9	11.7	20.1	0.3	0.8	0.3	22.1	0.1	24.0	0.0	1.6	0.0	0.0	2.4	0.0	0.1	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.3	2.3	1.4	0.0	1.0	5.7	5.2	0.4	6.2	6.4	5.5	2.6	3.4	2.2	1.7	5.0	3.0	1.0	3.2	1.7	3.3	4.1	8.2	12.5	9.5	10.8	6.5	6.2	7.5	2.2	18.6	4.7	12.9	2.1	2.3	4.9	42.0	1.9	12.2	1.8	6.4	10.7	1.4	16.8	0.4	9.5	18.7	8.3	7.2	43.8	12.4	0.0	14.8	1.1	1.6	5.7	3.3	9.1	29.2	8.2	9.4	46.3	3.3	10.8	22.8	1.8	9.4	9.7	4.4	1.0	9.0	0.6	39.1	19.2	17.3	4.3	18.0	36.7	9.3	5.6	5.2	13.1	1.8	6.7	0.3	1.1	11.2	9.1	2.3	1.0	2.9	16.9	36.6
SRD5A2		ENSG00000277893	"Steroid 5 alpha-reductase 2"	P31213	2	31522480-31580938	"Cancer-related genes, Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Differentiation, Sexual differentiation"	Oxidoreductase	"Cancer-related genes, Disease variant, FDA approved drug targets, Pseudohermaphroditism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	15	"epididymis: 23.5;fallopian tube: 20.4;liver: 60.8;prostate: 16.8;seminal vesicle: 18.0"	"Group enriched"	"Detected in some"	5	"Early spermatids: 71.7;Endometrial ciliated cells: 29.6;Hepatocytes: 20.0;Late spermatids: 59.9"	"Group enriched"	"Detected in some"	6	"endometrial cancer: 1.1;liver cancer: 4.2;prostate cancer: 3.2"	"Region enriched"	"Detected in single"	11	"midbrain: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"RT4: 1.5"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 85: Liver - Metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 34: Spermatids - Unknown function"				"unprognostic (6.75e-3)"	"unprognostic (2.00e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.08e-3)"	"unprognostic (5.92e-3)"	"unprognostic (3.37e-2)"	"unprognostic (2.79e-3)"	"unprognostic (6.56e-2)"	"unprognostic (9.10e-2)"	"unprognostic (1.39e-2)"	"unprognostic (3.06e-2)"	"unprognostic (9.79e-3)"	"unprognostic (6.61e-6)"	"unprognostic (4.37e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.85e-1)"	"unprognostic (3.48e-3)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	23.5	0.0	20.4	0.0	0.0	0.0	0.0	0.3	60.8	0.7	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	16.8	0.0	0.1	0.0	18.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	1.4	0.0	0.2	0.0	0.0	0.0	1.6	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.6	0.1	0.0	6.2	0.0	0.0	0.0	0.0	0.0	0.6	2.8	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	71.7	29.6	0.2	0.2	0.0	0.0	0.9	0.0	0.0	1.9	0.0	0.5	0.0	0.0	0.4	20.0	0.0	0.0	1.0	0.0	0.0	0.3	0.0	59.9	0.6	0.1	0.0	3.7	0.0	0.0	0.0	0.5	0.9	0.1	0.0	1.2	0.0	0.7	0.0	0.3	7.3	0.0	0.0	0.0	0.2	1.2	0.8	0.0	0.0	0.0	0.1	0.0	0.0	8.6
SRP14	"ALURBP, MGC14326"	ENSG00000140319	"Signal recognition particle 14"	P37108	15	40035690-40039181	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA053738, HPA065118"			Approved	Nucleoplasm,Nucleoli		NA	NA		440000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoli	Nucleoplasm	"HPA053738: , HPA065118: "	"unprognostic (2.52e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.04e-1)"	"unprognostic (5.39e-3)"	"unprognostic (2.97e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-1)"	"unprognostic (7.99e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.28e-1)"	"prognostic favorable (5.31e-4)"	"unprognostic (2.20e-1)"	"unprognostic (8.03e-3)"	"unprognostic (1.41e-3)"	"unprognostic (4.94e-2)"	309.1	307.5	330.1	118.1	327.1	252.7	300.4	323.8	426.0	301.7	320.4	272.5	121.5	311.2	282.1	257.7	270.7	155.8	390.1	317.9	349.3	391.5	229.5	220.8	168.0	357.0	402.7	323.5	192.4	324.3	306.8	143.8	339.7	264.4	158.9	212.8	237.8	158.9	354.7	201.2	215.7	163.4	321.1	219.7	247.6	165.6	326.2	276.9	275.6	338.5	172.9	266.7	253.9	355.1	131.8	163.7	399.5	301.4	300.0	275.5	189.4	232.4	265.0	213.4	223.3	297.8	113.7	107.9	245.0	305.1	319.5	216.6	322.8	260.9	207.0	257.5	230.3	258.3	530.2	364.0	231.4	238.2	211.8	276.0	298.3	177.8	213.3	391.0	360.6	297.7	280.2	204.2	356.3	204.5	370.2	291.4	217.6	520.1	301.3	247.6	176.8	192.6	477.5	401.7	287.2	255.0	231.2	243.2	171.2	243.7	332.8	448.6	290.9	240.4	160.3	229.4	171.1	161.8	494.7	291.0	234.7	255.4	229.7	729.8	525.0	875.7	484.5	485.8	473.9	600.9	547.9	549.0	562.5	509.0	522.0	510.2	452.7	525.9	459.5	1148.0	755.1	1262.6	330.1	327.1	323.8	426.0	317.9	349.3	357.0	402.7	339.7	321.1	326.2	355.1	1378.8	461.6	415.0	83.2	577.0	667.1	861.7	1395.7	427.4	432.9	617.7	914.5	880.3	649.1	906.9	995.0	125.1	867.3	812.5	742.7	2551.3	1366.9	353.1	1215.7	729.8	957.7	554.0	619.4	39.4	1087.2	1100.4	699.1	324.7	1513.6	564.0	669.5	654.7	819.4	1022.1	348.3	56.1	676.9	1226.8	631.1	882.8	377.3	1039.8	645.8	789.8	36.5	1174.3	1262.8	619.0	39.2	76.0	1240.7	894.4	986.9	610.9	826.3	874.5	2276.2	935.5	477.3	624.5	651.9	749.3	779.9	643.1	631.5	710.3	758.8	644.1	831.9	673.2	975.0
SRP19		ENSG00000153037	"Signal recognition particle 19"	P09132	5	112861188-112898371	"Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029272, HPA057315"	Approved		Supported	"Nuclear bodies,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 66: Spermatocytes - Spermatogenesis"	Cytosol	"Nuclear bodies"	"HPA029272: AB_10600910, HPA057315: "	"unprognostic (4.77e-2)"	"unprognostic (1.36e-1)"	"unprognostic (3.95e-1)"	"unprognostic (1.37e-1)"	"unprognostic (5.60e-3)"	"unprognostic (1.17e-1)"	"unprognostic (1.98e-3)"	"unprognostic (5.55e-2)"	"unprognostic (2.62e-2)"	"unprognostic (3.62e-1)"	"unprognostic (2.15e-1)"	"unprognostic (2.42e-1)"	"prognostic unfavorable (3.72e-10)"	"unprognostic (1.82e-1)"	"unprognostic (4.88e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.69e-3)"	30.2	32.5	18.9	29.0	19.8	79.2	29.0	19.2	25.8	21.6	17.7	25.1	24.6	25.2	38.2	29.3	22.0	23.1	25.4	20.0	21.4	27.7	48.1	24.4	38.4	18.4	19.1	17.9	41.7	25.4	40.5	28.6	19.0	32.6	27.2	14.5	29.6	18.0	33.9	23.8	23.4	30.2	17.5	30.0	25.8	20.2	20.4	36.0	39.9	23.9	39.9	28.7	22.3	20.6	60.1	40.7	49.3	78.6	45.2	52.4	118.7	82.0	51.8	69.2	82.3	68.0	45.8	62.3	55.0	53.2	110.0	39.0	54.6	84.5	82.2	66.0	88.8	55.1	80.5	80.6	72.4	44.7	58.5	61.2	80.5	64.9	95.6	45.5	64.7	67.1	41.9	72.3	59.5	70.1	72.6	79.0	51.1	60.5	61.6	45.6	44.3	94.4	68.6	75.5	56.1	49.6	66.4	42.4	40.3	56.5	64.7	63.2	52.1	57.1	48.6	57.3	98.3	85.2	111.4	107.9	55.4	75.4	60.3	66.7	34.1	43.6	49.3	37.3	60.9	54.9	55.0	52.7	39.9	45.8	46.3	52.4	48.1	50.9	41.3	86.8	72.2	36.3	18.9	19.8	19.2	25.8	20.0	21.4	18.4	19.1	19.0	17.5	20.4	20.6	64.7	80.1	49.9	17.9	60.6	86.4	74.8	102.2	9.1	15.6	75.1	85.9	52.0	41.5	87.8	44.1	20.9	80.0	120.2	29.6	103.7	96.4	38.9	76.0	85.0	53.4	119.0	52.2	26.7	103.2	125.0	55.9	16.3	80.4	73.5	54.6	35.7	65.3	84.5	13.5	24.6	67.6	79.3	53.3	53.8	24.0	38.8	56.6	51.6	21.5	87.8	30.7	90.6	21.6	41.1	130.4	38.9	39.5	65.7	107.5	33.5	117.1	74.1	24.6	26.3	40.8	58.3	157.4	44.7	22.6	87.8	148.2	71.3	54.2	41.2	112.7
SRP54		ENSG00000100883	"Signal recognition particle 54"	P61011	14	34981957-35029686	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		"Hydrolase, Ribonucleoprotein, RNA-binding"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"Early spermatids: 327.3;Late spermatids: 901.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048977, HPA062044"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 25: Spermatids - Spermatogenesis"	Cytosol		"HPA048977: AB_2680583, HPA062044: AB_2684668"	"unprognostic (1.22e-3)"	"unprognostic (6.04e-2)"	"unprognostic (9.06e-2)"	"unprognostic (1.72e-2)"	"unprognostic (3.88e-1)"	"unprognostic (2.67e-3)"	"unprognostic (2.06e-3)"	"unprognostic (6.44e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.50e-3)"	22.8	33.1	17.1	30.2	18.1	17.4	28.7	19.3	22.5	32.5	20.9	28.1	25.8	23.3	35.8	28.5	22.0	23.2	32.1	17.6	21.3	35.3	61.9	25.0	34.6	19.8	19.2	22.7	55.0	39.7	36.2	29.5	20.5	31.2	29.5	24.2	60.3	28.7	39.8	26.1	26.8	23.5	20.0	28.4	30.4	44.0	18.1	35.5	30.9	33.7	42.6	34.8	23.1	21.4	59.3	66.9	56.7	54.9	62.8	61.3	67.8	83.2	78.3	87.3	107.0	71.3	62.8	75.8	77.5	81.4	75.8	56.1	79.0	66.7	125.6	87.5	37.8	70.9	54.6	184.6	92.7	70.5	65.4	51.5	64.8	63.5	102.3	66.1	88.8	64.9	61.7	82.7	93.1	98.8	81.9	42.4	45.0	96.1	61.3	58.5	72.2	67.4	104.9	89.3	48.9	59.4	59.3	76.7	74.6	71.4	99.4	49.7	66.6	48.7	51.0	62.8	57.1	73.2	108.3	101.1	36.8	45.9	63.5	23.8	27.4	39.2	31.0	35.0	39.6	25.6	31.4	34.0	32.8	25.8	28.7	28.3	27.1	42.1	47.0	21.9	48.2	30.5	17.1	18.1	19.3	22.5	17.6	21.3	19.8	19.2	20.5	20.0	18.1	21.4	40.8	12.8	49.3	25.5	63.2	40.0	56.0	74.6	37.5	37.5	40.7	29.0	41.0	34.3	81.2	40.5	58.4	67.3	59.6	39.4	64.6	73.2	327.3	53.1	43.9	40.7	44.9	36.2	25.4	79.8	75.6	45.8	38.7	64.3	47.5	37.3	36.4	110.0	49.7	26.9	26.8	48.7	87.5	39.0	43.6	901.8	38.5	47.4	28.4	24.4	56.1	44.3	41.2	27.6	54.6	55.1	34.0	37.6	133.1	60.7	39.0	79.2	93.0	50.1	26.3	38.3	46.1	95.4	76.0	36.0	50.3	94.0	64.7	43.0	31.6	64.5
SRP68		ENSG00000167881	"Signal recognition particle 68"	Q9UHB9	17	76038775-76072517	"Plasma proteins, Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 314.6"	"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 162.3"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	4	"medulla oblongata: 314.6"	"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023303, HPA055617"	Approved		Supported	Cytosol		NA	NA		23000	"Cluster 26: Non-specific - Mitochondria"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol		"HPA023303: AB_1857477, HPA055617: AB_2682863"	"unprognostic (1.25e-1)"	"unprognostic (8.97e-2)"	"unprognostic (3.47e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (2.18e-4)"	"prognostic unfavorable (4.28e-5)"	"unprognostic (3.31e-2)"	"unprognostic (8.31e-2)"	"unprognostic (1.62e-2)"	"unprognostic (1.11e-1)"	"unprognostic (4.10e-2)"	"unprognostic (4.42e-2)"	"unprognostic (8.73e-2)"	"unprognostic (4.75e-2)"	"prognostic favorable (2.65e-4)"	"unprognostic (4.02e-3)"	37.5	34.6	23.7	24.8	25.2	21.9	36.3	25.5	76.6	39.4	24.6	47.2	21.3	39.7	35.1	49.8	37.4	17.3	42.8	34.8	27.7	31.6	37.0	34.0	29.0	314.6	25.1	39.8	65.7	37.7	37.7	33.1	49.6	30.6	27.4	28.0	38.5	26.1	103.1	43.7	32.2	34.5	30.5	31.5	41.5	22.2	25.9	30.8	32.8	47.0	36.7	41.9	37.9	26.4	98.0	89.8	51.0	54.9	71.5	57.2	94.3	72.4	50.7	80.7	62.9	75.5	45.5	81.6	36.8	70.5	69.2	66.2	98.2	74.2	119.2	34.3	118.1	72.6	63.4	102.8	86.3	83.9	54.7	48.5	81.3	70.7	61.1	60.0	95.1	47.4	109.0	70.9	67.2	60.1	84.6	43.5	50.3	81.2	91.0	70.1	137.1	79.9	59.2	80.6	63.2	64.9	61.9	103.8	81.8	85.2	91.5	76.4	62.3	89.2	70.7	42.7	99.4	70.5	34.7	87.1	64.0	62.2	66.4	7.6	28.6	37.3	24.5	26.3	26.4	30.5	34.8	37.9	34.3	25.3	39.2	29.4	4.3	45.4	27.1	27.1	34.6	19.4	23.7	25.2	25.5	76.6	34.8	27.7	314.6	25.1	49.6	30.5	25.9	26.4	20.9	28.9	22.9	12.1	27.9	31.4	49.3	30.2	22.2	24.2	18.2	19.2	27.2	28.6	25.9	12.9	37.5	86.9	21.2	18.3	37.2	43.6	15.0	24.3	26.1	28.1	14.4	41.3	11.1	41.4	63.2	26.8	16.8	28.5	17.1	25.6	21.8	23.2	37.9	37.0	10.8	22.8	20.3	18.5	17.4	20.0	24.2	17.8	24.9	11.2	31.8	36.8	29.9	7.1	11.5	39.0	15.8	28.2	37.9	46.5	20.7	30.4	23.7	26.7	0.0	28.5	31.7	47.2	24.4	26.6	31.7	162.3	25.2	30.2	24.1	48.9
SRP72		ENSG00000174780	"Signal recognition particle 72"	O76094	4	56467617-56503681	"Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"		Ribonucleoprotein	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA034621	Approved					NA	NA		23000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA034621: AB_10601593"	"unprognostic (1.96e-2)"	"unprognostic (1.40e-2)"	"prognostic favorable (3.83e-4)"	"unprognostic (2.75e-1)"	"unprognostic (1.76e-2)"	"unprognostic (9.40e-2)"	"prognostic unfavorable (3.25e-6)"	"unprognostic (7.76e-3)"	"unprognostic (2.88e-2)"	"unprognostic (4.09e-3)"	"unprognostic (4.60e-3)"	"unprognostic (9.63e-2)"	"unprognostic (2.53e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.13e-2)"	"unprognostic (3.35e-1)"	37.7	31.6	13.9	41.2	15.0	73.5	49.8	15.1	18.1	41.4	20.5	39.1	29.3	40.8	29.5	42.3	33.0	33.5	25.2	14.2	19.1	33.4	45.4	32.1	49.5	14.9	18.8	45.0	47.7	43.4	16.4	48.3	16.8	31.1	41.1	27.3	43.8	32.7	33.3	34.3	31.6	44.6	15.9	39.1	33.6	27.2	14.9	52.8	54.3	35.7	55.6	46.6	23.7	18.6	109.1	82.0	101.6	98.7	63.2	90.0	98.0	157.2	125.0	129.3	102.7	91.2	120.5	167.6	105.6	132.2	68.2	61.1	126.9	133.4	152.3	44.3	74.0	146.4	90.3	86.0	115.7	284.4	116.3	85.8	175.9	138.0	243.3	112.1	117.1	126.4	216.1	157.0	124.9	84.2	168.6	73.9	88.2	135.1	86.1	149.2	81.9	127.0	88.5	101.7	62.9	104.5	99.8	193.4	88.5	81.3	77.0	102.3	142.7	106.8	143.3	110.4	165.2	111.8	56.9	181.2	114.9	148.3	132.2	43.0	64.3	38.7	50.4	70.8	65.1	52.8	50.9	51.1	82.1	48.5	49.4	49.9	8.4	59.5	57.5	61.4	60.8	58.7	13.9	15.0	15.1	18.1	14.2	19.1	14.9	18.8	16.8	15.9	14.9	18.6	78.5	73.7	72.5	17.0	84.7	97.3	93.7	103.5	47.3	61.6	65.8	80.4	45.2	54.3	87.9	27.6	18.8	120.8	97.0	30.5	66.5	121.1	86.3	38.9	87.2	83.7	53.2	113.8	30.2	131.2	197.3	84.0	39.3	73.3	101.9	94.5	63.9	80.1	100.4	57.2	32.4	94.8	69.2	109.4	78.9	116.1	65.3	83.4	58.7	28.1	122.4	54.5	72.1	29.1	35.6	111.8	48.7	66.5	156.6	131.7	43.5	71.1	54.6	37.7	39.5	92.9	106.7	48.2	86.5	73.2	100.9	166.5	71.1	111.0	89.0	115.2
SRP9		ENSG00000143742	"Signal recognition particle 9"	P49458	1	225777813-225790468	"Predicted intracellular proteins, Transporters"		"Ribonucleoprotein, RNA-binding"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		22000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"				"unprognostic (1.45e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.84e-2)"	"unprognostic (9.00e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.75e-2)"	"unprognostic (3.40e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.78e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.06e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.34e-2)"	153.1	254.2	200.6	140.1	202.9	182.6	228.7	211.2	279.3	162.7	207.6	207.3	165.5	151.8	215.3	148.4	163.1	161.3	197.9	195.7	232.4	266.6	350.5	136.6	194.1	202.8	204.5	155.6	135.5	218.0	113.0	116.3	213.4	189.6	202.5	165.1	156.1	139.5	255.3	129.0	164.1	148.9	219.2	135.2	148.7	113.4	211.8	270.4	193.0	265.4	197.6	167.0	93.1	225.4	453.4	259.9	712.4	371.3	288.7	352.2	274.8	310.0	335.2	336.3	390.3	291.0	323.9	450.0	410.8	376.9	319.4	284.5	450.8	375.1	489.7	375.6	613.9	363.8	347.7	398.5	245.5	667.8	302.7	260.9	341.2	308.3	382.0	360.3	534.8	450.5	657.0	299.2	562.2	199.7	629.2	484.1	227.9	816.3	436.9	496.5	664.4	523.7	540.7	424.8	624.2	532.6	356.7	407.9	461.6	363.4	471.1	619.7	342.4	299.8	263.1	404.4	589.9	174.0	537.1	420.0	347.5	450.9	597.1	343.8	316.8	376.9	270.1	350.2	343.7	340.9	333.0	312.7	354.4	296.4	395.5	340.2	177.3	371.2	305.2	256.8	457.0	635.4	200.6	202.9	211.2	279.3	195.7	232.4	202.8	204.5	213.4	219.2	211.8	225.4	217.7	105.8	96.0	30.7	162.9	262.8	185.6	410.5	126.3	67.5	234.4	181.0	157.6	205.9	224.8	174.7	31.3	221.7	145.4	151.0	598.7	256.4	39.1	228.8	121.3	174.3	239.9	223.2	21.3	186.2	259.0	171.4	135.1	158.9	84.3	204.3	127.5	201.2	207.5	63.9	29.3	244.8	518.8	129.4	213.9	34.9	187.4	128.0	316.6	15.9	177.2	556.2	201.8	25.6	40.4	179.2	172.0	212.5	154.7	249.8	152.7	537.3	236.7	101.1	131.5	114.1	208.0	302.6	123.1	190.2	290.2	199.1	167.8	322.8	248.0	264.2
SRRM1	"MGC39488, POP101, SRM160"	ENSG00000133226	"Serine and arginine repetitive matrix 1"	Q8IYB3	1	24631716-24673281	"Plasma proteins, Predicted intracellular proteins, Transporters"	"mRNA processing, mRNA splicing"	"DNA-binding, RNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049941, HPA058612"	Supported		Enhanced	"Nuclear speckles"		NA	NA		20000	"Cluster 18: Basophils - Vesicular transport"	"Cluster 51: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 52: Non-specific - Transcription"	"Nuclear speckles"		"HPA049941: AB_2680962, HPA058612: AB_2683778"	"unprognostic (3.31e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.29e-1)"	"unprognostic (3.78e-1)"	"unprognostic (1.49e-1)"	"unprognostic (7.71e-3)"	"prognostic unfavorable (1.08e-4)"	"unprognostic (3.83e-2)"	"unprognostic (1.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (9.27e-2)"	"unprognostic (5.08e-3)"	"unprognostic (4.52e-2)"	"unprognostic (4.50e-2)"	"unprognostic (2.77e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.46e-1)"	43.2	32.8	28.5	30.7	32.9	68.9	45.3	37.2	35.8	62.6	33.8	48.8	27.7	50.7	83.8	37.5	58.4	22.9	40.5	28.3	29.4	31.2	32.1	40.2	40.3	32.6	31.1	79.2	35.7	26.2	37.6	33.3	33.7	53.5	26.9	52.4	40.6	31.9	52.0	54.8	43.2	30.6	27.4	45.7	36.8	39.3	30.7	31.4	39.8	21.5	37.0	41.6	50.3	46.0	52.4	40.4	79.2	74.2	44.4	46.0	78.0	57.7	40.5	59.1	67.4	45.2	88.1	115.0	36.6	50.4	39.2	66.0	82.1	58.2	78.4	39.2	54.3	89.9	83.3	53.0	30.7	101.3	58.5	30.6	34.9	48.4	68.1	66.4	53.7	55.2	92.8	65.5	61.5	44.1	96.3	69.6	139.4	42.9	29.0	89.4	63.3	58.0	52.4	51.6	49.3	43.0	63.5	54.5	45.5	59.8	49.3	50.7	56.7	54.2	53.2	71.4	62.5	54.7	46.0	138.3	58.4	122.4	61.0	32.3	18.1	20.9	21.6	23.3	26.7	19.9	20.4	21.3	20.7	20.0	18.6	21.6	23.2	29.7	27.5	16.8	16.5	16.9	28.5	32.9	37.2	35.8	28.3	29.4	32.6	31.1	33.7	27.4	30.7	46.0	231.5	157.0	165.3	67.9	266.8	302.3	280.8	194.6	271.5	178.4	164.6	188.0	154.8	128.7	172.7	121.4	118.9	152.1	315.1	146.5	199.6	174.1	330.2	211.3	247.6	170.7	118.4	230.1	53.6	147.2	170.0	177.2	142.2	260.0	241.0	148.6	140.7	225.6	149.5	124.5	56.7	174.4	120.1	178.7	311.3	134.1	167.7	205.3	154.7	45.9	286.6	187.1	256.4	58.8	173.2	147.5	149.1	150.8	236.8	329.8	141.8	198.4	145.5	186.9	138.1	252.3	220.3	219.4	223.3	282.5	295.4	241.2	288.6	135.9	194.3	308.9
SSTR3		ENSG00000278195	"Somatostatin receptor 3"	P32745	22	37204237-37212477	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 7.6;lymphoid tissue: 11.1;testis: 7.8"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 2.3;Late spermatids: 2.0;Microglial cells: 1.9"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 1.1"	"Lineage enriched"	"Detected in single"	10	"T-cells: 1.1"	"Group enriched"	"Detected in some"	11	"RPMI-8226: 23.3;SCLC-21H: 8.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB022647	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 63: NK-cells & T-cells - Immune response"			"CAB022647: "	"unprognostic (1.63e-2)"	"unprognostic (5.58e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.18e-2)"	"unprognostic (7.03e-2)"	"unprognostic (6.26e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.72e-2)"	"unprognostic (1.90e-2)"	"unprognostic (8.95e-2)"	"unprognostic (3.88e-3)"	"unprognostic (2.93e-1)"	"unprognostic (1.51e-7)"	"unprognostic (1.55e-1)"	"unprognostic (1.24e-2)"	"unprognostic (5.61e-3)"	"unprognostic (1.06e-2)"	0.1	0.3	2.2	1.0	2.2	0.4	0.0	1.2	6.4	0.0	0.0	0.2	1.3	1.1	0.0	0.0	0.1	0.0	0.0	1.9	2.2	0.1	0.0	0.0	1.8	6.8	3.5	3.3	1.8	0.0	2.6	0.0	6.7	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.5	1.0	1.2	0.6	0.2	7.8	7.6	11.1	0.0	0.0	0.9	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.3	0.0	0.0	8.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.1	1.1	0.9	0.0	0.0	0.0	0.0	0.1	0.2	2.2	2.2	1.2	6.4	1.9	2.2	6.8	3.5	6.7	1.2	7.6	2.3	0.0	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.6	0.4	0.0	0.0
ST14	"HAI, MT-SP1, PRSS14, SNC19, TMPRSS14"	ENSG00000149418	"ST14 transmembrane serine protease matriptase"	Q9Y5Y6	11	130159782-130210362	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Disease variant, Hypotrichosis, Ichthyosis"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 144.8"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 489.4;Paneth cells: 327.2;Proximal enterocytes: 251.9;Undifferentiated cells: 216.9;Urothelial cells: 286.8"	"Low cancer specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"thalamus: 10.0"	"Immune cell enriched"	"Detected in many"	4	"plasmacytoid DC: 25.0"	"Lineage enriched"	"Detected in many"	5	"dendritic cells: 25.0"	"Cell line enhanced"	"Detected in many"		"CACO-2: 224.2;CAPAN-2: 443.0;HaCaT: 311.4;OE19: 240.4;RPMI-8226: 301.2;SK-BR-3: 203.1;T-47d: 308.3;U-698: 218.5"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA047014, HPA056258"	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA		1100000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Vesicles"		"HPA047014: AB_2679902, HPA056258: "	"unprognostic (1.17e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.62e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.20e-1)"	"unprognostic (3.97e-2)"	"unprognostic (5.29e-1)"	"unprognostic (3.21e-1)"	"unprognostic (1.03e-3)"	"unprognostic (2.25e-1)"	"prognostic favorable (5.03e-11)"	"unprognostic (1.92e-2)"	"unprognostic (2.71e-1)"	"unprognostic (1.28e-2)"	"unprognostic (5.60e-2)"	4.3	3.9	0.8	26.7	1.2	4.3	17.7	1.8	2.9	18.6	1.2	124.7	130.7	5.7	21.8	104.5	37.1	32.6	0.9	0.9	1.1	43.2	6.3	18.5	11.9	1.8	1.7	0.6	59.2	36.5	19.1	15.1	3.1	23.1	60.1	0.0	58.7	23.6	0.3	50.2	144.8	5.4	1.1	9.1	64.9	1.0	10.0	10.5	28.6	0.0	20.9	34.8	42.5	2.7	167.2	0.2	0.0	0.6	0.0	0.0	86.4	0.0	0.0	0.0	0.0	224.2	443.0	163.6	16.7	0.0	0.1	311.4	0.0	99.3	0.0	0.1	0.2	0.1	0.1	0.9	0.0	22.0	0.8	0.0	49.3	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	128.5	0.3	1.1	1.7	240.4	0.9	0.2	0.0	301.2	28.8	134.2	17.8	0.4	1.5	203.1	0.4	1.6	308.3	32.0	0.1	0.4	2.7	0.7	0.7	0.2	0.3	218.5	0.3	50.4	0.5	0.0	3.6	3.4	0.0	2.2	0.1	5.0	0.0	0.0	6.2	3.6	0.0	0.0	0.5	0.0	0.3	25.0	0.0	1.2	0.8	1.2	1.8	2.9	0.9	1.1	1.8	1.7	3.1	1.1	10.0	2.7	0.2	32.1	28.6	0.0	18.2	40.9	51.5	45.2	26.2	0.0	36.5	21.5	1.2	77.2	61.6	62.5	0.0	45.6	26.1	489.4	3.9	115.8	37.8	43.9	5.7	1.7	123.4	0.8	1.0	91.8	14.6	3.2	112.1	79.6	11.4	0.2	0.4	2.1	58.1	0.0	0.4	201.0	148.5	22.7	13.2	13.9	1.8	28.0	7.2	0.0	13.6	0.0	1.0	0.0	0.1	153.4	327.2	0.7	5.9	108.7	251.9	10.0	76.4	0.0	6.6	0.0	4.9	0.2	0.3	61.3	43.9	39.7	2.9	0.0	216.9	286.8
STAB1	"CLEVER-1, FEEL-1, FELE-1, FEX1, KIAA0246, SCARH2, STAB-1"	ENSG00000010327	"Stabilin 1"	Q9NY15	3	52495338-52524495	"Predicted membrane proteins, Transporters"	"Inflammatory response"	Receptor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 439.5"	"Cell type enriched"	"Detected in many"	4	"Hepatic stellate cells: 745.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	59	"classical monocyte: 9.4;intermediate monocyte: 5.7;myeloid DC: 2.5"	"Group enriched"	"Detected in many"	60	"dendritic cells: 2.5;monocytes: 9.4"	"Group enriched"	"Detected in some"	46	"HUVEC TERT2: 103.1;NB-4: 146.9;TIME: 128.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005434	Approved		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA		96000000	"Cluster 25: Monocytes - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	Cytosol	"Nucleoplasm, Plasma membrane"	"HPA005434: AB_1080097"	"unprognostic (1.18e-1)"	"unprognostic (2.89e-1)"	"prognostic unfavorable (7.59e-4)"	"unprognostic (3.63e-2)"	"unprognostic (1.21e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.08e-2)"	"unprognostic (2.23e-1)"	"unprognostic (2.38e-1)"	"unprognostic (4.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (3.19e-1)"	"prognostic unfavorable (3.88e-7)"	"unprognostic (3.16e-2)"	"unprognostic (9.40e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.08e-1)"	194.2	160.4	41.0	50.4	42.9	13.8	84.5	41.4	58.3	54.4	62.8	87.7	29.6	45.3	8.5	29.2	79.3	25.8	74.6	41.9	44.4	85.6	102.1	104.7	12.9	50.0	48.4	32.2	32.2	5.0	52.0	55.4	53.7	57.6	31.0	0.6	45.7	16.0	25.9	24.0	95.1	33.8	43.0	439.5	53.2	21.0	65.3	6.8	55.1	4.6	8.2	105.7	48.6	47.8	0.1	0.0	0.1	0.0	0.0	0.0	1.2	0.1	0.0	0.0	0.0	0.5	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	2.7	0.2	0.2	0.6	0.0	0.0	1.8	0.1	0.0	0.1	0.0	103.1	0.1	0.3	0.1	0.0	0.0	0.0	146.9	0.0	0.2	0.2	0.1	0.1	0.3	0.0	0.0	0.4	0.4	0.0	0.3	0.0	0.1	0.0	0.0	128.8	0.0	0.0	0.0	0.0	0.1	0.1	0.2	0.2	0.1	0.1	0.0	9.4	0.0	0.0	5.7	0.0	0.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.5	41.0	42.9	41.4	58.3	41.9	44.4	50.0	48.4	53.7	43.0	65.3	47.8	31.3	0.0	3.8	0.0	5.5	6.0	0.6	0.0	1.8	1.0	1.5	2.7	2.4	11.5	0.0	3.7	0.0	1.7	1.9	0.0	0.0	0.0	0.5	0.4	0.5	43.0	1.2	21.5	0.3	0.0	2.0	3.3	0.5	0.3	18.3	0.0	745.0	19.7	130.7	0.0	0.3	0.0	0.0	185.4	30.3	2.9	4.4	147.0	12.4	30.0	21.9	0.5	2.1	0.5	0.1	0.0	0.0	20.3	2.0	0.2	0.0	0.8	0.0	0.1	19.7	2.0	1.4	0.9	2.2	1.5	4.8	2.2	2.3	0.5	0.0	0.2
STAC	STAC1	ENSG00000144681	"SH3 and cysteine rich domain"	Q99469	3	36380503-36548007	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 13.8"	"Cell type enhanced"	"Detected in some"		"Distal tubular cells: 5.9;Early spermatids: 5.2;granulocytes: 6.3;Granulosa cells: 12.5;Late spermatids: 5.3;Muller glia cells: 21.6;Smooth muscle cells: 5.0"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	5	"eosinophil: 1.5;NK-cell: 1.3;T-reg: 1.5"	"Group enriched"	"Detected in many"	5	"granulocytes: 1.5;NK-cells: 1.3;T-cells: 1.5"	"Cell line enhanced"	"Detected in many"		"fHDF/TERT166: 46.8;HaCaT: 34.1;SH-SY5Y: 49.1;U-251 MG: 30.3;U-87 MG: 48.1"	"Low region specificity"	"Detected in many"							HPA035143	Uncertain		Uncertain	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 40: Granulosa cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA035143: AB_10603892"	"unprognostic (5.29e-2)"	"unprognostic (7.61e-2)"	"unprognostic (2.58e-1)"	"unprognostic (1.44e-6)"	"unprognostic (4.24e-2)"	"unprognostic (1.83e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.89e-1)"	"unprognostic (2.02e-1)"	"unprognostic (3.31e-3)"	"unprognostic (1.77e-3)"	"unprognostic (5.82e-2)"	"unprognostic (8.07e-2)"	"unprognostic (1.73e-4)"	"unprognostic (8.93e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.94e-3)"	2.8	5.1	1.4	0.6	1.9	0.4	1.9	3.6	3.9	7.0	5.0	3.6	0.1	1.4	0.3	2.1	3.2	2.7	0.7	0.8	4.3	2.5	0.9	11.1	0.4	2.3	2.5	2.5	0.1	10.1	1.1	0.3	6.9	13.8	0.7	5.8	1.3	4.4	1.6	1.2	0.4	3.4	1.9	0.6	0.9	1.9	2.1	0.7	0.5	5.3	0.2	3.7	2.2	0.5	7.7	3.3	1.6	0.0	6.5	2.1	0.1	19.9	0.4	4.0	4.6	0.0	0.0	0.0	7.8	46.8	13.0	34.1	2.4	8.2	4.1	0.0	7.2	1.1	10.0	0.2	0.0	20.3	0.4	2.4	0.2	0.1	0.7	27.6	0.0	1.8	0.0	0.4	0.5	0.0	4.1	0.2	13.8	0.0	3.0	0.0	0.0	0.0	10.8	0.0	6.2	49.1	7.9	5.2	0.1	13.6	0.0	2.0	8.5	0.5	19.1	0.6	30.3	0.0	0.0	0.0	48.1	7.9	8.3	0.0	0.0	1.5	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	1.3	0.0	0.0	1.5	0.0	1.4	1.9	3.6	3.9	0.8	4.3	2.3	2.5	6.9	1.9	2.1	0.5	0.9	0.0	0.5	0.3	0.0	0.0	0.0	0.5	0.0	0.7	2.3	0.8	0.9	0.0	1.3	0.0	0.0	0.0	0.1	0.0	5.9	0.2	5.2	0.9	0.5	0.4	0.0	2.1	0.6	0.0	0.1	1.5	0.0	2.1	6.3	12.5	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	2.2	5.3	0.0	4.8	0.0	0.0	0.0	21.6	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.6	0.0	0.4	5.0	1.8	0.1	0.0	0.3	0.0	0.4	0.0	0.0	0.0
STARD3	"es64, MLN64"	ENSG00000131748	"StAR related lipid transfer domain containing 3"	Q14849	17	39637090-39664201	"Cancer-related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	4	"SK-BR-3: 260.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB017021, HPA024307, HPA073948"	Uncertain		Approved	"Nucleoplasm,Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nucleoplasm, Vesicles"	"Endoplasmic reticulum"	"CAB017021: , HPA024307: , HPA073948: "	"unprognostic (1.11e-1)"	"unprognostic (2.14e-2)"	"unprognostic (6.35e-2)"	"unprognostic (8.92e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.94e-1)"	"prognostic unfavorable (3.60e-5)"	"unprognostic (2.26e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.48e-1)"	"unprognostic (6.25e-3)"	"unprognostic (5.88e-2)"	"prognostic unfavorable (7.70e-4)"	"unprognostic (1.33e-1)"	"unprognostic (5.22e-2)"	"unprognostic (8.51e-3)"	"unprognostic (3.00e-2)"	24.8	33.4	18.3	18.8	29.1	25.4	23.4	21.6	18.9	22.3	14.9	21.5	24.1	20.4	2.7	24.1	21.5	17.2	16.3	17.9	15.4	18.9	25.8	28.8	22.3	21.1	21.3	21.3	26.5	15.2	24.0	17.1	19.0	20.1	5.2	3.2	21.2	11.3	23.9	27.0	26.7	9.2	18.7	33.1	26.5	26.2	22.5	14.8	21.4	9.5	8.8	21.0	20.1	18.5	29.3	47.6	18.6	33.5	19.9	22.9	31.2	23.1	24.9	27.1	24.3	24.0	47.6	25.2	47.7	17.8	30.8	55.4	11.3	21.0	6.3	36.2	34.5	15.2	18.8	30.1	25.9	29.6	35.5	24.5	19.0	29.8	12.6	19.0	23.4	36.4	41.0	27.4	23.5	24.7	32.2	25.6	22.2	15.3	20.6	28.5	31.4	40.1	15.0	35.7	24.9	29.1	16.1	260.8	64.0	10.8	34.1	41.7	26.3	43.2	29.5	46.5	43.6	27.5	37.8	18.7	36.2	36.8	45.1	23.7	36.3	54.4	42.7	35.5	30.7	20.8	29.6	32.7	38.3	26.1	29.1	27.8	63.6	39.6	29.3	18.7	38.5	33.8	18.3	29.1	21.6	18.9	17.9	15.4	21.1	21.3	19.0	18.7	22.5	18.5	45.8	3.2	7.5	31.0	23.2	16.6	13.0	23.4	14.2	12.6	19.9	14.6	3.4	18.6	14.8	11.0	37.5	28.5	32.9	21.0	9.8	26.5	2.7	9.7	11.7	35.8	27.5	11.1	17.3	35.4	37.2	16.2	29.6	11.0	19.0	22.2	45.0	11.9	49.8	18.5	14.8	11.6	14.2	49.0	18.5	5.3	17.1	27.7	5.4	9.4	18.5	15.8	29.9	12.1	30.2	35.9	22.9	13.2	24.3	20.2	41.5	10.3	8.3	13.2	13.1	21.8	14.4	9.3	16.2	15.9	16.9	40.0	35.2	18.6	15.1	20.1
STARD7	GTT1	ENSG00000084090	"StAR related lipid transfer domain containing 7"	Q9NQZ5	2	96184859-96208827	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB033965, HPA064958, HPA064978"	Supported		Approved	Mitochondria	"Intracellular and membrane"	NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 54: Cardiomyocytes - Muscle contraction"	Mitochondria		"CAB033965: AB_2302780, HPA064958: AB_2685391, HPA064978: AB_2685397"	"unprognostic (3.75e-2)"	"unprognostic (1.54e-2)"	"unprognostic (1.67e-1)"	"prognostic unfavorable (8.56e-5)"	"prognostic favorable (3.89e-6)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (2.72e-3)"	"unprognostic (2.38e-1)"	"unprognostic (2.93e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.78e-1)"	"prognostic favorable (4.38e-6)"	"unprognostic (1.02e-1)"	"unprognostic (2.04e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.42e-2)"	44.7	54.3	57.8	46.7	62.4	34.3	43.9	61.9	53.2	33.9	60.6	57.6	55.7	29.8	30.5	36.8	44.0	29.1	98.5	49.8	61.4	80.3	62.8	61.1	70.6	56.4	55.5	29.4	42.2	69.7	23.6	29.3	54.9	39.0	56.2	54.4	65.2	45.7	202.5	35.2	45.4	37.6	60.5	53.1	44.6	21.1	66.9	56.2	56.6	174.0	86.9	42.1	27.0	74.4	128.8	79.1	102.3	106.2	134.9	66.9	150.1	122.6	107.0	121.2	129.6	188.8	117.7	228.7	129.0	98.6	95.8	102.3	183.3	106.4	157.3	147.2	131.9	204.1	74.3	218.3	62.2	158.1	106.9	65.4	77.9	101.0	99.1	77.2	123.2	92.6	211.1	89.2	108.8	113.0	175.9	161.0	173.3	110.3	115.2	171.6	156.4	227.1	73.2	162.2	191.6	90.5	62.5	201.8	115.8	126.0	60.5	171.6	103.8	100.1	100.4	112.0	125.8	113.9	114.0	201.7	92.8	174.9	112.6	35.6	25.4	22.7	25.6	30.2	26.1	42.6	21.5	26.6	36.2	37.8	23.6	23.4	3.0	30.8	19.9	42.2	41.5	26.0	57.8	62.4	61.9	53.2	49.8	61.4	56.4	55.5	54.9	60.5	66.9	74.4	32.0	134.6	44.2	21.5	71.2	63.7	43.2	34.3	101.9	39.5	58.1	50.2	176.9	55.8	47.1	46.0	108.4	35.8	83.8	63.3	74.3	32.4	2.5	34.5	43.2	49.9	44.4	48.6	25.6	38.0	40.3	31.3	37.8	48.6	15.8	45.4	41.7	114.7	71.0	40.4	23.8	58.4	24.4	122.4	102.3	6.9	23.3	54.4	42.7	20.6	95.8	38.4	30.9	19.1	42.6	35.8	26.6	25.2	120.6	68.4	50.1	65.7	31.8	58.1	26.3	43.5	43.0	22.7	35.1	75.4	57.4	35.4	62.9	36.8	81.9	38.8
STATH	STR	ENSG00000126549	Statherin	P02808	4	69995966-70002570	"Plasma proteins, Predicted secreted proteins, Transporters"	Biomineralization			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	925	"salivary gland: 9143.2"	"Group enriched"	"Detected in some"	9	"Breast glandular cells: 9.8;Early spermatids: 2.8"	"Group enriched"	"Detected in some"	14	"head and neck cancer: 3.5;lung cancer: 0.9"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"											HPA044569	Enhanced				"Secreted to digestive system"	NA	NA				"Cluster 24: Salivary gland - Salivary secretion"		"Cluster 30: Mammary glandular cells - Lactation"			"HPA044569: AB_10966146"						"unprognostic (2.00e-2)"												0.0	0.1	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	1.8	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	2.1	9.8	0.0	5.6	0.8	0.0	0.1	0.0	0.0	9143.2	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	3.3	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.2	0.0	0.0	9.8	0.1	0.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STBD1	"FLJ41801, GENX-3414"	ENSG00000118804	"Starch binding domain 1"	O95210	4	76306733-76311130	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Autophagy, Carbohydrate metabolism, Glycogen metabolism"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 130.3;skeletal muscle: 248.5;tongue: 154.7"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 9.1;Ductal cells: 7.9;Glandular and luminal cells: 5.1;Plasma cells: 7.0;Proximal enterocytes: 19.5;Respiratory ciliated cells: 6.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"Karpas-707: 140.7;U-266/70: 62.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA011952, HPA012849"	Enhanced		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Endoplasmic reticulum"		"HPA011952: AB_1847461, HPA012849: AB_1847460"	"unprognostic (1.46e-1)"	"unprognostic (1.02e-3)"	"unprognostic (4.29e-2)"	"unprognostic (1.95e-1)"	"unprognostic (2.57e-1)"	"unprognostic (4.72e-2)"	"unprognostic (1.35e-2)"	"unprognostic (6.84e-2)"	"unprognostic (3.06e-1)"	"unprognostic (1.03e-1)"	"unprognostic (4.96e-3)"	"unprognostic (4.42e-2)"	"unprognostic (3.52e-2)"	"unprognostic (2.93e-1)"	"unprognostic (2.00e-1)"	"unprognostic (2.84e-1)"	"unprognostic (5.74e-2)"	109.7	5.3	4.3	7.3	4.0	19.9	11.8	3.5	6.3	7.0	2.9	29.0	9.6	9.3	3.2	15.1	13.7	12.8	52.7	4.0	7.0	10.0	130.3	14.1	1.3	6.7	5.4	10.0	12.0	7.9	1.7	16.8	6.2	20.7	26.4	4.0	4.7	13.9	248.5	1.5	26.1	28.0	5.6	2.2	15.5	9.7	5.6	1.3	2.6	154.7	2.1	22.1	4.5	5.6	15.9	9.9	2.0	10.0	46.3	13.9	12.7	21.9	21.6	12.0	12.6	12.6	17.9	0.0	13.1	25.8	26.2	9.2	9.6	6.1	7.4	52.4	3.6	1.7	18.2	16.5	4.8	9.5	10.5	7.1	24.0	10.2	8.2	32.4	0.9	0.0	0.6	140.7	23.7	13.0	0.6	7.4	2.5	24.1	7.2	0.0	3.8	9.9	8.0	17.2	2.6	17.7	12.9	20.2	0.3	5.0	4.9	3.7	3.9	11.6	5.9	29.4	12.5	62.8	17.1	0.0	19.6	7.5	5.4	0.1	2.6	5.7	2.0	3.1	1.1	0.1	2.4	2.4	2.5	0.0	0.5	0.9	0.3	4.4	1.2	0.3	0.8	1.3	4.3	4.0	3.5	6.3	4.0	7.0	6.7	5.4	6.2	5.6	5.6	5.6	0.0	0.0	0.5	0.0	0.1	0.0	1.1	0.0	0.0	0.0	0.5	0.4	0.0	0.0	0.0	0.0	0.0	0.6	0.2	9.1	0.0	7.9	0.0	2.8	1.5	0.1	0.0	0.4	0.0	3.9	1.4	1.0	2.6	5.1	0.0	0.3	0.0	1.5	0.2	0.0	0.0	3.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.6	0.0	1.0	0.0	0.0	3.3	2.9	0.0	7.0	0.5	19.5	0.3	6.6	0.0	0.0	1.1	3.0	0.2	0.0	1.1	0.0	0.8	0.3	0.3	1.4	0.9
STEAP1	"PRSS24, STEAP"	ENSG00000164647	"STEAP family member 1"	Q9UHE8	7	90154456-90164829	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 83.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 140.5;Club cells: 72.6;Prostatic glandular cells: 85.1;Theca cells: 64.4;Urothelial cells: 54.0"	"Cancer enriched"	"Detected in all"	6	"prostate cancer: 94.0"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC diff: 105.1;CAPAN-2: 135.2;U-138 MG: 169.2"	"Low region specificity"	"Detected in many"							HPA030985	Uncertain					NA	NA				"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA030985: AB_2673686"	"unprognostic (2.88e-3)"	"unprognostic (2.29e-1)"	"unprognostic (1.19e-1)"	"unprognostic (3.21e-3)"	"unprognostic (9.20e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.74e-3)"	"unprognostic (6.36e-2)"	"unprognostic (6.45e-3)"	"unprognostic (8.31e-3)"	"unprognostic (3.79e-1)"	"unprognostic (2.60e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.42e-1)"	"unprognostic (6.09e-2)"	"unprognostic (1.38e-1)"	32.9	2.2	1.0	32.9	1.4	0.0	18.5	0.8	2.3	9.6	1.4	18.1	5.2	4.2	0.8	12.6	10.7	16.4	7.2	1.3	1.0	6.6	27.6	14.2	0.3	1.3	0.8	6.0	6.0	0.3	3.7	0.7	1.0	83.8	13.7	0.7	15.1	2.1	1.3	4.6	7.8	26.9	0.8	2.5	13.9	4.2	1.0	0.9	5.0	2.5	4.6	34.5	5.8	1.1	26.9	52.5	3.3	9.8	105.1	89.5	0.9	17.8	20.5	2.4	2.7	38.8	135.2	0.3	0.9	28.9	43.5	5.3	22.0	22.6	5.1	0.0	7.6	0.1	0.5	13.0	4.3	0.0	0.1	59.7	3.7	68.0	37.4	16.6	92.6	7.3	1.2	74.0	29.6	0.4	0.0	0.9	15.7	1.3	23.2	0.1	0.0	0.3	20.8	5.5	0.0	1.2	6.4	0.2	12.1	1.9	29.4	0.4	50.8	169.2	8.0	83.9	22.8	14.0	0.5	0.1	83.4	0.0	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	1.4	0.8	2.3	1.3	1.0	1.3	0.8	1.0	0.8	1.0	1.1	1.8	0.0	0.5	2.3	0.3	4.2	41.9	140.5	7.4	0.1	12.8	11.4	0.8	5.7	72.6	1.8	0.0	0.0	0.6	7.0	0.0	3.4	0.4	1.3	4.9	4.5	7.2	0.0	5.3	38.6	0.1	25.2	10.7	4.6	0.0	10.5	1.8	33.1	0.5	0.0	1.7	4.3	24.4	0.8	5.4	1.1	0.9	1.3	7.2	0.0	0.0	10.5	0.0	1.5	1.3	44.4	20.5	1.5	1.3	85.1	2.5	14.7	13.1	0.3	6.6	6.0	26.9	17.1	36.9	12.2	2.3	0.3	0.4	64.4	16.6	54.0
STEAP2	"IPCA-1, PCANAP1, STAMP1, STMP"	ENSG00000157214	"STEAP2 metalloreductase"	Q8NFT2	7	90167590-90238137	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"prostate: 127.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 68.0;Inhibitory neurons: 53.0;Prostatic glandular cells: 102.9"	"Cancer enriched"	"Detected in many"	12	"prostate cancer: 88.1"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"A549: 22.5;CAPAN-2: 48.1;U-138 MG: 27.4"	"Low region specificity"	"Detected in all"							"HPA029115, HPA055603"	Uncertain		Supported	Vesicles		NA	NA				"Cluster 51: Non-specific - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 35: Glandular cells - Unknown function"	Vesicles		"HPA029115: AB_10603894, HPA055603: "	"unprognostic (6.26e-3)"	"unprognostic (2.48e-1)"	"unprognostic (2.55e-1)"	"unprognostic (1.65e-1)"	"unprognostic (8.20e-4)"	"unprognostic (2.34e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.67e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.70e-1)"	"unprognostic (9.92e-2)"	"unprognostic (1.34e-1)"	"unprognostic (2.71e-2)"	"unprognostic (9.73e-2)"	"unprognostic (6.11e-2)"	"unprognostic (9.86e-5)"	"unprognostic (3.69e-2)"	20.0	3.7	7.3	11.9	10.4	0.0	13.0	8.3	18.5	9.5	6.9	15.1	6.1	7.1	2.7	6.9	14.3	10.1	15.1	11.2	6.9	6.8	4.0	20.5	0.4	3.1	5.0	17.2	8.1	10.1	19.4	0.2	3.8	127.7	7.6	3.9	11.9	6.9	1.4	4.7	9.1	10.8	5.4	2.7	11.0	1.1	6.4	3.3	7.9	1.6	1.7	15.8	9.0	5.7	3.2	22.5	0.5	6.3	11.5	11.1	0.3	2.8	5.8	0.4	0.8	4.2	48.1	0.0	0.3	7.5	8.8	1.8	4.9	3.5	0.8	0.0	4.7	0.0	0.1	1.1	1.0	0.0	0.1	8.1	0.8	11.5	2.3	9.4	6.1	0.0	0.0	0.4	6.6	0.0	0.0	0.7	9.1	0.0	2.5	0.0	0.0	0.2	10.3	6.6	0.7	2.1	3.5	0.0	0.1	1.0	16.8	0.0	5.1	27.4	6.0	3.8	2.4	0.1	0.0	0.0	11.7	0.0	1.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.3	10.4	8.3	18.5	11.2	6.9	3.1	5.0	3.8	5.4	6.4	5.7	0.6	0.0	1.1	18.6	0.2	4.8	21.6	20.6	9.1	7.5	16.1	10.3	18.0	18.6	19.4	12.9	2.1	0.0	0.1	15.9	0.0	1.1	0.5	2.8	3.7	2.2	15.7	2.7	68.0	7.4	0.0	27.6	10.7	2.9	0.0	30.4	3.6	5.8	0.0	1.7	53.0	9.8	10.2	0.0	6.2	0.8	15.5	0.7	0.0	2.8	0.0	23.1	0.0	27.6	2.6	11.4	24.0	15.4	0.0	102.9	13.1	10.8	16.0	1.3	0.0	14.7	5.8	3.1	6.2	4.1	5.4	0.0	0.5	9.8	13.8	25.3
STEAP3	"dudlin-2, STMP3, TSAP6"	ENSG00000115107	"STEAP3 metalloreductase"	Q658P3	2	119223831-119265652	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Apoptosis, Cell cycle, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"liver: 189.5;parathyroid gland: 78.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 33.3;Exocrine glandular cells: 36.2;Hepatocytes: 91.6;Respiratory ciliated cells: 36.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	5	"classical monocyte: 2.4;intermediate monocyte: 2.7;myeloid DC: 4.1;NK-cell: 1.3"	"Group enriched"	"Detected in many"	6	"dendritic cells: 4.1;monocytes: 2.7;NK-cells: 1.3"	"Cell line enhanced"	"Detected in many"		"U-87 MG: 149.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA050510	Approved		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 85: Liver - Metabolism"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 15: Hepatocytes - Hemostasis"	Cytosol	Nucleoli	"HPA050510: AB_2681151"	"unprognostic (6.51e-2)"	"unprognostic (6.48e-2)"	"unprognostic (4.89e-2)"	"unprognostic (3.45e-2)"	"unprognostic (1.94e-3)"	"unprognostic (9.07e-2)"	"unprognostic (1.99e-2)"	"unprognostic (3.04e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.08e-3)"	"unprognostic (6.95e-2)"	"prognostic unfavorable (0.00e+0)"	"unprognostic (2.82e-1)"	"unprognostic (4.45e-1)"	"unprognostic (9.37e-2)"	"unprognostic (6.82e-2)"	9.1	6.3	4.3	3.9	3.7	16.9	14.5	7.1	4.6	16.7	10.6	9.5	22.1	3.6	5.3	15.8	7.7	2.3	9.5	7.0	7.5	6.9	189.5	9.1	0.9	14.4	9.4	4.4	27.1	78.9	13.8	11.3	12.8	11.8	6.9	0.7	34.3	7.5	29.9	9.0	10.9	3.1	7.6	1.8	22.5	1.9	7.2	2.2	5.4	12.5	3.1	7.0	7.2	12.7	21.8	25.6	0.0	8.7	12.1	112.9	22.1	6.8	7.4	13.1	11.8	19.5	29.0	0.1	49.9	38.5	94.1	35.9	11.1	22.4	14.9	0.1	35.9	42.1	22.2	38.8	30.0	10.5	7.7	67.3	38.7	78.0	27.7	89.8	11.4	0.0	20.9	4.2	37.6	20.6	0.1	6.2	34.2	33.3	52.7	0.2	14.7	18.5	16.2	54.1	41.9	7.7	18.8	64.1	4.9	4.9	12.7	13.7	49.6	81.2	46.8	17.4	37.4	0.1	0.1	0.2	149.1	26.2	17.2	0.0	2.4	0.4	0.1	2.7	0.0	0.4	0.0	0.0	4.1	0.1	0.0	0.0	0.0	1.3	0.4	0.2	0.0	1.0	4.3	3.7	7.1	4.6	7.0	7.5	14.4	9.4	12.8	7.6	7.2	12.7	9.1	0.0	7.9	2.3	1.0	2.0	7.4	11.9	8.0	0.6	15.5	10.7	6.2	2.8	16.2	0.0	0.0	33.3	0.2	12.2	0.0	8.1	0.2	8.1	1.9	6.2	1.8	29.5	1.3	36.2	4.1	3.6	23.4	5.7	3.8	3.5	1.4	91.6	10.9	0.0	1.0	6.0	8.2	5.9	3.8	0.7	1.8	6.1	0.0	1.9	1.4	0.1	0.0	0.5	0.0	20.8	7.7	7.5	0.1	8.3	11.8	1.5	36.1	0.1	6.6	4.1	3.3	0.6	0.2	19.5	1.4	23.7	0.4	13.1	11.6	8.9
STEAP4	"FLJ23153, SchLAH, STAMP2, TIARP, TNFAIP9"	ENSG00000127954	"STEAP4 metalloreductase"	Q687X5	7	88270892-88306894	"Enzymes, Predicted membrane proteins, Transporters"	"Electron transport, Ion transport, Iron transport, Transport"	Oxidoreductase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adipose tissue: 113.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 402.5;Club cells: 152.8;Sertoli cells: 460.2;Smooth muscle cells: 255.3"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 45.9"	"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in some"	12	"neutrophil: 163.6"	"Lineage enriched"	"Detected in many"	12	"granulocytes: 163.6"	"Group enriched"	"Detected in some"	6	"HSkMC: 122.1;SiHa: 119.7;U-2197: 166.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA065201			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 18: U-2197 - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nucleoplasm, Plasma membrane"		"HPA065201: "	"unprognostic (3.76e-2)"	"unprognostic (2.16e-2)"	"unprognostic (8.82e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.62e-1)"	"unprognostic (9.96e-2)"	"prognostic favorable (2.97e-4)"	"unprognostic (7.40e-2)"	"unprognostic (3.12e-1)"	"unprognostic (4.66e-2)"	"unprognostic (4.21e-1)"	"unprognostic (2.98e-1)"	"unprognostic (7.51e-3)"	"prognostic unfavorable (5.77e-4)"	"unprognostic (1.72e-1)"	"unprognostic (2.00e-1)"	"unprognostic (4.53e-2)"	113.7	46.3	1.0	31.7	0.9	7.1	68.6	2.8	1.5	21.3	17.0	13.3	3.8	17.9	7.8	15.4	36.1	22.7	24.1	1.4	1.0	11.8	24.3	67.5	7.2	1.2	0.9	4.4	10.6	16.0	13.0	15.3	0.8	60.0	9.2	1.9	26.8	10.6	13.4	19.3	10.6	29.3	0.4	5.4	10.6	13.4	1.1	7.8	53.1	16.6	5.1	34.3	22.7	1.1	4.9	0.0	0.1	0.1	0.1	1.9	0.3	0.0	0.3	0.0	0.1	0.1	23.6	0.1	0.1	0.0	0.4	18.7	0.1	0.0	0.1	0.0	0.1	0.1	7.9	0.1	0.1	0.1	0.2	122.1	0.1	0.4	0.9	0.0	0.0	0.1	0.3	0.4	0.0	3.0	0.1	0.5	0.1	1.0	0.0	0.2	0.1	0.3	0.0	0.3	0.2	0.2	119.7	9.9	0.0	0.1	0.8	0.0	0.1	0.4	0.3	166.4	0.1	0.1	0.1	0.1	0.2	0.9	0.2	0.4	13.5	1.4	0.0	0.8	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	163.6	0.2	0.1	0.3	0.0	3.2	1.0	0.9	2.8	1.5	1.4	1.0	1.2	0.9	0.8	0.4	1.1	1.1	77.2	54.5	402.5	0.0	0.8	9.4	5.8	8.6	1.8	1.8	21.6	8.3	9.1	0.0	152.8	0.0	2.1	0.4	1.1	0.4	0.0	14.6	23.8	14.6	20.5	14.7	0.0	0.0	0.5	9.6	10.6	39.8	1.1	51.2	16.4	0.0	15.4	0.7	2.8	0.0	0.8	0.2	16.2	7.2	7.4	10.9	114.9	12.2	5.4	6.5	19.0	2.7	0.0	1.0	0.1	18.6	0.0	9.1	0.2	49.3	0.1	0.1	72.8	0.3	460.2	9.6	255.3	0.9	0.3	1.5	18.8	10.9	3.1	57.7	0.2	16.6
STIM1	"D11S4896E, GOK"	ENSG00000167323	"Stromal interaction molecule 1"	Q13586	11	3854527-4093210	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocyte precursor cells: 77.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA011088, HPA012123, CAB037128, CAB037288"	Enhanced		Enhanced	"Endoplasmic reticulum"		NA	NA		1900000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Endoplasmic reticulum"		"CAB037128: AB_1079007, CAB037288: AB_1079008, HPA011088: AB_1849884, HPA012123: AB_1849882"	"unprognostic (2.06e-1)"	"unprognostic (9.75e-2)"	"unprognostic (1.34e-1)"	"unprognostic (3.85e-3)"	"unprognostic (3.13e-2)"	"unprognostic (4.12e-1)"	"unprognostic (3.43e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.25e-1)"	"unprognostic (7.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.88e-2)"	"unprognostic (9.35e-2)"	"unprognostic (1.40e-1)"	"unprognostic (2.73e-1)"	"unprognostic (3.48e-2)"	"unprognostic (1.39e-2)"	40.6	18.4	32.9	22.3	31.5	46.4	33.1	18.1	34.5	40.4	30.5	33.7	18.1	39.3	18.2	65.6	39.0	25.1	24.0	30.5	23.1	20.0	38.0	26.8	29.8	17.4	22.9	41.2	30.1	43.7	18.0	17.5	18.9	26.0	24.6	11.4	61.1	24.3	111.9	47.1	31.3	34.3	18.6	31.5	32.2	25.4	26.9	68.6	40.9	49.7	29.7	32.2	40.4	22.4	42.4	48.5	14.1	23.5	60.9	55.4	22.2	31.1	31.0	22.6	28.5	24.3	13.8	44.7	35.4	46.2	50.9	74.3	20.1	21.5	19.3	36.7	30.5	70.1	19.2	36.0	53.0	58.9	40.1	56.8	53.2	32.0	90.7	28.2	31.7	59.6	44.2	80.1	24.7	9.8	55.8	20.7	5.4	23.3	18.1	13.8	22.1	41.7	38.2	23.7	3.4	14.2	51.2	33.5	19.2	22.5	12.7	32.4	34.0	40.2	13.8	42.2	25.1	88.0	71.9	22.5	33.4	24.0	26.0	16.6	11.2	20.0	17.8	14.8	14.5	7.9	13.1	19.5	9.6	11.4	14.8	13.3	16.7	20.8	25.5	8.3	14.7	17.1	32.9	31.5	18.1	34.5	30.5	23.1	17.4	22.9	18.9	18.6	26.9	22.4	20.1	16.0	8.2	53.8	22.2	16.4	7.4	9.5	17.6	5.3	16.5	13.2	4.6	18.6	10.5	5.5	14.6	27.3	35.2	27.9	1.9	12.4	4.9	17.5	35.5	12.6	9.1	18.1	63.5	14.5	13.5	20.2	10.7	24.0	29.8	4.7	20.3	32.6	15.7	16.8	56.3	13.0	12.2	22.2	15.2	9.2	27.4	18.7	17.8	57.1	11.0	16.5	36.0	77.4	5.1	12.3	6.7	11.3	14.8	11.2	7.9	3.6	14.2	3.9	26.3	17.1	18.4	21.4	13.5	50.6	22.3	17.4	28.5	1.6	11.8	11.9
STIM2		ENSG00000109689	"Stromal interaction molecule 2"	Q9P246	4	26857601-27025381	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"choroid plexus: 84.2"	"Cell type enhanced"	"Detected in all"		"Astrocytes: 123.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"REH: 187.7;U-698: 90.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036933, CAB037196, HPA057511"	Supported					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 14: REH - Unknown function"	"Cluster 49: Ciliated cells - Cilium organization"			"CAB037196: AB_1841195, HPA036933: AB_2675391, HPA057511: AB_2683453"	"unprognostic (7.09e-2)"	"unprognostic (8.80e-3)"	"unprognostic (1.60e-3)"	"unprognostic (2.58e-2)"	"unprognostic (2.83e-1)"	"unprognostic (5.29e-3)"	"prognostic unfavorable (3.97e-5)"	"unprognostic (1.53e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.55e-1)"	"prognostic favorable (5.01e-4)"	"unprognostic (6.81e-2)"	"unprognostic (1.45e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.55e-2)"	"unprognostic (3.17e-1)"	"unprognostic (2.17e-3)"	11.2	7.5	11.5	16.9	14.3	17.3	11.6	11.1	14.3	11.0	84.2	11.5	16.6	10.8	22.5	6.2	12.3	19.8	6.9	17.7	12.4	13.0	9.9	15.1	25.4	12.7	12.2	18.8	14.2	8.4	13.7	10.3	12.5	13.9	14.4	18.8	12.9	7.3	8.2	13.9	15.0	10.2	9.7	22.1	14.9	7.4	13.7	20.8	10.6	6.5	23.4	13.9	7.7	14.3	10.0	14.1	13.9	17.5	14.7	9.2	12.7	24.0	7.7	12.6	15.1	12.4	34.4	44.5	13.6	9.4	13.1	11.9	10.4	28.3	13.4	13.4	16.2	13.0	26.3	11.9	11.7	23.3	13.5	12.1	13.7	16.9	8.8	16.3	15.4	17.7	14.1	8.8	31.0	11.9	17.2	22.9	15.2	20.8	18.9	187.7	26.0	10.9	10.6	22.3	24.3	8.8	16.9	12.3	6.6	9.9	7.6	19.8	16.3	17.1	11.1	11.8	15.7	23.7	20.8	90.6	18.4	24.8	28.0	12.9	1.7	1.4	3.9	1.4	2.6	4.1	4.2	3.3	1.3	4.8	4.5	3.5	3.0	1.8	6.5	5.0	2.2	1.3	11.5	14.3	11.1	14.3	17.7	12.4	12.7	12.2	12.5	9.7	13.7	14.3	55.8	12.8	26.9	123.7	57.1	16.4	14.1	42.4	17.6	39.0	18.7	16.3	8.8	22.8	30.6	33.1	81.3	11.9	62.7	17.3	13.7	10.5	9.8	18.0	19.9	49.3	45.7	14.9	69.9	20.1	6.9	20.2	26.0	14.7	36.8	32.4	32.2	11.2	7.4	30.3	68.1	30.8	46.8	20.4	16.2	8.3	15.2	29.2	8.8	58.1	18.9	19.2	65.9	101.0	87.5	12.7	15.9	7.2	37.1	10.9	19.4	5.1	112.4	61.1	19.7	22.5	18.3	19.9	24.0	7.8	15.5	4.9	48.3	37.0	14.4	12.9
STIMATE	"MGC52022, TMEM110"	ENSG00000213533	"STIM activating enhancer"	Q86TL2	3	52836219-52897548	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 7.3;Endometrial ciliated cells: 24.2;Extravillous trophoblasts: 6.9;Hofbauer cells: 9.7;Proximal tubular cells: 15.4;Respiratory ciliated cells: 9.5"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"											HPA051855	Uncertain		Approved	Cytosol		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 32: U-937 - Innate immune response"	"Cluster 49: Ciliated cells - Cilium organization"	Cytosol		"HPA051855: AB_2681639"	"unprognostic (1.45e-1)"	"unprognostic (7.93e-3)"	"unprognostic (2.19e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.29e-3)"	"unprognostic (3.87e-2)"	"unprognostic (9.31e-2)"	"unprognostic (7.55e-4)"	"unprognostic (3.34e-1)"	"unprognostic (6.55e-2)"	"unprognostic (3.10e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.33e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.81e-1)"	9.0	9.7	8.1	8.1	7.9	23.2	7.9	7.0	8.0	10.1	4.2	9.1	5.9	10.6	5.6	6.6	12.8	6.9	6.3	6.9	5.9	7.1	30.6	12.1	9.5	8.6	8.0	8.7	11.7	6.0	6.1	5.3	7.5	7.6	4.8	4.6	10.7	7.9	17.5	8.3	8.0	9.4	6.9	11.1	8.6	6.9	7.8	10.3	8.8	5.1	8.2	10.9	7.7	7.8	9.6	8.2	12.6	22.1	27.9	17.7	24.8	13.3	15.5	18.5	17.0	10.2	10.0	9.2	2.6	16.1	17.8	8.7	15.1	13.7	12.8	20.3	10.6	15.3	10.3	15.9	18.4	23.0	11.3	13.8	18.6	20.7	9.3	11.7	15.4	15.2	5.2	9.3	15.8	7.9	12.7	12.9	11.3	8.0	15.8	6.7	8.5	6.4	8.8	12.5	2.7	9.1	14.1	9.5	12.9	6.9	8.2	20.3	15.5	14.8	8.4	19.7	16.5	16.8	11.9	9.0	13.0	23.2	11.5	0.0	1.6	0.9	1.0	3.1	0.9	0.9	1.6	1.2	2.0	0.7	0.8	0.6	0.1	0.4	2.9	1.1	2.4	0.8	8.1	7.9	7.0	8.0	6.9	5.9	8.6	8.0	7.5	6.9	7.8	7.8	2.4	0.0	2.7	0.0	1.3	0.0	0.0	0.0	0.0	0.0	2.6	1.0	0.0	0.0	0.6	7.3	0.0	1.8	1.8	0.0	1.9	2.4	0.0	24.2	1.7	0.5	0.0	0.0	0.0	2.9	6.9	0.8	0.0	1.6	0.0	1.4	0.0	0.0	9.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	0.0	0.0	2.0	0.0	0.0	0.0	0.0	2.6	0.0	0.0	0.7	0.0	0.0	15.4	9.5	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	1.9	1.2	4.6	0.0	0.0
STOM	"BND7, EPB7, EPB72"	ENSG00000148175	Stomatin	P27105	9	121338987-121370304	"Plasma proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 454.6;Erythroid cells: 535.1;Hepatocytes: 371.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 591.3;hTCEpi: 497.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA010961, HPA011419"	Approved		Enhanced	"Vesicles,Plasma membrane,Cytosol"		NA	NA		16000000	"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA010961: AB_1080111, HPA011419: AB_1080109"	"unprognostic (1.11e-1)"	"unprognostic (2.15e-2)"	"unprognostic (5.27e-2)"	"unprognostic (7.93e-2)"	"unprognostic (5.68e-3)"	"unprognostic (1.65e-2)"	"unprognostic (9.20e-3)"	"unprognostic (7.86e-2)"	"unprognostic (1.76e-1)"	"unprognostic (3.59e-2)"	"unprognostic (3.32e-1)"	"unprognostic (1.26e-1)"	"unprognostic (5.23e-2)"	"unprognostic (9.15e-3)"	"unprognostic (2.27e-2)"	"unprognostic (7.82e-2)"	"unprognostic (2.99e-2)"	339.0	117.3	100.4	101.0	108.1	358.2	243.8	94.7	103.9	129.3	74.8	226.0	46.1	139.9	72.2	87.8	141.7	153.3	219.7	90.5	113.1	123.9	355.4	290.7	67.7	120.7	115.1	81.3	38.9	45.3	49.8	272.7	108.9	111.6	58.4	15.0	95.5	93.4	102.6	118.3	114.1	155.9	105.2	121.6	139.3	24.7	111.0	33.8	112.9	106.2	46.4	182.4	129.6	108.7	8.4	55.0	4.8	26.0	591.3	170.3	0.4	138.6	149.3	40.7	64.5	7.6	10.8	66.5	34.3	186.6	23.9	14.7	31.7	133.0	79.3	41.7	12.0	144.7	108.8	23.1	299.0	61.4	32.4	272.2	497.3	60.9	88.0	11.7	152.5	21.0	33.3	88.2	96.8	45.2	2.2	47.0	64.4	3.5	16.6	8.7	0.2	147.7	34.7	1.7	5.9	0.5	114.5	107.8	62.1	44.9	36.6	47.4	172.8	92.0	28.1	91.3	13.6	36.5	44.9	4.4	35.1	58.1	51.0	21.4	35.5	4.1	168.9	55.8	165.7	5.9	84.2	153.3	35.8	4.2	15.0	81.1	20.8	147.1	41.0	6.1	8.7	128.8	100.4	108.1	94.7	103.9	90.5	113.1	120.7	115.1	108.9	105.2	111.0	108.7	454.6	160.3	96.6	30.0	13.2	105.5	251.8	107.0	62.0	5.0	135.8	72.3	36.7	121.5	159.0	35.0	6.2	121.9	72.1	26.3	3.9	56.6	3.6	97.0	75.4	313.6	0.0	535.1	3.2	22.0	54.7	140.3	17.9	11.7	36.1	76.0	282.7	371.2	92.1	3.3	4.8	1.1	54.9	226.3	92.3	9.0	66.5	105.9	88.9	70.3	37.9	8.6	127.7	6.6	4.5	39.1	18.3	103.0	16.9	90.2	33.8	92.8	216.0	5.0	138.1	73.2	188.1	40.8	13.7	48.4	119.1	172.8	98.8	81.8	2.2	200.0
STOML3	"Epb7.2l, SRO"	ENSG00000133115	"Stomatin like 3"	Q8TAV4	13	38965925-38990859	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"fallopian tube: 34.9"	"Group enriched"	"Detected in some"	19	"Endometrial ciliated cells: 75.5;Respiratory ciliated cells: 109.2"	"Group enriched"	"Detected in some"	4	"endometrial cancer: 2.4;lung cancer: 0.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	40	"AF22: 17.5"	"Region enriched"	"Detected in many"	6	"olfactory bulb: 23.6"					"HPA012892, HPA071011"	Enhanced		Supported	"Plasma membrane"		NA	NA				"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 12: NES - Nervous system development"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"		"HPA012892: AB_1857610, HPA071011: AB_2732169"		"unprognostic (2.64e-1)"	"unprognostic (1.91e-2)"	"prognostic favorable (1.49e-4)"	"unprognostic (1.82e-1)"	"unprognostic (1.17e-1)"		"unprognostic (4.24e-2)"	"unprognostic (1.19e-1)"	"unprognostic (2.14e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.35e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.74e-1)"		"unprognostic (1.22e-1)"	0.0	0.0	0.9	0.0	0.5	0.0	0.0	0.5	0.0	0.7	1.3	0.1	0.0	0.6	0.0	0.0	34.9	0.0	0.0	1.1	1.8	0.0	0.0	2.1	0.0	4.7	5.1	0.0	0.0	0.0	0.0	0.1	5.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.0	0.0	0.0	0.1	0.9	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	17.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.5	0.5	0.0	1.1	1.8	4.7	5.1	5.0	2.0	0.9	1.3	0.0	0.0	1.5	0.0	0.0	0.1	0.1	2.6	0.0	0.0	0.0	0.4	0.1	0.0	4.8	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.4	75.5	0.4	0.3	0.0	0.0	0.1	0.0	1.1	0.4	0.0	1.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	2.0	0.0	0.0	1.5	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	109.2	0.0	0.0	0.0	0.7	0.0	0.2	0.0	0.1	0.7	0.0	0.0	0.0	0.1
STRA6	FLJ12541	ENSG00000137868	"Signaling receptor and transporter of retinol STRA6"	Q9BX79	15	74179466-74212267	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport	Receptor	"Disease variant, Microphthalmia"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"cervix: 24.5"	"Cell type enhanced"	"Detected in many"		"Club cells: 17.6;Endometrial stromal cells: 43.1;Extravillous trophoblasts: 12.1;Fibroblasts: 16.1;Proximal tubular cells: 10.3;Syncytiotrophoblasts: 26.4"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 33.7;CAPAN-2: 94.5;SH-SY5Y: 59.2;WM-115: 142.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040839	Approved					NA	NA				"Cluster 89: Fibroblasts - ECM organization"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 33: Fibroblasts - ECM organization"			"HPA040839: AB_10794881"	"unprognostic (1.20e-2)"	"unprognostic (4.99e-2)"	"unprognostic (3.71e-2)"	"unprognostic (3.55e-3)"	"unprognostic (1.37e-1)"	"unprognostic (2.09e-2)"	"unprognostic (4.38e-3)"	"unprognostic (1.67e-2)"	"unprognostic (9.16e-2)"	"unprognostic (1.21e-1)"	"unprognostic (5.35e-2)"	"unprognostic (3.89e-1)"	"unprognostic (7.91e-13)"	"unprognostic (2.90e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.51e-2)"	"unprognostic (1.91e-1)"	0.1	1.0	0.1	0.3	0.0	0.0	0.9	0.0	0.4	24.5	0.4	0.1	0.0	4.3	0.5	1.1	3.6	0.3	0.1	0.1	0.1	4.3	0.0	0.2	0.8	0.1	0.0	0.6	0.1	0.0	5.5	7.6	0.0	5.2	0.0	0.0	0.7	1.4	0.0	0.3	0.2	0.2	0.1	0.1	0.0	3.1	0.3	0.2	0.1	0.1	0.5	1.3	2.4	0.0	0.5	33.7	1.9	0.1	0.0	0.0	6.0	1.0	0.2	0.0	0.0	11.7	94.5	0.0	22.1	0.1	0.7	3.4	1.8	0.0	0.0	0.0	0.2	3.0	1.3	2.5	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.4	6.1	0.6	2.9	0.1	0.0	0.4	0.0	0.0	0.0	2.9	17.4	59.2	0.0	3.6	0.0	3.6	0.2	0.1	0.0	0.2	7.3	0.6	1.6	0.1	0.2	0.0	0.6	0.0	142.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.4	1.0	9.7	0.0	0.0	0.2	0.3	1.0	0.0	17.6	0.0	0.0	4.2	0.0	0.0	1.9	0.3	1.7	2.1	43.1	1.3	0.0	0.0	0.1	0.0	12.1	16.1	0.0	1.8	0.0	0.1	0.0	0.0	1.8	0.0	0.0	0.0	2.0	0.0	0.8	0.8	6.8	0.4	1.8	1.9	0.1	0.0	0.0	0.0	0.0	4.7	0.0	4.1	0.0	0.4	0.0	10.3	6.6	0.0	0.0	1.3	4.7	0.5	0.5	0.0	0.0	26.4	0.3	0.1	0.0	1.3
STRIT1	DWORF	ENSG00000240045	"Small transmembrane regulator of ion transport 1"	P0DN84	3	155290227-155293683	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	79	"skeletal muscle: 1711.3;tongue: 698.4"	"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.1;prostate cancer: 1.3"	"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in single"	7	"basophil: 1.0"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.0"	"Not detected"	"Not detected"																	NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"		"Cluster 50: Fibroblasts - ECM organization"							"unprognostic (6.77e-4)"		"unprognostic (1.60e-2)"					"unprognostic (6.62e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.82e-3)"	"unprognostic (1.33e-2)"				0.6	0.1	3.5	0.2	15.2	0.2	0.5	4.5	3.5	0.0	2.8	0.2	6.3	0.2	0.5	14.1	0.1	0.4	5.5	3.3	2.8	5.9	0.3	0.2	0.3	3.1	4.1	0.1	0.3	0.1	0.1	0.1	4.2	12.1	0.2	0.3	8.7	0.1	1711.3	2.2	3.6	0.0	1.7	0.2	0.2	0.2	7.5	0.0	0.4	698.4	0.1	0.0	0.1	5.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.1	0.5	0.0	0.0	0.0	0.1	0.2	0.0	0.1	0.2	0.3	0.0	0.0	0.4	0.2	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.2	0.2	0.2	0.4	0.2	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	3.5	15.2	4.5	3.5	3.3	2.8	3.1	4.1	4.2	1.7	7.5	5.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
STT3A	"ITM1, MGC9042, STT3-A, TMC"	ENSG00000134910	"STT3 oligosaccharyltransferase complex catalytic subunit A"	P46977	11	125591712-125625215	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"	"Cancer-related genes, Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 391.8"	"Cell type enhanced"	"Detected in all"		"Plasma cells: 91.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030735	Approved					NA	NA		23000	"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA030735: AB_10603342"	"unprognostic (8.25e-3)"	"unprognostic (5.45e-2)"	"unprognostic (3.02e-2)"	"prognostic favorable (1.32e-4)"	"unprognostic (5.10e-2)"	"unprognostic (1.72e-2)"	"prognostic unfavorable (3.57e-4)"	"unprognostic (8.40e-2)"	"unprognostic (4.80e-2)"	"unprognostic (1.16e-2)"	"unprognostic (8.96e-3)"	"unprognostic (1.31e-1)"	"prognostic unfavorable (4.96e-4)"	"unprognostic (2.60e-2)"	"unprognostic (6.38e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.82e-2)"	38.5	39.2	14.6	44.6	17.7	31.8	55.8	17.9	16.9	84.9	29.8	54.0	42.2	60.8	140.4	30.2	56.3	39.5	38.5	15.0	20.1	45.8	69.0	39.0	32.9	19.4	18.4	68.0	69.0	391.8	29.0	63.8	19.6	56.2	59.5	40.0	80.1	77.2	18.4	31.6	42.1	58.9	17.5	34.4	51.4	44.5	17.5	34.8	83.9	24.4	48.8	50.4	33.3	23.1	113.1	99.5	123.7	173.6	230.1	176.4	133.8	198.5	238.5	158.6	196.6	304.2	294.3	143.6	236.2	297.3	222.4	202.7	173.5	176.2	208.5	114.8	90.0	341.0	63.7	215.1	254.4	208.4	153.6	138.4	125.8	219.5	424.5	186.1	182.2	63.9	147.1	210.6	205.4	82.7	84.4	65.6	78.6	221.8	106.0	98.9	107.1	221.5	173.7	170.1	77.5	66.2	142.9	229.3	72.5	144.9	267.8	148.1	164.5	227.7	82.0	97.6	159.7	66.3	82.4	109.6	87.4	206.3	184.7	96.2	46.7	36.6	56.1	45.4	77.9	42.8	53.7	52.0	65.2	32.1	37.1	44.4	15.7	52.8	41.8	158.3	44.0	47.5	14.6	17.7	17.9	16.9	15.0	20.1	19.4	18.4	19.6	17.5	17.5	23.1	17.4	28.9	25.0	6.8	20.8	16.2	14.3	40.3	12.5	11.6	15.2	9.8	23.3	27.1	29.1	16.5	20.9	45.4	21.7	16.1	1.9	30.1	10.6	22.9	51.0	17.3	15.6	19.6	7.6	27.2	73.4	33.0	26.0	57.0	17.1	29.0	32.2	38.5	30.7	1.7	8.9	37.3	20.3	23.6	31.9	5.4	21.5	17.3	24.9	9.4	12.6	13.2	11.3	11.6	10.9	28.6	12.2	18.8	91.9	19.3	15.6	13.6	23.6	15.1	19.7	23.1	32.8	33.5	13.1	21.9	14.8	45.6	14.6	22.3	26.9	13.9
STT3B	"FLJ90106, SIMP, STT3-B"	ENSG00000163527	"STT3 oligosaccharyltransferase complex catalytic subunit B"	Q8TCJ2	3	31532638-31637616	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Glycosyltransferase, Transferase"	"Congenital disorder of glycosylation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 264.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036448, HPA036646"	Approved		Supported	"Endoplasmic reticulum"		NA	NA		17000	"Cluster 15: NK-cells - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 25: Spermatids - Spermatogenesis"	"Endoplasmic reticulum"		"HPA036448: AB_2675129, HPA036646: AB_10673472"	"unprognostic (2.17e-2)"	"unprognostic (2.23e-1)"	"prognostic favorable (7.91e-5)"	"unprognostic (1.60e-1)"	"unprognostic (3.11e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.60e-1)"	"unprognostic (3.26e-3)"	"unprognostic (3.68e-2)"	"unprognostic (3.86e-2)"	"unprognostic (9.18e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.71e-3)"	"unprognostic (1.02e-1)"	42.8	59.9	21.1	52.2	29.5	63.7	57.1	23.3	27.0	62.1	30.9	59.7	47.9	51.8	90.3	44.8	45.3	60.2	49.4	22.6	30.7	49.6	74.8	49.3	59.9	24.3	23.1	105.5	45.7	76.6	24.8	60.3	23.9	56.3	61.4	38.6	49.9	51.3	62.1	44.7	49.1	57.7	25.4	44.2	55.1	94.3	26.1	71.8	80.7	57.8	58.8	56.6	32.1	27.6	77.9	128.0	115.4	121.7	142.0	142.3	249.7	142.3	124.9	104.2	119.9	117.7	164.5	134.0	67.8	130.0	85.8	63.9	108.1	123.5	135.9	377.1	70.2	115.0	120.7	126.4	109.4	252.0	131.1	109.8	129.7	148.8	186.7	160.7	107.1	168.3	62.8	209.6	144.0	44.4	246.8	154.8	92.9	129.6	70.7	252.3	62.6	196.0	122.0	110.7	48.7	59.4	141.3	207.2	84.5	98.3	93.4	132.8	209.3	139.8	88.6	139.7	127.3	129.0	166.4	111.4	126.9	170.0	117.6	2.1	3.3	6.2	3.1	3.9	5.0	2.4	5.6	4.4	2.9	2.7	5.3	4.3	1.2	6.1	2.9	5.5	3.0	2.0	21.1	29.5	23.3	27.0	22.6	30.7	24.3	23.1	23.9	25.4	26.1	27.6	32.1	86.6	57.7	34.6	69.6	68.1	58.4	34.1	74.6	51.0	57.2	29.5	71.1	54.3	76.0	44.1	68.8	67.3	65.3	41.8	13.7	34.1	162.8	25.0	65.9	42.0	45.1	50.9	61.5	45.3	100.5	49.6	45.3	43.5	31.1	43.6	37.9	68.2	54.8	45.4	59.4	57.5	36.7	58.0	76.0	264.9	36.4	71.5	51.6	53.4	49.1	34.2	56.7	60.3	73.3	36.5	50.0	32.7	144.2	74.1	50.5	31.5	42.2	37.4	26.3	39.0	53.3	90.9	55.2	65.0	61.8	95.4	78.3	68.4	66.1	69.4
STX17	FLJ20651	ENSG00000136874	"Syntaxin 17"	P56962	9	99906654-99974534	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, ER-Golgi transport, Host-virus interaction, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001204	Approved		Uncertain	Nucleoli,Cytosol		NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 16: U-266 - Nucleosome"	"Cluster 23: Spermatids - Flagellum & Golgi organization"	"Nucleoli, Cytosol"		"HPA001204: AB_1080118"	"unprognostic (1.16e-1)"	"unprognostic (2.50e-1)"	"unprognostic (8.67e-2)"	"unprognostic (2.93e-1)"	"unprognostic (6.71e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.70e-2)"	"unprognostic (9.75e-2)"	"unprognostic (1.62e-1)"	"unprognostic (1.04e-2)"	"unprognostic (1.08e-1)"	"prognostic favorable (1.62e-5)"	"unprognostic (9.48e-2)"	"unprognostic (4.32e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.28e-1)"	9.3	9.4	7.6	9.3	8.3	11.3	12.3	12.9	8.9	9.5	10.2	9.5	8.9	10.8	10.9	12.0	8.0	8.5	8.1	7.6	7.8	9.7	18.3	9.3	9.2	7.6	7.1	10.9	12.1	11.0	7.6	10.7	7.7	12.4	9.8	10.9	12.8	11.3	16.7	17.6	9.4	10.5	6.7	10.5	10.9	7.9	7.9	11.4	13.2	13.0	10.3	7.7	9.8	10.9	12.9	12.4	11.2	13.0	14.0	13.2	22.3	9.7	13.1	10.1	8.4	14.1	15.8	25.2	9.2	9.5	17.7	14.1	9.6	13.6	7.1	21.3	7.7	16.0	16.3	8.3	15.9	22.5	5.3	12.2	15.9	10.9	15.7	11.7	12.0	21.9	22.4	12.5	8.2	15.4	14.5	8.4	10.0	15.3	8.8	10.8	20.3	10.5	13.7	15.5	6.2	11.9	19.1	13.3	10.2	7.0	13.8	6.9	9.1	6.5	9.9	11.1	8.3	18.5	24.4	4.8	9.2	9.5	6.9	18.6	3.6	7.3	6.4	3.9	9.1	6.3	7.7	7.2	4.6	5.1	8.8	8.4	4.0	14.5	8.2	2.8	4.6	4.6	7.6	8.3	12.9	8.9	7.6	7.8	7.6	7.1	7.7	6.7	7.9	10.9	25.1	16.0	32.6	35.6	26.2	10.6	19.2	13.9	34.7	14.9	20.1	20.6	19.1	14.3	19.4	23.9	20.9	24.7	21.5	10.7	29.4	19.0	67.2	13.5	21.6	18.7	25.2	26.9	41.9	19.4	19.5	18.0	28.1	15.6	26.0	24.0	18.5	25.0	10.4	10.1	40.5	15.7	20.3	12.7	10.6	36.7	25.7	17.1	8.8	45.0	24.8	21.8	24.7	48.7	47.4	15.7	18.1	18.0	24.4	30.9	17.8	21.1	19.6	13.5	39.5	19.6	20.2	33.6	18.1	27.3	12.1	27.4	26.6	27.0	16.2	18.3
STX19	MGC21382	ENSG00000178750	"Syntaxin 19"	Q8N4C7	3	94014365-94028597	"Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"epididymis: 16.3;intestine: 13.4"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 39.4;Glandular and luminal cells: 19.7;Intestinal goblet cells: 31.7;Paneth cells: 38.0;Proximal enterocytes: 19.2"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CAPAN-2: 6.0;HaCaT: 1.3;hTCEpi: 4.0"	"Not detected"	"Not detected"							HPA030604	Uncertain		Approved	"Intermediate filaments,Cytosol"		NA	NA				"Cluster 37: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Intermediate filaments"	Cytosol	"HPA030604: AB_10601268"	"unprognostic (7.35e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.12e-1)"	"unprognostic (5.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (1.13e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (9.04e-2)"	"unprognostic (1.29e-2)"	"unprognostic (4.32e-2)"	"unprognostic (7.00e-3)"	"unprognostic (1.19e-2)"	"unprognostic (1.96e-1)"	"unprognostic (2.12e-1)"	"unprognostic (4.87e-3)"	0.1	0.0	0.3	1.7	0.5	0.0	5.4	0.4	0.6	2.8	3.7	13.0	7.6	0.8	16.3	6.0	1.4	1.8	0.1	0.3	0.2	0.4	0.1	4.0	0.0	0.3	0.6	0.1	6.7	4.6	0.1	0.1	0.2	3.9	13.4	1.2	8.8	0.1	0.1	9.1	8.1	0.3	0.1	0.4	7.3	0.2	0.2	0.2	0.1	0.0	1.2	0.2	2.9	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.0	0.0	0.1	1.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	4.0	0.0	0.4	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.1	0.0	0.1	0.3	0.0	0.0	0.2	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.6	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.4	0.6	0.3	0.2	0.3	0.6	0.2	0.1	0.2	0.3	0.4	16.0	15.9	1.0	0.2	1.7	2.2	6.4	2.8	3.0	5.6	3.7	0.1	0.0	9.9	0.0	12.5	0.2	0.1	39.4	1.9	4.4	1.9	15.9	2.1	0.2	0.0	0.0	3.9	8.2	0.0	0.1	10.2	19.7	0.0	0.1	0.0	0.0	0.2	0.0	2.4	31.7	10.2	0.0	0.0	0.6	0.0	0.1	0.0	1.0	0.0	0.5	0.0	1.0	1.6	7.1	38.0	0.7	0.0	1.5	19.2	0.1	16.1	14.8	0.0	1.0	0.5	0.2	0.1	2.7	1.8	0.3	0.3	0.0	15.7	1.6
STX1A	"HPC-1, p35-1, STX1"	ENSG00000106089	"Syntaxin 1A"	Q16623	7	73699206-73719672	"Human disease related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Exocytosis, Neurotransmitter transport, Transport"		"Williams-Beuren syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	9	"brain: 128.5;pituitary gland: 98.5"	"Cell type enhanced"	"Detected in many"		"Enteroendocrine cells: 52.7;Excitatory neurons: 60.6;Pancreatic endocrine cells: 29.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 139.9;U-87 MG: 92.2"	"Group enriched"	"Detected in all"	5	"amygdala: 246.2;basal ganglia: 93.9;cerebral cortex: 354.4;hippocampal formation: 229.1;white matter: 116.1"	"Group enriched"	"Detected in all"	8	"amygdala: 37.6;cerebral cortex: 103.4;hippocampal formation: 87.2"	"CAB008372, HPA069176"	Enhanced		Approved	"Nuclear membrane,Vesicles"	"Intracellular and membrane"	NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 10: Brain - Neuronal signaling"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	"Nuclear membrane"	"CAB008372: AB_592786, HPA069176: AB_2686098"	"unprognostic (5.12e-3)"	"prognostic unfavorable (3.63e-4)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (1.94e-5)"	"unprognostic (3.12e-3)"	"unprognostic (1.88e-1)"	"unprognostic (3.02e-8)"	"unprognostic (1.11e-2)"	"unprognostic (6.97e-2)"	"unprognostic (3.52e-2)"	"unprognostic (6.34e-2)"	"unprognostic (7.70e-3)"	"unprognostic (4.18e-6)"	"unprognostic (2.65e-2)"	"unprognostic (1.50e-1)"	"unprognostic (1.14e-3)"	"unprognostic (6.20e-2)"	2.5	6.8	55.0	2.5	70.6	11.9	2.4	28.8	128.5	5.3	13.3	10.8	4.4	3.9	1.5	1.8	3.8	6.8	1.7	76.1	24.5	3.4	2.3	3.4	1.0	16.8	20.1	3.1	10.8	0.9	98.5	2.3	17.8	4.6	2.0	2.5	3.0	1.4	2.1	1.8	4.3	2.7	15.8	2.5	7.8	4.6	23.3	1.2	2.7	0.7	0.6	4.1	4.1	55.3	4.6	21.9	3.4	10.1	4.4	11.7	2.3	14.3	9.5	5.9	3.9	7.4	12.2	5.8	2.1	10.3	32.2	3.7	5.0	9.2	4.4	10.2	3.9	1.8	8.7	4.4	4.9	2.7	5.2	6.8	3.8	41.4	14.4	26.7	10.4	0.9	4.9	6.5	11.4	10.8	1.7	21.1	2.7	8.1	47.8	0.0	2.4	5.7	4.9	3.9	139.9	22.5	4.3	12.1	3.0	4.0	3.9	1.8	39.7	28.9	9.6	22.4	39.0	3.7	2.5	2.7	92.2	2.2	34.5	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.6	0.7	55.0	70.6	28.8	128.5	76.1	24.5	16.8	20.1	17.8	15.8	23.3	55.3	0.9	0.0	2.8	8.1	0.4	4.2	10.7	6.2	0.6	6.2	4.6	3.4	3.2	4.3	5.9	1.8	4.2	0.4	5.0	1.3	0.0	4.0	0.1	4.5	2.9	1.6	52.7	0.4	60.6	3.6	1.9	2.2	3.1	11.1	15.2	2.2	1.8	0.2	0.7	8.4	16.6	2.8	8.2	1.2	2.1	0.2	1.8	6.1	3.6	5.6	0.1	1.0	6.2	8.5	4.8	29.8	1.2	1.5	1.0	10.5	3.4	0.5	7.4	1.9	0.0	1.9	2.8	1.6	3.8	0.6	2.7	0.7	5.3	1.7	1.5	18.9
STX3	STX3A	ENSG00000166900	"Syntaxin 3"	Q13277	11	59713456-59805882	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 313.2"	"Cell type enhanced"	"Detected in all"		"Bipolar cells: 373.0;Cone photoreceptor cells: 394.0;Rod photoreceptor cells: 400.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	8	"basophil: 42.5;eosinophil: 74.1;neutrophil: 60.7"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 74.1"	"Cell line enhanced"	"Detected in many"		"SK-MEL-30: 167.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA002191, HPA069176"	Approved		Approved	"Nuclear membrane,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 77: Retina - Visual perception"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	Vesicles	"Nuclear membrane"	"HPA002191: AB_1080165, HPA069176: AB_2686098"	"unprognostic (2.24e-2)"	"unprognostic (1.97e-2)"	"unprognostic (7.96e-3)"	"unprognostic (1.02e-1)"	"unprognostic (2.84e-2)"	"unprognostic (2.36e-3)"	"prognostic unfavorable (8.41e-7)"	"unprognostic (1.64e-1)"	"unprognostic (3.00e-1)"	"unprognostic (7.71e-3)"	"unprognostic (2.07e-2)"	"unprognostic (5.55e-2)"	"prognostic favorable (1.14e-6)"	"unprognostic (1.06e-1)"	"unprognostic (2.85e-1)"	"unprognostic (4.02e-2)"	"unprognostic (1.17e-2)"	16.4	24.1	10.1	23.7	11.8	59.2	20.1	18.3	14.6	21.1	11.8	51.0	59.5	29.7	36.7	21.4	15.1	39.1	16.4	10.8	11.2	58.6	15.4	40.7	9.7	11.7	11.9	18.7	24.0	34.1	19.4	50.3	13.4	20.2	56.3	313.2	21.6	24.6	10.9	26.2	44.1	26.4	9.7	23.4	47.5	22.1	12.4	7.4	27.8	17.9	13.8	28.3	18.3	13.1	40.1	23.8	0.9	11.0	20.5	11.5	33.1	21.1	37.7	49.4	61.0	109.4	38.2	11.2	38.9	16.1	85.6	44.0	63.5	22.0	59.4	9.6	12.0	12.7	16.4	34.0	51.1	41.7	116.4	21.0	46.6	38.3	46.2	30.5	39.7	16.6	110.5	23.0	21.5	23.8	0.4	28.9	60.1	63.1	18.2	14.5	40.8	18.6	92.7	94.5	27.0	41.4	9.0	48.0	167.2	79.9	52.1	29.0	54.0	20.8	44.0	28.6	19.3	25.8	49.4	22.8	27.8	27.0	29.0	42.5	6.3	74.1	2.4	1.9	2.5	1.0	3.3	1.6	7.1	3.1	3.0	0.9	60.7	0.5	1.2	1.0	0.0	2.7	10.1	11.8	18.3	14.6	10.8	11.2	11.7	11.9	13.4	9.7	12.4	13.1	17.0	67.3	30.6	2.6	9.5	50.7	69.5	12.8	30.1	373.0	43.5	15.2	10.2	31.5	18.9	11.0	394.0	10.1	5.9	124.6	17.6	40.2	4.8	37.8	9.6	30.2	26.3	4.4	40.4	25.6	15.9	12.8	29.6	68.5	58.2	14.9	20.7	5.6	16.0	72.3	33.0	36.5	18.3	18.9	49.7	7.5	3.7	26.4	37.4	24.4	28.7	48.4	11.3	3.5	25.3	48.9	64.1	7.5	5.8	87.2	34.0	69.5	13.3	400.3	6.6	10.0	15.9	4.6	20.6	29.4	60.1	40.5	17.9	5.6	26.5	87.7
STX4	"p35-2, STX4A"	ENSG00000103496	"Syntaxin 4"	Q12846	16	31032889-31042975	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Langerhans cells: 149.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001330	Approved		Enhanced	"Plasma membrane"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 41: Macrophages - Immune response"	"Plasma membrane"		"HPA001330: AB_1080167"	"unprognostic (2.31e-3)"	"prognostic favorable (3.65e-4)"	"unprognostic (3.25e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.63e-1)"	"unprognostic (3.75e-3)"	"unprognostic (5.64e-3)"	"unprognostic (2.93e-2)"	"unprognostic (1.01e-2)"	"unprognostic (3.12e-1)"	"unprognostic (1.16e-2)"	"prognostic unfavorable (2.88e-9)"	"unprognostic (6.90e-2)"	"unprognostic (7.91e-2)"	"unprognostic (1.52e-1)"	"unprognostic (3.26e-2)"	38.3	44.0	33.1	34.2	36.2	22.3	33.9	37.4	36.4	36.3	32.3	37.5	38.3	31.4	24.4	35.8	29.8	27.7	39.8	33.2	37.8	33.5	35.8	36.2	31.1	38.0	36.6	30.4	27.7	38.4	23.2	32.3	37.7	29.9	28.6	8.5	29.9	26.5	45.8	44.3	35.9	31.6	36.1	43.7	32.4	14.9	36.2	28.4	29.5	33.8	37.1	38.1	32.6	39.0	51.9	70.6	16.0	36.1	51.1	52.1	33.8	47.7	79.2	47.5	48.7	22.1	53.2	35.4	58.9	80.8	54.4	36.6	15.2	52.6	45.6	60.3	43.8	25.3	48.7	59.7	58.3	29.2	80.1	50.2	36.1	82.1	61.1	58.5	64.3	22.3	29.9	38.6	84.9	80.3	28.0	44.8	33.1	36.9	36.7	24.0	47.1	46.1	45.9	38.7	13.1	24.6	40.6	41.1	17.4	20.7	33.7	38.7	74.4	48.3	21.8	55.8	26.6	41.2	37.0	14.6	73.3	46.4	29.7	21.3	21.7	27.3	17.6	23.8	15.4	12.7	14.7	17.9	18.8	17.5	11.0	14.2	23.0	24.6	21.9	11.1	9.0	11.2	33.1	36.2	37.4	36.4	33.2	37.8	38.0	36.6	37.7	36.1	36.2	39.0	34.9	44.8	22.7	7.8	32.6	65.1	34.6	56.3	31.9	7.4	22.3	20.6	23.6	48.6	35.2	22.0	12.5	31.1	35.9	69.7	29.4	60.6	12.9	22.1	26.6	46.0	25.7	11.1	4.8	67.7	35.7	51.7	43.3	29.0	60.3	42.1	33.9	20.0	89.5	5.0	3.6	39.5	38.7	49.6	149.9	15.7	38.5	83.2	30.2	2.8	51.7	24.1	42.2	3.0	16.0	73.4	58.5	35.3	23.0	61.6	77.7	50.8	31.3	6.9	39.5	40.6	36.4	9.4	6.7	27.0	65.1	33.1	35.4	39.0	47.9	36.2
STX5	"SED5, STX5A"	ENSG00000162236	"Syntaxin 5"	Q13190	11	62806860-62832051	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 177.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001358	Uncertain		Supported	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"	Nucleoplasm	"HPA001358: AB_1080119"	"unprognostic (3.51e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.79e-1)"	"unprognostic (1.91e-3)"	"unprognostic (1.54e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.71e-2)"	"unprognostic (3.30e-1)"	"unprognostic (1.13e-1)"	"unprognostic (3.34e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.67e-2)"	"unprognostic (3.42e-2)"	"unprognostic (2.79e-1)"	"unprognostic (2.86e-2)"	"unprognostic (8.22e-3)"	34.2	31.8	31.2	22.2	32.1	41.9	34.4	35.3	39.0	42.0	34.6	27.5	22.7	30.6	42.6	34.9	33.1	25.0	27.2	31.3	32.1	38.3	51.0	32.7	25.1	34.2	31.8	42.2	51.1	27.0	29.6	27.4	31.7	43.6	22.4	18.8	51.8	26.9	27.7	41.4	28.4	23.9	31.3	35.5	36.0	29.0	32.9	30.4	37.9	20.2	31.6	28.4	34.2	33.5	40.9	25.4	34.5	29.9	44.6	50.2	31.0	39.2	54.9	64.7	52.0	18.8	39.0	26.0	35.9	55.9	37.8	41.7	29.7	37.2	47.8	60.4	28.3	23.0	33.0	39.2	55.3	26.9	33.5	40.7	41.6	58.6	70.3	50.5	31.9	37.0	21.0	71.7	34.5	48.4	36.5	43.8	11.3	36.2	36.8	37.1	32.3	70.2	28.8	20.7	26.3	21.6	31.4	49.4	63.6	25.7	54.4	35.9	36.8	46.8	24.6	54.6	25.1	64.2	38.1	27.4	38.0	18.7	29.6	11.7	11.4	36.2	10.4	14.1	9.3	11.0	8.1	10.1	10.4	11.3	7.5	7.6	17.8	13.1	12.7	12.9	13.0	6.6	31.2	32.1	35.3	39.0	31.3	32.1	34.2	31.8	31.7	31.3	32.9	33.5	30.3	22.4	29.3	12.7	64.1	67.2	79.5	37.9	13.6	21.0	38.0	27.9	5.6	20.0	27.6	11.0	27.1	55.3	57.6	29.8	29.4	45.7	113.1	28.2	28.6	33.1	32.9	23.5	16.0	59.6	75.1	39.5	23.9	34.0	52.7	25.2	30.0	24.4	46.5	18.5	15.4	54.8	22.4	39.5	53.5	143.7	39.1	33.2	46.2	12.2	51.6	30.3	44.3	10.1	16.6	44.1	36.0	25.2	47.2	61.2	44.8	32.6	20.7	18.6	32.9	34.1	33.6	32.2	30.1	19.8	64.2	177.6	40.4	28.0	26.2	75.5
STX6		ENSG00000135823	"Syntaxin 6"	O43752	1	180972712-181023121	"Plasma proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038557, HPA038558"	Approved		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 4: Macrophages - Innate immune response"	"Golgi apparatus"	Nucleoplasm	"HPA038557: AB_2676082, HPA038558: AB_10672716"	"unprognostic (1.11e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.09e-3)"	"unprognostic (2.23e-1)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (6.24e-5)"	"unprognostic (2.12e-1)"	"unprognostic (6.12e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.62e-1)"	"prognostic unfavorable (1.93e-8)"	"unprognostic (2.59e-1)"	"unprognostic (1.59e-1)"	"unprognostic (2.46e-1)"	"unprognostic (1.00e-1)"	9.5	7.4	13.7	11.2	14.9	2.7	9.2	15.9	17.9	9.5	11.6	7.9	7.5	8.2	7.7	17.5	7.4	7.1	5.8	15.6	13.5	8.7	4.8	11.3	10.9	13.8	13.7	8.2	4.1	7.4	4.5	11.5	12.6	7.2	8.1	8.1	8.0	6.7	4.0	12.8	7.6	8.7	13.2	9.3	7.9	5.6	14.1	17.2	11.4	4.9	14.1	14.2	11.2	16.6	16.9	18.6	18.0	24.1	18.5	21.7	30.3	21.2	27.3	16.4	13.9	17.4	16.5	17.0	28.7	23.4	10.2	29.4	16.5	37.4	19.0	12.3	12.1	11.4	14.2	17.2	18.4	16.4	14.1	19.9	33.6	27.6	28.3	29.3	33.6	15.7	21.3	11.8	22.0	24.2	15.9	15.4	28.2	21.0	9.2	13.7	22.0	24.7	19.6	41.7	25.5	27.0	22.2	42.3	23.9	30.7	25.8	14.9	28.0	22.4	11.8	21.2	17.3	19.8	11.8	12.3	11.0	15.8	13.5	2.6	1.6	2.1	0.7	1.3	0.8	0.7	1.1	1.1	2.2	0.7	1.4	0.9	1.4	0.2	1.1	0.7	1.4	0.6	13.7	14.9	15.9	17.9	15.6	13.5	13.8	13.7	12.6	13.2	14.1	16.6	13.9	16.0	18.6	32.3	11.8	48.9	21.3	19.0	41.5	12.8	16.0	11.7	6.4	2.8	13.7	18.4	6.2	25.7	15.8	10.5	11.7	10.7	8.9	19.4	16.6	23.0	23.4	16.0	54.7	9.8	24.9	12.7	19.4	22.7	12.0	12.7	14.6	4.8	26.4	8.4	38.0	11.1	16.2	26.1	28.0	11.8	8.4	31.9	7.2	23.4	25.2	6.7	15.5	50.3	30.7	14.9	13.9	13.2	10.0	22.2	10.2	11.5	13.3	11.4	6.6	8.2	12.2	5.6	15.4	47.8	37.6	20.5	14.0	16.4	10.6	22.8
STXBP1	"hUNC18, MUNC18-1, rbSec1, UNC18"	ENSG00000136854	"Syntaxin binding protein 1"	P61764	9	127579370-127696027	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Epilepsy, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 174.5;pituitary gland: 66.4;retina: 214.2"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 131.0;Cone photoreceptor cells: 156.4;Excitatory neurons: 243.2;Inhibitory neurons: 157.5;Rod photoreceptor cells: 155.6"	"Cancer enhanced"	"Detected in all"		"melanoma: 39.6"	"Region enhanced"	"Detected in many"		"cerebral cortex: 174.5"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SCLC-21H: 144.1;SK-MEL-30: 131.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008209, HPA023483, CAB034434"	Enhanced		Approved	Nucleoplasm,Cytosol		NA	NA		29000	"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nucleoplasm, Cytosol"		"CAB034434: AB_2196699, HPA008209: AB_1857624, HPA023483: AB_1857625"	"unprognostic (2.32e-2)"	"unprognostic (7.33e-2)"	"unprognostic (3.85e-2)"	"prognostic unfavorable (4.78e-4)"	"unprognostic (1.80e-1)"	"prognostic unfavorable (1.47e-4)"	"prognostic unfavorable (5.73e-4)"	"unprognostic (2.87e-2)"	"unprognostic (2.31e-1)"	"unprognostic (3.08e-3)"	"prognostic favorable (9.81e-4)"	"unprognostic (1.30e-2)"	"unprognostic (1.67e-1)"	"unprognostic (2.68e-2)"	"unprognostic (5.51e-2)"	"unprognostic (7.66e-2)"	"unprognostic (3.36e-3)"	27.5	28.8	22.8	7.8	33.2	1.1	21.0	38.6	174.5	21.8	0.0	15.9	5.5	24.1	7.1	10.4	32.3	11.4	24.0	48.3	12.2	14.1	3.1	32.1	6.0	48.7	0.0	25.2	24.8	15.0	66.4	14.1	33.1	10.5	8.4	214.2	15.6	10.4	9.0	11.4	9.3	21.0	0.0	10.4	13.3	9.1	6.8	5.8	20.1	9.2	7.0	15.4	16.4	27.2	13.2	27.1	25.5	28.8	56.6	48.3	23.2	45.0	22.9	26.6	23.3	1.5	15.4	13.1	24.2	29.7	74.2	4.7	22.6	28.1	32.7	29.8	15.4	17.1	69.7	4.9	28.5	1.8	14.6	36.6	15.4	70.0	33.7	42.6	32.2	43.4	17.8	19.6	45.5	24.5	12.5	5.2	21.5	21.4	35.9	7.5	12.1	31.3	22.0	0.6	144.1	69.9	72.9	37.2	131.9	22.5	5.8	5.6	47.5	30.0	15.1	59.9	17.4	40.2	73.2	17.4	59.2	18.9	28.4	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.6	0.9	0.1	0.0	0.3	0.4	0.0	0.0	0.0	0.1	0.0	0.2	22.8	33.2	38.6	174.5	48.3	12.2	48.7	0.0	33.1	0.0	6.8	27.2	24.3	25.6	70.7	34.0	1.2	11.6	10.1	8.4	12.5	131.0	10.5	8.0	15.2	1.5	9.2	3.7	156.4	2.7	1.1	0.5	7.9	13.1	2.2	8.3	14.7	28.9	45.6	4.0	243.2	8.4	5.9	18.7	3.1	7.0	5.1	5.0	26.7	1.4	4.4	84.1	157.5	10.2	8.2	2.5	5.6	2.2	20.5	3.0	10.6	45.0	0.6	27.0	0.0	61.3	39.0	5.3	0.0	44.4	1.6	10.8	0.1	8.9	15.9	155.6	13.1	9.5	11.2	40.6	16.9	2.9	7.5	24.5	2.3	17.7	0.9	7.1
SUN1	"FLJ12407, KIAA0810, UNC84A"	ENSG00000164828	"Sad1 and UNC84 domain containing 1"	O94901	7	816615-896435	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Differentiation, Meiosis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 343.8;Late spermatids: 576.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008346, HPA008461"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 34: Spermatids - Unknown function"	"Nuclear membrane"		"HPA008346: AB_1080462, HPA008461: AB_1080461"	"unprognostic (2.70e-2)"	"unprognostic (1.51e-2)"	"unprognostic (1.10e-2)"	"unprognostic (2.33e-1)"	"unprognostic (1.25e-1)"	"unprognostic (2.57e-3)"	"unprognostic (1.82e-1)"	"unprognostic (1.67e-1)"	"unprognostic (4.57e-2)"	"unprognostic (3.32e-2)"	"unprognostic (1.69e-1)"	"unprognostic (8.10e-2)"	"unprognostic (1.08e-2)"	"unprognostic (1.47e-2)"	"unprognostic (4.63e-2)"	"unprognostic (1.34e-1)"	"unprognostic (9.33e-2)"	72.4	26.9	26.1	17.9	25.4	8.3	60.7	43.4	30.7	75.3	29.1	52.3	33.8	73.3	38.5	43.8	66.1	28.2	77.4	25.2	24.3	44.3	28.2	41.7	23.6	23.5	27.2	84.1	34.1	53.0	59.0	47.3	23.1	39.2	30.2	41.4	44.7	34.0	119.2	87.1	42.1	41.5	23.8	38.8	48.1	45.5	24.3	20.0	44.3	99.1	25.1	38.9	57.4	25.3	128.7	34.2	40.2	65.5	43.4	61.6	39.2	31.7	53.4	58.0	59.0	29.1	139.8	30.5	32.2	43.7	113.5	156.8	33.3	55.9	55.9	13.2	33.3	10.0	51.0	27.8	55.3	15.2	24.3	31.0	65.6	46.3	76.4	53.7	42.7	19.0	41.9	22.4	58.6	44.5	10.1	25.2	56.0	44.3	39.0	21.9	22.3	28.7	59.1	40.7	77.2	49.9	40.1	81.4	31.5	64.6	64.6	15.4	32.5	52.8	47.6	55.1	53.2	20.4	25.6	19.0	36.6	12.7	74.4	11.6	9.4	2.5	4.0	8.3	4.2	6.8	7.9	4.6	7.5	5.5	11.0	7.2	0.5	6.6	6.4	1.5	7.3	6.4	26.1	25.4	43.4	30.7	25.2	24.3	23.5	27.2	23.1	23.8	24.3	25.3	107.0	44.8	36.4	63.0	26.5	106.7	96.9	73.2	50.7	72.4	48.0	38.1	103.7	31.5	68.5	40.5	87.6	37.4	14.1	61.9	27.4	41.5	343.8	168.5	40.3	79.9	40.7	31.5	76.5	23.2	23.5	52.6	60.1	143.7	17.1	73.4	62.4	39.1	17.9	112.7	64.5	45.1	59.0	20.0	34.3	576.2	57.2	16.8	42.7	43.1	16.6	24.0	10.3	48.7	49.8	55.8	68.4	42.5	26.4	84.6	37.7	21.9	163.5	67.6	65.7	53.5	73.4	40.9	49.4	36.1	85.7	38.4	22.0	26.1	38.2	137.4
SUN2	UNC84B	ENSG00000100242	"Sad1 and UNC84 domain containing 2"	Q9UH99	22	38734725-38794143	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Meiosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"NK-cells: 201.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001209	Supported		Supported	"Nuclear membrane"		NA	Yes			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Nuclear membrane"		"HPA001209: AB_1080465"	"unprognostic (9.76e-2)"	"unprognostic (1.42e-1)"	"unprognostic (8.32e-2)"	"unprognostic (5.09e-2)"	"unprognostic (1.36e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.94e-2)"	"unprognostic (2.37e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.25e-3)"	"unprognostic (8.15e-2)"	"unprognostic (4.10e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.75e-1)"	"unprognostic (1.31e-1)"	"unprognostic (8.10e-2)"	"unprognostic (2.33e-2)"	137.8	35.1	123.6	73.6	219.0	160.4	111.7	149.1	155.3	95.4	41.4	107.8	47.6	128.2	22.2	84.0	125.3	41.1	86.7	118.3	133.1	52.8	121.9	107.0	104.0	187.1	182.2	112.9	78.0	18.2	40.3	28.7	170.7	78.2	25.2	12.3	74.9	52.1	145.4	90.3	93.1	46.1	107.2	97.2	94.3	34.6	163.3	74.3	53.1	63.8	60.0	121.7	89.0	257.7	89.8	41.0	40.0	44.7	118.8	29.5	52.0	60.2	69.4	69.7	58.9	36.8	98.7	28.1	71.9	85.9	43.1	65.4	13.4	44.7	28.4	98.0	54.7	18.4	44.7	33.7	71.9	62.3	184.0	25.0	37.3	33.6	31.2	46.9	56.2	55.3	23.5	154.3	38.5	28.7	35.0	53.9	3.9	63.0	26.2	57.6	55.8	85.7	17.4	43.1	35.3	13.2	67.0	73.7	35.1	18.5	49.5	115.3	95.2	50.6	43.3	44.9	79.5	113.1	38.2	30.4	93.8	74.2	86.6	29.0	13.7	18.6	42.3	15.6	27.5	10.8	27.0	34.9	10.7	10.1	27.6	33.6	13.9	24.8	26.9	6.7	19.9	24.8	123.6	219.0	149.1	155.3	118.3	133.1	187.1	182.2	170.7	107.2	163.3	257.7	55.5	22.4	22.9	20.2	57.0	18.1	28.4	15.1	24.5	9.9	36.5	39.0	6.2	40.0	17.8	33.1	8.4	16.9	141.8	65.6	3.9	34.9	1.8	11.6	15.8	37.4	18.6	31.8	12.5	47.6	65.9	34.0	42.8	32.9	25.4	41.5	52.1	109.6	25.0	21.9	7.7	30.1	8.2	42.4	21.4	4.4	61.2	41.8	17.8	16.9	25.5	21.4	201.8	7.1	132.9	60.0	41.8	65.5	44.7	22.0	42.2	18.9	5.7	13.0	52.6	100.7	37.0	3.8	1.1	32.1	17.2	14.8	133.4	10.9	21.4	21.4
SURF4	"ERV29, FLJ22993, MGC102753"	ENSG00000148248	"Surfeit 4"	O15260	9	133361450-133376166	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 325.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064613	Approved		Supported	"Nuclear membrane,Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	Yes		65000	"Cluster 16: MAIT-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	"Nuclear membrane, Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA064613: AB_2685299"	"prognostic unfavorable (5.85e-4)"	"unprognostic (1.38e-2)"	"unprognostic (1.92e-1)"	"unprognostic (2.04e-2)"	"unprognostic (3.40e-2)"	"prognostic unfavorable (1.47e-5)"	"prognostic unfavorable (8.11e-4)"	"unprognostic (1.10e-3)"	"unprognostic (3.13e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.30e-3)"	"unprognostic (1.23e-1)"	"unprognostic (9.76e-3)"	"unprognostic (7.58e-3)"	"unprognostic (1.25e-1)"	"unprognostic (2.29e-1)"	"unprognostic (4.29e-3)"	97.0	106.4	20.3	38.8	22.5	66.5	76.5	22.1	23.4	70.5	27.9	72.1	79.2	78.5	40.6	77.6	71.1	39.0	74.1	21.5	22.3	67.1	223.8	84.2	29.6	23.6	22.2	61.0	150.4	35.4	88.6	55.4	22.2	69.2	37.9	14.0	86.4	39.5	60.1	63.2	82.2	43.4	22.9	59.6	88.5	49.4	25.8	27.8	68.2	23.3	31.4	62.7	59.4	25.9	59.8	96.4	65.3	90.3	134.8	140.2	127.4	184.1	178.4	127.0	124.7	145.9	84.8	41.1	70.6	254.2	122.9	152.7	75.7	94.4	97.0	86.5	46.3	72.1	87.1	156.5	156.2	124.8	94.1	150.4	85.8	109.3	120.2	101.6	118.6	62.9	89.0	109.8	164.5	131.8	60.1	115.4	72.7	162.8	96.2	41.2	89.9	156.5	100.4	56.3	53.8	65.5	136.4	100.4	95.2	61.5	106.6	75.8	127.5	179.4	64.5	137.3	119.6	56.1	86.4	46.4	166.7	66.6	137.5	43.9	40.8	36.2	51.9	32.8	56.9	15.1	36.3	48.4	32.9	12.1	22.0	34.6	28.4	29.4	31.7	38.9	46.9	68.8	20.3	22.5	22.1	23.4	21.5	22.3	23.6	22.2	22.2	22.9	25.8	25.9	53.5	44.8	48.1	18.9	43.0	60.8	65.8	72.5	46.1	21.9	55.5	43.2	42.6	31.5	47.5	35.0	39.6	167.9	80.4	106.9	19.6	95.7	38.6	28.6	72.8	54.8	75.2	31.1	23.2	118.1	254.4	84.8	78.5	67.7	24.7	49.5	47.5	207.3	85.9	33.7	15.6	107.9	30.5	52.3	50.5	19.7	68.3	50.8	40.9	17.8	53.7	53.3	52.5	22.6	23.8	115.1	65.5	53.0	114.8	106.8	151.3	48.5	23.2	26.9	78.9	51.9	80.6	84.4	47.3	46.1	62.4	325.2	90.5	81.8	81.2	84.2
SV2B	"HsT19680, KIAA0735"	ENSG00000185518	"Synaptic vesicle glycoprotein 2B"	Q7L1I2	15	91099950-91302565	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	24	"brain: 34.5;retina: 56.3"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 137.1;Cone photoreceptor cells: 150.1;Excitatory neurons: 455.0;Rod photoreceptor cells: 139.0"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"RPMI-8226: 2.1;SCLC-21H: 3.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046247	Approved					NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA046247: AB_10963538"	"unprognostic (2.92e-1)"	"unprognostic (7.92e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.01e-5)"	"unprognostic (2.66e-3)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.01e-1)"	"unprognostic (3.57e-2)"	"unprognostic (9.89e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.88e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.11e-2)"	"unprognostic (3.10e-4)"	1.8	1.1	17.2	0.2	17.5	0.1	0.8	7.3	34.5	0.1	0.0	0.5	0.1	0.1	0.1	0.1	0.1	0.2	0.8	22.4	0.0	0.3	0.1	0.2	0.4	8.5	0.0	0.0	1.4	0.1	1.0	0.2	10.7	0.8	0.3	56.3	1.0	0.1	0.6	0.2	0.4	0.2	0.0	0.2	0.3	0.8	1.4	0.6	0.2	1.0	1.2	0.1	0.1	14.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	2.1	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	17.2	17.5	7.3	34.5	22.4	0.0	8.5	0.0	10.7	0.0	1.4	14.8	10.9	0.0	0.0	7.2	0.1	0.4	0.1	0.1	0.0	137.1	0.2	0.5	3.0	1.5	0.0	0.0	150.1	0.0	0.0	0.0	0.0	4.2	6.4	0.0	0.0	3.3	0.0	0.0	455.0	5.0	0.0	0.9	0.0	0.0	0.0	0.0	1.1	0.0	0.1	3.3	11.4	0.0	0.0	0.0	0.4	2.0	0.0	0.2	0.0	27.2	0.0	43.4	0.0	5.5	39.4	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	139.0	0.0	0.5	0.2	8.0	0.4	0.1	0.1	0.0	0.1	0.1	0.0	0.2
SV2C		ENSG00000122012	"Synaptic vesicle glycoprotein 2C"	Q496J9	5	76083383-76353939	"Predicted membrane proteins, Transporters"	"Neurotransmitter transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	13	"brain: 55.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 85.0;Inhibitory neurons: 82.6"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	15	"basophil: 1.5"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 1.5"	"Group enriched"	"Detected in some"	5	"Karpas-707: 9.1;SCLC-21H: 3.7;SH-SY5Y: 8.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040722, HPA040770"	Supported		Supported	Nucleoplasm,Vesicles		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	"Nucleoplasm, Vesicles"		"HPA040722: AB_10795624, HPA040770: AB_10805828"	"unprognostic (7.91e-2)"	"unprognostic (2.33e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.41e-2)"	"unprognostic (1.07e-1)"	"unprognostic (9.93e-2)"	"unprognostic (1.09e-2)"	"unprognostic (2.57e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.44e-1)"	"unprognostic (2.34e-2)"	"unprognostic (1.60e-3)"	"unprognostic (1.90e-1)"	"unprognostic (2.12e-1)"	"unprognostic (6.66e-2)"	"unprognostic (1.16e-1)"	0.0	1.2	4.7	0.2	31.4	0.1	0.2	11.1	32.0	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.3	0.0	0.1	0.0	55.7	0.0	0.0	0.0	0.0	26.1	39.5	0.5	0.1	0.0	0.4	0.0	42.2	0.1	0.1	4.3	0.3	0.2	0.0	0.0	0.2	0.2	9.1	0.0	0.5	0.1	20.2	0.0	0.0	0.0	0.0	0.0	0.1	10.2	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.1	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	3.7	8.6	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	31.4	11.1	32.0	0.0	55.7	26.1	39.5	42.2	9.1	20.2	10.2	0.5	0.0	0.0	5.5	0.1	0.0	0.7	0.4	0.0	5.4	0.7	0.1	0.8	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.6	2.5	0.6	0.4	19.8	0.0	85.0	0.2	0.0	0.1	0.0	2.1	0.0	0.5	0.7	0.0	0.1	0.0	82.6	0.6	2.0	0.6	0.3	0.8	0.0	0.2	3.6	2.8	0.0	1.0	0.0	3.0	3.1	0.0	0.2	0.0	0.3	0.6	0.0	0.0	0.1	5.6	0.0	0.2	0.4	0.2	0.7	0.0	0.1	0.0	0.2	0.8	0.2	1.5
SVOPL	MGC46715	ENSG00000157703	"SVOP like"	Q8N434	7	138594285-138701362	"Predicted membrane proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"parathyroid gland: 4.1;salivary gland: 4.0"	"Cell type enriched"	"Detected in some"	8	"granulocytes: 76.0"	"Low cancer specificity"	"Detected in some"			"Not detected"	"Not detected"			"Immune cell enriched"	"Detected in single"	14	"eosinophil: 2.1"	"Lineage enriched"	"Detected in single"	14	"granulocytes: 2.1"	"Cell line enhanced"	"Detected in some"		"HMC-1: 8.8;MOLT-4: 2.0;NTERA-2: 1.9;RT4: 2.0;T-47d: 5.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA018035	Uncertain					NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 60: Granulocytes - Receptor signaling"			"HPA018035: AB_2197028"	"unprognostic (6.70e-5)"	"unprognostic (1.96e-1)"	"unprognostic (1.67e-1)"	"unprognostic (2.49e-1)"	"unprognostic (5.24e-2)"	"unprognostic (2.38e-1)"	"unprognostic (7.69e-3)"	"unprognostic (2.59e-3)"	"unprognostic (7.16e-2)"	"unprognostic (1.64e-1)"	"unprognostic (4.46e-3)"	"unprognostic (5.03e-3)"	"unprognostic (2.22e-4)"	"unprognostic (1.18e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.51e-1)"	"unprognostic (8.51e-2)"	0.0	2.0	0.6	0.1	0.5	0.2	0.9	0.2	0.4	0.5	2.5	0.9	0.1	0.2	0.8	0.1	1.8	0.0	0.2	0.5	0.6	2.7	0.0	0.2	0.1	0.8	0.8	0.5	0.5	4.1	0.9	0.6	0.5	0.4	0.3	3.2	4.0	0.8	0.0	0.3	0.2	0.0	0.6	0.1	0.1	0.9	0.7	0.5	0.7	0.0	0.0	0.4	0.0	0.7	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.6	0.2	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	2.0	1.1	1.9	0.0	0.0	0.5	0.0	0.1	0.0	2.0	0.1	0.6	0.0	0.4	0.0	0.3	5.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.5	0.2	0.4	0.5	0.6	0.8	0.8	0.5	0.6	0.7	0.7	0.0	0.0	1.9	0.7	0.0	0.1	1.9	2.0	0.0	0.6	1.2	1.4	2.1	0.0	3.1	1.8	0.0	3.7	0.4	0.4	0.0	0.0	0.7	8.2	0.1	0.1	0.0	5.5	1.1	0.0	0.8	0.3	0.0	0.9	76.0	1.2	0.0	0.1	0.1	0.0	1.8	0.1	4.1	0.0	0.2	0.5	0.6	0.1	0.0	0.0	0.1	0.5	0.0	1.0	1.5	0.1	0.0	0.4	0.1	0.2	0.1	0.0	5.6	8.6	0.0	0.0	0.3	2.2	0.7	0.0	0.1	1.9	0.7	0.3	0.5	0.5
SYNDIG1	"C20orf39, DSPC2, FLJ14220, IFITMD5, TMEM90B"	ENSG00000101463	"Synapse differentiation inducing 1"	Q9H7V2	20	24469629-24666616	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.4;heart muscle: 26.9"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 157.4;Microglial cells: 472.2;Oligodendrocytes: 214.3"	"Cancer enhanced"	"Detected in many"		"glioma: 10.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Karpas-707: 15.4;RH-30: 43.4;RPMI-8226: 43.6;SCLC-21H: 10.0;U-87 MG: 26.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044271, HPA059267"			Enhanced	Vesicles		NA	NA				"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles		"HPA044271: AB_2732515, HPA059267: AB_2683961"	"unprognostic (9.33e-2)"	"unprognostic (1.83e-2)"	"unprognostic (2.17e-1)"	"unprognostic (9.56e-2)"	"unprognostic (5.03e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.06e-1)"	"unprognostic (1.62e-1)"	"unprognostic (4.69e-2)"	"unprognostic (4.23e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.94e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.21e-1)"	"prognostic unfavorable (6.16e-6)"	"unprognostic (1.40e-3)"	1.8	0.9	23.7	1.5	23.2	0.0	0.5	27.6	26.8	3.2	8.6	0.8	1.2	3.2	0.7	0.2	4.2	8.8	26.9	21.1	21.0	4.9	0.0	0.7	2.0	28.4	23.0	0.9	0.7	0.2	0.7	0.2	28.4	3.3	0.9	1.8	0.3	12.3	0.1	0.2	2.1	2.2	27.8	0.7	1.6	0.8	25.3	1.6	4.8	0.1	2.4	1.7	2.0	36.4	0.0	0.3	2.6	0.0	0.8	0.0	0.0	1.9	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	15.4	0.0	0.8	0.0	0.0	2.6	0.0	0.0	0.0	43.4	43.6	0.0	0.0	10.0	0.0	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.8	0.0	0.2	0.2	0.0	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.7	23.2	27.6	26.8	21.1	21.0	28.4	23.0	28.4	27.8	25.3	36.4	0.0	0.0	0.0	4.6	0.0	0.0	0.1	0.0	0.0	6.3	0.0	0.0	14.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.9	0.3	0.2	0.7	0.6	1.2	0.0	0.0	157.4	0.0	0.0	2.0	0.0	0.8	0.0	21.9	0.0	0.0	0.1	3.3	69.7	0.0	0.0	0.0	0.3	0.7	0.0	0.1	0.0	472.2	0.0	1.9	0.0	41.7	214.3	1.5	0.0	7.2	0.0	0.0	0.0	5.9	0.0	0.5	0.0	0.5	1.4	0.1	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0
SYNJ2BP	Arip2	ENSG00000213463	"Synaptojanin 2 binding protein"	P57105	14	70366499-70417090	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 140.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"							"Low region specificity"	"Detected in all"			HPA000866	Approved	Supported	Approved	Mitochondria		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 44: Endometrium - Transcription"	Mitochondria		"HPA000866: AB_2276678"	"unprognostic (2.68e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.67e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.60e-2)"	"unprognostic (5.70e-2)"	"unprognostic (6.14e-2)"	"unprognostic (6.35e-3)"	"unprognostic (1.44e-2)"	"prognostic favorable (1.11e-16)"	"unprognostic (2.81e-1)"	"unprognostic (1.38e-1)"	"unprognostic (5.35e-3)"	"unprognostic (1.14e-2)"	10.2	10.1	10.3	7.3	10.1	1.3	9.9	9.3	10.0	8.1	13.3	13.7	19.6	9.0	7.9	8.2	7.2	8.4	14.9	8.4	9.3	21.7	20.3	9.5	6.6	10.0	9.8	7.2	7.4	24.9	6.6	9.3	9.8	12.9	15.1	16.4	9.5	11.9	28.7	5.7	16.0	10.7	10.8	9.1	15.5	3.9	10.6	5.1	11.2	29.3	6.4	8.6	6.1	9.7	14.0	9.1	15.3	10.3	11.7	13.4	10.6	10.8	11.1	7.4	8.3	8.7	12.8	0.0	10.0	12.7	7.5	11.6	15.7	11.6	17.5	1.9	8.0	5.2	13.9	11.4	10.3	0.0	1.7	10.5	9.2	9.4	5.3	13.1	16.6	5.8	3.1	2.7	13.4	10.2	7.2	2.1	11.1	13.9	10.9	9.0	22.4	3.9	16.0	20.7	11.1	19.4	14.6	12.0	8.8	9.9	22.7	3.6	18.5	17.7	12.1	6.9	8.7	3.7	15.0	0.0	15.6	1.8	14.9	0.3	3.0	0.1	2.3	3.1	2.7	2.5	2.8	2.7	3.0	2.0	3.8	3.1	0.3	2.3	2.1	1.9	2.3	1.1	10.3	10.1	9.3	10.0	8.4	9.3	10.0	9.8	9.8	10.8	10.6	9.7	36.6	38.5	46.6	0.0	17.8	6.0	28.7	49.4	9.1	44.9	25.9	15.4	89.4	48.6	43.3	75.4	81.3	38.3	13.1	50.1	140.8	49.0	36.9	56.0	26.5	38.4	19.8	5.7	0.0	39.2	31.5	21.7	21.9	85.7	9.5	33.5	37.1	50.4	24.7	30.3	0.0	41.2	44.7	23.6	9.1	9.8	30.4	16.9	14.2	0.0	28.8	37.1	28.8	0.0	0.0	35.7	43.5	41.3	4.2	25.8	87.3	77.0	31.5	88.0	26.3	37.6	27.8	68.9	12.9	12.5	4.8	10.9	17.4	25.0	62.6	30.3
SYP	MRX96	ENSG00000102003	Synaptophysin	P08247	X	49187815-49200199	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 259.4;pituitary gland: 106.8;retina: 316.3"	"Group enriched"	"Detected in many"	4	"Bipolar cells: 529.2;Cone photoreceptor cells: 546.3;Rod photoreceptor cells: 594.4"	"Group enriched"	"Detected in many"	6	"glioma: 12.8;pancreatic cancer: 5.7"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.9"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"K-562: 20.3;SCLC-21H: 102.6;SH-SY5Y: 36.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000076, HPA002858, CAB055505, CAB078999, HPA079659"	Enhanced	Supported				NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"			"CAB000076: AB_2315411, CAB055505: AB_564017, CAB078999: , HPA002858: AB_1080153, HPA079659: "	"unprognostic (2.08e-1)"	"unprognostic (8.72e-2)"	"unprognostic (1.56e-1)"	"unprognostic (5.37e-3)"	"unprognostic (4.37e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.87e-1)"	"unprognostic (6.46e-5)"	"unprognostic (8.52e-3)"	"unprognostic (1.62e-1)"	"unprognostic (3.44e-3)"	"unprognostic (8.26e-2)"	"unprognostic (2.41e-2)"	"unprognostic (1.95e-1)"	"unprognostic (3.54e-1)"	"unprognostic (1.79e-2)"	"unprognostic (1.94e-1)"	2.6	40.1	115.7	3.6	132.0	0.8	1.9	26.0	259.4	1.8	0.0	7.4	12.4	1.5	2.0	1.2	1.7	0.8	3.1	144.0	137.9	5.0	0.8	3.0	0.9	89.5	25.8	1.7	7.6	3.3	106.8	0.8	76.2	1.6	3.9	316.3	1.3	1.1	1.9	1.8	13.9	1.9	4.7	2.0	5.3	1.7	86.0	4.2	2.3	1.4	0.7	1.5	2.2	116.9	0.9	3.9	2.9	5.8	3.2	0.5	0.4	0.2	0.1	0.7	0.8	3.6	2.1	3.2	0.5	0.1	4.4	2.9	3.1	0.4	0.7	6.5	3.5	4.9	1.4	1.1	0.1	0.6	10.5	0.4	0.1	0.5	0.7	0.4	0.3	2.7	20.3	7.6	0.6	1.1	1.7	0.4	9.6	2.5	0.8	0.6	0.6	1.5	0.2	0.4	102.6	36.8	1.1	0.4	1.5	0.9	1.9	1.8	0.6	0.6	3.2	1.0	0.4	0.5	6.7	0.8	1.7	1.3	3.2	0.7	0.2	0.1	0.0	0.2	0.1	0.2	0.1	0.2	0.1	0.4	0.1	0.1	1.9	0.2	0.1	0.6	0.1	0.0	115.7	132.0	26.0	259.4	144.0	137.9	89.5	25.8	76.2	4.7	86.0	116.9	7.5	0.0	3.9	24.2	6.3	2.5	2.8	1.0	1.2	529.2	5.8	8.1	1.8	2.8	2.9	9.2	546.3	1.1	1.9	11.3	0.0	0.9	10.3	1.4	3.1	6.5	116.4	0.4	115.1	2.6	0.6	3.7	10.2	3.1	8.8	3.4	6.1	1.2	1.2	122.8	118.4	37.7	10.2	1.9	4.9	12.6	4.1	3.6	3.6	17.8	2.7	54.4	3.1	28.1	33.7	1.2	2.1	3.8	1.5	1.5	16.3	0.9	4.6	594.4	6.6	5.4	7.8	2.4	2.8	3.4	2.6	1.4	3.5	41.3	10.8	1.0
SYT1	"P65, SVP65, SYT"	ENSG00000067715	"Synaptotagmin 1"	P21579	12	78863993-79452008	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation		"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	12	"brain: 403.3;retina: 197.7"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 1287.6;Cone photoreceptor cells: 894.5;Excitatory neurons: 3753.2;Inhibitory neurons: 2910.4;Rod photoreceptor cells: 905.8"	"Low cancer specificity"	"Detected in many"			"Group enriched"	"Detected in many"	10	"amygdala: 113.1;basal ganglia: 153.7;cerebral cortex: 403.3;hippocampal formation: 134.2;white matter: 146.0"	"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.0;naive B-cell: 1.4"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 39.4;hTERT-RPE1: 37.1;LHCN-M2: 31.9;SH-SY5Y: 30.9;WM-115: 29.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008394, HPA064788"	Enhanced	Supported				NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA008394: AB_1857696, HPA064788: AB_2685351"	"unprognostic (1.02e-3)"	"unprognostic (2.55e-1)"	"unprognostic (4.21e-3)"	"unprognostic (3.77e-2)"	"unprognostic (3.16e-2)"	"unprognostic (3.68e-5)"	"unprognostic (2.78e-2)"	"unprognostic (1.83e-2)"	"unprognostic (7.65e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.11e-1)"	"unprognostic (6.14e-3)"	"unprognostic (3.05e-8)"	"unprognostic (2.89e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.43e-1)"	"unprognostic (1.53e-2)"	0.5	21.7	113.1	2.2	153.7	0.6	0.7	19.7	403.3	1.4	0.0	4.4	1.5	9.9	0.7	0.7	0.8	1.3	0.2	134.2	2.0	1.9	1.9	0.9	0.3	0.0	0.0	5.2	0.3	0.0	6.4	2.6	3.0	6.6	2.8	197.7	0.2	5.5	0.2	0.2	3.4	25.2	0.0	2.6	1.3	0.7	12.5	0.5	0.3	0.5	0.3	1.6	2.5	146.0	0.0	19.2	14.2	0.0	1.4	4.0	0.0	1.4	1.7	1.0	1.1	1.0	0.5	0.0	2.8	0.2	5.0	0.6	0.3	2.2	1.6	0.3	0.7	1.0	0.5	0.0	3.6	0.0	0.3	1.1	1.4	5.2	39.4	37.1	13.6	0.7	0.7	2.2	31.9	3.1	1.8	0.0	10.3	2.1	5.3	0.0	14.3	0.0	0.0	5.5	18.8	30.9	0.0	2.4	0.3	9.5	6.8	0.0	5.4	2.0	0.7	0.0	6.2	3.4	8.0	0.1	4.5	0.0	29.0	0.0	0.7	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	113.1	153.7	19.7	403.3	134.2	2.0	0.0	0.0	3.0	0.0	12.5	146.0	2.2	0.0	0.6	124.7	9.0	0.9	0.1	0.0	0.0	1287.6	0.2	3.4	0.6	0.0	1.3	0.0	894.5	5.6	0.1	0.1	0.0	0.0	1.4	0.6	20.2	10.4	96.9	1.3	3753.2	0.2	2.2	5.9	0.0	0.7	0.0	0.7	1.8	0.1	13.9	62.2	2910.4	0.1	0.0	4.7	7.2	2.9	69.3	1.6	1.8	137.7	0.0	337.7	0.0	126.2	105.1	0.1	7.6	4.5	8.5	11.5	0.1	0.1	0.0	905.8	0.0	0.0	6.7	1.5	5.7	0.2	0.6	5.9	0.4	1.8	0.1	0.3
SYTL2	"CHR11SYT, exophilin-4, FLJ20163, FLJ21219, KIAA1597, MGC102768, PPP1R151, SGA72M, SLP2"	ENSG00000137501	"Synaptotagmin like 2"	Q9HCH5	11	85694224-85811159	"Plasma proteins, Predicted intracellular proteins, Transporters"	Exocytosis			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"intestine: 74.2;stomach 1: 127.7"	"Cell type enhanced"	"Detected in many"		"Gastric mucus-secreting cells: 382.2;granulocytes: 130.8;Intestinal goblet cells: 185.9;Respiratory ciliated cells: 138.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"gdT-cell: 14.0;MAIT T-cell: 23.7"	"Lineage enriched"	"Detected in many"	5	"T-cells: 23.7"	"Cell line enhanced"	"Detected in many"		"MCF7: 91.1;OE19: 148.1;RH-30: 175.8;RPTEC TERT1: 124.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039651	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 37: Intestine - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 27: Mucus-secreting cells - Mucin production"	"Nucleoplasm, Golgi apparatus"	"Plasma membrane"	"HPA039651: AB_10795153"	"unprognostic (8.07e-3)"	"unprognostic (6.72e-3)"	"prognostic favorable (2.67e-4)"	"unprognostic (9.34e-4)"	"unprognostic (6.60e-3)"	"unprognostic (2.19e-4)"	"unprognostic (2.24e-2)"	"unprognostic (5.37e-2)"	"unprognostic (5.56e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.92e-2)"	"unprognostic (2.97e-2)"	"unprognostic (2.85e-2)"	"unprognostic (4.03e-1)"	"unprognostic (1.87e-2)"	"unprognostic (9.72e-2)"	"prognostic favorable (9.07e-4)"	16.7	9.6	19.3	12.9	24.6	3.3	16.0	8.7	35.7	10.7	11.9	51.7	21.6	9.1	16.3	17.0	7.6	27.8	8.4	29.0	25.1	20.2	6.9	14.8	11.1	26.4	14.0	4.8	2.7	6.4	6.1	18.2	17.9	13.6	74.2	13.3	8.9	9.8	5.1	6.8	25.0	10.2	15.6	10.4	127.7	5.1	13.8	7.1	4.7	2.7	6.8	50.9	7.4	29.1	3.5	8.0	12.2	1.0	2.8	15.4	0.2	30.3	39.4	26.3	59.2	34.7	4.5	0.7	11.1	21.3	38.0	22.3	0.8	2.7	34.5	2.4	0.2	0.0	0.2	0.3	1.8	2.7	0.5	19.6	3.8	56.8	0.8	6.2	0.2	1.0	0.4	0.4	33.6	91.1	0.1	0.9	20.6	148.1	13.6	1.3	175.8	0.1	124.2	46.8	0.3	0.6	6.7	5.4	3.0	10.2	0.6	0.5	0.1	40.8	15.6	25.9	1.5	0.2	0.0	16.1	41.9	0.5	25.7	0.0	0.0	0.0	14.0	0.0	23.7	0.0	2.8	8.4	0.0	0.1	2.3	4.1	0.0	4.6	0.1	1.0	1.1	2.6	19.3	24.6	8.7	35.7	29.0	25.1	26.4	14.0	17.9	15.6	13.8	29.1	7.5	22.4	32.5	15.3	3.0	3.6	11.7	15.8	1.8	10.4	45.4	14.0	2.3	8.6	62.1	68.0	8.4	0.7	45.6	115.2	0.0	9.1	1.2	8.0	2.2	6.4	19.2	4.0	103.9	16.9	0.4	11.5	382.2	2.3	130.8	0.8	5.0	0.5	0.5	1.7	23.2	185.9	2.0	5.9	5.0	0.9	1.8	4.6	10.6	20.6	1.6	14.0	63.8	35.7	91.9	16.5	40.6	30.1	31.6	30.7	16.3	8.6	138.4	8.1	32.9	42.1	59.8	3.6	2.6	2.2	5.7	0.4	50.1	2.3	36.7	60.9
SYTL4		ENSG00000102362	"Synaptotagmin like 4"	Q96C24	X	100674491-100732123	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"ovary: 68.3"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 58.1;Leydig cells: 72.7;Sertoli cells: 52.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.7"	"Lineage enriched"	"Detected in single"	10	"granulocytes: 1.7"	"Cell line enhanced"	"Detected in many"		"HAP1: 29.5;HMC-1: 60.0;RT4: 40.8;TIME: 34.9"	"Region enriched"	"Detected in many"	5	"hypothalamus: 30.1"	"Low region specificity"	"Detected in all"			"HPA001475, HPA001589, HPA075138"	Approved		Approved	Vesicles		NA	Yes		3300000	"Cluster 1: Neutrophils - Mixed function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA001475: AB_1080172, HPA001589: AB_1080174, HPA075138: "	"unprognostic (7.82e-3)"	"unprognostic (1.52e-1)"	"unprognostic (3.43e-2)"	"unprognostic (6.16e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.78e-2)"	"unprognostic (1.32e-1)"	"unprognostic (3.35e-2)"	"unprognostic (2.81e-1)"	"unprognostic (1.07e-3)"	"unprognostic (5.62e-2)"	"prognostic unfavorable (2.09e-4)"	"unprognostic (1.30e-1)"	"unprognostic (1.56e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.60e-2)"	6.9	4.1	6.9	2.2	13.2	2.3	6.0	4.5	5.1	21.7	14.1	9.8	2.1	43.1	3.1	3.9	17.8	4.0	3.2	5.2	13.1	5.6	10.5	4.7	0.7	8.4	9.3	68.3	8.3	1.2	18.8	3.6	7.4	12.7	9.7	1.3	6.1	7.2	2.3	2.0	4.9	32.7	6.1	3.3	7.4	6.8	18.0	0.6	8.8	4.9	1.7	6.1	10.2	7.9	0.3	6.0	1.6	0.0	8.5	4.8	0.1	7.7	4.9	8.0	14.3	0.7	7.6	0.0	2.0	5.4	6.9	6.8	29.5	2.3	8.4	0.0	2.6	0.1	10.8	0.4	2.1	0.0	60.0	1.7	0.5	7.3	0.4	3.1	20.5	0.0	3.0	0.0	3.8	2.0	0.1	0.0	1.2	21.2	0.0	0.0	2.4	0.0	7.0	40.8	14.5	0.6	3.1	11.5	1.7	3.0	7.1	0.6	34.9	4.2	8.8	20.9	1.9	0.1	0.0	0.1	5.2	0.0	4.8	0.4	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.7	0.1	0.0	0.0	0.0	0.8	6.9	13.2	4.5	5.1	5.2	13.1	8.4	9.3	7.4	6.1	18.0	7.9	15.6	28.9	1.7	41.8	0.5	0.1	7.7	3.1	1.2	0.2	19.0	6.6	3.8	18.6	8.0	3.7	0.0	0.4	0.7	29.1	3.9	8.9	1.6	4.3	25.8	13.5	0.0	5.0	0.5	2.3	0.4	20.0	26.5	6.2	3.8	58.1	11.4	38.6	1.3	0.0	1.0	26.9	8.2	1.6	1.9	3.8	72.7	7.2	3.6	8.4	0.5	5.4	0.0	10.6	0.2	7.2	27.1	41.8	0.5	11.9	5.8	2.6	8.1	0.6	52.6	38.1	11.8	2.6	4.4	2.6	0.9	0.0	0.9	18.0	9.6	13.8
SYVN1	"DER3, HRD1"	ENSG00000162298	"Synoviolin 1"	Q86TM6	11	65121780-65134532	"Disease related genes, Enzymes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"	"Stress response, Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatocytes: 72.9;Plasma cells: 90.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 205.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005480, HPA024300, CAB037030"	Enhanced		Supported	"Nucleoplasm,Endoplasmic reticulum,Plasma membrane"		NA	NA			"Cluster 46: Basophils - DNA binding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 57: B-cells - Immune response"	Nucleoplasm	"Endoplasmic reticulum, Plasma membrane"	"CAB037030: AB_1840939, HPA005480: AB_1079084, HPA024300: AB_1851073"	"unprognostic (1.12e-1)"	"unprognostic (3.10e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.17e-2)"	"unprognostic (2.85e-2)"	"prognostic favorable (6.88e-4)"	"unprognostic (7.67e-2)"	"unprognostic (2.50e-2)"	"unprognostic (2.64e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.59e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.89e-1)"	"unprognostic (3.85e-2)"	"unprognostic (1.16e-1)"	29.2	40.3	19.3	37.1	25.6	31.0	27.6	23.2	21.4	30.7	26.7	29.2	26.1	29.1	38.8	28.4	30.6	19.7	25.3	18.6	21.2	24.5	117.5	27.0	60.9	27.9	25.6	30.9	90.9	35.0	38.2	26.2	24.6	28.5	29.0	18.7	55.9	30.3	34.2	29.3	39.4	25.9	22.8	51.2	39.4	24.3	23.4	18.3	43.4	19.0	81.1	25.8	24.8	25.9	32.4	40.6	24.0	32.5	59.8	33.8	23.8	32.8	33.5	40.9	28.8	22.2	55.0	181.0	43.8	42.4	53.8	48.8	26.4	33.3	33.6	28.4	20.0	28.6	46.8	50.2	72.3	43.3	49.6	43.3	59.0	36.1	81.0	36.4	27.0	19.0	36.4	90.1	24.3	47.9	19.1	31.2	26.1	33.6	28.0	31.9	20.3	74.0	25.7	31.5	15.6	32.0	30.4	74.1	53.3	21.0	55.4	28.2	25.9	28.3	18.6	51.2	22.4	178.1	134.2	205.9	38.1	21.8	32.3	16.8	7.4	14.0	7.4	4.7	6.5	21.9	5.2	6.9	4.4	22.6	3.7	3.9	7.0	3.5	4.7	18.4	5.3	6.6	19.3	25.6	23.2	21.4	18.6	21.2	27.9	25.6	24.6	22.8	23.4	25.9	11.5	16.0	21.4	11.1	43.5	17.6	6.9	13.8	12.0	10.7	21.0	15.5	4.0	22.8	20.8	11.0	33.3	14.5	16.4	23.1	1.9	13.6	6.6	14.2	16.2	11.3	8.4	13.2	9.6	18.9	16.5	14.2	17.9	22.1	1.3	10.1	15.0	72.9	15.1	13.5	9.5	33.6	16.2	15.3	13.2	4.1	20.5	10.8	12.4	9.4	10.5	11.0	13.4	13.0	15.8	18.2	11.7	13.2	90.5	14.9	14.0	7.7	15.1	18.7	13.1	11.9	10.7	19.3	13.2	9.7	16.1	42.8	11.7	13.6	18.6	13.8
TAP1	"ABCB2, D6S114E, PSF1, RING4"	ENSG00000168394	"Transporter 1, ATP binding cassette subfamily B member"	Q03518	6	32845209-32853816	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"BEWO: 126.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009516, HPA072354"	Approved		Approved	"Endoplasmic reticulum,Centriolar satellite"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum, Centriolar satellite"		"CAB009516: AB_2303048, HPA072354: AB_2686513"	"unprognostic (3.59e-2)"	"unprognostic (1.06e-1)"	"prognostic favorable (9.01e-4)"	"unprognostic (1.33e-1)"	"unprognostic (1.84e-1)"	"unprognostic (3.22e-2)"	"unprognostic (4.92e-2)"	"unprognostic (6.16e-3)"	"unprognostic (2.56e-2)"	"prognostic favorable (4.07e-4)"	"unprognostic (3.02e-3)"	"unprognostic (2.37e-1)"	"prognostic unfavorable (6.58e-5)"	"unprognostic (2.07e-2)"	"unprognostic (4.69e-2)"	"unprognostic (2.42e-2)"	"unprognostic (2.21e-2)"	28.4	24.9	16.1	50.1	16.2	13.7	20.7	15.8	20.3	21.6	16.2	30.3	36.0	20.5	2.5	31.6	17.8	12.7	25.4	14.7	16.2	21.8	19.3	52.7	50.0	24.0	16.1	12.1	14.5	7.0	11.6	12.1	21.2	21.9	12.5	1.7	25.9	7.0	16.3	51.2	42.6	11.5	18.6	73.0	33.4	11.5	19.4	25.5	17.0	7.4	21.3	23.9	24.4	17.4	22.9	13.7	0.1	16.1	8.8	11.4	126.2	8.1	34.3	59.3	86.5	2.0	27.3	41.8	25.0	12.6	48.9	45.8	4.5	20.6	5.3	81.0	6.1	26.5	4.1	10.8	42.3	0.1	17.5	15.0	17.9	17.1	10.4	8.6	15.4	8.4	1.9	55.0	10.6	10.5	17.7	27.4	0.8	3.1	11.1	47.6	5.2	32.8	25.0	10.5	0.2	1.2	6.7	38.0	33.4	1.7	30.9	37.4	9.7	21.5	8.1	53.1	11.4	59.9	82.6	12.6	16.6	16.6	16.4	176.8	99.5	270.1	155.8	101.6	133.8	137.3	125.2	153.7	95.0	107.5	120.9	124.6	295.6	132.9	94.6	94.8	213.8	221.2	16.1	16.2	15.8	20.3	14.7	16.2	24.0	16.1	21.2	18.6	19.4	17.4	72.1	25.6	24.0	9.1	62.1	74.7	47.1	54.5	27.3	4.8	21.5	15.9	7.3	24.3	33.1	5.5	0.0	5.6	108.0	78.8	5.9	81.6	0.5	31.3	39.3	63.6	16.8	12.6	1.1	75.3	95.0	26.9	42.8	77.9	26.6	13.8	27.1	11.1	45.9	15.2	1.9	55.9	57.0	31.9	90.6	0.3	13.1	43.9	23.2	16.9	115.9	25.1	149.3	12.1	3.6	91.3	38.8	10.5	84.8	70.2	84.6	6.9	29.4	2.8	6.6	18.1	27.8	1.0	1.3	20.4	76.4	4.8	92.3	18.2	54.5	52.1
TAP2	"ABCB3, D6S217E, PSF2, RING11"	ENSG00000204267	"Transporter 2, ATP binding cassette subfamily B member"	Q03519	6	32821833-32838770	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Host-virus interaction, Immunity, Peptide transport, Protein transport, Transport"	Translocase		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"monocytes: 69.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 61.4;U-251 MG: 52.0"									HPA001312	Approved		Supported	"Nuclear speckles,Endoplasmic reticulum"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 64: Macrophages - Immune response"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Endoplasmic reticulum"	"Nuclear speckles"	"HPA001312: AB_1080206"	"unprognostic (2.95e-3)"	"unprognostic (2.35e-1)"	"unprognostic (3.77e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.39e-1)"	"unprognostic (3.46e-1)"	"unprognostic (8.04e-2)"	"unprognostic (1.28e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.51e-2)"	"prognostic unfavorable (1.51e-4)"	"unprognostic (1.90e-1)"	"prognostic unfavorable (5.22e-8)"	"unprognostic (5.32e-1)"	"unprognostic (4.17e-2)"	"unprognostic (2.35e-1)"	"unprognostic (4.71e-2)"	17.1	11.7	1.0	4.3	1.0	8.8	14.7	0.8	1.2	16.3	0.5	14.6	10.2	13.7	1.1	26.0	11.9	1.1	14.4	1.2	2.0	12.4	11.5	25.7	7.9	1.6	1.1	9.2	9.0	3.7	8.2	3.1	1.5	9.9	5.5	2.5	11.2	2.1	8.6	14.5	25.2	4.1	0.8	29.8	11.4	2.5	1.8	9.7	12.3	5.8	8.1	10.6	17.2	1.7	4.4	2.0	0.5	5.0	6.1	6.5	0.0	2.3	3.3	13.1	17.7	3.9	41.0	36.5	7.5	9.1	37.1	38.8	15.8	61.4	6.9	43.8	1.9	20.3	11.6	1.3	8.5	0.0	29.5	0.6	2.6	10.3	24.8	0.0	12.1	0.0	20.0	12.2	0.4	1.6	5.8	2.4	0.5	0.0	11.7	25.8	0.0	12.8	10.9	1.1	0.0	0.0	16.0	37.3	4.1	1.0	7.4	1.9	5.7	25.7	6.9	3.9	52.0	17.9	31.4	33.3	19.5	25.7	10.9	1.8	1.3	1.6	3.0	3.2	1.7	0.4	0.8	1.7	0.8	0.3	0.6	0.7	3.8	1.9	2.8	1.3	1.2	0.8	1.0	1.0	0.8	1.2	1.2	2.0	1.6	1.1	1.5	0.8	1.8	1.7	48.2	0.0	7.5	7.5	20.7	0.0	15.6	0.0	3.4	5.0	9.2	8.0	3.5	4.3	3.7	14.7	2.1	1.9	37.9	21.0	1.9	34.1	0.1	18.0	19.4	32.0	3.6	4.0	6.6	33.4	45.8	8.0	10.7	41.9	5.1	8.7	16.4	8.3	23.9	18.5	14.6	14.9	0.0	18.9	0.0	0.0	5.6	20.3	0.0	14.0	69.3	17.7	47.4	10.6	6.5	35.1	12.6	6.0	18.0	29.7	55.9	4.8	1.5	5.8	0.0	8.6	10.3	0.7	2.5	11.1	0.0	1.6	24.0	20.3	14.3	16.7
TAPBP	TAPA	ENSG00000231925	"TAP binding protein"	O15533	6	33299694-33314387	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"CAPAN-2: 168.7;Karpas-707: 140.8;U-266/70: 140.5"	"Low region specificity"	"Detected in all"							HPA007066	Approved					NA	NA		20000	"Cluster 49: Eosinophils - Unknown function"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 1: Pancreatic cells - Digestion"			"HPA007066: AB_1857769"	"prognostic favorable (2.76e-4)"	"unprognostic (1.43e-2)"	"unprognostic (7.01e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.59e-3)"	"unprognostic (2.03e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.21e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (1.67e-2)"	"unprognostic (2.37e-1)"	"unprognostic (3.63e-1)"	"unprognostic (1.61e-2)"	"unprognostic (3.82e-1)"	"unprognostic (1.19e-2)"	"unprognostic (1.21e-1)"	"unprognostic (6.54e-3)"	47.3	73.1	2.4	28.5	4.8	25.0	43.1	1.9	2.8	40.1	1.2	66.7	52.3	38.2	13.3	57.3	43.8	10.5	63.7	2.9	1.8	67.4	107.5	82.1	21.2	2.7	3.2	33.3	48.2	14.9	38.8	18.7	2.0	64.3	19.6	4.1	61.9	17.2	26.7	54.0	81.9	23.1	1.9	129.0	52.1	16.2	2.0	24.4	59.1	6.5	36.7	45.0	43.4	2.4	3.3	1.2	6.3	26.1	20.3	25.6	92.9	18.5	88.1	42.5	57.1	0.1	168.7	48.1	38.1	41.3	92.2	2.9	0.3	30.3	15.8	125.5	4.1	19.1	9.9	24.8	0.2	20.4	63.0	51.7	20.6	0.8	8.2	37.8	0.4	16.0	1.5	140.8	14.7	19.6	51.9	44.1	0.5	0.0	6.3	2.8	0.4	1.3	35.5	1.2	8.6	0.6	0.6	2.4	23.7	3.7	1.4	0.9	45.5	89.4	18.6	1.3	2.0	140.5	117.4	46.2	58.6	38.8	58.8	159.7	87.9	172.1	137.3	121.6	117.0	97.1	99.7	114.3	90.0	86.0	76.2	109.9	151.3	159.6	139.0	102.9	85.9	150.5	2.4	4.8	1.9	2.8	2.9	1.8	2.7	3.2	2.0	1.9	2.0	2.4	116.8	125.0	102.1	22.5	186.6	77.0	93.3	148.2	66.6	34.7	82.0	64.1	73.9	84.4	105.8	71.7	33.3	46.9	223.7	259.6	13.7	256.4	1.9	64.0	52.4	99.1	84.6	58.0	25.9	282.9	85.9	63.9	105.5	78.4	91.9	65.9	75.0	143.7	119.7	20.2	15.0	174.6	83.4	124.3	128.0	9.2	33.2	131.9	119.2	30.9	229.3	34.7	195.7	23.6	8.7	215.5	172.4	32.0	194.9	130.4	283.2	33.1	113.3	30.4	32.9	39.3	57.6	1.2	0.6	53.6	56.3	49.1	163.7	66.4	162.3	141.0
TAS1R1	"GPR70, T1R1, TR1"	ENSG00000173662	"Taste 1 receptor member 1"	Q7RTX1	1	6555307-6579755	"G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	5	"testis: 4.3"	"Group enriched"	"Detected in some"	6	"Early spermatids: 6.1;Late spermatids: 18.4"	"Low cancer specificity"	"Detected in single"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 1.7;Hep G2: 1.6;LHCN-M2: 1.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA034579, HPA034580"	Approved					NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA034579: AB_2674232, HPA034580: AB_10671504"	"unprognostic (2.03e-2)"	"unprognostic (9.29e-3)"	"unprognostic (5.60e-4)"	"unprognostic (1.12e-1)"	"unprognostic (1.11e-1)"	"unprognostic (4.37e-2)"	"unprognostic (2.22e-1)"	"unprognostic (6.53e-4)"	"unprognostic (3.89e-2)"	"unprognostic (3.15e-1)"	"unprognostic (3.26e-2)"	"unprognostic (3.17e-1)"	"unprognostic (5.45e-3)"	"unprognostic (1.67e-1)"	"unprognostic (8.26e-2)"	"unprognostic (8.28e-2)"	"unprognostic (6.22e-2)"	0.1	0.3	0.2	0.1	0.3	0.6	0.1	0.2	0.5	0.2	0.3	0.4	0.1	0.0	0.0	0.1	0.1	0.3	0.0	0.2	0.2	0.1	0.1	0.3	0.1	0.4	0.5	0.3	0.0	0.0	0.2	0.1	0.3	0.0	0.0	0.2	0.8	0.0	0.2	0.5	0.1	0.1	0.3	0.6	0.2	4.3	0.3	0.0	0.0	0.2	0.2	0.1	0.1	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.9	0.0	0.0	0.1	0.0	0.0	1.7	0.0	0.0	0.0	1.6	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.3	0.2	0.5	0.2	0.2	0.4	0.5	0.3	0.3	0.3	0.2	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.1	0.1	0.3	0.4	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	6.1	0.1	0.0	0.1	0.0	0.0	1.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.3	0.1	0.0	0.9	0.0	0.0	0.0	0.0	18.4	0.0	0.0	0.0	1.0	0.0	1.7	0.0	0.0	0.6	0.0	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.1	0.8	1.9	0.0	0.1	0.0	0.0	1.5	0.0	0.1
TAS1R2	"GPR71, T1R2, TR2"	ENSG00000179002	"Taste 1 receptor member 2"	Q8TE23	1	18839599-18859682	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA																											0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TAS1R3	T1R3	ENSG00000169962	"Taste 1 receptor member 3"	Q7RTX0	1	1331280-1335314	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 12.1;salivary gland: 7.9"	"Cell type enhanced"	"Detected in some"		"B-cells: 2.9;Cardiomyocytes: 3.8;Muller glia cells: 1.3;Plasma cells: 5.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Immune cell enriched"	"Detected in single"	17	"memory B-cell: 1.6"	"Lineage enriched"	"Detected in single"	17	"B-cells: 1.6"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 2.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA053439	Uncertain					NA	NA			"Cluster 43: B-cells - Humoral immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 20: HeLa - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA053439: AB_2682150"	"unprognostic (1.35e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.85e-2)"	"unprognostic (9.22e-3)"	"unprognostic (2.88e-1)"	"unprognostic (1.09e-3)"	"unprognostic (4.32e-2)"	"unprognostic (2.05e-1)"	"unprognostic (6.95e-2)"	"unprognostic (4.22e-1)"	"unprognostic (8.44e-3)"	"unprognostic (7.59e-3)"	"unprognostic (8.37e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.11e-3)"	"unprognostic (1.04e-1)"	0.3	0.3	0.5	1.3	0.7	0.5	0.3	1.0	0.7	0.4	0.0	1.0	1.5	0.3	12.1	1.2	0.4	0.1	1.3	0.4	0.1	0.5	1.0	0.4	1.3	0.5	0.3	0.4	0.2	0.0	1.5	0.2	0.4	0.3	0.1	0.0	7.9	0.1	1.1	0.3	1.9	0.0	0.3	3.6	0.7	0.7	0.4	0.2	0.6	0.0	0.9	0.3	0.6	1.1	0.6	0.5	0.1	0.2	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.3	1.2	0.7	0.1	0.0	0.1	0.2	0.0	0.0	0.0	1.6	0.4	0.1	1.2	0.4	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.3	0.2	2.5	0.0	0.3	0.1	0.2	0.3	0.2	1.4	0.4	0.2	0.3	0.0	0.1	0.9	0.1	0.2	0.9	0.8	0.1	0.8	0.1	0.1	0.2	0.0	0.7	0.3	1.5	1.5	0.3	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.7	1.0	0.7	0.4	0.1	0.5	0.3	0.4	0.3	0.4	1.1	0.4	0.0	0.0	0.0	2.9	0.0	0.1	0.0	0.0	0.0	0.2	0.1	3.8	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.4	0.1	0.0	0.0	0.3	0.5	0.4	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.0	0.0	5.8	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.3	0.0
TAS2R19	"T2R19, T2R23, TAS2R23, TAS2R48"	ENSG00000212124	"Taste 2 receptor member 19"	P59542	12	11021619-11022620	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in some"			"Not detected"	"Not detected"			"Cancer enhanced"	"Detected in single"		"testis cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"																	NA	NA				"Cluster 72: Non-specific - Transcription"		"Cluster 52: Non-specific - Transcription"				"unprognostic (1.90e-2)"	"unprognostic (9.54e-2)"	"unprognostic (1.83e-1)"	"unprognostic (5.18e-3)"	"unprognostic (1.84e-1)"	"unprognostic (2.56e-1)"	"unprognostic (1.50e-2)"	"unprognostic (5.73e-2)"	"unprognostic (2.35e-1)"	"unprognostic (8.76e-2)"	"unprognostic (8.26e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.57e-8)"	"unprognostic (9.08e-2)"	"unprognostic (1.58e-1)"	"unprognostic (7.96e-2)"	"unprognostic (4.32e-1)"	0.3	0.3	0.1	0.0	0.2	0.0	0.3	0.2	0.3	0.7	0.1	0.4	0.0	0.6	0.0	0.2	0.4	0.0	0.4	0.2	0.3	0.3	0.2	0.4	0.0	0.3	0.2	1.4	0.4	0.0	1.0	0.0	0.2	0.4	0.0	0.2	0.2	0.0	0.5	0.2	0.3	0.0	0.1	0.3	0.3	0.6	0.2	0.1	0.4	0.0	0.0	0.4	0.4	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.3	0.2	0.3	0.3	0.2	0.2	0.1	0.2	0.4	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.5	0.4	0.1	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0
TAS2R38	"PTC, T2R61"	ENSG00000257138	"Taste 2 receptor member 38"	P59533	7	141972631-141973773	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Sensory transduction, Taste"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at transcript level"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"HPA043862, HPA054366"	Uncertain					NA	NA									"HPA043862: AB_2678703, HPA054366: AB_2682464"			"unprognostic (5.18e-3)"			"unprognostic (6.87e-2)"		"unprognostic (1.22e-1)"		"unprognostic (3.58e-1)"	"unprognostic (1.25e-1)"			"unprognostic (8.36e-2)"	"unprognostic (5.86e-2)"		"unprognostic (8.05e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TBC1D1	"KIAA1108, TBC, TBC1"	ENSG00000065882	"TBC1 domain family member 1"	Q86TI0	4	37891084-38139175	"Predicted intracellular proteins, Transporters"		"GTPase activation"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-698: 310.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041816, HPA058158"	Approved		Approved	Nucleoli		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 52: Non-specific - Ribosome"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 48: Smooth muscle cells - ECM organization"	Nucleoli		"HPA041816: AB_10796784, HPA058158: "	"unprognostic (3.77e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.14e-2)"	"unprognostic (1.06e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.32e-1)"	"unprognostic (1.01e-2)"	"prognostic unfavorable (5.22e-4)"	"unprognostic (1.37e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.22e-1)"	"unprognostic (9.42e-2)"	"prognostic favorable (1.47e-8)"	"unprognostic (1.49e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.41e-2)"	"unprognostic (1.21e-1)"	32.0	10.9	21.6	38.3	19.8	64.2	23.0	14.6	19.7	50.4	44.7	123.8	30.7	139.8	46.4	22.9	61.1	44.6	56.1	26.8	12.3	83.5	26.2	32.4	53.8	17.8	14.3	24.7	28.3	134.2	16.8	41.3	15.4	22.7	28.3	9.6	20.5	40.2	110.0	12.2	35.3	91.2	14.4	39.8	34.3	48.1	13.0	59.0	56.7	149.9	41.3	51.6	23.8	16.8	23.2	26.1	46.7	50.5	16.4	45.3	40.2	61.9	103.6	57.3	58.0	15.0	73.8	118.6	15.0	41.5	72.1	1.0	35.8	45.0	87.6	9.4	20.2	45.9	17.1	31.6	26.2	85.7	50.0	55.4	8.9	35.3	24.4	47.7	89.4	81.6	57.0	19.8	60.3	17.7	119.5	80.5	26.3	3.6	23.6	104.9	75.8	34.7	47.3	42.4	40.7	36.5	23.0	21.1	25.6	104.9	20.5	65.4	61.4	75.1	84.3	19.0	91.4	48.1	63.7	310.4	32.8	76.9	68.2	2.9	7.6	23.2	3.8	25.2	6.2	7.1	3.7	3.1	7.4	9.0	3.3	4.2	20.5	9.7	28.2	6.2	3.3	3.9	21.6	19.8	14.6	19.7	26.8	12.3	17.8	14.3	15.4	14.4	13.0	16.8	38.3	12.8	6.7	50.9	42.0	7.9	14.0	5.0	4.6	12.4	15.1	9.8	73.9	22.8	8.3	27.6	0.0	20.1	30.7	26.0	76.3	13.8	27.6	19.4	27.6	39.9	44.3	11.6	75.9	40.8	27.6	15.5	7.1	25.8	2.5	24.3	27.8	19.8	31.0	10.1	37.7	11.9	36.7	68.6	21.4	50.2	23.3	52.2	10.6	91.8	51.0	9.8	25.7	45.8	9.2	38.7	17.6	19.9	40.7	37.3	13.1	77.3	14.8	1.1	39.5	17.4	79.5	13.0	19.4	3.4	8.7	29.1	32.0	7.4	11.9	35.9
TBC1D4	"AS160, DKFZp779C0666, KIAA0603"	ENSG00000136111	"TBC1 domain family member 4"	O60343	13	75283503-75482169	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"		"GTPase activation"	"Diabetes mellitus"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 82.8"	"Cell type enhanced"	"Detected in many"		"Inhibitory neurons: 157.7;Microglial cells: 307.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"T-reg: 25.0"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"CACO-2: 84.7;HUVEC TERT2: 61.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040145, HPA059885"	Approved		Supported	Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Cytosol		"HPA040145: AB_2676860, HPA059885: AB_2684152"	"unprognostic (5.44e-3)"	"unprognostic (5.23e-1)"	"unprognostic (9.85e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.78e-2)"	"unprognostic (9.54e-3)"	"unprognostic (1.25e-2)"	"unprognostic (8.87e-2)"	"unprognostic (2.87e-1)"	"unprognostic (5.02e-2)"	"unprognostic (7.53e-2)"	"unprognostic (2.64e-1)"	"prognostic favorable (1.07e-11)"	"unprognostic (6.40e-2)"	"unprognostic (3.16e-1)"	"unprognostic (8.88e-2)"	"unprognostic (3.45e-1)"	14.8	70.6	13.2	15.7	12.5	3.4	20.1	12.5	15.1	10.0	7.1	8.7	4.6	8.5	18.4	9.4	10.7	14.1	33.8	10.5	13.8	25.2	11.7	11.9	34.2	15.9	12.0	44.8	15.0	22.1	5.3	20.7	16.7	12.3	10.4	1.6	27.6	4.3	82.8	21.4	10.3	10.2	12.0	21.0	11.0	5.3	20.0	10.7	24.3	54.9	32.6	8.4	9.2	10.5	12.9	14.9	9.2	0.6	21.3	22.8	12.0	11.0	5.8	8.7	9.6	84.7	15.5	2.7	2.4	15.7	4.2	12.0	23.4	11.0	9.0	42.6	24.3	41.5	19.8	25.9	5.4	20.0	0.5	25.0	19.7	9.7	22.4	14.9	61.6	46.0	12.0	1.3	10.0	6.2	29.4	3.6	12.9	24.7	8.8	26.4	8.7	15.2	8.5	9.3	16.9	5.2	4.8	14.6	8.0	4.8	5.0	0.7	26.2	9.8	12.1	5.2	13.0	0.7	0.1	0.3	17.4	18.5	14.7	5.0	0.4	0.0	0.7	0.1	0.0	0.6	11.2	2.5	0.6	0.5	10.4	4.9	0.5	0.5	0.1	9.9	25.0	2.3	13.2	12.5	12.5	15.1	10.5	13.8	15.9	12.0	16.7	12.0	20.0	10.5	17.8	6.4	29.1	32.3	2.6	36.2	10.0	2.0	19.9	1.6	33.1	41.1	81.4	10.0	6.1	14.7	0.0	10.8	32.4	8.0	15.6	12.3	25.5	14.3	17.7	32.6	21.0	5.0	78.0	7.4	9.7	17.3	7.1	8.7	5.1	81.5	26.0	19.4	26.6	1.7	157.7	10.7	24.4	24.8	25.8	5.2	3.7	12.9	21.4	307.3	33.6	0.4	1.0	40.7	5.1	4.9	2.9	7.2	2.1	16.4	3.4	10.8	3.9	0.6	6.6	24.8	21.6	2.4	7.7	24.2	44.2	4.9	25.2	8.1	15.5	10.6
TBC1D5	KIAA0210	ENSG00000131374	"TBC1 domain family member 5"	Q92609	3	17157162-18444817	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Protein transport, Transport"	"GTPase activation"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in all"	5	"Astrocytes: 226.6;Excitatory neurons: 333.2;Inhibitory neurons: 350.5;Microglial cells: 324.2;Oligodendrocyte precursor cells: 341.8;Oligodendrocytes: 565.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035125, HPA035126"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 34: Non-specific - Transcription"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	Vesicles	"Golgi apparatus"	"HPA035125: AB_2674479, HPA035126: AB_10670696"	"unprognostic (1.87e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.86e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.60e-1)"	"unprognostic (4.30e-3)"	"unprognostic (3.07e-2)"	"unprognostic (3.31e-1)"	"unprognostic (3.56e-2)"	"unprognostic (6.27e-2)"	"unprognostic (2.05e-1)"	"unprognostic (1.42e-1)"	"prognostic favorable (1.75e-7)"	"unprognostic (1.25e-1)"	"unprognostic (1.56e-1)"	"unprognostic (5.72e-2)"	"unprognostic (7.07e-2)"	17.9	17.4	13.7	17.0	21.1	25.2	18.6	18.2	15.5	20.1	6.0	13.5	10.8	17.6	12.1	16.8	22.5	19.2	15.8	13.8	16.1	19.9	14.7	18.0	23.1	21.9	17.7	28.1	18.3	25.7	8.5	17.5	22.8	14.0	13.9	10.9	14.1	16.4	9.3	14.0	13.8	18.3	18.3	24.0	13.8	18.9	16.0	20.3	30.0	11.3	23.2	14.8	10.1	29.9	26.3	28.8	23.2	22.0	45.0	65.5	25.4	27.6	39.7	17.7	15.3	14.0	23.2	48.5	29.1	56.3	27.1	8.0	20.6	33.6	36.6	43.0	7.9	46.6	11.1	16.5	28.8	45.7	39.0	42.6	39.3	38.5	23.2	39.8	40.9	28.3	29.6	43.6	43.5	17.6	22.5	10.5	19.1	16.8	30.0	48.9	29.6	34.7	26.3	20.0	8.8	41.0	52.5	12.2	18.6	21.7	34.6	37.6	44.7	48.7	21.6	25.6	30.4	25.2	36.6	46.7	37.5	42.3	46.5	11.7	8.1	11.9	5.8	6.5	7.5	10.3	4.4	4.2	9.2	11.3	3.2	3.8	10.4	4.3	6.3	5.8	5.2	4.8	13.7	21.1	18.2	15.5	13.8	16.1	21.9	17.7	22.8	18.3	16.0	29.9	40.4	16.0	35.0	226.6	56.0	18.4	20.0	15.8	42.7	20.3	23.0	19.9	18.6	25.8	27.8	14.7	10.4	17.1	28.9	9.2	5.9	17.7	64.1	19.6	28.9	30.7	13.1	31.3	333.2	9.9	16.7	32.5	20.4	28.2	18.9	31.5	34.6	19.9	21.4	35.3	350.5	13.4	10.2	35.6	22.9	40.2	30.7	34.9	14.2	324.2	23.2	26.6	32.0	341.8	565.6	12.3	9.1	30.5	20.7	9.8	13.7	15.9	16.3	22.3	6.6	34.0	20.4	20.7	25.5	28.4	17.0	8.2	30.0	35.5	14.5	17.6
TENM1	"ODZ1, ODZ3, TEN-M1, TEN1, TNM"	ENSG00000009694	"Teneurin transmembrane protein 1"	Q9UKZ4	X	124375903-124963817	"Predicted membrane proteins, Transporters"	"Stress response, Transcription, Transcription regulation"	"Neuropeptide, Repressor"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.1"	"Group enriched"	"Detected in many"	11	"Excitatory neurons: 126.0;Inhibitory neurons: 463.2;Oligodendrocyte precursor cells: 434.8"	"Cancer enhanced"	"Detected in many"		"thyroid cancer: 7.0"	"Region enhanced"	"Detected in all"		"cerebellum: 23.1"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 2.2;MOLT-4: 5.9;RPTEC TERT1: 2.0;SCLC-21H: 1.9;U-138 MG: 3.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002848	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA002848: AB_1079523"	"unprognostic (1.71e-3)"	"unprognostic (8.25e-2)"	"unprognostic (3.14e-1)"	"unprognostic (8.68e-4)"	"unprognostic (5.76e-3)"	"unprognostic (3.51e-2)"	"unprognostic (7.07e-2)"	"unprognostic (2.68e-4)"	"unprognostic (6.58e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.58e-1)"	"unprognostic (2.71e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.25e-3)"	"unprognostic (4.44e-2)"	2.6	1.6	4.8	0.2	4.9	2.1	1.1	23.1	3.7	0.2	0.0	1.8	0.1	1.9	1.2	0.2	1.7	0.7	0.4	4.4	5.8	1.3	8.0	1.4	0.6	2.2	3.6	0.1	0.1	0.1	4.7	0.0	4.0	4.6	0.2	2.5	1.4	0.9	1.0	1.3	1.2	0.6	2.3	0.6	0.8	0.4	4.2	8.1	1.7	0.8	0.4	0.5	0.3	1.9	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.3	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.0	0.0	1.3	0.0	0.6	0.0	0.0	5.9	0.0	0.3	0.0	0.8	0.0	0.0	0.0	2.0	0.0	1.9	0.0	0.0	0.4	0.0	1.2	0.4	0.0	0.0	3.2	0.1	0.0	0.2	0.2	0.4	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	0.3	0.2	0.5	0.1	0.0	0.0	0.0	0.0	4.8	4.9	23.1	3.7	4.4	5.8	2.2	3.6	4.0	2.3	4.2	1.9	0.7	0.0	0.0	29.0	0.2	3.3	0.1	0.0	1.8	10.2	0.6	0.3	1.6	1.5	0.0	1.8	0.0	0.0	3.4	0.1	0.0	0.0	1.2	0.2	0.0	0.9	0.0	2.7	126.0	0.0	0.0	6.8	0.0	0.2	7.6	2.2	0.4	22.9	0.0	6.7	463.2	0.0	0.0	1.0	0.8	0.4	5.0	0.3	3.6	5.6	0.6	0.7	2.1	434.8	7.7	0.0	0.0	0.0	3.0	13.7	0.0	4.0	0.0	0.6	0.0	0.6	1.8	0.0	3.4	0.1	1.8	0.0	2.2	0.0	0.0	0.3
TENM2	"KIAA1127, ODZ2, Ten-M2, TEN2"	ENSG00000145934	"Teneurin transmembrane protein 2"	Q9NT68	5	167284799-168264157	"Predicted membrane proteins, Transporters"	"Cell adhesion, Transcription, Transcription regulation"	Repressor		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 9.8;heart muscle: 35.1"	"Group enriched"	"Detected in many"	5	"Astrocytes: 512.9;Excitatory neurons: 706.2;Inhibitory neurons: 965.9"	"Cancer enriched"	"Detected in many"	6	"head and neck cancer: 15.4"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"fHDF/TERT166: 66.1;HBEC3-KT: 43.0;HDLM-2: 43.3;U-138 MG: 74.6;U-2 OS: 64.0;U-251 MG: 50.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA038018, HPA038420, HPA068691"	Uncertain		Approved	Nucleoli		No	No		11000		"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoli		"HPA038018: , HPA038420: AB_10674682, HPA068691: AB_2686019"	"unprognostic (6.00e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.94e-2)"	"unprognostic (9.16e-3)"	"unprognostic (3.88e-3)"	"unprognostic (3.81e-3)"	"unprognostic (5.81e-2)"	"unprognostic (2.41e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.10e-2)"	"unprognostic (3.68e-3)"	"unprognostic (4.34e-2)"	"unprognostic (4.69e-5)"	"unprognostic (3.47e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.16e-4)"	"prognostic unfavorable (7.52e-4)"	0.1	0.5	2.9	0.0	4.7	0.0	1.9	0.0	9.8	1.3	0.0	0.2	0.4	0.0	0.5	1.9	0.1	0.4	35.1	6.0	1.2	0.8	1.3	0.2	0.0	0.6	0.1	0.7	0.1	0.0	0.7	0.0	1.6	2.2	0.1	4.1	0.5	1.0	0.0	3.2	0.2	0.0	0.0	0.0	0.1	1.3	4.3	2.2	0.4	0.5	1.0	0.1	2.0	0.0	0.1	0.0	13.4	0.0	0.0	0.4	0.0	1.9	0.0	0.7	1.8	0.0	0.0	0.0	0.0	66.1	1.7	0.0	0.0	43.0	0.8	43.3	0.0	0.0	0.2	0.0	2.0	0.0	0.0	3.0	7.4	0.3	5.3	0.0	0.0	0.0	0.0	0.2	0.3	0.1	0.0	0.0	0.6	0.0	0.0	0.3	9.8	0.2	0.0	0.0	6.6	0.0	0.1	0.0	0.1	2.4	3.8	0.1	0.0	74.6	64.0	0.1	50.0	0.0	0.0	0.0	7.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	4.7	0.0	9.8	6.0	1.2	0.6	0.1	1.6	0.0	4.3	0.0	0.5	0.0	0.0	512.9	0.0	14.8	1.1	20.3	33.6	15.5	0.3	13.0	144.0	0.0	1.4	0.0	18.8	0.0	0.0	1.0	0.0	3.4	23.5	0.1	0.3	1.7	0.0	0.0	706.2	0.2	0.0	2.2	0.0	0.2	1.3	1.6	0.4	5.1	0.1	121.1	965.9	0.7	0.0	0.0	1.2	18.2	4.4	0.2	1.8	36.5	0.0	2.3	0.0	21.6	12.8	0.0	0.0	61.7	0.0	1.4	0.3	0.0	0.6	1.8	0.0	0.4	1.5	1.2	1.1	1.4	1.7	0.0	0.1	0.0	0.4	0.1
TEPSIN	"C17orf56, ENTHD2, FLJ31528"	ENSG00000167302	"TEPSIN adaptor related protein complex 4 accessory protein"	Q96N21	17	81228277-81239091	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 9.6;Cytotrophoblasts: 9.9;Syncytiotrophoblasts: 10.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA063410			Approved	"Nuclear membrane,Nuclear speckles,Golgi apparatus"		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 7: Non-specific - Mitochondria"	"Nuclear membrane, Nuclear speckles, Golgi apparatus"		"HPA063410: AB_2685008"	"unprognostic (6.90e-3)"	"unprognostic (1.03e-2)"	"unprognostic (4.26e-2)"	"unprognostic (3.64e-2)"	"unprognostic (1.00e-1)"	"prognostic favorable (9.96e-4)"	"unprognostic (1.16e-2)"	"unprognostic (4.85e-2)"	"unprognostic (8.52e-2)"	"unprognostic (2.29e-1)"	"prognostic favorable (6.95e-4)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (7.31e-8)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (3.58e-1)"	"unprognostic (3.16e-3)"	11.4	12.1	8.3	7.4	8.5	13.0	11.3	8.4	12.8	12.9	9.1	14.2	10.8	11.2	4.0	13.3	11.5	4.3	10.2	8.3	8.1	16.6	17.7	12.0	11.0	9.4	8.5	9.3	15.8	3.3	11.4	5.3	8.9	15.3	4.0	1.6	12.0	3.0	10.0	14.6	19.7	4.4	8.3	28.6	15.6	13.3	9.1	10.3	16.0	3.2	5.8	13.5	11.8	8.8	9.5	14.2	5.1	8.6	3.5	5.7	10.0	8.2	4.7	8.5	7.6	9.1	6.8	6.9	4.5	5.5	8.0	11.8	5.3	7.3	3.8	4.1	18.7	5.7	8.1	13.0	5.4	6.0	12.8	3.4	9.1	3.8	4.2	5.9	13.4	9.7	6.7	6.7	5.3	8.4	11.2	15.7	5.7	7.5	11.6	6.9	7.1	7.4	3.3	6.1	6.7	8.5	9.7	11.1	11.5	9.9	9.1	11.3	8.0	11.2	6.6	8.5	8.3	9.4	6.5	5.5	8.3	5.3	5.7	2.4	1.2	4.0	0.8	1.6	0.5	1.2	0.5	0.6	1.3	1.8	0.3	0.4	2.1	0.4	1.0	1.4	0.8	0.8	8.3	8.5	8.4	12.8	8.3	8.1	9.4	8.5	8.9	8.3	9.1	8.8	8.6	9.6	5.5	0.0	2.9	0.0	0.0	0.0	0.0	0.0	6.9	7.1	0.0	0.0	1.3	1.8	0.0	9.9	8.8	0.0	0.0	4.7	0.0	3.2	5.8	3.0	0.0	0.0	0.0	5.3	7.2	2.5	0.0	6.2	6.3	8.6	0.0	0.0	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	6.0	0.0	0.0	3.3	0.0	0.0	2.3	2.2	0.0	0.0	0.0	3.0	0.0	0.0	0.0	0.0	10.5	3.9	5.1	0.0	0.0
TEX14	CT113	ENSG00000121101	"Testis expressed 14, intercellular bridge forming factor"	Q8IWB6	17	58556678-58692055	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"testis: 27.0"	"Group enriched"	"Detected in many"	4	"Early spermatids: 23.3;Spermatocytes: 56.4;Spermatogonia: 16.2"	"Cancer enhanced"	"Detected in some"		"breast cancer: 0.9"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HDLM-2: 6.3;Karpas-707: 7.9;MCF7: 3.3"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"HPA030620, HPA077020"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA				"Cluster 78: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Cytosol	"Vesicles, Plasma membrane"	"HPA030620: AB_10601598, HPA077020: AB_2732327"	"unprognostic (1.21e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.06e-1)"	"unprognostic (9.49e-2)"	"unprognostic (2.48e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.07e-2)"	"unprognostic (1.61e-3)"	"unprognostic (2.67e-2)"	"unprognostic (8.10e-2)"	"unprognostic (1.76e-9)"	"unprognostic (1.77e-1)"	"unprognostic (2.54e-1)"	"unprognostic (5.00e-3)"	"unprognostic (5.88e-2)"	0.1	0.1	0.5	0.1	0.6	1.7	0.2	1.1	0.6	0.1	0.2	0.1	0.0	0.1	0.1	0.1	0.2	0.1	0.1	0.4	0.5	0.4	0.2	0.2	0.1	0.5	0.5	0.3	0.1	0.0	0.2	0.1	0.5	0.2	0.0	1.1	0.1	0.0	0.0	0.1	0.1	0.0	0.5	0.2	0.1	27.0	0.5	0.0	0.0	0.0	0.1	0.1	0.0	0.8	0.0	0.0	0.1	1.7	0.0	0.0	0.2	0.0	0.0	0.1	0.1	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.2	0.0	0.1	6.3	0.9	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.3	0.1	7.9	0.0	3.3	0.3	0.0	0.4	0.1	0.1	0.3	0.2	1.2	0.0	0.1	0.9	0.1	0.0	0.0	0.4	0.3	0.3	0.0	0.0	0.0	0.2	0.0	0.0	1.4	0.3	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	1.1	0.6	0.4	0.5	0.5	0.5	0.5	0.5	0.5	0.8	4.4	0.0	0.0	2.9	5.7	0.9	1.8	0.7	2.8	0.6	4.7	7.2	1.3	5.7	1.5	1.8	0.0	1.6	0.7	0.1	0.0	0.0	23.3	0.4	0.2	1.5	0.0	0.0	2.2	0.0	1.0	0.7	0.5	1.8	1.3	0.2	1.4	0.8	3.7	0.0	2.2	0.5	2.0	0.6	2.3	6.4	0.3	4.6	3.6	2.8	0.0	0.6	1.0	1.0	3.0	0.1	0.0	0.4	4.3	0.7	0.0	0.1	0.2	1.3	0.0	1.2	1.5	56.4	16.2	1.7	0.1	1.1	0.7	0.0	0.0	0.4
TFR2	"HFE3, TFRC2"	ENSG00000106327	"Transferrin receptor 2"	Q9UP52	7	100620416-100642779	"Disease related genes, Enzymes, FDA approved drug targets, Human disease related genes, Plasma proteins, Predicted membrane proteins, Transporters"		Receptor	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	15	"liver: 346.1"	"Group enriched"	"Detected in some"	13	"Erythroid cells: 152.8;Hepatocytes: 455.7"	"Cancer enriched"	"Detected in many"	70	"liver cancer: 136.2"	"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	22	"basophil: 2.5;eosinophil: 1.9"	"Lineage enriched"	"Detected in single"	25	"granulocytes: 2.5"	"Group enriched"	"Detected in some"	11	"HEL: 69.7;HMC-1: 92.7;K-562: 65.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"CAB016255, HPA017171, HPA073125"	Enhanced		Approved	"Golgi apparatus"		NA	NA		410000	"Cluster 46: Basophils - DNA binding"	"Cluster 60: Liver - Hemostasis & Lipid metabolism"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 15: Hepatocytes - Hemostasis"	"Golgi apparatus"		"CAB016255: AB_628395, HPA017171: , HPA073125: "	"unprognostic (4.18e-2)"	"unprognostic (1.97e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (4.13e-2)"	"prognostic favorable (2.48e-4)"	"unprognostic (2.29e-2)"	"unprognostic (4.49e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.93e-1)"	"unprognostic (2.90e-1)"	"unprognostic (1.18e-9)"	"unprognostic (6.51e-2)"	"unprognostic (1.68e-1)"	"unprognostic (3.28e-1)"	"unprognostic (8.18e-2)"	0.0	0.1	0.0	0.0	0.0	22.5	0.0	0.6	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	346.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	6.2	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	69.7	0.0	7.2	0.0	1.6	92.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	65.8	0.0	0.0	0.0	0.0	0.1	0.1	0.4	0.8	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	2.5	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.3	2.1	0.3	0.9	0.4	0.0	8.5	0.3	0.6	1.2	10.0	0.8	0.0	8.4	0.1	1.7	0.1	0.0	0.4	5.8	0.1	0.6	1.2	0.0	152.8	5.4	0.2	1.1	0.5	1.5	0.2	0.0	0.2	7.1	455.7	0.3	21.9	5.4	0.3	0.0	8.6	1.7	8.4	0.0	0.4	0.0	1.0	0.2	0.4	6.2	1.5	0.7	0.1	0.1	0.0	0.4	0.6	0.1	0.1	0.3	1.9	0.0	0.4	0.7	0.7	2.9	0.2	0.6	0.1	2.6	0.1	0.6	0.5
TFRC	"CD71, p90, TFR1"	ENSG00000072274	"Transferrin receptor"	P02786	3	196027183-196082096	"Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"	"Endocytosis, Host-virus interaction"	"Host cell receptor for virus entry, Receptor, Transducer"	"Cancer-related genes, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 254.5"	"Cell type enhanced"	"Detected in many"		"Erythroid cells: 556.4;Syncytiotrophoblasts: 502.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HDLM-2: 860.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB000153, HPA028598"	Enhanced		Supported	Endosomes,Lysosomes	"Secreted to blood"	NA	NA	1310000000	38000000	"Cluster 27: Non-specific - Gene expression"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 36: HEL - Hemostasis"	"Cluster 6: Erythroid cells - Oxygen transport"	"Endosomes, Lysosomes"		"CAB000153: AB_2533029, HPA028598: AB_10601599"	"unprognostic (2.95e-2)"	"prognostic unfavorable (3.67e-4)"	"unprognostic (2.55e-1)"	"unprognostic (1.48e-2)"	"unprognostic (6.75e-2)"	"unprognostic (7.88e-3)"	"prognostic unfavorable (1.15e-4)"	"unprognostic (6.92e-2)"	"unprognostic (3.30e-3)"	"unprognostic (4.35e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.14e-2)"	"unprognostic (3.63e-3)"	"unprognostic (3.65e-2)"	"unprognostic (1.19e-2)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (2.62e-2)"	44.6	28.7	21.6	63.4	18.3	254.5	20.2	18.5	32.3	31.3	15.7	77.2	35.9	23.8	11.1	36.0	25.9	24.9	31.0	21.9	19.0	26.4	27.8	78.0	23.0	24.2	19.9	93.9	15.9	44.8	13.1	103.2	26.3	13.2	55.6	47.3	15.7	13.4	76.2	21.8	32.1	31.5	20.8	15.5	21.4	21.6	25.3	22.0	20.1	68.7	28.1	68.5	17.4	20.7	175.3	155.0	69.8	142.1	151.7	87.3	438.7	242.5	183.7	168.1	276.3	384.6	156.6	178.5	446.3	91.0	363.5	261.8	243.3	81.1	204.2	860.4	82.4	677.4	120.2	179.2	119.4	561.8	130.4	99.1	78.6	144.5	129.0	47.8	56.9	95.6	287.3	164.1	132.8	161.7	185.8	116.8	214.9	228.6	314.0	97.3	103.9	214.1	148.3	435.3	159.3	65.9	234.4	613.9	55.2	115.9	595.0	115.8	72.5	198.4	159.7	175.3	369.7	46.3	387.8	276.7	232.3	149.2	122.3	0.0	1.6	2.2	2.2	7.3	1.4	5.1	2.4	1.5	3.5	3.1	2.1	1.7	0.2	1.9	13.2	7.1	6.4	2.1	21.6	18.3	18.5	32.3	21.9	19.0	24.2	19.9	26.3	20.8	25.3	20.7	25.4	44.8	32.1	43.1	46.6	60.3	37.2	33.6	21.1	53.1	37.1	34.9	103.0	41.5	38.8	20.2	148.0	122.5	53.2	156.6	0.0	49.4	3.5	35.3	20.3	23.6	56.1	556.4	24.7	41.8	25.3	32.4	77.5	56.1	23.4	40.2	8.6	93.2	73.4	13.5	28.3	67.8	22.4	37.1	77.6	5.3	11.5	161.7	17.8	44.0	49.4	22.0	9.2	11.6	8.2	52.0	50.8	8.6	42.1	25.6	48.3	13.1	32.1	44.4	26.3	36.3	29.3	23.8	18.2	51.3	35.8	502.7	42.6	16.6	103.5	23.7
TIRAP	"Mal, wyatt"	ENSG00000150455	"TIR domain containing adaptor protein"	P58753	11	126283065-126298845	"Predicted intracellular proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA054431	Uncertain		Approved	"Nucleoplasm,Cytokinetic bridge,Cytosol"		Yes	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 59: Non-specific - Transcription"	"Nucleoplasm, Cytokinetic bridge, Cytosol"		"HPA054431: AB_2682486"	"unprognostic (9.30e-3)"	"unprognostic (7.39e-2)"	"unprognostic (1.21e-1)"	"prognostic favorable (1.24e-4)"	"unprognostic (2.73e-2)"	"unprognostic (5.77e-2)"	"unprognostic (1.27e-1)"	"unprognostic (6.89e-2)"	"unprognostic (2.40e-1)"	"unprognostic (2.28e-1)"	"unprognostic (4.65e-2)"	"unprognostic (1.42e-1)"	"unprognostic (3.34e-3)"	"unprognostic (4.29e-3)"	"unprognostic (3.62e-2)"	"unprognostic (3.47e-1)"	"unprognostic (2.57e-1)"	4.3	4.3	1.5	4.9	1.4	2.9	4.5	3.1	2.4	5.4	3.6	5.3	7.6	4.5	2.5	4.4	5.3	4.5	5.3	1.3	2.1	3.9	6.3	4.2	4.1	1.9	1.8	8.0	4.7	7.2	3.6	4.9	2.1	5.7	5.5	3.1	8.0	6.4	5.3	4.3	6.9	4.7	1.0	5.0	4.3	1.5	1.6	3.1	4.8	4.9	5.1	4.5	3.3	1.1	2.2	7.0	3.7	6.2	6.2	8.5	4.4	5.7	9.3	3.9	3.7	11.0	8.3	5.7	9.6	5.9	6.9	6.2	3.9	4.4	1.5	15.3	3.7	15.4	4.2	7.1	4.9	9.6	7.9	6.4	6.0	7.4	5.1	4.7	6.5	4.6	4.2	12.9	4.6	4.0	0.3	1.5	1.7	15.9	6.3	2.0	1.0	5.4	3.1	7.8	4.6	5.8	6.8	6.7	4.6	4.8	18.2	4.9	6.5	2.2	2.1	4.5	4.3	3.6	5.6	4.2	3.4	7.5	7.0	5.3	5.8	2.9	4.0	4.5	3.7	2.1	3.1	4.2	4.6	3.8	2.5	2.4	4.9	2.6	3.2	3.2	3.5	3.7	1.5	1.4	3.1	2.4	1.3	2.1	1.9	1.8	2.1	1.0	1.6	1.1	1.7	6.4	2.6	2.3	3.7	0.4	1.8	2.0	4.0	3.5	2.7	2.0	1.3	2.8	2.8	3.7	0.0	3.4	2.2	4.2	0.0	3.3	0.0	1.1	2.3	3.2	1.2	0.8	3.7	4.0	4.9	2.7	2.0	1.7	1.3	2.0	2.5	4.8	5.2	3.3	5.0	3.9	2.0	4.4	0.8	0.3	4.7	3.7	1.8	3.7	2.1	3.6	4.1	3.0	1.8	3.6	8.1	4.5	9.2	2.0	6.5	2.2	1.6	2.5	0.0	2.0	2.5	0.1	0.6	3.5	0.1	2.6	4.2	2.3	2.4	1.5
TJP1	"DKFZp686M05161, MGC133289, ZO-1"	ENSG00000104067	"Tight junction protein 1"	Q07157	15	29699367-29968915	"Predicted intracellular proteins, Transporters"		Calmodulin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Oligodendrocytes: 893.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA001636, HPA001637, CAB010822"	Enhanced		Enhanced	"Cell Junctions"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 44: Endometrium - Transcription"	"Cell Junctions"		"CAB010822: , HPA001636: AB_1080762, HPA001637: AB_1080760"	"unprognostic (2.11e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.21e-1)"	"unprognostic (2.81e-2)"	"unprognostic (9.43e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.54e-2)"	"unprognostic (6.71e-3)"	"unprognostic (1.98e-1)"	"unprognostic (2.86e-1)"	"unprognostic (2.86e-3)"	"unprognostic (3.54e-1)"	"prognostic favorable (1.72e-4)"	"unprognostic (2.85e-3)"	"unprognostic (3.02e-1)"	"unprognostic (5.04e-2)"	"unprognostic (1.20e-1)"	37.4	16.5	22.1	4.4	35.3	1.1	30.8	21.4	24.4	33.2	17.9	30.5	7.1	42.3	16.5	60.4	27.8	12.6	37.1	22.0	22.2	24.3	18.6	34.0	5.7	26.6	28.6	22.3	30.0	13.4	16.8	31.6	25.2	20.4	9.5	10.0	29.6	10.9	22.0	27.8	19.8	17.4	20.6	13.5	25.8	29.7	30.3	3.7	24.8	5.0	10.2	23.8	35.3	42.6	62.4	36.8	29.1	18.4	17.0	31.7	28.9	18.6	21.1	18.0	20.2	59.2	22.9	0.3	24.8	24.6	21.3	47.4	20.1	23.8	19.0	0.5	14.9	0.3	22.3	24.7	57.9	0.1	0.8	16.5	15.8	21.4	39.2	23.0	38.2	0.1	24.3	12.5	14.2	32.2	0.2	0.7	21.9	23.4	14.6	0.1	35.0	0.2	28.1	33.4	12.9	16.8	39.2	12.8	16.8	42.9	13.3	0.6	54.7	14.3	23.9	12.5	25.6	4.4	4.6	0.4	17.8	0.3	9.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	22.1	35.3	21.4	24.4	22.0	22.2	26.6	28.6	25.2	20.6	30.3	42.6	212.1	169.9	49.2	299.7	1.6	35.8	115.2	36.4	39.3	42.4	53.7	28.6	107.2	51.5	48.6	58.8	10.4	32.3	0.8	87.7	25.4	116.0	19.1	132.2	97.0	166.0	46.0	2.7	293.8	83.7	11.3	56.6	86.6	290.7	5.7	87.7	100.3	49.1	3.8	126.2	187.3	45.4	32.6	6.1	12.1	13.7	33.8	5.2	64.0	266.1	1.6	32.8	0.0	345.3	893.8	178.3	82.0	63.9	5.9	151.4	37.8	26.0	39.2	52.4	78.9	64.1	118.7	63.0	83.9	139.2	60.1	33.7	4.1	120.8	33.1	194.6
TLR2	"CD282, TIL4"	ENSG00000137462	"Toll like receptor 2"	O60603	4	153684070-153706260	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 69.9;lymphoid tissue: 51.7"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 77.3;Kupffer cells: 117.2;Langerhans cells: 35.7;Macrophages: 101.8;Microglial cells: 33.7;monocytes: 68.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 199.6;intermediate monocyte: 178.9;myeloid DC: 121.3;neutrophil: 457.8;non-classical monocyte: 121.5"	"Group enriched"	"Detected in all"	49	"dendritic cells: 121.3;granulocytes: 457.8;monocytes: 199.6"	"Cell line enhanced"	"Detected in some"		"HL-60: 11.6;HSkMC: 12.5;hTCEpi: 12.7;NB-4: 11.4;RPTEC TERT1: 13.3;RT4: 16.3;THP-1: 62.0;U-937: 11.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA060231, HPA071546"			Supported	Nucleoplasm,Mitochondria		No	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 41: Macrophages - Immune response"	"Nucleoplasm, Mitochondria"		"HPA060231: , HPA071546: "	"unprognostic (4.15e-1)"	"unprognostic (3.29e-2)"	"unprognostic (5.32e-2)"	"unprognostic (1.52e-2)"	"unprognostic (3.46e-2)"	"unprognostic (4.88e-2)"	"unprognostic (1.39e-2)"	"unprognostic (4.24e-2)"	"unprognostic (2.48e-1)"	"unprognostic (2.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (1.33e-1)"	"prognostic unfavorable (1.11e-4)"	"unprognostic (7.87e-2)"	"unprognostic (3.80e-3)"	"unprognostic (1.42e-1)"	"unprognostic (5.93e-3)"	26.8	11.8	4.3	51.7	4.4	69.9	12.5	4.6	7.5	7.9	7.6	4.6	3.9	3.3	11.8	5.4	8.2	16.3	6.1	4.0	5.3	5.1	11.3	39.9	8.8	9.5	5.9	2.5	8.8	3.4	4.0	11.4	7.9	4.7	3.3	1.5	17.2	12.3	1.7	3.5	4.9	11.7	7.1	35.9	5.2	1.9	7.4	3.6	3.4	3.7	15.4	23.6	4.0	10.1	7.1	0.1	0.3	0.0	1.0	2.9	0.0	0.0	0.5	0.5	0.8	3.3	0.4	0.0	0.8	0.0	0.0	6.4	0.6	0.4	0.3	0.1	0.1	0.2	0.0	0.8	0.1	11.6	0.9	12.5	12.7	0.0	0.1	0.8	0.0	0.0	0.0	0.1	0.1	0.1	0.0	11.4	0.7	0.0	2.7	0.3	0.0	0.0	13.3	16.3	0.0	0.3	0.7	0.1	3.3	0.4	0.0	62.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.7	11.3	1.7	48.4	199.6	1.8	0.3	178.9	0.5	0.4	1.1	0.3	121.3	1.2	1.3	0.2	457.8	5.3	121.5	1.1	0.2	76.2	4.3	4.4	4.6	7.5	4.0	5.3	9.5	5.9	7.9	7.1	7.4	10.1	1.7	6.4	77.3	0.7	1.1	1.1	1.2	18.4	1.2	0.0	9.7	2.2	1.3	2.8	19.5	3.7	0.0	0.2	0.6	0.2	0.0	5.0	0.3	1.6	0.5	2.6	0.0	3.6	0.1	3.8	0.2	1.9	2.6	4.9	3.8	0.5	1.4	1.8	17.4	0.0	0.5	0.3	0.0	117.2	35.7	1.3	0.6	101.8	1.8	33.7	68.4	0.4	1.0	1.0	0.1	3.1	0.0	0.4	1.4	3.4	1.5	1.0	7.5	0.3	13.1	0.6	5.1	0.2	1.0	1.9	1.1	0.1	2.3	0.5	0.5	2.0
TLR4	"ARMD10, CD284, hToll, TLR-4"	ENSG00000136869	"Toll like receptor 4"	O00206	9	117704175-117724735	"CD markers, Enzymes, FDA approved drug targets, Human disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Immunity, Inflammatory response, Innate immunity"	"Hydrolase, Receptor"	"Age-related macular degeneration, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 38.6;Astrocytes: 50.9;Hepatic stellate cells: 62.8;Hofbauer cells: 38.2;Kupffer cells: 106.0;Macrophages: 64.5;monocytes: 54.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 86.8"	"Group enriched"	"Detected in many"	33	"dendritic cells: 22.4;granulocytes: 86.8;monocytes: 65.6"	"Cell line enhanced"	"Detected in many"		"Karpas-707: 60.0;TIME: 43.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB004025, HPA049174"	Approved		Supported	"Golgi apparatus,Plasma membrane"	"Intracellular and membrane"	NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	"Plasma membrane"	"Golgi apparatus"	"CAB004025: , HPA049174: AB_2680662"	"unprognostic (1.60e-1)"	"unprognostic (8.34e-2)"	"unprognostic (7.22e-2)"	"prognostic favorable (6.29e-4)"	"unprognostic (3.39e-1)"	"unprognostic (7.48e-2)"	"unprognostic (8.68e-2)"	"unprognostic (1.80e-1)"	"unprognostic (3.38e-1)"	"unprognostic (5.18e-2)"	"unprognostic (8.00e-2)"	"unprognostic (9.42e-2)"	"unprognostic (4.08e-2)"	"unprognostic (8.63e-2)"	"prognostic unfavorable (3.79e-4)"	"unprognostic (1.09e-2)"	"unprognostic (1.96e-2)"	31.1	11.0	12.4	25.7	15.7	22.3	12.0	11.7	8.3	6.5	1.7	6.7	4.3	5.6	1.2	4.8	4.8	10.8	8.4	10.3	17.8	6.8	16.7	16.2	13.1	12.3	14.0	6.0	2.6	2.5	2.1	23.9	12.4	4.6	7.3	2.9	6.0	3.2	3.1	3.5	5.8	10.8	14.9	32.6	4.4	1.5	14.2	3.5	5.5	12.0	7.7	13.3	2.7	10.1	0.0	0.0	25.5	0.0	11.1	23.0	0.1	10.2	17.9	2.5	1.5	0.0	2.6	3.6	0.5	26.7	7.5	0.1	0.0	2.2	3.7	0.0	0.0	5.7	5.1	0.4	8.1	19.1	0.1	14.2	0.0	5.4	0.7	22.5	31.4	0.0	0.0	60.0	29.2	0.0	0.0	2.9	3.1	2.4	1.2	0.0	28.0	19.8	0.9	28.9	0.0	0.1	6.4	0.0	1.0	2.2	0.0	10.4	43.5	1.4	18.4	0.1	4.8	0.0	0.0	0.0	0.9	19.1	15.2	64.0	64.9	21.5	0.1	57.5	0.0	1.7	0.1	0.0	22.4	0.5	0.0	0.0	86.8	0.1	65.6	0.9	0.0	25.5	12.4	15.7	11.7	8.3	10.3	17.8	12.3	14.0	12.4	14.9	14.2	10.1	38.6	0.0	5.0	50.9	2.3	0.8	0.3	0.1	0.6	0.2	3.5	1.0	2.9	2.8	2.9	0.0	0.0	0.3	0.1	1.6	0.0	0.1	0.1	3.5	29.2	31.6	0.0	1.3	0.2	0.2	0.2	11.5	1.5	6.8	15.8	1.2	62.8	1.9	38.2	0.0	0.2	2.0	0.0	106.0	8.6	0.4	0.0	64.5	1.8	26.2	54.0	8.8	2.1	7.5	0.3	0.5	6.1	0.0	0.1	0.1	0.0	0.4	3.7	1.3	6.6	5.5	4.5	0.1	0.3	0.3	0.0	0.8	0.9	3.1	1.2	3.3
TM4SF18	L6D	ENSG00000163762	"Transmembrane 4 L six family member 18"	Q96CE8	3	149318498-149334414	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 33.9"	"Group enriched"	"Detected in many"	4	"Adipocytes: 226.1;Endothelial cells: 188.9;Hepatic stellate cells: 151.0"	"Cancer enhanced"	"Detected in all"		"renal cancer: 17.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 94.8;EFO-21: 194.9;GAMG: 38.7;HUVEC TERT2: 65.9;NTERA-2: 47.2"					"Low region specificity"	"Detected in many"			"HPA053639, HPA069378"	Approved		Supported	Vesicles,Cytosol		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Vesicles	Cytosol	"HPA053639: , HPA069378: AB_2686133"	"unprognostic (2.25e-1)"	"unprognostic (3.68e-1)"	"unprognostic (4.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (9.11e-3)"	"unprognostic (1.05e-2)"	"prognostic favorable (8.63e-4)"	"unprognostic (2.84e-1)"	"unprognostic (6.13e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.90e-3)"	"unprognostic (1.75e-1)"	"unprognostic (5.71e-2)"	"unprognostic (3.56e-3)"	"unprognostic (1.65e-1)"	"unprognostic (3.01e-1)"	"unprognostic (1.97e-1)"	21.3	5.2	9.4	4.9	9.6	0.1	16.3	9.2	11.5	8.3	10.4	3.4	3.9	7.6	4.7	3.4	6.4	10.6	8.4	9.1	10.3	19.1	7.9	9.2	6.6	12.2	9.6	3.2	9.8	6.8	3.1	17.4	11.5	4.0	3.3	1.1	4.0	6.5	5.9	2.4	3.6	14.9	10.0	33.9	3.4	1.9	12.1	2.1	12.7	5.7	5.0	6.7	2.5	10.4	0.1	94.8	3.5	0.2	0.0	0.1	0.0	0.1	0.5	0.0	0.0	0.2	1.2	0.0	194.9	0.0	38.7	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.2	0.3	0.0	0.3	0.1	0.7	0.0	0.0	0.0	24.7	65.9	0.0	0.0	0.0	6.2	0.7	0.0	0.2	47.2	0.0	0.0	0.1	2.6	0.0	0.0	0.3	0.1	0.1	0.0	0.1	0.5	1.5	0.1	0.1	8.4	0.1	1.2	0.0	0.5	0.1	0.1	0.5	0.0	0.1	15.2	0.3	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	9.4	9.6	9.2	11.5	9.1	10.3	12.2	9.6	11.5	10.0	12.1	10.4	226.1	0.0	4.4	0.3	1.6	3.2	0.2	0.0	0.6	0.2	41.4	23.9	2.8	4.3	0.0	1.8	0.0	0.0	1.0	0.0	9.8	35.2	0.4	0.7	1.1	188.9	0.0	0.0	0.0	0.2	0.0	6.2	0.0	0.9	1.3	0.3	151.0	1.1	0.1	0.0	0.1	0.0	0.0	9.1	3.0	1.8	2.1	1.2	1.8	33.7	0.6	0.4	0.0	0.5	0.6	0.9	0.0	6.8	2.5	1.3	0.0	35.8	0.7	0.0	0.0	1.5	2.5	0.2	0.5	0.2	2.8	0.0	1.1	5.2	0.0	0.6
TM4SF19		ENSG00000145107	"Transmembrane 4 L six family member 19"	Q96DZ7	3	196319342-196338503	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"adipose tissue: 6.0;testis: 4.6"	"Cell type enriched"	"Detected in some"	8	"Hofbauer cells: 74.6"	"Group enriched"	"Detected in some"	4	"cervical cancer: 1.4;head and neck cancer: 3.4;lung cancer: 1.4;melanoma: 1.0;urothelial cancer: 0.9"	"Region enhanced"	"Detected in single"		"thalamus: 2.5"	"Group enriched"	"Detected in some"	6	"gdT-cell: 14.8;memory CD8 T-cell: 3.9;naive CD8 T-cell: 4.9"	"Lineage enriched"	"Detected in single"	16	"T-cells: 14.8"	"Cell line enriched"	"Detected in many"	12	"GAMG: 427.6"															NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 71: Testis - DNA repair"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 4: Macrophages - Innate immune response"				"unprognostic (9.90e-2)"	"unprognostic (1.17e-2)"	"unprognostic (3.60e-2)"	"unprognostic (1.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (7.19e-2)"	"unprognostic (8.90e-5)"	"unprognostic (8.86e-3)"	"unprognostic (1.30e-1)"	"unprognostic (3.21e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.86e-1)"	"unprognostic (1.06e-3)"	"unprognostic (4.23e-2)"	"unprognostic (4.20e-3)"	"unprognostic (2.60e-1)"	"unprognostic (1.18e-3)"	6.0	0.3	0.1	0.5	0.2	0.6	2.9	0.3	0.5	1.5	0.0	0.3	0.2	0.3	0.0	3.4	0.3	0.1	0.1	0.2	0.1	0.2	0.5	3.5	0.5	0.1	0.2	0.7	0.3	0.0	0.1	0.8	0.4	0.5	0.2	0.5	1.5	0.0	1.6	1.8	0.2	0.1	0.2	0.6	0.5	4.6	2.5	0.2	0.7	0.5	0.7	0.3	1.7	0.8	15.6	7.2	0.2	0.4	0.9	4.6	0.3	0.0	4.4	1.6	2.9	0.0	8.2	0.2	2.6	0.0	427.6	2.2	0.0	1.7	1.1	0.6	0.0	0.3	2.1	0.0	1.0	0.5	0.4	0.5	1.4	18.8	31.3	0.0	0.0	0.9	9.8	0.9	4.8	1.2	0.1	0.8	0.0	0.2	36.2	0.2	3.2	0.9	0.0	0.4	0.3	0.0	2.5	0.1	0.7	0.4	0.6	0.2	1.4	18.6	15.6	2.9	9.1	0.5	5.6	0.3	20.2	0.7	0.3	0.9	0.3	0.4	14.8	0.4	0.1	0.1	1.3	3.9	0.1	0.3	0.7	4.9	0.6	0.7	0.1	0.6	0.4	1.6	0.1	0.2	0.3	0.5	0.2	0.1	0.1	0.2	0.4	0.2	2.5	0.8	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.7	0.0	0.0	0.0	2.9	0.0	0.1	0.2	0.0	0.0	0.0	0.2	0.3	0.2	0.0	0.0	0.0	0.1	0.0	0.0	74.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.7	0.0	0.0	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	9.3	4.9	4.9	0.0	0.4	0.9	0.1	0.0	0.0
TM4SF20	"FLJ22800, TCCE518"	ENSG00000168955	"Transmembrane 4 L six family member 20"	Q53R12	2	227362038-227381995	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Autism spectrum disorder"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	76	"intestine: 266.6"	"Cell type enriched"	"Detected in some"	4	"Proximal enterocytes: 703.0"	"Group enriched"	"Detected in many"	6	"colorectal cancer: 5.0;liver cancer: 4.7;pancreatic cancer: 5.5;stomach cancer: 11.8"	"Region enhanced"	"Detected in single"		"cerebellum: 1.2"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 2.6;RPMI-8226: 1.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA051838, HPA063184, HPA065531"	Uncertain		Supported	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Focal adhesion sites"		"HPA051838: AB_2681631, HPA063184: AB_2684958, HPA065531: AB_2685506"	"unprognostic (4.68e-2)"	"unprognostic (1.13e-1)"	"unprognostic (8.75e-2)"		"unprognostic (4.96e-2)"	"unprognostic (2.84e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.51e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.20e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.44e-3)"	"unprognostic (7.76e-2)"	"unprognostic (2.60e-2)"	"unprognostic (3.04e-3)"		0.1	0.1	0.2	0.3	0.2	0.2	0.0	1.2	0.4	0.0	0.4	3.1	266.6	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	3.9	0.3	0.0	0.0	0.0	0.3	144.5	1.6	0.0	0.1	0.5	3.5	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.7	0.0	2.6	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.5	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.6	0.1	0.0	0.0	0.1	0.0	1.7	0.0	0.1	0.2	0.6	0.4	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	0.7	0.0	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.2	1.2	0.4	0.1	0.0	0.1	0.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	15.1	0.0	0.0	48.4	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	21.4	0.0	0.0	0.0	77.3	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.0	0.5	0.0	157.9	0.7	0.0	0.0	703.0	0.0	0.0	0.3	0.0	0.1	0.0	0.5	0.3	0.0	0.0	0.0	0.1	0.0	18.8	0.0
TM4SF4	il-TMP	ENSG00000169903	"Transmembrane 4 L six family member 4"	P48230	3	149474697-149503394	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	11	"gallbladder: 945.8;intestine: 650.8;liver: 703.8"	"Group enriched"	"Detected in some"	17	"Cholangiocytes: 2070.3;Hepatocytes: 578.1"	"Group enriched"	"Detected in many"	10	"liver cancer: 249.4;pancreatic cancer: 130.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"A549: 22.7;OE19: 20.3;RPTEC TERT1: 36.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA046430	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 2: Hepatocytes - Metabolism"	"Plasma membrane"	Cytosol	"HPA046430: AB_2679662"	"unprognostic (1.91e-2)"	"unprognostic (1.71e-1)"	"unprognostic (2.15e-1)"	"unprognostic (1.66e-1)"		"unprognostic (2.27e-1)"	"unprognostic (1.67e-1)"	"unprognostic (1.33e-1)"		"unprognostic (4.96e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.98e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.66e-2)"	"unprognostic (1.91e-2)"	"unprognostic (4.97e-1)"	0.3	1.2	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.1	0.0	2.0	650.8	0.6	2.3	0.7	0.5	945.8	0.3	0.0	0.0	0.8	703.8	0.3	0.8	0.0	0.0	0.0	72.5	0.0	0.1	0.0	0.0	0.1	1.2	0.0	0.0	0.0	0.0	0.0	514.8	0.9	0.0	0.1	21.3	0.6	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.0	22.7	0.0	0.0	0.0	0.0	1.5	1.1	0.0	0.0	0.0	0.6	0.3	0.2	4.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.7	0.0	0.1	0.8	0.1	20.3	0.0	0.0	0.5	1.4	36.5	0.0	0.6	1.2	1.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.5	0.0	0.1	0.1	0.5	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	3.2	0.5	0.0	1.0	0.1	0.1	0.0	0.0	0.0	0.2	0.1	4.1	2070.3	0.6	0.0	0.0	0.0	0.0	0.8	0.0	25.9	1.1	3.1	0.3	0.6	3.0	13.5	0.1	2.0	0.2	0.1	10.7	3.3	0.0	0.0	7.1	578.1	0.1	0.0	0.1	41.6	0.0	11.6	0.0	0.5	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.1	8.2	17.5	0.0	0.3	0.0	76.6	4.8	0.1	0.0	0.0	0.0	0.7	4.1	0.3	0.0	0.0	0.1	0.5	5.6	2.0	0.2
TM4SF5		ENSG00000142484	"Transmembrane 4 L six family member 5"	O14894	17	4771884-4783213	"Predicted membrane proteins, Transporters"	"Cell cycle"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"intestine: 174.7;liver: 204.6"	"Cell type enhanced"	"Detected in some"		"Enteroendocrine cells: 115.2;Hepatocytes: 275.4;Intestinal goblet cells: 143.9;Paneth cells: 285.4;Proximal enterocytes: 618.4"	"Cancer enriched"	"Detected in many"	9	"liver cancer: 219.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	13	"CACO-2: 53.7;Hep G2: 96.0;OE19: 60.0"	"Low region specificity"	"Detected in some"			"Not detected"	"Not detected"			HPA055674			Uncertain	"Nucleoplasm,Plasma membrane,Cell Junctions"		NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane, Cell Junctions"	Nucleoplasm	"HPA055674: "		"unprognostic (1.81e-1)"	"unprognostic (1.61e-1)"				"unprognostic (1.31e-1)"				"unprognostic (4.44e-2)"		"unprognostic (9.33e-2)"	"unprognostic (3.57e-2)"	"unprognostic (1.95e-1)"		"unprognostic (5.21e-3)"	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.4	174.7	0.1	0.0	0.0	0.0	3.2	0.0	0.0	0.0	11.6	204.6	0.0	0.2	0.0	0.0	0.0	1.4	8.1	0.0	0.6	0.0	0.0	6.2	0.0	0.0	0.0	0.0	0.0	158.1	0.0	0.0	0.1	28.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	53.7	2.6	0.1	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.3	0.2	96.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.4	0.0	0.7	0.0	60.0	0.2	0.0	0.0	1.2	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	22.8	0.0	1.8	0.0	0.1	0.0	40.5	5.9	0.9	2.0	0.0	0.0	0.1	115.2	5.3	0.1	8.9	4.6	0.0	57.6	0.0	4.5	0.0	4.6	275.4	0.1	0.0	0.1	143.9	0.0	4.8	0.3	2.3	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.1	8.0	285.4	0.0	0.1	0.0	618.4	72.8	0.1	0.0	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.5	0.0	47.8	0.0
TM6SF1		ENSG00000136404	"Transmembrane 6 superfamily member 1"	Q9BZW5	15	83107572-83144854	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"skeletal muscle: 47.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 30.5;granulocytes: 44.4;Hofbauer cells: 50.9;Kupffer cells: 37.8;Langerhans cells: 46.4;Macrophages: 45.9;Microglial cells: 46.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"basophil: 76.6;eosinophil: 195.8;neutrophil: 118.1"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 195.8"	"Cell line enhanced"	"Detected in some"		"HEL: 23.2;HHSteC: 49.6;HUVEC TERT2: 27.7;JURKAT: 36.4;TIME: 68.3;U-698: 17.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016051, HPA056857"	Uncertain					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 10: Non-specific - Unknown function"			"HPA016051: AB_2203924, HPA056857: AB_2683259"	"unprognostic (8.09e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.87e-2)"	"unprognostic (4.67e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.43e-1)"	"unprognostic (6.46e-2)"	"unprognostic (3.52e-3)"	"unprognostic (1.73e-1)"	"unprognostic (1.70e-2)"	"unprognostic (2.80e-1)"	"unprognostic (2.55e-1)"	"prognostic favorable (6.79e-4)"	"unprognostic (1.15e-2)"	"unprognostic (4.65e-3)"	"unprognostic (2.60e-2)"	"unprognostic (1.70e-1)"	6.5	3.9	5.4	5.2	6.0	5.3	4.6	7.7	8.8	3.3	6.3	2.6	2.0	2.8	2.1	3.1	2.8	3.7	9.6	5.2	5.6	1.9	2.3	10.7	5.7	6.8	6.0	1.7	1.2	1.8	0.9	7.8	6.6	2.1	2.6	2.8	2.9	1.3	47.3	1.8	2.6	3.9	6.9	6.2	2.1	3.6	5.4	2.2	10.4	21.8	3.0	3.8	1.5	7.6	0.0	0.5	0.2	0.1	0.0	0.0	0.0	0.3	5.6	0.0	0.2	0.0	0.3	0.1	1.0	0.0	0.3	0.0	3.7	0.0	0.0	0.0	0.3	23.2	0.0	0.0	49.6	1.6	0.1	0.2	0.0	0.0	0.1	0.3	27.7	36.4	0.9	0.0	0.4	0.0	0.0	3.0	0.6	0.0	0.0	0.0	4.2	0.0	0.1	0.4	1.2	0.3	0.2	0.0	1.9	0.5	0.0	14.9	68.3	0.6	0.9	0.1	0.3	2.1	0.0	17.0	0.1	3.4	0.1	76.6	31.7	195.8	5.0	13.4	0.0	0.3	0.5	0.8	18.9	0.9	0.1	0.8	118.1	5.0	6.4	2.6	0.0	11.8	5.4	6.0	7.7	8.8	5.2	5.6	6.8	6.0	6.6	6.9	5.4	7.6	30.5	0.0	6.0	2.9	0.9	2.4	0.1	0.4	0.6	1.6	0.5	1.8	1.2	1.5	0.8	0.0	0.0	0.3	7.5	0.0	0.0	0.2	13.1	0.6	0.2	16.7	0.0	4.4	18.7	2.0	0.4	1.5	0.0	0.3	44.4	0.0	7.9	0.1	50.9	0.0	22.4	0.0	0.0	37.8	46.4	7.4	0.9	45.9	3.6	46.9	19.4	0.5	16.5	2.0	1.9	0.4	0.0	0.0	0.7	0.1	0.0	0.0	1.4	1.3	0.0	1.4	0.6	13.1	7.5	0.1	1.7	0.3	4.2	0.1	0.0	0.1
TM6SF2	Lpr4	ENSG00000213996	"Transmembrane 6 superfamily member 2"	Q9BZW4	19	19264364-19273391	"Predicted membrane proteins, Transporters"	"Lipid metabolism"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	16	"intestine: 75.5;liver: 33.7"	"Cell type enriched"	"Detected in some"	6	"Proximal enterocytes: 231.1"	"Cancer enhanced"	"Detected in many"		"liver cancer: 6.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"Hep G2: 1.4;HHSteC: 1.8;LHCN-M2: 1.5;NTERA-2: 1.0;SH-SY5Y: 1.8"	"Low region specificity"	"Detected in single"							HPA066026	Uncertain					NA	NA				"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 45: Enterocytes - Digestion"			"HPA066026: AB_2685598"	"unprognostic (2.41e-1)"	"unprognostic (4.81e-3)"	"unprognostic (1.49e-1)"	"unprognostic (1.15e-3)"	"unprognostic (3.29e-1)"	"unprognostic (2.35e-1)"	"unprognostic (1.39e-3)"	"unprognostic (4.00e-2)"	"unprognostic (4.15e-2)"	"unprognostic (4.53e-4)"	"unprognostic (9.55e-3)"	"unprognostic (4.37e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.61e-1)"	"unprognostic (4.56e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.15e-2)"	0.2	0.4	0.2	0.1	0.2	0.0	0.2	0.2	0.5	1.0	0.4	2.2	75.5	0.6	0.2	0.1	0.3	0.5	0.5	0.2	0.7	3.3	33.7	0.4	0.1	0.2	0.2	0.0	0.1	0.2	0.6	0.5	0.2	0.6	2.0	0.0	0.1	0.3	0.0	0.1	68.8	0.3	0.1	0.1	2.4	0.1	0.4	0.0	0.1	0.1	0.0	0.2	0.5	0.2	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.8	0.4	0.4	0.5	0.4	0.0	0.0	0.4	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	1.4	1.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.3	1.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	1.8	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.2	0.5	0.2	0.7	0.2	0.2	0.2	0.1	0.4	0.2	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.6	0.0	0.1	0.5	0.3	0.0	0.0	0.0	0.0	0.0	0.0	10.7	3.9	0.0	0.0	0.2	1.8	0.1	0.0	0.0	0.8	0.2	0.3	1.2	21.4	0.1	4.5	0.0	1.1	35.6	0.1	0.0	1.1	8.6	0.0	0.3	0.4	0.0	0.6	0.0	1.8	1.0	0.0	0.0	0.0	3.5	0.1	0.1	29.7	0.4	0.0	0.0	231.1	5.5	0.0	0.0	0.0	0.1	0.7	0.0	0.2	0.1	0.1	0.1	0.1	0.1	9.6	0.0
TM9SF1	"HMP70, MP70"	ENSG00000100926	"Transmembrane 9 superfamily member 1"	O15321	14	24189149-24195687	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Plasma cells: 54.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA059249	Supported		Approved	"Golgi apparatus"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA059249: AB_2683959"	"unprognostic (3.27e-1)"	"prognostic unfavorable (8.94e-4)"	"unprognostic (9.31e-2)"	"unprognostic (1.48e-1)"	"unprognostic (3.84e-2)"	"unprognostic (1.19e-2)"	"unprognostic (4.84e-3)"	"prognostic unfavorable (2.04e-4)"	"unprognostic (2.54e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.23e-1)"	"unprognostic (2.62e-3)"	"unprognostic (2.44e-1)"	"unprognostic (4.24e-1)"	"unprognostic (2.20e-1)"	"unprognostic (4.18e-3)"	28.0	35.2	7.5	10.5	7.6	3.7	25.6	7.9	7.9	29.2	18.2	23.9	12.7	31.1	31.3	25.4	27.9	17.5	21.7	7.4	7.7	25.1	34.6	26.7	7.7	8.8	9.4	24.8	46.8	36.6	20.0	18.1	8.4	23.4	15.5	5.9	35.6	21.3	19.5	24.2	21.4	18.1	8.5	19.4	29.4	20.2	8.3	8.3	30.7	11.1	12.4	23.8	23.6	8.4	22.0	45.1	17.7	18.0	59.4	40.4	22.4	37.6	55.4	53.7	60.5	19.1	49.0	12.5	25.2	50.3	30.7	50.5	14.9	29.7	39.3	18.4	15.4	9.4	21.3	56.2	41.8	18.5	22.8	41.3	56.1	36.9	50.5	42.3	32.3	7.9	11.2	30.7	43.6	51.2	12.1	15.7	8.4	62.1	39.2	15.6	22.1	24.7	42.5	37.9	16.3	18.6	39.0	44.3	24.5	16.8	28.8	14.1	26.0	47.5	21.2	23.1	28.1	31.0	25.5	7.4	18.1	11.5	39.5	33.4	20.5	25.0	14.1	18.1	15.3	15.0	14.6	12.6	23.4	16.3	13.0	12.9	28.3	23.1	18.5	39.2	17.2	13.5	7.5	7.6	7.9	7.9	7.4	7.7	8.8	9.4	8.4	8.5	8.3	8.4	5.5	16.0	5.3	8.8	11.2	3.3	6.1	7.3	18.8	4.4	6.1	5.0	1.5	7.2	7.6	1.8	14.6	9.8	5.0	4.0	0.0	8.2	13.9	5.2	7.4	8.7	1.8	5.5	6.6	4.9	10.4	14.9	13.7	6.3	2.5	5.3	5.0	4.8	4.1	0.0	7.1	3.5	6.1	2.5	4.5	6.2	5.3	5.6	1.8	4.7	5.3	5.4	4.1	9.0	7.3	5.3	6.1	4.5	54.3	7.7	3.5	3.0	30.0	7.6	6.6	10.1	7.4	7.0	5.4	19.5	4.7	11.9	9.1	5.7	4.1	3.8
TM9SF2	P76	ENSG00000125304	"Transmembrane 9 superfamily member 2"	Q99805	13	99446311-99564048	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA005657	Supported					NA	NA		2100000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA005657: AB_1080303"	"unprognostic (9.77e-3)"	"unprognostic (3.51e-2)"	"unprognostic (2.85e-2)"	"unprognostic (1.09e-2)"	"unprognostic (3.76e-1)"	"prognostic unfavorable (6.40e-4)"	"unprognostic (5.96e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.97e-1)"	"unprognostic (2.99e-2)"	"unprognostic (1.66e-1)"	"unprognostic (5.19e-2)"	"prognostic favorable (5.21e-7)"	"unprognostic (6.49e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.20e-2)"	"unprognostic (2.21e-1)"	66.6	67.2	34.4	66.7	37.4	64.6	90.6	35.9	41.4	100.2	62.5	115.8	119.4	63.6	119.0	56.1	76.6	73.6	51.0	35.8	40.3	108.4	169.4	78.6	62.1	35.9	35.1	53.2	90.2	126.8	41.5	98.2	36.6	97.8	123.7	41.9	109.6	73.2	36.3	56.6	119.3	65.7	39.8	62.4	104.1	59.6	36.9	49.7	121.2	48.3	71.3	90.0	44.4	44.9	187.3	56.7	75.8	107.8	223.2	134.8	108.2	124.1	154.5	86.6	134.8	93.1	234.7	72.1	100.0	150.1	88.4	183.1	81.1	108.7	117.8	80.8	57.8	89.6	90.9	100.2	118.0	235.8	100.0	106.2	132.4	75.1	76.8	133.2	110.4	72.8	90.7	70.0	103.0	62.8	59.1	91.9	66.3	335.7	70.0	49.3	61.0	78.7	178.9	137.3	71.7	87.5	71.7	285.6	94.8	145.5	174.0	280.5	109.1	69.6	50.7	70.5	77.8	96.6	120.8	29.0	163.8	120.0	103.0	192.4	156.4	174.9	57.7	180.5	72.8	86.9	68.4	65.3	139.6	60.1	62.8	58.4	251.3	76.0	182.1	159.6	109.6	178.1	34.4	37.4	35.9	41.4	35.8	40.3	35.9	35.1	36.6	39.8	36.9	44.9	68.9	83.3	76.3	29.0	72.5	40.9	57.3	132.8	48.9	20.6	82.9	40.5	44.0	70.1	170.7	86.5	18.8	99.3	94.5	141.1	11.7	98.6	149.2	101.0	75.6	65.4	83.0	47.9	36.6	102.7	122.8	74.6	89.2	93.9	54.5	35.2	87.4	172.9	116.0	21.9	44.4	167.9	128.1	137.6	57.2	41.8	50.1	100.7	72.9	44.0	97.4	42.7	42.2	34.2	44.8	83.4	116.7	52.3	143.1	69.0	123.5	70.8	187.7	25.3	19.7	44.1	104.1	109.7	56.3	69.8	52.1	171.4	53.2	43.2	119.4	104.0
TM9SF4	"dJ836N17.2, KIAA0255"	ENSG00000101337	"Transmembrane 9 superfamily member 4"	Q92544	20	32109714-32167258	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA064099	Approved					NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 10: Non-specific - Unknown function"			"HPA064099: AB_2685190"	"unprognostic (3.10e-2)"	"unprognostic (9.03e-3)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (6.37e-6)"	"unprognostic (3.85e-1)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (2.15e-4)"	"unprognostic (1.37e-1)"	"unprognostic (3.23e-3)"	"unprognostic (1.91e-1)"	"unprognostic (6.65e-2)"	"unprognostic (7.68e-2)"	"unprognostic (6.98e-3)"	"unprognostic (7.66e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.04e-1)"	"unprognostic (4.23e-2)"	23.4	21.1	16.7	23.4	16.9	16.3	22.6	14.8	19.5	26.5	20.7	32.1	29.6	25.0	30.4	30.3	34.8	22.1	24.4	17.6	17.9	26.6	33.7	24.4	18.9	15.3	15.8	28.7	30.5	52.6	17.0	39.6	16.3	28.0	37.2	17.7	30.7	26.8	23.3	32.0	29.0	31.8	14.0	23.6	29.8	18.0	18.9	21.0	24.7	24.3	24.2	27.9	22.9	16.2	59.0	41.1	46.1	53.2	88.7	71.9	59.1	47.8	71.9	65.6	63.7	122.2	71.1	41.0	88.2	78.2	102.4	94.8	52.4	101.9	56.4	23.5	29.4	94.4	34.6	93.1	78.3	45.9	52.0	76.2	76.3	49.7	79.6	80.3	59.1	48.3	60.4	74.5	51.8	62.5	46.5	36.4	41.2	71.2	50.0	43.9	65.1	51.4	57.2	41.3	39.0	45.7	88.6	57.7	51.4	61.0	72.4	52.0	48.5	119.2	36.7	63.7	59.1	74.9	65.9	38.2	94.4	149.6	54.6	24.0	48.4	9.9	20.0	50.5	24.8	16.5	17.7	22.9	41.8	13.1	19.4	16.4	11.7	18.8	67.8	13.7	19.1	34.6	16.7	16.9	14.8	19.5	17.6	17.9	15.3	15.8	16.3	14.0	18.9	16.2	16.4	25.6	25.2	33.0	16.2	7.0	17.4	27.1	17.6	12.2	15.7	16.1	16.0	14.3	36.5	9.2	16.7	29.4	11.9	25.2	1.9	19.0	53.5	18.0	25.2	18.4	13.9	12.4	31.2	18.5	21.7	20.4	23.4	24.9	8.2	19.3	16.8	26.2	24.0	8.4	37.1	31.7	20.3	19.1	10.5	57.5	16.8	22.5	7.2	24.4	25.2	14.0	10.3	28.6	34.8	19.8	25.7	10.9	23.1	22.1	29.8	14.0	32.8	12.3	6.6	19.9	25.8	26.5	9.7	21.8	11.4	37.6	16.8	23.4	27.5	21.9
TMBIM1	"LFG3, PP1201, RECS1"	ENSG00000135926	"Transmembrane BAX inhibitor motif containing 1"	Q969X1	2	218274197-218292586	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Exocrine glandular cells: 281.2;Pancreatic endocrine cells: 294.3;Syncytiotrophoblasts: 282.1;Urothelial cells: 299.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"RT4: 573.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA012093, HPA070824"	Approved		Supported	Vesicles		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Vesicles		"HPA012093: AB_1858056, HPA070824: AB_2686317"	"unprognostic (4.36e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.73e-3)"	"unprognostic (2.34e-3)"	"unprognostic (3.81e-3)"	"unprognostic (8.91e-3)"	"unprognostic (5.58e-3)"	"unprognostic (9.85e-2)"	"unprognostic (3.76e-3)"	"prognostic unfavorable (4.22e-4)"	"unprognostic (1.69e-1)"	"prognostic favorable (3.38e-4)"	"unprognostic (1.22e-1)"	"unprognostic (4.63e-2)"	"unprognostic (2.75e-2)"	"unprognostic (4.50e-1)"	231.0	120.9	118.0	84.1	135.0	96.1	165.5	124.8	123.6	146.8	112.1	143.1	152.6	119.7	92.9	333.4	97.3	135.5	123.3	109.4	131.2	123.5	170.8	175.1	55.4	194.5	144.0	93.5	240.3	125.6	50.2	172.7	150.7	97.6	140.7	15.2	155.1	89.5	219.1	185.3	174.6	127.1	139.8	65.9	212.3	25.4	134.1	41.9	158.0	185.2	106.8	172.9	215.1	144.2	183.9	66.4	3.5	47.1	404.3	170.6	188.7	175.5	217.9	103.4	117.7	169.8	449.0	40.6	123.3	263.0	194.6	305.3	59.8	399.9	100.4	151.0	23.5	264.6	41.8	205.6	183.3	2.4	252.4	161.1	370.7	210.4	265.6	108.4	111.8	6.7	169.0	75.0	182.9	6.1	2.8	46.5	2.5	382.3	60.4	5.7	28.3	33.1	142.1	573.4	2.2	3.1	58.0	214.7	122.8	36.6	56.3	39.8	168.4	182.4	50.1	84.9	64.8	35.9	45.2	17.7	179.9	41.0	105.5	352.9	136.4	298.5	107.9	172.7	91.8	77.1	98.0	89.1	93.3	61.9	64.3	70.2	167.1	66.7	221.9	25.9	116.1	190.1	118.0	135.0	124.8	123.6	109.4	131.2	194.5	144.0	150.7	139.8	134.1	144.2	47.6	73.7	25.6	20.9	37.2	81.7	96.9	85.0	51.2	2.0	28.8	26.0	26.4	78.6	66.9	69.9	0.0	139.1	51.8	266.8	13.7	175.5	0.6	45.6	42.6	50.8	22.7	66.3	2.4	281.2	146.8	61.9	110.6	78.4	50.0	16.1	28.9	50.4	104.9	0.0	2.5	67.9	52.9	45.1	50.2	2.8	54.0	69.6	46.2	14.0	22.0	22.9	48.4	5.0	35.2	294.3	177.3	59.5	30.3	151.8	204.4	37.7	34.8	1.9	13.1	35.7	45.0	1.4	12.5	86.5	101.2	282.1	41.3	9.9	69.1	299.8
TMBIM4	"CGI-119, GAAP, LFG4, S1R, ZPRO"	ENSG00000155957	"Transmembrane BAX inhibitor motif containing 4"	Q9HC24	12	66135846-66170072	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA077642			Supported	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus"		"HPA077642: AB_2686849"	"unprognostic (5.41e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.19e-1)"	"unprognostic (8.14e-2)"	"unprognostic (2.69e-2)"	"unprognostic (5.62e-2)"	"unprognostic (7.18e-3)"	"unprognostic (8.51e-2)"	"unprognostic (2.49e-1)"	"unprognostic (1.33e-2)"	"unprognostic (3.36e-1)"	"unprognostic (9.93e-2)"	"unprognostic (2.49e-2)"	"unprognostic (3.70e-1)"	"unprognostic (3.68e-2)"	"unprognostic (3.75e-2)"	"unprognostic (2.20e-3)"	79.7	88.6	28.0	75.3	34.3	61.5	81.4	34.0	29.7	67.3	47.6	90.5	59.5	61.0	68.6	62.6	65.8	70.1	70.8	27.1	35.6	94.0	109.6	76.7	74.5	38.5	32.1	56.7	103.5	104.7	40.1	74.2	39.1	72.8	70.2	39.7	89.3	73.7	46.7	52.2	69.8	58.5	34.7	74.4	93.3	85.1	31.0	63.1	97.9	61.5	56.0	80.0	42.9	41.5	49.1	62.4	39.7	72.8	131.4	122.7	41.9	74.4	129.1	56.7	45.8	32.8	78.7	45.6	86.3	105.2	42.6	78.9	20.1	65.7	36.6	74.5	27.3	87.7	30.0	38.6	66.6	106.9	109.2	86.9	92.8	27.7	31.1	79.0	87.2	51.8	65.9	160.3	94.3	79.5	41.1	37.5	47.4	76.1	63.3	21.5	26.5	50.8	126.8	80.3	20.1	47.6	84.5	154.5	102.3	34.2	146.3	146.7	106.0	69.1	25.9	50.5	44.8	82.7	48.5	32.2	94.8	103.7	84.1	420.7	372.7	371.6	136.0	381.4	137.9	205.9	139.7	139.4	256.2	196.6	157.9	139.1	662.3	135.3	434.3	171.7	159.8	483.9	28.0	34.3	34.0	29.7	27.1	35.6	38.5	32.1	39.1	34.7	31.0	41.5	232.8	150.6	147.2	34.0	131.3	0.0	64.1	0.0	84.2	47.8	202.2	152.1	37.0	0.0	66.2	244.6	45.9	137.0	128.2	191.4	103.7	213.8	330.6	116.2	96.4	114.5	74.7	32.0	15.8	338.1	116.9	140.7	85.1	105.8	179.0	72.7	0.0	0.0	210.7	45.4	25.2	172.4	0.0	0.0	0.0	143.8	104.4	193.2	0.0	62.8	205.5	114.1	123.6	42.7	77.0	202.9	176.9	91.0	126.8	87.9	128.9	214.5	99.1	65.9	59.2	67.8	75.7	391.0	40.8	112.5	0.0	130.8	99.3	142.7	182.2	62.8
TMBIM6	"BAXI1, BI-1, TEGT"	ENSG00000139644	"Transmembrane BAX inhibitor motif containing 6"	P55061	12	49707725-49764934	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Apoptosis, Autophagy, Unfolded protein response"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 1803.2"	"Cell type enhanced"	"Detected in all"		"Hepatocytes: 2394.6;Late spermatids: 2375.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA017378	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 2: Hepatocytes - Metabolism"			"HPA017378: AB_2669604"	"prognostic unfavorable (3.54e-4)"	"unprognostic (6.25e-2)"	"unprognostic (1.90e-2)"	"unprognostic (6.52e-2)"	"unprognostic (8.46e-3)"	"prognostic unfavorable (1.91e-4)"	"unprognostic (1.37e-1)"	"unprognostic (2.19e-2)"	"unprognostic (1.22e-2)"	"unprognostic (6.25e-2)"	"unprognostic (5.91e-2)"	"unprognostic (3.80e-1)"	"prognostic favorable (1.00e-5)"	"unprognostic (1.95e-1)"	"unprognostic (9.27e-2)"	"unprognostic (1.28e-1)"	"unprognostic (1.54e-2)"	333.4	364.8	332.1	276.3	361.6	315.4	416.8	347.5	376.4	413.7	528.2	493.6	475.8	252.3	640.9	406.3	431.1	360.3	215.5	301.1	358.3	1144.5	1803.2	423.3	292.3	374.4	346.9	281.2	574.2	577.5	133.7	303.1	378.7	383.2	494.4	305.0	479.8	409.3	232.1	231.4	536.1	294.7	351.9	267.8	549.8	247.9	366.9	313.0	596.4	232.3	332.3	406.2	216.5	395.2	609.6	516.6	413.3	381.1	1169.3	645.1	513.6	450.2	854.0	572.0	519.7	837.6	1703.8	380.3	746.9	882.6	598.6	648.1	363.7	659.4	619.2	551.7	390.3	606.2	367.8	414.0	707.7	701.9	959.4	657.5	1511.3	640.9	925.8	809.3	481.6	461.0	556.2	1526.5	662.5	589.5	362.1	424.2	432.1	730.6	392.2	302.8	413.0	651.0	871.5	909.9	319.0	208.7	603.5	786.1	511.2	530.7	989.4	731.6	456.8	522.6	393.9	355.8	396.9	654.2	717.8	326.8	730.9	324.3	260.8	896.4	749.8	795.5	559.9	721.8	587.8	403.6	501.1	558.5	585.5	356.6	438.9	501.8	1242.0	463.8	769.5	587.0	544.8	1813.1	332.1	361.6	347.5	376.4	301.1	358.3	374.4	346.9	378.7	351.9	366.9	395.2	428.2	477.5	455.5	80.6	314.2	261.0	535.0	836.9	222.5	245.8	526.8	337.6	221.0	571.9	766.5	544.4	114.7	406.9	366.7	995.8	131.0	927.3	1504.8	340.5	240.0	321.9	294.9	232.7	43.9	816.9	913.0	336.0	325.7	501.9	257.7	194.5	358.7	2394.6	618.9	180.0	57.3	612.6	598.1	570.6	292.8	2375.1	288.6	458.2	247.3	58.1	540.3	467.7	285.3	94.5	115.5	846.7	651.3	287.3	589.8	550.0	1585.8	809.6	874.1	154.8	170.9	191.7	361.1	458.1	214.7	272.7	235.0	891.0	315.9	372.8	552.2	654.4
TMC1	"DFNA36, DFNB11, DFNB7"	ENSG00000165091	"Transmembrane channel like 1"	Q8TDI8	9	72521608-72838297	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Hearing, Ion transport, Transport"	"Ion channel"	"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"cervix: 1.0"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 19.2;Early spermatids: 7.9;Endometrial stromal cells: 5.5;Microglial cells: 5.6;Urothelial cells: 6.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 2.7;HAP1: 5.2;NTERA-2: 1.9;SuSa: 1.0;U-266/70: 1.3;U-266/84: 1.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 64: Astrocytes - Nervous system maintenance"				"unprognostic (6.36e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.79e-1)"	"unprognostic (7.19e-3)"	"unprognostic (3.97e-1)"	"unprognostic (5.67e-4)"	"unprognostic (1.63e-1)"	"unprognostic (1.91e-1)"	"unprognostic (2.10e-2)"	"unprognostic (3.74e-1)"	"unprognostic (3.94e-2)"	"unprognostic (2.12e-1)"	"unprognostic (2.67e-3)"	"unprognostic (1.80e-1)"	"unprognostic (2.35e-1)"	"unprognostic (3.94e-2)"	"unprognostic (1.31e-1)"	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.5	0.5	1.0	0.1	0.0	0.0	0.1	0.8	0.1	0.1	0.0	0.0	0.4	0.6	0.7	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.4	0.6	0.3	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	1.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.5	0.5	0.4	0.6	0.6	0.6	0.6	0.5	0.4	0.7	1.3	0.0	0.0	19.2	0.0	0.3	2.9	0.1	0.6	0.2	0.1	0.1	0.4	0.0	0.0	1.8	0.0	4.0	0.1	0.4	0.0	0.2	7.9	1.4	5.5	1.2	0.0	0.0	1.5	0.6	2.8	0.3	0.0	0.9	0.0	0.0	0.0	0.0	0.5	0.0	1.2	0.0	0.0	0.0	0.0	2.6	0.3	0.1	0.0	5.6	0.6	1.1	0.0	1.5	1.3	0.5	2.2	0.0	0.0	3.1	0.0	3.0	0.0	0.0	0.0	0.3	0.2	1.8	3.1	0.5	0.0	2.6	0.1	0.5	0.0	6.8
TMC5	FLJ13593	ENSG00000103534	"Transmembrane channel like 5"	Q6UXY8	16	19410496-19499113	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 53.4;stomach 1: 46.0"	"Cell type enhanced"	"Detected in many"		"Club cells: 282.4;Pancreatic endocrine cells: 302.2;Proximal enterocytes: 374.3;Respiratory ciliated cells: 624.7"	"Low cancer specificity"	"Detected in many"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"CAPAN-2: 69.7;OE19: 41.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA040810, HPA042037"	Enhanced		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 9: Intestine - Unknown function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"	"Plasma membrane"	Nucleoplasm	"HPA040810: AB_10795627, HPA042037: AB_10804126"	"unprognostic (2.47e-2)"	"unprognostic (3.68e-1)"	"unprognostic (3.50e-2)"	"unprognostic (2.74e-3)"	"unprognostic (1.01e-1)"	"unprognostic (3.64e-2)"	"prognostic unfavorable (7.96e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.59e-1)"	"unprognostic (9.74e-2)"	"unprognostic (3.27e-2)"	"unprognostic (3.71e-1)"	"unprognostic (2.28e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.88e-3)"	"unprognostic (1.75e-1)"	0.6	0.1	0.2	3.1	0.4	1.5	12.7	0.5	0.3	8.9	5.6	21.6	45.4	2.1	17.5	1.2	5.1	25.5	0.1	0.3	0.0	0.3	0.6	18.9	0.2	0.2	0.2	0.1	2.3	6.0	0.1	3.2	0.2	12.2	22.7	0.2	22.8	0.2	0.1	1.8	53.4	1.1	0.0	0.1	46.0	3.8	0.2	0.1	0.7	0.0	1.1	3.2	0.5	0.2	6.9	10.8	0.0	0.3	0.0	0.0	9.7	0.1	0.0	0.0	0.0	0.1	69.7	0.0	0.3	0.0	0.2	4.4	1.1	0.0	0.0	0.1	0.1	0.0	1.8	0.1	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	1.1	0.0	0.2	2.5	41.5	3.1	0.0	0.0	2.6	0.1	0.3	0.7	0.2	0.1	2.1	0.0	1.1	0.9	0.0	0.0	0.0	0.3	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.2	0.4	0.5	0.3	0.3	0.0	0.2	0.2	0.2	0.0	0.2	0.2	0.1	157.0	162.5	0.0	1.8	0.8	22.9	46.6	2.8	0.3	57.4	17.9	0.9	102.9	282.4	22.0	2.1	39.0	1.0	173.7	0.0	121.1	32.8	107.0	6.9	2.9	38.9	8.0	1.9	166.3	3.4	3.3	188.1	88.4	5.7	11.0	0.7	0.6	2.7	3.3	2.0	101.5	26.4	0.0	1.1	32.6	0.3	1.8	1.8	0.0	1.0	0.2	0.0	0.5	0.9	302.2	180.9	0.7	0.5	103.1	374.3	2.0	624.7	1.9	0.0	0.4	9.5	1.3	1.1	2.2	1.7	16.3	1.3	1.5	125.1	55.9
TMC6	"EVER1, EVIN1, LAK-4P, TNRC6C-AS1"	ENSG00000141524	"Transmembrane channel like 6"	Q7Z403	17	78107397-78132407	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 110.5"	"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"K-562: 108.7;SK-BR-3: 121.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA051430	Uncertain					NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 63: NK-cells & T-cells - Immune response"			"HPA051430: AB_2681483"	"unprognostic (6.34e-2)"	"unprognostic (5.14e-2)"	"unprognostic (5.55e-2)"	"unprognostic (2.81e-3)"	"unprognostic (3.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (5.36e-2)"	"unprognostic (6.27e-2)"	"unprognostic (1.47e-1)"	"unprognostic (9.94e-2)"	"unprognostic (1.74e-1)"	"unprognostic (6.61e-2)"	"unprognostic (1.16e-2)"	"prognostic favorable (1.82e-4)"	"unprognostic (2.70e-2)"	"unprognostic (1.10e-2)"	"prognostic favorable (3.20e-4)"	29.5	6.8	19.2	45.4	50.5	72.7	25.2	43.4	33.5	11.3	5.2	23.5	21.7	7.6	1.0	25.4	14.1	9.7	35.9	19.3	26.4	20.6	9.1	40.3	69.7	59.3	49.7	3.8	14.6	3.1	5.6	8.8	55.9	20.2	6.6	0.6	29.3	7.9	3.5	17.9	50.6	3.5	35.8	110.5	14.6	2.6	48.4	26.3	12.9	1.8	32.4	14.6	18.4	81.9	17.9	14.0	7.5	6.0	0.0	0.0	15.2	0.0	0.0	0.2	0.2	25.2	19.2	19.7	23.7	0.0	6.3	31.0	1.0	5.9	0.0	2.0	11.3	41.3	4.2	31.0	1.9	38.3	67.0	1.1	16.2	0.0	1.3	0.2	14.7	9.2	108.7	73.3	0.0	36.1	18.9	65.4	5.9	32.9	4.9	8.4	0.6	58.9	11.4	65.1	1.9	4.9	5.7	121.0	33.2	9.7	68.7	57.6	5.2	0.0	8.7	0.1	0.3	57.6	27.3	13.2	0.0	60.4	1.0	17.7	11.6	23.2	56.2	38.3	49.0	28.5	41.7	46.2	18.6	21.7	36.5	39.6	15.3	35.8	63.5	5.7	38.0	33.5	19.2	50.5	43.4	33.5	19.3	26.4	59.3	49.7	55.9	35.8	48.4	81.9	43.8	41.7	29.6	8.1	69.5	11.1	21.0	22.3	7.4	3.2	17.4	6.5	14.7	10.0	41.5	16.5	0.0	1.2	79.8	25.0	0.0	41.2	0.3	5.1	1.6	19.7	9.1	28.4	0.2	23.1	26.4	4.6	10.2	8.0	40.5	0.7	23.6	2.2	67.0	1.7	0.2	14.0	40.7	66.2	29.9	1.2	9.6	44.7	14.2	20.6	62.0	7.5	85.5	1.5	50.8	40.5	53.7	1.2	62.6	31.5	20.3	2.0	20.3	1.8	13.1	4.6	13.5	0.5	2.2	8.4	10.2	3.7	83.7	2.5	30.3	37.4
TMC8	"EVER2, EVIN2"	ENSG00000167895	"Transmembrane channel like 8"	Q8IU68	17	78130770-78142968	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"bone marrow: 91.8;intestine: 54.6;lymphoid tissue: 117.0"	"Cell type enhanced"	"Detected in many"		"B-cells: 44.9;dendritic cells: 52.3;granulocytes: 41.2;Langerhans cells: 44.6;NK-cells: 85.5;T-cells: 68.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 46.3;HL-60: 63.0;HMC-1: 119.9;Karpas-707: 103.9;RPMI-8226: 66.6;U-266/70: 49.3;U-937: 51.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"HPA047387, HPA054429"	Uncertain		Uncertain	"Golgi apparatus"		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 63: NK-cells & T-cells - Immune response"	"Golgi apparatus"		"HPA047387: , HPA054429: AB_2682485"	"unprognostic (8.54e-3)"	"prognostic favorable (8.45e-6)"	"unprognostic (1.32e-1)"	"unprognostic (2.33e-3)"	"unprognostic (3.59e-1)"	"prognostic favorable (4.19e-5)"	"unprognostic (6.38e-3)"	"unprognostic (6.47e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.39e-1)"	"unprognostic (6.06e-2)"	"unprognostic (4.27e-1)"	"prognostic unfavorable (1.96e-7)"	"unprognostic (6.24e-2)"	"unprognostic (1.01e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.89e-2)"	7.8	3.0	3.6	56.0	4.4	91.8	3.7	3.7	5.1	3.7	3.5	8.2	10.3	2.5	0.7	4.8	4.0	7.4	2.7	3.6	4.8	5.2	7.1	18.4	100.5	5.8	4.7	1.3	2.0	0.5	2.2	3.9	5.6	4.9	4.5	0.1	5.8	1.3	1.8	3.6	54.6	2.4	5.0	117.0	10.4	1.2	7.8	60.1	6.4	0.9	46.7	6.4	5.0	7.2	0.5	0.8	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	1.3	46.3	2.0	0.0	0.1	3.4	0.0	0.1	0.0	0.0	0.1	16.4	0.1	0.8	0.0	63.0	119.9	0.0	0.0	0.0	0.0	0.0	0.0	22.1	4.0	103.9	0.0	1.3	20.9	2.8	0.2	3.5	0.5	1.4	0.3	66.6	0.0	0.2	0.0	0.1	0.0	2.2	0.6	0.1	6.9	12.7	0.1	0.0	0.1	0.1	0.0	49.3	2.0	4.6	0.1	51.9	0.1	2.6	2.0	6.6	13.4	3.4	9.7	5.5	10.8	13.3	2.3	4.8	9.4	8.6	3.3	7.5	7.9	2.1	6.5	5.5	3.6	4.4	3.7	5.1	3.6	4.8	5.8	4.7	5.6	5.0	7.8	7.2	3.6	3.2	10.2	1.0	44.9	5.4	10.4	4.9	4.6	0.2	1.2	1.5	1.9	1.5	6.5	0.0	0.0	0.4	52.3	3.7	0.0	1.0	0.7	1.0	0.6	3.2	1.2	17.1	0.4	1.3	1.4	2.3	2.0	1.8	41.2	0.1	5.7	0.5	30.5	0.0	0.4	1.4	14.2	28.2	44.6	0.5	0.0	22.0	7.2	24.4	30.2	0.2	85.5	1.0	2.7	0.6	3.6	0.4	20.2	2.9	0.9	0.4	2.1	0.2	0.0	0.3	2.0	0.4	0.6	8.4	4.5	0.5	68.6	2.7	7.0	10.7
TMCC3	KIAA1145	ENSG00000057704	"Transmembrane and coiled-coil domain family 3"	Q9ULS5	12	94567122-94650557	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 36.3"	"Cell type enhanced"	"Detected in many"		"Adipocytes: 81.2;Distal enterocytes: 98.3;Microglial cells: 70.3;Oligodendrocytes: 119.8;Paneth cells: 70.1;Urothelial cells: 83.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"eosinophil: 46.9;neutrophil: 69.7"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 69.7"	"Cell line enhanced"	"Detected in many"		"HUVEC TERT2: 31.3;Karpas-707: 41.9;U-266/84: 30.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014272	Approved		Approved	"Endoplasmic reticulum,Vesicles"		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"	Vesicles	"HPA014272: AB_1858059"	"unprognostic (1.03e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.52e-3)"	"prognostic unfavorable (4.87e-4)"	"unprognostic (1.30e-1)"	"unprognostic (8.63e-2)"	"unprognostic (5.87e-2)"	"unprognostic (1.17e-2)"	"unprognostic (9.12e-2)"	"unprognostic (3.45e-3)"	"unprognostic (1.24e-1)"	"unprognostic (7.73e-2)"	"unprognostic (1.80e-3)"	"unprognostic (9.11e-2)"	"unprognostic (2.32e-1)"	"unprognostic (5.41e-2)"	"unprognostic (4.75e-2)"	11.7	4.5	13.6	9.4	25.8	10.0	9.6	23.1	16.5	11.6	3.9	22.5	14.9	7.7	3.1	6.1	5.7	5.3	2.3	13.2	19.6	8.1	4.1	5.3	4.4	26.9	25.9	4.7	3.2	4.6	3.4	17.8	26.7	8.3	16.4	0.9	2.8	5.4	18.4	6.1	21.0	7.9	20.8	12.2	7.3	2.0	24.8	4.0	13.3	7.0	6.3	7.5	4.8	36.3	7.8	0.4	1.9	0.0	0.7	2.7	13.6	0.0	0.0	0.5	1.9	0.0	1.7	0.2	0.1	0.0	6.8	19.1	10.7	12.9	2.6	3.5	2.6	5.1	0.8	0.0	0.5	0.0	10.2	1.7	1.7	7.2	10.1	11.3	31.3	0.0	0.2	41.9	1.0	0.4	0.0	0.4	1.0	2.7	6.5	0.0	0.6	5.1	2.0	16.4	0.2	0.8	0.2	8.0	0.4	8.8	0.0	0.4	19.0	0.0	0.2	0.1	3.4	19.4	30.1	0.3	3.9	1.6	1.7	16.4	4.3	46.9	3.3	6.0	0.3	5.4	1.2	1.9	2.5	3.1	0.0	2.2	69.7	3.3	7.8	2.8	0.0	3.1	13.6	25.8	23.1	16.5	13.2	19.6	26.9	25.9	26.7	20.8	24.8	36.3	81.2	0.0	2.7	2.9	5.7	20.6	32.7	3.2	9.6	4.4	2.1	1.3	2.0	4.3	3.2	7.3	0.0	16.0	16.3	98.3	0.0	1.9	5.8	24.5	3.6	31.9	12.0	0.0	0.6	3.8	3.2	4.8	10.2	39.8	0.0	17.1	31.8	0.6	4.1	0.0	15.0	13.0	0.0	15.0	9.2	8.3	1.8	20.3	3.6	70.3	19.0	0.1	11.3	11.6	119.8	12.9	70.1	1.2	7.8	16.8	48.1	8.9	3.0	0.3	6.6	19.7	6.1	0.0	2.2	30.4	16.2	7.1	7.7	2.5	8.2	83.3
TMCO1	"HP10122, TMCC4"	ENSG00000143183	"Transmembrane and coiled-coil domains 1"	Q9UM00	1	165724293-165827755	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, Glaucoma, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA054768, HPA078775"	Approved		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Endoplasmic reticulum"		"HPA054768: AB_2682597, HPA078775: "	"unprognostic (1.22e-2)"	"unprognostic (3.28e-3)"	"unprognostic (2.36e-1)"	"unprognostic (1.45e-1)"	"unprognostic (2.97e-1)"	"prognostic unfavorable (5.17e-7)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (5.92e-2)"	"unprognostic (4.16e-2)"	"unprognostic (7.95e-3)"	"unprognostic (1.78e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (2.85e-1)"	"unprognostic (1.94e-1)"	"unprognostic (2.14e-2)"	"unprognostic (9.80e-2)"	67.5	92.5	46.4	51.6	50.2	48.4	91.1	53.8	63.5	74.0	72.2	127.0	115.7	55.9	111.5	58.5	65.9	80.1	56.4	46.4	55.6	110.3	162.5	55.0	62.4	54.1	55.5	59.5	73.5	143.6	33.8	57.4	55.0	79.6	128.7	74.3	77.8	69.9	48.7	39.3	108.9	61.4	56.6	46.5	80.7	75.4	49.8	89.3	103.8	48.0	70.8	97.7	29.1	60.6	158.4	172.1	132.2	77.9	243.9	120.7	126.9	259.4	191.7	156.0	162.1	249.9	229.2	99.1	267.4	195.9	67.1	214.7	171.8	140.3	175.1	252.0	164.2	121.1	180.3	158.7	195.1	216.6	154.1	159.0	173.9	179.5	142.6	148.4	117.1	122.6	329.7	186.0	227.3	123.1	172.1	160.6	169.4	527.6	197.3	125.0	143.4	256.1	204.7	198.4	133.5	235.4	201.3	209.2	170.9	195.0	277.1	275.7	121.5	138.9	116.5	123.8	248.3	357.4	521.1	346.5	111.4	139.7	187.4	213.3	172.2	172.9	159.7	169.4	170.4	151.8	168.7	173.1	135.5	132.6	134.3	156.5	132.1	156.6	201.7	243.8	207.1	290.3	46.4	50.2	53.8	63.5	46.4	55.6	54.1	55.5	55.0	56.6	49.8	60.6	124.0	96.1	70.7	23.8	95.6	84.8	89.8	264.5	75.1	79.1	142.9	135.9	62.6	224.4	181.1	213.3	68.8	136.1	138.9	371.5	43.0	202.3	82.2	131.4	147.9	92.7	88.6	75.5	20.7	191.7	148.4	113.1	64.2	154.7	76.5	71.9	106.7	326.0	140.9	75.7	24.9	137.0	227.9	106.4	76.0	151.6	123.6	92.7	99.6	16.9	78.9	236.7	152.4	25.6	23.3	227.0	215.7	129.4	153.5	73.6	290.0	151.5	175.2	75.9	124.9	67.7	101.7	232.1	87.7	89.4	92.9	111.4	109.2	117.6	143.6	94.5
TMCO3	"C13orf11, FLJ20623"	ENSG00000150403	"Transmembrane and coiled-coil domains 3"	Q6UWJ1	13	113491021-113554590	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiport, Ion transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 20.2"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039561, HPA048126"	Uncertain		Approved	Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 27: Mucus-secreting cells - Mucin production"	Cytosol		"HPA039561: AB_2676573, HPA048126: AB_2680276"	"unprognostic (7.89e-2)"	"prognostic unfavorable (5.80e-4)"	"unprognostic (6.78e-2)"	"unprognostic (7.88e-2)"	"unprognostic (2.89e-1)"	"unprognostic (6.01e-2)"	"prognostic unfavorable (1.14e-5)"	"unprognostic (2.93e-2)"	"unprognostic (9.44e-2)"	"unprognostic (3.08e-3)"	"unprognostic (2.76e-2)"	"unprognostic (8.47e-3)"	"unprognostic (3.70e-3)"	"unprognostic (1.05e-1)"	"unprognostic (2.06e-1)"	"unprognostic (6.27e-3)"	"prognostic unfavorable (4.10e-4)"	24.2	26.9	20.5	18.6	18.3	76.7	22.7	29.8	21.5	31.1	49.2	23.1	21.0	33.1	20.0	14.4	25.2	27.7	28.2	17.3	16.3	24.2	14.3	24.3	16.3	19.4	18.8	25.2	40.7	35.1	23.1	30.1	19.4	22.1	22.0	18.1	38.7	21.6	19.1	13.4	22.7	29.6	19.6	19.8	44.3	16.1	19.6	12.4	10.7	15.2	13.1	19.6	18.9	21.2	97.8	32.6	46.3	32.0	93.1	136.4	25.0	105.0	99.6	45.1	45.3	35.7	41.9	23.1	25.9	115.7	61.7	38.5	24.8	38.0	70.0	48.0	25.1	20.9	52.2	36.0	87.9	34.3	41.7	112.0	88.5	33.9	68.9	116.7	74.5	14.3	30.3	31.6	79.6	17.5	18.0	20.6	23.2	46.5	50.9	22.4	28.0	16.7	74.3	12.6	40.4	33.5	32.3	70.3	33.6	65.3	41.5	64.6	117.4	50.3	53.5	36.9	44.8	39.2	23.9	14.8	167.2	17.8	24.6	3.1	8.3	8.5	1.3	5.6	1.5	3.1	1.5	2.0	6.0	1.8	1.7	1.7	20.2	5.0	11.3	1.3	1.5	2.7	20.5	18.3	29.8	21.5	17.3	16.3	19.4	18.8	19.4	19.6	19.6	21.2	34.3	12.8	15.1	21.5	12.5	9.8	37.2	25.8	21.6	16.4	39.2	17.5	20.3	24.3	27.8	25.8	14.6	21.6	13.5	37.1	5.9	46.8	14.6	28.2	39.2	31.3	34.2	23.5	42.9	37.4	53.8	35.0	39.3	28.6	26.6	18.4	35.0	12.4	19.1	21.9	41.0	69.2	12.2	31.3	18.8	37.1	36.7	24.5	17.8	12.2	31.4	25.9	17.5	24.6	31.9	52.6	28.2	47.8	19.2	64.0	20.0	11.2	45.2	19.0	6.6	26.2	31.9	17.6	12.2	15.9	7.1	13.0	11.8	34.4	17.7	31.3
TMED1	"Il1rl1l, IL1RL1LG, MGC1270, p24g1, p24gamma1, ST2L"	ENSG00000099203	"Transmembrane p24 trafficking protein 1"	Q13445	19	10832067-10836318	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Syncytiotrophoblasts: 146.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018507	Uncertain					NA	NA			"Cluster 22: NK-cells - Unknown function"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA018507: AB_1858063"	"unprognostic (6.98e-2)"	"unprognostic (3.42e-1)"	"unprognostic (3.03e-3)"	"unprognostic (1.28e-1)"	"unprognostic (8.65e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.98e-2)"	"unprognostic (4.20e-2)"	"unprognostic (9.86e-2)"	"unprognostic (7.27e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.93e-2)"	"prognostic favorable (8.66e-5)"	"unprognostic (9.49e-2)"	"unprognostic (2.56e-1)"	"unprognostic (5.16e-2)"	"unprognostic (2.45e-2)"	23.6	31.2	13.4	15.4	15.3	21.6	25.1	15.6	17.3	30.0	24.9	19.5	18.9	25.0	16.3	19.9	24.8	18.8	42.3	13.0	16.9	37.8	51.9	19.6	14.3	16.6	15.1	34.4	34.5	24.4	35.9	21.4	15.5	26.5	8.1	4.4	24.2	14.8	64.4	19.1	17.4	10.6	15.2	22.3	26.2	20.2	14.5	10.2	28.7	34.9	7.0	22.3	21.0	17.4	40.4	63.3	26.7	43.6	26.2	28.5	27.8	63.3	53.0	59.0	82.3	59.2	57.2	29.1	146.5	46.0	30.8	32.2	18.8	33.4	23.6	44.2	38.5	41.5	49.8	48.5	35.4	35.2	91.4	42.2	35.1	34.9	24.9	25.8	37.4	22.3	30.3	80.6	25.3	63.9	25.4	38.0	41.3	23.6	60.5	27.8	22.9	44.6	35.0	33.3	29.5	29.0	37.6	37.0	33.9	11.2	43.8	38.5	41.5	75.1	34.4	80.3	71.6	48.9	56.6	27.8	58.1	63.5	41.6	12.3	94.6	44.3	59.3	94.0	40.9	50.9	39.9	48.6	81.1	42.2	36.6	40.5	35.7	122.8	103.0	59.9	38.9	66.0	13.4	15.3	15.6	17.3	13.0	16.9	16.6	15.1	15.5	15.2	14.5	17.4	20.2	9.6	15.3	4.6	16.5	18.5	24.4	53.9	12.0	10.2	31.8	32.0	0.2	41.5	33.0	53.3	8.4	111.5	24.5	22.7	41.1	54.4	5.5	30.9	26.7	26.4	23.5	30.7	1.0	44.2	94.0	38.1	15.8	21.7	27.3	43.7	24.3	43.9	52.5	5.0	1.2	21.1	46.8	20.2	16.6	6.3	22.4	20.0	42.7	1.0	25.0	40.3	28.8	4.0	3.2	41.7	35.5	20.3	24.4	35.4	37.7	57.4	42.9	18.0	32.9	28.9	27.1	21.7	30.9	14.8	17.5	146.3	15.1	62.3	28.8	23.3
TMED10	"p23, P24(DELTA), p24d1, p24delta1, TMP21"	ENSG00000170348	"Transmembrane p24 trafficking protein 10"	P49755	14	75131469-75176612	"Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034442, CAB037251, HPA047139, HPA050539"	Enhanced		Supported	"Golgi apparatus"		NA	NA		220000	"Cluster 44: Non-specific - Transcription"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"CAB034442: AB_2204336, CAB037251: AB_1841216, HPA047139: AB_2679951, HPA050539: AB_2681163"	"unprognostic (2.00e-1)"	"unprognostic (1.73e-2)"	"unprognostic (2.02e-1)"	"unprognostic (2.51e-3)"	"unprognostic (4.06e-1)"	"unprognostic (1.17e-3)"	"unprognostic (5.88e-2)"	"unprognostic (1.21e-1)"	"unprognostic (3.68e-2)"	"unprognostic (6.46e-3)"	"unprognostic (1.01e-2)"	"unprognostic (1.27e-2)"	"unprognostic (1.36e-2)"	"unprognostic (1.43e-1)"	"unprognostic (2.82e-1)"	"prognostic unfavorable (8.67e-4)"	"unprognostic (2.06e-2)"	68.0	70.3	51.8	55.2	55.8	18.0	93.2	52.6	60.7	137.9	61.2	77.0	62.3	92.6	133.1	59.9	100.6	69.2	82.3	49.5	66.1	62.7	126.9	68.0	61.0	65.8	54.3	99.7	131.9	91.4	53.6	76.3	63.2	91.0	82.3	48.8	130.7	85.9	73.7	56.0	58.8	78.9	57.5	54.6	78.3	40.0	58.2	73.7	146.0	61.0	65.9	66.9	59.7	69.6	93.3	52.2	85.5	142.5	197.5	183.7	110.9	96.5	159.5	99.5	111.2	51.8	161.2	82.5	80.6	167.5	56.8	90.8	80.4	140.6	160.5	43.7	36.2	50.5	31.1	79.2	167.1	101.7	50.2	135.1	221.5	77.0	220.1	196.0	176.9	91.7	44.6	177.8	145.0	104.6	71.0	80.7	51.9	145.2	55.8	70.6	55.3	116.6	119.7	94.8	82.9	87.1	89.0	147.0	175.9	81.0	138.3	163.3	122.3	97.0	62.9	65.9	50.7	98.9	99.3	91.3	177.0	88.3	95.8	107.4	46.4	28.9	60.8	39.4	93.8	39.7	58.7	59.3	62.9	30.3	51.9	55.9	20.4	101.8	42.6	70.9	38.2	91.4	51.8	55.8	52.6	60.7	49.5	66.1	65.8	54.3	63.2	57.5	58.2	69.6	80.8	64.1	106.3	32.0	141.8	114.2	180.4	488.1	107.0	55.6	182.5	130.6	155.3	187.3	279.9	200.5	27.1	181.0	186.7	186.2	62.6	319.1	14.5	147.7	177.5	107.3	140.7	75.5	26.9	385.7	609.9	164.4	145.8	172.0	100.1	170.9	123.1	339.7	255.0	77.4	30.0	276.2	272.6	159.4	166.3	31.5	179.3	151.6	297.1	38.4	129.5	137.9	130.7	50.8	84.2	225.8	148.9	209.9	538.8	218.7	120.3	138.9	304.8	63.1	78.9	112.7	132.2	317.7	116.5	151.7	135.1	309.2	122.1	145.8	161.9	207.7
TMED2	"P24A, p24b1, p24beta1, RNP24"	ENSG00000086598	"Transmembrane p24 trafficking protein 2"	Q15363	12	123584533-123598582	"Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"ER-Golgi transport, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA014060	Approved		Supported	Vesicles		NA	NA		82000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Vesicles		"HPA014060: AB_1856389"	"unprognostic (6.36e-2)"	"unprognostic (3.38e-3)"	"unprognostic (5.41e-3)"	"unprognostic (1.75e-2)"	"unprognostic (2.98e-2)"	"prognostic unfavorable (3.36e-6)"	"unprognostic (3.57e-3)"	"unprognostic (2.20e-2)"	"unprognostic (4.31e-2)"	"unprognostic (9.76e-3)"	"unprognostic (1.03e-2)"	"unprognostic (3.94e-2)"	"prognostic unfavorable (2.35e-7)"	"unprognostic (2.97e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.51e-1)"	"unprognostic (9.87e-2)"	106.0	97.1	40.7	92.6	43.5	122.1	136.1	44.2	50.8	155.6	59.5	132.5	123.7	102.5	203.3	111.9	102.3	96.1	116.5	40.5	45.3	102.8	271.1	85.4	72.7	46.6	46.6	101.5	229.1	99.3	65.0	125.4	46.9	140.5	140.7	56.9	227.6	102.2	131.0	74.8	110.5	102.1	46.0	63.2	133.8	58.5	44.2	69.1	197.6	112.1	95.2	118.6	71.4	53.8	237.7	204.9	133.4	232.2	295.7	260.2	317.5	401.2	318.5	246.8	194.2	209.9	198.9	199.3	210.7	398.7	169.4	228.1	181.8	214.5	257.3	155.2	169.3	217.3	114.0	267.6	559.5	296.9	178.1	220.5	349.2	212.6	286.0	352.7	234.7	133.5	223.1	132.9	255.6	175.1	159.8	242.7	192.9	201.0	206.6	164.8	216.8	235.7	303.9	349.1	166.5	143.1	267.3	263.6	273.7	160.0	450.2	237.2	226.2	210.1	132.4	204.9	227.5	292.3	290.7	167.6	248.3	192.9	254.2	249.7	143.2	145.9	157.0	147.5	198.8	111.8	137.0	148.4	158.6	102.5	110.3	129.4	111.1	148.5	141.3	242.5	140.1	142.2	40.7	43.5	44.2	50.8	40.5	45.3	46.6	46.6	46.9	46.0	44.2	53.8	97.1	48.1	71.5	9.1	148.8	417.4	290.3	348.5	207.1	50.1	258.8	98.0	167.2	213.1	233.2	154.5	20.9	281.5	166.9	169.6	117.4	325.1	12.2	89.2	136.5	142.0	170.7	76.3	20.0	249.6	678.6	242.7	156.5	136.8	92.6	88.4	143.5	538.8	215.8	48.8	20.3	352.4	321.4	141.7	414.3	13.9	181.4	128.5	378.8	17.8	129.8	124.1	195.7	19.6	27.5	224.9	158.5	153.4	521.0	486.3	178.1	163.0	142.1	54.7	164.3	112.6	193.5	165.9	150.6	289.8	498.8	451.9	154.3	125.0	263.9	389.2
TMED3	"C15orf22, p24B, p24g4, p24gamma4"	ENSG00000166557	"Transmembrane p24 trafficking protein 3"	Q9Y3Q3	15	79311112-79427432	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"salivary gland: 409.4"	"Cell type enhanced"	"Detected in all"		"Extravillous trophoblasts: 294.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049314, HPA076949"	Enhanced		Supported	"Golgi apparatus"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"		"HPA049314: AB_2680708, HPA076949: AB_2686820"	"prognostic unfavorable (7.71e-4)"	"unprognostic (1.60e-1)"	"unprognostic (3.54e-3)"	"unprognostic (8.86e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.03e-3)"	"unprognostic (2.42e-2)"	"unprognostic (2.49e-1)"	"unprognostic (4.85e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.09e-2)"	"unprognostic (9.90e-2)"	"prognostic unfavorable (3.73e-4)"	"unprognostic (2.16e-1)"	"unprognostic (2.88e-1)"	"unprognostic (2.50e-1)"	"unprognostic (1.52e-1)"	25.9	26.2	19.6	23.1	19.2	37.0	66.4	21.5	20.5	56.6	30.6	49.9	25.4	38.3	138.7	132.3	38.7	37.8	41.9	20.8	31.9	34.7	12.4	30.9	26.0	22.4	22.0	30.9	246.7	54.9	89.6	42.4	26.5	60.0	55.4	11.3	409.4	54.6	4.6	106.8	26.6	37.3	21.6	32.4	73.1	35.0	22.6	23.1	76.3	7.2	37.8	48.7	75.1	25.1	68.1	169.0	31.9	63.6	220.3	167.5	69.0	153.0	206.7	103.3	126.9	141.4	123.3	31.5	117.3	236.0	135.9	124.5	95.7	98.5	53.0	62.7	145.6	104.5	143.0	110.3	131.5	112.2	200.4	126.5	144.4	59.6	86.9	123.5	120.8	105.9	47.1	0.6	101.4	144.3	32.1	106.0	45.7	251.6	92.2	39.1	47.4	158.9	94.2	51.4	99.4	48.8	80.6	162.1	159.3	103.5	141.5	81.7	98.5	85.2	75.7	2.2	111.4	61.7	78.8	44.1	109.8	180.7	103.1	74.9	69.8	95.1	58.1	85.3	62.7	75.5	57.2	63.9	106.7	63.6	71.4	69.1	6.0	61.4	95.7	109.1	73.1	92.2	19.6	19.2	21.5	20.5	20.8	31.9	22.4	22.0	26.5	21.6	22.6	25.1	9.9	28.9	43.6	6.8	41.2	95.8	109.4	125.6	64.9	14.9	153.8	132.8	16.9	55.8	108.5	57.0	8.4	167.8	40.7	67.7	23.5	143.4	48.9	31.6	39.6	31.7	83.9	33.7	10.0	250.5	294.5	68.1	54.6	70.4	47.0	44.0	65.7	6.4	100.5	13.5	10.2	219.3	87.5	52.7	54.4	118.6	49.7	49.2	85.4	9.4	60.0	38.0	44.3	17.1	12.9	173.3	79.9	27.4	71.1	165.2	43.9	28.9	37.7	17.0	19.7	25.6	57.0	51.1	60.3	104.7	121.8	172.4	30.4	64.6	126.4	200.1
TMED7	"CGI-109, FLJ90481, p24g3, p24gamma3"	ENSG00000134970	"Transmembrane p24 trafficking protein 7"	Q9Y3B3	5	115613210-115632992	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							"HPA008960, CAB025883"	Supported					NA	NA		13000	"Cluster 34: Basophils - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 27: Mucus-secreting cells - Mucin production"			"CAB025883: , HPA008960: AB_1080280"	"unprognostic (1.40e-1)"	"unprognostic (8.42e-2)"	"unprognostic (1.45e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.04e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.27e-1)"	"unprognostic (2.26e-3)"	"unprognostic (2.02e-1)"	"unprognostic (2.11e-2)"	"unprognostic (6.15e-3)"	"unprognostic (4.10e-2)"	"unprognostic (6.82e-2)"	"unprognostic (4.95e-2)"	"unprognostic (3.06e-1)"	"unprognostic (4.79e-2)"	"unprognostic (1.22e-1)"	35.0	41.2	23.1	29.5	31.9	31.8	37.8	31.2	32.7	50.5	37.8	42.1	36.9	41.2	70.2	32.4	38.6	33.5	43.5	21.9	24.6	54.2	80.2	30.5	23.4	39.8	27.2	31.0	35.2	53.6	28.0	43.8	28.1	48.7	42.3	19.2	43.4	44.3	22.0	18.9	38.3	45.0	33.3	25.9	41.5	18.9	28.5	19.5	79.8	24.9	24.1	37.6	22.6	44.8	63.6	42.4	43.8	54.7	112.3	84.4	68.1	109.8	116.4	79.7	129.8	36.3	110.1	33.1	105.7	115.1	99.5	49.6	41.3	128.0	125.7	76.0	34.4	30.5	39.2	76.8	119.8	31.9	59.0	78.2	60.5	76.1	95.8	100.4	78.5	22.3	29.6	44.5	87.1	30.1	24.0	28.5	30.8	37.7	35.5	25.9	65.1	63.8	98.6	44.6	33.3	39.8	90.0	52.3	68.1	41.7	63.0	41.8	80.1	109.0	46.3	79.2	66.3	29.3	24.0	33.5	88.7	52.2	61.8	25.5	23.8	20.2	14.9	23.1	15.3	10.4	11.5	13.3	19.3	9.1	11.1	12.0	16.3	14.2	18.5	13.3	11.5	20.7	23.1	31.9	31.2	32.7	21.9	24.6	39.8	27.2	28.1	33.3	28.5	44.8	37.8	38.5	29.8	0.0	26.9	45.6	30.1	35.3	15.4	31.5	47.4	21.5	42.4	61.5	29.3	46.0	10.4	44.2	30.6	63.8	13.7	37.4	28.7	34.5	48.9	30.6	87.3	9.1	0.0	28.3	103.6	51.8	34.1	45.6	10.1	20.4	44.3	114.2	50.1	30.3	0.0	85.8	24.4	51.6	55.5	20.1	46.9	38.4	51.6	0.0	36.8	52.6	19.6	0.0	0.0	37.4	39.9	53.4	13.9	60.5	50.0	42.2	36.9	25.8	39.5	42.9	43.1	39.2	18.0	25.3	44.0	82.8	23.6	33.9	46.9	55.6
TMEFF1	"C9orf2, CT120.1, H7365"	ENSG00000241697	"Transmembrane protein with EGF like and two follistatin like domains 1"	Q8IYR6	9	100473149-100577636	"Predicted membrane proteins, Transporters"		"Developmental protein"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	7	"brain: 28.9"	"Cell type enhanced"	"Detected in single"		"Endometrial stromal cells: 1.7"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 12.0;BEWO: 14.8;NTERA-2: 29.8;REH: 20.4;SCLC-21H: 25.4;SH-SY5Y: 16.9"	"Low region specificity"	"Detected in all"							HPA051501	Uncertain					NA	NA				"Cluster 70: Brain - Nervous system development"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 36: Stromal cells - Cell proliferation"			"HPA051501: AB_2681509"	"unprognostic (1.96e-1)"	"unprognostic (2.30e-1)"		"unprognostic (9.69e-3)"	"unprognostic (2.32e-2)"	"unprognostic (9.02e-2)"		"unprognostic (3.59e-2)"	"unprognostic (2.87e-2)"	"unprognostic (1.70e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.05e-1)"	"unprognostic (5.04e-6)"	"unprognostic (1.30e-4)"	"unprognostic (1.52e-1)"	"unprognostic (3.97e-2)"	"unprognostic (3.44e-3)"	0.0	0.0	6.1	0.0	16.2	0.0	0.0	10.3	10.7	0.4	0.0	0.4	0.0	0.7	0.0	0.0	0.0	0.2	0.0	9.0	9.3	0.0	0.0	0.0	0.1	13.8	12.7	0.3	0.0	0.0	0.2	0.3	13.2	0.2	0.0	0.2	0.0	0.1	0.0	0.0	0.1	0.1	8.4	0.1	0.1	4.0	13.6	0.2	0.8	0.1	0.0	0.0	0.1	28.9	0.0	0.0	12.0	0.6	0.1	0.4	14.8	0.9	0.2	0.6	0.8	0.8	0.1	0.0	2.7	0.4	0.2	0.0	4.6	0.0	0.7	0.0	6.7	0.0	0.3	0.7	0.6	0.0	0.0	0.4	0.0	0.7	0.2	0.5	1.9	5.3	0.2	0.0	0.9	0.1	7.7	0.0	29.8	0.0	0.4	20.4	10.3	0.0	0.5	0.0	25.4	16.9	0.1	0.0	0.4	6.8	0.0	0.1	2.7	2.3	3.9	0.1	0.9	4.6	3.5	4.5	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.1	16.2	10.3	10.7	9.0	9.3	13.8	12.7	13.2	8.4	13.6	28.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.4	1.7	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.0	0.1	0.0	0.1	0.0	0.1
TMEM101	"FLJ23987, MGC4251"	ENSG00000091947	"Transmembrane protein 101"	Q96IK0	17	44011188-44023946	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Group enriched"	"Detected in many"	5	"Endometrial ciliated cells: 237.2;Glandular and luminal cells: 507.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA039739, HPA075651"			Approved	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 44: Endometrium - Transcription"	"Nucleoplasm, Plasma membrane"		"HPA039739: AB_2676657, HPA075651: "	"unprognostic (1.40e-3)"	"unprognostic (1.75e-1)"	"unprognostic (1.67e-1)"	"prognostic favorable (4.29e-4)"	"unprognostic (5.91e-2)"	"unprognostic (3.91e-3)"	"prognostic unfavorable (7.10e-4)"	"unprognostic (1.80e-2)"	"unprognostic (2.43e-1)"	"unprognostic (2.03e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.61e-1)"	"prognostic favorable (4.10e-5)"	"unprognostic (1.59e-2)"	"unprognostic (2.02e-1)"	"unprognostic (1.48e-1)"	"unprognostic (2.32e-2)"	17.2	19.8	22.6	12.9	26.8	11.5	107.0	23.2	24.0	44.4	24.2	20.6	16.9	63.5	27.6	28.0	37.9	15.9	23.1	22.2	22.7	93.9	24.1	18.7	19.4	24.2	24.0	22.7	39.2	26.4	15.4	21.6	23.2	24.0	16.9	12.1	30.1	111.8	33.3	29.0	17.4	16.1	23.5	20.4	28.8	23.6	23.9	16.5	23.0	24.9	17.7	20.4	23.0	23.4	23.5	56.0	19.7	16.2	45.7	43.9	19.6	24.1	36.1	46.5	43.8	42.0	59.5	26.1	6.5	24.9	36.0	35.3	22.9	41.5	35.2	28.5	46.1	19.5	45.7	86.2	39.3	31.7	32.8	39.4	46.5	32.8	46.3	41.8	40.8	45.0	40.7	50.1	29.2	31.7	34.6	36.6	9.1	25.4	62.6	29.8	42.8	47.4	39.1	18.7	25.3	20.2	14.6	0.5	59.6	24.9	27.3	59.9	24.7	42.1	28.5	18.8	46.9	52.1	38.0	12.0	44.3	29.7	38.2	20.1	42.8	15.3	31.2	43.4	35.7	37.3	39.6	36.4	44.9	39.8	43.2	35.7	15.9	44.1	32.9	44.0	44.6	31.1	22.6	26.8	23.2	24.0	22.2	22.7	24.2	24.0	23.2	23.5	23.9	23.4	22.1	19.2	15.4	0.0	22.8	20.6	31.6	72.0	21.6	10.4	64.2	61.2	27.3	24.3	34.5	40.5	6.2	68.5	19.6	18.5	37.2	36.6	13.1	237.2	70.8	28.2	23.4	33.2	0.0	49.8	47.3	21.1	13.7	507.4	22.9	34.4	36.0	20.6	37.6	11.8	0.0	37.3	28.5	32.4	11.8	11.1	13.1	23.8	33.8	0.0	47.7	17.7	29.9	0.0	0.0	41.8	20.7	12.4	29.4	23.4	27.7	30.2	27.1	11.7	6.6	13.2	19.8	45.8	24.7	26.9	22.6	44.6	20.9	25.6	45.7	25.2
TMEM104	"FLJ00021, FLJ20255"	ENSG00000109066	"Transmembrane protein 104"	Q8NE00	17	74776499-74839753	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cardiomyocytes: 49.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044330	Approved		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 35: Non-specific - Unknown function"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 43: Cardiomyocytes - Nuclear processes"	Nucleoplasm	"Golgi apparatus"	"HPA044330: AB_10960543"	"unprognostic (1.05e-1)"	"unprognostic (1.42e-1)"	"unprognostic (2.70e-1)"	"unprognostic (1.71e-2)"	"unprognostic (5.95e-2)"	"unprognostic (4.99e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (7.46e-2)"	"unprognostic (2.86e-2)"	"unprognostic (4.75e-1)"	"prognostic favorable (1.97e-5)"	"unprognostic (8.14e-2)"	"unprognostic (6.17e-2)"	"unprognostic (8.46e-2)"	"unprognostic (7.95e-2)"	"unprognostic (2.82e-3)"	"unprognostic (1.00e-2)"	6.5	10.7	7.0	5.6	9.1	8.4	5.3	9.2	7.9	3.9	5.6	5.0	3.5	4.7	3.8	6.6	4.2	3.4	7.2	6.5	6.8	7.7	14.9	7.8	4.5	10.4	9.3	3.8	8.1	8.1	9.9	5.0	9.8	5.5	2.9	2.0	7.5	3.8	5.4	5.2	5.3	4.2	8.2	7.0	6.1	8.4	9.3	4.2	7.8	3.8	4.4	5.1	4.2	10.8	10.8	26.0	13.4	15.4	18.9	11.7	8.1	18.2	18.1	22.8	25.1	21.1	11.2	5.6	5.8	20.9	23.4	12.0	13.8	10.2	12.0	4.2	19.5	14.1	10.5	15.0	13.8	23.5	12.6	9.3	10.9	23.1	5.0	6.8	16.5	13.6	8.4	8.5	15.6	10.3	14.1	9.3	7.5	14.2	20.6	8.7	21.3	9.4	9.9	9.3	11.4	15.1	10.1	12.9	13.6	10.0	16.5	35.8	13.2	48.0	12.1	18.4	24.0	5.9	5.5	6.5	18.5	24.0	18.6	1.4	5.0	3.7	4.7	4.1	2.4	3.3	4.5	4.4	5.3	0.8	3.7	2.6	2.1	2.8	4.6	5.5	5.0	3.6	7.0	9.1	9.2	7.9	6.5	6.8	10.4	9.3	9.8	8.2	9.3	10.8	2.3	6.4	5.8	7.8	2.2	2.5	1.1	3.4	0.6	2.7	5.6	3.3	49.5	8.6	4.6	5.5	2.1	4.1	5.2	6.0	0.0	5.0	3.0	3.3	2.7	4.8	8.3	1.7	5.6	5.6	4.3	4.6	5.6	6.4	1.3	3.2	2.9	14.2	13.3	0.0	4.4	4.7	4.1	7.3	3.8	3.5	2.8	9.5	0.0	4.7	4.7	4.1	3.1	4.0	11.1	6.2	3.4	2.2	8.2	2.5	3.4	1.9	2.0	3.1	0.0	3.3	4.2	4.4	3.8	2.8	2.3	3.8	4.3	2.5	3.6	1.6
TMEM106A	MGC20235	ENSG00000184988	"Transmembrane protein 106A"	Q96A25	17	43211835-43220041	"Predicted membrane proteins, Transporters"	"Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 21.9"	"Cell type enhanced"	"Detected in many"		"Granulosa cells: 45.6;Hofbauer cells: 45.3;Kupffer cells: 44.8;Langerhans cells: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	4	"basophil: 26.7"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 26.7"	"Cell line enhanced"	"Detected in many"		"HMC-1: 16.8"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 40: Granulosa cells - Unknown function"				"unprognostic (9.71e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (9.61e-5)"	"unprognostic (4.95e-3)"	"unprognostic (8.62e-2)"	"unprognostic (1.79e-1)"	"unprognostic (9.11e-2)"	"unprognostic (1.76e-1)"	"unprognostic (5.77e-2)"	"unprognostic (2.01e-1)"	"unprognostic (2.99e-2)"	"unprognostic (6.08e-2)"	"unprognostic (7.89e-3)"	"unprognostic (1.39e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.30e-2)"	4.9	2.4	1.7	10.2	2.1	3.3	4.1	1.2	2.9	3.8	2.4	3.6	4.0	3.6	1.7	1.5	3.3	3.6	2.1	1.6	2.5	21.9	3.5	5.2	6.9	6.2	3.0	7.8	3.1	2.4	1.6	10.1	3.8	2.5	5.3	0.8	2.8	3.1	1.1	1.3	3.4	8.8	2.8	9.7	4.8	3.3	6.1	4.0	5.3	1.5	6.1	4.8	2.4	4.1	3.1	0.9	0.4	0.2	3.8	4.1	2.3	7.8	5.0	6.7	10.5	2.3	6.4	4.5	1.5	12.1	2.6	1.3	0.8	1.0	7.8	7.1	0.0	3.2	2.7	10.7	2.2	0.1	16.8	2.6	0.2	12.5	0.3	2.4	6.0	5.3	0.1	3.2	8.5	1.3	5.5	2.1	0.3	0.0	0.0	4.0	1.3	2.7	2.9	0.2	0.6	0.0	1.5	3.7	1.8	1.6	5.5	4.5	6.8	3.3	0.4	3.3	1.6	5.0	0.5	1.4	2.8	5.4	6.7	26.7	5.1	5.7	1.5	5.6	0.7	1.9	1.0	1.5	4.2	3.2	0.7	1.3	1.4	2.1	2.0	6.0	2.9	2.2	1.7	2.1	1.2	2.9	1.6	2.5	6.2	3.0	3.8	2.8	6.1	4.1	4.5	3.2	4.5	1.3	13.6	2.4	11.0	2.4	0.6	4.3	6.5	4.2	1.2	0.0	3.9	7.3	2.1	5.0	22.7	3.9	3.9	2.0	5.9	2.6	7.1	6.5	3.0	2.5	1.0	4.0	8.3	6.6	10.7	3.9	8.2	45.6	5.0	1.7	45.3	0.0	1.0	4.5	0.0	44.8	35.6	2.7	14.0	25.2	0.0	17.8	16.5	1.2	14.4	3.5	4.0	5.5	3.4	7.2	5.4	10.9	2.1	17.8	6.0	3.7	13.1	4.0	4.6	7.4	3.6	0.5	1.7	5.2	7.3	3.2	2.9	13.1
TMEM106B	"FLJ11273, MGC33727"	ENSG00000106460	"Transmembrane protein 106B"	Q9NUM4	7	12211270-12243367	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Transport		"Amyotrophic lateral sclerosis, Disease variant, Leukodystrophy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA058342	Approved		Supported	Endosomes,Lysosomes		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 33: Fibroblasts - ECM organization"	"Endosomes, Lysosomes"		"HPA058342: AB_2683684"	"unprognostic (5.29e-2)"	"unprognostic (2.34e-2)"	"unprognostic (4.20e-2)"	"unprognostic (6.20e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.87e-2)"	"unprognostic (3.50e-2)"	"unprognostic (5.89e-2)"	"unprognostic (4.44e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.01e-3)"	"unprognostic (2.09e-2)"	"unprognostic (1.75e-3)"	"unprognostic (5.52e-2)"	"unprognostic (3.06e-2)"	"unprognostic (2.16e-2)"	"unprognostic (1.70e-1)"	9.9	26.1	6.0	7.1	8.5	7.2	10.9	10.7	9.1	13.1	7.6	12.6	8.6	14.7	12.2	10.3	11.2	9.1	11.4	6.3	7.0	17.8	18.8	7.7	7.9	7.4	7.4	12.0	10.1	12.7	9.9	14.0	8.1	14.6	11.5	14.6	13.1	13.9	14.7	9.0	10.2	12.7	10.5	8.4	8.9	7.0	7.4	6.7	16.0	12.2	6.8	10.7	10.2	14.5	13.9	26.3	14.8	24.2	26.3	21.3	11.5	19.7	33.3	12.6	12.7	8.6	42.1	3.7	21.2	23.5	30.0	14.6	11.9	12.5	10.5	7.2	11.5	5.5	14.5	8.3	20.8	20.5	8.6	22.1	14.1	9.9	19.2	57.5	16.0	10.2	16.1	11.1	14.9	4.4	3.9	8.6	17.4	17.5	13.9	11.1	10.9	10.1	23.5	12.4	15.4	21.4	18.8	15.4	16.7	20.0	13.9	10.0	18.9	14.0	20.3	14.1	16.2	15.0	28.6	5.9	19.6	6.7	35.2	11.6	4.3	5.3	9.1	5.2	12.8	6.1	10.6	10.6	2.9	7.8	17.3	13.2	2.8	14.4	7.9	0.9	10.3	6.8	6.0	8.5	10.7	9.1	6.3	7.0	7.4	7.4	8.1	10.5	7.4	14.5	45.0	73.7	40.3	41.1	34.3	36.8	42.6	38.5	62.6	55.0	46.0	30.4	46.0	38.6	49.3	66.2	45.9	54.0	18.9	53.6	17.6	115.4	5.0	29.2	56.3	34.6	57.6	24.4	60.1	58.7	36.0	65.8	36.7	37.8	14.5	53.8	41.7	85.1	33.3	65.6	78.6	37.9	57.0	29.2	23.9	4.3	49.0	23.9	37.4	28.1	19.1	95.2	39.1	66.9	82.3	75.3	53.4	60.9	39.9	85.0	57.1	67.7	47.4	51.8	32.9	49.5	41.6	40.1	31.6	56.4	43.3	135.6	41.1	70.7	47.2	81.9
TMEM106C	MGC5576	ENSG00000134291	"Transmembrane protein 106C"	Q9BVX2	12	47963569-47968878	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 244.8;Muller glia cells: 268.4;Paneth cells: 208.3;Proximal enterocytes: 385.7;Undifferentiated cells: 220.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-937: 876.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047204	Enhanced					NA	Yes			"Cluster 35: T-regs - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"			"HPA047204: AB_2679982"	"unprognostic (1.63e-2)"	"unprognostic (5.84e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.40e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.04e-1)"	"prognostic unfavorable (5.27e-8)"	"unprognostic (1.05e-1)"	"unprognostic (1.90e-2)"	"unprognostic (1.52e-3)"	"unprognostic (3.60e-1)"	"unprognostic (7.29e-2)"	"prognostic favorable (4.62e-4)"	"unprognostic (1.12e-2)"	"unprognostic (1.16e-1)"	"unprognostic (2.57e-2)"	"unprognostic (1.83e-1)"	28.1	41.9	37.4	36.3	37.5	48.2	66.6	38.2	46.1	52.0	56.7	138.2	113.2	35.8	135.8	42.0	48.5	45.5	58.9	39.7	42.4	80.9	44.7	39.4	38.4	36.4	36.3	55.5	66.5	146.2	62.9	73.4	37.1	41.0	145.3	121.7	59.7	51.7	26.5	37.4	120.1	55.3	35.5	78.1	53.5	40.0	43.4	55.9	49.3	34.3	46.8	28.9	32.8	33.7	243.9	166.4	151.7	167.7	68.5	50.0	143.2	133.6	191.0	238.5	203.8	250.2	243.3	212.2	182.9	147.6	221.8	162.1	239.2	146.1	226.6	203.8	229.1	163.7	217.2	101.7	52.4	172.6	117.9	34.4	98.4	217.8	114.2	163.4	154.2	224.0	113.4	235.6	169.6	174.4	248.2	75.5	27.0	258.7	226.5	217.9	195.9	180.9	127.2	183.2	100.9	120.5	206.8	138.5	142.4	78.4	503.5	136.9	38.3	99.8	168.9	145.0	240.9	130.8	228.9	240.1	127.3	876.5	97.9	39.3	8.8	23.9	44.4	8.6	54.9	36.9	42.8	46.5	12.5	30.8	39.7	44.0	7.6	19.6	10.4	1.9	66.4	41.0	37.4	37.5	38.2	46.1	39.7	42.4	36.4	36.3	37.1	35.5	43.4	33.7	14.5	32.1	20.7	6.8	26.5	47.9	39.2	45.8	36.5	30.2	54.9	78.7	39.1	61.5	21.9	35.0	18.8	75.3	17.7	244.8	86.1	63.8	2.8	35.7	5.7	17.3	36.0	49.2	14.1	45.1	32.8	45.4	37.2	18.6	10.8	86.3	55.0	19.6	54.3	30.3	13.0	150.8	101.7	16.4	20.7	6.8	32.6	21.5	21.4	8.4	10.1	268.4	27.8	4.5	1.2	35.5	208.3	41.3	72.5	22.6	385.7	82.2	11.5	47.2	13.1	46.4	36.9	52.8	36.0	55.4	40.9	14.9	31.5	35.0	220.5	39.4
TMEM109	MGC5508	ENSG00000110108	"Transmembrane protein 109"	Q9BVC6	11	60914158-60923443	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011785	Approved		Approved	"Nuclear membrane,Cytosol"		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	"Nuclear membrane, Cytosol"		"HPA011785: AB_1858075"	"unprognostic (5.23e-2)"	"unprognostic (9.02e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.69e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.40e-2)"	"unprognostic (5.29e-3)"	"unprognostic (2.95e-1)"	"unprognostic (2.70e-1)"	"unprognostic (2.40e-2)"	"unprognostic (2.52e-1)"	"unprognostic (3.63e-2)"	"unprognostic (1.83e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.84e-2)"	"prognostic unfavorable (2.68e-4)"	83.0	46.4	22.2	44.4	23.2	27.0	71.9	23.3	25.5	85.4	42.1	75.1	26.2	97.7	26.7	93.8	73.7	35.7	84.0	19.8	23.2	47.3	32.1	71.8	48.0	26.7	24.5	81.5	46.1	67.3	41.1	46.8	25.4	52.4	27.0	14.3	81.8	60.8	99.4	69.7	47.8	70.0	25.9	58.1	58.2	14.4	25.5	41.4	57.3	77.0	50.3	70.4	79.9	24.7	111.5	103.5	63.3	102.1	169.4	77.7	51.5	107.3	100.4	118.5	99.8	94.5	115.7	131.5	190.4	130.1	69.9	143.5	73.2	48.8	72.5	102.5	97.0	96.2	44.3	21.1	50.2	188.4	77.0	54.1	61.6	92.9	46.8	41.9	148.1	104.8	48.4	330.4	85.4	217.2	139.9	80.8	104.6	62.8	111.4	132.3	123.9	183.0	56.6	63.6	25.3	44.4	86.2	196.8	102.7	44.8	110.4	35.8	143.7	136.9	65.9	174.4	95.8	108.7	89.5	69.9	121.2	82.0	159.7	39.0	76.0	56.4	188.7	69.5	193.3	116.5	108.4	161.4	227.4	140.4	97.4	124.8	8.2	121.1	52.4	470.0	91.1	139.4	22.2	23.2	23.3	25.5	19.8	23.2	26.7	24.5	25.4	25.9	25.5	24.7	118.2	70.5	23.2	5.5	60.2	50.7	43.8	30.9	63.7	13.4	39.5	45.3	34.6	25.8	23.9	25.8	0.0	120.7	83.4	6.8	25.4	76.6	20.7	18.7	25.9	91.2	7.2	33.0	5.3	80.2	116.4	75.9	10.7	27.9	50.7	22.2	71.0	18.9	66.8	30.3	3.8	10.1	22.4	21.3	69.1	11.1	89.5	43.4	51.6	11.2	45.4	30.2	68.0	3.5	5.1	53.1	14.7	97.4	38.4	36.5	10.6	17.1	18.7	34.8	39.5	45.0	67.6	5.9	7.2	55.1	50.6	53.2	52.7	25.8	16.8	33.9
TMEM117	DKFZp434K2435	ENSG00000139173	"Transmembrane protein 117"	Q9H0C3	12	43835967-44389762	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	5	"Astrocytes: 65.6;Excitatory neurons: 220.2;Inhibitory neurons: 190.3;Microglial cells: 80.6;Oligodendrocyte precursor cells: 123.1;Oligodendrocytes: 152.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046223	Uncertain					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA046223: AB_10960636"	"unprognostic (1.37e-2)"	"unprognostic (2.99e-1)"	"unprognostic (4.32e-1)"	"unprognostic (2.39e-2)"	"unprognostic (3.57e-2)"	"unprognostic (7.08e-2)"	"unprognostic (3.07e-1)"	"unprognostic (7.33e-2)"	"prognostic unfavorable (3.94e-4)"	"unprognostic (2.89e-1)"	"unprognostic (6.26e-2)"	"unprognostic (1.99e-3)"	"unprognostic (1.74e-2)"	"unprognostic (2.30e-2)"	"unprognostic (2.65e-1)"	"unprognostic (9.20e-3)"	"unprognostic (3.80e-1)"	1.8	1.9	0.9	1.2	1.4	0.1	2.7	1.5	2.1	3.8	8.8	3.4	6.0	4.0	2.6	5.8	2.3	3.5	4.2	1.3	1.3	2.2	2.1	1.1	1.4	2.4	1.5	2.5	3.7	4.1	1.7	3.0	2.8	3.5	3.5	2.3	2.1	5.2	3.3	4.0	4.2	4.0	1.4	0.7	2.1	2.4	1.3	0.9	2.3	3.3	2.3	4.1	3.8	2.6	1.2	0.4	4.0	6.7	4.5	9.6	0.1	12.6	6.2	2.3	2.7	10.0	4.3	4.5	0.9	9.0	0.6	6.4	2.6	2.8	1.7	1.9	7.4	1.2	2.5	4.0	1.3	1.8	4.7	5.0	9.9	1.3	0.7	9.2	0.4	0.5	2.2	1.9	4.4	1.1	0.0	1.1	0.8	0.0	2.4	3.0	4.5	1.8	4.5	2.7	0.6	6.1	4.8	1.5	10.2	1.6	0.3	4.7	1.5	3.4	1.1	1.8	3.3	3.4	3.9	2.6	1.7	2.0	1.2	0.0	0.0	0.0	1.2	0.0	1.7	1.0	0.3	1.2	0.0	0.9	0.5	0.6	0.0	0.4	0.0	0.1	0.2	0.4	0.9	1.4	1.5	2.1	1.3	1.3	2.4	1.5	2.8	1.4	1.3	2.6	3.2	0.0	1.3	65.6	8.4	6.5	4.8	3.4	9.6	3.9	2.4	2.8	5.4	2.8	2.5	7.3	4.2	15.0	2.8	6.9	3.9	2.8	25.8	3.9	5.5	2.1	0.0	1.7	220.2	3.0	2.7	3.8	18.3	6.0	2.5	6.0	4.2	2.7	5.6	5.0	190.3	4.2	12.2	3.8	2.5	9.5	6.2	2.1	12.4	80.6	0.1	3.4	3.1	123.1	152.4	2.5	19.2	6.4	11.2	2.1	13.8	1.3	2.7	5.2	0.0	2.2	3.8	1.4	5.5	17.7	12.1	11.5	5.1	2.3	5.0	4.9
TMEM119	OBIF	ENSG00000183160	"Transmembrane protein 119"	Q4V9L6	12	108589851-108598320	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Biomineralization, Differentiation, Osteogenesis, Spermatogenesis"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in some"		"Early spermatids: 8.3;Fibroblasts: 30.5;Late spermatids: 9.3;Melanocytes: 8.8;Microglial cells: 15.0;Peritubular cells: 24.0;Smooth muscle cells: 9.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"ASC diff: 559.2;ASC TERT1: 152.6;BJ hTERT+: 168.0;fHDF/TERT166: 81.9;HSkMC: 238.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051870, HPA052650"	Enhanced					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 33: Fibroblasts - ECM organization"			"HPA051870: AB_2681645, HPA052650: AB_2681901"	"unprognostic (4.90e-2)"	"unprognostic (2.66e-1)"	"unprognostic (6.84e-2)"	"unprognostic (5.97e-2)"	"unprognostic (2.35e-1)"	"unprognostic (3.29e-2)"	"unprognostic (6.67e-2)"	"unprognostic (8.40e-2)"	"unprognostic (1.51e-1)"	"prognostic unfavorable (8.37e-4)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-1)"	"prognostic unfavorable (2.06e-6)"	"unprognostic (1.29e-2)"	"unprognostic (8.76e-3)"	"unprognostic (1.40e-2)"	"unprognostic (1.87e-2)"	29.6	8.0	7.6	16.2	8.9	3.0	27.1	8.5	9.2	61.0	5.3	12.6	15.1	18.9	14.1	6.9	11.9	35.8	9.4	7.7	9.3	6.0	0.9	37.6	47.8	17.2	12.1	1.4	7.5	5.6	6.1	6.6	14.9	12.7	15.1	0.9	6.8	26.0	1.6	13.9	23.1	11.2	13.4	11.4	10.5	5.9	16.4	5.1	21.7	1.7	27.2	32.2	18.4	21.9	0.1	0.3	1.3	0.7	559.2	152.6	0.8	11.8	168.0	0.4	3.0	0.2	0.6	0.3	0.4	81.9	0.3	0.2	0.1	0.2	0.1	0.5	0.0	0.3	0.6	1.0	7.2	0.3	1.2	238.4	0.3	7.0	0.1	0.7	0.1	0.2	0.5	0.5	0.5	0.7	0.3	1.6	0.1	0.0	0.9	0.6	0.9	0.8	0.1	0.7	0.2	39.5	0.0	0.3	0.3	4.5	0.2	1.8	1.2	13.1	0.4	11.2	0.5	2.6	3.1	0.6	6.8	0.5	0.1	1.4	0.2	0.3	0.2	0.1	0.2	0.2	0.4	0.2	0.1	0.4	0.3	0.3	1.4	0.2	0.4	0.2	0.1	0.1	7.6	8.9	8.5	9.2	7.7	9.3	17.2	12.1	14.9	13.4	16.4	21.9	1.3	0.0	0.0	0.0	0.2	3.8	0.1	0.0	0.6	0.0	0.2	0.1	0.3	0.0	0.0	0.0	0.0	0.3	1.5	0.0	0.0	0.0	8.3	0.2	5.8	1.3	0.0	0.0	0.0	0.0	0.2	30.5	0.0	0.2	0.0	0.0	0.7	0.0	1.4	0.0	0.0	0.0	0.0	1.9	4.4	9.3	4.1	1.1	8.8	15.0	1.6	0.0	0.0	0.0	0.0	0.1	1.1	24.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.8	9.7	0.1	0.1	0.0	3.7	0.3	0.7	0.5	0.0	0.1
TMEM120A	"NET29, TMPIT"	ENSG00000189077	"Transmembrane protein 120A"	Q9BXJ8	7	75986831-75994656	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 289.1;Late spermatids: 1002.1;Proximal enterocytes: 414.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 223.0"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"									NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 25: Spermatids - Spermatogenesis"				"unprognostic (1.78e-2)"	"unprognostic (3.35e-2)"	"unprognostic (1.71e-2)"	"unprognostic (4.03e-2)"	"unprognostic (1.00e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.26e-1)"	"unprognostic (2.75e-3)"	"unprognostic (6.16e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.31e-2)"	"unprognostic (1.02e-1)"	"unprognostic (6.58e-2)"	"unprognostic (6.61e-2)"	"unprognostic (1.71e-1)"	"unprognostic (5.15e-2)"	54.4	95.0	33.9	11.0	32.7	13.9	44.4	36.9	40.6	33.1	33.2	33.7	50.6	22.6	21.6	31.8	32.0	16.6	111.9	32.3	34.4	38.9	84.7	25.0	10.1	57.6	36.1	56.1	43.2	17.4	20.0	15.6	61.5	26.5	14.8	6.1	24.7	23.3	79.3	18.5	63.4	11.0	31.2	28.2	44.3	77.1	34.7	8.0	19.4	94.4	12.0	32.9	27.3	31.8	10.3	15.3	7.7	61.7	52.1	35.1	16.9	10.0	27.8	13.7	17.2	26.8	14.3	4.8	7.6	30.4	39.1	11.8	7.6	10.3	4.7	9.0	8.5	5.2	10.6	38.2	50.6	2.1	32.6	37.5	9.2	10.1	12.2	14.3	22.4	8.7	9.8	7.9	24.5	18.5	3.3	32.6	3.5	23.7	16.3	3.5	7.8	23.6	28.2	9.3	3.8	18.0	11.4	32.5	16.7	19.1	22.7	15.4	12.8	38.1	12.0	22.1	8.6	8.5	7.0	2.2	20.7	5.3	8.9	106.6	58.0	109.5	26.4	53.7	20.0	15.8	21.7	20.5	27.2	17.9	15.1	14.8	223.0	31.2	55.2	10.7	50.9	46.5	33.9	32.7	36.9	40.6	32.3	34.4	57.6	36.1	61.5	31.2	34.7	31.8	22.4	22.4	12.3	12.7	14.1	0.0	18.1	0.0	18.8	5.6	36.2	22.2	112.7	51.5	8.6	27.6	6.2	20.9	17.6	133.9	25.4	50.3	289.1	9.8	29.3	21.4	8.4	11.4	4.1	38.9	16.2	36.0	31.1	18.1	24.6	172.6	29.3	115.6	36.1	11.8	7.2	40.5	0.0	34.2	0.0	1002.1	40.4	36.0	0.0	3.7	23.7	12.8	18.6	4.0	7.3	40.0	108.9	30.9	24.6	17.4	414.8	118.0	4.4	7.0	39.5	46.0	31.2	113.4	15.4	33.1	0.0	10.9	20.0	31.0	43.6	28.1
TMEM126A	"DKFZp586C1924, OPA7"	ENSG00000171202	"Transmembrane protein 126A"	Q9H061	11	85647967-85656547	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046648	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Cytosol	Nucleoplasm	"HPA046648: AB_2679737"	"unprognostic (3.79e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.08e-3)"	"unprognostic (1.08e-3)"	"unprognostic (2.08e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (8.60e-5)"	"unprognostic (8.25e-2)"	"unprognostic (6.00e-3)"	"unprognostic (2.66e-2)"	"unprognostic (1.02e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.87e-2)"	"unprognostic (2.70e-1)"	"unprognostic (6.94e-2)"	"unprognostic (2.17e-1)"	31.9	28.0	40.3	23.1	41.5	43.8	33.5	41.4	52.3	21.8	39.5	28.0	32.6	20.0	31.2	27.2	19.8	19.9	82.1	41.4	42.3	33.1	49.0	20.5	27.3	40.7	40.6	21.0	33.9	26.3	22.2	22.8	41.5	23.5	29.3	23.9	31.3	19.5	81.6	19.4	26.0	27.6	41.1	21.0	32.8	38.5	41.4	24.2	26.6	98.7	27.8	30.5	20.1	42.4	46.7	53.2	50.9	33.0	67.2	66.7	38.0	55.9	60.1	82.3	77.6	65.9	67.5	25.4	61.3	69.2	32.0	48.9	53.8	59.5	70.7	72.5	31.0	72.5	56.9	73.7	82.4	89.0	54.8	58.0	65.8	73.1	78.0	43.5	71.6	72.2	51.1	39.0	86.2	57.5	48.6	112.3	48.1	175.1	68.4	48.3	49.5	79.2	54.5	57.0	34.3	34.7	49.4	72.9	44.7	44.5	88.1	64.4	42.8	70.4	52.7	134.6	65.3	27.5	54.4	70.4	37.0	63.6	85.2	6.6	23.9	11.6	21.2	28.1	26.0	29.8	26.4	23.8	32.9	27.3	24.4	24.1	1.9	15.1	23.4	24.7	26.4	18.7	40.3	41.5	41.4	52.3	41.4	42.3	40.7	40.6	41.5	41.1	41.4	42.4	40.5	28.9	24.3	12.7	39.6	31.7	55.3	87.9	29.6	14.8	45.8	62.1	110.8	28.6	57.5	38.6	6.2	67.8	38.5	23.6	146.8	51.0	147.8	26.8	32.8	36.7	21.7	46.1	8.6	93.2	73.3	40.8	23.4	24.2	37.4	33.6	26.7	68.5	94.6	8.4	9.0	46.6	40.7	54.4	43.3	80.6	29.5	48.4	33.8	5.6	66.3	35.1	38.1	8.5	11.8	64.5	34.8	26.7	45.4	73.4	61.8	109.4	39.7	21.9	19.7	40.0	40.9	119.0	57.9	49.4	42.1	52.9	42.1	42.2	57.1	71.2
TMEM126B	HT007	ENSG00000171204	"Transmembrane protein 126B"	Q8IUX1	11	85628573-85636539	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Chaperone	"Disease variant, Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014480, HPA019186"	Uncertain		Supported	Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 68: Epididymis - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria		"HPA014480: AB_1858083, HPA019186: AB_1858084"	"unprognostic (1.11e-1)"	"unprognostic (4.97e-2)"	"unprognostic (1.10e-1)"	"unprognostic (2.79e-2)"	"unprognostic (5.67e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.55e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.45e-2)"	"unprognostic (6.70e-3)"	"unprognostic (4.42e-2)"	"unprognostic (4.30e-2)"	"unprognostic (1.94e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.50e-2)"	"unprognostic (5.86e-2)"	"unprognostic (2.66e-2)"	16.1	16.7	29.2	13.0	29.4	6.5	19.3	28.9	38.9	18.2	25.9	21.4	19.6	19.3	30.7	14.3	15.8	17.3	24.7	30.4	31.7	15.3	17.2	15.8	18.7	29.7	30.0	16.4	15.9	11.0	20.8	13.3	30.9	17.0	17.6	18.6	15.7	14.1	16.2	13.8	19.8	21.4	30.1	16.5	17.6	10.9	30.2	16.0	16.8	20.1	17.5	18.6	14.8	32.3	37.9	29.8	33.1	16.0	60.2	49.6	10.6	33.1	36.1	25.6	38.1	84.8	37.1	39.9	72.2	27.1	28.6	45.0	53.2	33.0	23.8	56.5	49.7	30.1	49.1	36.1	35.6	75.4	34.7	37.9	38.3	38.6	47.0	41.1	38.6	49.5	72.5	31.2	58.8	47.9	29.4	91.3	36.1	129.6	50.1	25.0	25.4	33.6	49.5	42.1	30.8	19.1	31.2	24.9	31.9	42.5	50.1	45.4	20.5	38.2	26.5	96.9	35.4	14.6	91.1	47.7	19.4	60.4	20.6	21.5	15.6	7.9	19.0	18.2	24.8	18.3	23.4	23.5	20.1	17.7	23.3	23.4	5.9	23.4	14.5	18.4	25.9	15.9	29.2	29.4	28.9	38.9	30.4	31.7	29.7	30.0	30.9	30.1	30.2	32.3	44.9	22.4	40.7	16.6	34.6	26.1	32.2	80.8	22.8	32.5	36.8	31.1	87.3	54.3	57.2	40.5	14.6	41.0	54.2	33.6	168.3	76.0	5.4	27.2	39.2	46.1	34.6	34.5	19.3	49.0	54.5	45.1	15.8	25.8	42.5	27.8	42.5	43.6	84.1	23.5	20.1	41.3	81.4	47.4	44.6	8.3	66.5	43.5	72.9	9.4	48.8	79.0	80.3	20.6	29.7	51.5	52.8	88.4	22.4	35.3	56.5	162.9	51.3	31.2	39.5	30.0	43.8	34.4	46.8	23.1	36.9	25.2	49.7	45.4	52.0	45.4
TMEM132A	"FLJ20539, GBP, HSPA5BP1"	ENSG00000006118	"Transmembrane protein 132A"	Q24JP5	11	60924460-60937159	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"brain: 187.8;choroid plexus: 117.3"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 82.3;Ductal cells: 80.0;Horizontal cells: 254.1;Muller glia cells: 188.8;Rod photoreceptor cells: 165.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"EFO-21: 174.1;MCF7: 177.8;SK-BR-3: 176.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051979, HPA060492"	Enhanced	Supported	Approved	Mitochondria		No	No		4100000		"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA051979: AB_2681681, HPA060492: "	"unprognostic (2.52e-2)"	"unprognostic (2.01e-1)"	"unprognostic (3.75e-2)"	"prognostic favorable (1.98e-5)"	"unprognostic (7.94e-3)"	"unprognostic (3.74e-1)"	"unprognostic (4.42e-3)"	"unprognostic (2.39e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.30e-1)"	"unprognostic (2.88e-1)"	"unprognostic (5.98e-2)"	"prognostic unfavorable (1.55e-9)"	"unprognostic (3.31e-1)"	"unprognostic (9.74e-2)"	"unprognostic (1.50e-1)"	"unprognostic (8.41e-3)"	7.7	21.0	137.9	8.6	134.3	0.3	7.7	119.4	187.8	12.0	117.3	5.5	2.5	13.6	1.2	19.5	4.8	5.5	13.7	134.1	136.9	13.9	2.1	10.1	1.7	154.5	131.2	18.8	6.8	12.4	23.6	16.6	126.4	9.4	1.0	28.1	25.9	1.8	3.9	6.1	6.0	3.7	123.0	5.7	32.4	6.7	144.6	1.3	4.8	3.1	5.4	4.2	9.2	114.7	37.0	50.7	44.1	88.0	3.6	1.7	78.1	27.0	84.5	24.6	20.3	18.0	33.3	0.3	174.1	7.8	79.9	67.6	10.3	46.0	9.5	0.5	14.8	1.1	33.3	32.7	30.8	0.5	1.3	7.7	8.6	45.8	7.1	38.7	42.1	7.0	2.3	2.3	7.8	177.8	0.9	0.2	58.5	1.2	26.9	0.4	18.6	4.2	36.4	18.7	43.7	104.1	19.3	176.4	16.7	22.3	123.7	0.6	49.4	9.5	43.2	2.7	52.3	0.4	0.3	2.1	78.5	0.1	46.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	137.9	134.3	119.4	187.8	134.1	136.9	154.5	131.2	126.4	123.0	144.6	114.7	11.8	0.0	0.0	82.3	0.6	1.3	2.7	56.2	5.7	62.8	17.1	11.7	0.8	4.3	22.2	5.5	18.8	31.4	0.1	0.7	1.9	80.0	0.5	12.4	7.0	11.9	15.6	0.0	22.6	13.3	28.7	7.7	9.2	27.7	0.0	57.5	11.4	0.0	3.3	254.1	29.1	2.7	20.3	0.3	1.0	1.0	1.8	0.7	0.0	7.5	3.1	188.8	0.0	12.1	3.3	63.2	1.6	3.4	0.0	9.7	0.0	0.4	4.0	165.3	6.6	4.4	15.2	1.2	4.0	5.7	0.9	27.1	0.3	19.2	2.3	7.2
TMEM132E	DFNB99	ENSG00000181291	"Transmembrane protein 132E"	Q6IEE7	17	34579487-34639318	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 17.9"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 4.1;Inhibitory neurons: 6.4;Oligodendrocyte precursor cells: 13.0;Proximal tubular cells: 11.5"	"Cancer enriched"	"Detected in some"	4	"glioma: 7.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	9	"RPMI-8226: 37.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA070608	Approved		Approved	"Nucleoplasm,Nuclear bodies,Golgi apparatus,Cytosol"		NA	NA		170000	"Cluster 40: NK-cells - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Nucleoplasm, Golgi apparatus"	"Nuclear bodies, Cytosol"	"HPA070608: AB_2686286"	"unprognostic (1.92e-1)"	"unprognostic (1.68e-1)"	"unprognostic (3.29e-5)"	"unprognostic (3.37e-1)"	"unprognostic (1.37e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.72e-1)"	"unprognostic (1.80e-1)"	"unprognostic (1.56e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.25e-1)"	"prognostic unfavorable (1.55e-4)"	"unprognostic (1.67e-2)"	"unprognostic (1.51e-2)"	"unprognostic (2.65e-1)"	"unprognostic (8.71e-2)"	0.3	0.1	4.6	0.0	3.0	0.0	0.1	6.1	6.4	0.4	0.0	0.1	1.2	0.1	0.0	0.1	0.1	0.1	0.5	2.6	6.2	3.6	0.4	0.1	0.1	17.9	5.1	0.2	0.0	0.0	0.1	0.1	10.2	0.1	0.0	0.1	0.2	0.1	0.0	0.1	0.7	0.1	8.7	0.3	0.1	1.9	6.5	0.0	0.2	0.0	0.1	0.1	0.2	11.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	1.1	4.3	0.0	0.0	0.0	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	37.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.2	0.0	0.0	0.0	0.0	4.6	3.0	6.1	6.4	2.6	6.2	17.9	5.1	10.2	8.7	6.5	11.1	0.1	0.0	0.0	2.6	0.1	0.3	0.0	0.0	0.0	1.9	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.1	0.0	0.0	4.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	6.4	0.0	0.0	1.9	0.7	2.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	13.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	11.5	0.0	0.1	0.0	0.2	0.5	1.2	2.5	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TMEM134	FLJ21749	ENSG00000172663	"Transmembrane protein 134"	Q9H6X4	11	67461710-67469272	"Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043744	Approved		Supported	Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Cytosol		"HPA043744: AB_10794773"	"unprognostic (1.44e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.22e-1)"	"unprognostic (4.67e-2)"	"unprognostic (8.66e-2)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-1)"	"unprognostic (7.22e-2)"	"unprognostic (3.85e-1)"	"unprognostic (1.39e-2)"	"unprognostic (4.30e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.12e-2)"	"unprognostic (1.70e-1)"	"unprognostic (1.30e-2)"	"unprognostic (4.43e-3)"	12.6	24.3	22.5	8.6	23.2	4.7	14.8	21.2	29.9	15.6	19.9	14.0	8.3	9.6	11.0	55.5	10.2	6.5	46.8	21.6	22.2	25.2	33.9	11.2	11.9	22.8	22.6	8.6	42.9	7.9	8.7	5.3	22.4	25.7	4.5	2.8	20.6	7.3	57.4	57.5	14.5	4.4	22.7	16.2	22.4	26.5	22.9	6.6	13.5	26.0	8.8	15.9	25.4	22.5	12.3	4.6	6.5	14.0	4.3	7.3	7.2	2.5	4.6	2.9	1.2	5.8	14.3	11.7	27.2	6.2	9.2	10.0	2.9	10.7	1.8	11.3	4.9	2.2	4.5	5.9	6.6	2.3	3.2	7.3	13.4	2.3	7.7	12.7	3.0	7.9	3.0	6.6	6.3	29.0	13.3	8.6	11.0	20.4	16.3	6.5	3.8	38.5	11.3	12.5	6.0	13.3	9.1	14.2	28.6	4.4	34.5	2.3	5.8	10.4	9.0	12.5	3.3	27.8	19.4	8.2	15.6	3.0	8.5	58.2	54.3	98.5	71.4	132.7	78.8	203.7	84.2	80.6	66.6	195.7	85.6	80.6	25.7	90.2	176.0	87.3	123.9	73.3	22.5	23.2	21.2	29.9	21.6	22.2	22.8	22.6	22.4	22.7	22.9	22.5	43.3	16.0	41.5	11.8	83.0	90.0	87.7	177.7	99.0	29.3	139.9	173.4	53.4	60.1	93.5	68.0	10.4	69.5	46.5	64.7	133.1	95.0	50.2	53.0	35.3	36.6	71.4	22.3	9.4	126.0	147.9	31.3	120.3	73.4	23.4	52.5	29.3	69.6	84.0	11.8	8.2	100.3	97.6	43.6	49.3	46.2	20.8	49.0	110.3	2.8	61.2	39.5	63.8	9.5	14.1	189.9	81.7	24.8	47.2	142.6	150.8	148.9	75.0	29.5	6.6	24.4	45.9	105.8	80.1	185.1	180.1	72.8	53.3	37.6	73.5	152.2
TMEM139	FLJ90586	ENSG00000178826	"Transmembrane protein 139"	Q8IV31	7	143279957-143288048	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"intestine: 33.8;kidney: 32.2"	"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 51.5;Ductal cells: 49.0;Proximal enterocytes: 90.7;Proximal tubular cells: 89.1"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 22.4;CAPAN-2: 40.8;EFO-21: 27.9;RPTEC TERT1: 70.5;SK-BR-3: 25.0;T-47d: 68.5"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA036982, HPA036983"	Approved		Approved	"Plasma membrane,Focal adhesion sites"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	"Plasma membrane"	"Focal adhesion sites"	"HPA036982: AB_2675413, HPA036983: AB_10672275"	"unprognostic (2.58e-1)"	"unprognostic (4.38e-1)"	"unprognostic (6.62e-3)"	"unprognostic (1.41e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.16e-3)"	"unprognostic (2.83e-2)"	"unprognostic (4.90e-2)"	"unprognostic (1.60e-1)"	"unprognostic (2.82e-2)"	"prognostic unfavorable (1.66e-4)"	"unprognostic (2.89e-1)"	"prognostic favorable (3.05e-5)"	"unprognostic (1.73e-1)"	"unprognostic (1.42e-2)"	"unprognostic (2.83e-2)"	"unprognostic (9.08e-3)"	1.1	2.7	1.9	2.2	6.4	0.0	3.2	6.6	3.2	8.9	2.9	5.7	33.8	1.2	1.3	0.4	6.8	7.2	3.3	1.6	4.1	32.2	9.2	5.1	0.2	10.5	6.9	0.4	8.7	6.8	1.8	5.2	8.9	0.9	4.5	0.8	4.8	3.1	0.1	1.2	19.3	0.4	5.9	0.9	2.5	3.8	5.7	0.0	7.2	0.0	0.1	1.8	0.3	13.9	22.4	1.6	0.3	0.1	0.0	0.0	14.3	0.2	0.0	0.0	0.0	5.2	40.8	0.3	27.9	0.0	1.8	18.5	0.0	9.3	0.0	0.3	0.0	0.0	2.4	3.1	0.0	0.2	0.1	0.0	0.0	0.0	0.2	0.9	0.0	1.3	0.0	0.5	0.0	1.5	1.6	1.0	0.0	0.5	1.6	0.4	0.3	0.0	70.5	5.6	0.4	0.1	1.1	25.0	0.2	0.5	68.5	0.0	0.0	0.3	0.7	0.0	0.1	0.0	0.1	0.3	0.3	0.3	0.3	0.0	0.0	0.2	0.0	0.8	0.0	0.1	0.3	0.2	0.0	0.0	0.3	0.1	0.0	0.0	0.8	0.0	0.6	0.1	1.9	6.4	6.6	3.2	1.6	4.1	10.5	6.9	8.9	5.9	5.7	13.9	0.6	16.0	5.9	0.7	0.2	0.1	2.1	2.8	0.0	0.2	8.2	15.5	2.3	27.1	5.4	51.5	0.0	30.5	0.2	28.9	35.2	49.0	14.8	16.2	1.6	0.7	3.6	0.0	0.0	4.7	5.2	0.4	3.1	17.9	0.0	2.2	1.4	16.2	1.9	0.0	0.2	6.7	0.0	0.6	0.3	13.6	0.0	0.7	5.4	0.0	1.1	7.7	0.0	0.0	5.2	30.6	23.3	0.0	0.0	1.2	90.7	89.1	3.8	0.1	0.0	0.0	0.9	0.1	0.2	0.6	0.0	6.4	0.8	0.7	12.9	1.4
TMEM147	"MGC1936, NIFIE14"	ENSG00000105677	"Transmembrane protein 147"	Q9BVK8	19	35545600-35547526	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (6.98e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (5.72e-2)"	"prognostic unfavorable (4.98e-6)"	"unprognostic (1.33e-1)"	"unprognostic (2.53e-1)"	"unprognostic (7.34e-2)"	"unprognostic (1.35e-1)"	"unprognostic (9.26e-2)"	"unprognostic (2.16e-1)"	"unprognostic (1.47e-1)"	"unprognostic (4.00e-2)"	"unprognostic (1.85e-1)"	"unprognostic (2.70e-1)"	78.5	153.3	75.1	36.6	80.3	41.8	71.1	84.8	85.8	72.7	117.4	67.6	43.2	77.5	101.8	105.0	64.1	36.3	112.2	74.1	83.1	96.5	63.8	68.2	29.9	80.8	79.0	69.1	149.6	129.5	76.1	46.1	79.6	54.8	54.0	42.0	80.6	58.1	137.7	118.9	52.3	57.5	80.9	58.6	84.0	76.3	80.3	26.7	99.7	85.8	45.1	77.2	73.5	85.2	161.2	353.2	68.9	162.0	298.4	135.8	110.5	94.3	167.2	124.6	115.2	168.6	96.9	93.3	156.8	156.4	135.1	62.8	119.9	147.4	101.7	140.8	156.3	99.3	98.9	200.3	237.2	145.4	105.6	148.8	226.3	117.5	291.5	107.2	115.6	126.8	127.9	325.2	134.1	201.6	82.4	80.8	96.9	492.8	141.3	79.1	62.3	225.4	198.5	164.6	60.5	101.0	93.7	215.3	204.9	69.2	78.2	121.4	73.8	140.5	109.9	81.0	205.0	165.9	182.2	52.8	122.3	195.7	115.6	41.0	219.7	103.3	100.6	212.6	142.6	177.0	135.9	116.3	199.9	149.0	101.0	102.6	12.2	106.1	154.0	237.5	147.1	237.4	75.1	80.3	84.8	85.8	74.1	83.1	80.8	79.0	79.6	80.9	80.3	85.2	74.4	44.8	44.1	7.2	71.5	101.2	135.7	195.5	63.2	55.3	167.2	165.1	101.5	118.7	110.2	156.3	18.8	176.3	63.2	59.6	111.6	223.0	102.5	56.4	72.5	96.8	88.9	42.5	6.0	255.2	228.7	94.7	51.0	68.1	50.2	90.9	82.8	95.5	260.6	45.4	8.0	105.9	140.4	133.6	113.3	333.8	139.4	96.5	240.1	7.5	83.7	138.9	71.1	10.1	12.2	179.9	74.1	121.1	136.0	349.1	100.3	277.1	77.9	62.8	118.3	58.1	138.9	327.9	155.7	94.9	167.8	138.3	60.6	86.1	144.3	200.6
TMEM150A	"FLJ90024, TM6P1, TMEM150, TTN1"	ENSG00000168890	"Transmembrane protein 150A"	Q86TG1	2	85598547-85603196	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 133.5;Early spermatids: 137.5;Proximal tubular cells: 85.0;Syncytiotrophoblasts: 146.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC diff: 52.9;HHSteC: 49.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019015	Uncertain					NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA019015: AB_2204758"	"unprognostic (2.80e-1)"	"unprognostic (1.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (1.42e-3)"	"unprognostic (4.09e-3)"	"unprognostic (5.65e-2)"	"unprognostic (2.38e-2)"	"unprognostic (1.42e-2)"	"unprognostic (5.80e-2)"	"unprognostic (2.64e-2)"	"unprognostic (2.54e-3)"	"unprognostic (7.16e-2)"	"unprognostic (8.27e-3)"	"unprognostic (2.09e-2)"	"unprognostic (2.89e-1)"	"unprognostic (1.37e-2)"	"unprognostic (6.87e-3)"	18.7	16.3	10.0	5.2	10.8	1.2	17.0	9.8	11.1	16.3	11.1	21.0	6.5	17.7	6.3	11.0	17.1	10.4	15.5	9.7	10.3	32.8	38.5	19.3	6.0	11.9	10.7	17.1	37.9	8.0	11.7	22.4	10.9	17.4	4.1	1.4	14.9	10.2	53.7	9.3	12.9	11.5	10.6	9.7	20.6	24.4	11.3	2.5	14.9	27.2	4.2	22.2	13.1	10.1	2.7	5.1	6.3	9.3	52.9	23.7	15.3	5.2	9.1	4.3	2.0	23.6	7.1	0.8	19.8	15.3	8.0	2.2	6.8	13.7	2.0	1.2	6.7	1.5	3.0	39.9	49.6	0.4	4.7	28.5	18.4	7.0	9.9	20.6	15.2	1.0	14.0	1.5	17.5	11.9	0.4	6.9	11.5	10.8	5.1	4.1	0.6	15.8	13.4	10.6	1.0	3.9	5.4	35.4	13.5	5.9	8.7	6.2	12.6	5.2	4.4	4.5	1.8	10.6	2.8	5.2	8.5	6.0	2.3	0.0	15.2	7.2	5.5	17.9	6.5	5.3	6.2	5.6	12.8	8.1	6.9	4.2	0.7	8.4	15.1	7.6	1.5	6.0	10.0	10.8	9.8	11.1	9.7	10.3	11.9	10.7	10.9	10.6	11.3	10.1	24.1	9.6	14.9	10.7	9.0	4.5	15.3	16.0	10.2	6.8	15.3	12.7	5.2	12.8	16.2	14.7	0.0	133.5	10.4	3.5	29.4	16.9	137.5	5.0	9.0	14.9	3.0	1.7	3.9	14.4	18.2	14.3	5.6	6.0	10.2	5.2	15.7	19.7	37.9	3.3	5.0	5.2	16.2	10.3	13.1	64.8	19.9	14.6	10.6	9.4	15.2	6.5	7.2	5.5	5.9	12.8	7.0	24.5	5.9	20.3	16.4	85.0	8.3	3.4	13.1	14.6	11.7	2.4	5.6	7.9	3.7	146.0	7.0	9.2	7.0	13.1
TMEM150B	"DRAM3, TMEM224, TTN2"	ENSG00000180061	"Transmembrane protein 150B"	A6NC51	19	55312801-55334048	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enriched"	"Detected in many"	5	"intestine: 64.1"	"Cell type enhanced"	"Detected in some"		"Distal enterocytes: 18.1;Kupffer cells: 11.8;monocytes: 8.0;Proximal enterocytes: 68.9"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 11.6"	"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in some"		"classical monocyte: 5.7"	"Group enriched"	"Detected in many"	7	"granulocytes: 1.9;monocytes: 5.7"	"Cell line enhanced"	"Detected in some"		"CACO-2: 8.3;HMC-1: 3.8;THP-1: 2.9;U-937: 18.1"	"Not detected"	"Not detected"													NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 56: Intestine - Transmembrane transport"	"Cluster 32: U-937 - Innate immune response"	"Cluster 45: Enterocytes - Digestion"				"unprognostic (3.19e-2)"	"unprognostic (1.00e-1)"	"unprognostic (5.76e-2)"	"unprognostic (4.94e-2)"	"unprognostic (5.33e-2)"	"unprognostic (6.70e-2)"	"unprognostic (5.51e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.74e-2)"	"unprognostic (3.06e-1)"	"prognostic unfavorable (6.14e-6)"	"unprognostic (1.48e-1)"	"unprognostic (1.63e-3)"	"unprognostic (2.45e-1)"	"unprognostic (1.18e-2)"	3.7	1.8	0.5	5.8	0.8	0.7	1.1	0.4	1.0	0.3	1.2	10.2	64.1	0.4	0.1	0.6	0.8	2.9	0.8	0.4	0.7	3.2	2.2	11.9	3.5	1.3	0.7	0.3	0.9	0.1	0.2	5.6	1.6	0.3	7.3	0.0	0.6	0.4	0.2	0.2	57.0	4.1	0.5	5.7	1.4	0.5	3.4	0.7	0.3	0.2	1.6	2.0	0.3	1.3	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.3	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	1.6	0.0	1.1	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	1.9	0.0	0.0	0.1	0.1	0.1	1.8	0.0	0.2	0.0	2.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	18.1	0.1	1.9	5.7	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.8	0.5	0.8	0.4	1.0	0.4	0.7	1.3	0.7	1.6	0.5	3.4	1.3	0.0	0.0	0.0	0.0	0.6	0.1	1.3	0.0	0.0	0.0	0.1	0.0	0.5	1.5	0.0	1.8	0.0	0.0	0.0	18.1	0.0	0.0	0.1	0.1	0.1	0.1	0.0	0.4	0.8	0.0	0.0	0.2	0.5	0.0	0.0	0.0	0.0	0.1	6.7	0.0	0.7	3.5	0.0	11.8	1.3	0.0	0.0	3.2	0.0	0.0	8.0	0.0	0.0	0.0	0.9	0.3	1.4	0.0	0.9	0.6	68.9	0.6	0.0	0.0	0.0	0.2	0.2	0.1	0.1	0.0	0.0	0.0	0.2	0.0	3.7	0.3
TMEM150C	"FLJ12993, TTN3"	ENSG00000249242	"Transmembrane protein 150C"	B9EJG8	4	82483170-82562357	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"epididymis: 134.9"	"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 88.6;Granulosa cells: 104.7;Syncytiotrophoblasts: 117.3"	"Cancer enhanced"	"Detected in all"		"breast cancer: 23.8"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"basophil: 2.6"	"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"AF22: 8.8;AN3-CA: 10.9;MCF7: 32.2;SCLC-21H: 20.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052921	Enhanced					NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"			"HPA052921: AB_2681988"	"unprognostic (2.99e-1)"	"unprognostic (4.31e-2)"	"unprognostic (2.27e-1)"	"unprognostic (1.89e-3)"	"unprognostic (1.71e-3)"	"prognostic favorable (7.87e-4)"	"unprognostic (2.94e-2)"	"unprognostic (5.55e-2)"	"unprognostic (1.06e-1)"	"unprognostic (3.94e-2)"	"prognostic favorable (5.68e-4)"	"unprognostic (4.57e-2)"	"prognostic favorable (4.59e-6)"	"unprognostic (4.18e-1)"	"unprognostic (2.64e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.51e-3)"	13.1	43.1	12.9	4.6	15.3	1.9	22.0	9.7	16.8	15.1	6.3	7.7	7.4	4.9	134.9	3.6	7.4	6.5	12.7	15.7	12.7	17.3	13.9	6.2	14.7	12.9	15.9	31.5	3.4	5.4	8.4	9.8	14.7	12.6	4.3	4.5	17.0	7.6	6.9	4.3	6.9	6.9	12.0	14.3	5.0	3.2	12.2	9.1	11.4	9.7	12.8	5.0	5.2	12.5	0.1	1.0	8.8	10.9	0.1	0.1	0.4	1.9	4.7	1.3	1.2	0.0	0.6	0.3	0.9	0.3	3.6	0.2	5.0	0.0	1.4	0.4	2.3	0.7	1.2	0.1	0.0	0.0	1.0	4.5	0.6	0.0	0.0	0.8	2.7	5.3	0.0	0.0	0.2	32.2	0.6	0.8	3.9	0.0	0.5	1.0	0.2	1.2	0.2	4.8	20.1	3.5	0.5	0.4	2.8	4.1	0.5	0.2	0.8	0.5	0.3	0.1	1.1	0.1	0.5	0.4	0.6	0.1	2.2	2.6	0.3	0.5	0.2	0.2	0.1	1.0	0.3	0.2	0.1	1.1	0.2	0.2	1.4	0.5	0.3	0.6	0.1	0.1	12.9	15.3	9.7	16.8	15.7	12.7	12.9	15.9	14.7	12.0	12.2	12.5	30.7	0.0	1.1	36.6	0.2	2.4	3.5	1.9	0.6	1.1	19.3	13.6	10.1	5.7	6.1	14.7	2.1	88.6	1.4	0.2	0.0	7.2	5.5	2.6	11.2	24.8	1.2	3.0	35.6	2.5	1.3	13.1	0.5	10.5	6.3	104.7	25.4	20.4	5.7	1.7	24.2	1.1	0.0	1.0	3.6	2.9	14.3	1.8	1.8	7.5	7.8	14.8	0.0	17.6	13.1	1.4	0.2	9.8	1.2	4.9	0.4	2.6	7.1	2.2	0.0	3.9	7.8	1.1	4.1	1.6	1.1	117.3	0.6	1.8	4.3	0.9
TMEM163	"DKFZP566N034, SV31"	ENSG00000152128	"Transmembrane protein 163"	Q8TC26	2	134455759-134719000	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.3;pancreas: 27.8"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 2: 36.9;Excitatory neurons: 62.2;Exocrine glandular cells: 30.8;Oligodendrocyte precursor cells: 219.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 20.3;RPTEC TERT1: 67.3;SCLC-21H: 30.2;U-937: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA007224	Uncertain					NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA007224: AB_2667780"	"unprognostic (1.05e-2)"	"unprognostic (1.33e-1)"	"unprognostic (7.25e-3)"	"unprognostic (3.18e-1)"	"unprognostic (1.47e-1)"	"unprognostic (2.25e-1)"	"unprognostic (6.08e-3)"	"prognostic favorable (7.94e-4)"	"unprognostic (9.05e-2)"	"unprognostic (9.62e-2)"	"unprognostic (6.02e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.60e-2)"	"unprognostic (2.64e-1)"	"unprognostic (3.62e-1)"	"unprognostic (6.75e-3)"	"prognostic favorable (3.15e-4)"	3.4	8.5	13.5	5.1	13.4	0.3	1.4	18.8	13.3	0.2	5.4	1.0	0.6	0.4	0.3	0.1	2.8	9.3	6.7	12.9	15.2	1.6	0.4	14.5	10.4	18.3	20.7	0.9	27.8	0.8	13.9	3.7	15.4	0.2	0.5	4.0	3.0	0.2	0.3	0.1	1.0	0.4	16.5	1.6	7.3	6.5	28.3	2.0	0.9	0.5	16.4	12.2	0.1	23.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.1	2.2	20.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.8	3.5	6.7	0.1	0.1	0.3	0.0	0.6	0.1	0.0	5.2	1.1	2.3	0.0	0.1	0.1	67.3	10.0	30.2	1.1	0.0	0.0	1.6	0.1	0.0	0.0	7.0	0.0	0.4	0.0	1.5	1.6	0.0	0.0	0.0	12.6	1.3	0.0	0.0	0.0	0.3	0.0	0.4	0.4	0.1	0.6	0.0	0.1	0.0	0.1	0.0	0.6	0.0	0.0	0.7	0.2	13.5	13.4	18.8	13.3	12.9	15.2	18.3	20.7	15.4	16.5	28.3	23.0	19.3	3.2	36.9	2.6	6.7	0.0	0.0	0.0	0.0	2.7	0.2	5.1	5.4	7.2	0.0	0.0	0.0	0.1	0.9	0.1	0.0	8.5	4.8	0.3	0.2	3.5	0.0	0.4	62.2	30.8	0.4	0.7	20.9	1.0	0.0	0.6	0.4	0.3	5.0	1.7	23.5	0.4	0.0	1.3	0.0	3.8	0.0	2.7	0.0	14.0	2.6	1.0	5.2	219.7	13.0	12.6	0.1	0.4	0.3	0.0	0.0	0.3	0.0	5.7	0.0	0.5	0.4	2.1	1.6	0.0	0.4	0.1	0.7	1.9	0.1	2.5
TMEM165	"GDT1, TMPT27, TPARL"	ENSG00000134851	"Transmembrane protein 165"	Q9HC07	4	55395957-55453397	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Oligodendrocytes: 1021.6;Urothelial cells: 601.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038299, HPA062424"	Supported		Enhanced	"Golgi apparatus"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"	"Golgi apparatus"		"HPA038299: AB_10675793, HPA062424: AB_2732682"	"unprognostic (2.53e-2)"	"unprognostic (1.08e-3)"	"unprognostic (3.46e-3)"	"unprognostic (7.07e-3)"	"unprognostic (5.97e-2)"	"unprognostic (9.84e-2)"	"prognostic unfavorable (2.08e-5)"	"unprognostic (1.41e-1)"	"unprognostic (1.18e-2)"	"unprognostic (8.00e-3)"	"unprognostic (1.55e-2)"	"unprognostic (2.61e-1)"	"prognostic unfavorable (1.18e-8)"	"unprognostic (9.05e-2)"	"unprognostic (8.96e-2)"	"unprognostic (2.72e-1)"	"unprognostic (2.18e-2)"	53.4	61.3	39.2	42.6	75.1	11.3	35.2	62.0	70.8	45.9	36.0	32.4	32.0	34.0	31.1	55.8	31.6	46.0	37.3	40.8	51.1	41.6	19.3	52.7	32.6	84.8	72.0	22.3	40.1	32.3	24.0	60.5	78.9	37.8	33.3	15.0	40.4	30.6	17.1	26.2	27.9	40.0	54.5	37.0	39.2	13.7	65.8	24.0	37.8	17.2	42.5	78.8	42.7	117.4	74.6	30.4	47.1	50.2	143.5	105.4	50.0	138.6	212.7	98.0	106.7	34.2	108.3	76.9	98.3	85.9	56.2	53.8	50.0	56.8	98.9	43.8	46.4	66.0	50.1	66.6	89.1	92.1	75.1	109.1	72.7	55.9	37.3	82.4	113.2	25.6	112.8	47.8	116.5	54.5	73.0	76.5	51.7	97.8	70.6	52.0	35.5	42.1	148.6	70.2	48.3	64.7	69.8	261.0	85.8	46.3	41.2	65.3	98.3	83.1	49.6	37.0	102.5	44.4	38.5	48.3	98.9	77.2	67.9	23.7	40.4	26.0	15.2	35.7	17.0	19.0	14.3	17.8	36.5	11.5	12.1	14.4	28.6	18.1	35.9	28.4	18.3	30.2	39.2	75.1	62.0	70.8	40.8	51.1	84.8	72.0	78.9	54.5	65.8	117.4	119.6	54.5	52.4	42.7	87.9	245.1	277.8	295.0	147.4	50.6	85.8	42.7	32.2	71.4	214.9	79.1	81.3	112.5	97.7	42.4	17.6	171.1	32.1	123.6	99.1	108.0	50.4	79.1	58.2	163.5	157.2	110.4	76.0	173.8	21.0	57.6	113.8	18.4	105.7	28.6	71.5	69.4	77.3	97.9	145.7	24.7	58.7	109.5	88.9	59.0	117.5	53.2	123.6	71.4	1021.6	248.0	48.6	63.6	117.1	239.3	51.3	50.0	125.2	91.9	98.6	92.2	129.0	37.8	24.6	169.4	268.8	80.6	81.6	90.6	61.6	601.6
TMEM17	FLJ34583	ENSG00000186889	"Transmembrane protein 17"	Q86X19	2	62500218-62511894	"Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Ciliopathy, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Respiratory ciliated cells: 25.4;Spermatocytes: 39.2;Spermatogonia: 21.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"plasmacytoid DC: 1.9"	"Low lineage specificity"	"Detected in single"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018100	Uncertain		Approved	"Actin filaments"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Actin filaments"		"HPA018100: AB_2240686"	"unprognostic (8.09e-2)"	"unprognostic (8.43e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.14e-1)"	"unprognostic (5.02e-3)"	"unprognostic (3.78e-1)"	"unprognostic (1.87e-4)"	"unprognostic (1.21e-1)"	"unprognostic (1.47e-1)"	"unprognostic (3.44e-2)"	"unprognostic (2.26e-1)"	"unprognostic (2.36e-1)"	"unprognostic (7.68e-3)"	"unprognostic (1.11e-2)"	"unprognostic (3.06e-2)"	"unprognostic (3.62e-1)"	"unprognostic (1.49e-6)"	2.4	5.0	4.1	0.5	4.3	0.8	2.4	2.6	4.2	1.8	4.8	1.4	1.0	2.3	1.6	2.6	4.3	2.9	2.2	4.4	9.5	4.3	2.3	1.8	1.0	4.5	5.5	3.1	3.2	6.1	4.3	1.7	5.5	2.5	0.9	4.0	2.2	2.0	1.8	2.4	0.8	1.6	3.5	0.8	1.3	4.8	8.5	1.4	4.6	1.8	0.9	1.5	1.3	3.4	3.3	4.6	4.7	1.8	2.4	3.1	3.0	2.5	2.3	2.0	2.1	0.3	6.1	0.0	3.2	3.3	6.7	3.2	2.1	1.4	1.5	3.2	1.4	1.5	1.8	0.3	3.5	2.3	1.8	2.8	3.9	1.7	3.9	3.4	2.5	0.3	1.4	0.2	5.3	0.9	0.4	0.5	2.3	3.0	2.3	0.2	0.6	0.2	4.3	1.0	1.2	4.0	2.6	0.9	9.1	1.6	1.5	3.0	1.7	4.0	2.2	4.8	2.6	0.4	0.0	0.0	5.8	0.4	8.4	0.5	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.2	0.5	0.3	0.1	1.9	0.0	0.4	4.1	4.3	2.6	4.2	4.4	9.5	4.5	5.5	5.5	3.5	8.5	3.4	2.9	3.2	4.1	2.6	0.4	5.0	2.3	10.7	9.1	7.1	3.0	2.8	2.6	4.3	7.5	5.5	8.4	2.3	1.5	0.1	0.0	5.3	4.8	11.4	2.1	2.7	1.2	1.7	2.8	8.5	2.2	4.2	1.1	1.7	1.3	2.8	3.9	2.5	2.6	10.1	3.9	0.9	6.1	0.6	1.5	2.8	4.7	1.4	3.6	1.0	0.9	9.9	0.0	0.0	2.9	7.9	0.3	3.8	1.4	1.0	0.4	2.5	25.4	4.8	6.6	2.4	1.8	39.2	21.7	5.5	2.8	0.4	0.3	5.4	1.1	1.5
TMEM170A	"FLJ37611, TMEM170"	ENSG00000166822	"Transmembrane protein 170A"	Q8WVE7	16	75443054-75465497	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"													NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (3.49e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.52e-3)"	"unprognostic (1.08e-1)"	"unprognostic (3.33e-2)"	"unprognostic (1.02e-2)"	"unprognostic (8.62e-2)"	"unprognostic (7.97e-2)"	"unprognostic (3.19e-2)"	"unprognostic (1.53e-1)"	"unprognostic (7.15e-2)"	"prognostic favorable (2.36e-9)"	"unprognostic (4.37e-2)"	"unprognostic (3.41e-1)"	"unprognostic (7.80e-2)"	"unprognostic (1.53e-3)"	8.2	9.8	7.7	10.6	10.6	36.6	6.0	9.2	9.0	7.7	7.9	12.1	14.5	8.0	6.0	8.4	7.6	7.8	7.2	7.4	9.3	9.2	12.7	8.0	11.9	11.3	10.2	10.2	10.2	3.9	8.7	10.2	9.9	7.6	10.1	14.9	6.5	3.2	3.7	7.8	13.7	6.3	9.3	9.2	7.3	17.4	8.5	6.8	9.7	4.9	9.7	8.1	7.8	16.9	14.2	17.1	21.8	22.3	9.5	7.7	38.9	9.2	5.2	7.4	11.3	35.3	30.7	19.6	17.0	4.4	16.4	25.9	18.3	8.9	13.0	12.0	11.4	10.6	16.4	22.4	6.3	25.3	27.3	6.7	6.8	12.5	9.4	8.7	6.5	22.7	21.8	15.2	3.9	28.8	22.3	16.8	26.1	17.2	9.2	43.5	8.5	15.7	5.1	18.3	12.8	14.9	22.4	7.0	12.6	25.6	9.4	11.6	9.6	12.6	21.4	10.1	10.2	13.7	17.3	60.3	9.8	14.7	14.4	14.5	26.6	38.2	27.9	29.1	36.6	28.9	29.1	31.8	24.0	28.8	30.9	27.3	33.3	25.4	26.9	26.8	23.1	21.6	7.7	10.6	9.2	9.0	7.4	9.3	11.3	10.2	9.9	9.3	8.5	16.9	39.7	19.2	15.0	20.5	49.0	19.9	45.7	37.8	26.7	25.6	37.7	27.1	9.3	40.0	25.3	20.2	37.5	73.0	65.0	86.2	25.4	26.8	40.5	62.5	23.6	37.2	34.1	17.1	17.6	19.3	51.5	24.3	16.8	67.7	28.6	57.3	35.3	24.2	37.2	37.0	15.9	37.6	22.4	31.8	29.7	8.7	24.2	38.3	21.4	11.2	41.2	43.7	42.2	24.1	29.8	23.3	67.6	21.4	29.2	57.5	53.5	30.2	32.4	38.3	32.9	19.9	20.1	88.5	61.8	19.7	20.0	53.4	49.0	36.7	56.0	67.8
TMEM175	MGC4618	ENSG00000127419	"Transmembrane protein 175"	Q9BSA9	4	932387-958656	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA057160	Approved		Approved	"Nucleoplasm,Nuclear membrane"		No	No			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 62: Horizontal cells - Visual perception"	"Nucleoplasm, Nuclear membrane"		"HPA057160: AB_2683356"	"unprognostic (3.84e-1)"	"unprognostic (4.27e-2)"	"unprognostic (1.28e-2)"	"unprognostic (9.61e-3)"	"unprognostic (2.43e-1)"	"unprognostic (2.33e-3)"	"unprognostic (1.12e-2)"	"unprognostic (3.25e-3)"	"unprognostic (1.22e-2)"	"unprognostic (1.50e-2)"	"prognostic favorable (9.85e-5)"	"unprognostic (4.71e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.74e-1)"	"unprognostic (1.96e-1)"	"unprognostic (7.51e-3)"	17.5	28.2	13.0	8.1	13.3	12.9	17.5	15.7	24.6	14.7	12.2	15.5	8.9	17.3	6.0	14.2	14.9	10.0	19.6	12.9	13.1	16.4	33.5	16.1	16.1	14.6	13.1	12.2	23.3	9.2	30.9	7.4	14.5	19.0	3.6	10.2	21.4	8.7	19.7	17.0	17.5	6.4	11.4	26.1	19.3	13.2	12.7	8.9	21.0	4.5	6.1	16.1	13.5	13.5	4.9	9.5	5.1	7.0	23.7	12.3	11.8	13.0	8.6	7.3	10.8	4.2	20.5	4.0	7.5	12.8	12.8	8.4	4.7	9.5	3.1	9.2	11.9	8.3	14.9	4.3	13.7	4.6	14.8	17.5	11.3	6.4	4.3	5.1	4.6	8.1	8.2	30.0	6.4	16.2	11.3	17.4	3.2	5.8	24.8	7.5	3.1	11.5	7.0	5.0	14.0	12.9	8.6	5.5	7.8	2.5	24.3	11.3	6.6	13.7	3.0	16.8	9.1	23.0	5.9	7.4	13.2	9.4	11.3	36.8	32.2	27.2	20.6	41.1	13.3	19.4	17.3	15.5	29.4	21.6	12.6	17.6	27.8	17.0	39.7	47.1	18.5	21.2	13.0	13.3	15.7	24.6	12.9	13.1	14.6	13.1	14.5	11.4	12.7	13.5	17.0	12.8	8.9	26.8	20.7	6.2	8.1	21.0	12.5	26.8	15.2	14.4	10.4	8.6	17.1	14.7	4.2	24.1	19.2	13.7	1.9	8.8	6.1	11.6	12.2	10.2	16.2	3.0	42.8	11.4	10.1	16.6	17.9	11.3	7.0	10.8	10.8	24.5	15.2	47.1	37.8	9.6	34.6	14.5	9.1	4.0	12.5	15.8	19.6	15.0	9.6	38.6	15.5	25.1	29.1	7.9	16.1	16.1	16.7	6.1	16.6	8.0	13.6	28.7	13.1	10.1	12.3	24.0	14.1	12.3	7.7	18.9	15.3	29.2	7.6	8.4
TMEM176A	"HCA112, MS4B1"	ENSG00000002933	"Transmembrane protein 176A"	Q96HP8	7	150800403-150805118	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 377.7;liver: 1170.6"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 1043.9;Paneth cells: 779.4;Proximal enterocytes: 1294.5;Proximal tubular cells: 1103.9"	"Cancer enhanced"	"Detected in all"		"liver cancer: 210.1"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 146.5;intermediate monocyte: 98.4"	"Lineage enriched"	"Detected in many"	5	"monocytes: 146.5"	"Cell line enriched"	"Detected in some"	31	"HSkMC: 730.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008770	Approved		Approved	Mitochondria		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 67: Proximal tubular cells - Tubular reabsorption"	Mitochondria		"HPA008770: AB_2256120"	"unprognostic (4.70e-2)"	"unprognostic (7.71e-2)"	"unprognostic (5.71e-3)"	"unprognostic (6.09e-2)"	"unprognostic (3.96e-3)"	"unprognostic (1.44e-2)"	"unprognostic (2.51e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (4.37e-2)"	"unprognostic (4.79e-1)"	"unprognostic (1.23e-2)"	"unprognostic (1.98e-2)"	"unprognostic (2.64e-1)"	"unprognostic (4.91e-2)"	76.6	33.1	46.5	124.8	48.0	6.8	49.3	49.2	50.8	45.7	39.1	143.9	113.2	18.6	17.9	28.5	48.9	129.8	90.9	43.6	56.2	377.7	1170.6	58.5	85.6	64.0	56.2	104.7	29.8	3.9	11.6	66.6	58.2	26.5	151.3	20.6	24.2	15.9	6.4	20.6	203.1	50.2	61.3	51.0	48.7	6.1	49.9	15.5	21.3	17.4	66.0	98.0	54.5	63.9	0.0	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	3.5	14.2	0.2	0.6	0.0	0.3	1.5	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.4	0.3	0.3	730.7	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.6	0.9	0.0	0.0	0.0	0.5	0.2	0.0	0.0	0.0	0.0	23.3	0.0	0.0	2.7	0.5	0.1	0.0	0.1	0.0	0.0	0.4	0.0	0.0	146.5	12.6	0.3	98.4	0.4	2.1	0.1	0.2	30.9	0.0	0.2	0.0	1.8	0.3	46.0	2.4	0.4	53.3	46.5	48.0	49.2	50.8	43.6	56.2	64.0	56.2	58.2	61.3	49.9	63.9	15.8	0.0	5.2	3.9	9.8	7.4	0.4	0.9	5.2	56.2	40.6	63.8	24.9	118.7	10.9	200.5	4.2	0.6	2.0	348.5	152.6	64.6	0.3	4.9	14.8	20.5	74.1	6.6	0.0	27.2	0.6	185.3	17.9	2.5	29.0	29.9	23.2	1043.9	52.2	0.0	0.2	237.7	73.2	56.9	26.2	1.5	60.3	109.4	5.4	1.9	313.0	80.8	1.0	1.0	0.0	56.0	779.4	7.5	0.9	1.8	1294.5	1103.9	10.6	5.3	0.0	5.7	32.8	0.9	1.6	2.9	8.4	1.4	6.4	0.1	262.4	2.7
TMEM176B	"LR8, MS4B2"	ENSG00000106565	"Transmembrane protein 176B"	Q3YBM2	7	150791285-150801360	"Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"liver: 1656.5"	"Cell type enhanced"	"Detected in many"		"Hepatocytes: 1171.9;monocytes: 502.3;Paneth cells: 762.4;Proximal enterocytes: 922.5;Proximal tubular cells: 976.5"	"Cancer enhanced"	"Detected in all"		"liver cancer: 537.9"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"classical monocyte: 865.5;intermediate monocyte: 586.0"	"Lineage enriched"	"Detected in many"	5	"monocytes: 865.5"	"Group enriched"	"Detected in some"	17	"HSkMC: 642.7;THP-1: 215.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA047509	Approved		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 2: Hepatocytes - Metabolism"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA047509: AB_2680072"	"unprognostic (5.21e-2)"	"unprognostic (7.86e-2)"	"unprognostic (1.30e-2)"	"unprognostic (8.27e-2)"	"unprognostic (3.35e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.23e-2)"	"unprognostic (2.74e-2)"	"unprognostic (5.31e-2)"	"unprognostic (1.47e-1)"	"unprognostic (5.72e-3)"	"unprognostic (7.50e-2)"	"unprognostic (3.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (2.17e-2)"	"unprognostic (1.53e-1)"	"unprognostic (4.05e-2)"	120.9	49.5	48.5	190.8	50.1	13.5	77.8	50.7	65.8	74.5	43.0	251.8	167.7	25.9	25.7	50.4	81.5	197.3	208.5	45.4	58.0	356.5	1656.5	95.6	177.5	69.2	60.1	143.1	53.6	7.3	22.7	115.0	64.5	48.9	244.9	34.1	42.5	28.3	11.0	34.7	286.6	99.0	65.0	87.0	94.5	11.1	52.2	26.1	33.6	36.1	93.7	158.6	92.4	73.2	0.0	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.2	25.7	0.4	0.8	0.0	0.1	0.6	0.1	0.1	0.0	0.1	0.8	0.4	0.0	0.0	0.6	0.8	0.2	642.7	0.0	0.3	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.7	0.1	0.9	0.5	0.1	0.0	0.1	1.0	11.8	0.1	0.0	1.9	1.4	0.6	0.3	0.2	0.2	0.0	215.7	0.0	0.0	3.2	0.5	0.2	0.4	0.2	0.6	0.0	0.3	0.0	5.3	865.5	50.5	2.3	586.0	3.4	2.5	0.6	0.7	164.3	0.6	0.7	0.4	8.6	0.6	309.3	7.7	0.6	498.5	48.5	50.1	50.7	65.8	45.4	58.0	69.2	60.1	64.5	65.0	52.2	73.2	22.2	3.2	9.3	14.4	16.9	12.6	0.5	0.9	5.7	156.9	52.2	74.0	73.7	190.1	14.4	375.2	2.1	0.9	2.8	419.4	166.3	95.1	18.5	6.1	14.5	19.8	128.1	13.5	0.1	34.0	1.0	243.7	14.8	2.1	54.4	61.9	22.9	1171.9	92.5	6.7	0.6	252.1	46.8	98.5	44.4	12.2	43.5	190.0	16.0	8.4	502.3	87.3	1.0	7.5	0.1	65.4	762.4	3.4	1.5	2.5	922.5	976.5	11.3	17.9	0.0	6.7	34.0	4.0	3.8	1.8	15.6	2.7	9.1	0.4	263.7	2.8
TMEM178A	"MGC33926, TMEM178"	ENSG00000152154	"Transmembrane protein 178A"	Q8NBL3	2	39664982-39717963	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 135.5"	"Cell type enhanced"	"Detected in many"		"Breast myoepithelial cells: 32.4;Excitatory neurons: 109.1;Inhibitory neurons: 109.2;Oligodendrocyte precursor cells: 33.7"	"Group enriched"	"Detected in many"	4	"endometrial cancer: 10.2;glioma: 13.2;prostate cancer: 19.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"AF22: 138.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA052128	Uncertain		Approved	Nucleoplasm,Vesicles		NA	NA				"Cluster 45: Intestine - Brush border"	"Cluster 12: NES - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles	Nucleoplasm	"HPA052128: AB_2681738"	"unprognostic (3.35e-2)"	"unprognostic (3.18e-1)"	"unprognostic (5.94e-2)"	"unprognostic (2.86e-1)"	"unprognostic (1.04e-1)"	"unprognostic (5.85e-2)"	"unprognostic (3.24e-3)"	"unprognostic (1.82e-3)"	"unprognostic (2.22e-1)"	"unprognostic (9.74e-2)"	"unprognostic (5.11e-4)"	"unprognostic (1.13e-1)"	"unprognostic (6.01e-3)"	"unprognostic (2.80e-3)"	"unprognostic (3.46e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.01e-3)"	5.9	7.6	65.4	0.6	71.3	0.2	6.2	135.5	104.1	4.1	38.6	8.9	1.9	3.6	1.5	1.8	6.3	2.7	4.5	71.7	51.3	42.7	9.9	6.7	0.5	64.7	54.9	5.9	4.6	2.3	12.9	3.2	65.5	11.6	1.7	15.7	21.9	1.6	2.8	3.3	3.2	2.4	65.7	2.6	8.6	2.2	51.5	0.5	12.3	1.9	0.5	3.9	3.0	108.0	0.0	0.0	138.7	0.1	0.1	3.3	0.2	0.6	0.1	0.0	0.3	0.0	0.3	0.0	3.7	0.0	0.0	0.3	4.5	0.0	0.5	0.3	0.1	0.0	0.0	0.4	1.1	0.1	0.0	2.6	0.3	0.0	0.4	4.3	0.0	0.0	0.0	0.3	0.4	0.0	0.1	0.2	17.7	0.2	0.1	1.7	0.0	0.0	1.0	0.2	25.7	0.6	0.0	0.6	0.3	23.7	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	65.4	71.3	135.5	104.1	71.7	51.3	64.7	54.9	65.5	65.7	51.5	108.0	3.2	0.0	2.0	14.7	0.0	0.4	0.5	0.6	1.8	9.1	1.1	32.4	3.9	0.0	1.3	12.9	6.2	0.3	0.1	0.8	0.0	0.2	0.4	3.0	1.2	4.3	16.1	0.0	109.1	0.2	0.0	2.6	0.0	6.5	0.0	1.4	0.7	0.5	0.2	1.7	109.2	0.4	2.0	0.0	0.4	0.1	0.0	0.2	1.8	7.5	0.0	1.1	0.0	33.7	19.3	0.4	0.3	0.0	0.0	3.7	0.5	0.7	4.3	6.1	0.0	0.9	0.6	0.2	0.5	0.1	0.6	0.5	0.1	0.5	0.4	0.3
TMEM179	"C14orf90, FLJ42486, TMEM179A"	ENSG00000258986	"Transmembrane protein 179"	Q6ZVK1	14	104474678-104605647	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 31.5;pituitary gland: 88.1"	"Group enriched"	"Detected in some"	5	"Bipolar cells: 58.1;Horizontal cells: 65.6"	"Group enriched"	"Detected in some"	4	"glioma: 2.7;pancreatic cancer: 3.1;testis cancer: 2.4"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"NTERA-2: 8.8;SCLC-21H: 37.3;SH-SY5Y: 11.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA002942			Uncertain	Mitochondria		NA	NA				"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 62: Horizontal cells - Visual perception"	Mitochondria		"HPA002942: AB_1078113"	"unprognostic (8.65e-2)"	"unprognostic (8.24e-2)"	"unprognostic (3.10e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.90e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.46e-2)"	"unprognostic (2.69e-1)"	"unprognostic (1.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.82e-3)"	"unprognostic (1.09e-1)"	"unprognostic (1.89e-4)"	"unprognostic (8.68e-3)"	"unprognostic (1.56e-1)"	"unprognostic (9.71e-6)"	"unprognostic (1.70e-2)"	0.2	11.4	18.9	0.3	19.3	0.0	0.1	12.0	29.7	0.1	4.6	3.8	0.2	0.1	0.4	0.1	0.3	0.1	1.0	17.8	24.6	0.5	0.5	0.1	0.0	25.9	24.9	0.1	4.0	0.1	88.1	0.8	31.5	0.8	0.2	6.2	0.1	0.1	0.1	0.0	1.4	0.3	12.5	0.0	1.3	5.2	18.8	0.0	0.1	0.0	0.0	0.1	0.7	20.5	0.0	0.5	0.3	0.8	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	2.7	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	8.8	0.0	0.0	0.0	0.0	0.2	0.0	0.0	37.3	11.6	0.0	0.3	0.0	0.1	0.8	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.9	19.3	12.0	29.7	17.8	24.6	25.9	24.9	31.5	12.5	18.8	20.5	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	58.1	0.0	0.0	1.2	0.0	0.0	0.0	4.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	12.0	0.0	0.0	0.5	0.0	0.0	0.0	0.6	0.0	0.0	0.1	65.6	12.3	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	1.0	0.0	1.5	0.0	7.5	1.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.0	0.0	0.1	0.7	3.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0
TMEM179B		ENSG00000185475	"Transmembrane protein 179B"	Q7Z7N9	11	62787402-62790400	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016585, HPA062068"			Enhanced	"Nuclear speckles"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nuclear speckles"		"HPA016585: AB_1844357, HPA062068: AB_2684676"	"unprognostic (1.18e-2)"	"unprognostic (2.83e-1)"	"unprognostic (2.20e-1)"	"unprognostic (1.78e-2)"	"unprognostic (1.68e-1)"	"unprognostic (6.11e-3)"	"unprognostic (1.96e-2)"	"unprognostic (2.35e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.61e-3)"	"unprognostic (2.76e-2)"	"unprognostic (4.56e-1)"	"unprognostic (1.64e-1)"	"unprognostic (2.16e-1)"	"unprognostic (5.74e-3)"	"unprognostic (3.60e-2)"	52.1	60.3	32.4	22.0	34.7	21.5	55.0	33.7	36.4	50.5	41.8	48.7	34.7	44.4	71.2	47.9	46.7	28.4	34.0	30.8	32.9	54.3	64.3	51.0	26.9	35.3	33.3	39.6	58.7	34.1	31.0	30.0	35.6	45.8	40.1	10.4	59.1	26.4	27.2	58.2	49.8	26.3	33.7	48.1	53.9	41.6	33.0	33.0	55.4	21.6	29.8	43.3	46.0	36.9	35.6	68.8	17.7	35.7	136.3	34.3	22.6	38.2	47.5	29.8	34.2	39.3	82.9	16.5	53.1	78.0	44.2	64.8	33.4	35.4	23.2	48.6	44.9	24.1	29.2	36.3	90.8	30.9	32.2	65.8	55.8	57.1	70.0	60.0	30.3	46.9	33.2	46.3	34.5	81.1	40.2	59.5	26.5	76.8	74.6	26.5	28.8	86.1	57.7	42.6	24.4	26.7	49.3	65.3	70.4	35.8	76.2	37.8	42.2	39.6	29.4	73.3	32.2	51.2	32.5	22.6	57.0	19.0	47.3	302.9	300.4	332.7	149.4	305.0	147.9	169.2	135.5	144.9	198.2	140.6	118.2	117.3	224.3	140.2	305.9	366.1	146.6	282.5	32.4	34.7	33.7	36.4	30.8	32.9	35.3	33.3	35.6	33.7	33.0	36.9	119.6	60.9	59.2	15.3	52.7	68.7	73.9	175.6	86.0	12.4	108.0	122.2	1.3	65.8	121.1	60.7	0.0	174.5	71.7	91.2	37.2	138.1	5.8	75.2	54.5	83.7	65.2	40.4	9.9	149.0	160.5	76.8	54.6	66.5	54.6	43.8	69.9	81.9	133.2	8.4	9.0	103.5	128.1	63.7	83.0	11.0	75.8	76.5	106.7	12.2	98.3	74.4	91.6	16.1	28.1	124.0	137.1	45.9	93.9	97.1	179.4	87.5	122.9	14.7	65.7	50.5	57.8	120.8	100.5	93.2	76.0	185.1	60.0	90.4	94.8	97.5
TMEM18	"DKFZp434C1714, lncND"	ENSG00000151353	"Transmembrane protein 18"	Q96B42	2	663877-677406	"Predicted membrane proteins, Transporters"	Transcription	DNA-binding		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA040233	Approved		Approved	"Endoplasmic reticulum,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 50: Non-specific - Ribosome"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 40: Granulosa cells - Unknown function"	Mitochondria	"Endoplasmic reticulum"	"HPA040233: AB_10794737"	"unprognostic (9.01e-3)"	"unprognostic (2.45e-1)"	"unprognostic (7.48e-2)"	"unprognostic (1.77e-3)"	"unprognostic (2.68e-2)"	"unprognostic (1.61e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.11e-2)"	"prognostic unfavorable (3.21e-4)"	"unprognostic (6.05e-2)"	"unprognostic (1.86e-1)"	"unprognostic (9.45e-2)"	"unprognostic (8.20e-2)"	"unprognostic (2.49e-1)"	"unprognostic (3.65e-1)"	"unprognostic (4.98e-3)"	"unprognostic (8.08e-2)"	18.5	19.9	9.3	6.3	9.1	8.8	18.5	8.8	11.7	14.8	7.6	12.3	8.9	17.7	9.7	14.8	15.8	8.5	11.6	9.6	10.0	13.2	10.1	11.0	8.4	9.8	9.4	28.3	25.2	12.4	9.7	9.9	9.8	9.5	6.2	12.0	14.3	7.0	27.3	15.4	10.1	9.5	9.4	9.2	13.3	12.2	10.2	7.0	12.8	12.2	6.4	13.6	13.1	10.4	17.4	14.1	20.3	21.7	23.9	35.4	19.0	23.8	19.0	20.2	19.5	1.9	27.6	25.1	44.5	31.1	10.7	24.0	7.2	26.3	17.8	37.1	16.6	14.4	7.6	28.7	25.9	13.5	11.9	24.6	26.4	35.1	26.7	18.2	5.9	39.1	14.7	14.7	30.5	48.1	32.7	32.1	13.8	15.1	21.4	17.8	9.9	17.8	21.0	16.3	14.4	24.9	13.1	22.7	25.4	9.5	16.2	25.6	19.5	19.0	25.5	12.6	36.7	19.3	34.4	21.8	20.7	14.4	13.1	3.8	16.1	6.9	11.8	15.7	11.3	18.4	13.5	9.5	16.6	14.8	14.8	14.4	1.0	18.5	18.4	22.3	17.1	13.1	9.3	9.1	8.8	11.7	9.6	10.0	9.8	9.4	9.8	9.4	10.2	10.4	49.2	22.4	32.8	4.6	39.4	35.9	29.7	46.0	61.5	19.8	68.3	108.2	28.3	31.5	39.2	27.6	8.4	72.5	28.1	26.0	31.3	34.1	14.2	37.5	53.7	41.0	19.8	37.9	4.1	46.3	62.1	47.1	27.0	53.1	29.8	77.6	38.2	37.4	49.1	20.2	3.9	39.4	36.7	37.4	31.5	13.1	63.3	31.2	40.9	2.8	36.4	49.8	20.6	4.5	10.2	36.6	50.7	51.1	43.1	40.1	51.0	45.8	32.1	33.7	19.7	31.8	48.8	93.3	68.1	72.6	43.2	81.1	30.0	63.5	41.7	40.4
TMEM184A	"MGC9712, SDMG1"	ENSG00000164855	"Transmembrane protein 184A"	Q6ZMB5	7	1542235-1560821	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"esophagus: 94.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 65.9;Intestinal goblet cells: 40.4;Paneth cells: 41.7;Proximal enterocytes: 60.5"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in single"	4	"cerebral cortex: 1.0"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"MCF7: 34.2;RT4: 37.9;SCLC-21H: 40.8;SK-BR-3: 58.4;T-47d: 53.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA053790, HPA071312"	Uncertain		Uncertain	Nucleoplasm		NA	NA				"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA053790: AB_2682263, HPA071312: AB_2686387"	"unprognostic (3.67e-1)"	"unprognostic (4.83e-2)"	"prognostic unfavorable (1.12e-4)"	"unprognostic (2.38e-1)"	"unprognostic (4.41e-3)"	"unprognostic (1.07e-1)"	"unprognostic (2.36e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.77e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.53e-1)"	"unprognostic (1.31e-1)"	"unprognostic (6.70e-2)"	"unprognostic (2.77e-1)"	"unprognostic (1.34e-1)"	"prognostic unfavorable (9.94e-4)"	"unprognostic (5.47e-2)"	0.4	0.3	0.1	1.4	0.1	0.7	3.0	0.1	1.0	20.6	0.2	12.1	24.4	1.1	0.3	94.6	7.0	3.6	0.4	0.0	0.2	6.2	24.4	2.2	0.2	0.2	0.0	0.2	22.9	5.2	11.4	1.7	0.1	11.3	6.6	0.1	22.5	4.5	4.9	37.0	23.6	0.3	0.0	0.1	12.6	3.7	0.2	0.6	0.6	0.6	4.3	12.8	41.0	0.1	23.7	15.0	0.1	0.0	0.0	0.1	5.0	0.8	0.3	0.9	0.1	20.9	25.4	0.5	7.6	0.3	7.5	17.0	0.0	9.7	0.3	0.2	0.9	0.1	15.3	9.7	0.2	0.0	0.0	0.0	8.9	0.3	8.0	0.4	0.1	6.3	0.2	0.1	0.0	34.2	0.2	0.1	0.7	13.5	19.3	0.5	0.0	10.9	7.3	37.9	40.8	0.1	6.4	58.4	0.1	0.5	53.7	0.1	0.0	0.0	8.2	9.7	1.1	0.1	0.0	0.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.1	1.0	0.0	0.2	0.2	0.0	0.1	0.0	0.2	0.1	2.9	3.2	4.4	0.0	1.6	4.0	5.8	7.2	2.2	1.1	12.1	5.5	7.5	11.5	18.2	9.2	0.0	7.1	1.4	65.9	1.9	13.2	0.0	19.3	3.4	1.4	7.2	0.0	0.3	11.0	8.7	1.7	23.4	31.7	1.3	0.5	0.0	14.2	0.8	0.0	0.1	40.4	14.2	0.6	2.6	0.0	0.0	1.4	0.0	0.0	0.6	0.5	0.0	0.0	0.0	13.1	41.7	0.0	4.6	10.4	60.5	5.1	28.0	0.6	0.0	1.8	3.0	0.0	0.1	15.4	9.2	16.8	1.2	0.1	19.4	16.0
TMEM184B	"C22orf5, DKFZP586A1024, FM08, HS5O6A"	ENSG00000198792	"Transmembrane protein 184B"	Q9Y519	22	38219291-38273010	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Astrocytes: 86.8;Oligodendrocytes: 93.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-266/84: 197.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024076	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 16: U-266 - Nucleosome"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus, Cytosol"	Nucleoplasm	"HPA024076: AB_1858106"	"unprognostic (1.52e-1)"	"unprognostic (9.17e-2)"	"unprognostic (1.86e-1)"	"unprognostic (8.96e-2)"	"unprognostic (3.82e-1)"	"unprognostic (2.77e-2)"	"prognostic unfavorable (5.94e-6)"	"unprognostic (1.14e-2)"	"unprognostic (5.18e-2)"	"unprognostic (4.52e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.77e-2)"	"unprognostic (1.52e-1)"	"unprognostic (5.67e-2)"	"unprognostic (1.65e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.96e-1)"	28.6	21.9	49.5	14.0	52.3	5.8	24.9	54.5	59.6	18.6	22.1	21.0	16.9	19.4	7.2	17.3	17.1	14.5	35.7	49.6	48.2	25.9	11.4	35.9	8.4	56.8	56.0	16.2	18.4	18.9	34.3	38.4	54.8	18.8	10.8	15.2	22.6	14.4	28.7	16.0	17.6	14.0	52.9	22.0	22.4	7.5	56.7	6.2	26.1	17.4	8.2	18.4	16.5	66.9	55.8	47.5	27.5	21.9	53.6	42.6	63.4	58.8	82.9	46.9	41.5	35.1	25.2	10.6	44.9	87.6	42.4	67.2	24.9	57.8	31.6	37.9	45.0	20.9	34.0	29.5	56.3	16.6	28.0	36.1	50.2	55.4	61.5	48.5	59.5	15.9	13.5	36.2	41.5	31.6	10.6	14.1	22.4	41.2	43.4	18.1	24.8	10.6	34.8	60.6	59.3	10.5	44.2	63.6	32.0	31.7	35.2	12.0	89.2	47.7	48.4	42.5	36.2	74.5	197.9	8.5	69.2	12.1	42.0	14.2	3.3	4.7	5.3	2.3	4.6	1.4	2.9	4.0	4.5	1.1	2.1	2.5	10.9	6.2	1.6	7.0	1.0	3.2	49.5	52.3	54.5	59.6	49.6	48.2	56.8	56.0	54.8	52.9	56.7	66.9	43.4	6.4	14.8	86.8	7.5	12.4	19.8	22.3	17.6	16.4	15.9	10.5	17.1	8.6	18.7	14.7	2.1	35.0	17.8	12.5	3.9	17.3	5.6	17.4	15.5	34.6	25.9	4.6	42.6	22.2	48.3	17.4	13.3	33.8	2.5	15.3	18.2	4.4	14.7	15.2	40.7	19.7	12.2	8.5	19.7	2.4	11.8	8.4	14.2	22.5	12.2	44.4	23.7	42.3	93.1	28.3	9.8	13.5	35.6	32.9	11.1	4.3	15.9	9.0	19.7	15.3	27.0	3.3	6.1	5.3	9.7	78.4	9.3	10.2	10.1	37.0
TMEM187	"CXorf12, DXS9878E, ITBA1"	ENSG00000177854	"Transmembrane protein 187"	Q14656	X	153972754-153983194	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in single"			HPA038134	Uncertain		Approved	Nucleoli,Cytosol		NA	NA			"Cluster 20: T-cells - T-cell receptor"	"Cluster 22: Non-specific - Unknown function"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoli, Cytosol"		"HPA038134: AB_10669517"	"unprognostic (1.51e-1)"	"unprognostic (4.35e-2)"	"unprognostic (1.41e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.08e-1)"	"unprognostic (7.88e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.41e-1)"	"unprognostic (3.09e-1)"	"unprognostic (4.22e-2)"	"unprognostic (5.33e-2)"	"unprognostic (7.41e-2)"	"prognostic favorable (9.14e-8)"	"unprognostic (6.73e-2)"	"unprognostic (1.57e-1)"	"unprognostic (1.05e-1)"	"unprognostic (7.04e-2)"	6.9	9.1	5.5	4.8	6.5	2.7	6.5	6.3	6.5	6.7	8.9	6.2	5.0	5.8	7.0	5.1	7.4	4.2	6.2	5.5	6.0	5.6	8.3	4.8	7.7	6.8	6.3	7.1	12.4	5.6	6.8	3.6	6.3	6.7	3.2	2.7	10.7	6.2	6.4	8.5	6.8	4.4	6.7	7.0	6.4	3.9	6.1	5.4	5.0	3.2	4.6	5.9	5.6	8.0	11.9	13.1	2.9	11.6	12.1	10.0	1.8	4.7	2.9	1.4	4.7	2.8	20.7	1.8	27.5	5.2	7.7	11.3	3.9	7.4	1.1	15.8	6.4	3.2	8.3	4.8	10.4	1.9	3.5	12.8	12.1	4.0	7.6	7.4	4.2	7.4	2.9	15.0	6.7	14.7	6.8	2.6	2.1	14.2	18.4	6.5	2.0	20.1	9.2	3.9	4.4	4.1	8.2	6.9	5.8	3.2	11.9	4.0	7.3	2.4	2.6	10.1	2.9	10.9	7.7	2.5	6.9	7.7	1.7	31.5	15.2	19.6	21.5	11.7	21.8	14.6	25.9	23.1	11.4	18.8	31.6	19.5	14.1	17.0	11.4	30.6	29.3	17.7	5.5	6.5	6.3	6.5	5.5	6.0	6.8	6.3	6.3	6.7	6.1	8.0	6.7	0.0	6.3	3.9	4.7	2.8	6.1	11.7	5.2	4.8	9.4	9.8	5.2	12.8	5.1	7.3	6.2	13.3	8.5	5.9	1.9	10.1	0.3	9.4	5.4	7.0	2.4	4.0	1.5	8.7	10.8	6.8	3.6	7.9	3.8	9.0	7.9	16.1	12.4	1.7	1.8	8.2	12.2	7.0	3.3	0.6	14.6	7.1	10.6	0.0	7.0	14.6	5.2	0.5	3.7	9.9	3.8	14.3	3.6	5.9	12.0	8.7	6.5	6.0	6.6	7.8	5.5	1.7	9.4	4.3	4.7	9.9	6.9	14.7	8.1	3.8
TMEM192	FLJ38482	ENSG00000170088	"Transmembrane protein 192"	Q8IY95	4	165070608-165208549	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014717, HPA024110"	Enhanced		Supported	Nucleoplasm,Endosomes,Lysosomes		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 81: Kidney & Liver - Metabolism"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"	"Endosomes, Lysosomes"	Nucleoplasm	"HPA014717: AB_1844373, HPA024110: AB_2204898"	"prognostic unfavorable (9.52e-4)"	"unprognostic (5.38e-3)"	"unprognostic (9.16e-2)"	"unprognostic (4.39e-2)"	"unprognostic (2.60e-2)"	"unprognostic (1.55e-2)"	"unprognostic (2.91e-3)"	"unprognostic (8.43e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.10e-1)"	"unprognostic (3.27e-2)"	"unprognostic (5.06e-2)"	"prognostic favorable (2.33e-14)"	"unprognostic (2.09e-2)"	"unprognostic (1.37e-1)"	"unprognostic (2.76e-2)"	"unprognostic (9.30e-2)"	12.0	15.2	4.9	7.2	5.9	6.6	13.2	7.5	7.0	9.9	7.1	11.5	9.7	10.5	9.0	8.8	11.2	10.3	12.6	4.8	5.2	48.3	45.2	10.6	8.9	4.7	5.5	24.5	22.3	24.6	5.1	10.8	5.0	22.1	13.3	10.7	14.5	8.4	15.0	5.4	9.3	8.6	4.6	9.1	10.5	9.8	4.8	6.6	26.8	17.0	7.7	8.5	5.4	6.2	13.5	19.9	7.1	18.0	18.1	6.4	16.5	20.1	29.4	20.5	22.8	11.7	21.6	29.5	11.7	13.0	33.4	11.8	26.8	20.6	23.6	19.2	13.8	16.4	14.1	13.4	46.1	41.0	21.2	23.3	42.8	18.4	37.4	17.8	17.0	15.6	28.4	48.1	25.4	29.4	7.1	12.0	14.8	28.1	16.9	16.0	6.2	27.1	16.4	19.6	15.2	15.9	31.4	49.1	31.9	10.4	23.9	18.5	12.6	9.0	11.1	28.6	23.0	46.9	67.0	40.8	21.6	22.2	36.6	2.9	16.6	4.8	12.1	14.9	16.3	26.7	9.4	12.6	15.7	20.2	10.4	12.6	1.7	18.7	8.3	16.3	8.5	10.7	4.9	5.9	7.5	7.0	4.8	5.2	4.7	5.5	5.0	4.6	4.8	6.2	12.3	32.1	36.2	18.9	24.0	9.7	18.4	10.5	10.2	33.0	21.5	15.7	35.0	42.9	19.1	55.2	16.7	31.4	15.4	17.0	11.7	21.0	26.4	11.2	17.0	19.0	21.7	10.1	16.4	25.8	20.5	18.9	7.7	15.5	40.4	26.1	27.8	77.7	38.2	37.0	16.5	18.2	6.1	27.4	17.7	11.1	39.7	22.3	28.4	11.2	21.3	35.8	28.8	14.6	20.9	11.5	14.3	33.4	11.8	33.7	26.3	63.4	10.9	27.1	6.6	30.7	20.7	17.8	18.3	12.0	12.9	33.7	15.9	27.1	24.0	14.2
TMEM199	"C17orf32, MGC45714, VMA12, VPH2"	ENSG00000244045	"Transmembrane protein 199"	Q8N511	17	28357642-28363683	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Congenital disorder of glycosylation, Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA027051	Uncertain					NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 3: Monocytes - Immune response regulation"			"HPA027051: AB_10600915"	"unprognostic (3.01e-1)"	"unprognostic (3.45e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (5.55e-4)"	"unprognostic (9.98e-2)"	"unprognostic (4.60e-2)"	"prognostic unfavorable (1.54e-4)"	"unprognostic (1.67e-2)"	"unprognostic (5.26e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.38e-3)"	"unprognostic (1.09e-1)"	"unprognostic (9.25e-2)"	"unprognostic (2.75e-1)"	"unprognostic (1.99e-1)"	"unprognostic (3.51e-3)"	"unprognostic (5.95e-2)"	8.3	11.9	9.2	10.3	10.4	13.3	8.6	10.1	13.0	9.1	9.6	9.0	7.4	9.5	9.6	10.6	8.0	6.2	9.3	9.5	10.5	12.9	14.4	8.5	12.7	10.2	10.1	8.0	8.9	15.5	11.7	9.5	10.1	9.8	7.9	13.9	9.5	6.8	7.2	11.6	9.0	6.2	9.5	13.2	8.9	7.8	10.4	12.8	10.8	7.5	11.2	8.8	8.8	12.0	12.2	20.4	19.6	16.7	7.9	6.8	16.5	14.8	9.5	20.6	18.5	48.9	9.6	17.6	14.8	11.0	26.4	20.6	21.8	13.9	18.0	32.8	19.6	13.0	17.7	23.6	15.9	18.7	22.0	9.7	12.6	19.6	13.0	12.2	10.2	16.1	21.6	21.8	15.4	24.1	21.3	25.6	16.2	21.0	13.9	17.2	24.4	16.3	15.5	20.2	24.8	26.0	17.8	45.6	27.1	20.1	28.7	16.9	14.0	17.4	13.5	15.0	25.3	29.3	38.9	16.2	21.6	11.4	22.2	28.5	24.2	20.0	15.1	25.2	16.6	17.1	13.1	13.4	20.0	16.0	16.4	14.5	18.9	15.6	23.0	14.0	14.9	19.1	9.2	10.4	10.1	13.0	9.5	10.5	10.2	10.1	10.1	9.5	10.4	12.0	12.4	32.1	8.6	8.8	21.0	5.7	10.5	34.3	15.4	13.8	14.3	14.4	5.6	12.8	23.5	9.2	8.4	40.2	15.5	21.1	43.0	40.2	3.7	12.0	11.4	14.6	15.6	12.2	11.0	31.4	38.1	10.6	7.7	10.9	7.6	11.9	17.5	26.8	51.3	11.8	10.5	15.7	32.6	22.9	9.5	4.5	11.5	22.4	21.4	6.5	45.0	19.1	25.7	7.5	13.7	35.4	19.4	6.4	15.1	13.1	20.3	54.0	15.1	14.0	13.1	8.6	14.2	26.5	35.4	14.0	8.8	48.4	15.2	14.7	13.0	11.4
TMEM202	FLJ27523	ENSG00000187806	"Transmembrane protein 202"	A6NGA9	15	72398302-72408367	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Tissue enriched"	"Detected in single"	116	"testis: 12.3"	"Group enriched"	"Detected in some"	34	"Early spermatids: 67.6;Late spermatids: 58.5;Spermatocytes: 61.2"	"Cancer enriched"	"Detected in single"	11	"testis cancer: 0.5"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA				"Cluster 74: Testis - Spermatogenesis"		"Cluster 66: Spermatocytes - Spermatogenesis"																		"unprognostic (1.31e-1)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.6	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	58.5	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	61.2	1.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TMEM203	"HBEBP1, MGC14327"	ENSG00000187713	"Transmembrane protein 203"	Q969S6	9	137204082-137205648	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"				"unprognostic (1.31e-1)"	"unprognostic (2.65e-2)"	"unprognostic (4.53e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.10e-1)"	"unprognostic (6.54e-2)"	"unprognostic (2.72e-2)"	"unprognostic (1.78e-1)"	"unprognostic (1.43e-1)"	"unprognostic (7.16e-2)"	"prognostic favorable (4.78e-6)"	"unprognostic (2.94e-1)"	"prognostic favorable (1.50e-5)"	"unprognostic (3.50e-3)"	"unprognostic (1.57e-1)"	"unprognostic (4.04e-2)"	"unprognostic (1.19e-1)"	25.7	32.6	32.8	17.2	33.6	10.9	25.5	33.8	36.8	28.1	33.1	30.2	22.2	29.9	26.4	31.4	24.2	16.4	45.9	32.9	33.4	33.2	49.2	20.5	27.0	33.6	33.6	27.7	26.2	30.7	25.6	15.9	33.4	27.1	18.2	16.4	26.8	21.8	49.7	43.6	28.5	16.9	32.8	30.4	30.1	19.1	34.9	20.3	25.1	45.9	22.7	27.8	27.6	33.0	38.0	39.3	36.5	60.7	53.1	41.1	43.6	48.4	46.6	55.1	41.1	32.6	33.3	39.0	45.7	42.2	53.0	72.6	45.3	48.1	32.1	71.0	43.5	27.0	45.5	37.4	44.3	63.1	26.8	39.6	75.4	36.0	47.4	36.8	35.8	50.5	64.2	44.4	43.2	65.2	50.5	54.6	60.8	72.4	63.2	54.2	51.1	78.2	46.5	27.2	48.3	47.3	38.6	48.8	39.2	25.0	68.8	50.6	32.0	56.3	30.1	63.6	55.1	23.8	80.0	49.5	43.5	46.3	47.3	4.7	3.8	4.1	5.2	4.3	6.4	8.3	5.8	6.5	4.6	4.5	8.7	6.0	1.9	7.5	3.9	4.8	4.0	2.6	32.8	33.6	33.8	36.8	32.9	33.4	33.6	33.6	33.4	32.8	34.9	33.0	23.2	9.6	6.8	4.6	21.4	17.6	22.7	7.0	23.9	33.6	29.6	33.8	13.5	40.0	7.9	31.3	4.2	30.5	23.7	15.9	52.8	49.4	3.5	15.3	24.2	20.7	16.3	29.8	5.7	42.0	26.3	22.3	14.8	13.3	5.7	31.7	21.4	41.1	29.3	32.0	6.2	13.4	10.2	27.1	13.2	9.4	22.1	20.8	24.9	5.6	54.2	58.8	24.7	2.5	6.1	41.7	10.8	20.7	13.3	37.2	18.5	59.2	4.9	25.7	13.1	19.5	32.5	18.6	15.9	28.5	27.3	19.4	24.4	36.2	18.6	17.9
TMEM204	"C16orf30, CLP24, FLJ20898"	ENSG00000131634	"Transmembrane protein 204"	Q9BSN7	16	1528688-1555580	"Predicted membrane proteins, Transporters"	"Stress response"			"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 208.2;Endothelial cells: 95.9;Hepatic stellate cells: 133.2;Peritubular cells: 67.4;Sertoli cells: 118.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"naive CD4 T-cell: 156.6"	"Lineage enriched"	"Detected in many"	5	"T-cells: 156.6"	"Cell line enhanced"	"Detected in some"		"ASC TERT1: 12.5;BJ: 16.5;BJ hTERT+: 21.2;fHDF/TERT166: 14.2;HHSteC: 36.9;HSkMC: 14.8;TIME: 12.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014028	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 82: Adipose tissue - ECM organization"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"HPA014028: AB_2204906"	"unprognostic (1.51e-1)"	"unprognostic (6.35e-2)"	"unprognostic (3.81e-3)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (1.81e-2)"	"prognostic favorable (4.76e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (8.44e-2)"	"unprognostic (2.95e-2)"	"unprognostic (4.04e-2)"	"unprognostic (7.62e-3)"	"unprognostic (5.11e-3)"	"unprognostic (3.18e-2)"	"unprognostic (1.60e-2)"	"unprognostic (2.53e-2)"	48.6	20.9	15.1	7.8	13.4	0.5	43.3	13.2	16.3	36.8	11.0	28.4	6.5	35.9	4.0	12.1	26.9	12.9	70.4	11.8	12.2	45.9	17.2	71.5	16.4	13.8	14.3	17.5	15.8	7.4	14.6	12.8	15.1	28.3	2.8	0.5	16.8	14.4	18.0	18.9	25.3	11.2	12.1	24.2	22.1	8.2	16.1	7.9	49.0	16.1	5.4	28.8	20.7	11.7	0.1	0.1	0.9	0.1	7.5	12.5	0.2	16.5	21.2	2.5	2.6	0.6	0.1	0.1	0.1	14.2	0.0	0.3	0.0	0.0	1.1	0.1	0.1	0.0	0.8	0.2	36.9	0.0	0.0	14.8	0.0	0.0	0.0	0.0	6.7	0.0	0.1	0.1	0.0	0.2	0.0	0.2	0.3	0.0	0.2	0.7	0.0	0.2	0.0	0.2	0.5	0.3	0.5	0.1	1.8	0.4	0.0	0.0	12.6	0.1	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	4.4	0.3	0.7	0.0	24.5	0.9	45.2	0.6	80.0	55.0	1.8	1.3	156.6	82.2	2.8	34.1	0.8	0.6	38.1	41.1	15.1	13.4	13.2	16.3	11.8	12.2	13.8	14.3	15.1	12.1	16.1	11.7	208.2	0.0	3.7	0.7	4.5	5.7	7.1	17.1	1.2	0.2	3.4	4.4	8.3	0.0	1.6	0.0	0.0	0.5	6.5	0.0	0.0	0.3	0.8	1.9	33.6	95.9	0.0	5.7	0.7	0.2	0.2	31.8	0.0	0.8	0.0	2.3	133.2	1.1	0.4	0.0	0.6	0.0	2.0	3.8	5.7	1.3	23.6	5.6	7.2	30.0	1.4	0.2	12.3	0.0	0.6	0.0	0.0	67.4	0.5	1.1	0.0	0.1	0.2	0.8	118.3	3.3	43.0	0.0	0.2	0.7	3.1	0.4	15.3	17.2	0.0	5.1
TMEM205	"MBC3205, UNQ501"	ENSG00000105518	"Transmembrane protein 205"	Q6UW68	19	11342776-11346518	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Early spermatids: 405.8;Hepatocytes: 520.1;Late spermatids: 662.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA041504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Endoplasmic reticulum"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 35: Non-specific - Unknown function"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 15: Hepatocytes - Hemostasis"	"Endoplasmic reticulum"	"Nucleoplasm, Nuclear membrane"	"HPA041504: AB_10795595"	"unprognostic (2.54e-2)"	"unprognostic (2.60e-2)"	"unprognostic (7.19e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.83e-2)"	"unprognostic (1.80e-1)"	"unprognostic (5.04e-3)"	"unprognostic (3.77e-2)"	"unprognostic (1.01e-2)"	"unprognostic (5.56e-3)"	"unprognostic (2.70e-2)"	"unprognostic (1.19e-1)"	"unprognostic (8.10e-2)"	"unprognostic (5.78e-2)"	"unprognostic (8.18e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.45e-1)"	70.3	177.5	111.5	36.8	113.2	55.2	76.0	110.7	142.9	92.8	135.4	73.8	62.3	69.5	92.6	53.7	85.2	61.1	119.7	117.2	122.4	139.2	276.9	73.9	38.9	112.8	113.1	86.8	155.0	210.0	97.4	53.6	114.0	93.2	36.4	25.9	92.4	78.7	122.2	74.3	57.2	42.2	113.6	62.6	86.3	78.8	113.6	39.3	132.1	66.0	34.1	92.4	64.0	122.7	95.5	229.7	28.5	96.2	54.1	64.5	52.6	35.2	80.9	75.9	59.4	70.0	29.5	84.7	209.3	71.6	74.5	95.6	40.5	106.6	50.5	100.7	39.2	23.0	76.5	117.7	135.9	38.9	69.8	61.3	106.7	48.7	81.0	78.5	92.3	79.9	70.4	349.8	47.0	238.8	58.6	108.9	49.9	123.0	174.5	54.3	43.4	225.9	186.9	169.0	50.2	76.7	37.3	151.1	88.1	33.1	132.2	111.3	54.0	94.3	36.2	104.4	80.2	207.0	225.3	51.5	90.4	172.2	74.0	31.8	336.5	36.7	67.2	150.0	67.9	112.7	54.7	58.5	208.2	95.8	43.9	52.2	52.6	55.8	91.0	150.9	73.7	175.8	111.5	113.2	110.7	142.9	117.2	122.4	112.8	113.1	114.0	113.6	113.6	122.7	80.5	67.3	70.5	40.1	44.1	51.5	135.9	281.3	62.0	32.5	113.3	134.4	68.5	175.8	202.3	152.6	12.5	123.7	27.7	53.7	60.7	159.2	405.8	63.2	65.8	72.4	117.6	14.5	30.8	162.7	83.0	76.4	26.0	97.0	29.2	45.4	69.3	520.1	94.4	26.9	27.3	81.4	136.3	67.5	50.0	662.3	80.8	61.2	96.0	5.6	62.1	91.9	19.6	17.6	22.2	97.7	68.6	68.1	70.7	136.7	104.1	224.6	69.3	33.1	46.0	76.3	70.9	38.1	15.6	46.4	54.0	96.7	29.8	101.6	79.3	130.9
TMEM208	HSPC171	ENSG00000168701	"Transmembrane protein 208"	Q9BTX3	16	67227103-67229278	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA041868, HPA041949"	Supported					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 35: Non-specific - Unknown function"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA041868: AB_10962347, HPA041949: AB_10959903"	"unprognostic (9.42e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.36e-3)"	"unprognostic (2.05e-2)"	"unprognostic (2.23e-2)"	"prognostic unfavorable (9.63e-5)"	"unprognostic (2.02e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.27e-1)"	"unprognostic (2.44e-1)"	"unprognostic (6.53e-2)"	"unprognostic (6.40e-2)"	"unprognostic (1.31e-2)"	"unprognostic (2.29e-1)"	"unprognostic (5.18e-2)"	"unprognostic (7.73e-2)"	"unprognostic (9.42e-2)"	35.5	83.8	41.8	31.7	41.9	22.5	40.3	44.0	50.1	34.7	50.3	42.9	45.8	29.2	57.5	41.0	32.7	27.8	26.6	41.8	44.8	52.9	124.7	34.9	28.0	43.8	44.6	25.2	65.3	67.6	62.6	32.7	43.9	34.1	41.7	13.8	44.9	31.1	26.5	32.9	39.1	28.1	43.4	38.2	47.4	30.4	43.8	26.5	41.3	19.0	32.1	36.9	28.7	44.9	64.6	82.1	40.0	48.6	124.3	59.3	73.4	66.3	83.3	72.1	61.4	106.4	80.1	63.4	76.1	93.8	64.6	86.2	64.4	89.8	45.6	27.9	90.1	34.9	64.0	110.1	128.6	56.2	91.6	79.9	112.7	95.1	82.1	51.5	54.3	57.6	61.2	81.4	85.7	128.0	56.2	82.5	67.2	105.5	56.1	61.0	48.7	186.2	97.4	42.9	66.2	67.6	119.1	50.2	54.8	27.2	65.0	70.7	33.8	54.5	35.9	78.3	74.0	122.7	127.9	131.8	96.0	54.1	79.8	79.2	108.5	59.4	74.0	102.7	66.5	70.7	68.7	63.9	85.1	58.5	56.1	61.6	69.7	53.3	81.3	168.5	74.2	93.9	41.8	41.9	44.0	50.1	41.8	44.8	43.8	44.6	43.9	43.4	43.8	44.9	51.7	25.6	36.9	8.1	71.8	51.7	79.5	131.0	48.9	44.7	92.1	96.9	29.8	102.9	111.1	57.0	33.3	98.9	69.2	81.8	60.7	158.8	19.8	57.6	54.3	49.5	76.8	31.6	7.8	202.0	142.9	66.7	50.0	64.1	53.3	47.1	43.5	209.6	120.5	26.9	9.3	119.0	140.4	54.7	53.6	7.4	62.1	59.4	88.9	6.5	90.2	102.6	55.6	9.0	12.3	129.7	107.8	41.8	197.3	137.6	145.4	162.7	109.7	55.5	26.3	43.6	100.6	68.4	58.4	62.7	51.9	143.7	52.4	65.9	95.4	128.0
TMEM212	FLJ23172	ENSG00000186329	"Transmembrane protein 212"	A6NML5	3	171843349-171938715	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"brain: 15.8;fallopian tube: 30.2"	"Cell type enhanced"	"Detected in some"		"Alveolar cells type 1: 35.3;Alveolar cells type 2: 30.9;Club cells: 25.8;granulocytes: 15.2;Respiratory ciliated cells: 102.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA045736			Approved	"Nucleoli fibrillar center,Endoplasmic reticulum"		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 21: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 49: Ciliated cells - Cilium organization"	"Nucleoli fibrillar center, Endoplasmic reticulum"		"HPA045736: AB_2679436"	"unprognostic (3.39e-2)"			"unprognostic (1.78e-2)"	"unprognostic (3.05e-1)"			"unprognostic (5.54e-2)"		"unprognostic (3.06e-1)"				"unprognostic (2.87e-1)"				1.0	0.9	2.6	1.5	5.7	3.8	0.9	15.8	12.9	0.9	0.8	1.9	1.0	1.7	1.6	0.6	30.2	1.1	0.9	4.9	0.6	0.8	6.5	4.2	1.6	0.6	1.7	1.4	0.9	0.8	0.0	1.2	1.3	1.1	1.9	7.9	1.4	0.6	2.6	2.7	1.4	0.5	0.0	1.5	1.2	2.8	3.1	0.6	1.3	0.3	1.0	0.6	0.0	10.8	2.1	1.5	1.5	1.5	0.4	0.1	3.0	1.2	0.5	0.6	0.6	1.3	1.7	3.0	1.5	0.9	1.4	1.4	1.0	0.8	1.4	4.3	1.4	2.7	4.5	1.5	0.2	2.4	2.2	0.7	0.6	0.8	0.6	0.7	0.8	1.8	2.2	4.5	0.5	1.7	1.7	2.2	2.4	0.9	1.3	1.4	2.1	2.2	0.6	2.2	1.9	1.6	2.1	1.6	1.1	1.4	1.6	1.6	3.6	2.0	2.4	3.4	1.5	2.7	2.3	1.8	1.1	1.4	1.1	3.2	0.7	0.6	0.8	0.6	0.6	0.5	0.5	0.5	0.3	1.1	0.6	0.7	1.5	1.2	0.7	1.1	0.4	0.2	2.6	5.7	15.8	12.9	4.9	0.6	0.6	1.7	1.3	0.0	3.1	10.8	0.0	35.3	30.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.1	0.0	25.8	0.0	0.0	0.0	0.0	0.1	0.0	0.0	1.2	9.2	0.2	3.6	0.0	0.0	0.1	0.0	0.0	2.7	0.0	0.1	15.2	0.1	0.0	0.0	0.0	0.0	0.1	0.0	4.1	0.0	0.0	0.5	0.3	1.9	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	102.7	0.0	0.0	0.3	0.3	0.7	0.5	0.0	0.1	0.0	1.8	0.0	0.0	0.1
TMEM223	MGC3196	ENSG00000168569	"Transmembrane protein 223"	A0PJW6	11	62771629-62792006	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014504	Approved		Approved	"Nucleoplasm,Nuclear membrane,Mitochondria"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 39: Non-specific - Basic cellular processes"	"Nucleoplasm, Nuclear membrane, Mitochondria"		"HPA014504: AB_1853881"	"unprognostic (1.35e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.87e-1)"	"unprognostic (3.15e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.97e-1)"	"unprognostic (4.35e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.29e-1)"	"unprognostic (2.50e-1)"	"unprognostic (5.20e-2)"	"unprognostic (7.26e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.14e-3)"	"unprognostic (9.75e-2)"	13.1	20.9	10.4	9.4	12.0	6.4	12.8	12.4	13.4	13.2	11.6	15.7	11.0	12.9	9.7	13.3	11.7	5.5	27.9	10.4	10.5	17.3	22.5	11.1	12.0	11.6	10.2	11.4	19.8	8.0	13.2	7.1	11.8	14.8	7.4	5.2	15.3	7.2	16.1	13.3	14.4	5.3	10.0	16.6	15.4	6.7	10.4	7.3	13.8	8.5	7.0	12.2	11.1	12.1	29.2	24.4	14.3	19.6	11.8	13.5	19.5	15.3	13.4	16.9	14.1	21.5	34.9	21.6	36.8	11.1	22.5	43.3	17.3	18.9	9.6	34.7	32.5	16.1	26.9	25.9	20.6	20.0	18.4	14.4	18.8	11.2	13.9	20.3	13.9	28.2	24.8	15.8	12.6	42.3	20.3	44.3	28.2	30.2	29.2	24.7	17.3	48.8	26.8	18.3	24.3	32.0	16.0	32.3	43.0	14.5	48.1	18.4	13.9	20.2	24.4	18.7	18.5	32.1	27.5	25.1	24.0	17.8	21.5	21.0	41.3	25.0	71.3	46.2	68.8	77.6	69.8	69.9	46.8	81.8	74.9	73.0	19.0	66.2	29.8	75.6	66.8	41.5	10.4	12.0	12.4	13.4	10.4	10.5	11.6	10.2	11.8	10.0	10.4	12.1	31.9	12.8	5.6	4.2	24.1	13.5	15.3	39.7	8.6	17.9	27.6	45.0	18.8	52.9	25.2	20.2	12.5	49.4	22.8	30.2	62.6	37.2	2.6	29.1	26.9	28.9	20.5	18.5	6.1	44.3	42.9	22.0	15.3	22.3	19.7	22.4	31.8	36.0	37.6	6.7	8.0	32.6	38.7	20.1	13.6	3.4	32.6	16.2	19.6	4.7	16.2	16.5	35.0	6.0	5.7	36.1	19.3	26.4	25.4	22.4	32.1	52.3	39.6	18.0	19.7	22.3	17.9	6.9	19.7	21.3	13.9	14.2	24.3	34.2	43.4	17.1
TMEM230	"C20orf30, HSPC274"	ENSG00000089063	"Transmembrane protein 230"	Q96A57	20	5068232-5113103	"Predicted membrane proteins, Transporters"			"Disease variant, Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal tubular cells: 502.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA009078, HPA061421"	Uncertain		Enhanced	"Endoplasmic reticulum"		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 15: Liver - Metabolism"	"Cluster 37: Hep G2 - Hepatocyte cell processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"		"HPA009078: AB_1078345, HPA061421: AB_2684513"	"unprognostic (1.39e-1)"	"unprognostic (3.61e-1)"	"unprognostic (3.73e-1)"	"unprognostic (1.28e-1)"	"unprognostic (3.71e-2)"	"unprognostic (9.67e-3)"	"unprognostic (5.85e-3)"	"unprognostic (4.34e-3)"	"unprognostic (4.18e-2)"	"unprognostic (1.65e-1)"	"unprognostic (2.74e-1)"	"unprognostic (4.07e-2)"	"unprognostic (9.70e-2)"	"unprognostic (2.31e-1)"	"unprognostic (2.09e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.55e-2)"	140.5	120.1	89.7	60.4	98.6	60.4	88.4	101.9	110.7	108.3	113.6	83.9	62.3	88.9	120.4	57.3	87.1	97.7	101.4	88.2	100.2	145.7	197.8	75.8	81.0	98.9	95.1	97.4	95.1	99.3	89.5	72.5	99.1	105.5	88.7	107.4	78.9	83.1	107.1	34.4	70.2	88.9	95.3	71.8	87.6	49.7	96.0	85.6	135.5	148.3	76.6	93.3	56.6	111.8	157.2	108.1	139.1	105.2	307.1	271.6	105.6	124.0	185.4	119.9	131.4	86.0	152.4	74.8	99.5	180.7	136.6	127.1	104.5	185.2	172.3	83.6	119.6	132.6	31.5	266.3	196.3	154.9	52.8	189.3	202.4	92.2	183.3	167.0	160.1	163.6	126.1	200.3	199.2	44.7	156.9	143.8	106.3	298.8	152.4	100.4	93.2	161.5	182.5	79.4	116.8	141.7	74.6	154.8	270.0	149.0	123.9	145.6	135.7	154.7	90.5	150.1	135.2	133.2	284.3	147.5	62.5	132.2	166.3	128.9	175.4	116.7	136.5	187.1	166.3	170.7	145.8	145.3	163.8	153.1	150.8	148.6	55.7	153.9	180.6	161.2	147.6	349.2	89.7	98.6	101.9	110.7	88.2	100.2	98.9	95.1	99.1	95.3	96.0	111.8	126.6	57.7	64.6	15.3	123.4	70.4	126.7	148.7	65.4	89.6	151.7	133.7	51.3	111.5	95.1	154.5	64.6	173.4	127.8	55.0	502.9	146.6	200.3	77.1	103.2	109.5	95.8	103.7	20.2	111.2	208.8	141.6	59.1	64.1	114.1	82.8	126.7	147.5	212.8	62.2	27.7	123.1	126.1	162.9	172.9	89.5	212.2	121.9	199.3	14.0	215.6	113.9	151.4	13.0	49.6	100.2	130.0	220.4	161.7	129.6	102.0	363.2	81.9	113.3	85.5	100.4	128.0	99.4	97.5	68.1	60.5	148.0	118.2	184.2	125.6	152.1
TMEM234	"C1orf91, dJ622L5.7, FLJ90779, RP4-622L5"	ENSG00000160055	"Transmembrane protein 234"	Q8WY98	1	32214472-32222359	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 55.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA015049	Uncertain		Approved	Vesicles		NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 51: Non-specific - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA015049: AB_1856409"	"unprognostic (1.39e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.52e-1)"	"unprognostic (1.26e-1)"	"unprognostic (2.44e-3)"	"unprognostic (3.09e-1)"	"prognostic unfavorable (2.35e-5)"	"unprognostic (2.67e-1)"	"unprognostic (1.07e-2)"	"unprognostic (6.49e-2)"	"unprognostic (2.66e-2)"	"unprognostic (1.05e-1)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (1.95e-1)"	"unprognostic (2.44e-1)"	"unprognostic (7.92e-2)"	"unprognostic (2.37e-2)"	6.5	7.4	5.7	2.6	5.8	2.8	6.8	5.0	6.4	7.9	7.4	6.4	2.2	7.6	9.4	9.0	7.3	3.4	9.2	5.7	6.1	9.7	6.3	6.4	3.5	5.9	6.7	9.9	5.8	6.9	12.3	5.9	6.0	8.5	4.1	6.1	7.2	7.0	3.0	4.8	5.2	4.4	5.2	7.5	5.6	9.0	5.8	3.1	12.3	1.7	3.5	6.6	7.6	5.4	10.0	7.5	4.2	4.4	12.0	9.4	4.4	14.6	10.5	7.3	5.5	5.4	9.8	3.1	16.1	13.5	5.7	8.0	5.4	10.5	6.2	6.4	5.9	6.1	11.9	6.2	8.7	7.4	4.0	11.9	10.5	7.6	5.5	12.8	10.7	3.3	5.9	1.9	12.4	3.0	2.9	6.2	7.6	2.5	5.7	4.0	3.3	3.6	16.3	5.1	5.3	5.4	10.6	5.7	5.0	13.6	2.8	2.3	12.9	2.6	4.1	10.3	10.6	3.1	1.8	1.3	8.0	2.6	9.8	25.9	11.9	19.1	5.8	13.3	9.3	6.9	4.6	6.6	11.4	6.9	3.3	4.2	35.8	10.8	9.3	8.6	3.1	6.7	5.7	5.8	5.0	6.4	5.7	6.1	5.9	6.7	6.0	5.2	5.8	5.4	7.5	9.6	1.5	10.4	8.3	2.7	6.6	14.5	5.2	5.3	9.0	9.1	3.6	4.3	11.4	23.9	2.1	26.0	5.0	17.4	1.9	20.9	27.8	17.9	9.1	7.5	6.0	7.4	10.8	15.5	23.0	9.1	16.3	10.0	3.8	10.8	6.4	5.6	19.3	1.7	7.8	11.8	10.2	8.3	3.2	55.6	9.3	8.2	14.2	8.4	11.4	8.6	9.2	3.5	2.8	18.4	12.2	7.9	5.1	5.6	12.5	11.0	23.7	13.5	6.6	5.7	9.2	31.8	15.0	5.9	3.1	21.3	6.9	15.2	9.9	8.0
TMEM237	"ALS2CR4, JBTS14"	ENSG00000155755	"Transmembrane protein 237"	Q96Q45	2	201620184-201643570	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Ciliopathy, Joubert syndrome"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	5	"retina: 89.3"	"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 81.7;Rod photoreceptor cells: 160.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052596, HPA054732"	Enhanced					NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 79: Retina - Phototransduction"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 46: Photoreceptor cells - Phototransduction"			"HPA052596: AB_2681879, HPA054732: AB_2682587"	"unprognostic (1.70e-1)"	"unprognostic (7.10e-2)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.51e-4)"	"unprognostic (1.73e-1)"	"unprognostic (4.06e-1)"	"unprognostic (8.30e-6)"	"unprognostic (4.15e-1)"	"prognostic unfavorable (1.33e-4)"	"unprognostic (2.62e-3)"	"unprognostic (2.46e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavorable (7.96e-6)"	"unprognostic (1.32e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.71e-1)"	4.1	15.1	6.3	1.7	6.5	2.3	11.0	7.1	7.8	5.0	6.0	3.0	0.8	6.0	4.6	6.0	5.8	4.1	7.7	6.8	6.7	5.4	1.9	5.1	2.3	6.9	6.9	8.4	1.9	5.0	3.0	5.2	7.2	7.8	3.7	89.3	5.1	4.8	7.7	18.5	1.8	5.8	7.1	1.4	2.2	3.0	6.4	7.0	4.6	9.2	3.1	4.1	3.4	6.8	3.7	7.2	32.3	16.4	7.8	10.1	3.1	22.6	9.9	14.7	28.4	5.9	5.3	3.7	6.9	21.9	12.7	6.8	5.6	24.4	27.1	6.9	20.6	10.7	21.4	19.4	15.1	10.4	2.1	9.0	5.0	20.4	5.1	24.8	25.5	23.4	7.8	13.0	29.8	5.2	29.7	16.3	32.7	1.9	23.8	43.9	30.8	7.6	12.2	9.7	33.7	47.4	21.4	8.4	12.6	20.3	12.5	18.7	6.8	26.8	7.3	8.6	9.5	6.0	14.9	11.4	22.7	9.7	17.0	0.0	0.0	0.0	1.0	1.1	0.9	0.7	1.0	1.6	1.3	0.1	1.1	1.4	0.0	0.9	0.7	0.3	1.8	0.5	6.3	6.5	7.1	7.8	6.8	6.7	6.9	6.9	7.2	7.1	6.4	6.8	6.8	6.4	9.6	12.4	1.6	71.2	81.7	46.7	50.7	33.3	17.1	41.4	20.2	2.8	18.9	18.4	41.7	21.0	3.1	0.6	13.7	11.1	8.9	16.3	10.9	11.6	4.8	8.6	16.5	7.6	26.8	25.8	3.1	7.7	5.1	19.9	10.4	2.7	9.4	32.0	15.3	4.5	18.3	2.2	12.2	7.0	21.8	2.9	12.4	4.7	5.7	38.5	0.0	14.1	10.8	6.5	1.9	21.4	3.0	36.9	0.7	3.9	19.8	160.3	6.6	33.2	20.6	33.3	22.0	30.0	45.3	15.1	4.2	39.8	5.3	29.2
TMEM25	FLJ14399	ENSG00000149582	"Transmembrane protein 25"	Q86YD3	11	118531041-118547280	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 149.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"hTERT-RPE1: 35.9;SK-BR-3: 33.7;T-47d: 43.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"HPA012163, HPA051562"	Approved		Approved	"Golgi apparatus,Vesicles"	"Intracellular and membrane"	NA	NA		6900000	"Cluster 48: NK-cells - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 45: Enterocytes - Digestion"	"Golgi apparatus, Vesicles"		"HPA012163: AB_1858112, HPA051562: AB_2681535"	"unprognostic (1.53e-2)"	"unprognostic (7.18e-2)"	"unprognostic (2.43e-1)"	"unprognostic (6.69e-2)"	"unprognostic (3.61e-1)"	"unprognostic (6.50e-2)"	"unprognostic (1.71e-1)"	"unprognostic (4.45e-3)"	"unprognostic (1.58e-1)"	"unprognostic (3.42e-1)"	"unprognostic (1.66e-2)"	"unprognostic (8.19e-2)"	"prognostic favorable (0.00e+0)"	"unprognostic (1.15e-1)"	"unprognostic (2.51e-1)"	"unprognostic (1.26e-1)"	"unprognostic (7.01e-2)"	6.9	25.3	35.0	3.8	36.0	2.2	14.6	33.9	44.3	14.9	32.2	16.0	46.0	15.3	25.7	11.1	13.7	8.9	8.9	37.5	36.7	18.6	23.1	9.9	4.8	32.1	30.3	23.4	17.6	23.3	29.5	6.0	32.0	15.7	3.7	22.3	21.0	18.3	18.5	8.7	35.2	10.8	31.5	5.3	13.3	6.5	35.1	5.1	15.9	9.9	5.3	14.4	11.6	35.1	3.4	0.7	5.8	9.5	6.0	0.9	5.6	5.2	9.9	4.9	9.8	27.1	18.8	0.3	20.1	5.3	10.9	14.8	0.0	18.3	4.4	11.9	11.1	0.5	5.4	6.0	16.0	0.3	0.5	7.3	10.9	5.3	0.9	35.9	7.2	13.7	2.6	11.7	4.9	4.1	6.0	0.5	4.9	0.1	12.8	8.1	4.2	12.3	25.3	0.3	17.0	11.5	5.1	33.7	0.1	8.7	43.8	0.6	2.5	2.1	10.6	0.4	1.6	11.7	8.3	3.1	0.4	0.2	0.2	0.7	0.2	0.2	5.1	0.2	7.1	4.0	7.3	2.9	0.5	2.6	10.0	5.4	0.4	7.4	0.2	3.4	6.0	3.5	35.0	36.0	33.9	44.3	37.5	36.7	32.1	30.3	32.0	31.5	35.1	35.1	5.1	6.4	3.9	11.1	6.2	5.7	10.7	14.7	13.1	27.7	27.7	30.6	6.1	14.3	9.3	16.5	29.2	37.1	4.8	0.9	11.7	16.6	2.8	4.1	5.0	6.4	11.4	5.2	20.1	6.4	16.9	8.7	2.6	5.5	8.9	18.0	3.6	9.6	2.9	11.8	22.0	7.8	10.2	0.0	1.9	5.5	23.3	1.1	7.2	2.8	3.4	28.8	5.2	8.5	6.5	5.0	5.5	23.3	5.5	5.5	149.1	25.6	7.4	41.1	0.0	12.1	7.5	3.9	5.2	4.0	3.7	16.3	4.7	15.3	15.0	5.7
TMEM255A	"FAM70A, FLJ20716"	ENSG00000125355	"Transmembrane protein 255A"	Q5JRV8	X	120258650-120311556	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 48.7;ovary: 19.6"	"Group enriched"	"Detected in some"	4	"Oligodendrocyte precursor cells: 32.6;Skeletal myocytes: 14.6"	"Group enriched"	"Detected in many"	10	"glioma: 21.3;melanoma: 8.0;renal cancer: 7.5"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"gdT-cell: 2.8"	"Lineage enriched"	"Detected in single"	9	"T-cells: 2.8"	"Cell line enhanced"	"Detected in some"		"Karpas-707: 25.3;NTERA-2: 9.5;RPMI-8226: 17.1;SK-MEL-30: 27.7;U-2 OS: 11.8;U-87 MG: 29.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA048470	Approved		Uncertain	"Nucleoplasm,Nuclear bodies"		No	No			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 50: Fibroblasts - ECM organization"	"Nucleoplasm, Nuclear bodies"		"HPA048470: AB_2680406"	"unprognostic (3.41e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.62e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.38e-1)"	"unprognostic (1.56e-1)"	"unprognostic (8.55e-4)"	"unprognostic (7.08e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.49e-3)"	"unprognostic (2.02e-1)"	"unprognostic (1.32e-2)"	"unprognostic (3.13e-2)"	"unprognostic (1.45e-1)"	"unprognostic (6.17e-2)"	"unprognostic (2.55e-4)"	4.7	3.3	7.4	1.8	5.8	0.7	3.2	4.8	9.2	11.9	1.7	2.6	0.7	1.9	1.6	2.8	3.8	1.1	1.3	3.8	27.4	1.4	0.6	3.0	3.6	22.7	48.7	19.6	0.4	1.4	3.8	0.2	33.0	1.4	2.3	1.5	1.2	1.8	1.4	2.6	2.3	0.9	19.9	1.7	1.8	0.2	36.8	8.1	0.4	2.7	3.8	1.9	8.5	11.5	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.1	0.0	1.5	0.5	0.2	0.0	0.1	0.3	0.0	2.9	0.0	1.9	0.7	0.7	0.0	1.1	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.0	0.0	0.0	1.0	0.0	0.0	0.0	25.3	0.4	0.0	0.0	0.1	9.5	0.0	0.0	0.1	0.0	17.1	0.0	0.0	5.1	0.1	0.5	0.0	27.7	0.3	0.0	0.3	0.0	0.0	11.8	0.0	5.1	0.0	5.2	3.7	29.7	0.0	0.0	0.0	0.3	0.0	2.8	0.1	1.4	0.2	0.2	1.0	0.1	0.0	0.1	0.7	0.0	0.0	0.0	0.0	0.0	0.4	7.4	5.8	4.8	9.2	3.8	27.4	22.7	48.7	33.0	19.9	36.8	11.5	0.1	3.2	0.0	1.6	0.0	0.4	0.1	0.1	0.6	1.9	0.2	1.3	0.5	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.1	0.5	0.0	0.0	0.2	0.0	0.0	4.4	0.0	0.4	0.0	0.3	0.4	0.0	1.3	0.0	4.3	0.0	0.0	1.0	0.7	1.6	0.6	1.6	5.4	1.9	3.7	0.3	0.0	32.6	1.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.8	0.5	0.0	14.6	0.6	0.1	0.1	0.0	1.3	0.1	0.4	0.0	0.0	0.0
TMEM255B	"FAM70B, MGC20579"	ENSG00000184497	"Transmembrane protein 255B"	Q8WV15	13	113759226-113816995	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 65.0;Endothelial cells: 81.5;granulocytes: 39.3;Hepatic stellate cells: 105.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"basophil: 31.2"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 31.2"	"Cell line enhanced"	"Detected in many"		"HMC-1: 28.6;HUVEC TERT2: 38.8;PC-3: 39.3;RPMI-8226: 25.1;TIME: 35.9;U-87 MG: 40.6"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			HPA043334	Approved		Approved	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 72: Non-specific - Transcription"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Nucleoplasm		"HPA043334: AB_10795982"	"unprognostic (2.20e-1)"	"unprognostic (2.57e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.36e-1)"	"unprognostic (4.90e-2)"	"unprognostic (1.05e-1)"	"unprognostic (2.88e-1)"	"unprognostic (1.13e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.49e-3)"	"unprognostic (3.00e-2)"	"unprognostic (9.39e-2)"	"prognostic unfavorable (4.12e-5)"	"unprognostic (4.65e-2)"	"unprognostic (1.84e-1)"	"unprognostic (4.00e-1)"	"unprognostic (2.83e-1)"	14.2	6.1	1.3	3.7	1.3	0.7	10.6	1.1	2.2	10.1	2.1	4.0	1.6	8.4	0.3	3.9	8.1	3.6	6.6	1.6	3.7	10.1	3.4	13.2	2.4	2.1	1.3	4.3	3.1	1.6	3.5	1.0	1.7	7.0	1.4	0.4	4.2	2.2	2.9	4.2	4.8	5.0	1.4	8.2	4.3	3.3	1.9	0.8	11.2	3.9	1.8	7.5	7.1	1.5	10.3	0.0	0.6	0.0	2.8	0.0	0.1	4.8	10.7	5.5	3.5	0.4	0.2	0.2	0.1	7.7	12.5	1.5	1.1	0.7	2.3	0.1	0.9	0.3	0.4	0.0	1.4	2.9	28.6	1.8	2.3	11.7	4.6	15.7	38.8	0.6	0.1	0.2	12.0	0.2	1.5	0.9	1.0	1.6	39.3	1.8	0.8	25.1	5.4	0.5	2.2	5.1	0.2	1.5	0.1	1.0	0.6	8.2	35.9	1.6	10.3	0.6	1.7	0.0	0.0	1.9	40.6	2.7	0.3	31.2	5.4	0.7	0.0	5.5	0.0	0.9	0.0	0.0	1.5	2.8	0.0	0.0	2.7	0.0	4.0	0.0	0.0	1.4	1.3	1.3	1.1	2.2	1.6	3.7	2.1	1.3	1.7	1.4	1.9	1.5	65.0	6.4	4.8	2.3	1.9	5.9	1.2	0.9	1.2	0.9	1.1	1.7	9.1	0.0	0.2	1.8	0.0	0.1	0.3	0.0	1.9	8.2	0.8	0.3	0.8	81.5	1.2	3.2	2.7	1.7	0.1	4.7	0.0	0.2	39.3	2.3	105.0	0.7	12.9	0.0	0.1	0.2	0.0	17.4	14.6	1.1	7.8	16.3	8.8	7.5	3.4	0.5	0.0	0.0	0.6	1.3	0.1	3.0	1.4	1.7	0.0	0.1	0.5	0.8	6.6	0.9	3.6	5.1	19.1	0.2	4.7	0.0	1.8	2.1	0.3	1.0
TMEM258	"C11orf10, Kud, Kuduk"	ENSG00000134825	"Transmembrane protein 258"	P61165	11	61768501-61792802	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA044602	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol	"Plasma membrane"	"HPA044602: AB_10961423"	"unprognostic (6.35e-2)"	"unprognostic (1.70e-1)"	"unprognostic (7.49e-2)"	"unprognostic (4.99e-3)"	"unprognostic (9.95e-2)"	"unprognostic (1.24e-2)"	"unprognostic (3.18e-2)"	"unprognostic (1.24e-1)"	"unprognostic (8.48e-2)"	"prognostic favorable (4.37e-4)"	"unprognostic (1.34e-3)"	"unprognostic (7.39e-2)"	"unprognostic (4.75e-3)"	"unprognostic (2.59e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.34e-2)"	"unprognostic (2.58e-1)"	116.4	158.4	125.5	66.1	128.7	128.4	120.8	130.8	162.2	142.2	123.0	112.4	80.9	116.0	350.1	122.8	123.1	59.3	170.8	122.6	128.7	123.5	160.6	110.0	83.0	130.0	125.6	154.9	300.3	80.5	128.9	80.4	130.3	105.5	107.6	44.0	183.9	88.7	146.7	95.3	99.8	81.5	131.1	124.4	142.8	79.1	126.8	111.7	109.1	120.6	108.9	107.5	111.7	140.1	144.3	254.9	194.9	173.3	329.0	308.4	117.1	113.9	177.1	104.5	124.8	223.5	265.5	103.9	205.9	272.1	196.1	154.8	186.7	222.7	149.1	141.7	168.6	86.8	258.3	347.6	310.7	186.9	96.3	272.5	339.6	137.1	364.8	267.9	210.9	207.4	221.7	394.5	185.4	501.1	131.2	318.8	267.1	315.6	172.9	142.1	144.6	673.0	241.5	243.7	169.3	173.1	103.8	221.7	211.5	179.6	244.5	347.3	108.0	129.2	111.7	166.1	78.3	248.6	201.7	173.6	183.8	112.6	135.7	507.9	225.6	287.6	169.5	200.4	216.5	233.2	198.8	190.1	177.8	187.1	167.1	166.7	182.4	151.7	204.4	496.4	236.8	244.9	125.5	128.7	130.8	162.2	122.6	128.7	130.0	125.6	130.3	131.1	126.8	140.1	211.3	102.5	224.1	6.8	323.6	228.9	220.5	794.5	170.8	41.3	525.1	608.3	491.3	403.2	445.9	318.2	18.8	409.5	279.8	306.2	295.4	534.8	234.4	369.2	304.7	254.8	311.1	197.7	7.4	654.4	667.7	314.8	210.5	305.6	226.7	261.8	335.2	572.9	461.4	37.0	8.2	631.5	441.5	401.7	396.9	142.8	335.5	265.7	569.2	3.7	430.0	418.6	270.8	6.0	25.8	469.4	432.6	214.4	821.3	296.6	392.2	553.8	470.9	73.9	170.9	192.3	248.5	399.4	433.8	297.4	279.0	508.0	245.2	135.3	442.1	274.9
TMEM263	"C12orf23, MGC17943"	ENSG00000151135	"Transmembrane protein 263"	Q8WUH6	12	106955719-106978778	"Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014453, HPA042339"	Uncertain		Approved	Vesicles		NA	NA		14000	"Cluster 40: NK-cells - Unknown function"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 36: Stromal cells - Cell proliferation"	Vesicles		"HPA014453: , HPA042339: AB_10795503"	"unprognostic (2.56e-2)"	"unprognostic (1.41e-1)"	"unprognostic (8.99e-2)"	"unprognostic (5.65e-2)"	"unprognostic (3.90e-1)"	"unprognostic (3.46e-2)"	"prognostic unfavorable (7.84e-4)"	"unprognostic (4.66e-2)"	"unprognostic (6.01e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.19e-1)"	"unprognostic (3.05e-3)"	"unprognostic (3.49e-2)"	"unprognostic (1.49e-1)"	"prognostic unfavorable (1.83e-4)"	"unprognostic (1.53e-1)"	20.6	27.1	14.5	20.4	15.6	7.4	22.3	14.2	18.2	41.6	21.8	17.8	17.3	28.3	33.4	9.5	16.2	30.4	28.6	15.5	22.1	29.4	44.6	15.3	21.1	13.2	17.1	29.3	23.4	20.7	37.5	43.2	16.5	28.5	19.2	16.8	21.0	21.6	11.5	8.6	15.3	29.9	13.3	16.4	30.9	19.4	21.4	31.0	33.6	14.2	19.7	22.1	13.9	13.5	32.7	28.2	54.1	37.4	125.8	141.6	23.5	123.1	114.0	59.0	74.6	30.1	14.0	3.2	37.5	174.3	33.3	14.9	34.4	48.6	80.9	61.5	38.0	45.5	41.0	65.0	65.1	2.4	28.3	98.6	23.1	63.9	53.8	137.3	73.4	35.1	22.1	12.1	83.6	26.7	35.4	21.4	17.7	21.1	60.3	77.1	41.3	7.9	60.7	27.3	28.2	38.6	67.3	31.2	51.2	41.9	36.5	13.7	86.7	50.6	30.7	66.9	31.6	50.8	31.5	30.3	39.2	7.7	79.4	11.7	1.4	1.6	15.8	1.6	18.3	15.7	15.2	13.7	4.3	16.8	26.8	24.9	1.0	19.8	0.6	14.8	17.4	13.9	14.5	15.6	14.2	18.2	15.5	22.1	13.2	17.1	16.5	13.3	21.4	13.5	31.6	9.6	23.6	12.1	33.5	0.0	52.0	0.0	53.5	24.4	47.7	25.8	55.4	22.8	11.2	23.9	31.3	40.4	54.3	12.4	92.0	19.2	34.8	19.9	75.7	26.4	28.8	10.9	15.4	33.0	72.6	61.5	50.0	32.4	29.9	33.7	33.2	44.4	13.5	11.8	16.5	65.1	0.0	6.7	0.0	37.2	47.2	10.4	0.0	22.5	9.6	34.1	22.6	24.1	8.4	17.3	13.2	43.6	68.3	48.6	23.0	47.7	12.4	21.0	26.3	39.1	41.7	51.2	22.5	12.7	0.0	36.0	36.3	30.6	16.4	44.2
TMEM30A	"C6orf67, CDC50A, FLJ10856"	ENSG00000112697	"Transmembrane protein 30A"	Q9NV96	6	75252924-75284948	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014561	Approved					NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA014561: AB_10601823"	"unprognostic (2.00e-1)"	"unprognostic (2.00e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.27e-2)"	"unprognostic (3.48e-1)"	"unprognostic (1.02e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.10e-1)"	"unprognostic (2.02e-1)"	"unprognostic (1.06e-1)"	"unprognostic (2.15e-1)"	"unprognostic (4.80e-2)"	"unprognostic (1.88e-1)"	"unprognostic (5.06e-2)"	"unprognostic (7.12e-2)"	"unprognostic (8.96e-2)"	"unprognostic (1.00e-1)"	62.9	57.0	60.3	59.1	70.2	53.7	54.0	65.2	67.5	61.3	72.8	64.7	43.9	62.0	50.2	58.1	47.4	60.0	45.3	67.2	73.5	77.3	99.6	91.7	53.5	63.3	64.5	47.6	70.8	96.2	47.6	48.5	64.6	64.7	70.8	57.0	55.2	58.6	29.2	38.3	46.4	79.1	73.5	62.1	59.4	28.8	69.5	47.6	84.5	40.4	60.9	66.4	34.8	82.1	54.2	60.6	91.5	77.6	228.2	212.0	76.3	217.9	171.3	82.3	128.2	56.3	129.1	61.9	148.3	194.8	82.7	62.4	41.5	120.4	211.5	84.9	63.8	60.4	55.1	56.7	129.2	73.7	104.6	197.2	116.5	116.9	63.7	175.2	262.4	59.1	59.4	107.8	158.4	37.2	27.1	54.2	32.7	46.1	46.7	44.4	65.6	78.5	315.3	131.1	64.9	62.9	111.9	52.8	74.9	105.8	58.6	224.8	234.5	103.8	116.9	65.6	153.3	90.3	136.1	27.9	81.7	137.2	165.7	44.5	85.8	59.0	37.1	84.7	44.8	27.1	37.3	36.7	78.6	22.6	34.8	34.5	138.3	42.5	87.5	33.2	53.0	61.5	60.3	70.2	65.2	67.5	67.2	73.5	63.3	64.5	64.6	73.5	69.5	82.1	73.2	163.5	132.5	7.5	38.8	71.2	33.7	67.6	42.1	24.5	53.1	27.6	43.8	40.0	96.1	66.2	45.9	39.6	51.0	67.6	11.7	51.0	11.1	46.7	57.0	68.0	36.2	20.8	15.8	111.2	52.1	65.7	43.3	76.0	39.8	31.4	66.0	79.1	54.3	20.2	14.5	44.3	54.9	89.3	79.1	9.5	45.4	57.8	48.0	10.3	62.4	40.7	35.0	17.1	15.6	101.6	38.5	62.4	55.8	80.9	31.1	33.2	95.2	24.0	32.9	56.1	77.2	45.0	21.2	41.8	78.3	94.4	43.3	62.5	28.8	65.9
TMEM30B	CDC50B	ENSG00000182107	"Transmembrane protein 30B"	Q3MIR4	14	61277370-61281761	"Predicted membrane proteins, Transporters"	"Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Basal prostatic cells: 124.0;Prostatic glandular cells: 101.1;Urothelial cells: 131.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 68.7;CAPAN-2: 54.4;HaCaT: 31.7;HBEC3-KT: 39.0;hTCEpi: 29.1;MCF7: 44.6;RT4: 94.9;T-47d: 30.4"	"Not detected"	"Not detected"							HPA043162	Uncertain					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA043162: AB_10796688"	"unprognostic (4.06e-2)"	"unprognostic (2.46e-1)"	"unprognostic (1.72e-1)"	"unprognostic (3.47e-2)"	"unprognostic (2.01e-1)"	"unprognostic (6.20e-2)"	"unprognostic (2.45e-3)"	"unprognostic (3.43e-2)"	"unprognostic (9.10e-2)"	"unprognostic (2.20e-1)"	"unprognostic (5.10e-2)"	"unprognostic (2.26e-1)"	"prognostic favorable (5.89e-5)"	"unprognostic (2.21e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.60e-1)"	"unprognostic (1.85e-1)"	3.9	1.6	0.5	3.7	0.7	0.4	14.8	0.5	1.0	16.4	0.9	29.1	43.3	3.8	28.2	14.1	15.2	23.9	2.0	0.3	0.7	12.3	12.3	14.5	1.2	0.6	0.5	2.5	35.7	59.1	18.2	5.7	0.5	21.9	26.1	0.3	27.7	13.4	1.2	8.6	34.4	1.7	0.5	0.7	42.2	2.6	0.6	5.3	50.0	1.9	4.4	16.1	9.3	0.4	68.7	0.2	0.0	0.0	6.7	1.6	0.1	0.1	0.0	0.0	0.0	11.6	54.4	0.0	0.1	0.0	0.0	31.7	0.0	39.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	29.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	44.6	0.0	0.1	0.6	28.2	1.6	0.0	1.5	0.2	0.0	94.9	11.2	0.1	0.8	25.6	0.1	1.9	30.4	0.1	0.0	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.3	0.1	0.0	0.0	0.7	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.5	0.7	0.5	1.0	0.3	0.7	0.6	0.5	0.5	0.5	0.6	0.4	0.6	28.9	31.9	0.0	0.6	64.9	124.0	19.5	61.5	0.0	32.2	16.5	1.9	47.1	24.5	40.5	0.0	28.0	1.1	90.8	13.7	24.8	0.9	23.8	3.9	3.9	23.4	0.0	0.0	37.2	11.4	5.5	62.7	45.3	2.5	0.7	4.2	14.1	2.0	0.0	0.0	73.1	20.3	1.0	6.8	1.6	8.7	1.5	5.4	1.0	0.6	2.9	2.1	0.0	0.1	31.9	75.3	79.0	0.4	101.1	73.6	1.0	22.7	0.3	13.1	2.4	5.4	5.9	3.6	43.3	63.6	35.8	3.6	0.9	64.7	131.9
TMEM31	MGC39655	ENSG00000179363	"Transmembrane protein 31"	Q5JXX7	X	103710909-103714032	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	32	"testis: 110.1"	"Cell type enriched"	"Detected in some"	5	"Late spermatids: 3288.8"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 1.8;BEWO: 4.3;MCF7: 6.4;NTERA-2: 1.8;U-937: 2.4"					"Low region specificity"	"Detected in all"			HPA052760			Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 78: Testis - Spermatogenesis"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 31: Spermatids - Spermatogenesis"	"Nucleoli fibrillar center"		"HPA052760: "	"unprognostic (9.42e-5)"	"unprognostic (1.46e-2)"	"unprognostic (1.18e-1)"	"unprognostic (7.51e-2)"	"unprognostic (7.75e-3)"	"unprognostic (1.22e-2)"	"unprognostic (2.43e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.39e-2)"	"unprognostic (3.77e-1)"	"unprognostic (5.91e-5)"	"unprognostic (1.75e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.68e-2)"	0.4	0.2	2.1	0.1	2.4	0.0	0.6	2.1	3.3	1.4	1.6	0.3	0.0	0.6	0.5	0.1	1.0	0.2	0.3	2.1	2.3	0.7	0.3	0.3	0.2	2.3	2.2	1.7	0.2	1.3	0.9	0.9	2.4	0.6	0.0	0.2	0.2	0.3	0.9	0.4	0.2	0.1	2.2	0.4	0.2	110.1	2.4	0.3	0.3	0.0	0.0	0.4	0.5	2.7	0.0	0.0	1.8	0.1	0.1	0.0	4.3	0.1	0.0	0.2	0.3	0.0	0.2	0.0	0.1	0.0	0.3	0.0	0.7	0.0	0.2	0.0	1.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.2	0.2	6.4	0.1	1.2	1.8	0.3	0.0	0.7	0.0	0.0	0.0	0.0	0.5	0.3	0.4	0.0	0.2	0.8	0.1	0.0	0.0	0.0	0.0	0.4	0.0	0.3	0.0	0.5	0.0	2.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.0	2.1	2.4	2.1	3.3	2.1	2.3	2.3	2.2	2.4	2.2	2.4	2.7	0.3	0.0	0.0	0.0	0.0	0.8	0.7	0.2	0.0	0.0	0.4	1.5	0.2	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.2	641.3	10.1	0.4	1.1	0.0	0.0	0.2	0.7	8.6	0.6	0.0	0.2	0.0	1.1	0.7	0.2	0.4	0.0	0.1	0.1	0.0	0.3	0.3	3288.8	13.4	1.2	0.0	0.0	0.0	0.0	0.0	0.5	0.7	0.1	0.0	7.5	0.0	0.3	0.0	0.2	0.0	0.0	13.1	0.3	0.3	19.6	12.1	0.0	0.3	2.9	0.0	0.2	0.0	0.2
TMEM33	"FLJ10525, Pom33"	ENSG00000109133	"Transmembrane protein 33"	P57088	4	41935129-41960803	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075863	Approved					NA	NA			"Cluster 18: Basophils - Vesicular transport"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 10: Non-specific - Unknown function"			"HPA075863: "	"unprognostic (7.14e-2)"	"unprognostic (9.25e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.58e-1)"	"unprognostic (1.92e-1)"	"unprognostic (2.49e-1)"	"unprognostic (2.04e-1)"	"unprognostic (3.94e-2)"	"unprognostic (5.45e-2)"	"unprognostic (2.09e-1)"	"unprognostic (1.16e-2)"	"unprognostic (3.75e-1)"	"prognostic favorable (1.35e-5)"	"unprognostic (7.70e-2)"	"unprognostic (4.20e-1)"	"unprognostic (9.35e-3)"	"unprognostic (2.36e-2)"	12.4	16.1	8.0	19.4	10.5	14.9	16.0	13.1	11.4	11.4	16.0	18.7	21.1	11.1	25.5	21.2	12.3	17.2	10.5	9.6	12.8	24.2	39.9	15.1	17.0	15.5	13.5	10.5	18.2	30.1	11.0	20.0	14.7	17.2	21.3	13.0	17.9	11.8	8.4	11.9	16.9	11.3	14.1	13.9	19.1	9.9	12.1	14.9	23.8	12.4	20.1	21.8	10.8	18.8	36.9	42.4	36.7	51.3	46.7	31.8	44.9	49.5	53.9	41.5	47.5	52.4	123.4	64.8	74.7	41.5	85.5	57.4	124.4	65.0	56.1	17.1	26.2	80.7	49.7	45.9	54.4	108.7	67.6	33.4	69.0	52.5	78.3	26.5	32.7	37.3	86.8	24.7	57.4	32.6	96.5	67.9	67.2	58.1	50.0	42.7	57.8	51.6	58.2	53.5	40.8	58.4	40.5	38.0	62.4	35.3	42.9	37.4	53.0	48.3	65.0	48.9	89.5	44.5	76.9	77.4	51.7	88.4	71.2	41.2	32.1	21.7	14.9	31.0	17.6	13.0	15.3	14.2	22.9	12.0	13.6	15.0	43.2	16.5	35.2	17.9	19.0	16.4	8.0	10.5	13.1	11.4	9.6	12.8	15.5	13.5	14.7	14.1	12.1	18.8	25.1	60.9	34.3	20.9	25.0	73.3	35.7	42.4	24.5	19.2	36.9	16.4	18.0	27.1	40.5	55.2	16.7	56.3	35.2	58.9	23.5	44.6	2.9	26.9	31.2	25.9	35.0	25.0	33.6	38.1	49.3	30.5	36.2	33.4	38.7	23.1	24.7	84.4	57.3	28.6	32.8	40.4	34.6	67.5	51.0	4.7	20.2	55.7	56.9	11.2	55.9	33.9	16.5	32.6	40.3	54.1	47.4	23.3	32.5	73.7	41.6	41.1	29.7	20.4	26.3	26.5	55.6	31.0	28.7	47.5	66.9	133.1	28.3	39.7	43.0	64.5
TMEM38B	"bA219P18.1, C9orf87, D4Ertd89e, FLJ10493, TRIC-B"	ENSG00000095209	"Transmembrane protein 38B"	Q9NVV0	9	105694541-105776629	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Potassium transport, Transport"	"Ion channel, Potassium channel"	"Osteogenesis imperfecta"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 77.4;tongue: 62.1"	"Cell type enhanced"	"Detected in many"		"Early spermatids: 267.0;Late spermatids: 488.4;Spermatocytes: 157.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA018465	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 16: U-266 - Nucleosome"	"Cluster 31: Spermatids - Spermatogenesis"			"HPA018465: AB_1858116"	"unprognostic (3.34e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.72e-1)"	"unprognostic (2.46e-2)"	"unprognostic (2.68e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-2)"	"unprognostic (3.11e-3)"	"unprognostic (1.88e-2)"	"unprognostic (3.54e-2)"	"unprognostic (5.82e-3)"	"unprognostic (5.80e-2)"	"prognostic favorable (7.96e-4)"	"unprognostic (1.09e-1)"	"unprognostic (2.09e-1)"	"unprognostic (3.89e-3)"	"unprognostic (9.98e-2)"	7.6	14.0	6.2	7.1	11.6	19.1	4.7	19.5	9.2	7.6	6.3	12.5	6.4	8.3	17.3	7.2	7.2	6.8	30.7	7.4	12.9	29.2	15.3	5.7	8.1	8.3	8.4	18.3	4.9	9.2	5.8	4.6	10.6	8.0	11.8	10.4	4.0	6.8	77.4	6.0	10.7	8.1	5.9	6.3	6.7	28.6	9.0	4.9	28.8	62.1	5.1	5.0	4.0	19.6	16.7	25.6	19.6	30.9	110.5	24.3	40.8	23.4	15.3	22.6	23.3	40.0	22.5	38.4	11.8	8.5	36.4	11.6	28.4	13.5	24.4	29.0	37.8	15.8	16.2	24.7	15.1	48.1	32.7	23.0	11.8	15.5	21.6	7.1	9.1	26.6	84.3	33.2	14.0	46.4	33.6	14.5	15.1	48.7	27.1	22.3	61.4	18.4	10.3	13.2	34.1	8.3	24.2	39.4	17.9	13.0	49.2	33.5	4.9	20.5	20.2	78.9	24.7	40.7	109.8	19.1	38.2	52.2	41.7	15.6	20.2	53.8	13.2	29.6	17.7	56.6	18.3	15.8	23.3	56.6	38.9	24.9	3.1	28.2	26.8	51.7	18.0	24.2	6.2	11.6	19.5	9.2	7.4	12.9	8.3	8.4	10.6	5.9	9.0	19.6	9.2	0.0	2.7	7.5	27.8	30.3	24.9	6.2	15.9	12.9	8.9	3.9	55.5	15.7	8.4	25.8	29.2	12.0	16.4	19.1	66.5	8.9	267.0	2.2	7.2	9.9	31.8	7.2	12.4	6.9	19.0	24.2	9.2	3.0	15.8	11.3	3.6	24.4	30.9	11.8	28.6	12.9	18.3	7.9	33.2	488.4	85.1	21.4	32.0	6.5	18.3	30.6	3.1	65.4	30.6	6.3	12.2	44.8	20.2	55.1	10.9	47.0	7.6	12.3	118.3	18.2	58.1	157.8	47.6	13.0	32.7	21.2	13.8	39.7	19.0	20.2
TMEM39A	"FLJ10902, SUSR2"	ENSG00000176142	"Transmembrane protein 39A"	Q9NV64	3	119428949-119468830	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039140	Approved		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Nucleoplasm	Vesicles	"HPA039140: AB_10673303"	"unprognostic (2.16e-1)"	"unprognostic (8.75e-2)"	"unprognostic (4.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (1.56e-2)"	"unprognostic (2.81e-1)"	"prognostic unfavorable (3.26e-4)"	"unprognostic (9.68e-2)"	"unprognostic (6.35e-2)"	"unprognostic (2.12e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.66e-2)"	"prognostic unfavorable (1.00e-5)"	"unprognostic (4.07e-1)"	"unprognostic (2.52e-2)"	"unprognostic (1.88e-1)"	"unprognostic (6.41e-2)"	12.4	10.5	2.2	14.4	4.3	12.9	10.2	4.1	3.5	19.5	10.9	9.0	10.0	13.2	10.9	9.0	11.7	12.6	11.1	2.2	3.1	6.4	13.0	12.4	10.0	4.0	3.4	13.1	28.4	12.8	15.4	18.1	4.3	9.1	9.3	5.0	13.3	14.3	7.2	8.8	8.0	9.7	3.1	9.2	9.8	7.8	4.7	12.1	16.6	11.9	13.6	14.4	10.5	6.2	28.3	15.1	24.1	17.4	56.1	54.2	24.1	26.4	54.3	37.2	50.0	26.1	21.2	12.0	27.4	28.7	37.9	28.7	29.3	12.1	38.0	12.6	11.2	15.5	13.5	25.4	37.9	27.1	23.4	29.7	20.5	25.9	61.5	37.5	23.6	18.5	16.1	35.5	19.6	14.1	13.7	7.0	20.5	29.8	31.5	16.5	11.3	25.7	9.2	10.7	10.7	15.8	26.6	15.2	33.4	17.3	14.8	23.8	18.5	20.2	17.2	13.8	17.3	39.5	12.5	28.5	27.6	18.2	26.8	12.7	10.9	7.3	11.7	5.8	11.9	7.7	7.1	9.6	12.3	9.0	5.6	6.1	3.8	11.9	4.6	17.3	8.9	9.4	2.2	4.3	4.1	3.5	2.2	3.1	4.0	3.4	4.3	3.1	4.7	6.2	8.5	9.6	15.8	9.8	14.3	22.8	16.0	21.8	8.6	4.7	14.6	10.8	10.8	7.2	16.2	7.3	6.2	26.5	24.7	7.4	5.9	11.6	22.8	8.2	26.3	10.8	10.8	9.0	12.4	14.2	57.6	28.9	13.3	17.9	1.3	13.5	7.9	12.0	13.3	1.7	14.0	18.3	6.1	15.0	54.9	6.8	17.1	17.8	10.6	12.2	31.0	3.9	9.2	25.1	21.8	10.2	6.6	13.2	57.8	20.6	8.0	3.0	14.9	6.4	6.6	15.9	25.2	26.1	18.5	9.6	21.7	59.8	17.4	9.4	11.1	20.4
TMEM41A	MGC15397	ENSG00000163900	"Transmembrane protein 41A"	Q96HV5	3	185476496-185499057	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Proximal enterocytes: 200.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"							"Low region specificity"	"Detected in all"			"HPA059101, HPA059790"	Approved		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 37: Intestine - Unknown function"	"Cluster 16: U-266 - Nucleosome"	"Cluster 45: Enterocytes - Digestion"	Nucleoplasm	"Golgi apparatus, Cytosol"	"HPA059101: AB_2683905, HPA059790: AB_2684125"	"unprognostic (2.17e-2)"	"unprognostic (7.94e-2)"	"unprognostic (1.99e-2)"	"prognostic unfavorable (6.70e-6)"	"unprognostic (2.67e-1)"	"unprognostic (2.15e-1)"	"prognostic unfavorable (1.04e-4)"	"unprognostic (2.84e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.79e-1)"	"prognostic unfavorable (4.72e-4)"	"unprognostic (3.63e-2)"	"unprognostic (2.56e-2)"	"unprognostic (3.73e-1)"	"unprognostic (3.68e-1)"	"unprognostic (1.46e-2)"	"unprognostic (1.02e-2)"	9.0	27.2	9.6	5.4	9.3	11.0	10.2	9.7	11.0	10.0	8.9	7.9	26.4	8.7	11.2	23.6	9.2	7.6	9.9	9.0	9.4	14.7	20.5	10.6	7.4	9.4	11.6	14.1	9.7	8.7	5.7	8.4	9.2	10.2	8.9	7.5	12.0	8.3	9.8	19.9	24.1	7.4	9.8	12.5	10.3	9.3	12.1	7.8	7.0	16.4	12.6	10.8	14.6	10.9	43.6	15.4	10.1	12.5	15.6	16.8	29.6	16.3	14.3	20.2	14.6	40.5	16.7	13.4	30.5	15.3	28.5	29.4	28.1	17.5	20.4	22.6	25.8	23.3	8.6	41.2	17.5	25.3	12.5	15.7	25.6	18.3	20.9	12.7	15.6	16.8	42.1	32.4	13.0	16.8	15.6	14.5	16.8	34.1	24.1	15.5	15.6	24.6	17.4	31.4	10.1	13.1	14.1	35.8	25.7	14.4	42.8	19.6	11.4	11.9	15.0	25.2	34.5	47.2	78.0	26.5	18.2	15.1	14.6	14.0	8.2	7.2	16.3	9.4	21.0	17.5	16.7	18.1	9.3	15.6	18.2	19.8	2.8	12.2	12.2	21.7	15.3	9.2	9.6	9.3	9.7	11.0	9.0	9.4	9.4	11.6	9.2	9.8	12.1	10.9	12.1	9.6	30.5	7.2	16.7	53.0	42.8	29.5	50.7	22.4	38.2	20.6	12.6	24.3	24.9	20.2	18.8	27.5	18.3	23.3	7.9	33.4	0.7	17.7	14.5	19.8	18.6	16.4	8.1	56.0	23.5	18.0	36.2	38.0	8.8	50.2	17.2	40.9	19.6	16.8	9.8	28.3	16.2	14.2	17.3	2.8	14.3	12.5	8.8	2.8	65.9	11.4	11.3	20.1	7.6	50.3	17.0	13.5	20.9	64.2	200.8	23.2	9.6	28.6	19.7	16.8	16.5	22.1	14.3	113.0	84.7	46.0	18.5	82.6	45.6	93.4
TMEM41B	KIAA0033	ENSG00000166471	"Transmembrane protein 41B"	Q5BJD5	11	9280654-9314636	"Predicted membrane proteins, Transporters"	"Autophagy, Host-virus interaction, Neurogenesis"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CAPAN-2: 108.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014946	Uncertain		Approved	Peroxisomes		NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 45: Intestine - Brush border"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 44: Endometrium - Transcription"	Peroxisomes		"HPA014946: AB_2205037"	"unprognostic (1.21e-1)"	"unprognostic (2.19e-1)"	"unprognostic (1.35e-1)"	"unprognostic (2.75e-3)"	"unprognostic (5.78e-3)"	"unprognostic (1.94e-1)"	"prognostic unfavorable (9.18e-6)"	"unprognostic (6.18e-2)"	"unprognostic (9.37e-3)"	"unprognostic (4.90e-3)"	"unprognostic (1.36e-2)"	"unprognostic (4.02e-2)"	"unprognostic (1.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.55e-2)"	"unprognostic (8.18e-2)"	6.0	7.6	9.9	7.2	11.0	11.1	8.8	12.5	15.1	5.3	8.9	11.6	17.6	5.4	9.9	8.0	4.9	7.4	8.8	9.5	11.5	11.6	18.8	14.7	8.9	12.8	12.2	4.7	9.6	10.2	3.0	11.4	12.0	11.7	9.5	8.3	9.7	6.1	5.1	9.7	17.1	3.3	12.8	6.8	12.1	8.1	11.6	9.2	15.7	5.0	7.9	7.8	3.4	15.9	34.1	25.5	17.3	18.4	17.8	25.0	47.6	31.5	24.6	14.3	26.3	17.9	108.8	13.2	26.2	18.8	28.5	42.0	19.8	16.4	18.4	20.9	19.4	12.0	21.3	21.1	24.5	11.5	14.2	20.1	23.5	14.5	17.5	18.0	13.0	16.2	25.5	32.8	29.3	11.2	16.0	12.6	50.1	18.8	17.3	12.1	23.9	18.7	25.6	32.2	5.6	20.7	26.1	23.7	26.4	22.5	20.4	15.8	17.9	16.7	21.1	28.9	17.3	9.3	17.6	22.5	18.4	8.0	14.6	9.9	1.4	5.5	5.5	1.7	6.7	7.0	4.1	6.9	1.7	5.3	8.2	10.4	3.5	9.5	1.7	8.5	4.1	3.4	9.9	11.0	12.5	15.1	9.5	11.5	12.8	12.2	12.0	12.8	11.6	15.9	21.6	48.1	77.1	32.3	27.9	76.0	57.8	48.5	42.7	36.7	36.4	21.0	21.3	34.3	44.3	31.3	66.7	44.6	34.8	58.0	7.9	30.6	1.3	48.5	31.5	20.1	39.8	29.0	47.3	39.4	60.5	29.0	22.4	89.2	17.1	24.8	21.4	55.4	22.7	20.2	52.1	42.3	36.7	18.9	44.6	2.0	18.0	24.7	19.6	26.2	23.4	24.0	22.6	37.2	69.3	57.9	40.3	13.9	26.6	58.4	56.0	17.2	34.2	38.4	19.7	37.9	25.4	50.9	44.6	47.0	63.6	56.1	28.3	31.3	33.8	77.0
TMEM47	"BCMP1, DKFZp564E153, DKFZP761J17121, TM4SF10, VAB-9"	ENSG00000147027	"Transmembrane protein 47"	Q9BQJ4	X	34627075-34657285	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 110.7;Astrocytes: 85.5;Leydig cells: 74.3;Muller glia cells: 148.0;Peritubular cells: 92.9;Sertoli cells: 92.1;Skeletal myocytes: 84.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 112.6;fHDF/TERT166: 348.1;RPTEC TERT1: 83.6;U-2197: 74.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA046658	Approved		Approved	"Nuclear membrane"		NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 48: Smooth muscle cells - ECM organization"	"Nuclear membrane"		"HPA046658: AB_2679742"	"unprognostic (1.50e-1)"	"unprognostic (1.44e-1)"	"unprognostic (5.97e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.52e-1)"	"unprognostic (3.82e-2)"	"unprognostic (6.74e-3)"	"unprognostic (7.29e-2)"	"prognostic unfavorable (2.10e-4)"	"unprognostic (1.67e-2)"	"unprognostic (4.23e-2)"	"unprognostic (1.36e-1)"	"prognostic favorable (4.05e-6)"	"unprognostic (2.69e-2)"	"unprognostic (7.19e-2)"	"unprognostic (2.76e-1)"	"unprognostic (9.94e-2)"	40.0	20.8	34.8	8.5	38.3	0.0	18.8	27.1	39.5	46.7	41.6	25.9	8.6	45.7	33.4	34.6	35.1	28.6	36.1	30.8	35.8	27.7	24.8	21.9	6.2	36.5	38.7	21.7	11.3	5.6	6.6	1.2	33.7	32.9	14.9	17.8	29.6	45.6	23.8	6.3	11.5	51.0	37.8	7.5	13.8	4.9	39.5	3.1	20.2	31.1	4.2	36.2	20.1	33.4	0.0	1.7	50.7	21.4	43.8	33.1	0.0	112.6	0.3	21.8	18.7	0.1	0.0	0.0	9.2	348.1	0.0	0.1	14.5	4.0	32.0	0.0	9.9	0.0	13.2	0.0	25.3	0.0	0.0	30.0	0.1	8.9	9.7	38.9	24.8	0.0	0.0	0.0	41.6	0.9	0.0	0.0	6.0	0.6	0.3	0.0	25.3	0.0	83.6	33.0	0.5	0.0	0.1	1.3	0.0	5.4	0.2	0.0	0.9	44.0	4.4	74.4	4.8	0.0	0.0	0.0	18.1	0.0	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.8	38.3	27.1	39.5	30.8	35.8	36.5	38.7	33.7	37.8	39.5	33.4	110.7	19.2	0.6	85.5	0.1	8.2	15.9	0.9	1.8	8.3	10.8	12.7	27.7	10.0	1.5	16.5	6.2	0.0	0.6	0.0	7.9	0.8	0.4	7.6	4.6	29.8	0.0	0.0	4.3	5.3	0.2	48.3	1.1	6.2	2.5	0.7	46.4	17.5	0.1	30.3	25.6	0.0	0.0	0.8	11.7	3.8	74.3	1.2	65.8	13.1	0.0	148.0	0.0	5.0	2.2	3.0	0.0	92.9	0.1	14.3	0.0	13.4	2.0	7.3	92.1	84.7	67.1	0.3	2.1	1.9	5.3	0.1	0.7	0.8	0.0	12.1
TMEM50A	SMP1	ENSG00000183726	"Transmembrane protein 50A"	O95807	1	25338317-25362361	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065192			Approved	"Plasma membrane,Actin filaments,Cytosol"		NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Plasma membrane"	"Actin filaments, Cytosol"	"HPA065192: AB_2685429"	"unprognostic (2.41e-2)"	"unprognostic (2.74e-1)"	"unprognostic (5.17e-3)"	"prognostic favorable (8.64e-5)"	"unprognostic (1.45e-1)"	"unprognostic (2.04e-2)"	"prognostic unfavorable (3.34e-4)"	"unprognostic (7.39e-2)"	"unprognostic (7.92e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.02e-2)"	"unprognostic (2.44e-2)"	"unprognostic (2.39e-3)"	"unprognostic (6.66e-2)"	"unprognostic (2.91e-1)"	"unprognostic (3.91e-3)"	"unprognostic (3.44e-2)"	47.2	63.0	43.9	44.5	47.8	41.8	55.5	45.3	55.8	47.0	43.7	58.5	49.6	35.7	53.0	36.5	38.4	45.7	44.2	45.0	44.4	55.0	33.4	58.1	52.2	46.5	44.4	26.2	32.6	49.5	14.6	57.7	46.4	54.4	65.7	45.4	81.5	52.7	16.9	41.1	55.4	46.0	47.2	46.9	49.5	16.1	45.5	47.1	47.0	26.5	47.3	55.1	29.8	50.4	43.3	44.6	74.3	42.3	132.9	119.8	28.1	89.0	123.6	143.4	159.5	36.5	110.9	50.2	47.9	274.6	55.7	62.6	56.3	61.9	161.2	126.1	81.4	104.7	47.5	55.2	96.5	82.4	80.3	128.0	91.4	106.1	60.5	69.7	107.0	50.8	73.1	79.5	140.9	30.6	53.2	90.2	90.6	73.7	37.1	45.7	85.3	88.9	148.8	30.9	64.5	42.3	89.0	64.2	72.2	69.3	32.7	52.0	171.0	86.5	36.6	144.9	36.8	52.3	61.5	45.0	117.1	117.2	50.3	275.5	76.9	109.8	87.9	94.7	91.9	49.6	77.2	91.1	55.9	40.9	55.1	76.6	159.2	80.5	117.3	51.9	95.4	106.3	43.9	47.8	45.3	55.8	45.0	44.4	46.5	44.4	46.4	47.2	45.5	50.4	244.8	144.2	84.2	21.2	107.9	253.4	184.5	392.3	146.8	43.9	162.0	164.8	105.6	102.9	212.7	169.2	27.1	108.9	191.0	175.6	50.9	300.3	25.4	136.4	119.3	203.3	83.0	93.6	31.6	215.6	312.5	198.1	91.3	180.8	126.6	58.2	152.0	68.3	227.1	25.2	27.3	170.7	309.3	162.4	245.1	12.7	151.9	223.8	199.3	16.9	253.8	102.0	154.5	28.1	48.8	315.3	164.8	98.9	168.2	340.6	120.0	113.1	205.1	41.7	210.4	71.6	200.6	94.7	47.0	166.8	317.7	181.6	180.9	116.9	106.9	274.3
TMEM50B	C21orf4	ENSG00000142188	"Transmembrane protein 50B"	P56557	21	33432485-33479974	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034199, HPA068995"	Approved		Approved	"Nucleoli fibrillar center"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nucleoli fibrillar center"		"CAB034199: AB_2205160, HPA068995: AB_2686066"	"unprognostic (3.22e-1)"	"unprognostic (5.93e-2)"	"unprognostic (7.82e-2)"	"unprognostic (6.14e-2)"	"unprognostic (1.26e-1)"	"prognostic favorable (3.00e-4)"	"unprognostic (2.24e-2)"	"prognostic favorable (3.33e-4)"	"unprognostic (8.65e-2)"	"unprognostic (3.36e-2)"	"unprognostic (1.85e-2)"	"unprognostic (3.54e-2)"	"unprognostic (9.58e-3)"	"unprognostic (3.41e-3)"	"unprognostic (8.28e-2)"	"unprognostic (3.47e-3)"	"unprognostic (3.32e-3)"	23.4	26.9	17.3	15.5	13.4	9.3	26.4	13.8	20.3	25.3	22.8	20.8	22.4	22.1	55.1	19.9	27.4	29.5	24.7	13.4	15.5	36.0	15.6	24.2	15.4	14.9	20.7	33.6	12.3	35.1	15.0	17.0	16.1	30.8	19.9	28.2	15.8	48.8	19.9	14.5	21.2	22.1	15.0	16.0	23.2	16.0	22.6	13.8	89.3	22.1	15.1	29.7	15.7	14.3	25.7	5.7	10.4	15.5	55.7	40.4	5.4	20.5	27.4	16.8	10.8	6.3	22.9	14.2	21.6	20.3	21.2	10.6	14.2	14.4	12.2	17.3	11.9	28.5	4.0	13.9	25.4	20.7	17.6	20.3	14.0	13.0	10.2	28.4	20.7	15.4	20.1	28.9	21.8	15.9	15.6	21.9	4.6	45.5	5.3	7.9	19.6	25.0	30.4	17.8	8.9	12.1	23.7	29.2	24.5	6.1	34.0	26.7	18.0	11.2	9.1	15.5	8.3	29.4	49.7	18.9	10.5	31.4	19.9	14.7	18.3	43.6	18.1	19.6	18.5	13.4	22.0	20.8	24.8	17.0	24.8	22.7	3.6	19.6	23.3	26.5	35.4	21.2	17.3	13.4	13.8	20.3	13.4	15.5	14.9	20.7	16.1	15.0	22.6	14.3	69.7	28.9	59.4	29.7	44.5	74.1	94.0	55.2	48.9	53.0	61.5	46.0	46.7	55.8	49.3	82.8	108.4	33.9	50.5	46.7	27.4	37.9	58.1	52.6	42.6	60.7	21.6	43.1	23.9	31.0	46.4	62.0	39.8	38.4	29.8	36.1	94.2	55.4	37.9	43.7	46.2	53.1	61.1	33.6	74.1	39.2	71.4	35.4	83.6	33.7	29.7	72.7	50.4	26.2	44.8	28.0	38.2	119.6	57.8	128.9	68.3	56.5	83.6	86.1	98.6	45.0	52.2	190.4	114.0	37.8	93.6	41.3	55.2	22.9	46.5	126.7
TMEM59	"C1orf8, HSPC001"	ENSG00000116209	"Transmembrane protein 59"	Q9BXS4	1	54026681-54053504	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA075447	Approved					NA	NA		27000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA075447: "	"unprognostic (2.63e-1)"	"unprognostic (9.88e-2)"	"unprognostic (2.63e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.63e-2)"	"unprognostic (8.28e-2)"	"unprognostic (4.10e-1)"	"unprognostic (6.57e-2)"	"unprognostic (1.19e-1)"	"unprognostic (4.49e-2)"	"unprognostic (6.34e-3)"	"unprognostic (9.84e-2)"	"unprognostic (1.70e-1)"	"unprognostic (6.83e-3)"	"unprognostic (7.38e-2)"	257.6	359.7	181.9	164.6	220.8	259.7	341.4	240.3	253.8	343.6	379.5	488.3	364.1	208.7	415.5	241.8	403.2	299.3	275.7	178.4	202.0	473.7	505.7	264.0	162.6	240.6	205.0	225.4	586.1	532.5	170.2	325.8	239.1	350.2	485.3	254.2	550.3	279.9	194.5	194.7	369.1	219.8	235.7	188.7	433.0	174.9	204.6	186.9	341.3	247.6	189.2	289.2	202.6	286.8	188.9	122.3	142.8	185.2	844.1	371.1	182.8	347.9	499.1	211.5	276.0	99.1	391.9	96.7	322.6	595.6	257.7	281.1	166.2	237.5	221.9	237.7	177.4	133.5	266.6	166.1	317.8	165.7	268.7	408.3	411.2	207.5	219.2	566.9	246.6	127.8	158.9	326.3	245.1	91.6	97.9	137.3	201.0	528.3	226.3	94.0	251.6	403.2	257.6	248.0	208.2	173.3	381.5	386.0	398.3	266.2	184.9	348.4	259.3	259.8	90.7	193.3	187.8	289.0	338.7	114.5	349.4	275.4	222.3	1183.5	654.6	831.5	439.7	532.9	461.8	449.3	465.9	480.4	520.9	405.2	430.3	426.4	1196.5	430.4	595.9	527.1	576.1	1153.8	181.9	220.8	240.3	253.8	178.4	202.0	240.6	205.0	239.1	235.7	204.6	286.8	355.3	233.9	181.3	49.6	221.3	404.2	637.0	1214.2	237.3	150.2	409.0	325.1	155.1	479.0	991.8	437.7	118.9	477.7	244.5	905.2	160.4	527.8	357.1	348.5	201.9	279.5	408.2	277.0	44.3	352.5	528.7	410.6	226.8	217.2	155.2	89.5	334.4	413.2	320.2	132.9	42.1	672.8	1131.1	302.9	290.3	183.1	432.7	225.4	690.1	27.2	209.3	473.5	190.5	60.3	176.6	329.3	1064.8	354.0	692.8	583.2	1015.8	468.8	977.4	183.6	368.1	198.6	350.4	488.9	210.1	245.5	414.3	687.1	227.2	185.8	534.9	750.4
TMEM59L	"BSMAP, C19orf4"	ENSG00000105696	"Transmembrane protein 59 like"	Q9UK28	19	18607430-18621039	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"brain: 282.6;pituitary gland: 82.1"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 35.9;Bipolar cells: 92.2;Excitatory neurons: 110.7;Horizontal cells: 50.5;Inhibitory neurons: 88.0;Muller glia cells: 67.9;Oligodendrocyte precursor cells: 42.3"	"Cancer enriched"	"Detected in many"	8	"glioma: 44.2"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 36.0;ASC diff: 42.6;EFO-21: 25.3;Hep G2: 27.3;hTERT-RPE1: 23.3;SH-SY5Y: 21.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA010661	Approved					NA	NA				"Cluster 65: Brain - Ion transport"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 56: Bipolar cells - Visual perception"			"HPA010661: AB_1078338"	"unprognostic (3.24e-2)"	"unprognostic (5.53e-2)"	"unprognostic (1.24e-4)"	"prognostic unfavorable (1.62e-4)"	"unprognostic (1.70e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.53e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.10e-1)"	"unprognostic (1.40e-3)"	"prognostic favorable (8.80e-4)"	"unprognostic (4.65e-2)"	"unprognostic (9.17e-7)"	"unprognostic (1.47e-3)"	"unprognostic (2.53e-1)"	"unprognostic (1.49e-1)"	"unprognostic (1.84e-5)"	1.9	16.8	205.4	1.3	228.2	0.0	1.6	90.2	282.6	2.7	29.6	8.4	0.5	2.6	0.4	2.3	1.4	1.9	10.4	238.3	265.6	3.1	0.5	1.3	0.2	133.0	121.9	0.6	3.2	3.9	82.1	0.9	119.1	1.8	0.8	21.2	1.2	1.3	2.9	0.7	3.5	2.2	100.3	0.5	2.6	2.4	177.3	0.1	5.8	0.2	0.1	0.7	2.3	166.3	0.0	1.0	0.3	36.0	42.6	2.0	0.0	3.9	0.7	1.4	0.8	0.1	1.8	0.1	25.3	2.3	3.6	0.5	10.7	0.1	1.2	0.2	1.7	0.0	0.5	27.3	6.5	0.0	0.5	15.8	0.0	0.5	1.2	23.3	0.0	1.5	0.0	0.3	1.0	1.6	0.2	0.0	3.3	0.0	1.1	0.2	0.0	0.4	0.0	0.0	0.6	21.0	2.5	0.0	0.0	0.3	0.3	0.0	0.4	0.8	8.4	0.3	2.4	5.3	2.1	0.3	1.4	0.0	3.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	205.4	228.2	90.2	282.6	238.3	265.6	133.0	121.9	119.1	100.3	177.3	166.3	0.2	0.0	0.0	35.9	0.0	0.0	0.2	1.9	0.0	92.2	0.1	2.5	0.5	0.0	0.1	0.0	14.6	0.0	0.1	0.0	0.0	0.5	1.7	0.4	11.7	0.4	0.0	0.0	110.7	0.0	0.1	4.1	0.0	0.3	0.0	0.3	0.0	0.0	0.2	50.5	88.0	0.0	0.0	0.0	0.3	1.6	0.3	0.1	0.0	18.7	0.6	67.9	0.0	42.3	18.6	0.2	0.0	0.0	0.0	0.2	0.0	0.0	1.0	27.5	0.0	1.2	4.1	3.1	1.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0
TMEM60	"C7orf35, DC32"	ENSG00000135211	"Transmembrane protein 60"	Q9H2L4	7	77793728-77798434	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA062625	Approved					NA	Yes			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA062625: AB_2684811"	"prognostic favorable (3.09e-4)"	"unprognostic (1.06e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.50e-1)"	"unprognostic (1.02e-3)"	"unprognostic (3.91e-2)"	"unprognostic (5.28e-3)"	"unprognostic (2.73e-3)"	"unprognostic (3.46e-1)"	"unprognostic (4.19e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-2)"	"unprognostic (2.72e-2)"	"unprognostic (9.44e-2)"	"unprognostic (2.07e-3)"	"unprognostic (4.43e-3)"	15.9	23.9	17.5	17.6	17.4	10.6	29.6	18.4	21.4	21.7	19.5	24.9	17.7	16.6	29.7	15.3	18.9	18.6	17.1	17.4	19.3	30.4	35.5	18.9	29.2	18.0	17.5	23.3	18.2	39.8	17.5	23.5	18.2	17.4	24.3	14.1	21.2	19.9	22.9	16.5	17.0	19.6	18.9	20.4	16.4	24.1	17.8	20.4	25.8	20.3	27.7	16.9	13.1	19.1	45.7	30.3	46.2	54.4	61.6	54.5	21.2	41.8	79.9	44.2	69.9	28.4	56.8	35.1	10.0	39.4	150.6	46.8	44.0	24.6	49.7	27.5	41.9	19.0	26.9	39.9	43.4	26.9	33.9	39.9	35.1	32.8	39.6	42.8	31.9	32.0	45.7	68.2	70.4	49.3	20.4	68.7	32.3	55.3	39.4	24.1	36.6	50.7	52.9	33.9	23.2	37.4	31.4	43.7	66.0	48.7	52.8	49.0	21.2	55.6	38.7	49.2	31.4	27.6	46.6	51.1	42.3	55.8	50.2	208.6	51.3	100.2	29.2	58.7	32.4	88.9	51.0	36.9	40.3	72.5	42.9	36.6	52.7	32.3	54.7	52.6	79.4	41.2	17.5	17.4	18.4	21.4	17.4	19.3	18.0	17.5	18.2	18.9	17.8	19.1	16.5	9.6	11.5	2.9	33.5	30.0	34.6	61.7	25.6	7.6	37.5	42.4	8.0	20.0	29.0	44.1	8.4	56.4	17.6	22.0	52.8	28.4	9.4	17.7	13.7	20.1	9.1	14.5	6.1	29.8	40.2	26.9	11.7	14.5	24.7	21.1	24.7	26.3	70.8	13.5	6.5	30.6	61.1	43.5	38.9	10.9	45.7	39.1	28.4	7.5	42.6	21.5	21.6	3.0	7.9	27.6	31.4	35.3	15.4	35.4	30.3	50.5	31.4	12.4	52.6	12.6	50.5	49.8	40.3	31.0	33.4	43.9	20.8	16.4	23.6	39.3
TMEM63B	"C6orf110, dJ421H19.2, DKFZp434P0531"	ENSG00000137216	"Transmembrane protein 63B"	Q5T3F8	6	44126914-44155519	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Late spermatids: 87.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in all"		"OE19: 163.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA029249, HPA029250, HPA029251"	Uncertain		Enhanced	"Plasma membrane,Actin filaments"		NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 21: OE19 - Mitochondria"	"Cluster 34: Spermatids - Unknown function"	"Plasma membrane, Actin filaments"		"HPA029249: AB_2672965, HPA029250: AB_2672966, HPA029251: AB_2672967"	"unprognostic (8.83e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.42e-3)"	"unprognostic (3.61e-1)"	"unprognostic (2.89e-1)"	"unprognostic (1.85e-1)"	"unprognostic (6.97e-3)"	"unprognostic (1.25e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.75e-1)"	"unprognostic (8.60e-2)"	"unprognostic (1.83e-1)"	"unprognostic (1.17e-2)"	"unprognostic (1.59e-1)"	"unprognostic (2.67e-2)"	"unprognostic (6.12e-3)"	"unprognostic (3.15e-1)"	12.4	19.6	18.1	9.5	18.9	17.9	12.6	18.9	24.7	17.8	15.1	24.6	17.1	11.4	12.1	34.6	10.7	12.8	26.5	25.1	21.0	17.1	39.2	38.3	5.8	19.9	17.5	12.1	12.6	20.2	15.6	13.6	20.4	17.4	19.4	31.6	20.9	8.6	51.6	41.4	18.5	9.9	15.7	9.8	25.4	31.0	19.8	8.6	16.2	21.2	8.6	18.8	23.2	18.3	41.7	23.1	21.1	34.6	32.3	18.6	34.6	17.0	22.8	18.7	17.7	16.1	15.7	7.2	25.5	25.3	30.1	37.8	25.6	62.6	12.3	20.6	19.5	20.8	17.2	49.1	22.2	4.6	19.2	24.8	55.5	26.2	16.7	37.8	18.9	15.3	67.7	11.2	22.0	42.7	4.6	10.3	11.4	163.7	11.2	5.8	14.0	13.2	52.2	44.5	24.3	18.8	15.2	35.5	35.8	26.0	40.1	11.6	21.8	23.8	27.0	17.9	20.7	14.0	11.1	8.8	35.9	6.6	30.7	0.2	0.4	0.2	0.2	0.1	0.4	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.3	0.0	0.2	0.2	0.4	0.2	18.1	18.9	18.9	24.7	25.1	21.0	19.9	17.5	20.4	15.7	19.8	18.3	7.2	16.0	19.7	17.6	3.3	13.6	14.9	41.3	21.1	18.4	11.2	9.3	3.8	10.0	25.1	11.0	16.7	14.1	4.2	75.1	1.9	17.0	72.9	10.6	8.9	6.9	18.6	28.4	26.3	15.2	16.6	11.0	45.9	25.1	0.0	11.0	11.7	43.4	26.4	16.8	28.4	32.4	30.5	11.7	11.4	87.6	11.8	9.1	7.2	15.0	8.5	9.4	5.2	21.6	12.1	32.5	45.7	9.1	6.4	21.9	32.7	10.8	15.7	27.6	6.6	10.4	12.0	2.1	14.7	19.4	18.3	20.0	5.5	7.1	24.3	29.4
TMEM63C	"C14orf171, CSC1, DKFZp434P0111, hsCSC1"	ENSG00000165548	"Transmembrane protein 63C"	Q9P1W3	14	77116568-77259495	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 28.7;pituitary gland: 41.9"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 9.5;Enteroendocrine cells: 19.2;Excitatory neurons: 25.8;Inhibitory neurons: 22.2;Oligodendrocyte precursor cells: 16.1"	"Cancer enhanced"	"Detected in many"		"breast cancer: 5.0"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"Daudi: 18.5;Karpas-707: 24.1;RPMI-8226: 12.7;SCLC-21H: 32.5;SK-BR-3: 29.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA030657	Uncertain		Approved	Centrosome		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 26: Pituitary gland - Hormone signaling"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Centrosome		"HPA030657: AB_10601699"	"unprognostic (2.74e-1)"	"unprognostic (1.79e-2)"	"unprognostic (2.30e-1)"	"unprognostic (4.30e-8)"	"unprognostic (2.85e-1)"	"unprognostic (5.26e-2)"	"unprognostic (2.68e-3)"	"unprognostic (1.61e-3)"	"unprognostic (2.51e-1)"	"unprognostic (1.71e-1)"	"unprognostic (1.21e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.90e-2)"	"unprognostic (1.35e-3)"	"unprognostic (3.72e-2)"	"unprognostic (1.34e-7)"	"unprognostic (5.90e-3)"	0.2	9.6	9.2	0.6	5.9	0.8	3.3	28.7	10.5	2.6	0.0	4.5	1.2	0.1	4.5	6.4	0.2	0.2	0.9	5.6	24.6	0.5	0.1	0.5	0.3	4.5	8.3	0.1	4.8	1.5	41.9	0.7	16.9	0.2	3.0	2.4	2.7	0.0	0.5	9.7	2.7	0.6	4.2	3.3	1.9	11.3	18.2	0.1	2.2	0.4	0.3	0.0	7.1	4.3	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.3	18.5	3.4	0.0	3.0	2.5	3.8	1.5	0.0	1.2	1.4	0.3	1.8	0.0	0.0	3.2	0.1	0.0	7.5	0.0	0.2	0.0	0.0	8.7	0.0	24.1	0.0	9.3	2.6	0.1	0.8	0.0	0.0	0.0	1.2	12.7	0.3	0.0	32.5	4.9	0.4	29.1	0.0	0.6	2.8	1.6	0.0	0.0	5.9	0.0	0.0	1.9	0.1	0.7	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.3	0.3	0.0	0.0	0.1	9.2	5.9	28.7	10.5	5.6	24.6	4.5	8.3	16.9	4.2	18.2	4.3	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.5	0.0	3.3	2.2	0.8	0.7	0.0	1.7	0.0	2.1	0.0	1.5	3.8	1.9	0.0	9.5	0.3	0.4	0.1	19.2	0.0	25.8	0.2	0.1	0.3	0.0	2.4	0.0	0.2	0.0	0.0	2.7	3.3	22.2	3.0	4.1	0.0	0.0	6.2	0.0	0.2	0.0	3.7	0.6	0.3	0.0	16.1	1.1	0.2	7.0	0.4	0.1	0.0	0.5	0.2	0.1	0.6	0.0	0.0	0.3	0.6	0.1	2.4	0.0	0.0	0.2	0.7	0.7	0.1
TMEM64	DKFZp762C1112	ENSG00000180694	"Transmembrane protein 64"	Q6YI46	8	90621995-90791632	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in all"	4	"choroid plexus: 42.5;epididymis: 144.9"	"Cell type enhanced"	"Detected in many"		"Basal squamous epithelial cells: 62.0;Hepatocytes: 51.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB034221	Uncertain					NA	NA			"Cluster 19: B-cells - Humoral immune response"	"Cluster 30: Epididymis - Antimicrobial activity"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"CAB034221: AB_1567653"	"unprognostic (3.61e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.58e-1)"	"unprognostic (3.70e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.27e-1)"	"unprognostic (2.55e-3)"	"unprognostic (4.84e-1)"	"unprognostic (2.04e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.30e-1)"	"unprognostic (2.35e-1)"	"unprognostic (2.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (1.19e-1)"	"unprognostic (6.17e-2)"	"unprognostic (1.97e-1)"	17.1	12.0	5.2	9.3	9.3	3.4	8.4	7.1	7.1	15.4	42.5	10.5	9.6	10.9	144.9	10.5	8.8	10.4	7.2	4.9	6.8	13.6	20.8	9.5	12.9	9.4	7.4	16.3	15.3	6.8	4.7	10.3	7.8	11.4	5.5	1.0	17.8	17.3	8.9	6.4	9.8	16.3	7.5	8.9	7.1	12.2	7.4	5.1	22.9	7.1	12.1	10.6	7.8	14.5	26.5	20.3	10.0	5.4	45.7	33.0	5.5	19.2	18.2	14.8	16.3	5.7	17.8	17.2	7.5	11.8	6.4	9.0	26.9	13.0	19.5	34.8	9.8	32.1	7.3	12.8	16.1	1.9	5.1	43.4	14.0	6.1	13.8	17.1	15.1	4.1	14.8	36.9	25.1	35.3	0.1	4.6	1.5	13.6	10.6	3.8	22.1	8.7	29.2	50.6	7.1	20.0	12.6	10.9	23.5	13.3	10.9	1.5	15.1	14.9	13.1	10.8	15.8	24.3	0.4	18.8	13.4	3.9	20.0	2.7	0.1	0.1	1.5	0.3	1.9	3.1	1.6	1.7	0.3	2.0	0.7	1.1	0.0	3.2	0.4	0.2	0.8	0.9	5.2	9.3	7.1	7.1	4.9	6.8	9.4	7.4	7.8	7.5	7.4	14.5	16.7	9.6	12.5	5.2	15.7	24.1	12.7	5.4	62.0	0.7	7.3	11.4	20.4	7.2	3.7	22.0	0.0	25.3	18.6	2.5	1.9	3.9	3.7	3.3	9.6	9.0	7.8	18.7	9.9	10.2	6.2	18.1	6.1	4.6	14.0	13.5	6.1	51.7	4.0	1.7	14.1	4.5	8.2	9.7	11.6	3.2	46.9	11.1	24.9	9.4	1.9	4.0	4.1	8.0	46.8	8.8	2.4	21.4	12.6	19.7	16.7	30.6	3.7	0.0	0.0	10.5	11.9	3.4	2.2	17.4	23.4	15.7	13.3	23.7	7.2	8.6
TMEM67	"JBTS6, MGC26979, MKS3, NPHP11"	ENSG00000164953	"Transmembrane protein 67"	Q5HYA8	8	93754844-93819234	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Cilium biogenesis/degradation"		"Bardet-Biedl syndrome, Ciliopathy, Deafness, Disease variant, Joubert syndrome, Meckel syndrome, Mental retardation, Nephronophthisis, Obesity, Retinitis pigmentosa"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 66.7;Excitatory neurons: 59.8;Respiratory ciliated cells: 95.8;Rod photoreceptor cells: 83.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 15: NK-cells - Transcription"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 49: Ciliated cells - Cilium organization"				"unprognostic (1.57e-3)"	"unprognostic (1.22e-1)"	"unprognostic (2.45e-2)"	"unprognostic (1.73e-1)"	"unprognostic (5.07e-2)"	"unprognostic (3.08e-1)"	"unprognostic (2.25e-5)"	"unprognostic (2.61e-1)"	"unprognostic (1.05e-1)"	"unprognostic (1.22e-2)"	"unprognostic (2.51e-1)"	"unprognostic (4.43e-2)"	"prognostic unfavorable (7.62e-4)"	"unprognostic (8.41e-2)"	"unprognostic (2.21e-1)"	"unprognostic (1.68e-2)"	"unprognostic (2.01e-1)"	2.4	2.5	1.7	1.3	2.7	1.4	3.5	2.8	2.7	3.6	10.3	2.1	1.4	4.2	6.3	1.8	13.3	2.8	5.0	2.5	3.0	3.1	1.2	3.6	1.4	6.5	6.8	4.2	2.6	4.7	5.8	2.1	3.1	2.8	2.2	6.1	1.9	3.2	1.2	3.7	1.3	2.4	3.5	1.9	2.0	6.8	3.1	1.4	6.0	0.6	1.7	2.5	2.2	3.9	5.8	3.7	5.2	4.1	4.4	9.8	3.1	3.3	5.4	3.8	7.5	2.1	13.0	1.5	6.9	3.6	6.9	5.9	1.9	3.3	5.6	1.1	4.3	3.6	4.8	1.8	4.0	2.7	1.5	4.2	3.0	6.8	3.0	7.1	4.0	6.1	2.5	0.9	4.0	1.4	4.5	2.0	4.3	2.3	3.4	1.6	1.7	0.0	4.7	2.5	3.4	5.7	3.3	0.9	5.6	4.6	6.8	1.4	2.1	4.1	1.7	5.7	3.0	1.8	5.5	1.6	7.4	0.8	3.9	1.7	0.5	0.2	1.5	0.2	1.2	0.7	1.3	1.3	1.0	1.5	1.5	1.5	0.5	1.8	0.2	1.1	0.3	0.5	1.7	2.7	2.8	2.7	2.5	3.0	6.5	6.8	3.1	3.5	3.1	3.9	5.0	12.8	8.7	27.4	6.3	2.8	5.6	12.2	2.2	14.6	6.0	5.6	31.9	5.7	12.5	20.2	66.7	3.4	5.6	1.2	0.0	6.4	24.5	50.9	15.1	6.8	9.0	4.6	59.8	2.7	5.6	9.8	4.1	4.9	5.1	16.1	10.0	1.6	2.2	23.5	34.2	2.4	8.2	2.9	2.6	7.7	16.1	1.8	1.8	13.1	1.5	9.3	3.1	17.6	3.4	2.1	0.5	10.5	2.7	2.1	0.4	3.9	95.8	83.2	6.6	18.9	6.9	47.6	16.5	2.6	1.4	2.3	5.6	13.7	2.8	1.6
TMEM70	FLJ20533	ENSG00000175606	"Transmembrane protein 70"	Q9BUB7	8	73972437-73982783	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Primary mitochondrial disease"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"skeletal muscle: 100.7"	"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"SK-BR-3: 78.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA023187, CAB034226"	Approved		Supported	Nucleoplasm,Mitochondria		NA	Yes			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"	Mitochondria	Nucleoplasm	"CAB034226: AB_2205189, HPA023187: AB_2671101"	"unprognostic (2.26e-3)"	"unprognostic (4.87e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.11e-2)"	"unprognostic (1.51e-3)"	"unprognostic (8.22e-3)"	"unprognostic (9.17e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.37e-2)"	"unprognostic (7.04e-2)"	"unprognostic (2.88e-2)"	"unprognostic (9.14e-2)"	"unprognostic (3.65e-3)"	"unprognostic (6.86e-2)"	"unprognostic (5.08e-2)"	"unprognostic (2.13e-1)"	"unprognostic (2.70e-2)"	18.1	18.2	9.2	9.8	9.7	10.4	11.3	10.5	12.3	8.0	9.5	12.6	5.8	8.9	10.6	9.3	11.3	8.9	19.3	10.3	10.2	12.0	24.4	9.0	10.1	9.6	9.1	10.5	25.0	8.3	7.6	10.3	10.1	7.4	9.7	6.1	9.9	5.9	100.7	7.7	9.5	9.1	9.5	9.6	17.8	9.8	9.5	11.0	6.0	20.5	10.3	11.3	7.4	10.1	21.2	16.4	13.1	13.8	14.9	12.7	13.6	17.6	15.8	19.4	15.3	15.8	11.9	28.4	15.0	12.0	16.4	19.1	24.9	16.8	21.4	18.9	17.5	28.3	10.0	21.2	14.7	15.5	14.5	11.8	15.3	12.2	6.4	7.3	16.4	14.2	22.0	13.5	20.5	15.9	35.8	29.6	12.3	26.6	20.6	25.4	12.8	24.2	20.5	20.0	29.7	13.1	11.0	78.0	23.3	10.2	16.0	14.1	10.6	11.1	13.7	20.7	16.9	19.9	18.7	28.1	16.4	12.1	12.5	6.3	9.1	6.7	8.0	10.2	9.1	17.7	9.0	9.3	9.6	10.9	10.3	9.6	6.7	5.8	7.9	11.0	7.9	12.0	9.2	9.7	10.5	12.3	10.3	10.2	9.6	9.1	10.1	9.5	9.5	10.1	136.2	16.0	30.1	5.5	37.1	67.3	43.7	54.8	24.5	23.9	26.2	22.2	46.3	14.3	35.7	22.0	8.4	71.2	48.1	69.0	66.5	36.6	20.3	40.8	26.2	96.4	13.8	26.5	12.8	63.5	59.6	50.2	17.3	17.1	39.9	17.0	28.5	50.3	132.4	10.1	11.4	31.7	42.7	70.0	74.5	12.1	29.8	73.2	40.9	5.6	38.9	23.1	22.6	3.5	8.1	43.6	37.9	29.0	68.6	42.1	28.8	75.4	58.7	17.5	39.5	61.9	40.8	70.6	29.5	21.5	59.7	70.3	39.8	52.6	34.1	26.2
TMEM74	"FLJ30668, NET36"	ENSG00000164841	"Transmembrane protein 74"	Q96NL1	8	108606850-108787594	"Predicted membrane proteins, Transporters"	Autophagy			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 8.2"	"Cell type enhanced"	"Detected in some"		"Basal squamous epithelial cells: 4.6;Bipolar cells: 4.7;Cone photoreceptor cells: 6.2;Excitatory neurons: 5.1;Muller glia cells: 3.3;Rod photoreceptor cells: 8.3;Spermatogonia: 4.1"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 1.7;JURKAT: 1.5;NTERA-2: 2.1;RH-30: 1.5;SCLC-21H: 5.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA015672, HPA076461"	Uncertain		Approved	"Golgi apparatus,Cytosol"		NA	NA				"Cluster 69: Cerebellum - Gene expression regulation"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 46: Photoreceptor cells - Phototransduction"	"Golgi apparatus, Cytosol"		"HPA015672: AB_1858132, HPA076461: "	"unprognostic (8.99e-2)"	"unprognostic (1.18e-1)"	"unprognostic (4.25e-2)"	"unprognostic (6.33e-2)"	"unprognostic (2.05e-1)"	"unprognostic (4.18e-1)"	"unprognostic (1.95e-2)"	"unprognostic (1.00e-1)"	"unprognostic (2.54e-1)"	"unprognostic (1.44e-2)"	"unprognostic (2.01e-2)"	"unprognostic (3.97e-2)"	"unprognostic (3.75e-4)"	"unprognostic (8.77e-2)"	"unprognostic (6.36e-2)"	"unprognostic (5.95e-2)"	"unprognostic (1.46e-3)"	0.3	0.2	1.8	0.1	2.2	0.0	0.2	4.7	2.4	0.2	1.4	1.3	0.0	0.1	0.0	0.5	0.1	0.1	1.3	3.7	3.0	0.1	0.8	0.1	0.0	3.8	1.7	0.1	0.5	0.0	0.4	0.0	3.5	0.1	0.1	2.5	0.2	0.1	0.8	0.3	0.2	0.4	6.1	0.1	0.3	0.3	1.6	0.3	0.1	0.2	0.1	0.2	0.4	8.2	0.0	0.1	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.0	0.0	0.0	0.0	0.8	0.1	0.0	0.1	1.7	0.7	0.1	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	1.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.9	0.0	1.5	0.0	0.0	0.0	5.3	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.5	0.7	0.0	0.1	0.2	0.0	0.0	0.7	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.8	2.2	4.7	2.4	3.7	3.0	3.8	1.7	3.5	6.1	1.6	8.2	0.4	0.0	0.0	2.0	0.0	0.9	0.7	0.0	4.6	4.7	0.2	0.6	0.8	0.0	0.0	0.0	6.2	0.2	0.0	0.0	0.0	0.2	0.1	0.1	0.1	0.3	1.8	0.0	5.1	0.2	0.8	0.7	0.0	0.1	0.0	0.5	0.0	0.7	0.1	0.0	2.0	0.0	0.0	0.0	0.7	0.0	0.0	0.9	0.0	0.0	0.0	3.3	0.0	0.0	0.7	0.2	0.0	0.0	0.1	0.2	0.0	0.0	0.0	8.3	0.0	0.8	0.9	0.2	4.1	2.0	0.6	0.1	0.1	0.1	0.0	0.0
TMEM8B	"C9orf127, FP588, LINC00950, NAG-5, NGX6, NGX6a"	ENSG00000137103	"Transmembrane protein 8B"	A6NDV4	9	35814451-35865518	"Predicted membrane proteins, Transporters"	"Cell adhesion, Growth regulation"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"dendritic cells: 36.1;Granulosa cells: 47.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in some"	6	"plasmacytoid DC: 51.2"	"Lineage enriched"	"Detected in many"	24	"dendritic cells: 51.2"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA052130, HPA062701"	Approved		Approved	Vesicles		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"HPA052130: AB_2681740, HPA062701: AB_2684839"	"unprognostic (5.54e-2)"	"unprognostic (3.32e-1)"	"unprognostic (3.96e-1)"	"unprognostic (3.53e-2)"	"unprognostic (3.81e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.09e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.62e-1)"	"prognostic favorable (3.14e-4)"	"unprognostic (5.93e-2)"	"prognostic favorable (1.89e-15)"	"unprognostic (8.00e-2)"	"unprognostic (1.26e-1)"	"unprognostic (1.68e-2)"	"unprognostic (3.29e-2)"	10.4	21.1	19.9	3.1	16.0	1.8	12.3	11.5	20.7	21.7	3.6	19.9	5.1	20.1	6.2	5.7	20.8	6.7	15.9	20.3	13.9	15.8	6.4	10.2	3.6	14.2	15.3	33.6	11.8	17.8	30.6	4.5	13.9	23.9	5.5	7.7	18.1	14.2	12.8	9.3	9.5	6.9	12.7	8.5	17.7	19.1	18.5	5.2	22.7	9.6	2.6	19.3	15.7	12.4	3.1	3.4	11.7	9.2	12.9	10.7	1.4	2.8	5.5	3.1	3.8	1.4	0.8	2.5	6.5	7.7	9.1	1.2	3.1	4.7	2.5	1.9	5.2	0.7	2.5	3.4	9.1	0.2	0.2	10.1	6.1	3.2	3.4	10.0	1.8	11.5	1.2	6.9	5.5	1.2	6.6	1.4	1.6	2.7	4.6	7.2	2.4	6.2	3.3	1.5	2.8	8.1	4.3	1.8	4.1	3.8	3.2	1.1	2.9	7.3	2.2	7.2	1.1	8.6	2.8	2.8	6.7	1.2	4.6	0.7	2.1	0.2	0.5	0.1	0.3	0.6	0.4	0.4	8.2	0.5	0.4	0.4	0.9	0.7	0.1	51.2	0.2	1.3	19.9	16.0	11.5	20.7	20.3	13.9	14.2	15.3	13.9	12.7	18.5	12.4	4.4	12.8	12.2	18.9	3.3	4.5	9.1	8.1	8.0	4.1	12.1	11.4	11.7	10.0	9.1	14.7	2.1	34.1	36.1	8.2	1.9	5.7	25.4	7.7	8.4	3.2	6.7	0.8	12.4	4.0	9.2	9.2	11.2	6.3	1.3	47.3	1.8	4.0	3.2	1.7	13.0	7.0	12.2	1.3	11.2	14.0	14.6	5.3	10.6	10.3	3.6	9.1	2.1	12.1	7.2	3.6	8.0	19.5	2.6	9.0	3.0	4.5	7.5	5.3	6.6	7.1	8.7	8.6	5.2	1.9	1.6	13.0	3.6	8.1	7.8	10.0
TMEM9	TMEM9A	ENSG00000116857	"Transmembrane protein 9"	Q9P0T7	1	201134772-201171574	"Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008483			Approved	"Vesicles,Microtubules,Cytokinetic bridge,Mitotic spindle"		Yes	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 35: Non-specific - Unknown function"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 33: Fibroblasts - ECM organization"	Vesicles	"Microtubules, Cytokinetic bridge, Mitotic spindle"	"HPA008483: "	"unprognostic (1.88e-1)"	"prognostic unfavorable (6.57e-4)"	"unprognostic (2.95e-1)"	"unprognostic (3.67e-2)"	"unprognostic (3.96e-1)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.05e-2)"	"unprognostic (1.47e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.69e-2)"	"unprognostic (2.46e-2)"	"unprognostic (2.99e-1)"	"unprognostic (1.88e-2)"	"unprognostic (2.38e-1)"	"unprognostic (9.17e-2)"	"unprognostic (3.32e-1)"	"unprognostic (9.90e-2)"	34.1	102.3	103.1	20.8	104.4	27.8	45.0	93.5	126.6	76.8	122.7	45.0	25.4	70.9	65.4	31.1	75.4	39.5	51.3	107.8	113.2	73.8	73.8	44.5	23.5	99.4	111.5	81.4	73.9	92.2	63.4	28.5	102.8	60.3	25.4	43.9	60.7	45.9	44.9	35.5	30.4	37.5	100.2	31.2	49.8	67.0	112.5	26.3	68.5	24.9	17.7	45.7	51.8	100.2	63.1	117.0	72.6	168.9	38.5	54.5	128.5	48.6	51.5	76.0	68.2	115.7	99.8	33.2	69.2	73.4	70.1	123.3	76.5	80.1	37.3	21.3	131.9	58.1	182.4	76.6	73.8	28.2	51.9	65.0	87.0	71.2	43.0	91.3	47.7	46.2	105.6	35.5	66.2	81.0	34.1	46.1	111.0	57.3	285.3	60.7	108.4	44.0	87.9	48.0	67.6	137.7	86.7	146.9	91.8	107.4	180.3	48.5	35.7	84.8	70.0	68.5	59.8	143.9	135.2	26.1	64.4	30.1	42.0	49.8	59.8	33.7	45.7	41.8	52.2	54.5	44.0	37.8	51.5	49.2	64.6	42.7	41.0	32.9	38.5	56.1	43.0	75.5	103.1	104.4	93.5	126.6	107.8	113.2	99.4	111.5	102.8	100.2	112.5	100.2	20.9	51.3	49.5	17.0	13.4	12.9	31.4	65.6	27.3	61.0	56.2	65.7	39.3	40.0	48.0	36.8	31.3	44.4	9.3	7.9	17.6	88.8	58.0	37.3	58.6	26.3	31.8	43.6	15.7	74.7	52.1	59.9	20.9	46.4	13.3	46.3	30.0	40.4	28.1	8.4	22.1	26.9	36.7	13.4	11.9	60.9	70.8	15.6	23.2	8.4	11.8	102.3	25.7	15.6	10.1	40.3	18.8	53.0	18.8	28.5	8.3	56.9	54.5	32.8	13.1	33.3	42.1	54.8	76.7	14.5	13.9	13.0	13.0	130.7	28.4	27.8
TMEM91	"DSPC3, FLJ27310, IFITMD6"	ENSG00000142046	"Transmembrane protein 91"	Q6ZNR0	19	41350911-41384083	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 212.0;Late spermatids: 451.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 193.3"	"Group enriched"	"Detected in all"	8	"granulocytes: 193.3;monocytes: 51.9"	"Cell line enhanced"	"Detected in many"		"HEL: 20.1;HSkMC: 20.5;TIME: 19.8"	"Low region specificity"	"Detected in all"							HPA053240	Uncertain					NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA053240: AB_2682085"	"unprognostic (3.02e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-3)"	"prognostic favorable (3.54e-5)"	"unprognostic (1.07e-1)"	"prognostic unfavorable (3.52e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.06e-2)"	24.0	12.8	32.3	6.9	43.1	36.2	19.7	19.5	35.2	39.1	27.7	26.6	3.5	18.6	10.2	22.6	30.2	8.2	16.4	29.3	49.0	20.3	9.6	23.3	6.5	29.2	33.3	20.1	17.7	4.1	26.2	9.4	28.4	23.0	3.9	9.2	11.4	8.6	5.4	66.3	14.3	8.7	23.3	37.5	12.3	37.8	52.7	5.7	20.5	7.3	7.6	29.8	31.3	24.2	3.3	7.0	5.4	2.7	6.4	13.6	5.0	2.6	3.4	1.3	2.1	0.5	2.9	1.5	2.4	3.0	2.1	0.9	1.3	2.4	3.0	2.3	3.6	20.1	5.7	11.1	12.3	3.4	5.2	20.5	12.6	4.0	9.8	14.8	9.2	3.7	3.8	6.2	2.1	6.3	2.5	6.6	2.3	0.9	4.2	4.2	1.2	1.4	3.4	1.6	1.4	3.3	5.0	1.0	4.1	3.8	1.3	9.9	19.8	3.1	3.0	2.9	2.7	3.8	0.6	1.1	6.5	4.6	1.2	36.8	51.9	4.0	5.9	12.3	7.4	0.7	3.4	3.1	9.5	1.4	8.0	3.9	193.3	1.5	9.1	14.6	4.7	41.2	32.3	43.1	19.5	35.2	29.3	49.0	29.2	33.3	28.4	23.3	52.7	24.2	20.2	3.2	22.4	23.8	3.5	17.8	22.9	59.8	7.4	8.3	10.7	15.9	5.3	2.8	25.0	7.3	6.2	2.7	10.6	0.7	1.9	5.3	212.0	12.0	12.1	13.7	14.4	4.8	11.7	3.2	84.3	21.7	1.1	4.8	34.2	13.0	20.0	3.8	15.7	8.4	18.9	1.6	10.2	67.6	8.4	451.5	14.0	51.6	8.8	7.5	30.7	4.1	20.6	5.0	5.8	3.8	18.5	7.2	1.7	6.5	2.3	2.5	13.5	6.4	6.6	4.8	8.6	4.9	9.0	9.7	21.3	8.6	7.8	3.7	1.7	10.4
TMEM94	KIAA0195	ENSG00000177728	"Transmembrane protein 94"	Q12767	17	75441159-75500452	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 43.0;Granulosa cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA008423, HPA050660"	Approved		Supported	"Nucleoplasm,Nuclear bodies"		NA	NA			"Cluster 24: B-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"	Nucleoplasm	"Nuclear bodies"	"HPA008423: AB_1852283, HPA050660: AB_2681207"	"unprognostic (4.05e-2)"	"unprognostic (3.43e-1)"	"unprognostic (5.78e-2)"	"unprognostic (4.32e-2)"	"unprognostic (1.01e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.32e-3)"	"unprognostic (1.70e-1)"	"unprognostic (1.42e-1)"	"unprognostic (7.27e-2)"	"prognostic favorable (2.26e-4)"	"unprognostic (9.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.21e-2)"	"unprognostic (3.33e-1)"	"unprognostic (1.44e-2)"	"unprognostic (4.96e-2)"	21.3	55.9	50.3	13.9	46.4	18.4	21.7	27.7	54.9	21.9	30.5	25.1	18.8	24.4	5.4	21.1	30.7	15.8	27.8	40.7	31.5	29.7	20.2	25.6	14.1	40.1	36.8	27.7	23.7	20.3	30.1	14.2	30.5	19.9	13.6	27.7	21.1	13.2	63.4	22.9	28.2	10.7	34.8	29.7	25.0	27.1	47.1	18.0	27.4	25.8	8.6	20.5	15.3	35.8	15.3	40.7	33.6	52.6	16.1	18.8	45.6	9.2	20.0	15.4	15.4	13.7	22.6	20.6	30.3	15.9	23.6	19.9	15.8	25.6	8.8	19.4	23.1	22.0	18.4	22.9	21.2	23.7	45.2	30.9	14.5	15.0	13.4	13.9	28.1	18.3	22.6	24.4	20.7	19.1	53.3	18.8	14.4	19.3	16.2	36.2	37.2	19.2	16.0	40.7	28.1	30.5	10.2	47.4	28.7	25.3	29.8	29.3	16.0	16.5	19.0	16.5	13.8	53.2	17.2	12.2	17.2	23.8	20.8	0.1	2.6	3.0	3.5	1.6	2.6	1.0	1.6	2.5	2.5	2.5	1.3	2.2	0.7	2.4	1.4	3.3	2.1	2.9	50.3	46.4	27.7	54.9	40.7	31.5	40.1	36.8	30.5	34.8	47.1	35.8	12.8	12.8	11.1	0.0	5.8	0.0	3.3	0.0	6.2	43.0	10.9	9.1	0.0	12.8	6.2	9.2	31.3	16.1	8.8	18.0	0.0	8.1	4.7	10.1	6.8	8.2	7.3	10.7	0.0	9.5	11.0	4.4	28.1	8.6	6.3	41.5	13.9	8.9	15.4	20.2	0.0	10.5	0.0	12.4	0.0	1.9	6.8	8.9	0.0	0.0	5.6	15.2	4.1	0.0	0.0	6.0	9.1	9.1	8.1	3.3	19.6	3.4	2.9	33.6	6.6	7.5	6.0	14.9	8.8	9.7	0.0	20.1	6.9	19.0	9.3	3.1
TMEM97	MAC30	ENSG00000109084	"Transmembrane protein 97"	Q5BJF2	17	28319200-28328685	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 113.4;pancreas: 322.0"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 121.5;Exocrine glandular cells: 196.4;Granulosa cells: 212.9;Hepatocytes: 226.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"CACO-2: 341.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044795, HPA076689"	Enhanced		Supported	"Endoplasmic reticulum"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 25: Pancreas - Digestion"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 40: Granulosa cells - Unknown function"	"Endoplasmic reticulum"		"HPA044795: AB_10959306, HPA076689: "	"unprognostic (1.35e-2)"	"unprognostic (2.70e-1)"	"unprognostic (1.39e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.81e-1)"	"unprognostic (4.34e-2)"	"unprognostic (3.20e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.04e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.11e-2)"	"unprognostic (5.17e-2)"	"prognostic unfavorable (1.24e-4)"	"unprognostic (1.08e-1)"	"unprognostic (2.26e-1)"	"unprognostic (1.99e-1)"	"unprognostic (4.01e-2)"	4.3	26.0	5.2	7.3	6.3	6.7	11.7	6.6	9.0	5.7	6.5	14.3	16.4	6.7	4.7	7.4	13.1	10.2	3.4	6.3	5.4	7.1	113.4	17.4	7.1	14.9	14.2	18.1	322.0	6.5	1.6	6.8	14.9	10.8	12.6	6.3	3.7	3.3	15.5	9.8	11.2	5.7	5.0	4.6	38.8	58.0	7.4	7.6	4.2	9.1	8.2	26.6	5.2	6.8	46.1	120.4	214.8	105.5	28.0	40.2	70.5	44.1	27.9	67.9	90.3	341.0	34.3	126.3	46.4	17.0	140.1	48.7	137.1	75.0	52.7	60.3	102.1	47.8	56.9	143.0	25.7	76.9	36.4	84.0	10.0	66.4	27.5	8.3	21.1	80.1	101.3	92.1	22.7	81.8	120.0	72.4	95.6	187.7	30.6	94.8	236.5	112.8	85.6	210.6	154.1	67.0	70.0	55.1	36.3	118.2	97.0	35.8	13.8	72.8	56.8	62.9	81.7	74.3	159.0	115.9	14.6	54.7	44.3	0.7	2.2	2.2	7.8	2.7	9.2	11.1	6.4	9.4	16.1	5.5	10.4	9.8	1.0	9.5	1.0	9.3	6.6	5.2	5.2	6.3	6.6	9.0	6.3	5.4	14.9	14.2	14.9	5.0	7.4	6.8	4.2	9.6	61.5	3.3	7.7	14.5	6.0	32.8	18.8	11.3	22.5	21.5	9.0	121.5	19.1	14.7	16.7	34.2	5.0	6.1	15.6	23.3	22.3	7.5	14.3	7.1	38.8	40.3	2.9	196.4	84.0	14.4	49.5	11.4	1.3	212.9	6.4	226.9	22.0	3.3	4.5	16.2	26.4	6.7	34.7	49.1	13.4	9.9	16.0	0.0	11.4	8.2	4.1	4.0	1.0	47.7	3.5	11.3	15.3	13.9	4.0	6.3	12.2	9.1	6.6	10.4	12.4	91.3	65.5	22.7	11.2	10.7	6.4	65.1	29.4	7.9
TMIE	DFNB6	ENSG00000181585	"Transmembrane inner ear"	Q8NEW7	3	46694528-46710886	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 19.6;choroid plexus: 10.5;pituitary gland: 9.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 3.8;Spermatocytes: 2.6;Spermatogonia: 3.2"	"Cancer enriched"	"Detected in many"	5	"glioma: 6.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in single"		"naive CD4 T-cell: 2.4"	"Lineage enriched"	"Detected in single"	15	"T-cells: 2.4"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 3.1;EFO-21: 2.7;JURKAT: 10.7;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038298	Uncertain		Uncertain	Vesicles,Cytosol		NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 56: Bipolar cells - Visual perception"	"Vesicles, Cytosol"		"HPA038298: AB_10675792"	"unprognostic (6.59e-2)"	"unprognostic (1.11e-1)"	"unprognostic (7.25e-3)"	"unprognostic (2.48e-3)"	"unprognostic (1.88e-2)"	"unprognostic (5.40e-3)"	"unprognostic (3.94e-2)"	"unprognostic (8.80e-2)"	"unprognostic (3.37e-2)"	"unprognostic (6.65e-2)"	"unprognostic (1.97e-1)"	"unprognostic (5.35e-2)"	"unprognostic (4.58e-2)"	"unprognostic (1.23e-1)"	"unprognostic (4.41e-2)"	"unprognostic (5.29e-2)"	"unprognostic (6.78e-2)"	0.7	6.2	14.2	0.5	14.1	0.0	0.4	14.0	18.0	0.7	10.5	1.0	0.4	0.5	0.7	1.5	0.6	0.2	0.7	14.1	19.3	2.3	0.8	1.0	0.8	19.6	15.7	1.5	0.2	0.1	9.9	0.4	19.2	0.5	0.3	0.7	0.5	1.0	3.6	0.7	0.5	0.4	16.0	0.7	0.3	1.5	18.7	0.5	0.9	1.2	0.8	0.6	0.9	14.9	1.0	0.4	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	3.1	0.0	2.7	0.0	0.5	0.1	0.1	0.2	0.0	0.0	0.0	0.8	0.0	0.0	0.8	0.0	0.0	0.0	1.8	0.0	1.2	0.0	0.5	10.7	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.7	0.1	1.2	0.0	0.3	0.1	0.1	0.3	2.3	0.3	0.3	0.0	0.1	0.0	0.5	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.4	0.1	0.0	2.4	0.4	0.0	0.0	0.0	0.0	0.4	0.4	14.2	14.1	14.0	18.0	14.1	19.3	19.6	15.7	19.2	16.0	18.7	14.9	1.9	0.0	0.0	0.3	0.0	0.8	0.2	0.5	0.0	3.8	0.2	0.6	0.9	0.0	0.3	0.0	0.0	0.0	0.0	0.1	1.9	0.4	0.5	0.2	0.0	0.7	0.0	0.0	1.7	0.4	0.1	0.4	0.0	0.1	0.0	0.1	0.4	0.1	0.6	0.0	0.8	0.0	0.0	0.0	0.4	1.5	0.6	0.3	0.0	1.9	0.1	1.4	0.0	0.0	0.3	1.2	0.0	0.4	0.0	0.3	0.0	0.0	0.6	0.5	0.0	1.1	1.0	2.6	3.2	0.0	0.9	0.1	0.2	0.1	0.0	0.2
TMPRSS11A	"ECRG1, HATL1, HESP"	ENSG00000187054	"Transmembrane serine protease 11A"	Q6ZMR5	4	67909395-67964140	"Enzymes, Predicted membrane proteins, Transporters"	"Cell cycle"	"Hydrolase, Protease, Serine protease"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 86.1;lymphoid tissue: 28.4;vagina: 41.7"	"Cell type enriched"	"Detected in some"	7	"Squamous epithelial cells: 50.7"	"Group enriched"	"Detected in some"	9	"cervical cancer: 14.4;head and neck cancer: 11.6;lung cancer: 4.0"	"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA078316	Enhanced					NA	NA				"Cluster 84: Esophagus - Epithelial cell function"		"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA078316: "	"unprognostic (1.63e-1)"	"unprognostic (4.60e-2)"				"unprognostic (1.76e-2)"		"unprognostic (6.98e-2)"	"unprognostic (1.98e-1)"	"unprognostic (2.66e-1)"		"unprognostic (4.58e-1)"	"unprognostic (1.32e-1)"	"unprognostic (4.36e-2)"	"unprognostic (1.05e-1)"	"unprognostic (3.50e-1)"	"unprognostic (2.33e-2)"	0.0	0.0	0.3	0.0	0.3	0.0	0.0	0.0	1.3	19.9	0.0	0.0	0.0	0.0	0.0	86.1	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.0	0.0	0.9	0.4	0.0	0.0	0.0	0.1	0.0	1.1	0.3	0.0	0.4	12.8	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.3	0.1	0.0	0.0	28.4	0.3	41.7	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.3	0.0	1.3	0.2	0.3	0.9	0.4	1.1	0.1	0.3	0.7	0.0	0.0	0.0	1.3	0.0	0.0	0.3	0.5	1.2	0.6	0.0	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.0	0.0	0.1	0.0	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.0	0.0	0.1	0.0	3.5	0.7	0.1	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.9	0.0	0.3	0.1	0.1	0.2	50.7	0.0	0.0	0.0	0.0	0.0	7.2
TMPRSS2	PRSS10	ENSG00000184012	"Transmembrane serine protease 2"	O15393	21	41464300-41531116	"Cancer-related genes, Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"prostate: 280.4;stomach 1: 146.2"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 404.8;Gastric mucus-secreting cells: 155.4;Paneth cells: 368.3;Prostatic glandular cells: 203.4;Proximal enterocytes: 159.6;Urothelial cells: 166.6"	"Cancer enriched"	"Detected in many"	7	"prostate cancer: 250.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 22.8;MCF7: 10.5;OE19: 35.9;RT4: 57.8;SK-BR-3: 11.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"HPA034493, HPA035787"	Enhanced		Supported	"Plasma membrane"	"Secreted in other tissues"	NA	NA				"Cluster 4: Stomach - Digestion"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Plasma membrane"		"HPA034493: , HPA035787: AB_2674782"	"unprognostic (4.80e-3)"	"unprognostic (3.49e-1)"	"unprognostic (2.16e-1)"	"prognostic favorable (2.56e-4)"	"unprognostic (1.72e-1)"	"unprognostic (1.05e-2)"	"unprognostic (4.28e-2)"	"unprognostic (1.51e-3)"	"unprognostic (9.43e-2)"	"unprognostic (9.02e-3)"	"unprognostic (6.24e-2)"	"unprognostic (6.43e-2)"	"prognostic favorable (7.86e-6)"	"unprognostic (2.00e-2)"	"unprognostic (1.68e-1)"	"unprognostic (1.41e-1)"	"unprognostic (2.15e-2)"	0.6	0.2	0.4	13.9	0.4	0.1	20.1	0.2	0.4	5.0	3.1	104.0	78.5	1.0	2.8	36.1	10.7	24.1	0.2	0.3	0.3	47.7	33.5	39.9	0.2	0.4	0.3	0.2	111.4	4.0	1.5	0.2	0.3	280.4	78.0	0.2	76.2	7.7	0.1	7.3	89.6	3.3	0.1	0.2	146.2	1.5	0.3	0.8	19.2	0.1	10.2	35.7	7.6	0.5	0.1	0.0	0.1	0.0	0.1	0.1	2.3	0.0	0.0	0.1	0.1	22.8	3.3	0.1	0.4	0.1	0.1	0.1	0.0	0.0	0.1	0.2	0.0	0.0	0.1	3.7	0.0	0.0	0.3	0.0	0.1	0.1	0.0	0.0	0.3	0.0	0.1	0.1	0.0	10.5	0.3	1.0	2.3	35.9	0.2	0.1	0.0	2.6	1.3	57.8	0.2	0.7	0.3	11.7	0.3	0.4	8.8	0.0	0.0	0.1	0.6	0.6	0.1	0.0	0.2	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.4	0.2	0.4	0.3	0.3	0.4	0.3	0.3	0.1	0.3	0.5	0.1	51.3	109.8	0.0	1.7	0.3	30.9	6.8	0.0	0.0	34.0	25.8	0.6	32.9	42.1	47.8	0.0	0.7	1.1	404.8	23.5	39.2	21.3	7.4	0.5	1.3	18.0	2.7	0.2	60.4	0.1	1.0	155.4	5.8	7.0	0.0	0.4	32.0	0.1	0.0	0.1	84.1	44.7	0.3	0.3	4.8	0.0	2.0	10.6	0.0	0.6	0.0	0.0	0.0	0.0	65.1	368.3	0.0	0.0	203.4	159.6	3.8	36.6	0.0	0.0	1.6	2.0	0.4	1.4	2.1	0.1	0.3	1.1	0.0	105.7	166.6
TMPRSS3	"DFNB10, DFNB8"	ENSG00000160183	"Transmembrane serine protease 3"	P57727	21	42371887-42396091	"Cancer-related genes, Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Protease, Serine protease"	"Cancer-related genes, Deafness, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"fallopian tube: 23.7;stomach 1: 14.5"	"Cell type enhanced"	"Detected in many"		"Breast glandular cells: 17.7;Cholangiocytes: 24.3;Ductal cells: 16.1;Endometrial ciliated cells: 17.1;Gastric mucus-secreting cells: 23.4;Ionocytes: 16.2;Muller glia cells: 20.4;Respiratory ciliated cells: 39.8"	"Cancer enhanced"	"Detected in many"		"ovarian cancer: 16.6"	"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"MAIT T-cell: 3.1"	"Lineage enriched"	"Detected in single"	6	"T-cells: 3.1"	"Cell line enriched"	"Detected in some"	4	"U-266/84: 274.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"									NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 42: Ciliated cells - Cilium & Cell projection"	"Cluster 16: U-266 - Nucleosome"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"				"unprognostic (8.47e-3)"	"unprognostic (2.83e-1)"	"prognostic unfavorable (3.64e-4)"	"unprognostic (2.85e-1)"	"unprognostic (2.45e-3)"	"unprognostic (3.97e-2)"	"unprognostic (1.43e-1)"	"unprognostic (8.17e-2)"	"unprognostic (9.62e-2)"	"unprognostic (4.81e-2)"	"unprognostic (2.65e-1)"	"unprognostic (1.42e-1)"	"prognostic unfavorable (8.24e-4)"	"unprognostic (2.66e-2)"	"unprognostic (2.73e-1)"	"unprognostic (8.00e-2)"	"unprognostic (1.33e-1)"	0.5	0.3	3.8	0.2	4.0	0.1	8.7	4.0	3.7	6.3	2.0	0.2	1.3	0.7	0.0	0.2	23.7	8.6	0.0	3.4	4.1	2.4	0.5	3.4	0.5	4.9	4.7	0.0	3.0	0.0	1.5	0.2	3.7	0.4	0.1	3.9	9.2	0.4	0.1	0.1	1.1	0.0	3.5	0.4	14.5	0.0	4.7	0.9	2.9	0.0	0.4	1.0	0.0	2.7	4.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	12.5	0.0	0.7	0.0	0.3	0.0	0.0	0.0	0.0	32.9	0.0	66.2	26.5	0.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	8.6	0.0	14.0	0.0	1.5	3.5	0.0	0.0	1.0	0.4	0.0	0.0	0.0	2.8	1.5	0.0	0.0	33.9	1.6	0.0	0.0	3.2	0.3	0.1	0.0	1.7	0.0	0.2	0.7	274.7	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.1	3.1	0.0	1.7	1.8	0.0	0.0	0.3	0.9	0.3	0.0	0.5	0.0	0.8	0.5	3.8	4.0	4.0	3.7	3.4	4.1	4.9	4.7	3.7	3.5	4.7	2.7	0.1	12.8	3.7	2.3	0.4	0.3	2.3	8.1	0.0	0.2	17.7	9.9	0.6	24.3	10.8	7.3	0.0	0.0	0.1	1.4	5.9	16.1	1.4	17.1	0.4	0.2	0.0	2.7	0.0	13.8	0.1	1.3	23.4	5.2	0.0	0.2	0.4	0.0	0.1	0.0	0.0	2.0	16.2	0.0	0.5	0.6	0.3	0.3	0.0	0.0	0.0	20.4	0.0	0.0	0.1	11.8	1.4	0.0	0.4	2.4	2.9	0.0	39.8	0.9	0.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	1.4	0.1	2.5	5.0
TMTC3	"FLJ90492, SMILE"	ENSG00000139324	"Transmembrane O-mannosyltransferase targeting cadherins 3"	Q6ZXV5	12	88142296-88199887	"Disease related genes, Enzymes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"		Transferase	"Disease variant, Lissencephaly"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Ionocytes: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038550	Approved					NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 31: Skin - Epidermis development"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 61: Squamous epithelial cells - Keratinization"			"HPA038550: AB_10672715"	"unprognostic (1.05e-1)"	"unprognostic (6.16e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.18e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.28e-2)"	"unprognostic (3.62e-3)"	"unprognostic (1.71e-2)"	"unprognostic (1.46e-1)"	"unprognostic (4.44e-1)"	"unprognostic (8.07e-3)"	"unprognostic (2.56e-2)"	"unprognostic (2.28e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.52e-1)"	"unprognostic (1.10e-1)"	"unprognostic (1.68e-1)"	5.9	4.4	3.6	3.8	3.8	1.7	6.7	5.8	4.7	5.6	2.1	4.5	5.4	6.4	5.2	9.1	3.9	5.7	3.8	3.9	4.6	8.1	9.0	5.2	2.9	3.4	3.9	5.3	3.2	6.2	2.8	10.2	4.1	7.4	4.7	7.9	3.8	6.3	1.7	12.5	4.4	9.2	3.2	3.9	3.8	4.1	3.6	4.0	6.3	4.3	4.5	6.8	4.7	4.1	13.2	14.0	12.6	11.9	28.8	25.4	22.5	28.1	26.6	15.8	16.9	20.3	9.2	4.1	5.0	25.8	9.6	28.9	13.5	22.4	26.5	2.4	10.2	4.0	9.5	9.3	15.0	4.3	2.5	21.7	12.0	30.5	12.0	16.2	24.9	3.4	8.9	1.4	17.8	7.9	3.0	5.5	9.7	5.0	7.3	2.6	27.4	4.1	13.7	21.3	10.7	10.6	22.8	16.1	7.3	13.3	25.9	4.3	26.4	21.8	12.0	19.4	13.7	4.5	6.3	4.7	6.8	5.0	16.5	7.4	1.3	2.3	1.8	1.1	2.2	2.3	2.0	1.4	0.9	1.8	2.4	2.0	1.3	1.2	1.6	0.9	1.7	0.7	3.6	3.8	5.8	4.7	3.9	4.6	3.4	3.9	4.1	3.2	3.6	4.1	15.9	12.8	8.2	19.6	6.9	34.2	24.4	29.1	24.5	12.5	11.4	8.1	11.1	5.7	20.0	7.3	27.1	29.6	3.5	6.7	3.9	14.5	26.8	23.7	22.2	16.9	3.6	9.5	51.6	10.8	18.2	23.8	8.6	21.9	9.5	12.4	15.7	19.2	8.2	13.5	46.8	5.9	75.3	5.9	6.0	18.2	20.2	3.7	8.8	20.6	2.8	8.3	2.1	28.1	42.4	12.4	4.9	19.5	4.6	18.0	7.3	13.9	34.9	23.4	19.7	17.1	22.3	12.0	8.7	32.6	40.5	17.8	5.2	14.1	7.1	14.4
TMUB1	"C7orf21, HOPS, SB144"	ENSG00000164897	"Transmembrane and ubiquitin like domain containing 1"	Q9BVT8	7	151081085-151083493	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Proximal enterocytes: 191.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029429	Approved		Approved	Nucleoplasm,Cytosol		NA	NA			"Cluster 52: Eosinophils - Transcription"	"Cluster 18: Non-specific - Mitochondria"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	Cytosol	"HPA029429: AB_10601825"	"unprognostic (8.14e-2)"	"unprognostic (2.19e-2)"	"unprognostic (2.76e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.23e-3)"	"unprognostic (7.04e-2)"	"unprognostic (2.12e-3)"	"unprognostic (7.73e-2)"	"unprognostic (1.25e-1)"	"unprognostic (2.93e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.24e-1)"	"unprognostic (1.97e-2)"	"unprognostic (2.49e-3)"	"unprognostic (2.74e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.31e-2)"	33.1	53.3	26.8	25.6	24.7	23.0	34.3	25.6	38.6	34.0	19.4	52.7	47.2	33.6	8.6	54.2	32.8	14.9	50.4	24.9	24.6	56.3	131.3	41.6	26.3	29.6	25.9	37.0	93.5	20.3	68.8	20.4	27.0	51.2	8.3	5.2	44.1	14.9	84.5	47.0	56.7	9.0	24.2	53.6	66.8	25.9	29.4	17.9	51.3	20.0	12.1	40.8	38.9	23.7	88.3	77.5	18.0	93.2	11.6	14.2	67.2	35.3	29.3	30.8	34.3	67.5	104.6	58.6	73.9	17.4	39.9	58.6	20.0	31.2	6.8	108.0	74.4	24.8	74.8	104.7	29.5	31.3	84.8	22.0	25.4	25.8	6.9	23.4	22.9	59.3	159.4	77.4	14.0	141.2	104.5	134.5	77.2	51.7	48.3	64.8	22.7	108.5	32.2	67.4	65.6	73.2	28.6	43.6	47.9	10.6	34.0	42.9	28.3	39.0	28.5	49.3	59.1	121.2	72.5	41.4	89.8	58.2	50.4	4.2	3.1	23.8	5.7	4.3	5.0	5.3	8.7	6.4	3.2	11.2	8.7	4.8	5.3	3.7	2.6	4.8	12.1	2.4	26.8	24.7	25.6	38.6	24.9	24.6	29.6	25.9	27.0	24.2	29.4	23.7	24.0	6.4	3.2	7.5	51.2	26.4	25.9	26.0	31.9	15.2	45.7	34.8	9.9	28.6	15.9	22.0	14.6	93.1	50.2	136.7	35.2	73.1	11.9	15.8	11.7	21.5	41.3	23.2	4.5	109.6	60.2	18.3	52.0	29.3	15.9	23.3	25.4	51.4	44.2	20.2	5.3	85.9	46.8	30.4	61.2	5.1	12.5	32.4	32.0	6.5	44.8	28.9	70.0	2.5	7.2	96.3	109.7	16.6	67.8	39.3	191.0	37.9	6.4	16.0	39.5	9.3	21.8	22.3	15.6	39.5	36.9	94.5	52.8	25.4	84.0	37.9
TMX1	"PDIA11, TMX, TXNDC, TXNDC1"	ENSG00000139921	"Thioredoxin related transmembrane protein 1"	Q9H3N1	14	51240162-51257655	"Predicted membrane proteins, Transporters"	"Electron transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003085	Approved		Supported	"Nucleoli,Endoplasmic reticulum"		NA	NA		26000	"Cluster 27: Non-specific - Gene expression"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"	Nucleoli	"HPA003085: AB_1080424"	"unprognostic (1.83e-1)"	"unprognostic (7.42e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.49e-2)"	"unprognostic (2.63e-1)"	"unprognostic (1.12e-2)"	"prognostic unfavorable (1.29e-6)"	"unprognostic (3.70e-2)"	"unprognostic (1.51e-1)"	"unprognostic (6.84e-2)"	"unprognostic (2.44e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.85e-2)"	"unprognostic (1.66e-1)"	"unprognostic (1.18e-1)"	"unprognostic (3.21e-3)"	11.0	8.8	5.8	10.8	6.3	10.7	11.3	6.7	8.7	7.8	7.4	12.3	10.6	8.1	10.8	9.1	6.6	8.5	4.8	5.4	6.6	10.2	12.6	9.3	12.4	6.5	6.8	6.6	9.1	9.4	5.5	13.2	7.0	7.9	12.2	6.8	8.3	9.2	5.2	9.8	9.3	9.9	6.9	10.7	10.4	5.0	7.0	11.6	11.4	4.4	10.5	13.0	6.6	7.0	27.0	23.8	33.8	18.4	26.0	20.3	35.5	33.5	26.8	33.2	42.2	24.9	49.0	38.8	30.0	22.6	15.6	26.1	60.3	21.5	60.4	38.6	19.6	28.4	19.4	24.7	22.4	66.2	27.4	24.4	19.5	22.2	16.3	24.0	29.7	31.2	23.6	25.9	32.1	32.6	29.7	35.5	38.3	42.2	28.5	30.9	60.9	23.4	32.2	34.8	21.1	15.5	26.6	17.8	24.6	22.2	25.8	28.6	19.0	34.9	32.2	24.8	30.9	22.4	23.9	31.4	15.4	36.6	33.5	10.5	12.2	6.2	8.6	14.7	10.6	7.7	8.8	9.0	13.6	6.3	8.5	10.1	4.3	11.5	11.0	15.7	11.0	12.4	5.8	6.3	6.7	8.7	5.4	6.6	6.5	6.8	7.0	6.9	7.0	7.0	43.0	38.5	29.1	24.5	55.9	108.6	63.1	80.5	71.2	13.7	40.7	20.8	9.2	44.3	55.7	35.0	12.5	73.9	82.6	38.2	9.8	62.1	2.5	22.0	42.2	47.5	17.4	81.2	8.9	67.6	149.3	48.4	32.1	28.0	43.6	24.4	43.2	44.0	73.2	10.1	11.2	29.2	63.1	61.1	84.3	4.3	24.8	65.7	55.2	18.7	70.0	27.0	46.4	22.1	25.2	50.3	44.0	28.6	79.2	58.4	29.3	32.4	42.2	32.6	59.2	37.3	49.4	59.5	68.7	79.0	97.3	57.7	62.5	58.7	46.5	59.5
TMX2	"PDIA12, TXNDC14"	ENSG00000213593	"Thioredoxin related transmembrane protein 2"	Q9Y320	11	57712593-57740973	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant, Lissencephaly, Mental retardation, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA040282, HPA063763"	Approved		Approved	Nucleoplasm,Cytosol	"Intracellular and membrane"	NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Nucleoplasm, Cytosol"		"HPA040282: AB_10697715, HPA063763: AB_2685116"	"unprognostic (3.66e-3)"	"unprognostic (6.96e-2)"	"unprognostic (6.69e-3)"	"unprognostic (2.73e-2)"	"unprognostic (2.12e-1)"	"prognostic unfavorable (3.64e-4)"	"prognostic unfavorable (4.11e-4)"	"unprognostic (4.48e-2)"	"unprognostic (2.98e-1)"	"unprognostic (7.26e-3)"	"unprognostic (1.90e-2)"	"unprognostic (2.22e-1)"	"prognostic favorable (1.55e-5)"	"unprognostic (5.88e-3)"	"unprognostic (4.19e-2)"	"unprognostic (3.40e-1)"	"prognostic unfavorable (3.37e-4)"	52.9	75.1	77.7	37.3	83.0	27.0	50.5	87.4	101.9	43.6	103.3	70.0	56.4	39.4	58.2	62.8	42.7	33.2	71.5	75.0	84.1	78.7	83.4	45.0	31.5	81.7	81.5	40.9	57.7	84.9	43.1	44.0	83.5	50.1	80.8	64.7	49.6	53.8	44.7	45.1	58.3	43.1	84.3	44.9	60.9	30.6	85.5	34.9	57.1	41.3	47.6	48.2	43.8	90.6	122.7	141.4	78.5	143.4	144.8	77.2	86.6	144.2	111.8	140.0	117.9	135.3	205.6	115.1	156.6	116.3	207.1	220.0	203.5	115.4	146.3	83.3	88.9	110.2	105.7	136.8	119.3	156.6	145.5	94.8	166.5	154.8	243.2	76.3	80.6	95.3	194.4	130.9	157.7	62.7	93.0	177.1	153.8	227.7	191.5	124.7	97.9	242.5	174.4	136.4	90.3	129.3	110.2	255.7	168.3	76.7	228.5	102.2	66.7	130.5	84.8	176.1	152.1	127.9	269.5	115.3	146.6	109.3	198.3	37.8	41.5	40.0	34.6	72.4	44.0	36.8	34.4	40.9	40.6	34.9	43.1	43.8	11.2	37.8	86.0	49.7	32.0	45.0	77.7	83.0	87.4	101.9	75.0	84.1	81.7	81.5	83.5	84.3	85.5	90.6	37.9	38.5	34.0	0.0	32.0	32.1	44.9	108.2	19.9	43.4	35.8	28.1	42.6	30.0	60.8	49.7	31.3	108.0	29.9	39.5	43.0	72.4	2.0	19.6	27.4	36.8	28.8	37.6	0.0	43.5	85.6	38.6	23.0	20.7	43.1	29.9	31.8	48.7	62.0	30.3	0.0	49.6	81.4	30.8	21.4	3.6	48.7	31.9	48.0	0.0	37.8	91.1	19.6	0.0	0.0	54.5	32.0	43.6	32.5	49.0	51.4	41.1	37.4	66.7	39.5	36.3	34.5	60.7	62.2	33.6	32.7	99.6	26.6	46.6	75.2	43.6
TMX3	"FLJ20793, KIAA1830, PDIA13, TXNDC10"	ENSG00000166479	"Thioredoxin related transmembrane protein 3"	Q96JJ7	18	68673688-68715108	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		Isomerase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014157	Uncertain				"Intracellular and membrane"	NA	NA		36000	"Cluster 27: Non-specific - Gene expression"	"Cluster 16: Immune cells - Immune response"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"			"HPA014157: AB_1858469"	"unprognostic (2.11e-1)"	"unprognostic (5.15e-2)"	"unprognostic (2.14e-2)"	"unprognostic (9.47e-2)"	"unprognostic (6.82e-2)"	"unprognostic (7.20e-2)"	"unprognostic (4.96e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.20e-2)"	"unprognostic (9.83e-3)"	"unprognostic (2.73e-1)"	"prognostic unfavorable (2.87e-4)"	"unprognostic (2.69e-2)"	"unprognostic (1.53e-2)"	"unprognostic (1.38e-2)"	"unprognostic (1.21e-1)"	22.7	16.2	11.7	24.1	13.0	14.1	19.2	14.2	15.4	15.0	9.9	12.7	18.2	16.6	20.4	14.1	13.8	16.5	20.8	13.5	13.2	14.6	16.2	19.5	27.9	11.1	11.2	13.0	11.9	15.9	9.6	19.8	12.1	17.7	16.3	26.0	10.6	13.0	11.0	16.7	18.8	21.0	11.4	22.6	14.0	11.4	12.1	23.3	17.7	21.0	22.7	20.1	11.2	11.5	11.1	17.4	32.9	25.9	66.6	70.7	24.5	85.7	91.0	61.0	67.7	8.4	31.9	31.4	16.6	125.4	25.9	40.8	21.9	42.9	92.8	30.3	19.6	28.8	27.4	14.7	70.6	62.0	45.7	56.5	27.1	66.2	59.2	61.8	78.4	27.0	18.9	42.5	73.1	6.9	33.3	19.6	13.9	9.1	28.2	30.7	65.5	38.5	51.7	24.2	31.5	24.5	42.0	26.7	31.8	32.4	17.6	52.1	76.4	108.4	30.0	24.7	63.6	28.4	30.4	29.4	65.5	50.1	81.3	2.2	2.9	2.4	3.8	4.7	5.5	3.1	3.9	3.6	4.7	2.1	4.3	4.4	0.7	4.9	3.3	6.4	4.4	2.7	11.7	13.0	14.2	15.4	13.5	13.2	11.1	11.2	12.1	11.4	12.1	11.5	31.4	28.9	27.8	36.2	25.0	20.3	17.2	17.6	12.0	29.1	21.0	15.6	25.1	10.0	18.8	16.5	18.8	15.0	44.3	10.6	1.9	15.2	8.9	18.7	38.5	27.3	18.0	17.0	77.9	10.2	20.8	34.5	13.3	25.6	20.3	24.2	34.2	26.6	18.6	26.9	45.6	13.8	14.2	23.3	26.8	3.3	24.2	23.9	24.9	32.8	18.2	20.5	20.6	49.8	53.1	15.4	15.4	16.6	29.8	19.4	17.5	8.0	28.8	32.5	39.5	23.6	32.0	23.8	28.3	21.7	24.3	12.4	23.3	22.9	9.4	16.6
TNFAIP2	"B94, EXOC3L3"	ENSG00000185215	"TNF alpha induced protein 2"	Q03169	14	103121476-103137439	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"urinary bladder: 277.5"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 295.5;Langerhans cells: 198.7;monocytes: 351.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"neutrophil: 48.4"	"Low lineage specificity"	"Detected in many"			"Cell line enriched"	"Detected in many"	5	"RT4: 785.1"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"CAB004598, HPA030624"	Enhanced		Approved	"Nucleoplasm,Nuclear membrane,Golgi apparatus,Cytosol"		NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Golgi apparatus, Cytosol"	"Nucleoplasm, Nuclear membrane"	"CAB004598: AB_628370, HPA030624: AB_2673552"	"unprognostic (5.01e-3)"	"unprognostic (4.93e-2)"	"unprognostic (1.56e-3)"	"unprognostic (8.02e-3)"	"unprognostic (3.39e-2)"	"unprognostic (2.98e-2)"	"unprognostic (5.52e-3)"	"unprognostic (5.97e-2)"	"unprognostic (1.94e-1)"	"unprognostic (7.02e-2)"	"unprognostic (1.22e-1)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (4.10e-4)"	"prognostic favorable (2.79e-5)"	"unprognostic (1.75e-2)"	"unprognostic (3.83e-2)"	"prognostic favorable (7.17e-5)"	119.9	76.8	9.0	103.6	11.5	106.8	78.4	6.7	12.2	53.8	12.1	39.8	38.0	50.9	6.6	88.3	57.1	102.2	48.3	8.0	9.7	67.7	61.6	142.4	87.4	17.1	10.4	16.9	33.6	66.8	16.6	48.4	16.2	73.6	26.8	1.6	84.0	14.9	35.0	53.3	52.5	24.8	13.6	147.9	37.4	37.1	21.4	39.5	36.8	32.5	80.3	277.5	74.6	16.1	34.7	156.3	1.1	0.6	10.1	45.9	54.5	9.7	43.2	26.4	8.9	1.6	148.7	0.3	120.3	48.5	142.5	104.2	11.6	0.0	11.9	6.1	0.6	15.4	120.0	0.7	19.2	7.7	20.0	17.8	1.6	8.4	0.1	10.5	14.2	7.7	15.5	35.3	3.6	3.4	0.4	11.6	9.7	19.6	13.4	6.8	18.9	24.9	80.8	785.1	1.3	2.3	150.2	52.4	1.9	5.6	83.8	50.4	28.4	5.1	13.5	30.3	31.5	31.4	2.4	0.9	38.1	34.0	16.1	5.9	16.8	9.0	0.1	18.6	0.1	0.1	0.1	0.0	9.4	0.2	0.1	0.1	48.4	0.2	15.0	0.5	0.0	4.5	9.0	11.5	6.7	12.2	8.0	9.7	17.1	10.4	16.2	13.6	21.4	16.1	45.8	0.0	25.1	2.3	8.2	28.3	41.8	295.5	6.8	1.1	24.2	11.4	14.1	51.5	126.1	27.6	0.0	1.2	1.3	1.0	0.0	160.9	36.8	92.4	122.2	47.1	17.3	1.7	2.5	44.7	61.2	123.3	5.6	172.8	33.7	4.5	18.9	8.0	54.1	0.0	5.7	0.3	85.5	151.2	198.7	48.8	8.4	163.3	30.2	25.3	351.9	5.9	5.2	1.0	0.9	122.1	18.3	2.2	11.7	186.0	0.7	14.4	121.5	0.7	19.7	104.9	39.7	2.1	4.6	20.7	33.4	4.8	8.3	1.1	1.9	138.6
TNKS	"ARTD5, PARP-5a, PARP5A, pART5, TIN1, TINF1, TNKS1"	ENSG00000173273	Tankyrase	O95271	8	9555912-9782346	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport, Wnt signaling pathway"	"Glycosyltransferase, Transferase"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 149.9;Excitatory neurons: 203.2;Inhibitory neurons: 230.6;Oligodendrocyte precursor cells: 313.1;Oligodendrocytes: 285.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA025690	Approved		Approved	"Nucleoplasm,Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 21: Non-specific - Transcription"	"Cluster 12: NES - Nervous system development"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Nucleoplasm	"Nuclear membrane, Nuclear bodies"	"HPA025690: AB_10602249"	"unprognostic (2.07e-1)"	"unprognostic (1.72e-2)"	"unprognostic (5.45e-3)"	"unprognostic (8.22e-2)"	"unprognostic (2.42e-1)"	"unprognostic (1.27e-2)"	"unprognostic (4.75e-2)"	"unprognostic (1.13e-1)"	"unprognostic (9.06e-2)"	"unprognostic (8.01e-2)"	"unprognostic (6.21e-2)"	"unprognostic (9.10e-2)"	"unprognostic (4.14e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.43e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.36e-2)"	7.3	9.3	14.2	6.5	20.5	12.2	9.9	18.5	15.8	12.1	6.9	7.5	6.0	10.5	17.5	5.9	8.2	6.2	7.0	13.4	16.8	6.1	7.5	6.6	8.5	21.5	18.5	13.1	7.5	12.5	12.6	7.9	22.2	7.8	6.8	21.0	7.1	7.7	18.4	11.4	7.8	7.1	14.7	6.5	7.2	20.3	18.3	10.5	9.7	11.8	8.6	7.9	6.9	32.2	8.8	11.5	28.8	17.4	17.8	23.7	10.7	13.4	15.1	10.7	12.0	6.9	6.9	18.9	5.4	13.2	14.3	9.2	16.5	12.5	15.4	4.9	8.6	13.3	10.7	15.6	16.0	6.9	7.9	16.9	14.8	11.1	21.6	17.3	14.6	14.5	12.7	19.6	19.9	5.8	17.5	10.4	18.9	9.7	6.7	13.9	17.8	5.5	12.8	17.8	29.1	21.4	10.5	9.9	19.3	17.3	6.6	10.2	19.7	17.4	10.6	11.9	10.0	6.7	11.8	13.3	18.7	9.5	17.1	2.4	1.1	0.9	2.0	1.1	1.0	1.9	1.6	1.9	1.4	3.2	1.8	2.2	3.5	1.5	1.4	1.8	0.8	0.7	14.2	20.5	18.5	15.8	13.4	16.8	21.5	18.5	22.2	14.7	18.3	32.2	19.7	16.0	11.7	130.9	23.1	11.5	12.8	11.4	12.0	34.1	15.8	13.6	17.0	15.7	12.0	9.2	14.6	11.2	14.9	9.2	1.9	12.4	149.9	19.9	30.6	15.5	13.8	14.5	203.2	8.5	10.9	20.3	19.9	20.9	10.1	33.7	18.9	18.0	7.1	42.1	230.6	10.8	16.2	9.4	8.5	76.3	16.8	10.3	12.4	92.8	8.4	15.1	5.2	313.1	285.7	13.4	12.8	18.0	20.7	12.8	17.2	6.9	28.1	37.0	0.0	28.7	16.6	37.7	15.4	12.9	15.5	12.3	18.1	39.5	12.2	12.8
TNPO1	"IPO2, KPNB2, MIP, MIP1, TRN"	ENSG00000083312	"Transportin 1"	Q92973	5	72816312-72916733	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB016325	Approved		Supported	"Nucleoplasm,Cytosol,Cytoplasmic bodies"		NA	NA		130000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	"Cytosol, Cytoplasmic bodies"	"CAB016325: AB_675691"	"unprognostic (1.16e-1)"	"unprognostic (1.18e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.43e-1)"	"unprognostic (3.15e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (6.55e-5)"	"unprognostic (8.93e-3)"	"unprognostic (9.03e-2)"	"unprognostic (3.40e-3)"	"unprognostic (2.09e-1)"	"unprognostic (3.07e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.23e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.27e-2)"	"unprognostic (2.49e-2)"	23.5	23.0	10.6	28.8	14.6	31.7	25.0	14.0	10.0	20.2	23.0	24.5	20.5	24.0	33.8	23.1	20.6	27.7	20.8	10.5	17.1	30.5	28.4	17.3	29.9	18.2	13.4	22.4	31.5	39.8	15.6	36.8	16.5	23.4	29.9	65.0	20.9	28.1	25.0	11.6	20.9	28.2	15.1	20.6	30.7	37.3	13.1	35.6	36.8	27.0	32.3	33.3	14.0	21.5	94.8	123.7	154.5	104.8	133.3	144.5	110.4	112.3	145.6	112.2	113.6	111.4	87.1	117.5	78.5	173.0	140.4	71.6	126.3	108.8	160.8	66.6	71.9	76.2	144.8	55.9	103.9	78.4	55.1	110.8	80.2	151.0	184.8	78.2	248.6	52.9	113.4	54.8	298.1	50.3	87.2	37.3	99.3	39.8	90.9	83.1	150.5	74.1	73.4	109.5	87.5	73.6	160.6	60.3	135.8	99.8	71.2	61.9	225.1	79.5	113.8	116.8	136.7	53.2	95.8	155.8	69.9	91.3	154.4	8.2	8.2	6.9	11.9	11.0	16.5	10.3	10.9	9.3	10.3	10.8	11.6	11.9	8.4	14.1	14.0	5.0	8.3	10.5	10.6	14.6	14.0	10.0	10.5	17.1	18.2	13.4	16.5	15.1	13.1	21.5	42.3	12.8	25.0	45.7	49.0	59.1	40.9	29.7	60.3	105.0	38.7	24.0	53.8	30.0	28.7	27.6	98.0	81.9	44.9	39.8	17.6	39.0	105.4	38.6	46.1	64.8	53.2	27.1	142.2	41.5	50.0	52.8	53.0	46.7	22.1	62.8	50.7	38.1	42.7	89.2	77.8	46.3	28.5	40.0	42.2	60.9	46.6	42.1	24.9	50.6	47.4	143.1	26.8	79.9	84.7	58.9	24.9	60.2	42.9	57.0	33.9	36.1	27.6	187.9	26.3	72.5	48.8	58.5	76.3	42.0	53.3	131.3	36.9	40.2	37.2	60.2
TNPO2	"FLJ12155, IPO3, KPNB2B, TRN2"	ENSG00000105576	"Transportin 2"	O14787	19	12699194-12724011	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cone photoreceptor cells: 100.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046446, HPA071498"	Approved		Approved	Nucleoplasm,Nucleoli		Yes	No			"Cluster 29: Plasmacytoid DCs - Unknown function"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Nucleoli"		"CAB046446: AB_10603392, HPA071498: AB_2686405"	"unprognostic (1.88e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.17e-2)"	"prognostic unfavorable (7.16e-5)"	"unprognostic (2.25e-1)"	"unprognostic (3.64e-2)"	"unprognostic (2.72e-2)"	"unprognostic (6.75e-2)"	"unprognostic (3.44e-1)"	"unprognostic (1.79e-1)"	"unprognostic (1.79e-2)"	"unprognostic (4.63e-2)"	"prognostic favorable (8.18e-4)"	"unprognostic (2.76e-3)"	"unprognostic (6.00e-2)"	"unprognostic (3.50e-3)"	"unprognostic (7.63e-2)"	28.3	33.0	50.3	21.7	54.4	26.8	24.8	36.7	57.3	30.9	28.2	28.4	17.3	33.3	25.5	31.3	30.3	20.5	26.6	54.6	44.1	22.5	18.4	23.0	23.4	51.3	45.4	40.3	20.6	32.3	33.6	20.9	50.9	26.6	19.8	33.0	22.2	23.9	25.7	48.1	23.4	28.1	39.5	26.3	23.5	32.7	51.5	27.8	26.8	20.1	23.9	28.6	27.6	51.2	54.4	40.5	61.0	78.3	36.3	47.6	39.5	61.0	40.1	86.5	60.6	55.9	28.5	36.6	46.5	51.7	24.1	70.5	109.2	60.3	47.9	45.6	87.6	56.5	72.1	68.4	40.9	100.6	52.0	42.9	46.8	57.5	60.4	55.8	41.0	72.7	89.4	33.9	48.5	93.4	84.8	68.8	71.0	39.8	120.8	80.7	47.6	67.0	51.2	38.9	148.6	73.8	49.6	62.2	30.7	41.2	43.5	35.2	41.5	131.5	34.9	71.3	91.2	66.8	70.4	62.3	39.2	89.9	47.9	0.2	0.2	0.1	0.6	0.3	0.9	0.4	0.4	0.5	0.4	0.4	0.8	1.0	0.8	0.1	0.4	1.5	0.2	0.2	50.3	54.4	36.7	57.3	54.6	44.1	51.3	45.4	50.9	39.5	51.5	51.2	13.2	6.4	17.9	24.2	10.7	31.0	8.9	10.6	14.8	42.4	22.8	17.1	17.6	11.5	10.0	22.0	100.1	10.9	11.0	14.1	5.9	9.7	12.2	16.2	20.6	17.0	22.9	14.9	22.3	8.5	6.6	18.0	10.2	12.9	3.8	20.7	19.2	17.8	10.5	57.2	26.6	17.7	8.2	13.0	14.9	19.5	31.1	8.7	8.8	22.5	11.1	24.6	6.2	19.6	24.7	15.2	9.1	32.4	8.7	19.3	11.9	16.7	11.3	33.6	6.6	23.8	15.3	23.8	11.3	21.9	41.5	14.5	9.5	16.5	16.6	9.3
TOM1		ENSG00000100284	"Target of myb1 membrane trafficking protein"	O60784	22	35299275-35347992	"Cancer-related genes, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 213.8"	"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 170.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA000818, HPA001749"	Approved		Approved	"Plasma membrane,Centriolar satellite,Cytosol"		NA	NA		44000	"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 59: Non-specific - Translation"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	Cytosol	"Plasma membrane, Centriolar satellite"	"HPA000818: AB_2666101, HPA001749: AB_1080323"	"unprognostic (3.75e-1)"	"unprognostic (8.07e-2)"	"unprognostic (5.18e-2)"	"prognostic favorable (2.20e-5)"	"unprognostic (1.11e-2)"	"unprognostic (7.55e-2)"	"unprognostic (4.07e-3)"	"unprognostic (2.24e-1)"	"unprognostic (9.92e-2)"	"unprognostic (2.32e-1)"	"unprognostic (3.71e-1)"	"unprognostic (8.16e-2)"	"prognostic favorable (3.72e-5)"	"unprognostic (1.22e-1)"	"unprognostic (1.30e-1)"	"unprognostic (7.54e-3)"	"unprognostic (3.31e-2)"	34.7	47.8	20.8	17.0	19.4	60.8	32.1	19.9	25.8	43.6	23.6	22.7	29.1	26.6	12.7	76.5	26.8	24.9	43.2	19.8	26.6	32.7	49.0	37.1	15.3	30.2	24.5	21.5	20.2	48.5	37.4	27.7	32.9	23.2	9.8	5.9	60.6	11.7	213.8	74.9	28.4	10.8	19.6	23.9	20.8	25.9	24.8	13.1	26.5	68.6	12.7	19.5	45.0	22.1	15.8	15.3	8.8	14.3	58.3	34.9	42.3	15.5	43.8	28.4	31.1	21.5	14.3	6.2	28.0	45.4	18.3	7.3	8.6	15.6	9.9	18.7	21.3	5.3	17.1	43.8	58.6	10.8	23.6	49.8	19.2	39.6	13.3	18.5	19.8	11.6	10.3	15.3	14.1	13.8	8.2	27.5	7.0	18.9	8.6	14.9	12.3	13.2	10.9	11.3	14.9	12.1	34.1	34.8	34.5	7.3	18.0	16.7	22.0	34.0	29.4	27.3	7.7	18.0	12.4	16.7	45.7	10.5	11.4	18.6	100.9	44.5	19.3	60.7	15.6	13.6	29.5	18.4	48.0	11.0	22.6	15.7	129.1	15.1	66.2	25.9	48.2	63.3	20.8	19.4	19.9	25.8	19.8	26.6	30.2	24.5	32.9	19.6	24.8	22.1	10.1	22.4	36.9	8.8	12.7	12.7	10.3	29.5	7.4	11.1	19.1	11.0	23.2	15.7	33.0	12.9	12.5	64.6	13.8	41.6	27.4	40.9	29.9	32.0	17.8	14.2	16.2	9.7	9.3	38.9	57.1	22.6	15.3	48.0	22.8	10.4	16.1	34.0	60.8	11.8	15.2	18.1	50.8	33.5	35.2	21.4	11.5	45.2	19.6	7.5	34.0	19.5	9.2	6.6	13.2	34.2	21.5	12.8	5.7	11.9	55.3	34.9	24.2	8.2	6.6	16.6	15.4	23.5	5.6	17.3	21.9	170.2	18.2	13.4	15.2	10.7
TOMM40	"C19orf1, D19S1177E, PER-EC1, PEREC1, TOM40"	ENSG00000130204	"Translocase of outer mitochondrial membrane 40"	O96008	19	44890569-44903689	"Predicted intracellular proteins, Transporters"	"Ion transport, Protein transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA036231, HPA036232"	Supported		Enhanced	Mitochondria,Cytosol		NA	NA		45000	"Cluster 37: B-cells - Transcription"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 39: Non-specific - Basic cellular processes"	Mitochondria	Cytosol	"HPA036231: AB_2675010, HPA036232: AB_2675011"	"unprognostic (2.14e-1)"	"unprognostic (9.58e-3)"	"unprognostic (1.66e-1)"	"unprognostic (6.75e-3)"	"unprognostic (2.37e-1)"	"unprognostic (2.17e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.13e-2)"	"unprognostic (7.84e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.85e-2)"	"unprognostic (1.35e-1)"	"unprognostic (5.86e-3)"	"unprognostic (5.30e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.16e-1)"	"unprognostic (2.87e-1)"	34.6	59.7	31.3	25.1	30.1	32.9	29.0	33.6	37.2	25.2	28.0	34.7	28.4	25.0	14.1	51.8	25.3	10.8	46.1	30.7	33.5	33.5	50.8	28.4	23.6	32.6	33.5	24.9	26.6	31.4	25.3	20.0	33.6	24.7	23.0	18.0	24.1	17.4	64.0	34.4	26.1	16.4	30.2	26.4	29.3	22.0	35.0	25.2	22.3	34.4	22.6	29.9	29.5	32.2	147.6	244.6	87.6	121.3	32.2	28.4	110.3	103.3	57.1	192.1	136.6	268.8	99.5	215.3	107.7	68.8	108.7	155.2	228.9	149.1	87.0	84.0	206.1	145.3	93.5	214.7	68.0	187.6	125.1	45.2	83.4	149.3	94.1	36.0	67.3	102.4	232.6	73.3	76.4	184.2	205.4	137.1	153.6	209.6	149.1	206.1	99.2	125.3	89.6	201.8	135.2	86.4	109.9	229.4	75.2	48.4	77.1	188.2	55.9	132.0	133.6	93.1	273.7	78.3	176.0	212.9	98.2	197.0	142.1	0.7	3.6	3.7	2.8	4.6	3.2	5.8	2.8	4.1	4.6	2.4	4.9	5.4	0.7	3.2	4.3	4.6	3.5	1.4	31.3	30.1	33.6	37.2	30.7	33.5	32.6	33.5	33.6	30.2	35.0	32.2	26.2	16.0	7.3	8.8	34.9	87.4	73.7	17.1	35.9	68.2	32.7	30.9	15.7	25.8	14.3	31.3	29.2	104.5	28.9	78.8	39.2	48.1	11.3	22.7	41.0	31.0	29.3	52.4	11.3	38.6	169.9	38.6	40.2	29.5	19.1	57.8	12.5	24.2	100.1	70.7	16.9	59.4	28.5	21.0	44.9	7.2	26.8	35.0	39.2	4.7	31.9	46.6	27.8	5.5	12.8	53.6	32.4	24.5	47.9	139.0	34.5	39.5	4.9	60.2	19.7	49.1	47.8	46.2	64.5	60.5	89.4	72.9	26.7	105.9	132.1	75.5
TP53	"LFS1, p53"	ENSG00000141510	"Tumor protein p53"	P04637	17	7661779-7687538	"Cancer-related genes, Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transcription factors, Transporters"	"Apoptosis, Biological rhythms, Cell cycle, Host-virus interaction, Necrosis, Transcription, Transcription regulation"	"Activator, DNA-binding, Repressor"	"Cancer-related genes, Disease variant, Li-Fraumeni syndrome, Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002973, CAB039238, CAB039239, HPA051244, HPA063532, CAB072876, CAB079965"	Enhanced		Supported	Nucleoplasm,Mitochondria,Cytosol		Yes	No			"Cluster 39: Non-specific - mRNA processing"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 14: REH - Unknown function"	"Cluster 32: Non-specific - Translation"	Nucleoplasm	"Mitochondria, Cytosol"	"CAB002973: AB_2206626, CAB039238: , CAB039239: , CAB072876: AB_2665731, CAB079965: , HPA051244: AB_2681403, HPA063532: "	"unprognostic (2.29e-2)"	"unprognostic (8.83e-3)"	"unprognostic (1.26e-2)"	"prognostic favorable (1.35e-4)"	"unprognostic (9.95e-2)"	"unprognostic (4.00e-2)"	"unprognostic (2.79e-3)"	"unprognostic (4.99e-2)"	"unprognostic (2.75e-2)"	"unprognostic (2.55e-1)"	"unprognostic (1.30e-1)"	"prognostic unfavorable (5.01e-4)"	"unprognostic (1.86e-3)"	"unprognostic (7.89e-3)"	"unprognostic (8.05e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.08e-1)"	19.3	13.8	10.4	27.1	12.6	19.6	22.5	10.4	16.5	19.9	10.3	29.0	18.9	24.5	12.8	28.8	31.3	13.2	11.1	10.1	11.4	14.9	16.5	15.1	34.6	18.7	13.6	27.3	18.3	9.4	7.3	23.5	12.5	17.7	27.5	4.1	18.9	15.3	12.3	37.4	20.4	24.6	12.6	31.1	22.6	10.4	12.3	47.2	17.4	6.1	45.4	20.8	19.9	13.3	81.5	145.3	81.1	57.3	37.3	43.9	82.8	28.4	66.1	78.5	100.2	4.2	40.6	190.5	126.9	58.7	77.6	174.9	119.7	80.4	72.8	42.7	76.5	77.6	76.8	70.9	111.5	1.6	37.0	55.7	93.0	38.9	106.5	45.6	79.4	24.7	3.8	6.9	41.5	145.1	130.0	96.3	80.2	10.4	2.4	252.2	56.1	66.2	59.4	87.3	46.0	80.5	94.1	62.6	24.3	39.4	109.2	7.4	100.7	91.6	30.2	1.0	48.3	47.6	37.9	82.5	23.6	9.7	80.1	1.2	21.2	3.4	13.0	21.7	15.9	21.5	13.3	14.6	30.3	19.1	13.7	15.4	2.4	17.5	19.3	27.3	17.3	14.7	10.4	12.6	10.4	16.5	10.1	11.4	18.7	13.6	12.5	12.6	12.3	13.3	21.1	9.6	12.8	16.3	26.0	28.7	14.5	24.6	24.5	2.6	36.1	30.4	2.5	18.6	15.4	20.2	0.0	36.9	24.7	16.9	9.8	24.8	12.8	11.5	29.0	24.5	30.7	21.7	2.1	18.1	39.6	17.0	11.2	19.5	1.3	31.7	22.1	18.0	24.2	0.0	3.2	43.0	18.3	27.8	20.1	3.8	23.0	19.3	12.4	7.5	31.9	4.9	25.7	9.0	8.0	15.8	16.4	17.0	7.8	15.7	10.3	10.1	8.8	2.6	13.1	25.9	20.6	0.5	4.9	28.7	32.8	22.4	16.5	27.4	54.1	11.5
TPCN1	"FLJ20612, KIAA1169, TPC1"	ENSG00000186815	"Two pore segment channel 1"	Q9ULQ1	12	113221050-113298585	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Astrocytes: 174.3;Microglial cells: 79.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"BJ hTERT+: 148.6;hTERT-RPE1: 121.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039757	Approved					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 64: Astrocytes - Nervous system maintenance"			"HPA039757: AB_10795156"	"unprognostic (7.87e-2)"	"unprognostic (7.98e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.22e-1)"	"unprognostic (7.34e-2)"	"unprognostic (3.07e-2)"	"unprognostic (1.32e-3)"	"unprognostic (4.53e-1)"	"unprognostic (5.34e-2)"	"unprognostic (1.48e-2)"	"unprognostic (1.74e-3)"	"unprognostic (1.52e-1)"	"unprognostic (1.11e-1)"	"unprognostic (2.23e-1)"	"unprognostic (9.08e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.47e-3)"	27.7	48.8	37.7	18.2	54.3	12.5	29.1	70.2	40.5	36.9	48.5	30.4	19.4	30.6	19.3	38.4	35.5	21.7	68.0	34.7	33.4	50.9	27.8	29.5	17.0	43.5	48.3	41.5	52.0	30.8	37.9	18.8	46.6	28.7	19.5	11.5	36.1	27.3	36.7	22.2	31.4	18.6	35.4	28.6	19.1	14.5	44.0	8.5	55.5	24.8	18.2	25.3	26.4	45.9	15.3	45.0	5.1	6.5	38.5	43.3	14.9	21.2	148.6	10.9	13.1	33.5	50.7	34.5	30.9	21.6	35.7	18.8	11.9	37.6	14.7	4.1	9.2	12.9	23.5	18.7	49.9	4.5	28.1	41.5	18.6	21.3	37.2	121.7	16.9	9.8	15.0	11.9	13.5	18.3	1.3	68.3	8.4	18.6	22.3	2.5	6.2	67.3	34.9	54.4	6.5	9.8	17.0	43.2	17.1	10.3	13.9	41.4	7.1	16.0	7.8	22.3	13.3	20.0	13.1	29.6	47.2	10.9	12.3	6.9	14.6	1.3	1.8	2.4	2.0	3.4	2.4	2.3	9.9	5.2	3.3	2.1	0.5	8.5	0.3	5.0	1.2	4.7	37.7	54.3	70.2	40.5	34.7	33.4	43.5	48.3	46.6	35.4	44.0	45.9	8.3	9.6	19.6	174.3	9.0	4.6	6.0	15.4	2.8	19.6	17.0	11.2	34.4	12.8	24.4	27.6	16.7	7.2	3.1	35.9	1.9	13.2	13.2	15.0	21.8	8.1	28.8	9.0	24.5	18.7	3.2	20.2	23.0	19.1	31.1	7.7	15.7	18.3	21.5	50.5	26.6	26.8	14.2	17.9	4.7	11.3	21.5	23.7	7.2	79.6	13.7	17.2	3.1	25.1	61.7	11.5	20.3	21.4	4.6	15.9	29.0	19.7	27.9	13.7	0.0	49.8	18.5	3.6	3.3	10.6	4.0	6.6	5.9	13.2	20.3	22.2
TPCN2	TPC2	ENSG00000162341	"Two pore segment channel 2"	Q8NHX9	11	69048932-69136316	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Voltage-gated channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 30.5;Melanocytes: 35.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"			"HPA016561, HPA027080"	Supported		Approved	Nucleoli		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 20: HeLa - Mitochondria"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Nucleoli		"HPA016561: AB_1858207, HPA027080: AB_10600917"	"unprognostic (1.29e-1)"	"unprognostic (1.53e-2)"	"unprognostic (1.39e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.63e-1)"	"prognostic unfavorable (2.96e-4)"	"unprognostic (7.60e-2)"	"unprognostic (7.04e-2)"	"unprognostic (3.59e-1)"	"prognostic unfavorable (1.49e-4)"	"unprognostic (4.15e-2)"	"unprognostic (1.89e-2)"	"unprognostic (6.87e-2)"	"unprognostic (2.22e-1)"	"unprognostic (2.24e-3)"	"unprognostic (5.01e-2)"	"unprognostic (4.88e-2)"	5.8	3.8	2.2	4.8	2.9	4.4	5.2	4.8	3.1	8.9	0.2	11.7	7.6	8.9	3.2	4.6	8.5	3.8	3.9	2.2	1.3	7.5	11.1	4.5	5.8	0.7	0.2	5.8	3.6	2.7	4.2	3.0	0.8	7.2	3.9	4.4	4.1	5.7	4.2	10.0	7.2	4.8	0.1	6.3	4.7	3.2	1.5	3.0	4.3	1.4	4.2	6.3	5.9	3.2	4.6	8.8	3.5	4.9	2.7	3.0	10.5	3.6	3.9	4.7	2.4	8.5	12.4	3.5	5.0	6.9	3.2	9.6	3.2	5.8	2.0	2.7	3.3	7.7	13.7	1.9	3.2	6.5	8.5	4.0	3.2	2.2	2.8	2.4	4.9	8.4	4.7	16.7	2.7	6.9	4.4	9.4	2.4	11.5	3.1	4.6	3.3	6.8	5.1	8.0	2.8	3.6	5.9	11.4	17.0	4.3	7.0	9.1	5.2	3.5	4.5	6.4	4.0	6.8	2.9	4.0	7.7	5.5	8.3	2.9	10.2	2.6	0.9	9.9	0.8	2.4	1.8	2.1	7.7	1.8	1.8	1.9	7.0	6.2	11.7	3.1	2.7	4.4	2.2	2.9	4.8	3.1	2.2	1.3	0.7	0.2	0.8	0.1	1.5	3.2	4.5	9.6	1.5	10.1	6.7	4.0	2.7	3.0	2.2	1.8	2.8	2.5	3.1	5.7	2.3	12.9	2.1	2.6	6.1	4.4	17.6	7.2	17.7	2.1	5.6	4.2	0.0	8.2	30.5	8.6	4.8	4.0	8.6	3.4	2.5	7.3	5.3	18.4	11.9	0.0	22.4	2.6	2.0	12.6	5.5	2.7	6.2	10.2	35.6	4.7	7.7	2.5	3.1	26.2	4.5	4.8	2.6	6.8	8.3	1.5	8.8	9.1	0.8	4.9	6.6	5.1	5.7	2.2	4.4	1.9	3.4	1.9	3.6	3.2	3.6	2.1
TPR		ENSG00000047410	"Translocated promoter region, nuclear basket protein"	P12270	1	186311652-186375693	"Cancer-related genes, Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Mitosis, mRNA transport, Protein transport, Translocation, Transport"		"Cancer-related genes, Proto-oncogene"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Spermatocytes: 772.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA019661, HPA019663, HPA024336"	Enhanced		Enhanced	"Nuclear membrane"		NA	NA		30000000	"Cluster 6: Non-specific - Transcription"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	"Nuclear membrane"		"HPA019661: AB_1858215, HPA019663: AB_1858216, HPA024336: AB_1858217"	"unprognostic (4.51e-2)"	"unprognostic (9.87e-3)"	"unprognostic (2.48e-1)"	"unprognostic (7.56e-2)"	"unprognostic (9.88e-3)"	"prognostic favorable (4.71e-4)"	"prognostic unfavorable (1.06e-4)"	"unprognostic (1.71e-1)"	"unprognostic (3.71e-2)"	"unprognostic (1.14e-1)"	"unprognostic (1.45e-2)"	"unprognostic (3.63e-2)"	"unprognostic (1.31e-3)"	"unprognostic (3.75e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.06e-2)"	"unprognostic (1.98e-2)"	19.8	14.5	12.2	23.4	14.1	28.9	19.7	14.4	10.9	17.6	18.4	17.6	15.5	20.3	19.7	14.8	15.0	16.1	17.1	9.5	12.9	16.0	15.4	18.0	26.0	13.6	12.0	23.1	15.5	34.2	13.4	26.7	13.8	17.2	20.0	19.8	15.8	17.6	20.4	24.2	19.3	17.6	12.2	22.9	19.1	43.8	13.3	31.0	22.7	22.3	26.0	19.6	14.5	15.1	55.9	46.7	68.2	39.8	53.4	47.4	73.2	62.0	41.2	42.8	40.4	70.5	45.9	64.0	47.1	42.1	29.4	70.9	51.9	42.4	52.1	51.8	58.6	86.8	78.3	49.7	28.7	93.1	53.5	36.4	25.0	64.4	49.4	39.3	51.3	36.5	106.0	57.3	45.8	47.5	46.2	24.5	76.1	49.9	16.0	54.3	54.3	56.5	34.8	65.0	37.7	59.5	72.9	47.1	37.6	92.5	53.1	58.0	73.0	42.5	40.6	47.7	76.6	63.2	77.6	57.0	27.5	45.8	38.7	121.4	34.1	69.0	43.8	30.0	37.7	48.9	38.6	36.8	20.6	55.4	47.3	32.8	145.7	33.0	50.4	58.7	49.1	17.3	12.2	14.1	14.4	10.9	9.5	12.9	13.6	12.0	13.8	12.2	13.3	15.1	126.4	218.0	119.6	43.1	122.9	101.2	105.5	98.6	114.9	89.8	65.8	79.8	180.0	54.3	110.0	58.8	79.2	136.9	136.8	51.2	23.5	107.1	199.3	129.1	151.7	123.8	67.7	102.4	42.5	74.7	99.9	126.5	80.5	134.4	81.0	134.2	74.6	40.8	72.8	99.3	42.6	61.9	93.6	64.2	79.3	50.4	125.6	92.6	55.2	39.4	137.3	101.1	139.0	48.2	62.8	90.1	56.7	117.4	113.7	95.1	52.4	27.7	120.9	111.4	131.5	172.5	152.1	772.9	250.4	85.6	99.2	150.8	145.8	160.0	77.7	96.0
TRAM1	"TRAM, TRAMP"	ENSG00000067167	"Translocation associated membrane protein 1"	Q15629	8	70573218-70608416	"Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Protein transport, Translocation, Transport, Unfolded protein response"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Plasma cells: 670.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023929	Approved					NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 55: Plasma cells - Humoral immune response"			"HPA023929: AB_1858239"	"unprognostic (3.85e-2)"	"prognostic unfavorable (2.06e-4)"	"unprognostic (8.34e-3)"	"unprognostic (1.31e-1)"	"unprognostic (3.52e-2)"	"unprognostic (5.93e-2)"	"unprognostic (8.94e-2)"	"unprognostic (2.21e-2)"	"unprognostic (1.86e-1)"	"unprognostic (2.12e-1)"	"unprognostic (3.39e-3)"	"unprognostic (3.61e-2)"	"prognostic unfavorable (7.79e-4)"	"unprognostic (7.45e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.31e-1)"	"unprognostic (3.85e-2)"	93.2	82.8	26.6	95.9	28.9	102.3	115.8	27.6	42.1	139.2	47.7	85.4	91.7	93.4	148.5	65.2	78.5	117.7	59.8	24.8	31.1	120.7	190.2	146.3	103.5	32.5	27.9	73.4	175.5	117.3	38.8	146.8	32.4	87.2	79.7	33.3	193.9	86.0	26.7	49.2	93.6	96.7	29.1	90.0	94.7	61.0	29.1	98.6	170.7	54.9	114.3	120.2	47.7	34.5	171.1	172.5	73.6	45.2	352.6	367.8	105.2	302.9	301.7	231.7	279.1	109.9	275.8	169.1	58.5	259.6	91.3	219.3	67.6	262.1	221.8	112.2	76.1	118.5	54.6	125.7	515.4	91.3	66.3	441.5	249.6	114.2	410.8	238.5	196.7	85.0	77.8	430.3	288.6	47.2	210.4	65.7	48.3	132.3	81.0	100.9	55.3	113.8	610.5	160.4	53.4	54.2	195.0	389.0	180.5	103.1	144.1	102.0	195.3	141.0	117.5	162.4	102.0	338.7	140.1	85.5	160.3	92.9	105.0	150.1	97.3	64.9	120.8	107.7	153.5	107.9	132.1	137.6	114.3	87.9	119.6	125.2	28.2	130.7	113.7	190.4	146.8	232.7	26.6	28.9	27.6	42.1	24.8	31.1	32.5	27.9	32.4	29.1	29.1	34.5	138.3	275.7	132.0	19.6	166.4	85.5	85.2	214.0	69.4	23.7	114.2	62.4	43.0	131.5	209.3	178.4	14.6	154.3	200.5	69.3	68.4	174.5	142.8	77.9	140.7	134.3	44.2	59.7	27.4	247.7	236.7	177.0	70.8	186.6	72.4	59.0	137.8	202.9	182.7	23.5	26.1	95.5	156.6	134.9	251.0	222.2	127.4	123.7	202.7	29.0	132.1	65.6	128.8	34.2	40.3	290.5	51.0	94.4	670.6	199.6	78.0	147.0	110.2	32.9	124.9	76.4	99.5	134.8	56.8	72.3	88.5	194.3	154.2	78.2	65.5	130.6
TRAM1L1	MGC26568	ENSG00000174599	"Translocation associated membrane protein 1 like 1"	Q8N609	4	117083554-117085576	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Bipolar cells: 6.8;Oligodendrocyte precursor cells: 8.0;Oligodendrocytes: 13.5;Spermatogonia: 6.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"SH-SY5Y: 9.0;U-138 MG: 11.0;U-266/70: 9.1"	"Low region specificity"	"Detected in all"							HPA044560	Uncertain		Uncertain	Mitochondria		NA	NA				"Cluster 68: Epididymis - Unknown function"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Mitochondria		"HPA044560: AB_10796097"	"unprognostic (9.06e-2)"	"unprognostic (2.87e-2)"	"unprognostic (4.40e-2)"	"unprognostic (2.17e-3)"	"unprognostic (9.77e-2)"	"unprognostic (2.37e-2)"	"unprognostic (5.97e-2)"	"unprognostic (3.02e-1)"	"unprognostic (1.14e-1)"	"unprognostic (3.25e-1)"	"unprognostic (1.09e-3)"	"unprognostic (1.56e-2)"	"unprognostic (2.76e-2)"	"unprognostic (1.68e-2)"	"unprognostic (1.62e-1)"	"unprognostic (4.82e-3)"	"unprognostic (1.23e-2)"	1.2	2.4	4.7	0.5	6.0	0.0	4.2	5.4	7.0	2.5	2.9	1.2	0.4	1.9	6.0	0.8	3.9	1.7	1.0	4.9	6.1	6.9	0.1	1.6	0.5	5.7	5.5	2.2	2.9	2.4	3.2	0.6	6.1	4.3	1.1	5.5	1.4	2.5	0.3	2.4	0.6	2.0	5.5	0.6	1.9	3.6	6.0	0.2	4.9	0.6	0.4	1.1	0.8	6.5	1.4	0.9	4.2	2.1	0.0	0.0	0.0	0.6	0.4	0.9	2.5	0.1	5.0	0.0	0.5	1.1	5.4	0.1	2.0	2.3	3.4	0.0	0.1	1.2	1.2	0.5	1.2	1.3	0.0	4.5	1.9	1.1	0.0	3.5	0.0	0.0	0.0	2.6	7.0	0.3	2.3	0.0	0.3	0.0	1.1	0.0	5.5	0.0	0.7	0.3	2.4	9.0	0.0	3.6	4.5	2.2	6.2	1.3	3.0	11.0	4.8	0.1	1.7	9.1	2.1	0.0	4.2	0.0	6.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.7	6.0	5.4	7.0	4.9	6.1	5.7	5.5	6.1	5.5	6.0	6.5	0.6	0.0	1.5	2.6	0.5	0.9	0.3	0.3	1.8	6.8	2.8	2.0	0.7	0.0	1.6	1.8	4.2	1.9	0.0	0.0	1.9	2.3	0.3	0.5	2.2	2.0	0.0	0.0	3.0	0.7	0.4	2.5	0.0	0.5	0.0	1.5	0.0	0.0	0.3	5.0	3.8	0.3	2.0	0.0	0.4	0.1	0.9	0.1	3.6	0.0	0.0	3.3	0.0	8.0	13.5	0.6	0.0	1.9	0.0	0.9	0.0	2.1	2.3	3.1	0.0	1.7	0.8	1.9	6.2	1.5	1.4	0.3	0.1	1.8	0.1	0.1
TRAM2	KIAA0057	ENSG00000065308	"Translocation associated membrane protein 2"	Q15035	6	52497408-52577060	"Predicted membrane proteins, Transporters"	"Protein transport, Translocation, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 122.0;Plasma cells: 69.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in all"		"ASC diff: 250.1;ASC TERT1: 265.8;fHDF/TERT166: 253.4"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"HPA035092, HPA057925"	Approved		Approved	Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 28: Placenta - Pregnancy"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 55: Plasma cells - Humoral immune response"	Cytosol		"HPA035092: AB_10610562, HPA057925: AB_2683557"	"unprognostic (2.32e-2)"	"unprognostic (2.19e-1)"	"unprognostic (1.72e-1)"	"prognostic unfavorable (1.88e-4)"	"unprognostic (1.12e-1)"	"unprognostic (4.07e-2)"	"unprognostic (8.90e-3)"	"unprognostic (1.14e-1)"	"unprognostic (1.65e-1)"	"unprognostic (3.03e-1)"	"unprognostic (3.01e-1)"	"unprognostic (5.05e-1)"	"prognostic unfavorable (1.41e-9)"	"unprognostic (1.37e-2)"	"unprognostic (1.60e-1)"	"unprognostic (6.64e-2)"	"unprognostic (1.19e-2)"	19.5	4.9	3.4	14.8	4.7	5.3	13.8	3.0	4.3	14.9	7.8	12.5	14.0	13.1	11.5	5.6	13.5	17.3	10.4	3.0	3.3	7.4	16.2	14.1	7.5	4.3	3.5	12.4	7.0	2.8	3.9	35.8	3.6	6.0	14.7	3.9	6.4	5.8	3.6	11.5	12.6	17.5	3.3	19.2	9.5	13.3	4.4	4.5	12.4	5.9	13.3	13.3	9.6	3.3	45.4	19.8	22.7	22.6	250.1	265.8	39.8	130.0	130.8	106.7	98.2	43.2	9.2	11.0	21.4	253.4	76.0	10.0	14.9	81.3	133.6	24.8	8.0	24.1	20.5	54.9	71.3	6.2	13.1	97.4	8.0	93.5	41.2	155.1	124.1	9.1	15.1	78.4	154.5	16.2	8.9	17.7	10.4	17.9	8.8	10.9	59.8	91.0	25.3	7.5	5.5	8.7	29.9	13.2	31.6	47.7	20.6	12.9	198.8	177.6	38.4	65.0	72.1	53.4	97.7	31.1	64.7	16.1	110.8	0.1	1.0	1.0	0.9	1.1	0.5	1.2	0.7	0.5	1.1	0.8	0.3	0.6	0.2	0.7	2.1	0.5	0.2	0.7	3.4	4.7	3.0	4.3	3.0	3.3	4.3	3.5	3.6	3.3	4.4	3.3	12.8	6.4	3.2	6.8	15.9	8.2	2.8	8.5	3.4	3.1	4.0	5.1	9.9	4.3	4.1	7.3	25.0	36.2	6.6	7.8	3.9	3.6	38.3	4.0	28.9	17.9	9.0	8.6	12.0	3.2	30.8	26.2	6.1	5.0	2.5	34.0	19.6	36.1	15.7	5.0	9.2	19.6	6.1	12.0	6.9	122.0	20.8	5.7	26.6	13.1	4.3	1.8	8.2	3.5	3.1	6.2	1.7	23.3	69.5	2.8	7.0	3.1	4.9	12.7	13.1	16.2	15.7	23.4	8.6	1.2	4.1	20.7	6.0	14.3	5.7	1.5
TRDN	TRISK	ENSG00000186439	Triadin	Q13061	6	123216339-123637093	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 421.6;skeletal muscle: 1944.1;tongue: 1018.2"	"Group enriched"	"Detected in some"	11	"Cardiomyocytes: 1145.1;Muller glia cells: 765.7;Skeletal myocytes: 398.6"	"Group enriched"	"Detected in some"	5	"head and neck cancer: 2.2;prostate cancer: 0.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in single"		"MCF7: 1.9"	"Region enriched"	"Detected in some"	10	"olfactory bulb: 11.0"	"Region enriched"	"Detected in some"	23	"olfactory bulb: 28.9"	"HPA038226, HPA058226"	Enhanced		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 41: Basophils - Cellular respiration"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 54: Cardiomyocytes - Muscle contraction"	"Plasma membrane, Cytosol"		"HPA038226: AB_10795574, HPA058226: AB_2683643"	"unprognostic (1.05e-2)"			"unprognostic (1.99e-1)"	"unprognostic (9.20e-2)"	"unprognostic (3.06e-3)"		"unprognostic (2.40e-1)"	"unprognostic (2.38e-1)"	"unprognostic (2.42e-1)"	"unprognostic (8.42e-2)"	"unprognostic (8.71e-2)"	"unprognostic (9.93e-3)"	"unprognostic (2.12e-1)"	"unprognostic (2.55e-2)"		"unprognostic (3.97e-2)"	16.3	2.6	4.2	0.0	3.7	0.0	2.0	4.0	5.8	0.7	3.1	0.4	0.0	1.7	10.4	18.5	12.5	0.2	421.6	3.0	12.5	0.4	0.1	0.4	0.1	6.7	7.0	1.3	0.1	0.0	15.3	0.2	7.9	17.0	0.3	83.5	13.1	0.9	1944.1	0.6	0.2	1.0	9.2	0.1	0.1	5.1	10.2	0.3	0.3	1018.2	0.1	0.0	0.6	6.3	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	1.9	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.8	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.2	3.7	4.0	5.8	3.0	12.5	6.7	7.0	7.9	9.2	10.2	6.3	0.3	0.0	0.0	4.2	0.0	0.0	0.5	0.0	0.0	7.9	0.0	0.3	1145.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.9	0.0	68.0	0.0	0.0	6.0	0.0	0.0	1.1	0.0	0.0	38.4	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	1.6	0.0	0.0	0.0	0.4	35.5	13.1	0.5	1.8	0.0	0.0	765.7	0.0	3.0	3.2	0.0	0.0	11.3	0.0	0.0	0.0	0.2	0.0	21.8	0.0	398.6	7.1	1.3	0.9	0.0	0.0	0.0	0.3	0.0	0.0	0.0
TRHR		ENSG00000174417	"Thyrotropin releasing hormone receptor"	P34981	8	109086585-109121565	"Disease related genes, FDA approved drug targets, G-protein coupled receptors, Human disease related genes, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"	"Congenital hypothyroidism, Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	8	"brain: 5.2"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA055162	Approved					NA	NA				"Cluster 65: Brain - Ion transport"		"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA055162: AB_2732592"										"unprognostic (1.92e-2)"				"unprognostic (8.58e-2)"		"unprognostic (1.17e-1)"		0.0	0.0	3.2	0.0	0.8	0.0	0.0	0.0	5.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.4	1.4	0.0	0.0	0.0	0.0	0.9	1.2	0.0	0.0	0.0	0.6	0.0	1.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.2	0.8	0.0	5.2	3.4	1.4	0.9	1.2	1.2	1.7	0.7	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRIAP1	"HSPC132, MDM35, P53CSV, WF-1"	ENSG00000170855	"TP53 regulated inhibitor of apoptosis 1"	O43715	12	120443964-120446384	"Predicted intracellular proteins, Transporters"	"Apoptosis, Lipid transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Cytotrophoblasts: 128.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"							HPA053640	Approved		Approved	Nucleoplasm,Mitochondria		NA	NA			"Cluster 44: Non-specific - Transcription"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Nucleoplasm, Mitochondria"		"HPA053640: AB_2682213"	"unprognostic (8.74e-3)"	"unprognostic (9.44e-2)"	"unprognostic (5.24e-2)"	"unprognostic (4.06e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.19e-2)"	"unprognostic (3.31e-2)"	"prognostic unfavorable (2.22e-4)"	"unprognostic (9.87e-3)"	"unprognostic (4.39e-2)"	"unprognostic (9.93e-2)"	"prognostic unfavorable (8.77e-4)"	"unprognostic (8.81e-2)"	"unprognostic (2.00e-1)"	"unprognostic (6.44e-2)"	"unprognostic (4.97e-2)"	21.8	24.6	16.6	18.9	16.8	32.9	28.4	17.1	23.0	16.6	18.0	24.6	19.2	14.1	20.8	22.9	17.2	15.4	19.4	16.8	17.5	21.1	66.4	16.8	24.8	16.9	16.7	12.1	52.5	14.7	12.3	29.1	17.1	20.1	30.5	8.8	25.3	15.3	60.4	27.0	18.5	20.9	17.2	16.3	19.6	13.2	16.9	25.7	15.7	39.1	27.5	24.1	15.6	18.2	56.2	75.1	67.4	46.3	57.5	88.1	161.0	71.8	51.2	62.5	51.6	63.2	30.4	110.0	59.6	59.2	25.0	37.4	79.3	118.6	65.8	49.1	88.5	66.9	48.7	167.9	85.4	113.6	49.6	91.6	146.7	61.4	87.0	62.3	131.1	59.8	109.3	27.7	92.1	70.3	86.0	152.7	96.5	67.9	60.4	70.4	63.5	114.4	81.1	62.0	66.3	43.2	82.7	28.1	64.6	105.7	93.9	65.6	74.8	40.0	60.7	40.7	44.1	70.6	120.6	118.5	61.5	86.9	71.2	26.7	47.1	18.2	41.0	52.7	48.8	35.1	39.2	39.0	59.1	31.8	48.3	43.1	4.0	49.6	36.5	53.1	37.3	45.0	16.6	16.8	17.1	23.0	16.8	17.5	16.9	16.7	17.1	17.2	16.9	18.2	25.8	3.2	15.2	3.6	30.5	51.2	28.5	108.2	44.3	10.6	35.9	44.1	12.1	45.8	36.0	7.3	6.2	128.5	29.4	16.9	66.5	48.4	8.3	22.4	27.7	34.3	22.1	23.7	3.9	50.4	91.2	23.1	15.3	16.4	17.2	34.9	24.3	63.3	52.0	3.3	2.9	22.6	40.7	23.3	27.6	5.7	16.4	19.1	39.2	1.0	48.0	15.4	44.3	3.0	4.7	43.2	20.7	18.4	19.8	37.7	30.1	49.4	25.4	9.5	19.7	18.9	27.3	34.5	31.4	45.6	71.3	75.4	28.3	47.0	39.5	28.9
TRIM72	MG53	ENSG00000177238	"Tripartite motif containing 72"	Q6ZMU5	16	31214091-31231537	"Predicted intracellular proteins, Transporters"	"Exocytosis, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	10	"skeletal muscle: 151.8;tongue: 43.0"	"Cell type enriched"	"Detected in many"	5	"Skeletal myocytes: 45.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 0.9"	"Region enriched"	"Detected in many"	7	"cerebellum: 9.3"	"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in some"		"HL-60: 7.2;LHCN-M2: 12.6;RH-30: 29.7;U-266/70: 17.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			HPA054909	Enhanced		Approved	Nucleoplasm,Vesicles		NA	NA			"Cluster 17: Basophils - Unknown function"	"Cluster 33: Striated muscle - Muscle contraction"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 37: Myocytes - Muscle contraction"	Vesicles	Nucleoplasm	"HPA054909: AB_2682639"	"unprognostic (2.61e-1)"	"unprognostic (3.21e-3)"	"unprognostic (5.07e-2)"	"unprognostic (9.77e-2)"	"unprognostic (3.71e-1)"	"unprognostic (3.13e-1)"	"unprognostic (2.01e-3)"	"unprognostic (2.80e-1)"	"unprognostic (6.57e-2)"	"unprognostic (4.90e-1)"	"unprognostic (1.90e-1)"	"unprognostic (2.49e-2)"	"unprognostic (2.24e-10)"	"unprognostic (7.70e-2)"	"unprognostic (6.72e-2)"	"unprognostic (4.15e-1)"	"unprognostic (4.30e-4)"	0.2	0.2	0.9	0.2	0.8	0.8	0.2	9.3	1.0	0.1	0.5	0.2	0.2	0.2	0.3	1.0	0.1	0.2	0.8	0.7	0.4	0.1	0.1	0.2	0.3	1.0	0.5	0.2	0.3	0.1	0.0	0.2	1.3	1.9	0.1	0.8	2.5	0.1	151.8	0.5	0.2	0.1	0.1	0.3	0.3	0.3	0.5	0.1	0.2	43.0	0.2	0.1	0.0	1.2	0.1	0.1	0.2	0.4	0.2	0.1	0.3	0.3	0.1	0.0	0.0	0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.3	0.1	0.2	0.7	0.2	0.2	7.2	0.3	1.2	0.1	0.0	0.1	0.1	0.0	0.2	0.3	0.8	12.6	0.1	0.1	0.5	0.2	0.2	0.2	0.3	29.7	4.1	0.0	0.2	2.6	0.2	0.1	0.3	0.1	0.3	0.2	2.6	0.1	0.2	0.2	0.2	0.1	17.9	1.7	0.2	0.2	0.4	0.2	1.9	0.3	0.5	0.3	0.3	0.3	0.4	0.3	0.2	0.3	0.6	0.4	0.3	1.5	0.6	0.4	0.6	0.2	0.1	0.9	0.8	9.3	1.0	0.7	0.4	1.0	0.5	1.3	0.1	0.5	1.2	4.7	3.2	3.8	0.0	0.8	0.1	3.1	0.0	0.0	1.0	3.1	8.0	3.0	0.0	2.5	0.0	2.1	0.3	2.4	0.0	0.0	0.0	0.3	1.5	4.7	1.5	0.0	0.0	0.2	0.0	0.3	2.5	0.0	4.0	1.3	0.8	0.4	0.0	0.2	0.0	0.1	0.2	0.0	1.2	0.3	0.0	0.0	3.1	0.0	0.0	0.6	0.3	1.0	0.0	0.0	0.0	0.0	0.0	0.3	1.9	0.1	0.1	0.0	0.9	0.0	45.6	2.2	0.1	0.2	0.8	0.3	0.1	2.2	1.2	0.9	1.5
TRPA1	ANKTM1	ENSG00000104321	"Transient receptor potential cation channel subfamily A member 1"	O75762	8	72019917-72075584	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 9.2;stomach 1: 10.3;urinary bladder: 27.7"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 10.9;Excitatory neurons: 5.0;Fibroblasts: 8.1;Intestinal goblet cells: 17.2;Skeletal myocytes: 4.5"	"Cancer enhanced"	"Detected in many"		"breast cancer: 2.7"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"HHSteC: 25.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"									NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 37: Intestine - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 27: Mucus-secreting cells - Mucin production"				"unprognostic (2.14e-2)"	"unprognostic (2.50e-2)"	"prognostic favorable (6.57e-4)"	"unprognostic (1.28e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.95e-1)"	"unprognostic (1.37e-2)"	"unprognostic (8.11e-3)"	"unprognostic (4.22e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.78e-3)"	"unprognostic (1.49e-1)"	"unprognostic (2.16e-4)"	"unprognostic (2.37e-1)"	"unprognostic (9.67e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.90e-1)"	0.3	0.4	0.1	3.8	0.0	0.0	0.0	0.0	0.7	0.1	0.0	7.9	6.3	0.3	0.0	1.0	0.2	7.0	0.8	0.8	0.0	0.1	0.0	0.2	0.8	0.3	0.0	0.8	0.1	0.0	0.0	0.7	0.0	0.1	9.2	0.0	0.2	0.0	0.1	0.1	7.4	0.3	0.0	0.5	10.3	0.5	0.0	0.2	0.1	0.0	0.2	27.7	0.3	0.2	0.0	2.8	0.8	0.0	0.0	0.1	0.0	0.3	2.5	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	2.0	0.4	1.5	0.1	0.0	0.5	0.0	25.9	0.0	0.2	1.7	0.0	1.2	0.2	5.5	0.0	0.0	0.0	0.0	3.2	0.0	0.0	0.1	0.6	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.1	0.1	0.5	0.0	2.6	0.2	0.0	0.4	0.0	0.1	4.0	1.2	0.0	0.3	0.3	0.0	1.9	0.0	1.9	0.0	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.2	0.0	0.1	0.0	0.0	0.7	0.8	0.0	0.3	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	10.9	0.0	0.1	0.0	0.0	0.0	5.0	0.0	0.0	8.1	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	17.2	0.0	0.0	0.0	0.8	0.3	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	2.6	0.0	0.0	0.0	0.0	4.5	0.8	0.0	0.7	0.0	0.0	0.0	0.0	0.2	0.5	0.0
TRPC1	HTRP-1	ENSG00000144935	"Transient receptor potential cation channel subfamily C member 1"	P48995	3	142724034-142807888	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"Astrocytes: 93.7;Excitatory neurons: 144.6;Granulosa cells: 91.8;Inhibitory neurons: 184.4;Microglial cells: 49.6;Oligodendrocyte precursor cells: 154.8;Oligodendrocytes: 164.8"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 23.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009387, HPA021130"	Supported		Approved	Vesicles		NA	NA				"Cluster 21: Non-specific - Transcription"	"Cluster 18: U-2197 - ECM organization"	"Cluster 40: Granulosa cells - Unknown function"	Vesicles		"CAB009387: AB_2240941, HPA021130: AB_1858361"	"unprognostic (1.66e-1)"	"unprognostic (7.38e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.37e-5)"	"unprognostic (5.53e-1)"	"unprognostic (1.40e-2)"	"unprognostic (5.90e-3)"	"unprognostic (1.59e-2)"	"unprognostic (1.36e-1)"	"unprognostic (2.17e-1)"	"unprognostic (8.46e-3)"	"unprognostic (6.25e-2)"	"prognostic unfavorable (2.72e-5)"	"unprognostic (1.44e-3)"	"unprognostic (1.57e-1)"	"unprognostic (1.61e-1)"	"unprognostic (2.49e-2)"	5.2	4.7	7.3	1.9	7.9	0.3	4.7	10.9	7.5	9.1	5.8	7.6	1.2	11.1	5.2	3.6	8.6	5.4	10.1	7.9	7.0	3.2	0.8	3.3	1.9	7.1	5.6	14.2	1.4	6.5	10.3	3.5	7.7	7.0	2.5	22.8	2.9	7.8	1.2	3.6	3.9	10.6	6.1	2.8	3.2	4.8	6.1	1.5	5.1	3.6	1.0	6.3	6.9	7.9	4.2	5.7	10.8	1.2	9.7	23.9	4.8	6.8	10.5	8.4	12.2	1.7	1.1	0.0	2.1	7.0	14.2	0.3	3.0	3.2	12.2	1.0	4.1	6.8	2.6	2.9	4.0	0.4	0.0	11.4	3.2	7.9	9.4	14.2	4.9	0.0	0.2	0.0	12.1	2.6	0.4	0.5	6.0	0.1	3.1	0.0	5.0	0.0	5.9	0.1	6.7	4.8	8.1	0.0	1.5	9.9	3.3	0.1	4.3	10.1	1.6	14.0	9.1	3.9	1.8	2.1	7.7	0.1	3.1	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	7.3	7.9	10.9	7.5	7.9	7.0	7.1	5.6	7.7	6.1	6.1	7.9	6.2	3.2	0.5	93.7	2.9	2.9	1.6	1.2	7.4	17.9	0.9	1.8	12.0	1.5	0.6	5.5	16.7	0.2	0.3	0.0	0.0	0.3	3.6	0.5	10.8	4.6	1.8	0.4	144.6	0.2	0.2	13.2	0.0	0.9	0.0	91.8	3.6	0.0	0.1	13.5	184.4	0.0	0.0	0.0	1.6	2.9	8.4	0.5	1.8	49.6	0.1	7.7	0.0	154.8	164.8	0.1	0.0	10.9	1.5	0.9	0.0	0.7	3.0	16.0	0.0	10.4	12.0	9.8	2.8	0.7	1.1	0.3	2.2	1.7	0.0	0.3
TRPC3		ENSG00000138741	"Transient receptor potential cation channel subfamily C member 3"	Q13507	4	121874481-121952060	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, Neurodegeneration, Spinocerebellar ataxia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 10.4;pituitary gland: 7.4"	"Cell type enhanced"	"Detected in some"		"Excitatory neurons: 18.1;Inhibitory neurons: 82.7;Oligodendrocyte precursor cells: 33.7;Rod photoreceptor cells: 32.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEL: 2.3;Karpas-707: 2.6;U-2 OS: 1.5;U-251 MG: 1.5"	"Region enhanced"	"Detected in all"		"cerebellum: 57.8"	"Low region specificity"	"Detected in many"									NA	NA			"Cluster 42: Non-specific - Transcription"	"Cluster 77: Retina - Visual perception"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (1.08e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.39e-1)"	"unprognostic (3.12e-2)"	"unprognostic (5.57e-2)"	"unprognostic (1.93e-2)"	"unprognostic (7.12e-3)"	"unprognostic (9.80e-2)"	"unprognostic (4.80e-3)"	"unprognostic (2.38e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.33e-3)"	"unprognostic (2.67e-3)"	"unprognostic (1.39e-1)"	"unprognostic (2.23e-1)"	"unprognostic (8.42e-3)"	0.3	0.0	2.3	0.1	4.0	0.0	0.2	4.6	5.8	0.8	0.1	0.2	0.1	0.4	0.2	0.0	0.5	0.8	0.2	0.8	3.2	0.1	0.1	0.9	0.1	10.4	2.8	0.1	0.0	0.2	7.4	1.1	2.2	0.2	0.1	3.9	0.1	0.6	0.4	0.1	0.5	2.6	1.6	0.2	0.2	0.4	4.6	0.0	0.1	0.2	0.0	1.7	0.7	1.7	0.0	0.0	0.8	0.1	0.1	0.1	0.0	0.4	0.4	0.7	0.2	0.0	0.0	0.0	0.0	0.5	0.3	0.1	0.4	0.0	0.1	0.0	1.3	2.3	0.2	0.0	0.1	0.7	0.3	0.2	0.0	0.0	0.0	1.1	0.0	0.1	0.0	2.6	0.5	0.1	0.8	0.0	0.4	0.0	0.2	0.0	0.2	0.0	0.0	0.0	1.1	0.1	0.2	0.1	0.0	0.1	0.0	0.0	0.1	1.2	1.5	0.1	1.5	0.1	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	2.3	4.0	4.6	5.8	0.8	3.2	10.4	2.8	2.2	1.6	4.6	1.7	0.5	0.0	0.0	6.5	0.0	0.0	0.0	0.0	0.0	2.8	0.0	0.0	0.8	0.0	0.0	0.0	8.4	0.0	0.5	0.0	0.0	0.0	2.3	0.0	0.3	0.2	0.0	0.0	18.1	0.0	0.0	0.1	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	82.7	0.0	0.0	0.0	0.3	0.4	0.3	0.0	0.0	0.0	0.1	4.6	0.0	33.7	1.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	32.0	0.0	0.3	1.4	0.5	0.8	0.0	0.0	0.0	0.5	0.5	0.0	0.1
TRPC4	"HTRP4, TRP4"	ENSG00000133107	"Transient receptor potential cation channel subfamily C member 4"	Q9UBN4	13	37632063-37869802	"Plasma proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"endometrium 1: 11.9;seminal vesicle: 9.0;smooth muscle: 12.6"	"Cell type enriched"	"Detected in some"	4	"Inhibitory neurons: 133.2"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 8.7;BJ: 20.2;BJ hTERT+ SV40 Large T+: 9.1;fHDF/TERT166: 19.6;U-2197: 9.3"	"Region enhanced"	"Detected in many"		"basal ganglia: 43.1"	"Low region specificity"	"Detected in all"									NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (4.52e-4)"	"unprognostic (9.99e-2)"	"unprognostic (5.42e-2)"	"unprognostic (2.38e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.57e-1)"	"unprognostic (3.28e-1)"	"unprognostic (1.60e-1)"	"unprognostic (5.10e-2)"	"unprognostic (1.99e-1)"	"unprognostic (1.47e-2)"	"unprognostic (3.95e-2)"	"unprognostic (1.07e-6)"	"unprognostic (3.73e-3)"	"unprognostic (1.93e-2)"	"unprognostic (3.24e-1)"	"unprognostic (1.43e-2)"	0.8	0.4	2.9	0.8	7.1	0.0	0.3	0.0	3.5	2.5	0.0	3.1	0.4	11.9	0.8	0.1	1.3	3.3	1.2	4.7	5.4	1.8	0.2	3.4	0.1	0.9	2.6	2.7	1.3	0.2	0.2	1.3	0.6	6.7	0.6	0.2	0.2	9.0	0.2	0.1	1.0	12.6	0.6	0.2	2.0	0.1	2.5	0.0	0.7	0.2	0.0	1.6	1.6	1.2	0.0	0.0	8.7	0.0	1.2	2.6	0.0	20.2	2.9	9.1	4.4	0.0	0.3	0.0	0.0	19.6	3.1	0.0	0.1	0.0	4.2	0.0	0.1	0.0	0.4	0.0	3.1	0.0	0.0	1.3	0.0	2.6	0.0	1.3	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	1.8	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.2	0.1	9.3	1.8	4.7	1.2	0.0	1.9	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	7.1	0.0	3.5	4.7	5.4	0.9	2.6	0.6	0.6	2.5	1.2	0.3	0.0	0.0	1.0	0.0	0.0	0.4	0.0	0.0	0.7	0.0	0.0	2.6	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.8	0.0	0.3	12.3	0.6	0.0	0.0	32.0	0.0	0.0	3.0	0.0	0.2	0.0	0.1	0.0	0.0	0.2	0.0	133.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	15.0	0.0	0.0	0.0	2.5	1.4	0.1	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.2	0.0	0.2	7.1	0.0	0.1	0.0	0.0	0.0	0.1	0.3	0.0	0.1
TRPC5	PPP1R159	ENSG00000072315	"Transient receptor potential cation channel subfamily C member 5"	Q9UL62	X	111768011-112082776	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	5	"brain: 3.7"	"Group enriched"	"Detected in some"	11	"Excitatory neurons: 46.3;Inhibitory neurons: 78.5;Oligodendrocytes: 38.3"	"Group enriched"	"Detected in some"	23	"testis cancer: 0.8;thyroid cancer: 2.8"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	6	"NTERA-2: 1.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"									NA	NA				"Cluster 73: Brain - Neuropeptide signaling"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"								"unprognostic (3.29e-2)"		"unprognostic (6.15e-2)"	"unprognostic (7.32e-2)"			"unprognostic (2.60e-3)"		"unprognostic (3.68e-2)"	"unprognostic (5.69e-2)"	"unprognostic (5.09e-2)"	"unprognostic (2.78e-2)"		0.0	0.1	0.6	0.0	2.7	0.1	0.0	0.9	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	2.1	0.0	0.8	0.0	0.0	1.9	3.7	0.0	0.0	0.0	0.0	0.0	2.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	2.7	0.9	1.7	1.3	2.1	1.9	3.7	2.2	0.3	0.6	0.8	0.0	0.0	0.0	4.9	0.2	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	46.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	78.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	4.5	38.3	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1
TRPC6	"FSGS2, TRP6"	ENSG00000137672	"Transient receptor potential cation channel subfamily C member 6"	Q9Y210	11	101451564-101872562	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 13.3;placenta: 20.8"	"Cell type enhanced"	"Detected in many"		"Club cells: 10.5;Excitatory neurons: 19.3;Inhibitory neurons: 47.2;Microglial cells: 12.2;Smooth muscle cells: 20.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Immune cell enriched"	"Detected in single"	6	"eosinophil: 2.3"	"Lineage enriched"	"Detected in single"	6	"granulocytes: 2.3"	"Cell line enhanced"	"Detected in some"		"A549: 4.9;ASC diff: 8.8;BJ hTERT+: 4.9;HEL: 4.8;RPTEC TERT1: 21.5"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			HPA045098	Approved					NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 28: Placenta - Pregnancy"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"HPA045098: AB_10959600"	"unprognostic (1.45e-1)"	"unprognostic (4.21e-1)"	"unprognostic (2.43e-1)"	"unprognostic (8.71e-5)"	"unprognostic (1.86e-1)"	"unprognostic (1.36e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.14e-1)"	"unprognostic (4.30e-2)"	"unprognostic (3.04e-1)"	"unprognostic (1.98e-2)"	"unprognostic (1.30e-1)"	"unprognostic (5.47e-4)"	"unprognostic (1.99e-3)"	"unprognostic (4.88e-2)"	"unprognostic (7.16e-2)"	"unprognostic (1.32e-2)"	4.3	0.5	1.2	0.7	1.5	0.2	3.3	0.6	1.3	3.4	5.8	2.8	1.2	4.8	1.6	5.7	5.4	2.3	0.5	1.5	1.9	1.4	0.1	13.3	1.1	1.8	3.4	1.2	0.7	0.9	0.2	20.8	1.2	2.2	1.6	0.3	0.9	5.4	0.4	1.9	1.2	4.0	1.6	2.2	1.6	0.6	2.0	0.2	9.4	1.0	0.8	1.8	2.0	1.2	0.0	4.9	0.2	0.0	8.8	2.1	0.0	3.2	4.9	0.7	0.1	0.2	0.0	0.5	0.0	0.4	0.0	0.0	0.0	0.0	0.2	0.0	0.1	4.8	0.0	0.0	0.1	0.0	0.0	2.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	21.5	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.5	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	0.4	0.0	0.1	1.2	1.5	0.6	1.3	1.5	1.9	1.8	3.4	1.2	1.6	2.0	1.2	3.4	0.0	2.6	2.0	0.0	2.3	1.9	0.0	0.0	1.4	0.4	2.9	0.7	0.0	10.5	3.7	0.0	1.3	0.0	0.1	0.0	0.0	1.0	3.0	4.0	1.6	0.0	0.0	19.3	0.2	0.0	3.1	0.0	8.0	0.0	0.1	0.0	0.0	0.3	0.0	47.2	0.0	0.0	0.0	5.3	0.5	6.2	1.8	1.8	12.2	0.1	0.0	0.0	2.0	0.3	0.0	5.1	0.7	0.0	0.2	0.0	0.1	0.8	0.0	0.0	0.3	20.2	0.1	0.7	0.1	3.4	0.4	0.1	2.1	0.0	1.5
TRPM1	"CSNB1C, LTRPC1, MLSN1"	ENSG00000134160	"Transient receptor potential cation channel subfamily M member 1"	Q7Z4N2	15	31001061-31161273	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport, Vision"	"Ion channel, Ligand-gated ion channel, Receptor"	"Congenital stationary night blindness, Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"retina: 9.4;skin 1: 4.1"	"Group enriched"	"Detected in some"	7	"Bipolar cells: 627.4;Melanocytes: 158.3"	"Cancer enriched"	"Detected in single"	179	"melanoma: 14.6"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in single"	112	"SK-MEL-30: 12.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA014779, HPA071139"	Enhanced		Uncertain	"Golgi apparatus,Plasma membrane,Centriolar satellite"		NA	NA				"Cluster 77: Retina - Visual perception"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 56: Bipolar cells - Visual perception"	"Centriolar satellite"	"Golgi apparatus, Plasma membrane"	"HPA014779: AB_2669090, HPA071139: "	"unprognostic (5.28e-2)"	"unprognostic (1.35e-1)"		"unprognostic (9.89e-2)"	"unprognostic (3.07e-1)"	"unprognostic (1.97e-1)"	"unprognostic (1.70e-1)"	"unprognostic (1.29e-3)"	"unprognostic (2.83e-1)"	"unprognostic (2.89e-2)"	"unprognostic (1.67e-1)"	"unprognostic (1.45e-2)"	"unprognostic (2.58e-1)"	"unprognostic (7.84e-2)"	"unprognostic (6.20e-4)"	"unprognostic (1.48e-1)"	"unprognostic (2.63e-2)"	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.3	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.0	0.0	0.0	0.2	0.4	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	9.4	0.1	0.0	0.0	4.1	0.0	0.0	0.5	0.0	0.0	1.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.3	0.3	0.1	0.2	0.2	0.4	0.3	0.5	0.3	0.5	0.0	0.0	0.0	0.7	0.0	4.2	0.0	0.0	0.0	627.4	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	50.5	0.1	0.1	1.7	0.0	0.0	0.9	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.0	0.1	0.1	13.5	0.8	0.0	0.0	0.0	1.0	6.3	0.0	0.0	158.3	0.0	0.0	11.0	0.0	0.0	19.4	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	22.2	0.0	0.1	0.1	10.1	4.4	1.8	1.0	1.0	0.0	0.0	0.0	0.1
TRPM2	"EREG1, KNP3, LTRPC2, NUDT9H, NUDT9L1, TRPC7"	ENSG00000142185	"Transient receptor potential cation channel subfamily M member 2"	O94759	21	44350163-44443081	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Sodium transport, Transport"	"Calcium channel, Ion channel, Sodium channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 28.2;brain: 26.4;lymphoid tissue: 18.4"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 52.7;Hofbauer cells: 18.3;Inhibitory neurons: 45.1;Macrophages: 16.7;Microglial cells: 27.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 7.8;plasmacytoid DC: 15.5"	"Group enriched"	"Detected in many"	6	"dendritic cells: 15.5;monocytes: 7.8"	"Cell line enhanced"	"Detected in many"		"HL-60: 41.7;NB-4: 58.6;OE19: 41.3;THP-1: 71.3;U-266/84: 31.8;U-937: 67.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA035260	Enhanced					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 32: U-937 - Innate immune response"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA035260: AB_2674540"	"unprognostic (3.61e-2)"	"unprognostic (2.18e-1)"	"unprognostic (7.55e-2)"	"prognostic favorable (9.28e-4)"	"unprognostic (6.49e-2)"	"unprognostic (4.54e-2)"	"unprognostic (5.17e-2)"	"unprognostic (2.23e-1)"	"unprognostic (8.13e-2)"	"unprognostic (2.41e-3)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavorable (4.39e-6)"	"unprognostic (1.40e-1)"	"unprognostic (3.31e-2)"	"unprognostic (8.88e-3)"	"prognostic favorable (7.59e-4)"	4.8	4.1	14.0	6.7	14.5	28.2	3.0	11.1	26.4	2.1	7.7	3.8	3.6	1.6	0.7	1.6	2.1	4.7	1.8	13.9	11.8	2.5	2.3	5.0	8.0	20.9	14.5	0.9	1.8	1.1	4.8	6.0	20.8	2.7	2.3	0.9	2.3	0.8	0.9	2.3	6.9	2.5	12.2	18.4	2.5	2.7	16.0	3.3	1.8	0.4	4.1	3.5	1.6	17.4	20.8	7.5	0.0	0.1	0.0	0.0	20.9	0.0	0.0	0.6	0.4	0.0	0.0	0.5	24.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	3.6	3.9	0.0	0.0	41.7	2.2	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.0	0.0	0.0	6.7	58.6	0.0	41.3	23.5	2.3	7.2	8.0	0.0	0.0	14.4	0.1	0.0	23.5	0.1	0.0	27.7	71.3	0.0	1.2	20.9	0.1	0.7	0.3	31.8	0.1	0.0	67.7	0.0	0.0	7.8	0.0	1.0	2.7	0.5	0.3	0.3	0.4	2.6	1.9	0.3	0.4	0.4	0.5	2.5	15.5	1.3	2.0	14.0	14.5	11.1	26.4	13.9	11.8	20.9	14.5	20.8	12.2	16.0	17.4	2.0	0.0	0.5	1.3	2.0	0.4	0.0	0.0	0.6	1.4	2.8	3.0	1.7	0.0	0.0	0.0	0.0	1.8	9.9	0.8	0.0	0.1	2.1	0.7	0.2	2.7	0.0	0.0	52.7	0.2	8.8	0.5	1.1	1.2	1.3	0.3	0.4	0.4	18.3	0.0	45.1	1.0	0.0	11.0	5.5	2.0	0.6	16.7	0.0	27.2	5.5	0.5	6.2	4.0	1.7	1.2	0.1	0.0	1.4	0.0	0.0	0.3	0.0	1.0	6.6	0.5	0.4	1.0	0.1	0.1	0.3	1.4	4.2	0.0	0.7	0.0
TRPM3	"GON-2, KIAA1616, LTRPC3"	ENSG00000083067	"Transient receptor potential cation channel subfamily M member 3"	Q9HCF6	9	70529060-71446904	"Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	17	"choroid plexus: 801.0"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 905.0;Excitatory neurons: 390.3;Inhibitory neurons: 186.9;Muller glia cells: 184.5"	"Cancer enhanced"	"Detected in single"		"renal cancer: 0.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	4	"HAP1: 17.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA072650, HPA074393"	Enhanced		Approved	Vesicles		NA	NA			"Cluster 48: NK-cells - Unknown function"	"Cluster 88: Choroid plexus - Transmembrane transport"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	Vesicles		"HPA072650: , HPA074393: "	"unprognostic (3.74e-1)"	"unprognostic (6.30e-2)"	"unprognostic (4.79e-2)"	"unprognostic (4.81e-2)"	"unprognostic (1.38e-2)"	"unprognostic (8.88e-2)"	"unprognostic (1.49e-2)"	"unprognostic (2.19e-2)"	"unprognostic (1.11e-1)"	"unprognostic (1.89e-2)"	"unprognostic (6.10e-2)"	"unprognostic (1.15e-2)"	"unprognostic (1.82e-7)"	"unprognostic (3.51e-2)"	"unprognostic (5.64e-2)"	"unprognostic (1.74e-2)"	"unprognostic (1.50e-2)"	0.7	0.6	22.0	0.1	30.4	0.2	0.1	40.5	9.6	1.0	801.0	0.2	0.8	1.1	1.3	0.1	0.4	0.4	0.8	39.3	27.8	16.5	0.2	0.1	0.1	36.7	46.8	3.6	0.5	0.0	2.9	0.1	20.8	0.5	0.1	23.0	0.1	2.5	0.3	0.1	0.0	0.2	25.2	0.3	0.6	5.1	41.6	0.2	0.9	0.1	0.0	0.1	0.4	15.4	0.0	0.0	0.9	0.0	1.1	2.6	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.1	0.1	0.0	0.0	17.2	0.0	0.1	0.0	0.1	0.1	1.5	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.2	2.3	0.2	0.0	0.0	1.0	4.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.2	0.0	0.9	0.0	1.1	0.0	0.2	0.0	0.3	0.2	0.0	0.0	3.1	0.0	0.1	3.1	0.0	0.0	0.0	0.0	0.4	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	22.0	30.4	40.5	9.6	39.3	27.8	36.7	46.8	20.8	25.2	41.6	15.4	0.3	3.2	3.0	905.0	0.5	0.4	0.9	0.0	0.6	16.4	0.3	0.5	5.3	5.7	2.5	16.5	66.7	0.1	0.2	0.1	5.9	0.1	4.8	1.4	1.0	1.3	15.4	0.0	390.3	0.2	0.1	3.0	0.0	3.2	0.0	1.4	0.7	0.3	0.2	1.7	186.9	0.1	0.0	0.9	1.4	2.3	5.6	0.8	0.0	56.2	0.2	184.5	1.0	105.6	8.3	0.1	0.1	9.1	0.0	0.5	0.1	33.3	0.8	10.1	0.0	3.5	1.3	1.3	0.6	0.0	0.9	0.3	0.9	0.6	0.0	0.3
TRPM4	FLJ20041	ENSG00000130529	"Transient receptor potential cation channel subfamily M member 4"	Q8TD43	19	49157741-49211836	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Adaptive immunity, Immunity, Ion transport, Transport"	"Calmodulin-binding, Ion channel"	"Disease variant, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 179.2;Hepatocytes: 81.7;Intestinal goblet cells: 114.8;Paneth cells: 77.1;Undifferentiated cells: 88.9"	"Cancer enriched"	"Detected in all"	4	"prostate cancer: 85.3"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	7	"dendritic cells: 3.3;granulocytes: 2.8;monocytes: 4.3"	"Cell line enhanced"	"Detected in many"		"OE19: 32.7;RT4: 60.8;SK-BR-3: 38.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA041169	Enhanced		Supported	"Nucleoplasm,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 41: Intestine & Liver - Lipid metabolism"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Plasma membrane"		"HPA041169: AB_2677343"	"unprognostic (8.20e-3)"	"unprognostic (1.41e-1)"	"unprognostic (7.86e-2)"	"prognostic favorable (2.88e-7)"	"unprognostic (1.62e-2)"	"unprognostic (9.78e-2)"	"unprognostic (1.77e-2)"	"unprognostic (2.90e-1)"	"unprognostic (3.33e-2)"	"unprognostic (3.38e-2)"	"unprognostic (2.94e-2)"	"unprognostic (2.79e-1)"	"prognostic favorable (2.53e-7)"	"unprognostic (8.46e-3)"	"unprognostic (2.16e-1)"	"unprognostic (5.70e-2)"	"unprognostic (1.00e-2)"	10.8	6.1	5.8	6.1	5.4	4.6	13.5	8.5	7.0	11.5	4.8	46.1	25.3	9.9	2.5	13.1	9.2	7.4	23.0	5.9	4.5	22.8	15.4	16.0	1.8	6.2	7.4	3.3	10.1	3.7	5.6	5.3	6.9	35.7	12.9	1.3	27.3	6.2	14.0	26.6	22.9	3.4	4.2	5.5	20.6	5.4	6.6	1.0	17.3	5.3	1.9	13.7	14.4	5.1	11.9	9.0	2.1	9.5	7.7	6.6	6.6	10.0	6.0	2.7	3.7	6.1	18.7	0.4	2.7	6.8	3.6	15.7	1.3	3.0	1.0	0.2	3.4	1.9	4.0	3.7	6.6	0.3	11.7	9.3	13.6	5.3	2.6	3.3	4.6	1.0	4.9	2.1	6.9	17.4	0.8	0.9	1.0	32.7	13.3	4.1	2.0	0.6	4.6	60.8	0.8	2.2	4.1	38.6	2.2	0.7	22.6	3.7	11.8	14.4	7.8	7.9	0.2	3.9	4.3	0.4	7.9	7.4	5.3	2.2	4.3	0.7	0.3	2.5	0.2	0.5	0.2	0.2	3.3	0.5	0.3	0.3	2.8	0.5	1.0	3.1	0.2	1.4	5.8	5.4	8.5	7.0	5.9	4.5	6.2	7.4	6.9	4.2	6.6	5.1	12.8	32.1	2.6	9.8	3.5	12.5	15.3	9.9	9.1	2.0	19.0	14.6	16.7	17.2	12.3	14.7	0.0	6.6	0.2	179.2	19.6	7.9	2.9	17.5	8.2	11.7	21.7	0.0	5.4	18.5	6.8	6.0	71.4	36.2	5.7	2.9	11.4	81.7	19.9	0.0	8.5	114.8	14.2	9.8	19.0	3.1	6.8	8.5	39.2	9.4	12.8	6.7	0.0	3.5	0.9	32.9	77.1	7.2	7.6	35.5	55.3	3.8	8.9	2.6	32.9	2.2	8.5	6.1	15.7	8.4	11.5	3.4	1.9	4.1	88.9	33.1
TRPM5	"LTRPC5, MTR1"	ENSG00000070985	"Transient receptor potential cation channel subfamily M member 5"	Q9NZQ8	11	2404515-2423045	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor, Voltage-gated channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"epididymis: 1.8;intestine: 3.3;pancreas: 2.4;seminal vesicle: 1.7"	"Cell type enriched"	"Detected in some"	4	"Gastric mucus-secreting cells: 9.7"	"Cancer enhanced"	"Detected in some"		"pancreatic cancer: 1.8"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"													NA	NA				"Cluster 29: Non-specific - Vesicular transport"		"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (1.82e-1)"	"unprognostic (1.98e-1)"	"unprognostic (6.47e-5)"	"unprognostic (6.81e-4)"	"unprognostic (7.90e-3)"	"unprognostic (1.18e-1)"	"unprognostic (1.13e-2)"	"unprognostic (2.24e-2)"	"unprognostic (4.75e-1)"	"unprognostic (1.53e-1)"	"unprognostic (2.36e-1)"	"unprognostic (3.19e-1)"	"unprognostic (5.07e-3)"	"unprognostic (2.40e-1)"	"unprognostic (5.21e-1)"	"unprognostic (5.72e-2)"	"unprognostic (4.91e-2)"	0.0	0.8	0.0	0.1	0.0	0.1	0.0	0.1	0.2	0.0	0.0	2.0	2.9	0.0	1.8	0.0	0.1	0.1	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	2.4	0.0	0.3	0.0	0.0	0.1	0.3	0.0	0.0	1.7	0.0	0.0	3.3	0.0	0.0	0.1	0.3	0.6	0.0	0.0	1.6	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.8	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	9.7	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	0.1	0.1	0.2	0.1	0.0	0.0	0.0	0.0	0.1	0.2	0.3	0.0	0.0	0.0	0.0	0.0	2.0	0.1
TRPM6	"CHAK2, FLJ22628, HOMG, HSH"	ENSG00000119121	"Transient receptor potential cation channel subfamily M member 6"	Q9BX84	9	74722495-74888094	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Disease variant, Primary hypomagnesemia"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 6.6;intestine: 16.6"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 128.9;Glandular and luminal cells: 36.5;Microglial cells: 39.4;Oligodendrocytes: 81.1;Proximal enterocytes: 23.3"	"Cancer enhanced"	"Detected in some"		"testis cancer: 1.8"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	6	"basophil: 23.1;neutrophil: 7.5"	"Lineage enriched"	"Detected in single"	41	"granulocytes: 23.1"	"Cell line enhanced"	"Detected in some"		"BEWO: 3.8;HeLa: 2.4;Karpas-707: 1.3;RT4: 3.8;U-266/70: 1.4"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 38: Basophils - Unknown function"	"Cluster 45: Intestine - Brush border"	"Cluster 15: RT4 - Unknown function"	"Cluster 53: Intestinal epithelial cells - Unknown function"				"unprognostic (3.95e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.76e-1)"	"unprognostic (1.65e-1)"	"unprognostic (7.80e-2)"	"unprognostic (9.20e-2)"	"unprognostic (1.59e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.82e-1)"	"unprognostic (1.84e-1)"	"unprognostic (5.72e-4)"	"unprognostic (1.58e-1)"	"unprognostic (1.71e-2)"	"unprognostic (8.10e-2)"	"unprognostic (7.54e-2)"	"unprognostic (1.89e-2)"	"unprognostic (2.11e-2)"	0.6	0.0	2.1	0.6	3.5	2.6	0.6	3.0	2.4	0.3	0.2	13.2	7.0	0.3	0.2	0.3	0.2	0.3	0.2	1.6	2.8	1.9	0.1	0.3	0.3	4.2	3.4	0.0	0.1	1.4	0.5	0.3	4.1	0.5	16.6	0.4	0.3	0.1	0.1	0.7	7.9	0.5	2.7	0.5	0.2	1.4	3.1	0.4	0.2	0.1	0.3	0.4	0.3	6.6	0.0	0.8	0.1	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.0	1.0	0.1	0.3	0.0	0.0	0.1	0.1	0.2	0.2	0.0	0.0	0.1	0.1	2.4	0.1	0.0	0.0	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.0	1.3	0.0	0.5	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	3.8	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	0.5	0.1	0.0	1.4	0.0	0.1	0.0	0.1	0.1	23.1	0.1	2.4	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.1	0.1	7.5	0.5	0.2	0.3	0.0	0.1	2.1	3.5	3.0	2.4	1.6	2.8	4.2	3.4	4.1	2.7	3.1	6.6	3.3	0.0	1.7	1.0	0.3	0.1	1.9	0.3	2.2	0.3	0.2	0.4	0.9	0.0	1.3	3.7	0.0	0.2	0.2	128.9	0.0	0.0	4.0	11.3	3.4	3.2	3.6	0.0	1.3	0.0	0.1	0.3	0.0	36.5	0.0	0.1	3.3	0.1	0.0	0.0	0.5	3.0	0.0	0.3	0.6	0.9	0.0	0.4	0.0	39.4	0.0	0.3	0.0	0.5	81.1	0.0	13.8	0.4	0.1	1.3	23.3	0.0	0.8	2.7	0.0	0.7	0.4	1.6	2.4	0.5	1.0	0.1	0.5	0.2	7.5	0.8
TRPM7	"CHAK1, LTRPC7, TRP-PLIK"	ENSG00000092439	"Transient receptor potential cation channel subfamily M member 7"	Q96QT4	15	50552473-50686797	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Necrosis, Transport"	"Calcium channel, Ion channel, Kinase, Serine/threonine-protein kinase, Transferase"	"Amyotrophic lateral sclerosis, Neurodegeneration, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"parathyroid gland: 108.9"	"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 122.2;Oligodendrocytes: 109.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-2197: 122.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035522, HPA052173"	Enhanced		Approved	"Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 18: U-2197 - ECM organization"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	"Vesicles, Cytosol"	"HPA035522: , HPA052173: AB_2681749"	"unprognostic (3.14e-2)"	"unprognostic (1.86e-1)"	"unprognostic (1.58e-1)"	"unprognostic (1.42e-2)"	"unprognostic (1.89e-1)"	"unprognostic (1.60e-2)"	"unprognostic (1.85e-2)"	"unprognostic (2.59e-2)"	"unprognostic (5.46e-3)"	"unprognostic (2.64e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.59e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.08e-1)"	"unprognostic (7.59e-2)"	"unprognostic (9.45e-2)"	"unprognostic (1.97e-1)"	11.5	9.6	4.3	13.3	6.5	21.4	13.6	15.4	6.7	10.3	29.3	13.8	14.4	12.7	14.6	8.6	9.4	11.1	15.5	4.8	3.5	22.9	25.3	11.6	16.6	4.9	3.9	16.4	12.2	108.9	5.3	13.3	5.9	10.9	14.4	10.5	10.9	10.6	7.8	16.6	13.1	11.4	3.2	12.2	13.6	9.9	6.4	15.5	17.3	9.1	14.4	11.4	8.1	10.4	21.4	21.0	17.2	19.1	48.5	36.2	20.9	26.4	36.7	16.5	21.6	29.1	11.6	46.4	12.7	30.8	42.5	35.1	23.3	19.5	23.4	26.0	13.7	37.1	31.5	15.4	44.0	38.8	27.6	33.9	22.4	18.8	35.0	24.0	13.5	28.8	42.6	34.5	30.4	33.7	25.1	18.8	13.0	29.4	12.8	27.2	23.7	22.7	23.0	49.9	14.2	18.1	18.2	28.7	35.8	30.1	18.0	41.6	20.7	26.1	12.4	122.4	30.8	23.3	54.9	44.0	28.4	77.5	24.8	1.8	1.3	1.6	2.5	1.3	2.9	2.2	1.8	1.7	1.5	2.3	1.6	1.9	1.7	2.4	1.4	1.9	2.0	0.8	4.3	6.5	15.4	6.7	4.8	3.5	4.9	3.9	5.9	3.2	6.4	10.4	23.9	19.2	31.3	73.1	36.4	31.6	17.2	11.0	44.9	21.9	18.8	11.9	25.9	21.5	8.2	12.9	12.5	23.0	38.4	17.0	3.9	11.7	33.3	21.6	27.1	19.7	18.5	29.6	122.2	12.7	9.4	26.1	37.8	23.1	17.7	26.0	14.6	43.9	14.6	21.9	92.7	19.5	6.1	22.4	19.8	26.0	26.4	26.5	19.6	66.5	24.2	8.5	29.9	80.9	109.1	15.5	13.9	20.3	33.2	24.9	23.4	11.0	19.3	22.6	13.1	30.0	22.0	23.1	23.6	25.7	24.2	16.3	34.5	22.2	20.4	11.1
TRPM8		ENSG00000144481	"Transient receptor potential cation channel subfamily M member 8"	Q7Z2W7	2	233917373-234019522	"FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Ion transport, Sensory transduction, Transport"	"Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	57	"liver: 31.5;prostate: 80.2"	"Group enriched"	"Detected in some"	5	"Hepatocytes: 45.2;Prostatic glandular cells: 16.3"	"Cancer enriched"	"Detected in some"	27	"prostate cancer: 72.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"GAMG: 3.4;Karpas-707: 5.5;RPTEC TERT1: 8.1;SK-MEL-30: 8.9;WM-115: 5.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 40: NK-cells - Unknown function"	"Cluster 85: Liver - Metabolism"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 2: Hepatocytes - Metabolism"				"unprognostic (4.41e-3)"	"unprognostic (7.91e-2)"	"unprognostic (1.11e-1)"	"unprognostic (5.49e-3)"	"unprognostic (1.05e-1)"	"unprognostic (4.60e-3)"	"prognostic favorable (7.15e-4)"	"unprognostic (3.28e-2)"	"unprognostic (3.71e-1)"	"unprognostic (9.88e-3)"	"unprognostic (7.10e-3)"	"unprognostic (4.69e-2)"	"unprognostic (3.36e-5)"	"unprognostic (1.11e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.18e-1)"	"unprognostic (5.53e-2)"	0.0	0.2	0.2	0.2	0.3	0.1	0.0	0.3	0.3	0.0	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.3	0.3	0.1	31.5	0.0	0.1	0.1	0.9	0.0	0.0	0.1	0.5	0.0	0.3	80.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.9	0.2	0.4	0.0	0.0	0.1	0.0	0.0	0.6	0.0	0.5	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.2	0.1	0.1	0.0	0.0	0.0	3.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	5.5	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.4	0.6	8.1	0.0	0.5	0.3	0.0	0.1	8.9	0.0	0.3	0.5	0.0	0.0	0.0	0.2	0.0	1.2	2.0	0.0	0.7	0.0	5.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.0	0.0	0.2	0.3	0.3	0.3	0.3	0.3	0.1	0.9	0.3	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.4	5.5	0.1	0.0	0.7	0.2	0.0	1.1	2.8	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.4	2.3	1.2	0.6	0.5	0.0	2.7	0.3	1.7	0.0	0.3	0.0	4.4	0.0	0.1	0.7	45.2	0.3	0.0	0.9	0.0	0.0	0.6	0.8	3.9	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.1	0.0	0.0	0.1	16.3	0.0	0.0	0.0	0.2	0.0	0.4	0.2	1.3	0.6	0.0	0.1	0.0	0.5	0.0	0.0	4.1
TRPV1	VR1	ENSG00000196689	"Transient receptor potential cation channel subfamily V member 1"	Q8NER1	17	3565444-3609411	"FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"liver: 24.6"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 20.2;Cone photoreceptor cells: 16.7;Oligodendrocytes: 18.8;Rod photoreceptor cells: 26.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HaCaT: 9.8"	"Not detected"	"Not detected"			"Not detected"	"Not detected"									NA	NA			"Cluster 2: Granulocytes - Unknown function"	"Cluster 15: Liver - Metabolism"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 46: Photoreceptor cells - Phototransduction"				"unprognostic (3.96e-2)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.33e-2)"	"unprognostic (6.83e-2)"	"unprognostic (3.21e-4)"	"unprognostic (9.90e-2)"	"unprognostic (2.95e-1)"	"unprognostic (2.03e-1)"	"unprognostic (2.56e-2)"	"unprognostic (3.43e-3)"	"unprognostic (6.17e-3)"	"unprognostic (6.97e-4)"	"unprognostic (4.25e-1)"	"unprognostic (4.78e-1)"	"unprognostic (3.81e-2)"	"unprognostic (5.12e-3)"	5.9	4.9	6.6	1.6	7.8	1.0	6.0	7.6	8.4	9.9	5.1	5.7	7.3	4.7	2.2	3.3	6.8	1.8	7.6	6.6	6.5	8.1	24.6	3.2	2.4	7.2	8.0	10.2	7.8	1.2	5.8	2.0	7.2	6.0	2.4	12.9	4.3	1.6	6.6	5.5	8.6	1.6	6.3	4.3	5.9	5.0	7.3	2.0	4.7	1.7	1.7	5.0	6.9	10.5	2.3	4.1	3.1	3.7	3.5	3.4	2.9	1.1	1.8	2.0	1.8	0.8	1.1	0.9	1.6	1.4	1.3	9.8	2.0	0.5	1.3	5.6	4.7	0.5	2.1	4.3	1.6	0.3	3.8	4.2	2.0	2.7	1.2	1.8	0.4	2.1	0.3	1.6	1.2	2.2	1.6	0.7	2.3	0.4	2.1	4.6	2.1	0.7	1.6	1.6	1.4	3.0	1.7	3.2	1.7	2.3	6.0	1.6	1.3	0.7	1.8	2.8	1.6	1.3	0.8	0.3	1.2	1.6	1.5	0.1	0.1	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.2	0.0	0.0	0.2	0.0	0.0	6.6	7.8	7.6	8.4	6.6	6.5	7.2	8.0	7.2	6.3	7.3	10.5	1.8	0.0	2.6	20.2	0.7	0.0	0.5	0.0	2.8	9.5	3.2	2.3	0.3	4.3	1.3	5.5	16.7	1.2	0.6	2.3	0.0	0.5	2.5	3.3	1.7	1.3	1.2	0.4	10.5	0.7	0.3	1.7	11.2	2.9	0.0	5.4	2.5	7.9	0.8	6.7	10.3	1.9	0.0	0.6	0.0	0.5	4.7	1.4	0.0	4.7	0.9	2.3	4.1	8.5	18.8	0.5	0.5	3.8	0.5	0.6	6.6	2.2	2.2	26.0	0.0	5.9	1.9	0.8	1.2	1.8	0.0	0.8	0.6	9.5	2.1	0.4
TRPV2	"VRL, VRL-1, VRL1"	ENSG00000187688	"Transient receptor potential cation channel subfamily V member 2"	Q9Y5S1	17	16415571-16437003	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"granulocytes: 50.0;Hofbauer cells: 50.6;monocytes: 39.4;NK-cells: 49.4"	"Cancer enriched"	"Detected in all"	8	"melanoma: 59.8"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"ASC TERT1: 78.8;fHDF/TERT166: 108.4;HMC-1: 89.0;SK-MEL-30: 94.7;TIME: 84.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			HPA044993	Uncertain		Supported	"Plasma membrane"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 2: Immune cells - Immune response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"HPA044993: AB_10960889"	"unprognostic (1.57e-1)"	"unprognostic (4.34e-3)"	"unprognostic (2.05e-2)"	"unprognostic (1.58e-2)"	"unprognostic (2.85e-2)"	"unprognostic (6.16e-3)"	"unprognostic (5.25e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.40e-3)"	"unprognostic (2.43e-1)"	"unprognostic (3.11e-2)"	"unprognostic (1.02e-1)"	"prognostic unfavorable (1.19e-6)"	"unprognostic (7.94e-2)"	"prognostic unfavorable (5.53e-4)"	"unprognostic (8.07e-2)"	"unprognostic (1.23e-1)"	17.1	20.5	6.2	18.3	8.0	22.8	10.4	5.7	7.6	7.9	3.9	7.0	6.6	7.6	1.8	5.3	7.3	8.5	11.2	6.1	9.8	4.7	4.0	30.2	24.6	10.6	15.4	7.8	6.3	8.9	1.6	20.1	17.2	6.0	6.2	1.0	4.5	2.6	3.9	6.5	10.7	11.8	7.1	23.7	5.9	2.0	7.3	15.7	6.2	5.5	16.2	10.7	7.2	8.0	0.3	1.6	0.0	0.0	25.6	78.8	4.9	8.3	9.4	9.1	8.9	0.3	0.3	9.6	2.2	108.4	7.8	0.2	0.2	0.0	5.1	43.0	0.7	10.7	0.0	26.1	30.0	14.8	89.0	35.2	0.0	54.0	0.7	4.1	3.8	12.9	37.2	26.0	43.4	0.5	19.1	20.5	0.1	0.1	0.2	11.3	0.3	4.3	40.6	1.1	1.2	0.1	0.0	0.0	94.7	41.0	0.0	12.7	84.9	0.2	0.3	0.3	1.1	0.1	0.3	5.1	8.2	21.6	12.6	60.8	26.6	35.8	63.4	52.8	55.5	19.2	46.0	59.3	58.7	20.3	25.7	44.8	6.8	63.2	49.4	51.3	49.9	43.1	6.2	8.0	5.7	7.6	6.1	9.8	10.6	15.4	17.2	7.1	7.3	8.0	15.8	0.0	5.3	1.0	11.1	2.8	0.1	0.0	0.0	0.6	0.5	0.4	1.1	1.5	0.6	0.0	0.0	2.2	29.3	0.0	0.0	0.2	0.3	0.4	0.1	12.3	0.0	6.7	3.3	3.6	2.3	11.0	1.1	0.1	50.0	16.7	8.9	0.4	50.6	0.0	2.6	0.0	0.0	19.5	18.2	0.0	1.8	28.7	28.4	4.7	39.4	0.3	49.4	0.5	0.5	4.7	0.1	4.5	15.1	0.0	0.0	0.1	0.8	0.6	26.3	7.9	23.6	1.3	5.9	0.4	1.7	16.1	26.8	2.8	0.0	0.1
TRPV3	VRL3	ENSG00000167723	"Transient receptor potential cation channel subfamily V member 3"	Q8NET8	17	3510502-3557812	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Ion channel"	"Disease variant, FDA approved drug targets, Palmoplantar keratoderma"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.2;skin 1: 4.8"	"Cell type enhanced"	"Detected in many"		"Basal keratinocytes: 18.7;Plasma cells: 15.9;Proximal enterocytes: 26.1;Suprabasal keratinocytes: 24.6"	"Cancer enhanced"	"Detected in some"		"head and neck cancer: 1.6"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A-431: 3.3;BEWO: 5.0;CACO-2: 3.1;RH-30: 11.9;T-47d: 5.2;U-266/70: 3.1;U-266/84: 2.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			HPA069550			Approved	"Plasma membrane,Centrosome,Cytosol"		NA	NA				"Cluster 31: Skin - Epidermis development"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 45: Enterocytes - Digestion"	"Plasma membrane"	"Centrosome, Cytosol"	"HPA069550: AB_2686149"	"unprognostic (1.84e-4)"	"unprognostic (2.25e-1)"	"unprognostic (5.22e-2)"	"unprognostic (3.92e-4)"	"unprognostic (4.87e-3)"	"unprognostic (2.96e-2)"	"unprognostic (6.66e-2)"	"unprognostic (4.88e-2)"	"unprognostic (7.02e-2)"	"unprognostic (2.68e-1)"	"unprognostic (4.88e-2)"	"unprognostic (3.69e-2)"	"unprognostic (0.00e+0)"	"unprognostic (1.12e-1)"	"unprognostic (1.77e-1)"	"unprognostic (8.64e-2)"	"unprognostic (2.93e-2)"	0.1	0.0	1.1	0.5	1.1	0.5	0.2	0.1	1.1	0.3	0.0	0.9	2.0	0.0	0.1	0.2	0.0	0.1	0.0	0.6	0.3	0.0	0.6	0.1	0.3	0.4	0.3	0.2	0.0	0.1	0.3	0.2	0.4	0.1	1.7	0.2	0.1	0.0	1.5	4.8	5.2	0.1	0.1	0.2	0.9	0.4	0.9	0.0	0.0	0.5	0.5	0.2	0.3	1.8	3.3	0.0	0.3	0.0	0.2	0.3	5.0	0.1	0.0	0.0	0.0	3.1	0.8	0.1	1.0	0.1	0.1	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.2	0.4	0.0	0.1	0.5	0.2	0.0	0.6	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.1	0.1	0.1	0.2	0.4	0.1	11.9	0.1	0.0	0.1	0.0	0.0	0.1	0.5	0.0	0.0	5.2	0.1	0.0	0.0	0.1	0.1	0.0	3.1	2.7	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	1.1	1.1	0.1	1.1	0.6	0.3	0.4	0.3	0.4	0.1	0.9	1.8	0.2	0.0	2.5	2.9	5.8	18.7	3.9	0.2	10.2	1.2	0.9	0.5	3.5	1.5	0.2	0.0	0.0	0.3	2.6	8.9	1.9	0.0	0.3	0.7	0.9	1.6	0.0	0.0	1.6	0.0	0.9	3.7	6.1	0.9	0.0	1.1	0.0	0.3	0.3	5.0	0.6	2.7	0.0	0.0	3.8	0.4	3.1	0.8	7.2	0.0	0.1	2.2	3.1	0.5	2.3	1.2	2.5	3.4	15.9	5.9	26.1	2.3	0.2	1.0	0.0	6.9	1.8	0.0	1.5	2.9	24.6	0.5	1.8	2.8	0.9	3.7
TRPV5	"CaT2, ECAC1"	ENSG00000127412	"Transient receptor potential cation channel subfamily V member 5"	Q9NQA5	7	142908101-142933746	"Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	4	"brain: 1.1;kidney: 4.4"	"Cell type enriched"	"Detected in some"	8	"Oligodendrocytes: 15.1"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Low region specificity"	"Detected in some"			HPA063175	Uncertain					NA	NA				"Cluster 7: Kidney - Transmembrane transport"		"Cluster 42: Oligodendrocytes - Myelin sheath organization"			"HPA063175: AB_2684954"	"unprognostic (7.44e-2)"	"unprognostic (3.93e-2)"		"unprognostic (1.22e-2)"	"unprognostic (4.20e-2)"	"unprognostic (1.98e-1)"		"unprognostic (3.26e-1)"	"unprognostic (3.05e-1)"	"unprognostic (2.78e-2)"	"unprognostic (1.07e-1)"	"unprognostic (7.95e-2)"	"unprognostic (7.73e-4)"	"unprognostic (4.87e-2)"	"unprognostic (3.41e-1)"	"unprognostic (4.58e-1)"	"unprognostic (7.76e-3)"	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.5	1.1	0.0	0.6	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	4.4	0.0	0.0	0.0	0.6	0.6	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.6	0.5	1.1	0.5	0.5	0.6	0.6	0.6	0.5	0.7	0.7	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	1.8	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	15.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0
TRPV6	"CaT1, ECAC2"	ENSG00000165125	"Transient receptor potential cation channel subfamily V member 6"	Q9H1D0	7	142871208-142885745	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters, Voltage-gated ion channels"	"Calcium transport, Ion transport, Transport"	"Calcium channel, Calmodulin-binding, Ion channel"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"pancreas: 38.3;prostate: 23.5;salivary gland: 69.3"	"Cell type enhanced"	"Detected in many"		"Cholangiocytes: 18.6;Collecting duct cells: 27.6;Cytotrophoblasts: 17.0;Ductal cells: 80.1;Early spermatids: 25.9;Late spermatids: 37.3"	"Cancer enriched"	"Detected in many"	5	"prostate cancer: 16.1"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"BEWO: 9.6;HaCaT: 18.0;RT4: 30.7;SK-BR-3: 23.5;T-47d: 52.8"	"Low region specificity"	"Detected in single"							HPA062864	Approved					NA	NA				"Cluster 24: Salivary gland - Salivary secretion"	"Cluster 6: T47d - Mammary gland"	"Cluster 1: Pancreatic cells - Digestion"			"HPA062864: AB_2684885"	"unprognostic (9.85e-2)"	"unprognostic (1.60e-2)"	"unprognostic (6.29e-2)"	"unprognostic (8.72e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.11e-2)"	"unprognostic (5.43e-2)"	"unprognostic (3.50e-1)"	"unprognostic (4.56e-2)"	"unprognostic (3.89e-2)"	"unprognostic (3.27e-2)"	"unprognostic (8.49e-2)"	"unprognostic (9.39e-3)"	"unprognostic (1.69e-1)"	"unprognostic (7.17e-3)"	"unprognostic (3.53e-2)"	0.0	0.0	0.5	0.0	0.6	0.1	4.2	0.6	1.1	0.5	0.6	0.1	8.1	0.1	0.3	2.7	0.2	8.2	0.1	0.5	0.6	5.2	0.9	0.2	0.0	0.6	0.6	0.0	38.3	1.5	0.5	11.9	0.8	23.5	0.0	0.0	69.3	1.6	0.0	6.4	2.2	0.0	0.6	0.0	4.5	1.2	0.6	0.0	1.8	0.0	0.2	0.4	1.4	0.6	0.0	0.0	0.0	0.0	0.0	0.0	9.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	30.7	1.9	0.1	0.0	23.5	0.6	0.9	52.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.6	0.6	1.1	0.5	0.6	0.6	0.6	0.8	0.6	0.6	0.6	0.0	3.2	0.0	0.0	0.0	0.5	1.1	0.2	5.2	0.6	2.4	2.0	1.9	18.6	1.4	27.6	0.0	17.0	0.1	0.1	0.0	80.1	25.9	0.7	0.2	0.2	0.0	0.0	0.1	3.3	0.8	0.2	3.6	1.6	0.0	0.0	0.4	0.0	1.6	3.3	0.1	0.3	0.0	0.0	0.0	37.3	0.9	0.2	0.0	0.0	2.0	0.7	0.0	0.0	6.8	8.9	0.1	0.0	0.0	10.6	0.1	0.3	0.7	0.2	0.0	1.0	0.3	0.3	0.4	4.3	1.8	6.0	0.0	0.0	0.2	3.1
TSPAN12	"NET-2, TM4SF12"	ENSG00000106025	"Tetraspanin 12"	O95859	7	120787320-120858402	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Angiogenesis		"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"kidney: 91.6"	"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 118.6;Collecting duct cells: 103.0;Distal tubular cells: 189.8;Glandular and luminal cells: 87.5;Proximal tubular cells: 111.1"	"Cancer enhanced"	"Detected in all"		"renal cancer: 44.6"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HEK 293: 53.0;HUVEC TERT2: 58.3;RH-30: 52.2;RPTEC TERT1: 90.5;RT4: 65.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA051570, HPA058244"	Uncertain		Approved	Vesicles,Microtubules		NA	NA				"Cluster 87: Intestine & Kidney - Transmembrane transport"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 44: Endometrium - Transcription"	Microtubules	Vesicles	"HPA051570: , HPA058244: AB_2683652"	"unprognostic (2.40e-2)"	"unprognostic (7.60e-2)"	"unprognostic (3.66e-3)"	"unprognostic (1.82e-2)"	"unprognostic (3.97e-1)"	"unprognostic (7.34e-3)"	"unprognostic (1.60e-1)"	"unprognostic (8.12e-2)"	"unprognostic (1.23e-1)"	"unprognostic (2.73e-1)"	"unprognostic (1.63e-2)"	"unprognostic (1.05e-1)"	"unprognostic (9.53e-2)"	"unprognostic (7.07e-2)"	"unprognostic (1.51e-1)"	"unprognostic (5.18e-2)"	"unprognostic (1.43e-1)"	11.9	65.9	4.1	5.3	4.4	0.4	8.7	5.2	5.2	21.4	2.8	24.0	39.4	10.5	14.9	5.0	10.9	20.4	47.7	3.3	4.7	91.6	35.8	45.8	4.5	8.0	6.2	1.7	17.4	10.7	7.5	20.3	5.2	6.8	20.4	1.8	46.8	22.4	3.3	1.6	42.0	11.9	4.6	28.2	22.1	3.9	8.1	2.7	23.4	5.5	4.3	17.5	4.0	3.6	0.0	1.4	15.1	0.2	3.1	1.0	14.7	0.3	0.6	1.2	5.0	2.5	4.0	0.0	10.4	0.4	1.8	0.2	7.7	1.6	1.9	0.0	53.0	2.8	14.5	2.2	8.1	0.1	2.5	0.3	0.0	0.4	0.3	2.1	58.3	0.0	0.7	1.8	6.8	2.0	0.2	0.4	24.5	11.1	9.4	0.1	52.2	2.0	90.5	65.4	12.5	7.4	0.7	1.3	0.0	20.0	8.0	1.9	2.5	12.3	3.8	0.1	6.5	15.8	0.0	0.2	1.7	0.0	5.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	4.1	4.4	5.2	5.2	3.3	4.7	8.0	6.2	5.2	4.6	8.1	3.6	40.0	118.6	45.0	18.6	1.7	2.5	20.3	1.8	14.8	0.0	19.4	3.8	62.5	64.3	19.9	103.0	0.0	40.5	0.0	18.0	189.8	6.8	0.6	63.4	9.0	38.0	9.6	2.7	1.8	7.2	53.5	10.0	14.8	87.5	2.5	1.8	18.2	32.9	4.1	0.0	2.9	16.9	6.1	0.8	3.6	1.5	4.1	1.5	5.4	3.7	0.0	0.5	0.0	10.1	0.4	4.7	30.5	0.7	2.2	9.1	68.3	111.1	5.7	0.1	0.0	11.6	16.6	0.6	8.9	13.8	2.0	24.2	1.9	9.6	35.5	28.3
TSPAN14	"DC-TM4F2, MGC11352, TM4SF14"	ENSG00000108219	"Tetraspanin 14"	Q8NG11	10	80454166-80533124	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Hepatic stellate cells: 156.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"TIME: 276.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014773, HPA057174"	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 19: Monocytes & Neutrophils - Innate immune response"	Vesicles		"HPA014773: AB_2208670, HPA057174: "	"unprognostic (7.52e-2)"	"prognostic favorable (3.56e-4)"	"unprognostic (6.55e-3)"	"unprognostic (1.56e-1)"	"unprognostic (4.40e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.11e-2)"	"unprognostic (8.90e-2)"	"unprognostic (5.21e-2)"	"unprognostic (3.13e-1)"	"unprognostic (5.15e-3)"	"unprognostic (4.12e-3)"	"prognostic favorable (4.20e-4)"	"unprognostic (2.52e-2)"	"unprognostic (1.53e-1)"	"unprognostic (2.99e-1)"	"unprognostic (2.57e-3)"	97.9	20.7	29.1	43.1	24.2	57.2	80.1	25.1	29.7	63.1	19.4	33.4	30.9	38.4	44.1	92.1	47.1	32.9	51.2	26.2	21.4	45.7	21.1	70.8	54.2	31.7	32.2	47.2	33.1	35.7	15.7	81.9	29.7	34.8	27.1	7.9	47.7	34.1	24.9	74.3	34.8	33.3	31.2	48.5	24.7	23.2	32.8	40.1	46.5	42.1	44.6	55.0	56.1	31.4	96.2	135.6	128.3	44.5	186.6	59.3	59.6	49.3	91.8	51.1	38.0	134.8	54.6	31.5	93.2	26.4	18.9	97.0	35.9	88.5	41.4	55.9	13.9	88.9	15.8	118.2	63.5	31.8	20.3	58.8	77.2	52.8	92.1	94.8	191.5	31.8	48.8	23.0	15.0	83.3	50.0	23.3	29.5	61.2	0.1	167.9	14.9	5.3	203.9	131.9	27.5	42.3	19.7	133.7	149.5	43.7	54.1	79.8	276.3	13.0	52.8	12.4	35.1	10.7	42.0	11.8	42.2	65.4	57.5	16.2	51.5	56.3	92.1	102.1	41.3	13.8	70.7	81.1	33.9	13.7	82.3	79.3	54.7	95.2	172.8	13.6	61.8	84.3	29.1	24.2	25.1	29.7	26.2	21.4	31.7	32.2	29.7	31.2	32.8	31.4	141.9	16.0	55.1	13.1	18.5	34.9	40.3	54.6	35.3	2.1	29.5	23.2	11.3	25.8	39.0	33.1	77.2	7.8	38.4	32.8	7.9	43.8	2.4	44.7	38.9	95.3	64.2	35.6	12.9	24.8	74.4	18.8	18.3	75.1	7.6	41.2	156.7	21.1	50.5	3.3	7.4	37.0	34.6	129.3	12.9	4.1	39.1	66.5	14.2	35.6	51.8	23.7	89.6	4.5	13.5	64.2	21.6	41.0	18.4	55.7	23.4	8.0	29.6	7.1	98.6	10.2	43.1	5.0	19.0	80.2	36.4	7.7	55.7	10.4	30.6	69.7
TSPAN15	"NET-7, TM4SF15"	ENSG00000099282	"Tetraspanin 15"	O95858	10	69451465-69507666	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 125.8;Ductal cells: 125.2;Exocrine glandular cells: 189.3;Pancreatic endocrine cells: 193.4;Paneth cells: 120.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	6	"MAIT T-cell: 19.5"	"Lineage enriched"	"Detected in many"	6	"T-cells: 19.5"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 154.7;EFO-21: 211.3;MCF7: 168.0;OE19: 153.2;PC-3: 266.8;SK-BR-3: 134.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044657, HPA071160"	Approved		Approved	"Nuclear bodies,Vesicles,Plasma membrane,Cytosol"		NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 57: Non-specific - Angiogenesis"	"Cluster 38: EFO-21 - Unknown function"	"Cluster 1: Pancreatic cells - Digestion"	"Nuclear bodies, Plasma membrane"	"Vesicles, Cytosol"	"HPA044657: AB_10967927, HPA071160: "	"unprognostic (2.03e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.43e-1)"	"unprognostic (1.48e-2)"	"unprognostic (9.44e-3)"	"unprognostic (6.81e-3)"	"prognostic unfavorable (8.00e-4)"	"unprognostic (2.23e-1)"	"unprognostic (3.65e-1)"	"unprognostic (2.76e-1)"	"unprognostic (8.22e-3)"	"unprognostic (2.36e-2)"	"prognostic unfavorable (1.25e-4)"	"unprognostic (8.49e-2)"	"unprognostic (4.66e-2)"	"unprognostic (6.34e-2)"	"unprognostic (3.78e-3)"	70.1	5.3	22.8	15.3	37.6	1.0	61.0	35.0	34.1	16.4	14.9	62.5	38.8	32.6	8.5	10.8	24.6	27.4	16.9	23.6	25.4	25.9	4.6	34.4	8.7	36.9	33.4	3.4	20.0	3.2	6.6	28.1	33.7	34.5	39.4	3.1	26.6	24.7	17.9	10.6	38.8	31.3	30.0	26.7	75.3	9.5	34.5	3.6	14.5	5.6	7.5	46.0	14.9	62.4	51.3	103.9	2.1	0.3	2.3	0.0	12.0	0.2	1.9	2.6	6.8	45.1	154.7	0.0	211.3	2.3	9.2	101.2	7.2	11.5	3.0	42.1	20.4	2.9	3.5	10.0	1.1	0.1	1.8	2.2	3.1	1.4	1.5	7.5	39.4	20.5	1.1	0.0	1.2	168.0	0.6	0.9	2.6	153.2	266.8	4.0	2.1	2.0	29.7	92.9	34.5	13.2	0.6	134.8	17.9	17.3	59.3	2.2	34.5	0.2	0.8	0.1	17.5	1.2	6.1	1.0	1.1	0.1	0.2	0.0	0.0	0.0	2.3	0.0	19.5	0.0	3.1	2.8	3.3	0.0	1.0	0.2	0.0	0.1	0.0	0.2	1.1	0.5	22.8	37.6	35.0	34.1	23.6	25.4	36.9	33.4	33.7	30.0	34.5	62.4	108.8	32.1	6.9	4.9	1.5	3.6	10.9	59.6	2.2	2.9	45.1	15.6	1.7	31.5	29.5	29.5	6.2	2.0	1.6	125.8	3.9	125.2	27.9	25.5	3.8	48.4	40.2	8.0	1.7	189.3	11.9	8.2	71.4	36.6	1.3	2.5	10.4	0.1	25.3	1.7	1.0	106.7	36.7	8.5	16.1	6.6	0.6	9.8	28.4	15.0	15.6	44.7	0.0	11.1	75.3	193.4	120.9	0.0	0.2	50.4	68.3	1.8	27.6	1.5	13.1	39.7	26.8	4.3	18.5	2.9	3.1	3.0	3.9	7.5	66.3	29.6
TSPAN18	TSPAN	ENSG00000157570	"Tetraspanin 18"	Q96SJ8	11	44726465-44932423	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"heart muscle: 83.5"	"Group enriched"	"Detected in many"	6	"Adipocytes: 72.2;Cardiomyocytes: 22.3;Early spermatids: 29.7;Endothelial cells: 51.8;Hepatic stellate cells: 70.3;Proximal tubular cells: 20.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in some"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"AF22: 36.7;CAPAN-2: 61.5;GAMG: 35.2;HDLM-2: 48.7;NTERA-2: 33.0;RH-30: 38.4;SCLC-21H: 31.9;SH-SY5Y: 36.2;SuSa: 99.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 12: NES - Nervous system development"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (1.09e-1)"	"unprognostic (1.97e-1)"	"unprognostic (8.53e-3)"	"unprognostic (3.48e-2)"	"unprognostic (6.30e-2)"	"unprognostic (8.64e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.91e-2)"	"unprognostic (8.75e-2)"	"unprognostic (1.07e-1)"	"unprognostic (1.19e-1)"	"unprognostic (2.29e-1)"	"unprognostic (1.04e-3)"	"unprognostic (6.78e-3)"	"unprognostic (3.22e-1)"	"unprognostic (2.19e-1)"	"unprognostic (5.59e-2)"	22.2	46.1	5.8	10.4	4.3	1.2	10.0	30.5	8.2	14.4	3.6	47.9	6.7	46.7	3.6	21.0	20.8	13.3	83.5	26.1	4.6	14.5	4.9	22.4	7.7	5.1	10.4	7.4	1.6	3.9	5.4	30.2	4.9	15.8	9.9	1.0	3.3	41.4	14.7	6.3	16.4	46.6	8.9	14.1	16.6	4.0	10.8	4.0	14.8	19.9	4.2	23.1	10.2	2.3	0.0	0.6	36.7	0.5	0.0	0.0	0.0	0.6	0.5	2.3	0.1	7.3	61.5	0.0	16.4	1.0	35.2	0.0	6.6	0.2	0.6	48.7	2.4	0.2	5.0	0.0	0.0	0.2	0.1	0.7	0.0	0.1	0.0	0.0	14.3	0.2	1.1	0.0	0.1	0.0	0.0	0.1	33.0	0.1	1.0	0.1	38.4	0.2	0.0	0.0	31.9	36.2	0.4	0.1	0.1	99.8	0.2	0.1	1.4	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	1.6	1.0	0.0	0.0	1.6	0.1	0.0	0.8	0.2	1.1	0.5	0.0	0.0	1.3	0.2	0.3	0.5	0.0	0.0	0.3	1.7	5.8	4.3	30.5	8.2	26.1	4.6	5.1	10.4	4.9	8.9	10.8	2.3	72.2	0.0	3.7	5.5	1.5	1.7	0.1	0.0	0.6	1.8	1.0	0.3	22.3	0.0	0.0	7.3	0.0	0.1	1.1	0.0	0.0	0.4	29.7	0.7	0.9	51.8	0.0	3.6	2.7	0.2	0.2	6.8	0.5	1.4	1.3	0.0	70.3	1.0	0.4	1.7	4.1	0.0	0.0	2.5	2.6	5.6	2.8	3.4	7.2	2.8	0.2	0.1	0.0	4.0	1.3	0.7	0.0	1.5	0.6	0.2	0.0	20.2	0.0	0.5	0.0	4.9	2.0	0.6	1.0	0.0	1.1	0.3	3.0	3.2	0.0	0.1
TSPAN3	"TM4-A, TM4SF8, TSPAN-3"	ENSG00000140391	"Tetraspanin 3"	O60637	15	77041404-77083984	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Distal enterocytes: 705.9;Muller glia cells: 508.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	4	"memory B-cell: 481.0;naive B-cell: 488.1;plasmacytoid DC: 313.2"	"Group enriched"	"Detected in all"	5	"B-cells: 488.1;dendritic cells: 313.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA015996	Uncertain		Approved	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 37: B-cells - Transcription"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 53: Intestinal epithelial cells - Unknown function"	"Nucleoplasm, Golgi apparatus"		"HPA015996: AB_1858406"	"unprognostic (5.94e-2)"	"unprognostic (3.05e-1)"	"unprognostic (7.32e-2)"	"unprognostic (2.15e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.92e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.09e-1)"	"unprognostic (5.41e-3)"	"unprognostic (3.51e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.11e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.75e-1)"	"unprognostic (3.79e-3)"	"unprognostic (1.35e-1)"	333.8	143.9	257.2	87.3	248.9	33.3	143.3	253.4	292.4	138.2	288.7	364.2	342.1	130.9	432.8	78.4	249.8	186.2	108.8	247.8	296.3	211.3	87.4	202.1	88.0	250.0	267.7	148.1	140.2	283.4	189.7	111.6	260.2	96.2	386.3	418.6	152.2	187.3	429.1	78.3	349.2	128.3	266.7	84.8	221.2	84.8	282.5	71.6	200.3	374.4	106.9	170.1	67.4	281.3	130.6	347.6	282.8	179.3	484.7	295.8	93.3	203.7	220.2	245.1	265.7	213.5	264.7	126.9	294.8	211.6	234.0	289.0	271.2	139.5	182.9	143.4	410.4	91.0	252.5	204.4	234.5	118.4	64.3	280.9	165.5	135.8	120.1	372.6	304.8	83.1	98.0	109.2	243.3	49.5	105.7	112.1	200.5	414.7	152.4	130.8	351.0	135.3	408.0	73.0	255.0	282.1	139.8	116.9	393.7	269.3	125.0	220.8	292.1	225.7	88.4	138.0	290.7	237.4	346.6	67.1	200.1	173.5	131.9	8.8	51.3	10.4	32.6	69.6	34.1	481.0	16.5	23.9	99.2	488.1	42.6	39.3	4.8	60.3	77.1	313.2	4.6	95.2	257.2	248.9	253.4	292.4	247.8	296.3	250.0	267.7	260.2	266.7	282.5	281.3	76.1	112.2	213.4	69.5	83.8	34.7	77.5	114.6	36.5	247.7	43.6	32.3	98.2	108.7	169.0	68.0	183.5	89.9	41.3	705.9	25.4	250.2	28.5	86.1	63.4	57.6	91.3	19.4	47.8	354.0	35.6	90.8	85.1	41.7	23.4	88.6	53.6	29.5	65.4	127.9	54.3	290.4	97.6	58.0	27.5	57.9	64.3	38.2	72.9	29.0	35.1	508.9	36.0	116.6	32.7	245.1	410.7	51.6	81.2	220.1	364.3	65.5	201.7	185.1	26.3	44.8	189.0	108.0	64.6	34.2	34.2	75.9	19.4	149.5	205.2	381.4
TSPAN33	"MGC50844, Penumbra"	ENSG00000158457	"Tetraspanin 33"	Q86UF1	7	129144707-129169699	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"kidney: 64.8"	"Cell type enhanced"	"Detected in many"		"B-cells: 27.8;Langerhans cells: 84.0;Macrophages: 32.0;monocytes: 44.8;Peritubular cells: 32.7;Proximal tubular cells: 59.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in some"		"memory B-cell: 1.1;naive B-cell: 1.3"	"Low lineage specificity"	"Detected in single"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 23.2;HEL: 38.2;U-266/70: 48.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA020357	Enhanced		Approved	Microtubules		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 7: Kidney - Transmembrane transport"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 41: Macrophages - Immune response"	Microtubules		"HPA020357: AB_1858410"	"unprognostic (3.95e-2)"	"unprognostic (1.27e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-2)"	"unprognostic (5.62e-2)"	"unprognostic (2.29e-2)"	"unprognostic (2.29e-1)"	"unprognostic (3.57e-1)"	"unprognostic (2.66e-1)"	"prognostic favorable (8.88e-4)"	"unprognostic (1.67e-1)"	"prognostic favorable (8.74e-5)"	"unprognostic (2.50e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.55e-2)"	"unprognostic (1.16e-2)"	3.2	4.4	8.2	9.1	8.0	3.9	3.0	6.9	7.2	2.0	5.4	6.4	3.6	1.5	10.9	3.9	2.1	3.1	8.6	6.8	11.9	64.8	28.2	5.0	16.3	10.8	13.4	2.4	21.2	11.1	19.9	3.8	12.2	7.4	3.4	1.3	18.8	7.0	13.0	7.6	12.3	2.2	11.0	16.9	6.2	11.4	14.1	6.7	8.4	4.4	14.4	7.9	3.8	10.0	1.5	4.3	1.0	23.2	0.0	0.0	0.9	0.0	0.2	0.5	0.1	0.7	2.1	18.4	1.8	0.4	12.9	1.7	12.3	4.0	0.5	18.7	14.0	38.2	0.8	8.2	0.9	5.5	0.8	0.9	3.8	0.2	1.2	0.0	0.5	9.4	0.4	2.6	0.0	4.6	11.5	0.1	8.5	0.8	4.5	3.9	0.5	0.4	1.4	5.0	5.8	6.9	2.3	0.7	13.6	5.3	4.7	2.4	0.1	0.1	1.8	1.9	0.6	48.8	5.8	8.1	0.4	18.4	2.7	0.0	0.3	0.0	0.0	0.7	0.0	1.1	0.0	0.0	0.6	1.3	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.4	8.2	8.0	6.9	7.2	6.8	11.9	10.8	13.4	12.2	11.0	14.1	10.0	0.9	0.0	0.6	3.3	27.8	2.5	0.7	0.8	0.6	3.5	10.5	9.8	6.2	0.0	0.2	5.5	4.2	0.1	7.6	0.7	13.7	2.2	2.5	2.7	0.5	1.4	3.5	5.2	3.6	8.7	0.2	6.7	0.0	1.6	0.0	1.4	0.4	15.8	8.4	0.0	1.7	0.6	0.0	23.6	84.0	4.2	2.8	32.0	1.8	3.7	44.8	8.4	0.0	3.5	0.1	2.4	1.1	32.7	1.3	1.9	1.0	59.2	2.2	1.7	0.0	11.3	1.0	0.8	4.1	0.4	3.0	0.1	2.2	8.4	0.4	1.3
TSPAN7	"A15, CD231, DXS1692E, MRX58, MXS1, TALLA-1, TM4SF2"	ENSG00000156298	"Tetraspanin 7"	P41732	X	38561542-38688920	"CD markers, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Host-virus interaction"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 542.1"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 274.9;Excitatory neurons: 215.6;Hepatic stellate cells: 407.3;Inhibitory neurons: 249.8;Oligodendrocyte precursor cells: 353.4"	"Cancer enhanced"	"Detected in all"		"glioma: 71.5"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"HDLM-2: 109.5;JURKAT: 380.9;MOLT-4: 239.7;SCLC-21H: 129.0;U-266/70: 163.2"	"Low region specificity"	"Detected in all"							"HPA003140, CAB062566, CAB068245"	Enhanced					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 58: Brain - Synaptic function"	"Cluster 22: JURKAT & MOLT-4 - Adaptive immune response"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"			"CAB062566: AB_2665608, CAB068245: AB_2665609, HPA003140: AB_1078454"	"unprognostic (1.12e-2)"	"unprognostic (1.42e-2)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (3.40e-4)"	"unprognostic (5.06e-2)"	"unprognostic (3.90e-3)"	"unprognostic (3.88e-3)"	"unprognostic (1.37e-2)"	"unprognostic (1.14e-1)"	"unprognostic (2.01e-2)"	"prognostic favorable (1.70e-4)"	"unprognostic (1.54e-1)"	"prognostic favorable (5.48e-7)"	"unprognostic (5.65e-3)"	"unprognostic (9.53e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.03e-3)"	56.1	125.6	355.5	17.2	433.8	1.3	33.5	369.5	542.1	42.6	271.3	68.1	36.3	43.8	37.6	33.6	36.5	25.8	70.3	413.7	334.3	56.2	45.0	67.4	41.1	290.3	298.8	19.6	19.8	13.9	28.0	25.1	283.6	18.8	64.6	286.9	12.5	26.8	153.9	19.4	34.0	51.1	291.7	96.3	14.5	4.8	331.7	15.7	51.3	232.3	28.9	29.7	16.9	384.6	0.1	0.0	2.9	0.0	0.4	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.1	0.0	0.0	0.0	3.8	1.6	0.0	109.5	14.9	0.5	0.0	67.2	0.0	0.1	1.2	1.5	0.0	0.0	0.0	0.0	0.0	380.9	0.0	0.4	1.7	0.4	239.7	0.0	11.2	0.1	0.0	14.6	4.6	0.0	11.0	1.4	129.0	14.4	0.0	0.0	4.3	6.5	0.0	0.3	0.0	0.1	3.1	0.1	1.0	163.2	54.8	0.0	5.4	0.4	2.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.0	0.0	0.0	355.5	433.8	369.5	542.1	413.7	334.3	290.3	298.8	283.6	291.7	331.7	384.6	116.1	12.8	23.8	274.9	1.1	10.6	2.7	6.3	6.2	92.0	1.0	3.8	34.1	1.5	4.6	11.0	43.8	0.4	0.2	69.1	23.5	0.4	0.0	2.1	1.6	153.3	18.7	5.3	215.6	0.6	0.4	14.0	4.6	5.6	10.1	108.1	407.3	4.8	45.1	97.6	249.8	23.5	0.0	15.0	10.0	1.9	0.6	1.5	14.2	46.9	0.0	102.3	0.0	353.4	50.6	0.9	21.9	3.0	1.5	2.4	40.3	9.8	1.2	107.4	59.2	26.5	11.7	0.6	3.3	9.9	6.5	0.8	2.6	27.0	35.7	0.9
TSPAN9	NET-5	ENSG00000011105	"Tetraspanin 9"	O75954	12	3077355-3286564	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"heart muscle: 128.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 68.7;Extravillous trophoblasts: 105.1;Syncytiotrophoblasts: 80.7"	"Low cancer specificity"	"Detected in all"			"Region enriched"	"Detected in all"	6	"cerebellum: 96.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"RH-30: 213.0"	"Low region specificity"	"Detected in all"			"Region enriched"	"Detected in all"	5	"cerebellum: 58.1"	HPA014002	Uncertain		Approved	"Nucleoplasm,Golgi apparatus,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 46: Fibroblasts - ECM organization"	"Cluster 31: RH-30 & LHCN-M2 - Muscle contraction"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Nucleoplasm, Golgi apparatus"	Cytosol	"HPA014002: AB_2304038"	"unprognostic (1.19e-1)"	"unprognostic (1.89e-1)"	"unprognostic (1.40e-2)"	"unprognostic (1.41e-2)"	"unprognostic (1.08e-2)"	"unprognostic (3.53e-2)"	"unprognostic (3.11e-2)"	"unprognostic (7.30e-2)"	"prognostic unfavorable (4.67e-4)"	"unprognostic (1.08e-2)"	"unprognostic (2.88e-2)"	"unprognostic (1.26e-2)"	"unprognostic (1.89e-1)"	"unprognostic (6.70e-2)"	"unprognostic (1.57e-1)"	"unprognostic (2.68e-2)"	"unprognostic (1.04e-2)"	25.4	12.9	11.0	7.1	12.1	0.6	25.0	96.6	13.5	29.6	9.7	18.0	7.9	32.3	11.5	15.4	23.2	35.2	128.8	6.9	12.6	45.8	54.8	35.8	5.4	12.3	13.0	35.3	13.1	28.1	8.6	58.7	14.5	27.6	6.2	14.8	18.0	24.4	16.8	27.9	12.3	23.6	8.6	20.6	13.4	5.1	17.1	19.1	18.4	12.4	7.1	18.4	22.3	7.6	1.5	12.7	20.1	16.1	19.2	15.5	48.3	26.7	82.3	20.1	26.1	30.6	11.6	0.8	23.9	14.6	19.7	3.1	9.5	9.6	11.8	5.0	9.3	36.3	8.5	20.6	42.2	0.2	3.0	17.7	7.4	40.4	16.9	50.4	55.7	1.1	1.0	1.1	17.6	16.7	0.0	0.8	25.5	7.8	7.4	9.9	213.0	3.1	61.7	7.4	36.8	22.6	18.8	36.6	16.4	45.9	13.7	0.2	27.2	8.5	28.8	14.8	25.7	0.2	0.6	0.3	20.3	0.5	10.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	1.2	11.0	12.1	96.6	13.5	6.9	12.6	12.3	13.0	14.5	8.6	17.1	7.6	60.1	0.0	4.1	10.4	0.8	19.2	13.3	22.4	13.1	68.7	19.8	9.0	50.1	11.5	6.5	12.9	2.1	53.1	0.2	1.7	5.9	21.1	3.0	2.3	24.9	43.1	6.0	5.3	16.8	9.1	105.1	22.2	2.0	5.7	0.0	13.0	41.0	36.7	6.2	33.7	45.5	2.3	2.0	3.2	3.5	4.1	17.4	7.1	12.4	30.9	0.8	4.0	0.0	9.0	2.0	9.9	0.6	17.3	1.4	13.8	2.4	22.4	2.5	4.7	19.7	1.4	20.9	1.3	3.4	9.7	11.9	80.7	1.5	6.4	2.5	10.5
TSPO2	"BZRPL1, dJ34B21.2"	ENSG00000112212	"Translocator protein 2"	Q5TGU0	6	41042467-41044337	"Predicted membrane proteins, Transporters"	Transport	Receptor		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	30	"bone marrow: 50.1"	"Cell type enriched"	"Detected in some"	115	"Erythroid cells: 253.9"	"Cancer enhanced"	"Detected in some"		"liver cancer: 0.8"	"Low region specificity"	"Detected in single"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	7	"OE19: 11.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA060691, HPA066996"			Enhanced	"Plasma membrane"		NA	NA				"Cluster 67: Neutrophils - Humoral immune response"	"Cluster 21: OE19 - Mitochondria"	"Cluster 6: Erythroid cells - Oxygen transport"	"Plasma membrane"		"HPA060691: , HPA066996: AB_2685761"	"unprognostic (1.89e-3)"	"unprognostic (8.35e-3)"	"unprognostic (2.57e-3)"	"unprognostic (2.29e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.66e-2)"	"unprognostic (6.61e-3)"	"unprognostic (2.29e-1)"	"unprognostic (3.37e-1)"	"unprognostic (2.89e-1)"	"unprognostic (2.71e-1)"	"unprognostic (4.92e-2)"	"unprognostic (1.86e-2)"	"unprognostic (2.70e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.37e-2)"	"unprognostic (1.76e-2)"	0.0	0.0	0.1	0.1	0.6	50.1	0.0	0.1	0.7	0.0	0.0	0.1	1.1	0.0	0.0	0.0	0.0	0.6	0.1	0.1	0.4	0.5	0.6	0.2	0.1	0.8	0.4	0.1	0.1	0.0	0.0	1.2	0.9	0.0	0.0	0.3	0.0	0.0	0.1	0.5	0.7	0.0	0.2	1.3	0.5	0.2	0.8	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.1	0.0	0.0	1.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.0	0.2	0.1	0.4	0.0	11.0	0.0	0.3	0.0	0.0	0.2	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.1	0.5	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.1	0.7	0.1	0.4	0.8	0.4	0.9	0.2	0.8	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.9	0.3	0.1	0.0	0.0	0.0	253.9	0.2	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.1	0.0	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	1.9	0.0	0.0	0.0	0.0	0.1	0.7	0.0	0.0	0.0	0.0	2.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.1	0.0	0.3	0.0
TTYH1		ENSG00000167614	"Tweety family member 1"	Q9H313	19	54415219-54436904	"Predicted membrane proteins, Transporters"	"Cell adhesion, Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 80.9;choroid plexus: 35.6;testis: 53.4"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 257.6;Bipolar cells: 138.6;Muller glia cells: 653.4;Oligodendrocytes: 97.5;Rod photoreceptor cells: 155.3"	"Cancer enriched"	"Detected in many"	15	"glioma: 63.9"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 7.9;AN3-CA: 11.7;U-2 OS: 2.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA005725, HPA023617, HPA050655"	Approved		Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 23: AN3-CA - Transcription regulation"	"Cluster 5: Muller glia cells - Visual perception"	"Nucleoplasm, Plasma membrane"		"HPA005725: , HPA023617: AB_10600836, HPA050655: AB_2681204"	"prognostic favorable (3.64e-4)"	"unprognostic (1.71e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.25e-1)"	"unprognostic (1.46e-2)"	"unprognostic (2.50e-3)"	"unprognostic (8.93e-2)"	"unprognostic (1.51e-2)"	"unprognostic (5.94e-3)"	"unprognostic (1.11e-1)"	"unprognostic (3.66e-1)"	"unprognostic (1.60e-1)"	"unprognostic (0.00e+0)"	"unprognostic (2.09e-1)"	"unprognostic (1.41e-1)"	"unprognostic (4.45e-2)"	"unprognostic (1.69e-1)"	0.9	0.9	64.3	0.0	67.9	0.0	3.5	64.0	80.9	4.0	35.6	10.0	0.2	1.6	0.0	1.1	10.4	0.2	3.6	57.6	59.7	1.2	0.7	0.2	0.0	69.4	66.5	1.5	19.4	0.0	17.7	0.0	63.5	3.5	0.0	3.2	3.6	0.4	3.3	5.9	2.6	0.0	67.6	1.4	2.5	53.4	69.3	0.0	0.3	0.0	0.0	1.7	4.2	66.8	0.1	0.0	7.9	11.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.0	0.0	0.0	0.2	0.8	0.0	0.0	0.2	0.3	0.0	0.1	0.8	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.1	0.1	1.7	0.0	0.1	0.1	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.4	0.4	0.0	0.2	0.0	0.0	0.1	2.9	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	64.3	67.9	64.0	80.9	57.6	59.7	69.4	66.5	63.5	67.6	69.3	66.8	0.4	3.2	0.6	257.6	0.4	0.8	1.2	0.6	0.0	138.6	44.3	42.2	1.3	4.3	3.0	0.0	20.9	0.9	1.3	0.2	0.0	30.4	3.9	0.3	0.9	2.8	1.2	0.0	26.4	0.6	0.7	1.5	0.0	0.7	0.0	13.7	0.7	0.1	0.3	10.1	3.3	0.0	0.0	0.0	1.5	4.8	1.8	0.3	23.2	19.7	0.3	653.4	0.0	48.2	97.5	2.2	0.0	0.7	0.1	1.9	0.4	0.7	2.8	155.3	6.6	2.3	7.8	2.2	5.1	0.0	0.9	4.2	0.6	0.5	0.3	1.9
TTYH2	C17orf29	ENSG00000141540	"Tweety family member 2"	Q9BSA4	17	74213571-74262020	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	6	"brain: 214.5"	"Cell type enhanced"	"Detected in many"		"Astrocytes: 46.0;Bipolar cells: 59.2;Langerhans cells: 52.1;Oligodendrocytes: 206.9"	"Group enriched"	"Detected in all"	6	"glioma: 16.7;melanoma: 20.3"	"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in many"	4	"classical monocyte: 13.3;intermediate monocyte: 22.3;myeloid DC: 14.6;non-classical monocyte: 28.6;plasmacytoid DC: 18.2"	"Group enriched"	"Detected in many"	5	"dendritic cells: 18.2;monocytes: 28.6"	"Cell line enhanced"	"Detected in many"		"HSkMC: 22.2;SK-MEL-30: 81.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 70: Brain - Nervous system development"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"				"unprognostic (1.19e-1)"	"unprognostic (5.08e-1)"	"unprognostic (1.58e-3)"	"unprognostic (3.51e-4)"	"unprognostic (1.59e-1)"	"unprognostic (2.44e-1)"	"unprognostic (1.67e-2)"	"unprognostic (5.90e-2)"	"unprognostic (8.71e-2)"	"unprognostic (2.85e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.87e-1)"	"prognostic unfavorable (9.74e-5)"	"unprognostic (8.98e-3)"	"unprognostic (5.70e-3)"	"unprognostic (2.50e-3)"	"unprognostic (3.51e-3)"	5.5	4.7	75.4	7.3	132.2	3.3	4.4	101.4	103.2	7.1	34.7	8.2	2.6	4.9	3.5	3.2	6.3	5.1	18.1	83.7	91.3	2.0	1.6	5.5	7.7	129.0	115.2	17.2	8.3	4.0	7.0	10.3	123.3	4.6	2.5	19.8	6.9	4.0	14.8	5.2	4.8	3.9	88.2	11.7	3.9	15.2	113.6	5.1	10.1	9.4	5.7	5.3	4.7	214.5	0.2	1.9	9.0	8.7	1.1	1.3	0.2	0.5	0.1	0.5	0.1	5.9	0.1	5.3	1.3	0.2	1.0	14.5	8.9	0.3	0.3	12.5	5.0	5.7	0.3	0.5	6.2	0.6	3.8	22.2	4.6	0.1	1.6	0.6	0.3	3.8	1.0	2.6	0.2	1.0	2.7	0.4	1.7	8.7	15.7	8.8	16.1	10.1	0.2	0.7	3.1	11.0	0.0	5.5	81.3	4.6	2.9	1.2	0.2	0.0	4.4	0.1	0.3	0.5	0.3	0.1	0.3	1.7	4.9	1.0	13.3	1.2	2.4	22.3	0.3	0.3	4.6	3.8	14.6	0.3	0.7	1.7	1.2	0.1	28.6	18.2	4.5	7.0	75.4	132.2	101.4	103.2	83.7	91.3	129.0	115.2	123.3	88.2	113.6	214.5	8.0	0.0	4.1	46.0	1.3	2.3	0.6	0.2	1.2	59.2	1.5	2.4	1.9	2.8	0.1	0.0	6.2	0.3	7.9	0.0	0.0	0.2	27.7	0.4	0.7	6.9	1.8	0.0	1.0	0.2	0.4	4.1	0.5	0.9	21.6	0.5	1.8	0.5	5.0	3.3	0.9	0.2	0.0	12.3	52.1	11.5	9.6	13.7	23.2	15.0	16.5	18.4	0.0	10.6	206.9	0.1	0.1	2.6	1.3	0.8	0.0	0.2	0.3	10.8	19.7	3.2	2.7	2.4	1.5	0.4	2.6	0.3	2.3	4.3	0.0	0.4
TTYH3	KIAA1691	ENSG00000136295	"Tweety family member 3"	Q9C0H2	7	2631986-2664802	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Chloride channel, Ion channel"		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 135.0;Kupffer cells: 85.0;Melanocytes: 56.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"intermediate monocyte: 10.0;non-classical monocyte: 8.4"	"Lineage enriched"	"Detected in many"	4	"monocytes: 10.0"	"Cell line enhanced"	"Detected in all"		"U-2 OS: 205.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053520	Uncertain					NA	NA		55000	"Cluster 7: Monocytes - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 4: Macrophages - Innate immune response"			"HPA053520: AB_2682176"	"unprognostic (2.53e-2)"	"unprognostic (6.65e-3)"	"unprognostic (3.86e-3)"	"unprognostic (1.35e-1)"	"unprognostic (5.25e-2)"	"unprognostic (7.42e-2)"	"prognostic unfavorable (2.53e-5)"	"unprognostic (5.53e-2)"	"unprognostic (1.96e-1)"	"unprognostic (8.59e-3)"	"unprognostic (5.40e-2)"	"unprognostic (2.06e-2)"	"prognostic unfavorable (2.58e-5)"	"unprognostic (7.90e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (8.85e-2)"	25.6	29.4	31.6	30.7	32.7	11.8	16.3	43.3	39.3	19.0	1.8	15.8	19.9	18.7	1.9	7.7	16.7	18.3	12.4	24.1	8.9	43.3	37.4	25.6	19.4	11.4	18.4	15.0	9.6	4.6	14.2	23.8	9.0	20.9	6.7	5.3	25.4	7.3	3.9	12.0	27.7	10.6	4.7	40.8	13.3	14.4	33.8	11.7	21.6	1.7	7.3	14.6	11.4	10.7	43.8	84.9	88.0	123.7	24.2	21.7	98.5	69.4	61.8	29.8	34.9	35.3	30.9	3.6	82.4	66.1	78.8	19.3	12.7	31.5	8.4	5.9	42.9	21.8	17.9	98.7	32.3	4.5	13.2	52.0	15.1	32.0	8.3	55.5	99.4	21.6	6.7	4.7	20.1	25.5	16.1	47.0	112.7	61.7	32.9	66.3	63.7	4.1	47.0	47.0	36.8	185.1	42.8	8.2	40.3	58.1	22.3	117.5	117.9	69.3	205.4	40.9	78.6	8.0	5.3	12.1	50.0	16.1	152.7	0.0	4.9	1.5	0.2	10.0	0.2	0.3	0.1	0.1	2.2	0.3	0.3	0.0	0.5	0.3	8.4	1.0	0.2	3.4	31.6	32.7	43.3	39.3	24.1	8.9	11.4	18.4	9.0	4.7	33.8	10.7	8.6	0.0	4.2	38.5	4.8	6.5	1.8	12.9	2.2	9.0	10.2	7.1	2.7	18.6	8.8	9.2	4.2	1.8	2.9	9.6	3.9	20.3	0.5	2.8	12.8	21.0	7.8	1.7	22.4	5.2	28.8	9.0	7.1	6.0	2.5	19.4	15.4	21.1	135.0	30.3	25.4	20.5	8.2	85.0	32.6	5.2	8.1	52.4	56.9	17.8	30.7	4.0	2.1	8.5	6.1	20.2	2.7	3.8	1.5	5.0	28.3	32.2	3.8	2.2	6.6	2.2	8.0	1.7	2.3	1.2	3.7	2.5	3.8	4.9	11.2	3.1
TUSC3	"MagT2, MGC13453, MRT22, MRT7, N33, OST3A, SLC58A2"	ENSG00000104723	"Tumor suppressor candidate 3"	Q13454	8	15417215-15766649	"Disease related genes, Human disease related genes, Metabolic proteins, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters"	Transport		"Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 472.9;Extravillous trophoblasts: 321.8;Syncytiotrophoblasts: 783.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049851, HPA049974"	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 89: Fibroblasts - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"			"HPA049851: AB_2680913, HPA049974: AB_2680976"	"unprognostic (3.31e-2)"	"unprognostic (7.17e-2)"	"unprognostic (2.94e-1)"	"unprognostic (1.42e-1)"	"unprognostic (4.46e-1)"	"unprognostic (2.34e-1)"	"unprognostic (7.15e-3)"	"unprognostic (5.02e-2)"	"unprognostic (7.39e-2)"	"unprognostic (4.79e-2)"	"unprognostic (1.59e-3)"	"unprognostic (4.81e-1)"	"unprognostic (1.60e-3)"	"unprognostic (5.99e-3)"	"unprognostic (1.17e-1)"	"prognostic favorable (7.86e-4)"	"unprognostic (1.55e-1)"	23.3	68.8	18.7	8.4	18.4	0.1	28.3	22.3	17.1	25.0	46.6	14.5	9.3	31.9	100.8	11.8	57.6	16.7	34.9	17.1	48.2	25.2	6.9	18.4	6.8	8.9	11.6	73.6	35.0	54.0	69.6	80.5	8.9	46.4	15.5	40.9	12.1	29.7	4.5	8.2	8.2	32.5	7.7	5.3	10.8	23.2	21.0	7.5	9.5	5.7	5.6	34.0	13.0	8.0	52.1	38.4	104.3	96.7	125.2	126.7	0.2	74.9	168.8	85.2	139.3	0.1	0.1	0.7	24.5	105.9	92.4	39.3	37.5	76.1	116.0	0.1	49.8	0.0	30.1	6.0	51.9	0.2	5.6	111.8	22.8	121.0	43.1	113.7	6.9	15.9	70.9	15.6	123.2	41.2	20.6	0.4	49.2	0.0	33.5	24.8	88.7	0.3	108.3	127.1	40.7	74.6	0.0	40.6	56.5	76.2	49.8	0.2	29.0	71.9	71.3	31.3	36.5	0.0	10.0	0.4	1.2	0.0	102.6	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	18.7	18.4	22.3	17.1	17.1	48.2	8.9	11.6	8.9	7.7	21.0	8.0	88.6	0.0	10.3	13.4	0.6	9.9	61.1	123.5	63.7	50.4	40.0	52.1	47.5	18.6	47.0	79.1	8.4	472.9	0.9	2.1	17.6	179.0	11.5	100.8	48.6	36.2	95.7	0.0	141.0	12.2	321.8	53.4	7.7	35.0	1.3	39.3	7.5	0.0	41.8	32.0	155.3	26.3	95.6	0.0	6.3	7.6	34.8	1.5	24.9	24.4	1.6	35.9	0.0	61.3	3.9	23.8	4.1	23.0	2.6	63.8	0.0	23.7	172.4	28.1	39.5	2.0	49.7	60.9	47.4	26.2	4.1	783.8	1.6	46.6	7.8	51.4
TYROBP	"DAP12, KARAP, PLO-SL, PLOSL"	ENSG00000011600	"Transmembrane immune signaling adaptor TYROBP"	O43914	19	35904401-35908295	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	Immunity			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 596.8;lymphoid tissue: 423.3"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 3777.1;Kupffer cells: 3698.1;Langerhans cells: 1990.8;Macrophages: 2837.1;monocytes: 3371.2;NK-cells: 1772.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"neutrophil: 6415.4"	"Low lineage specificity"	"Detected in all"			"Group enriched"	"Detected in some"	9	"HMC-1: 678.1;THP-1: 390.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB009493, HPA041899"	Enhanced		Supported	"Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 4: Macrophages - Innate immune response"	"Plasma membrane"		"CAB009493: AB_638987, HPA041899: AB_10795266"	"unprognostic (7.09e-2)"	"unprognostic (8.38e-3)"	"unprognostic (7.87e-2)"	"unprognostic (4.76e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.39e-1)"	"unprognostic (5.27e-2)"	"unprognostic (8.04e-2)"	"unprognostic (2.07e-2)"	"unprognostic (2.47e-1)"	"unprognostic (2.91e-1)"	"unprognostic (1.50e-1)"	"prognostic unfavorable (1.05e-4)"	"unprognostic (4.47e-2)"	"unprognostic (1.72e-2)"	"unprognostic (4.27e-2)"	"unprognostic (4.39e-2)"	126.3	76.1	55.8	234.3	54.3	596.8	59.1	58.6	116.8	44.3	61.4	62.0	70.6	25.9	15.0	28.1	43.7	105.0	39.7	53.0	66.4	34.4	85.5	261.5	161.0	81.7	64.0	18.3	24.7	22.0	27.0	124.7	74.8	31.7	49.8	3.9	38.3	26.7	10.6	21.5	78.8	68.0	74.1	423.3	43.1	15.0	74.0	52.5	21.9	31.6	36.6	131.7	21.5	114.4	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.1	0.0	56.7	0.0	0.0	0.5	33.2	678.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	1.0	0.0	0.0	0.0	49.1	0.3	0.0	0.0	0.5	0.0	0.6	0.0	0.0	0.3	0.5	0.0	0.0	0.2	0.9	0.0	390.6	0.0	0.0	0.3	0.8	0.1	0.4	0.1	1.0	0.1	10.8	0.1	974.2	4983.5	2573.9	468.0	3367.8	246.5	22.4	9.5	64.2	1912.0	8.4	11.7	51.2	6415.4	1664.1	3413.8	1653.1	9.5	5260.2	55.8	54.3	58.6	116.8	53.0	66.4	81.7	64.0	74.8	74.1	74.0	114.4	24.5	57.7	168.4	0.0	50.9	55.2	2.0	0.0	1.2	0.1	11.5	43.3	6.8	34.3	43.4	20.2	0.0	19.8	987.6	1.7	1.9	2.1	3.9	1.3	1.4	47.1	0.0	87.8	0.1	5.8	28.0	24.9	5.6	1.5	753.7	0.3	73.2	25.0	3777.1	0.0	0.1	0.2	0.0	3698.1	1990.8	11.6	9.3	2837.1	56.9	18.7	3371.2	0.6	1772.4	0.0	0.1	1.3	2.3	1.2	19.4	1.5	0.5	8.9	20.5	1.8	78.9	5.3	10.0	0.9	3.0	4.9	44.6	38.9	236.5	0.1	0.5	1.8
UBE2D2	"UBC4, UbcH5B"	ENSG00000131508	"Ubiquitin conjugating enzyme E2 D2"	P62837	5	139526431-139628434	"Enzymes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"	Transferase		"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003920	Approved		Approved	"Plasma membrane,Cytosol"		NA	NA			"Cluster 26: Non-specific - Mitochondria"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 44: Endometrium - Transcription"	"Plasma membrane, Cytosol"		"HPA003920: AB_1858519"	"unprognostic (1.14e-1)"	"unprognostic (2.75e-3)"	"prognostic favorable (5.09e-5)"	"prognostic favorable (5.90e-4)"	"unprognostic (2.33e-1)"	"unprognostic (8.19e-3)"	"prognostic unfavorable (9.63e-7)"	"unprognostic (7.41e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.33e-2)"	"unprognostic (1.41e-3)"	"prognostic unfavorable (2.09e-5)"	"unprognostic (8.00e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.20e-1)"	"unprognostic (1.07e-1)"	78.4	59.9	75.8	66.9	82.0	106.9	72.6	79.3	84.2	84.2	63.0	106.8	46.5	72.8	102.6	89.0	95.0	49.8	93.7	77.9	85.8	80.1	82.6	77.0	83.5	78.7	80.4	64.3	66.5	72.8	62.3	65.5	80.0	57.0	92.8	77.2	61.0	72.3	190.3	77.9	70.4	74.3	81.9	79.3	70.2	135.6	80.1	128.0	61.3	127.3	140.2	79.7	72.8	86.4	175.9	113.9	194.3	137.0	127.9	161.7	125.4	179.6	165.5	204.7	238.6	292.0	160.6	247.8	229.1	185.7	254.0	108.8	192.6	300.2	272.5	162.4	113.7	140.1	115.0	172.1	249.9	136.9	119.7	129.9	152.0	204.9	301.8	177.4	221.8	159.5	125.0	203.1	192.9	175.5	215.3	197.2	108.1	60.4	124.0	162.7	198.1	179.6	220.4	202.0	177.5	117.0	157.1	198.7	309.4	413.4	125.2	121.6	148.9	156.4	87.6	132.5	223.5	146.0	260.0	343.8	112.3	223.2	128.0	44.1	57.0	115.9	57.7	53.7	62.1	89.2	82.1	80.9	63.3	90.7	102.5	90.3	90.7	65.1	66.2	106.1	110.8	58.0	75.8	82.0	79.3	84.2	77.9	85.8	78.7	80.4	80.0	81.9	80.1	86.4	137.1	32.1	69.8	35.9	215.4	171.8	182.3	204.8	112.7	76.3	124.8	146.9	96.4	124.4	96.5	68.0	81.3	181.4	205.8	158.0	215.2	208.4	637.0	457.2	94.2	131.0	123.4	148.8	62.0	178.4	228.0	104.8	77.5	230.9	138.8	119.4	109.9	80.6	178.0	94.2	54.4	120.8	142.4	136.4	203.4	550.0	104.4	150.8	152.9	49.6	189.5	170.7	234.8	38.2	65.7	228.7	127.1	93.6	237.3	234.8	123.8	200.9	63.9	105.1	118.3	102.2	171.2	459.7	152.5	149.4	203.7	249.6	217.1	111.7	160.4	247.1
UBE2I	UBC9	ENSG00000103275	"Ubiquitin conjugating enzyme E2 I"	P63279	16	1308880-1327018	"Cancer-related genes, Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Cell cycle, Cell division, Chromosome partition, Host-virus interaction, Mitosis, Ubl conjugation pathway"	Transferase	"Cancer-related genes"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA003909, CAB009021, CAB079920"	Approved		Supported	Nucleoplasm,Nucleoli		NA	NA		130000	"Cluster 31: Non-specific - Inflammatory response"	"Cluster 34: Non-specific - Transcription"	"Cluster 14: REH - Unknown function"	"Cluster 10: Non-specific - Unknown function"	Nucleoplasm	Nucleoli	"CAB009021: AB_2210610, CAB079920: AB_2809487, HPA003909: AB_1858529"	"unprognostic (2.12e-1)"	"unprognostic (1.01e-2)"	"unprognostic (1.55e-2)"	"unprognostic (3.51e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.52e-1)"	"prognostic unfavorable (7.50e-4)"	"unprognostic (2.88e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.89e-2)"	"unprognostic (7.60e-3)"	"unprognostic (3.56e-1)"	"unprognostic (7.28e-2)"	"unprognostic (9.30e-2)"	"unprognostic (1.57e-1)"	"prognostic favorable (5.68e-4)"	"unprognostic (1.15e-3)"	62.5	76.3	42.5	60.3	44.0	81.6	62.0	46.1	49.3	64.7	37.1	63.8	45.1	72.7	48.7	74.2	67.3	34.3	68.2	45.2	45.2	63.4	40.8	53.1	76.0	39.3	42.3	93.1	49.1	72.0	61.6	58.1	40.2	53.4	47.3	31.7	56.4	46.7	58.0	68.0	61.1	53.8	42.2	71.9	52.9	47.6	47.1	110.3	53.2	57.0	89.3	66.6	63.1	42.1	121.3	161.1	269.0	157.7	112.7	135.8	114.4	170.0	121.7	154.3	152.9	191.8	190.1	208.2	137.7	148.1	140.7	142.4	193.2	159.2	197.9	151.2	133.4	130.6	136.6	188.4	178.6	194.9	148.0	127.1	100.7	152.1	180.0	149.0	170.0	169.9	190.3	124.3	148.0	254.4	349.6	193.0	219.0	136.0	118.5	434.0	170.9	238.4	145.7	106.6	150.3	159.8	149.3	164.1	177.7	152.8	167.5	234.4	139.4	149.2	172.6	134.0	155.5	132.1	170.4	423.4	85.3	142.9	164.7	278.7	214.3	327.1	165.9	256.6	200.9	297.8	167.8	170.3	214.7	241.1	148.2	149.6	149.5	202.6	249.5	186.3	196.5	260.9	42.5	44.0	46.1	49.3	45.2	45.2	39.3	42.3	40.2	42.2	47.1	42.1	109.5	51.3	67.0	16.3	172.8	178.6	186.4	275.6	97.3	64.6	101.9	105.7	89.1	84.4	140.9	62.5	50.1	312.8	153.9	77.4	105.7	211.9	64.4	66.6	100.6	118.3	102.3	127.4	17.2	148.2	293.1	134.4	55.5	104.6	109.5	149.7	94.2	43.7	213.5	47.1	16.8	97.1	162.8	104.8	182.1	37.8	129.8	124.8	128.1	15.9	220.2	104.7	209.1	16.6	26.7	212.3	91.8	107.6	144.1	294.8	90.4	117.7	65.7	63.1	78.9	82.1	185.4	139.6	145.7	158.4	206.7	418.1	144.7	134.9	134.7	304.5
UBQLN4	"A1U, C1orf6, UBIN"	ENSG00000160803	"Ubiquilin 4"	Q9NRR5	1	156035299-156053798	"Disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	5	"basophil: 9.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 9.7"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA061797	Approved		Supported	Nucleoplasm		NA	NA			"Cluster 34: Basophils - Unknown function"	"Cluster 80: Striated muscle - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm		"HPA061797: AB_2684613"	"unprognostic (3.91e-2)"	"unprognostic (2.01e-2)"	"unprognostic (1.95e-1)"	"unprognostic (1.29e-3)"	"unprognostic (1.52e-2)"	"unprognostic (6.75e-2)"	"unprognostic (1.58e-3)"	"unprognostic (5.48e-2)"	"unprognostic (1.53e-1)"	"unprognostic (1.32e-2)"	"unprognostic (1.91e-2)"	"unprognostic (1.01e-2)"	"unprognostic (2.54e-2)"	"unprognostic (7.25e-3)"	"unprognostic (7.65e-2)"	"unprognostic (4.73e-1)"	"unprognostic (1.57e-1)"	18.9	19.4	39.9	14.6	47.9	9.1	19.1	34.3	52.5	31.6	27.3	24.5	13.6	24.3	15.3	33.7	26.7	11.5	26.7	40.8	40.2	25.7	31.7	20.8	15.0	38.1	38.3	21.1	32.2	25.6	11.3	15.5	37.7	25.4	15.5	18.3	23.3	19.6	59.7	27.0	18.8	22.9	37.1	20.2	28.2	19.8	40.0	14.1	17.7	39.5	17.0	26.1	26.0	39.8	45.9	54.1	50.8	50.1	34.1	21.0	50.0	37.8	20.7	37.2	27.8	49.0	40.5	77.7	33.9	34.7	20.1	50.2	51.8	40.8	35.2	65.9	54.9	42.8	31.5	47.7	21.9	46.4	77.3	15.9	51.6	51.3	41.5	32.6	44.8	24.4	81.4	42.1	34.0	56.3	51.4	46.5	69.8	117.2	49.8	64.8	37.4	76.9	30.2	45.7	37.3	108.0	38.0	93.2	38.7	49.0	90.1	50.4	43.7	34.3	44.9	35.3	41.4	92.7	79.4	83.2	21.0	45.9	49.1	9.7	0.7	0.4	1.5	0.7	1.9	1.1	1.1	1.6	0.5	0.8	0.8	1.2	0.0	1.2	0.1	1.2	1.0	0.7	39.9	47.9	34.3	52.5	40.8	40.2	38.1	38.3	37.7	37.1	40.0	39.8	8.6	6.4	5.3	9.8	8.4	13.4	9.4	9.1	18.2	6.8	17.2	9.9	4.3	17.2	8.5	23.9	6.2	8.1	8.1	9.6	3.9	11.6	0.8	5.0	10.2	9.3	10.7	6.3	5.9	10.9	9.1	7.4	7.1	8.9	1.3	13.4	11.7	22.7	9.9	6.7	6.6	10.8	8.2	8.4	7.2	4.9	6.5	8.3	17.8	9.4	15.6	7.3	5.2	4.5	9.2	13.1	6.9	9.1	13.0	25.3	8.2	12.1	5.4	6.0	0.0	10.7	7.8	4.9	5.6	21.0	14.6	8.2	7.7	4.8	15.0	14.3
UCP1	"SLC25A7, UCP"	ENSG00000109424	"Uncoupling protein 1"	P25874	4	140559431-140568961	"Human disease related genes, Metabolic proteins, Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel"	"Diabetes mellitus, Obesity"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in single"		"adrenal gland: 2.7"	"Cell type enhanced"	"Detected in some"		"Cytotrophoblasts: 1.2;Syncytiotrophoblasts: 2.3"	"Cancer enhanced"	"Detected in single"		"breast cancer: 1.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	10	"BEWO: 4.7;HAP1: 3.3;JURKAT: 1.1"	"Not detected"	"Not detected"													NA	NA				"Cluster 57: Non-specific - Angiogenesis"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"				"unprognostic (5.08e-3)"	"unprognostic (4.44e-1)"		"unprognostic (2.65e-2)"	"unprognostic (2.30e-1)"	"unprognostic (7.17e-2)"		"unprognostic (6.08e-2)"	"unprognostic (3.98e-2)"	"unprognostic (1.85e-1)"	"unprognostic (5.75e-2)"	"unprognostic (1.38e-1)"		"unprognostic (4.45e-2)"	"unprognostic (2.29e-1)"	"unprognostic (1.40e-1)"	"unprognostic (4.58e-2)"	0.9	2.7	0.0	0.0	0.1	0.0	0.6	0.9	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	4.7	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.9	0.2	0.1	0.1	0.1	0.4	0.1	0.1	0.2	0.2	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.6	0.8	0.4	0.0	0.0	0.0	0.0	1.2	0.0	0.1	0.0	0.0	0.2	0.3	0.0	0.4	0.0	0.0	0.3	0.0	0.0	0.1	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	2.3	0.0	0.0	0.1	0.0
UCP2	"BMIQ4, SLC25A8"	ENSG00000175567	"Uncoupling protein 2"	P55851	11	73974672-73982843	"Human disease related genes, Metabolic proteins, Predicted intracellular proteins, Transporters"	Transport			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 278.1"	"Cell type enhanced"	"Detected in many"		"dendritic cells: 404.4;Enteroendocrine cells: 297.3;Erythroid cells: 695.6;Hofbauer cells: 442.2;Kupffer cells: 326.6;monocytes: 533.6;NK-cells: 509.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"Daudi: 360.2;SK-BR-3: 395.6;U-698: 293.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB025583, HPA075202"	Approved		Supported	Mitochondria		NA	NA			"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 3: T-cells - Adaptive immune response"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria		"CAB025583: , HPA075202: AB_2732284"	"unprognostic (1.13e-1)"	"prognostic favorable (4.65e-5)"	"unprognostic (8.07e-2)"	"unprognostic (1.21e-2)"	"unprognostic (1.08e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.92e-1)"	"unprognostic (1.82e-3)"	"unprognostic (2.07e-1)"	"unprognostic (4.59e-2)"	"unprognostic (1.13e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (7.80e-6)"	"unprognostic (3.77e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.77e-3)"	"unprognostic (3.88e-3)"	70.9	20.5	12.2	142.9	14.6	132.8	37.6	12.9	24.1	41.3	22.1	33.2	53.4	17.4	7.6	17.7	175.7	42.3	14.1	12.1	15.9	34.9	26.2	69.3	278.1	19.7	19.8	4.9	12.6	8.1	13.8	27.3	19.8	19.7	44.8	6.9	42.7	23.0	99.1	9.2	56.6	30.4	17.6	183.1	55.2	14.5	22.4	217.3	45.1	141.7	240.2	73.6	4.9	26.1	0.9	78.7	20.2	43.5	9.5	0.0	11.6	14.1	9.3	54.9	14.8	153.1	59.0	360.2	165.1	19.5	5.5	3.5	13.3	0.0	28.6	97.1	5.6	241.5	26.4	28.3	32.2	123.9	77.5	8.9	0.0	43.9	0.0	11.0	5.7	144.6	101.5	119.0	9.5	147.5	108.5	55.8	12.8	9.0	21.7	99.7	120.7	202.0	150.4	211.0	23.6	32.3	68.2	395.6	26.6	55.9	123.3	79.3	10.0	0.2	59.7	14.4	21.5	48.4	24.4	293.8	7.2	45.0	0.4	809.1	1116.7	1465.3	1462.8	1945.8	925.0	1914.8	1176.3	1233.5	1228.7	1851.8	1092.9	1143.1	154.2	1816.8	1692.3	3009.5	2589.5	2966.6	12.2	14.6	12.9	24.1	12.1	15.9	19.7	19.8	19.8	17.6	22.4	26.1	4.7	3.2	27.6	0.3	287.4	3.4	2.7	20.2	0.6	0.9	30.9	19.8	5.2	5.7	43.9	92.0	8.4	8.3	404.4	6.2	7.9	1.9	18.7	122.1	10.5	8.9	297.3	695.6	0.0	7.5	12.1	9.9	46.4	102.4	86.2	12.4	9.7	5.0	442.2	0.0	0.1	31.5	89.5	326.6	146.2	46.0	0.9	232.3	26.6	1.9	533.6	4.3	509.8	1.0	1.0	1.8	45.9	0.4	117.9	12.8	4.5	2.7	137.6	8.1	6.6	6.1	11.2	15.2	14.5	1.9	4.5	11.2	189.9	13.5	21.7	43.4
UCP3	SLC25A9	ENSG00000175564	"Uncoupling protein 3"	P55916	11	74000277-74009085	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	Transport		"Diabetes mellitus, Disease variant, Obesity"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	80	"skeletal muscle: 393.2;tongue: 263.1"	"Cell type enhanced"	"Detected in some"		"Early spermatids: 15.4;Late spermatids: 14.0;NK-cells: 6.2;Skeletal myocytes: 6.5"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in many"	4	"HDLM-2: 15.8"	"Low region specificity"	"Detected in all"			"Not detected"	"Not detected"			"CAB010771, HPA072225"	Enhanced		Approved	"Nucleoplasm,Plasma membrane,Cytosol"		NA	NA			"Cluster 36: GdT-cells - Adaptive immune response"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 37: Myocytes - Muscle contraction"	"Nucleoplasm, Cytosol"	"Plasma membrane"	"CAB010771: AB_261839, HPA072225: AB_2686498"	"unprognostic (3.76e-3)"	"unprognostic (1.24e-1)"	"unprognostic (2.82e-1)"	"unprognostic (5.98e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.49e-2)"	"unprognostic (3.95e-3)"	"unprognostic (6.61e-2)"	"unprognostic (1.25e-1)"	"unprognostic (8.58e-2)"	"unprognostic (2.13e-4)"	"unprognostic (1.61e-2)"	"unprognostic (3.25e-6)"	"unprognostic (2.68e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.76e-1)"	"unprognostic (2.50e-4)"	1.2	1.7	2.5	1.3	2.6	2.2	1.3	3.9	3.0	1.4	2.3	1.7	0.7	1.4	2.0	2.9	1.5	0.8	2.4	2.7	2.1	1.7	1.3	1.4	1.3	2.4	2.1	1.1	1.1	0.9	2.7	0.5	2.3	1.8	0.7	4.0	3.7	0.7	393.2	1.4	1.7	0.8	1.8	3.1	1.2	3.9	2.4	1.6	2.6	263.1	0.7	1.4	0.9	2.8	0.2	1.8	1.7	1.5	0.7	0.3	0.3	0.5	0.4	0.4	0.2	0.4	0.4	0.9	0.2	0.3	0.2	1.9	0.7	0.3	0.7	15.8	0.5	0.3	2.4	0.2	0.5	1.1	1.4	0.4	1.1	1.1	0.1	0.3	0.5	0.9	0.4	1.2	0.6	1.0	0.7	1.4	0.9	1.4	1.1	1.4	3.6	0.5	0.9	0.5	0.9	1.0	0.4	0.7	0.6	0.3	0.2	1.0	0.3	0.2	1.1	0.6	1.1	1.4	1.5	0.7	0.2	1.0	0.5	0.0	0.0	0.1	0.4	0.0	0.1	0.0	0.3	0.3	0.0	0.1	0.1	0.2	0.0	0.0	0.0	0.0	0.1	0.0	2.5	2.6	3.9	3.0	2.7	2.1	2.4	2.1	2.3	1.8	2.4	2.8	0.8	0.0	0.0	1.6	0.8	0.1	0.1	0.5	0.6	2.3	1.0	1.1	0.7	0.0	1.1	0.0	0.0	0.3	2.0	0.3	0.0	0.3	15.4	1.2	1.1	0.6	0.0	0.4	1.6	0.5	0.2	0.4	0.0	0.8	0.0	0.7	1.1	0.3	0.7	0.0	1.6	0.5	2.0	0.8	0.0	14.0	0.0	0.6	0.0	1.0	0.7	0.8	6.2	0.5	0.6	0.4	0.1	0.7	0.5	0.2	0.3	0.1	3.0	2.1	0.0	6.5	0.5	1.5	0.8	0.4	0.3	0.3	1.5	0.3	0.6	0.1
UFD1	UFD1L	ENSG00000070010	"Ubiquitin recognition factor in ER associated degradation 1"	Q92890	22	19449911-19479202	"Predicted intracellular proteins, Transporters"	"Ubl conjugation pathway"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 121.1;Ductal cells: 115.7;Exocrine glandular cells: 142.2;Extravillous trophoblasts: 107.3;Pancreatic endocrine cells: 149.9;Syncytiotrophoblasts: 170.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"K-562: 782.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030286, HPA030287"	Approved		Approved	Nucleoplasm,Nucleoli,Cytosol		NA	NA			"Cluster 5: Granulocytes - Unknown function"	"Cluster 59: Non-specific - Translation"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 7: Non-specific - Mitochondria"	"Nucleoplasm, Cytosol"	Nucleoli	"HPA030286: , HPA030287: AB_10601830"	"unprognostic (2.52e-1)"	"unprognostic (5.41e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.61e-2)"	"unprognostic (3.50e-2)"	"unprognostic (2.70e-2)"	"prognostic unfavorable (2.59e-4)"	"unprognostic (9.79e-2)"	"unprognostic (1.60e-1)"	"unprognostic (1.02e-3)"	"unprognostic (8.82e-2)"	"unprognostic (1.73e-2)"	"prognostic unfavorable (4.50e-8)"	"unprognostic (1.45e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.46e-1)"	"unprognostic (1.30e-2)"	43.8	39.8	23.6	36.8	26.3	64.8	37.8	27.6	29.8	33.9	25.7	42.5	32.1	46.8	54.4	48.4	31.4	29.3	44.8	24.6	28.6	36.7	51.9	37.2	43.4	28.9	26.7	31.8	39.3	44.7	31.7	35.3	29.5	32.1	38.4	21.7	38.1	30.1	98.3	42.5	35.7	39.5	27.2	38.6	40.8	53.3	27.1	61.6	34.9	42.5	47.5	40.2	37.0	29.7	187.5	132.4	110.6	168.5	89.0	62.0	86.0	150.2	148.8	202.9	187.1	147.8	78.8	129.2	114.1	126.7	93.3	157.5	131.5	132.1	175.1	239.8	138.0	136.5	88.3	119.4	84.4	218.6	177.7	57.4	133.0	173.2	84.4	59.1	164.7	67.9	782.0	240.5	125.1	268.5	142.0	133.4	79.8	232.2	111.9	170.1	262.0	50.1	126.6	172.5	90.5	102.2	118.2	126.0	123.3	114.2	75.9	103.5	180.9	169.6	230.8	143.2	164.1	102.9	221.7	168.8	142.5	110.3	158.6	150.9	90.6	158.1	107.0	140.3	103.7	87.7	122.5	112.4	81.0	82.6	104.6	102.9	167.1	105.7	140.7	113.1	224.5	129.5	23.6	26.3	27.6	29.8	24.6	28.6	28.9	26.7	29.5	27.2	27.1	29.7	68.3	25.6	34.5	0.0	16.4	0.0	0.0	0.0	0.0	0.0	39.7	55.2	0.0	0.0	16.7	27.6	0.0	121.1	44.9	0.0	84.1	115.7	0.0	43.1	36.9	32.6	0.0	0.0	0.0	142.2	107.3	25.4	0.0	44.9	27.8	36.0	0.0	0.0	88.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	31.0	0.0	0.0	76.0	0.0	0.0	0.0	0.0	149.9	0.0	0.0	7.5	0.0	0.0	81.0	27.7	0.0	0.0	0.0	37.2	0.0	0.0	0.0	0.0	170.3	26.3	61.5	0.0	0.0
UGCG	GCS	ENSG00000148154	"UDP-glucose ceramide glucosyltransferase"	Q16739	9	111896814-111935369	"Enzymes, FDA approved drug targets, Metabolic proteins, Predicted membrane proteins, Transporters"	"Lipid biosynthesis, Lipid metabolism, Sphingolipid metabolism"	"Glycosyltransferase, Transferase"	"FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"bone marrow: 112.9"	"Cell type enhanced"	"Detected in all"		"Glandular and luminal cells: 294.5;Urothelial cells: 534.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in many"	21	"plasmacytoid DC: 109.7"	"Lineage enriched"	"Detected in all"	21	"dendritic cells: 109.7"	"Cell line enhanced"	"Detected in all"		"LHCN-M2: 195.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024124	Approved					NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 40: Neutrophils - Inflammatory response"	"Cluster 4: Mesenchymal cell lines - Antiviral immune response"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA024124: AB_1858595"	"unprognostic (1.22e-2)"	"prognostic favorable (6.62e-4)"	"unprognostic (5.39e-2)"	"prognostic favorable (4.44e-5)"	"unprognostic (1.53e-2)"	"unprognostic (9.70e-2)"	"unprognostic (3.20e-2)"	"unprognostic (2.04e-1)"	"unprognostic (3.40e-1)"	"unprognostic (1.31e-1)"	"unprognostic (1.95e-2)"	"unprognostic (3.22e-1)"	"unprognostic (9.84e-3)"	"unprognostic (2.24e-2)"	"unprognostic (4.92e-2)"	"unprognostic (1.99e-1)"	"unprognostic (3.77e-2)"	39.1	65.6	9.5	34.6	9.6	112.9	25.2	11.1	10.9	23.1	10.4	20.5	23.8	16.3	7.3	40.8	15.7	42.6	14.4	9.7	13.1	29.7	32.5	33.7	41.8	11.0	12.4	12.0	16.6	5.5	12.5	27.6	10.3	13.8	17.8	12.2	14.1	7.7	9.0	32.8	31.7	21.4	10.2	35.5	47.9	7.9	11.6	20.5	9.9	7.7	46.8	72.3	28.5	13.7	93.4	9.8	15.7	10.5	33.2	39.7	8.3	57.0	59.7	65.3	87.9	19.8	70.0	21.9	44.1	38.0	142.9	46.6	18.4	24.7	69.6	8.9	10.7	8.9	14.3	9.8	23.7	9.8	13.8	39.6	18.9	62.4	89.1	151.0	20.3	10.8	49.4	41.5	195.7	15.9	10.7	10.9	17.9	31.4	10.1	12.4	111.5	7.1	151.0	35.2	7.6	12.0	25.3	21.1	66.1	92.2	113.6	10.1	96.6	30.0	15.2	84.8	41.1	7.7	30.3	10.2	37.0	6.1	41.6	0.1	0.3	0.2	1.2	0.7	2.0	4.2	2.2	1.6	1.9	5.3	2.0	2.0	1.2	1.4	1.0	109.7	3.6	1.4	9.5	9.6	11.1	10.9	9.7	13.1	11.0	12.4	10.3	10.2	11.6	13.7	128.0	41.7	51.1	17.6	66.6	75.7	151.6	90.6	76.8	29.8	71.8	37.8	11.8	47.1	130.7	29.5	62.6	7.3	262.4	69.8	17.6	108.2	20.6	125.0	83.4	116.1	18.5	26.5	40.4	50.6	12.8	64.6	121.8	294.5	10.8	18.3	90.7	20.6	21.4	18.5	41.9	55.1	36.7	34.0	109.2	5.9	49.0	49.1	58.7	24.4	44.4	8.4	9.2	25.1	12.8	72.2	65.1	38.4	33.3	216.6	42.6	77.2	143.9	16.5	13.1	153.2	74.9	1.8	8.7	99.7	122.2	3.4	41.4	30.5	22.1	534.7
UNC79	KIAA1409	ENSG00000133958	"Unc-79 homolog, NALCN channel complex subunit"	Q9P2D8	14	93333219-93707876	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"brain: 5.1;pituitary gland: 11.7"	"Group enriched"	"Detected in some"	4	"Excitatory neurons: 524.0;Inhibitory neurons: 463.6;Oligodendrocyte precursor cells: 270.4;Oligodendrocytes: 202.6"	"Cancer enhanced"	"Detected in some"		"glioma: 0.7"	"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	5	"REH: 4.3;SCLC-21H: 3.0;SH-SY5Y: 1.9;U-937: 1.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA071881			Approved	"Nucleoplasm,Plasma membrane"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 7: SCLC-21H - Neuronal signaling"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Plasma membrane"	Nucleoplasm	"HPA071881: AB_2732189"	"unprognostic (8.42e-2)"	"unprognostic (2.07e-1)"	"unprognostic (6.70e-2)"	"unprognostic (6.91e-2)"	"unprognostic (1.06e-1)"	"unprognostic (7.73e-2)"	"unprognostic (2.99e-2)"	"unprognostic (1.17e-1)"	"unprognostic (2.31e-1)"	"unprognostic (5.73e-3)"	"unprognostic (8.03e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.39e-2)"	"unprognostic (2.66e-2)"	"unprognostic (5.57e-2)"	"unprognostic (3.03e-2)"	"unprognostic (7.47e-2)"	0.0	0.7	2.2	0.0	2.8	0.0	0.0	5.1	4.7	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.0	0.1	2.1	1.9	0.3	0.0	0.0	0.0	0.0	0.1	0.0	1.8	0.2	11.7	0.0	0.0	0.0	0.0	3.0	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.3	2.5	0.4	0.0	0.1	0.3	0.0	0.0	0.0	2.3	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	4.3	0.0	0.0	0.1	0.1	3.0	1.9	0.0	0.0	0.0	0.1	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.8	5.1	4.7	2.1	1.9	0.0	0.1	0.0	0.0	0.4	2.3	0.3	0.0	0.0	89.8	0.4	0.3	0.3	0.5	0.0	41.9	0.3	0.3	2.8	0.0	0.1	0.0	10.4	0.1	0.3	0.7	0.0	0.3	36.9	4.8	0.9	0.6	0.0	0.4	524.0	0.2	0.1	0.6	1.1	0.8	0.0	0.3	0.4	0.2	0.3	40.4	463.6	0.3	0.0	0.6	0.4	16.4	0.6	0.4	0.0	23.4	0.1	2.1	0.0	270.4	202.6	0.4	0.1	0.4	0.0	0.3	0.6	1.9	0.9	5.7	0.0	0.5	0.8	3.4	2.5	0.2	0.3	0.7	0.2	0.5	0.2	0.3
UNC80	"C2orf21, FLJ33496, KIAA1843, UNC-80"	ENSG00000144406	"Unc-80 homolog, NALCN channel complex subunit"	Q8N2C7	2	209771832-209999300	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"			"Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	5	"brain: 21.0;pituitary gland: 13.6;retina: 18.9"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 117.7;Excitatory neurons: 432.0;Inhibitory neurons: 354.7;Oligodendrocyte precursor cells: 290.5"	"Cancer enhanced"	"Detected in some"		"glioma: 0.8;prostate cancer: 0.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	4	"AF22: 2.5;SCLC-21H: 4.0;SH-SY5Y: 2.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042472, HPA050959"	Enhanced		Approved	"Nuclear bodies,Vesicles"		NA	NA				"Cluster 58: Brain - Synaptic function"	"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"	"Nuclear bodies"	Vesicles	"HPA042472: AB_10965318, HPA050959: "	"unprognostic (7.91e-3)"	"unprognostic (2.25e-4)"	"unprognostic (1.44e-2)"	"unprognostic (3.20e-4)"	"unprognostic (1.92e-1)"	"unprognostic (3.40e-2)"	"unprognostic (3.31e-3)"	"unprognostic (5.36e-2)"	"unprognostic (5.16e-1)"	"unprognostic (7.85e-2)"	"unprognostic (5.24e-3)"	"unprognostic (8.94e-2)"	"unprognostic (1.50e-2)"	"unprognostic (1.51e-2)"	"unprognostic (6.50e-2)"	"unprognostic (1.95e-1)"	"unprognostic (7.40e-3)"	0.0	3.9	6.4	0.0	9.9	0.0	0.0	15.6	21.0	0.0	0.0	0.2	0.0	0.1	0.4	0.0	0.4	1.1	0.0	6.9	4.9	0.1	0.0	0.1	0.0	6.7	1.5	0.5	1.0	0.2	13.6	0.0	5.8	0.9	0.1	18.9	0.1	0.2	0.0	0.1	0.1	0.2	1.1	0.2	0.4	3.5	2.6	0.1	0.3	0.0	0.0	0.2	0.0	5.0	0.0	0.0	2.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.0	0.0	0.0	0.5	0.0	0.0	0.0	4.0	2.3	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.4	9.9	15.6	21.0	6.9	4.9	6.7	1.5	5.8	1.1	2.6	5.0	0.2	0.0	1.1	49.0	0.0	0.8	0.3	1.9	0.0	117.7	0.2	0.1	2.1	0.0	0.7	0.0	66.7	0.0	0.0	0.0	0.0	0.0	31.9	1.1	1.7	0.5	0.0	0.0	432.0	0.0	0.0	1.1	0.0	0.1	1.3	0.6	0.0	0.0	0.1	52.2	354.7	0.0	0.0	0.0	0.0	10.5	0.9	0.3	0.0	10.3	0.0	26.6	0.0	290.5	12.8	0.1	0.0	1.9	0.0	1.2	0.0	0.2	0.8	75.6	0.0	0.2	0.1	7.5	3.8	0.0	0.1	0.0	0.0	15.1	0.0	0.3
UNC93B1	UNC93	ENSG00000110057	"Unc-93 homolog B1, TLR signaling regulator"	Q9H1C4	11	67991100-68004982	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Adaptive immunity, Antiviral defense, Immunity, Innate immunity"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 76.7"	"Cell type enhanced"	"Detected in many"		"Hofbauer cells: 96.2;Kupffer cells: 78.3;Macrophages: 85.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in many"		"plasmacytoid DC: 14.8"	"Low lineage specificity"	"Detected in many"			"Group enriched"	"Detected in many"	4	"CAPAN-2: 128.9;RPMI-8226: 368.2;SK-BR-3: 95.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA038716, HPA038717, HPA042803"	Approved		Approved	Nucleoplasm		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 25: RPMI-8226 - Immune response"	"Cluster 4: Macrophages - Innate immune response"	Nucleoplasm		"HPA038716: AB_2676169, HPA038717: AB_10674836, HPA042803: AB_2678176"	"unprognostic (3.32e-2)"	"unprognostic (1.75e-1)"	"unprognostic (3.32e-2)"	"unprognostic (2.52e-1)"	"unprognostic (1.14e-1)"	"unprognostic (7.66e-2)"	"unprognostic (1.29e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.82e-2)"	"unprognostic (1.05e-2)"	"prognostic unfavorable (1.73e-4)"	"unprognostic (4.76e-2)"	"prognostic unfavorable (7.38e-4)"	"unprognostic (1.73e-2)"	"unprognostic (1.85e-2)"	"unprognostic (7.05e-3)"	"unprognostic (5.23e-3)"	18.7	17.7	4.9	19.9	5.6	19.9	15.4	5.0	7.5	19.0	6.4	20.2	22.5	7.7	0.8	20.5	15.7	9.8	7.3	4.9	5.0	16.4	15.3	29.5	29.5	10.7	6.5	6.2	17.1	2.6	6.7	6.4	8.1	16.4	3.1	0.1	27.9	8.8	3.5	16.3	35.8	3.1	7.9	76.7	20.6	1.7	6.8	3.5	14.8	1.5	7.3	20.6	15.0	10.2	18.9	34.1	2.5	13.8	7.2	2.7	28.2	8.3	7.7	13.0	11.8	2.8	128.9	40.9	30.8	4.0	11.0	44.9	1.0	7.0	0.4	14.1	9.3	4.2	11.1	6.4	11.2	30.0	22.7	6.0	7.6	3.8	1.5	5.0	2.6	6.4	3.0	19.3	2.0	18.7	0.2	23.9	6.2	46.8	16.7	24.5	0.0	368.2	11.8	10.7	3.9	5.5	14.0	95.6	19.3	1.0	35.4	39.0	9.2	8.6	12.2	12.8	0.8	13.2	18.8	7.0	16.0	30.7	10.5	0.1	3.8	6.6	0.1	7.2	0.2	2.5	0.2	0.2	5.1	2.7	0.0	0.0	3.2	2.1	7.7	14.8	0.0	1.2	4.9	5.6	5.0	7.5	4.9	5.0	10.7	6.5	8.1	7.9	6.8	10.2	12.5	9.6	9.1	4.6	45.3	4.0	21.9	12.5	9.1	0.0	16.4	13.1	1.8	40.0	21.0	16.5	0.0	10.3	63.3	23.2	1.9	36.8	0.8	32.0	5.9	10.0	4.2	3.0	1.1	23.4	47.8	8.0	20.9	17.2	7.0	9.3	10.0	5.4	96.2	5.0	0.1	17.2	14.2	78.3	28.4	0.1	4.4	85.3	23.2	13.1	57.5	4.7	8.2	0.0	0.7	49.7	25.6	4.1	33.8	27.0	31.7	6.9	57.3	0.5	0.0	8.3	9.8	0.2	1.1	12.9	6.5	7.3	10.5	2.1	23.1	37.7
UPK1A	TSPAN21	ENSG00000105668	"Uroplakin 1A"	O00322	19	35666516-35678483	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"esophagus: 43.2;urinary bladder: 205.7;vagina: 52.4"	"Cell type enriched"	"Detected in some"	4	"Urothelial cells: 29.1"	"Cancer enriched"	"Detected in many"	41	"urothelial cancer: 148.1"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enriched"	"Detected in some"	5	"RT4: 39.2"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			HPA049879	Enhanced					NA	NA			"Cluster 33: Neutrophils - Chromatin organization"	"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 15: RT4 - Unknown function"	"Cluster 22: Epithelial cell types - Mixed function"			"HPA049879: AB_2680929"	"unprognostic (3.29e-1)"	"unprognostic (1.78e-1)"	"unprognostic (1.19e-3)"	"unprognostic (3.40e-4)"	"unprognostic (4.05e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.74e-2)"	"unprognostic (3.11e-3)"	"unprognostic (2.30e-1)"	"unprognostic (1.78e-1)"	"unprognostic (4.62e-2)"	"unprognostic (2.34e-1)"	"unprognostic (2.48e-9)"	"unprognostic (1.48e-1)"	"unprognostic (4.14e-2)"	"unprognostic (2.45e-2)"	"unprognostic (1.72e-1)"	0.8	0.0	0.2	0.1	0.3	0.1	0.3	0.5	0.4	31.8	0.2	0.1	0.0	0.0	0.0	43.2	0.5	0.2	0.1	0.3	0.3	0.5	0.2	0.1	0.1	0.2	0.3	0.1	0.0	0.0	0.1	0.1	0.2	6.8	0.0	0.1	4.2	0.2	0.1	20.7	0.1	0.0	0.1	0.1	0.1	0.8	0.3	0.1	0.0	0.0	0.3	205.7	52.4	0.2	0.0	0.4	0.2	0.2	0.4	0.1	0.4	0.0	0.1	0.2	0.6	1.1	0.0	0.0	0.1	0.2	0.1	0.1	0.1	0.0	0.2	3.8	0.3	0.0	0.2	0.2	0.2	0.1	0.5	0.1	0.4	0.2	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.7	0.0	0.2	0.5	8.1	0.0	0.0	0.0	0.1	0.0	39.2	0.1	0.1	0.2	0.2	0.5	0.2	0.3	0.0	0.0	0.0	1.2	0.0	0.0	0.2	0.5	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.1	0.0	0.2	0.0	0.1	0.3	0.2	0.0	0.1	0.0	0.1	0.2	0.3	0.5	0.4	0.3	0.3	0.2	0.3	0.2	0.1	0.3	0.2	0.1	0.0	0.0	0.3	0.0	0.3	0.9	0.2	0.0	0.0	0.2	0.4	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	6.4	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.6	0.1	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.2	0.0	0.1	0.0	0.0	0.0	0.3	0.2	0.4	1.3	0.0	0.4	0.1	0.1	0.0	0.0	29.1
UPK1B	"TSPAN20, UPK1"	ENSG00000114638	"Uroplakin 1B"	O75841	3	119173517-119205143	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"stomach 1: 33.8;urinary bladder: 88.8"	"Cell type enhanced"	"Detected in many"		"Basal respiratory cells: 32.2;Club cells: 198.3;Glandular and luminal cells: 80.9;Urothelial cells: 46.3"	"Cancer enriched"	"Detected in many"	4	"urothelial cancer: 147.3"	"Region enhanced"	"Detected in single"		"basal ganglia: 1.6"	"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 17.7;CACO-2: 40.6;RPTEC TERT1: 36.5;RT4: 147.1"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"HPA031799, HPA031800"	Enhanced					NA	NA			"Cluster 11: Basophils - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA031799: AB_10671579, HPA031800: AB_10671580"	"unprognostic (1.20e-2)"	"unprognostic (7.18e-2)"		"prognostic favorable (3.87e-5)"	"unprognostic (2.22e-1)"	"unprognostic (1.39e-1)"		"unprognostic (8.77e-3)"	"unprognostic (3.67e-1)"	"unprognostic (2.71e-1)"	"unprognostic (3.26e-2)"	"unprognostic (2.03e-1)"	"unprognostic (1.92e-2)"	"prognostic unfavorable (7.76e-4)"	"unprognostic (1.68e-1)"	"unprognostic (6.76e-2)"	"unprognostic (2.95e-2)"	10.2	0.0	0.4	0.1	1.6	0.2	0.2	0.3	0.6	4.8	0.0	0.0	0.1	0.5	0.0	3.5	7.9	8.0	1.8	0.4	0.0	10.2	0.1	1.2	0.0	0.1	0.0	0.0	6.5	0.0	0.2	7.6	0.1	0.4	0.0	0.0	0.2	0.0	0.0	0.7	0.0	0.0	0.0	0.0	33.8	0.6	0.0	3.7	0.0	0.2	17.0	88.8	1.4	0.3	0.1	17.7	0.0	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.0	40.6	0.0	0.0	5.4	0.0	0.0	1.1	0.0	0.5	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	36.5	147.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.6	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.0	0.4	0.1	0.1	0.2	0.0	0.0	0.4	1.6	0.3	0.6	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.3	0.2	0.0	1.5	0.0	0.2	0.3	0.6	32.2	0.0	0.5	0.2	0.4	0.5	24.3	198.3	0.0	0.0	3.5	0.4	0.1	0.0	15.6	3.5	25.1	9.4	0.9	0.0	0.0	1.9	0.7	11.1	4.0	11.2	80.9	2.5	0.5	0.0	0.5	0.5	1.7	1.2	0.2	24.4	0.3	3.1	1.5	0.0	1.1	1.8	0.0	1.1	0.2	0.0	0.5	0.5	0.8	0.2	0.0	0.4	0.9	0.2	10.9	27.8	1.2	0.0	0.5	4.6	0.2	0.5	0.3	0.0	1.5	0.7	0.1	0.0	46.3
UPK2	"MGC138598, UP2, UPII"	ENSG00000110375	"Uroplakin 2"	O00526	11	118925164-118958559	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	28	"urinary bladder: 70.1"	"Group enriched"	"Detected in some"	7	"Club cells: 3.2;Cytotrophoblasts: 10.5;Syncytiotrophoblasts: 9.6;Urothelial cells: 6.9"	"Cancer enriched"	"Detected in many"	72	"urothelial cancer: 339.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	6	"MCF7: 144.4;RT4: 160.9"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"HPA043312, HPA061106"	Enhanced					NA	NA			"Cluster 35: T-regs - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 15: RT4 - Unknown function"	"Cluster 47: Cytotrophoblasts - Unknown function"			"HPA043312: AB_2678420, HPA061106: AB_2684429"	"unprognostic (6.04e-3)"	"unprognostic (1.23e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.97e-2)"	"unprognostic (1.21e-1)"	"unprognostic (4.12e-4)"	"unprognostic (1.65e-1)"	"prognostic unfavorable (9.57e-4)"	"unprognostic (3.13e-3)"	"unprognostic (1.37e-1)"	"unprognostic (1.05e-3)"	"unprognostic (6.35e-3)"	"prognostic unfavorable (7.30e-7)"	"unprognostic (6.69e-2)"	"unprognostic (7.45e-2)"	"unprognostic (2.98e-1)"	"unprognostic (1.00e-1)"	1.4	0.1	0.1	0.0	0.1	0.0	0.0	0.1	0.2	0.4	0.0	0.0	0.0	0.0	0.5	2.4	0.0	0.0	0.0	0.1	0.2	0.2	0.0	0.0	0.0	0.1	0.1	0.0	0.5	0.0	0.0	0.3	0.1	0.5	0.0	0.0	0.4	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.5	0.2	0.5	0.0	0.0	0.2	70.1	2.4	0.2	4.0	0.4	0.1	0.4	0.0	0.1	26.2	0.0	0.0	0.0	0.1	0.2	9.0	0.0	0.2	0.4	0.2	6.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	144.4	0.0	0.2	0.0	0.4	0.0	0.0	0.0	0.1	0.1	160.9	0.0	0.1	0.3	0.0	0.0	0.1	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.3	0.0	0.1	0.1	0.1	0.2	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.2	0.0	0.0	0.0	0.3	0.6	0.0	0.2	0.9	0.0	0.4	0.6	1.0	0.0	0.0	3.2	0.0	0.0	10.5	0.4	0.0	0.0	0.1	0.5	0.3	0.1	0.5	0.0	0.0	0.1	0.2	0.8	0.1	0.0	0.2	0.0	1.0	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.3	0.0	0.6	0.0	0.2	0.0	0.0	0.6	0.9	1.0	0.0	0.0	0.3	0.0	0.0	0.0	0.3	0.0	0.3	0.1	0.0	0.0	0.0	0.1	0.2	0.2	0.5	0.1	9.6	0.1	0.4	0.0	6.9
UPK3A	UPK3	ENSG00000100373	"Uroplakin 3A"	O75631	22	45284949-45295874	"Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"prostate: 21.3;skeletal muscle: 35.0;urinary bladder: 48.0"	"Cell type enhanced"	"Detected in some"		"Basal prostatic cells: 15.0;monocytes: 22.6;Prostatic glandular cells: 54.1;Proximal enterocytes: 29.8;Urothelial cells: 24.5"	"Group enriched"	"Detected in many"	6	"prostate cancer: 35.3;urothelial cancer: 78.0"	"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in many"		"myeloid DC: 86.6"	"Group enriched"	"Detected in many"	16	"dendritic cells: 86.6;monocytes: 32.0"	"Group enriched"	"Detected in some"	5	"Hep G2: 29.9;RT4: 48.9"	"Low region specificity"	"Detected in single"			"Low region specificity"	"Detected in many"			"HPA018407, HPA018415"	Enhanced		Uncertain	"Nuclear membrane,Nuclear bodies"		NA	NA			"Cluster 28: Myeloid DCs - Unknown function"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 15: RT4 - Unknown function"	"Cluster 35: Glandular cells - Unknown function"	"Nuclear membrane"	"Nuclear bodies"	"HPA018407: AB_1858641, HPA018415: AB_1858640"	"unprognostic (1.27e-2)"	"unprognostic (3.20e-3)"	"unprognostic (1.80e-1)"	"unprognostic (1.21e-1)"	"unprognostic (9.42e-2)"	"unprognostic (3.98e-5)"	"unprognostic (1.69e-2)"	"unprognostic (4.82e-4)"	"unprognostic (1.50e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.63e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.49e-5)"	"unprognostic (2.01e-2)"	"unprognostic (5.45e-2)"	"unprognostic (1.83e-1)"	"unprognostic (6.05e-3)"	0.2	0.1	0.1	0.5	0.1	1.5	0.2	0.1	0.4	0.0	0.3	1.0	0.0	0.1	0.1	0.3	0.3	0.9	0.1	0.1	0.2	0.1	0.0	0.2	0.9	0.2	0.1	0.1	0.2	4.9	0.7	0.0	0.2	21.3	0.7	0.0	2.8	0.2	35.0	0.0	1.3	0.1	0.1	1.1	0.1	0.1	0.1	0.7	2.3	4.5	0.8	48.0	1.1	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	29.9	0.0	4.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.5	0.0	4.6	0.0	0.1	0.0	0.2	0.0	48.9	0.1	0.0	0.2	0.8	0.0	0.0	0.1	5.0	0.0	0.0	0.0	0.0	0.0	2.5	0.0	0.1	0.0	0.0	0.0	0.0	21.2	0.0	0.0	25.8	0.0	1.2	0.0	0.1	86.6	0.5	0.0	0.0	3.6	0.4	32.0	32.9	0.0	7.4	0.1	0.1	0.1	0.4	0.1	0.2	0.2	0.1	0.2	0.1	0.1	0.3	0.2	0.0	0.0	0.7	1.2	0.1	15.0	0.1	0.0	0.1	4.6	3.6	0.2	2.8	0.1	0.0	0.0	0.0	4.0	3.3	0.0	0.0	0.4	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.3	0.0	0.2	0.0	0.0	0.0	0.0	1.7	0.0	0.1	3.5	0.0	4.8	8.7	1.7	0.3	6.4	0.0	0.0	22.6	0.8	2.1	0.0	0.0	0.0	9.3	0.0	0.1	54.1	29.8	0.0	0.1	0.0	0.0	1.6	0.5	0.0	0.4	0.0	0.4	0.1	0.2	0.0	4.4	24.5
UPK3B	"FLJ32198, MGC10902, p35, UPIIIb"	ENSG00000243566	"Uroplakin 3B"	Q9BT76	7	76510525-76516522	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	6	"adipose tissue: 120.6;esophagus: 64.8;lung: 50.0;urinary bladder: 42.2"	"Cell type enriched"	"Detected in some"	5	"Alveolar cells type 1: 121.8"	"Group enriched"	"Detected in many"	12	"ovarian cancer: 64.6;urothelial cancer: 78.4"	"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"A549: 13.2;CAPAN-2: 48.2;HaCaT: 10.0;RT4: 34.7;T-47d: 27.1"	"Not detected"	"Not detected"							HPA010506	Approved					NA	NA				"Cluster 11: Squamous epithelial cells - Epithelial cell function"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"			"HPA010506: AB_1080479"	"unprognostic (8.33e-2)"	"unprognostic (1.30e-1)"	"unprognostic (3.62e-3)"	"unprognostic (2.26e-3)"	"unprognostic (7.87e-2)"	"unprognostic (8.60e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.63e-1)"	"unprognostic (4.03e-1)"	"unprognostic (5.92e-2)"	"unprognostic (1.37e-2)"	"unprognostic (4.06e-2)"	"unprognostic (8.37e-9)"	"unprognostic (3.56e-2)"	"unprognostic (2.01e-1)"	"unprognostic (1.66e-1)"	"unprognostic (6.34e-2)"	120.6	0.7	0.1	0.1	0.4	0.1	1.4	0.0	0.4	8.0	1.0	1.2	0.0	0.7	0.2	64.8	10.0	0.1	10.6	0.0	0.2	0.6	1.0	50.0	0.1	0.1	0.2	6.9	1.3	0.0	1.7	0.0	0.2	2.7	0.0	0.2	8.3	0.0	0.5	4.1	0.9	0.0	0.0	2.1	2.9	4.2	0.7	0.0	1.4	0.0	1.8	42.2	12.1	0.1	1.1	13.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	48.2	0.0	0.4	0.0	0.1	10.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.1	0.0	2.9	0.1	0.0	0.0	0.0	0.0	34.7	0.0	0.0	0.3	3.9	0.0	0.1	27.1	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.0	0.4	0.0	0.2	0.1	0.2	0.2	0.0	0.7	0.1	0.3	121.8	3.3	0.0	0.3	1.7	0.4	18.3	4.6	0.4	0.2	0.0	0.3	20.0	20.4	3.7	4.2	0.1	0.0	0.2	0.0	0.1	0.0	0.5	0.0	0.9	0.0	0.0	0.0	0.0	0.0	13.9	1.1	0.5	1.3	0.1	0.7	0.1	0.1	1.7	0.0	0.0	6.1	0.3	2.5	0.0	12.2	0.3	3.6	0.0	0.0	0.3	0.0	0.0	0.0	0.1	0.1	0.0	0.0	0.7	0.1	0.0	11.1	0.2	0.0	0.0	1.1	0.0	0.1	2.1	2.8	0.1	0.4	0.0	0.2	14.2
VAMP1	"SYB1, VAMP-1"	ENSG00000139190	"Vesicle associated membrane protein 1"	P23763	12	6462237-6470677	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"			"Congenital myasthenic syndrome, Disease variant, FDA approved drug targets, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"brain: 192.8"	"Cell type enhanced"	"Detected in many"		"Bipolar cells: 20.0;Excitatory neurons: 22.6;Inhibitory neurons: 25.0;Oligodendrocytes: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Cell line enriched"	"Detected in all"	5	"U-698: 200.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB002779, CAB016119, CAB079000"	Approved	Supported				NA	NA			"Cluster 49: Eosinophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 27: U-698-M & Daudi - Adaptive immune response"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"			"CAB002779: , CAB016119: AB_628309, CAB079000: "	"unprognostic (2.33e-1)"	"unprognostic (6.72e-3)"	"prognostic unfavorable (6.37e-5)"	"unprognostic (8.09e-3)"	"unprognostic (2.17e-1)"	"unprognostic (1.14e-3)"	"prognostic unfavorable (6.97e-4)"	"unprognostic (1.22e-2)"	"unprognostic (6.33e-2)"	"unprognostic (1.05e-1)"	"unprognostic (1.40e-3)"	"unprognostic (3.48e-2)"	"prognostic unfavorable (1.04e-11)"	"unprognostic (1.47e-2)"	"unprognostic (5.99e-2)"	"unprognostic (1.62e-1)"	"unprognostic (3.65e-2)"	11.7	18.9	45.3	21.9	60.6	63.4	11.5	102.1	179.8	19.6	30.6	35.4	6.9	20.9	7.0	12.5	22.4	6.4	11.5	40.1	85.4	16.1	18.6	15.2	39.7	192.8	89.2	12.7	10.4	2.7	12.8	3.3	163.5	24.1	11.9	35.7	14.5	9.9	10.0	8.9	33.0	10.3	93.3	42.2	17.5	11.4	106.3	12.8	30.8	3.5	35.9	21.4	18.5	93.9	3.0	11.0	5.8	8.1	16.7	19.1	7.1	5.4	10.5	5.7	16.0	3.9	9.5	30.8	1.1	13.5	5.8	8.9	7.2	3.0	8.3	24.3	15.5	4.9	40.1	4.0	7.6	11.6	11.8	13.7	1.4	7.4	4.2	19.5	5.2	13.4	1.9	8.9	13.0	3.4	15.6	13.9	27.4	1.4	4.7	17.5	9.2	5.6	3.5	4.4	1.2	2.3	10.5	6.0	4.5	30.9	2.0	4.6	6.5	2.8	8.5	5.8	3.9	7.6	3.1	200.3	10.2	24.4	2.3	9.0	1.0	14.1	5.9	0.4	4.8	4.8	4.9	5.7	1.1	1.0	5.1	4.4	5.1	2.2	0.5	2.2	6.8	2.3	45.3	60.6	102.1	179.8	40.1	85.4	192.8	89.2	163.5	93.3	106.3	93.9	2.8	6.4	2.0	11.1	10.3	1.1	3.3	1.6	9.1	20.0	2.2	5.0	1.9	1.5	1.9	0.0	6.2	0.3	17.8	4.1	1.9	0.2	0.9	3.3	1.2	2.9	4.8	1.3	22.6	0.5	0.7	3.5	5.1	1.6	10.8	2.6	2.2	3.1	1.7	1.7	25.0	2.1	8.2	3.8	2.6	0.5	3.7	3.6	0.0	6.5	6.0	6.4	10.3	6.6	26.8	0.6	2.8	4.9	12.2	1.8	0.6	0.4	4.9	6.8	6.6	4.7	4.2	2.7	4.3	3.0	0.9	0.1	14.8	2.9	1.6	0.9
VAMP2	"SYB2, VAMP-2"	ENSG00000220205	"Vesicle associated membrane protein 2"	P63027	17	8159149-8163546	"Disease related genes, FDA approved drug targets, Human disease related genes, Predicted membrane proteins, Transporters"			"Disease variant, FDA approved drug targets, Mental retardation"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Bipolar cells: 1134.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											CAB078785		Supported				NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 58: Brain - Synaptic function"	"Cluster 11: RPE1 & U-87MG - Synaptic function"	"Cluster 56: Bipolar cells - Visual perception"			"CAB078785: "	"unprognostic (8.25e-2)"	"unprognostic (4.41e-2)"	"unprognostic (1.58e-2)"	"prognostic favorable (1.08e-4)"	"unprognostic (2.81e-2)"	"unprognostic (1.15e-1)"	"unprognostic (1.43e-2)"	"unprognostic (7.28e-2)"	"unprognostic (5.15e-2)"	"unprognostic (1.55e-1)"	"prognostic favorable (3.83e-6)"	"unprognostic (8.27e-2)"	"prognostic favorable (9.76e-8)"	"unprognostic (1.21e-2)"	"unprognostic (7.00e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.08e-1)"	88.5	126.6	264.4	47.5	284.2	172.0	88.6	175.5	341.5	116.9	43.8	95.5	43.1	109.3	63.0	60.8	119.9	39.0	99.9	288.2	268.2	130.8	59.8	85.4	70.3	219.8	255.7	170.9	80.5	181.3	227.4	42.4	252.7	102.9	51.4	450.9	72.1	68.6	98.8	118.9	91.6	67.5	139.6	115.4	88.2	66.0	239.9	71.5	102.1	63.7	65.0	78.9	90.1	266.8	28.3	21.6	52.6	28.1	45.1	35.0	22.3	25.7	34.2	27.0	36.8	8.7	19.6	32.3	18.0	43.8	25.1	34.4	34.8	29.0	31.1	37.6	36.0	23.1	61.4	12.0	40.1	15.6	33.6	39.0	42.9	30.9	46.4	55.4	26.6	56.3	17.5	37.6	46.5	15.5	40.9	20.7	11.8	19.7	15.2	50.7	23.8	26.0	34.8	19.5	23.6	37.8	20.6	11.7	27.7	22.9	26.2	19.7	39.1	16.2	21.0	29.6	25.0	38.4	24.6	23.4	41.5	26.5	37.8	46.5	21.9	78.4	79.0	21.7	69.5	79.8	79.6	86.1	17.5	68.1	93.0	85.8	113.8	79.3	28.9	46.7	65.1	29.7	264.4	284.2	175.5	341.5	288.2	268.2	219.8	255.7	252.7	139.6	239.9	266.8	175.1	41.7	28.3	43.4	193.9	113.8	179.6	184.7	72.8	1134.0	167.6	177.0	27.4	143.0	84.2	231.8	248.1	202.5	238.1	109.8	395.2	81.0	8.4	30.3	48.2	141.1	323.0	57.9	125.0	83.4	109.6	118.6	40.2	48.1	150.5	101.0	157.8	75.7	111.8	466.1	126.9	179.1	152.5	109.6	112.6	18.5	261.9	82.8	193.9	37.5	147.8	528.0	295.5	56.8	98.5	116.6	141.3	215.5	78.3	106.2	184.1	195.9	38.5	637.9	295.9	202.0	156.4	137.3	136.1	45.9	150.7	320.0	229.1	120.9	94.1	124.1
VAMP3	CEB	ENSG00000049245	"Vesicle associated membrane protein 3"	Q15836	1	7771296-7781432	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Protein transport, Transport"		"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"									NA	NA		260000	"Cluster 34: Basophils - Unknown function"	"Cluster 70: Brain - Nervous system development"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 16: Pancreatic endocrine cells - Mixed function"				"unprognostic (1.09e-2)"	"unprognostic (4.03e-1)"	"unprognostic (3.39e-3)"	"unprognostic (2.95e-1)"	"unprognostic (9.15e-3)"	"unprognostic (3.86e-3)"	"unprognostic (9.49e-3)"	"unprognostic (2.00e-1)"	"unprognostic (7.16e-2)"	"unprognostic (2.36e-1)"	"unprognostic (1.83e-3)"	"unprognostic (2.17e-1)"	"prognostic favorable (2.36e-4)"	"unprognostic (1.02e-1)"	"unprognostic (2.85e-1)"	"unprognostic (9.52e-2)"	"unprognostic (3.30e-2)"	108.3	79.2	81.8	50.1	102.7	113.4	76.8	101.2	102.7	73.9	70.8	67.9	63.4	74.1	66.1	82.1	65.1	64.7	78.6	78.7	91.3	77.0	63.6	91.7	44.0	111.4	102.3	78.2	33.0	74.0	46.8	87.1	111.1	60.2	74.1	26.2	45.7	81.7	89.4	71.0	69.7	85.5	97.2	56.7	60.6	43.8	93.6	37.1	67.9	98.9	52.3	86.4	60.8	123.6	92.3	64.3	67.9	81.4	181.9	204.1	47.7	162.5	183.3	170.8	160.5	70.8	116.1	12.1	89.1	205.8	86.9	78.5	75.2	109.9	218.1	9.6	93.5	59.2	56.8	99.3	118.0	35.4	56.2	167.2	80.7	121.8	98.7	168.4	209.6	26.8	61.9	54.5	241.7	41.2	26.7	31.5	30.0	102.9	111.6	21.9	98.7	37.4	133.7	52.4	18.6	70.8	141.2	68.5	152.2	81.1	69.4	37.3	186.9	152.5	52.3	160.0	79.4	44.7	65.2	35.1	174.7	140.9	122.9	63.7	63.0	63.0	15.9	71.7	16.5	13.8	14.9	14.1	43.1	11.2	11.9	13.0	84.0	19.0	65.0	14.0	20.9	30.2	81.8	102.7	101.2	102.7	78.7	91.3	111.4	102.3	111.1	97.2	93.6	123.6	88.0	48.1	46.1	11.8	18.6	43.6	58.2	38.8	50.1	12.5	30.5	29.1	44.8	37.1	31.8	40.5	4.2	85.6	24.2	60.1	64.6	67.9	24.3	24.7	35.4	88.1	31.2	28.8	9.6	50.5	113.7	46.1	26.5	28.8	58.2	31.1	73.2	37.5	78.0	8.4	9.9	42.8	42.7	78.2	63.3	12.5	32.3	65.9	56.9	8.4	72.0	76.0	27.8	12.5	24.4	89.8	44.5	47.0	21.6	62.0	65.5	100.0	29.4	8.6	46.0	52.2	53.0	61.3	49.3	61.7	51.3	114.5	21.3	53.3	43.0	86.1
VAMP8	EDB	ENSG00000118640	"Vesicle associated membrane protein 8"	Q9BV40	2	85561562-85582031	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Antiviral defense, Autophagy, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HL-60: 873.4;NB-4: 1362.5;U-937: 912.8"	"Low region specificity"	"Detected in all"							"HPA006882, HPA007215, CAB037132, CAB037147"	Enhanced		Approved	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA		220000	"Cluster 47: Plasmacytoid DCs - Protein folding"	"Cluster 29: Non-specific - Vesicular transport"	"Cluster 24: NB-4 - Immune response"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	"Golgi apparatus, Plasma membrane"	Nucleoplasm	"CAB037132: AB_1080547, CAB037147: AB_1080544, HPA006882: AB_1858716, HPA007215: "	"unprognostic (1.00e-1)"	"unprognostic (1.16e-1)"	"unprognostic (7.46e-3)"	"unprognostic (1.13e-1)"	"unprognostic (7.33e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.76e-2)"	"unprognostic (3.79e-3)"	"unprognostic (3.83e-2)"	"unprognostic (4.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (8.62e-2)"	"unprognostic (1.57e-3)"	"unprognostic (1.92e-2)"	"unprognostic (2.16e-1)"	"prognostic favorable (8.07e-9)"	"prognostic favorable (1.59e-6)"	74.0	34.7	26.9	148.4	28.2	299.7	225.1	28.7	53.8	121.8	51.6	250.6	229.9	30.6	144.5	303.1	166.1	119.2	24.6	26.5	29.9	280.1	247.4	266.5	212.4	35.6	31.6	10.4	182.5	270.3	33.7	265.7	34.3	107.7	300.9	4.4	322.5	90.4	24.3	210.2	252.1	71.4	31.9	175.9	228.4	23.4	35.5	173.5	126.0	27.3	311.7	198.0	150.0	36.5	255.0	33.2	2.6	2.3	2.4	1.4	241.6	0.7	0.3	0.2	0.3	191.2	225.2	56.8	174.4	1.2	17.9	175.2	2.4	451.6	0.6	232.3	173.7	290.3	104.4	220.7	3.3	873.4	287.1	2.3	317.5	0.3	72.3	1.2	58.2	1.2	214.9	11.6	103.8	363.9	0.8	1362.5	3.2	315.9	26.0	5.2	8.9	381.7	516.9	384.3	8.4	2.9	120.9	628.3	19.4	126.3	231.4	665.4	113.9	0.3	15.3	2.9	2.7	3.0	151.1	340.0	2.6	912.8	1.1	601.3	868.6	328.4	469.3	740.3	455.6	519.3	537.0	463.3	787.3	508.3	423.2	442.0	52.4	556.3	460.0	2135.6	665.3	1536.0	26.9	28.2	28.7	53.8	26.5	29.9	35.6	31.6	34.3	31.9	35.5	36.5	39.4	371.8	283.2	1.3	147.7	259.1	303.3	800.9	164.4	1.2	289.7	251.7	6.3	356.0	662.1	366.0	0.0	980.8	447.1	832.3	765.0	630.7	28.0	231.3	22.8	46.1	129.1	147.4	0.1	730.0	460.4	35.6	188.6	212.9	269.4	3.3	163.1	314.8	1191.1	0.0	0.1	391.8	545.3	1000.4	488.7	49.1	9.3	537.2	352.2	2.8	686.1	7.9	375.9	0.0	0.5	865.5	843.2	7.5	103.0	302.7	1184.0	1046.8	600.5	2.0	46.0	21.4	56.5	48.0	8.3	239.8	329.7	877.8	219.5	13.8	299.4	602.0
VANGL1	STB2	ENSG00000173218	"VANGL planar cell polarity protein 1"	Q8TAA9	1	115641970-115698224	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 39.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Immune cell enhanced"	"Detected in many"		"NK-cell: 6.2"	"Group enriched"	"Detected in many"	7	"dendritic cells: 2.3;NK-cells: 6.2;T-cells: 3.0"	"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025235, CAB076375"	Approved		Approved	"Plasma membrane"		NA	Yes			"Cluster 48: NK-cells - Unknown function"	"Cluster 12: Smooth muscle tissue - Mixed function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 26: Respiratory epithelial cells - Mucosal defense"	"Plasma membrane"		"CAB076375: AB_2665604, HPA025235: AB_1858718"	"unprognostic (1.04e-2)"	"unprognostic (2.04e-2)"	"prognostic favorable (7.53e-4)"	"unprognostic (9.94e-2)"	"unprognostic (1.71e-2)"	"unprognostic (5.18e-2)"	"unprognostic (2.18e-3)"	"unprognostic (5.11e-3)"	"unprognostic (2.11e-1)"	"unprognostic (6.43e-3)"	"prognostic unfavorable (7.89e-4)"	"unprognostic (1.88e-2)"	"unprognostic (1.74e-2)"	"unprognostic (7.71e-3)"	"unprognostic (1.21e-1)"	"unprognostic (4.50e-3)"	"unprognostic (9.06e-3)"	4.9	3.9	2.1	3.8	1.2	2.5	3.2	0.8	1.1	9.1	3.0	6.8	3.8	5.5	4.9	10.4	12.0	3.8	5.4	1.3	1.3	5.3	3.0	4.1	2.1	1.2	3.0	4.4	5.0	5.2	0.5	3.6	1.7	4.4	6.4	1.6	6.4	4.5	0.9	6.8	3.9	7.3	1.2	2.2	5.5	5.0	6.5	7.3	7.6	2.4	2.5	6.4	4.4	1.0	49.6	20.7	6.6	8.9	24.1	21.5	13.1	18.8	13.5	24.1	19.1	12.0	24.1	0.0	31.5	21.9	22.7	60.9	11.2	33.3	15.8	57.9	13.7	27.4	18.4	9.8	8.8	8.2	11.4	11.4	23.1	17.2	18.2	12.8	24.1	45.9	16.8	14.8	24.5	65.7	41.0	3.4	16.7	28.8	19.5	0.1	19.1	14.3	11.0	32.8	5.9	8.0	33.9	22.2	15.4	12.4	11.3	8.8	26.2	16.5	25.7	36.3	34.6	2.1	2.3	0.2	22.3	14.3	41.1	0.0	0.5	0.0	1.9	0.3	0.5	0.2	1.2	1.9	2.3	0.0	0.4	2.0	0.0	6.2	0.5	2.0	3.0	1.0	2.1	1.2	0.8	1.1	1.3	1.3	1.2	3.0	1.7	1.2	6.5	1.0	9.2	3.2	3.2	5.5	0.5	7.4	7.4	16.8	11.4	5.2	4.6	4.6	7.9	2.8	9.6	9.2	39.6	5.0	3.4	11.2	0.0	15.7	6.1	25.1	7.7	10.5	6.7	13.2	0.9	13.8	7.3	10.1	8.2	17.0	0.0	5.1	28.9	2.5	4.3	0.0	0.7	8.6	10.2	1.9	1.4	3.0	5.9	2.9	0.0	4.7	11.1	4.7	9.2	2.0	0.1	20.8	6.1	8.2	1.8	8.3	2.6	5.6	12.8	0.9	6.6	4.3	8.5	5.5	7.0	20.0	6.5	0.4	3.1	3.2	10.3	6.5
VAPA	"hVAP-33, VAP-A"	ENSG00000101558	"VAMP associated protein A"	Q9P0L0	18	9914016-9960021	"Metabolic proteins, Plasma proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA009174	Approved		Enhanced	"Endoplasmic reticulum"		NA	NA		580000	"Cluster 45: Eosinophils - Innate immune response"	"Cluster 55: Non-specific - Mitochondria & Proteasome"	"Cluster 3: HMC-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"	"Endoplasmic reticulum"		"HPA009174: AB_1080549"	"unprognostic (4.03e-2)"	"unprognostic (7.47e-2)"	"unprognostic (9.36e-2)"	"unprognostic (5.20e-2)"	"unprognostic (2.00e-1)"	"unprognostic (2.99e-2)"	"unprognostic (4.79e-3)"	"unprognostic (1.80e-1)"	"unprognostic (5.39e-2)"	"unprognostic (6.80e-3)"	"unprognostic (2.99e-2)"	"unprognostic (8.11e-2)"	"prognostic favorable (5.72e-7)"	"unprognostic (1.03e-1)"	"unprognostic (1.66e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.77e-2)"	33.1	67.1	21.5	24.2	26.8	97.1	29.5	30.7	28.1	30.2	21.5	38.6	31.2	32.9	24.8	47.5	29.3	31.9	37.5	23.2	24.9	32.6	36.6	33.9	25.7	34.9	26.3	39.1	40.9	36.2	17.7	29.8	34.5	24.5	35.4	20.1	32.6	22.0	69.7	32.3	30.6	27.4	27.8	26.7	38.9	29.1	25.5	30.0	35.2	38.4	26.3	36.5	32.2	30.7	58.1	34.4	40.7	26.7	46.9	50.5	56.8	69.9	57.9	62.3	67.9	46.6	55.9	56.5	63.6	61.5	53.9	39.7	39.8	66.7	70.7	35.6	49.8	92.4	33.8	72.3	110.8	126.3	169.7	47.8	66.3	59.0	69.6	48.7	64.0	45.4	94.6	57.3	55.2	31.2	97.4	72.9	26.2	197.6	54.3	50.4	55.2	77.5	60.9	57.3	57.2	31.2	81.1	48.7	53.2	37.2	45.7	64.2	68.9	100.7	75.3	105.6	86.3	101.9	89.2	66.6	57.0	53.5	70.8	131.3	143.3	251.0	69.8	127.9	82.9	100.0	72.1	75.4	118.1	94.4	78.1	72.1	226.2	90.8	109.5	84.6	98.9	183.9	21.5	26.8	30.7	28.1	23.2	24.9	34.9	26.3	34.5	27.8	25.5	30.7	173.6	128.2	178.8	63.0	160.0	673.4	358.4	356.5	278.3	113.9	248.2	179.3	218.3	167.3	229.4	207.8	62.6	296.9	148.0	427.2	457.8	291.8	10.5	235.9	182.2	232.4	144.6	188.1	91.4	361.3	321.6	221.4	156.0	255.8	225.2	220.2	211.3	141.1	287.8	136.3	93.2	180.6	390.6	288.2	459.8	21.7	182.0	285.9	279.3	63.7	350.4	124.3	108.1	102.1	150.4	310.2	262.7	216.3	146.6	335.4	255.9	390.4	265.5	79.5	190.7	204.8	371.4	231.3	201.4	267.3	622.5	452.6	190.2	253.6	201.0	390.8
VAPB	"ALS8, VAP-B, VAP-C"	ENSG00000124164	"VAMP associated protein B and C"	O95292	20	58389229-58451101	"Disease related genes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Host-virus interaction, Unfolded protein response"		"Amyotrophic lateral sclerosis, Disease variant, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA013144, CAB013722"	Supported		Enhanced	"Endoplasmic reticulum"		NA	NA		240000	"Cluster 32: T-cells - Unknown function"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 8: SK-BR-3 - Unknown function"	"Cluster 38: Extravillous trophoblasts - Unknown function"	"Endoplasmic reticulum"		"CAB013722: , HPA013144: AB_1858717"	"unprognostic (3.28e-3)"	"unprognostic (3.88e-2)"	"unprognostic (1.02e-1)"	"unprognostic (2.51e-2)"	"unprognostic (9.36e-2)"	"unprognostic (3.15e-2)"	"unprognostic (4.76e-3)"	"unprognostic (2.80e-1)"	"unprognostic (4.47e-2)"	"unprognostic (8.06e-3)"	"unprognostic (3.11e-2)"	"unprognostic (2.99e-1)"	"prognostic favorable (1.08e-8)"	"unprognostic (1.05e-1)"	"unprognostic (5.31e-1)"	"unprognostic (6.34e-3)"	"unprognostic (2.99e-2)"	15.7	36.4	32.1	11.2	30.4	4.2	14.2	29.6	30.1	13.7	20.3	24.2	19.6	16.4	10.3	19.3	14.9	9.7	29.4	28.8	33.5	24.8	35.0	14.1	9.6	34.6	34.0	17.9	18.9	27.9	21.0	9.2	36.2	17.8	9.9	14.3	16.2	12.3	46.4	13.0	18.2	11.6	36.4	15.0	19.0	8.8	37.0	12.2	23.3	39.6	6.7	18.1	12.9	31.5	31.0	30.4	33.6	18.0	30.3	12.5	29.5	27.0	11.2	41.0	20.1	123.0	29.0	27.2	37.7	18.3	32.3	57.6	27.1	38.9	24.6	12.8	20.2	16.5	32.2	38.9	30.2	15.5	19.8	28.9	44.4	22.8	18.7	19.8	20.5	26.7	39.5	14.9	20.0	96.7	24.5	30.6	17.7	60.2	40.0	24.2	31.3	18.0	31.6	40.7	47.1	32.6	44.7	117.0	48.0	18.4	48.0	23.2	28.6	65.8	31.9	33.3	36.9	19.9	23.1	31.4	55.7	16.8	33.8	2.1	2.3	3.1	3.9	2.4	4.5	2.8	4.6	3.2	2.3	2.3	3.3	4.8	3.7	3.7	3.0	2.3	2.7	2.6	32.1	30.4	29.6	30.1	28.8	33.5	34.6	34.0	36.2	36.4	37.0	31.5	22.5	44.8	26.8	31.6	18.7	11.7	13.5	17.2	23.9	29.7	23.6	21.1	46.5	24.3	16.6	31.3	29.2	34.8	20.7	28.6	35.2	35.1	5.0	18.2	20.9	23.2	21.7	18.7	34.3	30.5	50.3	24.0	20.4	16.0	9.5	23.3	15.7	40.3	16.1	35.3	34.7	23.4	22.4	18.5	10.0	6.1	18.6	17.3	14.2	40.3	22.8	34.3	20.6	35.2	43.7	37.5	22.4	25.2	14.0	17.7	38.9	42.9	19.1	29.7	13.1	22.2	26.0	22.0	29.4	18.2	10.5	44.5	20.5	37.4	27.6	16.6
VCP	"CDC48, IBMPFD, p97, TERA"	ENSG00000165280	"Valosin containing protein"	P55072	9	35053928-35072668	"Disease related genes, Enzymes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Autophagy, DNA damage, DNA repair, Transport, Ubl conjugation pathway"	Hydrolase	"Amyotrophic lateral sclerosis, Charcot-Marie-Tooth disease, Disease variant, Neurodegeneration, Neuropathy"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 540.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB005593, HPA012728, HPA012814"	Supported		Enhanced	Nucleoplasm,Cytosol		No	No		34000000	"Cluster 46: Basophils - DNA binding"	"Cluster 39: Non-specific - Mitochondria"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Nucleoplasm, Cytosol"		"CAB005593: AB_2214638, HPA012728: AB_1858730, HPA012814: AB_1858729"	"unprognostic (1.10e-1)"	"unprognostic (2.66e-1)"	"unprognostic (8.15e-2)"	"prognostic favorable (7.30e-4)"	"unprognostic (5.78e-2)"	"unprognostic (1.87e-1)"	"unprognostic (2.52e-3)"	"unprognostic (1.13e-2)"	"unprognostic (3.82e-2)"	"unprognostic (1.81e-2)"	"unprognostic (2.19e-2)"	"unprognostic (3.24e-1)"	"prognostic favorable (9.63e-7)"	"unprognostic (1.83e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.93e-1)"	"unprognostic (9.11e-2)"	59.8	88.4	56.8	33.7	59.0	52.0	54.2	58.9	58.0	57.8	72.0	51.8	33.8	59.0	51.6	84.9	49.4	35.3	117.5	60.4	66.2	59.1	87.5	57.2	42.5	64.4	62.0	46.1	61.2	65.7	57.3	46.0	68.2	54.5	36.5	26.3	63.2	58.9	176.0	64.0	51.8	42.5	62.3	64.1	62.5	45.1	63.7	59.6	49.7	135.3	53.3	57.9	55.3	69.8	167.6	223.8	124.6	57.5	187.4	135.3	98.3	153.8	215.0	244.1	197.6	160.0	60.1	140.8	137.2	242.9	173.1	69.5	253.1	230.7	227.6	146.2	126.0	95.3	216.5	238.0	146.5	92.4	106.2	148.5	136.4	239.2	115.6	104.4	276.2	56.3	97.6	71.4	219.2	154.7	114.3	234.9	152.2	82.7	219.1	80.7	111.8	72.8	204.1	175.7	65.7	84.1	100.4	81.2	45.1	152.2	71.5	60.3	215.5	77.5	112.5	63.7	118.6	41.9	116.5	104.3	139.5	67.0	105.4	142.0	62.7	75.0	58.8	70.0	62.4	59.2	59.0	65.6	75.3	53.0	42.3	44.4	71.1	67.1	80.4	49.8	91.2	111.8	56.8	59.0	58.9	58.0	60.4	66.2	64.4	62.0	68.2	62.3	63.7	69.8	86.5	80.1	73.7	22.9	124.3	77.0	120.8	147.6	111.5	86.6	66.0	47.2	220.4	47.1	115.1	55.2	118.9	276.8	91.0	111.9	74.3	188.6	43.6	97.8	85.6	127.7	84.2	137.0	27.4	187.5	164.7	109.7	133.5	105.8	62.1	106.2	111.0	126.0	133.1	74.0	27.7	108.3	89.5	57.9	65.6	47.0	83.9	81.5	76.5	16.9	159.6	88.7	54.6	18.6	31.4	247.9	69.0	86.9	267.6	118.3	77.2	113.4	102.5	90.0	138.1	74.1	154.9	144.5	118.7	126.2	90.6	540.6	105.4	129.6	96.4	135.6
VDAC2		ENSG00000165637	"Voltage dependent anion channel 2"	P45880	10	75210154-75231448	"Predicted intracellular proteins, Transporters"	"Ion transport, Transport"	Porin		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA043475	Enhanced		Supported	Mitochondria		NA	NA		490000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 19: HEK293 & PC-3 - Transcription regulation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"	Mitochondria		"HPA043475: AB_10795615"	"unprognostic (1.01e-2)"	"unprognostic (1.22e-1)"	"unprognostic (9.47e-2)"	"unprognostic (9.00e-3)"	"unprognostic (5.74e-2)"	"prognostic unfavorable (4.51e-4)"	"prognostic unfavorable (4.55e-4)"	"unprognostic (1.83e-3)"	"unprognostic (5.89e-2)"	"unprognostic (2.45e-1)"	"unprognostic (2.02e-2)"	"unprognostic (1.56e-2)"	"unprognostic (4.27e-2)"	"unprognostic (1.40e-1)"	"unprognostic (1.65e-1)"	"unprognostic (6.28e-2)"	"unprognostic (1.34e-2)"	138.2	150.3	95.5	93.3	97.4	138.5	116.2	116.2	115.0	165.5	117.1	209.1	151.3	116.6	90.7	322.1	117.4	85.4	420.5	99.0	109.0	177.5	115.9	112.0	83.5	105.7	107.1	132.8	150.6	192.7	85.3	115.6	110.1	108.8	184.4	198.4	151.4	134.0	539.4	171.6	148.4	149.2	105.0	77.7	159.4	104.6	107.1	92.7	111.0	565.9	148.3	163.6	207.1	110.4	304.4	245.0	291.0	370.5	253.3	342.1	305.2	384.9	430.4	412.7	386.6	367.5	281.8	358.6	210.9	324.3	228.6	398.2	539.2	382.2	402.1	196.0	313.5	209.4	191.4	425.2	252.6	402.0	223.4	305.6	441.7	352.8	747.3	578.2	310.0	222.9	359.9	283.7	439.4	222.6	262.6	325.7	250.7	341.2	937.6	308.2	230.0	228.3	408.9	187.5	183.4	216.5	212.4	701.7	467.4	337.8	409.7	177.4	241.4	204.4	279.8	305.7	419.8	226.7	333.1	369.0	296.3	390.4	178.1	168.2	179.0	138.9	106.7	193.1	130.8	154.2	144.3	119.4	220.4	127.9	144.2	134.5	61.5	135.5	238.4	107.3	178.6	221.6	95.5	97.4	116.2	115.0	99.0	109.0	105.7	107.1	110.1	105.0	107.1	110.4	130.3	96.1	54.9	30.3	135.5	381.4	417.8	575.6	280.6	149.6	149.5	159.1	325.1	128.7	246.3	112.2	43.8	315.0	128.0	583.7	669.1	413.3	257.6	172.2	110.9	146.5	149.7	148.5	22.1	345.7	437.6	142.6	158.0	199.9	112.3	197.5	165.9	79.2	266.1	129.5	30.7	305.1	284.8	164.8	220.3	110.8	169.9	180.2	224.1	16.9	264.3	275.5	92.7	23.1	26.0	443.5	497.2	166.3	172.2	386.3	610.9	324.3	119.5	161.1	177.5	170.3	289.0	359.7	149.7	493.3	420.4	396.5	129.6	210.5	355.7	568.1
VDR	"NR1I1, PPP1R163"	ENSG00000111424	"Vitamin D receptor"	P11473	12	47841537-47943048	"Disease related genes, FDA approved drug targets, Human disease related genes, Nuclear receptors, Predicted intracellular proteins, Transcription factors, Transporters"	"Transcription, Transcription regulation"	"DNA-binding, Receptor"	"Disease variant, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"parathyroid gland: 235.9"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 141.7;Proximal enterocytes: 88.7;Undifferentiated cells: 72.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in single"			"Group enriched"	"Detected in many"	7	"classical monocyte: 3.5;eosinophil: 1.9;intermediate monocyte: 6.5;myeloid DC: 5.1;neutrophil: 6.5;non-classical monocyte: 6.7"	"Group enriched"	"Detected in many"	8	"dendritic cells: 5.1;granulocytes: 6.5;monocytes: 6.7"	"Cell line enhanced"	"Detected in many"		"HBEC3-KT: 55.5;HDLM-2: 80.0;U-937: 85.3"	"Region enhanced"	"Detected in single"		"olfactory bulb: 2.1"	"Region enhanced"	"Detected in some"		"spinal cord: 4.3"	"CAB004617, HPA047740, HPA072102"			Supported	"Nucleoplasm,Intermediate filaments,Cytosol"		NA	NA			"Cluster 7: Monocytes - Unknown function"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 44: HDLM-2 - Immune response"	"Cluster 53: Intestinal epithelial cells - Unknown function"	Nucleoplasm	"Intermediate filaments, Cytosol"	"CAB004617: AB_628040, HPA047740: AB_2680142, HPA072102: "	"unprognostic (1.11e-2)"	"unprognostic (5.49e-2)"	"unprognostic (1.01e-1)"	"unprognostic (7.59e-3)"	"unprognostic (3.33e-3)"	"unprognostic (2.74e-2)"	"unprognostic (4.78e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.62e-1)"	"unprognostic (5.53e-3)"	"unprognostic (6.72e-2)"	"prognostic favorable (4.89e-6)"	"unprognostic (1.46e-1)"	"unprognostic (8.76e-2)"	"unprognostic (3.28e-1)"	"unprognostic (3.82e-2)"	3.6	13.7	0.2	13.3	0.2	8.2	11.3	0.2	0.4	5.0	0.9	40.4	56.0	1.6	0.4	13.6	1.8	8.5	1.2	0.2	0.7	21.0	1.1	7.7	5.3	0.7	0.4	0.5	2.1	235.9	11.1	2.9	0.6	1.9	35.3	0.2	6.1	1.8	2.8	22.1	55.0	3.8	0.1	2.6	7.4	1.0	1.4	1.5	2.2	0.6	7.2	10.4	7.6	0.3	15.0	2.6	0.1	0.1	12.0	16.4	0.2	17.7	8.6	15.0	12.9	10.6	12.1	3.5	17.4	13.6	10.7	27.1	0.5	55.5	6.4	80.0	4.0	6.3	3.1	0.9	8.1	12.2	20.3	23.6	30.5	16.4	26.0	22.3	1.2	1.3	1.8	3.9	7.0	9.2	0.3	6.0	0.2	34.8	19.1	0.3	0.0	9.9	13.3	13.5	6.2	0.2	14.7	42.6	5.9	0.1	47.6	6.7	1.0	28.8	7.3	8.2	10.2	2.2	0.1	3.0	8.6	85.3	7.7	0.1	3.5	1.9	0.0	6.5	0.1	0.5	0.3	0.0	5.1	0.0	0.1	0.0	6.5	0.2	6.7	0.4	0.7	1.5	0.2	0.2	0.2	0.4	0.2	0.7	0.7	0.4	0.6	0.1	1.4	0.3	0.4	12.8	20.1	0.3	1.4	36.1	9.0	8.5	24.5	0.5	21.2	13.7	1.7	0.0	9.2	7.3	0.0	0.2	0.9	141.7	7.9	3.5	0.2	11.9	0.5	1.3	21.7	0.0	0.4	10.9	0.1	5.3	14.3	4.7	7.0	0.2	0.0	0.3	3.4	0.0	0.3	32.8	2.0	7.3	43.4	0.0	0.0	21.2	8.8	1.0	10.4	0.2	0.0	0.5	0.1	22.4	43.3	0.4	10.9	8.3	88.7	32.0	9.0	0.2	0.0	1.1	2.2	0.7	0.3	23.4	40.6	0.3	2.8	0.0	72.4	11.6
VEGFC	"VEGF-C, VRP"	ENSG00000150630	"Vascular endothelial growth factor C"	P49767	4	176683538-176792922	"Cancer-related genes, Disease related genes, Human disease related genes, Potential drug targets, Predicted secreted proteins, RAS pathway related proteins, Transporters"	"Angiogenesis, Differentiation"	"Developmental protein, Growth factor, Mitogen"	"Cancer-related genes"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 39.3;Endothelial cells: 22.0;Leydig cells: 13.7;Microglial cells: 36.5"	"Cancer enhanced"	"Detected in all"		"thyroid cancer: 22.7"	"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in many"		"BJ: 146.5;HBF TERT88: 114.4;hTEC/SVTERT24-B: 116.5;LHCN-M2: 129.9"	"Low region specificity"	"Detected in all"			"Region enhanced"	"Detected in many"		"cerebellum: 7.0"						"Secreted to blood"	NA	NA	383000	340000		"Cluster 82: Adipose tissue - ECM organization"	"Cluster 10: BJ & FHDF - ECM organization"	"Cluster 14: Adipocytes & Endothelial cells - Angiogenesis"				"unprognostic (4.18e-1)"	"unprognostic (4.07e-2)"	"unprognostic (4.84e-3)"	"unprognostic (1.15e-2)"	"unprognostic (2.83e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.57e-1)"	"prognostic unfavorable (7.88e-5)"	"unprognostic (4.53e-1)"	"unprognostic (2.80e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.23e-1)"	"prognostic unfavorable (1.17e-4)"	"unprognostic (1.89e-3)"	"unprognostic (4.41e-2)"	"unprognostic (2.54e-1)"	"unprognostic (1.22e-1)"	25.0	6.9	2.6	4.2	2.5	0.2	16.7	2.7	2.8	9.7	2.1	4.7	2.4	7.3	1.8	4.0	8.5	6.8	12.7	2.4	2.4	6.7	4.2	16.8	8.0	3.1	2.8	5.9	1.8	2.7	1.5	19.3	2.9	5.1	3.3	1.2	7.4	5.0	3.1	5.1	6.8	6.6	2.6	3.9	3.2	1.4	3.7	1.1	27.7	4.1	3.4	10.3	7.6	2.5	5.9	2.8	1.8	0.0	25.5	25.3	0.0	146.5	87.3	79.2	62.5	0.0	0.7	0.0	0.0	82.7	33.1	4.4	1.3	54.8	114.4	0.1	2.8	0.0	3.8	0.0	13.9	0.0	0.0	27.0	2.5	116.5	80.5	79.3	49.7	0.0	0.0	0.0	129.9	2.1	0.0	0.0	1.3	0.0	47.1	0.0	8.4	0.0	0.0	3.3	0.0	0.0	2.3	3.3	0.1	0.7	0.7	0.2	24.2	83.6	9.2	20.8	42.1	0.2	0.0	0.0	34.9	0.0	9.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	2.6	2.5	2.7	2.8	2.4	2.4	3.1	2.8	2.9	2.6	3.7	2.5	39.3	3.2	0.0	10.1	0.1	2.4	1.3	3.2	0.0	1.0	3.2	1.7	1.5	0.0	1.8	0.0	0.0	0.0	0.2	0.0	0.0	0.5	3.1	8.3	10.9	22.0	0.0	0.0	2.0	0.0	0.0	9.1	0.0	11.0	0.0	8.5	10.0	0.0	0.3	1.7	2.0	0.0	4.1	0.3	2.2	1.2	13.7	0.4	3.6	36.5	0.0	3.4	0.0	1.5	0.6	0.1	0.0	0.0	0.0	1.8	0.0	0.0	0.4	0.2	0.0	1.9	11.7	0.2	2.0	0.3	2.0	0.0	0.2	1.9	0.0	3.6
VEZT	DKFZP761C241	ENSG00000028203	"Vezatin, adherens junctions transmembrane protein"	Q9HBM0	12	95217746-95302799	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA004811, HPA017066"	Approved		Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 46: Photoreceptor cells - Phototransduction"	Nucleoplasm	Cytosol	"HPA004811: AB_1080563, HPA017066: AB_1858742"	"unprognostic (3.91e-1)"	"unprognostic (6.34e-3)"	"unprognostic (3.48e-2)"	"unprognostic (1.64e-1)"	"unprognostic (1.47e-1)"	"unprognostic (1.31e-2)"	"prognostic unfavorable (1.71e-4)"	"unprognostic (2.28e-1)"	"unprognostic (9.93e-2)"	"unprognostic (4.18e-1)"	"unprognostic (1.10e-3)"	"unprognostic (3.37e-3)"	"prognostic unfavorable (1.93e-5)"	"prognostic unfavorable (3.68e-4)"	"unprognostic (1.51e-1)"	"unprognostic (4.06e-1)"	"unprognostic (5.02e-2)"	7.3	9.9	7.7	5.8	8.0	3.3	8.9	11.3	9.9	9.2	3.1	7.6	5.8	8.2	9.6	6.6	7.7	7.4	9.5	8.5	8.6	6.9	6.2	7.8	6.4	4.4	5.7	11.2	9.0	8.6	13.4	9.4	5.7	9.6	6.3	20.3	5.4	7.6	23.8	10.3	5.9	7.1	4.0	4.1	5.6	4.5	6.9	6.6	18.9	21.2	6.4	7.5	8.5	7.1	14.4	12.9	18.0	9.5	14.7	9.2	6.8	10.3	13.3	8.7	12.9	4.8	6.6	18.6	6.5	8.8	4.3	7.4	13.3	9.2	15.2	12.6	7.3	7.2	3.3	5.2	7.5	14.2	4.1	12.7	15.6	7.6	21.9	19.0	17.1	8.9	4.2	7.0	7.6	4.0	12.4	6.7	9.2	4.5	13.1	11.1	8.4	6.0	23.8	10.3	12.1	10.6	10.1	14.9	4.9	15.8	18.4	2.4	13.9	7.2	2.8	3.5	5.8	6.8	11.4	16.3	2.8	5.1	3.8	0.2	1.5	0.5	1.5	1.6	2.1	2.5	2.2	0.9	2.0	1.8	1.0	0.9	0.1	1.1	0.4	0.8	1.8	0.5	7.7	8.0	11.3	9.9	8.5	8.6	4.4	5.7	5.7	4.0	6.9	7.1	36.5	70.5	49.3	88.8	31.1	77.8	58.1	37.5	63.2	67.9	46.3	28.6	49.0	37.1	44.5	33.1	85.5	39.6	26.3	40.0	9.8	50.1	16.5	30.1	48.4	44.6	38.4	22.1	151.8	45.2	22.3	31.0	27.5	53.8	29.2	59.9	47.8	36.7	21.6	62.2	149.1	36.1	30.5	27.1	37.5	11.4	32.6	23.2	37.4	74.9	25.2	24.1	14.4	101.0	98.4	76.4	39.4	33.1	40.5	54.6	33.0	21.5	33.1	146.6	6.6	39.0	37.3	39.4	21.3	57.8	72.5	110.7	29.1	32.7	24.9	71.7
VIPR1	"HVR1, RDC1, VPAC1, VPAC1R"	ENSG00000114812	"Vasoactive intestinal peptide receptor 1"	P32241	3	42489299-42537573	"G-protein coupled receptors, Predicted membrane proteins, Transporters"		"G-protein coupled receptor, Receptor, Transducer"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lung: 132.1"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 71.8;Intestinal goblet cells: 48.6;Paneth cells: 96.2;Proximal enterocytes: 58.6"	"Cancer enhanced"	"Detected in many"		"prostate cancer: 10.7"	"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Group enriched"	"Detected in many"	22	"dendritic cells: 2.1;monocytes: 1.8;T-cells: 2.7"	"Cell line enhanced"	"Detected in some"		"CAPAN-2: 60.8;OE19: 36.2;RT4: 44.0;SK-BR-3: 24.7;WM-115: 79.0"	"Group enriched"	"Detected in many"	4	"amygdala: 6.3;basal ganglia: 4.5;cerebral cortex: 9.6;hippocampal formation: 7.7;white matter: 2.5"	"Low region specificity"	"Detected in all"			HPA026777	Approved					NA	NA			"Cluster 32: T-cells - Unknown function"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 17: WM-115 - Nervous system development"	"Cluster 53: Intestinal epithelial cells - Unknown function"			"HPA026777: AB_10604003"	"unprognostic (9.02e-2)"	"unprognostic (9.34e-3)"	"unprognostic (3.70e-1)"	"unprognostic (1.57e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.47e-2)"	"unprognostic (8.89e-4)"	"unprognostic (4.00e-3)"	"unprognostic (1.03e-1)"	"unprognostic (2.95e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.72e-1)"	"unprognostic (1.82e-3)"	"unprognostic (7.70e-2)"	"unprognostic (1.69e-1)"	"unprognostic (1.03e-2)"	"unprognostic (1.05e-2)"	17.5	2.6	10.1	3.4	12.7	2.3	16.9	13.5	15.2	2.9	5.1	28.0	34.5	1.2	6.6	5.3	1.3	6.0	6.5	13.0	5.5	2.7	32.4	132.1	4.6	5.3	4.8	0.6	2.5	4.2	1.9	2.8	6.3	25.0	27.7	4.2	22.7	8.9	1.2	29.8	30.0	1.3	4.4	5.7	6.1	1.4	4.7	1.9	15.1	4.9	2.4	8.7	5.0	12.1	0.1	2.4	0.1	0.0	0.0	0.0	2.1	0.0	0.0	0.1	0.4	2.2	60.8	0.2	3.1	0.0	0.0	2.4	0.0	1.6	0.1	0.0	5.2	3.8	1.8	0.0	0.3	0.0	0.5	0.0	3.8	0.2	1.2	0.0	0.7	0.6	0.0	0.0	0.0	5.2	0.0	0.3	3.8	36.2	0.2	0.5	0.0	2.8	0.0	44.0	1.3	0.0	0.0	24.7	0.0	7.1	15.2	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	79.0	0.0	1.8	0.0	0.2	1.5	1.0	0.0	2.4	1.0	2.1	0.0	2.7	0.8	0.0	0.0	1.3	0.0	0.4	0.9	10.1	12.7	13.5	15.2	13.0	5.5	5.3	4.8	6.3	4.4	4.7	12.1	16.0	3.2	6.0	3.3	1.3	7.6	4.5	2.2	22.2	0.2	19.2	21.5	2.6	5.7	2.1	1.8	8.4	0.1	0.4	71.8	0.0	0.3	3.0	0.2	0.1	2.8	4.8	0.0	26.9	0.9	1.0	1.0	16.3	0.6	0.0	0.3	19.6	0.4	0.7	0.0	1.5	48.6	0.0	8.7	4.0	0.6	0.0	5.9	0.0	3.7	8.9	1.4	0.0	3.0	1.7	1.2	96.2	0.0	1.5	6.3	58.6	0.1	1.0	5.4	32.9	0.2	20.8	0.1	0.1	4.1	7.7	0.3	2.9	0.1	24.0	3.9
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Autophagy, Cell adhesion"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Basal prostatic cells: 984.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enriched"	"Detected in all"	4	"neutrophil: 3000.2"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 3000.2"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"		NA	NA			"Cluster 50: Neutrophils - Cellular senescence"	"Cluster 86: Liver & Placenta - Transport via ER"	"Cluster 21: OE19 - Mitochondria"	"Cluster 22: Epithelial cell types - Mixed function"	"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: AB_2685348"	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavorable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavorable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavorable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	36.7	47.2	23.1	56.2	29.1	22.8	36.6	15.9	32.7	30.3	5.4	58.6	56.0	32.4	23.2	33.0	16.0	59.8	22.0	17.1	23.7	36.6	58.5	29.6	31.4	29.1	24.9	22.9	30.8	38.4	10.4	39.2	27.3	34.0	59.8	30.2	23.5	23.1	19.9	19.5	60.4	33.9	24.5	52.5	47.6	22.3	35.8	22.3	32.5	28.9	20.7	47.9	16.4	38.0	65.8	128.2	43.8	82.2	88.3	54.8	77.3	87.4	87.4	64.3	98.0	85.1	166.1	42.2	143.9	70.6	81.5	79.8	62.4	59.5	80.5	102.7	80.9	55.5	89.2	97.3	89.6	68.5	51.4	77.4	46.7	87.3	76.2	93.2	67.6	41.3	69.8	70.2	68.7	177.9	66.7	21.9	63.0	146.6	75.3	41.8	79.8	101.1	92.5	72.1	36.4	89.1	57.5	62.4	83.8	62.6	124.4	49.0	89.8	81.3	75.0	68.8	83.6	105.4	145.0	66.8	84.4	37.6	92.8	131.6	570.4	76.0	62.8	393.0	69.2	56.6	59.3	65.4	174.3	49.5	53.9	60.5	3000.2	69.0	666.9	59.2	73.9	501.6	23.1	29.1	15.9	32.7	17.1	23.7	29.1	24.9	27.3	24.5	35.8	38.0	164.8	89.8	124.1	35.3	68.6	161.1	984.4	188.9	665.9	36.1	429.1	187.1	27.9	125.8	273.3	275.8	58.4	91.7	71.0	511.1	23.5	223.1	7.2	372.8	197.7	148.2	310.6	29.9	80.1	137.9	123.5	193.6	367.0	708.6	135.4	111.2	48.2	108.4	121.7	28.6	84.6	254.1	168.9	335.2	270.7	11.5	35.8	322.6	129.9	45.0	231.1	50.4	51.5	51.8	141.2	160.7	508.1	35.3	92.5	553.1	361.1	72.6	289.7	51.6	92.1	59.2	293.5	83.6	44.6	672.6	129.7	175.8	127.3	67.5	241.7	629.2
VN1R1	"V1RL1, VNR19I1, ZVNH1, ZVNR1"	ENSG00000178201	"Vomeronasal 1 receptor 1"	Q9GZP7	19	57454790-57457142	"G-protein coupled receptors, Predicted membrane proteins, Transporters"	"Pheromone response"	"G-protein coupled receptor, Receptor, Transducer"		"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in many"		"retina: 8.2"	"Cell type enhanced"	"Detected in some"		"Bipolar cells: 4.5;Cone photoreceptor cells: 2.1;Horizontal cells: 6.7;Oligodendrocyte precursor cells: 2.5;Rod photoreceptor cells: 4.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"HEK 293: 2.9;U-266/70: 2.5;U-266/84: 3.3"					"Not detected"	"Not detected"			HPA062209			Uncertain	Nucleoplasm,Vesicles		NA	NA				"Cluster 54: Non-specific - Microtubule organization"	"Cluster 29: U-266 - Adaptive immune response"	"Cluster 62: Horizontal cells - Visual perception"	Vesicles	Nucleoplasm	"HPA062209: "	"unprognostic (7.11e-2)"	"unprognostic (1.32e-1)"	"unprognostic (2.52e-1)"	"unprognostic (3.17e-2)"	"unprognostic (1.61e-1)"	"unprognostic (2.53e-1)"	"unprognostic (1.51e-2)"	"unprognostic (5.28e-2)"	"unprognostic (1.01e-1)"	"unprognostic (2.84e-2)"	"unprognostic (1.65e-3)"	"unprognostic (1.21e-2)"	"unprognostic (5.41e-2)"	"unprognostic (5.68e-2)"	"unprognostic (2.73e-1)"	"unprognostic (1.25e-2)"	"unprognostic (4.59e-5)"	0.5	1.0	2.2	0.2	2.4	0.3	0.7	4.5	2.4	0.6	1.8	1.2	0.0	0.5	2.2	0.6	0.8	0.3	2.0	2.3	1.9	1.2	1.0	0.8	0.4	1.8	1.9	1.2	0.6	1.1	3.4	0.6	1.4	1.3	0.3	8.2	0.9	0.6	2.3	1.7	0.7	0.3	1.3	1.1	0.5	1.3	1.9	0.4	1.7	2.7	0.3	0.9	0.6	2.2	0.2	0.0	0.8	0.9	0.0	0.2	0.4	0.2	0.3	0.2	0.8	0.0	0.1	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.3	0.0	2.9	0.4	0.0	0.3	0.1	0.2	0.5	0.3	0.3	0.0	0.1	0.4	0.1	0.3	0.1	0.4	0.4	0.1	0.2	0.9	0.2	0.0	0.3	0.2	0.5	0.4	0.2	0.5	1.5	0.6	0.0	0.2	0.0	0.4	0.4	0.3	0.0	0.6	0.1	0.1	0.3	2.5	3.3	0.2	0.2	0.0	0.5	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.2	2.4	4.5	2.4	2.3	1.9	1.8	1.9	1.4	1.3	1.9	2.2	0.4	0.0	1.1	0.0	0.4	0.0	0.1	0.0	0.0	4.5	0.2	0.0	0.3	0.0	0.6	0.0	2.1	0.2	1.4	0.0	0.0	0.3	0.0	0.2	0.1	0.6	0.0	0.4	1.0	0.0	0.0	0.1	0.0	0.2	0.0	0.3	0.0	0.3	0.1	6.7	0.9	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.1	1.1	0.0	2.5	0.3	0.1	0.0	0.7	0.0	0.3	0.1	0.0	0.0	4.4	0.0	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.1	0.4	0.1	0.2
VPS13A	"CHAC, KIAA0986"	ENSG00000197969	"Vacuolar protein sorting 13 homolog A"	Q96RL7	9	77177445-77421537	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Epilepsy, Neurodegeneration"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Excitatory neurons: 228.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021652, HPA021662"	Supported					NA	NA			"Cluster 6: Non-specific - Transcription"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 21: Neurons & Oligodendrocytes - Neuronal signaling"			"HPA021652: AB_1858759, HPA021662: AB_1858760"	"unprognostic (1.52e-1)"	"unprognostic (4.19e-2)"	"unprognostic (5.49e-3)"	"unprognostic (2.96e-1)"	"unprognostic (4.68e-1)"	"unprognostic (8.54e-2)"	"unprognostic (8.91e-3)"	"unprognostic (1.69e-3)"	"unprognostic (9.67e-2)"	"unprognostic (9.74e-2)"	"unprognostic (1.14e-1)"	"unprognostic (9.96e-2)"	"unprognostic (5.63e-2)"	"unprognostic (6.53e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.05e-1)"	"unprognostic (1.70e-2)"	5.1	7.6	2.6	7.1	4.8	17.6	7.3	11.2	9.6	4.4	3.6	9.4	16.3	6.0	8.0	7.6	4.7	9.0	9.5	6.0	0.1	9.9	7.4	6.3	8.8	0.5	0.1	3.6	8.8	9.3	6.5	3.6	0.3	6.7	11.4	7.2	8.0	6.6	14.6	15.6	13.8	7.2	0.0	10.6	12.3	16.8	0.2	10.3	8.5	9.8	7.6	6.4	6.2	3.1	21.0	10.4	9.1	7.9	8.5	7.4	13.7	11.4	10.3	9.8	11.1	4.2	9.3	16.4	5.2	10.6	11.9	27.9	13.7	11.3	17.4	15.5	11.0	21.7	21.3	10.3	8.3	28.3	13.9	4.7	16.6	14.5	17.7	17.3	14.1	15.7	14.3	17.4	6.0	9.8	21.7	9.7	10.2	11.9	8.3	15.7	17.4	6.8	14.1	20.2	13.3	13.3	14.3	9.2	6.3	16.6	6.3	6.3	18.6	10.4	11.3	14.4	14.6	9.7	9.6	8.4	10.8	13.2	4.2	3.8	0.2	2.0	1.2	0.1	1.2	0.9	0.9	0.9	0.1	1.2	0.7	0.8	0.2	1.2	0.1	2.2	0.7	0.2	2.6	4.8	11.2	9.6	6.0	0.1	0.5	0.1	0.3	0.0	0.2	3.1	29.7	64.1	46.5	48.3	32.2	33.0	26.6	28.0	27.3	29.1	25.4	22.1	87.2	27.1	41.2	29.5	58.4	15.2	42.3	78.9	3.9	18.2	90.5	33.8	28.2	38.6	87.8	48.4	228.3	18.4	4.8	18.9	86.6	42.6	19.0	32.4	37.5	34.1	8.6	11.8	101.1	47.4	30.5	10.6	14.4	55.0	13.7	13.3	23.2	43.1	11.9	16.4	41.2	72.4	23.0	46.2	42.9	15.8	42.7	31.0	98.5	21.7	38.9	18.2	32.9	33.1	30.5	74.3	64.5	36.6	31.3	8.9	43.2	38.0	39.8	25.7
VPS26A	"Hbeta58, PEP8A, VPS26"	ENSG00000122958	"VPS26, retromer complex component A"	O75436	10	69123512-69174412	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Syncytiotrophoblasts: 243.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB011602, HPA057498, CAB075733"	Supported		Enhanced	Endosomes,Lysosomes		NA	NA		41000	"Cluster 7: Monocytes - Unknown function"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 18: Syncytiotrophoblasts - Pregnancy hormone signaling"	"Endosomes, Lysosomes"		"CAB011602: AB_2215043, CAB075733: AB_2665739, HPA057498: AB_2683448"	"unprognostic (1.17e-2)"	"unprognostic (6.94e-2)"	"unprognostic (5.58e-2)"	"unprognostic (9.35e-2)"	"unprognostic (5.95e-2)"	"prognostic unfavorable (1.72e-4)"	"prognostic unfavorable (1.70e-6)"	"unprognostic (1.17e-1)"	"unprognostic (1.35e-1)"	"unprognostic (7.88e-2)"	"prognostic unfavorable (9.18e-6)"	"unprognostic (4.63e-2)"	"unprognostic (2.15e-2)"	"unprognostic (7.14e-2)"	"unprognostic (6.68e-2)"	"unprognostic (4.33e-2)"	"unprognostic (1.72e-1)"	37.0	27.1	23.6	24.4	25.9	36.2	32.9	27.6	32.3	26.9	23.7	32.1	24.8	26.8	22.1	41.7	22.7	22.7	22.0	24.3	25.9	34.0	30.4	27.5	23.3	26.0	25.9	25.8	23.8	38.1	12.0	39.9	25.6	24.6	32.3	19.6	26.1	20.9	33.4	37.3	25.5	25.7	26.7	23.1	24.1	42.7	24.9	27.8	29.9	31.3	27.9	33.0	29.9	29.0	113.1	42.5	51.7	87.1	80.8	73.8	46.1	66.3	106.0	79.7	90.1	91.8	110.9	34.3	53.1	72.3	78.2	75.9	73.1	63.5	108.5	31.3	38.7	54.0	36.7	52.2	104.9	80.6	39.4	66.3	90.8	79.8	161.5	99.8	81.9	40.8	104.7	46.0	119.2	35.8	35.8	86.4	34.0	51.9	97.9	44.2	85.0	40.4	86.6	68.3	30.5	45.5	89.3	119.5	117.6	44.5	50.3	62.9	97.9	53.0	69.7	91.7	83.8	28.0	74.4	57.4	71.2	123.6	27.8	54.6	39.6	38.6	40.8	46.6	37.4	26.3	30.7	42.2	44.8	20.0	26.7	37.7	38.1	54.6	40.9	17.7	38.3	44.4	23.6	25.9	27.6	32.3	24.3	25.9	26.0	25.9	25.6	26.7	24.9	29.0	49.0	73.7	56.6	21.5	40.6	120.7	83.4	79.6	60.3	24.4	43.0	34.8	44.2	40.0	75.2	40.5	14.6	117.1	59.2	47.3	80.3	69.3	59.4	29.8	42.2	52.7	16.2	58.3	29.4	53.4	87.8	57.4	30.5	42.0	45.5	32.4	35.3	29.4	85.8	20.2	30.3	38.3	85.5	53.2	108.7	29.6	42.3	66.0	62.2	28.1	62.4	63.2	52.5	21.6	39.8	65.7	43.3	44.8	28.2	65.2	30.5	80.6	45.5	27.4	13.1	48.0	61.9	89.3	73.7	57.5	107.0	243.7	59.5	38.2	44.4	77.6
VPS26B	"MGC10485, Pep8b"	ENSG00000151502	"VPS26, retromer complex component B"	Q4G0F5	11	134224671-134247788	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038172	Uncertain					NA	NA		8800	"Cluster 52: Eosinophils - Transcription"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 25: Spermatids - Spermatogenesis"			"HPA038172: AB_10675630"	"unprognostic (1.55e-2)"	"unprognostic (6.56e-2)"	"unprognostic (7.02e-3)"	"unprognostic (2.52e-3)"	"unprognostic (1.52e-1)"	"unprognostic (5.76e-2)"	"unprognostic (5.29e-2)"	"unprognostic (1.71e-1)"	"unprognostic (3.54e-1)"	"unprognostic (7.77e-2)"	"unprognostic (6.97e-3)"	"unprognostic (1.66e-1)"	"unprognostic (3.42e-3)"	"unprognostic (3.15e-2)"	"unprognostic (7.05e-3)"	"unprognostic (2.44e-1)"	"unprognostic (2.13e-1)"	17.7	21.2	37.8	13.5	40.8	30.4	16.3	33.1	42.4	18.2	28.6	23.5	20.5	20.5	31.5	19.8	20.4	15.3	23.7	42.4	36.4	14.2	29.5	15.8	14.0	31.4	33.1	19.1	25.8	17.5	21.4	13.4	33.3	21.0	17.2	24.7	21.6	18.8	17.1	35.3	21.4	20.5	30.8	18.5	20.1	16.9	35.9	30.2	17.7	16.1	12.8	18.9	16.7	35.4	25.1	27.8	22.8	70.0	50.2	44.2	19.1	26.3	31.5	23.4	17.4	46.4	43.3	15.8	52.0	46.1	27.4	35.8	30.5	43.6	17.5	37.4	21.9	69.5	16.1	30.3	36.6	41.3	42.9	42.1	28.0	22.4	41.3	32.9	41.9	60.1	34.3	27.1	33.3	30.4	89.8	47.0	13.0	78.3	45.1	20.5	18.4	22.5	29.2	39.6	38.0	38.3	30.0	53.9	17.3	24.0	99.8	31.9	34.7	29.5	16.5	37.7	18.8	34.0	20.0	6.4	19.2	64.1	22.3	3.9	3.3	8.3	5.4	4.1	4.8	0.9	4.6	5.8	3.0	0.4	2.9	5.3	4.9	5.5	3.6	3.4	5.1	2.9	37.8	40.8	33.1	42.4	42.4	36.4	31.4	33.1	33.3	30.8	35.9	35.4	14.3	12.8	6.4	14.7	9.4	17.7	12.7	7.1	25.0	30.0	21.9	22.1	29.1	17.2	6.9	20.2	8.4	18.8	36.2	31.4	21.5	8.6	26.5	12.9	16.7	14.0	28.4	24.8	24.8	14.8	27.1	19.2	29.0	11.5	1.3	22.5	14.6	34.7	23.9	30.3	18.8	30.3	10.2	32.7	16.4	67.9	18.0	27.5	12.4	11.2	21.7	23.8	48.4	13.6	19.9	11.2	32.4	30.9	26.8	11.7	63.8	22.7	7.7	22.8	6.6	14.6	19.7	13.4	21.3	24.4	24.0	12.4	26.6	20.0	25.7	12.0
VPS26C	"DCRA, DSCR3"	ENSG00000157538	"VPS26 endosomal protein sorting factor C"	O14972	21	37223420-37267919	"Plasma proteins, Predicted intracellular proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Ductal cells: 26.4;Exocrine glandular cells: 28.0;Extravillous trophoblasts: 26.4;Hofbauer cells: 32.7;Pancreatic endocrine cells: 33.2;Proximal tubular cells: 29.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA023288	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA023288: AB_1847872"	"unprognostic (1.01e-3)"	"unprognostic (6.42e-2)"	"unprognostic (7.96e-3)"	"unprognostic (2.15e-2)"	"unprognostic (4.10e-3)"	"unprognostic (2.04e-1)"	"unprognostic (1.88e-2)"	"unprognostic (1.40e-1)"	"unprognostic (3.15e-1)"	"unprognostic (7.76e-2)"	"unprognostic (5.40e-2)"	"unprognostic (1.97e-1)"	"prognostic favorable (8.54e-4)"	"unprognostic (1.72e-1)"	"unprognostic (3.24e-1)"	"unprognostic (5.24e-2)"	"unprognostic (3.16e-1)"	19.8	24.5	14.8	18.5	16.1	21.4	15.8	16.8	15.8	16.3	15.9	26.6	28.0	14.8	11.4	21.2	13.8	19.6	24.9	14.4	15.6	32.9	29.5	22.1	22.6	16.1	15.9	17.4	22.6	17.7	8.6	21.4	16.6	14.3	26.0	13.6	16.9	15.8	31.5	15.7	26.9	19.9	16.2	20.2	21.2	7.5	16.5	28.1	18.1	37.8	23.6	21.9	14.2	17.6	31.8	13.8	30.2	26.5	55.4	49.4	34.3	29.9	66.2	26.6	40.2	19.2	32.7	22.0	11.7	70.0	63.9	15.0	32.6	32.1	26.1	52.8	23.5	37.6	13.6	18.7	49.1	27.8	24.3	43.5	31.2	31.0	50.4	48.1	51.4	40.5	24.0	46.8	52.5	14.1	47.2	23.7	34.4	48.7	13.8	44.8	14.5	32.5	32.8	23.7	24.4	32.6	20.6	40.9	65.5	39.0	38.4	22.0	41.0	30.6	10.8	33.2	18.5	71.3	78.0	30.3	48.3	47.9	35.2	58.6	48.6	84.9	50.7	60.5	46.8	37.5	43.1	45.4	47.7	29.4	39.8	41.0	50.1	52.9	55.7	19.4	54.9	54.1	14.8	16.1	16.8	15.8	14.4	15.6	16.1	15.9	16.6	16.2	16.5	17.6	18.1	9.6	21.9	0.0	4.3	0.0	0.0	0.0	0.0	0.0	14.5	13.3	0.0	0.0	6.8	9.2	0.0	16.0	23.8	0.0	21.5	26.4	0.0	12.5	12.7	8.4	0.0	0.0	0.0	28.0	26.4	5.4	0.0	16.1	8.8	19.0	0.0	0.0	32.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.3	0.0	0.0	16.5	0.0	0.0	0.0	0.0	33.2	0.0	0.0	3.1	0.0	0.0	29.7	4.4	0.0	0.0	0.0	7.3	0.0	0.0	0.0	0.0	14.6	8.5	10.1	0.0	0.0
VPS29	"DC15, DC7, PEP11"	ENSG00000111237	"VPS29 retromer complex component"	Q9UBQ0	12	110491083-110502111	"Metabolic proteins, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA039748	Uncertain		Supported	Vesicles,Cytosol		NA	NA		110000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 24: NB-4 - Immune response"	"Cluster 10: Non-specific - Unknown function"	"Vesicles, Cytosol"		"HPA039748: AB_10674426"	"unprognostic (9.46e-2)"	"unprognostic (3.46e-3)"	"unprognostic (2.16e-2)"	"unprognostic (2.58e-1)"	"unprognostic (3.08e-1)"	"unprognostic (2.26e-2)"	"prognostic unfavorable (2.79e-5)"	"unprognostic (1.52e-1)"	"unprognostic (3.37e-2)"	"prognostic favorable (7.70e-4)"	"unprognostic (1.64e-1)"	"unprognostic (2.10e-3)"	"unprognostic (2.96e-1)"	"unprognostic (2.04e-2)"	"unprognostic (2.11e-1)"	"unprognostic (5.57e-2)"	"unprognostic (4.29e-3)"	61.1	62.7	45.6	57.0	47.0	96.2	59.2	46.2	61.8	50.3	47.0	76.4	64.1	52.9	89.5	71.1	50.3	51.1	73.8	48.7	48.3	79.2	77.6	54.9	69.7	47.2	46.3	47.1	56.6	54.8	53.7	47.3	47.4	62.7	79.0	99.6	58.5	71.3	127.3	46.8	65.7	67.1	48.0	76.5	62.8	32.6	46.1	63.2	54.1	100.8	72.0	65.1	50.6	51.1	103.5	98.6	91.9	65.6	100.4	98.7	72.6	94.9	98.1	93.9	84.2	100.0	87.0	94.0	97.1	94.3	87.7	95.5	123.1	88.0	97.0	112.2	98.9	115.4	122.6	83.0	87.4	139.5	97.1	66.0	73.3	79.3	87.4	114.1	166.0	116.6	112.1	85.5	170.0	51.9	110.3	196.4	52.6	90.9	124.8	72.2	93.5	131.8	157.0	149.7	98.1	51.8	107.9	94.0	122.8	78.5	128.6	106.0	94.0	80.6	53.4	112.9	113.0	58.0	87.5	112.1	93.9	130.8	87.8	246.2	262.7	259.4	139.1	356.8	155.3	195.9	175.5	164.9	318.3	158.7	159.8	156.8	178.7	202.9	405.4	214.0	224.8	385.1	45.6	47.0	46.2	61.8	48.7	48.3	47.2	46.3	47.4	48.0	46.1	51.1	138.8	76.9	96.2	21.2	93.7	143.5	172.6	395.9	70.6	39.0	93.4	109.2	282.4	90.1	209.7	101.2	27.1	192.8	116.5	156.3	289.5	231.0	56.8	94.7	79.8	125.0	83.2	147.5	30.2	179.8	187.6	120.2	60.1	104.1	153.9	78.1	94.9	158.7	409.9	42.1	26.7	149.8	248.2	158.0	296.1	82.6	92.2	178.7	177.9	30.9	295.2	107.9	101.0	22.6	30.4	217.9	182.2	105.7	94.8	157.4	142.2	404.7	131.1	111.8	157.8	81.9	212.1	256.4	148.4	108.3	173.0	178.8	111.2	105.8	164.5	187.7
VPS35	"FLJ10752, MEM3, PARK17"	ENSG00000069329	"VPS35 retromer complex component"	Q96QK1	16	46656132-46689518	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, Transport"		"Neurodegeneration, Parkinson disease, Parkinsonism"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA040802	Supported		Supported	Endosomes,Lysosomes		NA	NA		500000	"Cluster 51: Monocytes - Innate immune response"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 40: Granulosa cells - Unknown function"	"Endosomes, Lysosomes"		"HPA040802: AB_2677142"	"unprognostic (1.11e-2)"	"unprognostic (8.70e-2)"	"prognostic favorable (7.74e-4)"	"unprognostic (4.75e-2)"	"unprognostic (1.90e-1)"	"unprognostic (5.67e-3)"	"prognostic unfavorable (2.10e-6)"	"unprognostic (5.32e-2)"	"unprognostic (1.49e-1)"	"unprognostic (2.29e-2)"	"unprognostic (3.33e-3)"	"unprognostic (2.49e-1)"	"prognostic favorable (9.75e-5)"	"unprognostic (3.68e-3)"	"unprognostic (2.43e-1)"	"unprognostic (1.34e-1)"	"unprognostic (6.89e-3)"	5.4	4.2	2.9	3.0	3.0	9.5	4.6	2.6	3.2	4.2	2.8	4.2	1.9	4.3	1.9	4.7	4.0	1.4	6.1	3.0	2.5	3.7	1.7	4.1	2.9	3.0	2.4	4.7	4.4	5.2	3.3	2.1	3.2	3.0	1.8	4.1	4.5	2.4	4.6	6.1	4.9	1.7	2.1	4.2	4.5	2.7	2.8	3.9	2.7	2.7	1.8	4.5	4.2	3.4	3.2	5.0	4.1	2.8	6.5	7.3	2.1	3.8	5.4	6.4	3.7	4.3	2.7	4.2	2.3	6.5	3.3	3.9	7.5	7.5	9.1	1.6	6.4	3.9	3.8	3.0	5.4	5.2	5.8	5.8	5.5	7.3	4.5	6.3	6.6	6.0	3.1	1.8	6.5	2.9	4.0	5.0	1.4	3.0	6.6	5.4	5.4	5.2	5.2	4.4	1.8	2.1	4.1	3.2	1.8	4.5	1.9	2.6	3.9	1.9	1.9	4.3	2.7	2.3	3.2	4.9	3.4	4.0	1.3	1.8	1.3	1.3	0.7	1.7	0.7	0.8	0.7	0.6	1.5	1.0	1.0	0.7	1.5	0.8	2.3	0.6	1.1	1.1	2.9	3.0	2.6	3.2	3.0	2.5	3.0	2.4	3.2	2.1	2.8	3.4	65.9	51.3	59.4	20.5	84.3	72.5	80.0	98.6	72.8	56.5	77.9	75.9	102.9	57.2	83.4	68.0	60.5	134.5	44.9	65.9	54.8	111.7	111.2	136.4	92.3	63.3	80.8	52.6	43.1	72.5	102.2	70.1	88.7	88.4	72.2	211.1	54.7	40.2	123.4	45.4	42.5	79.7	107.8	108.3	87.9	32.4	77.9	113.6	46.2	30.0	153.0	71.4	45.3	28.6	31.3	101.1	101.9	72.2	41.7	77.0	164.6	103.7	188.9	82.6	46.0	57.5	88.9	207.9	118.0	101.5	87.7	113.1	51.5	95.9	97.6	84.5
VPS35L	"C16orf62, MGC16824"	ENSG00000103544	"VPS35 endosomal protein sorting factor like"	Q7Z3J2	16	19555240-19706793	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 32.4;Cytotrophoblasts: 29.4;Distal tubular cells: 29.4;Hofbauer cells: 44.9;Syncytiotrophoblasts: 40.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA042969, HPA053547"	Uncertain		Approved	Mitochondria		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 48: Parathyroid gland - membrane proteins"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Mitochondria		"HPA042969: AB_10794920, HPA053547: AB_2682183"	"unprognostic (7.15e-2)"	"unprognostic (6.54e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.20e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.67e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.74e-1)"	"unprognostic (2.52e-1)"	"unprognostic (1.22e-3)"	"unprognostic (3.57e-2)"	"unprognostic (2.06e-1)"	"prognostic favorable (1.31e-8)"	"unprognostic (1.82e-3)"	"unprognostic (8.92e-2)"	"unprognostic (5.08e-2)"	"unprognostic (1.13e-2)"	19.3	22.7	23.3	15.9	33.5	13.2	17.1	21.8	24.9	21.2	11.7	19.2	13.7	20.1	22.4	16.8	19.2	17.5	17.8	20.7	23.5	22.2	14.4	16.2	14.6	23.3	24.4	23.3	16.5	35.6	20.4	20.2	24.6	15.9	19.4	16.1	12.4	18.9	22.2	13.8	15.3	25.1	20.5	17.2	13.3	31.5	28.0	16.1	22.7	25.2	16.6	18.3	15.6	40.3	22.3	37.5	35.7	28.4	44.2	60.1	5.8	32.5	52.3	33.9	38.9	6.4	37.0	27.1	67.4	51.7	0.2	6.2	27.5	16.7	36.5	1.6	15.7	16.4	32.6	0.6	57.4	25.9	31.6	43.9	24.4	31.7	21.5	48.2	54.4	13.2	22.3	6.2	55.7	15.7	23.0	7.2	24.8	3.9	5.1	19.6	11.7	7.1	38.6	5.2	21.8	22.1	43.7	1.5	18.6	27.2	12.9	22.2	61.0	17.4	16.2	25.7	3.7	23.8	45.2	10.6	33.6	21.1	27.5	26.5	35.3	16.5	18.9	42.0	23.5	14.7	18.0	18.8	42.6	23.5	21.0	18.6	4.2	37.6	37.7	11.5	21.6	28.5	23.3	33.5	21.8	24.9	20.7	23.5	23.3	24.4	24.6	20.5	28.0	40.3	32.4	6.4	16.4	0.0	3.0	0.0	0.0	0.0	0.0	0.0	9.5	9.1	0.0	0.0	8.1	16.5	0.0	29.4	5.0	0.0	29.4	20.4	0.0	8.2	15.8	15.5	0.0	0.0	0.0	17.0	19.5	8.1	0.0	11.1	3.8	18.1	0.0	0.0	44.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.0	0.0	0.0	7.2	0.0	0.0	0.0	0.0	10.5	0.0	0.0	1.2	0.0	0.0	21.9	2.9	0.0	0.0	0.0	6.1	0.0	0.0	0.0	0.0	40.2	3.4	21.0	0.0	0.0
VTI1B	VTI2	ENSG00000100568	"Vesicle transport through interaction with t-SNAREs 1B"	Q9UEU0	14	67647085-67674820	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 493.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA044121, HPA048150, HPA060118"	Approved		Enhanced	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 27: Brain & Skin - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 25: Spermatids - Spermatogenesis"	"Golgi apparatus, Vesicles"		"HPA044121: AB_2678819, HPA048150: AB_2680288, HPA060118: AB_2684206"	"unprognostic (2.26e-1)"	"unprognostic (4.83e-2)"	"unprognostic (8.09e-2)"	"unprognostic (2.24e-1)"	"unprognostic (3.00e-2)"	"unprognostic (2.36e-3)"	"unprognostic (3.25e-3)"	"unprognostic (9.12e-2)"	"unprognostic (1.90e-2)"	"unprognostic (3.86e-1)"	"unprognostic (2.60e-1)"	"unprognostic (2.11e-2)"	"prognostic favorable (3.53e-12)"	"unprognostic (8.35e-3)"	"unprognostic (1.53e-1)"	"unprognostic (1.43e-1)"	"unprognostic (8.02e-3)"	53.8	26.9	55.5	20.4	56.8	22.3	39.8	54.4	102.1	22.7	49.8	42.9	28.3	18.4	53.5	44.3	18.5	28.7	60.1	56.6	58.1	53.0	41.6	26.8	23.8	55.1	56.6	21.0	44.0	23.9	17.1	21.3	56.8	22.3	35.2	23.0	30.1	13.6	46.5	31.0	24.1	22.4	56.0	26.5	40.0	30.8	56.3	12.1	34.0	28.2	27.0	33.3	23.4	56.9	111.7	54.8	31.4	18.1	61.9	37.2	45.4	48.1	30.5	23.8	23.7	27.3	38.5	32.9	40.2	54.5	27.5	30.6	36.8	36.6	37.7	34.3	22.6	33.4	32.5	34.8	26.6	20.9	22.9	36.3	39.6	25.6	26.1	60.5	27.2	23.1	22.2	25.4	34.5	131.1	26.6	77.7	20.3	76.6	88.0	31.8	35.6	12.2	35.1	65.0	17.4	35.5	33.8	45.5	71.4	23.7	41.9	58.0	38.5	62.6	93.8	51.4	45.6	23.8	27.8	53.2	52.9	38.9	29.0	88.8	61.5	143.8	49.4	80.4	42.4	49.0	43.1	51.1	59.6	43.0	40.5	50.3	27.2	56.4	70.2	38.6	60.2	58.3	55.5	56.8	54.4	102.1	56.6	58.1	55.1	56.6	56.8	56.0	56.3	56.9	47.6	25.6	35.0	13.1	48.7	42.3	61.4	91.7	33.0	23.2	82.2	65.4	30.5	67.2	64.4	66.2	22.9	107.4	47.5	138.2	217.2	109.1	141.7	58.5	43.2	51.5	46.6	102.7	15.8	131.4	167.9	51.6	40.8	49.5	64.0	43.6	73.9	95.3	131.4	15.2	18.2	96.0	50.8	99.8	49.2	493.5	41.7	80.9	71.2	11.2	121.6	65.4	78.2	13.6	17.1	130.7	119.4	39.9	51.0	120.5	165.4	268.6	55.3	44.8	19.7	36.5	58.2	104.5	57.2	58.2	52.8	125.9	46.8	35.5	91.9	124.6
WASHC1	"FAM39E, FLJ00038, WASH1"	ENSG00000181404	"WASH complex subunit 1"	A8K0Z3	9	14475-73865	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"	Actin-binding		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 60.7;Distal tubular cells: 50.9;Proximal tubular cells: 47.5;Syncytiotrophoblasts: 42.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											HPA002689	Uncertain		Supported	Vesicles		NA	NA			"Cluster 51: Monocytes - Innate immune response"	"Cluster 72: Non-specific - Transcription"	"Cluster 20: HeLa - Mitochondria"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA002689: AB_1078803"	"unprognostic (9.43e-2)"	"unprognostic (1.62e-2)"	"unprognostic (3.16e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.43e-1)"	"unprognostic (2.33e-2)"	"unprognostic (3.22e-3)"	"unprognostic (2.06e-2)"	"unprognostic (5.00e-1)"	"unprognostic (5.40e-3)"	"unprognostic (3.37e-3)"	"unprognostic (6.95e-2)"	"unprognostic (3.90e-2)"	"unprognostic (1.88e-1)"	"unprognostic (3.38e-1)"	"unprognostic (2.31e-2)"	"unprognostic (1.02e-1)"	15.7	18.1	13.2	7.1	14.2	16.3	17.6	13.2	15.1	24.5	16.5	19.6	10.2	20.3	21.9	19.2	24.1	9.0	17.9	13.3	13.5	25.9	20.9	17.1	13.4	14.4	13.8	23.0	21.9	5.2	21.2	6.6	14.3	27.0	4.7	15.9	17.6	13.5	22.8	26.1	21.9	15.3	13.4	29.0	18.3	24.1	14.5	8.6	22.1	6.8	6.0	19.7	20.5	14.9	13.5	8.5	5.0	10.3	8.5	5.7	12.4	11.7	11.4	6.9	5.5	8.4	8.3	5.7	6.6	4.8	6.2	16.7	7.4	5.7	2.5	5.9	14.4	5.5	7.0	8.6	4.7	11.3	10.0	4.3	4.2	3.5	4.7	17.3	2.1	5.0	12.6	21.0	2.2	4.0	11.6	9.4	9.2	9.1	10.5	7.9	4.3	7.2	5.1	9.8	5.6	14.9	6.8	14.3	8.6	6.2	8.6	10.5	8.0	9.2	6.7	4.0	10.3	9.4	7.9	4.5	8.6	12.0	8.6	1.2	2.5	2.2	1.9	2.7	1.5	1.3	1.5	1.6	2.3	1.2	1.6	1.3	1.4	2.1	4.0	2.1	1.8	1.5	13.2	14.2	13.2	15.1	13.3	13.5	14.4	13.8	14.3	13.4	14.5	14.9	34.5	22.4	22.5	0.0	10.5	0.0	0.0	0.0	0.0	0.0	29.0	28.3	0.0	0.0	7.4	60.7	0.0	37.4	21.5	0.0	50.9	13.7	0.0	24.7	28.6	7.5	0.0	0.0	0.0	15.8	26.1	10.8	0.0	22.9	16.4	27.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.5	0.0	0.0	4.6	0.0	0.0	0.0	0.0	13.1	0.0	0.0	6.7	0.0	0.0	47.5	8.0	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	42.8	11.4	14.3	0.0	0.0
WASHC2A	"bA56A21.1, bA98I6.1, FAM21A, FAM21B, FLJ10824"	ENSG00000099290	"WASH complex subunit 2A"	Q641Q2	10	50067888-50133509	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 38.5;Alveolar cells type 2: 28.5;Endometrial ciliated cells: 45.7;Respiratory ciliated cells: 41.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 39: Non-specific - mRNA processing"	"Cluster 44: Heart - Cardiac muscle contraction"	"Cluster 18: U-2197 - ECM organization"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (2.46e-1)"	"unprognostic (1.11e-3)"	"unprognostic (8.82e-2)"	"unprognostic (3.28e-1)"	"unprognostic (2.75e-1)"	"unprognostic (6.51e-3)"	"prognostic unfavorable (6.75e-5)"	"unprognostic (4.60e-2)"	"unprognostic (2.85e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.04e-2)"	"unprognostic (2.73e-2)"	"unprognostic (1.18e-1)"	"unprognostic (2.57e-1)"	"unprognostic (2.95e-1)"	"unprognostic (1.85e-2)"	"unprognostic (4.40e-2)"	25.3	25.9	19.9	22.1	20.7	37.5	24.0	23.4	24.8	24.7	18.3	28.9	25.2	22.5	19.2	20.2	19.7	18.0	58.6	19.9	19.9	22.9	15.5	26.0	28.8	21.1	21.2	26.7	17.7	23.3	21.5	22.9	21.1	20.6	28.9	19.9	21.9	20.0	22.3	25.7	28.9	21.2	18.6	26.6	21.5	12.5	22.6	24.2	23.3	15.6	26.9	23.8	22.1	23.9	26.1	12.5	21.1	24.3	83.2	46.0	16.9	29.8	64.0	43.7	46.6	28.8	37.8	22.5	18.1	44.8	41.3	28.0	31.2	25.3	43.2	22.2	22.0	15.9	25.6	29.7	58.6	28.0	27.2	47.8	31.2	47.6	30.5	46.2	33.1	19.2	26.6	22.2	53.9	19.1	15.5	48.0	17.1	16.7	58.4	23.1	30.1	13.7	30.5	29.3	7.3	22.4	27.8	25.9	40.9	30.9	31.6	19.2	49.4	22.0	18.5	62.7	25.0	23.4	48.3	19.1	48.9	51.4	9.0	1.0	9.1	9.9	9.1	11.6	10.1	5.1	8.0	8.8	7.3	4.9	7.7	6.0	4.1	8.2	6.9	4.6	9.2	7.9	19.9	20.7	23.4	24.8	19.9	19.9	21.1	21.2	21.1	18.6	22.6	23.9	16.2	38.5	28.5	0.0	3.3	0.0	0.0	0.0	0.0	0.0	10.6	11.0	0.0	0.0	22.9	14.7	0.0	7.4	10.0	0.0	0.0	16.7	0.0	45.7	19.9	7.9	0.0	0.0	0.0	15.6	6.9	8.9	0.0	20.3	15.2	13.5	0.0	0.0	18.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.2	0.0	0.0	5.7	0.0	0.0	0.0	0.0	15.1	0.0	0.0	2.6	0.0	0.0	11.7	41.5	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	7.7	7.8	9.4	0.0	0.0
WASHC2C	"Em:AC012044.3, FAM21C, KIAA0592"	ENSG00000172661	"WASH complex subunit 2C"	Q9Y4E1	10	45727200-45792964	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 35.3;Alveolar cells type 2: 35.2;Collecting duct cells: 23.9;granulocytes: 30.3;Respiratory ciliated cells: 24.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"											"HPA047844, HPA060975, HPA061022"	Supported		Supported	Nucleoli,Vesicles,Cytosol		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 32: U-937 - Innate immune response"	"Cluster 7: Non-specific - Mitochondria"	Vesicles	"Nucleoli, Cytosol"	"HPA047844: AB_2680177, HPA060975: AB_2684401, HPA061022: AB_2732656"	"unprognostic (7.50e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.13e-1)"	"unprognostic (1.06e-1)"	"unprognostic (4.51e-2)"	"unprognostic (5.98e-3)"	"prognostic unfavorable (1.35e-5)"	"prognostic favorable (4.69e-4)"	"unprognostic (1.26e-1)"	"unprognostic (5.02e-2)"	"unprognostic (1.00e-3)"	"unprognostic (1.51e-1)"	"unprognostic (2.24e-1)"	"unprognostic (1.48e-1)"	"unprognostic (1.09e-1)"	"unprognostic (1.73e-1)"	"unprognostic (2.00e-2)"	19.4	15.7	10.9	17.3	11.8	42.5	17.5	14.8	14.9	19.1	13.5	20.3	15.2	16.8	12.4	13.5	14.9	16.5	22.0	11.3	11.4	18.0	15.9	17.7	20.2	12.5	12.2	21.6	11.6	21.4	13.9	13.7	12.7	15.6	22.0	14.2	15.3	14.6	17.1	17.6	19.7	19.0	9.6	19.3	15.0	12.9	14.1	21.2	17.1	9.8	18.7	17.7	14.6	14.0	24.5	25.9	20.7	23.5	52.1	45.8	12.4	28.4	45.8	32.4	30.8	16.0	23.3	20.1	18.8	41.7	30.8	21.6	23.2	13.0	32.6	18.9	19.2	20.9	32.3	12.3	55.0	21.4	24.6	43.4	30.4	35.4	26.1	31.6	33.7	16.5	33.9	15.7	40.1	12.8	14.0	35.9	14.8	14.7	3.9	17.4	30.5	10.5	23.8	38.2	10.0	22.3	32.8	16.1	39.4	21.0	22.1	20.6	58.1	16.8	18.0	44.7	19.1	21.5	36.3	19.6	23.5	49.4	9.2	14.1	17.1	11.7	12.2	17.9	11.8	9.9	10.1	12.7	11.7	9.2	10.0	8.9	16.8	12.5	22.8	8.1	10.4	13.3	10.9	11.8	14.8	14.9	11.3	11.4	12.5	12.2	12.7	9.6	14.1	14.0	16.2	35.3	35.2	0.0	3.0	0.0	0.0	0.0	0.0	0.0	11.3	8.8	0.0	0.0	11.8	23.9	0.0	6.8	11.8	0.0	3.9	13.5	0.0	11.3	17.9	6.1	0.0	0.0	0.0	14.0	6.4	7.9	0.0	13.9	30.3	13.7	0.0	0.0	18.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	10.3	0.0	0.0	0.0	0.0	11.9	0.0	0.0	3.8	0.0	0.0	12.8	24.8	0.0	0.0	0.0	5.9	0.0	0.0	0.0	0.0	7.8	7.0	12.1	0.0	0.0
WASHC3	"CCDC53, CGI-116"	ENSG00000120860	"WASH complex subunit 3"	Q9Y3C0	12	102012840-102062149	"Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Distal tubular cells: 125.2;Hofbauer cells: 73.1;Proximal tubular cells: 98.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038339	Uncertain		Approved	Vesicles		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 43: Testis - Unknown function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 7: Non-specific - Mitochondria"	Vesicles		"HPA038339: AB_2675966"	"unprognostic (4.25e-2)"	"unprognostic (1.61e-2)"	"unprognostic (2.28e-1)"	"unprognostic (3.45e-3)"	"unprognostic (1.21e-2)"	"unprognostic (2.42e-1)"	"unprognostic (2.11e-1)"	"unprognostic (1.12e-1)"	"unprognostic (1.04e-1)"	"unprognostic (9.63e-2)"	"unprognostic (7.54e-2)"	"unprognostic (4.98e-2)"	"unprognostic (7.81e-2)"	"unprognostic (7.41e-2)"	"unprognostic (1.74e-1)"	"unprognostic (1.08e-1)"	"unprognostic (1.08e-1)"	27.3	32.2	41.3	14.2	41.9	13.2	24.7	42.8	57.2	26.4	38.3	33.7	13.6	27.5	35.7	28.4	18.0	17.7	35.0	42.8	44.9	41.6	41.1	20.6	22.8	44.6	43.9	20.3	17.4	37.8	33.4	20.0	45.2	26.1	20.7	25.3	19.8	34.9	34.5	20.1	20.5	29.3	43.4	22.7	27.3	98.1	43.5	31.2	25.7	42.2	26.2	28.8	23.4	44.2	17.1	23.3	20.1	12.6	75.2	90.9	18.9	23.3	48.0	33.6	37.3	18.8	16.0	18.0	16.4	52.9	34.2	32.1	21.4	57.0	44.5	41.8	12.9	25.3	15.9	29.5	67.0	22.4	13.9	55.9	72.4	42.1	42.2	92.1	46.3	43.5	15.3	19.6	88.4	23.1	23.6	39.9	6.1	32.7	41.0	13.6	30.4	27.2	59.4	27.7	19.6	10.8	32.6	22.9	50.2	36.5	29.1	12.8	25.5	41.5	9.9	24.7	16.3	49.5	32.7	22.7	59.0	15.6	17.8	125.7	41.3	95.3	37.5	66.6	45.4	61.9	56.3	50.7	56.1	49.4	41.2	49.4	18.2	59.9	70.9	54.9	118.5	52.8	41.3	41.9	42.8	57.2	42.8	44.9	44.6	43.9	45.2	43.4	43.5	44.2	55.4	28.9	41.5	0.0	18.5	0.0	0.0	0.0	0.0	0.0	36.4	55.4	0.0	0.0	14.2	33.1	0.0	60.3	28.4	0.0	125.2	47.9	0.0	40.5	49.2	15.0	0.0	0.0	0.0	38.8	48.5	24.8	0.0	27.4	40.4	36.1	0.0	0.0	73.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.0	0.0	0.0	46.5	0.0	0.0	0.0	0.0	35.5	0.0	0.0	5.4	0.0	0.0	98.9	22.6	0.0	0.0	0.0	22.8	0.0	0.0	0.0	0.0	39.4	18.8	60.9	0.0	0.0
WASHC4	"KIAA1033, SWIP"	ENSG00000136051	"WASH complex subunit 4"	Q2M389	12	105107324-105169130	"Disease related genes, Human disease related genes, Potential drug targets, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"		"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Collecting duct cells: 44.1;Endometrial stromal cells: 48.3;Hofbauer cells: 51.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA045666, HPA046737"	Uncertain		Enhanced	Nucleoplasm		NA	NA			"Cluster 14: Monocytes - Unknown function"	"Cluster 64: Macrophages - Immune response"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 7: Non-specific - Mitochondria"	Nucleoplasm		"HPA045666: AB_2679411, HPA046737: AB_2679778"	"unprognostic (2.68e-2)"	"prognostic unfavorable (2.02e-4)"	"unprognostic (4.85e-2)"	"unprognostic (2.76e-1)"	"unprognostic (1.10e-1)"	"unprognostic (4.41e-1)"	"unprognostic (9.79e-3)"	"unprognostic (1.32e-2)"	"unprognostic (3.14e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.49e-2)"	"unprognostic (2.96e-1)"	"unprognostic (4.61e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.03e-1)"	"unprognostic (3.86e-2)"	22.4	21.1	9.4	30.9	13.8	23.8	20.8	13.8	12.2	20.7	11.8	16.1	15.3	20.1	19.9	15.1	13.1	22.6	14.3	9.1	13.8	23.5	29.7	20.2	44.0	17.8	13.0	22.8	18.3	20.4	8.5	30.5	18.4	19.2	18.4	15.4	16.1	15.8	12.2	31.2	18.4	19.8	15.2	32.9	17.9	12.1	14.5	18.0	22.1	14.2	39.5	17.6	12.6	22.1	24.0	28.2	24.6	18.2	56.3	56.6	29.5	36.5	41.5	41.7	38.0	20.2	13.5	53.4	19.8	61.0	26.5	21.9	21.5	22.3	33.5	19.2	15.3	11.1	25.6	16.8	38.4	30.9	20.5	45.7	25.7	37.3	30.4	45.1	68.7	18.1	22.1	18.6	45.9	12.1	17.1	32.6	30.1	16.8	23.5	32.7	32.8	16.6	55.6	27.5	15.4	19.0	37.7	26.4	37.9	31.0	19.6	32.9	84.1	49.8	13.6	32.1	23.9	23.3	23.9	42.7	35.4	26.1	51.4	21.3	15.1	9.2	3.0	18.4	4.4	16.2	4.7	4.1	11.9	12.9	4.9	4.7	16.7	8.0	34.2	5.8	3.5	6.9	9.4	13.8	13.8	12.2	9.1	13.8	17.8	13.0	18.4	15.2	14.5	22.1	37.5	35.3	24.3	0.0	25.3	0.0	0.0	0.0	0.0	0.0	16.4	11.0	0.0	0.0	11.8	44.1	0.0	24.1	17.5	0.0	19.6	25.8	0.0	23.8	48.3	18.0	0.0	0.0	0.0	22.1	28.0	14.6	0.0	31.7	26.5	30.7	0.0	0.0	51.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	36.3	0.0	0.0	26.9	0.0	0.0	0.0	0.0	24.2	0.0	0.0	5.2	0.0	0.0	41.8	17.5	0.0	0.0	0.0	17.4	0.0	0.0	0.0	0.0	32.0	8.9	29.1	0.0	0.0
WDR83OS	"Asterix, C19orf56, PTD008"	ENSG00000105583	"WD repeat domain 83 opposite strand"	Q9Y284	19	12668073-12669415	"Predicted membrane proteins, Transporters"		Chaperone		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA065685	Approved		Approved	"Endoplasmic reticulum"		NA	NA			"Cluster 31: Non-specific - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 39: Non-specific - Basic cellular processes"	"Endoplasmic reticulum"		"HPA065685: AB_2685531"	"unprognostic (1.73e-1)"	"unprognostic (5.37e-3)"	"unprognostic (1.03e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.27e-1)"	"unprognostic (3.29e-2)"	"unprognostic (7.47e-2)"	"prognostic favorable (2.09e-4)"	"unprognostic (1.71e-1)"	"prognostic favorable (8.84e-4)"	"unprognostic (4.17e-3)"	"unprognostic (1.09e-1)"	"unprognostic (7.87e-3)"	"unprognostic (2.67e-1)"	"unprognostic (1.02e-1)"	"unprognostic (1.02e-1)"	"unprognostic (8.34e-2)"	152.2	219.2	204.0	80.1	213.4	203.3	156.9	213.2	226.5	164.0	199.2	138.5	103.9	146.9	276.1	174.0	223.2	138.0	206.8	198.6	212.5	194.9	189.2	133.3	128.7	209.9	205.9	226.2	210.0	204.7	164.8	119.7	211.1	160.6	151.4	50.2	180.9	135.9	226.7	175.1	128.5	169.6	216.9	146.5	164.7	80.4	210.8	129.8	190.1	234.1	174.2	164.4	144.8	223.7	190.9	204.4	223.1	252.8	338.2	267.0	96.4	135.3	230.3	211.6	181.7	170.0	161.1	86.2	310.0	390.4	143.5	150.9	242.7	255.9	175.2	180.9	333.0	107.4	170.3	259.6	262.1	183.5	148.5	287.1	343.2	208.0	243.7	309.9	265.2	161.2	196.2	196.3	253.5	661.5	136.8	399.3	187.7	254.4	584.9	110.0	117.7	310.1	241.7	217.2	182.3	278.6	155.2	162.4	193.5	148.2	197.6	295.1	156.7	289.8	78.2	317.2	205.8	342.4	428.4	126.5	245.4	313.2	189.0	612.8	502.8	492.3	329.2	469.3	312.0	445.2	308.6	336.5	466.7	394.4	280.0	305.8	485.8	451.4	503.7	319.2	396.0	635.4	204.0	213.4	213.2	226.5	198.6	212.5	209.9	205.9	211.1	216.9	210.8	223.7	198.5	80.1	54.6	11.8	156.8	171.7	193.7	391.7	272.0	42.3	310.7	424.2	129.4	168.7	204.5	342.1	27.1	435.7	153.8	233.0	401.1	255.5	7.9	128.6	184.0	185.7	195.3	126.4	10.5	255.8	333.8	205.2	162.6	162.7	147.9	239.7	183.1	314.3	287.5	50.5	10.6	282.6	301.1	212.5	230.2	22.7	170.6	209.3	297.1	13.1	254.5	264.8	179.2	13.0	39.4	243.4	295.7	144.8	256.0	230.9	398.1	586.3	103.6	55.7	98.6	140.9	187.6	87.3	98.4	353.6	221.3	405.1	172.2	279.8	262.4	241.1
WFS1	"DFNA14, DFNA38, DFNA6, DIDMOAD, WFS"	ENSG00000109501	"Wolframin ER transmembrane glycoprotein"	O76024	4	6269849-6303265	"Disease related genes, Human disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters"			"Cataract, Deafness, Diabetes insipidus, Diabetes mellitus, Disease variant, Non-syndromic deafness"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell type enhanced"	"Detected in many"		"Alveolar cells type 1: 131.4;Extravillous trophoblasts: 120.2;Granulosa cells: 71.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BEWO: 100.4;Hep G2: 83.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA029128	Approved					NA	NA			"Cluster 16: MAIT-cells - Unknown function"	"Cluster 35: Non-specific - Unknown function"	"Cluster 28: BEWO - Transcription regulation"	"Cluster 40: Granulosa cells - Unknown function"			"HPA029128: AB_10603460"	"unprognostic (4.27e-2)"	"unprognostic (5.05e-2)"	"unprognostic (1.58e-1)"	"prognostic favorable (1.13e-6)"	"unprognostic (7.35e-2)"	"unprognostic (1.29e-2)"	"unprognostic (2.73e-2)"	"unprognostic (6.97e-3)"	"unprognostic (2.37e-1)"	"unprognostic (1.78e-1)"	"unprognostic (8.36e-3)"	"unprognostic (5.33e-3)"	"unprognostic (6.20e-2)"	"unprognostic (5.02e-2)"	"unprognostic (9.10e-2)"	"prognostic unfavorable (3.13e-4)"	"unprognostic (3.64e-2)"	39.4	20.2	43.7	6.8	71.2	0.7	36.0	34.3	47.2	51.9	34.5	44.8	12.2	75.4	14.0	11.3	58.6	12.4	64.3	35.9	36.8	16.8	17.1	43.8	5.9	34.4	43.7	87.1	20.1	7.2	50.2	16.6	36.6	34.6	3.4	6.9	14.6	36.3	16.0	26.8	22.0	17.0	33.7	29.3	29.1	31.8	44.1	2.9	48.1	7.5	2.3	57.8	29.1	32.1	14.1	35.3	9.1	33.9	37.2	10.2	100.4	23.0	32.7	15.8	14.6	24.8	37.2	5.5	34.3	26.3	74.8	8.0	6.8	14.2	6.4	5.7	14.1	0.0	11.0	83.0	34.5	0.0	1.1	33.7	18.8	15.0	13.6	12.3	25.3	2.5	0.6	24.3	9.7	28.0	1.1	0.3	13.5	20.3	38.0	3.4	9.6	7.5	6.7	52.4	6.1	15.4	12.2	17.4	13.1	9.6	31.5	0.3	19.9	19.8	22.8	19.1	14.8	26.0	10.1	0.5	23.9	0.2	18.3	0.0	0.7	0.0	2.7	0.9	3.9	2.4	1.3	2.1	0.2	1.2	1.3	1.5	0.0	1.5	1.1	0.4	0.8	1.4	43.7	71.2	34.3	47.2	35.9	36.8	34.4	43.7	36.6	33.7	44.1	32.1	38.4	131.4	12.4	40.5	3.6	2.4	1.9	2.5	2.2	4.9	9.7	6.0	42.5	5.7	5.7	25.8	0.0	22.2	1.0	2.0	0.0	5.5	10.3	18.1	12.6	21.1	33.5	0.0	2.7	4.4	120.2	15.4	13.3	25.5	1.3	71.4	21.4	10.7	19.0	3.3	4.7	5.7	4.1	1.3	2.4	19.1	40.0	2.5	12.4	12.2	0.7	31.7	0.0	9.5	2.4	10.9	1.6	57.9	19.0	4.7	3.7	3.7	12.1	5.0	13.1	3.6	15.1	10.8	14.6	2.2	3.4	39.7	1.6	11.0	4.7	2.1
WLS	"C1orf139, EVI, FLJ23091, GPR177, mig-14, MRP"	ENSG00000116729	"Wnt ligand secretion mediator"	Q5T9L3	1	68098473-68233120	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Wnt signaling pathway"	"Developmental protein"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Glandular and luminal cells: 235.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in some"	8	"classical monocyte: 22.1;neutrophil: 61.7"	"Group enriched"	"Detected in many"	46	"granulocytes: 61.7;monocytes: 22.1"	"Cell line enhanced"	"Detected in many"		"AF22: 392.1;ASC TERT1: 294.1;SuSa: 357.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069520	Approved		Supported	"Endoplasmic reticulum,Cytosol"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 68: Epididymis - Unknown function"	"Cluster 12: NES - Nervous system development"	"Cluster 44: Endometrium - Transcription"	"Endoplasmic reticulum, Cytosol"		"HPA069520: AB_2686144"	"prognostic favorable (4.03e-4)"	"unprognostic (8.73e-2)"	"unprognostic (2.51e-2)"	"unprognostic (8.13e-3)"	"unprognostic (5.93e-2)"	"unprognostic (4.51e-3)"	"unprognostic (5.41e-3)"	"unprognostic (7.46e-3)"	"unprognostic (7.70e-2)"	"prognostic favorable (9.43e-4)"	"unprognostic (1.34e-1)"	"unprognostic (4.82e-2)"	"prognostic favorable (3.67e-7)"	"unprognostic (4.48e-2)"	"unprognostic (1.54e-1)"	"unprognostic (1.41e-2)"	"prognostic unfavorable (3.51e-4)"	36.8	42.9	77.4	21.5	70.8	4.6	36.4	63.6	73.5	46.9	124.7	73.9	23.8	49.1	135.8	62.3	48.7	68.2	63.7	62.0	89.1	92.6	23.4	53.0	13.0	109.4	127.8	76.7	83.6	38.5	16.9	77.3	91.6	71.7	57.4	137.2	32.6	102.0	14.2	45.9	34.0	61.9	101.6	29.7	56.6	23.9	132.2	13.5	22.6	25.2	19.2	64.4	37.8	98.8	11.5	17.3	392.1	0.3	214.0	294.1	228.4	55.6	135.1	75.7	104.0	24.3	26.2	0.2	54.9	16.0	70.7	116.0	89.3	91.7	63.6	0.6	67.8	0.4	45.4	0.2	187.2	0.1	0.9	214.0	60.3	185.3	60.6	77.2	181.0	21.4	0.0	1.0	113.0	1.7	0.3	1.3	17.7	24.7	27.3	0.1	82.2	0.5	13.5	60.3	21.8	46.0	51.0	2.3	67.3	357.0	10.6	1.6	209.7	71.7	56.9	116.9	76.1	26.6	0.8	0.2	165.0	1.8	134.1	0.0	22.1	0.0	0.0	5.4	0.1	0.1	0.0	0.0	0.9	0.1	0.0	0.0	61.7	0.0	0.7	0.3	0.0	4.8	77.4	70.8	63.6	73.5	62.0	89.1	109.4	127.8	91.6	101.6	132.2	98.8	20.9	48.1	34.6	145.3	1.2	42.4	60.1	28.5	95.0	8.9	25.4	61.2	32.6	42.9	41.3	27.6	139.7	134.7	0.9	65.7	9.8	74.3	15.3	110.8	60.1	31.5	9.6	0.0	27.0	60.3	6.7	44.9	28.5	235.3	5.7	4.6	43.5	10.9	24.9	13.5	132.3	24.5	61.1	10.6	11.2	9.4	32.6	14.7	19.6	61.8	18.0	11.8	0.0	59.3	3.7	69.1	27.2	55.3	0.2	31.3	8.9	36.2	81.1	166.4	39.5	15.7	46.4	0.8	1.0	39.7	30.0	55.1	3.2	39.2	38.4	46.8
XK	"Kx, NA, NAC, X1k, XKR1"	ENSG00000047597	"X-linked Kx blood group"	P51811	X	37685791-37732130	"Blood group antigen proteins, Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"	"Amino-acid transport, Transport"	"Blood group antigen"	"Disease variant"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"bone marrow: 14.2;intestine: 12.2;stomach 1: 11.5"	"Cell type enhanced"	"Detected in many"		"Distal enterocytes: 26.7;Erythroid cells: 63.5;Gastric mucus-secreting cells: 17.9;Proximal enterocytes: 21.5;Undifferentiated cells: 14.7"	"Cancer enhanced"	"Detected in many"		"colorectal cancer: 6.5"	"Low region specificity"	"Detected in many"			"Group enriched"	"Detected in some"	53	"basophil: 10.2;eosinophil: 5.8"	"Lineage enriched"	"Detected in single"	102	"granulocytes: 10.2"	"Cell line enhanced"	"Detected in many"		"HEL: 44.4;HL-60: 23.2;K-562: 29.1;NB-4: 21.1;RPMI-8226: 20.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019036	Approved		Approved	Nucleoplasm,Vesicles,Mitochondria		No	No			"Cluster 2: Granulocytes - Unknown function"	"Cluster 75: Bone marrow - mRNA splicing & Cell cycle"	"Cluster 1: K-562 - Erythropoiesis"	"Cluster 6: Erythroid cells - Oxygen transport"	Mitochondria	"Nucleoplasm, Vesicles"	"HPA019036: AB_1846286"	"unprognostic (2.37e-2)"	"unprognostic (7.13e-3)"	"unprognostic (5.03e-2)"	"unprognostic (1.00e-2)"	"unprognostic (7.97e-2)"	"unprognostic (4.56e-1)"	"unprognostic (3.59e-2)"	"unprognostic (4.00e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.07e-2)"	"unprognostic (6.63e-2)"	"unprognostic (5.90e-2)"	"unprognostic (4.44e-8)"	"unprognostic (1.74e-1)"	"unprognostic (4.75e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.43e-1)"	0.2	2.1	2.5	1.4	2.5	14.2	0.7	2.3	3.0	1.2	0.2	12.2	10.8	0.7	0.5	2.0	3.8	0.9	4.3	3.2	4.9	0.9	0.8	1.0	0.2	1.6	0.9	0.7	4.9	0.7	1.3	0.7	2.0	1.5	11.2	2.1	1.2	0.9	5.4	0.7	10.6	1.8	0.5	0.5	11.5	1.4	2.8	0.2	0.9	5.8	0.5	1.1	0.8	1.4	17.4	1.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	15.9	14.7	0.3	0.0	0.8	2.7	15.4	0.1	0.0	0.0	4.2	44.4	2.4	0.0	0.0	23.2	3.5	0.0	0.8	0.0	0.0	0.0	0.0	0.0	29.1	10.9	0.1	1.7	0.2	21.1	5.5	0.7	5.6	0.0	0.0	20.2	0.0	1.1	4.1	0.1	0.8	1.4	0.1	0.9	2.1	5.6	0.0	0.0	0.8	0.0	2.4	9.3	16.5	0.0	0.2	12.1	0.1	10.2	0.0	5.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.4	2.5	2.5	2.3	3.0	3.2	4.9	1.6	0.9	2.0	0.5	2.8	1.4	0.0	0.0	1.1	2.6	0.8	0.4	0.4	0.1	1.2	0.7	1.1	0.8	7.9	0.0	0.1	0.0	6.2	0.3	0.1	26.7	0.0	0.0	1.2	4.0	0.1	0.3	6.1	63.5	11.0	3.1	0.1	0.6	17.9	0.9	0.0	0.1	0.0	0.9	0.1	3.3	12.6	10.9	2.0	0.3	0.0	0.4	0.0	0.2	1.8	1.9	0.0	0.0	0.0	4.5	1.2	1.1	9.2	0.7	2.2	0.9	21.5	0.1	1.7	1.4	0.0	0.7	1.3	10.2	6.1	3.8	1.1	0.0	0.3	0.1	14.7	1.5
XKR3	"MGC57211, XTES"	ENSG00000172967	"XK related 3"	Q5GH77	22	16783412-16821699	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in single"	43	"testis: 8.1"	"Cell type enriched"	"Detected in some"	10	"Early spermatids: 159.6"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Immune cell enhanced"	"Detected in single"		"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	13	"granulocytes: 1.6"	"Cell line enriched"	"Detected in some"	15	"Karpas-707: 230.8"									"HPA003379, HPA035081"	Uncertain					NA	NA			"Cluster 1: Neutrophils - Mixed function"	"Cluster 74: Testis - Spermatogenesis"	"Cluster 2: Karpas-707 - Immune response"	"Cluster 23: Spermatids - Flagellum & Golgi organization"			"HPA003379: AB_10602682, HPA035081: AB_2674451"	"unprognostic (4.57e-1)"				"unprognostic (3.37e-1)"								"unprognostic (3.11e-2)"	"unprognostic (3.13e-2)"	"unprognostic (5.77e-2)"			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	8.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.2	0.0	0.0	0.0	0.3	0.5	0.0	0.0	15.2	230.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.4	0.7	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.9	0.1	0.1	0.5	0.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	159.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	15.9	0.3	0.2	0.0	0.0	0.5	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.5	0.7	0.0	0.0	0.1	0.0	0.0	0.0	0.0
XKR4	KIAA1889	ENSG00000206579	"XK related 4"	Q5GH76	8	55102028-55542054	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enriched"	"Detected in some"	5	"brain: 8.1"	"Group enriched"	"Detected in some"	19	"Excitatory neurons: 306.3;Inhibitory neurons: 1019.5;Oligodendrocyte precursor cells: 721.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Group enriched"	"Detected in some"	7	"REH: 2.6;RPTEC TERT1: 9.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA025072, HPA028083"	Uncertain		Approved	Vesicles		NA	NA				"Cluster 10: Brain - Neuronal signaling"	"Cluster 35: RPTEC-TERT1 - Kidney processes"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"	Vesicles		"HPA025072: AB_1858886, HPA028083: AB_10601025"	"unprognostic (7.15e-4)"	"unprognostic (1.28e-3)"	"unprognostic (6.98e-2)"	"unprognostic (5.63e-3)"	"unprognostic (7.39e-2)"	"unprognostic (5.68e-3)"	"unprognostic (6.33e-2)"	"unprognostic (5.14e-2)"	"unprognostic (1.88e-1)"	"unprognostic (2.63e-1)"	"unprognostic (2.38e-3)"	"unprognostic (6.63e-2)"	"unprognostic (3.46e-4)"	"unprognostic (2.08e-2)"	"unprognostic (2.39e-2)"	"unprognostic (7.36e-2)"	"unprognostic (4.96e-2)"	0.1	0.2	7.6	0.5	7.1	0.0	0.0	0.9	8.1	0.3	0.0	1.7	0.2	0.1	0.2	0.5	0.1	0.2	0.7	7.0	2.2	0.1	0.0	0.0	0.4	0.1	2.2	0.0	0.2	0.0	0.7	0.0	0.0	0.3	0.4	0.6	0.3	0.5	0.0	0.2	0.3	0.1	0.0	0.1	0.3	0.1	5.8	0.5	0.0	0.0	0.4	0.3	0.4	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	2.6	0.0	0.0	9.9	0.0	0.1	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	7.6	7.1	0.9	8.1	7.0	2.2	0.1	2.2	0.0	0.0	5.8	1.1	0.5	9.6	18.7	7.8	0.1	0.4	0.6	0.0	0.6	12.5	0.1	0.3	2.1	0.0	9.3	3.7	35.5	0.1	0.4	0.1	0.0	0.1	0.9	0.6	0.2	2.4	0.0	0.0	306.3	0.9	0.1	2.3	0.0	1.1	0.0	0.2	1.1	0.4	0.1	0.0	1019.5	0.0	0.0	0.0	1.0	0.0	0.0	1.4	8.8	30.0	1.8	0.6	0.0	721.3	9.4	0.4	0.0	0.0	0.4	0.6	0.0	0.1	5.2	1.6	0.0	2.6	0.4	1.1	0.1	0.2	0.9	0.1	0.5	0.1	0.0	0.7
XKR5		ENSG00000275591	"XK related 5"	Q6UX68	8	6808517-6835524	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at transcript level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in single"		"Cardiomyocytes: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"AF22: 2.8;NTERA-2: 1.7;SCLC-21H: 1.3;SH-SY5Y: 3.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"									NA	NA					"Cluster 13: SH-SY5Y - Nervous system development"	"Cluster 52: Non-specific - Transcription"				"unprognostic (8.95e-2)"	"unprognostic (1.72e-1)"	"unprognostic (2.26e-1)"	"unprognostic (2.46e-2)"	"unprognostic (1.78e-1)"	"unprognostic (6.73e-2)"		"unprognostic (9.91e-2)"	"unprognostic (2.16e-3)"	"unprognostic (1.30e-1)"	"unprognostic (7.91e-3)"	"unprognostic (3.13e-2)"	"unprognostic (9.19e-2)"	"unprognostic (1.03e-2)"	"unprognostic (1.76e-1)"	"unprognostic (2.77e-2)"	"unprognostic (4.06e-2)"	0.0	0.0	0.1	0.0	0.1	0.5	0.0	0.3	0.2	0.7	0.2	0.0	0.1	0.4	0.2	0.1	0.4	0.1	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.1	0.1	0.1	0.1	0.0	0.0	0.1	0.1	0.4	0.1	0.1	0.1	0.4	0.1	0.2	0.1	0.4	0.1	0.1	0.0	0.1	0.1	0.1	0.1	0.0	0.1	0.1	0.0	0.4	0.0	0.1	2.8	0.5	0.0	0.0	0.1	0.9	0.2	0.5	0.8	0.1	0.2	0.1	0.3	0.1	0.0	0.1	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.4	0.0	0.1	0.4	0.0	0.1	0.4	1.7	0.1	0.0	0.1	0.5	0.1	0.1	0.2	1.3	3.0	0.1	0.0	0.0	0.3	0.1	0.1	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.3	0.4	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.1	0.1	0.3	0.2	0.1	0.1	0.1	0.1	0.1	0.1	0.1	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	1.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.5	0.0	0.0	0.1	0.0	0.1	0.2	0.0	0.1	0.0	0.5	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.1
XKR8	FLJ10307	ENSG00000158156	"XK related 8"	Q9H6D3	1	27959588-27968093	"Predicted membrane proteins, Transporters"	Apoptosis			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 62.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Group enriched"	"Detected in all"	7	"eosinophil: 202.8;neutrophil: 101.6"	"Lineage enriched"	"Detected in all"	13	"granulocytes: 202.8"	"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA049984, HPA053529"	Uncertain		Approved	"Golgi apparatus"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 5: NTERA-2 - Transcription"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"		"HPA049984: AB_2680982, HPA053529: AB_2682179"	"prognostic favorable (8.63e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.40e-1)"	"unprognostic (1.10e-3)"	"unprognostic (1.97e-2)"	"unprognostic (1.38e-2)"	"unprognostic (6.25e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.87e-2)"	"unprognostic (8.41e-2)"	"unprognostic (1.83e-3)"	"unprognostic (6.29e-2)"	"unprognostic (8.55e-2)"	"unprognostic (2.93e-2)"	"unprognostic (1.02e-1)"	"unprognostic (3.33e-1)"	"unprognostic (4.20e-2)"	5.8	4.4	17.7	8.6	18.0	22.7	6.6	18.7	19.1	6.2	18.5	6.0	7.0	5.7	8.1	5.3	7.7	6.7	8.1	18.3	19.3	6.8	15.3	7.4	8.8	18.9	18.6	9.1	14.0	9.7	4.5	15.2	18.0	6.3	6.1	5.4	10.3	8.0	6.2	5.6	6.0	9.3	17.9	9.4	9.0	6.3	19.1	6.9	6.5	11.7	7.4	7.0	4.7	17.9	10.9	8.6	12.4	13.4	10.5	15.5	13.5	8.8	17.1	19.5	18.7	18.2	7.6	4.1	9.1	21.1	14.5	4.6	19.0	9.5	9.8	15.0	18.2	13.8	5.2	15.4	15.7	6.8	4.7	16.9	18.8	21.8	15.2	19.7	19.3	12.5	21.6	8.9	14.1	10.0	8.5	19.7	40.3	9.1	12.6	15.1	4.0	8.8	15.6	6.3	2.9	4.1	3.8	9.6	6.2	21.7	6.2	16.8	8.0	11.4	10.2	23.9	8.0	13.1	13.6	6.5	29.3	9.2	8.7	20.3	11.9	202.8	15.1	11.9	14.8	7.6	15.7	14.1	13.0	7.1	14.4	13.5	101.6	14.0	10.2	6.3	14.8	11.2	17.7	18.0	18.7	19.1	18.3	19.3	18.9	18.6	18.0	17.9	19.1	17.9	4.4	3.2	1.1	2.6	8.8	1.9	3.8	3.5	1.8	4.5	5.2	3.4	3.3	5.7	4.4	3.7	0.0	62.0	15.5	4.7	3.9	7.8	0.5	1.8	2.9	6.8	1.8	2.1	2.2	11.4	15.8	6.1	5.6	2.4	1.3	5.2	8.6	5.6	14.0	3.3	2.2	6.1	2.0	6.6	3.7	0.9	3.4	8.0	1.8	1.0	21.1	14.0	16.5	3.5	5.5	7.2	2.8	3.8	14.0	5.1	7.2	4.5	1.7	1.3	6.6	5.1	4.0	0.6	7.8	2.2	3.0	22.4	9.1	4.4	5.2	4.1
XKR9		ENSG00000221947	"XK related 9"	Q5GH70	8	70669339-70790371	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"intestine: 5.3;testis: 7.7"	"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 42.0;Inhibitory neurons: 17.9;Oligodendrocytes: 23.0;Spermatocytes: 82.3;Spermatogonia: 19.7"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Cell line enhanced"	"Detected in some"		"CACO-2: 3.3;hTCEpi: 6.4"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			HPA044430	Enhanced		Approved	Mitochondria		NA	NA			"Cluster 4: T-regs - Cell cycle regulation"	"Cluster 45: Intestine - Brush border"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 13: Spermatocytes & Spermatogonia - Spermatogenesis"	Mitochondria		"HPA044430: AB_10961283"	"unprognostic (1.79e-2)"	"unprognostic (7.31e-2)"	"unprognostic (1.42e-1)"	"unprognostic (1.40e-3)"	"unprognostic (1.85e-1)"	"unprognostic (1.22e-1)"	"unprognostic (2.23e-2)"	"unprognostic (9.33e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.63e-2)"	"prognostic unfavorable (7.20e-4)"	"unprognostic (2.29e-1)"	"unprognostic (6.96e-6)"	"unprognostic (3.65e-1)"	"unprognostic (3.26e-1)"	"unprognostic (4.04e-3)"	"unprognostic (3.71e-2)"	0.2	1.1	0.5	0.4	0.5	0.5	0.4	0.0	1.6	0.2	0.0	0.9	2.6	0.2	1.3	0.5	0.1	2.2	0.2	0.5	0.3	0.5	3.3	0.6	0.5	0.6	0.2	0.2	0.3	0.1	0.6	0.4	1.1	0.6	0.5	2.4	0.5	0.0	0.2	0.9	5.3	0.3	0.0	0.5	1.8	7.7	0.3	0.5	0.4	0.3	0.5	1.0	0.2	1.5	2.3	0.1	0.5	0.2	0.0	0.5	0.3	0.9	0.4	0.3	0.9	3.3	0.2	0.3	1.5	0.0	1.1	0.1	0.0	0.5	1.1	0.4	0.3	0.2	0.2	0.2	0.0	0.7	1.2	0.6	6.4	0.1	0.0	0.2	0.0	1.6	0.1	2.3	0.1	0.3	0.4	0.3	1.3	0.1	0.4	0.3	0.6	0.1	0.1	1.7	1.4	0.2	0.4	1.0	0.3	0.1	0.3	0.1	0.2	0.3	0.6	0.4	0.3	2.0	0.5	1.5	0.1	0.2	0.2	0.2	0.0	0.0	0.2	0.0	0.4	0.2	0.4	0.2	0.0	0.2	0.6	0.4	0.1	0.2	0.0	0.0	0.8	0.0	0.5	0.5	0.0	1.6	0.5	0.3	0.6	0.2	1.1	0.0	0.3	1.5	0.1	6.4	2.2	14.4	1.1	2.7	3.5	3.9	4.6	2.2	0.7	1.0	0.4	1.5	3.3	0.0	8.4	1.0	0.3	1.4	0.0	1.6	5.3	0.5	0.3	0.6	0.0	0.0	42.0	4.6	0.6	0.8	6.1	0.6	0.0	0.3	0.0	2.3	0.3	1.7	17.9	3.4	0.0	0.3	0.4	4.9	0.9	0.2	0.0	1.9	0.0	1.5	2.1	1.5	23.0	6.0	1.3	0.4	0.8	1.7	11.7	0.5	3.2	5.3	0.0	0.1	0.2	82.3	19.7	0.5	0.9	1.0	1.0	0.1	0.4	2.3
XKRX	"XKR2, XPLAC"	ENSG00000182489	"XK related X-linked"	Q6PP77	X	100913445-100929433	"Predicted membrane proteins, Transporters"				"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Tissue enhanced"	"Detected in some"		"skin 1: 9.7"	"Cell type enhanced"	"Detected in some"		"Astrocytes: 9.4;Excitatory neurons: 4.3;Inhibitory neurons: 6.0;Microglial cells: 3.7;Oligodendrocytes: 5.5;Syncytiotrophoblasts: 2.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in some"			"Group enriched"	"Detected in some"	5	"naive B-cell: 1.9;naive CD4 T-cell: 1.5;naive CD8 T-cell: 1.2"	"Group enriched"	"Detected in many"	18	"B-cells: 1.9;T-cells: 1.5"	"Cell line enriched"	"Detected in some"	5	"CACO-2: 8.2"	"Low region specificity"	"Detected in some"			"Low region specificity"	"Detected in many"									NA	NA			"Cluster 21: B-cells - Adaptive immune response"	"Cluster 31: Skin - Epidermis development"	"Cluster 39: CACO-2 - Unknown function"	"Cluster 8: Neurons & Oligodendrocytes - Synaptic function"				"unprognostic (3.35e-1)"	"unprognostic (2.38e-2)"	"unprognostic (4.51e-3)"	"unprognostic (1.87e-1)"	"unprognostic (8.53e-2)"	"unprognostic (2.67e-2)"	"unprognostic (2.96e-2)"	"unprognostic (5.18e-2)"	"unprognostic (3.69e-2)"	"unprognostic (7.37e-2)"	"unprognostic (5.70e-2)"	"unprognostic (1.58e-2)"	"unprognostic (5.60e-6)"	"unprognostic (1.25e-1)"	"unprognostic (2.60e-1)"	"prognostic favorable (3.52e-4)"	"unprognostic (1.18e-1)"	0.0	0.6	0.5	0.8	0.3	0.1	0.6	0.1	0.3	0.7	0.0	0.7	0.3	0.2	1.1	2.3	0.6	0.1	0.0	0.2	1.7	0.1	0.0	1.2	1.6	0.3	0.4	0.2	0.0	0.0	1.0	0.3	0.3	0.3	0.8	0.2	0.5	0.9	0.1	9.7	2.4	0.1	0.2	0.5	0.3	0.2	1.2	1.8	0.4	0.0	3.5	0.3	1.7	0.2	0.2	0.6	0.0	0.0	0.1	0.0	0.0	0.0	0.3	0.0	0.0	8.2	1.0	0.6	0.0	0.0	0.7	0.1	0.0	0.6	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.2	0.0	0.0	0.1	1.5	0.6	0.0	0.0	0.0	0.4	0.1	0.0	0.3	1.6	0.0	0.0	0.0	1.6	0.1	1.3	0.2	0.7	0.1	0.7	0.0	0.1	0.2	0.0	1.4	0.0	0.2	0.0	0.0	1.2	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.2	0.0	0.0	0.0	1.9	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.5	0.3	0.1	0.3	0.2	1.7	0.3	0.4	0.3	0.2	1.2	0.2	0.0	0.0	0.0	9.4	0.7	0.0	0.1	0.5	0.0	0.3	0.0	0.0	0.4	0.0	0.4	0.0	0.0	0.6	0.0	0.1	0.0	0.0	0.1	0.3	0.1	0.0	0.0	0.0	4.3	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.1	0.0	6.0	0.4	0.0	0.0	0.0	0.2	0.0	0.0	1.8	3.7	0.1	0.2	0.0	1.0	5.5	0.1	0.1	0.0	0.0	0.1	1.2	0.0	0.5	0.1	0.0	0.0	0.0	0.1	0.3	1.0	0.9	2.6	0.2	0.0	0.2	0.4
XPO1	"CRM-1, CRM1, emb"	ENSG00000082898	"Exportin 1"	O14980	2	61476032-61538741	"Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Transporters"	"Host-virus interaction, mRNA transport, Protein transport, Transport"	RNA-binding	"Cancer-related genes, FDA approved drug targets"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB010184, HPA042933"	Supported		Enhanced	"Nucleoplasm,Nuclear membrane,Vesicles,Cytosol"		NA	NA		410000	"Cluster 27: Non-specific - Gene expression"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 36: Stromal cells - Cell proliferation"	"Nucleoplasm, Nuclear membrane"	"Vesicles, Cytosol"	"CAB010184: AB_2215817, HPA042933: AB_2678229"	"unprognostic (7.34e-2)"	"unprognostic (7.04e-2)"	"unprognostic (6.37e-2)"	"unprognostic (1.67e-2)"	"unprognostic (5.61e-2)"	"unprognostic (1.28e-1)"	"prognostic unfavorable (1.84e-5)"	"unprognostic (1.84e-1)"	"unprognostic (1.99e-3)"	"unprognostic (4.43e-1)"	"unprognostic (3.53e-3)"	"unprognostic (4.90e-2)"	"prognostic unfavorable (3.74e-4)"	"unprognostic (5.69e-2)"	"unprognostic (2.08e-1)"	"unprognostic (2.43e-1)"	"unprognostic (5.55e-2)"	33.2	29.8	30.1	48.7	31.4	25.8	39.2	35.7	44.3	37.9	31.6	34.9	24.7	52.5	37.0	35.1	45.9	32.0	36.0	27.9	33.7	30.8	41.7	31.9	65.3	28.9	30.5	58.9	26.2	38.5	22.0	52.1	30.4	34.2	42.0	52.0	19.9	34.9	37.5	34.2	33.2	48.6	30.9	43.4	31.9	54.5	32.8	73.6	38.8	47.2	60.9	38.6	22.4	38.9	169.1	152.9	194.1	135.8	91.4	107.9	145.5	166.6	109.2	192.9	151.8	217.3	114.7	256.0	117.4	127.1	186.3	125.0	307.9	126.5	268.6	151.6	110.7	242.8	136.2	148.4	55.4	234.6	145.4	62.9	103.8	149.4	145.9	126.0	149.5	108.7	285.5	127.7	164.9	97.8	212.6	100.4	213.1	189.9	111.5	175.6	208.0	148.1	103.0	124.9	152.8	77.5	174.2	142.8	87.1	185.6	108.6	110.8	98.9	153.7	178.7	137.2	175.0	102.8	203.2	347.0	96.8	214.0	151.0	3.3	1.4	2.2	1.8	2.2	1.9	1.1	1.0	1.8	2.1	0.7	1.0	1.0	0.6	2.7	1.2	1.6	1.2	1.2	30.1	31.4	35.7	44.3	27.9	33.7	28.9	30.5	30.4	30.9	32.8	38.9	42.0	41.7	43.2	114.3	55.3	52.1	32.1	45.5	78.6	67.5	40.2	38.6	64.5	38.6	38.7	31.3	95.9	54.1	56.6	27.3	13.7	29.7	4.2	58.6	79.7	47.7	45.1	73.2	87.9	26.1	49.3	49.9	42.3	68.6	41.8	100.4	41.4	55.8	57.2	72.3	101.3	34.2	40.7	55.3	58.4	11.9	33.5	63.9	37.4	68.4	64.2	33.4	61.8	83.4	102.5	32.3	20.9	30.9	57.2	55.6	21.0	22.2	56.9	101.7	19.7	50.5	55.7	65.9	91.6	83.3	56.8	30.1	54.5	54.4	46.2	47.7
XPO4	"FLJ13046, KIAA1721"	ENSG00000132953	"Exportin 4"	Q9C0E2	13	20777329-20903048	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"skeletal muscle: 44.1"	"Cell type enhanced"	"Detected in many"		"Cone photoreceptor cells: 64.6;Excitatory neurons: 72.8;Inhibitory neurons: 70.8;Oligodendrocytes: 82.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053768			Supported	Nucleoplasm,Cytosol		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 13: Striated muscle - Muscle contraction"	"Cluster 32: U-937 - Innate immune response"	"Cluster 58: T-cells - T-cell receptor"	"Nucleoplasm, Cytosol"		"HPA053768: AB_2682254"	"unprognostic (2.24e-1)"	"unprognostic (1.20e-2)"	"unprognostic (3.79e-2)"	"prognostic unfavorable (8.25e-4)"	"unprognostic (2.04e-1)"	"unprognostic (1.66e-1)"	"prognostic unfavorable (4.63e-4)"	"unprognostic (1.67e-1)"	"unprognostic (7.24e-3)"	"unprognostic (9.50e-3)"	"unprognostic (2.99e-1)"	"unprognostic (1.67e-2)"	"unprognostic (1.00e-2)"	"unprognostic (9.82e-2)"	"unprognostic (1.16e-1)"	"unprognostic (3.23e-2)"	"unprognostic (2.42e-1)"	4.3	3.6	3.1	5.7	4.3	10.2	6.1	5.6	3.8	4.4	4.5	4.7	3.7	6.1	4.1	4.8	4.1	3.5	10.7	3.0	3.5	5.1	4.1	6.0	7.3	3.7	3.6	6.1	4.2	6.5	3.0	5.2	3.8	5.4	5.7	13.5	3.7	3.9	44.1	5.6	3.8	5.6	3.8	5.8	4.6	5.8	3.7	7.1	6.5	16.7	7.0	4.6	3.7	5.6	10.1	7.5	12.0	11.5	5.7	9.9	12.4	11.2	8.2	13.0	10.7	15.3	12.4	22.0	5.9	10.8	9.8	16.2	28.0	15.2	24.0	15.1	8.0	35.0	9.5	10.3	8.6	31.0	11.0	9.8	9.4	13.1	24.7	7.6	15.9	12.5	16.8	7.1	12.4	8.3	14.9	13.6	13.6	21.2	6.9	16.3	19.8	9.2	9.0	12.1	13.6	9.4	9.7	13.9	11.5	12.0	8.2	16.8	13.2	9.1	7.1	11.3	16.1	4.7	7.4	17.9	4.5	19.5	13.9	1.5	0.7	0.8	1.1	0.8	1.3	1.0	1.0	1.0	1.0	0.8	1.2	1.2	0.0	1.1	2.5	0.7	1.0	0.4	3.1	4.3	5.6	3.8	3.0	3.5	3.7	3.6	3.8	3.8	3.7	5.6	10.0	12.8	12.5	36.6	24.0	8.3	10.7	12.1	11.4	17.0	8.5	6.1	22.2	10.0	5.6	9.2	64.6	8.3	11.4	4.7	0.0	5.4	10.4	6.1	11.9	9.5	1.2	10.9	72.8	4.1	7.4	9.8	18.3	7.7	15.2	11.9	12.1	10.5	10.8	10.1	70.8	7.5	6.1	10.0	8.0	8.2	17.4	9.5	12.4	44.0	11.6	5.4	10.3	58.8	82.5	5.4	3.6	8.2	21.3	11.8	3.4	5.4	6.3	21.4	32.9	11.6	10.0	14.2	18.8	14.7	11.2	12.9	18.6	7.1	9.6	10.4
XPO5	KIAA1291	ENSG00000124571	"Exportin 5"	Q9HAV4	6	43522334-43576038	"Predicted intracellular proteins, Transporters"	"Host-virus interaction, Protein transport, RNA-mediated gene silencing, Transport"	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB012357, HPA018402, HPA023959, HPA029909"	Enhanced		Enhanced	Nucleoplasm		NA	NA		13000	"Cluster 27: Non-specific - Gene expression"	"Cluster 23: Testis - Cell cycle regulation"	"Cluster 21: OE19 - Mitochondria"	"Cluster 39: Non-specific - Basic cellular processes"	Nucleoplasm		"CAB012357: , HPA018402: AB_1848330, HPA023959: AB_1848331, HPA029909: AB_10611245"	"unprognostic (6.98e-2)"	"unprognostic (4.34e-2)"	"unprognostic (5.13e-2)"	"prognostic unfavorable (4.94e-7)"	"unprognostic (6.16e-2)"	"unprognostic (2.43e-2)"	"prognostic unfavorable (3.98e-8)"	"unprognostic (4.78e-1)"	"unprognostic (4.72e-3)"	"unprognostic (1.72e-1)"	"unprognostic (4.86e-2)"	"unprognostic (1.49e-1)"	"unprognostic (1.07e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.45e-1)"	"unprognostic (9.48e-2)"	"unprognostic (5.66e-3)"	7.3	8.0	4.6	9.1	5.3	8.3	8.5	5.1	5.8	7.6	4.1	7.2	6.3	8.0	9.1	12.0	6.9	5.8	7.0	4.7	4.7	7.4	6.7	6.5	8.7	4.8	4.6	6.3	14.0	11.1	6.5	7.6	4.5	7.9	8.8	11.7	8.1	7.1	11.2	12.3	6.4	9.7	4.2	6.9	8.3	23.7	5.2	12.0	13.1	6.0	11.2	11.2	7.9	4.7	48.8	28.5	46.7	94.4	23.7	19.9	43.3	24.8	17.3	47.9	34.4	79.1	16.5	65.6	31.4	23.7	45.1	40.8	78.4	36.2	53.5	48.0	61.9	63.6	34.5	57.8	34.0	71.0	32.6	14.5	36.8	50.4	78.0	17.2	34.6	46.0	138.5	50.2	32.6	59.5	53.9	35.1	50.1	132.3	28.7	57.9	49.5	49.2	27.6	37.6	95.7	39.7	34.5	31.5	44.7	40.6	36.3	56.1	29.2	35.2	41.9	34.0	52.8	31.8	37.1	126.3	12.6	60.7	38.4	0.0	4.3	3.1	4.8	5.4	4.4	2.8	4.3	5.3	4.9	2.4	3.4	4.6	0.4	7.1	10.8	1.4	4.7	4.0	4.6	5.3	5.1	5.8	4.7	4.7	4.8	4.6	4.5	4.2	5.2	4.7	4.7	6.4	3.3	21.2	6.0	8.9	6.8	4.6	5.2	11.3	7.0	7.4	6.5	2.8	3.5	11.0	8.4	5.5	8.4	3.6	1.9	6.7	12.3	7.1	10.9	6.6	14.4	9.4	31.7	7.7	6.5	7.5	10.2	7.5	11.4	13.4	2.5	4.6	6.2	21.9	35.2	5.9	2.0	5.3	2.5	13.5	4.1	4.9	1.8	25.3	5.1	4.5	13.4	26.7	32.0	6.6	2.2	8.2	10.8	13.0	4.1	4.7	5.5	14.3	0.0	10.0	7.3	26.9	23.5	10.2	7.1	4.4	5.4	11.5	7.2	5.8
XPO7	"KIAA0745, RANBP16"	ENSG00000130227	"Exportin 7"	Q9UIA9	8	21919662-22006585	"Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Protein transport, Transport"			"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Erythroid cells: 169.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043727, HPA048153"	Uncertain					NA	NA		53000	"Cluster 44: Non-specific - Transcription"	"Cluster 34: Non-specific - Transcription"	"Cluster 26: Non-specific - Cell cycle regulation"	"Cluster 6: Erythroid cells - Oxygen transport"			"HPA043727: AB_2678638, HPA048153: AB_2680289"	"unprognostic (6.30e-2)"	"unprognostic (1.95e-2)"	"prognostic favorable (2.29e-4)"	"unprognostic (6.61e-3)"	"unprognostic (1.81e-1)"	"unprognostic (1.33e-2)"	"unprognostic (1.17e-2)"	"unprognostic (1.81e-1)"	"unprognostic (1.18e-1)"	"unprognostic (6.81e-3)"	"unprognostic (9.66e-2)"	"unprognostic (3.69e-2)"	"unprognostic (2.76e-2)"	"unprognostic (6.58e-2)"	"unprognostic (1.17e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.19e-1)"	20.0	21.8	25.1	21.9	27.2	61.9	26.6	24.5	25.7	26.5	24.7	24.7	15.9	30.7	28.5	26.5	30.5	20.3	31.3	27.9	23.2	40.3	19.2	22.5	26.8	19.7	20.7	39.7	21.7	43.4	19.9	31.8	20.3	21.3	28.3	45.0	20.6	24.7	33.2	28.0	17.7	28.6	22.4	23.2	23.6	41.0	24.3	33.4	35.5	40.5	31.2	23.9	21.6	28.4	47.8	83.2	60.7	43.9	49.9	43.3	47.9	46.2	54.3	67.2	60.4	63.6	29.1	78.0	51.5	57.6	61.0	45.5	87.9	66.2	117.8	23.7	44.7	87.5	67.9	46.9	34.0	42.3	63.9	34.0	45.9	67.1	64.0	48.8	65.5	69.1	106.0	61.0	49.9	36.8	105.6	39.4	78.3	81.2	33.0	60.5	78.3	40.9	44.3	98.0	36.7	57.9	43.8	45.3	46.4	61.2	41.2	34.7	42.9	35.0	44.5	50.3	47.0	21.4	25.9	83.0	53.5	50.9	63.1	6.4	3.4	2.6	5.1	4.6	4.3	4.5	4.5	3.9	5.1	3.2	3.4	4.3	1.6	3.4	4.3	1.8	4.9	3.9	25.1	27.2	24.5	25.7	27.9	23.2	19.7	20.7	20.3	22.4	24.3	28.4	14.8	22.4	11.4	37.5	14.6	14.3	6.3	9.0	10.2	31.8	11.8	10.7	38.1	15.7	13.5	18.4	14.6	11.5	12.0	11.2	3.9	10.3	70.5	12.0	12.0	12.4	20.9	169.5	65.8	11.2	13.4	13.1	19.9	11.3	7.6	32.1	13.6	14.1	14.4	50.5	68.8	12.0	8.2	23.9	11.3	39.7	15.5	16.8	10.6	37.5	17.3	15.3	11.3	70.4	70.9	10.7	6.5	17.7	15.7	10.3	7.8	15.3	9.8	23.5	13.1	14.9	13.2	21.6	21.4	16.0	12.1	5.6	9.4	13.2	12.8	8.5
XPOT	XPO3	ENSG00000184575	"Exportin for tRNA"	O43592	12	64404392-64451125	"Predicted intracellular proteins, Transporters"	Transport	"RNA-binding, tRNA-binding"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Muller glia cells: 80.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA048067, HPA057602"			Enhanced	Nucleoplasm,Cytosol		NA	NA		9800	"Cluster 15: NK-cells - Transcription"	"Cluster 76: Brain & Bone marrow - Chromatin organization"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 5: Muller glia cells - Visual perception"	Nucleoplasm	Cytosol	"HPA048067: AB_2680246, HPA057602: AB_2683481"	"unprognostic (4.53e-3)"	"unprognostic (7.20e-2)"	"unprognostic (1.38e-1)"	"unprognostic (3.78e-3)"	"unprognostic (1.01e-2)"	"unprognostic (3.14e-1)"	"prognostic unfavorable (1.81e-7)"	"unprognostic (1.50e-2)"	"unprognostic (2.22e-2)"	"unprognostic (1.50e-1)"	"unprognostic (2.16e-2)"	"unprognostic (8.87e-2)"	"prognostic unfavorable (2.41e-12)"	"unprognostic (2.72e-1)"	"unprognostic (3.68e-1)"	"unprognostic (5.20e-2)"	"prognostic unfavorable (5.79e-4)"	19.5	15.9	18.5	21.0	22.4	32.2	15.5	20.4	21.7	15.8	24.6	12.6	10.7	14.5	19.3	18.8	12.2	12.6	10.8	18.3	22.0	13.6	20.9	15.9	21.2	21.5	21.7	11.6	31.5	26.3	13.8	19.3	22.3	14.9	14.5	33.1	20.2	13.0	14.7	18.0	10.9	16.9	20.6	15.8	15.5	18.9	21.5	21.7	50.4	13.1	22.8	17.4	16.4	24.3	76.3	51.9	51.5	64.9	76.2	80.9	94.1	99.4	83.3	65.5	59.2	52.0	25.4	153.9	69.3	126.9	69.8	56.0	99.1	77.2	94.7	96.6	52.3	85.8	46.6	46.0	134.5	159.2	74.1	57.8	194.5	73.2	223.7	84.6	59.3	112.7	145.0	299.0	70.3	93.8	88.6	63.5	98.5	53.8	91.8	69.5	61.9	116.5	36.2	44.2	57.2	66.9	58.3	66.3	146.4	49.9	117.4	157.3	62.4	51.1	51.4	74.4	78.9	186.4	154.2	118.3	114.0	122.3	84.5	6.7	7.4	10.2	9.9	7.3	13.3	7.1	11.2	10.4	9.9	5.0	10.0	8.7	2.2	11.2	6.9	3.4	10.2	6.8	18.5	22.4	20.4	21.7	18.3	22.0	21.5	21.7	22.3	20.6	21.5	24.3	17.9	12.8	9.1	39.2	13.4	19.6	19.0	16.3	14.2	16.8	16.8	10.2	11.3	12.8	14.3	14.7	12.5	24.4	17.3	7.6	17.6	9.4	7.3	16.0	32.1	18.1	11.4	15.8	25.9	13.0	20.5	19.0	9.2	13.1	24.7	13.0	19.6	33.6	14.4	13.5	34.8	11.1	8.2	21.9	21.7	5.3	20.2	15.7	21.4	23.4	11.4	80.3	10.3	18.1	29.6	15.2	6.6	20.3	22.6	26.1	5.4	13.4	15.8	25.4	13.1	14.5	16.2	12.4	17.1	21.6	22.4	17.0	18.4	10.8	12.9	18.7
YIPF1	"DJ167A19.1, FinGER1"	ENSG00000058799	"Yip1 domain family member 1"	Q9Y548	1	53851719-53889798	"Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Cytotrophoblasts: 80.0;Syncytiotrophoblasts: 129.6"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014716, HPA073931"	Approved		Supported	"Nucleoplasm,Golgi apparatus,Plasma membrane"		NA	NA			"Cluster 8: Neutrophils - Inflammatory response"	"Cluster 8: Non-specific - Mitochondria"	"Cluster 33: SK-MEL-30 - Melanocyte processes"	"Cluster 47: Cytotrophoblasts - Unknown function"	"Golgi apparatus"	"Nucleoplasm, Plasma membrane"	"HPA014716: AB_1847686, HPA073931: "	"unprognostic (4.94e-2)"	"unprognostic (4.50e-1)"	"unprognostic (6.37e-2)"	"unprognostic (2.06e-2)"	"unprognostic (3.93e-2)"	"unprognostic (1.35e-1)"	"prognostic unfavorable (1.34e-4)"	"unprognostic (1.96e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.34e-1)"	"unprognostic (1.49e-1)"	"unprognostic (2.76e-1)"	"unprognostic (1.24e-2)"	"unprognostic (7.75e-3)"	"unprognostic (2.38e-1)"	"unprognostic (5.39e-3)"	"unprognostic (6.35e-1)"	7.1	9.2	5.3	6.2	5.6	5.7	8.5	5.8	15.2	6.7	6.9	7.9	6.9	4.1	7.6	9.0	6.3	5.5	6.6	5.9	6.3	11.1	13.5	7.7	7.1	6.7	5.8	7.0	6.8	7.0	6.2	9.7	6.8	11.3	9.2	7.2	11.7	4.8	14.6	9.4	6.9	6.0	6.2	8.2	8.7	7.2	6.0	8.8	22.1	10.4	10.7	7.7	7.1	6.4	11.0	6.4	10.1	7.1	11.9	13.1	9.0	7.7	12.0	14.0	18.3	7.1	3.3	3.8	12.9	9.2	21.6	13.2	12.9	17.0	14.4	27.4	10.3	8.9	6.4	11.6	15.9	10.0	8.1	13.3	15.8	11.3	13.5	12.0	15.0	13.2	9.6	10.0	14.0	9.2	10.8	14.2	7.7	12.7	10.4	6.6	9.3	15.4	11.5	5.8	4.5	5.6	7.4	13.8	35.4	31.0	21.4	11.1	7.1	5.7	5.8	10.4	6.8	20.1	24.7	7.0	9.3	8.1	5.0	19.1	18.4	20.2	11.8	16.5	11.0	10.4	10.0	12.1	16.6	13.8	9.5	9.2	38.3	11.0	23.3	11.5	24.3	16.5	5.3	5.6	5.8	15.2	5.9	6.3	6.7	5.8	6.8	6.2	6.0	6.4	11.6	6.4	12.6	9.8	9.0	8.5	17.6	19.2	9.6	6.6	20.0	12.4	9.6	24.3	24.0	9.2	0.0	80.0	8.5	14.6	11.7	28.3	30.5	11.4	10.9	10.9	9.6	12.2	9.8	32.6	28.4	9.9	9.7	14.7	9.5	6.3	11.7	20.8	39.7	10.1	8.2	27.5	30.5	19.4	7.7	54.9	5.9	18.9	10.6	11.2	20.2	16.5	21.6	8.5	11.5	32.5	10.8	9.4	28.1	33.2	12.3	17.7	19.7	6.5	0.0	5.6	17.7	22.2	20.9	12.3	10.9	129.6	10.8	17.7	10.8	29.0
YIPF2	"FinGER2, MGC3262"	ENSG00000130733	"Yip1 domain family member 2"	Q9BWQ6	19	10922185-10928681	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"				"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Spermatocytes: 159.1;Syncytiotrophoblasts: 174.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA019902	Approved		Approved	"Golgi apparatus,Mitochondria"		No	No			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 22: Non-specific - Unknown function"	"Cluster 40: Non-specific - Basic cellular processes"	"Cluster 66: Spermatocytes - Spermatogenesis"	"Golgi apparatus, Mitochondria"		"HPA019902: AB_1858925"	"unprognostic (1.27e-1)"	"unprognostic (8.56e-2)"	"unprognostic (2.90e-3)"	"unprognostic (8.38e-2)"	"unprognostic (3.66e-1)"	"unprognostic (3.96e-1)"	"unprognostic (1.93e-1)"	"unprognostic (7.65e-2)"	"unprognostic (4.30e-2)"	"unprognostic (5.62e-3)"	"unprognostic (1.13e-1)"	"unprognostic (1.51e-1)"	"unprognostic (1.06e-1)"	"unprognostic (3.28e-2)"	"unprognostic (3.92e-2)"	"unprognostic (5.99e-2)"	"unprognostic (2.00e-2)"	29.5	43.5	18.1	15.9	18.7	29.6	34.1	20.5	26.6	41.7	30.7	34.7	31.8	38.1	26.8	51.0	35.2	30.3	31.6	19.4	20.3	45.1	56.1	32.8	16.8	22.4	19.6	39.6	114.3	33.4	108.2	38.9	21.0	40.3	15.8	6.5	105.7	23.6	24.8	33.8	29.9	14.2	18.2	27.7	39.2	76.8	19.4	14.3	47.5	10.3	11.2	32.6	39.6	20.4	64.9	22.3	17.5	25.4	40.0	38.9	30.1	48.9	71.6	36.6	52.9	68.1	51.6	12.8	80.2	56.2	16.7	49.8	11.9	47.6	9.5	41.7	43.2	24.2	27.3	39.1	62.1	42.5	49.3	35.7	33.6	24.7	35.4	47.7	26.2	31.1	31.6	69.2	22.9	109.4	27.4	42.7	29.4	44.3	55.2	22.8	14.1	65.3	33.0	30.2	45.4	22.2	35.2	56.4	48.8	15.3	51.7	60.1	39.1	41.6	15.3	60.2	36.7	96.7	42.5	24.2	65.1	72.9	43.9	39.2	18.8	9.3	13.3	21.3	10.4	16.3	10.4	12.3	22.3	9.5	9.3	13.3	3.1	12.1	19.4	34.1	12.6	10.4	18.1	18.7	20.5	26.6	19.4	20.3	22.4	19.6	21.0	18.2	19.4	20.4	20.5	16.0	21.2	2.6	16.0	6.8	41.6	22.4	17.1	19.4	46.9	37.8	0.5	27.1	27.3	35.0	16.7	109.5	20.6	31.9	27.4	69.3	131.1	23.0	20.1	19.2	43.3	17.2	6.4	80.7	114.1	36.0	33.6	29.3	21.6	22.5	22.5	23.0	38.7	18.5	6.7	69.4	14.2	15.3	5.2	34.6	35.1	20.5	5.4	5.6	21.1	23.8	16.5	3.5	3.3	50.3	47.7	25.6	55.4	51.6	52.5	27.0	26.1	16.4	6.6	20.0	21.9	159.1	16.6	22.6	7.0	174.3	13.9	27.9	50.6	50.0
YIPF3	"C6orf109, dJ337H4.3, DKFZp566C243, FinGER3, KLIP1"	ENSG00000137207	"Yip1 domain family member 3"	Q9GZM5	6	43511832-43516985	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	Differentiation			"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"OE19: 494.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014859, HPA063699"	Supported		Enhanced	"Nucleoplasm,Golgi apparatus"		NA	NA			"Cluster 9: Neutrophils - Innate immune response"	"Cluster 22: Non-specific - Unknown function"	"Cluster 21: OE19 - Mitochondria"	"Cluster 55: Plasma cells - Humoral immune response"	"Golgi apparatus"	Nucleoplasm	"HPA014859: AB_1845729, HPA063699: AB_2685095"	"unprognostic (2.82e-2)"	"unprognostic (1.29e-1)"	"unprognostic (2.29e-2)"	"unprognostic (4.71e-2)"	"unprognostic (1.74e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.15e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.70e-3)"	"unprognostic (1.70e-2)"	"unprognostic (1.12e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.94e-2)"	"unprognostic (3.55e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.10e-1)"	72.3	120.2	78.9	43.3	79.9	46.4	70.0	79.5	92.0	74.0	102.6	74.3	65.2	72.1	100.5	80.3	69.7	63.3	87.6	80.2	78.9	78.2	105.4	68.9	42.6	80.5	79.2	75.6	152.0	110.0	91.9	77.8	81.2	76.3	62.1	49.8	118.6	61.1	82.8	70.0	66.1	57.5	78.3	67.2	106.1	48.0	81.6	46.0	74.3	83.4	46.5	69.1	67.3	80.8	95.0	66.2	95.3	185.4	208.3	168.5	56.1	111.9	174.6	91.8	115.7	79.1	67.6	37.8	84.4	208.6	78.4	93.4	71.0	110.2	59.4	69.9	95.7	61.2	91.8	153.2	163.2	64.7	85.9	169.0	141.2	77.9	78.3	154.4	141.1	61.1	67.8	88.2	111.5	146.9	47.5	82.3	49.7	494.4	71.1	42.6	43.0	103.2	164.3	101.4	76.7	109.0	50.3	66.9	122.2	72.8	111.4	133.5	133.5	103.1	53.4	57.0	78.8	102.5	88.8	74.3	73.2	53.5	71.5	147.2	84.8	128.7	60.0	82.2	52.3	46.1	53.7	54.1	78.7	48.5	42.7	48.5	316.0	65.5	83.2	70.3	79.8	78.2	78.9	79.9	79.5	92.0	80.2	78.9	80.5	79.2	81.2	78.3	81.6	80.8	77.8	35.3	33.6	12.7	41.4	40.7	63.8	121.7	63.2	54.6	62.8	49.4	31.7	82.9	86.5	55.2	37.5	192.2	41.1	109.7	49.0	149.6	38.1	63.5	60.5	78.9	107.1	42.1	12.1	101.8	209.5	78.2	59.7	67.9	40.6	77.9	74.6	71.0	99.3	58.9	14.7	117.6	101.7	49.1	31.2	79.0	69.9	49.6	65.8	14.0	72.4	115.0	42.2	15.1	17.7	117.5	108.8	67.0	111.6	71.4	129.1	74.9	51.2	63.5	32.9	45.5	64.4	44.0	40.8	52.8	35.5	264.1	34.9	101.9	80.0	81.6
YWHAZ	"14-3-3-zeta, KCIP-1, YWHAD"	ENSG00000164924	"Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein zeta"	P63104	8	100916523-100953388	"Plasma proteins, Predicted intracellular proteins, Transporters"			"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in all"		"Late spermatids: 2118.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			CAB005065	Approved					NA	NA		320000000	"Cluster 38: Basophils - Unknown function"	"Cluster 84: Esophagus - Epithelial cell function"	"Cluster 30: Epithelial cell lines - Translation"	"Cluster 16: Pancreatic endocrine cells - Mixed function"			"CAB005065: AB_2218378"	"unprognostic (4.70e-3)"	"unprognostic (7.38e-3)"	"unprognostic (8.09e-2)"	"prognostic unfavorable (3.91e-4)"	"unprognostic (1.83e-3)"	"unprognostic (2.00e-2)"	"prognostic unfavorable (2.28e-5)"	"prognostic unfavorable (3.93e-4)"	"unprognostic (1.65e-1)"	"unprognostic (3.72e-1)"	"prognostic unfavorable (1.20e-5)"	"unprognostic (1.09e-1)"	"prognostic unfavorable (2.03e-6)"	"unprognostic (1.02e-1)"	"unprognostic (1.69e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.49e-1)"	379.0	262.9	246.2	374.2	324.1	527.2	251.7	147.4	343.0	269.6	88.3	475.2	327.3	275.6	220.9	892.8	243.9	333.0	187.3	366.2	269.6	224.9	190.9	275.8	429.3	163.3	195.7	227.7	191.5	233.3	109.0	339.2	222.5	265.8	445.9	285.3	244.8	291.2	95.0	399.4	375.4	356.5	170.1	272.8	365.4	226.8	276.9	434.8	289.7	168.9	566.1	501.0	343.2	205.0	1902.4	879.2	1605.4	457.7	396.6	490.9	808.0	877.6	1099.2	1124.6	1098.2	602.4	1149.5	816.5	857.1	1349.3	937.2	785.0	1025.5	1213.5	1630.1	765.1	454.2	779.5	579.0	378.1	524.8	311.5	840.3	475.4	1524.0	936.7	1430.1	923.8	1008.7	584.9	887.8	758.9	920.2	660.6	1357.1	535.4	548.0	2269.0	1026.7	569.7	468.6	544.8	1023.1	963.5	889.7	642.7	669.5	609.8	1365.4	1094.7	896.0	374.6	879.0	554.6	834.3	693.7	798.3	503.6	625.3	994.6	925.8	595.2	2303.2	1340.5	427.5	705.8	559.0	589.1	559.3	484.8	463.3	537.3	497.3	395.9	348.3	441.8	616.5	503.7	726.9	313.4	663.9	1087.2	246.2	324.1	147.4	343.0	366.2	269.6	163.3	195.7	222.5	170.1	276.9	205.0	199.4	250.0	228.9	43.1	637.6	1007.0	438.4	309.3	507.6	120.4	285.9	209.9	87.0	188.8	321.3	263.0	89.6	243.4	491.2	552.7	121.3	405.2	1092.9	359.6	245.6	216.0	265.3	137.3	150.2	421.3	551.6	277.4	448.5	578.8	452.9	122.1	183.1	104.5	276.3	134.6	92.5	525.2	244.1	303.5	641.2	2118.0	125.6	456.9	391.3	56.2	334.9	110.9	407.8	51.3	91.5	771.0	452.7	147.1	457.2	427.2	310.6	160.4	292.0	96.3	131.5	229.4	290.4	170.2	92.6	908.0	1184.7	408.9	596.5	116.5	371.7	794.9
ZACN	"L2, LGICZ, LGICZ1, ZAC, ZAC1"	ENSG00000186919	"Zinc activated ion channel"	Q401N2	17	76071961-76083666	"Predicted membrane proteins, Transporters"	"Ion transport, Transport"	"Ion channel, Ligand-gated ion channel, Receptor"		"Evidence at protein level"	"No human protein/transcript evidence"	"Evidence at protein level"	"Evidence at protein level"	"Not detected"	"Not detected"			"Cell type enhanced"	"Detected in some"		"Gastric mucus-secreting cells: 1.1;Respiratory ciliated cells: 1.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Not detected in immune cells"	"Not detected"			"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Not detected"	"Not detected"									NA	NA						"Cluster 59: Non-specific - Transcription"				"unprognostic (8.27e-2)"	"unprognostic (2.89e-2)"	"unprognostic (8.92e-2)"	"unprognostic (7.43e-2)"	"unprognostic (5.46e-2)"	"unprognostic (1.13e-2)"	"unprognostic (5.10e-3)"	"unprognostic (5.17e-2)"	"unprognostic (4.49e-2)"	"unprognostic (7.42e-2)"	"unprognostic (3.16e-5)"	"unprognostic (2.70e-2)"	"unprognostic (5.19e-7)"	"unprognostic (6.27e-2)"	"unprognostic (3.59e-1)"	"unprognostic (2.14e-1)"	"unprognostic (1.16e-2)"	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.5	0.7	0.4	0.3	0.1	0.1	0.6	0.1	0.1	0.0	0.2	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.0	0.0	0.3	0.1	0.1	0.0	0.0	0.1	0.4	0.1	0.3	1.1	0.2	0.0	0.0	0.4	0.1	0.1	0.0	0.1	0.0	0.0	0.6	0.4	0.0	0.0	0.2	0.0	0.0	0.0	0.4	0.0	0.0	0.1	0.1	0.3	0.0	0.8	0.4	0.0	0.1	1.0	0.1	0.0	0.4	0.2	0.0	0.1	0.3	0.1	0.3	0.6	0.0	0.1	0.2
ZDHHC13	"FLJ10852, FLJ10941, HIP14L"	ENSG00000177054	"Zinc finger DHHC-type palmitoyltransferase 13"	Q8IUH4	11	19117099-19176422	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Early spermatids: 120.5;Urothelial cells: 103.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 136.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016759, HPA018791"	Uncertain		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 45: Eosinophils - Innate immune response"	"Cluster 37: Intestine - Unknown function"	"Cluster 41: TIME & HUVEC/TERT2 - Endothelial cell function"	"Cluster 22: Epithelial cell types - Mixed function"	Vesicles	"Golgi apparatus"	"HPA016759: AB_1858993, HPA018791: AB_1858992"	"unprognostic (1.43e-2)"	"unprognostic (4.00e-3)"	"unprognostic (1.08e-1)"	"unprognostic (1.11e-3)"	"unprognostic (2.95e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.55e-2)"	"unprognostic (1.57e-1)"	"unprognostic (3.57e-3)"	"unprognostic (3.03e-2)"	"unprognostic (1.63e-1)"	"unprognostic (2.16e-1)"	"unprognostic (6.95e-3)"	"unprognostic (1.15e-1)"	"unprognostic (7.93e-2)"	"unprognostic (2.17e-1)"	"unprognostic (2.76e-2)"	4.8	5.7	5.2	7.8	5.2	9.7	8.9	6.6	7.1	9.3	6.6	16.9	11.2	6.7	5.1	37.2	12.9	8.7	9.1	5.4	5.7	9.2	2.2	6.1	9.6	5.5	5.0	5.3	11.2	14.9	11.7	6.2	5.8	8.2	18.2	16.1	10.2	5.4	1.6	18.8	11.3	6.1	5.3	5.7	18.5	14.4	5.0	11.7	8.7	2.9	22.4	22.4	15.4	5.2	41.6	19.3	18.0	15.5	6.3	7.2	17.3	19.4	17.8	21.3	24.4	11.7	9.7	21.1	13.1	16.3	47.9	61.3	26.0	12.8	23.3	26.4	22.6	11.1	12.6	9.7	14.6	15.2	18.5	8.3	14.7	9.0	12.5	19.9	136.8	28.9	10.7	10.3	22.1	13.5	19.6	12.2	15.1	38.7	17.6	21.3	25.0	5.0	21.9	27.0	31.3	23.0	23.2	28.0	10.7	17.3	13.2	17.6	39.6	18.9	13.2	29.2	15.8	8.7	28.5	19.2	22.6	15.5	33.6	11.6	4.7	32.7	8.5	7.9	7.8	8.7	6.6	9.6	5.9	5.5	6.2	8.3	6.0	6.3	6.4	5.6	9.4	4.6	5.2	5.2	6.6	7.1	5.4	5.7	5.5	5.0	5.8	5.3	5.0	5.2	8.1	9.6	10.7	28.7	9.6	24.2	22.3	27.2	14.2	12.0	7.5	4.8	34.1	12.8	41.3	16.5	10.4	8.7	10.6	20.1	5.9	25.1	120.5	21.5	6.6	11.3	15.6	11.6	27.2	19.2	18.8	9.2	24.5	30.8	12.0	16.2	12.8	0.9	6.1	16.8	34.9	24.7	36.7	6.8	8.3	46.6	7.8	6.2	3.6	9.4	20.8	52.8	18.6	19.6	20.9	20.4	16.4	2.2	10.4	47.4	15.5	3.5	57.0	8.8	0.0	5.4	7.4	58.1	31.7	21.3	36.2	6.3	11.4	7.7	21.4	103.0
ZDHHC17	"HIP14, HYPH, KIAA0946"	ENSG00000186908	"Zinc finger DHHC-type palmitoyltransferase 17"	Q8IUH5	12	76764103-76853696	"Enzymes, Metabolic proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Tumor suppressor"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Excitatory neurons: 102.2;Inhibitory neurons: 95.1;Oligodendrocytes: 115.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Immune cell enhanced"	"Detected in all"		"plasmacytoid DC: 17.1"	"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA016807, HPA058674"	Approved		Supported	"Golgi apparatus,Vesicles"		NA	NA			"Cluster 3: Plasmacytoid DCs - Unknown function"	"Cluster 6: Brain - Smell perception"	"Cluster 12: NES - Nervous system development"	"Cluster 65: Plasmacytoid DCs - Unknown function"	"Golgi apparatus, Vesicles"		"HPA016807: AB_1858999, HPA058674: AB_2732626"	"unprognostic (1.06e-1)"	"unprognostic (2.26e-2)"	"unprognostic (2.63e-2)"	"unprognostic (3.04e-1)"	"unprognostic (6.12e-2)"	"unprognostic (2.83e-2)"	"unprognostic (2.35e-3)"	"unprognostic (3.09e-1)"	"unprognostic (8.38e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.56e-3)"	"unprognostic (5.42e-2)"	"prognostic unfavorable (7.11e-5)"	"unprognostic (1.77e-2)"	"unprognostic (2.69e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.71e-2)"	15.6	14.1	18.6	12.1	20.4	23.7	16.1	23.1	25.9	15.8	11.8	13.7	7.5	21.7	12.3	8.0	12.8	10.5	12.5	19.8	18.9	11.0	9.8	10.6	14.8	18.2	18.6	20.1	10.2	12.7	11.0	16.4	18.9	14.1	10.1	31.0	8.1	12.8	11.8	10.2	10.3	14.6	19.2	14.4	8.5	12.8	19.4	14.9	11.8	14.2	11.4	11.7	11.7	27.8	8.2	9.5	30.1	15.4	17.6	18.5	14.6	16.2	13.4	10.5	9.2	7.8	5.8	11.2	9.5	15.9	10.5	7.5	12.1	10.1	16.2	9.5	12.6	16.4	13.1	12.0	11.9	16.5	13.9	17.6	10.3	10.0	14.7	35.2	12.2	15.2	18.0	5.2	13.8	7.6	12.0	21.9	22.1	3.6	11.3	16.1	10.7	12.3	12.0	12.3	11.7	20.1	17.8	6.4	10.7	25.7	14.4	16.3	16.9	14.3	11.0	8.8	9.3	8.1	8.5	11.9	5.4	7.6	15.0	6.2	2.3	5.7	3.6	2.4	2.9	2.5	2.9	2.6	2.8	3.9	3.0	2.5	5.9	2.0	2.5	17.1	1.3	1.5	18.6	20.4	23.1	25.9	19.8	18.9	18.2	18.6	18.9	19.2	19.4	27.8	33.4	32.1	18.3	75.7	20.1	7.1	10.4	9.8	12.5	54.6	9.9	10.7	21.3	12.8	15.5	12.9	39.6	20.3	74.1	5.0	0.0	8.0	11.3	11.8	23.8	24.8	19.2	12.0	102.2	4.7	10.2	21.2	7.1	10.1	41.2	20.7	20.3	10.6	8.8	28.6	95.1	7.5	8.2	12.3	19.4	13.7	20.2	14.9	5.4	54.4	14.9	26.1	18.6	88.4	115.8	6.8	4.5	21.1	13.5	10.2	8.4	5.5	18.0	38.1	0.0	32.3	22.0	17.7	22.6	9.5	5.5	5.6	18.1	19.6	6.2	5.5
ZDHHC20	"DHHC20, FLJ25952"	ENSG00000180776	"Zinc finger DHHC-type palmitoyltransferase 20"	Q5W0Z9	13	21372571-21459370	"Enzymes, Metabolic proteins, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"		"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 95.0"	"Cell type enriched"	"Detected in many"	4	"Oligodendrocytes: 434.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA014483, HPA014702"	Approved		Supported	"Vesicles,Plasma membrane"		NA	NA			"Cluster 25: Monocytes - Inflammatory response"	"Cluster 70: Brain - Nervous system development"	"Cluster 42: Epithelial cell lines - Epithelial cell function"	"Cluster 42: Oligodendrocytes - Myelin sheath organization"	"Vesicles, Plasma membrane"		"HPA014483: AB_1859000, HPA014702: AB_1859001"	"unprognostic (1.31e-1)"	"unprognostic (2.16e-3)"	"unprognostic (7.31e-3)"	"unprognostic (8.89e-2)"	"unprognostic (3.37e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.06e-3)"	"unprognostic (3.77e-1)"	"unprognostic (1.24e-2)"	"unprognostic (1.26e-2)"	"prognostic unfavorable (6.55e-4)"	"unprognostic (1.10e-1)"	"prognostic unfavorable (1.01e-4)"	"unprognostic (3.76e-2)"	"unprognostic (7.65e-2)"	"unprognostic (6.15e-2)"	"unprognostic (1.13e-2)"	10.9	9.2	15.2	17.6	52.9	30.0	11.5	51.8	23.3	16.2	0.0	16.9	19.3	13.8	9.6	30.2	10.9	17.1	7.9	12.0	27.0	6.7	9.8	17.0	18.0	70.8	40.7	9.7	9.0	8.9	4.4	18.8	60.3	15.1	16.1	5.6	8.5	12.2	4.0	22.1	19.0	15.2	35.1	16.1	39.5	31.7	40.7	22.6	16.4	9.4	19.5	22.9	9.3	95.0	32.9	16.4	27.7	18.1	24.5	26.7	68.3	35.6	36.3	23.3	20.6	33.8	102.5	34.8	19.3	44.7	23.8	52.7	30.5	26.5	44.8	40.0	20.4	61.8	11.7	19.6	14.1	43.3	25.8	24.2	19.4	23.6	16.2	30.0	37.6	45.9	17.3	14.9	35.3	27.2	62.0	17.2	22.9	87.3	18.0	49.8	49.1	12.7	28.9	59.7	25.2	11.4	46.0	28.7	19.3	28.6	27.0	21.8	62.6	25.0	24.0	41.7	27.4	15.6	19.9	37.7	18.2	23.6	73.1	12.6	16.2	3.8	10.1	14.9	9.3	4.6	8.7	8.7	8.4	3.4	8.1	8.4	3.0	11.2	13.8	4.1	10.4	13.5	15.2	52.9	51.8	23.3	12.0	27.0	70.8	40.7	60.3	35.1	40.7	95.0	27.6	51.3	31.5	29.0	19.9	1.0	7.8	1.4	18.2	7.4	21.9	13.7	7.4	14.3	20.7	11.0	8.4	20.7	34.7	35.5	0.0	8.5	91.3	23.4	25.2	25.7	24.0	8.4	69.1	12.2	20.9	13.6	53.0	34.5	14.0	16.1	20.0	20.8	21.7	18.5	80.0	29.1	2.0	92.5	3.2	81.2	15.5	49.0	1.8	46.9	48.4	3.7	30.9	54.8	434.3	22.8	25.5	10.9	18.1	14.5	30.3	6.3	11.7	9.5	19.7	12.7	11.6	10.4	14.1	28.1	1.6	44.6	28.4	9.7	25.1	25.6
ZDHHC9	"CGI-89, CXorf11, DHHC9, ZDHHC10, ZNF379, ZNF380"	ENSG00000188706	"Zinc finger DHHC-type palmitoyltransferase 9"	Q9Y397	X	129803288-129843909	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Acyltransferase, Transferase"	"Disease variant, Mental retardation"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell type enhanced"	"Detected in many"		"Adipocytes: 66.0;Oligodendrocytes: 118.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in many"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA031814	Uncertain		Supported	"Endoplasmic reticulum,Golgi apparatus,Cytosol"		NA	NA			"Cluster 27: Non-specific - Gene expression"	"Cluster 45: Intestine - Brush border"	"Cluster 34: Mesenchymal cell lines - ECM organization"	"Cluster 50: Fibroblasts - ECM organization"	"Endoplasmic reticulum, Golgi apparatus"	Cytosol	"HPA031814: AB_10610700"	"prognostic unfavorable (9.77e-5)"	"prognostic unfavorable (4.64e-5)"	"unprognostic (2.83e-2)"	"unprognostic (7.53e-3)"	"unprognostic (2.68e-1)"	"prognostic unfavorable (2.45e-4)"	"unprognostic (4.01e-3)"	"unprognostic (1.02e-1)"	"unprognostic (4.04e-1)"	"unprognostic (3.49e-2)"	"unprognostic (9.70e-3)"	"unprognostic (4.76e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.05e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.17e-2)"	"unprognostic (4.11e-2)"	28.2	12.0	39.2	10.2	66.6	5.4	24.3	46.5	52.5	19.1	23.3	22.0	31.6	11.8	11.7	15.6	12.1	15.3	15.5	39.2	49.0	37.1	40.1	26.7	3.3	60.5	58.2	11.2	25.9	25.2	11.4	17.2	52.5	18.8	24.9	6.0	21.1	11.3	13.4	35.3	34.0	15.3	44.8	3.9	19.5	4.1	57.8	3.6	13.8	11.3	6.6	23.8	14.5	78.6	45.9	23.8	33.2	67.5	112.4	87.7	27.0	44.3	50.6	20.9	26.0	37.6	58.4	1.6	73.7	47.6	54.0	30.4	38.0	44.6	30.0	2.6	23.7	9.2	24.0	50.1	44.4	6.1	15.7	96.0	71.1	34.0	50.1	36.5	39.9	15.0	10.1	17.6	34.0	40.0	8.8	11.4	18.0	102.3	40.4	8.2	21.4	27.1	30.1	25.2	26.3	22.0	12.7	64.7	20.5	38.9	27.6	10.1	32.8	21.1	7.3	50.0	36.3	16.5	12.7	5.5	37.9	25.1	10.8	0.0	2.2	1.8	3.0	2.0	3.7	2.7	3.6	2.9	2.4	1.5	4.5	2.6	0.0	2.5	5.2	5.1	1.8	2.1	39.2	66.6	46.5	52.5	39.2	49.0	60.5	58.2	52.5	44.8	57.8	78.6	66.0	22.4	28.6	4.6	2.8	18.6	12.4	12.8	13.1	9.1	16.8	15.1	4.6	17.2	15.9	46.0	2.1	5.6	2.7	20.1	3.9	18.6	1.8	23.8	16.9	16.6	18.0	4.2	10.5	19.8	19.1	32.7	18.3	59.7	2.5	11.5	7.9	43.7	4.9	1.7	11.8	23.2	10.2	3.5	12.2	2.0	12.2	3.9	10.6	7.5	0.3	1.5	1.0	9.5	118.2	33.5	14.6	7.5	7.7	39.1	51.0	25.8	7.2	2.8	0.0	9.5	11.1	8.4	8.7	16.9	19.2	10.3	5.1	7.5	27.2	22.1
ZFYVE27	"FLJ32919, SPG33"	ENSG00000155256	"Zinc finger FYVE-type containing 27"	Q5T4F4	10	97737121-97760907	"Disease related genes, Human disease related genes, Potential drug targets, Predicted membrane proteins, Transporters"			"Disease variant, Hereditary spastic paraplegia, Neurodegeneration"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA037523, HPA069876"	Approved		Approved	Nucleoplasm,Vesicles,Cytosol		NA	NA			"Cluster 10: Basophils - Unknown function"	"Cluster 32: Brain & Lymphoid tissue - Unknown function"	"Cluster 24: NB-4 - Immune response"	"Cluster 9: Photoreceptor cells - Phototransduction"	"Nucleoplasm, Vesicles"	Cytosol	"HPA037523: AB_10672351, HPA069876: AB_2686218"	"unprognostic (2.21e-1)"	"unprognostic (1.91e-1)"	"prognostic unfavorable (6.91e-4)"	"unprognostic (3.12e-1)"	"unprognostic (3.42e-2)"	"unprognostic (9.76e-2)"	"unprognostic (1.22e-1)"	"unprognostic (2.30e-2)"	"unprognostic (2.48e-2)"	"unprognostic (7.15e-2)"	"unprognostic (2.05e-3)"	"unprognostic (5.24e-2)"	"unprognostic (3.38e-3)"	"prognostic favorable (7.54e-4)"	"unprognostic (4.18e-2)"	"unprognostic (1.26e-2)"	"prognostic favorable (7.80e-4)"	14.4	27.9	33.1	12.9	32.1	23.2	15.8	29.2	35.9	20.6	34.8	25.6	24.8	16.5	22.9	16.5	20.3	12.1	17.8	35.5	33.6	28.3	32.6	17.7	16.1	32.6	31.4	25.9	23.7	19.2	38.3	9.5	33.2	22.0	16.3	28.4	18.9	10.3	12.8	18.2	30.6	8.5	29.1	29.1	19.8	23.0	33.5	12.7	20.4	5.9	13.1	16.8	17.0	32.4	17.7	21.4	12.6	28.1	14.1	9.8	17.2	17.7	18.5	20.3	19.7	19.1	35.9	27.2	19.8	12.8	25.9	38.8	18.4	17.2	10.6	28.3	18.6	12.9	23.1	18.1	18.1	20.9	24.9	16.0	20.4	19.9	15.2	32.4	11.5	22.5	19.6	17.9	15.3	13.8	16.9	39.4	10.3	15.3	16.4	19.2	12.7	13.0	19.5	10.8	10.1	19.7	11.9	9.9	47.2	11.5	21.8	20.5	12.4	10.2	11.9	15.6	34.2	20.6	18.6	14.3	25.3	26.5	11.9	4.8	5.8	9.3	9.6	6.2	8.2	7.1	6.6	7.9	5.4	6.7	7.5	8.3	8.2	6.8	9.2	5.6	9.5	8.3	33.1	32.1	29.2	35.9	35.5	33.6	32.6	31.4	33.2	29.1	33.5	32.4	10.0	3.2	11.4	14.0	22.1	8.2	12.8	11.3	18.8	29.9	11.1	8.9	7.2	14.3	9.7	14.7	58.4	7.4	21.2	33.9	7.9	14.9	5.2	14.3	7.8	11.0	20.3	14.3	33.6	16.0	5.7	10.1	19.4	11.4	14.0	17.3	10.8	10.9	8.2	37.0	35.2	15.6	14.2	8.8	5.7	1.5	9.6	11.0	10.6	16.9	11.2	14.8	15.5	12.5	20.2	13.9	26.1	9.1	13.4	13.8	35.5	8.6	16.6	43.7	19.7	6.7	9.9	8.9	7.6	10.4	5.5	13.5	17.9	10.9	14.7	17.7
ZMPSTE24	"FACE-1, HGPS, PRO1, STE24, Ste24p"	ENSG00000084073	"Zinc metallopeptidase STE24"	O75844	1	40258041-40294180	"Disease related genes, Enzymes, Human disease related genes, Metabolic proteins, Potential drug targets, Predicted membrane proteins, Transporters"		"Hydrolase, Metalloprotease, Protease"	"Disease variant"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell type specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low immune cell specificity"	"Detected in all"			"Low lineage specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006988	Approved					NA	NA		50000	"Cluster 12: Non-specific - Basic cellular processes"	"Cluster 1: Thyroid gland - Transcription"	"Cluster 43: THP-1 - Innate immune response"	"Cluster 10: Non-specific - Unknown function"			"HPA006988: AB_1080659"	"unprognostic (6.32e-2)"	"unprognostic (1.63e-2)"	"unprognostic (3.75e-3)"	"unprognostic (4.63e-2)"	"unprognostic (4.16e-3)"	"unprognostic (1.37e-1)"	"prognostic unfavorable (5.73e-6)"	"unprognostic (1.86e-1)"	"unprognostic (1.17e-1)"	"unprognostic (1.84e-3)"	"unprognostic (4.78e-2)"	"unprognostic (7.96e-2)"	"unprognostic (5.06e-2)"	"unprognostic (3.65e-2)"	"unprognostic (2.65e-1)"	"prognostic unfavorable (6.34e-4)"	"unprognostic (2.71e-2)"	20.5	24.6	16.3	19.9	16.7	5.6	25.5	18.1	22.9	26.2	21.9	28.5	22.2	26.7	27.4	21.7	18.8	25.7	20.6	16.1	18.8	46.0	38.4	21.7	16.8	17.4	17.7	14.3	17.4	53.3	10.2	22.1	18.5	26.3	33.1	10.9	19.6	23.8	16.3	16.3	23.4	32.2	18.7	13.7	21.3	11.0	17.7	15.5	27.5	18.1	23.0	29.4	16.2	18.9	69.3	38.4	35.6	26.1	90.3	71.3	67.0	64.0	60.6	81.7	73.9	35.4	118.8	62.7	41.1	92.1	29.9	71.0	78.4	67.9	97.9	54.4	39.8	59.9	36.0	44.5	45.4	99.3	68.8	45.5	67.4	64.7	28.4	45.4	58.3	27.3	63.0	60.6	80.1	30.2	60.7	28.3	70.0	47.2	42.2	52.2	60.2	77.6	75.2	58.0	38.0	44.6	60.9	155.6	85.9	56.3	55.2	249.1	46.4	68.6	52.5	56.0	78.0	37.1	106.2	49.6	75.6	64.6	79.1	18.9	21.4	14.0	17.6	27.2	22.5	15.0	19.4	19.4	29.4	11.4	16.7	22.9	8.5	29.6	24.3	18.4	24.6	22.7	16.3	16.7	18.1	22.9	16.1	18.8	17.4	17.7	18.5	18.7	17.7	18.9	28.9	38.5	24.1	19.2	20.1	32.0	24.2	41.4	33.0	6.6	35.9	19.0	25.5	54.3	43.0	73.5	0.0	41.4	22.1	44.3	31.3	58.9	3.5	30.7	32.6	31.2	27.6	18.1	16.6	36.9	38.3	36.0	21.9	40.0	21.0	16.6	27.5	64.4	34.0	10.1	13.9	31.0	54.9	33.9	24.5	2.2	28.6	28.6	24.9	11.2	30.5	29.3	19.6	17.6	20.2	44.0	29.3	32.7	31.1	37.7	31.7	42.6	64.2	7.7	0.0	26.8	41.2	7.8	6.4	31.5	27.1	39.0	23.1	28.9	35.6	24.5